id|nct_id|result_group_id|ctgov_group_code|title|period|description|count
334566|NCT03489551|822982|P1|NOT COMPLETED|Overall Study||2
334567|NCT03489551|822982|P1|COMPLETED|Overall Study||15
334568|NCT03489551|822982|P1|STARTED|Overall Study||17
334569|NCT03446690|822988|P2|NOT COMPLETED|Overall Study||0
334570|NCT03446690|822989|P1|NOT COMPLETED|Overall Study||7
334571|NCT03446690|822988|P2|COMPLETED|Overall Study||29
334572|NCT03446690|822989|P1|COMPLETED|Overall Study||26
334573|NCT03446690|822988|P2|STARTED|Overall Study||29
334574|NCT03446690|822989|P1|STARTED|Overall Study||33
334575|NCT03407430|822997|P2|NOT COMPLETED|Second Intervention||0
334576|NCT03407430|822998|P1|NOT COMPLETED|Second Intervention||0
334577|NCT03407430|822997|P2|COMPLETED|Second Intervention||3
334578|NCT03407430|822998|P1|COMPLETED|Second Intervention||4
334579|NCT03407430|822997|P2|STARTED|Second Intervention||3
334580|NCT03407430|822998|P1|STARTED|Second Intervention||4
334581|NCT03407430|822997|P2|NOT COMPLETED|Washout||0
334582|NCT03407430|822998|P1|NOT COMPLETED|Washout||1
334583|NCT03407430|822997|P2|COMPLETED|Washout||3
334584|NCT03407430|822998|P1|COMPLETED|Washout||4
334585|NCT03407430|822997|P2|STARTED|Washout||3
334586|NCT03407430|822998|P1|STARTED|Washout||5
334587|NCT03407430|822997|P2|NOT COMPLETED|First Intervention||0
334588|NCT03407430|822998|P1|NOT COMPLETED|First Intervention||0
334589|NCT03407430|822997|P2|COMPLETED|First Intervention||3
334590|NCT03407430|822998|P1|COMPLETED|First Intervention||5
334591|NCT03407430|822997|P2|STARTED|First Intervention||3
334592|NCT03407430|822998|P1|STARTED|First Intervention||5
334593|NCT03405818|823030|P1|NOT COMPLETED|Overall Study||8
334594|NCT03405818|823030|P1|COMPLETED|Overall Study||47
334595|NCT03405818|823030|P1|STARTED|Overall Study||55
334596|NCT03363633|823071|P1|NOT COMPLETED|Overall Study||12
334597|NCT03363633|823071|P1|COMPLETED|Overall Study|See note in Pre-Assignment Details|0
334598|NCT03363633|823071|P1|STARTED|Overall Study||12
334599|NCT03350724|823081|P2|NOT COMPLETED|Overall Study||0
334600|NCT03350724|823082|P1|NOT COMPLETED|Overall Study||0
334601|NCT03350724|823081|P2|COMPLETED|Overall Study||17
334602|NCT03350724|823082|P1|COMPLETED|Overall Study||17
334603|NCT03350724|823081|P2|STARTED|Overall Study||17
334604|NCT03350724|823082|P1|STARTED|Overall Study||17
334605|NCT03349099|823138|P2|NOT COMPLETED|Overall Study||4
334606|NCT03349099|823139|P1|NOT COMPLETED|Overall Study||4
334607|NCT03349099|823138|P2|COMPLETED|Overall Study||43
334608|NCT03349099|823139|P1|COMPLETED|Overall Study||44
334609|NCT03349099|823138|P2|STARTED|Overall Study||47
334610|NCT03349099|823139|P1|STARTED|Overall Study||48
334611|NCT03338556|823153|P4|NOT COMPLETED|Overall Study||2
334612|NCT03338556|823154|P3|NOT COMPLETED|Overall Study||2
334613|NCT03338556|823155|P2|NOT COMPLETED|Overall Study||4
334614|NCT03338556|823156|P1|NOT COMPLETED|Overall Study||2
334615|NCT03338556|823153|P4|COMPLETED|Overall Study||24
334616|NCT03338556|823154|P3|COMPLETED|Overall Study||22
334617|NCT03338556|823155|P2|COMPLETED|Overall Study||23
334618|NCT03338556|823156|P1|COMPLETED|Overall Study||23
334619|NCT03338556|823153|P4|STARTED|Overall Study||26
334620|NCT03338556|823154|P3|STARTED|Overall Study||24
334621|NCT03338556|823155|P2|STARTED|Overall Study||27
334622|NCT03338556|823156|P1|STARTED|Overall Study||25
334629|NCT03294629|823199|P2|NOT COMPLETED|Second Intervention (2 Weeks)||2
334630|NCT03294629|823200|P1|NOT COMPLETED|Second Intervention (2 Weeks)||2
334631|NCT03294629|823199|P2|COMPLETED|Second Intervention (2 Weeks)||13
334632|NCT03294629|823200|P1|COMPLETED|Second Intervention (2 Weeks)||12
334633|NCT03294629|823199|P2|STARTED|Second Intervention (2 Weeks)||15
334634|NCT03294629|823200|P1|STARTED|Second Intervention (2 Weeks)||14
334635|NCT03294629|823199|P2|NOT COMPLETED|First Intervention (2 Weeks)||4
334636|NCT03294629|823200|P1|NOT COMPLETED|First Intervention (2 Weeks)||2
334637|NCT03294629|823199|P2|COMPLETED|First Intervention (2 Weeks)||15
334638|NCT03294629|823200|P1|COMPLETED|First Intervention (2 Weeks)||14
334639|NCT03294629|823199|P2|STARTED|First Intervention (2 Weeks)||19
334640|NCT03294629|823200|P1|STARTED|First Intervention (2 Weeks)||16
334641|NCT03292692|823230|P2|NOT COMPLETED|Overall Study||38
334642|NCT03292692|823231|P1|NOT COMPLETED|Overall Study||38
334643|NCT03292692|823230|P2|COMPLETED|Overall Study||260
334644|NCT03292692|823231|P1|COMPLETED|Overall Study||264
334645|NCT03292692|823230|P2|STARTED|Overall Study||298
334646|NCT03292692|823231|P1|STARTED|Overall Study||302
334647|NCT03274453|823247|P4|NOT COMPLETED|Overall Study||4
334648|NCT03274453|823248|P3|NOT COMPLETED|Overall Study||4
334649|NCT03274453|823249|P2|NOT COMPLETED|Overall Study||6
334650|NCT03274453|823250|P1|NOT COMPLETED|Overall Study||4
334651|NCT03274453|823247|P4|COMPLETED|Overall Study||25
334652|NCT03274453|823248|P3|COMPLETED|Overall Study||28
334653|NCT03274453|823249|P2|COMPLETED|Overall Study||24
334654|NCT03274453|823250|P1|COMPLETED|Overall Study||34
334655|NCT03274453|823247|P4|STARTED|Overall Study||29
334656|NCT03274453|823248|P3|STARTED|Overall Study||32
334657|NCT03274453|823249|P2|STARTED|Overall Study||30
334658|NCT03274453|823250|P1|STARTED|Overall Study||38
334659|NCT03271424|823263|P3|NOT COMPLETED|April-May 2016||0
334660|NCT03271424|823264|P2|NOT COMPLETED|April-May 2016||0
334661|NCT03271424|823265|P1|NOT COMPLETED|April-May 2016||0
334662|NCT03271424|823263|P3|COMPLETED|April-May 2016||40
334663|NCT03271424|823264|P2|COMPLETED|April-May 2016||0
334664|NCT03271424|823265|P1|COMPLETED|April-May 2016||0
334665|NCT03271424|823263|P3|STARTED|April-May 2016||40
334666|NCT03271424|823264|P2|STARTED|April-May 2016||0
334667|NCT03271424|823265|P1|STARTED|April-May 2016||0
334668|NCT03271424|823263|P3|NOT COMPLETED|December 2015||0
334669|NCT03271424|823264|P2|NOT COMPLETED|December 2015||0
334670|NCT03271424|823265|P1|NOT COMPLETED|December 2015||0
334671|NCT03271424|823263|P3|COMPLETED|December 2015||0
334672|NCT03271424|823264|P2|COMPLETED|December 2015||35
334673|NCT03271424|823265|P1|COMPLETED|December 2015||0
334674|NCT03271424|823263|P3|STARTED|December 2015||0
334675|NCT03271424|823264|P2|STARTED|December 2015||35
334676|NCT03271424|823265|P1|STARTED|December 2015||0
334677|NCT03271424|823263|P3|NOT COMPLETED|November 2015||0
334678|NCT03271424|823264|P2|NOT COMPLETED|November 2015||0
334679|NCT03271424|823265|P1|NOT COMPLETED|November 2015||0
334680|NCT03271424|823263|P3|COMPLETED|November 2015||0
334681|NCT03271424|823264|P2|COMPLETED|November 2015||0
334682|NCT03271424|823265|P1|COMPLETED|November 2015||20
334683|NCT03271424|823263|P3|STARTED|November 2015||0
334684|NCT03271424|823264|P2|STARTED|November 2015||0
334685|NCT03271424|823265|P1|STARTED|November 2015||20
334686|NCT03256552|823275|P1|NOT COMPLETED|Overall Study||5
334687|NCT03256552|823275|P1|COMPLETED|Overall Study||61
334688|NCT03256552|823275|P1|Placebo MDI|Overall Study||65
334689|NCT03256552|823275|P1|GP MDI 7.2 µg|Overall Study||62
334690|NCT03256552|823275|P1|GP MDI 14.4 µg|Overall Study||63
334691|NCT03256552|823275|P1|GP MDI 28.8 µg|Overall Study||61
334692|NCT03256552|823275|P1|STARTED|Overall Study||66
334693|NCT03255733|823297|P1|NOT COMPLETED|Overall Study||4
334694|NCT03255733|823297|P1|COMPLETED|Overall Study||25
334695|NCT03255733|823297|P1|STARTED|Overall Study||29
334696|NCT03255655|823304|P2|NOT COMPLETED|Overall Study||4
334697|NCT03255655|823305|P1|NOT COMPLETED|Overall Study||7
334698|NCT03255655|823304|P2|COMPLETED|Overall Study||8
334699|NCT03255655|823305|P1|COMPLETED|Overall Study||22
334700|NCT03255655|823304|P2|STARTED|Overall Study||12
334701|NCT03255655|823305|P1|STARTED|Overall Study||29
334702|NCT03254602|823313|P1|NOT COMPLETED|Overall Study||4
334703|NCT03254602|823313|P1|COMPLETED|Overall Study||29
334704|NCT03254602|823313|P1|STARTED|Overall Study||33
334705|NCT03247985|823321|P2|NOT COMPLETED|Overall Study||0
334706|NCT03247985|823322|P1|NOT COMPLETED|Overall Study||0
334707|NCT03247985|823321|P2|COMPLETED|Overall Study||19
334708|NCT03247985|823322|P1|COMPLETED|Overall Study||19
334709|NCT03247985|823321|P2|STARTED|Overall Study||19
334710|NCT03247985|823322|P1|STARTED|Overall Study||19
334711|NCT03238924|823338|P2|NOT COMPLETED|Overall Study||2
334712|NCT03238924|823339|P1|NOT COMPLETED|Overall Study||2
334713|NCT03238924|823338|P2|COMPLETED|Overall Study||7
334714|NCT03238924|823339|P1|COMPLETED|Overall Study||6
334715|NCT03238924|823338|P2|STARTED|Overall Study||9
334716|NCT03238924|823339|P1|STARTED|Overall Study||8
334717|NCT03238001|823349|P1|NOT COMPLETED|Visit 2 (Secondary Endpoint Cohort)||29
334718|NCT03238001|823349|P1|COMPLETED|Visit 2 (Secondary Endpoint Cohort)||403
334719|NCT03238001|823349|P1|STARTED|Visit 2 (Secondary Endpoint Cohort)||432
334720|NCT03238001|823349|P1|NOT COMPLETED|Visit 1 (Primary Endpoint Cohort)||4
334721|NCT03238001|823349|P1|COMPLETED|Visit 1 (Primary Endpoint Cohort)||432
334722|NCT03238001|823349|P1|STARTED|Visit 1 (Primary Endpoint Cohort)||436
334723|NCT03235817|823375|P3|NOT COMPLETED|Overall Study||2
334724|NCT03235817|823376|P2|NOT COMPLETED|Overall Study||1
334725|NCT03235817|823377|P1|NOT COMPLETED|Overall Study||3
334726|NCT03235817|823375|P3|COMPLETED|Overall Study||11
334727|NCT03235817|823376|P2|COMPLETED|Overall Study||12
334728|NCT03235817|823377|P1|COMPLETED|Overall Study||10
334729|NCT03235817|823375|P3|STARTED|Overall Study||13
334730|NCT03235817|823376|P2|STARTED|Overall Study||13
334731|NCT03235817|823377|P1|STARTED|Overall Study||13
334732|NCT03231371|823394|P1|NOT COMPLETED|Overall Study||13
334733|NCT03231371|823394|P1|COMPLETED|Overall Study||9
334734|NCT03231371|823394|P1|Optional and Age Limited (12 Yrs+) MRI|Overall Study||9
334735|NCT03231371|823394|P1|STARTED|Overall Study||22
334736|NCT03225001|823399|P1|NOT COMPLETED|Overall Study||9
334737|NCT03225001|823399|P1|COMPLETED|Overall Study||188
334738|NCT03225001|823399|P1|Valve-Implanted|Overall Study||195
334739|NCT03225001|823399|P1|STARTED|Overall Study||197
334740|NCT03218163|823404|P1|NOT COMPLETED|Overall Study||1
334741|NCT03218163|823404|P1|COMPLETED|Overall Study||0
334742|NCT03218163|823404|P1|STARTED|Overall Study||1
334743|NCT03217968|823408|P1|NOT COMPLETED|Overall Study||12
334744|NCT03217968|823408|P1|COMPLETED|Overall Study||48
334745|NCT03217968|823408|P1|STARTED|Overall Study||60
334746|NCT03191552|823420|P3|NOT COMPLETED|Overall Study||0
334747|NCT03191552|823421|P2|NOT COMPLETED|Overall Study||1
334748|NCT03191552|823422|P1|NOT COMPLETED|Overall Study||1
334749|NCT03191552|823420|P3|COMPLETED|Overall Study||8
334750|NCT03191552|823421|P2|COMPLETED|Overall Study||8
334751|NCT03191552|823422|P1|COMPLETED|Overall Study||8
334752|NCT03191552|823420|P3|STARTED|Overall Study||8
334753|NCT03191552|823421|P2|STARTED|Overall Study||9
334754|NCT03191552|823422|P1|STARTED|Overall Study||9
334755|NCT03182582|823473|P2|NOT COMPLETED|Treatment 2||0
334756|NCT03182582|823474|P1|NOT COMPLETED|Treatment 2||0
334757|NCT03182582|823473|P2|COMPLETED|Treatment 2||10
334758|NCT03182582|823474|P1|COMPLETED|Treatment 2||12
334759|NCT03182582|823473|P2|STARTED|Treatment 2||10
334760|NCT03182582|823474|P1|STARTED|Treatment 2||12
334761|NCT03182582|823473|P2|NOT COMPLETED|Treatment 1||0
334762|NCT03182582|823474|P1|NOT COMPLETED|Treatment 1||0
334763|NCT03182582|823473|P2|COMPLETED|Treatment 1||10
334764|NCT03182582|823474|P1|COMPLETED|Treatment 1||12
334765|NCT03182582|823473|P2|STARTED|Treatment 1||10
334766|NCT03182582|823474|P1|STARTED|Treatment 1||12
334767|NCT03180138|823492|P3|NOT COMPLETED|Overall Study||24
334768|NCT03180138|823493|P2|NOT COMPLETED|Overall Study||13
334769|NCT03180138|823494|P1|NOT COMPLETED|Overall Study||22
334770|NCT03180138|823492|P3|COMPLETED|Overall Study||179
334771|NCT03180138|823493|P2|COMPLETED|Overall Study||188
334772|NCT03180138|823494|P1|COMPLETED|Overall Study||182
334773|NCT03180138|823492|P3|STARTED|Overall Study||203
334774|NCT03180138|823493|P2|STARTED|Overall Study||201
334775|NCT03180138|823494|P1|STARTED|Overall Study||204
334776|NCT03163134|823507|P2|NOT COMPLETED|Overall Study||0
334777|NCT03163134|823508|P1|NOT COMPLETED|Overall Study||0
334778|NCT03163134|823507|P2|COMPLETED|Overall Study||85
334779|NCT03163134|823508|P1|COMPLETED|Overall Study||85
334780|NCT03163134|823507|P2|STARTED|Overall Study||85
334781|NCT03163134|823508|P1|STARTED|Overall Study||85
334782|NCT03159143|823516|P1|NOT COMPLETED|Overall Study||0
334783|NCT03159143|823516|P1|COMPLETED|Overall Study||22
334784|NCT03159143|823516|P1|STARTED|Overall Study||22
334785|NCT03157232|823523|P1|NOT COMPLETED|Overall Study||0
334786|NCT03157232|823523|P1|COMPLETED|Overall Study||18
334787|NCT03157232|823523|P1|STARTED|Overall Study||18
334788|NCT03151226|823527|P1|NOT COMPLETED|Overall Study||3
334789|NCT03151226|823527|P1|COMPLETED|Overall Study||0
334790|NCT03151226|823527|P1|STARTED|Overall Study||3
334809|NCT03134326|823551|P1|NOT COMPLETED|Overall Study||0
334810|NCT03134326|823551|P1|COMPLETED|Overall Study||21
334811|NCT03134326|823551|P1|STARTED|Overall Study||21
334812|NCT03134313|823555|P1|NOT COMPLETED|Overall Study||0
334813|NCT03134313|823555|P1|COMPLETED|Overall Study||25
334814|NCT03134313|823555|P1|STARTED|Overall Study||25
334815|NCT03134248|823559|P6|NOT COMPLETED|Week 3||0
334816|NCT03134248|823560|P5|NOT COMPLETED|Week 3||0
334817|NCT03134248|823561|P4|NOT COMPLETED|Week 3||0
334818|NCT03134248|823562|P3|NOT COMPLETED|Week 3||0
334819|NCT03134248|823563|P2|NOT COMPLETED|Week 3||0
334820|NCT03134248|823564|P1|NOT COMPLETED|Week 3||0
334821|NCT03134248|823559|P6|COMPLETED|Week 3||9
334822|NCT03134248|823560|P5|COMPLETED|Week 3||9
334823|NCT03134248|823561|P4|COMPLETED|Week 3||7
334824|NCT03134248|823562|P3|COMPLETED|Week 3||9
334825|NCT03134248|823563|P2|COMPLETED|Week 3||8
334826|NCT03134248|823564|P1|COMPLETED|Week 3||7
334827|NCT03134248|823559|P6|STARTED|Week 3||9
334828|NCT03134248|823560|P5|STARTED|Week 3||9
334829|NCT03134248|823561|P4|STARTED|Week 3||7
334830|NCT03134248|823562|P3|STARTED|Week 3||9
334831|NCT03134248|823563|P2|STARTED|Week 3||8
334832|NCT03134248|823564|P1|STARTED|Week 3||7
334833|NCT03134248|823559|P6|NOT COMPLETED|Week 2||0
334834|NCT03134248|823560|P5|NOT COMPLETED|Week 2||0
334835|NCT03134248|823561|P4|NOT COMPLETED|Week 2||0
334836|NCT03134248|823562|P3|NOT COMPLETED|Week 2||0
334837|NCT03134248|823563|P2|NOT COMPLETED|Week 2||0
334838|NCT03134248|823564|P1|NOT COMPLETED|Week 2||0
334839|NCT03134248|823559|P6|COMPLETED|Week 2||9
334840|NCT03134248|823560|P5|COMPLETED|Week 2||9
334841|NCT03134248|823561|P4|COMPLETED|Week 2||7
334842|NCT03134248|823562|P3|COMPLETED|Week 2||9
334843|NCT03134248|823563|P2|COMPLETED|Week 2||8
334844|NCT03134248|823564|P1|COMPLETED|Week 2||7
334845|NCT03134248|823559|P6|STARTED|Week 2||9
334846|NCT03134248|823560|P5|STARTED|Week 2||9
334847|NCT03134248|823561|P4|STARTED|Week 2||7
334848|NCT03134248|823562|P3|STARTED|Week 2||9
334849|NCT03134248|823563|P2|STARTED|Week 2||8
334850|NCT03134248|823564|P1|STARTED|Week 2||7
334851|NCT03134248|823559|P6|NOT COMPLETED|Week 1||0
334852|NCT03134248|823560|P5|NOT COMPLETED|Week 1||0
334853|NCT03134248|823561|P4|NOT COMPLETED|Week 1||0
334854|NCT03134248|823562|P3|NOT COMPLETED|Week 1||0
334855|NCT03134248|823563|P2|NOT COMPLETED|Week 1||0
334856|NCT03134248|823564|P1|NOT COMPLETED|Week 1||0
334857|NCT03134248|823559|P6|COMPLETED|Week 1||9
334858|NCT03134248|823560|P5|COMPLETED|Week 1||9
334859|NCT03134248|823561|P4|COMPLETED|Week 1||7
334860|NCT03134248|823562|P3|COMPLETED|Week 1||9
334861|NCT03134248|823563|P2|COMPLETED|Week 1||8
334862|NCT03134248|823564|P1|COMPLETED|Week 1||7
334863|NCT03134248|823559|P6|STARTED|Week 1||9
334864|NCT03134248|823560|P5|STARTED|Week 1||9
334865|NCT03134248|823561|P4|STARTED|Week 1||7
334866|NCT03134248|823562|P3|STARTED|Week 1||9
334867|NCT03134248|823563|P2|STARTED|Week 1||8
334868|NCT03134248|823564|P1|STARTED|Week 1||7
334869|NCT03128307|823580|P1|NOT COMPLETED|Overall Study||34
334870|NCT03128307|823580|P1|COMPLETED|Overall Study||570
334871|NCT03128307|823580|P1|STARTED|Overall Study||604
334872|NCT03125031|823585|P2|NOT COMPLETED|Overall Study||0
334873|NCT03125031|823586|P1|NOT COMPLETED|Overall Study||0
334874|NCT03125031|823585|P2|COMPLETED|Overall Study||44
334875|NCT03125031|823586|P1|COMPLETED|Overall Study||44
334876|NCT03125031|823585|P2|STARTED|Overall Study||44
334877|NCT03125031|823586|P1|STARTED|Overall Study||44
334878|NCT03125018|823591|P1|NOT COMPLETED|Overall Study||0
334879|NCT03125018|823591|P1|COMPLETED|Overall Study||13
334880|NCT03125018|823591|P1|STARTED|Overall Study||13
334881|NCT03125005|823595|P1|NOT COMPLETED|Overall Study||0
334882|NCT03125005|823595|P1|COMPLETED|Overall Study||51
334883|NCT03125005|823595|P1|STARTED|Overall Study||51
334884|NCT03124979|823599|P1|NOT COMPLETED|Overall Study||0
334885|NCT03124979|823599|P1|COMPLETED|Overall Study||13
334886|NCT03124979|823599|P1|STARTED|Overall Study||13
334887|NCT03124966|823603|P1|NOT COMPLETED|Overall Study||0
334888|NCT03124966|823603|P1|COMPLETED|Overall Study||118
334889|NCT03124966|823603|P1|STARTED|Overall Study||118
334890|NCT03124927|823607|P1|NOT COMPLETED|Overall Study||0
334891|NCT03124927|823607|P1|COMPLETED|Overall Study||25
334892|NCT03124927|823607|P1|STARTED|Overall Study||25
334893|NCT03124901|823611|P1|NOT COMPLETED|Overall Study||0
334894|NCT03124901|823611|P1|COMPLETED|Overall Study||147
334895|NCT03124901|823611|P1|STARTED|Overall Study||147
334896|NCT03124836|823615|P1|NOT COMPLETED|Overall Study||0
334897|NCT03124836|823615|P1|COMPLETED|Overall Study||28
334898|NCT03124836|823615|P1|STARTED|Overall Study||28
334899|NCT03124823|823619|P1|NOT COMPLETED|Overall Study||0
334900|NCT03124823|823619|P1|COMPLETED|Overall Study||11
334901|NCT03124823|823619|P1|STARTED|Overall Study||11
334902|NCT03124797|823623|P1|NOT COMPLETED|Overall Study||0
334903|NCT03124797|823623|P1|COMPLETED|Overall Study||18
334904|NCT03124797|823623|P1|STARTED|Overall Study||18
334905|NCT03124784|823627|P1|NOT COMPLETED|Overall Study||2
334906|NCT03124784|823627|P1|COMPLETED|Overall Study||25
334907|NCT03124784|823627|P1|STARTED|Overall Study||27
334908|NCT03124771|823631|P1|NOT COMPLETED|Overall Study||0
334909|NCT03124771|823631|P1|COMPLETED|Overall Study||132
334910|NCT03124771|823631|P1|STARTED|Overall Study||132
334911|NCT03124758|823635|P1|NOT COMPLETED|Overall Study||0
334912|NCT03124758|823635|P1|COMPLETED|Overall Study||354
334913|NCT03124758|823635|P1|STARTED|Overall Study||354
334914|NCT03124693|823639|P1|NOT COMPLETED|Overall Study||0
334915|NCT03124693|823639|P1|COMPLETED|Overall Study||90
334916|NCT03124693|823639|P1|STARTED|Overall Study||90
334917|NCT03124199|823643|P1|NOT COMPLETED|Overall Study||4
334918|NCT03124199|823643|P1|COMPLETED|Overall Study||36
334919|NCT03124199|823643|P1|STARTED|Overall Study||40
334920|NCT03123848|823649|P1|NOT COMPLETED|Overall Study||0
334921|NCT03123848|823649|P1|COMPLETED|Overall Study||8
334922|NCT03123848|823649|P1|STARTED|Overall Study||8
334923|NCT03123354|823671|P1|NOT COMPLETED|Overall Study||6
334924|NCT03123354|823671|P1|COMPLETED|Overall Study||38
334925|NCT03123354|823671|P1|STARTED|Overall Study||44
334926|NCT03119831|823678|P3|NOT COMPLETED|Overall Study||0
334927|NCT03119831|823679|P2|NOT COMPLETED|Overall Study||0
334928|NCT03119831|823680|P1|NOT COMPLETED|Overall Study||0
334929|NCT03119831|823678|P3|COMPLETED|Overall Study||14
334930|NCT03119831|823679|P2|COMPLETED|Overall Study||14
334931|NCT03119831|823680|P1|COMPLETED|Overall Study||14
334932|NCT03119831|823678|P3|STARTED|Overall Study||14
334933|NCT03119831|823679|P2|STARTED|Overall Study||14
334934|NCT03119831|823680|P1|STARTED|Overall Study||14
334935|NCT03115853|823697|P1|NOT COMPLETED|Overall Study||0
334936|NCT03115853|823697|P1|COMPLETED|Overall Study||31
334937|NCT03115853|823697|P1|STARTED|Overall Study||31
334938|NCT03115177|823717|P2|NOT COMPLETED|Overall Study||0
334939|NCT03115177|823718|P1|NOT COMPLETED|Overall Study||0
334940|NCT03115177|823717|P2|COMPLETED|Overall Study||29
334941|NCT03115177|823718|P1|COMPLETED|Overall Study||27
334942|NCT03115177|823717|P2|STARTED|Overall Study||29
334943|NCT03115177|823718|P1|STARTED|Overall Study||27
334944|NCT03114995|823727|P3|NOT COMPLETED|Overall Study||0
334945|NCT03114995|823728|P2|NOT COMPLETED|Overall Study||1
334946|NCT03114995|823729|P1|NOT COMPLETED|Overall Study||1
334947|NCT03114995|823727|P3|COMPLETED|Overall Study||78
334948|NCT03114995|823728|P2|COMPLETED|Overall Study||29
334949|NCT03114995|823729|P1|COMPLETED|Overall Study||29
334950|NCT03114995|823727|P3|STARTED|Overall Study||78
334951|NCT03114995|823728|P2|STARTED|Overall Study||30
334952|NCT03114995|823729|P1|STARTED|Overall Study||30
334953|NCT03110900|823745|P2|NOT COMPLETED|Overall Study||1
334954|NCT03110900|823746|P1|NOT COMPLETED|Overall Study||1
334955|NCT03110900|823745|P2|COMPLETED|Overall Study||0
334956|NCT03110900|823746|P1|COMPLETED|Overall Study||0
334957|NCT03110900|823745|P2|STARTED|Overall Study||1
334958|NCT03110900|823746|P1|STARTED|Overall Study||1
334959|NCT03109769|823754|P2|NOT COMPLETED|Overall Study||0
334960|NCT03109769|823755|P1|NOT COMPLETED|Overall Study||0
334961|NCT03109769|823754|P2|COMPLETED|Overall Study||22
334962|NCT03109769|823755|P1|COMPLETED|Overall Study||22
334963|NCT03109769|823754|P2|STARTED|Overall Study||22
334964|NCT03109769|823755|P1|STARTED|Overall Study||22
334965|NCT03106870|823765|P2|NOT COMPLETED|Overall Study||0
334966|NCT03106870|823766|P1|NOT COMPLETED|Overall Study||0
334967|NCT03106870|823765|P2|COMPLETED|Overall Study||31
334968|NCT03106870|823766|P1|COMPLETED|Overall Study||31
334969|NCT03106870|823765|P2|STARTED|Overall Study||31
334970|NCT03106870|823766|P1|STARTED|Overall Study||31
334971|NCT03106337|823776|P1|NOT COMPLETED|Overall Study||0
334972|NCT03106337|823776|P1|COMPLETED|Overall Study||35
334973|NCT03106337|823776|P1|STARTED|Overall Study||35
334974|NCT03105518|823781|P1|NOT COMPLETED|Overall Study||0
334975|NCT03105518|823781|P1|COMPLETED|Overall Study||100
334976|NCT03105518|823781|P1|STARTED|Overall Study||100
334980|NCT03098966|823793|P1|NOT COMPLETED|Overall Study||0
334981|NCT03098966|823793|P1|COMPLETED|Overall Study||368
334982|NCT03098966|823793|P1|STARTED|Overall Study||368
334983|NCT03091751|823799|P1|NOT COMPLETED|Overall Study||0
334984|NCT03091751|823799|P1|COMPLETED|Overall Study||22
334985|NCT03091751|823799|P1|STARTED|Overall Study||22
334986|NCT03090958|823807|P1|NOT COMPLETED|Overall Study||0
334987|NCT03090958|823807|P1|COMPLETED|Overall Study||20
334988|NCT03090958|823807|P1|STARTED|Overall Study||20
334989|NCT03083379|823821|P2|NOT COMPLETED|Overall Study||0
334990|NCT03083379|823822|P1|NOT COMPLETED|Overall Study||0
334991|NCT03083379|823821|P2|COMPLETED|Overall Study||15
334992|NCT03083379|823822|P1|COMPLETED|Overall Study||15
334993|NCT03083379|823821|P2|STARTED|Overall Study||15
334994|NCT03083379|823822|P1|STARTED|Overall Study||15
334995|NCT03073798|823828|P1|NOT COMPLETED|Overall Study||2
334996|NCT03073798|823828|P1|COMPLETED|Overall Study||10
334997|NCT03073798|823828|P1|STARTED|Overall Study||12
334998|NCT03072719|823841|P2|NOT COMPLETED|Overall Study||1
334999|NCT03072719|823842|P1|NOT COMPLETED|Overall Study||1
335000|NCT03072719|823841|P2|COMPLETED|Overall Study||59
335001|NCT03072719|823842|P1|COMPLETED|Overall Study||59
335002|NCT03072719|823841|P2|STARTED|Overall Study||60
335003|NCT03072719|823842|P1|STARTED|Overall Study||60
335004|NCT03070730|823855|P3|NOT COMPLETED|Overall Study||0
335005|NCT03070730|823856|P2|NOT COMPLETED|Overall Study||0
335006|NCT03070730|823857|P1|NOT COMPLETED|Overall Study||0
335007|NCT03070730|823855|P3|COMPLETED|Overall Study||0
335008|NCT03070730|823856|P2|COMPLETED|Overall Study||0
335009|NCT03070730|823857|P1|COMPLETED|Overall Study||0
335010|NCT03070730|823855|P3|STARTED|Overall Study||0
335011|NCT03070730|823856|P2|STARTED|Overall Study||0
335012|NCT03070730|823857|P1|STARTED|Overall Study||0
335013|NCT03069313|823988|P1|NOT COMPLETED|Overall Study||5
335014|NCT03069313|823988|P1|COMPLETED|Overall Study||36
335015|NCT03069313|823988|P1|STARTED|Overall Study||41
335016|NCT03065933|823995|P1|NOT COMPLETED|Overall Study||5
335017|NCT03065933|823995|P1|COMPLETED|Overall Study||0
335018|NCT03065933|823995|P1|STARTED|Overall Study||5
335019|NCT03061513|824001|P2|NOT COMPLETED|Overall Study||1
335020|NCT03061513|824002|P1|NOT COMPLETED|Overall Study||0
335021|NCT03061513|824001|P2|COMPLETED|Overall Study||4
335022|NCT03061513|824002|P1|COMPLETED|Overall Study||6
335023|NCT03061513|824001|P2|STARTED|Overall Study||5
335024|NCT03061513|824002|P1|STARTED|Overall Study||6
335025|NCT03057704|824012|P2|NOT COMPLETED|Overall Study||0
335026|NCT03057704|824013|P1|NOT COMPLETED|Overall Study||0
335027|NCT03057704|824012|P2|COMPLETED|Overall Study||25
335028|NCT03057704|824013|P1|COMPLETED|Overall Study||25
335029|NCT03057704|824012|P2|STARTED|Overall Study||25
335030|NCT03057704|824013|P1|STARTED|Overall Study||25
335031|NCT03055221|824023|P1|NOT COMPLETED|Overall Study||16
335032|NCT03055221|824023|P1|COMPLETED|Overall Study||0
335033|NCT03055221|824023|P1|STARTED|Overall Study||16
335034|NCT03054857|824030|P2|NOT COMPLETED|Overall Study||0
335035|NCT03054857|824031|P1|NOT COMPLETED|Overall Study||1
335036|NCT03054857|824030|P2|COMPLETED|Overall Study||50
335037|NCT03054857|824031|P1|COMPLETED|Overall Study||49
335038|NCT03054857|824030|P2|STARTED|Overall Study||50
335039|NCT03054857|824031|P1|STARTED|Overall Study||50
335040|NCT03054103|824048|P3|NOT COMPLETED|Overall Study||0
335041|NCT03054103|824049|P2|NOT COMPLETED|Overall Study||0
335042|NCT03054103|824050|P1|NOT COMPLETED|Overall Study||0
335043|NCT03054103|824048|P3|COMPLETED|Overall Study||35
335044|NCT03054103|824049|P2|COMPLETED|Overall Study||29
335045|NCT03054103|824050|P1|COMPLETED|Overall Study||41
335046|NCT03054103|824048|P3|STARTED|Overall Study||35
335047|NCT03054103|824049|P2|STARTED|Overall Study||29
335048|NCT03054103|824050|P1|STARTED|Overall Study||41
335049|NCT03054077|824069|P2|NOT COMPLETED|Overall Study||0
335050|NCT03054077|824070|P1|NOT COMPLETED|Overall Study||0
335051|NCT03054077|824069|P2|COMPLETED|Overall Study||12
335052|NCT03054077|824070|P1|COMPLETED|Overall Study||12
335053|NCT03054077|824069|P2|STARTED|Overall Study||12
335054|NCT03054077|824070|P1|STARTED|Overall Study||12
335055|NCT03052530|824076|P1|NOT COMPLETED|Overall Study||0
335056|NCT03052530|824076|P1|COMPLETED|Overall Study||61
335057|NCT03052530|824076|P1|STARTED|Overall Study||61
335058|NCT03050775|824085|P2|NOT COMPLETED|Overall Study||0
335059|NCT03050775|824086|P1|NOT COMPLETED|Overall Study||0
335060|NCT03050775|824085|P2|COMPLETED|Overall Study||35
335061|NCT03050775|824086|P1|COMPLETED|Overall Study||35
335062|NCT03050775|824085|P2|STARTED|Overall Study||35
335063|NCT03050775|824086|P1|STARTED|Overall Study||35
335073|NCT03050294|824124|P4|NOT COMPLETED|Overall Study||0
335074|NCT03050294|824125|P3|NOT COMPLETED|Overall Study||0
335075|NCT03050294|824126|P2|NOT COMPLETED|Overall Study||0
335076|NCT03050294|824127|P1|NOT COMPLETED|Overall Study||0
335077|NCT03050294|824124|P4|COMPLETED|Overall Study||6
335078|NCT03050294|824125|P3|COMPLETED|Overall Study||6
335079|NCT03050294|824126|P2|COMPLETED|Overall Study||6
335080|NCT03050294|824127|P1|COMPLETED|Overall Study||6
335081|NCT03050294|824124|P4|STARTED|Overall Study||6
335082|NCT03050294|824125|P3|STARTED|Overall Study||6
335083|NCT03050294|824126|P2|STARTED|Overall Study||6
335084|NCT03050294|824127|P1|STARTED|Overall Study||6
335085|NCT03048383|824152|P3|NOT COMPLETED|Overall Study||12
335086|NCT03048383|824153|P2|NOT COMPLETED|Overall Study||8
335087|NCT03048383|824154|P1|NOT COMPLETED|Overall Study||13
335088|NCT03048383|824152|P3|COMPLETED|Overall Study||10
335089|NCT03048383|824153|P2|COMPLETED|Overall Study||13
335090|NCT03048383|824154|P1|COMPLETED|Overall Study||15
335091|NCT03048383|824152|P3|STARTED|Overall Study||22
335092|NCT03048383|824153|P2|STARTED|Overall Study||21
335093|NCT03048383|824154|P1|STARTED|Overall Study||28
335094|NCT03048006|824165|P1|NOT COMPLETED|Overall Study||0
335095|NCT03048006|824165|P1|COMPLETED|Overall Study||44456
335096|NCT03048006|824165|P1|STARTED|Overall Study||44456
335097|NCT03047447|824174|P3|NOT COMPLETED|Overall Study||0
335098|NCT03047447|824175|P2|NOT COMPLETED|Overall Study||0
335099|NCT03047447|824176|P1|NOT COMPLETED|Overall Study||0
335100|NCT03047447|824174|P3|COMPLETED|Overall Study||10
335101|NCT03047447|824175|P2|COMPLETED|Overall Study||10
335102|NCT03047447|824176|P1|COMPLETED|Overall Study||10
335103|NCT03047447|824174|P3|STARTED|Overall Study||10
335104|NCT03047447|824175|P2|STARTED|Overall Study||10
335105|NCT03047447|824176|P1|STARTED|Overall Study||10
335106|NCT03046225|824198|P2|NOT COMPLETED|Overall Study||0
335107|NCT03046225|824199|P1|NOT COMPLETED|Overall Study||0
335108|NCT03046225|824198|P2|COMPLETED|Overall Study||13
335109|NCT03046225|824199|P1|COMPLETED|Overall Study||13
335110|NCT03046225|824198|P2|STARTED|Overall Study||13
335111|NCT03046225|824199|P1|STARTED|Overall Study||13
335112|NCT03046212|824211|P2|NOT COMPLETED|Overall Study||0
335113|NCT03046212|824212|P1|NOT COMPLETED|Overall Study||0
335114|NCT03046212|824211|P2|COMPLETED|Overall Study||15
335115|NCT03046212|824212|P1|COMPLETED|Overall Study||15
335116|NCT03046212|824211|P2|STARTED|Overall Study||15
335117|NCT03046212|824212|P1|STARTED|Overall Study||15
335118|NCT03044431|824222|P1|NOT COMPLETED|Overall Study||59
335119|NCT03044431|824222|P1|COMPLETED|Overall Study||148
335120|NCT03044431|824222|P1|STARTED|Overall Study||207
335121|NCT03043534|824234|P2|NOT COMPLETED|Overall Study||0
335122|NCT03043534|824235|P1|NOT COMPLETED|Overall Study||0
335123|NCT03043534|824234|P2|COMPLETED|Overall Study||14
335124|NCT03043534|824235|P1|COMPLETED|Overall Study||15
335125|NCT03043534|824234|P2|STARTED|Overall Study||14
335126|NCT03043534|824235|P1|STARTED|Overall Study||15
335127|NCT03041298|824243|P1|NOT COMPLETED|Overall Study||0
335128|NCT03041298|824243|P1|COMPLETED|Overall Study||1537
335129|NCT03041298|824243|P1|STARTED|Overall Study||1537
335130|NCT03039543|824253|P2|NOT COMPLETED|Overall Study||3
335131|NCT03039543|824254|P1|NOT COMPLETED|Overall Study||1
335132|NCT03039543|824253|P2|COMPLETED|Overall Study||51
335133|NCT03039543|824254|P1|COMPLETED|Overall Study||53
335134|NCT03039543|824253|P2|STARTED|Overall Study||54
335135|NCT03039543|824254|P1|STARTED|Overall Study||54
335136|NCT03039179|824270|P2|NOT COMPLETED|Overall Study||0
335137|NCT03039179|824271|P1|NOT COMPLETED|Overall Study||0
335138|NCT03039179|824270|P2|COMPLETED|Overall Study||42
335139|NCT03039179|824271|P1|COMPLETED|Overall Study||38
335140|NCT03039179|824270|P2|STARTED|Overall Study||42
335141|NCT03039179|824271|P1|STARTED|Overall Study||38
335142|NCT03037905|824281|P2|NOT COMPLETED|Overall Study||0
335143|NCT03037905|824282|P1|NOT COMPLETED|Overall Study||0
335144|NCT03037905|824281|P2|COMPLETED|Overall Study||50
335145|NCT03037905|824282|P1|COMPLETED|Overall Study||50
335146|NCT03037905|824281|P2|STARTED|Overall Study||50
335147|NCT03037905|824282|P1|STARTED|Overall Study||50
335148|NCT03037541|824296|P2|NOT COMPLETED|Overall Study||0
335149|NCT03037541|824297|P1|NOT COMPLETED|Overall Study||0
335150|NCT03037541|824296|P2|COMPLETED|Overall Study||30
335151|NCT03037541|824297|P1|COMPLETED|Overall Study||30
335152|NCT03037541|824296|P2|STARTED|Overall Study||30
335153|NCT03037541|824297|P1|STARTED|Overall Study||30
335154|NCT03036215|824307|P2|NOT COMPLETED|Overall Study||3
335155|NCT03036215|824308|P1|NOT COMPLETED|Overall Study||2
335156|NCT03036215|824307|P2|COMPLETED|Overall Study||36
335157|NCT03036215|824308|P1|COMPLETED|Overall Study||39
335158|NCT03036215|824307|P2|STARTED|Overall Study||39
335159|NCT03036215|824308|P1|STARTED|Overall Study||41
335160|NCT03035955|824320|P2|NOT COMPLETED|Overall Study||1
335161|NCT03035955|824321|P1|NOT COMPLETED|Overall Study||1
335162|NCT03035955|824320|P2|COMPLETED|Overall Study||9
335163|NCT03035955|824321|P1|COMPLETED|Overall Study||9
335164|NCT03035955|824320|P2|STARTED|Overall Study||10
335165|NCT03035955|824321|P1|STARTED|Overall Study||10
335166|NCT03035916|824330|P3|NOT COMPLETED|Overall Study||0
335167|NCT03035916|824331|P2|NOT COMPLETED|Overall Study||2
335168|NCT03035916|824332|P1|NOT COMPLETED|Overall Study||0
335169|NCT03035916|824330|P3|COMPLETED|Overall Study||31
335170|NCT03035916|824331|P2|COMPLETED|Overall Study||28
335171|NCT03035916|824332|P1|COMPLETED|Overall Study||30
335172|NCT03035916|824330|P3|STARTED|Overall Study||31
335173|NCT03035916|824331|P2|STARTED|Overall Study||30
335174|NCT03035916|824332|P1|STARTED|Overall Study||30
335175|NCT03032965|824381|P2|NOT COMPLETED|Overall Study||0
335176|NCT03032965|824382|P1|NOT COMPLETED|Overall Study||0
335177|NCT03032965|824381|P2|COMPLETED|Overall Study||68
335178|NCT03032965|824382|P1|COMPLETED|Overall Study||61
335179|NCT03032965|824381|P2|STARTED|Overall Study||68
335180|NCT03032965|824382|P1|STARTED|Overall Study||61
335181|NCT03029650|824404|P2|NOT COMPLETED|2nd Intervention (3 - 6 Days)||0
335182|NCT03029650|824405|P1|NOT COMPLETED|2nd Intervention (3 - 6 Days)||0
335183|NCT03029650|824404|P2|COMPLETED|2nd Intervention (3 - 6 Days)||10
335184|NCT03029650|824405|P1|COMPLETED|2nd Intervention (3 - 6 Days)||13
335185|NCT03029650|824404|P2|STARTED|2nd Intervention (3 - 6 Days)||10
335186|NCT03029650|824405|P1|STARTED|2nd Intervention (3 - 6 Days)||13
335187|NCT03029650|824404|P2|NOT COMPLETED|Washout (1 Week)||2
335188|NCT03029650|824405|P1|NOT COMPLETED|Washout (1 Week)||1
335189|NCT03029650|824404|P2|COMPLETED|Washout (1 Week)||10
335190|NCT03029650|824405|P1|COMPLETED|Washout (1 Week)||13
335191|NCT03029650|824404|P2|STARTED|Washout (1 Week)||12
335192|NCT03029650|824405|P1|STARTED|Washout (1 Week)||14
335193|NCT03029650|824404|P2|NOT COMPLETED|First Intervention (3 - 6 Days)||0
335194|NCT03029650|824405|P1|NOT COMPLETED|First Intervention (3 - 6 Days)||0
335195|NCT03029650|824404|P2|COMPLETED|First Intervention (3 - 6 Days)||12
335196|NCT03029650|824405|P1|COMPLETED|First Intervention (3 - 6 Days)||14
335197|NCT03029650|824404|P2|STARTED|First Intervention (3 - 6 Days)||12
335198|NCT03029650|824405|P1|STARTED|First Intervention (3 - 6 Days)|More subjects not enrolled after consent in other group leaving uneven number.|14
335199|NCT03028987|824422|P2|NOT COMPLETED|Overall Study||0
335200|NCT03028987|824423|P1|NOT COMPLETED|Overall Study||0
335201|NCT03028987|824422|P2|COMPLETED|Overall Study||5
335202|NCT03028987|824423|P1|COMPLETED|Overall Study||5
335203|NCT03028987|824422|P2|STARTED|Overall Study||5
335204|NCT03028987|824423|P1|STARTED|Overall Study||5
335205|NCT03028025|824433|P2|NOT COMPLETED|Overall Study||1
335206|NCT03028025|824434|P1|NOT COMPLETED|Overall Study||3
335207|NCT03028025|824433|P2|COMPLETED|Overall Study||93
335208|NCT03028025|824434|P1|COMPLETED|Overall Study||87
335209|NCT03028025|824433|P2|STARTED|Overall Study||94
335210|NCT03028025|824434|P1|STARTED|Overall Study||90
335211|NCT03026803|824442|P1|NOT COMPLETED|Overall Study||0
335212|NCT03026803|824442|P1|COMPLETED|Overall Study||4
335213|NCT03026803|824442|P1|STARTED|Overall Study||4
335214|NCT03024112|824448|P2|NOT COMPLETED|Overall Study||0
335215|NCT03024112|824449|P1|NOT COMPLETED|Overall Study||7
335216|NCT03024112|824448|P2|COMPLETED|Overall Study||26
335217|NCT03024112|824449|P1|COMPLETED|Overall Study||18
335218|NCT03024112|824448|P2|STARTED|Overall Study||26
335219|NCT03024112|824449|P1|STARTED|Overall Study||25
335220|NCT03023709|824463|P2|NOT COMPLETED|Overall Study||0
335221|NCT03023709|824464|P1|NOT COMPLETED|Overall Study||0
335222|NCT03023709|824463|P2|COMPLETED|Overall Study||0
335223|NCT03023709|824464|P1|COMPLETED|Overall Study||3
335224|NCT03023709|824463|P2|STARTED|Overall Study||0
335225|NCT03023709|824464|P1|STARTED|Overall Study||3
335226|NCT03023683|824474|P2|NOT COMPLETED|Overall Study||1
335227|NCT03023683|824475|P1|NOT COMPLETED|Overall Study||0
335228|NCT03023683|824474|P2|COMPLETED|Overall Study||17
335229|NCT03023683|824475|P1|COMPLETED|Overall Study||0
335230|NCT03023683|824474|P2|STARTED|Overall Study||18
335231|NCT03023683|824475|P1|STARTED|Overall Study||0
335232|NCT03023553|824485|P2|NOT COMPLETED|Overall Study||1
335233|NCT03023553|824486|P1|NOT COMPLETED|Overall Study||0
335234|NCT03023553|824485|P2|COMPLETED|Overall Study||8
335235|NCT03023553|824486|P1|COMPLETED|Overall Study||4
335236|NCT03023553|824485|P2|STARTED|Overall Study||9
335237|NCT03023553|824486|P1|STARTED|Overall Study||4
335238|NCT03023488|824494|P1|NOT COMPLETED|Overall Study||0
335239|NCT03023488|824494|P1|COMPLETED|Overall Study||46
335240|NCT03023488|824494|P1|STARTED|Overall Study||46
335241|NCT03023176|824507|P1|NOT COMPLETED|Overall Study||0
335242|NCT03023176|824507|P1|COMPLETED|Overall Study||20
335243|NCT03023176|824507|P1|STARTED|Overall Study||20
335244|NCT03023137|824514|P2|NOT COMPLETED|Overall Study||9
335245|NCT03023137|824515|P1|NOT COMPLETED|Overall Study||4
335246|NCT03023137|824514|P2|COMPLETED|Overall Study||162
335247|NCT03023137|824515|P1|COMPLETED|Overall Study||174
335248|NCT03023137|824514|P2|STARTED|Overall Study||171
335249|NCT03023137|824515|P1|STARTED|Overall Study||178
335250|NCT03022435|824546|P5|NOT COMPLETED|Overall Study||0
335251|NCT03022435|824547|P4|NOT COMPLETED|Overall Study||0
335252|NCT03022435|824548|P3|NOT COMPLETED|Overall Study||0
335253|NCT03022435|824549|P2|NOT COMPLETED|Overall Study||0
335254|NCT03022435|824550|P1|NOT COMPLETED|Overall Study||0
335255|NCT03022435|824546|P5|COMPLETED|Overall Study||3
335256|NCT03022435|824547|P4|COMPLETED|Overall Study||3
335257|NCT03022435|824548|P3|COMPLETED|Overall Study||6
335258|NCT03022435|824549|P2|COMPLETED|Overall Study||5
335259|NCT03022435|824550|P1|COMPLETED|Overall Study||5
335260|NCT03022435|824546|P5|STARTED|Overall Study||3
335261|NCT03022435|824547|P4|STARTED|Overall Study||3
335262|NCT03022435|824548|P3|STARTED|Overall Study||6
335263|NCT03022435|824549|P2|STARTED|Overall Study||5
335264|NCT03022435|824550|P1|STARTED|Overall Study||5
335265|NCT03022422|824573|P6|NOT COMPLETED|Overall Study||0
335266|NCT03022422|824574|P5|NOT COMPLETED|Overall Study||0
335267|NCT03022422|824575|P4|NOT COMPLETED|Overall Study||0
335268|NCT03022422|824576|P3|NOT COMPLETED|Overall Study||3
335269|NCT03022422|824577|P2|NOT COMPLETED|Overall Study||0
335270|NCT03022422|824578|P1|NOT COMPLETED|Overall Study||0
335271|NCT03022422|824573|P6|COMPLETED|Overall Study||5
335272|NCT03022422|824574|P5|COMPLETED|Overall Study||5
335273|NCT03022422|824575|P4|COMPLETED|Overall Study||12
335274|NCT03022422|824576|P3|COMPLETED|Overall Study||20
335275|NCT03022422|824577|P2|COMPLETED|Overall Study||10
335276|NCT03022422|824578|P1|COMPLETED|Overall Study||8
335277|NCT03022422|824573|P6|STARTED|Overall Study||5
335278|NCT03022422|824574|P5|STARTED|Overall Study||5
335279|NCT03022422|824575|P4|STARTED|Overall Study||12
335280|NCT03022422|824576|P3|STARTED|Overall Study||23
335281|NCT03022422|824577|P2|STARTED|Overall Study||10
335282|NCT03022422|824578|P1|STARTED|Overall Study||8
335283|NCT03022396|824604|P6|NOT COMPLETED|Overall Study||0
335284|NCT03022396|824605|P5|NOT COMPLETED|Overall Study||0
335285|NCT03022396|824606|P4|NOT COMPLETED|Overall Study||0
335286|NCT03022396|824607|P3|NOT COMPLETED|Overall Study||0
335287|NCT03022396|824608|P2|NOT COMPLETED|Overall Study||0
335288|NCT03022396|824609|P1|NOT COMPLETED|Overall Study||0
335289|NCT03022396|824604|P6|COMPLETED|Overall Study||8
335290|NCT03022396|824605|P5|COMPLETED|Overall Study||14
335291|NCT03022396|824606|P4|COMPLETED|Overall Study||20
335292|NCT03022396|824607|P3|COMPLETED|Overall Study||10
335293|NCT03022396|824608|P2|COMPLETED|Overall Study||14
335294|NCT03022396|824609|P1|COMPLETED|Overall Study||16
335295|NCT03022396|824604|P6|STARTED|Overall Study||8
335296|NCT03022396|824605|P5|STARTED|Overall Study||14
335297|NCT03022396|824606|P4|STARTED|Overall Study||20
335298|NCT03022396|824607|P3|STARTED|Overall Study||10
335299|NCT03022396|824608|P2|STARTED|Overall Study||14
335300|NCT03022396|824609|P1|STARTED|Overall Study||16
335301|NCT03021343|824631|P2|NOT COMPLETED|Overall Study||7
335302|NCT03021343|824632|P1|NOT COMPLETED|Overall Study||5
335303|NCT03021343|824631|P2|COMPLETED|Overall Study||174
335304|NCT03021343|824632|P1|COMPLETED|Overall Study||174
335305|NCT03021343|824631|P2|STARTED|Overall Study||181
335306|NCT03021343|824632|P1|STARTED|Overall Study||179
335307|NCT03021304|824640|P1|NOT COMPLETED|Overall Study||1
335308|NCT03021304|824640|P1|COMPLETED|Overall Study||55
335309|NCT03021304|824640|P1|STARTED|Overall Study||56
335310|NCT03020576|824647|P2|NOT COMPLETED|Overall Study||2
335311|NCT03020576|824648|P1|NOT COMPLETED|Overall Study||1
335312|NCT03020576|824647|P2|COMPLETED|Overall Study||14
335313|NCT03020576|824648|P1|COMPLETED|Overall Study||14
335314|NCT03020576|824647|P2|STARTED|Overall Study||16
335315|NCT03020576|824648|P1|STARTED|Overall Study||15
335316|NCT03020537|824670|P2|NOT COMPLETED|Overall Study||0
335317|NCT03020537|824671|P1|NOT COMPLETED|Overall Study||0
335318|NCT03020537|824670|P2|COMPLETED|Overall Study||7
335319|NCT03020537|824671|P1|COMPLETED|Overall Study||1
335320|NCT03020537|824670|P2|STARTED|Overall Study||7
335321|NCT03020537|824671|P1|STARTED|Overall Study||1
335322|NCT03020498|824682|P3|NOT COMPLETED|Overall Study||0
335323|NCT03020498|824683|P2|NOT COMPLETED|Overall Study||3
335324|NCT03020498|824684|P1|NOT COMPLETED|Overall Study||0
335325|NCT03020498|824682|P3|COMPLETED|Overall Study||36
335326|NCT03020498|824683|P2|COMPLETED|Overall Study||38
335327|NCT03020498|824684|P1|COMPLETED|Overall Study||14
335328|NCT03020498|824682|P3|STARTED|Overall Study||36
335329|NCT03020498|824683|P2|STARTED|Overall Study||41
335330|NCT03020498|824684|P1|STARTED|Overall Study||14
335331|NCT03020472|824695|P1|NOT COMPLETED|Overall Study||0
335332|NCT03020472|824695|P1|COMPLETED|Overall Study||6
335333|NCT03020472|824695|P1|STARTED|Overall Study||6
335334|NCT03020004|824701|P1|NOT COMPLETED|Overall Study||1
335335|NCT03020004|824701|P1|COMPLETED|Overall Study||69
335336|NCT03020004|824701|P1|STARTED|Overall Study||70
335337|NCT03019783|824707|P2|NOT COMPLETED|Overall Study||0
335338|NCT03019783|824708|P1|NOT COMPLETED|Overall Study||0
335339|NCT03019783|824707|P2|COMPLETED|Overall Study||31
335340|NCT03019783|824708|P1|COMPLETED|Overall Study||29
335341|NCT03019783|824707|P2|STARTED|Overall Study||31
335342|NCT03019783|824708|P1|STARTED|Overall Study||29
335343|NCT03018106|824718|P2|NOT COMPLETED|Overall Study||1
335344|NCT03018106|824719|P1|NOT COMPLETED|Overall Study||0
335345|NCT03018106|824718|P2|COMPLETED|Overall Study||0
335346|NCT03018106|824719|P1|COMPLETED|Overall Study||0
335347|NCT03018106|824718|P2|STARTED|Overall Study||1
335348|NCT03018106|824719|P1|STARTED|Overall Study||0
335349|NCT03017612|824727|P1|NOT COMPLETED|Overall Study||2
335350|NCT03017612|824727|P1|COMPLETED|Overall Study||11
335351|NCT03017612|824727|P1|STARTED|Overall Study||13
335352|NCT03016078|824735|P1|NOT COMPLETED|Overall Study||2
335353|NCT03016078|824735|P1|COMPLETED|Overall Study||19
335354|NCT03016078|824735|P1|STARTED|Overall Study||21
335355|NCT03011099|824748|P2|NOT COMPLETED|Overall Study||2
335356|NCT03011099|824749|P1|NOT COMPLETED|Overall Study||0
335357|NCT03011099|824748|P2|COMPLETED|Overall Study||3
335358|NCT03011099|824749|P1|COMPLETED|Overall Study||6
335359|NCT03011099|824748|P2|STARTED|Overall Study||5
335360|NCT03011099|824749|P1|STARTED|Overall Study||6
335361|NCT03010800|824775|P2|NOT COMPLETED|Cross Over||0
335362|NCT03010800|824776|P1|NOT COMPLETED|Cross Over||0
335363|NCT03010800|824775|P2|COMPLETED|Cross Over||4
335364|NCT03010800|824776|P1|COMPLETED|Cross Over||4
335365|NCT03010800|824775|P2|STARTED|Cross Over||4
335366|NCT03010800|824776|P1|STARTED|Cross Over||4
335367|NCT03010800|824775|P2|NOT COMPLETED|Initial Assignment||0
335368|NCT03010800|824776|P1|NOT COMPLETED|Initial Assignment||0
335369|NCT03010800|824775|P2|COMPLETED|Initial Assignment||4
335370|NCT03010800|824776|P1|COMPLETED|Initial Assignment||4
335371|NCT03010800|824775|P2|STARTED|Initial Assignment||4
335372|NCT03010800|824776|P1|STARTED|Initial Assignment||4
335373|NCT03005067|824784|P2|NOT COMPLETED|Overall Study||7
335374|NCT03005067|824785|P1|NOT COMPLETED|Overall Study||10
335375|NCT03005067|824784|P2|COMPLETED|Overall Study||74
335376|NCT03005067|824785|P1|COMPLETED|Overall Study||80
335377|NCT03005067|824784|P2|STARTED|Overall Study||81
335378|NCT03005067|824785|P1|STARTED|Overall Study||90
335379|NCT03005041|824797|P2|NOT COMPLETED|Period 2||0
335380|NCT03005041|824798|P1|NOT COMPLETED|Period 2||0
335381|NCT03005041|824797|P2|COMPLETED|Period 2||27
335382|NCT03005041|824798|P1|COMPLETED|Period 2||28
335383|NCT03005041|824797|P2|STARTED|Period 2||27
335384|NCT03005041|824798|P1|STARTED|Period 2||28
335385|NCT03005041|824797|P2|NOT COMPLETED|Washout Period 1||0
335386|NCT03005041|824798|P1|NOT COMPLETED|Washout Period 1||0
335387|NCT03005041|824797|P2|COMPLETED|Washout Period 1||27
335388|NCT03005041|824798|P1|COMPLETED|Washout Period 1||28
335389|NCT03005041|824797|P2|STARTED|Washout Period 1||27
335390|NCT03005041|824798|P1|STARTED|Washout Period 1||28
335391|NCT03005041|824797|P2|NOT COMPLETED|Period 1||0
335392|NCT03005041|824798|P1|NOT COMPLETED|Period 1||0
335393|NCT03005041|824797|P2|COMPLETED|Period 1||27
335394|NCT03005041|824798|P1|COMPLETED|Period 1||28
335395|NCT03005041|824797|P2|STARTED|Period 1||27
335396|NCT03005041|824798|P1|STARTED|Period 1||28
335397|NCT03002454|824810|P1|NOT COMPLETED|Overall Study||0
335398|NCT03002454|824810|P1|COMPLETED|Overall Study||4
335399|NCT03002454|824810|P1|STARTED|Overall Study||4
335400|NCT03001674|824817|P2|NOT COMPLETED|Overall Study||0
335401|NCT03001674|824818|P1|NOT COMPLETED|Overall Study||0
335402|NCT03001674|824817|P2|COMPLETED|Overall Study||5
335403|NCT03001674|824818|P1|COMPLETED|Overall Study||10
335404|NCT03001674|824817|P2|STARTED|Overall Study||5
335405|NCT03001674|824818|P1|STARTED|Overall Study||10
335406|NCT03001258|824827|P3|NOT COMPLETED|Overall Study||0
335407|NCT03001258|824828|P2|NOT COMPLETED|Overall Study||0
335408|NCT03001258|824829|P1|NOT COMPLETED|Overall Study||0
335409|NCT03001258|824827|P3|COMPLETED|Overall Study||485
335410|NCT03001258|824828|P2|COMPLETED|Overall Study||751
335411|NCT03001258|824829|P1|COMPLETED|Overall Study||765
335412|NCT03001258|824827|P3|STARTED|Overall Study||485
335413|NCT03001258|824828|P2|STARTED|Overall Study||751
335414|NCT03001258|824829|P1|STARTED|Overall Study||765
335415|NCT03000088|824839|P2|NOT COMPLETED|Overall Study||0
335416|NCT03000088|824840|P1|NOT COMPLETED|Overall Study||0
335417|NCT03000088|824839|P2|COMPLETED|Overall Study||70
335418|NCT03000088|824840|P1|COMPLETED|Overall Study||70
335419|NCT03000088|824839|P2|STARTED|Overall Study||70
335420|NCT03000088|824840|P1|STARTED|Overall Study||70
335421|NCT02997904|824848|P2|NOT COMPLETED|Overall Study||0
335422|NCT02997904|824849|P1|NOT COMPLETED|Overall Study||0
335423|NCT02997904|824848|P2|COMPLETED|Overall Study||49
335424|NCT02997904|824849|P1|COMPLETED|Overall Study||51
335425|NCT02997904|824848|P2|STARTED|Overall Study||49
335426|NCT02997904|824849|P1|STARTED|Overall Study||51
335427|NCT02990910|824861|P2|NOT COMPLETED|Overall Study||10
335428|NCT02990910|824862|P1|NOT COMPLETED|Overall Study||6
335429|NCT02990910|824861|P2|COMPLETED|Overall Study||130
335430|NCT02990910|824862|P1|COMPLETED|Overall Study||134
335431|NCT02990910|824861|P2|STARTED|Overall Study||140
335432|NCT02990910|824862|P1|STARTED|Overall Study||140
335433|NCT02988882|824872|P2|NOT COMPLETED|Overall Study||2
335434|NCT02988882|824873|P1|NOT COMPLETED|Overall Study||3
335435|NCT02988882|824872|P2|COMPLETED|Overall Study||40
335436|NCT02988882|824873|P1|COMPLETED|Overall Study||41
335437|NCT02988882|824872|P2|STARTED|Overall Study||42
335438|NCT02988882|824873|P1|STARTED|Overall Study||44
335439|NCT02988622|824883|P1|NOT COMPLETED|Overall Study||17
335440|NCT02988622|824883|P1|COMPLETED|Overall Study||83
335441|NCT02988622|824883|P1|STARTED|Overall Study||100
335442|NCT02988219|824907|P2|NOT COMPLETED|Overall Study||3
335443|NCT02988219|824908|P1|NOT COMPLETED|Overall Study||1
335444|NCT02988219|824907|P2|COMPLETED|Overall Study||22
335445|NCT02988219|824908|P1|COMPLETED|Overall Study||24
335446|NCT02988219|824907|P2|STARTED|Overall Study||25
335447|NCT02988219|824908|P1|STARTED|Overall Study||25
335448|NCT02987868|824916|P2|NOT COMPLETED|Second Intervention||0
335449|NCT02987868|824917|P1|NOT COMPLETED|Second Intervention||0
335450|NCT02987868|824916|P2|COMPLETED|Second Intervention||8
335451|NCT02987868|824917|P1|COMPLETED|Second Intervention||8
335452|NCT02987868|824916|P2|STARTED|Second Intervention||8
335453|NCT02987868|824917|P1|STARTED|Second Intervention||8
335454|NCT02987868|824916|P2|NOT COMPLETED|Wash Out Period 1 Week||0
335455|NCT02987868|824917|P1|NOT COMPLETED|Wash Out Period 1 Week||0
335456|NCT02987868|824916|P2|COMPLETED|Wash Out Period 1 Week||8
335457|NCT02987868|824917|P1|COMPLETED|Wash Out Period 1 Week||8
335458|NCT02987868|824916|P2|STARTED|Wash Out Period 1 Week||8
335459|NCT02987868|824917|P1|STARTED|Wash Out Period 1 Week||8
335460|NCT02987868|824916|P2|NOT COMPLETED|First Intervention||0
335461|NCT02987868|824917|P1|NOT COMPLETED|First Intervention||0
335462|NCT02987868|824916|P2|COMPLETED|First Intervention||8
335463|NCT02987868|824917|P1|COMPLETED|First Intervention||8
335464|NCT02987868|824916|P2|STARTED|First Intervention||8
335465|NCT02987868|824917|P1|STARTED|First Intervention||8
335466|NCT02987374|824923|P1|NOT COMPLETED|Overall Study||0
335467|NCT02987374|824923|P1|COMPLETED|Overall Study||10
335468|NCT02987374|824923|P1|STARTED|Overall Study||10
335469|NCT02987205|824928|P1|NOT COMPLETED|Overall Study||4
335470|NCT02987205|824928|P1|COMPLETED|Overall Study|Treatment is bilateral, subject lost to Restylane AE was lost to further Revanesse Ultra treatment|159
335471|NCT02987205|824928|P1|Treated - Bilateral NLF Injection|Overall Study||163
335472|NCT02987205|824928|P1|STARTED|Overall Study||163
335473|NCT02986282|824936|P1|NOT COMPLETED|Overall Study||16
335474|NCT02986282|824936|P1|COMPLETED|Overall Study||99
335475|NCT02986282|824936|P1|STARTED|Overall Study||115
335476|NCT02984878|824943|P2|NOT COMPLETED|Overall Study||0
335477|NCT02984878|824944|P1|NOT COMPLETED|Overall Study||0
335478|NCT02984878|824943|P2|COMPLETED|Overall Study||41
335479|NCT02984878|824944|P1|COMPLETED|Overall Study||30
335480|NCT02984878|824943|P2|STARTED|Overall Study||41
335481|NCT02984878|824944|P1|STARTED|Overall Study||30
335482|NCT02983981|824954|P1|NOT COMPLETED|Overall Study||0
335483|NCT02983981|824954|P1|COMPLETED|Overall Study||20
335484|NCT02983981|824954|P1|STARTED|Overall Study||20
335485|NCT02977572|824963|P2|NOT COMPLETED|Overall Study||2
335486|NCT02977572|824964|P1|NOT COMPLETED|Overall Study||2
335487|NCT02977572|824963|P2|COMPLETED|Overall Study||54
335488|NCT02977572|824964|P1|COMPLETED|Overall Study||56
335489|NCT02977572|824963|P2|STARTED|Overall Study||56
335490|NCT02977572|824964|P1|STARTED|Overall Study||58
335491|NCT02974543|824988|P2|NOT COMPLETED|Overall Study||0
335492|NCT02974543|824989|P1|NOT COMPLETED|Overall Study||1
335493|NCT02974543|824988|P2|COMPLETED|Overall Study||10
335494|NCT02974543|824989|P1|COMPLETED|Overall Study||10
335495|NCT02974543|824988|P2|Began Crossover Assignment|Overall Study||10
335496|NCT02974543|824989|P1|Began Crossover Assignment|Overall Study||10
335497|NCT02974543|824988|P2|Began Washout Period|Overall Study||10
335498|NCT02974543|824989|P1|Began Washout Period|Overall Study||10
335499|NCT02974543|824988|P2|STARTED|Overall Study||10
335500|NCT02974543|824989|P1|STARTED|Overall Study||11
335501|NCT02971670|825013|P4|NOT COMPLETED|Overall Study||2
335502|NCT02971670|825014|P3|NOT COMPLETED|Overall Study||1
335503|NCT02971670|825015|P2|NOT COMPLETED|Overall Study||1
335504|NCT02971670|825016|P1|NOT COMPLETED|Overall Study||4
335505|NCT02971670|825013|P4|COMPLETED|Overall Study||1
335506|NCT02971670|825014|P3|COMPLETED|Overall Study||4
335507|NCT02971670|825015|P2|COMPLETED|Overall Study||1
335508|NCT02971670|825016|P1|COMPLETED|Overall Study||9
335509|NCT02971670|825013|P4|STARTED|Overall Study||3
335510|NCT02971670|825014|P3|STARTED|Overall Study||5
335511|NCT02971670|825015|P2|STARTED|Overall Study||2
335512|NCT02971670|825016|P1|STARTED|Overall Study||13
335513|NCT02968173|825034|P1|NOT COMPLETED|Overall Study||1
335514|NCT02968173|825034|P1|COMPLETED|Overall Study||49
335515|NCT02968173|825034|P1|STARTED|Overall Study||50
335516|NCT02967393|825048|P2|NOT COMPLETED|Overall Study||0
335517|NCT02967393|825049|P1|NOT COMPLETED|Overall Study||0
335518|NCT02967393|825048|P2|COMPLETED|Overall Study||20
335519|NCT02967393|825049|P1|COMPLETED|Overall Study||20
335520|NCT02967393|825048|P2|STARTED|Overall Study||20
335521|NCT02967393|825049|P1|STARTED|Overall Study||20
335522|NCT02967354|825079|P5|NOT COMPLETED|Overall Study||0
335523|NCT02967354|825080|P4|NOT COMPLETED|Overall Study||0
335524|NCT02967354|825081|P3|NOT COMPLETED|Overall Study||0
335525|NCT02967354|825082|P2|NOT COMPLETED|Overall Study||0
335526|NCT02967354|825083|P1|NOT COMPLETED|Overall Study||0
335527|NCT02967354|825079|P5|COMPLETED|Overall Study||8
335528|NCT02967354|825080|P4|COMPLETED|Overall Study||7
335529|NCT02967354|825081|P3|COMPLETED|Overall Study||9
335530|NCT02967354|825082|P2|COMPLETED|Overall Study||7
335531|NCT02967354|825083|P1|COMPLETED|Overall Study||8
335532|NCT02967354|825079|P5|STARTED|Overall Study||8
335533|NCT02967354|825080|P4|STARTED|Overall Study||7
335534|NCT02967354|825081|P3|STARTED|Overall Study||9
335535|NCT02967354|825082|P2|STARTED|Overall Study||7
335536|NCT02967354|825083|P1|STARTED|Overall Study||8
335537|NCT02966509|825117|P2|NOT COMPLETED|End of Life Utilization and Cost 15month||48
335538|NCT02966509|825118|P1|NOT COMPLETED|End of Life Utilization and Cost 15month||45
335539|NCT02966509|825117|P2|COMPLETED|End of Life Utilization and Cost 15month||60
335540|NCT02966509|825118|P1|COMPLETED|End of Life Utilization and Cost 15month||60
335541|NCT02966509|825117|P2|STARTED|End of Life Utilization and Cost 15month||108
335542|NCT02966509|825118|P1|STARTED|End of Life Utilization and Cost 15month||105
335543|NCT02966509|825117|P2|NOT COMPLETED|End of Life Utilization and Cost 6 Month||75
335544|NCT02966509|825118|P1|NOT COMPLETED|End of Life Utilization and Cost 6 Month||69
335545|NCT02966509|825117|P2|COMPLETED|End of Life Utilization and Cost 6 Month||33
335546|NCT02966509|825118|P1|COMPLETED|End of Life Utilization and Cost 6 Month||36
335547|NCT02966509|825117|P2|STARTED|End of Life Utilization and Cost 6 Month||108
335548|NCT02966509|825118|P1|STARTED|End of Life Utilization and Cost 6 Month||105
335549|NCT02966509|825117|P2|NOT COMPLETED|15-Month Utilization and Cost||0
335550|NCT02966509|825118|P1|NOT COMPLETED|15-Month Utilization and Cost||0
335551|NCT02966509|825117|P2|COMPLETED|15-Month Utilization and Cost||108
335552|NCT02966509|825118|P1|COMPLETED|15-Month Utilization and Cost||105
335553|NCT02966509|825117|P2|STARTED|15-Month Utilization and Cost||108
335554|NCT02966509|825118|P1|STARTED|15-Month Utilization and Cost||105
335555|NCT02966509|825117|P2|NOT COMPLETED|6-Month Utilization and Cost||0
335556|NCT02966509|825118|P1|NOT COMPLETED|6-Month Utilization and Cost||0
335557|NCT02966509|825117|P2|COMPLETED|6-Month Utilization and Cost||108
335558|NCT02966509|825118|P1|COMPLETED|6-Month Utilization and Cost||105
335559|NCT02966509|825117|P2|STARTED|6-Month Utilization and Cost||108
335560|NCT02966509|825118|P1|STARTED|6-Month Utilization and Cost||105
335561|NCT02966509|825117|P2|NOT COMPLETED|6 Month Satisfaction Survey||48
335562|NCT02966509|825118|P1|NOT COMPLETED|6 Month Satisfaction Survey||47
335563|NCT02966509|825117|P2|COMPLETED|6 Month Satisfaction Survey||60
335564|NCT02966509|825118|P1|COMPLETED|6 Month Satisfaction Survey||58
335565|NCT02966509|825117|P2|STARTED|6 Month Satisfaction Survey||108
335566|NCT02966509|825118|P1|STARTED|6 Month Satisfaction Survey||105
335567|NCT02966509|825117|P2|NOT COMPLETED|4-Month Satisfaction Decision Survey||31
335568|NCT02966509|825118|P1|NOT COMPLETED|4-Month Satisfaction Decision Survey||25
335569|NCT02966509|825117|P2|COMPLETED|4-Month Satisfaction Decision Survey||77
335570|NCT02966509|825118|P1|COMPLETED|4-Month Satisfaction Decision Survey||80
335571|NCT02966509|825117|P2|STARTED|4-Month Satisfaction Decision Survey||108
335572|NCT02966509|825118|P1|STARTED|4-Month Satisfaction Decision Survey||105
335573|NCT02966509|825117|P2|NOT COMPLETED|Baseline Satisfaction Survey||7
335574|NCT02966509|825118|P1|NOT COMPLETED|Baseline Satisfaction Survey||4
335575|NCT02966509|825117|P2|COMPLETED|Baseline Satisfaction Survey||101
335576|NCT02966509|825118|P1|COMPLETED|Baseline Satisfaction Survey||101
335577|NCT02966509|825117|P2|STARTED|Baseline Satisfaction Survey||108
335578|NCT02966509|825118|P1|STARTED|Baseline Satisfaction Survey||105
335579|NCT02966015|825144|P2|NOT COMPLETED|Test Period||0
335580|NCT02966015|825145|P1|NOT COMPLETED|Test Period||0
335581|NCT02966015|825144|P2|COMPLETED|Test Period||55
335582|NCT02966015|825145|P1|COMPLETED|Test Period||87
335583|NCT02966015|825144|P2|STARTED|Test Period||55
335584|NCT02966015|825145|P1|STARTED|Test Period||87
335585|NCT02966015|825144|P2|NOT COMPLETED|Inclusion Visit||3
335586|NCT02966015|825145|P1|NOT COMPLETED|Inclusion Visit||8
335587|NCT02966015|825144|P2|COMPLETED|Inclusion Visit||55
335588|NCT02966015|825145|P1|COMPLETED|Inclusion Visit||87
335589|NCT02966015|825144|P2|STARTED|Inclusion Visit||58
335590|NCT02966015|825145|P1|STARTED|Inclusion Visit||95
335591|NCT02966002|825151|P1|NOT COMPLETED|Overall Study||4
335592|NCT02966002|825151|P1|COMPLETED|Overall Study||5
335593|NCT02966002|825151|P1|STARTED|Overall Study||9
335594|NCT02965833|825158|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
335595|NCT02965833|825159|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
335596|NCT02965833|825158|P2|COMPLETED|Period 2, Second 30 Days of Wear||52
335597|NCT02965833|825159|P1|COMPLETED|Period 2, Second 30 Days of Wear||62
335598|NCT02965833|825158|P2|STARTED|Period 2, Second 30 Days of Wear||52
335599|NCT02965833|825159|P1|STARTED|Period 2, Second 30 Days of Wear||64
335600|NCT02965833|825158|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||2
335601|NCT02965833|825159|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||3
335602|NCT02965833|825158|P2|COMPLETED|Period 1, First 30 Days of Wear||52
335603|NCT02965833|825159|P1|COMPLETED|Period 1, First 30 Days of Wear||64
335604|NCT02965833|825158|P2|STARTED|Period 1, First 30 Days of Wear||54
335605|NCT02965833|825159|P1|STARTED|Period 1, First 30 Days of Wear||67
335606|NCT02965820|825165|P2|NOT COMPLETED|Period 2, Second 30 Days||1
335607|NCT02965820|825166|P1|NOT COMPLETED|Period 2, Second 30 Days||1
335608|NCT02965820|825165|P2|COMPLETED|Period 2, Second 30 Days||61
335609|NCT02965820|825166|P1|COMPLETED|Period 2, Second 30 Days||57
335610|NCT02965820|825165|P2|STARTED|Period 2, Second 30 Days||62
335611|NCT02965820|825166|P1|STARTED|Period 2, Second 30 Days|One subject discontinued due to an AE after completion of Period 1 but before beginning Period 2.|58
335612|NCT02965820|825165|P2|NOT COMPLETED|Period 1, First 30 Days||0
335613|NCT02965820|825166|P1|NOT COMPLETED|Period 1, First 30 Days||0
335614|NCT02965820|825165|P2|COMPLETED|Period 1, First 30 Days||62
335615|NCT02965820|825166|P1|COMPLETED|Period 1, First 30 Days||59
335616|NCT02965820|825165|P2|STARTED|Period 1, First 30 Days||62
335617|NCT02965820|825166|P1|STARTED|Period 1, First 30 Days||59
335618|NCT02964767|825174|P2|NOT COMPLETED|Overall Study||0
335619|NCT02964767|825175|P1|NOT COMPLETED|Overall Study||0
335620|NCT02964767|825174|P2|COMPLETED|Overall Study||48
335621|NCT02964767|825175|P1|COMPLETED|Overall Study||171
335622|NCT02964767|825174|P2|STARTED|Overall Study||48
335623|NCT02964767|825175|P1|STARTED|Overall Study||171
335624|NCT02962882|825182|P1|NOT COMPLETED|Overall Study||36
335625|NCT02962882|825182|P1|COMPLETED|Overall Study||14
335626|NCT02962882|825182|P1|STARTED|Overall Study||50
335627|NCT02961244|825193|P2|NOT COMPLETED|Overall Study||9
335628|NCT02961244|825194|P1|NOT COMPLETED|Overall Study||1
335629|NCT02961244|825193|P2|COMPLETED|Overall Study||55
335630|NCT02961244|825194|P1|COMPLETED|Overall Study||63
335631|NCT02961244|825193|P2|Patients Excluded During Randomization|Overall Study||1
335632|NCT02961244|825194|P1|Patients Excluded During Randomization|Overall Study||0
335633|NCT02961244|825193|P2|STARTED|Overall Study||64
335634|NCT02961244|825194|P1|STARTED|Overall Study||64
335635|NCT02959840|825205|P3|NOT COMPLETED|Overall Study||0
335636|NCT02959840|825206|P2|NOT COMPLETED|Overall Study||0
335637|NCT02959840|825207|P1|NOT COMPLETED|Overall Study||0
335638|NCT02959840|825205|P3|COMPLETED|Overall Study||60
335639|NCT02959840|825206|P2|COMPLETED|Overall Study||60
335640|NCT02959840|825207|P1|COMPLETED|Overall Study||60
335641|NCT02959840|825205|P3|STARTED|Overall Study||60
335642|NCT02959840|825206|P2|STARTED|Overall Study||60
335643|NCT02959840|825207|P1|STARTED|Overall Study||60
335644|NCT02958995|825250|P2|NOT COMPLETED|Overall Study||0
335645|NCT02958995|825251|P1|NOT COMPLETED|Overall Study||0
335646|NCT02958995|825250|P2|COMPLETED|Overall Study||107495
335647|NCT02958995|825251|P1|COMPLETED|Overall Study||2630666
335648|NCT02958995|825250|P2|STARTED|Overall Study||107495
335649|NCT02958995|825251|P1|STARTED|Overall Study||2630666
335650|NCT02958956|825261|P2|NOT COMPLETED|Overall Study||0
335651|NCT02958956|825262|P1|NOT COMPLETED|Overall Study||0
335652|NCT02958956|825261|P2|COMPLETED|Overall Study||198317
335653|NCT02958956|825262|P1|COMPLETED|Overall Study||38190
335654|NCT02958956|825261|P2|STARTED|Overall Study||198317
335655|NCT02958956|825262|P1|STARTED|Overall Study||38190
335656|NCT02958787|825275|P1|NOT COMPLETED|Overall Study||0
335657|NCT02958787|825275|P1|COMPLETED|Overall Study||135
335658|NCT02958787|825275|P1|STARTED|Overall Study||135
335659|NCT02958345|825281|P2|NOT COMPLETED|Overall Study||1
335660|NCT02958345|825282|P1|NOT COMPLETED|Overall Study||1
335661|NCT02958345|825281|P2|COMPLETED|Overall Study||13
335662|NCT02958345|825282|P1|COMPLETED|Overall Study||13
335663|NCT02958345|825281|P2|STARTED|Overall Study||14
335664|NCT02958345|825282|P1|STARTED|Overall Study||14
335665|NCT02956460|825292|P2|NOT COMPLETED|Lens 2||0
335666|NCT02956460|825293|P1|NOT COMPLETED|Lens 2||0
335667|NCT02956460|825292|P2|COMPLETED|Lens 2||34
335668|NCT02956460|825293|P1|COMPLETED|Lens 2||29
335669|NCT02956460|825292|P2|STARTED|Lens 2||34
335670|NCT02956460|825293|P1|STARTED|Lens 2||29
335671|NCT02956460|825292|P2|NOT COMPLETED|Lens 1||0
335672|NCT02956460|825293|P1|NOT COMPLETED|Lens 1||1
335673|NCT02956460|825292|P2|COMPLETED|Lens 1||34
335674|NCT02956460|825293|P1|COMPLETED|Lens 1||29
335675|NCT02956460|825292|P2|STARTED|Lens 1||34
335676|NCT02956460|825293|P1|STARTED|Lens 1||30
335677|NCT02953886|825319|P1|NOT COMPLETED|Overall Study||0
335678|NCT02953886|825319|P1|COMPLETED|Overall Study||20
335679|NCT02953886|825319|P1|STARTED|Overall Study||20
335680|NCT02951767|825325|P1|NOT COMPLETED|Overall Study||119
335681|NCT02951767|825325|P1|COMPLETED|Overall Study||0
335682|NCT02951767|825325|P1|STARTED|Overall Study||119
335683|NCT02951702|825344|P2|NOT COMPLETED|Overall Study||0
335684|NCT02951702|825345|P1|NOT COMPLETED|Overall Study||0
335685|NCT02951702|825344|P2|COMPLETED|Overall Study||17
335686|NCT02951702|825345|P1|COMPLETED|Overall Study||34
335687|NCT02951702|825344|P2|STARTED|Overall Study||17
335688|NCT02951702|825345|P1|STARTED|Overall Study||34
335689|NCT02951312|825359|P4|NOT COMPLETED|Study Part 2||0
335690|NCT02951312|825360|P3|NOT COMPLETED|Study Part 2||0
335691|NCT02951312|825361|P2|NOT COMPLETED|Study Part 2||0
335692|NCT02951312|825362|P1|NOT COMPLETED|Study Part 2||0
335693|NCT02951312|825359|P4|COMPLETED|Study Part 2||6
335694|NCT02951312|825360|P3|COMPLETED|Study Part 2||6
335695|NCT02951312|825361|P2|COMPLETED|Study Part 2||0
335696|NCT02951312|825362|P1|COMPLETED|Study Part 2||0
335697|NCT02951312|825359|P4|STARTED|Study Part 2||6
335698|NCT02951312|825360|P3|STARTED|Study Part 2||6
335699|NCT02951312|825361|P2|STARTED|Study Part 2||0
335700|NCT02951312|825362|P1|STARTED|Study Part 2||0
335701|NCT02951312|825359|P4|NOT COMPLETED|Study Part 1||0
335702|NCT02951312|825360|P3|NOT COMPLETED|Study Part 1||0
335703|NCT02951312|825361|P2|NOT COMPLETED|Study Part 1||0
335704|NCT02951312|825362|P1|NOT COMPLETED|Study Part 1||0
335705|NCT02951312|825359|P4|COMPLETED|Study Part 1||0
335706|NCT02951312|825360|P3|COMPLETED|Study Part 1||0
335707|NCT02951312|825361|P2|COMPLETED|Study Part 1||6
335708|NCT02951312|825362|P1|COMPLETED|Study Part 1||6
335709|NCT02951312|825359|P4|STARTED|Study Part 1||0
335710|NCT02951312|825360|P3|STARTED|Study Part 1||0
335711|NCT02951312|825361|P2|STARTED|Study Part 1||6
335712|NCT02951312|825362|P1|STARTED|Study Part 1||6
335713|NCT02951273|825482|P1|NOT COMPLETED|Overall Study||3
335714|NCT02951273|825482|P1|COMPLETED|Overall Study||27
335715|NCT02951273|825482|P1|STARTED|Overall Study||30
335716|NCT02949141|825497|P1|NOT COMPLETED|Overall Study||0
335717|NCT02949141|825497|P1|COMPLETED|Overall Study||62
335718|NCT02949141|825497|P1|STARTED|Overall Study||62
335719|NCT02948582|825504|P6|NOT COMPLETED|Wshout Period 6||0
335720|NCT02948582|825505|P5|NOT COMPLETED|Wshout Period 6||0
335721|NCT02948582|825506|P4|NOT COMPLETED|Wshout Period 6||0
335722|NCT02948582|825507|P3|NOT COMPLETED|Wshout Period 6||0
335723|NCT02948582|825508|P2|NOT COMPLETED|Wshout Period 6||0
335724|NCT02948582|825509|P1|NOT COMPLETED|Wshout Period 6||0
335725|NCT02948582|825504|P6|COMPLETED|Wshout Period 6||6
335726|NCT02948582|825505|P5|COMPLETED|Wshout Period 6||7
335727|NCT02948582|825506|P4|COMPLETED|Wshout Period 6||6
335728|NCT02948582|825507|P3|COMPLETED|Wshout Period 6||6
335729|NCT02948582|825508|P2|COMPLETED|Wshout Period 6||4
335730|NCT02948582|825509|P1|COMPLETED|Wshout Period 6||6
335731|NCT02948582|825504|P6|STARTED|Wshout Period 6||6
335732|NCT02948582|825505|P5|STARTED|Wshout Period 6||7
335733|NCT02948582|825506|P4|STARTED|Wshout Period 6||6
335734|NCT02948582|825507|P3|STARTED|Wshout Period 6||6
335735|NCT02948582|825508|P2|STARTED|Wshout Period 6||4
335736|NCT02948582|825509|P1|STARTED|Wshout Period 6||6
335737|NCT02948582|825504|P6|NOT COMPLETED|Treatment Period 6||0
335738|NCT02948582|825505|P5|NOT COMPLETED|Treatment Period 6||0
335739|NCT02948582|825506|P4|NOT COMPLETED|Treatment Period 6||0
335740|NCT02948582|825507|P3|NOT COMPLETED|Treatment Period 6||0
335741|NCT02948582|825508|P2|NOT COMPLETED|Treatment Period 6||0
335742|NCT02948582|825509|P1|NOT COMPLETED|Treatment Period 6||0
335743|NCT02948582|825504|P6|COMPLETED|Treatment Period 6||6
335744|NCT02948582|825505|P5|COMPLETED|Treatment Period 6||7
335745|NCT02948582|825506|P4|COMPLETED|Treatment Period 6||6
335746|NCT02948582|825507|P3|COMPLETED|Treatment Period 6||6
335747|NCT02948582|825508|P2|COMPLETED|Treatment Period 6||4
335748|NCT02948582|825509|P1|COMPLETED|Treatment Period 6||6
335749|NCT02948582|825504|P6|STARTED|Treatment Period 6||6
335750|NCT02948582|825505|P5|STARTED|Treatment Period 6||7
335751|NCT02948582|825506|P4|STARTED|Treatment Period 6||6
335752|NCT02948582|825507|P3|STARTED|Treatment Period 6||6
335753|NCT02948582|825508|P2|STARTED|Treatment Period 6||4
335754|NCT02948582|825509|P1|STARTED|Treatment Period 6||6
335755|NCT02948582|825504|P6|NOT COMPLETED|Washout Period 5||0
335756|NCT02948582|825505|P5|NOT COMPLETED|Washout Period 5||0
335757|NCT02948582|825506|P4|NOT COMPLETED|Washout Period 5||0
335758|NCT02948582|825507|P3|NOT COMPLETED|Washout Period 5||0
335759|NCT02948582|825508|P2|NOT COMPLETED|Washout Period 5||0
335760|NCT02948582|825509|P1|NOT COMPLETED|Washout Period 5||0
335761|NCT02948582|825504|P6|COMPLETED|Washout Period 5||6
335762|NCT02948582|825505|P5|COMPLETED|Washout Period 5||7
335763|NCT02948582|825506|P4|COMPLETED|Washout Period 5||6
335764|NCT02948582|825507|P3|COMPLETED|Washout Period 5||6
335765|NCT02948582|825508|P2|COMPLETED|Washout Period 5||4
335766|NCT02948582|825509|P1|COMPLETED|Washout Period 5||6
335767|NCT02948582|825504|P6|STARTED|Washout Period 5||6
335768|NCT02948582|825505|P5|STARTED|Washout Period 5||7
335769|NCT02948582|825506|P4|STARTED|Washout Period 5||6
335770|NCT02948582|825507|P3|STARTED|Washout Period 5||6
335771|NCT02948582|825508|P2|STARTED|Washout Period 5||4
335772|NCT02948582|825509|P1|STARTED|Washout Period 5||6
335773|NCT02948582|825504|P6|NOT COMPLETED|Treatment Period 5||0
335774|NCT02948582|825505|P5|NOT COMPLETED|Treatment Period 5||0
335775|NCT02948582|825506|P4|NOT COMPLETED|Treatment Period 5||0
335776|NCT02948582|825507|P3|NOT COMPLETED|Treatment Period 5||0
335777|NCT02948582|825508|P2|NOT COMPLETED|Treatment Period 5||0
335778|NCT02948582|825509|P1|NOT COMPLETED|Treatment Period 5||0
335779|NCT02948582|825504|P6|COMPLETED|Treatment Period 5||6
335780|NCT02948582|825505|P5|COMPLETED|Treatment Period 5||7
335781|NCT02948582|825506|P4|COMPLETED|Treatment Period 5||6
335782|NCT02948582|825507|P3|COMPLETED|Treatment Period 5||6
335783|NCT02948582|825508|P2|COMPLETED|Treatment Period 5||4
335784|NCT02948582|825509|P1|COMPLETED|Treatment Period 5||6
335785|NCT02948582|825504|P6|STARTED|Treatment Period 5||6
335786|NCT02948582|825505|P5|STARTED|Treatment Period 5||7
335787|NCT02948582|825506|P4|STARTED|Treatment Period 5||6
335788|NCT02948582|825507|P3|STARTED|Treatment Period 5||6
335789|NCT02948582|825508|P2|STARTED|Treatment Period 5||4
335790|NCT02948582|825509|P1|STARTED|Treatment Period 5||6
335791|NCT02948582|825504|P6|NOT COMPLETED|Washout Period 4||0
335792|NCT02948582|825505|P5|NOT COMPLETED|Washout Period 4||0
335793|NCT02948582|825506|P4|NOT COMPLETED|Washout Period 4||0
335794|NCT02948582|825507|P3|NOT COMPLETED|Washout Period 4||1
335795|NCT02948582|825508|P2|NOT COMPLETED|Washout Period 4||0
335796|NCT02948582|825509|P1|NOT COMPLETED|Washout Period 4||1
335797|NCT02948582|825504|P6|COMPLETED|Washout Period 4||6
335798|NCT02948582|825505|P5|COMPLETED|Washout Period 4||7
335799|NCT02948582|825506|P4|COMPLETED|Washout Period 4||6
335800|NCT02948582|825507|P3|COMPLETED|Washout Period 4||6
335801|NCT02948582|825508|P2|COMPLETED|Washout Period 4||4
335802|NCT02948582|825509|P1|COMPLETED|Washout Period 4||6
335803|NCT02948582|825504|P6|STARTED|Washout Period 4||6
335804|NCT02948582|825505|P5|STARTED|Washout Period 4||7
335805|NCT02948582|825506|P4|STARTED|Washout Period 4||6
335806|NCT02948582|825507|P3|STARTED|Washout Period 4||7
335807|NCT02948582|825508|P2|STARTED|Washout Period 4||4
335808|NCT02948582|825509|P1|STARTED|Washout Period 4||7
335809|NCT02948582|825504|P6|NOT COMPLETED|Treatment Period 4||0
335810|NCT02948582|825505|P5|NOT COMPLETED|Treatment Period 4||0
335811|NCT02948582|825506|P4|NOT COMPLETED|Treatment Period 4||0
335812|NCT02948582|825507|P3|NOT COMPLETED|Treatment Period 4||0
335813|NCT02948582|825508|P2|NOT COMPLETED|Treatment Period 4||0
335814|NCT02948582|825509|P1|NOT COMPLETED|Treatment Period 4||0
335815|NCT02948582|825504|P6|COMPLETED|Treatment Period 4||6
335816|NCT02948582|825505|P5|COMPLETED|Treatment Period 4||7
335817|NCT02948582|825506|P4|COMPLETED|Treatment Period 4||6
335818|NCT02948582|825507|P3|COMPLETED|Treatment Period 4||7
335819|NCT02948582|825508|P2|COMPLETED|Treatment Period 4||4
335820|NCT02948582|825509|P1|COMPLETED|Treatment Period 4||7
335821|NCT02948582|825504|P6|STARTED|Treatment Period 4||6
335822|NCT02948582|825505|P5|STARTED|Treatment Period 4||7
335823|NCT02948582|825506|P4|STARTED|Treatment Period 4||6
335824|NCT02948582|825507|P3|STARTED|Treatment Period 4||7
335825|NCT02948582|825508|P2|STARTED|Treatment Period 4||4
335826|NCT02948582|825509|P1|STARTED|Treatment Period 4||7
335827|NCT02948582|825504|P6|NOT COMPLETED|Washout Period 3||0
335828|NCT02948582|825505|P5|NOT COMPLETED|Washout Period 3||0
335829|NCT02948582|825506|P4|NOT COMPLETED|Washout Period 3||0
335830|NCT02948582|825507|P3|NOT COMPLETED|Washout Period 3||0
335831|NCT02948582|825508|P2|NOT COMPLETED|Washout Period 3||0
335832|NCT02948582|825509|P1|NOT COMPLETED|Washout Period 3||0
335833|NCT02948582|825504|P6|COMPLETED|Washout Period 3||6
335834|NCT02948582|825505|P5|COMPLETED|Washout Period 3||7
335835|NCT02948582|825506|P4|COMPLETED|Washout Period 3||6
335836|NCT02948582|825507|P3|COMPLETED|Washout Period 3||7
335837|NCT02948582|825508|P2|COMPLETED|Washout Period 3||4
335838|NCT02948582|825509|P1|COMPLETED|Washout Period 3||7
335839|NCT02948582|825504|P6|STARTED|Washout Period 3||6
335840|NCT02948582|825505|P5|STARTED|Washout Period 3||7
335841|NCT02948582|825506|P4|STARTED|Washout Period 3||6
335842|NCT02948582|825507|P3|STARTED|Washout Period 3||7
335843|NCT02948582|825508|P2|STARTED|Washout Period 3||4
335844|NCT02948582|825509|P1|STARTED|Washout Period 3||7
335845|NCT02948582|825504|P6|NOT COMPLETED|Treatment Period 3||0
335846|NCT02948582|825505|P5|NOT COMPLETED|Treatment Period 3||0
335847|NCT02948582|825506|P4|NOT COMPLETED|Treatment Period 3||0
335848|NCT02948582|825507|P3|NOT COMPLETED|Treatment Period 3||0
335849|NCT02948582|825508|P2|NOT COMPLETED|Treatment Period 3||0
335850|NCT02948582|825509|P1|NOT COMPLETED|Treatment Period 3||0
335851|NCT02948582|825504|P6|COMPLETED|Treatment Period 3||6
335852|NCT02948582|825505|P5|COMPLETED|Treatment Period 3||7
335853|NCT02948582|825506|P4|COMPLETED|Treatment Period 3||6
335854|NCT02948582|825507|P3|COMPLETED|Treatment Period 3||7
335855|NCT02948582|825508|P2|COMPLETED|Treatment Period 3||4
335856|NCT02948582|825509|P1|COMPLETED|Treatment Period 3||7
335857|NCT02948582|825504|P6|STARTED|Treatment Period 3||6
335858|NCT02948582|825505|P5|STARTED|Treatment Period 3||7
335859|NCT02948582|825506|P4|STARTED|Treatment Period 3||6
335860|NCT02948582|825507|P3|STARTED|Treatment Period 3||7
335861|NCT02948582|825508|P2|STARTED|Treatment Period 3||4
335862|NCT02948582|825509|P1|STARTED|Treatment Period 3||7
335863|NCT02948582|825504|P6|NOT COMPLETED|Washout Period 2||0
335864|NCT02948582|825505|P5|NOT COMPLETED|Washout Period 2||0
335865|NCT02948582|825506|P4|NOT COMPLETED|Washout Period 2||1
335866|NCT02948582|825507|P3|NOT COMPLETED|Washout Period 2||0
335867|NCT02948582|825508|P2|NOT COMPLETED|Washout Period 2||1
335868|NCT02948582|825509|P1|NOT COMPLETED|Washout Period 2||0
335869|NCT02948582|825504|P6|COMPLETED|Washout Period 2||6
335870|NCT02948582|825505|P5|COMPLETED|Washout Period 2||7
335871|NCT02948582|825506|P4|COMPLETED|Washout Period 2||6
335872|NCT02948582|825507|P3|COMPLETED|Washout Period 2||7
335873|NCT02948582|825508|P2|COMPLETED|Washout Period 2||4
335874|NCT02948582|825509|P1|COMPLETED|Washout Period 2||7
335875|NCT02948582|825504|P6|STARTED|Washout Period 2||6
335876|NCT02948582|825505|P5|STARTED|Washout Period 2||7
335877|NCT02948582|825506|P4|STARTED|Washout Period 2||7
335878|NCT02948582|825507|P3|STARTED|Washout Period 2||7
335879|NCT02948582|825508|P2|STARTED|Washout Period 2||5
335880|NCT02948582|825509|P1|STARTED|Washout Period 2||7
335881|NCT02948582|825504|P6|NOT COMPLETED|Treatment Period 2||0
335882|NCT02948582|825505|P5|NOT COMPLETED|Treatment Period 2||0
335883|NCT02948582|825506|P4|NOT COMPLETED|Treatment Period 2||0
335884|NCT02948582|825507|P3|NOT COMPLETED|Treatment Period 2||0
335885|NCT02948582|825508|P2|NOT COMPLETED|Treatment Period 2||0
335886|NCT02948582|825509|P1|NOT COMPLETED|Treatment Period 2||0
335887|NCT02948582|825504|P6|COMPLETED|Treatment Period 2||6
335888|NCT02948582|825505|P5|COMPLETED|Treatment Period 2||7
335889|NCT02948582|825506|P4|COMPLETED|Treatment Period 2||7
335890|NCT02948582|825507|P3|COMPLETED|Treatment Period 2||7
335891|NCT02948582|825508|P2|COMPLETED|Treatment Period 2||5
335892|NCT02948582|825509|P1|COMPLETED|Treatment Period 2||7
335893|NCT02948582|825504|P6|STARTED|Treatment Period 2||6
335894|NCT02948582|825505|P5|STARTED|Treatment Period 2||7
335895|NCT02948582|825506|P4|STARTED|Treatment Period 2||7
335896|NCT02948582|825507|P3|STARTED|Treatment Period 2||7
335897|NCT02948582|825508|P2|STARTED|Treatment Period 2||5
335898|NCT02948582|825509|P1|STARTED|Treatment Period 2||7
335899|NCT02948582|825504|P6|NOT COMPLETED|Washout Period 1||1
335900|NCT02948582|825505|P5|NOT COMPLETED|Washout Period 1||0
335901|NCT02948582|825506|P4|NOT COMPLETED|Washout Period 1||0
335902|NCT02948582|825507|P3|NOT COMPLETED|Washout Period 1||0
335903|NCT02948582|825508|P2|NOT COMPLETED|Washout Period 1||2
335904|NCT02948582|825509|P1|NOT COMPLETED|Washout Period 1||0
335905|NCT02948582|825504|P6|COMPLETED|Washout Period 1||6
335906|NCT02948582|825505|P5|COMPLETED|Washout Period 1||7
335907|NCT02948582|825506|P4|COMPLETED|Washout Period 1||7
335908|NCT02948582|825507|P3|COMPLETED|Washout Period 1||7
335909|NCT02948582|825508|P2|COMPLETED|Washout Period 1||5
335910|NCT02948582|825509|P1|COMPLETED|Washout Period 1||7
335911|NCT02948582|825504|P6|STARTED|Washout Period 1||7
335912|NCT02948582|825505|P5|STARTED|Washout Period 1||7
335913|NCT02948582|825506|P4|STARTED|Washout Period 1||7
335914|NCT02948582|825507|P3|STARTED|Washout Period 1||7
335915|NCT02948582|825508|P2|STARTED|Washout Period 1||7
335916|NCT02948582|825509|P1|STARTED|Washout Period 1||7
335917|NCT02948582|825504|P6|NOT COMPLETED|Treatment Period 1||0
335918|NCT02948582|825505|P5|NOT COMPLETED|Treatment Period 1||0
335919|NCT02948582|825506|P4|NOT COMPLETED|Treatment Period 1||0
335920|NCT02948582|825507|P3|NOT COMPLETED|Treatment Period 1||0
335921|NCT02948582|825508|P2|NOT COMPLETED|Treatment Period 1||0
335922|NCT02948582|825509|P1|NOT COMPLETED|Treatment Period 1||0
335923|NCT02948582|825504|P6|COMPLETED|Treatment Period 1||7
335924|NCT02948582|825505|P5|COMPLETED|Treatment Period 1||7
335925|NCT02948582|825506|P4|COMPLETED|Treatment Period 1||7
335926|NCT02948582|825507|P3|COMPLETED|Treatment Period 1||7
335927|NCT02948582|825508|P2|COMPLETED|Treatment Period 1||7
335928|NCT02948582|825509|P1|COMPLETED|Treatment Period 1||7
335929|NCT02948582|825504|P6|STARTED|Treatment Period 1||7
335930|NCT02948582|825505|P5|STARTED|Treatment Period 1||7
335931|NCT02948582|825506|P4|STARTED|Treatment Period 1||7
335932|NCT02948582|825507|P3|STARTED|Treatment Period 1||7
335933|NCT02948582|825508|P2|STARTED|Treatment Period 1||7
335934|NCT02948582|825509|P1|STARTED|Treatment Period 1||7
335935|NCT02947984|825604|P2|NOT COMPLETED|Overall Study||0
335936|NCT02947984|825605|P1|NOT COMPLETED|Overall Study||0
335937|NCT02947984|825604|P2|COMPLETED|Overall Study||22
335938|NCT02947984|825605|P1|COMPLETED|Overall Study||22
335939|NCT02947984|825604|P2|STARTED|Overall Study||22
335940|NCT02947984|825605|P1|STARTED|Overall Study||22
335941|NCT02947022|825617|P1|NOT COMPLETED|Overall Study||1
335942|NCT02947022|825617|P1|COMPLETED|Overall Study||0
335943|NCT02947022|825617|P1|STARTED|Overall Study||1
335944|NCT02945254|825638|P2|NOT COMPLETED|Overall Study||0
335945|NCT02945254|825639|P1|NOT COMPLETED|Overall Study||2
335946|NCT02945254|825638|P2|COMPLETED|Overall Study||10
335947|NCT02945254|825639|P1|COMPLETED|Overall Study||8
335948|NCT02945254|825638|P2|STARTED|Overall Study||10
335949|NCT02945254|825639|P1|STARTED|Overall Study||10
335950|NCT02943226|825649|P2|NOT COMPLETED|Overall Study||0
335951|NCT02943226|825650|P1|NOT COMPLETED|Overall Study||0
335952|NCT02943226|825649|P2|COMPLETED|Overall Study||30
335953|NCT02943226|825650|P1|COMPLETED|Overall Study||31
335954|NCT02943226|825649|P2|STARTED|Overall Study||30
335955|NCT02943226|825650|P1|STARTED|Overall Study||31
335956|NCT02943213|825666|P1|NOT COMPLETED|Treatment Period 2||0
335957|NCT02943213|825666|P1|COMPLETED|Treatment Period 2||20
335958|NCT02943213|825666|P1|STARTED|Treatment Period 2||20
335959|NCT02943213|825666|P1|NOT COMPLETED|Treatment Period 1||0
335960|NCT02943213|825666|P1|COMPLETED|Treatment Period 1||20
335961|NCT02943213|825666|P1|STARTED|Treatment Period 1||20
335962|NCT02941640|825698|P4|NOT COMPLETED|Overall Study||0
335963|NCT02941640|825699|P3|NOT COMPLETED|Overall Study||0
335964|NCT02941640|825700|P2|NOT COMPLETED|Overall Study||0
335965|NCT02941640|825701|P1|NOT COMPLETED|Overall Study||0
335966|NCT02941640|825698|P4|COMPLETED|Overall Study||30
335967|NCT02941640|825699|P3|COMPLETED|Overall Study||30
335968|NCT02941640|825700|P2|COMPLETED|Overall Study||30
335969|NCT02941640|825701|P1|COMPLETED|Overall Study||30
335970|NCT02941640|825698|P4|STARTED|Overall Study||30
335971|NCT02941640|825699|P3|STARTED|Overall Study||30
335972|NCT02941640|825700|P2|STARTED|Overall Study||30
335973|NCT02941640|825701|P1|STARTED|Overall Study||30
335974|NCT02939170|825733|P2|NOT COMPLETED|Overall Study||0
335975|NCT02939170|825734|P1|NOT COMPLETED|Overall Study||0
335976|NCT02939170|825733|P2|COMPLETED|Overall Study||40
335977|NCT02939170|825734|P1|COMPLETED|Overall Study||40
335978|NCT02939170|825733|P2|STARTED|Overall Study||40
335979|NCT02939170|825734|P1|STARTED|Overall Study||40
335980|NCT02937870|825745|P1|NOT COMPLETED|Overall Study||3
335981|NCT02937870|825745|P1|COMPLETED|Overall Study||20
335982|NCT02937870|825745|P1|Received no Adhesive|Overall Study||20
335983|NCT02937870|825745|P1|Received Positive Control Adhesive|Overall Study||21
335984|NCT02937870|825745|P1|Received Test Adhesive 2|Overall Study||22
335985|NCT02937870|825745|P1|Received Test Adhesive 1|Overall Study||21
335986|NCT02937870|825745|P1|STARTED|Overall Study||23
335987|NCT02937623|825763|P2|NOT COMPLETED|Overall Study||0
335988|NCT02937623|825764|P1|NOT COMPLETED|Overall Study||0
335989|NCT02937623|825763|P2|COMPLETED|Overall Study||60
335990|NCT02937623|825764|P1|COMPLETED|Overall Study||60
335991|NCT02937623|825763|P2|STARTED|Overall Study||60
335992|NCT02937623|825764|P1|STARTED|Overall Study||60
335993|NCT02937506|825778|P2|NOT COMPLETED|Overall Study||0
335994|NCT02937506|825779|P1|NOT COMPLETED|Overall Study||0
335995|NCT02937506|825778|P2|COMPLETED|Overall Study||300
335996|NCT02937506|825779|P1|COMPLETED|Overall Study||300
335997|NCT02937506|825778|P2|STARTED|Overall Study||300
335998|NCT02937506|825779|P1|STARTED|Overall Study||300
335999|NCT02935894|825785|P1|NOT COMPLETED|Overall Study||1
336000|NCT02935894|825785|P1|COMPLETED|Overall Study||13
336001|NCT02935894|825785|P1|STARTED|Overall Study||14
336002|NCT02934347|825798|P2|NOT COMPLETED|Overall Study||0
336003|NCT02934347|825799|P1|NOT COMPLETED|Overall Study||0
336004|NCT02934347|825798|P2|COMPLETED|Overall Study||407
336005|NCT02934347|825799|P1|COMPLETED|Overall Study||374
336006|NCT02934347|825798|P2|STARTED|Overall Study||407
336007|NCT02934347|825799|P1|STARTED|Overall Study||374
336008|NCT02933476|825811|P1|NOT COMPLETED|Overall Study||0
336009|NCT02933476|825811|P1|COMPLETED|Overall Study||5
336010|NCT02933476|825811|P1|STARTED|Overall Study||5
336011|NCT02929823|825821|P3|NOT COMPLETED|Overall Study||4
336012|NCT02929823|825822|P2|NOT COMPLETED|Overall Study||6
336013|NCT02929823|825823|P1|NOT COMPLETED|Overall Study||3
336014|NCT02929823|825821|P3|COMPLETED|Overall Study||38
336015|NCT02929823|825822|P2|COMPLETED|Overall Study||40
336016|NCT02929823|825823|P1|COMPLETED|Overall Study||39
336017|NCT02929823|825821|P3|STARTED|Overall Study||42
336018|NCT02929823|825822|P2|STARTED|Overall Study||46
336019|NCT02929823|825823|P1|STARTED|Overall Study||42
336020|NCT02928380|825831|P6|NOT COMPLETED|Period 3||0
336021|NCT02928380|825832|P5|NOT COMPLETED|Period 3||0
336022|NCT02928380|825833|P4|NOT COMPLETED|Period 3||0
336023|NCT02928380|825834|P3|NOT COMPLETED|Period 3||0
336024|NCT02928380|825835|P2|NOT COMPLETED|Period 3||0
336025|NCT02928380|825836|P1|NOT COMPLETED|Period 3||0
336026|NCT02928380|825831|P6|COMPLETED|Period 3||14
336027|NCT02928380|825832|P5|COMPLETED|Period 3||14
336028|NCT02928380|825833|P4|COMPLETED|Period 3||14
336029|NCT02928380|825834|P3|COMPLETED|Period 3||14
336030|NCT02928380|825835|P2|COMPLETED|Period 3||14
336031|NCT02928380|825836|P1|COMPLETED|Period 3||13
336032|NCT02928380|825831|P6|STARTED|Period 3||14
336033|NCT02928380|825832|P5|STARTED|Period 3||14
336034|NCT02928380|825833|P4|STARTED|Period 3||14
336035|NCT02928380|825834|P3|STARTED|Period 3||14
336036|NCT02928380|825835|P2|STARTED|Period 3||14
336037|NCT02928380|825836|P1|STARTED|Period 3||13
336038|NCT02928380|825831|P6|NOT COMPLETED|Wash Out Period 2||0
336039|NCT02928380|825832|P5|NOT COMPLETED|Wash Out Period 2||0
336040|NCT02928380|825833|P4|NOT COMPLETED|Wash Out Period 2||0
336041|NCT02928380|825834|P3|NOT COMPLETED|Wash Out Period 2||0
336042|NCT02928380|825835|P2|NOT COMPLETED|Wash Out Period 2||0
336043|NCT02928380|825836|P1|NOT COMPLETED|Wash Out Period 2||0
336044|NCT02928380|825831|P6|COMPLETED|Wash Out Period 2||14
336045|NCT02928380|825832|P5|COMPLETED|Wash Out Period 2||14
336046|NCT02928380|825833|P4|COMPLETED|Wash Out Period 2||14
336047|NCT02928380|825834|P3|COMPLETED|Wash Out Period 2||14
336048|NCT02928380|825835|P2|COMPLETED|Wash Out Period 2||14
336049|NCT02928380|825836|P1|COMPLETED|Wash Out Period 2||13
336050|NCT02928380|825831|P6|STARTED|Wash Out Period 2||14
336051|NCT02928380|825832|P5|STARTED|Wash Out Period 2||14
336052|NCT02928380|825833|P4|STARTED|Wash Out Period 2||14
336053|NCT02928380|825834|P3|STARTED|Wash Out Period 2||14
336054|NCT02928380|825835|P2|STARTED|Wash Out Period 2||14
336055|NCT02928380|825836|P1|STARTED|Wash Out Period 2||13
336056|NCT02928380|825831|P6|NOT COMPLETED|Period 2||0
336057|NCT02928380|825832|P5|NOT COMPLETED|Period 2||0
336058|NCT02928380|825833|P4|NOT COMPLETED|Period 2||0
336059|NCT02928380|825834|P3|NOT COMPLETED|Period 2||0
336060|NCT02928380|825835|P2|NOT COMPLETED|Period 2||0
336061|NCT02928380|825836|P1|NOT COMPLETED|Period 2||0
336062|NCT02928380|825831|P6|COMPLETED|Period 2||14
336063|NCT02928380|825832|P5|COMPLETED|Period 2||14
336064|NCT02928380|825833|P4|COMPLETED|Period 2||14
336065|NCT02928380|825834|P3|COMPLETED|Period 2||14
336066|NCT02928380|825835|P2|COMPLETED|Period 2||14
336067|NCT02928380|825836|P1|COMPLETED|Period 2||13
336068|NCT02928380|825831|P6|STARTED|Period 2||14
336069|NCT02928380|825832|P5|STARTED|Period 2||14
336070|NCT02928380|825833|P4|STARTED|Period 2||14
336071|NCT02928380|825834|P3|STARTED|Period 2||14
336072|NCT02928380|825835|P2|STARTED|Period 2||14
336073|NCT02928380|825836|P1|STARTED|Period 2||13
336074|NCT02928380|825831|P6|NOT COMPLETED|Wash Out Period 1||0
336075|NCT02928380|825832|P5|NOT COMPLETED|Wash Out Period 1||0
336076|NCT02928380|825833|P4|NOT COMPLETED|Wash Out Period 1||0
336077|NCT02928380|825834|P3|NOT COMPLETED|Wash Out Period 1||0
336078|NCT02928380|825835|P2|NOT COMPLETED|Wash Out Period 1||0
336079|NCT02928380|825836|P1|NOT COMPLETED|Wash Out Period 1||0
336080|NCT02928380|825831|P6|COMPLETED|Wash Out Period 1||14
336081|NCT02928380|825832|P5|COMPLETED|Wash Out Period 1||14
336082|NCT02928380|825833|P4|COMPLETED|Wash Out Period 1||14
336083|NCT02928380|825834|P3|COMPLETED|Wash Out Period 1||14
336084|NCT02928380|825835|P2|COMPLETED|Wash Out Period 1||14
336085|NCT02928380|825836|P1|COMPLETED|Wash Out Period 1||13
336086|NCT02928380|825831|P6|STARTED|Wash Out Period 1||14
336087|NCT02928380|825832|P5|STARTED|Wash Out Period 1||14
336088|NCT02928380|825833|P4|STARTED|Wash Out Period 1||14
336089|NCT02928380|825834|P3|STARTED|Wash Out Period 1||14
336090|NCT02928380|825835|P2|STARTED|Wash Out Period 1||14
336091|NCT02928380|825836|P1|STARTED|Wash Out Period 1||13
336092|NCT02928380|825831|P6|NOT COMPLETED|Period 1||0
336093|NCT02928380|825832|P5|NOT COMPLETED|Period 1||0
336094|NCT02928380|825833|P4|NOT COMPLETED|Period 1||0
336095|NCT02928380|825834|P3|NOT COMPLETED|Period 1||0
336096|NCT02928380|825835|P2|NOT COMPLETED|Period 1||0
336097|NCT02928380|825836|P1|NOT COMPLETED|Period 1||0
336098|NCT02928380|825831|P6|COMPLETED|Period 1||14
336099|NCT02928380|825832|P5|COMPLETED|Period 1||14
336100|NCT02928380|825833|P4|COMPLETED|Period 1||14
336101|NCT02928380|825834|P3|COMPLETED|Period 1||14
336102|NCT02928380|825835|P2|COMPLETED|Period 1||14
336103|NCT02928380|825836|P1|COMPLETED|Period 1||13
336104|NCT02928380|825831|P6|STARTED|Period 1||14
336105|NCT02928380|825832|P5|STARTED|Period 1||14
336106|NCT02928380|825833|P4|STARTED|Period 1||14
336107|NCT02928380|825834|P3|STARTED|Period 1||14
336108|NCT02928380|825835|P2|STARTED|Period 1||14
336109|NCT02928380|825836|P1|STARTED|Period 1||13
336110|NCT02923245|825858|P2|NOT COMPLETED|Overall Study||1
336111|NCT02923245|825859|P1|NOT COMPLETED|Overall Study||2
336112|NCT02923245|825858|P2|COMPLETED|Overall Study||59
336113|NCT02923245|825859|P1|COMPLETED|Overall Study||58
336114|NCT02923245|825858|P2|STARTED|Overall Study||60
336115|NCT02923245|825859|P1|STARTED|Overall Study||60
336116|NCT02922868|825878|P2|NOT COMPLETED|Overall Study||0
336117|NCT02922868|825879|P1|NOT COMPLETED|Overall Study||0
336118|NCT02922868|825878|P2|COMPLETED|Overall Study||30
336119|NCT02922868|825879|P1|COMPLETED|Overall Study||30
336120|NCT02922868|825878|P2|STARTED|Overall Study||30
336121|NCT02922868|825879|P1|STARTED|Overall Study||30
336122|NCT02921412|825897|P1|NOT COMPLETED|Overall Study||0
336123|NCT02921412|825897|P1|COMPLETED|Overall Study||36
336124|NCT02921412|825897|P1|STARTED|Overall Study||36
336125|NCT02921386|825920|P1|NOT COMPLETED|Sequence E: FDA High Fat Breakfast||0
336126|NCT02921386|825920|P1|COMPLETED|Sequence E: FDA High Fat Breakfast||18
336127|NCT02921386|825920|P1|STARTED|Sequence E: FDA High Fat Breakfast||18
336128|NCT02921386|825920|P1|NOT COMPLETED|Sequence D: 45 g Fat Breakfast||0
336129|NCT02921386|825920|P1|COMPLETED|Sequence D: 45 g Fat Breakfast||18
336130|NCT02921386|825920|P1|STARTED|Sequence D: 45 g Fat Breakfast||18
336131|NCT02921386|825920|P1|NOT COMPLETED|Sequence C: 30 g Fat Breakfast||0
336132|NCT02921386|825920|P1|COMPLETED|Sequence C: 30 g Fat Breakfast||18
336133|NCT02921386|825920|P1|STARTED|Sequence C: 30 g Fat Breakfast||18
336134|NCT02921386|825920|P1|NOT COMPLETED|Sequence B: 15 g Fat Breakfast||0
336135|NCT02921386|825920|P1|COMPLETED|Sequence B: 15 g Fat Breakfast||18
336136|NCT02921386|825920|P1|STARTED|Sequence B: 15 g Fat Breakfast||18
336137|NCT02921386|825920|P1|NOT COMPLETED|Sequence A: Fasting||0
336138|NCT02921386|825920|P1|COMPLETED|Sequence A: Fasting||18
336139|NCT02921386|825920|P1|STARTED|Sequence A: Fasting||18
336140|NCT02921295|825943|P1|NOT COMPLETED|Conventional Prostheses||0
336141|NCT02921295|825943|P1|COMPLETED|Conventional Prostheses||1
336142|NCT02921295|825943|P1|STARTED|Conventional Prostheses||1
336143|NCT02921295|825943|P1|NOT COMPLETED|Sidekicks||0
336144|NCT02921295|825943|P1|COMPLETED|Sidekicks||1
336145|NCT02921295|825943|P1|STARTED|Sidekicks||1
336146|NCT02920957|825953|P2|NOT COMPLETED|Second Intervention: 1 Month||1
336147|NCT02920957|825954|P1|NOT COMPLETED|Second Intervention: 1 Month||0
336148|NCT02920957|825953|P2|COMPLETED|Second Intervention: 1 Month||40
336149|NCT02920957|825954|P1|COMPLETED|Second Intervention: 1 Month||42
336150|NCT02920957|825953|P2|STARTED|Second Intervention: 1 Month||41
336151|NCT02920957|825954|P1|STARTED|Second Intervention: 1 Month||42
336152|NCT02920957|825953|P2|NOT COMPLETED|First Intervention : 1 Month||0
336153|NCT02920957|825954|P1|NOT COMPLETED|First Intervention : 1 Month||4
336154|NCT02920957|825953|P2|COMPLETED|First Intervention : 1 Month||41
336155|NCT02920957|825954|P1|COMPLETED|First Intervention : 1 Month||42
336156|NCT02920957|825953|P2|STARTED|First Intervention : 1 Month||41
336157|NCT02920957|825954|P1|STARTED|First Intervention : 1 Month||46
336158|NCT02920749|826010|P4|NOT COMPLETED|Overall Study||0
336159|NCT02920749|826011|P3|NOT COMPLETED|Overall Study||0
336160|NCT02920749|826012|P2|NOT COMPLETED|Overall Study||0
336161|NCT02920749|826013|P1|NOT COMPLETED|Overall Study||0
336162|NCT02920749|826010|P4|COMPLETED|Overall Study||30
336163|NCT02920749|826011|P3|COMPLETED|Overall Study||30
336164|NCT02920749|826012|P2|COMPLETED|Overall Study||30
336165|NCT02920749|826013|P1|COMPLETED|Overall Study||30
336166|NCT02920749|826010|P4|STARTED|Overall Study||30
336167|NCT02920749|826011|P3|STARTED|Overall Study||30
336168|NCT02920749|826012|P2|STARTED|Overall Study||30
336169|NCT02920749|826013|P1|STARTED|Overall Study||30
336170|NCT02919657|826027|P2|NOT COMPLETED|Overall Study||0
336171|NCT02919657|826028|P1|NOT COMPLETED|Overall Study||0
336172|NCT02919657|826027|P2|COMPLETED|Overall Study|completed with the same initial 10 participants|10
336173|NCT02919657|826028|P1|COMPLETED|Overall Study|completed with the same initial 10 participants|10
336174|NCT02919657|826027|P2|STARTED|Overall Study|10 Participants|10
336175|NCT02919657|826028|P1|STARTED|Overall Study|10 Participants|10
336176|NCT02918396|826037|P3|NOT COMPLETED|Overall Study||0
336177|NCT02918396|826038|P2|NOT COMPLETED|Overall Study||0
336178|NCT02918396|826039|P1|NOT COMPLETED|Overall Study||0
336179|NCT02918396|826037|P3|COMPLETED|Overall Study||2
336180|NCT02918396|826038|P2|COMPLETED|Overall Study||1
336181|NCT02918396|826039|P1|COMPLETED|Overall Study||2
336182|NCT02918396|826037|P3|STARTED|Overall Study||2
336183|NCT02918396|826038|P2|STARTED|Overall Study||1
336184|NCT02918396|826039|P1|STARTED|Overall Study||2
336185|NCT02915978|826050|P3|NOT COMPLETED|Overall Study||0
336186|NCT02915978|826051|P2|NOT COMPLETED|Overall Study||1
336187|NCT02915978|826052|P1|NOT COMPLETED|Overall Study||2
336188|NCT02915978|826050|P3|COMPLETED|Overall Study||15
336189|NCT02915978|826051|P2|COMPLETED|Overall Study||14
336190|NCT02915978|826052|P1|COMPLETED|Overall Study||13
336191|NCT02915978|826050|P3|STARTED|Overall Study||15
336192|NCT02915978|826051|P2|STARTED|Overall Study||15
336193|NCT02915978|826052|P1|STARTED|Overall Study||15
336194|NCT02915302|826104|P2|NOT COMPLETED|Overall Study||78
336195|NCT02915302|826105|P1|NOT COMPLETED|Overall Study||65
336196|NCT02915302|826104|P2|COMPLETED|Overall Study||917
336197|NCT02915302|826105|P1|COMPLETED|Overall Study||890
336198|NCT02915302|826104|P2|Vaccinated (Safety Analysis Set)|Overall Study||992
336199|NCT02915302|826105|P1|Vaccinated (Safety Analysis Set)|Overall Study||949
336200|NCT02915302|826104|P2|STARTED|Overall Study||995
336201|NCT02915302|826105|P1|STARTED|Overall Study||955
336202|NCT02914236|826115|P1|NOT COMPLETED|Overall Study||1
336203|NCT02914236|826115|P1|COMPLETED|Overall Study||49
336204|NCT02914236|826115|P1|26-week Follow-up Visit|Overall Study||49
336205|NCT02914236|826115|P1|12-week Follow-up Visit|Overall Study||50
336206|NCT02914236|826115|P1|4-week Follow-up Visit|Overall Study||50
336207|NCT02914236|826115|P1|STARTED|Overall Study||50
336208|NCT02912650|826127|P4|NOT COMPLETED|Overall Study||5
336209|NCT02912650|826128|P3|NOT COMPLETED|Overall Study||2
336210|NCT02912650|826129|P2|NOT COMPLETED|Overall Study||0
336211|NCT02912650|826130|P1|NOT COMPLETED|Overall Study||1
336212|NCT02912650|826127|P4|COMPLETED|Overall Study||160
336213|NCT02912650|826128|P3|COMPLETED|Overall Study||173
336214|NCT02912650|826129|P2|COMPLETED|Overall Study||172
336215|NCT02912650|826130|P1|COMPLETED|Overall Study||55
336216|NCT02912650|826127|P4|STARTED|Overall Study||165
336217|NCT02912650|826128|P3|STARTED|Overall Study||175
336218|NCT02912650|826129|P2|STARTED|Overall Study||172
336219|NCT02912650|826130|P1|STARTED|Overall Study||56
336220|NCT02910362|826214|P2|NOT COMPLETED|Overall Study||0
336221|NCT02910362|826215|P1|NOT COMPLETED|Overall Study||0
336222|NCT02910362|826214|P2|COMPLETED|Overall Study||7
336223|NCT02910362|826215|P1|COMPLETED|Overall Study||8
336224|NCT02910362|826214|P2|STARTED|Overall Study||7
336225|NCT02910362|826215|P1|STARTED|Overall Study||8
336226|NCT02908269|826224|P3|NOT COMPLETED|Overall Study||0
336227|NCT02908269|826225|P2|NOT COMPLETED|Overall Study||0
336228|NCT02908269|826226|P1|NOT COMPLETED|Overall Study||0
336229|NCT02908269|826224|P3|COMPLETED|Overall Study||60
336230|NCT02908269|826225|P2|COMPLETED|Overall Study||60
336231|NCT02908269|826226|P1|COMPLETED|Overall Study||60
336232|NCT02908269|826224|P3|STARTED|Overall Study||60
336233|NCT02908269|826225|P2|STARTED|Overall Study||60
336234|NCT02908269|826226|P1|STARTED|Overall Study||60
336235|NCT02907268|826242|P2|NOT COMPLETED|Overall Study||0
336236|NCT02907268|826243|P1|NOT COMPLETED|Overall Study||0
336237|NCT02907268|826242|P2|COMPLETED|Overall Study||5
336238|NCT02907268|826243|P1|COMPLETED|Overall Study||5
336239|NCT02907268|826242|P2|STARTED|Overall Study||5
336240|NCT02907268|826243|P1|STARTED|Overall Study||5
336241|NCT02903238|826250|P1|NOT COMPLETED|Overall Study||4
336242|NCT02903238|826250|P1|COMPLETED|Overall Study||17
336243|NCT02903238|826250|P1|STARTED|Overall Study||21
336244|NCT02901054|826259|P1|NOT COMPLETED|Overall Study||4
336245|NCT02901054|826259|P1|COMPLETED|Overall Study||15
336246|NCT02901054|826259|P1|STARTED|Overall Study|19 consented, 3 withdrew prior to intervention, 1 received study drug but surgery was cancelled.|19
336247|NCT02895347|826265|P2|NOT COMPLETED|Overall Study||1
336248|NCT02895347|826266|P1|NOT COMPLETED|Overall Study||3
336249|NCT02895347|826265|P2|COMPLETED|Overall Study||19
336250|NCT02895347|826266|P1|COMPLETED|Overall Study||17
336251|NCT02895347|826265|P2|STARTED|Overall Study||20
336252|NCT02895347|826266|P1|STARTED|Overall Study||20
336253|NCT02891863|826275|P1|NOT COMPLETED|Overall Study||0
336254|NCT02891863|826275|P1|COMPLETED|Overall Study||9
336255|NCT02891863|826275|P1|STARTED|Overall Study||9
336256|NCT02890303|826280|P1|NOT COMPLETED|Overall Study||0
336257|NCT02890303|826280|P1|COMPLETED|Overall Study||100
336258|NCT02890303|826280|P1|STARTED|Overall Study||100
336259|NCT02889289|826284|P1|NOT COMPLETED|Overall Study||0
336260|NCT02889289|826284|P1|COMPLETED|Overall Study||1
336261|NCT02889289|826284|P1|STARTED|Overall Study||1
336262|NCT02886338|826293|P1|NOT COMPLETED|Overall Study||1
336263|NCT02886338|826293|P1|COMPLETED|Overall Study||9
336264|NCT02886338|826293|P1|STARTED|Overall Study||10
336265|NCT02884427|826300|P3|NOT COMPLETED|Overall Study||0
336266|NCT02884427|826301|P2|NOT COMPLETED|Overall Study||0
336267|NCT02884427|826302|P1|NOT COMPLETED|Overall Study||0
336268|NCT02884427|826300|P3|COMPLETED|Overall Study||50
336269|NCT02884427|826301|P2|COMPLETED|Overall Study||52
336270|NCT02884427|826302|P1|COMPLETED|Overall Study||48
336271|NCT02884427|826300|P3|STARTED|Overall Study||50
336272|NCT02884427|826301|P2|STARTED|Overall Study||52
336273|NCT02884427|826302|P1|STARTED|Overall Study||48
336274|NCT02882152|826318|P2|NOT COMPLETED|Overall Study||0
336275|NCT02882152|826319|P1|NOT COMPLETED|Overall Study||1
336276|NCT02882152|826318|P2|COMPLETED|Overall Study||20
336277|NCT02882152|826319|P1|COMPLETED|Overall Study||19
336278|NCT02882152|826318|P2|STARTED|Overall Study||20
336279|NCT02882152|826319|P1|STARTED|Overall Study||20
336280|NCT02881658|826329|P2|NOT COMPLETED|Overall Study||5
336281|NCT02881658|826330|P1|NOT COMPLETED|Overall Study||2
336282|NCT02881658|826329|P2|COMPLETED|Overall Study||96
336283|NCT02881658|826330|P1|COMPLETED|Overall Study||98
336284|NCT02881658|826329|P2|STARTED|Overall Study||101
336285|NCT02881658|826330|P1|STARTED|Overall Study||100
336286|NCT02877732|826366|P2|NOT COMPLETED|Overall Study||6
336287|NCT02877732|826367|P1|NOT COMPLETED|Overall Study||6
336288|NCT02877732|826366|P2|COMPLETED|Overall Study||0
336289|NCT02877732|826367|P1|COMPLETED|Overall Study||0
336290|NCT02877732|826366|P2|STARTED|Overall Study||6
336291|NCT02877732|826367|P1|STARTED|Overall Study||6
336292|NCT02877082|826383|P1|NOT COMPLETED|Overall Study||5
336293|NCT02877082|826383|P1|COMPLETED|Overall Study||0
336294|NCT02877082|826383|P1|STARTED|Overall Study||5
336295|NCT02876757|826393|P2|NOT COMPLETED|Overall Study||0
336296|NCT02876757|826394|P1|NOT COMPLETED|Overall Study||0
336297|NCT02876757|826393|P2|COMPLETED|Overall Study||93197
336298|NCT02876757|826394|P1|COMPLETED|Overall Study||93197
336299|NCT02876757|826393|P2|STARTED|Overall Study||93197
336300|NCT02876757|826394|P1|STARTED|Overall Study||93197
336301|NCT02874846|826406|P2|NOT COMPLETED|Overall Study||0
336302|NCT02874846|826407|P1|NOT COMPLETED|Overall Study||0
336303|NCT02874846|826406|P2|COMPLETED|Overall Study||4
336304|NCT02874846|826407|P1|COMPLETED|Overall Study||8
336305|NCT02874846|826406|P2|STARTED|Overall Study||4
336306|NCT02874846|826407|P1|STARTED|Overall Study||8
336307|NCT02873481|826417|P2|NOT COMPLETED|Overall Study||0
336308|NCT02873481|826418|P1|NOT COMPLETED|Overall Study||0
336309|NCT02873481|826417|P2|COMPLETED|Overall Study||17
336310|NCT02873481|826418|P1|COMPLETED|Overall Study||15
336311|NCT02873481|826417|P2|STARTED|Overall Study||17
336312|NCT02873481|826418|P1|STARTED|Overall Study||15
336313|NCT02873429|826435|P2|NOT COMPLETED|16 Weeks||2
336314|NCT02873429|826436|P1|NOT COMPLETED|16 Weeks||5
336315|NCT02873429|826435|P2|COMPLETED|16 Weeks||96
336316|NCT02873429|826436|P1|COMPLETED|16 Weeks||100
336317|NCT02873429|826435|P2|STARTED|16 Weeks|1 Conv. participant Missed 6-8 week but was eligible for 16 week|98
336318|NCT02873429|826436|P1|STARTED|16 Weeks|10 CAM participants Missed 6-8 week but are eligible for 16 week|105
336319|NCT02873429|826435|P2|NOT COMPLETED|6-8 Weeks||1
336320|NCT02873429|826436|P1|NOT COMPLETED|6-8 Weeks||10
336321|NCT02873429|826435|P2|COMPLETED|6-8 Weeks||97
336322|NCT02873429|826436|P1|COMPLETED|6-8 Weeks||95
336323|NCT02873429|826435|P2|STARTED|6-8 Weeks|2 Con. participants not eligible to complete follow ups because they did not continue treatment.|98
336324|NCT02873429|826436|P1|STARTED|6-8 Weeks|4 CAM participants not eligible to complete follow ups because they did not continue treatment.|105
336325|NCT02873429|826435|P2|NOT COMPLETED|Baseline||0
336326|NCT02873429|826436|P1|NOT COMPLETED|Baseline||0
336327|NCT02873429|826435|P2|COMPLETED|Baseline||100
336328|NCT02873429|826436|P1|COMPLETED|Baseline||109
336329|NCT02873429|826435|P2|STARTED|Baseline||100
336330|NCT02873429|826436|P1|STARTED|Baseline||109
336331|NCT02873104|826448|P2|NOT COMPLETED|Overall Study||0
336332|NCT02873104|826449|P1|NOT COMPLETED|Overall Study||1
336333|NCT02873104|826448|P2|COMPLETED|Overall Study||23
336334|NCT02873104|826449|P1|COMPLETED|Overall Study||46
336335|NCT02873104|826448|P2|STARTED|Overall Study||23
336336|NCT02873104|826449|P1|STARTED|Overall Study||47
336337|NCT02871375|826461|P2|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
336338|NCT02871375|826462|P1|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
336339|NCT02871375|826461|P2|COMPLETED|Period 2, Second 14 Days of Wear||76
336340|NCT02871375|826462|P1|COMPLETED|Period 2, Second 14 Days of Wear||89
336341|NCT02871375|826461|P2|STARTED|Period 2, Second 14 Days of Wear||76
336342|NCT02871375|826462|P1|STARTED|Period 2, Second 14 Days of Wear||89
336343|NCT02871375|826461|P2|NOT COMPLETED|Period 1, First 14 Days of Wear||1
336344|NCT02871375|826462|P1|NOT COMPLETED|Period 1, First 14 Days of Wear||0
336345|NCT02871375|826461|P2|COMPLETED|Period 1, First 14 Days of Wear||76
336346|NCT02871375|826462|P1|COMPLETED|Period 1, First 14 Days of Wear||89
336347|NCT02871375|826461|P2|STARTED|Period 1, First 14 Days of Wear||77
336348|NCT02871375|826462|P1|STARTED|Period 1, First 14 Days of Wear||89
336349|NCT02870205|826475|P4|NOT COMPLETED|Overall Study||7
336350|NCT02870205|826476|P3|NOT COMPLETED|Overall Study||7
336351|NCT02870205|826477|P2|NOT COMPLETED|Overall Study||5
336352|NCT02870205|826478|P1|NOT COMPLETED|Overall Study||10
336353|NCT02870205|826475|P4|COMPLETED|Overall Study||287
336354|NCT02870205|826476|P3|COMPLETED|Overall Study||287
336355|NCT02870205|826477|P2|COMPLETED|Overall Study||289
336356|NCT02870205|826478|P1|COMPLETED|Overall Study||284
336357|NCT02870205|826475|P4|STARTED|Overall Study||294
336358|NCT02870205|826476|P3|STARTED|Overall Study||294
336359|NCT02870205|826477|P2|STARTED|Overall Study||294
336360|NCT02870205|826478|P1|STARTED|Overall Study||294
336361|NCT02869451|826488|P1|NOT COMPLETED|Overall Study||0
336362|NCT02869451|826488|P1|COMPLETED|Overall Study||5
336363|NCT02869451|826488|P1|STARTED|Overall Study||5
336364|NCT02867150|826510|P1|NOT COMPLETED|Overall Study||0
336365|NCT02867150|826510|P1|COMPLETED|Overall Study||58
336366|NCT02867150|826510|P1|STARTED|Overall Study||58
336367|NCT02865083|826516|P2|NOT COMPLETED|Overall Study||1
336368|NCT02865083|826517|P1|NOT COMPLETED|Overall Study||3
336369|NCT02865083|826516|P2|COMPLETED|Overall Study||0
336370|NCT02865083|826517|P1|COMPLETED|Overall Study||0
336371|NCT02865083|826516|P2|STARTED|Overall Study||1
336372|NCT02865083|826517|P1|STARTED|Overall Study||3
336373|NCT02864732|826537|P2|NOT COMPLETED|Overall Study||2
336374|NCT02864732|826538|P1|NOT COMPLETED|Overall Study||2
336375|NCT02864732|826537|P2|COMPLETED|Overall Study||13
336376|NCT02864732|826538|P1|COMPLETED|Overall Study||13
336377|NCT02864732|826537|P2|STARTED|Overall Study||15
336378|NCT02864732|826538|P1|STARTED|Overall Study||15
336379|NCT02863198|826555|P2|NOT COMPLETED|Overall Study||0
336380|NCT02863198|826556|P1|NOT COMPLETED|Overall Study||0
336381|NCT02863198|826555|P2|COMPLETED|Overall Study||60
336382|NCT02863198|826556|P1|COMPLETED|Overall Study||60
336383|NCT02863198|826555|P2|STARTED|Overall Study||60
336384|NCT02863198|826556|P1|STARTED|Overall Study||60
336385|NCT02862730|826572|P7|NOT COMPLETED|Fourth Intervention (84 Hours)||0
336386|NCT02862730|826573|P6|NOT COMPLETED|Fourth Intervention (84 Hours)||0
336387|NCT02862730|826574|P5|NOT COMPLETED|Fourth Intervention (84 Hours)||0
336388|NCT02862730|826575|P4|NOT COMPLETED|Fourth Intervention (84 Hours)||0
336389|NCT02862730|826576|P3|NOT COMPLETED|Fourth Intervention (84 Hours)||0
336390|NCT02862730|826577|P2|NOT COMPLETED|Fourth Intervention (84 Hours)||0
336391|NCT02862730|826578|P1|NOT COMPLETED|Fourth Intervention (84 Hours)||0
336392|NCT02862730|826572|P7|COMPLETED|Fourth Intervention (84 Hours)||1
336393|NCT02862730|826573|P6|COMPLETED|Fourth Intervention (84 Hours)||1
336394|NCT02862730|826574|P5|COMPLETED|Fourth Intervention (84 Hours)||4
336395|NCT02862730|826575|P4|COMPLETED|Fourth Intervention (84 Hours)||4
336396|NCT02862730|826576|P3|COMPLETED|Fourth Intervention (84 Hours)||6
336397|NCT02862730|826577|P2|COMPLETED|Fourth Intervention (84 Hours)||1
336398|NCT02862730|826578|P1|COMPLETED|Fourth Intervention (84 Hours)||3
336399|NCT02862730|826572|P7|STARTED|Fourth Intervention (84 Hours)||1
336400|NCT02862730|826573|P6|STARTED|Fourth Intervention (84 Hours)||1
336401|NCT02862730|826574|P5|STARTED|Fourth Intervention (84 Hours)||4
336402|NCT02862730|826575|P4|STARTED|Fourth Intervention (84 Hours)||4
336403|NCT02862730|826576|P3|STARTED|Fourth Intervention (84 Hours)||6
336404|NCT02862730|826577|P2|STARTED|Fourth Intervention (84 Hours)||1
336405|NCT02862730|826578|P1|STARTED|Fourth Intervention (84 Hours)||3
336406|NCT02862730|826572|P7|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
336407|NCT02862730|826573|P6|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
336408|NCT02862730|826574|P5|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
336409|NCT02862730|826575|P4|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
336410|NCT02862730|826576|P3|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
336411|NCT02862730|826577|P2|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
336412|NCT02862730|826578|P1|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
336413|NCT02862730|826572|P7|COMPLETED|Fourth Rest Period (7-45 Days)||1
336414|NCT02862730|826573|P6|COMPLETED|Fourth Rest Period (7-45 Days)||1
336415|NCT02862730|826574|P5|COMPLETED|Fourth Rest Period (7-45 Days)||4
336416|NCT02862730|826575|P4|COMPLETED|Fourth Rest Period (7-45 Days)||4
336417|NCT02862730|826576|P3|COMPLETED|Fourth Rest Period (7-45 Days)||6
336418|NCT02862730|826577|P2|COMPLETED|Fourth Rest Period (7-45 Days)||1
336419|NCT02862730|826578|P1|COMPLETED|Fourth Rest Period (7-45 Days)||3
336420|NCT02862730|826572|P7|STARTED|Fourth Rest Period (7-45 Days)||1
336421|NCT02862730|826573|P6|STARTED|Fourth Rest Period (7-45 Days)||1
336422|NCT02862730|826574|P5|STARTED|Fourth Rest Period (7-45 Days)||4
336423|NCT02862730|826575|P4|STARTED|Fourth Rest Period (7-45 Days)||4
336424|NCT02862730|826576|P3|STARTED|Fourth Rest Period (7-45 Days)||6
336425|NCT02862730|826577|P2|STARTED|Fourth Rest Period (7-45 Days)||1
336426|NCT02862730|826578|P1|STARTED|Fourth Rest Period (7-45 Days)||3
336427|NCT02862730|826572|P7|NOT COMPLETED|Third Intervention (84 Hours)||0
336428|NCT02862730|826573|P6|NOT COMPLETED|Third Intervention (84 Hours)||0
336429|NCT02862730|826574|P5|NOT COMPLETED|Third Intervention (84 Hours)||0
336430|NCT02862730|826575|P4|NOT COMPLETED|Third Intervention (84 Hours)||1
336431|NCT02862730|826576|P3|NOT COMPLETED|Third Intervention (84 Hours)||0
336432|NCT02862730|826577|P2|NOT COMPLETED|Third Intervention (84 Hours)||0
336433|NCT02862730|826578|P1|NOT COMPLETED|Third Intervention (84 Hours)||0
336434|NCT02862730|826572|P7|COMPLETED|Third Intervention (84 Hours)||1
336435|NCT02862730|826573|P6|COMPLETED|Third Intervention (84 Hours)||1
336436|NCT02862730|826574|P5|COMPLETED|Third Intervention (84 Hours)||4
336437|NCT02862730|826575|P4|COMPLETED|Third Intervention (84 Hours)||4
336438|NCT02862730|826576|P3|COMPLETED|Third Intervention (84 Hours)||6
336439|NCT02862730|826577|P2|COMPLETED|Third Intervention (84 Hours)||1
336440|NCT02862730|826578|P1|COMPLETED|Third Intervention (84 Hours)||3
336441|NCT02862730|826572|P7|STARTED|Third Intervention (84 Hours)||1
336442|NCT02862730|826573|P6|STARTED|Third Intervention (84 Hours)||1
336443|NCT02862730|826574|P5|STARTED|Third Intervention (84 Hours)||4
336444|NCT02862730|826575|P4|STARTED|Third Intervention (84 Hours)||5
336445|NCT02862730|826576|P3|STARTED|Third Intervention (84 Hours)||6
336446|NCT02862730|826577|P2|STARTED|Third Intervention (84 Hours)||1
336447|NCT02862730|826578|P1|STARTED|Third Intervention (84 Hours)||3
336448|NCT02862730|826572|P7|NOT COMPLETED|Third Rest Period (7-45 Days)||0
336449|NCT02862730|826573|P6|NOT COMPLETED|Third Rest Period (7-45 Days)||0
336450|NCT02862730|826574|P5|NOT COMPLETED|Third Rest Period (7-45 Days)||1
336451|NCT02862730|826575|P4|NOT COMPLETED|Third Rest Period (7-45 Days)||0
336452|NCT02862730|826576|P3|NOT COMPLETED|Third Rest Period (7-45 Days)||1
336453|NCT02862730|826577|P2|NOT COMPLETED|Third Rest Period (7-45 Days)||0
336454|NCT02862730|826578|P1|NOT COMPLETED|Third Rest Period (7-45 Days)||0
336455|NCT02862730|826572|P7|COMPLETED|Third Rest Period (7-45 Days)||1
336456|NCT02862730|826573|P6|COMPLETED|Third Rest Period (7-45 Days)||1
336457|NCT02862730|826574|P5|COMPLETED|Third Rest Period (7-45 Days)||4
336458|NCT02862730|826575|P4|COMPLETED|Third Rest Period (7-45 Days)||5
336459|NCT02862730|826576|P3|COMPLETED|Third Rest Period (7-45 Days)||6
336460|NCT02862730|826577|P2|COMPLETED|Third Rest Period (7-45 Days)||1
336461|NCT02862730|826578|P1|COMPLETED|Third Rest Period (7-45 Days)||3
336462|NCT02862730|826572|P7|STARTED|Third Rest Period (7-45 Days)||1
336463|NCT02862730|826573|P6|STARTED|Third Rest Period (7-45 Days)||1
336464|NCT02862730|826574|P5|STARTED|Third Rest Period (7-45 Days)||5
336465|NCT02862730|826575|P4|STARTED|Third Rest Period (7-45 Days)||5
336466|NCT02862730|826576|P3|STARTED|Third Rest Period (7-45 Days)||7
336467|NCT02862730|826577|P2|STARTED|Third Rest Period (7-45 Days)||1
336468|NCT02862730|826578|P1|STARTED|Third Rest Period (7-45 Days)||3
336469|NCT02862730|826572|P7|NOT COMPLETED|Second Intervention (84 Hours)||0
336470|NCT02862730|826573|P6|NOT COMPLETED|Second Intervention (84 Hours)||0
336471|NCT02862730|826574|P5|NOT COMPLETED|Second Intervention (84 Hours)||0
336472|NCT02862730|826575|P4|NOT COMPLETED|Second Intervention (84 Hours)||0
336473|NCT02862730|826576|P3|NOT COMPLETED|Second Intervention (84 Hours)||0
336474|NCT02862730|826577|P2|NOT COMPLETED|Second Intervention (84 Hours)||0
336475|NCT02862730|826578|P1|NOT COMPLETED|Second Intervention (84 Hours)||1
336476|NCT02862730|826572|P7|COMPLETED|Second Intervention (84 Hours)||1
336477|NCT02862730|826573|P6|COMPLETED|Second Intervention (84 Hours)||1
336478|NCT02862730|826574|P5|COMPLETED|Second Intervention (84 Hours)||5
336479|NCT02862730|826575|P4|COMPLETED|Second Intervention (84 Hours)||5
336480|NCT02862730|826576|P3|COMPLETED|Second Intervention (84 Hours)||7
336481|NCT02862730|826577|P2|COMPLETED|Second Intervention (84 Hours)||1
336482|NCT02862730|826578|P1|COMPLETED|Second Intervention (84 Hours)||3
336483|NCT02862730|826572|P7|STARTED|Second Intervention (84 Hours)||1
336484|NCT02862730|826573|P6|STARTED|Second Intervention (84 Hours)||1
336485|NCT02862730|826574|P5|STARTED|Second Intervention (84 Hours)||5
336486|NCT02862730|826575|P4|STARTED|Second Intervention (84 Hours)||5
336487|NCT02862730|826576|P3|STARTED|Second Intervention (84 Hours)||7
336488|NCT02862730|826577|P2|STARTED|Second Intervention (84 Hours)||1
336489|NCT02862730|826578|P1|STARTED|Second Intervention (84 Hours)||4
336490|NCT02862730|826572|P7|NOT COMPLETED|Second Rest Period (7-45 Days)||0
336491|NCT02862730|826573|P6|NOT COMPLETED|Second Rest Period (7-45 Days)||0
336492|NCT02862730|826574|P5|NOT COMPLETED|Second Rest Period (7-45 Days)||0
336493|NCT02862730|826575|P4|NOT COMPLETED|Second Rest Period (7-45 Days)||0
336494|NCT02862730|826576|P3|NOT COMPLETED|Second Rest Period (7-45 Days)||0
336495|NCT02862730|826577|P2|NOT COMPLETED|Second Rest Period (7-45 Days)||0
336496|NCT02862730|826578|P1|NOT COMPLETED|Second Rest Period (7-45 Days)||0
336497|NCT02862730|826572|P7|COMPLETED|Second Rest Period (7-45 Days)||1
336498|NCT02862730|826573|P6|COMPLETED|Second Rest Period (7-45 Days)||1
336499|NCT02862730|826574|P5|COMPLETED|Second Rest Period (7-45 Days)||5
336500|NCT02862730|826575|P4|COMPLETED|Second Rest Period (7-45 Days)||5
336501|NCT02862730|826576|P3|COMPLETED|Second Rest Period (7-45 Days)||7
336502|NCT02862730|826577|P2|COMPLETED|Second Rest Period (7-45 Days)||1
336503|NCT02862730|826578|P1|COMPLETED|Second Rest Period (7-45 Days)||4
336504|NCT02862730|826572|P7|STARTED|Second Rest Period (7-45 Days)||1
336505|NCT02862730|826573|P6|STARTED|Second Rest Period (7-45 Days)||1
336506|NCT02862730|826574|P5|STARTED|Second Rest Period (7-45 Days)||5
336507|NCT02862730|826575|P4|STARTED|Second Rest Period (7-45 Days)||5
336508|NCT02862730|826576|P3|STARTED|Second Rest Period (7-45 Days)||7
336509|NCT02862730|826577|P2|STARTED|Second Rest Period (7-45 Days)||1
336510|NCT02862730|826578|P1|STARTED|Second Rest Period (7-45 Days)||4
336511|NCT02862730|826572|P7|NOT COMPLETED|First Intervention (84 Hours)||0
336512|NCT02862730|826573|P6|NOT COMPLETED|First Intervention (84 Hours)||0
336513|NCT02862730|826574|P5|NOT COMPLETED|First Intervention (84 Hours)||0
336514|NCT02862730|826575|P4|NOT COMPLETED|First Intervention (84 Hours)||0
336515|NCT02862730|826576|P3|NOT COMPLETED|First Intervention (84 Hours)||0
336516|NCT02862730|826577|P2|NOT COMPLETED|First Intervention (84 Hours)||0
336517|NCT02862730|826578|P1|NOT COMPLETED|First Intervention (84 Hours)||0
336518|NCT02862730|826572|P7|COMPLETED|First Intervention (84 Hours)||1
336519|NCT02862730|826573|P6|COMPLETED|First Intervention (84 Hours)||1
336520|NCT02862730|826574|P5|COMPLETED|First Intervention (84 Hours)||5
336521|NCT02862730|826575|P4|COMPLETED|First Intervention (84 Hours)||5
336522|NCT02862730|826576|P3|COMPLETED|First Intervention (84 Hours)||7
336523|NCT02862730|826577|P2|COMPLETED|First Intervention (84 Hours)||1
336524|NCT02862730|826578|P1|COMPLETED|First Intervention (84 Hours)||4
336525|NCT02862730|826572|P7|STARTED|First Intervention (84 Hours)||1
336526|NCT02862730|826573|P6|STARTED|First Intervention (84 Hours)||1
336527|NCT02862730|826574|P5|STARTED|First Intervention (84 Hours)||5
336528|NCT02862730|826575|P4|STARTED|First Intervention (84 Hours)||5
336529|NCT02862730|826576|P3|STARTED|First Intervention (84 Hours)||7
336530|NCT02862730|826577|P2|STARTED|First Intervention (84 Hours)||1
336531|NCT02862730|826578|P1|STARTED|First Intervention (84 Hours)||4
336532|NCT02862730|826572|P7|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
336533|NCT02862730|826573|P6|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
336534|NCT02862730|826574|P5|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
336535|NCT02862730|826575|P4|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
336536|NCT02862730|826576|P3|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
336537|NCT02862730|826577|P2|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
336538|NCT02862730|826578|P1|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
336539|NCT02862730|826572|P7|COMPLETED|First Rest Period (1-12 Weeks)||1
336540|NCT02862730|826573|P6|COMPLETED|First Rest Period (1-12 Weeks)||1
336541|NCT02862730|826574|P5|COMPLETED|First Rest Period (1-12 Weeks)||5
336542|NCT02862730|826575|P4|COMPLETED|First Rest Period (1-12 Weeks)||5
336543|NCT02862730|826576|P3|COMPLETED|First Rest Period (1-12 Weeks)||7
336544|NCT02862730|826577|P2|COMPLETED|First Rest Period (1-12 Weeks)||1
336545|NCT02862730|826578|P1|COMPLETED|First Rest Period (1-12 Weeks)||4
336546|NCT02862730|826572|P7|STARTED|First Rest Period (1-12 Weeks)||1
336547|NCT02862730|826573|P6|STARTED|First Rest Period (1-12 Weeks)||1
336548|NCT02862730|826574|P5|STARTED|First Rest Period (1-12 Weeks)||5
336549|NCT02862730|826575|P4|STARTED|First Rest Period (1-12 Weeks)||5
336550|NCT02862730|826576|P3|STARTED|First Rest Period (1-12 Weeks)||7
336551|NCT02862730|826577|P2|STARTED|First Rest Period (1-12 Weeks)||1
336552|NCT02862730|826578|P1|STARTED|First Rest Period (1-12 Weeks)||4
336553|NCT02862730|826572|P7|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
336554|NCT02862730|826573|P6|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
336555|NCT02862730|826574|P5|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
336556|NCT02862730|826575|P4|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
336557|NCT02862730|826576|P3|NOT COMPLETED|Tslim Training Visit (2 Weeks)||1
336558|NCT02862730|826577|P2|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
336559|NCT02862730|826578|P1|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
336560|NCT02862730|826572|P7|COMPLETED|Tslim Training Visit (2 Weeks)||1
336561|NCT02862730|826573|P6|COMPLETED|Tslim Training Visit (2 Weeks)||1
336562|NCT02862730|826574|P5|COMPLETED|Tslim Training Visit (2 Weeks)||5
336563|NCT02862730|826575|P4|COMPLETED|Tslim Training Visit (2 Weeks)||5
336564|NCT02862730|826576|P3|COMPLETED|Tslim Training Visit (2 Weeks)||7
336565|NCT02862730|826577|P2|COMPLETED|Tslim Training Visit (2 Weeks)||1
336566|NCT02862730|826578|P1|COMPLETED|Tslim Training Visit (2 Weeks)||4
336567|NCT02862730|826572|P7|STARTED|Tslim Training Visit (2 Weeks)||1
336568|NCT02862730|826573|P6|STARTED|Tslim Training Visit (2 Weeks)||1
336569|NCT02862730|826574|P5|STARTED|Tslim Training Visit (2 Weeks)||5
336570|NCT02862730|826575|P4|STARTED|Tslim Training Visit (2 Weeks)||5
336571|NCT02862730|826576|P3|STARTED|Tslim Training Visit (2 Weeks)||8
336572|NCT02862730|826577|P2|STARTED|Tslim Training Visit (2 Weeks)||1
336573|NCT02862730|826578|P1|STARTED|Tslim Training Visit (2 Weeks)||4
336574|NCT02862600|826633|P1|NOT COMPLETED|Period 2--Perhexiline-high Target Range||7
336575|NCT02862600|826633|P1|COMPLETED|Period 2--Perhexiline-high Target Range|Study terminated on April 26, 2017 due to lack of efficacy in first 15 subjects completing Period 2.|15
336576|NCT02862600|826633|P1|STARTED|Period 2--Perhexiline-high Target Range|First subject completed Period 1 and moved into Period 2 perhexiline dosing on October 17, 2016|22
336577|NCT02862600|826633|P1|NOT COMPLETED|Period 1--Perhexiline-low Target Range||13
336578|NCT02862600|826633|P1|COMPLETED|Period 1--Perhexiline-low Target Range|Study terminated on April 26, 2017 due to lack of efficacy.|22
336579|NCT02862600|826633|P1|STARTED|Period 1--Perhexiline-low Target Range|First subject underwent baseline functional assessment and perhexiline dosing on August 22, 2016|35
336580|NCT02862574|826643|P3|NOT COMPLETED|Open-Label Treatment Period||1
336581|NCT02862574|826644|P2|NOT COMPLETED|Open-Label Treatment Period||3
336582|NCT02862574|826645|P1|NOT COMPLETED|Open-Label Treatment Period||2
336583|NCT02862574|826643|P3|COMPLETED|Open-Label Treatment Period||0
336584|NCT02862574|826644|P2|COMPLETED|Open-Label Treatment Period||0
336585|NCT02862574|826645|P1|COMPLETED|Open-Label Treatment Period||0
336586|NCT02862574|826643|P3|STARTED|Open-Label Treatment Period||1
336587|NCT02862574|826644|P2|STARTED|Open-Label Treatment Period||3
336588|NCT02862574|826645|P1|STARTED|Open-Label Treatment Period||2
336589|NCT02862574|826643|P3|NOT COMPLETED|Double-Blind Treatment Period||4
336590|NCT02862574|826644|P2|NOT COMPLETED|Double-Blind Treatment Period||2
336591|NCT02862574|826645|P1|NOT COMPLETED|Double-Blind Treatment Period||3
336592|NCT02862574|826643|P3|COMPLETED|Double-Blind Treatment Period||1
336593|NCT02862574|826644|P2|COMPLETED|Double-Blind Treatment Period||3
336594|NCT02862574|826645|P1|COMPLETED|Double-Blind Treatment Period||2
336595|NCT02862574|826643|P3|STARTED|Double-Blind Treatment Period||5
336596|NCT02862574|826644|P2|STARTED|Double-Blind Treatment Period||5
336597|NCT02862574|826645|P1|STARTED|Double-Blind Treatment Period||5
336598|NCT02862106|826669|P2|NOT COMPLETED|Overall Study||6
336599|NCT02862106|826670|P1|NOT COMPLETED|Overall Study||38
336600|NCT02862106|826669|P2|COMPLETED|Overall Study||20
336601|NCT02862106|826670|P1|COMPLETED|Overall Study||145
336602|NCT02862106|826669|P2|STARTED|Overall Study||26
336603|NCT02862106|826670|P1|STARTED|Overall Study||183
336604|NCT02856880|826728|P1|NOT COMPLETED|Overall Study||1
336605|NCT02856880|826728|P1|COMPLETED|Overall Study||44
336606|NCT02856880|826728|P1|Received SLS Negative Control|Overall Study||44
336607|NCT02856880|826728|P1|Received Non-SLS Negative Control|Overall Study||44
336608|NCT02856880|826728|P1|Received Positive Control|Overall Study||45
336609|NCT02856880|826728|P1|Received Test Zinc Non-IPMP|Overall Study||44
336610|NCT02856880|826728|P1|Received Test Zinc-IPMP|Overall Study||44
336611|NCT02856880|826728|P1|STARTED|Overall Study||45
336612|NCT02855411|826752|P1|NOT COMPLETED|Overall Study||35
336613|NCT02855411|826752|P1|COMPLETED|Overall Study||0
336614|NCT02855411|826752|P1|Assigned to Study Treatment|Overall Study||0
336615|NCT02855411|826752|P1|STARTED|Overall Study||35
336616|NCT02855086|826774|P2|NOT COMPLETED|Overall Study||0
336617|NCT02855086|826775|P1|NOT COMPLETED|Overall Study||0
336618|NCT02855086|826774|P2|COMPLETED|Overall Study||1
336619|NCT02855086|826775|P1|COMPLETED|Overall Study||2
336620|NCT02855086|826774|P2|STARTED|Overall Study||1
336621|NCT02855086|826775|P1|STARTED|Overall Study||2
336622|NCT02852434|826785|P2|NOT COMPLETED|Overall Study||1
336623|NCT02852434|826786|P1|NOT COMPLETED|Overall Study||2
336624|NCT02852434|826785|P2|COMPLETED|Overall Study||35
336625|NCT02852434|826786|P1|COMPLETED|Overall Study||34
336626|NCT02852434|826785|P2|STARTED|Overall Study||36
336627|NCT02852434|826786|P1|STARTED|Overall Study||36
336628|NCT02851823|826800|P1|NOT COMPLETED|Overall Study||0
336629|NCT02851823|826800|P1|COMPLETED|Overall Study||25
336630|NCT02851823|826800|P1|3 Months|Overall Study||25
336631|NCT02851823|826800|P1|1 Month|Overall Study||25
336632|NCT02851823|826800|P1|STARTED|Overall Study||25
336633|NCT02850159|826810|P2|NOT COMPLETED|Overall Study||0
336634|NCT02850159|826811|P1|NOT COMPLETED|Overall Study||0
336635|NCT02850159|826810|P2|COMPLETED|Overall Study||16
336636|NCT02850159|826811|P1|COMPLETED|Overall Study||16
336637|NCT02850159|826810|P2|STARTED|Overall Study||16
336638|NCT02850159|826811|P1|STARTED|Overall Study||16
336639|NCT02849678|826819|P2|NOT COMPLETED|Overall Study||6
336640|NCT02849678|826820|P1|NOT COMPLETED|Overall Study||3
336641|NCT02849678|826819|P2|COMPLETED|Overall Study||18
336642|NCT02849678|826820|P1|COMPLETED|Overall Study||17
336643|NCT02849678|826819|P2|STARTED|Overall Study||24
336644|NCT02849678|826820|P1|STARTED|Overall Study||20
336645|NCT02848222|826841|P3|NOT COMPLETED|Overall Study||0
336646|NCT02848222|826842|P2|NOT COMPLETED|Overall Study||1
336647|NCT02848222|826843|P1|NOT COMPLETED|Overall Study||7
336648|NCT02848222|826841|P3|COMPLETED|Overall Study||17
336649|NCT02848222|826842|P2|COMPLETED|Overall Study||17
336650|NCT02848222|826843|P1|COMPLETED|Overall Study||18
336651|NCT02848222|826841|P3|STARTED|Overall Study||17
336652|NCT02848222|826842|P2|STARTED|Overall Study||18
336653|NCT02848222|826843|P1|STARTED|Overall Study||25
336654|NCT02847260|826851|P1|NOT COMPLETED|Overall Study||7
336655|NCT02847260|826851|P1|COMPLETED|Overall Study||32
336656|NCT02847260|826851|P1|STARTED|Overall Study||39
336657|NCT02847169|826863|P2|NOT COMPLETED|Second Intervention (1 Week)||0
336658|NCT02847169|826864|P1|NOT COMPLETED|Second Intervention (1 Week)||0
336659|NCT02847169|826863|P2|COMPLETED|Second Intervention (1 Week)||15
336660|NCT02847169|826864|P1|COMPLETED|Second Intervention (1 Week)||15
336661|NCT02847169|826863|P2|STARTED|Second Intervention (1 Week)||15
336662|NCT02847169|826864|P1|STARTED|Second Intervention (1 Week)||15
336663|NCT02847169|826863|P2|NOT COMPLETED|First Intervention (1 Week)||0
336664|NCT02847169|826864|P1|NOT COMPLETED|First Intervention (1 Week)||0
336665|NCT02847169|826863|P2|COMPLETED|First Intervention (1 Week)||15
336666|NCT02847169|826864|P1|COMPLETED|First Intervention (1 Week)||15
336667|NCT02847169|826863|P2|STARTED|First Intervention (1 Week)||15
336668|NCT02847169|826864|P1|STARTED|First Intervention (1 Week)||15
336669|NCT02846558|826902|P4|NOT COMPLETED|Overall Study||2
336670|NCT02846558|826903|P3|NOT COMPLETED|Overall Study||2
336671|NCT02846558|826904|P2|NOT COMPLETED|Overall Study||4
336672|NCT02846558|826905|P1|NOT COMPLETED|Overall Study||8
336673|NCT02846558|826902|P4|COMPLETED|Overall Study||11
336674|NCT02846558|826903|P3|COMPLETED|Overall Study||12
336675|NCT02846558|826904|P2|COMPLETED|Overall Study||8
336676|NCT02846558|826905|P1|COMPLETED|Overall Study||7
336677|NCT02846558|826902|P4|3 Month Study Visit|Overall Study||11
336678|NCT02846558|826903|P3|3 Month Study Visit|Overall Study||12
336679|NCT02846558|826904|P2|3 Month Study Visit|Overall Study||8
336680|NCT02846558|826905|P1|3 Month Study Visit|Overall Study||7
336681|NCT02846558|826902|P4|Baseline Study Visit|Overall Study||12
336682|NCT02846558|826903|P3|Baseline Study Visit|Overall Study||14
336683|NCT02846558|826904|P2|Baseline Study Visit|Overall Study||9
336684|NCT02846558|826905|P1|Baseline Study Visit|Overall Study||10
336685|NCT02846558|826902|P4|STARTED|Overall Study||13
336686|NCT02846558|826903|P3|STARTED|Overall Study||14
336687|NCT02846558|826904|P2|STARTED|Overall Study||12
336688|NCT02846558|826905|P1|STARTED|Overall Study||15
336689|NCT02844998|826944|P3|NOT COMPLETED|Overall Study||4
336690|NCT02844998|826945|P2|NOT COMPLETED|Overall Study||4
336691|NCT02844998|826946|P1|NOT COMPLETED|Overall Study||7
336692|NCT02844998|826944|P3|COMPLETED|Overall Study||35
336693|NCT02844998|826945|P2|COMPLETED|Overall Study||35
336694|NCT02844998|826946|P1|COMPLETED|Overall Study||35
336695|NCT02844998|826944|P3|STARTED|Overall Study||39
336696|NCT02844998|826945|P2|STARTED|Overall Study||39
336697|NCT02844998|826946|P1|STARTED|Overall Study||42
336698|NCT02844543|826957|P1|NOT COMPLETED|Overall Study||5
336699|NCT02844543|826957|P1|COMPLETED|Overall Study||150
336700|NCT02844543|826957|P1|STARTED|Overall Study||155
336701|NCT02840916|826966|P2|NOT COMPLETED|Overall Study||3
336702|NCT02840916|826967|P1|NOT COMPLETED|Overall Study||1
336703|NCT02840916|826966|P2|COMPLETED|Overall Study||30
336704|NCT02840916|826967|P1|COMPLETED|Overall Study||32
336705|NCT02840916|826966|P2|STARTED|Overall Study||33
336706|NCT02840916|826967|P1|STARTED|Overall Study||33
336707|NCT02839772|826979|P2|NOT COMPLETED|Overall Study||0
336708|NCT02839772|826980|P1|NOT COMPLETED|Overall Study||1
336709|NCT02839772|826979|P2|COMPLETED|Overall Study||96
336710|NCT02839772|826980|P1|COMPLETED|Overall Study|1 participant in Clinic B did not return for the 3 months post- intervention data collection.|96
336711|NCT02839772|826979|P2|STARTED|Overall Study||96
336712|NCT02839772|826980|P1|STARTED|Overall Study|Stratification was used. Clinic A enrolled 94 participants and Clinic B 99 participants|97
336713|NCT02838901|827019|P2|NOT COMPLETED|Overall Study||2
336714|NCT02838901|827020|P1|NOT COMPLETED|Overall Study||2
336715|NCT02838901|827019|P2|COMPLETED|Overall Study||7
336716|NCT02838901|827020|P1|COMPLETED|Overall Study||7
336717|NCT02838901|827019|P2|STARTED|Overall Study||9
336718|NCT02838901|827020|P1|STARTED|Overall Study||9
336719|NCT02837952|827050|P2|NOT COMPLETED|Overall Study||6
336720|NCT02837952|827051|P1|NOT COMPLETED|Overall Study||5
336721|NCT02837952|827050|P2|COMPLETED|Overall Study||76
336722|NCT02837952|827051|P1|COMPLETED|Overall Study||36
336723|NCT02837952|827050|P2|STARTED|Overall Study||82
336724|NCT02837952|827051|P1|STARTED|Overall Study||41
336725|NCT02836249|827065|P2|NOT COMPLETED|Overall Study||58
336726|NCT02836249|827066|P1|NOT COMPLETED|Overall Study||123
336727|NCT02836249|827065|P2|COMPLETED|Overall Study||0
336728|NCT02836249|827066|P1|COMPLETED|Overall Study||0
336729|NCT02836249|827065|P2|STARTED|Overall Study||58
336730|NCT02836249|827066|P1|STARTED|Overall Study||123
336731|NCT02836236|827084|P2|NOT COMPLETED|Overall Study||50
336732|NCT02836236|827085|P1|NOT COMPLETED|Overall Study||105
336733|NCT02836236|827084|P2|COMPLETED|Overall Study||0
336734|NCT02836236|827085|P1|COMPLETED|Overall Study||0
336735|NCT02836236|827084|P2|STARTED|Overall Study||50
336736|NCT02836236|827085|P1|STARTED|Overall Study||105
336737|NCT02834624|827101|P2|NOT COMPLETED|Overall Study||0
336738|NCT02834624|827102|P1|NOT COMPLETED|Overall Study||0
336739|NCT02834624|827101|P2|COMPLETED|Overall Study||15
336740|NCT02834624|827102|P1|COMPLETED|Overall Study||15
336741|NCT02834624|827101|P2|STARTED|Overall Study||15
336742|NCT02834624|827102|P1|STARTED|Overall Study||15
336743|NCT02832674|827112|P1|NOT COMPLETED|Overall Study||5
336744|NCT02832674|827112|P1|COMPLETED|Overall Study||67
336745|NCT02832674|827112|P1|STARTED|Overall Study||72
336746|NCT02832375|827123|P2|NOT COMPLETED|Overall Study||0
336747|NCT02832375|827124|P1|NOT COMPLETED|Overall Study||2
336748|NCT02832375|827123|P2|COMPLETED|Overall Study||121
336749|NCT02832375|827124|P1|COMPLETED|Overall Study||119
336750|NCT02832375|827123|P2|STARTED|Overall Study||121
336751|NCT02832375|827124|P1|STARTED|Overall Study||121
336752|NCT02831660|827134|P1|NOT COMPLETED|Overall Study||0
336753|NCT02831660|827134|P1|COMPLETED|Overall Study||1
336754|NCT02831660|827134|P1|STARTED|Overall Study||1
336755|NCT02829996|827143|P5|NOT COMPLETED|Overall Study||0
336756|NCT02829996|827144|P4|NOT COMPLETED|Overall Study||0
336757|NCT02829996|827145|P3|NOT COMPLETED|Overall Study||0
336758|NCT02829996|827146|P2|NOT COMPLETED|Overall Study||0
336759|NCT02829996|827147|P1|NOT COMPLETED|Overall Study||1
336760|NCT02829996|827143|P5|COMPLETED|Overall Study||42
336761|NCT02829996|827144|P4|COMPLETED|Overall Study||41
336762|NCT02829996|827145|P3|COMPLETED|Overall Study||40
336763|NCT02829996|827146|P2|COMPLETED|Overall Study||39
336764|NCT02829996|827147|P1|COMPLETED|Overall Study||38
336765|NCT02829996|827143|P5|STARTED|Overall Study||42
336766|NCT02829996|827144|P4|STARTED|Overall Study||41
336767|NCT02829996|827145|P3|STARTED|Overall Study||40
336768|NCT02829996|827146|P2|STARTED|Overall Study||39
336769|NCT02829996|827147|P1|STARTED|Overall Study||39
336770|NCT02829983|827161|P2|NOT COMPLETED|Overall Study||0
336771|NCT02829983|827162|P1|NOT COMPLETED|Overall Study||0
336772|NCT02829983|827161|P2|COMPLETED|Overall Study||20
336773|NCT02829983|827162|P1|COMPLETED|Overall Study||20
336774|NCT02829983|827161|P2|STARTED|Overall Study||20
336775|NCT02829983|827162|P1|STARTED|Overall Study||20
336776|NCT02829775|827170|P1|NOT COMPLETED|Overall Study||5
336777|NCT02829775|827170|P1|COMPLETED|Overall Study||4
336778|NCT02829775|827170|P1|STARTED|Overall Study||9
336779|NCT02829463|827177|P2|NOT COMPLETED|Overall Study||0
336780|NCT02829463|827178|P1|NOT COMPLETED|Overall Study||0
336781|NCT02829463|827177|P2|COMPLETED|Overall Study||62
336782|NCT02829463|827178|P1|COMPLETED|Overall Study||59
336783|NCT02829463|827177|P2|STARTED|Overall Study||62
336784|NCT02829463|827178|P1|STARTED|Overall Study||59
336785|NCT02829138|827186|P2|NOT COMPLETED|Overall Study||0
336786|NCT02829138|827187|P1|NOT COMPLETED|Overall Study||1
336787|NCT02829138|827186|P2|COMPLETED|Overall Study||28
336788|NCT02829138|827187|P1|COMPLETED|Overall Study||28
336789|NCT02829138|827186|P2|STARTED|Overall Study||28
336790|NCT02829138|827187|P1|STARTED|Overall Study||29
336791|NCT02828137|827200|P3|NOT COMPLETED|Overall Study||0
336792|NCT02828137|827201|P2|NOT COMPLETED|Overall Study||0
336793|NCT02828137|827202|P1|NOT COMPLETED|Overall Study||0
336794|NCT02828137|827200|P3|COMPLETED|Overall Study||41
336795|NCT02828137|827201|P2|COMPLETED|Overall Study||41
336796|NCT02828137|827202|P1|COMPLETED|Overall Study||41
336797|NCT02828137|827200|P3|STARTED|Overall Study||41
336798|NCT02828137|827201|P2|STARTED|Overall Study||41
336799|NCT02828137|827202|P1|STARTED|Overall Study||41
336800|NCT02826551|827212|P2|NOT COMPLETED|Overall Study||0
336801|NCT02826551|827213|P1|NOT COMPLETED|Overall Study||0
336802|NCT02826551|827212|P2|COMPLETED|Overall Study||12
336803|NCT02826551|827213|P1|COMPLETED|Overall Study||11
336804|NCT02826551|827212|P2|STARTED|Overall Study||12
336805|NCT02826551|827213|P1|STARTED|Overall Study||11
336806|NCT02826421|827223|P4|NOT COMPLETED|Overall Study||2
336807|NCT02826421|827224|P3|NOT COMPLETED|Overall Study||2
336808|NCT02826421|827225|P2|NOT COMPLETED|Overall Study||3
336809|NCT02826421|827226|P1|NOT COMPLETED|Overall Study||3
336810|NCT02826421|827223|P4|COMPLETED|Overall Study||28
336811|NCT02826421|827224|P3|COMPLETED|Overall Study||26
336812|NCT02826421|827225|P2|COMPLETED|Overall Study||26
336813|NCT02826421|827226|P1|COMPLETED|Overall Study||19
336814|NCT02826421|827223|P4|Treated|Overall Study||28
336815|NCT02826421|827224|P3|Treated|Overall Study||26
336816|NCT02826421|827225|P2|Treated|Overall Study||26
336817|NCT02826421|827226|P1|Treated|Overall Study||19
336818|NCT02826421|827223|P4|STARTED|Overall Study||30
336819|NCT02826421|827224|P3|STARTED|Overall Study||28
336820|NCT02826421|827225|P2|STARTED|Overall Study||29
336821|NCT02826421|827226|P1|STARTED|Overall Study||22
336822|NCT02824913|827240|P2|NOT COMPLETED|Second Intervention(1 Day)||0
336823|NCT02824913|827241|P1|NOT COMPLETED|Second Intervention(1 Day)||0
336824|NCT02824913|827240|P2|COMPLETED|Second Intervention(1 Day)||0
336825|NCT02824913|827241|P1|COMPLETED|Second Intervention(1 Day)||1
336826|NCT02824913|827240|P2|STARTED|Second Intervention(1 Day)||0
336827|NCT02824913|827241|P1|STARTED|Second Intervention(1 Day)||1
336828|NCT02824913|827240|P2|NOT COMPLETED|Washout (7-14 Days)||0
336829|NCT02824913|827241|P1|NOT COMPLETED|Washout (7-14 Days)||0
336830|NCT02824913|827240|P2|COMPLETED|Washout (7-14 Days)||0
336831|NCT02824913|827241|P1|COMPLETED|Washout (7-14 Days)||1
336832|NCT02824913|827240|P2|STARTED|Washout (7-14 Days)||0
336833|NCT02824913|827241|P1|STARTED|Washout (7-14 Days)||1
336834|NCT02824913|827240|P2|NOT COMPLETED|First Intervention (1 Day)||0
336835|NCT02824913|827241|P1|NOT COMPLETED|First Intervention (1 Day)||0
336836|NCT02824913|827240|P2|COMPLETED|First Intervention (1 Day)|Only one subject was enrolled in the study and received both study treatments.|0
336837|NCT02824913|827241|P1|COMPLETED|First Intervention (1 Day)|Only one subject was enrolled in the study and received both study treatments.|1
336838|NCT02824913|827240|P2|STARTED|First Intervention (1 Day)||0
336839|NCT02824913|827241|P1|STARTED|First Intervention (1 Day)||1
336840|NCT02823964|827251|P1|NOT COMPLETED|Overall Study||5
336841|NCT02823964|827251|P1|COMPLETED|Overall Study||20
336842|NCT02823964|827251|P1|STARTED|Overall Study||25
336843|NCT02823080|827257|P2|NOT COMPLETED|Overall Study||0
336844|NCT02823080|827258|P1|NOT COMPLETED|Overall Study||0
336845|NCT02823080|827257|P2|COMPLETED|Overall Study||24
336846|NCT02823080|827258|P1|COMPLETED|Overall Study||24
336847|NCT02823080|827257|P2|STARTED|Overall Study||24
336848|NCT02823080|827258|P1|STARTED|Overall Study||24
336849|NCT02822885|827276|P1|NOT COMPLETED|Overall Study||0
336850|NCT02822885|827276|P1|COMPLETED|Overall Study||70
336851|NCT02822885|827276|P1|STARTED|Overall Study||70
336852|NCT02822287|827284|P1|NOT COMPLETED|Overall Study||0
336853|NCT02822287|827284|P1|COMPLETED|Overall Study||57
336854|NCT02822287|827284|P1|STARTED|Overall Study||57
336855|NCT02821403|827296|P2|NOT COMPLETED|"Third Intervention (1 Month)"||0
336856|NCT02821403|827297|P1|NOT COMPLETED|"Third Intervention (1 Month)"||0
336857|NCT02821403|827296|P2|COMPLETED|"Third Intervention (1 Month)"||40
336858|NCT02821403|827297|P1|COMPLETED|"Third Intervention (1 Month)"||40
336859|NCT02821403|827296|P2|Used Blue-filtering Coated Lens|"Third Intervention (1 Month)"||14
336860|NCT02821403|827297|P1|Used Blue-filtering Coated Lens|"Third Intervention (1 Month)"||13
336861|NCT02821403|827296|P2|Used Yellow Tinted Lens|"Third Intervention (1 Month)"||13
336862|NCT02821403|827297|P1|Used Yellow Tinted Lens|"Third Intervention (1 Month)"||13
336863|NCT02821403|827296|P2|Used Clear Lens|"Third Intervention (1 Month)"||13
336864|NCT02821403|827297|P1|Used Clear Lens|"Third Intervention (1 Month)"||14
336865|NCT02821403|827296|P2|STARTED|"Third Intervention (1 Month)"||40
336866|NCT02821403|827297|P1|STARTED|"Third Intervention (1 Month)"||40
336867|NCT02821403|827296|P2|NOT COMPLETED|"Second Intervention (1 Month)"||0
336868|NCT02821403|827297|P1|NOT COMPLETED|"Second Intervention (1 Month)"||0
336869|NCT02821403|827296|P2|COMPLETED|"Second Intervention (1 Month)"||40
336870|NCT02821403|827297|P1|COMPLETED|"Second Intervention (1 Month)"||40
336871|NCT02821403|827296|P2|Used Blue-filtering Coated Lens|"Second Intervention (1 Month)"||13
336872|NCT02821403|827297|P1|Used Blue-filtering Coated Lens|"Second Intervention (1 Month)"||13
336873|NCT02821403|827296|P2|Used Yellow Tinted Lens|"Second Intervention (1 Month)"||13
336874|NCT02821403|827297|P1|Used Yellow Tinted Lens|"Second Intervention (1 Month)"||14
336875|NCT02821403|827296|P2|Used Clear Lens|"Second Intervention (1 Month)"||14
336876|NCT02821403|827297|P1|Used Clear Lens|"Second Intervention (1 Month)"||13
336877|NCT02821403|827296|P2|STARTED|"Second Intervention (1 Month)"||40
336878|NCT02821403|827297|P1|STARTED|"Second Intervention (1 Month)"||40
336879|NCT02821403|827296|P2|NOT COMPLETED|"First Intervention (1 Month)"||0
336880|NCT02821403|827297|P1|NOT COMPLETED|"First Intervention (1 Month)"||0
336881|NCT02821403|827296|P2|COMPLETED|"First Intervention (1 Month)"||40
336882|NCT02821403|827297|P1|COMPLETED|"First Intervention (1 Month)"||40
336883|NCT02821403|827296|P2|Used Blue-filtering Coated Lens|"First Intervention (1 Month)"||13
336884|NCT02821403|827297|P1|Used Blue-filtering Coated Lens|"First Intervention (1 Month)"||14
336885|NCT02821403|827296|P2|Used Yellow Tinted Lens|"First Intervention (1 Month)"||14
336886|NCT02821403|827297|P1|Used Yellow Tinted Lens|"First Intervention (1 Month)"||13
336887|NCT02821403|827296|P2|Used Clear Lens|"First Intervention (1 Month)"||13
336888|NCT02821403|827297|P1|Used Clear Lens|"First Intervention (1 Month)"||13
336889|NCT02821403|827296|P2|STARTED|"First Intervention (1 Month)"||40
336890|NCT02821403|827297|P1|STARTED|"First Intervention (1 Month)"||40
336891|NCT02818244|827319|P4|NOT COMPLETED|Overall Study||0
336892|NCT02818244|827320|P3|NOT COMPLETED|Overall Study||0
336893|NCT02818244|827321|P2|NOT COMPLETED|Overall Study||0
336894|NCT02818244|827322|P1|NOT COMPLETED|Overall Study||0
336895|NCT02818244|827319|P4|COMPLETED|Overall Study||25
336896|NCT02818244|827320|P3|COMPLETED|Overall Study||25
336897|NCT02818244|827321|P2|COMPLETED|Overall Study||25
336898|NCT02818244|827322|P1|COMPLETED|Overall Study||25
336899|NCT02818244|827319|P4|STARTED|Overall Study||25
336900|NCT02818244|827320|P3|STARTED|Overall Study||25
336901|NCT02818244|827321|P2|STARTED|Overall Study||25
336902|NCT02818244|827322|P1|STARTED|Overall Study||25
336903|NCT02817763|827334|P2|NOT COMPLETED|Overall Study||0
336904|NCT02817763|827335|P1|NOT COMPLETED|Overall Study||0
336905|NCT02817763|827334|P2|COMPLETED|Overall Study||20
336906|NCT02817763|827335|P1|COMPLETED|Overall Study||20
336907|NCT02817763|827334|P2|STARTED|Overall Study||20
336908|NCT02817763|827335|P1|STARTED|Overall Study||20
336909|NCT02815735|827343|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
336910|NCT02815735|827344|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
336911|NCT02815735|827343|P2|COMPLETED|Second Intervention (4 Weeks)||37
336912|NCT02815735|827344|P1|COMPLETED|Second Intervention (4 Weeks)||33
336913|NCT02815735|827343|P2|STARTED|Second Intervention (4 Weeks)||37
336914|NCT02815735|827344|P1|STARTED|Second Intervention (4 Weeks)||34
336915|NCT02815735|827343|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
336916|NCT02815735|827344|P1|NOT COMPLETED|First Intervention (4 Weeks)||2
336917|NCT02815735|827343|P2|COMPLETED|First Intervention (4 Weeks)||37
336918|NCT02815735|827344|P1|COMPLETED|First Intervention (4 Weeks)||34
336919|NCT02815735|827343|P2|STARTED|First Intervention (4 Weeks)||38
336920|NCT02815735|827344|P1|STARTED|First Intervention (4 Weeks)||36
336921|NCT02815397|827359|P1|NOT COMPLETED|Overall Study||2
336922|NCT02815397|827359|P1|COMPLETED|Overall Study||0
336923|NCT02815397|827359|P1|STARTED|Overall Study||2
336924|NCT02814643|827368|P2|NOT COMPLETED|Overall Study||3
336925|NCT02814643|827369|P1|NOT COMPLETED|Overall Study||1
336926|NCT02814643|827368|P2|COMPLETED|Overall Study||49
336927|NCT02814643|827369|P1|COMPLETED|Overall Study||50
336928|NCT02814643|827368|P2|STARTED|Overall Study||52
336929|NCT02814643|827369|P1|STARTED|Overall Study||51
336930|NCT02814279|827393|P2|NOT COMPLETED|Overall Study||0
336931|NCT02814279|827394|P1|NOT COMPLETED|Overall Study||0
336932|NCT02814279|827393|P2|COMPLETED|Overall Study||21
336933|NCT02814279|827394|P1|COMPLETED|Overall Study||21
336934|NCT02814279|827393|P2|STARTED|Overall Study||21
336935|NCT02814279|827394|P1|STARTED|Overall Study||21
336936|NCT02814227|827402|P1|NOT COMPLETED|Overall Study||0
336937|NCT02814227|827402|P1|COMPLETED|Overall Study||52
336938|NCT02814227|827402|P1|STARTED|Overall Study||52
336939|NCT02813070|827412|P3|NOT COMPLETED|Overall Study||11
336940|NCT02813070|827413|P2|NOT COMPLETED|Overall Study||3
336941|NCT02813070|827414|P1|NOT COMPLETED|Overall Study||3
336942|NCT02813070|827412|P3|COMPLETED|Overall Study||25
336943|NCT02813070|827413|P2|COMPLETED|Overall Study||20
336944|NCT02813070|827414|P1|COMPLETED|Overall Study||25
336945|NCT02813070|827412|P3|Treated (Safety Population)|Overall Study||25
336946|NCT02813070|827413|P2|Treated (Safety Population)|Overall Study||20
336947|NCT02813070|827414|P1|Treated (Safety Population)|Overall Study||25
336948|NCT02813070|827412|P3|STARTED|Overall Study||36
336949|NCT02813070|827413|P2|STARTED|Overall Study||23
336950|NCT02813070|827414|P1|STARTED|Overall Study||28
336951|NCT02811965|827423|P1|NOT COMPLETED|Overall Study||0
336952|NCT02811965|827423|P1|COMPLETED|Overall Study||21
336953|NCT02811965|827423|P1|STARTED|Overall Study||21
336954|NCT02810873|827448|P2|NOT COMPLETED|Overall Study||0
336955|NCT02810873|827449|P1|NOT COMPLETED|Overall Study||0
336956|NCT02810873|827448|P2|COMPLETED|Overall Study||13
336957|NCT02810873|827449|P1|COMPLETED|Overall Study||6
336958|NCT02810873|827448|P2|STARTED|Overall Study||13
336959|NCT02810873|827449|P1|STARTED|Overall Study||6
336960|NCT02809911|827459|P2|NOT COMPLETED|Overall Study||0
336961|NCT02809911|827460|P1|NOT COMPLETED|Overall Study||0
336962|NCT02809911|827459|P2|COMPLETED|Overall Study|This is the Initial Treatment Population (subjects that completed the Enrollment Visit / Visit 2)|19
336963|NCT02809911|827460|P1|COMPLETED|Overall Study|This is the Initial Treatment Population (subjects that completed the Enrollment Visit / Visit 2)|22
336964|NCT02809911|827459|P2|STARTED|Overall Study|This is the Initial Treatment Population (subjects that started the Enrollment Visit / Visit 2)|19
336965|NCT02809911|827460|P1|STARTED|Overall Study|This is the Initial Treatment Population (subjects that started the Enrollment Visit / Visit 2)|22
336966|NCT02809833|827468|P1|NOT COMPLETED|Overall Study||300
336967|NCT02809833|827468|P1|COMPLETED|Overall Study||550
336968|NCT02809833|827468|P1|STARTED|Overall Study||850
336969|NCT02808130|827548|P6|NOT COMPLETED|Overall Study||0
336970|NCT02808130|827549|P5|NOT COMPLETED|Overall Study||0
336971|NCT02808130|827550|P4|NOT COMPLETED|Overall Study||0
336972|NCT02808130|827551|P3|NOT COMPLETED|Overall Study||0
336973|NCT02808130|827552|P2|NOT COMPLETED|Overall Study||0
336974|NCT02808130|827553|P1|NOT COMPLETED|Overall Study||0
336975|NCT02808130|827548|P6|COMPLETED|Overall Study||15
336976|NCT02808130|827549|P5|COMPLETED|Overall Study||15
336977|NCT02808130|827550|P4|COMPLETED|Overall Study||15
336978|NCT02808130|827551|P3|COMPLETED|Overall Study||15
336979|NCT02808130|827552|P2|COMPLETED|Overall Study||15
336980|NCT02808130|827553|P1|COMPLETED|Overall Study||15
336981|NCT02808130|827548|P6|STARTED|Overall Study||15
336982|NCT02808130|827549|P5|STARTED|Overall Study||15
336983|NCT02808130|827550|P4|STARTED|Overall Study||15
336984|NCT02808130|827551|P3|STARTED|Overall Study||15
336985|NCT02808130|827552|P2|STARTED|Overall Study||15
336986|NCT02808130|827553|P1|STARTED|Overall Study||15
336987|NCT02806869|827581|P2|NOT COMPLETED|Second Intervention (1 Day)||2
336988|NCT02806869|827582|P1|NOT COMPLETED|Second Intervention (1 Day)||0
336989|NCT02806869|827581|P2|COMPLETED|Second Intervention (1 Day)||5
336990|NCT02806869|827582|P1|COMPLETED|Second Intervention (1 Day)||7
336991|NCT02806869|827581|P2|STARTED|Second Intervention (1 Day)||7
336992|NCT02806869|827582|P1|STARTED|Second Intervention (1 Day)||7
336993|NCT02806869|827581|P2|NOT COMPLETED|Washout (7 Days)||0
336994|NCT02806869|827582|P1|NOT COMPLETED|Washout (7 Days)||0
336995|NCT02806869|827581|P2|COMPLETED|Washout (7 Days)||7
336996|NCT02806869|827582|P1|COMPLETED|Washout (7 Days)||7
336997|NCT02806869|827581|P2|STARTED|Washout (7 Days)||7
336998|NCT02806869|827582|P1|STARTED|Washout (7 Days)||7
336999|NCT02806869|827581|P2|NOT COMPLETED|First Intervention (1 Day)||12
337000|NCT02806869|827582|P1|NOT COMPLETED|First Intervention (1 Day)||11
337001|NCT02806869|827581|P2|COMPLETED|First Intervention (1 Day)||12
337002|NCT02806869|827582|P1|COMPLETED|First Intervention (1 Day)||13
337003|NCT02806869|827581|P2|STARTED|First Intervention (1 Day)||24
337004|NCT02806869|827582|P1|STARTED|First Intervention (1 Day)||24
337005|NCT02806544|827592|P1|NOT COMPLETED|Overall Study||4
337006|NCT02806544|827592|P1|COMPLETED|Overall Study||31
337007|NCT02806544|827592|P1|STARTED|Overall Study||35
337008|NCT02806505|827603|P2|NOT COMPLETED|Overall Study||11
337009|NCT02806505|827604|P1|NOT COMPLETED|Overall Study||10
337010|NCT02806505|827603|P2|COMPLETED|Overall Study||32
337011|NCT02806505|827604|P1|COMPLETED|Overall Study||28
337012|NCT02806505|827603|P2|STARTED|Overall Study||43
337013|NCT02806505|827604|P1|STARTED|Overall Study||38
337014|NCT02805907|827616|P2|NOT COMPLETED|Overall Study||3
337015|NCT02805907|827617|P1|NOT COMPLETED|Overall Study||3
337016|NCT02805907|827616|P2|COMPLETED|Overall Study||53
337017|NCT02805907|827617|P1|COMPLETED|Overall Study||53
337018|NCT02805907|827616|P2|STARTED|Overall Study||56
337019|NCT02805907|827617|P1|STARTED|Overall Study||56
337020|NCT02802878|827631|P2|NOT COMPLETED|Overall Study||3
337021|NCT02802878|827632|P1|NOT COMPLETED|Overall Study||4
337022|NCT02802878|827631|P2|COMPLETED|Overall Study||18
337023|NCT02802878|827632|P1|COMPLETED|Overall Study||17
337024|NCT02802878|827631|P2|STARTED|Overall Study||21
337025|NCT02802878|827632|P1|STARTED|Overall Study||21
337026|NCT02802592|827646|P1|NOT COMPLETED|Overall Study||4
337027|NCT02802592|827646|P1|COMPLETED|Overall Study||0
337028|NCT02802592|827646|P1|STARTED|Overall Study||4
337029|NCT02802449|827657|P2|NOT COMPLETED|Overall Study||17
337030|NCT02802449|827658|P1|NOT COMPLETED|Overall Study||9
337031|NCT02802449|827657|P2|COMPLETED|Overall Study||202
337032|NCT02802449|827658|P1|COMPLETED|Overall Study||102
337033|NCT02802449|827657|P2|STARTED|Overall Study||219
337034|NCT02802449|827658|P1|STARTED|Overall Study||111
337035|NCT02801396|827674|P6|NOT COMPLETED|Period 3||0
337036|NCT02801396|827675|P5|NOT COMPLETED|Period 3||0
337037|NCT02801396|827676|P4|NOT COMPLETED|Period 3||0
337038|NCT02801396|827677|P3|NOT COMPLETED|Period 3||0
337039|NCT02801396|827678|P2|NOT COMPLETED|Period 3||0
337040|NCT02801396|827679|P1|NOT COMPLETED|Period 3||0
337041|NCT02801396|827674|P6|COMPLETED|Period 3||17
337042|NCT02801396|827675|P5|COMPLETED|Period 3||16
337043|NCT02801396|827676|P4|COMPLETED|Period 3||16
337044|NCT02801396|827677|P3|COMPLETED|Period 3||17
337045|NCT02801396|827678|P2|COMPLETED|Period 3||17
337046|NCT02801396|827679|P1|COMPLETED|Period 3||17
337047|NCT02801396|827674|P6|STARTED|Period 3||17
337048|NCT02801396|827675|P5|STARTED|Period 3||16
337049|NCT02801396|827676|P4|STARTED|Period 3||16
337050|NCT02801396|827677|P3|STARTED|Period 3||17
337051|NCT02801396|827678|P2|STARTED|Period 3||17
337052|NCT02801396|827679|P1|STARTED|Period 3||17
337053|NCT02801396|827674|P6|NOT COMPLETED|Period 2||0
337054|NCT02801396|827675|P5|NOT COMPLETED|Period 2||0
337055|NCT02801396|827676|P4|NOT COMPLETED|Period 2||0
337056|NCT02801396|827677|P3|NOT COMPLETED|Period 2||0
337057|NCT02801396|827678|P2|NOT COMPLETED|Period 2||0
337058|NCT02801396|827679|P1|NOT COMPLETED|Period 2||0
337059|NCT02801396|827674|P6|COMPLETED|Period 2||17
337060|NCT02801396|827675|P5|COMPLETED|Period 2||16
337061|NCT02801396|827676|P4|COMPLETED|Period 2||16
337062|NCT02801396|827677|P3|COMPLETED|Period 2||17
337063|NCT02801396|827678|P2|COMPLETED|Period 2||17
337064|NCT02801396|827679|P1|COMPLETED|Period 2||17
337065|NCT02801396|827674|P6|STARTED|Period 2||17
337066|NCT02801396|827675|P5|STARTED|Period 2||16
337067|NCT02801396|827676|P4|STARTED|Period 2||16
337068|NCT02801396|827677|P3|STARTED|Period 2||17
337069|NCT02801396|827678|P2|STARTED|Period 2||17
337070|NCT02801396|827679|P1|STARTED|Period 2||17
337071|NCT02801396|827674|P6|NOT COMPLETED|Period 1||0
337072|NCT02801396|827675|P5|NOT COMPLETED|Period 1||1
337073|NCT02801396|827676|P4|NOT COMPLETED|Period 1||0
337074|NCT02801396|827677|P3|NOT COMPLETED|Period 1||0
337075|NCT02801396|827678|P2|NOT COMPLETED|Period 1||0
337076|NCT02801396|827679|P1|NOT COMPLETED|Period 1||0
337077|NCT02801396|827674|P6|COMPLETED|Period 1||17
337078|NCT02801396|827675|P5|COMPLETED|Period 1||16
337079|NCT02801396|827676|P4|COMPLETED|Period 1||16
337080|NCT02801396|827677|P3|COMPLETED|Period 1||17
337081|NCT02801396|827678|P2|COMPLETED|Period 1||17
337082|NCT02801396|827679|P1|COMPLETED|Period 1||17
337083|NCT02801396|827674|P6|STARTED|Period 1||17
337084|NCT02801396|827675|P5|STARTED|Period 1||17
337085|NCT02801396|827676|P4|STARTED|Period 1||16
337086|NCT02801396|827677|P3|STARTED|Period 1||17
337087|NCT02801396|827678|P2|STARTED|Period 1||17
337088|NCT02801396|827679|P1|STARTED|Period 1||17
337089|NCT02801006|827696|P2|NOT COMPLETED|Lens 2||0
337090|NCT02801006|827697|P1|NOT COMPLETED|Lens 2||0
337091|NCT02801006|827696|P2|COMPLETED|Lens 2||19
337092|NCT02801006|827697|P1|COMPLETED|Lens 2||22
337093|NCT02801006|827696|P2|STARTED|Lens 2||19
337094|NCT02801006|827697|P1|STARTED|Lens 2||22
337095|NCT02801006|827696|P2|NOT COMPLETED|Lens 1||0
337096|NCT02801006|827697|P1|NOT COMPLETED|Lens 1||0
337097|NCT02801006|827696|P2|COMPLETED|Lens 1||19
337098|NCT02801006|827697|P1|COMPLETED|Lens 1||22
337099|NCT02801006|827696|P2|STARTED|Lens 1||19
337100|NCT02801006|827697|P1|STARTED|Lens 1||22
337101|NCT02800213|827715|P2|NOT COMPLETED|Second Intervention||0
337102|NCT02800213|827716|P1|NOT COMPLETED|Second Intervention||0
337103|NCT02800213|827715|P2|COMPLETED|Second Intervention||35
337104|NCT02800213|827716|P1|COMPLETED|Second Intervention||35
337105|NCT02800213|827715|P2|STARTED|Second Intervention||35
337106|NCT02800213|827716|P1|STARTED|Second Intervention||35
337107|NCT02800213|827715|P2|NOT COMPLETED|First Intervention||0
337108|NCT02800213|827716|P1|NOT COMPLETED|First Intervention||0
337109|NCT02800213|827715|P2|COMPLETED|First Intervention||35
337110|NCT02800213|827716|P1|COMPLETED|First Intervention||35
337111|NCT02800213|827715|P2|STARTED|First Intervention||35
337112|NCT02800213|827716|P1|STARTED|First Intervention||35
337113|NCT02799082|827724|P2|NOT COMPLETED|Overall Study||4
337114|NCT02799082|827725|P1|NOT COMPLETED|Overall Study||4
337115|NCT02799082|827724|P2|COMPLETED|Overall Study||77
337116|NCT02799082|827725|P1|COMPLETED|Overall Study||37
337117|NCT02799082|827724|P2|STARTED|Overall Study||81
337118|NCT02799082|827725|P1|STARTED|Overall Study||41
337119|NCT02799069|827762|P3|NOT COMPLETED|Overall Study||7
337120|NCT02799069|827763|P2|NOT COMPLETED|Overall Study||7
337121|NCT02799069|827764|P1|NOT COMPLETED|Overall Study||8
337122|NCT02799069|827762|P3|COMPLETED|Overall Study||240
337123|NCT02799069|827763|P2|COMPLETED|Overall Study||241
337124|NCT02799069|827764|P1|COMPLETED|Overall Study||68
337125|NCT02799069|827762|P3|ITT/Safety|Overall Study|1 subject received medication without Illumination and thus was excluded from ITT/safety population|246
337126|NCT02799069|827763|P2|ITT/Safety|Overall Study||248
337127|NCT02799069|827764|P1|ITT/Safety|Overall Study||76
337128|NCT02799069|827762|P3|STARTED|Overall Study||247
337129|NCT02799069|827763|P2|STARTED|Overall Study||248
337130|NCT02799069|827764|P1|STARTED|Overall Study||76
337131|NCT02798289|827874|P1|NOT COMPLETED|Overall Study||0
337132|NCT02798289|827874|P1|COMPLETED|Overall Study||55
337133|NCT02798289|827874|P1|STARTED|Overall Study||55
337134|NCT02797080|827878|P1|NOT COMPLETED|Overall Study||2
337135|NCT02797080|827878|P1|COMPLETED|Overall Study||36
337136|NCT02797080|827878|P1|STARTED|Overall Study||38
337137|NCT02796963|827886|P4|NOT COMPLETED|Overall Study||72
337138|NCT02796963|827887|P3|NOT COMPLETED|Overall Study||69
337139|NCT02796963|827888|P2|NOT COMPLETED|Overall Study||76
337140|NCT02796963|827889|P1|NOT COMPLETED|Overall Study||89
337141|NCT02796963|827886|P4|COMPLETED|Overall Study||282
337142|NCT02796963|827887|P3|COMPLETED|Overall Study||247
337143|NCT02796963|827888|P2|COMPLETED|Overall Study||252
337144|NCT02796963|827889|P1|COMPLETED|Overall Study||294
337145|NCT02796963|827886|P4|HIV Sero Converted|Overall Study||19
337146|NCT02796963|827887|P3|HIV Sero Converted|Overall Study||11
337147|NCT02796963|827888|P2|HIV Sero Converted|Overall Study||19
337148|NCT02796963|827889|P1|HIV Sero Converted|Overall Study||19
337149|NCT02796963|827886|P4|Fourth Follow up|Overall Study||263
337150|NCT02796963|827887|P3|Fourth Follow up|Overall Study||236
337151|NCT02796963|827888|P2|Fourth Follow up|Overall Study||233
337152|NCT02796963|827889|P1|Fourth Follow up|Overall Study||275
337153|NCT02796963|827886|P4|Third Follow up|Overall Study||286
337154|NCT02796963|827887|P3|Third Follow up|Overall Study||245
337155|NCT02796963|827888|P2|Third Follow up|Overall Study||237
337156|NCT02796963|827889|P1|Third Follow up|Overall Study||276
337157|NCT02796963|827886|P4|Second Follow up|Overall Study||293
337158|NCT02796963|827887|P3|Second Follow up|Overall Study||255
337159|NCT02796963|827888|P2|Second Follow up|Overall Study||260
337160|NCT02796963|827889|P1|Second Follow up|Overall Study||280
337161|NCT02796963|827886|P4|First Follow up|Overall Study||291
337162|NCT02796963|827887|P3|First Follow up|Overall Study||257
337163|NCT02796963|827888|P2|First Follow up|Overall Study||279
337164|NCT02796963|827889|P1|First Follow up|Overall Study||293
337165|NCT02796963|827886|P4|STARTED|Overall Study||354
337166|NCT02796963|827887|P3|STARTED|Overall Study||316
337167|NCT02796963|827888|P2|STARTED|Overall Study||328
337168|NCT02796963|827889|P1|STARTED|Overall Study||383
337169|NCT02796651|827951|P1|NOT COMPLETED|Overall Study||26
337170|NCT02796651|827951|P1|COMPLETED|Overall Study||106
337171|NCT02796651|827951|P1|Placebo (Lactose Monohydrate)|Overall Study||38
337172|NCT02796651|827951|P1|Perforomist 40 μg|Overall Study||108
337173|NCT02796651|827951|P1|Perforomist 20 μg|Overall Study||118
337174|NCT02796651|827951|P1|Formoterol Fumarate (FF) 24 μg|Overall Study||105
337175|NCT02796651|827951|P1|Formoterol Fumarate (FF) 12 μg|Overall Study||121
337176|NCT02796651|827951|P1|Formoterol Fumarate (FF) 6 μg|Overall Study||107
337177|NCT02796651|827951|P1|STARTED|Overall Study||132
337178|NCT02796352|827980|P1|NOT COMPLETED|Overall Study||0
337179|NCT02796352|827980|P1|COMPLETED|Overall Study||1
337180|NCT02796352|827980|P1|STARTED|Overall Study||1
337181|NCT02796092|827989|P2|NOT COMPLETED|Overall Study||0
337182|NCT02796092|827990|P1|NOT COMPLETED|Overall Study||0
337183|NCT02796092|827989|P2|COMPLETED|Overall Study||50
337184|NCT02796092|827990|P1|COMPLETED|Overall Study||50
337185|NCT02796092|827989|P2|STARTED|Overall Study||50
337186|NCT02796092|827990|P1|STARTED|Overall Study||50
337187|NCT02794844|828022|P1|NOT COMPLETED|Overall Study||5
337188|NCT02794844|828022|P1|COMPLETED|Overall Study||23
337189|NCT02794844|828022|P1|STARTED|Overall Study||28
337190|NCT02794480|828032|P4|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||1
337191|NCT02794480|828033|P3|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||0
337192|NCT02794480|828034|P2|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||0
337193|NCT02794480|828035|P1|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||1
337194|NCT02794480|828032|P4|COMPLETED|Period 2: Treatment Period 2 (28 Days)||77
337195|NCT02794480|828033|P3|COMPLETED|Period 2: Treatment Period 2 (28 Days)||79
337196|NCT02794480|828034|P2|COMPLETED|Period 2: Treatment Period 2 (28 Days)||80
337197|NCT02794480|828035|P1|COMPLETED|Period 2: Treatment Period 2 (28 Days)||79
337198|NCT02794480|828032|P4|STARTED|Period 2: Treatment Period 2 (28 Days)||78
337199|NCT02794480|828033|P3|STARTED|Period 2: Treatment Period 2 (28 Days)||79
337200|NCT02794480|828034|P2|STARTED|Period 2: Treatment Period 2 (28 Days)||80
337201|NCT02794480|828035|P1|STARTED|Period 2: Treatment Period 2 (28 Days)||80
337202|NCT02794480|828032|P4|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||3
337203|NCT02794480|828033|P3|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||2
337204|NCT02794480|828034|P2|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||2
337205|NCT02794480|828035|P1|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||0
337206|NCT02794480|828032|P4|COMPLETED|Period 1: Treatment Period 1 (28 Days)||78
337207|NCT02794480|828033|P3|COMPLETED|Period 1: Treatment Period 1 (28 Days)||79
337208|NCT02794480|828034|P2|COMPLETED|Period 1: Treatment Period 1 (28 Days)||80
337209|NCT02794480|828035|P1|COMPLETED|Period 1: Treatment Period 1 (28 Days)||80
337210|NCT02794480|828032|P4|STARTED|Period 1: Treatment Period 1 (28 Days)||81
337211|NCT02794480|828033|P3|STARTED|Period 1: Treatment Period 1 (28 Days)||81
337212|NCT02794480|828034|P2|STARTED|Period 1: Treatment Period 1 (28 Days)||82
337213|NCT02794480|828035|P1|STARTED|Period 1: Treatment Period 1 (28 Days)||80
337214|NCT02793947|828055|P2|NOT COMPLETED|Overall Study||5
337215|NCT02793947|828056|P1|NOT COMPLETED|Overall Study||2
337216|NCT02793947|828055|P2|COMPLETED|Overall Study||50
337217|NCT02793947|828056|P1|COMPLETED|Overall Study||45
337218|NCT02793947|828055|P2|STARTED|Overall Study||55
337219|NCT02793947|828056|P1|STARTED|Overall Study||47
337220|NCT02793154|828069|P3|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
337221|NCT02793154|828070|P2|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
337222|NCT02793154|828071|P1|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
337223|NCT02793154|828069|P3|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
337224|NCT02793154|828070|P2|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
337225|NCT02793154|828071|P1|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
337226|NCT02793154|828069|P3|STARTED|Part B (Parallel Group-up to 84 Days)||0
337227|NCT02793154|828070|P2|STARTED|Part B (Parallel Group-up to 84 Days)||0
337228|NCT02793154|828071|P1|STARTED|Part B (Parallel Group-up to 84 Days)||0
337229|NCT02793154|828069|P3|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
337230|NCT02793154|828070|P2|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
337231|NCT02793154|828071|P1|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
337232|NCT02793154|828069|P3|COMPLETED|Part A (Single Group-up to 12 Days)||0
337233|NCT02793154|828070|P2|COMPLETED|Part A (Single Group-up to 12 Days)||0
337234|NCT02793154|828071|P1|COMPLETED|Part A (Single Group-up to 12 Days)||4
337235|NCT02793154|828069|P3|STARTED|Part A (Single Group-up to 12 Days)||0
337236|NCT02793154|828070|P2|STARTED|Part A (Single Group-up to 12 Days)||0
337237|NCT02793154|828071|P1|STARTED|Part A (Single Group-up to 12 Days)||4
337238|NCT02792062|828143|P6|NOT COMPLETED|Intervention Period 3 (6 Days)||0
337239|NCT02792062|828144|P5|NOT COMPLETED|Intervention Period 3 (6 Days)||0
337240|NCT02792062|828145|P4|NOT COMPLETED|Intervention Period 3 (6 Days)||0
337241|NCT02792062|828146|P3|NOT COMPLETED|Intervention Period 3 (6 Days)||0
337242|NCT02792062|828147|P2|NOT COMPLETED|Intervention Period 3 (6 Days)||0
337243|NCT02792062|828148|P1|NOT COMPLETED|Intervention Period 3 (6 Days)||0
337244|NCT02792062|828143|P6|COMPLETED|Intervention Period 3 (6 Days)||2
337245|NCT02792062|828144|P5|COMPLETED|Intervention Period 3 (6 Days)||2
337246|NCT02792062|828145|P4|COMPLETED|Intervention Period 3 (6 Days)||2
337247|NCT02792062|828146|P3|COMPLETED|Intervention Period 3 (6 Days)||2
337248|NCT02792062|828147|P2|COMPLETED|Intervention Period 3 (6 Days)||2
337249|NCT02792062|828148|P1|COMPLETED|Intervention Period 3 (6 Days)||1
337250|NCT02792062|828143|P6|STARTED|Intervention Period 3 (6 Days)||2
337251|NCT02792062|828144|P5|STARTED|Intervention Period 3 (6 Days)||2
337252|NCT02792062|828145|P4|STARTED|Intervention Period 3 (6 Days)||2
337253|NCT02792062|828146|P3|STARTED|Intervention Period 3 (6 Days)||2
337254|NCT02792062|828147|P2|STARTED|Intervention Period 3 (6 Days)||2
337255|NCT02792062|828148|P1|STARTED|Intervention Period 3 (6 Days)||1
337256|NCT02792062|828143|P6|NOT COMPLETED|Washout Period (at Least 14 Days)||0
337257|NCT02792062|828144|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||0
337258|NCT02792062|828145|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
337259|NCT02792062|828146|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
337260|NCT02792062|828147|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
337261|NCT02792062|828148|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||1
337262|NCT02792062|828143|P6|COMPLETED|Washout Period (at Least 14 Days)||2
337263|NCT02792062|828144|P5|COMPLETED|Washout Period (at Least 14 Days)||2
337264|NCT02792062|828145|P4|COMPLETED|Washout Period (at Least 14 Days)||2
337265|NCT02792062|828146|P3|COMPLETED|Washout Period (at Least 14 Days)||2
337266|NCT02792062|828147|P2|COMPLETED|Washout Period (at Least 14 Days)||2
337267|NCT02792062|828148|P1|COMPLETED|Washout Period (at Least 14 Days)||1
337268|NCT02792062|828143|P6|STARTED|Washout Period (at Least 14 Days)||2
337269|NCT02792062|828144|P5|STARTED|Washout Period (at Least 14 Days)||2
337270|NCT02792062|828145|P4|STARTED|Washout Period (at Least 14 Days)||2
337271|NCT02792062|828146|P3|STARTED|Washout Period (at Least 14 Days)||2
337272|NCT02792062|828147|P2|STARTED|Washout Period (at Least 14 Days)||2
337273|NCT02792062|828148|P1|STARTED|Washout Period (at Least 14 Days)||2
337274|NCT02792062|828143|P6|NOT COMPLETED|Intervention Period 2 (6 Days)||0
337275|NCT02792062|828144|P5|NOT COMPLETED|Intervention Period 2 (6 Days)||0
337276|NCT02792062|828145|P4|NOT COMPLETED|Intervention Period 2 (6 Days)||0
337277|NCT02792062|828146|P3|NOT COMPLETED|Intervention Period 2 (6 Days)||0
337278|NCT02792062|828147|P2|NOT COMPLETED|Intervention Period 2 (6 Days)||0
337279|NCT02792062|828148|P1|NOT COMPLETED|Intervention Period 2 (6 Days)||0
337280|NCT02792062|828143|P6|COMPLETED|Intervention Period 2 (6 Days)||2
337281|NCT02792062|828144|P5|COMPLETED|Intervention Period 2 (6 Days)||2
337282|NCT02792062|828145|P4|COMPLETED|Intervention Period 2 (6 Days)||2
337283|NCT02792062|828146|P3|COMPLETED|Intervention Period 2 (6 Days)||2
337284|NCT02792062|828147|P2|COMPLETED|Intervention Period 2 (6 Days)||2
337285|NCT02792062|828148|P1|COMPLETED|Intervention Period 2 (6 Days)||2
337286|NCT02792062|828143|P6|STARTED|Intervention Period 2 (6 Days)||2
337287|NCT02792062|828144|P5|STARTED|Intervention Period 2 (6 Days)||2
337288|NCT02792062|828145|P4|STARTED|Intervention Period 2 (6 Days)||2
337289|NCT02792062|828146|P3|STARTED|Intervention Period 2 (6 Days)||2
337290|NCT02792062|828147|P2|STARTED|Intervention Period 2 (6 Days)||2
337291|NCT02792062|828148|P1|STARTED|Intervention Period 2 (6 Days)||2
337292|NCT02792062|828143|P6|NOT COMPLETED|Washout Period (at Least 14 Days)||0
337293|NCT02792062|828144|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||0
337294|NCT02792062|828145|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
337295|NCT02792062|828146|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
337296|NCT02792062|828147|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
337297|NCT02792062|828148|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
337298|NCT02792062|828143|P6|COMPLETED|Washout Period (at Least 14 Days)||2
337299|NCT02792062|828144|P5|COMPLETED|Washout Period (at Least 14 Days)||2
337300|NCT02792062|828145|P4|COMPLETED|Washout Period (at Least 14 Days)||2
337301|NCT02792062|828146|P3|COMPLETED|Washout Period (at Least 14 Days)||2
337302|NCT02792062|828147|P2|COMPLETED|Washout Period (at Least 14 Days)||2
337303|NCT02792062|828148|P1|COMPLETED|Washout Period (at Least 14 Days)||2
337304|NCT02792062|828143|P6|STARTED|Washout Period (at Least 14 Days)||2
337305|NCT02792062|828144|P5|STARTED|Washout Period (at Least 14 Days)||2
337306|NCT02792062|828145|P4|STARTED|Washout Period (at Least 14 Days)||2
337307|NCT02792062|828146|P3|STARTED|Washout Period (at Least 14 Days)||2
337308|NCT02792062|828147|P2|STARTED|Washout Period (at Least 14 Days)||2
337309|NCT02792062|828148|P1|STARTED|Washout Period (at Least 14 Days)||2
337310|NCT02792062|828143|P6|NOT COMPLETED|Intervention Period 1 (6 Days)||0
337311|NCT02792062|828144|P5|NOT COMPLETED|Intervention Period 1 (6 Days)||0
337312|NCT02792062|828145|P4|NOT COMPLETED|Intervention Period 1 (6 Days)||0
337313|NCT02792062|828146|P3|NOT COMPLETED|Intervention Period 1 (6 Days)||0
337314|NCT02792062|828147|P2|NOT COMPLETED|Intervention Period 1 (6 Days)||0
337315|NCT02792062|828148|P1|NOT COMPLETED|Intervention Period 1 (6 Days)||0
337316|NCT02792062|828143|P6|COMPLETED|Intervention Period 1 (6 Days)||2
337317|NCT02792062|828144|P5|COMPLETED|Intervention Period 1 (6 Days)||2
337318|NCT02792062|828145|P4|COMPLETED|Intervention Period 1 (6 Days)||2
337319|NCT02792062|828146|P3|COMPLETED|Intervention Period 1 (6 Days)||2
337320|NCT02792062|828147|P2|COMPLETED|Intervention Period 1 (6 Days)||2
337321|NCT02792062|828148|P1|COMPLETED|Intervention Period 1 (6 Days)||2
337322|NCT02792062|828143|P6|STARTED|Intervention Period 1 (6 Days)||2
337323|NCT02792062|828144|P5|STARTED|Intervention Period 1 (6 Days)||2
337324|NCT02792062|828145|P4|STARTED|Intervention Period 1 (6 Days)||2
337325|NCT02792062|828146|P3|STARTED|Intervention Period 1 (6 Days)||2
337326|NCT02792062|828147|P2|STARTED|Intervention Period 1 (6 Days)||2
337327|NCT02792062|828148|P1|STARTED|Intervention Period 1 (6 Days)||2
337328|NCT02792049|828182|P2|NOT COMPLETED|Overall Study||0
337329|NCT02792049|828183|P1|NOT COMPLETED|Overall Study||0
337330|NCT02792049|828182|P2|COMPLETED|Overall Study||35
337331|NCT02792049|828183|P1|COMPLETED|Overall Study||35
337332|NCT02792049|828182|P2|STARTED|Overall Study||35
337333|NCT02792049|828183|P1|STARTED|Overall Study||35
337334|NCT02791659|828199|P2|NOT COMPLETED|Overall Study||1
337335|NCT02791659|828200|P1|NOT COMPLETED|Overall Study||0
337336|NCT02791659|828199|P2|COMPLETED|Overall Study||27
337337|NCT02791659|828200|P1|COMPLETED|Overall Study||27
337338|NCT02791659|828199|P2|STARTED|Overall Study||28
337339|NCT02791659|828200|P1|STARTED|Overall Study||27
337340|NCT02791269|828208|P2|NOT COMPLETED|Overall Study||1
337341|NCT02791269|828209|P1|NOT COMPLETED|Overall Study||0
337342|NCT02791269|828208|P2|COMPLETED|Overall Study||19
337343|NCT02791269|828209|P1|COMPLETED|Overall Study||4
337344|NCT02791269|828208|P2|STARTED|Overall Study||20
337345|NCT02791269|828209|P1|STARTED|Overall Study||4
337346|NCT02790281|828223|P1|NOT COMPLETED|Overall Study||0
337347|NCT02790281|828223|P1|COMPLETED|Overall Study||33
337348|NCT02790281|828223|P1|STARTED|Overall Study||33
337349|NCT02788357|828231|P2|NOT COMPLETED|Overall Study||0
337350|NCT02788357|828232|P1|NOT COMPLETED|Overall Study||3
337351|NCT02788357|828231|P2|COMPLETED|Overall Study||6
337352|NCT02788357|828232|P1|COMPLETED|Overall Study||3
337353|NCT02788357|828231|P2|STARTED|Overall Study||6
337354|NCT02788357|828232|P1|STARTED|Overall Study||6
337355|NCT02788188|828251|P7|NOT COMPLETED|Overall Study||0
337356|NCT02788188|828252|P6|NOT COMPLETED|Overall Study||0
337357|NCT02788188|828253|P5|NOT COMPLETED|Overall Study||0
337358|NCT02788188|828254|P4|NOT COMPLETED|Overall Study||0
337359|NCT02788188|828255|P3|NOT COMPLETED|Overall Study||0
337360|NCT02788188|828256|P2|NOT COMPLETED|Overall Study||0
337361|NCT02788188|828257|P1|NOT COMPLETED|Overall Study||0
337362|NCT02788188|828251|P7|COMPLETED|Overall Study||10
337363|NCT02788188|828252|P6|COMPLETED|Overall Study||8
337364|NCT02788188|828253|P5|COMPLETED|Overall Study||8
337365|NCT02788188|828254|P4|COMPLETED|Overall Study||4
337366|NCT02788188|828255|P3|COMPLETED|Overall Study||4
337367|NCT02788188|828256|P2|COMPLETED|Overall Study||2
337368|NCT02788188|828257|P1|COMPLETED|Overall Study||2
337369|NCT02788188|828251|P7|STARTED|Overall Study||10
337370|NCT02788188|828252|P6|STARTED|Overall Study||8
337371|NCT02788188|828253|P5|STARTED|Overall Study||8
337372|NCT02788188|828254|P4|STARTED|Overall Study||4
337373|NCT02788188|828255|P3|STARTED|Overall Study||4
337374|NCT02788188|828256|P2|STARTED|Overall Study||2
337375|NCT02788188|828257|P1|STARTED|Overall Study||2
337376|NCT02788097|828275|P2|NOT COMPLETED|Overall Study||0
337377|NCT02788097|828276|P1|NOT COMPLETED|Overall Study||0
337378|NCT02788097|828275|P2|COMPLETED|Overall Study||69
337379|NCT02788097|828276|P1|COMPLETED|Overall Study||61
337380|NCT02788097|828275|P2|STARTED|Overall Study||69
337381|NCT02788097|828276|P1|STARTED|Overall Study||61
337382|NCT02787564|828284|P2|NOT COMPLETED|Overall Study||2
337383|NCT02787564|828285|P1|NOT COMPLETED|Overall Study||7
337384|NCT02787564|828284|P2|COMPLETED|Overall Study|n=12 food bank users; n=15 non-food bank users|27
337385|NCT02787564|828285|P1|COMPLETED|Overall Study|n=12 food bank users; n=13 non-food bank users|25
337386|NCT02787564|828284|P2|STARTED|Overall Study||29
337387|NCT02787564|828285|P1|STARTED|Overall Study||32
337388|NCT02786927|828301|P1|NOT COMPLETED|Overall Study||5
337389|NCT02786927|828301|P1|COMPLETED|Overall Study||207
337390|NCT02786927|828301|P1|STARTED|Overall Study||212
337391|NCT02786810|828308|P1|NOT COMPLETED|Overall Study||0
337392|NCT02786810|828308|P1|COMPLETED|Overall Study||10
337393|NCT02786810|828308|P1|STARTED|Overall Study||10
337394|NCT02786771|828315|P2|NOT COMPLETED|Overall Study||6
337395|NCT02786771|828316|P1|NOT COMPLETED|Overall Study||10
337396|NCT02786771|828315|P2|COMPLETED|Overall Study||56
337397|NCT02786771|828316|P1|COMPLETED|Overall Study||53
337398|NCT02786771|828315|P2|STARTED|Overall Study||62
337399|NCT02786771|828316|P1|STARTED|Overall Study||63
337400|NCT02786004|828324|P2|NOT COMPLETED|Overall Study||14
337401|NCT02786004|828325|P1|NOT COMPLETED|Overall Study||9
337402|NCT02786004|828324|P2|COMPLETED|Overall Study||9
337403|NCT02786004|828325|P1|COMPLETED|Overall Study||14
337404|NCT02786004|828324|P2|STARTED|Overall Study||23
337405|NCT02786004|828325|P1|STARTED|Overall Study||23
337406|NCT02784925|828331|P1|NOT COMPLETED|Overall Study||0
337407|NCT02784925|828331|P1|COMPLETED|Overall Study||30
337408|NCT02784925|828331|P1|STARTED|Overall Study||30
337409|NCT02784275|828339|P4|NOT COMPLETED|Overall Study||1
337410|NCT02784275|828340|P3|NOT COMPLETED|Overall Study||1
337411|NCT02784275|828341|P2|NOT COMPLETED|Overall Study||0
337412|NCT02784275|828342|P1|NOT COMPLETED|Overall Study||1
337413|NCT02784275|828339|P4|COMPLETED|Overall Study||14
337414|NCT02784275|828340|P3|COMPLETED|Overall Study||16
337415|NCT02784275|828341|P2|COMPLETED|Overall Study||16
337416|NCT02784275|828342|P1|COMPLETED|Overall Study||15
337417|NCT02784275|828339|P4|STARTED|Overall Study||15
337418|NCT02784275|828340|P3|STARTED|Overall Study||17
337419|NCT02784275|828341|P2|STARTED|Overall Study||16
337420|NCT02784275|828342|P1|STARTED|Overall Study||16
337421|NCT02784106|828382|P4|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||2
337422|NCT02784106|828383|P3|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||3
337423|NCT02784106|828384|P2|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||0
337424|NCT02784106|828385|P1|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||0
337425|NCT02784106|828382|P4|COMPLETED|Open-Label Extension Period (26 Weeks)||19
337426|NCT02784106|828383|P3|COMPLETED|Open-Label Extension Period (26 Weeks)||15
337427|NCT02784106|828384|P2|COMPLETED|Open-Label Extension Period (26 Weeks)||0
337428|NCT02784106|828385|P1|COMPLETED|Open-Label Extension Period (26 Weeks)||0
337429|NCT02784106|828382|P4|STARTED|Open-Label Extension Period (26 Weeks)||21
337430|NCT02784106|828383|P3|STARTED|Open-Label Extension Period (26 Weeks)||18
337431|NCT02784106|828384|P2|STARTED|Open-Label Extension Period (26 Weeks)||0
337432|NCT02784106|828385|P1|STARTED|Open-Label Extension Period (26 Weeks)||0
337433|NCT02784106|828382|P4|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
337434|NCT02784106|828383|P3|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
337435|NCT02784106|828384|P2|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||6
337436|NCT02784106|828385|P1|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||8
337437|NCT02784106|828382|P4|COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
337438|NCT02784106|828383|P3|COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
337439|NCT02784106|828384|P2|COMPLETED|Double-Blind Treatment Period (12 Weeks)||27
337440|NCT02784106|828385|P1|COMPLETED|Double-Blind Treatment Period (12 Weeks)||24
337441|NCT02784106|828382|P4|STARTED|Double-Blind Treatment Period (12 Weeks)||0
337442|NCT02784106|828383|P3|STARTED|Double-Blind Treatment Period (12 Weeks)||0
337443|NCT02784106|828384|P2|STARTED|Double-Blind Treatment Period (12 Weeks)||33
337444|NCT02784106|828385|P1|STARTED|Double-Blind Treatment Period (12 Weeks)||32
337445|NCT02782676|828446|P2|NOT COMPLETED|Overall Study||1
337446|NCT02782676|828447|P1|NOT COMPLETED|Overall Study||0
337447|NCT02782676|828446|P2|COMPLETED|Overall Study||209
337448|NCT02782676|828447|P1|COMPLETED|Overall Study||211
337449|NCT02782676|828446|P2|STARTED|Overall Study||210
337450|NCT02782676|828447|P1|STARTED|Overall Study||211
337451|NCT02782169|828477|P2|NOT COMPLETED|Overall Study||2
337452|NCT02782169|828478|P1|NOT COMPLETED|Overall Study||1
337453|NCT02782169|828477|P2|COMPLETED|Overall Study||52
337454|NCT02782169|828478|P1|COMPLETED|Overall Study||55
337455|NCT02782169|828477|P2|STARTED|Overall Study||54
337456|NCT02782169|828478|P1|STARTED|Overall Study||56
337457|NCT02781818|828495|P3|NOT COMPLETED|Overall Study||1
337458|NCT02781818|828496|P2|NOT COMPLETED|Overall Study||2
337459|NCT02781818|828497|P1|NOT COMPLETED|Overall Study||4
337460|NCT02781818|828495|P3|COMPLETED|Overall Study||16
337461|NCT02781818|828496|P2|COMPLETED|Overall Study||16
337462|NCT02781818|828497|P1|COMPLETED|Overall Study||16
337463|NCT02781818|828495|P3|STARTED|Overall Study||17
337464|NCT02781818|828496|P2|STARTED|Overall Study||18
337465|NCT02781818|828497|P1|STARTED|Overall Study||20
337466|NCT02781649|828514|P3|NOT COMPLETED|Overall Study||0
337467|NCT02781649|828515|P2|NOT COMPLETED|Overall Study||0
337468|NCT02781649|828516|P1|NOT COMPLETED|Overall Study||0
337469|NCT02781649|828514|P3|COMPLETED|Overall Study||3
337470|NCT02781649|828515|P2|COMPLETED|Overall Study||0
337471|NCT02781649|828516|P1|COMPLETED|Overall Study||7
337472|NCT02781649|828514|P3|STARTED|Overall Study||3
337473|NCT02781649|828515|P2|STARTED|Overall Study||0
337474|NCT02781649|828516|P1|STARTED|Overall Study|4 in this group had insufficient viral RNA for genotyping. They were treated as 1a|7
337475|NCT02780622|828542|P2|NOT COMPLETED|Treatment Period 2||0
337476|NCT02780622|828543|P1|NOT COMPLETED|Treatment Period 2||0
337477|NCT02780622|828542|P2|COMPLETED|Treatment Period 2||10
337478|NCT02780622|828543|P1|COMPLETED|Treatment Period 2||10
337479|NCT02780622|828542|P2|STARTED|Treatment Period 2||10
337480|NCT02780622|828543|P1|STARTED|Treatment Period 2||10
337481|NCT02780622|828542|P2|NOT COMPLETED|Treatment Period 1||0
337482|NCT02780622|828543|P1|NOT COMPLETED|Treatment Period 1||0
337483|NCT02780622|828542|P2|COMPLETED|Treatment Period 1||10
337484|NCT02780622|828543|P1|COMPLETED|Treatment Period 1||10
337485|NCT02780622|828542|P2|STARTED|Treatment Period 1||10
337486|NCT02780622|828543|P1|STARTED|Treatment Period 1||10
337487|NCT02780349|828581|P1|NOT COMPLETED|Overall Study||2
337488|NCT02780349|828581|P1|COMPLETED|Overall Study||101
337489|NCT02780349|828581|P1|STARTED|Overall Study||103
337490|NCT02780167|828590|P5|NOT COMPLETED|Overall Study||17
337491|NCT02780167|828591|P4|NOT COMPLETED|Overall Study||19
337492|NCT02780167|828592|P3|NOT COMPLETED|Overall Study||24
337493|NCT02780167|828593|P2|NOT COMPLETED|Overall Study||22
337494|NCT02780167|828594|P1|NOT COMPLETED|Overall Study||28
337495|NCT02780167|828590|P5|COMPLETED|Overall Study||38
337496|NCT02780167|828591|P4|COMPLETED|Overall Study||37
337497|NCT02780167|828592|P3|COMPLETED|Overall Study||27
337498|NCT02780167|828593|P2|COMPLETED|Overall Study||27
337499|NCT02780167|828594|P1|COMPLETED|Overall Study||28
337500|NCT02780167|828590|P5|STARTED|Overall Study||55
337501|NCT02780167|828591|P4|STARTED|Overall Study||56
337502|NCT02780167|828592|P3|STARTED|Overall Study||51
337503|NCT02780167|828593|P2|STARTED|Overall Study||49
337504|NCT02780167|828594|P1|STARTED|Overall Study||56
337505|NCT02777931|828728|P2|NOT COMPLETED|Overall Study||13
337506|NCT02777931|828729|P1|NOT COMPLETED|Overall Study||12
337507|NCT02777931|828728|P2|COMPLETED|Overall Study||39
337508|NCT02777931|828729|P1|COMPLETED|Overall Study||37
337509|NCT02777931|828728|P2|Modified Intent to Treat Population|Overall Study||50
337510|NCT02777931|828729|P1|Modified Intent to Treat Population|Overall Study||46
337511|NCT02777931|828728|P2|Safety Population|Overall Study||50
337512|NCT02777931|828729|P1|Safety Population|Overall Study||47
337513|NCT02777931|828728|P2|STARTED|Overall Study||52
337514|NCT02777931|828729|P1|STARTED|Overall Study||49
337515|NCT02777268|828737|P1|NOT COMPLETED|Overall Study||0
337516|NCT02777268|828737|P1|COMPLETED|Overall Study||16
337517|NCT02777268|828737|P1|STARTED|Overall Study||16
337518|NCT02777242|828763|P1|NOT COMPLETED|Overall Study||6
337519|NCT02777242|828763|P1|COMPLETED|Overall Study||59
337520|NCT02777242|828763|P1|STARTED|Overall Study||65
337521|NCT02777125|828769|P2|NOT COMPLETED|Overall Study||47
337522|NCT02777125|828770|P1|NOT COMPLETED|Overall Study||43
337523|NCT02777125|828769|P2|COMPLETED|Overall Study||445
337524|NCT02777125|828770|P1|COMPLETED|Overall Study||445
337525|NCT02777125|828769|P2|STARTED|Overall Study||492
337526|NCT02777125|828770|P1|STARTED|Overall Study||488
337527|NCT02774343|828786|P2|NOT COMPLETED|Overall Study||3
337528|NCT02774343|828787|P1|NOT COMPLETED|Overall Study||6
337529|NCT02774343|828786|P2|COMPLETED|Overall Study||12
337530|NCT02774343|828787|P1|COMPLETED|Overall Study||9
337531|NCT02774343|828786|P2|Received at Least One Capsule|Overall Study||14
337532|NCT02774343|828787|P1|Received at Least One Capsule|Overall Study||12
337533|NCT02774343|828786|P2|STARTED|Overall Study||15
337534|NCT02774343|828787|P1|STARTED|Overall Study||15
337535|NCT02774278|828823|P1|NOT COMPLETED|Overall Study||264
337536|NCT02774278|828823|P1|COMPLETED|Overall Study||0
337537|NCT02774278|828823|P1|Safety Analysis Population (SAP)|Overall Study|SAP: all participants who received at least 1 dose of trial medication and had a safety follow-up.|261
337538|NCT02774278|828823|P1|STARTED|Overall Study||264
337539|NCT02774148|828833|P2|NOT COMPLETED|Overall Study||0
337540|NCT02774148|828834|P1|NOT COMPLETED|Overall Study||0
337541|NCT02774148|828833|P2|COMPLETED|Overall Study||0
337542|NCT02774148|828834|P1|COMPLETED|Overall Study||0
337543|NCT02774148|828833|P2|STARTED|Overall Study||0
337544|NCT02774148|828834|P1|STARTED|Overall Study||0
337545|NCT02773758|828850|P2|NOT COMPLETED|Overall Study||0
337546|NCT02773758|828851|P1|NOT COMPLETED|Overall Study||0
337547|NCT02773758|828850|P2|COMPLETED|Overall Study||70
337548|NCT02773758|828851|P1|COMPLETED|Overall Study||71
337549|NCT02773758|828850|P2|STARTED|Overall Study||70
337550|NCT02773758|828851|P1|STARTED|Overall Study||71
337551|NCT02772666|828861|P1|NOT COMPLETED|SFT Then O-Glass||0
337552|NCT02772666|828861|P1|COMPLETED|SFT Then O-Glass||44
337553|NCT02772666|828861|P1|STARTED|SFT Then O-Glass||44
337554|NCT02772666|828861|P1|NOT COMPLETED|O-Glas Then SFT||0
337555|NCT02772666|828861|P1|COMPLETED|O-Glas Then SFT||44
337556|NCT02772666|828861|P1|STARTED|O-Glas Then SFT||44
337557|NCT02770625|828866|P1|NOT COMPLETED|Overall Study||0
337558|NCT02770625|828866|P1|COMPLETED|Overall Study||8
337559|NCT02770625|828866|P1|STARTED|Overall Study||8
337560|NCT02770248|828881|P2|NOT COMPLETED|Overall Study||2
337561|NCT02770248|828882|P1|NOT COMPLETED|Overall Study||0
337562|NCT02770248|828881|P2|COMPLETED|Overall Study||61
337563|NCT02770248|828882|P1|COMPLETED|Overall Study||62
337564|NCT02770248|828881|P2|STARTED|Overall Study||63
337565|NCT02770248|828882|P1|STARTED|Overall Study||62
337566|NCT02769858|828894|P1|NOT COMPLETED|Overall Study||2
337567|NCT02769858|828894|P1|COMPLETED|Overall Study||8
337568|NCT02769858|828894|P1|STARTED|Overall Study||10
337569|NCT02769442|828902|P2|NOT COMPLETED|Overall Study||0
337570|NCT02769442|828903|P1|NOT COMPLETED|Overall Study||0
337571|NCT02769442|828902|P2|COMPLETED|Overall Study||291
337572|NCT02769442|828903|P1|COMPLETED|Overall Study||309
337573|NCT02769442|828902|P2|STARTED|Overall Study||291
337574|NCT02769442|828903|P1|STARTED|Overall Study||309
337575|NCT02768194|828911|P6|NOT COMPLETED|Period 3||0
337576|NCT02768194|828912|P5|NOT COMPLETED|Period 3||0
337577|NCT02768194|828913|P4|NOT COMPLETED|Period 3||0
337578|NCT02768194|828914|P3|NOT COMPLETED|Period 3||0
337579|NCT02768194|828915|P2|NOT COMPLETED|Period 3||1
337580|NCT02768194|828916|P1|NOT COMPLETED|Period 3||0
337581|NCT02768194|828911|P6|COMPLETED|Period 3||4
337582|NCT02768194|828912|P5|COMPLETED|Period 3||4
337583|NCT02768194|828913|P4|COMPLETED|Period 3||3
337584|NCT02768194|828914|P3|COMPLETED|Period 3||4
337585|NCT02768194|828915|P2|COMPLETED|Period 3||3
337586|NCT02768194|828916|P1|COMPLETED|Period 3||3
337587|NCT02768194|828911|P6|STARTED|Period 3||4
337588|NCT02768194|828912|P5|STARTED|Period 3||4
337589|NCT02768194|828913|P4|STARTED|Period 3||3
337590|NCT02768194|828914|P3|STARTED|Period 3||4
337591|NCT02768194|828915|P2|STARTED|Period 3||4
337592|NCT02768194|828916|P1|STARTED|Period 3||3
337593|NCT02768194|828911|P6|NOT COMPLETED|Period 2||0
337594|NCT02768194|828912|P5|NOT COMPLETED|Period 2||0
337595|NCT02768194|828913|P4|NOT COMPLETED|Period 2||0
337596|NCT02768194|828914|P3|NOT COMPLETED|Period 2||0
337597|NCT02768194|828915|P2|NOT COMPLETED|Period 2||0
337598|NCT02768194|828916|P1|NOT COMPLETED|Period 2||1
337599|NCT02768194|828911|P6|COMPLETED|Period 2||4
337600|NCT02768194|828912|P5|COMPLETED|Period 2||4
337601|NCT02768194|828913|P4|COMPLETED|Period 2||3
337602|NCT02768194|828914|P3|COMPLETED|Period 2||4
337603|NCT02768194|828915|P2|COMPLETED|Period 2||4
337604|NCT02768194|828916|P1|COMPLETED|Period 2||3
337605|NCT02768194|828911|P6|STARTED|Period 2||4
337606|NCT02768194|828912|P5|STARTED|Period 2||4
337607|NCT02768194|828913|P4|STARTED|Period 2||3
337608|NCT02768194|828914|P3|STARTED|Period 2||4
337609|NCT02768194|828915|P2|STARTED|Period 2||4
337610|NCT02768194|828916|P1|STARTED|Period 2||4
337611|NCT02768194|828911|P6|NOT COMPLETED|Period 1||0
337612|NCT02768194|828912|P5|NOT COMPLETED|Period 1||0
337613|NCT02768194|828913|P4|NOT COMPLETED|Period 1||1
337614|NCT02768194|828914|P3|NOT COMPLETED|Period 1||0
337615|NCT02768194|828915|P2|NOT COMPLETED|Period 1||0
337616|NCT02768194|828916|P1|NOT COMPLETED|Period 1||0
337617|NCT02768194|828911|P6|COMPLETED|Period 1||4
337618|NCT02768194|828912|P5|COMPLETED|Period 1||4
337619|NCT02768194|828913|P4|COMPLETED|Period 1||3
337620|NCT02768194|828914|P3|COMPLETED|Period 1||4
337621|NCT02768194|828915|P2|COMPLETED|Period 1||4
337622|NCT02768194|828916|P1|COMPLETED|Period 1||4
337623|NCT02768194|828911|P6|STARTED|Period 1||4
337624|NCT02768194|828912|P5|STARTED|Period 1||4
337625|NCT02768194|828913|P4|STARTED|Period 1||4
337626|NCT02768194|828914|P3|STARTED|Period 1||4
337627|NCT02768194|828915|P2|STARTED|Period 1||4
337628|NCT02768194|828916|P1|STARTED|Period 1||4
337629|NCT02767843|828927|P1|NOT COMPLETED|Overall Study||0
337630|NCT02767843|828927|P1|COMPLETED|Overall Study||4
337631|NCT02767843|828927|P1|STARTED|Overall Study||4
337632|NCT02767765|828933|P1|NOT COMPLETED|Overall Study||11
337633|NCT02767765|828933|P1|COMPLETED|Overall Study||50
337634|NCT02767765|828933|P1|STARTED|Overall Study||61
337635|NCT02766400|828944|P2|NOT COMPLETED|Overall Study||2
337636|NCT02766400|828945|P1|NOT COMPLETED|Overall Study||2
337637|NCT02766400|828944|P2|COMPLETED|Overall Study||20
337638|NCT02766400|828945|P1|COMPLETED|Overall Study||19
337639|NCT02766400|828944|P2|STARTED|Overall Study||22
337640|NCT02766400|828945|P1|STARTED|Overall Study||21
337641|NCT02766283|828951|P1|NOT COMPLETED|Overall Study||27
337642|NCT02766283|828951|P1|COMPLETED|Overall Study||816
337643|NCT02766283|828951|P1|STARTED|Overall Study||843
337644|NCT02766244|828975|P1|NOT COMPLETED|Overall Study||0
337645|NCT02766244|828975|P1|COMPLETED|Overall Study||3
337646|NCT02766244|828975|P1|STARTED|Overall Study||3
337647|NCT02765269|828986|P2|NOT COMPLETED|Overall Study||0
337648|NCT02765269|828987|P1|NOT COMPLETED|Overall Study||0
337649|NCT02765269|828986|P2|COMPLETED|Overall Study||21
337650|NCT02765269|828987|P1|COMPLETED|Overall Study||25
337651|NCT02765269|828986|P2|STARTED|Overall Study||21
337652|NCT02765269|828987|P1|STARTED|Overall Study||25
337653|NCT02764970|829001|P2|NOT COMPLETED|Overall Study||0
337654|NCT02764970|829002|P1|NOT COMPLETED|Overall Study||0
337655|NCT02764970|829001|P2|COMPLETED|Overall Study||47
337656|NCT02764970|829002|P1|COMPLETED|Overall Study||65
337657|NCT02764970|829001|P2|STARTED|Overall Study||47
337658|NCT02764970|829002|P1|STARTED|Overall Study||65
337659|NCT02763189|829016|P2|NOT COMPLETED|Overall Study||2
337660|NCT02763189|829017|P1|NOT COMPLETED|Overall Study||0
337661|NCT02763189|829016|P2|COMPLETED|Overall Study||2
337662|NCT02763189|829017|P1|COMPLETED|Overall Study||4
337663|NCT02763189|829016|P2|STARTED|Overall Study||4
337664|NCT02763189|829017|P1|STARTED|Overall Study||4
337665|NCT02762370|829027|P2|NOT COMPLETED|Overall Study||0
337666|NCT02762370|829028|P1|NOT COMPLETED|Overall Study||1
337667|NCT02762370|829027|P2|COMPLETED|Overall Study||15
337668|NCT02762370|829028|P1|COMPLETED|Overall Study||17
337669|NCT02762370|829027|P2|STARTED|Overall Study||15
337670|NCT02762370|829028|P1|STARTED|Overall Study||18
337671|NCT02761733|829050|P4|NOT COMPLETED|Overall Study||15
337672|NCT02761733|829051|P3|NOT COMPLETED|Overall Study||27
337673|NCT02761733|829052|P2|NOT COMPLETED|Overall Study||21
337674|NCT02761733|829053|P1|NOT COMPLETED|Overall Study||30
337675|NCT02761733|829050|P4|COMPLETED|Overall Study||45
337676|NCT02761733|829051|P3|COMPLETED|Overall Study||33
337677|NCT02761733|829052|P2|COMPLETED|Overall Study||39
337678|NCT02761733|829053|P1|COMPLETED|Overall Study||30
337679|NCT02761733|829050|P4|9/30/2015|Overall Study||50
337680|NCT02761733|829051|P3|9/30/2015|Overall Study||33
337681|NCT02761733|829052|P2|9/30/2015|Overall Study||44
337682|NCT02761733|829053|P1|9/30/2015|Overall Study||40
337683|NCT02761733|829050|P4|3/31/2015|Overall Study||50
337684|NCT02761733|829051|P3|3/31/2015|Overall Study||43
337685|NCT02761733|829052|P2|3/31/2015|Overall Study||47
337686|NCT02761733|829053|P1|3/31/2015|Overall Study||48
337687|NCT02761733|829050|P4|9/30/2014|Overall Study||55
337688|NCT02761733|829051|P3|9/30/2014|Overall Study||48
337689|NCT02761733|829052|P2|9/30/2014|Overall Study||56
337690|NCT02761733|829053|P1|9/30/2014|Overall Study||53
337691|NCT02761733|829050|P4|STARTED|Overall Study||60
337692|NCT02761733|829051|P3|STARTED|Overall Study||60
337693|NCT02761733|829052|P2|STARTED|Overall Study||60
337694|NCT02761733|829053|P1|STARTED|Overall Study||60
337695|NCT02761629|829085|P2|NOT COMPLETED|Overall Study||32
337696|NCT02761629|829086|P1|NOT COMPLETED|Overall Study||27
337697|NCT02761629|829085|P2|COMPLETED|Overall Study||58
337698|NCT02761629|829086|P1|COMPLETED|Overall Study||63
337699|NCT02761629|829085|P2|Treated|Overall Study||86
337700|NCT02761629|829086|P1|Treated|Overall Study||82
337701|NCT02761629|829085|P2|STARTED|Overall Study||90
337702|NCT02761629|829086|P1|STARTED|Overall Study||90
337703|NCT02760810|829106|P1|NOT COMPLETED|Overall Study||1
337704|NCT02760810|829106|P1|COMPLETED|Overall Study||29
337705|NCT02760810|829106|P1|STARTED|Overall Study||30
337706|NCT02760654|829114|P2|NOT COMPLETED|Overall Study||6
337707|NCT02760654|829115|P1|NOT COMPLETED|Overall Study||7
337708|NCT02760654|829114|P2|COMPLETED|Overall Study||24
337709|NCT02760654|829115|P1|COMPLETED|Overall Study||23
337710|NCT02760654|829114|P2|STARTED|Overall Study||30
337711|NCT02760654|829115|P1|STARTED|Overall Study||30
337712|NCT02759692|829139|P2|NOT COMPLETED|Period 3||0
337713|NCT02759692|829140|P1|NOT COMPLETED|Period 3||0
337714|NCT02759692|829139|P2|COMPLETED|Period 3||139
337715|NCT02759692|829140|P1|COMPLETED|Period 3||137
337716|NCT02759692|829139|P2|STARTED|Period 3||139
337717|NCT02759692|829140|P1|STARTED|Period 3||137
337718|NCT02759692|829139|P2|NOT COMPLETED|Period 2||1
337719|NCT02759692|829140|P1|NOT COMPLETED|Period 2||1
337720|NCT02759692|829139|P2|COMPLETED|Period 2||139
337721|NCT02759692|829140|P1|COMPLETED|Period 2||137
337722|NCT02759692|829139|P2|STARTED|Period 2||140
337723|NCT02759692|829140|P1|STARTED|Period 2||138
337724|NCT02759692|829139|P2|NOT COMPLETED|Period 1||2
337725|NCT02759692|829140|P1|NOT COMPLETED|Period 1||3
337726|NCT02759692|829139|P2|COMPLETED|Period 1||140
337727|NCT02759692|829140|P1|COMPLETED|Period 1||138
337728|NCT02759692|829139|P2|STARTED|Period 1||142
337729|NCT02759692|829140|P1|STARTED|Period 1||141
337730|NCT02759471|829156|P1|NOT COMPLETED|Overall Study||2
337731|NCT02759471|829156|P1|COMPLETED|Overall Study||52
337732|NCT02759471|829156|P1|STARTED|Overall Study||54
337733|NCT02758613|829170|P4|NOT COMPLETED|Follow-up||0
337734|NCT02758613|829171|P3|NOT COMPLETED|Follow-up||0
337735|NCT02758613|829172|P2|NOT COMPLETED|Follow-up||0
337736|NCT02758613|829173|P1|NOT COMPLETED|Follow-up||0
337737|NCT02758613|829170|P4|COMPLETED|Follow-up||8
337738|NCT02758613|829171|P3|COMPLETED|Follow-up||8
337739|NCT02758613|829172|P2|COMPLETED|Follow-up||8
337740|NCT02758613|829173|P1|COMPLETED|Follow-up||6
337741|NCT02758613|829170|P4|STARTED|Follow-up||8
337742|NCT02758613|829171|P3|STARTED|Follow-up||8
337743|NCT02758613|829172|P2|STARTED|Follow-up||8
337744|NCT02758613|829173|P1|STARTED|Follow-up||6
337745|NCT02758613|829170|P4|NOT COMPLETED|Treatment||0
337746|NCT02758613|829171|P3|NOT COMPLETED|Treatment||1
337747|NCT02758613|829172|P2|NOT COMPLETED|Treatment||0
337748|NCT02758613|829173|P1|NOT COMPLETED|Treatment||2
337749|NCT02758613|829170|P4|COMPLETED|Treatment||8
337750|NCT02758613|829171|P3|COMPLETED|Treatment||8
337751|NCT02758613|829172|P2|COMPLETED|Treatment||8
337752|NCT02758613|829173|P1|COMPLETED|Treatment||6
337753|NCT02758613|829170|P4|Received at Least One Dose of Study Drug|Treatment||8
337754|NCT02758613|829171|P3|Received at Least One Dose of Study Drug|Treatment||9
337755|NCT02758613|829172|P2|Received at Least One Dose of Study Drug|Treatment||8
337756|NCT02758613|829173|P1|Received at Least One Dose of Study Drug|Treatment||8
337757|NCT02758613|829170|P4|STARTED|Treatment||8
337758|NCT02758613|829171|P3|STARTED|Treatment||9
337759|NCT02758613|829172|P2|STARTED|Treatment||8
337760|NCT02758613|829173|P1|STARTED|Treatment||8
337761|NCT02758210|829189|P1|NOT COMPLETED|Overall Study||0
337762|NCT02758210|829189|P1|COMPLETED|Overall Study||20
337763|NCT02758210|829189|P1|STARTED|Overall Study||20
337764|NCT02758171|829200|P2|NOT COMPLETED|Treatment Period 2||0
337765|NCT02758171|829201|P1|NOT COMPLETED|Treatment Period 2||0
337766|NCT02758171|829200|P2|COMPLETED|Treatment Period 2||28
337767|NCT02758171|829201|P1|COMPLETED|Treatment Period 2||26
337768|NCT02758171|829200|P2|STARTED|Treatment Period 2||28
337769|NCT02758171|829201|P1|STARTED|Treatment Period 2||26
337770|NCT02758171|829200|P2|NOT COMPLETED|Wash-out||0
337771|NCT02758171|829201|P1|NOT COMPLETED|Wash-out||2
337772|NCT02758171|829200|P2|COMPLETED|Wash-out||28
337773|NCT02758171|829201|P1|COMPLETED|Wash-out||26
337774|NCT02758171|829200|P2|STARTED|Wash-out||28
337775|NCT02758171|829201|P1|STARTED|Wash-out||28
337776|NCT02758171|829200|P2|NOT COMPLETED|Treatment Period 1||0
337777|NCT02758171|829201|P1|NOT COMPLETED|Treatment Period 1||0
337778|NCT02758171|829200|P2|COMPLETED|Treatment Period 1||28
337779|NCT02758171|829201|P1|COMPLETED|Treatment Period 1||28
337780|NCT02758171|829200|P2|STARTED|Treatment Period 1||28
337781|NCT02758171|829201|P1|STARTED|Treatment Period 1||28
337782|NCT02757053|829219|P2|NOT COMPLETED|Overall Study||5
337783|NCT02757053|829220|P1|NOT COMPLETED|Overall Study||3
337784|NCT02757053|829219|P2|COMPLETED|Overall Study||0
337785|NCT02757053|829220|P1|COMPLETED|Overall Study||0
337786|NCT02757053|829219|P2|STARTED|Overall Study||5
337787|NCT02757053|829220|P1|STARTED|Overall Study||3
337788|NCT02756637|829234|P2|NOT COMPLETED|Overall Study||54
337789|NCT02756637|829235|P1|NOT COMPLETED|Overall Study||87
337790|NCT02756637|829234|P2|COMPLETED|Overall Study||263
337791|NCT02756637|829235|P1|COMPLETED|Overall Study||230
337792|NCT02756637|829234|P2|Completed Curative Treatment|Overall Study||0
337793|NCT02756637|829235|P1|Completed Curative Treatment|Overall Study||230
337794|NCT02756637|829234|P2|Had NLR Value|Overall Study||263
337795|NCT02756637|829235|P1|Had NLR Value|Overall Study||263
337796|NCT02756637|829234|P2|Eligible for SWOG 8710|Overall Study||307
337797|NCT02756637|829235|P1|Eligible for SWOG 8710|Overall Study||307
337798|NCT02756637|829234|P2|STARTED|Overall Study||317
337799|NCT02756637|829235|P1|STARTED|Overall Study||317
337800|NCT02756624|829243|P2|NOT COMPLETED|Overall Study||7
337801|NCT02756624|829244|P1|NOT COMPLETED|Overall Study||16
337802|NCT02756624|829243|P2|COMPLETED|Overall Study||166
337803|NCT02756624|829244|P1|COMPLETED|Overall Study||327
337804|NCT02756624|829243|P2|STARTED|Overall Study||173
337805|NCT02756624|829244|P1|STARTED|Overall Study||343
337806|NCT02756351|829258|P2|NOT COMPLETED|Overall Study||0
337807|NCT02756351|829259|P1|NOT COMPLETED|Overall Study||0
337808|NCT02756351|829258|P2|COMPLETED|Overall Study||24
337809|NCT02756351|829259|P1|COMPLETED|Overall Study||24
337810|NCT02756351|829258|P2|STARTED|Overall Study||24
337811|NCT02756351|829259|P1|STARTED|Overall Study||24
337812|NCT02755935|829267|P1|NOT COMPLETED|Overall Study||2
337813|NCT02755935|829267|P1|COMPLETED|Overall Study||22
337814|NCT02755935|829267|P1|STARTED|Overall Study||24
337815|NCT02755805|829274|P2|NOT COMPLETED|Overall Study||4
337816|NCT02755805|829275|P1|NOT COMPLETED|Overall Study||2
337817|NCT02755805|829274|P2|COMPLETED|Overall Study||11
337818|NCT02755805|829275|P1|COMPLETED|Overall Study||13
337819|NCT02755805|829274|P2|STARTED|Overall Study||15
337820|NCT02755805|829275|P1|STARTED|Overall Study||15
337821|NCT02755090|829289|P2|NOT COMPLETED|Overall Study||0
337822|NCT02755090|829290|P1|NOT COMPLETED|Overall Study||1
337823|NCT02755090|829289|P2|COMPLETED|Overall Study||20
337824|NCT02755090|829290|P1|COMPLETED|Overall Study||18
337825|NCT02755090|829289|P2|STARTED|Overall Study||20
337826|NCT02755090|829290|P1|STARTED|Overall Study||19
337827|NCT02754492|829302|P4|NOT COMPLETED|Overall Study||23
337828|NCT02754492|829303|P3|NOT COMPLETED|Overall Study||2
337829|NCT02754492|829304|P2|NOT COMPLETED|Overall Study||2
337830|NCT02754492|829305|P1|NOT COMPLETED|Overall Study||4
337831|NCT02754492|829302|P4|COMPLETED|Overall Study||0
337832|NCT02754492|829303|P3|COMPLETED|Overall Study||93
337833|NCT02754492|829304|P2|COMPLETED|Overall Study||93
337834|NCT02754492|829305|P1|COMPLETED|Overall Study||93
337835|NCT02754492|829302|P4|STARTED|Overall Study||23
337836|NCT02754492|829303|P3|STARTED|Overall Study||95
337837|NCT02754492|829304|P2|STARTED|Overall Study||95
337838|NCT02754492|829305|P1|STARTED|Overall Study||97
337839|NCT02754440|829321|P4|NOT COMPLETED|Overall Study||35
337840|NCT02754440|829322|P3|NOT COMPLETED|Overall Study||7
337841|NCT02754440|829323|P2|NOT COMPLETED|Overall Study||8
337842|NCT02754440|829324|P1|NOT COMPLETED|Overall Study||6
337843|NCT02754440|829321|P4|COMPLETED|Overall Study||0
337844|NCT02754440|829322|P3|COMPLETED|Overall Study||93
337845|NCT02754440|829323|P2|COMPLETED|Overall Study||93
337846|NCT02754440|829324|P1|COMPLETED|Overall Study||93
337847|NCT02754440|829321|P4|STARTED|Overall Study||35
337848|NCT02754440|829322|P3|STARTED|Overall Study||100
337849|NCT02754440|829323|P2|STARTED|Overall Study||101
337850|NCT02754440|829324|P1|STARTED|Overall Study||99
337851|NCT02753699|829339|P3|NOT COMPLETED|Overall Study||23
337852|NCT02753699|829340|P2|NOT COMPLETED|Overall Study||43
337853|NCT02753699|829341|P1|NOT COMPLETED|Overall Study||14
337854|NCT02753699|829339|P3|COMPLETED|Overall Study||139
337855|NCT02753699|829340|P2|COMPLETED|Overall Study||354
337856|NCT02753699|829341|P1|COMPLETED|Overall Study||150
337857|NCT02753699|829339|P3|STARTED|Overall Study||162
337858|NCT02753699|829340|P2|STARTED|Overall Study||397
337859|NCT02753699|829341|P1|STARTED|Overall Study||164
337860|NCT02753413|829357|P2|NOT COMPLETED|Overall Study||0
337861|NCT02753413|829358|P1|NOT COMPLETED|Overall Study||0
337862|NCT02753413|829357|P2|COMPLETED|Overall Study||51
337863|NCT02753413|829358|P1|COMPLETED|Overall Study||49
337864|NCT02753413|829357|P2|STARTED|Overall Study||51
337865|NCT02753413|829358|P1|STARTED|Overall Study||49
337866|NCT02753075|829393|P3|NOT COMPLETED|Overall Study||3
337867|NCT02753075|829394|P2|NOT COMPLETED|Overall Study||3
337868|NCT02753075|829395|P1|NOT COMPLETED|Overall Study||8
337869|NCT02753075|829393|P3|COMPLETED|Overall Study||78
337870|NCT02753075|829394|P2|COMPLETED|Overall Study||77
337871|NCT02753075|829395|P1|COMPLETED|Overall Study||71
337872|NCT02753075|829393|P3|STARTED|Overall Study||81
337873|NCT02753075|829394|P2|STARTED|Overall Study||80
337874|NCT02753075|829395|P1|STARTED|Overall Study||79
337875|NCT02752802|829422|P2|NOT COMPLETED|Overall Study||0
337876|NCT02752802|829423|P1|NOT COMPLETED|Overall Study||1
337877|NCT02752802|829422|P2|COMPLETED|Overall Study||48
337878|NCT02752802|829423|P1|COMPLETED|Overall Study||47
337879|NCT02752802|829422|P2|STARTED|Overall Study||48
337880|NCT02752802|829423|P1|STARTED|Overall Study||48
337881|NCT02752633|829432|P1|NOT COMPLETED|Overall Study||1
337882|NCT02752633|829432|P1|COMPLETED|Overall Study||8
337883|NCT02752633|829432|P1|STARTED|Overall Study||9
337884|NCT02752490|829438|P2|NOT COMPLETED|Overall Study||0
337885|NCT02752490|829439|P1|NOT COMPLETED|Overall Study||0
337886|NCT02752490|829438|P2|COMPLETED|Overall Study||435
337887|NCT02752490|829439|P1|COMPLETED|Overall Study||409
337888|NCT02752490|829438|P2|STARTED|Overall Study||435
337889|NCT02752490|829439|P1|STARTED|Overall Study||409
337890|NCT02751450|829461|P2|NOT COMPLETED|Overall Study||0
337891|NCT02751450|829462|P1|NOT COMPLETED|Overall Study||1
337892|NCT02751450|829461|P2|COMPLETED|Overall Study||116
337893|NCT02751450|829462|P1|COMPLETED|Overall Study||116
337894|NCT02751450|829461|P2|STARTED|Overall Study||116
337895|NCT02751450|829462|P1|STARTED|Overall Study||117
337896|NCT02751320|829474|P1|NOT COMPLETED|Overall Study||3
337897|NCT02751320|829474|P1|COMPLETED|Overall Study||42
337898|NCT02751320|829474|P1|Received Reference Product 3|Overall Study||28
337899|NCT02751320|829474|P1|Received Reference Product 2|Overall Study||28
337900|NCT02751320|829474|P1|Received Reference Product 1|Overall Study||29
337901|NCT02751320|829474|P1|Received Test Prodcut 3|Overall Study||28
337902|NCT02751320|829474|P1|Received Test Prodcut 2|Overall Study||28
337903|NCT02751320|829474|P1|Received Test Product 1|Overall Study||29
337904|NCT02751320|829474|P1|STARTED|Overall Study||45
337905|NCT02750943|829512|P2|NOT COMPLETED|Overall Study||9
337906|NCT02750943|829513|P1|NOT COMPLETED|Overall Study||6
337907|NCT02750943|829512|P2|COMPLETED|Overall Study||119
337908|NCT02750943|829513|P1|COMPLETED|Overall Study||119
337909|NCT02750943|829512|P2|STARTED|Overall Study||128
337910|NCT02750943|829513|P1|STARTED|Overall Study||125
337911|NCT02750930|829527|P1|NOT COMPLETED|Overall Study||8
337912|NCT02750930|829527|P1|COMPLETED|Overall Study||0
337913|NCT02750930|829527|P1|STARTED|Overall Study||8
337914|NCT02750813|829539|P2|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
337915|NCT02750813|829540|P1|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
337916|NCT02750813|829539|P2|COMPLETED|Period 2, Second 14 Days of Wear||120
337917|NCT02750813|829540|P1|COMPLETED|Period 2, Second 14 Days of Wear||124
337918|NCT02750813|829539|P2|STARTED|Period 2, Second 14 Days of Wear||120
337919|NCT02750813|829540|P1|STARTED|Period 2, Second 14 Days of Wear||124
337920|NCT02750813|829539|P2|NOT COMPLETED|Period 1, First 14 Days of Wear||1
337921|NCT02750813|829540|P1|NOT COMPLETED|Period 1, First 14 Days of Wear||1
337922|NCT02750813|829539|P2|COMPLETED|Period 1, First 14 Days of Wear||120
337923|NCT02750813|829540|P1|COMPLETED|Period 1, First 14 Days of Wear||124
337924|NCT02750813|829539|P2|STARTED|Period 1, First 14 Days of Wear||121
337925|NCT02750813|829540|P1|STARTED|Period 1, First 14 Days of Wear||125
337926|NCT02750709|829549|P6|NOT COMPLETED|Treatment Period 3||0
337927|NCT02750709|829550|P5|NOT COMPLETED|Treatment Period 3||0
337928|NCT02750709|829551|P4|NOT COMPLETED|Treatment Period 3||0
337929|NCT02750709|829552|P3|NOT COMPLETED|Treatment Period 3||0
337930|NCT02750709|829553|P2|NOT COMPLETED|Treatment Period 3||0
337931|NCT02750709|829554|P1|NOT COMPLETED|Treatment Period 3||0
337932|NCT02750709|829549|P6|COMPLETED|Treatment Period 3||3
337933|NCT02750709|829550|P5|COMPLETED|Treatment Period 3||4
337934|NCT02750709|829551|P4|COMPLETED|Treatment Period 3||4
337935|NCT02750709|829552|P3|COMPLETED|Treatment Period 3||4
337936|NCT02750709|829553|P2|COMPLETED|Treatment Period 3||4
337937|NCT02750709|829554|P1|COMPLETED|Treatment Period 3||4
337938|NCT02750709|829549|P6|STARTED|Treatment Period 3||3
337939|NCT02750709|829550|P5|STARTED|Treatment Period 3||4
337940|NCT02750709|829551|P4|STARTED|Treatment Period 3||4
337941|NCT02750709|829552|P3|STARTED|Treatment Period 3||4
337942|NCT02750709|829553|P2|STARTED|Treatment Period 3||4
337943|NCT02750709|829554|P1|STARTED|Treatment Period 3||4
337944|NCT02750709|829549|P6|NOT COMPLETED|Treatment Period 2||0
337945|NCT02750709|829550|P5|NOT COMPLETED|Treatment Period 2||0
337946|NCT02750709|829551|P4|NOT COMPLETED|Treatment Period 2||0
337947|NCT02750709|829552|P3|NOT COMPLETED|Treatment Period 2||0
337948|NCT02750709|829553|P2|NOT COMPLETED|Treatment Period 2||0
337949|NCT02750709|829554|P1|NOT COMPLETED|Treatment Period 2||0
337950|NCT02750709|829549|P6|COMPLETED|Treatment Period 2||3
337951|NCT02750709|829550|P5|COMPLETED|Treatment Period 2||4
337952|NCT02750709|829551|P4|COMPLETED|Treatment Period 2||4
337953|NCT02750709|829552|P3|COMPLETED|Treatment Period 2||4
337954|NCT02750709|829553|P2|COMPLETED|Treatment Period 2||4
337955|NCT02750709|829554|P1|COMPLETED|Treatment Period 2||4
337956|NCT02750709|829549|P6|STARTED|Treatment Period 2||3
337957|NCT02750709|829550|P5|STARTED|Treatment Period 2||4
337958|NCT02750709|829551|P4|STARTED|Treatment Period 2||4
337959|NCT02750709|829552|P3|STARTED|Treatment Period 2||4
337960|NCT02750709|829553|P2|STARTED|Treatment Period 2||4
337961|NCT02750709|829554|P1|STARTED|Treatment Period 2||4
337962|NCT02750709|829549|P6|NOT COMPLETED|Treatment Period 1||1
337963|NCT02750709|829550|P5|NOT COMPLETED|Treatment Period 1||0
337964|NCT02750709|829551|P4|NOT COMPLETED|Treatment Period 1||0
337965|NCT02750709|829552|P3|NOT COMPLETED|Treatment Period 1||0
337966|NCT02750709|829553|P2|NOT COMPLETED|Treatment Period 1||0
337967|NCT02750709|829554|P1|NOT COMPLETED|Treatment Period 1||0
337968|NCT02750709|829549|P6|COMPLETED|Treatment Period 1||3
337969|NCT02750709|829550|P5|COMPLETED|Treatment Period 1||4
337970|NCT02750709|829551|P4|COMPLETED|Treatment Period 1||4
337971|NCT02750709|829552|P3|COMPLETED|Treatment Period 1||4
337972|NCT02750709|829553|P2|COMPLETED|Treatment Period 1||4
337973|NCT02750709|829554|P1|COMPLETED|Treatment Period 1||4
337974|NCT02750709|829549|P6|STARTED|Treatment Period 1||4
337975|NCT02750709|829550|P5|STARTED|Treatment Period 1||4
337976|NCT02750709|829551|P4|STARTED|Treatment Period 1||4
337977|NCT02750709|829552|P3|STARTED|Treatment Period 1||4
337978|NCT02750709|829553|P2|STARTED|Treatment Period 1||4
337979|NCT02750709|829554|P1|STARTED|Treatment Period 1||4
337980|NCT02750618|829580|P1|NOT COMPLETED|Overall Study||0
337981|NCT02750618|829580|P1|COMPLETED|Overall Study||13
337982|NCT02750618|829580|P1|STARTED|Overall Study||13
337983|NCT02750345|829593|P6|NOT COMPLETED|Intervention 3||0
337984|NCT02750345|829594|P5|NOT COMPLETED|Intervention 3||0
337985|NCT02750345|829595|P4|NOT COMPLETED|Intervention 3||0
337986|NCT02750345|829596|P3|NOT COMPLETED|Intervention 3||0
337987|NCT02750345|829597|P2|NOT COMPLETED|Intervention 3||0
337988|NCT02750345|829598|P1|NOT COMPLETED|Intervention 3||0
337989|NCT02750345|829593|P6|COMPLETED|Intervention 3||4
337990|NCT02750345|829594|P5|COMPLETED|Intervention 3||3
337991|NCT02750345|829595|P4|COMPLETED|Intervention 3||4
337992|NCT02750345|829596|P3|COMPLETED|Intervention 3||4
337993|NCT02750345|829597|P2|COMPLETED|Intervention 3||4
337994|NCT02750345|829598|P1|COMPLETED|Intervention 3||4
337995|NCT02750345|829593|P6|STARTED|Intervention 3||4
337996|NCT02750345|829594|P5|STARTED|Intervention 3||3
337997|NCT02750345|829595|P4|STARTED|Intervention 3||4
337998|NCT02750345|829596|P3|STARTED|Intervention 3||4
337999|NCT02750345|829597|P2|STARTED|Intervention 3||4
338000|NCT02750345|829598|P1|STARTED|Intervention 3||4
338001|NCT02750345|829593|P6|NOT COMPLETED|Intervention 2||0
338002|NCT02750345|829594|P5|NOT COMPLETED|Intervention 2||0
338003|NCT02750345|829595|P4|NOT COMPLETED|Intervention 2||0
338004|NCT02750345|829596|P3|NOT COMPLETED|Intervention 2||0
338005|NCT02750345|829597|P2|NOT COMPLETED|Intervention 2||0
338006|NCT02750345|829598|P1|NOT COMPLETED|Intervention 2||0
338007|NCT02750345|829593|P6|COMPLETED|Intervention 2||4
338008|NCT02750345|829594|P5|COMPLETED|Intervention 2||3
338009|NCT02750345|829595|P4|COMPLETED|Intervention 2||4
338010|NCT02750345|829596|P3|COMPLETED|Intervention 2||4
338011|NCT02750345|829597|P2|COMPLETED|Intervention 2||4
338012|NCT02750345|829598|P1|COMPLETED|Intervention 2||4
338013|NCT02750345|829593|P6|STARTED|Intervention 2||4
338014|NCT02750345|829594|P5|STARTED|Intervention 2||3
338015|NCT02750345|829595|P4|STARTED|Intervention 2||4
338016|NCT02750345|829596|P3|STARTED|Intervention 2||4
338017|NCT02750345|829597|P2|STARTED|Intervention 2||4
338018|NCT02750345|829598|P1|STARTED|Intervention 2||4
338019|NCT02750345|829593|P6|NOT COMPLETED|Intervention 1||0
338020|NCT02750345|829594|P5|NOT COMPLETED|Intervention 1||1
338021|NCT02750345|829595|P4|NOT COMPLETED|Intervention 1||0
338022|NCT02750345|829596|P3|NOT COMPLETED|Intervention 1||0
338023|NCT02750345|829597|P2|NOT COMPLETED|Intervention 1||0
338024|NCT02750345|829598|P1|NOT COMPLETED|Intervention 1||0
338025|NCT02750345|829593|P6|COMPLETED|Intervention 1||4
338026|NCT02750345|829594|P5|COMPLETED|Intervention 1||3
338027|NCT02750345|829595|P4|COMPLETED|Intervention 1||4
338028|NCT02750345|829596|P3|COMPLETED|Intervention 1||4
338029|NCT02750345|829597|P2|COMPLETED|Intervention 1||4
338030|NCT02750345|829598|P1|COMPLETED|Intervention 1||4
338031|NCT02750345|829593|P6|STARTED|Intervention 1||4
338032|NCT02750345|829594|P5|STARTED|Intervention 1||4
338033|NCT02750345|829595|P4|STARTED|Intervention 1||4
338034|NCT02750345|829596|P3|STARTED|Intervention 1||4
338035|NCT02750345|829597|P2|STARTED|Intervention 1||4
338036|NCT02750345|829598|P1|STARTED|Intervention 1||4
338037|NCT02750332|829624|P2|NOT COMPLETED|Treatment Period 2||0
338038|NCT02750332|829625|P1|NOT COMPLETED|Treatment Period 2||0
338039|NCT02750332|829624|P2|COMPLETED|Treatment Period 2||9
338040|NCT02750332|829625|P1|COMPLETED|Treatment Period 2||10
338041|NCT02750332|829624|P2|STARTED|Treatment Period 2||9
338042|NCT02750332|829625|P1|STARTED|Treatment Period 2||10
338043|NCT02750332|829624|P2|NOT COMPLETED|Treatment Period 1||1
338044|NCT02750332|829625|P1|NOT COMPLETED|Treatment Period 1||0
338045|NCT02750332|829624|P2|COMPLETED|Treatment Period 1||9
338046|NCT02750332|829625|P1|COMPLETED|Treatment Period 1||10
338047|NCT02750332|829624|P2|STARTED|Treatment Period 1||10
338048|NCT02750332|829625|P1|STARTED|Treatment Period 1||10
338049|NCT02750267|829645|P2|NOT COMPLETED|Overall Study||0
338050|NCT02750267|829646|P1|NOT COMPLETED|Overall Study||0
338051|NCT02750267|829645|P2|COMPLETED|Overall Study||6
338052|NCT02750267|829646|P1|COMPLETED|Overall Study||6
338053|NCT02750267|829645|P2|STARTED|Overall Study||6
338054|NCT02750267|829646|P1|STARTED|Overall Study||6
338055|NCT02748213|829686|P2|NOT COMPLETED|Overall Study||112
338056|NCT02748213|829687|P1|NOT COMPLETED|Overall Study||113
338057|NCT02748213|829686|P2|COMPLETED|Overall Study||0
338058|NCT02748213|829687|P1|COMPLETED|Overall Study|"*The reason Refused Treatment also includes those who did not cooperate or withdrew consent."|0
338059|NCT02748213|829686|P2|Treated|Overall Study||110
338060|NCT02748213|829687|P1|Treated|Overall Study||112
338061|NCT02748213|829686|P2|STARTED|Overall Study||112
338062|NCT02748213|829687|P1|STARTED|Overall Study||113
338063|NCT02746809|829703|P1|NOT COMPLETED|Baseline-6 Months||5
338064|NCT02746809|829703|P1|COMPLETED|Baseline-6 Months||54
338065|NCT02746809|829703|P1|STARTED|Baseline-6 Months||59
338066|NCT02746809|829703|P1|NOT COMPLETED|Baseline- 30 Days||1
338067|NCT02746809|829703|P1|COMPLETED|Baseline- 30 Days||59
338068|NCT02746809|829703|P1|STARTED|Baseline- 30 Days||60
338069|NCT02746679|829723|P2|NOT COMPLETED|Overall Study||6
338070|NCT02746679|829724|P1|NOT COMPLETED|Overall Study||4
338071|NCT02746679|829723|P2|COMPLETED|Overall Study||75
338072|NCT02746679|829724|P1|COMPLETED|Overall Study||76
338073|NCT02746679|829723|P2|STARTED|Overall Study||81
338074|NCT02746679|829724|P1|STARTED|Overall Study||80
338075|NCT02746406|829754|P1|NOT COMPLETED|Overall Study||0
338076|NCT02746406|829754|P1|COMPLETED|Overall Study||5
338077|NCT02746406|829754|P1|STARTED|Overall Study||5
338078|NCT02746107|829758|P1|NOT COMPLETED|Overall Study||0
338079|NCT02746107|829758|P1|COMPLETED|Overall Study||968
338080|NCT02746107|829758|P1|CHA2DS2-VASC Score = 5|Overall Study||192
338081|NCT02746107|829758|P1|CHA2DS2-VASC Score = 4|Overall Study||197
338082|NCT02746107|829758|P1|CHA2DS2-VASC Score = 3|Overall Study||195
338083|NCT02746107|829758|P1|CHA2DS2-VASC Score = 2|Overall Study||189
338084|NCT02746107|829758|P1|CHA2DS2-VASC Score = 1|Overall Study||195
338085|NCT02746107|829758|P1|Target=Physician|Overall Study||482
338086|NCT02746107|829758|P1|Target=Patient|Overall Study||486
338087|NCT02746107|829758|P1|5year Risk Estimate|Overall Study||485
338088|NCT02746107|829758|P1|1year Risk Estimate|Overall Study||483
338089|NCT02746107|829758|P1|1 Diagram DA|Overall Study||486
338090|NCT02746107|829758|P1|2 Diagrams DA|Overall Study||482
338091|NCT02746107|829758|P1|STARTED|Overall Study||968
338092|NCT02745626|829776|P3|NOT COMPLETED|Overall Study||3
338093|NCT02745626|829777|P2|NOT COMPLETED|Overall Study||6
338094|NCT02745626|829778|P1|NOT COMPLETED|Overall Study||3
338095|NCT02745626|829776|P3|COMPLETED|Overall Study||19
338096|NCT02745626|829777|P2|COMPLETED|Overall Study||16
338097|NCT02745626|829778|P1|COMPLETED|Overall Study||21
338098|NCT02745626|829776|P3|STARTED|Overall Study||22
338099|NCT02745626|829777|P2|STARTED|Overall Study||22
338100|NCT02745626|829778|P1|STARTED|Overall Study||24
338101|NCT02745392|829808|P4|NOT COMPLETED|Overall Study||0
338102|NCT02745392|829809|P3|NOT COMPLETED|Overall Study||0
338103|NCT02745392|829810|P2|NOT COMPLETED|Overall Study||1
338104|NCT02745392|829811|P1|NOT COMPLETED|Overall Study||0
338105|NCT02745392|829808|P4|COMPLETED|Overall Study||92
338106|NCT02745392|829809|P3|COMPLETED|Overall Study||92
338107|NCT02745392|829810|P2|COMPLETED|Overall Study||89
338108|NCT02745392|829811|P1|COMPLETED|Overall Study||91
338109|NCT02745392|829808|P4|STARTED|Overall Study||92
338110|NCT02745392|829809|P3|STARTED|Overall Study||92
338111|NCT02745392|829810|P2|STARTED|Overall Study||90
338112|NCT02745392|829811|P1|STARTED|Overall Study||91
338113|NCT02743962|829827|P2|NOT COMPLETED|Overall Study||0
338114|NCT02743962|829828|P1|NOT COMPLETED|Overall Study||1
338115|NCT02743962|829827|P2|COMPLETED|Overall Study||5
338116|NCT02743962|829828|P1|COMPLETED|Overall Study||4
338117|NCT02743962|829827|P2|STARTED|Overall Study||5
338118|NCT02743962|829828|P1|STARTED|Overall Study||5
338119|NCT02743936|829849|P2|NOT COMPLETED|Overall Study||0
338120|NCT02743936|829850|P1|NOT COMPLETED|Overall Study||0
338121|NCT02743936|829849|P2|COMPLETED|Overall Study||32
338122|NCT02743936|829850|P1|COMPLETED|Overall Study||32
338123|NCT02743936|829849|P2|STARTED|Overall Study||32
338124|NCT02743936|829850|P1|STARTED|Overall Study||32
338125|NCT02743780|829863|P5|NOT COMPLETED|Part 3 (7 Days)||0
338126|NCT02743780|829864|P4|NOT COMPLETED|Part 3 (7 Days)||0
338127|NCT02743780|829865|P3|NOT COMPLETED|Part 3 (7 Days)||1
338128|NCT02743780|829866|P2|NOT COMPLETED|Part 3 (7 Days)||0
338129|NCT02743780|829867|P1|NOT COMPLETED|Part 3 (7 Days)||0
338130|NCT02743780|829863|P5|COMPLETED|Part 3 (7 Days)||25
338131|NCT02743780|829864|P4|COMPLETED|Part 3 (7 Days)||0
338132|NCT02743780|829865|P3|COMPLETED|Part 3 (7 Days)||24
338133|NCT02743780|829866|P2|COMPLETED|Part 3 (7 Days)||0
338134|NCT02743780|829867|P1|COMPLETED|Part 3 (7 Days)||0
338135|NCT02743780|829863|P5|STARTED|Part 3 (7 Days)||25
338136|NCT02743780|829864|P4|STARTED|Part 3 (7 Days)||0
338137|NCT02743780|829865|P3|STARTED|Part 3 (7 Days)||25
338138|NCT02743780|829866|P2|STARTED|Part 3 (7 Days)||0
338139|NCT02743780|829867|P1|STARTED|Part 3 (7 Days)||0
338140|NCT02743780|829863|P5|NOT COMPLETED|Part 2 (8 Days)||0
338141|NCT02743780|829864|P4|NOT COMPLETED|Part 2 (8 Days)||0
338142|NCT02743780|829865|P3|NOT COMPLETED|Part 2 (8 Days)||0
338143|NCT02743780|829866|P2|NOT COMPLETED|Part 2 (8 Days)||0
338144|NCT02743780|829867|P1|NOT COMPLETED|Part 2 (8 Days)||0
338145|NCT02743780|829863|P5|COMPLETED|Part 2 (8 Days)||4
338146|NCT02743780|829864|P4|COMPLETED|Part 2 (8 Days)||0
338147|NCT02743780|829865|P3|COMPLETED|Part 2 (8 Days)||6
338148|NCT02743780|829866|P2|COMPLETED|Part 2 (8 Days)||6
338149|NCT02743780|829867|P1|COMPLETED|Part 2 (8 Days)||0
338150|NCT02743780|829863|P5|STARTED|Part 2 (8 Days)||4
338151|NCT02743780|829864|P4|STARTED|Part 2 (8 Days)||0
338152|NCT02743780|829865|P3|STARTED|Part 2 (8 Days)||6
338153|NCT02743780|829866|P2|STARTED|Part 2 (8 Days)||6
338154|NCT02743780|829867|P1|STARTED|Part 2 (8 Days)||0
338155|NCT02743780|829863|P5|NOT COMPLETED|Part 1 (3 Days)||0
338156|NCT02743780|829864|P4|NOT COMPLETED|Part 1 (3 Days)||0
338157|NCT02743780|829865|P3|NOT COMPLETED|Part 1 (3 Days)||0
338158|NCT02743780|829866|P2|NOT COMPLETED|Part 1 (3 Days)||0
338159|NCT02743780|829867|P1|NOT COMPLETED|Part 1 (3 Days)||0
338160|NCT02743780|829863|P5|COMPLETED|Part 1 (3 Days)||8
338161|NCT02743780|829864|P4|COMPLETED|Part 1 (3 Days)||6
338162|NCT02743780|829865|P3|COMPLETED|Part 1 (3 Days)||6
338163|NCT02743780|829866|P2|COMPLETED|Part 1 (3 Days)||6
338164|NCT02743780|829867|P1|COMPLETED|Part 1 (3 Days)||6
338165|NCT02743780|829863|P5|STARTED|Part 1 (3 Days)||8
338166|NCT02743780|829864|P4|STARTED|Part 1 (3 Days)||6
338167|NCT02743780|829865|P3|STARTED|Part 1 (3 Days)||6
338168|NCT02743780|829866|P2|STARTED|Part 1 (3 Days)||6
338169|NCT02743780|829867|P1|STARTED|Part 1 (3 Days)||6
338170|NCT02743702|829914|P2|NOT COMPLETED|Overall Study||0
338171|NCT02743702|829915|P1|NOT COMPLETED|Overall Study||0
338172|NCT02743702|829914|P2|COMPLETED|Overall Study||10
338173|NCT02743702|829915|P1|COMPLETED|Overall Study||11
338174|NCT02743702|829914|P2|STARTED|Overall Study||10
338175|NCT02743702|829915|P1|STARTED|Overall Study||11
338176|NCT02743117|829923|P2|NOT COMPLETED|Overall Study||1
338177|NCT02743117|829924|P1|NOT COMPLETED|Overall Study||1
338178|NCT02743117|829923|P2|COMPLETED|Overall Study||240
338179|NCT02743117|829924|P1|COMPLETED|Overall Study||59
338180|NCT02743117|829923|P2|Treated|Overall Study||241
338181|NCT02743117|829924|P1|Treated|Overall Study||59
338182|NCT02743117|829923|P2|STARTED|Overall Study||241
338183|NCT02743117|829924|P1|STARTED|Overall Study||60
338184|NCT02742987|829940|P2|NOT COMPLETED|Overall Study||0
338185|NCT02742987|829941|P1|NOT COMPLETED|Overall Study||0
338186|NCT02742987|829940|P2|COMPLETED|Overall Study||21
338187|NCT02742987|829941|P1|COMPLETED|Overall Study||21
338188|NCT02742987|829940|P2|STARTED|Overall Study||21
338189|NCT02742987|829941|P1|STARTED|Overall Study||21
338190|NCT02742818|829949|P2|NOT COMPLETED|Overall Study||2
338191|NCT02742818|829950|P1|NOT COMPLETED|Overall Study||0
338192|NCT02742818|829949|P2|COMPLETED|Overall Study||23
338193|NCT02742818|829950|P1|COMPLETED|Overall Study||25
338194|NCT02742818|829949|P2|STARTED|Overall Study||25
338195|NCT02742818|829950|P1|STARTED|Overall Study||25
338196|NCT02741687|829966|P2|NOT COMPLETED|Overall Study||0
338197|NCT02741687|829967|P1|NOT COMPLETED|Overall Study||0
338198|NCT02741687|829966|P2|COMPLETED|Overall Study||44
338199|NCT02741687|829967|P1|COMPLETED|Overall Study||36
338200|NCT02741687|829966|P2|STARTED|Overall Study||44
338201|NCT02741687|829967|P1|STARTED|Overall Study||36
338202|NCT02741245|829996|P5|NOT COMPLETED|Overall Study||2
338203|NCT02741245|829997|P4|NOT COMPLETED|Overall Study||4
338204|NCT02741245|829998|P3|NOT COMPLETED|Overall Study||0
338205|NCT02741245|829999|P2|NOT COMPLETED|Overall Study||1
338206|NCT02741245|830000|P1|NOT COMPLETED|Overall Study||0
338207|NCT02741245|829996|P5|COMPLETED|Overall Study||70
338208|NCT02741245|829997|P4|COMPLETED|Overall Study||67
338209|NCT02741245|829998|P3|COMPLETED|Overall Study||71
338210|NCT02741245|829999|P2|COMPLETED|Overall Study||71
338211|NCT02741245|830000|P1|COMPLETED|Overall Study||35
338212|NCT02741245|829996|P5|STARTED|Overall Study||72
338213|NCT02741245|829997|P4|STARTED|Overall Study||71
338214|NCT02741245|829998|P3|STARTED|Overall Study||71
338215|NCT02741245|829999|P2|STARTED|Overall Study||72
338216|NCT02741245|830000|P1|STARTED|Overall Study||35
338217|NCT02739698|830104|P2|NOT COMPLETED|Overall Study||5
338218|NCT02739698|830105|P1|NOT COMPLETED|Overall Study||6
338219|NCT02739698|830104|P2|COMPLETED|Overall Study||16
338220|NCT02739698|830105|P1|COMPLETED|Overall Study||16
338221|NCT02739698|830104|P2|STARTED|Overall Study||21
338222|NCT02739698|830105|P1|STARTED|Overall Study||22
338223|NCT02739594|830113|P2|NOT COMPLETED|Overall Study||28
338224|NCT02739594|830114|P1|NOT COMPLETED|Overall Study||25
338225|NCT02739594|830113|P2|COMPLETED|Overall Study|Includes all participants who reached the protocol-defined end of study (either Week 44 or 96).|15
338226|NCT02739594|830114|P1|COMPLETED|Overall Study|Includes all participants who reached the protocol-defined end of study (either Week 44 or 96).|21
338227|NCT02739594|830113|P2|Completed at Week 96|Overall Study||10
338228|NCT02739594|830114|P1|Completed at Week 96|Overall Study||10
338229|NCT02739594|830113|P2|Completed at Week 44|Overall Study||5
338230|NCT02739594|830114|P1|Completed at Week 44|Overall Study||11
338231|NCT02739594|830113|P2|STARTED|Overall Study||43
338232|NCT02739594|830114|P1|STARTED|Overall Study||46
338233|NCT02739321|830146|P2|NOT COMPLETED|Overall Study||4
338234|NCT02739321|830147|P1|NOT COMPLETED|Overall Study||3
338235|NCT02739321|830146|P2|COMPLETED|Overall Study||18
338236|NCT02739321|830147|P1|COMPLETED|Overall Study||20
338237|NCT02739321|830146|P2|STARTED|Overall Study||22
338238|NCT02739321|830147|P1|STARTED|Overall Study||23
338239|NCT02738853|830191|P1|NOT COMPLETED|30 Days- 6 Months||2
338240|NCT02738853|830191|P1|COMPLETED|30 Days- 6 Months||57
338241|NCT02738853|830191|P1|STARTED|30 Days- 6 Months||59
338242|NCT02738853|830191|P1|NOT COMPLETED|Baseline -30 Days||1
338243|NCT02738853|830191|P1|COMPLETED|Baseline -30 Days||59
338244|NCT02738853|830191|P1|STARTED|Baseline -30 Days||60
338245|NCT02738333|830210|P3|NOT COMPLETED|Overall Study||0
338246|NCT02738333|830211|P2|NOT COMPLETED|Overall Study||0
338247|NCT02738333|830212|P1|NOT COMPLETED|Overall Study||2
338248|NCT02738333|830210|P3|COMPLETED|Overall Study||25
338249|NCT02738333|830211|P2|COMPLETED|Overall Study||108
338250|NCT02738333|830212|P1|COMPLETED|Overall Study||104
338251|NCT02738333|830210|P3|STARTED|Overall Study||25
338252|NCT02738333|830211|P2|STARTED|Overall Study||108
338253|NCT02738333|830212|P1|STARTED|Overall Study||106
338254|NCT02738138|830288|P2|NOT COMPLETED|Overall Study||1
338255|NCT02738138|830289|P1|NOT COMPLETED|Overall Study||3
338256|NCT02738138|830288|P2|COMPLETED|Overall Study||15
338257|NCT02738138|830289|P1|COMPLETED|Overall Study||134
338258|NCT02738138|830288|P2|STARTED|Overall Study||16
338259|NCT02738138|830289|P1|STARTED|Overall Study||137
338260|NCT02737852|830296|P1|NOT COMPLETED|Overall Study||2
338261|NCT02737852|830296|P1|COMPLETED|Overall Study||30
338262|NCT02737852|830296|P1|STARTED|Overall Study||32
338263|NCT02737631|830301|P1|NOT COMPLETED|Overall Study||0
338264|NCT02737631|830301|P1|COMPLETED|Overall Study||222
338265|NCT02737631|830301|P1|STARTED|Overall Study||222
338266|NCT02737618|830306|P1|NOT COMPLETED|Overall Study||9
338267|NCT02737618|830306|P1|COMPLETED|Overall Study||34
338268|NCT02737618|830306|P1|STARTED|Overall Study||43
338269|NCT02737592|830311|P1|NOT COMPLETED|Overall Study||1
338270|NCT02737592|830311|P1|COMPLETED|Overall Study||33
338271|NCT02737592|830311|P1|STARTED|Overall Study||34
338272|NCT02736721|830316|P1|NOT COMPLETED|Overall Study||16
338273|NCT02736721|830316|P1|COMPLETED|Overall Study||25
338274|NCT02736721|830316|P1|STARTED|Overall Study||41
338275|NCT02736175|830327|P2|NOT COMPLETED|Overall Study||1
338276|NCT02736175|830328|P1|NOT COMPLETED|Overall Study||2
338277|NCT02736175|830327|P2|COMPLETED|Overall Study||221
338278|NCT02736175|830328|P1|COMPLETED|Overall Study||214
338279|NCT02736175|830327|P2|STARTED|Overall Study||222
338280|NCT02736175|830328|P1|STARTED|Overall Study||216
338281|NCT02735200|830338|P2|NOT COMPLETED|Overall Study||5
338282|NCT02735200|830339|P1|NOT COMPLETED|Overall Study||8
338283|NCT02735200|830338|P2|COMPLETED|Overall Study||345
338284|NCT02735200|830339|P1|COMPLETED|Overall Study||192
338285|NCT02735200|830338|P2|STARTED|Overall Study||350
338286|NCT02735200|830339|P1|STARTED|Overall Study||200
338287|NCT02734940|830347|P2|NOT COMPLETED|Overall Study||0
338288|NCT02734940|830348|P1|NOT COMPLETED|Overall Study||0
338289|NCT02734940|830347|P2|COMPLETED|Overall Study||0
338290|NCT02734940|830348|P1|COMPLETED|Overall Study||0
338291|NCT02734940|830347|P2|STARTED|Overall Study||0
338292|NCT02734940|830348|P1|STARTED|Overall Study||0
338293|NCT02734810|830372|P2|NOT COMPLETED|Overall Study||0
338294|NCT02734810|830373|P1|NOT COMPLETED|Overall Study||2
338295|NCT02734810|830372|P2|COMPLETED|Overall Study||0
338296|NCT02734810|830373|P1|COMPLETED|Overall Study||13
338297|NCT02734810|830372|P2|STARTED|Overall Study||0
338298|NCT02734810|830373|P1|STARTED|Overall Study||15
338299|NCT02734355|830381|P2|NOT COMPLETED|Overall Study||0
338300|NCT02734355|830382|P1|NOT COMPLETED|Overall Study||0
338301|NCT02734355|830381|P2|COMPLETED|Overall Study||30
338302|NCT02734355|830382|P1|COMPLETED|Overall Study||34
338303|NCT02734355|830381|P2|STARTED|Overall Study||30
338304|NCT02734355|830382|P1|STARTED|Overall Study||34
338305|NCT02734212|830414|P2|NOT COMPLETED|Overall Study||10
338306|NCT02734212|830415|P1|NOT COMPLETED|Overall Study||5
338307|NCT02734212|830414|P2|COMPLETED|Overall Study||18
338308|NCT02734212|830415|P1|COMPLETED|Overall Study||24
338309|NCT02734212|830414|P2|STARTED|Overall Study||28
338310|NCT02734212|830415|P1|STARTED|Overall Study||29
338311|NCT02734056|830427|P2|NOT COMPLETED|Overall Study||1
338312|NCT02734056|830428|P1|NOT COMPLETED|Overall Study||0
338313|NCT02734056|830427|P2|COMPLETED|Overall Study||49
338314|NCT02734056|830428|P1|COMPLETED|Overall Study||50
338315|NCT02734056|830427|P2|STARTED|Overall Study||50
338316|NCT02734056|830428|P1|STARTED|Overall Study||50
338317|NCT02732899|830436|P2|NOT COMPLETED|Overall Study||0
338318|NCT02732899|830437|P1|NOT COMPLETED|Overall Study||0
338319|NCT02732899|830436|P2|COMPLETED|Overall Study||10
338320|NCT02732899|830437|P1|COMPLETED|Overall Study||10
338321|NCT02732899|830436|P2|STARTED|Overall Study||10
338322|NCT02732899|830437|P1|STARTED|Overall Study||10
338323|NCT02732639|830445|P1|NOT COMPLETED|Overall Study||1
338324|NCT02732639|830445|P1|COMPLETED|Overall Study||30
338325|NCT02732639|830445|P1|STARTED|Overall Study||31
338326|NCT02732561|830458|P2|NOT COMPLETED|Overall Study||1
338327|NCT02732561|830459|P1|NOT COMPLETED|Overall Study||2
338328|NCT02732561|830458|P2|COMPLETED|Overall Study||4
338329|NCT02732561|830459|P1|COMPLETED|Overall Study||3
338330|NCT02732561|830458|P2|STARTED|Overall Study||5
338331|NCT02732561|830459|P1|STARTED|Overall Study||5
338332|NCT02732327|830469|P2|NOT COMPLETED|Overall Study||1
338333|NCT02732327|830470|P1|NOT COMPLETED|Overall Study||0
338334|NCT02732327|830469|P2|COMPLETED|Overall Study||1
338335|NCT02732327|830470|P1|COMPLETED|Overall Study||0
338336|NCT02732327|830469|P2|STARTED|Overall Study||2
338337|NCT02732327|830470|P1|STARTED|Overall Study||0
338338|NCT02732210|830478|P2|NOT COMPLETED|Overall Study||294
338339|NCT02732210|830479|P1|NOT COMPLETED|Overall Study||85
338340|NCT02732210|830478|P2|COMPLETED|Overall Study||338
338341|NCT02732210|830479|P1|COMPLETED|Overall Study||218
338342|NCT02732210|830478|P2|STARTED|Overall Study||632
338343|NCT02732210|830479|P1|STARTED|Overall Study||303
338344|NCT02731833|830497|P2|NOT COMPLETED|Overall Study||0
338345|NCT02731833|830498|P1|NOT COMPLETED|Overall Study||0
338346|NCT02731833|830497|P2|COMPLETED|Overall Study||111
338347|NCT02731833|830498|P1|COMPLETED|Overall Study||111
338348|NCT02731833|830497|P2|STARTED|Overall Study||111
338349|NCT02731833|830498|P1|STARTED|Overall Study||111
338350|NCT02731313|830510|P1|NOT COMPLETED|Overall Study||0
338351|NCT02731313|830510|P1|COMPLETED|Overall Study||367
338352|NCT02731313|830510|P1|STARTED|Overall Study||367
338353|NCT02731300|830520|P2|NOT COMPLETED|Overall Study||0
338354|NCT02731300|830521|P1|NOT COMPLETED|Overall Study||0
338355|NCT02731300|830520|P2|COMPLETED|Overall Study||7
338356|NCT02731300|830521|P1|COMPLETED|Overall Study||15
338357|NCT02731300|830520|P2|STARTED|Overall Study||7
338358|NCT02731300|830521|P1|STARTED|Overall Study||15
338359|NCT02731131|830531|P2|NOT COMPLETED|Overall Study||2
338360|NCT02731131|830532|P1|NOT COMPLETED|Overall Study||0
338361|NCT02731131|830531|P2|COMPLETED|Overall Study||4
338362|NCT02731131|830532|P1|COMPLETED|Overall Study||6
338363|NCT02731131|830531|P2|STARTED|Overall Study||6
338364|NCT02731131|830532|P1|STARTED|Overall Study||6
338365|NCT02730819|830548|P1|NOT COMPLETED|Overall Study||9
338366|NCT02730819|830548|P1|COMPLETED|Overall Study||10
338367|NCT02730819|830548|P1|Follow-up Week 20|Overall Study||10
338368|NCT02730819|830548|P1|Follow-up Week 16|Overall Study||11
338369|NCT02730819|830548|P1|Follow-up Week 12|Overall Study||11
338370|NCT02730819|830548|P1|Follow-up Week 8|Overall Study||14
338371|NCT02730819|830548|P1|Follow-up Week 4|Overall Study||16
338372|NCT02730819|830548|P1|Follow-up Week 2|Overall Study||15
338373|NCT02730819|830548|P1|STARTED|Overall Study||19
338374|NCT02730728|830557|P3|NOT COMPLETED|Overall Study||1
338375|NCT02730728|830558|P2|NOT COMPLETED|Overall Study||2
338376|NCT02730728|830559|P1|NOT COMPLETED|Overall Study||0
338377|NCT02730728|830557|P3|COMPLETED|Overall Study||52
338378|NCT02730728|830558|P2|COMPLETED|Overall Study||51
338379|NCT02730728|830559|P1|COMPLETED|Overall Study||53
338380|NCT02730728|830557|P3|STARTED|Overall Study||53
338381|NCT02730728|830558|P2|STARTED|Overall Study||53
338382|NCT02730728|830559|P1|STARTED|Overall Study||53
338383|NCT02730598|830578|P2|NOT COMPLETED|Overall Study||4
338384|NCT02730598|830579|P1|NOT COMPLETED|Overall Study||4
338385|NCT02730598|830578|P2|COMPLETED|Overall Study||10
338386|NCT02730598|830579|P1|COMPLETED|Overall Study||10
338387|NCT02730598|830578|P2|STARTED|Overall Study||14
338388|NCT02730598|830579|P1|STARTED|Overall Study||14
338389|NCT02730351|830599|P2|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
338390|NCT02730351|830600|P1|NOT COMPLETED|Treatment Period 2 (2 Weeks)||2
338391|NCT02730351|830599|P2|COMPLETED|Treatment Period 2 (2 Weeks)||36
338392|NCT02730351|830600|P1|COMPLETED|Treatment Period 2 (2 Weeks)||33
338393|NCT02730351|830599|P2|STARTED|Treatment Period 2 (2 Weeks)||36
338394|NCT02730351|830600|P1|STARTED|Treatment Period 2 (2 Weeks)||35
338395|NCT02730351|830599|P2|NOT COMPLETED|Wash-out Period (2 Weeks)||1
338396|NCT02730351|830600|P1|NOT COMPLETED|Wash-out Period (2 Weeks)||1
338397|NCT02730351|830599|P2|COMPLETED|Wash-out Period (2 Weeks)||36
338398|NCT02730351|830600|P1|COMPLETED|Wash-out Period (2 Weeks)||35
338399|NCT02730351|830599|P2|STARTED|Wash-out Period (2 Weeks)||37
338400|NCT02730351|830600|P1|STARTED|Wash-out Period (2 Weeks)||36
338401|NCT02730351|830599|P2|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
338402|NCT02730351|830600|P1|NOT COMPLETED|Treatment Period 1 (2 Weeks)||1
338403|NCT02730351|830599|P2|COMPLETED|Treatment Period 1 (2 Weeks)||37
338404|NCT02730351|830600|P1|COMPLETED|Treatment Period 1 (2 Weeks)||36
338405|NCT02730351|830599|P2|STARTED|Treatment Period 1 (2 Weeks)||37
338406|NCT02730351|830600|P1|STARTED|Treatment Period 1 (2 Weeks)||37
338407|NCT02730260|830614|P2|NOT COMPLETED|Overall Study||75
338408|NCT02730260|830615|P1|NOT COMPLETED|Overall Study||82
338409|NCT02730260|830614|P2|COMPLETED|Overall Study||185
338410|NCT02730260|830615|P1|COMPLETED|Overall Study||176
338411|NCT02730260|830614|P2|STARTED|Overall Study||260
338412|NCT02730260|830615|P1|STARTED|Overall Study||258
338413|NCT02727816|830621|P1|NOT COMPLETED|Overall Study||0
338414|NCT02727816|830621|P1|COMPLETED|Overall Study||35
338415|NCT02727816|830621|P1|STARTED|Overall Study||35
338416|NCT02726971|830670|P2|NOT COMPLETED|Overall Study||9
338417|NCT02726971|830671|P1|NOT COMPLETED|Overall Study||11
338418|NCT02726971|830670|P2|COMPLETED|Overall Study||62
338419|NCT02726971|830671|P1|COMPLETED|Overall Study||59
338420|NCT02726971|830670|P2|STARTED|Overall Study||71
338421|NCT02726971|830671|P1|STARTED|Overall Study||70
338422|NCT02726178|830683|P2|NOT COMPLETED|Overall Study||0
338423|NCT02726178|830684|P1|NOT COMPLETED|Overall Study||0
338424|NCT02726178|830683|P2|COMPLETED|Overall Study||28
338425|NCT02726178|830684|P1|COMPLETED|Overall Study||28
338426|NCT02726178|830683|P2|STARTED|Overall Study||28
338427|NCT02726178|830684|P1|STARTED|Overall Study||28
338428|NCT02726022|830692|P1|NOT COMPLETED|Overall Study||36
338429|NCT02726022|830692|P1|COMPLETED|Overall Study||78
338430|NCT02726022|830692|P1|STARTED|Overall Study||114
338431|NCT02725788|830703|P2|NOT COMPLETED|Overall Study||2
338432|NCT02725788|830704|P1|NOT COMPLETED|Overall Study||1
338433|NCT02725788|830703|P2|COMPLETED|Overall Study||122
338434|NCT02725788|830704|P1|COMPLETED|Overall Study||122
338435|NCT02725788|830703|P2|STARTED|Overall Study||124
338436|NCT02725788|830704|P1|STARTED|Overall Study||123
338437|NCT02724644|830712|P2|NOT COMPLETED|Overall Study||4
338438|NCT02724644|830713|P1|NOT COMPLETED|Overall Study||21
338439|NCT02724644|830712|P2|COMPLETED|Overall Study||182
338440|NCT02724644|830713|P1|COMPLETED|Overall Study||168
338441|NCT02724644|830712|P2|STARTED|Overall Study||186
338442|NCT02724644|830713|P1|STARTED|Overall Study||189
338443|NCT02724449|830741|P1|NOT COMPLETED|Overall Study||0
338444|NCT02724449|830741|P1|COMPLETED|Overall Study||16
338445|NCT02724449|830741|P1|STARTED|Overall Study||16
338446|NCT02724111|830747|P2|NOT COMPLETED|Overall Study||5
338447|NCT02724111|830748|P1|NOT COMPLETED|Overall Study||2
338448|NCT02724111|830747|P2|COMPLETED|Overall Study||40
338449|NCT02724111|830748|P1|COMPLETED|Overall Study||43
338450|NCT02724111|830747|P2|STARTED|Overall Study||45
338451|NCT02724111|830748|P1|STARTED|Overall Study||45
338452|NCT02723201|830771|P3|NOT COMPLETED|Fourth Intervention Period||0
338453|NCT02723201|830772|P2|NOT COMPLETED|Fourth Intervention Period||0
338454|NCT02723201|830773|P1|NOT COMPLETED|Fourth Intervention Period||0
338455|NCT02723201|830771|P3|COMPLETED|Fourth Intervention Period||0
338456|NCT02723201|830772|P2|COMPLETED|Fourth Intervention Period||0
338457|NCT02723201|830773|P1|COMPLETED|Fourth Intervention Period||9
338458|NCT02723201|830771|P3|STARTED|Fourth Intervention Period||0
338459|NCT02723201|830772|P2|STARTED|Fourth Intervention Period||0
338460|NCT02723201|830773|P1|STARTED|Fourth Intervention Period||9
338461|NCT02723201|830771|P3|NOT COMPLETED|Washout Period 3||0
338462|NCT02723201|830772|P2|NOT COMPLETED|Washout Period 3||0
338463|NCT02723201|830773|P1|NOT COMPLETED|Washout Period 3||0
338464|NCT02723201|830771|P3|COMPLETED|Washout Period 3||0
338465|NCT02723201|830772|P2|COMPLETED|Washout Period 3||0
338466|NCT02723201|830773|P1|COMPLETED|Washout Period 3||9
338467|NCT02723201|830771|P3|STARTED|Washout Period 3||0
338468|NCT02723201|830772|P2|STARTED|Washout Period 3||0
338469|NCT02723201|830773|P1|STARTED|Washout Period 3||9
338470|NCT02723201|830771|P3|NOT COMPLETED|Third Intervention Period||0
338471|NCT02723201|830772|P2|NOT COMPLETED|Third Intervention Period||0
338472|NCT02723201|830773|P1|NOT COMPLETED|Third Intervention Period||0
338473|NCT02723201|830771|P3|COMPLETED|Third Intervention Period||0
338474|NCT02723201|830772|P2|COMPLETED|Third Intervention Period||0
338475|NCT02723201|830773|P1|COMPLETED|Third Intervention Period||9
338476|NCT02723201|830771|P3|STARTED|Third Intervention Period||0
338477|NCT02723201|830772|P2|STARTED|Third Intervention Period||0
338478|NCT02723201|830773|P1|STARTED|Third Intervention Period||9
338479|NCT02723201|830771|P3|NOT COMPLETED|Washout Period 2||0
338480|NCT02723201|830772|P2|NOT COMPLETED|Washout Period 2||0
338481|NCT02723201|830773|P1|NOT COMPLETED|Washout Period 2||0
338482|NCT02723201|830771|P3|COMPLETED|Washout Period 2||0
338483|NCT02723201|830772|P2|COMPLETED|Washout Period 2||0
338484|NCT02723201|830773|P1|COMPLETED|Washout Period 2||9
338485|NCT02723201|830771|P3|STARTED|Washout Period 2||0
338486|NCT02723201|830772|P2|STARTED|Washout Period 2||0
338487|NCT02723201|830773|P1|STARTED|Washout Period 2||9
338488|NCT02723201|830771|P3|NOT COMPLETED|Second Intervention Period||0
338489|NCT02723201|830772|P2|NOT COMPLETED|Second Intervention Period||0
338490|NCT02723201|830773|P1|NOT COMPLETED|Second Intervention Period||2
338491|NCT02723201|830771|P3|COMPLETED|Second Intervention Period||7
338492|NCT02723201|830772|P2|COMPLETED|Second Intervention Period||7
338493|NCT02723201|830773|P1|COMPLETED|Second Intervention Period||9
338494|NCT02723201|830771|P3|STARTED|Second Intervention Period||7
338495|NCT02723201|830772|P2|STARTED|Second Intervention Period||7
338496|NCT02723201|830773|P1|STARTED|Second Intervention Period||11
338497|NCT02723201|830771|P3|NOT COMPLETED|Washout Period 1||0
338498|NCT02723201|830772|P2|NOT COMPLETED|Washout Period 1||0
338499|NCT02723201|830773|P1|NOT COMPLETED|Washout Period 1||0
338500|NCT02723201|830771|P3|COMPLETED|Washout Period 1||7
338501|NCT02723201|830772|P2|COMPLETED|Washout Period 1||7
338502|NCT02723201|830773|P1|COMPLETED|Washout Period 1||11
338503|NCT02723201|830771|P3|STARTED|Washout Period 1||7
338504|NCT02723201|830772|P2|STARTED|Washout Period 1||7
338505|NCT02723201|830773|P1|STARTED|Washout Period 1||11
338506|NCT02723201|830771|P3|NOT COMPLETED|First Intervention Period||0
338507|NCT02723201|830772|P2|NOT COMPLETED|First Intervention Period||0
338508|NCT02723201|830773|P1|NOT COMPLETED|First Intervention Period||0
338509|NCT02723201|830771|P3|COMPLETED|First Intervention Period||7
338510|NCT02723201|830772|P2|COMPLETED|First Intervention Period||7
338511|NCT02723201|830773|P1|COMPLETED|First Intervention Period||11
338512|NCT02723201|830771|P3|STARTED|First Intervention Period||7
338513|NCT02723201|830772|P2|STARTED|First Intervention Period||7
338514|NCT02723201|830773|P1|STARTED|First Intervention Period||11
338515|NCT02723188|830832|P3|NOT COMPLETED|Overall Study||0
338516|NCT02723188|830833|P2|NOT COMPLETED|Overall Study||0
338517|NCT02723188|830834|P1|NOT COMPLETED|Overall Study||1
338518|NCT02723188|830832|P3|COMPLETED|Overall Study||15
338519|NCT02723188|830833|P2|COMPLETED|Overall Study||15
338520|NCT02723188|830834|P1|COMPLETED|Overall Study||14
338521|NCT02723188|830832|P3|STARTED|Overall Study||15
338522|NCT02723188|830833|P2|STARTED|Overall Study||15
338523|NCT02723188|830834|P1|STARTED|Overall Study||15
338524|NCT02722967|830848|P3|NOT COMPLETED|Overall Study||4
338525|NCT02722967|830849|P2|NOT COMPLETED|Overall Study||2
338526|NCT02722967|830850|P1|NOT COMPLETED|Overall Study||5
338527|NCT02722967|830848|P3|COMPLETED|Overall Study||11
338528|NCT02722967|830849|P2|COMPLETED|Overall Study||10
338529|NCT02722967|830850|P1|COMPLETED|Overall Study||17
338530|NCT02722967|830848|P3|STARTED|Overall Study||15
338531|NCT02722967|830849|P2|STARTED|Overall Study||12
338532|NCT02722967|830850|P1|STARTED|Overall Study||22
338533|NCT02722564|830858|P1|NOT COMPLETED|Overall Study||0
338534|NCT02722564|830858|P1|COMPLETED|Overall Study||55
338535|NCT02722564|830858|P1|STARTED|Overall Study||55
338536|NCT02722278|830864|P2|NOT COMPLETED|Overall Study||7
338537|NCT02722278|830865|P1|NOT COMPLETED|Overall Study||12
338538|NCT02722278|830864|P2|COMPLETED|Overall Study||49
338539|NCT02722278|830865|P1|COMPLETED|Overall Study||154
338540|NCT02722278|830864|P2|STARTED|Overall Study||56
338541|NCT02722278|830865|P1|STARTED|Overall Study||166
338542|NCT02722239|830875|P2|NOT COMPLETED|Overall Study||0
338543|NCT02722239|830876|P1|NOT COMPLETED|Overall Study||0
338544|NCT02722239|830875|P2|COMPLETED|Overall Study||20
338545|NCT02722239|830876|P1|COMPLETED|Overall Study||20
338546|NCT02722239|830875|P2|Second Intervention (1 Day)|Overall Study||20
338547|NCT02722239|830876|P1|Second Intervention (1 Day)|Overall Study||20
338548|NCT02722239|830875|P2|Washout (7 Days)|Overall Study||20
338549|NCT02722239|830876|P1|Washout (7 Days)|Overall Study||20
338550|NCT02722239|830875|P2|First Intervention (1 Day)|Overall Study||20
338551|NCT02722239|830876|P1|First Intervention (1 Day)|Overall Study||20
338552|NCT02722239|830875|P2|STARTED|Overall Study||20
338553|NCT02722239|830876|P1|STARTED|Overall Study||20
338554|NCT02722044|830889|P1|NOT COMPLETED|Overall Study||5
338555|NCT02722044|830889|P1|COMPLETED|Overall Study||28
338556|NCT02722044|830889|P1|STARTED|Overall Study||33
338557|NCT02721641|830916|P1|NOT COMPLETED|Overall Study||0
338558|NCT02721641|830916|P1|COMPLETED|Overall Study|In this continued access study, all participants were considered to have completed per protocol.|69
338559|NCT02721641|830916|P1|STARTED|Overall Study||69
338560|NCT02721277|830922|P1|NOT COMPLETED|Overall Study||0
338561|NCT02721277|830922|P1|COMPLETED|Overall Study||2
338562|NCT02721277|830922|P1|STARTED|Overall Study||2
338563|NCT02720952|830951|P1|NOT COMPLETED|Overall Study||0
338564|NCT02720952|830951|P1|COMPLETED|Overall Study||24
338565|NCT02720952|830951|P1|STARTED|Overall Study||24
338566|NCT02718898|830962|P2|NOT COMPLETED|Overall Study||1
338567|NCT02718898|830963|P1|NOT COMPLETED|Overall Study||9
338568|NCT02718898|830962|P2|COMPLETED|Overall Study||74
338569|NCT02718898|830963|P1|COMPLETED|Overall Study||65
338570|NCT02718898|830962|P2|STARTED|Overall Study||75
338571|NCT02718898|830963|P1|STARTED|Overall Study||74
338572|NCT02717754|830997|P6|NOT COMPLETED|Overall Study||20
338573|NCT02717754|830998|P5|NOT COMPLETED|Overall Study||20
338574|NCT02717754|830999|P4|NOT COMPLETED|Overall Study||10
338575|NCT02717754|831000|P3|NOT COMPLETED|Overall Study||0
338576|NCT02717754|831001|P2|NOT COMPLETED|Overall Study||0
338577|NCT02717754|831002|P1|NOT COMPLETED|Overall Study||0
338578|NCT02717754|830997|P6|COMPLETED|Overall Study||0
338579|NCT02717754|830998|P5|COMPLETED|Overall Study||0
338580|NCT02717754|830999|P4|COMPLETED|Overall Study||0
338581|NCT02717754|831000|P3|COMPLETED|Overall Study||20
338582|NCT02717754|831001|P2|COMPLETED|Overall Study||19
338583|NCT02717754|831002|P1|COMPLETED|Overall Study||10
338584|NCT02717754|830997|P6|STARTED|Overall Study||20
338585|NCT02717754|830998|P5|STARTED|Overall Study||20
338586|NCT02717754|830999|P4|STARTED|Overall Study||10
338587|NCT02717754|831000|P3|STARTED|Overall Study||20
338588|NCT02717754|831001|P2|STARTED|Overall Study||19
338589|NCT02717754|831002|P1|STARTED|Overall Study||10
338590|NCT02716779|831033|P3|NOT COMPLETED|Combination Therapy||1
338591|NCT02716779|831034|P2|NOT COMPLETED|Combination Therapy||2
338592|NCT02716779|831035|P1|NOT COMPLETED|Combination Therapy||0
338593|NCT02716779|831033|P3|COMPLETED|Combination Therapy||25
338594|NCT02716779|831034|P2|COMPLETED|Combination Therapy||23
338595|NCT02716779|831035|P1|COMPLETED|Combination Therapy||14
338596|NCT02716779|831033|P3|STARTED|Combination Therapy||26
338597|NCT02716779|831034|P2|STARTED|Combination Therapy||25
338598|NCT02716779|831035|P1|STARTED|Combination Therapy||14
338599|NCT02716779|831033|P3|NOT COMPLETED|Monotherapy||1
338600|NCT02716779|831034|P2|NOT COMPLETED|Monotherapy||1
338601|NCT02716779|831035|P1|NOT COMPLETED|Monotherapy||0
338602|NCT02716779|831033|P3|COMPLETED|Monotherapy||26
338603|NCT02716779|831034|P2|COMPLETED|Monotherapy||25
338604|NCT02716779|831035|P1|COMPLETED|Monotherapy||14
338605|NCT02716779|831033|P3|STARTED|Monotherapy||27
338606|NCT02716779|831034|P2|STARTED|Monotherapy||26
338607|NCT02716779|831035|P1|STARTED|Monotherapy||14
338608|NCT02716714|831081|P2|NOT COMPLETED|Overall Study||2
338609|NCT02716714|831082|P1|NOT COMPLETED|Overall Study||12
338610|NCT02716714|831081|P2|COMPLETED|Overall Study||8
338611|NCT02716714|831082|P1|COMPLETED|Overall Study||55
338612|NCT02716714|831081|P2|STARTED|Overall Study||10
338613|NCT02716714|831082|P1|STARTED|Overall Study||67
338614|NCT02716298|831108|P2|NOT COMPLETED|Second Intervention (1 Month)||0
338615|NCT02716298|831109|P1|NOT COMPLETED|Second Intervention (1 Month)||0
338616|NCT02716298|831108|P2|COMPLETED|Second Intervention (1 Month)||23
338617|NCT02716298|831109|P1|COMPLETED|Second Intervention (1 Month)||24
338618|NCT02716298|831108|P2|STARTED|Second Intervention (1 Month)||23
338619|NCT02716298|831109|P1|STARTED|Second Intervention (1 Month)||24
338620|NCT02716298|831108|P2|NOT COMPLETED|First Intervention (1 Month)||1
338621|NCT02716298|831109|P1|NOT COMPLETED|First Intervention (1 Month)||1
338622|NCT02716298|831108|P2|COMPLETED|First Intervention (1 Month)||23
338623|NCT02716298|831109|P1|COMPLETED|First Intervention (1 Month)||24
338624|NCT02716298|831108|P2|STARTED|First Intervention (1 Month)||24
338625|NCT02716298|831109|P1|STARTED|First Intervention (1 Month)||25
338626|NCT02714062|831127|P3|NOT COMPLETED|Overall Study||3
338627|NCT02714062|831128|P2|NOT COMPLETED|Overall Study||1
338628|NCT02714062|831129|P1|NOT COMPLETED|Overall Study||1
338629|NCT02714062|831127|P3|COMPLETED|Overall Study||10
338630|NCT02714062|831128|P2|COMPLETED|Overall Study||14
338631|NCT02714062|831129|P1|COMPLETED|Overall Study||13
338632|NCT02714062|831127|P3|STARTED|Overall Study||13
338633|NCT02714062|831128|P2|STARTED|Overall Study||15
338634|NCT02714062|831129|P1|STARTED|Overall Study||14
338635|NCT02713594|831175|P2|NOT COMPLETED|Overall Study||396
338636|NCT02713594|831176|P1|NOT COMPLETED|Overall Study||390
338637|NCT02713594|831175|P2|COMPLETED|Overall Study||552
338638|NCT02713594|831176|P1|COMPLETED|Overall Study||562
338639|NCT02713594|831175|P2|STARTED|Overall Study||948
338640|NCT02713594|831176|P1|STARTED|Overall Study||952
338641|NCT02713256|831186|P1|NOT COMPLETED|Overall Study||0
338642|NCT02713256|831186|P1|COMPLETED|Overall Study||15
338643|NCT02713256|831186|P1|STARTED|Overall Study||15
338644|NCT02712333|831194|P2|NOT COMPLETED|Second Period||0
338645|NCT02712333|831195|P1|NOT COMPLETED|Second Period||0
338646|NCT02712333|831194|P2|COMPLETED|Second Period||24
338647|NCT02712333|831195|P1|COMPLETED|Second Period||31
338648|NCT02712333|831194|P2|STARTED|Second Period||24
338649|NCT02712333|831195|P1|STARTED|Second Period||31
338650|NCT02712333|831194|P2|NOT COMPLETED|First Period||2
338651|NCT02712333|831195|P1|NOT COMPLETED|First Period||3
338652|NCT02712333|831194|P2|COMPLETED|First Period||24
338653|NCT02712333|831195|P1|COMPLETED|First Period||31
338654|NCT02712333|831194|P2|STARTED|First Period||26
338655|NCT02712333|831195|P1|STARTED|First Period||34
338656|NCT02712099|831215|P2|NOT COMPLETED|Overall Study||0
338657|NCT02712099|831216|P1|NOT COMPLETED|Overall Study||0
338658|NCT02712099|831215|P2|COMPLETED|Overall Study||20
338659|NCT02712099|831216|P1|COMPLETED|Overall Study||30
338660|NCT02712099|831215|P2|STARTED|Overall Study||20
338661|NCT02712099|831216|P1|STARTED|Overall Study||30
338662|NCT02711995|831232|P1|NOT COMPLETED|Second Intervention (30 Days)||0
338663|NCT02711995|831232|P1|COMPLETED|Second Intervention (30 Days)||7
338664|NCT02711995|831232|P1|STARTED|Second Intervention (30 Days)||7
338665|NCT02711995|831232|P1|NOT COMPLETED|Washout (90 Days)||1
338666|NCT02711995|831232|P1|COMPLETED|Washout (90 Days)||7
338667|NCT02711995|831232|P1|STARTED|Washout (90 Days)||8
338668|NCT02711995|831232|P1|NOT COMPLETED|First Intervention (30 Days)||0
338669|NCT02711995|831232|P1|COMPLETED|First Intervention (30 Days)||8
338670|NCT02711995|831232|P1|STARTED|First Intervention (30 Days)||8
338671|NCT02710630|831259|P5|NOT COMPLETED|Period 6||0
338672|NCT02710630|831260|P4|NOT COMPLETED|Period 6||0
338673|NCT02710630|831261|P3|NOT COMPLETED|Period 6||0
338674|NCT02710630|831262|P2|NOT COMPLETED|Period 6||0
338675|NCT02710630|831263|P1|NOT COMPLETED|Period 6||0
338676|NCT02710630|831259|P5|COMPLETED|Period 6||7
338677|NCT02710630|831260|P4|COMPLETED|Period 6||7
338678|NCT02710630|831261|P3|COMPLETED|Period 6||7
338679|NCT02710630|831262|P2|COMPLETED|Period 6||7
338680|NCT02710630|831263|P1|COMPLETED|Period 6||7
338681|NCT02710630|831259|P5|STARTED|Period 6||7
338682|NCT02710630|831260|P4|STARTED|Period 6||7
338683|NCT02710630|831261|P3|STARTED|Period 6||7
338684|NCT02710630|831262|P2|STARTED|Period 6||7
338685|NCT02710630|831263|P1|STARTED|Period 6||7
338686|NCT02710630|831259|P5|NOT COMPLETED|Period 5||0
338687|NCT02710630|831260|P4|NOT COMPLETED|Period 5||0
338688|NCT02710630|831261|P3|NOT COMPLETED|Period 5||0
338689|NCT02710630|831262|P2|NOT COMPLETED|Period 5||0
338690|NCT02710630|831263|P1|NOT COMPLETED|Period 5||0
338691|NCT02710630|831259|P5|COMPLETED|Period 5||7
338692|NCT02710630|831260|P4|COMPLETED|Period 5||7
338693|NCT02710630|831261|P3|COMPLETED|Period 5||7
338694|NCT02710630|831262|P2|COMPLETED|Period 5||7
338695|NCT02710630|831263|P1|COMPLETED|Period 5||7
338696|NCT02710630|831259|P5|STARTED|Period 5||7
338697|NCT02710630|831260|P4|STARTED|Period 5||7
338698|NCT02710630|831261|P3|STARTED|Period 5||7
338699|NCT02710630|831262|P2|STARTED|Period 5||7
338700|NCT02710630|831263|P1|STARTED|Period 5||7
338701|NCT02710630|831259|P5|NOT COMPLETED|Period 4||0
338702|NCT02710630|831260|P4|NOT COMPLETED|Period 4||0
338703|NCT02710630|831261|P3|NOT COMPLETED|Period 4||0
338704|NCT02710630|831262|P2|NOT COMPLETED|Period 4||0
338705|NCT02710630|831263|P1|NOT COMPLETED|Period 4||0
338706|NCT02710630|831259|P5|COMPLETED|Period 4||7
338707|NCT02710630|831260|P4|COMPLETED|Period 4||7
338708|NCT02710630|831261|P3|COMPLETED|Period 4||7
338709|NCT02710630|831262|P2|COMPLETED|Period 4||7
338710|NCT02710630|831263|P1|COMPLETED|Period 4||7
338711|NCT02710630|831259|P5|STARTED|Period 4||7
338712|NCT02710630|831260|P4|STARTED|Period 4||7
338713|NCT02710630|831261|P3|STARTED|Period 4||7
338714|NCT02710630|831262|P2|STARTED|Period 4||7
338715|NCT02710630|831263|P1|STARTED|Period 4||7
338716|NCT02710630|831259|P5|NOT COMPLETED|Period 3||0
338717|NCT02710630|831260|P4|NOT COMPLETED|Period 3||0
338718|NCT02710630|831261|P3|NOT COMPLETED|Period 3||0
338719|NCT02710630|831262|P2|NOT COMPLETED|Period 3||0
338720|NCT02710630|831263|P1|NOT COMPLETED|Period 3||0
338721|NCT02710630|831259|P5|COMPLETED|Period 3||7
338722|NCT02710630|831260|P4|COMPLETED|Period 3||7
338723|NCT02710630|831261|P3|COMPLETED|Period 3||7
338724|NCT02710630|831262|P2|COMPLETED|Period 3||7
338725|NCT02710630|831263|P1|COMPLETED|Period 3||7
338726|NCT02710630|831259|P5|STARTED|Period 3||7
338727|NCT02710630|831260|P4|STARTED|Period 3||7
338728|NCT02710630|831261|P3|STARTED|Period 3||7
338729|NCT02710630|831262|P2|STARTED|Period 3||7
338730|NCT02710630|831263|P1|STARTED|Period 3||7
338731|NCT02710630|831259|P5|NOT COMPLETED|Period 2||0
338732|NCT02710630|831260|P4|NOT COMPLETED|Period 2||0
338733|NCT02710630|831261|P3|NOT COMPLETED|Period 2||0
338734|NCT02710630|831262|P2|NOT COMPLETED|Period 2||0
338735|NCT02710630|831263|P1|NOT COMPLETED|Period 2||0
338736|NCT02710630|831259|P5|COMPLETED|Period 2||7
338737|NCT02710630|831260|P4|COMPLETED|Period 2||7
338738|NCT02710630|831261|P3|COMPLETED|Period 2||7
338739|NCT02710630|831262|P2|COMPLETED|Period 2||7
338740|NCT02710630|831263|P1|COMPLETED|Period 2||7
338741|NCT02710630|831259|P5|Not Treated|Period 2||0
338742|NCT02710630|831260|P4|Not Treated|Period 2||0
338743|NCT02710630|831261|P3|Not Treated|Period 2||0
338744|NCT02710630|831262|P2|Not Treated|Period 2||0
338745|NCT02710630|831263|P1|Not Treated|Period 2||1
338746|NCT02710630|831259|P5|STARTED|Period 2||7
338747|NCT02710630|831260|P4|STARTED|Period 2||7
338748|NCT02710630|831261|P3|STARTED|Period 2||7
338749|NCT02710630|831262|P2|STARTED|Period 2||7
338750|NCT02710630|831263|P1|STARTED|Period 2||7
338751|NCT02710630|831259|P5|NOT COMPLETED|Period 1||0
338752|NCT02710630|831260|P4|NOT COMPLETED|Period 1||0
338753|NCT02710630|831261|P3|NOT COMPLETED|Period 1||0
338754|NCT02710630|831262|P2|NOT COMPLETED|Period 1||0
338755|NCT02710630|831263|P1|NOT COMPLETED|Period 1||0
338756|NCT02710630|831259|P5|COMPLETED|Period 1||7
338757|NCT02710630|831260|P4|COMPLETED|Period 1||7
338758|NCT02710630|831261|P3|COMPLETED|Period 1||7
338759|NCT02710630|831262|P2|COMPLETED|Period 1||7
338760|NCT02710630|831263|P1|COMPLETED|Period 1||7
338761|NCT02710630|831259|P5|STARTED|Period 1||7
338762|NCT02710630|831260|P4|STARTED|Period 1||7
338763|NCT02710630|831261|P3|STARTED|Period 1||7
338764|NCT02710630|831262|P2|STARTED|Period 1||7
338765|NCT02710630|831263|P1|STARTED|Period 1||7
338766|NCT02710292|831307|P2|NOT COMPLETED|Period 2, Second 10 Days of Wear||0
338767|NCT02710292|831308|P1|NOT COMPLETED|Period 2, Second 10 Days of Wear||0
338768|NCT02710292|831307|P2|COMPLETED|Period 2, Second 10 Days of Wear||49
338769|NCT02710292|831308|P1|COMPLETED|Period 2, Second 10 Days of Wear||46
338770|NCT02710292|831307|P2|STARTED|Period 2, Second 10 Days of Wear||49
338771|NCT02710292|831308|P1|STARTED|Period 2, Second 10 Days of Wear||46
338772|NCT02710292|831307|P2|NOT COMPLETED|Period 1, First 10 Days of Wear||3
338773|NCT02710292|831308|P1|NOT COMPLETED|Period 1, First 10 Days of Wear||1
338774|NCT02710292|831307|P2|COMPLETED|Period 1, First 10 Days of Wear||49
338775|NCT02710292|831308|P1|COMPLETED|Period 1, First 10 Days of Wear||46
338776|NCT02710292|831307|P2|STARTED|Period 1, First 10 Days of Wear||52
338777|NCT02710292|831308|P1|STARTED|Period 1, First 10 Days of Wear||47
338778|NCT02709577|831317|P4|NOT COMPLETED|Overall Study||0
338779|NCT02709577|831318|P3|NOT COMPLETED|Overall Study||2
338780|NCT02709577|831319|P2|NOT COMPLETED|Overall Study||5
338781|NCT02709577|831320|P1|NOT COMPLETED|Overall Study||2
338782|NCT02709577|831317|P4|COMPLETED|Overall Study||5
338783|NCT02709577|831318|P3|COMPLETED|Overall Study||4
338784|NCT02709577|831319|P2|COMPLETED|Overall Study||8
338785|NCT02709577|831320|P1|COMPLETED|Overall Study||10
338786|NCT02709577|831317|P4|STARTED|Overall Study||5
338787|NCT02709577|831318|P3|STARTED|Overall Study||6
338788|NCT02709577|831319|P2|STARTED|Overall Study||13
338789|NCT02709577|831320|P1|STARTED|Overall Study||12
338790|NCT02709096|831334|P2|NOT COMPLETED|Overall Study||1
338791|NCT02709096|831335|P1|NOT COMPLETED|Overall Study||1
338792|NCT02709096|831334|P2|COMPLETED|Overall Study||10
338793|NCT02709096|831335|P1|COMPLETED|Overall Study||21
338794|NCT02709096|831334|P2|STARTED|Overall Study||11
338795|NCT02709096|831335|P1|STARTED|Overall Study||22
338796|NCT02708524|831345|P4|NOT COMPLETED|Overall Study||0
338797|NCT02708524|831346|P3|NOT COMPLETED|Overall Study||3
338798|NCT02708524|831347|P2|NOT COMPLETED|Overall Study||6
338799|NCT02708524|831348|P1|NOT COMPLETED|Overall Study||4
338800|NCT02708524|831345|P4|COMPLETED|Overall Study||136
338801|NCT02708524|831346|P3|COMPLETED|Overall Study||134
338802|NCT02708524|831347|P2|COMPLETED|Overall Study||130
338803|NCT02708524|831348|P1|COMPLETED|Overall Study||135
338804|NCT02708524|831345|P4|STARTED|Overall Study||136
338805|NCT02708524|831346|P3|STARTED|Overall Study||137
338806|NCT02708524|831347|P2|STARTED|Overall Study||136
338807|NCT02708524|831348|P1|STARTED|Overall Study||139
338808|NCT02708355|831397|P3|NOT COMPLETED|Overall Study||0
338809|NCT02708355|831398|P2|NOT COMPLETED|Overall Study||0
338810|NCT02708355|831399|P1|NOT COMPLETED|Overall Study||1
338811|NCT02708355|831397|P3|COMPLETED|Overall Study||12
338812|NCT02708355|831398|P2|COMPLETED|Overall Study||22
338813|NCT02708355|831399|P1|COMPLETED|Overall Study||20
338814|NCT02708355|831397|P3|STARTED|Overall Study||12
338815|NCT02708355|831398|P2|STARTED|Overall Study||22
338816|NCT02708355|831399|P1|STARTED|Overall Study||21
338817|NCT02708277|831412|P2|NOT COMPLETED|Overall Study||4
338818|NCT02708277|831413|P1|NOT COMPLETED|Overall Study||7
338819|NCT02708277|831412|P2|COMPLETED|Overall Study||39
338820|NCT02708277|831413|P1|COMPLETED|Overall Study||43
338821|NCT02708277|831412|P2|STARTED|Overall Study||43
338822|NCT02708277|831413|P1|STARTED|Overall Study||50
338823|NCT02708238|831428|P3|NOT COMPLETED|Overall Study||3
338824|NCT02708238|831429|P2|NOT COMPLETED|Overall Study||1
338825|NCT02708238|831430|P1|NOT COMPLETED|Overall Study||0
338826|NCT02708238|831428|P3|COMPLETED|Overall Study||57
338827|NCT02708238|831429|P2|COMPLETED|Overall Study||59
338828|NCT02708238|831430|P1|COMPLETED|Overall Study||60
338829|NCT02708238|831428|P3|STARTED|Overall Study||60
338830|NCT02708238|831429|P2|STARTED|Overall Study||60
338831|NCT02708238|831430|P1|STARTED|Overall Study||60
338832|NCT02708212|831443|P2|NOT COMPLETED|Overall Study||0
338833|NCT02708212|831444|P1|NOT COMPLETED|Overall Study||0
338834|NCT02708212|831443|P2|COMPLETED|Overall Study||60
338835|NCT02708212|831444|P1|COMPLETED|Overall Study||60
338836|NCT02708212|831443|P2|STARTED|Overall Study||60
338837|NCT02708212|831444|P1|STARTED|Overall Study||60
338838|NCT02707640|831456|P2|NOT COMPLETED|Overall Study||7
338839|NCT02707640|831457|P1|NOT COMPLETED|Overall Study||9
338840|NCT02707640|831456|P2|COMPLETED|Overall Study||55
338841|NCT02707640|831457|P1|COMPLETED|Overall Study||52
338842|NCT02707640|831456|P2|STARTED|Overall Study||62
338843|NCT02707640|831457|P1|STARTED|Overall Study||61
338844|NCT02707172|831475|P1|NOT COMPLETED|2nd Set of Experiment||0
338845|NCT02707172|831475|P1|COMPLETED|2nd Set of Experiment||28
338846|NCT02707172|831475|P1|STARTED|2nd Set of Experiment||28
338847|NCT02707172|831475|P1|NOT COMPLETED|Wash Out||0
338848|NCT02707172|831475|P1|COMPLETED|Wash Out||28
338849|NCT02707172|831475|P1|STARTED|Wash Out||28
338850|NCT02707172|831475|P1|NOT COMPLETED|1st Set of Experiment||0
338851|NCT02707172|831475|P1|COMPLETED|1st Set of Experiment||28
338852|NCT02707172|831475|P1|STARTED|1st Set of Experiment||28
338853|NCT02706717|831482|P2|NOT COMPLETED|Overall Study||11
338854|NCT02706717|831483|P1|NOT COMPLETED|Overall Study||1
338855|NCT02706717|831482|P2|COMPLETED|Overall Study||35
338856|NCT02706717|831483|P1|COMPLETED|Overall Study||46
338857|NCT02706717|831482|P2|STARTED|Overall Study|3 placebo participants never initiated study treatment.|46
338858|NCT02706717|831483|P1|STARTED|Overall Study||47
338859|NCT02706327|831504|P3|NOT COMPLETED|Overall Study||2
338860|NCT02706327|831505|P2|NOT COMPLETED|Overall Study||1
338861|NCT02706327|831506|P1|NOT COMPLETED|Overall Study||1
338862|NCT02706327|831504|P3|COMPLETED|Overall Study||21
338863|NCT02706327|831505|P2|COMPLETED|Overall Study||21
338864|NCT02706327|831506|P1|COMPLETED|Overall Study||21
338865|NCT02706327|831504|P3|STARTED|Overall Study||23
338866|NCT02706327|831505|P2|STARTED|Overall Study||22
338867|NCT02706327|831506|P1|STARTED|Overall Study||22
338868|NCT02705807|831526|P1|NOT COMPLETED|Overall Study||0
338869|NCT02705807|831526|P1|COMPLETED|Overall Study||10
338870|NCT02705807|831526|P1|STARTED|Overall Study||10
338871|NCT02705716|831558|P2|NOT COMPLETED|Overall Study||2
338872|NCT02705716|831559|P1|NOT COMPLETED|Overall Study||4
338873|NCT02705716|831558|P2|COMPLETED|Overall Study||68
338874|NCT02705716|831559|P1|COMPLETED|Overall Study||68
338875|NCT02705716|831558|P2|STARTED|Overall Study||70
338876|NCT02705716|831559|P1|STARTED|Overall Study||72
338877|NCT02705365|831571|P2|NOT COMPLETED|Overall Study||0
338878|NCT02705365|831572|P1|NOT COMPLETED|Overall Study||0
338879|NCT02705365|831571|P2|COMPLETED|Overall Study||800
338880|NCT02705365|831572|P1|COMPLETED|Overall Study||400
338881|NCT02705365|831571|P2|STARTED|Overall Study||800
338882|NCT02705365|831572|P1|STARTED|Overall Study||400
338883|NCT02704689|831580|P1|NOT COMPLETED|Overall Study||3
338884|NCT02704689|831580|P1|COMPLETED|Overall Study||6
338885|NCT02704689|831580|P1|STARTED|Overall Study||9
338886|NCT02703948|831597|P1|NOT COMPLETED|Overall Study||3
338887|NCT02703948|831597|P1|COMPLETED|Overall Study||57
338888|NCT02703948|831597|P1|STARTED|Overall Study||60
338889|NCT02703909|831605|P4|NOT COMPLETED|Overall Study||0
338890|NCT02703909|831606|P3|NOT COMPLETED|Overall Study||0
338891|NCT02703909|831607|P2|NOT COMPLETED|Overall Study||0
338892|NCT02703909|831608|P1|NOT COMPLETED|Overall Study||0
338893|NCT02703909|831605|P4|COMPLETED|Overall Study||35
338894|NCT02703909|831606|P3|COMPLETED|Overall Study||36
338895|NCT02703909|831607|P2|COMPLETED|Overall Study||37
338896|NCT02703909|831608|P1|COMPLETED|Overall Study||36
338897|NCT02703909|831605|P4|STARTED|Overall Study||35
338898|NCT02703909|831606|P3|STARTED|Overall Study||36
338899|NCT02703909|831607|P2|STARTED|Overall Study||37
338900|NCT02703909|831608|P1|STARTED|Overall Study||36
338907|NCT02702011|831639|P4|NOT COMPLETED|Overall Study||0
338908|NCT02702011|831640|P3|NOT COMPLETED|Overall Study||0
338909|NCT02702011|831641|P2|NOT COMPLETED|Overall Study||1
338910|NCT02702011|831642|P1|NOT COMPLETED|Overall Study||0
338911|NCT02702011|831639|P4|COMPLETED|Overall Study||12
338912|NCT02702011|831640|P3|COMPLETED|Overall Study||12
338913|NCT02702011|831641|P2|COMPLETED|Overall Study||12
338914|NCT02702011|831642|P1|COMPLETED|Overall Study||11
338915|NCT02702011|831639|P4|STARTED|Overall Study|Started are the treated patients.|12
338916|NCT02702011|831640|P3|STARTED|Overall Study|Started are the treated patients.|12
338917|NCT02702011|831641|P2|STARTED|Overall Study|Started are the treated patients.|13
338918|NCT02702011|831642|P1|STARTED|Overall Study|Started are the treated patients.|11
338919|NCT02701556|831654|P2|NOT COMPLETED|Overall Study||20
338920|NCT02701556|831655|P1|NOT COMPLETED|Overall Study||23
338921|NCT02701556|831654|P2|COMPLETED|Overall Study||178
338922|NCT02701556|831655|P1|COMPLETED|Overall Study||175
338923|NCT02701556|831654|P2|STARTED|Overall Study||198
338924|NCT02701556|831655|P1|STARTED|Overall Study||198
338925|NCT02701387|831661|P1|NOT COMPLETED|Overall Study||0
338926|NCT02701387|831661|P1|COMPLETED|Overall Study||7
338927|NCT02701387|831661|P1|STARTED|Overall Study||7
338928|NCT02701361|831669|P3|NOT COMPLETED|Overall Study||2
338929|NCT02701361|831670|P2|NOT COMPLETED|Overall Study||3
338930|NCT02701361|831671|P1|NOT COMPLETED|Overall Study||9
338931|NCT02701361|831669|P3|COMPLETED|Overall Study||16
338932|NCT02701361|831670|P2|COMPLETED|Overall Study||28
338933|NCT02701361|831671|P1|COMPLETED|Overall Study||22
338934|NCT02701361|831669|P3|STARTED|Overall Study||18
338935|NCT02701361|831670|P2|STARTED|Overall Study||31
338936|NCT02701361|831671|P1|STARTED|Overall Study||31
338937|NCT02701296|831712|P2|NOT COMPLETED|Overall Study||2
338938|NCT02701296|831713|P1|NOT COMPLETED|Overall Study||0
338939|NCT02701296|831712|P2|COMPLETED|Overall Study|Data was incomplete for two participants their data was not included in the overall data analysis.|36
338940|NCT02701296|831713|P1|COMPLETED|Overall Study||42
338941|NCT02701296|831712|P2|STARTED|Overall Study||38
338942|NCT02701296|831713|P1|STARTED|Overall Study||42
338943|NCT02701270|831729|P4|NOT COMPLETED|Fourth Intervention at Visit 4||0
338944|NCT02701270|831730|P3|NOT COMPLETED|Fourth Intervention at Visit 4||0
338945|NCT02701270|831731|P2|NOT COMPLETED|Fourth Intervention at Visit 4||0
338946|NCT02701270|831732|P1|NOT COMPLETED|Fourth Intervention at Visit 4||0
338947|NCT02701270|831729|P4|COMPLETED|Fourth Intervention at Visit 4||3
338948|NCT02701270|831730|P3|COMPLETED|Fourth Intervention at Visit 4||3
338949|NCT02701270|831731|P2|COMPLETED|Fourth Intervention at Visit 4||3
338950|NCT02701270|831732|P1|COMPLETED|Fourth Intervention at Visit 4||2
338951|NCT02701270|831729|P4|STARTED|Fourth Intervention at Visit 4||3
338952|NCT02701270|831730|P3|STARTED|Fourth Intervention at Visit 4||3
338953|NCT02701270|831731|P2|STARTED|Fourth Intervention at Visit 4||3
338954|NCT02701270|831732|P1|STARTED|Fourth Intervention at Visit 4||2
338955|NCT02701270|831729|P4|NOT COMPLETED|Third Intervention at Visit 3||0
338956|NCT02701270|831730|P3|NOT COMPLETED|Third Intervention at Visit 3||0
338957|NCT02701270|831731|P2|NOT COMPLETED|Third Intervention at Visit 3||0
338958|NCT02701270|831732|P1|NOT COMPLETED|Third Intervention at Visit 3||0
338959|NCT02701270|831729|P4|COMPLETED|Third Intervention at Visit 3||3
338960|NCT02701270|831730|P3|COMPLETED|Third Intervention at Visit 3||3
338961|NCT02701270|831731|P2|COMPLETED|Third Intervention at Visit 3||3
338962|NCT02701270|831732|P1|COMPLETED|Third Intervention at Visit 3||2
338963|NCT02701270|831729|P4|STARTED|Third Intervention at Visit 3||3
338964|NCT02701270|831730|P3|STARTED|Third Intervention at Visit 3||3
338965|NCT02701270|831731|P2|STARTED|Third Intervention at Visit 3||3
338966|NCT02701270|831732|P1|STARTED|Third Intervention at Visit 3||2
338967|NCT02701270|831729|P4|NOT COMPLETED|Second Intervention at Visit 2||0
338968|NCT02701270|831730|P3|NOT COMPLETED|Second Intervention at Visit 2||0
338969|NCT02701270|831731|P2|NOT COMPLETED|Second Intervention at Visit 2||0
338970|NCT02701270|831732|P1|NOT COMPLETED|Second Intervention at Visit 2||0
338971|NCT02701270|831729|P4|COMPLETED|Second Intervention at Visit 2||3
338972|NCT02701270|831730|P3|COMPLETED|Second Intervention at Visit 2||3
338973|NCT02701270|831731|P2|COMPLETED|Second Intervention at Visit 2||3
338974|NCT02701270|831732|P1|COMPLETED|Second Intervention at Visit 2||2
338975|NCT02701270|831729|P4|STARTED|Second Intervention at Visit 2||3
338976|NCT02701270|831730|P3|STARTED|Second Intervention at Visit 2||3
338977|NCT02701270|831731|P2|STARTED|Second Intervention at Visit 2||3
338978|NCT02701270|831732|P1|STARTED|Second Intervention at Visit 2||2
338979|NCT02701270|831729|P4|NOT COMPLETED|First Intervention at Visit 1||0
338980|NCT02701270|831730|P3|NOT COMPLETED|First Intervention at Visit 1||0
338981|NCT02701270|831731|P2|NOT COMPLETED|First Intervention at Visit 1||0
338982|NCT02701270|831732|P1|NOT COMPLETED|First Intervention at Visit 1||0
338983|NCT02701270|831729|P4|COMPLETED|First Intervention at Visit 1||3
338984|NCT02701270|831730|P3|COMPLETED|First Intervention at Visit 1||3
338985|NCT02701270|831731|P2|COMPLETED|First Intervention at Visit 1||3
338986|NCT02701270|831732|P1|COMPLETED|First Intervention at Visit 1||2
338987|NCT02701270|831729|P4|STARTED|First Intervention at Visit 1||3
338988|NCT02701270|831730|P3|STARTED|First Intervention at Visit 1||3
338989|NCT02701270|831731|P2|STARTED|First Intervention at Visit 1||3
338990|NCT02701270|831732|P1|STARTED|First Intervention at Visit 1||2
338991|NCT02699892|831746|P1|NOT COMPLETED|Overall Study||36
338992|NCT02699892|831746|P1|COMPLETED|Overall Study||94
338993|NCT02699892|831746|P1|STARTED|Overall Study||130
338994|NCT02699684|831751|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
338995|NCT02699684|831752|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
338996|NCT02699684|831751|P2|COMPLETED|Period 2, Second 30 Days of Wear||38
338997|NCT02699684|831752|P1|COMPLETED|Period 2, Second 30 Days of Wear||36
338998|NCT02699684|831751|P2|STARTED|Period 2, Second 30 Days of Wear||38
338999|NCT02699684|831752|P1|STARTED|Period 2, Second 30 Days of Wear||37
339000|NCT02699684|831751|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||0
339001|NCT02699684|831752|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||0
339002|NCT02699684|831751|P2|COMPLETED|Period 1, First 30 Days of Wear||38
339003|NCT02699684|831752|P1|COMPLETED|Period 1, First 30 Days of Wear||37
339004|NCT02699684|831751|P2|STARTED|Period 1, First 30 Days of Wear||38
339005|NCT02699684|831752|P1|STARTED|Period 1, First 30 Days of Wear||37
339006|NCT02699632|831762|P1|NOT COMPLETED|Overall Study||2
339007|NCT02699632|831762|P1|COMPLETED|Overall Study||358
339008|NCT02699632|831762|P1|STARTED|Overall Study||360
339009|NCT02699593|831769|P2|NOT COMPLETED|Period 2||2
339010|NCT02699593|831770|P1|NOT COMPLETED|Period 2||2
339011|NCT02699593|831769|P2|COMPLETED|Period 2||60
339012|NCT02699593|831770|P1|COMPLETED|Period 2||65
339013|NCT02699593|831769|P2|STARTED|Period 2||62
339014|NCT02699593|831770|P1|STARTED|Period 2||67
339015|NCT02699593|831769|P2|NOT COMPLETED|Period 1||7
339016|NCT02699593|831770|P1|NOT COMPLETED|Period 1||5
339017|NCT02699593|831769|P2|COMPLETED|Period 1||62
339018|NCT02699593|831770|P1|COMPLETED|Period 1||67
339019|NCT02699593|831769|P2|STARTED|Period 1||69
339020|NCT02699593|831770|P1|STARTED|Period 1||72
339021|NCT02698566|831778|P2|NOT COMPLETED|Overall Study||0
339022|NCT02698566|831779|P1|NOT COMPLETED|Overall Study||0
339023|NCT02698566|831778|P2|COMPLETED|Overall Study||3
339024|NCT02698566|831779|P1|COMPLETED|Overall Study||35
339025|NCT02698566|831778|P2|STARTED|Overall Study||3
339026|NCT02698566|831779|P1|STARTED|Overall Study||35
339027|NCT02698436|831787|P2|NOT COMPLETED|Overall Study||7
339028|NCT02698436|831788|P1|NOT COMPLETED|Overall Study||7
339029|NCT02698436|831787|P2|COMPLETED|Overall Study||51
339030|NCT02698436|831788|P1|COMPLETED|Overall Study||52
339031|NCT02698436|831787|P2|STARTED|Overall Study||58
339032|NCT02698436|831788|P1|STARTED|Overall Study||59
339033|NCT02698423|831828|P2|NOT COMPLETED|Overall Study||24
339034|NCT02698423|831829|P1|NOT COMPLETED|Overall Study||19
339035|NCT02698423|831828|P2|COMPLETED|Overall Study||307
339036|NCT02698423|831829|P1|COMPLETED|Overall Study||317
339037|NCT02698423|831828|P2|STARTED|Overall Study||331
339038|NCT02698423|831829|P1|STARTED|Overall Study||336
339039|NCT02697890|831839|P2|NOT COMPLETED|Overall Study||0
339040|NCT02697890|831840|P1|NOT COMPLETED|Overall Study||0
339041|NCT02697890|831839|P2|COMPLETED|Overall Study||14
339042|NCT02697890|831840|P1|COMPLETED|Overall Study||14
339043|NCT02697890|831839|P2|STARTED|Overall Study||14
339044|NCT02697890|831840|P1|STARTED|Overall Study||14
339045|NCT02696317|831852|P2|NOT COMPLETED|Period 2, 10 Days of Wear||0
339046|NCT02696317|831853|P1|NOT COMPLETED|Period 2, 10 Days of Wear||1
339047|NCT02696317|831852|P2|COMPLETED|Period 2, 10 Days of Wear||36
339048|NCT02696317|831853|P1|COMPLETED|Period 2, 10 Days of Wear||39
339049|NCT02696317|831852|P2|STARTED|Period 2, 10 Days of Wear||36
339050|NCT02696317|831853|P1|STARTED|Period 2, 10 Days of Wear||40
339051|NCT02696317|831852|P2|NOT COMPLETED|Period 1, 10 Days of Wear||0
339052|NCT02696317|831853|P1|NOT COMPLETED|Period 1, 10 Days of Wear||0
339053|NCT02696317|831852|P2|COMPLETED|Period 1, 10 Days of Wear||36
339054|NCT02696317|831853|P1|COMPLETED|Period 1, 10 Days of Wear||40
339055|NCT02696317|831852|P2|STARTED|Period 1, 10 Days of Wear||36
339056|NCT02696317|831853|P1|STARTED|Period 1, 10 Days of Wear||40
339057|NCT02696317|831852|P2|NOT COMPLETED|Habitual, 10 Days of Wear||4
339058|NCT02696317|831853|P1|NOT COMPLETED|Habitual, 10 Days of Wear||2
339059|NCT02696317|831852|P2|COMPLETED|Habitual, 10 Days of Wear||36
339060|NCT02696317|831853|P1|COMPLETED|Habitual, 10 Days of Wear||40
339061|NCT02696317|831852|P2|STARTED|Habitual, 10 Days of Wear||40
339062|NCT02696317|831853|P1|STARTED|Habitual, 10 Days of Wear||42
339063|NCT02696291|831869|P2|NOT COMPLETED|Overall Study||0
339064|NCT02696291|831870|P1|NOT COMPLETED|Overall Study||0
339065|NCT02696291|831869|P2|COMPLETED|Overall Study||2
339066|NCT02696291|831870|P1|COMPLETED|Overall Study||5
339067|NCT02696291|831869|P2|STARTED|Overall Study||2
339068|NCT02696291|831870|P1|STARTED|Overall Study||5
339069|NCT02696226|831897|P4|NOT COMPLETED|Overall Study||0
339070|NCT02696226|831898|P3|NOT COMPLETED|Overall Study||2
339071|NCT02696226|831899|P2|NOT COMPLETED|Overall Study||0
339072|NCT02696226|831900|P1|NOT COMPLETED|Overall Study||1
339073|NCT02696226|831897|P4|COMPLETED|Overall Study||0
339074|NCT02696226|831898|P3|COMPLETED|Overall Study||0
339075|NCT02696226|831899|P2|COMPLETED|Overall Study||0
339076|NCT02696226|831900|P1|COMPLETED|Overall Study||0
339077|NCT02696226|831897|P4|STARTED|Overall Study||0
339078|NCT02696226|831898|P3|STARTED|Overall Study||2
339079|NCT02696226|831899|P2|STARTED|Overall Study||0
339080|NCT02696226|831900|P1|STARTED|Overall Study||1
339081|NCT02696083|831910|P1|NOT COMPLETED|Overall Study||6
339082|NCT02696083|831910|P1|COMPLETED|Overall Study||13
339083|NCT02696083|831910|P1|STARTED|Overall Study||19
339084|NCT02696070|831921|P2|NOT COMPLETED|Overall Study||2
339085|NCT02696070|831922|P1|NOT COMPLETED|Overall Study||1
339086|NCT02696070|831921|P2|COMPLETED|Overall Study||12
339087|NCT02696070|831922|P1|COMPLETED|Overall Study||7
339088|NCT02696070|831921|P2|STARTED|Overall Study||14
339089|NCT02696070|831922|P1|STARTED|Overall Study||8
339090|NCT02695446|831928|P1|NOT COMPLETED|Overall Study||0
339091|NCT02695446|831928|P1|COMPLETED|Overall Study||12
339092|NCT02695446|831928|P1|STARTED|Overall Study||12
339093|NCT02695290|831933|P1|NOT COMPLETED|Overall Study||0
339094|NCT02695290|831933|P1|COMPLETED|Overall Study||1
339095|NCT02695290|831933|P1|STARTED|Overall Study||1
339096|NCT02694978|831941|P2|NOT COMPLETED|Overall Study||60
339097|NCT02694978|831942|P1|NOT COMPLETED|Overall Study||71
339098|NCT02694978|831941|P2|COMPLETED|Overall Study||948
339099|NCT02694978|831942|P1|COMPLETED|Overall Study||935
339100|NCT02694978|831941|P2|Received at Least 1 Dose of Study Drug|Overall Study||1000
339101|NCT02694978|831942|P1|Received at Least 1 Dose of Study Drug|Overall Study||997
339102|NCT02694978|831941|P2|STARTED|Overall Study||1008
339103|NCT02694978|831942|P1|STARTED|Overall Study||1006
339104|NCT02694744|831956|P2|NOT COMPLETED|Overall Study||5
339105|NCT02694744|831957|P1|NOT COMPLETED|Overall Study||6
339106|NCT02694744|831956|P2|COMPLETED|Overall Study||52
339107|NCT02694744|831957|P1|COMPLETED|Overall Study||51
339108|NCT02694744|831956|P2|ITT|Overall Study||55
339109|NCT02694744|831957|P1|ITT|Overall Study||57
339110|NCT02694744|831956|P2|Safety Population|Overall Study||56
339111|NCT02694744|831957|P1|Safety Population|Overall Study||57
339112|NCT02694744|831956|P2|STARTED|Overall Study||57
339113|NCT02694744|831957|P1|STARTED|Overall Study||57
339114|NCT02694718|831965|P1|NOT COMPLETED|Overall Study||2
339115|NCT02694718|831965|P1|COMPLETED|Overall Study||58
339116|NCT02694718|831965|P1|STARTED|Overall Study||60
339117|NCT02694601|831975|P1|NOT COMPLETED|Overall Study||0
339118|NCT02694601|831975|P1|COMPLETED|Overall Study||10
339119|NCT02694601|831975|P1|STARTED|Overall Study||10
339120|NCT02694536|831995|P1|NOT COMPLETED|Overall Study||80
339121|NCT02694536|831995|P1|COMPLETED|Overall Study||0
339122|NCT02694536|831995|P1|STARTED|Overall Study||80
339123|NCT02694315|832004|P1|NOT COMPLETED|Overall Study||0
339124|NCT02694315|832004|P1|COMPLETED|Overall Study||200
339125|NCT02694315|832004|P1|STARTED|Overall Study||200
339126|NCT02694198|832009|P1|NOT COMPLETED|Overall Study||0
339127|NCT02694198|832009|P1|COMPLETED|Overall Study||135
339128|NCT02694198|832009|P1|STARTED|Overall Study||135
339129|NCT02693704|832018|P4|NOT COMPLETED|Overall Study||0
339130|NCT02693704|832019|P3|NOT COMPLETED|Overall Study||0
339131|NCT02693704|832020|P2|NOT COMPLETED|Overall Study||0
339132|NCT02693704|832021|P1|NOT COMPLETED|Overall Study||0
339133|NCT02693704|832018|P4|COMPLETED|Overall Study||10
339134|NCT02693704|832019|P3|COMPLETED|Overall Study||10
339135|NCT02693704|832020|P2|COMPLETED|Overall Study||10
339136|NCT02693704|832021|P1|COMPLETED|Overall Study||10
339137|NCT02693704|832018|P4|STARTED|Overall Study||10
339138|NCT02693704|832019|P3|STARTED|Overall Study||10
339139|NCT02693704|832020|P2|STARTED|Overall Study||10
339140|NCT02693704|832021|P1|STARTED|Overall Study||10
339141|NCT02692859|832041|P2|NOT COMPLETED|Overall Study||95
339142|NCT02692859|832042|P1|NOT COMPLETED|Overall Study||84
339143|NCT02692859|832041|P2|COMPLETED|Overall Study||901
339144|NCT02692859|832042|P1|COMPLETED|Overall Study||912
339145|NCT02692859|832041|P2|STARTED|Overall Study||996
339146|NCT02692859|832042|P1|STARTED|Overall Study||996
339147|NCT02692703|832048|P1|NOT COMPLETED|Overall Study||2
339148|NCT02692703|832048|P1|COMPLETED|Overall Study||98
339149|NCT02692703|832048|P1|STARTED|Overall Study||100
339156|NCT02692495|832079|P2|NOT COMPLETED|Overall Study||0
339157|NCT02692495|832080|P1|NOT COMPLETED|Overall Study||0
339158|NCT02692495|832079|P2|COMPLETED|Overall Study||4
339159|NCT02692495|832080|P1|COMPLETED|Overall Study||12
339160|NCT02692495|832079|P2|STARTED|Overall Study||4
339161|NCT02692495|832080|P1|STARTED|Overall Study||12
339162|NCT02691507|832097|P2|NOT COMPLETED|Overall Study||1
339163|NCT02691507|832098|P1|NOT COMPLETED|Overall Study||0
339164|NCT02691507|832097|P2|COMPLETED|Overall Study||12
339165|NCT02691507|832098|P1|COMPLETED|Overall Study||40
339166|NCT02691507|832097|P2|STARTED|Overall Study||13
339167|NCT02691507|832098|P1|STARTED|Overall Study||40
339168|NCT02691416|832230|P2|NOT COMPLETED|Overall Study||0
339169|NCT02691416|832231|P1|NOT COMPLETED|Overall Study||0
339170|NCT02691416|832230|P2|COMPLETED|Overall Study||30
339171|NCT02691416|832231|P1|COMPLETED|Overall Study||30
339172|NCT02691416|832230|P2|STARTED|Overall Study||30
339173|NCT02691416|832231|P1|STARTED|Overall Study||30
339174|NCT02691143|832253|P2|NOT COMPLETED|Overall Study||0
339175|NCT02691143|832254|P1|NOT COMPLETED|Overall Study||0
339176|NCT02691143|832253|P2|COMPLETED|Overall Study||23
339177|NCT02691143|832254|P1|COMPLETED|Overall Study||27
339178|NCT02691143|832253|P2|STARTED|Overall Study||23
339179|NCT02691143|832254|P1|STARTED|Overall Study||27
339180|NCT02690935|832264|P2|NOT COMPLETED|Overall Study||0
339181|NCT02690935|832265|P1|NOT COMPLETED|Overall Study||0
339182|NCT02690935|832264|P2|COMPLETED|Overall Study|Count of participants|51
339183|NCT02690935|832265|P1|COMPLETED|Overall Study|Count of participants|51
339184|NCT02690935|832264|P2|STARTED|Overall Study|Count of participants|51
339185|NCT02690935|832265|P1|STARTED|Overall Study|Count of participants|51
339186|NCT02690727|832273|P2|NOT COMPLETED|Overall Study||2
339187|NCT02690727|832274|P1|NOT COMPLETED|Overall Study||2
339188|NCT02690727|832273|P2|COMPLETED|Overall Study||7
339189|NCT02690727|832274|P1|COMPLETED|Overall Study||7
339190|NCT02690727|832273|P2|STARTED|Overall Study||9
339191|NCT02690727|832274|P1|STARTED|Overall Study||9
339192|NCT02689804|832286|P2|NOT COMPLETED|Overall Study||0
339193|NCT02689804|832287|P1|NOT COMPLETED|Overall Study||2
339194|NCT02689804|832286|P2|COMPLETED|Overall Study||16
339195|NCT02689804|832287|P1|COMPLETED|Overall Study||16
339196|NCT02689804|832286|P2|STARTED|Overall Study||16
339197|NCT02689804|832287|P1|STARTED|Overall Study||18
339198|NCT02689206|832318|P5|NOT COMPLETED|Overall Study||8
339199|NCT02689206|832319|P4|NOT COMPLETED|Overall Study||4
339200|NCT02689206|832320|P3|NOT COMPLETED|Overall Study||4
339201|NCT02689206|832321|P2|NOT COMPLETED|Overall Study||1
339202|NCT02689206|832322|P1|NOT COMPLETED|Overall Study||3
339203|NCT02689206|832318|P5|COMPLETED|Overall Study||14
339204|NCT02689206|832319|P4|COMPLETED|Overall Study||17
339205|NCT02689206|832320|P3|COMPLETED|Overall Study||16
339206|NCT02689206|832321|P2|COMPLETED|Overall Study||19
339207|NCT02689206|832322|P1|COMPLETED|Overall Study||17
339208|NCT02689206|832318|P5|STARTED|Overall Study||22
339209|NCT02689206|832319|P4|STARTED|Overall Study||21
339210|NCT02689206|832320|P3|STARTED|Overall Study||20
339211|NCT02689206|832321|P2|STARTED|Overall Study||20
339212|NCT02689206|832322|P1|STARTED|Overall Study||20
339213|NCT02688153|832528|P2|NOT COMPLETED|Overall Study||7
339214|NCT02688153|832529|P1|NOT COMPLETED|Overall Study||15
339215|NCT02688153|832528|P2|COMPLETED|Overall Study||51
339216|NCT02688153|832529|P1|COMPLETED|Overall Study||47
339217|NCT02688153|832528|P2|Final Randomized Arm/Group|Overall Study||61
339218|NCT02688153|832529|P1|Final Randomized Arm/Group|Overall Study||59
339219|NCT02688153|832528|P2|STARTED|Overall Study||58
339220|NCT02688153|832529|P1|STARTED|Overall Study||62
339221|NCT02687217|832589|P2|NOT COMPLETED|Overall Study||0
339222|NCT02687217|832590|P1|NOT COMPLETED|Overall Study||0
339223|NCT02687217|832589|P2|COMPLETED|Overall Study||30
339224|NCT02687217|832590|P1|COMPLETED|Overall Study||30
339225|NCT02687217|832589|P2|STARTED|Overall Study||30
339226|NCT02687217|832590|P1|STARTED|Overall Study||30
339227|NCT02687126|832600|P1|NOT COMPLETED|Data Analysis||0
339228|NCT02687126|832600|P1|COMPLETED|Data Analysis||106
339229|NCT02687126|832600|P1|STARTED|Data Analysis||106
339230|NCT02687126|832600|P1|NOT COMPLETED|Data Collection||0
339231|NCT02687126|832600|P1|COMPLETED|Data Collection||106
339232|NCT02687126|832600|P1|STARTED|Data Collection||106
339233|NCT02686437|832609|P2|NOT COMPLETED|Overall Study||8
339234|NCT02686437|832610|P1|NOT COMPLETED|Overall Study||3
339235|NCT02686437|832609|P2|COMPLETED|Overall Study||12
339236|NCT02686437|832610|P1|COMPLETED|Overall Study||13
339237|NCT02686437|832609|P2|STARTED|Overall Study||20
339238|NCT02686437|832610|P1|STARTED|Overall Study||16
339239|NCT02685488|832620|P2|NOT COMPLETED|Overall Study||1
339240|NCT02685488|832621|P1|NOT COMPLETED|Overall Study||0
339241|NCT02685488|832620|P2|COMPLETED|Overall Study||13
339242|NCT02685488|832621|P1|COMPLETED|Overall Study||12
339243|NCT02685488|832620|P2|STARTED|Overall Study||14
339244|NCT02685488|832621|P1|STARTED|Overall Study||12
339245|NCT02685202|832635|P1|NOT COMPLETED|Overall Study||9
339246|NCT02685202|832635|P1|COMPLETED|Overall Study||0
339247|NCT02685202|832635|P1|STARTED|Overall Study||9
339248|NCT02684942|832641|P6|NOT COMPLETED|Overall Study||0
339249|NCT02684942|832642|P5|NOT COMPLETED|Overall Study||0
339250|NCT02684942|832643|P4|NOT COMPLETED|Overall Study||0
339251|NCT02684942|832644|P3|NOT COMPLETED|Overall Study||0
339252|NCT02684942|832645|P2|NOT COMPLETED|Overall Study||0
339253|NCT02684942|832646|P1|NOT COMPLETED|Overall Study||0
339254|NCT02684942|832641|P6|COMPLETED|Overall Study||6
339255|NCT02684942|832642|P5|COMPLETED|Overall Study||6
339256|NCT02684942|832643|P4|COMPLETED|Overall Study||7
339257|NCT02684942|832644|P3|COMPLETED|Overall Study||7
339258|NCT02684942|832645|P2|COMPLETED|Overall Study||7
339259|NCT02684942|832646|P1|COMPLETED|Overall Study||7
339260|NCT02684942|832641|P6|STARTED|Overall Study||6
339261|NCT02684942|832642|P5|STARTED|Overall Study||6
339262|NCT02684942|832643|P4|STARTED|Overall Study||7
339263|NCT02684942|832644|P3|STARTED|Overall Study||7
339264|NCT02684942|832645|P2|STARTED|Overall Study||7
339265|NCT02684942|832646|P1|STARTED|Overall Study||7
339266|NCT02684630|832662|P2|NOT COMPLETED|Overall Study||3
339267|NCT02684630|832663|P1|NOT COMPLETED|Overall Study||5
339268|NCT02684630|832662|P2|COMPLETED|Overall Study||60
339269|NCT02684630|832663|P1|COMPLETED|Overall Study||60
339270|NCT02684630|832662|P2|STARTED|Overall Study||63
339271|NCT02684630|832663|P1|STARTED|Overall Study||65
339272|NCT02684604|832673|P2|NOT COMPLETED|Overall Study||0
339273|NCT02684604|832674|P1|NOT COMPLETED|Overall Study||0
339274|NCT02684604|832673|P2|COMPLETED|Overall Study||44
339275|NCT02684604|832674|P1|COMPLETED|Overall Study||44
339276|NCT02684604|832673|P2|STARTED|Overall Study||44
339277|NCT02684604|832674|P1|STARTED|Overall Study||44
339278|NCT02684396|832686|P6|NOT COMPLETED|Overall Study||0
339279|NCT02684396|832687|P5|NOT COMPLETED|Overall Study||0
339280|NCT02684396|832688|P4|NOT COMPLETED|Overall Study||0
339281|NCT02684396|832689|P3|NOT COMPLETED|Overall Study||0
339282|NCT02684396|832690|P2|NOT COMPLETED|Overall Study||0
339283|NCT02684396|832691|P1|NOT COMPLETED|Overall Study||0
339284|NCT02684396|832686|P6|COMPLETED|Overall Study||10
339285|NCT02684396|832687|P5|COMPLETED|Overall Study||5
339286|NCT02684396|832688|P4|COMPLETED|Overall Study||6
339287|NCT02684396|832689|P3|COMPLETED|Overall Study||6
339288|NCT02684396|832690|P2|COMPLETED|Overall Study||6
339289|NCT02684396|832691|P1|COMPLETED|Overall Study||6
339290|NCT02684396|832686|P6|STARTED|Overall Study||10
339291|NCT02684396|832687|P5|STARTED|Overall Study||5
339292|NCT02684396|832688|P4|STARTED|Overall Study||6
339293|NCT02684396|832689|P3|STARTED|Overall Study||6
339294|NCT02684396|832690|P2|STARTED|Overall Study||6
339295|NCT02684396|832691|P1|STARTED|Overall Study||6
339296|NCT02684188|832745|P2|NOT COMPLETED|Overall Study||3
339297|NCT02684188|832746|P1|NOT COMPLETED|Overall Study||2
339298|NCT02684188|832745|P2|COMPLETED|Overall Study||47
339299|NCT02684188|832746|P1|COMPLETED|Overall Study||75
339300|NCT02684188|832745|P2|STARTED|Overall Study||50
339301|NCT02684188|832746|P1|STARTED|Overall Study||77
339302|NCT02683954|832772|P2|NOT COMPLETED|Overall Study||0
339303|NCT02683954|832773|P1|NOT COMPLETED|Overall Study||0
339304|NCT02683954|832772|P2|COMPLETED|Overall Study||30
339305|NCT02683954|832773|P1|COMPLETED|Overall Study||30
339306|NCT02683954|832772|P2|STARTED|Overall Study||30
339307|NCT02683954|832773|P1|STARTED|Overall Study||30
339308|NCT02683746|832781|P2|NOT COMPLETED|Overall Study||14
339309|NCT02683746|832782|P1|NOT COMPLETED|Overall Study||16
339310|NCT02683746|832781|P2|COMPLETED|Overall Study||140
339311|NCT02683746|832782|P1|COMPLETED|Overall Study||138
339312|NCT02683746|832781|P2|STARTED|Overall Study||154
339313|NCT02683746|832782|P1|STARTED|Overall Study||154
339314|NCT02683707|832812|P2|NOT COMPLETED|Overall Study||0
339315|NCT02683707|832813|P1|NOT COMPLETED|Overall Study||0
339316|NCT02683707|832812|P2|COMPLETED|Overall Study||107
339317|NCT02683707|832813|P1|COMPLETED|Overall Study||105
339318|NCT02683707|832812|P2|STARTED|Overall Study||107
339319|NCT02683707|832813|P1|STARTED|Overall Study||105
339320|NCT02683577|832828|P3|NOT COMPLETED|Overall Study||0
339321|NCT02683577|832829|P2|NOT COMPLETED|Overall Study||0
339322|NCT02683577|832830|P1|NOT COMPLETED|Overall Study||0
339323|NCT02683577|832828|P3|COMPLETED|Overall Study||8
339324|NCT02683577|832829|P2|COMPLETED|Overall Study||8
339325|NCT02683577|832830|P1|COMPLETED|Overall Study||8
339326|NCT02683577|832828|P3|STARTED|Overall Study||8
339327|NCT02683577|832829|P2|STARTED|Overall Study||8
339328|NCT02683577|832830|P1|STARTED|Overall Study||8
339329|NCT02683161|832876|P1|NOT COMPLETED|Overall Study||0
339330|NCT02683161|832876|P1|COMPLETED|Overall Study||5
339331|NCT02683161|832876|P1|STARTED|Overall Study||5
339332|NCT02682498|832882|P2|NOT COMPLETED|Overall Study||0
339333|NCT02682498|832883|P1|NOT COMPLETED|Overall Study||0
339334|NCT02682498|832882|P2|COMPLETED|Overall Study||20
339335|NCT02682498|832883|P1|COMPLETED|Overall Study||18
339336|NCT02682498|832882|P2|STARTED|Overall Study||20
339337|NCT02682498|832883|P1|STARTED|Overall Study||18
339338|NCT02681510|832897|P1|NOT COMPLETED|Overall Study||10
339339|NCT02681510|832897|P1|COMPLETED|Overall Study||26
339340|NCT02681510|832897|P1|STARTED|Overall Study||36
339341|NCT02681458|832906|P2|NOT COMPLETED|Overall Study||656
339342|NCT02681458|832907|P1|NOT COMPLETED|Overall Study||645
339343|NCT02681458|832906|P2|COMPLETED|Overall Study||62
339344|NCT02681458|832907|P1|COMPLETED|Overall Study||73
339345|NCT02681458|832906|P2|STARTED|Overall Study||718
339346|NCT02681458|832907|P1|STARTED|Overall Study||718
339347|NCT02679976|832913|P1|NOT COMPLETED|Overall Study||0
339348|NCT02679976|832913|P1|COMPLETED|Overall Study||30
339349|NCT02679976|832913|P1|Myopes|Overall Study||14
339350|NCT02679976|832913|P1|Hyperopes|Overall Study||16
339351|NCT02679976|832913|P1|STARTED|Overall Study||30
339352|NCT02679469|832922|P1|NOT COMPLETED|Overall Study||0
339353|NCT02679469|832922|P1|COMPLETED|Overall Study||7
339354|NCT02679469|832922|P1|STARTED|Overall Study||7
339355|NCT02678923|832930|P2|NOT COMPLETED|Overall Study||5
339356|NCT02678923|832931|P1|NOT COMPLETED|Overall Study||6
339357|NCT02678923|832930|P2|COMPLETED|Overall Study||62
339358|NCT02678923|832931|P1|COMPLETED|Overall Study||53
339359|NCT02678923|832930|P2|mITT Population|Overall Study||61
339360|NCT02678923|832931|P1|mITT Population|Overall Study||52
339361|NCT02678923|832930|P2|Received at Least 1 Dose of Study Drug|Overall Study||64
339362|NCT02678923|832931|P1|Received at Least 1 Dose of Study Drug|Overall Study||58
339363|NCT02678923|832930|P2|STARTED|Overall Study||67
339364|NCT02678923|832931|P1|STARTED|Overall Study||59
339365|NCT02678676|832947|P2|NOT COMPLETED|Overall Study||872
339366|NCT02678676|832948|P1|NOT COMPLETED|Overall Study||888
339367|NCT02678676|832947|P2|COMPLETED|Overall Study||907
339368|NCT02678676|832948|P1|COMPLETED|Overall Study||932
339369|NCT02678676|832947|P2|STARTED|Overall Study||1779
339370|NCT02678676|832948|P1|STARTED|Overall Study||1820
339371|NCT02678286|832958|P2|NOT COMPLETED|Study Overall (28 Day Follow-Up)||4
339372|NCT02678286|832959|P1|NOT COMPLETED|Study Overall (28 Day Follow-Up)||6
339373|NCT02678286|832958|P2|COMPLETED|Study Overall (28 Day Follow-Up)||105
339374|NCT02678286|832959|P1|COMPLETED|Study Overall (28 Day Follow-Up)||104
339375|NCT02678286|832958|P2|STARTED|Study Overall (28 Day Follow-Up)||109
339376|NCT02678286|832959|P1|STARTED|Study Overall (28 Day Follow-Up)||110
339377|NCT02678286|832958|P2|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||2
339378|NCT02678286|832959|P1|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||2
339379|NCT02678286|832958|P2|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||107
339380|NCT02678286|832959|P1|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||108
339381|NCT02678286|832958|P2|STARTED|Treatment Phase (48 Hours Post-Dose 1)||109
339382|NCT02678286|832959|P1|STARTED|Treatment Phase (48 Hours Post-Dose 1)||110
339383|NCT02678039|832991|P2|NOT COMPLETED|Overall Study||0
339384|NCT02678039|832992|P1|NOT COMPLETED|Overall Study||0
339385|NCT02678039|832991|P2|COMPLETED|Overall Study||47
339386|NCT02678039|832992|P1|COMPLETED|Overall Study||53
339387|NCT02678039|832991|P2|STARTED|Overall Study||47
339388|NCT02678039|832992|P1|STARTED|Overall Study||53
339389|NCT02677779|833008|P2|NOT COMPLETED|Overall Study||0
339390|NCT02677779|833009|P1|NOT COMPLETED|Overall Study||0
339391|NCT02677779|833008|P2|COMPLETED|Overall Study||10
339392|NCT02677779|833009|P1|COMPLETED|Overall Study||10
339393|NCT02677779|833008|P2|STARTED|Overall Study||10
339394|NCT02677779|833009|P1|STARTED|Overall Study||10
339395|NCT02677493|833026|P3|NOT COMPLETED|Overall Study||3
339396|NCT02677493|833027|P2|NOT COMPLETED|Overall Study||2
339397|NCT02677493|833028|P1|NOT COMPLETED|Overall Study||11
339398|NCT02677493|833026|P3|COMPLETED|Overall Study||296
339399|NCT02677493|833027|P2|COMPLETED|Overall Study||296
339400|NCT02677493|833028|P1|COMPLETED|Overall Study||1186
339401|NCT02677493|833026|P3|STARTED|Overall Study||299
339402|NCT02677493|833027|P2|STARTED|Overall Study||298
339403|NCT02677493|833028|P1|STARTED|Overall Study||1197
339404|NCT02675907|833041|P2|NOT COMPLETED|Study Overall||4
339405|NCT02675907|833042|P1|NOT COMPLETED|Study Overall||3
339406|NCT02675907|833041|P2|COMPLETED|Study Overall||97
339407|NCT02675907|833042|P1|COMPLETED|Study Overall||97
339408|NCT02675907|833041|P2|STARTED|Study Overall||101
339409|NCT02675907|833042|P1|STARTED|Study Overall||100
339410|NCT02675907|833041|P2|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||5
339411|NCT02675907|833042|P1|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||5
339412|NCT02675907|833041|P2|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||96
339413|NCT02675907|833042|P1|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||95
339414|NCT02675907|833041|P2|STARTED|Treatment Phase (48 Hours Post-Dose 1)||101
339415|NCT02675907|833042|P1|STARTED|Treatment Phase (48 Hours Post-Dose 1)||100
339416|NCT02675634|833072|P6|NOT COMPLETED|Test Period 3||0
339417|NCT02675634|833073|P5|NOT COMPLETED|Test Period 3||0
339418|NCT02675634|833074|P4|NOT COMPLETED|Test Period 3||0
339419|NCT02675634|833075|P3|NOT COMPLETED|Test Period 3||0
339420|NCT02675634|833076|P2|NOT COMPLETED|Test Period 3||0
339421|NCT02675634|833077|P1|NOT COMPLETED|Test Period 3||0
339422|NCT02675634|833072|P6|COMPLETED|Test Period 3||8
339423|NCT02675634|833073|P5|COMPLETED|Test Period 3||10
339424|NCT02675634|833074|P4|COMPLETED|Test Period 3||8
339425|NCT02675634|833075|P3|COMPLETED|Test Period 3||8
339426|NCT02675634|833076|P2|COMPLETED|Test Period 3||7
339427|NCT02675634|833077|P1|COMPLETED|Test Period 3||9
339428|NCT02675634|833072|P6|STARTED|Test Period 3||8
339429|NCT02675634|833073|P5|STARTED|Test Period 3||10
339430|NCT02675634|833074|P4|STARTED|Test Period 3||8
339431|NCT02675634|833075|P3|STARTED|Test Period 3||8
339432|NCT02675634|833076|P2|STARTED|Test Period 3||7
339433|NCT02675634|833077|P1|STARTED|Test Period 3||9
339434|NCT02675634|833072|P6|NOT COMPLETED|Test Period 2||1
339435|NCT02675634|833073|P5|NOT COMPLETED|Test Period 2||0
339436|NCT02675634|833074|P4|NOT COMPLETED|Test Period 2||0
339437|NCT02675634|833075|P3|NOT COMPLETED|Test Period 2||0
339438|NCT02675634|833076|P2|NOT COMPLETED|Test Period 2||0
339439|NCT02675634|833077|P1|NOT COMPLETED|Test Period 2||1
339440|NCT02675634|833072|P6|COMPLETED|Test Period 2||8
339441|NCT02675634|833073|P5|COMPLETED|Test Period 2||10
339442|NCT02675634|833074|P4|COMPLETED|Test Period 2||8
339443|NCT02675634|833075|P3|COMPLETED|Test Period 2||8
339444|NCT02675634|833076|P2|COMPLETED|Test Period 2||7
339445|NCT02675634|833077|P1|COMPLETED|Test Period 2||9
339446|NCT02675634|833072|P6|STARTED|Test Period 2||9
339447|NCT02675634|833073|P5|STARTED|Test Period 2||10
339448|NCT02675634|833074|P4|STARTED|Test Period 2||8
339449|NCT02675634|833075|P3|STARTED|Test Period 2||8
339450|NCT02675634|833076|P2|STARTED|Test Period 2||7
339451|NCT02675634|833077|P1|STARTED|Test Period 2||10
339452|NCT02675634|833072|P6|NOT COMPLETED|Test Period 1||0
339453|NCT02675634|833073|P5|NOT COMPLETED|Test Period 1||0
339454|NCT02675634|833074|P4|NOT COMPLETED|Test Period 1||1
339455|NCT02675634|833075|P3|NOT COMPLETED|Test Period 1||1
339456|NCT02675634|833076|P2|NOT COMPLETED|Test Period 1||1
339457|NCT02675634|833077|P1|NOT COMPLETED|Test Period 1||0
339458|NCT02675634|833072|P6|COMPLETED|Test Period 1||9
339459|NCT02675634|833073|P5|COMPLETED|Test Period 1||10
339460|NCT02675634|833074|P4|COMPLETED|Test Period 1||8
339461|NCT02675634|833075|P3|COMPLETED|Test Period 1||8
339462|NCT02675634|833076|P2|COMPLETED|Test Period 1||7
339463|NCT02675634|833077|P1|COMPLETED|Test Period 1||10
339464|NCT02675634|833072|P6|STARTED|Test Period 1||9
339465|NCT02675634|833073|P5|STARTED|Test Period 1||10
339466|NCT02675634|833074|P4|STARTED|Test Period 1||9
339467|NCT02675634|833075|P3|STARTED|Test Period 1||9
339468|NCT02675634|833076|P2|STARTED|Test Period 1||8
339469|NCT02675634|833077|P1|STARTED|Test Period 1||10
339470|NCT02675543|833087|P2|NOT COMPLETED|Overall Study||0
339471|NCT02675543|833088|P1|NOT COMPLETED|Overall Study||0
339472|NCT02675543|833087|P2|COMPLETED|Overall Study||20
339473|NCT02675543|833088|P1|COMPLETED|Overall Study||15
339474|NCT02675543|833087|P2|STARTED|Overall Study||20
339475|NCT02675543|833088|P1|STARTED|Overall Study||15
339476|NCT02674334|833096|P2|NOT COMPLETED|Overall Study||3
339477|NCT02674334|833097|P1|NOT COMPLETED|Overall Study||7
339478|NCT02674334|833096|P2|COMPLETED|Overall Study||40
339479|NCT02674334|833097|P1|COMPLETED|Overall Study||40
339480|NCT02674334|833096|P2|STARTED|Overall Study||43
339481|NCT02674334|833097|P1|STARTED|Overall Study||47
339482|NCT02673944|833105|P1|NOT COMPLETED|Overall Study||0
339483|NCT02673944|833105|P1|COMPLETED|Overall Study||10
339484|NCT02673944|833105|P1|STARTED|Overall Study||10
339485|NCT02673619|833114|P4|NOT COMPLETED|Overall Study||0
339486|NCT02673619|833115|P3|NOT COMPLETED|Overall Study||3
339487|NCT02673619|833116|P2|NOT COMPLETED|Overall Study||1
339488|NCT02673619|833117|P1|NOT COMPLETED|Overall Study||2
339489|NCT02673619|833114|P4|COMPLETED|Overall Study||7
339490|NCT02673619|833115|P3|COMPLETED|Overall Study||23
339491|NCT02673619|833116|P2|COMPLETED|Overall Study||4
339492|NCT02673619|833117|P1|COMPLETED|Overall Study||18
339493|NCT02673619|833114|P4|STARTED|Overall Study||7
339494|NCT02673619|833115|P3|STARTED|Overall Study||26
339495|NCT02673619|833116|P2|STARTED|Overall Study||5
339496|NCT02673619|833117|P1|STARTED|Overall Study||20
339497|NCT02673489|833209|P2|NOT COMPLETED|Follow Up Period||2
339498|NCT02673489|833210|P1|NOT COMPLETED|Follow Up Period||0
339499|NCT02673489|833209|P2|COMPLETED|Follow Up Period||21
339500|NCT02673489|833210|P1|COMPLETED|Follow Up Period||50
339501|NCT02673489|833209|P2|STARTED|Follow Up Period||23
339502|NCT02673489|833210|P1|STARTED|Follow Up Period||50
339503|NCT02673489|833209|P2|NOT COMPLETED|Treatment Period||3
339504|NCT02673489|833210|P1|NOT COMPLETED|Treatment Period||5
339505|NCT02673489|833209|P2|COMPLETED|Treatment Period||21
339506|NCT02673489|833210|P1|COMPLETED|Treatment Period||49
339507|NCT02673489|833209|P2|STARTED|Treatment Period||24
339508|NCT02673489|833210|P1|STARTED|Treatment Period||54
339509|NCT02672514|833225|P2|NOT COMPLETED|Overall Study||0
339510|NCT02672514|833226|P1|NOT COMPLETED|Overall Study||0
339511|NCT02672514|833225|P2|COMPLETED|Overall Study||51
339512|NCT02672514|833226|P1|COMPLETED|Overall Study||53
339513|NCT02672514|833225|P2|STARTED|Overall Study||51
339514|NCT02672514|833226|P1|STARTED|Overall Study||53
339515|NCT02671760|833232|P3|NOT COMPLETED|Overall Study||0
339516|NCT02671760|833233|P2|NOT COMPLETED|Overall Study||1
339517|NCT02671760|833234|P1|NOT COMPLETED|Overall Study||0
339518|NCT02671760|833232|P3|COMPLETED|Overall Study||13
339519|NCT02671760|833233|P2|COMPLETED|Overall Study|1 Subject could not be contacted for f/u phone call. Data included in safety and efficacy analyses.|12
339520|NCT02671760|833234|P1|COMPLETED|Overall Study||13
339521|NCT02671760|833232|P3|STARTED|Overall Study||13
339522|NCT02671760|833233|P2|STARTED|Overall Study||13
339523|NCT02671760|833234|P1|STARTED|Overall Study||13
339524|NCT02671461|833263|P3|NOT COMPLETED|Follow-up||1
339525|NCT02671461|833264|P2|NOT COMPLETED|Follow-up||1
339526|NCT02671461|833265|P1|NOT COMPLETED|Follow-up||1
339527|NCT02671461|833263|P3|COMPLETED|Follow-up||6
339528|NCT02671461|833264|P2|COMPLETED|Follow-up||4
339529|NCT02671461|833265|P1|COMPLETED|Follow-up||1
339530|NCT02671461|833263|P3|STARTED|Follow-up||7
339531|NCT02671461|833264|P2|STARTED|Follow-up||5
339532|NCT02671461|833265|P1|STARTED|Follow-up||2
339533|NCT02671461|833263|P3|NOT COMPLETED|Treatment||5
339534|NCT02671461|833264|P2|NOT COMPLETED|Treatment||3
339535|NCT02671461|833265|P1|NOT COMPLETED|Treatment||2
339536|NCT02671461|833263|P3|COMPLETED|Treatment||2
339537|NCT02671461|833264|P2|COMPLETED|Treatment||2
339538|NCT02671461|833265|P1|COMPLETED|Treatment||1
339539|NCT02671461|833263|P3|STARTED|Treatment||7
339540|NCT02671461|833264|P2|STARTED|Treatment||5
339541|NCT02671461|833265|P1|STARTED|Treatment||3
339542|NCT02670811|833290|P2|NOT COMPLETED|Overall Study||0
339543|NCT02670811|833291|P1|NOT COMPLETED|Overall Study||1
339544|NCT02670811|833290|P2|COMPLETED|Overall Study||18
339545|NCT02670811|833291|P1|COMPLETED|Overall Study||17
339546|NCT02670811|833290|P2|STARTED|Overall Study||18
339547|NCT02670811|833291|P1|STARTED|Overall Study||18
339548|NCT02670473|833307|P1|NOT COMPLETED|Overall Study||1
339549|NCT02670473|833307|P1|COMPLETED|Overall Study||34
339550|NCT02670473|833307|P1|STARTED|Overall Study||35
339551|NCT02670343|833360|P1|NOT COMPLETED|Overall Study||0
339552|NCT02670343|833360|P1|COMPLETED|Overall Study||8
339553|NCT02670343|833360|P1|STARTED|Overall Study||8
339554|NCT02669095|833366|P2|NOT COMPLETED|Overall Study||3
339555|NCT02669095|833367|P1|NOT COMPLETED|Overall Study||1
339556|NCT02669095|833366|P2|COMPLETED|Overall Study||72
339557|NCT02669095|833367|P1|COMPLETED|Overall Study||74
339558|NCT02669095|833366|P2|STARTED|Overall Study||75
339559|NCT02669095|833367|P1|STARTED|Overall Study||75
339560|NCT02669043|833375|P1|NOT COMPLETED|Overall Study||4
339561|NCT02669043|833375|P1|COMPLETED|Overall Study||4
339562|NCT02669043|833375|P1|STARTED|Overall Study||8
339563|NCT02668952|833381|P2|NOT COMPLETED|Overall Study||0
339564|NCT02668952|833382|P1|NOT COMPLETED|Overall Study||0
339565|NCT02668952|833381|P2|COMPLETED|Overall Study||14
339566|NCT02668952|833382|P1|COMPLETED|Overall Study||16
339567|NCT02668952|833381|P2|STARTED|Overall Study||14
339568|NCT02668952|833382|P1|STARTED|Overall Study||16
339569|NCT02668822|833402|P2|NOT COMPLETED|Overall Study||9
339570|NCT02668822|833403|P1|NOT COMPLETED|Overall Study||9
339571|NCT02668822|833402|P2|COMPLETED|Overall Study||0
339572|NCT02668822|833403|P1|COMPLETED|Overall Study||0
339573|NCT02668822|833402|P2|STARTED|Overall Study||9
339574|NCT02668822|833403|P1|STARTED|Overall Study||9
339575|NCT02668783|833425|P2|NOT COMPLETED|Overall Study||12
339576|NCT02668783|833426|P1|NOT COMPLETED|Overall Study||13
339577|NCT02668783|833425|P2|COMPLETED|Overall Study||0
339578|NCT02668783|833426|P1|COMPLETED|Overall Study||0
339579|NCT02668783|833425|P2|Treated|Overall Study||11
339580|NCT02668783|833426|P1|Treated|Overall Study||13
339581|NCT02668783|833425|P2|STARTED|Overall Study||12
339582|NCT02668783|833426|P1|STARTED|Overall Study||13
339583|NCT02667821|833446|P1|NOT COMPLETED|Overall Study||0
339584|NCT02667821|833446|P1|COMPLETED|Overall Study||20
339585|NCT02667821|833446|P1|STARTED|Overall Study||20
339586|NCT02667704|833452|P1|NOT COMPLETED|Treatment Period 2||0
339587|NCT02667704|833452|P1|COMPLETED|Treatment Period 2||13
339588|NCT02667704|833452|P1|STARTED|Treatment Period 2||13
339589|NCT02667704|833452|P1|NOT COMPLETED|Treatment Period 1||0
339590|NCT02667704|833452|P1|COMPLETED|Treatment Period 1||13
339591|NCT02667704|833452|P1|STARTED|Treatment Period 1||13
339592|NCT02667288|833463|P1|NOT COMPLETED|Overall Study||13
339593|NCT02667288|833463|P1|COMPLETED|Overall Study||134
339594|NCT02667288|833463|P1|STARTED|Overall Study||147
339595|NCT02667275|833470|P2|NOT COMPLETED|Overall Study||15
339596|NCT02667275|833471|P1|NOT COMPLETED|Overall Study||11
339597|NCT02667275|833470|P2|COMPLETED|Overall Study||228
339598|NCT02667275|833471|P1|COMPLETED|Overall Study||233
339599|NCT02667275|833470|P2|STARTED|Overall Study||243
339600|NCT02667275|833471|P1|STARTED|Overall Study||244
339601|NCT02667236|833481|P2|NOT COMPLETED|Overall Study||1
339602|NCT02667236|833482|P1|NOT COMPLETED|Overall Study||3
339603|NCT02667236|833481|P2|COMPLETED|Overall Study||226
339604|NCT02667236|833482|P1|COMPLETED|Overall Study||220
339605|NCT02667236|833481|P2|STARTED|Overall Study||227
339606|NCT02667236|833482|P1|STARTED|Overall Study||223
339607|NCT02666560|833490|P2|NOT COMPLETED|Condition 2 (1 Day)||0
339608|NCT02666560|833491|P1|NOT COMPLETED|Condition 2 (1 Day)||0
339609|NCT02666560|833490|P2|COMPLETED|Condition 2 (1 Day)||11
339610|NCT02666560|833491|P1|COMPLETED|Condition 2 (1 Day)||8
339611|NCT02666560|833490|P2|STARTED|Condition 2 (1 Day)||11
339612|NCT02666560|833491|P1|STARTED|Condition 2 (1 Day)||8
339613|NCT02666560|833490|P2|NOT COMPLETED|Condition 1 (1 Day)||0
339614|NCT02666560|833491|P1|NOT COMPLETED|Condition 1 (1 Day)||0
339615|NCT02666560|833490|P2|COMPLETED|Condition 1 (1 Day)||11
339616|NCT02666560|833491|P1|COMPLETED|Condition 1 (1 Day)||8
339617|NCT02666560|833490|P2|STARTED|Condition 1 (1 Day)||11
339618|NCT02666560|833491|P1|STARTED|Condition 1 (1 Day)||8
339619|NCT02666222|833507|P1|NOT COMPLETED|Overall Study||2
339620|NCT02666222|833507|P1|COMPLETED|Overall Study||49
339621|NCT02666222|833507|P1|STARTED|Overall Study||51
339622|NCT02665455|833515|P1|NOT COMPLETED|Overall Study||9
339623|NCT02665455|833515|P1|COMPLETED|Overall Study||74
339624|NCT02665455|833515|P1|STARTED|Overall Study||83
339625|NCT02665286|833522|P3|NOT COMPLETED|Overall Study||1
339626|NCT02665286|833523|P2|NOT COMPLETED|Overall Study||2
339627|NCT02665286|833524|P1|NOT COMPLETED|Overall Study||3
339628|NCT02665286|833522|P3|COMPLETED|Overall Study||80
339629|NCT02665286|833523|P2|COMPLETED|Overall Study||78
339630|NCT02665286|833524|P1|COMPLETED|Overall Study||76
339631|NCT02665286|833522|P3|STARTED|Overall Study||81
339632|NCT02665286|833523|P2|STARTED|Overall Study||80
339633|NCT02665286|833524|P1|STARTED|Overall Study||79
339634|NCT02665260|833545|P4|NOT COMPLETED|Overall Study||1
339635|NCT02665260|833546|P3|NOT COMPLETED|Overall Study||4
339636|NCT02665260|833547|P2|NOT COMPLETED|Overall Study||1
339637|NCT02665260|833548|P1|NOT COMPLETED|Overall Study||2
339638|NCT02665260|833545|P4|COMPLETED|Overall Study||21
339639|NCT02665260|833546|P3|COMPLETED|Overall Study||21
339640|NCT02665260|833547|P2|COMPLETED|Overall Study||22
339641|NCT02665260|833548|P1|COMPLETED|Overall Study||22
339642|NCT02665260|833545|P4|STARTED|Overall Study||22
339643|NCT02665260|833546|P3|STARTED|Overall Study||25
339644|NCT02665260|833547|P2|STARTED|Overall Study||23
339645|NCT02665260|833548|P1|STARTED|Overall Study||24
339646|NCT02665221|833564|P2|NOT COMPLETED|Overall Study||15
339647|NCT02665221|833565|P1|NOT COMPLETED|Overall Study||15
339648|NCT02665221|833564|P2|COMPLETED|Overall Study||0
339649|NCT02665221|833565|P1|COMPLETED|Overall Study||0
339650|NCT02665221|833564|P2|STARTED|Overall Study||15
339651|NCT02665221|833565|P1|STARTED|Overall Study||15
339652|NCT02664987|833577|P1|NOT COMPLETED|Overall Study||0
339653|NCT02664987|833577|P1|COMPLETED|Overall Study||462
339654|NCT02664987|833577|P1|STARTED|Overall Study||462
339655|NCT02664610|833588|P2|NOT COMPLETED|Overall Study||7
339656|NCT02664610|833589|P1|NOT COMPLETED|Overall Study||14
339657|NCT02664610|833588|P2|COMPLETED|Overall Study||41
339658|NCT02664610|833589|P1|COMPLETED|Overall Study||32
339659|NCT02664610|833588|P2|STARTED|Overall Study||48
339660|NCT02664610|833589|P1|STARTED|Overall Study||46
339661|NCT02664532|833599|P2|NOT COMPLETED|Overall Study||0
339662|NCT02664532|833600|P1|NOT COMPLETED|Overall Study||0
339663|NCT02664532|833599|P2|COMPLETED|Overall Study||75
339664|NCT02664532|833600|P1|COMPLETED|Overall Study||75
339665|NCT02664532|833599|P2|STARTED|Overall Study||75
339666|NCT02664532|833600|P1|STARTED|Overall Study||75
339667|NCT02664311|833614|P2|NOT COMPLETED|Overall Study||0
339668|NCT02664311|833615|P1|NOT COMPLETED|Overall Study||0
339669|NCT02664311|833614|P2|COMPLETED|Overall Study||3
339670|NCT02664311|833615|P1|COMPLETED|Overall Study||6
339671|NCT02664311|833614|P2|STARTED|Overall Study||3
339672|NCT02664311|833615|P1|STARTED|Overall Study||6
339673|NCT02663453|833627|P2|NOT COMPLETED|Overall Study||4
339674|NCT02663453|833628|P1|NOT COMPLETED|Overall Study||5
339675|NCT02663453|833627|P2|COMPLETED|Overall Study||18
339676|NCT02663453|833628|P1|COMPLETED|Overall Study||17
339677|NCT02663453|833627|P2|STARTED|Overall Study||22
339678|NCT02663453|833628|P1|STARTED|Overall Study||22
339679|NCT02663232|833650|P1|NOT COMPLETED|Overall Study||0
339680|NCT02663232|833650|P1|COMPLETED|Overall Study||264
339681|NCT02663232|833650|P1|STARTED|Overall Study||264
339682|NCT02662608|833671|P1|NOT COMPLETED|Overall Study||0
339683|NCT02662608|833671|P1|COMPLETED|Overall Study||1
339684|NCT02662608|833671|P1|STARTED|Overall Study||1
339685|NCT02662556|833675|P1|NOT COMPLETED|Overall Study||8
339686|NCT02662556|833675|P1|COMPLETED|Overall Study||132
339687|NCT02662556|833675|P1|STARTED|Overall Study||140
339688|NCT02662387|833684|P2|NOT COMPLETED|Overall Study||0
339689|NCT02662387|833685|P1|NOT COMPLETED|Overall Study||0
339690|NCT02662387|833684|P2|COMPLETED|Overall Study||28
339691|NCT02662387|833685|P1|COMPLETED|Overall Study||27
339692|NCT02662387|833684|P2|STARTED|Overall Study||28
339693|NCT02662387|833685|P1|STARTED|Overall Study||27
339694|NCT02661594|833697|P4|NOT COMPLETED|Overall Study||0
339695|NCT02661594|833698|P3|NOT COMPLETED|Overall Study||1
339696|NCT02661594|833699|P2|NOT COMPLETED|Overall Study||0
339697|NCT02661594|833700|P1|NOT COMPLETED|Overall Study||1
339698|NCT02661594|833697|P4|COMPLETED|Overall Study||9
339699|NCT02661594|833698|P3|COMPLETED|Overall Study||9
339700|NCT02661594|833699|P2|COMPLETED|Overall Study||11
339701|NCT02661594|833700|P1|COMPLETED|Overall Study||9
339702|NCT02661594|833697|P4|STARTED|Overall Study||9
339703|NCT02661594|833698|P3|STARTED|Overall Study||10
339704|NCT02661594|833699|P2|STARTED|Overall Study||11
339705|NCT02661594|833700|P1|STARTED|Overall Study||10
339706|NCT02658461|833713|P3|NOT COMPLETED|Overall Study||0
339707|NCT02658461|833714|P2|NOT COMPLETED|Overall Study||0
339708|NCT02658461|833715|P1|NOT COMPLETED|Overall Study||0
339709|NCT02658461|833713|P3|COMPLETED|Overall Study||12
339710|NCT02658461|833714|P2|COMPLETED|Overall Study||12
339711|NCT02658461|833715|P1|COMPLETED|Overall Study||12
339712|NCT02658461|833713|P3|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
339713|NCT02658461|833714|P2|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
339714|NCT02658461|833715|P1|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
339715|NCT02658149|833743|P2|NOT COMPLETED|Overall Study||0
339716|NCT02658149|833744|P1|NOT COMPLETED|Overall Study||1
339717|NCT02658149|833743|P2|COMPLETED|Overall Study||50
339718|NCT02658149|833744|P1|COMPLETED|Overall Study||49
339719|NCT02658149|833743|P2|STARTED|Overall Study||50
339720|NCT02658149|833744|P1|STARTED|Overall Study||50
339721|NCT02657629|833760|P2|NOT COMPLETED|Overall Study||0
339722|NCT02657629|833761|P1|NOT COMPLETED|Overall Study||2
339723|NCT02657629|833760|P2|COMPLETED|Overall Study||14
339724|NCT02657629|833761|P1|COMPLETED|Overall Study||12
339725|NCT02657629|833760|P2|STARTED|Overall Study||14
339726|NCT02657629|833761|P1|STARTED|Overall Study||14
339727|NCT02657538|833767|P1|NOT COMPLETED|Overall Study||4
339728|NCT02657538|833767|P1|COMPLETED|Overall Study||31
339729|NCT02657538|833767|P1|Received Visual Caries Detection + Bite|Overall Study||35
339730|NCT02657538|833767|P1|Received Near Infrared Transillumination|Overall Study||35
339731|NCT02657538|833767|P1|STARTED|Overall Study||35
339732|NCT02657252|833776|P2|NOT COMPLETED|Overall Study||7
339733|NCT02657252|833777|P1|NOT COMPLETED|Overall Study||10
339734|NCT02657252|833776|P2|COMPLETED|Overall Study||51
339735|NCT02657252|833777|P1|COMPLETED|Overall Study||47
339736|NCT02657252|833776|P2|STARTED|Overall Study||58
339737|NCT02657252|833777|P1|STARTED|Overall Study||57
339738|NCT02657031|833789|P2|NOT COMPLETED|Overall Study||2
339739|NCT02657031|833790|P1|NOT COMPLETED|Overall Study||1
339740|NCT02657031|833789|P2|COMPLETED|Overall Study||23
339741|NCT02657031|833790|P1|COMPLETED|Overall Study||28
339742|NCT02657031|833789|P2|STARTED|Overall Study||25
339743|NCT02657031|833790|P1|STARTED|Overall Study||29
339744|NCT02656485|833808|P4|NOT COMPLETED|Overall Study||2
339745|NCT02656485|833809|P3|NOT COMPLETED|Overall Study||2
339746|NCT02656485|833810|P2|NOT COMPLETED|Overall Study||3
339747|NCT02656485|833811|P1|NOT COMPLETED|Overall Study||2
339748|NCT02656485|833808|P4|COMPLETED|Overall Study||7
339749|NCT02656485|833809|P3|COMPLETED|Overall Study||7
339750|NCT02656485|833810|P2|COMPLETED|Overall Study||6
339751|NCT02656485|833811|P1|COMPLETED|Overall Study||7
339752|NCT02656485|833808|P4|STARTED|Overall Study||9
339753|NCT02656485|833809|P3|STARTED|Overall Study||9
339754|NCT02656485|833810|P2|STARTED|Overall Study||9
339755|NCT02656485|833811|P1|STARTED|Overall Study||9
339756|NCT02656160|833823|P2|NOT COMPLETED|Second Study Night||0
339757|NCT02656160|833824|P1|NOT COMPLETED|Second Study Night||0
339758|NCT02656160|833823|P2|COMPLETED|Second Study Night||6
339759|NCT02656160|833824|P1|COMPLETED|Second Study Night||4
339760|NCT02656160|833823|P2|STARTED|Second Study Night||6
339761|NCT02656160|833824|P1|STARTED|Second Study Night|3 subjects did not return for the second study night|4
339762|NCT02656160|833823|P2|NOT COMPLETED|First Study Night||0
339763|NCT02656160|833824|P1|NOT COMPLETED|First Study Night||0
339764|NCT02656160|833823|P2|COMPLETED|First Study Night||6
339765|NCT02656160|833824|P1|COMPLETED|First Study Night||7
339766|NCT02656160|833823|P2|STARTED|First Study Night||6
339767|NCT02656160|833824|P1|STARTED|First Study Night||7
339768|NCT02654145|833832|P1|NOT COMPLETED|Overall Study||7
339769|NCT02654145|833832|P1|COMPLETED|Overall Study||138
339770|NCT02654145|833832|P1|STARTED|Overall Study||145
339771|NCT02653872|833839|P1|NOT COMPLETED|Overall Study||0
339772|NCT02653872|833839|P1|COMPLETED|Overall Study||15
339773|NCT02653872|833839|P1|Treatment Period 3:|Overall Study|Participants received: itraconazole 200 mg + AZD7986.|15
339774|NCT02653872|833839|P1|Treatment Period 2:|Overall Study|Participants received Verapamil (240 mg; extended release formulation) + AZD7986 (25 mg).|15
339775|NCT02653872|833839|P1|Treatment Period 1:|Overall Study|Participants received single AZD7986 (25 mg).|15
339776|NCT02653872|833839|P1|STARTED|Overall Study||15
339777|NCT02653560|833874|P4|NOT COMPLETED|Placebo Phase||0
339778|NCT02653560|833875|P3|NOT COMPLETED|Placebo Phase||0
339779|NCT02653560|833876|P2|NOT COMPLETED|Placebo Phase||0
339780|NCT02653560|833877|P1|NOT COMPLETED|Placebo Phase||0
339781|NCT02653560|833874|P4|COMPLETED|Placebo Phase||30
339782|NCT02653560|833875|P3|COMPLETED|Placebo Phase||0
339783|NCT02653560|833876|P2|COMPLETED|Placebo Phase||0
339784|NCT02653560|833877|P1|COMPLETED|Placebo Phase||0
339785|NCT02653560|833874|P4|STARTED|Placebo Phase||30
339786|NCT02653560|833875|P3|STARTED|Placebo Phase||0
339787|NCT02653560|833876|P2|STARTED|Placebo Phase||0
339788|NCT02653560|833877|P1|STARTED|Placebo Phase||0
339789|NCT02653560|833874|P4|NOT COMPLETED|KCl Phase||0
339790|NCT02653560|833875|P3|NOT COMPLETED|KCl Phase||0
339791|NCT02653560|833876|P2|NOT COMPLETED|KCl Phase||0
339792|NCT02653560|833877|P1|NOT COMPLETED|KCl Phase||0
339793|NCT02653560|833874|P4|COMPLETED|KCl Phase||0
339794|NCT02653560|833875|P3|COMPLETED|KCl Phase||30
339795|NCT02653560|833876|P2|COMPLETED|KCl Phase||0
339796|NCT02653560|833877|P1|COMPLETED|KCl Phase||0
339797|NCT02653560|833874|P4|STARTED|KCl Phase||0
339798|NCT02653560|833875|P3|STARTED|KCl Phase||30
339799|NCT02653560|833876|P2|STARTED|KCl Phase||0
339800|NCT02653560|833877|P1|STARTED|KCl Phase||0
339801|NCT02653560|833874|P4|NOT COMPLETED|K Citrate Phase||0
339802|NCT02653560|833875|P3|NOT COMPLETED|K Citrate Phase||0
339803|NCT02653560|833876|P2|NOT COMPLETED|K Citrate Phase||0
339804|NCT02653560|833877|P1|NOT COMPLETED|K Citrate Phase||0
339805|NCT02653560|833874|P4|COMPLETED|K Citrate Phase||0
339806|NCT02653560|833875|P3|COMPLETED|K Citrate Phase||0
339807|NCT02653560|833876|P2|COMPLETED|K Citrate Phase||30
339808|NCT02653560|833877|P1|COMPLETED|K Citrate Phase||0
339809|NCT02653560|833874|P4|STARTED|K Citrate Phase||0
339810|NCT02653560|833875|P3|STARTED|K Citrate Phase||0
339811|NCT02653560|833876|P2|STARTED|K Citrate Phase||30
339812|NCT02653560|833877|P1|STARTED|K Citrate Phase||0
339813|NCT02653560|833874|P4|NOT COMPLETED|KMgCit Phase||0
339814|NCT02653560|833875|P3|NOT COMPLETED|KMgCit Phase||0
339815|NCT02653560|833876|P2|NOT COMPLETED|KMgCit Phase||0
339816|NCT02653560|833877|P1|NOT COMPLETED|KMgCit Phase||0
339817|NCT02653560|833874|P4|COMPLETED|KMgCit Phase||0
339818|NCT02653560|833875|P3|COMPLETED|KMgCit Phase||0
339819|NCT02653560|833876|P2|COMPLETED|KMgCit Phase||0
339820|NCT02653560|833877|P1|COMPLETED|KMgCit Phase||30
339821|NCT02653560|833874|P4|STARTED|KMgCit Phase||0
339822|NCT02653560|833875|P3|STARTED|KMgCit Phase||0
339823|NCT02653560|833876|P2|STARTED|KMgCit Phase||0
339824|NCT02653560|833877|P1|STARTED|KMgCit Phase||30
339825|NCT02653495|833889|P2|NOT COMPLETED|Overall Study||0
339826|NCT02653495|833890|P1|NOT COMPLETED|Overall Study||12
339827|NCT02653495|833889|P2|COMPLETED|Overall Study||2
339828|NCT02653495|833890|P1|COMPLETED|Overall Study||3
339829|NCT02653495|833889|P2|STARTED|Overall Study||2
339830|NCT02653495|833890|P1|STARTED|Overall Study||15
339831|NCT02652221|833904|P1|NOT COMPLETED|Overall Study||0
339832|NCT02652221|833904|P1|COMPLETED|Overall Study||55
339833|NCT02652221|833904|P1|STARTED|Overall Study||55
339834|NCT02652208|833913|P2|NOT COMPLETED|Overall Study||2
339835|NCT02652208|833914|P1|NOT COMPLETED|Overall Study||4
339836|NCT02652208|833913|P2|COMPLETED|Overall Study||15
339837|NCT02652208|833914|P1|COMPLETED|Overall Study||13
339838|NCT02652208|833913|P2|STARTED|Overall Study||17
339839|NCT02652208|833914|P1|STARTED|Overall Study||17
339840|NCT02651922|833924|P1|NOT COMPLETED|Overall Study||2
339841|NCT02651922|833924|P1|COMPLETED|Overall Study||154
339842|NCT02651922|833924|P1|STARTED|Overall Study||156
339843|NCT02651467|833944|P3|NOT COMPLETED|Overall Study||4
339844|NCT02651467|833945|P2|NOT COMPLETED|Overall Study||0
339845|NCT02651467|833946|P1|NOT COMPLETED|Overall Study||1
339846|NCT02651467|833944|P3|COMPLETED|Overall Study||69
339847|NCT02651467|833945|P2|COMPLETED|Overall Study||74
339848|NCT02651467|833946|P1|COMPLETED|Overall Study||73
339849|NCT02651467|833944|P3|STARTED|Overall Study||73
339850|NCT02651467|833945|P2|STARTED|Overall Study||74
339851|NCT02651467|833946|P1|STARTED|Overall Study||74
339852|NCT02651194|833965|P1|NOT COMPLETED|Overall Study||5
339853|NCT02651194|833965|P1|COMPLETED|Overall Study||99
339854|NCT02651194|833965|P1|STARTED|Overall Study||104
339855|NCT02650440|833973|P2|NOT COMPLETED|Overall Study||2
339856|NCT02650440|833974|P1|NOT COMPLETED|Overall Study||0
339857|NCT02650440|833973|P2|COMPLETED|Overall Study||8
339858|NCT02650440|833974|P1|COMPLETED|Overall Study||10
339859|NCT02650440|833973|P2|STARTED|Overall Study||10
339860|NCT02650440|833974|P1|STARTED|Overall Study||10
339861|NCT02650219|833992|P2|NOT COMPLETED|Overall Study||0
339862|NCT02650219|833993|P1|NOT COMPLETED|Overall Study||0
339863|NCT02650219|833992|P2|COMPLETED|Overall Study||20
339864|NCT02650219|833993|P1|COMPLETED|Overall Study||40
339865|NCT02650219|833992|P2|STARTED|Overall Study||20
339866|NCT02650219|833993|P1|STARTED|Overall Study||40
339867|NCT02649634|834005|P2|NOT COMPLETED|Overall Study||6
339868|NCT02649634|834006|P1|NOT COMPLETED|Overall Study||3
339869|NCT02649634|834005|P2|COMPLETED|Overall Study||60
339870|NCT02649634|834006|P1|COMPLETED|Overall Study||66
339871|NCT02649634|834005|P2|STARTED|Overall Study||66
339872|NCT02649634|834006|P1|STARTED|Overall Study||69
339873|NCT02648438|834065|P3|NOT COMPLETED|Overall Study||0
339874|NCT02648438|834066|P2|NOT COMPLETED|Overall Study||3
339875|NCT02648438|834067|P1|NOT COMPLETED|Overall Study||3
339876|NCT02648438|834065|P3|COMPLETED|Overall Study||6
339877|NCT02648438|834066|P2|COMPLETED|Overall Study||9
339878|NCT02648438|834067|P1|COMPLETED|Overall Study||9
339879|NCT02648438|834065|P3|STARTED|Overall Study||6
339880|NCT02648438|834066|P2|STARTED|Overall Study||12
339881|NCT02648438|834067|P1|STARTED|Overall Study||12
339882|NCT02648204|834111|P4|NOT COMPLETED|Overall Study||16
339883|NCT02648204|834112|P3|NOT COMPLETED|Overall Study||13
339884|NCT02648204|834113|P2|NOT COMPLETED|Overall Study||21
339885|NCT02648204|834114|P1|NOT COMPLETED|Overall Study||22
339886|NCT02648204|834111|P4|COMPLETED|Overall Study||284
339887|NCT02648204|834112|P3|COMPLETED|Overall Study||287
339888|NCT02648204|834113|P2|COMPLETED|Overall Study||279
339889|NCT02648204|834114|P1|COMPLETED|Overall Study||279
339890|NCT02648204|834111|P4|Exposed|Overall Study||299
339891|NCT02648204|834112|P3|Exposed|Overall Study||299
339892|NCT02648204|834113|P2|Exposed|Overall Study||300
339893|NCT02648204|834114|P1|Exposed|Overall Study||301
339894|NCT02648204|834111|P4|STARTED|Overall Study||300
339895|NCT02648204|834112|P3|STARTED|Overall Study||300
339896|NCT02648204|834113|P2|STARTED|Overall Study||300
339897|NCT02648204|834114|P1|STARTED|Overall Study||301
339898|NCT02648022|834234|P2|NOT COMPLETED|Overall Study||0
339899|NCT02648022|834235|P1|NOT COMPLETED|Overall Study||0
339900|NCT02648022|834234|P2|COMPLETED|Overall Study||39
339901|NCT02648022|834235|P1|COMPLETED|Overall Study||40
339902|NCT02648022|834234|P2|STARTED|Overall Study||39
339903|NCT02648022|834235|P1|STARTED|Overall Study||40
339904|NCT02647944|834247|P2|NOT COMPLETED|Overall Study||3
339905|NCT02647944|834248|P1|NOT COMPLETED|Overall Study||2
339906|NCT02647944|834247|P2|COMPLETED|Overall Study||18
339907|NCT02647944|834248|P1|COMPLETED|Overall Study||17
339908|NCT02647944|834247|P2|STARTED|Overall Study||21
339909|NCT02647944|834248|P1|STARTED|Overall Study||19
339910|NCT02647905|834272|P1|NOT COMPLETED|Overall Study||3
339911|NCT02647905|834272|P1|COMPLETED|Overall Study||87
339912|NCT02647905|834272|P1|STARTED|Overall Study||90
339913|NCT02647320|834282|P5|NOT COMPLETED|Overall Study||17
339914|NCT02647320|834283|P4|NOT COMPLETED|Overall Study||10
339915|NCT02647320|834284|P3|NOT COMPLETED|Overall Study||15
339916|NCT02647320|834285|P2|NOT COMPLETED|Overall Study||11
339917|NCT02647320|834286|P1|NOT COMPLETED|Overall Study||12
339918|NCT02647320|834282|P5|COMPLETED|Overall Study||52
339919|NCT02647320|834283|P4|COMPLETED|Overall Study||58
339920|NCT02647320|834284|P3|COMPLETED|Overall Study||54
339921|NCT02647320|834285|P2|COMPLETED|Overall Study||35
339922|NCT02647320|834286|P1|COMPLETED|Overall Study||34
339923|NCT02647320|834282|P5|Modified Intent-to-Treat Set (mITT)|Overall Study||62
339924|NCT02647320|834283|P4|Modified Intent-to-Treat Set (mITT)|Overall Study||62
339925|NCT02647320|834284|P3|Modified Intent-to-Treat Set (mITT)|Overall Study||61
339926|NCT02647320|834285|P2|Modified Intent-to-Treat Set (mITT)|Overall Study||38
339927|NCT02647320|834286|P1|Modified Intent-to-Treat Set (mITT)|Overall Study||40
339928|NCT02647320|834282|P5|Safety Set|Overall Study||69
339929|NCT02647320|834283|P4|Safety Set|Overall Study||68
339930|NCT02647320|834284|P3|Safety Set|Overall Study||68
339931|NCT02647320|834285|P2|Safety Set|Overall Study||44
339932|NCT02647320|834286|P1|Safety Set|Overall Study||43
339933|NCT02647320|834282|P5|Inadvertently Randomized|Overall Study||0
339934|NCT02647320|834283|P4|Inadvertently Randomized|Overall Study||1
339935|NCT02647320|834284|P3|Inadvertently Randomized|Overall Study||0
339936|NCT02647320|834285|P2|Inadvertently Randomized|Overall Study||0
339937|NCT02647320|834286|P1|Inadvertently Randomized|Overall Study||0
339938|NCT02647320|834282|P5|STARTED|Overall Study||69
339939|NCT02647320|834283|P4|STARTED|Overall Study||68
339940|NCT02647320|834284|P3|STARTED|Overall Study||69
339941|NCT02647320|834285|P2|STARTED|Overall Study||46
339942|NCT02647320|834286|P1|STARTED|Overall Study||46
339943|NCT02646449|834370|P2|NOT COMPLETED|Overall Study||0
339944|NCT02646449|834371|P1|NOT COMPLETED|Overall Study||0
339945|NCT02646449|834370|P2|COMPLETED|Overall Study||3
339946|NCT02646449|834371|P1|COMPLETED|Overall Study||4
339947|NCT02646449|834370|P2|STARTED|Overall Study||3
339948|NCT02646449|834371|P1|STARTED|Overall Study||4
339949|NCT02645760|834381|P2|NOT COMPLETED|Overall Study||0
339950|NCT02645760|834382|P1|NOT COMPLETED|Overall Study||0
339951|NCT02645760|834381|P2|COMPLETED|Overall Study||19
339952|NCT02645760|834382|P1|COMPLETED|Overall Study||19
339953|NCT02645760|834381|P2|STARTED|Overall Study||19
339954|NCT02645760|834382|P1|STARTED|Overall Study||19
339955|NCT02645253|834398|P4|NOT COMPLETED|Overall Study||0
339956|NCT02645253|834399|P3|NOT COMPLETED|Overall Study||0
339957|NCT02645253|834400|P2|NOT COMPLETED|Overall Study||0
339958|NCT02645253|834401|P1|NOT COMPLETED|Overall Study||0
339959|NCT02645253|834398|P4|COMPLETED|Overall Study||6
339960|NCT02645253|834399|P3|COMPLETED|Overall Study||7
339961|NCT02645253|834400|P2|COMPLETED|Overall Study||7
339962|NCT02645253|834401|P1|COMPLETED|Overall Study||7
339963|NCT02645253|834398|P4|STARTED|Overall Study||6
339964|NCT02645253|834399|P3|STARTED|Overall Study||7
339965|NCT02645253|834400|P2|STARTED|Overall Study||7
339966|NCT02645253|834401|P1|STARTED|Overall Study||7
339967|NCT02645123|834523|P3|NOT COMPLETED|Overall Study||0
339968|NCT02645123|834524|P2|NOT COMPLETED|Overall Study||0
339969|NCT02645123|834525|P1|NOT COMPLETED|Overall Study||0
339970|NCT02645123|834523|P3|COMPLETED|Overall Study||25
339971|NCT02645123|834524|P2|COMPLETED|Overall Study||25
339972|NCT02645123|834525|P1|COMPLETED|Overall Study||25
339973|NCT02645123|834523|P3|STARTED|Overall Study||25
339974|NCT02645123|834524|P2|STARTED|Overall Study||25
339975|NCT02645123|834525|P1|STARTED|Overall Study||25
339976|NCT02644356|834542|P1|NOT COMPLETED|Overall Study||2
339977|NCT02644356|834542|P1|COMPLETED|Overall Study|49 of the 51 consented subjects completed pre-post knowledge testing (96%)|49
339978|NCT02644356|834542|P1|STARTED|Overall Study||51
339979|NCT02644122|834552|P1|NOT COMPLETED|Overall Study||1
339980|NCT02644122|834552|P1|COMPLETED|Overall Study||0
339981|NCT02644122|834552|P1|STARTED|Overall Study||1
339982|NCT02644109|834562|P2|NOT COMPLETED|Overall Study||4
339983|NCT02644109|834563|P1|NOT COMPLETED|Overall Study||0
339984|NCT02644109|834562|P2|COMPLETED|Overall Study||24
339985|NCT02644109|834563|P1|COMPLETED|Overall Study||24
339986|NCT02644109|834562|P2|STARTED|Overall Study||28
339987|NCT02644109|834563|P1|STARTED|Overall Study||24
339988|NCT02644096|834571|P2|NOT COMPLETED|Overall Study||25
339989|NCT02644096|834572|P1|NOT COMPLETED|Overall Study||28
339990|NCT02644096|834571|P2|COMPLETED|Overall Study||57
339991|NCT02644096|834572|P1|COMPLETED|Overall Study||65
339992|NCT02644096|834571|P2|9 Month SF-36 Questionnaire|Overall Study||57
339993|NCT02644096|834572|P1|9 Month SF-36 Questionnaire|Overall Study||65
339994|NCT02644096|834571|P2|12 Week SF-36 Questionnaire|Overall Study||59
339995|NCT02644096|834572|P1|12 Week SF-36 Questionnaire|Overall Study||68
339996|NCT02644096|834571|P2|10 Week Interview|Overall Study||59
339997|NCT02644096|834572|P1|10 Week Interview|Overall Study|Not done in control group|0
339998|NCT02644096|834571|P2|2 Week Interview|Overall Study||68
339999|NCT02644096|834572|P1|2 Week Interview|Overall Study|Not done in control group|0
340000|NCT02644096|834571|P2|STARTED|Overall Study||82
340001|NCT02644096|834572|P1|STARTED|Overall Study||93
340002|NCT02643862|834580|P2|NOT COMPLETED|Overall Study||0
340003|NCT02643862|834581|P1|NOT COMPLETED|Overall Study||0
340004|NCT02643862|834580|P2|COMPLETED|Overall Study||12
340005|NCT02643862|834581|P1|COMPLETED|Overall Study||36
340006|NCT02643862|834580|P2|STARTED|Overall Study||12
340007|NCT02643862|834581|P1|STARTED|Overall Study||36
340008|NCT02643615|834591|P2|NOT COMPLETED|Overall Study||0
340009|NCT02643615|834592|P1|NOT COMPLETED|Overall Study||0
340010|NCT02643615|834591|P2|COMPLETED|Overall Study||11
340011|NCT02643615|834592|P1|COMPLETED|Overall Study||9
340012|NCT02643615|834591|P2|STARTED|Overall Study||11
340013|NCT02643615|834592|P1|STARTED|Overall Study||9
340014|NCT02643394|834606|P2|NOT COMPLETED|Overall Study||5
340015|NCT02643394|834607|P1|NOT COMPLETED|Overall Study||4
340016|NCT02643394|834606|P2|COMPLETED|Overall Study||50
340017|NCT02643394|834607|P1|COMPLETED|Overall Study||51
340018|NCT02643394|834606|P2|STARTED|Overall Study||55
340019|NCT02643394|834607|P1|STARTED|Overall Study||55
340020|NCT02643251|834617|P2|NOT COMPLETED|Overall Study||2
340021|NCT02643251|834618|P1|NOT COMPLETED|Overall Study||11
340022|NCT02643251|834617|P2|COMPLETED|Overall Study||67
340023|NCT02643251|834618|P1|COMPLETED|Overall Study||58
340024|NCT02643251|834617|P2|STARTED|Overall Study||69
340025|NCT02643251|834618|P1|STARTED|Overall Study||69
340026|NCT02643225|834628|P2|NOT COMPLETED|Overall Study||0
340027|NCT02643225|834629|P1|NOT COMPLETED|Overall Study||0
340028|NCT02643225|834628|P2|COMPLETED|Overall Study||40
340029|NCT02643225|834629|P1|COMPLETED|Overall Study||40
340030|NCT02643225|834628|P2|STARTED|Overall Study||40
340031|NCT02643225|834629|P1|STARTED|Overall Study||40
340032|NCT02643199|834641|P1|NOT COMPLETED|Overall Study||0
340033|NCT02643199|834641|P1|COMPLETED|Overall Study||90
340034|NCT02643199|834641|P1|STARTED|Overall Study||90
340035|NCT02643004|834646|P2|NOT COMPLETED|Second Intervention (One Week)||0
340036|NCT02643004|834647|P1|NOT COMPLETED|Second Intervention (One Week)||0
340037|NCT02643004|834646|P2|COMPLETED|Second Intervention (One Week)||35
340038|NCT02643004|834647|P1|COMPLETED|Second Intervention (One Week)||35
340039|NCT02643004|834646|P2|STARTED|Second Intervention (One Week)||35
340040|NCT02643004|834647|P1|STARTED|Second Intervention (One Week)||35
340041|NCT02643004|834646|P2|NOT COMPLETED|First Intervention (One Week)||0
340042|NCT02643004|834647|P1|NOT COMPLETED|First Intervention (One Week)||0
340043|NCT02643004|834646|P2|COMPLETED|First Intervention (One Week)||35
340044|NCT02643004|834647|P1|COMPLETED|First Intervention (One Week)||35
340045|NCT02643004|834646|P2|STARTED|First Intervention (One Week)||35
340046|NCT02643004|834647|P1|STARTED|First Intervention (One Week)||35
340047|NCT02642835|834687|P1|NOT COMPLETED|Overall Study||0
340048|NCT02642835|834687|P1|COMPLETED|Overall Study||48
340049|NCT02642835|834687|P1|STARTED|Overall Study||48
340050|NCT02642679|834700|P1|NOT COMPLETED|Overall Study||3
340051|NCT02642679|834700|P1|COMPLETED|Overall Study||16
340052|NCT02642679|834700|P1|STARTED|Overall Study||19
340053|NCT02642575|834706|P1|NOT COMPLETED|Overall Study||0
340054|NCT02642575|834706|P1|COMPLETED|Overall Study||67
340055|NCT02642575|834706|P1|STARTED|Overall Study||67
340056|NCT02642536|834714|P2|NOT COMPLETED|Overall Study||5
340057|NCT02642536|834715|P1|NOT COMPLETED|Overall Study||2
340058|NCT02642536|834714|P2|COMPLETED|Overall Study||18
340059|NCT02642536|834715|P1|COMPLETED|Overall Study||19
340060|NCT02642536|834714|P2|STARTED|Overall Study||23
340061|NCT02642536|834715|P1|STARTED|Overall Study||21
340062|NCT02642432|834741|P1|NOT COMPLETED|Overall Study||8
340063|NCT02642432|834741|P1|COMPLETED|Overall Study||138
340064|NCT02642432|834741|P1|STARTED|Overall Study||146
340065|NCT02642159|834749|P2|NOT COMPLETED|Overall Study||8
340066|NCT02642159|834750|P1|NOT COMPLETED|Overall Study||31
340067|NCT02642159|834749|P2|COMPLETED|Overall Study||129
340068|NCT02642159|834750|P1|COMPLETED|Overall Study||245
340069|NCT02642159|834749|P2|ITT: Intent to Prescribe Fenofibrate|Overall Study||24
340070|NCT02642159|834750|P1|ITT: Intent to Prescribe Fenofibrate|Overall Study|Fenofibrate was only ‘intended to prescribe’ in the Alirocumab arm but not actually administered.|47
340071|NCT02642159|834749|P2|ITT Population|Overall Study||136
340072|NCT02642159|834750|P1|ITT Population|Overall Study||273
340073|NCT02642159|834749|P2|Treated (Safety Population)|Overall Study||137
340074|NCT02642159|834750|P1|Treated (Safety Population)|Overall Study||275
340075|NCT02642159|834749|P2|STARTED|Overall Study|Randomized|137
340076|NCT02642159|834750|P1|STARTED|Overall Study|Randomized|276
340077|NCT02641912|834802|P2|NOT COMPLETED|Overall Study||0
340078|NCT02641912|834803|P1|NOT COMPLETED|Overall Study||0
340079|NCT02641912|834802|P2|COMPLETED|Overall Study||47
340080|NCT02641912|834803|P1|COMPLETED|Overall Study||53
340081|NCT02641912|834802|P2|STARTED|Overall Study||47
340082|NCT02641912|834803|P1|STARTED|Overall Study||53
340083|NCT02641561|834875|P4|NOT COMPLETED|Overall Study||0
340084|NCT02641561|834876|P3|NOT COMPLETED|Overall Study||0
340085|NCT02641561|834877|P2|NOT COMPLETED|Overall Study||0
340086|NCT02641561|834878|P1|NOT COMPLETED|Overall Study||0
340087|NCT02641561|834875|P4|COMPLETED|Overall Study||48
340088|NCT02641561|834876|P3|COMPLETED|Overall Study||48
340089|NCT02641561|834877|P2|COMPLETED|Overall Study||48
340090|NCT02641561|834878|P1|COMPLETED|Overall Study||48
340091|NCT02641561|834875|P4|STARTED|Overall Study||48
340092|NCT02641561|834876|P3|STARTED|Overall Study||48
340093|NCT02641561|834877|P2|STARTED|Overall Study||48
340094|NCT02641561|834878|P1|STARTED|Overall Study||48
340095|NCT02641379|834975|P11|NOT COMPLETED|Overall Study||8
340096|NCT02641379|834976|P10|NOT COMPLETED|Overall Study||9
340097|NCT02641379|834977|P9|NOT COMPLETED|Overall Study||6
340098|NCT02641379|834978|P8|NOT COMPLETED|Overall Study||19
340099|NCT02641379|834979|P7|NOT COMPLETED|Overall Study||13
340100|NCT02641379|834980|P6|NOT COMPLETED|Overall Study||16
340101|NCT02641379|834981|P5|NOT COMPLETED|Overall Study||17
340102|NCT02641379|834982|P4|NOT COMPLETED|Overall Study||17
340103|NCT02641379|834983|P3|NOT COMPLETED|Overall Study||71
340104|NCT02641379|834984|P2|NOT COMPLETED|Overall Study||51
340105|NCT02641379|834985|P1|NOT COMPLETED|Overall Study||35
340106|NCT02641379|834975|P11|COMPLETED|Overall Study||0
340107|NCT02641379|834976|P10|COMPLETED|Overall Study||36
340108|NCT02641379|834977|P9|COMPLETED|Overall Study||36
340109|NCT02641379|834978|P8|COMPLETED|Overall Study||1
340110|NCT02641379|834979|P7|COMPLETED|Overall Study||12
340111|NCT02641379|834980|P6|COMPLETED|Overall Study||20
340112|NCT02641379|834981|P5|COMPLETED|Overall Study||0
340113|NCT02641379|834982|P4|COMPLETED|Overall Study||139
340114|NCT02641379|834983|P3|COMPLETED|Overall Study||7
340115|NCT02641379|834984|P2|COMPLETED|Overall Study||101
340116|NCT02641379|834985|P1|COMPLETED|Overall Study||107
340117|NCT02641379|834975|P11|STARTED|Overall Study||8
340118|NCT02641379|834976|P10|STARTED|Overall Study||45
340119|NCT02641379|834977|P9|STARTED|Overall Study||42
340120|NCT02641379|834978|P8|STARTED|Overall Study||20
340121|NCT02641379|834979|P7|STARTED|Overall Study||25
340122|NCT02641379|834980|P6|STARTED|Overall Study||36
340123|NCT02641379|834981|P5|STARTED|Overall Study||17
340124|NCT02641379|834982|P4|STARTED|Overall Study||156
340125|NCT02641379|834983|P3|STARTED|Overall Study||78
340126|NCT02641379|834984|P2|STARTED|Overall Study||152
340127|NCT02641379|834985|P1|STARTED|Overall Study||142
340128|NCT02641249|835050|P1|NOT COMPLETED|Overall Study||4
340129|NCT02641249|835050|P1|COMPLETED|Overall Study||15
340130|NCT02641249|835050|P1|STARTED|Overall Study||19
340131|NCT02640482|835061|P2|NOT COMPLETED|Overall Study||0
340132|NCT02640482|835062|P1|NOT COMPLETED|Overall Study||3
340133|NCT02640482|835061|P2|COMPLETED|Overall Study||100
340134|NCT02640482|835062|P1|COMPLETED|Overall Study||199
340135|NCT02640482|835061|P2|STARTED|Overall Study||100
340136|NCT02640482|835062|P1|STARTED|Overall Study||202
340137|NCT02640404|835074|P2|NOT COMPLETED|Overall Study||0
340138|NCT02640404|835075|P1|NOT COMPLETED|Overall Study||2
340139|NCT02640404|835074|P2|COMPLETED|Overall Study||112
340140|NCT02640404|835075|P1|COMPLETED|Overall Study||110
340141|NCT02640404|835074|P2|STARTED|Overall Study||112
340142|NCT02640404|835075|P1|STARTED|Overall Study||112
340143|NCT02640157|835086|P3|NOT COMPLETED|Overall Study||10
340144|NCT02640157|835087|P2|NOT COMPLETED|Overall Study||5
340145|NCT02640157|835088|P1|NOT COMPLETED|Overall Study||13
340146|NCT02640157|835086|P3|COMPLETED|Overall Study||147
340147|NCT02640157|835087|P2|COMPLETED|Overall Study||111
340148|NCT02640157|835088|P1|COMPLETED|Overall Study||220
340149|NCT02640157|835086|P3|Discontinued Study Drug|Overall Study||3
340150|NCT02640157|835087|P2|Discontinued Study Drug|Overall Study||3
340151|NCT02640157|835088|P1|Discontinued Study Drug|Overall Study||8
340152|NCT02640157|835086|P3|Completed Study Drug|Overall Study||154
340153|NCT02640157|835087|P2|Completed Study Drug|Overall Study||112
340154|NCT02640157|835088|P1|Completed Study Drug|Overall Study||225
340155|NCT02640157|835086|P3|Received Study Drug|Overall Study||157
340156|NCT02640157|835087|P2|Received Study Drug|Overall Study|One participant in Arm B was randomized in error and never dispensed study drug.|115
340157|NCT02640157|835088|P1|Received Study Drug|Overall Study||233
340158|NCT02640157|835086|P3|STARTED|Overall Study|Intent-to-treat population: all participants who received at least 1 dose of study drug|157
340159|NCT02640157|835087|P2|STARTED|Overall Study||116
340160|NCT02640157|835088|P1|STARTED|Overall Study|Intent-to-treat population: all participants who received at least 1 dose of study drug|233
340161|NCT02639338|835107|P2|NOT COMPLETED|Overall Study||5
340162|NCT02639338|835108|P1|NOT COMPLETED|Overall Study||4
340163|NCT02639338|835107|P2|COMPLETED|Overall Study||105
340164|NCT02639338|835108|P1|COMPLETED|Overall Study||106
340165|NCT02639338|835107|P2|STARTED|Overall Study||110
340166|NCT02639338|835108|P1|STARTED|Overall Study||110
340167|NCT02639247|835126|P2|NOT COMPLETED|Overall Study||2
340168|NCT02639247|835127|P1|NOT COMPLETED|Overall Study||5
340169|NCT02639247|835126|P2|COMPLETED|Overall Study||149
340170|NCT02639247|835127|P1|COMPLETED|Overall Study||177
340171|NCT02639247|835126|P2|STARTED|Overall Study||151
340172|NCT02639247|835127|P1|STARTED|Overall Study||182
340173|NCT02639052|835143|P1|NOT COMPLETED|Overall Study||1
340174|NCT02639052|835143|P1|COMPLETED|Overall Study||34
340175|NCT02639052|835143|P1|Visit 4 (3-month Follow-up)|Overall Study||34
340176|NCT02639052|835143|P1|Visit 3 (1-month Follow-up)|Overall Study||35
340177|NCT02639052|835143|P1|Visit 2 (1-week Follow-up)|Overall Study||35
340178|NCT02639052|835143|P1|Visit 1 (Baseline)|Overall Study||35
340179|NCT02639052|835143|P1|STARTED|Overall Study||35
340180|NCT02638493|835160|P3|NOT COMPLETED|Overall Study||0
340181|NCT02638493|835161|P2|NOT COMPLETED|Overall Study||0
340182|NCT02638493|835162|P1|NOT COMPLETED|Overall Study||2
340183|NCT02638493|835160|P3|COMPLETED|Overall Study||8
340184|NCT02638493|835161|P2|COMPLETED|Overall Study||8
340185|NCT02638493|835162|P1|COMPLETED|Overall Study||8
340186|NCT02638493|835160|P3|STARTED|Overall Study||8
340187|NCT02638493|835161|P2|STARTED|Overall Study||8
340188|NCT02638493|835162|P1|STARTED|Overall Study|Two men were not able to provide semen samples, and thus were replaced|10
340189|NCT02638259|835193|P2|NOT COMPLETED|Treatment Period 2||11
340190|NCT02638259|835194|P1|NOT COMPLETED|Treatment Period 2||6
340191|NCT02638259|835193|P2|COMPLETED|Treatment Period 2||155
340192|NCT02638259|835194|P1|COMPLETED|Treatment Period 2||169
340193|NCT02638259|835193|P2|STARTED|Treatment Period 2|6 patients did not proceed to TP2 (4 not eligible, 1 consent withdrawal, 1 adverse event).|166
340194|NCT02638259|835194|P1|STARTED|Treatment Period 2|6 patients did not proceed to TP2 (3 not eligible, 2 consent withdrawal, 1 IP delay)|175
340195|NCT02638259|835193|P2|NOT COMPLETED|Treatment Period 1||18
340196|NCT02638259|835194|P1|NOT COMPLETED|Treatment Period 1||5
340197|NCT02638259|835193|P2|COMPLETED|Treatment Period 1||172
340198|NCT02638259|835194|P1|COMPLETED|Treatment Period 1||181
340199|NCT02638259|835193|P2|STARTED|Treatment Period 1||190
340200|NCT02638259|835194|P1|STARTED|Treatment Period 1||186
340201|NCT02638129|835206|P2|NOT COMPLETED|Overall Study||30
340202|NCT02638129|835207|P1|NOT COMPLETED|Overall Study||28
340203|NCT02638129|835206|P2|COMPLETED|Overall Study||0
340204|NCT02638129|835207|P1|COMPLETED|Overall Study||0
340205|NCT02638129|835206|P2|STARTED|Overall Study||30
340206|NCT02638129|835207|P1|STARTED|Overall Study||28
340207|NCT02638051|835221|P2|NOT COMPLETED|Overall Study||0
340208|NCT02638051|835222|P1|NOT COMPLETED|Overall Study||0
340209|NCT02638051|835221|P2|COMPLETED|Overall Study||130
340210|NCT02638051|835222|P1|COMPLETED|Overall Study||130
340211|NCT02638051|835221|P2|STARTED|Overall Study||130
340212|NCT02638051|835222|P1|STARTED|Overall Study||130
340213|NCT02637999|835235|P3|NOT COMPLETED|Overall Study||2
340214|NCT02637999|835236|P2|NOT COMPLETED|Overall Study||2
340215|NCT02637999|835237|P1|NOT COMPLETED|Overall Study||1
340216|NCT02637999|835235|P3|COMPLETED|Overall Study||6
340217|NCT02637999|835236|P2|COMPLETED|Overall Study||6
340218|NCT02637999|835237|P1|COMPLETED|Overall Study||7
340219|NCT02637999|835235|P3|STARTED|Overall Study||8
340220|NCT02637999|835236|P2|STARTED|Overall Study||8
340221|NCT02637999|835237|P1|STARTED|Overall Study||8
340222|NCT02637804|835271|P4|NOT COMPLETED|Second Intervention (1 Week)||0
340223|NCT02637804|835272|P3|NOT COMPLETED|Second Intervention (1 Week)||0
340224|NCT02637804|835273|P2|NOT COMPLETED|Second Intervention (1 Week)||0
340225|NCT02637804|835274|P1|NOT COMPLETED|Second Intervention (1 Week)||0
340226|NCT02637804|835271|P4|COMPLETED|Second Intervention (1 Week)||26
340227|NCT02637804|835272|P3|COMPLETED|Second Intervention (1 Week)||25
340228|NCT02637804|835273|P2|COMPLETED|Second Intervention (1 Week)||28
340229|NCT02637804|835274|P1|COMPLETED|Second Intervention (1 Week)||27
340230|NCT02637804|835271|P4|STARTED|Second Intervention (1 Week)||26
340231|NCT02637804|835272|P3|STARTED|Second Intervention (1 Week)||25
340232|NCT02637804|835273|P2|STARTED|Second Intervention (1 Week)||28
340233|NCT02637804|835274|P1|STARTED|Second Intervention (1 Week)||27
340234|NCT02637804|835271|P4|NOT COMPLETED|First Intervention (1 Week)||0
340235|NCT02637804|835272|P3|NOT COMPLETED|First Intervention (1 Week)||0
340236|NCT02637804|835273|P2|NOT COMPLETED|First Intervention (1 Week)||0
340237|NCT02637804|835274|P1|NOT COMPLETED|First Intervention (1 Week)||0
340238|NCT02637804|835271|P4|COMPLETED|First Intervention (1 Week)||26
340239|NCT02637804|835272|P3|COMPLETED|First Intervention (1 Week)||25
340240|NCT02637804|835273|P2|COMPLETED|First Intervention (1 Week)||28
340241|NCT02637804|835274|P1|COMPLETED|First Intervention (1 Week)||27
340242|NCT02637804|835271|P4|STARTED|First Intervention (1 Week)||26
340243|NCT02637804|835272|P3|STARTED|First Intervention (1 Week)||25
340244|NCT02637804|835273|P2|STARTED|First Intervention (1 Week)||28
340245|NCT02637804|835274|P1|STARTED|First Intervention (1 Week)||27
340246|NCT02637323|835380|P2|NOT COMPLETED|Overall Study||1
340247|NCT02637323|835381|P1|NOT COMPLETED|Overall Study||2
340248|NCT02637323|835380|P2|COMPLETED|Overall Study||17
340249|NCT02637323|835381|P1|COMPLETED|Overall Study||61
340250|NCT02637323|835380|P2|STARTED|Overall Study||18
340251|NCT02637323|835381|P1|STARTED|Overall Study||63
340252|NCT02637063|835392|P3|NOT COMPLETED|Overall Study||6
340253|NCT02637063|835393|P2|NOT COMPLETED|Overall Study||4
340254|NCT02637063|835394|P1|NOT COMPLETED|Overall Study||5
340255|NCT02637063|835392|P3|COMPLETED|Overall Study||62
340256|NCT02637063|835393|P2|COMPLETED|Overall Study||64
340257|NCT02637063|835394|P1|COMPLETED|Overall Study||62
340258|NCT02637063|835392|P3|STARTED|Overall Study||68
340259|NCT02637063|835393|P2|STARTED|Overall Study||68
340260|NCT02637063|835394|P1|STARTED|Overall Study||67
340261|NCT02637037|835422|P2|NOT COMPLETED|Overall Study||1
340262|NCT02637037|835423|P1|NOT COMPLETED|Overall Study||4
340263|NCT02637037|835422|P2|COMPLETED|Overall Study||39
340264|NCT02637037|835423|P1|COMPLETED|Overall Study||36
340265|NCT02637037|835422|P2|STARTED|Overall Study||40
340266|NCT02637037|835423|P1|STARTED|Overall Study||40
340267|NCT02636907|835489|P1|NOT COMPLETED|Overall Study||4
340268|NCT02636907|835489|P1|COMPLETED|Overall Study|Completed autoinjector assessment period (Day 50).|73
340269|NCT02636907|835489|P1|STARTED|Overall Study|Assigned to treatment.|77
340270|NCT02636595|835496|P1|NOT COMPLETED|Overall Study||2
340271|NCT02636595|835496|P1|COMPLETED|Overall Study||119
340272|NCT02636595|835496|P1|STARTED|Overall Study||121
340273|NCT02635828|835502|P1|NOT COMPLETED|Overall Study||14
340274|NCT02635828|835502|P1|COMPLETED|Overall Study||40
340275|NCT02635828|835502|P1|STARTED|Overall Study||54
340276|NCT02635425|835509|P2|NOT COMPLETED|Overall Study||0
340277|NCT02635425|835510|P1|NOT COMPLETED|Overall Study||0
340278|NCT02635425|835509|P2|COMPLETED|Overall Study||15
340279|NCT02635425|835510|P1|COMPLETED|Overall Study||15
340280|NCT02635425|835509|P2|STARTED|Overall Study||15
340281|NCT02635425|835510|P1|STARTED|Overall Study||15
340282|NCT02635204|835518|P2|NOT COMPLETED|Overall Study||1
340283|NCT02635204|835519|P1|NOT COMPLETED|Overall Study||2
340284|NCT02635204|835518|P2|COMPLETED|Overall Study||88
340285|NCT02635204|835519|P1|COMPLETED|Overall Study||176
340286|NCT02635204|835518|P2|STARTED|Overall Study||89
340287|NCT02635204|835519|P1|STARTED|Overall Study||178
340288|NCT02634788|835533|P4|NOT COMPLETED|Overall Study||5
340289|NCT02634788|835534|P3|NOT COMPLETED|Overall Study||5
340290|NCT02634788|835535|P2|NOT COMPLETED|Overall Study||10
340291|NCT02634788|835536|P1|NOT COMPLETED|Overall Study||4
340292|NCT02634788|835533|P4|COMPLETED|Overall Study||77
340293|NCT02634788|835534|P3|COMPLETED|Overall Study||75
340294|NCT02634788|835535|P2|COMPLETED|Overall Study||71
340295|NCT02634788|835536|P1|COMPLETED|Overall Study||75
340296|NCT02634788|835533|P4|STARTED|Overall Study||82
340297|NCT02634788|835534|P3|STARTED|Overall Study||80
340298|NCT02634788|835535|P2|STARTED|Overall Study||81
340299|NCT02634788|835536|P1|STARTED|Overall Study||79
340300|NCT02634346|835605|P3|NOT COMPLETED|Overall Study||23
340301|NCT02634346|835606|P2|NOT COMPLETED|Overall Study||14
340302|NCT02634346|835607|P1|NOT COMPLETED|Overall Study||12
340303|NCT02634346|835605|P3|COMPLETED|Overall Study||111
340304|NCT02634346|835606|P2|COMPLETED|Overall Study||119
340305|NCT02634346|835607|P1|COMPLETED|Overall Study||122
340306|NCT02634346|835605|P3|STARTED|Overall Study||134
340307|NCT02634346|835606|P2|STARTED|Overall Study||133
340308|NCT02634346|835607|P1|STARTED|Overall Study||134
340309|NCT02634073|835621|P4|NOT COMPLETED|Overall Study||0
340310|NCT02634073|835622|P3|NOT COMPLETED|Overall Study||0
340311|NCT02634073|835623|P2|NOT COMPLETED|Overall Study||0
340312|NCT02634073|835624|P1|NOT COMPLETED|Overall Study||0
340313|NCT02634073|835621|P4|COMPLETED|Overall Study||4
340314|NCT02634073|835622|P3|COMPLETED|Overall Study||4
340315|NCT02634073|835623|P2|COMPLETED|Overall Study||4
340316|NCT02634073|835624|P1|COMPLETED|Overall Study||4
340317|NCT02634073|835621|P4|STARTED|Overall Study||4
340318|NCT02634073|835622|P3|STARTED|Overall Study||4
340319|NCT02634073|835623|P2|STARTED|Overall Study||4
340320|NCT02634073|835624|P1|STARTED|Overall Study||4
340321|NCT02633956|835714|P4|NOT COMPLETED|Overall Study||0
340322|NCT02633956|835715|P3|NOT COMPLETED|Overall Study||2
340323|NCT02633956|835716|P2|NOT COMPLETED|Overall Study||2
340324|NCT02633956|835717|P1|NOT COMPLETED|Overall Study||1
340325|NCT02633956|835714|P4|COMPLETED|Overall Study||21
340326|NCT02633956|835715|P3|COMPLETED|Overall Study||20
340327|NCT02633956|835716|P2|COMPLETED|Overall Study||19
340328|NCT02633956|835717|P1|COMPLETED|Overall Study||19
340329|NCT02633956|835714|P4|STARTED|Overall Study||21
340330|NCT02633956|835715|P3|STARTED|Overall Study||22
340331|NCT02633956|835716|P2|STARTED|Overall Study||21
340332|NCT02633956|835717|P1|STARTED|Overall Study||20
340333|NCT02633787|835735|P1|NOT COMPLETED|Overall Study||1
340334|NCT02633787|835735|P1|COMPLETED|Overall Study||109
340335|NCT02633787|835735|P1|STARTED|Overall Study||110
340336|NCT02633371|835741|P1|NOT COMPLETED|Overall Study||3
340337|NCT02633371|835741|P1|COMPLETED|Overall Study||7
340338|NCT02633371|835741|P1|STARTED|Overall Study||10
340339|NCT02633215|835747|P2|NOT COMPLETED|Overall Study||3
340340|NCT02633215|835748|P1|NOT COMPLETED|Overall Study||2
340341|NCT02633215|835747|P2|COMPLETED|Overall Study||15
340342|NCT02633215|835748|P1|COMPLETED|Overall Study||16
340343|NCT02633215|835747|P2|STARTED|Overall Study||18
340344|NCT02633215|835748|P1|STARTED|Overall Study||18
340345|NCT02632838|835760|P2|NOT COMPLETED|Overall Study||2
340346|NCT02632838|835761|P1|NOT COMPLETED|Overall Study||3
340347|NCT02632838|835760|P2|COMPLETED|Overall Study||13
340348|NCT02632838|835761|P1|COMPLETED|Overall Study||12
340349|NCT02632838|835760|P2|STARTED|Overall Study||15
340350|NCT02632838|835761|P1|STARTED|Overall Study||15
340351|NCT02632812|835777|P2|NOT COMPLETED|Overall Study||0
340352|NCT02632812|835778|P1|NOT COMPLETED|Overall Study||0
340353|NCT02632812|835777|P2|COMPLETED|Overall Study||12
340354|NCT02632812|835778|P1|COMPLETED|Overall Study||12
340355|NCT02632812|835777|P2|STARTED|Overall Study||12
340356|NCT02632812|835778|P1|STARTED|Overall Study||12
340357|NCT02632110|835801|P10|NOT COMPLETED|Overall Study||1
340358|NCT02632110|835802|P9|NOT COMPLETED|Overall Study||1
340359|NCT02632110|835803|P8|NOT COMPLETED|Overall Study||3
340360|NCT02632110|835804|P7|NOT COMPLETED|Overall Study||3
340361|NCT02632110|835805|P6|NOT COMPLETED|Overall Study||1
340362|NCT02632110|835806|P5|NOT COMPLETED|Overall Study||1
340363|NCT02632110|835807|P4|NOT COMPLETED|Overall Study||0
340364|NCT02632110|835808|P3|NOT COMPLETED|Overall Study||0
340365|NCT02632110|835809|P2|NOT COMPLETED|Overall Study||1
340366|NCT02632110|835810|P1|NOT COMPLETED|Overall Study||1
340367|NCT02632110|835801|P10|COMPLETED|Overall Study||29
340368|NCT02632110|835802|P9|COMPLETED|Overall Study||29
340369|NCT02632110|835803|P8|COMPLETED|Overall Study||23
340370|NCT02632110|835804|P7|COMPLETED|Overall Study||23
340371|NCT02632110|835805|P6|COMPLETED|Overall Study||28
340372|NCT02632110|835806|P5|COMPLETED|Overall Study||28
340373|NCT02632110|835807|P4|COMPLETED|Overall Study||27
340374|NCT02632110|835808|P3|COMPLETED|Overall Study||27
340375|NCT02632110|835809|P2|COMPLETED|Overall Study||24
340376|NCT02632110|835810|P1|COMPLETED|Overall Study||24
340377|NCT02632110|835801|P10|STARTED|Overall Study||30
340378|NCT02632110|835802|P9|STARTED|Overall Study||30
340379|NCT02632110|835803|P8|STARTED|Overall Study||26
340380|NCT02632110|835804|P7|STARTED|Overall Study||26
340381|NCT02632110|835805|P6|STARTED|Overall Study||29
340382|NCT02632110|835806|P5|STARTED|Overall Study||29
340383|NCT02632110|835807|P4|STARTED|Overall Study||27
340384|NCT02632110|835808|P3|STARTED|Overall Study||27
340385|NCT02632110|835809|P2|STARTED|Overall Study||25
340386|NCT02632110|835810|P1|STARTED|Overall Study||25
340387|NCT02631057|836279|P2|NOT COMPLETED|Overall Study||0
340388|NCT02631057|836280|P1|NOT COMPLETED|Overall Study||0
340389|NCT02631057|836279|P2|COMPLETED|Overall Study||3414
340390|NCT02631057|836280|P1|COMPLETED|Overall Study||899
340391|NCT02631057|836279|P2|STARTED|Overall Study||3414
340392|NCT02631057|836280|P1|STARTED|Overall Study||899
340393|NCT02630992|836286|P1|NOT COMPLETED|Overall Study||13
340394|NCT02630992|836286|P1|COMPLETED|Overall Study||99
340395|NCT02630992|836286|P1|STARTED|Overall Study||112
340396|NCT02630563|836303|P1|NOT COMPLETED|Overall Study||1
340397|NCT02630563|836303|P1|COMPLETED|Overall Study||8
340398|NCT02630563|836303|P1|STARTED|Overall Study||9
340399|NCT02629354|836314|P2|NOT COMPLETED|Follow-up||0
340400|NCT02629354|836315|P1|NOT COMPLETED|Follow-up||0
340401|NCT02629354|836314|P2|COMPLETED|Follow-up||18
340402|NCT02629354|836315|P1|COMPLETED|Follow-up||18
340403|NCT02629354|836314|P2|STARTED|Follow-up||18
340404|NCT02629354|836315|P1|STARTED|Follow-up||18
340405|NCT02629354|836314|P2|NOT COMPLETED|Period 2||0
340406|NCT02629354|836315|P1|NOT COMPLETED|Period 2||0
340407|NCT02629354|836314|P2|COMPLETED|Period 2||18
340408|NCT02629354|836315|P1|COMPLETED|Period 2||18
340409|NCT02629354|836314|P2|STARTED|Period 2||18
340410|NCT02629354|836315|P1|STARTED|Period 2||18
340411|NCT02629354|836314|P2|NOT COMPLETED|Washout Period||0
340412|NCT02629354|836315|P1|NOT COMPLETED|Washout Period||0
340413|NCT02629354|836314|P2|COMPLETED|Washout Period||18
340414|NCT02629354|836315|P1|COMPLETED|Washout Period||18
340415|NCT02629354|836314|P2|STARTED|Washout Period||18
340416|NCT02629354|836315|P1|STARTED|Washout Period||18
340417|NCT02629354|836314|P2|NOT COMPLETED|Period 1||0
340418|NCT02629354|836315|P1|NOT COMPLETED|Period 1||0
340419|NCT02629354|836314|P2|COMPLETED|Period 1||18
340420|NCT02629354|836315|P1|COMPLETED|Period 1||18
340421|NCT02629354|836314|P2|STARTED|Period 1||18
340422|NCT02629354|836315|P1|STARTED|Period 1||18
340423|NCT02628938|836340|P3|NOT COMPLETED|Overall Study||4
340424|NCT02628938|836341|P2|NOT COMPLETED|Overall Study||2
340425|NCT02628938|836342|P1|NOT COMPLETED|Overall Study||5
340426|NCT02628938|836340|P3|COMPLETED|Overall Study||11
340427|NCT02628938|836341|P2|COMPLETED|Overall Study||13
340428|NCT02628938|836342|P1|COMPLETED|Overall Study||10
340429|NCT02628938|836340|P3|STARTED|Overall Study||15
340430|NCT02628938|836341|P2|STARTED|Overall Study||15
340431|NCT02628938|836342|P1|STARTED|Overall Study||15
340432|NCT02628418|836358|P2|NOT COMPLETED|Overall Study||2
340433|NCT02628418|836359|P1|NOT COMPLETED|Overall Study||1
340434|NCT02628418|836358|P2|COMPLETED|Overall Study||13
340435|NCT02628418|836359|P1|COMPLETED|Overall Study||14
340436|NCT02628418|836358|P2|STARTED|Overall Study||15
340437|NCT02628418|836359|P1|STARTED|Overall Study||15
340438|NCT02628236|836380|P1|NOT COMPLETED|Overall Study||0
340439|NCT02628236|836380|P1|COMPLETED|Overall Study||14
340440|NCT02628236|836380|P1|STARTED|Overall Study||14
340441|NCT02628106|836417|P1|NOT COMPLETED|Overall Study||0
340442|NCT02628106|836417|P1|COMPLETED|Overall Study||21
340443|NCT02628106|836417|P1|STARTED|Overall Study||21
340444|NCT02627794|836421|P1|NOT COMPLETED|Overall Study||0
340445|NCT02627794|836421|P1|COMPLETED|Overall Study||3
340446|NCT02627794|836421|P1|STARTED|Overall Study||3
340447|NCT02627144|836434|P1|NOT COMPLETED|Overall Study||365
340448|NCT02627144|836434|P1|COMPLETED|Overall Study||0
340449|NCT02627144|836434|P1|Treated|Overall Study||359
340450|NCT02627144|836434|P1|STARTED|Overall Study||365
340451|NCT02627118|836442|P1|NOT COMPLETED|Overall Study||0
340452|NCT02627118|836442|P1|COMPLETED|Overall Study||10
340453|NCT02627118|836442|P1|STARTED|Overall Study||10
340454|NCT02627001|836449|P2|NOT COMPLETED|Overall Study||0
340455|NCT02627001|836450|P1|NOT COMPLETED|Overall Study||0
340456|NCT02627001|836449|P2|COMPLETED|Overall Study||14
340457|NCT02627001|836450|P1|COMPLETED|Overall Study||13
340458|NCT02627001|836449|P2|STARTED|Overall Study||14
340459|NCT02627001|836450|P1|STARTED|Overall Study||13
340460|NCT02626910|836460|P4|NOT COMPLETED|Overall Study||0
340461|NCT02626910|836461|P3|NOT COMPLETED|Overall Study||0
340462|NCT02626910|836462|P2|NOT COMPLETED|Overall Study||0
340463|NCT02626910|836463|P1|NOT COMPLETED|Overall Study||0
340464|NCT02626910|836460|P4|COMPLETED|Overall Study||10
340465|NCT02626910|836461|P3|COMPLETED|Overall Study||6
340466|NCT02626910|836462|P2|COMPLETED|Overall Study||10
340467|NCT02626910|836463|P1|COMPLETED|Overall Study||23
340468|NCT02626910|836460|P4|STARTED|Overall Study||10
340469|NCT02626910|836461|P3|STARTED|Overall Study||6
340470|NCT02626910|836462|P2|STARTED|Overall Study||10
340471|NCT02626910|836463|P1|STARTED|Overall Study||23
340472|NCT02626611|836476|P3|NOT COMPLETED|Overall Study||3
340473|NCT02626611|836477|P2|NOT COMPLETED|Overall Study||1
340474|NCT02626611|836478|P1|NOT COMPLETED|Overall Study||4
340475|NCT02626611|836476|P3|COMPLETED|Overall Study||16
340476|NCT02626611|836477|P2|COMPLETED|Overall Study||20
340477|NCT02626611|836478|P1|COMPLETED|Overall Study||16
340478|NCT02626611|836476|P3|STARTED|Overall Study||19
340479|NCT02626611|836477|P2|STARTED|Overall Study||21
340480|NCT02626611|836478|P1|STARTED|Overall Study||20
340481|NCT02625844|836499|P1|NOT COMPLETED|Overall Study||0
340482|NCT02625844|836499|P1|COMPLETED|Overall Study||110
340483|NCT02625844|836499|P1|STARTED|Overall Study||110
340484|NCT02625402|836505|P2|NOT COMPLETED|Overall Study||12
340485|NCT02625402|836506|P1|NOT COMPLETED|Overall Study||9
340486|NCT02625402|836505|P2|COMPLETED|Overall Study||25
340487|NCT02625402|836506|P1|COMPLETED|Overall Study||33
340488|NCT02625402|836505|P2|STARTED|Overall Study||37
340489|NCT02625402|836506|P1|STARTED|Overall Study||42
340490|NCT02625298|836518|P2|NOT COMPLETED|Overall Study||0
340491|NCT02625298|836519|P1|NOT COMPLETED|Overall Study||1
340492|NCT02625298|836518|P2|COMPLETED|Overall Study||13
340493|NCT02625298|836519|P1|COMPLETED|Overall Study||10
340494|NCT02625298|836518|P2|STARTED|Overall Study||13
340495|NCT02625298|836519|P1|STARTED|Overall Study||11
340496|NCT02625259|836532|P5|NOT COMPLETED|Second Intervention (Day 15)||0
340497|NCT02625259|836533|P4|NOT COMPLETED|Second Intervention (Day 15)||0
340498|NCT02625259|836534|P3|NOT COMPLETED|Second Intervention (Day 15)||0
340499|NCT02625259|836535|P2|NOT COMPLETED|Second Intervention (Day 15)||0
340500|NCT02625259|836536|P1|NOT COMPLETED|Second Intervention (Day 15)||0
340501|NCT02625259|836532|P5|COMPLETED|Second Intervention (Day 15)||0
340502|NCT02625259|836533|P4|COMPLETED|Second Intervention (Day 15)||9
340503|NCT02625259|836534|P3|COMPLETED|Second Intervention (Day 15)||7
340504|NCT02625259|836535|P2|COMPLETED|Second Intervention (Day 15)||8
340505|NCT02625259|836536|P1|COMPLETED|Second Intervention (Day 15)||9
340506|NCT02625259|836532|P5|STARTED|Second Intervention (Day 15)||0
340507|NCT02625259|836533|P4|STARTED|Second Intervention (Day 15)||9
340508|NCT02625259|836534|P3|STARTED|Second Intervention (Day 15)||7
340509|NCT02625259|836535|P2|STARTED|Second Intervention (Day 15)||8
340510|NCT02625259|836536|P1|STARTED|Second Intervention (Day 15)||9
340511|NCT02625259|836532|P5|NOT COMPLETED|Washout (Day 2 to Day 14)||0
340512|NCT02625259|836533|P4|NOT COMPLETED|Washout (Day 2 to Day 14)||0
340513|NCT02625259|836534|P3|NOT COMPLETED|Washout (Day 2 to Day 14)||0
340514|NCT02625259|836535|P2|NOT COMPLETED|Washout (Day 2 to Day 14)||0
340515|NCT02625259|836536|P1|NOT COMPLETED|Washout (Day 2 to Day 14)||0
340516|NCT02625259|836532|P5|COMPLETED|Washout (Day 2 to Day 14)||0
340517|NCT02625259|836533|P4|COMPLETED|Washout (Day 2 to Day 14)||9
340518|NCT02625259|836534|P3|COMPLETED|Washout (Day 2 to Day 14)||7
340519|NCT02625259|836535|P2|COMPLETED|Washout (Day 2 to Day 14)||8
340520|NCT02625259|836536|P1|COMPLETED|Washout (Day 2 to Day 14)||9
340521|NCT02625259|836532|P5|STARTED|Washout (Day 2 to Day 14)||0
340522|NCT02625259|836533|P4|STARTED|Washout (Day 2 to Day 14)||9
340523|NCT02625259|836534|P3|STARTED|Washout (Day 2 to Day 14)||7
340524|NCT02625259|836535|P2|STARTED|Washout (Day 2 to Day 14)||8
340525|NCT02625259|836536|P1|STARTED|Washout (Day 2 to Day 14)||9
340526|NCT02625259|836532|P5|NOT COMPLETED|First Intervention (Day 1)||0
340527|NCT02625259|836533|P4|NOT COMPLETED|First Intervention (Day 1)||1
340528|NCT02625259|836534|P3|NOT COMPLETED|First Intervention (Day 1)||1
340529|NCT02625259|836535|P2|NOT COMPLETED|First Intervention (Day 1)||1
340530|NCT02625259|836536|P1|NOT COMPLETED|First Intervention (Day 1)||2
340531|NCT02625259|836532|P5|COMPLETED|First Intervention (Day 1)||16
340532|NCT02625259|836533|P4|COMPLETED|First Intervention (Day 1)||9
340533|NCT02625259|836534|P3|COMPLETED|First Intervention (Day 1)||7
340534|NCT02625259|836535|P2|COMPLETED|First Intervention (Day 1)||8
340535|NCT02625259|836536|P1|COMPLETED|First Intervention (Day 1)||9
340536|NCT02625259|836532|P5|STARTED|First Intervention (Day 1)||16
340537|NCT02625259|836533|P4|STARTED|First Intervention (Day 1)||10
340538|NCT02625259|836534|P3|STARTED|First Intervention (Day 1)||8
340539|NCT02625259|836535|P2|STARTED|First Intervention (Day 1)||9
340540|NCT02625259|836536|P1|STARTED|First Intervention (Day 1)||11
340541|NCT02625233|836573|P2|NOT COMPLETED|Overall Study||0
340542|NCT02625233|836574|P1|NOT COMPLETED|Overall Study||2
340543|NCT02625233|836573|P2|COMPLETED|Overall Study||56
340544|NCT02625233|836574|P1|COMPLETED|Overall Study||47
340545|NCT02625233|836573|P2|STARTED|Overall Study||56
340546|NCT02625233|836574|P1|STARTED|Overall Study||49
340547|NCT02625220|836582|P1|NOT COMPLETED|Overall Study||7
340548|NCT02625220|836582|P1|COMPLETED|Overall Study||163
340549|NCT02625220|836582|P1|STARTED|Overall Study||170
340550|NCT02625207|836593|P4|NOT COMPLETED|Part 2 (11 Days)||0
340551|NCT02625207|836594|P3|NOT COMPLETED|Part 2 (11 Days)||0
340552|NCT02625207|836595|P2|NOT COMPLETED|Part 2 (11 Days)||0
340553|NCT02625207|836596|P1|NOT COMPLETED|Part 2 (11 Days)||0
340554|NCT02625207|836593|P4|COMPLETED|Part 2 (11 Days)||0
340555|NCT02625207|836594|P3|COMPLETED|Part 2 (11 Days)||12
340556|NCT02625207|836595|P2|COMPLETED|Part 2 (11 Days)||0
340557|NCT02625207|836596|P1|COMPLETED|Part 2 (11 Days)||11
340558|NCT02625207|836593|P4|STARTED|Part 2 (11 Days)|Part 2 was conducted only in Cohorts 1 and 3, as pre-specified in protocol.|0
340559|NCT02625207|836594|P3|STARTED|Part 2 (11 Days)||12
340560|NCT02625207|836595|P2|STARTED|Part 2 (11 Days)|Part 2 was conducted only in Cohorts 1 and 3, as pre-specified in protocol.|0
340561|NCT02625207|836596|P1|STARTED|Part 2 (11 Days)||11
340562|NCT02625207|836593|P4|NOT COMPLETED|Part 1 (6 Days)||0
340563|NCT02625207|836594|P3|NOT COMPLETED|Part 1 (6 Days)||0
340564|NCT02625207|836595|P2|NOT COMPLETED|Part 1 (6 Days)||0
340565|NCT02625207|836596|P1|NOT COMPLETED|Part 1 (6 Days)||0
340566|NCT02625207|836593|P4|COMPLETED|Part 1 (6 Days)||12
340567|NCT02625207|836594|P3|COMPLETED|Part 1 (6 Days)||12
340568|NCT02625207|836595|P2|COMPLETED|Part 1 (6 Days)||12
340569|NCT02625207|836596|P1|COMPLETED|Part 1 (6 Days)||11
340570|NCT02625207|836593|P4|STARTED|Part 1 (6 Days)||12
340571|NCT02625207|836594|P3|STARTED|Part 1 (6 Days)||12
340572|NCT02625207|836595|P2|STARTED|Part 1 (6 Days)||12
340573|NCT02625207|836596|P1|STARTED|Part 1 (6 Days)||11
340574|NCT02624791|836682|P6|NOT COMPLETED|Overall Study||0
340575|NCT02624791|836683|P5|NOT COMPLETED|Overall Study||0
340576|NCT02624791|836684|P4|NOT COMPLETED|Overall Study||0
340577|NCT02624791|836685|P3|NOT COMPLETED|Overall Study||0
340578|NCT02624791|836686|P2|NOT COMPLETED|Overall Study||0
340579|NCT02624791|836687|P1|NOT COMPLETED|Overall Study||2
340580|NCT02624791|836682|P6|COMPLETED|Overall Study||2
340581|NCT02624791|836683|P5|COMPLETED|Overall Study||2
340582|NCT02624791|836684|P4|COMPLETED|Overall Study||2
340583|NCT02624791|836685|P3|COMPLETED|Overall Study||2
340584|NCT02624791|836686|P2|COMPLETED|Overall Study||1
340585|NCT02624791|836687|P1|COMPLETED|Overall Study||0
340586|NCT02624791|836682|P6|STARTED|Overall Study||2
340587|NCT02624791|836683|P5|STARTED|Overall Study||2
340588|NCT02624791|836684|P4|STARTED|Overall Study||2
340589|NCT02624791|836685|P3|STARTED|Overall Study||2
340590|NCT02624791|836686|P2|STARTED|Overall Study||1
340591|NCT02624791|836687|P1|STARTED|Overall Study||2
340592|NCT02622568|836694|P2|NOT COMPLETED|Overall Study||5
340593|NCT02622568|836695|P1|NOT COMPLETED|Overall Study||5
340594|NCT02622568|836694|P2|COMPLETED|Overall Study||9
340595|NCT02622568|836695|P1|COMPLETED|Overall Study||9
340596|NCT02622568|836694|P2|STARTED|Overall Study||14
340597|NCT02622568|836695|P1|STARTED|Overall Study||14
340598|NCT02622321|836705|P4|NOT COMPLETED|Overall Study||7
340599|NCT02622321|836706|P3|NOT COMPLETED|Overall Study||49
340600|NCT02622321|836707|P2|NOT COMPLETED|Overall Study||18
340601|NCT02622321|836708|P1|NOT COMPLETED|Overall Study||35
340602|NCT02622321|836705|P4|COMPLETED|Overall Study||0
340603|NCT02622321|836706|P3|COMPLETED|Overall Study||0
340604|NCT02622321|836707|P2|COMPLETED|Overall Study||0
340605|NCT02622321|836708|P1|COMPLETED|Overall Study||0
340606|NCT02622321|836705|P4|Treated|Overall Study||7
340607|NCT02622321|836706|P3|Treated|Overall Study||49
340608|NCT02622321|836707|P2|Treated|Overall Study||18
340609|NCT02622321|836708|P1|Treated|Overall Study||34
340610|NCT02622321|836705|P4|STARTED|Overall Study||7
340611|NCT02622321|836706|P3|STARTED|Overall Study||49
340612|NCT02622321|836707|P2|STARTED|Overall Study||18
340613|NCT02622321|836708|P1|STARTED|Overall Study||35
340614|NCT02621034|836754|P3|NOT COMPLETED|Overall Study||5
340615|NCT02621034|836755|P2|NOT COMPLETED|Overall Study||2
340616|NCT02621034|836756|P1|NOT COMPLETED|Overall Study||3
340617|NCT02621034|836754|P3|COMPLETED|Overall Study||50
340618|NCT02621034|836755|P2|COMPLETED|Overall Study||50
340619|NCT02621034|836756|P1|COMPLETED|Overall Study||50
340620|NCT02621034|836754|P3|STARTED|Overall Study||55
340621|NCT02621034|836755|P2|STARTED|Overall Study||52
340622|NCT02621034|836756|P1|STARTED|Overall Study||53
340623|NCT02620683|836769|P2|NOT COMPLETED|Second Intervention (Visit 2)||0
340624|NCT02620683|836770|P1|NOT COMPLETED|Second Intervention (Visit 2)||0
340625|NCT02620683|836769|P2|COMPLETED|Second Intervention (Visit 2)||11
340626|NCT02620683|836770|P1|COMPLETED|Second Intervention (Visit 2)||12
340627|NCT02620683|836769|P2|STARTED|Second Intervention (Visit 2)||11
340628|NCT02620683|836770|P1|STARTED|Second Intervention (Visit 2)||12
340629|NCT02620683|836769|P2|NOT COMPLETED|Washout (2 Weeks)||0
340630|NCT02620683|836770|P1|NOT COMPLETED|Washout (2 Weeks)||0
340631|NCT02620683|836769|P2|COMPLETED|Washout (2 Weeks)||11
340632|NCT02620683|836770|P1|COMPLETED|Washout (2 Weeks)||12
340633|NCT02620683|836769|P2|STARTED|Washout (2 Weeks)||11
340634|NCT02620683|836770|P1|STARTED|Washout (2 Weeks)||12
340635|NCT02620683|836769|P2|NOT COMPLETED|First Intervention (Visit 1)||0
340636|NCT02620683|836770|P1|NOT COMPLETED|First Intervention (Visit 1)||0
340637|NCT02620683|836769|P2|COMPLETED|First Intervention (Visit 1)||11
340638|NCT02620683|836770|P1|COMPLETED|First Intervention (Visit 1)||12
340639|NCT02620683|836769|P2|STARTED|First Intervention (Visit 1)||11
340640|NCT02620683|836770|P1|STARTED|First Intervention (Visit 1)||12
340641|NCT02619812|836782|P4|NOT COMPLETED|Overall Study||2
340642|NCT02619812|836783|P3|NOT COMPLETED|Overall Study||1
340643|NCT02619812|836784|P2|NOT COMPLETED|Overall Study||0
340644|NCT02619812|836785|P1|NOT COMPLETED|Overall Study||0
340645|NCT02619812|836782|P4|COMPLETED|Overall Study||0
340646|NCT02619812|836783|P3|COMPLETED|Overall Study||0
340647|NCT02619812|836784|P2|COMPLETED|Overall Study||0
340648|NCT02619812|836785|P1|COMPLETED|Overall Study||0
340649|NCT02619812|836782|P4|STARTED|Overall Study||2
340650|NCT02619812|836783|P3|STARTED|Overall Study||1
340651|NCT02619812|836784|P2|STARTED|Overall Study||0
340652|NCT02619812|836785|P1|STARTED|Overall Study||0
340653|NCT02619799|836801|P2|NOT COMPLETED|Overall Study||0
340654|NCT02619799|836802|P1|NOT COMPLETED|Overall Study||0
340655|NCT02619799|836801|P2|COMPLETED|Overall Study||25
340656|NCT02619799|836802|P1|COMPLETED|Overall Study||25
340657|NCT02619799|836801|P2|STARTED|Overall Study||25
340658|NCT02619799|836802|P1|STARTED|Overall Study||25
340659|NCT02619591|836820|P2|NOT COMPLETED|Overall Study||121
340660|NCT02619591|836821|P1|NOT COMPLETED|Overall Study||139
340661|NCT02619591|836820|P2|COMPLETED|Overall Study||0
340662|NCT02619591|836821|P1|COMPLETED|Overall Study||0
340663|NCT02619591|836820|P2|STARTED|Overall Study||121
340664|NCT02619591|836821|P1|STARTED|Overall Study||139
340665|NCT02618772|836829|P2|NOT COMPLETED|Overall Study||0
340666|NCT02618772|836830|P1|NOT COMPLETED|Overall Study||1
340667|NCT02618772|836829|P2|COMPLETED|Overall Study||40
340668|NCT02618772|836830|P1|COMPLETED|Overall Study||38
340669|NCT02618772|836829|P2|Withdrawal by Subject|Overall Study||0
340670|NCT02618772|836830|P1|Withdrawal by Subject|Overall Study|The participant's family withdrew from the study after administration of the trial intervention.|1
340671|NCT02618772|836829|P2|STARTED|Overall Study||40
340672|NCT02618772|836830|P1|STARTED|Overall Study||39
340673|NCT02618512|836862|P1|NOT COMPLETED|Overall Study||0
340674|NCT02618512|836862|P1|COMPLETED|Overall Study||3
340675|NCT02618512|836862|P1|STARTED|Overall Study||3
340676|NCT02617901|836866|P1|NOT COMPLETED|Overall Study||0
340677|NCT02617901|836866|P1|COMPLETED|Overall Study||20
340678|NCT02617901|836866|P1|STARTED|Overall Study||20
340679|NCT02617888|836873|P3|NOT COMPLETED|Overall Study||0
340680|NCT02617888|836874|P2|NOT COMPLETED|Overall Study||7
340681|NCT02617888|836875|P1|NOT COMPLETED|Overall Study||1
340682|NCT02617888|836873|P3|COMPLETED|Overall Study||127
340683|NCT02617888|836874|P2|COMPLETED|Overall Study|Incomplete due to inadequate double-strand DNA break samples.|44
340684|NCT02617888|836875|P1|COMPLETED|Overall Study|Incomplete due to inadequate double-strand DNA break sample.|49
340685|NCT02617888|836873|P3|STARTED|Overall Study||127
340686|NCT02617888|836874|P2|STARTED|Overall Study||51
340687|NCT02617888|836875|P1|STARTED|Overall Study||50
340688|NCT02617784|836884|P2|NOT COMPLETED|Overall Study||0
340689|NCT02617784|836885|P1|NOT COMPLETED|Overall Study||0
340690|NCT02617784|836884|P2|COMPLETED|Overall Study||12
340691|NCT02617784|836885|P1|COMPLETED|Overall Study||12
340692|NCT02617784|836884|P2|Second Dose Assessment Period|Overall Study||12
340693|NCT02617784|836885|P1|Second Dose Assessment Period|Overall Study||11
340694|NCT02617784|836884|P2|First Dose Assessment Period|Overall Study||12
340695|NCT02617784|836885|P1|First Dose Assessment Period|Overall Study||12
340696|NCT02617784|836884|P2|STARTED|Overall Study||12
340697|NCT02617784|836885|P1|STARTED|Overall Study|None were prematurely withdrawn; 1 switched to CAPD mid-study and was excluded from second analysis.|12
340698|NCT02616523|836935|P3|NOT COMPLETED|Overall Study||0
340699|NCT02616523|836936|P2|NOT COMPLETED|Overall Study||0
340700|NCT02616523|836937|P1|NOT COMPLETED|Overall Study||1
340701|NCT02616523|836935|P3|COMPLETED|Overall Study|April 2015|20
340702|NCT02616523|836936|P2|COMPLETED|Overall Study|April 2015|20
340703|NCT02616523|836937|P1|COMPLETED|Overall Study|April 2015|19
340704|NCT02616523|836935|P3|STARTED|Overall Study|June 2014|20
340705|NCT02616523|836936|P2|STARTED|Overall Study|June 2014|20
340706|NCT02616523|836937|P1|STARTED|Overall Study|June 2014|20
340707|NCT02616250|836953|P2|NOT COMPLETED|Overall Study||9
340708|NCT02616250|836954|P1|NOT COMPLETED|Overall Study||10
340709|NCT02616250|836953|P2|COMPLETED|Overall Study||86
340710|NCT02616250|836954|P1|COMPLETED|Overall Study||85
340711|NCT02616250|836953|P2|STARTED|Overall Study||95
340712|NCT02616250|836954|P1|STARTED|Overall Study||95
340713|NCT02615990|836962|P2|NOT COMPLETED|Overall Study||1
340714|NCT02615990|836963|P1|NOT COMPLETED|Overall Study||1
340715|NCT02615990|836962|P2|COMPLETED|Overall Study||0
340716|NCT02615990|836963|P1|COMPLETED|Overall Study||0
340717|NCT02615990|836962|P2|STARTED|Overall Study||1
340718|NCT02615990|836963|P1|STARTED|Overall Study||1
340719|NCT02615743|837009|P2|NOT COMPLETED|Overall Study||3
340720|NCT02615743|837010|P1|NOT COMPLETED|Overall Study||6
340721|NCT02615743|837009|P2|COMPLETED|Overall Study||17
340722|NCT02615743|837010|P1|COMPLETED|Overall Study||15
340723|NCT02615743|837009|P2|STARTED|Overall Study||20
340724|NCT02615743|837010|P1|STARTED|Overall Study||21
340725|NCT02615717|837024|P2|NOT COMPLETED|Overall Study||0
340726|NCT02615717|837025|P1|NOT COMPLETED|Overall Study||0
340727|NCT02615717|837024|P2|COMPLETED|Overall Study||3
340728|NCT02615717|837025|P1|COMPLETED|Overall Study||3
340729|NCT02615717|837024|P2|STARTED|Overall Study||3
340730|NCT02615717|837025|P1|STARTED|Overall Study||3
340731|NCT02614924|837039|P2|NOT COMPLETED|Overall Study||0
340732|NCT02614924|837040|P1|NOT COMPLETED|Overall Study||0
340733|NCT02614924|837039|P2|COMPLETED|Overall Study||20
340734|NCT02614924|837040|P1|COMPLETED|Overall Study||20
340735|NCT02614924|837039|P2|STARTED|Overall Study||20
340736|NCT02614924|837040|P1|STARTED|Overall Study||20
340737|NCT02614586|837048|P1|NOT COMPLETED|Overall Study||0
340738|NCT02614586|837048|P1|COMPLETED|Overall Study||11
340739|NCT02614586|837048|P1|STARTED|Overall Study||11
340740|NCT02614469|837055|P2|NOT COMPLETED|Period 2||0
340741|NCT02614469|837056|P1|NOT COMPLETED|Period 2||0
340742|NCT02614469|837055|P2|COMPLETED|Period 2||9
340743|NCT02614469|837056|P1|COMPLETED|Period 2||9
340744|NCT02614469|837055|P2|STARTED|Period 2||9
340745|NCT02614469|837056|P1|STARTED|Period 2||9
340746|NCT02614469|837055|P2|NOT COMPLETED|Period 1||0
340747|NCT02614469|837056|P1|NOT COMPLETED|Period 1||0
340748|NCT02614469|837055|P2|COMPLETED|Period 1||9
340749|NCT02614469|837056|P1|COMPLETED|Period 1||9
340750|NCT02614469|837055|P2|STARTED|Period 1||9
340751|NCT02614469|837056|P1|STARTED|Period 1||9
340752|NCT02614222|837086|P2|NOT COMPLETED|Overall Study||0
340753|NCT02614222|837087|P1|NOT COMPLETED|Overall Study||0
340754|NCT02614222|837086|P2|COMPLETED|Overall Study||14
340755|NCT02614222|837087|P1|COMPLETED|Overall Study||13
340756|NCT02614222|837086|P2|STARTED|Overall Study||14
340757|NCT02614222|837087|P1|STARTED|Overall Study||13
340758|NCT02614079|837107|P1|NOT COMPLETED|Overall Study||1
340759|NCT02614079|837107|P1|COMPLETED|Overall Study|1 participant withdrew from the study prior to completion of DSSEP testing|5
340760|NCT02614079|837107|P1|STARTED|Overall Study||6
340761|NCT02613910|837111|P1|NOT COMPLETED|Overall Study||1
340762|NCT02613910|837111|P1|COMPLETED|Overall Study||0
340763|NCT02613910|837111|P1|STARTED|Overall Study||1
340764|NCT02613871|837160|P1|NOT COMPLETED|Overall Study||111
340765|NCT02613871|837160|P1|COMPLETED|Overall Study||0
340766|NCT02613871|837160|P1|STARTED|Overall Study||111
340767|NCT02613403|837179|P5|NOT COMPLETED|Overall Study||0
340768|NCT02613403|837180|P4|NOT COMPLETED|Overall Study||0
340769|NCT02613403|837181|P3|NOT COMPLETED|Overall Study||0
340770|NCT02613403|837182|P2|NOT COMPLETED|Overall Study||1
340771|NCT02613403|837183|P1|NOT COMPLETED|Overall Study||2
340772|NCT02613403|837179|P5|COMPLETED|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
340773|NCT02613403|837180|P4|COMPLETED|Overall Study||13
340774|NCT02613403|837181|P3|COMPLETED|Overall Study||9
340775|NCT02613403|837182|P2|COMPLETED|Overall Study||35
340776|NCT02613403|837183|P1|COMPLETED|Overall Study||34
340777|NCT02613403|837179|P5|Treated|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
340778|NCT02613403|837180|P4|Treated|Overall Study||13
340779|NCT02613403|837181|P3|Treated|Overall Study||9
340780|NCT02613403|837182|P2|Treated|Overall Study||36
340781|NCT02613403|837183|P1|Treated|Overall Study||35
340782|NCT02613403|837179|P5|STARTED|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
340783|NCT02613403|837180|P4|STARTED|Overall Study||13
340784|NCT02613403|837181|P3|STARTED|Overall Study||9
340785|NCT02613403|837182|P2|STARTED|Overall Study||36
340786|NCT02613403|837183|P1|STARTED|Overall Study||36
340787|NCT02612610|837229|P4|NOT COMPLETED|Overall Study||13
340788|NCT02612610|837230|P3|NOT COMPLETED|Overall Study||5
340789|NCT02612610|837231|P2|NOT COMPLETED|Overall Study||8
340790|NCT02612610|837232|P1|NOT COMPLETED|Overall Study||5
340791|NCT02612610|837229|P4|COMPLETED|Overall Study||50
340792|NCT02612610|837230|P3|COMPLETED|Overall Study||58
340793|NCT02612610|837231|P2|COMPLETED|Overall Study||56
340794|NCT02612610|837232|P1|COMPLETED|Overall Study||58
340795|NCT02612610|837229|P4|Treated|Overall Study||63
340796|NCT02612610|837230|P3|Treated|Overall Study||63
340797|NCT02612610|837231|P2|Treated|Overall Study||63
340798|NCT02612610|837232|P1|Treated|Overall Study||63
340799|NCT02612610|837229|P4|STARTED|Overall Study||63
340800|NCT02612610|837230|P3|STARTED|Overall Study||63
340801|NCT02612610|837231|P2|STARTED|Overall Study||64
340802|NCT02612610|837232|P1|STARTED|Overall Study||63
340803|NCT02612077|837474|P1|NOT COMPLETED|Overall Study||466
340804|NCT02612077|837474|P1|COMPLETED|Overall Study||299
340805|NCT02612077|837474|P1|Efficacy Analysis Set|Overall Study||737
340806|NCT02612077|837474|P1|Safety Analysis Set|Overall Study||760
340807|NCT02612077|837474|P1|Did Not Receive Study Product|Overall Study||5
340808|NCT02612077|837474|P1|STARTED|Overall Study||765
340809|NCT02612064|837486|P2|NOT COMPLETED|Overall Study||3
340810|NCT02612064|837487|P1|NOT COMPLETED|Overall Study||1
340811|NCT02612064|837486|P2|COMPLETED|Overall Study||112
340812|NCT02612064|837487|P1|COMPLETED|Overall Study||114
340813|NCT02612064|837486|P2|STARTED|Overall Study||115
340814|NCT02612064|837487|P1|STARTED|Overall Study||115
340815|NCT02611765|837499|P2|NOT COMPLETED|Overall Study||6
340816|NCT02611765|837500|P1|NOT COMPLETED|Overall Study||2
340817|NCT02611765|837499|P2|COMPLETED|Overall Study||29
340818|NCT02611765|837500|P1|COMPLETED|Overall Study||27
340819|NCT02611765|837499|P2|STARTED|Overall Study||35
340820|NCT02611765|837500|P1|STARTED|Overall Study||29
340821|NCT02611154|837506|P1|NOT COMPLETED|Overall Study||0
340822|NCT02611154|837506|P1|COMPLETED|Overall Study||5
340823|NCT02611154|837506|P1|STARTED|Overall Study||5
340824|NCT02610634|837527|P2|NOT COMPLETED|Overall Study||0
340825|NCT02610634|837528|P1|NOT COMPLETED|Overall Study||0
340826|NCT02610634|837527|P2|COMPLETED|Overall Study||40
340827|NCT02610634|837528|P1|COMPLETED|Overall Study||60
340828|NCT02610634|837527|P2|STARTED|Overall Study||40
340829|NCT02610634|837528|P1|STARTED|Overall Study||60
340830|NCT02609841|837536|P1|NOT COMPLETED|Overall Study||28
340831|NCT02609841|837536|P1|COMPLETED|Overall Study||212
340832|NCT02609841|837536|P1|STARTED|Overall Study||240
340833|NCT02609672|837544|P2|NOT COMPLETED|Overall Study||1
340834|NCT02609672|837545|P1|NOT COMPLETED|Overall Study||3
340835|NCT02609672|837544|P2|COMPLETED|Overall Study||11
340836|NCT02609672|837545|P1|COMPLETED|Overall Study||9
340837|NCT02609672|837544|P2|STARTED|Overall Study||12
340838|NCT02609672|837545|P1|STARTED|Overall Study||12
340839|NCT02609659|837579|P1|NOT COMPLETED|Overall Study||8
340840|NCT02609659|837579|P1|COMPLETED|Overall Study||97
340841|NCT02609659|837579|P1|STARTED|Overall Study||105
340842|NCT02609633|837589|P2|NOT COMPLETED|Overall Study||2
340843|NCT02609633|837590|P1|NOT COMPLETED|Overall Study||5
340844|NCT02609633|837589|P2|COMPLETED|Overall Study||54
340845|NCT02609633|837590|P1|COMPLETED|Overall Study||37
340846|NCT02609633|837589|P2|Full Analysis Set (FAS)|Overall Study||46
340847|NCT02609633|837590|P1|Full Analysis Set (FAS)|Overall Study||32
340848|NCT02609633|837589|P2|STARTED|Overall Study||56
340849|NCT02609633|837590|P1|STARTED|Overall Study||42
340850|NCT02609399|837617|P2|NOT COMPLETED|Influenza Season 2016-2017||5
340851|NCT02609399|837618|P1|NOT COMPLETED|Influenza Season 2016-2017||9
340852|NCT02609399|837617|P2|COMPLETED|Influenza Season 2016-2017||59
340853|NCT02609399|837618|P1|COMPLETED|Influenza Season 2016-2017||49
340854|NCT02609399|837617|P2|STARTED|Influenza Season 2016-2017||64
340855|NCT02609399|837618|P1|STARTED|Influenza Season 2016-2017||58
340856|NCT02609399|837617|P2|NOT COMPLETED|Influenza Season 2015-2016||2
340857|NCT02609399|837618|P1|NOT COMPLETED|Influenza Season 2015-2016||3
340858|NCT02609399|837617|P2|COMPLETED|Influenza Season 2015-2016||29
340859|NCT02609399|837618|P1|COMPLETED|Influenza Season 2015-2016||24
340860|NCT02609399|837617|P2|STARTED|Influenza Season 2015-2016||31
340861|NCT02609399|837618|P1|STARTED|Influenza Season 2015-2016||27
340862|NCT02609178|837630|P6|NOT COMPLETED|Third Crown||0
340863|NCT02609178|837631|P5|NOT COMPLETED|Third Crown||0
340864|NCT02609178|837632|P4|NOT COMPLETED|Third Crown||0
340865|NCT02609178|837633|P3|NOT COMPLETED|Third Crown||0
340866|NCT02609178|837634|P2|NOT COMPLETED|Third Crown||0
340867|NCT02609178|837635|P1|NOT COMPLETED|Third Crown||0
340868|NCT02609178|837630|P6|COMPLETED|Third Crown||2
340869|NCT02609178|837631|P5|COMPLETED|Third Crown||0
340870|NCT02609178|837632|P4|COMPLETED|Third Crown||2
340871|NCT02609178|837633|P3|COMPLETED|Third Crown||5
340872|NCT02609178|837634|P2|COMPLETED|Third Crown||1
340873|NCT02609178|837635|P1|COMPLETED|Third Crown||0
340874|NCT02609178|837630|P6|STARTED|Third Crown||2
340875|NCT02609178|837631|P5|STARTED|Third Crown||0
340876|NCT02609178|837632|P4|STARTED|Third Crown||2
340877|NCT02609178|837633|P3|STARTED|Third Crown||5
340878|NCT02609178|837634|P2|STARTED|Third Crown||1
340879|NCT02609178|837635|P1|STARTED|Third Crown||0
340880|NCT02609178|837630|P6|NOT COMPLETED|5-minute Washout Time||0
340881|NCT02609178|837631|P5|NOT COMPLETED|5-minute Washout Time||0
340882|NCT02609178|837632|P4|NOT COMPLETED|5-minute Washout Time||0
340883|NCT02609178|837633|P3|NOT COMPLETED|5-minute Washout Time||0
340884|NCT02609178|837634|P2|NOT COMPLETED|5-minute Washout Time||0
340885|NCT02609178|837635|P1|NOT COMPLETED|5-minute Washout Time||0
340886|NCT02609178|837630|P6|COMPLETED|5-minute Washout Time||2
340887|NCT02609178|837631|P5|COMPLETED|5-minute Washout Time||0
340888|NCT02609178|837632|P4|COMPLETED|5-minute Washout Time||2
340889|NCT02609178|837633|P3|COMPLETED|5-minute Washout Time||5
340890|NCT02609178|837634|P2|COMPLETED|5-minute Washout Time||1
340891|NCT02609178|837635|P1|COMPLETED|5-minute Washout Time||0
340892|NCT02609178|837630|P6|STARTED|5-minute Washout Time||2
340893|NCT02609178|837631|P5|STARTED|5-minute Washout Time||0
340894|NCT02609178|837632|P4|STARTED|5-minute Washout Time||2
340895|NCT02609178|837633|P3|STARTED|5-minute Washout Time||5
340896|NCT02609178|837634|P2|STARTED|5-minute Washout Time||1
340897|NCT02609178|837635|P1|STARTED|5-minute Washout Time||0
340898|NCT02609178|837630|P6|NOT COMPLETED|Second Crown||0
340899|NCT02609178|837631|P5|NOT COMPLETED|Second Crown||0
340900|NCT02609178|837632|P4|NOT COMPLETED|Second Crown||0
340901|NCT02609178|837633|P3|NOT COMPLETED|Second Crown||0
340902|NCT02609178|837634|P2|NOT COMPLETED|Second Crown||0
340903|NCT02609178|837635|P1|NOT COMPLETED|Second Crown||0
340904|NCT02609178|837630|P6|COMPLETED|Second Crown||2
340905|NCT02609178|837631|P5|COMPLETED|Second Crown||0
340906|NCT02609178|837632|P4|COMPLETED|Second Crown||2
340907|NCT02609178|837633|P3|COMPLETED|Second Crown||5
340908|NCT02609178|837634|P2|COMPLETED|Second Crown||1
340909|NCT02609178|837635|P1|COMPLETED|Second Crown||0
340910|NCT02609178|837630|P6|STARTED|Second Crown||2
340911|NCT02609178|837631|P5|STARTED|Second Crown||0
340912|NCT02609178|837632|P4|STARTED|Second Crown||2
340913|NCT02609178|837633|P3|STARTED|Second Crown||5
340914|NCT02609178|837634|P2|STARTED|Second Crown||1
340915|NCT02609178|837635|P1|STARTED|Second Crown||0
340916|NCT02609178|837630|P6|NOT COMPLETED|5-minute Washout Time||0
340917|NCT02609178|837631|P5|NOT COMPLETED|5-minute Washout Time||0
340918|NCT02609178|837632|P4|NOT COMPLETED|5-minute Washout Time||0
340919|NCT02609178|837633|P3|NOT COMPLETED|5-minute Washout Time||0
340920|NCT02609178|837634|P2|NOT COMPLETED|5-minute Washout Time||0
340921|NCT02609178|837635|P1|NOT COMPLETED|5-minute Washout Time||0
340922|NCT02609178|837630|P6|COMPLETED|5-minute Washout Time||2
340923|NCT02609178|837631|P5|COMPLETED|5-minute Washout Time||0
340924|NCT02609178|837632|P4|COMPLETED|5-minute Washout Time||2
340925|NCT02609178|837633|P3|COMPLETED|5-minute Washout Time||5
340926|NCT02609178|837634|P2|COMPLETED|5-minute Washout Time||1
340927|NCT02609178|837635|P1|COMPLETED|5-minute Washout Time||0
340928|NCT02609178|837630|P6|STARTED|5-minute Washout Time||2
340929|NCT02609178|837631|P5|STARTED|5-minute Washout Time||0
340930|NCT02609178|837632|P4|STARTED|5-minute Washout Time||2
340931|NCT02609178|837633|P3|STARTED|5-minute Washout Time||5
340932|NCT02609178|837634|P2|STARTED|5-minute Washout Time||1
340933|NCT02609178|837635|P1|STARTED|5-minute Washout Time||0
340934|NCT02609178|837630|P6|NOT COMPLETED|First Crown||0
340935|NCT02609178|837631|P5|NOT COMPLETED|First Crown||0
340936|NCT02609178|837632|P4|NOT COMPLETED|First Crown||1
340937|NCT02609178|837633|P3|NOT COMPLETED|First Crown||1
340938|NCT02609178|837634|P2|NOT COMPLETED|First Crown||0
340939|NCT02609178|837635|P1|NOT COMPLETED|First Crown||0
340940|NCT02609178|837630|P6|COMPLETED|First Crown||2
340941|NCT02609178|837631|P5|COMPLETED|First Crown||0
340942|NCT02609178|837632|P4|COMPLETED|First Crown||2
340943|NCT02609178|837633|P3|COMPLETED|First Crown||5
340944|NCT02609178|837634|P2|COMPLETED|First Crown||1
340945|NCT02609178|837635|P1|COMPLETED|First Crown||0
340946|NCT02609178|837630|P6|STARTED|First Crown||2
340947|NCT02609178|837631|P5|STARTED|First Crown||0
340948|NCT02609178|837632|P4|STARTED|First Crown||3
340949|NCT02609178|837633|P3|STARTED|First Crown||6
340950|NCT02609178|837634|P2|STARTED|First Crown||1
340951|NCT02609178|837635|P1|STARTED|First Crown||0
340952|NCT02609113|837652|P2|NOT COMPLETED|Overall Study||2
340953|NCT02609113|837653|P1|NOT COMPLETED|Overall Study||2
340954|NCT02609113|837652|P2|COMPLETED|Overall Study||9
340955|NCT02609113|837653|P1|COMPLETED|Overall Study||9
340956|NCT02609113|837652|P2|STARTED|Overall Study||11
340957|NCT02609113|837653|P1|STARTED|Overall Study||11
340958|NCT02609100|837667|P2|NOT COMPLETED|Overall Study||0
340959|NCT02609100|837668|P1|NOT COMPLETED|Overall Study||0
340960|NCT02609100|837667|P2|COMPLETED|Overall Study||2
340961|NCT02609100|837668|P1|COMPLETED|Overall Study||2
340962|NCT02609100|837667|P2|STARTED|Overall Study||2
340963|NCT02609100|837668|P1|STARTED|Overall Study||2
340964|NCT02608489|837686|P2|NOT COMPLETED|Overall Study||10
340965|NCT02608489|837687|P1|NOT COMPLETED|Overall Study||13
340966|NCT02608489|837686|P2|COMPLETED|Overall Study||33
340967|NCT02608489|837687|P1|COMPLETED|Overall Study||30
340968|NCT02608489|837686|P2|STARTED|Overall Study||43
340969|NCT02608489|837687|P1|STARTED|Overall Study||43
340970|NCT02607956|837709|P2|NOT COMPLETED|Overall Study||330
340971|NCT02607956|837710|P1|NOT COMPLETED|Overall Study||327
340972|NCT02607956|837709|P2|COMPLETED|Overall Study||0
340973|NCT02607956|837710|P1|COMPLETED|Overall Study||0
340974|NCT02607956|837709|P2|STARTED|Overall Study||330
340975|NCT02607956|837710|P1|STARTED|Overall Study||327
340976|NCT02607800|837724|P2|NOT COMPLETED|Overall Study||11
340977|NCT02607800|837725|P1|NOT COMPLETED|Overall Study||10
340978|NCT02607800|837724|P2|COMPLETED|Overall Study||430
340979|NCT02607800|837725|P1|COMPLETED|Overall Study||492
340980|NCT02607800|837724|P2|STARTED|Overall Study||441
340981|NCT02607800|837725|P1|STARTED|Overall Study||502
340982|NCT02607735|837743|P2|NOT COMPLETED|Overall Study||0
340983|NCT02607735|837744|P1|NOT COMPLETED|Overall Study||7
340984|NCT02607735|837743|P2|COMPLETED|Overall Study||152
340985|NCT02607735|837744|P1|COMPLETED|Overall Study||257
340986|NCT02607735|837743|P2|STARTED|Overall Study||152
340987|NCT02607735|837744|P1|STARTED|Overall Study||264
340988|NCT02606838|837758|P1|NOT COMPLETED|Overall Study||0
340989|NCT02606838|837758|P1|COMPLETED|Overall Study||119
340990|NCT02606838|837758|P1|STARTED|Overall Study||119
340991|NCT02606734|837766|P1|NOT COMPLETED|Overall Study||0
340992|NCT02606734|837766|P1|COMPLETED|Overall Study||44
340993|NCT02606734|837766|P1|STARTED|Overall Study||44
340994|NCT02606279|837772|P2|NOT COMPLETED|Overall Study||1
340995|NCT02606279|837773|P1|NOT COMPLETED|Overall Study||0
340996|NCT02606279|837772|P2|COMPLETED|Overall Study||0
340997|NCT02606279|837773|P1|COMPLETED|Overall Study||0
340998|NCT02606279|837772|P2|STARTED|Overall Study||1
340999|NCT02606279|837773|P1|STARTED|Overall Study||0
341000|NCT02605928|837785|P1|NOT COMPLETED|Overall Study||33
341001|NCT02605928|837785|P1|COMPLETED|Overall Study||46
341002|NCT02605928|837785|P1|Pivotal Phase, Statistical Phase|Overall Study||51
341003|NCT02605928|837785|P1|STARTED|Overall Study||79
341004|NCT02605863|837791|P2|NOT COMPLETED|Overall Study||0
341005|NCT02605863|837792|P1|NOT COMPLETED|Overall Study||0
341006|NCT02605863|837791|P2|COMPLETED|Overall Study||0
341007|NCT02605863|837792|P1|COMPLETED|Overall Study||1
341008|NCT02605863|837791|P2|STARTED|Overall Study||0
341009|NCT02605863|837792|P1|STARTED|Overall Study||1
341010|NCT02605304|837800|P2|NOT COMPLETED|Overall Study||0
341011|NCT02605304|837801|P1|NOT COMPLETED|Overall Study||0
341012|NCT02605304|837800|P2|COMPLETED|Overall Study||3
341013|NCT02605304|837801|P1|COMPLETED|Overall Study||4
341014|NCT02605304|837800|P2|STARTED|Overall Study||3
341015|NCT02605304|837801|P1|STARTED|Overall Study||4
341016|NCT02605187|837825|P4|NOT COMPLETED|Overall Study||1
341017|NCT02605187|837826|P3|NOT COMPLETED|Overall Study||11
341018|NCT02605187|837827|P2|NOT COMPLETED|Overall Study||2
341019|NCT02605187|837828|P1|NOT COMPLETED|Overall Study||8
341020|NCT02605187|837825|P4|COMPLETED|Overall Study||15
341021|NCT02605187|837826|P3|COMPLETED|Overall Study||72
341022|NCT02605187|837827|P2|COMPLETED|Overall Study||19
341023|NCT02605187|837828|P1|COMPLETED|Overall Study||32
341024|NCT02605187|837825|P4|STARTED|Overall Study||16
341025|NCT02605187|837826|P3|STARTED|Overall Study||83
341026|NCT02605187|837827|P2|STARTED|Overall Study||21
341027|NCT02605187|837828|P1|STARTED|Overall Study||40
341028|NCT02604589|837881|P3|NOT COMPLETED|Overall Study||1
341029|NCT02604589|837882|P2|NOT COMPLETED|Overall Study||0
341030|NCT02604589|837883|P1|NOT COMPLETED|Overall Study||0
341031|NCT02604589|837881|P3|COMPLETED|Overall Study||1
341032|NCT02604589|837882|P2|COMPLETED|Overall Study||5
341033|NCT02604589|837883|P1|COMPLETED|Overall Study||3
341034|NCT02604589|837881|P3|STARTED|Overall Study||2
341035|NCT02604589|837882|P2|STARTED|Overall Study||5
341036|NCT02604589|837883|P1|STARTED|Overall Study||3
341037|NCT02604550|837911|P2|NOT COMPLETED|Overall Study||26
341038|NCT02604550|837912|P1|NOT COMPLETED|Overall Study||25
341039|NCT02604550|837911|P2|COMPLETED|Overall Study||33
341040|NCT02604550|837912|P1|COMPLETED|Overall Study||31
341041|NCT02604550|837911|P2|STARTED|Overall Study||59
341042|NCT02604550|837912|P1|STARTED|Overall Study||56
341043|NCT02604407|837939|P3|NOT COMPLETED|Overall Study||16
341044|NCT02604407|837940|P2|NOT COMPLETED|Overall Study||12
341045|NCT02604407|837941|P1|NOT COMPLETED|Overall Study||11
341046|NCT02604407|837939|P3|COMPLETED|Overall Study||76
341047|NCT02604407|837940|P2|COMPLETED|Overall Study||80
341048|NCT02604407|837941|P1|COMPLETED|Overall Study||80
341049|NCT02604407|837939|P3|TREATED|Overall Study||90
341050|NCT02604407|837940|P2|TREATED|Overall Study||92
341051|NCT02604407|837941|P1|TREATED|Overall Study||89
341052|NCT02604407|837939|P3|STARTED|Overall Study||92
341053|NCT02604407|837940|P2|STARTED|Overall Study||92
341054|NCT02604407|837941|P1|STARTED|Overall Study||91
341055|NCT02604342|837954|P2|NOT COMPLETED|Overall Study||35
341056|NCT02604342|837955|P1|NOT COMPLETED|Overall Study||72
341057|NCT02604342|837954|P2|COMPLETED|Overall Study||0
341058|NCT02604342|837955|P1|COMPLETED|Overall Study||0
341059|NCT02604342|837954|P2|STARTED|Overall Study||35
341060|NCT02604342|837955|P1|STARTED|Overall Study||72
341061|NCT02604264|838007|P2|NOT COMPLETED|Overall Study||242
341062|NCT02604264|838008|P1|NOT COMPLETED|Overall Study||200
341063|NCT02604264|838007|P2|COMPLETED|Overall Study||1225
341064|NCT02604264|838008|P1|COMPLETED|Overall Study||1245
341065|NCT02604264|838007|P2|STARTED|Overall Study||1467
341066|NCT02604264|838008|P1|STARTED|Overall Study||1445
341067|NCT02604173|838017|P3|NOT COMPLETED|Overall Study||0
341068|NCT02604173|838018|P2|NOT COMPLETED|Overall Study||0
341069|NCT02604173|838019|P1|NOT COMPLETED|Overall Study||0
341070|NCT02604173|838017|P3|COMPLETED|Overall Study||35
341071|NCT02604173|838018|P2|COMPLETED|Overall Study||35
341072|NCT02604173|838019|P1|COMPLETED|Overall Study||33
341073|NCT02604173|838017|P3|STARTED|Overall Study||35
341074|NCT02604173|838018|P2|STARTED|Overall Study||35
341075|NCT02604173|838019|P1|STARTED|Overall Study||33
341076|NCT02604017|838035|P2|NOT COMPLETED|Overall Study||8
341077|NCT02604017|838036|P1|NOT COMPLETED|Overall Study||6
341078|NCT02604017|838035|P2|COMPLETED|Overall Study||343
341079|NCT02604017|838036|P1|COMPLETED|Overall Study||346
341080|NCT02604017|838035|P2|STARTED|Overall Study||351
341081|NCT02604017|838036|P1|STARTED|Overall Study||352
341082|NCT02603952|838065|P4|NOT COMPLETED|Overall Study||1
341083|NCT02603952|838066|P3|NOT COMPLETED|Overall Study||0
341084|NCT02603952|838067|P2|NOT COMPLETED|Overall Study||0
341085|NCT02603952|838068|P1|NOT COMPLETED|Overall Study||1
341086|NCT02603952|838065|P4|COMPLETED|Overall Study||31
341087|NCT02603952|838066|P3|COMPLETED|Overall Study||31
341088|NCT02603952|838067|P2|COMPLETED|Overall Study||31
341089|NCT02603952|838068|P1|COMPLETED|Overall Study||31
341090|NCT02603952|838065|P4|Treated|Overall Study||31
341091|NCT02603952|838066|P3|Treated|Overall Study||31
341092|NCT02603952|838067|P2|Treated|Overall Study||31
341093|NCT02603952|838068|P1|Treated|Overall Study||32
341094|NCT02603952|838065|P4|STARTED|Overall Study||32
341095|NCT02603952|838066|P3|STARTED|Overall Study||31
341096|NCT02603952|838067|P2|STARTED|Overall Study||31
341097|NCT02603952|838068|P1|STARTED|Overall Study||32
341098|NCT02603666|838109|P1|NOT COMPLETED|Overall Study||0
341099|NCT02603666|838109|P1|COMPLETED|Overall Study||130
341100|NCT02603666|838109|P1|STARTED|Overall Study||130
341101|NCT02603107|838115|P2|NOT COMPLETED|Optional Extension Phase||213
341102|NCT02603107|838116|P1|NOT COMPLETED|Optional Extension Phase||241
341103|NCT02603107|838115|P2|COMPLETED|Optional Extension Phase||0
341104|NCT02603107|838116|P1|COMPLETED|Optional Extension Phase||0
341105|NCT02603107|838115|P2|STARTED|Optional Extension Phase|27 participants who completed the Randomized Phase did not continue in the Optional Extension Phase.|213
341106|NCT02603107|838116|P1|STARTED|Optional Extension Phase|4 participants who completed the Randomized Phase did not continue in the Optional Extension Phase.|241
341107|NCT02603107|838115|P2|NOT COMPLETED|Randomized Phase||48
341108|NCT02603107|838116|P1|NOT COMPLETED|Randomized Phase||45
341109|NCT02603107|838115|P2|COMPLETED|Randomized Phase||240
341110|NCT02603107|838116|P1|COMPLETED|Randomized Phase||245
341111|NCT02603107|838115|P2|STARTED|Randomized Phase||288
341112|NCT02603107|838116|P1|STARTED|Randomized Phase||290
341113|NCT02602223|838126|P1|NOT COMPLETED|Overall Study||0
341114|NCT02602223|838126|P1|COMPLETED|Overall Study||9
341115|NCT02602223|838126|P1|STARTED|Overall Study||9
341116|NCT02601573|838147|P5|NOT COMPLETED|Overall Study||2
341117|NCT02601573|838148|P4|NOT COMPLETED|Overall Study||1
341118|NCT02601573|838149|P3|NOT COMPLETED|Overall Study||1
341119|NCT02601573|838150|P2|NOT COMPLETED|Overall Study||4
341120|NCT02601573|838151|P1|NOT COMPLETED|Overall Study||0
341121|NCT02601573|838147|P5|COMPLETED|Overall Study||16
341122|NCT02601573|838148|P4|COMPLETED|Overall Study||17
341123|NCT02601573|838149|P3|COMPLETED|Overall Study||16
341124|NCT02601573|838150|P2|COMPLETED|Overall Study||20
341125|NCT02601573|838151|P1|COMPLETED|Overall Study||23
341126|NCT02601573|838147|P5|STARTED|Overall Study|Number randomized and treated.|18
341127|NCT02601573|838148|P4|STARTED|Overall Study|Number randomized and treated.|18
341128|NCT02601573|838149|P3|STARTED|Overall Study|Number randomized and treated.|17
341129|NCT02601573|838150|P2|STARTED|Overall Study|Number randomized and treated.|24
341130|NCT02601573|838151|P1|STARTED|Overall Study|Number randomized and treated.|23
341131|NCT02601560|838186|P8|NOT COMPLETED|Overall Study||0
341132|NCT02601560|838187|P7|NOT COMPLETED|Overall Study||1
341133|NCT02601560|838188|P6|NOT COMPLETED|Overall Study||0
341134|NCT02601560|838189|P5|NOT COMPLETED|Overall Study||0
341135|NCT02601560|838190|P4|NOT COMPLETED|Overall Study||0
341136|NCT02601560|838191|P3|NOT COMPLETED|Overall Study||0
341137|NCT02601560|838192|P2|NOT COMPLETED|Overall Study||0
341138|NCT02601560|838193|P1|NOT COMPLETED|Overall Study||0
341139|NCT02601560|838186|P8|COMPLETED|Overall Study||6
341140|NCT02601560|838187|P7|COMPLETED|Overall Study||5
341141|NCT02601560|838188|P6|COMPLETED|Overall Study||4
341142|NCT02601560|838189|P5|COMPLETED|Overall Study||6
341143|NCT02601560|838190|P4|COMPLETED|Overall Study||6
341144|NCT02601560|838191|P3|COMPLETED|Overall Study||6
341145|NCT02601560|838192|P2|COMPLETED|Overall Study||6
341146|NCT02601560|838193|P1|COMPLETED|Overall Study||8
341147|NCT02601560|838186|P8|STARTED|Overall Study||6
341148|NCT02601560|838187|P7|STARTED|Overall Study||6
341149|NCT02601560|838188|P6|STARTED|Overall Study||4
341150|NCT02601560|838189|P5|STARTED|Overall Study||6
341151|NCT02601560|838190|P4|STARTED|Overall Study||6
341152|NCT02601560|838191|P3|STARTED|Overall Study||6
341153|NCT02601560|838192|P2|STARTED|Overall Study||6
341154|NCT02601560|838193|P1|STARTED|Overall Study||8
341155|NCT02600871|838377|P2|NOT COMPLETED|Overall Study||10
341156|NCT02600871|838378|P1|NOT COMPLETED|Overall Study||13
341157|NCT02600871|838377|P2|COMPLETED|Overall Study|45 subjects completed the 7-10 day follow up 39 subjects completed the 30-day follow up|39
341158|NCT02600871|838378|P1|COMPLETED|Overall Study|51 subjects completed the 7-10 day follow up 39 subjects completed the 30-day follow up|39
341159|NCT02600871|838377|P2|STARTED|Overall Study||49
341160|NCT02600871|838378|P1|STARTED|Overall Study||52
341161|NCT02600845|838388|P1|NOT COMPLETED|Overall Study||18
341162|NCT02600845|838388|P1|COMPLETED|Overall Study||104
341163|NCT02600845|838388|P1|STARTED|Overall Study||122
341164|NCT02600767|838403|P1|NOT COMPLETED|Overall Study||5
341165|NCT02600767|838403|P1|COMPLETED|Overall Study||74
341166|NCT02600767|838403|P1|STARTED|Overall Study||79
341167|NCT02600611|838409|P2|NOT COMPLETED|Overall Study||0
341168|NCT02600611|838410|P1|NOT COMPLETED|Overall Study||2
341169|NCT02600611|838409|P2|COMPLETED|Overall Study||300
341170|NCT02600611|838410|P1|COMPLETED|Overall Study||298
341171|NCT02600611|838409|P2|STARTED|Overall Study||300
341172|NCT02600611|838410|P1|STARTED|Overall Study||300
341173|NCT02600403|838421|P3|NOT COMPLETED|Overall Study||0
341174|NCT02600403|838422|P2|NOT COMPLETED|Overall Study||0
341175|NCT02600403|838423|P1|NOT COMPLETED|Overall Study||0
341176|NCT02600403|838421|P3|COMPLETED|Overall Study||11
341177|NCT02600403|838422|P2|COMPLETED|Overall Study||6
341178|NCT02600403|838423|P1|COMPLETED|Overall Study||44
341179|NCT02600403|838421|P3|STARTED|Overall Study||11
341180|NCT02600403|838422|P2|STARTED|Overall Study||6
341181|NCT02600403|838423|P1|STARTED|Overall Study||44
341182|NCT02600351|838450|P4|NOT COMPLETED|Overall Study||5
341183|NCT02600351|838451|P3|NOT COMPLETED|Overall Study||6
341184|NCT02600351|838452|P2|NOT COMPLETED|Overall Study||0
341185|NCT02600351|838453|P1|NOT COMPLETED|Overall Study||5
341186|NCT02600351|838450|P4|COMPLETED|Overall Study||22
341187|NCT02600351|838451|P3|COMPLETED|Overall Study||20
341188|NCT02600351|838452|P2|COMPLETED|Overall Study||17
341189|NCT02600351|838453|P1|COMPLETED|Overall Study||12
341190|NCT02600351|838450|P4|STARTED|Overall Study||27
341191|NCT02600351|838451|P3|STARTED|Overall Study||26
341192|NCT02600351|838452|P2|STARTED|Overall Study||17
341193|NCT02600351|838453|P1|STARTED|Overall Study||17
341194|NCT02599129|838485|P2|NOT COMPLETED|Overall Study||3
341195|NCT02599129|838486|P1|NOT COMPLETED|Overall Study||5
341196|NCT02599129|838485|P2|COMPLETED|Overall Study||1
341197|NCT02599129|838486|P1|COMPLETED|Overall Study||2
341198|NCT02599129|838485|P2|STARTED|Overall Study||4
341199|NCT02599129|838486|P1|STARTED|Overall Study||7
341200|NCT02598934|838502|P2|NOT COMPLETED|Overall Study||22
341201|NCT02598934|838503|P1|NOT COMPLETED|Overall Study||19
341202|NCT02598934|838502|P2|COMPLETED|Overall Study||132
341203|NCT02598934|838503|P1|COMPLETED|Overall Study||135
341204|NCT02598934|838502|P2|STARTED|Overall Study||154
341205|NCT02598934|838503|P1|STARTED|Overall Study||154
341206|NCT02598622|838515|P2|NOT COMPLETED|Overall Study||0
341207|NCT02598622|838516|P1|NOT COMPLETED|Overall Study||6
341208|NCT02598622|838515|P2|COMPLETED|Overall Study||0
341209|NCT02598622|838516|P1|COMPLETED|Overall Study||2
341210|NCT02598622|838515|P2|STARTED|Overall Study|Study terminated prior to randomization phase. No enrollment in this arm.|0
341211|NCT02598622|838516|P1|STARTED|Overall Study||8
341212|NCT02598583|838524|P2|NOT COMPLETED|Overall Study||0
341213|NCT02598583|838525|P1|NOT COMPLETED|Overall Study||0
341214|NCT02598583|838524|P2|COMPLETED|Overall Study||7
341215|NCT02598583|838525|P1|COMPLETED|Overall Study||6
341216|NCT02598583|838524|P2|STARTED|Overall Study||7
341217|NCT02598583|838525|P1|STARTED|Overall Study||6
341218|NCT02598193|838543|P1|NOT COMPLETED|Overall Study||16
341219|NCT02598193|838543|P1|COMPLETED|Overall Study||73
341220|NCT02598193|838543|P1|STARTED|Overall Study||89
341221|NCT02598128|838551|P4|NOT COMPLETED|Period C: Days 12 to 20||0
341222|NCT02598128|838552|P3|NOT COMPLETED|Period C: Days 12 to 20||0
341223|NCT02598128|838553|P2|NOT COMPLETED|Period C: Days 12 to 20||0
341224|NCT02598128|838554|P1|NOT COMPLETED|Period C: Days 12 to 20||0
341225|NCT02598128|838551|P4|COMPLETED|Period C: Days 12 to 20||33
341226|NCT02598128|838552|P3|COMPLETED|Period C: Days 12 to 20||0
341227|NCT02598128|838553|P2|COMPLETED|Period C: Days 12 to 20||0
341228|NCT02598128|838554|P1|COMPLETED|Period C: Days 12 to 20||0
341229|NCT02598128|838551|P4|STARTED|Period C: Days 12 to 20||33
341230|NCT02598128|838552|P3|STARTED|Period C: Days 12 to 20||0
341231|NCT02598128|838553|P2|STARTED|Period C: Days 12 to 20||0
341232|NCT02598128|838554|P1|STARTED|Period C: Days 12 to 20||0
341233|NCT02598128|838551|P4|NOT COMPLETED|Period B: Days 1 to 11||0
341234|NCT02598128|838552|P3|NOT COMPLETED|Period B: Days 1 to 11||0
341235|NCT02598128|838553|P2|NOT COMPLETED|Period B: Days 1 to 11||0
341236|NCT02598128|838554|P1|NOT COMPLETED|Period B: Days 1 to 11||0
341237|NCT02598128|838551|P4|COMPLETED|Period B: Days 1 to 11||0
341238|NCT02598128|838552|P3|COMPLETED|Period B: Days 1 to 11||16
341239|NCT02598128|838553|P2|COMPLETED|Period B: Days 1 to 11||17
341240|NCT02598128|838554|P1|COMPLETED|Period B: Days 1 to 11||0
341241|NCT02598128|838551|P4|STARTED|Period B: Days 1 to 11||0
341242|NCT02598128|838552|P3|STARTED|Period B: Days 1 to 11||16
341243|NCT02598128|838553|P2|STARTED|Period B: Days 1 to 11||17
341244|NCT02598128|838554|P1|STARTED|Period B: Days 1 to 11||0
341245|NCT02598128|838551|P4|NOT COMPLETED|Period A: Days -7 to -1||0
341246|NCT02598128|838552|P3|NOT COMPLETED|Period A: Days -7 to -1||0
341247|NCT02598128|838553|P2|NOT COMPLETED|Period A: Days -7 to -1||0
341248|NCT02598128|838554|P1|NOT COMPLETED|Period A: Days -7 to -1||1
341249|NCT02598128|838551|P4|COMPLETED|Period A: Days -7 to -1||0
341250|NCT02598128|838552|P3|COMPLETED|Period A: Days -7 to -1||0
341251|NCT02598128|838553|P2|COMPLETED|Period A: Days -7 to -1||0
341252|NCT02598128|838554|P1|COMPLETED|Period A: Days -7 to -1||33
341253|NCT02598128|838551|P4|STARTED|Period A: Days -7 to -1||0
341254|NCT02598128|838552|P3|STARTED|Period A: Days -7 to -1||0
341255|NCT02598128|838553|P2|STARTED|Period A: Days -7 to -1||0
341256|NCT02598128|838554|P1|STARTED|Period A: Days -7 to -1||34
341257|NCT02597907|838568|P2|NOT COMPLETED|Overall Study||0
341258|NCT02597907|838569|P1|NOT COMPLETED|Overall Study||0
341259|NCT02597907|838568|P2|COMPLETED|Overall Study||44
341260|NCT02597907|838569|P1|COMPLETED|Overall Study||44
341261|NCT02597907|838568|P2|STARTED|Overall Study||44
341262|NCT02597907|838569|P1|STARTED|Overall Study||44
341263|NCT02597855|838577|P2|NOT COMPLETED|Overall Study||1
341264|NCT02597855|838578|P1|NOT COMPLETED|Overall Study||2
341265|NCT02597855|838577|P2|COMPLETED|Overall Study||13
341266|NCT02597855|838578|P1|COMPLETED|Overall Study||16
341267|NCT02597855|838577|P2|STARTED|Overall Study||14
341268|NCT02597855|838578|P1|STARTED|Overall Study||18
341269|NCT02597582|838588|P2|NOT COMPLETED|Overall Study||0
341270|NCT02597582|838589|P1|NOT COMPLETED|Overall Study||0
341271|NCT02597582|838588|P2|COMPLETED|Overall Study||20
341272|NCT02597582|838589|P1|COMPLETED|Overall Study||21
341273|NCT02597582|838588|P2|STARTED|Overall Study||20
341274|NCT02597582|838589|P1|STARTED|Overall Study||21
341275|NCT02597543|838607|P2|NOT COMPLETED|Overall Study||0
341276|NCT02597543|838608|P1|NOT COMPLETED|Overall Study||0
341277|NCT02597543|838607|P2|COMPLETED|Overall Study||8
341278|NCT02597543|838608|P1|COMPLETED|Overall Study||6
341279|NCT02597543|838607|P2|STARTED|Overall Study||8
341280|NCT02597543|838608|P1|STARTED|Overall Study||6
341281|NCT02597049|838627|P3|NOT COMPLETED|Overall Study||3
341282|NCT02597049|838628|P2|NOT COMPLETED|Overall Study||5
341283|NCT02597049|838629|P1|NOT COMPLETED|Overall Study||7
341284|NCT02597049|838627|P3|COMPLETED|Overall Study||137
341285|NCT02597049|838628|P2|COMPLETED|Overall Study||137
341286|NCT02597049|838629|P1|COMPLETED|Overall Study||135
341287|NCT02597049|838627|P3|Received at Least One Dose of Study Drug|Overall Study||140
341288|NCT02597049|838628|P2|Received at Least One Dose of Study Drug|Overall Study||141
341289|NCT02597049|838629|P1|Received at Least One Dose of Study Drug|Overall Study||142
341290|NCT02597049|838627|P3|STARTED|Overall Study||140
341291|NCT02597049|838628|P2|STARTED|Overall Study||142
341292|NCT02597049|838629|P1|STARTED|Overall Study||142
341293|NCT02596958|838667|P1|NOT COMPLETED|Overall Study||996
341294|NCT02596958|838667|P1|COMPLETED|Overall Study||0
341295|NCT02596958|838667|P1|STARTED|Overall Study||996
341296|NCT02596945|838679|P1|NOT COMPLETED|Overall Study||56
341297|NCT02596945|838679|P1|COMPLETED|Overall Study||167
341298|NCT02596945|838679|P1|Treated|Overall Study||220
341299|NCT02596945|838679|P1|STARTED|Overall Study||223
341300|NCT02596867|838685|P1|NOT COMPLETED|Overall Study||0
341301|NCT02596867|838685|P1|COMPLETED|Overall Study||2
341302|NCT02596867|838685|P1|2 Patients Prospectively Recruited|Overall Study||2
341303|NCT02596867|838685|P1|STARTED|Overall Study||2
341304|NCT02596854|838690|P1|NOT COMPLETED|Overall Study||8
341305|NCT02596854|838690|P1|COMPLETED|Overall Study||109
341306|NCT02596854|838690|P1|STARTED|Overall Study||117
341307|NCT02596620|838696|P2|NOT COMPLETED|Overall Study||1
341308|NCT02596620|838697|P1|NOT COMPLETED|Overall Study||1
341309|NCT02596620|838696|P2|COMPLETED|Overall Study|Completed on 30th September 2015|81
341310|NCT02596620|838697|P1|COMPLETED|Overall Study|Completed on 30th September 2015|81
341311|NCT02596620|838696|P2|STARTED|Overall Study|Started from 1st October 2013|82
341312|NCT02596620|838697|P1|STARTED|Overall Study|Started from 1st October 2013|82
341313|NCT02596451|838706|P3|NOT COMPLETED|Overall Study||14
341314|NCT02596451|838707|P2|NOT COMPLETED|Overall Study||18
341315|NCT02596451|838708|P1|NOT COMPLETED|Overall Study||4
341316|NCT02596451|838706|P3|COMPLETED|Overall Study||373
341317|NCT02596451|838707|P2|COMPLETED|Overall Study||374
341318|NCT02596451|838708|P1|COMPLETED|Overall Study||381
341319|NCT02596451|838706|P3|STARTED|Overall Study||387
341320|NCT02596451|838707|P2|STARTED|Overall Study||392
341321|NCT02596451|838708|P1|STARTED|Overall Study||385
341322|NCT02596321|838717|P2|NOT COMPLETED|Overall Study||0
341323|NCT02596321|838718|P1|NOT COMPLETED|Overall Study||3
341324|NCT02596321|838717|P2|COMPLETED|Overall Study||56
341325|NCT02596321|838718|P1|COMPLETED|Overall Study||53
341326|NCT02596321|838717|P2|STARTED|Overall Study||56
341327|NCT02596321|838718|P1|STARTED|Overall Study||56
341328|NCT02596022|838732|P2|NOT COMPLETED|Overall Study||0
341329|NCT02596022|838733|P1|NOT COMPLETED|Overall Study||0
341330|NCT02596022|838732|P2|COMPLETED|Overall Study||8
341331|NCT02596022|838733|P1|COMPLETED|Overall Study||10
341332|NCT02596022|838732|P2|STARTED|Overall Study||8
341333|NCT02596022|838733|P1|STARTED|Overall Study||10
341334|NCT02596009|838739|P6|NOT COMPLETED|Overall Study||0
341335|NCT02596009|838740|P5|NOT COMPLETED|Overall Study||0
341336|NCT02596009|838741|P4|NOT COMPLETED|Overall Study||0
341337|NCT02596009|838742|P3|NOT COMPLETED|Overall Study||0
341338|NCT02596009|838743|P2|NOT COMPLETED|Overall Study||1
341339|NCT02596009|838744|P1|NOT COMPLETED|Overall Study||0
341340|NCT02596009|838739|P6|COMPLETED|Overall Study||17
341341|NCT02596009|838740|P5|COMPLETED|Overall Study||18
341342|NCT02596009|838741|P4|COMPLETED|Overall Study||16
341343|NCT02596009|838742|P3|COMPLETED|Overall Study||16
341344|NCT02596009|838743|P2|COMPLETED|Overall Study||15
341345|NCT02596009|838744|P1|COMPLETED|Overall Study||14
341346|NCT02596009|838739|P6|STARTED|Overall Study||17
341347|NCT02596009|838740|P5|STARTED|Overall Study||18
341348|NCT02596009|838741|P4|STARTED|Overall Study||16
341349|NCT02596009|838742|P3|STARTED|Overall Study||16
341350|NCT02596009|838743|P2|STARTED|Overall Study||16
341351|NCT02596009|838744|P1|STARTED|Overall Study||14
341352|NCT02595567|838753|P1|NOT COMPLETED|Overall Study||0
341353|NCT02595567|838753|P1|COMPLETED|Overall Study||25
341354|NCT02595567|838753|P1|STARTED|Overall Study||25
341355|NCT02595502|838757|P2|NOT COMPLETED|Period 3||2
341356|NCT02595502|838758|P1|NOT COMPLETED|Period 3||1
341357|NCT02595502|838757|P2|COMPLETED|Period 3||136
341358|NCT02595502|838758|P1|COMPLETED|Period 3||140
341359|NCT02595502|838757|P2|STARTED|Period 3||138
341360|NCT02595502|838758|P1|STARTED|Period 3||141
341361|NCT02595502|838757|P2|NOT COMPLETED|Period 2||2
341362|NCT02595502|838758|P1|NOT COMPLETED|Period 2||1
341363|NCT02595502|838757|P2|COMPLETED|Period 2||138
341364|NCT02595502|838758|P1|COMPLETED|Period 2||141
341365|NCT02595502|838757|P2|STARTED|Period 2||140
341366|NCT02595502|838758|P1|STARTED|Period 2||142
341367|NCT02595502|838757|P2|NOT COMPLETED|Period 1||2
341368|NCT02595502|838758|P1|NOT COMPLETED|Period 1||1
341369|NCT02595502|838757|P2|COMPLETED|Period 1||140
341370|NCT02595502|838758|P1|COMPLETED|Period 1||142
341371|NCT02595502|838757|P2|STARTED|Period 1||142
341372|NCT02595502|838758|P1|STARTED|Period 1||143
341373|NCT02595450|838764|P1|NOT COMPLETED|Overall Study||81
341374|NCT02595450|838764|P1|COMPLETED|Overall Study||218
341375|NCT02595450|838764|P1|Treated|Overall Study||291
341376|NCT02595450|838764|P1|STARTED|Overall Study||299
341377|NCT02594826|838772|P2|NOT COMPLETED|Overall Study||60
341378|NCT02594826|838773|P1|NOT COMPLETED|Overall Study||57
341379|NCT02594826|838772|P2|COMPLETED|Overall Study||298
341380|NCT02594826|838773|P1|COMPLETED|Overall Study||290
341381|NCT02594826|838772|P2|STARTED|Overall Study||358
341382|NCT02594826|838773|P1|STARTED|Overall Study||347
341383|NCT02593773|838779|P1|NOT COMPLETED|Overall Study||35
341384|NCT02593773|838779|P1|COMPLETED|Overall Study||51
341385|NCT02593773|838779|P1|STARTED|Overall Study||86
341386|NCT02592655|838791|P1|NOT COMPLETED|Fourth Tourniquet Right Thigh.||0
341387|NCT02592655|838791|P1|COMPLETED|Fourth Tourniquet Right Thigh.||4
341388|NCT02592655|838791|P1|Tourniquet Tape 5 cm Width|Fourth Tourniquet Right Thigh.||0
341389|NCT02592655|838791|P1|Tourniquet Tape 10 cm Width|Fourth Tourniquet Right Thigh.||3
341390|NCT02592655|838791|P1|Windlass Tourniquet|Fourth Tourniquet Right Thigh.||0
341391|NCT02592655|838791|P1|ATS (Pneumatic)|Fourth Tourniquet Right Thigh.||1
341392|NCT02592655|838791|P1|STARTED|Fourth Tourniquet Right Thigh.|Only the first 4 participants received all four interventions.|4
341393|NCT02592655|838791|P1|NOT COMPLETED|Third Tourniquet, Left Thigh.||0
341394|NCT02592655|838791|P1|COMPLETED|Third Tourniquet, Left Thigh.||19
341395|NCT02592655|838791|P1|Tourniquet Tape 5 cm Width|Third Tourniquet, Left Thigh.||1
341396|NCT02592655|838791|P1|Tourniquet Tape 10 cm Width|Third Tourniquet, Left Thigh.||6
341397|NCT02592655|838791|P1|Windlass Tourniquet|Third Tourniquet, Left Thigh.||4
341398|NCT02592655|838791|P1|ATS (Pneumatic)|Third Tourniquet, Left Thigh.||8
341399|NCT02592655|838791|P1|STARTED|Third Tourniquet, Left Thigh.||19
341400|NCT02592655|838791|P1|NOT COMPLETED|Second Tourniquet Right Thigh.||0
341401|NCT02592655|838791|P1|COMPLETED|Second Tourniquet Right Thigh.||19
341402|NCT02592655|838791|P1|Tourniquet Tape 5 cm Width|Second Tourniquet Right Thigh.||1
341403|NCT02592655|838791|P1|Tourniquet Tape 10 cm Width|Second Tourniquet Right Thigh.||5
341404|NCT02592655|838791|P1|Windlass Tourniquet|Second Tourniquet Right Thigh.||8
341405|NCT02592655|838791|P1|ATS (Pneumatic)|Second Tourniquet Right Thigh.||5
341406|NCT02592655|838791|P1|STARTED|Second Tourniquet Right Thigh.||19
341407|NCT02592655|838791|P1|NOT COMPLETED|First Tourniquet, Left Thigh.||0
341408|NCT02592655|838791|P1|COMPLETED|First Tourniquet, Left Thigh.||19
341409|NCT02592655|838791|P1|Tourniquet Tape 5 cm Width|First Tourniquet, Left Thigh.||2
341410|NCT02592655|838791|P1|Tourniquet Tape 10 cm Width|First Tourniquet, Left Thigh.||5
341411|NCT02592655|838791|P1|Windlass Tourniquet|First Tourniquet, Left Thigh.||7
341412|NCT02592655|838791|P1|ATS (Pneumatic)|First Tourniquet, Left Thigh.||5
341413|NCT02592655|838791|P1|STARTED|First Tourniquet, Left Thigh.||19
341414|NCT02591537|838808|P2|NOT COMPLETED|Overall Study||0
341415|NCT02591537|838809|P1|NOT COMPLETED|Overall Study||0
341416|NCT02591537|838808|P2|COMPLETED|Overall Study||8
341417|NCT02591537|838809|P1|COMPLETED|Overall Study||8
341418|NCT02591537|838808|P2|STARTED|Overall Study||8
341419|NCT02591537|838809|P1|STARTED|Overall Study||8
341420|NCT02591290|838829|P1|NOT COMPLETED|Overall Study||2
341421|NCT02591290|838829|P1|COMPLETED|Overall Study||58
341422|NCT02591290|838829|P1|Vaccinated Dose 2|Overall Study||58
341423|NCT02591290|838829|P1|Vaccinated Dose 1|Overall Study||60
341424|NCT02591290|838829|P1|STARTED|Overall Study||60
341425|NCT02591238|838839|P4|NOT COMPLETED|Overall Study||3
341426|NCT02591238|838840|P3|NOT COMPLETED|Overall Study||0
341427|NCT02591238|838841|P2|NOT COMPLETED|Overall Study||1
341428|NCT02591238|838842|P1|NOT COMPLETED|Overall Study||1
341429|NCT02591238|838839|P4|COMPLETED|Overall Study||15
341430|NCT02591238|838840|P3|COMPLETED|Overall Study||17
341431|NCT02591238|838841|P2|COMPLETED|Overall Study||16
341432|NCT02591238|838842|P1|COMPLETED|Overall Study||15
341433|NCT02591238|838839|P4|STARTED|Overall Study||18
341434|NCT02591238|838840|P3|STARTED|Overall Study||17
341435|NCT02591238|838841|P2|STARTED|Overall Study||17
341436|NCT02591238|838842|P1|STARTED|Overall Study||16
341437|NCT02591056|838872|P1|NOT COMPLETED|Overall Study||0
341438|NCT02591056|838872|P1|COMPLETED|Overall Study||27
341439|NCT02591056|838872|P1|STARTED|Overall Study||27
341440|NCT02590939|838878|P2|NOT COMPLETED|Overall Study||2
341441|NCT02590939|838879|P1|NOT COMPLETED|Overall Study||5
341442|NCT02590939|838878|P2|COMPLETED|Overall Study||52
341443|NCT02590939|838879|P1|COMPLETED|Overall Study||47
341444|NCT02590939|838878|P2|STARTED|Overall Study||54
341445|NCT02590939|838879|P1|STARTED|Overall Study||52
341446|NCT02590588|838899|P1|NOT COMPLETED|Overall Study||1
341447|NCT02590588|838899|P1|COMPLETED|Overall Study||0
341448|NCT02590588|838899|P1|STARTED|Overall Study||1
341449|NCT02590562|838907|P1|NOT COMPLETED|Overall Study||6
341450|NCT02590562|838907|P1|COMPLETED|Overall Study||802
341451|NCT02590562|838907|P1|STARTED|Overall Study||808
341452|NCT02590003|838966|P2|NOT COMPLETED|Overall Study||2
341453|NCT02590003|838967|P1|NOT COMPLETED|Overall Study||1
341454|NCT02590003|838966|P2|COMPLETED|Overall Study||0
341455|NCT02590003|838967|P1|COMPLETED|Overall Study||0
341456|NCT02590003|838966|P2|STARTED|Overall Study||2
341457|NCT02590003|838967|P1|STARTED|Overall Study||1
341458|NCT02588976|838987|P1|NOT COMPLETED|Overall Study||0
341459|NCT02588976|838987|P1|COMPLETED|Overall Study||30
341460|NCT02588976|838987|P1|STARTED|Overall Study||30
341461|NCT02588872|838994|P2|NOT COMPLETED|Overall Study||0
341462|NCT02588872|838995|P1|NOT COMPLETED|Overall Study||0
341463|NCT02588872|838994|P2|COMPLETED|Overall Study||52
341464|NCT02588872|838995|P1|COMPLETED|Overall Study||59
341465|NCT02588872|838994|P2|STARTED|Overall Study||52
341466|NCT02588872|838995|P1|STARTED|Overall Study||59
341467|NCT02588599|839009|P1|NOT COMPLETED|Overall Study||0
341468|NCT02588599|839009|P1|COMPLETED|Overall Study||54
341469|NCT02588599|839009|P1|STARTED|Overall Study||54
341470|NCT02587819|839014|P1|NOT COMPLETED|Overall Study||2
341471|NCT02587819|839014|P1|COMPLETED|Overall Study||19
341472|NCT02587819|839014|P1|Exposed|Overall Study||21
341473|NCT02587819|839014|P1|STARTED|Overall Study||21
341474|NCT02587234|839023|P2|NOT COMPLETED|Overall Study||3
341475|NCT02587234|839024|P1|NOT COMPLETED|Overall Study||1
341476|NCT02587234|839023|P2|COMPLETED|Overall Study||7
341477|NCT02587234|839024|P1|COMPLETED|Overall Study||10
341478|NCT02587234|839023|P2|STARTED|Overall Study||10
341479|NCT02587234|839024|P1|STARTED|Overall Study||11
341480|NCT02587117|839036|P2|NOT COMPLETED|Overall Study||0
341481|NCT02587117|839037|P1|NOT COMPLETED|Overall Study||0
341482|NCT02587117|839036|P2|COMPLETED|Overall Study||15
341483|NCT02587117|839037|P1|COMPLETED|Overall Study||13
341484|NCT02587117|839036|P2|STARTED|Overall Study||15
341485|NCT02587117|839037|P1|STARTED|Overall Study||13
341486|NCT02586805|839049|P4|NOT COMPLETED|Overall Study||2
341487|NCT02586805|839050|P3|NOT COMPLETED|Overall Study||3
341488|NCT02586805|839051|P2|NOT COMPLETED|Overall Study||1
341489|NCT02586805|839052|P1|NOT COMPLETED|Overall Study||6
341490|NCT02586805|839049|P4|COMPLETED|Overall Study||25
341491|NCT02586805|839050|P3|COMPLETED|Overall Study||26
341492|NCT02586805|839051|P2|COMPLETED|Overall Study||27
341493|NCT02586805|839052|P1|COMPLETED|Overall Study||35
341494|NCT02586805|839049|P4|STARTED|Overall Study||27
341495|NCT02586805|839050|P3|STARTED|Overall Study||29
341496|NCT02586805|839051|P2|STARTED|Overall Study||28
341497|NCT02586805|839052|P1|STARTED|Overall Study||41
341498|NCT02586506|839074|P1|NOT COMPLETED|Overall Study||9
341499|NCT02586506|839074|P1|COMPLETED|Overall Study||250
341500|NCT02586506|839074|P1|STARTED|Overall Study||259
341501|NCT02586493|839080|P1|NOT COMPLETED|Overall Study||12
341502|NCT02586493|839080|P1|COMPLETED|Overall Study||266
341503|NCT02586493|839080|P1|STARTED|Overall Study||278
341504|NCT02585999|839086|P1|NOT COMPLETED|Overall Study||2
341505|NCT02585999|839086|P1|COMPLETED|Overall Study|28 participants enrolled; 2 withdrew prior to starting, leaving 26 to complete study activity.|26
341506|NCT02585999|839086|P1|STARTED|Overall Study||28
341507|NCT02585895|839093|P2|NOT COMPLETED|Post-primary Period||0
341508|NCT02585895|839094|P1|NOT COMPLETED|Post-primary Period||0
341509|NCT02585895|839093|P2|COMPLETED|Post-primary Period||19
341510|NCT02585895|839094|P1|COMPLETED|Post-primary Period||20
341511|NCT02585895|839093|P2|STARTED|Post-primary Period||19
341512|NCT02585895|839094|P1|STARTED|Post-primary Period||20
341513|NCT02585895|839093|P2|NOT COMPLETED|Primary Period||0
341514|NCT02585895|839094|P1|NOT COMPLETED|Primary Period||0
341515|NCT02585895|839093|P2|COMPLETED|Primary Period||19
341516|NCT02585895|839094|P1|COMPLETED|Primary Period||20
341517|NCT02585895|839093|P2|STARTED|Primary Period||19
341518|NCT02585895|839094|P1|STARTED|Primary Period||20
341519|NCT02585778|839113|P2|NOT COMPLETED|Overall Study||15
341520|NCT02585778|839114|P1|NOT COMPLETED|Overall Study||33
341521|NCT02585778|839113|P2|COMPLETED|Overall Study||157
341522|NCT02585778|839114|P1|COMPLETED|Overall Study||312
341523|NCT02585778|839113|P2|T2DM Participants|Overall Study||147
341524|NCT02585778|839114|P1|T2DM Participants|Overall Study||294
341525|NCT02585778|839113|P2|T1DM Participants|Overall Study||25
341526|NCT02585778|839114|P1|T1DM Participants|Overall Study||51
341527|NCT02585778|839113|P2|mITT Population|Overall Study||164
341528|NCT02585778|839114|P1|mITT Population|Overall Study||333
341529|NCT02585778|839113|P2|ITT Population|Overall Study||167
341530|NCT02585778|839114|P1|ITT Population|Overall Study||336
341531|NCT02585778|839113|P2|Treated (Safety Population)|Overall Study||170
341532|NCT02585778|839114|P1|Treated (Safety Population)|Overall Study||344
341533|NCT02585778|839113|P2|STARTED|Overall Study|Randomized|172
341534|NCT02585778|839114|P1|STARTED|Overall Study|Randomized|345
341535|NCT02585245|839228|P1|NOT COMPLETED|Overall Study||13
341536|NCT02585245|839228|P1|COMPLETED|Overall Study||594
341537|NCT02585245|839228|P1|STARTED|Overall Study||607
341538|NCT02584790|839233|P1|NOT COMPLETED|Overall Study||15
341539|NCT02584790|839233|P1|COMPLETED|Overall Study||40
341540|NCT02584790|839233|P1|STARTED|Overall Study||55
341541|NCT02584686|839241|P2|NOT COMPLETED|Overall Study||0
341542|NCT02584686|839242|P1|NOT COMPLETED|Overall Study||0
341543|NCT02584686|839241|P2|COMPLETED|Overall Study||12
341544|NCT02584686|839242|P1|COMPLETED|Overall Study||12
341545|NCT02584686|839241|P2|STARTED|Overall Study||12
341546|NCT02584686|839242|P1|STARTED|Overall Study||12
341547|NCT02584673|839270|P2|NOT COMPLETED|Overall Study||0
341548|NCT02584673|839271|P1|NOT COMPLETED|Overall Study||0
341549|NCT02584673|839270|P2|COMPLETED|Overall Study||15
341550|NCT02584673|839271|P1|COMPLETED|Overall Study||15
341551|NCT02584673|839270|P2|STARTED|Overall Study||15
341552|NCT02584673|839271|P1|STARTED|Overall Study||15
341553|NCT02584660|839285|P2|NOT COMPLETED|Overall Study||8
341554|NCT02584660|839286|P1|NOT COMPLETED|Overall Study||7
341555|NCT02584660|839285|P2|COMPLETED|Overall Study||55
341556|NCT02584660|839286|P1|COMPLETED|Overall Study||44
341557|NCT02584660|839285|P2|Treated|Overall Study||63
341558|NCT02584660|839286|P1|Treated|Overall Study||49
341559|NCT02584660|839285|P2|STARTED|Overall Study||63
341560|NCT02584660|839286|P1|STARTED|Overall Study||51
341561|NCT02584504|839305|P3|NOT COMPLETED|Open-label Treatment||55
341562|NCT02584504|839306|P2|NOT COMPLETED|Open-label Treatment||51
341563|NCT02584504|839307|P1|NOT COMPLETED|Open-label Treatment||54
341564|NCT02584504|839305|P3|COMPLETED|Open-label Treatment||0
341565|NCT02584504|839306|P2|COMPLETED|Open-label Treatment||0
341566|NCT02584504|839307|P1|COMPLETED|Open-label Treatment||0
341567|NCT02584504|839305|P3|Completed 12 Week Treatment|Open-label Treatment||52
341568|NCT02584504|839306|P2|Completed 12 Week Treatment|Open-label Treatment||49
341569|NCT02584504|839307|P1|Completed 12 Week Treatment|Open-label Treatment||54
341570|NCT02584504|839305|P3|Treated|Open-label Treatment||54
341571|NCT02584504|839306|P2|Treated|Open-label Treatment||50
341572|NCT02584504|839307|P1|Treated|Open-label Treatment||54
341573|NCT02584504|839305|P3|STARTED|Open-label Treatment||55
341574|NCT02584504|839306|P2|STARTED|Open-label Treatment||51
341575|NCT02584504|839307|P1|STARTED|Open-label Treatment||54
341576|NCT02584504|839305|P3|NOT COMPLETED|Double-blind Treatment||1
341577|NCT02584504|839306|P2|NOT COMPLETED|Double-blind Treatment||2
341578|NCT02584504|839307|P1|NOT COMPLETED|Double-blind Treatment||0
341579|NCT02584504|839305|P3|COMPLETED|Double-blind Treatment||55
341580|NCT02584504|839306|P2|COMPLETED|Double-blind Treatment||51
341581|NCT02584504|839307|P1|COMPLETED|Double-blind Treatment||54
341582|NCT02584504|839305|P3|Safety Population|Double-blind Treatment||56
341583|NCT02584504|839306|P2|Safety Population|Double-blind Treatment||53
341584|NCT02584504|839307|P1|Safety Population|Double-blind Treatment||54
341585|NCT02584504|839305|P3|mITT Population|Double-blind Treatment||56
341586|NCT02584504|839306|P2|mITT Population|Double-blind Treatment||53
341587|NCT02584504|839307|P1|mITT Population|Double-blind Treatment||54
341588|NCT02584504|839305|P3|ITT Population|Double-blind Treatment||56
341589|NCT02584504|839306|P2|ITT Population|Double-blind Treatment||53
341590|NCT02584504|839307|P1|ITT Population|Double-blind Treatment||54
341591|NCT02584504|839305|P3|STARTED|Double-blind Treatment|Randomized|56
341592|NCT02584504|839306|P2|STARTED|Double-blind Treatment|Randomized|53
341593|NCT02584504|839307|P1|STARTED|Double-blind Treatment|Randomized|54
341594|NCT02583425|839358|P1|NOT COMPLETED|Treatment Period||1
341595|NCT02583425|839358|P1|COMPLETED|Treatment Period||9
341596|NCT02583425|839358|P1|STARTED|Treatment Period||10
341597|NCT02583425|839358|P1|NOT COMPLETED|Baseline||5
341598|NCT02583425|839358|P1|COMPLETED|Baseline||10
341599|NCT02583425|839358|P1|STARTED|Baseline||15
341600|NCT02583425|839358|P1|NOT COMPLETED|Screening||12
341601|NCT02583425|839358|P1|COMPLETED|Screening||15
341602|NCT02583425|839358|P1|STARTED|Screening||27
341603|NCT02582983|839363|P1|NOT COMPLETED|Overall Study||6
341604|NCT02582983|839363|P1|COMPLETED|Overall Study||17
341605|NCT02582983|839363|P1|STARTED|Overall Study||23
341606|NCT02582970|839368|P1|NOT COMPLETED|Overall Study||0
341607|NCT02582970|839368|P1|COMPLETED|Overall Study||40
341608|NCT02582970|839368|P1|STARTED|Overall Study||40
341609|NCT02582684|839378|P1|NOT COMPLETED|Overall Study||17
341610|NCT02582684|839378|P1|COMPLETED|Overall Study||105
341611|NCT02582684|839378|P1|STARTED|Overall Study||122
341612|NCT02582632|839397|P1|NOT COMPLETED|Overall Study||1
341613|NCT02582632|839397|P1|COMPLETED|Overall Study||165
341614|NCT02582632|839397|P1|STARTED|Overall Study||166
341615|NCT02582242|839412|P2|NOT COMPLETED|Overall Study||17
341616|NCT02582242|839413|P1|NOT COMPLETED|Overall Study||20
341617|NCT02582242|839412|P2|COMPLETED|Overall Study||200
341618|NCT02582242|839413|P1|COMPLETED|Overall Study||200
341619|NCT02582242|839412|P2|STARTED|Overall Study||217
341620|NCT02582242|839413|P1|STARTED|Overall Study||220
341621|NCT02581475|839455|P2|NOT COMPLETED|Overall Study||15
341622|NCT02581475|839456|P1|NOT COMPLETED|Overall Study||11
341623|NCT02581475|839455|P2|COMPLETED|Overall Study||178
341624|NCT02581475|839456|P1|COMPLETED|Overall Study||182
341625|NCT02581475|839455|P2|STARTED|Overall Study||193
341626|NCT02581475|839456|P1|STARTED|Overall Study||193
341627|NCT02581410|839470|P2|NOT COMPLETED|Overall Study||3
341628|NCT02581410|839471|P1|NOT COMPLETED|Overall Study||2
341629|NCT02581410|839470|P2|COMPLETED|Overall Study||212
341630|NCT02581410|839471|P1|COMPLETED|Overall Study||213
341631|NCT02581410|839470|P2|STARTED|Overall Study||215
341632|NCT02581410|839471|P1|STARTED|Overall Study||215
341633|NCT02580799|839491|P1|NOT COMPLETED|Overall Study||0
341634|NCT02580799|839491|P1|COMPLETED|Overall Study||30
341635|NCT02580799|839491|P1|STARTED|Overall Study||30
341636|NCT02580357|839516|P3|NOT COMPLETED|Overall Study||0
341637|NCT02580357|839517|P2|NOT COMPLETED|Overall Study||0
341638|NCT02580357|839518|P1|NOT COMPLETED|Overall Study||3
341639|NCT02580357|839516|P3|COMPLETED|Overall Study||18
341640|NCT02580357|839517|P2|COMPLETED|Overall Study||18
341641|NCT02580357|839518|P1|COMPLETED|Overall Study||15
341642|NCT02580357|839516|P3|STARTED|Overall Study||18
341643|NCT02580357|839517|P2|STARTED|Overall Study||18
341644|NCT02580357|839518|P1|STARTED|Overall Study||18
341645|NCT02580318|839529|P1|NOT COMPLETED|Overall Study||0
341646|NCT02580318|839529|P1|COMPLETED|Overall Study||54
341647|NCT02580318|839529|P1|Drinking Water (5 Minutes)|Overall Study||54
341648|NCT02580318|839529|P1|Drinking Water (Immediate)|Overall Study||51
341649|NCT02580318|839529|P1|Hyperventilation (10 Minutes)|Overall Study||54
341650|NCT02580318|839529|P1|Hyperventilation (5 Minutes)|Overall Study||54
341651|NCT02580318|839529|P1|Hyperventilation (Immediate)|Overall Study||54
341652|NCT02580318|839529|P1|Poor Effort|Overall Study||53
341653|NCT02580318|839529|P1|STARTED|Overall Study||54
341654|NCT02580240|839535|P2|NOT COMPLETED|Overall Study||0
341655|NCT02580240|839536|P1|NOT COMPLETED|Overall Study||2
341656|NCT02580240|839535|P2|COMPLETED|Overall Study||58
341657|NCT02580240|839536|P1|COMPLETED|Overall Study||60
341658|NCT02580240|839535|P2|STARTED|Overall Study||58
341659|NCT02580240|839536|P1|STARTED|Overall Study||62
341660|NCT02579772|839544|P2|NOT COMPLETED|Overall Study||2
341661|NCT02579772|839545|P1|NOT COMPLETED|Overall Study||2
341662|NCT02579772|839544|P2|COMPLETED|Overall Study||3
341663|NCT02579772|839545|P1|COMPLETED|Overall Study||6
341664|NCT02579772|839544|P2|STARTED|Overall Study||5
341665|NCT02579772|839545|P1|STARTED|Overall Study||8
341666|NCT02579603|839565|P2|NOT COMPLETED|Overall Study||2
341667|NCT02579603|839566|P1|NOT COMPLETED|Overall Study||4
341668|NCT02579603|839565|P2|COMPLETED|Overall Study||51
341669|NCT02579603|839566|P1|COMPLETED|Overall Study||48
341670|NCT02579603|839565|P2|Number of Patients Treated|Overall Study||53
341671|NCT02579603|839566|P1|Number of Patients Treated|Overall Study||51
341672|NCT02579603|839565|P2|STARTED|Overall Study|Started are the randomised patients|53
341673|NCT02579603|839566|P1|STARTED|Overall Study|Started are the randomised patients|52
341674|NCT02579057|839577|P2|NOT COMPLETED|Overall Study||0
341675|NCT02579057|839578|P1|NOT COMPLETED|Overall Study||0
341676|NCT02579057|839577|P2|COMPLETED|Overall Study||21
341677|NCT02579057|839578|P1|COMPLETED|Overall Study||19
341678|NCT02579057|839577|P2|STARTED|Overall Study||21
341679|NCT02579057|839578|P1|STARTED|Overall Study||19
341680|NCT02578992|839592|P2|NOT COMPLETED|Overall Study||3
341681|NCT02578992|839593|P1|NOT COMPLETED|Overall Study||3
341682|NCT02578992|839592|P2|COMPLETED|Overall Study|October 2015|62
341683|NCT02578992|839593|P1|COMPLETED|Overall Study|October 2015|62
341684|NCT02578992|839592|P2|STARTED|Overall Study|November 2014|65
341685|NCT02578992|839593|P1|STARTED|Overall Study|November 2014|65
341686|NCT02578706|839608|P3|NOT COMPLETED|Overall Study||0
341687|NCT02578706|839609|P2|NOT COMPLETED|Overall Study||5
341688|NCT02578706|839610|P1|NOT COMPLETED|Overall Study||1
341689|NCT02578706|839608|P3|COMPLETED|Overall Study||8
341690|NCT02578706|839609|P2|COMPLETED|Overall Study||5
341691|NCT02578706|839610|P1|COMPLETED|Overall Study||8
341692|NCT02578706|839608|P3|STARTED|Overall Study||8
341693|NCT02578706|839609|P2|STARTED|Overall Study||10
341694|NCT02578706|839610|P1|STARTED|Overall Study||9
341695|NCT02578316|839687|P1|NOT COMPLETED|Extension Phase||6
341696|NCT02578316|839687|P1|COMPLETED|Extension Phase||0
341697|NCT02578316|839687|P1|STARTED|Extension Phase||6
341698|NCT02578316|839687|P1|NOT COMPLETED|Study Phase||0
341699|NCT02578316|839687|P1|COMPLETED|Study Phase||6
341700|NCT02578316|839687|P1|STARTED|Study Phase||6
341701|NCT02578199|839711|P1|NOT COMPLETED|Overall Study||4
341702|NCT02578199|839711|P1|COMPLETED|Overall Study||27
341703|NCT02578199|839711|P1|STARTED|Overall Study||31
341704|NCT02578186|839716|P2|NOT COMPLETED|Period 2 (Second of Crossover)||0
341705|NCT02578186|839717|P1|NOT COMPLETED|Period 2 (Second of Crossover)||0
341706|NCT02578186|839716|P2|COMPLETED|Period 2 (Second of Crossover)||13
341707|NCT02578186|839717|P1|COMPLETED|Period 2 (Second of Crossover)||12
341708|NCT02578186|839716|P2|STARTED|Period 2 (Second of Crossover)||13
341709|NCT02578186|839717|P1|STARTED|Period 2 (Second of Crossover)||12
341710|NCT02578186|839716|P2|NOT COMPLETED|Period 1 (First of Crossover)||5
341711|NCT02578186|839717|P1|NOT COMPLETED|Period 1 (First of Crossover)||5
341712|NCT02578186|839716|P2|COMPLETED|Period 1 (First of Crossover)||13
341713|NCT02578186|839717|P1|COMPLETED|Period 1 (First of Crossover)||12
341714|NCT02578186|839716|P2|STARTED|Period 1 (First of Crossover)||18
341715|NCT02578186|839717|P1|STARTED|Period 1 (First of Crossover)||17
341716|NCT02577718|839723|P1|NOT COMPLETED|Overall Study||8
341717|NCT02577718|839723|P1|COMPLETED|Overall Study||52
341718|NCT02577718|839723|P1|STARTED|Overall Study||60
341719|NCT02577510|839729|P2|NOT COMPLETED|Overall Study||0
341720|NCT02577510|839730|P1|NOT COMPLETED|Overall Study||0
341721|NCT02577510|839729|P2|COMPLETED|Overall Study||21
341722|NCT02577510|839730|P1|COMPLETED|Overall Study||21
341723|NCT02577510|839729|P2|STARTED|Overall Study||21
341724|NCT02577510|839730|P1|STARTED|Overall Study||21
341725|NCT02577445|839744|P2|NOT COMPLETED|Overall Study||17
341726|NCT02577445|839745|P1|NOT COMPLETED|Overall Study||14
341727|NCT02577445|839744|P2|COMPLETED|Overall Study|study terminated prematurely|0
341728|NCT02577445|839745|P1|COMPLETED|Overall Study|study terminated prematurely|0
341729|NCT02577445|839744|P2|STARTED|Overall Study||17
341730|NCT02577445|839745|P1|STARTED|Overall Study||14
341731|NCT02577315|839758|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
341732|NCT02577315|839759|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
341733|NCT02577315|839758|P2|COMPLETED|Treatment Period 2 (4 Days)||12
341734|NCT02577315|839759|P1|COMPLETED|Treatment Period 2 (4 Days)||12
341735|NCT02577315|839758|P2|STARTED|Treatment Period 2 (4 Days)||12
341736|NCT02577315|839759|P1|STARTED|Treatment Period 2 (4 Days)||12
341737|NCT02577315|839758|P2|NOT COMPLETED|Washout Period (5 Days)||0
341738|NCT02577315|839759|P1|NOT COMPLETED|Washout Period (5 Days)||0
341739|NCT02577315|839758|P2|COMPLETED|Washout Period (5 Days)||12
341740|NCT02577315|839759|P1|COMPLETED|Washout Period (5 Days)||12
341741|NCT02577315|839758|P2|STARTED|Washout Period (5 Days)||12
341742|NCT02577315|839759|P1|STARTED|Washout Period (5 Days)||12
341743|NCT02577315|839758|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||1
341744|NCT02577315|839759|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||0
341745|NCT02577315|839758|P2|COMPLETED|Treatment Period 1 (4 Days)||12
341746|NCT02577315|839759|P1|COMPLETED|Treatment Period 1 (4 Days)||12
341747|NCT02577315|839758|P2|STARTED|Treatment Period 1 (4 Days)||13
341748|NCT02577315|839759|P1|STARTED|Treatment Period 1 (4 Days)||12
341749|NCT02577107|839777|P2|NOT COMPLETED|Overall Study||1
341750|NCT02577107|839778|P1|NOT COMPLETED|Overall Study||0
341751|NCT02577107|839777|P2|COMPLETED|Overall Study||5
341752|NCT02577107|839778|P1|COMPLETED|Overall Study||6
341753|NCT02577107|839777|P2|STARTED|Overall Study||6
341754|NCT02577107|839778|P1|STARTED|Overall Study||6
341755|NCT02577016|839792|P2|NOT COMPLETED|Overall Study||2
341756|NCT02577016|839793|P1|NOT COMPLETED|Overall Study||2
341757|NCT02577016|839792|P2|COMPLETED|Overall Study||69
341758|NCT02577016|839793|P1|COMPLETED|Overall Study||68
341759|NCT02577016|839792|P2|STARTED|Overall Study||71
341760|NCT02577016|839793|P1|STARTED|Overall Study||70
341761|NCT02577003|839811|P2|NOT COMPLETED|Overall Study||5
341762|NCT02577003|839812|P1|NOT COMPLETED|Overall Study||2
341763|NCT02577003|839811|P2|COMPLETED|Overall Study||65
341764|NCT02577003|839812|P1|COMPLETED|Overall Study||71
341765|NCT02577003|839811|P2|STARTED|Overall Study||70
341766|NCT02577003|839812|P1|STARTED|Overall Study||73
341767|NCT02576938|839833|P3|NOT COMPLETED|Overall Study||12
341768|NCT02576938|839834|P2|NOT COMPLETED|Overall Study||12
341769|NCT02576938|839835|P1|NOT COMPLETED|Overall Study||20
341770|NCT02576938|839833|P3|COMPLETED|Overall Study||26
341771|NCT02576938|839834|P2|COMPLETED|Overall Study||25
341772|NCT02576938|839835|P1|COMPLETED|Overall Study||29
341773|NCT02576938|839833|P3|Received at Least One Dose of Study Drug|Overall Study||38
341774|NCT02576938|839834|P2|Received at Least One Dose of Study Drug|Overall Study||37
341775|NCT02576938|839835|P1|Received at Least One Dose of Study Drug|Overall Study||49
341776|NCT02576938|839833|P3|STARTED|Overall Study||38
341777|NCT02576938|839834|P2|STARTED|Overall Study||37
341778|NCT02576938|839835|P1|STARTED|Overall Study||49
341779|NCT02576639|839868|P5|NOT COMPLETED|Overall Study||4
341780|NCT02576639|839869|P4|NOT COMPLETED|Overall Study||1
341781|NCT02576639|839870|P3|NOT COMPLETED|Overall Study||2
341782|NCT02576639|839871|P2|NOT COMPLETED|Overall Study||2
341783|NCT02576639|839872|P1|NOT COMPLETED|Overall Study||2
341784|NCT02576639|839868|P5|COMPLETED|Overall Study||20
341785|NCT02576639|839869|P4|COMPLETED|Overall Study||25
341786|NCT02576639|839870|P3|COMPLETED|Overall Study||23
341787|NCT02576639|839871|P2|COMPLETED|Overall Study||23
341788|NCT02576639|839872|P1|COMPLETED|Overall Study||22
341789|NCT02576639|839868|P5|Safety Analysis Set|Overall Study||24
341790|NCT02576639|839869|P4|Safety Analysis Set|Overall Study||26
341791|NCT02576639|839870|P3|Safety Analysis Set|Overall Study||25
341792|NCT02576639|839871|P2|Safety Analysis Set|Overall Study||25
341793|NCT02576639|839872|P1|Safety Analysis Set|Overall Study||24
341794|NCT02576639|839868|P5|Pharmacokinetic Analysis Set|Overall Study||24
341795|NCT02576639|839869|P4|Pharmacokinetic Analysis Set|Overall Study||26
341796|NCT02576639|839870|P3|Pharmacokinetic Analysis Set|Overall Study||25
341797|NCT02576639|839871|P2|Pharmacokinetic Analysis Set|Overall Study||25
341798|NCT02576639|839872|P1|Pharmacokinetic Analysis Set|Overall Study||0
341799|NCT02576639|839868|P5|Pharmacodynamic Analysis Set|Overall Study||25
341800|NCT02576639|839869|P4|Pharmacodynamic Analysis Set|Overall Study||25
341801|NCT02576639|839870|P3|Pharmacodynamic Analysis Set|Overall Study||25
341802|NCT02576639|839871|P2|Pharmacodynamic Analysis Set|Overall Study||24
341803|NCT02576639|839872|P1|Pharmacodynamic Analysis Set|Overall Study||24
341804|NCT02576639|839868|P5|STARTED|Overall Study||24
341805|NCT02576639|839869|P4|STARTED|Overall Study||26
341806|NCT02576639|839870|P3|STARTED|Overall Study||25
341807|NCT02576639|839871|P2|STARTED|Overall Study||25
341808|NCT02576639|839872|P1|STARTED|Overall Study||24
341809|NCT02576535|839929|P1|NOT COMPLETED|Overall Study||2
341810|NCT02576535|839929|P1|COMPLETED|Overall Study||16
341811|NCT02576535|839929|P1|STARTED|Overall Study||18
341812|NCT02576249|839940|P2|NOT COMPLETED|Overall Study||0
341813|NCT02576249|839941|P1|NOT COMPLETED|Overall Study||0
341814|NCT02576249|839940|P2|COMPLETED|Overall Study||14
341815|NCT02576249|839941|P1|COMPLETED|Overall Study||15
341816|NCT02576249|839940|P2|STARTED|Overall Study||14
341817|NCT02576249|839941|P1|STARTED|Overall Study||15
341818|NCT02576145|839953|P2|NOT COMPLETED|Overall Study||1
341819|NCT02576145|839954|P1|NOT COMPLETED|Overall Study||3
341820|NCT02576145|839953|P2|COMPLETED|Overall Study||4
341821|NCT02576145|839954|P1|COMPLETED|Overall Study||3
341822|NCT02576145|839953|P2|STARTED|Overall Study||5
341823|NCT02576145|839954|P1|STARTED|Overall Study||6
341824|NCT02576041|839990|P1|NOT COMPLETED|Bilastine (Active Treatement)||0
341825|NCT02576041|839990|P1|COMPLETED|Bilastine (Active Treatement)||18
341826|NCT02576041|839990|P1|STARTED|Bilastine (Active Treatement)||18
341827|NCT02576041|839990|P1|NOT COMPLETED|Placebo (run-in)||0
341828|NCT02576041|839990|P1|COMPLETED|Placebo (run-in)||18
341829|NCT02576041|839990|P1|STARTED|Placebo (run-in)||18
341830|NCT02575911|839996|P1|NOT COMPLETED|Overall Study||1
341831|NCT02575911|839996|P1|COMPLETED|Overall Study||29
341832|NCT02575911|839996|P1|STARTED|Overall Study||30
341833|NCT02574858|840014|P1|NOT COMPLETED|Overall Study||0
341834|NCT02574858|840014|P1|COMPLETED|Overall Study||25
341835|NCT02574858|840014|P1|STARTED|Overall Study||25
341836|NCT02574845|840025|P6|NOT COMPLETED|Overall Study||1
341837|NCT02574845|840026|P5|NOT COMPLETED|Overall Study||1
341838|NCT02574845|840027|P4|NOT COMPLETED|Overall Study||0
341839|NCT02574845|840028|P3|NOT COMPLETED|Overall Study||0
341840|NCT02574845|840029|P2|NOT COMPLETED|Overall Study||1
341841|NCT02574845|840030|P1|NOT COMPLETED|Overall Study||0
341842|NCT02574845|840025|P6|COMPLETED|Overall Study||2
341843|NCT02574845|840026|P5|COMPLETED|Overall Study||2
341844|NCT02574845|840027|P4|COMPLETED|Overall Study||3
341845|NCT02574845|840028|P3|COMPLETED|Overall Study||3
341846|NCT02574845|840029|P2|COMPLETED|Overall Study||2
341847|NCT02574845|840030|P1|COMPLETED|Overall Study||3
341848|NCT02574845|840025|P6|Received R|Overall Study||3
341849|NCT02574845|840026|P5|Received R|Overall Study||2
341850|NCT02574845|840027|P4|Received R|Overall Study||3
341851|NCT02574845|840028|P3|Received R|Overall Study||3
341852|NCT02574845|840029|P2|Received R|Overall Study||2
341853|NCT02574845|840030|P1|Received R|Overall Study||3
341854|NCT02574845|840025|P6|Received T5|Overall Study||2
341855|NCT02574845|840026|P5|Received T5|Overall Study||3
341856|NCT02574845|840027|P4|Received T5|Overall Study||3
341857|NCT02574845|840028|P3|Received T5|Overall Study||3
341858|NCT02574845|840029|P2|Received T5|Overall Study||2
341859|NCT02574845|840030|P1|Received T5|Overall Study||3
341860|NCT02574845|840025|P6|Received T4|Overall Study||2
341861|NCT02574845|840026|P5|Received T4|Overall Study||2
341862|NCT02574845|840027|P4|Received T4|Overall Study||3
341863|NCT02574845|840028|P3|Received T4|Overall Study||3
341864|NCT02574845|840029|P2|Received T4|Overall Study||2
341865|NCT02574845|840030|P1|Received T4|Overall Study||3
341866|NCT02574845|840025|P6|Received T3|Overall Study||3
341867|NCT02574845|840026|P5|Received T3|Overall Study||2
341868|NCT02574845|840027|P4|Received T3|Overall Study||3
341869|NCT02574845|840028|P3|Received T3|Overall Study||3
341870|NCT02574845|840029|P2|Received T3|Overall Study||2
341871|NCT02574845|840030|P1|Received T3|Overall Study|one subject missed treatment period 2|2
341872|NCT02574845|840025|P6|Received T2|Overall Study||3
341873|NCT02574845|840026|P5|Received T2|Overall Study||2
341874|NCT02574845|840027|P4|Received T2|Overall Study||3
341875|NCT02574845|840028|P3|Received T2|Overall Study||3
341876|NCT02574845|840029|P2|Received T2|Overall Study||3
341877|NCT02574845|840030|P1|Received T2|Overall Study||3
341878|NCT02574845|840025|P6|Received T1|Overall Study|one subject missed treatment period 2|2
341879|NCT02574845|840026|P5|Received T1|Overall Study||2
341880|NCT02574845|840027|P4|Received T1|Overall Study||3
341881|NCT02574845|840028|P3|Received T1|Overall Study||3
341882|NCT02574845|840029|P2|Received T1|Overall Study||2
341883|NCT02574845|840030|P1|Received T1|Overall Study||3
341884|NCT02574845|840025|P6|STARTED|Overall Study||3
341885|NCT02574845|840026|P5|STARTED|Overall Study||3
341886|NCT02574845|840027|P4|STARTED|Overall Study||3
341887|NCT02574845|840028|P3|STARTED|Overall Study||3
341888|NCT02574845|840029|P2|STARTED|Overall Study||3
341889|NCT02574845|840030|P1|STARTED|Overall Study||3
341890|NCT02574832|840056|P1|NOT COMPLETED|Overall Study||0
341891|NCT02574832|840056|P1|COMPLETED|Overall Study||2
341892|NCT02574832|840056|P1|STARTED|Overall Study||2
341893|NCT02574260|840060|P1|NOT COMPLETED|Overall Study||1
341894|NCT02574260|840060|P1|COMPLETED|Overall Study||2
341895|NCT02574260|840060|P1|STARTED|Overall Study||3
341896|NCT02574247|840069|P3|NOT COMPLETED|Overall Study||5
341897|NCT02574247|840070|P2|NOT COMPLETED|Overall Study||3
341898|NCT02574247|840071|P1|NOT COMPLETED|Overall Study||5
341899|NCT02574247|840069|P3|COMPLETED|Overall Study||5
341900|NCT02574247|840070|P2|COMPLETED|Overall Study||5
341901|NCT02574247|840071|P1|COMPLETED|Overall Study||5
341902|NCT02574247|840069|P3|STARTED|Overall Study||10
341903|NCT02574247|840070|P2|STARTED|Overall Study||8
341904|NCT02574247|840071|P1|STARTED|Overall Study||10
341905|NCT02573870|840085|P2|NOT COMPLETED|Overall Study||7
341906|NCT02573870|840086|P1|NOT COMPLETED|Overall Study||0
341907|NCT02573870|840085|P2|COMPLETED|Overall Study||35
341908|NCT02573870|840086|P1|COMPLETED|Overall Study||20
341909|NCT02573870|840085|P2|STARTED|Overall Study||42
341910|NCT02573870|840086|P1|STARTED|Overall Study||20
341911|NCT02573467|840096|P4|NOT COMPLETED|Post-treatment Follow up Epoch||3
341912|NCT02573467|840097|P3|NOT COMPLETED|Post-treatment Follow up Epoch||10
341913|NCT02573467|840098|P2|NOT COMPLETED|Post-treatment Follow up Epoch||5
341914|NCT02573467|840099|P1|NOT COMPLETED|Post-treatment Follow up Epoch||6
341915|NCT02573467|840096|P4|COMPLETED|Post-treatment Follow up Epoch||44
341916|NCT02573467|840097|P3|COMPLETED|Post-treatment Follow up Epoch||34
341917|NCT02573467|840098|P2|COMPLETED|Post-treatment Follow up Epoch||41
341918|NCT02573467|840099|P1|COMPLETED|Post-treatment Follow up Epoch||35
341919|NCT02573467|840096|P4|STARTED|Post-treatment Follow up Epoch||47
341920|NCT02573467|840097|P3|STARTED|Post-treatment Follow up Epoch||44
341921|NCT02573467|840098|P2|STARTED|Post-treatment Follow up Epoch||46
341922|NCT02573467|840099|P1|STARTED|Post-treatment Follow up Epoch||41
341923|NCT02573467|840096|P4|NOT COMPLETED|Double-blind Treatment Epoch||55
341924|NCT02573467|840097|P3|NOT COMPLETED|Double-blind Treatment Epoch||51
341925|NCT02573467|840098|P2|NOT COMPLETED|Double-blind Treatment Epoch||52
341926|NCT02573467|840099|P1|NOT COMPLETED|Double-blind Treatment Epoch||53
341927|NCT02573467|840096|P4|COMPLETED|Double-blind Treatment Epoch||0
341928|NCT02573467|840097|P3|COMPLETED|Double-blind Treatment Epoch||0
341929|NCT02573467|840098|P2|COMPLETED|Double-blind Treatment Epoch||0
341930|NCT02573467|840099|P1|COMPLETED|Double-blind Treatment Epoch||0
341931|NCT02573467|840096|P4|Full Analysis Set|Double-blind Treatment Epoch||55
341932|NCT02573467|840097|P3|Full Analysis Set|Double-blind Treatment Epoch||51
341933|NCT02573467|840098|P2|Full Analysis Set|Double-blind Treatment Epoch||52
341934|NCT02573467|840099|P1|Full Analysis Set|Double-blind Treatment Epoch||53
341935|NCT02573467|840096|P4|STARTED|Double-blind Treatment Epoch||55
341936|NCT02573467|840097|P3|STARTED|Double-blind Treatment Epoch||51
341937|NCT02573467|840098|P2|STARTED|Double-blind Treatment Epoch||52
341938|NCT02573467|840099|P1|STARTED|Double-blind Treatment Epoch||53
341939|NCT02572752|840141|P3|NOT COMPLETED|Period 3 Including Washout||0
341940|NCT02572752|840142|P2|NOT COMPLETED|Period 3 Including Washout||0
341941|NCT02572752|840143|P1|NOT COMPLETED|Period 3 Including Washout||0
341942|NCT02572752|840141|P3|COMPLETED|Period 3 Including Washout||24
341943|NCT02572752|840142|P2|COMPLETED|Period 3 Including Washout||23
341944|NCT02572752|840143|P1|COMPLETED|Period 3 Including Washout||23
341945|NCT02572752|840141|P3|STARTED|Period 3 Including Washout||24
341946|NCT02572752|840142|P2|STARTED|Period 3 Including Washout||23
341947|NCT02572752|840143|P1|STARTED|Period 3 Including Washout||23
341948|NCT02572752|840141|P3|NOT COMPLETED|Period 2 Including Washout||0
341949|NCT02572752|840142|P2|NOT COMPLETED|Period 2 Including Washout||0
341950|NCT02572752|840143|P1|NOT COMPLETED|Period 2 Including Washout||0
341951|NCT02572752|840141|P3|COMPLETED|Period 2 Including Washout||24
341952|NCT02572752|840142|P2|COMPLETED|Period 2 Including Washout||23
341953|NCT02572752|840143|P1|COMPLETED|Period 2 Including Washout||23
341954|NCT02572752|840141|P3|STARTED|Period 2 Including Washout||24
341955|NCT02572752|840142|P2|STARTED|Period 2 Including Washout||23
341956|NCT02572752|840143|P1|STARTED|Period 2 Including Washout||23
341957|NCT02572752|840141|P3|NOT COMPLETED|Period 1 Including Washout||0
341958|NCT02572752|840142|P2|NOT COMPLETED|Period 1 Including Washout||0
341959|NCT02572752|840143|P1|NOT COMPLETED|Period 1 Including Washout||0
341960|NCT02572752|840141|P3|COMPLETED|Period 1 Including Washout||24
341961|NCT02572752|840142|P2|COMPLETED|Period 1 Including Washout||23
341962|NCT02572752|840143|P1|COMPLETED|Period 1 Including Washout||23
341963|NCT02572752|840141|P3|STARTED|Period 1 Including Washout||24
341964|NCT02572752|840142|P2|STARTED|Period 1 Including Washout||23
341965|NCT02572752|840143|P1|STARTED|Period 1 Including Washout||23
341966|NCT02572609|840158|P2|NOT COMPLETED|Period 2: Treatment Period 2||0
341967|NCT02572609|840159|P1|NOT COMPLETED|Period 2: Treatment Period 2||0
341968|NCT02572609|840158|P2|COMPLETED|Period 2: Treatment Period 2||18
341969|NCT02572609|840159|P1|COMPLETED|Period 2: Treatment Period 2||18
341970|NCT02572609|840158|P2|STARTED|Period 2: Treatment Period 2||18
341971|NCT02572609|840159|P1|STARTED|Period 2: Treatment Period 2||18
341972|NCT02572609|840158|P2|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
341973|NCT02572609|840159|P1|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
341974|NCT02572609|840158|P2|COMPLETED|Period 1: Treatment Period 1 + Washout||18
341975|NCT02572609|840159|P1|COMPLETED|Period 1: Treatment Period 1 + Washout||18
341976|NCT02572609|840158|P2|STARTED|Period 1: Treatment Period 1 + Washout||18
341977|NCT02572609|840159|P1|STARTED|Period 1: Treatment Period 1 + Washout||18
341978|NCT02572427|840169|P2|NOT COMPLETED|Overall Study||9
341979|NCT02572427|840170|P1|NOT COMPLETED|Overall Study||6
341980|NCT02572427|840169|P2|COMPLETED|Overall Study||36
341981|NCT02572427|840170|P1|COMPLETED|Overall Study||31
341982|NCT02572427|840169|P2|STARTED|Overall Study||45
341983|NCT02572427|840170|P1|STARTED|Overall Study||37
341984|NCT02571634|840178|P1|NOT COMPLETED|Overall Study||0
341985|NCT02571634|840178|P1|COMPLETED|Overall Study|The final subject was enrolled on this date.|23
341986|NCT02571634|840178|P1|STARTED|Overall Study|First subject wasn't enrolled until July related to receipt of medications from sponsor.|23
341987|NCT02571153|840189|P3|NOT COMPLETED|Overall Study||2
341988|NCT02571153|840190|P2|NOT COMPLETED|Overall Study||8
341989|NCT02571153|840191|P1|NOT COMPLETED|Overall Study||6
341990|NCT02571153|840189|P3|COMPLETED|Overall Study||43
341991|NCT02571153|840190|P2|COMPLETED|Overall Study||37
341992|NCT02571153|840191|P1|COMPLETED|Overall Study||39
341993|NCT02571153|840189|P3|STARTED|Overall Study||45
341994|NCT02571153|840190|P2|STARTED|Overall Study||45
341995|NCT02571153|840191|P1|STARTED|Overall Study||45
341996|NCT02570425|840219|P2|NOT COMPLETED|Visit 3||0
341997|NCT02570425|840220|P1|NOT COMPLETED|Visit 3||0
341998|NCT02570425|840219|P2|COMPLETED|Visit 3||231
341999|NCT02570425|840220|P1|COMPLETED|Visit 3||229
342000|NCT02570425|840219|P2|STARTED|Visit 3|In total 38 patients who completed Visit 2, did not attend Visit 3.|231
342001|NCT02570425|840220|P1|STARTED|Visit 3|In total 38 patients who completed Visit 2, did not attend Visit 3.|229
342002|NCT02570425|840219|P2|NOT COMPLETED|Visit 2||0
342003|NCT02570425|840220|P1|NOT COMPLETED|Visit 2||0
342004|NCT02570425|840219|P2|COMPLETED|Visit 2||247
342005|NCT02570425|840220|P1|COMPLETED|Visit 2||251
342006|NCT02570425|840219|P2|STARTED|Visit 2|In total 18 patients who completed Visit 1, did not attend Visit 2.|247
342007|NCT02570425|840220|P1|STARTED|Visit 2|In total 18 patients who completed Visit 1, did not attend Visit 2.|251
342008|NCT02570425|840219|P2|NOT COMPLETED|Visit 1||0
342009|NCT02570425|840220|P1|NOT COMPLETED|Visit 1||0
342010|NCT02570425|840219|P2|COMPLETED|Visit 1||242
342011|NCT02570425|840220|P1|COMPLETED|Visit 1||274
342012|NCT02570425|840219|P2|STARTED|Visit 1||242
342013|NCT02570425|840220|P1|STARTED|Visit 1||274
342014|NCT02570295|840269|P2|NOT COMPLETED|Overall Study||58
342015|NCT02570295|840270|P1|NOT COMPLETED|Overall Study||11
342016|NCT02570295|840269|P2|COMPLETED|Overall Study||289
342017|NCT02570295|840270|P1|COMPLETED|Overall Study||364
342018|NCT02570295|840269|P2|STARTED|Overall Study||347
342019|NCT02570295|840270|P1|STARTED|Overall Study||375
342020|NCT02570165|840299|P7|NOT COMPLETED|Overall Study||0
342021|NCT02570165|840300|P6|NOT COMPLETED|Overall Study||2
342022|NCT02570165|840301|P5|NOT COMPLETED|Overall Study||6
342023|NCT02570165|840302|P4|NOT COMPLETED|Overall Study||5
342024|NCT02570165|840303|P3|NOT COMPLETED|Overall Study||5
342025|NCT02570165|840304|P2|NOT COMPLETED|Overall Study||3
342026|NCT02570165|840305|P1|NOT COMPLETED|Overall Study||2
342027|NCT02570165|840299|P7|COMPLETED|Overall Study||47
342028|NCT02570165|840300|P6|COMPLETED|Overall Study||44
342029|NCT02570165|840301|P5|COMPLETED|Overall Study||41
342030|NCT02570165|840302|P4|COMPLETED|Overall Study||40
342031|NCT02570165|840303|P3|COMPLETED|Overall Study||41
342032|NCT02570165|840304|P2|COMPLETED|Overall Study||43
342033|NCT02570165|840305|P1|COMPLETED|Overall Study||44
342034|NCT02570165|840299|P7|STARTED|Overall Study||47
342035|NCT02570165|840300|P6|STARTED|Overall Study||46
342036|NCT02570165|840301|P5|STARTED|Overall Study||47
342037|NCT02570165|840302|P4|STARTED|Overall Study||45
342038|NCT02570165|840303|P3|STARTED|Overall Study||46
342039|NCT02570165|840304|P2|STARTED|Overall Study||46
342040|NCT02570165|840305|P1|STARTED|Overall Study||46
342041|NCT02570126|840330|P2|NOT COMPLETED|Overall Study||9
342042|NCT02570126|840331|P1|NOT COMPLETED|Overall Study||6
342043|NCT02570126|840330|P2|COMPLETED|Overall Study||607
342044|NCT02570126|840331|P1|COMPLETED|Overall Study||609
342045|NCT02570126|840330|P2|STARTED|Overall Study||616
342046|NCT02570126|840331|P1|STARTED|Overall Study||615
342047|NCT02570022|840357|P2|NOT COMPLETED|Overall Study||0
342048|NCT02570022|840358|P1|NOT COMPLETED|Overall Study||0
342049|NCT02570022|840357|P2|COMPLETED|Overall Study||31
342050|NCT02570022|840358|P1|COMPLETED|Overall Study||26
342051|NCT02570022|840357|P2|STARTED|Overall Study||31
342052|NCT02570022|840358|P1|STARTED|Overall Study||26
342053|NCT02569996|840366|P1|NOT COMPLETED|Overall Study||55
342054|NCT02569996|840366|P1|COMPLETED|Overall Study||69
342055|NCT02569996|840366|P1|STARTED|Overall Study||124
342056|NCT02569957|840378|P2|NOT COMPLETED|Overall Study||1
342057|NCT02569957|840379|P1|NOT COMPLETED|Overall Study||0
342058|NCT02569957|840378|P2|COMPLETED|Overall Study||0
342059|NCT02569957|840379|P1|COMPLETED|Overall Study||0
342060|NCT02569957|840378|P2|STARTED|Overall Study||1
342061|NCT02569957|840379|P1|STARTED|Overall Study||0
342062|NCT02569658|840411|P2|NOT COMPLETED|Overall Study||1
342063|NCT02569658|840412|P1|NOT COMPLETED|Overall Study||1
342064|NCT02569658|840411|P2|COMPLETED|Overall Study||56
342065|NCT02569658|840412|P1|COMPLETED|Overall Study||52
342066|NCT02569658|840411|P2|STARTED|Overall Study||57
342067|NCT02569658|840412|P1|STARTED|Overall Study||53
342068|NCT02569437|840430|P2|NOT COMPLETED|Overall Study||14
342069|NCT02569437|840431|P1|NOT COMPLETED|Overall Study||12
342070|NCT02569437|840430|P2|COMPLETED|Overall Study||11
342071|NCT02569437|840431|P1|COMPLETED|Overall Study||12
342072|NCT02569437|840430|P2|STARTED|Overall Study||25
342073|NCT02569437|840431|P1|STARTED|Overall Study||24
342074|NCT02569112|840445|P2|NOT COMPLETED|Overall Study||0
342075|NCT02569112|840446|P1|NOT COMPLETED|Overall Study||0
342076|NCT02569112|840445|P2|COMPLETED|Overall Study|Each subject received multipolar RF with varipulse technology to only one side of their body.|10
342077|NCT02569112|840446|P1|COMPLETED|Overall Study||10
342078|NCT02569112|840445|P2|STARTED|Overall Study||10
342079|NCT02569112|840446|P1|STARTED|Overall Study||10
342080|NCT02569086|840451|P1|NOT COMPLETED|Overall Study||0
342081|NCT02569086|840451|P1|COMPLETED|Overall Study||22
342082|NCT02569086|840451|P1|STARTED|Overall Study||22
342083|NCT02568852|840458|P2|NOT COMPLETED|Overall Study||0
342084|NCT02568852|840459|P1|NOT COMPLETED|Overall Study||0
342085|NCT02568852|840458|P2|COMPLETED|Overall Study||25
342086|NCT02568852|840459|P1|COMPLETED|Overall Study||25
342087|NCT02568852|840458|P2|STARTED|Overall Study||25
342088|NCT02568852|840459|P1|STARTED|Overall Study||25
342089|NCT02568384|840495|P1|NOT COMPLETED|Overall Study||2
342090|NCT02568384|840495|P1|COMPLETED|Overall Study||43
342091|NCT02568384|840495|P1|STARTED|Overall Study||45
342092|NCT02568345|840505|P1|NOT COMPLETED|Overall Study||0
342093|NCT02568345|840505|P1|COMPLETED|Overall Study||31
342094|NCT02568345|840505|P1|Treated at 2.6 mg/kg|Overall Study|Patients: 8th-10th|3
342095|NCT02568345|840505|P1|Treated at 2.4 mg/kg|Overall Study|Patients: 1st-5th; 7th; 11th-15th; 21st-25th; 27th-31st|25
342096|NCT02568345|840505|P1|Treated at 2.2 mg/kg|Overall Study|patients: 6th, 20th, 26th|3
342097|NCT02568345|840505|P1|STARTED|Overall Study||31
342098|NCT02568254|840509|P6|NOT COMPLETED|Period 3||0
342099|NCT02568254|840510|P5|NOT COMPLETED|Period 3||1
342100|NCT02568254|840511|P4|NOT COMPLETED|Period 3||0
342101|NCT02568254|840512|P3|NOT COMPLETED|Period 3||0
342102|NCT02568254|840513|P2|NOT COMPLETED|Period 3||0
342103|NCT02568254|840514|P1|NOT COMPLETED|Period 3||0
342104|NCT02568254|840509|P6|COMPLETED|Period 3||12
342105|NCT02568254|840510|P5|COMPLETED|Period 3||11
342106|NCT02568254|840511|P4|COMPLETED|Period 3||12
342107|NCT02568254|840512|P3|COMPLETED|Period 3||12
342108|NCT02568254|840513|P2|COMPLETED|Period 3||12
342109|NCT02568254|840514|P1|COMPLETED|Period 3||13
342110|NCT02568254|840509|P6|STARTED|Period 3||12
342111|NCT02568254|840510|P5|STARTED|Period 3||12
342112|NCT02568254|840511|P4|STARTED|Period 3||12
342113|NCT02568254|840512|P3|STARTED|Period 3||12
342114|NCT02568254|840513|P2|STARTED|Period 3||12
342115|NCT02568254|840514|P1|STARTED|Period 3||13
342116|NCT02568254|840509|P6|NOT COMPLETED|Period 2||0
342117|NCT02568254|840510|P5|NOT COMPLETED|Period 2||0
342118|NCT02568254|840511|P4|NOT COMPLETED|Period 2||0
342119|NCT02568254|840512|P3|NOT COMPLETED|Period 2||1
342120|NCT02568254|840513|P2|NOT COMPLETED|Period 2||0
342121|NCT02568254|840514|P1|NOT COMPLETED|Period 2||0
342122|NCT02568254|840509|P6|COMPLETED|Period 2||12
342123|NCT02568254|840510|P5|COMPLETED|Period 2||12
342124|NCT02568254|840511|P4|COMPLETED|Period 2||12
342125|NCT02568254|840512|P3|COMPLETED|Period 2||12
342126|NCT02568254|840513|P2|COMPLETED|Period 2||12
342127|NCT02568254|840514|P1|COMPLETED|Period 2||13
342128|NCT02568254|840509|P6|STARTED|Period 2||12
342129|NCT02568254|840510|P5|STARTED|Period 2||12
342130|NCT02568254|840511|P4|STARTED|Period 2||12
342131|NCT02568254|840512|P3|STARTED|Period 2||13
342132|NCT02568254|840513|P2|STARTED|Period 2||12
342133|NCT02568254|840514|P1|STARTED|Period 2||13
342134|NCT02568254|840509|P6|NOT COMPLETED|Period 1||0
342135|NCT02568254|840510|P5|NOT COMPLETED|Period 1||0
342136|NCT02568254|840511|P4|NOT COMPLETED|Period 1||0
342137|NCT02568254|840512|P3|NOT COMPLETED|Period 1||0
342138|NCT02568254|840513|P2|NOT COMPLETED|Period 1||0
342139|NCT02568254|840514|P1|NOT COMPLETED|Period 1||0
342140|NCT02568254|840509|P6|COMPLETED|Period 1||12
342141|NCT02568254|840510|P5|COMPLETED|Period 1||12
342142|NCT02568254|840511|P4|COMPLETED|Period 1||12
342143|NCT02568254|840512|P3|COMPLETED|Period 1||13
342144|NCT02568254|840513|P2|COMPLETED|Period 1||12
342145|NCT02568254|840514|P1|COMPLETED|Period 1||13
342146|NCT02568254|840509|P6|STARTED|Period 1||12
342147|NCT02568254|840510|P5|STARTED|Period 1||12
342148|NCT02568254|840511|P4|STARTED|Period 1||12
342149|NCT02568254|840512|P3|STARTED|Period 1||13
342150|NCT02568254|840513|P2|STARTED|Period 1||12
342151|NCT02568254|840514|P1|STARTED|Period 1||13
342152|NCT02567552|840524|P2|NOT COMPLETED|Overall Study||1
342153|NCT02567552|840525|P1|NOT COMPLETED|Overall Study||0
342154|NCT02567552|840524|P2|COMPLETED|Overall Study|dropout by pain in the puncture site|11
342155|NCT02567552|840525|P1|COMPLETED|Overall Study||12
342156|NCT02567552|840524|P2|STARTED|Overall Study||12
342157|NCT02567552|840525|P1|STARTED|Overall Study||12
342158|NCT02567188|840555|P1|NOT COMPLETED|Overall Study||35
342159|NCT02567188|840555|P1|COMPLETED|Overall Study||109
342160|NCT02567188|840555|P1|STARTED|Overall Study||144
342161|NCT02566759|840601|P17|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342162|NCT02566759|840602|P16|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342163|NCT02566759|840603|P15|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342164|NCT02566759|840604|P14|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342165|NCT02566759|840605|P13|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342166|NCT02566759|840606|P12|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342167|NCT02566759|840607|P11|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342168|NCT02566759|840608|P10|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342169|NCT02566759|840609|P9|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342170|NCT02566759|840610|P8|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342171|NCT02566759|840611|P7|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342172|NCT02566759|840612|P6|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342173|NCT02566759|840613|P5|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342174|NCT02566759|840614|P4|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342175|NCT02566759|840615|P3|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342176|NCT02566759|840616|P2|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342177|NCT02566759|840617|P1|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342178|NCT02566759|840601|P17|COMPLETED|Crossover Treatment (Part 4: 1 Day)||7
342179|NCT02566759|840602|P16|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
342180|NCT02566759|840603|P15|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
342181|NCT02566759|840604|P14|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342182|NCT02566759|840605|P13|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342183|NCT02566759|840606|P12|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342184|NCT02566759|840607|P11|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342185|NCT02566759|840608|P10|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342186|NCT02566759|840609|P9|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342187|NCT02566759|840610|P8|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342188|NCT02566759|840611|P7|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342189|NCT02566759|840612|P6|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342190|NCT02566759|840613|P5|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342191|NCT02566759|840614|P4|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342192|NCT02566759|840615|P3|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342193|NCT02566759|840616|P2|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342194|NCT02566759|840617|P1|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342195|NCT02566759|840601|P17|STARTED|Crossover Treatment (Part 4: 1 Day)||7
342196|NCT02566759|840602|P16|STARTED|Crossover Treatment (Part 4: 1 Day)||8
342197|NCT02566759|840603|P15|STARTED|Crossover Treatment (Part 4: 1 Day)||8
342198|NCT02566759|840604|P14|STARTED|Crossover Treatment (Part 4: 1 Day)||0
342199|NCT02566759|840605|P13|STARTED|Crossover Treatment (Part 4: 1 Day)||0
342200|NCT02566759|840606|P12|STARTED|Crossover Treatment (Part 4: 1 Day)||0
342201|NCT02566759|840607|P11|STARTED|Crossover Treatment (Part 4: 1 Day)||0
342202|NCT02566759|840608|P10|STARTED|Crossover Treatment (Part 4: 1 Day)||0
342203|NCT02566759|840609|P9|STARTED|Crossover Treatment (Part 4: 1 Day)||0
342204|NCT02566759|840610|P8|STARTED|Crossover Treatment (Part 4: 1 Day)||0
342205|NCT02566759|840611|P7|STARTED|Crossover Treatment (Part 4: 1 Day)||0
342206|NCT02566759|840612|P6|STARTED|Crossover Treatment (Part 4: 1 Day)||0
342207|NCT02566759|840613|P5|STARTED|Crossover Treatment (Part 4: 1 Day)||0
342208|NCT02566759|840614|P4|STARTED|Crossover Treatment (Part 4: 1 Day)||0
342209|NCT02566759|840615|P3|STARTED|Crossover Treatment (Part 4: 1 Day)||0
342210|NCT02566759|840616|P2|STARTED|Crossover Treatment (Part 4: 1 Day)||0
342211|NCT02566759|840617|P1|STARTED|Crossover Treatment (Part 4: 1 Day)||0
342212|NCT02566759|840601|P17|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342213|NCT02566759|840602|P16|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342214|NCT02566759|840603|P15|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342215|NCT02566759|840604|P14|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342216|NCT02566759|840605|P13|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342217|NCT02566759|840606|P12|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342218|NCT02566759|840607|P11|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342219|NCT02566759|840608|P10|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342220|NCT02566759|840609|P9|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342221|NCT02566759|840610|P8|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342222|NCT02566759|840611|P7|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342223|NCT02566759|840612|P6|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342224|NCT02566759|840613|P5|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342225|NCT02566759|840614|P4|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342226|NCT02566759|840615|P3|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342227|NCT02566759|840616|P2|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342228|NCT02566759|840617|P1|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342229|NCT02566759|840601|P17|COMPLETED|Washout Crossover Period (Part 4:5 Days)||7
342230|NCT02566759|840602|P16|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
342231|NCT02566759|840603|P15|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
342307|NCT02566759|840611|P7|STARTED|Crossover Treatment (Part 4: 1 Day)||0
342232|NCT02566759|840604|P14|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342233|NCT02566759|840605|P13|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342234|NCT02566759|840606|P12|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342235|NCT02566759|840607|P11|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342236|NCT02566759|840608|P10|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342237|NCT02566759|840609|P9|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342238|NCT02566759|840610|P8|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342239|NCT02566759|840611|P7|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342240|NCT02566759|840612|P6|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342241|NCT02566759|840613|P5|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342242|NCT02566759|840614|P4|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342243|NCT02566759|840615|P3|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342244|NCT02566759|840616|P2|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342245|NCT02566759|840617|P1|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342246|NCT02566759|840601|P17|STARTED|Washout Crossover Period (Part 4:5 Days)||7
342247|NCT02566759|840602|P16|STARTED|Washout Crossover Period (Part 4:5 Days)||8
342248|NCT02566759|840603|P15|STARTED|Washout Crossover Period (Part 4:5 Days)||8
342249|NCT02566759|840604|P14|STARTED|Washout Crossover Period (Part 4:5 Days)||0
342250|NCT02566759|840605|P13|STARTED|Washout Crossover Period (Part 4:5 Days)||0
342251|NCT02566759|840606|P12|STARTED|Washout Crossover Period (Part 4:5 Days)||0
342252|NCT02566759|840607|P11|STARTED|Washout Crossover Period (Part 4:5 Days)||0
342253|NCT02566759|840608|P10|STARTED|Washout Crossover Period (Part 4:5 Days)||0
342254|NCT02566759|840609|P9|STARTED|Washout Crossover Period (Part 4:5 Days)||0
342255|NCT02566759|840610|P8|STARTED|Washout Crossover Period (Part 4:5 Days)||0
342256|NCT02566759|840611|P7|STARTED|Washout Crossover Period (Part 4:5 Days)||0
342257|NCT02566759|840612|P6|STARTED|Washout Crossover Period (Part 4:5 Days)||0
342258|NCT02566759|840613|P5|STARTED|Washout Crossover Period (Part 4:5 Days)||0
342259|NCT02566759|840614|P4|STARTED|Washout Crossover Period (Part 4:5 Days)||0
342260|NCT02566759|840615|P3|STARTED|Washout Crossover Period (Part 4:5 Days)||0
342261|NCT02566759|840616|P2|STARTED|Washout Crossover Period (Part 4:5 Days)||0
342262|NCT02566759|840617|P1|STARTED|Washout Crossover Period (Part 4:5 Days)||0
342263|NCT02566759|840601|P17|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||1
342264|NCT02566759|840602|P16|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342265|NCT02566759|840603|P15|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342266|NCT02566759|840604|P14|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342267|NCT02566759|840605|P13|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342268|NCT02566759|840606|P12|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342269|NCT02566759|840607|P11|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342270|NCT02566759|840608|P10|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342271|NCT02566759|840609|P9|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342272|NCT02566759|840610|P8|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342273|NCT02566759|840611|P7|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342274|NCT02566759|840612|P6|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342275|NCT02566759|840613|P5|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342276|NCT02566759|840614|P4|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342277|NCT02566759|840615|P3|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342278|NCT02566759|840616|P2|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342279|NCT02566759|840617|P1|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342280|NCT02566759|840601|P17|COMPLETED|Crossover Treatment (Part 4: 1 Day)||7
342281|NCT02566759|840602|P16|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
342282|NCT02566759|840603|P15|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
342283|NCT02566759|840604|P14|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342284|NCT02566759|840605|P13|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342285|NCT02566759|840606|P12|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342286|NCT02566759|840607|P11|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342287|NCT02566759|840608|P10|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342288|NCT02566759|840609|P9|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342289|NCT02566759|840610|P8|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342290|NCT02566759|840611|P7|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342291|NCT02566759|840612|P6|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342292|NCT02566759|840613|P5|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342293|NCT02566759|840614|P4|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342294|NCT02566759|840615|P3|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342295|NCT02566759|840616|P2|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342296|NCT02566759|840617|P1|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
342297|NCT02566759|840601|P17|STARTED|Crossover Treatment (Part 4: 1 Day)||8
342298|NCT02566759|840602|P16|STARTED|Crossover Treatment (Part 4: 1 Day)||8
342299|NCT02566759|840603|P15|STARTED|Crossover Treatment (Part 4: 1 Day)||8
342300|NCT02566759|840604|P14|STARTED|Crossover Treatment (Part 4: 1 Day)||0
342301|NCT02566759|840605|P13|STARTED|Crossover Treatment (Part 4: 1 Day)||0
342302|NCT02566759|840606|P12|STARTED|Crossover Treatment (Part 4: 1 Day)||0
342303|NCT02566759|840607|P11|STARTED|Crossover Treatment (Part 4: 1 Day)||0
342304|NCT02566759|840608|P10|STARTED|Crossover Treatment (Part 4: 1 Day)||0
342305|NCT02566759|840609|P9|STARTED|Crossover Treatment (Part 4: 1 Day)||0
342306|NCT02566759|840610|P8|STARTED|Crossover Treatment (Part 4: 1 Day)||0
342308|NCT02566759|840612|P6|STARTED|Crossover Treatment (Part 4: 1 Day)||0
342309|NCT02566759|840613|P5|STARTED|Crossover Treatment (Part 4: 1 Day)||0
342310|NCT02566759|840614|P4|STARTED|Crossover Treatment (Part 4: 1 Day)||0
342311|NCT02566759|840615|P3|STARTED|Crossover Treatment (Part 4: 1 Day)||0
342312|NCT02566759|840616|P2|STARTED|Crossover Treatment (Part 4: 1 Day)||0
342313|NCT02566759|840617|P1|STARTED|Crossover Treatment (Part 4: 1 Day)||0
342314|NCT02566759|840601|P17|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342315|NCT02566759|840602|P16|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342316|NCT02566759|840603|P15|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342317|NCT02566759|840604|P14|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342318|NCT02566759|840605|P13|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342319|NCT02566759|840606|P12|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342320|NCT02566759|840607|P11|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342321|NCT02566759|840608|P10|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342322|NCT02566759|840609|P9|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342323|NCT02566759|840610|P8|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342324|NCT02566759|840611|P7|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342325|NCT02566759|840612|P6|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342326|NCT02566759|840613|P5|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342327|NCT02566759|840614|P4|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342328|NCT02566759|840615|P3|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342329|NCT02566759|840616|P2|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342330|NCT02566759|840617|P1|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342331|NCT02566759|840601|P17|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
342332|NCT02566759|840602|P16|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
342333|NCT02566759|840603|P15|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
342334|NCT02566759|840604|P14|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342335|NCT02566759|840605|P13|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342336|NCT02566759|840606|P12|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342337|NCT02566759|840607|P11|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342338|NCT02566759|840608|P10|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342339|NCT02566759|840609|P9|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342340|NCT02566759|840610|P8|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342341|NCT02566759|840611|P7|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342342|NCT02566759|840612|P6|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342343|NCT02566759|840613|P5|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342344|NCT02566759|840614|P4|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342345|NCT02566759|840615|P3|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342346|NCT02566759|840616|P2|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342347|NCT02566759|840617|P1|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
342348|NCT02566759|840601|P17|STARTED|Washout Crossover Period (Part 4:5 Days)||8
342349|NCT02566759|840602|P16|STARTED|Washout Crossover Period (Part 4:5 Days)||8
342350|NCT02566759|840603|P15|STARTED|Washout Crossover Period (Part 4:5 Days)||8
342351|NCT02566759|840604|P14|STARTED|Washout Crossover Period (Part 4:5 Days)||0
342352|NCT02566759|840605|P13|STARTED|Washout Crossover Period (Part 4:5 Days)||0
342353|NCT02566759|840606|P12|STARTED|Washout Crossover Period (Part 4:5 Days)||0
342354|NCT02566759|840607|P11|STARTED|Washout Crossover Period (Part 4:5 Days)||0
342355|NCT02566759|840608|P10|STARTED|Washout Crossover Period (Part 4:5 Days)||0
342356|NCT02566759|840609|P9|STARTED|Washout Crossover Period (Part 4:5 Days)||0
342357|NCT02566759|840610|P8|STARTED|Washout Crossover Period (Part 4:5 Days)||0
342358|NCT02566759|840611|P7|STARTED|Washout Crossover Period (Part 4:5 Days)||0
342359|NCT02566759|840612|P6|STARTED|Washout Crossover Period (Part 4:5 Days)||0
342360|NCT02566759|840613|P5|STARTED|Washout Crossover Period (Part 4:5 Days)||0
342361|NCT02566759|840614|P4|STARTED|Washout Crossover Period (Part 4:5 Days)||0
342362|NCT02566759|840615|P3|STARTED|Washout Crossover Period (Part 4:5 Days)||0
342363|NCT02566759|840616|P2|STARTED|Washout Crossover Period (Part 4:5 Days)||0
342364|NCT02566759|840617|P1|STARTED|Washout Crossover Period (Part 4:5 Days)||0
342365|NCT02566759|840601|P17|NOT COMPLETED|All Parts||0
342366|NCT02566759|840602|P16|NOT COMPLETED|All Parts||0
342367|NCT02566759|840603|P15|NOT COMPLETED|All Parts||0
342368|NCT02566759|840604|P14|NOT COMPLETED|All Parts||5
342369|NCT02566759|840605|P13|NOT COMPLETED|All Parts||1
342370|NCT02566759|840606|P12|NOT COMPLETED|All Parts||0
342371|NCT02566759|840607|P11|NOT COMPLETED|All Parts||0
342372|NCT02566759|840608|P10|NOT COMPLETED|All Parts||0
342373|NCT02566759|840609|P9|NOT COMPLETED|All Parts||0
342374|NCT02566759|840610|P8|NOT COMPLETED|All Parts||0
342375|NCT02566759|840611|P7|NOT COMPLETED|All Parts||0
342376|NCT02566759|840612|P6|NOT COMPLETED|All Parts||0
342377|NCT02566759|840613|P5|NOT COMPLETED|All Parts||0
342378|NCT02566759|840614|P4|NOT COMPLETED|All Parts||0
342379|NCT02566759|840615|P3|NOT COMPLETED|All Parts||0
342380|NCT02566759|840616|P2|NOT COMPLETED|All Parts||1
342381|NCT02566759|840617|P1|NOT COMPLETED|All Parts||0
342382|NCT02566759|840601|P17|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
342383|NCT02566759|840602|P16|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
342384|NCT02566759|840603|P15|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
342385|NCT02566759|840604|P14|COMPLETED|All Parts||0
342386|NCT02566759|840605|P13|COMPLETED|All Parts||0
342387|NCT02566759|840606|P12|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
342388|NCT02566759|840607|P11|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
342389|NCT02566759|840608|P10|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
342390|NCT02566759|840609|P9|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
342391|NCT02566759|840610|P8|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|8
342392|NCT02566759|840611|P7|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
342393|NCT02566759|840612|P6|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
342394|NCT02566759|840613|P5|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
342395|NCT02566759|840614|P4|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
342396|NCT02566759|840615|P3|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
342397|NCT02566759|840616|P2|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|5
342398|NCT02566759|840617|P1|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|12
342399|NCT02566759|840601|P17|STARTED|All Parts||8
342400|NCT02566759|840602|P16|STARTED|All Parts||8
342401|NCT02566759|840603|P15|STARTED|All Parts||8
342402|NCT02566759|840604|P14|STARTED|All Parts||5
342403|NCT02566759|840605|P13|STARTED|All Parts||1
342404|NCT02566759|840606|P12|STARTED|All Parts||6
342405|NCT02566759|840607|P11|STARTED|All Parts||6
342406|NCT02566759|840608|P10|STARTED|All Parts||6
342407|NCT02566759|840609|P9|STARTED|All Parts||6
342408|NCT02566759|840610|P8|STARTED|All Parts||8
342409|NCT02566759|840611|P7|STARTED|All Parts||6
342410|NCT02566759|840612|P6|STARTED|All Parts||6
342411|NCT02566759|840613|P5|STARTED|All Parts||6
342412|NCT02566759|840614|P4|STARTED|All Parts||6
342413|NCT02566759|840615|P3|STARTED|All Parts||6
342414|NCT02566759|840616|P2|STARTED|All Parts||6
342415|NCT02566759|840617|P1|STARTED|All Parts||12
342416|NCT02566005|840770|P2|NOT COMPLETED|Overall Study||6
342417|NCT02566005|840771|P1|NOT COMPLETED|Overall Study||8
342418|NCT02566005|840770|P2|COMPLETED|Overall Study||94
342419|NCT02566005|840771|P1|COMPLETED|Overall Study||92
342420|NCT02566005|840770|P2|STARTED|Overall Study||100
342421|NCT02566005|840771|P1|STARTED|Overall Study||100
342422|NCT02565628|840801|P2|NOT COMPLETED|Overall Study||0
342423|NCT02565628|840802|P1|NOT COMPLETED|Overall Study||0
342424|NCT02565628|840801|P2|COMPLETED|Overall Study||9
342425|NCT02565628|840802|P1|COMPLETED|Overall Study||10
342426|NCT02565628|840801|P2|Received Treatment|Overall Study||9
342427|NCT02565628|840802|P1|Received Treatment|Overall Study||10
342428|NCT02565628|840801|P2|STARTED|Overall Study||9
342429|NCT02565628|840802|P1|STARTED|Overall Study||10
342430|NCT02565485|840832|P2|NOT COMPLETED|Overall Study||0
342431|NCT02565485|840833|P1|NOT COMPLETED|Overall Study||0
342432|NCT02565485|840832|P2|COMPLETED|Overall Study||137
342433|NCT02565485|840833|P1|COMPLETED|Overall Study||139
342434|NCT02565485|840832|P2|STARTED|Overall Study||137
342435|NCT02565485|840833|P1|STARTED|Overall Study||139
342436|NCT02565381|840848|P3|NOT COMPLETED|Overall Study||1
342437|NCT02565381|840849|P2|NOT COMPLETED|Overall Study||0
342438|NCT02565381|840850|P1|NOT COMPLETED|Overall Study||1
342439|NCT02565381|840848|P3|COMPLETED|Overall Study||24
342440|NCT02565381|840849|P2|COMPLETED|Overall Study||25
342441|NCT02565381|840850|P1|COMPLETED|Overall Study||24
342442|NCT02565381|840848|P3|STARTED|Overall Study||25
342443|NCT02565381|840849|P2|STARTED|Overall Study||25
342444|NCT02565381|840850|P1|STARTED|Overall Study||25
342445|NCT02564211|840888|P1|NOT COMPLETED|Overall Study||4
342446|NCT02564211|840888|P1|COMPLETED|Overall Study||73
342447|NCT02564211|840888|P1|STARTED|Overall Study||77
342448|NCT02564055|840900|P6|NOT COMPLETED|Overall Study||12
342449|NCT02564055|840901|P5|NOT COMPLETED|Overall Study||15
342450|NCT02564055|840902|P4|NOT COMPLETED|Overall Study||6
342451|NCT02564055|840903|P3|NOT COMPLETED|Overall Study||12
342452|NCT02564055|840904|P2|NOT COMPLETED|Overall Study||5
342453|NCT02564055|840905|P1|NOT COMPLETED|Overall Study||6
342454|NCT02564055|840900|P6|COMPLETED|Overall Study||28
342455|NCT02564055|840901|P5|COMPLETED|Overall Study||27
342456|NCT02564055|840902|P4|COMPLETED|Overall Study||35
342457|NCT02564055|840903|P3|COMPLETED|Overall Study||31
342458|NCT02564055|840904|P2|COMPLETED|Overall Study||36
342459|NCT02564055|840905|P1|COMPLETED|Overall Study||34
342460|NCT02564055|840900|P6|STARTED|Overall Study||40
342461|NCT02564055|840901|P5|STARTED|Overall Study||42
342462|NCT02564055|840902|P4|STARTED|Overall Study||41
342463|NCT02564055|840903|P3|STARTED|Overall Study||43
342464|NCT02564055|840904|P2|STARTED|Overall Study||41
342465|NCT02564055|840905|P1|STARTED|Overall Study||40
342466|NCT02564042|841159|P6|NOT COMPLETED|Overall Study||14
342467|NCT02564042|841160|P5|NOT COMPLETED|Overall Study||11
342468|NCT02564042|841161|P4|NOT COMPLETED|Overall Study||3
342469|NCT02564042|841162|P3|NOT COMPLETED|Overall Study||6
342470|NCT02564042|841163|P2|NOT COMPLETED|Overall Study||8
342471|NCT02564042|841164|P1|NOT COMPLETED|Overall Study||11
342472|NCT02564042|841159|P6|COMPLETED|Overall Study||24
342473|NCT02564042|841160|P5|COMPLETED|Overall Study||26
342474|NCT02564042|841161|P4|COMPLETED|Overall Study||35
342475|NCT02564042|841162|P3|COMPLETED|Overall Study||32
342476|NCT02564042|841163|P2|COMPLETED|Overall Study||30
342477|NCT02564042|841164|P1|COMPLETED|Overall Study||27
342478|NCT02564042|841159|P6|STARTED|Overall Study||38
342479|NCT02564042|841160|P5|STARTED|Overall Study||37
342480|NCT02564042|841161|P4|STARTED|Overall Study||38
342481|NCT02564042|841162|P3|STARTED|Overall Study||38
342482|NCT02564042|841163|P2|STARTED|Overall Study||38
342483|NCT02564042|841164|P1|STARTED|Overall Study||38
342484|NCT02564029|841376|P1|NOT COMPLETED|Overall Study||0
342485|NCT02564029|841376|P1|COMPLETED|Overall Study||7
342486|NCT02564029|841376|P1|STARTED|Overall Study||7
342487|NCT02563899|841421|P4|NOT COMPLETED|Overall Study||0
342488|NCT02563899|841422|P3|NOT COMPLETED|Overall Study||1
342489|NCT02563899|841423|P2|NOT COMPLETED|Overall Study||0
342490|NCT02563899|841424|P1|NOT COMPLETED|Overall Study||1
342491|NCT02563899|841421|P4|COMPLETED|Overall Study||6
342492|NCT02563899|841422|P3|COMPLETED|Overall Study||9
342493|NCT02563899|841423|P2|COMPLETED|Overall Study||5
342494|NCT02563899|841424|P1|COMPLETED|Overall Study||17
342495|NCT02563899|841421|P4|STARTED|Overall Study||6
342496|NCT02563899|841422|P3|STARTED|Overall Study||10
342497|NCT02563899|841423|P2|STARTED|Overall Study||5
342498|NCT02563899|841424|P1|STARTED|Overall Study||18
342499|NCT02563834|841467|P2|NOT COMPLETED|Insulin Infusion (*Day 2)||0
342500|NCT02563834|841468|P1|NOT COMPLETED|Insulin Infusion (*Day 2)||0
342501|NCT02563834|841467|P2|COMPLETED|Insulin Infusion (*Day 2)||8
342502|NCT02563834|841468|P1|COMPLETED|Insulin Infusion (*Day 2)||10
342503|NCT02563834|841467|P2|STARTED|Insulin Infusion (*Day 2)||8
342504|NCT02563834|841468|P1|STARTED|Insulin Infusion (*Day 2)||10
342505|NCT02563834|841467|P2|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0
342506|NCT02563834|841468|P1|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0
342507|NCT02563834|841467|P2|COMPLETED|Control (Saline) Infusion (*Day 1)||8
342508|NCT02563834|841468|P1|COMPLETED|Control (Saline) Infusion (*Day 1)||10
342509|NCT02563834|841467|P2|STARTED|Control (Saline) Infusion (*Day 1)||8
342510|NCT02563834|841468|P1|STARTED|Control (Saline) Infusion (*Day 1)||10
342511|NCT02563106|841486|P2|NOT COMPLETED|Overall Study||29
342512|NCT02563106|841487|P1|NOT COMPLETED|Overall Study||34
342513|NCT02563106|841486|P2|COMPLETED|Overall Study||178
342514|NCT02563106|841487|P1|COMPLETED|Overall Study||172
342515|NCT02563106|841486|P2|STARTED|Overall Study||207
342516|NCT02563106|841487|P1|STARTED|Overall Study||206
342517|NCT02563093|841497|P4|NOT COMPLETED|Overall Study||0
342518|NCT02563093|841498|P3|NOT COMPLETED|Overall Study||0
342519|NCT02563093|841499|P2|NOT COMPLETED|Overall Study||0
342520|NCT02563093|841500|P1|NOT COMPLETED|Overall Study||0
342521|NCT02563093|841497|P4|COMPLETED|Overall Study||51
342522|NCT02563093|841498|P3|COMPLETED|Overall Study||53
342523|NCT02563093|841499|P2|COMPLETED|Overall Study||52
342524|NCT02563093|841500|P1|COMPLETED|Overall Study||52
342525|NCT02563093|841497|P4|STARTED|Overall Study||51
342526|NCT02563093|841498|P3|STARTED|Overall Study||53
342527|NCT02563093|841499|P2|STARTED|Overall Study||52
342528|NCT02563093|841500|P1|STARTED|Overall Study||52
342529|NCT02562521|841528|P2|NOT COMPLETED|Overall Study||0
342530|NCT02562521|841529|P1|NOT COMPLETED|Overall Study||0
342531|NCT02562521|841528|P2|COMPLETED|Overall Study||7
342532|NCT02562521|841529|P1|COMPLETED|Overall Study||18
342533|NCT02562521|841528|P2|STARTED|Overall Study||7
342534|NCT02562521|841529|P1|STARTED|Overall Study||18
342535|NCT02561806|841545|P2|NOT COMPLETED|Overall Study||4
342536|NCT02561806|841546|P1|NOT COMPLETED|Overall Study||1
342537|NCT02561806|841545|P2|COMPLETED|Overall Study||132
342538|NCT02561806|841546|P1|COMPLETED|Overall Study||165
342539|NCT02561806|841545|P2|Received At Least One Dose of Study Drug|Overall Study||135
342540|NCT02561806|841546|P1|Received At Least One Dose of Study Drug|Overall Study||166
342541|NCT02561806|841545|P2|STARTED|Overall Study||136
342542|NCT02561806|841546|P1|STARTED|Overall Study||166
342543|NCT02561702|841598|P2|NOT COMPLETED|Second Intervention||0
342544|NCT02561702|841599|P1|NOT COMPLETED|Second Intervention||0
342545|NCT02561702|841598|P2|COMPLETED|Second Intervention||2
342546|NCT02561702|841599|P1|COMPLETED|Second Intervention||2
342547|NCT02561702|841598|P2|STARTED|Second Intervention||2
342548|NCT02561702|841599|P1|STARTED|Second Intervention||2
342549|NCT02561702|841598|P2|NOT COMPLETED|Washout||0
342550|NCT02561702|841599|P1|NOT COMPLETED|Washout||0
342551|NCT02561702|841598|P2|COMPLETED|Washout||2
342552|NCT02561702|841599|P1|COMPLETED|Washout||2
342553|NCT02561702|841598|P2|STARTED|Washout||2
342554|NCT02561702|841599|P1|STARTED|Washout||2
342555|NCT02561702|841598|P2|NOT COMPLETED|First Intervention||0
342556|NCT02561702|841599|P1|NOT COMPLETED|First Intervention||0
342557|NCT02561702|841598|P2|COMPLETED|First Intervention||2
342558|NCT02561702|841599|P1|COMPLETED|First Intervention||2
342559|NCT02561702|841598|P2|STARTED|First Intervention||2
342560|NCT02561702|841599|P1|STARTED|First Intervention||2
342561|NCT02561572|841609|P2|NOT COMPLETED|Overall Study||2
342562|NCT02561572|841610|P1|NOT COMPLETED|Overall Study||2
342563|NCT02561572|841609|P2|COMPLETED|Overall Study||62
342564|NCT02561572|841610|P1|COMPLETED|Overall Study||62
342565|NCT02561572|841609|P2|STARTED|Overall Study||64
342566|NCT02561572|841610|P1|STARTED|Overall Study||64
342567|NCT02561195|841632|P6|NOT COMPLETED|Overall Study||10
342568|NCT02561195|841633|P5|NOT COMPLETED|Overall Study||28
342569|NCT02561195|841634|P4|NOT COMPLETED|Overall Study||26
342570|NCT02561195|841635|P3|NOT COMPLETED|Overall Study||6
342571|NCT02561195|841636|P2|NOT COMPLETED|Overall Study||22
342572|NCT02561195|841637|P1|NOT COMPLETED|Overall Study||23
342573|NCT02561195|841632|P6|COMPLETED|Overall Study||51
342574|NCT02561195|841633|P5|COMPLETED|Overall Study||155
342575|NCT02561195|841634|P4|COMPLETED|Overall Study||157
342576|NCT02561195|841635|P3|COMPLETED|Overall Study||55
342577|NCT02561195|841636|P2|COMPLETED|Overall Study||162
342578|NCT02561195|841637|P1|COMPLETED|Overall Study||160
342579|NCT02561195|841632|P6|Treated|Overall Study||61
342580|NCT02561195|841633|P5|Treated|Overall Study||183
342581|NCT02561195|841634|P4|Treated|Overall Study||183
342582|NCT02561195|841635|P3|Treated|Overall Study||61
342583|NCT02561195|841636|P2|Treated|Overall Study||184
342584|NCT02561195|841637|P1|Treated|Overall Study||182
342585|NCT02561195|841632|P6|STARTED|Overall Study||61
342586|NCT02561195|841633|P5|STARTED|Overall Study||183
342587|NCT02561195|841634|P4|STARTED|Overall Study||183
342588|NCT02561195|841635|P3|STARTED|Overall Study||61
342589|NCT02561195|841636|P2|STARTED|Overall Study||184
342590|NCT02561195|841637|P1|STARTED|Overall Study||183
342591|NCT02559622|841789|P4|NOT COMPLETED|Overall Study||3
342592|NCT02559622|841790|P3|NOT COMPLETED|Overall Study||2
342593|NCT02559622|841791|P2|NOT COMPLETED|Overall Study||5
342594|NCT02559622|841792|P1|NOT COMPLETED|Overall Study||1
342595|NCT02559622|841789|P4|COMPLETED|Overall Study||20
342596|NCT02559622|841790|P3|COMPLETED|Overall Study||24
342597|NCT02559622|841791|P2|COMPLETED|Overall Study||49
342598|NCT02559622|841792|P1|COMPLETED|Overall Study||47
342599|NCT02559622|841789|P4|STARTED|Overall Study||23
342600|NCT02559622|841790|P3|STARTED|Overall Study||26
342601|NCT02559622|841791|P2|STARTED|Overall Study||54
342602|NCT02559622|841792|P1|STARTED|Overall Study||48
342603|NCT02559414|841874|P3|NOT COMPLETED|Overall Study||2
342604|NCT02559414|841875|P2|NOT COMPLETED|Overall Study||2
342605|NCT02559414|841876|P1|NOT COMPLETED|Overall Study||1
342606|NCT02559414|841874|P3|COMPLETED|Overall Study||20
342607|NCT02559414|841875|P2|COMPLETED|Overall Study||20
342608|NCT02559414|841876|P1|COMPLETED|Overall Study||10
342609|NCT02559414|841874|P3|STARTED|Overall Study||22
342610|NCT02559414|841875|P2|STARTED|Overall Study||22
342611|NCT02559414|841876|P1|STARTED|Overall Study||11
342612|NCT02558829|841900|P8|NOT COMPLETED|Overall Study||3
342613|NCT02558829|841901|P7|NOT COMPLETED|Overall Study||1
342614|NCT02558829|841902|P6|NOT COMPLETED|Overall Study||2
342615|NCT02558829|841903|P5|NOT COMPLETED|Overall Study||2
342616|NCT02558829|841904|P4|NOT COMPLETED|Overall Study||2
342617|NCT02558829|841905|P3|NOT COMPLETED|Overall Study||3
342618|NCT02558829|841906|P2|NOT COMPLETED|Overall Study||3
342619|NCT02558829|841907|P1|NOT COMPLETED|Overall Study||1
342620|NCT02558829|841900|P8|COMPLETED|Overall Study||8
342621|NCT02558829|841901|P7|COMPLETED|Overall Study||17
342622|NCT02558829|841902|P6|COMPLETED|Overall Study||24
342623|NCT02558829|841903|P5|COMPLETED|Overall Study||16
342624|NCT02558829|841904|P4|COMPLETED|Overall Study||16
342625|NCT02558829|841905|P3|COMPLETED|Overall Study||21
342626|NCT02558829|841906|P2|COMPLETED|Overall Study||18
342627|NCT02558829|841907|P1|COMPLETED|Overall Study||20
342628|NCT02558829|841900|P8|STARTED|Overall Study||11
342629|NCT02558829|841901|P7|STARTED|Overall Study||18
342630|NCT02558829|841902|P6|STARTED|Overall Study||26
342631|NCT02558829|841903|P5|STARTED|Overall Study||18
342632|NCT02558829|841904|P4|STARTED|Overall Study||18
342633|NCT02558829|841905|P3|STARTED|Overall Study||24
342634|NCT02558829|841906|P2|STARTED|Overall Study||21
342635|NCT02558829|841907|P1|STARTED|Overall Study||21
342636|NCT02558790|841933|P1|NOT COMPLETED|Overall Study||7
342637|NCT02558790|841933|P1|COMPLETED|Overall Study||13
342638|NCT02558790|841933|P1|Treated|Overall Study||15
342639|NCT02558790|841933|P1|STARTED|Overall Study|20 subjects signed consent to participate in the study. 15 subjects began taking L-TAMS.|20
342640|NCT02558374|841939|P2|NOT COMPLETED|Overall Study||43
342641|NCT02558374|841940|P1|NOT COMPLETED|Overall Study||108
342642|NCT02558374|841939|P2|COMPLETED|Overall Study||314
342643|NCT02558374|841940|P1|COMPLETED|Overall Study||243
342644|NCT02558374|841939|P2|STARTED|Overall Study||357
342645|NCT02558374|841940|P1|STARTED|Overall Study||351
342646|NCT02557698|841950|P2|NOT COMPLETED|Overall Study||0
342647|NCT02557698|841951|P1|NOT COMPLETED|Overall Study||0
342648|NCT02557698|841950|P2|COMPLETED|Overall Study||30
342649|NCT02557698|841951|P1|COMPLETED|Overall Study||30
342650|NCT02557698|841950|P2|STARTED|Overall Study||30
342651|NCT02557698|841951|P1|STARTED|Overall Study||30
342652|NCT02557646|842015|P1|NOT COMPLETED|Overall Study||276
342653|NCT02557646|842015|P1|COMPLETED|Overall Study||417
342654|NCT02557646|842015|P1|STARTED|Overall Study||693
342655|NCT02557555|842033|P1|NOT COMPLETED|Overall Study||0
342656|NCT02557555|842033|P1|COMPLETED|Overall Study||100
342657|NCT02557555|842033|P1|STARTED|Overall Study||100
342658|NCT02557399|842040|P2|NOT COMPLETED|Overall Study||8
342659|NCT02557399|842041|P1|NOT COMPLETED|Overall Study||7
342660|NCT02557399|842040|P2|COMPLETED|Overall Study||169
342661|NCT02557399|842041|P1|COMPLETED|Overall Study||165
342662|NCT02557399|842040|P2|STARTED|Overall Study||177
342663|NCT02557399|842041|P1|STARTED|Overall Study||172
342664|NCT02557035|842075|P2|NOT COMPLETED|Overall Study||9
342665|NCT02557035|842076|P1|NOT COMPLETED|Overall Study||7
342666|NCT02557035|842075|P2|COMPLETED|Overall Study||206
342667|NCT02557035|842076|P1|COMPLETED|Overall Study||218
342668|NCT02557035|842075|P2|STARTED|Overall Study||215
342669|NCT02557035|842076|P1|STARTED|Overall Study||225
342670|NCT02556632|842101|P3|NOT COMPLETED|Overall Study||9
342671|NCT02556632|842102|P2|NOT COMPLETED|Overall Study||6
342672|NCT02556632|842103|P1|NOT COMPLETED|Overall Study||5
342673|NCT02556632|842101|P3|COMPLETED|Overall Study||53
342674|NCT02556632|842102|P2|COMPLETED|Overall Study||59
342675|NCT02556632|842103|P1|COMPLETED|Overall Study||59
342676|NCT02556632|842101|P3|STARTED|Overall Study||62
342677|NCT02556632|842102|P2|STARTED|Overall Study||65
342678|NCT02556632|842103|P1|STARTED|Overall Study||64
342679|NCT02556333|842117|P1|NOT COMPLETED|Overall Study||0
342680|NCT02556333|842117|P1|COMPLETED|Overall Study||1
342681|NCT02556333|842117|P1|STARTED|Overall Study||1
342682|NCT02556307|842121|P1|NOT COMPLETED|Overall Study||53
342683|NCT02556307|842121|P1|COMPLETED|Overall Study||217
342684|NCT02556307|842121|P1|Treated|Overall Study||268
342685|NCT02556307|842121|P1|STARTED|Overall Study||270
342686|NCT02556138|842131|P1|NOT COMPLETED|Overall Study||1
342687|NCT02556138|842131|P1|COMPLETED|Overall Study|One patient withdrew from the study due to intolerance of the balloon after 1 month.|7
342688|NCT02556138|842131|P1|STARTED|Overall Study||8
342689|NCT02555722|842139|P2|NOT COMPLETED|Month 3||0
342690|NCT02555722|842140|P1|NOT COMPLETED|Month 3||0
342691|NCT02555722|842139|P2|COMPLETED|Month 3||29
342692|NCT02555722|842140|P1|COMPLETED|Month 3||53
342693|NCT02555722|842139|P2|STARTED|Month 3||29
342694|NCT02555722|842140|P1|STARTED|Month 3||53
342695|NCT02555722|842139|P2|NOT COMPLETED|Month 2||0
342696|NCT02555722|842140|P1|NOT COMPLETED|Month 2||3
342697|NCT02555722|842139|P2|COMPLETED|Month 2||29
342698|NCT02555722|842140|P1|COMPLETED|Month 2||53
342699|NCT02555722|842139|P2|STARTED|Month 2||29
342700|NCT02555722|842140|P1|STARTED|Month 2||56
342701|NCT02555722|842139|P2|NOT COMPLETED|Month 1||0
342702|NCT02555722|842140|P1|NOT COMPLETED|Month 1||2
342703|NCT02555722|842139|P2|COMPLETED|Month 1||29
342704|NCT02555722|842140|P1|COMPLETED|Month 1||56
342705|NCT02555722|842139|P2|STARTED|Month 1||29
342706|NCT02555722|842140|P1|STARTED|Month 1||58
342707|NCT02555722|842139|P2|NOT COMPLETED|Week 2||1
342708|NCT02555722|842140|P1|NOT COMPLETED|Week 2||0
342709|NCT02555722|842139|P2|COMPLETED|Week 2||29
342710|NCT02555722|842140|P1|COMPLETED|Week 2||58
342711|NCT02555722|842139|P2|STARTED|Week 2||30
342712|NCT02555722|842140|P1|STARTED|Week 2||58
342713|NCT02555722|842139|P2|NOT COMPLETED|Week 1||0
342714|NCT02555722|842140|P1|NOT COMPLETED|Week 1||1
342715|NCT02555722|842139|P2|COMPLETED|Week 1||30
342716|NCT02555722|842140|P1|COMPLETED|Week 1||58
342717|NCT02555722|842139|P2|STARTED|Week 1||30
342718|NCT02555722|842140|P1|STARTED|Week 1||59
342719|NCT02555722|842139|P2|NOT COMPLETED|Lens Dispensed||0
342720|NCT02555722|842140|P1|NOT COMPLETED|Lens Dispensed||0
342721|NCT02555722|842139|P2|COMPLETED|Lens Dispensed||30
342722|NCT02555722|842140|P1|COMPLETED|Lens Dispensed||59
342723|NCT02555722|842139|P2|STARTED|Lens Dispensed||30
342724|NCT02555722|842140|P1|STARTED|Lens Dispensed||59
342725|NCT02555631|842298|P1|NOT COMPLETED|Overall Study||4
342726|NCT02555631|842298|P1|COMPLETED|Overall Study||25
342727|NCT02555631|842298|P1|STARTED|Overall Study||29
342728|NCT02555618|842307|P2|NOT COMPLETED|Overall Study||0
342729|NCT02555618|842308|P1|NOT COMPLETED|Overall Study||1
342730|NCT02555618|842307|P2|COMPLETED|Overall Study||200
342731|NCT02555618|842308|P1|COMPLETED|Overall Study||199
342732|NCT02555618|842307|P2|STARTED|Overall Study||200
342733|NCT02555618|842308|P1|STARTED|Overall Study||200
342734|NCT02555228|842352|P2|NOT COMPLETED|Overall Study||0
342735|NCT02555228|842353|P1|NOT COMPLETED|Overall Study||0
342736|NCT02555228|842352|P2|COMPLETED|Overall Study|29th October 2015|27
342737|NCT02555228|842353|P1|COMPLETED|Overall Study|19th November 2015|27
342738|NCT02555228|842352|P2|STARTED|Overall Study|14th August 2015|27
342739|NCT02555228|842353|P1|STARTED|Overall Study|20th August 2015|27
342740|NCT02554981|842365|P1|NOT COMPLETED|Overall Study||5
342741|NCT02554981|842365|P1|COMPLETED|Overall Study||46
342742|NCT02554981|842365|P1|STARTED|Overall Study||51
342743|NCT02554877|842393|P4|NOT COMPLETED|Overall Study||7
342744|NCT02554877|842394|P3|NOT COMPLETED|Overall Study||6
342745|NCT02554877|842395|P2|NOT COMPLETED|Overall Study||7
342746|NCT02554877|842396|P1|NOT COMPLETED|Overall Study||12
342747|NCT02554877|842393|P4|COMPLETED|Overall Study||45
342748|NCT02554877|842394|P3|COMPLETED|Overall Study||46
342749|NCT02554877|842395|P2|COMPLETED|Overall Study||44
342750|NCT02554877|842396|P1|COMPLETED|Overall Study||39
342751|NCT02554877|842393|P4|STARTED|Overall Study||52
342752|NCT02554877|842394|P3|STARTED|Overall Study||52
342753|NCT02554877|842395|P2|STARTED|Overall Study||51
342754|NCT02554877|842396|P1|STARTED|Overall Study||51
342755|NCT02554279|842460|P2|NOT COMPLETED|Overall Study||18
342756|NCT02554279|842461|P1|NOT COMPLETED|Overall Study||32
342757|NCT02554279|842460|P2|COMPLETED|Overall Study||291
342758|NCT02554279|842461|P1|COMPLETED|Overall Study||279
342759|NCT02554279|842460|P2|Completed Fresh Blastocyst Transfer|Overall Study||191
342760|NCT02554279|842461|P1|Completed Fresh Blastocyst Transfer|Overall Study||201
342761|NCT02554279|842460|P2|Completed Oocyte Retrieval|Overall Study||306
342762|NCT02554279|842461|P1|Completed Oocyte Retrieval|Overall Study||292
342763|NCT02554279|842460|P2|Received Trigger|Overall Study||307
342764|NCT02554279|842461|P1|Received Trigger|Overall Study||293
342765|NCT02554279|842460|P2|Completed Day 6 of Stimulation|Overall Study||309
342766|NCT02554279|842461|P1|Completed Day 6 of Stimulation|Overall Study||308
342767|NCT02554279|842460|P2|Treated|Overall Study||309
342768|NCT02554279|842461|P1|Treated|Overall Study||310
342769|NCT02554279|842460|P2|STARTED|Overall Study||309
342770|NCT02554279|842461|P1|STARTED|Overall Study||311
342771|NCT02553772|842495|P2|NOT COMPLETED|Overall Study||6
342772|NCT02553772|842496|P1|NOT COMPLETED|Overall Study||6
342773|NCT02553772|842495|P2|COMPLETED|Overall Study||116
342774|NCT02553772|842496|P1|COMPLETED|Overall Study||114
342775|NCT02553772|842495|P2|STARTED|Overall Study||122
342776|NCT02553772|842496|P1|STARTED|Overall Study||120
342777|NCT02553629|842512|P2|NOT COMPLETED|Overall Study||6
342778|NCT02553629|842513|P1|NOT COMPLETED|Overall Study||3
342779|NCT02553629|842512|P2|COMPLETED|Overall Study||50
342780|NCT02553629|842513|P1|COMPLETED|Overall Study||50
342781|NCT02553629|842512|P2|STARTED|Overall Study||56
342782|NCT02553629|842513|P1|STARTED|Overall Study||53
342783|NCT02553538|842529|P2|NOT COMPLETED|Overall Study||56
342784|NCT02553538|842530|P1|NOT COMPLETED|Overall Study||187
342785|NCT02553538|842529|P2|COMPLETED|Overall Study||764
342786|NCT02553538|842530|P1|COMPLETED|Overall Study||605
342787|NCT02553538|842529|P2|STARTED|Overall Study||820
342788|NCT02553538|842530|P1|STARTED|Overall Study||792
342789|NCT02553512|842542|P1|NOT COMPLETED|Overall Study||23
342790|NCT02553512|842542|P1|COMPLETED|Overall Study||144
342791|NCT02553512|842542|P1|STARTED|Overall Study||167
342792|NCT02553421|842552|P2|NOT COMPLETED|Overall Study||1
342793|NCT02553421|842553|P1|NOT COMPLETED|Overall Study||29
342794|NCT02553421|842552|P2|COMPLETED|Overall Study||57
342795|NCT02553421|842553|P1|COMPLETED|Overall Study||156
342796|NCT02553421|842552|P2|STARTED|Overall Study||58
342797|NCT02553421|842553|P1|STARTED|Overall Study||185
342798|NCT02552810|842563|P2|NOT COMPLETED|Overall Study||0
342799|NCT02552810|842564|P1|NOT COMPLETED|Overall Study||0
342800|NCT02552810|842563|P2|COMPLETED|Overall Study||15
342801|NCT02552810|842564|P1|COMPLETED|Overall Study||15
342802|NCT02552810|842563|P2|STARTED|Overall Study||15
342803|NCT02552810|842564|P1|STARTED|Overall Study||15
342804|NCT02552303|842584|P4|NOT COMPLETED|Follow-Up||0
342805|NCT02552303|842585|P3|NOT COMPLETED|Follow-Up||1
342806|NCT02552303|842586|P2|NOT COMPLETED|Follow-Up||2
342807|NCT02552303|842587|P1|NOT COMPLETED|Follow-Up||0
342808|NCT02552303|842584|P4|COMPLETED|Follow-Up||10
342809|NCT02552303|842585|P3|COMPLETED|Follow-Up||6
342810|NCT02552303|842586|P2|COMPLETED|Follow-Up||6
342811|NCT02552303|842587|P1|COMPLETED|Follow-Up||7
342812|NCT02552303|842584|P4|STARTED|Follow-Up||10
342813|NCT02552303|842585|P3|STARTED|Follow-Up||7
342814|NCT02552303|842586|P2|STARTED|Follow-Up||8
342815|NCT02552303|842587|P1|STARTED|Follow-Up||7
342816|NCT02552303|842584|P4|NOT COMPLETED|Allocation||1
342817|NCT02552303|842585|P3|NOT COMPLETED|Allocation||1
342818|NCT02552303|842586|P2|NOT COMPLETED|Allocation||2
342819|NCT02552303|842587|P1|NOT COMPLETED|Allocation||3
342820|NCT02552303|842584|P4|COMPLETED|Allocation||10
342821|NCT02552303|842585|P3|COMPLETED|Allocation||7
342822|NCT02552303|842586|P2|COMPLETED|Allocation||8
342823|NCT02552303|842587|P1|COMPLETED|Allocation||7
342824|NCT02552303|842584|P4|STARTED|Allocation||11
342825|NCT02552303|842585|P3|STARTED|Allocation||8
342826|NCT02552303|842586|P2|STARTED|Allocation||10
342827|NCT02552303|842587|P1|STARTED|Allocation||10
342828|NCT02551887|842604|P3|NOT COMPLETED|Overall Study||0
342829|NCT02551887|842605|P2|NOT COMPLETED|Overall Study||0
342830|NCT02551887|842606|P1|NOT COMPLETED|Overall Study||0
342831|NCT02551887|842604|P3|COMPLETED|Overall Study||222
342832|NCT02551887|842605|P2|COMPLETED|Overall Study||124
342833|NCT02551887|842606|P1|COMPLETED|Overall Study||301
342834|NCT02551887|842604|P3|STARTED|Overall Study||222
342835|NCT02551887|842605|P2|STARTED|Overall Study||124
342836|NCT02551887|842606|P1|STARTED|Overall Study||301
342837|NCT02551822|842619|P2|NOT COMPLETED|Overall Study||2
342838|NCT02551822|842620|P1|NOT COMPLETED|Overall Study||2
342839|NCT02551822|842619|P2|COMPLETED|Overall Study||10
342840|NCT02551822|842620|P1|COMPLETED|Overall Study||9
342841|NCT02551822|842619|P2|STARTED|Overall Study||12
342842|NCT02551822|842620|P1|STARTED|Overall Study||11
342843|NCT02551224|842630|P2|NOT COMPLETED|Second Intervention (5 Min After First )||0
342844|NCT02551224|842631|P1|NOT COMPLETED|Second Intervention (5 Min After First )||0
342845|NCT02551224|842630|P2|COMPLETED|Second Intervention (5 Min After First )||50
342846|NCT02551224|842631|P1|COMPLETED|Second Intervention (5 Min After First )||50
342847|NCT02551224|842630|P2|STARTED|Second Intervention (5 Min After First )||50
342848|NCT02551224|842631|P1|STARTED|Second Intervention (5 Min After First )||50
342849|NCT02551224|842630|P2|NOT COMPLETED|First Intervention||0
342850|NCT02551224|842631|P1|NOT COMPLETED|First Intervention||0
342851|NCT02551224|842630|P2|COMPLETED|First Intervention||50
342852|NCT02551224|842631|P1|COMPLETED|First Intervention||50
342853|NCT02551224|842630|P2|STARTED|First Intervention||50
342854|NCT02551224|842631|P1|STARTED|First Intervention||50
342855|NCT02550288|842644|P5|NOT COMPLETED|Overall Study||3
342856|NCT02550288|842645|P4|NOT COMPLETED|Overall Study||3
342857|NCT02550288|842646|P3|NOT COMPLETED|Overall Study||1
342858|NCT02550288|842647|P2|NOT COMPLETED|Overall Study||3
342859|NCT02550288|842648|P1|NOT COMPLETED|Overall Study||2
342860|NCT02550288|842644|P5|COMPLETED|Overall Study||66
342861|NCT02550288|842645|P4|COMPLETED|Overall Study||65
342862|NCT02550288|842646|P3|COMPLETED|Overall Study||68
342863|NCT02550288|842647|P2|COMPLETED|Overall Study||65
342864|NCT02550288|842648|P1|COMPLETED|Overall Study||33
342865|NCT02550288|842644|P5|STARTED|Overall Study||69
342866|NCT02550288|842645|P4|STARTED|Overall Study||68
342867|NCT02550288|842646|P3|STARTED|Overall Study||69
342868|NCT02550288|842647|P2|STARTED|Overall Study||68
342869|NCT02550288|842648|P1|STARTED|Overall Study||35
342870|NCT02550197|842747|P2|NOT COMPLETED|Overall Study||0
342871|NCT02550197|842748|P1|NOT COMPLETED|Overall Study||0
342872|NCT02550197|842747|P2|COMPLETED|Overall Study||100
342873|NCT02550197|842748|P1|COMPLETED|Overall Study||200
342874|NCT02550197|842747|P2|STARTED|Overall Study||100
342875|NCT02550197|842748|P1|STARTED|Overall Study||200
342876|NCT02550132|842766|P1|NOT COMPLETED|Overall Study||0
342877|NCT02550132|842766|P1|COMPLETED|Overall Study||25
342878|NCT02550132|842766|P1|STARTED|Overall Study||25
342879|NCT02549755|842797|P1|NOT COMPLETED|Overall Study||1
342880|NCT02549755|842797|P1|COMPLETED|Overall Study||0
342881|NCT02549755|842797|P1|STARTED|Overall Study||1
342882|NCT02549573|842803|P2|NOT COMPLETED|Overall Study||3
342883|NCT02549573|842804|P1|NOT COMPLETED|Overall Study||0
342884|NCT02549573|842803|P2|COMPLETED|Overall Study||4
342885|NCT02549573|842804|P1|COMPLETED|Overall Study||6
342886|NCT02549573|842803|P2|STARTED|Overall Study||7
342887|NCT02549573|842804|P1|STARTED|Overall Study||6
342888|NCT02549027|842846|P6|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
342889|NCT02549027|842847|P5|NOT COMPLETED|Period 5 - MK-6096 or Placebo||2
342890|NCT02549027|842848|P4|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
342891|NCT02549027|842849|P3|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
342892|NCT02549027|842850|P2|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
342893|NCT02549027|842851|P1|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
342894|NCT02549027|842846|P6|COMPLETED|Period 5 - MK-6096 or Placebo||1
342895|NCT02549027|842847|P5|COMPLETED|Period 5 - MK-6096 or Placebo|The 2 participants who did not complete Period 5 did not receive study drug in Period 5|14
342896|NCT02549027|842848|P4|COMPLETED|Period 5 - MK-6096 or Placebo||0
342897|NCT02549027|842849|P3|COMPLETED|Period 5 - MK-6096 or Placebo||0
342898|NCT02549027|842850|P2|COMPLETED|Period 5 - MK-6096 or Placebo||0
342899|NCT02549027|842851|P1|COMPLETED|Period 5 - MK-6096 or Placebo||0
342900|NCT02549027|842846|P6|STARTED|Period 5 - MK-6096 or Placebo|Participants entering Period 5 were previously in MK-1064/Placebo (Period 1-4) arms|1
342901|NCT02549027|842847|P5|STARTED|Period 5 - MK-6096 or Placebo|Participants entering Period 5 were previously in MK-1064/Placebo (Period 1-4) arms|16
342902|NCT02549027|842848|P4|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
342903|NCT02549027|842849|P3|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
342904|NCT02549027|842850|P2|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
342905|NCT02549027|842851|P1|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg/Placebo (Period 5) arms|0
342906|NCT02549027|842846|P6|NOT COMPLETED|Washout After Period 4||0
342907|NCT02549027|842847|P5|NOT COMPLETED|Washout After Period 4||0
342908|NCT02549027|842848|P4|NOT COMPLETED|Washout After Period 4||1
342909|NCT02549027|842849|P3|NOT COMPLETED|Washout After Period 4||1
342910|NCT02549027|842850|P2|NOT COMPLETED|Washout After Period 4||1
342911|NCT02549027|842851|P1|NOT COMPLETED|Washout After Period 4||0
342912|NCT02549027|842846|P6|COMPLETED|Washout After Period 4||0
342913|NCT02549027|842847|P5|COMPLETED|Washout After Period 4||0
342914|NCT02549027|842848|P4|COMPLETED|Washout After Period 4||4
342915|NCT02549027|842849|P3|COMPLETED|Washout After Period 4||4
342916|NCT02549027|842850|P2|COMPLETED|Washout After Period 4||4
342917|NCT02549027|842851|P1|COMPLETED|Washout After Period 4||5
342918|NCT02549027|842846|P6|STARTED|Washout After Period 4||0
342919|NCT02549027|842847|P5|STARTED|Washout After Period 4||0
342920|NCT02549027|842848|P4|STARTED|Washout After Period 4||5
342921|NCT02549027|842849|P3|STARTED|Washout After Period 4||5
342922|NCT02549027|842850|P2|STARTED|Washout After Period 4||5
342923|NCT02549027|842851|P1|STARTED|Washout After Period 4||5
342924|NCT02549027|842846|P6|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
342925|NCT02549027|842847|P5|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
342926|NCT02549027|842848|P4|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
342927|NCT02549027|842849|P3|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
342928|NCT02549027|842850|P2|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
342929|NCT02549027|842851|P1|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
342930|NCT02549027|842846|P6|COMPLETED|Period 4 - MK-1064 or Placebo||0
342931|NCT02549027|842847|P5|COMPLETED|Period 4 - MK-1064 or Placebo||0
342932|NCT02549027|842848|P4|COMPLETED|Period 4 - MK-1064 or Placebo||5
342933|NCT02549027|842849|P3|COMPLETED|Period 4 - MK-1064 or Placebo||5
342934|NCT02549027|842850|P2|COMPLETED|Period 4 - MK-1064 or Placebo||5
342935|NCT02549027|842851|P1|COMPLETED|Period 4 - MK-1064 or Placebo||5
342936|NCT02549027|842846|P6|STARTED|Period 4 - MK-1064 or Placebo||0
342937|NCT02549027|842847|P5|STARTED|Period 4 - MK-1064 or Placebo||0
342938|NCT02549027|842848|P4|STARTED|Period 4 - MK-1064 or Placebo||5
342939|NCT02549027|842849|P3|STARTED|Period 4 - MK-1064 or Placebo||5
342940|NCT02549027|842850|P2|STARTED|Period 4 - MK-1064 or Placebo||5
342941|NCT02549027|842851|P1|STARTED|Period 4 - MK-1064 or Placebo||5
342942|NCT02549027|842846|P6|NOT COMPLETED|Washout After Period 3||0
342943|NCT02549027|842847|P5|NOT COMPLETED|Washout After Period 3||0
342944|NCT02549027|842848|P4|NOT COMPLETED|Washout After Period 3||0
342945|NCT02549027|842849|P3|NOT COMPLETED|Washout After Period 3||0
342946|NCT02549027|842850|P2|NOT COMPLETED|Washout After Period 3||0
342947|NCT02549027|842851|P1|NOT COMPLETED|Washout After Period 3||0
342948|NCT02549027|842846|P6|COMPLETED|Washout After Period 3||0
342949|NCT02549027|842847|P5|COMPLETED|Washout After Period 3||0
342950|NCT02549027|842848|P4|COMPLETED|Washout After Period 3||5
342951|NCT02549027|842849|P3|COMPLETED|Washout After Period 3||5
342952|NCT02549027|842850|P2|COMPLETED|Washout After Period 3||5
342953|NCT02549027|842851|P1|COMPLETED|Washout After Period 3||5
342954|NCT02549027|842846|P6|STARTED|Washout After Period 3||0
342955|NCT02549027|842847|P5|STARTED|Washout After Period 3||0
342956|NCT02549027|842848|P4|STARTED|Washout After Period 3||5
342957|NCT02549027|842849|P3|STARTED|Washout After Period 3||5
342958|NCT02549027|842850|P2|STARTED|Washout After Period 3||5
342959|NCT02549027|842851|P1|STARTED|Washout After Period 3||5
342960|NCT02549027|842846|P6|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
342961|NCT02549027|842847|P5|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
342962|NCT02549027|842848|P4|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
342963|NCT02549027|842849|P3|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
342964|NCT02549027|842850|P2|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
342965|NCT02549027|842851|P1|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
342966|NCT02549027|842846|P6|COMPLETED|Period 3 - MK-1064 or Placebo||0
342967|NCT02549027|842847|P5|COMPLETED|Period 3 - MK-1064 or Placebo||0
342968|NCT02549027|842848|P4|COMPLETED|Period 3 - MK-1064 or Placebo||5
342969|NCT02549027|842849|P3|COMPLETED|Period 3 - MK-1064 or Placebo||5
342970|NCT02549027|842850|P2|COMPLETED|Period 3 - MK-1064 or Placebo||5
342971|NCT02549027|842851|P1|COMPLETED|Period 3 - MK-1064 or Placebo||5
342972|NCT02549027|842846|P6|STARTED|Period 3 - MK-1064 or Placebo||0
342973|NCT02549027|842847|P5|STARTED|Period 3 - MK-1064 or Placebo||0
342974|NCT02549027|842848|P4|STARTED|Period 3 - MK-1064 or Placebo||5
342975|NCT02549027|842849|P3|STARTED|Period 3 - MK-1064 or Placebo||5
342976|NCT02549027|842850|P2|STARTED|Period 3 - MK-1064 or Placebo||5
342977|NCT02549027|842851|P1|STARTED|Period 3 - MK-1064 or Placebo||5
342978|NCT02549027|842846|P6|NOT COMPLETED|Washout After Period 2||0
342979|NCT02549027|842847|P5|NOT COMPLETED|Washout After Period 2||0
342980|NCT02549027|842848|P4|NOT COMPLETED|Washout After Period 2||0
342981|NCT02549027|842849|P3|NOT COMPLETED|Washout After Period 2||0
342982|NCT02549027|842850|P2|NOT COMPLETED|Washout After Period 2||0
342983|NCT02549027|842851|P1|NOT COMPLETED|Washout After Period 2||0
342984|NCT02549027|842846|P6|COMPLETED|Washout After Period 2||0
342985|NCT02549027|842847|P5|COMPLETED|Washout After Period 2||0
342986|NCT02549027|842848|P4|COMPLETED|Washout After Period 2||5
342987|NCT02549027|842849|P3|COMPLETED|Washout After Period 2||5
342988|NCT02549027|842850|P2|COMPLETED|Washout After Period 2||5
342989|NCT02549027|842851|P1|COMPLETED|Washout After Period 2||5
342990|NCT02549027|842846|P6|STARTED|Washout After Period 2||0
342991|NCT02549027|842847|P5|STARTED|Washout After Period 2||0
342992|NCT02549027|842848|P4|STARTED|Washout After Period 2||5
342993|NCT02549027|842849|P3|STARTED|Washout After Period 2||5
342994|NCT02549027|842850|P2|STARTED|Washout After Period 2||5
342995|NCT02549027|842851|P1|STARTED|Washout After Period 2||5
342996|NCT02549027|842846|P6|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
342997|NCT02549027|842847|P5|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
342998|NCT02549027|842848|P4|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
342999|NCT02549027|842849|P3|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
343000|NCT02549027|842850|P2|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
343001|NCT02549027|842851|P1|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
343002|NCT02549027|842846|P6|COMPLETED|Period 2 - MK-1064 or Placebo||0
343003|NCT02549027|842847|P5|COMPLETED|Period 2 - MK-1064 or Placebo||0
343004|NCT02549027|842848|P4|COMPLETED|Period 2 - MK-1064 or Placebo||5
343005|NCT02549027|842849|P3|COMPLETED|Period 2 - MK-1064 or Placebo||5
343006|NCT02549027|842850|P2|COMPLETED|Period 2 - MK-1064 or Placebo||5
343007|NCT02549027|842851|P1|COMPLETED|Period 2 - MK-1064 or Placebo||5
343008|NCT02549027|842846|P6|STARTED|Period 2 - MK-1064 or Placebo||0
343009|NCT02549027|842847|P5|STARTED|Period 2 - MK-1064 or Placebo||0
343010|NCT02549027|842848|P4|STARTED|Period 2 - MK-1064 or Placebo||5
343011|NCT02549027|842849|P3|STARTED|Period 2 - MK-1064 or Placebo||5
343012|NCT02549027|842850|P2|STARTED|Period 2 - MK-1064 or Placebo||5
343013|NCT02549027|842851|P1|STARTED|Period 2 - MK-1064 or Placebo||5
343014|NCT02549027|842846|P6|NOT COMPLETED|Washout After Period 1||0
343015|NCT02549027|842847|P5|NOT COMPLETED|Washout After Period 1||0
343016|NCT02549027|842848|P4|NOT COMPLETED|Washout After Period 1||0
343017|NCT02549027|842849|P3|NOT COMPLETED|Washout After Period 1||0
343018|NCT02549027|842850|P2|NOT COMPLETED|Washout After Period 1||0
343019|NCT02549027|842851|P1|NOT COMPLETED|Washout After Period 1||0
343020|NCT02549027|842846|P6|COMPLETED|Washout After Period 1||0
343021|NCT02549027|842847|P5|COMPLETED|Washout After Period 1||0
343022|NCT02549027|842848|P4|COMPLETED|Washout After Period 1||5
343023|NCT02549027|842849|P3|COMPLETED|Washout After Period 1||5
343024|NCT02549027|842850|P2|COMPLETED|Washout After Period 1||5
343025|NCT02549027|842851|P1|COMPLETED|Washout After Period 1||5
343026|NCT02549027|842846|P6|STARTED|Washout After Period 1||0
343027|NCT02549027|842847|P5|STARTED|Washout After Period 1||0
343028|NCT02549027|842848|P4|STARTED|Washout After Period 1||5
343029|NCT02549027|842849|P3|STARTED|Washout After Period 1||5
343030|NCT02549027|842850|P2|STARTED|Washout After Period 1||5
343031|NCT02549027|842851|P1|STARTED|Washout After Period 1||5
343032|NCT02549027|842846|P6|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
343033|NCT02549027|842847|P5|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
343034|NCT02549027|842848|P4|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
343035|NCT02549027|842849|P3|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
343036|NCT02549027|842850|P2|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
343037|NCT02549027|842851|P1|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
343038|NCT02549027|842846|P6|COMPLETED|Period 1 - MK-1064 or Placebo||0
343039|NCT02549027|842847|P5|COMPLETED|Period 1 - MK-1064 or Placebo||0
343040|NCT02549027|842848|P4|COMPLETED|Period 1 - MK-1064 or Placebo||5
343041|NCT02549027|842849|P3|COMPLETED|Period 1 - MK-1064 or Placebo||5
343042|NCT02549027|842850|P2|COMPLETED|Period 1 - MK-1064 or Placebo||5
343043|NCT02549027|842851|P1|COMPLETED|Period 1 - MK-1064 or Placebo||5
343044|NCT02549027|842846|P6|STARTED|Period 1 - MK-1064 or Placebo||0
343045|NCT02549027|842847|P5|STARTED|Period 1 - MK-1064 or Placebo||0
343046|NCT02549027|842848|P4|STARTED|Period 1 - MK-1064 or Placebo||5
343047|NCT02549027|842849|P3|STARTED|Period 1 - MK-1064 or Placebo||5
343048|NCT02549027|842850|P2|STARTED|Period 1 - MK-1064 or Placebo||5
343049|NCT02549027|842851|P1|STARTED|Period 1 - MK-1064 or Placebo||5
343050|NCT02549014|842888|P2|NOT COMPLETED|Overall Study||0
343051|NCT02549014|842889|P1|NOT COMPLETED|Overall Study||0
343052|NCT02549014|842888|P2|COMPLETED|Overall Study||8
343053|NCT02549014|842889|P1|COMPLETED|Overall Study||8
343054|NCT02549014|842888|P2|STARTED|Overall Study||8
343055|NCT02549014|842889|P1|STARTED|Overall Study||8
343056|NCT02548455|842979|P1|NOT COMPLETED|Overall Study||240
343057|NCT02548455|842979|P1|COMPLETED|Overall Study|Completed 6-Month Follow-up|259
343058|NCT02548455|842979|P1|Completed 12-Month Follow-up|Overall Study|Study completed prior to all subjects reaching the 6- and 12-month visits.|61
343059|NCT02548455|842979|P1|Completed 6-Month Follow-up|Overall Study||259
343060|NCT02548455|842979|P1|Completed Pre-Discharge|Overall Study||484
343061|NCT02548455|842979|P1|STARTED|Overall Study|A total of 499 subjects were enrolled at 31 investigational sites.|499
343062|NCT02548156|842983|P6|NOT COMPLETED|Period 3||0
343063|NCT02548156|842984|P5|NOT COMPLETED|Period 3||0
343064|NCT02548156|842985|P4|NOT COMPLETED|Period 3||0
343065|NCT02548156|842986|P3|NOT COMPLETED|Period 3||0
343066|NCT02548156|842987|P2|NOT COMPLETED|Period 3||0
343067|NCT02548156|842988|P1|NOT COMPLETED|Period 3||0
343068|NCT02548156|842983|P6|COMPLETED|Period 3||5
343069|NCT02548156|842984|P5|COMPLETED|Period 3||4
343070|NCT02548156|842985|P4|COMPLETED|Period 3||5
343071|NCT02548156|842986|P3|COMPLETED|Period 3||4
343072|NCT02548156|842987|P2|COMPLETED|Period 3||5
343073|NCT02548156|842988|P1|COMPLETED|Period 3||5
343074|NCT02548156|842983|P6|STARTED|Period 3||5
343075|NCT02548156|842984|P5|STARTED|Period 3||4
343076|NCT02548156|842985|P4|STARTED|Period 3||5
343077|NCT02548156|842986|P3|STARTED|Period 3||4
343078|NCT02548156|842987|P2|STARTED|Period 3||5
343079|NCT02548156|842988|P1|STARTED|Period 3||5
343080|NCT02548156|842983|P6|NOT COMPLETED|Washout Period 2||0
343081|NCT02548156|842984|P5|NOT COMPLETED|Washout Period 2||0
343082|NCT02548156|842985|P4|NOT COMPLETED|Washout Period 2||0
343083|NCT02548156|842986|P3|NOT COMPLETED|Washout Period 2||0
343084|NCT02548156|842987|P2|NOT COMPLETED|Washout Period 2||0
343085|NCT02548156|842988|P1|NOT COMPLETED|Washout Period 2||0
343086|NCT02548156|842983|P6|COMPLETED|Washout Period 2||5
343087|NCT02548156|842984|P5|COMPLETED|Washout Period 2||4
343088|NCT02548156|842985|P4|COMPLETED|Washout Period 2||5
343089|NCT02548156|842986|P3|COMPLETED|Washout Period 2||4
343090|NCT02548156|842987|P2|COMPLETED|Washout Period 2||5
343091|NCT02548156|842988|P1|COMPLETED|Washout Period 2||5
343092|NCT02548156|842983|P6|STARTED|Washout Period 2||5
343093|NCT02548156|842984|P5|STARTED|Washout Period 2||4
343094|NCT02548156|842985|P4|STARTED|Washout Period 2||5
343095|NCT02548156|842986|P3|STARTED|Washout Period 2||4
343096|NCT02548156|842987|P2|STARTED|Washout Period 2||5
343097|NCT02548156|842988|P1|STARTED|Washout Period 2||5
343098|NCT02548156|842983|P6|NOT COMPLETED|Period 2||0
343099|NCT02548156|842984|P5|NOT COMPLETED|Period 2||0
343100|NCT02548156|842985|P4|NOT COMPLETED|Period 2||0
343101|NCT02548156|842986|P3|NOT COMPLETED|Period 2||0
343102|NCT02548156|842987|P2|NOT COMPLETED|Period 2||0
343103|NCT02548156|842988|P1|NOT COMPLETED|Period 2||0
343104|NCT02548156|842983|P6|COMPLETED|Period 2||5
343105|NCT02548156|842984|P5|COMPLETED|Period 2||4
343106|NCT02548156|842985|P4|COMPLETED|Period 2||5
343107|NCT02548156|842986|P3|COMPLETED|Period 2||4
343108|NCT02548156|842987|P2|COMPLETED|Period 2||5
343109|NCT02548156|842988|P1|COMPLETED|Period 2||5
343110|NCT02548156|842983|P6|STARTED|Period 2||5
343111|NCT02548156|842984|P5|STARTED|Period 2||4
343112|NCT02548156|842985|P4|STARTED|Period 2||5
343113|NCT02548156|842986|P3|STARTED|Period 2||4
343114|NCT02548156|842987|P2|STARTED|Period 2||5
343115|NCT02548156|842988|P1|STARTED|Period 2||5
343116|NCT02548156|842983|P6|NOT COMPLETED|Washout Period 1||0
343117|NCT02548156|842984|P5|NOT COMPLETED|Washout Period 1||1
343118|NCT02548156|842985|P4|NOT COMPLETED|Washout Period 1||0
343119|NCT02548156|842986|P3|NOT COMPLETED|Washout Period 1||0
343120|NCT02548156|842987|P2|NOT COMPLETED|Washout Period 1||0
343121|NCT02548156|842988|P1|NOT COMPLETED|Washout Period 1||0
343122|NCT02548156|842983|P6|COMPLETED|Washout Period 1||5
343123|NCT02548156|842984|P5|COMPLETED|Washout Period 1||4
343124|NCT02548156|842985|P4|COMPLETED|Washout Period 1||5
343125|NCT02548156|842986|P3|COMPLETED|Washout Period 1||4
343126|NCT02548156|842987|P2|COMPLETED|Washout Period 1||5
343127|NCT02548156|842988|P1|COMPLETED|Washout Period 1||5
343128|NCT02548156|842983|P6|STARTED|Washout Period 1||5
343129|NCT02548156|842984|P5|STARTED|Washout Period 1||5
343130|NCT02548156|842985|P4|STARTED|Washout Period 1||5
343131|NCT02548156|842986|P3|STARTED|Washout Period 1||4
343132|NCT02548156|842987|P2|STARTED|Washout Period 1||5
343133|NCT02548156|842988|P1|STARTED|Washout Period 1||5
343134|NCT02548156|842983|P6|NOT COMPLETED|Period 1||0
343135|NCT02548156|842984|P5|NOT COMPLETED|Period 1||0
343136|NCT02548156|842985|P4|NOT COMPLETED|Period 1||0
343137|NCT02548156|842986|P3|NOT COMPLETED|Period 1||0
343138|NCT02548156|842987|P2|NOT COMPLETED|Period 1||0
343139|NCT02548156|842988|P1|NOT COMPLETED|Period 1||0
343140|NCT02548156|842983|P6|COMPLETED|Period 1||5
343141|NCT02548156|842984|P5|COMPLETED|Period 1||5
343142|NCT02548156|842985|P4|COMPLETED|Period 1||5
343143|NCT02548156|842986|P3|COMPLETED|Period 1||4
343144|NCT02548156|842987|P2|COMPLETED|Period 1||5
343145|NCT02548156|842988|P1|COMPLETED|Period 1||5
343146|NCT02548156|842983|P6|STARTED|Period 1||5
343147|NCT02548156|842984|P5|STARTED|Period 1||5
343148|NCT02548156|842985|P4|STARTED|Period 1||5
343149|NCT02548156|842986|P3|STARTED|Period 1||4
343150|NCT02548156|842987|P2|STARTED|Period 1||5
343151|NCT02548156|842988|P1|STARTED|Period 1||5
343152|NCT02548078|843007|P2|NOT COMPLETED|Overall Study||6
343153|NCT02548078|843008|P1|NOT COMPLETED|Overall Study||5
343154|NCT02548078|843007|P2|COMPLETED|Overall Study||294
343155|NCT02548078|843008|P1|COMPLETED|Overall Study||295
343156|NCT02548078|843007|P2|STARTED|Overall Study||300
343157|NCT02548078|843008|P1|STARTED|Overall Study||300
343158|NCT02547714|843196|P1|NOT COMPLETED|Overall Study||0
343159|NCT02547714|843196|P1|COMPLETED|Overall Study||34
343160|NCT02547714|843196|P1|STARTED|Overall Study||34
343161|NCT02547623|843208|P2|NOT COMPLETED|Overall Study||3
343162|NCT02547623|843209|P1|NOT COMPLETED|Overall Study||4
343163|NCT02547623|843208|P2|COMPLETED|Overall Study||52
343164|NCT02547623|843209|P1|COMPLETED|Overall Study||122
343165|NCT02547623|843208|P2|STARTED|Overall Study||55
343166|NCT02547623|843209|P1|STARTED|Overall Study||126
343167|NCT02547454|843239|P1|NOT COMPLETED|Overall Study||172
343168|NCT02547454|843239|P1|COMPLETED|Overall Study||221
343169|NCT02547454|843239|P1|STARTED|Overall Study||393
343170|NCT02547064|843269|P2|NOT COMPLETED|Overall Study||2
343171|NCT02547064|843270|P1|NOT COMPLETED|Overall Study||3
343172|NCT02547064|843269|P2|COMPLETED|Overall Study||79
343173|NCT02547064|843270|P1|COMPLETED|Overall Study||78
343174|NCT02547064|843269|P2|STARTED|Overall Study||81
343175|NCT02547064|843270|P1|STARTED|Overall Study||81
343176|NCT02546986|843298|P2|NOT COMPLETED|Survival Follow-Up Phase||35
343177|NCT02546986|843299|P1|NOT COMPLETED|Survival Follow-Up Phase||36
343178|NCT02546986|843298|P2|COMPLETED|Survival Follow-Up Phase||0
343179|NCT02546986|843299|P1|COMPLETED|Survival Follow-Up Phase||0
343180|NCT02546986|843298|P2|STARTED|Survival Follow-Up Phase||35
343181|NCT02546986|843299|P1|STARTED|Survival Follow-Up Phase||36
343182|NCT02546986|843298|P2|NOT COMPLETED|Treatment Period||49
343183|NCT02546986|843299|P1|NOT COMPLETED|Treatment Period||51
343184|NCT02546986|843298|P2|COMPLETED|Treatment Period||0
343185|NCT02546986|843299|P1|COMPLETED|Treatment Period||0
343186|NCT02546986|843298|P2|STARTED|Treatment Period||49
343187|NCT02546986|843299|P1|STARTED|Treatment Period||51
343188|NCT02546609|843325|P3|NOT COMPLETED|Overall Study||7
343189|NCT02546609|843326|P2|NOT COMPLETED|Overall Study||11
343190|NCT02546609|843327|P1|NOT COMPLETED|Overall Study||2
343191|NCT02546609|843325|P3|COMPLETED|Overall Study||25
343192|NCT02546609|843326|P2|COMPLETED|Overall Study||24
343193|NCT02546609|843327|P1|COMPLETED|Overall Study||22
343194|NCT02546609|843325|P3|STARTED|Overall Study||32
343195|NCT02546609|843326|P2|STARTED|Overall Study||35
343196|NCT02546609|843327|P1|STARTED|Overall Study||24
343197|NCT02545868|843371|P3|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||34
343198|NCT02545868|843372|P2|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||35
343199|NCT02545868|843373|P1|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||33
343200|NCT02545868|843371|P3|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
343201|NCT02545868|843372|P2|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
343202|NCT02545868|843373|P1|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
343203|NCT02545868|843371|P3|STARTED|Optional Ocrelizumab Ext (OOE) Period||34
343204|NCT02545868|843372|P2|STARTED|Optional Ocrelizumab Ext (OOE) Period||35
343205|NCT02545868|843373|P1|STARTED|Optional Ocrelizumab Ext (OOE) Period||33
343206|NCT02545868|843371|P3|NOT COMPLETED|Immunization Study Period (ISP)||0
343207|NCT02545868|843372|P2|NOT COMPLETED|Immunization Study Period (ISP)||0
343208|NCT02545868|843373|P1|NOT COMPLETED|Immunization Study Period (ISP)||0
343209|NCT02545868|843371|P3|COMPLETED|Immunization Study Period (ISP)||34
343210|NCT02545868|843372|P2|COMPLETED|Immunization Study Period (ISP)||35
343211|NCT02545868|843373|P1|COMPLETED|Immunization Study Period (ISP)||33
343212|NCT02545868|843371|P3|STARTED|Immunization Study Period (ISP)||34
343213|NCT02545868|843372|P2|STARTED|Immunization Study Period (ISP)||35
343214|NCT02545868|843373|P1|STARTED|Immunization Study Period (ISP)||33
343215|NCT02545543|843446|P2|NOT COMPLETED|Overall Study||34
343216|NCT02545543|843447|P1|NOT COMPLETED|Overall Study||81
343217|NCT02545543|843446|P2|COMPLETED|Overall Study||535
343218|NCT02545543|843447|P1|COMPLETED|Overall Study||1628
343219|NCT02545543|843446|P2|STARTED|Overall Study||569
343220|NCT02545543|843447|P1|STARTED|Overall Study||1709
343221|NCT02545322|843471|P1|NOT COMPLETED|Overall Study||3
343222|NCT02545322|843471|P1|COMPLETED|Overall Study||15
343223|NCT02545322|843471|P1|STARTED|Overall Study||18
343224|NCT02545101|843476|P1|NOT COMPLETED|Overall Study||0
343225|NCT02545101|843476|P1|COMPLETED|Overall Study||100
343226|NCT02545101|843476|P1|STARTED|Overall Study||100
343227|NCT02544984|843495|P2|NOT COMPLETED|Overall Study||2
343228|NCT02544984|843496|P1|NOT COMPLETED|Overall Study||2
343229|NCT02544984|843495|P2|COMPLETED|Overall Study||28
343230|NCT02544984|843496|P1|COMPLETED|Overall Study||28
343231|NCT02544984|843495|P2|STARTED|Overall Study||30
343232|NCT02544984|843496|P1|STARTED|Overall Study||30
343233|NCT02544074|843527|P21|NOT COMPLETED|Overall Study||0
343234|NCT02544074|843528|P20|NOT COMPLETED|Overall Study||0
343235|NCT02544074|843529|P19|NOT COMPLETED|Overall Study||0
343236|NCT02544074|843530|P18|NOT COMPLETED|Overall Study||0
343237|NCT02544074|843531|P17|NOT COMPLETED|Overall Study||0
343238|NCT02544074|843532|P16|NOT COMPLETED|Overall Study||0
343239|NCT02544074|843533|P15|NOT COMPLETED|Overall Study||0
343240|NCT02544074|843534|P14|NOT COMPLETED|Overall Study||0
343241|NCT02544074|843535|P13|NOT COMPLETED|Overall Study||0
343242|NCT02544074|843536|P12|NOT COMPLETED|Overall Study||0
343243|NCT02544074|843537|P11|NOT COMPLETED|Overall Study||0
343244|NCT02544074|843538|P10|NOT COMPLETED|Overall Study||1
343245|NCT02544074|843539|P9|NOT COMPLETED|Overall Study||0
343246|NCT02544074|843540|P8|NOT COMPLETED|Overall Study||0
343247|NCT02544074|843541|P7|NOT COMPLETED|Overall Study||0
343248|NCT02544074|843542|P6|NOT COMPLETED|Overall Study||1
343249|NCT02544074|843543|P5|NOT COMPLETED|Overall Study||0
343250|NCT02544074|843544|P4|NOT COMPLETED|Overall Study||0
343251|NCT02544074|843545|P3|NOT COMPLETED|Overall Study||0
343252|NCT02544074|843546|P2|NOT COMPLETED|Overall Study||1
343253|NCT02544074|843547|P1|NOT COMPLETED|Overall Study||0
343254|NCT02544074|843527|P21|COMPLETED|Overall Study||3
343255|NCT02544074|843528|P20|COMPLETED|Overall Study||3
343256|NCT02544074|843529|P19|COMPLETED|Overall Study||4
343257|NCT02544074|843530|P18|COMPLETED|Overall Study||3
343258|NCT02544074|843531|P17|COMPLETED|Overall Study||6
343259|NCT02544074|843532|P16|COMPLETED|Overall Study||8
343260|NCT02544074|843533|P15|COMPLETED|Overall Study||5
343261|NCT02544074|843534|P14|COMPLETED|Overall Study||5
343262|NCT02544074|843535|P13|COMPLETED|Overall Study||4
343263|NCT02544074|843536|P12|COMPLETED|Overall Study||3
343264|NCT02544074|843537|P11|COMPLETED|Overall Study||2
343265|NCT02544074|843538|P10|COMPLETED|Overall Study||1
343266|NCT02544074|843539|P9|COMPLETED|Overall Study||6
343267|NCT02544074|843540|P8|COMPLETED|Overall Study||4
343268|NCT02544074|843541|P7|COMPLETED|Overall Study||2
343269|NCT02544074|843542|P6|COMPLETED|Overall Study||0
343270|NCT02544074|843543|P5|COMPLETED|Overall Study||4
343271|NCT02544074|843544|P4|COMPLETED|Overall Study||1
343272|NCT02544074|843545|P3|COMPLETED|Overall Study||1
343273|NCT02544074|843546|P2|COMPLETED|Overall Study||0
343274|NCT02544074|843547|P1|COMPLETED|Overall Study||1
343275|NCT02544074|843527|P21|STARTED|Overall Study||3
343276|NCT02544074|843528|P20|STARTED|Overall Study||3
343277|NCT02544074|843529|P19|STARTED|Overall Study||4
343278|NCT02544074|843530|P18|STARTED|Overall Study||3
343279|NCT02544074|843531|P17|STARTED|Overall Study||6
343280|NCT02544074|843532|P16|STARTED|Overall Study||8
343281|NCT02544074|843533|P15|STARTED|Overall Study||5
343282|NCT02544074|843534|P14|STARTED|Overall Study||5
343283|NCT02544074|843535|P13|STARTED|Overall Study||4
343284|NCT02544074|843536|P12|STARTED|Overall Study||3
343285|NCT02544074|843537|P11|STARTED|Overall Study||2
343286|NCT02544074|843538|P10|STARTED|Overall Study||2
343287|NCT02544074|843539|P9|STARTED|Overall Study||6
343288|NCT02544074|843540|P8|STARTED|Overall Study||4
343289|NCT02544074|843541|P7|STARTED|Overall Study||2
343290|NCT02544074|843542|P6|STARTED|Overall Study||1
343291|NCT02544074|843543|P5|STARTED|Overall Study||4
343292|NCT02544074|843544|P4|STARTED|Overall Study||1
343293|NCT02544074|843545|P3|STARTED|Overall Study||1
343294|NCT02544074|843546|P2|STARTED|Overall Study||1
343295|NCT02544074|843547|P1|STARTED|Overall Study||1
343296|NCT02543918|843583|P2|NOT COMPLETED|Overall Study||4
343297|NCT02543918|843584|P1|NOT COMPLETED|Overall Study||3
343298|NCT02543918|843583|P2|COMPLETED|Overall Study||39
343299|NCT02543918|843584|P1|COMPLETED|Overall Study||38
343300|NCT02543918|843583|P2|Received at Least 1 Dose of Study Drug|Overall Study||42
343301|NCT02543918|843584|P1|Received at Least 1 Dose of Study Drug|Overall Study||41
343302|NCT02543918|843583|P2|STARTED|Overall Study||43
343303|NCT02543918|843584|P1|STARTED|Overall Study||41
343304|NCT02543528|843590|P5|NOT COMPLETED|Extended Wear Period||0
343305|NCT02543528|843591|P4|NOT COMPLETED|Extended Wear Period||12
343306|NCT02543528|843592|P3|NOT COMPLETED|Extended Wear Period||28
343307|NCT02543528|843593|P2|NOT COMPLETED|Extended Wear Period||21
343308|NCT02543528|843594|P1|NOT COMPLETED|Extended Wear Period||23
343309|NCT02543528|843590|P5|COMPLETED|Extended Wear Period||0
343310|NCT02543528|843591|P4|COMPLETED|Extended Wear Period||23
343311|NCT02543528|843592|P3|COMPLETED|Extended Wear Period||8
343312|NCT02543528|843593|P2|COMPLETED|Extended Wear Period||14
343313|NCT02543528|843594|P1|COMPLETED|Extended Wear Period||13
343314|NCT02543528|843590|P5|STARTED|Extended Wear Period||0
343315|NCT02543528|843591|P4|STARTED|Extended Wear Period||35
343316|NCT02543528|843592|P3|STARTED|Extended Wear Period||36
343317|NCT02543528|843593|P2|STARTED|Extended Wear Period||35
343318|NCT02543528|843594|P1|STARTED|Extended Wear Period||36
343319|NCT02543528|843590|P5|NOT COMPLETED|Adaptation Period||26
343320|NCT02543528|843591|P4|NOT COMPLETED|Adaptation Period||0
343321|NCT02543528|843592|P3|NOT COMPLETED|Adaptation Period||0
343322|NCT02543528|843593|P2|NOT COMPLETED|Adaptation Period||0
343323|NCT02543528|843594|P1|NOT COMPLETED|Adaptation Period||0
343324|NCT02543528|843590|P5|COMPLETED|Adaptation Period||142
343325|NCT02543528|843591|P4|COMPLETED|Adaptation Period||0
343326|NCT02543528|843592|P3|COMPLETED|Adaptation Period||0
343327|NCT02543528|843593|P2|COMPLETED|Adaptation Period||0
343328|NCT02543528|843594|P1|COMPLETED|Adaptation Period||0
343329|NCT02543528|843590|P5|STARTED|Adaptation Period||168
343330|NCT02543528|843591|P4|STARTED|Adaptation Period||0
343331|NCT02543528|843592|P3|STARTED|Adaptation Period||0
343332|NCT02543528|843593|P2|STARTED|Adaptation Period||0
343333|NCT02543528|843594|P1|STARTED|Adaptation Period||0
343334|NCT02543437|843613|P1|NOT COMPLETED|Overall Study||0
343335|NCT02543437|843613|P1|COMPLETED|Overall Study||117
343336|NCT02543437|843613|P1|STARTED|Overall Study||117
343337|NCT02543398|843620|P2|NOT COMPLETED|Overall Study||0
343338|NCT02543398|843621|P1|NOT COMPLETED|Overall Study||0
343339|NCT02543398|843620|P2|COMPLETED|Overall Study||20
343340|NCT02543398|843621|P1|COMPLETED|Overall Study||20
343341|NCT02543398|843620|P2|STARTED|Overall Study||20
343342|NCT02543398|843621|P1|STARTED|Overall Study||20
343343|NCT02542943|843630|P3|NOT COMPLETED|Overall Study||0
343344|NCT02542943|843631|P2|NOT COMPLETED|Overall Study||1
343345|NCT02542943|843632|P1|NOT COMPLETED|Overall Study||1
343346|NCT02542943|843630|P3|COMPLETED|Overall Study||81
343347|NCT02542943|843631|P2|COMPLETED|Overall Study||79
343348|NCT02542943|843632|P1|COMPLETED|Overall Study||78
343349|NCT02542943|843630|P3|STARTED|Overall Study||81
343350|NCT02542943|843631|P2|STARTED|Overall Study||80
343351|NCT02542943|843632|P1|STARTED|Overall Study||79
343352|NCT02542761|843657|P2|NOT COMPLETED|Second Intervention||0
343353|NCT02542761|843658|P1|NOT COMPLETED|Second Intervention||0
343354|NCT02542761|843657|P2|COMPLETED|Second Intervention||5
343355|NCT02542761|843658|P1|COMPLETED|Second Intervention||5
343356|NCT02542761|843657|P2|STARTED|Second Intervention||5
343357|NCT02542761|843658|P1|STARTED|Second Intervention||5
343358|NCT02542761|843657|P2|NOT COMPLETED|Acclimation Period 2||0
343359|NCT02542761|843658|P1|NOT COMPLETED|Acclimation Period 2||0
343360|NCT02542761|843657|P2|COMPLETED|Acclimation Period 2||5
343361|NCT02542761|843658|P1|COMPLETED|Acclimation Period 2||5
343362|NCT02542761|843657|P2|STARTED|Acclimation Period 2||5
343363|NCT02542761|843658|P1|STARTED|Acclimation Period 2||5
343364|NCT02542761|843657|P2|NOT COMPLETED|First Intervention||0
343365|NCT02542761|843658|P1|NOT COMPLETED|First Intervention||0
343366|NCT02542761|843657|P2|COMPLETED|First Intervention||5
343367|NCT02542761|843658|P1|COMPLETED|First Intervention||5
343368|NCT02542761|843657|P2|STARTED|First Intervention||5
343369|NCT02542761|843658|P1|STARTED|First Intervention||5
343370|NCT02542761|843657|P2|NOT COMPLETED|Acclimation Period 1||0
343371|NCT02542761|843658|P1|NOT COMPLETED|Acclimation Period 1||0
343372|NCT02542761|843657|P2|COMPLETED|Acclimation Period 1||5
343373|NCT02542761|843658|P1|COMPLETED|Acclimation Period 1||5
343374|NCT02542761|843657|P2|STARTED|Acclimation Period 1||5
343375|NCT02542761|843658|P1|STARTED|Acclimation Period 1||5
343376|NCT02542280|843676|P2|NOT COMPLETED|Overall Study||8
343377|NCT02542280|843677|P1|NOT COMPLETED|Overall Study||12
343378|NCT02542280|843676|P2|COMPLETED|Overall Study||167
343379|NCT02542280|843677|P1|COMPLETED|Overall Study||162
343380|NCT02542280|843676|P2|STARTED|Overall Study||175
343381|NCT02542280|843677|P1|STARTED|Overall Study||174
343382|NCT02542072|843687|P2|NOT COMPLETED|Second Intervention (1 Month)||0
343383|NCT02542072|843688|P1|NOT COMPLETED|Second Intervention (1 Month)||2
343384|NCT02542072|843687|P2|COMPLETED|Second Intervention (1 Month)||43
343385|NCT02542072|843688|P1|COMPLETED|Second Intervention (1 Month)||37
343386|NCT02542072|843687|P2|STARTED|Second Intervention (1 Month)||43
343387|NCT02542072|843688|P1|STARTED|Second Intervention (1 Month)||39
343388|NCT02542072|843687|P2|NOT COMPLETED|First Intervention (1 Month)||3
343389|NCT02542072|843688|P1|NOT COMPLETED|First Intervention (1 Month)||5
343390|NCT02542072|843687|P2|COMPLETED|First Intervention (1 Month)||43
343391|NCT02542072|843688|P1|COMPLETED|First Intervention (1 Month)||39
343392|NCT02542072|843687|P2|STARTED|First Intervention (1 Month)||46
343393|NCT02542072|843688|P1|STARTED|First Intervention (1 Month)||44
343394|NCT02541864|843790|P2|NOT COMPLETED|Overall Study||0
343395|NCT02541864|843791|P1|NOT COMPLETED|Overall Study||0
343396|NCT02541864|843790|P2|COMPLETED|Overall Study||166
343397|NCT02541864|843791|P1|COMPLETED|Overall Study||164
343398|NCT02541864|843790|P2|STARTED|Overall Study||166
343399|NCT02541864|843791|P1|STARTED|Overall Study||164
343400|NCT02541422|843797|P2|NOT COMPLETED|Second Intervention||0
343401|NCT02541422|843798|P1|NOT COMPLETED|Second Intervention||0
343402|NCT02541422|843797|P2|COMPLETED|Second Intervention||26
343403|NCT02541422|843798|P1|COMPLETED|Second Intervention||23
343404|NCT02541422|843797|P2|STARTED|Second Intervention||26
343405|NCT02541422|843798|P1|STARTED|Second Intervention||23
343406|NCT02541422|843797|P2|NOT COMPLETED|First Intervention||0
343407|NCT02541422|843798|P1|NOT COMPLETED|First Intervention||0
343408|NCT02541422|843797|P2|COMPLETED|First Intervention||26
343409|NCT02541422|843798|P1|COMPLETED|First Intervention||23
343410|NCT02541422|843797|P2|STARTED|First Intervention||26
343411|NCT02541422|843798|P1|STARTED|First Intervention||23
343412|NCT02540850|843807|P3|NOT COMPLETED|Overall Study||34
343413|NCT02540850|843808|P2|NOT COMPLETED|Overall Study||66
343414|NCT02540850|843809|P1|NOT COMPLETED|Overall Study||69
343415|NCT02540850|843807|P3|COMPLETED|Overall Study||410
343416|NCT02540850|843808|P2|COMPLETED|Overall Study||330
343417|NCT02540850|843809|P1|COMPLETED|Overall Study||291
343418|NCT02540850|843807|P3|STARTED|Overall Study||444
343419|NCT02540850|843808|P2|STARTED|Overall Study||396
343420|NCT02540850|843809|P1|STARTED|Overall Study||360
343421|NCT02540772|843837|P2|NOT COMPLETED|Overall Study||0
343422|NCT02540772|843838|P1|NOT COMPLETED|Overall Study||0
343423|NCT02540772|843837|P2|COMPLETED|Overall Study||10
343424|NCT02540772|843838|P1|COMPLETED|Overall Study||10
343425|NCT02540772|843837|P2|STARTED|Overall Study||10
343426|NCT02540772|843838|P1|STARTED|Overall Study||10
343427|NCT02540447|843852|P2|NOT COMPLETED|Overall Study||0
343428|NCT02540447|843853|P1|NOT COMPLETED|Overall Study||0
343429|NCT02540447|843852|P2|COMPLETED|Overall Study||40
343430|NCT02540447|843853|P1|COMPLETED|Overall Study||40
343431|NCT02540447|843852|P2|STARTED|Overall Study||40
343432|NCT02540447|843853|P1|STARTED|Overall Study||40
343433|NCT02540434|843869|P2|NOT COMPLETED|Overall Study||0
343434|NCT02540434|843870|P1|NOT COMPLETED|Overall Study||0
343435|NCT02540434|843869|P2|COMPLETED|Overall Study||1
343436|NCT02540434|843870|P1|COMPLETED|Overall Study||0
343437|NCT02540434|843869|P2|STARTED|Overall Study||1
343438|NCT02540434|843870|P1|STARTED|Overall Study||0
343439|NCT02540356|843880|P2|NOT COMPLETED|Overall Study||0
343440|NCT02540356|843881|P1|NOT COMPLETED|Overall Study||1
343441|NCT02540356|843880|P2|COMPLETED|Overall Study||0
343442|NCT02540356|843881|P1|COMPLETED|Overall Study||0
343443|NCT02540356|843880|P2|STARTED|Overall Study||0
343444|NCT02540356|843881|P1|STARTED|Overall Study||1
343445|NCT02540265|843915|P3|NOT COMPLETED|Overall Study||1
343446|NCT02540265|843916|P2|NOT COMPLETED|Overall Study||0
343447|NCT02540265|843917|P1|NOT COMPLETED|Overall Study||0
343448|NCT02540265|843915|P3|COMPLETED|Overall Study||18
343449|NCT02540265|843916|P2|COMPLETED|Overall Study||20
343450|NCT02540265|843917|P1|COMPLETED|Overall Study||20
343451|NCT02540265|843915|P3|Treatment Completion|Overall Study||18
343452|NCT02540265|843916|P2|Treatment Completion|Overall Study||19
343453|NCT02540265|843917|P1|Treatment Completion|Overall Study||20
343454|NCT02540265|843915|P3|STARTED|Overall Study||19
343455|NCT02540265|843916|P2|STARTED|Overall Study||20
343456|NCT02540265|843917|P1|STARTED|Overall Study||20
343457|NCT02540213|843937|P1|NOT COMPLETED|Overall Study||39
343458|NCT02540213|843937|P1|COMPLETED|Overall Study||201
343459|NCT02540213|843937|P1|STARTED|Overall Study||240
343460|NCT02539992|843961|P3|NOT COMPLETED|Overall Study||4
343461|NCT02539992|843962|P2|NOT COMPLETED|Overall Study||4
343462|NCT02539992|843963|P1|NOT COMPLETED|Overall Study||0
343463|NCT02539992|843961|P3|COMPLETED|Overall Study||14
343464|NCT02539992|843962|P2|COMPLETED|Overall Study||7
343465|NCT02539992|843963|P1|COMPLETED|Overall Study||15
343466|NCT02539992|843961|P3|STARTED|Overall Study||18
343467|NCT02539992|843962|P2|STARTED|Overall Study||11
343468|NCT02539992|843963|P1|STARTED|Overall Study||15
343469|NCT02539797|843989|P3|NOT COMPLETED|Overall Study||0
343470|NCT02539797|843990|P2|NOT COMPLETED|Overall Study||1
343471|NCT02539797|843991|P1|NOT COMPLETED|Overall Study||0
343472|NCT02539797|843989|P3|COMPLETED|Overall Study||13
343473|NCT02539797|843990|P2|COMPLETED|Overall Study||12
343474|NCT02539797|843991|P1|COMPLETED|Overall Study||12
343475|NCT02539797|843989|P3|STARTED|Overall Study||13
343476|NCT02539797|843990|P2|STARTED|Overall Study||13
343477|NCT02539797|843991|P1|STARTED|Overall Study||12
343478|NCT02539134|844008|P6|NOT COMPLETED|Overall Study||0
343479|NCT02539134|844009|P5|NOT COMPLETED|Overall Study||0
343480|NCT02539134|844010|P4|NOT COMPLETED|Overall Study||0
343481|NCT02539134|844011|P3|NOT COMPLETED|Overall Study||0
343482|NCT02539134|844012|P2|NOT COMPLETED|Overall Study||0
343483|NCT02539134|844013|P1|NOT COMPLETED|Overall Study||1
343484|NCT02539134|844008|P6|COMPLETED|Overall Study||6
343485|NCT02539134|844009|P5|COMPLETED|Overall Study||6
343486|NCT02539134|844010|P4|COMPLETED|Overall Study||6
343487|NCT02539134|844011|P3|COMPLETED|Overall Study||6
343488|NCT02539134|844012|P2|COMPLETED|Overall Study||6
343489|NCT02539134|844013|P1|COMPLETED|Overall Study||9
343490|NCT02539134|844008|P6|STARTED|Overall Study||6
343491|NCT02539134|844009|P5|STARTED|Overall Study||6
343492|NCT02539134|844010|P4|STARTED|Overall Study||6
343493|NCT02539134|844011|P3|STARTED|Overall Study||6
343494|NCT02539134|844012|P2|STARTED|Overall Study||6
343495|NCT02539134|844013|P1|STARTED|Overall Study||10
343496|NCT02539108|844067|P2|NOT COMPLETED|Overall Study||0
343497|NCT02539108|844068|P1|NOT COMPLETED|Overall Study||0
343498|NCT02539108|844067|P2|COMPLETED|Overall Study||30
343499|NCT02539108|844068|P1|COMPLETED|Overall Study||30
343500|NCT02539108|844067|P2|STARTED|Overall Study||30
343501|NCT02539108|844068|P1|STARTED|Overall Study||30
343502|NCT02538679|844085|P3|NOT COMPLETED|Overall Study||8
343503|NCT02538679|844086|P2|NOT COMPLETED|Overall Study||9
343504|NCT02538679|844087|P1|NOT COMPLETED|Overall Study||3
343505|NCT02538679|844085|P3|COMPLETED|Overall Study||41
343506|NCT02538679|844086|P2|COMPLETED|Overall Study||45
343507|NCT02538679|844087|P1|COMPLETED|Overall Study||21
343508|NCT02538679|844085|P3|STARTED|Overall Study||49
343509|NCT02538679|844086|P2|STARTED|Overall Study||54
343510|NCT02538679|844087|P1|STARTED|Overall Study||24
343511|NCT02538107|844095|P1|NOT COMPLETED|Overall Study||110
343512|NCT02538107|844095|P1|COMPLETED|Overall Study||180
343513|NCT02538107|844095|P1|STARTED|Overall Study||290
343514|NCT02537730|844115|P2|NOT COMPLETED|Second Intervention (7 Days)||0
343515|NCT02537730|844116|P1|NOT COMPLETED|Second Intervention (7 Days)||0
343516|NCT02537730|844115|P2|COMPLETED|Second Intervention (7 Days)||16
343517|NCT02537730|844116|P1|COMPLETED|Second Intervention (7 Days)||17
343518|NCT02537730|844115|P2|STARTED|Second Intervention (7 Days)||16
343519|NCT02537730|844116|P1|STARTED|Second Intervention (7 Days)||17
343520|NCT02537730|844115|P2|NOT COMPLETED|First Intervention (7 Days)||0
343521|NCT02537730|844116|P1|NOT COMPLETED|First Intervention (7 Days)||0
343522|NCT02537730|844115|P2|COMPLETED|First Intervention (7 Days)||16
343523|NCT02537730|844116|P1|COMPLETED|First Intervention (7 Days)||17
343524|NCT02537730|844115|P2|STARTED|First Intervention (7 Days)||16
343525|NCT02537730|844116|P1|STARTED|First Intervention (7 Days)||17
343526|NCT02537522|844128|P4|NOT COMPLETED|Phase II - Period 2 Bilateral||0
343527|NCT02537522|844129|P3|NOT COMPLETED|Phase II - Period 2 Bilateral||0
343528|NCT02537522|844130|P2|NOT COMPLETED|Phase II - Period 2 Bilateral||0
343529|NCT02537522|844131|P1|NOT COMPLETED|Phase II - Period 2 Bilateral||0
343530|NCT02537522|844128|P4|COMPLETED|Phase II - Period 2 Bilateral||22
343531|NCT02537522|844129|P3|COMPLETED|Phase II - Period 2 Bilateral||23
343532|NCT02537522|844130|P2|COMPLETED|Phase II - Period 2 Bilateral||0
343533|NCT02537522|844131|P1|COMPLETED|Phase II - Period 2 Bilateral||0
343534|NCT02537522|844128|P4|STARTED|Phase II - Period 2 Bilateral||22
343535|NCT02537522|844129|P3|STARTED|Phase II - Period 2 Bilateral||23
343536|NCT02537522|844130|P2|STARTED|Phase II - Period 2 Bilateral||0
343537|NCT02537522|844131|P1|STARTED|Phase II - Period 2 Bilateral||0
343538|NCT02537522|844128|P4|NOT COMPLETED|Phase II - Period 1 Bilateral||1
343539|NCT02537522|844129|P3|NOT COMPLETED|Phase II - Period 1 Bilateral||0
343540|NCT02537522|844130|P2|NOT COMPLETED|Phase II - Period 1 Bilateral||0
343541|NCT02537522|844131|P1|NOT COMPLETED|Phase II - Period 1 Bilateral||0
343542|NCT02537522|844128|P4|COMPLETED|Phase II - Period 1 Bilateral||22
343543|NCT02537522|844129|P3|COMPLETED|Phase II - Period 1 Bilateral||23
343544|NCT02537522|844130|P2|COMPLETED|Phase II - Period 1 Bilateral||0
343545|NCT02537522|844131|P1|COMPLETED|Phase II - Period 1 Bilateral||0
343546|NCT02537522|844128|P4|STARTED|Phase II - Period 1 Bilateral||23
343547|NCT02537522|844129|P3|STARTED|Phase II - Period 1 Bilateral||23
343548|NCT02537522|844130|P2|STARTED|Phase II - Period 1 Bilateral||0
343549|NCT02537522|844131|P1|STARTED|Phase II - Period 1 Bilateral||0
343550|NCT02537522|844128|P4|NOT COMPLETED|Phase I - Contralateral||0
343551|NCT02537522|844129|P3|NOT COMPLETED|Phase I - Contralateral||0
343552|NCT02537522|844130|P2|NOT COMPLETED|Phase I - Contralateral||10
343553|NCT02537522|844131|P1|NOT COMPLETED|Phase I - Contralateral||15
343554|NCT02537522|844128|P4|COMPLETED|Phase I - Contralateral||0
343555|NCT02537522|844129|P3|COMPLETED|Phase I - Contralateral||0
343556|NCT02537522|844130|P2|COMPLETED|Phase I - Contralateral||27
343557|NCT02537522|844131|P1|COMPLETED|Phase I - Contralateral||19
343558|NCT02537522|844128|P4|STARTED|Phase I - Contralateral||0
343559|NCT02537522|844129|P3|STARTED|Phase I - Contralateral||0
343560|NCT02537522|844130|P2|STARTED|Phase I - Contralateral||37
343561|NCT02537522|844131|P1|STARTED|Phase I - Contralateral||34
343562|NCT02536781|844141|P2|NOT COMPLETED|Overall Study||0
343563|NCT02536781|844142|P1|NOT COMPLETED|Overall Study||2
343564|NCT02536781|844141|P2|COMPLETED|Overall Study||34
343565|NCT02536781|844142|P1|COMPLETED|Overall Study||34
343566|NCT02536781|844141|P2|STARTED|Overall Study||34
343567|NCT02536781|844142|P1|STARTED|Overall Study||36
343568|NCT02536664|844152|P2|NOT COMPLETED|Overall Study||80
343569|NCT02536664|844153|P1|NOT COMPLETED|Overall Study||107
343570|NCT02536664|844152|P2|COMPLETED|Overall Study||97
343571|NCT02536664|844153|P1|COMPLETED|Overall Study||205
343572|NCT02536664|844152|P2|STARTED|Overall Study||177
343573|NCT02536664|844153|P1|STARTED|Overall Study||312
343574|NCT02536313|844173|P2|NOT COMPLETED|Overall Study||1
343575|NCT02536313|844174|P1|NOT COMPLETED|Overall Study||0
343576|NCT02536313|844173|P2|COMPLETED|Overall Study||24
343577|NCT02536313|844174|P1|COMPLETED|Overall Study||24
343578|NCT02536313|844173|P2|STARTED|Overall Study||25
343579|NCT02536313|844174|P1|STARTED|Overall Study||24
343580|NCT02535741|844190|P1|NOT COMPLETED|Overall Study||32
343581|NCT02535741|844190|P1|COMPLETED|Overall Study|Completed cases at 2 years follow-up|136
343582|NCT02535741|844190|P1|STARTED|Overall Study||168
343583|NCT02535416|844207|P9|NOT COMPLETED|Overall Study||0
343584|NCT02535416|844208|P8|NOT COMPLETED|Overall Study||0
343585|NCT02535416|844209|P7|NOT COMPLETED|Overall Study||0
343586|NCT02535416|844210|P6|NOT COMPLETED|Overall Study||0
343587|NCT02535416|844211|P5|NOT COMPLETED|Overall Study||0
343588|NCT02535416|844212|P4|NOT COMPLETED|Overall Study||0
343589|NCT02535416|844213|P3|NOT COMPLETED|Overall Study||0
343590|NCT02535416|844214|P2|NOT COMPLETED|Overall Study||0
343591|NCT02535416|844215|P1|NOT COMPLETED|Overall Study||1
343592|NCT02535416|844207|P9|COMPLETED|Overall Study||6
343593|NCT02535416|844208|P8|COMPLETED|Overall Study||6
343594|NCT02535416|844209|P7|COMPLETED|Overall Study||6
343595|NCT02535416|844210|P6|COMPLETED|Overall Study||4
343596|NCT02535416|844211|P5|COMPLETED|Overall Study||4
343597|NCT02535416|844212|P4|COMPLETED|Overall Study||4
343598|NCT02535416|844213|P3|COMPLETED|Overall Study||4
343599|NCT02535416|844214|P2|COMPLETED|Overall Study||2
343600|NCT02535416|844215|P1|COMPLETED|Overall Study||3
343601|NCT02535416|844207|P9|STARTED|Overall Study||6
343602|NCT02535416|844208|P8|STARTED|Overall Study||6
343603|NCT02535416|844209|P7|STARTED|Overall Study||6
343604|NCT02535416|844210|P6|STARTED|Overall Study||4
343605|NCT02535416|844211|P5|STARTED|Overall Study||4
343606|NCT02535416|844212|P4|STARTED|Overall Study||4
343607|NCT02535416|844213|P3|STARTED|Overall Study||4
343608|NCT02535416|844214|P2|STARTED|Overall Study||2
343609|NCT02535416|844215|P1|STARTED|Overall Study||4
343610|NCT02535065|844267|P1|NOT COMPLETED|Overall Study||62
343611|NCT02535065|844267|P1|COMPLETED|Overall Study||0
343612|NCT02535065|844267|P1|12-Month Follow-up|Overall Study||61
343613|NCT02535065|844267|P1|1-Month Follow-up|Overall Study||62
343614|NCT02535065|844267|P1|STARTED|Overall Study||62
343615|NCT02535026|844272|P1|NOT COMPLETED|Overall Study||0
343616|NCT02535026|844272|P1|COMPLETED|Overall Study||580
343617|NCT02535026|844272|P1|STARTED|Overall Study||580
343618|NCT02534935|844327|P3|NOT COMPLETED|Overall Study||5
343619|NCT02534935|844328|P2|NOT COMPLETED|Overall Study||10
343620|NCT02534935|844329|P1|NOT COMPLETED|Overall Study||0
343621|NCT02534935|844327|P3|COMPLETED|Overall Study||127
343622|NCT02534935|844328|P2|COMPLETED|Overall Study||210
343623|NCT02534935|844329|P1|COMPLETED|Overall Study||44
343624|NCT02534935|844327|P3|STARTED|Overall Study||132
343625|NCT02534935|844328|P2|STARTED|Overall Study||220
343626|NCT02534935|844329|P1|STARTED|Overall Study||44
343627|NCT02534493|844487|P1|NOT COMPLETED|Overall Study||2
343628|NCT02534493|844487|P1|COMPLETED|Overall Study||11
343629|NCT02534493|844487|P1|STARTED|Overall Study||13
343630|NCT02534324|844498|P2|NOT COMPLETED|Overall Study||8
343631|NCT02534324|844499|P1|NOT COMPLETED|Overall Study||25
343632|NCT02534324|844498|P2|COMPLETED|Overall Study||40
343633|NCT02534324|844499|P1|COMPLETED|Overall Study||73
343634|NCT02534324|844498|P2|STARTED|Overall Study||48
343635|NCT02534324|844499|P1|STARTED|Overall Study||98
343636|NCT02534129|844509|P2|NOT COMPLETED|Overall Study||0
343637|NCT02534129|844510|P1|NOT COMPLETED|Overall Study||0
343638|NCT02534129|844509|P2|COMPLETED|Overall Study||13
343639|NCT02534129|844510|P1|COMPLETED|Overall Study||13
343640|NCT02534129|844509|P2|STARTED|Overall Study||13
343641|NCT02534129|844510|P1|STARTED|Overall Study||13
343642|NCT02533999|844518|P2|NOT COMPLETED|Overall Study||7
343643|NCT02533999|844519|P1|NOT COMPLETED|Overall Study||6
343644|NCT02533999|844518|P2|COMPLETED|Overall Study||30
343645|NCT02533999|844519|P1|COMPLETED|Overall Study||32
343646|NCT02533999|844518|P2|STARTED|Overall Study||37
343647|NCT02533999|844519|P1|STARTED|Overall Study||38
343648|NCT02533726|844539|P2|NOT COMPLETED|Treatment||0
343649|NCT02533726|844540|P1|NOT COMPLETED|Treatment||0
343650|NCT02533726|844539|P2|COMPLETED|Treatment||603
343651|NCT02533726|844540|P1|COMPLETED|Treatment||709
343652|NCT02533726|844539|P2|Per Protocol Population|Treatment||555
343653|NCT02533726|844540|P1|Per Protocol Population|Treatment||671
343654|NCT02533726|844539|P2|STARTED|Treatment|4 participants allocated to Optimal Turning actually received Standard Care|603
343655|NCT02533726|844540|P1|STARTED|Treatment|54 participants allocated to Standard Care actually received Optimal Turning|709
343656|NCT02533726|844539|P2|NOT COMPLETED|Initial Allocation||0
343657|NCT02533726|844540|P1|NOT COMPLETED|Initial Allocation||0
343658|NCT02533726|844539|P2|COMPLETED|Initial Allocation||653
343659|NCT02533726|844540|P1|COMPLETED|Initial Allocation||659
343660|NCT02533726|844539|P2|STARTED|Initial Allocation||653
343661|NCT02533726|844540|P1|STARTED|Initial Allocation||659
343662|NCT02533570|844551|P3|NOT COMPLETED|Overall Study||1
343663|NCT02533570|844552|P2|NOT COMPLETED|Overall Study||1
343664|NCT02533570|844553|P1|NOT COMPLETED|Overall Study||0
343665|NCT02533570|844551|P3|COMPLETED|Overall Study||7
343666|NCT02533570|844552|P2|COMPLETED|Overall Study||7
343667|NCT02533570|844553|P1|COMPLETED|Overall Study||4
343668|NCT02533570|844551|P3|STARTED|Overall Study||8
343669|NCT02533570|844552|P2|STARTED|Overall Study||8
343670|NCT02533570|844553|P1|STARTED|Overall Study||4
343671|NCT02533531|844564|P1|NOT COMPLETED|Overall Study||1
343672|NCT02533531|844564|P1|COMPLETED|Overall Study||0
343673|NCT02533531|844564|P1|STARTED|Overall Study||1
343674|NCT02533466|844571|P2|NOT COMPLETED|Overall Study||0
343675|NCT02533466|844572|P1|NOT COMPLETED|Overall Study||0
343676|NCT02533466|844571|P2|COMPLETED|Overall Study||14
343677|NCT02533466|844572|P1|COMPLETED|Overall Study||16
343678|NCT02533466|844571|P2|STARTED|Overall Study||14
343679|NCT02533466|844572|P1|STARTED|Overall Study||16
343680|NCT02533401|844596|P1|NOT COMPLETED|Overall Study||11
343681|NCT02533401|844596|P1|COMPLETED|Overall Study||23
343682|NCT02533401|844596|P1|STARTED|Overall Study||34
343683|NCT02533258|844604|P1|NOT COMPLETED|Overall Study||8
343684|NCT02533258|844604|P1|COMPLETED|Overall Study||5
343685|NCT02533258|844604|P1|STARTED|Overall Study||13
343686|NCT02532998|844616|P1|NOT COMPLETED|Overall Study||0
343687|NCT02532998|844616|P1|COMPLETED|Overall Study||23
343688|NCT02532998|844616|P1|STARTED|Overall Study||23
343689|NCT02532374|844698|P1|NOT COMPLETED|Overall Study||2
343690|NCT02532374|844698|P1|COMPLETED|Overall Study||14
343691|NCT02532374|844698|P1|P3L150 μg/Puff (Visit 6)|Overall Study||14
343692|NCT02532374|844698|P1|P3L 80 μg/Puff (Visit 5)|Overall Study||14
343693|NCT02532374|844698|P1|P3L 50 μg/Puff (Visit 4)|Overall Study||15
343694|NCT02532374|844698|P1|Nicorette Inhalator (Visit 3)|Overall Study||15
343695|NCT02532374|844698|P1|STARTED|Overall Study||16
343696|NCT02532179|844722|P1|NOT COMPLETED|Overall Study||3
343697|NCT02532179|844722|P1|COMPLETED|Overall Study||9
343698|NCT02532179|844722|P1|STARTED|Overall Study||12
343699|NCT02532010|844733|P2|NOT COMPLETED|Overall Study||4
343700|NCT02532010|844734|P1|NOT COMPLETED|Overall Study||9
343701|NCT02532010|844733|P2|COMPLETED|Overall Study||0
343702|NCT02532010|844734|P1|COMPLETED|Overall Study||0
343703|NCT02532010|844733|P2|STARTED|Overall Study||4
343704|NCT02532010|844734|P1|STARTED|Overall Study||9
343705|NCT02531867|844752|P1|NOT COMPLETED|Overall Study||0
343706|NCT02531867|844752|P1|COMPLETED|Overall Study||13
343707|NCT02531867|844752|P1|STARTED|Overall Study||13
343708|NCT02531698|844758|P2|NOT COMPLETED|Overall Study||2
343709|NCT02531698|844759|P1|NOT COMPLETED|Overall Study||11
343710|NCT02531698|844758|P2|COMPLETED|Overall Study||104
343711|NCT02531698|844759|P1|COMPLETED|Overall Study||283
343712|NCT02531698|844758|P2|STARTED|Overall Study||106
343713|NCT02531698|844759|P1|STARTED|Overall Study||294
343714|NCT02531646|845006|P3|NOT COMPLETED|Overall Study||0
343715|NCT02531646|845007|P2|NOT COMPLETED|Overall Study||1
343716|NCT02531646|845008|P1|NOT COMPLETED|Overall Study||5
343717|NCT02531646|845006|P3|COMPLETED|Overall Study||11
343718|NCT02531646|845007|P2|COMPLETED|Overall Study||17
343719|NCT02531646|845008|P1|COMPLETED|Overall Study||32
343720|NCT02531646|845006|P3|STARTED|Overall Study||11
343721|NCT02531646|845007|P2|STARTED|Overall Study||18
343722|NCT02531646|845008|P1|STARTED|Overall Study||37
343723|NCT02531373|845031|P9|NOT COMPLETED|Overall Study||9
343724|NCT02531373|845032|P8|NOT COMPLETED|Overall Study||9
343725|NCT02531373|845033|P7|NOT COMPLETED|Overall Study||11
343726|NCT02531373|845034|P6|NOT COMPLETED|Overall Study||9
343727|NCT02531373|845035|P5|NOT COMPLETED|Overall Study||8
343728|NCT02531373|845036|P4|NOT COMPLETED|Overall Study||0
343729|NCT02531373|845037|P3|NOT COMPLETED|Overall Study||0
343730|NCT02531373|845038|P2|NOT COMPLETED|Overall Study||0
343731|NCT02531373|845039|P1|NOT COMPLETED|Overall Study||0
343732|NCT02531373|845031|P9|COMPLETED|Overall Study||43
343733|NCT02531373|845032|P8|COMPLETED|Overall Study||43
343734|NCT02531373|845033|P7|COMPLETED|Overall Study||41
343735|NCT02531373|845034|P6|COMPLETED|Overall Study||42
343736|NCT02531373|845035|P5|COMPLETED|Overall Study||43
343737|NCT02531373|845036|P4|COMPLETED|Overall Study||20
343738|NCT02531373|845037|P3|COMPLETED|Overall Study||20
343739|NCT02531373|845038|P2|COMPLETED|Overall Study||20
343740|NCT02531373|845039|P1|COMPLETED|Overall Study||20
343741|NCT02531373|845031|P9|Vaccination 4|Overall Study||43
343742|NCT02531373|845032|P8|Vaccination 4|Overall Study||43
343743|NCT02531373|845033|P7|Vaccination 4|Overall Study||43
343744|NCT02531373|845034|P6|Vaccination 4|Overall Study||43
343745|NCT02531373|845035|P5|Vaccination 4|Overall Study||44
343746|NCT02531373|845036|P4|Vaccination 4|Overall Study||0
343747|NCT02531373|845037|P3|Vaccination 4|Overall Study||0
343748|NCT02531373|845038|P2|Vaccination 4|Overall Study||0
343749|NCT02531373|845039|P1|Vaccination 4|Overall Study||0
343750|NCT02531373|845031|P9|Vaccination 3|Overall Study||49
343751|NCT02531373|845032|P8|Vaccination 3|Overall Study||51
343752|NCT02531373|845033|P7|Vaccination 3|Overall Study||49
343753|NCT02531373|845034|P6|Vaccination 3|Overall Study||47
343754|NCT02531373|845035|P5|Vaccination 3|Overall Study||48
343755|NCT02531373|845036|P4|Vaccination 3|Overall Study||0
343756|NCT02531373|845037|P3|Vaccination 3|Overall Study||0
343757|NCT02531373|845038|P2|Vaccination 3|Overall Study||0
343758|NCT02531373|845039|P1|Vaccination 3|Overall Study||0
343759|NCT02531373|845031|P9|Vaccination 2|Overall Study||51
343760|NCT02531373|845032|P8|Vaccination 2|Overall Study||51
343761|NCT02531373|845033|P7|Vaccination 2|Overall Study||50
343762|NCT02531373|845034|P6|Vaccination 2|Overall Study||48
343763|NCT02531373|845035|P5|Vaccination 2|Overall Study||49
343764|NCT02531373|845036|P4|Vaccination 2|Overall Study||0
343765|NCT02531373|845037|P3|Vaccination 2|Overall Study||0
343766|NCT02531373|845038|P2|Vaccination 2|Overall Study||0
343767|NCT02531373|845039|P1|Vaccination 2|Overall Study||0
343768|NCT02531373|845031|P9|Vaccination 1|Overall Study||52
343769|NCT02531373|845032|P8|Vaccination 1|Overall Study||52
343770|NCT02531373|845033|P7|Vaccination 1|Overall Study||52
343771|NCT02531373|845034|P6|Vaccination 1|Overall Study||50
343772|NCT02531373|845035|P5|Vaccination 1|Overall Study||50
343773|NCT02531373|845036|P4|Vaccination 1|Overall Study||20
343774|NCT02531373|845037|P3|Vaccination 1|Overall Study||20
343775|NCT02531373|845038|P2|Vaccination 1|Overall Study||20
343776|NCT02531373|845039|P1|Vaccination 1|Overall Study||20
343777|NCT02531373|845031|P9|STARTED|Overall Study||52
343778|NCT02531373|845032|P8|STARTED|Overall Study||52
343779|NCT02531373|845033|P7|STARTED|Overall Study||52
343780|NCT02531373|845034|P6|STARTED|Overall Study||51
343781|NCT02531373|845035|P5|STARTED|Overall Study||51
343782|NCT02531373|845036|P4|STARTED|Overall Study||20
343783|NCT02531373|845037|P3|STARTED|Overall Study||20
343784|NCT02531373|845038|P2|STARTED|Overall Study||20
343785|NCT02531373|845039|P1|STARTED|Overall Study||20
343786|NCT02531308|845096|P1|NOT COMPLETED|Overall Study||3
343787|NCT02531308|845096|P1|COMPLETED|Overall Study||2
343788|NCT02531308|845096|P1|STARTED|Overall Study||5
343789|NCT02530671|845102|P2|NOT COMPLETED|Overall Study||0
343790|NCT02530671|845103|P1|NOT COMPLETED|Overall Study||3
343791|NCT02530671|845102|P2|COMPLETED|Overall Study||55
343792|NCT02530671|845103|P1|COMPLETED|Overall Study||52
343793|NCT02530671|845102|P2|STARTED|Overall Study||55
343794|NCT02530671|845103|P1|STARTED|Overall Study||55
343795|NCT02530450|845121|P2|NOT COMPLETED|Overall Study||5
343796|NCT02530450|845122|P1|NOT COMPLETED|Overall Study||6
343797|NCT02530450|845121|P2|COMPLETED|Overall Study||9
343798|NCT02530450|845122|P1|COMPLETED|Overall Study||10
343799|NCT02530450|845121|P2|STARTED|Overall Study||14
343800|NCT02530450|845122|P1|STARTED|Overall Study||16
343801|NCT02530125|845128|P1|NOT COMPLETED|Followed for Survival for 2 Years||3
343802|NCT02530125|845128|P1|COMPLETED|Followed for Survival for 2 Years||0
343803|NCT02530125|845128|P1|STARTED|Followed for Survival for 2 Years||3
343804|NCT02530125|845128|P1|NOT COMPLETED|Completed Treatment||1
343805|NCT02530125|845128|P1|COMPLETED|Completed Treatment||3
343806|NCT02530125|845128|P1|STARTED|Completed Treatment||4
343807|NCT02529995|845142|P2|NOT COMPLETED|Part B||12
343808|NCT02529995|845143|P1|NOT COMPLETED|Part B||6
343809|NCT02529995|845142|P2|COMPLETED|Part B||4
343810|NCT02529995|845143|P1|COMPLETED|Part B||9
343811|NCT02529995|845142|P2|STARTED|Part B||16
343812|NCT02529995|845143|P1|STARTED|Part B||15
343813|NCT02529995|845142|P2|NOT COMPLETED|Part A||16
343814|NCT02529995|845143|P1|NOT COMPLETED|Part A||15
343815|NCT02529995|845142|P2|COMPLETED|Part A|'Completed' means 'Completed the Study', i.e. zero patient completed the study in part A.|0
343816|NCT02529995|845143|P1|COMPLETED|Part A|'Completed' means 'Completed the Study', i.e. zero patient completed the study in part A.|0
343817|NCT02529995|845142|P2|STARTED|Part A||16
343818|NCT02529995|845143|P1|STARTED|Part A||15
343819|NCT02529488|845177|P1|NOT COMPLETED|Overall Study||4
343820|NCT02529488|845177|P1|COMPLETED|Overall Study||145
343821|NCT02529488|845177|P1|STARTED|Overall Study||149
343822|NCT02528786|845185|P1|NOT COMPLETED|Overall Study||0
343823|NCT02528786|845185|P1|COMPLETED|Overall Study||8
343824|NCT02528786|845185|P1|STARTED|Overall Study||8
343825|NCT02528721|845191|P2|NOT COMPLETED|Overall Study||3
343826|NCT02528721|845192|P1|NOT COMPLETED|Overall Study||7
343827|NCT02528721|845191|P2|COMPLETED|Overall Study||76
343828|NCT02528721|845192|P1|COMPLETED|Overall Study||196
343829|NCT02528721|845191|P2|STARTED|Overall Study||79
343830|NCT02528721|845192|P1|STARTED|Overall Study||203
343831|NCT02528331|845202|P1|NOT COMPLETED|Overall Study||2
343832|NCT02528331|845202|P1|COMPLETED|Overall Study||0
343833|NCT02528331|845202|P1|STARTED|Overall Study||2
343834|NCT02528305|845209|P1|NOT COMPLETED|Overall Study||3
343835|NCT02528305|845209|P1|COMPLETED|Overall Study||9
343836|NCT02528305|845209|P1|End of Intervention Period Assessment|Overall Study||9
343837|NCT02528305|845209|P1|End of Control Period Assessment|Overall Study||11
343838|NCT02528305|845209|P1|STARTED|Overall Study||12
343839|NCT02528097|845253|P2|NOT COMPLETED|Overall Study||0
343840|NCT02528097|845254|P1|NOT COMPLETED|Overall Study||0
343841|NCT02528097|845253|P2|COMPLETED|Overall Study||1
343842|NCT02528097|845254|P1|COMPLETED|Overall Study||1
343843|NCT02528097|845253|P2|STARTED|Overall Study||1
343844|NCT02528097|845254|P1|STARTED|Overall Study||1
343845|NCT02527161|845262|P1|NOT COMPLETED|Overall Study||62
343846|NCT02527161|845262|P1|COMPLETED|Overall Study|Completed/Not completed counts are for knees at the 6 mo primary outcome interval.|96
343847|NCT02527161|845262|P1|STARTED|Overall Study|All results are reported by knee throughout record. Participant=knee.|158
343848|NCT02527148|845281|P2|NOT COMPLETED|Overall Study||0
343849|NCT02527148|845282|P1|NOT COMPLETED|Overall Study||1
343850|NCT02527148|845281|P2|COMPLETED|Overall Study||50
343851|NCT02527148|845282|P1|COMPLETED|Overall Study||49
343852|NCT02527148|845281|P2|STARTED|Overall Study||50
343853|NCT02527148|845282|P1|STARTED|Overall Study||50
343854|NCT02526550|845300|P1|NOT COMPLETED|Overall Study||1
343855|NCT02526550|845300|P1|COMPLETED|Overall Study||49
343856|NCT02526550|845300|P1|STARTED|Overall Study||50
343857|NCT02526524|845312|P6|NOT COMPLETED|Overall Study||21
343858|NCT02526524|845313|P5|NOT COMPLETED|Overall Study||24
343859|NCT02526524|845314|P4|NOT COMPLETED|Overall Study||7
343860|NCT02526524|845315|P3|NOT COMPLETED|Overall Study||26
343861|NCT02526524|845316|P2|NOT COMPLETED|Overall Study||9
343862|NCT02526524|845317|P1|NOT COMPLETED|Overall Study||12
343863|NCT02526524|845312|P6|COMPLETED|Overall Study||73
343864|NCT02526524|845313|P5|COMPLETED|Overall Study||72
343865|NCT02526524|845314|P4|COMPLETED|Overall Study||89
343866|NCT02526524|845315|P3|COMPLETED|Overall Study||70
343867|NCT02526524|845316|P2|COMPLETED|Overall Study||86
343868|NCT02526524|845317|P1|COMPLETED|Overall Study||82
343869|NCT02526524|845312|P6|STARTED|Overall Study||94
343870|NCT02526524|845313|P5|STARTED|Overall Study||96
343871|NCT02526524|845314|P4|STARTED|Overall Study||96
343872|NCT02526524|845315|P3|STARTED|Overall Study||96
343873|NCT02526524|845316|P2|STARTED|Overall Study||95
343874|NCT02526524|845317|P1|STARTED|Overall Study||94
343875|NCT02526290|845331|P1|NOT COMPLETED|Overall Study||8
343876|NCT02526290|845331|P1|COMPLETED|Overall Study||89
343877|NCT02526290|845331|P1|STARTED|Overall Study||97
343878|NCT02525536|845341|P3|NOT COMPLETED|Overall Study||0
343879|NCT02525536|845342|P2|NOT COMPLETED|Overall Study||0
343880|NCT02525536|845343|P1|NOT COMPLETED|Overall Study||0
343881|NCT02525536|845341|P3|COMPLETED|Overall Study||6
343882|NCT02525536|845342|P2|COMPLETED|Overall Study||6
343883|NCT02525536|845343|P1|COMPLETED|Overall Study||6
343884|NCT02525536|845341|P3|STARTED|Overall Study||6
343885|NCT02525536|845342|P2|STARTED|Overall Study||6
343886|NCT02525536|845343|P1|STARTED|Overall Study||6
343887|NCT02525094|845416|P2|NOT COMPLETED|Overall Study||8
343888|NCT02525094|845417|P1|NOT COMPLETED|Overall Study||8
343889|NCT02525094|845416|P2|COMPLETED|Overall Study||48
343890|NCT02525094|845417|P1|COMPLETED|Overall Study||49
343891|NCT02525094|845416|P2|Treated|Overall Study||55
343892|NCT02525094|845417|P1|Treated|Overall Study||56
343893|NCT02525094|845416|P2|STARTED|Overall Study||56
343894|NCT02525094|845417|P1|STARTED|Overall Study||57
343895|NCT02524665|845444|P1|NOT COMPLETED|Overall Study||1
343896|NCT02524665|845444|P1|COMPLETED|Overall Study||19
343897|NCT02524665|845444|P1|STARTED|Overall Study||20
343898|NCT02524561|845462|P3|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
343899|NCT02524561|845463|P2|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
343900|NCT02524561|845464|P1|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
343901|NCT02524561|845462|P3|COMPLETED|Final: Year 3 or 4 Post-randomization||187
343902|NCT02524561|845463|P2|COMPLETED|Final: Year 3 or 4 Post-randomization||162
343903|NCT02524561|845464|P1|COMPLETED|Final: Year 3 or 4 Post-randomization||168
343904|NCT02524561|845462|P3|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||151
343905|NCT02524561|845463|P2|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||139
343906|NCT02524561|845464|P1|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||143
343907|NCT02524561|845462|P3|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|187
343908|NCT02524561|845463|P2|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|162
343909|NCT02524561|845464|P1|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|168
343910|NCT02524561|845462|P3|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
343911|NCT02524561|845463|P2|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
343912|NCT02524561|845464|P1|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
343913|NCT02524561|845462|P3|COMPLETED|Year 1: Post Randomization Mammograms||187
343914|NCT02524561|845463|P2|COMPLETED|Year 1: Post Randomization Mammograms||162
343915|NCT02524561|845464|P1|COMPLETED|Year 1: Post Randomization Mammograms||168
343916|NCT02524561|845462|P3|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post randomization mammogram|148
343917|NCT02524561|845463|P2|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post randomization mammogram|123
343918|NCT02524561|845464|P1|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post-randomization mammogram|136
343919|NCT02524561|845462|P3|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|187
343920|NCT02524561|845463|P2|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|162
343921|NCT02524561|845464|P1|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|168
343922|NCT02524561|845462|P3|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
343923|NCT02524561|845463|P2|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
343924|NCT02524561|845464|P1|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
343925|NCT02524561|845462|P3|COMPLETED|Baseline: Pre-randomization Mammogram||187
343926|NCT02524561|845463|P2|COMPLETED|Baseline: Pre-randomization Mammogram||162
343927|NCT02524561|845464|P1|COMPLETED|Baseline: Pre-randomization Mammogram||168
343928|NCT02524561|845462|P3|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||151
343929|NCT02524561|845463|P2|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||133
343930|NCT02524561|845464|P1|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||137
343931|NCT02524561|845462|P3|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS.|187
343932|NCT02524561|845463|P2|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS|162
343933|NCT02524561|845464|P1|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS|168
343934|NCT02524418|845481|P1|NOT COMPLETED|Overall Study||13
343935|NCT02524418|845481|P1|COMPLETED|Overall Study||75
343936|NCT02524418|845481|P1|STARTED|Overall Study||88
343937|NCT02524288|845495|P1|NOT COMPLETED|Overall Study||1941
343938|NCT02524288|845495|P1|COMPLETED|Overall Study||0
343939|NCT02524288|845495|P1|Treated|Overall Study||1936
343940|NCT02524288|845495|P1|STARTED|Overall Study||1941
343941|NCT02524158|845505|P2|NOT COMPLETED|6-month Assessment||21
343942|NCT02524158|845506|P1|NOT COMPLETED|6-month Assessment||22
343943|NCT02524158|845505|P2|COMPLETED|6-month Assessment||55
343944|NCT02524158|845506|P1|COMPLETED|6-month Assessment||54
343945|NCT02524158|845505|P2|STARTED|6-month Assessment||76
343946|NCT02524158|845506|P1|STARTED|6-month Assessment||76
343947|NCT02524158|845505|P2|NOT COMPLETED|12-weeks Assessment||13
343948|NCT02524158|845506|P1|NOT COMPLETED|12-weeks Assessment||19
343949|NCT02524158|845505|P2|COMPLETED|12-weeks Assessment||63
343950|NCT02524158|845506|P1|COMPLETED|12-weeks Assessment||57
343951|NCT02524158|845505|P2|STARTED|12-weeks Assessment||76
343952|NCT02524158|845506|P1|STARTED|12-weeks Assessment||76
343953|NCT02524054|845520|P3|NOT COMPLETED|Overall Study||0
343954|NCT02524054|845521|P2|NOT COMPLETED|Overall Study||0
343955|NCT02524054|845522|P1|NOT COMPLETED|Overall Study||0
343956|NCT02524054|845520|P3|COMPLETED|Overall Study||8
343957|NCT02524054|845521|P2|COMPLETED|Overall Study||9
343958|NCT02524054|845522|P1|COMPLETED|Overall Study||7
343959|NCT02524054|845520|P3|STARTED|Overall Study||8
343960|NCT02524054|845521|P2|STARTED|Overall Study||9
343961|NCT02524054|845522|P1|STARTED|Overall Study||7
343962|NCT02522624|845535|P2|NOT COMPLETED|Overall Study||0
343963|NCT02522624|845536|P1|NOT COMPLETED|Overall Study||1
343964|NCT02522624|845535|P2|COMPLETED|Overall Study||163
343965|NCT02522624|845536|P1|COMPLETED|Overall Study|Discontinued intervention due to technical failure (n=1)|164
343966|NCT02522624|845535|P2|STARTED|Overall Study||163
343967|NCT02522624|845536|P1|STARTED|Overall Study||165
343968|NCT02520726|845554|P2|NOT COMPLETED|Overall Study||2
343969|NCT02520726|845555|P1|NOT COMPLETED|Overall Study||3
343970|NCT02520726|845554|P2|COMPLETED|Overall Study||0
343971|NCT02520726|845555|P1|COMPLETED|Overall Study||0
343972|NCT02520726|845554|P2|STARTED|Overall Study||2
343973|NCT02520726|845555|P1|STARTED|Overall Study||3
343974|NCT02520414|845563|P1|NOT COMPLETED|Overall Study||0
343975|NCT02520414|845563|P1|COMPLETED|Overall Study||10
343976|NCT02520414|845563|P1|STARTED|Overall Study||10
343977|NCT02519855|845569|P2|NOT COMPLETED|Overall Study||4
343978|NCT02519855|845570|P1|NOT COMPLETED|Overall Study||3
343979|NCT02519855|845569|P2|COMPLETED|Overall Study||437
343980|NCT02519855|845570|P1|COMPLETED|Overall Study||438
343981|NCT02519855|845569|P2|Vaccinated at Week 4|Overall Study||424
343982|NCT02519855|845570|P1|Vaccinated at Week 4|Overall Study||432
343983|NCT02519855|845569|P2|Vaccinated on Day 1|Overall Study||441
343984|NCT02519855|845570|P1|Vaccinated on Day 1|Overall Study||440
343985|NCT02519855|845569|P2|STARTED|Overall Study|Participants are included as treated|441
343986|NCT02519855|845570|P1|STARTED|Overall Study|Participants are included as treated|441
343987|NCT02519842|845588|P3|NOT COMPLETED|Optional Extension: Cycles 2-6||29
343988|NCT02519842|845589|P2|NOT COMPLETED|Optional Extension: Cycles 2-6||0
343989|NCT02519842|845590|P1|NOT COMPLETED|Optional Extension: Cycles 2-6||0
343990|NCT02519842|845588|P3|COMPLETED|Optional Extension: Cycles 2-6||26
343991|NCT02519842|845589|P2|COMPLETED|Optional Extension: Cycles 2-6||0
343992|NCT02519842|845590|P1|COMPLETED|Optional Extension: Cycles 2-6||0
343993|NCT02519842|845588|P3|Treated|Optional Extension: Cycles 2-6||55
343994|NCT02519842|845589|P2|Treated|Optional Extension: Cycles 2-6||0
343995|NCT02519842|845590|P1|Treated|Optional Extension: Cycles 2-6||0
343996|NCT02519842|845588|P3|STARTED|Optional Extension: Cycles 2-6|Enrollment in Cycles 2-6 was optional.|55
343997|NCT02519842|845589|P2|STARTED|Optional Extension: Cycles 2-6|28 participants from this arm in Cycle 1 entered optional Cycles 2-6|0
343998|NCT02519842|845590|P1|STARTED|Optional Extension: Cycles 2-6|27 participants from this arm in Cycle 1 entered optional Cycles 2-6|0
343999|NCT02519842|845588|P3|NOT COMPLETED|Base Study: Cycle 1||0
344000|NCT02519842|845589|P2|NOT COMPLETED|Base Study: Cycle 1||3
344001|NCT02519842|845590|P1|NOT COMPLETED|Base Study: Cycle 1||2
344002|NCT02519842|845588|P3|COMPLETED|Base Study: Cycle 1||0
344003|NCT02519842|845589|P2|COMPLETED|Base Study: Cycle 1||34
344004|NCT02519842|845590|P1|COMPLETED|Base Study: Cycle 1||36
344005|NCT02519842|845588|P3|Treated|Base Study: Cycle 1||0
344006|NCT02519842|845589|P2|Treated|Base Study: Cycle 1||34
344007|NCT02519842|845590|P1|Treated|Base Study: Cycle 1||37
344008|NCT02519842|845588|P3|STARTED|Base Study: Cycle 1||0
344009|NCT02519842|845589|P2|STARTED|Base Study: Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6.|37
344010|NCT02519842|845590|P1|STARTED|Base Study: Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6.|38
344011|NCT02519712|845609|P1|NOT COMPLETED|Overall Study||4
344012|NCT02519712|845609|P1|COMPLETED|Overall Study||0
344013|NCT02519712|845609|P1|STARTED|Overall Study||4
344014|NCT02519595|845616|P3|NOT COMPLETED|Overall Study||16
344015|NCT02519595|845617|P2|NOT COMPLETED|Overall Study||22
344016|NCT02519595|845618|P1|NOT COMPLETED|Overall Study||8
344017|NCT02519595|845616|P3|COMPLETED|Overall Study||40
344018|NCT02519595|845617|P2|COMPLETED|Overall Study||35
344019|NCT02519595|845618|P1|COMPLETED|Overall Study||50
344020|NCT02519595|845616|P3|STARTED|Overall Study||56
344021|NCT02519595|845617|P2|STARTED|Overall Study||57
344022|NCT02519595|845618|P1|STARTED|Overall Study||58
344023|NCT02519387|845641|P1|NOT COMPLETED|Overall Study||22
344024|NCT02519387|845641|P1|COMPLETED|Overall Study||56
344025|NCT02519387|845641|P1|STARTED|Overall Study||78
344026|NCT02518048|845649|P1|NOT COMPLETED|Overall Study||1
344027|NCT02518048|845649|P1|COMPLETED|Overall Study||34
344028|NCT02518048|845649|P1|STARTED|Overall Study||35
344029|NCT02517580|845660|P1|NOT COMPLETED|Overall Study||4
344030|NCT02517580|845660|P1|COMPLETED|Overall Study||56
344031|NCT02517580|845660|P1|STARTED|Overall Study||60
344032|NCT02517567|845664|P4|NOT COMPLETED|Fourth Exposure (8 Hours)||0
344033|NCT02517567|845665|P3|NOT COMPLETED|Fourth Exposure (8 Hours)||0
344034|NCT02517567|845666|P2|NOT COMPLETED|Fourth Exposure (8 Hours)||0
344035|NCT02517567|845667|P1|NOT COMPLETED|Fourth Exposure (8 Hours)||0
344036|NCT02517567|845664|P4|COMPLETED|Fourth Exposure (8 Hours)||8
344037|NCT02517567|845665|P3|COMPLETED|Fourth Exposure (8 Hours)||6
344038|NCT02517567|845666|P2|COMPLETED|Fourth Exposure (8 Hours)||8
344039|NCT02517567|845667|P1|COMPLETED|Fourth Exposure (8 Hours)||6
344040|NCT02517567|845664|P4|STARTED|Fourth Exposure (8 Hours)||8
344041|NCT02517567|845665|P3|STARTED|Fourth Exposure (8 Hours)|One subject discontinued between Period 3 and Period 4 (withdrawal by subject)|6
344042|NCT02517567|845666|P2|STARTED|Fourth Exposure (8 Hours)||8
344043|NCT02517567|845667|P1|STARTED|Fourth Exposure (8 Hours)||6
344044|NCT02517567|845664|P4|NOT COMPLETED|Third Exposure (8 Hours)||0
344045|NCT02517567|845665|P3|NOT COMPLETED|Third Exposure (8 Hours)||0
344046|NCT02517567|845666|P2|NOT COMPLETED|Third Exposure (8 Hours)||0
344047|NCT02517567|845667|P1|NOT COMPLETED|Third Exposure (8 Hours)||0
344048|NCT02517567|845664|P4|COMPLETED|Third Exposure (8 Hours)||8
344049|NCT02517567|845665|P3|COMPLETED|Third Exposure (8 Hours)||7
344050|NCT02517567|845666|P2|COMPLETED|Third Exposure (8 Hours)||8
344051|NCT02517567|845667|P1|COMPLETED|Third Exposure (8 Hours)||6
344052|NCT02517567|845664|P4|STARTED|Third Exposure (8 Hours)||8
344053|NCT02517567|845665|P3|STARTED|Third Exposure (8 Hours)||7
344054|NCT02517567|845666|P2|STARTED|Third Exposure (8 Hours)||8
344055|NCT02517567|845667|P1|STARTED|Third Exposure (8 Hours)||6
344056|NCT02517567|845664|P4|NOT COMPLETED|Second Exposure (8 Hours)||0
344057|NCT02517567|845665|P3|NOT COMPLETED|Second Exposure (8 Hours)||0
344058|NCT02517567|845666|P2|NOT COMPLETED|Second Exposure (8 Hours)||0
344059|NCT02517567|845667|P1|NOT COMPLETED|Second Exposure (8 Hours)||0
344060|NCT02517567|845664|P4|COMPLETED|Second Exposure (8 Hours)||8
344061|NCT02517567|845665|P3|COMPLETED|Second Exposure (8 Hours)||7
344062|NCT02517567|845666|P2|COMPLETED|Second Exposure (8 Hours)||8
344063|NCT02517567|845667|P1|COMPLETED|Second Exposure (8 Hours)||6
344064|NCT02517567|845664|P4|STARTED|Second Exposure (8 Hours)||8
344065|NCT02517567|845665|P3|STARTED|Second Exposure (8 Hours)||7
344066|NCT02517567|845666|P2|STARTED|Second Exposure (8 Hours)||8
344067|NCT02517567|845667|P1|STARTED|Second Exposure (8 Hours)||6
344068|NCT02517567|845664|P4|NOT COMPLETED|First Exposure (8 Hours)||0
344069|NCT02517567|845665|P3|NOT COMPLETED|First Exposure (8 Hours)||0
344070|NCT02517567|845666|P2|NOT COMPLETED|First Exposure (8 Hours)||0
344071|NCT02517567|845667|P1|NOT COMPLETED|First Exposure (8 Hours)||0
344072|NCT02517567|845664|P4|COMPLETED|First Exposure (8 Hours)||8
344073|NCT02517567|845665|P3|COMPLETED|First Exposure (8 Hours)||7
344074|NCT02517567|845666|P2|COMPLETED|First Exposure (8 Hours)||8
344075|NCT02517567|845667|P1|COMPLETED|First Exposure (8 Hours)||6
344076|NCT02517567|845664|P4|STARTED|First Exposure (8 Hours)||8
344077|NCT02517567|845665|P3|STARTED|First Exposure (8 Hours)||7
344078|NCT02517567|845666|P2|STARTED|First Exposure (8 Hours)||8
344079|NCT02517567|845667|P1|STARTED|First Exposure (8 Hours)||6
344080|NCT02517515|845678|P2|NOT COMPLETED|Overall Study||2
344081|NCT02517515|845679|P1|NOT COMPLETED|Overall Study||2
344082|NCT02517515|845678|P2|COMPLETED|Overall Study||323
344083|NCT02517515|845679|P1|COMPLETED|Overall Study||323
344084|NCT02517515|845678|P2|STARTED|Overall Study||325
344085|NCT02517515|845679|P1|STARTED|Overall Study||325
344086|NCT02517047|845694|P1|NOT COMPLETED|Overall Study||2
344087|NCT02517047|845694|P1|COMPLETED|Overall Study||24
344088|NCT02517047|845694|P1|STARTED|Overall Study||26
344089|NCT02517021|845703|P2|NOT COMPLETED|Overall Study||85
344090|NCT02517021|845704|P1|NOT COMPLETED|Overall Study||83
344091|NCT02517021|845703|P2|COMPLETED|Overall Study||117
344092|NCT02517021|845704|P1|COMPLETED|Overall Study||120
344093|NCT02517021|845703|P2|STARTED|Overall Study||202
344094|NCT02517021|845704|P1|STARTED|Overall Study||203
344095|NCT02516410|845730|P2|NOT COMPLETED|Overall Study||2
344096|NCT02516410|845731|P1|NOT COMPLETED|Overall Study||0
344097|NCT02516410|845730|P2|COMPLETED|Overall Study||81
344098|NCT02516410|845731|P1|COMPLETED|Overall Study||85
344099|NCT02516410|845730|P2|STARTED|Overall Study||83
344100|NCT02516410|845731|P1|STARTED|Overall Study||85
344101|NCT02516306|845760|P2|NOT COMPLETED|Period 2: Day 8 - 91||2
344102|NCT02516306|845761|P1|NOT COMPLETED|Period 2: Day 8 - 91||1
344103|NCT02516306|845760|P2|COMPLETED|Period 2: Day 8 - 91||23
344104|NCT02516306|845761|P1|COMPLETED|Period 2: Day 8 - 91||49
344105|NCT02516306|845760|P2|STARTED|Period 2: Day 8 - 91||25
344106|NCT02516306|845761|P1|STARTED|Period 2: Day 8 - 91||50
344107|NCT02516306|845760|P2|NOT COMPLETED|Period 1: Day 1 - 7||0
344108|NCT02516306|845761|P1|NOT COMPLETED|Period 1: Day 1 - 7||0
344109|NCT02516306|845760|P2|COMPLETED|Period 1: Day 1 - 7||25
344110|NCT02516306|845761|P1|COMPLETED|Period 1: Day 1 - 7||50
344111|NCT02516306|845760|P2|STARTED|Period 1: Day 1 - 7||25
344112|NCT02516306|845761|P1|STARTED|Period 1: Day 1 - 7||50
344113|NCT02516163|845767|P1|NOT COMPLETED|Overall Study||28
344114|NCT02516163|845767|P1|COMPLETED|Overall Study||24
344115|NCT02516163|845767|P1|STARTED|Overall Study||52
344116|NCT02516150|845771|P1|NOT COMPLETED|Overall Study||0
344117|NCT02516150|845771|P1|COMPLETED|Overall Study||15
344118|NCT02516150|845771|P1|STARTED|Overall Study||15
344119|NCT02516098|845781|P2|NOT COMPLETED|Washout After Period 2||0
344120|NCT02516098|845782|P1|NOT COMPLETED|Washout After Period 2||0
344121|NCT02516098|845781|P2|COMPLETED|Washout After Period 2||26
344122|NCT02516098|845782|P1|COMPLETED|Washout After Period 2||27
344123|NCT02516098|845781|P2|STARTED|Washout After Period 2||26
344124|NCT02516098|845782|P1|STARTED|Washout After Period 2||27
344125|NCT02516098|845781|P2|NOT COMPLETED|Period 2||1
344126|NCT02516098|845782|P1|NOT COMPLETED|Period 2||0
344127|NCT02516098|845781|P2|COMPLETED|Period 2||26
344128|NCT02516098|845782|P1|COMPLETED|Period 2||27
344129|NCT02516098|845781|P2|STARTED|Period 2||27
344130|NCT02516098|845782|P1|STARTED|Period 2||27
344131|NCT02516098|845781|P2|NOT COMPLETED|Washout After Period 1||1
344132|NCT02516098|845782|P1|NOT COMPLETED|Washout After Period 1||0
344133|NCT02516098|845781|P2|COMPLETED|Washout After Period 1||27
344134|NCT02516098|845782|P1|COMPLETED|Washout After Period 1||27
344135|NCT02516098|845781|P2|STARTED|Washout After Period 1||28
344136|NCT02516098|845782|P1|STARTED|Washout After Period 1||27
344137|NCT02516098|845781|P2|NOT COMPLETED|Period 1||0
344138|NCT02516098|845782|P1|NOT COMPLETED|Period 1||1
344139|NCT02516098|845781|P2|COMPLETED|Period 1||28
344140|NCT02516098|845782|P1|COMPLETED|Period 1||27
344141|NCT02516098|845781|P2|STARTED|Period 1||28
344142|NCT02516098|845782|P1|STARTED|Period 1||28
344143|NCT02515994|845796|P2|NOT COMPLETED|Overall Study||7
344144|NCT02515994|845797|P1|NOT COMPLETED|Overall Study||10
344145|NCT02515994|845796|P2|COMPLETED|Overall Study||105
344146|NCT02515994|845797|P1|COMPLETED|Overall Study||99
344147|NCT02515994|845796|P2|STARTED|Overall Study||112
344148|NCT02515994|845797|P1|STARTED|Overall Study||109
344149|NCT02515851|845811|P2|NOT COMPLETED|Overall Study||0
344150|NCT02515851|845812|P1|NOT COMPLETED|Overall Study||0
344151|NCT02515851|845811|P2|COMPLETED|Overall Study||15
344152|NCT02515851|845812|P1|COMPLETED|Overall Study||15
344153|NCT02515851|845811|P2|STARTED|Overall Study||15
344154|NCT02515851|845812|P1|STARTED|Overall Study||15
344155|NCT02515279|845824|P1|NOT COMPLETED|Overall Study||104
344156|NCT02515279|845824|P1|COMPLETED|Overall Study||359
344157|NCT02515279|845824|P1|STARTED|Overall Study||463
344158|NCT02515058|845832|P2|NOT COMPLETED|Overall Study||2
344159|NCT02515058|845833|P1|NOT COMPLETED|Overall Study||3
344160|NCT02515058|845832|P2|COMPLETED|Overall Study||20
344161|NCT02515058|845833|P1|COMPLETED|Overall Study||18
344162|NCT02515058|845832|P2|STARTED|Overall Study||22
344163|NCT02515058|845833|P1|STARTED|Overall Study||21
344164|NCT02515045|845843|P3|NOT COMPLETED|Overall Study||4
344165|NCT02515045|845844|P2|NOT COMPLETED|Overall Study||4
344166|NCT02515045|845845|P1|NOT COMPLETED|Overall Study||0
344167|NCT02515045|845843|P3|COMPLETED|Overall Study||55
344168|NCT02515045|845844|P2|COMPLETED|Overall Study||26
344169|NCT02515045|845845|P1|COMPLETED|Overall Study||29
344170|NCT02515045|845843|P3|STARTED|Overall Study||59
344171|NCT02515045|845844|P2|STARTED|Overall Study||30
344172|NCT02515045|845845|P1|STARTED|Overall Study||29
344173|NCT02514889|845861|P2|NOT COMPLETED|Follow-up Assessment Participation||12
344174|NCT02514889|845862|P1|NOT COMPLETED|Follow-up Assessment Participation||10
344175|NCT02514889|845861|P2|COMPLETED|Follow-up Assessment Participation||86
344176|NCT02514889|845862|P1|COMPLETED|Follow-up Assessment Participation||92
344177|NCT02514889|845861|P2|STARTED|Follow-up Assessment Participation||98
344178|NCT02514889|845862|P1|STARTED|Follow-up Assessment Participation||102
344179|NCT02514889|845861|P2|NOT COMPLETED|Intervention Participation||8
344180|NCT02514889|845862|P1|NOT COMPLETED|Intervention Participation||9
344181|NCT02514889|845861|P2|COMPLETED|Intervention Participation||98
344182|NCT02514889|845862|P1|COMPLETED|Intervention Participation||102
344183|NCT02514889|845861|P2|STARTED|Intervention Participation||106
344184|NCT02514889|845862|P1|STARTED|Intervention Participation||111
344185|NCT02514889|845861|P2|NOT COMPLETED|Randomization/Allocation to Condition||24
344186|NCT02514889|845862|P1|NOT COMPLETED|Randomization/Allocation to Condition||20
344187|NCT02514889|845861|P2|COMPLETED|Randomization/Allocation to Condition||106
344188|NCT02514889|845862|P1|COMPLETED|Randomization/Allocation to Condition||111
344189|NCT02514889|845861|P2|STARTED|Randomization/Allocation to Condition||130
344190|NCT02514889|845862|P1|STARTED|Randomization/Allocation to Condition||131
344191|NCT02514772|845882|P2|NOT COMPLETED|Overall Study||2
344192|NCT02514772|845883|P1|NOT COMPLETED|Overall Study||3
344193|NCT02514772|845882|P2|COMPLETED|Overall Study||52
344194|NCT02514772|845883|P1|COMPLETED|Overall Study||50
344195|NCT02514772|845882|P2|STARTED|Overall Study||54
344196|NCT02514772|845883|P1|STARTED|Overall Study||53
344197|NCT02514473|845897|P2|NOT COMPLETED|Overall Study||5
344198|NCT02514473|845898|P1|NOT COMPLETED|Overall Study||3
344199|NCT02514473|845897|P2|COMPLETED|Overall Study||98
344200|NCT02514473|845898|P1|COMPLETED|Overall Study||98
344201|NCT02514473|845897|P2|STARTED|Overall Study||103
344202|NCT02514473|845898|P1|STARTED|Overall Study||101
344203|NCT02513771|845941|P2|NOT COMPLETED|Overall Study||1
344204|NCT02513771|845942|P1|NOT COMPLETED|Overall Study||2
344205|NCT02513771|845941|P2|COMPLETED|Overall Study||44
344206|NCT02513771|845942|P1|COMPLETED|Overall Study||43
344207|NCT02513771|845941|P2|STARTED|Overall Study||45
344208|NCT02513771|845942|P1|STARTED|Overall Study||45
344209|NCT02513550|845981|P3|NOT COMPLETED|Overall Study||74
344210|NCT02513550|845982|P2|NOT COMPLETED|Overall Study||38
344211|NCT02513550|845983|P1|NOT COMPLETED|Overall Study||36
344212|NCT02513550|845981|P3|COMPLETED|Overall Study||537
344213|NCT02513550|845982|P2|COMPLETED|Overall Study||268
344214|NCT02513550|845983|P1|COMPLETED|Overall Study||274
344215|NCT02513550|845981|P3|Received at Least One Dose of Study Drug|Overall Study||609
344216|NCT02513550|845982|P2|Received at Least One Dose of Study Drug|Overall Study||306
344217|NCT02513550|845983|P1|Received at Least One Dose of Study Drug|Overall Study||310
344218|NCT02513550|845981|P3|STARTED|Overall Study||611
344219|NCT02513550|845982|P2|STARTED|Overall Study||306
344220|NCT02513550|845983|P1|STARTED|Overall Study||310
344221|NCT02513160|846050|P4|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||2
344222|NCT02513160|846051|P3|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||1
344223|NCT02513160|846052|P2|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||4
344224|NCT02513160|846053|P1|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||6
344225|NCT02513160|846050|P4|COMPLETED|Treatment Period (Day 0 to Week 6)||103
344226|NCT02513160|846051|P3|COMPLETED|Treatment Period (Day 0 to Week 6)||104
344227|NCT02513160|846052|P2|COMPLETED|Treatment Period (Day 0 to Week 6)||104
344228|NCT02513160|846053|P1|COMPLETED|Treatment Period (Day 0 to Week 6)||101
344229|NCT02513160|846050|P4|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|105
344230|NCT02513160|846051|P3|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|105
344231|NCT02513160|846052|P2|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|108
344232|NCT02513160|846053|P1|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|107
344233|NCT02513160|846050|P4|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
344234|NCT02513160|846051|P3|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
344235|NCT02513160|846052|P2|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
344236|NCT02513160|846053|P1|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||288
344237|NCT02513160|846050|P4|COMPLETED|Run-In Period (Days -14 to Day -1)||0
344238|NCT02513160|846051|P3|COMPLETED|Run-In Period (Days -14 to Day -1)||0
344239|NCT02513160|846052|P2|COMPLETED|Run-In Period (Days -14 to Day -1)||0
344240|NCT02513160|846053|P1|COMPLETED|Run-In Period (Days -14 to Day -1)||425
344241|NCT02513160|846050|P4|STARTED|Run-In Period (Days -14 to Day -1)||0
344242|NCT02513160|846051|P3|STARTED|Run-In Period (Days -14 to Day -1)||0
344243|NCT02513160|846052|P2|STARTED|Run-In Period (Days -14 to Day -1)||0
344244|NCT02513160|846053|P1|STARTED|Run-In Period (Days -14 to Day -1)|Enrolled|713
344245|NCT02513095|846090|P2|NOT COMPLETED|Overall Study||16
344246|NCT02513095|846091|P1|NOT COMPLETED|Overall Study||14
344247|NCT02513095|846090|P2|COMPLETED|Overall Study||1
344248|NCT02513095|846091|P1|COMPLETED|Overall Study||3
344249|NCT02513095|846090|P2|STARTED|Overall Study||17
344250|NCT02513095|846091|P1|STARTED|Overall Study||17
344251|NCT02512900|846099|P2|NOT COMPLETED|Overall Study||0
344252|NCT02512900|846100|P1|NOT COMPLETED|Overall Study||0
344253|NCT02512900|846099|P2|COMPLETED|Overall Study||10
344254|NCT02512900|846100|P1|COMPLETED|Overall Study||11
344255|NCT02512900|846099|P2|STARTED|Overall Study||10
344256|NCT02512900|846100|P1|STARTED|Overall Study||11
344257|NCT02512783|846133|P2|NOT COMPLETED|Overall Study||0
344258|NCT02512783|846134|P1|NOT COMPLETED|Overall Study||0
344259|NCT02512783|846133|P2|COMPLETED|Overall Study||75
344260|NCT02512783|846134|P1|COMPLETED|Overall Study||96
344261|NCT02512783|846133|P2|STARTED|Overall Study||75
344262|NCT02512783|846134|P1|STARTED|Overall Study||96
344263|NCT02512679|846142|P2|NOT COMPLETED|Overall Study||0
344264|NCT02512679|846143|P1|NOT COMPLETED|Overall Study||0
344265|NCT02512679|846142|P2|COMPLETED|Overall Study||0
344266|NCT02512679|846143|P1|COMPLETED|Overall Study||20
344267|NCT02512679|846142|P2|STARTED|Overall Study||0
344268|NCT02512679|846143|P1|STARTED|Overall Study||20
344269|NCT02512393|846153|P2|NOT COMPLETED|Overall Study||0
344270|NCT02512393|846154|P1|NOT COMPLETED|Overall Study||1
344271|NCT02512393|846153|P2|COMPLETED|Overall Study||20
344272|NCT02512393|846154|P1|COMPLETED|Overall Study||20
344273|NCT02512393|846153|P2|STARTED|Overall Study||20
344274|NCT02512393|846154|P1|STARTED|Overall Study||21
344275|NCT02512224|846236|P2|NOT COMPLETED|Overall Study||0
344276|NCT02512224|846237|P1|NOT COMPLETED|Overall Study||0
344277|NCT02512224|846236|P2|COMPLETED|Overall Study||2912
344278|NCT02512224|846237|P1|COMPLETED|Overall Study||2912
344279|NCT02512224|846236|P2|STARTED|Overall Study||2912
344280|NCT02512224|846237|P1|STARTED|Overall Study||2912
344281|NCT02512094|846253|P1|NOT COMPLETED|Overall Study||0
344282|NCT02512094|846253|P1|COMPLETED|Overall Study||53
344283|NCT02512094|846253|P1|STARTED|Overall Study||53
344284|NCT02511782|846260|P3|NOT COMPLETED|Overall Study||0
344285|NCT02511782|846261|P2|NOT COMPLETED|Overall Study||0
344286|NCT02511782|846262|P1|NOT COMPLETED|Overall Study||1
344287|NCT02511782|846260|P3|COMPLETED|Overall Study||10
344288|NCT02511782|846261|P2|COMPLETED|Overall Study||2
344289|NCT02511782|846262|P1|COMPLETED|Overall Study||50
344290|NCT02511782|846260|P3|STARTED|Overall Study||10
344291|NCT02511782|846261|P2|STARTED|Overall Study||2
344292|NCT02511782|846262|P1|STARTED|Overall Study||51
344293|NCT02511587|846274|P2|NOT COMPLETED|Overall Study||0
344294|NCT02511587|846275|P1|NOT COMPLETED|Overall Study||0
344295|NCT02511587|846274|P2|COMPLETED|Overall Study||58
344296|NCT02511587|846275|P1|COMPLETED|Overall Study||58
344297|NCT02511587|846274|P2|STARTED|Overall Study||58
344298|NCT02511587|846275|P1|STARTED|Overall Study||58
344299|NCT02511431|846291|P6|NOT COMPLETED|Post-treatment Follow-up||0
344300|NCT02511431|846292|P5|NOT COMPLETED|Post-treatment Follow-up||0
344301|NCT02511431|846293|P4|NOT COMPLETED|Post-treatment Follow-up||0
344302|NCT02511431|846294|P3|NOT COMPLETED|Post-treatment Follow-up||0
344303|NCT02511431|846295|P2|NOT COMPLETED|Post-treatment Follow-up||0
344304|NCT02511431|846296|P1|NOT COMPLETED|Post-treatment Follow-up||0
344305|NCT02511431|846291|P6|COMPLETED|Post-treatment Follow-up||2
344306|NCT02511431|846292|P5|COMPLETED|Post-treatment Follow-up||3
344307|NCT02511431|846293|P4|COMPLETED|Post-treatment Follow-up||3
344308|NCT02511431|846294|P3|COMPLETED|Post-treatment Follow-up||3
344309|NCT02511431|846295|P2|COMPLETED|Post-treatment Follow-up||4
344310|NCT02511431|846296|P1|COMPLETED|Post-treatment Follow-up||4
344311|NCT02511431|846291|P6|STARTED|Post-treatment Follow-up||2
344312|NCT02511431|846292|P5|STARTED|Post-treatment Follow-up||3
344313|NCT02511431|846293|P4|STARTED|Post-treatment Follow-up||3
344314|NCT02511431|846294|P3|STARTED|Post-treatment Follow-up||3
344315|NCT02511431|846295|P2|STARTED|Post-treatment Follow-up||4
344316|NCT02511431|846296|P1|STARTED|Post-treatment Follow-up||4
344317|NCT02511431|846291|P6|NOT COMPLETED|Treatment||1
344318|NCT02511431|846292|P5|NOT COMPLETED|Treatment||0
344319|NCT02511431|846293|P4|NOT COMPLETED|Treatment||0
344320|NCT02511431|846294|P3|NOT COMPLETED|Treatment||1
344321|NCT02511431|846295|P2|NOT COMPLETED|Treatment||0
344322|NCT02511431|846296|P1|NOT COMPLETED|Treatment||0
344323|NCT02511431|846291|P6|COMPLETED|Treatment||2
344324|NCT02511431|846292|P5|COMPLETED|Treatment||3
344325|NCT02511431|846293|P4|COMPLETED|Treatment||3
344326|NCT02511431|846294|P3|COMPLETED|Treatment||3
344327|NCT02511431|846295|P2|COMPLETED|Treatment||4
344328|NCT02511431|846296|P1|COMPLETED|Treatment||4
344329|NCT02511431|846291|P6|STARTED|Treatment||3
344330|NCT02511431|846292|P5|STARTED|Treatment||3
344331|NCT02511431|846293|P4|STARTED|Treatment||3
344332|NCT02511431|846294|P3|STARTED|Treatment||4
344333|NCT02511431|846295|P2|STARTED|Treatment||4
344334|NCT02511431|846296|P1|STARTED|Treatment||4
344335|NCT02510820|846316|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
344336|NCT02510820|846317|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
344337|NCT02510820|846316|P2|COMPLETED|Second Intervention (4 Weeks)||26
344338|NCT02510820|846317|P1|COMPLETED|Second Intervention (4 Weeks)||20
344339|NCT02510820|846316|P2|STARTED|Second Intervention (4 Weeks)||26
344340|NCT02510820|846317|P1|STARTED|Second Intervention (4 Weeks)||21
344341|NCT02510820|846316|P2|NOT COMPLETED|Washout (1 Week)||0
344342|NCT02510820|846317|P1|NOT COMPLETED|Washout (1 Week)||0
344343|NCT02510820|846316|P2|COMPLETED|Washout (1 Week)||26
344344|NCT02510820|846317|P1|COMPLETED|Washout (1 Week)||21
344345|NCT02510820|846316|P2|STARTED|Washout (1 Week)||26
344346|NCT02510820|846317|P1|STARTED|Washout (1 Week)||21
344347|NCT02510820|846316|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
344348|NCT02510820|846317|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
344349|NCT02510820|846316|P2|COMPLETED|First Intervention (4 Weeks)||26
344350|NCT02510820|846317|P1|COMPLETED|First Intervention (4 Weeks)||21
344351|NCT02510820|846316|P2|STARTED|First Intervention (4 Weeks)||27
344352|NCT02510820|846317|P1|STARTED|First Intervention (4 Weeks)||21
344353|NCT02510014|846357|P2|NOT COMPLETED|Treatment Period||57
344354|NCT02510014|846358|P1|NOT COMPLETED|Treatment Period||206
344355|NCT02510014|846357|P2|COMPLETED|Treatment Period||200
344356|NCT02510014|846358|P1|COMPLETED|Treatment Period||206
344357|NCT02510014|846357|P2|STARTED|Treatment Period||257
344358|NCT02510014|846358|P1|STARTED|Treatment Period||412
344359|NCT02510014|846357|P2|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||10
344360|NCT02510014|846358|P1|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||96
344361|NCT02510014|846357|P2|COMPLETED|Run-In Period (Days -14 to Day -1)||257
344362|NCT02510014|846358|P1|COMPLETED|Run-In Period (Days -14 to Day -1)||412
344363|NCT02510014|846357|P2|STARTED|Run-In Period (Days -14 to Day -1)||267
344364|NCT02510014|846358|P1|STARTED|Run-In Period (Days -14 to Day -1)||508
344365|NCT02508194|846380|P2|NOT COMPLETED|Overall Study||44
344366|NCT02508194|846381|P1|NOT COMPLETED|Overall Study||52
344367|NCT02508194|846380|P2|COMPLETED|Overall Study||907
344368|NCT02508194|846381|P1|COMPLETED|Overall Study||897
344369|NCT02508194|846380|P2|STARTED|Overall Study||951
344370|NCT02508194|846381|P1|STARTED|Overall Study||949
344371|NCT02508103|846421|P2|NOT COMPLETED|Overall Study||0
344372|NCT02508103|846422|P1|NOT COMPLETED|Overall Study||0
344373|NCT02508103|846421|P2|COMPLETED|Overall Study||5
344374|NCT02508103|846422|P1|COMPLETED|Overall Study||5
344375|NCT02508103|846421|P2|STARTED|Overall Study||5
344376|NCT02508103|846422|P1|STARTED|Overall Study||5
344377|NCT02507752|846430|P1|NOT COMPLETED|Overall Study||17
344378|NCT02507752|846430|P1|COMPLETED|Overall Study||55
344379|NCT02507752|846430|P1|STARTED|Overall Study||72
344380|NCT02507388|846450|P2|NOT COMPLETED|Overall Study||0
344381|NCT02507388|846451|P1|NOT COMPLETED|Overall Study||0
344382|NCT02507388|846450|P2|COMPLETED|Overall Study||25
344383|NCT02507388|846451|P1|COMPLETED|Overall Study||25
344384|NCT02507388|846450|P2|STARTED|Overall Study||25
344385|NCT02507388|846451|P1|STARTED|Overall Study||25
344386|NCT02507375|846474|P2|NOT COMPLETED|Overall Study||8
344387|NCT02507375|846475|P1|NOT COMPLETED|Overall Study||4
344388|NCT02507375|846474|P2|COMPLETED|Overall Study||1
344389|NCT02507375|846475|P1|COMPLETED|Overall Study||2
344390|NCT02507375|846474|P2|Extension Period|Overall Study||1
344391|NCT02507375|846475|P1|Extension Period|Overall Study||2
344392|NCT02507375|846474|P2|Cycle 6|Overall Study||1
344393|NCT02507375|846475|P1|Cycle 6|Overall Study||3
344394|NCT02507375|846474|P2|Cycle 5|Overall Study||1
344395|NCT02507375|846475|P1|Cycle 5|Overall Study||3
344396|NCT02507375|846474|P2|Cycle 4|Overall Study||2
344397|NCT02507375|846475|P1|Cycle 4|Overall Study||4
344398|NCT02507375|846474|P2|Cycle 3|Overall Study||5
344399|NCT02507375|846475|P1|Cycle 3|Overall Study||4
344400|NCT02507375|846474|P2|Cycle 2|Overall Study||5
344401|NCT02507375|846475|P1|Cycle 2|Overall Study||5
344402|NCT02507375|846474|P2|Received Pertuzumab|Overall Study||6
344403|NCT02507375|846475|P1|Received Pertuzumab|Overall Study||6
344404|NCT02507375|846474|P2|Cycle 1|Overall Study||9
344405|NCT02507375|846475|P1|Cycle 1|Overall Study||6
344406|NCT02507375|846474|P2|STARTED|Overall Study|Two patients in cohort 2 did not begin treatment in Cycle 1 so were not included in the analysis set|9
344407|NCT02507375|846475|P1|STARTED|Overall Study||6
344408|NCT02507219|846492|P6|NOT COMPLETED|Overall Study||0
344409|NCT02507219|846493|P5|NOT COMPLETED|Overall Study||1
344410|NCT02507219|846494|P4|NOT COMPLETED|Overall Study||0
344411|NCT02507219|846495|P3|NOT COMPLETED|Overall Study||0
344412|NCT02507219|846496|P2|NOT COMPLETED|Overall Study||0
344413|NCT02507219|846497|P1|NOT COMPLETED|Overall Study||1
344414|NCT02507219|846492|P6|COMPLETED|Overall Study||3
344415|NCT02507219|846493|P5|COMPLETED|Overall Study||3
344416|NCT02507219|846494|P4|COMPLETED|Overall Study||3
344417|NCT02507219|846495|P3|COMPLETED|Overall Study||3
344418|NCT02507219|846496|P2|COMPLETED|Overall Study||4
344419|NCT02507219|846497|P1|COMPLETED|Overall Study||4
344420|NCT02507219|846492|P6|STARTED|Overall Study||3
344421|NCT02507219|846493|P5|STARTED|Overall Study||4
344422|NCT02507219|846494|P4|STARTED|Overall Study||3
344423|NCT02507219|846495|P3|STARTED|Overall Study||3
344424|NCT02507219|846496|P2|STARTED|Overall Study||4
344425|NCT02507219|846497|P1|STARTED|Overall Study||5
344426|NCT02506881|846509|P4|NOT COMPLETED|Second Intervention (Day 1)||0
344427|NCT02506881|846510|P3|NOT COMPLETED|Second Intervention (Day 1)||0
344428|NCT02506881|846511|P2|NOT COMPLETED|Second Intervention (Day 1)||0
344429|NCT02506881|846512|P1|NOT COMPLETED|Second Intervention (Day 1)||0
344430|NCT02506881|846509|P4|COMPLETED|Second Intervention (Day 1)||12
344431|NCT02506881|846510|P3|COMPLETED|Second Intervention (Day 1)||12
344432|NCT02506881|846511|P2|COMPLETED|Second Intervention (Day 1)||12
344433|NCT02506881|846512|P1|COMPLETED|Second Intervention (Day 1)||12
344434|NCT02506881|846509|P4|STARTED|Second Intervention (Day 1)||12
344435|NCT02506881|846510|P3|STARTED|Second Intervention (Day 1)||12
344436|NCT02506881|846511|P2|STARTED|Second Intervention (Day 1)||12
344437|NCT02506881|846512|P1|STARTED|Second Intervention (Day 1)||12
344438|NCT02506881|846509|P4|NOT COMPLETED|Washout (at Least 25 Days)||0
344439|NCT02506881|846510|P3|NOT COMPLETED|Washout (at Least 25 Days)||0
344440|NCT02506881|846511|P2|NOT COMPLETED|Washout (at Least 25 Days)||0
344441|NCT02506881|846512|P1|NOT COMPLETED|Washout (at Least 25 Days)||0
344442|NCT02506881|846509|P4|COMPLETED|Washout (at Least 25 Days)||12
344443|NCT02506881|846510|P3|COMPLETED|Washout (at Least 25 Days)||12
344444|NCT02506881|846511|P2|COMPLETED|Washout (at Least 25 Days)||12
344445|NCT02506881|846512|P1|COMPLETED|Washout (at Least 25 Days)||12
344446|NCT02506881|846509|P4|STARTED|Washout (at Least 25 Days)||12
344447|NCT02506881|846510|P3|STARTED|Washout (at Least 25 Days)||12
344448|NCT02506881|846511|P2|STARTED|Washout (at Least 25 Days)||12
344449|NCT02506881|846512|P1|STARTED|Washout (at Least 25 Days)||12
344450|NCT02506881|846509|P4|NOT COMPLETED|First Intervention (Day 1)||12
344451|NCT02506881|846510|P3|NOT COMPLETED|First Intervention (Day 1)||13
344452|NCT02506881|846511|P2|NOT COMPLETED|First Intervention (Day 1)||0
344453|NCT02506881|846512|P1|NOT COMPLETED|First Intervention (Day 1)||1
344454|NCT02506881|846509|P4|COMPLETED|First Intervention (Day 1)||12
344455|NCT02506881|846510|P3|COMPLETED|First Intervention (Day 1)||12
344456|NCT02506881|846511|P2|COMPLETED|First Intervention (Day 1)||12
344457|NCT02506881|846512|P1|COMPLETED|First Intervention (Day 1)||12
344458|NCT02506881|846509|P4|STARTED|First Intervention (Day 1)||24
344459|NCT02506881|846510|P3|STARTED|First Intervention (Day 1)||25
344460|NCT02506881|846511|P2|STARTED|First Intervention (Day 1)||12
344461|NCT02506881|846512|P1|STARTED|First Intervention (Day 1)||13
344462|NCT02506309|846548|P2|NOT COMPLETED|Overall Study||1
344463|NCT02506309|846549|P1|NOT COMPLETED|Overall Study||2
344464|NCT02506309|846548|P2|COMPLETED|Overall Study||44
344465|NCT02506309|846549|P1|COMPLETED|Overall Study||46
344466|NCT02506309|846548|P2|STARTED|Overall Study||45
344467|NCT02506309|846549|P1|STARTED|Overall Study||48
344468|NCT02506257|846565|P4|NOT COMPLETED|Overall Study||0
344469|NCT02506257|846566|P3|NOT COMPLETED|Overall Study||4
344470|NCT02506257|846567|P2|NOT COMPLETED|Overall Study||2
344471|NCT02506257|846568|P1|NOT COMPLETED|Overall Study||0
344472|NCT02506257|846565|P4|COMPLETED|Overall Study||9
344473|NCT02506257|846566|P3|COMPLETED|Overall Study||23
344474|NCT02506257|846567|P2|COMPLETED|Overall Study||26
344475|NCT02506257|846568|P1|COMPLETED|Overall Study||26
344476|NCT02506257|846565|P4|STARTED|Overall Study||9
344477|NCT02506257|846566|P3|STARTED|Overall Study||27
344478|NCT02506257|846567|P2|STARTED|Overall Study||28
344479|NCT02506257|846568|P1|STARTED|Overall Study||26
344480|NCT02506101|846600|P2|NOT COMPLETED|Overall Study||0
344481|NCT02506101|846601|P1|NOT COMPLETED|Overall Study||2
344482|NCT02506101|846600|P2|COMPLETED|Overall Study||0
344483|NCT02506101|846601|P1|COMPLETED|Overall Study||0
344484|NCT02506101|846600|P2|STARTED|Overall Study||0
344485|NCT02506101|846601|P1|STARTED|Overall Study||2
344486|NCT02505334|846617|P2|NOT COMPLETED|Extension Treatment Period||0
344487|NCT02505334|846618|P1|NOT COMPLETED|Extension Treatment Period||18
344488|NCT02505334|846617|P2|COMPLETED|Extension Treatment Period||0
344489|NCT02505334|846618|P1|COMPLETED|Extension Treatment Period||194
344490|NCT02505334|846617|P2|STARTED|Extension Treatment Period|This treatment arm is not considered for this period as the subjects were treated for 26 weeks|0
344491|NCT02505334|846618|P1|STARTED|Extension Treatment Period|6 subjects withdrew from the trial after the main period and prior to entering the extension period|212
344492|NCT02505334|846617|P2|NOT COMPLETED|Main Treatment Period||39
344493|NCT02505334|846618|P1|NOT COMPLETED|Main Treatment Period||15
344494|NCT02505334|846617|P2|COMPLETED|Main Treatment Period||194
344495|NCT02505334|846618|P1|COMPLETED|Main Treatment Period||218
344496|NCT02505334|846617|P2|STARTED|Main Treatment Period||233
344497|NCT02505334|846618|P1|STARTED|Main Treatment Period||233
344498|NCT02504931|846690|P2|NOT COMPLETED|Overall Study||10
344499|NCT02504931|846691|P1|NOT COMPLETED|Overall Study||12
344500|NCT02504931|846690|P2|COMPLETED|Overall Study||13
344501|NCT02504931|846691|P1|COMPLETED|Overall Study||14
344502|NCT02504931|846690|P2|STARTED|Overall Study||23
344503|NCT02504931|846691|P1|STARTED|Overall Study||26
344504|NCT02504775|846699|P2|NOT COMPLETED|Period 2||0
344505|NCT02504775|846700|P1|NOT COMPLETED|Period 2||0
344506|NCT02504775|846699|P2|COMPLETED|Period 2||14
344507|NCT02504775|846700|P1|COMPLETED|Period 2||14
344508|NCT02504775|846699|P2|STARTED|Period 2||14
344509|NCT02504775|846700|P1|STARTED|Period 2||14
344510|NCT02504775|846699|P2|NOT COMPLETED|Washout||0
344511|NCT02504775|846700|P1|NOT COMPLETED|Washout||0
344512|NCT02504775|846699|P2|COMPLETED|Washout||14
344513|NCT02504775|846700|P1|COMPLETED|Washout||14
344514|NCT02504775|846699|P2|STARTED|Washout||14
344515|NCT02504775|846700|P1|STARTED|Washout||14
344516|NCT02504775|846699|P2|NOT COMPLETED|Period 1||0
344517|NCT02504775|846700|P1|NOT COMPLETED|Period 1||0
344518|NCT02504775|846699|P2|COMPLETED|Period 1||14
344519|NCT02504775|846700|P1|COMPLETED|Period 1||14
344520|NCT02504775|846699|P2|STARTED|Period 1||14
344521|NCT02504775|846700|P1|STARTED|Period 1||14
344522|NCT02504723|846714|P2|NOT COMPLETED|Overall Study||0
344523|NCT02504723|846715|P1|NOT COMPLETED|Overall Study||0
344524|NCT02504723|846714|P2|COMPLETED|Overall Study||61
344525|NCT02504723|846715|P1|COMPLETED|Overall Study||60
344526|NCT02504723|846714|P2|STARTED|Overall Study||61
344527|NCT02504723|846715|P1|STARTED|Overall Study||60
344528|NCT02504541|846727|P1|NOT COMPLETED|Overall Study||20
344529|NCT02504541|846727|P1|COMPLETED|Overall Study||113
344530|NCT02504541|846727|P1|STARTED|Overall Study||133
344531|NCT02504502|846733|P2|NOT COMPLETED|Crossover to Enhanced Report||0
344532|NCT02504502|846734|P1|NOT COMPLETED|Crossover to Enhanced Report||5
344533|NCT02504502|846733|P2|COMPLETED|Crossover to Enhanced Report|the enhanced report arm was completed in first period and does not carry forward to period 2|0
344534|NCT02504502|846734|P1|COMPLETED|Crossover to Enhanced Report||15
344535|NCT02504502|846733|P2|STARTED|Crossover to Enhanced Report|The enhanced report arm was completed in first period and does not carry forward to period 2.|0
344536|NCT02504502|846734|P1|STARTED|Crossover to Enhanced Report||20
344537|NCT02504502|846733|P2|NOT COMPLETED|Routine Care vs. Enhanced Report||7
344538|NCT02504502|846734|P1|NOT COMPLETED|Routine Care vs. Enhanced Report||4
344539|NCT02504502|846733|P2|COMPLETED|Routine Care vs. Enhanced Report||21
344540|NCT02504502|846734|P1|COMPLETED|Routine Care vs. Enhanced Report||20
344541|NCT02504502|846733|P2|STARTED|Routine Care vs. Enhanced Report||28
344542|NCT02504502|846734|P1|STARTED|Routine Care vs. Enhanced Report||24
344543|NCT02504320|846744|P4|NOT COMPLETED|Treatment Period 4||0
344544|NCT02504320|846745|P3|NOT COMPLETED|Treatment Period 4||0
344545|NCT02504320|846746|P2|NOT COMPLETED|Treatment Period 4||0
344546|NCT02504320|846747|P1|NOT COMPLETED|Treatment Period 4||0
344547|NCT02504320|846744|P4|COMPLETED|Treatment Period 4||19
344548|NCT02504320|846745|P3|COMPLETED|Treatment Period 4||18
344549|NCT02504320|846746|P2|COMPLETED|Treatment Period 4||18
344550|NCT02504320|846747|P1|COMPLETED|Treatment Period 4||19
344551|NCT02504320|846744|P4|STARTED|Treatment Period 4||19
344552|NCT02504320|846745|P3|STARTED|Treatment Period 4||18
344553|NCT02504320|846746|P2|STARTED|Treatment Period 4||18
344554|NCT02504320|846747|P1|STARTED|Treatment Period 4||19
344555|NCT02504320|846744|P4|NOT COMPLETED|Treatment Period 3||1
344556|NCT02504320|846745|P3|NOT COMPLETED|Treatment Period 3||1
344557|NCT02504320|846746|P2|NOT COMPLETED|Treatment Period 3||0
344558|NCT02504320|846747|P1|NOT COMPLETED|Treatment Period 3||0
344559|NCT02504320|846744|P4|COMPLETED|Treatment Period 3||19
344560|NCT02504320|846745|P3|COMPLETED|Treatment Period 3||18
344561|NCT02504320|846746|P2|COMPLETED|Treatment Period 3||18
344562|NCT02504320|846747|P1|COMPLETED|Treatment Period 3||19
344563|NCT02504320|846744|P4|STARTED|Treatment Period 3||20
344564|NCT02504320|846745|P3|STARTED|Treatment Period 3||19
344565|NCT02504320|846746|P2|STARTED|Treatment Period 3||18
344566|NCT02504320|846747|P1|STARTED|Treatment Period 3||19
344567|NCT02504320|846744|P4|NOT COMPLETED|Treatment Period 2||0
344568|NCT02504320|846745|P3|NOT COMPLETED|Treatment Period 2||0
344569|NCT02504320|846746|P2|NOT COMPLETED|Treatment Period 2||1
344570|NCT02504320|846747|P1|NOT COMPLETED|Treatment Period 2||0
344571|NCT02504320|846744|P4|COMPLETED|Treatment Period 2||20
344572|NCT02504320|846745|P3|COMPLETED|Treatment Period 2||19
344573|NCT02504320|846746|P2|COMPLETED|Treatment Period 2||18
344574|NCT02504320|846747|P1|COMPLETED|Treatment Period 2||19
344575|NCT02504320|846744|P4|STARTED|Treatment Period 2||20
344576|NCT02504320|846745|P3|STARTED|Treatment Period 2||19
344577|NCT02504320|846746|P2|STARTED|Treatment Period 2||19
344578|NCT02504320|846747|P1|STARTED|Treatment Period 2||19
344579|NCT02504320|846744|P4|NOT COMPLETED|Treatment Period 1||0
344580|NCT02504320|846745|P3|NOT COMPLETED|Treatment Period 1||1
344581|NCT02504320|846746|P2|NOT COMPLETED|Treatment Period 1||0
344582|NCT02504320|846747|P1|NOT COMPLETED|Treatment Period 1||0
344583|NCT02504320|846744|P4|COMPLETED|Treatment Period 1||20
344584|NCT02504320|846745|P3|COMPLETED|Treatment Period 1||19
344585|NCT02504320|846746|P2|COMPLETED|Treatment Period 1||19
344586|NCT02504320|846747|P1|COMPLETED|Treatment Period 1||19
344587|NCT02504320|846744|P4|STARTED|Treatment Period 1||20
344588|NCT02504320|846745|P3|STARTED|Treatment Period 1||20
344589|NCT02504320|846746|P2|STARTED|Treatment Period 1||19
344590|NCT02504320|846747|P1|STARTED|Treatment Period 1||19
344591|NCT02504294|846767|P2|NOT COMPLETED|Overall Study||48
344592|NCT02504294|846768|P1|NOT COMPLETED|Overall Study||56
344593|NCT02504294|846767|P2|COMPLETED|Overall Study||158
344594|NCT02504294|846768|P1|COMPLETED|Overall Study||156
344595|NCT02504294|846767|P2|STARTED|Overall Study||206
344596|NCT02504294|846768|P1|STARTED|Overall Study||212
344597|NCT02504099|846776|P1|NOT COMPLETED|Overall Study||0
344598|NCT02504099|846776|P1|COMPLETED|Overall Study||3
344599|NCT02504099|846776|P1|STARTED|Overall Study||3
344600|NCT02504073|846784|P1|NOT COMPLETED|Overall Study||0
344601|NCT02504073|846784|P1|COMPLETED|Overall Study||54
344602|NCT02504073|846784|P1|STARTED|Overall Study||54
344603|NCT02503982|846790|P1|NOT COMPLETED|Overall Study||0
344604|NCT02503982|846790|P1|COMPLETED|Overall Study||13
344605|NCT02503982|846790|P1|STARTED|Overall Study||13
344606|NCT02503865|846797|P3|NOT COMPLETED|Overall Study||2
344607|NCT02503865|846798|P2|NOT COMPLETED|Overall Study||47
344608|NCT02503865|846799|P1|NOT COMPLETED|Overall Study||5
344609|NCT02503865|846797|P3|COMPLETED|Overall Study||64
344610|NCT02503865|846798|P2|COMPLETED|Overall Study||222
344611|NCT02503865|846799|P1|COMPLETED|Overall Study||65
344612|NCT02503865|846797|P3|STARTED|Overall Study||66
344613|NCT02503865|846798|P2|STARTED|Overall Study||269
344614|NCT02503865|846799|P1|STARTED|Overall Study||70
344615|NCT02503787|846819|P1|NOT COMPLETED|Implant to 3 Month Endpoint||3
344616|NCT02503787|846819|P1|COMPLETED|Implant to 3 Month Endpoint||29
344617|NCT02503787|846819|P1|STARTED|Implant to 3 Month Endpoint||32
344618|NCT02503787|846819|P1|NOT COMPLETED|Successful Trial (≥50% Pain Relief)||5
344619|NCT02503787|846819|P1|COMPLETED|Successful Trial (≥50% Pain Relief)||32
344620|NCT02503787|846819|P1|STARTED|Successful Trial (≥50% Pain Relief)||37
344621|NCT02503787|846819|P1|NOT COMPLETED|Device Trial (HD Programming Trial)||7
344622|NCT02503787|846819|P1|COMPLETED|Device Trial (HD Programming Trial)||37
344623|NCT02503787|846819|P1|STARTED|Device Trial (HD Programming Trial)||44
344624|NCT02503787|846819|P1|NOT COMPLETED|Enrollment||20
344625|NCT02503787|846819|P1|COMPLETED|Enrollment||44
344626|NCT02503787|846819|P1|STARTED|Enrollment||64
344627|NCT02503254|846828|P2|NOT COMPLETED|Overall Study||0
344628|NCT02503254|846829|P1|NOT COMPLETED|Overall Study||0
344629|NCT02503254|846828|P2|COMPLETED|Overall Study||39
344630|NCT02503254|846829|P1|COMPLETED|Overall Study||41
344631|NCT02503254|846828|P2|STARTED|Overall Study||39
344632|NCT02503254|846829|P1|STARTED|Overall Study||41
344633|NCT02503215|846842|P1|NOT COMPLETED|Overall Study||3
344634|NCT02503215|846842|P1|COMPLETED|Overall Study||14
344635|NCT02503215|846842|P1|STARTED|Overall Study||17
344636|NCT02503085|846848|P4|NOT COMPLETED|Period 4||0
344637|NCT02503085|846849|P3|NOT COMPLETED|Period 4||0
344638|NCT02503085|846850|P2|NOT COMPLETED|Period 4||0
344639|NCT02503085|846851|P1|NOT COMPLETED|Period 4||0
344640|NCT02503085|846848|P4|COMPLETED|Period 4||7
344641|NCT02503085|846849|P3|COMPLETED|Period 4||6
344642|NCT02503085|846850|P2|COMPLETED|Period 4||7
344643|NCT02503085|846851|P1|COMPLETED|Period 4||6
344644|NCT02503085|846848|P4|STARTED|Period 4||7
344645|NCT02503085|846849|P3|STARTED|Period 4||6
344646|NCT02503085|846850|P2|STARTED|Period 4||7
344647|NCT02503085|846851|P1|STARTED|Period 4||6
344648|NCT02503085|846848|P4|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
344649|NCT02503085|846849|P3|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
344650|NCT02503085|846850|P2|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
344651|NCT02503085|846851|P1|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
344652|NCT02503085|846848|P4|COMPLETED|Period 3: Washout (3 to 7 Days)||7
344653|NCT02503085|846849|P3|COMPLETED|Period 3: Washout (3 to 7 Days)||6
344654|NCT02503085|846850|P2|COMPLETED|Period 3: Washout (3 to 7 Days)||7
344655|NCT02503085|846851|P1|COMPLETED|Period 3: Washout (3 to 7 Days)||6
344656|NCT02503085|846848|P4|STARTED|Period 3: Washout (3 to 7 Days)||7
344657|NCT02503085|846849|P3|STARTED|Period 3: Washout (3 to 7 Days)||6
344658|NCT02503085|846850|P2|STARTED|Period 3: Washout (3 to 7 Days)||7
344659|NCT02503085|846851|P1|STARTED|Period 3: Washout (3 to 7 Days)||6
344660|NCT02503085|846848|P4|NOT COMPLETED|Period 3||0
344661|NCT02503085|846849|P3|NOT COMPLETED|Period 3||0
344662|NCT02503085|846850|P2|NOT COMPLETED|Period 3||0
344663|NCT02503085|846851|P1|NOT COMPLETED|Period 3||0
344664|NCT02503085|846848|P4|COMPLETED|Period 3||7
344665|NCT02503085|846849|P3|COMPLETED|Period 3||6
344666|NCT02503085|846850|P2|COMPLETED|Period 3||7
344667|NCT02503085|846851|P1|COMPLETED|Period 3||6
344668|NCT02503085|846848|P4|STARTED|Period 3||7
344669|NCT02503085|846849|P3|STARTED|Period 3||6
344670|NCT02503085|846850|P2|STARTED|Period 3||7
344671|NCT02503085|846851|P1|STARTED|Period 3||6
344672|NCT02503085|846848|P4|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
344673|NCT02503085|846849|P3|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||1
344674|NCT02503085|846850|P2|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
344675|NCT02503085|846851|P1|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||1
344676|NCT02503085|846848|P4|COMPLETED|Period 2: Washout (3 to 7 Days)||7
344677|NCT02503085|846849|P3|COMPLETED|Period 2: Washout (3 to 7 Days)||6
344678|NCT02503085|846850|P2|COMPLETED|Period 2: Washout (3 to 7 Days)||7
344679|NCT02503085|846851|P1|COMPLETED|Period 2: Washout (3 to 7 Days)||6
344680|NCT02503085|846848|P4|STARTED|Period 2: Washout (3 to 7 Days)||7
344681|NCT02503085|846849|P3|STARTED|Period 2: Washout (3 to 7 Days)||7
344682|NCT02503085|846850|P2|STARTED|Period 2: Washout (3 to 7 Days)||7
344683|NCT02503085|846851|P1|STARTED|Period 2: Washout (3 to 7 Days)||7
344684|NCT02503085|846848|P4|NOT COMPLETED|Period 2||0
344685|NCT02503085|846849|P3|NOT COMPLETED|Period 2||0
344686|NCT02503085|846850|P2|NOT COMPLETED|Period 2||0
344687|NCT02503085|846851|P1|NOT COMPLETED|Period 2||0
344688|NCT02503085|846848|P4|COMPLETED|Period 2||7
344689|NCT02503085|846849|P3|COMPLETED|Period 2||7
344690|NCT02503085|846850|P2|COMPLETED|Period 2||7
344691|NCT02503085|846851|P1|COMPLETED|Period 2||7
344692|NCT02503085|846848|P4|STARTED|Period 2||7
344693|NCT02503085|846849|P3|STARTED|Period 2||7
344694|NCT02503085|846850|P2|STARTED|Period 2||7
344695|NCT02503085|846851|P1|STARTED|Period 2||7
344696|NCT02503085|846848|P4|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
344697|NCT02503085|846849|P3|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
344698|NCT02503085|846850|P2|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
344699|NCT02503085|846851|P1|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
344700|NCT02503085|846848|P4|COMPLETED|Period 1: Washout (3 to 7 Days)||7
344701|NCT02503085|846849|P3|COMPLETED|Period 1: Washout (3 to 7 Days)||7
344702|NCT02503085|846850|P2|COMPLETED|Period 1: Washout (3 to 7 Days)||7
344703|NCT02503085|846851|P1|COMPLETED|Period 1: Washout (3 to 7 Days)||7
344704|NCT02503085|846848|P4|STARTED|Period 1: Washout (3 to 7 Days)||7
344705|NCT02503085|846849|P3|STARTED|Period 1: Washout (3 to 7 Days)||7
344706|NCT02503085|846850|P2|STARTED|Period 1: Washout (3 to 7 Days)||7
344707|NCT02503085|846851|P1|STARTED|Period 1: Washout (3 to 7 Days)||7
344708|NCT02503085|846848|P4|NOT COMPLETED|Period 1||0
344709|NCT02503085|846849|P3|NOT COMPLETED|Period 1||0
344710|NCT02503085|846850|P2|NOT COMPLETED|Period 1||0
344711|NCT02503085|846851|P1|NOT COMPLETED|Period 1||0
344712|NCT02503085|846848|P4|COMPLETED|Period 1||7
344713|NCT02503085|846849|P3|COMPLETED|Period 1||7
344714|NCT02503085|846850|P2|COMPLETED|Period 1||7
344715|NCT02503085|846851|P1|COMPLETED|Period 1||7
344716|NCT02503085|846848|P4|STARTED|Period 1||7
344717|NCT02503085|846849|P3|STARTED|Period 1||7
344718|NCT02503085|846850|P2|STARTED|Period 1||7
344719|NCT02503085|846851|P1|STARTED|Period 1||7
344720|NCT02502734|846890|P2|NOT COMPLETED|Double-blind Treatment Period 2||0
344721|NCT02502734|846891|P1|NOT COMPLETED|Double-blind Treatment Period 2||0
344722|NCT02502734|846890|P2|COMPLETED|Double-blind Treatment Period 2||30
344723|NCT02502734|846891|P1|COMPLETED|Double-blind Treatment Period 2||28
344724|NCT02502734|846890|P2|STARTED|Double-blind Treatment Period 2||30
344725|NCT02502734|846891|P1|STARTED|Double-blind Treatment Period 2||28
344726|NCT02502734|846890|P2|NOT COMPLETED|Washout Period||0
344727|NCT02502734|846891|P1|NOT COMPLETED|Washout Period||1
344728|NCT02502734|846890|P2|COMPLETED|Washout Period||30
344729|NCT02502734|846891|P1|COMPLETED|Washout Period||28
344730|NCT02502734|846890|P2|STARTED|Washout Period||30
344731|NCT02502734|846891|P1|STARTED|Washout Period||29
344732|NCT02502734|846890|P2|NOT COMPLETED|Double-blind Treatment Period 1||0
344733|NCT02502734|846891|P1|NOT COMPLETED|Double-blind Treatment Period 1||1
344734|NCT02502734|846890|P2|COMPLETED|Double-blind Treatment Period 1||30
344735|NCT02502734|846891|P1|COMPLETED|Double-blind Treatment Period 1||29
344736|NCT02502734|846890|P2|STARTED|Double-blind Treatment Period 1||30
344737|NCT02502734|846891|P1|STARTED|Double-blind Treatment Period 1||30
344738|NCT02502526|846902|P3|NOT COMPLETED|Overall Study||6
344739|NCT02502526|846903|P2|NOT COMPLETED|Overall Study||4
344740|NCT02502526|846904|P1|NOT COMPLETED|Overall Study||6
344741|NCT02502526|846902|P3|COMPLETED|Overall Study||55
344742|NCT02502526|846903|P2|COMPLETED|Overall Study||55
344743|NCT02502526|846904|P1|COMPLETED|Overall Study||56
344744|NCT02502526|846902|P3|Intent-to-Treat (ITT)|Overall Study||59
344745|NCT02502526|846903|P2|Intent-to-Treat (ITT)|Overall Study||57
344746|NCT02502526|846904|P1|Intent-to-Treat (ITT)|Overall Study||57
344747|NCT02502526|846902|P3|STARTED|Overall Study||61
344748|NCT02502526|846903|P2|STARTED|Overall Study||59
344749|NCT02502526|846904|P1|STARTED|Overall Study||62
344750|NCT02502487|846920|P3|NOT COMPLETED|Overall Study||0
344751|NCT02502487|846921|P2|NOT COMPLETED|Overall Study||0
344752|NCT02502487|846922|P1|NOT COMPLETED|Overall Study||0
344753|NCT02502487|846920|P3|COMPLETED|Overall Study||86
344754|NCT02502487|846921|P2|COMPLETED|Overall Study||86
344755|NCT02502487|846922|P1|COMPLETED|Overall Study||86
344756|NCT02502487|846920|P3|STARTED|Overall Study||86
344757|NCT02502487|846921|P2|STARTED|Overall Study||86
344758|NCT02502487|846922|P1|STARTED|Overall Study||86
344759|NCT02502149|846990|P5|NOT COMPLETED|Treatment Period||0
344760|NCT02502149|846991|P4|NOT COMPLETED|Treatment Period||0
344761|NCT02502149|846992|P3|NOT COMPLETED|Treatment Period||0
344762|NCT02502149|846993|P2|NOT COMPLETED|Treatment Period||0
344763|NCT02502149|846994|P1|NOT COMPLETED|Treatment Period||0
344764|NCT02502149|846990|P5|COMPLETED|Treatment Period||12
344765|NCT02502149|846991|P4|COMPLETED|Treatment Period||11
344766|NCT02502149|846992|P3|COMPLETED|Treatment Period||0
344767|NCT02502149|846993|P2|COMPLETED|Treatment Period||0
344768|NCT02502149|846994|P1|COMPLETED|Treatment Period||0
344769|NCT02502149|846990|P5|STARTED|Treatment Period||12
344770|NCT02502149|846991|P4|STARTED|Treatment Period||11
344771|NCT02502149|846992|P3|STARTED|Treatment Period||0
344772|NCT02502149|846993|P2|STARTED|Treatment Period||0
344773|NCT02502149|846994|P1|STARTED|Treatment Period||0
344774|NCT02502149|846990|P5|NOT COMPLETED|PK2 Assessment Period||0
344775|NCT02502149|846991|P4|NOT COMPLETED|PK2 Assessment Period||0
344776|NCT02502149|846992|P3|NOT COMPLETED|PK2 Assessment Period||0
344777|NCT02502149|846993|P2|NOT COMPLETED|PK2 Assessment Period||0
344778|NCT02502149|846994|P1|NOT COMPLETED|PK2 Assessment Period||0
344779|NCT02502149|846990|P5|COMPLETED|PK2 Assessment Period||0
344780|NCT02502149|846991|P4|COMPLETED|PK2 Assessment Period||0
344781|NCT02502149|846992|P3|COMPLETED|PK2 Assessment Period||12
344782|NCT02502149|846993|P2|COMPLETED|PK2 Assessment Period||11
344783|NCT02502149|846994|P1|COMPLETED|PK2 Assessment Period||0
344784|NCT02502149|846990|P5|STARTED|PK2 Assessment Period||0
344785|NCT02502149|846991|P4|STARTED|PK2 Assessment Period||0
344786|NCT02502149|846992|P3|STARTED|PK2 Assessment Period||12
344787|NCT02502149|846993|P2|STARTED|PK2 Assessment Period||11
344788|NCT02502149|846994|P1|STARTED|PK2 Assessment Period||0
344789|NCT02502149|846990|P5|NOT COMPLETED|Intermediate||0
344790|NCT02502149|846991|P4|NOT COMPLETED|Intermediate||0
344791|NCT02502149|846992|P3|NOT COMPLETED|Intermediate||0
344792|NCT02502149|846993|P2|NOT COMPLETED|Intermediate||0
344793|NCT02502149|846994|P1|NOT COMPLETED|Intermediate||1
344794|NCT02502149|846990|P5|COMPLETED|Intermediate||0
344795|NCT02502149|846991|P4|COMPLETED|Intermediate||0
344796|NCT02502149|846992|P3|COMPLETED|Intermediate||0
344797|NCT02502149|846993|P2|COMPLETED|Intermediate||0
344798|NCT02502149|846994|P1|COMPLETED|Intermediate||23
344799|NCT02502149|846990|P5|STARTED|Intermediate||0
344800|NCT02502149|846991|P4|STARTED|Intermediate||0
344801|NCT02502149|846992|P3|STARTED|Intermediate||0
344802|NCT02502149|846993|P2|STARTED|Intermediate||0
344803|NCT02502149|846994|P1|STARTED|Intermediate||24
344804|NCT02502149|846990|P5|NOT COMPLETED|PK1 Assessment Period||0
344805|NCT02502149|846991|P4|NOT COMPLETED|PK1 Assessment Period||0
344806|NCT02502149|846992|P3|NOT COMPLETED|PK1 Assessment Period||0
344807|NCT02502149|846993|P2|NOT COMPLETED|PK1 Assessment Period||0
344808|NCT02502149|846994|P1|NOT COMPLETED|PK1 Assessment Period||0
344809|NCT02502149|846990|P5|COMPLETED|PK1 Assessment Period||0
344810|NCT02502149|846991|P4|COMPLETED|PK1 Assessment Period||0
344811|NCT02502149|846992|P3|COMPLETED|PK1 Assessment Period||0
344812|NCT02502149|846993|P2|COMPLETED|PK1 Assessment Period||0
344813|NCT02502149|846994|P1|COMPLETED|PK1 Assessment Period||24
344814|NCT02502149|846990|P5|STARTED|PK1 Assessment Period||0
344815|NCT02502149|846991|P4|STARTED|PK1 Assessment Period||0
344816|NCT02502149|846992|P3|STARTED|PK1 Assessment Period||0
344817|NCT02502149|846993|P2|STARTED|PK1 Assessment Period||0
344818|NCT02502149|846994|P1|STARTED|PK1 Assessment Period||24
344819|NCT02501590|847115|P2|NOT COMPLETED|Overall Study||0
344820|NCT02501590|847116|P1|NOT COMPLETED|Overall Study||0
344821|NCT02501590|847115|P2|COMPLETED|Overall Study||35
344822|NCT02501590|847116|P1|COMPLETED|Overall Study||13
344823|NCT02501590|847115|P2|STARTED|Overall Study||35
344824|NCT02501590|847116|P1|STARTED|Overall Study||13
344825|NCT02500836|847125|P3|NOT COMPLETED|Overall Study||1
344826|NCT02500836|847126|P2|NOT COMPLETED|Overall Study||5
344827|NCT02500836|847127|P1|NOT COMPLETED|Overall Study||3
344828|NCT02500836|847125|P3|COMPLETED|Overall Study||127
344829|NCT02500836|847126|P2|COMPLETED|Overall Study||254
344830|NCT02500836|847127|P1|COMPLETED|Overall Study||256
344831|NCT02500836|847125|P3|STARTED|Overall Study||128
344832|NCT02500836|847126|P2|STARTED|Overall Study||259
344833|NCT02500836|847127|P1|STARTED|Overall Study||259
344834|NCT02500758|847138|P2|NOT COMPLETED|Second Intervention (2 Minutes)||2
344835|NCT02500758|847139|P1|NOT COMPLETED|Second Intervention (2 Minutes)||3
344836|NCT02500758|847138|P2|COMPLETED|Second Intervention (2 Minutes)||10
344837|NCT02500758|847139|P1|COMPLETED|Second Intervention (2 Minutes)||10
344838|NCT02500758|847138|P2|STARTED|Second Intervention (2 Minutes)||12
344839|NCT02500758|847139|P1|STARTED|Second Intervention (2 Minutes)||13
344840|NCT02500758|847138|P2|NOT COMPLETED|Washout (1 Week)||2
344841|NCT02500758|847139|P1|NOT COMPLETED|Washout (1 Week)||2
344842|NCT02500758|847138|P2|COMPLETED|Washout (1 Week)||12
344843|NCT02500758|847139|P1|COMPLETED|Washout (1 Week)||13
344844|NCT02500758|847138|P2|STARTED|Washout (1 Week)||14
344845|NCT02500758|847139|P1|STARTED|Washout (1 Week)||15
344846|NCT02500758|847138|P2|NOT COMPLETED|First Intervention (2 Minutes)||1
344847|NCT02500758|847139|P1|NOT COMPLETED|First Intervention (2 Minutes)||0
344848|NCT02500758|847138|P2|COMPLETED|First Intervention (2 Minutes)||14
344849|NCT02500758|847139|P1|COMPLETED|First Intervention (2 Minutes)||15
344850|NCT02500758|847138|P2|STARTED|First Intervention (2 Minutes)||15
344851|NCT02500758|847139|P1|STARTED|First Intervention (2 Minutes)||15
344852|NCT02500628|847149|P2|NOT COMPLETED|Overall Study||0
344853|NCT02500628|847150|P1|NOT COMPLETED|Overall Study||0
344854|NCT02500628|847149|P2|COMPLETED|Overall Study||23
344855|NCT02500628|847150|P1|COMPLETED|Overall Study||38
344856|NCT02500628|847149|P2|STARTED|Overall Study||23
344857|NCT02500628|847150|P1|STARTED|Overall Study||38
344858|NCT02500537|847162|P2|NOT COMPLETED|Overall Study||1
344859|NCT02500537|847163|P1|NOT COMPLETED|Overall Study||3
344860|NCT02500537|847162|P2|COMPLETED|Overall Study||39
344861|NCT02500537|847163|P1|COMPLETED|Overall Study||57
344862|NCT02500537|847162|P2|STARTED|Overall Study||40
344863|NCT02500537|847163|P1|STARTED|Overall Study||60
344864|NCT02500368|847181|P2|NOT COMPLETED|Second Intervention (1 Week)||0
344865|NCT02500368|847182|P1|NOT COMPLETED|Second Intervention (1 Week)||0
344866|NCT02500368|847181|P2|COMPLETED|Second Intervention (1 Week)||20
344867|NCT02500368|847182|P1|COMPLETED|Second Intervention (1 Week)||20
344868|NCT02500368|847181|P2|STARTED|Second Intervention (1 Week)||20
344869|NCT02500368|847182|P1|STARTED|Second Intervention (1 Week)||20
344870|NCT02500368|847181|P2|NOT COMPLETED|First Intervention (1 Week)||0
344871|NCT02500368|847182|P1|NOT COMPLETED|First Intervention (1 Week)||0
344872|NCT02500368|847181|P2|COMPLETED|First Intervention (1 Week)||20
344873|NCT02500368|847182|P1|COMPLETED|First Intervention (1 Week)||20
344874|NCT02500368|847181|P2|STARTED|First Intervention (1 Week)||20
344875|NCT02500368|847182|P1|STARTED|First Intervention (1 Week)||20
344876|NCT02500056|847232|P2|NOT COMPLETED|Overall Study||8
344877|NCT02500056|847233|P1|NOT COMPLETED|Overall Study||7
344878|NCT02500056|847232|P2|COMPLETED|Overall Study||65
344879|NCT02500056|847233|P1|COMPLETED|Overall Study||63
344880|NCT02500056|847232|P2|STARTED|Overall Study||73
344881|NCT02500056|847233|P1|STARTED|Overall Study||70
344882|NCT02499952|847243|P1|NOT COMPLETED|Overall Study||10
344883|NCT02499952|847243|P1|COMPLETED|Overall Study||2
344884|NCT02499952|847243|P1|STARTED|Overall Study||12
344885|NCT02499692|847250|P1|NOT COMPLETED|Overall Study||0
344886|NCT02499692|847250|P1|COMPLETED|Overall Study||103
344887|NCT02499692|847250|P1|STARTED|Overall Study||103
344888|NCT02499575|847261|P2|NOT COMPLETED|Overall Study||1
344889|NCT02499575|847262|P1|NOT COMPLETED|Overall Study||0
344890|NCT02499575|847261|P2|COMPLETED|Overall Study||0
344891|NCT02499575|847262|P1|COMPLETED|Overall Study||1
344892|NCT02499575|847261|P2|STARTED|Overall Study||1
344893|NCT02499575|847262|P1|STARTED|Overall Study||1
344894|NCT02498821|847274|P2|NOT COMPLETED|Overall Study||5
344895|NCT02498821|847275|P1|NOT COMPLETED|Overall Study||3
344896|NCT02498821|847274|P2|COMPLETED|Overall Study||60
344897|NCT02498821|847275|P1|COMPLETED|Overall Study||60
344898|NCT02498821|847274|P2|STARTED|Overall Study||65
344899|NCT02498821|847275|P1|STARTED|Overall Study||63
344900|NCT02498678|847304|P2|NOT COMPLETED|Overall Study||2
344901|NCT02498678|847305|P1|NOT COMPLETED|Overall Study||0
344902|NCT02498678|847304|P2|COMPLETED|Overall Study||23
344903|NCT02498678|847305|P1|COMPLETED|Overall Study||25
344904|NCT02498678|847304|P2|STARTED|Overall Study||25
344905|NCT02498678|847305|P1|STARTED|Overall Study||25
344906|NCT02498652|847321|P2|NOT COMPLETED|Overall Study||1
344907|NCT02498652|847322|P1|NOT COMPLETED|Overall Study||0
344908|NCT02498652|847321|P2|COMPLETED|Overall Study|One subject was withdrawn due to noncompliance/protocol violation|20
344909|NCT02498652|847322|P1|COMPLETED|Overall Study||20
344910|NCT02498652|847321|P2|STARTED|Overall Study||21
344911|NCT02498652|847322|P1|STARTED|Overall Study||20
344912|NCT02498522|847423|P2|NOT COMPLETED|Overall Study||2
344913|NCT02498522|847424|P1|NOT COMPLETED|Overall Study||2
344914|NCT02498522|847423|P2|COMPLETED|Overall Study||83
344915|NCT02498522|847424|P1|COMPLETED|Overall Study||83
344916|NCT02498522|847423|P2|STARTED|Overall Study||85
344917|NCT02498522|847424|P1|STARTED|Overall Study||85
344918|NCT02497976|847432|P2|NOT COMPLETED|Overall Study||1
344919|NCT02497976|847433|P1|NOT COMPLETED|Overall Study||2
344920|NCT02497976|847432|P2|COMPLETED|Overall Study||13
344921|NCT02497976|847433|P1|COMPLETED|Overall Study||26
344922|NCT02497976|847432|P2|STARTED|Overall Study||14
344923|NCT02497976|847433|P1|STARTED|Overall Study||28
344924|NCT02497781|847451|P2|NOT COMPLETED|Overall Study||3
344925|NCT02497781|847452|P1|NOT COMPLETED|Overall Study||4
344926|NCT02497781|847451|P2|COMPLETED|Overall Study||26
344927|NCT02497781|847452|P1|COMPLETED|Overall Study||64
344928|NCT02497781|847451|P2|Treated|Overall Study||28
344929|NCT02497781|847452|P1|Treated|Overall Study||67
344930|NCT02497781|847451|P2|STARTED|Overall Study||29
344931|NCT02497781|847452|P1|STARTED|Overall Study||68
344932|NCT02497755|847515|P2|NOT COMPLETED|Overall Study||0
344933|NCT02497755|847516|P1|NOT COMPLETED|Overall Study||1
344934|NCT02497755|847515|P2|COMPLETED|Overall Study||1
344935|NCT02497755|847516|P1|COMPLETED|Overall Study||17
344936|NCT02497755|847515|P2|STARTED|Overall Study||1
344937|NCT02497755|847516|P1|STARTED|Overall Study||18
344938|NCT02497235|847534|P5|NOT COMPLETED|Overall Study||0
344939|NCT02497235|847535|P4|NOT COMPLETED|Overall Study||0
344940|NCT02497235|847536|P3|NOT COMPLETED|Overall Study||0
344941|NCT02497235|847537|P2|NOT COMPLETED|Overall Study||0
344942|NCT02497235|847538|P1|NOT COMPLETED|Overall Study||0
344943|NCT02497235|847534|P5|COMPLETED|Overall Study||3
344944|NCT02497235|847535|P4|COMPLETED|Overall Study||2
344945|NCT02497235|847536|P3|COMPLETED|Overall Study||2
344946|NCT02497235|847537|P2|COMPLETED|Overall Study||2
344947|NCT02497235|847538|P1|COMPLETED|Overall Study||2
344948|NCT02497235|847534|P5|STARTED|Overall Study||3
344949|NCT02497235|847535|P4|STARTED|Overall Study||2
344950|NCT02497235|847536|P3|STARTED|Overall Study||2
344951|NCT02497235|847537|P2|STARTED|Overall Study||2
344952|NCT02497235|847538|P1|STARTED|Overall Study||2
344953|NCT02497040|847571|P3|NOT COMPLETED|Overall Study||0
344954|NCT02497040|847572|P2|NOT COMPLETED|Overall Study||0
344955|NCT02497040|847573|P1|NOT COMPLETED|Overall Study||0
344956|NCT02497040|847571|P3|COMPLETED|Overall Study||30
344957|NCT02497040|847572|P2|COMPLETED|Overall Study||30
344958|NCT02497040|847573|P1|COMPLETED|Overall Study||30
344959|NCT02497040|847571|P3|STARTED|Overall Study||30
344960|NCT02497040|847572|P2|STARTED|Overall Study||30
344961|NCT02497040|847573|P1|STARTED|Overall Study||30
344962|NCT02496533|847583|P2|NOT COMPLETED|Overall Study||6
344963|NCT02496533|847584|P1|NOT COMPLETED|Overall Study||3
344964|NCT02496533|847583|P2|COMPLETED|Overall Study||106
344965|NCT02496533|847584|P1|COMPLETED|Overall Study||102
344966|NCT02496533|847583|P2|STARTED|Overall Study||112
344967|NCT02496533|847584|P1|STARTED|Overall Study||105
344968|NCT02496221|847596|P2|NOT COMPLETED|Treatment Period 2 - 4 Days||1
344969|NCT02496221|847597|P1|NOT COMPLETED|Treatment Period 2 - 4 Days||2
344970|NCT02496221|847596|P2|COMPLETED|Treatment Period 2 - 4 Days||9
344971|NCT02496221|847597|P1|COMPLETED|Treatment Period 2 - 4 Days||8
344972|NCT02496221|847596|P2|STARTED|Treatment Period 2 - 4 Days||10
344973|NCT02496221|847597|P1|STARTED|Treatment Period 2 - 4 Days||10
344974|NCT02496221|847596|P2|NOT COMPLETED|Treatment Period 1 - 4 Days||0
344975|NCT02496221|847597|P1|NOT COMPLETED|Treatment Period 1 - 4 Days||0
344976|NCT02496221|847596|P2|COMPLETED|Treatment Period 1 - 4 Days||10
344977|NCT02496221|847597|P1|COMPLETED|Treatment Period 1 - 4 Days||10
344978|NCT02496221|847596|P2|STARTED|Treatment Period 1 - 4 Days||10
344979|NCT02496221|847597|P1|STARTED|Treatment Period 1 - 4 Days||10
344980|NCT02496039|847631|P1|NOT COMPLETED|Overall Study||4
344981|NCT02496039|847631|P1|COMPLETED|Overall Study||1
344982|NCT02496039|847631|P1|STARTED|Overall Study||5
344983|NCT02496000|847646|P3|NOT COMPLETED|Overall Study||2
344984|NCT02496000|847647|P2|NOT COMPLETED|Overall Study||5
344985|NCT02496000|847648|P1|NOT COMPLETED|Overall Study||2
344986|NCT02496000|847646|P3|COMPLETED|Overall Study||61
344987|NCT02496000|847647|P2|COMPLETED|Overall Study||56
344988|NCT02496000|847648|P1|COMPLETED|Overall Study||62
344989|NCT02496000|847646|P3|STARTED|Overall Study||63
344990|NCT02496000|847647|P2|STARTED|Overall Study||61
344991|NCT02496000|847648|P1|STARTED|Overall Study||64
344992|NCT02495948|847657|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
344993|NCT02495948|847658|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
344994|NCT02495948|847657|P2|COMPLETED|Period 2, Second 30 Days of Wear||82
344995|NCT02495948|847658|P1|COMPLETED|Period 2, Second 30 Days of Wear||82
344996|NCT02495948|847657|P2|STARTED|Period 2, Second 30 Days of Wear||83
344997|NCT02495948|847658|P1|STARTED|Period 2, Second 30 Days of Wear||83
344998|NCT02495948|847657|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||1
344999|NCT02495948|847658|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||0
345000|NCT02495948|847657|P2|COMPLETED|Period 1, First 30 Days of Wear||83
345001|NCT02495948|847658|P1|COMPLETED|Period 1, First 30 Days of Wear||83
345002|NCT02495948|847657|P2|STARTED|Period 1, First 30 Days of Wear||84
345003|NCT02495948|847658|P1|STARTED|Period 1, First 30 Days of Wear||83
345004|NCT02495831|847665|P2|NOT COMPLETED|Second Intervention||0
345005|NCT02495831|847666|P1|NOT COMPLETED|Second Intervention||0
345006|NCT02495831|847665|P2|COMPLETED|Second Intervention||10
345007|NCT02495831|847666|P1|COMPLETED|Second Intervention||12
345008|NCT02495831|847665|P2|STARTED|Second Intervention||10
345009|NCT02495831|847666|P1|STARTED|Second Intervention|One participant withdrew at the end of period 1|12
345010|NCT02495831|847665|P2|NOT COMPLETED|First Intervention||0
345011|NCT02495831|847666|P1|NOT COMPLETED|First Intervention||0
345012|NCT02495831|847665|P2|COMPLETED|First Intervention||10
345013|NCT02495831|847666|P1|COMPLETED|First Intervention||13
345014|NCT02495831|847665|P2|STARTED|First Intervention||10
345015|NCT02495831|847666|P1|STARTED|First Intervention||13
345016|NCT02495623|847683|P3|NOT COMPLETED|Overall Study||8
345017|NCT02495623|847684|P2|NOT COMPLETED|Overall Study||9
345018|NCT02495623|847685|P1|NOT COMPLETED|Overall Study||5
345019|NCT02495623|847683|P3|COMPLETED|Overall Study||20
345020|NCT02495623|847684|P2|COMPLETED|Overall Study||17
345021|NCT02495623|847685|P1|COMPLETED|Overall Study||20
345022|NCT02495623|847683|P3|Dosed|Overall Study||22
345023|NCT02495623|847684|P2|Dosed|Overall Study||19
345024|NCT02495623|847685|P1|Dosed|Overall Study||22
345025|NCT02495623|847683|P3|STARTED|Overall Study||28
345026|NCT02495623|847684|P2|STARTED|Overall Study||26
345027|NCT02495623|847685|P1|STARTED|Overall Study||25
345028|NCT02495038|847696|P3|NOT COMPLETED|Overall Study||0
345029|NCT02495038|847697|P2|NOT COMPLETED|Overall Study||0
345030|NCT02495038|847698|P1|NOT COMPLETED|Overall Study||0
345031|NCT02495038|847696|P3|COMPLETED|Overall Study||27
345032|NCT02495038|847697|P2|COMPLETED|Overall Study||27
345033|NCT02495038|847698|P1|COMPLETED|Overall Study||27
345034|NCT02495038|847696|P3|STARTED|Overall Study||27
345035|NCT02495038|847697|P2|STARTED|Overall Study||27
345036|NCT02495038|847698|P1|STARTED|Overall Study||27
345037|NCT02494596|847733|P3|NOT COMPLETED|Overall Study||1
345038|NCT02494596|847734|P2|NOT COMPLETED|Overall Study||5
345039|NCT02494596|847735|P1|NOT COMPLETED|Overall Study||3
345040|NCT02494596|847733|P3|COMPLETED|Overall Study||6
345041|NCT02494596|847734|P2|COMPLETED|Overall Study||2
345042|NCT02494596|847735|P1|COMPLETED|Overall Study||2
345043|NCT02494596|847733|P3|STARTED|Overall Study||7
345044|NCT02494596|847734|P2|STARTED|Overall Study||7
345045|NCT02494596|847735|P1|STARTED|Overall Study||5
345046|NCT02494440|847760|P1|NOT COMPLETED|Overall Study||0
345047|NCT02494440|847760|P1|COMPLETED|Overall Study||90
345048|NCT02494440|847760|P1|STARTED|Overall Study||90
345049|NCT02494323|847766|P1|NOT COMPLETED|Overall Study||0
345050|NCT02494323|847766|P1|COMPLETED|Overall Study||70
345051|NCT02494323|847766|P1|STARTED|Overall Study||70
345052|NCT02494076|847773|P2|NOT COMPLETED|Overall Study||0
345053|NCT02494076|847774|P1|NOT COMPLETED|Overall Study||0
345054|NCT02494076|847773|P2|COMPLETED|Overall Study||26
345055|NCT02494076|847774|P1|COMPLETED|Overall Study||26
345056|NCT02494076|847773|P2|STARTED|Overall Study||26
345057|NCT02494076|847774|P1|STARTED|Overall Study||26
345058|NCT02493855|847787|P3|NOT COMPLETED|Overall Study||0
345059|NCT02493855|847788|P2|NOT COMPLETED|Overall Study||1
345060|NCT02493855|847789|P1|NOT COMPLETED|Overall Study||2
345061|NCT02493855|847787|P3|COMPLETED|Overall Study||6
345062|NCT02493855|847788|P2|COMPLETED|Overall Study||18
345063|NCT02493855|847789|P1|COMPLETED|Overall Study||19
345064|NCT02493855|847787|P3|STARTED|Overall Study||6
345065|NCT02493855|847788|P2|STARTED|Overall Study||19
345066|NCT02493855|847789|P1|STARTED|Overall Study||21
345067|NCT02493127|847799|P2|NOT COMPLETED|Overall Study||1
345068|NCT02493127|847800|P1|NOT COMPLETED|Overall Study||1
345069|NCT02493127|847799|P2|COMPLETED|Overall Study||60
345070|NCT02493127|847800|P1|COMPLETED|Overall Study||60
345071|NCT02493127|847799|P2|STARTED|Overall Study||61
345072|NCT02493127|847800|P1|STARTED|Overall Study||61
345073|NCT02493088|847812|P1|NOT COMPLETED|Overall Study||0
345074|NCT02493088|847812|P1|COMPLETED|Overall Study||11
345075|NCT02493088|847812|P1|STARTED|Overall Study||11
345076|NCT02493036|847821|P3|NOT COMPLETED|Overall Study||2
345077|NCT02493036|847822|P2|NOT COMPLETED|Overall Study||2
345078|NCT02493036|847823|P1|NOT COMPLETED|Overall Study||1
345079|NCT02493036|847821|P3|COMPLETED|Overall Study||15
345080|NCT02493036|847822|P2|COMPLETED|Overall Study||18
345081|NCT02493036|847823|P1|COMPLETED|Overall Study||16
345082|NCT02493036|847821|P3|STARTED|Overall Study||17
345083|NCT02493036|847822|P2|STARTED|Overall Study||20
345084|NCT02493036|847823|P1|STARTED|Overall Study||17
345085|NCT02492984|847833|P2|NOT COMPLETED|Overall Study||0
345086|NCT02492984|847834|P1|NOT COMPLETED|Overall Study||3
345087|NCT02492984|847833|P2|COMPLETED|Overall Study||14
345088|NCT02492984|847834|P1|COMPLETED|Overall Study||70
345089|NCT02492984|847833|P2|STARTED|Overall Study||14
345090|NCT02492984|847834|P1|STARTED|Overall Study||73
345091|NCT02492841|847857|P3|NOT COMPLETED|Overall Study||35
345092|NCT02492841|847858|P2|NOT COMPLETED|Overall Study||31
345093|NCT02492841|847859|P1|NOT COMPLETED|Overall Study||34
345094|NCT02492841|847857|P3|COMPLETED|Overall Study||25
345095|NCT02492841|847858|P2|COMPLETED|Overall Study||22
345096|NCT02492841|847859|P1|COMPLETED|Overall Study||22
345097|NCT02492841|847857|P3|STARTED|Overall Study||60
345098|NCT02492841|847858|P2|STARTED|Overall Study||53
345099|NCT02492841|847859|P1|STARTED|Overall Study||56
345100|NCT02492763|847874|P4|NOT COMPLETED|Overall Study||13
345101|NCT02492763|847875|P3|NOT COMPLETED|Overall Study||10
345102|NCT02492763|847876|P2|NOT COMPLETED|Overall Study||15
345103|NCT02492763|847877|P1|NOT COMPLETED|Overall Study||16
345104|NCT02492763|847874|P4|COMPLETED|Overall Study||30
345105|NCT02492763|847875|P3|COMPLETED|Overall Study||33
345106|NCT02492763|847876|P2|COMPLETED|Overall Study||29
345107|NCT02492763|847877|P1|COMPLETED|Overall Study||30
345108|NCT02492763|847874|P4|Treated|Overall Study||42
345109|NCT02492763|847875|P3|Treated|Overall Study||43
345110|NCT02492763|847876|P2|Treated|Overall Study||44
345111|NCT02492763|847877|P1|Treated|Overall Study||46
345112|NCT02492763|847874|P4|STARTED|Overall Study||43
345113|NCT02492763|847875|P3|STARTED|Overall Study||43
345114|NCT02492763|847876|P2|STARTED|Overall Study||44
345115|NCT02492763|847877|P1|STARTED|Overall Study||46
345116|NCT02492451|847934|P3|NOT COMPLETED|Overall Study||0
345117|NCT02492451|847935|P2|NOT COMPLETED|Overall Study||0
345118|NCT02492451|847936|P1|NOT COMPLETED|Overall Study||0
345119|NCT02492451|847934|P3|COMPLETED|Overall Study||39
345120|NCT02492451|847935|P2|COMPLETED|Overall Study||39
345121|NCT02492451|847936|P1|COMPLETED|Overall Study||40
345122|NCT02492451|847934|P3|STARTED|Overall Study||39
345123|NCT02492451|847935|P2|STARTED|Overall Study||39
345124|NCT02492451|847936|P1|STARTED|Overall Study||40
345125|NCT02492165|847948|P4|NOT COMPLETED|Overall Study||0
345126|NCT02492165|847949|P3|NOT COMPLETED|Overall Study||0
345127|NCT02492165|847950|P2|NOT COMPLETED|Overall Study||1
345128|NCT02492165|847951|P1|NOT COMPLETED|Overall Study||0
345129|NCT02492165|847948|P4|COMPLETED|Overall Study||30
345130|NCT02492165|847949|P3|COMPLETED|Overall Study||60
345131|NCT02492165|847950|P2|COMPLETED|Overall Study||59
345132|NCT02492165|847951|P1|COMPLETED|Overall Study||100
345133|NCT02492165|847948|P4|STARTED|Overall Study||30
345134|NCT02492165|847949|P3|STARTED|Overall Study||60
345135|NCT02492165|847950|P2|STARTED|Overall Study||60
345136|NCT02492165|847951|P1|STARTED|Overall Study||100
345137|NCT02491944|847973|P1|NOT COMPLETED|Overall Study||0
345138|NCT02491944|847973|P1|COMPLETED|Overall Study||10
345139|NCT02491944|847973|P1|STARTED|Overall Study||10
345140|NCT02491892|847995|P2|NOT COMPLETED|Overall Study||38
345141|NCT02491892|847996|P1|NOT COMPLETED|Overall Study||41
345142|NCT02491892|847995|P2|COMPLETED|Overall Study||0
345143|NCT02491892|847996|P1|COMPLETED|Overall Study||0
345144|NCT02491892|847995|P2|Treated|Overall Study|One participant was randomized but died before receiving study medication.|37
345145|NCT02491892|847996|P1|Treated|Overall Study||41
345146|NCT02491892|847995|P2|STARTED|Overall Study||38
345147|NCT02491892|847996|P1|STARTED|Overall Study||41
345148|NCT02491073|848042|P2|NOT COMPLETED|Overall Study||0
345149|NCT02491073|848043|P1|NOT COMPLETED|Overall Study||1
345150|NCT02491073|848042|P2|COMPLETED|Overall Study||34
345151|NCT02491073|848043|P1|COMPLETED|Overall Study||36
345152|NCT02491073|848042|P2|STARTED|Overall Study||34
345153|NCT02491073|848043|P1|STARTED|Overall Study||37
345154|NCT02490670|848071|P2|NOT COMPLETED|Period 2 (19 Days)||0
345155|NCT02490670|848072|P1|NOT COMPLETED|Period 2 (19 Days)||0
345156|NCT02490670|848071|P2|COMPLETED|Period 2 (19 Days)||14
345157|NCT02490670|848072|P1|COMPLETED|Period 2 (19 Days)||14
345158|NCT02490670|848071|P2|STARTED|Period 2 (19 Days)||14
345159|NCT02490670|848072|P1|STARTED|Period 2 (19 Days)||14
345160|NCT02490670|848071|P2|NOT COMPLETED|Washout Period (7 Days)||0
345161|NCT02490670|848072|P1|NOT COMPLETED|Washout Period (7 Days)||0
345162|NCT02490670|848071|P2|COMPLETED|Washout Period (7 Days)||14
345163|NCT02490670|848072|P1|COMPLETED|Washout Period (7 Days)||14
345164|NCT02490670|848071|P2|STARTED|Washout Period (7 Days)||14
345165|NCT02490670|848072|P1|STARTED|Washout Period (7 Days)||14
345166|NCT02490670|848071|P2|NOT COMPLETED|Period 1 (19 Days)||0
345167|NCT02490670|848072|P1|NOT COMPLETED|Period 1 (19 Days)||0
345168|NCT02490670|848071|P2|COMPLETED|Period 1 (19 Days)||14
345169|NCT02490670|848072|P1|COMPLETED|Period 1 (19 Days)||14
345170|NCT02490670|848071|P2|STARTED|Period 1 (19 Days)||14
345171|NCT02490670|848072|P1|STARTED|Period 1 (19 Days)||14
345172|NCT02490475|848084|P4|NOT COMPLETED|Period 2: Extension Phase||1
345173|NCT02490475|848085|P3|NOT COMPLETED|Period 2: Extension Phase||3
345174|NCT02490475|848086|P2|NOT COMPLETED|Period 2: Extension Phase||0
345175|NCT02490475|848087|P1|NOT COMPLETED|Period 2: Extension Phase||1
345176|NCT02490475|848084|P4|COMPLETED|Period 2: Extension Phase||0
345177|NCT02490475|848085|P3|COMPLETED|Period 2: Extension Phase||0
345178|NCT02490475|848086|P2|COMPLETED|Period 2: Extension Phase||0
345179|NCT02490475|848087|P1|COMPLETED|Period 2: Extension Phase||0
345180|NCT02490475|848084|P4|STARTED|Period 2: Extension Phase||1
345181|NCT02490475|848085|P3|STARTED|Period 2: Extension Phase||3
345182|NCT02490475|848086|P2|STARTED|Period 2: Extension Phase||0
345183|NCT02490475|848087|P1|STARTED|Period 2: Extension Phase||1
345184|NCT02490475|848084|P4|NOT COMPLETED|Period 1: First 6 Cycles||5
345185|NCT02490475|848085|P3|NOT COMPLETED|Period 1: First 6 Cycles||6
345186|NCT02490475|848086|P2|NOT COMPLETED|Period 1: First 6 Cycles||2
345187|NCT02490475|848087|P1|NOT COMPLETED|Period 1: First 6 Cycles||6
345188|NCT02490475|848084|P4|COMPLETED|Period 1: First 6 Cycles||0
345189|NCT02490475|848085|P3|COMPLETED|Period 1: First 6 Cycles||0
345190|NCT02490475|848086|P2|COMPLETED|Period 1: First 6 Cycles||0
345191|NCT02490475|848087|P1|COMPLETED|Period 1: First 6 Cycles||0
345192|NCT02490475|848084|P4|STARTED|Period 1: First 6 Cycles||5
345193|NCT02490475|848085|P3|STARTED|Period 1: First 6 Cycles||6
345194|NCT02490475|848086|P2|STARTED|Period 1: First 6 Cycles||2
345195|NCT02490475|848087|P1|STARTED|Period 1: First 6 Cycles||6
345196|NCT02490293|848165|P2|NOT COMPLETED|Overall Study||3
345197|NCT02490293|848166|P1|NOT COMPLETED|Overall Study||2
345198|NCT02490293|848165|P2|COMPLETED|Overall Study||99
345199|NCT02490293|848166|P1|COMPLETED|Overall Study||94
345200|NCT02490293|848165|P2|STARTED|Overall Study||102
345201|NCT02490293|848166|P1|STARTED|Overall Study||96
345202|NCT02489799|848176|P2|NOT COMPLETED|Overall Study||9
345203|NCT02489799|848177|P1|NOT COMPLETED|Overall Study||9
345204|NCT02489799|848176|P2|COMPLETED|Overall Study||38
345205|NCT02489799|848177|P1|COMPLETED|Overall Study||36
345206|NCT02489799|848176|P2|Postsurgical One Week Visit (V3)|Overall Study||39
345207|NCT02489799|848177|P1|Postsurgical One Week Visit (V3)|Overall Study||40
345208|NCT02489799|848176|P2|Presurgical Consent Visit (V2)|Overall Study||39
345209|NCT02489799|848177|P1|Presurgical Consent Visit (V2)|Overall Study||40
345210|NCT02489799|848176|P2|STARTED|Overall Study||47
345211|NCT02489799|848177|P1|STARTED|Overall Study||45
345212|NCT02488980|848204|P3|NOT COMPLETED|Overall Study||2
345213|NCT02488980|848205|P2|NOT COMPLETED|Overall Study||2
345214|NCT02488980|848206|P1|NOT COMPLETED|Overall Study||2
345215|NCT02488980|848204|P3|COMPLETED|Overall Study||99
345216|NCT02488980|848205|P2|COMPLETED|Overall Study||99
345217|NCT02488980|848206|P1|COMPLETED|Overall Study||102
345218|NCT02488980|848204|P3|STARTED|Overall Study||101
345219|NCT02488980|848205|P2|STARTED|Overall Study||101
345220|NCT02488980|848206|P1|STARTED|Overall Study||104
345221|NCT02488681|848223|P1|NOT COMPLETED|Overall Study||7
345222|NCT02488681|848223|P1|COMPLETED|Overall Study|Patients successfully implanted with Micra|269
345223|NCT02488681|848223|P1|STARTED|Overall Study|Patients with Micra implant attempt|276
345224|NCT02488317|848229|P2|NOT COMPLETED|Overall Study||47
345225|NCT02488317|848230|P1|NOT COMPLETED|Overall Study||54
345226|NCT02488317|848229|P2|COMPLETED|Overall Study||70
345227|NCT02488317|848230|P1|COMPLETED|Overall Study||63
345228|NCT02488317|848229|P2|STARTED|Overall Study||117
345229|NCT02488317|848230|P1|STARTED|Overall Study||117
345230|NCT02488070|848244|P1|NOT COMPLETED|Overall Study||0
345231|NCT02488070|848244|P1|COMPLETED|Overall Study||10
345232|NCT02488070|848244|P1|STARTED|Overall Study||10
345233|NCT02488018|848252|P1|NOT COMPLETED|Overall Study||0
345234|NCT02488018|848252|P1|COMPLETED|Overall Study||10
345235|NCT02488018|848252|P1|STARTED|Overall Study||10
345236|NCT02487771|848258|P2|NOT COMPLETED|Overall Study||14
345237|NCT02487771|848259|P1|NOT COMPLETED|Overall Study||10
345238|NCT02487771|848258|P2|COMPLETED|Overall Study||85
345239|NCT02487771|848259|P1|COMPLETED|Overall Study||81
345240|NCT02487771|848258|P2|STARTED|Overall Study||99
345241|NCT02487771|848259|P1|STARTED|Overall Study||91
345242|NCT02487498|848409|P2|NOT COMPLETED|Period: Period 2||5
345243|NCT02487498|848410|P1|NOT COMPLETED|Period: Period 2||6
345244|NCT02487498|848409|P2|COMPLETED|Period: Period 2||154
345245|NCT02487498|848410|P1|COMPLETED|Period: Period 2||164
345246|NCT02487498|848409|P2|STARTED|Period: Period 2||159
345247|NCT02487498|848410|P1|STARTED|Period: Period 2||170
345248|NCT02487498|848409|P2|NOT COMPLETED|Period: Washout||7
345249|NCT02487498|848410|P1|NOT COMPLETED|Period: Washout||2
345250|NCT02487498|848409|P2|COMPLETED|Period: Washout||159
345251|NCT02487498|848410|P1|COMPLETED|Period: Washout||170
345252|NCT02487498|848409|P2|STARTED|Period: Washout||166
345253|NCT02487498|848410|P1|STARTED|Period: Washout||172
345254|NCT02487498|848409|P2|NOT COMPLETED|Period: Period 1||11
345255|NCT02487498|848410|P1|NOT COMPLETED|Period: Period 1||6
345256|NCT02487498|848409|P2|COMPLETED|Period: Period 1||166
345257|NCT02487498|848410|P1|COMPLETED|Period: Period 1||172
345258|NCT02487498|848409|P2|STARTED|Period: Period 1||177
345259|NCT02487498|848410|P1|STARTED|Period: Period 1||178
345260|NCT02487446|848433|P2|NOT COMPLETED|Period 2||5
345261|NCT02487446|848434|P1|NOT COMPLETED|Period 2||8
345262|NCT02487446|848433|P2|COMPLETED|Period 2||158
345263|NCT02487446|848434|P1|COMPLETED|Period 2||154
345264|NCT02487446|848433|P2|STARTED|Period 2||163
345265|NCT02487446|848434|P1|STARTED|Period 2||162
345266|NCT02487446|848433|P2|NOT COMPLETED|Washout||8
345267|NCT02487446|848434|P1|NOT COMPLETED|Washout||3
345268|NCT02487446|848433|P2|COMPLETED|Washout||163
345269|NCT02487446|848434|P1|COMPLETED|Washout||162
345270|NCT02487446|848433|P2|STARTED|Washout||171
345271|NCT02487446|848434|P1|STARTED|Washout||165
345272|NCT02487446|848433|P2|NOT COMPLETED|Period 1||8
345273|NCT02487446|848434|P1|NOT COMPLETED|Period 1||13
345274|NCT02487446|848433|P2|COMPLETED|Period 1||171
345275|NCT02487446|848434|P1|COMPLETED|Period 1||165
345276|NCT02487446|848433|P2|STARTED|Period 1||179
345277|NCT02487446|848434|P1|STARTED|Period 1||178
345278|NCT02487199|848459|P2|NOT COMPLETED|Overall Study||1
345279|NCT02487199|848460|P1|NOT COMPLETED|Overall Study||0
345280|NCT02487199|848459|P2|COMPLETED|Overall Study||4
345281|NCT02487199|848460|P1|COMPLETED|Overall Study||13
345282|NCT02487199|848459|P2|STARTED|Overall Study||5
345283|NCT02487199|848460|P1|STARTED|Overall Study||13
345284|NCT02487030|848479|P7|NOT COMPLETED|Overall Study||0
345285|NCT02487030|848480|P6|NOT COMPLETED|Overall Study||1
345286|NCT02487030|848481|P5|NOT COMPLETED|Overall Study||2
345287|NCT02487030|848482|P4|NOT COMPLETED|Overall Study||2
345288|NCT02487030|848483|P3|NOT COMPLETED|Overall Study||2
345289|NCT02487030|848484|P2|NOT COMPLETED|Overall Study||4
345290|NCT02487030|848485|P1|NOT COMPLETED|Overall Study||2
345291|NCT02487030|848479|P7|COMPLETED|Overall Study||11
345292|NCT02487030|848480|P6|COMPLETED|Overall Study||37
345293|NCT02487030|848481|P5|COMPLETED|Overall Study||34
345294|NCT02487030|848482|P4|COMPLETED|Overall Study||40
345295|NCT02487030|848483|P3|COMPLETED|Overall Study||41
345296|NCT02487030|848484|P2|COMPLETED|Overall Study||38
345297|NCT02487030|848485|P1|COMPLETED|Overall Study||41
345298|NCT02487030|848479|P7|STARTED|Overall Study||11
345299|NCT02487030|848480|P6|STARTED|Overall Study||38
345300|NCT02487030|848481|P5|STARTED|Overall Study||36
345301|NCT02487030|848482|P4|STARTED|Overall Study||42
345302|NCT02487030|848483|P3|STARTED|Overall Study||43
345303|NCT02487030|848484|P2|STARTED|Overall Study||42
345304|NCT02487030|848485|P1|STARTED|Overall Study||43
345305|NCT02486952|848516|P1|NOT COMPLETED|Overall Study||50
345306|NCT02486952|848516|P1|COMPLETED|Overall Study||104
345307|NCT02486952|848516|P1|Started Induction Therapy|Overall Study||151
345308|NCT02486952|848516|P1|STARTED|Overall Study||154
345309|NCT02485483|848523|P2|NOT COMPLETED|Overall Study||0
345310|NCT02485483|848524|P1|NOT COMPLETED|Overall Study||54
345311|NCT02485483|848523|P2|COMPLETED|Overall Study||1015
345312|NCT02485483|848524|P1|COMPLETED|Overall Study||223
345313|NCT02485483|848523|P2|STARTED|Overall Study||1015
345314|NCT02485483|848524|P1|STARTED|Overall Study||277
345315|NCT02485353|848539|P1|NOT COMPLETED|Overall Study||2
345316|NCT02485353|848539|P1|COMPLETED|Overall Study||0
345317|NCT02485353|848539|P1|STARTED|Overall Study||2
345318|NCT02485301|848546|P2|NOT COMPLETED|Overall Study||49
345319|NCT02485301|848547|P1|NOT COMPLETED|Overall Study||38
345320|NCT02485301|848546|P2|COMPLETED|Overall Study||1455
345321|NCT02485301|848547|P1|COMPLETED|Overall Study||1471
345322|NCT02485301|848546|P2|STARTED|Overall Study||1504
345323|NCT02485301|848547|P1|STARTED|Overall Study||1509
345324|NCT02485158|848597|P1|NOT COMPLETED|Overall Study||4
345325|NCT02485158|848597|P1|COMPLETED|Overall Study||24
345326|NCT02485158|848597|P1|STARTED|Overall Study||28
345327|NCT02484911|848686|P2|NOT COMPLETED|Overall Study||2
345328|NCT02484911|848687|P1|NOT COMPLETED|Overall Study||4
345329|NCT02484911|848686|P2|COMPLETED|Overall Study||58
345330|NCT02484911|848687|P1|COMPLETED|Overall Study||56
345331|NCT02484911|848686|P2|STARTED|Overall Study||60
345332|NCT02484911|848687|P1|STARTED|Overall Study||60
345333|NCT02484898|848715|P1|NOT COMPLETED|Overall Study||18
345334|NCT02484898|848715|P1|COMPLETED|Overall Study||182
345335|NCT02484898|848715|P1|STARTED|Overall Study||200
345336|NCT02484729|848729|P10|NOT COMPLETED|Overall Study||1
345337|NCT02484729|848730|P9|NOT COMPLETED|Overall Study||0
345338|NCT02484729|848731|P8|NOT COMPLETED|Overall Study||0
345339|NCT02484729|848732|P7|NOT COMPLETED|Overall Study||0
345340|NCT02484729|848733|P6|NOT COMPLETED|Overall Study||0
345341|NCT02484729|848734|P5|NOT COMPLETED|Overall Study||0
345342|NCT02484729|848735|P4|NOT COMPLETED|Overall Study||0
345343|NCT02484729|848736|P3|NOT COMPLETED|Overall Study||0
345344|NCT02484729|848737|P2|NOT COMPLETED|Overall Study||0
345345|NCT02484729|848738|P1|NOT COMPLETED|Overall Study||0
345346|NCT02484729|848729|P10|COMPLETED|Overall Study||7
345347|NCT02484729|848730|P9|COMPLETED|Overall Study||6
345348|NCT02484729|848731|P8|COMPLETED|Overall Study||6
345349|NCT02484729|848732|P7|COMPLETED|Overall Study||5
345350|NCT02484729|848733|P6|COMPLETED|Overall Study||6
345351|NCT02484729|848734|P5|COMPLETED|Overall Study||5
345352|NCT02484729|848735|P4|COMPLETED|Overall Study||6
345353|NCT02484729|848736|P3|COMPLETED|Overall Study||6
345354|NCT02484729|848737|P2|COMPLETED|Overall Study||6
345355|NCT02484729|848738|P1|COMPLETED|Overall Study||16
345356|NCT02484729|848729|P10|STARTED|Overall Study||8
345357|NCT02484729|848730|P9|STARTED|Overall Study||6
345358|NCT02484729|848731|P8|STARTED|Overall Study||6
345359|NCT02484729|848732|P7|STARTED|Overall Study||5
345360|NCT02484729|848733|P6|STARTED|Overall Study||6
345361|NCT02484729|848734|P5|STARTED|Overall Study||5
345362|NCT02484729|848735|P4|STARTED|Overall Study||6
345363|NCT02484729|848736|P3|STARTED|Overall Study||6
345364|NCT02484729|848737|P2|STARTED|Overall Study||6
345365|NCT02484729|848738|P1|STARTED|Overall Study||16
345366|NCT02483975|848936|P2|NOT COMPLETED|Overall Study||2
345367|NCT02483975|848937|P1|NOT COMPLETED|Overall Study||2
345368|NCT02483975|848936|P2|COMPLETED|Overall Study|Subject reported as not completed due to AE was discontinued due to exacerbation, was not an AE/SAE|53
345369|NCT02483975|848937|P1|COMPLETED|Overall Study||54
345370|NCT02483975|848936|P2|STARTED|Overall Study||55
345371|NCT02483975|848937|P1|STARTED|Overall Study||56
345372|NCT02483611|848954|P3|NOT COMPLETED|Overall Study||1
345373|NCT02483611|848955|P2|NOT COMPLETED|Overall Study||0
345374|NCT02483611|848956|P1|NOT COMPLETED|Overall Study||0
345375|NCT02483611|848954|P3|COMPLETED|Overall Study|One patient required decurarization|15
345376|NCT02483611|848955|P2|COMPLETED|Overall Study||16
345377|NCT02483611|848956|P1|COMPLETED|Overall Study||16
345378|NCT02483611|848954|P3|STARTED|Overall Study||16
345379|NCT02483611|848955|P2|STARTED|Overall Study||16
345380|NCT02483611|848956|P1|STARTED|Overall Study||16
345381|NCT02483585|849053|P2|NOT COMPLETED|Open-label Treatment Phase||25
345382|NCT02483585|849054|P1|NOT COMPLETED|Open-label Treatment Phase||27
345383|NCT02483585|849053|P2|COMPLETED|Open-label Treatment Phase||243
345384|NCT02483585|849054|P1|COMPLETED|Open-label Treatment Phase||243
345385|NCT02483585|849053|P2|STARTED|Open-label Treatment Phase|Three participants who completed the double-blind phase did not enter the open-label treatment phase|268
345386|NCT02483585|849054|P1|STARTED|Open-label Treatment Phase|Five participants who completed the double-blind phase did not enter the open-label treatment phase|270
345387|NCT02483585|849053|P2|NOT COMPLETED|Double-blind Treatment Phase||15
345388|NCT02483585|849054|P1|NOT COMPLETED|Double-blind Treatment Phase||16
345389|NCT02483585|849053|P2|COMPLETED|Double-blind Treatment Phase||271
345390|NCT02483585|849054|P1|COMPLETED|Double-blind Treatment Phase||275
345391|NCT02483585|849053|P2|Received Treatment|Double-blind Treatment Phase||283
345392|NCT02483585|849054|P1|Received Treatment|Double-blind Treatment Phase||289
345393|NCT02483585|849053|P2|STARTED|Double-blind Treatment Phase||286
345394|NCT02483585|849054|P1|STARTED|Double-blind Treatment Phase||291
345395|NCT02482870|849074|P2|NOT COMPLETED|Period 2 - Rest of the Study||0
345396|NCT02482870|849075|P1|NOT COMPLETED|Period 2 - Rest of the Study||0
345397|NCT02482870|849074|P2|COMPLETED|Period 2 - Rest of the Study||202
345398|NCT02482870|849075|P1|COMPLETED|Period 2 - Rest of the Study||186
345399|NCT02482870|849074|P2|STARTED|Period 2 - Rest of the Study||202
345400|NCT02482870|849075|P1|STARTED|Period 2 - Rest of the Study||186
345401|NCT02482870|849074|P2|NOT COMPLETED|Period 1 - First 60 Patients||0
345402|NCT02482870|849075|P1|NOT COMPLETED|Period 1 - First 60 Patients||0
345403|NCT02482870|849074|P2|COMPLETED|Period 1 - First 60 Patients||30
345404|NCT02482870|849075|P1|COMPLETED|Period 1 - First 60 Patients||30
345405|NCT02482870|849074|P2|STARTED|Period 1 - First 60 Patients||30
345406|NCT02482870|849075|P1|STARTED|Period 1 - First 60 Patients||30
345407|NCT02482805|849092|P3|NOT COMPLETED|Overall Study||0
345408|NCT02482805|849093|P2|NOT COMPLETED|Overall Study||4
345409|NCT02482805|849094|P1|NOT COMPLETED|Overall Study||4
345410|NCT02482805|849092|P3|COMPLETED|Overall Study||20
345411|NCT02482805|849093|P2|COMPLETED|Overall Study||23
345412|NCT02482805|849094|P1|COMPLETED|Overall Study||22
345413|NCT02482805|849092|P3|STARTED|Overall Study||20
345414|NCT02482805|849093|P2|STARTED|Overall Study||27
345415|NCT02482805|849094|P1|STARTED|Overall Study||26
345416|NCT02482571|849108|P1|NOT COMPLETED|Overall Study||8
345417|NCT02482571|849108|P1|COMPLETED|Overall Study||17
345418|NCT02482571|849108|P1|STARTED|Overall Study||25
345419|NCT02482428|849120|P5|NOT COMPLETED|Overall Study||7
345420|NCT02482428|849121|P4|NOT COMPLETED|Overall Study||2
345421|NCT02482428|849122|P3|NOT COMPLETED|Overall Study||1
345422|NCT02482428|849123|P2|NOT COMPLETED|Overall Study||12
345423|NCT02482428|849124|P1|NOT COMPLETED|Overall Study||9
345424|NCT02482428|849120|P5|COMPLETED|Overall Study||15
345425|NCT02482428|849121|P4|COMPLETED|Overall Study||8
345426|NCT02482428|849122|P3|COMPLETED|Overall Study||9
345427|NCT02482428|849123|P2|COMPLETED|Overall Study||10
345428|NCT02482428|849124|P1|COMPLETED|Overall Study||15
345429|NCT02482428|849120|P5|STARTED|Overall Study||22
345430|NCT02482428|849121|P4|STARTED|Overall Study||10
345431|NCT02482428|849122|P3|STARTED|Overall Study||10
345432|NCT02482428|849123|P2|STARTED|Overall Study||22
345433|NCT02482428|849124|P1|STARTED|Overall Study||24
345434|NCT02482298|849147|P3|NOT COMPLETED|Overall Study||3
345435|NCT02482298|849148|P2|NOT COMPLETED|Overall Study||3
345436|NCT02482298|849149|P1|NOT COMPLETED|Overall Study||2
345437|NCT02482298|849147|P3|COMPLETED|Overall Study||27
345438|NCT02482298|849148|P2|COMPLETED|Overall Study||24
345439|NCT02482298|849149|P1|COMPLETED|Overall Study||28
345440|NCT02482298|849147|P3|STARTED|Overall Study||30
345441|NCT02482298|849148|P2|STARTED|Overall Study||27
345442|NCT02482298|849149|P1|STARTED|Overall Study||30
345443|NCT02482129|849171|P2|NOT COMPLETED|Overall Study||2
345444|NCT02482129|849172|P1|NOT COMPLETED|Overall Study||6
345445|NCT02482129|849171|P2|COMPLETED|Overall Study||9
345446|NCT02482129|849172|P1|COMPLETED|Overall Study||26
345447|NCT02482129|849171|P2|Treated, as Randomized|Overall Study||9
345448|NCT02482129|849172|P1|Treated, as Randomized|Overall Study||30
345449|NCT02482129|849171|P2|STARTED|Overall Study||11
345450|NCT02482129|849172|P1|STARTED|Overall Study||32
345451|NCT02481934|849199|P1|NOT COMPLETED|Overall Study||2
345452|NCT02481934|849199|P1|COMPLETED|Overall Study||3
345453|NCT02481934|849199|P1|STARTED|Overall Study||5
345454|NCT02481219|849206|P2|NOT COMPLETED|Overall Study||1
345455|NCT02481219|849207|P1|NOT COMPLETED|Overall Study||2
345456|NCT02481219|849206|P2|COMPLETED|Overall Study||61
345457|NCT02481219|849207|P1|COMPLETED|Overall Study||58
345458|NCT02481219|849206|P2|STARTED|Overall Study||62
345459|NCT02481219|849207|P1|STARTED|Overall Study||60
345460|NCT02481141|849225|P2|NOT COMPLETED|Overall Study||5
345461|NCT02481141|849226|P1|NOT COMPLETED|Overall Study||9
345462|NCT02481141|849225|P2|COMPLETED|Overall Study||13
345463|NCT02481141|849226|P1|COMPLETED|Overall Study||26
345464|NCT02481141|849225|P2|STARTED|Overall Study||18
345465|NCT02481141|849226|P1|STARTED|Overall Study||35
345466|NCT02480712|849278|P1|NOT COMPLETED|Overall Study||11
345467|NCT02480712|849278|P1|COMPLETED|Overall Study||96
345468|NCT02480712|849278|P1|STARTED|Overall Study||107
345469|NCT02480621|849297|P2|NOT COMPLETED|Follow Up||2
345470|NCT02480621|849298|P1|NOT COMPLETED|Follow Up||4
345471|NCT02480621|849297|P2|COMPLETED|Follow Up||37
345472|NCT02480621|849298|P1|COMPLETED|Follow Up||39
345473|NCT02480621|849297|P2|STARTED|Follow Up||39
345474|NCT02480621|849298|P1|STARTED|Follow Up||43
345475|NCT02480621|849297|P2|NOT COMPLETED|Randomization||1
345476|NCT02480621|849298|P1|NOT COMPLETED|Randomization||1
345477|NCT02480621|849297|P2|COMPLETED|Randomization||39
345478|NCT02480621|849298|P1|COMPLETED|Randomization||43
345479|NCT02480621|849297|P2|STARTED|Randomization||40
345480|NCT02480621|849298|P1|STARTED|Randomization||44
345481|NCT02480582|849304|P6|NOT COMPLETED|Overall Study||0
345482|NCT02480582|849305|P5|NOT COMPLETED|Overall Study||0
345483|NCT02480582|849306|P4|NOT COMPLETED|Overall Study||0
345484|NCT02480582|849307|P3|NOT COMPLETED|Overall Study||0
345485|NCT02480582|849308|P2|NOT COMPLETED|Overall Study||0
345486|NCT02480582|849309|P1|NOT COMPLETED|Overall Study||0
345487|NCT02480582|849304|P6|COMPLETED|Overall Study||7
345488|NCT02480582|849305|P5|COMPLETED|Overall Study||7
345489|NCT02480582|849306|P4|COMPLETED|Overall Study||7
345490|NCT02480582|849307|P3|COMPLETED|Overall Study||7
345491|NCT02480582|849308|P2|COMPLETED|Overall Study||7
345492|NCT02480582|849309|P1|COMPLETED|Overall Study||7
345493|NCT02480582|849304|P6|STARTED|Overall Study||7
345494|NCT02480582|849305|P5|STARTED|Overall Study||7
345495|NCT02480582|849306|P4|STARTED|Overall Study||7
345496|NCT02480582|849307|P3|STARTED|Overall Study||7
345497|NCT02480582|849308|P2|STARTED|Overall Study||7
345498|NCT02480582|849309|P1|STARTED|Overall Study||7
345499|NCT02480439|849332|P3|NOT COMPLETED|Treatment Period 3||0
345500|NCT02480439|849333|P2|NOT COMPLETED|Treatment Period 3||0
345501|NCT02480439|849334|P1|NOT COMPLETED|Treatment Period 3||0
345502|NCT02480439|849332|P3|COMPLETED|Treatment Period 3||7
345503|NCT02480439|849333|P2|COMPLETED|Treatment Period 3||7
345504|NCT02480439|849334|P1|COMPLETED|Treatment Period 3||8
345505|NCT02480439|849332|P3|STARTED|Treatment Period 3|1 Participant was withdrawn due to an Adverse Event after completing Period 2.|7
345506|NCT02480439|849333|P2|STARTED|Treatment Period 3||7
345507|NCT02480439|849334|P1|STARTED|Treatment Period 3||8
345508|NCT02480439|849332|P3|NOT COMPLETED|Treatment Period 2||0
345509|NCT02480439|849333|P2|NOT COMPLETED|Treatment Period 2||0
345510|NCT02480439|849334|P1|NOT COMPLETED|Treatment Period 2||0
345511|NCT02480439|849332|P3|COMPLETED|Treatment Period 2||8
345512|NCT02480439|849333|P2|COMPLETED|Treatment Period 2||7
345513|NCT02480439|849334|P1|COMPLETED|Treatment Period 2||8
345514|NCT02480439|849332|P3|STARTED|Treatment Period 2||8
345515|NCT02480439|849333|P2|STARTED|Treatment Period 2|1 Participant was withdrawn due to an Adverse Event after completing Period 1.|7
345516|NCT02480439|849334|P1|STARTED|Treatment Period 2||8
345517|NCT02480439|849332|P3|NOT COMPLETED|Treatment Period 1||0
345518|NCT02480439|849333|P2|NOT COMPLETED|Treatment Period 1||0
345519|NCT02480439|849334|P1|NOT COMPLETED|Treatment Period 1||0
345520|NCT02480439|849332|P3|COMPLETED|Treatment Period 1||8
345521|NCT02480439|849333|P2|COMPLETED|Treatment Period 1||8
345522|NCT02480439|849334|P1|COMPLETED|Treatment Period 1||8
345523|NCT02480439|849332|P3|STARTED|Treatment Period 1||8
345524|NCT02480439|849333|P2|STARTED|Treatment Period 1||8
345525|NCT02480439|849334|P1|STARTED|Treatment Period 1||8
345526|NCT02480166|849360|P3|NOT COMPLETED|Overall Study||0
345527|NCT02480166|849361|P2|NOT COMPLETED|Overall Study||0
345528|NCT02480166|849362|P1|NOT COMPLETED|Overall Study||0
345529|NCT02480166|849360|P3|COMPLETED|Overall Study||4
345530|NCT02480166|849361|P2|COMPLETED|Overall Study||36
345531|NCT02480166|849362|P1|COMPLETED|Overall Study||20
345532|NCT02480166|849360|P3|STARTED|Overall Study||4
345533|NCT02480166|849361|P2|STARTED|Overall Study||36
345534|NCT02480166|849362|P1|STARTED|Overall Study||20
345535|NCT02480153|849375|P2|NOT COMPLETED|Overall Study||27
345536|NCT02480153|849376|P1|NOT COMPLETED|Overall Study||11
345537|NCT02480153|849375|P2|COMPLETED|Overall Study||273
345538|NCT02480153|849376|P1|COMPLETED|Overall Study||286
345539|NCT02480153|849375|P2|Received Treatment|Overall Study||299
345540|NCT02480153|849376|P1|Received Treatment|Overall Study||297
345541|NCT02480153|849375|P2|STARTED|Overall Study||300
345542|NCT02480153|849376|P1|STARTED|Overall Study||297
345543|NCT02480010|849384|P2|NOT COMPLETED|Overall Study||33
345544|NCT02480010|849385|P1|NOT COMPLETED|Overall Study||35
345545|NCT02480010|849384|P2|COMPLETED|Overall Study||0
345546|NCT02480010|849385|P1|COMPLETED|Overall Study||0
345547|NCT02480010|849384|P2|STARTED|Overall Study||33
345548|NCT02480010|849385|P1|STARTED|Overall Study||35
345549|NCT02479763|849431|P2|NOT COMPLETED|Overall Study||3
345550|NCT02479763|849432|P1|NOT COMPLETED|Overall Study||3
345551|NCT02479763|849431|P2|COMPLETED|Overall Study||50
345552|NCT02479763|849432|P1|COMPLETED|Overall Study||50
345553|NCT02479763|849431|P2|STARTED|Overall Study||53
345554|NCT02479763|849432|P1|STARTED|Overall Study||53
345555|NCT02479412|849447|P9|NOT COMPLETED|Overall Study||1
345556|NCT02479412|849448|P8|NOT COMPLETED|Overall Study||1
345557|NCT02479412|849449|P7|NOT COMPLETED|Overall Study||0
345558|NCT02479412|849450|P6|NOT COMPLETED|Overall Study||0
345559|NCT02479412|849451|P5|NOT COMPLETED|Overall Study||1
345560|NCT02479412|849452|P4|NOT COMPLETED|Overall Study||1
345561|NCT02479412|849453|P3|NOT COMPLETED|Overall Study||2
345562|NCT02479412|849454|P2|NOT COMPLETED|Overall Study||0
345563|NCT02479412|849455|P1|NOT COMPLETED|Overall Study||0
345564|NCT02479412|849447|P9|COMPLETED|Overall Study||6
345565|NCT02479412|849448|P8|COMPLETED|Overall Study||4
345566|NCT02479412|849449|P7|COMPLETED|Overall Study||6
345567|NCT02479412|849450|P6|COMPLETED|Overall Study||5
345568|NCT02479412|849451|P5|COMPLETED|Overall Study||5
345569|NCT02479412|849452|P4|COMPLETED|Overall Study||6
345570|NCT02479412|849453|P3|COMPLETED|Overall Study||4
345571|NCT02479412|849454|P2|COMPLETED|Overall Study||6
345572|NCT02479412|849455|P1|COMPLETED|Overall Study||6
345573|NCT02479412|849447|P9|STARTED|Overall Study||7
345574|NCT02479412|849448|P8|STARTED|Overall Study||5
345575|NCT02479412|849449|P7|STARTED|Overall Study||6
345576|NCT02479412|849450|P6|STARTED|Overall Study||5
345577|NCT02479412|849451|P5|STARTED|Overall Study||6
345578|NCT02479412|849452|P4|STARTED|Overall Study||7
345579|NCT02479412|849453|P3|STARTED|Overall Study||6
345580|NCT02479412|849454|P2|STARTED|Overall Study||6
345581|NCT02479412|849455|P1|STARTED|Overall Study||6
345582|NCT02479139|849532|P6|NOT COMPLETED|Overall Study||6
345583|NCT02479139|849533|P5|NOT COMPLETED|Overall Study||5
345584|NCT02479139|849534|P4|NOT COMPLETED|Overall Study||7
345585|NCT02479139|849535|P3|NOT COMPLETED|Overall Study||7
345586|NCT02479139|849536|P2|NOT COMPLETED|Overall Study||10
345587|NCT02479139|849537|P1|NOT COMPLETED|Overall Study||8
345588|NCT02479139|849532|P6|COMPLETED|Overall Study||19
345589|NCT02479139|849533|P5|COMPLETED|Overall Study||17
345590|NCT02479139|849534|P4|COMPLETED|Overall Study||14
345591|NCT02479139|849535|P3|COMPLETED|Overall Study||21
345592|NCT02479139|849536|P2|COMPLETED|Overall Study||12
345593|NCT02479139|849537|P1|COMPLETED|Overall Study||19
345594|NCT02479139|849532|P6|STARTED|Overall Study||25
345595|NCT02479139|849533|P5|STARTED|Overall Study||22
345596|NCT02479139|849534|P4|STARTED|Overall Study||21
345597|NCT02479139|849535|P3|STARTED|Overall Study||28
345598|NCT02479139|849536|P2|STARTED|Overall Study||22
345599|NCT02479139|849537|P1|STARTED|Overall Study||27
345600|NCT02478671|849563|P1|NOT COMPLETED|Overall Study||0
345601|NCT02478671|849563|P1|COMPLETED|Overall Study||4
345602|NCT02478671|849563|P1|STARTED|Overall Study||4
345603|NCT02478632|849570|P2|NOT COMPLETED|Overall Study||5
345604|NCT02478632|849571|P1|NOT COMPLETED|Overall Study||4
345605|NCT02478632|849570|P2|COMPLETED|Overall Study||44
345606|NCT02478632|849571|P1|COMPLETED|Overall Study||49
345607|NCT02478632|849570|P2|STARTED|Overall Study||49
345608|NCT02478632|849571|P1|STARTED|Overall Study||53
345609|NCT02478580|849587|P2|NOT COMPLETED|Overall Study||0
345610|NCT02478580|849588|P1|NOT COMPLETED|Overall Study||0
345611|NCT02478580|849587|P2|COMPLETED|Overall Study||33
345612|NCT02478580|849588|P1|COMPLETED|Overall Study||34
345613|NCT02478580|849587|P2|STARTED|Overall Study||33
345614|NCT02478580|849588|P1|STARTED|Overall Study||34
345615|NCT02478372|849598|P2|NOT COMPLETED|Overall Study||14
345616|NCT02478372|849599|P1|NOT COMPLETED|Overall Study||13
345617|NCT02478372|849598|P2|COMPLETED|Overall Study||107
345618|NCT02478372|849599|P1|COMPLETED|Overall Study||108
345619|NCT02478372|849598|P2|Reviewed at One Year|Overall Study|Routine folow up at one year - four patients did not attend, two patients died|107
345620|NCT02478372|849599|P1|Reviewed at One Year|Overall Study|Routine follow up at one year|108
345621|NCT02478372|849598|P2|Reviewed at Six Weeks|Overall Study|Routine follow up at six weeks|113
345622|NCT02478372|849599|P1|Reviewed at Six Weeks|Overall Study|Routine follow up at six weeks - one patient refused to attend|108
345623|NCT02478372|849598|P2|Recieved Allocation Intervention|Overall Study||113
345624|NCT02478372|849599|P1|Recieved Allocation Intervention|Overall Study||109
345625|NCT02478372|849598|P2|STARTED|Overall Study||121
345626|NCT02478372|849599|P1|STARTED|Overall Study||121
345627|NCT02478164|849621|P1|NOT COMPLETED|Overall Study||15
345628|NCT02478164|849621|P1|COMPLETED|Overall Study||0
345629|NCT02478164|849621|P1|STARTED|Overall Study|17 participants enrolled. 15 of 17 received ponatinib as 2 participants withdrew prior to ponatinib.|15
345630|NCT02477709|849628|P1|NOT COMPLETED|Overall Study||0
345631|NCT02477709|849628|P1|COMPLETED|Overall Study||6
345632|NCT02477709|849628|P1|STARTED|Overall Study||6
345633|NCT02477605|849634|P2|NOT COMPLETED|Overall Study||4
345634|NCT02477605|849635|P1|NOT COMPLETED|Overall Study||1
345635|NCT02477605|849634|P2|COMPLETED|Overall Study||64
345636|NCT02477605|849635|P1|COMPLETED|Overall Study||67
345637|NCT02477605|849634|P2|Randomized and Treated|Overall Study||68
345638|NCT02477605|849635|P1|Randomized and Treated|Overall Study||67
345639|NCT02477605|849634|P2|STARTED|Overall Study||68
345640|NCT02477605|849635|P1|STARTED|Overall Study||68
345641|NCT02477527|849649|P1|NOT COMPLETED|Overall Study||6
345642|NCT02477527|849649|P1|COMPLETED|Overall Study||21
345643|NCT02477527|849649|P1|STARTED|Overall Study||27
345644|NCT02477020|849659|P2|NOT COMPLETED|Overall Study||28
345645|NCT02477020|849660|P1|NOT COMPLETED|Overall Study||30
345646|NCT02477020|849659|P2|COMPLETED|Overall Study|Completed = participants who completed study treatment.|55
345647|NCT02477020|849660|P1|COMPLETED|Overall Study|Completed = participants who completed study treatment.|51
345648|NCT02477020|849659|P2|STARTED|Overall Study||83
345649|NCT02477020|849660|P1|STARTED|Overall Study||81
345650|NCT02476994|849690|P2|NOT COMPLETED|Overall Study||0
345651|NCT02476994|849691|P1|NOT COMPLETED|Overall Study||1
345652|NCT02476994|849690|P2|COMPLETED|Overall Study||0
345653|NCT02476994|849691|P1|COMPLETED|Overall Study||0
345654|NCT02476994|849690|P2|STARTED|Overall Study||0
345655|NCT02476994|849691|P1|STARTED|Overall Study||1
345656|NCT02476890|849721|P4|NOT COMPLETED|Overall Study||0
345657|NCT02476890|849722|P3|NOT COMPLETED|Overall Study||0
345658|NCT02476890|849723|P2|NOT COMPLETED|Overall Study||0
345659|NCT02476890|849724|P1|NOT COMPLETED|Overall Study||0
345660|NCT02476890|849721|P4|COMPLETED|Overall Study||12
345661|NCT02476890|849722|P3|COMPLETED|Overall Study||12
345662|NCT02476890|849723|P2|COMPLETED|Overall Study||6
345663|NCT02476890|849724|P1|COMPLETED|Overall Study||6
345664|NCT02476890|849721|P4|Washout|Overall Study||12
345665|NCT02476890|849722|P3|Washout|Overall Study||12
345666|NCT02476890|849723|P2|Washout|Overall Study||6
345667|NCT02476890|849724|P1|Washout|Overall Study||6
345668|NCT02476890|849721|P4|STARTED|Overall Study|Crossover study|12
345669|NCT02476890|849722|P3|STARTED|Overall Study|Crossover study|12
345670|NCT02476890|849723|P2|STARTED|Overall Study|Crossover study|6
345671|NCT02476890|849724|P1|STARTED|Overall Study|Crossover study|6
345672|NCT02476617|849760|P1|NOT COMPLETED|Overall Study||2
345673|NCT02476617|849760|P1|COMPLETED|Overall Study||23
345674|NCT02476617|849760|P1|STARTED|Overall Study||25
345675|NCT02476565|849766|P2|NOT COMPLETED|Overall Study||0
345676|NCT02476565|849767|P1|NOT COMPLETED|Overall Study||0
345677|NCT02476565|849766|P2|COMPLETED|Overall Study||19
345678|NCT02476565|849767|P1|COMPLETED|Overall Study||20
345679|NCT02476565|849766|P2|STARTED|Overall Study||19
345680|NCT02476565|849767|P1|STARTED|Overall Study||20
345681|NCT02476422|849789|P2|NOT COMPLETED|Overall Study||1
345682|NCT02476422|849790|P1|NOT COMPLETED|Overall Study||0
345683|NCT02476422|849789|P2|COMPLETED|Overall Study||161
345684|NCT02476422|849790|P1|COMPLETED|Overall Study||166
345685|NCT02476422|849789|P2|STARTED|Overall Study||162
345686|NCT02476422|849790|P1|STARTED|Overall Study|"started = Randomized Set/Full analysis set/Safety set"|166
345687|NCT02476175|849820|P1|NOT COMPLETED|Overall Study||2
345688|NCT02476175|849820|P1|COMPLETED|Overall Study||33
345689|NCT02476175|849820|P1|STARTED|Overall Study||35
345690|NCT02476032|849831|P3|NOT COMPLETED|Overall Study||1
345691|NCT02476032|849832|P2|NOT COMPLETED|Overall Study||1
345692|NCT02476032|849833|P1|NOT COMPLETED|Overall Study||0
345693|NCT02476032|849831|P3|COMPLETED|Overall Study||19
345694|NCT02476032|849832|P2|COMPLETED|Overall Study||19
345695|NCT02476032|849833|P1|COMPLETED|Overall Study||20
345696|NCT02476032|849831|P3|STARTED|Overall Study||20
345697|NCT02476032|849832|P2|STARTED|Overall Study||20
345698|NCT02476032|849833|P1|STARTED|Overall Study||20
345699|NCT02475980|849844|P1|NOT COMPLETED|Overall Study||5
345700|NCT02475980|849844|P1|COMPLETED|Overall Study||8
345701|NCT02475980|849844|P1|STARTED|Overall Study||13
345702|NCT02475564|849855|P2|NOT COMPLETED|Overall Study||1
345703|NCT02475564|849856|P1|NOT COMPLETED|Overall Study||4
345704|NCT02475564|849855|P2|COMPLETED|Overall Study||21
345705|NCT02475564|849856|P1|COMPLETED|Overall Study||18
345706|NCT02475564|849855|P2|STARTED|Overall Study||22
345707|NCT02475564|849856|P1|STARTED|Overall Study||22
345708|NCT02475395|849868|P2|NOT COMPLETED|Overall Study||3
345709|NCT02475395|849869|P1|NOT COMPLETED|Overall Study||30
345710|NCT02475395|849868|P2|COMPLETED|Overall Study||11
345711|NCT02475395|849869|P1|COMPLETED|Overall Study||228
345712|NCT02475395|849868|P2|STARTED|Overall Study||14
345713|NCT02475395|849869|P1|STARTED|Overall Study||258
345714|NCT02475278|849879|P1|NOT COMPLETED|Overall Study||2
345715|NCT02475278|849879|P1|COMPLETED|Overall Study||48
345716|NCT02475278|849879|P1|STARTED|Overall Study||50
345717|NCT02475031|849892|P2|NOT COMPLETED|Overall Study||0
345718|NCT02475031|849893|P1|NOT COMPLETED|Overall Study||0
345719|NCT02475031|849892|P2|COMPLETED|Overall Study||35
345720|NCT02475031|849893|P1|COMPLETED|Overall Study||35
345721|NCT02475031|849892|P2|STARTED|Overall Study||35
345722|NCT02475031|849893|P1|STARTED|Overall Study||35
345723|NCT02474901|849909|P2|NOT COMPLETED|Overall Study||0
345724|NCT02474901|849910|P1|NOT COMPLETED|Overall Study||1
345725|NCT02474901|849909|P2|COMPLETED|Overall Study||56
345726|NCT02474901|849910|P1|COMPLETED|Overall Study||44
345727|NCT02474901|849909|P2|STARTED|Overall Study||56
345728|NCT02474901|849910|P1|STARTED|Overall Study||45
345729|NCT02474589|849926|P2|NOT COMPLETED|Overall Study||5
345730|NCT02474589|849927|P1|NOT COMPLETED|Overall Study||25
345731|NCT02474589|849926|P2|COMPLETED|Overall Study||85
345732|NCT02474589|849927|P1|COMPLETED|Overall Study||334
345733|NCT02474589|849926|P2|STARTED|Overall Study||90
345734|NCT02474589|849927|P1|STARTED|Overall Study||359
345735|NCT02474498|849936|P3|NOT COMPLETED|Overall Study||0
345736|NCT02474498|849937|P2|NOT COMPLETED|Overall Study||0
345737|NCT02474498|849938|P1|NOT COMPLETED|Overall Study||0
345738|NCT02474498|849936|P3|COMPLETED|Overall Study||14
345739|NCT02474498|849937|P2|COMPLETED|Overall Study||14
345740|NCT02474498|849938|P1|COMPLETED|Overall Study||13
345741|NCT02474498|849936|P3|STARTED|Overall Study||14
345742|NCT02474498|849937|P2|STARTED|Overall Study||14
345743|NCT02474498|849938|P1|STARTED|Overall Study||13
345744|NCT02474082|849957|P2|NOT COMPLETED|Overall Study||54
345745|NCT02474082|849958|P1|NOT COMPLETED|Overall Study||6
345746|NCT02474082|849957|P2|COMPLETED|Overall Study||43
345747|NCT02474082|849958|P1|COMPLETED|Overall Study||99
345748|NCT02474082|849957|P2|Full Analysis Set (FAS)|Overall Study||95
345749|NCT02474082|849958|P1|Full Analysis Set (FAS)|Overall Study||105
345750|NCT02474082|849957|P2|STARTED|Overall Study||97
345751|NCT02474082|849958|P1|STARTED|Overall Study||105
345752|NCT02473991|849992|P1|NOT COMPLETED|Overall Study||0
345753|NCT02473991|849992|P1|COMPLETED|Overall Study||395
345754|NCT02473991|849992|P1|STARTED|Overall Study||395
345755|NCT02473783|850000|P2|NOT COMPLETED|Overall Study||0
345756|NCT02473783|850001|P1|NOT COMPLETED|Overall Study||0
345757|NCT02473783|850000|P2|COMPLETED|Overall Study||17
345758|NCT02473783|850001|P1|COMPLETED|Overall Study||20
345759|NCT02473783|850000|P2|STARTED|Overall Study||17
345760|NCT02473783|850001|P1|STARTED|Overall Study||20
345761|NCT02473718|850011|P2|NOT COMPLETED|Overall Study||0
345762|NCT02473718|850012|P1|NOT COMPLETED|Overall Study||0
345763|NCT02473718|850011|P2|COMPLETED|Overall Study||41
345764|NCT02473718|850012|P1|COMPLETED|Overall Study||41
345765|NCT02473718|850011|P2|STARTED|Overall Study||41
345766|NCT02473718|850012|P1|STARTED|Overall Study||41
345767|NCT02473640|850032|P1|NOT COMPLETED|Treatment Period 2||0
345768|NCT02473640|850032|P1|COMPLETED|Treatment Period 2||14
345769|NCT02473640|850032|P1|STARTED|Treatment Period 2||14
345770|NCT02473640|850032|P1|NOT COMPLETED|Run-in Phase||0
345771|NCT02473640|850032|P1|COMPLETED|Run-in Phase||14
345772|NCT02473640|850032|P1|STARTED|Run-in Phase||14
345773|NCT02473640|850032|P1|NOT COMPLETED|Treatment Period 1||1
345774|NCT02473640|850032|P1|COMPLETED|Treatment Period 1||14
345775|NCT02473640|850032|P1|STARTED|Treatment Period 1||15
345776|NCT02473523|850041|P1|NOT COMPLETED|Overall Study||2
345777|NCT02473523|850041|P1|COMPLETED|Overall Study||0
345778|NCT02473523|850041|P1|STARTED|Overall Study||2
345779|NCT02473510|850062|P2|NOT COMPLETED|Overall Study||2
345780|NCT02473510|850063|P1|NOT COMPLETED|Overall Study||1
345781|NCT02473510|850062|P2|COMPLETED|Overall Study||238
345782|NCT02473510|850063|P1|COMPLETED|Overall Study||59
345783|NCT02473510|850062|P2|STARTED|Overall Study||240
345784|NCT02473510|850063|P1|STARTED|Overall Study||60
345785|NCT02473471|850077|P1|NOT COMPLETED|Overall Study||3
345786|NCT02473471|850077|P1|COMPLETED|Overall Study||32
345787|NCT02473471|850077|P1|Randomized Not Treated|Overall Study||2
345788|NCT02473471|850077|P1|Received Allocated Intervention|Overall Study||33
345789|NCT02473471|850077|P1|STARTED|Overall Study||35
345790|NCT02473445|850108|P1|NOT COMPLETED|Overall Study||22
345791|NCT02473445|850108|P1|COMPLETED|Overall Study||0
345792|NCT02473445|850108|P1|STARTED|Overall Study||22
345793|NCT02473367|850114|P1|NOT COMPLETED|Period 4||1
345794|NCT02473367|850114|P1|COMPLETED|Period 4||18
345795|NCT02473367|850114|P1|STARTED|Period 4||19
345796|NCT02473367|850114|P1|NOT COMPLETED|Wait 3||0
345797|NCT02473367|850114|P1|COMPLETED|Wait 3||19
345798|NCT02473367|850114|P1|STARTED|Wait 3||19
345799|NCT02473367|850114|P1|NOT COMPLETED|Period 3||0
345800|NCT02473367|850114|P1|COMPLETED|Period 3||19
345801|NCT02473367|850114|P1|STARTED|Period 3||19
345802|NCT02473367|850114|P1|NOT COMPLETED|Wait 2||0
345803|NCT02473367|850114|P1|COMPLETED|Wait 2||19
345804|NCT02473367|850114|P1|STARTED|Wait 2||19
345805|NCT02473367|850114|P1|NOT COMPLETED|Period 2||0
345806|NCT02473367|850114|P1|COMPLETED|Period 2||19
345807|NCT02473367|850114|P1|STARTED|Period 2||19
345808|NCT02473367|850114|P1|NOT COMPLETED|Wait 1||1
345809|NCT02473367|850114|P1|COMPLETED|Wait 1||19
345810|NCT02473367|850114|P1|STARTED|Wait 1||20
345811|NCT02473367|850114|P1|NOT COMPLETED|Period 1||0
345812|NCT02473367|850114|P1|COMPLETED|Period 1||20
345813|NCT02473367|850114|P1|STARTED|Period 1||20
345814|NCT02472977|850135|P3|NOT COMPLETED|Overall Study||8
345815|NCT02472977|850136|P2|NOT COMPLETED|Overall Study||27
345816|NCT02472977|850137|P1|NOT COMPLETED|Overall Study||6
345817|NCT02472977|850135|P3|COMPLETED|Overall Study||0
345818|NCT02472977|850136|P2|COMPLETED|Overall Study||0
345819|NCT02472977|850137|P1|COMPLETED|Overall Study||0
345820|NCT02472977|850135|P3|STARTED|Overall Study||8
345821|NCT02472977|850136|P2|STARTED|Overall Study||27
345822|NCT02472977|850137|P1|STARTED|Overall Study||6
345823|NCT02472886|850163|P3|NOT COMPLETED|Overall Study||1
345824|NCT02472886|850164|P2|NOT COMPLETED|Overall Study||2
345825|NCT02472886|850165|P1|NOT COMPLETED|Overall Study||0
345826|NCT02472886|850163|P3|COMPLETED|Overall Study||26
345827|NCT02472886|850164|P2|COMPLETED|Overall Study||57
345828|NCT02472886|850165|P1|COMPLETED|Overall Study||67
345829|NCT02472886|850163|P3|STARTED|Overall Study||27
345830|NCT02472886|850164|P2|STARTED|Overall Study||59
345831|NCT02472886|850165|P1|STARTED|Overall Study||67
345832|NCT02472847|850193|P2|NOT COMPLETED|Overall Study||5
345833|NCT02472847|850194|P1|NOT COMPLETED|Overall Study||1
345834|NCT02472847|850193|P2|COMPLETED|Overall Study||21
345835|NCT02472847|850194|P1|COMPLETED|Overall Study||23
345836|NCT02472847|850193|P2|STARTED|Overall Study||26
345837|NCT02472847|850194|P1|STARTED|Overall Study||24
345838|NCT02472756|850200|P1|NOT COMPLETED|Maintenance (Approximately 2 Years)||10
345839|NCT02472756|850200|P1|COMPLETED|Maintenance (Approximately 2 Years)||10
345840|NCT02472756|850200|P1|STARTED|Maintenance (Approximately 2 Years)|Out of 39 participants who completed induction period, 19 did not continue in maintenance period.|20
345841|NCT02472756|850200|P1|NOT COMPLETED|Induction (Approximately 6 Months)||2
345842|NCT02472756|850200|P1|COMPLETED|Induction (Approximately 6 Months)||39
345843|NCT02472756|850200|P1|Treated|Induction (Approximately 6 Months)||40
345844|NCT02472756|850200|P1|STARTED|Induction (Approximately 6 Months)||41
345845|NCT02472639|850208|P2|NOT COMPLETED|Overall Study||3
345846|NCT02472639|850209|P1|NOT COMPLETED|Overall Study||4
345847|NCT02472639|850208|P2|COMPLETED|Overall Study||0
345848|NCT02472639|850209|P1|COMPLETED|Overall Study||0
345849|NCT02472639|850208|P2|STARTED|Overall Study||3
345850|NCT02472639|850209|P1|STARTED|Overall Study||4
345851|NCT02472522|850225|P2|NOT COMPLETED|Overall Study||0
345852|NCT02472522|850226|P1|NOT COMPLETED|Overall Study||0
345853|NCT02472522|850225|P2|COMPLETED|Overall Study||50
345854|NCT02472522|850226|P1|COMPLETED|Overall Study||50
345855|NCT02472522|850225|P2|STARTED|Overall Study||50
345856|NCT02472522|850226|P1|STARTED|Overall Study||50
345857|NCT02472366|850258|P2|NOT COMPLETED|Overall Study||0
345858|NCT02472366|850259|P1|NOT COMPLETED|Overall Study||1
345859|NCT02472366|850258|P2|COMPLETED|Overall Study||10
345860|NCT02472366|850259|P1|COMPLETED|Overall Study||5
345861|NCT02472366|850258|P2|STARTED|Overall Study||10
345862|NCT02472366|850259|P1|STARTED|Overall Study|6 subjects receiving ILUVIEN, 7 eyes receiving ILUVIEN|6
345863|NCT02471755|850275|P2|NOT COMPLETED|Overall Study||1
345864|NCT02471755|850276|P1|NOT COMPLETED|Overall Study||1
345865|NCT02471755|850275|P2|COMPLETED|Overall Study||44
345866|NCT02471755|850276|P1|COMPLETED|Overall Study||44
345867|NCT02471755|850275|P2|STARTED|Overall Study||45
345868|NCT02471755|850276|P1|STARTED|Overall Study||45
345869|NCT02471612|850292|P1|NOT COMPLETED|Overall Study||2
345870|NCT02471612|850292|P1|COMPLETED|Overall Study||157
345871|NCT02471612|850292|P1|STARTED|Overall Study||159
345872|NCT02471326|850309|P1|NOT COMPLETED|Overall Study||1
345873|NCT02471326|850309|P1|COMPLETED|Overall Study||9
345874|NCT02471326|850309|P1|STARTED|Overall Study||10
345875|NCT02471183|850314|P1|NOT COMPLETED|Extended Treatment Period||1
345876|NCT02471183|850314|P1|COMPLETED|Extended Treatment Period||31
345877|NCT02471183|850314|P1|STARTED|Extended Treatment Period||32
345878|NCT02471183|850314|P1|NOT COMPLETED|Main Treatment Period||2
345879|NCT02471183|850314|P1|COMPLETED|Main Treatment Period||32
345880|NCT02471183|850314|P1|STARTED|Main Treatment Period||34
345881|NCT02470949|850329|P2|NOT COMPLETED|Second Intervention||0
345882|NCT02470949|850330|P1|NOT COMPLETED|Second Intervention||0
345883|NCT02470949|850329|P2|COMPLETED|Second Intervention||2
345884|NCT02470949|850330|P1|COMPLETED|Second Intervention||4
345885|NCT02470949|850329|P2|STARTED|Second Intervention||2
345886|NCT02470949|850330|P1|STARTED|Second Intervention||4
345887|NCT02470949|850329|P2|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0
345888|NCT02470949|850330|P1|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0
345889|NCT02470949|850329|P2|COMPLETED|Washout Period for a Minimum of 4 Weeks||5
345890|NCT02470949|850330|P1|COMPLETED|Washout Period for a Minimum of 4 Weeks||4
345891|NCT02470949|850329|P2|STARTED|Washout Period for a Minimum of 4 Weeks||5
345892|NCT02470949|850330|P1|STARTED|Washout Period for a Minimum of 4 Weeks||4
345893|NCT02470949|850329|P2|NOT COMPLETED|First Intervention||0
345894|NCT02470949|850330|P1|NOT COMPLETED|First Intervention||0
345895|NCT02470949|850329|P2|COMPLETED|First Intervention||5
345896|NCT02470949|850330|P1|COMPLETED|First Intervention||4
345897|NCT02470949|850329|P2|STARTED|First Intervention||5
345898|NCT02470949|850330|P1|STARTED|First Intervention||4
345899|NCT02470494|850340|P1|NOT COMPLETED|Overall Study||5
345900|NCT02470494|850340|P1|COMPLETED|Overall Study||41
345901|NCT02470494|850340|P1|STARTED|Overall Study||46
345902|NCT02470429|850350|P2|NOT COMPLETED|Overall Study||0
345903|NCT02470429|850351|P1|NOT COMPLETED|Overall Study||2
345904|NCT02470429|850350|P2|COMPLETED|Overall Study||49
345905|NCT02470429|850351|P1|COMPLETED|Overall Study||48
345906|NCT02470429|850350|P2|STARTED|Overall Study||49
345907|NCT02470429|850351|P1|STARTED|Overall Study||50
345908|NCT02470403|850369|P5|NOT COMPLETED|Overall Study||0
345909|NCT02470403|850370|P4|NOT COMPLETED|Overall Study||4
345910|NCT02470403|850371|P3|NOT COMPLETED|Overall Study||0
345911|NCT02470403|850372|P2|NOT COMPLETED|Overall Study||1
345912|NCT02470403|850373|P1|NOT COMPLETED|Overall Study||2
345913|NCT02470403|850369|P5|COMPLETED|Overall Study||10
345914|NCT02470403|850370|P4|COMPLETED|Overall Study||39
345915|NCT02470403|850371|P3|COMPLETED|Overall Study||40
345916|NCT02470403|850372|P2|COMPLETED|Overall Study||43
345917|NCT02470403|850373|P1|COMPLETED|Overall Study||42
345918|NCT02470403|850369|P5|Normoglycemic|Overall Study||5
345919|NCT02470403|850370|P4|Normoglycemic|Overall Study||23
345920|NCT02470403|850371|P3|Normoglycemic|Overall Study||20
345921|NCT02470403|850372|P2|Normoglycemic|Overall Study||20
345922|NCT02470403|850373|P1|Normoglycemic|Overall Study||20
345923|NCT02470403|850369|P5|Dysglycemic|Overall Study||5
345924|NCT02470403|850370|P4|Dysglycemic|Overall Study||20
345925|NCT02470403|850371|P3|Dysglycemic|Overall Study||20
345926|NCT02470403|850372|P2|Dysglycemic|Overall Study||24
345927|NCT02470403|850373|P1|Dysglycemic|Overall Study||24
345928|NCT02470403|850369|P5|STARTED|Overall Study||10
345929|NCT02470403|850370|P4|STARTED|Overall Study||43
345930|NCT02470403|850371|P3|STARTED|Overall Study||40
345931|NCT02470403|850372|P2|STARTED|Overall Study||44
345932|NCT02470403|850373|P1|STARTED|Overall Study||44
345933|NCT02470390|850413|P2|NOT COMPLETED|Overall Study||1
345934|NCT02470390|850414|P1|NOT COMPLETED|Overall Study||0
345935|NCT02470390|850413|P2|COMPLETED|Overall Study||6
345936|NCT02470390|850414|P1|COMPLETED|Overall Study||6
345937|NCT02470390|850413|P2|STARTED|Overall Study||7
345938|NCT02470390|850414|P1|STARTED|Overall Study||6
345939|NCT02469961|850442|P2|NOT COMPLETED|Overall Study||1
345940|NCT02469961|850443|P1|NOT COMPLETED|Overall Study||4
345941|NCT02469961|850442|P2|COMPLETED|Overall Study||24
345942|NCT02469961|850443|P1|COMPLETED|Overall Study||21
345943|NCT02469961|850442|P2|STARTED|Overall Study||25
345944|NCT02469961|850443|P1|STARTED|Overall Study||25
345945|NCT02469701|850455|P1|NOT COMPLETED|Overall Study||0
345946|NCT02469701|850455|P1|COMPLETED|Overall Study||10
345947|NCT02469701|850455|P1|STARTED|Overall Study||10
345948|NCT02469597|850461|P2|NOT COMPLETED|Overall Study||0
345949|NCT02469597|850462|P1|NOT COMPLETED|Overall Study||0
345950|NCT02469597|850461|P2|COMPLETED|Overall Study||24
345951|NCT02469597|850462|P1|COMPLETED|Overall Study||22
345952|NCT02469597|850461|P2|STARTED|Overall Study||24
345953|NCT02469597|850462|P1|STARTED|Overall Study||22
345954|NCT02469415|850478|P1|NOT COMPLETED|Overall Study||3
345955|NCT02469415|850478|P1|COMPLETED|Overall Study||0
345956|NCT02469415|850478|P1|STARTED|Overall Study||3
345957|NCT02469298|850486|P4|NOT COMPLETED|Overall Study||2
345958|NCT02469298|850487|P3|NOT COMPLETED|Overall Study||2
345959|NCT02469298|850488|P2|NOT COMPLETED|Overall Study||1
345960|NCT02469298|850489|P1|NOT COMPLETED|Overall Study||1
345961|NCT02469298|850486|P4|COMPLETED|Overall Study||5
345962|NCT02469298|850487|P3|COMPLETED|Overall Study||14
345963|NCT02469298|850488|P2|COMPLETED|Overall Study||6
345964|NCT02469298|850489|P1|COMPLETED|Overall Study||14
345965|NCT02469298|850486|P4|STARTED|Overall Study||7
345966|NCT02469298|850487|P3|STARTED|Overall Study||16
345967|NCT02469298|850488|P2|STARTED|Overall Study||7
345968|NCT02469298|850489|P1|STARTED|Overall Study||15
345969|NCT02469246|850629|P2|NOT COMPLETED|Overall Study||282
345970|NCT02469246|850630|P1|NOT COMPLETED|Overall Study||285
345971|NCT02469246|850629|P2|COMPLETED|Overall Study||0
345972|NCT02469246|850630|P1|COMPLETED|Overall Study||0
345973|NCT02469246|850629|P2|STARTED|Overall Study||282
345974|NCT02469246|850630|P1|STARTED|Overall Study||285
345975|NCT02469168|850648|P2|NOT COMPLETED|Overall Study||0
345976|NCT02469168|850649|P1|NOT COMPLETED|Overall Study||1
345977|NCT02469168|850648|P2|COMPLETED|Overall Study||0
345978|NCT02469168|850649|P1|COMPLETED|Overall Study||0
345979|NCT02469168|850648|P2|STARTED|Overall Study||0
345980|NCT02469168|850649|P1|STARTED|Overall Study||1
345981|NCT02469116|850657|P1|NOT COMPLETED|Overall Study||0
345982|NCT02469116|850657|P1|COMPLETED|Overall Study||18
345983|NCT02469116|850657|P1|STARTED|Overall Study||18
345984|NCT02468830|850667|P1|NOT COMPLETED|Overall Study||3
345985|NCT02468830|850667|P1|COMPLETED|Overall Study||55
345986|NCT02468830|850667|P1|STARTED|Overall Study||58
345987|NCT02468700|850677|P2|NOT COMPLETED|Overall Study||2
345988|NCT02468700|850678|P1|NOT COMPLETED|Overall Study||2
345989|NCT02468700|850677|P2|COMPLETED|Overall Study||19
345990|NCT02468700|850678|P1|COMPLETED|Overall Study||20
345991|NCT02468700|850677|P2|STARTED|Overall Study||21
345992|NCT02468700|850678|P1|STARTED|Overall Study||22
345993|NCT02468583|850692|P2|NOT COMPLETED|Overall Study||0
345994|NCT02468583|850693|P1|NOT COMPLETED|Overall Study||0
345995|NCT02468583|850692|P2|COMPLETED|Overall Study||3
345996|NCT02468583|850693|P1|COMPLETED|Overall Study||3
345997|NCT02468583|850692|P2|STARTED|Overall Study||3
345998|NCT02468583|850693|P1|STARTED|Overall Study||3
345999|NCT02468414|850701|P2|NOT COMPLETED|Overall Study||0
346000|NCT02468414|850702|P1|NOT COMPLETED|Overall Study||3
346001|NCT02468414|850701|P2|COMPLETED|Overall Study||0
346002|NCT02468414|850702|P1|COMPLETED|Overall Study||0
346003|NCT02468414|850701|P2|Safety Follow-up|Overall Study||0
346004|NCT02468414|850702|P1|Safety Follow-up|Overall Study||0
346005|NCT02468414|850701|P2|Implantation|Overall Study||0
346006|NCT02468414|850702|P1|Implantation|Overall Study||1
346007|NCT02468414|850701|P2|Harvesting|Overall Study||0
346008|NCT02468414|850702|P1|Harvesting|Overall Study||1
346009|NCT02468414|850701|P2|Successfully Screened|Overall Study||0
346010|NCT02468414|850702|P1|Successfully Screened|Overall Study||2
346011|NCT02468414|850701|P2|STARTED|Overall Study||0
346012|NCT02468414|850702|P1|STARTED|Overall Study||3
346013|NCT02468154|850710|P2|NOT COMPLETED|Overall Study||0
346014|NCT02468154|850711|P1|NOT COMPLETED|Overall Study||0
346015|NCT02468154|850710|P2|COMPLETED|Overall Study||28
346016|NCT02468154|850711|P1|COMPLETED|Overall Study||29
346017|NCT02468154|850710|P2|STARTED|Overall Study||28
346018|NCT02468154|850711|P1|STARTED|Overall Study||29
346019|NCT02467777|850725|P2|NOT COMPLETED|Overall Study||0
346020|NCT02467777|850726|P1|NOT COMPLETED|Overall Study||0
346021|NCT02467777|850725|P2|COMPLETED|Overall Study||27
346022|NCT02467777|850726|P1|COMPLETED|Overall Study||23
346023|NCT02467777|850725|P2|STARTED|Overall Study||27
346024|NCT02467777|850726|P1|STARTED|Overall Study||23
346025|NCT02467491|850732|P1|NOT COMPLETED|Overall Study||0
346026|NCT02467491|850732|P1|COMPLETED|Overall Study||12
346027|NCT02467491|850732|P1|STARTED|Overall Study||12
346028|NCT02467075|850743|P2|NOT COMPLETED|30 Day Follow-up||0
346029|NCT02467075|850744|P1|NOT COMPLETED|30 Day Follow-up||0
346030|NCT02467075|850743|P2|COMPLETED|30 Day Follow-up||1
346031|NCT02467075|850744|P1|COMPLETED|30 Day Follow-up||0
346032|NCT02467075|850743|P2|STARTED|30 Day Follow-up||1
346033|NCT02467075|850744|P1|STARTED|30 Day Follow-up||0
346034|NCT02467075|850743|P2|NOT COMPLETED|72 Hour Follow-up||0
346035|NCT02467075|850744|P1|NOT COMPLETED|72 Hour Follow-up||0
346036|NCT02467075|850743|P2|COMPLETED|72 Hour Follow-up||1
346037|NCT02467075|850744|P1|COMPLETED|72 Hour Follow-up||0
346038|NCT02467075|850743|P2|STARTED|72 Hour Follow-up||1
346039|NCT02467075|850744|P1|STARTED|72 Hour Follow-up||0
346040|NCT02467075|850743|P2|NOT COMPLETED|48 Hour Follow-up||0
346041|NCT02467075|850744|P1|NOT COMPLETED|48 Hour Follow-up||0
346042|NCT02467075|850743|P2|COMPLETED|48 Hour Follow-up||1
346043|NCT02467075|850744|P1|COMPLETED|48 Hour Follow-up||0
346044|NCT02467075|850743|P2|STARTED|48 Hour Follow-up||1
346045|NCT02467075|850744|P1|STARTED|48 Hour Follow-up||0
346046|NCT02467075|850743|P2|NOT COMPLETED|Initial CT Scan||0
346047|NCT02467075|850744|P1|NOT COMPLETED|Initial CT Scan||0
346048|NCT02467075|850743|P2|COMPLETED|Initial CT Scan||1
346049|NCT02467075|850744|P1|COMPLETED|Initial CT Scan||0
346050|NCT02467075|850743|P2|STARTED|Initial CT Scan||1
346051|NCT02467075|850744|P1|STARTED|Initial CT Scan||0
346052|NCT02466659|850762|P2|NOT COMPLETED|Overall Study||2
346053|NCT02466659|850763|P1|NOT COMPLETED|Overall Study||5
346054|NCT02466659|850762|P2|COMPLETED|Overall Study||1
346055|NCT02466659|850763|P1|COMPLETED|Overall Study||0
346056|NCT02466659|850762|P2|STARTED|Overall Study||3
346057|NCT02466659|850763|P1|STARTED|Overall Study||5
346058|NCT02466425|850773|P2|NOT COMPLETED|Overall Study||16
346059|NCT02466425|850774|P1|NOT COMPLETED|Overall Study||14
346060|NCT02466425|850773|P2|COMPLETED|Overall Study||116
346061|NCT02466425|850774|P1|COMPLETED|Overall Study||118
346062|NCT02466425|850773|P2|Treated|Overall Study||132
346063|NCT02466425|850774|P1|Treated|Overall Study||131
346064|NCT02466425|850773|P2|STARTED|Overall Study||132
346065|NCT02466425|850774|P1|STARTED|Overall Study||132
346066|NCT02466412|850784|P2|NOT COMPLETED|Second Intervention (Day 3)||0
346067|NCT02466412|850785|P1|NOT COMPLETED|Second Intervention (Day 3)||0
346068|NCT02466412|850784|P2|COMPLETED|Second Intervention (Day 3)||24
346069|NCT02466412|850785|P1|COMPLETED|Second Intervention (Day 3)||24
346070|NCT02466412|850784|P2|STARTED|Second Intervention (Day 3)||24
346071|NCT02466412|850785|P1|STARTED|Second Intervention (Day 3)||24
346072|NCT02466412|850784|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
346073|NCT02466412|850785|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
346074|NCT02466412|850784|P2|COMPLETED|Washout Period of 1 Day (Day 2)||24
346075|NCT02466412|850785|P1|COMPLETED|Washout Period of 1 Day (Day 2)||24
346076|NCT02466412|850784|P2|STARTED|Washout Period of 1 Day (Day 2)||24
346077|NCT02466412|850785|P1|STARTED|Washout Period of 1 Day (Day 2)||24
346078|NCT02466412|850784|P2|NOT COMPLETED|First Intervention (Day 1)||0
346079|NCT02466412|850785|P1|NOT COMPLETED|First Intervention (Day 1)||0
346080|NCT02466412|850784|P2|COMPLETED|First Intervention (Day 1)||24
346081|NCT02466412|850785|P1|COMPLETED|First Intervention (Day 1)||24
346082|NCT02466412|850784|P2|STARTED|First Intervention (Day 1)||24
346083|NCT02466412|850785|P1|STARTED|First Intervention (Day 1)||24
346084|NCT02466412|850784|P2|NOT COMPLETED|Washout Period of 1 Day (Day -1)||0
346085|NCT02466412|850785|P1|NOT COMPLETED|Washout Period of 1 Day (Day -1)||0
346086|NCT02466412|850784|P2|COMPLETED|Washout Period of 1 Day (Day -1)||24
346087|NCT02466412|850785|P1|COMPLETED|Washout Period of 1 Day (Day -1)||24
346088|NCT02466412|850784|P2|STARTED|Washout Period of 1 Day (Day -1)||24
346089|NCT02466412|850785|P1|STARTED|Washout Period of 1 Day (Day -1)||24
346090|NCT02465866|850794|P4|NOT COMPLETED|Period 4: Washout (14 Days)||0
346091|NCT02465866|850795|P3|NOT COMPLETED|Period 4: Washout (14 Days)||0
346092|NCT02465866|850796|P2|NOT COMPLETED|Period 4: Washout (14 Days)||0
346093|NCT02465866|850797|P1|NOT COMPLETED|Period 4: Washout (14 Days)||0
346094|NCT02465866|850794|P4|COMPLETED|Period 4: Washout (14 Days)||5
346095|NCT02465866|850795|P3|COMPLETED|Period 4: Washout (14 Days)||5
346096|NCT02465866|850796|P2|COMPLETED|Period 4: Washout (14 Days)||4
346097|NCT02465866|850797|P1|COMPLETED|Period 4: Washout (14 Days)||5
346098|NCT02465866|850794|P4|STARTED|Period 4: Washout (14 Days)||5
346099|NCT02465866|850795|P3|STARTED|Period 4: Washout (14 Days)||5
346100|NCT02465866|850796|P2|STARTED|Period 4: Washout (14 Days)||4
346101|NCT02465866|850797|P1|STARTED|Period 4: Washout (14 Days)||5
346102|NCT02465866|850794|P4|NOT COMPLETED|Period 4||0
346103|NCT02465866|850795|P3|NOT COMPLETED|Period 4||0
346104|NCT02465866|850796|P2|NOT COMPLETED|Period 4||0
346105|NCT02465866|850797|P1|NOT COMPLETED|Period 4||0
346106|NCT02465866|850794|P4|COMPLETED|Period 4||5
346107|NCT02465866|850795|P3|COMPLETED|Period 4||5
346108|NCT02465866|850796|P2|COMPLETED|Period 4||4
346109|NCT02465866|850797|P1|COMPLETED|Period 4||5
346110|NCT02465866|850794|P4|STARTED|Period 4||5
346111|NCT02465866|850795|P3|STARTED|Period 4||5
346112|NCT02465866|850796|P2|STARTED|Period 4||4
346113|NCT02465866|850797|P1|STARTED|Period 4||5
346114|NCT02465866|850794|P4|NOT COMPLETED|Period 3: Washout (14 Days)||0
346115|NCT02465866|850795|P3|NOT COMPLETED|Period 3: Washout (14 Days)||0
346116|NCT02465866|850796|P2|NOT COMPLETED|Period 3: Washout (14 Days)||0
346117|NCT02465866|850797|P1|NOT COMPLETED|Period 3: Washout (14 Days)||0
346118|NCT02465866|850794|P4|COMPLETED|Period 3: Washout (14 Days)||5
346119|NCT02465866|850795|P3|COMPLETED|Period 3: Washout (14 Days)||5
346120|NCT02465866|850796|P2|COMPLETED|Period 3: Washout (14 Days)||4
346121|NCT02465866|850797|P1|COMPLETED|Period 3: Washout (14 Days)||5
346122|NCT02465866|850794|P4|STARTED|Period 3: Washout (14 Days)||5
346123|NCT02465866|850795|P3|STARTED|Period 3: Washout (14 Days)||5
346124|NCT02465866|850796|P2|STARTED|Period 3: Washout (14 Days)||4
346125|NCT02465866|850797|P1|STARTED|Period 3: Washout (14 Days)||5
346126|NCT02465866|850794|P4|NOT COMPLETED|Period 3||0
346127|NCT02465866|850795|P3|NOT COMPLETED|Period 3||0
346128|NCT02465866|850796|P2|NOT COMPLETED|Period 3||1
346129|NCT02465866|850797|P1|NOT COMPLETED|Period 3||0
346130|NCT02465866|850794|P4|COMPLETED|Period 3||5
346131|NCT02465866|850795|P3|COMPLETED|Period 3||5
346132|NCT02465866|850796|P2|COMPLETED|Period 3||4
346133|NCT02465866|850797|P1|COMPLETED|Period 3||5
346134|NCT02465866|850794|P4|STARTED|Period 3||5
346135|NCT02465866|850795|P3|STARTED|Period 3||5
346136|NCT02465866|850796|P2|STARTED|Period 3||5
346137|NCT02465866|850797|P1|STARTED|Period 3||5
346138|NCT02465866|850794|P4|NOT COMPLETED|Period 2: Washout (14 Days)||0
346139|NCT02465866|850795|P3|NOT COMPLETED|Period 2: Washout (14 Days)||0
346140|NCT02465866|850796|P2|NOT COMPLETED|Period 2: Washout (14 Days)||0
346141|NCT02465866|850797|P1|NOT COMPLETED|Period 2: Washout (14 Days)||0
346142|NCT02465866|850794|P4|COMPLETED|Period 2: Washout (14 Days)||5
346143|NCT02465866|850795|P3|COMPLETED|Period 2: Washout (14 Days)||5
346144|NCT02465866|850796|P2|COMPLETED|Period 2: Washout (14 Days)||5
346145|NCT02465866|850797|P1|COMPLETED|Period 2: Washout (14 Days)||5
346146|NCT02465866|850794|P4|STARTED|Period 2: Washout (14 Days)||5
346147|NCT02465866|850795|P3|STARTED|Period 2: Washout (14 Days)||5
346148|NCT02465866|850796|P2|STARTED|Period 2: Washout (14 Days)||5
346149|NCT02465866|850797|P1|STARTED|Period 2: Washout (14 Days)||5
346150|NCT02465866|850794|P4|NOT COMPLETED|Period 2||0
346151|NCT02465866|850795|P3|NOT COMPLETED|Period 2||0
346152|NCT02465866|850796|P2|NOT COMPLETED|Period 2||0
346153|NCT02465866|850797|P1|NOT COMPLETED|Period 2||0
346154|NCT02465866|850794|P4|COMPLETED|Period 2||5
346155|NCT02465866|850795|P3|COMPLETED|Period 2||5
346156|NCT02465866|850796|P2|COMPLETED|Period 2||5
346157|NCT02465866|850797|P1|COMPLETED|Period 2||5
346158|NCT02465866|850794|P4|STARTED|Period 2||5
346159|NCT02465866|850795|P3|STARTED|Period 2||5
346160|NCT02465866|850796|P2|STARTED|Period 2||5
346161|NCT02465866|850797|P1|STARTED|Period 2||5
346162|NCT02465866|850794|P4|NOT COMPLETED|Period 1: Washout (14 Days)||0
346163|NCT02465866|850795|P3|NOT COMPLETED|Period 1: Washout (14 Days)||0
346164|NCT02465866|850796|P2|NOT COMPLETED|Period 1: Washout (14 Days)||0
346165|NCT02465866|850797|P1|NOT COMPLETED|Period 1: Washout (14 Days)||0
346166|NCT02465866|850794|P4|COMPLETED|Period 1: Washout (14 Days)||5
346167|NCT02465866|850795|P3|COMPLETED|Period 1: Washout (14 Days)||5
346168|NCT02465866|850796|P2|COMPLETED|Period 1: Washout (14 Days)||5
346169|NCT02465866|850797|P1|COMPLETED|Period 1: Washout (14 Days)||5
346170|NCT02465866|850794|P4|STARTED|Period 1: Washout (14 Days)||5
346171|NCT02465866|850795|P3|STARTED|Period 1: Washout (14 Days)||5
346172|NCT02465866|850796|P2|STARTED|Period 1: Washout (14 Days)||5
346173|NCT02465866|850797|P1|STARTED|Period 1: Washout (14 Days)||5
346174|NCT02465866|850794|P4|NOT COMPLETED|Period 1||0
346175|NCT02465866|850795|P3|NOT COMPLETED|Period 1||0
346176|NCT02465866|850796|P2|NOT COMPLETED|Period 1||0
346177|NCT02465866|850797|P1|NOT COMPLETED|Period 1||0
346178|NCT02465866|850794|P4|COMPLETED|Period 1||5
346179|NCT02465866|850795|P3|COMPLETED|Period 1||5
346180|NCT02465866|850796|P2|COMPLETED|Period 1||5
346181|NCT02465866|850797|P1|COMPLETED|Period 1||5
346182|NCT02465866|850794|P4|STARTED|Period 1||5
346183|NCT02465866|850795|P3|STARTED|Period 1||5
346184|NCT02465866|850796|P2|STARTED|Period 1||5
346185|NCT02465866|850797|P1|STARTED|Period 1||5
346186|NCT02465632|850870|P3|NOT COMPLETED|Overall Study||17
346187|NCT02465632|850871|P2|NOT COMPLETED|Overall Study||23
346188|NCT02465632|850872|P1|NOT COMPLETED|Overall Study||31
346189|NCT02465632|850870|P3|COMPLETED|Overall Study||203
346190|NCT02465632|850871|P2|COMPLETED|Overall Study||417
346191|NCT02465632|850872|P1|COMPLETED|Overall Study||409
346192|NCT02465632|850870|P3|STARTED|Overall Study||220
346193|NCT02465632|850871|P2|STARTED|Overall Study||440
346194|NCT02465632|850872|P1|STARTED|Overall Study||440
346195|NCT02465489|850883|P1|NOT COMPLETED|Overall Study||5
346196|NCT02465489|850883|P1|COMPLETED|Overall Study||15
346197|NCT02465489|850883|P1|STARTED|Overall Study||20
346198|NCT02465463|850912|P2|NOT COMPLETED|Overall Study||1
346199|NCT02465463|850913|P1|NOT COMPLETED|Overall Study||4
346200|NCT02465463|850912|P2|COMPLETED|Overall Study||4
346201|NCT02465463|850913|P1|COMPLETED|Overall Study||4
346202|NCT02465463|850912|P2|STARTED|Overall Study||5
346203|NCT02465463|850913|P1|STARTED|Overall Study||8
346204|NCT02465450|850932|P6|NOT COMPLETED|Treatment Period 2||0
346205|NCT02465450|850933|P5|NOT COMPLETED|Treatment Period 2||4
346206|NCT02465450|850934|P4|NOT COMPLETED|Treatment Period 2||3
346207|NCT02465450|850935|P3|NOT COMPLETED|Treatment Period 2||0
346208|NCT02465450|850936|P2|NOT COMPLETED|Treatment Period 2||0
346209|NCT02465450|850937|P1|NOT COMPLETED|Treatment Period 2||0
346210|NCT02465450|850932|P6|COMPLETED|Treatment Period 2||23
346211|NCT02465450|850933|P5|COMPLETED|Treatment Period 2||24
346212|NCT02465450|850934|P4|COMPLETED|Treatment Period 2||27
346213|NCT02465450|850935|P3|COMPLETED|Treatment Period 2||0
346214|NCT02465450|850936|P2|COMPLETED|Treatment Period 2||0
346215|NCT02465450|850937|P1|COMPLETED|Treatment Period 2||0
346216|NCT02465450|850932|P6|STARTED|Treatment Period 2||23
346217|NCT02465450|850933|P5|STARTED|Treatment Period 2||28
346218|NCT02465450|850934|P4|STARTED|Treatment Period 2||30
346219|NCT02465450|850935|P3|STARTED|Treatment Period 2||0
346220|NCT02465450|850936|P2|STARTED|Treatment Period 2||0
346221|NCT02465450|850937|P1|STARTED|Treatment Period 2||0
346222|NCT02465450|850932|P6|NOT COMPLETED|Treatment Period 1||0
346223|NCT02465450|850933|P5|NOT COMPLETED|Treatment Period 1||0
346224|NCT02465450|850934|P4|NOT COMPLETED|Treatment Period 1||0
346225|NCT02465450|850935|P3|NOT COMPLETED|Treatment Period 1||1
346226|NCT02465450|850936|P2|NOT COMPLETED|Treatment Period 1||1
346227|NCT02465450|850937|P1|NOT COMPLETED|Treatment Period 1||2
346228|NCT02465450|850932|P6|COMPLETED|Treatment Period 1||0
346229|NCT02465450|850933|P5|COMPLETED|Treatment Period 1||0
346230|NCT02465450|850934|P4|COMPLETED|Treatment Period 1||0
346231|NCT02465450|850935|P3|COMPLETED|Treatment Period 1||34
346232|NCT02465450|850936|P2|COMPLETED|Treatment Period 1||23
346233|NCT02465450|850937|P1|COMPLETED|Treatment Period 1||24
346234|NCT02465450|850932|P6|STARTED|Treatment Period 1||0
346235|NCT02465450|850933|P5|STARTED|Treatment Period 1||0
346236|NCT02465450|850934|P4|STARTED|Treatment Period 1||0
346237|NCT02465450|850935|P3|STARTED|Treatment Period 1||35
346238|NCT02465450|850936|P2|STARTED|Treatment Period 1||24
346239|NCT02465450|850937|P1|STARTED|Treatment Period 1||26
346240|NCT02465203|850960|P3|NOT COMPLETED|Overall Study||13
346241|NCT02465203|850961|P2|NOT COMPLETED|Overall Study||36
346242|NCT02465203|850962|P1|NOT COMPLETED|Overall Study||56
346243|NCT02465203|850960|P3|COMPLETED|Overall Study||0
346244|NCT02465203|850961|P2|COMPLETED|Overall Study||0
346245|NCT02465203|850962|P1|COMPLETED|Overall Study||0
346246|NCT02465203|850960|P3|STARTED|Overall Study||13
346247|NCT02465203|850961|P2|STARTED|Overall Study||36
346248|NCT02465203|850962|P1|STARTED|Overall Study||56
346249|NCT02465099|850975|P2|NOT COMPLETED|Overall Study||0
346250|NCT02465099|850976|P1|NOT COMPLETED|Overall Study||0
346251|NCT02465099|850975|P2|COMPLETED|Overall Study||19
346252|NCT02465099|850976|P1|COMPLETED|Overall Study||45
346253|NCT02465099|850975|P2|STARTED|Overall Study||19
346254|NCT02465099|850976|P1|STARTED|Overall Study||45
346255|NCT02465073|850985|P3|NOT COMPLETED|Overall Study||1
346256|NCT02465073|850986|P2|NOT COMPLETED|Overall Study||1
346257|NCT02465073|850987|P1|NOT COMPLETED|Overall Study||2
346258|NCT02465073|850985|P3|COMPLETED|Overall Study||15
346259|NCT02465073|850986|P2|COMPLETED|Overall Study||15
346260|NCT02465073|850987|P1|COMPLETED|Overall Study||15
346261|NCT02465073|850985|P3|STARTED|Overall Study||16
346262|NCT02465073|850986|P2|STARTED|Overall Study||16
346263|NCT02465073|850987|P1|STARTED|Overall Study||17
346264|NCT02464176|850998|P3|NOT COMPLETED|Overall Study||0
346265|NCT02464176|850999|P2|NOT COMPLETED|Overall Study||0
346266|NCT02464176|851000|P1|NOT COMPLETED|Overall Study||0
346267|NCT02464176|850998|P3|COMPLETED|Overall Study||15
346268|NCT02464176|850999|P2|COMPLETED|Overall Study||50
346269|NCT02464176|851000|P1|COMPLETED|Overall Study||50
346270|NCT02464176|850998|P3|STARTED|Overall Study||15
346271|NCT02464176|850999|P2|STARTED|Overall Study||50
346272|NCT02464176|851000|P1|STARTED|Overall Study||50
346273|NCT02464163|851021|P4|NOT COMPLETED|Overall Study||5
346274|NCT02464163|851022|P3|NOT COMPLETED|Overall Study||5
346275|NCT02464163|851023|P2|NOT COMPLETED|Overall Study||8
346276|NCT02464163|851024|P1|NOT COMPLETED|Overall Study||3
346277|NCT02464163|851021|P4|COMPLETED|Overall Study||96
346278|NCT02464163|851022|P3|COMPLETED|Overall Study||97
346279|NCT02464163|851023|P2|COMPLETED|Overall Study||94
346280|NCT02464163|851024|P1|COMPLETED|Overall Study||99
346281|NCT02464163|851021|P4|STARTED|Overall Study||101
346282|NCT02464163|851022|P3|STARTED|Overall Study||102
346283|NCT02464163|851023|P2|STARTED|Overall Study||102
346284|NCT02464163|851024|P1|STARTED|Overall Study||102
346285|NCT02463981|851048|P2|NOT COMPLETED|Overall Study||2
346286|NCT02463981|851049|P1|NOT COMPLETED|Overall Study||3
346287|NCT02463981|851048|P2|COMPLETED|Overall Study||14
346288|NCT02463981|851049|P1|COMPLETED|Overall Study||18
346289|NCT02463981|851048|P2|STARTED|Overall Study||16
346290|NCT02463981|851049|P1|STARTED|Overall Study||21
346291|NCT02463409|851057|P1|NOT COMPLETED|Overall Study||2
346292|NCT02463409|851057|P1|COMPLETED|Overall Study||4
346293|NCT02463409|851057|P1|STARTED|Overall Study||6
346294|NCT02463331|851065|P2|NOT COMPLETED|Overall Study||6
346295|NCT02463331|851066|P1|NOT COMPLETED|Overall Study||16
346296|NCT02463331|851065|P2|COMPLETED|Overall Study||25
346297|NCT02463331|851066|P1|COMPLETED|Overall Study||10
346298|NCT02463331|851065|P2|STARTED|Overall Study||31
346299|NCT02463331|851066|P1|STARTED|Overall Study||26
346300|NCT02463227|851074|P1|NOT COMPLETED|Overall Study||0
346301|NCT02463227|851074|P1|COMPLETED|Overall Study||14
346302|NCT02463227|851074|P1|STARTED|Overall Study||14
346303|NCT02463097|851082|P1|NOT COMPLETED|Overall Study||1
346304|NCT02463097|851082|P1|COMPLETED|Overall Study||123
346305|NCT02463097|851082|P1|STARTED|Overall Study||124
346306|NCT02462720|851088|P2|NOT COMPLETED|Part 2||1
346307|NCT02462720|851089|P1|NOT COMPLETED|Part 2||1
346308|NCT02462720|851088|P2|COMPLETED|Part 2||16
346309|NCT02462720|851089|P1|COMPLETED|Part 2||17
346310|NCT02462720|851088|P2|STARTED|Part 2||17
346311|NCT02462720|851089|P1|STARTED|Part 2||18
346312|NCT02462720|851088|P2|NOT COMPLETED|Part 1||0
346313|NCT02462720|851089|P1|NOT COMPLETED|Part 1||0
346314|NCT02462720|851088|P2|COMPLETED|Part 1||17
346315|NCT02462720|851089|P1|COMPLETED|Part 1||18
346316|NCT02462720|851088|P2|STARTED|Part 1||17
346317|NCT02462720|851089|P1|STARTED|Part 1||18
346318|NCT02462473|851099|P1|NOT COMPLETED|Overall Study||4
346319|NCT02462473|851099|P1|COMPLETED|Overall Study||5
346320|NCT02462473|851099|P1|STARTED|Overall Study||9
346321|NCT02462291|851112|P2|NOT COMPLETED|Overall Study||6
346322|NCT02462291|851113|P1|NOT COMPLETED|Overall Study||5
346323|NCT02462291|851112|P2|COMPLETED|Overall Study||75
346324|NCT02462291|851113|P1|COMPLETED|Overall Study||77
346325|NCT02462291|851112|P2|STARTED|Overall Study||81
346326|NCT02462291|851113|P1|STARTED|Overall Study||82
346327|NCT02461992|851151|P1|NOT COMPLETED|Overall Study||0
346328|NCT02461992|851151|P1|COMPLETED|Overall Study||13
346329|NCT02461992|851151|P1|STARTED|Overall Study||13
346330|NCT02461966|851171|P3|NOT COMPLETED|Overall Study||0
346331|NCT02461966|851172|P2|NOT COMPLETED|Overall Study||0
346332|NCT02461966|851173|P1|NOT COMPLETED|Overall Study||0
346333|NCT02461966|851171|P3|COMPLETED|Overall Study||60
346334|NCT02461966|851172|P2|COMPLETED|Overall Study||80
346335|NCT02461966|851173|P1|COMPLETED|Overall Study||160
346336|NCT02461966|851171|P3|STARTED|Overall Study||60
346337|NCT02461966|851172|P2|STARTED|Overall Study||80
346338|NCT02461966|851173|P1|STARTED|Overall Study||160
346339|NCT02461693|851183|P2|NOT COMPLETED|Overall Study||0
346340|NCT02461693|851184|P1|NOT COMPLETED|Overall Study||0
346341|NCT02461693|851183|P2|COMPLETED|Overall Study||102
346342|NCT02461693|851184|P1|COMPLETED|Overall Study||103
346343|NCT02461693|851183|P2|STARTED|Overall Study||102
346344|NCT02461693|851184|P1|STARTED|Overall Study||103
346345|NCT02461589|851206|P10|NOT COMPLETED|Overall Study||5
346346|NCT02461589|851207|P9|NOT COMPLETED|Overall Study||6
346347|NCT02461589|851208|P8|NOT COMPLETED|Overall Study||5
346348|NCT02461589|851209|P7|NOT COMPLETED|Overall Study||6
346349|NCT02461589|851210|P6|NOT COMPLETED|Overall Study||3
346350|NCT02461589|851211|P5|NOT COMPLETED|Overall Study||2
346351|NCT02461589|851212|P4|NOT COMPLETED|Overall Study||5
346352|NCT02461589|851213|P3|NOT COMPLETED|Overall Study||5
346353|NCT02461589|851214|P2|NOT COMPLETED|Overall Study||2
346354|NCT02461589|851215|P1|NOT COMPLETED|Overall Study||6
346355|NCT02461589|851206|P10|COMPLETED|Overall Study||60
346356|NCT02461589|851207|P9|COMPLETED|Overall Study||123
346357|NCT02461589|851208|P8|COMPLETED|Overall Study||60
346358|NCT02461589|851209|P7|COMPLETED|Overall Study||58
346359|NCT02461589|851210|P6|COMPLETED|Overall Study||61
346360|NCT02461589|851211|P5|COMPLETED|Overall Study||62
346361|NCT02461589|851212|P4|COMPLETED|Overall Study||58
346362|NCT02461589|851213|P3|COMPLETED|Overall Study||60
346363|NCT02461589|851214|P2|COMPLETED|Overall Study||61
346364|NCT02461589|851215|P1|COMPLETED|Overall Study||58
346365|NCT02461589|851206|P10|Exposed|Overall Study||64
346366|NCT02461589|851207|P9|Exposed|Overall Study||129
346367|NCT02461589|851208|P8|Exposed|Overall Study||65
346368|NCT02461589|851209|P7|Exposed|Overall Study||64
346369|NCT02461589|851210|P6|Exposed|Overall Study||64
346370|NCT02461589|851211|P5|Exposed|Overall Study||64
346371|NCT02461589|851212|P4|Exposed|Overall Study||63
346372|NCT02461589|851213|P3|Exposed|Overall Study||65
346373|NCT02461589|851214|P2|Exposed|Overall Study||63
346374|NCT02461589|851215|P1|Exposed|Overall Study||64
346375|NCT02461589|851206|P10|STARTED|Overall Study||65
346376|NCT02461589|851207|P9|STARTED|Overall Study||129
346377|NCT02461589|851208|P8|STARTED|Overall Study||65
346378|NCT02461589|851209|P7|STARTED|Overall Study||64
346379|NCT02461589|851210|P6|STARTED|Overall Study||64
346380|NCT02461589|851211|P5|STARTED|Overall Study||64
346381|NCT02461589|851212|P4|STARTED|Overall Study||63
346382|NCT02461589|851213|P3|STARTED|Overall Study||65
346383|NCT02461589|851214|P2|STARTED|Overall Study||63
346384|NCT02461589|851215|P1|STARTED|Overall Study||64
346385|NCT02461550|851267|P1|NOT COMPLETED|Overall Study||0
346386|NCT02461550|851267|P1|COMPLETED|Overall Study||2
346387|NCT02461550|851267|P1|STARTED|Overall Study||2
346388|NCT02461433|851273|P2|NOT COMPLETED|Overall Study||0
346389|NCT02461433|851274|P1|NOT COMPLETED|Overall Study||0
346390|NCT02461433|851273|P2|COMPLETED|Overall Study||1
346391|NCT02461433|851274|P1|COMPLETED|Overall Study||1
346392|NCT02461433|851273|P2|STARTED|Overall Study||1
346393|NCT02461433|851274|P1|STARTED|Overall Study||1
346394|NCT02461290|851300|P1|NOT COMPLETED|Overall Study||10
346395|NCT02461290|851300|P1|COMPLETED|Overall Study||89
346396|NCT02461290|851300|P1|STARTED|Overall Study||99
346397|NCT02461134|851307|P1|NOT COMPLETED|Overall Study||1
346398|NCT02461134|851307|P1|COMPLETED|Overall Study||0
346399|NCT02461134|851307|P1|STARTED|Overall Study||1
346400|NCT02460991|851315|P2|NOT COMPLETED|Overall Study||2
346401|NCT02460991|851316|P1|NOT COMPLETED|Overall Study||0
346402|NCT02460991|851315|P2|COMPLETED|Overall Study||0
346403|NCT02460991|851316|P1|COMPLETED|Overall Study||0
346404|NCT02460991|851315|P2|STARTED|Overall Study||2
346405|NCT02460991|851316|P1|STARTED|Overall Study||0
346406|NCT02460822|851322|P1|NOT COMPLETED|Overall Study||1
346407|NCT02460822|851322|P1|COMPLETED|Overall Study||15
346408|NCT02460822|851322|P1|STARTED|Overall Study||16
346409|NCT02460458|851331|P1|NOT COMPLETED|Prospective Phase||0
346410|NCT02460458|851331|P1|COMPLETED|Prospective Phase|Information not yet available.|0
346411|NCT02460458|851331|P1|STARTED|Prospective Phase|Information not yet available.|0
346412|NCT02460458|851331|P1|NOT COMPLETED|Confirmatory Phase||266
346413|NCT02460458|851331|P1|COMPLETED|Confirmatory Phase|Information not yet available.|0
346414|NCT02460458|851331|P1|STARTED|Confirmatory Phase||266
346415|NCT02460458|851331|P1|NOT COMPLETED|Retrospective Phase||0
346416|NCT02460458|851331|P1|COMPLETED|Retrospective Phase||266
346417|NCT02460458|851331|P1|STARTED|Retrospective Phase||266
346418|NCT02460159|851339|P2|NOT COMPLETED|Overall Study||1
346419|NCT02460159|851340|P1|NOT COMPLETED|Overall Study||6
346420|NCT02460159|851339|P2|COMPLETED|Overall Study||17
346421|NCT02460159|851340|P1|COMPLETED|Overall Study||111
346422|NCT02460159|851339|P2|STARTED|Overall Study||18
346423|NCT02460159|851340|P1|STARTED|Overall Study||117
346434|NCT02459093|851393|P2|NOT COMPLETED|Overall Study||18
346435|NCT02459093|851394|P1|NOT COMPLETED|Overall Study||12
346436|NCT02459093|851393|P2|COMPLETED|Overall Study||257
346437|NCT02459093|851394|P1|COMPLETED|Overall Study||263
346438|NCT02459093|851393|P2|STARTED|Overall Study||275
346439|NCT02459093|851394|P1|STARTED|Overall Study||275
346440|NCT02458768|851404|P2|NOT COMPLETED|Overall Study||5
346441|NCT02458768|851405|P1|NOT COMPLETED|Overall Study||7
346442|NCT02458768|851404|P2|COMPLETED|Overall Study||50
346443|NCT02458768|851405|P1|COMPLETED|Overall Study||50
346444|NCT02458768|851404|P2|STARTED|Overall Study||55
346445|NCT02458768|851405|P1|STARTED|Overall Study||57
346446|NCT02458365|851413|P2|NOT COMPLETED|Overall Study||294
346447|NCT02458365|851414|P1|NOT COMPLETED|Overall Study||277
346448|NCT02458365|851413|P2|COMPLETED|Overall Study||1607
346449|NCT02458365|851414|P1|COMPLETED|Overall Study||1723
346450|NCT02458365|851413|P2|STARTED|Overall Study||1901
346451|NCT02458365|851414|P1|STARTED|Overall Study||2000
346452|NCT02458287|851438|P4|NOT COMPLETED|Overall Study||3
346453|NCT02458287|851439|P3|NOT COMPLETED|Overall Study||3
346454|NCT02458287|851440|P2|NOT COMPLETED|Overall Study||4
346455|NCT02458287|851441|P1|NOT COMPLETED|Overall Study||0
346456|NCT02458287|851438|P4|COMPLETED|Overall Study||97
346457|NCT02458287|851439|P3|COMPLETED|Overall Study||46
346458|NCT02458287|851440|P2|COMPLETED|Overall Study||96
346459|NCT02458287|851441|P1|COMPLETED|Overall Study||50
346460|NCT02458287|851438|P4|STARTED|Overall Study||100
346461|NCT02458287|851439|P3|STARTED|Overall Study||49
346462|NCT02458287|851440|P2|STARTED|Overall Study||100
346463|NCT02458287|851441|P1|STARTED|Overall Study||50
346464|NCT02457728|851486|P1|NOT COMPLETED|Overall Study||0
346465|NCT02457728|851486|P1|COMPLETED|Overall Study||34
346466|NCT02457728|851486|P1|STARTED|Overall Study||34
346467|NCT02457611|851490|P1|NOT COMPLETED|Overall Study||3
346468|NCT02457611|851490|P1|COMPLETED|Overall Study||23
346469|NCT02457611|851490|P1|STARTED|Overall Study||26
346470|NCT02457247|851506|P4|NOT COMPLETED|Period 2||0
346471|NCT02457247|851507|P3|NOT COMPLETED|Period 2||0
346472|NCT02457247|851508|P2|NOT COMPLETED|Period 2||3
346473|NCT02457247|851509|P1|NOT COMPLETED|Period 2||2
346474|NCT02457247|851506|P4|COMPLETED|Period 2||70
346475|NCT02457247|851507|P3|COMPLETED|Period 2||68
346476|NCT02457247|851508|P2|COMPLETED|Period 2||65
346477|NCT02457247|851509|P1|COMPLETED|Period 2||64
346478|NCT02457247|851506|P4|STARTED|Period 2||70
346479|NCT02457247|851507|P3|STARTED|Period 2||68
346480|NCT02457247|851508|P2|STARTED|Period 2||68
346481|NCT02457247|851509|P1|STARTED|Period 2||66
346482|NCT02457247|851506|P4|NOT COMPLETED|Period 1||0
346483|NCT02457247|851507|P3|NOT COMPLETED|Period 1||0
346484|NCT02457247|851508|P2|NOT COMPLETED|Period 1||2
346485|NCT02457247|851509|P1|NOT COMPLETED|Period 1||2
346486|NCT02457247|851506|P4|COMPLETED|Period 1||70
346487|NCT02457247|851507|P3|COMPLETED|Period 1||68
346488|NCT02457247|851508|P2|COMPLETED|Period 1||68
346489|NCT02457247|851509|P1|COMPLETED|Period 1||66
346490|NCT02457247|851506|P4|STARTED|Period 1||70
346491|NCT02457247|851507|P3|STARTED|Period 1||68
346492|NCT02457247|851508|P2|STARTED|Period 1||70
346493|NCT02457247|851509|P1|STARTED|Period 1||68
346494|NCT02455518|851533|P4|NOT COMPLETED|Overall Study||3
346495|NCT02455518|851534|P3|NOT COMPLETED|Overall Study||1
346496|NCT02455518|851535|P2|NOT COMPLETED|Overall Study||1
346497|NCT02455518|851536|P1|NOT COMPLETED|Overall Study||0
346498|NCT02455518|851533|P4|COMPLETED|Overall Study||101
346499|NCT02455518|851534|P3|COMPLETED|Overall Study||103
346500|NCT02455518|851535|P2|COMPLETED|Overall Study||103
346501|NCT02455518|851536|P1|COMPLETED|Overall Study||104
346502|NCT02455518|851533|P4|STARTED|Overall Study||104
346503|NCT02455518|851534|P3|STARTED|Overall Study||104
346504|NCT02455518|851535|P2|STARTED|Overall Study||104
346505|NCT02455518|851536|P1|STARTED|Overall Study||104
346506|NCT02455050|851554|P4|NOT COMPLETED|Treatment Period 2||1
346507|NCT02455050|851555|P3|NOT COMPLETED|Treatment Period 2||2
346508|NCT02455050|851556|P2|NOT COMPLETED|Treatment Period 2||0
346509|NCT02455050|851557|P1|NOT COMPLETED|Treatment Period 2||1
346510|NCT02455050|851554|P4|COMPLETED|Treatment Period 2||17
346511|NCT02455050|851555|P3|COMPLETED|Treatment Period 2||17
346512|NCT02455050|851556|P2|COMPLETED|Treatment Period 2||18
346513|NCT02455050|851557|P1|COMPLETED|Treatment Period 2||18
346514|NCT02455050|851554|P4|STARTED|Treatment Period 2||18
346515|NCT02455050|851555|P3|STARTED|Treatment Period 2||19
346516|NCT02455050|851556|P2|STARTED|Treatment Period 2||18
346517|NCT02455050|851557|P1|STARTED|Treatment Period 2||19
346518|NCT02455050|851554|P4|NOT COMPLETED|Treatment Period 1||2
346519|NCT02455050|851555|P3|NOT COMPLETED|Treatment Period 1||1
346520|NCT02455050|851556|P2|NOT COMPLETED|Treatment Period 1||1
346521|NCT02455050|851557|P1|NOT COMPLETED|Treatment Period 1||1
346522|NCT02455050|851554|P4|COMPLETED|Treatment Period 1||18
346523|NCT02455050|851555|P3|COMPLETED|Treatment Period 1||19
346524|NCT02455050|851556|P2|COMPLETED|Treatment Period 1||18
346525|NCT02455050|851557|P1|COMPLETED|Treatment Period 1||19
346526|NCT02455050|851554|P4|STARTED|Treatment Period 1||20
346527|NCT02455050|851555|P3|STARTED|Treatment Period 1||20
346528|NCT02455050|851556|P2|STARTED|Treatment Period 1||19
346529|NCT02455050|851557|P1|STARTED|Treatment Period 1||20
346530|NCT02454959|851621|P1|NOT COMPLETED|Overall Study||9
346531|NCT02454959|851621|P1|COMPLETED|Overall Study||70
346532|NCT02454959|851621|P1|GFF MDI (PT003) Without Aerochamber|Overall Study||77
346533|NCT02454959|851621|P1|GFF MDI (PT003) With Aerochamber|Overall Study||73
346534|NCT02454959|851621|P1|STARTED|Overall Study||79
346535|NCT02454608|851642|P3|NOT COMPLETED|Open Label Period||19
346536|NCT02454608|851643|P2|NOT COMPLETED|Open Label Period||0
346537|NCT02454608|851644|P1|NOT COMPLETED|Open Label Period||0
346538|NCT02454608|851642|P3|COMPLETED|Open Label Period||10
346539|NCT02454608|851643|P2|COMPLETED|Open Label Period|This arm is not part of this period of the study|0
346540|NCT02454608|851644|P1|COMPLETED|Open Label Period|This arm is not part of this period of the study|0
346541|NCT02454608|851642|P3|STARTED|Open Label Period||29
346542|NCT02454608|851643|P2|STARTED|Open Label Period|This arm is not part of this period of the study|0
346543|NCT02454608|851644|P1|STARTED|Open Label Period|This arm is not part of this period of the study|0
346544|NCT02454608|851642|P3|NOT COMPLETED|Double-Blind Period||0
346545|NCT02454608|851643|P2|NOT COMPLETED|Double-Blind Period||2
346546|NCT02454608|851644|P1|NOT COMPLETED|Double-Blind Period||0
346547|NCT02454608|851642|P3|COMPLETED|Double-Blind Period|This arm is not part of this period of the study|0
346548|NCT02454608|851643|P2|COMPLETED|Double-Blind Period||12
346549|NCT02454608|851644|P1|COMPLETED|Double-Blind Period||15
346550|NCT02454608|851642|P3|STARTED|Double-Blind Period|This arm is not part of this period of the study|0
346551|NCT02454608|851643|P2|STARTED|Double-Blind Period||14
346552|NCT02454608|851644|P1|STARTED|Double-Blind Period||15
346553|NCT02454296|851667|P2|NOT COMPLETED|Overall Study||0
346554|NCT02454296|851668|P1|NOT COMPLETED|Overall Study||0
346555|NCT02454296|851667|P2|COMPLETED|Overall Study||21
346556|NCT02454296|851668|P1|COMPLETED|Overall Study||20
346557|NCT02454296|851667|P2|STARTED|Overall Study||21
346558|NCT02454296|851668|P1|STARTED|Overall Study||20
346559|NCT02454283|851680|P2|NOT COMPLETED|Overall Study||0
346560|NCT02454283|851681|P1|NOT COMPLETED|Overall Study||0
346561|NCT02454283|851680|P2|COMPLETED|Overall Study||15
346562|NCT02454283|851681|P1|COMPLETED|Overall Study||26
346563|NCT02454283|851680|P2|STARTED|Overall Study||15
346564|NCT02454283|851681|P1|STARTED|Overall Study||26
346565|NCT02454127|851693|P4|NOT COMPLETED|Overall Study||20
346566|NCT02454127|851694|P3|NOT COMPLETED|Overall Study||14
346567|NCT02454127|851695|P2|NOT COMPLETED|Overall Study||14
346568|NCT02454127|851696|P1|NOT COMPLETED|Overall Study||19
346569|NCT02454127|851693|P4|COMPLETED|Overall Study||20
346570|NCT02454127|851694|P3|COMPLETED|Overall Study||26
346571|NCT02454127|851695|P2|COMPLETED|Overall Study||26
346572|NCT02454127|851696|P1|COMPLETED|Overall Study||21
346573|NCT02454127|851693|P4|STARTED|Overall Study||40
346574|NCT02454127|851694|P3|STARTED|Overall Study||40
346575|NCT02454127|851695|P2|STARTED|Overall Study||40
346576|NCT02454127|851696|P1|STARTED|Overall Study||40
346577|NCT02454101|851736|P2|NOT COMPLETED|Overall Study||7
346578|NCT02454101|851737|P1|NOT COMPLETED|Overall Study||5
346579|NCT02454101|851736|P2|COMPLETED|Overall Study||143
346580|NCT02454101|851737|P1|COMPLETED|Overall Study||145
346581|NCT02454101|851736|P2|STARTED|Overall Study||150
346582|NCT02454101|851737|P1|STARTED|Overall Study||150
346583|NCT02453581|851759|P3|NOT COMPLETED|Overall Study||0
346584|NCT02453581|851760|P2|NOT COMPLETED|Overall Study||0
346585|NCT02453581|851761|P1|NOT COMPLETED|Overall Study||0
346586|NCT02453581|851759|P3|COMPLETED|Overall Study||8
346587|NCT02453581|851760|P2|COMPLETED|Overall Study||8
346588|NCT02453581|851761|P1|COMPLETED|Overall Study||8
346589|NCT02453581|851759|P3|STARTED|Overall Study||8
346590|NCT02453581|851760|P2|STARTED|Overall Study||8
346591|NCT02453581|851761|P1|STARTED|Overall Study||8
346592|NCT02453347|851781|P1|NOT COMPLETED|Overall Study||0
346593|NCT02453347|851781|P1|COMPLETED|Overall Study||6
346594|NCT02453347|851781|P1|STARTED|Overall Study||6
346595|NCT02453321|851797|P3|NOT COMPLETED|Overall Study||2
346596|NCT02453321|851798|P2|NOT COMPLETED|Overall Study||2
346597|NCT02453321|851799|P1|NOT COMPLETED|Overall Study||1
346598|NCT02453321|851797|P3|COMPLETED|Overall Study||19
346599|NCT02453321|851798|P2|COMPLETED|Overall Study||19
346600|NCT02453321|851799|P1|COMPLETED|Overall Study||19
346601|NCT02453321|851797|P3|STARTED|Overall Study||21
346602|NCT02453321|851798|P2|STARTED|Overall Study||21
346603|NCT02453321|851799|P1|STARTED|Overall Study||20
346604|NCT02452944|851818|P2|NOT COMPLETED|Overall Study||0
346605|NCT02452944|851819|P1|NOT COMPLETED|Overall Study||0
346606|NCT02452944|851818|P2|COMPLETED|Overall Study||31
346607|NCT02452944|851819|P1|COMPLETED|Overall Study||31
346608|NCT02452944|851818|P2|STARTED|Overall Study||31
346609|NCT02452944|851819|P1|STARTED|Overall Study||31
346610|NCT02452892|851831|P4|NOT COMPLETED|Follow-up||1
346611|NCT02452892|851832|P3|NOT COMPLETED|Follow-up||0
346612|NCT02452892|851833|P2|NOT COMPLETED|Follow-up||0
346613|NCT02452892|851834|P1|NOT COMPLETED|Follow-up||1
346614|NCT02452892|851831|P4|COMPLETED|Follow-up||38
346615|NCT02452892|851832|P3|COMPLETED|Follow-up||7
346616|NCT02452892|851833|P2|COMPLETED|Follow-up||7
346617|NCT02452892|851834|P1|COMPLETED|Follow-up||62
346618|NCT02452892|851831|P4|STARTED|Follow-up||39
346619|NCT02452892|851832|P3|STARTED|Follow-up||7
346620|NCT02452892|851833|P2|STARTED|Follow-up||7
346621|NCT02452892|851834|P1|STARTED|Follow-up||63
346622|NCT02452892|851831|P4|NOT COMPLETED|Week 2 Stratification & Re-Randomization||2
346623|NCT02452892|851832|P3|NOT COMPLETED|Week 2 Stratification & Re-Randomization||0
346624|NCT02452892|851833|P2|NOT COMPLETED|Week 2 Stratification & Re-Randomization||0
346625|NCT02452892|851834|P1|NOT COMPLETED|Week 2 Stratification & Re-Randomization||2
346626|NCT02452892|851831|P4|COMPLETED|Week 2 Stratification & Re-Randomization||39
346627|NCT02452892|851832|P3|COMPLETED|Week 2 Stratification & Re-Randomization||7
346628|NCT02452892|851833|P2|COMPLETED|Week 2 Stratification & Re-Randomization||7
346629|NCT02452892|851834|P1|COMPLETED|Week 2 Stratification & Re-Randomization||63
346630|NCT02452892|851831|P4|Responders|Week 2 Stratification & Re-Randomization||0
346631|NCT02452892|851832|P3|Responders|Week 2 Stratification & Re-Randomization||7
346632|NCT02452892|851833|P2|Responders|Week 2 Stratification & Re-Randomization||7
346633|NCT02452892|851834|P1|Responders|Week 2 Stratification & Re-Randomization||27
346634|NCT02452892|851831|P4|Non-reponders|Week 2 Stratification & Re-Randomization||41
346635|NCT02452892|851832|P3|Non-reponders|Week 2 Stratification & Re-Randomization||0
346636|NCT02452892|851833|P2|Non-reponders|Week 2 Stratification & Re-Randomization||0
346637|NCT02452892|851834|P1|Non-reponders|Week 2 Stratification & Re-Randomization||38
346638|NCT02452892|851831|P4|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (13), LFMS 20min (14), and LFMS 60 min (14).|41
346639|NCT02452892|851832|P3|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (0),LFMS 20min (0), LFMS 60min (7)|7
346640|NCT02452892|851833|P2|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (0), LFMS 20min (7), and LFMS 60min(0).|7
346641|NCT02452892|851834|P1|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that started LFMS sham (27), LFMS 20min (19), and LFMS 60min (19)|65
346642|NCT02452892|851831|P4|NOT COMPLETED|Week 1 Initial Randommization||0
346643|NCT02452892|851832|P3|NOT COMPLETED|Week 1 Initial Randommization||1
346644|NCT02452892|851833|P2|NOT COMPLETED|Week 1 Initial Randommization||0
346645|NCT02452892|851834|P1|NOT COMPLETED|Week 1 Initial Randommization||1
346646|NCT02452892|851831|P4|COMPLETED|Week 1 Initial Randommization||0
346647|NCT02452892|851832|P3|COMPLETED|Week 1 Initial Randommization||40
346648|NCT02452892|851833|P2|COMPLETED|Week 1 Initial Randommization||40
346649|NCT02452892|851834|P1|COMPLETED|Week 1 Initial Randommization||40
346650|NCT02452892|851831|P4|STARTED|Week 1 Initial Randommization||0
346651|NCT02452892|851832|P3|STARTED|Week 1 Initial Randommization||41
346652|NCT02452892|851833|P2|STARTED|Week 1 Initial Randommization||40
346653|NCT02452892|851834|P1|STARTED|Week 1 Initial Randommization||41
346654|NCT02452528|851865|P2|NOT COMPLETED|Overall Study||1
346655|NCT02452528|851866|P1|NOT COMPLETED|Overall Study||1
346656|NCT02452528|851865|P2|COMPLETED|Overall Study||1
346657|NCT02452528|851866|P1|COMPLETED|Overall Study||1
346658|NCT02452528|851865|P2|STARTED|Overall Study||2
346659|NCT02452528|851866|P1|STARTED|Overall Study||2
346660|NCT02452346|851898|P1|NOT COMPLETED|Overall Study||9
346661|NCT02452346|851898|P1|COMPLETED|Overall Study||3
346662|NCT02452346|851898|P1|STARTED|Overall Study||12
346663|NCT02452320|851906|P2|NOT COMPLETED|Overall Study||1
346664|NCT02452320|851907|P1|NOT COMPLETED|Overall Study||0
346665|NCT02452320|851906|P2|COMPLETED|Overall Study||63
346666|NCT02452320|851907|P1|COMPLETED|Overall Study||64
346667|NCT02452320|851906|P2|STARTED|Overall Study||64
346668|NCT02452320|851907|P1|STARTED|Overall Study||64
346669|NCT02451917|851919|P2|NOT COMPLETED|Second Intervention (24 Weeks)||0
346670|NCT02451917|851920|P1|NOT COMPLETED|Second Intervention (24 Weeks)||0
346671|NCT02451917|851919|P2|COMPLETED|Second Intervention (24 Weeks)||15
346672|NCT02451917|851920|P1|COMPLETED|Second Intervention (24 Weeks)||14
346673|NCT02451917|851919|P2|STARTED|Second Intervention (24 Weeks)||15
346674|NCT02451917|851920|P1|STARTED|Second Intervention (24 Weeks)||14
346675|NCT02451917|851919|P2|NOT COMPLETED|First Intervention (24 Weeks)||3
346676|NCT02451917|851920|P1|NOT COMPLETED|First Intervention (24 Weeks)||2
346677|NCT02451917|851919|P2|COMPLETED|First Intervention (24 Weeks)||15
346678|NCT02451917|851920|P1|COMPLETED|First Intervention (24 Weeks)||14
346679|NCT02451917|851919|P2|STARTED|First Intervention (24 Weeks)||18
346680|NCT02451917|851920|P1|STARTED|First Intervention (24 Weeks)||16
346681|NCT02451358|851942|P4|NOT COMPLETED|Overall Study||0
346682|NCT02451358|851943|P3|NOT COMPLETED|Overall Study||1
346683|NCT02451358|851944|P2|NOT COMPLETED|Overall Study||2
346684|NCT02451358|851945|P1|NOT COMPLETED|Overall Study||1
346685|NCT02451358|851942|P4|COMPLETED|Overall Study||100
346686|NCT02451358|851943|P3|COMPLETED|Overall Study||99
346687|NCT02451358|851944|P2|COMPLETED|Overall Study||98
346688|NCT02451358|851945|P1|COMPLETED|Overall Study||99
346689|NCT02451358|851942|P4|Vaccinated at Day 28|Overall Study|Participants aged 9 years and older received only 1 dose of Quadrivalent Influenza Vaccine.|0
346690|NCT02451358|851943|P3|Vaccinated at Day 28|Overall Study|Participants aged 9 years and older received only 1 dose of Quadrivalent Influenza Vaccine.|0
346691|NCT02451358|851944|P2|Vaccinated at Day 28|Overall Study||98
346692|NCT02451358|851945|P1|Vaccinated at Day 28|Overall Study||99
346693|NCT02451358|851942|P4|Vaccinated at Day 0|Overall Study||100
346694|NCT02451358|851943|P3|Vaccinated at Day 0|Overall Study||100
346695|NCT02451358|851944|P2|Vaccinated at Day 0|Overall Study||100
346696|NCT02451358|851945|P1|Vaccinated at Day 0|Overall Study||100
346697|NCT02451358|851942|P4|STARTED|Overall Study||100
346698|NCT02451358|851943|P3|STARTED|Overall Study||100
346699|NCT02451358|851944|P2|STARTED|Overall Study||100
346700|NCT02451358|851945|P1|STARTED|Overall Study||100
346701|NCT02451150|851969|P2|NOT COMPLETED|Overall Study||0
346702|NCT02451150|851970|P1|NOT COMPLETED|Overall Study||0
346703|NCT02451150|851969|P2|COMPLETED|Overall Study||3
346704|NCT02451150|851970|P1|COMPLETED|Overall Study||3
346705|NCT02451150|851969|P2|STARTED|Overall Study||3
346706|NCT02451150|851970|P1|STARTED|Overall Study||3
346707|NCT02450799|852023|P3|NOT COMPLETED|Overall Study||0
346708|NCT02450799|852024|P2|NOT COMPLETED|Overall Study||0
346709|NCT02450799|852025|P1|NOT COMPLETED|Overall Study||0
346710|NCT02450799|852023|P3|COMPLETED|Overall Study||30
346711|NCT02450799|852024|P2|COMPLETED|Overall Study||37
346712|NCT02450799|852025|P1|COMPLETED|Overall Study||31
346713|NCT02450799|852023|P3|STARTED|Overall Study||30
346714|NCT02450799|852024|P2|STARTED|Overall Study||37
346715|NCT02450799|852025|P1|STARTED|Overall Study||31
346716|NCT02450747|852036|P1|NOT COMPLETED|Overall Study||0
346717|NCT02450747|852036|P1|COMPLETED|Overall Study||39
346718|NCT02450747|852036|P1|STARTED|Overall Study||39
346719|NCT02450591|852045|P1|NOT COMPLETED|Overall Study||0
346720|NCT02450591|852045|P1|COMPLETED|Overall Study||4
346721|NCT02450591|852045|P1|STARTED|Overall Study||4
346722|NCT02450539|852051|P2|NOT COMPLETED|Overall Study||33
346723|NCT02450539|852052|P1|NOT COMPLETED|Overall Study||50
346724|NCT02450539|852051|P2|COMPLETED|Overall Study||20
346725|NCT02450539|852052|P1|COMPLETED|Overall Study||56
346726|NCT02450539|852051|P2|Death|Overall Study||20
346727|NCT02450539|852052|P1|Death|Overall Study||56
346728|NCT02450539|852051|P2|Received at Least One Dose of Study Drug|Overall Study||52
346729|NCT02450539|852052|P1|Received at Least One Dose of Study Drug|Overall Study||106
346730|NCT02450539|852051|P2|STARTED|Overall Study||53
346731|NCT02450539|852052|P1|STARTED|Overall Study||106
346732|NCT02450383|852074|P2|NOT COMPLETED|Overall Study||0
346733|NCT02450383|852075|P1|NOT COMPLETED|Overall Study||0
346734|NCT02450383|852074|P2|COMPLETED|Overall Study||10
346735|NCT02450383|852075|P1|COMPLETED|Overall Study||10
346736|NCT02450383|852074|P2|STARTED|Overall Study||10
346737|NCT02450383|852075|P1|STARTED|Overall Study||10
346738|NCT02449915|852089|P2|NOT COMPLETED|Overall Study||4
346739|NCT02449915|852090|P1|NOT COMPLETED|Overall Study||2
346740|NCT02449915|852089|P2|COMPLETED|Overall Study||31
346741|NCT02449915|852090|P1|COMPLETED|Overall Study||33
346742|NCT02449915|852089|P2|STARTED|Overall Study||35
346743|NCT02449915|852090|P1|STARTED|Overall Study||35
346744|NCT02449902|852098|P2|NOT COMPLETED|Overall Study||2
346745|NCT02449902|852099|P1|NOT COMPLETED|Overall Study||0
346746|NCT02449902|852098|P2|COMPLETED|Overall Study||24
346747|NCT02449902|852099|P1|COMPLETED|Overall Study||24
346748|NCT02449902|852098|P2|STARTED|Overall Study||26
346749|NCT02449902|852099|P1|STARTED|Overall Study||24
346750|NCT02449798|852123|P1|NOT COMPLETED|Overall Study||0
346751|NCT02449798|852123|P1|COMPLETED|Overall Study||120
346752|NCT02449798|852123|P1|STARTED|Overall Study||120
346753|NCT02449356|852137|P2|NOT COMPLETED|Overall Study||0
346754|NCT02449356|852138|P1|NOT COMPLETED|Overall Study||0
346755|NCT02449356|852137|P2|COMPLETED|Overall Study||30
346756|NCT02449356|852138|P1|COMPLETED|Overall Study||30
346757|NCT02449356|852137|P2|STARTED|Overall Study||30
346758|NCT02449356|852138|P1|STARTED|Overall Study||30
346759|NCT02449044|852154|P1|NOT COMPLETED|Overall Study||64
346760|NCT02449044|852154|P1|COMPLETED|Overall Study|Participants who completed Weeks 58, 106 and 216 visit.|47
346761|NCT02449044|852154|P1|STARTED|Overall Study||111
346762|NCT02449018|852175|P2|NOT COMPLETED|Overall Study||2
346763|NCT02449018|852176|P1|NOT COMPLETED|Overall Study||12
346764|NCT02449018|852175|P2|COMPLETED|Overall Study||26
346765|NCT02449018|852176|P1|COMPLETED|Overall Study||52
346766|NCT02449018|852175|P2|STARTED|Overall Study||28
346767|NCT02449018|852176|P1|STARTED|Overall Study||64
346768|NCT02448914|852203|P2|NOT COMPLETED|Second Intervention (1 Day)||0
346769|NCT02448914|852204|P1|NOT COMPLETED|Second Intervention (1 Day)||0
346770|NCT02448914|852203|P2|COMPLETED|Second Intervention (1 Day)||5
346771|NCT02448914|852204|P1|COMPLETED|Second Intervention (1 Day)||6
346772|NCT02448914|852203|P2|STARTED|Second Intervention (1 Day)||5
346773|NCT02448914|852204|P1|STARTED|Second Intervention (1 Day)||6
346774|NCT02448914|852203|P2|NOT COMPLETED|First Intervention (1 Day)||0
346775|NCT02448914|852204|P1|NOT COMPLETED|First Intervention (1 Day)||0
346776|NCT02448914|852203|P2|COMPLETED|First Intervention (1 Day)||5
346777|NCT02448914|852204|P1|COMPLETED|First Intervention (1 Day)||6
346778|NCT02448914|852203|P2|STARTED|First Intervention (1 Day)||5
346779|NCT02448914|852204|P1|STARTED|First Intervention (1 Day)||6
346780|NCT02448862|852222|P2|NOT COMPLETED|Overall Study||0
346781|NCT02448862|852223|P1|NOT COMPLETED|Overall Study||0
346782|NCT02448862|852222|P2|COMPLETED|Overall Study||6050
346783|NCT02448862|852223|P1|COMPLETED|Overall Study||4525
346784|NCT02448862|852222|P2|STARTED|Overall Study||6050
346785|NCT02448862|852223|P1|STARTED|Overall Study||4525
346786|NCT02448810|852245|P8|NOT COMPLETED|Overall Study||8
346787|NCT02448810|852246|P7|NOT COMPLETED|Overall Study||18
346788|NCT02448810|852247|P6|NOT COMPLETED|Overall Study||16
346789|NCT02448810|852248|P5|NOT COMPLETED|Overall Study||31
346790|NCT02448810|852249|P4|NOT COMPLETED|Overall Study||3
346791|NCT02448810|852250|P3|NOT COMPLETED|Overall Study||3
346792|NCT02448810|852251|P2|NOT COMPLETED|Overall Study||3
346793|NCT02448810|852252|P1|NOT COMPLETED|Overall Study||3
346794|NCT02448810|852245|P8|COMPLETED|Overall Study||0
346795|NCT02448810|852246|P7|COMPLETED|Overall Study||0
346796|NCT02448810|852247|P6|COMPLETED|Overall Study||0
346797|NCT02448810|852248|P5|COMPLETED|Overall Study||0
346798|NCT02448810|852249|P4|COMPLETED|Overall Study||0
346799|NCT02448810|852250|P3|COMPLETED|Overall Study||0
346800|NCT02448810|852251|P2|COMPLETED|Overall Study||0
346801|NCT02448810|852252|P1|COMPLETED|Overall Study||0
346802|NCT02448810|852245|P8|Treated|Overall Study||7
346803|NCT02448810|852246|P7|Treated|Overall Study||18
346804|NCT02448810|852247|P6|Treated|Overall Study||13
346805|NCT02448810|852248|P5|Treated|Overall Study||29
346806|NCT02448810|852249|P4|Treated|Overall Study||3
346807|NCT02448810|852250|P3|Treated|Overall Study||3
346808|NCT02448810|852251|P2|Treated|Overall Study||3
346809|NCT02448810|852252|P1|Treated|Overall Study||3
346810|NCT02448810|852245|P8|STARTED|Overall Study||8
346811|NCT02448810|852246|P7|STARTED|Overall Study||18
346812|NCT02448810|852247|P6|STARTED|Overall Study||16
346813|NCT02448810|852248|P5|STARTED|Overall Study||31
346814|NCT02448810|852249|P4|STARTED|Overall Study||3
346815|NCT02448810|852250|P3|STARTED|Overall Study||3
346816|NCT02448810|852251|P2|STARTED|Overall Study||3
346817|NCT02448810|852252|P1|STARTED|Overall Study||3
346818|NCT02448563|852322|P2|NOT COMPLETED|Overall Study||11
346819|NCT02448563|852323|P1|NOT COMPLETED|Overall Study||16
346820|NCT02448563|852322|P2|COMPLETED|Overall Study||19
346821|NCT02448563|852323|P1|COMPLETED|Overall Study||16
346822|NCT02448563|852322|P2|STARTED|Overall Study|Randomized after completing Visit 2|30
346823|NCT02448563|852323|P1|STARTED|Overall Study|Randomized after completing Visit 2|32
346824|NCT02448537|852345|P3|NOT COMPLETED|Overall Study||1
346825|NCT02448537|852346|P2|NOT COMPLETED|Overall Study||1
346826|NCT02448537|852347|P1|NOT COMPLETED|Overall Study||1
346827|NCT02448537|852345|P3|COMPLETED|Overall Study||11
346828|NCT02448537|852346|P2|COMPLETED|Overall Study||9
346829|NCT02448537|852347|P1|COMPLETED|Overall Study||19
346830|NCT02448537|852345|P3|STARTED|Overall Study||12
346831|NCT02448537|852346|P2|STARTED|Overall Study||10
346832|NCT02448537|852347|P1|STARTED|Overall Study||20
346833|NCT02447848|852361|P1|NOT COMPLETED|Overall Study||11
346834|NCT02447848|852361|P1|COMPLETED|Overall Study||65
346835|NCT02447848|852361|P1|STARTED|Overall Study||76
346836|NCT02447458|852373|P6|NOT COMPLETED|Overall Study||0
346837|NCT02447458|852374|P5|NOT COMPLETED|Overall Study||0
346838|NCT02447458|852375|P4|NOT COMPLETED|Overall Study||0
346839|NCT02447458|852376|P3|NOT COMPLETED|Overall Study||1
346840|NCT02447458|852377|P2|NOT COMPLETED|Overall Study||0
346841|NCT02447458|852378|P1|NOT COMPLETED|Overall Study||0
346842|NCT02447458|852373|P6|COMPLETED|Overall Study||10
346843|NCT02447458|852374|P5|COMPLETED|Overall Study||6
346844|NCT02447458|852375|P4|COMPLETED|Overall Study||6
346845|NCT02447458|852376|P3|COMPLETED|Overall Study||5
346846|NCT02447458|852377|P2|COMPLETED|Overall Study||6
346847|NCT02447458|852378|P1|COMPLETED|Overall Study||5
346848|NCT02447458|852373|P6|STARTED|Overall Study||10
346849|NCT02447458|852374|P5|STARTED|Overall Study||6
346850|NCT02447458|852375|P4|STARTED|Overall Study||6
346851|NCT02447458|852376|P3|STARTED|Overall Study||6
346852|NCT02447458|852377|P2|STARTED|Overall Study||6
346853|NCT02447458|852378|P1|STARTED|Overall Study||5
346854|NCT02447432|852476|P2|NOT COMPLETED|Epoch 002||0
346855|NCT02447432|852477|P1|NOT COMPLETED|Epoch 002||0
346856|NCT02447432|852476|P2|COMPLETED|Epoch 002||145
346857|NCT02447432|852477|P1|COMPLETED|Epoch 002||152
346858|NCT02447432|852476|P2|STARTED|Epoch 002||145
346859|NCT02447432|852477|P1|STARTED|Epoch 002||152
346860|NCT02447432|852476|P2|NOT COMPLETED|Epoch 001||13
346861|NCT02447432|852477|P1|NOT COMPLETED|Epoch 001||5
346862|NCT02447432|852476|P2|COMPLETED|Epoch 001||147
346863|NCT02447432|852477|P1|COMPLETED|Epoch 001||155
346864|NCT02447432|852476|P2|STARTED|Epoch 001||160
346865|NCT02447432|852477|P1|STARTED|Epoch 001||160
346866|NCT02447328|852509|P1|NOT COMPLETED|Overall Study||1
346867|NCT02447328|852509|P1|COMPLETED|Overall Study||82
346868|NCT02447328|852509|P1|STARTED|Overall Study|Enrolment 85 Screening Failure 2 starting study drug 83|83
346869|NCT02447133|852513|P1|NOT COMPLETED|Overall Study||0
346870|NCT02447133|852513|P1|COMPLETED|Overall Study||12
346871|NCT02447133|852513|P1|STARTED|Overall Study||12
346872|NCT02447029|852521|P2|NOT COMPLETED|Overall Study||2
346873|NCT02447029|852522|P1|NOT COMPLETED|Overall Study||3
346874|NCT02447029|852521|P2|COMPLETED|Overall Study||68
346875|NCT02447029|852522|P1|COMPLETED|Overall Study||69
346876|NCT02447029|852521|P2|Treated|Overall Study||68
346877|NCT02447029|852522|P1|Treated|Overall Study||69
346878|NCT02447029|852521|P2|STARTED|Overall Study||70
346879|NCT02447029|852522|P1|STARTED|Overall Study||72
346880|NCT02446990|852542|P2|NOT COMPLETED|Overall Study||658
346881|NCT02446990|852543|P1|NOT COMPLETED|Overall Study||720
346882|NCT02446990|852542|P2|COMPLETED|Overall Study||8894
346883|NCT02446990|852543|P1|COMPLETED|Overall Study||8830
346884|NCT02446990|852542|P2|STARTED|Overall Study||9552
346885|NCT02446990|852543|P1|STARTED|Overall Study||9550
346886|NCT02446743|852577|P2|NOT COMPLETED|Overall Study||5
346887|NCT02446743|852578|P1|NOT COMPLETED|Overall Study||5
346888|NCT02446743|852577|P2|COMPLETED|Overall Study||250
346889|NCT02446743|852578|P1|COMPLETED|Overall Study||271
346890|NCT02446743|852577|P2|STARTED|Overall Study||255
346891|NCT02446743|852578|P1|STARTED|Overall Study||276
346892|NCT02446717|852710|P5|NOT COMPLETED|Overall Study||1
346893|NCT02446717|852711|P4|NOT COMPLETED|Overall Study||1
346894|NCT02446717|852712|P3|NOT COMPLETED|Overall Study||2
346895|NCT02446717|852713|P2|NOT COMPLETED|Overall Study||1
346896|NCT02446717|852714|P1|NOT COMPLETED|Overall Study||0
346897|NCT02446717|852710|P5|COMPLETED|Overall Study||46
346898|NCT02446717|852711|P4|COMPLETED|Overall Study||43
346899|NCT02446717|852712|P3|COMPLETED|Overall Study||20
346900|NCT02446717|852713|P2|COMPLETED|Overall Study||21
346901|NCT02446717|852714|P1|COMPLETED|Overall Study||6
346902|NCT02446717|852710|P5|STARTED|Overall Study||47
346903|NCT02446717|852711|P4|STARTED|Overall Study||44
346904|NCT02446717|852712|P3|STARTED|Overall Study||22
346905|NCT02446717|852713|P2|STARTED|Overall Study||22
346906|NCT02446717|852714|P1|STARTED|Overall Study||6
346907|NCT02446613|852743|P2|NOT COMPLETED|Overall Study||0
346908|NCT02446613|852744|P1|NOT COMPLETED|Overall Study||0
346909|NCT02446613|852743|P2|COMPLETED|Overall Study||10
346910|NCT02446613|852744|P1|COMPLETED|Overall Study||6
346911|NCT02446613|852743|P2|STARTED|Overall Study||10
346912|NCT02446613|852744|P1|STARTED|Overall Study||6
346913|NCT02446496|852766|P1|NOT COMPLETED|Overall Study||0
346914|NCT02446496|852766|P1|COMPLETED|Overall Study||24
346915|NCT02446496|852766|P1|STARTED|Overall Study||24
346916|NCT02446483|852778|P2|NOT COMPLETED|Period 3: Intervention Period 2||0
346917|NCT02446483|852779|P1|NOT COMPLETED|Period 3: Intervention Period 2||0
346918|NCT02446483|852778|P2|COMPLETED|Period 3: Intervention Period 2||30
346919|NCT02446483|852779|P1|COMPLETED|Period 3: Intervention Period 2||30
346920|NCT02446483|852778|P2|STARTED|Period 3: Intervention Period 2||30
346921|NCT02446483|852779|P1|STARTED|Period 3: Intervention Period 2||30
346922|NCT02446483|852778|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
346923|NCT02446483|852779|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
346924|NCT02446483|852778|P2|COMPLETED|Period 2: Washout Period (7 Days)||30
346925|NCT02446483|852779|P1|COMPLETED|Period 2: Washout Period (7 Days)||30
346926|NCT02446483|852778|P2|STARTED|Period 2: Washout Period (7 Days)||30
346927|NCT02446483|852779|P1|STARTED|Period 2: Washout Period (7 Days)||30
346928|NCT02446483|852778|P2|NOT COMPLETED|Period 1: Intervention Period 1||0
346929|NCT02446483|852779|P1|NOT COMPLETED|Period 1: Intervention Period 1||0
346930|NCT02446483|852778|P2|COMPLETED|Period 1: Intervention Period 1||30
346931|NCT02446483|852779|P1|COMPLETED|Period 1: Intervention Period 1||30
346932|NCT02446483|852778|P2|STARTED|Period 1: Intervention Period 1||30
346933|NCT02446483|852779|P1|STARTED|Period 1: Intervention Period 1||30
346934|NCT02446171|852795|P4|NOT COMPLETED|Overall Study||0
346935|NCT02446171|852796|P3|NOT COMPLETED|Overall Study||2
346936|NCT02446171|852797|P2|NOT COMPLETED|Overall Study||0
346937|NCT02446171|852798|P1|NOT COMPLETED|Overall Study||0
346938|NCT02446171|852795|P4|COMPLETED|Overall Study||11
346939|NCT02446171|852796|P3|COMPLETED|Overall Study||9
346940|NCT02446171|852797|P2|COMPLETED|Overall Study||11
346941|NCT02446171|852798|P1|COMPLETED|Overall Study||11
346942|NCT02446171|852795|P4|STARTED|Overall Study||11
346943|NCT02446171|852796|P3|STARTED|Overall Study||11
346944|NCT02446171|852797|P2|STARTED|Overall Study||11
346945|NCT02446171|852798|P1|STARTED|Overall Study||11
346946|NCT02446015|852869|P2|NOT COMPLETED|Overall Study||1
346947|NCT02446015|852870|P1|NOT COMPLETED|Overall Study||1
346948|NCT02446015|852869|P2|COMPLETED|Overall Study||62
346949|NCT02446015|852870|P1|COMPLETED|Overall Study||33
346950|NCT02446015|852869|P2|STARTED|Overall Study||63
346951|NCT02446015|852870|P1|STARTED|Overall Study||34
346952|NCT02445807|852883|P2|NOT COMPLETED|Overall Study||0
346953|NCT02445807|852884|P1|NOT COMPLETED|Overall Study||0
346954|NCT02445807|852883|P2|COMPLETED|Overall Study||89
346955|NCT02445807|852884|P1|COMPLETED|Overall Study||176
346956|NCT02445807|852883|P2|STARTED|Overall Study||89
346957|NCT02445807|852884|P1|STARTED|Overall Study||176
346958|NCT02445755|852894|P1|NOT COMPLETED|Overall Study||13
346959|NCT02445755|852894|P1|COMPLETED|Overall Study||100
346960|NCT02445755|852894|P1|STARTED|Overall Study|Neonates will be tested with 3 transcutaneous (TcB) devices +/-30 minutes of routine bilirubin labs|113
346961|NCT02445573|852903|P2|NOT COMPLETED|Overall Study||2
346962|NCT02445573|852904|P1|NOT COMPLETED|Overall Study||1
346963|NCT02445573|852903|P2|COMPLETED|Overall Study||38
346964|NCT02445573|852904|P1|COMPLETED|Overall Study||39
346965|NCT02445573|852903|P2|STARTED|Overall Study||40
346966|NCT02445573|852904|P1|STARTED|Overall Study||40
346967|NCT02445326|852920|P2|NOT COMPLETED|Overall Study||1
346968|NCT02445326|852921|P1|NOT COMPLETED|Overall Study||2
346969|NCT02445326|852920|P2|COMPLETED|Overall Study||37
346970|NCT02445326|852921|P1|COMPLETED|Overall Study||33
346971|NCT02445326|852920|P2|STARTED|Overall Study||38
346972|NCT02445326|852921|P1|STARTED|Overall Study||35
346973|NCT02445287|852939|P2|NOT COMPLETED|Overall Study||0
346974|NCT02445287|852940|P1|NOT COMPLETED|Overall Study||0
346975|NCT02445287|852939|P2|COMPLETED|Overall Study||13
346976|NCT02445287|852940|P1|COMPLETED|Overall Study||35
346977|NCT02445287|852939|P2|STARTED|Overall Study||13
346978|NCT02445287|852940|P1|STARTED|Overall Study||35
346979|NCT02445196|852955|P2|NOT COMPLETED|Overall Study||6
346980|NCT02445196|852956|P1|NOT COMPLETED|Overall Study||11
346981|NCT02445196|852955|P2|COMPLETED|Overall Study||52
346982|NCT02445196|852956|P1|COMPLETED|Overall Study||51
346983|NCT02445196|852955|P2|STARTED|Overall Study||58
346984|NCT02445196|852956|P1|STARTED|Overall Study||62
346985|NCT02444936|852971|P2|NOT COMPLETED|Overall Study||0
346986|NCT02444936|852972|P1|NOT COMPLETED|Overall Study||0
346987|NCT02444936|852971|P2|COMPLETED|Overall Study||12
346988|NCT02444936|852972|P1|COMPLETED|Overall Study||10
346989|NCT02444936|852971|P2|STARTED|Overall Study||12
346990|NCT02444936|852972|P1|STARTED|Overall Study||10
346991|NCT02444715|852980|P2|NOT COMPLETED|Overall Study||16
346992|NCT02444715|852981|P1|NOT COMPLETED|Overall Study||10
346993|NCT02444715|852980|P2|COMPLETED|Overall Study||32
346994|NCT02444715|852981|P1|COMPLETED|Overall Study||36
346995|NCT02444715|852980|P2|STARTED|Overall Study||48
346996|NCT02444715|852981|P1|STARTED|Overall Study||46
346997|NCT02444533|853012|P2|NOT COMPLETED|Overall Study||4
346998|NCT02444533|853013|P1|NOT COMPLETED|Overall Study||2
346999|NCT02444533|853012|P2|COMPLETED|Overall Study||18
347000|NCT02444533|853013|P1|COMPLETED|Overall Study||15
347001|NCT02444533|853012|P2|STARTED|Overall Study||22
347002|NCT02444533|853013|P1|STARTED|Overall Study||17
347003|NCT02444182|853029|P2|NOT COMPLETED|Overall Study||5
347004|NCT02444182|853030|P1|NOT COMPLETED|Overall Study||2
347005|NCT02444182|853029|P2|COMPLETED|Overall Study||49
347006|NCT02444182|853030|P1|COMPLETED|Overall Study||52
347007|NCT02444182|853029|P2|STARTED|Overall Study||54
347008|NCT02444182|853030|P1|STARTED|Overall Study||54
347009|NCT02443883|853042|P4|NOT COMPLETED|Overall Study||7
347010|NCT02443883|853043|P3|NOT COMPLETED|Overall Study||4
347011|NCT02443883|853044|P2|NOT COMPLETED|Overall Study||5
347012|NCT02443883|853045|P1|NOT COMPLETED|Overall Study||6
347013|NCT02443883|853042|P4|COMPLETED|Overall Study||34
347014|NCT02443883|853043|P3|COMPLETED|Overall Study||37
347015|NCT02443883|853044|P2|COMPLETED|Overall Study||37
347016|NCT02443883|853045|P1|COMPLETED|Overall Study||34
347017|NCT02443883|853042|P4|Received at Least One Dose of Study Drug|Overall Study||40
347018|NCT02443883|853043|P3|Received at Least One Dose of Study Drug|Overall Study||41
347019|NCT02443883|853044|P2|Received at Least One Dose of Study Drug|Overall Study||42
347020|NCT02443883|853045|P1|Received at Least One Dose of Study Drug|Overall Study||38
347021|NCT02443883|853042|P4|STARTED|Overall Study||41
347022|NCT02443883|853043|P3|STARTED|Overall Study||41
347023|NCT02443883|853044|P2|STARTED|Overall Study||42
347024|NCT02443883|853045|P1|STARTED|Overall Study||40
347025|NCT02443792|853065|P2|NOT COMPLETED|Overall Study||2
347026|NCT02443792|853066|P1|NOT COMPLETED|Overall Study||7
347027|NCT02443792|853065|P2|COMPLETED|Overall Study||23
347028|NCT02443792|853066|P1|COMPLETED|Overall Study||43
347029|NCT02443792|853065|P2|STARTED|Overall Study||25
347030|NCT02443792|853066|P1|STARTED|Overall Study||50
347031|NCT02443740|853084|P11|NOT COMPLETED|Intervention Period 4 (3 Days)||0
347032|NCT02443740|853085|P10|NOT COMPLETED|Intervention Period 4 (3 Days)||0
347033|NCT02443740|853086|P9|NOT COMPLETED|Intervention Period 4 (3 Days)||0
347034|NCT02443740|853087|P8|NOT COMPLETED|Intervention Period 4 (3 Days)||0
347035|NCT02443740|853088|P7|NOT COMPLETED|Intervention Period 4 (3 Days)||0
347036|NCT02443740|853089|P6|NOT COMPLETED|Intervention Period 4 (3 Days)||0
347037|NCT02443740|853090|P5|NOT COMPLETED|Intervention Period 4 (3 Days)||0
347038|NCT02443740|853091|P4|NOT COMPLETED|Intervention Period 4 (3 Days)||0
347039|NCT02443740|853092|P3|NOT COMPLETED|Intervention Period 4 (3 Days)||0
347040|NCT02443740|853093|P2|NOT COMPLETED|Intervention Period 4 (3 Days)||0
347041|NCT02443740|853094|P1|NOT COMPLETED|Intervention Period 4 (3 Days)||0
347042|NCT02443740|853084|P11|COMPLETED|Intervention Period 4 (3 Days)||0
347043|NCT02443740|853085|P10|COMPLETED|Intervention Period 4 (3 Days)||0
347044|NCT02443740|853086|P9|COMPLETED|Intervention Period 4 (3 Days)||0
347045|NCT02443740|853087|P8|COMPLETED|Intervention Period 4 (3 Days)||2
347046|NCT02443740|853088|P7|COMPLETED|Intervention Period 4 (3 Days)||2
347047|NCT02443740|853089|P6|COMPLETED|Intervention Period 4 (3 Days)||2
347048|NCT02443740|853090|P5|COMPLETED|Intervention Period 4 (3 Days)||2
347049|NCT02443740|853091|P4|COMPLETED|Intervention Period 4 (3 Days)||3
347050|NCT02443740|853092|P3|COMPLETED|Intervention Period 4 (3 Days)||2
347051|NCT02443740|853093|P2|COMPLETED|Intervention Period 4 (3 Days)||2
347052|NCT02443740|853094|P1|COMPLETED|Intervention Period 4 (3 Days)||1
347053|NCT02443740|853084|P11|STARTED|Intervention Period 4 (3 Days)||0
347054|NCT02443740|853085|P10|STARTED|Intervention Period 4 (3 Days)||0
347055|NCT02443740|853086|P9|STARTED|Intervention Period 4 (3 Days)||0
347056|NCT02443740|853087|P8|STARTED|Intervention Period 4 (3 Days)||2
347057|NCT02443740|853088|P7|STARTED|Intervention Period 4 (3 Days)||2
347058|NCT02443740|853089|P6|STARTED|Intervention Period 4 (3 Days)||2
347059|NCT02443740|853090|P5|STARTED|Intervention Period 4 (3 Days)||2
347060|NCT02443740|853091|P4|STARTED|Intervention Period 4 (3 Days)||3
347061|NCT02443740|853092|P3|STARTED|Intervention Period 4 (3 Days)||2
347062|NCT02443740|853093|P2|STARTED|Intervention Period 4 (3 Days)||2
347063|NCT02443740|853094|P1|STARTED|Intervention Period 4 (3 Days)||1
347064|NCT02443740|853084|P11|NOT COMPLETED|Washout Period 3 (7 Days)||0
347065|NCT02443740|853085|P10|NOT COMPLETED|Washout Period 3 (7 Days)||0
347066|NCT02443740|853086|P9|NOT COMPLETED|Washout Period 3 (7 Days)||0
347067|NCT02443740|853087|P8|NOT COMPLETED|Washout Period 3 (7 Days)||0
347068|NCT02443740|853088|P7|NOT COMPLETED|Washout Period 3 (7 Days)||0
347069|NCT02443740|853089|P6|NOT COMPLETED|Washout Period 3 (7 Days)||0
347070|NCT02443740|853090|P5|NOT COMPLETED|Washout Period 3 (7 Days)||0
347071|NCT02443740|853091|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
347072|NCT02443740|853092|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
347073|NCT02443740|853093|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
347074|NCT02443740|853094|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
347075|NCT02443740|853084|P11|COMPLETED|Washout Period 3 (7 Days)||0
347076|NCT02443740|853085|P10|COMPLETED|Washout Period 3 (7 Days)||0
347077|NCT02443740|853086|P9|COMPLETED|Washout Period 3 (7 Days)||0
347078|NCT02443740|853087|P8|COMPLETED|Washout Period 3 (7 Days)||2
347079|NCT02443740|853088|P7|COMPLETED|Washout Period 3 (7 Days)||2
347080|NCT02443740|853089|P6|COMPLETED|Washout Period 3 (7 Days)||2
347081|NCT02443740|853090|P5|COMPLETED|Washout Period 3 (7 Days)||2
347082|NCT02443740|853091|P4|COMPLETED|Washout Period 3 (7 Days)||3
347083|NCT02443740|853092|P3|COMPLETED|Washout Period 3 (7 Days)||2
347084|NCT02443740|853093|P2|COMPLETED|Washout Period 3 (7 Days)||2
347085|NCT02443740|853094|P1|COMPLETED|Washout Period 3 (7 Days)||1
347086|NCT02443740|853084|P11|STARTED|Washout Period 3 (7 Days)||0
347087|NCT02443740|853085|P10|STARTED|Washout Period 3 (7 Days)||0
347088|NCT02443740|853086|P9|STARTED|Washout Period 3 (7 Days)||0
347089|NCT02443740|853087|P8|STARTED|Washout Period 3 (7 Days)||2
347090|NCT02443740|853088|P7|STARTED|Washout Period 3 (7 Days)||2
347091|NCT02443740|853089|P6|STARTED|Washout Period 3 (7 Days)||2
347092|NCT02443740|853090|P5|STARTED|Washout Period 3 (7 Days)||2
347093|NCT02443740|853091|P4|STARTED|Washout Period 3 (7 Days)||3
347094|NCT02443740|853092|P3|STARTED|Washout Period 3 (7 Days)||2
347095|NCT02443740|853093|P2|STARTED|Washout Period 3 (7 Days)||2
347096|NCT02443740|853094|P1|STARTED|Washout Period 3 (7 Days)||1
347097|NCT02443740|853084|P11|NOT COMPLETED|Intervention Period 3 (3 Days)||0
347098|NCT02443740|853085|P10|NOT COMPLETED|Intervention Period 3 (3 Days)||0
347099|NCT02443740|853086|P9|NOT COMPLETED|Intervention Period 3 (3 Days)||0
347100|NCT02443740|853087|P8|NOT COMPLETED|Intervention Period 3 (3 Days)||0
347101|NCT02443740|853088|P7|NOT COMPLETED|Intervention Period 3 (3 Days)||0
347102|NCT02443740|853089|P6|NOT COMPLETED|Intervention Period 3 (3 Days)||0
347103|NCT02443740|853090|P5|NOT COMPLETED|Intervention Period 3 (3 Days)||0
347104|NCT02443740|853091|P4|NOT COMPLETED|Intervention Period 3 (3 Days)||0
347105|NCT02443740|853092|P3|NOT COMPLETED|Intervention Period 3 (3 Days)||0
347106|NCT02443740|853093|P2|NOT COMPLETED|Intervention Period 3 (3 Days)||0
347107|NCT02443740|853094|P1|NOT COMPLETED|Intervention Period 3 (3 Days)||0
347108|NCT02443740|853084|P11|COMPLETED|Intervention Period 3 (3 Days)||0
347109|NCT02443740|853085|P10|COMPLETED|Intervention Period 3 (3 Days)||0
347110|NCT02443740|853086|P9|COMPLETED|Intervention Period 3 (3 Days)||0
347111|NCT02443740|853087|P8|COMPLETED|Intervention Period 3 (3 Days)||2
347112|NCT02443740|853088|P7|COMPLETED|Intervention Period 3 (3 Days)||2
347113|NCT02443740|853089|P6|COMPLETED|Intervention Period 3 (3 Days)||2
347114|NCT02443740|853090|P5|COMPLETED|Intervention Period 3 (3 Days)||2
347115|NCT02443740|853091|P4|COMPLETED|Intervention Period 3 (3 Days)||3
347116|NCT02443740|853092|P3|COMPLETED|Intervention Period 3 (3 Days)||2
347117|NCT02443740|853093|P2|COMPLETED|Intervention Period 3 (3 Days)||2
347118|NCT02443740|853094|P1|COMPLETED|Intervention Period 3 (3 Days)||1
347119|NCT02443740|853084|P11|STARTED|Intervention Period 3 (3 Days)||0
347120|NCT02443740|853085|P10|STARTED|Intervention Period 3 (3 Days)||0
347121|NCT02443740|853086|P9|STARTED|Intervention Period 3 (3 Days)||0
347122|NCT02443740|853087|P8|STARTED|Intervention Period 3 (3 Days)||2
347123|NCT02443740|853088|P7|STARTED|Intervention Period 3 (3 Days)||2
347124|NCT02443740|853089|P6|STARTED|Intervention Period 3 (3 Days)||2
347125|NCT02443740|853090|P5|STARTED|Intervention Period 3 (3 Days)||2
347126|NCT02443740|853091|P4|STARTED|Intervention Period 3 (3 Days)||3
347127|NCT02443740|853092|P3|STARTED|Intervention Period 3 (3 Days)||2
347128|NCT02443740|853093|P2|STARTED|Intervention Period 3 (3 Days)||2
347129|NCT02443740|853094|P1|STARTED|Intervention Period 3 (3 Days)||1
347130|NCT02443740|853084|P11|NOT COMPLETED|Washout Period 2 (7 Days)||0
347131|NCT02443740|853085|P10|NOT COMPLETED|Washout Period 2 (7 Days)||0
347132|NCT02443740|853086|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
347133|NCT02443740|853087|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
347134|NCT02443740|853088|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
347135|NCT02443740|853089|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
347136|NCT02443740|853090|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
347137|NCT02443740|853091|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
347138|NCT02443740|853092|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
347139|NCT02443740|853093|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
347140|NCT02443740|853094|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
347141|NCT02443740|853084|P11|COMPLETED|Washout Period 2 (7 Days)||0
347142|NCT02443740|853085|P10|COMPLETED|Washout Period 2 (7 Days)||0
347143|NCT02443740|853086|P9|COMPLETED|Washout Period 2 (7 Days)||0
347144|NCT02443740|853087|P8|COMPLETED|Washout Period 2 (7 Days)||2
347145|NCT02443740|853088|P7|COMPLETED|Washout Period 2 (7 Days)||2
347146|NCT02443740|853089|P6|COMPLETED|Washout Period 2 (7 Days)||2
347147|NCT02443740|853090|P5|COMPLETED|Washout Period 2 (7 Days)||2
347148|NCT02443740|853091|P4|COMPLETED|Washout Period 2 (7 Days)||3
347149|NCT02443740|853092|P3|COMPLETED|Washout Period 2 (7 Days)||2
347150|NCT02443740|853093|P2|COMPLETED|Washout Period 2 (7 Days)||2
347151|NCT02443740|853094|P1|COMPLETED|Washout Period 2 (7 Days)||1
347152|NCT02443740|853084|P11|STARTED|Washout Period 2 (7 Days)||0
347153|NCT02443740|853085|P10|STARTED|Washout Period 2 (7 Days)||0
347154|NCT02443740|853086|P9|STARTED|Washout Period 2 (7 Days)||0
347155|NCT02443740|853087|P8|STARTED|Washout Period 2 (7 Days)||2
347156|NCT02443740|853088|P7|STARTED|Washout Period 2 (7 Days)||2
347157|NCT02443740|853089|P6|STARTED|Washout Period 2 (7 Days)||2
347158|NCT02443740|853090|P5|STARTED|Washout Period 2 (7 Days)||2
347159|NCT02443740|853091|P4|STARTED|Washout Period 2 (7 Days)||3
347160|NCT02443740|853092|P3|STARTED|Washout Period 2 (7 Days)||2
347161|NCT02443740|853093|P2|STARTED|Washout Period 2 (7 Days)||2
347162|NCT02443740|853094|P1|STARTED|Washout Period 2 (7 Days)||1
347163|NCT02443740|853084|P11|NOT COMPLETED|Intervention Period 2 (3 Days)||0
347164|NCT02443740|853085|P10|NOT COMPLETED|Intervention Period 2 (3 Days)||0
347165|NCT02443740|853086|P9|NOT COMPLETED|Intervention Period 2 (3 Days)||0
347166|NCT02443740|853087|P8|NOT COMPLETED|Intervention Period 2 (3 Days)||0
347167|NCT02443740|853088|P7|NOT COMPLETED|Intervention Period 2 (3 Days)||0
347168|NCT02443740|853089|P6|NOT COMPLETED|Intervention Period 2 (3 Days)||0
347169|NCT02443740|853090|P5|NOT COMPLETED|Intervention Period 2 (3 Days)||0
347170|NCT02443740|853091|P4|NOT COMPLETED|Intervention Period 2 (3 Days)||0
347171|NCT02443740|853092|P3|NOT COMPLETED|Intervention Period 2 (3 Days)||0
347172|NCT02443740|853093|P2|NOT COMPLETED|Intervention Period 2 (3 Days)||0
347173|NCT02443740|853094|P1|NOT COMPLETED|Intervention Period 2 (3 Days)||0
347174|NCT02443740|853084|P11|COMPLETED|Intervention Period 2 (3 Days)||3
347175|NCT02443740|853085|P10|COMPLETED|Intervention Period 2 (3 Days)||3
347176|NCT02443740|853086|P9|COMPLETED|Intervention Period 2 (3 Days)||0
347177|NCT02443740|853087|P8|COMPLETED|Intervention Period 2 (3 Days)||2
347178|NCT02443740|853088|P7|COMPLETED|Intervention Period 2 (3 Days)||2
347179|NCT02443740|853089|P6|COMPLETED|Intervention Period 2 (3 Days)||2
347180|NCT02443740|853090|P5|COMPLETED|Intervention Period 2 (3 Days)||2
347181|NCT02443740|853091|P4|COMPLETED|Intervention Period 2 (3 Days)||3
347182|NCT02443740|853092|P3|COMPLETED|Intervention Period 2 (3 Days)||2
347183|NCT02443740|853093|P2|COMPLETED|Intervention Period 2 (3 Days)||2
347184|NCT02443740|853094|P1|COMPLETED|Intervention Period 2 (3 Days)||1
347185|NCT02443740|853084|P11|STARTED|Intervention Period 2 (3 Days)||3
347186|NCT02443740|853085|P10|STARTED|Intervention Period 2 (3 Days)||3
347187|NCT02443740|853086|P9|STARTED|Intervention Period 2 (3 Days)||0
347188|NCT02443740|853087|P8|STARTED|Intervention Period 2 (3 Days)||2
347189|NCT02443740|853088|P7|STARTED|Intervention Period 2 (3 Days)||2
347190|NCT02443740|853089|P6|STARTED|Intervention Period 2 (3 Days)||2
347191|NCT02443740|853090|P5|STARTED|Intervention Period 2 (3 Days)||2
347192|NCT02443740|853091|P4|STARTED|Intervention Period 2 (3 Days)||3
347193|NCT02443740|853092|P3|STARTED|Intervention Period 2 (3 Days)||2
347194|NCT02443740|853093|P2|STARTED|Intervention Period 2 (3 Days)||2
347195|NCT02443740|853094|P1|STARTED|Intervention Period 2 (3 Days)||1
347196|NCT02443740|853084|P11|NOT COMPLETED|Washout Period 1 (7 Days)||0
347197|NCT02443740|853085|P10|NOT COMPLETED|Washout Period 1 (7 Days)||0
347198|NCT02443740|853086|P9|NOT COMPLETED|Washout Period 1 (7 Days)||0
347199|NCT02443740|853087|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
347200|NCT02443740|853088|P7|NOT COMPLETED|Washout Period 1 (7 Days)||0
347201|NCT02443740|853089|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
347202|NCT02443740|853090|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
347203|NCT02443740|853091|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
347204|NCT02443740|853092|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
347205|NCT02443740|853093|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
347206|NCT02443740|853094|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
347207|NCT02443740|853084|P11|COMPLETED|Washout Period 1 (7 Days)||3
347208|NCT02443740|853085|P10|COMPLETED|Washout Period 1 (7 Days)||3
347209|NCT02443740|853086|P9|COMPLETED|Washout Period 1 (7 Days)||0
347210|NCT02443740|853087|P8|COMPLETED|Washout Period 1 (7 Days)||2
347211|NCT02443740|853088|P7|COMPLETED|Washout Period 1 (7 Days)||2
347212|NCT02443740|853089|P6|COMPLETED|Washout Period 1 (7 Days)||2
347213|NCT02443740|853090|P5|COMPLETED|Washout Period 1 (7 Days)||2
347214|NCT02443740|853091|P4|COMPLETED|Washout Period 1 (7 Days)||3
347215|NCT02443740|853092|P3|COMPLETED|Washout Period 1 (7 Days)||2
347216|NCT02443740|853093|P2|COMPLETED|Washout Period 1 (7 Days)||2
347217|NCT02443740|853094|P1|COMPLETED|Washout Period 1 (7 Days)||1
347218|NCT02443740|853084|P11|STARTED|Washout Period 1 (7 Days)||3
347219|NCT02443740|853085|P10|STARTED|Washout Period 1 (7 Days)||3
347220|NCT02443740|853086|P9|STARTED|Washout Period 1 (7 Days)||0
347221|NCT02443740|853087|P8|STARTED|Washout Period 1 (7 Days)||2
347222|NCT02443740|853088|P7|STARTED|Washout Period 1 (7 Days)||2
347223|NCT02443740|853089|P6|STARTED|Washout Period 1 (7 Days)||2
347224|NCT02443740|853090|P5|STARTED|Washout Period 1 (7 Days)||2
347225|NCT02443740|853091|P4|STARTED|Washout Period 1 (7 Days)||3
347226|NCT02443740|853092|P3|STARTED|Washout Period 1 (7 Days)||2
347227|NCT02443740|853093|P2|STARTED|Washout Period 1 (7 Days)||2
347228|NCT02443740|853094|P1|STARTED|Washout Period 1 (7 Days)||1
347229|NCT02443740|853084|P11|NOT COMPLETED|Intervention Period 1 (3 Days)||0
347230|NCT02443740|853085|P10|NOT COMPLETED|Intervention Period 1 (3 Days)||0
347231|NCT02443740|853086|P9|NOT COMPLETED|Intervention Period 1 (3 Days)||0
347232|NCT02443740|853087|P8|NOT COMPLETED|Intervention Period 1 (3 Days)||0
347233|NCT02443740|853088|P7|NOT COMPLETED|Intervention Period 1 (3 Days)||1
347234|NCT02443740|853089|P6|NOT COMPLETED|Intervention Period 1 (3 Days)||2
347235|NCT02443740|853090|P5|NOT COMPLETED|Intervention Period 1 (3 Days)||0
347236|NCT02443740|853091|P4|NOT COMPLETED|Intervention Period 1 (3 Days)||0
347237|NCT02443740|853092|P3|NOT COMPLETED|Intervention Period 1 (3 Days)||0
347238|NCT02443740|853093|P2|NOT COMPLETED|Intervention Period 1 (3 Days)||0
347239|NCT02443740|853094|P1|NOT COMPLETED|Intervention Period 1 (3 Days)||1
347240|NCT02443740|853084|P11|COMPLETED|Intervention Period 1 (3 Days)||3
347241|NCT02443740|853085|P10|COMPLETED|Intervention Period 1 (3 Days)||3
347242|NCT02443740|853086|P9|COMPLETED|Intervention Period 1 (3 Days)||6
347243|NCT02443740|853087|P8|COMPLETED|Intervention Period 1 (3 Days)||2
347244|NCT02443740|853088|P7|COMPLETED|Intervention Period 1 (3 Days)||2
347245|NCT02443740|853089|P6|COMPLETED|Intervention Period 1 (3 Days)||2
347246|NCT02443740|853090|P5|COMPLETED|Intervention Period 1 (3 Days)||2
347247|NCT02443740|853091|P4|COMPLETED|Intervention Period 1 (3 Days)||3
347248|NCT02443740|853092|P3|COMPLETED|Intervention Period 1 (3 Days)||2
347249|NCT02443740|853093|P2|COMPLETED|Intervention Period 1 (3 Days)||2
347250|NCT02443740|853094|P1|COMPLETED|Intervention Period 1 (3 Days)||1
347251|NCT02443740|853084|P11|STARTED|Intervention Period 1 (3 Days)||3
347252|NCT02443740|853085|P10|STARTED|Intervention Period 1 (3 Days)||3
347253|NCT02443740|853086|P9|STARTED|Intervention Period 1 (3 Days)||6
347254|NCT02443740|853087|P8|STARTED|Intervention Period 1 (3 Days)||2
347255|NCT02443740|853088|P7|STARTED|Intervention Period 1 (3 Days)||3
347256|NCT02443740|853089|P6|STARTED|Intervention Period 1 (3 Days)||4
347257|NCT02443740|853090|P5|STARTED|Intervention Period 1 (3 Days)||2
347258|NCT02443740|853091|P4|STARTED|Intervention Period 1 (3 Days)||3
347259|NCT02443740|853092|P3|STARTED|Intervention Period 1 (3 Days)||2
347260|NCT02443740|853093|P2|STARTED|Intervention Period 1 (3 Days)||2
347261|NCT02443740|853094|P1|STARTED|Intervention Period 1 (3 Days)||2
347262|NCT02443402|853275|P2|NOT COMPLETED|Overall Study||3
347263|NCT02443402|853276|P1|NOT COMPLETED|Overall Study||4
347264|NCT02443402|853275|P2|COMPLETED|Overall Study||28
347265|NCT02443402|853276|P1|COMPLETED|Overall Study||32
347266|NCT02443402|853275|P2|STARTED|Overall Study||31
347267|NCT02443402|853276|P1|STARTED|Overall Study||36
347268|NCT02443103|853336|P1|NOT COMPLETED|Overall Study||3
347269|NCT02443103|853336|P1|COMPLETED|Overall Study||1
347270|NCT02443103|853336|P1|STARTED|Overall Study||4
347271|NCT02442804|853343|P2|NOT COMPLETED|Overall Study||1
347272|NCT02442804|853344|P1|NOT COMPLETED|Overall Study||1
347273|NCT02442804|853343|P2|COMPLETED|Overall Study||7
347274|NCT02442804|853344|P1|COMPLETED|Overall Study||7
347275|NCT02442804|853343|P2|STARTED|Overall Study||8
347276|NCT02442804|853344|P1|STARTED|Overall Study||8
347277|NCT02442700|853374|P2|NOT COMPLETED|Later 12 Weeks||0
347278|NCT02442700|853375|P1|NOT COMPLETED|Later 12 Weeks||0
347279|NCT02442700|853374|P2|COMPLETED|Later 12 Weeks||12
347280|NCT02442700|853375|P1|COMPLETED|Later 12 Weeks||12
347281|NCT02442700|853374|P2|STARTED|Later 12 Weeks||12
347282|NCT02442700|853375|P1|STARTED|Later 12 Weeks||12
347283|NCT02442700|853374|P2|NOT COMPLETED|First 12 Weeks||0
347284|NCT02442700|853375|P1|NOT COMPLETED|First 12 Weeks||0
347285|NCT02442700|853374|P2|COMPLETED|First 12 Weeks||12
347286|NCT02442700|853375|P1|COMPLETED|First 12 Weeks||12
347287|NCT02442700|853374|P2|STARTED|First 12 Weeks||12
347288|NCT02442700|853375|P1|STARTED|First 12 Weeks||12
347289|NCT02442349|853383|P1|NOT COMPLETED|Overall Study||171
347290|NCT02442349|853383|P1|COMPLETED|Overall Study||0
347291|NCT02442349|853383|P1|STARTED|Overall Study||171
347292|NCT02442310|853388|P1|NOT COMPLETED|Overall Study||3
347293|NCT02442310|853388|P1|COMPLETED|Overall Study||17
347294|NCT02442310|853388|P1|STARTED|Overall Study||20
347295|NCT02442284|853410|P1|NOT COMPLETED|Overall Study||7
347296|NCT02442284|853410|P1|COMPLETED|Overall Study||92
347297|NCT02442284|853410|P1|STARTED|Overall Study||99
347298|NCT02442271|853417|P1|NOT COMPLETED|Overall Study||4
347299|NCT02442271|853417|P1|COMPLETED|Overall Study||218
347300|NCT02442271|853417|P1|STARTED|Overall Study||222
347301|NCT02441946|853444|P3|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
347302|NCT02441946|853445|P2|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
347303|NCT02441946|853446|P1|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||27
347304|NCT02441946|853444|P3|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
347305|NCT02441946|853445|P2|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
347306|NCT02441946|853446|P1|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||190
347307|NCT02441946|853444|P3|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||0
347308|NCT02441946|853445|P2|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||0
347309|NCT02441946|853446|P1|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||214
347310|NCT02441946|853444|P3|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned abemaciclib + anastrozole post cycle 1.|0
347311|NCT02441946|853445|P2|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned abemaciclib + anastrozole post cycle 1.|0
347312|NCT02441946|853446|P1|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned to abemaciclib + anastrozole post cycle 1.|217
347313|NCT02441946|853444|P3|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
347314|NCT02441946|853445|P2|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||5
347315|NCT02441946|853446|P1|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||2
347316|NCT02441946|853444|P3|COMPLETED|Cycle 1 Period 1 (2 Weeks)||74
347317|NCT02441946|853445|P2|COMPLETED|Cycle 1 Period 1 (2 Weeks)||71
347318|NCT02441946|853446|P1|COMPLETED|Cycle 1 Period 1 (2 Weeks)||72
347319|NCT02441946|853444|P3|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)||74
347320|NCT02441946|853445|P2|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)|1 participant did not receive drug due to an error in randomization.|75
347321|NCT02441946|853446|P1|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)||74
347322|NCT02441946|853444|P3|STARTED|Cycle 1 Period 1 (2 Weeks)||74
347323|NCT02441946|853445|P2|STARTED|Cycle 1 Period 1 (2 Weeks)||76
347324|NCT02441946|853446|P1|STARTED|Cycle 1 Period 1 (2 Weeks)||74
347325|NCT02441517|853458|P1|NOT COMPLETED|Overall Study||4
347326|NCT02441517|853458|P1|COMPLETED|Overall Study||0
347327|NCT02441517|853458|P1|Received Treatment|Overall Study||4
347328|NCT02441517|853458|P1|STARTED|Overall Study||4
347329|NCT02441218|853470|P2|NOT COMPLETED|Overall Study||612
347330|NCT02441218|853471|P1|NOT COMPLETED|Overall Study||578
347331|NCT02441218|853470|P2|COMPLETED|Overall Study||2652
347332|NCT02441218|853471|P1|COMPLETED|Overall Study||2663
347333|NCT02441218|853470|P2|STARTED|Overall Study||3264
347334|NCT02441218|853471|P1|STARTED|Overall Study||3241
347335|NCT02441179|853497|P2|NOT COMPLETED|Overall Study||1
347336|NCT02441179|853498|P1|NOT COMPLETED|Overall Study||1
347337|NCT02441179|853497|P2|COMPLETED|Overall Study||16
347338|NCT02441179|853498|P1|COMPLETED|Overall Study||17
347339|NCT02441179|853497|P2|STARTED|Overall Study||17
347340|NCT02441179|853498|P1|STARTED|Overall Study||18
347341|NCT02441114|853516|P1|NOT COMPLETED|Period3||0
347342|NCT02441114|853516|P1|COMPLETED|Period3||6
347343|NCT02441114|853516|P1|STARTED|Period3||6
347344|NCT02441114|853516|P1|NOT COMPLETED|Washout2||4
347345|NCT02441114|853516|P1|COMPLETED|Washout2||6
347346|NCT02441114|853516|P1|STARTED|Washout2||10
347347|NCT02441114|853516|P1|NOT COMPLETED|Period2||0
347348|NCT02441114|853516|P1|COMPLETED|Period2||10
347349|NCT02441114|853516|P1|STARTED|Period2||10
347350|NCT02441114|853516|P1|NOT COMPLETED|Washout1||0
347351|NCT02441114|853516|P1|COMPLETED|Washout1||10
347352|NCT02441114|853516|P1|STARTED|Washout1||10
347353|NCT02441114|853516|P1|NOT COMPLETED|Period1||0
347354|NCT02441114|853516|P1|COMPLETED|Period1||10
347355|NCT02441114|853516|P1|STARTED|Period1||10
347356|NCT02440659|853524|P2|NOT COMPLETED|Overall Study||335
347357|NCT02440659|853525|P1|NOT COMPLETED|Overall Study||651
347358|NCT02440659|853524|P2|COMPLETED|Overall Study||614
347359|NCT02440659|853525|P1|COMPLETED|Overall Study||1346
347360|NCT02440659|853524|P2|STARTED|Overall Study||949
347361|NCT02440659|853525|P1|STARTED|Overall Study||1997
347362|NCT02440633|853531|P1|NOT COMPLETED|Overall Study||0
347363|NCT02440633|853531|P1|COMPLETED|Overall Study||8
347364|NCT02440633|853531|P1|STARTED|Overall Study||8
347365|NCT02440308|853540|P1|NOT COMPLETED|Overall Study||0
347366|NCT02440308|853540|P1|COMPLETED|Overall Study||10
347367|NCT02440308|853540|P1|STARTED|Overall Study||10
347368|NCT02439879|853547|P2|NOT COMPLETED|Overall Study||0
347369|NCT02439879|853548|P1|NOT COMPLETED|Overall Study||0
347370|NCT02439879|853547|P2|COMPLETED|Overall Study||17
347371|NCT02439879|853548|P1|COMPLETED|Overall Study||16
347372|NCT02439879|853547|P2|STARTED|Overall Study||17
347373|NCT02439879|853548|P1|STARTED|Overall Study||16
347374|NCT02439814|853556|P2|NOT COMPLETED|Overall Study||0
347375|NCT02439814|853557|P1|NOT COMPLETED|Overall Study||0
347376|NCT02439814|853556|P2|COMPLETED|Overall Study||10
347377|NCT02439814|853557|P1|COMPLETED|Overall Study||11
347378|NCT02439814|853556|P2|STARTED|Overall Study||10
347379|NCT02439814|853557|P1|STARTED|Overall Study||11
347380|NCT02439164|853565|P2|NOT COMPLETED|Overall Study||0
347381|NCT02439164|853566|P1|NOT COMPLETED|Overall Study||0
347382|NCT02439164|853565|P2|COMPLETED|Overall Study||18
347383|NCT02439164|853566|P1|COMPLETED|Overall Study||18
347384|NCT02439164|853565|P2|STARTED|Overall Study||18
347385|NCT02439164|853566|P1|STARTED|Overall Study||18
347386|NCT02439138|853579|P1|NOT COMPLETED|Overall Study||3
347387|NCT02439138|853579|P1|COMPLETED|Overall Study||2
347388|NCT02439138|853579|P1|STARTED|Overall Study||5
347389|NCT02438540|853592|P2|NOT COMPLETED|Overall Study||0
347390|NCT02438540|853593|P1|NOT COMPLETED|Overall Study||0
347391|NCT02438540|853592|P2|COMPLETED|Overall Study||20
347392|NCT02438540|853593|P1|COMPLETED|Overall Study||19
347393|NCT02438540|853592|P2|STARTED|Overall Study||20
347394|NCT02438540|853593|P1|STARTED|Overall Study||19
347395|NCT02438137|853635|P2|NOT COMPLETED|Overall Study||6
347396|NCT02438137|853636|P1|NOT COMPLETED|Overall Study||8
347397|NCT02438137|853635|P2|COMPLETED|Overall Study||15
347398|NCT02438137|853636|P1|COMPLETED|Overall Study||36
347399|NCT02438137|853635|P2|STARTED|Overall Study||21
347400|NCT02438137|853636|P1|STARTED|Overall Study||44
347401|NCT02437903|853644|P1|NOT COMPLETED|Overall Study||5
347402|NCT02437903|853644|P1|COMPLETED|Overall Study||25
347403|NCT02437903|853644|P1|STARTED|Overall Study||30
347404|NCT02437513|853652|P1|NOT COMPLETED|Overall Study||2
347405|NCT02437513|853652|P1|COMPLETED|Overall Study||0
347406|NCT02437513|853652|P1|STARTED|Overall Study||2
347407|NCT02437409|853660|P1|NOT COMPLETED|Overall Study||15
347408|NCT02437409|853660|P1|COMPLETED|Overall Study|In total 100 patients fulfilled the in-and exclusion criteria,15 patients were excluded/discontinued|100
347409|NCT02437409|853660|P1|STARTED|Overall Study|Eventually 100 evaluable patients, attrition rate of 15%|115
347410|NCT02437344|853669|P1|NOT COMPLETED|Overall Study||1
347411|NCT02437344|853669|P1|COMPLETED|Overall Study||15
347412|NCT02437344|853669|P1|STARTED|Overall Study||16
347413|NCT02437305|853675|P2|NOT COMPLETED|Overall Study||12
347414|NCT02437305|853676|P1|NOT COMPLETED|Overall Study||18
347415|NCT02437305|853675|P2|COMPLETED|Overall Study||38
347416|NCT02437305|853676|P1|COMPLETED|Overall Study||32
347417|NCT02437305|853675|P2|STARTED|Overall Study||50
347418|NCT02437305|853676|P1|STARTED|Overall Study||50
347419|NCT02437253|853686|P2|NOT COMPLETED|Overall Study||0
347420|NCT02437253|853687|P1|NOT COMPLETED|Overall Study||0
347421|NCT02437253|853686|P2|COMPLETED|Overall Study||1
347422|NCT02437253|853687|P1|COMPLETED|Overall Study||1
347423|NCT02437253|853686|P2|STARTED|Overall Study||1
347424|NCT02437253|853687|P1|STARTED|Overall Study||1
347425|NCT02437162|853704|P3|NOT COMPLETED|Overall Study||1
347426|NCT02437162|853705|P2|NOT COMPLETED|Overall Study||1
347427|NCT02437162|853706|P1|NOT COMPLETED|Overall Study||3
347428|NCT02437162|853704|P3|COMPLETED|Overall Study||114
347429|NCT02437162|853705|P2|COMPLETED|Overall Study||115
347430|NCT02437162|853706|P1|COMPLETED|Overall Study||113
347431|NCT02437162|853704|P3|Randomized and Treated|Overall Study||114
347432|NCT02437162|853705|P2|Randomized and Treated|Overall Study||116
347433|NCT02437162|853706|P1|Randomized and Treated|Overall Study||116
347434|NCT02437162|853704|P3|STARTED|Overall Study||115
347435|NCT02437162|853705|P2|STARTED|Overall Study||116
347436|NCT02437162|853706|P1|STARTED|Overall Study||116
347437|NCT02436811|853717|P3|NOT COMPLETED|Overall Study||7
347438|NCT02436811|853718|P2|NOT COMPLETED|Overall Study||9
347439|NCT02436811|853719|P1|NOT COMPLETED|Overall Study||2
347440|NCT02436811|853717|P3|COMPLETED|Overall Study||53
347441|NCT02436811|853718|P2|COMPLETED|Overall Study||51
347442|NCT02436811|853719|P1|COMPLETED|Overall Study||58
347443|NCT02436811|853717|P3|STARTED|Overall Study||60
347444|NCT02436811|853718|P2|STARTED|Overall Study||60
347445|NCT02436811|853719|P1|STARTED|Overall Study||60
347446|NCT02436577|853733|P6|NOT COMPLETED|Overall Study||0
347447|NCT02436577|853734|P5|NOT COMPLETED|Overall Study||0
347448|NCT02436577|853735|P4|NOT COMPLETED|Overall Study||0
347449|NCT02436577|853736|P3|NOT COMPLETED|Overall Study||0
347450|NCT02436577|853737|P2|NOT COMPLETED|Overall Study||1
347451|NCT02436577|853738|P1|NOT COMPLETED|Overall Study||0
347452|NCT02436577|853733|P6|COMPLETED|Overall Study||7
347453|NCT02436577|853734|P5|COMPLETED|Overall Study||7
347454|NCT02436577|853735|P4|COMPLETED|Overall Study||7
347455|NCT02436577|853736|P3|COMPLETED|Overall Study||7
347456|NCT02436577|853737|P2|COMPLETED|Overall Study||6
347457|NCT02436577|853738|P1|COMPLETED|Overall Study||7
347458|NCT02436577|853733|P6|STARTED|Overall Study||7
347459|NCT02436577|853734|P5|STARTED|Overall Study||7
347460|NCT02436577|853735|P4|STARTED|Overall Study||7
347461|NCT02436577|853736|P3|STARTED|Overall Study||7
347462|NCT02436577|853737|P2|STARTED|Overall Study||7
347463|NCT02436577|853738|P1|STARTED|Overall Study||7
347464|NCT02436330|853793|P2|NOT COMPLETED|Cohort 6||1
347465|NCT02436330|853794|P1|NOT COMPLETED|Cohort 6||3
347466|NCT02436330|853793|P2|COMPLETED|Cohort 6||4
347467|NCT02436330|853794|P1|COMPLETED|Cohort 6||1
347468|NCT02436330|853793|P2|STARTED|Cohort 6||5
347469|NCT02436330|853794|P1|STARTED|Cohort 6||4
347470|NCT02436330|853793|P2|NOT COMPLETED|Cohort 5||4
347471|NCT02436330|853794|P1|NOT COMPLETED|Cohort 5||6
347472|NCT02436330|853793|P2|COMPLETED|Cohort 5||1
347473|NCT02436330|853794|P1|COMPLETED|Cohort 5||4
347474|NCT02436330|853793|P2|STARTED|Cohort 5||5
347475|NCT02436330|853794|P1|STARTED|Cohort 5||10
347476|NCT02436330|853793|P2|NOT COMPLETED|Cohort 4||0
347477|NCT02436330|853794|P1|NOT COMPLETED|Cohort 4||2
347478|NCT02436330|853793|P2|COMPLETED|Cohort 4||0
347479|NCT02436330|853794|P1|COMPLETED|Cohort 4||4
347480|NCT02436330|853793|P2|STARTED|Cohort 4|Enrollment too low to have control group. All subjects in this cohort received intervention.|0
347481|NCT02436330|853794|P1|STARTED|Cohort 4||6
347482|NCT02436330|853793|P2|NOT COMPLETED|Cohort 3||0
347483|NCT02436330|853794|P1|NOT COMPLETED|Cohort 3||5
347484|NCT02436330|853793|P2|COMPLETED|Cohort 3||0
347485|NCT02436330|853794|P1|COMPLETED|Cohort 3||7
347486|NCT02436330|853793|P2|STARTED|Cohort 3|Enrollment too low to have control group. All subjects in this cohort received intervention.|0
347487|NCT02436330|853794|P1|STARTED|Cohort 3||12
347488|NCT02436330|853793|P2|NOT COMPLETED|Cohort 2||3
347489|NCT02436330|853794|P1|NOT COMPLETED|Cohort 2||4
347490|NCT02436330|853793|P2|COMPLETED|Cohort 2||7
347491|NCT02436330|853794|P1|COMPLETED|Cohort 2||10
347492|NCT02436330|853793|P2|STARTED|Cohort 2||10
347493|NCT02436330|853794|P1|STARTED|Cohort 2||14
347494|NCT02436330|853793|P2|NOT COMPLETED|Cohort 1||3
347495|NCT02436330|853794|P1|NOT COMPLETED|Cohort 1||5
347496|NCT02436330|853793|P2|COMPLETED|Cohort 1||1
347497|NCT02436330|853794|P1|COMPLETED|Cohort 1||9
347498|NCT02436330|853793|P2|STARTED|Cohort 1||4
347499|NCT02436330|853794|P1|STARTED|Cohort 1||14
347500|NCT02436304|853839|P3|NOT COMPLETED|Overall Study||1
347501|NCT02436304|853840|P2|NOT COMPLETED|Overall Study||2
347502|NCT02436304|853841|P1|NOT COMPLETED|Overall Study||0
347503|NCT02436304|853839|P3|COMPLETED|Overall Study||100
347504|NCT02436304|853840|P2|COMPLETED|Overall Study||100
347505|NCT02436304|853841|P1|COMPLETED|Overall Study||153
347506|NCT02436304|853839|P3|STARTED|Overall Study||101
347507|NCT02436304|853840|P2|STARTED|Overall Study||102
347508|NCT02436304|853841|P1|STARTED|Overall Study||153
347509|NCT02436031|853856|P2|NOT COMPLETED|Second Study Night||0
347510|NCT02436031|853857|P1|NOT COMPLETED|Second Study Night||0
347511|NCT02436031|853856|P2|COMPLETED|Second Study Night||8
347512|NCT02436031|853857|P1|COMPLETED|Second Study Night||7
347513|NCT02436031|853856|P2|STARTED|Second Study Night||8
347514|NCT02436031|853857|P1|STARTED|Second Study Night|1 participant did not tolerate the study setup so did not participate in the second study night|7
347515|NCT02436031|853856|P2|NOT COMPLETED|First Study Night||0
347516|NCT02436031|853857|P1|NOT COMPLETED|First Study Night||0
347517|NCT02436031|853856|P2|COMPLETED|First Study Night||8
347518|NCT02436031|853857|P1|COMPLETED|First Study Night||8
347519|NCT02436031|853856|P2|STARTED|First Study Night||8
347520|NCT02436031|853857|P1|STARTED|First Study Night||8
347521|NCT02435966|853870|P3|NOT COMPLETED|Overall Study||0
347522|NCT02435966|853871|P2|NOT COMPLETED|Overall Study||1
347523|NCT02435966|853872|P1|NOT COMPLETED|Overall Study||0
347524|NCT02435966|853870|P3|COMPLETED|Overall Study||30
347525|NCT02435966|853871|P2|COMPLETED|Overall Study||53
347526|NCT02435966|853872|P1|COMPLETED|Overall Study||47
347527|NCT02435966|853870|P3|Follow-up|Overall Study||30
347528|NCT02435966|853871|P2|Follow-up|Overall Study||53
347529|NCT02435966|853872|P1|Follow-up|Overall Study||47
347530|NCT02435966|853870|P3|Second Intervention|Overall Study||30
347531|NCT02435966|853871|P2|Second Intervention|Overall Study||53
347532|NCT02435966|853872|P1|Second Intervention|Overall Study||47
347533|NCT02435966|853870|P3|First Intervention|Overall Study||30
347534|NCT02435966|853871|P2|First Intervention|Overall Study||54
347535|NCT02435966|853872|P1|First Intervention|Overall Study||47
347536|NCT02435966|853870|P3|STARTED|Overall Study||30
347537|NCT02435966|853871|P2|STARTED|Overall Study||54
347538|NCT02435966|853872|P1|STARTED|Overall Study||47
347539|NCT02435836|853880|P1|NOT COMPLETED|Overall Study||631
347540|NCT02435836|853880|P1|COMPLETED|Overall Study||0
347541|NCT02435836|853880|P1|STARTED|Overall Study||631
347542|NCT02435277|853900|P4|NOT COMPLETED|Overall Study||0
347543|NCT02435277|853901|P3|NOT COMPLETED|Overall Study||0
347544|NCT02435277|853902|P2|NOT COMPLETED|Overall Study||1
347545|NCT02435277|853903|P1|NOT COMPLETED|Overall Study||2
347546|NCT02435277|853900|P4|COMPLETED|Overall Study||11
347547|NCT02435277|853901|P3|COMPLETED|Overall Study||11
347548|NCT02435277|853902|P2|COMPLETED|Overall Study||15
347549|NCT02435277|853903|P1|COMPLETED|Overall Study||10
347550|NCT02435277|853900|P4|STARTED|Overall Study||11
347551|NCT02435277|853901|P3|STARTED|Overall Study||11
347552|NCT02435277|853902|P2|STARTED|Overall Study||16
347553|NCT02435277|853903|P1|STARTED|Overall Study||12
347554|NCT02434939|853919|P2|NOT COMPLETED|Overall Study||49
347555|NCT02434939|853920|P1|NOT COMPLETED|Overall Study||37
347556|NCT02434939|853919|P2|COMPLETED|Overall Study||71
347557|NCT02434939|853920|P1|COMPLETED|Overall Study||83
347558|NCT02434939|853919|P2|STARTED|Overall Study||120
347559|NCT02434939|853920|P1|STARTED|Overall Study||120
347560|NCT02434523|853934|P2|NOT COMPLETED|Overall Study||6
347561|NCT02434523|853935|P1|NOT COMPLETED|Overall Study||5
347562|NCT02434523|853934|P2|COMPLETED|Overall Study||9
347563|NCT02434523|853935|P1|COMPLETED|Overall Study||10
347564|NCT02434523|853934|P2|STARTED|Overall Study||15
347565|NCT02434523|853935|P1|STARTED|Overall Study||15
347566|NCT02434497|853947|P1|NOT COMPLETED|Overall Study||5
347567|NCT02434497|853947|P1|COMPLETED|Overall Study||4
347568|NCT02434497|853947|P1|STARTED|Overall Study||9
347569|NCT02434471|854047|P1|NOT COMPLETED|Overall Study||9
347570|NCT02434471|854047|P1|COMPLETED|Overall Study||25
347571|NCT02434471|854047|P1|STARTED|Overall Study||34
347572|NCT02434146|854054|P1|NOT COMPLETED|Overall Study||0
347573|NCT02434146|854054|P1|COMPLETED|Overall Study||3
347574|NCT02434146|854054|P1|STARTED|Overall Study||3
347575|NCT02433834|854066|P1|NOT COMPLETED|Overall Study||37
347576|NCT02433834|854066|P1|COMPLETED|Overall Study|Subject PT001101-040014 did not complete Period 4 but completed the study. CSR states 210 completed.|211
347577|NCT02433834|854066|P1|SAL 50 µg|Overall Study||167
347578|NCT02433834|854066|P1|Placebo MDI|Overall Study||174
347579|NCT02433834|854066|P1|GP MDI 1.9 µg|Overall Study||107
347580|NCT02433834|854066|P1|GP MDI 3.6 µg|Overall Study||118
347581|NCT02433834|854066|P1|GP MDI 7.2 µg|Overall Study||228
347582|NCT02433834|854066|P1|GP MDI 14.4 µg|Overall Study||230
347583|NCT02433834|854066|P1|GP MDI 28.8 µg|Overall Study||112
347584|NCT02433834|854066|P1|STARTED|Overall Study||248
347585|NCT02433483|854124|P1|NOT COMPLETED|Overall Study||2
347586|NCT02433483|854124|P1|COMPLETED|Overall Study||0
347587|NCT02433483|854124|P1|STARTED|Overall Study||2
347588|NCT02433366|854138|P2|NOT COMPLETED|Overall Study||0
347589|NCT02433366|854139|P1|NOT COMPLETED|Overall Study||0
347590|NCT02433366|854138|P2|COMPLETED|Overall Study||802
347591|NCT02433366|854139|P1|COMPLETED|Overall Study||411
347592|NCT02433366|854138|P2|STARTED|Overall Study||802
347593|NCT02433366|854139|P1|STARTED|Overall Study||411
347594|NCT02433340|854151|P4|NOT COMPLETED|Overall Study||2
347595|NCT02433340|854152|P3|NOT COMPLETED|Overall Study||2
347596|NCT02433340|854153|P2|NOT COMPLETED|Overall Study||2
347597|NCT02433340|854154|P1|NOT COMPLETED|Overall Study||2
347598|NCT02433340|854151|P4|COMPLETED|Overall Study||38
347599|NCT02433340|854152|P3|COMPLETED|Overall Study||37
347600|NCT02433340|854153|P2|COMPLETED|Overall Study||35
347601|NCT02433340|854154|P1|COMPLETED|Overall Study||40
347602|NCT02433340|854151|P4|STARTED|Overall Study||40
347603|NCT02433340|854152|P3|STARTED|Overall Study||39
347604|NCT02433340|854153|P2|STARTED|Overall Study||37
347605|NCT02433340|854154|P1|STARTED|Overall Study||42
347606|NCT02432300|855046|P1|NOT COMPLETED|Overall Study||4
347607|NCT02432300|855046|P1|COMPLETED|Overall Study||13
347608|NCT02432300|855046|P1|STARTED|Overall Study||17
347609|NCT02432287|855055|P2|NOT COMPLETED|Second Intervention||0
347610|NCT02432287|855056|P1|NOT COMPLETED|Second Intervention||0
347611|NCT02432287|855055|P2|COMPLETED|Second Intervention||7
347612|NCT02432287|855056|P1|COMPLETED|Second Intervention||7
347613|NCT02432287|855055|P2|STARTED|Second Intervention||7
347614|NCT02432287|855056|P1|STARTED|Second Intervention||7
347615|NCT02432287|855055|P2|NOT COMPLETED|Washout Period||0
347616|NCT02432287|855056|P1|NOT COMPLETED|Washout Period||0
347617|NCT02432287|855055|P2|COMPLETED|Washout Period||7
347618|NCT02432287|855056|P1|COMPLETED|Washout Period||7
347619|NCT02432287|855055|P2|STARTED|Washout Period||7
347620|NCT02432287|855056|P1|STARTED|Washout Period||7
347621|NCT02432287|855055|P2|NOT COMPLETED|First Intervention||1
347622|NCT02432287|855056|P1|NOT COMPLETED|First Intervention||0
347623|NCT02432287|855055|P2|COMPLETED|First Intervention||7
347624|NCT02432287|855056|P1|COMPLETED|First Intervention||8
347625|NCT02432287|855055|P2|STARTED|First Intervention||8
347626|NCT02432287|855056|P1|STARTED|First Intervention||8
347627|NCT02432105|855067|P3|NOT COMPLETED|Overall Study||3
347628|NCT02432105|855068|P2|NOT COMPLETED|Overall Study||2
347629|NCT02432105|855069|P1|NOT COMPLETED|Overall Study||2
347630|NCT02432105|855067|P3|COMPLETED|Overall Study||108
347631|NCT02432105|855068|P2|COMPLETED|Overall Study||108
347632|NCT02432105|855069|P1|COMPLETED|Overall Study||162
347633|NCT02432105|855067|P3|STARTED|Overall Study||111
347634|NCT02432105|855068|P2|STARTED|Overall Study||110
347635|NCT02432105|855069|P1|STARTED|Overall Study||164
347636|NCT02432040|855086|P2|NOT COMPLETED|Overall Study||6
347637|NCT02432040|855087|P1|NOT COMPLETED|Overall Study||8
347638|NCT02432040|855086|P2|COMPLETED|Overall Study||8
347639|NCT02432040|855087|P1|COMPLETED|Overall Study||6
347640|NCT02432040|855086|P2|STARTED|Overall Study||14
347641|NCT02432040|855087|P1|STARTED|Overall Study||14
347642|NCT02431754|855109|P2|NOT COMPLETED|Period 2 (8 Weeks)||4
347643|NCT02431754|855110|P1|NOT COMPLETED|Period 2 (8 Weeks)||1
347644|NCT02431754|855109|P2|COMPLETED|Period 2 (8 Weeks)||78
347645|NCT02431754|855110|P1|COMPLETED|Period 2 (8 Weeks)||74
347646|NCT02431754|855109|P2|STARTED|Period 2 (8 Weeks)||82
347647|NCT02431754|855110|P1|STARTED|Period 2 (8 Weeks)||75
347648|NCT02431754|855109|P2|NOT COMPLETED|Wash-out Period (4 Weeks)||0
347649|NCT02431754|855110|P1|NOT COMPLETED|Wash-out Period (4 Weeks)||4
347650|NCT02431754|855109|P2|COMPLETED|Wash-out Period (4 Weeks)||82
347651|NCT02431754|855110|P1|COMPLETED|Wash-out Period (4 Weeks)||75
347652|NCT02431754|855109|P2|STARTED|Wash-out Period (4 Weeks)||82
347653|NCT02431754|855110|P1|STARTED|Wash-out Period (4 Weeks)||79
347654|NCT02431754|855109|P2|NOT COMPLETED|Period 1 (8 Weeks)||4
347655|NCT02431754|855110|P1|NOT COMPLETED|Period 1 (8 Weeks)||6
347656|NCT02431754|855109|P2|COMPLETED|Period 1 (8 Weeks)||82
347657|NCT02431754|855110|P1|COMPLETED|Period 1 (8 Weeks)||79
347658|NCT02431754|855109|P2|Received at Least One Dose of Study Drug|Period 1 (8 Weeks)||86
347659|NCT02431754|855110|P1|Received at Least One Dose of Study Drug|Period 1 (8 Weeks)||85
347660|NCT02431754|855109|P2|STARTED|Period 1 (8 Weeks)||86
347661|NCT02431754|855110|P1|STARTED|Period 1 (8 Weeks)||85
347662|NCT02431741|855128|P1|NOT COMPLETED|Overall Study||0
347663|NCT02431741|855128|P1|COMPLETED|Overall Study||14
347664|NCT02431741|855128|P1|STARTED|Overall Study||14
347665|NCT02431598|855132|P6|NOT COMPLETED|Overall Study||0
347666|NCT02431598|855133|P5|NOT COMPLETED|Overall Study||0
347667|NCT02431598|855134|P4|NOT COMPLETED|Overall Study||0
347668|NCT02431598|855135|P3|NOT COMPLETED|Overall Study||0
347669|NCT02431598|855136|P2|NOT COMPLETED|Overall Study||0
347670|NCT02431598|855137|P1|NOT COMPLETED|Overall Study||0
347671|NCT02431598|855132|P6|COMPLETED|Overall Study||6
347672|NCT02431598|855133|P5|COMPLETED|Overall Study||7
347673|NCT02431598|855134|P4|COMPLETED|Overall Study||7
347674|NCT02431598|855135|P3|COMPLETED|Overall Study||9
347675|NCT02431598|855136|P2|COMPLETED|Overall Study||9
347676|NCT02431598|855137|P1|COMPLETED|Overall Study||6
347677|NCT02431598|855132|P6|STARTED|Overall Study||6
347678|NCT02431598|855133|P5|STARTED|Overall Study||7
347679|NCT02431598|855134|P4|STARTED|Overall Study||7
347680|NCT02431598|855135|P3|STARTED|Overall Study||9
347681|NCT02431598|855136|P2|STARTED|Overall Study||9
347682|NCT02431598|855137|P1|STARTED|Overall Study||6
347683|NCT02431455|855163|P2|NOT COMPLETED|Overall Study||0
347684|NCT02431455|855164|P1|NOT COMPLETED|Overall Study||0
347685|NCT02431455|855163|P2|COMPLETED|Overall Study||112
347686|NCT02431455|855164|P1|COMPLETED|Overall Study||112
347687|NCT02431455|855163|P2|STARTED|Overall Study||112
347688|NCT02431455|855164|P1|STARTED|Overall Study||112
347689|NCT02431299|855178|P2|NOT COMPLETED|Overall Study||1
347690|NCT02431299|855179|P1|NOT COMPLETED|Overall Study||53
347691|NCT02431299|855178|P2|COMPLETED|Overall Study||62
347692|NCT02431299|855179|P1|COMPLETED|Overall Study||183
347693|NCT02431299|855178|P2|STARTED|Overall Study||63
347694|NCT02431299|855179|P1|STARTED|Overall Study||236
347695|NCT02430870|855200|P8|NOT COMPLETED|Part 2||1
347696|NCT02430870|855201|P7|NOT COMPLETED|Part 2||1
347697|NCT02430870|855202|P6|NOT COMPLETED|Part 2||0
347698|NCT02430870|855203|P5|NOT COMPLETED|Part 2||0
347699|NCT02430870|855204|P4|NOT COMPLETED|Part 2||0
347700|NCT02430870|855205|P3|NOT COMPLETED|Part 2||0
347701|NCT02430870|855206|P2|NOT COMPLETED|Part 2||0
347702|NCT02430870|855207|P1|NOT COMPLETED|Part 2||0
347703|NCT02430870|855200|P8|COMPLETED|Part 2||7
347704|NCT02430870|855201|P7|COMPLETED|Part 2||5
347705|NCT02430870|855202|P6|COMPLETED|Part 2||6
347706|NCT02430870|855203|P5|COMPLETED|Part 2||6
347707|NCT02430870|855204|P4|COMPLETED|Part 2||6
347708|NCT02430870|855205|P3|COMPLETED|Part 2||0
347709|NCT02430870|855206|P2|COMPLETED|Part 2||0
347710|NCT02430870|855207|P1|COMPLETED|Part 2||0
347711|NCT02430870|855200|P8|STARTED|Part 2||8
347712|NCT02430870|855201|P7|STARTED|Part 2||6
347713|NCT02430870|855202|P6|STARTED|Part 2||6
347714|NCT02430870|855203|P5|STARTED|Part 2||6
347715|NCT02430870|855204|P4|STARTED|Part 2||6
347716|NCT02430870|855205|P3|STARTED|Part 2||0
347717|NCT02430870|855206|P2|STARTED|Part 2||0
347718|NCT02430870|855207|P1|STARTED|Part 2||0
347719|NCT02430870|855200|P8|NOT COMPLETED|Part 1||0
347720|NCT02430870|855201|P7|NOT COMPLETED|Part 1||0
347721|NCT02430870|855202|P6|NOT COMPLETED|Part 1||0
347722|NCT02430870|855203|P5|NOT COMPLETED|Part 1||0
347723|NCT02430870|855204|P4|NOT COMPLETED|Part 1||0
347724|NCT02430870|855205|P3|NOT COMPLETED|Part 1||0
347725|NCT02430870|855206|P2|NOT COMPLETED|Part 1||0
347726|NCT02430870|855207|P1|NOT COMPLETED|Part 1||0
347727|NCT02430870|855200|P8|COMPLETED|Part 1||0
347728|NCT02430870|855201|P7|COMPLETED|Part 1||0
347729|NCT02430870|855202|P6|COMPLETED|Part 1||0
347730|NCT02430870|855203|P5|COMPLETED|Part 1||0
347731|NCT02430870|855204|P4|COMPLETED|Part 1||0
347732|NCT02430870|855205|P3|COMPLETED|Part 1||4
347733|NCT02430870|855206|P2|COMPLETED|Part 1||6
347734|NCT02430870|855207|P1|COMPLETED|Part 1||6
347735|NCT02430870|855200|P8|STARTED|Part 1||0
347736|NCT02430870|855201|P7|STARTED|Part 1||0
347737|NCT02430870|855202|P6|STARTED|Part 1||0
347738|NCT02430870|855203|P5|STARTED|Part 1||0
347739|NCT02430870|855204|P4|STARTED|Part 1||0
347740|NCT02430870|855205|P3|STARTED|Part 1||4
347741|NCT02430870|855206|P2|STARTED|Part 1||6
347742|NCT02430870|855207|P1|STARTED|Part 1||6
347743|NCT02430532|855281|P2|NOT COMPLETED|Overall Study||28
347744|NCT02430532|855282|P1|NOT COMPLETED|Overall Study||30
347745|NCT02430532|855281|P2|COMPLETED|Overall Study||0
347746|NCT02430532|855282|P1|COMPLETED|Overall Study||0
347747|NCT02430532|855281|P2|STARTED|Overall Study||28
347748|NCT02430532|855282|P1|STARTED|Overall Study||30
347749|NCT02430389|855298|P2|NOT COMPLETED|Overall Study||0
347750|NCT02430389|855299|P1|NOT COMPLETED|Overall Study||0
347751|NCT02430389|855298|P2|COMPLETED|Overall Study||10
347752|NCT02430389|855299|P1|COMPLETED|Overall Study||10
347753|NCT02430389|855298|P2|STARTED|Overall Study||10
347754|NCT02430389|855299|P1|STARTED|Overall Study||10
347755|NCT02430090|855310|P3|NOT COMPLETED|Overall Study||0
347756|NCT02430090|855311|P2|NOT COMPLETED|Overall Study||0
347757|NCT02430090|855312|P1|NOT COMPLETED|Overall Study||0
347758|NCT02430090|855310|P3|COMPLETED|Overall Study||15
347759|NCT02430090|855311|P2|COMPLETED|Overall Study||15
347760|NCT02430090|855312|P1|COMPLETED|Overall Study||15
347761|NCT02430090|855310|P3|STARTED|Overall Study||15
347762|NCT02430090|855311|P2|STARTED|Overall Study||15
347763|NCT02430090|855312|P1|STARTED|Overall Study||15
347764|NCT02429791|855322|P2|NOT COMPLETED|Overall Study||18
347765|NCT02429791|855323|P1|NOT COMPLETED|Overall Study||13
347766|NCT02429791|855322|P2|COMPLETED|Overall Study||238
347767|NCT02429791|855323|P1|COMPLETED|Overall Study||239
347768|NCT02429791|855322|P2|STARTED|Overall Study||256
347769|NCT02429791|855323|P1|STARTED|Overall Study||252
347770|NCT02429258|855395|P2|NOT COMPLETED|Overall Study||1
347771|NCT02429258|855396|P1|NOT COMPLETED|Overall Study||2
347772|NCT02429258|855395|P2|COMPLETED|Overall Study||49
347773|NCT02429258|855396|P1|COMPLETED|Overall Study||48
347774|NCT02429258|855395|P2|STARTED|Overall Study||50
347775|NCT02429258|855396|P1|STARTED|Overall Study||50
347776|NCT02428478|855422|P2|NOT COMPLETED|Second Study Night||0
347777|NCT02428478|855423|P1|NOT COMPLETED|Second Study Night||0
347778|NCT02428478|855422|P2|COMPLETED|Second Study Night||6
347779|NCT02428478|855423|P1|COMPLETED|Second Study Night||8
347780|NCT02428478|855422|P2|STARTED|Second Study Night|2 participants did not return for the second study night|6
347781|NCT02428478|855423|P1|STARTED|Second Study Night|1 participant did not return for the second study night|8
347782|NCT02428478|855422|P2|NOT COMPLETED|First Study Night||0
347783|NCT02428478|855423|P1|NOT COMPLETED|First Study Night||0
347784|NCT02428478|855422|P2|COMPLETED|First Study Night||8
347785|NCT02428478|855423|P1|COMPLETED|First Study Night||9
347786|NCT02428478|855422|P2|STARTED|First Study Night||8
347787|NCT02428478|855423|P1|STARTED|First Study Night||9
347788|NCT02428413|855433|P2|NOT COMPLETED|Overall Study||9
347789|NCT02428413|855434|P1|NOT COMPLETED|Overall Study||8
347790|NCT02428413|855433|P2|COMPLETED|Overall Study||52
347791|NCT02428413|855434|P1|COMPLETED|Overall Study||56
347792|NCT02428413|855433|P2|STARTED|Overall Study||61
347793|NCT02428413|855434|P1|STARTED|Overall Study||64
347794|NCT02428231|855448|P2|NOT COMPLETED|Overall Study||17
347795|NCT02428231|855449|P1|NOT COMPLETED|Overall Study||13
347796|NCT02428231|855448|P2|COMPLETED|Overall Study||15
347797|NCT02428231|855449|P1|COMPLETED|Overall Study||17
347798|NCT02428231|855448|P2|STARTED|Overall Study||32
347799|NCT02428231|855449|P1|STARTED|Overall Study||30
347800|NCT02427984|855466|P3|NOT COMPLETED|Overall Study||18
347801|NCT02427984|855467|P2|NOT COMPLETED|Overall Study||5
347802|NCT02427984|855468|P1|NOT COMPLETED|Overall Study||13
347803|NCT02427984|855466|P3|COMPLETED|Overall Study||32
347804|NCT02427984|855467|P2|COMPLETED|Overall Study||40
347805|NCT02427984|855468|P1|COMPLETED|Overall Study||40
347806|NCT02427984|855466|P3|STARTED|Overall Study||50
347807|NCT02427984|855467|P2|STARTED|Overall Study||45
347808|NCT02427984|855468|P1|STARTED|Overall Study||53
347809|NCT02427750|855484|P2|NOT COMPLETED|Overall Study||0
347810|NCT02427750|855485|P1|NOT COMPLETED|Overall Study||0
347811|NCT02427750|855484|P2|COMPLETED|Overall Study||63
347812|NCT02427750|855485|P1|COMPLETED|Overall Study||63
347813|NCT02427750|855484|P2|STARTED|Overall Study||63
347814|NCT02427750|855485|P1|STARTED|Overall Study||63
347815|NCT02427477|855510|P2|NOT COMPLETED|Period 3||0
347816|NCT02427477|855511|P1|NOT COMPLETED|Period 3||0
347817|NCT02427477|855510|P2|COMPLETED|Period 3||60
347818|NCT02427477|855511|P1|COMPLETED|Period 3||59
347819|NCT02427477|855510|P2|STARTED|Period 3||60
347820|NCT02427477|855511|P1|STARTED|Period 3||59
347821|NCT02427477|855510|P2|NOT COMPLETED|Period 2||0
347822|NCT02427477|855511|P1|NOT COMPLETED|Period 2||0
347823|NCT02427477|855510|P2|COMPLETED|Period 2||60
347824|NCT02427477|855511|P1|COMPLETED|Period 2||59
347825|NCT02427477|855510|P2|STARTED|Period 2||60
347826|NCT02427477|855511|P1|STARTED|Period 2||59
347827|NCT02427477|855510|P2|NOT COMPLETED|Period 1||0
347828|NCT02427477|855511|P1|NOT COMPLETED|Period 1||1
347829|NCT02427477|855510|P2|COMPLETED|Period 1||60
347830|NCT02427477|855511|P1|COMPLETED|Period 1||59
347831|NCT02427477|855510|P2|STARTED|Period 1||60
347832|NCT02427477|855511|P1|STARTED|Period 1||60
347833|NCT02427399|855524|P5|NOT COMPLETED|Overall Study||15
347834|NCT02427399|855525|P4|NOT COMPLETED|Overall Study||18
347835|NCT02427399|855526|P3|NOT COMPLETED|Overall Study||12
347836|NCT02427399|855527|P2|NOT COMPLETED|Overall Study||16
347837|NCT02427399|855528|P1|NOT COMPLETED|Overall Study||14
347838|NCT02427399|855524|P5|COMPLETED|Overall Study||205
347839|NCT02427399|855525|P4|COMPLETED|Overall Study||202
347840|NCT02427399|855526|P3|COMPLETED|Overall Study||208
347841|NCT02427399|855527|P2|COMPLETED|Overall Study||204
347842|NCT02427399|855528|P1|COMPLETED|Overall Study||206
347843|NCT02427399|855524|P5|STARTED|Overall Study||220
347844|NCT02427399|855525|P4|STARTED|Overall Study||220
347845|NCT02427399|855526|P3|STARTED|Overall Study||220
347846|NCT02427399|855527|P2|STARTED|Overall Study||220
347847|NCT02427399|855528|P1|STARTED|Overall Study||220
347848|NCT02426541|855552|P2|NOT COMPLETED|Overall Study||0
347849|NCT02426541|855553|P1|NOT COMPLETED|Overall Study||1
347850|NCT02426541|855552|P2|COMPLETED|Overall Study||16
347851|NCT02426541|855553|P1|COMPLETED|Overall Study||15
347852|NCT02426541|855552|P2|STARTED|Overall Study||16
347853|NCT02426541|855553|P1|STARTED|Overall Study||16
347854|NCT02425956|855563|P1|NOT COMPLETED|Overall Study||0
347855|NCT02425956|855563|P1|COMPLETED|Overall Study||21
347856|NCT02425956|855563|P1|STARTED|Overall Study||21
347857|NCT02425826|855570|P3|NOT COMPLETED|Post-Treatment Observational Follow-Up||0
347858|NCT02425826|855571|P2|NOT COMPLETED|Post-Treatment Observational Follow-Up||0
347859|NCT02425826|855572|P1|NOT COMPLETED|Post-Treatment Observational Follow-Up||1
347860|NCT02425826|855570|P3|COMPLETED|Post-Treatment Observational Follow-Up||49
347861|NCT02425826|855571|P2|COMPLETED|Post-Treatment Observational Follow-Up||0
347862|NCT02425826|855572|P1|COMPLETED|Post-Treatment Observational Follow-Up||80
347863|NCT02425826|855570|P3|STARTED|Post-Treatment Observational Follow-Up||49
347864|NCT02425826|855571|P2|STARTED|Post-Treatment Observational Follow-Up||0
347865|NCT02425826|855572|P1|STARTED|Post-Treatment Observational Follow-Up||81
347866|NCT02425826|855570|P3|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||14
347867|NCT02425826|855571|P2|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||0
347868|NCT02425826|855572|P1|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||35
347869|NCT02425826|855570|P3|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||50
347870|NCT02425826|855571|P2|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||0
347871|NCT02425826|855572|P1|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||86
347872|NCT02425826|855570|P3|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||64
347873|NCT02425826|855571|P2|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||0
347874|NCT02425826|855572|P1|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||121
347875|NCT02425826|855570|P3|STARTED|Apremilast Extension Phase (Weeks 16-52)||64
347876|NCT02425826|855571|P2|STARTED|Apremilast Extension Phase (Weeks 16-52)||0
347877|NCT02425826|855572|P1|STARTED|Apremilast Extension Phase (Weeks 16-52)||121
347878|NCT02425826|855570|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||0
347879|NCT02425826|855571|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||9
347880|NCT02425826|855572|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||27
347881|NCT02425826|855570|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 16)||0
347882|NCT02425826|855571|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 16)|Completed = participants who completed Week 16|64
347883|NCT02425826|855572|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 16)|Completed = participants who completed Week 16|121
347884|NCT02425826|855570|P3|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)||0
347885|NCT02425826|855571|P2|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)|ITT = includes participants who received at least one dose of study drug.|73
347886|NCT02425826|855572|P1|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)|ITT = includes participants who received at least one dose of study drug.|147
347887|NCT02425826|855570|P3|STARTED|Placebo-controlled Phase (Week 0 - 16)||0
347888|NCT02425826|855571|P2|STARTED|Placebo-controlled Phase (Week 0 - 16)||73
347889|NCT02425826|855572|P1|STARTED|Placebo-controlled Phase (Week 0 - 16)||148
347890|NCT02425449|855610|P5|NOT COMPLETED|Overall Study||0
347891|NCT02425449|855611|P4|NOT COMPLETED|Overall Study||0
347892|NCT02425449|855612|P3|NOT COMPLETED|Overall Study||0
347893|NCT02425449|855613|P2|NOT COMPLETED|Overall Study||0
347894|NCT02425449|855614|P1|NOT COMPLETED|Overall Study||0
347895|NCT02425449|855610|P5|COMPLETED|Overall Study||5
347896|NCT02425449|855611|P4|COMPLETED|Overall Study||5
347897|NCT02425449|855612|P3|COMPLETED|Overall Study||5
347898|NCT02425449|855613|P2|COMPLETED|Overall Study||4
347899|NCT02425449|855614|P1|COMPLETED|Overall Study||0
347900|NCT02425449|855610|P5|STARTED|Overall Study||5
347901|NCT02425449|855611|P4|STARTED|Overall Study||5
347902|NCT02425449|855612|P3|STARTED|Overall Study||5
347903|NCT02425449|855613|P2|STARTED|Overall Study||4
347904|NCT02425449|855614|P1|STARTED|Overall Study||0
347905|NCT02424591|855628|P2|NOT COMPLETED|Overall Study||3
347906|NCT02424591|855629|P1|NOT COMPLETED|Overall Study||2
347907|NCT02424591|855628|P2|COMPLETED|Overall Study||20
347908|NCT02424591|855629|P1|COMPLETED|Overall Study||20
347909|NCT02424591|855628|P2|STARTED|Overall Study||23
347910|NCT02424591|855629|P1|STARTED|Overall Study||22
347911|NCT02424578|855641|P2|NOT COMPLETED|Overall Study||1
347912|NCT02424578|855642|P1|NOT COMPLETED|Overall Study||0
347913|NCT02424578|855641|P2|COMPLETED|Overall Study||14
347914|NCT02424578|855642|P1|COMPLETED|Overall Study||15
347915|NCT02424578|855641|P2|STARTED|Overall Study||15
347916|NCT02424578|855642|P1|STARTED|Overall Study||15
347917|NCT02424565|855648|P2|NOT COMPLETED|Period 2 (D3)||0
347918|NCT02424565|855649|P1|NOT COMPLETED|Period 2 (D3)||0
347919|NCT02424565|855648|P2|COMPLETED|Period 2 (D3)||6
347920|NCT02424565|855649|P1|COMPLETED|Period 2 (D3)||8
347921|NCT02424565|855648|P2|STARTED|Period 2 (D3)||6
347922|NCT02424565|855649|P1|STARTED|Period 2 (D3)||8
347923|NCT02424565|855648|P2|NOT COMPLETED|Washout Period||0
347924|NCT02424565|855649|P1|NOT COMPLETED|Washout Period||0
347925|NCT02424565|855648|P2|COMPLETED|Washout Period||6
347926|NCT02424565|855649|P1|COMPLETED|Washout Period||8
347927|NCT02424565|855648|P2|STARTED|Washout Period||6
347928|NCT02424565|855649|P1|STARTED|Washout Period||8
347929|NCT02424565|855648|P2|NOT COMPLETED|Period 1 (D0)||1
347930|NCT02424565|855649|P1|NOT COMPLETED|Period 1 (D0)||0
347931|NCT02424565|855648|P2|COMPLETED|Period 1 (D0)||6
347932|NCT02424565|855649|P1|COMPLETED|Period 1 (D0)||8
347933|NCT02424565|855648|P2|STARTED|Period 1 (D0)||7
347934|NCT02424565|855649|P1|STARTED|Period 1 (D0)||8
347935|NCT02424357|855657|P2|NOT COMPLETED|Overall Study||0
347936|NCT02424357|855658|P1|NOT COMPLETED|Overall Study||0
347937|NCT02424357|855657|P2|COMPLETED|Overall Study||30
347938|NCT02424357|855658|P1|COMPLETED|Overall Study||35
347939|NCT02424357|855657|P2|STARTED|Overall Study||30
347940|NCT02424357|855658|P1|STARTED|Overall Study||35
347941|NCT02424149|855668|P2|NOT COMPLETED|Overall Study||1
347942|NCT02424149|855669|P1|NOT COMPLETED|Overall Study||2
347943|NCT02424149|855668|P2|COMPLETED|Overall Study||52
347944|NCT02424149|855669|P1|COMPLETED|Overall Study||52
347945|NCT02424149|855668|P2|STARTED|Overall Study||53
347946|NCT02424149|855669|P1|STARTED|Overall Study||54
347947|NCT02423993|855687|P4|NOT COMPLETED|Overall Study||0
347948|NCT02423993|855688|P3|NOT COMPLETED|Overall Study||0
347949|NCT02423993|855689|P2|NOT COMPLETED|Overall Study||0
347950|NCT02423993|855690|P1|NOT COMPLETED|Overall Study||0
347951|NCT02423993|855687|P4|COMPLETED|Overall Study||19
347952|NCT02423993|855688|P3|COMPLETED|Overall Study||23
347953|NCT02423993|855689|P2|COMPLETED|Overall Study||16
347954|NCT02423993|855690|P1|COMPLETED|Overall Study||19
347955|NCT02423993|855687|P4|STARTED|Overall Study||19
347956|NCT02423993|855688|P3|STARTED|Overall Study||23
347957|NCT02423993|855689|P2|STARTED|Overall Study||16
347958|NCT02423993|855690|P1|STARTED|Overall Study||19
347959|NCT02423980|855720|P1|NOT COMPLETED|Overall Study||0
347960|NCT02423980|855720|P1|COMPLETED|Overall Study||7
347961|NCT02423980|855720|P1|STARTED|Overall Study||7
347962|NCT02423798|855730|P1|NOT COMPLETED|Overall Study||3
347963|NCT02423798|855730|P1|COMPLETED|Overall Study||21
347964|NCT02423798|855730|P1|STARTED|Overall Study||24
347965|NCT02423577|855738|P2|NOT COMPLETED|Overall Study||0
347966|NCT02423577|855739|P1|NOT COMPLETED|Overall Study||0
347967|NCT02423577|855738|P2|COMPLETED|Overall Study||26
347968|NCT02423577|855739|P1|COMPLETED|Overall Study||53
347969|NCT02423577|855738|P2|STARTED|Overall Study||26
347970|NCT02423577|855739|P1|STARTED|Overall Study||53
347971|NCT02423447|855745|P2|NOT COMPLETED|Overall Study||0
347972|NCT02423447|855746|P1|NOT COMPLETED|Overall Study||0
347973|NCT02423447|855745|P2|COMPLETED|Overall Study||12
347974|NCT02423447|855746|P1|COMPLETED|Overall Study||13
347975|NCT02423447|855745|P2|STARTED|Overall Study||12
347976|NCT02423447|855746|P1|STARTED|Overall Study||13
347977|NCT02423408|855762|P2|NOT COMPLETED|Overall Study||2
347978|NCT02423408|855763|P1|NOT COMPLETED|Overall Study||1
347979|NCT02423408|855762|P2|COMPLETED|Overall Study||80
347980|NCT02423408|855763|P1|COMPLETED|Overall Study||82
347981|NCT02423408|855762|P2|STARTED|Overall Study||82
347982|NCT02423408|855763|P1|STARTED|Overall Study||83
347983|NCT02423317|855777|P2|NOT COMPLETED|Overall Study||0
347984|NCT02423317|855778|P1|NOT COMPLETED|Overall Study||0
347985|NCT02423317|855777|P2|COMPLETED|Overall Study||30
347986|NCT02423317|855778|P1|COMPLETED|Overall Study||30
347987|NCT02423317|855777|P2|STARTED|Overall Study||30
347988|NCT02423317|855778|P1|STARTED|Overall Study||30
347989|NCT02423291|855796|P1|NOT COMPLETED|Overall Study||15
347990|NCT02423291|855796|P1|COMPLETED|Overall Study|Patients that have completed therapy|0
347991|NCT02423291|855796|P1|STARTED|Overall Study|Patients enrolled|15
347992|NCT02423200|855802|P2|NOT COMPLETED|Overall Study||0
347993|NCT02423200|855803|P1|NOT COMPLETED|Overall Study||1
347994|NCT02423200|855802|P2|COMPLETED|Overall Study||1
347995|NCT02423200|855803|P1|COMPLETED|Overall Study||7
347996|NCT02423200|855802|P2|STARTED|Overall Study||1
347997|NCT02423200|855803|P1|STARTED|Overall Study||8
347998|NCT02423109|855811|P2|NOT COMPLETED|Lens 2||0
347999|NCT02423109|855812|P1|NOT COMPLETED|Lens 2||0
348000|NCT02423109|855811|P2|COMPLETED|Lens 2||14
348001|NCT02423109|855812|P1|COMPLETED|Lens 2||18
348002|NCT02423109|855811|P2|STARTED|Lens 2||14
348003|NCT02423109|855812|P1|STARTED|Lens 2||18
348004|NCT02423109|855811|P2|NOT COMPLETED|Lens 1||0
348005|NCT02423109|855812|P1|NOT COMPLETED|Lens 1||1
348006|NCT02423109|855811|P2|COMPLETED|Lens 1||14
348007|NCT02423109|855812|P1|COMPLETED|Lens 1||18
348008|NCT02423109|855811|P2|STARTED|Lens 1||14
348009|NCT02423109|855812|P1|STARTED|Lens 1||19
348010|NCT02422797|855822|P2|NOT COMPLETED|Overall Study||16
348011|NCT02422797|855823|P1|NOT COMPLETED|Overall Study||16
348012|NCT02422797|855822|P2|COMPLETED|Overall Study||239
348013|NCT02422797|855823|P1|COMPLETED|Overall Study||245
348014|NCT02422797|855822|P2|STARTED|Overall Study||255
348015|NCT02422797|855823|P1|STARTED|Overall Study||261
348016|NCT02422446|855895|P2|NOT COMPLETED|Overall Study||0
348017|NCT02422446|855896|P1|NOT COMPLETED|Overall Study||0
348018|NCT02422446|855895|P2|COMPLETED|Overall Study||1
348019|NCT02422446|855896|P1|COMPLETED|Overall Study||1
348020|NCT02422446|855895|P2|STARTED|Overall Study||1
348021|NCT02422446|855896|P1|STARTED|Overall Study||1
348022|NCT02422303|855904|P2|NOT COMPLETED|Overall Study||1
348023|NCT02422303|855905|P1|NOT COMPLETED|Overall Study||1
348024|NCT02422303|855904|P2|COMPLETED|Overall Study||5
348025|NCT02422303|855905|P1|COMPLETED|Overall Study||5
348026|NCT02422303|855904|P2|STARTED|Overall Study||6
348027|NCT02422303|855905|P1|STARTED|Overall Study||6
348028|NCT02421419|855914|P3|NOT COMPLETED|Overall Study||1
348029|NCT02421419|855915|P2|NOT COMPLETED|Overall Study||0
348030|NCT02421419|855916|P1|NOT COMPLETED|Overall Study||0
348031|NCT02421419|855914|P3|COMPLETED|Overall Study||8
348032|NCT02421419|855915|P2|COMPLETED|Overall Study||11
348033|NCT02421419|855916|P1|COMPLETED|Overall Study||6
348034|NCT02421419|855914|P3|STARTED|Overall Study||9
348035|NCT02421419|855915|P2|STARTED|Overall Study||11
348036|NCT02421419|855916|P1|STARTED|Overall Study||6
348037|NCT02421211|855935|P2|NOT COMPLETED|Overall Study||0
348038|NCT02421211|855936|P1|NOT COMPLETED|Overall Study||0
348039|NCT02421211|855935|P2|COMPLETED|Overall Study||20
348040|NCT02421211|855936|P1|COMPLETED|Overall Study||20
348041|NCT02421211|855935|P2|STARTED|Overall Study||20
348042|NCT02421211|855936|P1|STARTED|Overall Study||20
348043|NCT02421146|855984|P4|NOT COMPLETED|Overall Study||0
348044|NCT02421146|855985|P3|NOT COMPLETED|Overall Study||0
348045|NCT02421146|855986|P2|NOT COMPLETED|Overall Study||0
348046|NCT02421146|855987|P1|NOT COMPLETED|Overall Study||0
348047|NCT02421146|855984|P4|COMPLETED|Overall Study||3
348048|NCT02421146|855985|P3|COMPLETED|Overall Study||3
348049|NCT02421146|855986|P2|COMPLETED|Overall Study||4
348050|NCT02421146|855987|P1|COMPLETED|Overall Study||2
348051|NCT02421146|855984|P4|STARTED|Overall Study||3
348052|NCT02421146|855985|P3|STARTED|Overall Study||3
348053|NCT02421146|855986|P2|STARTED|Overall Study||4
348054|NCT02421146|855987|P1|STARTED|Overall Study||2
348055|NCT02421120|856001|P1|NOT COMPLETED|Overall Study||1
348056|NCT02421120|856001|P1|COMPLETED|Overall Study||20
348057|NCT02421120|856001|P1|STARTED|Overall Study||21
348058|NCT02420951|856011|P2|NOT COMPLETED|Overall Study||0
348059|NCT02420951|856012|P1|NOT COMPLETED|Overall Study||0
348060|NCT02420951|856011|P2|COMPLETED|Overall Study||25
348061|NCT02420951|856012|P1|COMPLETED|Overall Study||25
348062|NCT02420951|856011|P2|STARTED|Overall Study||25
348063|NCT02420951|856012|P1|STARTED|Overall Study||25
348064|NCT02420262|856030|P2|NOT COMPLETED|Overall Study||5
348065|NCT02420262|856031|P1|NOT COMPLETED|Overall Study||2
348066|NCT02420262|856030|P2|COMPLETED|Overall Study||249
348067|NCT02420262|856031|P1|COMPLETED|Overall Study||250
348068|NCT02420262|856030|P2|Exposed|Overall Study|One subject withdrew consent before exposure to trial product due to personal reasons.|253
348069|NCT02420262|856031|P1|Exposed|Overall Study||252
348070|NCT02420262|856030|P2|STARTED|Overall Study||254
348071|NCT02420262|856031|P1|STARTED|Overall Study||252
348072|NCT02420210|856045|P1|NOT COMPLETED|Overall Study||0
348073|NCT02420210|856045|P1|COMPLETED|Overall Study||2
348074|NCT02420210|856045|P1|STARTED|Overall Study||2
348075|NCT02420093|856057|P2|NOT COMPLETED|Overall Study||1
348076|NCT02420093|856058|P1|NOT COMPLETED|Overall Study||1
348077|NCT02420093|856057|P2|COMPLETED|Overall Study||7
348078|NCT02420093|856058|P1|COMPLETED|Overall Study||8
348079|NCT02420093|856057|P2|STARTED|Overall Study||8
348080|NCT02420093|856058|P1|STARTED|Overall Study||9
348081|NCT02420041|856074|P2|NOT COMPLETED|Overall Study||0
348082|NCT02420041|856075|P1|NOT COMPLETED|Overall Study||0
348083|NCT02420041|856074|P2|COMPLETED|Overall Study||14
348084|NCT02420041|856075|P1|COMPLETED|Overall Study||14
348085|NCT02420041|856074|P2|STARTED|Overall Study||14
348086|NCT02420041|856075|P1|STARTED|Overall Study||14
348087|NCT02419937|856101|P2|NOT COMPLETED|Overall Study||0
348088|NCT02419937|856102|P1|NOT COMPLETED|Overall Study||1
348089|NCT02419937|856101|P2|COMPLETED|Overall Study||16
348090|NCT02419937|856102|P1|COMPLETED|Overall Study||11
348091|NCT02419937|856101|P2|STARTED|Overall Study||16
348092|NCT02419937|856102|P1|STARTED|Overall Study||12
348093|NCT02419755|856110|P2|NOT COMPLETED|Overall Study||4
348094|NCT02419755|856111|P1|NOT COMPLETED|Overall Study||3
348095|NCT02419755|856110|P2|COMPLETED|Overall Study||2
348096|NCT02419755|856111|P1|COMPLETED|Overall Study||3
348097|NCT02419755|856110|P2|STARTED|Overall Study||6
348098|NCT02419755|856111|P1|STARTED|Overall Study||6
348099|NCT02419521|856135|P1|NOT COMPLETED|Overall Study||1
348100|NCT02419521|856135|P1|COMPLETED|Overall Study||74
348101|NCT02419521|856135|P1|STARTED|Overall Study||75
348102|NCT02419469|856147|P1|NOT COMPLETED|Overall Study||1
348103|NCT02419469|856147|P1|COMPLETED|Overall Study||0
348104|NCT02419469|856147|P1|STARTED|Overall Study||1
348105|NCT02419313|856151|P2|NOT COMPLETED|Second Intervention||0
348106|NCT02419313|856152|P1|NOT COMPLETED|Second Intervention||1
348107|NCT02419313|856151|P2|COMPLETED|Second Intervention||15
348108|NCT02419313|856152|P1|COMPLETED|Second Intervention||15
348109|NCT02419313|856151|P2|STARTED|Second Intervention||15
348110|NCT02419313|856152|P1|STARTED|Second Intervention||16
348111|NCT02419313|856151|P2|NOT COMPLETED|First Intervention||0
348112|NCT02419313|856152|P1|NOT COMPLETED|First Intervention||2
348113|NCT02419313|856151|P2|COMPLETED|First Intervention||15
348114|NCT02419313|856152|P1|COMPLETED|First Intervention||16
348115|NCT02419313|856151|P2|STARTED|First Intervention||15
348116|NCT02419313|856152|P1|STARTED|First Intervention||18
348117|NCT02419001|856164|P2|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0
348118|NCT02419001|856165|P1|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0
348119|NCT02419001|856164|P2|COMPLETED|Period 2- Ceftriaxone With SYN-004||5
348120|NCT02419001|856165|P1|COMPLETED|Period 2- Ceftriaxone With SYN-004||5
348121|NCT02419001|856164|P2|STARTED|Period 2- Ceftriaxone With SYN-004||5
348122|NCT02419001|856165|P1|STARTED|Period 2- Ceftriaxone With SYN-004||5
348123|NCT02419001|856164|P2|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||0
348124|NCT02419001|856165|P1|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||1
348125|NCT02419001|856164|P2|COMPLETED|Period 1- Ceftriaxone Without SYN-004||5
348126|NCT02419001|856165|P1|COMPLETED|Period 1- Ceftriaxone Without SYN-004|The Adverse Event (AE) was with ceftriaxone, not with Investigational Product (IP)|5
348127|NCT02419001|856164|P2|STARTED|Period 1- Ceftriaxone Without SYN-004||5
348128|NCT02419001|856165|P1|STARTED|Period 1- Ceftriaxone Without SYN-004||6
348129|NCT02418676|856178|P3|NOT COMPLETED|Overall Study||0
348130|NCT02418676|856179|P2|NOT COMPLETED|Overall Study||0
348131|NCT02418676|856180|P1|NOT COMPLETED|Overall Study||0
348132|NCT02418676|856178|P3|COMPLETED|Overall Study||5
348133|NCT02418676|856179|P2|COMPLETED|Overall Study||5
348134|NCT02418676|856180|P1|COMPLETED|Overall Study||5
348135|NCT02418676|856178|P3|STARTED|Overall Study||5
348136|NCT02418676|856179|P2|STARTED|Overall Study||5
348137|NCT02418676|856180|P1|STARTED|Overall Study||5
348138|NCT02418468|856193|P2|NOT COMPLETED|Overall Study||1
348139|NCT02418468|856194|P1|NOT COMPLETED|Overall Study||2
348140|NCT02418468|856193|P2|COMPLETED|Overall Study||10
348141|NCT02418468|856194|P1|COMPLETED|Overall Study||11
348142|NCT02418468|856193|P2|STARTED|Overall Study||11
348143|NCT02418468|856194|P1|STARTED|Overall Study||13
348144|NCT02418234|856200|P1|NOT COMPLETED|Overall Study||0
348145|NCT02418234|856200|P1|COMPLETED|Overall Study||314
348146|NCT02418234|856200|P1|STARTED|Overall Study||314
348147|NCT02418026|856213|P2|NOT COMPLETED|Overall Study||0
348148|NCT02418026|856214|P1|NOT COMPLETED|Overall Study||0
348149|NCT02418026|856213|P2|COMPLETED|Overall Study||35
348150|NCT02418026|856214|P1|COMPLETED|Overall Study||44
348151|NCT02418026|856213|P2|STARTED|Overall Study||35
348152|NCT02418026|856214|P1|STARTED|Overall Study||44
348153|NCT02417961|856244|P1|NOT COMPLETED|Overall Study||4
348154|NCT02417961|856244|P1|COMPLETED|Overall Study||112
348155|NCT02417961|856244|P1|STARTED|Overall Study||116
348156|NCT02417753|856254|P1|NOT COMPLETED|Overall Study||1
348157|NCT02417753|856254|P1|COMPLETED|Overall Study||0
348158|NCT02417753|856254|P1|STARTED|Overall Study||1
348159|NCT02417532|856264|P1|NOT COMPLETED|Overall Study||4
348160|NCT02417532|856264|P1|COMPLETED|Overall Study||52
348161|NCT02417532|856264|P1|STARTED|Overall Study||56
348162|NCT02417376|856277|P2|NOT COMPLETED|Overall Study||10
348163|NCT02417376|856278|P1|NOT COMPLETED|Overall Study||5
348164|NCT02417376|856277|P2|COMPLETED|Overall Study||25
348165|NCT02417376|856278|P1|COMPLETED|Overall Study||30
348166|NCT02417376|856277|P2|STARTED|Overall Study||35
348167|NCT02417376|856278|P1|STARTED|Overall Study||35
348168|NCT02417129|856322|P2|NOT COMPLETED|Overall Study||0
348169|NCT02417129|856323|P1|NOT COMPLETED|Overall Study||0
348170|NCT02417129|856322|P2|COMPLETED|Overall Study||0
348171|NCT02417129|856323|P1|COMPLETED|Overall Study||2
348172|NCT02417129|856322|P2|STARTED|Overall Study||0
348173|NCT02417129|856323|P1|STARTED|Overall Study||2
348174|NCT02416973|856336|P3|NOT COMPLETED|Overall Study||1
348175|NCT02416973|856337|P2|NOT COMPLETED|Overall Study||3
348176|NCT02416973|856338|P1|NOT COMPLETED|Overall Study||1
348177|NCT02416973|856336|P3|COMPLETED|Overall Study||13
348178|NCT02416973|856337|P2|COMPLETED|Overall Study||10
348179|NCT02416973|856338|P1|COMPLETED|Overall Study||13
348180|NCT02416973|856336|P3|STARTED|Overall Study||14
348181|NCT02416973|856337|P2|STARTED|Overall Study||13
348182|NCT02416973|856338|P1|STARTED|Overall Study||14
348183|NCT02416934|856348|P2|NOT COMPLETED|Overall Study||7
348184|NCT02416934|856349|P1|NOT COMPLETED|Overall Study||3
348185|NCT02416934|856348|P2|COMPLETED|Overall Study||31
348186|NCT02416934|856349|P1|COMPLETED|Overall Study||33
348187|NCT02416934|856348|P2|Last Participant Completed 1 yr|Overall Study||31
348188|NCT02416934|856349|P1|Last Participant Completed 1 yr|Overall Study||33
348189|NCT02416934|856348|P2|Double Blind (0-52 Weeks)|Overall Study||38
348190|NCT02416934|856349|P1|Double Blind (0-52 Weeks)|Overall Study||36
348191|NCT02416934|856348|P2|STARTED|Overall Study||38
348192|NCT02416934|856349|P1|STARTED|Overall Study||36
348193|NCT02416180|856359|P1|NOT COMPLETED|Overall Study||1
348194|NCT02416180|856359|P1|COMPLETED|Overall Study||110
348195|NCT02416180|856359|P1|STARTED|Overall Study||111
348196|NCT02415959|856371|P5|NOT COMPLETED|Overall Study||0
348197|NCT02415959|856372|P4|NOT COMPLETED|Overall Study||1
348198|NCT02415959|856373|P3|NOT COMPLETED|Overall Study||0
348199|NCT02415959|856374|P2|NOT COMPLETED|Overall Study||1
348200|NCT02415959|856375|P1|NOT COMPLETED|Overall Study||0
348201|NCT02415959|856371|P5|COMPLETED|Overall Study||14
348202|NCT02415959|856372|P4|COMPLETED|Overall Study||13
348203|NCT02415959|856373|P3|COMPLETED|Overall Study||14
348204|NCT02415959|856374|P2|COMPLETED|Overall Study||13
348205|NCT02415959|856375|P1|COMPLETED|Overall Study||14
348206|NCT02415959|856371|P5|STARTED|Overall Study||14
348207|NCT02415959|856372|P4|STARTED|Overall Study||14
348208|NCT02415959|856373|P3|STARTED|Overall Study||14
348209|NCT02415959|856374|P2|STARTED|Overall Study||14
348210|NCT02415959|856375|P1|STARTED|Overall Study||14
348211|NCT02415439|856420|P13|NOT COMPLETED|Overall Study||0
348212|NCT02415439|856421|P12|NOT COMPLETED|Overall Study||0
348213|NCT02415439|856422|P11|NOT COMPLETED|Overall Study||0
348214|NCT02415439|856423|P10|NOT COMPLETED|Overall Study||0
348215|NCT02415439|856424|P9|NOT COMPLETED|Overall Study||1
348216|NCT02415439|856425|P8|NOT COMPLETED|Overall Study||0
348217|NCT02415439|856426|P7|NOT COMPLETED|Overall Study||0
348218|NCT02415439|856427|P6|NOT COMPLETED|Overall Study||0
348219|NCT02415439|856428|P5|NOT COMPLETED|Overall Study||0
348220|NCT02415439|856429|P4|NOT COMPLETED|Overall Study||0
348221|NCT02415439|856430|P3|NOT COMPLETED|Overall Study||0
348222|NCT02415439|856431|P2|NOT COMPLETED|Overall Study||0
348223|NCT02415439|856432|P1|NOT COMPLETED|Overall Study||0
348224|NCT02415439|856420|P13|COMPLETED|Overall Study||8
348225|NCT02415439|856421|P12|COMPLETED|Overall Study||6
348226|NCT02415439|856422|P11|COMPLETED|Overall Study||6
348227|NCT02415439|856423|P10|COMPLETED|Overall Study||6
348228|NCT02415439|856424|P9|COMPLETED|Overall Study||5
348229|NCT02415439|856425|P8|COMPLETED|Overall Study||12
348230|NCT02415439|856426|P7|COMPLETED|Overall Study||6
348231|NCT02415439|856427|P6|COMPLETED|Overall Study||6
348232|NCT02415439|856428|P5|COMPLETED|Overall Study||6
348233|NCT02415439|856429|P4|COMPLETED|Overall Study||6
348234|NCT02415439|856430|P3|COMPLETED|Overall Study||6
348235|NCT02415439|856431|P2|COMPLETED|Overall Study||6
348236|NCT02415439|856432|P1|COMPLETED|Overall Study||6
348237|NCT02415439|856420|P13|STARTED|Overall Study||8
348238|NCT02415439|856421|P12|STARTED|Overall Study||6
348239|NCT02415439|856422|P11|STARTED|Overall Study||6
348240|NCT02415439|856423|P10|STARTED|Overall Study||6
348241|NCT02415439|856424|P9|STARTED|Overall Study||6
348242|NCT02415439|856425|P8|STARTED|Overall Study||12
348243|NCT02415439|856426|P7|STARTED|Overall Study||6
348244|NCT02415439|856427|P6|STARTED|Overall Study||6
348245|NCT02415439|856428|P5|STARTED|Overall Study||6
348246|NCT02415439|856429|P4|STARTED|Overall Study||6
348247|NCT02415439|856430|P3|STARTED|Overall Study||6
348248|NCT02415439|856431|P2|STARTED|Overall Study||6
348249|NCT02415439|856432|P1|STARTED|Overall Study||6
348250|NCT02415166|856490|P4|NOT COMPLETED|Overall Study||0
348251|NCT02415166|856491|P3|NOT COMPLETED|Overall Study||0
348252|NCT02415166|856492|P2|NOT COMPLETED|Overall Study||0
348253|NCT02415166|856493|P1|NOT COMPLETED|Overall Study||0
348254|NCT02415166|856490|P4|COMPLETED|Overall Study||0
348255|NCT02415166|856491|P3|COMPLETED|Overall Study||0
348256|NCT02415166|856492|P2|COMPLETED|Overall Study||0
348257|NCT02415166|856493|P1|COMPLETED|Overall Study||6
348258|NCT02415166|856490|P4|STARTED|Overall Study||0
348259|NCT02415166|856491|P3|STARTED|Overall Study||0
348260|NCT02415166|856492|P2|STARTED|Overall Study||0
348261|NCT02415166|856493|P1|STARTED|Overall Study||6
348262|NCT02415127|856521|P2|NOT COMPLETED|Overall Study||0
348263|NCT02415127|856522|P1|NOT COMPLETED|Overall Study||1
348264|NCT02415127|856521|P2|COMPLETED|Overall Study||45
348265|NCT02415127|856522|P1|COMPLETED|Overall Study||46
348266|NCT02415127|856521|P2|STARTED|Overall Study||45
348267|NCT02415127|856522|P1|STARTED|Overall Study||47
348268|NCT02414828|856540|P4|NOT COMPLETED|Overall Study||2
348269|NCT02414828|856541|P3|NOT COMPLETED|Overall Study||1
348270|NCT02414828|856542|P2|NOT COMPLETED|Overall Study||1
348271|NCT02414828|856543|P1|NOT COMPLETED|Overall Study||0
348272|NCT02414828|856540|P4|COMPLETED|Overall Study||29
348273|NCT02414828|856541|P3|COMPLETED|Overall Study||19
348274|NCT02414828|856542|P2|COMPLETED|Overall Study||9
348275|NCT02414828|856543|P1|COMPLETED|Overall Study||11
348276|NCT02414828|856540|P4|STARTED|Overall Study||31
348277|NCT02414828|856541|P3|STARTED|Overall Study||20
348278|NCT02414828|856542|P2|STARTED|Overall Study||10
348279|NCT02414828|856543|P1|STARTED|Overall Study||11
348280|NCT02414152|856581|P1|NOT COMPLETED|Overall Study||2
348281|NCT02414152|856581|P1|COMPLETED|Overall Study|Both subjects completed 56 days of anakinra but did not complete all visits in observational period|0
348282|NCT02414152|856581|P1|STARTED|Overall Study||2
348283|NCT02413918|856585|P1|NOT COMPLETED|Overall Study||25
348284|NCT02413918|856585|P1|COMPLETED|Overall Study||16
348285|NCT02413918|856585|P1|STARTED|Overall Study||41
348286|NCT02413879|856592|P1|NOT COMPLETED|Overall Study||0
348287|NCT02413879|856592|P1|COMPLETED|Overall Study||86
348288|NCT02413879|856592|P1|STARTED|Overall Study||86
348289|NCT02413593|856598|P1|NOT COMPLETED|Overall Study||4
348290|NCT02413593|856598|P1|COMPLETED|Overall Study||107
348291|NCT02413593|856598|P1|STARTED|Overall Study||111
348292|NCT02413489|856610|P3|NOT COMPLETED|Overall Study||5
348293|NCT02413489|856611|P2|NOT COMPLETED|Overall Study||16
348294|NCT02413489|856612|P1|NOT COMPLETED|Overall Study||15
348295|NCT02413489|856610|P3|COMPLETED|Overall Study||0
348296|NCT02413489|856611|P2|COMPLETED|Overall Study||0
348297|NCT02413489|856612|P1|COMPLETED|Overall Study||0
348298|NCT02413489|856610|P3|STARTED|Overall Study||5
348299|NCT02413489|856611|P2|STARTED|Overall Study||16
348300|NCT02413489|856612|P1|STARTED|Overall Study||15
348301|NCT02413346|856634|P2|NOT COMPLETED|Overall Study||70
348302|NCT02413346|856635|P1|NOT COMPLETED|Overall Study||59
348303|NCT02413346|856634|P2|COMPLETED|Overall Study||177
348304|NCT02413346|856635|P1|COMPLETED|Overall Study||177
348305|NCT02413346|856634|P2|STARTED|Overall Study||247
348306|NCT02413346|856635|P1|STARTED|Overall Study||236
348307|NCT02413333|856645|P2|NOT COMPLETED|Period 2||0
348308|NCT02413333|856646|P1|NOT COMPLETED|Period 2||1
348309|NCT02413333|856645|P2|COMPLETED|Period 2||65
348310|NCT02413333|856646|P1|COMPLETED|Period 2||64
348311|NCT02413333|856645|P2|STARTED|Period 2||65
348312|NCT02413333|856646|P1|STARTED|Period 2||65
348313|NCT02413333|856645|P2|NOT COMPLETED|Period 1||1
348314|NCT02413333|856646|P1|NOT COMPLETED|Period 1||1
348315|NCT02413333|856645|P2|COMPLETED|Period 1||65
348316|NCT02413333|856646|P1|COMPLETED|Period 1||65
348317|NCT02413333|856645|P2|Randomized and Treated|Period 1||66
348318|NCT02413333|856646|P1|Randomized and Treated|Period 1||66
348319|NCT02413333|856645|P2|STARTED|Period 1||66
348320|NCT02413333|856646|P1|STARTED|Period 1||66
348321|NCT02413294|856654|P1|NOT COMPLETED|Overall Study||1
348322|NCT02413294|856654|P1|COMPLETED|Overall Study||11
348323|NCT02413294|856654|P1|STARTED|Overall Study||12
348324|NCT02413203|856674|P2|NOT COMPLETED|Overall Study||0
348325|NCT02413203|856675|P1|NOT COMPLETED|Overall Study||0
348326|NCT02413203|856674|P2|COMPLETED|Overall Study||10
348327|NCT02413203|856675|P1|COMPLETED|Overall Study||10
348328|NCT02413203|856674|P2|STARTED|Overall Study||10
348329|NCT02413203|856675|P1|STARTED|Overall Study||10
348330|NCT02413034|856697|P2|NOT COMPLETED|Overall Study||0
348331|NCT02413034|856698|P1|NOT COMPLETED|Overall Study||0
348332|NCT02413034|856697|P2|COMPLETED|Overall Study||14
348333|NCT02413034|856698|P1|COMPLETED|Overall Study||14
348334|NCT02413034|856697|P2|STARTED|Overall Study||14
348335|NCT02413034|856698|P1|STARTED|Overall Study||14
348336|NCT02412657|856709|P3|NOT COMPLETED|Overall Study||3
348337|NCT02412657|856710|P2|NOT COMPLETED|Overall Study||2
348338|NCT02412657|856711|P1|NOT COMPLETED|Overall Study||1
348339|NCT02412657|856709|P3|COMPLETED|Overall Study||22
348340|NCT02412657|856710|P2|COMPLETED|Overall Study||23
348341|NCT02412657|856711|P1|COMPLETED|Overall Study||24
348342|NCT02412657|856709|P3|STARTED|Overall Study||25
348343|NCT02412657|856710|P2|STARTED|Overall Study||25
348344|NCT02412657|856711|P1|STARTED|Overall Study||25
348345|NCT02412501|856719|P1|NOT COMPLETED|Overall Study||1
348346|NCT02412501|856719|P1|COMPLETED|Overall Study||100
348347|NCT02412501|856719|P1|STARTED|Overall Study||101
348348|NCT02411929|856728|P1|NOT COMPLETED|Period 2||0
348349|NCT02411929|856728|P1|COMPLETED|Period 2||8
348350|NCT02411929|856728|P1|STARTED|Period 2||8
348351|NCT02411929|856728|P1|NOT COMPLETED|Washout Period||0
348352|NCT02411929|856728|P1|COMPLETED|Washout Period||8
348353|NCT02411929|856728|P1|STARTED|Washout Period||8
348354|NCT02411929|856728|P1|NOT COMPLETED|Period 1||0
348355|NCT02411929|856728|P1|COMPLETED|Period 1||8
348356|NCT02411929|856728|P1|STARTED|Period 1||8
348357|NCT02411747|856760|P2|NOT COMPLETED|Overall Study||4
348358|NCT02411747|856761|P1|NOT COMPLETED|Overall Study||3
348359|NCT02411747|856760|P2|COMPLETED|Overall Study||12
348360|NCT02411747|856761|P1|COMPLETED|Overall Study||13
348361|NCT02411747|856760|P2|Simulation Training Completed|Overall Study||16
348362|NCT02411747|856761|P1|Simulation Training Completed|Overall Study||16
348363|NCT02411747|856760|P2|STARTED|Overall Study||16
348364|NCT02411747|856761|P1|STARTED|Overall Study||16
348365|NCT02411578|856769|P2|NOT COMPLETED|Extension Phase||0
348366|NCT02411578|856770|P1|NOT COMPLETED|Extension Phase||0
348367|NCT02411578|856769|P2|COMPLETED|Extension Phase||9
348368|NCT02411578|856770|P1|COMPLETED|Extension Phase||8
348369|NCT02411578|856769|P2|STARTED|Extension Phase|2 Crossover Trial participants could not continue due to study syringes expiration|9
348370|NCT02411578|856770|P1|STARTED|Extension Phase||8
348371|NCT02411578|856769|P2|NOT COMPLETED|Crossover Trial Phase||1
348372|NCT02411578|856770|P1|NOT COMPLETED|Crossover Trial Phase||0
348373|NCT02411578|856769|P2|COMPLETED|Crossover Trial Phase||11
348374|NCT02411578|856770|P1|COMPLETED|Crossover Trial Phase||8
348375|NCT02411578|856769|P2|STARTED|Crossover Trial Phase||12
348376|NCT02411578|856770|P1|STARTED|Crossover Trial Phase||8
348377|NCT02411539|856812|P2|NOT COMPLETED|Overall Study||1
348378|NCT02411539|856813|P1|NOT COMPLETED|Overall Study||2
348379|NCT02411539|856812|P2|COMPLETED|Overall Study||19
348380|NCT02411539|856813|P1|COMPLETED|Overall Study||18
348381|NCT02411539|856812|P2|STARTED|Overall Study||20
348382|NCT02411539|856813|P1|STARTED|Overall Study||20
348383|NCT02411461|856891|P3|NOT COMPLETED|Overall Study||0
348384|NCT02411461|856892|P2|NOT COMPLETED|Overall Study||0
348385|NCT02411461|856893|P1|NOT COMPLETED|Overall Study||0
348386|NCT02411461|856891|P3|COMPLETED|Overall Study||15
348387|NCT02411461|856892|P2|COMPLETED|Overall Study||8
348388|NCT02411461|856893|P1|COMPLETED|Overall Study||16
348389|NCT02411461|856891|P3|STARTED|Overall Study||15
348390|NCT02411461|856892|P2|STARTED|Overall Study||8
348391|NCT02411461|856893|P1|STARTED|Overall Study||16
348392|NCT02411292|856901|P1|NOT COMPLETED|Overall Study||21
348393|NCT02411292|856901|P1|COMPLETED|Overall Study||89
348394|NCT02411292|856901|P1|STARTED|Overall Study||110
348395|NCT02411201|856907|P1|NOT COMPLETED|Overall Study||6
348396|NCT02411201|856907|P1|COMPLETED|Overall Study||45
348397|NCT02411201|856907|P1|STARTED|Overall Study||51
348398|NCT02411110|856920|P2|NOT COMPLETED|Treatment Period 2||4
348399|NCT02411110|856921|P1|NOT COMPLETED|Treatment Period 2||1
348400|NCT02411110|856920|P2|COMPLETED|Treatment Period 2||44
348401|NCT02411110|856921|P1|COMPLETED|Treatment Period 2||49
348402|NCT02411110|856920|P2|STARTED|Treatment Period 2|Period 2 was optional.|48
348403|NCT02411110|856921|P1|STARTED|Treatment Period 2|Period 2 was optional.|50
348404|NCT02411110|856920|P2|NOT COMPLETED|Treatment Period 1||7
348405|NCT02411110|856921|P1|NOT COMPLETED|Treatment Period 1||9
348406|NCT02411110|856920|P2|COMPLETED|Treatment Period 1||59
348407|NCT02411110|856921|P1|COMPLETED|Treatment Period 1||56
348408|NCT02411110|856920|P2|STARTED|Treatment Period 1||66
348409|NCT02411110|856921|P1|STARTED|Treatment Period 1||65
348410|NCT02410967|856931|P2|NOT COMPLETED|Follow-up Phase (8 Weeks)||6
348411|NCT02410967|856932|P1|NOT COMPLETED|Follow-up Phase (8 Weeks)||4
348412|NCT02410967|856931|P2|COMPLETED|Follow-up Phase (8 Weeks)||16
348413|NCT02410967|856932|P1|COMPLETED|Follow-up Phase (8 Weeks)||22
348414|NCT02410967|856931|P2|STARTED|Follow-up Phase (8 Weeks)||22
348415|NCT02410967|856932|P1|STARTED|Follow-up Phase (8 Weeks)||26
348416|NCT02410967|856931|P2|NOT COMPLETED|Treatment Phase (4 Weeks)||4
348417|NCT02410967|856932|P1|NOT COMPLETED|Treatment Phase (4 Weeks)||1
348418|NCT02410967|856931|P2|COMPLETED|Treatment Phase (4 Weeks)||22
348419|NCT02410967|856932|P1|COMPLETED|Treatment Phase (4 Weeks)||26
348420|NCT02410967|856931|P2|STARTED|Treatment Phase (4 Weeks)||26
348421|NCT02410967|856932|P1|STARTED|Treatment Phase (4 Weeks)||27
348422|NCT02410824|856948|P2|NOT COMPLETED|Second Intervention (One Week)||0
348423|NCT02410824|856949|P1|NOT COMPLETED|Second Intervention (One Week)||0
348424|NCT02410824|856948|P2|COMPLETED|Second Intervention (One Week)||22
348425|NCT02410824|856949|P1|COMPLETED|Second Intervention (One Week)||22
348426|NCT02410824|856948|P2|STARTED|Second Intervention (One Week)||22
348427|NCT02410824|856949|P1|STARTED|Second Intervention (One Week)||22
348428|NCT02410824|856948|P2|NOT COMPLETED|First Intervention (One Week)||1
348429|NCT02410824|856949|P1|NOT COMPLETED|First Intervention (One Week)||0
348430|NCT02410824|856948|P2|COMPLETED|First Intervention (One Week)||22
348431|NCT02410824|856949|P1|COMPLETED|First Intervention (One Week)||22
348432|NCT02410824|856948|P2|STARTED|First Intervention (One Week)||23
348433|NCT02410824|856949|P1|STARTED|First Intervention (One Week)||22
348434|NCT02410343|856983|P2|NOT COMPLETED|Extension Period (12 Months)||1
348435|NCT02410343|856984|P1|NOT COMPLETED|Extension Period (12 Months)||1
348436|NCT02410343|856983|P2|COMPLETED|Extension Period (12 Months)||0
348437|NCT02410343|856984|P1|COMPLETED|Extension Period (12 Months)||0
348438|NCT02410343|856983|P2|STARTED|Extension Period (12 Months)||1
348439|NCT02410343|856984|P1|STARTED|Extension Period (12 Months)||1
348440|NCT02410343|856983|P2|NOT COMPLETED|Core Period (24 Weeks)||7
348441|NCT02410343|856984|P1|NOT COMPLETED|Core Period (24 Weeks)||5
348442|NCT02410343|856983|P2|COMPLETED|Core Period (24 Weeks)||1
348443|NCT02410343|856984|P1|COMPLETED|Core Period (24 Weeks)||1
348444|NCT02410343|856983|P2|STARTED|Core Period (24 Weeks)||8
348445|NCT02410343|856984|P1|STARTED|Core Period (24 Weeks)||6
348446|NCT02410291|857021|P2|NOT COMPLETED|Overall Study||0
348447|NCT02410291|857022|P1|NOT COMPLETED|Overall Study||0
348448|NCT02410291|857021|P2|COMPLETED|Overall Study||29
348449|NCT02410291|857022|P1|COMPLETED|Overall Study||29
348450|NCT02410291|857021|P2|STARTED|Overall Study||29
348451|NCT02410291|857022|P1|STARTED|Overall Study||29
348452|NCT02410213|857028|P2|NOT COMPLETED|Overall Study||0
348453|NCT02410213|857029|P1|NOT COMPLETED|Overall Study||0
348454|NCT02410213|857028|P2|COMPLETED|Overall Study||19
348455|NCT02410213|857029|P1|COMPLETED|Overall Study||16
348456|NCT02410213|857028|P2|STARTED|Overall Study||19
348457|NCT02410213|857029|P1|STARTED|Overall Study||16
348458|NCT02410200|857035|P1|NOT COMPLETED|Overall Study||2
348459|NCT02410200|857035|P1|COMPLETED|Overall Study||20
348460|NCT02410200|857035|P1|STARTED|Overall Study||22
348461|NCT02409784|857046|P1|NOT COMPLETED|Overall Study||0
348462|NCT02409784|857046|P1|COMPLETED|Overall Study||10
348463|NCT02409784|857046|P1|STARTED|Overall Study||10
348464|NCT02409459|857056|P2|NOT COMPLETED|Overall Study||1
348465|NCT02409459|857057|P1|NOT COMPLETED|Overall Study||1
348466|NCT02409459|857056|P2|COMPLETED|Overall Study||39
348467|NCT02409459|857057|P1|COMPLETED|Overall Study||40
348468|NCT02409459|857056|P2|STARTED|Overall Study||40
348469|NCT02409459|857057|P1|STARTED|Overall Study||41
348470|NCT02408692|857078|P3|NOT COMPLETED|Overall Study||0
348471|NCT02408692|857079|P2|NOT COMPLETED|Overall Study||0
348472|NCT02408692|857080|P1|NOT COMPLETED|Overall Study||0
348473|NCT02408692|857078|P3|COMPLETED|Overall Study||5
348474|NCT02408692|857079|P2|COMPLETED|Overall Study||5
348475|NCT02408692|857080|P1|COMPLETED|Overall Study||5
348476|NCT02408692|857078|P3|STARTED|Overall Study||5
348477|NCT02408692|857079|P2|STARTED|Overall Study||5
348478|NCT02408692|857080|P1|STARTED|Overall Study||5
348479|NCT02408263|857091|P2|NOT COMPLETED|Overall Study||0
348480|NCT02408263|857092|P1|NOT COMPLETED|Overall Study||0
348481|NCT02408263|857091|P2|COMPLETED|Overall Study||25
348482|NCT02408263|857092|P1|COMPLETED|Overall Study||25
348483|NCT02408263|857091|P2|STARTED|Overall Study||25
348484|NCT02408263|857092|P1|STARTED|Overall Study||25
348485|NCT02408068|857098|P6|NOT COMPLETED|Treatment 3 (1.5 Days)||0
348486|NCT02408068|857099|P5|NOT COMPLETED|Treatment 3 (1.5 Days)||0
348487|NCT02408068|857100|P4|NOT COMPLETED|Treatment 3 (1.5 Days)||0
348488|NCT02408068|857101|P3|NOT COMPLETED|Treatment 3 (1.5 Days)||1
348489|NCT02408068|857102|P2|NOT COMPLETED|Treatment 3 (1.5 Days)||0
348490|NCT02408068|857103|P1|NOT COMPLETED|Treatment 3 (1.5 Days)||0
348491|NCT02408068|857098|P6|COMPLETED|Treatment 3 (1.5 Days)||3
348492|NCT02408068|857099|P5|COMPLETED|Treatment 3 (1.5 Days)||3
348493|NCT02408068|857100|P4|COMPLETED|Treatment 3 (1.5 Days)||3
348494|NCT02408068|857101|P3|COMPLETED|Treatment 3 (1.5 Days)||2
348495|NCT02408068|857102|P2|COMPLETED|Treatment 3 (1.5 Days)||3
348496|NCT02408068|857103|P1|COMPLETED|Treatment 3 (1.5 Days)||3
348497|NCT02408068|857098|P6|STARTED|Treatment 3 (1.5 Days)||3
348498|NCT02408068|857099|P5|STARTED|Treatment 3 (1.5 Days)||3
348499|NCT02408068|857100|P4|STARTED|Treatment 3 (1.5 Days)||3
348500|NCT02408068|857101|P3|STARTED|Treatment 3 (1.5 Days)||3
348501|NCT02408068|857102|P2|STARTED|Treatment 3 (1.5 Days)||3
348502|NCT02408068|857103|P1|STARTED|Treatment 3 (1.5 Days)||3
348503|NCT02408068|857098|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
348504|NCT02408068|857099|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
348505|NCT02408068|857100|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
348506|NCT02408068|857101|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
348507|NCT02408068|857102|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
348508|NCT02408068|857103|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
348509|NCT02408068|857098|P6|COMPLETED|Washout Period 2 (7 Days)||3
348510|NCT02408068|857099|P5|COMPLETED|Washout Period 2 (7 Days)||3
348511|NCT02408068|857100|P4|COMPLETED|Washout Period 2 (7 Days)||3
348512|NCT02408068|857101|P3|COMPLETED|Washout Period 2 (7 Days)||3
348513|NCT02408068|857102|P2|COMPLETED|Washout Period 2 (7 Days)||3
348514|NCT02408068|857103|P1|COMPLETED|Washout Period 2 (7 Days)||3
348515|NCT02408068|857098|P6|STARTED|Washout Period 2 (7 Days)||3
348516|NCT02408068|857099|P5|STARTED|Washout Period 2 (7 Days)||3
348517|NCT02408068|857100|P4|STARTED|Washout Period 2 (7 Days)||3
348518|NCT02408068|857101|P3|STARTED|Washout Period 2 (7 Days)||3
348519|NCT02408068|857102|P2|STARTED|Washout Period 2 (7 Days)||3
348520|NCT02408068|857103|P1|STARTED|Washout Period 2 (7 Days)||3
348521|NCT02408068|857098|P6|NOT COMPLETED|Treatment 2 (1.5 Days)||0
348522|NCT02408068|857099|P5|NOT COMPLETED|Treatment 2 (1.5 Days)||0
348523|NCT02408068|857100|P4|NOT COMPLETED|Treatment 2 (1.5 Days)||0
348524|NCT02408068|857101|P3|NOT COMPLETED|Treatment 2 (1.5 Days)||0
348525|NCT02408068|857102|P2|NOT COMPLETED|Treatment 2 (1.5 Days)||0
348526|NCT02408068|857103|P1|NOT COMPLETED|Treatment 2 (1.5 Days)||0
348527|NCT02408068|857098|P6|COMPLETED|Treatment 2 (1.5 Days)||3
348528|NCT02408068|857099|P5|COMPLETED|Treatment 2 (1.5 Days)||3
348529|NCT02408068|857100|P4|COMPLETED|Treatment 2 (1.5 Days)||3
348530|NCT02408068|857101|P3|COMPLETED|Treatment 2 (1.5 Days)||3
348531|NCT02408068|857102|P2|COMPLETED|Treatment 2 (1.5 Days)||3
348532|NCT02408068|857103|P1|COMPLETED|Treatment 2 (1.5 Days)||3
348533|NCT02408068|857098|P6|STARTED|Treatment 2 (1.5 Days)||3
348534|NCT02408068|857099|P5|STARTED|Treatment 2 (1.5 Days)||3
348535|NCT02408068|857100|P4|STARTED|Treatment 2 (1.5 Days)||3
348536|NCT02408068|857101|P3|STARTED|Treatment 2 (1.5 Days)||3
348537|NCT02408068|857102|P2|STARTED|Treatment 2 (1.5 Days)||3
348538|NCT02408068|857103|P1|STARTED|Treatment 2 (1.5 Days)||3
348539|NCT02408068|857098|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
348540|NCT02408068|857099|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
348541|NCT02408068|857100|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
348542|NCT02408068|857101|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
348543|NCT02408068|857102|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
348544|NCT02408068|857103|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
348545|NCT02408068|857098|P6|COMPLETED|Washout Period 1 (7 Days)||3
348546|NCT02408068|857099|P5|COMPLETED|Washout Period 1 (7 Days)||3
348547|NCT02408068|857100|P4|COMPLETED|Washout Period 1 (7 Days)||3
348548|NCT02408068|857101|P3|COMPLETED|Washout Period 1 (7 Days)||3
348549|NCT02408068|857102|P2|COMPLETED|Washout Period 1 (7 Days)||3
348550|NCT02408068|857103|P1|COMPLETED|Washout Period 1 (7 Days)||3
348551|NCT02408068|857098|P6|STARTED|Washout Period 1 (7 Days)||3
348552|NCT02408068|857099|P5|STARTED|Washout Period 1 (7 Days)||3
348553|NCT02408068|857100|P4|STARTED|Washout Period 1 (7 Days)||3
348554|NCT02408068|857101|P3|STARTED|Washout Period 1 (7 Days)||3
348555|NCT02408068|857102|P2|STARTED|Washout Period 1 (7 Days)||3
348556|NCT02408068|857103|P1|STARTED|Washout Period 1 (7 Days)||3
348557|NCT02408068|857098|P6|NOT COMPLETED|Treatment 1 (1.5 Days)||0
348558|NCT02408068|857099|P5|NOT COMPLETED|Treatment 1 (1.5 Days)||0
348559|NCT02408068|857100|P4|NOT COMPLETED|Treatment 1 (1.5 Days)||0
348560|NCT02408068|857101|P3|NOT COMPLETED|Treatment 1 (1.5 Days)||0
348561|NCT02408068|857102|P2|NOT COMPLETED|Treatment 1 (1.5 Days)||0
348562|NCT02408068|857103|P1|NOT COMPLETED|Treatment 1 (1.5 Days)||0
348563|NCT02408068|857098|P6|COMPLETED|Treatment 1 (1.5 Days)||3
348564|NCT02408068|857099|P5|COMPLETED|Treatment 1 (1.5 Days)||3
348565|NCT02408068|857100|P4|COMPLETED|Treatment 1 (1.5 Days)||3
348566|NCT02408068|857101|P3|COMPLETED|Treatment 1 (1.5 Days)||3
348567|NCT02408068|857102|P2|COMPLETED|Treatment 1 (1.5 Days)||3
348568|NCT02408068|857103|P1|COMPLETED|Treatment 1 (1.5 Days)||3
348569|NCT02408068|857098|P6|STARTED|Treatment 1 (1.5 Days)||3
348570|NCT02408068|857099|P5|STARTED|Treatment 1 (1.5 Days)||3
348571|NCT02408068|857100|P4|STARTED|Treatment 1 (1.5 Days)||3
348572|NCT02408068|857101|P3|STARTED|Treatment 1 (1.5 Days)||3
348573|NCT02408068|857102|P2|STARTED|Treatment 1 (1.5 Days)||3
348574|NCT02408068|857103|P1|STARTED|Treatment 1 (1.5 Days)||3
348575|NCT02407704|857130|P4|NOT COMPLETED|Overall Study||3
348576|NCT02407704|857131|P3|NOT COMPLETED|Overall Study||1
348577|NCT02407704|857132|P2|NOT COMPLETED|Overall Study||0
348578|NCT02407704|857133|P1|NOT COMPLETED|Overall Study||0
348579|NCT02407704|857130|P4|COMPLETED|Overall Study||2
348580|NCT02407704|857131|P3|COMPLETED|Overall Study||4
348581|NCT02407704|857132|P2|COMPLETED|Overall Study||3
348582|NCT02407704|857133|P1|COMPLETED|Overall Study||2
348583|NCT02407704|857130|P4|STARTED|Overall Study||5
348584|NCT02407704|857131|P3|STARTED|Overall Study||5
348585|NCT02407704|857132|P2|STARTED|Overall Study||3
348586|NCT02407704|857133|P1|STARTED|Overall Study||2
348587|NCT02406937|857170|P3|NOT COMPLETED|Overall Study||2
348588|NCT02406937|857171|P2|NOT COMPLETED|Overall Study||1
348589|NCT02406937|857172|P1|NOT COMPLETED|Overall Study||1
348590|NCT02406937|857170|P3|COMPLETED|Overall Study||58
348591|NCT02406937|857171|P2|COMPLETED|Overall Study||59
348592|NCT02406937|857172|P1|COMPLETED|Overall Study||59
348593|NCT02406937|857170|P3|STARTED|Overall Study||60
348594|NCT02406937|857171|P2|STARTED|Overall Study||60
348595|NCT02406937|857172|P1|STARTED|Overall Study||60
348596|NCT02406586|857231|P3|NOT COMPLETED|Overall Study||2
348597|NCT02406586|857232|P2|NOT COMPLETED|Overall Study||4
348598|NCT02406586|857233|P1|NOT COMPLETED|Overall Study||1
348599|NCT02406586|857231|P3|COMPLETED|Overall Study||10
348600|NCT02406586|857232|P2|COMPLETED|Overall Study||8
348601|NCT02406586|857233|P1|COMPLETED|Overall Study||11
348602|NCT02406586|857231|P3|STARTED|Overall Study||12
348603|NCT02406586|857232|P2|STARTED|Overall Study||12
348604|NCT02406586|857233|P1|STARTED|Overall Study||12
348605|NCT02406495|857286|P1|NOT COMPLETED|Overall Study||0
348606|NCT02406495|857286|P1|COMPLETED|Overall Study||40
348607|NCT02406495|857286|P1|STARTED|Overall Study||40
348608|NCT02406443|857327|P2|NOT COMPLETED|Overall Study||2
348609|NCT02406443|857328|P1|NOT COMPLETED|Overall Study||2
348610|NCT02406443|857327|P2|COMPLETED|Overall Study||16
348611|NCT02406443|857328|P1|COMPLETED|Overall Study||16
348612|NCT02406443|857327|P2|STARTED|Overall Study||18
348613|NCT02406443|857328|P1|STARTED|Overall Study||18
348614|NCT02405429|857346|P1|NOT COMPLETED|Overall Study||0
348615|NCT02405429|857346|P1|COMPLETED|Overall Study||49
348616|NCT02405429|857346|P1|STARTED|Overall Study||49
348617|NCT02405390|857356|P2|NOT COMPLETED|Overall Study||0
348618|NCT02405390|857357|P1|NOT COMPLETED|Overall Study||0
348619|NCT02405390|857356|P2|COMPLETED|Overall Study||46
348620|NCT02405390|857357|P1|COMPLETED|Overall Study||46
348621|NCT02405390|857356|P2|STARTED|Overall Study||46
348622|NCT02405390|857357|P1|STARTED|Overall Study||46
348623|NCT02404649|857367|P2|NOT COMPLETED|Overall Study||2
348624|NCT02404649|857368|P1|NOT COMPLETED|Overall Study||1
348625|NCT02404649|857367|P2|COMPLETED|Overall Study||14
348626|NCT02404649|857368|P1|COMPLETED|Overall Study||16
348627|NCT02404649|857367|P2|STARTED|Overall Study||16
348628|NCT02404649|857368|P1|STARTED|Overall Study||17
348629|NCT02404545|857376|P2|NOT COMPLETED|Overall Study||6
348630|NCT02404545|857377|P1|NOT COMPLETED|Overall Study||6
348631|NCT02404545|857376|P2|COMPLETED|Overall Study||0
348632|NCT02404545|857377|P1|COMPLETED|Overall Study||0
348633|NCT02404545|857376|P2|STARTED|Overall Study||6
348634|NCT02404545|857377|P1|STARTED|Overall Study||6
348635|NCT02404493|857386|P2|NOT COMPLETED|Overall Study||1
348636|NCT02404493|857387|P1|NOT COMPLETED|Overall Study||1
348637|NCT02404493|857386|P2|COMPLETED|Overall Study||5
348638|NCT02404493|857387|P1|COMPLETED|Overall Study||16
348639|NCT02404493|857386|P2|STARTED|Overall Study||6
348640|NCT02404493|857387|P1|STARTED|Overall Study||17
348641|NCT02404389|857632|P5|NOT COMPLETED|Overall Study||3
348642|NCT02404389|857633|P4|NOT COMPLETED|Overall Study||1
348643|NCT02404389|857634|P3|NOT COMPLETED|Overall Study||1
348644|NCT02404389|857635|P2|NOT COMPLETED|Overall Study||0
348645|NCT02404389|857636|P1|NOT COMPLETED|Overall Study||2
348646|NCT02404389|857632|P5|COMPLETED|Overall Study||18
348647|NCT02404389|857633|P4|COMPLETED|Overall Study||9
348648|NCT02404389|857634|P3|COMPLETED|Overall Study||10
348649|NCT02404389|857635|P2|COMPLETED|Overall Study||20
348650|NCT02404389|857636|P1|COMPLETED|Overall Study||18
348651|NCT02404389|857632|P5|STARTED|Overall Study||21
348652|NCT02404389|857633|P4|STARTED|Overall Study||10
348653|NCT02404389|857634|P3|STARTED|Overall Study||11
348654|NCT02404389|857635|P2|STARTED|Overall Study||20
348655|NCT02404389|857636|P1|STARTED|Overall Study||20
348656|NCT02404103|857674|P2|NOT COMPLETED|Overall Study||3
348657|NCT02404103|857675|P1|NOT COMPLETED|Overall Study||4
348658|NCT02404103|857674|P2|COMPLETED|Overall Study||9
348659|NCT02404103|857675|P1|COMPLETED|Overall Study||10
348660|NCT02404103|857674|P2|STARTED|Overall Study||12
348661|NCT02404103|857675|P1|STARTED|Overall Study||14
348662|NCT02403830|857695|P2|NOT COMPLETED|Visit 2||0
348663|NCT02403830|857696|P1|NOT COMPLETED|Visit 2||0
348664|NCT02403830|857695|P2|COMPLETED|Visit 2||15
348665|NCT02403830|857696|P1|COMPLETED|Visit 2||14
348666|NCT02403830|857695|P2|STARTED|Visit 2||15
348667|NCT02403830|857696|P1|STARTED|Visit 2|One subject completed visit 1 and then withdrew from the study for an adverse event (nausea).|14
348668|NCT02403830|857695|P2|NOT COMPLETED|Visit 1||0
348669|NCT02403830|857696|P1|NOT COMPLETED|Visit 1||0
348670|NCT02403830|857695|P2|COMPLETED|Visit 1||15
348671|NCT02403830|857696|P1|COMPLETED|Visit 1||15
348672|NCT02403830|857695|P2|STARTED|Visit 1||15
348673|NCT02403830|857696|P1|STARTED|Visit 1||15
348674|NCT02403674|857708|P2|NOT COMPLETED|Overall Study||63
348675|NCT02403674|857709|P1|NOT COMPLETED|Overall Study||55
348676|NCT02403674|857708|P2|COMPLETED|Overall Study||303
348677|NCT02403674|857709|P1|COMPLETED|Overall Study||313
348678|NCT02403674|857708|P2|Treated|Overall Study||364
348679|NCT02403674|857709|P1|Treated|Overall Study||364
348680|NCT02403674|857708|P2|STARTED|Overall Study||366
348681|NCT02403674|857709|P1|STARTED|Overall Study||368
348682|NCT02403206|857750|P2|NOT COMPLETED|Overall Study||10
348683|NCT02403206|857751|P1|NOT COMPLETED|Overall Study||11
348684|NCT02403206|857750|P2|COMPLETED|Overall Study||186
348685|NCT02403206|857751|P1|COMPLETED|Overall Study||183
348686|NCT02403206|857750|P2|Randomized and Treated|Overall Study||190
348687|NCT02403206|857751|P1|Randomized and Treated|Overall Study||188
348688|NCT02403206|857750|P2|Treated Prior to Randomization|Overall Study||1
348689|NCT02403206|857751|P1|Treated Prior to Randomization|Overall Study||0
348690|NCT02403206|857750|P2|STARTED|Overall Study||196
348691|NCT02403206|857751|P1|STARTED|Overall Study||194
348692|NCT02403180|857762|P2|NOT COMPLETED|Period 2 (5 Days)||1
348693|NCT02403180|857763|P1|NOT COMPLETED|Period 2 (5 Days)||0
348694|NCT02403180|857762|P2|COMPLETED|Period 2 (5 Days)||32
348695|NCT02403180|857763|P1|COMPLETED|Period 2 (5 Days)||36
348696|NCT02403180|857762|P2|STARTED|Period 2 (5 Days)||33
348697|NCT02403180|857763|P1|STARTED|Period 2 (5 Days)||36
348698|NCT02403180|857762|P2|NOT COMPLETED|Period 1 (5 Days)||0
348699|NCT02403180|857763|P1|NOT COMPLETED|Period 1 (5 Days)||0
348700|NCT02403180|857762|P2|COMPLETED|Period 1 (5 Days)||33
348701|NCT02403180|857763|P1|COMPLETED|Period 1 (5 Days)||36
348702|NCT02403180|857762|P2|Randomized|Period 1 (5 Days)||33
348703|NCT02403180|857763|P1|Randomized|Period 1 (5 Days)||36
348704|NCT02403180|857762|P2|STARTED|Period 1 (5 Days)||33
348705|NCT02403180|857763|P1|STARTED|Period 1 (5 Days)||36
348706|NCT02403180|857762|P2|NOT COMPLETED|Pre-Treatment Period||1
348707|NCT02403180|857763|P1|NOT COMPLETED|Pre-Treatment Period||0
348708|NCT02403180|857762|P2|COMPLETED|Pre-Treatment Period||33
348709|NCT02403180|857763|P1|COMPLETED|Pre-Treatment Period||36
348710|NCT02403180|857762|P2|STARTED|Pre-Treatment Period||34
348711|NCT02403180|857763|P1|STARTED|Pre-Treatment Period||36
348712|NCT02403154|857775|P4|NOT COMPLETED|Overall Study||1
348713|NCT02403154|857776|P3|NOT COMPLETED|Overall Study||1
348714|NCT02403154|857777|P2|NOT COMPLETED|Overall Study||0
348715|NCT02403154|857778|P1|NOT COMPLETED|Overall Study||2
348716|NCT02403154|857775|P4|COMPLETED|Overall Study||0
348717|NCT02403154|857776|P3|COMPLETED|Overall Study||0
348718|NCT02403154|857777|P2|COMPLETED|Overall Study||0
348719|NCT02403154|857778|P1|COMPLETED|Overall Study||0
348720|NCT02403154|857775|P4|STARTED|Overall Study||1
348721|NCT02403154|857776|P3|STARTED|Overall Study||1
348722|NCT02403154|857777|P2|STARTED|Overall Study||0
348723|NCT02403154|857778|P1|STARTED|Overall Study||2
348724|NCT02402933|857792|P1|NOT COMPLETED|Overall Study||14
348725|NCT02402933|857792|P1|COMPLETED|Overall Study||12
348726|NCT02402933|857792|P1|Received at Least One Dose of Study Drug|Overall Study||22
348727|NCT02402933|857792|P1|STARTED|Overall Study||26
348728|NCT02402764|857799|P1|NOT COMPLETED|Overall Study||0
348729|NCT02402764|857799|P1|COMPLETED|Overall Study||10
348730|NCT02402764|857799|P1|STARTED|Overall Study||10
348731|NCT02402322|857810|P3|NOT COMPLETED|Follow-up||24
348732|NCT02402322|857811|P2|NOT COMPLETED|Follow-up||3
348733|NCT02402322|857812|P1|NOT COMPLETED|Follow-up||6
348734|NCT02402322|857810|P3|COMPLETED|Follow-up||0
348735|NCT02402322|857811|P2|COMPLETED|Follow-up||21
348736|NCT02402322|857812|P1|COMPLETED|Follow-up||18
348737|NCT02402322|857810|P3|STARTED|Follow-up|These individuals were not evaluated at this follow-up as they started an alternative treatment.|24
348738|NCT02402322|857811|P2|STARTED|Follow-up||24
348739|NCT02402322|857812|P1|STARTED|Follow-up||24
348740|NCT02402322|857810|P3|NOT COMPLETED|Pretreatment||1
348741|NCT02402322|857811|P2|NOT COMPLETED|Pretreatment||1
348742|NCT02402322|857812|P1|NOT COMPLETED|Pretreatment||3
348743|NCT02402322|857810|P3|COMPLETED|Pretreatment||24
348744|NCT02402322|857811|P2|COMPLETED|Pretreatment||24
348745|NCT02402322|857812|P1|COMPLETED|Pretreatment||24
348746|NCT02402322|857810|P3|Posttreatment Measures|Pretreatment||24
348747|NCT02402322|857811|P2|Posttreatment Measures|Pretreatment||24
348748|NCT02402322|857812|P1|Posttreatment Measures|Pretreatment||24
348749|NCT02402322|857810|P3|STARTED|Pretreatment||25
348750|NCT02402322|857811|P2|STARTED|Pretreatment||25
348751|NCT02402322|857812|P1|STARTED|Pretreatment||27
348752|NCT02402296|857846|P2|NOT COMPLETED|Overall Study||0
348753|NCT02402296|857847|P1|NOT COMPLETED|Overall Study||0
348754|NCT02402296|857846|P2|COMPLETED|Overall Study||15
348755|NCT02402296|857847|P1|COMPLETED|Overall Study||15
348756|NCT02402296|857846|P2|STARTED|Overall Study||15
348757|NCT02402296|857847|P1|STARTED|Overall Study||15
348758|NCT02402127|857865|P6|NOT COMPLETED|Third Wear Period (1 Day)||0
348759|NCT02402127|857866|P5|NOT COMPLETED|Third Wear Period (1 Day)||0
348760|NCT02402127|857867|P4|NOT COMPLETED|Third Wear Period (1 Day)||0
348761|NCT02402127|857868|P3|NOT COMPLETED|Third Wear Period (1 Day)||0
348762|NCT02402127|857869|P2|NOT COMPLETED|Third Wear Period (1 Day)||0
348763|NCT02402127|857870|P1|NOT COMPLETED|Third Wear Period (1 Day)||0
348764|NCT02402127|857865|P6|COMPLETED|Third Wear Period (1 Day)||4
348765|NCT02402127|857866|P5|COMPLETED|Third Wear Period (1 Day)||4
348766|NCT02402127|857867|P4|COMPLETED|Third Wear Period (1 Day)||4
348767|NCT02402127|857868|P3|COMPLETED|Third Wear Period (1 Day)||4
348768|NCT02402127|857869|P2|COMPLETED|Third Wear Period (1 Day)||4
348769|NCT02402127|857870|P1|COMPLETED|Third Wear Period (1 Day)||4
348770|NCT02402127|857865|P6|STARTED|Third Wear Period (1 Day)||4
348771|NCT02402127|857866|P5|STARTED|Third Wear Period (1 Day)||4
348772|NCT02402127|857867|P4|STARTED|Third Wear Period (1 Day)||4
348773|NCT02402127|857868|P3|STARTED|Third Wear Period (1 Day)||4
348774|NCT02402127|857869|P2|STARTED|Third Wear Period (1 Day)||4
348775|NCT02402127|857870|P1|STARTED|Third Wear Period (1 Day)||4
348776|NCT02402127|857865|P6|NOT COMPLETED|Second Wear Period (1 Day)||0
348777|NCT02402127|857866|P5|NOT COMPLETED|Second Wear Period (1 Day)||0
348778|NCT02402127|857867|P4|NOT COMPLETED|Second Wear Period (1 Day)||0
348779|NCT02402127|857868|P3|NOT COMPLETED|Second Wear Period (1 Day)||0
348780|NCT02402127|857869|P2|NOT COMPLETED|Second Wear Period (1 Day)||0
348781|NCT02402127|857870|P1|NOT COMPLETED|Second Wear Period (1 Day)||0
348782|NCT02402127|857865|P6|COMPLETED|Second Wear Period (1 Day)||4
348783|NCT02402127|857866|P5|COMPLETED|Second Wear Period (1 Day)||4
348784|NCT02402127|857867|P4|COMPLETED|Second Wear Period (1 Day)||4
348785|NCT02402127|857868|P3|COMPLETED|Second Wear Period (1 Day)||4
348786|NCT02402127|857869|P2|COMPLETED|Second Wear Period (1 Day)||4
348787|NCT02402127|857870|P1|COMPLETED|Second Wear Period (1 Day)||4
348788|NCT02402127|857865|P6|STARTED|Second Wear Period (1 Day)||4
348789|NCT02402127|857866|P5|STARTED|Second Wear Period (1 Day)||4
348790|NCT02402127|857867|P4|STARTED|Second Wear Period (1 Day)||4
348791|NCT02402127|857868|P3|STARTED|Second Wear Period (1 Day)||4
348792|NCT02402127|857869|P2|STARTED|Second Wear Period (1 Day)||4
348793|NCT02402127|857870|P1|STARTED|Second Wear Period (1 Day)||4
348794|NCT02402127|857865|P6|NOT COMPLETED|First Wear Period (1 Day)||0
348795|NCT02402127|857866|P5|NOT COMPLETED|First Wear Period (1 Day)||0
348796|NCT02402127|857867|P4|NOT COMPLETED|First Wear Period (1 Day)||0
348797|NCT02402127|857868|P3|NOT COMPLETED|First Wear Period (1 Day)||0
348798|NCT02402127|857869|P2|NOT COMPLETED|First Wear Period (1 Day)||0
348799|NCT02402127|857870|P1|NOT COMPLETED|First Wear Period (1 Day)||0
348800|NCT02402127|857865|P6|COMPLETED|First Wear Period (1 Day)||4
348801|NCT02402127|857866|P5|COMPLETED|First Wear Period (1 Day)||4
348802|NCT02402127|857867|P4|COMPLETED|First Wear Period (1 Day)||4
348803|NCT02402127|857868|P3|COMPLETED|First Wear Period (1 Day)||4
348804|NCT02402127|857869|P2|COMPLETED|First Wear Period (1 Day)||4
348805|NCT02402127|857870|P1|COMPLETED|First Wear Period (1 Day)||4
348806|NCT02402127|857865|P6|Randomized and Treated|First Wear Period (1 Day)||4
348807|NCT02402127|857866|P5|Randomized and Treated|First Wear Period (1 Day)||4
348808|NCT02402127|857867|P4|Randomized and Treated|First Wear Period (1 Day)||4
348809|NCT02402127|857868|P3|Randomized and Treated|First Wear Period (1 Day)||4
348810|NCT02402127|857869|P2|Randomized and Treated|First Wear Period (1 Day)||4
348811|NCT02402127|857870|P1|Randomized and Treated|First Wear Period (1 Day)||4
348812|NCT02402127|857865|P6|STARTED|First Wear Period (1 Day)||4
348813|NCT02402127|857866|P5|STARTED|First Wear Period (1 Day)||4
348814|NCT02402127|857867|P4|STARTED|First Wear Period (1 Day)||4
348815|NCT02402127|857868|P3|STARTED|First Wear Period (1 Day)||4
348816|NCT02402127|857869|P2|STARTED|First Wear Period (1 Day)||4
348817|NCT02402127|857870|P1|STARTED|First Wear Period (1 Day)||4
348818|NCT02401867|857881|P1|NOT COMPLETED|Analysis||9
348819|NCT02401867|857881|P1|COMPLETED|Analysis|Comparative analysis of vaginal HPV DNA results and cervical HPV DNA results|131
348820|NCT02401867|857881|P1|STARTED|Analysis||140
348821|NCT02401867|857881|P1|NOT COMPLETED|Specimen Collection||10
348822|NCT02401867|857881|P1|COMPLETED|Specimen Collection|Completed both vaginal self-swab and provider-collected cervical swab|140
348823|NCT02401867|857881|P1|STARTED|Specimen Collection||150
348824|NCT02401867|857881|P1|NOT COMPLETED|Enrolled||0
348825|NCT02401867|857881|P1|COMPLETED|Enrolled||150
348826|NCT02401867|857881|P1|STARTED|Enrolled||150
348827|NCT02401555|857889|P3|NOT COMPLETED|Overall Study||0
348828|NCT02401555|857890|P2|NOT COMPLETED|Overall Study||0
348829|NCT02401555|857891|P1|NOT COMPLETED|Overall Study||0
348830|NCT02401555|857889|P3|COMPLETED|Overall Study||120
348831|NCT02401555|857890|P2|COMPLETED|Overall Study||212
348832|NCT02401555|857891|P1|COMPLETED|Overall Study||87
348833|NCT02401555|857889|P3|STARTED|Overall Study||120
348834|NCT02401555|857890|P2|STARTED|Overall Study||212
348835|NCT02401555|857891|P1|STARTED|Overall Study||87
348836|NCT02401529|857901|P2|NOT COMPLETED|Overall Study||7
348837|NCT02401529|857902|P1|NOT COMPLETED|Overall Study||9
348838|NCT02401529|857901|P2|COMPLETED|Overall Study||50
348839|NCT02401529|857902|P1|COMPLETED|Overall Study||50
348840|NCT02401529|857901|P2|STARTED|Overall Study||57
348841|NCT02401529|857902|P1|STARTED|Overall Study||59
348842|NCT02401464|857930|P4|NOT COMPLETED|Intervention Period 2 (6 Days)||0
348843|NCT02401464|857931|P3|NOT COMPLETED|Intervention Period 2 (6 Days)||0
348844|NCT02401464|857932|P2|NOT COMPLETED|Intervention Period 2 (6 Days)||0
348845|NCT02401464|857933|P1|NOT COMPLETED|Intervention Period 2 (6 Days)||0
348846|NCT02401464|857930|P4|COMPLETED|Intervention Period 2 (6 Days)||13
348847|NCT02401464|857931|P3|COMPLETED|Intervention Period 2 (6 Days)||13
348848|NCT02401464|857932|P2|COMPLETED|Intervention Period 2 (6 Days)||13
348849|NCT02401464|857933|P1|COMPLETED|Intervention Period 2 (6 Days)||13
348850|NCT02401464|857930|P4|STARTED|Intervention Period 2 (6 Days)||13
348851|NCT02401464|857931|P3|STARTED|Intervention Period 2 (6 Days)||13
348852|NCT02401464|857932|P2|STARTED|Intervention Period 2 (6 Days)||13
348853|NCT02401464|857933|P1|STARTED|Intervention Period 2 (6 Days)||13
348854|NCT02401464|857930|P4|NOT COMPLETED|Washout Period (At Least 6 Days)||0
348855|NCT02401464|857931|P3|NOT COMPLETED|Washout Period (At Least 6 Days)||0
348856|NCT02401464|857932|P2|NOT COMPLETED|Washout Period (At Least 6 Days)||0
348857|NCT02401464|857933|P1|NOT COMPLETED|Washout Period (At Least 6 Days)||0
348858|NCT02401464|857930|P4|COMPLETED|Washout Period (At Least 6 Days)||13
348859|NCT02401464|857931|P3|COMPLETED|Washout Period (At Least 6 Days)||13
348860|NCT02401464|857932|P2|COMPLETED|Washout Period (At Least 6 Days)||13
348861|NCT02401464|857933|P1|COMPLETED|Washout Period (At Least 6 Days)||13
348862|NCT02401464|857930|P4|STARTED|Washout Period (At Least 6 Days)||13
348863|NCT02401464|857931|P3|STARTED|Washout Period (At Least 6 Days)||13
348864|NCT02401464|857932|P2|STARTED|Washout Period (At Least 6 Days)||13
348865|NCT02401464|857933|P1|STARTED|Washout Period (At Least 6 Days)||13
348866|NCT02401464|857930|P4|NOT COMPLETED|Intervention Period 1 (6 Days)||0
348867|NCT02401464|857931|P3|NOT COMPLETED|Intervention Period 1 (6 Days)||0
348868|NCT02401464|857932|P2|NOT COMPLETED|Intervention Period 1 (6 Days)||0
348869|NCT02401464|857933|P1|NOT COMPLETED|Intervention Period 1 (6 Days)||0
348870|NCT02401464|857930|P4|COMPLETED|Intervention Period 1 (6 Days)||13
348871|NCT02401464|857931|P3|COMPLETED|Intervention Period 1 (6 Days)||13
348872|NCT02401464|857932|P2|COMPLETED|Intervention Period 1 (6 Days)||13
348873|NCT02401464|857933|P1|COMPLETED|Intervention Period 1 (6 Days)||13
348874|NCT02401464|857930|P4|STARTED|Intervention Period 1 (6 Days)||13
348875|NCT02401464|857931|P3|STARTED|Intervention Period 1 (6 Days)||13
348876|NCT02401464|857932|P2|STARTED|Intervention Period 1 (6 Days)||13
348877|NCT02401464|857933|P1|STARTED|Intervention Period 1 (6 Days)||13
348878|NCT02401256|857967|P1|NOT COMPLETED|Overall Study||17
348879|NCT02401256|857967|P1|COMPLETED|Overall Study||53
348880|NCT02401256|857967|P1|Analysed|Overall Study|Volunteers that completed at least until Phase 2 inpatient visit (Volunteers with Efavirenz PK data)|61
348881|NCT02401256|857967|P1|Finished Phase 3|Overall Study||53
348882|NCT02401256|857967|P1|Finished Phase 2|Overall Study||58
348883|NCT02401256|857967|P1|Finished Phase 1|Overall Study||64
348884|NCT02401256|857967|P1|STARTED|Overall Study||70
348885|NCT02401230|857976|P3|NOT COMPLETED|Overall Study||4
348886|NCT02401230|857977|P2|NOT COMPLETED|Overall Study||6
348887|NCT02401230|857978|P1|NOT COMPLETED|Overall Study||6
348888|NCT02401230|857976|P3|COMPLETED|Overall Study||21
348889|NCT02401230|857977|P2|COMPLETED|Overall Study||19
348890|NCT02401230|857978|P1|COMPLETED|Overall Study||20
348891|NCT02401230|857976|P3|STARTED|Overall Study||25
348892|NCT02401230|857977|P2|STARTED|Overall Study||25
348893|NCT02401230|857978|P1|STARTED|Overall Study||26
348894|NCT02401022|858013|P2|NOT COMPLETED|Overall Study||20
348895|NCT02401022|858014|P1|NOT COMPLETED|Overall Study||15
348896|NCT02401022|858013|P2|COMPLETED|Overall Study||90
348897|NCT02401022|858014|P1|COMPLETED|Overall Study||89
348898|NCT02401022|858013|P2|STARTED|Overall Study||110
348899|NCT02401022|858014|P1|STARTED|Overall Study||104
348900|NCT02400996|858020|P1|NOT COMPLETED|Overall Study||0
348901|NCT02400996|858020|P1|COMPLETED|Overall Study||40
348902|NCT02400996|858020|P1|STARTED|Overall Study||40
348903|NCT02400710|858026|P2|NOT COMPLETED|Overall Study||0
348904|NCT02400710|858027|P1|NOT COMPLETED|Overall Study||0
348905|NCT02400710|858026|P2|COMPLETED|Overall Study||10
348906|NCT02400710|858027|P1|COMPLETED|Overall Study||10
348907|NCT02400710|858026|P2|STARTED|Overall Study||10
348908|NCT02400710|858027|P1|STARTED|Overall Study||10
348909|NCT02400580|858037|P2|NOT COMPLETED|Overall Study||1
348910|NCT02400580|858038|P1|NOT COMPLETED|Overall Study||2
348911|NCT02400580|858037|P2|COMPLETED|Overall Study||91
348912|NCT02400580|858038|P1|COMPLETED|Overall Study||89
348913|NCT02400580|858037|P2|STARTED|Overall Study||92
348914|NCT02400580|858038|P1|STARTED|Overall Study||91
348915|NCT02400346|858054|P1|NOT COMPLETED|Overall Study||44
348916|NCT02400346|858054|P1|COMPLETED|Overall Study||88
348917|NCT02400346|858054|P1|STARTED|Overall Study||132
348918|NCT02400333|858062|P4|NOT COMPLETED|Overall Study||2
348919|NCT02400333|858063|P3|NOT COMPLETED|Overall Study||2
348920|NCT02400333|858064|P2|NOT COMPLETED|Overall Study||1
348921|NCT02400333|858065|P1|NOT COMPLETED|Overall Study||1
348922|NCT02400333|858062|P4|COMPLETED|Overall Study||7
348923|NCT02400333|858063|P3|COMPLETED|Overall Study||7
348924|NCT02400333|858064|P2|COMPLETED|Overall Study||8
348925|NCT02400333|858065|P1|COMPLETED|Overall Study||8
348926|NCT02400333|858062|P4|STARTED|Overall Study||9
348927|NCT02400333|858063|P3|STARTED|Overall Study||9
348928|NCT02400333|858064|P2|STARTED|Overall Study||9
348929|NCT02400333|858065|P1|STARTED|Overall Study||9
348930|NCT02399345|858123|P1|NOT COMPLETED|Overall Study||0
348931|NCT02399345|858123|P1|COMPLETED|Overall Study||10
348932|NCT02399345|858123|P1|STARTED|Overall Study||10
348933|NCT02399163|858129|P1|NOT COMPLETED|Overall Study||9
348934|NCT02399163|858129|P1|COMPLETED|Overall Study||53
348935|NCT02399163|858129|P1|STARTED|Overall Study||62
348936|NCT02399111|858157|P4|NOT COMPLETED|Overall Study||0
348937|NCT02399111|858158|P3|NOT COMPLETED|Overall Study||0
348938|NCT02399111|858159|P2|NOT COMPLETED|Overall Study||0
348939|NCT02399111|858160|P1|NOT COMPLETED|Overall Study||0
348940|NCT02399111|858157|P4|COMPLETED|Overall Study||0
348941|NCT02399111|858158|P3|COMPLETED|Overall Study||4
348942|NCT02399111|858159|P2|COMPLETED|Overall Study||1
348943|NCT02399111|858160|P1|COMPLETED|Overall Study||4
348944|NCT02399111|858157|P4|STARTED|Overall Study||0
348945|NCT02399111|858158|P3|STARTED|Overall Study||4
348946|NCT02399111|858159|P2|STARTED|Overall Study||1
348947|NCT02399111|858160|P1|STARTED|Overall Study||4
348948|NCT02397915|858174|P4|NOT COMPLETED|Period 2||0
348949|NCT02397915|858175|P3|NOT COMPLETED|Period 2||0
348950|NCT02397915|858176|P2|NOT COMPLETED|Period 2||0
348951|NCT02397915|858177|P1|NOT COMPLETED|Period 2||0
348952|NCT02397915|858174|P4|COMPLETED|Period 2||149
348953|NCT02397915|858175|P3|COMPLETED|Period 2||149
348954|NCT02397915|858176|P2|COMPLETED|Period 2||0
348955|NCT02397915|858177|P1|COMPLETED|Period 2||0
348956|NCT02397915|858174|P4|STARTED|Period 2||149
348957|NCT02397915|858175|P3|STARTED|Period 2||149
348958|NCT02397915|858176|P2|STARTED|Period 2||0
348959|NCT02397915|858177|P1|STARTED|Period 2||0
348960|NCT02397915|858174|P4|NOT COMPLETED|Period 1||0
348961|NCT02397915|858175|P3|NOT COMPLETED|Period 1||0
348962|NCT02397915|858176|P2|NOT COMPLETED|Period 1||1
348963|NCT02397915|858177|P1|NOT COMPLETED|Period 1||1
348964|NCT02397915|858174|P4|COMPLETED|Period 1||0
348965|NCT02397915|858175|P3|COMPLETED|Period 1||0
348966|NCT02397915|858176|P2|COMPLETED|Period 1||149
348967|NCT02397915|858177|P1|COMPLETED|Period 1||149
348968|NCT02397915|858174|P4|STARTED|Period 1||0
348969|NCT02397915|858175|P3|STARTED|Period 1||0
348970|NCT02397915|858176|P2|STARTED|Period 1||150
348971|NCT02397915|858177|P1|STARTED|Period 1||150
348972|NCT02397785|858229|P2|NOT COMPLETED|Overall Study||9
348973|NCT02397785|858230|P1|NOT COMPLETED|Overall Study||2
348974|NCT02397785|858229|P2|COMPLETED|Overall Study||25
348975|NCT02397785|858230|P1|COMPLETED|Overall Study||22
348976|NCT02397785|858229|P2|STARTED|Overall Study||34
348977|NCT02397785|858230|P1|STARTED|Overall Study||24
348978|NCT02397694|858276|P2|NOT COMPLETED|Open Label Extension Phase||30
348979|NCT02397694|858277|P1|NOT COMPLETED|Open Label Extension Phase||62
348980|NCT02397694|858276|P2|COMPLETED|Open Label Extension Phase||0
348981|NCT02397694|858277|P1|COMPLETED|Open Label Extension Phase||0
348982|NCT02397694|858276|P2|STARTED|Open Label Extension Phase||30
348983|NCT02397694|858277|P1|STARTED|Open Label Extension Phase||62
348984|NCT02397694|858276|P2|NOT COMPLETED|Double-Blinded Phase||3
348985|NCT02397694|858277|P1|NOT COMPLETED|Double-Blinded Phase||3
348986|NCT02397694|858276|P2|COMPLETED|Double-Blinded Phase||30
348987|NCT02397694|858277|P1|COMPLETED|Double-Blinded Phase||62
348988|NCT02397694|858276|P2|STARTED|Double-Blinded Phase||33
348989|NCT02397694|858277|P1|STARTED|Double-Blinded Phase||65
348990|NCT02397655|858315|P1|NOT COMPLETED|Overall Study||1301
348991|NCT02397655|858315|P1|COMPLETED|Overall Study||10711
348992|NCT02397655|858315|P1|STARTED|Overall Study||12012
348993|NCT02397564|858319|P1|NOT COMPLETED|Overall Study||4
348994|NCT02397564|858319|P1|COMPLETED|Overall Study||16
348995|NCT02397564|858319|P1|STARTED|Overall Study||20
348996|NCT02397122|858326|P2|NOT COMPLETED|Overall Study||0
348997|NCT02397122|858327|P1|NOT COMPLETED|Overall Study||0
348998|NCT02397122|858326|P2|COMPLETED|Overall Study||20
348999|NCT02397122|858327|P1|COMPLETED|Overall Study||20
349000|NCT02397122|858326|P2|STARTED|Overall Study||20
349001|NCT02397122|858327|P1|STARTED|Overall Study||20
349002|NCT02396537|858345|P2|NOT COMPLETED|Overall Study||1
349003|NCT02396537|858346|P1|NOT COMPLETED|Overall Study||0
349004|NCT02396537|858345|P2|COMPLETED|Overall Study||36
349005|NCT02396537|858346|P1|COMPLETED|Overall Study||40
349006|NCT02396537|858345|P2|STARTED|Overall Study||37
349007|NCT02396537|858346|P1|STARTED|Overall Study||40
349008|NCT02396316|858354|P2|NOT COMPLETED|Overall Study||5
349009|NCT02396316|858355|P1|NOT COMPLETED|Overall Study||7
349010|NCT02396316|858354|P2|COMPLETED|Overall Study||22
349011|NCT02396316|858355|P1|COMPLETED|Overall Study||20
349012|NCT02396316|858354|P2|Received Active Injection at Week 9|Overall Study||1
349013|NCT02396316|858355|P1|Received Active Injection at Week 9|Overall Study||2
349014|NCT02396316|858354|P2|Received Active Injection at Week 5|Overall Study||4
349015|NCT02396316|858355|P1|Received Active Injection at Week 5|Overall Study||4
349016|NCT02396316|858354|P2|Received AFL Injection at Week 1|Overall Study||22
349017|NCT02396316|858355|P1|Received AFL Injection at Week 1|Overall Study||0
349018|NCT02396316|858354|P2|Received Sham Injection at Week 1|Overall Study||0
349019|NCT02396316|858355|P1|Received Sham Injection at Week 1|Overall Study||10
349020|NCT02396316|858354|P2|Treated|Overall Study||27
349021|NCT02396316|858355|P1|Treated|Overall Study||27
349022|NCT02396316|858354|P2|STARTED|Overall Study||27
349023|NCT02396316|858355|P1|STARTED|Overall Study||27
349024|NCT02396160|858367|P2|NOT COMPLETED|Overall Study||2
349025|NCT02396160|858368|P1|NOT COMPLETED|Overall Study||6
349026|NCT02396160|858367|P2|COMPLETED|Overall Study||73
349027|NCT02396160|858368|P1|COMPLETED|Overall Study||69
349028|NCT02396160|858367|P2|STARTED|Overall Study||75
349029|NCT02396160|858368|P1|STARTED|Overall Study||75
349030|NCT02396147|858384|P2|NOT COMPLETED|Period 3||0
349031|NCT02396147|858385|P1|NOT COMPLETED|Period 3||0
349032|NCT02396147|858384|P2|COMPLETED|Period 3||27
349033|NCT02396147|858385|P1|COMPLETED|Period 3||27
349034|NCT02396147|858384|P2|STARTED|Period 3||27
349035|NCT02396147|858385|P1|STARTED|Period 3||27
349036|NCT02396147|858384|P2|NOT COMPLETED|Period 2||0
349037|NCT02396147|858385|P1|NOT COMPLETED|Period 2||0
349038|NCT02396147|858384|P2|COMPLETED|Period 2||27
349039|NCT02396147|858385|P1|COMPLETED|Period 2||27
349040|NCT02396147|858384|P2|STARTED|Period 2||27
349041|NCT02396147|858385|P1|STARTED|Period 2||27
349042|NCT02396147|858384|P2|NOT COMPLETED|Period 1||0
349043|NCT02396147|858385|P1|NOT COMPLETED|Period 1||0
349044|NCT02396147|858384|P2|COMPLETED|Period 1||27
349045|NCT02396147|858385|P1|COMPLETED|Period 1||27
349046|NCT02396147|858384|P2|STARTED|Period 1||27
349047|NCT02396147|858385|P1|STARTED|Period 1||27
349048|NCT02395822|858453|P1|NOT COMPLETED|Overall Study||2
349049|NCT02395822|858453|P1|COMPLETED|Overall Study||15
349050|NCT02395822|858453|P1|STARTED|Overall Study||17
349051|NCT02395653|858461|P1|NOT COMPLETED|Overall Study||12
349052|NCT02395653|858461|P1|COMPLETED|Overall Study||59
349053|NCT02395653|858461|P1|Received at Least 1 Dose of Study Drug|Overall Study||61
349054|NCT02395653|858461|P1|STARTED|Overall Study||71
349055|NCT02395536|858470|P2|NOT COMPLETED|Overall Study||30
349056|NCT02395536|858471|P1|NOT COMPLETED|Overall Study||20
349057|NCT02395536|858470|P2|COMPLETED|Overall Study||227
349058|NCT02395536|858471|P1|COMPLETED|Overall Study||244
349059|NCT02395536|858470|P2|REVEAL LINQ Insertion|Overall Study||231
349060|NCT02395536|858471|P1|REVEAL LINQ Insertion|Overall Study||251
349061|NCT02395536|858470|P2|STARTED|Overall Study||257
349062|NCT02395536|858471|P1|STARTED|Overall Study||264
349063|NCT02395302|858477|P1|NOT COMPLETED|Overall Study||14
349064|NCT02395302|858477|P1|COMPLETED|Overall Study||14
349065|NCT02395302|858477|P1|STARTED|Overall Study||28
349066|NCT02395185|858481|P1|NOT COMPLETED|Overall Study||0
349067|NCT02395185|858481|P1|COMPLETED|Overall Study||33
349068|NCT02395185|858481|P1|Sequence 18 (m,w,m,s,w,s)|Overall Study||1
349069|NCT02395185|858481|P1|Sequence 17 (w,m,s,w,s,m)|Overall Study||1
349070|NCT02395185|858481|P1|Sequence 16 (m,s,w,s,m,w)|Overall Study||1
349071|NCT02395185|858481|P1|Sequence 15 (s,w,s,m,w,m)|Overall Study||2
349072|NCT02395185|858481|P1|Sequence 14 (w,s,m,w,m,s)|Overall Study||2
349073|NCT02395185|858481|P1|Sequence 13 (s,m,w,m,s,w)|Overall Study||2
349074|NCT02395185|858481|P1|Sequence 12 (s,w,w,m,m,s)|Overall Study||2
349075|NCT02395185|858481|P1|Sequence 11 (w,w,m,m,s,s)|Overall Study||2
349076|NCT02395185|858481|P1|Sequence 10 (w,m,m,s,s,w)|Overall Study||2
349077|NCT02395185|858481|P1|Sequence 9 (m,m,s,s,w,w)|Overall Study||2
349078|NCT02395185|858481|P1|Sequence 8 (m,s,s,w,w,m)|Overall Study||2
349079|NCT02395185|858481|P1|Sequence 7 (s,s,w,w,m,m)|Overall Study||2
349080|NCT02395185|858481|P1|Sequence 6 (s,m,m,w,w,s)|Overall Study||2
349081|NCT02395185|858481|P1|Sequence 5 (m,m,w,w,s,s)|Overall Study||2
349082|NCT02395185|858481|P1|Sequence 4 (m,w,w,s,s,m)|Overall Study||2
349083|NCT02395185|858481|P1|Sequence 3 (w,w,s,s,m,m)|Overall Study||2
349084|NCT02395185|858481|P1|Sequence 2 (w,s,s,m,m,w)|Overall Study||2
349085|NCT02395185|858481|P1|Sequence 1 (s,s,m,m,w,w)|Overall Study|one of the participants in this milestone did not have a guardian enrolled due to age.|2
349086|NCT02395185|858481|P1|STARTED|Overall Study|32 guardians participated with these infants. one infant did not have a guardian participate.|33
349087|NCT02395055|858497|P2|NOT COMPLETED|Overall Study||3
349088|NCT02395055|858498|P1|NOT COMPLETED|Overall Study||7
349089|NCT02395055|858497|P2|COMPLETED|Overall Study||44
349090|NCT02395055|858498|P1|COMPLETED|Overall Study||40
349091|NCT02395055|858497|P2|STARTED|Overall Study||47
349092|NCT02395055|858498|P1|STARTED|Overall Study||47
349093|NCT02394925|858508|P1|NOT COMPLETED|Overall Study||29
349094|NCT02394925|858508|P1|COMPLETED|Overall Study||79
349095|NCT02394925|858508|P1|STARTED|Overall Study||108
349096|NCT02394912|858512|P1|NOT COMPLETED|Overall Study||0
349097|NCT02394912|858512|P1|COMPLETED|Overall Study||21
349098|NCT02394912|858512|P1|STARTED|Overall Study||21
349099|NCT02394808|858516|P2|NOT COMPLETED|Period 2||0
349100|NCT02394808|858517|P1|NOT COMPLETED|Period 2||1
349101|NCT02394808|858516|P2|COMPLETED|Period 2||28
349102|NCT02394808|858517|P1|COMPLETED|Period 2||24
349103|NCT02394808|858516|P2|STARTED|Period 2||28
349104|NCT02394808|858517|P1|STARTED|Period 2||25
349105|NCT02394808|858516|P2|NOT COMPLETED|Period 1||1
349106|NCT02394808|858517|P1|NOT COMPLETED|Period 1||0
349107|NCT02394808|858516|P2|COMPLETED|Period 1||28
349108|NCT02394808|858517|P1|COMPLETED|Period 1||25
349109|NCT02394808|858516|P2|STARTED|Period 1||29
349110|NCT02394808|858517|P1|STARTED|Period 1||25
349111|NCT02394756|858525|P6|NOT COMPLETED|Period 3||0
349112|NCT02394756|858526|P5|NOT COMPLETED|Period 3||0
349113|NCT02394756|858527|P4|NOT COMPLETED|Period 3||0
349114|NCT02394756|858528|P3|NOT COMPLETED|Period 3||0
349115|NCT02394756|858529|P2|NOT COMPLETED|Period 3||0
349116|NCT02394756|858530|P1|NOT COMPLETED|Period 3||0
349117|NCT02394756|858525|P6|COMPLETED|Period 3||6
349118|NCT02394756|858526|P5|COMPLETED|Period 3||6
349119|NCT02394756|858527|P4|COMPLETED|Period 3||6
349120|NCT02394756|858528|P3|COMPLETED|Period 3||6
349121|NCT02394756|858529|P2|COMPLETED|Period 3||6
349122|NCT02394756|858530|P1|COMPLETED|Period 3||7
349123|NCT02394756|858525|P6|STARTED|Period 3||6
349124|NCT02394756|858526|P5|STARTED|Period 3||6
349125|NCT02394756|858527|P4|STARTED|Period 3||6
349126|NCT02394756|858528|P3|STARTED|Period 3||6
349127|NCT02394756|858529|P2|STARTED|Period 3||6
349128|NCT02394756|858530|P1|STARTED|Period 3||7
349129|NCT02394756|858525|P6|NOT COMPLETED|Period 2||0
349130|NCT02394756|858526|P5|NOT COMPLETED|Period 2||1
349131|NCT02394756|858527|P4|NOT COMPLETED|Period 2||0
349132|NCT02394756|858528|P3|NOT COMPLETED|Period 2||0
349133|NCT02394756|858529|P2|NOT COMPLETED|Period 2||0
349134|NCT02394756|858530|P1|NOT COMPLETED|Period 2||0
349135|NCT02394756|858525|P6|COMPLETED|Period 2||6
349136|NCT02394756|858526|P5|COMPLETED|Period 2||6
349137|NCT02394756|858527|P4|COMPLETED|Period 2||6
349138|NCT02394756|858528|P3|COMPLETED|Period 2||6
349139|NCT02394756|858529|P2|COMPLETED|Period 2||6
349140|NCT02394756|858530|P1|COMPLETED|Period 2||7
349141|NCT02394756|858525|P6|STARTED|Period 2||6
349142|NCT02394756|858526|P5|STARTED|Period 2||7
349143|NCT02394756|858527|P4|STARTED|Period 2||6
349144|NCT02394756|858528|P3|STARTED|Period 2||6
349145|NCT02394756|858529|P2|STARTED|Period 2||6
349146|NCT02394756|858530|P1|STARTED|Period 2||7
349147|NCT02394756|858525|P6|NOT COMPLETED|Period 1||1
349148|NCT02394756|858526|P5|NOT COMPLETED|Period 1||0
349149|NCT02394756|858527|P4|NOT COMPLETED|Period 1||1
349150|NCT02394756|858528|P3|NOT COMPLETED|Period 1||1
349151|NCT02394756|858529|P2|NOT COMPLETED|Period 1||1
349152|NCT02394756|858530|P1|NOT COMPLETED|Period 1||0
349153|NCT02394756|858525|P6|COMPLETED|Period 1||6
349154|NCT02394756|858526|P5|COMPLETED|Period 1||7
349155|NCT02394756|858527|P4|COMPLETED|Period 1||6
349156|NCT02394756|858528|P3|COMPLETED|Period 1||6
349157|NCT02394756|858529|P2|COMPLETED|Period 1||6
349158|NCT02394756|858530|P1|COMPLETED|Period 1||7
349159|NCT02394756|858525|P6|STARTED|Period 1||7
349160|NCT02394756|858526|P5|STARTED|Period 1||7
349161|NCT02394756|858527|P4|STARTED|Period 1||7
349162|NCT02394756|858528|P3|STARTED|Period 1||7
349163|NCT02394756|858529|P2|STARTED|Period 1||7
349164|NCT02394756|858530|P1|STARTED|Period 1||7
349165|NCT02394665|858544|P3|NOT COMPLETED|Overall Study||0
349166|NCT02394665|858545|P2|NOT COMPLETED|Overall Study||0
349167|NCT02394665|858546|P1|NOT COMPLETED|Overall Study||1
349168|NCT02394665|858544|P3|COMPLETED|Overall Study||0
349169|NCT02394665|858545|P2|COMPLETED|Overall Study||0
349170|NCT02394665|858546|P1|COMPLETED|Overall Study||0
349171|NCT02394665|858544|P3|STARTED|Overall Study||0
349172|NCT02394665|858545|P2|STARTED|Overall Study||0
349173|NCT02394665|858546|P1|STARTED|Overall Study||1
349174|NCT02394600|858568|P2|NOT COMPLETED|Overall Study||2
349175|NCT02394600|858569|P1|NOT COMPLETED|Overall Study||4
349176|NCT02394600|858568|P2|COMPLETED|Overall Study||44
349177|NCT02394600|858569|P1|COMPLETED|Overall Study||43
349178|NCT02394600|858568|P2|STARTED|Overall Study||46
349179|NCT02394600|858569|P1|STARTED|Overall Study||47
349180|NCT02394457|858579|P2|NOT COMPLETED|Overall Study||0
349181|NCT02394457|858580|P1|NOT COMPLETED|Overall Study||0
349182|NCT02394457|858579|P2|COMPLETED|Overall Study||13
349183|NCT02394457|858580|P1|COMPLETED|Overall Study||15
349184|NCT02394457|858579|P2|STARTED|Overall Study||13
349185|NCT02394457|858580|P1|STARTED|Overall Study||15
349186|NCT02393950|858598|P2|NOT COMPLETED|Overall Study||1
349187|NCT02393950|858599|P1|NOT COMPLETED|Overall Study||1
349188|NCT02393950|858598|P2|COMPLETED|Overall Study||8
349189|NCT02393950|858599|P1|COMPLETED|Overall Study||8
349190|NCT02393950|858598|P2|Period 4|Overall Study|6 subjects ODM-106 Capsule A 100 mg (10 x 10mg) and 2 subjects on placebo|8
349191|NCT02393950|858599|P1|Period 4|Overall Study|6 subjects ODM-106 Capsule B 50 mg and 2 subjects on placebo|8
349192|NCT02393950|858598|P2|Period 3|Overall Study|6 subjects ODM-106 Capsule B 200 mg (20 x 10mg) and 2 subjects on placebo|8
349193|NCT02393950|858599|P1|Period 3|Overall Study|6 subjects ODM-106 Capsule B 25 mg and 2 subjects on placebo|8
349194|NCT02393950|858598|P2|Period 2|Overall Study|6 subjects ODM-106 Capsule B 100 mg (10 x 10mg) and 2 subjects on placebo|8
349195|NCT02393950|858599|P1|Period 2|Overall Study|6 subjects ODM-106 Capsule B 10 mg and 2 subjects on placebo|8
349196|NCT02393950|858598|P2|Period 1|Overall Study|6 subjects ODM-106 Capsule B 100 mg (1 x 100mg) and 2 subjects on placebo|8
349197|NCT02393950|858599|P1|Period 1|Overall Study|6 subjects ODM-106 Capsule B 2 mg and 2 subjects on placebo|8
349198|NCT02393950|858598|P2|STARTED|Overall Study||9
349199|NCT02393950|858599|P1|STARTED|Overall Study||9
349200|NCT02393677|858666|P2|NOT COMPLETED|Overall Study||0
349201|NCT02393677|858667|P1|NOT COMPLETED|Overall Study||0
349202|NCT02393677|858666|P2|COMPLETED|Overall Study||40
349203|NCT02393677|858667|P1|COMPLETED|Overall Study||40
349204|NCT02393677|858666|P2|STARTED|Overall Study||40
349205|NCT02393677|858667|P1|STARTED|Overall Study||40
349206|NCT02393547|858673|P1|NOT COMPLETED|Overall Study||6
349207|NCT02393547|858673|P1|COMPLETED|Overall Study||14
349208|NCT02393547|858673|P1|STARTED|Overall Study||20
349209|NCT02393209|858682|P4|NOT COMPLETED|Overall Study||0
349210|NCT02393209|858683|P3|NOT COMPLETED|Overall Study||0
349211|NCT02393209|858684|P2|NOT COMPLETED|Overall Study||8
349212|NCT02393209|858685|P1|NOT COMPLETED|Overall Study||6
349213|NCT02393209|858682|P4|COMPLETED|Overall Study||0
349214|NCT02393209|858683|P3|COMPLETED|Overall Study||0
349215|NCT02393209|858684|P2|COMPLETED|Overall Study||0
349216|NCT02393209|858685|P1|COMPLETED|Overall Study||0
349217|NCT02393209|858682|P4|STARTED|Overall Study||0
349218|NCT02393209|858683|P3|STARTED|Overall Study||0
349219|NCT02393209|858684|P2|STARTED|Overall Study||8
349220|NCT02393209|858685|P1|STARTED|Overall Study||6
349221|NCT02392806|858743|P2|NOT COMPLETED|Overall Study||0
349222|NCT02392806|858744|P1|NOT COMPLETED|Overall Study||0
349223|NCT02392806|858743|P2|COMPLETED|Overall Study||21
349224|NCT02392806|858744|P1|COMPLETED|Overall Study||22
349225|NCT02392806|858743|P2|STARTED|Overall Study||21
349226|NCT02392806|858744|P1|STARTED|Overall Study||22
349227|NCT02392767|858754|P2|NOT COMPLETED|Overall Study||0
349228|NCT02392767|858755|P1|NOT COMPLETED|Overall Study||0
349229|NCT02392767|858754|P2|COMPLETED|Overall Study||13
349230|NCT02392767|858755|P1|COMPLETED|Overall Study||12
349231|NCT02392767|858754|P2|STARTED|Overall Study||13
349232|NCT02392767|858755|P1|STARTED|Overall Study||12
349233|NCT02392624|858774|P3|NOT COMPLETED|Overall Study||13
349234|NCT02392624|858775|P2|NOT COMPLETED|Overall Study||15
349235|NCT02392624|858776|P1|NOT COMPLETED|Overall Study||71
349236|NCT02392624|858774|P3|COMPLETED|Overall Study||40
349237|NCT02392624|858775|P2|COMPLETED|Overall Study||66
349238|NCT02392624|858776|P1|COMPLETED|Overall Study||0
349239|NCT02392624|858774|P3|STARTED|Overall Study||53
349240|NCT02392624|858775|P2|STARTED|Overall Study||81
349241|NCT02392624|858776|P1|STARTED|Overall Study||71
349242|NCT02392377|858791|P2|NOT COMPLETED|Overall Study||1
349243|NCT02392377|858792|P1|NOT COMPLETED|Overall Study||0
349244|NCT02392377|858791|P2|COMPLETED|Overall Study||0
349245|NCT02392377|858792|P1|COMPLETED|Overall Study||0
349246|NCT02392377|858791|P2|STARTED|Overall Study||1
349247|NCT02392377|858792|P1|STARTED|Overall Study||0
349248|NCT02392247|858816|P1|NOT COMPLETED|Overall Study||2
349249|NCT02392247|858816|P1|COMPLETED|Overall Study||50
349250|NCT02392247|858816|P1|STARTED|Overall Study||52
349251|NCT02392234|858827|P6|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
349252|NCT02392234|858828|P5|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
349253|NCT02392234|858829|P4|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
349254|NCT02392234|858830|P3|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
349255|NCT02392234|858831|P2|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
349256|NCT02392234|858832|P1|NOT COMPLETED|Treatment Period 2 (8 Weeks)||1
349257|NCT02392234|858827|P6|COMPLETED|Treatment Period 2 (8 Weeks)||38
349258|NCT02392234|858828|P5|COMPLETED|Treatment Period 2 (8 Weeks)||37
349259|NCT02392234|858829|P4|COMPLETED|Treatment Period 2 (8 Weeks)||41
349260|NCT02392234|858830|P3|COMPLETED|Treatment Period 2 (8 Weeks)||38
349261|NCT02392234|858831|P2|COMPLETED|Treatment Period 2 (8 Weeks)||43
349262|NCT02392234|858832|P1|COMPLETED|Treatment Period 2 (8 Weeks)||37
349263|NCT02392234|858827|P6|STARTED|Treatment Period 2 (8 Weeks)||38
349264|NCT02392234|858828|P5|STARTED|Treatment Period 2 (8 Weeks)||37
349265|NCT02392234|858829|P4|STARTED|Treatment Period 2 (8 Weeks)||41
349266|NCT02392234|858830|P3|STARTED|Treatment Period 2 (8 Weeks)||38
349267|NCT02392234|858831|P2|STARTED|Treatment Period 2 (8 Weeks)||43
349268|NCT02392234|858832|P1|STARTED|Treatment Period 2 (8 Weeks)||38
349269|NCT02392234|858827|P6|NOT COMPLETED|Treatment Period 1 (8 Weeks)||3
349270|NCT02392234|858828|P5|NOT COMPLETED|Treatment Period 1 (8 Weeks)||4
349271|NCT02392234|858829|P4|NOT COMPLETED|Treatment Period 1 (8 Weeks)||1
349272|NCT02392234|858830|P3|NOT COMPLETED|Treatment Period 1 (8 Weeks)||2
349273|NCT02392234|858831|P2|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
349274|NCT02392234|858832|P1|NOT COMPLETED|Treatment Period 1 (8 Weeks)||3
349275|NCT02392234|858827|P6|COMPLETED|Treatment Period 1 (8 Weeks)||38
349276|NCT02392234|858828|P5|COMPLETED|Treatment Period 1 (8 Weeks)||37
349277|NCT02392234|858829|P4|COMPLETED|Treatment Period 1 (8 Weeks)||41
349278|NCT02392234|858830|P3|COMPLETED|Treatment Period 1 (8 Weeks)||38
349279|NCT02392234|858831|P2|COMPLETED|Treatment Period 1 (8 Weeks)||43
349280|NCT02392234|858832|P1|COMPLETED|Treatment Period 1 (8 Weeks)||38
349281|NCT02392234|858827|P6|Treated|Treatment Period 1 (8 Weeks)||41
349282|NCT02392234|858828|P5|Treated|Treatment Period 1 (8 Weeks)||40
349283|NCT02392234|858829|P4|Treated|Treatment Period 1 (8 Weeks)||42
349284|NCT02392234|858830|P3|Treated|Treatment Period 1 (8 Weeks)||39
349285|NCT02392234|858831|P2|Treated|Treatment Period 1 (8 Weeks)||43
349286|NCT02392234|858832|P1|Treated|Treatment Period 1 (8 Weeks)||41
349287|NCT02392234|858827|P6|STARTED|Treatment Period 1 (8 Weeks)||41
349288|NCT02392234|858828|P5|STARTED|Treatment Period 1 (8 Weeks)||41
349289|NCT02392234|858829|P4|STARTED|Treatment Period 1 (8 Weeks)||42
349290|NCT02392234|858830|P3|STARTED|Treatment Period 1 (8 Weeks)||40
349291|NCT02392234|858831|P2|STARTED|Treatment Period 1 (8 Weeks)||43
349292|NCT02392234|858832|P1|STARTED|Treatment Period 1 (8 Weeks)||41
349293|NCT02392208|858854|P1|NOT COMPLETED|Telavancin After Hemodialysis||0
349294|NCT02392208|858854|P1|COMPLETED|Telavancin After Hemodialysis||8
349295|NCT02392208|858854|P1|STARTED|Telavancin After Hemodialysis||8
349296|NCT02392208|858854|P1|NOT COMPLETED|Telavancin Before Hemodialysis||0
349297|NCT02392208|858854|P1|COMPLETED|Telavancin Before Hemodialysis||8
349298|NCT02392208|858854|P1|STARTED|Telavancin Before Hemodialysis||8
349299|NCT02392000|858864|P1|NOT COMPLETED|Overall Study||27
349300|NCT02392000|858864|P1|COMPLETED|Overall Study||11
349301|NCT02392000|858864|P1|STARTED|Overall Study||38
349302|NCT02391714|858874|P2|NOT COMPLETED|Overall Study||0
349303|NCT02391714|858875|P1|NOT COMPLETED|Overall Study||0
349304|NCT02391714|858874|P2|COMPLETED|Overall Study||40
349305|NCT02391714|858875|P1|COMPLETED|Overall Study||40
349306|NCT02391714|858874|P2|STARTED|Overall Study||40
349307|NCT02391714|858875|P1|STARTED|Overall Study||40
349308|NCT02391311|858887|P2|NOT COMPLETED|Overall Study||2
349309|NCT02391311|858888|P1|NOT COMPLETED|Overall Study||3
349310|NCT02391311|858887|P2|COMPLETED|Overall Study||19
349311|NCT02391311|858888|P1|COMPLETED|Overall Study||18
349312|NCT02391311|858887|P2|STARTED|Overall Study||21
349313|NCT02391311|858888|P1|STARTED|Overall Study||21
349314|NCT02391116|858896|P1|NOT COMPLETED|Survival Follow-up||14
349315|NCT02391116|858896|P1|COMPLETED|Survival Follow-up|Reason for completion in this period was death.|31
349316|NCT02391116|858896|P1|STARTED|Survival Follow-up|21 patients discontinued from treatment didn't enter due to withdrawal by subject(3) and death(18)|45
349317|NCT02391116|858896|P1|NOT COMPLETED|Active Follow-up||3
349318|NCT02391116|858896|P1|COMPLETED|Active Follow-up|Reasons for completion in this period included death (2) and PD.|7
349319|NCT02391116|858896|P1|STARTED|Active Follow-up|This period incorporates safety follow-up with radiological assessments|10
349320|NCT02391116|858896|P1|NOT COMPLETED|Safety Follow-up||13
349321|NCT02391116|858896|P1|COMPLETED|Safety Follow-up|14 subjects were considered completed due to death.|41
349322|NCT02391116|858896|P1|STARTED|Safety Follow-up|This period excludes 2 deaths on treatment and 10 subjects entering active follow-up|54
349323|NCT02391116|858896|P1|NOT COMPLETED|Treatment||15
349324|NCT02391116|858896|P1|COMPLETED|Treatment|Reasons for completion in this period included death (2), PD and lack of efficacy (1).|52
349325|NCT02391116|858896|P1|Included in Per Protocol Set|Treatment||40
349326|NCT02391116|858896|P1|STARTED|Treatment||67
349327|NCT02391038|858949|P3|NOT COMPLETED|Overall Study||6
349328|NCT02391038|858950|P2|NOT COMPLETED|Overall Study||3
349329|NCT02391038|858951|P1|NOT COMPLETED|Overall Study||3
349330|NCT02391038|858949|P3|COMPLETED|Overall Study||0
349331|NCT02391038|858950|P2|COMPLETED|Overall Study||0
349332|NCT02391038|858951|P1|COMPLETED|Overall Study||0
349333|NCT02391038|858949|P3|STARTED|Overall Study||6
349334|NCT02391038|858950|P2|STARTED|Overall Study||3
349335|NCT02391038|858951|P1|STARTED|Overall Study||3
349336|NCT02390219|859065|P1|NOT COMPLETED|Overall Study||13
349337|NCT02390219|859065|P1|COMPLETED|Overall Study||33
349338|NCT02390219|859065|P1|STARTED|Overall Study||46
349339|NCT02390167|859075|P1|NOT COMPLETED|Overall Study||1
349340|NCT02390167|859075|P1|COMPLETED|Overall Study||375
349341|NCT02390167|859075|P1|Without Diabetes|Overall Study||43
349342|NCT02390167|859075|P1|With Diabetes|Overall Study||333
349343|NCT02390167|859075|P1|STARTED|Overall Study||376
349344|NCT02389881|859101|P7|NOT COMPLETED|Overall Study||0
349345|NCT02389881|859102|P6|NOT COMPLETED|Overall Study||0
349346|NCT02389881|859103|P5|NOT COMPLETED|Overall Study||0
349347|NCT02389881|859104|P4|NOT COMPLETED|Overall Study||0
349348|NCT02389881|859105|P3|NOT COMPLETED|Overall Study||0
349349|NCT02389881|859106|P2|NOT COMPLETED|Overall Study||0
349350|NCT02389881|859107|P1|NOT COMPLETED|Overall Study||0
349351|NCT02389881|859101|P7|COMPLETED|Overall Study||2
349352|NCT02389881|859102|P6|COMPLETED|Overall Study||8
349353|NCT02389881|859103|P5|COMPLETED|Overall Study||6
349354|NCT02389881|859104|P4|COMPLETED|Overall Study||6
349355|NCT02389881|859105|P3|COMPLETED|Overall Study||6
349356|NCT02389881|859106|P2|COMPLETED|Overall Study||6
349357|NCT02389881|859107|P1|COMPLETED|Overall Study||6
349358|NCT02389881|859101|P7|STARTED|Overall Study||2
349359|NCT02389881|859102|P6|STARTED|Overall Study||8
349360|NCT02389881|859103|P5|STARTED|Overall Study||6
349361|NCT02389881|859104|P4|STARTED|Overall Study||6
349362|NCT02389881|859105|P3|STARTED|Overall Study||6
349363|NCT02389881|859106|P2|STARTED|Overall Study||6
349364|NCT02389881|859107|P1|STARTED|Overall Study||6
349365|NCT02389829|859158|P2|NOT COMPLETED|Overall Study||1
349366|NCT02389829|859159|P1|NOT COMPLETED|Overall Study||0
349367|NCT02389829|859158|P2|COMPLETED|Overall Study||62
349368|NCT02389829|859159|P1|COMPLETED|Overall Study||64
349369|NCT02389829|859158|P2|STARTED|Overall Study||63
349370|NCT02389829|859159|P1|STARTED|Overall Study||64
349371|NCT02389452|859171|P1|NOT COMPLETED|Overall Study||25
349372|NCT02389452|859171|P1|COMPLETED|Overall Study||369
349373|NCT02389452|859171|P1|Participants Received Repeat Injection|Overall Study|Repeat injection based on physician's assessment of efficacy and safety at Week 26, 39 or 52.|11
349374|NCT02389452|859171|P1|STARTED|Overall Study||394
349375|NCT02389374|859192|P3|NOT COMPLETED|Overall Study||1
349376|NCT02389374|859193|P2|NOT COMPLETED|Overall Study||28
349377|NCT02389374|859194|P1|NOT COMPLETED|Overall Study||9
349378|NCT02389374|859192|P3|COMPLETED|Overall Study||10
349379|NCT02389374|859193|P2|COMPLETED|Overall Study||87
349380|NCT02389374|859194|P1|COMPLETED|Overall Study||46
349381|NCT02389374|859192|P3|STARTED|Overall Study||11
349382|NCT02389374|859193|P2|STARTED|Overall Study||115
349383|NCT02389374|859194|P1|STARTED|Overall Study||55
349384|NCT02389361|859226|P2|NOT COMPLETED|Overall Study||0
349385|NCT02389361|859227|P1|NOT COMPLETED|Overall Study||0
349386|NCT02389361|859226|P2|COMPLETED|Overall Study||27
349387|NCT02389361|859227|P1|COMPLETED|Overall Study||24
349388|NCT02389361|859226|P2|STARTED|Overall Study||27
349389|NCT02389361|859227|P1|STARTED|Overall Study||24
349390|NCT02389088|859233|P1|NOT COMPLETED|Phase II - All Study Participants||0
349391|NCT02389088|859233|P1|COMPLETED|Phase II - All Study Participants||9
349392|NCT02389088|859233|P1|STARTED|Phase II - All Study Participants||9
349393|NCT02389088|859233|P1|NOT COMPLETED|Overall Study - Phase I||0
349394|NCT02389088|859233|P1|COMPLETED|Overall Study - Phase I||9
349395|NCT02389088|859233|P1|STARTED|Overall Study - Phase I||9
349396|NCT02388815|859277|P1|NOT COMPLETED|Overall Study||4
349397|NCT02388815|859277|P1|COMPLETED|Overall Study||85
349398|NCT02388815|859277|P1|STARTED|Overall Study||89
349399|NCT02388776|859281|P1|NOT COMPLETED|Overall Study||2
349400|NCT02388776|859281|P1|COMPLETED|Overall Study||0
349401|NCT02388776|859281|P1|STARTED|Overall Study||2
349402|NCT02388763|859286|P2|NOT COMPLETED|Period 2, 10 Days of Wear||0
349403|NCT02388763|859287|P1|NOT COMPLETED|Period 2, 10 Days of Wear||0
349404|NCT02388763|859286|P2|COMPLETED|Period 2, 10 Days of Wear||30
349405|NCT02388763|859287|P1|COMPLETED|Period 2, 10 Days of Wear||30
349406|NCT02388763|859286|P2|STARTED|Period 2, 10 Days of Wear||30
349407|NCT02388763|859287|P1|STARTED|Period 2, 10 Days of Wear||30
349408|NCT02388763|859286|P2|NOT COMPLETED|Period 1, 10 Days of Wear||1
349409|NCT02388763|859287|P1|NOT COMPLETED|Period 1, 10 Days of Wear||1
349410|NCT02388763|859286|P2|COMPLETED|Period 1, 10 Days of Wear||30
349411|NCT02388763|859287|P1|COMPLETED|Period 1, 10 Days of Wear||30
349412|NCT02388763|859286|P2|STARTED|Period 1, 10 Days of Wear||31
349413|NCT02388763|859287|P1|STARTED|Period 1, 10 Days of Wear||31
349414|NCT02388763|859286|P2|NOT COMPLETED|Habitual, 10 Days of Wear||1
349415|NCT02388763|859287|P1|NOT COMPLETED|Habitual, 10 Days of Wear||1
349416|NCT02388763|859286|P2|COMPLETED|Habitual, 10 Days of Wear||31
349417|NCT02388763|859287|P1|COMPLETED|Habitual, 10 Days of Wear||31
349418|NCT02388763|859286|P2|STARTED|Habitual, 10 Days of Wear||32
349419|NCT02388763|859287|P1|STARTED|Habitual, 10 Days of Wear||32
349420|NCT02388568|859300|P2|NOT COMPLETED|Overall Study||15
349421|NCT02388568|859301|P1|NOT COMPLETED|Overall Study||10
349422|NCT02388568|859300|P2|COMPLETED|Overall Study||53
349423|NCT02388568|859301|P1|COMPLETED|Overall Study||59
349424|NCT02388568|859300|P2|STARTED|Overall Study||68
349425|NCT02388568|859301|P1|STARTED|Overall Study||69
349426|NCT02388347|859322|P5|NOT COMPLETED|Overall Study||0
349427|NCT02388347|859323|P4|NOT COMPLETED|Overall Study||0
349428|NCT02388347|859324|P3|NOT COMPLETED|Overall Study||1
349429|NCT02388347|859325|P2|NOT COMPLETED|Overall Study||0
349430|NCT02388347|859326|P1|NOT COMPLETED|Overall Study||0
349431|NCT02388347|859322|P5|COMPLETED|Overall Study||6
349432|NCT02388347|859323|P4|COMPLETED|Overall Study||6
349433|NCT02388347|859324|P3|COMPLETED|Overall Study||5
349434|NCT02388347|859325|P2|COMPLETED|Overall Study||6
349435|NCT02388347|859326|P1|COMPLETED|Overall Study||8
349436|NCT02388347|859322|P5|STARTED|Overall Study||6
349437|NCT02388347|859323|P4|STARTED|Overall Study||6
349438|NCT02388347|859324|P3|STARTED|Overall Study||6
349439|NCT02388347|859325|P2|STARTED|Overall Study||6
349440|NCT02388347|859326|P1|STARTED|Overall Study||8
349441|NCT02388321|859393|P2|NOT COMPLETED|Overall Study||0
349442|NCT02388321|859394|P1|NOT COMPLETED|Overall Study||0
349443|NCT02388321|859393|P2|COMPLETED|Overall Study||11
349444|NCT02388321|859394|P1|COMPLETED|Overall Study||11
349445|NCT02388321|859393|P2|STARTED|Overall Study||11
349446|NCT02388321|859394|P1|STARTED|Overall Study||11
349447|NCT02388295|859405|P3|NOT COMPLETED|Treatment Weeks 3 to 12||0
349448|NCT02388295|859406|P2|NOT COMPLETED|Treatment Weeks 3 to 12||1
349449|NCT02388295|859407|P1|NOT COMPLETED|Treatment Weeks 3 to 12||1
349450|NCT02388295|859405|P3|COMPLETED|Treatment Weeks 3 to 12||17
349451|NCT02388295|859406|P2|COMPLETED|Treatment Weeks 3 to 12||13
349452|NCT02388295|859407|P1|COMPLETED|Treatment Weeks 3 to 12||15
349453|NCT02388295|859405|P3|STARTED|Treatment Weeks 3 to 12||17
349454|NCT02388295|859406|P2|STARTED|Treatment Weeks 3 to 12||14
349455|NCT02388295|859407|P1|STARTED|Treatment Weeks 3 to 12||16
349456|NCT02388295|859405|P3|NOT COMPLETED|Dose Escalation Week 2||1
349457|NCT02388295|859406|P2|NOT COMPLETED|Dose Escalation Week 2||2
349458|NCT02388295|859407|P1|NOT COMPLETED|Dose Escalation Week 2||1
349459|NCT02388295|859405|P3|COMPLETED|Dose Escalation Week 2||17
349460|NCT02388295|859406|P2|COMPLETED|Dose Escalation Week 2||14
349461|NCT02388295|859407|P1|COMPLETED|Dose Escalation Week 2||16
349462|NCT02388295|859405|P3|STARTED|Dose Escalation Week 2||18
349463|NCT02388295|859406|P2|STARTED|Dose Escalation Week 2||16
349464|NCT02388295|859407|P1|STARTED|Dose Escalation Week 2||17
349465|NCT02388295|859405|P3|NOT COMPLETED|Dose Escalation Week 1||2
349466|NCT02388295|859406|P2|NOT COMPLETED|Dose Escalation Week 1||3
349467|NCT02388295|859407|P1|NOT COMPLETED|Dose Escalation Week 1||2
349468|NCT02388295|859405|P3|COMPLETED|Dose Escalation Week 1||18
349469|NCT02388295|859406|P2|COMPLETED|Dose Escalation Week 1||16
349470|NCT02388295|859407|P1|COMPLETED|Dose Escalation Week 1||17
349471|NCT02388295|859405|P3|STARTED|Dose Escalation Week 1|Number randomized to treatment|20
349472|NCT02388295|859406|P2|STARTED|Dose Escalation Week 1|Number randomized to treatment|19
349473|NCT02388295|859407|P1|STARTED|Dose Escalation Week 1|Number randomized to treatment|19
349474|NCT02388269|859425|P3|NOT COMPLETED|Overall Study||10
349475|NCT02388269|859426|P2|NOT COMPLETED|Overall Study||2
349476|NCT02388269|859427|P1|NOT COMPLETED|Overall Study||9
349477|NCT02388269|859425|P3|COMPLETED|Overall Study||0
349478|NCT02388269|859426|P2|COMPLETED|Overall Study||38
349479|NCT02388269|859427|P1|COMPLETED|Overall Study||32
349480|NCT02388269|859425|P3|Open Label|Overall Study||0
349481|NCT02388269|859426|P2|Open Label|Overall Study||38
349482|NCT02388269|859427|P1|Open Label|Overall Study||37
349483|NCT02388269|859425|P3|Randomised Period|Overall Study||0
349484|NCT02388269|859426|P2|Randomised Period|Overall Study||40
349485|NCT02388269|859427|P1|Randomised Period|Overall Study||41
349486|NCT02388269|859425|P3|STARTED|Overall Study||10
349487|NCT02388269|859426|P2|STARTED|Overall Study||40
349488|NCT02388269|859427|P1|STARTED|Overall Study||41
349489|NCT02388191|859459|P2|NOT COMPLETED|Overall Study||0
349490|NCT02388191|859460|P1|NOT COMPLETED|Overall Study||1
349491|NCT02388191|859459|P2|COMPLETED|Overall Study||60
349492|NCT02388191|859460|P1|COMPLETED|Overall Study||58
349493|NCT02388191|859459|P2|STARTED|Overall Study||60
349494|NCT02388191|859460|P1|STARTED|Overall Study||59
349495|NCT02388074|859474|P1|NOT COMPLETED|Overall Study||3
349496|NCT02388074|859474|P1|COMPLETED|Overall Study||22
349497|NCT02388074|859474|P1|STARTED|Overall Study||25
349498|NCT02387996|859478|P1|NOT COMPLETED|Overall Study||204
349499|NCT02387996|859478|P1|COMPLETED|Overall Study|Completed equals continuing in the Treatment Period|66
349500|NCT02387996|859478|P1|STARTED|Overall Study||270
349501|NCT02387983|859489|P1|NOT COMPLETED|Overall Study||7
349502|NCT02387983|859489|P1|COMPLETED|Overall Study||58
349503|NCT02387983|859489|P1|STARTED|Overall Study||65
349504|NCT02387801|859503|P2|NOT COMPLETED|Post-Treatment Follow-up||0
349505|NCT02387801|859504|P1|NOT COMPLETED|Post-Treatment Follow-up||0
349506|NCT02387801|859503|P2|COMPLETED|Post-Treatment Follow-up||12
349507|NCT02387801|859504|P1|COMPLETED|Post-Treatment Follow-up||0
349508|NCT02387801|859503|P2|STARTED|Post-Treatment Follow-up||12
349509|NCT02387801|859504|P1|STARTED|Post-Treatment Follow-up||0
349510|NCT02387801|859503|P2|NOT COMPLETED|Maintenance Dosing Period||0
349511|NCT02387801|859504|P1|NOT COMPLETED|Maintenance Dosing Period||0
349512|NCT02387801|859503|P2|COMPLETED|Maintenance Dosing Period||12
349513|NCT02387801|859504|P1|COMPLETED|Maintenance Dosing Period||0
349514|NCT02387801|859503|P2|STARTED|Maintenance Dosing Period||12
349515|NCT02387801|859504|P1|STARTED|Maintenance Dosing Period|All participants from Induction Dosing Period went to ixe Q4W arm during Maintenance Dosing Period.|0
349516|NCT02387801|859503|P2|NOT COMPLETED|Induction Dosing Period||0
349517|NCT02387801|859504|P1|NOT COMPLETED|Induction Dosing Period||0
349518|NCT02387801|859503|P2|COMPLETED|Induction Dosing Period||6
349519|NCT02387801|859504|P1|COMPLETED|Induction Dosing Period||6
349520|NCT02387801|859503|P2|STARTED|Induction Dosing Period||6
349521|NCT02387801|859504|P1|STARTED|Induction Dosing Period||6
349522|NCT02387749|859522|P1|NOT COMPLETED|Overall Study||0
349523|NCT02387749|859522|P1|COMPLETED|Overall Study||10
349524|NCT02387749|859522|P1|STARTED|Overall Study||10
349525|NCT02387710|859531|P2|NOT COMPLETED|Second Study Night||0
349526|NCT02387710|859532|P1|NOT COMPLETED|Second Study Night||0
349527|NCT02387710|859531|P2|COMPLETED|Second Study Night||7
349528|NCT02387710|859532|P1|COMPLETED|Second Study Night||9
349529|NCT02387710|859531|P2|STARTED|Second Study Night|2 patients did not come back for excessive sleep disruption due to the equipment|7
349530|NCT02387710|859532|P1|STARTED|Second Study Night||9
349531|NCT02387710|859531|P2|NOT COMPLETED|First Study Night||0
349532|NCT02387710|859532|P1|NOT COMPLETED|First Study Night||0
349533|NCT02387710|859531|P2|COMPLETED|First Study Night||9
349534|NCT02387710|859532|P1|COMPLETED|First Study Night||9
349535|NCT02387710|859531|P2|STARTED|First Study Night||9
349536|NCT02387710|859532|P1|STARTED|First Study Night||9
349537|NCT02387580|859548|P6|NOT COMPLETED|Overall Study||0
349538|NCT02387580|859549|P5|NOT COMPLETED|Overall Study||0
349539|NCT02387580|859550|P4|NOT COMPLETED|Overall Study||1
349540|NCT02387580|859551|P3|NOT COMPLETED|Overall Study||0
349541|NCT02387580|859552|P2|NOT COMPLETED|Overall Study||0
349542|NCT02387580|859553|P1|NOT COMPLETED|Overall Study||0
349543|NCT02387580|859548|P6|COMPLETED|Overall Study||8
349544|NCT02387580|859549|P5|COMPLETED|Overall Study||8
349545|NCT02387580|859550|P4|COMPLETED|Overall Study||7
349546|NCT02387580|859551|P3|COMPLETED|Overall Study||8
349547|NCT02387580|859552|P2|COMPLETED|Overall Study||8
349548|NCT02387580|859553|P1|COMPLETED|Overall Study||8
349549|NCT02387580|859548|P6|STARTED|Overall Study||8
349550|NCT02387580|859549|P5|STARTED|Overall Study||8
349551|NCT02387580|859550|P4|STARTED|Overall Study||8
349552|NCT02387580|859551|P3|STARTED|Overall Study||8
349553|NCT02387580|859552|P2|STARTED|Overall Study||8
349554|NCT02387580|859553|P1|STARTED|Overall Study||8
349555|NCT02387554|859589|P4|NOT COMPLETED|Overall Study||2
349556|NCT02387554|859590|P3|NOT COMPLETED|Overall Study||2
349557|NCT02387554|859591|P2|NOT COMPLETED|Overall Study||0
349558|NCT02387554|859592|P1|NOT COMPLETED|Overall Study||3
349559|NCT02387554|859589|P4|COMPLETED|Overall Study||6
349560|NCT02387554|859590|P3|COMPLETED|Overall Study||6
349561|NCT02387554|859591|P2|COMPLETED|Overall Study||7
349562|NCT02387554|859592|P1|COMPLETED|Overall Study||7
349563|NCT02387554|859589|P4|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|8
349564|NCT02387554|859590|P3|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|8
349565|NCT02387554|859591|P2|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|7
349566|NCT02387554|859592|P1|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|10
349567|NCT02387502|859605|P3|NOT COMPLETED|Overall Study||0
349568|NCT02387502|859606|P2|NOT COMPLETED|Overall Study||0
349569|NCT02387502|859607|P1|NOT COMPLETED|Overall Study||0
349570|NCT02387502|859605|P3|COMPLETED|Overall Study||40
349571|NCT02387502|859606|P2|COMPLETED|Overall Study||40
349572|NCT02387502|859607|P1|COMPLETED|Overall Study||40
349573|NCT02387502|859605|P3|STARTED|Overall Study||40
349574|NCT02387502|859606|P2|STARTED|Overall Study||40
349575|NCT02387502|859607|P1|STARTED|Overall Study||40
349576|NCT02387476|859617|P2|NOT COMPLETED|Overall Study||5
349577|NCT02387476|859618|P1|NOT COMPLETED|Overall Study||6
349578|NCT02387476|859617|P2|COMPLETED|Overall Study||17
349579|NCT02387476|859618|P1|COMPLETED|Overall Study||19
349580|NCT02387476|859617|P2|STARTED|Overall Study||22
349581|NCT02387476|859618|P1|STARTED|Overall Study||25
349582|NCT02387268|859644|P1|NOT COMPLETED|Overall Study||1
349583|NCT02387268|859644|P1|COMPLETED|Overall Study||9
349584|NCT02387268|859644|P1|STARTED|Overall Study||10
349585|NCT02384538|859651|P2|NOT COMPLETED|Overall Study||15
349586|NCT02384538|859652|P1|NOT COMPLETED|Overall Study||6
349587|NCT02384538|859651|P2|COMPLETED|Overall Study||49
349588|NCT02384538|859652|P1|COMPLETED|Overall Study||61
349589|NCT02384538|859651|P2|STARTED|Overall Study||64
349590|NCT02384538|859652|P1|STARTED|Overall Study||67
349591|NCT02384070|859673|P3|NOT COMPLETED|Overall Study||0
349592|NCT02384070|859674|P2|NOT COMPLETED|Overall Study||0
349593|NCT02384070|859675|P1|NOT COMPLETED|Overall Study||0
349594|NCT02384070|859673|P3|COMPLETED|Overall Study||100
349595|NCT02384070|859674|P2|COMPLETED|Overall Study||100
349596|NCT02384070|859675|P1|COMPLETED|Overall Study||100
349597|NCT02384070|859673|P3|STARTED|Overall Study||100
349598|NCT02384070|859674|P2|STARTED|Overall Study||100
349599|NCT02384070|859675|P1|STARTED|Overall Study||100
349600|NCT02383862|859691|P2|NOT COMPLETED|3 Month Follow up||21
349601|NCT02383862|859692|P1|NOT COMPLETED|3 Month Follow up||23
349602|NCT02383862|859691|P2|COMPLETED|3 Month Follow up||128
349603|NCT02383862|859692|P1|COMPLETED|3 Month Follow up||128
349604|NCT02383862|859691|P2|STARTED|3 Month Follow up||149
349605|NCT02383862|859692|P1|STARTED|3 Month Follow up||151
349606|NCT02383862|859691|P2|NOT COMPLETED|Baseline||0
349607|NCT02383862|859692|P1|NOT COMPLETED|Baseline||0
349608|NCT02383862|859691|P2|COMPLETED|Baseline||149
349609|NCT02383862|859692|P1|COMPLETED|Baseline||151
349610|NCT02383862|859691|P2|STARTED|Baseline||149
349611|NCT02383862|859692|P1|STARTED|Baseline||151
349612|NCT02383758|859725|P2|NOT COMPLETED|Overall Study||2
349613|NCT02383758|859726|P1|NOT COMPLETED|Overall Study||0
349614|NCT02383758|859725|P2|COMPLETED|Overall Study||8
349615|NCT02383758|859726|P1|COMPLETED|Overall Study||10
349616|NCT02383758|859725|P2|STARTED|Overall Study||10
349617|NCT02383758|859726|P1|STARTED|Overall Study||10
349618|NCT02383719|859738|P1|NOT COMPLETED|Overall Study||0
349619|NCT02383719|859738|P1|COMPLETED|Overall Study||18
349620|NCT02383719|859738|P1|STARTED|Overall Study||18
349621|NCT02383576|859744|P2|NOT COMPLETED|Overall Study||45
349622|NCT02383576|859745|P1|NOT COMPLETED|Overall Study||63
349623|NCT02383576|859744|P2|COMPLETED|Overall Study||46
349624|NCT02383576|859745|P1|COMPLETED|Overall Study||31
349625|NCT02383576|859744|P2|STARTED|Overall Study||91
349626|NCT02383576|859745|P1|STARTED|Overall Study||94
349633|NCT02383420|859779|P3|NOT COMPLETED|Overall Study||0
349634|NCT02383420|859780|P2|NOT COMPLETED|Overall Study||0
349635|NCT02383420|859781|P1|NOT COMPLETED|Overall Study||2
349636|NCT02383420|859779|P3|COMPLETED|Overall Study||3
349637|NCT02383420|859780|P2|COMPLETED|Overall Study||10
349638|NCT02383420|859781|P1|COMPLETED|Overall Study||8
349639|NCT02383420|859779|P3|STARTED|Overall Study||3
349640|NCT02383420|859780|P2|STARTED|Overall Study||10
349641|NCT02383420|859781|P1|STARTED|Overall Study||10
349642|NCT02382913|859799|P10|NOT COMPLETED|Overall Study||0
349643|NCT02382913|859800|P9|NOT COMPLETED|Overall Study||0
349644|NCT02382913|859801|P8|NOT COMPLETED|Overall Study||0
349645|NCT02382913|859802|P7|NOT COMPLETED|Overall Study||0
349646|NCT02382913|859803|P6|NOT COMPLETED|Overall Study||0
349647|NCT02382913|859804|P5|NOT COMPLETED|Overall Study||0
349648|NCT02382913|859805|P4|NOT COMPLETED|Overall Study||0
349649|NCT02382913|859806|P3|NOT COMPLETED|Overall Study||0
349650|NCT02382913|859807|P2|NOT COMPLETED|Overall Study||0
349651|NCT02382913|859808|P1|NOT COMPLETED|Overall Study||0
349652|NCT02382913|859799|P10|COMPLETED|Overall Study||33
349653|NCT02382913|859800|P9|COMPLETED|Overall Study||30
349654|NCT02382913|859801|P8|COMPLETED|Overall Study||30
349655|NCT02382913|859802|P7|COMPLETED|Overall Study||37
349656|NCT02382913|859803|P6|COMPLETED|Overall Study||30
349657|NCT02382913|859804|P5|COMPLETED|Overall Study||33
349658|NCT02382913|859805|P4|COMPLETED|Overall Study||27
349659|NCT02382913|859806|P3|COMPLETED|Overall Study||32
349660|NCT02382913|859807|P2|COMPLETED|Overall Study||36
349661|NCT02382913|859808|P1|COMPLETED|Overall Study||27
349662|NCT02382913|859799|P10|STARTED|Overall Study||33
349663|NCT02382913|859800|P9|STARTED|Overall Study||30
349664|NCT02382913|859801|P8|STARTED|Overall Study||30
349665|NCT02382913|859802|P7|STARTED|Overall Study||37
349666|NCT02382913|859803|P6|STARTED|Overall Study||30
349667|NCT02382913|859804|P5|STARTED|Overall Study||33
349668|NCT02382913|859805|P4|STARTED|Overall Study||27
349669|NCT02382913|859806|P3|STARTED|Overall Study||32
349670|NCT02382913|859807|P2|STARTED|Overall Study||36
349671|NCT02382913|859808|P1|STARTED|Overall Study||27
349672|NCT02382744|859846|P2|NOT COMPLETED|Overall Study||0
349673|NCT02382744|859847|P1|NOT COMPLETED|Overall Study||0
349674|NCT02382744|859846|P2|COMPLETED|Overall Study||40
349675|NCT02382744|859847|P1|COMPLETED|Overall Study||40
349676|NCT02382744|859846|P2|Analyzed|Overall Study||40
349677|NCT02382744|859847|P1|Analyzed|Overall Study||40
349678|NCT02382744|859846|P2|Allocated|Overall Study||40
349679|NCT02382744|859847|P1|Allocated|Overall Study||40
349680|NCT02382744|859846|P2|STARTED|Overall Study||40
349681|NCT02382744|859847|P1|STARTED|Overall Study||40
349682|NCT02382640|859882|P4|NOT COMPLETED|Intervention Period 4 (3 Days)||0
349683|NCT02382640|859883|P3|NOT COMPLETED|Intervention Period 4 (3 Days)||0
349684|NCT02382640|859884|P2|NOT COMPLETED|Intervention Period 4 (3 Days)||0
349685|NCT02382640|859885|P1|NOT COMPLETED|Intervention Period 4 (3 Days)||1
349686|NCT02382640|859882|P4|COMPLETED|Intervention Period 4 (3 Days)||9
349687|NCT02382640|859883|P3|COMPLETED|Intervention Period 4 (3 Days)||9
349688|NCT02382640|859884|P2|COMPLETED|Intervention Period 4 (3 Days)||9
349689|NCT02382640|859885|P1|COMPLETED|Intervention Period 4 (3 Days)||8
349690|NCT02382640|859882|P4|STARTED|Intervention Period 4 (3 Days)||9
349691|NCT02382640|859883|P3|STARTED|Intervention Period 4 (3 Days)||9
349692|NCT02382640|859884|P2|STARTED|Intervention Period 4 (3 Days)||9
349693|NCT02382640|859885|P1|STARTED|Intervention Period 4 (3 Days)||9
349694|NCT02382640|859882|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
349695|NCT02382640|859883|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
349696|NCT02382640|859884|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
349697|NCT02382640|859885|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
349698|NCT02382640|859882|P4|COMPLETED|Washout Period 3 (7 Days)||9
349699|NCT02382640|859883|P3|COMPLETED|Washout Period 3 (7 Days)||9
349700|NCT02382640|859884|P2|COMPLETED|Washout Period 3 (7 Days)||9
349701|NCT02382640|859885|P1|COMPLETED|Washout Period 3 (7 Days)||9
349702|NCT02382640|859882|P4|STARTED|Washout Period 3 (7 Days)||9
349703|NCT02382640|859883|P3|STARTED|Washout Period 3 (7 Days)||9
349704|NCT02382640|859884|P2|STARTED|Washout Period 3 (7 Days)||9
349705|NCT02382640|859885|P1|STARTED|Washout Period 3 (7 Days)||9
349706|NCT02382640|859882|P4|NOT COMPLETED|Intervention Period 3 (3 Days)||0
349707|NCT02382640|859883|P3|NOT COMPLETED|Intervention Period 3 (3 Days)||0
349708|NCT02382640|859884|P2|NOT COMPLETED|Intervention Period 3 (3 Days)||0
349709|NCT02382640|859885|P1|NOT COMPLETED|Intervention Period 3 (3 Days)||0
349710|NCT02382640|859882|P4|COMPLETED|Intervention Period 3 (3 Days)||9
349711|NCT02382640|859883|P3|COMPLETED|Intervention Period 3 (3 Days)||9
349712|NCT02382640|859884|P2|COMPLETED|Intervention Period 3 (3 Days)||9
349713|NCT02382640|859885|P1|COMPLETED|Intervention Period 3 (3 Days)||9
349714|NCT02382640|859882|P4|STARTED|Intervention Period 3 (3 Days)||9
349715|NCT02382640|859883|P3|STARTED|Intervention Period 3 (3 Days)||9
349716|NCT02382640|859884|P2|STARTED|Intervention Period 3 (3 Days)||9
349717|NCT02382640|859885|P1|STARTED|Intervention Period 3 (3 Days)||9
349718|NCT02382640|859882|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
349719|NCT02382640|859883|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
349720|NCT02382640|859884|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
349721|NCT02382640|859885|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
349722|NCT02382640|859882|P4|COMPLETED|Washout Period 2 (7 Days)||9
349723|NCT02382640|859883|P3|COMPLETED|Washout Period 2 (7 Days)||9
349724|NCT02382640|859884|P2|COMPLETED|Washout Period 2 (7 Days)||9
349725|NCT02382640|859885|P1|COMPLETED|Washout Period 2 (7 Days)||9
349726|NCT02382640|859882|P4|STARTED|Washout Period 2 (7 Days)||9
349727|NCT02382640|859883|P3|STARTED|Washout Period 2 (7 Days)||9
349728|NCT02382640|859884|P2|STARTED|Washout Period 2 (7 Days)||9
349729|NCT02382640|859885|P1|STARTED|Washout Period 2 (7 Days)||9
349730|NCT02382640|859882|P4|NOT COMPLETED|Intervention Period 2 (3 Days)||0
349731|NCT02382640|859883|P3|NOT COMPLETED|Intervention Period 2 (3 Days)||0
349732|NCT02382640|859884|P2|NOT COMPLETED|Intervention Period 2 (3 Days)||0
349733|NCT02382640|859885|P1|NOT COMPLETED|Intervention Period 2 (3 Days)||0
349734|NCT02382640|859882|P4|COMPLETED|Intervention Period 2 (3 Days)||9
349735|NCT02382640|859883|P3|COMPLETED|Intervention Period 2 (3 Days)||9
349736|NCT02382640|859884|P2|COMPLETED|Intervention Period 2 (3 Days)||9
349737|NCT02382640|859885|P1|COMPLETED|Intervention Period 2 (3 Days)||9
349738|NCT02382640|859882|P4|STARTED|Intervention Period 2 (3 Days)||9
349739|NCT02382640|859883|P3|STARTED|Intervention Period 2 (3 Days)||9
349740|NCT02382640|859884|P2|STARTED|Intervention Period 2 (3 Days)||9
349741|NCT02382640|859885|P1|STARTED|Intervention Period 2 (3 Days)||9
349742|NCT02382640|859882|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
349743|NCT02382640|859883|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
349744|NCT02382640|859884|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
349745|NCT02382640|859885|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
349746|NCT02382640|859882|P4|COMPLETED|Washout Period 1 (7 Days)||9
349747|NCT02382640|859883|P3|COMPLETED|Washout Period 1 (7 Days)||9
349748|NCT02382640|859884|P2|COMPLETED|Washout Period 1 (7 Days)||9
349749|NCT02382640|859885|P1|COMPLETED|Washout Period 1 (7 Days)||9
349750|NCT02382640|859882|P4|STARTED|Washout Period 1 (7 Days)||9
349751|NCT02382640|859883|P3|STARTED|Washout Period 1 (7 Days)||9
349752|NCT02382640|859884|P2|STARTED|Washout Period 1 (7 Days)||9
349753|NCT02382640|859885|P1|STARTED|Washout Period 1 (7 Days)||9
349754|NCT02382640|859882|P4|NOT COMPLETED|Intervention Period 1 (3 Days)||0
349755|NCT02382640|859883|P3|NOT COMPLETED|Intervention Period 1 (3 Days)||0
349756|NCT02382640|859884|P2|NOT COMPLETED|Intervention Period 1 (3 Days)||0
349757|NCT02382640|859885|P1|NOT COMPLETED|Intervention Period 1 (3 Days)||0
349758|NCT02382640|859882|P4|COMPLETED|Intervention Period 1 (3 Days)||9
349759|NCT02382640|859883|P3|COMPLETED|Intervention Period 1 (3 Days)||9
349760|NCT02382640|859884|P2|COMPLETED|Intervention Period 1 (3 Days)||9
349761|NCT02382640|859885|P1|COMPLETED|Intervention Period 1 (3 Days)||9
349762|NCT02382640|859882|P4|STARTED|Intervention Period 1 (3 Days)||9
349763|NCT02382640|859883|P3|STARTED|Intervention Period 1 (3 Days)||9
349764|NCT02382640|859884|P2|STARTED|Intervention Period 1 (3 Days)||9
349765|NCT02382640|859885|P1|STARTED|Intervention Period 1 (3 Days)||9
349766|NCT02382133|859923|P1|NOT COMPLETED|Overall Study||33
349767|NCT02382133|859923|P1|COMPLETED|Overall Study||10
349768|NCT02382133|859923|P1|STARTED|Overall Study||43
349769|NCT02381795|859928|P1|NOT COMPLETED|Overall Study||3
349770|NCT02381795|859928|P1|COMPLETED|Overall Study||7
349771|NCT02381795|859928|P1|STARTED|Overall Study||10
349772|NCT02381678|859932|P3|NOT COMPLETED|Overall Study||0
349773|NCT02381678|859933|P2|NOT COMPLETED|Overall Study||0
349774|NCT02381678|859934|P1|NOT COMPLETED|Overall Study||0
349775|NCT02381678|859932|P3|COMPLETED|Overall Study||32
349776|NCT02381678|859933|P2|COMPLETED|Overall Study||139
349777|NCT02381678|859934|P1|COMPLETED|Overall Study||54
349778|NCT02381678|859932|P3|STARTED|Overall Study||32
349779|NCT02381678|859933|P2|STARTED|Overall Study||139
349780|NCT02381678|859934|P1|STARTED|Overall Study||54
349781|NCT02381418|859940|P1|NOT COMPLETED|Overall Study||0
349782|NCT02381418|859940|P1|COMPLETED|Overall Study||120
349783|NCT02381418|859940|P1|STARTED|Overall Study||120
349784|NCT02381392|859948|P2|NOT COMPLETED|Overall Study||0
349785|NCT02381392|859949|P1|NOT COMPLETED|Overall Study||0
349786|NCT02381392|859948|P2|COMPLETED|Overall Study||12
349787|NCT02381392|859949|P1|COMPLETED|Overall Study||11
349788|NCT02381392|859948|P2|STARTED|Overall Study||12
349789|NCT02381392|859949|P1|STARTED|Overall Study||11
349790|NCT02381288|859967|P4|NOT COMPLETED|Overall Study||0
349791|NCT02381288|859968|P3|NOT COMPLETED|Overall Study||0
349792|NCT02381288|859969|P2|NOT COMPLETED|Overall Study||0
349793|NCT02381288|859970|P1|NOT COMPLETED|Overall Study||0
349794|NCT02381288|859967|P4|COMPLETED|Overall Study||5
349795|NCT02381288|859968|P3|COMPLETED|Overall Study||5
349796|NCT02381288|859969|P2|COMPLETED|Overall Study||2
349797|NCT02381288|859970|P1|COMPLETED|Overall Study||5
349798|NCT02381288|859967|P4|STARTED|Overall Study||5
349799|NCT02381288|859968|P3|STARTED|Overall Study||5
349800|NCT02381288|859969|P2|STARTED|Overall Study||2
349801|NCT02381288|859970|P1|STARTED|Overall Study||5
349802|NCT02380742|859999|P2|NOT COMPLETED|Overall Study||0
349803|NCT02380742|860000|P1|NOT COMPLETED|Overall Study||1
349804|NCT02380742|859999|P2|COMPLETED|Overall Study||26
349805|NCT02380742|860000|P1|COMPLETED|Overall Study||27
349806|NCT02380742|859999|P2|STARTED|Overall Study||26
349807|NCT02380742|860000|P1|STARTED|Overall Study||28
349808|NCT02380287|860020|P8|NOT COMPLETED|Overall Study||0
349809|NCT02380287|860021|P7|NOT COMPLETED|Overall Study||0
349810|NCT02380287|860022|P6|NOT COMPLETED|Overall Study||0
349811|NCT02380287|860023|P5|NOT COMPLETED|Overall Study||0
349812|NCT02380287|860024|P4|NOT COMPLETED|Overall Study||0
349813|NCT02380287|860025|P3|NOT COMPLETED|Overall Study||1
349814|NCT02380287|860026|P2|NOT COMPLETED|Overall Study||0
349815|NCT02380287|860027|P1|NOT COMPLETED|Overall Study||0
349816|NCT02380287|860020|P8|COMPLETED|Overall Study||3
349817|NCT02380287|860021|P7|COMPLETED|Overall Study||3
349818|NCT02380287|860022|P6|COMPLETED|Overall Study||3
349819|NCT02380287|860023|P5|COMPLETED|Overall Study||3
349820|NCT02380287|860024|P4|COMPLETED|Overall Study||3
349821|NCT02380287|860025|P3|COMPLETED|Overall Study||2
349822|NCT02380287|860026|P2|COMPLETED|Overall Study||3
349823|NCT02380287|860027|P1|COMPLETED|Overall Study||1
349824|NCT02380287|860020|P8|STARTED|Overall Study||3
349825|NCT02380287|860021|P7|STARTED|Overall Study||3
349826|NCT02380287|860022|P6|STARTED|Overall Study||3
349827|NCT02380287|860023|P5|STARTED|Overall Study||3
349828|NCT02380287|860024|P4|STARTED|Overall Study||3
349829|NCT02380287|860025|P3|STARTED|Overall Study||3
349830|NCT02380287|860026|P2|STARTED|Overall Study||3
349831|NCT02380287|860027|P1|STARTED|Overall Study||1
349832|NCT02380261|860038|P1|NOT COMPLETED|Overall Study||0
349833|NCT02380261|860038|P1|COMPLETED|Overall Study||35
349834|NCT02380261|860038|P1|STARTED|Overall Study||35
349835|NCT02380248|860043|P1|NOT COMPLETED|Overall Study||14
349836|NCT02380248|860043|P1|COMPLETED|Overall Study||186
349837|NCT02380248|860043|P1|STARTED|Overall Study||200
349838|NCT02379637|860050|P2|NOT COMPLETED|Overall Study||1
349839|NCT02379637|860051|P1|NOT COMPLETED|Overall Study||2
349840|NCT02379637|860050|P2|COMPLETED|Overall Study||34
349841|NCT02379637|860051|P1|COMPLETED|Overall Study||33
349842|NCT02379637|860050|P2|STARTED|Overall Study||35
349843|NCT02379637|860051|P1|STARTED|Overall Study||35
349844|NCT02379585|860061|P2|NOT COMPLETED|Overall Study||5
349845|NCT02379585|860062|P1|NOT COMPLETED|Overall Study||3
349846|NCT02379585|860061|P2|COMPLETED|Overall Study||0
349847|NCT02379585|860062|P1|COMPLETED|Overall Study||0
349848|NCT02379585|860061|P2|STARTED|Overall Study||5
349849|NCT02379585|860062|P1|STARTED|Overall Study||3
349850|NCT02378961|860088|P4|NOT COMPLETED|Overall Study||1
349851|NCT02378961|860089|P3|NOT COMPLETED|Overall Study||1
349852|NCT02378961|860090|P2|NOT COMPLETED|Overall Study||2
349853|NCT02378961|860091|P1|NOT COMPLETED|Overall Study||4
349854|NCT02378961|860088|P4|COMPLETED|Overall Study||28
349855|NCT02378961|860089|P3|COMPLETED|Overall Study||35
349856|NCT02378961|860090|P2|COMPLETED|Overall Study||28
349857|NCT02378961|860091|P1|COMPLETED|Overall Study||29
349858|NCT02378961|860088|P4|STARTED|Overall Study||29
349859|NCT02378961|860089|P3|STARTED|Overall Study||36
349860|NCT02378961|860090|P2|STARTED|Overall Study||30
349861|NCT02378961|860091|P1|STARTED|Overall Study||33
349862|NCT02378935|860128|P7|NOT COMPLETED|Overall Study||0
349863|NCT02378935|860129|P6|NOT COMPLETED|Overall Study||0
349864|NCT02378935|860130|P5|NOT COMPLETED|Overall Study||0
349865|NCT02378935|860131|P4|NOT COMPLETED|Overall Study||6
349866|NCT02378935|860132|P3|NOT COMPLETED|Overall Study||3
349867|NCT02378935|860133|P2|NOT COMPLETED|Overall Study||0
349868|NCT02378935|860134|P1|NOT COMPLETED|Overall Study||10
349869|NCT02378935|860128|P7|COMPLETED|Overall Study||8
349870|NCT02378935|860129|P6|COMPLETED|Overall Study||32
349871|NCT02378935|860130|P5|COMPLETED|Overall Study||31
349872|NCT02378935|860131|P4|COMPLETED|Overall Study||25
349873|NCT02378935|860132|P3|COMPLETED|Overall Study||30
349874|NCT02378935|860133|P2|COMPLETED|Overall Study||36
349875|NCT02378935|860134|P1|COMPLETED|Overall Study||24
349876|NCT02378935|860128|P7|STARTED|Overall Study||8
349877|NCT02378935|860129|P6|STARTED|Overall Study||32
349878|NCT02378935|860130|P5|STARTED|Overall Study||31
349879|NCT02378935|860131|P4|STARTED|Overall Study||31
349880|NCT02378935|860132|P3|STARTED|Overall Study||33
349881|NCT02378935|860133|P2|STARTED|Overall Study||36
349882|NCT02378935|860134|P1|STARTED|Overall Study||34
349883|NCT02378753|860187|P2|NOT COMPLETED|Overall Study||695
349884|NCT02378753|860188|P1|NOT COMPLETED|Overall Study||218
349885|NCT02378753|860187|P2|COMPLETED|Overall Study||3637
349886|NCT02378753|860188|P1|COMPLETED|Overall Study||4101
349887|NCT02378753|860187|P2|STARTED|Overall Study||4332
349888|NCT02378753|860188|P1|STARTED|Overall Study||4319
349889|NCT02378506|860206|P1|NOT COMPLETED|Overall Study||25
349890|NCT02378506|860206|P1|COMPLETED|Overall Study||163
349891|NCT02378506|860206|P1|Treated|Overall Study||187
349892|NCT02378506|860206|P1|STARTED|Overall Study||188
349893|NCT02377427|860225|P2|NOT COMPLETED|Overall Study||0
349894|NCT02377427|860226|P1|NOT COMPLETED|Overall Study||4
349895|NCT02377427|860225|P2|COMPLETED|Overall Study||10
349896|NCT02377427|860226|P1|COMPLETED|Overall Study||22
349897|NCT02377427|860225|P2|STARTED|Overall Study||10
349898|NCT02377427|860226|P1|STARTED|Overall Study||26
349899|NCT02376998|860257|P1|NOT COMPLETED|Overall Study||9
349900|NCT02376998|860257|P1|COMPLETED|Overall Study||11
349901|NCT02376998|860257|P1|STARTED|Overall Study||20
349902|NCT02376530|860265|P4|NOT COMPLETED|Overall Study||0
349903|NCT02376530|860266|P3|NOT COMPLETED|Overall Study||0
349904|NCT02376530|860267|P2|NOT COMPLETED|Overall Study||0
349905|NCT02376530|860268|P1|NOT COMPLETED|Overall Study||0
349906|NCT02376530|860265|P4|COMPLETED|Overall Study||197
349907|NCT02376530|860266|P3|COMPLETED|Overall Study||197
349908|NCT02376530|860267|P2|COMPLETED|Overall Study||198
349909|NCT02376530|860268|P1|COMPLETED|Overall Study||196
349910|NCT02376530|860265|P4|STARTED|Overall Study||197
349911|NCT02376530|860266|P3|STARTED|Overall Study||197
349912|NCT02376530|860267|P2|STARTED|Overall Study||198
349913|NCT02376530|860268|P1|STARTED|Overall Study||196
349914|NCT02376166|860278|P1|NOT COMPLETED|Overall Study||3
349915|NCT02376166|860278|P1|COMPLETED|Overall Study||12
349916|NCT02376166|860278|P1|STARTED|Overall Study||15
349917|NCT02375724|860305|P2|NOT COMPLETED|Overall Study||6
349918|NCT02375724|860306|P1|NOT COMPLETED|Overall Study||6
349919|NCT02375724|860305|P2|COMPLETED|Overall Study||128
349920|NCT02375724|860306|P1|COMPLETED|Overall Study||129
349921|NCT02375724|860305|P2|STARTED|Overall Study||134
349922|NCT02375724|860306|P1|STARTED|Overall Study||135
349923|NCT02375373|860316|P1|NOT COMPLETED|Overall Study||11
349924|NCT02375373|860316|P1|COMPLETED|Overall Study||1
349925|NCT02375373|860316|P1|STARTED|Overall Study||12
349926|NCT02375347|860320|P1|NOT COMPLETED|Overall Study||1
349927|NCT02375347|860320|P1|COMPLETED|Overall Study||12
349928|NCT02375347|860320|P1|STARTED|Overall Study||13
349929|NCT02374593|860326|P2|NOT COMPLETED|Overall Study||0
349930|NCT02374593|860327|P1|NOT COMPLETED|Overall Study||2
349931|NCT02374593|860326|P2|COMPLETED|Overall Study||44
349932|NCT02374593|860327|P1|COMPLETED|Overall Study||22
349933|NCT02374593|860326|P2|STARTED|Overall Study||44
349934|NCT02374593|860327|P1|STARTED|Overall Study||24
349935|NCT02374398|860341|P4|NOT COMPLETED|Overall Study||0
349936|NCT02374398|860342|P3|NOT COMPLETED|Overall Study||3
349937|NCT02374398|860343|P2|NOT COMPLETED|Overall Study||1
349938|NCT02374398|860344|P1|NOT COMPLETED|Overall Study||2
349939|NCT02374398|860341|P4|COMPLETED|Overall Study||32
349940|NCT02374398|860342|P3|COMPLETED|Overall Study||29
349941|NCT02374398|860343|P2|COMPLETED|Overall Study||31
349942|NCT02374398|860344|P1|COMPLETED|Overall Study||29
349943|NCT02374398|860341|P4|STARTED|Overall Study||32
349944|NCT02374398|860342|P3|STARTED|Overall Study||32
349945|NCT02374398|860343|P2|STARTED|Overall Study||32
349946|NCT02374398|860344|P1|STARTED|Overall Study||31
349947|NCT02374346|860370|P1|NOT COMPLETED|Overall Study||48
349948|NCT02374346|860370|P1|COMPLETED|Overall Study||446
349949|NCT02374346|860370|P1|STARTED|Overall Study||494
349950|NCT02374164|860379|P3|NOT COMPLETED|Treatment Period 3||0
349951|NCT02374164|860380|P2|NOT COMPLETED|Treatment Period 3||0
349952|NCT02374164|860381|P1|NOT COMPLETED|Treatment Period 3||0
349953|NCT02374164|860379|P3|COMPLETED|Treatment Period 3||12
349954|NCT02374164|860380|P2|COMPLETED|Treatment Period 3||11
349955|NCT02374164|860381|P1|COMPLETED|Treatment Period 3||12
349956|NCT02374164|860379|P3|STARTED|Treatment Period 3||12
349957|NCT02374164|860380|P2|STARTED|Treatment Period 3|One participant was Lost-to-Follow-Up prior to treatment A.|11
349958|NCT02374164|860381|P1|STARTED|Treatment Period 3||12
349959|NCT02374164|860379|P3|NOT COMPLETED|Treatment Period 2||0
349960|NCT02374164|860380|P2|NOT COMPLETED|Treatment Period 2||0
349961|NCT02374164|860381|P1|NOT COMPLETED|Treatment Period 2||0
349962|NCT02374164|860379|P3|COMPLETED|Treatment Period 2||12
349963|NCT02374164|860380|P2|COMPLETED|Treatment Period 2||12
349964|NCT02374164|860381|P1|COMPLETED|Treatment Period 2||12
349965|NCT02374164|860379|P3|STARTED|Treatment Period 2||12
349966|NCT02374164|860380|P2|STARTED|Treatment Period 2||12
349967|NCT02374164|860381|P1|STARTED|Treatment Period 2||12
349968|NCT02374164|860379|P3|NOT COMPLETED|Treatment Period 1||0
349969|NCT02374164|860380|P2|NOT COMPLETED|Treatment Period 1||0
349970|NCT02374164|860381|P1|NOT COMPLETED|Treatment Period 1||0
349971|NCT02374164|860379|P3|COMPLETED|Treatment Period 1||12
349972|NCT02374164|860380|P2|COMPLETED|Treatment Period 1||12
349973|NCT02374164|860381|P1|COMPLETED|Treatment Period 1||12
349974|NCT02374164|860379|P3|STARTED|Treatment Period 1||12
349975|NCT02374164|860380|P2|STARTED|Treatment Period 1||12
349976|NCT02374164|860381|P1|STARTED|Treatment Period 1||12
349977|NCT02373202|860402|P4|NOT COMPLETED|Overall Study||1
349978|NCT02373202|860403|P3|NOT COMPLETED|Overall Study||3
349979|NCT02373202|860404|P2|NOT COMPLETED|Overall Study||6
349980|NCT02373202|860405|P1|NOT COMPLETED|Overall Study||2
349981|NCT02373202|860402|P4|COMPLETED|Overall Study||30
349982|NCT02373202|860403|P3|COMPLETED|Overall Study||27
349983|NCT02373202|860404|P2|COMPLETED|Overall Study||9
349984|NCT02373202|860405|P1|COMPLETED|Overall Study||13
349985|NCT02373202|860402|P4|STARTED|Overall Study||31
349986|NCT02373202|860403|P3|STARTED|Overall Study||30
349987|NCT02373202|860404|P2|STARTED|Overall Study||15
349988|NCT02373202|860405|P1|STARTED|Overall Study||15
349989|NCT02372344|860455|P3|NOT COMPLETED|Period 3 (Visit 4)||0
349990|NCT02372344|860456|P2|NOT COMPLETED|Period 3 (Visit 4)||0
349991|NCT02372344|860457|P1|NOT COMPLETED|Period 3 (Visit 4)||0
349992|NCT02372344|860455|P3|COMPLETED|Period 3 (Visit 4)||14
349993|NCT02372344|860456|P2|COMPLETED|Period 3 (Visit 4)||14
349994|NCT02372344|860457|P1|COMPLETED|Period 3 (Visit 4)||14
349995|NCT02372344|860455|P3|STARTED|Period 3 (Visit 4)||14
349996|NCT02372344|860456|P2|STARTED|Period 3 (Visit 4)||14
349997|NCT02372344|860457|P1|STARTED|Period 3 (Visit 4)||14
349998|NCT02372344|860455|P3|NOT COMPLETED|Period 2 (Visit 3)||0
349999|NCT02372344|860456|P2|NOT COMPLETED|Period 2 (Visit 3)||0
350000|NCT02372344|860457|P1|NOT COMPLETED|Period 2 (Visit 3)||0
350001|NCT02372344|860455|P3|COMPLETED|Period 2 (Visit 3)||14
350002|NCT02372344|860456|P2|COMPLETED|Period 2 (Visit 3)||14
350003|NCT02372344|860457|P1|COMPLETED|Period 2 (Visit 3)||14
350004|NCT02372344|860455|P3|STARTED|Period 2 (Visit 3)||14
350005|NCT02372344|860456|P2|STARTED|Period 2 (Visit 3)||14
350006|NCT02372344|860457|P1|STARTED|Period 2 (Visit 3)||14
350007|NCT02372344|860455|P3|NOT COMPLETED|Period 1 (Visit 2)||0
350008|NCT02372344|860456|P2|NOT COMPLETED|Period 1 (Visit 2)||0
350009|NCT02372344|860457|P1|NOT COMPLETED|Period 1 (Visit 2)||0
350010|NCT02372344|860455|P3|COMPLETED|Period 1 (Visit 2)||14
350011|NCT02372344|860456|P2|COMPLETED|Period 1 (Visit 2)||14
350012|NCT02372344|860457|P1|COMPLETED|Period 1 (Visit 2)||14
350013|NCT02372344|860455|P3|STARTED|Period 1 (Visit 2)||14
350014|NCT02372344|860456|P2|STARTED|Period 1 (Visit 2)||14
350015|NCT02372344|860457|P1|STARTED|Period 1 (Visit 2)||14
350016|NCT02372097|860473|P2|NOT COMPLETED|Second Intervention Period (8 Days)||0
350017|NCT02372097|860474|P1|NOT COMPLETED|Second Intervention Period (8 Days)||0
350018|NCT02372097|860473|P2|COMPLETED|Second Intervention Period (8 Days)||12
350019|NCT02372097|860474|P1|COMPLETED|Second Intervention Period (8 Days)||12
350020|NCT02372097|860473|P2|STARTED|Second Intervention Period (8 Days)||12
350021|NCT02372097|860474|P1|STARTED|Second Intervention Period (8 Days)||12
350022|NCT02372097|860473|P2|NOT COMPLETED|Wash Out Period (13 Days)||0
350023|NCT02372097|860474|P1|NOT COMPLETED|Wash Out Period (13 Days)||0
350024|NCT02372097|860473|P2|COMPLETED|Wash Out Period (13 Days)||12
350025|NCT02372097|860474|P1|COMPLETED|Wash Out Period (13 Days)||12
350026|NCT02372097|860473|P2|STARTED|Wash Out Period (13 Days)||12
350027|NCT02372097|860474|P1|STARTED|Wash Out Period (13 Days)||12
350028|NCT02372097|860473|P2|NOT COMPLETED|First Intervention Period (8 Days)||0
350029|NCT02372097|860474|P1|NOT COMPLETED|First Intervention Period (8 Days)||0
350030|NCT02372097|860473|P2|COMPLETED|First Intervention Period (8 Days)||12
350031|NCT02372097|860474|P1|COMPLETED|First Intervention Period (8 Days)||12
350032|NCT02372097|860473|P2|STARTED|First Intervention Period (8 Days)||12
350033|NCT02372097|860474|P1|STARTED|First Intervention Period (8 Days)||12
350034|NCT02372071|860500|P1|NOT COMPLETED|Overall Study||18
350035|NCT02372071|860500|P1|COMPLETED|Overall Study||93
350036|NCT02372071|860500|P1|STARTED|Overall Study||111
350037|NCT02372058|860505|P1|NOT COMPLETED|Overall Study||3
350038|NCT02372058|860505|P1|COMPLETED|Overall Study||100
350039|NCT02372058|860505|P1|STARTED|Overall Study||103
350040|NCT02371876|860511|P1|NOT COMPLETED|Overall Study||0
350041|NCT02371876|860511|P1|COMPLETED|Overall Study||134
350042|NCT02371876|860511|P1|STARTED|Overall Study||134
350043|NCT02371850|860521|P1|NOT COMPLETED|Overall Study||0
350044|NCT02371850|860521|P1|COMPLETED|Overall Study||10
350045|NCT02371850|860521|P1|STARTED|Overall Study||10
350046|NCT02371759|860534|P8|NOT COMPLETED|Overall Study||4
350047|NCT02371759|860535|P7|NOT COMPLETED|Overall Study||0
350048|NCT02371759|860536|P6|NOT COMPLETED|Overall Study||1
350049|NCT02371759|860537|P5|NOT COMPLETED|Overall Study||3
350050|NCT02371759|860538|P4|NOT COMPLETED|Overall Study||0
350051|NCT02371759|860539|P3|NOT COMPLETED|Overall Study||1
350052|NCT02371759|860540|P2|NOT COMPLETED|Overall Study||1
350053|NCT02371759|860541|P1|NOT COMPLETED|Overall Study||3
350054|NCT02371759|860534|P8|COMPLETED|Overall Study||24
350055|NCT02371759|860535|P7|COMPLETED|Overall Study||25
350056|NCT02371759|860536|P6|COMPLETED|Overall Study||25
350057|NCT02371759|860537|P5|COMPLETED|Overall Study||24
350058|NCT02371759|860538|P4|COMPLETED|Overall Study||31
350059|NCT02371759|860539|P3|COMPLETED|Overall Study||32
350060|NCT02371759|860540|P2|COMPLETED|Overall Study||30
350061|NCT02371759|860541|P1|COMPLETED|Overall Study||29
350062|NCT02371759|860534|P8|STARTED|Overall Study||28
350063|NCT02371759|860535|P7|STARTED|Overall Study||25
350064|NCT02371759|860536|P6|STARTED|Overall Study||26
350065|NCT02371759|860537|P5|STARTED|Overall Study||27
350066|NCT02371759|860538|P4|STARTED|Overall Study||31
350067|NCT02371759|860539|P3|STARTED|Overall Study||33
350068|NCT02371759|860540|P2|STARTED|Overall Study||31
350069|NCT02371759|860541|P1|STARTED|Overall Study||32
350070|NCT02371616|860753|P2|NOT COMPLETED|Overall Study||7
350071|NCT02371616|860754|P1|NOT COMPLETED|Overall Study||4
350072|NCT02371616|860753|P2|COMPLETED|Overall Study||147
350073|NCT02371616|860754|P1|COMPLETED|Overall Study||146
350074|NCT02371616|860753|P2|STARTED|Overall Study||154
350075|NCT02371616|860754|P1|STARTED|Overall Study||150
350076|NCT02370914|860766|P1|NOT COMPLETED|Overall Study||2
350077|NCT02370914|860766|P1|COMPLETED|Overall Study||82
350078|NCT02370914|860766|P1|STARTED|Overall Study||84
350079|NCT02370667|860773|P3|NOT COMPLETED|Overall Study||0
350080|NCT02370667|860774|P2|NOT COMPLETED|Overall Study||1
350081|NCT02370667|860775|P1|NOT COMPLETED|Overall Study||0
350082|NCT02370667|860773|P3|COMPLETED|Overall Study||10
350083|NCT02370667|860774|P2|COMPLETED|Overall Study||10
350084|NCT02370667|860775|P1|COMPLETED|Overall Study||10
350085|NCT02370667|860773|P3|STARTED|Overall Study||10
350086|NCT02370667|860774|P2|STARTED|Overall Study||11
350087|NCT02370667|860775|P1|STARTED|Overall Study||10
350088|NCT02370615|860839|P2|NOT COMPLETED|Overall Study||0
350089|NCT02370615|860840|P1|NOT COMPLETED|Overall Study||1
350090|NCT02370615|860839|P2|COMPLETED|Overall Study||18
350091|NCT02370615|860840|P1|COMPLETED|Overall Study||15
350092|NCT02370615|860839|P2|STARTED|Overall Study||18
350093|NCT02370615|860840|P1|STARTED|Overall Study||16
350094|NCT02370602|860883|P6|NOT COMPLETED|Overall Study||0
350095|NCT02370602|860884|P5|NOT COMPLETED|Overall Study||0
350096|NCT02370602|860885|P4|NOT COMPLETED|Overall Study||0
350097|NCT02370602|860886|P3|NOT COMPLETED|Overall Study||0
350098|NCT02370602|860887|P2|NOT COMPLETED|Overall Study||0
350099|NCT02370602|860888|P1|NOT COMPLETED|Overall Study||1
350100|NCT02370602|860883|P6|COMPLETED|Overall Study||2
350101|NCT02370602|860884|P5|COMPLETED|Overall Study||3
350102|NCT02370602|860885|P4|COMPLETED|Overall Study||3
350103|NCT02370602|860886|P3|COMPLETED|Overall Study||2
350104|NCT02370602|860887|P2|COMPLETED|Overall Study||2
350105|NCT02370602|860888|P1|COMPLETED|Overall Study||0
350106|NCT02370602|860883|P6|STARTED|Overall Study||2
350107|NCT02370602|860884|P5|STARTED|Overall Study||3
350108|NCT02370602|860885|P4|STARTED|Overall Study||3
350109|NCT02370602|860886|P3|STARTED|Overall Study||2
350110|NCT02370602|860887|P2|STARTED|Overall Study||2
350111|NCT02370602|860888|P1|STARTED|Overall Study||1
350112|NCT02370537|860982|P3|NOT COMPLETED|Part B||259
350113|NCT02370537|860983|P2|NOT COMPLETED|Part B||3
350114|NCT02370537|860984|P1|NOT COMPLETED|Part B||1
350115|NCT02370537|860982|P3|COMPLETED|Part B||23
350116|NCT02370537|860983|P2|COMPLETED|Part B||12
350117|NCT02370537|860984|P1|COMPLETED|Part B||15
350118|NCT02370537|860982|P3|Period 2 Sequence BA|Part B||12
350119|NCT02370537|860983|P2|Period 2 Sequence BA|Part B||7
350120|NCT02370537|860984|P1|Period 2 Sequence BA|Part B||7
350121|NCT02370537|860982|P3|Period 2 Sequence AB|Part B||11
350122|NCT02370537|860983|P2|Period 2 Sequence AB|Part B||5
350123|NCT02370537|860984|P1|Period 2 Sequence AB|Part B||8
350124|NCT02370537|860982|P3|Period 1 Sequence BA|Part B||12
350125|NCT02370537|860983|P2|Period 1 Sequence BA|Part B||7
350126|NCT02370537|860984|P1|Period 1 Sequence BA|Part B||7
350127|NCT02370537|860982|P3|Period 1 Sequence AB|Part B||11
350128|NCT02370537|860983|P2|Period 1 Sequence AB|Part B||6
350129|NCT02370537|860984|P1|Period 1 Sequence AB|Part B||8
350130|NCT02370537|860982|P3|Eligible for Randomisation|Part B||23
350131|NCT02370537|860983|P2|Eligible for Randomisation|Part B||13
350132|NCT02370537|860984|P1|Eligible for Randomisation|Part B||15
350133|NCT02370537|860982|P3|STARTED|Part B||282
350134|NCT02370537|860983|P2|STARTED|Part B||15
350135|NCT02370537|860984|P1|STARTED|Part B||16
350136|NCT02370537|860982|P3|NOT COMPLETED|Part A (Open-label Recruitment)||1
350137|NCT02370537|860983|P2|NOT COMPLETED|Part A (Open-label Recruitment)||1
350138|NCT02370537|860984|P1|NOT COMPLETED|Part A (Open-label Recruitment)||0
350139|NCT02370537|860982|P3|COMPLETED|Part A (Open-label Recruitment)||282
350140|NCT02370537|860983|P2|COMPLETED|Part A (Open-label Recruitment)||15
350141|NCT02370537|860984|P1|COMPLETED|Part A (Open-label Recruitment)||16
350142|NCT02370537|860982|P3|STARTED|Part A (Open-label Recruitment)||283
350143|NCT02370537|860983|P2|STARTED|Part A (Open-label Recruitment)||16
350144|NCT02370537|860984|P1|STARTED|Part A (Open-label Recruitment)||16
350145|NCT02370420|861033|P2|NOT COMPLETED|Overall Study||12
350146|NCT02370420|861034|P1|NOT COMPLETED|Overall Study||14
350147|NCT02370420|861033|P2|COMPLETED|Overall Study||15
350148|NCT02370420|861034|P1|COMPLETED|Overall Study||15
350149|NCT02370420|861033|P2|STARTED|Overall Study||27
350150|NCT02370420|861034|P1|STARTED|Overall Study||29
350151|NCT02370407|861046|P2|NOT COMPLETED|Overall Study||0
350152|NCT02370407|861047|P1|NOT COMPLETED|Overall Study||0
350153|NCT02370407|861046|P2|COMPLETED|Overall Study||20
350154|NCT02370407|861047|P1|COMPLETED|Overall Study||20
350155|NCT02370407|861046|P2|STARTED|Overall Study||20
350156|NCT02370407|861047|P1|STARTED|Overall Study||20
350157|NCT02370394|861071|P2|NOT COMPLETED|Overall Study||2
350158|NCT02370394|861072|P1|NOT COMPLETED|Overall Study||2
350159|NCT02370394|861071|P2|COMPLETED|Overall Study||23
350160|NCT02370394|861072|P1|COMPLETED|Overall Study||26
350161|NCT02370394|861071|P2|STARTED|Overall Study||25
350162|NCT02370394|861072|P1|STARTED|Overall Study||28
350163|NCT02370121|861088|P2|NOT COMPLETED|Overall Study||1
350164|NCT02370121|861089|P1|NOT COMPLETED|Overall Study||1
350165|NCT02370121|861088|P2|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
350166|NCT02370121|861089|P1|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
350167|NCT02370121|861088|P2|STARTED|Overall Study||12
350168|NCT02370121|861089|P1|STARTED|Overall Study||12
350169|NCT02369848|861127|P1|NOT COMPLETED|Overall Study||4
350170|NCT02369848|861127|P1|COMPLETED|Overall Study||56
350171|NCT02369848|861127|P1|12 Month Primary Endpoint|Overall Study||30
350172|NCT02369848|861127|P1|30 Day Primary Safety Endpoint|Overall Study||58
350173|NCT02369848|861127|P1|STARTED|Overall Study||60
350174|NCT02369796|861146|P5|NOT COMPLETED|Overall Study||0
350175|NCT02369796|861147|P4|NOT COMPLETED|Overall Study||0
350176|NCT02369796|861148|P3|NOT COMPLETED|Overall Study||0
350177|NCT02369796|861149|P2|NOT COMPLETED|Overall Study||0
350178|NCT02369796|861150|P1|NOT COMPLETED|Overall Study||0
350179|NCT02369796|861146|P5|COMPLETED|Overall Study||3
350180|NCT02369796|861147|P4|COMPLETED|Overall Study||3
350181|NCT02369796|861148|P3|COMPLETED|Overall Study||3
350182|NCT02369796|861149|P2|COMPLETED|Overall Study||3
350183|NCT02369796|861150|P1|COMPLETED|Overall Study||3
350184|NCT02369796|861146|P5|STARTED|Overall Study||3
350185|NCT02369796|861147|P4|STARTED|Overall Study||3
350186|NCT02369796|861148|P3|STARTED|Overall Study||3
350187|NCT02369796|861149|P2|STARTED|Overall Study||3
350188|NCT02369796|861150|P1|STARTED|Overall Study||3
350189|NCT02369510|861192|P3|NOT COMPLETED|Overall Study||6
350190|NCT02369510|861193|P2|NOT COMPLETED|Overall Study||3
350191|NCT02369510|861194|P1|NOT COMPLETED|Overall Study||2
350192|NCT02369510|861192|P3|COMPLETED|Overall Study||17
350193|NCT02369510|861193|P2|COMPLETED|Overall Study||19
350194|NCT02369510|861194|P1|COMPLETED|Overall Study||21
350195|NCT02369510|861192|P3|STARTED|Overall Study||23
350196|NCT02369510|861193|P2|STARTED|Overall Study||22
350197|NCT02369510|861194|P1|STARTED|Overall Study||23
350198|NCT02369341|861225|P2|NOT COMPLETED|Overall Study||0
350199|NCT02369341|861226|P1|NOT COMPLETED|Overall Study||1
350200|NCT02369341|861225|P2|COMPLETED|Overall Study||57
350201|NCT02369341|861226|P1|COMPLETED|Overall Study||62
350202|NCT02369341|861225|P2|STARTED|Overall Study||57
350203|NCT02369341|861226|P1|STARTED|Overall Study||63
350204|NCT02368457|861282|P2|NOT COMPLETED|Overall Study||0
350205|NCT02368457|861283|P1|NOT COMPLETED|Overall Study||0
350206|NCT02368457|861282|P2|COMPLETED|Overall Study||12
350207|NCT02368457|861283|P1|COMPLETED|Overall Study||12
350208|NCT02368457|861282|P2|STARTED|Overall Study||12
350209|NCT02368457|861283|P1|STARTED|Overall Study||12
350210|NCT02368314|861293|P2|NOT COMPLETED|Overall Study||3
350211|NCT02368314|861294|P1|NOT COMPLETED|Overall Study||3
350212|NCT02368314|861293|P2|COMPLETED|Overall Study||57
350213|NCT02368314|861294|P1|COMPLETED|Overall Study||61
350214|NCT02368314|861293|P2|STARTED|Overall Study||60
350215|NCT02368314|861294|P1|STARTED|Overall Study||64
350216|NCT02368093|861306|P2|NOT COMPLETED|Overall Study||0
350217|NCT02368093|861307|P1|NOT COMPLETED|Overall Study||0
350218|NCT02368093|861306|P2|COMPLETED|Overall Study||24
350219|NCT02368093|861307|P1|COMPLETED|Overall Study||24
350220|NCT02368093|861306|P2|STARTED|Overall Study||24
350221|NCT02368093|861307|P1|STARTED|Overall Study||24
350222|NCT02367885|861316|P3|NOT COMPLETED|Overall Study||0
350223|NCT02367885|861317|P2|NOT COMPLETED|Overall Study||0
350224|NCT02367885|861318|P1|NOT COMPLETED|Overall Study||2
350225|NCT02367885|861316|P3|COMPLETED|Overall Study||33
350226|NCT02367885|861317|P2|COMPLETED|Overall Study||33
350227|NCT02367885|861318|P1|COMPLETED|Overall Study||31
350228|NCT02367885|861316|P3|STARTED|Overall Study||33
350229|NCT02367885|861317|P2|STARTED|Overall Study||33
350230|NCT02367885|861318|P1|STARTED|Overall Study||33
350231|NCT02367872|861391|P8|NOT COMPLETED|Overall Study||0
350232|NCT02367872|861392|P7|NOT COMPLETED|Overall Study||0
350233|NCT02367872|861393|P6|NOT COMPLETED|Overall Study||0
350234|NCT02367872|861394|P5|NOT COMPLETED|Overall Study||0
350235|NCT02367872|861395|P4|NOT COMPLETED|Overall Study||0
350236|NCT02367872|861396|P3|NOT COMPLETED|Overall Study||0
350237|NCT02367872|861397|P2|NOT COMPLETED|Overall Study||0
350238|NCT02367872|861398|P1|NOT COMPLETED|Overall Study||0
350239|NCT02367872|861391|P8|COMPLETED|Overall Study||6
350240|NCT02367872|861392|P7|COMPLETED|Overall Study||6
350241|NCT02367872|861393|P6|COMPLETED|Overall Study||6
350242|NCT02367872|861394|P5|COMPLETED|Overall Study||6
350243|NCT02367872|861395|P4|COMPLETED|Overall Study||6
350244|NCT02367872|861396|P3|COMPLETED|Overall Study||6
350245|NCT02367872|861397|P2|COMPLETED|Overall Study||6
350246|NCT02367872|861398|P1|COMPLETED|Overall Study||6
350247|NCT02367872|861391|P8|STARTED|Overall Study||6
350248|NCT02367872|861392|P7|STARTED|Overall Study||6
350249|NCT02367872|861393|P6|STARTED|Overall Study||6
350250|NCT02367872|861394|P5|STARTED|Overall Study||6
350251|NCT02367872|861395|P4|STARTED|Overall Study||6
350252|NCT02367872|861396|P3|STARTED|Overall Study||6
350253|NCT02367872|861397|P2|STARTED|Overall Study||6
350254|NCT02367872|861398|P1|STARTED|Overall Study||6
350255|NCT02367391|861553|P2|NOT COMPLETED|Overall Study||0
350256|NCT02367391|861554|P1|NOT COMPLETED|Overall Study||2
350257|NCT02367391|861553|P2|COMPLETED|Overall Study||76
350258|NCT02367391|861554|P1|COMPLETED|Overall Study||74
350259|NCT02367391|861553|P2|STARTED|Overall Study||76
350260|NCT02367391|861554|P1|STARTED|Overall Study||76
350261|NCT02367170|861574|P2|NOT COMPLETED|Overall Study||0
350262|NCT02367170|861575|P1|NOT COMPLETED|Overall Study||0
350263|NCT02367170|861574|P2|COMPLETED|Overall Study||0
350264|NCT02367170|861575|P1|COMPLETED|Overall Study||1
350265|NCT02367170|861574|P2|STARTED|Overall Study||0
350266|NCT02367170|861575|P1|STARTED|Overall Study||1
350267|NCT02367131|861585|P1|NOT COMPLETED|Overall Study||222
350268|NCT02367131|861585|P1|COMPLETED|Overall Study||201
350269|NCT02367131|861585|P1|STARTED|Overall Study|Started are the treated patients|423
350270|NCT02367066|861593|P2|NOT COMPLETED|Overall Study||0
350271|NCT02367066|861594|P1|NOT COMPLETED|Overall Study||0
350272|NCT02367066|861593|P2|COMPLETED|Overall Study||10
350273|NCT02367066|861594|P1|COMPLETED|Overall Study||10
350274|NCT02367066|861593|P2|STARTED|Overall Study||10
350275|NCT02367066|861594|P1|STARTED|Overall Study||10
350276|NCT02366936|861652|P1|NOT COMPLETED|Overall Study||8
350277|NCT02366936|861652|P1|COMPLETED|Overall Study||24
350278|NCT02366936|861652|P1|STARTED|Overall Study||32
350279|NCT02366923|861657|P1|NOT COMPLETED|Overall Study||6
350280|NCT02366923|861657|P1|COMPLETED|Overall Study||22
350281|NCT02366923|861657|P1|STARTED|Overall Study||28
350282|NCT02366910|861670|P1|NOT COMPLETED|Overall Study||5
350283|NCT02366910|861670|P1|COMPLETED|Overall Study||21
350284|NCT02366910|861670|P1|STARTED|Overall Study||26
350285|NCT02366767|861684|P2|NOT COMPLETED|Overall Study||0
350286|NCT02366767|861685|P1|NOT COMPLETED|Overall Study||1
350287|NCT02366767|861684|P2|COMPLETED|Overall Study||10
350288|NCT02366767|861685|P1|COMPLETED|Overall Study||10
350289|NCT02366767|861684|P2|STARTED|Overall Study||10
350290|NCT02366767|861685|P1|STARTED|Overall Study||11
350291|NCT02366689|861698|P3|NOT COMPLETED|Overall Study||2
350292|NCT02366689|861699|P2|NOT COMPLETED|Overall Study||3
350293|NCT02366689|861700|P1|NOT COMPLETED|Overall Study||4
350294|NCT02366689|861698|P3|COMPLETED|Overall Study||59
350295|NCT02366689|861699|P2|COMPLETED|Overall Study||55
350296|NCT02366689|861700|P1|COMPLETED|Overall Study||56
350297|NCT02366689|861698|P3|STARTED|Overall Study||61
350298|NCT02366689|861699|P2|STARTED|Overall Study||58
350299|NCT02366689|861700|P1|STARTED|Overall Study||60
350300|NCT02366663|861725|P2|NOT COMPLETED|Overall Study||0
350301|NCT02366663|861726|P1|NOT COMPLETED|Overall Study||0
350302|NCT02366663|861725|P2|COMPLETED|Overall Study||1
350303|NCT02366663|861726|P1|COMPLETED|Overall Study||2
350304|NCT02366663|861725|P2|STARTED|Overall Study||1
350305|NCT02366663|861726|P1|STARTED|Overall Study||2
350306|NCT02366637|861752|P2|NOT COMPLETED|Second Intervention Period||1
350307|NCT02366637|861753|P1|NOT COMPLETED|Second Intervention Period||1
350308|NCT02366637|861752|P2|COMPLETED|Second Intervention Period||0
350309|NCT02366637|861753|P1|COMPLETED|Second Intervention Period||0
350310|NCT02366637|861752|P2|STARTED|Second Intervention Period||1
350311|NCT02366637|861753|P1|STARTED|Second Intervention Period||1
350312|NCT02366637|861752|P2|NOT COMPLETED|Washout Period 28 to 49 Days||0
350313|NCT02366637|861753|P1|NOT COMPLETED|Washout Period 28 to 49 Days||0
350314|NCT02366637|861752|P2|COMPLETED|Washout Period 28 to 49 Days||1
350315|NCT02366637|861753|P1|COMPLETED|Washout Period 28 to 49 Days||1
350316|NCT02366637|861752|P2|STARTED|Washout Period 28 to 49 Days||1
350317|NCT02366637|861753|P1|STARTED|Washout Period 28 to 49 Days||1
350318|NCT02366637|861752|P2|NOT COMPLETED|First Intervention Period||5
350319|NCT02366637|861753|P1|NOT COMPLETED|First Intervention Period||6
350320|NCT02366637|861752|P2|COMPLETED|First Intervention Period||1
350321|NCT02366637|861753|P1|COMPLETED|First Intervention Period||1
350322|NCT02366637|861752|P2|STARTED|First Intervention Period||6
350323|NCT02366637|861753|P1|STARTED|First Intervention Period||7
350324|NCT02366338|861780|P3|NOT COMPLETED|Overall Study||0
350325|NCT02366338|861781|P2|NOT COMPLETED|Overall Study||0
350326|NCT02366338|861782|P1|NOT COMPLETED|Overall Study||0
350327|NCT02366338|861780|P3|COMPLETED|Overall Study||36
350328|NCT02366338|861781|P2|COMPLETED|Overall Study||39
350329|NCT02366338|861782|P1|COMPLETED|Overall Study||73
350330|NCT02366338|861780|P3|STARTED|Overall Study||36
350331|NCT02366338|861781|P2|STARTED|Overall Study||39
350332|NCT02366338|861782|P1|STARTED|Overall Study||73
350333|NCT02365714|861790|P1|NOT COMPLETED|Overall Study||0
350334|NCT02365714|861790|P1|COMPLETED|Overall Study||2
350335|NCT02365714|861790|P1|STARTED|Overall Study||2
350336|NCT02365688|861796|P1|NOT COMPLETED|Overall Study||0
350337|NCT02365688|861796|P1|COMPLETED|Overall Study|All subjects consented to an change in standard infusion volume pre-incision|18
350338|NCT02365688|861796|P1|STARTED|Overall Study|All subjects received a bolus of 500cc before first incision|18
350339|NCT02365519|861802|P3|NOT COMPLETED|Randomized and Treated||1
350340|NCT02365519|861803|P2|NOT COMPLETED|Randomized and Treated||2
350341|NCT02365519|861804|P1|NOT COMPLETED|Randomized and Treated||0
350342|NCT02365519|861802|P3|COMPLETED|Randomized and Treated||64
350343|NCT02365519|861803|P2|COMPLETED|Randomized and Treated||67
350344|NCT02365519|861804|P1|COMPLETED|Randomized and Treated||0
350345|NCT02365519|861802|P3|STARTED|Randomized and Treated||65
350346|NCT02365519|861803|P2|STARTED|Randomized and Treated||69
350347|NCT02365519|861804|P1|STARTED|Randomized and Treated||0
350348|NCT02365519|861802|P3|NOT COMPLETED|Vehicle Run-In||0
350349|NCT02365519|861803|P2|NOT COMPLETED|Vehicle Run-In||0
350350|NCT02365519|861804|P1|NOT COMPLETED|Vehicle Run-In||79
350351|NCT02365519|861802|P3|COMPLETED|Vehicle Run-In||0
350352|NCT02365519|861803|P2|COMPLETED|Vehicle Run-In||0
350353|NCT02365519|861804|P1|COMPLETED|Vehicle Run-In||134
350354|NCT02365519|861802|P3|STARTED|Vehicle Run-In||0
350355|NCT02365519|861803|P2|STARTED|Vehicle Run-In||0
350356|NCT02365519|861804|P1|STARTED|Vehicle Run-In||213
350357|NCT02365298|861825|P2|NOT COMPLETED|Period 2||2
350358|NCT02365298|861826|P1|NOT COMPLETED|Period 2||2
350359|NCT02365298|861825|P2|COMPLETED|Period 2||12
350360|NCT02365298|861826|P1|COMPLETED|Period 2||12
350361|NCT02365298|861825|P2|STARTED|Period 2||14
350362|NCT02365298|861826|P1|STARTED|Period 2||14
350363|NCT02365298|861825|P2|NOT COMPLETED|Period 1||0
350364|NCT02365298|861826|P1|NOT COMPLETED|Period 1||0
350365|NCT02365298|861825|P2|COMPLETED|Period 1||14
350366|NCT02365298|861826|P1|COMPLETED|Period 1||14
350367|NCT02365298|861825|P2|STARTED|Period 1||14
350368|NCT02365298|861826|P1|STARTED|Period 1||14
350369|NCT02364999|861844|P2|NOT COMPLETED|Overall Study||322
350370|NCT02364999|861845|P1|NOT COMPLETED|Overall Study||318
350371|NCT02364999|861844|P2|COMPLETED|Overall Study||39
350372|NCT02364999|861845|P1|COMPLETED|Overall Study||40
350373|NCT02364999|861844|P2|Received Treatment|Overall Study||358
350374|NCT02364999|861845|P1|Received Treatment|Overall Study||356
350375|NCT02364999|861844|P2|STARTED|Overall Study||361
350376|NCT02364999|861845|P1|STARTED|Overall Study||358
350377|NCT02364778|861854|P1|NOT COMPLETED|Overall Study||0
350378|NCT02364778|861854|P1|COMPLETED|Overall Study||30
350379|NCT02364778|861854|P1|STARTED|Overall Study||30
350380|NCT02364700|861866|P1|NOT COMPLETED|Overall Study||0
350381|NCT02364700|861866|P1|COMPLETED|Overall Study||12
350382|NCT02364700|861866|P1|STARTED|Overall Study||12
350383|NCT02364180|861875|P1|NOT COMPLETED|Overall Study||1
350384|NCT02364180|861875|P1|COMPLETED|Overall Study||10
350385|NCT02364180|861875|P1|STARTED|Overall Study||11
350386|NCT02363933|861879|P1|NOT COMPLETED|Overall Study||6
350387|NCT02363933|861879|P1|COMPLETED|Overall Study||2
350388|NCT02363933|861879|P1|STARTED|Overall Study||8
350389|NCT02363907|861884|P1|NOT COMPLETED|Overall Study||0
350390|NCT02363907|861884|P1|COMPLETED|Overall Study||30
350391|NCT02363907|861884|P1|STARTED|Overall Study||30
350392|NCT02363478|861888|P1|NOT COMPLETED|Overall Study||8
350393|NCT02363478|861888|P1|COMPLETED|Overall Study||22
350394|NCT02363478|861888|P1|STARTED|Overall Study||30
350395|NCT02363439|861895|P1|NOT COMPLETED|Overall Study||4
350396|NCT02363439|861895|P1|COMPLETED|Overall Study||1
350397|NCT02363439|861895|P1|STARTED|Overall Study||5
350398|NCT02363270|861901|P2|NOT COMPLETED|Overall Study||0
350399|NCT02363270|861902|P1|NOT COMPLETED|Overall Study||0
350400|NCT02363270|861901|P2|COMPLETED|Overall Study||24
350401|NCT02363270|861902|P1|COMPLETED|Overall Study||24
350402|NCT02363270|861901|P2|STARTED|Overall Study||24
350403|NCT02363270|861902|P1|STARTED|Overall Study||24
350404|NCT02362412|861908|P2|NOT COMPLETED|Treatment Period III||1
350405|NCT02362412|861909|P1|NOT COMPLETED|Treatment Period III||0
350406|NCT02362412|861908|P2|COMPLETED|Treatment Period III||10
350407|NCT02362412|861909|P1|COMPLETED|Treatment Period III||9
350408|NCT02362412|861908|P2|TREATED|Treatment Period III||11
350409|NCT02362412|861909|P1|TREATED|Treatment Period III||9
350410|NCT02362412|861908|P2|STARTED|Treatment Period III||11
350411|NCT02362412|861909|P1|STARTED|Treatment Period III||9
350412|NCT02362412|861908|P2|NOT COMPLETED|Treatment Period II||0
350413|NCT02362412|861909|P1|NOT COMPLETED|Treatment Period II||0
350414|NCT02362412|861908|P2|COMPLETED|Treatment Period II||11
350415|NCT02362412|861909|P1|COMPLETED|Treatment Period II||9
350416|NCT02362412|861908|P2|TREATED|Treatment Period II||11
350417|NCT02362412|861909|P1|TREATED|Treatment Period II||9
350418|NCT02362412|861908|P2|STARTED|Treatment Period II||11
350419|NCT02362412|861909|P1|STARTED|Treatment Period II||9
350420|NCT02362373|861935|P1|NOT COMPLETED|Overall Study||0
350421|NCT02362373|861935|P1|COMPLETED|Overall Study||20
350422|NCT02362373|861935|P1|STARTED|Overall Study||20
350423|NCT02362360|861943|P2|NOT COMPLETED|Period 2||0
350424|NCT02362360|861944|P1|NOT COMPLETED|Period 2||0
350425|NCT02362360|861943|P2|COMPLETED|Period 2||25
350426|NCT02362360|861944|P1|COMPLETED|Period 2||23
350427|NCT02362360|861943|P2|STARTED|Period 2||25
350428|NCT02362360|861944|P1|STARTED|Period 2||23
350429|NCT02362360|861943|P2|NOT COMPLETED|Period 1||1
350430|NCT02362360|861944|P1|NOT COMPLETED|Period 1||3
350431|NCT02362360|861943|P2|COMPLETED|Period 1||25
350432|NCT02362360|861944|P1|COMPLETED|Period 1||23
350433|NCT02362360|861943|P2|STARTED|Period 1||26
350434|NCT02362360|861944|P1|STARTED|Period 1||26
350435|NCT02362321|861952|P2|NOT COMPLETED|Overall Study||0
350436|NCT02362321|861953|P1|NOT COMPLETED|Overall Study||4
350437|NCT02362321|861952|P2|COMPLETED|Overall Study||10
350438|NCT02362321|861953|P1|COMPLETED|Overall Study||6
350439|NCT02362321|861952|P2|STARTED|Overall Study||10
350440|NCT02362321|861953|P1|STARTED|Overall Study||10
350441|NCT02361736|861961|P2|NOT COMPLETED|Overall Study||1
350442|NCT02361736|861962|P1|NOT COMPLETED|Overall Study||1
350443|NCT02361736|861961|P2|COMPLETED|Overall Study||59
350444|NCT02361736|861962|P1|COMPLETED|Overall Study||59
350445|NCT02361736|861961|P2|STARTED|Overall Study||60
350446|NCT02361736|861962|P1|STARTED|Overall Study||60
350447|NCT02361580|861982|P2|NOT COMPLETED|Overall Study||3
350448|NCT02361580|861983|P1|NOT COMPLETED|Overall Study||6
350449|NCT02361580|861982|P2|COMPLETED|Overall Study||0
350450|NCT02361580|861983|P1|COMPLETED|Overall Study||0
350451|NCT02361580|861982|P2|STARTED|Overall Study||3
350452|NCT02361580|861983|P1|STARTED|Overall Study||6
350453|NCT02360995|861996|P3|NOT COMPLETED|Overall Study||2
350454|NCT02360995|861997|P2|NOT COMPLETED|Overall Study||1
350455|NCT02360995|861998|P1|NOT COMPLETED|Overall Study||2
350456|NCT02360995|861996|P3|COMPLETED|Overall Study||41
350457|NCT02360995|861997|P2|COMPLETED|Overall Study||42
350458|NCT02360995|861998|P1|COMPLETED|Overall Study||41
350459|NCT02360995|861996|P3|STARTED|Overall Study||43
350460|NCT02360995|861997|P2|STARTED|Overall Study||43
350461|NCT02360995|861998|P1|STARTED|Overall Study||43
350462|NCT02360475|862025|P4|NOT COMPLETED|Overall Study||5
350463|NCT02360475|862026|P3|NOT COMPLETED|Overall Study||8
350464|NCT02360475|862027|P2|NOT COMPLETED|Overall Study||13
350465|NCT02360475|862028|P1|NOT COMPLETED|Overall Study||4
350466|NCT02360475|862025|P4|COMPLETED|Overall Study||120
350467|NCT02360475|862026|P3|COMPLETED|Overall Study||117
350468|NCT02360475|862027|P2|COMPLETED|Overall Study||111
350469|NCT02360475|862028|P1|COMPLETED|Overall Study||122
350470|NCT02360475|862025|P4|STARTED|Overall Study||125
350471|NCT02360475|862026|P3|STARTED|Overall Study||125
350472|NCT02360475|862027|P2|STARTED|Overall Study||124
350473|NCT02360475|862028|P1|STARTED|Overall Study||126
350474|NCT02360228|862089|P3|NOT COMPLETED|Overall Study||1
350475|NCT02360228|862090|P2|NOT COMPLETED|Overall Study||1
350476|NCT02360228|862091|P1|NOT COMPLETED|Overall Study||1
350477|NCT02360228|862089|P3|COMPLETED|Overall Study||7
350478|NCT02360228|862090|P2|COMPLETED|Overall Study||7
350479|NCT02360228|862091|P1|COMPLETED|Overall Study||8
350480|NCT02360228|862089|P3|STARTED|Overall Study||8
350481|NCT02360228|862090|P2|STARTED|Overall Study||8
350482|NCT02360228|862091|P1|STARTED|Overall Study||9
350483|NCT02360124|862120|P3|NOT COMPLETED|Overall Study||26
350484|NCT02360124|862121|P2|NOT COMPLETED|Overall Study||12
350485|NCT02360124|862122|P1|NOT COMPLETED|Overall Study||28
350486|NCT02360124|862120|P3|COMPLETED|Overall Study||82
350487|NCT02360124|862121|P2|COMPLETED|Overall Study||95
350488|NCT02360124|862122|P1|COMPLETED|Overall Study||80
350489|NCT02360124|862120|P3|STARTED|Overall Study||108
350490|NCT02360124|862121|P2|STARTED|Overall Study||107
350491|NCT02360124|862122|P1|STARTED|Overall Study||108
350492|NCT02360059|862135|P2|NOT COMPLETED|Overall Study||0
350493|NCT02360059|862136|P1|NOT COMPLETED|Overall Study||0
350494|NCT02360059|862135|P2|COMPLETED|Overall Study||0
350495|NCT02360059|862136|P1|COMPLETED|Overall Study||1
350496|NCT02360059|862135|P2|STARTED|Overall Study||0
350497|NCT02360059|862136|P1|STARTED|Overall Study||1
350498|NCT02359955|862144|P2|NOT COMPLETED|Overall Study||0
350499|NCT02359955|862145|P1|NOT COMPLETED|Overall Study||0
350500|NCT02359955|862144|P2|COMPLETED|Overall Study||10
350501|NCT02359955|862145|P1|COMPLETED|Overall Study||10
350502|NCT02359955|862144|P2|STARTED|Overall Study||10
350503|NCT02359955|862145|P1|STARTED|Overall Study||10
350504|NCT02359916|862168|P7|NOT COMPLETED|Overall Study||0
350505|NCT02359916|862169|P6|NOT COMPLETED|Overall Study||0
350506|NCT02359916|862170|P5|NOT COMPLETED|Overall Study||0
350507|NCT02359916|862171|P4|NOT COMPLETED|Overall Study||0
350508|NCT02359916|862172|P3|NOT COMPLETED|Overall Study||0
350509|NCT02359916|862173|P2|NOT COMPLETED|Overall Study||0
350510|NCT02359916|862174|P1|NOT COMPLETED|Overall Study||0
350511|NCT02359916|862168|P7|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
350512|NCT02359916|862169|P6|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
350513|NCT02359916|862170|P5|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
350514|NCT02359916|862171|P4|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
350515|NCT02359916|862172|P3|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
350516|NCT02359916|862173|P2|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
350517|NCT02359916|862174|P1|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
350518|NCT02359916|862168|P7|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
350519|NCT02359916|862169|P6|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
350520|NCT02359916|862170|P5|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
350521|NCT02359916|862171|P4|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
350522|NCT02359916|862172|P3|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
350523|NCT02359916|862173|P2|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
350524|NCT02359916|862174|P1|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
350525|NCT02359903|862196|P2|NOT COMPLETED|Overall Study||2
350526|NCT02359903|862197|P1|NOT COMPLETED|Overall Study||0
350527|NCT02359903|862196|P2|COMPLETED|Overall Study||43
350528|NCT02359903|862197|P1|COMPLETED|Overall Study||45
350529|NCT02359903|862196|P2|STARTED|Overall Study||45
350530|NCT02359903|862197|P1|STARTED|Overall Study||45
350531|NCT02359890|862205|P1|NOT COMPLETED|Overall Study||10
350532|NCT02359890|862205|P1|COMPLETED|Overall Study||155
350533|NCT02359890|862205|P1|Per-Protocol (PP) Population|Overall Study|Subjects part of mITT population who had undergone RF ablation.|155
350534|NCT02359890|862205|P1|mITT Population|Overall Study|Enrolled subjects who met the inclusion/exclusion criteria and had the study catheter inserted|155
350535|NCT02359890|862205|P1|Safety Population|Overall Study|Enrolled subjects who had the study catheter inserted|159
350536|NCT02359890|862205|P1|STARTED|Overall Study|Patients who enrolled in the study are those who signed informed consent forms.|165
350537|NCT02359877|862215|P4|NOT COMPLETED|Overall Study||3
350538|NCT02359877|862216|P3|NOT COMPLETED|Overall Study||0
350539|NCT02359877|862217|P2|NOT COMPLETED|Overall Study||0
350540|NCT02359877|862218|P1|NOT COMPLETED|Overall Study||1
350541|NCT02359877|862215|P4|COMPLETED|Overall Study||11
350542|NCT02359877|862216|P3|COMPLETED|Overall Study||6
350543|NCT02359877|862217|P2|COMPLETED|Overall Study||6
350544|NCT02359877|862218|P1|COMPLETED|Overall Study||33
350545|NCT02359877|862215|P4|STARTED|Overall Study||14
350546|NCT02359877|862216|P3|STARTED|Overall Study||6
350547|NCT02359877|862217|P2|STARTED|Overall Study||6
350548|NCT02359877|862218|P1|STARTED|Overall Study||34
350549|NCT02359851|862268|P1|NOT COMPLETED|Overall Study||2
350550|NCT02359851|862268|P1|COMPLETED|Overall Study||3
350551|NCT02359851|862268|P1|STARTED|Overall Study||5
350552|NCT02359435|862278|P2|NOT COMPLETED|Overall Study||4
350553|NCT02359435|862279|P1|NOT COMPLETED|Overall Study||4
350554|NCT02359435|862278|P2|COMPLETED|Overall Study||216
350555|NCT02359435|862279|P1|COMPLETED|Overall Study||216
350556|NCT02359435|862278|P2|STARTED|Overall Study||220
350557|NCT02359435|862279|P1|STARTED|Overall Study||220
350558|NCT02359305|862287|P2|NOT COMPLETED|Overall Study||0
350559|NCT02359305|862288|P1|NOT COMPLETED|Overall Study||0
350560|NCT02359305|862287|P2|COMPLETED|Overall Study||34
350561|NCT02359305|862288|P1|COMPLETED|Overall Study||34
350562|NCT02359305|862287|P2|STARTED|Overall Study||34
350563|NCT02359305|862288|P1|STARTED|Overall Study||34
350564|NCT02359110|862300|P2|NOT COMPLETED|Overall Study||0
350565|NCT02359110|862301|P1|NOT COMPLETED|Overall Study||0
350566|NCT02359110|862300|P2|COMPLETED|Overall Study||54
350567|NCT02359110|862301|P1|COMPLETED|Overall Study||55
350568|NCT02359110|862300|P2|STARTED|Overall Study||54
350569|NCT02359110|862301|P1|STARTED|Overall Study||55
350570|NCT02359058|862314|P3|NOT COMPLETED|Overall Study||0
350571|NCT02359058|862315|P2|NOT COMPLETED|Overall Study||0
350572|NCT02359058|862316|P1|NOT COMPLETED|Overall Study||0
350573|NCT02359058|862314|P3|COMPLETED|Overall Study||6
350574|NCT02359058|862315|P2|COMPLETED|Overall Study||6
350575|NCT02359058|862316|P1|COMPLETED|Overall Study||6
350576|NCT02359058|862314|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
350577|NCT02359058|862315|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
350578|NCT02359058|862316|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
350579|NCT02359058|862314|P3|STARTED|Overall Study||6
350580|NCT02359058|862315|P2|STARTED|Overall Study||6
350581|NCT02359058|862316|P1|STARTED|Overall Study||6
350582|NCT02359045|862339|P2|NOT COMPLETED|Overall Study||3
350583|NCT02359045|862340|P1|NOT COMPLETED|Overall Study||4
350584|NCT02359045|862339|P2|COMPLETED|Overall Study||39
350585|NCT02359045|862340|P1|COMPLETED|Overall Study||36
350586|NCT02359045|862339|P2|STARTED|Overall Study||42
350587|NCT02359045|862340|P1|STARTED|Overall Study||40
350588|NCT02358876|862573|P1|NOT COMPLETED|Overall Study||2
350589|NCT02358876|862573|P1|COMPLETED|Overall Study|All 32 participants completed the in-clinic portion and 30 out of the 32 completed the home portion.|30
350590|NCT02358876|862573|P1|STARTED|Overall Study||32
350591|NCT02358863|862577|P1|NOT COMPLETED|Overall Study||3
350592|NCT02358863|862577|P1|COMPLETED|Overall Study||10
350593|NCT02358863|862577|P1|STARTED|Overall Study||13
350594|NCT02358668|862584|P3|NOT COMPLETED|Overall Study||0
350595|NCT02358668|862585|P2|NOT COMPLETED|Overall Study||1
350596|NCT02358668|862586|P1|NOT COMPLETED|Overall Study||2
350597|NCT02358668|862584|P3|COMPLETED|Overall Study||12
350598|NCT02358668|862585|P2|COMPLETED|Overall Study||23
350599|NCT02358668|862586|P1|COMPLETED|Overall Study||22
350600|NCT02358668|862584|P3|STARTED|Overall Study||12
350601|NCT02358668|862585|P2|STARTED|Overall Study||24
350602|NCT02358668|862586|P1|STARTED|Overall Study||24
350603|NCT02358044|862728|P2|NOT COMPLETED|Overall Study||7
350604|NCT02358044|862729|P1|NOT COMPLETED|Overall Study||2
350605|NCT02358044|862728|P2|COMPLETED|Overall Study|Completed = Completed Follow-up Week 24 (end of study)|121
350606|NCT02358044|862729|P1|COMPLETED|Overall Study|Completed = Completed Follow-up Week 24 (end of study)|127
350607|NCT02358044|862728|P2|Treated|Overall Study||126
350608|NCT02358044|862729|P1|Treated|Overall Study||129
350609|NCT02358044|862728|P2|STARTED|Overall Study||128
350610|NCT02358044|862729|P1|STARTED|Overall Study||129
350611|NCT02357940|862747|P2|NOT COMPLETED|Overall Study||2
350612|NCT02357940|862748|P1|NOT COMPLETED|Overall Study||0
350613|NCT02357940|862747|P2|COMPLETED|Overall Study||30
350614|NCT02357940|862748|P1|COMPLETED|Overall Study||9
350615|NCT02357940|862747|P2|STARTED|Overall Study||32
350616|NCT02357940|862748|P1|STARTED|Overall Study||9
350617|NCT02357901|862875|P4|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||66
350618|NCT02357901|862876|P3|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||72
350619|NCT02357901|862877|P2|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||78
350620|NCT02357901|862878|P1|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||0
350621|NCT02357901|862875|P4|COMPLETED|Treatment Period (Day 1 to Week 24)||34
350622|NCT02357901|862876|P3|COMPLETED|Treatment Period (Day 1 to Week 24)||129
350623|NCT02357901|862877|P2|COMPLETED|Treatment Period (Day 1 to Week 24)||125
350624|NCT02357901|862878|P1|COMPLETED|Treatment Period (Day 1 to Week 24)||0
350625|NCT02357901|862875|P4|Full Analysis Set|Treatment Period (Day 1 to Week 24)||99
350626|NCT02357901|862876|P3|Full Analysis Set|Treatment Period (Day 1 to Week 24)||196
350627|NCT02357901|862877|P2|Full Analysis Set|Treatment Period (Day 1 to Week 24)||194
350628|NCT02357901|862878|P1|Full Analysis Set|Treatment Period (Day 1 to Week 24)||0
350629|NCT02357901|862875|P4|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||100
350630|NCT02357901|862876|P3|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||201
350631|NCT02357901|862877|P2|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||203
350632|NCT02357901|862878|P1|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||0
350633|NCT02357901|862875|P4|STARTED|Treatment Period (Day 1 to Week 24)||100
350634|NCT02357901|862876|P3|STARTED|Treatment Period (Day 1 to Week 24)||201
350635|NCT02357901|862877|P2|STARTED|Treatment Period (Day 1 to Week 24)||203
350636|NCT02357901|862878|P1|STARTED|Treatment Period (Day 1 to Week 24)||0
350637|NCT02357901|862875|P4|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
350638|NCT02357901|862876|P3|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
350639|NCT02357901|862877|P2|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
350640|NCT02357901|862878|P1|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||161
350641|NCT02357901|862875|P4|COMPLETED|Run-In Period (Days -14 to Day -1)||0
350642|NCT02357901|862876|P3|COMPLETED|Run-In Period (Days -14 to Day -1)||0
350643|NCT02357901|862877|P2|COMPLETED|Run-In Period (Days -14 to Day -1)||0
350644|NCT02357901|862878|P1|COMPLETED|Run-In Period (Days -14 to Day -1)||504
350645|NCT02357901|862875|P4|STARTED|Run-In Period (Days -14 to Day -1)||0
350646|NCT02357901|862876|P3|STARTED|Run-In Period (Days -14 to Day -1)||0
350647|NCT02357901|862877|P2|STARTED|Run-In Period (Days -14 to Day -1)||0
350648|NCT02357901|862878|P1|STARTED|Run-In Period (Days -14 to Day -1)|Received at least one dose of SUBOXONE sublingual film.|665
350649|NCT02357485|862928|P1|NOT COMPLETED|Overall Study||0
350650|NCT02357485|862928|P1|COMPLETED|Overall Study||6
350651|NCT02357485|862928|P1|STARTED|Overall Study|6 subjects, 8 knees ( 2 bilateral & 4 unilateral)|6
350652|NCT02357459|862939|P3|NOT COMPLETED|Overall Study||12
350653|NCT02357459|862940|P2|NOT COMPLETED|Overall Study||14
350654|NCT02357459|862941|P1|NOT COMPLETED|Overall Study||17
350655|NCT02357459|862939|P3|COMPLETED|Overall Study||150
350656|NCT02357459|862940|P2|COMPLETED|Overall Study||149
350657|NCT02357459|862941|P1|COMPLETED|Overall Study||144
350658|NCT02357459|862939|P3|STARTED|Overall Study||162
350659|NCT02357459|862940|P2|STARTED|Overall Study||163
350660|NCT02357459|862941|P1|STARTED|Overall Study||161
350661|NCT02357342|862985|P2|NOT COMPLETED|Extension Study||0
350662|NCT02357342|862986|P1|NOT COMPLETED|Extension Study||0
350663|NCT02357342|862985|P2|COMPLETED|Extension Study||9
350664|NCT02357342|862986|P1|COMPLETED|Extension Study||4
350665|NCT02357342|862985|P2|STARTED|Extension Study||9
350666|NCT02357342|862986|P1|STARTED|Extension Study||4
350667|NCT02357342|862985|P2|NOT COMPLETED|First 6 Months||0
350668|NCT02357342|862986|P1|NOT COMPLETED|First 6 Months||2
350669|NCT02357342|862985|P2|COMPLETED|First 6 Months||20
350670|NCT02357342|862986|P1|COMPLETED|First 6 Months|2 patients died. Neither deaths were study drug related.|18
350671|NCT02357342|862985|P2|STARTED|First 6 Months||20
350672|NCT02357342|862986|P1|STARTED|First 6 Months||20
350673|NCT02357264|862998|P2|NOT COMPLETED|Overall Study||0
350674|NCT02357264|862999|P1|NOT COMPLETED|Overall Study||0
350675|NCT02357264|862998|P2|COMPLETED|Overall Study||130
350676|NCT02357264|862999|P1|COMPLETED|Overall Study||56
350677|NCT02357264|862998|P2|STARTED|Overall Study||130
350678|NCT02357264|862999|P1|STARTED|Overall Study||56
350679|NCT02357173|863008|P3|NOT COMPLETED|Overall Study||6
350680|NCT02357173|863009|P2|NOT COMPLETED|Overall Study||6
350681|NCT02357173|863010|P1|NOT COMPLETED|Overall Study||6
350682|NCT02357173|863008|P3|COMPLETED|Overall Study||16
350683|NCT02357173|863009|P2|COMPLETED|Overall Study||15
350684|NCT02357173|863010|P1|COMPLETED|Overall Study||19
350685|NCT02357173|863008|P3|STARTED|Overall Study||22
350686|NCT02357173|863009|P2|STARTED|Overall Study||21
350687|NCT02357173|863010|P1|STARTED|Overall Study||25
350688|NCT02356900|863029|P2|NOT COMPLETED|Overall Study||0
350689|NCT02356900|863030|P1|NOT COMPLETED|Overall Study||0
350690|NCT02356900|863029|P2|COMPLETED|Overall Study||10
350691|NCT02356900|863030|P1|COMPLETED|Overall Study||11
350692|NCT02356900|863029|P2|STARTED|Overall Study||10
350693|NCT02356900|863030|P1|STARTED|Overall Study||11
350694|NCT02356783|863050|P2|NOT COMPLETED|Overall Study||3
350695|NCT02356783|863051|P1|NOT COMPLETED|Overall Study||1
350696|NCT02356783|863050|P2|COMPLETED|Overall Study||14
350697|NCT02356783|863051|P1|COMPLETED|Overall Study||15
350698|NCT02356783|863050|P2|STARTED|Overall Study||17
350699|NCT02356783|863051|P1|STARTED|Overall Study||16
350700|NCT02356588|863061|P2|NOT COMPLETED|Overall Study||13
350701|NCT02356588|863062|P1|NOT COMPLETED|Overall Study||5
350702|NCT02356588|863061|P2|COMPLETED|Overall Study||41
350703|NCT02356588|863062|P1|COMPLETED|Overall Study||102
350704|NCT02356588|863061|P2|STARTED|Overall Study||54
350705|NCT02356588|863062|P1|STARTED|Overall Study||107
350706|NCT02356562|863096|P2|NOT COMPLETED|Overall Study||1
350707|NCT02356562|863097|P1|NOT COMPLETED|Overall Study||2
350708|NCT02356562|863096|P2|COMPLETED|Overall Study||6
350709|NCT02356562|863097|P1|COMPLETED|Overall Study||20
350710|NCT02356562|863096|P2|STARTED|Overall Study||7
350711|NCT02356562|863097|P1|STARTED|Overall Study||22
350712|NCT02356107|863107|P1|NOT COMPLETED|Overall Study||3
350713|NCT02356107|863107|P1|COMPLETED|Overall Study||12
350714|NCT02356107|863107|P1|STARTED|Overall Study||15
350715|NCT02355977|863114|P3|NOT COMPLETED|Overall Study||0
350716|NCT02355977|863115|P2|NOT COMPLETED|Overall Study||0
350717|NCT02355977|863116|P1|NOT COMPLETED|Overall Study||0
350718|NCT02355977|863114|P3|COMPLETED|Overall Study||23
350719|NCT02355977|863115|P2|COMPLETED|Overall Study||26
350720|NCT02355977|863116|P1|COMPLETED|Overall Study||21
350721|NCT02355977|863114|P3|STARTED|Overall Study||23
350722|NCT02355977|863115|P2|STARTED|Overall Study||26
350723|NCT02355977|863116|P1|STARTED|Overall Study||21
350724|NCT02355743|863130|P1|NOT COMPLETED|Overall Study||2
350725|NCT02355743|863130|P1|COMPLETED|Overall Study||6
350726|NCT02355743|863130|P1|STARTED|Overall Study||8
350727|NCT02355691|863138|P2|NOT COMPLETED|Overall Study||9
350728|NCT02355691|863139|P1|NOT COMPLETED|Overall Study||7
350729|NCT02355691|863138|P2|COMPLETED|Overall Study||0
350730|NCT02355691|863139|P1|COMPLETED|Overall Study||0
350731|NCT02355691|863138|P2|2nd Postop Visit|Overall Study||9
350732|NCT02355691|863139|P1|2nd Postop Visit|Overall Study||7
350733|NCT02355691|863138|P2|1st Postop Visit|Overall Study||9
350734|NCT02355691|863139|P1|1st Postop Visit|Overall Study||7
350735|NCT02355691|863138|P2|STARTED|Overall Study||9
350736|NCT02355691|863139|P1|STARTED|Overall Study||7
350737|NCT02355275|863147|P1|NOT COMPLETED|Overall Study||8
350738|NCT02355275|863147|P1|COMPLETED|Overall Study||14
350739|NCT02355275|863147|P1|STARTED|Overall Study||22
350740|NCT02355158|863152|P1|NOT COMPLETED|Overall Study||150
350741|NCT02355158|863152|P1|COMPLETED|Overall Study||47
350742|NCT02355158|863152|P1|STARTED|Overall Study||197
350743|NCT02355028|863158|P2|NOT COMPLETED|Overall Study||5
350744|NCT02355028|863159|P1|NOT COMPLETED|Overall Study||11
350745|NCT02355028|863158|P2|COMPLETED|Overall Study||41
350746|NCT02355028|863159|P1|COMPLETED|Overall Study||36
350747|NCT02355028|863158|P2|Treated|Overall Study||45
350748|NCT02355028|863159|P1|Treated|Overall Study||46
350749|NCT02355028|863158|P2|STARTED|Overall Study||46
350750|NCT02355028|863159|P1|STARTED|Overall Study||47
350751|NCT02354924|863194|P2|NOT COMPLETED|Overall Study||0
350752|NCT02354924|863195|P1|NOT COMPLETED|Overall Study||0
350753|NCT02354924|863194|P2|COMPLETED|Overall Study||20
350754|NCT02354924|863195|P1|COMPLETED|Overall Study||40
350755|NCT02354924|863194|P2|STARTED|Overall Study||20
350756|NCT02354924|863195|P1|STARTED|Overall Study||40
350757|NCT02354833|863207|P2|NOT COMPLETED|Overall Study||0
350758|NCT02354833|863208|P1|NOT COMPLETED|Overall Study||0
350759|NCT02354833|863207|P2|COMPLETED|Overall Study||43
350760|NCT02354833|863208|P1|COMPLETED|Overall Study||38
350761|NCT02354833|863207|P2|STARTED|Overall Study||43
350762|NCT02354833|863208|P1|STARTED|Overall Study||38
350763|NCT02354599|863226|P6|NOT COMPLETED|Overall Study||1
350764|NCT02354599|863227|P5|NOT COMPLETED|Overall Study||0
350765|NCT02354599|863228|P4|NOT COMPLETED|Overall Study||0
350766|NCT02354599|863229|P3|NOT COMPLETED|Overall Study||0
350767|NCT02354599|863230|P2|NOT COMPLETED|Overall Study||1
350768|NCT02354599|863231|P1|NOT COMPLETED|Overall Study||1
350769|NCT02354599|863226|P6|COMPLETED|Overall Study||5
350770|NCT02354599|863227|P5|COMPLETED|Overall Study||2
350771|NCT02354599|863228|P4|COMPLETED|Overall Study||6
350772|NCT02354599|863229|P3|COMPLETED|Overall Study||6
350773|NCT02354599|863230|P2|COMPLETED|Overall Study||5
350774|NCT02354599|863231|P1|COMPLETED|Overall Study||5
350775|NCT02354599|863226|P6|STARTED|Overall Study||6
350776|NCT02354599|863227|P5|STARTED|Overall Study||2
350777|NCT02354599|863228|P4|STARTED|Overall Study||6
350778|NCT02354599|863229|P3|STARTED|Overall Study||6
350779|NCT02354599|863230|P2|STARTED|Overall Study||6
350780|NCT02354599|863231|P1|STARTED|Overall Study||6
350781|NCT02353871|863303|P2|NOT COMPLETED|Overall Study||9
350782|NCT02353871|863304|P1|NOT COMPLETED|Overall Study||3
350783|NCT02353871|863303|P2|COMPLETED|Overall Study||51
350784|NCT02353871|863304|P1|COMPLETED|Overall Study||122
350785|NCT02353871|863303|P2|STARTED|Overall Study|Randomised. Included a subject who was randomised by mistake (excluded from mITT population).|60
350786|NCT02353871|863304|P1|STARTED|Overall Study|Randomised.|125
350787|NCT02353754|863326|P2|NOT COMPLETED|Overall Study||0
350788|NCT02353754|863327|P1|NOT COMPLETED|Overall Study||2
350789|NCT02353754|863326|P2|COMPLETED|Overall Study||0
350790|NCT02353754|863327|P1|COMPLETED|Overall Study||10
350791|NCT02353754|863326|P2|STARTED|Overall Study||0
350792|NCT02353754|863327|P1|STARTED|Overall Study||12
350793|NCT02353572|863337|P1|NOT COMPLETED|Overall Study||3
350794|NCT02353572|863337|P1|COMPLETED|Overall Study||0
350795|NCT02353572|863337|P1|STARTED|Overall Study||3
350796|NCT02353468|863341|P1|NOT COMPLETED|Overall Study||3
350797|NCT02353468|863341|P1|COMPLETED|Overall Study||0
350798|NCT02353468|863341|P1|STARTED|Overall Study||3
350799|NCT02353442|863347|P2|NOT COMPLETED|Overall Study||4
350800|NCT02353442|863348|P1|NOT COMPLETED|Overall Study||3
350801|NCT02353442|863347|P2|COMPLETED|Overall Study||27
350802|NCT02353442|863348|P1|COMPLETED|Overall Study||25
350803|NCT02353442|863347|P2|STARTED|Overall Study||31
350804|NCT02353442|863348|P1|STARTED|Overall Study||28
350805|NCT02353299|863362|P4|NOT COMPLETED|Fourth Intervention (1 Night)||0
350806|NCT02353299|863363|P3|NOT COMPLETED|Fourth Intervention (1 Night)||0
350807|NCT02353299|863364|P2|NOT COMPLETED|Fourth Intervention (1 Night)||0
350808|NCT02353299|863365|P1|NOT COMPLETED|Fourth Intervention (1 Night)||0
350809|NCT02353299|863362|P4|COMPLETED|Fourth Intervention (1 Night)||13
350810|NCT02353299|863363|P3|COMPLETED|Fourth Intervention (1 Night)||13
350811|NCT02353299|863364|P2|COMPLETED|Fourth Intervention (1 Night)||12
350812|NCT02353299|863365|P1|COMPLETED|Fourth Intervention (1 Night)||13
350813|NCT02353299|863362|P4|STARTED|Fourth Intervention (1 Night)||13
350814|NCT02353299|863363|P3|STARTED|Fourth Intervention (1 Night)||13
350815|NCT02353299|863364|P2|STARTED|Fourth Intervention (1 Night)|One patient withdrawn from study prior to start of fourth intervention.|12
350816|NCT02353299|863365|P1|STARTED|Fourth Intervention (1 Night)||13
350817|NCT02353299|863362|P4|NOT COMPLETED|Third Intervention (1 Night)||0
350818|NCT02353299|863363|P3|NOT COMPLETED|Third Intervention (1 Night)||0
350819|NCT02353299|863364|P2|NOT COMPLETED|Third Intervention (1 Night)||0
350820|NCT02353299|863365|P1|NOT COMPLETED|Third Intervention (1 Night)||0
350821|NCT02353299|863362|P4|COMPLETED|Third Intervention (1 Night)||13
350822|NCT02353299|863363|P3|COMPLETED|Third Intervention (1 Night)||13
350823|NCT02353299|863364|P2|COMPLETED|Third Intervention (1 Night)||13
350824|NCT02353299|863365|P1|COMPLETED|Third Intervention (1 Night)||13
350825|NCT02353299|863362|P4|STARTED|Third Intervention (1 Night)||13
350826|NCT02353299|863363|P3|STARTED|Third Intervention (1 Night)||13
350827|NCT02353299|863364|P2|STARTED|Third Intervention (1 Night)||13
350828|NCT02353299|863365|P1|STARTED|Third Intervention (1 Night)||13
350829|NCT02353299|863362|P4|NOT COMPLETED|Second Intervention (1 Night)||0
350830|NCT02353299|863363|P3|NOT COMPLETED|Second Intervention (1 Night)||0
350831|NCT02353299|863364|P2|NOT COMPLETED|Second Intervention (1 Night)||0
350832|NCT02353299|863365|P1|NOT COMPLETED|Second Intervention (1 Night)||0
350833|NCT02353299|863362|P4|COMPLETED|Second Intervention (1 Night)||13
350834|NCT02353299|863363|P3|COMPLETED|Second Intervention (1 Night)||13
350835|NCT02353299|863364|P2|COMPLETED|Second Intervention (1 Night)||13
350836|NCT02353299|863365|P1|COMPLETED|Second Intervention (1 Night)||13
350837|NCT02353299|863362|P4|STARTED|Second Intervention (1 Night)||13
350838|NCT02353299|863363|P3|STARTED|Second Intervention (1 Night)||13
350839|NCT02353299|863364|P2|STARTED|Second Intervention (1 Night)||13
350840|NCT02353299|863365|P1|STARTED|Second Intervention (1 Night)||13
350841|NCT02353299|863362|P4|NOT COMPLETED|First Intervention (1 Night)||0
350842|NCT02353299|863363|P3|NOT COMPLETED|First Intervention (1 Night)||0
350843|NCT02353299|863364|P2|NOT COMPLETED|First Intervention (1 Night)||0
350844|NCT02353299|863365|P1|NOT COMPLETED|First Intervention (1 Night)||0
350845|NCT02353299|863362|P4|COMPLETED|First Intervention (1 Night)||13
350846|NCT02353299|863363|P3|COMPLETED|First Intervention (1 Night)||13
350847|NCT02353299|863364|P2|COMPLETED|First Intervention (1 Night)||13
350848|NCT02353299|863365|P1|COMPLETED|First Intervention (1 Night)||13
350849|NCT02353299|863362|P4|STARTED|First Intervention (1 Night)||13
350850|NCT02353299|863363|P3|STARTED|First Intervention (1 Night)||13
350851|NCT02353299|863364|P2|STARTED|First Intervention (1 Night)||13
350852|NCT02353299|863365|P1|STARTED|First Intervention (1 Night)||13
350853|NCT02352779|863402|P3|NOT COMPLETED|Overall Study||2
350854|NCT02352779|863403|P2|NOT COMPLETED|Overall Study||1
350855|NCT02352779|863404|P1|NOT COMPLETED|Overall Study||8
350856|NCT02352779|863402|P3|COMPLETED|Overall Study||33
350857|NCT02352779|863403|P2|COMPLETED|Overall Study||35
350858|NCT02352779|863404|P1|COMPLETED|Overall Study||29
350859|NCT02352779|863402|P3|STARTED|Overall Study||35
350860|NCT02352779|863403|P2|STARTED|Overall Study||36
350861|NCT02352779|863404|P1|STARTED|Overall Study||37
350862|NCT02352298|863412|P1|NOT COMPLETED|Overall Study||0
350863|NCT02352298|863412|P1|COMPLETED|Overall Study||52
350864|NCT02352298|863412|P1|STARTED|Overall Study||52
350865|NCT02351960|863419|P2|NOT COMPLETED|Overall Study||12
350866|NCT02351960|863420|P1|NOT COMPLETED|Overall Study||11
350867|NCT02351960|863419|P2|COMPLETED|Overall Study||76
350868|NCT02351960|863420|P1|COMPLETED|Overall Study||197
350869|NCT02351960|863419|P2|STARTED|Overall Study||88
350870|NCT02351960|863420|P1|STARTED|Overall Study||208
350871|NCT02351934|863441|P2|NOT COMPLETED|Follow-Up||10
350872|NCT02351934|863442|P1|NOT COMPLETED|Follow-Up||12
350873|NCT02351934|863441|P2|COMPLETED|Follow-Up||51
350874|NCT02351934|863442|P1|COMPLETED|Follow-Up||44
350875|NCT02351934|863441|P2|STARTED|Follow-Up||61
350876|NCT02351934|863442|P1|STARTED|Follow-Up||56
350877|NCT02351934|863441|P2|NOT COMPLETED|Allocation||0
350878|NCT02351934|863442|P1|NOT COMPLETED|Allocation||6
350879|NCT02351934|863441|P2|COMPLETED|Allocation||61
350880|NCT02351934|863442|P1|COMPLETED|Allocation||56
350881|NCT02351934|863441|P2|Received Allocation|Allocation||61
350882|NCT02351934|863442|P1|Received Allocation|Allocation||56
350883|NCT02351934|863441|P2|STARTED|Allocation||61
350884|NCT02351934|863442|P1|STARTED|Allocation||62
350885|NCT02351817|863458|P2|NOT COMPLETED|Period 2||2
350886|NCT02351817|863459|P1|NOT COMPLETED|Period 2||1
350887|NCT02351817|863458|P2|COMPLETED|Period 2||3
350888|NCT02351817|863459|P1|COMPLETED|Period 2||4
350889|NCT02351817|863458|P2|STARTED|Period 2|Subjects who did not complete Period 1 as planned were allowed to continue to Period 2|5
350890|NCT02351817|863459|P1|STARTED|Period 2|Subjects who did not complete Period 1 as planned were allowed to continue to Period 2|5
350891|NCT02351817|863458|P2|NOT COMPLETED|Period 1||3
350892|NCT02351817|863459|P1|NOT COMPLETED|Period 1||1
350893|NCT02351817|863458|P2|COMPLETED|Period 1||2
350894|NCT02351817|863459|P1|COMPLETED|Period 1||4
350895|NCT02351817|863458|P2|STARTED|Period 1||5
350896|NCT02351817|863459|P1|STARTED|Period 1||5
350897|NCT02351817|863458|P2|NOT COMPLETED|Baseline Period||0
350898|NCT02351817|863459|P1|NOT COMPLETED|Baseline Period||0
350899|NCT02351817|863458|P2|COMPLETED|Baseline Period||5
350900|NCT02351817|863459|P1|COMPLETED|Baseline Period||5
350901|NCT02351817|863458|P2|STARTED|Baseline Period||5
350902|NCT02351817|863459|P1|STARTED|Baseline Period||5
350903|NCT02351505|863466|P1|NOT COMPLETED|Overall Study||0
350904|NCT02351505|863466|P1|COMPLETED|Overall Study||1
350905|NCT02351505|863466|P1|STARTED|Overall Study||1
350906|NCT02350881|863477|P1|NOT COMPLETED|Overall Study||0
350907|NCT02350881|863477|P1|COMPLETED|Overall Study|64 patients were completed (6 bilateral)|64
350908|NCT02350881|863477|P1|STARTED|Overall Study|64 patients were included (6 bilateral)|64
350909|NCT02350777|863507|P2|NOT COMPLETED|Overall Study||0
350910|NCT02350777|863508|P1|NOT COMPLETED|Overall Study||0
350911|NCT02350777|863507|P2|COMPLETED|Overall Study||2
350912|NCT02350777|863508|P1|COMPLETED|Overall Study||2
350913|NCT02350777|863507|P2|STARTED|Overall Study||2
350914|NCT02350777|863508|P1|STARTED|Overall Study||2
350915|NCT02350569|863514|P1|NOT COMPLETED|Retreatment (LDV/SOF 12 Weeks)||0
350916|NCT02350569|863514|P1|COMPLETED|Retreatment (LDV/SOF 12 Weeks)||1
350917|NCT02350569|863514|P1|STARTED|Retreatment (LDV/SOF 12 Weeks)|1 completed treatment (Main Study), experienced virologic failure, and entered Retreatment Phase|1
350918|NCT02350569|863514|P1|NOT COMPLETED|Main Study (LDV/SOF 4 Weeks)||0
350919|NCT02350569|863514|P1|COMPLETED|Main Study (LDV/SOF 4 Weeks)|1 participant discontinued treatment, but completed follow-up visits and study.|16
350920|NCT02350569|863514|P1|STARTED|Main Study (LDV/SOF 4 Weeks)||16
350921|NCT02349711|863526|P2|NOT COMPLETED|Overall Study||2
350922|NCT02349711|863527|P1|NOT COMPLETED|Overall Study||3
350923|NCT02349711|863526|P2|COMPLETED|Overall Study||84
350924|NCT02349711|863527|P1|COMPLETED|Overall Study||84
350925|NCT02349711|863526|P2|STARTED|Overall Study||86
350926|NCT02349711|863527|P1|STARTED|Overall Study||87
350927|NCT02349685|863542|P3|NOT COMPLETED|Overall Study||4
350928|NCT02349685|863543|P2|NOT COMPLETED|Overall Study||2
350929|NCT02349685|863544|P1|NOT COMPLETED|Overall Study||5
350930|NCT02349685|863542|P3|COMPLETED|Overall Study||37
350931|NCT02349685|863543|P2|COMPLETED|Overall Study||87
350932|NCT02349685|863544|P1|COMPLETED|Overall Study||84
350933|NCT02349685|863542|P3|STARTED|Overall Study||41
350934|NCT02349685|863543|P2|STARTED|Overall Study||89
350935|NCT02349685|863544|P1|STARTED|Overall Study||89
350936|NCT02349646|863555|P1|NOT COMPLETED|Overall Study||17
350937|NCT02349646|863555|P1|COMPLETED|Overall Study||16
350938|NCT02349646|863555|P1|Receive Permanent System|Overall Study||27
350939|NCT02349646|863555|P1|Received Trial System|Overall Study||24
350940|NCT02349646|863555|P1|STARTED|Overall Study||33
350941|NCT02349542|863560|P1|NOT COMPLETED|Overall Study||5
350942|NCT02349542|863560|P1|COMPLETED|Overall Study||15
350943|NCT02349542|863560|P1|STARTED|Overall Study||20
350944|NCT02349451|863569|P4|NOT COMPLETED|Overall Study||1
350945|NCT02349451|863570|P3|NOT COMPLETED|Overall Study||2
350946|NCT02349451|863571|P2|NOT COMPLETED|Overall Study||1
350947|NCT02349451|863572|P1|NOT COMPLETED|Overall Study||0
350948|NCT02349451|863569|P4|COMPLETED|Overall Study||72
350949|NCT02349451|863570|P3|COMPLETED|Overall Study||69
350950|NCT02349451|863571|P2|COMPLETED|Overall Study||71
350951|NCT02349451|863572|P1|COMPLETED|Overall Study||24
350952|NCT02349451|863569|P4|STARTED|Overall Study||73
350953|NCT02349451|863570|P3|STARTED|Overall Study||71
350954|NCT02349451|863571|P2|STARTED|Overall Study||72
350955|NCT02349451|863572|P1|STARTED|Overall Study||24
350956|NCT02349438|863608|P2|NOT COMPLETED|Period 2||0
350957|NCT02349438|863609|P1|NOT COMPLETED|Period 2||0
350958|NCT02349438|863608|P2|COMPLETED|Period 2||10
350959|NCT02349438|863609|P1|COMPLETED|Period 2||11
350960|NCT02349438|863608|P2|STARTED|Period 2||10
350961|NCT02349438|863609|P1|STARTED|Period 2||11
350962|NCT02349438|863608|P2|NOT COMPLETED|Period 1||0
350963|NCT02349438|863609|P1|NOT COMPLETED|Period 1||0
350964|NCT02349438|863608|P2|COMPLETED|Period 1||10
350965|NCT02349438|863609|P1|COMPLETED|Period 1||11
350966|NCT02349438|863608|P2|STARTED|Period 1||10
350967|NCT02349438|863609|P1|STARTED|Period 1||11
350968|NCT02349360|863621|P2|NOT COMPLETED|Overall Study||1
350969|NCT02349360|863622|P1|NOT COMPLETED|Overall Study||0
350970|NCT02349360|863621|P2|COMPLETED|Overall Study||20
350971|NCT02349360|863622|P1|COMPLETED|Overall Study||21
350972|NCT02349360|863621|P2|STARTED|Overall Study||21
350973|NCT02349360|863622|P1|STARTED|Overall Study||21
350974|NCT02349295|863633|P5|NOT COMPLETED|IR (Week 16-24)||1
350975|NCT02349295|863634|P4|NOT COMPLETED|IR (Week 16-24)||0
350976|NCT02349295|863635|P3|NOT COMPLETED|IR (Week 16-24)||0
350977|NCT02349295|863636|P2|NOT COMPLETED|IR (Week 16-24)||0
350978|NCT02349295|863637|P1|NOT COMPLETED|IR (Week 16-24)||0
350979|NCT02349295|863633|P5|COMPLETED|IR (Week 16-24)||32
350980|NCT02349295|863634|P4|COMPLETED|IR (Week 16-24)||31
350981|NCT02349295|863635|P3|COMPLETED|IR (Week 16-24)||0
350982|NCT02349295|863636|P2|COMPLETED|IR (Week 16-24)||0
350983|NCT02349295|863637|P1|COMPLETED|IR (Week 16-24)||0
350984|NCT02349295|863633|P5|STARTED|IR (Week 16-24)|IR from placebo who re-randomized (1:1) to ixekizumab 80 mg Q2W and IR from ixekizumab 80 mg Q2W.|33
350985|NCT02349295|863634|P4|STARTED|IR (Week 16-24)|IR from placebo who re-randomized (1:1) to ixekizumab 80 mg Q4W and IR from ixekizumab 80 mg Q4W.|31
350986|NCT02349295|863635|P3|STARTED|IR (Week 16-24)|Only IR participants were included.|0
350987|NCT02349295|863636|P2|STARTED|IR (Week 16-24)|Only IR participants were included.|0
350988|NCT02349295|863637|P1|STARTED|IR (Week 16-24)|Only IR participants were included.|0
350989|NCT02349295|863633|P5|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
350990|NCT02349295|863634|P4|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
350991|NCT02349295|863635|P3|NOT COMPLETED|Double Blind Treatment (Week 0-24)||14
350992|NCT02349295|863636|P2|NOT COMPLETED|Double Blind Treatment (Week 0-24)||11
350993|NCT02349295|863637|P1|NOT COMPLETED|Double Blind Treatment (Week 0-24)||24
350994|NCT02349295|863633|P5|COMPLETED|Double Blind Treatment (Week 0-24)||0
350995|NCT02349295|863634|P4|COMPLETED|Double Blind Treatment (Week 0-24)||0
350996|NCT02349295|863635|P3|COMPLETED|Double Blind Treatment (Week 0-24)||109
350997|NCT02349295|863636|P2|COMPLETED|Double Blind Treatment (Week 0-24)||111
350998|NCT02349295|863637|P1|COMPLETED|Double Blind Treatment (Week 0-24)||94
350999|NCT02349295|863633|P5|STARTED|Double Blind Treatment (Week 0-24)||0
351000|NCT02349295|863634|P4|STARTED|Double Blind Treatment (Week 0-24)||0
351001|NCT02349295|863635|P3|STARTED|Double Blind Treatment (Week 0-24)||123
351002|NCT02349295|863636|P2|STARTED|Double Blind Treatment (Week 0-24)||122
351003|NCT02349295|863637|P1|STARTED|Double Blind Treatment (Week 0-24)||118
351004|NCT02349152|863713|P2|NOT COMPLETED|Overall Study||4
351005|NCT02349152|863714|P1|NOT COMPLETED|Overall Study||6
351006|NCT02349152|863713|P2|COMPLETED|Overall Study||52
351007|NCT02349152|863714|P1|COMPLETED|Overall Study||54
351008|NCT02349152|863713|P2|STARTED|Overall Study||56
351009|NCT02349152|863714|P1|STARTED|Overall Study||60
351010|NCT02349061|863740|P2|NOT COMPLETED|Overall Study||4
351011|NCT02349061|863741|P1|NOT COMPLETED|Overall Study||9
351012|NCT02349061|863740|P2|COMPLETED|Overall Study||56
351013|NCT02349061|863741|P1|COMPLETED|Overall Study||33
351014|NCT02349061|863740|P2|STARTED|Overall Study||60
351015|NCT02349061|863741|P1|STARTED|Overall Study||42
351016|NCT02349048|863749|P2|NOT COMPLETED|Overall Study||0
351017|NCT02349048|863750|P1|NOT COMPLETED|Overall Study||5
351018|NCT02349048|863749|P2|COMPLETED|Overall Study||9
351019|NCT02349048|863750|P1|COMPLETED|Overall Study||54
351020|NCT02349048|863749|P2|STARTED|Overall Study||9
351021|NCT02349048|863750|P1|STARTED|Overall Study||59
351022|NCT02348723|863772|P2|NOT COMPLETED|Overall Study||26
351023|NCT02348723|863773|P1|NOT COMPLETED|Overall Study||28
351024|NCT02348723|863772|P2|COMPLETED|Overall Study||312
351025|NCT02348723|863773|P1|COMPLETED|Overall Study||310
351026|NCT02348723|863772|P2|STARTED|Overall Study||338
351027|NCT02348723|863773|P1|STARTED|Overall Study||338
351028|NCT02348658|863785|P2|NOT COMPLETED|Period 2 (7 Days)||0
351029|NCT02348658|863786|P1|NOT COMPLETED|Period 2 (7 Days)||0
351030|NCT02348658|863785|P2|COMPLETED|Period 2 (7 Days)||6
351031|NCT02348658|863786|P1|COMPLETED|Period 2 (7 Days)||6
351032|NCT02348658|863785|P2|STARTED|Period 2 (7 Days)||6
351033|NCT02348658|863786|P1|STARTED|Period 2 (7 Days)||6
351034|NCT02348658|863785|P2|NOT COMPLETED|Washout Period (22 Days)||0
351035|NCT02348658|863786|P1|NOT COMPLETED|Washout Period (22 Days)||0
351036|NCT02348658|863785|P2|COMPLETED|Washout Period (22 Days)||6
351037|NCT02348658|863786|P1|COMPLETED|Washout Period (22 Days)||6
351038|NCT02348658|863785|P2|STARTED|Washout Period (22 Days)||6
351039|NCT02348658|863786|P1|STARTED|Washout Period (22 Days)||6
351040|NCT02348658|863785|P2|NOT COMPLETED|Period 1 (7 Days)||0
351041|NCT02348658|863786|P1|NOT COMPLETED|Period 1 (7 Days)||0
351042|NCT02348658|863785|P2|COMPLETED|Period 1 (7 Days)||6
351043|NCT02348658|863786|P1|COMPLETED|Period 1 (7 Days)||6
351044|NCT02348658|863785|P2|STARTED|Period 1 (7 Days)||6
351045|NCT02348658|863786|P1|STARTED|Period 1 (7 Days)||6
351046|NCT02348359|863824|P4|NOT COMPLETED|Overall Study||12
351047|NCT02348359|863825|P3|NOT COMPLETED|Overall Study||14
351048|NCT02348359|863826|P2|NOT COMPLETED|Overall Study||17
351049|NCT02348359|863827|P1|NOT COMPLETED|Overall Study||11
351050|NCT02348359|863824|P4|COMPLETED|Overall Study||27
351051|NCT02348359|863825|P3|COMPLETED|Overall Study||25
351052|NCT02348359|863826|P2|COMPLETED|Overall Study||22
351053|NCT02348359|863827|P1|COMPLETED|Overall Study||29
351054|NCT02348359|863824|P4|STARTED|Overall Study||39
351055|NCT02348359|863825|P3|STARTED|Overall Study||39
351056|NCT02348359|863826|P2|STARTED|Overall Study||39
351057|NCT02348359|863827|P1|STARTED|Overall Study||40
351058|NCT02347774|863840|P3|NOT COMPLETED|On Study Treatment||36
351059|NCT02347774|863841|P2|NOT COMPLETED|On Study Treatment||31
351060|NCT02347774|863842|P1|NOT COMPLETED|On Study Treatment||24
351061|NCT02347774|863840|P3|COMPLETED|On Study Treatment||177
351062|NCT02347774|863841|P2|COMPLETED|On Study Treatment||183
351063|NCT02347774|863842|P1|COMPLETED|On Study Treatment||190
351064|NCT02347774|863840|P3|STARTED|On Study Treatment|One subject randomized in error to the placebo arm was never dosed .|213
351065|NCT02347774|863841|P2|STARTED|On Study Treatment||214
351066|NCT02347774|863842|P1|STARTED|On Study Treatment||214
351067|NCT02347774|863840|P3|NOT COMPLETED|Study Participation||25
351068|NCT02347774|863841|P2|NOT COMPLETED|Study Participation||21
351069|NCT02347774|863842|P1|NOT COMPLETED|Study Participation||15
351070|NCT02347774|863840|P3|COMPLETED|Study Participation||188
351071|NCT02347774|863841|P2|COMPLETED|Study Participation||193
351072|NCT02347774|863842|P1|COMPLETED|Study Participation||199
351073|NCT02347774|863840|P3|STARTED|Study Participation|One subject randomized in error to the placebo arm was never dosed .|213
351074|NCT02347774|863841|P2|STARTED|Study Participation||214
351075|NCT02347774|863842|P1|STARTED|Study Participation||214
351076|NCT02347761|863898|P3|NOT COMPLETED|On Study Treatment||42
351077|NCT02347761|863899|P2|NOT COMPLETED|On Study Treatment||23
351078|NCT02347761|863900|P1|NOT COMPLETED|On Study Treatment||27
351079|NCT02347761|863898|P3|COMPLETED|On Study Treatment||176
351080|NCT02347761|863899|P2|COMPLETED|On Study Treatment||194
351081|NCT02347761|863900|P1|COMPLETED|On Study Treatment||191
351082|NCT02347761|863898|P3|STARTED|On Study Treatment||218
351083|NCT02347761|863899|P2|STARTED|On Study Treatment||217
351084|NCT02347761|863900|P1|STARTED|On Study Treatment||218
351085|NCT02347761|863898|P3|NOT COMPLETED|All Collected||27
351086|NCT02347761|863899|P2|NOT COMPLETED|All Collected||14
351087|NCT02347761|863900|P1|NOT COMPLETED|All Collected||17
351088|NCT02347761|863898|P3|COMPLETED|All Collected||191
351089|NCT02347761|863899|P2|COMPLETED|All Collected||203
351090|NCT02347761|863900|P1|COMPLETED|All Collected||201
351091|NCT02347761|863898|P3|STARTED|All Collected||218
351092|NCT02347761|863899|P2|STARTED|All Collected||217
351093|NCT02347761|863900|P1|STARTED|All Collected||218
351094|NCT02347657|863961|P2|NOT COMPLETED|Overall Study||15
351095|NCT02347657|863962|P1|NOT COMPLETED|Overall Study||18
351096|NCT02347657|863961|P2|COMPLETED|Overall Study||236
351097|NCT02347657|863962|P1|COMPLETED|Overall Study||241
351098|NCT02347657|863961|P2|Treated|Overall Study||251
351099|NCT02347657|863962|P1|Treated|Overall Study||258
351100|NCT02347657|863961|P2|STARTED|Overall Study||251
351101|NCT02347657|863962|P1|STARTED|Overall Study||259
351102|NCT02347605|863993|P6|NOT COMPLETED|Overall Study||2
351103|NCT02347605|863994|P5|NOT COMPLETED|Overall Study||3
351104|NCT02347605|863995|P4|NOT COMPLETED|Overall Study||4
351105|NCT02347605|863996|P3|NOT COMPLETED|Overall Study||1
351106|NCT02347605|863997|P2|NOT COMPLETED|Overall Study||3
351107|NCT02347605|863998|P1|NOT COMPLETED|Overall Study||3
351108|NCT02347605|863993|P6|COMPLETED|Overall Study||7
351109|NCT02347605|863994|P5|COMPLETED|Overall Study||6
351110|NCT02347605|863995|P4|COMPLETED|Overall Study||6
351111|NCT02347605|863996|P3|COMPLETED|Overall Study||7
351112|NCT02347605|863997|P2|COMPLETED|Overall Study||7
351113|NCT02347605|863998|P1|COMPLETED|Overall Study||7
351114|NCT02347605|863993|P6|Completed Lab 2|Overall Study||8
351115|NCT02347605|863994|P5|Completed Lab 2|Overall Study||6
351116|NCT02347605|863995|P4|Completed Lab 2|Overall Study||7
351117|NCT02347605|863996|P3|Completed Lab 2|Overall Study||7
351118|NCT02347605|863997|P2|Completed Lab 2|Overall Study||7
351119|NCT02347605|863998|P1|Completed Lab 2|Overall Study||7
351120|NCT02347605|863993|P6|Completed Lab 1|Overall Study||9
351121|NCT02347605|863994|P5|Completed Lab 1|Overall Study||8
351122|NCT02347605|863995|P4|Completed Lab 1|Overall Study||10
351123|NCT02347605|863996|P3|Completed Lab 1|Overall Study||8
351124|NCT02347605|863997|P2|Completed Lab 1|Overall Study||10
351125|NCT02347605|863998|P1|Completed Lab 1|Overall Study||10
351126|NCT02347605|863993|P6|STARTED|Overall Study||9
351127|NCT02347605|863994|P5|STARTED|Overall Study||9
351128|NCT02347605|863995|P4|STARTED|Overall Study||10
351129|NCT02347605|863996|P3|STARTED|Overall Study||8
351130|NCT02347605|863997|P2|STARTED|Overall Study||10
351131|NCT02347605|863998|P1|STARTED|Overall Study||10
351132|NCT02347488|864009|P1|NOT COMPLETED|Overall Study||0
351133|NCT02347488|864009|P1|COMPLETED|Overall Study||30
351134|NCT02347488|864009|P1|STARTED|Overall Study||30
351135|NCT02347189|864019|P1|NOT COMPLETED|Overall Study||11
351136|NCT02347189|864019|P1|COMPLETED|Overall Study||28
351137|NCT02347189|864019|P1|Implanted > 24 Hours|Overall Study||30
351138|NCT02347189|864019|P1|Implanted|Overall Study||30
351139|NCT02347189|864019|P1|Catheterized|Overall Study||39
351140|NCT02347189|864019|P1|STARTED|Overall Study||39
351141|NCT02347176|864027|P4|NOT COMPLETED|Overall Study||4
351142|NCT02347176|864028|P3|NOT COMPLETED|Overall Study||8
351143|NCT02347176|864029|P2|NOT COMPLETED|Overall Study||10
351144|NCT02347176|864030|P1|NOT COMPLETED|Overall Study||12
351145|NCT02347176|864027|P4|COMPLETED|Overall Study||48
351146|NCT02347176|864028|P3|COMPLETED|Overall Study||43
351147|NCT02347176|864029|P2|COMPLETED|Overall Study||40
351148|NCT02347176|864030|P1|COMPLETED|Overall Study||39
351149|NCT02347176|864027|P4|STARTED|Overall Study||52
351150|NCT02347176|864028|P3|STARTED|Overall Study||51
351151|NCT02347176|864029|P2|STARTED|Overall Study||50
351152|NCT02347176|864030|P1|STARTED|Overall Study||51
351153|NCT02347124|864078|P2|NOT COMPLETED|Overall Study||99
351154|NCT02347124|864079|P1|NOT COMPLETED|Overall Study||93
351155|NCT02347124|864078|P2|COMPLETED|Overall Study||259
351156|NCT02347124|864079|P1|COMPLETED|Overall Study||267
351157|NCT02347124|864078|P2|2 Month Follow-up|Overall Study||275
351158|NCT02347124|864079|P1|2 Month Follow-up|Overall Study||298
351159|NCT02347124|864078|P2|STARTED|Overall Study||358
351160|NCT02347124|864079|P1|STARTED|Overall Study||360
351161|NCT02347085|864113|P1|NOT COMPLETED|Overall Study||10
351162|NCT02347085|864113|P1|COMPLETED|Overall Study||33
351163|NCT02347085|864113|P1|Placebo MDI|Overall Study||40
351164|NCT02347085|864113|P1|GFF MDI 14.4/9.6 µg|Overall Study||40
351165|NCT02347085|864113|P1|STARTED|Overall Study||43
351166|NCT02347072|864135|P1|NOT COMPLETED|Overall Study||18
351167|NCT02347072|864135|P1|COMPLETED|Overall Study||62
351168|NCT02347072|864135|P1|Spiriva Respimat 5 µg|Overall Study||73
351169|NCT02347072|864135|P1|Placebo MDI|Overall Study||72
351170|NCT02347072|864135|P1|GFF MDI 14.4/9.6 µg|Overall Study||75
351171|NCT02347072|864135|P1|STARTED|Overall Study||80
351172|NCT02346877|864169|P2|NOT COMPLETED|Overall Study||0
351173|NCT02346877|864170|P1|NOT COMPLETED|Overall Study||19
351174|NCT02346877|864169|P2|COMPLETED|Overall Study||0
351175|NCT02346877|864170|P1|COMPLETED|Overall Study||0
351176|NCT02346877|864169|P2|STARTED|Overall Study||0
351177|NCT02346877|864170|P1|STARTED|Overall Study||19
351178|NCT02346721|864180|P1|NOT COMPLETED|Overall Study||4
351179|NCT02346721|864180|P1|COMPLETED|Overall Study||107
351180|NCT02346721|864180|P1|STARTED|Overall Study||111
351181|NCT02346643|864189|P1|NOT COMPLETED|Overall Study||35
351182|NCT02346643|864189|P1|COMPLETED|Overall Study||6
351183|NCT02346643|864189|P1|Received Permanent System|Overall Study||31
351184|NCT02346643|864189|P1|Received Trial System|Overall Study||29
351185|NCT02346643|864189|P1|STARTED|Overall Study||41
351186|NCT02345772|864194|P1|NOT COMPLETED|Overall Study||4
351187|NCT02345772|864194|P1|COMPLETED|Overall Study||0
351188|NCT02345772|864194|P1|STARTED|Overall Study||4
351189|NCT02345720|864200|P1|NOT COMPLETED|Overall Study||0
351190|NCT02345720|864200|P1|COMPLETED|Overall Study||20
351191|NCT02345720|864200|P1|STARTED|Overall Study||20
351192|NCT02345642|864208|P2|NOT COMPLETED|Overall Study||0
351193|NCT02345642|864209|P1|NOT COMPLETED|Overall Study||0
351194|NCT02345642|864208|P2|COMPLETED|Overall Study||10
351195|NCT02345642|864209|P1|COMPLETED|Overall Study||10
351196|NCT02345642|864208|P2|STARTED|Overall Study||10
351197|NCT02345642|864209|P1|STARTED|Overall Study||10
351198|NCT02345330|864215|P1|NOT COMPLETED|Overall Study||3
351199|NCT02345330|864215|P1|COMPLETED|Overall Study||1
351200|NCT02345330|864215|P1|STARTED|Overall Study||4
351201|NCT02345252|864227|P2|NOT COMPLETED|Overall Study||316
351202|NCT02345252|864228|P1|NOT COMPLETED|Overall Study||316
351203|NCT02345252|864227|P2|COMPLETED|Overall Study||0
351204|NCT02345252|864228|P1|COMPLETED|Overall Study||0
351205|NCT02345252|864227|P2|STARTED|Overall Study||316
351206|NCT02345252|864228|P1|STARTED|Overall Study||316
351207|NCT02345226|864244|P2|NOT COMPLETED|Overall Study||441
351208|NCT02345226|864245|P1|NOT COMPLETED|Overall Study||440
351209|NCT02345226|864244|P2|COMPLETED|Overall Study||0
351210|NCT02345226|864245|P1|COMPLETED|Overall Study||0
351211|NCT02345226|864244|P2|STARTED|Overall Study||441
351212|NCT02345226|864245|P1|STARTED|Overall Study||440
351213|NCT02345031|864263|P2|NOT COMPLETED|Overall Study||1
351214|NCT02345031|864264|P1|NOT COMPLETED|Overall Study||1
351215|NCT02345031|864263|P2|COMPLETED|Overall Study||39
351216|NCT02345031|864264|P1|COMPLETED|Overall Study||37
351217|NCT02345031|864263|P2|STARTED|Overall Study||40
351218|NCT02345031|864264|P1|STARTED|Overall Study||38
351219|NCT02344745|864278|P2|NOT COMPLETED|Overall Study||0
351220|NCT02344745|864279|P1|NOT COMPLETED|Overall Study||2
351221|NCT02344745|864278|P2|COMPLETED|Overall Study||40
351222|NCT02344745|864279|P1|COMPLETED|Overall Study||38
351223|NCT02344745|864278|P2|STARTED|Overall Study||40
351224|NCT02344745|864279|P1|STARTED|Overall Study||40
351225|NCT02344407|864294|P3|NOT COMPLETED|Overall Study||6
351226|NCT02344407|864295|P2|NOT COMPLETED|Overall Study||9
351227|NCT02344407|864296|P1|NOT COMPLETED|Overall Study||8
351228|NCT02344407|864294|P3|COMPLETED|Overall Study||494
351229|NCT02344407|864295|P2|COMPLETED|Overall Study||491
351230|NCT02344407|864296|P1|COMPLETED|Overall Study||492
351231|NCT02344407|864294|P3|STARTED|Overall Study||500
351232|NCT02344407|864295|P2|STARTED|Overall Study||500
351233|NCT02344407|864296|P1|STARTED|Overall Study||500
351234|NCT02344342|864311|P4|NOT COMPLETED|Overall Study||10
351235|NCT02344342|864312|P3|NOT COMPLETED|Overall Study||14
351236|NCT02344342|864313|P2|NOT COMPLETED|Overall Study||9
351237|NCT02344342|864314|P1|NOT COMPLETED|Overall Study||11
351238|NCT02344342|864311|P4|COMPLETED|Overall Study||3
351239|NCT02344342|864312|P3|COMPLETED|Overall Study||0
351240|NCT02344342|864313|P2|COMPLETED|Overall Study||2
351241|NCT02344342|864314|P1|COMPLETED|Overall Study||2
351242|NCT02344342|864311|P4|STARTED|Overall Study||13
351243|NCT02344342|864312|P3|STARTED|Overall Study||14
351244|NCT02344342|864313|P2|STARTED|Overall Study||11
351245|NCT02344342|864314|P1|STARTED|Overall Study||13
351246|NCT02344251|864338|P2|NOT COMPLETED|Overall Study||0
351247|NCT02344251|864339|P1|NOT COMPLETED|Overall Study||0
351248|NCT02344251|864338|P2|COMPLETED|Overall Study||20
351249|NCT02344251|864339|P1|COMPLETED|Overall Study||20
351250|NCT02344251|864338|P2|STARTED|Overall Study||20
351251|NCT02344251|864339|P1|STARTED|Overall Study||20
351252|NCT02343380|864349|P2|NOT COMPLETED|Overall Study||0
351253|NCT02343380|864350|P1|NOT COMPLETED|Overall Study||0
351254|NCT02343380|864349|P2|COMPLETED|Overall Study|Morning test (second week)|10
351255|NCT02343380|864350|P1|COMPLETED|Overall Study|Evening test (second week)|10
351256|NCT02343380|864349|P2|STARTED|Overall Study|Evening test (first week)|10
351257|NCT02343380|864350|P1|STARTED|Overall Study|Morning test (first week)|10
351258|NCT02343159|864369|P3|NOT COMPLETED|Overall Study||30
351259|NCT02343159|864370|P2|NOT COMPLETED|Overall Study||26
351260|NCT02343159|864371|P1|NOT COMPLETED|Overall Study||26
351261|NCT02343159|864369|P3|COMPLETED|Overall Study||0
351262|NCT02343159|864370|P2|COMPLETED|Overall Study||1
351263|NCT02343159|864371|P1|COMPLETED|Overall Study||1
351264|NCT02343159|864369|P3|STARTED|Overall Study||30
351265|NCT02343159|864370|P2|STARTED|Overall Study||27
351266|NCT02343159|864371|P1|STARTED|Overall Study||27
351267|NCT02343081|864398|P2|NOT COMPLETED|Second Intervention (Day 4)||0
351268|NCT02343081|864399|P1|NOT COMPLETED|Second Intervention (Day 4)||0
351269|NCT02343081|864398|P2|COMPLETED|Second Intervention (Day 4)||8
351270|NCT02343081|864399|P1|COMPLETED|Second Intervention (Day 4)||8
351271|NCT02343081|864398|P2|Received Intervention|Second Intervention (Day 4)||8
351272|NCT02343081|864399|P1|Received Intervention|Second Intervention (Day 4)||8
351273|NCT02343081|864398|P2|STARTED|Second Intervention (Day 4)||8
351274|NCT02343081|864399|P1|STARTED|Second Intervention (Day 4)||8
351275|NCT02343081|864398|P2|NOT COMPLETED|Washout (10 Hours)||0
351276|NCT02343081|864399|P1|NOT COMPLETED|Washout (10 Hours)||0
351277|NCT02343081|864398|P2|COMPLETED|Washout (10 Hours)||8
351278|NCT02343081|864399|P1|COMPLETED|Washout (10 Hours)||8
351279|NCT02343081|864398|P2|STARTED|Washout (10 Hours)||8
351280|NCT02343081|864399|P1|STARTED|Washout (10 Hours)||8
351281|NCT02343081|864398|P2|NOT COMPLETED|First Intervention (Day 3)||0
351282|NCT02343081|864399|P1|NOT COMPLETED|First Intervention (Day 3)||0
351283|NCT02343081|864398|P2|COMPLETED|First Intervention (Day 3)||8
351284|NCT02343081|864399|P1|COMPLETED|First Intervention (Day 3)||8
351285|NCT02343081|864398|P2|Received Intervention|First Intervention (Day 3)||8
351286|NCT02343081|864399|P1|Received Intervention|First Intervention (Day 3)||8
351287|NCT02343081|864398|P2|STARTED|First Intervention (Day 3)||8
351288|NCT02343081|864399|P1|STARTED|First Intervention (Day 3)||8
351289|NCT02343003|864415|P2|NOT COMPLETED|Overall Study||7
351290|NCT02343003|864416|P1|NOT COMPLETED|Overall Study||18
351291|NCT02343003|864415|P2|COMPLETED|Overall Study||68
351292|NCT02343003|864416|P1|COMPLETED|Overall Study||58
351293|NCT02343003|864415|P2|STARTED|Overall Study||75
351294|NCT02343003|864416|P1|STARTED|Overall Study||76
351295|NCT02342704|864434|P2|NOT COMPLETED|Overall Study||51
351296|NCT02342704|864435|P1|NOT COMPLETED|Overall Study||53
351297|NCT02342704|864434|P2|COMPLETED|Overall Study||3
351298|NCT02342704|864435|P1|COMPLETED|Overall Study||1
351299|NCT02342704|864434|P2|STARTED|Overall Study|Safety Population: randomized participants who received at least 1 dose of study treatment.|54
351300|NCT02342704|864435|P1|STARTED|Overall Study|Safety Population: randomized participants who received at least 1 dose of study treatment.|54
351301|NCT02342561|864461|P1|NOT COMPLETED|Overall Study||0
351302|NCT02342561|864461|P1|COMPLETED|Overall Study||20
351303|NCT02342561|864461|P1|STARTED|Overall Study||20
351304|NCT02342548|864472|P3|NOT COMPLETED|Overall Study||43
351305|NCT02342548|864473|P2|NOT COMPLETED|Overall Study||62
351306|NCT02342548|864474|P1|NOT COMPLETED|Overall Study||34
351307|NCT02342548|864472|P3|COMPLETED|Overall Study||23
351308|NCT02342548|864473|P2|COMPLETED|Overall Study||9
351309|NCT02342548|864474|P1|COMPLETED|Overall Study||17
351310|NCT02342548|864472|P3|STARTED|Overall Study||66
351311|NCT02342548|864473|P2|STARTED|Overall Study||71
351312|NCT02342548|864474|P1|STARTED|Overall Study||51
351313|NCT02342535|864512|P1|NOT COMPLETED|Overall Study||0
351314|NCT02342535|864512|P1|COMPLETED|Overall Study|30 women in aerobic class and 38 kids in kids exercise class|68
351315|NCT02342535|864512|P1|STARTED|Overall Study|30 women who participated in the aerobic exercise class and 38 children.|68
351316|NCT02342418|864518|P2|NOT COMPLETED|Overall Study||1
351317|NCT02342418|864519|P1|NOT COMPLETED|Overall Study||0
351318|NCT02342418|864518|P2|COMPLETED|Overall Study||9
351319|NCT02342418|864519|P1|COMPLETED|Overall Study||9
351320|NCT02342418|864518|P2|STARTED|Overall Study||10
351321|NCT02342418|864519|P1|STARTED|Overall Study||9
351322|NCT02342288|864529|P2|NOT COMPLETED|Overall Study||6
351323|NCT02342288|864530|P1|NOT COMPLETED|Overall Study||5
351324|NCT02342288|864529|P2|COMPLETED|Overall Study||27
351325|NCT02342288|864530|P1|COMPLETED|Overall Study||25
351326|NCT02342288|864529|P2|STARTED|Overall Study|various issues listed below caused removal of subjects|33
351327|NCT02342288|864530|P1|STARTED|Overall Study|16 patients were not randomized to either arm.|30
351328|NCT02342223|864536|P1|NOT COMPLETED|Overall Study||1
351329|NCT02342223|864536|P1|COMPLETED|Overall Study||19
351330|NCT02342223|864536|P1|STARTED|Overall Study||20
351331|NCT02342197|864547|P2|NOT COMPLETED|Overall Study||2
351332|NCT02342197|864548|P1|NOT COMPLETED|Overall Study||3
351333|NCT02342197|864547|P2|COMPLETED|Overall Study||28
351334|NCT02342197|864548|P1|COMPLETED|Overall Study||27
351335|NCT02342197|864547|P2|STARTED|Overall Study||30
351336|NCT02342197|864548|P1|STARTED|Overall Study||30
351337|NCT02341859|864554|P2|NOT COMPLETED|Second Intervention (1 Day)||0
351338|NCT02341859|864555|P1|NOT COMPLETED|Second Intervention (1 Day)||0
351339|NCT02341859|864554|P2|COMPLETED|Second Intervention (1 Day)||9
351340|NCT02341859|864555|P1|COMPLETED|Second Intervention (1 Day)||10
351341|NCT02341859|864554|P2|STARTED|Second Intervention (1 Day)||9
351342|NCT02341859|864555|P1|STARTED|Second Intervention (1 Day)||10
351343|NCT02341859|864554|P2|NOT COMPLETED|First Intervention (1 Day)||0
351344|NCT02341859|864555|P1|NOT COMPLETED|First Intervention (1 Day)||0
351345|NCT02341859|864554|P2|COMPLETED|First Intervention (1 Day)||9
351346|NCT02341859|864555|P1|COMPLETED|First Intervention (1 Day)||10
351347|NCT02341859|864554|P2|STARTED|First Intervention (1 Day)||9
351348|NCT02341859|864555|P1|STARTED|First Intervention (1 Day)||10
351349|NCT02341482|864708|P1|NOT COMPLETED|Overall Study||1
351350|NCT02341482|864708|P1|COMPLETED|Overall Study||12
351351|NCT02341482|864708|P1|STARTED|Overall Study||13
351352|NCT02341417|864737|P3|NOT COMPLETED|Overall Study||1
351353|NCT02341417|864738|P2|NOT COMPLETED|Overall Study||2
351354|NCT02341417|864739|P1|NOT COMPLETED|Overall Study||2
351355|NCT02341417|864737|P3|COMPLETED|Overall Study||0
351356|NCT02341417|864738|P2|COMPLETED|Overall Study||12
351357|NCT02341417|864739|P1|COMPLETED|Overall Study||11
351358|NCT02341417|864737|P3|STARTED|Overall Study||1
351359|NCT02341417|864738|P2|STARTED|Overall Study||14
351360|NCT02341417|864739|P1|STARTED|Overall Study||13
351361|NCT02341144|864783|P2|NOT COMPLETED|Overall Study||1
351362|NCT02341144|864784|P1|NOT COMPLETED|Overall Study||2
351363|NCT02341144|864783|P2|COMPLETED|Overall Study||30
351364|NCT02341144|864784|P1|COMPLETED|Overall Study||28
351365|NCT02341144|864783|P2|STARTED|Overall Study||31
351366|NCT02341144|864784|P1|STARTED|Overall Study||30
351367|NCT02340715|864798|P1|NOT COMPLETED|Overall Study||0
351368|NCT02340715|864798|P1|COMPLETED|Overall Study|158|158
351369|NCT02340715|864798|P1|STARTED|Overall Study|158|158
351370|NCT02340520|864802|P1|NOT COMPLETED|Overall Study||3
351371|NCT02340520|864802|P1|COMPLETED|Overall Study||8
351372|NCT02340520|864802|P1|STARTED|Overall Study||11
351373|NCT02340338|864814|P7|NOT COMPLETED|Overall Study||0
351374|NCT02340338|864815|P6|NOT COMPLETED|Overall Study||0
351375|NCT02340338|864816|P5|NOT COMPLETED|Overall Study||0
351376|NCT02340338|864817|P4|NOT COMPLETED|Overall Study||0
351377|NCT02340338|864818|P3|NOT COMPLETED|Overall Study||0
351378|NCT02340338|864819|P2|NOT COMPLETED|Overall Study||0
351379|NCT02340338|864820|P1|NOT COMPLETED|Overall Study||0
351380|NCT02340338|864814|P7|COMPLETED|Overall Study||12
351381|NCT02340338|864815|P6|COMPLETED|Overall Study|1 withdrew voluntarily after the first immunization; safety and serum assessment completed.|9
351382|NCT02340338|864816|P5|COMPLETED|Overall Study||9
351383|NCT02340338|864817|P4|COMPLETED|Overall Study||9
351384|NCT02340338|864818|P3|COMPLETED|Overall Study||3
351385|NCT02340338|864819|P2|COMPLETED|Overall Study||2
351386|NCT02340338|864820|P1|COMPLETED|Overall Study||2
351387|NCT02340338|864814|P7|STARTED|Overall Study|Placebos were randomly assigned to dose groups 1-6, included in the 46 participants.|12
351388|NCT02340338|864815|P6|STARTED|Overall Study|9 vaccine + 3 placebo|9
351389|NCT02340338|864816|P5|STARTED|Overall Study|9 vaccine + 3 placebo|9
351390|NCT02340338|864817|P4|STARTED|Overall Study|9 vaccine + 3 placebo|9
351391|NCT02340338|864818|P3|STARTED|Overall Study|3 vaccine + 1 placebo|3
351392|NCT02340338|864819|P2|STARTED|Overall Study|2 vaccine + 1 placebo|2
351393|NCT02340338|864820|P1|STARTED|Overall Study|2 vaccine + 1 placebo|2
351394|NCT02340104|864843|P1|NOT COMPLETED|Overall Study||0
351395|NCT02340104|864843|P1|COMPLETED|Overall Study||8
351396|NCT02340104|864843|P1|STARTED|Overall Study||8
351397|NCT02340000|864850|P2|NOT COMPLETED|Time Period 2||15
351398|NCT02340000|864851|P1|NOT COMPLETED|Time Period 2||19
351399|NCT02340000|864850|P2|COMPLETED|Time Period 2||52
351400|NCT02340000|864851|P1|COMPLETED|Time Period 2||50
351401|NCT02340000|864850|P2|STARTED|Time Period 2||67
351402|NCT02340000|864851|P1|STARTED|Time Period 2||69
351403|NCT02340000|864850|P2|NOT COMPLETED|Time Period 1||15
351404|NCT02340000|864851|P1|NOT COMPLETED|Time Period 1||12
351405|NCT02340000|864850|P2|COMPLETED|Time Period 1||74
351406|NCT02340000|864851|P1|COMPLETED|Time Period 1||78
351407|NCT02340000|864850|P2|STARTED|Time Period 1||89
351408|NCT02340000|864851|P1|STARTED|Time Period 1||90
351409|NCT02339831|864880|P2|NOT COMPLETED|Overall Study||7
351410|NCT02339831|864881|P1|NOT COMPLETED|Overall Study||20
351411|NCT02339831|864880|P2|COMPLETED|Overall Study||45
351412|NCT02339831|864881|P1|COMPLETED|Overall Study||38
351413|NCT02339831|864880|P2|Lost to Follow Up|Overall Study||7
351414|NCT02339831|864881|P1|Lost to Follow Up|Overall Study||20
351415|NCT02339831|864880|P2|STARTED|Overall Study||52
351416|NCT02339831|864881|P1|STARTED|Overall Study||58
351417|NCT02339584|864905|P2|NOT COMPLETED|Overall Study||15
351418|NCT02339584|864906|P1|NOT COMPLETED|Overall Study||15
351419|NCT02339584|864905|P2|COMPLETED|Overall Study||176
351420|NCT02339584|864906|P1|COMPLETED|Overall Study||173
351421|NCT02339584|864905|P2|STARTED|Overall Study||191
351422|NCT02339584|864906|P1|STARTED|Overall Study||188
351423|NCT02339506|864912|P2|NOT COMPLETED|Period 3 (Placebo or Cosyntropin)||0
351424|NCT02339506|864913|P1|NOT COMPLETED|Period 3 (Placebo or Cosyntropin)||0
351425|NCT02339506|864912|P2|COMPLETED|Period 3 (Placebo or Cosyntropin)||10
351426|NCT02339506|864913|P1|COMPLETED|Period 3 (Placebo or Cosyntropin)||10
351427|NCT02339506|864912|P2|STARTED|Period 3 (Placebo or Cosyntropin)||10
351428|NCT02339506|864913|P1|STARTED|Period 3 (Placebo or Cosyntropin)||10
351429|NCT02339506|864912|P2|NOT COMPLETED|Washout (Period 2)||0
351430|NCT02339506|864913|P1|NOT COMPLETED|Washout (Period 2)||2
351431|NCT02339506|864912|P2|COMPLETED|Washout (Period 2)||10
351432|NCT02339506|864913|P1|COMPLETED|Washout (Period 2)||10
351433|NCT02339506|864912|P2|STARTED|Washout (Period 2)||10
351434|NCT02339506|864913|P1|STARTED|Washout (Period 2)||12
351435|NCT02339506|864912|P2|NOT COMPLETED|Period 1 (Placebo or Cosyntropin)||1
351436|NCT02339506|864913|P1|NOT COMPLETED|Period 1 (Placebo or Cosyntropin)||0
351437|NCT02339506|864912|P2|COMPLETED|Period 1 (Placebo or Cosyntropin)||10
351438|NCT02339506|864913|P1|COMPLETED|Period 1 (Placebo or Cosyntropin)||12
351439|NCT02339506|864912|P2|STARTED|Period 1 (Placebo or Cosyntropin)||11
351440|NCT02339506|864913|P1|STARTED|Period 1 (Placebo or Cosyntropin)||12
351441|NCT02339389|864919|P1|NOT COMPLETED|Overall Study||16
351442|NCT02339389|864919|P1|COMPLETED|Overall Study||41
351443|NCT02339389|864919|P1|STARTED|Overall Study||57
351444|NCT02339246|864926|P3|NOT COMPLETED|Third Period (7 Days)||0
351445|NCT02339246|864927|P2|NOT COMPLETED|Third Period (7 Days)||0
351446|NCT02339246|864928|P1|NOT COMPLETED|Third Period (7 Days)||0
351447|NCT02339246|864926|P3|COMPLETED|Third Period (7 Days)||0
351448|NCT02339246|864927|P2|COMPLETED|Third Period (7 Days)||16
351449|NCT02339246|864928|P1|COMPLETED|Third Period (7 Days)||15
351450|NCT02339246|864926|P3|STARTED|Third Period (7 Days)||0
351451|NCT02339246|864927|P2|STARTED|Third Period (7 Days)||16
351452|NCT02339246|864928|P1|STARTED|Third Period (7 Days)||15
351453|NCT02339246|864926|P3|NOT COMPLETED|Second Intervention (7 Days)||0
351454|NCT02339246|864927|P2|NOT COMPLETED|Second Intervention (7 Days)||0
351455|NCT02339246|864928|P1|NOT COMPLETED|Second Intervention (7 Days)||0
351456|NCT02339246|864926|P3|COMPLETED|Second Intervention (7 Days)||0
351457|NCT02339246|864927|P2|COMPLETED|Second Intervention (7 Days)||15
351458|NCT02339246|864928|P1|COMPLETED|Second Intervention (7 Days)||16
351459|NCT02339246|864926|P3|STARTED|Second Intervention (7 Days)||0
351460|NCT02339246|864927|P2|STARTED|Second Intervention (7 Days)||15
351461|NCT02339246|864928|P1|STARTED|Second Intervention (7 Days)||16
351462|NCT02339246|864926|P3|NOT COMPLETED|First Intervention (7 Days)||0
351463|NCT02339246|864927|P2|NOT COMPLETED|First Intervention (7 Days)||0
351464|NCT02339246|864928|P1|NOT COMPLETED|First Intervention (7 Days)||0
351465|NCT02339246|864926|P3|COMPLETED|First Intervention (7 Days)||31
351466|NCT02339246|864927|P2|COMPLETED|First Intervention (7 Days)||0
351467|NCT02339246|864928|P1|COMPLETED|First Intervention (7 Days)||0
351468|NCT02339246|864926|P3|STARTED|First Intervention (7 Days)||31
351469|NCT02339246|864927|P2|STARTED|First Intervention (7 Days)||0
351470|NCT02339246|864928|P1|STARTED|First Intervention (7 Days)||0
351471|NCT02339155|864944|P2|NOT COMPLETED|Overall Study||21
351472|NCT02339155|864945|P1|NOT COMPLETED|Overall Study||15
351473|NCT02339155|864944|P2|COMPLETED|Overall Study||266
351474|NCT02339155|864945|P1|COMPLETED|Overall Study||271
351475|NCT02339155|864944|P2|Received Study Treatment|Overall Study||281
351476|NCT02339155|864945|P1|Received Study Treatment|Overall Study||285
351477|NCT02339155|864944|P2|STARTED|Overall Study||287
351478|NCT02339155|864945|P1|STARTED|Overall Study||286
351479|NCT02339038|864971|P1|NOT COMPLETED|Overall Study||600
351480|NCT02339038|864971|P1|COMPLETED|Overall Study||0
351481|NCT02339038|864971|P1|STARTED|Overall Study||600
351482|NCT02338843|864977|P2|NOT COMPLETED|Overall Study||58
351483|NCT02338843|864978|P1|NOT COMPLETED|Overall Study||44
351484|NCT02338843|864977|P2|COMPLETED|Overall Study||100
351485|NCT02338843|864978|P1|COMPLETED|Overall Study||119
351486|NCT02338843|864977|P2|STARTED|Overall Study||158
351487|NCT02338843|864978|P1|STARTED|Overall Study||163
351488|NCT02338713|864984|P1|NOT COMPLETED|Overall Study||0
351489|NCT02338713|864984|P1|COMPLETED|Overall Study||27
351490|NCT02338713|864984|P1|STARTED|Overall Study||27
351491|NCT02338492|865006|P1|NOT COMPLETED|Overall Study||45
351492|NCT02338492|865006|P1|COMPLETED|Overall Study||36
351493|NCT02338492|865006|P1|Treatment Failure|Overall Study||2
351494|NCT02338492|865006|P1|Device Implanted|Overall Study||79
351495|NCT02338492|865006|P1|Enrolled|Overall Study||81
351496|NCT02338492|865006|P1|STARTED|Overall Study||81
351497|NCT02338336|865022|P4|NOT COMPLETED|Overall Study||0
351498|NCT02338336|865023|P3|NOT COMPLETED|Overall Study||0
351499|NCT02338336|865024|P2|NOT COMPLETED|Overall Study||0
351500|NCT02338336|865025|P1|NOT COMPLETED|Overall Study||2
351501|NCT02338336|865022|P4|COMPLETED|Overall Study||4
351502|NCT02338336|865023|P3|COMPLETED|Overall Study||7
351503|NCT02338336|865024|P2|COMPLETED|Overall Study||17
351504|NCT02338336|865025|P1|COMPLETED|Overall Study||24
351505|NCT02338336|865022|P4|STARTED|Overall Study||4
351506|NCT02338336|865023|P3|STARTED|Overall Study||7
351507|NCT02338336|865024|P2|STARTED|Overall Study||17
351508|NCT02338336|865025|P1|STARTED|Overall Study||26
351509|NCT02338076|865033|P1|NOT COMPLETED|Overall Study||0
351510|NCT02338076|865033|P1|COMPLETED|Overall Study||20
351511|NCT02338076|865033|P1|STARTED|Overall Study||20
351512|NCT02337959|865051|P3|NOT COMPLETED|Overall Study||0
351513|NCT02337959|865052|P2|NOT COMPLETED|Overall Study||3
351514|NCT02337959|865053|P1|NOT COMPLETED|Overall Study||0
351515|NCT02337959|865051|P3|COMPLETED|Overall Study||7
351516|NCT02337959|865052|P2|COMPLETED|Overall Study||7
351517|NCT02337959|865053|P1|COMPLETED|Overall Study||10
351518|NCT02337959|865051|P3|STARTED|Overall Study||7
351519|NCT02337959|865052|P2|STARTED|Overall Study||10
351520|NCT02337959|865053|P1|STARTED|Overall Study||10
351521|NCT02337491|865063|P2|NOT COMPLETED|Overall Study||30
351522|NCT02337491|865064|P1|NOT COMPLETED|Overall Study||50
351523|NCT02337491|865063|P2|COMPLETED|Overall Study||0
351524|NCT02337491|865064|P1|COMPLETED|Overall Study||0
351525|NCT02337491|865063|P2|STARTED|Overall Study||30
351526|NCT02337491|865064|P1|STARTED|Overall Study||50
351527|NCT02337062|865080|P2|NOT COMPLETED|Overall Study||19
351528|NCT02337062|865081|P1|NOT COMPLETED|Overall Study||17
351529|NCT02337062|865080|P2|COMPLETED|Overall Study||556
351530|NCT02337062|865081|P1|COMPLETED|Overall Study||555
351531|NCT02337062|865080|P2|STARTED|Overall Study||575
351532|NCT02337062|865081|P1|STARTED|Overall Study||572
351533|NCT02336958|865089|P2|NOT COMPLETED|Overall Study||0
351534|NCT02336958|865090|P1|NOT COMPLETED|Overall Study||0
351535|NCT02336958|865089|P2|COMPLETED|Overall Study||20
351536|NCT02336958|865090|P1|COMPLETED|Overall Study||20
351537|NCT02336958|865089|P2|STARTED|Overall Study||20
351538|NCT02336958|865090|P1|STARTED|Overall Study||20
351539|NCT02336763|865098|P1|NOT COMPLETED|Overall Study||0
351540|NCT02336763|865098|P1|COMPLETED|Overall Study||2
351541|NCT02336763|865098|P1|STARTED|Overall Study||2
351542|NCT02336607|865112|P4|NOT COMPLETED|Overall Study||87
351543|NCT02336607|865113|P3|NOT COMPLETED|Overall Study||6
351544|NCT02336607|865114|P2|NOT COMPLETED|Overall Study||10
351545|NCT02336607|865115|P1|NOT COMPLETED|Overall Study||4
351546|NCT02336607|865112|P4|COMPLETED|Overall Study||180
351547|NCT02336607|865113|P3|COMPLETED|Overall Study||86
351548|NCT02336607|865114|P2|COMPLETED|Overall Study||75
351549|NCT02336607|865115|P1|COMPLETED|Overall Study||81
351550|NCT02336607|865112|P4|Patients Included in Safety Population|Overall Study||260
351551|NCT02336607|865113|P3|Patients Included in Safety Population|Overall Study||92
351552|NCT02336607|865114|P2|Patients Included in Safety Population|Overall Study||85
351553|NCT02336607|865115|P1|Patients Included in Safety Population|Overall Study||85
351554|NCT02336607|865112|P4|Patients Included in PP Population|Overall Study||162
351555|NCT02336607|865113|P3|Patients Included in PP Population|Overall Study||75
351556|NCT02336607|865114|P2|Patients Included in PP Population|Overall Study||75
351557|NCT02336607|865115|P1|Patients Included in PP Population|Overall Study||78
351558|NCT02336607|865112|P4|Patients Included in ITT Population|Overall Study||222
351559|NCT02336607|865113|P3|Patients Included in ITT Population|Overall Study||91
351560|NCT02336607|865114|P2|Patients Included in ITT Population|Overall Study||84
351561|NCT02336607|865115|P1|Patients Included in ITT Population|Overall Study||84
351562|NCT02336607|865112|P4|STARTED|Overall Study||267
351563|NCT02336607|865113|P3|STARTED|Overall Study||92
351564|NCT02336607|865114|P2|STARTED|Overall Study||85
351565|NCT02336607|865115|P1|STARTED|Overall Study||85
351566|NCT02336594|865173|P4|NOT COMPLETED|Overall Study||0
351567|NCT02336594|865174|P3|NOT COMPLETED|Overall Study||0
351568|NCT02336594|865175|P2|NOT COMPLETED|Overall Study||0
351569|NCT02336594|865176|P1|NOT COMPLETED|Overall Study||0
351570|NCT02336594|865173|P4|COMPLETED|Overall Study||4
351571|NCT02336594|865174|P3|COMPLETED|Overall Study||4
351572|NCT02336594|865175|P2|COMPLETED|Overall Study||4
351573|NCT02336594|865176|P1|COMPLETED|Overall Study||3
351574|NCT02336594|865173|P4|STARTED|Overall Study||4
351575|NCT02336594|865174|P3|STARTED|Overall Study||4
351576|NCT02336594|865175|P2|STARTED|Overall Study||4
351577|NCT02336594|865176|P1|STARTED|Overall Study||3
351578|NCT02336438|865216|P1|NOT COMPLETED|Overall Study||1
351579|NCT02336438|865216|P1|COMPLETED|Overall Study||10
351580|NCT02336438|865216|P1|STARTED|Overall Study||11
351581|NCT02336425|865229|P4|NOT COMPLETED|Overall Study||3
351582|NCT02336425|865230|P3|NOT COMPLETED|Overall Study||3
351583|NCT02336425|865231|P2|NOT COMPLETED|Overall Study||2
351584|NCT02336425|865232|P1|NOT COMPLETED|Overall Study||2
351585|NCT02336425|865229|P4|COMPLETED|Overall Study||0
351586|NCT02336425|865230|P3|COMPLETED|Overall Study||0
351587|NCT02336425|865231|P2|COMPLETED|Overall Study||0
351588|NCT02336425|865232|P1|COMPLETED|Overall Study||0
351589|NCT02336425|865229|P4|STARTED|Overall Study||3
351590|NCT02336425|865230|P3|STARTED|Overall Study||3
351591|NCT02336425|865231|P2|STARTED|Overall Study||2
351592|NCT02336425|865232|P1|STARTED|Overall Study||2
351593|NCT02336178|865282|P1|NOT COMPLETED|Overall Study||4
351594|NCT02336178|865282|P1|COMPLETED|Overall Study||66
351595|NCT02336178|865282|P1|STARTED|Overall Study||70
351596|NCT02335710|865370|P2|NOT COMPLETED|Overall Study||0
351597|NCT02335710|865371|P1|NOT COMPLETED|Overall Study||0
351598|NCT02335710|865370|P2|COMPLETED|Overall Study||10
351599|NCT02335710|865371|P1|COMPLETED|Overall Study||40
351600|NCT02335710|865370|P2|STARTED|Overall Study||10
351601|NCT02335710|865371|P1|STARTED|Overall Study||40
351602|NCT02335502|865391|P1|NOT COMPLETED|Overall Study||17
351603|NCT02335502|865391|P1|COMPLETED|Overall Study||49
351604|NCT02335502|865391|P1|Receiving Permanent System|Overall Study||56
351605|NCT02335502|865391|P1|Received Trial System|Overall Study||65
351606|NCT02335502|865391|P1|STARTED|Overall Study||66
351607|NCT02335489|865396|P1|NOT COMPLETED|Overall Study||10
351608|NCT02335489|865396|P1|COMPLETED|Overall Study||0
351609|NCT02335489|865396|P1|Receiving Permanent System|Overall Study||8
351610|NCT02335489|865396|P1|Received Trial System|Overall Study||9
351611|NCT02335489|865396|P1|STARTED|Overall Study||10
351612|NCT02335346|865400|P1|NOT COMPLETED|Overall Study||12
351613|NCT02335346|865400|P1|COMPLETED|Overall Study||81
351614|NCT02335346|865400|P1|Received At Least 1 Dose of Study Drug|Overall Study||93
351615|NCT02335346|865400|P1|STARTED|Overall Study||93
351616|NCT02335216|865412|P1|NOT COMPLETED|Overall Study||13
351617|NCT02335216|865412|P1|COMPLETED|Overall Study||9
351618|NCT02335216|865412|P1|Received Permanent System|Overall Study||13
351619|NCT02335216|865412|P1|Received Trial System|Overall Study||16
351620|NCT02335216|865412|P1|STARTED|Overall Study||22
351621|NCT02334982|865424|P7|NOT COMPLETED|Overall Study||0
351622|NCT02334982|865425|P6|NOT COMPLETED|Overall Study||0
351623|NCT02334982|865426|P5|NOT COMPLETED|Overall Study||0
351624|NCT02334982|865427|P4|NOT COMPLETED|Overall Study||0
351625|NCT02334982|865428|P3|NOT COMPLETED|Overall Study||0
351626|NCT02334982|865429|P2|NOT COMPLETED|Overall Study||0
351627|NCT02334982|865430|P1|NOT COMPLETED|Overall Study||0
351628|NCT02334982|865424|P7|COMPLETED|Overall Study||12
351629|NCT02334982|865425|P6|COMPLETED|Overall Study||6
351630|NCT02334982|865426|P5|COMPLETED|Overall Study||6
351631|NCT02334982|865427|P4|COMPLETED|Overall Study||6
351632|NCT02334982|865428|P3|COMPLETED|Overall Study||6
351633|NCT02334982|865429|P2|COMPLETED|Overall Study||5
351634|NCT02334982|865430|P1|COMPLETED|Overall Study||6
351635|NCT02334982|865424|P7|STARTED|Overall Study||12
351636|NCT02334982|865425|P6|STARTED|Overall Study||6
351637|NCT02334982|865426|P5|STARTED|Overall Study||6
351638|NCT02334982|865427|P4|STARTED|Overall Study||6
351639|NCT02334982|865428|P3|STARTED|Overall Study||6
351640|NCT02334982|865429|P2|STARTED|Overall Study||5
351641|NCT02334982|865430|P1|STARTED|Overall Study||6
351642|NCT02334813|865536|P2|NOT COMPLETED|Overall Study||1
351643|NCT02334813|865537|P1|NOT COMPLETED|Overall Study||3
351644|NCT02334813|865536|P2|COMPLETED|Overall Study||13
351645|NCT02334813|865537|P1|COMPLETED|Overall Study||9
351646|NCT02334813|865536|P2|STARTED|Overall Study||14
351647|NCT02334813|865537|P1|STARTED|Overall Study||12
351648|NCT02334800|865547|P4|NOT COMPLETED|Overall Study||0
351649|NCT02334800|865548|P3|NOT COMPLETED|Overall Study||0
351650|NCT02334800|865549|P2|NOT COMPLETED|Overall Study||0
351651|NCT02334800|865550|P1|NOT COMPLETED|Overall Study||0
351652|NCT02334800|865547|P4|COMPLETED|Overall Study||7
351653|NCT02334800|865548|P3|COMPLETED|Overall Study||7
351654|NCT02334800|865549|P2|COMPLETED|Overall Study||7
351655|NCT02334800|865550|P1|COMPLETED|Overall Study||7
351656|NCT02334800|865547|P4|Received Treatment|Overall Study||7
351657|NCT02334800|865548|P3|Received Treatment|Overall Study||7
351658|NCT02334800|865549|P2|Received Treatment|Overall Study||7
351659|NCT02334800|865550|P1|Received Treatment|Overall Study||7
351660|NCT02334800|865547|P4|STARTED|Overall Study||7
351661|NCT02334800|865548|P3|STARTED|Overall Study||7
351662|NCT02334800|865549|P2|STARTED|Overall Study||7
351663|NCT02334800|865550|P1|STARTED|Overall Study||7
351664|NCT02334787|865644|P4|NOT COMPLETED|Overall Study||0
351665|NCT02334787|865645|P3|NOT COMPLETED|Overall Study||0
351666|NCT02334787|865646|P2|NOT COMPLETED|Overall Study||0
351667|NCT02334787|865647|P1|NOT COMPLETED|Overall Study||0
351668|NCT02334787|865644|P4|COMPLETED|Overall Study||8
351669|NCT02334787|865645|P3|COMPLETED|Overall Study||8
351670|NCT02334787|865646|P2|COMPLETED|Overall Study||8
351671|NCT02334787|865647|P1|COMPLETED|Overall Study||8
351672|NCT02334787|865644|P4|STARTED|Overall Study||8
351673|NCT02334787|865645|P3|STARTED|Overall Study||8
351674|NCT02334787|865646|P2|STARTED|Overall Study||8
351675|NCT02334787|865647|P1|STARTED|Overall Study||8
351676|NCT02334527|865669|P1|NOT COMPLETED|Overall Study||0
351677|NCT02334527|865669|P1|COMPLETED|Overall Study||12
351678|NCT02334527|865669|P1|STARTED|Overall Study||12
351679|NCT02334267|865680|P2|NOT COMPLETED|Overall Study||0
351680|NCT02334267|865681|P1|NOT COMPLETED|Overall Study||1
351681|NCT02334267|865680|P2|COMPLETED|Overall Study||5
351682|NCT02334267|865681|P1|COMPLETED|Overall Study||5
351683|NCT02334267|865680|P2|STARTED|Overall Study||5
351684|NCT02334267|865681|P1|STARTED|Overall Study||6
351685|NCT02333045|865695|P2|NOT COMPLETED|Overall Study||0
351686|NCT02333045|865696|P1|NOT COMPLETED|Overall Study||0
351687|NCT02333045|865695|P2|COMPLETED|Overall Study||3
351688|NCT02333045|865696|P1|COMPLETED|Overall Study||1
351689|NCT02333045|865695|P2|STARTED|Overall Study||3
351690|NCT02333045|865696|P1|STARTED|Overall Study||1
351691|NCT02332902|865706|P1|NOT COMPLETED|Overall Study||7
351692|NCT02332902|865706|P1|COMPLETED|Overall Study||17
351693|NCT02332902|865706|P1|STARTED|Overall Study||24
351694|NCT02332889|865711|P1|NOT COMPLETED|Overall Study||1
351695|NCT02332889|865711|P1|COMPLETED|Overall Study||0
351696|NCT02332889|865711|P1|STARTED|Overall Study||1
351697|NCT02332798|865718|P3|NOT COMPLETED|Overall Study||1
351698|NCT02332798|865719|P2|NOT COMPLETED|Overall Study||2
351699|NCT02332798|865720|P1|NOT COMPLETED|Overall Study||1
351700|NCT02332798|865718|P3|COMPLETED|Overall Study||11
351701|NCT02332798|865719|P2|COMPLETED|Overall Study||12
351702|NCT02332798|865720|P1|COMPLETED|Overall Study||12
351703|NCT02332798|865718|P3|STARTED|Overall Study||12
351704|NCT02332798|865719|P2|STARTED|Overall Study||14
351705|NCT02332798|865720|P1|STARTED|Overall Study||13
351706|NCT02332707|865788|P18|NOT COMPLETED|Overall Study||0
351707|NCT02332707|865789|P17|NOT COMPLETED|Overall Study||0
351708|NCT02332707|865790|P16|NOT COMPLETED|Overall Study||0
351709|NCT02332707|865791|P15|NOT COMPLETED|Overall Study||0
351710|NCT02332707|865792|P14|NOT COMPLETED|Overall Study||0
351711|NCT02332707|865793|P13|NOT COMPLETED|Overall Study||5
351712|NCT02332707|865794|P12|NOT COMPLETED|Overall Study||0
351713|NCT02332707|865795|P11|NOT COMPLETED|Overall Study||2
351714|NCT02332707|865796|P10|NOT COMPLETED|Overall Study||3
351715|NCT02332707|865797|P9|NOT COMPLETED|Overall Study||0
351716|NCT02332707|865798|P8|NOT COMPLETED|Overall Study||0
351717|NCT02332707|865799|P7|NOT COMPLETED|Overall Study||0
351718|NCT02332707|865800|P6|NOT COMPLETED|Overall Study||1
351719|NCT02332707|865801|P5|NOT COMPLETED|Overall Study||0
351720|NCT02332707|865802|P4|NOT COMPLETED|Overall Study||1
351721|NCT02332707|865803|P3|NOT COMPLETED|Overall Study||1
351722|NCT02332707|865804|P2|NOT COMPLETED|Overall Study||0
351723|NCT02332707|865805|P1|NOT COMPLETED|Overall Study||0
351724|NCT02332707|865788|P18|COMPLETED|Overall Study||16
351725|NCT02332707|865789|P17|COMPLETED|Overall Study||30
351726|NCT02332707|865790|P16|COMPLETED|Overall Study||26
351727|NCT02332707|865791|P15|COMPLETED|Overall Study||16
351728|NCT02332707|865792|P14|COMPLETED|Overall Study||15
351729|NCT02332707|865793|P13|COMPLETED|Overall Study||35
351730|NCT02332707|865794|P12|COMPLETED|Overall Study||35
351731|NCT02332707|865795|P11|COMPLETED|Overall Study||29
351732|NCT02332707|865796|P10|COMPLETED|Overall Study||28
351733|NCT02332707|865797|P9|COMPLETED|Overall Study||48
351734|NCT02332707|865798|P8|COMPLETED|Overall Study||16
351735|NCT02332707|865799|P7|COMPLETED|Overall Study||15
351736|NCT02332707|865800|P6|COMPLETED|Overall Study||22
351737|NCT02332707|865801|P5|COMPLETED|Overall Study||23
351738|NCT02332707|865802|P4|COMPLETED|Overall Study||13
351739|NCT02332707|865803|P3|COMPLETED|Overall Study||15
351740|NCT02332707|865804|P2|COMPLETED|Overall Study||24
351741|NCT02332707|865805|P1|COMPLETED|Overall Study||23
351742|NCT02332707|865788|P18|STARTED|Overall Study||16
351743|NCT02332707|865789|P17|STARTED|Overall Study||30
351744|NCT02332707|865790|P16|STARTED|Overall Study||26
351745|NCT02332707|865791|P15|STARTED|Overall Study||16
351746|NCT02332707|865792|P14|STARTED|Overall Study||15
351747|NCT02332707|865793|P13|STARTED|Overall Study||40
351748|NCT02332707|865794|P12|STARTED|Overall Study||35
351749|NCT02332707|865795|P11|STARTED|Overall Study||31
351750|NCT02332707|865796|P10|STARTED|Overall Study||31
351751|NCT02332707|865797|P9|STARTED|Overall Study||48
351752|NCT02332707|865798|P8|STARTED|Overall Study||16
351753|NCT02332707|865799|P7|STARTED|Overall Study||15
351754|NCT02332707|865800|P6|STARTED|Overall Study||23
351755|NCT02332707|865801|P5|STARTED|Overall Study||23
351756|NCT02332707|865802|P4|STARTED|Overall Study||14
351757|NCT02332707|865803|P3|STARTED|Overall Study||16
351758|NCT02332707|865804|P2|STARTED|Overall Study||24
351759|NCT02332707|865805|P1|STARTED|Overall Study||23
351760|NCT02332590|865899|P2|NOT COMPLETED|Overall Study||19
351761|NCT02332590|865900|P1|NOT COMPLETED|Overall Study||29
351762|NCT02332590|865899|P2|COMPLETED|Overall Study|All 165 participants entered open-label treatment period.|165
351763|NCT02332590|865900|P1|COMPLETED|Overall Study|155 participants entered open-label treatment period and 1 did not enroll.|156
351764|NCT02332590|865899|P2|Treated|Overall Study||184
351765|NCT02332590|865900|P1|Treated|Overall Study||184
351766|NCT02332590|865899|P2|STARTED|Overall Study||184
351767|NCT02332590|865900|P1|STARTED|Overall Study||185
351768|NCT02332239|865964|P2|NOT COMPLETED|Overall Study||6
351769|NCT02332239|865965|P1|NOT COMPLETED|Overall Study||4
351770|NCT02332239|865964|P2|COMPLETED|Overall Study||52
351771|NCT02332239|865965|P1|COMPLETED|Overall Study||54
351772|NCT02332239|865964|P2|STARTED|Overall Study||58
351773|NCT02332239|865965|P1|STARTED|Overall Study||58
351774|NCT02331940|865980|P2|NOT COMPLETED|Overall Study||5
351775|NCT02331940|865981|P1|NOT COMPLETED|Overall Study||7
351776|NCT02331940|865980|P2|COMPLETED|Overall Study||95
351777|NCT02331940|865981|P1|COMPLETED|Overall Study||93
351778|NCT02331940|865980|P2|STARTED|Overall Study||100
351779|NCT02331940|865981|P1|STARTED|Overall Study||100
351780|NCT02331589|865995|P2|NOT COMPLETED|Overall Study||5
351781|NCT02331589|865996|P1|NOT COMPLETED|Overall Study||5
351782|NCT02331589|865995|P2|COMPLETED|Overall Study||31
351783|NCT02331589|865996|P1|COMPLETED|Overall Study||34
351784|NCT02331589|865995|P2|STARTED|Overall Study||36
351785|NCT02331589|865996|P1|STARTED|Overall Study||39
351786|NCT02331446|866012|P4|NOT COMPLETED|Overall Study||3
351787|NCT02331446|866013|P3|NOT COMPLETED|Overall Study||3
351788|NCT02331446|866014|P2|NOT COMPLETED|Overall Study||5
351789|NCT02331446|866015|P1|NOT COMPLETED|Overall Study||4
351790|NCT02331446|866012|P4|COMPLETED|Overall Study||8
351791|NCT02331446|866013|P3|COMPLETED|Overall Study||8
351792|NCT02331446|866014|P2|COMPLETED|Overall Study||6
351793|NCT02331446|866015|P1|COMPLETED|Overall Study||5
351794|NCT02331446|866012|P4|STARTED|Overall Study||11
351795|NCT02331446|866013|P3|STARTED|Overall Study||11
351796|NCT02331446|866014|P2|STARTED|Overall Study||11
351797|NCT02331446|866015|P1|STARTED|Overall Study||9
351798|NCT02331108|866091|P6|NOT COMPLETED|Overall Study||2
351799|NCT02331108|866092|P5|NOT COMPLETED|Overall Study||2
351800|NCT02331108|866093|P4|NOT COMPLETED|Overall Study||1
351801|NCT02331108|866094|P3|NOT COMPLETED|Overall Study||1
351802|NCT02331108|866095|P2|NOT COMPLETED|Overall Study||2
351803|NCT02331108|866096|P1|NOT COMPLETED|Overall Study||1
351804|NCT02331108|866091|P6|COMPLETED|Overall Study||50
351805|NCT02331108|866092|P5|COMPLETED|Overall Study||50
351806|NCT02331108|866093|P4|COMPLETED|Overall Study||50
351807|NCT02331108|866094|P3|COMPLETED|Overall Study||50
351808|NCT02331108|866095|P2|COMPLETED|Overall Study||50
351809|NCT02331108|866096|P1|COMPLETED|Overall Study||50
351810|NCT02331108|866091|P6|STARTED|Overall Study||52
351811|NCT02331108|866092|P5|STARTED|Overall Study||52
351812|NCT02331108|866093|P4|STARTED|Overall Study||51
351813|NCT02331108|866094|P3|STARTED|Overall Study||51
351814|NCT02331108|866095|P2|STARTED|Overall Study||52
351815|NCT02331108|866096|P1|STARTED|Overall Study||51
351816|NCT02330588|866123|P5|NOT COMPLETED|Overall Study||19
351817|NCT02330588|866124|P4|NOT COMPLETED|Overall Study||22
351818|NCT02330588|866125|P3|NOT COMPLETED|Overall Study||15
351819|NCT02330588|866126|P2|NOT COMPLETED|Overall Study||18
351820|NCT02330588|866127|P1|NOT COMPLETED|Overall Study||16
351821|NCT02330588|866123|P5|COMPLETED|Overall Study||28
351822|NCT02330588|866124|P4|COMPLETED|Overall Study||24
351823|NCT02330588|866125|P3|COMPLETED|Overall Study||31
351824|NCT02330588|866126|P2|COMPLETED|Overall Study||25
351825|NCT02330588|866127|P1|COMPLETED|Overall Study||28
351826|NCT02330588|866123|P5|STARTED|Overall Study||47
351827|NCT02330588|866124|P4|STARTED|Overall Study||46
351828|NCT02330588|866125|P3|STARTED|Overall Study||46
351829|NCT02330588|866126|P2|STARTED|Overall Study||43
351830|NCT02330588|866127|P1|STARTED|Overall Study||44
351831|NCT02330523|866154|P2|NOT COMPLETED|Overall Study||0
351832|NCT02330523|866155|P1|NOT COMPLETED|Overall Study||0
351833|NCT02330523|866154|P2|COMPLETED|Overall Study||19
351834|NCT02330523|866155|P1|COMPLETED|Overall Study||21
351835|NCT02330523|866154|P2|STARTED|Overall Study||19
351836|NCT02330523|866155|P1|STARTED|Overall Study||21
351837|NCT02330276|866168|P3|NOT COMPLETED|Overall Study||0
351838|NCT02330276|866169|P2|NOT COMPLETED|Overall Study||0
351839|NCT02330276|866170|P1|NOT COMPLETED|Overall Study||0
351840|NCT02330276|866168|P3|COMPLETED|Overall Study||4
351841|NCT02330276|866169|P2|COMPLETED|Overall Study||4
351842|NCT02330276|866170|P1|COMPLETED|Overall Study||4
351843|NCT02330276|866168|P3|STARTED|Overall Study||4
351844|NCT02330276|866169|P2|STARTED|Overall Study||4
351845|NCT02330276|866170|P1|STARTED|Overall Study||4
351846|NCT02330172|866192|P2|NOT COMPLETED|Overall Study||1
351847|NCT02330172|866193|P1|NOT COMPLETED|Overall Study||3
351848|NCT02330172|866192|P2|COMPLETED|Overall Study||21
351849|NCT02330172|866193|P1|COMPLETED|Overall Study||19
351850|NCT02330172|866192|P2|STARTED|Overall Study||22
351851|NCT02330172|866193|P1|STARTED|Overall Study||22
351852|NCT02330055|866203|P2|NOT COMPLETED|Overall Study||9
351853|NCT02330055|866204|P1|NOT COMPLETED|Overall Study||10
351854|NCT02330055|866203|P2|COMPLETED|Overall Study||40
351855|NCT02330055|866204|P1|COMPLETED|Overall Study||40
351856|NCT02330055|866203|P2|STARTED|Overall Study||49
351857|NCT02330055|866204|P1|STARTED|Overall Study||50
351858|NCT02329964|866224|P2|NOT COMPLETED|Overall Study||0
351859|NCT02329964|866225|P1|NOT COMPLETED|Overall Study||0
351860|NCT02329964|866224|P2|COMPLETED|Overall Study||40
351861|NCT02329964|866225|P1|COMPLETED|Overall Study||40
351862|NCT02329964|866224|P2|STARTED|Overall Study||40
351863|NCT02329964|866225|P1|STARTED|Overall Study||40
351864|NCT02329730|866251|P12|NOT COMPLETED|Overall Study||0
351865|NCT02329730|866252|P11|NOT COMPLETED|Overall Study||0
351866|NCT02329730|866253|P10|NOT COMPLETED|Overall Study||1
351867|NCT02329730|866254|P9|NOT COMPLETED|Overall Study||1
351868|NCT02329730|866255|P8|NOT COMPLETED|Overall Study||1
351869|NCT02329730|866256|P7|NOT COMPLETED|Overall Study||1
351870|NCT02329730|866257|P6|NOT COMPLETED|Overall Study||2
351871|NCT02329730|866258|P5|NOT COMPLETED|Overall Study||3
351872|NCT02329730|866259|P4|NOT COMPLETED|Overall Study||0
351873|NCT02329730|866260|P3|NOT COMPLETED|Overall Study||0
351874|NCT02329730|866261|P2|NOT COMPLETED|Overall Study||0
351875|NCT02329730|866262|P1|NOT COMPLETED|Overall Study||0
351876|NCT02329730|866251|P12|COMPLETED|Overall Study||8
351877|NCT02329730|866252|P11|COMPLETED|Overall Study||8
351878|NCT02329730|866253|P10|COMPLETED|Overall Study||7
351879|NCT02329730|866254|P9|COMPLETED|Overall Study||7
351880|NCT02329730|866255|P8|COMPLETED|Overall Study||13
351881|NCT02329730|866256|P7|COMPLETED|Overall Study||13
351882|NCT02329730|866257|P6|COMPLETED|Overall Study||12
351883|NCT02329730|866258|P5|COMPLETED|Overall Study||11
351884|NCT02329730|866259|P4|COMPLETED|Overall Study||14
351885|NCT02329730|866260|P3|COMPLETED|Overall Study||14
351886|NCT02329730|866261|P2|COMPLETED|Overall Study||14
351887|NCT02329730|866262|P1|COMPLETED|Overall Study||14
351888|NCT02329730|866251|P12|STARTED|Overall Study||8
351889|NCT02329730|866252|P11|STARTED|Overall Study||8
351890|NCT02329730|866253|P10|STARTED|Overall Study||8
351891|NCT02329730|866254|P9|STARTED|Overall Study||8
351892|NCT02329730|866255|P8|STARTED|Overall Study||14
351893|NCT02329730|866256|P7|STARTED|Overall Study||14
351894|NCT02329730|866257|P6|STARTED|Overall Study||14
351895|NCT02329730|866258|P5|STARTED|Overall Study||14
351896|NCT02329730|866259|P4|STARTED|Overall Study||14
351897|NCT02329730|866260|P3|STARTED|Overall Study||14
351898|NCT02329730|866261|P2|STARTED|Overall Study||14
351899|NCT02329730|866262|P1|STARTED|Overall Study||14
351900|NCT02329600|866339|P3|NOT COMPLETED|Overall Study||0
351901|NCT02329600|866340|P2|NOT COMPLETED|Overall Study||0
351902|NCT02329600|866341|P1|NOT COMPLETED|Overall Study||0
351903|NCT02329600|866339|P3|COMPLETED|Overall Study||15
351904|NCT02329600|866340|P2|COMPLETED|Overall Study||15
351905|NCT02329600|866341|P1|COMPLETED|Overall Study||10
351906|NCT02329600|866339|P3|STARTED|Overall Study||15
351907|NCT02329600|866340|P2|STARTED|Overall Study||15
351908|NCT02329600|866341|P1|STARTED|Overall Study||10
351909|NCT02329587|866354|P2|NOT COMPLETED|1-month Follow-up||1
351910|NCT02329587|866355|P1|NOT COMPLETED|1-month Follow-up||0
351911|NCT02329587|866354|P2|COMPLETED|1-month Follow-up||5
351912|NCT02329587|866355|P1|COMPLETED|1-month Follow-up||4
351913|NCT02329587|866354|P2|STARTED|1-month Follow-up||6
351914|NCT02329587|866355|P1|STARTED|1-month Follow-up||4
351915|NCT02329587|866354|P2|NOT COMPLETED|Baseline Thru Post-treatment Assessment||1
351916|NCT02329587|866355|P1|NOT COMPLETED|Baseline Thru Post-treatment Assessment||1
351917|NCT02329587|866354|P2|COMPLETED|Baseline Thru Post-treatment Assessment||6
351918|NCT02329587|866355|P1|COMPLETED|Baseline Thru Post-treatment Assessment||4
351919|NCT02329587|866354|P2|Completed All Intervention Sessions|Baseline Thru Post-treatment Assessment||4
351920|NCT02329587|866355|P1|Completed All Intervention Sessions|Baseline Thru Post-treatment Assessment||3
351921|NCT02329587|866354|P2|STARTED|Baseline Thru Post-treatment Assessment||7
351922|NCT02329587|866355|P1|STARTED|Baseline Thru Post-treatment Assessment||5
351923|NCT02329431|866373|P2|NOT COMPLETED|Overall Study||13
351924|NCT02329431|866374|P1|NOT COMPLETED|Overall Study||20
351925|NCT02329431|866373|P2|COMPLETED|Overall Study||76
351926|NCT02329431|866374|P1|COMPLETED|Overall Study||72
351927|NCT02329431|866373|P2|Baseline Interview|Overall Study||85
351928|NCT02329431|866374|P1|Baseline Interview|Overall Study||87
351929|NCT02329431|866373|P2|STARTED|Overall Study||89
351930|NCT02329431|866374|P1|STARTED|Overall Study||92
351931|NCT02329223|866393|P3|NOT COMPLETED|Overall Study||6
351932|NCT02329223|866394|P2|NOT COMPLETED|Overall Study||3
351933|NCT02329223|866395|P1|NOT COMPLETED|Overall Study||1
351934|NCT02329223|866393|P3|COMPLETED|Overall Study||68
351935|NCT02329223|866394|P2|COMPLETED|Overall Study||68
351936|NCT02329223|866395|P1|COMPLETED|Overall Study||72
351937|NCT02329223|866393|P3|Safety Set|Overall Study||74
351938|NCT02329223|866394|P2|Safety Set|Overall Study||71
351939|NCT02329223|866395|P1|Safety Set|Overall Study||73
351940|NCT02329223|866393|P3|Full Analysis Set|Overall Study||74
351941|NCT02329223|866394|P2|Full Analysis Set|Overall Study||70
351942|NCT02329223|866395|P1|Full Analysis Set|Overall Study||73
351943|NCT02329223|866393|P3|STARTED|Overall Study||74
351944|NCT02329223|866394|P2|STARTED|Overall Study||71
351945|NCT02329223|866395|P1|STARTED|Overall Study||73
351946|NCT02329015|866428|P2|NOT COMPLETED|Overall Study||0
351947|NCT02329015|866429|P1|NOT COMPLETED|Overall Study||0
351948|NCT02329015|866428|P2|COMPLETED|Overall Study||64
351949|NCT02329015|866429|P1|COMPLETED|Overall Study||48
351950|NCT02329015|866428|P2|STARTED|Overall Study||64
351951|NCT02329015|866429|P1|STARTED|Overall Study||48
351952|NCT02328937|866445|P6|NOT COMPLETED|Period 3||0
351953|NCT02328937|866446|P5|NOT COMPLETED|Period 3||0
351954|NCT02328937|866447|P4|NOT COMPLETED|Period 3||0
351955|NCT02328937|866448|P3|NOT COMPLETED|Period 3||0
351956|NCT02328937|866449|P2|NOT COMPLETED|Period 3||0
351957|NCT02328937|866450|P1|NOT COMPLETED|Period 3||0
351958|NCT02328937|866445|P6|COMPLETED|Period 3||6
351959|NCT02328937|866446|P5|COMPLETED|Period 3||6
351960|NCT02328937|866447|P4|COMPLETED|Period 3||5
351961|NCT02328937|866448|P3|COMPLETED|Period 3||6
351962|NCT02328937|866449|P2|COMPLETED|Period 3||6
351963|NCT02328937|866450|P1|COMPLETED|Period 3||7
351964|NCT02328937|866445|P6|STARTED|Period 3||6
351965|NCT02328937|866446|P5|STARTED|Period 3||6
351966|NCT02328937|866447|P4|STARTED|Period 3||5
351967|NCT02328937|866448|P3|STARTED|Period 3||6
351968|NCT02328937|866449|P2|STARTED|Period 3||6
351969|NCT02328937|866450|P1|STARTED|Period 3||7
351970|NCT02328937|866445|P6|NOT COMPLETED|Period 2||0
351971|NCT02328937|866446|P5|NOT COMPLETED|Period 2||0
351972|NCT02328937|866447|P4|NOT COMPLETED|Period 2||0
351973|NCT02328937|866448|P3|NOT COMPLETED|Period 2||1
351974|NCT02328937|866449|P2|NOT COMPLETED|Period 2||0
351975|NCT02328937|866450|P1|NOT COMPLETED|Period 2||0
351976|NCT02328937|866445|P6|COMPLETED|Period 2||6
351977|NCT02328937|866446|P5|COMPLETED|Period 2||6
351978|NCT02328937|866447|P4|COMPLETED|Period 2||5
351979|NCT02328937|866448|P3|COMPLETED|Period 2||6
351980|NCT02328937|866449|P2|COMPLETED|Period 2||6
351981|NCT02328937|866450|P1|COMPLETED|Period 2||7
351982|NCT02328937|866445|P6|STARTED|Period 2||6
351983|NCT02328937|866446|P5|STARTED|Period 2||6
351984|NCT02328937|866447|P4|STARTED|Period 2||5
351985|NCT02328937|866448|P3|STARTED|Period 2||7
351986|NCT02328937|866449|P2|STARTED|Period 2||6
351987|NCT02328937|866450|P1|STARTED|Period 2||7
351988|NCT02328937|866445|P6|NOT COMPLETED|Period 1||0
351989|NCT02328937|866446|P5|NOT COMPLETED|Period 1||0
351990|NCT02328937|866447|P4|NOT COMPLETED|Period 1||1
351991|NCT02328937|866448|P3|NOT COMPLETED|Period 1||0
351992|NCT02328937|866449|P2|NOT COMPLETED|Period 1||0
351993|NCT02328937|866450|P1|NOT COMPLETED|Period 1||0
351994|NCT02328937|866445|P6|COMPLETED|Period 1||6
351995|NCT02328937|866446|P5|COMPLETED|Period 1||6
351996|NCT02328937|866447|P4|COMPLETED|Period 1||5
351997|NCT02328937|866448|P3|COMPLETED|Period 1||7
351998|NCT02328937|866449|P2|COMPLETED|Period 1||6
351999|NCT02328937|866450|P1|COMPLETED|Period 1||7
352000|NCT02328937|866445|P6|STARTED|Period 1||6
352001|NCT02328937|866446|P5|STARTED|Period 1||6
352002|NCT02328937|866447|P4|STARTED|Period 1||6
352003|NCT02328937|866448|P3|STARTED|Period 1||7
352004|NCT02328937|866449|P2|STARTED|Period 1||6
352005|NCT02328937|866450|P1|STARTED|Period 1||7
352006|NCT02328404|866463|P2|NOT COMPLETED|Overall Study||1
352007|NCT02328404|866464|P1|NOT COMPLETED|Overall Study||1
352008|NCT02328404|866463|P2|COMPLETED|Overall Study||29
352009|NCT02328404|866464|P1|COMPLETED|Overall Study||29
352010|NCT02328404|866463|P2|STARTED|Overall Study||30
352011|NCT02328404|866464|P1|STARTED|Overall Study||30
352012|NCT02327429|866498|P1|NOT COMPLETED|Overall Study||2
352013|NCT02327429|866498|P1|COMPLETED|Overall Study||17
352014|NCT02327429|866498|P1|STARTED|Overall Study||19
352015|NCT02327117|866520|P2|NOT COMPLETED|Overall Study||0
352016|NCT02327117|866521|P1|NOT COMPLETED|Overall Study||0
352017|NCT02327117|866520|P2|COMPLETED|Overall Study||45
352018|NCT02327117|866521|P1|COMPLETED|Overall Study||45
352019|NCT02327117|866520|P2|STARTED|Overall Study||45
352020|NCT02327117|866521|P1|STARTED|Overall Study||45
352021|NCT02327013|866530|P5|NOT COMPLETED|Overall Study||4
352022|NCT02327013|866531|P4|NOT COMPLETED|Overall Study||1
352023|NCT02327013|866532|P3|NOT COMPLETED|Overall Study||42
352024|NCT02327013|866533|P2|NOT COMPLETED|Overall Study||16
352025|NCT02327013|866534|P1|NOT COMPLETED|Overall Study||13
352026|NCT02327013|866530|P5|COMPLETED|Overall Study||12
352027|NCT02327013|866531|P4|COMPLETED|Overall Study||20
352028|NCT02327013|866532|P3|COMPLETED|Overall Study||54
352029|NCT02327013|866533|P2|COMPLETED|Overall Study||29
352030|NCT02327013|866534|P1|COMPLETED|Overall Study||36
352031|NCT02327013|866530|P5|STARTED|Overall Study||16
352032|NCT02327013|866531|P4|STARTED|Overall Study||21
352033|NCT02327013|866532|P3|STARTED|Overall Study||96
352034|NCT02327013|866533|P2|STARTED|Overall Study||45
352035|NCT02327013|866534|P1|STARTED|Overall Study||49
352036|NCT02326844|866707|P1|NOT COMPLETED|Overall Study||0
352037|NCT02326844|866707|P1|COMPLETED|Overall Study||3
352038|NCT02326844|866707|P1|STARTED|Overall Study||3
352039|NCT02326649|866714|P1|NOT COMPLETED|Overall Study||12
352040|NCT02326649|866714|P1|COMPLETED|Overall Study||21
352041|NCT02326649|866714|P1|STARTED|Overall Study||33
352042|NCT02325856|866720|P2|NOT COMPLETED|Overall Study||27
352043|NCT02325856|866721|P1|NOT COMPLETED|Overall Study||20
352044|NCT02325856|866720|P2|COMPLETED|Overall Study||123
352045|NCT02325856|866721|P1|COMPLETED|Overall Study||128
352046|NCT02325856|866720|P2|STARTED|Overall Study||150
352047|NCT02325856|866721|P1|STARTED|Overall Study||148
352048|NCT02325713|866745|P16|NOT COMPLETED|Intervention Period 4 (2 Days)||0
352049|NCT02325713|866746|P15|NOT COMPLETED|Intervention Period 4 (2 Days)||0
352050|NCT02325713|866747|P14|NOT COMPLETED|Intervention Period 4 (2 Days)||0
352051|NCT02325713|866748|P13|NOT COMPLETED|Intervention Period 4 (2 Days)||0
352052|NCT02325713|866749|P12|NOT COMPLETED|Intervention Period 4 (2 Days)||0
352053|NCT02325713|866750|P11|NOT COMPLETED|Intervention Period 4 (2 Days)||0
352054|NCT02325713|866751|P10|NOT COMPLETED|Intervention Period 4 (2 Days)||0
352055|NCT02325713|866752|P9|NOT COMPLETED|Intervention Period 4 (2 Days)||0
352056|NCT02325713|866753|P8|NOT COMPLETED|Intervention Period 4 (2 Days)||0
352057|NCT02325713|866754|P7|NOT COMPLETED|Intervention Period 4 (2 Days)||0
352058|NCT02325713|866755|P6|NOT COMPLETED|Intervention Period 4 (2 Days)||0
352059|NCT02325713|866756|P5|NOT COMPLETED|Intervention Period 4 (2 Days)||0
352060|NCT02325713|866757|P4|NOT COMPLETED|Intervention Period 4 (2 Days)||0
352061|NCT02325713|866758|P3|NOT COMPLETED|Intervention Period 4 (2 Days)||0
352062|NCT02325713|866759|P2|NOT COMPLETED|Intervention Period 4 (2 Days)||0
352063|NCT02325713|866760|P1|NOT COMPLETED|Intervention Period 4 (2 Days)||0
352064|NCT02325713|866745|P16|COMPLETED|Intervention Period 4 (2 Days)||2
352065|NCT02325713|866746|P15|COMPLETED|Intervention Period 4 (2 Days)||2
352066|NCT02325713|866747|P14|COMPLETED|Intervention Period 4 (2 Days)||2
352067|NCT02325713|866748|P13|COMPLETED|Intervention Period 4 (2 Days)||2
352068|NCT02325713|866749|P12|COMPLETED|Intervention Period 4 (2 Days)||2
352069|NCT02325713|866750|P11|COMPLETED|Intervention Period 4 (2 Days)||1
352070|NCT02325713|866751|P10|COMPLETED|Intervention Period 4 (2 Days)||1
352071|NCT02325713|866752|P9|COMPLETED|Intervention Period 4 (2 Days)||2
352072|NCT02325713|866753|P8|COMPLETED|Intervention Period 4 (2 Days)||2
352073|NCT02325713|866754|P7|COMPLETED|Intervention Period 4 (2 Days)||2
352074|NCT02325713|866755|P6|COMPLETED|Intervention Period 4 (2 Days)||2
352075|NCT02325713|866756|P5|COMPLETED|Intervention Period 4 (2 Days)||2
352076|NCT02325713|866757|P4|COMPLETED|Intervention Period 4 (2 Days)||2
352077|NCT02325713|866758|P3|COMPLETED|Intervention Period 4 (2 Days)||2
352078|NCT02325713|866759|P2|COMPLETED|Intervention Period 4 (2 Days)||2
352079|NCT02325713|866760|P1|COMPLETED|Intervention Period 4 (2 Days)||1
352080|NCT02325713|866745|P16|STARTED|Intervention Period 4 (2 Days)||2
352081|NCT02325713|866746|P15|STARTED|Intervention Period 4 (2 Days)||2
352082|NCT02325713|866747|P14|STARTED|Intervention Period 4 (2 Days)||2
352083|NCT02325713|866748|P13|STARTED|Intervention Period 4 (2 Days)||2
352084|NCT02325713|866749|P12|STARTED|Intervention Period 4 (2 Days)||2
352085|NCT02325713|866750|P11|STARTED|Intervention Period 4 (2 Days)||1
352086|NCT02325713|866751|P10|STARTED|Intervention Period 4 (2 Days)||1
352087|NCT02325713|866752|P9|STARTED|Intervention Period 4 (2 Days)||2
352088|NCT02325713|866753|P8|STARTED|Intervention Period 4 (2 Days)||2
352089|NCT02325713|866754|P7|STARTED|Intervention Period 4 (2 Days)||2
352090|NCT02325713|866755|P6|STARTED|Intervention Period 4 (2 Days)||2
352091|NCT02325713|866756|P5|STARTED|Intervention Period 4 (2 Days)||2
352092|NCT02325713|866757|P4|STARTED|Intervention Period 4 (2 Days)||2
352093|NCT02325713|866758|P3|STARTED|Intervention Period 4 (2 Days)||2
352094|NCT02325713|866759|P2|STARTED|Intervention Period 4 (2 Days)||2
352095|NCT02325713|866760|P1|STARTED|Intervention Period 4 (2 Days)||1
352096|NCT02325713|866745|P16|NOT COMPLETED|Intervention Period 3 (2 Days)||0
352097|NCT02325713|866746|P15|NOT COMPLETED|Intervention Period 3 (2 Days)||0
352098|NCT02325713|866747|P14|NOT COMPLETED|Intervention Period 3 (2 Days)||0
352099|NCT02325713|866748|P13|NOT COMPLETED|Intervention Period 3 (2 Days)||0
352100|NCT02325713|866749|P12|NOT COMPLETED|Intervention Period 3 (2 Days)||0
352101|NCT02325713|866750|P11|NOT COMPLETED|Intervention Period 3 (2 Days)||0
352102|NCT02325713|866751|P10|NOT COMPLETED|Intervention Period 3 (2 Days)||1
352103|NCT02325713|866752|P9|NOT COMPLETED|Intervention Period 3 (2 Days)||0
352104|NCT02325713|866753|P8|NOT COMPLETED|Intervention Period 3 (2 Days)||0
352105|NCT02325713|866754|P7|NOT COMPLETED|Intervention Period 3 (2 Days)||0
352106|NCT02325713|866755|P6|NOT COMPLETED|Intervention Period 3 (2 Days)||0
352107|NCT02325713|866756|P5|NOT COMPLETED|Intervention Period 3 (2 Days)||0
352108|NCT02325713|866757|P4|NOT COMPLETED|Intervention Period 3 (2 Days)||0
352109|NCT02325713|866758|P3|NOT COMPLETED|Intervention Period 3 (2 Days)||0
352110|NCT02325713|866759|P2|NOT COMPLETED|Intervention Period 3 (2 Days)||0
352111|NCT02325713|866760|P1|NOT COMPLETED|Intervention Period 3 (2 Days)||0
352112|NCT02325713|866745|P16|COMPLETED|Intervention Period 3 (2 Days)||2
352113|NCT02325713|866746|P15|COMPLETED|Intervention Period 3 (2 Days)||2
352114|NCT02325713|866747|P14|COMPLETED|Intervention Period 3 (2 Days)||2
352115|NCT02325713|866748|P13|COMPLETED|Intervention Period 3 (2 Days)||2
352116|NCT02325713|866749|P12|COMPLETED|Intervention Period 3 (2 Days)||2
352117|NCT02325713|866750|P11|COMPLETED|Intervention Period 3 (2 Days)||1
352118|NCT02325713|866751|P10|COMPLETED|Intervention Period 3 (2 Days)||1
352119|NCT02325713|866752|P9|COMPLETED|Intervention Period 3 (2 Days)||2
352120|NCT02325713|866753|P8|COMPLETED|Intervention Period 3 (2 Days)||2
352121|NCT02325713|866754|P7|COMPLETED|Intervention Period 3 (2 Days)||2
352122|NCT02325713|866755|P6|COMPLETED|Intervention Period 3 (2 Days)||2
352123|NCT02325713|866756|P5|COMPLETED|Intervention Period 3 (2 Days)||2
352124|NCT02325713|866757|P4|COMPLETED|Intervention Period 3 (2 Days)||2
352125|NCT02325713|866758|P3|COMPLETED|Intervention Period 3 (2 Days)||2
352126|NCT02325713|866759|P2|COMPLETED|Intervention Period 3 (2 Days)||2
352127|NCT02325713|866760|P1|COMPLETED|Intervention Period 3 (2 Days)||1
352128|NCT02325713|866745|P16|STARTED|Intervention Period 3 (2 Days)||2
352129|NCT02325713|866746|P15|STARTED|Intervention Period 3 (2 Days)||2
352130|NCT02325713|866747|P14|STARTED|Intervention Period 3 (2 Days)||2
352131|NCT02325713|866748|P13|STARTED|Intervention Period 3 (2 Days)||2
352132|NCT02325713|866749|P12|STARTED|Intervention Period 3 (2 Days)||2
352133|NCT02325713|866750|P11|STARTED|Intervention Period 3 (2 Days)||1
352134|NCT02325713|866751|P10|STARTED|Intervention Period 3 (2 Days)||2
352135|NCT02325713|866752|P9|STARTED|Intervention Period 3 (2 Days)||2
352136|NCT02325713|866753|P8|STARTED|Intervention Period 3 (2 Days)||2
352137|NCT02325713|866754|P7|STARTED|Intervention Period 3 (2 Days)||2
352138|NCT02325713|866755|P6|STARTED|Intervention Period 3 (2 Days)||2
352139|NCT02325713|866756|P5|STARTED|Intervention Period 3 (2 Days)||2
352140|NCT02325713|866757|P4|STARTED|Intervention Period 3 (2 Days)||2
352141|NCT02325713|866758|P3|STARTED|Intervention Period 3 (2 Days)||2
352142|NCT02325713|866759|P2|STARTED|Intervention Period 3 (2 Days)||2
352143|NCT02325713|866760|P1|STARTED|Intervention Period 3 (2 Days)||1
352144|NCT02325713|866745|P16|NOT COMPLETED|Intervention Period 2 (2 Days)||0
352145|NCT02325713|866746|P15|NOT COMPLETED|Intervention Period 2 (2 Days)||0
352146|NCT02325713|866747|P14|NOT COMPLETED|Intervention Period 2 (2 Days)||0
352147|NCT02325713|866748|P13|NOT COMPLETED|Intervention Period 2 (2 Days)||0
352148|NCT02325713|866749|P12|NOT COMPLETED|Intervention Period 2 (2 Days)||0
352149|NCT02325713|866750|P11|NOT COMPLETED|Intervention Period 2 (2 Days)||0
352150|NCT02325713|866751|P10|NOT COMPLETED|Intervention Period 2 (2 Days)||0
352151|NCT02325713|866752|P9|NOT COMPLETED|Intervention Period 2 (2 Days)||0
352152|NCT02325713|866753|P8|NOT COMPLETED|Intervention Period 2 (2 Days)||0
352153|NCT02325713|866754|P7|NOT COMPLETED|Intervention Period 2 (2 Days)||0
352154|NCT02325713|866755|P6|NOT COMPLETED|Intervention Period 2 (2 Days)||0
352155|NCT02325713|866756|P5|NOT COMPLETED|Intervention Period 2 (2 Days)||0
352156|NCT02325713|866757|P4|NOT COMPLETED|Intervention Period 2 (2 Days)||0
352157|NCT02325713|866758|P3|NOT COMPLETED|Intervention Period 2 (2 Days)||0
352158|NCT02325713|866759|P2|NOT COMPLETED|Intervention Period 2 (2 Days)||0
352159|NCT02325713|866760|P1|NOT COMPLETED|Intervention Period 2 (2 Days)||1
352160|NCT02325713|866745|P16|COMPLETED|Intervention Period 2 (2 Days)||2
352161|NCT02325713|866746|P15|COMPLETED|Intervention Period 2 (2 Days)||2
352162|NCT02325713|866747|P14|COMPLETED|Intervention Period 2 (2 Days)||2
352163|NCT02325713|866748|P13|COMPLETED|Intervention Period 2 (2 Days)||2
352164|NCT02325713|866749|P12|COMPLETED|Intervention Period 2 (2 Days)||2
352165|NCT02325713|866750|P11|COMPLETED|Intervention Period 2 (2 Days)||1
352166|NCT02325713|866751|P10|COMPLETED|Intervention Period 2 (2 Days)||2
352167|NCT02325713|866752|P9|COMPLETED|Intervention Period 2 (2 Days)||2
352168|NCT02325713|866753|P8|COMPLETED|Intervention Period 2 (2 Days)||2
352169|NCT02325713|866754|P7|COMPLETED|Intervention Period 2 (2 Days)||2
352170|NCT02325713|866755|P6|COMPLETED|Intervention Period 2 (2 Days)||2
352171|NCT02325713|866756|P5|COMPLETED|Intervention Period 2 (2 Days)||2
352172|NCT02325713|866757|P4|COMPLETED|Intervention Period 2 (2 Days)||2
352173|NCT02325713|866758|P3|COMPLETED|Intervention Period 2 (2 Days)||2
352174|NCT02325713|866759|P2|COMPLETED|Intervention Period 2 (2 Days)||2
352175|NCT02325713|866760|P1|COMPLETED|Intervention Period 2 (2 Days)||1
352176|NCT02325713|866745|P16|STARTED|Intervention Period 2 (2 Days)||2
352177|NCT02325713|866746|P15|STARTED|Intervention Period 2 (2 Days)||2
352178|NCT02325713|866747|P14|STARTED|Intervention Period 2 (2 Days)||2
352179|NCT02325713|866748|P13|STARTED|Intervention Period 2 (2 Days)||2
352180|NCT02325713|866749|P12|STARTED|Intervention Period 2 (2 Days)||2
352181|NCT02325713|866750|P11|STARTED|Intervention Period 2 (2 Days)||1
352182|NCT02325713|866751|P10|STARTED|Intervention Period 2 (2 Days)||2
352183|NCT02325713|866752|P9|STARTED|Intervention Period 2 (2 Days)||2
352184|NCT02325713|866753|P8|STARTED|Intervention Period 2 (2 Days)||2
352185|NCT02325713|866754|P7|STARTED|Intervention Period 2 (2 Days)||2
352186|NCT02325713|866755|P6|STARTED|Intervention Period 2 (2 Days)||2
352187|NCT02325713|866756|P5|STARTED|Intervention Period 2 (2 Days)||2
352188|NCT02325713|866757|P4|STARTED|Intervention Period 2 (2 Days)||2
352189|NCT02325713|866758|P3|STARTED|Intervention Period 2 (2 Days)||2
352190|NCT02325713|866759|P2|STARTED|Intervention Period 2 (2 Days)||2
352191|NCT02325713|866760|P1|STARTED|Intervention Period 2 (2 Days)||2
352192|NCT02325713|866745|P16|NOT COMPLETED|Intervention Period 1 (2 Days)||0
352193|NCT02325713|866746|P15|NOT COMPLETED|Intervention Period 1 (2 Days)||0
352194|NCT02325713|866747|P14|NOT COMPLETED|Intervention Period 1 (2 Days)||0
352195|NCT02325713|866748|P13|NOT COMPLETED|Intervention Period 1 (2 Days)||0
352196|NCT02325713|866749|P12|NOT COMPLETED|Intervention Period 1 (2 Days)||0
352197|NCT02325713|866750|P11|NOT COMPLETED|Intervention Period 1 (2 Days)||1
352198|NCT02325713|866751|P10|NOT COMPLETED|Intervention Period 1 (2 Days)||0
352199|NCT02325713|866752|P9|NOT COMPLETED|Intervention Period 1 (2 Days)||0
352200|NCT02325713|866753|P8|NOT COMPLETED|Intervention Period 1 (2 Days)||0
352201|NCT02325713|866754|P7|NOT COMPLETED|Intervention Period 1 (2 Days)||0
352202|NCT02325713|866755|P6|NOT COMPLETED|Intervention Period 1 (2 Days)||0
352203|NCT02325713|866756|P5|NOT COMPLETED|Intervention Period 1 (2 Days)||0
352204|NCT02325713|866757|P4|NOT COMPLETED|Intervention Period 1 (2 Days)||0
352205|NCT02325713|866758|P3|NOT COMPLETED|Intervention Period 1 (2 Days)||0
352206|NCT02325713|866759|P2|NOT COMPLETED|Intervention Period 1 (2 Days)||0
352207|NCT02325713|866760|P1|NOT COMPLETED|Intervention Period 1 (2 Days)||0
352208|NCT02325713|866745|P16|COMPLETED|Intervention Period 1 (2 Days)||2
352209|NCT02325713|866746|P15|COMPLETED|Intervention Period 1 (2 Days)||2
352210|NCT02325713|866747|P14|COMPLETED|Intervention Period 1 (2 Days)||2
352211|NCT02325713|866748|P13|COMPLETED|Intervention Period 1 (2 Days)||2
352212|NCT02325713|866749|P12|COMPLETED|Intervention Period 1 (2 Days)||2
352213|NCT02325713|866750|P11|COMPLETED|Intervention Period 1 (2 Days)||1
352214|NCT02325713|866751|P10|COMPLETED|Intervention Period 1 (2 Days)||2
352215|NCT02325713|866752|P9|COMPLETED|Intervention Period 1 (2 Days)||2
352216|NCT02325713|866753|P8|COMPLETED|Intervention Period 1 (2 Days)||2
352217|NCT02325713|866754|P7|COMPLETED|Intervention Period 1 (2 Days)||2
352218|NCT02325713|866755|P6|COMPLETED|Intervention Period 1 (2 Days)||2
352219|NCT02325713|866756|P5|COMPLETED|Intervention Period 1 (2 Days)||2
352220|NCT02325713|866757|P4|COMPLETED|Intervention Period 1 (2 Days)||2
352221|NCT02325713|866758|P3|COMPLETED|Intervention Period 1 (2 Days)||2
352222|NCT02325713|866759|P2|COMPLETED|Intervention Period 1 (2 Days)||2
352223|NCT02325713|866760|P1|COMPLETED|Intervention Period 1 (2 Days)||2
352224|NCT02325713|866745|P16|STARTED|Intervention Period 1 (2 Days)||2
352225|NCT02325713|866746|P15|STARTED|Intervention Period 1 (2 Days)||2
352226|NCT02325713|866747|P14|STARTED|Intervention Period 1 (2 Days)||2
352227|NCT02325713|866748|P13|STARTED|Intervention Period 1 (2 Days)||2
352228|NCT02325713|866749|P12|STARTED|Intervention Period 1 (2 Days)||2
352229|NCT02325713|866750|P11|STARTED|Intervention Period 1 (2 Days)||2
352230|NCT02325713|866751|P10|STARTED|Intervention Period 1 (2 Days)||2
352231|NCT02325713|866752|P9|STARTED|Intervention Period 1 (2 Days)||2
352232|NCT02325713|866753|P8|STARTED|Intervention Period 1 (2 Days)||2
352233|NCT02325713|866754|P7|STARTED|Intervention Period 1 (2 Days)||2
352234|NCT02325713|866755|P6|STARTED|Intervention Period 1 (2 Days)||2
352235|NCT02325713|866756|P5|STARTED|Intervention Period 1 (2 Days)||2
352236|NCT02325713|866757|P4|STARTED|Intervention Period 1 (2 Days)||2
352237|NCT02325713|866758|P3|STARTED|Intervention Period 1 (2 Days)||2
352238|NCT02325713|866759|P2|STARTED|Intervention Period 1 (2 Days)||2
352239|NCT02325713|866760|P1|STARTED|Intervention Period 1 (2 Days)||2
352240|NCT02325518|866855|P2|NOT COMPLETED|Overall Study||3
352241|NCT02325518|866856|P1|NOT COMPLETED|Overall Study||4
352242|NCT02325518|866855|P2|COMPLETED|Overall Study||100
352243|NCT02325518|866856|P1|COMPLETED|Overall Study||94
352244|NCT02325518|866855|P2|Per Protocol Set (PPS)|Overall Study||97
352245|NCT02325518|866856|P1|Per Protocol Set (PPS)|Overall Study||92
352246|NCT02325518|866855|P2|Full Analysis Set (FAS)|Overall Study||101
352247|NCT02325518|866856|P1|Full Analysis Set (FAS)|Overall Study||98
352248|NCT02325518|866855|P2|Safety Set|Overall Study||103
352249|NCT02325518|866856|P1|Safety Set|Overall Study||98
352250|NCT02325518|866855|P2|STARTED|Overall Study||103
352251|NCT02325518|866856|P1|STARTED|Overall Study||98
352252|NCT02324673|866868|P3|NOT COMPLETED|Overall Study||0
352253|NCT02324673|866869|P2|NOT COMPLETED|Overall Study||0
352254|NCT02324673|866870|P1|NOT COMPLETED|Overall Study||0
352255|NCT02324673|866868|P3|COMPLETED|Overall Study||21
352256|NCT02324673|866869|P2|COMPLETED|Overall Study||20
352257|NCT02324673|866870|P1|COMPLETED|Overall Study||20
352258|NCT02324673|866868|P3|STARTED|Overall Study||21
352259|NCT02324673|866869|P2|STARTED|Overall Study||20
352260|NCT02324673|866870|P1|STARTED|Overall Study||20
352261|NCT02324660|866971|P1|NOT COMPLETED|Overall Study||32
352262|NCT02324660|866971|P1|COMPLETED|Overall Study||137
352263|NCT02324660|866971|P1|STARTED|Overall Study||169
352264|NCT02324504|866976|P1|NOT COMPLETED|Overall Study||0
352265|NCT02324504|866976|P1|COMPLETED|Overall Study||60
352266|NCT02324504|866976|P1|STARTED|Overall Study||60
352267|NCT02323854|866983|P1|NOT COMPLETED|Overall Study||0
352268|NCT02323854|866983|P1|COMPLETED|Overall Study||15
352269|NCT02323854|866983|P1|STARTED|Overall Study||15
352270|NCT02322892|866991|P2|NOT COMPLETED|Overall Study||3
352271|NCT02322892|866992|P1|NOT COMPLETED|Overall Study||2
352272|NCT02322892|866991|P2|COMPLETED|Overall Study|Received thiamine|31
352273|NCT02322892|866992|P1|COMPLETED|Overall Study|Received placebo|33
352274|NCT02322892|866991|P2|STARTED|Overall Study|Number randomized|34
352275|NCT02322892|866992|P1|STARTED|Overall Study|Number randomized|35
352276|NCT02322879|867008|P2|NOT COMPLETED|Second Intervention||0
352277|NCT02322879|867009|P1|NOT COMPLETED|Second Intervention||0
352278|NCT02322879|867008|P2|COMPLETED|Second Intervention||10
352279|NCT02322879|867009|P1|COMPLETED|Second Intervention||10
352280|NCT02322879|867008|P2|STARTED|Second Intervention||10
352281|NCT02322879|867009|P1|STARTED|Second Intervention||10
352282|NCT02322879|867008|P2|NOT COMPLETED|Washout||0
352283|NCT02322879|867009|P1|NOT COMPLETED|Washout||0
352284|NCT02322879|867008|P2|COMPLETED|Washout||10
352285|NCT02322879|867009|P1|COMPLETED|Washout||10
352286|NCT02322879|867008|P2|STARTED|Washout||10
352287|NCT02322879|867009|P1|STARTED|Washout||10
352288|NCT02322879|867008|P2|NOT COMPLETED|First Intervention||0
352289|NCT02322879|867009|P1|NOT COMPLETED|First Intervention||1
352290|NCT02322879|867008|P2|COMPLETED|First Intervention||10
352291|NCT02322879|867009|P1|COMPLETED|First Intervention||10
352292|NCT02322879|867008|P2|STARTED|First Intervention||10
352293|NCT02322879|867009|P1|STARTED|First Intervention||11
352294|NCT02322866|867017|P2|NOT COMPLETED|Overall Study||86
352295|NCT02322866|867018|P1|NOT COMPLETED|Overall Study||71
352296|NCT02322866|867017|P2|COMPLETED|Overall Study||433
352297|NCT02322866|867018|P1|COMPLETED|Overall Study||444
352298|NCT02322866|867017|P2|STARTED|Overall Study||519
352299|NCT02322866|867018|P1|STARTED|Overall Study||515
352300|NCT02322788|867040|P4|NOT COMPLETED|Visit 6||0
352301|NCT02322788|867041|P3|NOT COMPLETED|Visit 6||0
352302|NCT02322788|867042|P2|NOT COMPLETED|Visit 6||0
352303|NCT02322788|867043|P1|NOT COMPLETED|Visit 6||0
352304|NCT02322788|867040|P4|COMPLETED|Visit 6||15
352305|NCT02322788|867041|P3|COMPLETED|Visit 6||15
352306|NCT02322788|867042|P2|COMPLETED|Visit 6||16
352307|NCT02322788|867043|P1|COMPLETED|Visit 6||14
352308|NCT02322788|867040|P4|STARTED|Visit 6||15
352309|NCT02322788|867041|P3|STARTED|Visit 6||15
352310|NCT02322788|867042|P2|STARTED|Visit 6||16
352311|NCT02322788|867043|P1|STARTED|Visit 6||14
352312|NCT02322788|867040|P4|NOT COMPLETED|Visit 5||0
352313|NCT02322788|867041|P3|NOT COMPLETED|Visit 5||0
352314|NCT02322788|867042|P2|NOT COMPLETED|Visit 5||0
352315|NCT02322788|867043|P1|NOT COMPLETED|Visit 5||0
352316|NCT02322788|867040|P4|COMPLETED|Visit 5||14
352317|NCT02322788|867041|P3|COMPLETED|Visit 5||15
352318|NCT02322788|867042|P2|COMPLETED|Visit 5||15
352319|NCT02322788|867043|P1|COMPLETED|Visit 5||16
352320|NCT02322788|867040|P4|STARTED|Visit 5||14
352321|NCT02322788|867041|P3|STARTED|Visit 5||15
352322|NCT02322788|867042|P2|STARTED|Visit 5||15
352323|NCT02322788|867043|P1|STARTED|Visit 5||16
352324|NCT02322788|867040|P4|NOT COMPLETED|Visit 4||0
352325|NCT02322788|867041|P3|NOT COMPLETED|Visit 4||0
352326|NCT02322788|867042|P2|NOT COMPLETED|Visit 4||0
352327|NCT02322788|867043|P1|NOT COMPLETED|Visit 4||0
352328|NCT02322788|867040|P4|COMPLETED|Visit 4||15
352329|NCT02322788|867041|P3|COMPLETED|Visit 4||16
352330|NCT02322788|867042|P2|COMPLETED|Visit 4||14
352331|NCT02322788|867043|P1|COMPLETED|Visit 4||15
352332|NCT02322788|867040|P4|STARTED|Visit 4||15
352333|NCT02322788|867041|P3|STARTED|Visit 4||16
352334|NCT02322788|867042|P2|STARTED|Visit 4||14
352335|NCT02322788|867043|P1|STARTED|Visit 4||15
352336|NCT02322788|867040|P4|NOT COMPLETED|Visit 3||0
352337|NCT02322788|867041|P3|NOT COMPLETED|Visit 3||0
352338|NCT02322788|867042|P2|NOT COMPLETED|Visit 3||0
352339|NCT02322788|867043|P1|NOT COMPLETED|Visit 3||0
352340|NCT02322788|867040|P4|COMPLETED|Visit 3||16
352341|NCT02322788|867041|P3|COMPLETED|Visit 3||14
352342|NCT02322788|867042|P2|COMPLETED|Visit 3||15
352343|NCT02322788|867043|P1|COMPLETED|Visit 3||15
352344|NCT02322788|867040|P4|STARTED|Visit 3||16
352345|NCT02322788|867041|P3|STARTED|Visit 3||14
352346|NCT02322788|867042|P2|STARTED|Visit 3||15
352347|NCT02322788|867043|P1|STARTED|Visit 3||15
352348|NCT02322775|867055|P2|NOT COMPLETED|Overall Study||6
352349|NCT02322775|867056|P1|NOT COMPLETED|Overall Study||5
352350|NCT02322775|867055|P2|COMPLETED|Overall Study||99
352351|NCT02322775|867056|P1|COMPLETED|Overall Study||101
352352|NCT02322775|867055|P2|STARTED|Overall Study||105
352353|NCT02322775|867056|P1|STARTED|Overall Study||106
352354|NCT02322749|867082|P6|NOT COMPLETED|Period 3||0
352355|NCT02322749|867083|P5|NOT COMPLETED|Period 3||0
352356|NCT02322749|867084|P4|NOT COMPLETED|Period 3||0
352357|NCT02322749|867085|P3|NOT COMPLETED|Period 3||1
352358|NCT02322749|867086|P2|NOT COMPLETED|Period 3||0
352359|NCT02322749|867087|P1|NOT COMPLETED|Period 3||0
352360|NCT02322749|867082|P6|COMPLETED|Period 3||8
352361|NCT02322749|867083|P5|COMPLETED|Period 3||8
352362|NCT02322749|867084|P4|COMPLETED|Period 3||6
352363|NCT02322749|867085|P3|COMPLETED|Period 3||7
352364|NCT02322749|867086|P2|COMPLETED|Period 3||8
352365|NCT02322749|867087|P1|COMPLETED|Period 3||8
352366|NCT02322749|867082|P6|STARTED|Period 3||8
352367|NCT02322749|867083|P5|STARTED|Period 3||8
352368|NCT02322749|867084|P4|STARTED|Period 3||6
352369|NCT02322749|867085|P3|STARTED|Period 3||8
352370|NCT02322749|867086|P2|STARTED|Period 3||8
352371|NCT02322749|867087|P1|STARTED|Period 3||8
352372|NCT02322749|867082|P6|NOT COMPLETED|Period 2||0
352373|NCT02322749|867083|P5|NOT COMPLETED|Period 2||0
352374|NCT02322749|867084|P4|NOT COMPLETED|Period 2||2
352375|NCT02322749|867085|P3|NOT COMPLETED|Period 2||0
352376|NCT02322749|867086|P2|NOT COMPLETED|Period 2||0
352377|NCT02322749|867087|P1|NOT COMPLETED|Period 2||0
352378|NCT02322749|867082|P6|COMPLETED|Period 2||8
352379|NCT02322749|867083|P5|COMPLETED|Period 2||8
352380|NCT02322749|867084|P4|COMPLETED|Period 2||6
352381|NCT02322749|867085|P3|COMPLETED|Period 2||8
352382|NCT02322749|867086|P2|COMPLETED|Period 2||8
352383|NCT02322749|867087|P1|COMPLETED|Period 2||8
352384|NCT02322749|867082|P6|STARTED|Period 2||8
352385|NCT02322749|867083|P5|STARTED|Period 2||8
352386|NCT02322749|867084|P4|STARTED|Period 2||8
352387|NCT02322749|867085|P3|STARTED|Period 2||8
352388|NCT02322749|867086|P2|STARTED|Period 2||8
352389|NCT02322749|867087|P1|STARTED|Period 2||8
352390|NCT02322749|867082|P6|NOT COMPLETED|Period 1||0
352391|NCT02322749|867083|P5|NOT COMPLETED|Period 1||0
352392|NCT02322749|867084|P4|NOT COMPLETED|Period 1||0
352393|NCT02322749|867085|P3|NOT COMPLETED|Period 1||0
352394|NCT02322749|867086|P2|NOT COMPLETED|Period 1||0
352395|NCT02322749|867087|P1|NOT COMPLETED|Period 1||0
352396|NCT02322749|867082|P6|COMPLETED|Period 1||8
352397|NCT02322749|867083|P5|COMPLETED|Period 1||8
352398|NCT02322749|867084|P4|COMPLETED|Period 1||8
352399|NCT02322749|867085|P3|COMPLETED|Period 1||8
352400|NCT02322749|867086|P2|COMPLETED|Period 1||8
352401|NCT02322749|867087|P1|COMPLETED|Period 1||8
352402|NCT02322749|867082|P6|STARTED|Period 1||8
352403|NCT02322749|867083|P5|STARTED|Period 1||8
352404|NCT02322749|867084|P4|STARTED|Period 1||8
352405|NCT02322749|867085|P3|STARTED|Period 1||8
352406|NCT02322749|867086|P2|STARTED|Period 1||8
352407|NCT02322749|867087|P1|STARTED|Period 1||8
352408|NCT02322528|867110|P1|NOT COMPLETED|Overall Study||0
352409|NCT02322528|867110|P1|COMPLETED|Overall Study||10
352410|NCT02322528|867110|P1|STARTED|Overall Study||10
352411|NCT02322216|867117|P2|NOT COMPLETED|Overall Study||4
352412|NCT02322216|867118|P1|NOT COMPLETED|Overall Study||2
352413|NCT02322216|867117|P2|COMPLETED|Overall Study||123
352414|NCT02322216|867118|P1|COMPLETED|Overall Study||124
352415|NCT02322216|867117|P2|Per Protocol Set (PPS)|Overall Study||122
352416|NCT02322216|867118|P1|Per Protocol Set (PPS)|Overall Study||123
352417|NCT02322216|867117|P2|Treated (Safety Set)|Overall Study||126
352418|NCT02322216|867118|P1|Treated (Safety Set)|Overall Study||126
352419|NCT02322216|867117|P2|STARTED|Overall Study||127
352420|NCT02322216|867118|P1|STARTED|Overall Study||126
352421|NCT02321527|867125|P1|NOT COMPLETED|Overall Study||1
352422|NCT02321527|867125|P1|COMPLETED|Overall Study||20
352423|NCT02321527|867125|P1|STARTED|Overall Study||21
352424|NCT02321436|867131|P2|NOT COMPLETED|Overall Study||1
352425|NCT02321436|867132|P1|NOT COMPLETED|Overall Study||1
352426|NCT02321436|867131|P2|COMPLETED|Overall Study||13
352427|NCT02321436|867132|P1|COMPLETED|Overall Study||27
352428|NCT02321436|867131|P2|STARTED|Overall Study||14
352429|NCT02321436|867132|P1|STARTED|Overall Study||28
352430|NCT02320903|867151|P3|NOT COMPLETED|Overall Study||16
352431|NCT02320903|867152|P2|NOT COMPLETED|Overall Study||16
352432|NCT02320903|867153|P1|NOT COMPLETED|Overall Study||8
352433|NCT02320903|867151|P3|COMPLETED|Overall Study||16
352434|NCT02320903|867152|P2|COMPLETED|Overall Study||16
352435|NCT02320903|867153|P1|COMPLETED|Overall Study||16
352436|NCT02320903|867151|P3|STARTED|Overall Study||32
352437|NCT02320903|867152|P2|STARTED|Overall Study||32
352438|NCT02320903|867153|P1|STARTED|Overall Study||24
352439|NCT02320838|867186|P5|NOT COMPLETED|Third Intervention (1 Day)||0
352440|NCT02320838|867187|P4|NOT COMPLETED|Third Intervention (1 Day)||0
352441|NCT02320838|867188|P3|NOT COMPLETED|Third Intervention (1 Day)||0
352442|NCT02320838|867189|P2|NOT COMPLETED|Third Intervention (1 Day)||0
352443|NCT02320838|867190|P1|NOT COMPLETED|Third Intervention (1 Day)||0
352444|NCT02320838|867186|P5|COMPLETED|Third Intervention (1 Day)||7
352445|NCT02320838|867187|P4|COMPLETED|Third Intervention (1 Day)||7
352446|NCT02320838|867188|P3|COMPLETED|Third Intervention (1 Day)||8
352447|NCT02320838|867189|P2|COMPLETED|Third Intervention (1 Day)||8
352448|NCT02320838|867190|P1|COMPLETED|Third Intervention (1 Day)||8
352449|NCT02320838|867186|P5|STARTED|Third Intervention (1 Day)||7
352450|NCT02320838|867187|P4|STARTED|Third Intervention (1 Day)||7
352451|NCT02320838|867188|P3|STARTED|Third Intervention (1 Day)||8
352452|NCT02320838|867189|P2|STARTED|Third Intervention (1 Day)||8
352453|NCT02320838|867190|P1|STARTED|Third Intervention (1 Day)||8
352454|NCT02320838|867186|P5|NOT COMPLETED|Washout (1 Day)||0
352455|NCT02320838|867187|P4|NOT COMPLETED|Washout (1 Day)||0
352456|NCT02320838|867188|P3|NOT COMPLETED|Washout (1 Day)||0
352457|NCT02320838|867189|P2|NOT COMPLETED|Washout (1 Day)||0
352458|NCT02320838|867190|P1|NOT COMPLETED|Washout (1 Day)||0
352459|NCT02320838|867186|P5|COMPLETED|Washout (1 Day)||7
352460|NCT02320838|867187|P4|COMPLETED|Washout (1 Day)||7
352461|NCT02320838|867188|P3|COMPLETED|Washout (1 Day)||8
352462|NCT02320838|867189|P2|COMPLETED|Washout (1 Day)||8
352463|NCT02320838|867190|P1|COMPLETED|Washout (1 Day)||8
352464|NCT02320838|867186|P5|STARTED|Washout (1 Day)||7
352465|NCT02320838|867187|P4|STARTED|Washout (1 Day)||7
352466|NCT02320838|867188|P3|STARTED|Washout (1 Day)||8
352467|NCT02320838|867189|P2|STARTED|Washout (1 Day)||8
352468|NCT02320838|867190|P1|STARTED|Washout (1 Day)||8
352469|NCT02320838|867186|P5|NOT COMPLETED|Second Intervention (1 Day)||0
352470|NCT02320838|867187|P4|NOT COMPLETED|Second Intervention (1 Day)||0
352471|NCT02320838|867188|P3|NOT COMPLETED|Second Intervention (1 Day)||0
352472|NCT02320838|867189|P2|NOT COMPLETED|Second Intervention (1 Day)||0
352473|NCT02320838|867190|P1|NOT COMPLETED|Second Intervention (1 Day)||0
352474|NCT02320838|867186|P5|COMPLETED|Second Intervention (1 Day)||7
352475|NCT02320838|867187|P4|COMPLETED|Second Intervention (1 Day)||7
352476|NCT02320838|867188|P3|COMPLETED|Second Intervention (1 Day)||8
352477|NCT02320838|867189|P2|COMPLETED|Second Intervention (1 Day)||8
352478|NCT02320838|867190|P1|COMPLETED|Second Intervention (1 Day)||8
352479|NCT02320838|867186|P5|STARTED|Second Intervention (1 Day)||7
352480|NCT02320838|867187|P4|STARTED|Second Intervention (1 Day)||7
352481|NCT02320838|867188|P3|STARTED|Second Intervention (1 Day)||8
352482|NCT02320838|867189|P2|STARTED|Second Intervention (1 Day)||8
352483|NCT02320838|867190|P1|STARTED|Second Intervention (1 Day)||8
352484|NCT02320838|867186|P5|NOT COMPLETED|Washout (1 Day)||0
352485|NCT02320838|867187|P4|NOT COMPLETED|Washout (1 Day)||0
352486|NCT02320838|867188|P3|NOT COMPLETED|Washout (1 Day)||0
352487|NCT02320838|867189|P2|NOT COMPLETED|Washout (1 Day)||0
352488|NCT02320838|867190|P1|NOT COMPLETED|Washout (1 Day)||0
352489|NCT02320838|867186|P5|COMPLETED|Washout (1 Day)||7
352490|NCT02320838|867187|P4|COMPLETED|Washout (1 Day)||7
352491|NCT02320838|867188|P3|COMPLETED|Washout (1 Day)||8
352492|NCT02320838|867189|P2|COMPLETED|Washout (1 Day)||8
352493|NCT02320838|867190|P1|COMPLETED|Washout (1 Day)||8
352494|NCT02320838|867186|P5|STARTED|Washout (1 Day)||7
352495|NCT02320838|867187|P4|STARTED|Washout (1 Day)||7
352496|NCT02320838|867188|P3|STARTED|Washout (1 Day)||8
352497|NCT02320838|867189|P2|STARTED|Washout (1 Day)||8
352498|NCT02320838|867190|P1|STARTED|Washout (1 Day)||8
352499|NCT02320838|867186|P5|NOT COMPLETED|First Intervention (1 Day)||0
352500|NCT02320838|867187|P4|NOT COMPLETED|First Intervention (1 Day)||0
352501|NCT02320838|867188|P3|NOT COMPLETED|First Intervention (1 Day)||0
352502|NCT02320838|867189|P2|NOT COMPLETED|First Intervention (1 Day)||0
352503|NCT02320838|867190|P1|NOT COMPLETED|First Intervention (1 Day)||0
352504|NCT02320838|867186|P5|COMPLETED|First Intervention (1 Day)||7
352505|NCT02320838|867187|P4|COMPLETED|First Intervention (1 Day)||7
352506|NCT02320838|867188|P3|COMPLETED|First Intervention (1 Day)||8
352507|NCT02320838|867189|P2|COMPLETED|First Intervention (1 Day)||8
352508|NCT02320838|867190|P1|COMPLETED|First Intervention (1 Day)||8
352509|NCT02320838|867186|P5|STARTED|First Intervention (1 Day)||7
352510|NCT02320838|867187|P4|STARTED|First Intervention (1 Day)||7
352511|NCT02320838|867188|P3|STARTED|First Intervention (1 Day)||8
352512|NCT02320838|867189|P2|STARTED|First Intervention (1 Day)||8
352513|NCT02320838|867190|P1|STARTED|First Intervention (1 Day)||8
352514|NCT02320721|867257|P2|NOT COMPLETED|Overall Study||34
352515|NCT02320721|867258|P1|NOT COMPLETED|Overall Study||27
352516|NCT02320721|867257|P2|COMPLETED|Overall Study||472
352517|NCT02320721|867258|P1|COMPLETED|Overall Study||481
352518|NCT02320721|867257|P2|Treated (Safety Population)|Overall Study||505
352519|NCT02320721|867258|P1|Treated (Safety Population)|Overall Study||508
352520|NCT02320721|867257|P2|STARTED|Overall Study||506
352521|NCT02320721|867258|P1|STARTED|Overall Study||508
352522|NCT02320695|867286|P1|NOT COMPLETED|Overall Study||0
352523|NCT02320695|867286|P1|COMPLETED|Overall Study||60
352524|NCT02320695|867286|P1|Pain Relief Ointment|Overall Study||60
352525|NCT02320695|867286|P1|Original Ointment|Overall Study||60
352526|NCT02320695|867286|P1|Antibiotic/Pain Relieving Ointment|Overall Study||60
352527|NCT02320695|867286|P1|Pain Relieving Cream|Overall Study||59
352528|NCT02320695|867286|P1|Alcohol|Overall Study||60
352529|NCT02320695|867286|P1|Saline|Overall Study||60
352530|NCT02320695|867286|P1|STARTED|Overall Study||60
352531|NCT02320487|867313|P1|NOT COMPLETED|Overall Study||21
352532|NCT02320487|867313|P1|COMPLETED|Overall Study|Completed = completed the 6-cycle Treatment Period.|81
352533|NCT02320487|867313|P1|STARTED|Overall Study||102
352534|NCT02320396|867333|P2|NOT COMPLETED|Overall Study||4
352535|NCT02320396|867334|P1|NOT COMPLETED|Overall Study||4
352536|NCT02320396|867333|P2|COMPLETED|Overall Study||221
352537|NCT02320396|867334|P1|COMPLETED|Overall Study||220
352538|NCT02320396|867333|P2|Treated (Full Analysis Set)|Overall Study||225
352539|NCT02320396|867334|P1|Treated (Full Analysis Set)|Overall Study||223
352540|NCT02320396|867333|P2|STARTED|Overall Study||225
352541|NCT02320396|867334|P1|STARTED|Overall Study||224
352542|NCT02320227|867364|P1|NOT COMPLETED|Overall Study||0
352543|NCT02320227|867364|P1|COMPLETED|Overall Study||30
352544|NCT02320227|867364|P1|STARTED|Overall Study||30
352545|NCT02320214|867369|P1|NOT COMPLETED|Overall Study||0
352546|NCT02320214|867369|P1|COMPLETED|Overall Study||30
352547|NCT02320214|867369|P1|STARTED|Overall Study||30
352548|NCT02320149|867376|P2|NOT COMPLETED|Overall Study||80
352549|NCT02320149|867377|P1|NOT COMPLETED|Overall Study||63
352550|NCT02320149|867376|P2|COMPLETED|Overall Study||405
352551|NCT02320149|867377|P1|COMPLETED|Overall Study||420
352552|NCT02320149|867376|P2|STARTED|Overall Study||485
352553|NCT02320149|867377|P1|STARTED|Overall Study||483
352554|NCT02319824|867415|P1|NOT COMPLETED|Overall Study||0
352555|NCT02319824|867415|P1|COMPLETED|Overall Study||2
352556|NCT02319824|867415|P1|STARTED|Overall Study||2
352557|NCT02319668|867423|P2|NOT COMPLETED|Overall Study||2
352558|NCT02319668|867424|P1|NOT COMPLETED|Overall Study||0
352559|NCT02319668|867423|P2|COMPLETED|Overall Study||17
352560|NCT02319668|867424|P1|COMPLETED|Overall Study||19
352561|NCT02319668|867423|P2|STARTED|Overall Study||19
352562|NCT02319668|867424|P1|STARTED|Overall Study||19
352563|NCT02319525|867438|P2|NOT COMPLETED|Overall Study||1
352564|NCT02319525|867439|P1|NOT COMPLETED|Overall Study||2
352565|NCT02319525|867438|P2|COMPLETED|Overall Study||147
352566|NCT02319525|867439|P1|COMPLETED|Overall Study||151
352567|NCT02319525|867438|P2|Primary Research Completion|Overall Study||147
352568|NCT02319525|867439|P1|Primary Research Completion|Overall Study||151
352569|NCT02319525|867438|P2|STARTED|Overall Study||148
352570|NCT02319525|867439|P1|STARTED|Overall Study||153
352571|NCT02319486|867457|P1|NOT COMPLETED|Overall Study||0
352572|NCT02319486|867457|P1|COMPLETED|Overall Study||26
352573|NCT02319486|867457|P1|STARTED|Overall Study||26
352574|NCT02319317|867465|P2|NOT COMPLETED|Overall Study||0
352575|NCT02319317|867466|P1|NOT COMPLETED|Overall Study||0
352576|NCT02319317|867465|P2|COMPLETED|Overall Study||29
352577|NCT02319317|867466|P1|COMPLETED|Overall Study||31
352578|NCT02319317|867465|P2|STARTED|Overall Study||29
352579|NCT02319317|867466|P1|STARTED|Overall Study||31
352580|NCT02319148|867475|P4|NOT COMPLETED|Second Intervention Period||2
352581|NCT02319148|867476|P3|NOT COMPLETED|Second Intervention Period||1
352582|NCT02319148|867477|P2|NOT COMPLETED|Second Intervention Period||1
352583|NCT02319148|867478|P1|NOT COMPLETED|Second Intervention Period||0
352584|NCT02319148|867475|P4|COMPLETED|Second Intervention Period||6
352585|NCT02319148|867476|P3|COMPLETED|Second Intervention Period||6
352586|NCT02319148|867477|P2|COMPLETED|Second Intervention Period||6
352587|NCT02319148|867478|P1|COMPLETED|Second Intervention Period||0
352588|NCT02319148|867475|P4|STARTED|Second Intervention Period||8
352589|NCT02319148|867476|P3|STARTED|Second Intervention Period||7
352590|NCT02319148|867477|P2|STARTED|Second Intervention Period||7
352591|NCT02319148|867478|P1|STARTED|Second Intervention Period||0
352592|NCT02319148|867475|P4|NOT COMPLETED|Washout Period 4 Days||0
352593|NCT02319148|867476|P3|NOT COMPLETED|Washout Period 4 Days||0
352594|NCT02319148|867477|P2|NOT COMPLETED|Washout Period 4 Days||0
352595|NCT02319148|867478|P1|NOT COMPLETED|Washout Period 4 Days||0
352596|NCT02319148|867475|P4|COMPLETED|Washout Period 4 Days||0
352597|NCT02319148|867476|P3|COMPLETED|Washout Period 4 Days||0
352598|NCT02319148|867477|P2|COMPLETED|Washout Period 4 Days||0
352599|NCT02319148|867478|P1|COMPLETED|Washout Period 4 Days||22
352600|NCT02319148|867475|P4|STARTED|Washout Period 4 Days||0
352601|NCT02319148|867476|P3|STARTED|Washout Period 4 Days||0
352602|NCT02319148|867477|P2|STARTED|Washout Period 4 Days||0
352603|NCT02319148|867478|P1|STARTED|Washout Period 4 Days||22
352604|NCT02319148|867475|P4|NOT COMPLETED|First Intervention Period||0
352605|NCT02319148|867476|P3|NOT COMPLETED|First Intervention Period||0
352606|NCT02319148|867477|P2|NOT COMPLETED|First Intervention Period||0
352607|NCT02319148|867478|P1|NOT COMPLETED|First Intervention Period||0
352608|NCT02319148|867475|P4|COMPLETED|First Intervention Period||0
352609|NCT02319148|867476|P3|COMPLETED|First Intervention Period||0
352610|NCT02319148|867477|P2|COMPLETED|First Intervention Period||0
352611|NCT02319148|867478|P1|COMPLETED|First Intervention Period||22
352612|NCT02319148|867475|P4|STARTED|First Intervention Period||0
352613|NCT02319148|867476|P3|STARTED|First Intervention Period||0
352614|NCT02319148|867477|P2|STARTED|First Intervention Period||0
352615|NCT02319148|867478|P1|STARTED|First Intervention Period||22
352616|NCT02319044|867541|P3|NOT COMPLETED|Overall Study||67
352617|NCT02319044|867542|P2|NOT COMPLETED|Overall Study||60
352618|NCT02319044|867543|P1|NOT COMPLETED|Overall Study||122
352619|NCT02319044|867541|P3|COMPLETED|Overall Study||0
352620|NCT02319044|867542|P2|COMPLETED|Overall Study||7
352621|NCT02319044|867543|P1|COMPLETED|Overall Study||11
352622|NCT02319044|867541|P3|STARTED|Overall Study||67
352623|NCT02319044|867542|P2|STARTED|Overall Study||67
352624|NCT02319044|867543|P1|STARTED|Overall Study||133
352625|NCT02319031|867599|P2|NOT COMPLETED|Follow-Up Period||0
352626|NCT02319031|867600|P1|NOT COMPLETED|Follow-Up Period||0
352627|NCT02319031|867599|P2|COMPLETED|Follow-Up Period||26
352628|NCT02319031|867600|P1|COMPLETED|Follow-Up Period||23
352629|NCT02319031|867599|P2|STARTED|Follow-Up Period||26
352630|NCT02319031|867600|P1|STARTED|Follow-Up Period||23
352631|NCT02319031|867599|P2|NOT COMPLETED|Treatment Period||0
352632|NCT02319031|867600|P1|NOT COMPLETED|Treatment Period||1
352633|NCT02319031|867599|P2|COMPLETED|Treatment Period||26
352634|NCT02319031|867600|P1|COMPLETED|Treatment Period||23
352635|NCT02319031|867599|P2|STARTED|Treatment Period||26
352636|NCT02319031|867600|P1|STARTED|Treatment Period||24
352637|NCT02318940|867612|P2|NOT COMPLETED|Overall Study||0
352638|NCT02318940|867613|P1|NOT COMPLETED|Overall Study||1
352639|NCT02318940|867612|P2|COMPLETED|Overall Study||50
352640|NCT02318940|867613|P1|COMPLETED|Overall Study||49
352641|NCT02318940|867612|P2|STARTED|Overall Study||50
352642|NCT02318940|867613|P1|STARTED|Overall Study|in the last patient we lost the record.|50
352643|NCT02318797|867627|P2|NOT COMPLETED|Overall Study||102
352644|NCT02318797|867628|P1|NOT COMPLETED|Overall Study||88
352645|NCT02318797|867627|P2|COMPLETED|Overall Study||611
352646|NCT02318797|867628|P1|COMPLETED|Overall Study||428
352647|NCT02318797|867627|P2|STARTED|Overall Study||713
352648|NCT02318797|867628|P1|STARTED|Overall Study||516
352649|NCT02318693|867668|P2|NOT COMPLETED|Overall Study||1
352650|NCT02318693|867669|P1|NOT COMPLETED|Overall Study||0
352651|NCT02318693|867668|P2|COMPLETED|Overall Study||26
352652|NCT02318693|867669|P1|COMPLETED|Overall Study||26
352653|NCT02318693|867668|P2|Treated|Overall Study|1 randomized participant did not receive treatment.|26
352654|NCT02318693|867669|P1|Treated|Overall Study||26
352655|NCT02318693|867668|P2|STARTED|Overall Study||27
352656|NCT02318693|867669|P1|STARTED|Overall Study||26
352657|NCT02318303|867690|P7|NOT COMPLETED|Overall Study||2
352658|NCT02318303|867691|P6|NOT COMPLETED|Overall Study||6
352659|NCT02318303|867692|P5|NOT COMPLETED|Overall Study||5
352660|NCT02318303|867693|P4|NOT COMPLETED|Overall Study||3
352661|NCT02318303|867694|P3|NOT COMPLETED|Overall Study||3
352662|NCT02318303|867695|P2|NOT COMPLETED|Overall Study||3
352663|NCT02318303|867696|P1|NOT COMPLETED|Overall Study||4
352664|NCT02318303|867690|P7|COMPLETED|Overall Study||158
352665|NCT02318303|867691|P6|COMPLETED|Overall Study||153
352666|NCT02318303|867692|P5|COMPLETED|Overall Study||152
352667|NCT02318303|867693|P4|COMPLETED|Overall Study||155
352668|NCT02318303|867694|P3|COMPLETED|Overall Study||157
352669|NCT02318303|867695|P2|COMPLETED|Overall Study||155
352670|NCT02318303|867696|P1|COMPLETED|Overall Study||155
352671|NCT02318303|867690|P7|STARTED|Overall Study||160
352672|NCT02318303|867691|P6|STARTED|Overall Study||159
352673|NCT02318303|867692|P5|STARTED|Overall Study||157
352674|NCT02318303|867693|P4|STARTED|Overall Study||158
352675|NCT02318303|867694|P3|STARTED|Overall Study||160
352676|NCT02318303|867695|P2|STARTED|Overall Study||158
352677|NCT02318303|867696|P1|STARTED|Overall Study||159
352678|NCT02317809|867712|P2|NOT COMPLETED|Second Intervention Period (8 Days)||0
352679|NCT02317809|867713|P1|NOT COMPLETED|Second Intervention Period (8 Days)||0
352680|NCT02317809|867712|P2|COMPLETED|Second Intervention Period (8 Days)||17
352681|NCT02317809|867713|P1|COMPLETED|Second Intervention Period (8 Days)||14
352682|NCT02317809|867712|P2|STARTED|Second Intervention Period (8 Days)||17
352683|NCT02317809|867713|P1|STARTED|Second Intervention Period (8 Days)||14
352684|NCT02317809|867712|P2|NOT COMPLETED|First Intervention Period (8 Days)||0
352685|NCT02317809|867713|P1|NOT COMPLETED|First Intervention Period (8 Days)||3
352686|NCT02317809|867712|P2|COMPLETED|First Intervention Period (8 Days)||17
352687|NCT02317809|867713|P1|COMPLETED|First Intervention Period (8 Days)||14
352688|NCT02317809|867712|P2|STARTED|First Intervention Period (8 Days)||17
352689|NCT02317809|867713|P1|STARTED|First Intervention Period (8 Days)||17
352690|NCT02317744|867757|P2|NOT COMPLETED|Overall Study||2
352691|NCT02317744|867758|P1|NOT COMPLETED|Overall Study||1
352692|NCT02317744|867757|P2|COMPLETED|Overall Study|One Placebo participant stopped the treatment but completed assessments.|8
352693|NCT02317744|867758|P1|COMPLETED|Overall Study|One NB participant stopped the treatment but completed assessments.|11
352694|NCT02317744|867757|P2|Completed Treatment|Overall Study||7
352695|NCT02317744|867758|P1|Completed Treatment|Overall Study||10
352696|NCT02317744|867757|P2|STARTED|Overall Study||10
352697|NCT02317744|867758|P1|STARTED|Overall Study||12
352698|NCT02317692|867772|P2|NOT COMPLETED|Overall Study||0
352699|NCT02317692|867773|P1|NOT COMPLETED|Overall Study||6
352700|NCT02317692|867772|P2|COMPLETED|Overall Study||77
352701|NCT02317692|867773|P1|COMPLETED|Overall Study||63
352702|NCT02317692|867772|P2|STARTED|Overall Study||77
352703|NCT02317692|867773|P1|STARTED|Overall Study||69
352704|NCT02317549|867793|P2|NOT COMPLETED|Overall Study||0
352705|NCT02317549|867794|P1|NOT COMPLETED|Overall Study||0
352706|NCT02317549|867793|P2|COMPLETED|Overall Study||3
352707|NCT02317549|867794|P1|COMPLETED|Overall Study||5
352708|NCT02317549|867793|P2|STARTED|Overall Study||3
352709|NCT02317549|867794|P1|STARTED|Overall Study||5
352710|NCT02317510|867802|P2|NOT COMPLETED|Overall Study||1
352711|NCT02317510|867803|P1|NOT COMPLETED|Overall Study||0
352712|NCT02317510|867802|P2|COMPLETED|Overall Study||24
352713|NCT02317510|867803|P1|COMPLETED|Overall Study||25
352714|NCT02317510|867802|P2|STARTED|Overall Study||25
352715|NCT02317510|867803|P1|STARTED|Overall Study||25
352716|NCT02317016|867831|P1|NOT COMPLETED|Part B: Day 35 to End Part B (AZD9291)||31
352717|NCT02317016|867831|P1|COMPLETED|Part B: Day 35 to End Part B (AZD9291)||11
352718|NCT02317016|867831|P1|STARTED|Part B: Day 35 to End Part B (AZD9291)|41 completed Part A + 1 entered Part B without completing Part A (due to AE) = 42 started Part B|42
352719|NCT02317016|867831|P1|NOT COMPLETED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||2
352720|NCT02317016|867831|P1|COMPLETED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||41
352721|NCT02317016|867831|P1|STARTED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||43
352722|NCT02317016|867831|P1|NOT COMPLETED|Part A: Day 4-31 (AZD9291 Alone)||1
352723|NCT02317016|867831|P1|COMPLETED|Part A: Day 4-31 (AZD9291 Alone)||43
352724|NCT02317016|867831|P1|STARTED|Part A: Day 4-31 (AZD9291 Alone)||44
352725|NCT02317016|867831|P1|NOT COMPLETED|Part A: Day 1-3 (Rosuvastatin Alone)||0
352726|NCT02317016|867831|P1|COMPLETED|Part A: Day 1-3 (Rosuvastatin Alone)||44
352727|NCT02317016|867831|P1|STARTED|Part A: Day 1-3 (Rosuvastatin Alone)||44
352728|NCT02316769|867859|P2|NOT COMPLETED|Overall Study||0
352729|NCT02316769|867860|P1|NOT COMPLETED|Overall Study||2
352730|NCT02316769|867859|P2|COMPLETED|Overall Study||33
352731|NCT02316769|867860|P1|COMPLETED|Overall Study||31
352732|NCT02316769|867859|P2|STARTED|Overall Study||33
352733|NCT02316769|867860|P1|STARTED|Overall Study||33
352734|NCT02316678|867870|P2|NOT COMPLETED|Overall Study||0
352735|NCT02316678|867871|P1|NOT COMPLETED|Overall Study||0
352736|NCT02316678|867870|P2|COMPLETED|Overall Study||7694
352737|NCT02316678|867871|P1|COMPLETED|Overall Study||1879
352738|NCT02316678|867870|P2|STARTED|Overall Study||7694
352739|NCT02316678|867871|P1|STARTED|Overall Study||1879
352740|NCT02316613|867877|P1|NOT COMPLETED|Overall Study||104
352741|NCT02316613|867877|P1|COMPLETED|Overall Study||156
352742|NCT02316613|867877|P1|Overall Population|Overall Study||241
352743|NCT02316613|867877|P1|Safety Population|Overall Study||255
352744|NCT02316613|867877|P1|STARTED|Overall Study||260
352745|NCT02316548|867916|P2|NOT COMPLETED|Overall Study||1
352746|NCT02316548|867917|P1|NOT COMPLETED|Overall Study||0
352747|NCT02316548|867916|P2|COMPLETED|Overall Study|Eligible patients on study until study termination|6
352748|NCT02316548|867917|P1|COMPLETED|Overall Study|Eligible patients on study until study termination|6
352749|NCT02316548|867916|P2|Eligible With Adverse Event Data|Overall Study||2
352750|NCT02316548|867917|P1|Eligible With Adverse Event Data|Overall Study||4
352751|NCT02316548|867916|P2|Eligible With Disease Assessment|Overall Study||1
352752|NCT02316548|867917|P1|Eligible With Disease Assessment|Overall Study||4
352753|NCT02316548|867916|P2|Eligible Population|Overall Study||6
352754|NCT02316548|867917|P1|Eligible Population|Overall Study||6
352755|NCT02316548|867916|P2|STARTED|Overall Study|Randomized|7
352756|NCT02316548|867917|P1|STARTED|Overall Study|Randomized|6
352757|NCT02316470|867931|P4|NOT COMPLETED|Overall Study||2
352758|NCT02316470|867932|P3|NOT COMPLETED|Overall Study||5
352759|NCT02316470|867933|P2|NOT COMPLETED|Overall Study||6
352760|NCT02316470|867934|P1|NOT COMPLETED|Overall Study||5
352761|NCT02316470|867931|P4|COMPLETED|Overall Study||46
352762|NCT02316470|867932|P3|COMPLETED|Overall Study||147
352763|NCT02316470|867933|P2|COMPLETED|Overall Study||146
352764|NCT02316470|867934|P1|COMPLETED|Overall Study||143
352765|NCT02316470|867931|P4|STARTED|Overall Study||48
352766|NCT02316470|867932|P3|STARTED|Overall Study||152
352767|NCT02316470|867933|P2|STARTED|Overall Study||152
352768|NCT02316470|867934|P1|STARTED|Overall Study||148
352769|NCT02316366|868030|P2|NOT COMPLETED|Overall Study||0
352770|NCT02316366|868031|P1|NOT COMPLETED|Overall Study||0
352771|NCT02316366|868030|P2|COMPLETED|Overall Study||40
352772|NCT02316366|868031|P1|COMPLETED|Overall Study||40
352773|NCT02316366|868030|P2|STARTED|Overall Study||40
352774|NCT02316366|868031|P1|STARTED|Overall Study||40
352775|NCT02315989|868041|P1|NOT COMPLETED|Overall Study||0
352776|NCT02315989|868041|P1|COMPLETED|Overall Study||6
352777|NCT02315989|868041|P1|STARTED|Overall Study||6
352778|NCT02315560|868049|P1|NOT COMPLETED|Overall Study||3
352779|NCT02315560|868049|P1|COMPLETED|Overall Study||22
352780|NCT02315560|868049|P1|STARTED|Overall Study||25
352781|NCT02315352|868056|P8|NOT COMPLETED|Fifth Intervention (Day 2)||0
352782|NCT02315352|868057|P7|NOT COMPLETED|Fifth Intervention (Day 2)||0
352783|NCT02315352|868058|P6|NOT COMPLETED|Fifth Intervention (Day 2)||0
352784|NCT02315352|868059|P5|NOT COMPLETED|Fifth Intervention (Day 2)||0
352785|NCT02315352|868060|P4|NOT COMPLETED|Fifth Intervention (Day 2)||0
352786|NCT02315352|868061|P3|NOT COMPLETED|Fifth Intervention (Day 2)||0
352787|NCT02315352|868062|P2|NOT COMPLETED|Fifth Intervention (Day 2)||0
352788|NCT02315352|868063|P1|NOT COMPLETED|Fifth Intervention (Day 2)||0
352789|NCT02315352|868056|P8|COMPLETED|Fifth Intervention (Day 2)||8
352790|NCT02315352|868057|P7|COMPLETED|Fifth Intervention (Day 2)||9
352791|NCT02315352|868058|P6|COMPLETED|Fifth Intervention (Day 2)||7
352792|NCT02315352|868059|P5|COMPLETED|Fifth Intervention (Day 2)||8
352793|NCT02315352|868060|P4|COMPLETED|Fifth Intervention (Day 2)||8
352794|NCT02315352|868061|P3|COMPLETED|Fifth Intervention (Day 2)||7
352795|NCT02315352|868062|P2|COMPLETED|Fifth Intervention (Day 2)||0
352796|NCT02315352|868063|P1|COMPLETED|Fifth Intervention (Day 2)||0
352797|NCT02315352|868056|P8|STARTED|Fifth Intervention (Day 2)||8
352798|NCT02315352|868057|P7|STARTED|Fifth Intervention (Day 2)||9
352799|NCT02315352|868058|P6|STARTED|Fifth Intervention (Day 2)||7
352800|NCT02315352|868059|P5|STARTED|Fifth Intervention (Day 2)||8
352801|NCT02315352|868060|P4|STARTED|Fifth Intervention (Day 2)||8
352802|NCT02315352|868061|P3|STARTED|Fifth Intervention (Day 2)||7
352803|NCT02315352|868062|P2|STARTED|Fifth Intervention (Day 2)||0
352804|NCT02315352|868063|P1|STARTED|Fifth Intervention (Day 2)||0
352805|NCT02315352|868056|P8|NOT COMPLETED|Fourth Intervention (Day 2)||0
352806|NCT02315352|868057|P7|NOT COMPLETED|Fourth Intervention (Day 2)||0
352807|NCT02315352|868058|P6|NOT COMPLETED|Fourth Intervention (Day 2)||0
352808|NCT02315352|868059|P5|NOT COMPLETED|Fourth Intervention (Day 2)||0
352809|NCT02315352|868060|P4|NOT COMPLETED|Fourth Intervention (Day 2)||0
352810|NCT02315352|868061|P3|NOT COMPLETED|Fourth Intervention (Day 2)||0
352811|NCT02315352|868062|P2|NOT COMPLETED|Fourth Intervention (Day 2)||0
352812|NCT02315352|868063|P1|NOT COMPLETED|Fourth Intervention (Day 2)||0
352813|NCT02315352|868056|P8|COMPLETED|Fourth Intervention (Day 2)||8
352814|NCT02315352|868057|P7|COMPLETED|Fourth Intervention (Day 2)||9
352815|NCT02315352|868058|P6|COMPLETED|Fourth Intervention (Day 2)||7
352816|NCT02315352|868059|P5|COMPLETED|Fourth Intervention (Day 2)||8
352817|NCT02315352|868060|P4|COMPLETED|Fourth Intervention (Day 2)||8
352818|NCT02315352|868061|P3|COMPLETED|Fourth Intervention (Day 2)||7
352819|NCT02315352|868062|P2|COMPLETED|Fourth Intervention (Day 2)||0
352820|NCT02315352|868063|P1|COMPLETED|Fourth Intervention (Day 2)||0
352821|NCT02315352|868056|P8|STARTED|Fourth Intervention (Day 2)||8
352822|NCT02315352|868057|P7|STARTED|Fourth Intervention (Day 2)||9
352823|NCT02315352|868058|P6|STARTED|Fourth Intervention (Day 2)||7
352824|NCT02315352|868059|P5|STARTED|Fourth Intervention (Day 2)||8
352825|NCT02315352|868060|P4|STARTED|Fourth Intervention (Day 2)||8
352826|NCT02315352|868061|P3|STARTED|Fourth Intervention (Day 2)||7
352827|NCT02315352|868062|P2|STARTED|Fourth Intervention (Day 2)||0
352828|NCT02315352|868063|P1|STARTED|Fourth Intervention (Day 2)||0
352829|NCT02315352|868056|P8|NOT COMPLETED|Third Intervention (Day 2)||0
352830|NCT02315352|868057|P7|NOT COMPLETED|Third Intervention (Day 2)||0
352831|NCT02315352|868058|P6|NOT COMPLETED|Third Intervention (Day 2)||0
352832|NCT02315352|868059|P5|NOT COMPLETED|Third Intervention (Day 2)||0
352833|NCT02315352|868060|P4|NOT COMPLETED|Third Intervention (Day 2)||0
352834|NCT02315352|868061|P3|NOT COMPLETED|Third Intervention (Day 2)||0
352835|NCT02315352|868062|P2|NOT COMPLETED|Third Intervention (Day 2)||0
352836|NCT02315352|868063|P1|NOT COMPLETED|Third Intervention (Day 2)||0
352837|NCT02315352|868056|P8|COMPLETED|Third Intervention (Day 2)||8
352838|NCT02315352|868057|P7|COMPLETED|Third Intervention (Day 2)||9
352839|NCT02315352|868058|P6|COMPLETED|Third Intervention (Day 2)||7
352840|NCT02315352|868059|P5|COMPLETED|Third Intervention (Day 2)||8
352841|NCT02315352|868060|P4|COMPLETED|Third Intervention (Day 2)||8
352842|NCT02315352|868061|P3|COMPLETED|Third Intervention (Day 2)||7
352843|NCT02315352|868062|P2|COMPLETED|Third Intervention (Day 2)||0
352844|NCT02315352|868063|P1|COMPLETED|Third Intervention (Day 2)||0
352845|NCT02315352|868056|P8|STARTED|Third Intervention (Day 2)||8
352846|NCT02315352|868057|P7|STARTED|Third Intervention (Day 2)||9
352847|NCT02315352|868058|P6|STARTED|Third Intervention (Day 2)||7
352848|NCT02315352|868059|P5|STARTED|Third Intervention (Day 2)||8
352849|NCT02315352|868060|P4|STARTED|Third Intervention (Day 2)||8
352850|NCT02315352|868061|P3|STARTED|Third Intervention (Day 2)||7
352851|NCT02315352|868062|P2|STARTED|Third Intervention (Day 2)||0
352852|NCT02315352|868063|P1|STARTED|Third Intervention (Day 2)||0
352853|NCT02315352|868056|P8|NOT COMPLETED|Second Intervention (Day 1)||0
352854|NCT02315352|868057|P7|NOT COMPLETED|Second Intervention (Day 1)||0
352855|NCT02315352|868058|P6|NOT COMPLETED|Second Intervention (Day 1)||0
352856|NCT02315352|868059|P5|NOT COMPLETED|Second Intervention (Day 1)||0
352857|NCT02315352|868060|P4|NOT COMPLETED|Second Intervention (Day 1)||0
352858|NCT02315352|868061|P3|NOT COMPLETED|Second Intervention (Day 1)||0
352859|NCT02315352|868062|P2|NOT COMPLETED|Second Intervention (Day 1)||0
352860|NCT02315352|868063|P1|NOT COMPLETED|Second Intervention (Day 1)||0
352861|NCT02315352|868056|P8|COMPLETED|Second Intervention (Day 1)||0
352862|NCT02315352|868057|P7|COMPLETED|Second Intervention (Day 1)||0
352863|NCT02315352|868058|P6|COMPLETED|Second Intervention (Day 1)||0
352864|NCT02315352|868059|P5|COMPLETED|Second Intervention (Day 1)||0
352865|NCT02315352|868060|P4|COMPLETED|Second Intervention (Day 1)||0
352866|NCT02315352|868061|P3|COMPLETED|Second Intervention (Day 1)||0
352867|NCT02315352|868062|P2|COMPLETED|Second Intervention (Day 1)||24
352868|NCT02315352|868063|P1|COMPLETED|Second Intervention (Day 1)|Out of 24 subjects completing this period, 1 discontinued before assignment to any sequence on Day 2|24
352869|NCT02315352|868056|P8|STARTED|Second Intervention (Day 1)||0
352870|NCT02315352|868057|P7|STARTED|Second Intervention (Day 1)||0
352871|NCT02315352|868058|P6|STARTED|Second Intervention (Day 1)||0
352872|NCT02315352|868059|P5|STARTED|Second Intervention (Day 1)||0
352873|NCT02315352|868060|P4|STARTED|Second Intervention (Day 1)||0
352874|NCT02315352|868061|P3|STARTED|Second Intervention (Day 1)||0
352875|NCT02315352|868062|P2|STARTED|Second Intervention (Day 1)||24
352876|NCT02315352|868063|P1|STARTED|Second Intervention (Day 1)||24
352877|NCT02315352|868056|P8|NOT COMPLETED|First Intervention (Day 1)||0
352878|NCT02315352|868057|P7|NOT COMPLETED|First Intervention (Day 1)||0
352879|NCT02315352|868058|P6|NOT COMPLETED|First Intervention (Day 1)||0
352880|NCT02315352|868059|P5|NOT COMPLETED|First Intervention (Day 1)||0
352881|NCT02315352|868060|P4|NOT COMPLETED|First Intervention (Day 1)||0
352882|NCT02315352|868061|P3|NOT COMPLETED|First Intervention (Day 1)||0
352883|NCT02315352|868062|P2|NOT COMPLETED|First Intervention (Day 1)||0
352884|NCT02315352|868063|P1|NOT COMPLETED|First Intervention (Day 1)||0
352885|NCT02315352|868056|P8|COMPLETED|First Intervention (Day 1)||0
352886|NCT02315352|868057|P7|COMPLETED|First Intervention (Day 1)||0
352887|NCT02315352|868058|P6|COMPLETED|First Intervention (Day 1)||0
352888|NCT02315352|868059|P5|COMPLETED|First Intervention (Day 1)||0
352889|NCT02315352|868060|P4|COMPLETED|First Intervention (Day 1)||0
352890|NCT02315352|868061|P3|COMPLETED|First Intervention (Day 1)||0
352891|NCT02315352|868062|P2|COMPLETED|First Intervention (Day 1)||24
352892|NCT02315352|868063|P1|COMPLETED|First Intervention (Day 1)||24
352893|NCT02315352|868056|P8|STARTED|First Intervention (Day 1)||0
352894|NCT02315352|868057|P7|STARTED|First Intervention (Day 1)||0
352895|NCT02315352|868058|P6|STARTED|First Intervention (Day 1)||0
352896|NCT02315352|868059|P5|STARTED|First Intervention (Day 1)||0
352897|NCT02315352|868060|P4|STARTED|First Intervention (Day 1)||0
352898|NCT02315352|868061|P3|STARTED|First Intervention (Day 1)||0
352899|NCT02315352|868062|P2|STARTED|First Intervention (Day 1)||24
352900|NCT02315352|868063|P1|STARTED|First Intervention (Day 1)||24
352901|NCT02314689|868090|P1|NOT COMPLETED|Overall Study||0
352902|NCT02314689|868090|P1|COMPLETED|Overall Study|Target citrulline level reached with first 4 subjects enrolled at initial IV citrulline of 20 mg/kg|4
352903|NCT02314689|868090|P1|STARTED|Overall Study||4
352904|NCT02314637|868096|P2|NOT COMPLETED|Overall Study||14
352905|NCT02314637|868097|P1|NOT COMPLETED|Overall Study||16
352906|NCT02314637|868096|P2|COMPLETED|Overall Study||75
352907|NCT02314637|868097|P1|COMPLETED|Overall Study||135
352908|NCT02314637|868096|P2|STARTED|Overall Study||89
352909|NCT02314637|868097|P1|STARTED|Overall Study||151
352910|NCT02314546|868110|P3|NOT COMPLETED|Overall Study||0
352911|NCT02314546|868111|P2|NOT COMPLETED|Overall Study||0
352912|NCT02314546|868112|P1|NOT COMPLETED|Overall Study||0
352913|NCT02314546|868110|P3|COMPLETED|Overall Study||5
352914|NCT02314546|868111|P2|COMPLETED|Overall Study||5
352915|NCT02314546|868112|P1|COMPLETED|Overall Study||5
352916|NCT02314546|868110|P3|STARTED|Overall Study||5
352917|NCT02314546|868111|P2|STARTED|Overall Study||5
352918|NCT02314546|868112|P1|STARTED|Overall Study||5
352919|NCT02314520|868140|P2|NOT COMPLETED|Overall Study||0
352920|NCT02314520|868141|P1|NOT COMPLETED|Overall Study||0
352921|NCT02314520|868140|P2|COMPLETED|Overall Study||80
352922|NCT02314520|868141|P1|COMPLETED|Overall Study||72
352923|NCT02314520|868140|P2|STARTED|Overall Study||80
352924|NCT02314520|868141|P1|STARTED|Overall Study||72
352925|NCT02314260|868153|P1|NOT COMPLETED|Overall Study||0
352926|NCT02314260|868153|P1|COMPLETED|Overall Study||80
352927|NCT02314260|868153|P1|STARTED|Overall Study||80
352928|NCT02314117|868162|P2|NOT COMPLETED|Overall Study||38
352929|NCT02314117|868163|P1|NOT COMPLETED|Overall Study||41
352930|NCT02314117|868162|P2|COMPLETED|Overall Study||281
352931|NCT02314117|868163|P1|COMPLETED|Overall Study||285
352932|NCT02314117|868162|P2|Alive But Off Treatment|Overall Study||50
352933|NCT02314117|868163|P1|Alive But Off Treatment|Overall Study||46
352934|NCT02314117|868162|P2|Death|Overall Study||231
352935|NCT02314117|868163|P1|Death|Overall Study||239
352936|NCT02314117|868162|P2|Received at Least One Dose of Study Drug|Overall Study||315
352937|NCT02314117|868163|P1|Received at Least One Dose of Study Drug|Overall Study||323
352938|NCT02314117|868162|P2|STARTED|Overall Study||319
352939|NCT02314117|868163|P1|STARTED|Overall Study||326
352940|NCT02314104|868194|P3|NOT COMPLETED|Overall Study||18
352941|NCT02314104|868195|P2|NOT COMPLETED|Overall Study||20
352942|NCT02314104|868196|P1|NOT COMPLETED|Overall Study||14
352943|NCT02314104|868194|P3|COMPLETED|Overall Study||53
352944|NCT02314104|868195|P2|COMPLETED|Overall Study||58
352945|NCT02314104|868196|P1|COMPLETED|Overall Study||57
352946|NCT02314104|868194|P3|STARTED|Overall Study||71
352947|NCT02314104|868195|P2|STARTED|Overall Study||78
352948|NCT02314104|868196|P1|STARTED|Overall Study||71
352949|NCT02313766|868219|P3|NOT COMPLETED|Overall Study||0
352950|NCT02313766|868220|P2|NOT COMPLETED|Overall Study||3
352951|NCT02313766|868221|P1|NOT COMPLETED|Overall Study||1
352952|NCT02313766|868219|P3|COMPLETED|Overall Study||50
352953|NCT02313766|868220|P2|COMPLETED|Overall Study||47
352954|NCT02313766|868221|P1|COMPLETED|Overall Study||49
352955|NCT02313766|868219|P3|STARTED|Overall Study||50
352956|NCT02313766|868220|P2|STARTED|Overall Study||50
352957|NCT02313766|868221|P1|STARTED|Overall Study||50
352958|NCT02313675|868239|P4|NOT COMPLETED|Overall Study||0
352959|NCT02313675|868240|P3|NOT COMPLETED|Overall Study||0
352960|NCT02313675|868241|P2|NOT COMPLETED|Overall Study||0
352961|NCT02313675|868242|P1|NOT COMPLETED|Overall Study||0
352962|NCT02313675|868239|P4|COMPLETED|Overall Study||11
352963|NCT02313675|868240|P3|COMPLETED|Overall Study||11
352964|NCT02313675|868241|P2|COMPLETED|Overall Study||11
352965|NCT02313675|868242|P1|COMPLETED|Overall Study||11
352966|NCT02313675|868239|P4|STARTED|Overall Study||11
352967|NCT02313675|868240|P3|STARTED|Overall Study||11
352968|NCT02313675|868241|P2|STARTED|Overall Study||11
352969|NCT02313675|868242|P1|STARTED|Overall Study||11
352970|NCT02313558|868258|P2|NOT COMPLETED|Overall Study||4
352971|NCT02313558|868259|P1|NOT COMPLETED|Overall Study||6
352972|NCT02313558|868258|P2|COMPLETED|Overall Study||46
352973|NCT02313558|868259|P1|COMPLETED|Overall Study||44
352974|NCT02313558|868258|P2|STARTED|Overall Study||50
352975|NCT02313558|868259|P1|STARTED|Overall Study||50
352976|NCT02313233|868273|P2|NOT COMPLETED|Overall Study||3
352977|NCT02313233|868274|P1|NOT COMPLETED|Overall Study||2
352978|NCT02313233|868273|P2|COMPLETED|Overall Study||18
352979|NCT02313233|868274|P1|COMPLETED|Overall Study||18
352980|NCT02313233|868273|P2|STARTED|Overall Study||21
352981|NCT02313233|868274|P1|STARTED|Overall Study||20
352982|NCT02313155|868296|P2|NOT COMPLETED|Overall Study||1
352983|NCT02313155|868297|P1|NOT COMPLETED|Overall Study||0
352984|NCT02313155|868296|P2|COMPLETED|Overall Study||54
352985|NCT02313155|868297|P1|COMPLETED|Overall Study||55
352986|NCT02313155|868296|P2|STARTED|Overall Study||55
352987|NCT02313155|868297|P1|STARTED|Overall Study||55
352988|NCT02312882|868345|P1|NOT COMPLETED|Overall Study||4
352989|NCT02312882|868345|P1|COMPLETED|Overall Study||36
352990|NCT02312882|868345|P1|STARTED|Overall Study||40
352991|NCT02312739|868351|P2|NOT COMPLETED|Overall Study||2
352992|NCT02312739|868352|P1|NOT COMPLETED|Overall Study||6
352993|NCT02312739|868351|P2|COMPLETED|Overall Study||34
352994|NCT02312739|868352|P1|COMPLETED|Overall Study||30
352995|NCT02312739|868351|P2|Withdrawn Prior to Procedure|Overall Study||2
352996|NCT02312739|868352|P1|Withdrawn Prior to Procedure|Overall Study||6
352997|NCT02312739|868351|P2|STARTED|Overall Study||36
352998|NCT02312739|868352|P1|STARTED|Overall Study||36
352999|NCT02312726|868366|P3|NOT COMPLETED|Overall Study||67
353000|NCT02312726|868367|P2|NOT COMPLETED|Overall Study||0
353001|NCT02312726|868368|P1|NOT COMPLETED|Overall Study||0
353002|NCT02312726|868366|P3|COMPLETED|Overall Study||0
353003|NCT02312726|868367|P2|COMPLETED|Overall Study||30
353004|NCT02312726|868368|P1|COMPLETED|Overall Study||38
353005|NCT02312726|868366|P3|STARTED|Overall Study||67
353006|NCT02312726|868367|P2|STARTED|Overall Study||30
353007|NCT02312726|868368|P1|STARTED|Overall Study||38
353008|NCT02312713|868383|P3|NOT COMPLETED|Overall Study||5
353009|NCT02312713|868384|P2|NOT COMPLETED|Overall Study||30
353010|NCT02312713|868385|P1|NOT COMPLETED|Overall Study||11
353011|NCT02312713|868383|P3|COMPLETED|Overall Study||63
353012|NCT02312713|868384|P2|COMPLETED|Overall Study||112
353013|NCT02312713|868385|P1|COMPLETED|Overall Study||129
353014|NCT02312713|868383|P3|STARTED|Overall Study||68
353015|NCT02312713|868384|P2|STARTED|Overall Study||142
353016|NCT02312713|868385|P1|STARTED|Overall Study||140
353017|NCT02312154|868429|P1|NOT COMPLETED|Overall Study||1
353018|NCT02312154|868429|P1|COMPLETED|Overall Study||24
353019|NCT02312154|868429|P1|STARTED|Overall Study||25
353020|NCT02311972|868446|P2|NOT COMPLETED|Overall Study||0
353021|NCT02311972|868447|P1|NOT COMPLETED|Overall Study||0
353022|NCT02311972|868446|P2|COMPLETED|Overall Study||8
353023|NCT02311972|868447|P1|COMPLETED|Overall Study||12
353024|NCT02311972|868446|P2|STARTED|Overall Study||8
353025|NCT02311972|868447|P1|STARTED|Overall Study||12
353026|NCT02311907|868466|P2|NOT COMPLETED|Overall Study||0
353027|NCT02311907|868467|P1|NOT COMPLETED|Overall Study||0
353028|NCT02311907|868466|P2|COMPLETED|Overall Study||91
353029|NCT02311907|868467|P1|COMPLETED|Overall Study||94
353030|NCT02311907|868466|P2|STARTED|Overall Study||91
353031|NCT02311907|868467|P1|STARTED|Overall Study||94
353032|NCT02311881|868492|P3|NOT COMPLETED|Overall Study||41
353033|NCT02311881|868493|P2|NOT COMPLETED|Overall Study||43
353034|NCT02311881|868494|P1|NOT COMPLETED|Overall Study||35
353035|NCT02311881|868492|P3|COMPLETED|Overall Study||196
353036|NCT02311881|868493|P2|COMPLETED|Overall Study||193
353037|NCT02311881|868494|P1|COMPLETED|Overall Study||200
353038|NCT02311881|868492|P3|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|237
353039|NCT02311881|868493|P2|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|236
353040|NCT02311881|868494|P1|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|234
353041|NCT02311881|868492|P3|STARTED|Overall Study|Started refers to all randomized participants.|237
353042|NCT02311881|868493|P2|STARTED|Overall Study|Started refers to all randomized participants.|236
353043|NCT02311881|868494|P1|STARTED|Overall Study|Started refers to all randomized participants.|235
353044|NCT02311309|868532|P3|NOT COMPLETED|Overall Study||0
353045|NCT02311309|868533|P2|NOT COMPLETED|Overall Study||0
353046|NCT02311309|868534|P1|NOT COMPLETED|Overall Study||0
353047|NCT02311309|868532|P3|COMPLETED|Overall Study||863
353048|NCT02311309|868533|P2|COMPLETED|Overall Study||35
353049|NCT02311309|868534|P1|COMPLETED|Overall Study||541
353050|NCT02311309|868532|P3|STARTED|Overall Study||863
353051|NCT02311309|868533|P2|STARTED|Overall Study|There were 863 patients with no peroperative bleeding in the 1439 patients studied|35
353052|NCT02311309|868534|P1|STARTED|Overall Study|There were 863 patients with no peroperative bleeding in the 1439 patients studied|541
353053|NCT02311153|868547|P2|NOT COMPLETED|Overall Study||7
353054|NCT02311153|868548|P1|NOT COMPLETED|Overall Study||5
353055|NCT02311153|868547|P2|COMPLETED|Overall Study||42
353056|NCT02311153|868548|P1|COMPLETED|Overall Study||48
353057|NCT02311153|868547|P2|STARTED|Overall Study||49
353058|NCT02311153|868548|P1|STARTED|Overall Study||53
353059|NCT02310789|868564|P1|NOT COMPLETED|Overall Study||1
353060|NCT02310789|868564|P1|COMPLETED|Overall Study||7
353061|NCT02310789|868564|P1|STARTED|Overall Study||8
353062|NCT02310776|868569|P1|NOT COMPLETED|Overall Study||0
353063|NCT02310776|868569|P1|COMPLETED|Overall Study||501
353064|NCT02310776|868569|P1|STARTED|Overall Study||501
353065|NCT02310750|868584|P16|NOT COMPLETED|HP MAD and Fasted/Fed||0
353066|NCT02310750|868585|P15|NOT COMPLETED|HP MAD and Fasted/Fed||0
353067|NCT02310750|868586|P14|NOT COMPLETED|HP MAD and Fasted/Fed||0
353068|NCT02310750|868587|P13|NOT COMPLETED|HP MAD and Fasted/Fed||0
353069|NCT02310750|868588|P12|NOT COMPLETED|HP MAD and Fasted/Fed||0
353070|NCT02310750|868589|P11|NOT COMPLETED|HP MAD and Fasted/Fed||0
353071|NCT02310750|868590|P10|NOT COMPLETED|HP MAD and Fasted/Fed||0
353072|NCT02310750|868591|P9|NOT COMPLETED|HP MAD and Fasted/Fed||0
353073|NCT02310750|868592|P8|NOT COMPLETED|HP MAD and Fasted/Fed||0
353074|NCT02310750|868593|P7|NOT COMPLETED|HP MAD and Fasted/Fed||0
353075|NCT02310750|868594|P6|NOT COMPLETED|HP MAD and Fasted/Fed||0
353076|NCT02310750|868595|P5|NOT COMPLETED|HP MAD and Fasted/Fed||1
353077|NCT02310750|868596|P4|NOT COMPLETED|HP MAD and Fasted/Fed||0
353078|NCT02310750|868597|P3|NOT COMPLETED|HP MAD and Fasted/Fed||0
353079|NCT02310750|868598|P2|NOT COMPLETED|HP MAD and Fasted/Fed||0
353080|NCT02310750|868599|P1|NOT COMPLETED|HP MAD and Fasted/Fed||0
353081|NCT02310750|868584|P16|COMPLETED|HP MAD and Fasted/Fed||2
353082|NCT02310750|868585|P15|COMPLETED|HP MAD and Fasted/Fed||2
353083|NCT02310750|868586|P14|COMPLETED|HP MAD and Fasted/Fed||2
353084|NCT02310750|868587|P13|COMPLETED|HP MAD and Fasted/Fed||2
353085|NCT02310750|868588|P12|COMPLETED|HP MAD and Fasted/Fed||2
353086|NCT02310750|868589|P11|COMPLETED|HP MAD and Fasted/Fed||2
353087|NCT02310750|868590|P10|COMPLETED|HP MAD and Fasted/Fed||0
353088|NCT02310750|868591|P9|COMPLETED|HP MAD and Fasted/Fed||0
353089|NCT02310750|868592|P8|COMPLETED|HP MAD and Fasted/Fed||0
353090|NCT02310750|868593|P7|COMPLETED|HP MAD and Fasted/Fed||2
353091|NCT02310750|868594|P6|COMPLETED|HP MAD and Fasted/Fed||0
353092|NCT02310750|868595|P5|COMPLETED|HP MAD and Fasted/Fed||4
353093|NCT02310750|868596|P4|COMPLETED|HP MAD and Fasted/Fed||0
353094|NCT02310750|868597|P3|COMPLETED|HP MAD and Fasted/Fed||0
353095|NCT02310750|868598|P2|COMPLETED|HP MAD and Fasted/Fed||0
353096|NCT02310750|868599|P1|COMPLETED|HP MAD and Fasted/Fed||0
353097|NCT02310750|868584|P16|STARTED|HP MAD and Fasted/Fed||2
353098|NCT02310750|868585|P15|STARTED|HP MAD and Fasted/Fed||2
353099|NCT02310750|868586|P14|STARTED|HP MAD and Fasted/Fed||2
353100|NCT02310750|868587|P13|STARTED|HP MAD and Fasted/Fed||2
353101|NCT02310750|868588|P12|STARTED|HP MAD and Fasted/Fed||2
353102|NCT02310750|868589|P11|STARTED|HP MAD and Fasted/Fed||2
353103|NCT02310750|868590|P10|STARTED|HP MAD and Fasted/Fed||0
353104|NCT02310750|868591|P9|STARTED|HP MAD and Fasted/Fed||0
353105|NCT02310750|868592|P8|STARTED|HP MAD and Fasted/Fed||0
353106|NCT02310750|868593|P7|STARTED|HP MAD and Fasted/Fed||2
353107|NCT02310750|868594|P6|STARTED|HP MAD and Fasted/Fed||0
353108|NCT02310750|868595|P5|STARTED|HP MAD and Fasted/Fed||5
353109|NCT02310750|868596|P4|STARTED|HP MAD and Fasted/Fed||0
353110|NCT02310750|868597|P3|STARTED|HP MAD and Fasted/Fed||0
353111|NCT02310750|868598|P2|STARTED|HP MAD and Fasted/Fed||0
353112|NCT02310750|868599|P1|STARTED|HP MAD and Fasted/Fed||0
353113|NCT02310750|868584|P16|NOT COMPLETED|HP Washout 2||0
353114|NCT02310750|868585|P15|NOT COMPLETED|HP Washout 2||0
353115|NCT02310750|868586|P14|NOT COMPLETED|HP Washout 2||0
353116|NCT02310750|868587|P13|NOT COMPLETED|HP Washout 2||0
353117|NCT02310750|868588|P12|NOT COMPLETED|HP Washout 2||0
353118|NCT02310750|868589|P11|NOT COMPLETED|HP Washout 2||0
353119|NCT02310750|868590|P10|NOT COMPLETED|HP Washout 2||0
353120|NCT02310750|868591|P9|NOT COMPLETED|HP Washout 2||0
353121|NCT02310750|868592|P8|NOT COMPLETED|HP Washout 2||0
353122|NCT02310750|868593|P7|NOT COMPLETED|HP Washout 2||7
353123|NCT02310750|868594|P6|NOT COMPLETED|HP Washout 2||0
353124|NCT02310750|868595|P5|NOT COMPLETED|HP Washout 2||1
353125|NCT02310750|868596|P4|NOT COMPLETED|HP Washout 2||0
353126|NCT02310750|868597|P3|NOT COMPLETED|HP Washout 2||0
353127|NCT02310750|868598|P2|NOT COMPLETED|HP Washout 2||0
353128|NCT02310750|868599|P1|NOT COMPLETED|HP Washout 2||0
353129|NCT02310750|868584|P16|COMPLETED|HP Washout 2||2
353130|NCT02310750|868585|P15|COMPLETED|HP Washout 2||2
353131|NCT02310750|868586|P14|COMPLETED|HP Washout 2||2
353132|NCT02310750|868587|P13|COMPLETED|HP Washout 2||2
353133|NCT02310750|868588|P12|COMPLETED|HP Washout 2||2
353134|NCT02310750|868589|P11|COMPLETED|HP Washout 2||2
353135|NCT02310750|868590|P10|COMPLETED|HP Washout 2||0
353136|NCT02310750|868591|P9|COMPLETED|HP Washout 2||0
353137|NCT02310750|868592|P8|COMPLETED|HP Washout 2||0
353138|NCT02310750|868593|P7|COMPLETED|HP Washout 2||2
353139|NCT02310750|868594|P6|COMPLETED|HP Washout 2||0
353140|NCT02310750|868595|P5|COMPLETED|HP Washout 2||5
353141|NCT02310750|868596|P4|COMPLETED|HP Washout 2||0
353142|NCT02310750|868597|P3|COMPLETED|HP Washout 2||0
353143|NCT02310750|868598|P2|COMPLETED|HP Washout 2||0
353144|NCT02310750|868599|P1|COMPLETED|HP Washout 2||0
353145|NCT02310750|868584|P16|STARTED|HP Washout 2||2
353146|NCT02310750|868585|P15|STARTED|HP Washout 2||2
353147|NCT02310750|868586|P14|STARTED|HP Washout 2||2
353148|NCT02310750|868587|P13|STARTED|HP Washout 2||2
353149|NCT02310750|868588|P12|STARTED|HP Washout 2||2
353150|NCT02310750|868589|P11|STARTED|HP Washout 2||2
353151|NCT02310750|868590|P10|STARTED|HP Washout 2||0
353152|NCT02310750|868591|P9|STARTED|HP Washout 2||0
353153|NCT02310750|868592|P8|STARTED|HP Washout 2||0
353154|NCT02310750|868593|P7|STARTED|HP Washout 2||9
353155|NCT02310750|868594|P6|STARTED|HP Washout 2||0
353156|NCT02310750|868595|P5|STARTED|HP Washout 2||6
353157|NCT02310750|868596|P4|STARTED|HP Washout 2||0
353158|NCT02310750|868597|P3|STARTED|HP Washout 2||0
353159|NCT02310750|868598|P2|STARTED|HP Washout 2||0
353160|NCT02310750|868599|P1|STARTED|HP Washout 2||0
353161|NCT02310750|868584|P16|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
353162|NCT02310750|868585|P15|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
353163|NCT02310750|868586|P14|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
353164|NCT02310750|868587|P13|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
353165|NCT02310750|868588|P12|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
353166|NCT02310750|868589|P11|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
353167|NCT02310750|868590|P10|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||3
353168|NCT02310750|868591|P9|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||8
353169|NCT02310750|868592|P8|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
353170|NCT02310750|868593|P7|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
353171|NCT02310750|868594|P6|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
353172|NCT02310750|868595|P5|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
353173|NCT02310750|868596|P4|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||1
353174|NCT02310750|868597|P3|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
353175|NCT02310750|868598|P2|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
353176|NCT02310750|868599|P1|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
353177|NCT02310750|868584|P16|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
353178|NCT02310750|868585|P15|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
353179|NCT02310750|868586|P14|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
353180|NCT02310750|868587|P13|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
353181|NCT02310750|868588|P12|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
353182|NCT02310750|868589|P11|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
353183|NCT02310750|868590|P10|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
353184|NCT02310750|868591|P9|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
353185|NCT02310750|868592|P8|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||7
353186|NCT02310750|868593|P7|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
353187|NCT02310750|868594|P6|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
353188|NCT02310750|868595|P5|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
353189|NCT02310750|868596|P4|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||3
353190|NCT02310750|868597|P3|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||5
353191|NCT02310750|868598|P2|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
353192|NCT02310750|868599|P1|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
353193|NCT02310750|868584|P16|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
353194|NCT02310750|868585|P15|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
353195|NCT02310750|868586|P14|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
353196|NCT02310750|868587|P13|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
353197|NCT02310750|868588|P12|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
353198|NCT02310750|868589|P11|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
353199|NCT02310750|868590|P10|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||7
353200|NCT02310750|868591|P9|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||14
353201|NCT02310750|868592|P8|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
353202|NCT02310750|868593|P7|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
353203|NCT02310750|868594|P6|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
353204|NCT02310750|868595|P5|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
353205|NCT02310750|868596|P4|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
353206|NCT02310750|868597|P3|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||5
353207|NCT02310750|868598|P2|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
353208|NCT02310750|868599|P1|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
353209|NCT02310750|868584|P16|NOT COMPLETED|HP Washout 1||0
353210|NCT02310750|868585|P15|NOT COMPLETED|HP Washout 1||0
353211|NCT02310750|868586|P14|NOT COMPLETED|HP Washout 1||0
353212|NCT02310750|868587|P13|NOT COMPLETED|HP Washout 1||0
353213|NCT02310750|868588|P12|NOT COMPLETED|HP Washout 1||0
353214|NCT02310750|868589|P11|NOT COMPLETED|HP Washout 1||0
353215|NCT02310750|868590|P10|NOT COMPLETED|HP Washout 1||0
353216|NCT02310750|868591|P9|NOT COMPLETED|HP Washout 1||0
353217|NCT02310750|868592|P8|NOT COMPLETED|HP Washout 1||0
353218|NCT02310750|868593|P7|NOT COMPLETED|HP Washout 1||3
353219|NCT02310750|868594|P6|NOT COMPLETED|HP Washout 1||2
353220|NCT02310750|868595|P5|NOT COMPLETED|HP Washout 1||2
353221|NCT02310750|868596|P4|NOT COMPLETED|HP Washout 1||1
353222|NCT02310750|868597|P3|NOT COMPLETED|HP Washout 1||1
353223|NCT02310750|868598|P2|NOT COMPLETED|HP Washout 1||0
353224|NCT02310750|868599|P1|NOT COMPLETED|HP Washout 1||0
353225|NCT02310750|868584|P16|COMPLETED|HP Washout 1||2
353226|NCT02310750|868585|P15|COMPLETED|HP Washout 1||2
353227|NCT02310750|868586|P14|COMPLETED|HP Washout 1||2
353228|NCT02310750|868587|P13|COMPLETED|HP Washout 1||2
353229|NCT02310750|868588|P12|COMPLETED|HP Washout 1||2
353230|NCT02310750|868589|P11|COMPLETED|HP Washout 1||2
353231|NCT02310750|868590|P10|COMPLETED|HP Washout 1||0
353232|NCT02310750|868591|P9|COMPLETED|HP Washout 1||0
353233|NCT02310750|868592|P8|COMPLETED|HP Washout 1||0
353234|NCT02310750|868593|P7|COMPLETED|HP Washout 1||9
353235|NCT02310750|868594|P6|COMPLETED|HP Washout 1||6
353236|NCT02310750|868595|P5|COMPLETED|HP Washout 1||6
353237|NCT02310750|868596|P4|COMPLETED|HP Washout 1||4
353238|NCT02310750|868597|P3|COMPLETED|HP Washout 1||5
353239|NCT02310750|868598|P2|COMPLETED|HP Washout 1||0
353240|NCT02310750|868599|P1|COMPLETED|HP Washout 1||0
353241|NCT02310750|868584|P16|STARTED|HP Washout 1||2
353242|NCT02310750|868585|P15|STARTED|HP Washout 1||2
353243|NCT02310750|868586|P14|STARTED|HP Washout 1||2
353244|NCT02310750|868587|P13|STARTED|HP Washout 1||2
353245|NCT02310750|868588|P12|STARTED|HP Washout 1||2
353246|NCT02310750|868589|P11|STARTED|HP Washout 1||2
353247|NCT02310750|868590|P10|STARTED|HP Washout 1||0
353248|NCT02310750|868591|P9|STARTED|HP Washout 1||0
353249|NCT02310750|868592|P8|STARTED|HP Washout 1||0
353250|NCT02310750|868593|P7|STARTED|HP Washout 1||12
353251|NCT02310750|868594|P6|STARTED|HP Washout 1||8
353252|NCT02310750|868595|P5|STARTED|HP Washout 1||8
353253|NCT02310750|868596|P4|STARTED|HP Washout 1||5
353254|NCT02310750|868597|P3|STARTED|HP Washout 1||6
353255|NCT02310750|868598|P2|STARTED|HP Washout 1||0
353256|NCT02310750|868599|P1|STARTED|HP Washout 1||0
353257|NCT02310750|868584|P16|NOT COMPLETED|HP Period 1||0
353258|NCT02310750|868585|P15|NOT COMPLETED|HP Period 1||0
353259|NCT02310750|868586|P14|NOT COMPLETED|HP Period 1||0
353260|NCT02310750|868587|P13|NOT COMPLETED|HP Period 1||0
353261|NCT02310750|868588|P12|NOT COMPLETED|HP Period 1||0
353262|NCT02310750|868589|P11|NOT COMPLETED|HP Period 1||0
353263|NCT02310750|868590|P10|NOT COMPLETED|HP Period 1||0
353264|NCT02310750|868591|P9|NOT COMPLETED|HP Period 1||0
353265|NCT02310750|868592|P8|NOT COMPLETED|HP Period 1||0
353266|NCT02310750|868593|P7|NOT COMPLETED|HP Period 1||1
353267|NCT02310750|868594|P6|NOT COMPLETED|HP Period 1||0
353268|NCT02310750|868595|P5|NOT COMPLETED|HP Period 1||0
353269|NCT02310750|868596|P4|NOT COMPLETED|HP Period 1||1
353270|NCT02310750|868597|P3|NOT COMPLETED|HP Period 1||0
353271|NCT02310750|868598|P2|NOT COMPLETED|HP Period 1||0
353272|NCT02310750|868599|P1|NOT COMPLETED|HP Period 1||1
353273|NCT02310750|868584|P16|COMPLETED|HP Period 1||2
353274|NCT02310750|868585|P15|COMPLETED|HP Period 1||2
353275|NCT02310750|868586|P14|COMPLETED|HP Period 1||2
353276|NCT02310750|868587|P13|COMPLETED|HP Period 1||2
353277|NCT02310750|868588|P12|COMPLETED|HP Period 1||2
353278|NCT02310750|868589|P11|COMPLETED|HP Period 1||2
353279|NCT02310750|868590|P10|COMPLETED|HP Period 1||0
353280|NCT02310750|868591|P9|COMPLETED|HP Period 1||0
353281|NCT02310750|868592|P8|COMPLETED|HP Period 1||0
353282|NCT02310750|868593|P7|COMPLETED|HP Period 1||12
353283|NCT02310750|868594|P6|COMPLETED|HP Period 1||8
353284|NCT02310750|868595|P5|COMPLETED|HP Period 1||8
353285|NCT02310750|868596|P4|COMPLETED|HP Period 1||5
353286|NCT02310750|868597|P3|COMPLETED|HP Period 1||6
353287|NCT02310750|868598|P2|COMPLETED|HP Period 1||6
353288|NCT02310750|868599|P1|COMPLETED|HP Period 1||6
353289|NCT02310750|868584|P16|STARTED|HP Period 1||2
353290|NCT02310750|868585|P15|STARTED|HP Period 1||2
353291|NCT02310750|868586|P14|STARTED|HP Period 1||2
353292|NCT02310750|868587|P13|STARTED|HP Period 1||2
353293|NCT02310750|868588|P12|STARTED|HP Period 1||2
353294|NCT02310750|868589|P11|STARTED|HP Period 1||2
353295|NCT02310750|868590|P10|STARTED|HP Period 1||0
353296|NCT02310750|868591|P9|STARTED|HP Period 1||0
353297|NCT02310750|868592|P8|STARTED|HP Period 1||0
353298|NCT02310750|868593|P7|STARTED|HP Period 1||13
353299|NCT02310750|868594|P6|STARTED|HP Period 1||8
353300|NCT02310750|868595|P5|STARTED|HP Period 1||8
353301|NCT02310750|868596|P4|STARTED|HP Period 1||6
353302|NCT02310750|868597|P3|STARTED|HP Period 1||6
353303|NCT02310750|868598|P2|STARTED|HP Period 1||6
353304|NCT02310750|868599|P1|STARTED|HP Period 1||7
353305|NCT02310646|869040|P2|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0
353306|NCT02310646|869041|P1|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0
353307|NCT02310646|869040|P2|COMPLETED|Second Intervention (Day 8 - Day 14)||104
353308|NCT02310646|869041|P1|COMPLETED|Second Intervention (Day 8 - Day 14)||107
353309|NCT02310646|869040|P2|STARTED|Second Intervention (Day 8 - Day 14)||104
353310|NCT02310646|869041|P1|STARTED|Second Intervention (Day 8 - Day 14)||107
353311|NCT02310646|869040|P2|NOT COMPLETED|First Intervention (Day 1 - Day 7)||0
353312|NCT02310646|869041|P1|NOT COMPLETED|First Intervention (Day 1 - Day 7)||2
353313|NCT02310646|869040|P2|COMPLETED|First Intervention (Day 1 - Day 7)||104
353314|NCT02310646|869041|P1|COMPLETED|First Intervention (Day 1 - Day 7)||107
353315|NCT02310646|869040|P2|STARTED|First Intervention (Day 1 - Day 7)||104
353316|NCT02310646|869041|P1|STARTED|First Intervention (Day 1 - Day 7)||109
353317|NCT02310581|869069|P4|NOT COMPLETED|Overall Study||1
353318|NCT02310581|869070|P3|NOT COMPLETED|Overall Study||1
353319|NCT02310581|869071|P2|NOT COMPLETED|Overall Study||2
353320|NCT02310581|869072|P1|NOT COMPLETED|Overall Study||3
353321|NCT02310581|869069|P4|COMPLETED|Overall Study||9
353322|NCT02310581|869070|P3|COMPLETED|Overall Study||9
353323|NCT02310581|869071|P2|COMPLETED|Overall Study||9
353324|NCT02310581|869072|P1|COMPLETED|Overall Study||6
353325|NCT02310581|869069|P4|STARTED|Overall Study||10
353326|NCT02310581|869070|P3|STARTED|Overall Study||10
353327|NCT02310581|869071|P2|STARTED|Overall Study||11
353328|NCT02310581|869072|P1|STARTED|Overall Study||9
353329|NCT02310568|869111|P5|NOT COMPLETED|Stage 2 (4 Weeks)||1
353330|NCT02310568|869112|P4|NOT COMPLETED|Stage 2 (4 Weeks)||5
353331|NCT02310568|869113|P3|NOT COMPLETED|Stage 2 (4 Weeks)||1
353332|NCT02310568|869114|P2|NOT COMPLETED|Stage 2 (4 Weeks)||1
353333|NCT02310568|869115|P1|NOT COMPLETED|Stage 2 (4 Weeks)||1
353334|NCT02310568|869111|P5|COMPLETED|Stage 2 (4 Weeks)||19
353335|NCT02310568|869112|P4|COMPLETED|Stage 2 (4 Weeks)||17
353336|NCT02310568|869113|P3|COMPLETED|Stage 2 (4 Weeks)||13
353337|NCT02310568|869114|P2|COMPLETED|Stage 2 (4 Weeks)||12
353338|NCT02310568|869115|P1|COMPLETED|Stage 2 (4 Weeks)||11
353339|NCT02310568|869111|P5|STARTED|Stage 2 (4 Weeks)||20
353340|NCT02310568|869112|P4|STARTED|Stage 2 (4 Weeks)||22
353341|NCT02310568|869113|P3|STARTED|Stage 2 (4 Weeks)||14
353342|NCT02310568|869114|P2|STARTED|Stage 2 (4 Weeks)||13
353343|NCT02310568|869115|P1|STARTED|Stage 2 (4 Weeks)||12
353344|NCT02310568|869111|P5|NOT COMPLETED|Stage 1 ( 4 Weeks)||1
353345|NCT02310568|869112|P4|NOT COMPLETED|Stage 1 ( 4 Weeks)||2
353346|NCT02310568|869113|P3|NOT COMPLETED|Stage 1 ( 4 Weeks)||1
353347|NCT02310568|869114|P2|NOT COMPLETED|Stage 1 ( 4 Weeks)||2
353348|NCT02310568|869115|P1|NOT COMPLETED|Stage 1 ( 4 Weeks)||3
353349|NCT02310568|869111|P5|COMPLETED|Stage 1 ( 4 Weeks)||20
353350|NCT02310568|869112|P4|COMPLETED|Stage 1 ( 4 Weeks)||22
353351|NCT02310568|869113|P3|COMPLETED|Stage 1 ( 4 Weeks)||14
353352|NCT02310568|869114|P2|COMPLETED|Stage 1 ( 4 Weeks)||13
353353|NCT02310568|869115|P1|COMPLETED|Stage 1 ( 4 Weeks)||12
353354|NCT02310568|869111|P5|STARTED|Stage 1 ( 4 Weeks)||21
353355|NCT02310568|869112|P4|STARTED|Stage 1 ( 4 Weeks)||24
353356|NCT02310568|869113|P3|STARTED|Stage 1 ( 4 Weeks)||15
353357|NCT02310568|869114|P2|STARTED|Stage 1 ( 4 Weeks)||15
353358|NCT02310568|869115|P1|STARTED|Stage 1 ( 4 Weeks)||15
353359|NCT02310126|869195|P2|NOT COMPLETED|Period 2 (15 Minutes)||0
353360|NCT02310126|869196|P1|NOT COMPLETED|Period 2 (15 Minutes)||0
353361|NCT02310126|869195|P2|COMPLETED|Period 2 (15 Minutes)||95
353362|NCT02310126|869196|P1|COMPLETED|Period 2 (15 Minutes)||94
353363|NCT02310126|869195|P2|Myopes|Period 2 (15 Minutes)||63
353364|NCT02310126|869196|P1|Myopes|Period 2 (15 Minutes)||56
353365|NCT02310126|869195|P2|Hyperopes|Period 2 (15 Minutes)||32
353366|NCT02310126|869196|P1|Hyperopes|Period 2 (15 Minutes)||38
353367|NCT02310126|869195|P2|STARTED|Period 2 (15 Minutes)||95
353368|NCT02310126|869196|P1|STARTED|Period 2 (15 Minutes)||94
353369|NCT02310126|869195|P2|NOT COMPLETED|Period 1 (15 Minutes)||2
353370|NCT02310126|869196|P1|NOT COMPLETED|Period 1 (15 Minutes)||0
353371|NCT02310126|869195|P2|COMPLETED|Period 1 (15 Minutes)||95
353372|NCT02310126|869196|P1|COMPLETED|Period 1 (15 Minutes)||94
353373|NCT02310126|869195|P2|Myopes|Period 1 (15 Minutes)||64
353374|NCT02310126|869196|P1|Myopes|Period 1 (15 Minutes)||56
353375|NCT02310126|869195|P2|Hyperopes|Period 1 (15 Minutes)||33
353376|NCT02310126|869196|P1|Hyperopes|Period 1 (15 Minutes)||38
353377|NCT02310126|869195|P2|STARTED|Period 1 (15 Minutes)||97
353378|NCT02310126|869196|P1|STARTED|Period 1 (15 Minutes)||94
353379|NCT02309723|869205|P3|NOT COMPLETED|Overall Study||24
353380|NCT02309723|869206|P2|NOT COMPLETED|Overall Study||23
353381|NCT02309723|869207|P1|NOT COMPLETED|Overall Study||24
353382|NCT02309723|869205|P3|COMPLETED|Overall Study||105
353383|NCT02309723|869206|P2|COMPLETED|Overall Study||105
353384|NCT02309723|869207|P1|COMPLETED|Overall Study||105
353385|NCT02309723|869205|P3|STARTED|Overall Study||129
353386|NCT02309723|869206|P2|STARTED|Overall Study||128
353387|NCT02309723|869207|P1|STARTED|Overall Study||129
353388|NCT02309411|869224|P3|NOT COMPLETED|Overall Study||0
353389|NCT02309411|869225|P2|NOT COMPLETED|Overall Study||1
353390|NCT02309411|869226|P1|NOT COMPLETED|Overall Study||2
353391|NCT02309411|869224|P3|COMPLETED|Overall Study||6
353392|NCT02309411|869225|P2|COMPLETED|Overall Study||14
353393|NCT02309411|869226|P1|COMPLETED|Overall Study||23
353394|NCT02309411|869224|P3|STARTED|Overall Study||6
353395|NCT02309411|869225|P2|STARTED|Overall Study||15
353396|NCT02309411|869226|P1|STARTED|Overall Study||25
353397|NCT02309294|869245|P1|NOT COMPLETED|Overall Study||2
353398|NCT02309294|869245|P1|COMPLETED|Overall Study||41
353399|NCT02309294|869245|P1|STARTED|Overall Study||43
353400|NCT02309112|869252|P3|NOT COMPLETED|Overall Study||1
353401|NCT02309112|869253|P2|NOT COMPLETED|Overall Study||1
353402|NCT02309112|869254|P1|NOT COMPLETED|Overall Study||1
353403|NCT02309112|869252|P3|COMPLETED|Overall Study||4
353404|NCT02309112|869253|P2|COMPLETED|Overall Study||4
353405|NCT02309112|869254|P1|COMPLETED|Overall Study||4
353406|NCT02309112|869252|P3|Completed Yoga Intervention|Overall Study||4
353407|NCT02309112|869253|P2|Completed Yoga Intervention|Overall Study||5
353408|NCT02309112|869254|P1|Completed Yoga Intervention|Overall Study||4
353409|NCT02309112|869252|P3|STARTED|Overall Study||5
353410|NCT02309112|869253|P2|STARTED|Overall Study||5
353411|NCT02309112|869254|P1|STARTED|Overall Study||5
353412|NCT02308787|869275|P1|NOT COMPLETED|Overall Study||0
353413|NCT02308787|869275|P1|COMPLETED|Overall Study|Data were collected from 20 PLTD procedures performed in 12 subjects|12
353414|NCT02308787|869275|P1|STARTED|Overall Study|Data were collected from 20 PLTD procedures performed in 12 subjects|12
353415|NCT02308748|869290|P10|NOT COMPLETED|Period 5||0
353416|NCT02308748|869291|P9|NOT COMPLETED|Period 5||1
353417|NCT02308748|869292|P8|NOT COMPLETED|Period 5||0
353418|NCT02308748|869293|P7|NOT COMPLETED|Period 5||0
353419|NCT02308748|869294|P6|NOT COMPLETED|Period 5||0
353420|NCT02308748|869295|P5|NOT COMPLETED|Period 5||0
353421|NCT02308748|869296|P4|NOT COMPLETED|Period 5||0
353422|NCT02308748|869297|P3|NOT COMPLETED|Period 5||0
353423|NCT02308748|869298|P2|NOT COMPLETED|Period 5||0
353424|NCT02308748|869299|P1|NOT COMPLETED|Period 5||1
353425|NCT02308748|869290|P10|COMPLETED|Period 5||2
353426|NCT02308748|869291|P9|COMPLETED|Period 5||1
353427|NCT02308748|869292|P8|COMPLETED|Period 5||1
353428|NCT02308748|869293|P7|COMPLETED|Period 5||2
353429|NCT02308748|869294|P6|COMPLETED|Period 5||3
353430|NCT02308748|869295|P5|COMPLETED|Period 5||2
353431|NCT02308748|869296|P4|COMPLETED|Period 5||2
353432|NCT02308748|869297|P3|COMPLETED|Period 5||1
353433|NCT02308748|869298|P2|COMPLETED|Period 5||2
353434|NCT02308748|869299|P1|COMPLETED|Period 5||1
353435|NCT02308748|869290|P10|STARTED|Period 5||2
353436|NCT02308748|869291|P9|STARTED|Period 5||2
353437|NCT02308748|869292|P8|STARTED|Period 5||1
353438|NCT02308748|869293|P7|STARTED|Period 5||2
353439|NCT02308748|869294|P6|STARTED|Period 5||3
353440|NCT02308748|869295|P5|STARTED|Period 5||2
353441|NCT02308748|869296|P4|STARTED|Period 5||2
353442|NCT02308748|869297|P3|STARTED|Period 5||1
353443|NCT02308748|869298|P2|STARTED|Period 5||2
353444|NCT02308748|869299|P1|STARTED|Period 5||2
353445|NCT02308748|869290|P10|NOT COMPLETED|Period 4||0
353446|NCT02308748|869291|P9|NOT COMPLETED|Period 4||0
353447|NCT02308748|869292|P8|NOT COMPLETED|Period 4||0
353448|NCT02308748|869293|P7|NOT COMPLETED|Period 4||0
353449|NCT02308748|869294|P6|NOT COMPLETED|Period 4||0
353450|NCT02308748|869295|P5|NOT COMPLETED|Period 4||0
353451|NCT02308748|869296|P4|NOT COMPLETED|Period 4||0
353452|NCT02308748|869297|P3|NOT COMPLETED|Period 4||0
353453|NCT02308748|869298|P2|NOT COMPLETED|Period 4||0
353454|NCT02308748|869299|P1|NOT COMPLETED|Period 4||0
353455|NCT02308748|869290|P10|COMPLETED|Period 4||2
353456|NCT02308748|869291|P9|COMPLETED|Period 4||2
353457|NCT02308748|869292|P8|COMPLETED|Period 4||1
353458|NCT02308748|869293|P7|COMPLETED|Period 4||2
353459|NCT02308748|869294|P6|COMPLETED|Period 4||3
353460|NCT02308748|869295|P5|COMPLETED|Period 4||2
353461|NCT02308748|869296|P4|COMPLETED|Period 4||2
353462|NCT02308748|869297|P3|COMPLETED|Period 4||1
353463|NCT02308748|869298|P2|COMPLETED|Period 4||2
353464|NCT02308748|869299|P1|COMPLETED|Period 4||2
353465|NCT02308748|869290|P10|STARTED|Period 4||2
353466|NCT02308748|869291|P9|STARTED|Period 4||2
353467|NCT02308748|869292|P8|STARTED|Period 4||1
353468|NCT02308748|869293|P7|STARTED|Period 4||2
353469|NCT02308748|869294|P6|STARTED|Period 4||3
353470|NCT02308748|869295|P5|STARTED|Period 4||2
353471|NCT02308748|869296|P4|STARTED|Period 4||2
353472|NCT02308748|869297|P3|STARTED|Period 4||1
353473|NCT02308748|869298|P2|STARTED|Period 4||2
353474|NCT02308748|869299|P1|STARTED|Period 4||2
353475|NCT02308748|869290|P10|NOT COMPLETED|Period 3||1
353476|NCT02308748|869291|P9|NOT COMPLETED|Period 3||0
353477|NCT02308748|869292|P8|NOT COMPLETED|Period 3||0
353478|NCT02308748|869293|P7|NOT COMPLETED|Period 3||0
353479|NCT02308748|869294|P6|NOT COMPLETED|Period 3||0
353480|NCT02308748|869295|P5|NOT COMPLETED|Period 3||0
353481|NCT02308748|869296|P4|NOT COMPLETED|Period 3||0
353482|NCT02308748|869297|P3|NOT COMPLETED|Period 3||0
353483|NCT02308748|869298|P2|NOT COMPLETED|Period 3||0
353484|NCT02308748|869299|P1|NOT COMPLETED|Period 3||0
353485|NCT02308748|869290|P10|COMPLETED|Period 3||2
353486|NCT02308748|869291|P9|COMPLETED|Period 3||2
353487|NCT02308748|869292|P8|COMPLETED|Period 3||1
353488|NCT02308748|869293|P7|COMPLETED|Period 3||2
353489|NCT02308748|869294|P6|COMPLETED|Period 3||3
353490|NCT02308748|869295|P5|COMPLETED|Period 3||2
353491|NCT02308748|869296|P4|COMPLETED|Period 3||2
353492|NCT02308748|869297|P3|COMPLETED|Period 3||1
353493|NCT02308748|869298|P2|COMPLETED|Period 3||2
353494|NCT02308748|869299|P1|COMPLETED|Period 3||2
353495|NCT02308748|869290|P10|STARTED|Period 3||3
353496|NCT02308748|869291|P9|STARTED|Period 3||2
353497|NCT02308748|869292|P8|STARTED|Period 3||1
353498|NCT02308748|869293|P7|STARTED|Period 3||2
353499|NCT02308748|869294|P6|STARTED|Period 3||3
353500|NCT02308748|869295|P5|STARTED|Period 3||2
353501|NCT02308748|869296|P4|STARTED|Period 3||2
353502|NCT02308748|869297|P3|STARTED|Period 3||1
353503|NCT02308748|869298|P2|STARTED|Period 3||2
353504|NCT02308748|869299|P1|STARTED|Period 3||2
353505|NCT02308748|869290|P10|NOT COMPLETED|Period 2||0
353506|NCT02308748|869291|P9|NOT COMPLETED|Period 2||0
353507|NCT02308748|869292|P8|NOT COMPLETED|Period 2||1
353508|NCT02308748|869293|P7|NOT COMPLETED|Period 2||0
353509|NCT02308748|869294|P6|NOT COMPLETED|Period 2||0
353510|NCT02308748|869295|P5|NOT COMPLETED|Period 2||0
353511|NCT02308748|869296|P4|NOT COMPLETED|Period 2||0
353512|NCT02308748|869297|P3|NOT COMPLETED|Period 2||0
353513|NCT02308748|869298|P2|NOT COMPLETED|Period 2||0
353514|NCT02308748|869299|P1|NOT COMPLETED|Period 2||0
353515|NCT02308748|869290|P10|COMPLETED|Period 2||3
353516|NCT02308748|869291|P9|COMPLETED|Period 2||2
353517|NCT02308748|869292|P8|COMPLETED|Period 2||1
353518|NCT02308748|869293|P7|COMPLETED|Period 2||2
353519|NCT02308748|869294|P6|COMPLETED|Period 2||3
353520|NCT02308748|869295|P5|COMPLETED|Period 2||2
353521|NCT02308748|869296|P4|COMPLETED|Period 2||2
353522|NCT02308748|869297|P3|COMPLETED|Period 2||1
353523|NCT02308748|869298|P2|COMPLETED|Period 2||2
353524|NCT02308748|869299|P1|COMPLETED|Period 2||2
353525|NCT02308748|869290|P10|STARTED|Period 2||3
353526|NCT02308748|869291|P9|STARTED|Period 2||2
353527|NCT02308748|869292|P8|STARTED|Period 2||2
353528|NCT02308748|869293|P7|STARTED|Period 2||2
353529|NCT02308748|869294|P6|STARTED|Period 2||3
353530|NCT02308748|869295|P5|STARTED|Period 2||2
353531|NCT02308748|869296|P4|STARTED|Period 2||2
353532|NCT02308748|869297|P3|STARTED|Period 2||1
353533|NCT02308748|869298|P2|STARTED|Period 2||2
353534|NCT02308748|869299|P1|STARTED|Period 2||2
353535|NCT02308748|869290|P10|NOT COMPLETED|Period 1||0
353536|NCT02308748|869291|P9|NOT COMPLETED|Period 1||0
353537|NCT02308748|869292|P8|NOT COMPLETED|Period 1||0
353538|NCT02308748|869293|P7|NOT COMPLETED|Period 1||0
353539|NCT02308748|869294|P6|NOT COMPLETED|Period 1||0
353540|NCT02308748|869295|P5|NOT COMPLETED|Period 1||0
353541|NCT02308748|869296|P4|NOT COMPLETED|Period 1||0
353542|NCT02308748|869297|P3|NOT COMPLETED|Period 1||1
353543|NCT02308748|869298|P2|NOT COMPLETED|Period 1||0
353544|NCT02308748|869299|P1|NOT COMPLETED|Period 1||0
353545|NCT02308748|869290|P10|COMPLETED|Period 1||3
353546|NCT02308748|869291|P9|COMPLETED|Period 1||2
353547|NCT02308748|869292|P8|COMPLETED|Period 1||2
353548|NCT02308748|869293|P7|COMPLETED|Period 1||2
353549|NCT02308748|869294|P6|COMPLETED|Period 1||3
353550|NCT02308748|869295|P5|COMPLETED|Period 1||2
353551|NCT02308748|869296|P4|COMPLETED|Period 1||2
353552|NCT02308748|869297|P3|COMPLETED|Period 1|One subject withdraw consent before starting Period 2|1
353553|NCT02308748|869298|P2|COMPLETED|Period 1||2
353554|NCT02308748|869299|P1|COMPLETED|Period 1||2
353555|NCT02308748|869290|P10|STARTED|Period 1||3
353556|NCT02308748|869291|P9|STARTED|Period 1||2
353557|NCT02308748|869292|P8|STARTED|Period 1||2
353558|NCT02308748|869293|P7|STARTED|Period 1||2
353559|NCT02308748|869294|P6|STARTED|Period 1||3
353560|NCT02308748|869295|P5|STARTED|Period 1||2
353561|NCT02308748|869296|P4|STARTED|Period 1||2
353562|NCT02308748|869297|P3|STARTED|Period 1||2
353563|NCT02308748|869298|P2|STARTED|Period 1||2
353564|NCT02308748|869299|P1|STARTED|Period 1||2
353565|NCT02308371|869313|P2|NOT COMPLETED|Overall Study||0
353566|NCT02308371|869314|P1|NOT COMPLETED|Overall Study||0
353567|NCT02308371|869313|P2|COMPLETED|Overall Study|Consider eligible for retrospective enrollment if admitted up until 10/15/2012|50
353568|NCT02308371|869314|P1|COMPLETED|Overall Study|Ended enrollment and recruitment 3/1/2016|50
353569|NCT02308371|869313|P2|STARTED|Overall Study|Consider eligible for retrospective enrollment if admitted after 4/1/2012|50
353570|NCT02308371|869314|P1|STARTED|Overall Study|Started enrollment and recruitment 11/26/2014|50
353571|NCT02308189|869330|P2|NOT COMPLETED|Overall Study||1
353572|NCT02308189|869331|P1|NOT COMPLETED|Overall Study||1
353573|NCT02308189|869330|P2|COMPLETED|Overall Study||14
353574|NCT02308189|869331|P1|COMPLETED|Overall Study||16
353575|NCT02308189|869330|P2|STARTED|Overall Study||15
353576|NCT02308189|869331|P1|STARTED|Overall Study||17
353577|NCT02308124|869344|P3|NOT COMPLETED|Overall Study||8
353578|NCT02308124|869345|P2|NOT COMPLETED|Overall Study||8
353579|NCT02308124|869346|P1|NOT COMPLETED|Overall Study||6
353580|NCT02308124|869344|P3|COMPLETED|Overall Study||21
353581|NCT02308124|869345|P2|COMPLETED|Overall Study||21
353582|NCT02308124|869346|P1|COMPLETED|Overall Study||23
353583|NCT02308124|869344|P3|STARTED|Overall Study||29
353584|NCT02308124|869345|P2|STARTED|Overall Study||29
353585|NCT02308124|869346|P1|STARTED|Overall Study||29
353586|NCT02307838|869369|P3|NOT COMPLETED|Overall Study||0
353587|NCT02307838|869370|P2|NOT COMPLETED|Overall Study||0
353588|NCT02307838|869371|P1|NOT COMPLETED|Overall Study||0
353589|NCT02307838|869369|P3|COMPLETED|Overall Study||55
353590|NCT02307838|869370|P2|COMPLETED|Overall Study||64
353591|NCT02307838|869371|P1|COMPLETED|Overall Study||56
353592|NCT02307838|869369|P3|STARTED|Overall Study||55
353593|NCT02307838|869370|P2|STARTED|Overall Study||64
353594|NCT02307838|869371|P1|STARTED|Overall Study||56
353595|NCT02307552|869414|P1|NOT COMPLETED|Overall Study||0
353596|NCT02307552|869414|P1|COMPLETED|Overall Study||1
353597|NCT02307552|869414|P1|STARTED|Overall Study||1
353598|NCT02307526|869418|P1|NOT COMPLETED|Day 2 - 60 mg of Pyridostigmine||0
353599|NCT02307526|869418|P1|COMPLETED|Day 2 - 60 mg of Pyridostigmine||10
353600|NCT02307526|869418|P1|STARTED|Day 2 - 60 mg of Pyridostigmine||10
353601|NCT02307526|869418|P1|NOT COMPLETED|Day 1 - No Drug||0
353602|NCT02307526|869418|P1|COMPLETED|Day 1 - No Drug||10
353603|NCT02307526|869418|P1|STARTED|Day 1 - No Drug||10
353604|NCT02307318|869428|P1|NOT COMPLETED|Overall Study||0
353605|NCT02307318|869428|P1|COMPLETED|Overall Study||51
353606|NCT02307318|869428|P1|STARTED|Overall Study||51
353607|NCT02307266|869438|P3|NOT COMPLETED|Overall Study||6
353608|NCT02307266|869439|P2|NOT COMPLETED|Overall Study||1
353609|NCT02307266|869440|P1|NOT COMPLETED|Overall Study||8
353610|NCT02307266|869438|P3|COMPLETED|Overall Study||25
353611|NCT02307266|869439|P2|COMPLETED|Overall Study||32
353612|NCT02307266|869440|P1|COMPLETED|Overall Study||25
353613|NCT02307266|869438|P3|STARTED|Overall Study||31
353614|NCT02307266|869439|P2|STARTED|Overall Study||33
353615|NCT02307266|869440|P1|STARTED|Overall Study||33
353616|NCT02307188|869448|P1|NOT COMPLETED|Overall Study||4
353617|NCT02307188|869448|P1|COMPLETED|Overall Study|Four of 5 patients did not meet required criteria to complete the study after they were enrolled.|1
353618|NCT02307188|869448|P1|STARTED|Overall Study||5
353619|NCT02307123|869452|P1|NOT COMPLETED|Overall Study||0
353620|NCT02307123|869452|P1|COMPLETED|Overall Study||483
353621|NCT02307123|869452|P1|STARTED|Overall Study||483
353622|NCT02306928|869457|P1|NOT COMPLETED|Overall Study||0
353623|NCT02306928|869457|P1|COMPLETED|Overall Study||15
353624|NCT02306928|869457|P1|STARTED|Overall Study||15
353625|NCT02306759|869467|P2|NOT COMPLETED|Overall Study||0
353626|NCT02306759|869468|P1|NOT COMPLETED|Overall Study||0
353627|NCT02306759|869467|P2|COMPLETED|Overall Study||30
353628|NCT02306759|869468|P1|COMPLETED|Overall Study||30
353629|NCT02306759|869467|P2|STARTED|Overall Study||30
353630|NCT02306759|869468|P1|STARTED|Overall Study||30
353631|NCT02305446|869482|P1|NOT COMPLETED|Overall Study||1
353632|NCT02305446|869482|P1|COMPLETED|Overall Study||54
353633|NCT02305446|869482|P1|STARTED|Overall Study||55
353634|NCT02305381|869490|P3|NOT COMPLETED|Overall Study||7
353635|NCT02305381|869491|P2|NOT COMPLETED|Overall Study||5
353636|NCT02305381|869492|P1|NOT COMPLETED|Overall Study||5
353637|NCT02305381|869490|P3|COMPLETED|Overall Study|Subjects who completed the trial.|126
353638|NCT02305381|869491|P2|COMPLETED|Overall Study|Subjects who completed the trial.|127
353639|NCT02305381|869492|P1|COMPLETED|Overall Study|Subjects who completed the trial.|127
353640|NCT02305381|869490|P3|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|13
353641|NCT02305381|869491|P2|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial|16
353642|NCT02305381|869492|P1|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|14
353643|NCT02305381|869490|P3|Exposed|Overall Study||133
353644|NCT02305381|869491|P2|Exposed|Overall Study||131
353645|NCT02305381|869492|P1|Exposed|Overall Study||132
353646|NCT02305381|869490|P3|STARTED|Overall Study||133
353647|NCT02305381|869491|P2|STARTED|Overall Study||132
353648|NCT02305381|869492|P1|STARTED|Overall Study||132
353649|NCT02305329|869525|P4|NOT COMPLETED|Overall Study||0
353650|NCT02305329|869526|P3|NOT COMPLETED|Overall Study||0
353651|NCT02305329|869527|P2|NOT COMPLETED|Overall Study||1
353652|NCT02305329|869528|P1|NOT COMPLETED|Overall Study||0
353653|NCT02305329|869525|P4|COMPLETED|Overall Study||14
353654|NCT02305329|869526|P3|COMPLETED|Overall Study||14
353655|NCT02305329|869527|P2|COMPLETED|Overall Study||13
353656|NCT02305329|869528|P1|COMPLETED|Overall Study||14
353657|NCT02305329|869525|P4|Period 2|Overall Study||14
353658|NCT02305329|869526|P3|Period 2|Overall Study||14
353659|NCT02305329|869527|P2|Period 2|Overall Study||13
353660|NCT02305329|869528|P1|Period 2|Overall Study||14
353661|NCT02305329|869525|P4|Period 1|Overall Study||14
353662|NCT02305329|869526|P3|Period 1|Overall Study||14
353663|NCT02305329|869527|P2|Period 1|Overall Study||14
353664|NCT02305329|869528|P1|Period 1|Overall Study||14
353665|NCT02305329|869525|P4|STARTED|Overall Study||14
353666|NCT02305329|869526|P3|STARTED|Overall Study||14
353667|NCT02305329|869527|P2|STARTED|Overall Study||14
353668|NCT02305329|869528|P1|STARTED|Overall Study||14
353669|NCT02305316|869552|P2|NOT COMPLETED|Overall Study||0
353670|NCT02305316|869553|P1|NOT COMPLETED|Overall Study||0
353671|NCT02305316|869552|P2|COMPLETED|Overall Study||14
353672|NCT02305316|869553|P1|COMPLETED|Overall Study||14
353673|NCT02305316|869552|P2|STARTED|Overall Study||14
353674|NCT02305316|869553|P1|STARTED|Overall Study||14
353675|NCT02305277|869571|P6|NOT COMPLETED|Overall Study||0
353676|NCT02305277|869572|P5|NOT COMPLETED|Overall Study||1
353677|NCT02305277|869573|P4|NOT COMPLETED|Overall Study||0
353678|NCT02305277|869574|P3|NOT COMPLETED|Overall Study||0
353679|NCT02305277|869575|P2|NOT COMPLETED|Overall Study||0
353680|NCT02305277|869576|P1|NOT COMPLETED|Overall Study||1
353681|NCT02305277|869571|P6|COMPLETED|Overall Study||14
353682|NCT02305277|869572|P5|COMPLETED|Overall Study||13
353683|NCT02305277|869573|P4|COMPLETED|Overall Study||14
353684|NCT02305277|869574|P3|COMPLETED|Overall Study||14
353685|NCT02305277|869575|P2|COMPLETED|Overall Study||14
353686|NCT02305277|869576|P1|COMPLETED|Overall Study||14
353687|NCT02305277|869571|P6|Received TBM|Overall Study||14
353688|NCT02305277|869572|P5|Received TBM|Overall Study||14
353689|NCT02305277|869573|P4|Received TBM|Overall Study||14
353690|NCT02305277|869574|P3|Received TBM|Overall Study||14
353691|NCT02305277|869575|P2|Received TBM|Overall Study||14
353692|NCT02305277|869576|P1|Received TBM|Overall Study||15
353693|NCT02305277|869571|P6|Received CM|Overall Study||14
353694|NCT02305277|869572|P5|Received CM|Overall Study||14
353695|NCT02305277|869573|P4|Received CM|Overall Study||14
353696|NCT02305277|869574|P3|Received CM|Overall Study||14
353697|NCT02305277|869575|P2|Received CM|Overall Study||14
353698|NCT02305277|869576|P1|Received CM|Overall Study||15
353699|NCT02305277|869571|P6|STARTED|Overall Study||14
353700|NCT02305277|869572|P5|STARTED|Overall Study||14
353701|NCT02305277|869573|P4|STARTED|Overall Study||14
353702|NCT02305277|869574|P3|STARTED|Overall Study||14
353703|NCT02305277|869575|P2|STARTED|Overall Study||14
353704|NCT02305277|869576|P1|STARTED|Overall Study||15
353705|NCT02305238|869605|P3|NOT COMPLETED|Overall Study||8
353706|NCT02305238|869606|P2|NOT COMPLETED|Overall Study||7
353707|NCT02305238|869607|P1|NOT COMPLETED|Overall Study||13
353708|NCT02305238|869605|P3|COMPLETED|Overall Study||0
353709|NCT02305238|869606|P2|COMPLETED|Overall Study||116
353710|NCT02305238|869607|P1|COMPLETED|Overall Study||111
353711|NCT02305238|869605|P3|BCVA Post-randomization Assessment|Overall Study||0
353712|NCT02305238|869606|P2|BCVA Post-randomization Assessment|Overall Study||123
353713|NCT02305238|869607|P1|BCVA Post-randomization Assessment|Overall Study||123
353714|NCT02305238|869605|P3|Randomized|Overall Study||0
353715|NCT02305238|869606|P2|Randomized|Overall Study||123
353716|NCT02305238|869607|P1|Randomized|Overall Study||124
353717|NCT02305238|869605|P3|Treated|Overall Study||7
353718|NCT02305238|869606|P2|Treated|Overall Study||123
353719|NCT02305238|869607|P1|Treated|Overall Study||124
353720|NCT02305238|869605|P3|STARTED|Overall Study||8
353721|NCT02305238|869606|P2|STARTED|Overall Study||123
353722|NCT02305238|869607|P1|STARTED|Overall Study||124
353723|NCT02305017|869624|P2|NOT COMPLETED|Overall Study||0
353724|NCT02305017|869625|P1|NOT COMPLETED|Overall Study||0
353725|NCT02305017|869624|P2|COMPLETED|Overall Study||14
353726|NCT02305017|869625|P1|COMPLETED|Overall Study||14
353727|NCT02305017|869624|P2|STARTED|Overall Study||14
353728|NCT02305017|869625|P1|STARTED|Overall Study||14
353729|NCT02304926|869639|P2|NOT COMPLETED|Overall Study||1
353730|NCT02304926|869640|P1|NOT COMPLETED|Overall Study||2
353731|NCT02304926|869639|P2|COMPLETED|Overall Study||19
353732|NCT02304926|869640|P1|COMPLETED|Overall Study||20
353733|NCT02304926|869639|P2|STARTED|Overall Study||20
353734|NCT02304926|869640|P1|STARTED|Overall Study||22
353735|NCT02304432|869684|P4|NOT COMPLETED|Second Open Label DCS||0
353736|NCT02304432|869685|P3|NOT COMPLETED|Second Open Label DCS||0
353737|NCT02304432|869686|P2|NOT COMPLETED|Second Open Label DCS||0
353738|NCT02304432|869687|P1|NOT COMPLETED|Second Open Label DCS||0
353739|NCT02304432|869684|P4|COMPLETED|Second Open Label DCS||2
353740|NCT02304432|869685|P3|COMPLETED|Second Open Label DCS||0
353741|NCT02304432|869686|P2|COMPLETED|Second Open Label DCS||0
353742|NCT02304432|869687|P1|COMPLETED|Second Open Label DCS||0
353743|NCT02304432|869684|P4|STARTED|Second Open Label DCS||2
353744|NCT02304432|869685|P3|STARTED|Second Open Label DCS||0
353745|NCT02304432|869686|P2|STARTED|Second Open Label DCS||0
353746|NCT02304432|869687|P1|STARTED|Second Open Label DCS||0
353747|NCT02304432|869684|P4|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
353748|NCT02304432|869685|P3|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
353749|NCT02304432|869686|P2|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
353750|NCT02304432|869687|P1|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
353751|NCT02304432|869684|P4|COMPLETED|Double-Blind DCS Placebo Crossover||0
353752|NCT02304432|869685|P3|COMPLETED|Double-Blind DCS Placebo Crossover||1
353753|NCT02304432|869686|P2|COMPLETED|Double-Blind DCS Placebo Crossover||1
353754|NCT02304432|869687|P1|COMPLETED|Double-Blind DCS Placebo Crossover||0
353755|NCT02304432|869684|P4|STARTED|Double-Blind DCS Placebo Crossover||0
353756|NCT02304432|869685|P3|STARTED|Double-Blind DCS Placebo Crossover||1
353757|NCT02304432|869686|P2|STARTED|Double-Blind DCS Placebo Crossover||1
353758|NCT02304432|869687|P1|STARTED|Double-Blind DCS Placebo Crossover||0
353759|NCT02304432|869684|P4|NOT COMPLETED|Open Label DCS||0
353760|NCT02304432|869685|P3|NOT COMPLETED|Open Label DCS||0
353761|NCT02304432|869686|P2|NOT COMPLETED|Open Label DCS||0
353762|NCT02304432|869687|P1|NOT COMPLETED|Open Label DCS||0
353763|NCT02304432|869684|P4|COMPLETED|Open Label DCS||0
353764|NCT02304432|869685|P3|COMPLETED|Open Label DCS||0
353765|NCT02304432|869686|P2|COMPLETED|Open Label DCS||0
353766|NCT02304432|869687|P1|COMPLETED|Open Label DCS||2
353767|NCT02304432|869684|P4|STARTED|Open Label DCS||0
353768|NCT02304432|869685|P3|STARTED|Open Label DCS||0
353769|NCT02304432|869686|P2|STARTED|Open Label DCS||0
353770|NCT02304432|869687|P1|STARTED|Open Label DCS||2
353771|NCT02303743|869721|P2|NOT COMPLETED|Overall Study||0
353772|NCT02303743|869722|P1|NOT COMPLETED|Overall Study||0
353773|NCT02303743|869721|P2|COMPLETED|Overall Study||152
353774|NCT02303743|869722|P1|COMPLETED|Overall Study||108
353775|NCT02303743|869721|P2|STARTED|Overall Study||152
353776|NCT02303743|869722|P1|STARTED|Overall Study||108
353777|NCT02303704|869732|P2|NOT COMPLETED|Overall Study||9
353778|NCT02303704|869733|P1|NOT COMPLETED|Overall Study||5
353779|NCT02303704|869732|P2|COMPLETED|Overall Study||219
353780|NCT02303704|869733|P1|COMPLETED|Overall Study||215
353781|NCT02303704|869732|P2|STARTED|Overall Study||228
353782|NCT02303704|869733|P1|STARTED|Overall Study||220
353783|NCT02302807|869751|P2|NOT COMPLETED|Overall Study||334
353784|NCT02302807|869752|P1|NOT COMPLETED|Overall Study||375
353785|NCT02302807|869751|P2|COMPLETED|Overall Study||133
353786|NCT02302807|869752|P1|COMPLETED|Overall Study||89
353787|NCT02302807|869751|P2|Received Treatment|Overall Study||459
353788|NCT02302807|869752|P1|Received Treatment|Overall Study||443
353789|NCT02302807|869751|P2|STARTED|Overall Study||467
353790|NCT02302807|869752|P1|STARTED|Overall Study||464
353791|NCT02302716|869799|P2|NOT COMPLETED|Overall Study||19
353792|NCT02302716|869800|P1|NOT COMPLETED|Overall Study||19
353793|NCT02302716|869799|P2|COMPLETED|Overall Study||225
353794|NCT02302716|869800|P1|COMPLETED|Overall Study||230
353795|NCT02302716|869799|P2|Received at Least 1 Dose of Study Drug|Overall Study||244
353796|NCT02302716|869800|P1|Received at Least 1 Dose of Study Drug|Overall Study||249
353797|NCT02302716|869799|P2|STARTED|Overall Study||244
353798|NCT02302716|869800|P1|STARTED|Overall Study||249
353799|NCT02302365|869826|P1|NOT COMPLETED|Overall Study||2
353800|NCT02302365|869826|P1|COMPLETED|Overall Study|The Per-protocol Analysis Set comprised 54 procedures performed in 41 subjects|41
353801|NCT02302365|869826|P1|STARTED|Overall Study|Data were collected from 58 WBCD procedures performed in 43 subjects - Full and Safety Analysis Sets|43
353802|NCT02302092|869844|P2|NOT COMPLETED|Overall Study||0
353803|NCT02302092|869845|P1|NOT COMPLETED|Overall Study||0
353804|NCT02302092|869844|P2|COMPLETED|Overall Study||7
353805|NCT02302092|869845|P1|COMPLETED|Overall Study||6
353806|NCT02302092|869844|P2|STARTED|Overall Study||7
353807|NCT02302092|869845|P1|STARTED|Overall Study||6
353808|NCT02301975|869874|P3|NOT COMPLETED|Overall Study||22
353809|NCT02301975|869875|P2|NOT COMPLETED|Overall Study||25
353810|NCT02301975|869876|P1|NOT COMPLETED|Overall Study||31
353811|NCT02301975|869874|P3|COMPLETED|Overall Study||477
353812|NCT02301975|869875|P2|COMPLETED|Overall Study||476
353813|NCT02301975|869876|P1|COMPLETED|Overall Study||473
353814|NCT02301975|869874|P3|STARTED|Overall Study||499
353815|NCT02301975|869875|P2|STARTED|Overall Study||501
353816|NCT02301975|869876|P1|STARTED|Overall Study||504
353817|NCT02301936|869904|P2|NOT COMPLETED|Overall Study||0
353818|NCT02301936|869905|P1|NOT COMPLETED|Overall Study||1
353819|NCT02301936|869904|P2|COMPLETED|Overall Study||1
353820|NCT02301936|869905|P1|COMPLETED|Overall Study||8
353821|NCT02301936|869904|P2|STARTED|Overall Study||1
353822|NCT02301936|869905|P1|STARTED|Overall Study||9
353823|NCT02301429|869927|P1|NOT COMPLETED|Overall Study||3
353824|NCT02301429|869927|P1|COMPLETED|Overall Study||13
353825|NCT02301429|869927|P1|STARTED|Overall Study||16
353826|NCT02301377|869933|P2|NOT COMPLETED|Overall Study||0
353827|NCT02301377|869934|P1|NOT COMPLETED|Overall Study||0
353828|NCT02301377|869933|P2|COMPLETED|Overall Study||2
353829|NCT02301377|869934|P1|COMPLETED|Overall Study||3
353830|NCT02301377|869933|P2|STARTED|Overall Study||2
353831|NCT02301377|869934|P1|STARTED|Overall Study||3
353832|NCT02301364|869944|P1|NOT COMPLETED|Overall Study||0
353833|NCT02301364|869944|P1|COMPLETED|Overall Study||4
353834|NCT02301364|869944|P1|STARTED|Overall Study||4
353835|NCT02301169|869953|P2|NOT COMPLETED|Overall Study||0
353836|NCT02301169|869954|P1|NOT COMPLETED|Overall Study||1
353837|NCT02301169|869953|P2|COMPLETED|Overall Study||21
353838|NCT02301169|869954|P1|COMPLETED|Overall Study||20
353839|NCT02301169|869953|P2|STARTED|Overall Study||21
353840|NCT02301169|869954|P1|STARTED|Overall Study||21
353841|NCT02300558|869968|P1|NOT COMPLETED|Open-Label (OL) Extension Phase||32
353842|NCT02300558|869968|P1|COMPLETED|Open-Label (OL) Extension Phase||0
353843|NCT02300558|869968|P1|STARTED|Open-Label (OL) Extension Phase||32
353844|NCT02300558|869968|P1|NOT COMPLETED|Single Blind Phase (24 Weeks)||6
353845|NCT02300558|869968|P1|COMPLETED|Single Blind Phase (24 Weeks)||35
353846|NCT02300558|869968|P1|STARTED|Single Blind Phase (24 Weeks)||41
353847|NCT02300311|869981|P2|NOT COMPLETED|Overall Study||0
353848|NCT02300311|869982|P1|NOT COMPLETED|Overall Study||19
353849|NCT02300311|869981|P2|COMPLETED|Overall Study||69
353850|NCT02300311|869982|P1|COMPLETED|Overall Study||50
353851|NCT02300311|869981|P2|STARTED|Overall Study||69
353852|NCT02300311|869982|P1|STARTED|Overall Study||69
353853|NCT02300129|869994|P4|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
353854|NCT02300129|869995|P3|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
353855|NCT02300129|869996|P2|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
353856|NCT02300129|869997|P1|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
353857|NCT02300129|869994|P4|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10
353858|NCT02300129|869995|P3|COMPLETED|Period 2 Treatment 2 (2 Weeks)||7
353859|NCT02300129|869996|P2|COMPLETED|Period 2 Treatment 2 (2 Weeks)||4
353860|NCT02300129|869997|P1|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10
353861|NCT02300129|869994|P4|STARTED|Period 2 Treatment 2 (2 Weeks)||10
353862|NCT02300129|869995|P3|STARTED|Period 2 Treatment 2 (2 Weeks)||7
353863|NCT02300129|869996|P2|STARTED|Period 2 Treatment 2 (2 Weeks)||4
353864|NCT02300129|869997|P1|STARTED|Period 2 Treatment 2 (2 Weeks)||10
353865|NCT02300129|869994|P4|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1
353866|NCT02300129|869995|P3|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0
353867|NCT02300129|869996|P2|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0
353868|NCT02300129|869997|P1|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1
353869|NCT02300129|869994|P4|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10
353870|NCT02300129|869995|P3|COMPLETED|Period 2 Treatment 1 (2 Weeks)||7
353871|NCT02300129|869996|P2|COMPLETED|Period 2 Treatment 1 (2 Weeks)||4
353872|NCT02300129|869997|P1|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10
353873|NCT02300129|869994|P4|STARTED|Period 2 Treatment 1 (2 Weeks)|Withdrawal consent of 1 subject between the Period 1 and Period 2|11
353874|NCT02300129|869995|P3|STARTED|Period 2 Treatment 1 (2 Weeks)||7
353875|NCT02300129|869996|P2|STARTED|Period 2 Treatment 1 (2 Weeks)||4
353876|NCT02300129|869997|P1|STARTED|Period 2 Treatment 1 (2 Weeks)||11
353877|NCT02300129|869994|P4|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
353878|NCT02300129|869995|P3|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
353879|NCT02300129|869996|P2|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
353880|NCT02300129|869997|P1|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
353881|NCT02300129|869994|P4|COMPLETED|Period 1 Session 3 (Day 5)||11
353882|NCT02300129|869995|P3|COMPLETED|Period 1 Session 3 (Day 5)||7
353883|NCT02300129|869996|P2|COMPLETED|Period 1 Session 3 (Day 5)||4
353884|NCT02300129|869997|P1|COMPLETED|Period 1 Session 3 (Day 5)||11
353885|NCT02300129|869994|P4|STARTED|Period 1 Session 3 (Day 5)||11
353886|NCT02300129|869995|P3|STARTED|Period 1 Session 3 (Day 5)||7
353887|NCT02300129|869996|P2|STARTED|Period 1 Session 3 (Day 5)||4
353888|NCT02300129|869997|P1|STARTED|Period 1 Session 3 (Day 5)||11
353889|NCT02300129|869994|P4|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
353890|NCT02300129|869995|P3|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
353891|NCT02300129|869996|P2|NOT COMPLETED|Period 1 Session 2 (Day 3)||1
353892|NCT02300129|869997|P1|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
353893|NCT02300129|869994|P4|COMPLETED|Period 1 Session 2 (Day 3)||11
353894|NCT02300129|869995|P3|COMPLETED|Period 1 Session 2 (Day 3)||7
353895|NCT02300129|869996|P2|COMPLETED|Period 1 Session 2 (Day 3)||4
353896|NCT02300129|869997|P1|COMPLETED|Period 1 Session 2 (Day 3)||11
353897|NCT02300129|869994|P4|STARTED|Period 1 Session 2 (Day 3)||11
353898|NCT02300129|869995|P3|STARTED|Period 1 Session 2 (Day 3)||7
353899|NCT02300129|869996|P2|STARTED|Period 1 Session 2 (Day 3)|Withdrawal consent of 1 subject between Day 1 and Day 3|5
353900|NCT02300129|869997|P1|STARTED|Period 1 Session 2 (Day 3)||11
353901|NCT02300129|869994|P4|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
353902|NCT02300129|869995|P3|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
353903|NCT02300129|869996|P2|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
353904|NCT02300129|869997|P1|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
353905|NCT02300129|869994|P4|COMPLETED|Period 1 Session 1 (Day 1)||11
353906|NCT02300129|869995|P3|COMPLETED|Period 1 Session 1 (Day 1)||7
353907|NCT02300129|869996|P2|COMPLETED|Period 1 Session 1 (Day 1)||5
353908|NCT02300129|869997|P1|COMPLETED|Period 1 Session 1 (Day 1)||11
353909|NCT02300129|869994|P4|STARTED|Period 1 Session 1 (Day 1)||11
353910|NCT02300129|869995|P3|STARTED|Period 1 Session 1 (Day 1)||7
353911|NCT02300129|869996|P2|STARTED|Period 1 Session 1 (Day 1)||5
353912|NCT02300129|869997|P1|STARTED|Period 1 Session 1 (Day 1)||11
353913|NCT02300103|870007|P1|NOT COMPLETED|Overall Study||6
353914|NCT02300103|870007|P1|COMPLETED|Overall Study||63
353915|NCT02300103|870007|P1|STARTED|Overall Study||69
353916|NCT02300025|870020|P4|NOT COMPLETED|Overall Study||0
353917|NCT02300025|870021|P3|NOT COMPLETED|Overall Study||0
353918|NCT02300025|870022|P2|NOT COMPLETED|Overall Study||0
353919|NCT02300025|870023|P1|NOT COMPLETED|Overall Study||0
353920|NCT02300025|870020|P4|COMPLETED|Overall Study||6
353921|NCT02300025|870021|P3|COMPLETED|Overall Study||6
353922|NCT02300025|870022|P2|COMPLETED|Overall Study||6
353923|NCT02300025|870023|P1|COMPLETED|Overall Study||10
353924|NCT02300025|870020|P4|STARTED|Overall Study||6
353925|NCT02300025|870021|P3|STARTED|Overall Study||6
353926|NCT02300025|870022|P2|STARTED|Overall Study||6
353927|NCT02300025|870023|P1|STARTED|Overall Study||10
353928|NCT02299869|870069|P4|NOT COMPLETED|Overall Study||0
353929|NCT02299869|870070|P3|NOT COMPLETED|Overall Study||0
353930|NCT02299869|870071|P2|NOT COMPLETED|Overall Study||0
353931|NCT02299869|870072|P1|NOT COMPLETED|Overall Study||0
353932|NCT02299869|870069|P4|COMPLETED|Overall Study||10
353933|NCT02299869|870070|P3|COMPLETED|Overall Study||10
353934|NCT02299869|870071|P2|COMPLETED|Overall Study||10
353935|NCT02299869|870072|P1|COMPLETED|Overall Study||10
353936|NCT02299869|870069|P4|STARTED|Overall Study||10
353937|NCT02299869|870070|P3|STARTED|Overall Study||10
353938|NCT02299869|870071|P2|STARTED|Overall Study||10
353939|NCT02299869|870072|P1|STARTED|Overall Study||10
353940|NCT02299791|870097|P2|NOT COMPLETED|Overall Study||0
353941|NCT02299791|870098|P1|NOT COMPLETED|Overall Study||0
353942|NCT02299791|870097|P2|COMPLETED|Overall Study||2803
353943|NCT02299791|870098|P1|COMPLETED|Overall Study||2053
353944|NCT02299791|870097|P2|STARTED|Overall Study||2803
353945|NCT02299791|870098|P1|STARTED|Overall Study||2053
353946|NCT02299635|870104|P1|NOT COMPLETED|Overall Study||19
353947|NCT02299635|870104|P1|COMPLETED|Overall Study||0
353948|NCT02299635|870104|P1|STARTED|Overall Study||19
353949|NCT02299427|870125|P2|NOT COMPLETED|Overall Study||3
353950|NCT02299427|870126|P1|NOT COMPLETED|Overall Study||23
353951|NCT02299427|870125|P2|COMPLETED|Overall Study||31
353952|NCT02299427|870126|P1|COMPLETED|Overall Study||12
353953|NCT02299427|870125|P2|STARTED|Overall Study||34
353954|NCT02299427|870126|P1|STARTED|Overall Study||35
353955|NCT02299349|870136|P2|NOT COMPLETED|Overall Study||0
353956|NCT02299349|870137|P1|NOT COMPLETED|Overall Study||0
353957|NCT02299349|870136|P2|COMPLETED|Overall Study||35
353958|NCT02299349|870137|P1|COMPLETED|Overall Study||35
353959|NCT02299349|870136|P2|STARTED|Overall Study||35
353960|NCT02299349|870137|P1|STARTED|Overall Study||35
353961|NCT02299336|870145|P1|NOT COMPLETED|Overall Study||14
353962|NCT02299336|870145|P1|COMPLETED|Overall Study||46
353963|NCT02299336|870145|P1|STARTED|Overall Study||60
353964|NCT02299258|870160|P2|NOT COMPLETED|Overall Study||1
353965|NCT02299258|870161|P1|NOT COMPLETED|Overall Study||1
353966|NCT02299258|870160|P2|COMPLETED|Overall Study||30
353967|NCT02299258|870161|P1|COMPLETED|Overall Study||31
353968|NCT02299258|870160|P2|STARTED|Overall Study||31
353969|NCT02299258|870161|P1|STARTED|Overall Study||32
353970|NCT02299206|870169|P1|NOT COMPLETED|Overall Study||2
353971|NCT02299206|870169|P1|COMPLETED|Overall Study||2
353972|NCT02299206|870169|P1|STARTED|Overall Study||4
353973|NCT02299089|870181|P4|NOT COMPLETED|Overall Study||0
353974|NCT02299089|870182|P3|NOT COMPLETED|Overall Study||0
353975|NCT02299089|870183|P2|NOT COMPLETED|Overall Study||0
353976|NCT02299089|870184|P1|NOT COMPLETED|Overall Study||0
353977|NCT02299089|870181|P4|COMPLETED|Overall Study||4
353978|NCT02299089|870182|P3|COMPLETED|Overall Study||1
353979|NCT02299089|870183|P2|COMPLETED|Overall Study||4
353980|NCT02299089|870184|P1|COMPLETED|Overall Study||3
353981|NCT02299089|870181|P4|STARTED|Overall Study||4
353982|NCT02299089|870182|P3|STARTED|Overall Study||1
353983|NCT02299089|870183|P2|STARTED|Overall Study||4
353984|NCT02299089|870184|P1|STARTED|Overall Study||3
353985|NCT02299076|870230|P2|NOT COMPLETED|Overall Study||14
353986|NCT02299076|870231|P1|NOT COMPLETED|Overall Study||20
353987|NCT02299076|870230|P2|COMPLETED|Overall Study||212
353988|NCT02299076|870231|P1|COMPLETED|Overall Study||210
353989|NCT02299076|870230|P2|STARTED|Overall Study||226
353990|NCT02299076|870231|P1|STARTED|Overall Study||230
353991|NCT02298868|870239|P1|NOT COMPLETED|Overall Study||3
353992|NCT02298868|870239|P1|COMPLETED|Overall Study||7
353993|NCT02298868|870239|P1|STARTED|Overall Study||10
353994|NCT02298842|870253|P2|NOT COMPLETED|Second Platelet Donation (Day 6-8)||6
353995|NCT02298842|870254|P1|NOT COMPLETED|Second Platelet Donation (Day 6-8)||8
353996|NCT02298842|870253|P2|COMPLETED|Second Platelet Donation (Day 6-8)||30
353997|NCT02298842|870254|P1|COMPLETED|Second Platelet Donation (Day 6-8)||30
353998|NCT02298842|870253|P2|STARTED|Second Platelet Donation (Day 6-8)||36
353999|NCT02298842|870254|P1|STARTED|Second Platelet Donation (Day 6-8)||38
354000|NCT02298842|870253|P2|NOT COMPLETED|First Platelet Donation (Day 0)||5
354001|NCT02298842|870254|P1|NOT COMPLETED|First Platelet Donation (Day 0)||6
354002|NCT02298842|870253|P2|COMPLETED|First Platelet Donation (Day 0)||36
354003|NCT02298842|870254|P1|COMPLETED|First Platelet Donation (Day 0)||38
354004|NCT02298842|870253|P2|STARTED|First Platelet Donation (Day 0)||41
354005|NCT02298842|870254|P1|STARTED|First Platelet Donation (Day 0)||44
354006|NCT02298803|870280|P1|NOT COMPLETED|Overall Study||0
354007|NCT02298803|870280|P1|COMPLETED|Overall Study||30
354008|NCT02298803|870280|P1|STARTED|Overall Study||30
354009|NCT02298361|870292|P3|NOT COMPLETED|Overall Study||0
354010|NCT02298361|870293|P2|NOT COMPLETED|Overall Study||0
354011|NCT02298361|870294|P1|NOT COMPLETED|Overall Study||0
354012|NCT02298361|870292|P3|COMPLETED|Overall Study||12227
354013|NCT02298361|870293|P2|COMPLETED|Overall Study||12784
354014|NCT02298361|870294|P1|COMPLETED|Overall Study||2240
354015|NCT02298361|870292|P3|STARTED|Overall Study||12227
354016|NCT02298361|870293|P2|STARTED|Overall Study||12784
354017|NCT02298361|870294|P1|STARTED|Overall Study||2240
354018|NCT02298192|870310|P2|NOT COMPLETED|Overall Study||6
354019|NCT02298192|870311|P1|NOT COMPLETED|Overall Study||19
354020|NCT02298192|870310|P2|COMPLETED|Overall Study||204
354021|NCT02298192|870311|P1|COMPLETED|Overall Study||191
354022|NCT02298192|870310|P2|STARTED|Overall Study||210
354023|NCT02298192|870311|P1|STARTED|Overall Study||210
354024|NCT02297841|870323|P1|NOT COMPLETED|Overall Study||8
354025|NCT02297841|870323|P1|COMPLETED|Overall Study||201
354026|NCT02297841|870323|P1|Challenge Phase|Overall Study||201
354027|NCT02297841|870323|P1|Induction Phase|Overall Study||209
354028|NCT02297841|870323|P1|STARTED|Overall Study||209
354029|NCT02297815|870329|P2|NOT COMPLETED|Overall Study||140
354030|NCT02297815|870330|P1|NOT COMPLETED|Overall Study||236
354031|NCT02297815|870329|P2|COMPLETED|Overall Study||728
354032|NCT02297815|870330|P1|COMPLETED|Overall Study||1368
354033|NCT02297815|870329|P2|14-20 Day Interview|Overall Study||728
354034|NCT02297815|870330|P1|14-20 Day Interview|Overall Study||1368
354035|NCT02297815|870329|P2|5-10 Day Interview|Overall Study||868
354036|NCT02297815|870330|P1|5-10 Day Interview|Overall Study||1604
354037|NCT02297815|870329|P2|STARTED|Overall Study||868
354038|NCT02297815|870330|P1|STARTED|Overall Study||1604
354039|NCT02297308|870344|P1|NOT COMPLETED|Overall Study||0
354040|NCT02297308|870344|P1|COMPLETED|Overall Study||90
354041|NCT02297308|870344|P1|STARTED|Overall Study||90
354042|NCT02297230|870353|P4|NOT COMPLETED|Overall Study||0
354043|NCT02297230|870354|P3|NOT COMPLETED|Overall Study||0
354044|NCT02297230|870355|P2|NOT COMPLETED|Overall Study||0
354045|NCT02297230|870356|P1|NOT COMPLETED|Overall Study||0
354046|NCT02297230|870353|P4|COMPLETED|Overall Study||11
354047|NCT02297230|870354|P3|COMPLETED|Overall Study||11
354048|NCT02297230|870355|P2|COMPLETED|Overall Study||11
354049|NCT02297230|870356|P1|COMPLETED|Overall Study||11
354050|NCT02297230|870353|P4|STARTED|Overall Study||11
354051|NCT02297230|870354|P3|STARTED|Overall Study||11
354052|NCT02297230|870355|P2|STARTED|Overall Study||11
354053|NCT02297230|870356|P1|STARTED|Overall Study||11
354054|NCT02297100|870380|P2|NOT COMPLETED|Overall Study||0
354055|NCT02297100|870381|P1|NOT COMPLETED|Overall Study||0
354056|NCT02297100|870380|P2|COMPLETED|Overall Study||14
354057|NCT02297100|870381|P1|COMPLETED|Overall Study||13
354058|NCT02297100|870380|P2|STARTED|Overall Study||14
354059|NCT02297100|870381|P1|STARTED|Overall Study||13
354060|NCT02296931|870395|P2|NOT COMPLETED|Overall Study||2
354061|NCT02296931|870396|P1|NOT COMPLETED|Overall Study||0
354062|NCT02296931|870395|P2|COMPLETED|Overall Study||22
354063|NCT02296931|870396|P1|COMPLETED|Overall Study||10
354064|NCT02296931|870395|P2|STARTED|Overall Study||24
354065|NCT02296931|870396|P1|STARTED|Overall Study||10
354066|NCT02296840|870404|P2|NOT COMPLETED|Overall Study||19
354067|NCT02296840|870405|P1|NOT COMPLETED|Overall Study||9
354068|NCT02296840|870404|P2|COMPLETED|Overall Study||8
354069|NCT02296840|870405|P1|COMPLETED|Overall Study||9
354070|NCT02296840|870404|P2|STARTED|Overall Study||27
354071|NCT02296840|870405|P1|STARTED|Overall Study||18
354072|NCT02296606|870413|P1|NOT COMPLETED|Overall Study||0
354073|NCT02296606|870413|P1|COMPLETED|Overall Study||127
354074|NCT02296606|870413|P1|STARTED|Overall Study||127
354075|NCT02296476|870420|P3|NOT COMPLETED|Overall Study||2
354076|NCT02296476|870421|P2|NOT COMPLETED|Overall Study||4
354077|NCT02296476|870422|P1|NOT COMPLETED|Overall Study||6
354078|NCT02296476|870420|P3|COMPLETED|Overall Study||0
354079|NCT02296476|870421|P2|COMPLETED|Overall Study||0
354080|NCT02296476|870422|P1|COMPLETED|Overall Study||0
354081|NCT02296476|870420|P3|STARTED|Overall Study||2
354082|NCT02296476|870421|P2|STARTED|Overall Study||4
354083|NCT02296476|870422|P1|STARTED|Overall Study||6
354084|NCT02296138|870477|P2|NOT COMPLETED|Overall Study||500
354085|NCT02296138|870478|P1|NOT COMPLETED|Overall Study||661
354086|NCT02296138|870477|P2|COMPLETED|Overall Study||3451
354087|NCT02296138|870478|P1|COMPLETED|Overall Study||3291
354088|NCT02296138|870477|P2|Treated|Overall Study||3939
354089|NCT02296138|870478|P1|Treated|Overall Study||3941
354090|NCT02296138|870477|P2|STARTED|Overall Study||3951
354091|NCT02296138|870478|P1|STARTED|Overall Study||3952
354092|NCT02296099|870494|P2|NOT COMPLETED|Overall Study||2
354093|NCT02296099|870495|P1|NOT COMPLETED|Overall Study||3
354094|NCT02296099|870494|P2|COMPLETED|Overall Study||55
354095|NCT02296099|870495|P1|COMPLETED|Overall Study||54
354096|NCT02296099|870494|P2|STARTED|Overall Study||57
354097|NCT02296099|870495|P1|STARTED|Overall Study||57
354098|NCT02295774|870519|P1|NOT COMPLETED|Overall Study||3
354099|NCT02295774|870519|P1|COMPLETED|Overall Study||10
354100|NCT02295774|870519|P1|STARTED|Overall Study||13
354101|NCT02295644|870527|P4|NOT COMPLETED|Overall Study||2
354102|NCT02295644|870528|P3|NOT COMPLETED|Overall Study||1
354103|NCT02295644|870529|P2|NOT COMPLETED|Overall Study||0
354104|NCT02295644|870530|P1|NOT COMPLETED|Overall Study||0
354105|NCT02295644|870527|P4|COMPLETED|Overall Study||5
354106|NCT02295644|870528|P3|COMPLETED|Overall Study||6
354107|NCT02295644|870529|P2|COMPLETED|Overall Study||7
354108|NCT02295644|870530|P1|COMPLETED|Overall Study||7
354109|NCT02295644|870527|P4|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
354110|NCT02295644|870528|P3|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
354111|NCT02295644|870529|P2|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
354112|NCT02295644|870530|P1|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
354113|NCT02295280|870550|P2|NOT COMPLETED|Overall Study||1
354114|NCT02295280|870551|P1|NOT COMPLETED|Overall Study||0
354115|NCT02295280|870550|P2|COMPLETED|Overall Study||34
354116|NCT02295280|870551|P1|COMPLETED|Overall Study||35
354117|NCT02295280|870550|P2|STARTED|Overall Study||35
354118|NCT02295280|870551|P1|STARTED|Overall Study||35
354119|NCT02295020|870559|P2|NOT COMPLETED|Overall Study||3
354120|NCT02295020|870560|P1|NOT COMPLETED|Overall Study||3
354121|NCT02295020|870559|P2|COMPLETED|Overall Study||17
354122|NCT02295020|870560|P1|COMPLETED|Overall Study||17
354123|NCT02295020|870559|P2|STARTED|Overall Study||20
354124|NCT02295020|870560|P1|STARTED|Overall Study||20
354125|NCT02294773|870592|P2|NOT COMPLETED|Overall Study||2
354126|NCT02294773|870593|P1|NOT COMPLETED|Overall Study||0
354127|NCT02294773|870592|P2|COMPLETED|Overall Study||4
354128|NCT02294773|870593|P1|COMPLETED|Overall Study||7
354129|NCT02294773|870592|P2|STARTED|Overall Study||6
354130|NCT02294773|870593|P1|STARTED|Overall Study||7
354131|NCT02294734|870609|P2|NOT COMPLETED|Overall Study||8
354132|NCT02294734|870610|P1|NOT COMPLETED|Overall Study||14
354133|NCT02294734|870609|P2|COMPLETED|Overall Study||55
354134|NCT02294734|870610|P1|COMPLETED|Overall Study||49
354135|NCT02294734|870609|P2|STARTED|Overall Study||63
354136|NCT02294734|870610|P1|STARTED|Overall Study||63
354137|NCT02294682|870662|P2|NOT COMPLETED|Overall Study||0
354138|NCT02294682|870663|P1|NOT COMPLETED|Overall Study||1
354139|NCT02294682|870662|P2|COMPLETED|Overall Study||53
354140|NCT02294682|870663|P1|COMPLETED|Overall Study||52
354141|NCT02294682|870662|P2|STARTED|Overall Study||53
354142|NCT02294682|870663|P1|STARTED|Overall Study||53
354143|NCT02294604|870706|P3|NOT COMPLETED|Overall Study||0
354144|NCT02294604|870707|P2|NOT COMPLETED|Overall Study||3
354145|NCT02294604|870708|P1|NOT COMPLETED|Overall Study||1
354146|NCT02294604|870706|P3|COMPLETED|Overall Study||80
354147|NCT02294604|870707|P2|COMPLETED|Overall Study||77
354148|NCT02294604|870708|P1|COMPLETED|Overall Study||79
354149|NCT02294604|870706|P3|STARTED|Overall Study||80
354150|NCT02294604|870707|P2|STARTED|Overall Study||80
354151|NCT02294604|870708|P1|STARTED|Overall Study||80
354152|NCT02294474|870727|P2|NOT COMPLETED|Overall Study||22
354153|NCT02294474|870728|P1|NOT COMPLETED|Overall Study||25
354154|NCT02294474|870727|P2|COMPLETED|Overall Study||230
354155|NCT02294474|870728|P1|COMPLETED|Overall Study||228
354156|NCT02294474|870727|P2|STARTED|Overall Study||252
354157|NCT02294474|870728|P1|STARTED|Overall Study||253
354158|NCT02294461|870752|P2|NOT COMPLETED|Overall Study||131
354159|NCT02294461|870753|P1|NOT COMPLETED|Overall Study||62
354160|NCT02294461|870752|P2|COMPLETED|Overall Study||59
354161|NCT02294461|870753|P1|COMPLETED|Overall Study|Participants still receiving treatment as of 20 Sept 2016. Data cutoff date: 20 Sep 2015/20 Jan 2016|136
354162|NCT02294461|870752|P2|Treated/Received Study Drug|Overall Study||190
354163|NCT02294461|870753|P1|Treated/Received Study Drug|Overall Study||198
354164|NCT02294461|870752|P2|STARTED|Overall Study||190
354165|NCT02294461|870753|P1|STARTED|Overall Study||198
354166|NCT02294019|870805|P1|NOT COMPLETED|Overall Study||103
354167|NCT02294019|870805|P1|COMPLETED|Overall Study||635
354168|NCT02294019|870805|P1|STARTED|Overall Study||738
354169|NCT02293902|870813|P5|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||6
354170|NCT02293902|870814|P4|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||1
354171|NCT02293902|870815|P3|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||2
354172|NCT02293902|870816|P2|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||8
354173|NCT02293902|870817|P1|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||0
354174|NCT02293902|870813|P5|COMPLETED|Single-Blind Period (Week 25 to Week 52)|18 rescued and 13 not rescued completed.|31
354175|NCT02293902|870814|P4|COMPLETED|Single-Blind Period (Week 25 to Week 52)|20 rescued and 13 not rescued completed.|33
354176|NCT02293902|870815|P3|COMPLETED|Single-Blind Period (Week 25 to Week 52)|8 rescued and 60 not rescued completed.|68
354177|NCT02293902|870816|P2|COMPLETED|Single-Blind Period (Week 25 to Week 52)|5 rescued and 61 not rescued completed.|66
354178|NCT02293902|870817|P1|COMPLETED|Single-Blind Period (Week 25 to Week 52)||0
354179|NCT02293902|870813|P5|STARTED|Single-Blind Period (Week 25 to Week 52)|15 participants not rescued were switched and 22 rescued continued open label treatment.|37
354180|NCT02293902|870814|P4|STARTED|Single-Blind Period (Week 25 to Week 52)|14 participants not rescued were switched and 20 rescued continued open label treatment.|34
354181|NCT02293902|870815|P3|STARTED|Single-Blind Period (Week 25 to Week 52)|62 participants not rescued continued same treatment and 8 rescued continued open label treatment.|70
354182|NCT02293902|870816|P2|STARTED|Single-Blind Period (Week 25 to Week 52)|68 participants not rescued continued same treatment and 6 rescued continued open label treatment.|74
354183|NCT02293902|870817|P1|STARTED|Single-Blind Period (Week 25 to Week 52)||0
354184|NCT02293902|870813|P5|NOT COMPLETED|Double-Blind Period (Up to Week 24)||0
354185|NCT02293902|870814|P4|NOT COMPLETED|Double-Blind Period (Up to Week 24)||0
354186|NCT02293902|870815|P3|NOT COMPLETED|Double-Blind Period (Up to Week 24)||10
354187|NCT02293902|870816|P2|NOT COMPLETED|Double-Blind Period (Up to Week 24)||7
354188|NCT02293902|870817|P1|NOT COMPLETED|Double-Blind Period (Up to Week 24)||11
354189|NCT02293902|870813|P5|COMPLETED|Double-Blind Period (Up to Week 24)||0
354190|NCT02293902|870814|P4|COMPLETED|Double-Blind Period (Up to Week 24)||0
354191|NCT02293902|870815|P3|COMPLETED|Double-Blind Period (Up to Week 24)|8 rescued and 62 not rescued completed.|70
354192|NCT02293902|870816|P2|COMPLETED|Double-Blind Period (Up to Week 24)|6 rescued and 68 not rescued completed.|74
354193|NCT02293902|870817|P1|COMPLETED|Double-Blind Period (Up to Week 24)|42 rescued and 29 not rescued completed.|71
354194|NCT02293902|870813|P5|Rescued|Double-Blind Period (Up to Week 24)||0
354195|NCT02293902|870814|P4|Rescued|Double-Blind Period (Up to Week 24)||0
354196|NCT02293902|870815|P3|Rescued|Double-Blind Period (Up to Week 24)||8
354197|NCT02293902|870816|P2|Rescued|Double-Blind Period (Up to Week 24)||6
354198|NCT02293902|870817|P1|Rescued|Double-Blind Period (Up to Week 24)||44
354199|NCT02293902|870813|P5|Treated|Double-Blind Period (Up to Week 24)||0
354200|NCT02293902|870814|P4|Treated|Double-Blind Period (Up to Week 24)||0
354201|NCT02293902|870815|P3|Treated|Double-Blind Period (Up to Week 24)||80
354202|NCT02293902|870816|P2|Treated|Double-Blind Period (Up to Week 24)||81
354203|NCT02293902|870817|P1|Treated|Double-Blind Period (Up to Week 24)||81
354204|NCT02293902|870813|P5|STARTED|Double-Blind Period (Up to Week 24)||0
354205|NCT02293902|870814|P4|STARTED|Double-Blind Period (Up to Week 24)||0
354206|NCT02293902|870815|P3|STARTED|Double-Blind Period (Up to Week 24)||80
354207|NCT02293902|870816|P2|STARTED|Double-Blind Period (Up to Week 24)||81
354208|NCT02293902|870817|P1|STARTED|Double-Blind Period (Up to Week 24)||82
354209|NCT02293863|870879|P3|NOT COMPLETED|Overall Study||9
354210|NCT02293863|870880|P2|NOT COMPLETED|Overall Study||13
354211|NCT02293863|870881|P1|NOT COMPLETED|Overall Study||9
354212|NCT02293863|870879|P3|COMPLETED|Overall Study||38
354213|NCT02293863|870880|P2|COMPLETED|Overall Study||42
354214|NCT02293863|870881|P1|COMPLETED|Overall Study||47
354215|NCT02293863|870879|P3|STARTED|Overall Study||47
354216|NCT02293863|870880|P2|STARTED|Overall Study||55
354217|NCT02293863|870881|P1|STARTED|Overall Study||56
354218|NCT02293538|870946|P2|NOT COMPLETED|Overall Study||2
354219|NCT02293538|870947|P1|NOT COMPLETED|Overall Study||1
354220|NCT02293538|870946|P2|COMPLETED|Overall Study||69
354221|NCT02293538|870947|P1|COMPLETED|Overall Study||72
354222|NCT02293538|870946|P2|STARTED|Overall Study||71
354223|NCT02293538|870947|P1|STARTED|Overall Study||73
354224|NCT02293395|870962|P2|NOT COMPLETED|Overall Study||7
354225|NCT02293395|870963|P1|NOT COMPLETED|Overall Study||9
354226|NCT02293395|870962|P2|COMPLETED|Overall Study||1511
354227|NCT02293395|870963|P1|COMPLETED|Overall Study||1510
354228|NCT02293395|870962|P2|Treated|Overall Study||1506
354229|NCT02293395|870963|P1|Treated|Overall Study||1510
354230|NCT02293395|870962|P2|STARTED|Overall Study||1518
354231|NCT02293395|870963|P1|STARTED|Overall Study||1519
354232|NCT02292849|870972|P3|NOT COMPLETED|Overall Study||2
354233|NCT02292849|870973|P2|NOT COMPLETED|Overall Study||2
354234|NCT02292849|870974|P1|NOT COMPLETED|Overall Study||4
354235|NCT02292849|870972|P3|COMPLETED|Overall Study||8
354236|NCT02292849|870973|P2|COMPLETED|Overall Study||6
354237|NCT02292849|870974|P1|COMPLETED|Overall Study||7
354238|NCT02292849|870972|P3|STARTED|Overall Study||10
354239|NCT02292849|870973|P2|STARTED|Overall Study||8
354240|NCT02292849|870974|P1|STARTED|Overall Study||11
354241|NCT02292537|870984|P2|NOT COMPLETED|Overall Study||0
354242|NCT02292537|870985|P1|NOT COMPLETED|Overall Study||0
354243|NCT02292537|870984|P2|COMPLETED|Overall Study||84
354244|NCT02292537|870985|P1|COMPLETED|Overall Study||42
354245|NCT02292537|870984|P2|Completed Treatment|Overall Study|1 participant completed the study but did not complete treatments due to early study closure|83
354246|NCT02292537|870985|P1|Completed Treatment|Overall Study||42
354247|NCT02292537|870984|P2|STARTED|Overall Study||84
354248|NCT02292537|870985|P1|STARTED|Overall Study||42
354249|NCT02292433|871022|P3|NOT COMPLETED|Third Intervention Period (7 Days)||0
354250|NCT02292433|871023|P2|NOT COMPLETED|Third Intervention Period (7 Days)||0
354251|NCT02292433|871024|P1|NOT COMPLETED|Third Intervention Period (7 Days)||0
354252|NCT02292433|871022|P3|COMPLETED|Third Intervention Period (7 Days)||4
354253|NCT02292433|871023|P2|COMPLETED|Third Intervention Period (7 Days)||4
354254|NCT02292433|871024|P1|COMPLETED|Third Intervention Period (7 Days)||4
354255|NCT02292433|871022|P3|STARTED|Third Intervention Period (7 Days)||4
354256|NCT02292433|871023|P2|STARTED|Third Intervention Period (7 Days)||4
354257|NCT02292433|871024|P1|STARTED|Third Intervention Period (7 Days)||4
354258|NCT02292433|871022|P3|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
354259|NCT02292433|871023|P2|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
354260|NCT02292433|871024|P1|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
354261|NCT02292433|871022|P3|COMPLETED|Second Washout Period (7 to 14 Days)||4
354262|NCT02292433|871023|P2|COMPLETED|Second Washout Period (7 to 14 Days)||4
354263|NCT02292433|871024|P1|COMPLETED|Second Washout Period (7 to 14 Days)||4
354264|NCT02292433|871022|P3|STARTED|Second Washout Period (7 to 14 Days)||4
354265|NCT02292433|871023|P2|STARTED|Second Washout Period (7 to 14 Days)||4
354266|NCT02292433|871024|P1|STARTED|Second Washout Period (7 to 14 Days)||4
354267|NCT02292433|871022|P3|NOT COMPLETED|Second Intervention Period (7 Days)||0
354268|NCT02292433|871023|P2|NOT COMPLETED|Second Intervention Period (7 Days)||0
354269|NCT02292433|871024|P1|NOT COMPLETED|Second Intervention Period (7 Days)||0
354270|NCT02292433|871022|P3|COMPLETED|Second Intervention Period (7 Days)||4
354271|NCT02292433|871023|P2|COMPLETED|Second Intervention Period (7 Days)||4
354272|NCT02292433|871024|P1|COMPLETED|Second Intervention Period (7 Days)||4
354273|NCT02292433|871022|P3|STARTED|Second Intervention Period (7 Days)||4
354274|NCT02292433|871023|P2|STARTED|Second Intervention Period (7 Days)||4
354275|NCT02292433|871024|P1|STARTED|Second Intervention Period (7 Days)||4
354276|NCT02292433|871022|P3|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
354277|NCT02292433|871023|P2|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
354278|NCT02292433|871024|P1|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
354279|NCT02292433|871022|P3|COMPLETED|First Washout Period (7 to 14 Days)||4
354280|NCT02292433|871023|P2|COMPLETED|First Washout Period (7 to 14 Days)||4
354281|NCT02292433|871024|P1|COMPLETED|First Washout Period (7 to 14 Days)||4
354282|NCT02292433|871022|P3|STARTED|First Washout Period (7 to 14 Days)||4
354283|NCT02292433|871023|P2|STARTED|First Washout Period (7 to 14 Days)||4
354284|NCT02292433|871024|P1|STARTED|First Washout Period (7 to 14 Days)||4
354285|NCT02292433|871022|P3|NOT COMPLETED|First Intervention Period (7 Days)||0
354286|NCT02292433|871023|P2|NOT COMPLETED|First Intervention Period (7 Days)||0
354287|NCT02292433|871024|P1|NOT COMPLETED|First Intervention Period (7 Days)||0
354288|NCT02292433|871022|P3|COMPLETED|First Intervention Period (7 Days)||4
354289|NCT02292433|871023|P2|COMPLETED|First Intervention Period (7 Days)||4
354290|NCT02292433|871024|P1|COMPLETED|First Intervention Period (7 Days)||4
354291|NCT02292433|871022|P3|STARTED|First Intervention Period (7 Days)||4
354292|NCT02292433|871023|P2|STARTED|First Intervention Period (7 Days)||4
354293|NCT02292433|871024|P1|STARTED|First Intervention Period (7 Days)||4
354294|NCT02292212|871095|P1|NOT COMPLETED|Post-ViE Phase||0
354295|NCT02292212|871095|P1|COMPLETED|Post-ViE Phase||14
354296|NCT02292212|871095|P1|STARTED|Post-ViE Phase||14
354297|NCT02292212|871095|P1|NOT COMPLETED|ViE Phase||3
354298|NCT02292212|871095|P1|COMPLETED|ViE Phase||14
354299|NCT02292212|871095|P1|STARTED|ViE Phase||17
354300|NCT02292212|871095|P1|NOT COMPLETED|Pre-ViE Phase||0
354301|NCT02292212|871095|P1|COMPLETED|Pre-ViE Phase||17
354302|NCT02292212|871095|P1|STARTED|Pre-ViE Phase||17
354303|NCT02292186|871127|P1|NOT COMPLETED|Overall Study||18
354304|NCT02292186|871127|P1|COMPLETED|Overall Study||7
354305|NCT02292186|871127|P1|STARTED|Overall Study||25
354306|NCT02291861|871139|P4|NOT COMPLETED|Overall Study||10
354307|NCT02291861|871140|P3|NOT COMPLETED|Overall Study||9
354308|NCT02291861|871141|P2|NOT COMPLETED|Overall Study||8
354309|NCT02291861|871142|P1|NOT COMPLETED|Overall Study||7
354310|NCT02291861|871139|P4|COMPLETED|Overall Study||65
354311|NCT02291861|871140|P3|COMPLETED|Overall Study||65
354312|NCT02291861|871141|P2|COMPLETED|Overall Study||67
354313|NCT02291861|871142|P1|COMPLETED|Overall Study||67
354314|NCT02291861|871139|P4|Modified Intent to Treat Pop (mITT)|Overall Study||55
354315|NCT02291861|871140|P3|Modified Intent to Treat Pop (mITT)|Overall Study||49
354316|NCT02291861|871141|P2|Modified Intent to Treat Pop (mITT)|Overall Study||60
354317|NCT02291861|871142|P1|Modified Intent to Treat Pop (mITT)|Overall Study||58
354318|NCT02291861|871139|P4|Safety Population|Overall Study||74
354319|NCT02291861|871140|P3|Safety Population|Overall Study||73
354320|NCT02291861|871141|P2|Safety Population|Overall Study||74
354321|NCT02291861|871142|P1|Safety Population|Overall Study||72
354322|NCT02291861|871139|P4|STARTED|Overall Study||75
354323|NCT02291861|871140|P3|STARTED|Overall Study||74
354324|NCT02291861|871141|P2|STARTED|Overall Study||75
354325|NCT02291861|871142|P1|STARTED|Overall Study||74
354326|NCT02291718|871183|P3|NOT COMPLETED|Overall Study||0
354327|NCT02291718|871184|P2|NOT COMPLETED|Overall Study||0
354328|NCT02291718|871185|P1|NOT COMPLETED|Overall Study||0
354329|NCT02291718|871183|P3|COMPLETED|Overall Study||50
354330|NCT02291718|871184|P2|COMPLETED|Overall Study||50
354331|NCT02291718|871185|P1|COMPLETED|Overall Study||50
354332|NCT02291718|871183|P3|STARTED|Overall Study||50
354333|NCT02291718|871184|P2|STARTED|Overall Study||50
354334|NCT02291718|871185|P1|STARTED|Overall Study||50
354335|NCT02291679|871205|P3|NOT COMPLETED|Overall Study||59
354336|NCT02291679|871206|P2|NOT COMPLETED|Overall Study||42
354337|NCT02291679|871207|P1|NOT COMPLETED|Overall Study||44
354338|NCT02291679|871205|P3|COMPLETED|Overall Study||352
354339|NCT02291679|871206|P2|COMPLETED|Overall Study||369
354340|NCT02291679|871207|P1|COMPLETED|Overall Study||357
354341|NCT02291679|871205|P3|STARTED|Overall Study||411
354342|NCT02291679|871206|P2|STARTED|Overall Study||411
354343|NCT02291679|871207|P1|STARTED|Overall Study||401
354344|NCT02291510|871240|P4|NOT COMPLETED|Overall Study||1
354345|NCT02291510|871241|P3|NOT COMPLETED|Overall Study||0
354346|NCT02291510|871242|P2|NOT COMPLETED|Overall Study||0
354347|NCT02291510|871243|P1|NOT COMPLETED|Overall Study||0
354348|NCT02291510|871240|P4|COMPLETED|Overall Study||4
354349|NCT02291510|871241|P3|COMPLETED|Overall Study||5
354350|NCT02291510|871242|P2|COMPLETED|Overall Study||5
354351|NCT02291510|871243|P1|COMPLETED|Overall Study||5
354352|NCT02291510|871240|P4|Completed Treatment D|Overall Study||5
354353|NCT02291510|871241|P3|Completed Treatment D|Overall Study||5
354354|NCT02291510|871242|P2|Completed Treatment D|Overall Study||5
354355|NCT02291510|871243|P1|Completed Treatment D|Overall Study||5
354356|NCT02291510|871240|P4|Completed Treatment C|Overall Study||4
354357|NCT02291510|871241|P3|Completed Treatment C|Overall Study||5
354358|NCT02291510|871242|P2|Completed Treatment C|Overall Study||5
354359|NCT02291510|871243|P1|Completed Treatment C|Overall Study||5
354360|NCT02291510|871240|P4|Completed Treatment B|Overall Study||4
354361|NCT02291510|871241|P3|Completed Treatment B|Overall Study||5
354362|NCT02291510|871242|P2|Completed Treatment B|Overall Study||5
354363|NCT02291510|871243|P1|Completed Treatment B|Overall Study||5
354364|NCT02291510|871240|P4|Completed Treatment A|Overall Study||5
354365|NCT02291510|871241|P3|Completed Treatment A|Overall Study||5
354366|NCT02291510|871242|P2|Completed Treatment A|Overall Study||5
354367|NCT02291510|871243|P1|Completed Treatment A|Overall Study||5
354368|NCT02291510|871240|P4|STARTED|Overall Study||5
354369|NCT02291510|871241|P3|STARTED|Overall Study||5
354370|NCT02291510|871242|P2|STARTED|Overall Study||5
354371|NCT02291510|871243|P1|STARTED|Overall Study||5
354372|NCT02291419|871259|P2|NOT COMPLETED|Overall Study||5
354373|NCT02291419|871260|P1|NOT COMPLETED|Overall Study||1
354374|NCT02291419|871259|P2|COMPLETED|Overall Study||0
354375|NCT02291419|871260|P1|COMPLETED|Overall Study||0
354376|NCT02291419|871259|P2|STARTED|Overall Study||5
354377|NCT02291419|871260|P1|STARTED|Overall Study||1
354378|NCT02291237|871278|P2|NOT COMPLETED|Overall Study||86
354379|NCT02291237|871279|P1|NOT COMPLETED|Overall Study||86
354380|NCT02291237|871278|P2|COMPLETED|Overall Study||0
354381|NCT02291237|871279|P1|COMPLETED|Overall Study||0
354382|NCT02291237|871278|P2|STARTED|Overall Study||86
354383|NCT02291237|871279|P1|STARTED|Overall Study||86
354384|NCT02290821|871297|P2|NOT COMPLETED|Overall Study||3
354385|NCT02290821|871298|P1|NOT COMPLETED|Overall Study||6
354386|NCT02290821|871297|P2|COMPLETED|Overall Study||103
354387|NCT02290821|871298|P1|COMPLETED|Overall Study||103
354388|NCT02290821|871297|P2|STARTED|Overall Study||106
354389|NCT02290821|871298|P1|STARTED|Overall Study||109
354390|NCT02290691|871306|P2|NOT COMPLETED|Overall Study||9
354391|NCT02290691|871307|P1|NOT COMPLETED|Overall Study||8
354392|NCT02290691|871306|P2|COMPLETED|Overall Study||479
354393|NCT02290691|871307|P1|COMPLETED|Overall Study||488
354394|NCT02290691|871306|P2|STARTED|Overall Study||488
354395|NCT02290691|871307|P1|STARTED|Overall Study||496
354396|NCT02290509|871323|P2|NOT COMPLETED|Overall Study||14
354397|NCT02290509|871324|P1|NOT COMPLETED|Overall Study||49
354398|NCT02290509|871323|P2|COMPLETED|Overall Study||325
354399|NCT02290509|871324|P1|COMPLETED|Overall Study||962
354400|NCT02290509|871323|P2|STARTED|Overall Study||339
354401|NCT02290509|871324|P1|STARTED|Overall Study||1011
354402|NCT02289989|871338|P2|NOT COMPLETED|Overall Study||0
354403|NCT02289989|871339|P1|NOT COMPLETED|Overall Study||0
354404|NCT02289989|871338|P2|COMPLETED|Overall Study||1
354405|NCT02289989|871339|P1|COMPLETED|Overall Study||0
354406|NCT02289989|871338|P2|STARTED|Overall Study||1
354407|NCT02289989|871339|P1|STARTED|Overall Study||0
354408|NCT02289963|871357|P2|NOT COMPLETED|Overall Study||10
354409|NCT02289963|871358|P1|NOT COMPLETED|Overall Study||5
354410|NCT02289963|871357|P2|COMPLETED|Overall Study||87
354411|NCT02289963|871358|P1|COMPLETED|Overall Study||97
354412|NCT02289963|871357|P2|Treated|Overall Study||97
354413|NCT02289963|871358|P1|Treated|Overall Study||102
354414|NCT02289963|871357|P2|STARTED|Overall Study|Randomized|97
354415|NCT02289963|871358|P1|STARTED|Overall Study|Randomized|102
354416|NCT02289833|871408|P2|NOT COMPLETED|Overall Study||20
354417|NCT02289833|871409|P1|NOT COMPLETED|Overall Study||29
354418|NCT02289833|871408|P2|COMPLETED|Overall Study||0
354419|NCT02289833|871409|P1|COMPLETED|Overall Study||0
354420|NCT02289833|871408|P2|STARTED|Overall Study||20
354421|NCT02289833|871409|P1|STARTED|Overall Study||29
354422|NCT02289820|871447|P7|NOT COMPLETED|Overall Study||2
354423|NCT02289820|871448|P6|NOT COMPLETED|Overall Study||1
354424|NCT02289820|871449|P5|NOT COMPLETED|Overall Study||0
354425|NCT02289820|871450|P4|NOT COMPLETED|Overall Study||2
354426|NCT02289820|871451|P3|NOT COMPLETED|Overall Study||6
354427|NCT02289820|871452|P2|NOT COMPLETED|Overall Study||2
354428|NCT02289820|871453|P1|NOT COMPLETED|Overall Study||2
354429|NCT02289820|871447|P7|COMPLETED|Overall Study||37
354430|NCT02289820|871448|P6|COMPLETED|Overall Study||39
354431|NCT02289820|871449|P5|COMPLETED|Overall Study||40
354432|NCT02289820|871450|P4|COMPLETED|Overall Study||37
354433|NCT02289820|871451|P3|COMPLETED|Overall Study||38
354434|NCT02289820|871452|P2|COMPLETED|Overall Study||18
354435|NCT02289820|871453|P1|COMPLETED|Overall Study||37
354436|NCT02289820|871447|P7|STARTED|Overall Study||39
354437|NCT02289820|871448|P6|STARTED|Overall Study||40
354438|NCT02289820|871449|P5|STARTED|Overall Study||40
354439|NCT02289820|871450|P4|STARTED|Overall Study||39
354440|NCT02289820|871451|P3|STARTED|Overall Study||44
354441|NCT02289820|871452|P2|STARTED|Overall Study||20
354442|NCT02289820|871453|P1|STARTED|Overall Study||39
354443|NCT02289755|871564|P1|NOT COMPLETED|Follow up Period [4 Days]||0
354444|NCT02289755|871564|P1|COMPLETED|Follow up Period [4 Days]||16
354445|NCT02289755|871564|P1|STARTED|Follow up Period [4 Days]||16
354446|NCT02289755|871564|P1|NOT COMPLETED|ALLN-177 Treatment Period [4 Days]||0
354447|NCT02289755|871564|P1|COMPLETED|ALLN-177 Treatment Period [4 Days]||16
354448|NCT02289755|871564|P1|STARTED|ALLN-177 Treatment Period [4 Days]||16
354449|NCT02289755|871564|P1|NOT COMPLETED|Baseline Period [No Treatment, 3 Days]||0
354450|NCT02289755|871564|P1|COMPLETED|Baseline Period [No Treatment, 3 Days]||16
354451|NCT02289755|871564|P1|STARTED|Baseline Period [No Treatment, 3 Days]||16
354452|NCT02289742|871571|P4|NOT COMPLETED|Third Wear Period||1
354453|NCT02289742|871572|P3|NOT COMPLETED|Third Wear Period||0
354454|NCT02289742|871573|P2|NOT COMPLETED|Third Wear Period||1
354455|NCT02289742|871574|P1|NOT COMPLETED|Third Wear Period||0
354456|NCT02289742|871571|P4|COMPLETED|Third Wear Period||8
354457|NCT02289742|871572|P3|COMPLETED|Third Wear Period||11
354458|NCT02289742|871573|P2|COMPLETED|Third Wear Period||10
354459|NCT02289742|871574|P1|COMPLETED|Third Wear Period||11
354460|NCT02289742|871571|P4|STARTED|Third Wear Period||9
354461|NCT02289742|871572|P3|STARTED|Third Wear Period||11
354462|NCT02289742|871573|P2|STARTED|Third Wear Period||11
354463|NCT02289742|871574|P1|STARTED|Third Wear Period||11
354464|NCT02289742|871571|P4|NOT COMPLETED|Second Wear Period||0
354465|NCT02289742|871572|P3|NOT COMPLETED|Second Wear Period||0
354466|NCT02289742|871573|P2|NOT COMPLETED|Second Wear Period||0
354467|NCT02289742|871574|P1|NOT COMPLETED|Second Wear Period||0
354468|NCT02289742|871571|P4|COMPLETED|Second Wear Period||9
354469|NCT02289742|871572|P3|COMPLETED|Second Wear Period||11
354470|NCT02289742|871573|P2|COMPLETED|Second Wear Period||11
354471|NCT02289742|871574|P1|COMPLETED|Second Wear Period||11
354472|NCT02289742|871571|P4|STARTED|Second Wear Period||9
354473|NCT02289742|871572|P3|STARTED|Second Wear Period||11
354474|NCT02289742|871573|P2|STARTED|Second Wear Period||11
354475|NCT02289742|871574|P1|STARTED|Second Wear Period||11
354476|NCT02289742|871571|P4|NOT COMPLETED|First Wear Period||1
354477|NCT02289742|871572|P3|NOT COMPLETED|First Wear Period||1
354478|NCT02289742|871573|P2|NOT COMPLETED|First Wear Period||1
354479|NCT02289742|871574|P1|NOT COMPLETED|First Wear Period||0
354480|NCT02289742|871571|P4|COMPLETED|First Wear Period||9
354481|NCT02289742|871572|P3|COMPLETED|First Wear Period||11
354482|NCT02289742|871573|P2|COMPLETED|First Wear Period||11
354483|NCT02289742|871574|P1|COMPLETED|First Wear Period||11
354484|NCT02289742|871571|P4|Treated|First Wear Period||9
354485|NCT02289742|871572|P3|Treated|First Wear Period||12
354486|NCT02289742|871573|P2|Treated|First Wear Period||11
354487|NCT02289742|871574|P1|Treated|First Wear Period||11
354488|NCT02289742|871571|P4|STARTED|First Wear Period||10
354489|NCT02289742|871572|P3|STARTED|First Wear Period||12
354490|NCT02289742|871573|P2|STARTED|First Wear Period||12
354491|NCT02289742|871574|P1|STARTED|First Wear Period||11
354492|NCT02289469|871593|P2|NOT COMPLETED|Overall Study||0
354493|NCT02289469|871594|P1|NOT COMPLETED|Overall Study||6
354494|NCT02289469|871593|P2|COMPLETED|Overall Study||244
354495|NCT02289469|871594|P1|COMPLETED|Overall Study||244
354496|NCT02289469|871593|P2|STARTED|Overall Study||244
354497|NCT02289469|871594|P1|STARTED|Overall Study||250
354498|NCT02289456|871602|P1|NOT COMPLETED|Monotherapy Period||16
354499|NCT02289456|871602|P1|COMPLETED|Monotherapy Period||0
354500|NCT02289456|871602|P1|STARTED|Monotherapy Period||16
354501|NCT02289456|871602|P1|NOT COMPLETED|Induction Period||24
354502|NCT02289456|871602|P1|COMPLETED|Induction Period||16
354503|NCT02289456|871602|P1|Treated Population|Induction Period||40
354504|NCT02289456|871602|P1|STARTED|Induction Period||40
354505|NCT02289105|871624|P2|NOT COMPLETED|Overall Study||0
354506|NCT02289105|871625|P1|NOT COMPLETED|Overall Study||0
354507|NCT02289105|871624|P2|COMPLETED|Overall Study||637
354508|NCT02289105|871625|P1|COMPLETED|Overall Study||642
354509|NCT02289105|871624|P2|STARTED|Overall Study||637
354510|NCT02289105|871625|P1|STARTED|Overall Study||642
354511|NCT02289079|871637|P2|NOT COMPLETED|Overall Study||1
354512|NCT02289079|871638|P1|NOT COMPLETED|Overall Study||2
354513|NCT02289079|871637|P2|COMPLETED|Overall Study||29
354514|NCT02289079|871638|P1|COMPLETED|Overall Study||28
354515|NCT02289079|871637|P2|STARTED|Overall Study||30
354516|NCT02289079|871638|P1|STARTED|Overall Study||30
354517|NCT02288364|871652|P2|NOT COMPLETED|Overall Study||0
354518|NCT02288364|871653|P1|NOT COMPLETED|Overall Study||0
354519|NCT02288364|871652|P2|COMPLETED|Overall Study||44
354520|NCT02288364|871653|P1|COMPLETED|Overall Study||42
354521|NCT02288364|871652|P2|STARTED|Overall Study||44
354522|NCT02288364|871653|P1|STARTED|Overall Study||42
354523|NCT02288312|871680|P3|NOT COMPLETED|Overall Study||0
354524|NCT02288312|871681|P2|NOT COMPLETED|Overall Study||0
354525|NCT02288312|871682|P1|NOT COMPLETED|Overall Study||1
354526|NCT02288312|871680|P3|COMPLETED|Overall Study||6
354527|NCT02288312|871681|P2|COMPLETED|Overall Study||6
354528|NCT02288312|871682|P1|COMPLETED|Overall Study||5
354529|NCT02288312|871680|P3|STARTED|Overall Study||6
354530|NCT02288312|871681|P2|STARTED|Overall Study||6
354531|NCT02288312|871682|P1|STARTED|Overall Study||6
354532|NCT02288273|871701|P2|NOT COMPLETED|Overall Study||8
354533|NCT02288273|871702|P1|NOT COMPLETED|Overall Study||8
354534|NCT02288273|871701|P2|COMPLETED|Overall Study||48
354535|NCT02288273|871702|P1|COMPLETED|Overall Study||53
354536|NCT02288273|871701|P2|STARTED|Overall Study||56
354537|NCT02288273|871702|P1|STARTED|Overall Study||61
354538|NCT02288091|871720|P1|NOT COMPLETED|Overall Study||8
354539|NCT02288091|871720|P1|COMPLETED|Overall Study||24
354540|NCT02288091|871720|P1|Randomized/Treated|Overall Study||25
354541|NCT02288091|871720|P1|STARTED|Overall Study||32
354542|NCT02287883|871730|P2|NOT COMPLETED|Overall Study||426
354543|NCT02287883|871731|P1|NOT COMPLETED|Overall Study||459
354544|NCT02287883|871730|P2|COMPLETED|Overall Study||669
354545|NCT02287883|871731|P1|COMPLETED|Overall Study||622
354546|NCT02287883|871730|P2|One-year Follow-up Survey|Overall Study||669
354547|NCT02287883|871731|P1|One-year Follow-up Survey|Overall Study||622
354548|NCT02287883|871730|P2|STARTED|Overall Study||1095
354549|NCT02287883|871731|P1|STARTED|Overall Study||1081
354550|NCT02287779|871749|P8|NOT COMPLETED|Overall Study||0
354551|NCT02287779|871750|P7|NOT COMPLETED|Overall Study||0
354552|NCT02287779|871751|P6|NOT COMPLETED|Overall Study||0
354553|NCT02287779|871752|P5|NOT COMPLETED|Overall Study||0
354554|NCT02287779|871753|P4|NOT COMPLETED|Overall Study||0
354555|NCT02287779|871754|P3|NOT COMPLETED|Overall Study||0
354556|NCT02287779|871755|P2|NOT COMPLETED|Overall Study||0
354557|NCT02287779|871756|P1|NOT COMPLETED|Overall Study||0
354558|NCT02287779|871749|P8|COMPLETED|Overall Study||9
354559|NCT02287779|871750|P7|COMPLETED|Overall Study||9
354560|NCT02287779|871751|P6|COMPLETED|Overall Study||9
354561|NCT02287779|871752|P5|COMPLETED|Overall Study||9
354562|NCT02287779|871753|P4|COMPLETED|Overall Study||9
354563|NCT02287779|871754|P3|COMPLETED|Overall Study||9
354564|NCT02287779|871755|P2|COMPLETED|Overall Study||9
354565|NCT02287779|871756|P1|COMPLETED|Overall Study||21
354566|NCT02287779|871749|P8|STARTED|Overall Study||9
354567|NCT02287779|871750|P7|STARTED|Overall Study||9
354568|NCT02287779|871751|P6|STARTED|Overall Study||9
354569|NCT02287779|871752|P5|STARTED|Overall Study||9
354570|NCT02287779|871753|P4|STARTED|Overall Study||9
354571|NCT02287779|871754|P3|STARTED|Overall Study||9
354572|NCT02287779|871755|P2|STARTED|Overall Study||9
354573|NCT02287779|871756|P1|STARTED|Overall Study||21
354574|NCT02287623|871896|P2|NOT COMPLETED|Overall Study||1
354575|NCT02287623|871897|P1|NOT COMPLETED|Overall Study||0
354576|NCT02287623|871896|P2|COMPLETED|Overall Study||29
354577|NCT02287623|871897|P1|COMPLETED|Overall Study||30
354578|NCT02287623|871896|P2|STARTED|Overall Study||30
354579|NCT02287623|871897|P1|STARTED|Overall Study||30
354580|NCT02287610|871913|P1|NOT COMPLETED|Overall Study||16
354581|NCT02287610|871913|P1|COMPLETED|Overall Study||48
354582|NCT02287610|871913|P1|Per Protocol Follow-Up|Overall Study||56
354583|NCT02287610|871913|P1|STARTED|Overall Study||64
354584|NCT02287415|871946|P1|NOT COMPLETED|Overall Study||0
354585|NCT02287415|871946|P1|COMPLETED|Overall Study||13
354586|NCT02287415|871946|P1|STARTED|Overall Study||13
354587|NCT02287402|871952|P1|NOT COMPLETED|Follow-up||3
354588|NCT02287402|871952|P1|COMPLETED|Follow-up||103
354589|NCT02287402|871952|P1|STARTED|Follow-up|64 participants who completed the Treatment Period did not continue to Follow-up.|106
354590|NCT02287402|871952|P1|NOT COMPLETED|Treatment Period||27
354591|NCT02287402|871952|P1|COMPLETED|Treatment Period||170
354592|NCT02287402|871952|P1|STARTED|Treatment Period||197
354593|NCT02287376|871967|P1|NOT COMPLETED|Overall Study||0
354594|NCT02287376|871967|P1|COMPLETED|Overall Study||25
354595|NCT02287376|871967|P1|STARTED|Overall Study||25
354596|NCT02287350|872010|P1|NOT COMPLETED|Overall Study||3
354597|NCT02287350|872010|P1|COMPLETED|Overall Study||48
354598|NCT02287350|872010|P1|STARTED|Overall Study||51
354599|NCT02287025|872057|P2|NOT COMPLETED|Overall Study||9
354600|NCT02287025|872058|P1|NOT COMPLETED|Overall Study||10
354601|NCT02287025|872057|P2|COMPLETED|Overall Study||2
354602|NCT02287025|872058|P1|COMPLETED|Overall Study||2
354603|NCT02287025|872057|P2|STARTED|Overall Study||11
354604|NCT02287025|872058|P1|STARTED|Overall Study||12
354605|NCT02286518|872081|P14|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
354606|NCT02286518|872082|P13|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
354607|NCT02286518|872083|P12|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
354608|NCT02286518|872084|P11|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
354609|NCT02286518|872085|P10|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
354610|NCT02286518|872086|P9|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
354611|NCT02286518|872087|P8|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
354612|NCT02286518|872088|P7|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
354613|NCT02286518|872089|P6|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
354614|NCT02286518|872090|P5|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
354615|NCT02286518|872091|P4|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
354616|NCT02286518|872092|P3|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
354617|NCT02286518|872093|P2|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
354618|NCT02286518|872094|P1|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
354619|NCT02286518|872081|P14|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
354620|NCT02286518|872082|P13|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
354621|NCT02286518|872083|P12|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
354622|NCT02286518|872084|P11|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
354623|NCT02286518|872085|P10|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
354624|NCT02286518|872086|P9|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6
354625|NCT02286518|872087|P8|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6
354626|NCT02286518|872088|P7|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
354627|NCT02286518|872089|P6|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
354628|NCT02286518|872090|P5|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
354629|NCT02286518|872091|P4|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
354630|NCT02286518|872092|P3|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
354631|NCT02286518|872093|P2|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
354632|NCT02286518|872094|P1|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
354633|NCT02286518|872081|P14|STARTED|Crossover Treatment (Part 2: 3 Days)||0
354634|NCT02286518|872082|P13|STARTED|Crossover Treatment (Part 2: 3 Days)||0
354635|NCT02286518|872083|P12|STARTED|Crossover Treatment (Part 2: 3 Days)||0
354636|NCT02286518|872084|P11|STARTED|Crossover Treatment (Part 2: 3 Days)||0
354637|NCT02286518|872085|P10|STARTED|Crossover Treatment (Part 2: 3 Days)||0
354638|NCT02286518|872086|P9|STARTED|Crossover Treatment (Part 2: 3 Days)||6
354639|NCT02286518|872087|P8|STARTED|Crossover Treatment (Part 2: 3 Days)||6
354640|NCT02286518|872088|P7|STARTED|Crossover Treatment (Part 2: 3 Days)||0
354641|NCT02286518|872089|P6|STARTED|Crossover Treatment (Part 2: 3 Days)||0
354642|NCT02286518|872090|P5|STARTED|Crossover Treatment (Part 2: 3 Days)||0
354643|NCT02286518|872091|P4|STARTED|Crossover Treatment (Part 2: 3 Days)||0
354644|NCT02286518|872092|P3|STARTED|Crossover Treatment (Part 2: 3 Days)||0
354645|NCT02286518|872093|P2|STARTED|Crossover Treatment (Part 2: 3 Days)||0
354646|NCT02286518|872094|P1|STARTED|Crossover Treatment (Part 2: 3 Days)||0
354647|NCT02286518|872081|P14|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
354648|NCT02286518|872082|P13|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
354649|NCT02286518|872083|P12|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
354650|NCT02286518|872084|P11|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
354651|NCT02286518|872085|P10|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
354652|NCT02286518|872086|P9|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
354653|NCT02286518|872087|P8|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
354654|NCT02286518|872088|P7|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
354655|NCT02286518|872089|P6|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
354656|NCT02286518|872090|P5|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
354657|NCT02286518|872091|P4|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
354658|NCT02286518|872092|P3|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
354659|NCT02286518|872093|P2|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
354660|NCT02286518|872094|P1|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
354661|NCT02286518|872081|P14|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
354662|NCT02286518|872082|P13|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
354663|NCT02286518|872083|P12|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
354664|NCT02286518|872084|P11|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
354665|NCT02286518|872085|P10|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
354666|NCT02286518|872086|P9|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6
354667|NCT02286518|872087|P8|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6
354668|NCT02286518|872088|P7|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
354669|NCT02286518|872089|P6|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
354670|NCT02286518|872090|P5|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
354671|NCT02286518|872091|P4|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
354672|NCT02286518|872092|P3|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
354673|NCT02286518|872093|P2|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
354674|NCT02286518|872094|P1|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
354675|NCT02286518|872081|P14|STARTED|Washout Crossover Period(Part 2:14 Days)||0
354676|NCT02286518|872082|P13|STARTED|Washout Crossover Period(Part 2:14 Days)||0
354677|NCT02286518|872083|P12|STARTED|Washout Crossover Period(Part 2:14 Days)||0
354678|NCT02286518|872084|P11|STARTED|Washout Crossover Period(Part 2:14 Days)||0
354679|NCT02286518|872085|P10|STARTED|Washout Crossover Period(Part 2:14 Days)||0
354680|NCT02286518|872086|P9|STARTED|Washout Crossover Period(Part 2:14 Days)||6
354681|NCT02286518|872087|P8|STARTED|Washout Crossover Period(Part 2:14 Days)||6
354682|NCT02286518|872088|P7|STARTED|Washout Crossover Period(Part 2:14 Days)||0
354683|NCT02286518|872089|P6|STARTED|Washout Crossover Period(Part 2:14 Days)||0
354684|NCT02286518|872090|P5|STARTED|Washout Crossover Period(Part 2:14 Days)||0
354685|NCT02286518|872091|P4|STARTED|Washout Crossover Period(Part 2:14 Days)||0
354686|NCT02286518|872092|P3|STARTED|Washout Crossover Period(Part 2:14 Days)||0
354687|NCT02286518|872093|P2|STARTED|Washout Crossover Period(Part 2:14 Days)||0
354688|NCT02286518|872094|P1|STARTED|Washout Crossover Period(Part 2:14 Days)||0
354689|NCT02286518|872081|P14|NOT COMPLETED|All Parts (16 Days)||0
354690|NCT02286518|872082|P13|NOT COMPLETED|All Parts (16 Days)||0
354691|NCT02286518|872083|P12|NOT COMPLETED|All Parts (16 Days)||0
354692|NCT02286518|872084|P11|NOT COMPLETED|All Parts (16 Days)||0
354693|NCT02286518|872085|P10|NOT COMPLETED|All Parts (16 Days)||0
354694|NCT02286518|872086|P9|NOT COMPLETED|All Parts (16 Days)||0
354695|NCT02286518|872087|P8|NOT COMPLETED|All Parts (16 Days)||0
354696|NCT02286518|872088|P7|NOT COMPLETED|All Parts (16 Days)||0
354697|NCT02286518|872089|P6|NOT COMPLETED|All Parts (16 Days)||0
354698|NCT02286518|872090|P5|NOT COMPLETED|All Parts (16 Days)||0
354699|NCT02286518|872091|P4|NOT COMPLETED|All Parts (16 Days)||0
354700|NCT02286518|872092|P3|NOT COMPLETED|All Parts (16 Days)||0
354701|NCT02286518|872093|P2|NOT COMPLETED|All Parts (16 Days)||0
354702|NCT02286518|872094|P1|NOT COMPLETED|All Parts (16 Days)||0
354703|NCT02286518|872081|P14|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
354704|NCT02286518|872082|P13|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
354705|NCT02286518|872083|P12|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
354706|NCT02286518|872084|P11|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
354707|NCT02286518|872085|P10|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|4
354708|NCT02286518|872086|P9|COMPLETED|All Parts (16 Days)|Only participants of Part 2 would continue in next period.|6
354709|NCT02286518|872087|P8|COMPLETED|All Parts (16 Days)|Only participants of Part 2 continued in next period.|6
354710|NCT02286518|872088|P7|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
354711|NCT02286518|872089|P6|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
354712|NCT02286518|872090|P5|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
354713|NCT02286518|872091|P4|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
354714|NCT02286518|872092|P3|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
354715|NCT02286518|872093|P2|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
354716|NCT02286518|872094|P1|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
354717|NCT02286518|872081|P14|STARTED|All Parts (16 Days)||6
354718|NCT02286518|872082|P13|STARTED|All Parts (16 Days)||6
354719|NCT02286518|872083|P12|STARTED|All Parts (16 Days)||6
354720|NCT02286518|872084|P11|STARTED|All Parts (16 Days)||6
354721|NCT02286518|872085|P10|STARTED|All Parts (16 Days)||4
354722|NCT02286518|872086|P9|STARTED|All Parts (16 Days)||6
354723|NCT02286518|872087|P8|STARTED|All Parts (16 Days)||6
354724|NCT02286518|872088|P7|STARTED|All Parts (16 Days)||6
354725|NCT02286518|872089|P6|STARTED|All Parts (16 Days)||6
354726|NCT02286518|872090|P5|STARTED|All Parts (16 Days)||6
354727|NCT02286518|872091|P4|STARTED|All Parts (16 Days)||6
354728|NCT02286518|872092|P3|STARTED|All Parts (16 Days)||6
354729|NCT02286518|872093|P2|STARTED|All Parts (16 Days)||6
354730|NCT02286518|872094|P1|STARTED|All Parts (16 Days)||6
354731|NCT02286193|872234|P1|NOT COMPLETED|Overall Study||204
354732|NCT02286193|872234|P1|COMPLETED|Overall Study||418
354733|NCT02286193|872234|P1|STARTED|Overall Study||622
354734|NCT02286102|872241|P2|NOT COMPLETED|Overall Study||1
354735|NCT02286102|872242|P1|NOT COMPLETED|Overall Study||1
354736|NCT02286102|872241|P2|COMPLETED|Overall Study||33
354737|NCT02286102|872242|P1|COMPLETED|Overall Study||35
354738|NCT02286102|872241|P2|STARTED|Overall Study||34
354739|NCT02286102|872242|P1|STARTED|Overall Study||36
354740|NCT02285998|872254|P2|NOT COMPLETED|Overall Study||253
354741|NCT02285998|872255|P1|NOT COMPLETED|Overall Study||246
354742|NCT02285998|872254|P2|COMPLETED|Overall Study||4236
354743|NCT02285998|872255|P1|COMPLETED|Overall Study||4228
354744|NCT02285998|872254|P2|STARTED|Overall Study||4489
354745|NCT02285998|872255|P1|STARTED|Overall Study||4474
354746|NCT02285907|872279|P1|NOT COMPLETED|Overall Study||0
354747|NCT02285907|872279|P1|COMPLETED|Overall Study||21
354748|NCT02285907|872279|P1|Began 4th Intervention|Overall Study||21
354749|NCT02285907|872279|P1|Began 3rd Intervention|Overall Study||21
354750|NCT02285907|872279|P1|Began 2nd Intervention|Overall Study||21
354751|NCT02285907|872279|P1|Began 1st Intervention|Overall Study||21
354752|NCT02285907|872279|P1|STARTED|Overall Study||21
354753|NCT02285777|872307|P2|NOT COMPLETED|Overall Study||3
354754|NCT02285777|872308|P1|NOT COMPLETED|Overall Study||5
354755|NCT02285777|872307|P2|COMPLETED|Overall Study||91
354756|NCT02285777|872308|P1|COMPLETED|Overall Study||90
354757|NCT02285777|872307|P2|STARTED|Overall Study||94
354758|NCT02285777|872308|P1|STARTED|Overall Study||95
354759|NCT02285270|872340|P1|NOT COMPLETED|Overall Study||5
354760|NCT02285270|872340|P1|COMPLETED|Overall Study||5
354761|NCT02285270|872340|P1|STARTED|Overall Study||10
354762|NCT02284893|872348|P2|NOT COMPLETED|52 Week (Long Term)||13
354763|NCT02284893|872349|P1|NOT COMPLETED|52 Week (Long Term)||11
354764|NCT02284893|872348|P2|COMPLETED|52 Week (Long Term)||180
354765|NCT02284893|872349|P1|COMPLETED|52 Week (Long Term)||198
354766|NCT02284893|872348|P2|STARTED|52 Week (Long Term)||193
354767|NCT02284893|872349|P1|STARTED|52 Week (Long Term)||209
354768|NCT02284893|872348|P2|NOT COMPLETED|26 Week (Short Term)||31
354769|NCT02284893|872349|P1|NOT COMPLETED|26 Week (Short Term)||19
354770|NCT02284893|872348|P2|COMPLETED|26 Week (Short Term)||198
354771|NCT02284893|872349|P1|COMPLETED|26 Week (Short Term)||213
354772|NCT02284893|872348|P2|STARTED|26 Week (Short Term)||229
354773|NCT02284893|872349|P1|STARTED|26 Week (Short Term)||232
354774|NCT02284880|872363|P4|NOT COMPLETED|Overall Study||0
354775|NCT02284880|872364|P3|NOT COMPLETED|Overall Study||2
354776|NCT02284880|872365|P2|NOT COMPLETED|Overall Study||0
354777|NCT02284880|872366|P1|NOT COMPLETED|Overall Study||0
354778|NCT02284880|872363|P4|COMPLETED|Overall Study||10
354779|NCT02284880|872364|P3|COMPLETED|Overall Study||8
354780|NCT02284880|872365|P2|COMPLETED|Overall Study||9
354781|NCT02284880|872366|P1|COMPLETED|Overall Study||11
354782|NCT02284880|872363|P4|Second Period (4 Days)|Overall Study||10
354783|NCT02284880|872364|P3|Second Period (4 Days)|Overall Study||8
354784|NCT02284880|872365|P2|Second Period (4 Days)|Overall Study||9
354785|NCT02284880|872366|P1|Second Period (4 Days)|Overall Study||11
354786|NCT02284880|872363|P4|Wash-out Period (7 Days)|Overall Study||10
354787|NCT02284880|872364|P3|Wash-out Period (7 Days)|Overall Study||10
354788|NCT02284880|872365|P2|Wash-out Period (7 Days)|Overall Study||9
354789|NCT02284880|872366|P1|Wash-out Period (7 Days)|Overall Study||11
354790|NCT02284880|872363|P4|First Period (4 Days)|Overall Study||10
354791|NCT02284880|872364|P3|First Period (4 Days)|Overall Study||10
354792|NCT02284880|872365|P2|First Period (4 Days)|Overall Study||9
354793|NCT02284880|872366|P1|First Period (4 Days)|Overall Study||11
354794|NCT02284880|872363|P4|STARTED|Overall Study||10
354795|NCT02284880|872364|P3|STARTED|Overall Study||10
354796|NCT02284880|872365|P2|STARTED|Overall Study||9
354797|NCT02284880|872366|P1|STARTED|Overall Study||11
354798|NCT02284867|872382|P2|NOT COMPLETED|Overall Study||0
354799|NCT02284867|872383|P1|NOT COMPLETED|Overall Study||0
354800|NCT02284867|872382|P2|COMPLETED|Overall Study||30
354801|NCT02284867|872383|P1|COMPLETED|Overall Study||30
354802|NCT02284867|872382|P2|STARTED|Overall Study||30
354803|NCT02284867|872383|P1|STARTED|Overall Study||30
354804|NCT02284854|872393|P2|NOT COMPLETED|Overall Study||0
354805|NCT02284854|872394|P1|NOT COMPLETED|Overall Study||5
354806|NCT02284854|872393|P2|COMPLETED|Overall Study||20
354807|NCT02284854|872394|P1|COMPLETED|Overall Study||18
354808|NCT02284854|872393|P2|STARTED|Overall Study||20
354809|NCT02284854|872394|P1|STARTED|Overall Study||23
354810|NCT02284828|872411|P1|NOT COMPLETED|Overall Study||4
354811|NCT02284828|872411|P1|COMPLETED|Overall Study||22
354812|NCT02284828|872411|P1|STARTED|Overall Study||26
354813|NCT02284555|872423|P1|NOT COMPLETED|Overall Study||0
354814|NCT02284555|872423|P1|COMPLETED|Overall Study||12
354815|NCT02284555|872423|P1|STARTED|Overall Study||12
354816|NCT02284516|872430|P2|NOT COMPLETED|Overall Study||36
354817|NCT02284516|872431|P1|NOT COMPLETED|Overall Study||38
354818|NCT02284516|872430|P2|COMPLETED|Overall Study||319
354819|NCT02284516|872431|P1|COMPLETED|Overall Study||318
354820|NCT02284516|872430|P2|Safety Population|Overall Study|Two placebo participants were included in Lifitegrast arm for safety analysis set (N=357).|357
354821|NCT02284516|872431|P1|Safety Population|Overall Study|Two placebo participants were considered for Lifitegrast arm; Placebo safety analysis set (N= 354).|354
354822|NCT02284516|872430|P2|STARTED|Overall Study||355
354823|NCT02284516|872431|P1|STARTED|Overall Study||356
354824|NCT02284386|872439|P1|NOT COMPLETED|Overall Study||0
354825|NCT02284386|872439|P1|COMPLETED|Overall Study||15
354826|NCT02284386|872439|P1|STARTED|Overall Study||15
354827|NCT02284347|872448|P1|NOT COMPLETED|Overall Study||3
354828|NCT02284347|872448|P1|COMPLETED|Overall Study||48
354829|NCT02284347|872448|P1|STARTED|Overall Study||51
354830|NCT02284243|872456|P2|NOT COMPLETED|Overall Study||3
354831|NCT02284243|872457|P1|NOT COMPLETED|Overall Study||4
354832|NCT02284243|872456|P2|COMPLETED|Overall Study||81
354833|NCT02284243|872457|P1|COMPLETED|Overall Study||80
354834|NCT02284243|872456|P2|STARTED|Overall Study||84
354835|NCT02284243|872457|P1|STARTED|Overall Study||84
354836|NCT02284165|872478|P3|NOT COMPLETED|Overall Study||0
354837|NCT02284165|872479|P2|NOT COMPLETED|Overall Study||0
354838|NCT02284165|872480|P1|NOT COMPLETED|Overall Study||0
354839|NCT02284165|872478|P3|COMPLETED|Overall Study||70996
354840|NCT02284165|872479|P2|COMPLETED|Overall Study||40272
354841|NCT02284165|872480|P1|COMPLETED|Overall Study||36448
354842|NCT02284165|872478|P3|STARTED|Overall Study||70996
354843|NCT02284165|872479|P2|STARTED|Overall Study||40272
354844|NCT02284165|872480|P1|STARTED|Overall Study||36448
354845|NCT02283840|872499|P3|NOT COMPLETED|Overall Study||0
354846|NCT02283840|872500|P2|NOT COMPLETED|Overall Study||1
354847|NCT02283840|872501|P1|NOT COMPLETED|Overall Study||0
354848|NCT02283840|872499|P3|COMPLETED|Overall Study||20
354849|NCT02283840|872500|P2|COMPLETED|Overall Study||19
354850|NCT02283840|872501|P1|COMPLETED|Overall Study||20
354851|NCT02283840|872499|P3|STARTED|Overall Study||20
354852|NCT02283840|872500|P2|STARTED|Overall Study||20
354853|NCT02283840|872501|P1|STARTED|Overall Study||20
354854|NCT02283827|872520|P2|NOT COMPLETED|Overall Study||3
354855|NCT02283827|872521|P1|NOT COMPLETED|Overall Study||1
354856|NCT02283827|872520|P2|COMPLETED|Overall Study||13
354857|NCT02283827|872521|P1|COMPLETED|Overall Study||15
354858|NCT02283827|872520|P2|STARTED|Overall Study||16
354859|NCT02283827|872521|P1|STARTED|Overall Study||16
354860|NCT02283814|872538|P2|NOT COMPLETED|Overall Study||2
354861|NCT02283814|872539|P1|NOT COMPLETED|Overall Study||3
354862|NCT02283814|872538|P2|COMPLETED|Overall Study||14
354863|NCT02283814|872539|P1|COMPLETED|Overall Study||13
354864|NCT02283814|872538|P2|STARTED|Overall Study||16
354865|NCT02283814|872539|P1|STARTED|Overall Study||16
354866|NCT02283788|872553|P4|NOT COMPLETED|Overall Study||2
354867|NCT02283788|872554|P3|NOT COMPLETED|Overall Study||5
354868|NCT02283788|872555|P2|NOT COMPLETED|Overall Study||4
354869|NCT02283788|872556|P1|NOT COMPLETED|Overall Study||1
354870|NCT02283788|872553|P4|COMPLETED|Overall Study||14
354871|NCT02283788|872554|P3|COMPLETED|Overall Study||12
354872|NCT02283788|872555|P2|COMPLETED|Overall Study||13
354873|NCT02283788|872556|P1|COMPLETED|Overall Study||16
354874|NCT02283788|872553|P4|STARTED|Overall Study||16
354875|NCT02283788|872554|P3|STARTED|Overall Study||17
354876|NCT02283788|872555|P2|STARTED|Overall Study||17
354877|NCT02283788|872556|P1|STARTED|Overall Study||17
354878|NCT02283749|872566|P1|NOT COMPLETED|Overall Study||0
354879|NCT02283749|872566|P1|COMPLETED|Overall Study||5
354880|NCT02283749|872566|P1|STARTED|Overall Study||5
354881|NCT02283411|872572|P1|NOT COMPLETED|Overall Study||31
354882|NCT02283411|872572|P1|COMPLETED|Overall Study||125
354883|NCT02283411|872572|P1|STARTED|Overall Study||156
354884|NCT02283268|872580|P1|NOT COMPLETED|Overall Study||1
354885|NCT02283268|872580|P1|COMPLETED|Overall Study||14
354886|NCT02283268|872580|P1|STARTED|Overall Study||15
354887|NCT02282982|872641|P1|NOT COMPLETED|Overall Study||206
354888|NCT02282982|872641|P1|COMPLETED|Overall Study||153
354889|NCT02282982|872641|P1|Attended Follow-up Visit|Overall Study||349
354890|NCT02282982|872641|P1|Attended Visit 5|Overall Study||83
354891|NCT02282982|872641|P1|Attended Visit 4|Overall Study||194
354892|NCT02282982|872641|P1|Attended Visit 3|Overall Study||298
354893|NCT02282982|872641|P1|Attended Visit 2|Overall Study||341
354894|NCT02282982|872641|P1|Attended Visit 1|Overall Study||359
354895|NCT02282982|872641|P1|STARTED|Overall Study||359
354896|NCT02282813|872659|P3|NOT COMPLETED|Overall Study||3
354897|NCT02282813|872660|P2|NOT COMPLETED|Overall Study||23
354898|NCT02282813|872661|P1|NOT COMPLETED|Overall Study||12
354899|NCT02282813|872659|P3|COMPLETED|Overall Study||39
354900|NCT02282813|872660|P2|COMPLETED|Overall Study||130
354901|NCT02282813|872661|P1|COMPLETED|Overall Study||91
354902|NCT02282813|872659|P3|STARTED|Overall Study|Randomization to take adjunctive treatment in addition to CTAP101 capsules began after week 12.|42
354903|NCT02282813|872660|P2|STARTED|Overall Study|ITT Population - not randomized or randomized to CTAP101 monotherapy|153
354904|NCT02282813|872661|P1|STARTED|Overall Study|ITT Population|103
354905|NCT02282722|872680|P2|NOT COMPLETED|Overall Study||19
354906|NCT02282722|872681|P1|NOT COMPLETED|Overall Study||23
354907|NCT02282722|872680|P2|COMPLETED|Overall Study||73
354908|NCT02282722|872681|P1|COMPLETED|Overall Study||71
354909|NCT02282722|872680|P2|3-month Assessment|Overall Study||73
354910|NCT02282722|872681|P1|3-month Assessment|Overall Study||71
354911|NCT02282722|872680|P2|2-week Assessment|Overall Study||75
354912|NCT02282722|872681|P1|2-week Assessment|Overall Study||79
354913|NCT02282722|872680|P2|STARTED|Overall Study||92
354914|NCT02282722|872681|P1|STARTED|Overall Study||94
354915|NCT02282631|872707|P2|NOT COMPLETED|Overall Study||0
354916|NCT02282631|872708|P1|NOT COMPLETED|Overall Study||2
354917|NCT02282631|872707|P2|COMPLETED|Overall Study||15
354918|NCT02282631|872708|P1|COMPLETED|Overall Study||12
354919|NCT02282631|872707|P2|STARTED|Overall Study||15
354920|NCT02282631|872708|P1|STARTED|Overall Study|The two dropouts happened on the 2nd and 3rd weeks post-baseline, respectively|14
354921|NCT02282605|872749|P3|NOT COMPLETED|Overall Study||0
354922|NCT02282605|872750|P2|NOT COMPLETED|Overall Study||0
354923|NCT02282605|872751|P1|NOT COMPLETED|Overall Study||3
354924|NCT02282605|872749|P3|COMPLETED|Overall Study||24
354925|NCT02282605|872750|P2|COMPLETED|Overall Study||12
354926|NCT02282605|872751|P1|COMPLETED|Overall Study||24
354927|NCT02282605|872749|P3|STARTED|Overall Study||24
354928|NCT02282605|872750|P2|STARTED|Overall Study||12
354929|NCT02282605|872751|P1|STARTED|Overall Study||27
354930|NCT02282527|872773|P2|NOT COMPLETED|Overall Study||1
354931|NCT02282527|872774|P1|NOT COMPLETED|Overall Study||1
354932|NCT02282527|872773|P2|COMPLETED|Overall Study||15
354933|NCT02282527|872774|P1|COMPLETED|Overall Study||15
354934|NCT02282527|872773|P2|STARTED|Overall Study||16
354935|NCT02282527|872774|P1|STARTED|Overall Study||16
354936|NCT02281773|872789|P5|NOT COMPLETED|Overall Study||30
354937|NCT02281773|872790|P4|NOT COMPLETED|Overall Study||21
354938|NCT02281773|872791|P3|NOT COMPLETED|Overall Study||18
354939|NCT02281773|872792|P2|NOT COMPLETED|Overall Study||15
354940|NCT02281773|872793|P1|NOT COMPLETED|Overall Study||11
354941|NCT02281773|872789|P5|COMPLETED|Overall Study||143
354942|NCT02281773|872790|P4|COMPLETED|Overall Study||65
354943|NCT02281773|872791|P3|COMPLETED|Overall Study||67
354944|NCT02281773|872792|P2|COMPLETED|Overall Study||70
354945|NCT02281773|872793|P1|COMPLETED|Overall Study||76
354946|NCT02281773|872789|P5|STARTED|Overall Study|Started are the treated patients|173
354947|NCT02281773|872790|P4|STARTED|Overall Study||86
354948|NCT02281773|872791|P3|STARTED|Overall Study||85
354949|NCT02281773|872792|P2|STARTED|Overall Study|Started are the treated patients|85
354950|NCT02281773|872793|P1|STARTED|Overall Study||87
354951|NCT02281591|872854|P4|NOT COMPLETED|Overall Study||0
354952|NCT02281591|872855|P3|NOT COMPLETED|Overall Study||0
354953|NCT02281591|872856|P2|NOT COMPLETED|Overall Study||0
354954|NCT02281591|872857|P1|NOT COMPLETED|Overall Study||0
354955|NCT02281591|872854|P4|COMPLETED|Overall Study||8
354956|NCT02281591|872855|P3|COMPLETED|Overall Study||8
354957|NCT02281591|872856|P2|COMPLETED|Overall Study||8
354958|NCT02281591|872857|P1|COMPLETED|Overall Study||8
354959|NCT02281591|872854|P4|STARTED|Overall Study||8
354960|NCT02281591|872855|P3|STARTED|Overall Study||8
354961|NCT02281591|872856|P2|STARTED|Overall Study||8
354962|NCT02281591|872857|P1|STARTED|Overall Study||8
354963|NCT02281526|872881|P2|NOT COMPLETED|Overall Study||0
354964|NCT02281526|872882|P1|NOT COMPLETED|Overall Study||1
354965|NCT02281526|872881|P2|COMPLETED|Overall Study||8
354966|NCT02281526|872882|P1|COMPLETED|Overall Study||8
354967|NCT02281526|872881|P2|STARTED|Overall Study||8
354968|NCT02281526|872882|P1|STARTED|Overall Study||9
354969|NCT02281448|872892|P2|NOT COMPLETED|Overall Study||1
354970|NCT02281448|872893|P1|NOT COMPLETED|Overall Study||2
354971|NCT02281448|872892|P2|COMPLETED|Overall Study||9
354972|NCT02281448|872893|P1|COMPLETED|Overall Study||8
354973|NCT02281448|872892|P2|STARTED|Overall Study||10
354974|NCT02281448|872893|P1|STARTED|Overall Study||10
354975|NCT02281422|872906|P5|NOT COMPLETED|Overall Study||0
354976|NCT02281422|872907|P4|NOT COMPLETED|Overall Study||0
354977|NCT02281422|872908|P3|NOT COMPLETED|Overall Study||0
354978|NCT02281422|872909|P2|NOT COMPLETED|Overall Study||0
354979|NCT02281422|872910|P1|NOT COMPLETED|Overall Study||0
354980|NCT02281422|872906|P5|COMPLETED|Overall Study||8
354981|NCT02281422|872907|P4|COMPLETED|Overall Study||8
354982|NCT02281422|872908|P3|COMPLETED|Overall Study||8
354983|NCT02281422|872909|P2|COMPLETED|Overall Study||8
354984|NCT02281422|872910|P1|COMPLETED|Overall Study||8
354985|NCT02281422|872906|P5|STARTED|Overall Study||8
354986|NCT02281422|872907|P4|STARTED|Overall Study||8
354987|NCT02281422|872908|P3|STARTED|Overall Study||8
354988|NCT02281422|872909|P2|STARTED|Overall Study||8
354989|NCT02281422|872910|P1|STARTED|Overall Study||8
354990|NCT02281357|872934|P2|NOT COMPLETED|Overall Study||4
354991|NCT02281357|872935|P1|NOT COMPLETED|Overall Study||7
354992|NCT02281357|872934|P2|COMPLETED|Overall Study||66
354993|NCT02281357|872935|P1|COMPLETED|Overall Study||63
354994|NCT02281357|872934|P2|STARTED|Overall Study||70
354995|NCT02281357|872935|P1|STARTED|Overall Study||70
354996|NCT02281318|872949|P2|NOT COMPLETED|Overall Study||5
354997|NCT02281318|872950|P1|NOT COMPLETED|Overall Study||14
354998|NCT02281318|872949|P2|COMPLETED|Overall Study||269
354999|NCT02281318|872950|P1|COMPLETED|Overall Study||263
355000|NCT02281318|872949|P2|STARTED|Overall Study||274
355001|NCT02281318|872950|P1|STARTED|Overall Study||277
355002|NCT02281136|872962|P1|NOT COMPLETED|Overall Study||0
355003|NCT02281136|872962|P1|COMPLETED|Overall Study||29
355004|NCT02281136|872962|P1|STARTED|Overall Study||29
355005|NCT02280811|872999|P5|NOT COMPLETED|Retreated at the MTD||0
355006|NCT02280811|873000|P4|NOT COMPLETED|Retreated at the MTD||0
355007|NCT02280811|873001|P3|NOT COMPLETED|Retreated at the MTD||0
355008|NCT02280811|873002|P2|NOT COMPLETED|Retreated at the MTD||0
355009|NCT02280811|873003|P1|NOT COMPLETED|Retreated at the MTD||0
355010|NCT02280811|872999|P5|COMPLETED|Retreated at the MTD||1
355011|NCT02280811|873000|P4|COMPLETED|Retreated at the MTD||0
355012|NCT02280811|873001|P3|COMPLETED|Retreated at the MTD||0
355013|NCT02280811|873002|P2|COMPLETED|Retreated at the MTD||0
355014|NCT02280811|873003|P1|COMPLETED|Retreated at the MTD||0
355015|NCT02280811|872999|P5|STARTED|Retreated at the MTD|Patient originally started in Grp1(HPV-16 E6mTCR PBL 1x10^9+HD IL-2) and was retreated at the MTD.|1
355016|NCT02280811|873000|P4|STARTED|Retreated at the MTD||0
355017|NCT02280811|873001|P3|STARTED|Retreated at the MTD||0
355018|NCT02280811|873002|P2|STARTED|Retreated at the MTD||0
355019|NCT02280811|873003|P1|STARTED|Retreated at the MTD||0
355020|NCT02280811|872999|P5|NOT COMPLETED|Drug Administration||0
355021|NCT02280811|873000|P4|NOT COMPLETED|Drug Administration||0
355022|NCT02280811|873001|P3|NOT COMPLETED|Drug Administration||0
355023|NCT02280811|873002|P2|NOT COMPLETED|Drug Administration||0
355024|NCT02280811|873003|P1|NOT COMPLETED|Drug Administration||0
355025|NCT02280811|872999|P5|COMPLETED|Drug Administration||2
355026|NCT02280811|873000|P4|COMPLETED|Drug Administration||6
355027|NCT02280811|873001|P3|COMPLETED|Drug Administration||1
355028|NCT02280811|873002|P2|COMPLETED|Drug Administration||2
355029|NCT02280811|873003|P1|COMPLETED|Drug Administration||1
355030|NCT02280811|872999|P5|STARTED|Drug Administration||2
355031|NCT02280811|873000|P4|STARTED|Drug Administration||6
355032|NCT02280811|873001|P3|STARTED|Drug Administration||1
355033|NCT02280811|873002|P2|STARTED|Drug Administration||2
355034|NCT02280811|873003|P1|STARTED|Drug Administration||1
355035|NCT02280655|873044|P2|NOT COMPLETED|Overall Study||0
355036|NCT02280655|873045|P1|NOT COMPLETED|Overall Study||0
355037|NCT02280655|873044|P2|COMPLETED|Overall Study||18
355038|NCT02280655|873045|P1|COMPLETED|Overall Study||25
355039|NCT02280655|873044|P2|STARTED|Overall Study||18
355040|NCT02280655|873045|P1|STARTED|Overall Study||25
355041|NCT02280499|873053|P1|NOT COMPLETED|Overall Study||61
355042|NCT02280499|873053|P1|COMPLETED|Overall Study||26
355043|NCT02280499|873053|P1|STARTED|Overall Study||87
355044|NCT02280473|873061|P2|NOT COMPLETED|Overall Study||3
355045|NCT02280473|873062|P1|NOT COMPLETED|Overall Study||1
355046|NCT02280473|873061|P2|COMPLETED|Overall Study||91
355047|NCT02280473|873062|P1|COMPLETED|Overall Study||93
355048|NCT02280473|873061|P2|STARTED|Overall Study||94
355049|NCT02280473|873062|P1|STARTED|Overall Study||94
355050|NCT02280226|873076|P1|NOT COMPLETED|Overall Study||0
355051|NCT02280226|873076|P1|COMPLETED|Overall Study||17
355052|NCT02280226|873076|P1|STARTED|Overall Study||17
355053|NCT02280187|873081|P1|NOT COMPLETED|Overall Study||218
355054|NCT02280187|873081|P1|COMPLETED|Overall Study||182
355055|NCT02280187|873081|P1|STARTED|Overall Study||400
355056|NCT02280122|873099|P3|NOT COMPLETED|Overall Study||0
355057|NCT02280122|873100|P2|NOT COMPLETED|Overall Study||0
355058|NCT02280122|873101|P1|NOT COMPLETED|Overall Study||0
355059|NCT02280122|873099|P3|COMPLETED|Overall Study||30
355060|NCT02280122|873100|P2|COMPLETED|Overall Study||15
355061|NCT02280122|873101|P1|COMPLETED|Overall Study||15
355062|NCT02280122|873099|P3|STARTED|Overall Study||30
355063|NCT02280122|873100|P2|STARTED|Overall Study||15
355064|NCT02280122|873101|P1|STARTED|Overall Study||15
355065|NCT02279667|873110|P3|NOT COMPLETED|Overall Study||0
355066|NCT02279667|873111|P2|NOT COMPLETED|Overall Study||0
355067|NCT02279667|873112|P1|NOT COMPLETED|Overall Study||0
355068|NCT02279667|873110|P3|COMPLETED|Overall Study||6
355069|NCT02279667|873111|P2|COMPLETED|Overall Study||6
355070|NCT02279667|873112|P1|COMPLETED|Overall Study||6
355071|NCT02279667|873110|P3|STARTED|Overall Study||6
355072|NCT02279667|873111|P2|STARTED|Overall Study||6
355073|NCT02279667|873112|P1|STARTED|Overall Study||6
355074|NCT02279641|873132|P2|NOT COMPLETED|Overall Study||0
355075|NCT02279641|873133|P1|NOT COMPLETED|Overall Study||0
355076|NCT02279641|873132|P2|COMPLETED|Overall Study||6
355077|NCT02279641|873133|P1|COMPLETED|Overall Study||6
355078|NCT02279641|873132|P2|STARTED|Overall Study||6
355079|NCT02279641|873133|P1|STARTED|Overall Study||6
355080|NCT02279420|873187|P1|NOT COMPLETED|Overall Study||23
355081|NCT02279420|873187|P1|COMPLETED|Overall Study||50
355082|NCT02279420|873187|P1|STARTED|Overall Study||73
355083|NCT02279407|873195|P4|NOT COMPLETED|Overall Study||1
355084|NCT02279407|873196|P3|NOT COMPLETED|Overall Study||5
355085|NCT02279407|873197|P2|NOT COMPLETED|Overall Study||1
355086|NCT02279407|873198|P1|NOT COMPLETED|Overall Study||2
355087|NCT02279407|873195|P4|COMPLETED|Overall Study||20
355088|NCT02279407|873196|P3|COMPLETED|Overall Study||15
355089|NCT02279407|873197|P2|COMPLETED|Overall Study||20
355090|NCT02279407|873198|P1|COMPLETED|Overall Study||20
355091|NCT02279407|873195|P4|STARTED|Overall Study||21
355092|NCT02279407|873196|P3|STARTED|Overall Study||20
355093|NCT02279407|873197|P2|STARTED|Overall Study||21
355094|NCT02279407|873198|P1|STARTED|Overall Study||22
355095|NCT02279108|873211|P2|NOT COMPLETED|Overall Study||1
355096|NCT02279108|873212|P1|NOT COMPLETED|Overall Study||0
355097|NCT02279108|873211|P2|COMPLETED|Overall Study||49
355098|NCT02279108|873212|P1|COMPLETED|Overall Study||50
355099|NCT02279108|873211|P2|STARTED|Overall Study||50
355100|NCT02279108|873212|P1|STARTED|Overall Study||50
355101|NCT02279082|873234|P1|NOT COMPLETED|Overall Study||33
355102|NCT02279082|873234|P1|COMPLETED|Overall Study||134
355103|NCT02279082|873234|P1|STARTED|Overall Study|Intentions were to have 173 participants, but only 167 participants received study drug.|167
355104|NCT02278783|873238|P1|NOT COMPLETED|Overall Study||0
355105|NCT02278783|873238|P1|COMPLETED|Overall Study||1
355106|NCT02278783|873238|P1|STARTED|Overall Study||1
355107|NCT02278640|873245|P1|NOT COMPLETED|Overall Study||0
355108|NCT02278640|873245|P1|COMPLETED|Overall Study||40
355109|NCT02278640|873245|P1|STARTED|Overall Study||40
355110|NCT02278614|873254|P2|NOT COMPLETED|Overall Study||5
355111|NCT02278614|873255|P1|NOT COMPLETED|Overall Study||5
355112|NCT02278614|873254|P2|COMPLETED|Overall Study||110
355113|NCT02278614|873255|P1|COMPLETED|Overall Study||122
355114|NCT02278614|873254|P2|STARTED|Overall Study||115
355115|NCT02278614|873255|P1|STARTED|Overall Study||127
355116|NCT02278562|873264|P3|NOT COMPLETED|Overall Study||0
355117|NCT02278562|873265|P2|NOT COMPLETED|Overall Study||0
355118|NCT02278562|873266|P1|NOT COMPLETED|Overall Study||0
355119|NCT02278562|873264|P3|COMPLETED|Overall Study||8
355120|NCT02278562|873265|P2|COMPLETED|Overall Study||7
355121|NCT02278562|873266|P1|COMPLETED|Overall Study||9
355122|NCT02278562|873264|P3|STARTED|Overall Study||8
355123|NCT02278562|873265|P2|STARTED|Overall Study||7
355124|NCT02278562|873266|P1|STARTED|Overall Study||9
355125|NCT02278484|873280|P1|NOT COMPLETED|Overall Study||0
355126|NCT02278484|873280|P1|COMPLETED|Overall Study||50
355127|NCT02278484|873280|P1|STARTED|Overall Study||50
355128|NCT02278146|873289|P2|NOT COMPLETED|Overall Study||2
355129|NCT02278146|873290|P1|NOT COMPLETED|Overall Study||0
355130|NCT02278146|873289|P2|COMPLETED|Overall Study||8
355131|NCT02278146|873290|P1|COMPLETED|Overall Study||6
355132|NCT02278146|873289|P2|STARTED|Overall Study||10
355133|NCT02278146|873290|P1|STARTED|Overall Study||6
355134|NCT02278003|873302|P2|NOT COMPLETED|Overall Study||0
355135|NCT02278003|873303|P1|NOT COMPLETED|Overall Study||19
355136|NCT02278003|873302|P2|COMPLETED|Overall Study||20
355137|NCT02278003|873303|P1|COMPLETED|Overall Study||30
355138|NCT02278003|873302|P2|STARTED|Overall Study||20
355139|NCT02278003|873303|P1|STARTED|Overall Study||49
355140|NCT02277769|873314|P3|NOT COMPLETED|Overall Study||18
355141|NCT02277769|873315|P2|NOT COMPLETED|Overall Study||13
355142|NCT02277769|873316|P1|NOT COMPLETED|Overall Study||46
355143|NCT02277769|873314|P3|COMPLETED|Overall Study||221
355144|NCT02277769|873315|P2|COMPLETED|Overall Study||220
355145|NCT02277769|873316|P1|COMPLETED|Overall Study||190
355146|NCT02277769|873314|P3|Safety Population|Overall Study|2 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|237
355147|NCT02277769|873315|P2|Safety Population|Overall Study|3 participants (1 [placebo] + 2 [Dupilumab 300 mg qw arm]) analyzed in Dupilumab 300 mg q2w arm|236
355148|NCT02277769|873316|P1|Safety Population|Overall Study|1 participant received at least 1 injection of Dupilumab 300mg(analyzed in Dupilumab 300 mg q2w arm)|234
355149|NCT02277769|873314|P3|Treated|Overall Study||239
355150|NCT02277769|873315|P2|Treated|Overall Study||233
355151|NCT02277769|873316|P1|Treated|Overall Study||235
355152|NCT02277769|873314|P3|STARTED|Overall Study||239
355153|NCT02277769|873315|P2|STARTED|Overall Study||233
355154|NCT02277769|873316|P1|STARTED|Overall Study||236
355155|NCT02277743|873387|P3|NOT COMPLETED|Overall Study||26
355156|NCT02277743|873388|P2|NOT COMPLETED|Overall Study||16
355157|NCT02277743|873389|P1|NOT COMPLETED|Overall Study||40
355158|NCT02277743|873387|P3|COMPLETED|Overall Study||197
355159|NCT02277743|873388|P2|COMPLETED|Overall Study||208
355160|NCT02277743|873389|P1|COMPLETED|Overall Study||184
355161|NCT02277743|873387|P3|Safety Population|Overall Study|5 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|218
355162|NCT02277743|873388|P2|Safety Population|Overall Study|6 participants (1 [placebo] + 5 [Dupilumab 300 mg qw arm]) analyzed in Dupilumab 300 mg q2w arm|229
355163|NCT02277743|873389|P1|Safety Population|Overall Study|1 participant received at least 1 injection of Dupilumab 300mg(analyzed in Dupilumab 300 mg q2w arm)|222
355164|NCT02277743|873387|P3|Treated|Overall Study||223
355165|NCT02277743|873388|P2|Treated|Overall Study||223
355166|NCT02277743|873389|P1|Treated|Overall Study||223
355167|NCT02277743|873387|P3|STARTED|Overall Study||223
355168|NCT02277743|873388|P2|STARTED|Overall Study||224
355169|NCT02277743|873389|P1|STARTED|Overall Study||224
355170|NCT02277691|873457|P1|NOT COMPLETED|Overall Study||46
355171|NCT02277691|873457|P1|COMPLETED|Overall Study||295
355172|NCT02277691|873457|P1|STARTED|Overall Study||341
355173|NCT02277639|873469|P2|NOT COMPLETED|Overall Study||0
355174|NCT02277639|873470|P1|NOT COMPLETED|Overall Study||0
355175|NCT02277639|873469|P2|COMPLETED|Overall Study||2
355176|NCT02277639|873470|P1|COMPLETED|Overall Study||0
355177|NCT02277639|873469|P2|STARTED|Overall Study||2
355178|NCT02277639|873470|P1|STARTED|Overall Study||0
355179|NCT02277626|873476|P2|NOT COMPLETED|Overall Study||0
355180|NCT02277626|873477|P1|NOT COMPLETED|Overall Study||0
355181|NCT02277626|873476|P2|COMPLETED|Overall Study||9
355182|NCT02277626|873477|P1|COMPLETED|Overall Study||6
355183|NCT02277626|873476|P2|STARTED|Overall Study||9
355184|NCT02277626|873477|P1|STARTED|Overall Study||6
355185|NCT02277249|873493|P2|NOT COMPLETED|Overall Study||0
355186|NCT02277249|873494|P1|NOT COMPLETED|Overall Study||0
355187|NCT02277249|873493|P2|COMPLETED|Overall Study||30
355188|NCT02277249|873494|P1|COMPLETED|Overall Study||30
355189|NCT02277249|873493|P2|STARTED|Overall Study||30
355190|NCT02277249|873494|P1|STARTED|Overall Study||30
355191|NCT02277119|873503|P3|NOT COMPLETED|Overall Study||8
355192|NCT02277119|873504|P2|NOT COMPLETED|Overall Study||4
355193|NCT02277119|873505|P1|NOT COMPLETED|Overall Study||3
355194|NCT02277119|873503|P3|COMPLETED|Overall Study||19
355195|NCT02277119|873504|P2|COMPLETED|Overall Study||20
355196|NCT02277119|873505|P1|COMPLETED|Overall Study||55
355197|NCT02277119|873503|P3|STARTED|Overall Study||27
355198|NCT02277119|873504|P2|STARTED|Overall Study||24
355199|NCT02277119|873505|P1|STARTED|Overall Study||58
355200|NCT02277093|873522|P1|NOT COMPLETED|Overall Study||0
355201|NCT02277093|873522|P1|COMPLETED|Overall Study||11
355202|NCT02277093|873522|P1|STARTED|Overall Study||11
355203|NCT02276612|873532|P2|NOT COMPLETED|Overall Study||0
355204|NCT02276612|873533|P1|NOT COMPLETED|Overall Study||4
355205|NCT02276612|873532|P2|COMPLETED|Overall Study||10
355206|NCT02276612|873533|P1|COMPLETED|Overall Study||46
355207|NCT02276612|873532|P2|STARTED|Overall Study||10
355208|NCT02276612|873533|P1|STARTED|Overall Study||50
355209|NCT02276560|873556|P3|NOT COMPLETED|Overall Study||0
355210|NCT02276560|873557|P2|NOT COMPLETED|Overall Study||0
355211|NCT02276560|873558|P1|NOT COMPLETED|Overall Study||1
355212|NCT02276560|873556|P3|COMPLETED|Overall Study||0
355213|NCT02276560|873557|P2|COMPLETED|Overall Study||0
355214|NCT02276560|873558|P1|COMPLETED|Overall Study||0
355215|NCT02276560|873556|P3|STARTED|Overall Study||0
355216|NCT02276560|873557|P2|STARTED|Overall Study||0
355217|NCT02276560|873558|P1|STARTED|Overall Study||1
355218|NCT02276274|873568|P2|NOT COMPLETED|Second Intervention Period||0
355219|NCT02276274|873569|P1|NOT COMPLETED|Second Intervention Period||0
355220|NCT02276274|873568|P2|COMPLETED|Second Intervention Period||6
355221|NCT02276274|873569|P1|COMPLETED|Second Intervention Period||6
355222|NCT02276274|873568|P2|STARTED|Second Intervention Period||6
355223|NCT02276274|873569|P1|STARTED|Second Intervention Period||6
355224|NCT02276274|873568|P2|NOT COMPLETED|Washout Period (at Least 15 Days)||0
355225|NCT02276274|873569|P1|NOT COMPLETED|Washout Period (at Least 15 Days)||0
355226|NCT02276274|873568|P2|COMPLETED|Washout Period (at Least 15 Days)||6
355227|NCT02276274|873569|P1|COMPLETED|Washout Period (at Least 15 Days)||6
355228|NCT02276274|873568|P2|STARTED|Washout Period (at Least 15 Days)||6
355229|NCT02276274|873569|P1|STARTED|Washout Period (at Least 15 Days)||6
355230|NCT02276274|873568|P2|NOT COMPLETED|First Intervention Period||0
355231|NCT02276274|873569|P1|NOT COMPLETED|First Intervention Period||0
355232|NCT02276274|873568|P2|COMPLETED|First Intervention Period||6
355233|NCT02276274|873569|P1|COMPLETED|First Intervention Period||6
355234|NCT02276274|873568|P2|STARTED|First Intervention Period||6
355235|NCT02276274|873569|P1|STARTED|First Intervention Period||6
355236|NCT02276222|873679|P2|NOT COMPLETED|Overall Study||64
355237|NCT02276222|873680|P1|NOT COMPLETED|Overall Study||185
355238|NCT02276222|873679|P2|COMPLETED|Overall Study||402
355239|NCT02276222|873680|P1|COMPLETED|Overall Study|one subject withdrew at randomization due to a pre-treatment event prior to being dosed|436
355240|NCT02276222|873679|P2|STARTED|Overall Study||466
355241|NCT02276222|873680|P1|STARTED|Overall Study||621
355242|NCT02276040|873704|P1|NOT COMPLETED|Overall Study||15
355243|NCT02276040|873704|P1|COMPLETED|Overall Study||11
355244|NCT02276040|873704|P1|STARTED|Overall Study||26
355245|NCT02275767|873711|P3|NOT COMPLETED|Overall Study||3
355246|NCT02275767|873712|P2|NOT COMPLETED|Overall Study||4
355247|NCT02275767|873713|P1|NOT COMPLETED|Overall Study||2
355248|NCT02275767|873711|P3|COMPLETED|Overall Study||19
355249|NCT02275767|873712|P2|COMPLETED|Overall Study||18
355250|NCT02275767|873713|P1|COMPLETED|Overall Study||20
355251|NCT02275767|873711|P3|STARTED|Overall Study||22
355252|NCT02275767|873712|P2|STARTED|Overall Study||22
355253|NCT02275767|873713|P1|STARTED|Overall Study||22
355254|NCT02275611|873728|P4|NOT COMPLETED|Outpatient Drinking||0
355255|NCT02275611|873729|P3|NOT COMPLETED|Outpatient Drinking||0
355256|NCT02275611|873730|P2|NOT COMPLETED|Outpatient Drinking||0
355257|NCT02275611|873731|P1|NOT COMPLETED|Outpatient Drinking||0
355258|NCT02275611|873728|P4|COMPLETED|Outpatient Drinking||3
355259|NCT02275611|873729|P3|COMPLETED|Outpatient Drinking||6
355260|NCT02275611|873730|P2|COMPLETED|Outpatient Drinking||0
355261|NCT02275611|873731|P1|COMPLETED|Outpatient Drinking||0
355262|NCT02275611|873728|P4|STARTED|Outpatient Drinking||3
355263|NCT02275611|873729|P3|STARTED|Outpatient Drinking||6
355264|NCT02275611|873730|P2|STARTED|Outpatient Drinking||0
355265|NCT02275611|873731|P1|STARTED|Outpatient Drinking||0
355266|NCT02275611|873728|P4|NOT COMPLETED|Inpatient Withdrawal||0
355267|NCT02275611|873729|P3|NOT COMPLETED|Inpatient Withdrawal||0
355268|NCT02275611|873730|P2|NOT COMPLETED|Inpatient Withdrawal||0
355269|NCT02275611|873731|P1|NOT COMPLETED|Inpatient Withdrawal||1
355270|NCT02275611|873728|P4|COMPLETED|Inpatient Withdrawal||0
355271|NCT02275611|873729|P3|COMPLETED|Inpatient Withdrawal||0
355272|NCT02275611|873730|P2|COMPLETED|Inpatient Withdrawal||4
355273|NCT02275611|873731|P1|COMPLETED|Inpatient Withdrawal||4
355274|NCT02275611|873728|P4|STARTED|Inpatient Withdrawal||0
355275|NCT02275611|873729|P3|STARTED|Inpatient Withdrawal||0
355276|NCT02275611|873730|P2|STARTED|Inpatient Withdrawal||4
355277|NCT02275611|873731|P1|STARTED|Inpatient Withdrawal||5
355278|NCT02275546|873743|P2|NOT COMPLETED|Treatment Period 2||2
355279|NCT02275546|873744|P1|NOT COMPLETED|Treatment Period 2||2
355280|NCT02275546|873743|P2|COMPLETED|Treatment Period 2||81
355281|NCT02275546|873744|P1|COMPLETED|Treatment Period 2||79
355282|NCT02275546|873743|P2|STARTED|Treatment Period 2||83
355283|NCT02275546|873744|P1|STARTED|Treatment Period 2||81
355284|NCT02275546|873743|P2|NOT COMPLETED|Treatment Period 1||0
355285|NCT02275546|873744|P1|NOT COMPLETED|Treatment Period 1||0
355286|NCT02275546|873743|P2|COMPLETED|Treatment Period 1||83
355287|NCT02275546|873744|P1|COMPLETED|Treatment Period 1||81
355288|NCT02275546|873743|P2|STARTED|Treatment Period 1||83
355289|NCT02275546|873744|P1|STARTED|Treatment Period 1||81
355290|NCT02275481|873754|P2|NOT COMPLETED|Overall Study||3
355291|NCT02275481|873755|P1|NOT COMPLETED|Overall Study||9
355292|NCT02275481|873754|P2|COMPLETED|Overall Study||31
355293|NCT02275481|873755|P1|COMPLETED|Overall Study||23
355294|NCT02275481|873754|P2|STARTED|Overall Study||34
355295|NCT02275481|873755|P1|STARTED|Overall Study||32
355296|NCT02275364|873761|P2|NOT COMPLETED|Period 4||0
355297|NCT02275364|873762|P1|NOT COMPLETED|Period 4||0
355298|NCT02275364|873761|P2|COMPLETED|Period 4||14
355299|NCT02275364|873762|P1|COMPLETED|Period 4||12
355300|NCT02275364|873761|P2|STARTED|Period 4||14
355301|NCT02275364|873762|P1|STARTED|Period 4||12
355302|NCT02275364|873761|P2|NOT COMPLETED|Period 3||0
355303|NCT02275364|873762|P1|NOT COMPLETED|Period 3||0
355304|NCT02275364|873761|P2|COMPLETED|Period 3||14
355305|NCT02275364|873762|P1|COMPLETED|Period 3||12
355306|NCT02275364|873761|P2|STARTED|Period 3||14
355307|NCT02275364|873762|P1|STARTED|Period 3||12
355308|NCT02275364|873761|P2|NOT COMPLETED|Washout Period 2||0
355309|NCT02275364|873762|P1|NOT COMPLETED|Washout Period 2||0
355310|NCT02275364|873761|P2|COMPLETED|Washout Period 2||14
355311|NCT02275364|873762|P1|COMPLETED|Washout Period 2||12
355312|NCT02275364|873761|P2|STARTED|Washout Period 2||14
355313|NCT02275364|873762|P1|STARTED|Washout Period 2||12
355314|NCT02275364|873761|P2|NOT COMPLETED|Period 2||0
355315|NCT02275364|873762|P1|NOT COMPLETED|Period 2||0
355316|NCT02275364|873761|P2|COMPLETED|Period 2||14
355317|NCT02275364|873762|P1|COMPLETED|Period 2||12
355318|NCT02275364|873761|P2|STARTED|Period 2||14
355319|NCT02275364|873762|P1|STARTED|Period 2||12
355320|NCT02275364|873761|P2|NOT COMPLETED|Washout Period 1||0
355321|NCT02275364|873762|P1|NOT COMPLETED|Washout Period 1||0
355322|NCT02275364|873761|P2|COMPLETED|Washout Period 1||14
355323|NCT02275364|873762|P1|COMPLETED|Washout Period 1||12
355324|NCT02275364|873761|P2|STARTED|Washout Period 1||14
355325|NCT02275364|873762|P1|STARTED|Washout Period 1||12
355326|NCT02275364|873761|P2|NOT COMPLETED|Period 1||0
355327|NCT02275364|873762|P1|NOT COMPLETED|Period 1||2
355328|NCT02275364|873761|P2|COMPLETED|Period 1||14
355329|NCT02275364|873762|P1|COMPLETED|Period 1||12
355330|NCT02275364|873761|P2|STARTED|Period 1||14
355331|NCT02275364|873762|P1|STARTED|Period 1||14
355332|NCT02275156|873794|P3|NOT COMPLETED|Overall Study||0
355333|NCT02275156|873795|P2|NOT COMPLETED|Overall Study||0
355334|NCT02275156|873796|P1|NOT COMPLETED|Overall Study||0
355335|NCT02275156|873794|P3|COMPLETED|Overall Study||6
355336|NCT02275156|873795|P2|COMPLETED|Overall Study||6
355337|NCT02275156|873796|P1|COMPLETED|Overall Study||6
355338|NCT02275156|873794|P3|STARTED|Overall Study||6
355339|NCT02275156|873795|P2|STARTED|Overall Study||6
355340|NCT02275156|873796|P1|STARTED|Overall Study||6
355341|NCT02275052|873823|P4|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||14
355342|NCT02275052|873824|P3|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||5
355343|NCT02275052|873825|P2|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
355344|NCT02275052|873826|P1|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
355345|NCT02275052|873823|P4|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||72
355346|NCT02275052|873824|P3|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||88
355347|NCT02275052|873825|P2|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
355348|NCT02275052|873826|P1|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
355349|NCT02275052|873823|P4|STARTED|Period 2: Treatment Period 2 (12 Weeks)||86
355350|NCT02275052|873824|P3|STARTED|Period 2: Treatment Period 2 (12 Weeks)||93
355351|NCT02275052|873825|P2|STARTED|Period 2: Treatment Period 2 (12 Weeks)||0
355352|NCT02275052|873826|P1|STARTED|Period 2: Treatment Period 2 (12 Weeks)||0
355353|NCT02275052|873823|P4|NOT COMPLETED|Washout Period (12-17 Days)||0
355354|NCT02275052|873824|P3|NOT COMPLETED|Washout Period (12-17 Days)||0
355355|NCT02275052|873825|P2|NOT COMPLETED|Washout Period (12-17 Days)||0
355356|NCT02275052|873826|P1|NOT COMPLETED|Washout Period (12-17 Days)||4
355357|NCT02275052|873823|P4|COMPLETED|Washout Period (12-17 Days)||0
355358|NCT02275052|873824|P3|COMPLETED|Washout Period (12-17 Days)||0
355359|NCT02275052|873825|P2|COMPLETED|Washout Period (12-17 Days)||93
355360|NCT02275052|873826|P1|COMPLETED|Washout Period (12-17 Days)||86
355361|NCT02275052|873823|P4|STARTED|Washout Period (12-17 Days)||0
355362|NCT02275052|873824|P3|STARTED|Washout Period (12-17 Days)||0
355363|NCT02275052|873825|P2|STARTED|Washout Period (12-17 Days)||93
355364|NCT02275052|873826|P1|STARTED|Washout Period (12-17 Days)||90
355365|NCT02275052|873823|P4|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
355366|NCT02275052|873824|P3|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
355367|NCT02275052|873825|P2|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||6
355368|NCT02275052|873826|P1|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||9
355369|NCT02275052|873823|P4|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
355370|NCT02275052|873824|P3|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
355371|NCT02275052|873825|P2|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||93
355372|NCT02275052|873826|P1|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||90
355373|NCT02275052|873823|P4|STARTED|Period 1: Treatment Period 1 (12 Weeks)||0
355374|NCT02275052|873824|P3|STARTED|Period 1: Treatment Period 1 (12 Weeks)||0
355375|NCT02275052|873825|P2|STARTED|Period 1: Treatment Period 1 (12 Weeks)||99
355376|NCT02275052|873826|P1|STARTED|Period 1: Treatment Period 1 (12 Weeks)||99
355377|NCT02274948|873840|P2|NOT COMPLETED|Overall Study||91
355378|NCT02274948|873841|P1|NOT COMPLETED|Overall Study||98
355379|NCT02274948|873840|P2|COMPLETED|Overall Study||82
355380|NCT02274948|873841|P1|COMPLETED|Overall Study||68
355381|NCT02274948|873840|P2|STARTED|Overall Study||173
355382|NCT02274948|873841|P1|STARTED|Overall Study||166
355383|NCT02274870|873857|P2|NOT COMPLETED|Overall Study||0
355384|NCT02274870|873858|P1|NOT COMPLETED|Overall Study||0
355385|NCT02274870|873857|P2|COMPLETED|Overall Study||33
355386|NCT02274870|873858|P1|COMPLETED|Overall Study||32
355387|NCT02274870|873857|P2|STARTED|Overall Study||33
355388|NCT02274870|873858|P1|STARTED|Overall Study||32
355389|NCT02274792|873882|P1|NOT COMPLETED|Overall Study||25
355390|NCT02274792|873882|P1|COMPLETED|Overall Study||107
355391|NCT02274792|873882|P1|Received Treatment|Overall Study||131
355392|NCT02274792|873882|P1|STARTED|Overall Study||132
355393|NCT02274766|873892|P2|NOT COMPLETED|Overall Study||9
355394|NCT02274766|873893|P1|NOT COMPLETED|Overall Study||4
355395|NCT02274766|873892|P2|COMPLETED|Overall Study||29
355396|NCT02274766|873893|P1|COMPLETED|Overall Study||35
355397|NCT02274766|873892|P2|Received Study Drug|Overall Study||37
355398|NCT02274766|873893|P1|Received Study Drug|Overall Study||38
355399|NCT02274766|873892|P2|STARTED|Overall Study||38
355400|NCT02274766|873893|P1|STARTED|Overall Study||39
355401|NCT02274688|873903|P2|NOT COMPLETED|Overall Study||13
355402|NCT02274688|873904|P1|NOT COMPLETED|Overall Study||14
355403|NCT02274688|873903|P2|COMPLETED|Overall Study||72
355404|NCT02274688|873904|P1|COMPLETED|Overall Study||72
355405|NCT02274688|873903|P2|STARTED|Overall Study||85
355406|NCT02274688|873904|P1|STARTED|Overall Study||86
355407|NCT02274675|873926|P1|NOT COMPLETED|Overall Study||0
355408|NCT02274675|873926|P1|COMPLETED|Overall Study||7
355409|NCT02274675|873926|P1|STARTED|Overall Study||7
355410|NCT02274558|873939|P3|NOT COMPLETED|Overall Study||9
355411|NCT02274558|873940|P2|NOT COMPLETED|Overall Study||13
355412|NCT02274558|873941|P1|NOT COMPLETED|Overall Study||7
355413|NCT02274558|873939|P3|COMPLETED|Overall Study||71
355414|NCT02274558|873940|P2|COMPLETED|Overall Study||63
355415|NCT02274558|873941|P1|COMPLETED|Overall Study||71
355416|NCT02274558|873939|P3|Included in the Safety Analysis Set|Overall Study||79
355417|NCT02274558|873940|P2|Included in the Safety Analysis Set|Overall Study||72
355418|NCT02274558|873941|P1|Included in the Safety Analysis Set|Overall Study||76
355419|NCT02274558|873939|P3|STARTED|Overall Study||80
355420|NCT02274558|873940|P2|STARTED|Overall Study||76
355421|NCT02274558|873941|P1|STARTED|Overall Study||78
355422|NCT02273973|873957|P2|NOT COMPLETED|Overall Study||8
355423|NCT02273973|873958|P1|NOT COMPLETED|Overall Study||9
355424|NCT02273973|873957|P2|COMPLETED|Overall Study||160
355425|NCT02273973|873958|P1|COMPLETED|Overall Study||157
355426|NCT02273973|873957|P2|STARTED|Overall Study||168
355427|NCT02273973|873958|P1|STARTED|Overall Study||166
355428|NCT02273908|874000|P2|NOT COMPLETED|Overall Study||5
355429|NCT02273908|874001|P1|NOT COMPLETED|Overall Study||33
355430|NCT02273908|874000|P2|COMPLETED|Overall Study||169
355431|NCT02273908|874001|P1|COMPLETED|Overall Study||124
355432|NCT02273908|874000|P2|STARTED|Overall Study||174
355433|NCT02273908|874001|P1|STARTED|Overall Study||157
355434|NCT02273752|874023|P1|NOT COMPLETED|Overall Study||2
355435|NCT02273752|874023|P1|COMPLETED|Overall Study||0
355436|NCT02273752|874023|P1|STARTED|Overall Study||2
355437|NCT02273323|874034|P2|NOT COMPLETED|Overall Study||0
355438|NCT02273323|874035|P1|NOT COMPLETED|Overall Study||0
355439|NCT02273323|874034|P2|COMPLETED|Overall Study||15
355440|NCT02273323|874035|P1|COMPLETED|Overall Study||15
355441|NCT02273323|874034|P2|STARTED|Overall Study||15
355442|NCT02273323|874035|P1|STARTED|Overall Study||15
355443|NCT02273310|874053|P2|NOT COMPLETED|Overall Study||3
355444|NCT02273310|874054|P1|NOT COMPLETED|Overall Study||18
355445|NCT02273310|874053|P2|COMPLETED|Overall Study||38
355446|NCT02273310|874054|P1|COMPLETED|Overall Study||24
355447|NCT02273310|874053|P2|STARTED|Overall Study||41
355448|NCT02273310|874054|P1|STARTED|Overall Study||42
355449|NCT02273180|874067|P2|NOT COMPLETED|Overall Study||19
355450|NCT02273180|874068|P1|NOT COMPLETED|Overall Study||27
355451|NCT02273180|874067|P2|COMPLETED|Overall Study||235
355452|NCT02273180|874068|P1|COMPLETED|Overall Study||226
355453|NCT02273180|874067|P2|Treated|Overall Study||254
355454|NCT02273180|874068|P1|Treated|Overall Study||252
355455|NCT02273180|874067|P2|STARTED|Overall Study||254
355456|NCT02273180|874068|P1|STARTED|Overall Study||253
355457|NCT02273167|874093|P3|NOT COMPLETED|Overall Study||21
355458|NCT02273167|874094|P2|NOT COMPLETED|Overall Study||23
355459|NCT02273167|874095|P1|NOT COMPLETED|Overall Study||24
355460|NCT02273167|874093|P3|COMPLETED|Overall Study||262
355461|NCT02273167|874094|P2|COMPLETED|Overall Study||260
355462|NCT02273167|874095|P1|COMPLETED|Overall Study||259
355463|NCT02273167|874093|P3|STARTED|Overall Study||283
355464|NCT02273167|874094|P2|STARTED|Overall Study||283
355465|NCT02273167|874095|P1|STARTED|Overall Study||283
355466|NCT02273141|874120|P2|NOT COMPLETED|Overall Study||25
355467|NCT02273141|874121|P1|NOT COMPLETED|Overall Study||17
355468|NCT02273141|874120|P2|COMPLETED|Overall Study||233
355469|NCT02273141|874121|P1|COMPLETED|Overall Study||240
355470|NCT02273141|874120|P2|STARTED|Overall Study||258
355471|NCT02273141|874121|P1|STARTED|Overall Study||257
355472|NCT02273115|874141|P4|NOT COMPLETED|Overall Study||1
355473|NCT02273115|874142|P3|NOT COMPLETED|Overall Study||0
355474|NCT02273115|874143|P2|NOT COMPLETED|Overall Study||0
355475|NCT02273115|874144|P1|NOT COMPLETED|Overall Study||0
355476|NCT02273115|874141|P4|COMPLETED|Overall Study||71
355477|NCT02273115|874142|P3|COMPLETED|Overall Study||67
355478|NCT02273115|874143|P2|COMPLETED|Overall Study||90
355479|NCT02273115|874144|P1|COMPLETED|Overall Study||94
355480|NCT02273115|874141|P4|STARTED|Overall Study||72
355481|NCT02273115|874142|P3|STARTED|Overall Study||67
355482|NCT02273115|874143|P2|STARTED|Overall Study||90
355483|NCT02273115|874144|P1|STARTED|Overall Study||94
355484|NCT02273050|874189|P3|NOT COMPLETED|Overall Study||29
355485|NCT02273050|874190|P2|NOT COMPLETED|Overall Study||22
355486|NCT02273050|874191|P1|NOT COMPLETED|Overall Study||24
355487|NCT02273050|874189|P3|COMPLETED|Overall Study||185
355488|NCT02273050|874190|P2|COMPLETED|Overall Study||194
355489|NCT02273050|874191|P1|COMPLETED|Overall Study||186
355490|NCT02273050|874189|P3|STARTED|Overall Study||214
355491|NCT02273050|874190|P2|STARTED|Overall Study||216
355492|NCT02273050|874191|P1|STARTED|Overall Study||210
355493|NCT02272803|874219|P2|NOT COMPLETED|Overall Study||17
355494|NCT02272803|874220|P1|NOT COMPLETED|Overall Study||9
355495|NCT02272803|874219|P2|COMPLETED|Overall Study|Completed = Still receiving treatment|25
355496|NCT02272803|874220|P1|COMPLETED|Overall Study|Completed = Still receiving treatment|31
355497|NCT02272803|874219|P2|STARTED|Overall Study||42
355498|NCT02272803|874220|P1|STARTED|Overall Study||40
355499|NCT02272725|874233|P2|NOT COMPLETED|Overall Study||0
355500|NCT02272725|874234|P1|NOT COMPLETED|Overall Study||2
355501|NCT02272725|874233|P2|COMPLETED|Overall Study||42
355502|NCT02272725|874234|P1|COMPLETED|Overall Study||47
355503|NCT02272725|874233|P2|STARTED|Overall Study||42
355504|NCT02272725|874234|P1|STARTED|Overall Study||49
355505|NCT02271984|874244|P12|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
355506|NCT02271984|874245|P11|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
355507|NCT02271984|874246|P10|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
355508|NCT02271984|874247|P9|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
355509|NCT02271984|874248|P8|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
355510|NCT02271984|874249|P7|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
355511|NCT02271984|874250|P6|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
355512|NCT02271984|874251|P5|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
355513|NCT02271984|874252|P4|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
355514|NCT02271984|874253|P3|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
355515|NCT02271984|874254|P2|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
355516|NCT02271984|874255|P1|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
355517|NCT02271984|874244|P12|COMPLETED|Fifth Intervention Period (1 Day)||3
355518|NCT02271984|874245|P11|COMPLETED|Fifth Intervention Period (1 Day)||3
355519|NCT02271984|874246|P10|COMPLETED|Fifth Intervention Period (1 Day)||3
355520|NCT02271984|874247|P9|COMPLETED|Fifth Intervention Period (1 Day)||3
355521|NCT02271984|874248|P8|COMPLETED|Fifth Intervention Period (1 Day)||2
355522|NCT02271984|874249|P7|COMPLETED|Fifth Intervention Period (1 Day)||3
355523|NCT02271984|874250|P6|COMPLETED|Fifth Intervention Period (1 Day)||2
355524|NCT02271984|874251|P5|COMPLETED|Fifth Intervention Period (1 Day)||3
355525|NCT02271984|874252|P4|COMPLETED|Fifth Intervention Period (1 Day)||3
355526|NCT02271984|874253|P3|COMPLETED|Fifth Intervention Period (1 Day)||3
355527|NCT02271984|874254|P2|COMPLETED|Fifth Intervention Period (1 Day)||3
355528|NCT02271984|874255|P1|COMPLETED|Fifth Intervention Period (1 Day)||3
355529|NCT02271984|874244|P12|STARTED|Fifth Intervention Period (1 Day)||3
355530|NCT02271984|874245|P11|STARTED|Fifth Intervention Period (1 Day)||3
355531|NCT02271984|874246|P10|STARTED|Fifth Intervention Period (1 Day)||3
355532|NCT02271984|874247|P9|STARTED|Fifth Intervention Period (1 Day)||3
355533|NCT02271984|874248|P8|STARTED|Fifth Intervention Period (1 Day)||2
355534|NCT02271984|874249|P7|STARTED|Fifth Intervention Period (1 Day)||3
355535|NCT02271984|874250|P6|STARTED|Fifth Intervention Period (1 Day)||2
355536|NCT02271984|874251|P5|STARTED|Fifth Intervention Period (1 Day)||3
355537|NCT02271984|874252|P4|STARTED|Fifth Intervention Period (1 Day)||3
355538|NCT02271984|874253|P3|STARTED|Fifth Intervention Period (1 Day)||3
355539|NCT02271984|874254|P2|STARTED|Fifth Intervention Period (1 Day)||3
355540|NCT02271984|874255|P1|STARTED|Fifth Intervention Period (1 Day)||3
355541|NCT02271984|874244|P12|NOT COMPLETED|Washout Period 4 (7 Days)||0
355542|NCT02271984|874245|P11|NOT COMPLETED|Washout Period 4 (7 Days)||0
355543|NCT02271984|874246|P10|NOT COMPLETED|Washout Period 4 (7 Days)||0
355544|NCT02271984|874247|P9|NOT COMPLETED|Washout Period 4 (7 Days)||0
355545|NCT02271984|874248|P8|NOT COMPLETED|Washout Period 4 (7 Days)||1
355546|NCT02271984|874249|P7|NOT COMPLETED|Washout Period 4 (7 Days)||0
355547|NCT02271984|874250|P6|NOT COMPLETED|Washout Period 4 (7 Days)||1
355548|NCT02271984|874251|P5|NOT COMPLETED|Washout Period 4 (7 Days)||0
355549|NCT02271984|874252|P4|NOT COMPLETED|Washout Period 4 (7 Days)||0
355550|NCT02271984|874253|P3|NOT COMPLETED|Washout Period 4 (7 Days)||0
355551|NCT02271984|874254|P2|NOT COMPLETED|Washout Period 4 (7 Days)||0
355552|NCT02271984|874255|P1|NOT COMPLETED|Washout Period 4 (7 Days)||0
355553|NCT02271984|874244|P12|COMPLETED|Washout Period 4 (7 Days)||3
355554|NCT02271984|874245|P11|COMPLETED|Washout Period 4 (7 Days)||3
355555|NCT02271984|874246|P10|COMPLETED|Washout Period 4 (7 Days)||3
355556|NCT02271984|874247|P9|COMPLETED|Washout Period 4 (7 Days)||3
355557|NCT02271984|874248|P8|COMPLETED|Washout Period 4 (7 Days)||2
355558|NCT02271984|874249|P7|COMPLETED|Washout Period 4 (7 Days)||3
355559|NCT02271984|874250|P6|COMPLETED|Washout Period 4 (7 Days)||2
355560|NCT02271984|874251|P5|COMPLETED|Washout Period 4 (7 Days)||3
355561|NCT02271984|874252|P4|COMPLETED|Washout Period 4 (7 Days)||3
355562|NCT02271984|874253|P3|COMPLETED|Washout Period 4 (7 Days)||3
355563|NCT02271984|874254|P2|COMPLETED|Washout Period 4 (7 Days)||3
355564|NCT02271984|874255|P1|COMPLETED|Washout Period 4 (7 Days)||3
355565|NCT02271984|874244|P12|STARTED|Washout Period 4 (7 Days)||3
355566|NCT02271984|874245|P11|STARTED|Washout Period 4 (7 Days)||3
355567|NCT02271984|874246|P10|STARTED|Washout Period 4 (7 Days)||3
355568|NCT02271984|874247|P9|STARTED|Washout Period 4 (7 Days)||3
355569|NCT02271984|874248|P8|STARTED|Washout Period 4 (7 Days)||3
355570|NCT02271984|874249|P7|STARTED|Washout Period 4 (7 Days)||3
355571|NCT02271984|874250|P6|STARTED|Washout Period 4 (7 Days)||3
355572|NCT02271984|874251|P5|STARTED|Washout Period 4 (7 Days)||3
355573|NCT02271984|874252|P4|STARTED|Washout Period 4 (7 Days)||3
355574|NCT02271984|874253|P3|STARTED|Washout Period 4 (7 Days)||3
355575|NCT02271984|874254|P2|STARTED|Washout Period 4 (7 Days)||3
355576|NCT02271984|874255|P1|STARTED|Washout Period 4 (7 Days)||3
355577|NCT02271984|874244|P12|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
355578|NCT02271984|874245|P11|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
355579|NCT02271984|874246|P10|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
355580|NCT02271984|874247|P9|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
355581|NCT02271984|874248|P8|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
355582|NCT02271984|874249|P7|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
355583|NCT02271984|874250|P6|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
355584|NCT02271984|874251|P5|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
355585|NCT02271984|874252|P4|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
355586|NCT02271984|874253|P3|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
355587|NCT02271984|874254|P2|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
355588|NCT02271984|874255|P1|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
355589|NCT02271984|874244|P12|COMPLETED|Fourth Intervention Period (Day 1)||3
355590|NCT02271984|874245|P11|COMPLETED|Fourth Intervention Period (Day 1)||3
355591|NCT02271984|874246|P10|COMPLETED|Fourth Intervention Period (Day 1)||3
355592|NCT02271984|874247|P9|COMPLETED|Fourth Intervention Period (Day 1)||3
355593|NCT02271984|874248|P8|COMPLETED|Fourth Intervention Period (Day 1)||3
355594|NCT02271984|874249|P7|COMPLETED|Fourth Intervention Period (Day 1)||3
355595|NCT02271984|874250|P6|COMPLETED|Fourth Intervention Period (Day 1)||3
355596|NCT02271984|874251|P5|COMPLETED|Fourth Intervention Period (Day 1)||3
355597|NCT02271984|874252|P4|COMPLETED|Fourth Intervention Period (Day 1)||3
355598|NCT02271984|874253|P3|COMPLETED|Fourth Intervention Period (Day 1)||3
355599|NCT02271984|874254|P2|COMPLETED|Fourth Intervention Period (Day 1)||3
355600|NCT02271984|874255|P1|COMPLETED|Fourth Intervention Period (Day 1)||3
355601|NCT02271984|874244|P12|STARTED|Fourth Intervention Period (Day 1)||3
355602|NCT02271984|874245|P11|STARTED|Fourth Intervention Period (Day 1)||3
355603|NCT02271984|874246|P10|STARTED|Fourth Intervention Period (Day 1)||3
355604|NCT02271984|874247|P9|STARTED|Fourth Intervention Period (Day 1)||3
355605|NCT02271984|874248|P8|STARTED|Fourth Intervention Period (Day 1)||3
355606|NCT02271984|874249|P7|STARTED|Fourth Intervention Period (Day 1)||3
355607|NCT02271984|874250|P6|STARTED|Fourth Intervention Period (Day 1)||3
355608|NCT02271984|874251|P5|STARTED|Fourth Intervention Period (Day 1)||3
355609|NCT02271984|874252|P4|STARTED|Fourth Intervention Period (Day 1)||3
355610|NCT02271984|874253|P3|STARTED|Fourth Intervention Period (Day 1)||3
355611|NCT02271984|874254|P2|STARTED|Fourth Intervention Period (Day 1)||3
355612|NCT02271984|874255|P1|STARTED|Fourth Intervention Period (Day 1)||3
355613|NCT02271984|874244|P12|NOT COMPLETED|Washout Period 3 (7 Days)||0
355614|NCT02271984|874245|P11|NOT COMPLETED|Washout Period 3 (7 Days)||0
355615|NCT02271984|874246|P10|NOT COMPLETED|Washout Period 3 (7 Days)||0
355616|NCT02271984|874247|P9|NOT COMPLETED|Washout Period 3 (7 Days)||0
355617|NCT02271984|874248|P8|NOT COMPLETED|Washout Period 3 (7 Days)||0
355618|NCT02271984|874249|P7|NOT COMPLETED|Washout Period 3 (7 Days)||0
355619|NCT02271984|874250|P6|NOT COMPLETED|Washout Period 3 (7 Days)||0
355620|NCT02271984|874251|P5|NOT COMPLETED|Washout Period 3 (7 Days)||0
355621|NCT02271984|874252|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
355622|NCT02271984|874253|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
355623|NCT02271984|874254|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
355624|NCT02271984|874255|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
355625|NCT02271984|874244|P12|COMPLETED|Washout Period 3 (7 Days)||3
355626|NCT02271984|874245|P11|COMPLETED|Washout Period 3 (7 Days)||3
355627|NCT02271984|874246|P10|COMPLETED|Washout Period 3 (7 Days)||3
355628|NCT02271984|874247|P9|COMPLETED|Washout Period 3 (7 Days)||3
355629|NCT02271984|874248|P8|COMPLETED|Washout Period 3 (7 Days)||3
355630|NCT02271984|874249|P7|COMPLETED|Washout Period 3 (7 Days)||3
355631|NCT02271984|874250|P6|COMPLETED|Washout Period 3 (7 Days)||3
355632|NCT02271984|874251|P5|COMPLETED|Washout Period 3 (7 Days)||3
355633|NCT02271984|874252|P4|COMPLETED|Washout Period 3 (7 Days)||3
355634|NCT02271984|874253|P3|COMPLETED|Washout Period 3 (7 Days)||3
355635|NCT02271984|874254|P2|COMPLETED|Washout Period 3 (7 Days)||3
355636|NCT02271984|874255|P1|COMPLETED|Washout Period 3 (7 Days)||3
355637|NCT02271984|874244|P12|STARTED|Washout Period 3 (7 Days)||3
355638|NCT02271984|874245|P11|STARTED|Washout Period 3 (7 Days)||3
355639|NCT02271984|874246|P10|STARTED|Washout Period 3 (7 Days)||3
355640|NCT02271984|874247|P9|STARTED|Washout Period 3 (7 Days)||3
355641|NCT02271984|874248|P8|STARTED|Washout Period 3 (7 Days)||3
355642|NCT02271984|874249|P7|STARTED|Washout Period 3 (7 Days)||3
355643|NCT02271984|874250|P6|STARTED|Washout Period 3 (7 Days)||3
355644|NCT02271984|874251|P5|STARTED|Washout Period 3 (7 Days)||3
355645|NCT02271984|874252|P4|STARTED|Washout Period 3 (7 Days)||3
355646|NCT02271984|874253|P3|STARTED|Washout Period 3 (7 Days)||3
355647|NCT02271984|874254|P2|STARTED|Washout Period 3 (7 Days)||3
355648|NCT02271984|874255|P1|STARTED|Washout Period 3 (7 Days)||3
355649|NCT02271984|874244|P12|NOT COMPLETED|Third Intervention Period (1 Day)||0
355650|NCT02271984|874245|P11|NOT COMPLETED|Third Intervention Period (1 Day)||0
355651|NCT02271984|874246|P10|NOT COMPLETED|Third Intervention Period (1 Day)||0
355652|NCT02271984|874247|P9|NOT COMPLETED|Third Intervention Period (1 Day)||0
355653|NCT02271984|874248|P8|NOT COMPLETED|Third Intervention Period (1 Day)||0
355654|NCT02271984|874249|P7|NOT COMPLETED|Third Intervention Period (1 Day)||0
355655|NCT02271984|874250|P6|NOT COMPLETED|Third Intervention Period (1 Day)||0
355656|NCT02271984|874251|P5|NOT COMPLETED|Third Intervention Period (1 Day)||0
355657|NCT02271984|874252|P4|NOT COMPLETED|Third Intervention Period (1 Day)||0
355658|NCT02271984|874253|P3|NOT COMPLETED|Third Intervention Period (1 Day)||0
355659|NCT02271984|874254|P2|NOT COMPLETED|Third Intervention Period (1 Day)||0
355660|NCT02271984|874255|P1|NOT COMPLETED|Third Intervention Period (1 Day)||0
355661|NCT02271984|874244|P12|COMPLETED|Third Intervention Period (1 Day)||3
355662|NCT02271984|874245|P11|COMPLETED|Third Intervention Period (1 Day)||3
355663|NCT02271984|874246|P10|COMPLETED|Third Intervention Period (1 Day)||3
355664|NCT02271984|874247|P9|COMPLETED|Third Intervention Period (1 Day)||3
355665|NCT02271984|874248|P8|COMPLETED|Third Intervention Period (1 Day)||3
355666|NCT02271984|874249|P7|COMPLETED|Third Intervention Period (1 Day)||3
355667|NCT02271984|874250|P6|COMPLETED|Third Intervention Period (1 Day)||3
355668|NCT02271984|874251|P5|COMPLETED|Third Intervention Period (1 Day)||3
355669|NCT02271984|874252|P4|COMPLETED|Third Intervention Period (1 Day)||3
355670|NCT02271984|874253|P3|COMPLETED|Third Intervention Period (1 Day)||3
355671|NCT02271984|874254|P2|COMPLETED|Third Intervention Period (1 Day)||3
355672|NCT02271984|874255|P1|COMPLETED|Third Intervention Period (1 Day)||3
355673|NCT02271984|874244|P12|STARTED|Third Intervention Period (1 Day)||3
355674|NCT02271984|874245|P11|STARTED|Third Intervention Period (1 Day)||3
355675|NCT02271984|874246|P10|STARTED|Third Intervention Period (1 Day)||3
355676|NCT02271984|874247|P9|STARTED|Third Intervention Period (1 Day)||3
355677|NCT02271984|874248|P8|STARTED|Third Intervention Period (1 Day)||3
355678|NCT02271984|874249|P7|STARTED|Third Intervention Period (1 Day)||3
355679|NCT02271984|874250|P6|STARTED|Third Intervention Period (1 Day)||3
355680|NCT02271984|874251|P5|STARTED|Third Intervention Period (1 Day)||3
355681|NCT02271984|874252|P4|STARTED|Third Intervention Period (1 Day)||3
355682|NCT02271984|874253|P3|STARTED|Third Intervention Period (1 Day)||3
355683|NCT02271984|874254|P2|STARTED|Third Intervention Period (1 Day)||3
355684|NCT02271984|874255|P1|STARTED|Third Intervention Period (1 Day)||3
355685|NCT02271984|874244|P12|NOT COMPLETED|Washout Period 2 (7 Days)||0
355686|NCT02271984|874245|P11|NOT COMPLETED|Washout Period 2 (7 Days)||0
355687|NCT02271984|874246|P10|NOT COMPLETED|Washout Period 2 (7 Days)||0
355688|NCT02271984|874247|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
355689|NCT02271984|874248|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
355690|NCT02271984|874249|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
355691|NCT02271984|874250|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
355692|NCT02271984|874251|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
355693|NCT02271984|874252|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
355694|NCT02271984|874253|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
355695|NCT02271984|874254|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
355696|NCT02271984|874255|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
355697|NCT02271984|874244|P12|COMPLETED|Washout Period 2 (7 Days)||3
355698|NCT02271984|874245|P11|COMPLETED|Washout Period 2 (7 Days)||3
355699|NCT02271984|874246|P10|COMPLETED|Washout Period 2 (7 Days)||3
355700|NCT02271984|874247|P9|COMPLETED|Washout Period 2 (7 Days)||3
355701|NCT02271984|874248|P8|COMPLETED|Washout Period 2 (7 Days)||3
355702|NCT02271984|874249|P7|COMPLETED|Washout Period 2 (7 Days)||3
355703|NCT02271984|874250|P6|COMPLETED|Washout Period 2 (7 Days)||3
355704|NCT02271984|874251|P5|COMPLETED|Washout Period 2 (7 Days)||3
355705|NCT02271984|874252|P4|COMPLETED|Washout Period 2 (7 Days)||3
355706|NCT02271984|874253|P3|COMPLETED|Washout Period 2 (7 Days)||3
355707|NCT02271984|874254|P2|COMPLETED|Washout Period 2 (7 Days)||3
355708|NCT02271984|874255|P1|COMPLETED|Washout Period 2 (7 Days)||3
355709|NCT02271984|874244|P12|STARTED|Washout Period 2 (7 Days)||3
355710|NCT02271984|874245|P11|STARTED|Washout Period 2 (7 Days)||3
355711|NCT02271984|874246|P10|STARTED|Washout Period 2 (7 Days)||3
355712|NCT02271984|874247|P9|STARTED|Washout Period 2 (7 Days)||3
355713|NCT02271984|874248|P8|STARTED|Washout Period 2 (7 Days)||3
355714|NCT02271984|874249|P7|STARTED|Washout Period 2 (7 Days)||3
355715|NCT02271984|874250|P6|STARTED|Washout Period 2 (7 Days)||3
355716|NCT02271984|874251|P5|STARTED|Washout Period 2 (7 Days)||3
355717|NCT02271984|874252|P4|STARTED|Washout Period 2 (7 Days)||3
355718|NCT02271984|874253|P3|STARTED|Washout Period 2 (7 Days)||3
355719|NCT02271984|874254|P2|STARTED|Washout Period 2 (7 Days)||3
355720|NCT02271984|874255|P1|STARTED|Washout Period 2 (7 Days)||3
355721|NCT02271984|874244|P12|NOT COMPLETED|Second Intervention Period (1 Day)||0
355722|NCT02271984|874245|P11|NOT COMPLETED|Second Intervention Period (1 Day)||0
355723|NCT02271984|874246|P10|NOT COMPLETED|Second Intervention Period (1 Day)||0
355724|NCT02271984|874247|P9|NOT COMPLETED|Second Intervention Period (1 Day)||0
355725|NCT02271984|874248|P8|NOT COMPLETED|Second Intervention Period (1 Day)||0
355726|NCT02271984|874249|P7|NOT COMPLETED|Second Intervention Period (1 Day)||0
355727|NCT02271984|874250|P6|NOT COMPLETED|Second Intervention Period (1 Day)||0
355728|NCT02271984|874251|P5|NOT COMPLETED|Second Intervention Period (1 Day)||0
355729|NCT02271984|874252|P4|NOT COMPLETED|Second Intervention Period (1 Day)||0
355730|NCT02271984|874253|P3|NOT COMPLETED|Second Intervention Period (1 Day)||0
355731|NCT02271984|874254|P2|NOT COMPLETED|Second Intervention Period (1 Day)||0
355732|NCT02271984|874255|P1|NOT COMPLETED|Second Intervention Period (1 Day)||0
355733|NCT02271984|874244|P12|COMPLETED|Second Intervention Period (1 Day)||3
355734|NCT02271984|874245|P11|COMPLETED|Second Intervention Period (1 Day)||3
355735|NCT02271984|874246|P10|COMPLETED|Second Intervention Period (1 Day)||3
355736|NCT02271984|874247|P9|COMPLETED|Second Intervention Period (1 Day)||3
355737|NCT02271984|874248|P8|COMPLETED|Second Intervention Period (1 Day)||3
355738|NCT02271984|874249|P7|COMPLETED|Second Intervention Period (1 Day)||3
355739|NCT02271984|874250|P6|COMPLETED|Second Intervention Period (1 Day)||3
355740|NCT02271984|874251|P5|COMPLETED|Second Intervention Period (1 Day)||3
355741|NCT02271984|874252|P4|COMPLETED|Second Intervention Period (1 Day)||3
355742|NCT02271984|874253|P3|COMPLETED|Second Intervention Period (1 Day)||3
355743|NCT02271984|874254|P2|COMPLETED|Second Intervention Period (1 Day)||3
355744|NCT02271984|874255|P1|COMPLETED|Second Intervention Period (1 Day)||3
355745|NCT02271984|874244|P12|STARTED|Second Intervention Period (1 Day)||3
355746|NCT02271984|874245|P11|STARTED|Second Intervention Period (1 Day)||3
355747|NCT02271984|874246|P10|STARTED|Second Intervention Period (1 Day)||3
355748|NCT02271984|874247|P9|STARTED|Second Intervention Period (1 Day)||3
355749|NCT02271984|874248|P8|STARTED|Second Intervention Period (1 Day)||3
355750|NCT02271984|874249|P7|STARTED|Second Intervention Period (1 Day)||3
355751|NCT02271984|874250|P6|STARTED|Second Intervention Period (1 Day)||3
355752|NCT02271984|874251|P5|STARTED|Second Intervention Period (1 Day)||3
355753|NCT02271984|874252|P4|STARTED|Second Intervention Period (1 Day)||3
355754|NCT02271984|874253|P3|STARTED|Second Intervention Period (1 Day)||3
355755|NCT02271984|874254|P2|STARTED|Second Intervention Period (1 Day)||3
355756|NCT02271984|874255|P1|STARTED|Second Intervention Period (1 Day)||3
355757|NCT02271984|874244|P12|NOT COMPLETED|Washout Period 1 (7 Days)||0
355758|NCT02271984|874245|P11|NOT COMPLETED|Washout Period 1 (7 Days)||0
355759|NCT02271984|874246|P10|NOT COMPLETED|Washout Period 1 (7 Days)||0
355760|NCT02271984|874247|P9|NOT COMPLETED|Washout Period 1 (7 Days)||0
355761|NCT02271984|874248|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
355762|NCT02271984|874249|P7|NOT COMPLETED|Washout Period 1 (7 Days)||0
355763|NCT02271984|874250|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
355764|NCT02271984|874251|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
355765|NCT02271984|874252|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
355766|NCT02271984|874253|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
355767|NCT02271984|874254|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
355768|NCT02271984|874255|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
355769|NCT02271984|874244|P12|COMPLETED|Washout Period 1 (7 Days)||3
355770|NCT02271984|874245|P11|COMPLETED|Washout Period 1 (7 Days)||3
355771|NCT02271984|874246|P10|COMPLETED|Washout Period 1 (7 Days)||3
355772|NCT02271984|874247|P9|COMPLETED|Washout Period 1 (7 Days)||3
355773|NCT02271984|874248|P8|COMPLETED|Washout Period 1 (7 Days)||3
355774|NCT02271984|874249|P7|COMPLETED|Washout Period 1 (7 Days)||3
355775|NCT02271984|874250|P6|COMPLETED|Washout Period 1 (7 Days)||3
355776|NCT02271984|874251|P5|COMPLETED|Washout Period 1 (7 Days)||3
355777|NCT02271984|874252|P4|COMPLETED|Washout Period 1 (7 Days)||3
355778|NCT02271984|874253|P3|COMPLETED|Washout Period 1 (7 Days)||3
355779|NCT02271984|874254|P2|COMPLETED|Washout Period 1 (7 Days)||3
355780|NCT02271984|874255|P1|COMPLETED|Washout Period 1 (7 Days)||3
355781|NCT02271984|874244|P12|STARTED|Washout Period 1 (7 Days)||3
355782|NCT02271984|874245|P11|STARTED|Washout Period 1 (7 Days)||3
355783|NCT02271984|874246|P10|STARTED|Washout Period 1 (7 Days)||3
355784|NCT02271984|874247|P9|STARTED|Washout Period 1 (7 Days)||3
355785|NCT02271984|874248|P8|STARTED|Washout Period 1 (7 Days)||3
355786|NCT02271984|874249|P7|STARTED|Washout Period 1 (7 Days)||3
355787|NCT02271984|874250|P6|STARTED|Washout Period 1 (7 Days)||3
355788|NCT02271984|874251|P5|STARTED|Washout Period 1 (7 Days)||3
355789|NCT02271984|874252|P4|STARTED|Washout Period 1 (7 Days)||3
355790|NCT02271984|874253|P3|STARTED|Washout Period 1 (7 Days)||3
355791|NCT02271984|874254|P2|STARTED|Washout Period 1 (7 Days)||3
355792|NCT02271984|874255|P1|STARTED|Washout Period 1 (7 Days)||3
355793|NCT02271984|874244|P12|NOT COMPLETED|First Intervention Period (1 Day)||0
355794|NCT02271984|874245|P11|NOT COMPLETED|First Intervention Period (1 Day)||0
355795|NCT02271984|874246|P10|NOT COMPLETED|First Intervention Period (1 Day)||0
355796|NCT02271984|874247|P9|NOT COMPLETED|First Intervention Period (1 Day)||0
355797|NCT02271984|874248|P8|NOT COMPLETED|First Intervention Period (1 Day)||0
355798|NCT02271984|874249|P7|NOT COMPLETED|First Intervention Period (1 Day)||0
355799|NCT02271984|874250|P6|NOT COMPLETED|First Intervention Period (1 Day)||0
355800|NCT02271984|874251|P5|NOT COMPLETED|First Intervention Period (1 Day)||0
355801|NCT02271984|874252|P4|NOT COMPLETED|First Intervention Period (1 Day)||0
355802|NCT02271984|874253|P3|NOT COMPLETED|First Intervention Period (1 Day)||0
355803|NCT02271984|874254|P2|NOT COMPLETED|First Intervention Period (1 Day)||0
355804|NCT02271984|874255|P1|NOT COMPLETED|First Intervention Period (1 Day)||0
355805|NCT02271984|874244|P12|COMPLETED|First Intervention Period (1 Day)||3
355806|NCT02271984|874245|P11|COMPLETED|First Intervention Period (1 Day)||3
355807|NCT02271984|874246|P10|COMPLETED|First Intervention Period (1 Day)||3
355808|NCT02271984|874247|P9|COMPLETED|First Intervention Period (1 Day)||3
355809|NCT02271984|874248|P8|COMPLETED|First Intervention Period (1 Day)||3
355810|NCT02271984|874249|P7|COMPLETED|First Intervention Period (1 Day)||3
355811|NCT02271984|874250|P6|COMPLETED|First Intervention Period (1 Day)||3
355812|NCT02271984|874251|P5|COMPLETED|First Intervention Period (1 Day)||3
355813|NCT02271984|874252|P4|COMPLETED|First Intervention Period (1 Day)||3
355814|NCT02271984|874253|P3|COMPLETED|First Intervention Period (1 Day)||3
355815|NCT02271984|874254|P2|COMPLETED|First Intervention Period (1 Day)||3
355816|NCT02271984|874255|P1|COMPLETED|First Intervention Period (1 Day)||3
355817|NCT02271984|874244|P12|STARTED|First Intervention Period (1 Day)||3
355818|NCT02271984|874245|P11|STARTED|First Intervention Period (1 Day)||3
355819|NCT02271984|874246|P10|STARTED|First Intervention Period (1 Day)||3
355820|NCT02271984|874247|P9|STARTED|First Intervention Period (1 Day)||3
355821|NCT02271984|874248|P8|STARTED|First Intervention Period (1 Day)||3
355822|NCT02271984|874249|P7|STARTED|First Intervention Period (1 Day)||3
355823|NCT02271984|874250|P6|STARTED|First Intervention Period (1 Day)||3
355824|NCT02271984|874251|P5|STARTED|First Intervention Period (1 Day)||3
355825|NCT02271984|874252|P4|STARTED|First Intervention Period (1 Day)||3
355826|NCT02271984|874253|P3|STARTED|First Intervention Period (1 Day)||3
355827|NCT02271984|874254|P2|STARTED|First Intervention Period (1 Day)||3
355828|NCT02271984|874255|P1|STARTED|First Intervention Period (1 Day)||3
355829|NCT02271945|874344|P2|NOT COMPLETED|Overall Study||5
355830|NCT02271945|874345|P1|NOT COMPLETED|Overall Study||5
355831|NCT02271945|874344|P2|COMPLETED|Overall Study||0
355832|NCT02271945|874345|P1|COMPLETED|Overall Study||0
355833|NCT02271945|874344|P2|STARTED|Overall Study||5
355834|NCT02271945|874345|P1|STARTED|Overall Study||5
355835|NCT02271880|874383|P2|NOT COMPLETED|Overall Study||4
355836|NCT02271880|874384|P1|NOT COMPLETED|Overall Study||3
355837|NCT02271880|874383|P2|COMPLETED|Overall Study||0
355838|NCT02271880|874384|P1|COMPLETED|Overall Study||0
355839|NCT02271880|874383|P2|STARTED|Overall Study||4
355840|NCT02271880|874384|P1|STARTED|Overall Study||3
355841|NCT02271854|874390|P1|NOT COMPLETED|Overall Study||4
355842|NCT02271854|874390|P1|COMPLETED|Overall Study||98
355843|NCT02271854|874390|P1|STARTED|Overall Study||102
355844|NCT02271698|874401|P4|NOT COMPLETED|Overall Study||0
355845|NCT02271698|874402|P3|NOT COMPLETED|Overall Study||0
355846|NCT02271698|874403|P2|NOT COMPLETED|Overall Study||0
355847|NCT02271698|874404|P1|NOT COMPLETED|Overall Study||0
355848|NCT02271698|874401|P4|COMPLETED|Overall Study||11
355849|NCT02271698|874402|P3|COMPLETED|Overall Study||10
355850|NCT02271698|874403|P2|COMPLETED|Overall Study||10
355851|NCT02271698|874404|P1|COMPLETED|Overall Study||11
355852|NCT02271698|874401|P4|STARTED|Overall Study||11
355853|NCT02271698|874402|P3|STARTED|Overall Study||10
355854|NCT02271698|874403|P2|STARTED|Overall Study||10
355855|NCT02271698|874404|P1|STARTED|Overall Study||11
355856|NCT02271529|874430|P1|NOT COMPLETED|Overall Study||1
355857|NCT02271529|874430|P1|COMPLETED|Overall Study||39
355858|NCT02271529|874430|P1|STARTED|Overall Study||40
355859|NCT02271477|874436|P2|NOT COMPLETED|Overall Study||0
355860|NCT02271477|874437|P1|NOT COMPLETED|Overall Study||0
355861|NCT02271477|874436|P2|COMPLETED|Overall Study||80
355862|NCT02271477|874437|P1|COMPLETED|Overall Study||80
355863|NCT02271477|874436|P2|STARTED|Overall Study||80
355864|NCT02271477|874437|P1|STARTED|Overall Study||80
355865|NCT02271217|874452|P3|NOT COMPLETED|Overall Study||12
355866|NCT02271217|874453|P2|NOT COMPLETED|Overall Study||13
355867|NCT02271217|874454|P1|NOT COMPLETED|Overall Study||11
355868|NCT02271217|874452|P3|COMPLETED|Overall Study||113
355869|NCT02271217|874453|P2|COMPLETED|Overall Study||113
355870|NCT02271217|874454|P1|COMPLETED|Overall Study||115
355871|NCT02271217|874452|P3|STARTED|Overall Study||125
355872|NCT02271217|874453|P2|STARTED|Overall Study||126
355873|NCT02271217|874454|P1|STARTED|Overall Study||126
355874|NCT02270944|874467|P2|NOT COMPLETED|Overall Study||5
355875|NCT02270944|874468|P1|NOT COMPLETED|Overall Study||11
355876|NCT02270944|874467|P2|COMPLETED|Overall Study||516
355877|NCT02270944|874468|P1|COMPLETED|Overall Study||518
355878|NCT02270944|874467|P2|STARTED|Overall Study||521
355879|NCT02270944|874468|P1|STARTED|Overall Study||529
355880|NCT02270684|874484|P2|NOT COMPLETED|Overall Study||3
355881|NCT02270684|874485|P1|NOT COMPLETED|Overall Study||1
355882|NCT02270684|874484|P2|COMPLETED|Overall Study||0
355883|NCT02270684|874485|P1|COMPLETED|Overall Study||0
355884|NCT02270684|874484|P2|STARTED|Overall Study||3
355885|NCT02270684|874485|P1|STARTED|Overall Study||1
355886|NCT02270515|874491|P1|NOT COMPLETED|Intervention Period 3: 12-18 Months||24
355887|NCT02270515|874491|P1|COMPLETED|Intervention Period 3: 12-18 Months||103
355888|NCT02270515|874491|P1|STARTED|Intervention Period 3: 12-18 Months||127
355889|NCT02270515|874491|P1|NOT COMPLETED|Intervention Period 2: 6-12 Months||32
355890|NCT02270515|874491|P1|COMPLETED|Intervention Period 2: 6-12 Months||127
355891|NCT02270515|874491|P1|STARTED|Intervention Period 2: 6-12 Months||159
355892|NCT02270515|874491|P1|NOT COMPLETED|Intervention Period 1: 0-6 Months||16
355893|NCT02270515|874491|P1|COMPLETED|Intervention Period 1: 0-6 Months||159
355894|NCT02270515|874491|P1|STARTED|Intervention Period 1: 0-6 Months||175
355895|NCT02269943|874508|P2|NOT COMPLETED|Follow-Up Survival Period||26
355896|NCT02269943|874509|P1|NOT COMPLETED|Follow-Up Survival Period||5
355897|NCT02269943|874508|P2|COMPLETED|Follow-Up Survival Period|Not applicable according to the study design.|0
355898|NCT02269943|874509|P1|COMPLETED|Follow-Up Survival Period|Not applicable according to the study design.|0
355899|NCT02269943|874508|P2|STARTED|Follow-Up Survival Period||26
355900|NCT02269943|874509|P1|STARTED|Follow-Up Survival Period||5
355901|NCT02269943|874508|P2|NOT COMPLETED|Treatment Period||30
355902|NCT02269943|874509|P1|NOT COMPLETED|Treatment Period||6
355903|NCT02269943|874508|P2|COMPLETED|Treatment Period|Not applicable according to the study design|0
355904|NCT02269943|874509|P1|COMPLETED|Treatment Period|Not applicable according to the study design|0
355905|NCT02269943|874508|P2|Investigational Product (IP) Stopped|Treatment Period||30
355906|NCT02269943|874509|P1|Investigational Product (IP) Stopped|Treatment Period||6
355907|NCT02269943|874508|P2|STARTED|Treatment Period||30
355908|NCT02269943|874509|P1|STARTED|Treatment Period||6
355909|NCT02269709|874537|P1|NOT COMPLETED|Six Month Follow-up||12
355910|NCT02269709|874537|P1|COMPLETED|Six Month Follow-up||5
355911|NCT02269709|874537|P1|STARTED|Six Month Follow-up||17
355912|NCT02269709|874537|P1|NOT COMPLETED|Prior to Hospital Discharge||0
355913|NCT02269709|874537|P1|COMPLETED|Prior to Hospital Discharge||17
355914|NCT02269709|874537|P1|STARTED|Prior to Hospital Discharge||17
355915|NCT02269709|874537|P1|NOT COMPLETED|Follow-up #1 (24-72 Hours Post-surgery)||1
355916|NCT02269709|874537|P1|COMPLETED|Follow-up #1 (24-72 Hours Post-surgery)||17
355917|NCT02269709|874537|P1|STARTED|Follow-up #1 (24-72 Hours Post-surgery)||18
355918|NCT02269709|874537|P1|NOT COMPLETED|Time of Enrollment||3
355919|NCT02269709|874537|P1|COMPLETED|Time of Enrollment||18
355920|NCT02269709|874537|P1|STARTED|Time of Enrollment||21
355921|NCT02269657|874542|P1|NOT COMPLETED|Overall Study||3
355922|NCT02269657|874542|P1|COMPLETED|Overall Study||37
355923|NCT02269657|874542|P1|STARTED|Overall Study||40
355924|NCT02269488|874556|P1|NOT COMPLETED|Overall Study||0
355925|NCT02269488|874556|P1|COMPLETED|Overall Study||100
355926|NCT02269488|874556|P1|STARTED|Overall Study||100
355927|NCT02269475|874562|P2|NOT COMPLETED|Overall Study||1
355928|NCT02269475|874563|P1|NOT COMPLETED|Overall Study||3
355929|NCT02269475|874562|P2|COMPLETED|Overall Study||432
355930|NCT02269475|874563|P1|COMPLETED|Overall Study||865
355931|NCT02269475|874562|P2|Per Protocol Population|Overall Study||430
355932|NCT02269475|874563|P1|Per Protocol Population|Overall Study||849
355933|NCT02269475|874562|P2|Received IP (Safety Population)|Overall Study||433
355934|NCT02269475|874563|P1|Received IP (Safety Population)|Overall Study||868
355935|NCT02269475|874562|P2|STARTED|Overall Study||433
355936|NCT02269475|874563|P1|STARTED|Overall Study||868
355937|NCT02269098|874576|P2|NOT COMPLETED|Overall Study||9
355938|NCT02269098|874577|P1|NOT COMPLETED|Overall Study||14
355939|NCT02269098|874576|P2|COMPLETED|Overall Study||41
355940|NCT02269098|874577|P1|COMPLETED|Overall Study||37
355941|NCT02269098|874576|P2|STARTED|Overall Study||50
355942|NCT02269098|874577|P1|STARTED|Overall Study||51
355943|NCT02268994|874593|P2|NOT COMPLETED|Overall Study||35
355944|NCT02268994|874594|P1|NOT COMPLETED|Overall Study||31
355945|NCT02268994|874593|P2|COMPLETED|Overall Study||81
355946|NCT02268994|874594|P1|COMPLETED|Overall Study||86
355947|NCT02268994|874593|P2|STARTED|Overall Study||116
355948|NCT02268994|874594|P1|STARTED|Overall Study||117
355949|NCT02268877|874612|P2|NOT COMPLETED|Overall Study||5
355950|NCT02268877|874613|P1|NOT COMPLETED|Overall Study||4
355951|NCT02268877|874612|P2|COMPLETED|Overall Study|106 patients received the intervention.|106
355952|NCT02268877|874613|P1|COMPLETED|Overall Study||118
355953|NCT02268877|874612|P2|STARTED|Overall Study|111 patients were randomized to this arm.|111
355954|NCT02268877|874613|P1|STARTED|Overall Study||122
355955|NCT02268864|874624|P3|NOT COMPLETED|Overall Study||0
355956|NCT02268864|874625|P2|NOT COMPLETED|Overall Study||1
355957|NCT02268864|874626|P1|NOT COMPLETED|Overall Study||2
355958|NCT02268864|874624|P3|COMPLETED|Overall Study||64
355959|NCT02268864|874625|P2|COMPLETED|Overall Study||24
355960|NCT02268864|874626|P1|COMPLETED|Overall Study||15
355961|NCT02268864|874624|P3|STARTED|Overall Study||64
355962|NCT02268864|874625|P2|STARTED|Overall Study||25
355963|NCT02268864|874626|P1|STARTED|Overall Study||17
355964|NCT02268526|874651|P3|NOT COMPLETED|Overall Study||5
355965|NCT02268526|874652|P2|NOT COMPLETED|Overall Study||21
355966|NCT02268526|874653|P1|NOT COMPLETED|Overall Study||1
355967|NCT02268526|874651|P3|COMPLETED|Overall Study||16
355968|NCT02268526|874652|P2|COMPLETED|Overall Study||38
355969|NCT02268526|874653|P1|COMPLETED|Overall Study||5
355970|NCT02268526|874651|P3|PD Analysis Set (Cohort 2)|Overall Study||17
355971|NCT02268526|874652|P2|PD Analysis Set (Cohort 2)|Overall Study||42
355972|NCT02268526|874653|P1|PD Analysis Set (Cohort 2)|Overall Study||0
355973|NCT02268526|874651|P3|STARTED|Overall Study||21
355974|NCT02268526|874652|P2|STARTED|Overall Study||59
355975|NCT02268526|874653|P1|STARTED|Overall Study||6
355976|NCT02268396|874674|P1|NOT COMPLETED|Overall Study||12
355977|NCT02268396|874674|P1|COMPLETED|Overall Study||126
355978|NCT02268396|874674|P1|STARTED|Overall Study||138
355979|NCT02268214|874686|P3|NOT COMPLETED|Overall Study||28
355980|NCT02268214|874687|P2|NOT COMPLETED|Overall Study||23
355981|NCT02268214|874688|P1|NOT COMPLETED|Overall Study||24
355982|NCT02268214|874686|P3|COMPLETED|Overall Study||232
355983|NCT02268214|874687|P2|COMPLETED|Overall Study||273
355984|NCT02268214|874688|P1|COMPLETED|Overall Study||253
355985|NCT02268214|874686|P3|STARTED|Overall Study||260
355986|NCT02268214|874687|P2|STARTED|Overall Study||296
355987|NCT02268214|874688|P1|STARTED|Overall Study||277
355988|NCT02268058|874718|P4|NOT COMPLETED|Overall Study||0
355989|NCT02268058|874719|P3|NOT COMPLETED|Overall Study||0
355990|NCT02268058|874720|P2|NOT COMPLETED|Overall Study||0
355991|NCT02268058|874721|P1|NOT COMPLETED|Overall Study||1
355992|NCT02268058|874718|P4|COMPLETED|Overall Study||20
355993|NCT02268058|874719|P3|COMPLETED|Overall Study||20
355994|NCT02268058|874720|P2|COMPLETED|Overall Study||20
355995|NCT02268058|874721|P1|COMPLETED|Overall Study||19
355996|NCT02268058|874718|P4|STARTED|Overall Study||20
355997|NCT02268058|874719|P3|STARTED|Overall Study||20
355998|NCT02268058|874720|P2|STARTED|Overall Study||20
355999|NCT02268058|874721|P1|STARTED|Overall Study||20
356000|NCT02267850|874745|P2|NOT COMPLETED|Overall Study||2
356001|NCT02267850|874746|P1|NOT COMPLETED|Overall Study||1
356002|NCT02267850|874745|P2|COMPLETED|Overall Study||12
356003|NCT02267850|874746|P1|COMPLETED|Overall Study||14
356004|NCT02267850|874745|P2|STARTED|Overall Study||14
356005|NCT02267850|874746|P1|STARTED|Overall Study||15
356006|NCT02267837|874754|P2|NOT COMPLETED|Overall Study||0
356007|NCT02267837|874755|P1|NOT COMPLETED|Overall Study||0
356008|NCT02267837|874754|P2|COMPLETED|Overall Study||9
356009|NCT02267837|874755|P1|COMPLETED|Overall Study||11
356010|NCT02267837|874754|P2|STARTED|Overall Study||9
356011|NCT02267837|874755|P1|STARTED|Overall Study||11
356012|NCT02267824|874763|P2|NOT COMPLETED|Overall Study||1
356013|NCT02267824|874764|P1|NOT COMPLETED|Overall Study||10
356014|NCT02267824|874763|P2|COMPLETED|Overall Study||17
356015|NCT02267824|874764|P1|COMPLETED|Overall Study||73
356016|NCT02267824|874763|P2|STARTED|Overall Study||18
356017|NCT02267824|874764|P1|STARTED|Overall Study||83
356018|NCT02267629|874770|P1|NOT COMPLETED|Overall Study||0
356019|NCT02267629|874770|P1|COMPLETED|Overall Study||7
356020|NCT02267629|874770|P1|STARTED|Overall Study||7
356021|NCT02267538|874777|P2|NOT COMPLETED|Overall Study||0
356022|NCT02267538|874778|P1|NOT COMPLETED|Overall Study||0
356023|NCT02267538|874777|P2|COMPLETED|Overall Study||143
356024|NCT02267538|874778|P1|COMPLETED|Overall Study||142
356025|NCT02267538|874777|P2|STARTED|Overall Study||143
356026|NCT02267538|874778|P1|STARTED|Overall Study||142
356027|NCT02267447|874798|P2|NOT COMPLETED|Overall Study||0
356028|NCT02267447|874799|P1|NOT COMPLETED|Overall Study||0
356029|NCT02267447|874798|P2|COMPLETED|Overall Study||26968
356030|NCT02267447|874799|P1|COMPLETED|Overall Study||77251
356031|NCT02267447|874798|P2|STARTED|Overall Study||26968
356032|NCT02267447|874799|P1|STARTED|Overall Study||77251
356033|NCT02267187|874807|P1|NOT COMPLETED|Overall Study||2
356034|NCT02267187|874807|P1|COMPLETED|Overall Study||10
356035|NCT02267187|874807|P1|STARTED|Overall Study||12
356036|NCT02267135|874815|P2|NOT COMPLETED|Period 2 (Randomized Set)||1
356037|NCT02267135|874816|P1|NOT COMPLETED|Period 2 (Randomized Set)||4
356038|NCT02267135|874815|P2|COMPLETED|Period 2 (Randomized Set)||46
356039|NCT02267135|874816|P1|COMPLETED|Period 2 (Randomized Set)||46
356040|NCT02267135|874815|P2|STARTED|Period 2 (Randomized Set)||47
356041|NCT02267135|874816|P1|STARTED|Period 2 (Randomized Set)||50
356042|NCT02267135|874815|P2|NOT COMPLETED|Period 1 (Randomized Set)||4
356043|NCT02267135|874816|P1|NOT COMPLETED|Period 1 (Randomized Set)||1
356044|NCT02267135|874815|P2|COMPLETED|Period 1 (Randomized Set)||47
356045|NCT02267135|874816|P1|COMPLETED|Period 1 (Randomized Set)||50
356046|NCT02267135|874815|P2|STARTED|Period 1 (Randomized Set)||51
356047|NCT02267135|874816|P1|STARTED|Period 1 (Randomized Set)||51
356048|NCT02267083|874847|P1|NOT COMPLETED|Overall Study||19
356049|NCT02267083|874847|P1|COMPLETED|Overall Study||3
356050|NCT02267083|874847|P1|STARTED|Overall Study||22
356051|NCT02266875|874856|P2|NOT COMPLETED|Overall Study||0
356052|NCT02266875|874857|P1|NOT COMPLETED|Overall Study||11
356053|NCT02266875|874856|P2|COMPLETED|Overall Study||30
356054|NCT02266875|874857|P1|COMPLETED|Overall Study||29
356055|NCT02266875|874856|P2|STARTED|Overall Study||30
356056|NCT02266875|874857|P1|STARTED|Overall Study||40
356057|NCT02266810|874869|P2|NOT COMPLETED|Overall Study||1
356058|NCT02266810|874870|P1|NOT COMPLETED|Overall Study||1
356059|NCT02266810|874869|P2|COMPLETED|Overall Study|sinus sides|79
356060|NCT02266810|874870|P1|COMPLETED|Overall Study|sinus sides|79
356061|NCT02266810|874869|P2|STARTED|Overall Study|sinus sides|80
356062|NCT02266810|874870|P1|STARTED|Overall Study|sinus sides|80
356063|NCT02266797|874896|P2|NOT COMPLETED|Overall Study||1
356064|NCT02266797|874897|P1|NOT COMPLETED|Overall Study||0
356065|NCT02266797|874896|P2|COMPLETED|Overall Study||2
356066|NCT02266797|874897|P1|COMPLETED|Overall Study||1
356067|NCT02266797|874896|P2|STARTED|Overall Study||3
356068|NCT02266797|874897|P1|STARTED|Overall Study||1
356069|NCT02266472|874915|P2|NOT COMPLETED|Period 2+ Washout||0
356070|NCT02266472|874916|P1|NOT COMPLETED|Period 2+ Washout||0
356071|NCT02266472|874915|P2|COMPLETED|Period 2+ Washout||15
356072|NCT02266472|874916|P1|COMPLETED|Period 2+ Washout||15
356073|NCT02266472|874915|P2|STARTED|Period 2+ Washout||15
356074|NCT02266472|874916|P1|STARTED|Period 2+ Washout||15
356075|NCT02266472|874915|P2|NOT COMPLETED|Period 1+ Washout||0
356076|NCT02266472|874916|P1|NOT COMPLETED|Period 1+ Washout||0
356077|NCT02266472|874915|P2|COMPLETED|Period 1+ Washout||15
356078|NCT02266472|874916|P1|COMPLETED|Period 1+ Washout||15
356079|NCT02266472|874915|P2|STARTED|Period 1+ Washout||15
356080|NCT02266472|874916|P1|STARTED|Period 1+ Washout||15
356081|NCT02266381|874935|P3|NOT COMPLETED|Overall Study||4
356082|NCT02266381|874936|P2|NOT COMPLETED|Overall Study||5
356083|NCT02266381|874937|P1|NOT COMPLETED|Overall Study||3
356084|NCT02266381|874935|P3|COMPLETED|Overall Study||146
356085|NCT02266381|874936|P2|COMPLETED|Overall Study||145
356086|NCT02266381|874937|P1|COMPLETED|Overall Study||147
356087|NCT02266381|874935|P3|STARTED|Overall Study||150
356088|NCT02266381|874936|P2|STARTED|Overall Study||150
356089|NCT02266381|874937|P1|STARTED|Overall Study||150
356090|NCT02266277|874960|P6|NOT COMPLETED|Overall Study||0
356091|NCT02266277|874961|P5|NOT COMPLETED|Overall Study||0
356092|NCT02266277|874962|P4|NOT COMPLETED|Overall Study||0
356093|NCT02266277|874963|P3|NOT COMPLETED|Overall Study||0
356094|NCT02266277|874964|P2|NOT COMPLETED|Overall Study||0
356095|NCT02266277|874965|P1|NOT COMPLETED|Overall Study||0
356096|NCT02266277|874960|P6|COMPLETED|Overall Study||5000
356097|NCT02266277|874961|P5|COMPLETED|Overall Study||5000
356098|NCT02266277|874962|P4|COMPLETED|Overall Study||5000
356099|NCT02266277|874963|P3|COMPLETED|Overall Study||5000
356100|NCT02266277|874964|P2|COMPLETED|Overall Study||5000
356101|NCT02266277|874965|P1|COMPLETED|Overall Study||5000
356102|NCT02266277|874960|P6|STARTED|Overall Study||5000
356103|NCT02266277|874961|P5|STARTED|Overall Study||5000
356104|NCT02266277|874962|P4|STARTED|Overall Study||5000
356105|NCT02266277|874963|P3|STARTED|Overall Study||5000
356106|NCT02266277|874964|P2|STARTED|Overall Study||5000
356107|NCT02266277|874965|P1|STARTED|Overall Study||5000
356108|NCT02265848|874989|P2|NOT COMPLETED|Overall Study||0
356109|NCT02265848|874990|P1|NOT COMPLETED|Overall Study||0
356110|NCT02265848|874989|P2|COMPLETED|Overall Study|Last subject for this study completed the visit on December 24, 2014|11
356111|NCT02265848|874990|P1|COMPLETED|Overall Study||11
356112|NCT02265848|874989|P2|STARTED|Overall Study||11
356113|NCT02265848|874990|P1|STARTED|Overall Study|First subject for this study was randomized on October 1st 2014|11
356114|NCT02265796|875004|P2|NOT COMPLETED|Overall Study||1
356115|NCT02265796|875005|P1|NOT COMPLETED|Overall Study||3
356116|NCT02265796|875004|P2|COMPLETED|Overall Study||24
356117|NCT02265796|875005|P1|COMPLETED|Overall Study||22
356118|NCT02265796|875004|P2|STARTED|Overall Study||25
356119|NCT02265796|875005|P1|STARTED|Overall Study||25
356120|NCT02265783|875015|P1|NOT COMPLETED|Overall Study||0
356121|NCT02265783|875015|P1|COMPLETED|Overall Study|All subjects completed, one excluded from the analysis due to an issue with the data collection|20
356122|NCT02265783|875015|P1|STARTED|Overall Study||20
356123|NCT02265237|875023|P4|NOT COMPLETED|As Treated (Overall Study)||1
356124|NCT02265237|875024|P3|NOT COMPLETED|As Treated (Overall Study)||10
356125|NCT02265237|875025|P2|NOT COMPLETED|As Treated (Overall Study)||3
356126|NCT02265237|875026|P1|NOT COMPLETED|As Treated (Overall Study)||5
356127|NCT02265237|875023|P4|COMPLETED|As Treated (Overall Study)||2
356128|NCT02265237|875024|P3|COMPLETED|As Treated (Overall Study)||51
356129|NCT02265237|875025|P2|COMPLETED|As Treated (Overall Study)||57
356130|NCT02265237|875026|P1|COMPLETED|As Treated (Overall Study)||55
356131|NCT02265237|875023|P4|STARTED|As Treated (Overall Study)||3
356132|NCT02265237|875024|P3|STARTED|As Treated (Overall Study)||61
356133|NCT02265237|875025|P2|STARTED|As Treated (Overall Study)|One arm B subject received the drug for the duration for arm A and was included in arm A for safety.|60
356134|NCT02265237|875026|P1|STARTED|As Treated (Overall Study)|One arm B subject received the drug for the duration for arm A and was included in arm A for safety.|60
356135|NCT02265237|875023|P4|NOT COMPLETED|As Enrolled (Overall Study)||1
356136|NCT02265237|875024|P3|NOT COMPLETED|As Enrolled (Overall Study)||10
356137|NCT02265237|875025|P2|NOT COMPLETED|As Enrolled (Overall Study)||3
356138|NCT02265237|875026|P1|NOT COMPLETED|As Enrolled (Overall Study)||5
356139|NCT02265237|875023|P4|COMPLETED|As Enrolled (Overall Study)||2
356140|NCT02265237|875024|P3|COMPLETED|As Enrolled (Overall Study)||51
356141|NCT02265237|875025|P2|COMPLETED|As Enrolled (Overall Study)||58
356142|NCT02265237|875026|P1|COMPLETED|As Enrolled (Overall Study)||54
356143|NCT02265237|875023|P4|STARTED|As Enrolled (Overall Study)||3
356144|NCT02265237|875024|P3|STARTED|As Enrolled (Overall Study)||61
356145|NCT02265237|875025|P2|STARTED|As Enrolled (Overall Study)||61
356146|NCT02265237|875026|P1|STARTED|As Enrolled (Overall Study)||59
356147|NCT02264977|875045|P1|NOT COMPLETED|Overall Study||7
356148|NCT02264977|875045|P1|COMPLETED|Overall Study||2
356149|NCT02264977|875045|P1|STARTED|Overall Study||9
356150|NCT02264821|875056|P3|NOT COMPLETED|Overall Study||6
356151|NCT02264821|875057|P2|NOT COMPLETED|Overall Study||3
356152|NCT02264821|875058|P1|NOT COMPLETED|Overall Study||1
356153|NCT02264821|875056|P3|COMPLETED|Overall Study||58
356154|NCT02264821|875057|P2|COMPLETED|Overall Study||61
356155|NCT02264821|875058|P1|COMPLETED|Overall Study||63
356156|NCT02264821|875056|P3|STARTED|Overall Study|Double Blind|64
356157|NCT02264821|875057|P2|STARTED|Overall Study|Double Blind|64
356158|NCT02264821|875058|P1|STARTED|Overall Study|Double Blind|64
356159|NCT02264249|875072|P3|NOT COMPLETED|Overall Study||0
356160|NCT02264249|875073|P2|NOT COMPLETED|Overall Study||0
356161|NCT02264249|875074|P1|NOT COMPLETED|Overall Study||0
356162|NCT02264249|875072|P3|COMPLETED|Overall Study||241
356163|NCT02264249|875073|P2|COMPLETED|Overall Study||187
356164|NCT02264249|875074|P1|COMPLETED|Overall Study||21
356165|NCT02264249|875072|P3|STARTED|Overall Study||241
356166|NCT02264249|875073|P2|STARTED|Overall Study||187
356167|NCT02264249|875074|P1|STARTED|Overall Study||21
356168|NCT02263911|875088|P4|NOT COMPLETED|Period 5||0
356169|NCT02263911|875089|P3|NOT COMPLETED|Period 5||0
356170|NCT02263911|875090|P2|NOT COMPLETED|Period 5||0
356171|NCT02263911|875091|P1|NOT COMPLETED|Period 5||0
356172|NCT02263911|875088|P4|COMPLETED|Period 5||4
356173|NCT02263911|875089|P3|COMPLETED|Period 5||4
356174|NCT02263911|875090|P2|COMPLETED|Period 5||4
356175|NCT02263911|875091|P1|COMPLETED|Period 5||4
356176|NCT02263911|875088|P4|STARTED|Period 5||4
356177|NCT02263911|875089|P3|STARTED|Period 5||4
356178|NCT02263911|875090|P2|STARTED|Period 5||4
356179|NCT02263911|875091|P1|STARTED|Period 5||4
356180|NCT02263911|875088|P4|NOT COMPLETED|Period 4 Washout||0
356181|NCT02263911|875089|P3|NOT COMPLETED|Period 4 Washout||0
356182|NCT02263911|875090|P2|NOT COMPLETED|Period 4 Washout||0
356183|NCT02263911|875091|P1|NOT COMPLETED|Period 4 Washout||0
356184|NCT02263911|875088|P4|COMPLETED|Period 4 Washout||4
356185|NCT02263911|875089|P3|COMPLETED|Period 4 Washout||4
356186|NCT02263911|875090|P2|COMPLETED|Period 4 Washout||4
356187|NCT02263911|875091|P1|COMPLETED|Period 4 Washout||4
356188|NCT02263911|875088|P4|STARTED|Period 4 Washout||4
356189|NCT02263911|875089|P3|STARTED|Period 4 Washout||4
356190|NCT02263911|875090|P2|STARTED|Period 4 Washout||4
356191|NCT02263911|875091|P1|STARTED|Period 4 Washout||4
356192|NCT02263911|875088|P4|NOT COMPLETED|Period 4||0
356193|NCT02263911|875089|P3|NOT COMPLETED|Period 4||0
356194|NCT02263911|875090|P2|NOT COMPLETED|Period 4||0
356195|NCT02263911|875091|P1|NOT COMPLETED|Period 4||0
356196|NCT02263911|875088|P4|COMPLETED|Period 4||4
356197|NCT02263911|875089|P3|COMPLETED|Period 4||4
356198|NCT02263911|875090|P2|COMPLETED|Period 4||4
356199|NCT02263911|875091|P1|COMPLETED|Period 4||4
356200|NCT02263911|875088|P4|STARTED|Period 4||4
356201|NCT02263911|875089|P3|STARTED|Period 4||4
356202|NCT02263911|875090|P2|STARTED|Period 4||4
356203|NCT02263911|875091|P1|STARTED|Period 4||4
356204|NCT02263911|875088|P4|NOT COMPLETED|Period 3 Washout||0
356205|NCT02263911|875089|P3|NOT COMPLETED|Period 3 Washout||0
356206|NCT02263911|875090|P2|NOT COMPLETED|Period 3 Washout||0
356207|NCT02263911|875091|P1|NOT COMPLETED|Period 3 Washout||0
356208|NCT02263911|875088|P4|COMPLETED|Period 3 Washout||4
356209|NCT02263911|875089|P3|COMPLETED|Period 3 Washout||4
356210|NCT02263911|875090|P2|COMPLETED|Period 3 Washout||4
356211|NCT02263911|875091|P1|COMPLETED|Period 3 Washout||4
356212|NCT02263911|875088|P4|STARTED|Period 3 Washout||4
356213|NCT02263911|875089|P3|STARTED|Period 3 Washout||4
356214|NCT02263911|875090|P2|STARTED|Period 3 Washout||4
356215|NCT02263911|875091|P1|STARTED|Period 3 Washout||4
356216|NCT02263911|875088|P4|NOT COMPLETED|Period 3||0
356217|NCT02263911|875089|P3|NOT COMPLETED|Period 3||0
356218|NCT02263911|875090|P2|NOT COMPLETED|Period 3||0
356219|NCT02263911|875091|P1|NOT COMPLETED|Period 3||0
356220|NCT02263911|875088|P4|COMPLETED|Period 3||4
356221|NCT02263911|875089|P3|COMPLETED|Period 3||4
356222|NCT02263911|875090|P2|COMPLETED|Period 3||4
356223|NCT02263911|875091|P1|COMPLETED|Period 3||4
356224|NCT02263911|875088|P4|STARTED|Period 3||4
356225|NCT02263911|875089|P3|STARTED|Period 3||4
356226|NCT02263911|875090|P2|STARTED|Period 3||4
356227|NCT02263911|875091|P1|STARTED|Period 3||4
356228|NCT02263911|875088|P4|NOT COMPLETED|Period 2 Washout||0
356229|NCT02263911|875089|P3|NOT COMPLETED|Period 2 Washout||0
356230|NCT02263911|875090|P2|NOT COMPLETED|Period 2 Washout||0
356231|NCT02263911|875091|P1|NOT COMPLETED|Period 2 Washout||0
356232|NCT02263911|875088|P4|COMPLETED|Period 2 Washout||4
356233|NCT02263911|875089|P3|COMPLETED|Period 2 Washout||4
356234|NCT02263911|875090|P2|COMPLETED|Period 2 Washout||4
356235|NCT02263911|875091|P1|COMPLETED|Period 2 Washout||4
356236|NCT02263911|875088|P4|STARTED|Period 2 Washout||4
356237|NCT02263911|875089|P3|STARTED|Period 2 Washout||4
356238|NCT02263911|875090|P2|STARTED|Period 2 Washout||4
356239|NCT02263911|875091|P1|STARTED|Period 2 Washout||4
356240|NCT02263911|875088|P4|NOT COMPLETED|Period 2||0
356241|NCT02263911|875089|P3|NOT COMPLETED|Period 2||0
356242|NCT02263911|875090|P2|NOT COMPLETED|Period 2||0
356243|NCT02263911|875091|P1|NOT COMPLETED|Period 2||0
356244|NCT02263911|875088|P4|COMPLETED|Period 2||4
356245|NCT02263911|875089|P3|COMPLETED|Period 2||4
356246|NCT02263911|875090|P2|COMPLETED|Period 2||4
356247|NCT02263911|875091|P1|COMPLETED|Period 2||4
356248|NCT02263911|875088|P4|STARTED|Period 2||4
356249|NCT02263911|875089|P3|STARTED|Period 2||4
356250|NCT02263911|875090|P2|STARTED|Period 2||4
356251|NCT02263911|875091|P1|STARTED|Period 2||4
356252|NCT02263911|875088|P4|NOT COMPLETED|Period 1 Washout||0
356253|NCT02263911|875089|P3|NOT COMPLETED|Period 1 Washout||0
356254|NCT02263911|875090|P2|NOT COMPLETED|Period 1 Washout||0
356255|NCT02263911|875091|P1|NOT COMPLETED|Period 1 Washout||0
356256|NCT02263911|875088|P4|COMPLETED|Period 1 Washout||4
356257|NCT02263911|875089|P3|COMPLETED|Period 1 Washout||4
356258|NCT02263911|875090|P2|COMPLETED|Period 1 Washout||4
356259|NCT02263911|875091|P1|COMPLETED|Period 1 Washout||4
356260|NCT02263911|875088|P4|STARTED|Period 1 Washout||4
356261|NCT02263911|875089|P3|STARTED|Period 1 Washout||4
356262|NCT02263911|875090|P2|STARTED|Period 1 Washout||4
356263|NCT02263911|875091|P1|STARTED|Period 1 Washout||4
356264|NCT02263911|875088|P4|NOT COMPLETED|Period 1||0
356265|NCT02263911|875089|P3|NOT COMPLETED|Period 1||0
356266|NCT02263911|875090|P2|NOT COMPLETED|Period 1||0
356267|NCT02263911|875091|P1|NOT COMPLETED|Period 1||0
356268|NCT02263911|875088|P4|COMPLETED|Period 1||4
356269|NCT02263911|875089|P3|COMPLETED|Period 1||4
356270|NCT02263911|875090|P2|COMPLETED|Period 1||4
356271|NCT02263911|875091|P1|COMPLETED|Period 1||4
356272|NCT02263911|875088|P4|STARTED|Period 1||4
356273|NCT02263911|875089|P3|STARTED|Period 1||4
356274|NCT02263911|875090|P2|STARTED|Period 1||4
356275|NCT02263911|875091|P1|STARTED|Period 1||4
356276|NCT02263833|875113|P1|NOT COMPLETED|Overall Study||0
356277|NCT02263833|875113|P1|COMPLETED|Overall Study||742
356278|NCT02263833|875113|P1|STARTED|Overall Study||742
356279|NCT02263365|875120|P2|NOT COMPLETED|Overall Study||18
356280|NCT02263365|875121|P1|NOT COMPLETED|Overall Study||22
356281|NCT02263365|875120|P2|COMPLETED|Overall Study||0
356282|NCT02263365|875121|P1|COMPLETED|Overall Study||0
356283|NCT02263365|875120|P2|STARTED|Overall Study||18
356284|NCT02263365|875121|P1|STARTED|Overall Study||22
356285|NCT02263131|875135|P2|NOT COMPLETED|Overall Study||1
356286|NCT02263131|875136|P1|NOT COMPLETED|Overall Study||10
356287|NCT02263131|875135|P2|COMPLETED|Overall Study||68
356288|NCT02263131|875136|P1|COMPLETED|Overall Study||337
356289|NCT02263131|875135|P2|STARTED|Overall Study||69
356290|NCT02263131|875136|P1|STARTED|Overall Study||347
356291|NCT02263118|875148|P4|NOT COMPLETED|Overall Study||2
356292|NCT02263118|875149|P3|NOT COMPLETED|Overall Study||8
356293|NCT02263118|875150|P2|NOT COMPLETED|Overall Study||8
356294|NCT02263118|875151|P1|NOT COMPLETED|Overall Study||4
356295|NCT02263118|875148|P4|COMPLETED|Overall Study||12
356296|NCT02263118|875149|P3|COMPLETED|Overall Study||22
356297|NCT02263118|875150|P2|COMPLETED|Overall Study||24
356298|NCT02263118|875151|P1|COMPLETED|Overall Study||20
356299|NCT02263118|875148|P4|STARTED|Overall Study||14
356300|NCT02263118|875149|P3|STARTED|Overall Study||30
356301|NCT02263118|875150|P2|STARTED|Overall Study||32
356302|NCT02263118|875151|P1|STARTED|Overall Study||24
356303|NCT02262754|875176|P3|NOT COMPLETED|Overall Study||9
356304|NCT02262754|875177|P2|NOT COMPLETED|Overall Study||9
356305|NCT02262754|875178|P1|NOT COMPLETED|Overall Study||16
356306|NCT02262754|875176|P3|COMPLETED|Overall Study||65
356307|NCT02262754|875177|P2|COMPLETED|Overall Study||65
356308|NCT02262754|875178|P1|COMPLETED|Overall Study||58
356309|NCT02262754|875176|P3|STARTED|Overall Study||74
356310|NCT02262754|875177|P2|STARTED|Overall Study||74
356311|NCT02262754|875178|P1|STARTED|Overall Study||74
356312|NCT02262728|875253|P2|NOT COMPLETED|Overall Study||0
356313|NCT02262728|875254|P1|NOT COMPLETED|Overall Study||0
356314|NCT02262728|875253|P2|COMPLETED|Overall Study||21
356315|NCT02262728|875254|P1|COMPLETED|Overall Study||19
356316|NCT02262728|875253|P2|STARTED|Overall Study||21
356317|NCT02262728|875254|P1|STARTED|Overall Study||19
356318|NCT02262078|875284|P2|NOT COMPLETED|Overall Study||0
356319|NCT02262078|875285|P1|NOT COMPLETED|Overall Study||0
356320|NCT02262078|875284|P2|COMPLETED|Overall Study||13
356321|NCT02262078|875285|P1|COMPLETED|Overall Study||13
356322|NCT02262078|875284|P2|STARTED|Overall Study||13
356323|NCT02262078|875285|P1|STARTED|Overall Study||13
356324|NCT02262039|875293|P2|NOT COMPLETED|Overall Study||0
356325|NCT02262039|875294|P1|NOT COMPLETED|Overall Study||0
356326|NCT02262039|875293|P2|COMPLETED|Overall Study||27
356327|NCT02262039|875294|P1|COMPLETED|Overall Study||14
356328|NCT02262039|875293|P2|STARTED|Overall Study||27
356329|NCT02262039|875294|P1|STARTED|Overall Study||14
356330|NCT02261974|875314|P2|NOT COMPLETED|Overall Study||7
356331|NCT02261974|875315|P1|NOT COMPLETED|Overall Study||15
356332|NCT02261974|875314|P2|COMPLETED|Overall Study||56
356333|NCT02261974|875315|P1|COMPLETED|Overall Study||108
356334|NCT02261974|875314|P2|Treated|Overall Study||57
356335|NCT02261974|875315|P1|Treated|Overall Study||117
356336|NCT02261974|875314|P2|STARTED|Overall Study||63
356337|NCT02261974|875315|P1|STARTED|Overall Study||123
356338|NCT02261948|875331|P2|NOT COMPLETED|Overall Study||0
356339|NCT02261948|875332|P1|NOT COMPLETED|Overall Study||0
356340|NCT02261948|875331|P2|COMPLETED|Overall Study||19
356341|NCT02261948|875332|P1|COMPLETED|Overall Study||23
356342|NCT02261948|875331|P2|STARTED|Overall Study||19
356343|NCT02261948|875332|P1|STARTED|Overall Study||23
356344|NCT02261818|875342|P1|NOT COMPLETED|Overall Study||3
356345|NCT02261818|875342|P1|COMPLETED|Overall Study||27
356346|NCT02261818|875342|P1|STARTED|Overall Study||30
356347|NCT02261805|875346|P3|NOT COMPLETED|Overall Study||0
356348|NCT02261805|875347|P2|NOT COMPLETED|Overall Study||0
356349|NCT02261805|875348|P1|NOT COMPLETED|Overall Study||0
356350|NCT02261805|875346|P3|COMPLETED|Overall Study||2
356351|NCT02261805|875347|P2|COMPLETED|Overall Study||6
356352|NCT02261805|875348|P1|COMPLETED|Overall Study||3
356353|NCT02261805|875346|P3|STARTED|Overall Study||2
356354|NCT02261805|875347|P2|STARTED|Overall Study||6
356355|NCT02261805|875348|P1|STARTED|Overall Study||3
356356|NCT02261493|875359|P3|NOT COMPLETED|Overall Study||26
356357|NCT02261493|875360|P2|NOT COMPLETED|Overall Study||47
356358|NCT02261493|875361|P1|NOT COMPLETED|Overall Study||30
356359|NCT02261493|875359|P3|COMPLETED|Overall Study||287
356360|NCT02261493|875360|P2|COMPLETED|Overall Study||271
356361|NCT02261493|875361|P1|COMPLETED|Overall Study||126
356362|NCT02261493|875359|P3|STARTED|Overall Study||313
356363|NCT02261493|875360|P2|STARTED|Overall Study||318
356364|NCT02261493|875361|P1|STARTED|Overall Study||156
356365|NCT02261467|875389|P2|NOT COMPLETED|Overall Study||37
356366|NCT02261467|875390|P1|NOT COMPLETED|Overall Study||21
356367|NCT02261467|875389|P2|COMPLETED|Overall Study||253
356368|NCT02261467|875390|P1|COMPLETED|Overall Study||80
356369|NCT02261467|875389|P2|STARTED|Overall Study||290
356370|NCT02261467|875390|P1|STARTED|Overall Study||101
356371|NCT02261428|875410|P2|NOT COMPLETED|Overall Study||0
356372|NCT02261428|875411|P1|NOT COMPLETED|Overall Study||0
356373|NCT02261428|875410|P2|COMPLETED|Overall Study||10
356374|NCT02261428|875411|P1|COMPLETED|Overall Study||10
356375|NCT02261428|875410|P2|STARTED|Overall Study|Washout (30 minutes)|10
356376|NCT02261428|875411|P1|STARTED|Overall Study|Washout (30 minutes)|10
356377|NCT02260986|875432|P3|NOT COMPLETED|Overall Study||41
356378|NCT02260986|875433|P2|NOT COMPLETED|Overall Study||13
356379|NCT02260986|875434|P1|NOT COMPLETED|Overall Study||90
356380|NCT02260986|875432|P3|COMPLETED|Overall Study||278
356381|NCT02260986|875433|P2|COMPLETED|Overall Study||93
356382|NCT02260986|875434|P1|COMPLETED|Overall Study||225
356383|NCT02260986|875432|P3|Safety Population|Overall Study|4 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|315
356384|NCT02260986|875433|P2|Safety Population|Overall Study|4 participants from Dupilumab 300 mg qw arm analyzed in Dupilumab 300 mg q2w arm|110
356385|NCT02260986|875434|P1|Safety Population|Overall Study||315
356386|NCT02260986|875432|P3|STARTED|Overall Study||319
356387|NCT02260986|875433|P2|STARTED|Overall Study||106
356388|NCT02260986|875434|P1|STARTED|Overall Study||315
356389|NCT02260882|875552|P2|NOT COMPLETED|Overall Study||1
356390|NCT02260882|875553|P1|NOT COMPLETED|Overall Study||0
356391|NCT02260882|875552|P2|COMPLETED|Overall Study||81
356392|NCT02260882|875553|P1|COMPLETED|Overall Study||161
356393|NCT02260882|875552|P2|STARTED|Overall Study||82
356394|NCT02260882|875553|P1|STARTED|Overall Study||161
356395|NCT02260791|875577|P2|NOT COMPLETED|Overall Study||34
356396|NCT02260791|875578|P1|NOT COMPLETED|Overall Study||33
356397|NCT02260791|875577|P2|COMPLETED|Overall Study||328
356398|NCT02260791|875578|P1|COMPLETED|Overall Study||333
356399|NCT02260791|875577|P2|STARTED|Overall Study||362
356400|NCT02260791|875578|P1|STARTED|Overall Study||366
356401|NCT02260492|875617|P3|NOT COMPLETED|Overall Study||5
356402|NCT02260492|875618|P2|NOT COMPLETED|Overall Study||13
356403|NCT02260492|875619|P1|NOT COMPLETED|Overall Study||23
356404|NCT02260492|875617|P3|COMPLETED|Overall Study||37
356405|NCT02260492|875618|P2|COMPLETED|Overall Study||406
356406|NCT02260492|875619|P1|COMPLETED|Overall Study||395
356407|NCT02260492|875617|P3|Completed Day 1|Overall Study||42
356408|NCT02260492|875618|P2|Completed Day 1|Overall Study||419
356409|NCT02260492|875619|P1|Completed Day 1|Overall Study||418
356410|NCT02260492|875617|P3|STARTED|Overall Study||42
356411|NCT02260492|875618|P2|STARTED|Overall Study||419
356412|NCT02260492|875619|P1|STARTED|Overall Study||418
356413|NCT02260440|875633|P1|NOT COMPLETED|Overall Study||0
356414|NCT02260440|875633|P1|COMPLETED|Overall Study||31
356415|NCT02260440|875633|P1|STARTED|Overall Study||31
356416|NCT02260401|875641|P2|NOT COMPLETED|Overall Study||12
356417|NCT02260401|875642|P1|NOT COMPLETED|Overall Study||5
356418|NCT02260401|875641|P2|COMPLETED|Overall Study||73
356419|NCT02260401|875642|P1|COMPLETED|Overall Study||75
356420|NCT02260401|875641|P2|STARTED|Overall Study||85
356421|NCT02260401|875642|P1|STARTED|Overall Study||80
356422|NCT02259608|875648|P1|NOT COMPLETED|Overall Study||0
356423|NCT02259608|875648|P1|COMPLETED|Overall Study||15
356424|NCT02259608|875648|P1|STARTED|Overall Study||15
356425|NCT02259400|875655|P2|NOT COMPLETED|Overall Study||2
356426|NCT02259400|875656|P1|NOT COMPLETED|Overall Study||0
356427|NCT02259400|875655|P2|COMPLETED|Overall Study||60
356428|NCT02259400|875656|P1|COMPLETED|Overall Study||62
356429|NCT02259400|875655|P2|STARTED|Overall Study||62
356430|NCT02259400|875656|P1|STARTED|Overall Study||62
356431|NCT02259348|875688|P1|NOT COMPLETED|Overall Study||10
356432|NCT02259348|875688|P1|COMPLETED|Overall Study||2
356433|NCT02259348|875688|P1|One Year Post-transplant|Overall Study||2
356434|NCT02259348|875688|P1|STARTED|Overall Study||12
356435|NCT02258529|875700|P1|NOT COMPLETED|Overall Study||10
356436|NCT02258529|875700|P1|COMPLETED|Overall Study||0
356437|NCT02258529|875700|P1|STARTED|Overall Study||10
356438|NCT02258477|875712|P4|NOT COMPLETED|Fourth Intervention (1 Week)||0
356439|NCT02258477|875713|P3|NOT COMPLETED|Fourth Intervention (1 Week)||0
356440|NCT02258477|875714|P2|NOT COMPLETED|Fourth Intervention (1 Week)||0
356441|NCT02258477|875715|P1|NOT COMPLETED|Fourth Intervention (1 Week)||0
356442|NCT02258477|875712|P4|COMPLETED|Fourth Intervention (1 Week)||8
356443|NCT02258477|875713|P3|COMPLETED|Fourth Intervention (1 Week)||8
356444|NCT02258477|875714|P2|COMPLETED|Fourth Intervention (1 Week)||8
356445|NCT02258477|875715|P1|COMPLETED|Fourth Intervention (1 Week)||9
356446|NCT02258477|875712|P4|STARTED|Fourth Intervention (1 Week)||8
356447|NCT02258477|875713|P3|STARTED|Fourth Intervention (1 Week)||8
356448|NCT02258477|875714|P2|STARTED|Fourth Intervention (1 Week)||8
356449|NCT02258477|875715|P1|STARTED|Fourth Intervention (1 Week)||9
356450|NCT02258477|875712|P4|NOT COMPLETED|Third Intervention (1 Week)||0
356451|NCT02258477|875713|P3|NOT COMPLETED|Third Intervention (1 Week)||0
356452|NCT02258477|875714|P2|NOT COMPLETED|Third Intervention (1 Week)||0
356453|NCT02258477|875715|P1|NOT COMPLETED|Third Intervention (1 Week)||0
356454|NCT02258477|875712|P4|COMPLETED|Third Intervention (1 Week)||8
356455|NCT02258477|875713|P3|COMPLETED|Third Intervention (1 Week)||8
356456|NCT02258477|875714|P2|COMPLETED|Third Intervention (1 Week)||8
356457|NCT02258477|875715|P1|COMPLETED|Third Intervention (1 Week)||9
356458|NCT02258477|875712|P4|STARTED|Third Intervention (1 Week)||8
356459|NCT02258477|875713|P3|STARTED|Third Intervention (1 Week)||8
356460|NCT02258477|875714|P2|STARTED|Third Intervention (1 Week)||8
356461|NCT02258477|875715|P1|STARTED|Third Intervention (1 Week)||9
356462|NCT02258477|875712|P4|NOT COMPLETED|Second Intervention (1 Week)||1
356463|NCT02258477|875713|P3|NOT COMPLETED|Second Intervention (1 Week)||1
356464|NCT02258477|875714|P2|NOT COMPLETED|Second Intervention (1 Week)||0
356465|NCT02258477|875715|P1|NOT COMPLETED|Second Intervention (1 Week)||0
356466|NCT02258477|875712|P4|COMPLETED|Second Intervention (1 Week)||8
356467|NCT02258477|875713|P3|COMPLETED|Second Intervention (1 Week)||8
356468|NCT02258477|875714|P2|COMPLETED|Second Intervention (1 Week)||8
356469|NCT02258477|875715|P1|COMPLETED|Second Intervention (1 Week)||9
356470|NCT02258477|875712|P4|STARTED|Second Intervention (1 Week)||9
356471|NCT02258477|875713|P3|STARTED|Second Intervention (1 Week)||9
356472|NCT02258477|875714|P2|STARTED|Second Intervention (1 Week)||8
356473|NCT02258477|875715|P1|STARTED|Second Intervention (1 Week)||9
356474|NCT02258477|875712|P4|NOT COMPLETED|First Intervention (1 Week)||0
356475|NCT02258477|875713|P3|NOT COMPLETED|First Intervention (1 Week)||0
356476|NCT02258477|875714|P2|NOT COMPLETED|First Intervention (1 Week)||1
356477|NCT02258477|875715|P1|NOT COMPLETED|First Intervention (1 Week)||1
356478|NCT02258477|875712|P4|COMPLETED|First Intervention (1 Week)||9
356479|NCT02258477|875713|P3|COMPLETED|First Intervention (1 Week)||9
356480|NCT02258477|875714|P2|COMPLETED|First Intervention (1 Week)||8
356481|NCT02258477|875715|P1|COMPLETED|First Intervention (1 Week)||9
356482|NCT02258477|875712|P4|STARTED|First Intervention (1 Week)||9
356483|NCT02258477|875713|P3|STARTED|First Intervention (1 Week)||9
356484|NCT02258477|875714|P2|STARTED|First Intervention (1 Week)||9
356485|NCT02258477|875715|P1|STARTED|First Intervention (1 Week)||10
356486|NCT02258412|875733|P3|NOT COMPLETED|Overall Study||0
356487|NCT02258412|875734|P2|NOT COMPLETED|Overall Study||0
356488|NCT02258412|875735|P1|NOT COMPLETED|Overall Study||0
356489|NCT02258412|875733|P3|COMPLETED|Overall Study||61
356490|NCT02258412|875734|P2|COMPLETED|Overall Study||25
356491|NCT02258412|875735|P1|COMPLETED|Overall Study||26
356492|NCT02258412|875733|P3|STARTED|Overall Study||61
356493|NCT02258412|875734|P2|STARTED|Overall Study||25
356494|NCT02258412|875735|P1|STARTED|Overall Study||26
356495|NCT02258334|875746|P4|NOT COMPLETED|Overall Study||0
356496|NCT02258334|875747|P3|NOT COMPLETED|Overall Study||0
356497|NCT02258334|875748|P2|NOT COMPLETED|Overall Study||0
356498|NCT02258334|875749|P1|NOT COMPLETED|Overall Study||1
356499|NCT02258334|875746|P4|COMPLETED|Overall Study||52
356500|NCT02258334|875747|P3|COMPLETED|Overall Study||52
356501|NCT02258334|875748|P2|COMPLETED|Overall Study||54
356502|NCT02258334|875749|P1|COMPLETED|Overall Study||49
356503|NCT02258334|875746|P4|STARTED|Overall Study||52
356504|NCT02258334|875747|P3|STARTED|Overall Study||52
356505|NCT02258334|875748|P2|STARTED|Overall Study||54
356506|NCT02258334|875749|P1|STARTED|Overall Study||50
356507|NCT02257918|875778|P3|NOT COMPLETED|Overall Study||2
356508|NCT02257918|875779|P2|NOT COMPLETED|Overall Study||1
356509|NCT02257918|875780|P1|NOT COMPLETED|Overall Study||4
356510|NCT02257918|875778|P3|COMPLETED|Overall Study||39
356511|NCT02257918|875779|P2|COMPLETED|Overall Study||66
356512|NCT02257918|875780|P1|COMPLETED|Overall Study||68
356513|NCT02257918|875778|P3|Test of Cure Visit|Overall Study||40
356514|NCT02257918|875779|P2|Test of Cure Visit|Overall Study||67
356515|NCT02257918|875780|P1|Test of Cure Visit|Overall Study||72
356516|NCT02257918|875778|P3|STARTED|Overall Study||41
356517|NCT02257918|875779|P2|STARTED|Overall Study||67
356518|NCT02257918|875780|P1|STARTED|Overall Study||72
356519|NCT02257684|875830|P1|NOT COMPLETED|Overall Study||4
356520|NCT02257684|875830|P1|COMPLETED|Overall Study||0
356521|NCT02257684|875830|P1|STARTED|Overall Study||4
356522|NCT02257385|875840|P2|NOT COMPLETED|Overall Study||22
356523|NCT02257385|875841|P1|NOT COMPLETED|Overall Study||22
356524|NCT02257385|875840|P2|COMPLETED|Overall Study||457
356525|NCT02257385|875841|P1|COMPLETED|Overall Study||460
356526|NCT02257385|875840|P2|STARTED|Overall Study||479
356527|NCT02257385|875841|P1|STARTED|Overall Study||482
356528|NCT02257372|875851|P2|NOT COMPLETED|Overall Study||10
356529|NCT02257372|875852|P1|NOT COMPLETED|Overall Study||7
356530|NCT02257372|875851|P2|COMPLETED|Overall Study||109
356531|NCT02257372|875852|P1|COMPLETED|Overall Study||110
356532|NCT02257372|875851|P2|STARTED|Overall Study||119
356533|NCT02257372|875852|P1|STARTED|Overall Study||117
356534|NCT02256982|875862|P2|NOT COMPLETED|Overall Study||1
356535|NCT02256982|875863|P1|NOT COMPLETED|Overall Study||0
356536|NCT02256982|875862|P2|COMPLETED|Overall Study||1
356537|NCT02256982|875863|P1|COMPLETED|Overall Study||1
356538|NCT02256982|875862|P2|STARTED|Overall Study||2
356539|NCT02256982|875863|P1|STARTED|Overall Study||1
356540|NCT02256969|875872|P3|NOT COMPLETED|Overall Study||1
356541|NCT02256969|875873|P2|NOT COMPLETED|Overall Study||1
356542|NCT02256969|875874|P1|NOT COMPLETED|Overall Study||2
356543|NCT02256969|875872|P3|COMPLETED|Overall Study||14
356544|NCT02256969|875873|P2|COMPLETED|Overall Study||14
356545|NCT02256969|875874|P1|COMPLETED|Overall Study||13
356546|NCT02256969|875872|P3|STARTED|Overall Study||15
356547|NCT02256969|875873|P2|STARTED|Overall Study||15
356548|NCT02256969|875874|P1|STARTED|Overall Study||15
356549|NCT02256891|875893|P2|NOT COMPLETED|Overall Study||13
356550|NCT02256891|875894|P1|NOT COMPLETED|Overall Study||12
356551|NCT02256891|875893|P2|COMPLETED|Overall Study||29
356552|NCT02256891|875894|P1|COMPLETED|Overall Study||43
356553|NCT02256891|875893|P2|STARTED|Overall Study||42
356554|NCT02256891|875894|P1|STARTED|Overall Study||55
356555|NCT02256553|875918|P1|NOT COMPLETED|Period III||3
356556|NCT02256553|875918|P1|COMPLETED|Period III||91
356557|NCT02256553|875918|P1|STARTED|Period III||94
356558|NCT02256553|875918|P1|NOT COMPLETED|Period II||2
356559|NCT02256553|875918|P1|COMPLETED|Period II||94
356560|NCT02256553|875918|P1|STARTED|Period II||96
356561|NCT02256553|875918|P1|NOT COMPLETED|Period I||6
356562|NCT02256553|875918|P1|COMPLETED|Period I||96
356563|NCT02256553|875918|P1|STARTED|Period I||102
356564|NCT02256488|875931|P4|NOT COMPLETED|Overall Study||6
356565|NCT02256488|875932|P3|NOT COMPLETED|Overall Study||10
356566|NCT02256488|875933|P2|NOT COMPLETED|Overall Study||6
356567|NCT02256488|875934|P1|NOT COMPLETED|Overall Study||8
356568|NCT02256488|875931|P4|COMPLETED|Overall Study||384
356569|NCT02256488|875932|P3|COMPLETED|Overall Study||382
356570|NCT02256488|875933|P2|COMPLETED|Overall Study||386
356571|NCT02256488|875934|P1|COMPLETED|Overall Study||379
356572|NCT02256488|875931|P4|STARTED|Overall Study||390
356573|NCT02256488|875932|P3|STARTED|Overall Study||392
356574|NCT02256488|875933|P2|STARTED|Overall Study||392
356575|NCT02256488|875934|P1|STARTED|Overall Study||387
356576|NCT02256436|875950|P2|NOT COMPLETED|Overall Study||272
356577|NCT02256436|875951|P1|NOT COMPLETED|Overall Study||270
356578|NCT02256436|875950|P2|COMPLETED|Overall Study||0
356579|NCT02256436|875951|P1|COMPLETED|Overall Study||0
356580|NCT02256436|875950|P2|Treated|Overall Study||255
356581|NCT02256436|875951|P1|Treated|Overall Study||266
356582|NCT02256436|875950|P2|STARTED|Overall Study||272
356583|NCT02256436|875951|P1|STARTED|Overall Study||270
356584|NCT02256358|875989|P2|NOT COMPLETED|Overall Study||1
356585|NCT02256358|875990|P1|NOT COMPLETED|Overall Study||0
356586|NCT02256358|875989|P2|COMPLETED|Overall Study||33
356587|NCT02256358|875990|P1|COMPLETED|Overall Study||34
356588|NCT02256358|875989|P2|STARTED|Overall Study||34
356589|NCT02256358|875990|P1|STARTED|Overall Study||34
356590|NCT02256345|875998|P2|NOT COMPLETED|Overall Study||0
356591|NCT02256345|875999|P1|NOT COMPLETED|Overall Study||0
356592|NCT02256345|875998|P2|COMPLETED|Overall Study||3
356593|NCT02256345|875999|P1|COMPLETED|Overall Study||9
356594|NCT02256345|875998|P2|STARTED|Overall Study||3
356595|NCT02256345|875999|P1|STARTED|Overall Study||9
356596|NCT02256072|876013|P2|NOT COMPLETED|Overall Study||29
356597|NCT02256072|876014|P1|NOT COMPLETED|Overall Study||42
356598|NCT02256072|876013|P2|COMPLETED|Overall Study||162
356599|NCT02256072|876014|P1|COMPLETED|Overall Study|Completed the 3-month follow-up|152
356600|NCT02256072|876013|P2|Completed 1 Month Follow-Up|Overall Study||179
356601|NCT02256072|876014|P1|Completed 1 Month Follow-Up|Overall Study|Completed the 1-month follow-up|167
356602|NCT02256072|876013|P2|STARTED|Overall Study||191
356603|NCT02256072|876014|P1|STARTED|Overall Study||194
356604|NCT02255565|876031|P3|NOT COMPLETED|Overall Study||0
356605|NCT02255565|876032|P2|NOT COMPLETED|Overall Study||1
356606|NCT02255565|876033|P1|NOT COMPLETED|Overall Study||0
356607|NCT02255565|876031|P3|COMPLETED|Overall Study||9
356608|NCT02255565|876032|P2|COMPLETED|Overall Study||8
356609|NCT02255565|876033|P1|COMPLETED|Overall Study||9
356610|NCT02255565|876031|P3|STARTED|Overall Study||9
356611|NCT02255565|876032|P2|STARTED|Overall Study||9
356612|NCT02255565|876033|P1|STARTED|Overall Study||9
356613|NCT02255279|876094|P2|NOT COMPLETED|Overall Study||9
356614|NCT02255279|876095|P1|NOT COMPLETED|Overall Study||5
356615|NCT02255279|876094|P2|COMPLETED|Overall Study||134
356616|NCT02255279|876095|P1|COMPLETED|Overall Study||139
356617|NCT02255279|876094|P2|STARTED|Overall Study||143
356618|NCT02255279|876095|P1|STARTED|Overall Study||144
356619|NCT02255149|876121|P1|NOT COMPLETED|Overall Study||5
356620|NCT02255149|876121|P1|COMPLETED|Overall Study||5
356621|NCT02255149|876121|P1|STARTED|Overall Study||10
356622|NCT02255097|876125|P1|NOT COMPLETED|Overall Study||172
356623|NCT02255097|876125|P1|COMPLETED|Overall Study||0
356624|NCT02255097|876125|P1|Treated|Overall Study||171
356625|NCT02255097|876125|P1|STARTED|Overall Study||172
356626|NCT02254772|876146|P1|NOT COMPLETED|Overall Study||2
356627|NCT02254772|876146|P1|COMPLETED|Overall Study||7
356628|NCT02254772|876146|P1|STARTED|Overall Study||9
356629|NCT02254551|876152|P1|NOT COMPLETED|Maintenance||0
356630|NCT02254551|876152|P1|COMPLETED|Maintenance||0
356631|NCT02254551|876152|P1|STARTED|Maintenance||0
356632|NCT02254551|876152|P1|NOT COMPLETED|Expansion||0
356633|NCT02254551|876152|P1|COMPLETED|Expansion||0
356634|NCT02254551|876152|P1|STARTED|Expansion||0
356635|NCT02254551|876152|P1|NOT COMPLETED|Dose Escalation||3
356636|NCT02254551|876152|P1|COMPLETED|Dose Escalation|Due to toxicity and lack of efficacy, no other dose levels were examined.|4
356637|NCT02254551|876152|P1|Cohort 3: LDE225 800mg|Dose Escalation||0
356638|NCT02254551|876152|P1|Cohort 2: LDE225 600mg|Dose Escalation||0
356639|NCT02254551|876152|P1|Cohort 1: LDE225 400mg|Dose Escalation|1 patient was found to be refractory to bortezomib and deemed ineligible.|7
356640|NCT02254551|876152|P1|STARTED|Dose Escalation||7
356641|NCT02254486|876162|P2|NOT COMPLETED|Overall Study||55
356642|NCT02254486|876163|P1|NOT COMPLETED|Overall Study||50
356643|NCT02254486|876162|P2|COMPLETED|Overall Study||255
356644|NCT02254486|876163|P1|COMPLETED|Overall Study||261
356645|NCT02254486|876162|P2|STARTED|Overall Study||310
356646|NCT02254486|876163|P1|STARTED|Overall Study||311
356647|NCT02254460|876179|P2|NOT COMPLETED|Overall Study||0
356648|NCT02254460|876180|P1|NOT COMPLETED|Overall Study||1
356649|NCT02254460|876179|P2|COMPLETED|Overall Study||12
356650|NCT02254460|876180|P1|COMPLETED|Overall Study||12
356651|NCT02254460|876179|P2|STARTED|Overall Study||12
356652|NCT02254460|876180|P1|STARTED|Overall Study||13
356653|NCT02254421|876188|P2|NOT COMPLETED|Overall Study||3
356654|NCT02254421|876189|P1|NOT COMPLETED|Overall Study||2
356655|NCT02254421|876188|P2|COMPLETED|Overall Study||26
356656|NCT02254421|876189|P1|COMPLETED|Overall Study||29
356657|NCT02254421|876188|P2|STARTED|Overall Study||29
356658|NCT02254421|876189|P1|STARTED|Overall Study||31
356659|NCT02254304|876203|P2|NOT COMPLETED|Overall Study||4
356660|NCT02254304|876204|P1|NOT COMPLETED|Overall Study||14
356661|NCT02254304|876203|P2|COMPLETED|Overall Study||13
356662|NCT02254304|876204|P1|COMPLETED|Overall Study||75
356663|NCT02254304|876203|P2|STARTED|Overall Study||17
356664|NCT02254304|876204|P1|STARTED|Overall Study||89
356665|NCT02254252|876263|P2|NOT COMPLETED|Overall Study||2
356666|NCT02254252|876264|P1|NOT COMPLETED|Overall Study||3
356667|NCT02254252|876263|P2|COMPLETED|Overall Study||25
356668|NCT02254252|876264|P1|COMPLETED|Overall Study||24
356669|NCT02254252|876263|P2|STARTED|Overall Study||27
356670|NCT02254252|876264|P1|STARTED|Overall Study||27
356671|NCT02253654|876276|P2|NOT COMPLETED|Overall Study||18
356672|NCT02253654|876277|P1|NOT COMPLETED|Overall Study||23
356673|NCT02253654|876276|P2|COMPLETED|Overall Study||90
356674|NCT02253654|876277|P1|COMPLETED|Overall Study||85
356675|NCT02253654|876276|P2|Received Treatment|Overall Study||107
356676|NCT02253654|876277|P1|Received Treatment|Overall Study||104
356677|NCT02253654|876276|P2|STARTED|Overall Study||108
356678|NCT02253654|876277|P1|STARTED|Overall Study||108
356679|NCT02253173|876301|P4|NOT COMPLETED|Overall Study||14
356680|NCT02253173|876302|P3|NOT COMPLETED|Overall Study||13
356681|NCT02253173|876303|P2|NOT COMPLETED|Overall Study||17
356682|NCT02253173|876304|P1|NOT COMPLETED|Overall Study||16
356683|NCT02253173|876301|P4|COMPLETED|Overall Study||178
356684|NCT02253173|876302|P3|COMPLETED|Overall Study||177
356685|NCT02253173|876303|P2|COMPLETED|Overall Study||174
356686|NCT02253173|876304|P1|COMPLETED|Overall Study||175
356687|NCT02253173|876301|P4|STARTED|Overall Study||192
356688|NCT02253173|876302|P3|STARTED|Overall Study||190
356689|NCT02253173|876303|P2|STARTED|Overall Study||191
356690|NCT02253173|876304|P1|STARTED|Overall Study||191
356691|NCT02253160|876501|P3|NOT COMPLETED|Overall Study||0
356692|NCT02253160|876502|P2|NOT COMPLETED|Overall Study||0
356693|NCT02253160|876503|P1|NOT COMPLETED|Overall Study||0
356694|NCT02253160|876501|P3|COMPLETED|Overall Study||10
356695|NCT02253160|876502|P2|COMPLETED|Overall Study||12
356696|NCT02253160|876503|P1|COMPLETED|Overall Study||1
356697|NCT02253160|876501|P3|STARTED|Overall Study||10
356698|NCT02253160|876502|P2|STARTED|Overall Study||12
356699|NCT02253160|876503|P1|STARTED|Overall Study||1
356700|NCT02253147|876539|P1|NOT COMPLETED|Overall Study||47
356701|NCT02253147|876539|P1|COMPLETED|Overall Study||71
356702|NCT02253147|876539|P1|N Patients at W52|Overall Study||84
356703|NCT02253147|876539|P1|N Patients at W36|Overall Study||86
356704|NCT02253147|876539|P1|N Patients at W24 (Primary Outcome)|Overall Study||88
356705|NCT02253147|876539|P1|STARTED|Overall Study||118
356706|NCT02252965|876573|P2|NOT COMPLETED|Overall Study||43
356707|NCT02252965|876574|P1|NOT COMPLETED|Overall Study||40
356708|NCT02252965|876573|P2|COMPLETED|Overall Study||222
356709|NCT02252965|876574|P1|COMPLETED|Overall Study||227
356710|NCT02252965|876573|P2|Safety Population|Overall Study||264
356711|NCT02252965|876574|P1|Safety Population|Overall Study|Out of 261, 12 subjects intolerant to the Metformin IR switched to Metformin XR group.|261
356712|NCT02252965|876573|P2|STARTED|Overall Study||265
356713|NCT02252965|876574|P1|STARTED|Overall Study||267
356714|NCT02252939|876601|P1|NOT COMPLETED|Overall Study||3
356715|NCT02252939|876601|P1|COMPLETED|Overall Study||59
356716|NCT02252939|876601|P1|STARTED|Overall Study||62
356717|NCT02252744|876605|P1|NOT COMPLETED|Overall Study||0
356718|NCT02252744|876605|P1|COMPLETED|Overall Study||286
356719|NCT02252744|876605|P1|STARTED|Overall Study||286
356720|NCT02252718|876609|P1|NOT COMPLETED|Overall Study||0
356721|NCT02252718|876609|P1|COMPLETED|Overall Study||100
356722|NCT02252718|876609|P1|STARTED|Overall Study||100
356723|NCT02252445|876615|P2|NOT COMPLETED|Overall Study||0
356724|NCT02252445|876616|P1|NOT COMPLETED|Overall Study||0
356725|NCT02252445|876615|P2|COMPLETED|Overall Study||41
356726|NCT02252445|876616|P1|COMPLETED|Overall Study||41
356727|NCT02252445|876615|P2|STARTED|Overall Study||41
356728|NCT02252445|876616|P1|STARTED|Overall Study||41
356729|NCT02252354|876642|P2|NOT COMPLETED|Overall Study||0
356730|NCT02252354|876643|P1|NOT COMPLETED|Overall Study||0
356731|NCT02252354|876642|P2|COMPLETED|Overall Study||6
356732|NCT02252354|876643|P1|COMPLETED|Overall Study||6
356733|NCT02252354|876642|P2|STARTED|Overall Study||6
356734|NCT02252354|876643|P1|STARTED|Overall Study||6
356735|NCT02252146|876688|P1|NOT COMPLETED|Overall Study||6
356736|NCT02252146|876688|P1|COMPLETED|Overall Study||0
356737|NCT02252146|876688|P1|STARTED|Overall Study||6
356738|NCT02252133|876692|P2|NOT COMPLETED|Period 2||0
356739|NCT02252133|876693|P1|NOT COMPLETED|Period 2||0
356740|NCT02252133|876692|P2|COMPLETED|Period 2||24
356741|NCT02252133|876693|P1|COMPLETED|Period 2||23
356742|NCT02252133|876692|P2|STARTED|Period 2||24
356743|NCT02252133|876693|P1|STARTED|Period 2||23
356744|NCT02252133|876692|P2|NOT COMPLETED|Period 1||0
356745|NCT02252133|876693|P1|NOT COMPLETED|Period 1||0
356746|NCT02252133|876692|P2|COMPLETED|Period 1||24
356747|NCT02252133|876693|P1|COMPLETED|Period 1||23
356748|NCT02252133|876692|P2|STARTED|Period 1||24
356749|NCT02252133|876693|P1|STARTED|Period 1||23
356750|NCT02252016|876701|P2|NOT COMPLETED|Overall Study||3
356751|NCT02252016|876702|P1|NOT COMPLETED|Overall Study||3
356752|NCT02252016|876701|P2|COMPLETED|Overall Study|Completed = completed 24 weeks of follow-up|49
356753|NCT02252016|876702|P1|COMPLETED|Overall Study|Completed = completed 24 weeks of follow-up|104
356754|NCT02252016|876701|P2|STARTED|Overall Study||52
356755|NCT02252016|876702|P1|STARTED|Overall Study||107
356756|NCT02251990|876716|P2|NOT COMPLETED|Period 3 (DTG Follow-up)||0
356757|NCT02251990|876717|P1|NOT COMPLETED|Period 3 (DTG Follow-up)||0
356758|NCT02251990|876716|P2|COMPLETED|Period 3 (DTG Follow-up)|Completed 24 weeks of follow-up|121
356759|NCT02251990|876717|P1|COMPLETED|Period 3 (DTG Follow-up)||0
356760|NCT02251990|876716|P2|STARTED|Period 3 (DTG Follow-up)|3 participants that discontinued treatment in Period 2 were included in Follow-up.|121
356761|NCT02251990|876717|P1|STARTED|Period 3 (DTG Follow-up)|The ITG completed the study with Period 2|0
356762|NCT02251990|876716|P2|NOT COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)||3
356763|NCT02251990|876717|P1|NOT COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)||0
356764|NCT02251990|876716|P2|COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)|Completed 12 weeks of Grazoprevir/Elbasvir|118
356765|NCT02251990|876717|P1|COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)|Completed 24 weeks of follow-up|360
356766|NCT02251990|876716|P2|STARTED|Period 2 (ITG Follow-up/DTG Open Label)|1 participant completing Period 1 was not eligible for Period 2 and was not treated.|121
356767|NCT02251990|876717|P1|STARTED|Period 2 (ITG Follow-up/DTG Open Label)|2 participants that did not complete Period 1 treatment were included in Follow-up.|360
356768|NCT02251990|876716|P2|NOT COMPLETED|Period 1 (Double-blind [DB])||1
356769|NCT02251990|876717|P1|NOT COMPLETED|Period 1 (Double-blind [DB])||8
356770|NCT02251990|876716|P2|COMPLETED|Period 1 (Double-blind [DB])|Completed 12 weeks of Placebo|122
356771|NCT02251990|876717|P1|COMPLETED|Period 1 (Double-blind [DB])|Completed 12 weeks of Grazoprevir/Elbasvir|358
356772|NCT02251990|876716|P2|Treated|Period 1 (Double-blind [DB])|Started Placebo|123
356773|NCT02251990|876717|P1|Treated|Period 1 (Double-blind [DB])|Started Grazoprevir/Elbasvir|365
356774|NCT02251990|876716|P2|STARTED|Period 1 (Double-blind [DB])||123
356775|NCT02251990|876717|P1|STARTED|Period 1 (Double-blind [DB])||366
356776|NCT02251912|876734|P2|NOT COMPLETED|Overall Study||5
356777|NCT02251912|876735|P1|NOT COMPLETED|Overall Study||2
356778|NCT02251912|876734|P2|COMPLETED|Overall Study||5
356779|NCT02251912|876735|P1|COMPLETED|Overall Study||10
356780|NCT02251912|876734|P2|STARTED|Overall Study||10
356781|NCT02251912|876735|P1|STARTED|Overall Study||12
356782|NCT02251886|876749|P4|NOT COMPLETED|Overall Study||0
356783|NCT02251886|876750|P3|NOT COMPLETED|Overall Study||0
356784|NCT02251886|876751|P2|NOT COMPLETED|Overall Study||0
356785|NCT02251886|876752|P1|NOT COMPLETED|Overall Study||0
356786|NCT02251886|876749|P4|COMPLETED|Overall Study||54
356787|NCT02251886|876750|P3|COMPLETED|Overall Study||44
356788|NCT02251886|876751|P2|COMPLETED|Overall Study||54
356789|NCT02251886|876752|P1|COMPLETED|Overall Study||48
356790|NCT02251886|876749|P4|STARTED|Overall Study||54
356791|NCT02251886|876750|P3|STARTED|Overall Study||44
356792|NCT02251886|876751|P2|STARTED|Overall Study||54
356793|NCT02251886|876752|P1|STARTED|Overall Study||48
356794|NCT02251717|876764|P2|NOT COMPLETED|Overall Study||1
356795|NCT02251717|876765|P1|NOT COMPLETED|Overall Study||1
356796|NCT02251717|876764|P2|COMPLETED|Overall Study||56
356797|NCT02251717|876765|P1|COMPLETED|Overall Study||56
356798|NCT02251717|876764|P2|STARTED|Overall Study||57
356799|NCT02251717|876765|P1|STARTED|Overall Study||57
356800|NCT02251652|876777|P1|NOT COMPLETED|Overall Study||1
356801|NCT02251652|876777|P1|COMPLETED|Overall Study||16
356802|NCT02251652|876777|P1|STARTED|Overall Study||17
356803|NCT02251613|876787|P1|NOT COMPLETED|Overall Study||0
356804|NCT02251613|876787|P1|COMPLETED|Overall Study||50
356805|NCT02251613|876787|P1|STARTED|Overall Study||50
356806|NCT02251561|876795|P1|NOT COMPLETED|Overall Study||0
356807|NCT02251561|876795|P1|COMPLETED|Overall Study||28
356808|NCT02251561|876795|P1|STARTED|Overall Study||28
356809|NCT02250807|876803|P1|NOT COMPLETED|Overall Study||0
356810|NCT02250807|876803|P1|COMPLETED|Overall Study||40
356811|NCT02250807|876803|P1|STARTED|Overall Study||40
356812|NCT02250703|876815|P2|NOT COMPLETED|Overall Study||1
356813|NCT02250703|876816|P1|NOT COMPLETED|Overall Study||1
356814|NCT02250703|876815|P2|COMPLETED|Overall Study||36
356815|NCT02250703|876816|P1|COMPLETED|Overall Study||37
356816|NCT02250703|876815|P2|STARTED|Overall Study||37
356817|NCT02250703|876816|P1|STARTED|Overall Study||38
356818|NCT02250443|876828|P1|NOT COMPLETED|Overall Study||10
356819|NCT02250443|876828|P1|COMPLETED|Overall Study||0
356820|NCT02250443|876828|P1|STARTED|Overall Study||10
356821|NCT02250274|876843|P2|NOT COMPLETED|Overall Study||6
356822|NCT02250274|876844|P1|NOT COMPLETED|Overall Study||7
356823|NCT02250274|876843|P2|COMPLETED|Overall Study||40
356824|NCT02250274|876844|P1|COMPLETED|Overall Study||78
356825|NCT02250274|876843|P2|STARTED|Overall Study||46
356826|NCT02250274|876844|P1|STARTED|Overall Study||85
356827|NCT02249819|876860|P2|NOT COMPLETED|Overall Study||0
356828|NCT02249819|876861|P1|NOT COMPLETED|Overall Study||0
356829|NCT02249819|876860|P2|COMPLETED|Overall Study||7
356830|NCT02249819|876861|P1|COMPLETED|Overall Study||8
356831|NCT02249819|876860|P2|STARTED|Overall Study||7
356832|NCT02249819|876861|P1|STARTED|Overall Study||8
356833|NCT02249728|876867|P1|NOT COMPLETED|Part Two (up to 6 Days)||0
356834|NCT02249728|876867|P1|COMPLETED|Part Two (up to 6 Days)||6
356835|NCT02249728|876867|P1|STARTED|Part Two (up to 6 Days)||6
356836|NCT02249728|876867|P1|NOT COMPLETED|Part One (4 Days)||0
356837|NCT02249728|876867|P1|COMPLETED|Part One (4 Days)||6
356838|NCT02249728|876867|P1|STARTED|Part One (4 Days)||6
356839|NCT02249104|876877|P1|NOT COMPLETED|Overall Study||3
356840|NCT02249104|876877|P1|COMPLETED|Overall Study||25
356841|NCT02249104|876877|P1|STARTED|Overall Study||28
356842|NCT02249065|876886|P1|NOT COMPLETED|Overall Study||29
356843|NCT02249065|876886|P1|COMPLETED|Overall Study||176
356844|NCT02249065|876886|P1|Treated|Overall Study||181
356845|NCT02249065|876886|P1|STARTED|Overall Study||205
356846|NCT02249052|876894|P1|NOT COMPLETED|Overall Study||0
356847|NCT02249052|876894|P1|COMPLETED|Overall Study||19
356848|NCT02249052|876894|P1|STARTED|Overall Study||19
356849|NCT02248818|876918|P9|NOT COMPLETED|Randomised Study||0
356850|NCT02248818|876919|P8|NOT COMPLETED|Randomised Study||0
356851|NCT02248818|876920|P7|NOT COMPLETED|Randomised Study||0
356852|NCT02248818|876921|P6|NOT COMPLETED|Randomised Study||8
356853|NCT02248818|876922|P5|NOT COMPLETED|Randomised Study||0
356854|NCT02248818|876923|P4|NOT COMPLETED|Randomised Study||0
356855|NCT02248818|876924|P3|NOT COMPLETED|Randomised Study||0
356856|NCT02248818|876925|P2|NOT COMPLETED|Randomised Study||0
356857|NCT02248818|876926|P1|NOT COMPLETED|Randomised Study||0
356858|NCT02248818|876918|P9|COMPLETED|Randomised Study||0
356859|NCT02248818|876919|P8|COMPLETED|Randomised Study||4
356860|NCT02248818|876920|P7|COMPLETED|Randomised Study||6
356861|NCT02248818|876921|P6|COMPLETED|Randomised Study||0
356862|NCT02248818|876922|P5|COMPLETED|Randomised Study||6
356863|NCT02248818|876923|P4|COMPLETED|Randomised Study||6
356864|NCT02248818|876924|P3|COMPLETED|Randomised Study||6
356865|NCT02248818|876925|P2|COMPLETED|Randomised Study||6
356866|NCT02248818|876926|P1|COMPLETED|Randomised Study||6
356867|NCT02248818|876918|P9|STARTED|Randomised Study||0
356868|NCT02248818|876919|P8|STARTED|Randomised Study||4
356869|NCT02248818|876920|P7|STARTED|Randomised Study||6
356870|NCT02248818|876921|P6|STARTED|Randomised Study||8
356871|NCT02248818|876922|P5|STARTED|Randomised Study||6
356872|NCT02248818|876923|P4|STARTED|Randomised Study||6
356873|NCT02248818|876924|P3|STARTED|Randomised Study||6
356874|NCT02248818|876925|P2|STARTED|Randomised Study||6
356875|NCT02248818|876926|P1|STARTED|Randomised Study||6
356876|NCT02248818|876918|P9|NOT COMPLETED|Screening||107
356877|NCT02248818|876919|P8|NOT COMPLETED|Screening||0
356878|NCT02248818|876920|P7|NOT COMPLETED|Screening||0
356879|NCT02248818|876921|P6|NOT COMPLETED|Screening||0
356880|NCT02248818|876922|P5|NOT COMPLETED|Screening||0
356881|NCT02248818|876923|P4|NOT COMPLETED|Screening||0
356882|NCT02248818|876924|P3|NOT COMPLETED|Screening||0
356883|NCT02248818|876925|P2|NOT COMPLETED|Screening||0
356884|NCT02248818|876926|P1|NOT COMPLETED|Screening||0
356885|NCT02248818|876918|P9|COMPLETED|Screening||48
356886|NCT02248818|876919|P8|COMPLETED|Screening||0
356887|NCT02248818|876920|P7|COMPLETED|Screening||0
356888|NCT02248818|876921|P6|COMPLETED|Screening||0
356889|NCT02248818|876922|P5|COMPLETED|Screening||0
356890|NCT02248818|876923|P4|COMPLETED|Screening||0
356891|NCT02248818|876924|P3|COMPLETED|Screening||0
356892|NCT02248818|876925|P2|COMPLETED|Screening||0
356893|NCT02248818|876926|P1|COMPLETED|Screening||0
356894|NCT02248818|876918|P9|STARTED|Screening||155
356895|NCT02248818|876919|P8|STARTED|Screening||0
356896|NCT02248818|876920|P7|STARTED|Screening||0
356897|NCT02248818|876921|P6|STARTED|Screening||0
356898|NCT02248818|876922|P5|STARTED|Screening||0
356899|NCT02248818|876923|P4|STARTED|Screening||0
356900|NCT02248818|876924|P3|STARTED|Screening||0
356901|NCT02248818|876925|P2|STARTED|Screening||0
356902|NCT02248818|876926|P1|STARTED|Screening||0
356903|NCT02248766|877064|P1|NOT COMPLETED|Overall Study||0
356904|NCT02248766|877064|P1|COMPLETED|Overall Study||30
356905|NCT02248766|877064|P1|STARTED|Overall Study||30
356906|NCT02248727|877076|P1|NOT COMPLETED|Overall Study||0
356907|NCT02248727|877076|P1|COMPLETED|Overall Study||30
356908|NCT02248727|877076|P1|STARTED|Overall Study||30
356909|NCT02248675|877089|P2|NOT COMPLETED|Overall Study||1
356910|NCT02248675|877090|P1|NOT COMPLETED|Overall Study||3
356911|NCT02248675|877089|P2|COMPLETED|Overall Study||27
356912|NCT02248675|877090|P1|COMPLETED|Overall Study||23
356913|NCT02248675|877089|P2|STARTED|Overall Study||28
356914|NCT02248675|877090|P1|STARTED|Overall Study||26
356915|NCT02248558|877104|P2|NOT COMPLETED|Overall Study||45
356916|NCT02248558|877105|P1|NOT COMPLETED|Overall Study||52
356917|NCT02248558|877104|P2|COMPLETED|Overall Study||307
356918|NCT02248558|877105|P1|COMPLETED|Overall Study||317
356919|NCT02248558|877104|P2|STARTED|Overall Study||352
356920|NCT02248558|877105|P1|STARTED|Overall Study||369
356921|NCT02248480|877117|P2|NOT COMPLETED|Overall Study||14
356922|NCT02248480|877118|P1|NOT COMPLETED|Overall Study||17
356923|NCT02248480|877117|P2|COMPLETED|Overall Study||162
356924|NCT02248480|877118|P1|COMPLETED|Overall Study||161
356925|NCT02248480|877117|P2|Efficacy Population|Overall Study||176
356926|NCT02248480|877118|P1|Efficacy Population|Overall Study||177
356927|NCT02248480|877117|P2|STARTED|Overall Study||176
356928|NCT02248480|877118|P1|STARTED|Overall Study||178
356929|NCT02248285|877158|P2|NOT COMPLETED|Overall Study||287
356930|NCT02248285|877159|P1|NOT COMPLETED|Overall Study||101
356931|NCT02248285|877158|P2|COMPLETED|Overall Study||571
356932|NCT02248285|877159|P1|COMPLETED|Overall Study||586
356933|NCT02248285|877158|P2|STARTED|Overall Study||858
356934|NCT02248285|877159|P1|STARTED|Overall Study||687
356935|NCT02248246|877165|P1|NOT COMPLETED|Overall Study||0
356936|NCT02248246|877165|P1|COMPLETED|Overall Study||40
356937|NCT02248246|877165|P1|STARTED|Overall Study||40
356938|NCT02248103|877172|P2|NOT COMPLETED|Overall Study||0
356939|NCT02248103|877173|P1|NOT COMPLETED|Overall Study||0
356940|NCT02248103|877172|P2|COMPLETED|Overall Study||10
356941|NCT02248103|877173|P1|COMPLETED|Overall Study||10
356942|NCT02248103|877172|P2|STARTED|Overall Study||10
356943|NCT02248103|877173|P1|STARTED|Overall Study||10
356944|NCT02247960|877185|P2|NOT COMPLETED|Catheter Removed||10
356945|NCT02247960|877186|P1|NOT COMPLETED|Catheter Removed||7
356946|NCT02247960|877185|P2|COMPLETED|Catheter Removed||74
356947|NCT02247960|877186|P1|COMPLETED|Catheter Removed||76
356948|NCT02247960|877185|P2|STARTED|Catheter Removed||84
356949|NCT02247960|877186|P1|STARTED|Catheter Removed||83
356950|NCT02247960|877185|P2|NOT COMPLETED|Patient Consent and Randomization||6
356951|NCT02247960|877186|P1|NOT COMPLETED|Patient Consent and Randomization||2
356952|NCT02247960|877185|P2|COMPLETED|Patient Consent and Randomization||84
356953|NCT02247960|877186|P1|COMPLETED|Patient Consent and Randomization||83
356954|NCT02247960|877185|P2|STARTED|Patient Consent and Randomization||90
356955|NCT02247960|877186|P1|STARTED|Patient Consent and Randomization||85
356956|NCT02247765|877196|P1|NOT COMPLETED|Overall Study||0
356957|NCT02247765|877196|P1|COMPLETED|Overall Study||18
356958|NCT02247765|877196|P1|STARTED|Overall Study||18
356959|NCT02247739|877201|P6|NOT COMPLETED|Overall Study||1
356960|NCT02247739|877202|P5|NOT COMPLETED|Overall Study||1
356961|NCT02247739|877203|P4|NOT COMPLETED|Overall Study||0
356962|NCT02247739|877204|P3|NOT COMPLETED|Overall Study||1
356963|NCT02247739|877205|P2|NOT COMPLETED|Overall Study||3
356964|NCT02247739|877206|P1|NOT COMPLETED|Overall Study||0
356965|NCT02247739|877201|P6|COMPLETED|Overall Study||4
356966|NCT02247739|877202|P5|COMPLETED|Overall Study||5
356967|NCT02247739|877203|P4|COMPLETED|Overall Study||5
356968|NCT02247739|877204|P3|COMPLETED|Overall Study||4
356969|NCT02247739|877205|P2|COMPLETED|Overall Study||3
356970|NCT02247739|877206|P1|COMPLETED|Overall Study||5
356971|NCT02247739|877201|P6|STARTED|Overall Study||5
356972|NCT02247739|877202|P5|STARTED|Overall Study||6
356973|NCT02247739|877203|P4|STARTED|Overall Study||5
356974|NCT02247739|877204|P3|STARTED|Overall Study||5
356975|NCT02247739|877205|P2|STARTED|Overall Study||6
356976|NCT02247739|877206|P1|STARTED|Overall Study||5
356977|NCT02247401|877225|P3|NOT COMPLETED|Overall Study||2
356978|NCT02247401|877226|P2|NOT COMPLETED|Overall Study||2
356979|NCT02247401|877227|P1|NOT COMPLETED|Overall Study||6
356980|NCT02247401|877225|P3|COMPLETED|Overall Study||27
356981|NCT02247401|877226|P2|COMPLETED|Overall Study||29
356982|NCT02247401|877227|P1|COMPLETED|Overall Study||94
356983|NCT02247401|877225|P3|STARTED|Overall Study||29
356984|NCT02247401|877226|P2|STARTED|Overall Study||31
356985|NCT02247401|877227|P1|STARTED|Overall Study||100
356986|NCT02247063|877246|P2|NOT COMPLETED|Overall Study||0
356987|NCT02247063|877247|P1|NOT COMPLETED|Overall Study||0
356988|NCT02247063|877246|P2|COMPLETED|Overall Study||12
356989|NCT02247063|877247|P1|COMPLETED|Overall Study||12
356990|NCT02247063|877246|P2|STARTED|Overall Study||12
356991|NCT02247063|877247|P1|STARTED|Overall Study||12
356992|NCT02247011|877257|P1|NOT COMPLETED|Overall Study||125
356993|NCT02247011|877257|P1|COMPLETED|Overall Study||975
356994|NCT02247011|877257|P1|STARTED|Overall Study||1100
356995|NCT02246998|877278|P4|NOT COMPLETED|Overall Study||2
356996|NCT02246998|877279|P3|NOT COMPLETED|Overall Study||3
356997|NCT02246998|877280|P2|NOT COMPLETED|Overall Study||3
356998|NCT02246998|877281|P1|NOT COMPLETED|Overall Study||2
356999|NCT02246998|877278|P4|COMPLETED|Overall Study||16
357000|NCT02246998|877279|P3|COMPLETED|Overall Study||15
357001|NCT02246998|877280|P2|COMPLETED|Overall Study||15
357002|NCT02246998|877281|P1|COMPLETED|Overall Study||16
357003|NCT02246998|877278|P4|STARTED|Overall Study||18
357004|NCT02246998|877279|P3|STARTED|Overall Study||18
357005|NCT02246998|877280|P2|STARTED|Overall Study||18
357006|NCT02246998|877281|P1|STARTED|Overall Study||18
357007|NCT02246764|877394|P3|NOT COMPLETED|Overall Study||4
357008|NCT02246764|877395|P2|NOT COMPLETED|Overall Study||32
357009|NCT02246764|877396|P1|NOT COMPLETED|Overall Study||18
357010|NCT02246764|877394|P3|COMPLETED|Overall Study||19
357011|NCT02246764|877395|P2|COMPLETED|Overall Study||4
357012|NCT02246764|877396|P1|COMPLETED|Overall Study||16
357013|NCT02246764|877394|P3|STARTED|Overall Study||23
357014|NCT02246764|877395|P2|STARTED|Overall Study||36
357015|NCT02246764|877396|P1|STARTED|Overall Study||34
357016|NCT02246673|877409|P5|NOT COMPLETED|Overall Study||1
357017|NCT02246673|877410|P4|NOT COMPLETED|Overall Study||2
357018|NCT02246673|877411|P3|NOT COMPLETED|Overall Study||0
357019|NCT02246673|877412|P2|NOT COMPLETED|Overall Study||0
357020|NCT02246673|877413|P1|NOT COMPLETED|Overall Study||1
357021|NCT02246673|877409|P5|COMPLETED|Overall Study||11
357022|NCT02246673|877410|P4|COMPLETED|Overall Study||12
357023|NCT02246673|877411|P3|COMPLETED|Overall Study||12
357024|NCT02246673|877412|P2|COMPLETED|Overall Study||12
357025|NCT02246673|877413|P1|COMPLETED|Overall Study||13
357026|NCT02246673|877409|P5|STARTED|Overall Study||12
357027|NCT02246673|877410|P4|STARTED|Overall Study||14
357028|NCT02246673|877411|P3|STARTED|Overall Study||12
357029|NCT02246673|877412|P2|STARTED|Overall Study||12
357030|NCT02246673|877413|P1|STARTED|Overall Study||14
357031|NCT02246660|877521|P3|NOT COMPLETED|Overall Study||1
357032|NCT02246660|877522|P2|NOT COMPLETED|Overall Study||1
357033|NCT02246660|877523|P1|NOT COMPLETED|Overall Study||0
357034|NCT02246660|877521|P3|COMPLETED|Overall Study||21
357035|NCT02246660|877522|P2|COMPLETED|Overall Study||20
357036|NCT02246660|877523|P1|COMPLETED|Overall Study||23
357037|NCT02246660|877521|P3|STARTED|Overall Study||22
357038|NCT02246660|877522|P2|STARTED|Overall Study||21
357039|NCT02246660|877523|P1|STARTED|Overall Study||23
357040|NCT02246621|877533|P2|NOT COMPLETED|Overall Study||148
357041|NCT02246621|877534|P1|NOT COMPLETED|Overall Study||296
357042|NCT02246621|877533|P2|COMPLETED|Overall Study||17
357043|NCT02246621|877534|P1|COMPLETED|Overall Study||32
357044|NCT02246621|877533|P2|Received At Least One Dose of Study Drug|Overall Study||162
357045|NCT02246621|877534|P1|Received At Least One Dose of Study Drug|Overall Study||326
357046|NCT02246621|877533|P2|STARTED|Overall Study||165
357047|NCT02246621|877534|P1|STARTED|Overall Study||328
357048|NCT02246582|877560|P2|NOT COMPLETED|Overall Study||4
357049|NCT02246582|877561|P1|NOT COMPLETED|Overall Study||3
357050|NCT02246582|877560|P2|COMPLETED|Overall Study||41
357051|NCT02246582|877561|P1|COMPLETED|Overall Study||41
357052|NCT02246582|877560|P2|STARTED|Overall Study||45
357053|NCT02246582|877561|P1|STARTED|Overall Study||44
357054|NCT02246309|877569|P2|NOT COMPLETED|Overall Study||0
357055|NCT02246309|877570|P1|NOT COMPLETED|Overall Study||0
357056|NCT02246309|877569|P2|COMPLETED|Overall Study||15
357057|NCT02246309|877570|P1|COMPLETED|Overall Study||16
357058|NCT02246309|877569|P2|STARTED|Overall Study||15
357059|NCT02246309|877570|P1|STARTED|Overall Study|16 patients going through Time Lapse System and 15 through Standard Embryo Culture.|16
357060|NCT02246166|877582|P2|NOT COMPLETED|Overall Study||0
357061|NCT02246166|877583|P1|NOT COMPLETED|Overall Study||1
357062|NCT02246166|877582|P2|COMPLETED|Overall Study||27
357063|NCT02246166|877583|P1|COMPLETED|Overall Study||25
357064|NCT02246166|877582|P2|STARTED|Overall Study||27
357065|NCT02246166|877583|P1|STARTED|Overall Study||26
357066|NCT02246114|877619|P2|NOT COMPLETED|Overall Study||0
357067|NCT02246114|877620|P1|NOT COMPLETED|Overall Study||1
357068|NCT02246114|877619|P2|COMPLETED|Overall Study||0
357069|NCT02246114|877620|P1|COMPLETED|Overall Study||0
357070|NCT02246114|877619|P2|STARTED|Overall Study||0
357071|NCT02246114|877620|P1|STARTED|Overall Study||1
357072|NCT02246062|877630|P4|NOT COMPLETED|Overall Study||0
357073|NCT02246062|877631|P3|NOT COMPLETED|Overall Study||0
357074|NCT02246062|877632|P2|NOT COMPLETED|Overall Study||0
357075|NCT02246062|877633|P1|NOT COMPLETED|Overall Study||0
357076|NCT02246062|877630|P4|COMPLETED|Overall Study||21
357077|NCT02246062|877631|P3|COMPLETED|Overall Study||21
357078|NCT02246062|877632|P2|COMPLETED|Overall Study||21
357079|NCT02246062|877633|P1|COMPLETED|Overall Study||21
357080|NCT02246062|877630|P4|STARTED|Overall Study||21
357081|NCT02246062|877631|P3|STARTED|Overall Study||21
357082|NCT02246062|877632|P2|STARTED|Overall Study||21
357083|NCT02246062|877633|P1|STARTED|Overall Study||21
357084|NCT02245412|877654|P3|NOT COMPLETED|Overall Study||0
357085|NCT02245412|877655|P2|NOT COMPLETED|Overall Study||3
357086|NCT02245412|877656|P1|NOT COMPLETED|Overall Study||5
357087|NCT02245412|877654|P3|COMPLETED|Overall Study||2
357088|NCT02245412|877655|P2|COMPLETED|Overall Study||3
357089|NCT02245412|877656|P1|COMPLETED|Overall Study||12
357090|NCT02245412|877654|P3|STARTED|Overall Study||2
357091|NCT02245412|877655|P2|STARTED|Overall Study||6
357092|NCT02245412|877656|P1|STARTED|Overall Study||17
357093|NCT02245360|877675|P2|NOT COMPLETED|Overall Study||2
357094|NCT02245360|877676|P1|NOT COMPLETED|Overall Study||5
357095|NCT02245360|877675|P2|COMPLETED|Overall Study||52
357096|NCT02245360|877676|P1|COMPLETED|Overall Study||48
357097|NCT02245360|877675|P2|STARTED|Overall Study||54
357098|NCT02245360|877676|P1|STARTED|Overall Study||53
357099|NCT02245217|877684|P1|NOT COMPLETED|Overall Study||2
357100|NCT02245217|877684|P1|COMPLETED|Overall Study||7
357101|NCT02245217|877684|P1|STARTED|Overall Study||9
357102|NCT02244944|877690|P1|NOT COMPLETED|Overall Study||2
357103|NCT02244944|877690|P1|COMPLETED|Overall Study||0
357104|NCT02244944|877690|P1|STARTED|Overall Study||2
357105|NCT02244840|877696|P1|NOT COMPLETED|Overall Study||0
357106|NCT02244840|877696|P1|COMPLETED|Overall Study||40
357107|NCT02244840|877696|P1|STARTED|Overall Study||40
357108|NCT02244619|877702|P2|NOT COMPLETED|Overall Study||21
357109|NCT02244619|877703|P1|NOT COMPLETED|Overall Study||8
357110|NCT02244619|877702|P2|COMPLETED|Overall Study||245
357111|NCT02244619|877703|P1|COMPLETED|Overall Study||241
357112|NCT02244619|877702|P2|STARTED|Overall Study||266
357113|NCT02244619|877703|P1|STARTED|Overall Study||249
357114|NCT02244580|877721|P1|NOT COMPLETED|Overall Study||241
357115|NCT02244580|877721|P1|COMPLETED|Overall Study|An RT-qPCR assay was performed from breast cancer tissues of 769 out of the 1010 patients.|769
357116|NCT02244580|877721|P1|STARTED|Overall Study||1010
357117|NCT02243943|877731|P2|NOT COMPLETED|Overall Study||0
357118|NCT02243943|877732|P1|NOT COMPLETED|Overall Study||0
357119|NCT02243943|877731|P2|COMPLETED|Overall Study||50
357120|NCT02243943|877732|P1|COMPLETED|Overall Study||50
357121|NCT02243943|877731|P2|STARTED|Overall Study||50
357122|NCT02243943|877732|P1|STARTED|Overall Study||50
357123|NCT02243293|877759|P22|NOT COMPLETED|Overall Study||3
357124|NCT02243293|877760|P21|NOT COMPLETED|Overall Study||2
357125|NCT02243293|877761|P20|NOT COMPLETED|Overall Study||1
357126|NCT02243293|877762|P19|NOT COMPLETED|Overall Study||0
357127|NCT02243293|877763|P18|NOT COMPLETED|Overall Study||1
357128|NCT02243293|877764|P17|NOT COMPLETED|Overall Study||3
357129|NCT02243293|877765|P16|NOT COMPLETED|Overall Study||1
357130|NCT02243293|877766|P15|NOT COMPLETED|Overall Study||1
357131|NCT02243293|877767|P14|NOT COMPLETED|Overall Study||0
357132|NCT02243293|877768|P13|NOT COMPLETED|Overall Study||0
357133|NCT02243293|877769|P12|NOT COMPLETED|Overall Study||3
357134|NCT02243293|877770|P11|NOT COMPLETED|Overall Study||0
357135|NCT02243293|877771|P10|NOT COMPLETED|Overall Study||2
357136|NCT02243293|877772|P9|NOT COMPLETED|Overall Study||0
357137|NCT02243293|877773|P8|NOT COMPLETED|Overall Study||0
357138|NCT02243293|877774|P7|NOT COMPLETED|Overall Study||3
357139|NCT02243293|877775|P6|NOT COMPLETED|Overall Study||0
357140|NCT02243293|877776|P5|NOT COMPLETED|Overall Study||1
357141|NCT02243293|877777|P4|NOT COMPLETED|Overall Study||1
357142|NCT02243293|877778|P3|NOT COMPLETED|Overall Study||1
357143|NCT02243293|877779|P2|NOT COMPLETED|Overall Study||1
357144|NCT02243293|877780|P1|NOT COMPLETED|Overall Study||2
357145|NCT02243293|877759|P22|COMPLETED|Overall Study||55
357146|NCT02243293|877760|P21|COMPLETED|Overall Study||143
357147|NCT02243293|877761|P20|COMPLETED|Overall Study||47
357148|NCT02243293|877762|P19|COMPLETED|Overall Study||22
357149|NCT02243293|877763|P18|COMPLETED|Overall Study||21
357150|NCT02243293|877764|P17|COMPLETED|Overall Study||37
357151|NCT02243293|877765|P16|COMPLETED|Overall Study||26
357152|NCT02243293|877766|P15|COMPLETED|Overall Study||27
357153|NCT02243293|877767|P14|COMPLETED|Overall Study||0
357154|NCT02243293|877768|P13|COMPLETED|Overall Study||0
357155|NCT02243293|877769|P12|COMPLETED|Overall Study||50
357156|NCT02243293|877770|P11|COMPLETED|Overall Study||0
357157|NCT02243293|877771|P10|COMPLETED|Overall Study||53
357158|NCT02243293|877772|P9|COMPLETED|Overall Study||0
357159|NCT02243293|877773|P8|COMPLETED|Overall Study||0
357160|NCT02243293|877774|P7|COMPLETED|Overall Study||27
357161|NCT02243293|877775|P6|COMPLETED|Overall Study||31
357162|NCT02243293|877776|P5|COMPLETED|Overall Study||30
357163|NCT02243293|877777|P4|COMPLETED|Overall Study||29
357164|NCT02243293|877778|P3|COMPLETED|Overall Study||24
357165|NCT02243293|877779|P2|COMPLETED|Overall Study||23
357166|NCT02243293|877780|P1|COMPLETED|Overall Study||23
357167|NCT02243293|877759|P22|STARTED|Overall Study||58
357168|NCT02243293|877760|P21|STARTED|Overall Study||145
357169|NCT02243293|877761|P20|STARTED|Overall Study||48
357170|NCT02243293|877762|P19|STARTED|Overall Study||22
357171|NCT02243293|877763|P18|STARTED|Overall Study||22
357172|NCT02243293|877764|P17|STARTED|Overall Study||40
357173|NCT02243293|877765|P16|STARTED|Overall Study||27
357174|NCT02243293|877766|P15|STARTED|Overall Study||28
357175|NCT02243293|877767|P14|STARTED|Overall Study||0
357176|NCT02243293|877768|P13|STARTED|Overall Study||0
357177|NCT02243293|877769|P12|STARTED|Overall Study||53
357178|NCT02243293|877770|P11|STARTED|Overall Study||0
357179|NCT02243293|877771|P10|STARTED|Overall Study||55
357180|NCT02243293|877772|P9|STARTED|Overall Study||0
357181|NCT02243293|877773|P8|STARTED|Overall Study||0
357182|NCT02243293|877774|P7|STARTED|Overall Study||30
357183|NCT02243293|877775|P6|STARTED|Overall Study||31
357184|NCT02243293|877776|P5|STARTED|Overall Study||31
357185|NCT02243293|877777|P4|STARTED|Overall Study||30
357186|NCT02243293|877778|P3|STARTED|Overall Study||25
357187|NCT02243293|877779|P2|STARTED|Overall Study||24
357188|NCT02243293|877780|P1|STARTED|Overall Study||25
357189|NCT02243280|877879|P11|NOT COMPLETED|Treated||3
357190|NCT02243280|877880|P10|NOT COMPLETED|Treated||0
357191|NCT02243280|877881|P9|NOT COMPLETED|Treated||1
357192|NCT02243280|877882|P8|NOT COMPLETED|Treated||0
357193|NCT02243280|877883|P7|NOT COMPLETED|Treated||0
357194|NCT02243280|877884|P6|NOT COMPLETED|Treated||0
357195|NCT02243280|877885|P5|NOT COMPLETED|Treated||0
357196|NCT02243280|877886|P4|NOT COMPLETED|Treated||0
357197|NCT02243280|877887|P3|NOT COMPLETED|Treated||0
357198|NCT02243280|877888|P2|NOT COMPLETED|Treated||0
357199|NCT02243280|877889|P1|NOT COMPLETED|Treated||1
357200|NCT02243280|877879|P11|COMPLETED|Treated||31
357201|NCT02243280|877880|P10|COMPLETED|Treated||0
357202|NCT02243280|877881|P9|COMPLETED|Treated||31
357203|NCT02243280|877882|P8|COMPLETED|Treated||0
357204|NCT02243280|877883|P7|COMPLETED|Treated||0
357205|NCT02243280|877884|P6|COMPLETED|Treated||27
357206|NCT02243280|877885|P5|COMPLETED|Treated||0
357207|NCT02243280|877886|P4|COMPLETED|Treated||0
357208|NCT02243280|877887|P3|COMPLETED|Treated||0
357209|NCT02243280|877888|P2|COMPLETED|Treated||39
357210|NCT02243280|877889|P1|COMPLETED|Treated||41
357211|NCT02243280|877879|P11|Completed Treatment|Treated||33
357212|NCT02243280|877880|P10|Completed Treatment|Treated||0
357213|NCT02243280|877881|P9|Completed Treatment|Treated||32
357214|NCT02243280|877882|P8|Completed Treatment|Treated||0
357215|NCT02243280|877883|P7|Completed Treatment|Treated||0
357216|NCT02243280|877884|P6|Completed Treatment|Treated||27
357217|NCT02243280|877885|P5|Completed Treatment|Treated||0
357218|NCT02243280|877886|P4|Completed Treatment|Treated||0
357219|NCT02243280|877887|P3|Completed Treatment|Treated||0
357220|NCT02243280|877888|P2|Completed Treatment|Treated||38
357221|NCT02243280|877889|P1|Completed Treatment|Treated||42
357222|NCT02243280|877879|P11|STARTED|Treated||34
357223|NCT02243280|877880|P10|STARTED|Treated||0
357224|NCT02243280|877881|P9|STARTED|Treated|Two Arm I participants received ABT-493 doses of 200 mg instead of 300 mg and are included in Arm A|32
357225|NCT02243280|877882|P8|STARTED|Treated||0
357226|NCT02243280|877883|P7|STARTED|Treated||0
357227|NCT02243280|877884|P6|STARTED|Treated||27
357228|NCT02243280|877885|P5|STARTED|Treated||0
357229|NCT02243280|877886|P4|STARTED|Treated||0
357230|NCT02243280|877887|P3|STARTED|Treated||0
357231|NCT02243280|877888|P2|STARTED|Treated||39
357232|NCT02243280|877889|P1|STARTED|Treated|Two Arm I participants received ABT-493 doses of 200 mg instead of 300 mg and are included in Arm A|42
357233|NCT02243280|877879|P11|NOT COMPLETED|Enrolled||0
357234|NCT02243280|877880|P10|NOT COMPLETED|Enrolled||0
357235|NCT02243280|877881|P9|NOT COMPLETED|Enrolled||0
357236|NCT02243280|877882|P8|NOT COMPLETED|Enrolled||0
357237|NCT02243280|877883|P7|NOT COMPLETED|Enrolled||0
357238|NCT02243280|877884|P6|NOT COMPLETED|Enrolled||0
357239|NCT02243280|877885|P5|NOT COMPLETED|Enrolled||0
357240|NCT02243280|877886|P4|NOT COMPLETED|Enrolled||0
357241|NCT02243280|877887|P3|NOT COMPLETED|Enrolled||0
357242|NCT02243280|877888|P2|NOT COMPLETED|Enrolled||0
357243|NCT02243280|877889|P1|NOT COMPLETED|Enrolled||0
357244|NCT02243280|877879|P11|COMPLETED|Enrolled||34
357245|NCT02243280|877880|P10|COMPLETED|Enrolled||0
357246|NCT02243280|877881|P9|COMPLETED|Enrolled||34
357247|NCT02243280|877882|P8|COMPLETED|Enrolled||0
357248|NCT02243280|877883|P7|COMPLETED|Enrolled||0
357249|NCT02243280|877884|P6|COMPLETED|Enrolled||27
357250|NCT02243280|877885|P5|COMPLETED|Enrolled||0
357251|NCT02243280|877886|P4|COMPLETED|Enrolled||0
357252|NCT02243280|877887|P3|COMPLETED|Enrolled||0
357253|NCT02243280|877888|P2|COMPLETED|Enrolled||39
357254|NCT02243280|877889|P1|COMPLETED|Enrolled||40
357255|NCT02243280|877879|P11|STARTED|Enrolled||34
357256|NCT02243280|877880|P10|STARTED|Enrolled||0
357257|NCT02243280|877881|P9|STARTED|Enrolled||34
357258|NCT02243280|877882|P8|STARTED|Enrolled||0
357259|NCT02243280|877883|P7|STARTED|Enrolled||0
357260|NCT02243280|877884|P6|STARTED|Enrolled||27
357261|NCT02243280|877885|P5|STARTED|Enrolled||0
357262|NCT02243280|877886|P4|STARTED|Enrolled||0
357263|NCT02243280|877887|P3|STARTED|Enrolled||0
357264|NCT02243280|877888|P2|STARTED|Enrolled||39
357265|NCT02243280|877889|P1|STARTED|Enrolled||40
357266|NCT02243202|877944|P4|NOT COMPLETED|Overall Study||23
357267|NCT02243202|877945|P3|NOT COMPLETED|Overall Study||31
357268|NCT02243202|877946|P2|NOT COMPLETED|Overall Study||25
357269|NCT02243202|877947|P1|NOT COMPLETED|Overall Study||25
357270|NCT02243202|877944|P4|COMPLETED|Overall Study||61
357271|NCT02243202|877945|P3|COMPLETED|Overall Study||53
357272|NCT02243202|877946|P2|COMPLETED|Overall Study||60
357273|NCT02243202|877947|P1|COMPLETED|Overall Study||57
357274|NCT02243202|877944|P4|Treated|Overall Study||83
357275|NCT02243202|877945|P3|Treated|Overall Study||84
357276|NCT02243202|877946|P2|Treated|Overall Study||85
357277|NCT02243202|877947|P1|Treated|Overall Study||82
357278|NCT02243202|877944|P4|STARTED|Overall Study||84
357279|NCT02243202|877945|P3|STARTED|Overall Study||84
357280|NCT02243202|877946|P2|STARTED|Overall Study||85
357281|NCT02243202|877947|P1|STARTED|Overall Study||82
357282|NCT02243176|877983|P2|NOT COMPLETED|Overall Study||15
357283|NCT02243176|877984|P1|NOT COMPLETED|Overall Study||14
357284|NCT02243176|877983|P2|COMPLETED|Overall Study||229
357285|NCT02243176|877984|P1|COMPLETED|Overall Study||230
357286|NCT02243176|877983|P2|STARTED|Overall Study||244
357287|NCT02243176|877984|P1|STARTED|Overall Study|3 of the randomized subjects withdrew before taking any medication|244
357288|NCT02243046|878009|P3|NOT COMPLETED|Overall Study||4
357289|NCT02243046|878010|P2|NOT COMPLETED|Overall Study||1
357290|NCT02243046|878011|P1|NOT COMPLETED|Overall Study||1
357291|NCT02243046|878009|P3|COMPLETED|Overall Study||49
357292|NCT02243046|878010|P2|COMPLETED|Overall Study||53
357293|NCT02243046|878011|P1|COMPLETED|Overall Study||54
357294|NCT02243046|878009|P3|6 Month|Overall Study|2 subjects didn't return for 6 month clinic visit|49
357295|NCT02243046|878010|P2|6 Month|Overall Study||53
357296|NCT02243046|878011|P1|6 Month|Overall Study||54
357297|NCT02243046|878009|P3|3 Month|Overall Study|2 subjects didn't return for 3 month clinic visit|51
357298|NCT02243046|878010|P2|3 Month|Overall Study|1 subject didn't return for 3 month clinic visit|53
357299|NCT02243046|878011|P1|3 Month|Overall Study|1 subject didn't return for 3 month clinic visit|54
357300|NCT02243046|878009|P3|STARTED|Overall Study||53
357301|NCT02243046|878010|P2|STARTED|Overall Study||54
357302|NCT02243046|878011|P1|STARTED|Overall Study||55
357303|NCT02243007|878036|P2|NOT COMPLETED|Overall Study||0
357304|NCT02243007|878037|P1|NOT COMPLETED|Overall Study||0
357305|NCT02243007|878036|P2|COMPLETED|Overall Study||3
357306|NCT02243007|878037|P1|COMPLETED|Overall Study||4
357307|NCT02243007|878036|P2|STARTED|Overall Study||3
357308|NCT02243007|878037|P1|STARTED|Overall Study||4
357309|NCT02242994|878059|P1|NOT COMPLETED|Overall Study||0
357310|NCT02242994|878059|P1|COMPLETED|Overall Study||5
357311|NCT02242994|878059|P1|STARTED|Overall Study||5
357312|NCT02242643|878066|P2|NOT COMPLETED|Overall Study||78
357313|NCT02242643|878067|P1|NOT COMPLETED|Overall Study||75
357314|NCT02242643|878066|P2|COMPLETED|Overall Study||1139
357315|NCT02242643|878067|P1|COMPLETED|Overall Study||1132
357316|NCT02242643|878066|P2|STARTED|Overall Study||1217
357317|NCT02242643|878067|P1|STARTED|Overall Study||1207
357318|NCT02242630|878103|P4|NOT COMPLETED|Overall Study||0
357319|NCT02242630|878104|P3|NOT COMPLETED|Overall Study||0
357320|NCT02242630|878105|P2|NOT COMPLETED|Overall Study||0
357321|NCT02242630|878106|P1|NOT COMPLETED|Overall Study||0
357322|NCT02242630|878103|P4|COMPLETED|Overall Study||16
357323|NCT02242630|878104|P3|COMPLETED|Overall Study||15
357324|NCT02242630|878105|P2|COMPLETED|Overall Study||15
357325|NCT02242630|878106|P1|COMPLETED|Overall Study||15
357326|NCT02242630|878103|P4|STARTED|Overall Study||16
357327|NCT02242630|878104|P3|STARTED|Overall Study||15
357328|NCT02242630|878105|P2|STARTED|Overall Study||15
357329|NCT02242630|878106|P1|STARTED|Overall Study||15
357330|NCT02242305|878122|P2|NOT COMPLETED|Overall Study||10
357331|NCT02242305|878123|P1|NOT COMPLETED|Overall Study||6
357332|NCT02242305|878122|P2|COMPLETED|Overall Study||141
357333|NCT02242305|878123|P1|COMPLETED|Overall Study||145
357334|NCT02242305|878122|P2|STARTED|Overall Study||151
357335|NCT02242305|878123|P1|STARTED|Overall Study||151
357336|NCT02242201|878144|P3|NOT COMPLETED|Overall Study||1
357337|NCT02242201|878145|P2|NOT COMPLETED|Overall Study||1
357338|NCT02242201|878146|P1|NOT COMPLETED|Overall Study||4
357339|NCT02242201|878144|P3|COMPLETED|Overall Study||54
357340|NCT02242201|878145|P2|COMPLETED|Overall Study||54
357341|NCT02242201|878146|P1|COMPLETED|Overall Study||51
357342|NCT02242201|878144|P3|STARTED|Overall Study||55
357343|NCT02242201|878145|P2|STARTED|Overall Study||55
357344|NCT02242201|878146|P1|STARTED|Overall Study||55
357345|NCT02242019|878178|P1|NOT COMPLETED|Overall Study||0
357346|NCT02242019|878178|P1|COMPLETED|Overall Study||109
357347|NCT02242019|878178|P1|STARTED|Overall Study||109
357348|NCT02241889|878184|P6|NOT COMPLETED|Overall Study||1
357349|NCT02241889|878185|P5|NOT COMPLETED|Overall Study||0
357350|NCT02241889|878186|P4|NOT COMPLETED|Overall Study||0
357351|NCT02241889|878187|P3|NOT COMPLETED|Overall Study||1
357352|NCT02241889|878188|P2|NOT COMPLETED|Overall Study||0
357353|NCT02241889|878189|P1|NOT COMPLETED|Overall Study||0
357354|NCT02241889|878184|P6|COMPLETED|Overall Study||3
357355|NCT02241889|878185|P5|COMPLETED|Overall Study||5
357356|NCT02241889|878186|P4|COMPLETED|Overall Study||3
357357|NCT02241889|878187|P3|COMPLETED|Overall Study||2
357358|NCT02241889|878188|P2|COMPLETED|Overall Study||4
357359|NCT02241889|878189|P1|COMPLETED|Overall Study||4
357360|NCT02241889|878184|P6|STARTED|Overall Study||4
357361|NCT02241889|878185|P5|STARTED|Overall Study||5
357362|NCT02241889|878186|P4|STARTED|Overall Study||3
357363|NCT02241889|878187|P3|STARTED|Overall Study||3
357364|NCT02241889|878188|P2|STARTED|Overall Study||4
357365|NCT02241889|878189|P1|STARTED|Overall Study||4
357366|NCT02241785|878224|P1|NOT COMPLETED|Overall Study||47
357367|NCT02241785|878224|P1|COMPLETED|Overall Study||0
357368|NCT02241785|878224|P1|STARTED|Overall Study||47
357369|NCT02241720|878232|P1|NOT COMPLETED|Overall Study||4
357370|NCT02241720|878232|P1|COMPLETED|Overall Study||1
357371|NCT02241720|878232|P1|STARTED|Overall Study||5
357372|NCT02241551|878238|P2|NOT COMPLETED|Overall Study||0
357373|NCT02241551|878239|P1|NOT COMPLETED|Overall Study||1
357374|NCT02241551|878238|P2|COMPLETED|Overall Study||0
357375|NCT02241551|878239|P1|COMPLETED|Overall Study||0
357376|NCT02241551|878238|P2|STARTED|Overall Study||0
357377|NCT02241551|878239|P1|STARTED|Overall Study||1
357378|NCT02241486|878259|P1|NOT COMPLETED|Overall Study||0
357379|NCT02241486|878259|P1|COMPLETED|Overall Study||2
357380|NCT02241486|878259|P1|STARTED|Overall Study||2
357381|NCT02241187|878263|P1|NOT COMPLETED|Overall Study||2
357382|NCT02241187|878263|P1|COMPLETED|Overall Study||0
357383|NCT02241187|878263|P1|STARTED|Overall Study||2
357384|NCT02240654|878273|P5|NOT COMPLETED|Overall Study||0
357385|NCT02240654|878274|P4|NOT COMPLETED|Overall Study||0
357386|NCT02240654|878275|P3|NOT COMPLETED|Overall Study||0
357387|NCT02240654|878276|P2|NOT COMPLETED|Overall Study||0
357388|NCT02240654|878277|P1|NOT COMPLETED|Overall Study||0
357389|NCT02240654|878273|P5|COMPLETED|Overall Study||1285
357390|NCT02240654|878274|P4|COMPLETED|Overall Study||2150
357391|NCT02240654|878275|P3|COMPLETED|Overall Study||28619
357392|NCT02240654|878276|P2|COMPLETED|Overall Study||2813
357393|NCT02240654|878277|P1|COMPLETED|Overall Study||1706
357394|NCT02240654|878273|P5|STARTED|Overall Study||1285
357395|NCT02240654|878274|P4|STARTED|Overall Study||2150
357396|NCT02240654|878275|P3|STARTED|Overall Study||28619
357397|NCT02240654|878276|P2|STARTED|Overall Study||2813
357398|NCT02240654|878277|P1|STARTED|Overall Study||1706
357399|NCT02240628|878291|P2|NOT COMPLETED|Overall Study||5
357400|NCT02240628|878292|P1|NOT COMPLETED|Overall Study||6
357401|NCT02240628|878291|P2|COMPLETED|Overall Study||33
357402|NCT02240628|878292|P1|COMPLETED|Overall Study||32
357403|NCT02240628|878291|P2|STARTED|Overall Study||38
357404|NCT02240628|878292|P1|STARTED|Overall Study||38
357405|NCT02240589|878302|P2|NOT COMPLETED|Overall Study||2
357406|NCT02240589|878303|P1|NOT COMPLETED|Overall Study||2
357407|NCT02240589|878302|P2|COMPLETED|Overall Study||4
357408|NCT02240589|878303|P1|COMPLETED|Overall Study||3
357409|NCT02240589|878302|P2|STARTED|Overall Study||6
357410|NCT02240589|878303|P1|STARTED|Overall Study||5
357411|NCT02240368|878326|P3|NOT COMPLETED|Overall Study||1
357412|NCT02240368|878327|P2|NOT COMPLETED|Overall Study||0
357413|NCT02240368|878328|P1|NOT COMPLETED|Overall Study||1
357414|NCT02240368|878326|P3|COMPLETED|Overall Study||18
357415|NCT02240368|878327|P2|COMPLETED|Overall Study||22
357416|NCT02240368|878328|P1|COMPLETED|Overall Study||8
357417|NCT02240368|878326|P3|STARTED|Overall Study||19
357418|NCT02240368|878327|P2|STARTED|Overall Study||22
357419|NCT02240368|878328|P1|STARTED|Overall Study||9
357420|NCT02240329|878345|P1|NOT COMPLETED|Overall Study||0
357421|NCT02240329|878345|P1|COMPLETED|Overall Study||4
357422|NCT02240329|878345|P1|Determination of Urge to Cough|Overall Study||4
357423|NCT02240329|878345|P1|STARTED|Overall Study||4
357424|NCT02240030|878353|P3|NOT COMPLETED|Overall Study||15
357425|NCT02240030|878354|P2|NOT COMPLETED|Overall Study||17
357426|NCT02240030|878355|P1|NOT COMPLETED|Overall Study||17
357427|NCT02240030|878353|P3|COMPLETED|Overall Study||97
357428|NCT02240030|878354|P2|COMPLETED|Overall Study||97
357429|NCT02240030|878355|P1|COMPLETED|Overall Study||96
357430|NCT02240030|878353|P3|STARTED|Overall Study||112
357431|NCT02240030|878354|P2|STARTED|Overall Study||114
357432|NCT02240030|878355|P1|STARTED|Overall Study||113
357433|NCT02239978|878379|P2|NOT COMPLETED|Overall Study||0
357434|NCT02239978|878380|P1|NOT COMPLETED|Overall Study||2
357435|NCT02239978|878379|P2|COMPLETED|Overall Study||12
357436|NCT02239978|878380|P1|COMPLETED|Overall Study||28
357437|NCT02239978|878379|P2|STARTED|Overall Study||12
357438|NCT02239978|878380|P1|STARTED|Overall Study||30
357439|NCT02239939|878397|P2|NOT COMPLETED|Overall Study||2
357440|NCT02239939|878398|P1|NOT COMPLETED|Overall Study||2
357441|NCT02239939|878397|P2|COMPLETED|Overall Study||15
357442|NCT02239939|878398|P1|COMPLETED|Overall Study||18
357443|NCT02239939|878397|P2|STARTED|Overall Study||17
357444|NCT02239939|878398|P1|STARTED|Overall Study||20
357445|NCT02239926|878414|P2|NOT COMPLETED|Overall Study||1
357446|NCT02239926|878415|P1|NOT COMPLETED|Overall Study||0
357447|NCT02239926|878414|P2|COMPLETED|Overall Study||1
357448|NCT02239926|878415|P1|COMPLETED|Overall Study||0
357449|NCT02239926|878414|P2|STARTED|Overall Study||2
357450|NCT02239926|878415|P1|STARTED|Overall Study||0
357451|NCT02239744|878425|P2|NOT COMPLETED|Period 2||0
357452|NCT02239744|878426|P1|NOT COMPLETED|Period 2||0
357453|NCT02239744|878425|P2|COMPLETED|Period 2||18
357454|NCT02239744|878426|P1|COMPLETED|Period 2||17
357455|NCT02239744|878425|P2|STARTED|Period 2||18
357456|NCT02239744|878426|P1|STARTED|Period 2||17
357457|NCT02239744|878425|P2|NOT COMPLETED|Period 1||0
357458|NCT02239744|878426|P1|NOT COMPLETED|Period 1||0
357459|NCT02239744|878425|P2|COMPLETED|Period 1||18
357460|NCT02239744|878426|P1|COMPLETED|Period 1||17
357461|NCT02239744|878425|P2|STARTED|Period 1||18
357462|NCT02239744|878426|P1|STARTED|Period 1||17
357463|NCT02239692|878440|P2|NOT COMPLETED|Overall Study||13
357464|NCT02239692|878441|P1|NOT COMPLETED|Overall Study||6
357465|NCT02239692|878440|P2|COMPLETED|Overall Study||118
357466|NCT02239692|878441|P1|COMPLETED|Overall Study||67
357467|NCT02239692|878440|P2|Safety Analysis Set|Overall Study||125
357468|NCT02239692|878441|P1|Safety Analysis Set|Overall Study||70
357469|NCT02239692|878440|P2|Per-protocol Analysis Set|Overall Study||120
357470|NCT02239692|878441|P1|Per-protocol Analysis Set|Overall Study||66
357471|NCT02239692|878440|P2|Intention-to-treat Analysis Set|Overall Study||131
357472|NCT02239692|878441|P1|Intention-to-treat Analysis Set|Overall Study||73
357473|NCT02239692|878440|P2|STARTED|Overall Study||131
357474|NCT02239692|878441|P1|STARTED|Overall Study||73
357475|NCT02239679|878460|P3|NOT COMPLETED|Overall Study||1
357476|NCT02239679|878461|P2|NOT COMPLETED|Overall Study||3
357477|NCT02239679|878462|P1|NOT COMPLETED|Overall Study||3
357478|NCT02239679|878460|P3|COMPLETED|Overall Study||53
357479|NCT02239679|878461|P2|COMPLETED|Overall Study||56
357480|NCT02239679|878462|P1|COMPLETED|Overall Study||50
357481|NCT02239679|878460|P3|STARTED|Overall Study||54
357482|NCT02239679|878461|P2|STARTED|Overall Study||59
357483|NCT02239679|878462|P1|STARTED|Overall Study||53
357484|NCT02239289|878674|P1|NOT COMPLETED|Overall Study||0
357485|NCT02239289|878674|P1|COMPLETED|Overall Study||21
357486|NCT02239289|878674|P1|STARTED|Overall Study||21
357487|NCT02239094|878693|P1|NOT COMPLETED|Overall Study||2
357488|NCT02239094|878693|P1|COMPLETED|Overall Study||18
357489|NCT02239094|878693|P1|STARTED|Overall Study||20
357490|NCT02238925|878698|P1|NOT COMPLETED|Overall Study||25
357491|NCT02238925|878698|P1|COMPLETED|Overall Study||1
357492|NCT02238925|878698|P1|STARTED|Overall Study||26
357493|NCT02238782|878706|P1|NOT COMPLETED|Overall Study||0
357494|NCT02238782|878706|P1|COMPLETED|Overall Study||12
357495|NCT02238782|878706|P1|Subjects Treated|Overall Study||12
357496|NCT02238782|878706|P1|STARTED|Overall Study||12
357497|NCT02238483|878712|P2|NOT COMPLETED|Overall Study||14
357498|NCT02238483|878713|P1|NOT COMPLETED|Overall Study||15
357499|NCT02238483|878712|P2|COMPLETED|Overall Study||91
357500|NCT02238483|878713|P1|COMPLETED|Overall Study||93
357501|NCT02238483|878712|P2|STARTED|Overall Study||105
357502|NCT02238483|878713|P1|STARTED|Overall Study||108
357503|NCT02238379|878751|P2|NOT COMPLETED|Overall Study||0
357504|NCT02238379|878752|P1|NOT COMPLETED|Overall Study||1
357505|NCT02238379|878751|P2|COMPLETED|Overall Study||14
357506|NCT02238379|878752|P1|COMPLETED|Overall Study||11
357507|NCT02238379|878751|P2|STARTED|Overall Study||14
357508|NCT02238379|878752|P1|STARTED|Overall Study||12
357509|NCT02238080|878778|P1|NOT COMPLETED|Overall Study||25
357510|NCT02238080|878778|P1|COMPLETED|Overall Study||172
357511|NCT02238080|878778|P1|STARTED|Overall Study||197
357512|NCT02238067|878792|P1|NOT COMPLETED|Overall Study||45
357513|NCT02238067|878792|P1|COMPLETED|Overall Study||151
357514|NCT02238067|878792|P1|STARTED|Overall Study||196
357515|NCT02238028|878815|P2|NOT COMPLETED|Overall Study||2
357516|NCT02238028|878816|P1|NOT COMPLETED|Overall Study||2
357517|NCT02238028|878815|P2|COMPLETED|Overall Study||12
357518|NCT02238028|878816|P1|COMPLETED|Overall Study||12
357519|NCT02238028|878815|P2|STARTED|Overall Study||14
357520|NCT02238028|878816|P1|STARTED|Overall Study||14
357521|NCT02237118|878837|P2|NOT COMPLETED|Overall Study||1
357522|NCT02237118|878838|P1|NOT COMPLETED|Overall Study||1
357523|NCT02237118|878837|P2|COMPLETED|Overall Study||62
357524|NCT02237118|878838|P1|COMPLETED|Overall Study||59
357525|NCT02237118|878837|P2|STARTED|Overall Study||63
357526|NCT02237118|878838|P1|STARTED|Overall Study||60
357527|NCT02237092|878852|P1|NOT COMPLETED|Overall Study||0
357528|NCT02237092|878852|P1|COMPLETED|Overall Study||196
357529|NCT02237092|878852|P1|STARTED|Overall Study||196
357530|NCT02236767|878869|P1|NOT COMPLETED|Overall Study||0
357531|NCT02236767|878869|P1|COMPLETED|Overall Study||1
357532|NCT02236767|878869|P1|STARTED|Overall Study||1
357533|NCT02236611|878875|P2|NOT COMPLETED|Overall Study||34
357534|NCT02236611|878876|P1|NOT COMPLETED|Overall Study||26
357535|NCT02236611|878875|P2|COMPLETED|Overall Study||484
357536|NCT02236611|878876|P1|COMPLETED|Overall Study||490
357537|NCT02236611|878875|P2|STARTED|Overall Study||518
357538|NCT02236611|878876|P1|STARTED|Overall Study||516
357539|NCT02236598|878884|P2|NOT COMPLETED|Overall Study||2
357540|NCT02236598|878885|P1|NOT COMPLETED|Overall Study||0
357541|NCT02236598|878884|P2|COMPLETED|Overall Study||12
357542|NCT02236598|878885|P1|COMPLETED|Overall Study||15
357543|NCT02236598|878884|P2|STARTED|Overall Study||14
357544|NCT02236598|878885|P1|STARTED|Overall Study||15
357545|NCT02236546|878897|P1|NOT COMPLETED|Overall Study||0
357546|NCT02236546|878897|P1|COMPLETED|Overall Study||3
357547|NCT02236546|878897|P1|STARTED|Overall Study||3
357548|NCT02236338|878906|P2|NOT COMPLETED|Overall Study||0
357549|NCT02236338|878907|P1|NOT COMPLETED|Overall Study||0
357550|NCT02236338|878906|P2|COMPLETED|Overall Study||100
357551|NCT02236338|878907|P1|COMPLETED|Overall Study||100
357552|NCT02236338|878906|P2|STARTED|Overall Study||100
357553|NCT02236338|878907|P1|STARTED|Overall Study||100
357554|NCT02236130|878921|P2|NOT COMPLETED|Overall Study||12
357555|NCT02236130|878922|P1|NOT COMPLETED|Overall Study||7
357556|NCT02236130|878921|P2|COMPLETED|Overall Study||15
357557|NCT02236130|878922|P1|COMPLETED|Overall Study||15
357558|NCT02236130|878921|P2|STARTED|Overall Study||27
357559|NCT02236130|878922|P1|STARTED|Overall Study||22
357560|NCT02235987|878930|P1|NOT COMPLETED|Overall Study||1
357561|NCT02235987|878930|P1|COMPLETED|Overall Study||19
357562|NCT02235987|878930|P1|Received 1800 µg DG3173|Overall Study||19
357563|NCT02235987|878930|P1|Received 900 µg DG3173|Overall Study||19
357564|NCT02235987|878930|P1|Received 300 µg DG3173|Overall Study||20
357565|NCT02235987|878930|P1|Received 100 µg DG3173|Overall Study||20
357566|NCT02235987|878930|P1|Received Octreotide|Overall Study||20
357567|NCT02235987|878930|P1|STARTED|Overall Study||20
357568|NCT02235870|878945|P2|NOT COMPLETED|Overall Study||61
357569|NCT02235870|878946|P1|NOT COMPLETED|Overall Study||38
357570|NCT02235870|878945|P2|COMPLETED|Overall Study||128
357571|NCT02235870|878946|P1|COMPLETED|Overall Study||160
357572|NCT02235870|878945|P2|Crossover (Week 24)|Overall Study||138
357573|NCT02235870|878946|P1|Crossover (Week 24)|Overall Study||170
357574|NCT02235870|878945|P2|Completed Phase I (Week 24)|Overall Study||179
357575|NCT02235870|878946|P1|Completed Phase I (Week 24)|Overall Study||182
357576|NCT02235870|878945|P2|STARTED|Overall Study||189
357577|NCT02235870|878946|P1|STARTED|Overall Study||198
357578|NCT02235831|878955|P6|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
357579|NCT02235831|878956|P5|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
357580|NCT02235831|878957|P4|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
357581|NCT02235831|878958|P3|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
357582|NCT02235831|878959|P2|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
357583|NCT02235831|878960|P1|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
357584|NCT02235831|878955|P6|COMPLETED|Period 3, Third 5 Days of Wear||4
357585|NCT02235831|878956|P5|COMPLETED|Period 3, Third 5 Days of Wear||4
357586|NCT02235831|878957|P4|COMPLETED|Period 3, Third 5 Days of Wear||4
357587|NCT02235831|878958|P3|COMPLETED|Period 3, Third 5 Days of Wear||4
357588|NCT02235831|878959|P2|COMPLETED|Period 3, Third 5 Days of Wear||4
357589|NCT02235831|878960|P1|COMPLETED|Period 3, Third 5 Days of Wear||4
357590|NCT02235831|878955|P6|STARTED|Period 3, Third 5 Days of Wear||4
357591|NCT02235831|878956|P5|STARTED|Period 3, Third 5 Days of Wear||4
357592|NCT02235831|878957|P4|STARTED|Period 3, Third 5 Days of Wear||4
357593|NCT02235831|878958|P3|STARTED|Period 3, Third 5 Days of Wear||4
357594|NCT02235831|878959|P2|STARTED|Period 3, Third 5 Days of Wear||4
357595|NCT02235831|878960|P1|STARTED|Period 3, Third 5 Days of Wear||4
357596|NCT02235831|878955|P6|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
357597|NCT02235831|878956|P5|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
357598|NCT02235831|878957|P4|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
357599|NCT02235831|878958|P3|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
357600|NCT02235831|878959|P2|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
357601|NCT02235831|878960|P1|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
357602|NCT02235831|878955|P6|COMPLETED|Period 2, Second 5 Days of Wear||4
357603|NCT02235831|878956|P5|COMPLETED|Period 2, Second 5 Days of Wear||4
357604|NCT02235831|878957|P4|COMPLETED|Period 2, Second 5 Days of Wear||4
357605|NCT02235831|878958|P3|COMPLETED|Period 2, Second 5 Days of Wear||4
357606|NCT02235831|878959|P2|COMPLETED|Period 2, Second 5 Days of Wear||4
357607|NCT02235831|878960|P1|COMPLETED|Period 2, Second 5 Days of Wear||4
357608|NCT02235831|878955|P6|STARTED|Period 2, Second 5 Days of Wear||4
357609|NCT02235831|878956|P5|STARTED|Period 2, Second 5 Days of Wear||4
357610|NCT02235831|878957|P4|STARTED|Period 2, Second 5 Days of Wear||4
357611|NCT02235831|878958|P3|STARTED|Period 2, Second 5 Days of Wear||4
357612|NCT02235831|878959|P2|STARTED|Period 2, Second 5 Days of Wear||4
357613|NCT02235831|878960|P1|STARTED|Period 2, Second 5 Days of Wear||4
357614|NCT02235831|878955|P6|NOT COMPLETED|Period 1, First 5 Days of Wear||0
357615|NCT02235831|878956|P5|NOT COMPLETED|Period 1, First 5 Days of Wear||0
357616|NCT02235831|878957|P4|NOT COMPLETED|Period 1, First 5 Days of Wear||0
357617|NCT02235831|878958|P3|NOT COMPLETED|Period 1, First 5 Days of Wear||0
357618|NCT02235831|878959|P2|NOT COMPLETED|Period 1, First 5 Days of Wear||0
357619|NCT02235831|878960|P1|NOT COMPLETED|Period 1, First 5 Days of Wear||0
357620|NCT02235831|878955|P6|COMPLETED|Period 1, First 5 Days of Wear||4
357621|NCT02235831|878956|P5|COMPLETED|Period 1, First 5 Days of Wear||4
357622|NCT02235831|878957|P4|COMPLETED|Period 1, First 5 Days of Wear||4
357623|NCT02235831|878958|P3|COMPLETED|Period 1, First 5 Days of Wear||4
357624|NCT02235831|878959|P2|COMPLETED|Period 1, First 5 Days of Wear||4
357625|NCT02235831|878960|P1|COMPLETED|Period 1, First 5 Days of Wear||4
357626|NCT02235831|878955|P6|STARTED|Period 1, First 5 Days of Wear||4
357627|NCT02235831|878956|P5|STARTED|Period 1, First 5 Days of Wear||4
357628|NCT02235831|878957|P4|STARTED|Period 1, First 5 Days of Wear||4
357629|NCT02235831|878958|P3|STARTED|Period 1, First 5 Days of Wear||4
357630|NCT02235831|878959|P2|STARTED|Period 1, First 5 Days of Wear||4
357631|NCT02235831|878960|P1|STARTED|Period 1, First 5 Days of Wear||4
357632|NCT02235493|878967|P1|NOT COMPLETED|Overall Study||0
357633|NCT02235493|878967|P1|COMPLETED|Overall Study||6
357634|NCT02235493|878967|P1|STARTED|Overall Study||6
357635|NCT02235454|878972|P1|NOT COMPLETED|Overall Study||2
357636|NCT02235454|878972|P1|COMPLETED|Overall Study||55
357637|NCT02235454|878972|P1|STARTED|Overall Study||57
357638|NCT02235311|878978|P2|NOT COMPLETED|Overall Study||2
357639|NCT02235311|878979|P1|NOT COMPLETED|Overall Study||0
357640|NCT02235311|878978|P2|COMPLETED|Overall Study||0
357641|NCT02235311|878979|P1|COMPLETED|Overall Study||1
357642|NCT02235311|878978|P2|STARTED|Overall Study||2
357643|NCT02235311|878979|P1|STARTED|Overall Study||1
357644|NCT02235285|878991|P1|NOT COMPLETED|Overall Study||13
357645|NCT02235285|878991|P1|COMPLETED|Overall Study||149
357646|NCT02235285|878991|P1|STARTED|Overall Study||162
357647|NCT02235077|878997|P2|NOT COMPLETED|Overall Study||19
357648|NCT02235077|878998|P1|NOT COMPLETED|Overall Study||18
357649|NCT02235077|878997|P2|COMPLETED|Overall Study||159
357650|NCT02235077|878998|P1|COMPLETED|Overall Study||164
357651|NCT02235077|878997|P2|STARTED|Overall Study||178
357652|NCT02235077|878998|P1|STARTED|Overall Study||182
357653|NCT02235064|879026|P2|NOT COMPLETED|Overall Study||0
357654|NCT02235064|879027|P1|NOT COMPLETED|Overall Study||0
357655|NCT02235064|879026|P2|COMPLETED|Overall Study||1
357656|NCT02235064|879027|P1|COMPLETED|Overall Study||1
357657|NCT02235064|879026|P2|STARTED|Overall Study||1
357658|NCT02235064|879027|P1|STARTED|Overall Study||1
357659|NCT02234752|879053|P1|NOT COMPLETED|Overall Study||1
357660|NCT02234752|879053|P1|COMPLETED|Overall Study||2
357661|NCT02234752|879053|P1|STARTED|Overall Study||3
357662|NCT02234479|879066|P2|NOT COMPLETED|Overall Study||3
357663|NCT02234479|879067|P1|NOT COMPLETED|Overall Study||1
357664|NCT02234479|879066|P2|COMPLETED|Overall Study||15
357665|NCT02234479|879067|P1|COMPLETED|Overall Study||15
357666|NCT02234479|879066|P2|STARTED|Overall Study||18
357667|NCT02234479|879067|P1|STARTED|Overall Study||16
357668|NCT02234427|879073|P1|NOT COMPLETED|Overall Study||1
357669|NCT02234427|879073|P1|COMPLETED|Overall Study|One individual withdrew after first visit|33
357670|NCT02234427|879073|P1|STARTED|Overall Study||34
357671|NCT02234362|879077|P1|NOT COMPLETED|Overall Study||26
357672|NCT02234362|879077|P1|COMPLETED|Overall Study||21
357673|NCT02234362|879077|P1|Received at Least One Dose of Medication|Overall Study||27
357674|NCT02234362|879077|P1|STARTED|Overall Study||47
357675|NCT02234115|879094|P1|NOT COMPLETED|Overall Study||15
357676|NCT02234115|879094|P1|COMPLETED|Overall Study||122
357677|NCT02234115|879094|P1|PK Subgroup|Overall Study||31
357678|NCT02234115|879094|P1|PP|Overall Study||124
357679|NCT02234115|879094|P1|ITT|Overall Study||137
357680|NCT02234115|879094|P1|STARTED|Overall Study||137
357681|NCT02234011|879099|P1|NOT COMPLETED|Overall Study||0
357682|NCT02234011|879099|P1|COMPLETED|Overall Study||0
357683|NCT02234011|879099|P1|STARTED|Overall Study||0
357684|NCT02233998|879106|P3|NOT COMPLETED|Overall Study||0
357685|NCT02233998|879107|P2|NOT COMPLETED|Overall Study||0
357686|NCT02233998|879108|P1|NOT COMPLETED|Overall Study||0
357687|NCT02233998|879106|P3|COMPLETED|Overall Study||53
357688|NCT02233998|879107|P2|COMPLETED|Overall Study||52
357689|NCT02233998|879108|P1|COMPLETED|Overall Study||53
357690|NCT02233998|879106|P3|STARTED|Overall Study||53
357691|NCT02233998|879107|P2|STARTED|Overall Study||52
357692|NCT02233998|879108|P1|STARTED|Overall Study||53
357693|NCT02233985|879142|P2|NOT COMPLETED|Overall Study||0
357694|NCT02233985|879143|P1|NOT COMPLETED|Overall Study||0
357695|NCT02233985|879142|P2|COMPLETED|Overall Study||31
357696|NCT02233985|879143|P1|COMPLETED|Overall Study||33
357697|NCT02233985|879142|P2|STARTED|Overall Study||31
357698|NCT02233985|879143|P1|STARTED|Overall Study||33
357699|NCT02233842|879151|P1|NOT COMPLETED|Questionnaire 3 Version 2||0
357700|NCT02233842|879151|P1|COMPLETED|Questionnaire 3 Version 2||5
357701|NCT02233842|879151|P1|STARTED|Questionnaire 3 Version 2||5
357702|NCT02233842|879151|P1|NOT COMPLETED|Questionnaire 3 Version 1||0
357703|NCT02233842|879151|P1|COMPLETED|Questionnaire 3 Version 1||5
357704|NCT02233842|879151|P1|STARTED|Questionnaire 3 Version 1||5
357705|NCT02233842|879151|P1|NOT COMPLETED|Questionnaire 2 Version 2||0
357706|NCT02233842|879151|P1|COMPLETED|Questionnaire 2 Version 2||5
357707|NCT02233842|879151|P1|STARTED|Questionnaire 2 Version 2||5
357708|NCT02233842|879151|P1|NOT COMPLETED|Questionnaire 2 Version 1||0
357709|NCT02233842|879151|P1|COMPLETED|Questionnaire 2 Version 1||5
357710|NCT02233842|879151|P1|STARTED|Questionnaire 2 Version 1||5
357711|NCT02233842|879151|P1|NOT COMPLETED|Questionnaire 1 Version 2||0
357712|NCT02233842|879151|P1|COMPLETED|Questionnaire 1 Version 2||5
357713|NCT02233842|879151|P1|STARTED|Questionnaire 1 Version 2||5
357714|NCT02233842|879151|P1|NOT COMPLETED|Questionnaire 1 Version 1||0
357715|NCT02233842|879151|P1|COMPLETED|Questionnaire 1 Version 1||5
357716|NCT02233842|879151|P1|STARTED|Questionnaire 1 Version 1||5
357717|NCT02233803|879158|P2|NOT COMPLETED|Treatment Period 2 (4-Wks)||2
357718|NCT02233803|879159|P1|NOT COMPLETED|Treatment Period 2 (4-Wks)||2
357719|NCT02233803|879158|P2|COMPLETED|Treatment Period 2 (4-Wks)||91
357720|NCT02233803|879159|P1|COMPLETED|Treatment Period 2 (4-Wks)||93
357721|NCT02233803|879158|P2|STARTED|Treatment Period 2 (4-Wks)||93
357722|NCT02233803|879159|P1|STARTED|Treatment Period 2 (4-Wks)||95
357723|NCT02233803|879158|P2|NOT COMPLETED|Washout Period (4-Wks)||2
357724|NCT02233803|879159|P1|NOT COMPLETED|Washout Period (4-Wks)||2
357725|NCT02233803|879158|P2|COMPLETED|Washout Period (4-Wks)||93
357726|NCT02233803|879159|P1|COMPLETED|Washout Period (4-Wks)||95
357727|NCT02233803|879158|P2|STARTED|Washout Period (4-Wks)||95
357728|NCT02233803|879159|P1|STARTED|Washout Period (4-Wks)||97
357729|NCT02233803|879158|P2|NOT COMPLETED|Treatment Period 1 (4-Wks)||4
357730|NCT02233803|879159|P1|NOT COMPLETED|Treatment Period 1 (4-Wks)||3
357731|NCT02233803|879158|P2|COMPLETED|Treatment Period 1 (4-Wks)||95
357732|NCT02233803|879159|P1|COMPLETED|Treatment Period 1 (4-Wks)||97
357733|NCT02233803|879158|P2|STARTED|Treatment Period 1 (4-Wks)||99
357734|NCT02233803|879159|P1|STARTED|Treatment Period 1 (4-Wks)||100
357735|NCT02233647|879169|P1|NOT COMPLETED|Overall Study||1
357736|NCT02233647|879169|P1|COMPLETED|Overall Study||10
357737|NCT02233647|879169|P1|80 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
357738|NCT02233647|879169|P1|40 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
357739|NCT02233647|879169|P1|20 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
357740|NCT02233647|879169|P1|10 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
357741|NCT02233647|879169|P1|0 mg Cocaine With 210 mg Phendimetrazine|Overall Study||10
357742|NCT02233647|879169|P1|80 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
357743|NCT02233647|879169|P1|40 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
357744|NCT02233647|879169|P1|20 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
357745|NCT02233647|879169|P1|10 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
357746|NCT02233647|879169|P1|0 mg Cocaine With 140 mg Phendimetrazine|Overall Study||10
357747|NCT02233647|879169|P1|80 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
357748|NCT02233647|879169|P1|40 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
357749|NCT02233647|879169|P1|20 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
357750|NCT02233647|879169|P1|10 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
357751|NCT02233647|879169|P1|0 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
357752|NCT02233647|879169|P1|80 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
357753|NCT02233647|879169|P1|40 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
357754|NCT02233647|879169|P1|20 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
357755|NCT02233647|879169|P1|10 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11
357756|NCT02233647|879169|P1|0 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11
357757|NCT02233647|879169|P1|STARTED|Overall Study||11
357758|NCT02233309|879198|P1|NOT COMPLETED|Overall Study||5
357759|NCT02233309|879198|P1|COMPLETED|Overall Study||31
357760|NCT02233309|879198|P1|STARTED|Overall Study||36
357761|NCT02233296|879204|P2|NOT COMPLETED|Overall Study||0
357762|NCT02233296|879205|P1|NOT COMPLETED|Overall Study||0
357763|NCT02233296|879204|P2|COMPLETED|Overall Study||14
357764|NCT02233296|879205|P1|COMPLETED|Overall Study||16
357765|NCT02233296|879204|P2|STARTED|Overall Study||14
357766|NCT02233296|879205|P1|STARTED|Overall Study||16
357767|NCT02233101|879223|P2|NOT COMPLETED|Overall Study||1
357768|NCT02233101|879224|P1|NOT COMPLETED|Overall Study||12
357769|NCT02233101|879223|P2|COMPLETED|Overall Study||80
357770|NCT02233101|879224|P1|COMPLETED|Overall Study||74
357771|NCT02233101|879223|P2|STARTED|Overall Study||81
357772|NCT02233101|879224|P1|STARTED|Overall Study||86
357773|NCT02232880|879232|P1|NOT COMPLETED|Overall Study||1
357774|NCT02232880|879232|P1|COMPLETED|Overall Study||0
357775|NCT02232880|879232|P1|STARTED|Overall Study||1
357776|NCT02232698|879241|P2|NOT COMPLETED|Overall Study||20
357777|NCT02232698|879242|P1|NOT COMPLETED|Overall Study||10
357778|NCT02232698|879241|P2|COMPLETED|Overall Study||101
357779|NCT02232698|879242|P1|COMPLETED|Overall Study||110
357780|NCT02232698|879241|P2|STARTED|Overall Study||121
357781|NCT02232698|879242|P1|STARTED|Overall Study||120
357782|NCT02232126|879265|P2|NOT COMPLETED|Overall Study||0
357783|NCT02232126|879266|P1|NOT COMPLETED|Overall Study||0
357784|NCT02232126|879265|P2|COMPLETED|Overall Study||90
357785|NCT02232126|879266|P1|COMPLETED|Overall Study||91
357786|NCT02232126|879265|P2|STARTED|Overall Study||90
357787|NCT02232126|879266|P1|STARTED|Overall Study||91
357788|NCT02231918|879277|P3|NOT COMPLETED|Overall Study||1
357789|NCT02231918|879278|P2|NOT COMPLETED|Overall Study||1
357790|NCT02231918|879279|P1|NOT COMPLETED|Overall Study||0
357791|NCT02231918|879277|P3|COMPLETED|Overall Study||1
357792|NCT02231918|879278|P2|COMPLETED|Overall Study||14
357793|NCT02231918|879279|P1|COMPLETED|Overall Study||9
357794|NCT02231918|879277|P3|STARTED|Overall Study||2
357795|NCT02231918|879278|P2|STARTED|Overall Study||15
357796|NCT02231918|879279|P1|STARTED|Overall Study||9
357797|NCT02231580|879343|P2|NOT COMPLETED|Overall Study||0
357798|NCT02231580|879344|P1|NOT COMPLETED|Overall Study||5
357799|NCT02231580|879343|P2|COMPLETED|Overall Study||3
357800|NCT02231580|879344|P1|COMPLETED|Overall Study||9
357801|NCT02231580|879343|P2|Cohort 2|Overall Study||1
357802|NCT02231580|879344|P1|Cohort 2|Overall Study||6
357803|NCT02231580|879343|P2|Cohort 1|Overall Study||2
357804|NCT02231580|879344|P1|Cohort 1|Overall Study||8
357805|NCT02231580|879343|P2|STARTED|Overall Study||3
357806|NCT02231580|879344|P1|STARTED|Overall Study||14
357807|NCT02231177|879400|P6|NOT COMPLETED|Treatment Period 3 (21 Days)||0
357808|NCT02231177|879401|P5|NOT COMPLETED|Treatment Period 3 (21 Days)||0
357809|NCT02231177|879402|P4|NOT COMPLETED|Treatment Period 3 (21 Days)||0
357810|NCT02231177|879403|P3|NOT COMPLETED|Treatment Period 3 (21 Days)||0
357811|NCT02231177|879404|P2|NOT COMPLETED|Treatment Period 3 (21 Days)||0
357812|NCT02231177|879405|P1|NOT COMPLETED|Treatment Period 3 (21 Days)||0
357813|NCT02231177|879400|P6|COMPLETED|Treatment Period 3 (21 Days)||9
357814|NCT02231177|879401|P5|COMPLETED|Treatment Period 3 (21 Days)||8
357815|NCT02231177|879402|P4|COMPLETED|Treatment Period 3 (21 Days)||7
357816|NCT02231177|879403|P3|COMPLETED|Treatment Period 3 (21 Days)||8
357817|NCT02231177|879404|P2|COMPLETED|Treatment Period 3 (21 Days)||7
357818|NCT02231177|879405|P1|COMPLETED|Treatment Period 3 (21 Days)||8
357819|NCT02231177|879400|P6|STARTED|Treatment Period 3 (21 Days)||9
357820|NCT02231177|879401|P5|STARTED|Treatment Period 3 (21 Days)||8
357821|NCT02231177|879402|P4|STARTED|Treatment Period 3 (21 Days)||7
357822|NCT02231177|879403|P3|STARTED|Treatment Period 3 (21 Days)||8
357823|NCT02231177|879404|P2|STARTED|Treatment Period 3 (21 Days)||7
357824|NCT02231177|879405|P1|STARTED|Treatment Period 3 (21 Days)||8
357825|NCT02231177|879400|P6|NOT COMPLETED|Treatment Period 2 (21 Days)||0
357826|NCT02231177|879401|P5|NOT COMPLETED|Treatment Period 2 (21 Days)||0
357827|NCT02231177|879402|P4|NOT COMPLETED|Treatment Period 2 (21 Days)||0
357828|NCT02231177|879403|P3|NOT COMPLETED|Treatment Period 2 (21 Days)||0
357829|NCT02231177|879404|P2|NOT COMPLETED|Treatment Period 2 (21 Days)||0
357830|NCT02231177|879405|P1|NOT COMPLETED|Treatment Period 2 (21 Days)||0
357831|NCT02231177|879400|P6|COMPLETED|Treatment Period 2 (21 Days)||9
357832|NCT02231177|879401|P5|COMPLETED|Treatment Period 2 (21 Days)||8
357833|NCT02231177|879402|P4|COMPLETED|Treatment Period 2 (21 Days)||7
357834|NCT02231177|879403|P3|COMPLETED|Treatment Period 2 (21 Days)||8
357835|NCT02231177|879404|P2|COMPLETED|Treatment Period 2 (21 Days)||7
357836|NCT02231177|879405|P1|COMPLETED|Treatment Period 2 (21 Days)||8
357837|NCT02231177|879400|P6|STARTED|Treatment Period 2 (21 Days)||9
357838|NCT02231177|879401|P5|STARTED|Treatment Period 2 (21 Days)||8
357839|NCT02231177|879402|P4|STARTED|Treatment Period 2 (21 Days)||7
357840|NCT02231177|879403|P3|STARTED|Treatment Period 2 (21 Days)||8
357841|NCT02231177|879404|P2|STARTED|Treatment Period 2 (21 Days)||7
357842|NCT02231177|879405|P1|STARTED|Treatment Period 2 (21 Days)||8
357843|NCT02231177|879400|P6|NOT COMPLETED|Treatment Period 1 (21 Days)||0
357844|NCT02231177|879401|P5|NOT COMPLETED|Treatment Period 1 (21 Days)||0
357845|NCT02231177|879402|P4|NOT COMPLETED|Treatment Period 1 (21 Days)||0
357846|NCT02231177|879403|P3|NOT COMPLETED|Treatment Period 1 (21 Days)||0
357847|NCT02231177|879404|P2|NOT COMPLETED|Treatment Period 1 (21 Days)||0
357848|NCT02231177|879405|P1|NOT COMPLETED|Treatment Period 1 (21 Days)||0
357849|NCT02231177|879400|P6|COMPLETED|Treatment Period 1 (21 Days)||9
357850|NCT02231177|879401|P5|COMPLETED|Treatment Period 1 (21 Days)||8
357851|NCT02231177|879402|P4|COMPLETED|Treatment Period 1 (21 Days)||7
357852|NCT02231177|879403|P3|COMPLETED|Treatment Period 1 (21 Days)||8
357853|NCT02231177|879404|P2|COMPLETED|Treatment Period 1 (21 Days)||7
357854|NCT02231177|879405|P1|COMPLETED|Treatment Period 1 (21 Days)||8
357855|NCT02231177|879400|P6|STARTED|Treatment Period 1 (21 Days)||9
357856|NCT02231177|879401|P5|STARTED|Treatment Period 1 (21 Days)||8
357857|NCT02231177|879402|P4|STARTED|Treatment Period 1 (21 Days)||7
357858|NCT02231177|879403|P3|STARTED|Treatment Period 1 (21 Days)||8
357859|NCT02231177|879404|P2|STARTED|Treatment Period 1 (21 Days)||7
357860|NCT02231177|879405|P1|STARTED|Treatment Period 1 (21 Days)||8
357861|NCT02231164|879461|P2|NOT COMPLETED|Overall Study||6
357862|NCT02231164|879462|P1|NOT COMPLETED|Overall Study||6
357863|NCT02231164|879461|P2|COMPLETED|Overall Study||0
357864|NCT02231164|879462|P1|COMPLETED|Overall Study||0
357865|NCT02231164|879461|P2|STARTED|Overall Study||6
357866|NCT02231164|879462|P1|STARTED|Overall Study||6
357867|NCT02230995|879470|P2|NOT COMPLETED|Period 2 + Washout||0
357868|NCT02230995|879471|P1|NOT COMPLETED|Period 2 + Washout||0
357869|NCT02230995|879470|P2|COMPLETED|Period 2 + Washout||15
357870|NCT02230995|879471|P1|COMPLETED|Period 2 + Washout||15
357871|NCT02230995|879470|P2|STARTED|Period 2 + Washout||15
357872|NCT02230995|879471|P1|STARTED|Period 2 + Washout||15
357873|NCT02230995|879470|P2|NOT COMPLETED|Period 1 + Washout||0
357874|NCT02230995|879471|P1|NOT COMPLETED|Period 1 + Washout||0
357875|NCT02230995|879470|P2|COMPLETED|Period 1 + Washout||15
357876|NCT02230995|879471|P1|COMPLETED|Period 1 + Washout||15
357877|NCT02230995|879470|P2|STARTED|Period 1 + Washout||15
357878|NCT02230995|879471|P1|STARTED|Period 1 + Washout||15
357879|NCT02230956|879490|P3|NOT COMPLETED|Overall Study||7
357880|NCT02230956|879491|P2|NOT COMPLETED|Overall Study||6
357881|NCT02230956|879492|P1|NOT COMPLETED|Overall Study||5
357882|NCT02230956|879490|P3|COMPLETED|Overall Study||82
357883|NCT02230956|879491|P2|COMPLETED|Overall Study||37
357884|NCT02230956|879492|P1|COMPLETED|Overall Study||39
357885|NCT02230956|879490|P3|STARTED|Overall Study||89
357886|NCT02230956|879491|P2|STARTED|Overall Study||43
357887|NCT02230956|879492|P1|STARTED|Overall Study||44
357888|NCT02230904|879514|P2|NOT COMPLETED|Overall Study||1
357889|NCT02230904|879515|P1|NOT COMPLETED|Overall Study||0
357890|NCT02230904|879514|P2|COMPLETED|Overall Study||27
357891|NCT02230904|879515|P1|COMPLETED|Overall Study||29
357892|NCT02230904|879514|P2|STARTED|Overall Study||28
357893|NCT02230904|879515|P1|STARTED|Overall Study||29
357894|NCT02230761|879537|P2|NOT COMPLETED|Overall Study||1
357895|NCT02230761|879538|P1|NOT COMPLETED|Overall Study||0
357896|NCT02230761|879537|P2|COMPLETED|Overall Study||29
357897|NCT02230761|879538|P1|COMPLETED|Overall Study||60
357898|NCT02230761|879537|P2|STARTED|Overall Study||30
357899|NCT02230761|879538|P1|STARTED|Overall Study||60
357900|NCT02230683|879548|P1|NOT COMPLETED|Overall Study||1
357901|NCT02230683|879548|P1|COMPLETED|Overall Study||22
357902|NCT02230683|879548|P1|STARTED|Overall Study||23
357903|NCT02230670|879565|P2|NOT COMPLETED|Overall Study||8
357904|NCT02230670|879566|P1|NOT COMPLETED|Overall Study||4
357905|NCT02230670|879565|P2|COMPLETED|Overall Study||34
357906|NCT02230670|879566|P1|COMPLETED|Overall Study||40
357907|NCT02230670|879565|P2|STARTED|Overall Study|One subject randomized to placebo withdrew from the study before receiving any study treatment.|42
357908|NCT02230670|879566|P1|STARTED|Overall Study||44
357909|NCT02230566|879580|P4|NOT COMPLETED|Overall Study||0
357910|NCT02230566|879581|P3|NOT COMPLETED|Overall Study||0
357911|NCT02230566|879582|P2|NOT COMPLETED|Overall Study||0
357912|NCT02230566|879583|P1|NOT COMPLETED|Overall Study||0
357913|NCT02230566|879580|P4|COMPLETED|Overall Study||3
357914|NCT02230566|879581|P3|COMPLETED|Overall Study||3
357915|NCT02230566|879582|P2|COMPLETED|Overall Study||3
357916|NCT02230566|879583|P1|COMPLETED|Overall Study||3
357917|NCT02230566|879580|P4|STARTED|Overall Study||3
357918|NCT02230566|879581|P3|STARTED|Overall Study||3
357919|NCT02230566|879582|P2|STARTED|Overall Study||3
357920|NCT02230566|879583|P1|STARTED|Overall Study||3
357921|NCT02230540|879598|P2|NOT COMPLETED|Overall Study||0
357922|NCT02230540|879599|P1|NOT COMPLETED|Overall Study||0
357923|NCT02230540|879598|P2|COMPLETED|Overall Study||0
357924|NCT02230540|879599|P1|COMPLETED|Overall Study||8
357925|NCT02230540|879598|P2|STARTED|Overall Study|The study was terminated before initiation of sequence B. Sequence B was therefore not initiated.|0
357926|NCT02230540|879599|P1|STARTED|Overall Study||8
357927|NCT02230384|879605|P2|NOT COMPLETED|Phase 2 Wash Out||0
357928|NCT02230384|879606|P1|NOT COMPLETED|Phase 2 Wash Out||0
357929|NCT02230384|879605|P2|COMPLETED|Phase 2 Wash Out||30
357930|NCT02230384|879606|P1|COMPLETED|Phase 2 Wash Out||26
357931|NCT02230384|879605|P2|STARTED|Phase 2 Wash Out||30
357932|NCT02230384|879606|P1|STARTED|Phase 2 Wash Out||26
357933|NCT02230384|879605|P2|NOT COMPLETED|Phase 2 - Switch||1
357934|NCT02230384|879606|P1|NOT COMPLETED|Phase 2 - Switch||3
357935|NCT02230384|879605|P2|COMPLETED|Phase 2 - Switch||30
357936|NCT02230384|879606|P1|COMPLETED|Phase 2 - Switch||26
357937|NCT02230384|879605|P2|STARTED|Phase 2 - Switch||31
357938|NCT02230384|879606|P1|STARTED|Phase 2 - Switch||29
357939|NCT02230384|879605|P2|NOT COMPLETED|Phase 1 Wash Out||0
357940|NCT02230384|879606|P1|NOT COMPLETED|Phase 1 Wash Out||0
357941|NCT02230384|879605|P2|COMPLETED|Phase 1 Wash Out||31
357942|NCT02230384|879606|P1|COMPLETED|Phase 1 Wash Out||29
357943|NCT02230384|879605|P2|STARTED|Phase 1 Wash Out|Cross over study|31
357944|NCT02230384|879606|P1|STARTED|Phase 1 Wash Out||29
357945|NCT02230384|879605|P2|NOT COMPLETED|Phase 1||1
357946|NCT02230384|879606|P1|NOT COMPLETED|Phase 1||1
357947|NCT02230384|879605|P2|COMPLETED|Phase 1||31
357948|NCT02230384|879606|P1|COMPLETED|Phase 1||29
357949|NCT02230384|879605|P2|STARTED|Phase 1||32
357950|NCT02230384|879606|P1|STARTED|Phase 1||30
357951|NCT02230332|879614|P2|NOT COMPLETED|Overall Study||1
357952|NCT02230332|879615|P1|NOT COMPLETED|Overall Study||4
357953|NCT02230332|879614|P2|COMPLETED|Overall Study||39
357954|NCT02230332|879615|P1|COMPLETED|Overall Study||34
357955|NCT02230332|879614|P2|STARTED|Overall Study||40
357956|NCT02230332|879615|P1|STARTED|Overall Study||38
357957|NCT02230306|879631|P1|NOT COMPLETED|Overall Study||1
357958|NCT02230306|879631|P1|COMPLETED|Overall Study||4
357959|NCT02230306|879631|P1|STARTED|Overall Study||5
357960|NCT02230085|879642|P1|NOT COMPLETED|Overall Study||4
357961|NCT02230085|879642|P1|COMPLETED|Overall Study||106
357962|NCT02230085|879642|P1|STARTED|Overall Study||110
357963|NCT02229864|879646|P1|NOT COMPLETED|3 - Year Visit||2
357964|NCT02229864|879646|P1|COMPLETED|3 - Year Visit||10
357965|NCT02229864|879646|P1|STARTED|3 - Year Visit|The missed visit participant in the 2nd year has joined the study for 3rd year follow-up.|12
357966|NCT02229864|879646|P1|NOT COMPLETED|2 - Year Visit||1
357967|NCT02229864|879646|P1|COMPLETED|2 - Year Visit||11
357968|NCT02229864|879646|P1|STARTED|2 - Year Visit||12
357969|NCT02229864|879646|P1|NOT COMPLETED|1 - Year Visit||0
357970|NCT02229864|879646|P1|COMPLETED|1 - Year Visit||12
357971|NCT02229864|879646|P1|STARTED|1 - Year Visit||12
357972|NCT02229864|879646|P1|NOT COMPLETED|6 - Month Visit||0
357973|NCT02229864|879646|P1|COMPLETED|6 - Month Visit||12
357974|NCT02229864|879646|P1|STARTED|6 - Month Visit||12
357975|NCT02229864|879646|P1|NOT COMPLETED|1 - Month Visit||0
357976|NCT02229864|879646|P1|COMPLETED|1 - Month Visit||12
357977|NCT02229864|879646|P1|STARTED|1 - Month Visit||12
357978|NCT02229539|879701|P3|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||10
357979|NCT02229539|879702|P2|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||7
357980|NCT02229539|879703|P1|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||9
357981|NCT02229539|879701|P3|COMPLETED|Cycle 2 (Optional Continuation Phase)||22
357982|NCT02229539|879702|P2|COMPLETED|Cycle 2 (Optional Continuation Phase)||29
357983|NCT02229539|879703|P1|COMPLETED|Cycle 2 (Optional Continuation Phase)||26
357984|NCT02229539|879701|P3|STARTED|Cycle 2 (Optional Continuation Phase)||32
357985|NCT02229539|879702|P2|STARTED|Cycle 2 (Optional Continuation Phase)||36
357986|NCT02229539|879703|P1|STARTED|Cycle 2 (Optional Continuation Phase)||35
357987|NCT02229539|879701|P3|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||3
357988|NCT02229539|879702|P2|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||5
357989|NCT02229539|879703|P1|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||3
357990|NCT02229539|879701|P3|COMPLETED|Cycle 1 (Treatment Per Protocol)||72
357991|NCT02229539|879702|P2|COMPLETED|Cycle 1 (Treatment Per Protocol)||71
357992|NCT02229539|879703|P1|COMPLETED|Cycle 1 (Treatment Per Protocol)||74
357993|NCT02229539|879701|P3|STARTED|Cycle 1 (Treatment Per Protocol)||75
357994|NCT02229539|879702|P2|STARTED|Cycle 1 (Treatment Per Protocol)||76
357995|NCT02229539|879703|P1|STARTED|Cycle 1 (Treatment Per Protocol)||77
357996|NCT02229513|879713|P2|NOT COMPLETED|Overall Study||0
357997|NCT02229513|879714|P1|NOT COMPLETED|Overall Study||0
357998|NCT02229513|879713|P2|COMPLETED|Overall Study||100
357999|NCT02229513|879714|P1|COMPLETED|Overall Study||100
358000|NCT02229513|879713|P2|STARTED|Overall Study||100
358001|NCT02229513|879714|P1|STARTED|Overall Study||100
358002|NCT02229487|879750|P2|NOT COMPLETED|Overall Study||0
358003|NCT02229487|879751|P1|NOT COMPLETED|Overall Study||0
358004|NCT02229487|879750|P2|COMPLETED|Overall Study||27
358005|NCT02229487|879751|P1|COMPLETED|Overall Study||24
358006|NCT02229487|879750|P2|STARTED|Overall Study||27
358007|NCT02229487|879751|P1|STARTED|Overall Study||24
358008|NCT02229474|879759|P2|NOT COMPLETED|Overall Study||3
358009|NCT02229474|879760|P1|NOT COMPLETED|Overall Study||0
358010|NCT02229474|879759|P2|COMPLETED|Overall Study||15
358011|NCT02229474|879760|P1|COMPLETED|Overall Study||16
358012|NCT02229474|879759|P2|STARTED|Overall Study||18
358013|NCT02229474|879760|P1|STARTED|Overall Study||16
358014|NCT02229461|879793|P6|NOT COMPLETED|Overall Study||0
358015|NCT02229461|879794|P5|NOT COMPLETED|Overall Study||0
358016|NCT02229461|879795|P4|NOT COMPLETED|Overall Study||0
358017|NCT02229461|879796|P3|NOT COMPLETED|Overall Study||0
358018|NCT02229461|879797|P2|NOT COMPLETED|Overall Study||0
358019|NCT02229461|879798|P1|NOT COMPLETED|Overall Study||0
358020|NCT02229461|879793|P6|COMPLETED|Overall Study||17
358021|NCT02229461|879794|P5|COMPLETED|Overall Study||17
358022|NCT02229461|879795|P4|COMPLETED|Overall Study||17
358023|NCT02229461|879796|P3|COMPLETED|Overall Study||17
358024|NCT02229461|879797|P2|COMPLETED|Overall Study||17
358025|NCT02229461|879798|P1|COMPLETED|Overall Study||17
358026|NCT02229461|879793|P6|STARTED|Overall Study|Randomized and received treatment|17
358027|NCT02229461|879794|P5|STARTED|Overall Study|Randomized and received treatment|17
358028|NCT02229461|879795|P4|STARTED|Overall Study|Randomized and received treatment|17
358029|NCT02229461|879796|P3|STARTED|Overall Study|Randomized and received treatment|17
358030|NCT02229461|879797|P2|STARTED|Overall Study|Randomized and received treatment|17
358031|NCT02229461|879798|P1|STARTED|Overall Study|Randomized and received treatment|17
358032|NCT02229396|879834|P3|NOT COMPLETED|Overall Study||38
358033|NCT02229396|879835|P2|NOT COMPLETED|Overall Study||29
358034|NCT02229396|879836|P1|NOT COMPLETED|Overall Study||25
358035|NCT02229396|879834|P3|COMPLETED|Overall Study||193
358036|NCT02229396|879835|P2|COMPLETED|Overall Study||202
358037|NCT02229396|879836|P1|COMPLETED|Overall Study||208
358038|NCT02229396|879834|P3|ITT Analysis Set|Overall Study||227
358039|NCT02229396|879835|P2|ITT Analysis Set|Overall Study||228
358040|NCT02229396|879836|P1|ITT Analysis Set|Overall Study||230
358041|NCT02229396|879834|P3|Safety Analysis Set|Overall Study||230
358042|NCT02229396|879835|P2|Safety Analysis Set|Overall Study||231
358043|NCT02229396|879836|P1|Safety Analysis Set|Overall Study||233
358044|NCT02229396|879834|P3|RANDOMIZATION CODE ALLOCATED|Overall Study||231
358045|NCT02229396|879835|P2|RANDOMIZATION CODE ALLOCATED|Overall Study||231
358046|NCT02229396|879836|P1|RANDOMIZATION CODE ALLOCATED|Overall Study||233
358047|NCT02229396|879834|P3|STARTED|Overall Study||231
358048|NCT02229396|879835|P2|STARTED|Overall Study||231
358049|NCT02229396|879836|P1|STARTED|Overall Study||233
358050|NCT02229383|879867|P2|NOT COMPLETED|Overall Study||24
358051|NCT02229383|879868|P1|NOT COMPLETED|Overall Study||22
358052|NCT02229383|879867|P2|COMPLETED|Overall Study||207
358053|NCT02229383|879868|P1|COMPLETED|Overall Study||211
358054|NCT02229383|879867|P2|ITT Analysis Set|Overall Study||230
358055|NCT02229383|879868|P1|ITT Analysis Set|Overall Study||231
358056|NCT02229383|879867|P2|Safety Analysis Set|Overall Study||231
358057|NCT02229383|879868|P1|Safety Analysis Set|Overall Study||232
358058|NCT02229383|879867|P2|Received Treatment|Overall Study||231
358059|NCT02229383|879868|P1|Received Treatment|Overall Study||232
358060|NCT02229383|879867|P2|STARTED|Overall Study||231
358061|NCT02229383|879868|P1|STARTED|Overall Study||233
358062|NCT02229318|879886|P1|NOT COMPLETED|Overall Study||0
358063|NCT02229318|879886|P1|COMPLETED|Overall Study|September 15th 2014 11 completed|11
358064|NCT02229318|879886|P1|STARTED|Overall Study|September 6th 2014 11 enrolled|11
358071|NCT02229214|879979|P2|NOT COMPLETED|Overall Study||0
358072|NCT02229214|879980|P1|NOT COMPLETED|Overall Study||6
358073|NCT02229214|879979|P2|COMPLETED|Overall Study||10
358074|NCT02229214|879980|P1|COMPLETED|Overall Study||35
358075|NCT02229214|879979|P2|STARTED|Overall Study||10
358076|NCT02229214|879980|P1|STARTED|Overall Study||41
358077|NCT02228980|880004|P4|NOT COMPLETED|Overall Study||3
358078|NCT02228980|880005|P3|NOT COMPLETED|Overall Study||2
358079|NCT02228980|880006|P2|NOT COMPLETED|Overall Study||3
358080|NCT02228980|880007|P1|NOT COMPLETED|Overall Study||24
358081|NCT02228980|880004|P4|COMPLETED|Overall Study||148
358082|NCT02228980|880005|P3|COMPLETED|Overall Study||149
358083|NCT02228980|880006|P2|COMPLETED|Overall Study||147
358084|NCT02228980|880007|P1|COMPLETED|Overall Study||126
358085|NCT02228980|880004|P4|STARTED|Overall Study||151
358086|NCT02228980|880005|P3|STARTED|Overall Study||151
358087|NCT02228980|880006|P2|STARTED|Overall Study||150
358088|NCT02228980|880007|P1|STARTED|Overall Study||150
358089|NCT02228720|880029|P1|NOT COMPLETED|Open Label - Day 90||0
358090|NCT02228720|880029|P1|COMPLETED|Open Label - Day 90||14
358091|NCT02228720|880029|P1|STARTED|Open Label - Day 90||14
358092|NCT02228720|880029|P1|NOT COMPLETED|Open Label - Day 30||1
358093|NCT02228720|880029|P1|COMPLETED|Open Label - Day 30||14
358094|NCT02228720|880029|P1|STARTED|Open Label - Day 30||15
358095|NCT02228720|880029|P1|NOT COMPLETED|Open Label - Baseline||0
358096|NCT02228720|880029|P1|COMPLETED|Open Label - Baseline||15
358097|NCT02228720|880029|P1|STARTED|Open Label - Baseline||15
358098|NCT02228395|880037|P3|NOT COMPLETED|Third Intervention Period||0
358099|NCT02228395|880038|P2|NOT COMPLETED|Third Intervention Period||0
358100|NCT02228395|880039|P1|NOT COMPLETED|Third Intervention Period||0
358101|NCT02228395|880037|P3|COMPLETED|Third Intervention Period||3
358102|NCT02228395|880038|P2|COMPLETED|Third Intervention Period||3
358103|NCT02228395|880039|P1|COMPLETED|Third Intervention Period||3
358104|NCT02228395|880037|P3|STARTED|Third Intervention Period||3
358105|NCT02228395|880038|P2|STARTED|Third Intervention Period||3
358106|NCT02228395|880039|P1|STARTED|Third Intervention Period||3
358107|NCT02228395|880037|P3|NOT COMPLETED|Washout Period (at Least 10 Days)||0
358108|NCT02228395|880038|P2|NOT COMPLETED|Washout Period (at Least 10 Days)||0
358109|NCT02228395|880039|P1|NOT COMPLETED|Washout Period (at Least 10 Days)||0
358110|NCT02228395|880037|P3|COMPLETED|Washout Period (at Least 10 Days)||3
358111|NCT02228395|880038|P2|COMPLETED|Washout Period (at Least 10 Days)||3
358112|NCT02228395|880039|P1|COMPLETED|Washout Period (at Least 10 Days)||3
358113|NCT02228395|880037|P3|STARTED|Washout Period (at Least 10 Days)||3
358114|NCT02228395|880038|P2|STARTED|Washout Period (at Least 10 Days)||3
358115|NCT02228395|880039|P1|STARTED|Washout Period (at Least 10 Days)||3
358116|NCT02228395|880037|P3|NOT COMPLETED|Second Intervention Period||0
358117|NCT02228395|880038|P2|NOT COMPLETED|Second Intervention Period||0
358118|NCT02228395|880039|P1|NOT COMPLETED|Second Intervention Period||0
358119|NCT02228395|880037|P3|COMPLETED|Second Intervention Period||3
358120|NCT02228395|880038|P2|COMPLETED|Second Intervention Period||3
358121|NCT02228395|880039|P1|COMPLETED|Second Intervention Period||3
358122|NCT02228395|880037|P3|STARTED|Second Intervention Period||3
358123|NCT02228395|880038|P2|STARTED|Second Intervention Period||3
358124|NCT02228395|880039|P1|STARTED|Second Intervention Period||3
358125|NCT02228395|880037|P3|NOT COMPLETED|Washout Period (at Least 10 Days)||0
358126|NCT02228395|880038|P2|NOT COMPLETED|Washout Period (at Least 10 Days)||0
358127|NCT02228395|880039|P1|NOT COMPLETED|Washout Period (at Least 10 Days)||0
358128|NCT02228395|880037|P3|COMPLETED|Washout Period (at Least 10 Days)||3
358129|NCT02228395|880038|P2|COMPLETED|Washout Period (at Least 10 Days)||3
358130|NCT02228395|880039|P1|COMPLETED|Washout Period (at Least 10 Days)||3
358131|NCT02228395|880037|P3|STARTED|Washout Period (at Least 10 Days)||3
358132|NCT02228395|880038|P2|STARTED|Washout Period (at Least 10 Days)||3
358133|NCT02228395|880039|P1|STARTED|Washout Period (at Least 10 Days)||3
358134|NCT02228395|880037|P3|NOT COMPLETED|First Intervention Period||1
358135|NCT02228395|880038|P2|NOT COMPLETED|First Intervention Period||1
358136|NCT02228395|880039|P1|NOT COMPLETED|First Intervention Period||1
358137|NCT02228395|880037|P3|COMPLETED|First Intervention Period||2
358138|NCT02228395|880038|P2|COMPLETED|First Intervention Period||2
358139|NCT02228395|880039|P1|COMPLETED|First Intervention Period||2
358140|NCT02228395|880037|P3|STARTED|First Intervention Period||3
358141|NCT02228395|880038|P2|STARTED|First Intervention Period||3
358142|NCT02228395|880039|P1|STARTED|First Intervention Period||3
358143|NCT02227810|880105|P2|NOT COMPLETED|Overall Study||5
358144|NCT02227810|880106|P1|NOT COMPLETED|Overall Study||2
358145|NCT02227810|880105|P2|COMPLETED|Overall Study||29
358146|NCT02227810|880106|P1|COMPLETED|Overall Study||17
358147|NCT02227810|880105|P2|STARTED|Overall Study||34
358148|NCT02227810|880106|P1|STARTED|Overall Study||19
358149|NCT02227784|880122|P5|NOT COMPLETED|Open-Label Extension Phase (OLE)||248
358150|NCT02227784|880123|P4|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
358151|NCT02227784|880124|P3|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
358152|NCT02227784|880125|P2|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
358153|NCT02227784|880126|P1|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
358154|NCT02227784|880122|P5|COMPLETED|Open-Label Extension Phase (OLE)||0
358155|NCT02227784|880123|P4|COMPLETED|Open-Label Extension Phase (OLE)||0
358156|NCT02227784|880124|P3|COMPLETED|Open-Label Extension Phase (OLE)||0
358157|NCT02227784|880125|P2|COMPLETED|Open-Label Extension Phase (OLE)||0
358158|NCT02227784|880126|P1|COMPLETED|Open-Label Extension Phase (OLE)||0
358159|NCT02227784|880122|P5|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||247
358160|NCT02227784|880123|P4|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
358161|NCT02227784|880124|P3|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
358162|NCT02227784|880125|P2|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
358163|NCT02227784|880126|P1|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
358164|NCT02227784|880122|P5|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|248
358165|NCT02227784|880123|P4|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
358166|NCT02227784|880124|P3|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
358167|NCT02227784|880125|P2|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
358168|NCT02227784|880126|P1|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
358169|NCT02227784|880122|P5|NOT COMPLETED|Double-Blind Phase||0
358170|NCT02227784|880123|P4|NOT COMPLETED|Double-Blind Phase||39
358171|NCT02227784|880124|P3|NOT COMPLETED|Double-Blind Phase||21
358172|NCT02227784|880125|P2|NOT COMPLETED|Double-Blind Phase||18
358173|NCT02227784|880126|P1|NOT COMPLETED|Double-Blind Phase||40
358174|NCT02227784|880122|P5|COMPLETED|Double-Blind Phase||0
358175|NCT02227784|880123|P4|COMPLETED|Double-Blind Phase||88
358176|NCT02227784|880124|P3|COMPLETED|Double-Blind Phase||41
358177|NCT02227784|880125|P2|COMPLETED|Double-Blind Phase||36
358178|NCT02227784|880126|P1|COMPLETED|Double-Blind Phase||83
358179|NCT02227784|880122|P5|STARTED|Double-Blind Phase||0
358180|NCT02227784|880123|P4|STARTED|Double-Blind Phase||127
358181|NCT02227784|880124|P3|STARTED|Double-Blind Phase||62
358182|NCT02227784|880125|P2|STARTED|Double-Blind Phase||54
358183|NCT02227784|880126|P1|STARTED|Double-Blind Phase||123
358184|NCT02227485|880163|P2|NOT COMPLETED|Second Follow-up||2
358185|NCT02227485|880164|P1|NOT COMPLETED|Second Follow-up||2
358186|NCT02227485|880163|P2|COMPLETED|Second Follow-up|At the second follow-up we lost 2 patients.|36
358187|NCT02227485|880164|P1|COMPLETED|Second Follow-up|At the second follow-up we lost 2 patients.|34
358188|NCT02227485|880163|P2|STARTED|Second Follow-up||38
358189|NCT02227485|880164|P1|STARTED|Second Follow-up||36
358190|NCT02227485|880163|P2|NOT COMPLETED|First Follow-up||2
358191|NCT02227485|880164|P1|NOT COMPLETED|First Follow-up||4
358192|NCT02227485|880163|P2|COMPLETED|First Follow-up|After 2 weeks, 2 patients had withdrew the study.|38
358193|NCT02227485|880164|P1|COMPLETED|First Follow-up|At the first follow-up we lost 4 patients.|36
358194|NCT02227485|880163|P2|STARTED|First Follow-up||40
358195|NCT02227485|880164|P1|STARTED|First Follow-up||40
358196|NCT02227368|880182|P2|NOT COMPLETED|Overall Study||4
358197|NCT02227368|880183|P1|NOT COMPLETED|Overall Study||2
358198|NCT02227368|880182|P2|COMPLETED|Overall Study|Subjects who discontinued treatment were encouraged to remain in the study.|20
358199|NCT02227368|880183|P1|COMPLETED|Overall Study|Subjects who discontinued treatment were encouraged to remain in the study.|14
358200|NCT02227368|880182|P2|Sujects Who Completed Treatment|Overall Study||17
358201|NCT02227368|880183|P1|Sujects Who Completed Treatment|Overall Study||10
358202|NCT02227368|880182|P2|Sujects Who Received Treatment|Overall Study||24
358203|NCT02227368|880183|P1|Sujects Who Received Treatment|Overall Study||16
358204|NCT02227368|880182|P2|STARTED|Overall Study||24
358205|NCT02227368|880183|P1|STARTED|Overall Study||16
358206|NCT02227329|880193|P2|NOT COMPLETED|Overall Study||0
358207|NCT02227329|880194|P1|NOT COMPLETED|Overall Study||0
358208|NCT02227329|880193|P2|COMPLETED|Overall Study||20
358209|NCT02227329|880194|P1|COMPLETED|Overall Study||18
358210|NCT02227329|880193|P2|STARTED|Overall Study||20
358211|NCT02227329|880194|P1|STARTED|Overall Study||18
358212|NCT02227316|880204|P4|NOT COMPLETED|Overall Study||0
358213|NCT02227316|880205|P3|NOT COMPLETED|Overall Study||0
358214|NCT02227316|880206|P2|NOT COMPLETED|Overall Study||0
358215|NCT02227316|880207|P1|NOT COMPLETED|Overall Study||0
358216|NCT02227316|880204|P4|COMPLETED|Overall Study||16
358217|NCT02227316|880205|P3|COMPLETED|Overall Study||16
358218|NCT02227316|880206|P2|COMPLETED|Overall Study||4
358219|NCT02227316|880207|P1|COMPLETED|Overall Study||4
358220|NCT02227316|880204|P4|STARTED|Overall Study||16
358221|NCT02227316|880205|P3|STARTED|Overall Study||16
358222|NCT02227316|880206|P2|STARTED|Overall Study||4
358223|NCT02227316|880207|P1|STARTED|Overall Study||4
358224|NCT02227121|880237|P1|NOT COMPLETED|Overall Study||0
358225|NCT02227121|880237|P1|COMPLETED|Overall Study||16
358226|NCT02227121|880237|P1|STARTED|Overall Study||16
358227|NCT02227108|880241|P1|NOT COMPLETED|Overall Study||31
358228|NCT02227108|880241|P1|COMPLETED|Overall Study||1
358229|NCT02227108|880241|P1|Treated|Overall Study||30
358230|NCT02227108|880241|P1|STARTED|Overall Study||32
358231|NCT02226562|880270|P2|NOT COMPLETED|Overall Study||1
358232|NCT02226562|880271|P1|NOT COMPLETED|Overall Study||0
358233|NCT02226562|880270|P2|COMPLETED|Overall Study|Lost to follow up|95
358234|NCT02226562|880271|P1|COMPLETED|Overall Study||95
358235|NCT02226562|880270|P2|STARTED|Overall Study||96
358236|NCT02226562|880271|P1|STARTED|Overall Study||95
358237|NCT02226549|880289|P2|NOT COMPLETED|Overall Study||1
358238|NCT02226549|880290|P1|NOT COMPLETED|Overall Study||1
358239|NCT02226549|880289|P2|COMPLETED|Overall Study||23
358240|NCT02226549|880290|P1|COMPLETED|Overall Study||22
358241|NCT02226549|880289|P2|STARTED|Overall Study||24
358242|NCT02226549|880290|P1|STARTED|Overall Study||23
358243|NCT02226198|880300|P3|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
358244|NCT02226198|880301|P2|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
358245|NCT02226198|880302|P1|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
358246|NCT02226198|880300|P3|COMPLETED|Maintenance Phase (12 Weeks)||0
358247|NCT02226198|880301|P2|COMPLETED|Maintenance Phase (12 Weeks)||0
358248|NCT02226198|880302|P1|COMPLETED|Maintenance Phase (12 Weeks)||13
358249|NCT02226198|880300|P3|STARTED|Maintenance Phase (12 Weeks)||0
358250|NCT02226198|880301|P2|STARTED|Maintenance Phase (12 Weeks)||0
358251|NCT02226198|880302|P1|STARTED|Maintenance Phase (12 Weeks)||13
358252|NCT02226198|880300|P3|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
358253|NCT02226198|880301|P2|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
358254|NCT02226198|880302|P1|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
358255|NCT02226198|880300|P3|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||7
358256|NCT02226198|880301|P2|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||6
358257|NCT02226198|880302|P1|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
358258|NCT02226198|880300|P3|STARTED|Cross-Over: Second Interv. (6 Weeks)||7
358259|NCT02226198|880301|P2|STARTED|Cross-Over: Second Interv. (6 Weeks)||6
358260|NCT02226198|880302|P1|STARTED|Cross-Over: Second Interv. (6 Weeks)||0
358261|NCT02226198|880300|P3|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
358262|NCT02226198|880301|P2|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||1
358263|NCT02226198|880302|P1|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
358264|NCT02226198|880300|P3|COMPLETED|Cross-Over: First Intervention (6 Weeks)||7
358265|NCT02226198|880301|P2|COMPLETED|Cross-Over: First Intervention (6 Weeks)||6
358266|NCT02226198|880302|P1|COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
358267|NCT02226198|880300|P3|STARTED|Cross-Over: First Intervention (6 Weeks)||7
358268|NCT02226198|880301|P2|STARTED|Cross-Over: First Intervention (6 Weeks)||7
358269|NCT02226198|880302|P1|STARTED|Cross-Over: First Intervention (6 Weeks)||0
358270|NCT02226198|880300|P3|NOT COMPLETED|Lead-in Phase||0
358271|NCT02226198|880301|P2|NOT COMPLETED|Lead-in Phase||0
358272|NCT02226198|880302|P1|NOT COMPLETED|Lead-in Phase||1
358273|NCT02226198|880300|P3|COMPLETED|Lead-in Phase||0
358274|NCT02226198|880301|P2|COMPLETED|Lead-in Phase||0
358275|NCT02226198|880302|P1|COMPLETED|Lead-in Phase||10
358276|NCT02226198|880300|P3|STARTED|Lead-in Phase||0
358277|NCT02226198|880301|P2|STARTED|Lead-in Phase||0
358278|NCT02226198|880302|P1|STARTED|Lead-in Phase||11
358279|NCT02226172|880375|P1|NOT COMPLETED|Overall Study||13
358280|NCT02226172|880375|P1|COMPLETED|Overall Study||8
358281|NCT02226172|880375|P1|STARTED|Overall Study||21
358282|NCT02226003|880397|P3|NOT COMPLETED|Overall Study||6
358283|NCT02226003|880398|P2|NOT COMPLETED|Overall Study||1
358284|NCT02226003|880399|P1|NOT COMPLETED|Overall Study||2
358285|NCT02226003|880397|P3|COMPLETED|Overall Study||91
358286|NCT02226003|880398|P2|COMPLETED|Overall Study||95
358287|NCT02226003|880399|P1|COMPLETED|Overall Study||96
358288|NCT02226003|880397|P3|STARTED|Overall Study||97
358289|NCT02226003|880398|P2|STARTED|Overall Study||96
358290|NCT02226003|880399|P1|STARTED|Overall Study||98
358291|NCT02225860|880433|P2|NOT COMPLETED|Overall Study||0
358292|NCT02225860|880434|P1|NOT COMPLETED|Overall Study||1
358293|NCT02225860|880433|P2|COMPLETED|Overall Study||17
358294|NCT02225860|880434|P1|COMPLETED|Overall Study||16
358295|NCT02225860|880433|P2|STARTED|Overall Study||17
358296|NCT02225860|880434|P1|STARTED|Overall Study||17
358297|NCT02224846|880446|P2|NOT COMPLETED|Period 2 (Month 12 to Month 24)||74
358298|NCT02224846|880447|P1|NOT COMPLETED|Period 2 (Month 12 to Month 24)||42
358299|NCT02224846|880446|P2|COMPLETED|Period 2 (Month 12 to Month 24)||283
358300|NCT02224846|880447|P1|COMPLETED|Period 2 (Month 12 to Month 24)||131
358301|NCT02224846|880446|P2|STARTED|Period 2 (Month 12 to Month 24)||357
358302|NCT02224846|880447|P1|STARTED|Period 2 (Month 12 to Month 24)||173
358303|NCT02224846|880446|P2|NOT COMPLETED|Period 2 (Month 3 to Month 12)||31
358304|NCT02224846|880447|P1|NOT COMPLETED|Period 2 (Month 3 to Month 12)||19
358305|NCT02224846|880446|P2|COMPLETED|Period 2 (Month 3 to Month 12)||357
358306|NCT02224846|880447|P1|COMPLETED|Period 2 (Month 3 to Month 12)||173
358307|NCT02224846|880446|P2|STARTED|Period 2 (Month 3 to Month 12)||388
358308|NCT02224846|880447|P1|STARTED|Period 2 (Month 3 to Month 12)||192
358309|NCT02224846|880446|P2|NOT COMPLETED|Period 1 (Month 3)||36
358310|NCT02224846|880447|P1|NOT COMPLETED|Period 1 (Month 3)||19
358311|NCT02224846|880446|P2|COMPLETED|Period 1 (Month 3)||388
358312|NCT02224846|880447|P1|COMPLETED|Period 1 (Month 3)||192
358313|NCT02224846|880446|P2|Received at Least One Dose of Study Drug|Period 1 (Month 3)||421
358314|NCT02224846|880447|P1|Received at Least One Dose of Study Drug|Period 1 (Month 3)||210
358315|NCT02224846|880446|P2|STARTED|Period 1 (Month 3)||424
358316|NCT02224846|880447|P1|STARTED|Period 1 (Month 3)||211
358317|NCT02224820|880467|P1|NOT COMPLETED|Overall Study||0
358318|NCT02224820|880467|P1|COMPLETED|Overall Study|One patient did not receive full dose|8
358319|NCT02224820|880467|P1|STARTED|Overall Study||8
358320|NCT02224729|880475|P1|NOT COMPLETED|Overall Study||0
358321|NCT02224729|880475|P1|COMPLETED|Overall Study||24
358322|NCT02224729|880475|P1|STARTED|Overall Study||24
358323|NCT02224664|880483|P5|NOT COMPLETED|Dose Escalation Period (21 Days)||11
358324|NCT02224664|880484|P4|NOT COMPLETED|Dose Escalation Period (21 Days)||3
358325|NCT02224664|880485|P3|NOT COMPLETED|Dose Escalation Period (21 Days)||2
358326|NCT02224664|880486|P2|NOT COMPLETED|Dose Escalation Period (21 Days)||0
358327|NCT02224664|880487|P1|NOT COMPLETED|Dose Escalation Period (21 Days)||0
358328|NCT02224664|880483|P5|COMPLETED|Dose Escalation Period (21 Days)||8
358329|NCT02224664|880484|P4|COMPLETED|Dose Escalation Period (21 Days)||3
358330|NCT02224664|880485|P3|COMPLETED|Dose Escalation Period (21 Days)||9
358331|NCT02224664|880486|P2|COMPLETED|Dose Escalation Period (21 Days)||9
358332|NCT02224664|880487|P1|COMPLETED|Dose Escalation Period (21 Days)||0
358333|NCT02224664|880483|P5|STARTED|Dose Escalation Period (21 Days)||19
358334|NCT02224664|880484|P4|STARTED|Dose Escalation Period (21 Days)||6
358335|NCT02224664|880485|P3|STARTED|Dose Escalation Period (21 Days)||11
358336|NCT02224664|880486|P2|STARTED|Dose Escalation Period (21 Days)||9
358337|NCT02224664|880487|P1|STARTED|Dose Escalation Period (21 Days)||0
358338|NCT02224664|880483|P5|NOT COMPLETED|Lead-in Period (3 Days)||0
358339|NCT02224664|880484|P4|NOT COMPLETED|Lead-in Period (3 Days)||0
358340|NCT02224664|880485|P3|NOT COMPLETED|Lead-in Period (3 Days)||0
358341|NCT02224664|880486|P2|NOT COMPLETED|Lead-in Period (3 Days)||0
358342|NCT02224664|880487|P1|NOT COMPLETED|Lead-in Period (3 Days)||5
358343|NCT02224664|880483|P5|COMPLETED|Lead-in Period (3 Days)||0
358344|NCT02224664|880484|P4|COMPLETED|Lead-in Period (3 Days)||0
358345|NCT02224664|880485|P3|COMPLETED|Lead-in Period (3 Days)||0
358346|NCT02224664|880486|P2|COMPLETED|Lead-in Period (3 Days)||0
358347|NCT02224664|880487|P1|COMPLETED|Lead-in Period (3 Days)||45
358348|NCT02224664|880483|P5|STARTED|Lead-in Period (3 Days)||0
358349|NCT02224664|880484|P4|STARTED|Lead-in Period (3 Days)||0
358350|NCT02224664|880485|P3|STARTED|Lead-in Period (3 Days)||0
358351|NCT02224664|880486|P2|STARTED|Lead-in Period (3 Days)||0
358352|NCT02224664|880487|P1|STARTED|Lead-in Period (3 Days)||50
358353|NCT02224625|880567|P1|NOT COMPLETED|Sensitization||55
358354|NCT02224625|880567|P1|COMPLETED|Sensitization||194
358355|NCT02224625|880567|P1|STARTED|Sensitization|Subjects from Irritation study also participated in Sensitization Study|249
358356|NCT02224625|880567|P1|NOT COMPLETED|Irritation||6
358357|NCT02224625|880567|P1|COMPLETED|Irritation||33
358358|NCT02224625|880567|P1|STARTED|Irritation||39
358359|NCT02224508|880581|P2|NOT COMPLETED|Overall Study||0
358360|NCT02224508|880582|P1|NOT COMPLETED|Overall Study||0
358361|NCT02224508|880581|P2|COMPLETED|Overall Study||653
358362|NCT02224508|880582|P1|COMPLETED|Overall Study||935
358363|NCT02224508|880581|P2|STARTED|Overall Study|Number of patients surveyed in the control segment of the health plan (contracted care).|653
358364|NCT02224508|880582|P1|STARTED|Overall Study|Number of patients surveyed in intervention segment of the health plan (group practice).|935
358365|NCT02224404|880592|P1|NOT COMPLETED|Overall Study||0
358366|NCT02224404|880592|P1|COMPLETED|Overall Study||21
358367|NCT02224404|880592|P1|STARTED|Overall Study||21
358368|NCT02224053|880597|P1|NOT COMPLETED|AZD9291 Alone||0
358369|NCT02224053|880597|P1|COMPLETED|AZD9291 Alone||47
358370|NCT02224053|880597|P1|STARTED|AZD9291 Alone||47
358371|NCT02224053|880597|P1|NOT COMPLETED|AZD9291 and Omeprazole Co-administration||21
358372|NCT02224053|880597|P1|COMPLETED|AZD9291 and Omeprazole Co-administration||47
358373|NCT02224053|880597|P1|STARTED|AZD9291 and Omeprazole Co-administration||68
358374|NCT02223871|880629|P1|NOT COMPLETED|Overall Study||0
358375|NCT02223871|880629|P1|COMPLETED|Overall Study||8
358376|NCT02223871|880629|P1|STARTED|Overall Study||8
358377|NCT02223754|880643|P2|NOT COMPLETED|Period 2||3
358378|NCT02223754|880644|P1|NOT COMPLETED|Period 2||3
358379|NCT02223754|880643|P2|COMPLETED|Period 2||141
358380|NCT02223754|880644|P1|COMPLETED|Period 2||156
358381|NCT02223754|880643|P2|STARTED|Period 2||144
358382|NCT02223754|880644|P1|STARTED|Period 2||159
358383|NCT02223754|880643|P2|NOT COMPLETED|Period 1||15
358384|NCT02223754|880644|P1|NOT COMPLETED|Period 1||4
358385|NCT02223754|880643|P2|COMPLETED|Period 1||144
358386|NCT02223754|880644|P1|COMPLETED|Period 1||159
358387|NCT02223754|880643|P2|STARTED|Period 1||159
358388|NCT02223754|880644|P1|STARTED|Period 1||163
358389|NCT02223715|880664|P1|NOT COMPLETED|Overall Study||104
358390|NCT02223715|880664|P1|COMPLETED|Overall Study||496
358391|NCT02223715|880664|P1|STARTED|Overall Study||600
358392|NCT02223650|880673|P2|NOT COMPLETED|Overall Study||0
358393|NCT02223650|880674|P1|NOT COMPLETED|Overall Study||0
358394|NCT02223650|880673|P2|COMPLETED|Overall Study||31
358395|NCT02223650|880674|P1|COMPLETED|Overall Study||27
358396|NCT02223650|880673|P2|STARTED|Overall Study||31
358397|NCT02223650|880674|P1|STARTED|Overall Study||27
358398|NCT02223429|880708|P4|NOT COMPLETED|Overall Study||0
358399|NCT02223429|880709|P3|NOT COMPLETED|Overall Study||0
358400|NCT02223429|880710|P2|NOT COMPLETED|Overall Study||0
358401|NCT02223429|880711|P1|NOT COMPLETED|Overall Study||1
358402|NCT02223429|880708|P4|COMPLETED|Overall Study||8
358403|NCT02223429|880709|P3|COMPLETED|Overall Study||8
358404|NCT02223429|880710|P2|COMPLETED|Overall Study||8
358405|NCT02223429|880711|P1|COMPLETED|Overall Study||7
358406|NCT02223429|880708|P4|STARTED|Overall Study||8
358407|NCT02223429|880709|P3|STARTED|Overall Study||8
358408|NCT02223429|880710|P2|STARTED|Overall Study||8
358409|NCT02223429|880711|P1|STARTED|Overall Study||8
358410|NCT02223364|880742|P3|NOT COMPLETED|Overall Study||3
358411|NCT02223364|880743|P2|NOT COMPLETED|Overall Study||0
358412|NCT02223364|880744|P1|NOT COMPLETED|Overall Study||5
358413|NCT02223364|880742|P3|COMPLETED|Overall Study||52
358414|NCT02223364|880743|P2|COMPLETED|Overall Study||55
358415|NCT02223364|880744|P1|COMPLETED|Overall Study||50
358416|NCT02223364|880742|P3|STARTED|Overall Study||55
358417|NCT02223364|880743|P2|STARTED|Overall Study||55
358418|NCT02223364|880744|P1|STARTED|Overall Study||55
358419|NCT02223338|880796|P2|NOT COMPLETED|Overall Study||0
358420|NCT02223338|880797|P1|NOT COMPLETED|Overall Study||0
358421|NCT02223338|880796|P2|COMPLETED|Overall Study||60
358422|NCT02223338|880797|P1|COMPLETED|Overall Study||60
358423|NCT02223338|880796|P2|STARTED|Overall Study||60
358424|NCT02223338|880797|P1|STARTED|Overall Study||60
358425|NCT02223260|880805|P1|NOT COMPLETED|Overall Study||0
358426|NCT02223260|880805|P1|COMPLETED|Overall Study||8
358427|NCT02223260|880805|P1|STARTED|Overall Study||8
358428|NCT02223065|880823|P2|NOT COMPLETED|Overall Study||0
358429|NCT02223065|880824|P1|NOT COMPLETED|Overall Study||0
358430|NCT02223065|880823|P2|COMPLETED|Overall Study||18
358431|NCT02223065|880824|P1|COMPLETED|Overall Study||18
358432|NCT02223065|880823|P2|STARTED|Overall Study||18
358433|NCT02223065|880824|P1|STARTED|Overall Study||18
358434|NCT02222870|880842|P2|NOT COMPLETED|Overall Study||0
358435|NCT02222870|880843|P1|NOT COMPLETED|Overall Study||0
358436|NCT02222870|880842|P2|COMPLETED|Overall Study||30
358437|NCT02222870|880843|P1|COMPLETED|Overall Study||30
358438|NCT02222870|880842|P2|STARTED|Overall Study||30
358439|NCT02222870|880843|P1|STARTED|Overall Study||30
358440|NCT02222818|880859|P2|NOT COMPLETED|Period 2||0
358441|NCT02222818|880860|P1|NOT COMPLETED|Period 2||0
358442|NCT02222818|880859|P2|COMPLETED|Period 2|End of CAFR evaluation period|30
358443|NCT02222818|880860|P1|COMPLETED|Period 2|End of CAFRPlus evaluation period|33
358444|NCT02222818|880859|P2|STARTED|Period 2|Start of CAFR evaluation period|30
358445|NCT02222818|880860|P1|STARTED|Period 2|Start of CAFRPlus evaluation period|33
358446|NCT02222818|880859|P2|NOT COMPLETED|Period 1||3
358447|NCT02222818|880860|P1|NOT COMPLETED|Period 1||0
358448|NCT02222818|880859|P2|COMPLETED|Period 1|End of CAFRPlus evaluation period|30
358449|NCT02222818|880860|P1|COMPLETED|Period 1|End of CAFR evaluation period|33
358450|NCT02222818|880859|P2|STARTED|Period 1|Start of CAFRPlus evaluation period|33
358451|NCT02222818|880860|P1|STARTED|Period 1|Start of CAFR evaluation period|33
358452|NCT02222558|880867|P6|NOT COMPLETED|Period 3||1
358453|NCT02222558|880868|P5|NOT COMPLETED|Period 3||0
358454|NCT02222558|880869|P4|NOT COMPLETED|Period 3||0
358455|NCT02222558|880870|P3|NOT COMPLETED|Period 3||0
358456|NCT02222558|880871|P2|NOT COMPLETED|Period 3||0
358457|NCT02222558|880872|P1|NOT COMPLETED|Period 3||0
358458|NCT02222558|880867|P6|COMPLETED|Period 3||7
358459|NCT02222558|880868|P5|COMPLETED|Period 3||8
358460|NCT02222558|880869|P4|COMPLETED|Period 3||1
358461|NCT02222558|880870|P3|COMPLETED|Period 3||4
358462|NCT02222558|880871|P2|COMPLETED|Period 3||0
358463|NCT02222558|880872|P1|COMPLETED|Period 3||0
358464|NCT02222558|880867|P6|STARTED|Period 3||8
358465|NCT02222558|880868|P5|STARTED|Period 3||8
358466|NCT02222558|880869|P4|STARTED|Period 3||1
358467|NCT02222558|880870|P3|STARTED|Period 3||4
358468|NCT02222558|880871|P2|STARTED|Period 3||0
358469|NCT02222558|880872|P1|STARTED|Period 3||0
358470|NCT02222558|880867|P6|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
358471|NCT02222558|880868|P5|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
358472|NCT02222558|880869|P4|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
358473|NCT02222558|880870|P3|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
358474|NCT02222558|880871|P2|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
358475|NCT02222558|880872|P1|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
358476|NCT02222558|880867|P6|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
358477|NCT02222558|880868|P5|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
358478|NCT02222558|880869|P4|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
358479|NCT02222558|880870|P3|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
358480|NCT02222558|880871|P2|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||21
358481|NCT02222558|880872|P1|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
358482|NCT02222558|880867|P6|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
358483|NCT02222558|880868|P5|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
358484|NCT02222558|880869|P4|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
358485|NCT02222558|880870|P3|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
358486|NCT02222558|880871|P2|STARTED|Period 2: Two Times Daily Dosing 90 mg||21
358487|NCT02222558|880872|P1|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
358488|NCT02222558|880867|P6|NOT COMPLETED|Period 1: Single Dose||0
358489|NCT02222558|880868|P5|NOT COMPLETED|Period 1: Single Dose||0
358490|NCT02222558|880869|P4|NOT COMPLETED|Period 1: Single Dose||0
358491|NCT02222558|880870|P3|NOT COMPLETED|Period 1: Single Dose||0
358492|NCT02222558|880871|P2|NOT COMPLETED|Period 1: Single Dose||0
358493|NCT02222558|880872|P1|NOT COMPLETED|Period 1: Single Dose||4
358494|NCT02222558|880867|P6|COMPLETED|Period 1: Single Dose||0
358495|NCT02222558|880868|P5|COMPLETED|Period 1: Single Dose||0
358496|NCT02222558|880869|P4|COMPLETED|Period 1: Single Dose||0
358497|NCT02222558|880870|P3|COMPLETED|Period 1: Single Dose||0
358498|NCT02222558|880871|P2|COMPLETED|Period 1: Single Dose||0
358499|NCT02222558|880872|P1|COMPLETED|Period 1: Single Dose||21
358500|NCT02222558|880867|P6|STARTED|Period 1: Single Dose||0
358501|NCT02222558|880868|P5|STARTED|Period 1: Single Dose||0
358502|NCT02222558|880869|P4|STARTED|Period 1: Single Dose||0
358503|NCT02222558|880870|P3|STARTED|Period 1: Single Dose||0
358504|NCT02222558|880871|P2|STARTED|Period 1: Single Dose||0
358505|NCT02222558|880872|P1|STARTED|Period 1: Single Dose||25
358506|NCT02222493|880888|P2|NOT COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||0
358507|NCT02222493|880889|P1|NOT COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||31
358508|NCT02222493|880888|P2|COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||0
358509|NCT02222493|880889|P1|COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||474
358510|NCT02222493|880888|P2|STARTED|Period 3: Week 54 Dosing-Week 78 Visit||0
358511|NCT02222493|880889|P1|STARTED|Period 3: Week 54 Dosing-Week 78 Visit||505
358512|NCT02222493|880888|P2|NOT COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||17
358513|NCT02222493|880889|P1|NOT COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||43
358514|NCT02222493|880888|P2|COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||126
358515|NCT02222493|880889|P1|COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||380
358516|NCT02222493|880888|P2|STARTED|Period 2: Week30 Dosing-Week54(Pre-dose)||143
358517|NCT02222493|880889|P1|STARTED|Period 2: Week30 Dosing-Week54(Pre-dose)||423
358518|NCT02222493|880888|P2|NOT COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||40
358519|NCT02222493|880889|P1|NOT COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||44
358520|NCT02222493|880888|P2|COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||286
358521|NCT02222493|880889|P1|COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||280
358522|NCT02222493|880888|P2|Received Treatment|Period 1: First Dose-Week 30 (Pre-dose)||326
358523|NCT02222493|880889|P1|Received Treatment|Period 1: First Dose-Week 30 (Pre-dose)||323
358524|NCT02222493|880888|P2|STARTED|Period 1: First Dose-Week 30 (Pre-dose)||326
358525|NCT02222493|880889|P1|STARTED|Period 1: First Dose-Week 30 (Pre-dose)||324
358526|NCT02222246|881007|P2|NOT COMPLETED|Overall Study||27
358527|NCT02222246|881008|P1|NOT COMPLETED|Overall Study||27
358528|NCT02222246|881007|P2|COMPLETED|Overall Study||26
358529|NCT02222246|881008|P1|COMPLETED|Overall Study||26
358530|NCT02222246|881007|P2|STARTED|Overall Study||53
358531|NCT02222246|881008|P1|STARTED|Overall Study||53
358532|NCT02222207|881036|P1|NOT COMPLETED|Overall Study||4
358533|NCT02222207|881036|P1|COMPLETED|Overall Study||48
358534|NCT02222207|881036|P1|Treated and Valid for Full Analysis Set|Overall Study||51
358535|NCT02222207|881036|P1|STARTED|Overall Study||52
358536|NCT02222181|881043|P1|NOT COMPLETED|Overall Study||108
358537|NCT02222181|881043|P1|COMPLETED|Overall Study||55
358538|NCT02222181|881043|P1|STARTED|Overall Study||163
358539|NCT02222129|881055|P2|NOT COMPLETED|Overall Study||0
358540|NCT02222129|881056|P1|NOT COMPLETED|Overall Study||0
358541|NCT02222129|881055|P2|COMPLETED|Overall Study||106
358542|NCT02222129|881056|P1|COMPLETED|Overall Study||100
358543|NCT02222129|881055|P2|STARTED|Overall Study||106
358544|NCT02222129|881056|P1|STARTED|Overall Study||100
358545|NCT02221947|881064|P2|NOT COMPLETED|Overall Study||0
358546|NCT02221947|881065|P1|NOT COMPLETED|Overall Study||0
358547|NCT02221947|881064|P2|COMPLETED|Overall Study||3
358548|NCT02221947|881065|P1|COMPLETED|Overall Study||6
358549|NCT02221947|881064|P2|STARTED|Overall Study||3
358550|NCT02221947|881065|P1|STARTED|Overall Study||6
358551|NCT02221674|881080|P3|NOT COMPLETED|Overall Study||0
358552|NCT02221674|881081|P2|NOT COMPLETED|Overall Study||0
358553|NCT02221674|881082|P1|NOT COMPLETED|Overall Study||1
358554|NCT02221674|881080|P3|COMPLETED|Overall Study||5
358555|NCT02221674|881081|P2|COMPLETED|Overall Study||6
358556|NCT02221674|881082|P1|COMPLETED|Overall Study||7
358557|NCT02221674|881080|P3|STARTED|Overall Study||5
358558|NCT02221674|881081|P2|STARTED|Overall Study||6
358559|NCT02221674|881082|P1|STARTED|Overall Study||8
358560|NCT02221648|881098|P2|NOT COMPLETED|Overall Study||3
358561|NCT02221648|881099|P1|NOT COMPLETED|Overall Study||3
358562|NCT02221648|881098|P2|COMPLETED|Overall Study||18
358563|NCT02221648|881099|P1|COMPLETED|Overall Study||19
358564|NCT02221648|881098|P2|STARTED|Overall Study||21
358565|NCT02221648|881099|P1|STARTED|Overall Study||22
358566|NCT02221557|881109|P1|NOT COMPLETED|Overall Study||3
358567|NCT02221557|881109|P1|COMPLETED|Overall Study||5
358568|NCT02221557|881109|P1|STARTED|Overall Study||8
358569|NCT02220998|881115|P2|NOT COMPLETED|Overall Study||11
358570|NCT02220998|881116|P1|NOT COMPLETED|Overall Study||7
358571|NCT02220998|881115|P2|COMPLETED|Overall Study||123
358572|NCT02220998|881116|P1|COMPLETED|Overall Study||128
358573|NCT02220998|881115|P2|STARTED|Overall Study||134
358574|NCT02220998|881116|P1|STARTED|Overall Study||135
358575|NCT02220920|881134|P2|NOT COMPLETED|Overall Study||3
358576|NCT02220920|881135|P1|NOT COMPLETED|Overall Study||3
358577|NCT02220920|881134|P2|COMPLETED|Overall Study||67
358578|NCT02220920|881135|P1|COMPLETED|Overall Study||73
358579|NCT02220920|881134|P2|STARTED|Overall Study||70
358580|NCT02220920|881135|P1|STARTED|Overall Study||76
358581|NCT02220764|881151|P2|NOT COMPLETED|Overall Study||1
358582|NCT02220764|881152|P1|NOT COMPLETED|Overall Study||4
358583|NCT02220764|881151|P2|COMPLETED|Overall Study||7
358584|NCT02220764|881152|P1|COMPLETED|Overall Study||20
358585|NCT02220764|881151|P2|STARTED|Overall Study||8
358586|NCT02220764|881152|P1|STARTED|Overall Study||24
358587|NCT02220205|881164|P2|NOT COMPLETED|Overall Study||0
358588|NCT02220205|881165|P1|NOT COMPLETED|Overall Study||1
358589|NCT02220205|881164|P2|COMPLETED|Overall Study||30
358590|NCT02220205|881165|P1|COMPLETED|Overall Study||29
358591|NCT02220205|881164|P2|STARTED|Overall Study||30
358592|NCT02220205|881165|P1|STARTED|Overall Study||30
358593|NCT02219997|881175|P3|NOT COMPLETED|Second Filter||0
358594|NCT02219997|881176|P2|NOT COMPLETED|Second Filter||0
358595|NCT02219997|881177|P1|NOT COMPLETED|Second Filter||0
358596|NCT02219997|881175|P3|COMPLETED|Second Filter||18
358597|NCT02219997|881176|P2|COMPLETED|Second Filter||17
358598|NCT02219997|881177|P1|COMPLETED|Second Filter||0
358599|NCT02219997|881175|P3|STARTED|Second Filter||18
358600|NCT02219997|881176|P2|STARTED|Second Filter||17
358601|NCT02219997|881177|P1|STARTED|Second Filter||0
358602|NCT02219997|881175|P3|NOT COMPLETED|First Filter||0
358603|NCT02219997|881176|P2|NOT COMPLETED|First Filter||0
358604|NCT02219997|881177|P1|NOT COMPLETED|First Filter||0
358605|NCT02219997|881175|P3|COMPLETED|First Filter||18
358606|NCT02219997|881176|P2|COMPLETED|First Filter||17
358607|NCT02219997|881177|P1|COMPLETED|First Filter||33
358608|NCT02219997|881175|P3|STARTED|First Filter||18
358609|NCT02219997|881176|P2|STARTED|First Filter||17
358610|NCT02219997|881177|P1|STARTED|First Filter||33
358611|NCT02219932|881190|P2|NOT COMPLETED|Overall Study||51
358612|NCT02219932|881191|P1|NOT COMPLETED|Overall Study||65
358613|NCT02219932|881190|P2|COMPLETED|Overall Study||266
358614|NCT02219932|881191|P1|COMPLETED|Overall Study||254
358615|NCT02219932|881190|P2|Randomized, Not Treated|Overall Study||1
358616|NCT02219932|881191|P1|Randomized, Not Treated|Overall Study||0
358617|NCT02219932|881190|P2|STARTED|Overall Study||317
358618|NCT02219932|881191|P1|STARTED|Overall Study||319
358619|NCT02219685|881207|P2|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0
358620|NCT02219685|881208|P1|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0
358621|NCT02219685|881207|P2|COMPLETED|Open-Label (After Posttreatment Week 4)||14
358622|NCT02219685|881208|P1|COMPLETED|Open-Label (After Posttreatment Week 4)||0
358623|NCT02219685|881207|P2|STARTED|Open-Label (After Posttreatment Week 4)||14
358624|NCT02219685|881208|P1|STARTED|Open-Label (After Posttreatment Week 4)|Only participants from the Placebo arm were eligible to enroll in the Open-Label Phase.|0
358625|NCT02219685|881207|P2|NOT COMPLETED|Blinded Treatment Phase||0
358626|NCT02219685|881208|P1|NOT COMPLETED|Blinded Treatment Phase||2
358627|NCT02219685|881207|P2|COMPLETED|Blinded Treatment Phase||14
358628|NCT02219685|881208|P1|COMPLETED|Blinded Treatment Phase||24
358629|NCT02219685|881207|P2|STARTED|Blinded Treatment Phase||14
358630|NCT02219685|881208|P1|STARTED|Blinded Treatment Phase||26
358631|NCT02219516|881256|P4|NOT COMPLETED|Overall Study||0
358632|NCT02219516|881257|P3|NOT COMPLETED|Overall Study||0
358633|NCT02219516|881258|P2|NOT COMPLETED|Overall Study||0
358634|NCT02219516|881259|P1|NOT COMPLETED|Overall Study||0
358635|NCT02219516|881256|P4|COMPLETED|Overall Study||8
358636|NCT02219516|881257|P3|COMPLETED|Overall Study||7
358637|NCT02219516|881258|P2|COMPLETED|Overall Study||8
358638|NCT02219516|881259|P1|COMPLETED|Overall Study||8
358639|NCT02219516|881256|P4|STARTED|Overall Study||8
358640|NCT02219516|881257|P3|STARTED|Overall Study||7
358641|NCT02219516|881258|P2|STARTED|Overall Study||8
358642|NCT02219516|881259|P1|STARTED|Overall Study||8
358643|NCT02219503|881305|P1|NOT COMPLETED|Overall Study||0
358644|NCT02219503|881305|P1|COMPLETED|Overall Study||60
358645|NCT02219503|881305|P1|STARTED|Overall Study||60
358646|NCT02219477|881314|P3|NOT COMPLETED|Overall Study||1
358647|NCT02219477|881315|P2|NOT COMPLETED|Overall Study||2
358648|NCT02219477|881316|P1|NOT COMPLETED|Overall Study||0
358649|NCT02219477|881314|P3|COMPLETED|Overall Study||2
358650|NCT02219477|881315|P2|COMPLETED|Overall Study||22
358651|NCT02219477|881316|P1|COMPLETED|Overall Study||9
358652|NCT02219477|881314|P3|STARTED|Overall Study||3
358653|NCT02219477|881315|P2|STARTED|Overall Study||24
358654|NCT02219477|881316|P1|STARTED|Overall Study||9
358655|NCT02219464|881344|P2|NOT COMPLETED|Overall Study||0
358656|NCT02219464|881345|P1|NOT COMPLETED|Overall Study||3
358657|NCT02219464|881344|P2|COMPLETED|Overall Study||30
358658|NCT02219464|881345|P1|COMPLETED|Overall Study||27
358659|NCT02219464|881344|P2|STARTED|Overall Study||30
358660|NCT02219464|881345|P1|STARTED|Overall Study||30
358661|NCT02219282|881355|P2|NOT COMPLETED|Overall Study||1
358662|NCT02219282|881356|P1|NOT COMPLETED|Overall Study||1
358663|NCT02219282|881355|P2|COMPLETED|Overall Study||32
358664|NCT02219282|881356|P1|COMPLETED|Overall Study||32
358665|NCT02219282|881355|P2|STARTED|Overall Study||33
358666|NCT02219282|881356|P1|STARTED|Overall Study||33
358667|NCT02219256|881382|P12|NOT COMPLETED|Overall Study||0
358668|NCT02219256|881383|P11|NOT COMPLETED|Overall Study||0
358669|NCT02219256|881384|P10|NOT COMPLETED|Overall Study||0
358670|NCT02219256|881385|P9|NOT COMPLETED|Overall Study||0
358671|NCT02219256|881386|P8|NOT COMPLETED|Overall Study||0
358672|NCT02219256|881387|P7|NOT COMPLETED|Overall Study||0
358673|NCT02219256|881388|P6|NOT COMPLETED|Overall Study||0
358674|NCT02219256|881389|P5|NOT COMPLETED|Overall Study||0
358675|NCT02219256|881390|P4|NOT COMPLETED|Overall Study||0
358676|NCT02219256|881391|P3|NOT COMPLETED|Overall Study||0
358677|NCT02219256|881392|P2|NOT COMPLETED|Overall Study||0
358678|NCT02219256|881393|P1|NOT COMPLETED|Overall Study||0
358679|NCT02219256|881382|P12|COMPLETED|Overall Study||6
358680|NCT02219256|881383|P11|COMPLETED|Overall Study||6
358681|NCT02219256|881384|P10|COMPLETED|Overall Study||6
358682|NCT02219256|881385|P9|COMPLETED|Overall Study||6
358683|NCT02219256|881386|P8|COMPLETED|Overall Study||8
358684|NCT02219256|881387|P7|COMPLETED|Overall Study||6
358685|NCT02219256|881388|P6|COMPLETED|Overall Study||6
358686|NCT02219256|881389|P5|COMPLETED|Overall Study||6
358687|NCT02219256|881390|P4|COMPLETED|Overall Study||4
358688|NCT02219256|881391|P3|COMPLETED|Overall Study||4
358689|NCT02219256|881392|P2|COMPLETED|Overall Study||4
358690|NCT02219256|881393|P1|COMPLETED|Overall Study||12
358691|NCT02219256|881382|P12|STARTED|Overall Study||6
358692|NCT02219256|881383|P11|STARTED|Overall Study||6
358693|NCT02219256|881384|P10|STARTED|Overall Study||6
358694|NCT02219256|881385|P9|STARTED|Overall Study||6
358695|NCT02219256|881386|P8|STARTED|Overall Study||8
358696|NCT02219256|881387|P7|STARTED|Overall Study||6
358697|NCT02219256|881388|P6|STARTED|Overall Study||6
358698|NCT02219256|881389|P5|STARTED|Overall Study||6
358699|NCT02219256|881390|P4|STARTED|Overall Study||4
358700|NCT02219256|881391|P3|STARTED|Overall Study||4
358701|NCT02219256|881392|P2|STARTED|Overall Study||4
358702|NCT02219256|881393|P1|STARTED|Overall Study||12
358703|NCT02219087|881505|P2|NOT COMPLETED|Overall Study||1
358704|NCT02219087|881506|P1|NOT COMPLETED|Overall Study||0
358705|NCT02219087|881505|P2|COMPLETED|Overall Study|Randomization envelope pulled out of sequence for consented patient. Excluded by request of IRB|29
358706|NCT02219087|881506|P1|COMPLETED|Overall Study||30
358707|NCT02219087|881505|P2|STARTED|Overall Study||30
358708|NCT02219087|881506|P1|STARTED|Overall Study||30
358709|NCT02218697|881526|P2|NOT COMPLETED|Overall Study||6
358710|NCT02218697|881527|P1|NOT COMPLETED|Overall Study||2
358711|NCT02218697|881526|P2|COMPLETED|Overall Study||171
358712|NCT02218697|881527|P1|COMPLETED|Overall Study||177
358713|NCT02218697|881526|P2|STARTED|Overall Study||177
358714|NCT02218697|881527|P1|STARTED|Overall Study||179
358715|NCT02218307|881567|P2|NOT COMPLETED|Overall Study||1
358716|NCT02218307|881568|P1|NOT COMPLETED|Overall Study||9
358717|NCT02218307|881567|P2|COMPLETED|Overall Study||33
358718|NCT02218307|881568|P1|COMPLETED|Overall Study||25
358719|NCT02218307|881567|P2|STARTED|Overall Study||34
358720|NCT02218307|881568|P1|STARTED|Overall Study||34
358721|NCT02218268|881576|P2|NOT COMPLETED|Final Phase (2 Hours)||0
358722|NCT02218268|881577|P1|NOT COMPLETED|Final Phase (2 Hours)||0
358723|NCT02218268|881576|P2|COMPLETED|Final Phase (2 Hours)||21
358724|NCT02218268|881577|P1|COMPLETED|Final Phase (2 Hours)||19
358725|NCT02218268|881576|P2|STARTED|Final Phase (2 Hours)||21
358726|NCT02218268|881577|P1|STARTED|Final Phase (2 Hours)||19
358727|NCT02218268|881576|P2|NOT COMPLETED|24 Hour Washout||9
358728|NCT02218268|881577|P1|NOT COMPLETED|24 Hour Washout||11
358729|NCT02218268|881576|P2|COMPLETED|24 Hour Washout||21
358730|NCT02218268|881577|P1|COMPLETED|24 Hour Washout||19
358731|NCT02218268|881576|P2|STARTED|24 Hour Washout||30
358732|NCT02218268|881577|P1|STARTED|24 Hour Washout||30
358733|NCT02218268|881576|P2|NOT COMPLETED|First Phase (2 Hours)||0
358734|NCT02218268|881577|P1|NOT COMPLETED|First Phase (2 Hours)||0
358735|NCT02218268|881576|P2|COMPLETED|First Phase (2 Hours)||30
358736|NCT02218268|881577|P1|COMPLETED|First Phase (2 Hours)||30
358737|NCT02218268|881576|P2|STARTED|First Phase (2 Hours)||30
358738|NCT02218268|881577|P1|STARTED|First Phase (2 Hours)||30
358739|NCT02218216|881585|P3|NOT COMPLETED|Overall Study||0
358740|NCT02218216|881586|P2|NOT COMPLETED|Overall Study||0
358741|NCT02218216|881587|P1|NOT COMPLETED|Overall Study||6
358742|NCT02218216|881585|P3|COMPLETED|Overall Study||3
358743|NCT02218216|881586|P2|COMPLETED|Overall Study||2
358744|NCT02218216|881587|P1|COMPLETED|Overall Study||8
358745|NCT02218216|881585|P3|STARTED|Overall Study||3
358746|NCT02218216|881586|P2|STARTED|Overall Study||2
358747|NCT02218216|881587|P1|STARTED|Overall Study||14
358748|NCT02218203|881595|P1|NOT COMPLETED|Overall Study||0
358749|NCT02218203|881595|P1|COMPLETED|Overall Study|2 subjects did not complete the placebo, medium dose, and high dose dex/lido combination arms.|26
358750|NCT02218203|881595|P1|High Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||24
358751|NCT02218203|881595|P1|High Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||24
358752|NCT02218203|881595|P1|High Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||24
358753|NCT02218203|881595|P1|High Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||24
358754|NCT02218203|881595|P1|Medium Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||24
358755|NCT02218203|881595|P1|Medium Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||24
358756|NCT02218203|881595|P1|Medium Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||24
358757|NCT02218203|881595|P1|Medium Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||24
358758|NCT02218203|881595|P1|Low Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||26
358759|NCT02218203|881595|P1|Low Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||26
358760|NCT02218203|881595|P1|Low Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||26
358761|NCT02218203|881595|P1|Low Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||26
358762|NCT02218203|881595|P1|Placebo Dex v. 4mg/km LBM Lidocaine|Overall Study||24
358763|NCT02218203|881595|P1|Placebo Dex v. 2mg/km LBM Lidocaine|Overall Study||24
358764|NCT02218203|881595|P1|Placebo Dex v. 1mg/km LBM Lidocaine|Overall Study||24
358765|NCT02218203|881595|P1|Placebo Dex v. 0mg/km LBM Lidocaine|Overall Study||24
358766|NCT02218203|881595|P1|STARTED|Overall Study||26
358767|NCT02217982|881619|P2|NOT COMPLETED|Overall Study||1
358768|NCT02217982|881620|P1|NOT COMPLETED|Overall Study||1
358769|NCT02217982|881619|P2|COMPLETED|Overall Study||3
358770|NCT02217982|881620|P1|COMPLETED|Overall Study|Trial closed before patient finished|0
358771|NCT02217982|881619|P2|STARTED|Overall Study||4
358772|NCT02217982|881620|P1|STARTED|Overall Study||1
358773|NCT02217878|881630|P2|NOT COMPLETED|Overall Study||2
358774|NCT02217878|881631|P1|NOT COMPLETED|Overall Study||2
358775|NCT02217878|881630|P2|COMPLETED|Overall Study||35
358776|NCT02217878|881631|P1|COMPLETED|Overall Study||35
358777|NCT02217878|881630|P2|STARTED|Overall Study||37
358778|NCT02217878|881631|P1|STARTED|Overall Study||37
358779|NCT02217800|881711|P1|NOT COMPLETED|Overall Study||0
358780|NCT02217800|881711|P1|COMPLETED|Overall Study||8
358781|NCT02217800|881711|P1|STARTED|Overall Study||8
358782|NCT02217280|881723|P1|NOT COMPLETED|Overall Study||4
358783|NCT02217280|881723|P1|COMPLETED|Overall Study||16
358784|NCT02217280|881723|P1|STARTED|Overall Study||20
358785|NCT02216695|881728|P1|NOT COMPLETED|Overall Study||0
358786|NCT02216695|881728|P1|COMPLETED|Overall Study|This is a database study and hence, 64882 patients were finally included|64882
358787|NCT02216695|881728|P1|STARTED|Overall Study||64882
358788|NCT02216591|881739|P2|NOT COMPLETED|Overall Study||1
358789|NCT02216591|881740|P1|NOT COMPLETED|Overall Study||0
358790|NCT02216591|881739|P2|COMPLETED|Overall Study||9
358791|NCT02216591|881740|P1|COMPLETED|Overall Study||11
358792|NCT02216591|881739|P2|STARTED|Overall Study||10
358793|NCT02216591|881740|P1|STARTED|Overall Study||11
358794|NCT02216526|881753|P3|NOT COMPLETED|Overall Study||8
358795|NCT02216526|881754|P2|NOT COMPLETED|Overall Study||3
358796|NCT02216526|881755|P1|NOT COMPLETED|Overall Study||5
358797|NCT02216526|881753|P3|COMPLETED|Overall Study||36
358798|NCT02216526|881754|P2|COMPLETED|Overall Study||41
358799|NCT02216526|881755|P1|COMPLETED|Overall Study||40
358800|NCT02216526|881753|P3|STARTED|Overall Study||44
358801|NCT02216526|881754|P2|STARTED|Overall Study||44
358802|NCT02216526|881755|P1|STARTED|Overall Study||45
358803|NCT02216422|881865|P1|NOT COMPLETED|Overall Study||0
358804|NCT02216422|881865|P1|COMPLETED|Overall Study||36
358805|NCT02216422|881865|P1|STARTED|Overall Study||36
358806|NCT02216357|881873|P2|NOT COMPLETED|Overall Study||1
358807|NCT02216357|881874|P1|NOT COMPLETED|Overall Study||2
358808|NCT02216357|881873|P2|COMPLETED|Overall Study||4
358809|NCT02216357|881874|P1|COMPLETED|Overall Study||12
358810|NCT02216357|881873|P2|STARTED|Overall Study||5
358811|NCT02216357|881874|P1|STARTED|Overall Study||14
358812|NCT02216123|881900|P2|NOT COMPLETED|Overall Study||2
358813|NCT02216123|881901|P1|NOT COMPLETED|Overall Study||6
358814|NCT02216123|881900|P2|COMPLETED|Overall Study||83
358815|NCT02216123|881901|P1|COMPLETED|Overall Study||160
358816|NCT02216123|881900|P2|STARTED|Overall Study||85
358817|NCT02216123|881901|P1|STARTED|Overall Study||166
358818|NCT02216097|881967|P2|NOT COMPLETED|Overall Study||0
358819|NCT02216097|881968|P1|NOT COMPLETED|Overall Study||0
358820|NCT02216097|881967|P2|COMPLETED|Overall Study||6
358821|NCT02216097|881968|P1|COMPLETED|Overall Study||8
358822|NCT02216097|881967|P2|STARTED|Overall Study||6
358823|NCT02216097|881968|P1|STARTED|Overall Study||8
358824|NCT02215954|881993|P3|NOT COMPLETED|Overall Study||6
358825|NCT02215954|881994|P2|NOT COMPLETED|Overall Study||1
358826|NCT02215954|881995|P1|NOT COMPLETED|Overall Study||1
358827|NCT02215954|881993|P3|COMPLETED|Overall Study||205
358828|NCT02215954|881994|P2|COMPLETED|Overall Study||211
358829|NCT02215954|881995|P1|COMPLETED|Overall Study||213
358830|NCT02215954|881993|P3|Safety Analysis Set|Overall Study||208
358831|NCT02215954|881994|P2|Safety Analysis Set|Overall Study||211
358832|NCT02215954|881995|P1|Safety Analysis Set|Overall Study||213
358833|NCT02215954|881993|P3|Per Protocol (PP) Analysis Set|Overall Study||205
358834|NCT02215954|881994|P2|Per Protocol (PP) Analysis Set|Overall Study||208
358835|NCT02215954|881995|P1|Per Protocol (PP) Analysis Set|Overall Study||212
358836|NCT02215954|881993|P3|Intention-To-Treat (ITT) Analysis Set|Overall Study||211
358837|NCT02215954|881994|P2|Intention-To-Treat (ITT) Analysis Set|Overall Study||212
358838|NCT02215954|881995|P1|Intention-To-Treat (ITT) Analysis Set|Overall Study||214
358839|NCT02215954|881993|P3|STARTED|Overall Study||211
358840|NCT02215954|881994|P2|STARTED|Overall Study||212
358841|NCT02215954|881995|P1|STARTED|Overall Study||214
358842|NCT02215252|882018|P3|NOT COMPLETED|Overall Study||4
358843|NCT02215252|882019|P2|NOT COMPLETED|Overall Study||8
358844|NCT02215252|882020|P1|NOT COMPLETED|Overall Study||2
358845|NCT02215252|882018|P3|COMPLETED|Overall Study||41
358846|NCT02215252|882019|P2|COMPLETED|Overall Study||38
358847|NCT02215252|882020|P1|COMPLETED|Overall Study||42
358848|NCT02215252|882018|P3|STARTED|Overall Study||45
358849|NCT02215252|882019|P2|STARTED|Overall Study||46
358850|NCT02215252|882020|P1|STARTED|Overall Study||44
358851|NCT02215161|882077|P1|NOT COMPLETED|Overall Study||0
358852|NCT02215161|882077|P1|COMPLETED|Overall Study||14
358853|NCT02215161|882077|P1|STARTED|Overall Study||14
358854|NCT02214615|882097|P2|NOT COMPLETED|Second Intervention||0
358855|NCT02214615|882098|P1|NOT COMPLETED|Second Intervention||0
358856|NCT02214615|882097|P2|COMPLETED|Second Intervention||1
358857|NCT02214615|882098|P1|COMPLETED|Second Intervention||1
358858|NCT02214615|882097|P2|STARTED|Second Intervention||1
358859|NCT02214615|882098|P1|STARTED|Second Intervention||1
358860|NCT02214615|882097|P2|NOT COMPLETED|Washout||0
358861|NCT02214615|882098|P1|NOT COMPLETED|Washout||0
358862|NCT02214615|882097|P2|COMPLETED|Washout||1
358863|NCT02214615|882098|P1|COMPLETED|Washout||1
358864|NCT02214615|882097|P2|STARTED|Washout||1
358865|NCT02214615|882098|P1|STARTED|Washout||1
358866|NCT02214615|882097|P2|NOT COMPLETED|First Intervention||0
358867|NCT02214615|882098|P1|NOT COMPLETED|First Intervention||0
358868|NCT02214615|882097|P2|COMPLETED|First Intervention||1
358869|NCT02214615|882098|P1|COMPLETED|First Intervention||1
358870|NCT02214615|882097|P2|STARTED|First Intervention||1
358871|NCT02214615|882098|P1|STARTED|First Intervention||1
358872|NCT02214420|882108|P2|NOT COMPLETED|Overall Study||0
358873|NCT02214420|882109|P1|NOT COMPLETED|Overall Study||1
358874|NCT02214420|882108|P2|COMPLETED|Overall Study||10
358875|NCT02214420|882109|P1|COMPLETED|Overall Study||13
358876|NCT02214420|882108|P2|STARTED|Overall Study||10
358877|NCT02214420|882109|P1|STARTED|Overall Study||14
358878|NCT02214277|882118|P3|NOT COMPLETED|Overall Study||34
358879|NCT02214277|882119|P2|NOT COMPLETED|Overall Study||25
358880|NCT02214277|882120|P1|NOT COMPLETED|Overall Study||19
358881|NCT02214277|882118|P3|COMPLETED|Overall Study||85
358882|NCT02214277|882119|P2|COMPLETED|Overall Study||96
358883|NCT02214277|882120|P1|COMPLETED|Overall Study||104
358884|NCT02214277|882118|P3|STARTED|Overall Study||119
358885|NCT02214277|882119|P2|STARTED|Overall Study||121
358886|NCT02214277|882120|P1|STARTED|Overall Study||123
358887|NCT02214238|882130|P2|NOT COMPLETED|Overall Study||6
358888|NCT02214238|882131|P1|NOT COMPLETED|Overall Study||6
358889|NCT02214238|882130|P2|COMPLETED|Overall Study||17
358890|NCT02214238|882131|P1|COMPLETED|Overall Study||20
358891|NCT02214238|882130|P2|STARTED|Overall Study||23
358892|NCT02214238|882131|P1|STARTED|Overall Study||26
358893|NCT02214225|882144|P3|NOT COMPLETED|Overall Study||22
358894|NCT02214225|882145|P2|NOT COMPLETED|Overall Study||19
358895|NCT02214225|882146|P1|NOT COMPLETED|Overall Study||55
358896|NCT02214225|882144|P3|COMPLETED|Overall Study||850
358897|NCT02214225|882145|P2|COMPLETED|Overall Study||852
358898|NCT02214225|882146|P1|COMPLETED|Overall Study||1686
358899|NCT02214225|882144|P3|STARTED|Overall Study||872
358900|NCT02214225|882145|P2|STARTED|Overall Study||871
358901|NCT02214225|882146|P1|STARTED|Overall Study||1741
358902|NCT02214186|882205|P2|NOT COMPLETED|Overall Study||2
358903|NCT02214186|882206|P1|NOT COMPLETED|Overall Study||2
358904|NCT02214186|882205|P2|COMPLETED|Overall Study||21
358905|NCT02214186|882206|P1|COMPLETED|Overall Study||21
358906|NCT02214186|882205|P2|STARTED|Overall Study||23
358907|NCT02214186|882206|P1|STARTED|Overall Study||23
358908|NCT02214121|882231|P3|NOT COMPLETED|Part B||1
358909|NCT02214121|882232|P2|NOT COMPLETED|Part B||3
358910|NCT02214121|882233|P1|NOT COMPLETED|Part B||0
358911|NCT02214121|882231|P3|COMPLETED|Part B||7
358912|NCT02214121|882232|P2|COMPLETED|Part B||14
358913|NCT02214121|882233|P1|COMPLETED|Part B||0
358914|NCT02214121|882231|P3|STARTED|Part B||8
358915|NCT02214121|882232|P2|STARTED|Part B||17
358916|NCT02214121|882233|P1|STARTED|Part B||0
358917|NCT02214121|882231|P3|NOT COMPLETED|Part A||0
358918|NCT02214121|882232|P2|NOT COMPLETED|Part A||0
358919|NCT02214121|882233|P1|NOT COMPLETED|Part A||7
358920|NCT02214121|882231|P3|COMPLETED|Part A||0
358921|NCT02214121|882232|P2|COMPLETED|Part A||0
358922|NCT02214121|882233|P1|COMPLETED|Part A||39
358923|NCT02214121|882231|P3|STARTED|Part A||0
358924|NCT02214121|882232|P2|STARTED|Part A||0
358925|NCT02214121|882233|P1|STARTED|Part A||46
358926|NCT02213900|882312|P2|NOT COMPLETED|Overall Study||0
358927|NCT02213900|882313|P1|NOT COMPLETED|Overall Study||0
358928|NCT02213900|882312|P2|COMPLETED|Overall Study||67
358929|NCT02213900|882313|P1|COMPLETED|Overall Study||68
358930|NCT02213900|882312|P2|STARTED|Overall Study||67
358931|NCT02213900|882313|P1|STARTED|Overall Study||68
358932|NCT02213666|882325|P1|NOT COMPLETED|Overall Study||1
358933|NCT02213666|882325|P1|COMPLETED|Overall Study||71
358934|NCT02213666|882325|P1|STARTED|Overall Study||72
358935|NCT02213510|882331|P2|NOT COMPLETED|Overall Study||1
358936|NCT02213510|882332|P1|NOT COMPLETED|Overall Study||1
358937|NCT02213510|882331|P2|COMPLETED|Overall Study||18
358938|NCT02213510|882332|P1|COMPLETED|Overall Study||20
358939|NCT02213510|882331|P2|STARTED|Overall Study||19
358940|NCT02213510|882332|P1|STARTED|Overall Study||21
358941|NCT02213250|882358|P2|NOT COMPLETED|Overall Study||0
358942|NCT02213250|882359|P1|NOT COMPLETED|Overall Study||0
358943|NCT02213250|882358|P2|COMPLETED|Overall Study||8
358944|NCT02213250|882359|P1|COMPLETED|Overall Study||4
358945|NCT02213250|882358|P2|STARTED|Overall Study||8
358946|NCT02213250|882359|P1|STARTED|Overall Study||4
358947|NCT02213198|882390|P2|NOT COMPLETED|Follow up 2 6 Months Post TCC Treatment||7
358948|NCT02213198|882391|P1|NOT COMPLETED|Follow up 2 6 Months Post TCC Treatment||23
358949|NCT02213198|882390|P2|COMPLETED|Follow up 2 6 Months Post TCC Treatment||60
358950|NCT02213198|882391|P1|COMPLETED|Follow up 2 6 Months Post TCC Treatment||102
358951|NCT02213198|882390|P2|STARTED|Follow up 2 6 Months Post TCC Treatment||67
358952|NCT02213198|882391|P1|STARTED|Follow up 2 6 Months Post TCC Treatment||125
358953|NCT02213198|882390|P2|NOT COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||41
358954|NCT02213198|882391|P1|NOT COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||93
358955|NCT02213198|882390|P2|COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||67
358956|NCT02213198|882391|P1|COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||125
358957|NCT02213198|882390|P2|STARTED|Follow up 1 3 Mos Post BL End of TCC tx||108
358958|NCT02213198|882391|P1|STARTED|Follow up 1 3 Mos Post BL End of TCC tx||218
358959|NCT02213198|882390|P2|NOT COMPLETED|Baseline||51
358960|NCT02213198|882391|P1|NOT COMPLETED|Baseline||88
358961|NCT02213198|882390|P2|COMPLETED|Baseline||108
358962|NCT02213198|882391|P1|COMPLETED|Baseline||218
358963|NCT02213198|882390|P2|STARTED|Baseline||159
358964|NCT02213198|882391|P1|STARTED|Baseline||306
358965|NCT02213055|882401|P2|NOT COMPLETED|Overall Study||0
358966|NCT02213055|882402|P1|NOT COMPLETED|Overall Study||39
358967|NCT02213055|882401|P2|COMPLETED|Overall Study||0
358968|NCT02213055|882402|P1|COMPLETED|Overall Study||58
358969|NCT02213055|882401|P2|STARTED|Overall Study||0
358970|NCT02213055|882402|P1|STARTED|Overall Study||97
358971|NCT02212977|882410|P2|NOT COMPLETED|Overall Study||6
358972|NCT02212977|882411|P1|NOT COMPLETED|Overall Study||5
358973|NCT02212977|882410|P2|COMPLETED|Overall Study||48
358974|NCT02212977|882411|P1|COMPLETED|Overall Study||50
358975|NCT02212977|882410|P2|STARTED|Overall Study||54
358976|NCT02212977|882411|P1|STARTED|Overall Study||55
358977|NCT02212834|882427|P2|NOT COMPLETED|Overall Study||0
358978|NCT02212834|882428|P1|NOT COMPLETED|Overall Study||0
358979|NCT02212834|882427|P2|COMPLETED|Overall Study||2506
358980|NCT02212834|882428|P1|COMPLETED|Overall Study||33938
358981|NCT02212834|882427|P2|STARTED|Overall Study||2506
358982|NCT02212834|882428|P1|STARTED|Overall Study||33938
358983|NCT02212457|882440|P6|NOT COMPLETED|Overall Study||13
358984|NCT02212457|882441|P5|NOT COMPLETED|Overall Study||15
358985|NCT02212457|882442|P4|NOT COMPLETED|Overall Study||11
358986|NCT02212457|882443|P3|NOT COMPLETED|Overall Study||16
358987|NCT02212457|882444|P2|NOT COMPLETED|Overall Study||21
358988|NCT02212457|882445|P1|NOT COMPLETED|Overall Study||19
358989|NCT02212457|882440|P6|COMPLETED|Overall Study||147
358990|NCT02212457|882441|P5|COMPLETED|Overall Study||137
358991|NCT02212457|882442|P4|COMPLETED|Overall Study||123
358992|NCT02212457|882443|P3|COMPLETED|Overall Study||141
358993|NCT02212457|882444|P2|COMPLETED|Overall Study||211
358994|NCT02212457|882445|P1|COMPLETED|Overall Study||209
358995|NCT02212457|882440|P6|STARTED|Overall Study||160
358996|NCT02212457|882441|P5|STARTED|Overall Study||152
358997|NCT02212457|882442|P4|STARTED|Overall Study||134
358998|NCT02212457|882443|P3|STARTED|Overall Study||157
358999|NCT02212457|882444|P2|STARTED|Overall Study||232
359000|NCT02212457|882445|P1|STARTED|Overall Study||228
359001|NCT02212301|882483|P2|NOT COMPLETED|Period 2||0
359002|NCT02212301|882484|P1|NOT COMPLETED|Period 2||0
359003|NCT02212301|882483|P2|COMPLETED|Period 2||21
359004|NCT02212301|882484|P1|COMPLETED|Period 2||21
359005|NCT02212301|882483|P2|STARTED|Period 2||21
359006|NCT02212301|882484|P1|STARTED|Period 2||21
359007|NCT02212301|882483|P2|NOT COMPLETED|Period 1||1
359008|NCT02212301|882484|P1|NOT COMPLETED|Period 1||0
359009|NCT02212301|882483|P2|COMPLETED|Period 1||21
359010|NCT02212301|882484|P1|COMPLETED|Period 1||21
359011|NCT02212301|882483|P2|STARTED|Period 1||22
359012|NCT02212301|882484|P1|STARTED|Period 1||21
359013|NCT02212197|882495|P3|NOT COMPLETED|Overall Study||0
359014|NCT02212197|882496|P2|NOT COMPLETED|Overall Study||0
359015|NCT02212197|882497|P1|NOT COMPLETED|Overall Study||1
359016|NCT02212197|882495|P3|COMPLETED|Overall Study||17
359017|NCT02212197|882496|P2|COMPLETED|Overall Study||15
359018|NCT02212197|882497|P1|COMPLETED|Overall Study||18
359019|NCT02212197|882495|P3|STARTED|Overall Study||17
359020|NCT02212197|882496|P2|STARTED|Overall Study||15
359021|NCT02212197|882497|P1|STARTED|Overall Study||19
359022|NCT02212106|882522|P2|NOT COMPLETED|Overall Study||4
359023|NCT02212106|882523|P1|NOT COMPLETED|Overall Study||10
359024|NCT02212106|882522|P2|COMPLETED|Overall Study||96
359025|NCT02212106|882523|P1|COMPLETED|Overall Study||292
359026|NCT02212106|882522|P2|STARTED|Overall Study||100
359027|NCT02212106|882523|P1|STARTED|Overall Study||302
359028|NCT02212028|882541|P2|NOT COMPLETED|Overall Study||0
359029|NCT02212028|882542|P1|NOT COMPLETED|Overall Study||0
359030|NCT02212028|882541|P2|COMPLETED|Overall Study||26
359031|NCT02212028|882542|P1|COMPLETED|Overall Study||26
359032|NCT02212028|882541|P2|STARTED|Overall Study||26
359033|NCT02212028|882542|P1|STARTED|Overall Study||26
359034|NCT02211534|882552|P2|NOT COMPLETED|Overall Study||5
359035|NCT02211534|882553|P1|NOT COMPLETED|Overall Study||13
359036|NCT02211534|882552|P2|COMPLETED|Overall Study||6
359037|NCT02211534|882553|P1|COMPLETED|Overall Study||11
359038|NCT02211534|882552|P2|STARTED|Overall Study||11
359039|NCT02211534|882553|P1|STARTED|Overall Study||24
359040|NCT02210208|882573|P1|NOT COMPLETED|Period B (Donor Site)||7
359041|NCT02210208|882573|P1|COMPLETED|Period B (Donor Site)||12
359042|NCT02210208|882573|P1|STARTED|Period B (Donor Site)|6 subjects was decided by the Physician not to be included in the Part B.|19
359043|NCT02210208|882573|P1|NOT COMPLETED|Period A (Graft Site)||2
359044|NCT02210208|882573|P1|COMPLETED|Period A (Graft Site)||23
359045|NCT02210208|882573|P1|STARTED|Period A (Graft Site)||25
359046|NCT02210195|882582|P2|NOT COMPLETED|Overall Study||0
359047|NCT02210195|882583|P1|NOT COMPLETED|Overall Study||4
359048|NCT02210195|882582|P2|COMPLETED|Overall Study||10
359049|NCT02210195|882583|P1|COMPLETED|Overall Study||6
359050|NCT02210195|882582|P2|STARTED|Overall Study||10
359051|NCT02210195|882583|P1|STARTED|Overall Study||10
359052|NCT02210091|882593|P2|NOT COMPLETED|Overall Study||2
359053|NCT02210091|882594|P1|NOT COMPLETED|Overall Study||0
359054|NCT02210091|882593|P2|COMPLETED|Overall Study||32
359055|NCT02210091|882594|P1|COMPLETED|Overall Study||32
359056|NCT02210091|882593|P2|STARTED|Overall Study||34
359057|NCT02210091|882594|P1|STARTED|Overall Study||32
359058|NCT02210052|882666|P1|NOT COMPLETED|Overall Study||0
359059|NCT02210052|882666|P1|COMPLETED|Overall Study||6
359060|NCT02210052|882666|P1|STARTED|Overall Study||6
359061|NCT02210000|882672|P2|NOT COMPLETED|Overall Study||21
359062|NCT02210000|882673|P1|NOT COMPLETED|Overall Study||19
359063|NCT02210000|882672|P2|COMPLETED|Overall Study||36
359064|NCT02210000|882673|P1|COMPLETED|Overall Study||38
359065|NCT02210000|882672|P2|STARTED|Overall Study||57
359066|NCT02210000|882673|P1|STARTED|Overall Study||57
359067|NCT02209766|882699|P5|NOT COMPLETED|Overall Study||0
359068|NCT02209766|882700|P4|NOT COMPLETED|Overall Study||1
359069|NCT02209766|882701|P3|NOT COMPLETED|Overall Study||0
359070|NCT02209766|882702|P2|NOT COMPLETED|Overall Study||0
359071|NCT02209766|882703|P1|NOT COMPLETED|Overall Study||0
359072|NCT02209766|882699|P5|COMPLETED|Overall Study||6
359073|NCT02209766|882700|P4|COMPLETED|Overall Study||2
359074|NCT02209766|882701|P3|COMPLETED|Overall Study||6
359075|NCT02209766|882702|P2|COMPLETED|Overall Study||3
359076|NCT02209766|882703|P1|COMPLETED|Overall Study||6
359077|NCT02209766|882699|P5|STARTED|Overall Study||6
359078|NCT02209766|882700|P4|STARTED|Overall Study||3
359079|NCT02209766|882701|P3|STARTED|Overall Study||6
359080|NCT02209766|882702|P2|STARTED|Overall Study||3
359081|NCT02209766|882703|P1|STARTED|Overall Study||6
359082|NCT02209506|882754|P5|NOT COMPLETED|Overall Study||1
359083|NCT02209506|882755|P4|NOT COMPLETED|Overall Study||0
359084|NCT02209506|882756|P3|NOT COMPLETED|Overall Study||0
359085|NCT02209506|882757|P2|NOT COMPLETED|Overall Study||0
359086|NCT02209506|882758|P1|NOT COMPLETED|Overall Study||0
359087|NCT02209506|882754|P5|COMPLETED|Overall Study||5
359088|NCT02209506|882755|P4|COMPLETED|Overall Study||2
359089|NCT02209506|882756|P3|COMPLETED|Overall Study||6
359090|NCT02209506|882757|P2|COMPLETED|Overall Study||6
359091|NCT02209506|882758|P1|COMPLETED|Overall Study||3
359092|NCT02209506|882754|P5|STARTED|Overall Study||6
359093|NCT02209506|882755|P4|STARTED|Overall Study||2
359094|NCT02209506|882756|P3|STARTED|Overall Study||6
359095|NCT02209506|882757|P2|STARTED|Overall Study||6
359096|NCT02209506|882758|P1|STARTED|Overall Study||3
359097|NCT02209454|882833|P2|NOT COMPLETED|Second Period||0
359098|NCT02209454|882834|P1|NOT COMPLETED|Second Period||1
359099|NCT02209454|882833|P2|COMPLETED|Second Period||13
359100|NCT02209454|882834|P1|COMPLETED|Second Period||12
359101|NCT02209454|882833|P2|STARTED|Second Period||13
359102|NCT02209454|882834|P1|STARTED|Second Period||13
359103|NCT02209454|882833|P2|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0
359104|NCT02209454|882834|P1|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0
359105|NCT02209454|882833|P2|COMPLETED|Washout Period a Minimum of a 7 Day||13
359106|NCT02209454|882834|P1|COMPLETED|Washout Period a Minimum of a 7 Day||13
359107|NCT02209454|882833|P2|STARTED|Washout Period a Minimum of a 7 Day||13
359108|NCT02209454|882834|P1|STARTED|Washout Period a Minimum of a 7 Day||13
359109|NCT02209454|882833|P2|NOT COMPLETED|First Period||0
359110|NCT02209454|882834|P1|NOT COMPLETED|First Period||0
359111|NCT02209454|882833|P2|COMPLETED|First Period||13
359112|NCT02209454|882834|P1|COMPLETED|First Period||13
359113|NCT02209454|882833|P2|STARTED|First Period||13
359114|NCT02209454|882834|P1|STARTED|First Period||13
359115|NCT02209259|882851|P3|NOT COMPLETED|Overall Study||0
359116|NCT02209259|882852|P2|NOT COMPLETED|Overall Study||0
359117|NCT02209259|882853|P1|NOT COMPLETED|Overall Study||0
359118|NCT02209259|882851|P3|COMPLETED|Overall Study||56
359119|NCT02209259|882852|P2|COMPLETED|Overall Study||56
359120|NCT02209259|882853|P1|COMPLETED|Overall Study||56
359121|NCT02209259|882851|P3|STARTED|Overall Study||56
359122|NCT02209259|882852|P2|STARTED|Overall Study||56
359123|NCT02209259|882853|P1|STARTED|Overall Study||56
359124|NCT02209181|882871|P4|NOT COMPLETED|Overall Study||0
359125|NCT02209181|882872|P3|NOT COMPLETED|Overall Study||1
359126|NCT02209181|882873|P2|NOT COMPLETED|Overall Study||1
359127|NCT02209181|882874|P1|NOT COMPLETED|Overall Study||1
359128|NCT02209181|882871|P4|COMPLETED|Overall Study||66
359129|NCT02209181|882872|P3|COMPLETED|Overall Study||68
359130|NCT02209181|882873|P2|COMPLETED|Overall Study||66
359131|NCT02209181|882874|P1|COMPLETED|Overall Study||66
359132|NCT02209181|882871|P4|STARTED|Overall Study||66
359133|NCT02209181|882872|P3|STARTED|Overall Study||69
359134|NCT02209181|882873|P2|STARTED|Overall Study||67
359135|NCT02209181|882874|P1|STARTED|Overall Study||67
359136|NCT02209064|883036|P1|NOT COMPLETED|Overall Study||0
359137|NCT02209064|883036|P1|COMPLETED|Overall Study||25
359138|NCT02209064|883036|P1|STARTED|Overall Study||25
359139|NCT02208349|883045|P2|NOT COMPLETED|Sixth 6 Month||0
359140|NCT02208349|883046|P1|NOT COMPLETED|Sixth 6 Month||0
359141|NCT02208349|883045|P2|COMPLETED|Sixth 6 Month||2
359142|NCT02208349|883046|P1|COMPLETED|Sixth 6 Month||3
359143|NCT02208349|883045|P2|STARTED|Sixth 6 Month||2
359144|NCT02208349|883046|P1|STARTED|Sixth 6 Month||3
359145|NCT02208349|883045|P2|NOT COMPLETED|Fifth 6 Month||0
359146|NCT02208349|883046|P1|NOT COMPLETED|Fifth 6 Month||0
359147|NCT02208349|883045|P2|COMPLETED|Fifth 6 Month||2
359148|NCT02208349|883046|P1|COMPLETED|Fifth 6 Month||7
359149|NCT02208349|883045|P2|STARTED|Fifth 6 Month||2
359150|NCT02208349|883046|P1|STARTED|Fifth 6 Month||7
359151|NCT02208349|883045|P2|NOT COMPLETED|Fourth 6 Month||0
359152|NCT02208349|883046|P1|NOT COMPLETED|Fourth 6 Month||0
359153|NCT02208349|883045|P2|COMPLETED|Fourth 6 Month||2
359154|NCT02208349|883046|P1|COMPLETED|Fourth 6 Month||14
359155|NCT02208349|883045|P2|STARTED|Fourth 6 Month||2
359156|NCT02208349|883046|P1|STARTED|Fourth 6 Month||14
359157|NCT02208349|883045|P2|NOT COMPLETED|Third 6 Month||0
359158|NCT02208349|883046|P1|NOT COMPLETED|Third 6 Month||0
359159|NCT02208349|883045|P2|COMPLETED|Third 6 Month||3
359160|NCT02208349|883046|P1|COMPLETED|Third 6 Month||6
359161|NCT02208349|883045|P2|STARTED|Third 6 Month||3
359162|NCT02208349|883046|P1|STARTED|Third 6 Month||6
359163|NCT02208349|883045|P2|NOT COMPLETED|Second 6 Months||0
359164|NCT02208349|883046|P1|NOT COMPLETED|Second 6 Months||0
359165|NCT02208349|883045|P2|COMPLETED|Second 6 Months||7
359166|NCT02208349|883046|P1|COMPLETED|Second 6 Months||11
359167|NCT02208349|883045|P2|STARTED|Second 6 Months||7
359168|NCT02208349|883046|P1|STARTED|Second 6 Months||11
359169|NCT02208349|883045|P2|NOT COMPLETED|Initial 6 Months||0
359170|NCT02208349|883046|P1|NOT COMPLETED|Initial 6 Months||0
359171|NCT02208349|883045|P2|COMPLETED|Initial 6 Months||9
359172|NCT02208349|883046|P1|COMPLETED|Initial 6 Months||16
359173|NCT02208349|883045|P2|STARTED|Initial 6 Months||9
359174|NCT02208349|883046|P1|STARTED|Initial 6 Months||16
359175|NCT02208310|883056|P2|NOT COMPLETED|Overall Study||5
359176|NCT02208310|883057|P1|NOT COMPLETED|Overall Study||6
359177|NCT02208310|883056|P2|COMPLETED|Overall Study||0
359178|NCT02208310|883057|P1|COMPLETED|Overall Study||0
359179|NCT02208310|883056|P2|Day 180|Overall Study||1
359180|NCT02208310|883057|P1|Day 180|Overall Study||0
359181|NCT02208310|883056|P2|STARTED|Overall Study||5
359182|NCT02208310|883057|P1|STARTED|Overall Study||6
359183|NCT02207972|883089|P2|NOT COMPLETED|Overall Study||0
359184|NCT02207972|883090|P1|NOT COMPLETED|Overall Study||0
359185|NCT02207972|883089|P2|COMPLETED|Overall Study||24
359186|NCT02207972|883090|P1|COMPLETED|Overall Study||22
359187|NCT02207972|883089|P2|STARTED|Overall Study||24
359188|NCT02207972|883090|P1|STARTED|Overall Study||22
359189|NCT02207907|883102|P2|NOT COMPLETED|Overall Study||8
359190|NCT02207907|883103|P1|NOT COMPLETED|Overall Study||11
359191|NCT02207907|883102|P2|COMPLETED|Overall Study||115
359192|NCT02207907|883103|P1|COMPLETED|Overall Study||113
359193|NCT02207907|883102|P2|STARTED|Overall Study||123
359194|NCT02207907|883103|P1|STARTED|Overall Study||124
359195|NCT02207829|883121|P2|NOT COMPLETED|Overall Study||34
359196|NCT02207829|883122|P1|NOT COMPLETED|Overall Study||42
359197|NCT02207829|883121|P2|COMPLETED|Overall Study||474
359198|NCT02207829|883122|P1|COMPLETED|Overall Study||467
359199|NCT02207829|883121|P2|STARTED|Overall Study||508
359200|NCT02207829|883122|P1|STARTED|Overall Study||509
359201|NCT02207803|883130|P2|NOT COMPLETED|Overall Study||17
359202|NCT02207803|883131|P1|NOT COMPLETED|Overall Study||15
359203|NCT02207803|883130|P2|COMPLETED|Overall Study||108
359204|NCT02207803|883131|P1|COMPLETED|Overall Study||110
359205|NCT02207803|883130|P2|STARTED|Overall Study||125
359206|NCT02207803|883131|P1|STARTED|Overall Study||125
359207|NCT02207634|883141|P2|NOT COMPLETED|Overall Study||31
359208|NCT02207634|883142|P1|NOT COMPLETED|Overall Study||22
359209|NCT02207634|883141|P2|COMPLETED|Overall Study||953
359210|NCT02207634|883142|P1|COMPLETED|Overall Study||968
359211|NCT02207634|883141|P2|Received Treatment|Overall Study||983
359212|NCT02207634|883142|P1|Received Treatment|Overall Study||990
359213|NCT02207634|883141|P2|STARTED|Overall Study||984
359214|NCT02207634|883142|P1|STARTED|Overall Study||990
359215|NCT02207621|883157|P3|NOT COMPLETED|Overall Study||168
359216|NCT02207621|883158|P2|NOT COMPLETED|Overall Study||47
359217|NCT02207621|883159|P1|NOT COMPLETED|Overall Study||105
359218|NCT02207621|883157|P3|COMPLETED|Overall Study||86
359219|NCT02207621|883158|P2|COMPLETED|Overall Study||204
359220|NCT02207621|883159|P1|COMPLETED|Overall Study||146
359221|NCT02207621|883157|P3|STARTED|Overall Study||254
359222|NCT02207621|883158|P2|STARTED|Overall Study||251
359223|NCT02207621|883159|P1|STARTED|Overall Study||251
359224|NCT02207608|883172|P2|NOT COMPLETED|Overall Study||0
359225|NCT02207608|883173|P1|NOT COMPLETED|Overall Study||1
359226|NCT02207608|883172|P2|COMPLETED|Overall Study||15
359227|NCT02207608|883173|P1|COMPLETED|Overall Study||14
359228|NCT02207608|883172|P2|STARTED|Overall Study||15
359229|NCT02207608|883173|P1|STARTED|Overall Study||15
359230|NCT02207569|883179|P1|NOT COMPLETED|6 Months - 1 Year||9
359231|NCT02207569|883179|P1|COMPLETED|6 Months - 1 Year||213
359232|NCT02207569|883179|P1|STARTED|6 Months - 1 Year||222
359233|NCT02207569|883179|P1|NOT COMPLETED|30 Days to 6 Months||11
359234|NCT02207569|883179|P1|COMPLETED|30 Days to 6 Months||222
359235|NCT02207569|883179|P1|STARTED|30 Days to 6 Months||233
359236|NCT02207569|883179|P1|NOT COMPLETED|Implant to 30 Days||4
359237|NCT02207569|883179|P1|COMPLETED|Implant to 30 Days||233
359238|NCT02207569|883179|P1|STARTED|Implant to 30 Days||237
359239|NCT02207569|883179|P1|NOT COMPLETED|Enrolled to Implant||4
359240|NCT02207569|883179|P1|COMPLETED|Enrolled to Implant|237 actual implants|237
359241|NCT02207569|883179|P1|STARTED|Enrolled to Implant|241 entered procedure room for implant|241
359242|NCT02207530|883197|P1|NOT COMPLETED|Overall Study||91
359243|NCT02207530|883197|P1|COMPLETED|Overall Study||21
359244|NCT02207530|883197|P1|STARTED|Overall Study||112
359245|NCT02207491|883211|P2|NOT COMPLETED|Overall Study||13
359246|NCT02207491|883212|P1|NOT COMPLETED|Overall Study||31
359247|NCT02207491|883211|P2|COMPLETED|Overall Study||196
359248|NCT02207491|883212|P1|COMPLETED|Overall Study||171
359249|NCT02207491|883211|P2|STARTED|Overall Study||209
359250|NCT02207491|883212|P1|STARTED|Overall Study||202
359251|NCT02207478|883222|P2|NOT COMPLETED|Overall Study||0
359252|NCT02207478|883223|P1|NOT COMPLETED|Overall Study||0
359253|NCT02207478|883222|P2|COMPLETED|Overall Study||46
359254|NCT02207478|883223|P1|COMPLETED|Overall Study||40
359255|NCT02207478|883222|P2|STARTED|Overall Study||46
359256|NCT02207478|883223|P1|STARTED|Overall Study||40
359257|NCT02207413|883237|P6|NOT COMPLETED|Overall Study||13
359258|NCT02207413|883238|P5|NOT COMPLETED|Overall Study||7
359259|NCT02207413|883239|P4|NOT COMPLETED|Overall Study||1
359260|NCT02207413|883240|P3|NOT COMPLETED|Overall Study||0
359261|NCT02207413|883241|P2|NOT COMPLETED|Overall Study||0
359262|NCT02207413|883242|P1|NOT COMPLETED|Overall Study||1
359263|NCT02207413|883237|P6|COMPLETED|Overall Study|Primed subjects: 41; Unprimed subjects: 420|461
359264|NCT02207413|883238|P5|COMPLETED|Overall Study|Primed subjects: 40; Unprimed subjects: 419|459
359265|NCT02207413|883239|P4|COMPLETED|Overall Study|Primed subjects: 312; Unprimed subjects: 98|410
359266|NCT02207413|883240|P3|COMPLETED|Overall Study|Primed subjects: 309; Unprimed subjects: 101|410
359267|NCT02207413|883241|P2|COMPLETED|Overall Study||60
359268|NCT02207413|883242|P1|COMPLETED|Overall Study||59
359269|NCT02207413|883237|P6|STARTED|Overall Study||474
359270|NCT02207413|883238|P5|STARTED|Overall Study||466
359271|NCT02207413|883239|P4|STARTED|Overall Study||411
359272|NCT02207413|883240|P3|STARTED|Overall Study||410
359273|NCT02207413|883241|P2|STARTED|Overall Study||60
359274|NCT02207413|883242|P1|STARTED|Overall Study||60
359275|NCT02207400|883338|P2|NOT COMPLETED|Overall Study||14
359276|NCT02207400|883339|P1|NOT COMPLETED|Overall Study||16
359277|NCT02207400|883338|P2|COMPLETED|Overall Study||109
359278|NCT02207400|883339|P1|COMPLETED|Overall Study||107
359279|NCT02207400|883338|P2|STARTED|Overall Study||123
359280|NCT02207400|883339|P1|STARTED|Overall Study||123
359281|NCT02207244|883360|P9|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||8
359282|NCT02207244|883361|P8|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||13
359283|NCT02207244|883362|P7|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||8
359284|NCT02207244|883363|P6|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
359285|NCT02207244|883364|P5|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
359286|NCT02207244|883365|P4|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
359287|NCT02207244|883366|P3|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
359288|NCT02207244|883367|P2|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
359289|NCT02207244|883368|P1|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
359290|NCT02207244|883360|P9|COMPLETED|Withdrawal, Retreatment Period:Week28-48||220
359291|NCT02207244|883361|P8|COMPLETED|Withdrawal, Retreatment Period:Week28-48||457
359292|NCT02207244|883362|P7|COMPLETED|Withdrawal, Retreatment Period:Week28-48||219
359293|NCT02207244|883363|P6|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
359294|NCT02207244|883364|P5|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
359295|NCT02207244|883365|P4|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
359296|NCT02207244|883366|P3|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
359297|NCT02207244|883367|P2|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
359298|NCT02207244|883368|P1|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
359299|NCT02207244|883360|P9|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||34
359300|NCT02207244|883361|P8|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||16
359301|NCT02207244|883362|P7|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||4
359302|NCT02207244|883363|P6|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
359303|NCT02207244|883364|P5|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
359304|NCT02207244|883365|P4|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
359305|NCT02207244|883366|P3|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
359306|NCT02207244|883367|P2|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
359307|NCT02207244|883368|P1|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
359308|NCT02207244|883360|P9|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
359309|NCT02207244|883361|P8|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||193
359310|NCT02207244|883362|P7|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
359311|NCT02207244|883363|P6|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
359312|NCT02207244|883364|P5|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
359313|NCT02207244|883365|P4|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
359314|NCT02207244|883366|P3|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
359315|NCT02207244|883367|P2|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
359316|NCT02207244|883368|P1|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
359317|NCT02207244|883360|P9|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||82
359318|NCT02207244|883361|P8|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||166
359319|NCT02207244|883362|P7|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||143
359320|NCT02207244|883363|P6|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
359321|NCT02207244|883364|P5|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
359322|NCT02207244|883365|P4|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
359323|NCT02207244|883366|P3|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
359324|NCT02207244|883367|P2|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
359325|NCT02207244|883368|P1|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
359326|NCT02207244|883360|P9|Non-Responders|Withdrawal, Retreatment Period:Week28-48||112
359327|NCT02207244|883361|P8|Non-Responders|Withdrawal, Retreatment Period:Week28-48||95
359328|NCT02207244|883362|P7|Non-Responders|Withdrawal, Retreatment Period:Week28-48||80
359329|NCT02207244|883363|P6|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
359330|NCT02207244|883364|P5|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
359331|NCT02207244|883365|P4|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
359332|NCT02207244|883366|P3|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
359333|NCT02207244|883367|P2|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
359334|NCT02207244|883368|P1|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
359335|NCT02207244|883360|P9|STARTED|Withdrawal, Retreatment Period:Week28-48||228
359336|NCT02207244|883361|P8|STARTED|Withdrawal, Retreatment Period:Week28-48||470
359337|NCT02207244|883362|P7|STARTED|Withdrawal, Retreatment Period:Week28-48||227
359338|NCT02207244|883363|P6|STARTED|Withdrawal, Retreatment Period:Week28-48||0
359339|NCT02207244|883364|P5|STARTED|Withdrawal, Retreatment Period:Week28-48||0
359340|NCT02207244|883365|P4|STARTED|Withdrawal, Retreatment Period:Week28-48||0
359341|NCT02207244|883366|P3|STARTED|Withdrawal, Retreatment Period:Week28-48||0
359342|NCT02207244|883367|P2|STARTED|Withdrawal, Retreatment Period:Week28-48||0
359343|NCT02207244|883368|P1|STARTED|Withdrawal, Retreatment Period:Week28-48||0
359344|NCT02207244|883360|P9|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
359345|NCT02207244|883361|P8|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
359346|NCT02207244|883362|P7|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
359347|NCT02207244|883363|P6|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||9
359348|NCT02207244|883364|P5|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||8
359349|NCT02207244|883365|P4|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||6
359350|NCT02207244|883366|P3|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
359351|NCT02207244|883367|P2|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
359352|NCT02207244|883368|P1|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
359353|NCT02207244|883360|P9|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
359354|NCT02207244|883361|P8|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
359355|NCT02207244|883362|P7|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
359356|NCT02207244|883363|P6|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||228
359357|NCT02207244|883364|P5|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||470
359358|NCT02207244|883365|P4|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||227
359359|NCT02207244|883366|P3|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
359360|NCT02207244|883367|P2|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
359361|NCT02207244|883368|P1|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
359362|NCT02207244|883360|P9|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
359363|NCT02207244|883361|P8|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
359364|NCT02207244|883362|P7|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
359365|NCT02207244|883363|P6|STARTED|Placebo Crossover and ACP: Week 16 - 28||237
359366|NCT02207244|883364|P5|STARTED|Placebo Crossover and ACP: Week 16 - 28||478
359367|NCT02207244|883365|P4|STARTED|Placebo Crossover and ACP: Week 16 - 28||233
359368|NCT02207244|883366|P3|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
359369|NCT02207244|883367|P2|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
359370|NCT02207244|883368|P1|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
359371|NCT02207244|883360|P9|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
359372|NCT02207244|883361|P8|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
359373|NCT02207244|883362|P7|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
359374|NCT02207244|883363|P6|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
359375|NCT02207244|883364|P5|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
359376|NCT02207244|883365|P4|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
359377|NCT02207244|883366|P3|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||11
359378|NCT02207244|883367|P2|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||18
359379|NCT02207244|883368|P1|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||15
359380|NCT02207244|883360|P9|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
359381|NCT02207244|883361|P8|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
359382|NCT02207244|883362|P7|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
359383|NCT02207244|883363|P6|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
359384|NCT02207244|883364|P5|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
359385|NCT02207244|883365|P4|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
359386|NCT02207244|883366|P3|COMPLETED|Placebo Controlled Period: Week 0 - 16||237
359387|NCT02207244|883367|P2|COMPLETED|Placebo Controlled Period: Week 0 - 16||478
359388|NCT02207244|883368|P1|COMPLETED|Placebo Controlled Period: Week 0 - 16||233
359389|NCT02207244|883360|P9|Treated|Placebo Controlled Period: Week 0 - 16||0
359390|NCT02207244|883361|P8|Treated|Placebo Controlled Period: Week 0 - 16||0
359391|NCT02207244|883362|P7|Treated|Placebo Controlled Period: Week 0 - 16||0
359392|NCT02207244|883363|P6|Treated|Placebo Controlled Period: Week 0 - 16||0
359393|NCT02207244|883364|P5|Treated|Placebo Controlled Period: Week 0 - 16||0
359394|NCT02207244|883365|P4|Treated|Placebo Controlled Period: Week 0 - 16||0
359395|NCT02207244|883366|P3|Treated|Placebo Controlled Period: Week 0 - 16||248
359396|NCT02207244|883367|P2|Treated|Placebo Controlled Period: Week 0 - 16||494
359397|NCT02207244|883368|P1|Treated|Placebo Controlled Period: Week 0 - 16||248
359398|NCT02207244|883360|P9|STARTED|Placebo Controlled Period: Week 0 - 16||0
359399|NCT02207244|883361|P8|STARTED|Placebo Controlled Period: Week 0 - 16||0
359400|NCT02207244|883362|P7|STARTED|Placebo Controlled Period: Week 0 - 16||0
359401|NCT02207244|883363|P6|STARTED|Placebo Controlled Period: Week 0 - 16||0
359402|NCT02207244|883364|P5|STARTED|Placebo Controlled Period: Week 0 - 16||0
359403|NCT02207244|883365|P4|STARTED|Placebo Controlled Period: Week 0 - 16||0
359404|NCT02207244|883366|P3|STARTED|Placebo Controlled Period: Week 0 - 16||248
359405|NCT02207244|883367|P2|STARTED|Placebo Controlled Period: Week 0 - 16||496
359406|NCT02207244|883368|P1|STARTED|Placebo Controlled Period: Week 0 - 16||248
359407|NCT02207231|883409|P3|NOT COMPLETED|Active Controlled Period: Week 16 - 48||42
359408|NCT02207231|883410|P2|NOT COMPLETED|Active Controlled Period: Week 16 - 48||21
359409|NCT02207231|883411|P1|NOT COMPLETED|Active Controlled Period: Week 16 - 48||3
359410|NCT02207231|883409|P3|COMPLETED|Active Controlled Period: Week 16 - 48||282
359411|NCT02207231|883410|P2|COMPLETED|Active Controlled Period: Week 16 - 48||301
359412|NCT02207231|883411|P1|COMPLETED|Active Controlled Period: Week 16 - 48||162
359413|NCT02207231|883409|P3|STARTED|Active Controlled Period: Week 16 - 48||324
359414|NCT02207231|883410|P2|STARTED|Active Controlled Period: Week 16 - 48||322
359415|NCT02207231|883411|P1|STARTED|Active Controlled Period: Week 16 - 48|2 participants did not cross-over.|165
359416|NCT02207231|883409|P3|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||10
359417|NCT02207231|883410|P2|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||7
359418|NCT02207231|883411|P1|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||7
359419|NCT02207231|883409|P3|COMPLETED|Placebo Controlled Period: Week 0 - 16||324
359420|NCT02207231|883410|P2|COMPLETED|Placebo Controlled Period: Week 0 - 16||322
359421|NCT02207231|883411|P1|COMPLETED|Placebo Controlled Period: Week 0 - 16||167
359422|NCT02207231|883409|P3|Treated|Placebo Controlled Period: Week 0 - 16||333
359423|NCT02207231|883410|P2|Treated|Placebo Controlled Period: Week 0 - 16||329
359424|NCT02207231|883411|P1|Treated|Placebo Controlled Period: Week 0 - 16||174
359425|NCT02207231|883409|P3|STARTED|Placebo Controlled Period: Week 0 - 16||334
359426|NCT02207231|883410|P2|STARTED|Placebo Controlled Period: Week 0 - 16||329
359427|NCT02207231|883411|P1|STARTED|Placebo Controlled Period: Week 0 - 16||174
359428|NCT02207088|883443|P1|NOT COMPLETED|Overall Study||2
359429|NCT02207088|883443|P1|COMPLETED|Overall Study||66
359430|NCT02207088|883443|P1|STARTED|Overall Study||68
359431|NCT02206776|883451|P2|NOT COMPLETED|Overall Study||0
359432|NCT02206776|883452|P1|NOT COMPLETED|Overall Study||0
359433|NCT02206776|883451|P2|COMPLETED|Overall Study||1
359434|NCT02206776|883452|P1|COMPLETED|Overall Study||1
359435|NCT02206776|883451|P2|STARTED|Overall Study||1
359436|NCT02206776|883452|P1|STARTED|Overall Study||1
359437|NCT02206607|883458|P5|NOT COMPLETED|Fourth Intervention Period||0
359438|NCT02206607|883459|P4|NOT COMPLETED|Fourth Intervention Period||0
359439|NCT02206607|883460|P3|NOT COMPLETED|Fourth Intervention Period||0
359440|NCT02206607|883461|P2|NOT COMPLETED|Fourth Intervention Period||0
359441|NCT02206607|883462|P1|NOT COMPLETED|Fourth Intervention Period||0
359442|NCT02206607|883458|P5|COMPLETED|Fourth Intervention Period||10
359443|NCT02206607|883459|P4|COMPLETED|Fourth Intervention Period||10
359444|NCT02206607|883460|P3|COMPLETED|Fourth Intervention Period||9
359445|NCT02206607|883461|P2|COMPLETED|Fourth Intervention Period||9
359446|NCT02206607|883462|P1|COMPLETED|Fourth Intervention Period||0
359447|NCT02206607|883458|P5|STARTED|Fourth Intervention Period||10
359448|NCT02206607|883459|P4|STARTED|Fourth Intervention Period||10
359449|NCT02206607|883460|P3|STARTED|Fourth Intervention Period||9
359450|NCT02206607|883461|P2|STARTED|Fourth Intervention Period||9
359451|NCT02206607|883462|P1|STARTED|Fourth Intervention Period||0
359452|NCT02206607|883458|P5|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
359453|NCT02206607|883459|P4|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
359454|NCT02206607|883460|P3|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
359455|NCT02206607|883461|P2|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
359456|NCT02206607|883462|P1|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
359457|NCT02206607|883458|P5|COMPLETED|Third Washout Period 5 to 10 Days||10
359458|NCT02206607|883459|P4|COMPLETED|Third Washout Period 5 to 10 Days||10
359459|NCT02206607|883460|P3|COMPLETED|Third Washout Period 5 to 10 Days||9
359460|NCT02206607|883461|P2|COMPLETED|Third Washout Period 5 to 10 Days||9
359461|NCT02206607|883462|P1|COMPLETED|Third Washout Period 5 to 10 Days||0
359462|NCT02206607|883458|P5|STARTED|Third Washout Period 5 to 10 Days||10
359463|NCT02206607|883459|P4|STARTED|Third Washout Period 5 to 10 Days||10
359464|NCT02206607|883460|P3|STARTED|Third Washout Period 5 to 10 Days||9
359465|NCT02206607|883461|P2|STARTED|Third Washout Period 5 to 10 Days||9
359466|NCT02206607|883462|P1|STARTED|Third Washout Period 5 to 10 Days||0
359467|NCT02206607|883458|P5|NOT COMPLETED|Third Intervention Period||0
359468|NCT02206607|883459|P4|NOT COMPLETED|Third Intervention Period||0
359469|NCT02206607|883460|P3|NOT COMPLETED|Third Intervention Period||0
359470|NCT02206607|883461|P2|NOT COMPLETED|Third Intervention Period||0
359471|NCT02206607|883462|P1|NOT COMPLETED|Third Intervention Period||0
359472|NCT02206607|883458|P5|COMPLETED|Third Intervention Period||10
359473|NCT02206607|883459|P4|COMPLETED|Third Intervention Period||10
359474|NCT02206607|883460|P3|COMPLETED|Third Intervention Period||9
359475|NCT02206607|883461|P2|COMPLETED|Third Intervention Period||9
359476|NCT02206607|883462|P1|COMPLETED|Third Intervention Period||0
359477|NCT02206607|883458|P5|STARTED|Third Intervention Period||10
359478|NCT02206607|883459|P4|STARTED|Third Intervention Period||10
359479|NCT02206607|883460|P3|STARTED|Third Intervention Period||9
359480|NCT02206607|883461|P2|STARTED|Third Intervention Period||9
359481|NCT02206607|883462|P1|STARTED|Third Intervention Period||0
359482|NCT02206607|883458|P5|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
359483|NCT02206607|883459|P4|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
359484|NCT02206607|883460|P3|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
359485|NCT02206607|883461|P2|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
359486|NCT02206607|883462|P1|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
359487|NCT02206607|883458|P5|COMPLETED|Second Washout Period 5 to 10 Days||10
359488|NCT02206607|883459|P4|COMPLETED|Second Washout Period 5 to 10 Days||10
359489|NCT02206607|883460|P3|COMPLETED|Second Washout Period 5 to 10 Days||9
359490|NCT02206607|883461|P2|COMPLETED|Second Washout Period 5 to 10 Days||9
359491|NCT02206607|883462|P1|COMPLETED|Second Washout Period 5 to 10 Days||0
359492|NCT02206607|883458|P5|STARTED|Second Washout Period 5 to 10 Days||10
359493|NCT02206607|883459|P4|STARTED|Second Washout Period 5 to 10 Days||10
359494|NCT02206607|883460|P3|STARTED|Second Washout Period 5 to 10 Days||9
359495|NCT02206607|883461|P2|STARTED|Second Washout Period 5 to 10 Days||9
359496|NCT02206607|883462|P1|STARTED|Second Washout Period 5 to 10 Days||0
359497|NCT02206607|883458|P5|NOT COMPLETED|Second Intervention Period||0
359498|NCT02206607|883459|P4|NOT COMPLETED|Second Intervention Period||1
359499|NCT02206607|883460|P3|NOT COMPLETED|Second Intervention Period||0
359500|NCT02206607|883461|P2|NOT COMPLETED|Second Intervention Period||0
359501|NCT02206607|883462|P1|NOT COMPLETED|Second Intervention Period||0
359502|NCT02206607|883458|P5|COMPLETED|Second Intervention Period||10
359503|NCT02206607|883459|P4|COMPLETED|Second Intervention Period||10
359504|NCT02206607|883460|P3|COMPLETED|Second Intervention Period||9
359505|NCT02206607|883461|P2|COMPLETED|Second Intervention Period||9
359506|NCT02206607|883462|P1|COMPLETED|Second Intervention Period||0
359507|NCT02206607|883458|P5|STARTED|Second Intervention Period||10
359508|NCT02206607|883459|P4|STARTED|Second Intervention Period||11
359509|NCT02206607|883460|P3|STARTED|Second Intervention Period||9
359510|NCT02206607|883461|P2|STARTED|Second Intervention Period||9
359511|NCT02206607|883462|P1|STARTED|Second Intervention Period||0
359512|NCT02206607|883458|P5|NOT COMPLETED|First Washout Period 5 to 10 Days||0
359513|NCT02206607|883459|P4|NOT COMPLETED|First Washout Period 5 to 10 Days||0
359514|NCT02206607|883460|P3|NOT COMPLETED|First Washout Period 5 to 10 Days||0
359515|NCT02206607|883461|P2|NOT COMPLETED|First Washout Period 5 to 10 Days||0
359516|NCT02206607|883462|P1|NOT COMPLETED|First Washout Period 5 to 10 Days||0
359517|NCT02206607|883458|P5|COMPLETED|First Washout Period 5 to 10 Days||10
359518|NCT02206607|883459|P4|COMPLETED|First Washout Period 5 to 10 Days||11
359519|NCT02206607|883460|P3|COMPLETED|First Washout Period 5 to 10 Days||9
359520|NCT02206607|883461|P2|COMPLETED|First Washout Period 5 to 10 Days||9
359521|NCT02206607|883462|P1|COMPLETED|First Washout Period 5 to 10 Days||0
359522|NCT02206607|883458|P5|STARTED|First Washout Period 5 to 10 Days||10
359523|NCT02206607|883459|P4|STARTED|First Washout Period 5 to 10 Days||11
359524|NCT02206607|883460|P3|STARTED|First Washout Period 5 to 10 Days||9
359525|NCT02206607|883461|P2|STARTED|First Washout Period 5 to 10 Days||9
359526|NCT02206607|883462|P1|STARTED|First Washout Period 5 to 10 Days||0
359527|NCT02206607|883458|P5|NOT COMPLETED|First Intervention Period||0
359528|NCT02206607|883459|P4|NOT COMPLETED|First Intervention Period||0
359529|NCT02206607|883460|P3|NOT COMPLETED|First Intervention Period||0
359530|NCT02206607|883461|P2|NOT COMPLETED|First Intervention Period||0
359531|NCT02206607|883462|P1|NOT COMPLETED|First Intervention Period||0
359532|NCT02206607|883458|P5|COMPLETED|First Intervention Period||10
359533|NCT02206607|883459|P4|COMPLETED|First Intervention Period||11
359534|NCT02206607|883460|P3|COMPLETED|First Intervention Period||9
359535|NCT02206607|883461|P2|COMPLETED|First Intervention Period||9
359536|NCT02206607|883462|P1|COMPLETED|First Intervention Period||0
359537|NCT02206607|883458|P5|STARTED|First Intervention Period||10
359538|NCT02206607|883459|P4|STARTED|First Intervention Period||11
359539|NCT02206607|883460|P3|STARTED|First Intervention Period||9
359540|NCT02206607|883461|P2|STARTED|First Intervention Period||9
359541|NCT02206607|883462|P1|STARTED|First Intervention Period||0
359542|NCT02206607|883458|P5|NOT COMPLETED|Open-Label Run-In||0
359543|NCT02206607|883459|P4|NOT COMPLETED|Open-Label Run-In||0
359544|NCT02206607|883460|P3|NOT COMPLETED|Open-Label Run-In||0
359545|NCT02206607|883461|P2|NOT COMPLETED|Open-Label Run-In||0
359546|NCT02206607|883462|P1|NOT COMPLETED|Open-Label Run-In||3
359547|NCT02206607|883458|P5|COMPLETED|Open-Label Run-In||0
359548|NCT02206607|883459|P4|COMPLETED|Open-Label Run-In||0
359549|NCT02206607|883460|P3|COMPLETED|Open-Label Run-In||0
359550|NCT02206607|883461|P2|COMPLETED|Open-Label Run-In||0
359551|NCT02206607|883462|P1|COMPLETED|Open-Label Run-In||39
359552|NCT02206607|883458|P5|STARTED|Open-Label Run-In||0
359553|NCT02206607|883459|P4|STARTED|Open-Label Run-In||0
359554|NCT02206607|883460|P3|STARTED|Open-Label Run-In||0
359555|NCT02206607|883461|P2|STARTED|Open-Label Run-In||0
359556|NCT02206607|883462|P1|STARTED|Open-Label Run-In||42
359557|NCT02205814|883518|P4|NOT COMPLETED|Overall Study||4
359558|NCT02205814|883519|P3|NOT COMPLETED|Overall Study||5
359559|NCT02205814|883520|P2|NOT COMPLETED|Overall Study||1
359560|NCT02205814|883521|P1|NOT COMPLETED|Overall Study||2
359561|NCT02205814|883518|P4|COMPLETED|Overall Study||104
359562|NCT02205814|883519|P3|COMPLETED|Overall Study||103
359563|NCT02205814|883520|P2|COMPLETED|Overall Study||109
359564|NCT02205814|883521|P1|COMPLETED|Overall Study||108
359565|NCT02205814|883518|P4|STARTED|Overall Study||108
359566|NCT02205814|883519|P3|STARTED|Overall Study||108
359567|NCT02205814|883520|P2|STARTED|Overall Study||110
359568|NCT02205814|883521|P1|STARTED|Overall Study||110
359569|NCT02205801|883547|P4|NOT COMPLETED|Overall Study||0
359570|NCT02205801|883548|P3|NOT COMPLETED|Overall Study||0
359571|NCT02205801|883549|P2|NOT COMPLETED|Overall Study||0
359572|NCT02205801|883550|P1|NOT COMPLETED|Overall Study||0
359573|NCT02205801|883547|P4|COMPLETED|Overall Study||8
359574|NCT02205801|883548|P3|COMPLETED|Overall Study||9
359575|NCT02205801|883549|P2|COMPLETED|Overall Study||8
359576|NCT02205801|883550|P1|COMPLETED|Overall Study||11
359577|NCT02205801|883547|P4|STARTED|Overall Study||8
359578|NCT02205801|883548|P3|STARTED|Overall Study||9
359579|NCT02205801|883549|P2|STARTED|Overall Study||8
359580|NCT02205801|883550|P1|STARTED|Overall Study||11
359581|NCT02205476|883574|P2|NOT COMPLETED|Overall Study||3
359582|NCT02205476|883575|P1|NOT COMPLETED|Overall Study||7
359583|NCT02205476|883574|P2|COMPLETED|Overall Study||0
359584|NCT02205476|883575|P1|COMPLETED|Overall Study||0
359585|NCT02205476|883574|P2|STARTED|Overall Study||3
359586|NCT02205476|883575|P1|STARTED|Overall Study||7
359587|NCT02205333|883614|P9|NOT COMPLETED|Overall Study||0
359588|NCT02205333|883615|P8|NOT COMPLETED|Overall Study||2
359589|NCT02205333|883616|P7|NOT COMPLETED|Overall Study||5
359590|NCT02205333|883617|P6|NOT COMPLETED|Overall Study||3
359591|NCT02205333|883618|P5|NOT COMPLETED|Overall Study||5
359592|NCT02205333|883619|P4|NOT COMPLETED|Overall Study||7
359593|NCT02205333|883620|P3|NOT COMPLETED|Overall Study||2
359594|NCT02205333|883621|P2|NOT COMPLETED|Overall Study||6
359595|NCT02205333|883622|P1|NOT COMPLETED|Overall Study||6
359596|NCT02205333|883614|P9|COMPLETED|Overall Study||1
359597|NCT02205333|883615|P8|COMPLETED|Overall Study||1
359598|NCT02205333|883616|P7|COMPLETED|Overall Study||2
359599|NCT02205333|883617|P6|COMPLETED|Overall Study||4
359600|NCT02205333|883618|P5|COMPLETED|Overall Study||1
359601|NCT02205333|883619|P4|COMPLETED|Overall Study||0
359602|NCT02205333|883620|P3|COMPLETED|Overall Study||1
359603|NCT02205333|883621|P2|COMPLETED|Overall Study||0
359604|NCT02205333|883622|P1|COMPLETED|Overall Study||2
359605|NCT02205333|883614|P9|STARTED|Overall Study||1
359606|NCT02205333|883615|P8|STARTED|Overall Study||3
359607|NCT02205333|883616|P7|STARTED|Overall Study||7
359608|NCT02205333|883617|P6|STARTED|Overall Study||7
359609|NCT02205333|883618|P5|STARTED|Overall Study||6
359610|NCT02205333|883619|P4|STARTED|Overall Study||7
359611|NCT02205333|883620|P3|STARTED|Overall Study||3
359612|NCT02205333|883621|P2|STARTED|Overall Study||6
359613|NCT02205333|883622|P1|STARTED|Overall Study||8
359614|NCT02204748|883795|P1|NOT COMPLETED|Overall Study||0
359615|NCT02204748|883795|P1|COMPLETED|Overall Study||5
359616|NCT02204748|883795|P1|STARTED|Overall Study||5
359617|NCT02204657|883809|P2|NOT COMPLETED|Overall Study||0
359618|NCT02204657|883810|P1|NOT COMPLETED|Overall Study||7
359619|NCT02204657|883809|P2|COMPLETED|Overall Study||25
359620|NCT02204657|883810|P1|COMPLETED|Overall Study||25
359621|NCT02204657|883809|P2|STARTED|Overall Study||25
359622|NCT02204657|883810|P1|STARTED|Overall Study||32
359623|NCT02204579|883818|P1|NOT COMPLETED|Overall Study||2
359624|NCT02204579|883818|P1|COMPLETED|Overall Study||5
359625|NCT02204579|883818|P1|Treated|Overall Study||5
359626|NCT02204579|883818|P1|Participants Started in Post-Amendment|Overall Study|Two participants from pre-amendment were re-enrolled with different identification numbers.|5
359627|NCT02204579|883818|P1|Participants Started in Pre-Amendment|Overall Study|Two participants completed treatment in pre-amendment and were re-enrolled in post-amendment.|2
359628|NCT02204579|883818|P1|STARTED|Overall Study||7
359629|NCT02204449|883872|P2|NOT COMPLETED|Overall Study||11
359630|NCT02204449|883873|P1|NOT COMPLETED|Overall Study||7
359631|NCT02204449|883872|P2|COMPLETED|Overall Study||37
359632|NCT02204449|883873|P1|COMPLETED|Overall Study||39
359633|NCT02204449|883872|P2|STARTED|Overall Study||48
359634|NCT02204449|883873|P1|STARTED|Overall Study||46
359635|NCT02204410|883883|P1|NOT COMPLETED|Overall Study||11
359636|NCT02204410|883883|P1|COMPLETED|Overall Study||10
359637|NCT02204410|883883|P1|STARTED|Overall Study||21
359638|NCT02204371|883888|P1|NOT COMPLETED|Overall Study||1
359639|NCT02204371|883888|P1|COMPLETED|Overall Study||6
359640|NCT02204371|883888|P1|STARTED|Overall Study||7
359641|NCT02204319|883911|P1|NOT COMPLETED|Overall Study||3
359642|NCT02204319|883911|P1|COMPLETED|Overall Study|3 did not complete study.|7
359643|NCT02204319|883911|P1|STARTED|Overall Study||10
359644|NCT02204007|883919|P2|NOT COMPLETED|Overall Study||1
359645|NCT02204007|883920|P1|NOT COMPLETED|Overall Study||1
359646|NCT02204007|883919|P2|COMPLETED|Overall Study||17
359647|NCT02204007|883920|P1|COMPLETED|Overall Study||17
359648|NCT02204007|883919|P2|STARTED|Overall Study||18
359649|NCT02204007|883920|P1|STARTED|Overall Study||18
359650|NCT02203916|883931|P3|NOT COMPLETED|Overall Study||11
359651|NCT02203916|883932|P2|NOT COMPLETED|Overall Study||10
359652|NCT02203916|883933|P1|NOT COMPLETED|Overall Study||8
359653|NCT02203916|883931|P3|COMPLETED|Overall Study||120
359654|NCT02203916|883932|P2|COMPLETED|Overall Study||122
359655|NCT02203916|883933|P1|COMPLETED|Overall Study||57
359656|NCT02203916|883931|P3|Safety Analysis Set (SAS)|Overall Study|1 participant was randomized twice, counted once in randomized set, and excluded from the SAS.|130
359657|NCT02203916|883932|P2|Safety Analysis Set (SAS)|Overall Study||132
359658|NCT02203916|883933|P1|Safety Analysis Set (SAS)|Overall Study||65
359659|NCT02203916|883931|P3|Full Analysis Set (FAS)|Overall Study|1 participant was randomized twice, counted once in randomized set, and excluded from the FAS.|130
359660|NCT02203916|883932|P2|Full Analysis Set (FAS)|Overall Study||132
359661|NCT02203916|883933|P1|Full Analysis Set (FAS)|Overall Study||65
359662|NCT02203916|883931|P3|STARTED|Overall Study|1 participant was randomized twice and counted only once.|131
359663|NCT02203916|883932|P2|STARTED|Overall Study||132
359664|NCT02203916|883933|P1|STARTED|Overall Study||65
359665|NCT02203786|883957|P4|NOT COMPLETED|Overall Study||0
359666|NCT02203786|883958|P3|NOT COMPLETED|Overall Study||2
359667|NCT02203786|883959|P2|NOT COMPLETED|Overall Study||0
359668|NCT02203786|883960|P1|NOT COMPLETED|Overall Study||0
359669|NCT02203786|883957|P4|COMPLETED|Overall Study||15
359670|NCT02203786|883958|P3|COMPLETED|Overall Study||15
359671|NCT02203786|883959|P2|COMPLETED|Overall Study||15
359672|NCT02203786|883960|P1|COMPLETED|Overall Study||15
359673|NCT02203786|883957|P4|STARTED|Overall Study||15
359674|NCT02203786|883958|P3|STARTED|Overall Study||17
359675|NCT02203786|883959|P2|STARTED|Overall Study||15
359676|NCT02203786|883960|P1|STARTED|Overall Study||15
359677|NCT02203747|883992|P2|NOT COMPLETED|Overall Study||0
359678|NCT02203747|883993|P1|NOT COMPLETED|Overall Study||0
359679|NCT02203747|883992|P2|COMPLETED|Overall Study||34
359680|NCT02203747|883993|P1|COMPLETED|Overall Study||45
359681|NCT02203747|883992|P2|STARTED|Overall Study||34
359682|NCT02203747|883993|P1|STARTED|Overall Study||45
359683|NCT02203721|884003|P2|NOT COMPLETED|Overall Study||3
359684|NCT02203721|884004|P1|NOT COMPLETED|Overall Study||1
359685|NCT02203721|884003|P2|COMPLETED|Overall Study||148
359686|NCT02203721|884004|P1|COMPLETED|Overall Study||147
359687|NCT02203721|884003|P2|STARTED|Overall Study||151
359688|NCT02203721|884004|P1|STARTED|Overall Study||148
359689|NCT02203630|884014|P2|NOT COMPLETED|Overall Study||0
359690|NCT02203630|884015|P1|NOT COMPLETED|Overall Study||0
359691|NCT02203630|884014|P2|COMPLETED|Overall Study||9
359692|NCT02203630|884015|P1|COMPLETED|Overall Study||8
359693|NCT02203630|884014|P2|STARTED|Overall Study||9
359694|NCT02203630|884015|P1|STARTED|Overall Study||8
359695|NCT02203578|884085|P1|NOT COMPLETED|Overall Study||0
359696|NCT02203578|884085|P1|COMPLETED|Overall Study||1
359697|NCT02203578|884085|P1|STARTED|Overall Study||1
359698|NCT02203565|884097|P1|NOT COMPLETED|Overall Study||1
359699|NCT02203565|884097|P1|COMPLETED|Overall Study||19
359700|NCT02203565|884097|P1|STARTED|Overall Study||20
359701|NCT02203331|884107|P6|NOT COMPLETED|Overall Study||7
359702|NCT02203331|884108|P5|NOT COMPLETED|Overall Study||7
359703|NCT02203331|884109|P4|NOT COMPLETED|Overall Study||7
359704|NCT02203331|884110|P3|NOT COMPLETED|Overall Study||5
359705|NCT02203331|884111|P2|NOT COMPLETED|Overall Study||14
359706|NCT02203331|884112|P1|NOT COMPLETED|Overall Study||7
359707|NCT02203331|884107|P6|COMPLETED|Overall Study||46
359708|NCT02203331|884108|P5|COMPLETED|Overall Study||46
359709|NCT02203331|884109|P4|COMPLETED|Overall Study||46
359710|NCT02203331|884110|P3|COMPLETED|Overall Study||50
359711|NCT02203331|884111|P2|COMPLETED|Overall Study||39
359712|NCT02203331|884112|P1|COMPLETED|Overall Study||45
359713|NCT02203331|884107|P6|Treated|Overall Study||53
359714|NCT02203331|884108|P5|Treated|Overall Study||50
359715|NCT02203331|884109|P4|Treated|Overall Study||49
359716|NCT02203331|884110|P3|Treated|Overall Study||54
359717|NCT02203331|884111|P2|Treated|Overall Study||50
359718|NCT02203331|884112|P1|Treated|Overall Study||49
359719|NCT02203331|884107|P6|STARTED|Overall Study||53
359720|NCT02203331|884108|P5|STARTED|Overall Study||53
359721|NCT02203331|884109|P4|STARTED|Overall Study||53
359722|NCT02203331|884110|P3|STARTED|Overall Study||55
359723|NCT02203331|884111|P2|STARTED|Overall Study||53
359724|NCT02203331|884112|P1|STARTED|Overall Study||52
359725|NCT02203162|884162|P1|NOT COMPLETED|Overall Study||0
359726|NCT02203162|884162|P1|COMPLETED|Overall Study||30
359727|NCT02203162|884162|P1|STARTED|Overall Study||30
359728|NCT02203149|884171|P5|NOT COMPLETED|Part 2||1
359729|NCT02203149|884172|P4|NOT COMPLETED|Part 2||3
359730|NCT02203149|884173|P3|NOT COMPLETED|Part 2||1
359731|NCT02203149|884174|P2|NOT COMPLETED|Part 2||0
359732|NCT02203149|884175|P1|NOT COMPLETED|Part 2||0
359733|NCT02203149|884171|P5|COMPLETED|Part 2||34
359734|NCT02203149|884172|P4|COMPLETED|Part 2||71
359735|NCT02203149|884173|P3|COMPLETED|Part 2||226
359736|NCT02203149|884174|P2|COMPLETED|Part 2||0
359737|NCT02203149|884175|P1|COMPLETED|Part 2||0
359738|NCT02203149|884171|P5|Started Deferred Active Treatment|Part 2||0
359739|NCT02203149|884172|P4|Started Deferred Active Treatment|Part 2|1 participant in Deferred Treatment Arm receiving Placebo did not receive Deferred Active Treatment.|73
359740|NCT02203149|884173|P3|Started Deferred Active Treatment|Part 2||0
359741|NCT02203149|884174|P2|Started Deferred Active Treatment|Part 2||0
359742|NCT02203149|884175|P1|Started Deferred Active Treatment|Part 2||0
359743|NCT02203149|884171|P5|STARTED|Part 2||35
359744|NCT02203149|884172|P4|STARTED|Part 2||74
359745|NCT02203149|884173|P3|STARTED|Part 2||227
359746|NCT02203149|884174|P2|STARTED|Part 2|Participants of Part 1 did not enter Part 2|0
359747|NCT02203149|884175|P1|STARTED|Part 2|Participants of Part 1 did not enter Part 2|0
359748|NCT02203149|884171|P5|NOT COMPLETED|Part 1||0
359749|NCT02203149|884172|P4|NOT COMPLETED|Part 1||0
359750|NCT02203149|884173|P3|NOT COMPLETED|Part 1||0
359751|NCT02203149|884174|P2|NOT COMPLETED|Part 1||1
359752|NCT02203149|884175|P1|NOT COMPLETED|Part 1||0
359753|NCT02203149|884171|P5|COMPLETED|Part 1||0
359754|NCT02203149|884172|P4|COMPLETED|Part 1||0
359755|NCT02203149|884173|P3|COMPLETED|Part 1||0
359756|NCT02203149|884174|P2|COMPLETED|Part 1||31
359757|NCT02203149|884175|P1|COMPLETED|Part 1||31
359758|NCT02203149|884171|P5|STARTED|Part 1||0
359759|NCT02203149|884172|P4|STARTED|Part 1||0
359760|NCT02203149|884173|P3|STARTED|Part 1||0
359761|NCT02203149|884174|P2|STARTED|Part 1||32
359762|NCT02203149|884175|P1|STARTED|Part 1||31
359763|NCT02203032|884208|P4|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||46
359764|NCT02203032|884209|P3|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||26
359765|NCT02203032|884210|P2|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||15
359766|NCT02203032|884211|P1|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||0
359767|NCT02203032|884208|P4|COMPLETED|Blinded Phase (Week 16 to Week 44)||539
359768|NCT02203032|884209|P3|COMPLETED|Blinded Phase (Week 16 to Week 44)||107
359769|NCT02203032|884210|P2|COMPLETED|Blinded Phase (Week 16 to Week 44)||120
359770|NCT02203032|884211|P1|COMPLETED|Blinded Phase (Week 16 to Week 44)||0
359771|NCT02203032|884208|P4|STARTED|Blinded Phase (Week 16 to Week 44)||585
359772|NCT02203032|884209|P3|STARTED|Blinded Phase (Week 16 to Week 44)||133
359773|NCT02203032|884210|P2|STARTED|Blinded Phase (Week 16 to Week 44)||135
359774|NCT02203032|884211|P1|STARTED|Blinded Phase (Week 16 to Week 44)||0
359775|NCT02203032|884208|P4|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
359776|NCT02203032|884209|P3|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
359777|NCT02203032|884210|P2|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
359778|NCT02203032|884211|P1|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||19
359779|NCT02203032|884208|P4|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
359780|NCT02203032|884209|P3|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
359781|NCT02203032|884210|P2|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
359782|NCT02203032|884211|P1|COMPLETED|Open Label Run-in (Week 0 to Week 16)||853
359783|NCT02203032|884208|P4|Treated|Open Label Run-in (Week 0 to Week 16)||0
359784|NCT02203032|884209|P3|Treated|Open Label Run-in (Week 0 to Week 16)||0
359785|NCT02203032|884210|P2|Treated|Open Label Run-in (Week 0 to Week 16)||0
359786|NCT02203032|884211|P1|Treated|Open Label Run-in (Week 0 to Week 16)||871
359787|NCT02203032|884208|P4|STARTED|Open Label Run-in (Week 0 to Week 16)||0
359788|NCT02203032|884209|P3|STARTED|Open Label Run-in (Week 0 to Week 16)||0
359789|NCT02203032|884210|P2|STARTED|Open Label Run-in (Week 0 to Week 16)||0
359790|NCT02203032|884211|P1|STARTED|Open Label Run-in (Week 0 to Week 16)||872
359791|NCT02202980|884239|P14|NOT COMPLETED|Overall Study||0
359792|NCT02202980|884240|P13|NOT COMPLETED|Overall Study||11
359793|NCT02202980|884241|P12|NOT COMPLETED|Overall Study||3
359794|NCT02202980|884242|P11|NOT COMPLETED|Overall Study||0
359795|NCT02202980|884243|P10|NOT COMPLETED|Overall Study||0
359796|NCT02202980|884244|P9|NOT COMPLETED|Overall Study||4
359797|NCT02202980|884245|P8|NOT COMPLETED|Overall Study||3
359798|NCT02202980|884246|P7|NOT COMPLETED|Overall Study||11
359799|NCT02202980|884247|P6|NOT COMPLETED|Overall Study||1
359800|NCT02202980|884248|P5|NOT COMPLETED|Overall Study||6
359801|NCT02202980|884249|P4|NOT COMPLETED|Overall Study||4
359802|NCT02202980|884250|P3|NOT COMPLETED|Overall Study||10
359803|NCT02202980|884251|P2|NOT COMPLETED|Overall Study||2
359804|NCT02202980|884252|P1|NOT COMPLETED|Overall Study||1
359805|NCT02202980|884239|P14|COMPLETED|Overall Study||4
359806|NCT02202980|884240|P13|COMPLETED|Overall Study||19
359807|NCT02202980|884241|P12|COMPLETED|Overall Study||25
359808|NCT02202980|884242|P11|COMPLETED|Overall Study||19
359809|NCT02202980|884243|P10|COMPLETED|Overall Study||17
359810|NCT02202980|884244|P9|COMPLETED|Overall Study||14
359811|NCT02202980|884245|P8|COMPLETED|Overall Study||12
359812|NCT02202980|884246|P7|COMPLETED|Overall Study||4
359813|NCT02202980|884247|P6|COMPLETED|Overall Study||14
359814|NCT02202980|884248|P5|COMPLETED|Overall Study||7
359815|NCT02202980|884249|P4|COMPLETED|Overall Study||28
359816|NCT02202980|884250|P3|COMPLETED|Overall Study||17
359817|NCT02202980|884251|P2|COMPLETED|Overall Study||24
359818|NCT02202980|884252|P1|COMPLETED|Overall Study||13
359819|NCT02202980|884239|P14|STARTED|Overall Study||4
359820|NCT02202980|884240|P13|STARTED|Overall Study||30
359821|NCT02202980|884241|P12|STARTED|Overall Study||28
359822|NCT02202980|884242|P11|STARTED|Overall Study||19
359823|NCT02202980|884243|P10|STARTED|Overall Study||17
359824|NCT02202980|884244|P9|STARTED|Overall Study||18
359825|NCT02202980|884245|P8|STARTED|Overall Study||15
359826|NCT02202980|884246|P7|STARTED|Overall Study||15
359827|NCT02202980|884247|P6|STARTED|Overall Study||15
359828|NCT02202980|884248|P5|STARTED|Overall Study||13
359829|NCT02202980|884249|P4|STARTED|Overall Study||32
359830|NCT02202980|884250|P3|STARTED|Overall Study||27
359831|NCT02202980|884251|P2|STARTED|Overall Study||26
359832|NCT02202980|884252|P1|STARTED|Overall Study||14
359833|NCT02202785|884341|P3|NOT COMPLETED|Overall Study||17
359834|NCT02202785|884342|P2|NOT COMPLETED|Overall Study||15
359835|NCT02202785|884343|P1|NOT COMPLETED|Overall Study||11
359836|NCT02202785|884341|P3|COMPLETED|Overall Study||0
359837|NCT02202785|884342|P2|COMPLETED|Overall Study||0
359838|NCT02202785|884343|P1|COMPLETED|Overall Study||0
359839|NCT02202785|884341|P3|STARTED|Overall Study||17
359840|NCT02202785|884342|P2|STARTED|Overall Study||15
359841|NCT02202785|884343|P1|STARTED|Overall Study||11
359842|NCT02202759|884380|P3|NOT COMPLETED|Overall Study||14
359843|NCT02202759|884381|P2|NOT COMPLETED|Overall Study||15
359844|NCT02202759|884382|P1|NOT COMPLETED|Overall Study||9
359845|NCT02202759|884380|P3|COMPLETED|Overall Study||0
359846|NCT02202759|884381|P2|COMPLETED|Overall Study||0
359847|NCT02202759|884382|P1|COMPLETED|Overall Study||0
359848|NCT02202759|884380|P3|STARTED|Overall Study||14
359849|NCT02202759|884381|P2|STARTED|Overall Study||15
359850|NCT02202759|884382|P1|STARTED|Overall Study||9
359851|NCT02202538|884416|P1|NOT COMPLETED|Overall Study||8
359852|NCT02202538|884416|P1|COMPLETED|Overall Study||45
359853|NCT02202538|884416|P1|Screen Failure|Overall Study||2
359854|NCT02202538|884416|P1|STARTED|Overall Study||53
359855|NCT02202317|884427|P1|NOT COMPLETED|Overall Study||1
359856|NCT02202317|884427|P1|COMPLETED|Overall Study||8
359857|NCT02202317|884427|P1|STARTED|Overall Study||9
359858|NCT02202252|884435|P2|NOT COMPLETED|Overall Study||0
359859|NCT02202252|884436|P1|NOT COMPLETED|Overall Study||0
359860|NCT02202252|884435|P2|COMPLETED|Overall Study||30
359861|NCT02202252|884436|P1|COMPLETED|Overall Study||30
359862|NCT02202252|884435|P2|STARTED|Overall Study||30
359863|NCT02202252|884436|P1|STARTED|Overall Study||30
359864|NCT02202161|884454|P8|NOT COMPLETED|Overall Study||6
359865|NCT02202161|884455|P7|NOT COMPLETED|Overall Study||0
359866|NCT02202161|884456|P6|NOT COMPLETED|Overall Study||1
359867|NCT02202161|884457|P5|NOT COMPLETED|Overall Study||1
359868|NCT02202161|884458|P4|NOT COMPLETED|Overall Study||0
359869|NCT02202161|884459|P3|NOT COMPLETED|Overall Study||0
359870|NCT02202161|884460|P2|NOT COMPLETED|Overall Study||1
359871|NCT02202161|884461|P1|NOT COMPLETED|Overall Study||1
359872|NCT02202161|884454|P8|COMPLETED|Overall Study||0
359873|NCT02202161|884455|P7|COMPLETED|Overall Study||13
359874|NCT02202161|884456|P6|COMPLETED|Overall Study||9
359875|NCT02202161|884457|P5|COMPLETED|Overall Study||8
359876|NCT02202161|884458|P4|COMPLETED|Overall Study||9
359877|NCT02202161|884459|P3|COMPLETED|Overall Study||5
359878|NCT02202161|884460|P2|COMPLETED|Overall Study||4
359879|NCT02202161|884461|P1|COMPLETED|Overall Study||12
359880|NCT02202161|884454|P8|STARTED|Overall Study||6
359881|NCT02202161|884455|P7|STARTED|Overall Study||13
359882|NCT02202161|884456|P6|STARTED|Overall Study||10
359883|NCT02202161|884457|P5|STARTED|Overall Study||9
359884|NCT02202161|884458|P4|STARTED|Overall Study||9
359885|NCT02202161|884459|P3|STARTED|Overall Study||5
359886|NCT02202161|884460|P2|STARTED|Overall Study||5
359887|NCT02202161|884461|P1|STARTED|Overall Study||13
359888|NCT02202135|884615|P1|NOT COMPLETED|Overall Study||0
359889|NCT02202135|884615|P1|COMPLETED|Overall Study||4
359890|NCT02202135|884615|P1|STARTED|Overall Study||4
359891|NCT02201953|884621|P2|NOT COMPLETED|Overall Study||56
359892|NCT02201953|884622|P1|NOT COMPLETED|Overall Study||20
359893|NCT02201953|884621|P2|COMPLETED|Overall Study||224
359894|NCT02201953|884622|P1|COMPLETED|Overall Study||258
359895|NCT02201953|884621|P2|STARTED|Overall Study||280
359896|NCT02201953|884622|P1|STARTED|Overall Study||278
359897|NCT02201940|884640|P2|NOT COMPLETED|Overall Study||116
359898|NCT02201940|884641|P1|NOT COMPLETED|Overall Study||12
359899|NCT02201940|884640|P2|COMPLETED|Overall Study||0
359900|NCT02201940|884641|P1|COMPLETED|Overall Study||613
359901|NCT02201940|884640|P2|STARTED|Overall Study||116
359902|NCT02201940|884641|P1|STARTED|Overall Study||625
359903|NCT02201901|884660|P3|NOT COMPLETED|Overall Study||13
359904|NCT02201901|884661|P2|NOT COMPLETED|Overall Study||9
359905|NCT02201901|884662|P1|NOT COMPLETED|Overall Study||15
359906|NCT02201901|884660|P3|COMPLETED|Overall Study||77
359907|NCT02201901|884661|P2|COMPLETED|Overall Study||79
359908|NCT02201901|884662|P1|COMPLETED|Overall Study||75
359909|NCT02201901|884660|P3|STARTED|Overall Study||90
359910|NCT02201901|884661|P2|STARTED|Overall Study||88
359911|NCT02201901|884662|P1|STARTED|Overall Study||90
359912|NCT02201784|884693|P2|NOT COMPLETED|Overall Study||0
359913|NCT02201784|884694|P1|NOT COMPLETED|Overall Study||2
359914|NCT02201784|884693|P2|COMPLETED|Overall Study||30
359915|NCT02201784|884694|P1|COMPLETED|Overall Study||28
359916|NCT02201784|884693|P2|STARTED|Overall Study||30
359917|NCT02201784|884694|P1|STARTED|Overall Study||30
359918|NCT02201524|884712|P4|NOT COMPLETED|Overall Study||4
359919|NCT02201524|884713|P3|NOT COMPLETED|Overall Study||4
359920|NCT02201524|884714|P2|NOT COMPLETED|Overall Study||3
359921|NCT02201524|884715|P1|NOT COMPLETED|Overall Study||2
359922|NCT02201524|884712|P4|COMPLETED|Overall Study||10
359923|NCT02201524|884713|P3|COMPLETED|Overall Study||12
359924|NCT02201524|884714|P2|COMPLETED|Overall Study||12
359925|NCT02201524|884715|P1|COMPLETED|Overall Study||12
359926|NCT02201524|884712|P4|STARTED|Overall Study||14
359927|NCT02201524|884713|P3|STARTED|Overall Study||16
359928|NCT02201524|884714|P2|STARTED|Overall Study||15
359929|NCT02201524|884715|P1|STARTED|Overall Study||14
359930|NCT02201446|884799|P2|NOT COMPLETED|Overall Study||0
359931|NCT02201446|884800|P1|NOT COMPLETED|Overall Study||0
359932|NCT02201446|884799|P2|COMPLETED|Overall Study||58
359933|NCT02201446|884800|P1|COMPLETED|Overall Study||81
359934|NCT02201446|884799|P2|STARTED|Overall Study||58
359935|NCT02201446|884800|P1|STARTED|Overall Study||81
359936|NCT02201420|884828|P1|NOT COMPLETED|Overall Study||0
359937|NCT02201420|884828|P1|COMPLETED|Overall Study||5
359938|NCT02201420|884828|P1|STARTED|Overall Study||5
359939|NCT02201394|884833|P1|NOT COMPLETED|Maintenance Dose||0
359940|NCT02201394|884833|P1|COMPLETED|Maintenance Dose||20
359941|NCT02201394|884833|P1|STARTED|Maintenance Dose||20
359942|NCT02201394|884833|P1|NOT COMPLETED|Loading Dose||0
359943|NCT02201394|884833|P1|COMPLETED|Loading Dose||20
359944|NCT02201394|884833|P1|STARTED|Loading Dose||20
359945|NCT02201056|884847|P7|NOT COMPLETED|Overall Study||0
359946|NCT02201056|884848|P6|NOT COMPLETED|Overall Study||0
359947|NCT02201056|884849|P5|NOT COMPLETED|Overall Study||0
359948|NCT02201056|884850|P4|NOT COMPLETED|Overall Study||0
359949|NCT02201056|884851|P3|NOT COMPLETED|Overall Study||0
359950|NCT02201056|884852|P2|NOT COMPLETED|Overall Study||0
359951|NCT02201056|884853|P1|NOT COMPLETED|Overall Study||0
359952|NCT02201056|884847|P7|COMPLETED|Overall Study||6
359953|NCT02201056|884848|P6|COMPLETED|Overall Study||6
359954|NCT02201056|884849|P5|COMPLETED|Overall Study||6
359955|NCT02201056|884850|P4|COMPLETED|Overall Study||6
359956|NCT02201056|884851|P3|COMPLETED|Overall Study||6
359957|NCT02201056|884852|P2|COMPLETED|Overall Study||6
359958|NCT02201056|884853|P1|COMPLETED|Overall Study||12
359959|NCT02201056|884847|P7|STARTED|Overall Study||6
359960|NCT02201056|884848|P6|STARTED|Overall Study||6
359961|NCT02201056|884849|P5|STARTED|Overall Study||6
359962|NCT02201056|884850|P4|STARTED|Overall Study||6
359963|NCT02201056|884851|P3|STARTED|Overall Study||6
359964|NCT02201056|884852|P2|STARTED|Overall Study||6
359965|NCT02201056|884853|P1|STARTED|Overall Study||12
359966|NCT02200536|884911|P3|NOT COMPLETED|Overall Study||0
359967|NCT02200536|884912|P2|NOT COMPLETED|Overall Study||0
359968|NCT02200536|884913|P1|NOT COMPLETED|Overall Study||0
359969|NCT02200536|884911|P3|COMPLETED|Overall Study||30
359970|NCT02200536|884912|P2|COMPLETED|Overall Study||30
359971|NCT02200536|884913|P1|COMPLETED|Overall Study||32
359972|NCT02200536|884911|P3|STARTED|Overall Study||30
359973|NCT02200536|884912|P2|STARTED|Overall Study||30
359974|NCT02200536|884913|P1|STARTED|Overall Study||32
359975|NCT02200510|884926|P2|NOT COMPLETED|Overall Study||3
359976|NCT02200510|884927|P1|NOT COMPLETED|Overall Study||9
359977|NCT02200510|884926|P2|COMPLETED|Overall Study|This number is the number of participants with both baseline and post data.|44
359978|NCT02200510|884927|P1|COMPLETED|Overall Study|This is the number of participants with baseline and post data.|22
359979|NCT02200510|884926|P2|STARTED|Overall Study|Number who only completed portal or completed it before self-management (could do 6 months later).|47
359980|NCT02200510|884927|P1|STARTED|Overall Study|Number who only completed self-management or completed it before portal (could do 6 months later).|31
359981|NCT02200458|884933|P1|NOT COMPLETED|Overall Study||0
359982|NCT02200458|884933|P1|COMPLETED|Overall Study||62
359983|NCT02200458|884933|P1|STARTED|Overall Study||62
359984|NCT02200328|884939|P2|NOT COMPLETED|Overall Study||33
359985|NCT02200328|884940|P1|NOT COMPLETED|Overall Study||43
359986|NCT02200328|884939|P2|COMPLETED|Overall Study||0
359987|NCT02200328|884940|P1|COMPLETED|Overall Study||0
359988|NCT02200328|884939|P2|STARTED|Overall Study||33
359989|NCT02200328|884940|P1|STARTED|Overall Study||43
359990|NCT02199795|884950|P2|NOT COMPLETED|Overall Study||0
359991|NCT02199795|884951|P1|NOT COMPLETED|Overall Study||2
359992|NCT02199795|884950|P2|COMPLETED|Overall Study||3
359993|NCT02199795|884951|P1|COMPLETED|Overall Study||2
359994|NCT02199795|884950|P2|STARTED|Overall Study||3
359995|NCT02199795|884951|P1|STARTED|Overall Study||4
359996|NCT02199717|884963|P1|NOT COMPLETED|Overall Study||0
359997|NCT02199717|884963|P1|COMPLETED|Overall Study||66
359998|NCT02199717|884963|P1|STARTED|Overall Study||66
359999|NCT02199574|884970|P1|NOT COMPLETED|Overall Study||0
360000|NCT02199574|884970|P1|COMPLETED|Overall Study||12
360001|NCT02199574|884970|P1|STARTED|Overall Study||12
360002|NCT02199509|884979|P2|NOT COMPLETED|Overall Study||1
360003|NCT02199509|884980|P1|NOT COMPLETED|Overall Study||1
360004|NCT02199509|884979|P2|COMPLETED|Overall Study||3
360005|NCT02199509|884980|P1|COMPLETED|Overall Study||2
360006|NCT02199509|884979|P2|STARTED|Overall Study||4
360007|NCT02199509|884980|P1|STARTED|Overall Study||3
360008|NCT02199041|884992|P1|NOT COMPLETED|Overall Study||0
360009|NCT02199041|884992|P1|COMPLETED|Overall Study||12
360010|NCT02199041|884992|P1|STARTED|Overall Study||12
360011|NCT02198963|885005|P1|NOT COMPLETED|Overall Study||7
360012|NCT02198963|885005|P1|COMPLETED|Overall Study||36
360013|NCT02198963|885005|P1|STARTED|Overall Study||43
360014|NCT02198833|885016|P2|NOT COMPLETED|Overall Study||0
360015|NCT02198833|885017|P1|NOT COMPLETED|Overall Study||0
360016|NCT02198833|885016|P2|COMPLETED|Overall Study||1
360017|NCT02198833|885017|P1|COMPLETED|Overall Study||1
360018|NCT02198833|885016|P2|STARTED|Overall Study|Unable to clear urine of bacteria for all but one patient therefore catheter not placed.|1
360019|NCT02198833|885017|P1|STARTED|Overall Study|Unable to clear urine of bacteria for all but one patient therefore catheter not placed|1
360020|NCT02198430|885031|P2|NOT COMPLETED|Overall Study||0
360021|NCT02198430|885032|P1|NOT COMPLETED|Overall Study||0
360022|NCT02198430|885031|P2|COMPLETED|Overall Study||51
360023|NCT02198430|885032|P1|COMPLETED|Overall Study||53
360024|NCT02198430|885031|P2|STARTED|Overall Study||51
360025|NCT02198430|885032|P1|STARTED|Overall Study||53
360026|NCT02198235|885047|P3|NOT COMPLETED|Overall Study||2
360027|NCT02198235|885048|P2|NOT COMPLETED|Overall Study||2
360028|NCT02198235|885049|P1|NOT COMPLETED|Overall Study||3
360029|NCT02198235|885047|P3|COMPLETED|Overall Study||28
360030|NCT02198235|885048|P2|COMPLETED|Overall Study||28
360031|NCT02198235|885049|P1|COMPLETED|Overall Study||27
360032|NCT02198235|885047|P3|STARTED|Overall Study||30
360033|NCT02198235|885048|P2|STARTED|Overall Study||30
360034|NCT02198235|885049|P1|STARTED|Overall Study||30
360035|NCT02198040|885069|P3|NOT COMPLETED|Overall Study||1
360036|NCT02198040|885070|P2|NOT COMPLETED|Overall Study||1
360037|NCT02198040|885071|P1|NOT COMPLETED|Overall Study||0
360038|NCT02198040|885069|P3|COMPLETED|Overall Study||8
360039|NCT02198040|885070|P2|COMPLETED|Overall Study||8
360040|NCT02198040|885071|P1|COMPLETED|Overall Study||9
360041|NCT02198040|885069|P3|STARTED|Overall Study||9
360042|NCT02198040|885070|P2|STARTED|Overall Study||9
360043|NCT02198040|885071|P1|STARTED|Overall Study||9
360044|NCT02197806|885101|P4|NOT COMPLETED|Overall Study||1
360045|NCT02197806|885102|P3|NOT COMPLETED|Overall Study||0
360046|NCT02197806|885103|P2|NOT COMPLETED|Overall Study||1
360047|NCT02197806|885104|P1|NOT COMPLETED|Overall Study||0
360048|NCT02197806|885101|P4|COMPLETED|Overall Study||16
360049|NCT02197806|885102|P3|COMPLETED|Overall Study||16
360050|NCT02197806|885103|P2|COMPLETED|Overall Study||16
360051|NCT02197806|885104|P1|COMPLETED|Overall Study||15
360052|NCT02197806|885101|P4|STARTED|Overall Study||17
360053|NCT02197806|885102|P3|STARTED|Overall Study||16
360054|NCT02197806|885103|P2|STARTED|Overall Study||17
360055|NCT02197806|885104|P1|STARTED|Overall Study||15
360056|NCT02197481|885116|P2|NOT COMPLETED|Overall Study||0
360057|NCT02197481|885117|P1|NOT COMPLETED|Overall Study||0
360058|NCT02197481|885116|P2|COMPLETED|Overall Study||43
360059|NCT02197481|885117|P1|COMPLETED|Overall Study|February 2016|43
360060|NCT02197481|885116|P2|STARTED|Overall Study||43
360061|NCT02197481|885117|P1|STARTED|Overall Study|October 2014|43
360062|NCT02197455|885137|P1|NOT COMPLETED|Overall Study||0
360063|NCT02197455|885137|P1|COMPLETED|Overall Study||30
360064|NCT02197455|885137|P1|STARTED|Overall Study||30
360065|NCT02197273|885144|P2|NOT COMPLETED|Overall Study||0
360066|NCT02197273|885145|P1|NOT COMPLETED|Overall Study||0
360067|NCT02197273|885144|P2|COMPLETED|Overall Study||104
360068|NCT02197273|885145|P1|COMPLETED|Overall Study||107
360069|NCT02197273|885144|P2|STARTED|Overall Study||104
360070|NCT02197273|885145|P1|STARTED|Overall Study||107
360071|NCT02197247|885155|P1|NOT COMPLETED|Part B: Day 78 to End Part B (AZD9291)||15
360072|NCT02197247|885155|P1|COMPLETED|Part B: Day 78 to End Part B (AZD9291)||19
360073|NCT02197247|885155|P1|STARTED|Part B: Day 78 to End Part B (AZD9291)|32 completed Part A + 2 entered Part B without completing Part A (both due to AE) =34 started Part B|34
360074|NCT02197247|885155|P1|NOT COMPLETED|Part A: Day 50-77 (AZD9291 Alone)||5
360075|NCT02197247|885155|P1|COMPLETED|Part A: Day 50-77 (AZD9291 Alone)||32
360076|NCT02197247|885155|P1|STARTED|Part A: Day 50-77 (AZD9291 Alone)||37
360077|NCT02197247|885155|P1|NOT COMPLETED|Part A: Day 29-49 (AZD9291+Rifampicin)||4
360078|NCT02197247|885155|P1|COMPLETED|Part A: Day 29-49 (AZD9291+Rifampicin)||37
360079|NCT02197247|885155|P1|STARTED|Part A: Day 29-49 (AZD9291+Rifampicin)||41
360080|NCT02197247|885155|P1|NOT COMPLETED|Part A: Day 1-28 (AZD9291 Alone)||0
360081|NCT02197247|885155|P1|COMPLETED|Part A: Day 1-28 (AZD9291 Alone)||41
360082|NCT02197247|885155|P1|STARTED|Part A: Day 1-28 (AZD9291 Alone)||41
360083|NCT02197234|885200|P1|NOT COMPLETED|Part B: Day 33 to End Part B (AZD9291)||30
360084|NCT02197234|885200|P1|COMPLETED|Part B: Day 33 to End Part B (AZD9291)||20
360085|NCT02197234|885200|P1|STARTED|Part B: Day 33 to End Part B (AZD9291)|49 completed Part A + 1 entered Part B without completing Part A (due to AE) = 50 started Part B|50
360086|NCT02197234|885200|P1|NOT COMPLETED|Part A: Day 31-32 (Simvastatin+AZD9291)||0
360087|NCT02197234|885200|P1|COMPLETED|Part A: Day 31-32 (Simvastatin+AZD9291)||49
360088|NCT02197234|885200|P1|STARTED|Part A: Day 31-32 (Simvastatin+AZD9291)||49
360089|NCT02197234|885200|P1|NOT COMPLETED|Part A: Day 3-30 (AZD9291 Alone)||3
360090|NCT02197234|885200|P1|COMPLETED|Part A: Day 3-30 (AZD9291 Alone)||49
360091|NCT02197234|885200|P1|STARTED|Part A: Day 3-30 (AZD9291 Alone)||52
360092|NCT02197234|885200|P1|NOT COMPLETED|Part A: Day 1-2 (Simvastatin Alone)||0
360093|NCT02197234|885200|P1|COMPLETED|Part A: Day 1-2 (Simvastatin Alone)||52
360094|NCT02197234|885200|P1|STARTED|Part A: Day 1-2 (Simvastatin Alone)||52
360095|NCT02197130|885222|P3|NOT COMPLETED|Overall Study||32
360096|NCT02197130|885223|P2|NOT COMPLETED|Overall Study||8
360097|NCT02197130|885224|P1|NOT COMPLETED|Overall Study||16
360098|NCT02197130|885222|P3|COMPLETED|Overall Study||56
360099|NCT02197130|885223|P2|COMPLETED|Overall Study||81
360100|NCT02197130|885224|P1|COMPLETED|Overall Study||79
360101|NCT02197130|885222|P3|Received Treatment|Overall Study||87
360102|NCT02197130|885223|P2|Received Treatment|Overall Study||88
360103|NCT02197130|885224|P1|Received Treatment|Overall Study||95
360104|NCT02197130|885222|P3|STARTED|Overall Study||88
360105|NCT02197130|885223|P2|STARTED|Overall Study||89
360106|NCT02197130|885224|P1|STARTED|Overall Study||95
360107|NCT02197065|885276|P2|NOT COMPLETED|Overall Study||0
360108|NCT02197065|885277|P1|NOT COMPLETED|Overall Study||0
360109|NCT02197065|885276|P2|COMPLETED|Overall Study||10
360110|NCT02197065|885277|P1|COMPLETED|Overall Study||10
360111|NCT02197065|885276|P2|STARTED|Overall Study||10
360112|NCT02197065|885277|P1|STARTED|Overall Study||10
360113|NCT02196922|885288|P2|NOT COMPLETED|Overall Study||0
360114|NCT02196922|885289|P1|NOT COMPLETED|Overall Study||0
360115|NCT02196922|885288|P2|COMPLETED|Overall Study||46
360116|NCT02196922|885289|P1|COMPLETED|Overall Study||58
360117|NCT02196922|885288|P2|STARTED|Overall Study||46
360118|NCT02196922|885289|P1|STARTED|Overall Study||58
360119|NCT02196766|885299|P2|NOT COMPLETED|Second Intervention (7 Days)||0
360120|NCT02196766|885300|P1|NOT COMPLETED|Second Intervention (7 Days)||0
360121|NCT02196766|885299|P2|COMPLETED|Second Intervention (7 Days)||15
360122|NCT02196766|885300|P1|COMPLETED|Second Intervention (7 Days)||15
360123|NCT02196766|885299|P2|STARTED|Second Intervention (7 Days)||15
360124|NCT02196766|885300|P1|STARTED|Second Intervention (7 Days)||15
360125|NCT02196766|885299|P2|NOT COMPLETED|First Intervention (7 Days)||0
360126|NCT02196766|885300|P1|NOT COMPLETED|First Intervention (7 Days)||0
360127|NCT02196766|885299|P2|COMPLETED|First Intervention (7 Days)||15
360128|NCT02196766|885300|P1|COMPLETED|First Intervention (7 Days)||15
360129|NCT02196766|885299|P2|STARTED|First Intervention (7 Days)||15
360130|NCT02196766|885300|P1|STARTED|First Intervention (7 Days)||15
360131|NCT02196714|885316|P4|NOT COMPLETED|Overall Study||0
360132|NCT02196714|885317|P3|NOT COMPLETED|Overall Study||1
360133|NCT02196714|885318|P2|NOT COMPLETED|Overall Study||0
360134|NCT02196714|885319|P1|NOT COMPLETED|Overall Study||0
360135|NCT02196714|885316|P4|COMPLETED|Overall Study||24
360136|NCT02196714|885317|P3|COMPLETED|Overall Study||23
360137|NCT02196714|885318|P2|COMPLETED|Overall Study||23
360138|NCT02196714|885319|P1|COMPLETED|Overall Study||24
360139|NCT02196714|885316|P4|STARTED|Overall Study||24
360140|NCT02196714|885317|P3|STARTED|Overall Study||24
360141|NCT02196714|885318|P2|STARTED|Overall Study||23
360142|NCT02196714|885319|P1|STARTED|Overall Study||24
360143|NCT02196701|885441|P1|NOT COMPLETED|Overall Study||3
360144|NCT02196701|885441|P1|COMPLETED|Overall Study||43
360145|NCT02196701|885441|P1|STARTED|Overall Study||46
360146|NCT02196675|885500|P3|NOT COMPLETED|Overall Study||1
360147|NCT02196675|885501|P2|NOT COMPLETED|Overall Study||2
360148|NCT02196675|885502|P1|NOT COMPLETED|Overall Study||2
360149|NCT02196675|885500|P3|COMPLETED|Overall Study||7
360150|NCT02196675|885501|P2|COMPLETED|Overall Study||68
360151|NCT02196675|885502|P1|COMPLETED|Overall Study||25
360152|NCT02196675|885500|P3|STARTED|Overall Study||8
360153|NCT02196675|885501|P2|STARTED|Overall Study||70
360154|NCT02196675|885502|P1|STARTED|Overall Study||27
360155|NCT02196259|885525|P3|NOT COMPLETED|Overall Study||1
360156|NCT02196259|885526|P2|NOT COMPLETED|Overall Study||3
360157|NCT02196259|885527|P1|NOT COMPLETED|Overall Study||0
360158|NCT02196259|885525|P3|COMPLETED|Overall Study||2
360159|NCT02196259|885526|P2|COMPLETED|Overall Study||4
360160|NCT02196259|885527|P1|COMPLETED|Overall Study||3
360161|NCT02196259|885525|P3|STARTED|Overall Study||3
360162|NCT02196259|885526|P2|STARTED|Overall Study||7
360163|NCT02196259|885527|P1|STARTED|Overall Study||3
360164|NCT02196168|885536|P2|NOT COMPLETED|Overall Study||0
360165|NCT02196168|885537|P1|NOT COMPLETED|Overall Study||0
360166|NCT02196168|885536|P2|COMPLETED|Overall Study||0
360167|NCT02196168|885537|P1|COMPLETED|Overall Study||6
360168|NCT02196168|885536|P2|STARTED|Overall Study||0
360169|NCT02196168|885537|P1|STARTED|Overall Study||6
360170|NCT02196077|885555|P1|NOT COMPLETED|Overall Study||47
360171|NCT02196077|885555|P1|COMPLETED|Overall Study||133
360172|NCT02196077|885555|P1|FF MDI 9.6 μg|Overall Study||157
360173|NCT02196077|885555|P1|BD MDI 320 μg|Overall Study||108
360174|NCT02196077|885555|P1|BFF MDI 80/9.6 μg|Overall Study||103
360175|NCT02196077|885555|P1|BFF MDI 160/9.6 μg|Overall Study||106
360176|NCT02196077|885555|P1|BFF MDI 320/9.6 μg|Overall Study||155
360177|NCT02196077|885555|P1|STARTED|Overall Study||180
360178|NCT02195986|885605|P3|NOT COMPLETED|Overall Study||2
360179|NCT02195986|885606|P2|NOT COMPLETED|Overall Study||5
360180|NCT02195986|885607|P1|NOT COMPLETED|Overall Study||3
360181|NCT02195986|885605|P3|COMPLETED|Overall Study||71
360182|NCT02195986|885606|P2|COMPLETED|Overall Study||142
360183|NCT02195986|885607|P1|COMPLETED|Overall Study||143
360184|NCT02195986|885605|P3|STARTED|Overall Study||73
360185|NCT02195986|885606|P2|STARTED|Overall Study||147
360186|NCT02195986|885607|P1|STARTED|Overall Study||146
360187|NCT02195713|885624|P2|NOT COMPLETED|Overall Study||0
360188|NCT02195713|885625|P1|NOT COMPLETED|Overall Study||0
360189|NCT02195713|885624|P2|COMPLETED|Overall Study||10
360190|NCT02195713|885625|P1|COMPLETED|Overall Study||10
360191|NCT02195713|885624|P2|STARTED|Overall Study||10
360192|NCT02195713|885625|P1|STARTED|Overall Study||10
360193|NCT02195700|885633|P2|NOT COMPLETED|Overall Study||7
360194|NCT02195700|885634|P1|NOT COMPLETED|Overall Study||6
360195|NCT02195700|885633|P2|COMPLETED|Overall Study||52
360196|NCT02195700|885634|P1|COMPLETED|Overall Study||52
360197|NCT02195700|885633|P2|Maintenance Period|Overall Study||54
360198|NCT02195700|885634|P1|Maintenance Period|Overall Study||53
360199|NCT02195700|885633|P2|Modified ITT Population|Overall Study|ITT who received study drug and >=1 centrally read post-baseline AIMS from weeks 2, 4, 6, 9, or 12|57
360200|NCT02195700|885634|P1|Modified ITT Population|Overall Study|ITT who received study drug and >=1 centrally read post-baseline AIMS from weeks 2, 4, 6, 9, or 12|56
360201|NCT02195700|885633|P2|Safety and ITT Populations|Overall Study||59
360202|NCT02195700|885634|P1|Safety and ITT Populations|Overall Study||58
360203|NCT02195700|885633|P2|STARTED|Overall Study||59
360204|NCT02195700|885634|P1|STARTED|Overall Study||58
360205|NCT02195687|885656|P2|NOT COMPLETED|Overall Study||2
360206|NCT02195687|885657|P1|NOT COMPLETED|Overall Study||5
360207|NCT02195687|885656|P2|COMPLETED|Overall Study||99
360208|NCT02195687|885657|P1|COMPLETED|Overall Study||311
360209|NCT02195687|885656|P2|STARTED|Overall Study||101
360210|NCT02195687|885657|P1|STARTED|Overall Study||316
360211|NCT02195583|885673|P1|NOT COMPLETED|Overall Study||9
360212|NCT02195583|885673|P1|COMPLETED|Overall Study||53
360213|NCT02195583|885673|P1|Sodium Fluoride (1426 Ppm) + Zinc Base B|Overall Study|Discontinuations: 1 withdrawal of consent in Period 2;1 adverse event each in Period 3 and Period 4|60
360214|NCT02195583|885673|P1|Sodium Fluoride (1426 Ppm)|Overall Study|Discontinuation:1 lost to follow up, 1 withdrawal of consent in Period 2, 1 other reason in Period 5|59
360215|NCT02195583|885673|P1|Sodium Fluoride (250 Ppm)|Overall Study||55
360216|NCT02195583|885673|P1|Sodium Fluoride (1426 Ppm) + Zinc Base A|Overall Study|Discontinuations: 1 withdrawal of consent in Period 3 and 1 withdrawal of consent in Period 4|58
360217|NCT02195583|885673|P1|Sodium Fluoride (0 Ppm)|Overall Study||59
360218|NCT02195583|885673|P1|Sodium Fluoride (1150 Ppm)|Overall Study|Discontinuations: 1 due to other reason in Period 5|57
360219|NCT02195583|885673|P1|STARTED|Overall Study||62
360220|NCT02195427|885707|P2|NOT COMPLETED|Overall Study||27
360221|NCT02195427|885708|P1|NOT COMPLETED|Overall Study||26
360222|NCT02195427|885707|P2|COMPLETED|Overall Study||47
360223|NCT02195427|885708|P1|COMPLETED|Overall Study||47
360224|NCT02195427|885707|P2|N Patients at W52|Overall Study||56
360225|NCT02195427|885708|P1|N Patients at W52|Overall Study||63
360226|NCT02195427|885707|P2|N Patients at W36|Overall Study||59
360227|NCT02195427|885708|P1|N Patients at W36|Overall Study||65
360228|NCT02195427|885707|P2|N Patients at W24 (Primary Outcome)|Overall Study||62
360229|NCT02195427|885708|P1|N Patients at W24 (Primary Outcome)|Overall Study||67
360230|NCT02195427|885707|P2|STARTED|Overall Study||74
360231|NCT02195427|885708|P1|STARTED|Overall Study||73
360232|NCT02195414|885770|P1|NOT COMPLETED|Overall Study||0
360233|NCT02195414|885770|P1|COMPLETED|Overall Study||31
360234|NCT02195414|885770|P1|Primary Endpoint|Overall Study||31
360235|NCT02195414|885770|P1|STARTED|Overall Study||31
360236|NCT02194699|885779|P2|NOT COMPLETED|With Potential to Receive 52 Weeks of IP||52
360237|NCT02194699|885780|P1|NOT COMPLETED|With Potential to Receive 52 Weeks of IP||50
360327|NCT02193074|886144|P1|COMPLETED|Overall Study||24
360238|NCT02194699|885779|P2|COMPLETED|With Potential to Receive 52 Weeks of IP||365
360239|NCT02194699|885780|P1|COMPLETED|With Potential to Receive 52 Weeks of IP||370
360240|NCT02194699|885779|P2|STARTED|With Potential to Receive 52 Weeks of IP|Includes all patients randomised with the potential to receive 52 weeks of IP and receiving any IP.|417
360241|NCT02194699|885780|P1|STARTED|With Potential to Receive 52 Weeks of IP|Includes all patients randomised with the potential to receive 52 weeks of IP and receiving any IP.|420
360242|NCT02194699|885779|P2|NOT COMPLETED|Randomised||11
360243|NCT02194699|885780|P1|NOT COMPLETED|Randomised||8
360244|NCT02194699|885779|P2|COMPLETED|Randomised||417
360245|NCT02194699|885780|P1|COMPLETED|Randomised||420
360246|NCT02194699|885779|P2|STARTED|Randomised||428
360247|NCT02194699|885780|P1|STARTED|Randomised||428
360248|NCT02194621|885888|P3|NOT COMPLETED|Overall Study||9
360249|NCT02194621|885889|P2|NOT COMPLETED|Overall Study||6
360250|NCT02194621|885890|P1|NOT COMPLETED|Overall Study||6
360251|NCT02194621|885888|P3|COMPLETED|Overall Study||34
360252|NCT02194621|885889|P2|COMPLETED|Overall Study||36
360253|NCT02194621|885890|P1|COMPLETED|Overall Study||37
360254|NCT02194621|885888|P3|STARTED|Overall Study||43
360255|NCT02194621|885889|P2|STARTED|Overall Study||42
360256|NCT02194621|885890|P1|STARTED|Overall Study||43
360257|NCT02194088|885909|P2|NOT COMPLETED|Overall Study||0
360258|NCT02194088|885910|P1|NOT COMPLETED|Overall Study||0
360259|NCT02194088|885909|P2|COMPLETED|Overall Study||25
360260|NCT02194088|885910|P1|COMPLETED|Overall Study||75
360261|NCT02194088|885909|P2|STARTED|Overall Study||25
360262|NCT02194088|885910|P1|STARTED|Overall Study||75
360263|NCT02194062|885923|P3|NOT COMPLETED|Overall Study||5
360264|NCT02194062|885924|P2|NOT COMPLETED|Overall Study||2
360265|NCT02194062|885925|P1|NOT COMPLETED|Overall Study||2
360266|NCT02194062|885923|P3|COMPLETED|Overall Study||7
360267|NCT02194062|885924|P2|COMPLETED|Overall Study||8
360268|NCT02194062|885925|P1|COMPLETED|Overall Study||8
360269|NCT02194062|885923|P3|STARTED|Overall Study||12
360270|NCT02194062|885924|P2|STARTED|Overall Study||10
360271|NCT02194062|885925|P1|STARTED|Overall Study||10
360272|NCT02193828|885940|P4|NOT COMPLETED|Overall Study||1
360273|NCT02193828|885941|P3|NOT COMPLETED|Overall Study||1
360274|NCT02193828|885942|P2|NOT COMPLETED|Overall Study||0
360275|NCT02193828|885943|P1|NOT COMPLETED|Overall Study||0
360276|NCT02193828|885940|P4|COMPLETED|Overall Study||16
360277|NCT02193828|885941|P3|COMPLETED|Overall Study||22
360278|NCT02193828|885942|P2|COMPLETED|Overall Study||18
360279|NCT02193828|885943|P1|COMPLETED|Overall Study||18
360280|NCT02193828|885940|P4|STARTED|Overall Study||17
360281|NCT02193828|885941|P3|STARTED|Overall Study||23
360282|NCT02193828|885942|P2|STARTED|Overall Study||18
360283|NCT02193828|885943|P1|STARTED|Overall Study||18
360284|NCT02193815|885981|P1|NOT COMPLETED|Overall Study||0
360285|NCT02193815|885981|P1|COMPLETED|Overall Study||15
360286|NCT02193815|885981|P1|STARTED|Overall Study||15
360287|NCT02193178|886016|P1|NOT COMPLETED|Overall Study||2
360288|NCT02193178|886016|P1|COMPLETED|Overall Study||13
360289|NCT02193178|886016|P1|STARTED|Overall Study||15
360290|NCT02193165|886066|P3|NOT COMPLETED|6 Week Product Use||0
360291|NCT02193165|886067|P2|NOT COMPLETED|6 Week Product Use||1
360292|NCT02193165|886068|P1|NOT COMPLETED|6 Week Product Use||0
360293|NCT02193165|886066|P3|COMPLETED|6 Week Product Use||39
360294|NCT02193165|886067|P2|COMPLETED|6 Week Product Use|1 subject failed to keep appointment time and didn't return to clinical site.|38
360295|NCT02193165|886068|P1|COMPLETED|6 Week Product Use||39
360296|NCT02193165|886066|P3|STARTED|6 Week Product Use||39
360297|NCT02193165|886067|P2|STARTED|6 Week Product Use||39
360298|NCT02193165|886068|P1|STARTED|6 Week Product Use||39
360299|NCT02193165|886066|P3|NOT COMPLETED|4 Week Product Use||1
360300|NCT02193165|886067|P2|NOT COMPLETED|4 Week Product Use||1
360301|NCT02193165|886068|P1|NOT COMPLETED|4 Week Product Use||1
360302|NCT02193165|886066|P3|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
360303|NCT02193165|886067|P2|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
360304|NCT02193165|886068|P1|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
360305|NCT02193165|886066|P3|STARTED|4 Week Product Use||40
360306|NCT02193165|886067|P2|STARTED|4 Week Product Use||40
360307|NCT02193165|886068|P1|STARTED|4 Week Product Use||40
360308|NCT02193087|886095|P4|NOT COMPLETED|Overall Study||79
360309|NCT02193087|886096|P3|NOT COMPLETED|Overall Study||7
360310|NCT02193087|886097|P2|NOT COMPLETED|Overall Study||14
360311|NCT02193087|886098|P1|NOT COMPLETED|Overall Study||37
360312|NCT02193087|886095|P4|COMPLETED|Overall Study||524
360313|NCT02193087|886096|P3|COMPLETED|Overall Study||93
360314|NCT02193087|886097|P2|COMPLETED|Overall Study||86
360315|NCT02193087|886098|P1|COMPLETED|Overall Study||162
360316|NCT02193087|886095|P4|Received Vaccination|Overall Study||602
360317|NCT02193087|886096|P3|Received Vaccination|Overall Study||100
360318|NCT02193087|886097|P2|Received Vaccination|Overall Study||97
360319|NCT02193087|886098|P1|Received Vaccination|Overall Study||197
360320|NCT02193087|886095|P4|STARTED|Overall Study||603
360321|NCT02193087|886096|P3|STARTED|Overall Study||100
360322|NCT02193087|886097|P2|STARTED|Overall Study||100
360323|NCT02193087|886098|P1|STARTED|Overall Study||199
360324|NCT02193074|886143|P2|NOT COMPLETED|Overall Study||15
360325|NCT02193074|886144|P1|NOT COMPLETED|Overall Study||17
360326|NCT02193074|886143|P2|COMPLETED|Overall Study||65
360328|NCT02193074|886143|P2|Completed Due to Early Study Termination|Overall Study||39
360329|NCT02193074|886144|P1|Completed Due to Early Study Termination|Overall Study||13
360330|NCT02193074|886143|P2|Completed During Follow-Up Period|Overall Study||26
360331|NCT02193074|886144|P1|Completed During Follow-Up Period|Overall Study||11
360332|NCT02193074|886143|P2|STARTED|Overall Study|Randomized and received double-blind treatment.|80
360333|NCT02193074|886144|P1|STARTED|Overall Study|Randomized and received double-blind treatment.|41
360334|NCT02192905|886176|P1|NOT COMPLETED|Overall Study||1
360335|NCT02192905|886176|P1|COMPLETED|Overall Study|Reporting a minimum of current weight at 16-week follow-up|42
360336|NCT02192905|886176|P1|STARTED|Overall Study||43
360337|NCT02192879|886190|P3|NOT COMPLETED|Overall Study||0
360338|NCT02192879|886191|P2|NOT COMPLETED|Overall Study||0
360339|NCT02192879|886192|P1|NOT COMPLETED|Overall Study||0
360340|NCT02192879|886190|P3|COMPLETED|Overall Study||3
360341|NCT02192879|886191|P2|COMPLETED|Overall Study||4
360342|NCT02192879|886192|P1|COMPLETED|Overall Study||3
360343|NCT02192879|886190|P3|STARTED|Overall Study||3
360344|NCT02192879|886191|P2|STARTED|Overall Study||4
360345|NCT02192879|886192|P1|STARTED|Overall Study||3
360346|NCT02192814|886218|P1|NOT COMPLETED|Overall Study||0
360347|NCT02192814|886218|P1|COMPLETED|Overall Study||9
360348|NCT02192814|886218|P1|STARTED|Overall Study||9
360349|NCT02192684|886231|P2|NOT COMPLETED|Overall Study||0
360350|NCT02192684|886232|P1|NOT COMPLETED|Overall Study||0
360351|NCT02192684|886231|P2|COMPLETED|Overall Study||15
360352|NCT02192684|886232|P1|COMPLETED|Overall Study||30
360353|NCT02192684|886231|P2|STARTED|Overall Study||15
360354|NCT02192684|886232|P1|STARTED|Overall Study||30
360355|NCT02192606|886240|P2|NOT COMPLETED|Overall Study||4
360356|NCT02192606|886241|P1|NOT COMPLETED|Overall Study||2
360357|NCT02192606|886240|P2|COMPLETED|Overall Study||24
360358|NCT02192606|886241|P1|COMPLETED|Overall Study||27
360359|NCT02192606|886240|P2|STARTED|Overall Study||28
360360|NCT02192606|886241|P1|STARTED|Overall Study||29
360361|NCT02192541|886251|P2|NOT COMPLETED|Overall Study||0
360362|NCT02192541|886252|P1|NOT COMPLETED|Overall Study||0
360363|NCT02192541|886251|P2|COMPLETED|Overall Study||3
360364|NCT02192541|886252|P1|COMPLETED|Overall Study||2
360365|NCT02192541|886251|P2|Evaluable for Response|Overall Study||3
360366|NCT02192541|886252|P1|Evaluable for Response|Overall Study||1
360367|NCT02192541|886251|P2|Treated|Overall Study||3
360368|NCT02192541|886252|P1|Treated|Overall Study||2
360369|NCT02192541|886251|P2|STARTED|Overall Study||3
360370|NCT02192541|886252|P1|STARTED|Overall Study||2
360371|NCT02192164|886272|P1|NOT COMPLETED|Overall Study||14
360372|NCT02192164|886272|P1|COMPLETED|Overall Study||112
360373|NCT02192164|886272|P1|Etanercept Treated Population|Overall Study||112
360374|NCT02192164|886272|P1|STARTED|Overall Study||126
360375|NCT02191865|886291|P3|NOT COMPLETED|Overall Study||0
360376|NCT02191865|886292|P2|NOT COMPLETED|Overall Study||0
360377|NCT02191865|886293|P1|NOT COMPLETED|Overall Study||0
360378|NCT02191865|886291|P3|COMPLETED|Overall Study||17
360379|NCT02191865|886292|P2|COMPLETED|Overall Study||8
360380|NCT02191865|886293|P1|COMPLETED|Overall Study||8
360381|NCT02191865|886291|P3|STARTED|Overall Study||17
360382|NCT02191865|886292|P2|STARTED|Overall Study||8
360383|NCT02191865|886293|P1|STARTED|Overall Study||8
360384|NCT02191579|886315|P2|NOT COMPLETED|Treatment 2||25
360385|NCT02191579|886316|P1|NOT COMPLETED|Treatment 2||0
360386|NCT02191579|886315|P2|COMPLETED|Treatment 2||55
360387|NCT02191579|886316|P1|COMPLETED|Treatment 2||0
360388|NCT02191579|886315|P2|STARTED|Treatment 2||80
360389|NCT02191579|886316|P1|STARTED|Treatment 2||0
360390|NCT02191579|886315|P2|NOT COMPLETED|Treatment 1||58
360391|NCT02191579|886316|P1|NOT COMPLETED|Treatment 1||27
360392|NCT02191579|886315|P2|COMPLETED|Treatment 1||84
360393|NCT02191579|886316|P1|COMPLETED|Treatment 1||113
360394|NCT02191579|886315|P2|STARTED|Treatment 1||142
360395|NCT02191579|886316|P1|STARTED|Treatment 1||140
360396|NCT02191267|886331|P3|NOT COMPLETED|Overall Study||0
360397|NCT02191267|886332|P2|NOT COMPLETED|Overall Study||0
360398|NCT02191267|886333|P1|NOT COMPLETED|Overall Study||1
360399|NCT02191267|886331|P3|COMPLETED|Overall Study||4
360400|NCT02191267|886332|P2|COMPLETED|Overall Study||6
360401|NCT02191267|886333|P1|COMPLETED|Overall Study||19
360402|NCT02191267|886331|P3|STARTED|Overall Study||4
360403|NCT02191267|886332|P2|STARTED|Overall Study||6
360404|NCT02191267|886333|P1|STARTED|Overall Study||20
360405|NCT02191137|886344|P1|NOT COMPLETED|Follow-up||5
360406|NCT02191137|886344|P1|COMPLETED|Follow-up||60
360407|NCT02191137|886344|P1|STARTED|Follow-up||65
360408|NCT02191137|886344|P1|NOT COMPLETED|Treatment||10
360409|NCT02191137|886344|P1|COMPLETED|Treatment||65
360410|NCT02191137|886344|P1|STARTED|Treatment||75
360411|NCT02191046|886374|P2|NOT COMPLETED|Overall Study||1
360412|NCT02191046|886375|P1|NOT COMPLETED|Overall Study||5
360413|NCT02191046|886374|P2|COMPLETED|Overall Study|exclude 1 patient because low compliance|38
360414|NCT02191046|886375|P1|COMPLETED|Overall Study|exclude 5 patients because low compliance|36
360415|NCT02191046|886374|P2|STARTED|Overall Study||39
360416|NCT02191046|886375|P1|STARTED|Overall Study||41
360417|NCT02191033|886383|P2|NOT COMPLETED|Overall Study||1
360418|NCT02191033|886384|P1|NOT COMPLETED|Overall Study||2
360419|NCT02191033|886383|P2|COMPLETED|Overall Study||19
360420|NCT02191033|886384|P1|COMPLETED|Overall Study||18
360421|NCT02191033|886383|P2|STARTED|Overall Study||20
360422|NCT02191033|886384|P1|STARTED|Overall Study||20
360423|NCT02190604|886413|P19|NOT COMPLETED|Part 3 (Patients)||0
360424|NCT02190604|886414|P18|NOT COMPLETED|Part 3 (Patients)||0
360425|NCT02190604|886415|P17|NOT COMPLETED|Part 3 (Patients)||0
360426|NCT02190604|886416|P16|NOT COMPLETED|Part 3 (Patients)||0
360427|NCT02190604|886417|P15|NOT COMPLETED|Part 3 (Patients)||0
360428|NCT02190604|886418|P14|NOT COMPLETED|Part 3 (Patients)||0
360429|NCT02190604|886419|P13|NOT COMPLETED|Part 3 (Patients)||0
360430|NCT02190604|886420|P12|NOT COMPLETED|Part 3 (Patients)||0
360431|NCT02190604|886421|P11|NOT COMPLETED|Part 3 (Patients)||0
360432|NCT02190604|886422|P10|NOT COMPLETED|Part 3 (Patients)||0
360433|NCT02190604|886423|P9|NOT COMPLETED|Part 3 (Patients)||0
360434|NCT02190604|886424|P8|NOT COMPLETED|Part 3 (Patients)||0
360435|NCT02190604|886425|P7|NOT COMPLETED|Part 3 (Patients)||0
360436|NCT02190604|886426|P6|NOT COMPLETED|Part 3 (Patients)||0
360437|NCT02190604|886427|P5|NOT COMPLETED|Part 3 (Patients)||0
360438|NCT02190604|886428|P4|NOT COMPLETED|Part 3 (Patients)||0
360439|NCT02190604|886429|P3|NOT COMPLETED|Part 3 (Patients)||0
360440|NCT02190604|886430|P2|NOT COMPLETED|Part 3 (Patients)||0
360441|NCT02190604|886431|P1|NOT COMPLETED|Part 3 (Patients)||0
360442|NCT02190604|886413|P19|COMPLETED|Part 3 (Patients)||12
360443|NCT02190604|886414|P18|COMPLETED|Part 3 (Patients)||19
360444|NCT02190604|886415|P17|COMPLETED|Part 3 (Patients)||12
360445|NCT02190604|886416|P16|COMPLETED|Part 3 (Patients)||6
360446|NCT02190604|886417|P15|COMPLETED|Part 3 (Patients)||0
360447|NCT02190604|886418|P14|COMPLETED|Part 3 (Patients)||0
360448|NCT02190604|886419|P13|COMPLETED|Part 3 (Patients)||0
360449|NCT02190604|886420|P12|COMPLETED|Part 3 (Patients)||0
360450|NCT02190604|886421|P11|COMPLETED|Part 3 (Patients)||0
360451|NCT02190604|886422|P10|COMPLETED|Part 3 (Patients)||0
360452|NCT02190604|886423|P9|COMPLETED|Part 3 (Patients)||0
360453|NCT02190604|886424|P8|COMPLETED|Part 3 (Patients)||0
360454|NCT02190604|886425|P7|COMPLETED|Part 3 (Patients)||0
360455|NCT02190604|886426|P6|COMPLETED|Part 3 (Patients)||0
360456|NCT02190604|886427|P5|COMPLETED|Part 3 (Patients)||0
360457|NCT02190604|886428|P4|COMPLETED|Part 3 (Patients)||0
360458|NCT02190604|886429|P3|COMPLETED|Part 3 (Patients)||0
360459|NCT02190604|886430|P2|COMPLETED|Part 3 (Patients)||0
360460|NCT02190604|886431|P1|COMPLETED|Part 3 (Patients)||0
360461|NCT02190604|886413|P19|STARTED|Part 3 (Patients)||12
360462|NCT02190604|886414|P18|STARTED|Part 3 (Patients)||19
360463|NCT02190604|886415|P17|STARTED|Part 3 (Patients)||12
360464|NCT02190604|886416|P16|STARTED|Part 3 (Patients)||6
360465|NCT02190604|886417|P15|STARTED|Part 3 (Patients)||0
360466|NCT02190604|886418|P14|STARTED|Part 3 (Patients)||0
360467|NCT02190604|886419|P13|STARTED|Part 3 (Patients)||0
360468|NCT02190604|886420|P12|STARTED|Part 3 (Patients)||0
360469|NCT02190604|886421|P11|STARTED|Part 3 (Patients)||0
360470|NCT02190604|886422|P10|STARTED|Part 3 (Patients)||0
360471|NCT02190604|886423|P9|STARTED|Part 3 (Patients)||0
360472|NCT02190604|886424|P8|STARTED|Part 3 (Patients)||0
360473|NCT02190604|886425|P7|STARTED|Part 3 (Patients)||0
360474|NCT02190604|886426|P6|STARTED|Part 3 (Patients)||0
360475|NCT02190604|886427|P5|STARTED|Part 3 (Patients)||0
360476|NCT02190604|886428|P4|STARTED|Part 3 (Patients)||0
360477|NCT02190604|886429|P3|STARTED|Part 3 (Patients)||0
360478|NCT02190604|886430|P2|STARTED|Part 3 (Patients)||0
360479|NCT02190604|886431|P1|STARTED|Part 3 (Patients)||0
360480|NCT02190604|886413|P19|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
360481|NCT02190604|886414|P18|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
360482|NCT02190604|886415|P17|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
360483|NCT02190604|886416|P16|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
360484|NCT02190604|886417|P15|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||2
360485|NCT02190604|886418|P14|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||1
360486|NCT02190604|886419|P13|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
360487|NCT02190604|886420|P12|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
360488|NCT02190604|886421|P11|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
360489|NCT02190604|886422|P10|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
360490|NCT02190604|886423|P9|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
360491|NCT02190604|886424|P8|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
360492|NCT02190604|886425|P7|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
360493|NCT02190604|886426|P6|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
360494|NCT02190604|886427|P5|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
360495|NCT02190604|886428|P4|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
360496|NCT02190604|886429|P3|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
360497|NCT02190604|886430|P2|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
360498|NCT02190604|886431|P1|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
360499|NCT02190604|886413|P19|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
360500|NCT02190604|886414|P18|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
360501|NCT02190604|886415|P17|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
360502|NCT02190604|886416|P16|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
360503|NCT02190604|886417|P15|COMPLETED|Part 1 and 2 (Healthy Volunteers)||8
360504|NCT02190604|886418|P14|COMPLETED|Part 1 and 2 (Healthy Volunteers)||5
360505|NCT02190604|886419|P13|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
360506|NCT02190604|886420|P12|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
360507|NCT02190604|886421|P11|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
360508|NCT02190604|886422|P10|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
360509|NCT02190604|886423|P9|COMPLETED|Part 1 and 2 (Healthy Volunteers)||16
360510|NCT02190604|886424|P8|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
360511|NCT02190604|886425|P7|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
360512|NCT02190604|886426|P6|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
360513|NCT02190604|886427|P5|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
360514|NCT02190604|886428|P4|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
360515|NCT02190604|886429|P3|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
360516|NCT02190604|886430|P2|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
360517|NCT02190604|886431|P1|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
360518|NCT02190604|886413|P19|STARTED|Part 1 and 2 (Healthy Volunteers)||0
360519|NCT02190604|886414|P18|STARTED|Part 1 and 2 (Healthy Volunteers)||0
360520|NCT02190604|886415|P17|STARTED|Part 1 and 2 (Healthy Volunteers)||0
360521|NCT02190604|886416|P16|STARTED|Part 1 and 2 (Healthy Volunteers)||0
360522|NCT02190604|886417|P15|STARTED|Part 1 and 2 (Healthy Volunteers)||10
360523|NCT02190604|886418|P14|STARTED|Part 1 and 2 (Healthy Volunteers)||6
360524|NCT02190604|886419|P13|STARTED|Part 1 and 2 (Healthy Volunteers)||6
360525|NCT02190604|886420|P12|STARTED|Part 1 and 2 (Healthy Volunteers)||6
360526|NCT02190604|886421|P11|STARTED|Part 1 and 2 (Healthy Volunteers)||6
360527|NCT02190604|886422|P10|STARTED|Part 1 and 2 (Healthy Volunteers)||6
360528|NCT02190604|886423|P9|STARTED|Part 1 and 2 (Healthy Volunteers)||16
360529|NCT02190604|886424|P8|STARTED|Part 1 and 2 (Healthy Volunteers)||6
360530|NCT02190604|886425|P7|STARTED|Part 1 and 2 (Healthy Volunteers)||6
360531|NCT02190604|886426|P6|STARTED|Part 1 and 2 (Healthy Volunteers)||6
360532|NCT02190604|886427|P5|STARTED|Part 1 and 2 (Healthy Volunteers)||6
360533|NCT02190604|886428|P4|STARTED|Part 1 and 2 (Healthy Volunteers)||6
360534|NCT02190604|886429|P3|STARTED|Part 1 and 2 (Healthy Volunteers)||6
360535|NCT02190604|886430|P2|STARTED|Part 1 and 2 (Healthy Volunteers)||6
360536|NCT02190604|886431|P1|STARTED|Part 1 and 2 (Healthy Volunteers)||6
360537|NCT02190591|886622|P2|NOT COMPLETED|Overall Study||11
360538|NCT02190591|886623|P1|NOT COMPLETED|Overall Study||2
360539|NCT02190591|886622|P2|COMPLETED|Overall Study||91
360540|NCT02190591|886623|P1|COMPLETED|Overall Study||100
360541|NCT02190591|886622|P2|STARTED|Overall Study||102
360542|NCT02190591|886623|P1|STARTED|Overall Study||102
360543|NCT02190435|886635|P2|NOT COMPLETED|Overall Study||0
360544|NCT02190435|886636|P1|NOT COMPLETED|Overall Study||15
360545|NCT02190435|886635|P2|COMPLETED|Overall Study||24
360546|NCT02190435|886636|P1|COMPLETED|Overall Study||26
360547|NCT02190435|886635|P2|STARTED|Overall Study||24
360548|NCT02190435|886636|P1|STARTED|Overall Study||41
360549|NCT02189954|886646|P2|NOT COMPLETED|Overall Study||0
360550|NCT02189954|886647|P1|NOT COMPLETED|Overall Study||0
360551|NCT02189954|886646|P2|COMPLETED|Overall Study||45
360552|NCT02189954|886647|P1|COMPLETED|Overall Study||45
360553|NCT02189954|886646|P2|STARTED|Overall Study||45
360554|NCT02189954|886647|P1|STARTED|Overall Study||45
360555|NCT02189941|886655|P3|NOT COMPLETED|Overall Study||1
360556|NCT02189941|886656|P2|NOT COMPLETED|Overall Study||0
360557|NCT02189941|886657|P1|NOT COMPLETED|Overall Study||0
360558|NCT02189941|886655|P3|COMPLETED|Overall Study||2
360559|NCT02189941|886656|P2|COMPLETED|Overall Study||4
360560|NCT02189941|886657|P1|COMPLETED|Overall Study||4
360561|NCT02189941|886655|P3|STARTED|Overall Study||3
360562|NCT02189941|886656|P2|STARTED|Overall Study||4
360563|NCT02189941|886657|P1|STARTED|Overall Study||4
360564|NCT02189915|886680|P1|NOT COMPLETED|Overall Study||3
360565|NCT02189915|886680|P1|COMPLETED|Overall Study||11
360566|NCT02189915|886680|P1|STARTED|Overall Study||14
360567|NCT02189863|886685|P2|NOT COMPLETED|Second 2 Weeks||0
360568|NCT02189863|886686|P1|NOT COMPLETED|Second 2 Weeks||0
360569|NCT02189863|886685|P2|COMPLETED|Second 2 Weeks||13
360570|NCT02189863|886686|P1|COMPLETED|Second 2 Weeks||8
360571|NCT02189863|886685|P2|STARTED|Second 2 Weeks||13
360572|NCT02189863|886686|P1|STARTED|Second 2 Weeks||8
360573|NCT02189863|886685|P2|NOT COMPLETED|First 2 Weeks||2
360574|NCT02189863|886686|P1|NOT COMPLETED|First 2 Weeks||4
360575|NCT02189863|886685|P2|COMPLETED|First 2 Weeks||13
360576|NCT02189863|886686|P1|COMPLETED|First 2 Weeks||8
360577|NCT02189863|886685|P2|STARTED|First 2 Weeks||15
360578|NCT02189863|886686|P1|STARTED|First 2 Weeks||12
360579|NCT02189837|886701|P4|NOT COMPLETED|Overall Study||2
360580|NCT02189837|886702|P3|NOT COMPLETED|Overall Study||3
360581|NCT02189837|886703|P2|NOT COMPLETED|Overall Study||1
360582|NCT02189837|886704|P1|NOT COMPLETED|Overall Study||2
360583|NCT02189837|886701|P4|COMPLETED|Overall Study||19
360584|NCT02189837|886702|P3|COMPLETED|Overall Study||20
360585|NCT02189837|886703|P2|COMPLETED|Overall Study||22
360586|NCT02189837|886704|P1|COMPLETED|Overall Study||20
360587|NCT02189837|886701|P4|Received Treatment|Overall Study||20
360588|NCT02189837|886702|P3|Received Treatment|Overall Study||22
360589|NCT02189837|886703|P2|Received Treatment|Overall Study||22
360590|NCT02189837|886704|P1|Received Treatment|Overall Study||21
360591|NCT02189837|886701|P4|STARTED|Overall Study||21
360592|NCT02189837|886702|P3|STARTED|Overall Study||23
360593|NCT02189837|886703|P2|STARTED|Overall Study||23
360594|NCT02189837|886704|P1|STARTED|Overall Study||22
360595|NCT02189759|886734|P4|NOT COMPLETED|Overall Study||5
360596|NCT02189759|886735|P3|NOT COMPLETED|Overall Study||2
360597|NCT02189759|886736|P2|NOT COMPLETED|Overall Study||0
360598|NCT02189759|886737|P1|NOT COMPLETED|Overall Study||0
360599|NCT02189759|886734|P4|COMPLETED|Overall Study||84
360600|NCT02189759|886735|P3|COMPLETED|Overall Study||81
360601|NCT02189759|886736|P2|COMPLETED|Overall Study||101
360602|NCT02189759|886737|P1|COMPLETED|Overall Study||102
360603|NCT02189759|886734|P4|STARTED|Overall Study||89
360604|NCT02189759|886735|P3|STARTED|Overall Study||83
360605|NCT02189759|886736|P2|STARTED|Overall Study||101
360606|NCT02189759|886737|P1|STARTED|Overall Study||102
360607|NCT02189668|886757|P2|NOT COMPLETED|Overall Study||0
360608|NCT02189668|886758|P1|NOT COMPLETED|Overall Study||0
360609|NCT02189668|886757|P2|COMPLETED|Overall Study||9
360610|NCT02189668|886758|P1|COMPLETED|Overall Study||5
360611|NCT02189668|886757|P2|STARTED|Overall Study||9
360612|NCT02189668|886758|P1|STARTED|Overall Study||5
360613|NCT02189317|886768|P2|NOT COMPLETED|Overall Study||0
360614|NCT02189317|886769|P1|NOT COMPLETED|Overall Study||0
360615|NCT02189317|886768|P2|COMPLETED|Overall Study||16
360616|NCT02189317|886769|P1|COMPLETED|Overall Study||16
360617|NCT02189317|886768|P2|STARTED|Overall Study||16
360618|NCT02189317|886769|P1|STARTED|Overall Study||16
360619|NCT02189252|886783|P4|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
360620|NCT02189252|886784|P3|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
360621|NCT02189252|886785|P2|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
360622|NCT02189252|886786|P1|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
360623|NCT02189252|886783|P4|COMPLETED|Period 2 (Visit6b, Week 12)||4
360624|NCT02189252|886784|P3|COMPLETED|Period 2 (Visit6b, Week 12)||3
360625|NCT02189252|886785|P2|COMPLETED|Period 2 (Visit6b, Week 12)||2
360626|NCT02189252|886786|P1|COMPLETED|Period 2 (Visit6b, Week 12)||4
360627|NCT02189252|886783|P4|STARTED|Period 2 (Visit6b, Week 12)||4
360628|NCT02189252|886784|P3|STARTED|Period 2 (Visit6b, Week 12)||3
360629|NCT02189252|886785|P2|STARTED|Period 2 (Visit6b, Week 12)||2
360630|NCT02189252|886786|P1|STARTED|Period 2 (Visit6b, Week 12)||4
360631|NCT02189252|886783|P4|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
360632|NCT02189252|886784|P3|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
360633|NCT02189252|886785|P2|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||2
360634|NCT02189252|886786|P1|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
360635|NCT02189252|886783|P4|COMPLETED|Period 1 (Visit 4b, Week 4)||4
360636|NCT02189252|886784|P3|COMPLETED|Period 1 (Visit 4b, Week 4)||3
360637|NCT02189252|886785|P2|COMPLETED|Period 1 (Visit 4b, Week 4)||2
360638|NCT02189252|886786|P1|COMPLETED|Period 1 (Visit 4b, Week 4)||4
360639|NCT02189252|886783|P4|STARTED|Period 1 (Visit 4b, Week 4)||4
360640|NCT02189252|886784|P3|STARTED|Period 1 (Visit 4b, Week 4)||3
360641|NCT02189252|886785|P2|STARTED|Period 1 (Visit 4b, Week 4)||4
360642|NCT02189252|886786|P1|STARTED|Period 1 (Visit 4b, Week 4)||4
360643|NCT02189161|886818|P1|NOT COMPLETED|Overall Study||0
360644|NCT02189161|886818|P1|COMPLETED|Overall Study||10
360645|NCT02189161|886818|P1|STARTED|Overall Study||10
360646|NCT02189122|886826|P2|NOT COMPLETED|Overall Study||0
360647|NCT02189122|886827|P1|NOT COMPLETED|Overall Study||0
360648|NCT02189122|886826|P2|COMPLETED|Overall Study||18
360649|NCT02189122|886827|P1|COMPLETED|Overall Study||18
360650|NCT02189122|886826|P2|STARTED|Overall Study||18
360651|NCT02189122|886827|P1|STARTED|Overall Study||18
360652|NCT02188849|886845|P2|NOT COMPLETED|Overall Study||8
360653|NCT02188849|886846|P1|NOT COMPLETED|Overall Study||3
360654|NCT02188849|886845|P2|COMPLETED|Overall Study||17
360655|NCT02188849|886846|P1|COMPLETED|Overall Study||22
360656|NCT02188849|886845|P2|STARTED|Overall Study||25
360657|NCT02188849|886846|P1|STARTED|Overall Study||25
360658|NCT02188784|886860|P2|NOT COMPLETED|Overall Study||13
360659|NCT02188784|886861|P1|NOT COMPLETED|Overall Study||9
360660|NCT02188784|886860|P2|COMPLETED|Overall Study|Patients completing the protocol excluding death, lost to follow-up and withdrawn consent.|101
360661|NCT02188784|886861|P1|COMPLETED|Overall Study|Patients completing the protocol excluding death, lost to follow-up and withdrawn consent.|102
360662|NCT02188784|886860|P2|STARTED|Overall Study||114
360663|NCT02188784|886861|P1|STARTED|Overall Study||111
360664|NCT02188589|886877|P1|NOT COMPLETED|Overall Study||0
360665|NCT02188589|886877|P1|COMPLETED|Overall Study||30
360666|NCT02188589|886877|P1|STARTED|Overall Study||30
360667|NCT02187887|886884|P2|NOT COMPLETED|Overall Study||4
360668|NCT02187887|886885|P1|NOT COMPLETED|Overall Study||5
360669|NCT02187887|886884|P2|COMPLETED|Overall Study||396
360670|NCT02187887|886885|P1|COMPLETED|Overall Study||388
360671|NCT02187887|886884|P2|STARTED|Overall Study||400
360672|NCT02187887|886885|P1|STARTED|Overall Study||393
360673|NCT02187861|886897|P4|NOT COMPLETED|Overall Study||51
360674|NCT02187861|886898|P3|NOT COMPLETED|Overall Study||51
360675|NCT02187861|886899|P2|NOT COMPLETED|Overall Study||53
360676|NCT02187861|886900|P1|NOT COMPLETED|Overall Study||9
360677|NCT02187861|886897|P4|COMPLETED|Overall Study||0
360678|NCT02187861|886898|P3|COMPLETED|Overall Study||0
360679|NCT02187861|886899|P2|COMPLETED|Overall Study||0
360680|NCT02187861|886900|P1|COMPLETED|Overall Study||0
360681|NCT02187861|886897|P4|Treated|Overall Study||50
360682|NCT02187861|886898|P3|Treated|Overall Study||49
360683|NCT02187861|886899|P2|Treated|Overall Study||52
360684|NCT02187861|886900|P1|Treated|Overall Study||9
360685|NCT02187861|886897|P4|STARTED|Overall Study||51
360686|NCT02187861|886898|P3|STARTED|Overall Study||51
360687|NCT02187861|886899|P2|STARTED|Overall Study||53
360688|NCT02187861|886900|P1|STARTED|Overall Study||9
360689|NCT02187809|886996|P1|NOT COMPLETED|Overall Study||3
360690|NCT02187809|886996|P1|COMPLETED|Overall Study||0
360691|NCT02187809|886996|P1|Treated|Overall Study||1
360692|NCT02187809|886996|P1|STARTED|Overall Study||3
360693|NCT02187744|887008|P2|NOT COMPLETED|Treatment||5
360694|NCT02187744|887009|P1|NOT COMPLETED|Treatment||4
360695|NCT02187744|887008|P2|COMPLETED|Treatment||107
360696|NCT02187744|887009|P1|COMPLETED|Treatment||109
360697|NCT02187744|887008|P2|STARTED|Treatment||112
360698|NCT02187744|887009|P1|STARTED|Treatment||113
360699|NCT02187744|887008|P2|NOT COMPLETED|Study||6
360700|NCT02187744|887009|P1|NOT COMPLETED|Study||4
360701|NCT02187744|887008|P2|COMPLETED|Study||106
360702|NCT02187744|887009|P1|COMPLETED|Study||109
360703|NCT02187744|887008|P2|STARTED|Study|Received treatment|112
360704|NCT02187744|887009|P1|STARTED|Study|Received treatment|113
360705|NCT02187055|887028|P3|NOT COMPLETED|Overall Study||74
360706|NCT02187055|887029|P2|NOT COMPLETED|Overall Study||73
360707|NCT02187055|887030|P1|NOT COMPLETED|Overall Study||69
360708|NCT02187055|887028|P3|COMPLETED|Overall Study||312
360709|NCT02187055|887029|P2|COMPLETED|Overall Study||303
360710|NCT02187055|887030|P1|COMPLETED|Overall Study||315
360711|NCT02187055|887028|P3|STARTED|Overall Study|Treated|386
360712|NCT02187055|887029|P2|STARTED|Overall Study|Treated|376
360713|NCT02187055|887030|P1|STARTED|Overall Study|Treated|384
360714|NCT02187029|887132|P4|NOT COMPLETED|Overall Study||3
360715|NCT02187029|887133|P3|NOT COMPLETED|Overall Study||11
360716|NCT02187029|887134|P2|NOT COMPLETED|Overall Study||1
360717|NCT02187029|887135|P1|NOT COMPLETED|Overall Study||1
360718|NCT02187029|887132|P4|COMPLETED|Overall Study||6
360719|NCT02187029|887133|P3|COMPLETED|Overall Study||0
360720|NCT02187029|887134|P2|COMPLETED|Overall Study||2
360721|NCT02187029|887135|P1|COMPLETED|Overall Study||6
360722|NCT02187029|887132|P4|STARTED|Overall Study||9
360723|NCT02187029|887133|P3|STARTED|Overall Study||11
360724|NCT02187029|887134|P2|STARTED|Overall Study||3
360725|NCT02187029|887135|P1|STARTED|Overall Study||7
360726|NCT02187016|887211|P4|NOT COMPLETED|Overall Study||0
360727|NCT02187016|887212|P3|NOT COMPLETED|Overall Study||1
360728|NCT02187016|887213|P2|NOT COMPLETED|Overall Study||2
360729|NCT02187016|887214|P1|NOT COMPLETED|Overall Study||1
360730|NCT02187016|887211|P4|COMPLETED|Overall Study||51
360731|NCT02187016|887212|P3|COMPLETED|Overall Study||78
360732|NCT02187016|887213|P2|COMPLETED|Overall Study||78
360733|NCT02187016|887214|P1|COMPLETED|Overall Study||79
360734|NCT02187016|887211|P4|STARTED|Overall Study||51
360735|NCT02187016|887212|P3|STARTED|Overall Study||79
360736|NCT02187016|887213|P2|STARTED|Overall Study||80
360737|NCT02187016|887214|P1|STARTED|Overall Study||80
360738|NCT02186873|887246|P2|NOT COMPLETED|Overall Study||8
360739|NCT02186873|887247|P1|NOT COMPLETED|Overall Study||9
360740|NCT02186873|887246|P2|COMPLETED|Overall Study||97
360741|NCT02186873|887247|P1|COMPLETED|Overall Study||94
360742|NCT02186873|887246|P2|End of Control Period|Overall Study|Participants continued to receive golimumab|105
360743|NCT02186873|887247|P1|End of Control Period|Overall Study|Participants taking placebo crossed over to golimumab|99
360744|NCT02186873|887246|P2|STARTED|Overall Study||105
360745|NCT02186873|887247|P1|STARTED|Overall Study||103
360746|NCT02186808|887270|P1|NOT COMPLETED|Overall Study||13
360747|NCT02186808|887270|P1|COMPLETED|Overall Study||67
360748|NCT02186808|887270|P1|STARTED|Overall Study||80
360749|NCT02186665|887277|P2|NOT COMPLETED|Overall Study||1
360750|NCT02186665|887278|P1|NOT COMPLETED|Overall Study||0
360751|NCT02186665|887277|P2|COMPLETED|Overall Study||10
360752|NCT02186665|887278|P1|COMPLETED|Overall Study||8
360753|NCT02186665|887277|P2|STARTED|Overall Study||11
360754|NCT02186665|887278|P1|STARTED|Overall Study||8
360755|NCT02186587|887286|P2|NOT COMPLETED|Overall Study||0
360756|NCT02186587|887287|P1|NOT COMPLETED|Overall Study||5
360757|NCT02186587|887286|P2|COMPLETED|Overall Study||0
360758|NCT02186587|887287|P1|COMPLETED|Overall Study||23
360759|NCT02186587|887286|P2|STARTED|Overall Study||0
360760|NCT02186587|887287|P1|STARTED|Overall Study||28
360761|NCT02186223|887292|P1|NOT COMPLETED|Overall Study||21
360762|NCT02186223|887292|P1|COMPLETED|Overall Study||151
360763|NCT02186223|887292|P1|Device Placed|Overall Study||163
360764|NCT02186223|887292|P1|STARTED|Overall Study||172
360765|NCT02185729|887301|P1|NOT COMPLETED|24 Hours Into Dextrose Infusion||0
360766|NCT02185729|887301|P1|COMPLETED|24 Hours Into Dextrose Infusion||12
360767|NCT02185729|887301|P1|STARTED|24 Hours Into Dextrose Infusion||12
360768|NCT02185729|887301|P1|NOT COMPLETED|4 Hours Into Dextrose Infusion||0
360769|NCT02185729|887301|P1|COMPLETED|4 Hours Into Dextrose Infusion||12
360770|NCT02185729|887301|P1|STARTED|4 Hours Into Dextrose Infusion||12
360771|NCT02185729|887301|P1|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0
360772|NCT02185729|887301|P1|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12
360773|NCT02185729|887301|P1|STARTED|0 Hour (Baseline) of Dextrose Infusion||12
360774|NCT02185729|887301|P1|NOT COMPLETED|24 Hours Into ClinOleic Infusion||0
360775|NCT02185729|887301|P1|COMPLETED|24 Hours Into ClinOleic Infusion||12
360776|NCT02185729|887301|P1|STARTED|24 Hours Into ClinOleic Infusion||12
360777|NCT02185729|887301|P1|NOT COMPLETED|4 Hours Into ClinOleic Infusion||0
360778|NCT02185729|887301|P1|COMPLETED|4 Hours Into ClinOleic Infusion||12
360779|NCT02185729|887301|P1|STARTED|4 Hours Into ClinOleic Infusion||12
360780|NCT02185729|887301|P1|NOT COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||0
360781|NCT02185729|887301|P1|COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||12
360782|NCT02185729|887301|P1|STARTED|0 Hour (Baseline) of ClinOleic Infusion||12
360783|NCT02185729|887301|P1|NOT COMPLETED|24 Hours Into Intralipid Infusion||0
360784|NCT02185729|887301|P1|COMPLETED|24 Hours Into Intralipid Infusion||12
360785|NCT02185729|887301|P1|STARTED|24 Hours Into Intralipid Infusion||12
360786|NCT02185729|887301|P1|NOT COMPLETED|4 Hours Into Intralipid Infusion||0
360787|NCT02185729|887301|P1|COMPLETED|4 Hours Into Intralipid Infusion||12
360788|NCT02185729|887301|P1|STARTED|4 Hours Into Intralipid Infusion||12
360789|NCT02185729|887301|P1|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0
360790|NCT02185729|887301|P1|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12
360791|NCT02185729|887301|P1|STARTED|0 Hour (Baseline) of Intralipid Infusion||12
360792|NCT02185729|887301|P1|NOT COMPLETED|24 Hours Into Saline Infusion||0
360793|NCT02185729|887301|P1|COMPLETED|24 Hours Into Saline Infusion||12
360794|NCT02185729|887301|P1|STARTED|24 Hours Into Saline Infusion||12
360795|NCT02185729|887301|P1|NOT COMPLETED|4 Hours Into Saline Infusion||0
360796|NCT02185729|887301|P1|COMPLETED|4 Hours Into Saline Infusion||12
360797|NCT02185729|887301|P1|STARTED|4 Hours Into Saline Infusion||12
360798|NCT02185729|887301|P1|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0
360799|NCT02185729|887301|P1|COMPLETED|0 Hour (Baseline) of Saline Infusion||12
360800|NCT02185729|887301|P1|STARTED|0 Hour (Baseline) of Saline Infusion||12
360801|NCT02185534|887322|P6|NOT COMPLETED|Third Period||0
360802|NCT02185534|887323|P5|NOT COMPLETED|Third Period||0
360803|NCT02185534|887324|P4|NOT COMPLETED|Third Period||0
360804|NCT02185534|887325|P3|NOT COMPLETED|Third Period||0
360805|NCT02185534|887326|P2|NOT COMPLETED|Third Period||0
360806|NCT02185534|887327|P1|NOT COMPLETED|Third Period||0
360807|NCT02185534|887322|P6|COMPLETED|Third Period||13
360808|NCT02185534|887323|P5|COMPLETED|Third Period||13
360809|NCT02185534|887324|P4|COMPLETED|Third Period||13
360810|NCT02185534|887325|P3|COMPLETED|Third Period||14
360811|NCT02185534|887326|P2|COMPLETED|Third Period||14
360812|NCT02185534|887327|P1|COMPLETED|Third Period||13
360813|NCT02185534|887322|P6|STARTED|Third Period||13
360814|NCT02185534|887323|P5|STARTED|Third Period||13
360815|NCT02185534|887324|P4|STARTED|Third Period||13
360816|NCT02185534|887325|P3|STARTED|Third Period||14
360817|NCT02185534|887326|P2|STARTED|Third Period||14
360818|NCT02185534|887327|P1|STARTED|Third Period||13
360819|NCT02185534|887322|P6|NOT COMPLETED|Second Washout Period||0
360820|NCT02185534|887323|P5|NOT COMPLETED|Second Washout Period||0
360821|NCT02185534|887324|P4|NOT COMPLETED|Second Washout Period||0
360822|NCT02185534|887325|P3|NOT COMPLETED|Second Washout Period||0
360823|NCT02185534|887326|P2|NOT COMPLETED|Second Washout Period||0
360824|NCT02185534|887327|P1|NOT COMPLETED|Second Washout Period||0
360825|NCT02185534|887322|P6|COMPLETED|Second Washout Period||13
360826|NCT02185534|887323|P5|COMPLETED|Second Washout Period||13
360827|NCT02185534|887324|P4|COMPLETED|Second Washout Period||13
360828|NCT02185534|887325|P3|COMPLETED|Second Washout Period||14
360829|NCT02185534|887326|P2|COMPLETED|Second Washout Period||14
360830|NCT02185534|887327|P1|COMPLETED|Second Washout Period||13
360831|NCT02185534|887322|P6|STARTED|Second Washout Period||13
360832|NCT02185534|887323|P5|STARTED|Second Washout Period||13
360833|NCT02185534|887324|P4|STARTED|Second Washout Period||13
360834|NCT02185534|887325|P3|STARTED|Second Washout Period||14
360835|NCT02185534|887326|P2|STARTED|Second Washout Period||14
360836|NCT02185534|887327|P1|STARTED|Second Washout Period||13
360837|NCT02185534|887322|P6|NOT COMPLETED|Second Period||0
360838|NCT02185534|887323|P5|NOT COMPLETED|Second Period||0
360839|NCT02185534|887324|P4|NOT COMPLETED|Second Period||0
360840|NCT02185534|887325|P3|NOT COMPLETED|Second Period||0
360841|NCT02185534|887326|P2|NOT COMPLETED|Second Period||0
360842|NCT02185534|887327|P1|NOT COMPLETED|Second Period||0
360843|NCT02185534|887322|P6|COMPLETED|Second Period||13
360844|NCT02185534|887323|P5|COMPLETED|Second Period||13
360845|NCT02185534|887324|P4|COMPLETED|Second Period||13
360846|NCT02185534|887325|P3|COMPLETED|Second Period||14
360847|NCT02185534|887326|P2|COMPLETED|Second Period||14
360848|NCT02185534|887327|P1|COMPLETED|Second Period||13
360849|NCT02185534|887322|P6|STARTED|Second Period||13
360850|NCT02185534|887323|P5|STARTED|Second Period||13
360851|NCT02185534|887324|P4|STARTED|Second Period||13
360852|NCT02185534|887325|P3|STARTED|Second Period||14
360853|NCT02185534|887326|P2|STARTED|Second Period||14
360854|NCT02185534|887327|P1|STARTED|Second Period||13
360855|NCT02185534|887322|P6|NOT COMPLETED|First Washout Period||1
360856|NCT02185534|887323|P5|NOT COMPLETED|First Washout Period||1
360857|NCT02185534|887324|P4|NOT COMPLETED|First Washout Period||0
360858|NCT02185534|887325|P3|NOT COMPLETED|First Washout Period||0
360859|NCT02185534|887326|P2|NOT COMPLETED|First Washout Period||0
360860|NCT02185534|887327|P1|NOT COMPLETED|First Washout Period||1
360861|NCT02185534|887322|P6|COMPLETED|First Washout Period||13
360862|NCT02185534|887323|P5|COMPLETED|First Washout Period||13
360863|NCT02185534|887324|P4|COMPLETED|First Washout Period||13
360864|NCT02185534|887325|P3|COMPLETED|First Washout Period||14
360865|NCT02185534|887326|P2|COMPLETED|First Washout Period||14
360866|NCT02185534|887327|P1|COMPLETED|First Washout Period||13
360867|NCT02185534|887322|P6|STARTED|First Washout Period||14
360868|NCT02185534|887323|P5|STARTED|First Washout Period||14
360869|NCT02185534|887324|P4|STARTED|First Washout Period||13
360870|NCT02185534|887325|P3|STARTED|First Washout Period||14
360871|NCT02185534|887326|P2|STARTED|First Washout Period||14
360872|NCT02185534|887327|P1|STARTED|First Washout Period||14
360873|NCT02185534|887322|P6|NOT COMPLETED|First Period||0
360874|NCT02185534|887323|P5|NOT COMPLETED|First Period||0
360875|NCT02185534|887324|P4|NOT COMPLETED|First Period||1
360876|NCT02185534|887325|P3|NOT COMPLETED|First Period||0
360877|NCT02185534|887326|P2|NOT COMPLETED|First Period||0
360878|NCT02185534|887327|P1|NOT COMPLETED|First Period||0
360879|NCT02185534|887322|P6|COMPLETED|First Period||14
360880|NCT02185534|887323|P5|COMPLETED|First Period||14
360881|NCT02185534|887324|P4|COMPLETED|First Period||13
360882|NCT02185534|887325|P3|COMPLETED|First Period||14
360883|NCT02185534|887326|P2|COMPLETED|First Period||14
360884|NCT02185534|887327|P1|COMPLETED|First Period||14
360885|NCT02185534|887322|P6|STARTED|First Period||14
360886|NCT02185534|887323|P5|STARTED|First Period||14
360887|NCT02185534|887324|P4|STARTED|First Period||14
360888|NCT02185534|887325|P3|STARTED|First Period||14
360889|NCT02185534|887326|P2|STARTED|First Period||14
360890|NCT02185534|887327|P1|STARTED|First Period||14
360891|NCT02185339|887344|P2|NOT COMPLETED|Overall Study||1
360892|NCT02185339|887345|P1|NOT COMPLETED|Overall Study||0
360893|NCT02185339|887344|P2|COMPLETED|Overall Study||30
360894|NCT02185339|887345|P1|COMPLETED|Overall Study||30
360895|NCT02185339|887344|P2|STARTED|Overall Study||31
360896|NCT02185339|887345|P1|STARTED|Overall Study||30
360897|NCT02185183|887367|P1|NOT COMPLETED|Overall Study||0
360898|NCT02185183|887367|P1|COMPLETED|Overall Study||14
360899|NCT02185183|887367|P1|STARTED|Overall Study||14
360900|NCT02185131|887373|P2|NOT COMPLETED|Overall Study||1
360901|NCT02185131|887374|P1|NOT COMPLETED|Overall Study||1
360902|NCT02185131|887373|P2|COMPLETED|Overall Study||8
360903|NCT02185131|887374|P1|COMPLETED|Overall Study||6
360904|NCT02185131|887373|P2|STARTED|Overall Study||9
360905|NCT02185131|887374|P1|STARTED|Overall Study||7
360906|NCT02185105|887382|P1|NOT COMPLETED|Overall Study||0
360907|NCT02185105|887382|P1|COMPLETED|Overall Study||30
360908|NCT02185105|887382|P1|STARTED|Overall Study||30
360909|NCT02184624|887430|P5|NOT COMPLETED|Overall Study||0
360910|NCT02184624|887431|P4|NOT COMPLETED|Overall Study||0
360911|NCT02184624|887432|P3|NOT COMPLETED|Overall Study||0
360912|NCT02184624|887433|P2|NOT COMPLETED|Overall Study||0
360913|NCT02184624|887434|P1|NOT COMPLETED|Overall Study||0
360914|NCT02184624|887430|P5|COMPLETED|Overall Study||98
360915|NCT02184624|887431|P4|COMPLETED|Overall Study||118
360916|NCT02184624|887432|P3|COMPLETED|Overall Study||100
360917|NCT02184624|887433|P2|COMPLETED|Overall Study||80
360918|NCT02184624|887434|P1|COMPLETED|Overall Study||171
360919|NCT02184624|887430|P5|STARTED|Overall Study||98
360920|NCT02184624|887431|P4|STARTED|Overall Study||118
360921|NCT02184624|887432|P3|STARTED|Overall Study||100
360922|NCT02184624|887433|P2|STARTED|Overall Study||80
360923|NCT02184624|887434|P1|STARTED|Overall Study||171
360924|NCT02184494|887479|P3|NOT COMPLETED|Overall Study||0
360925|NCT02184494|887480|P2|NOT COMPLETED|Overall Study||2
360926|NCT02184494|887481|P1|NOT COMPLETED|Overall Study||1
360927|NCT02184494|887479|P3|COMPLETED|Overall Study||8
360928|NCT02184494|887480|P2|COMPLETED|Overall Study||11
360929|NCT02184494|887481|P1|COMPLETED|Overall Study||12
360930|NCT02184494|887479|P3|STARTED|Overall Study||8
360931|NCT02184494|887480|P2|STARTED|Overall Study||13
360932|NCT02184494|887481|P1|STARTED|Overall Study||13
360933|NCT02184208|887501|P1|NOT COMPLETED|Overall Study||56
360934|NCT02184208|887501|P1|COMPLETED|Overall Study||222
360935|NCT02184208|887501|P1|STARTED|Overall Study||278
360936|NCT02183675|887513|P6|NOT COMPLETED|Treatment Period 3 (10 Days)||0
360937|NCT02183675|887514|P5|NOT COMPLETED|Treatment Period 3 (10 Days)||0
360938|NCT02183675|887515|P4|NOT COMPLETED|Treatment Period 3 (10 Days)||0
360939|NCT02183675|887516|P3|NOT COMPLETED|Treatment Period 3 (10 Days)||0
360940|NCT02183675|887517|P2|NOT COMPLETED|Treatment Period 3 (10 Days)||0
360941|NCT02183675|887518|P1|NOT COMPLETED|Treatment Period 3 (10 Days)||0
360942|NCT02183675|887513|P6|COMPLETED|Treatment Period 3 (10 Days)||4
360943|NCT02183675|887514|P5|COMPLETED|Treatment Period 3 (10 Days)||6
360944|NCT02183675|887515|P4|COMPLETED|Treatment Period 3 (10 Days)||6
360945|NCT02183675|887516|P3|COMPLETED|Treatment Period 3 (10 Days)||6
360946|NCT02183675|887517|P2|COMPLETED|Treatment Period 3 (10 Days)||6
360947|NCT02183675|887518|P1|COMPLETED|Treatment Period 3 (10 Days)||6
360948|NCT02183675|887513|P6|STARTED|Treatment Period 3 (10 Days)||4
360949|NCT02183675|887514|P5|STARTED|Treatment Period 3 (10 Days)||6
360950|NCT02183675|887515|P4|STARTED|Treatment Period 3 (10 Days)||6
360951|NCT02183675|887516|P3|STARTED|Treatment Period 3 (10 Days)||6
360952|NCT02183675|887517|P2|STARTED|Treatment Period 3 (10 Days)||6
360953|NCT02183675|887518|P1|STARTED|Treatment Period 3 (10 Days)||6
360954|NCT02183675|887513|P6|NOT COMPLETED|Treatment Period 2 (10 Days)||2
360955|NCT02183675|887514|P5|NOT COMPLETED|Treatment Period 2 (10 Days)||0
360956|NCT02183675|887515|P4|NOT COMPLETED|Treatment Period 2 (10 Days)||0
360957|NCT02183675|887516|P3|NOT COMPLETED|Treatment Period 2 (10 Days)||0
360958|NCT02183675|887517|P2|NOT COMPLETED|Treatment Period 2 (10 Days)||0
360959|NCT02183675|887518|P1|NOT COMPLETED|Treatment Period 2 (10 Days)||0
360960|NCT02183675|887513|P6|COMPLETED|Treatment Period 2 (10 Days)|Patients withdrew after completion of treatment period 2 but before beginning of treatment period 3|4
360961|NCT02183675|887514|P5|COMPLETED|Treatment Period 2 (10 Days)||6
360962|NCT02183675|887515|P4|COMPLETED|Treatment Period 2 (10 Days)||6
360963|NCT02183675|887516|P3|COMPLETED|Treatment Period 2 (10 Days)||6
360964|NCT02183675|887517|P2|COMPLETED|Treatment Period 2 (10 Days)||6
360965|NCT02183675|887518|P1|COMPLETED|Treatment Period 2 (10 Days)||6
360966|NCT02183675|887513|P6|STARTED|Treatment Period 2 (10 Days)||6
360967|NCT02183675|887514|P5|STARTED|Treatment Period 2 (10 Days)||6
360968|NCT02183675|887515|P4|STARTED|Treatment Period 2 (10 Days)||6
360969|NCT02183675|887516|P3|STARTED|Treatment Period 2 (10 Days)||6
360970|NCT02183675|887517|P2|STARTED|Treatment Period 2 (10 Days)||6
360971|NCT02183675|887518|P1|STARTED|Treatment Period 2 (10 Days)||6
360972|NCT02183675|887513|P6|NOT COMPLETED|Treatment Period 1 (10 Days)||0
360973|NCT02183675|887514|P5|NOT COMPLETED|Treatment Period 1 (10 Days)||0
360974|NCT02183675|887515|P4|NOT COMPLETED|Treatment Period 1 (10 Days)||0
360975|NCT02183675|887516|P3|NOT COMPLETED|Treatment Period 1 (10 Days)||0
360976|NCT02183675|887517|P2|NOT COMPLETED|Treatment Period 1 (10 Days)||0
360977|NCT02183675|887518|P1|NOT COMPLETED|Treatment Period 1 (10 Days)||0
360978|NCT02183675|887513|P6|COMPLETED|Treatment Period 1 (10 Days)||6
360979|NCT02183675|887514|P5|COMPLETED|Treatment Period 1 (10 Days)||6
360980|NCT02183675|887515|P4|COMPLETED|Treatment Period 1 (10 Days)||6
360981|NCT02183675|887516|P3|COMPLETED|Treatment Period 1 (10 Days)||6
360982|NCT02183675|887517|P2|COMPLETED|Treatment Period 1 (10 Days)||6
360983|NCT02183675|887518|P1|COMPLETED|Treatment Period 1 (10 Days)||6
360984|NCT02183675|887513|P6|STARTED|Treatment Period 1 (10 Days)||6
360985|NCT02183675|887514|P5|STARTED|Treatment Period 1 (10 Days)||6
360986|NCT02183675|887515|P4|STARTED|Treatment Period 1 (10 Days)||6
360987|NCT02183675|887516|P3|STARTED|Treatment Period 1 (10 Days)||6
360988|NCT02183675|887517|P2|STARTED|Treatment Period 1 (10 Days)||6
360989|NCT02183675|887518|P1|STARTED|Treatment Period 1 (10 Days)||6
360990|NCT02183519|887542|P2|NOT COMPLETED|Overall Study||3
360991|NCT02183519|887543|P1|NOT COMPLETED|Overall Study||3
360992|NCT02183519|887542|P2|COMPLETED|Overall Study||13
360993|NCT02183519|887543|P1|COMPLETED|Overall Study||25
360994|NCT02183519|887542|P2|STARTED|Overall Study||16
360995|NCT02183519|887543|P1|STARTED|Overall Study||28
360996|NCT02182895|887551|P2|NOT COMPLETED|Overall Study||4
360997|NCT02182895|887552|P1|NOT COMPLETED|Overall Study||2
360998|NCT02182895|887551|P2|COMPLETED|Overall Study||33
360999|NCT02182895|887552|P1|COMPLETED|Overall Study||33
361000|NCT02182895|887551|P2|STARTED|Overall Study||37
361001|NCT02182895|887552|P1|STARTED|Overall Study||35
361002|NCT02182115|887574|P2|NOT COMPLETED|Overall Study||0
361003|NCT02182115|887575|P1|NOT COMPLETED|Overall Study||0
361004|NCT02182115|887574|P2|COMPLETED|Overall Study||57
361005|NCT02182115|887575|P1|COMPLETED|Overall Study||53
361006|NCT02182115|887574|P2|STARTED|Overall Study||57
361007|NCT02182115|887575|P1|STARTED|Overall Study||53
361008|NCT02181790|887583|P2|NOT COMPLETED|Overall Study||0
361009|NCT02181790|887584|P1|NOT COMPLETED|Overall Study||2
361010|NCT02181790|887583|P2|COMPLETED|Overall Study||0
361011|NCT02181790|887584|P1|COMPLETED|Overall Study||0
361012|NCT02181790|887583|P2|STARTED|Overall Study||0
361013|NCT02181790|887584|P1|STARTED|Overall Study||2
361014|NCT02181673|887594|P3|NOT COMPLETED|Week 24-Week 60||17
361015|NCT02181673|887595|P2|NOT COMPLETED|Week 24-Week 60||8
361016|NCT02181673|887596|P1|NOT COMPLETED|Week 24-Week 60||0
361017|NCT02181673|887594|P3|COMPLETED|Week 24-Week 60||213
361018|NCT02181673|887595|P2|COMPLETED|Week 24-Week 60||214
361019|NCT02181673|887596|P1|COMPLETED|Week 24-Week 60||0
361020|NCT02181673|887594|P3|Treated|Week 24-Week 60||230
361021|NCT02181673|887595|P2|Treated|Week 24-Week 60||220
361022|NCT02181673|887596|P1|Treated|Week 24-Week 60||0
361023|NCT02181673|887594|P3|STARTED|Week 24-Week 60||230
361024|NCT02181673|887595|P2|STARTED|Week 24-Week 60||222
361025|NCT02181673|887596|P1|STARTED|Week 24-Week 60||0
361026|NCT02181673|887594|P3|NOT COMPLETED|Up to Week 24||11
361027|NCT02181673|887595|P2|NOT COMPLETED|Up to Week 24||0
361028|NCT02181673|887596|P1|NOT COMPLETED|Up to Week 24||17
361029|NCT02181673|887594|P3|COMPLETED|Up to Week 24||230
361030|NCT02181673|887595|P2|COMPLETED|Up to Week 24||0
361031|NCT02181673|887596|P1|COMPLETED|Up to Week 24||222
361032|NCT02181673|887594|P3|Treated|Up to Week 24||240
361033|NCT02181673|887595|P2|Treated|Up to Week 24||0
361034|NCT02181673|887596|P1|Treated|Up to Week 24||239
361035|NCT02181673|887594|P3|STARTED|Up to Week 24||241
361036|NCT02181673|887595|P2|STARTED|Up to Week 24||0
361037|NCT02181673|887596|P1|STARTED|Up to Week 24||239
361038|NCT02181634|887623|P1|NOT COMPLETED|Overall Study||72
361039|NCT02181634|887623|P1|COMPLETED|Overall Study||2
361040|NCT02181634|887623|P1|Eligible and Treated|Overall Study||73
361041|NCT02181634|887623|P1|STARTED|Overall Study||74
361042|NCT02181530|887634|P1|NOT COMPLETED|Overall Study||0
361043|NCT02181530|887634|P1|COMPLETED|Overall Study||43
361044|NCT02181530|887634|P1|STARTED|Overall Study||43
361045|NCT02181517|887647|P3|NOT COMPLETED|Overall Study||0
361046|NCT02181517|887648|P2|NOT COMPLETED|Overall Study||0
361047|NCT02181517|887649|P1|NOT COMPLETED|Overall Study||0
361048|NCT02181517|887647|P3|COMPLETED|Overall Study||5
361049|NCT02181517|887648|P2|COMPLETED|Overall Study||10
361050|NCT02181517|887649|P1|COMPLETED|Overall Study||10
361051|NCT02181517|887647|P3|STARTED|Overall Study||5
361052|NCT02181517|887648|P2|STARTED|Overall Study||10
361053|NCT02181517|887649|P1|STARTED|Overall Study||10
361054|NCT02181504|887672|P3|NOT COMPLETED|Overall Study||1
361055|NCT02181504|887673|P2|NOT COMPLETED|Overall Study||1
361056|NCT02181504|887674|P1|NOT COMPLETED|Overall Study||1
361057|NCT02181504|887672|P3|COMPLETED|Overall Study||4
361058|NCT02181504|887673|P2|COMPLETED|Overall Study||9
361059|NCT02181504|887674|P1|COMPLETED|Overall Study||9
361060|NCT02181504|887672|P3|STARTED|Overall Study||5
361061|NCT02181504|887673|P2|STARTED|Overall Study||10
361062|NCT02181504|887674|P1|STARTED|Overall Study||10
361063|NCT02181426|887698|P4|NOT COMPLETED|Overall Study||0
361064|NCT02181426|887699|P3|NOT COMPLETED|Overall Study||0
361065|NCT02181426|887700|P2|NOT COMPLETED|Overall Study||0
361066|NCT02181426|887701|P1|NOT COMPLETED|Overall Study||0
361067|NCT02181426|887698|P4|COMPLETED|Overall Study||28
361068|NCT02181426|887699|P3|COMPLETED|Overall Study||28
361069|NCT02181426|887700|P2|COMPLETED|Overall Study||28
361070|NCT02181426|887701|P1|COMPLETED|Overall Study||28
361071|NCT02181426|887698|P4|STARTED|Overall Study||28
361072|NCT02181426|887699|P3|STARTED|Overall Study||28
361073|NCT02181426|887700|P2|STARTED|Overall Study||28
361074|NCT02181426|887701|P1|STARTED|Overall Study||28
361075|NCT02181387|887713|P2|NOT COMPLETED|Overall Study||4
361076|NCT02181387|887714|P1|NOT COMPLETED|Overall Study||2
361077|NCT02181387|887713|P2|COMPLETED|Overall Study||15
361078|NCT02181387|887714|P1|COMPLETED|Overall Study||12
361079|NCT02181387|887713|P2|STARTED|Overall Study||19
361080|NCT02181387|887714|P1|STARTED|Overall Study||14
361081|NCT02181140|887720|P1|NOT COMPLETED|Overall Study||0
361082|NCT02181140|887720|P1|COMPLETED|Overall Study||56
361083|NCT02181140|887720|P1|STARTED|Overall Study||56
361084|NCT02181127|887726|P1|NOT COMPLETED|Overall Study||0
361085|NCT02181127|887726|P1|COMPLETED|Overall Study||22
361086|NCT02181127|887726|P1|STARTED|Overall Study||22
361087|NCT02180893|887733|P2|NOT COMPLETED|Overall Study||7
361088|NCT02180893|887734|P1|NOT COMPLETED|Overall Study||3
361089|NCT02180893|887733|P2|COMPLETED|Overall Study||23
361090|NCT02180893|887734|P1|COMPLETED|Overall Study||27
361091|NCT02180893|887733|P2|STARTED|Overall Study||30
361092|NCT02180893|887734|P1|STARTED|Overall Study||30
361093|NCT02180828|887748|P2|NOT COMPLETED|Overall Study||7
361094|NCT02180828|887749|P1|NOT COMPLETED|Overall Study||5
361095|NCT02180828|887748|P2|COMPLETED|Overall Study||113
361096|NCT02180828|887749|P1|COMPLETED|Overall Study||115
361097|NCT02180828|887748|P2|STARTED|Overall Study||120
361098|NCT02180828|887749|P1|STARTED|Overall Study||120
361099|NCT02180646|887773|P2|NOT COMPLETED|Second Intervention (7 Days)||0
361100|NCT02180646|887774|P1|NOT COMPLETED|Second Intervention (7 Days)||0
361101|NCT02180646|887773|P2|COMPLETED|Second Intervention (7 Days)||6
361102|NCT02180646|887774|P1|COMPLETED|Second Intervention (7 Days)||6
361103|NCT02180646|887773|P2|STARTED|Second Intervention (7 Days)||6
361104|NCT02180646|887774|P1|STARTED|Second Intervention (7 Days)||6
361105|NCT02180646|887773|P2|NOT COMPLETED|Washout (7 Days)||0
361106|NCT02180646|887774|P1|NOT COMPLETED|Washout (7 Days)||0
361107|NCT02180646|887773|P2|COMPLETED|Washout (7 Days)||6
361108|NCT02180646|887774|P1|COMPLETED|Washout (7 Days)||6
361109|NCT02180646|887773|P2|STARTED|Washout (7 Days)||6
361110|NCT02180646|887774|P1|STARTED|Washout (7 Days)||6
361111|NCT02180646|887773|P2|NOT COMPLETED|First Intervention (7 Days)||0
361112|NCT02180646|887774|P1|NOT COMPLETED|First Intervention (7 Days)||0
361113|NCT02180646|887773|P2|COMPLETED|First Intervention (7 Days)||6
361114|NCT02180646|887774|P1|COMPLETED|First Intervention (7 Days)||6
361115|NCT02180646|887773|P2|STARTED|First Intervention (7 Days)||6
361116|NCT02180646|887774|P1|STARTED|First Intervention (7 Days)||6
361117|NCT02180438|887784|P1|NOT COMPLETED|Overall Study||1
361118|NCT02180438|887784|P1|COMPLETED|Overall Study||29
361119|NCT02180438|887784|P1|STARTED|Overall Study||30
361120|NCT02180230|887795|P1|NOT COMPLETED|Overall Study||7
361121|NCT02180230|887795|P1|COMPLETED|Overall Study||31
361122|NCT02180230|887795|P1|STARTED|Overall Study||38
361123|NCT02180061|887802|P2|NOT COMPLETED|Overall Study||8
361124|NCT02180061|887803|P1|NOT COMPLETED|Overall Study||34
361125|NCT02180061|887802|P2|COMPLETED|Overall Study||0
361126|NCT02180061|887803|P1|COMPLETED|Overall Study||0
361127|NCT02180061|887802|P2|STARTED|Overall Study||8
361128|NCT02180061|887803|P1|STARTED|Overall Study||34
361129|NCT02179892|887819|P2|NOT COMPLETED|Overall Study||0
361130|NCT02179892|887820|P1|NOT COMPLETED|Overall Study||0
361131|NCT02179892|887819|P2|COMPLETED|Overall Study||4
361132|NCT02179892|887820|P1|COMPLETED|Overall Study||5
361133|NCT02179892|887819|P2|STARTED|Overall Study||4
361134|NCT02179892|887820|P1|STARTED|Overall Study||5
361135|NCT02179424|887836|P4|NOT COMPLETED|Overall Study||0
361136|NCT02179424|887837|P3|NOT COMPLETED|Overall Study||0
361137|NCT02179424|887838|P2|NOT COMPLETED|Overall Study||0
361138|NCT02179424|887839|P1|NOT COMPLETED|Overall Study||0
361139|NCT02179424|887836|P4|COMPLETED|Overall Study||39
361140|NCT02179424|887837|P3|COMPLETED|Overall Study||516
361141|NCT02179424|887838|P2|COMPLETED|Overall Study||11
361142|NCT02179424|887839|P1|COMPLETED|Overall Study||76
361143|NCT02179424|887836|P4|STARTED|Overall Study||39
361144|NCT02179424|887837|P3|STARTED|Overall Study||516
361145|NCT02179424|887838|P2|STARTED|Overall Study||11
361146|NCT02179424|887839|P1|STARTED|Overall Study||76
361147|NCT02179398|887856|P2|NOT COMPLETED|Overall Study||4
361148|NCT02179398|887857|P1|NOT COMPLETED|Overall Study||3
361149|NCT02179398|887856|P2|COMPLETED|Overall Study||140
361150|NCT02179398|887857|P1|COMPLETED|Overall Study||131
361151|NCT02179398|887856|P2|STARTED|Overall Study||144
361152|NCT02179398|887857|P1|STARTED|Overall Study||134
361153|NCT02178995|887877|P9|NOT COMPLETED|Open Label||0
361154|NCT02178995|887878|P8|NOT COMPLETED|Open Label||0
361155|NCT02178995|887879|P7|NOT COMPLETED|Open Label||0
361156|NCT02178995|887880|P6|NOT COMPLETED|Open Label||0
361157|NCT02178995|887881|P5|NOT COMPLETED|Open Label||0
361158|NCT02178995|887882|P4|NOT COMPLETED|Open Label||0
361159|NCT02178995|887883|P3|NOT COMPLETED|Open Label||0
361160|NCT02178995|887884|P2|NOT COMPLETED|Open Label||0
361161|NCT02178995|887885|P1|NOT COMPLETED|Open Label||2
361162|NCT02178995|887877|P9|COMPLETED|Open Label||0
361163|NCT02178995|887878|P8|COMPLETED|Open Label||0
361164|NCT02178995|887879|P7|COMPLETED|Open Label||0
361165|NCT02178995|887880|P6|COMPLETED|Open Label||0
361166|NCT02178995|887881|P5|COMPLETED|Open Label||0
361167|NCT02178995|887882|P4|COMPLETED|Open Label||0
361168|NCT02178995|887883|P3|COMPLETED|Open Label||0
361169|NCT02178995|887884|P2|COMPLETED|Open Label||14
361170|NCT02178995|887885|P1|COMPLETED|Open Label||28
361171|NCT02178995|887877|P9|STARTED|Open Label||0
361172|NCT02178995|887878|P8|STARTED|Open Label||0
361173|NCT02178995|887879|P7|STARTED|Open Label||0
361174|NCT02178995|887880|P6|STARTED|Open Label||0
361175|NCT02178995|887881|P5|STARTED|Open Label||0
361176|NCT02178995|887882|P4|STARTED|Open Label||0
361177|NCT02178995|887883|P3|STARTED|Open Label||0
361178|NCT02178995|887884|P2|STARTED|Open Label|One was lost to follow-up after completion of visit 4.|14
361179|NCT02178995|887885|P1|STARTED|Open Label|2 declined to join open-label. 1 withdrew from double-blind but rejoined open-label due to benefit.|30
361180|NCT02178995|887877|P9|NOT COMPLETED|Double Blind||1
361181|NCT02178995|887878|P8|NOT COMPLETED|Double Blind||2
361182|NCT02178995|887879|P7|NOT COMPLETED|Double Blind||0
361183|NCT02178995|887880|P6|NOT COMPLETED|Double Blind||1
361184|NCT02178995|887881|P5|NOT COMPLETED|Double Blind||0
361185|NCT02178995|887882|P4|NOT COMPLETED|Double Blind||0
361186|NCT02178995|887883|P3|NOT COMPLETED|Double Blind||0
361187|NCT02178995|887884|P2|NOT COMPLETED|Double Blind||1
361188|NCT02178995|887885|P1|NOT COMPLETED|Double Blind||0
361189|NCT02178995|887877|P9|COMPLETED|Double Blind||0
361190|NCT02178995|887878|P8|COMPLETED|Double Blind||4
361191|NCT02178995|887879|P7|COMPLETED|Double Blind||5
361192|NCT02178995|887880|P6|COMPLETED|Double Blind||5
361193|NCT02178995|887881|P5|COMPLETED|Double Blind||6
361194|NCT02178995|887882|P4|COMPLETED|Double Blind||6
361195|NCT02178995|887883|P3|COMPLETED|Double Blind||5
361196|NCT02178995|887884|P2|COMPLETED|Double Blind||15
361197|NCT02178995|887885|P1|COMPLETED|Double Blind||0
361198|NCT02178995|887877|P9|STARTED|Double Blind||1
361199|NCT02178995|887878|P8|STARTED|Double Blind||6
361200|NCT02178995|887879|P7|STARTED|Double Blind||5
361201|NCT02178995|887880|P6|STARTED|Double Blind||6
361202|NCT02178995|887881|P5|STARTED|Double Blind||6
361203|NCT02178995|887882|P4|STARTED|Double Blind||6
361204|NCT02178995|887883|P3|STARTED|Double Blind||5
361205|NCT02178995|887884|P2|STARTED|Double Blind||16
361206|NCT02178995|887885|P1|STARTED|Double Blind||0
361207|NCT02178787|887958|P2|NOT COMPLETED|Overall Study||9
361208|NCT02178787|887959|P1|NOT COMPLETED|Overall Study||5
361209|NCT02178787|887958|P2|COMPLETED|Overall Study||30
361210|NCT02178787|887959|P1|COMPLETED|Overall Study||30
361211|NCT02178787|887958|P2|STARTED|Overall Study||39
361212|NCT02178787|887959|P1|STARTED|Overall Study||35
361213|NCT02178696|887967|P2|NOT COMPLETED|Open-label Antidepressant||7
361214|NCT02178696|887968|P1|NOT COMPLETED|Open-label Antidepressant||6
361215|NCT02178696|887967|P2|COMPLETED|Open-label Antidepressant||13
361216|NCT02178696|887968|P1|COMPLETED|Open-label Antidepressant||14
361217|NCT02178696|887967|P2|STARTED|Open-label Antidepressant||20
361218|NCT02178696|887968|P1|STARTED|Open-label Antidepressant||20
361219|NCT02178696|887967|P2|NOT COMPLETED|Second Assignment After Crossover||0
361220|NCT02178696|887968|P1|NOT COMPLETED|Second Assignment After Crossover||0
361221|NCT02178696|887967|P2|COMPLETED|Second Assignment After Crossover||20
361222|NCT02178696|887968|P1|COMPLETED|Second Assignment After Crossover||20
361223|NCT02178696|887967|P2|STARTED|Second Assignment After Crossover||20
361224|NCT02178696|887968|P1|STARTED|Second Assignment After Crossover||20
361225|NCT02178696|887967|P2|NOT COMPLETED|First Assignment and Washout||0
361226|NCT02178696|887968|P1|NOT COMPLETED|First Assignment and Washout||0
361227|NCT02178696|887967|P2|COMPLETED|First Assignment and Washout||20
361228|NCT02178696|887968|P1|COMPLETED|First Assignment and Washout||20
361229|NCT02178696|887967|P2|STARTED|First Assignment and Washout||20
361230|NCT02178696|887968|P1|STARTED|First Assignment and Washout||20
361231|NCT02178540|887981|P1|NOT COMPLETED|Overall Study||0
361232|NCT02178540|887981|P1|COMPLETED|Overall Study||45
361233|NCT02178540|887981|P1|STARTED|Overall Study||45
361234|NCT02178059|887988|P2|NOT COMPLETED|Second Intervention||0
361235|NCT02178059|887989|P1|NOT COMPLETED|Second Intervention||0
361236|NCT02178059|887988|P2|COMPLETED|Second Intervention||17
361237|NCT02178059|887989|P1|COMPLETED|Second Intervention||16
361238|NCT02178059|887988|P2|STARTED|Second Intervention||17
361239|NCT02178059|887989|P1|STARTED|Second Intervention||16
361240|NCT02178059|887988|P2|NOT COMPLETED|Washout||0
361241|NCT02178059|887989|P1|NOT COMPLETED|Washout||1
361242|NCT02178059|887988|P2|COMPLETED|Washout||17
361243|NCT02178059|887989|P1|COMPLETED|Washout||16
361244|NCT02178059|887988|P2|STARTED|Washout||17
361245|NCT02178059|887989|P1|STARTED|Washout||17
361246|NCT02178059|887988|P2|NOT COMPLETED|First Intervention||0
361247|NCT02178059|887989|P1|NOT COMPLETED|First Intervention||0
361248|NCT02178059|887988|P2|COMPLETED|First Intervention||17
361249|NCT02178059|887989|P1|COMPLETED|First Intervention||17
361250|NCT02178059|887988|P2|STARTED|First Intervention||17
361251|NCT02178059|887989|P1|STARTED|First Intervention||17
361252|NCT02177266|888007|P2|NOT COMPLETED|Overall Study||1
361253|NCT02177266|888008|P1|NOT COMPLETED|Overall Study||1
361254|NCT02177266|888007|P2|COMPLETED|Overall Study||0
361255|NCT02177266|888008|P1|COMPLETED|Overall Study||0
361256|NCT02177266|888007|P2|STARTED|Overall Study||1
361257|NCT02177266|888008|P1|STARTED|Overall Study||1
361258|NCT02177201|888020|P2|NOT COMPLETED|Overall Study||3
361259|NCT02177201|888021|P1|NOT COMPLETED|Overall Study||3
361260|NCT02177201|888020|P2|COMPLETED|Overall Study||77
361261|NCT02177201|888021|P1|COMPLETED|Overall Study||77
361262|NCT02177201|888020|P2|STARTED|Overall Study||80
361263|NCT02177201|888021|P1|STARTED|Overall Study||80
361264|NCT02177136|888030|P3|NOT COMPLETED|Overall Study||4
361265|NCT02177136|888031|P2|NOT COMPLETED|Overall Study||5
361266|NCT02177136|888032|P1|NOT COMPLETED|Overall Study||6
361267|NCT02177136|888030|P3|COMPLETED|Overall Study||21
361268|NCT02177136|888031|P2|COMPLETED|Overall Study||21
361269|NCT02177136|888032|P1|COMPLETED|Overall Study||19
361270|NCT02177136|888030|P3|STARTED|Overall Study||25
361271|NCT02177136|888031|P2|STARTED|Overall Study||26
361272|NCT02177136|888032|P1|STARTED|Overall Study||25
361273|NCT02177032|888065|P4|NOT COMPLETED|Overall Study||0
361274|NCT02177032|888066|P3|NOT COMPLETED|Overall Study||3
361275|NCT02177032|888067|P2|NOT COMPLETED|Overall Study||2
361276|NCT02177032|888068|P1|NOT COMPLETED|Overall Study||5
361277|NCT02177032|888065|P4|COMPLETED|Overall Study||88
361278|NCT02177032|888066|P3|COMPLETED|Overall Study||351
361279|NCT02177032|888067|P2|COMPLETED|Overall Study||86
361280|NCT02177032|888068|P1|COMPLETED|Overall Study||350
361281|NCT02177032|888065|P4|STARTED|Overall Study||88
361282|NCT02177032|888066|P3|STARTED|Overall Study||354
361283|NCT02177032|888067|P2|STARTED|Overall Study||88
361284|NCT02177032|888068|P1|STARTED|Overall Study||355
361285|NCT02176837|888102|P1|NOT COMPLETED|Overall Study||6
361286|NCT02176837|888102|P1|COMPLETED|Overall Study||0
361287|NCT02176837|888102|P1|STARTED|Overall Study||6
361288|NCT02176655|888106|P1|NOT COMPLETED|Overall Study||6
361289|NCT02176655|888106|P1|COMPLETED|Overall Study||25
361290|NCT02176655|888106|P1|STARTED|Overall Study||31
361291|NCT02176642|888129|P2|NOT COMPLETED|Overall Study||1
361292|NCT02176642|888130|P1|NOT COMPLETED|Overall Study||0
361293|NCT02176642|888129|P2|COMPLETED|Overall Study||16
361294|NCT02176642|888130|P1|COMPLETED|Overall Study||18
361295|NCT02176642|888129|P2|STARTED|Overall Study||17
361296|NCT02176642|888130|P1|STARTED|Overall Study||18
361297|NCT02176525|888160|P8|NOT COMPLETED|Overall Study||0
361298|NCT02176525|888161|P7|NOT COMPLETED|Overall Study||1
361299|NCT02176525|888162|P6|NOT COMPLETED|Overall Study||1
361300|NCT02176525|888163|P5|NOT COMPLETED|Overall Study||1
361301|NCT02176525|888164|P4|NOT COMPLETED|Overall Study||1
361302|NCT02176525|888165|P3|NOT COMPLETED|Overall Study||0
361303|NCT02176525|888166|P2|NOT COMPLETED|Overall Study||0
361304|NCT02176525|888167|P1|NOT COMPLETED|Overall Study||1
361305|NCT02176525|888160|P8|COMPLETED|Overall Study||10
361306|NCT02176525|888161|P7|COMPLETED|Overall Study||8
361307|NCT02176525|888162|P6|COMPLETED|Overall Study||5
361308|NCT02176525|888163|P5|COMPLETED|Overall Study||7
361309|NCT02176525|888164|P4|COMPLETED|Overall Study||8
361310|NCT02176525|888165|P3|COMPLETED|Overall Study||9
361311|NCT02176525|888166|P2|COMPLETED|Overall Study||9
361312|NCT02176525|888167|P1|COMPLETED|Overall Study||14
361313|NCT02176525|888160|P8|STARTED|Overall Study||10
361314|NCT02176525|888161|P7|STARTED|Overall Study||9
361315|NCT02176525|888162|P6|STARTED|Overall Study|6 subjects randomized, 5 subjects treated with at least one dose, 1 subject was not treated|6
361316|NCT02176525|888163|P5|STARTED|Overall Study||8
361317|NCT02176525|888164|P4|STARTED|Overall Study||9
361318|NCT02176525|888165|P3|STARTED|Overall Study||9
361319|NCT02176525|888166|P2|STARTED|Overall Study||9
361320|NCT02176525|888167|P1|STARTED|Overall Study|15 subjects randomized, 14 subjects treated with at least one dose, 1 subject was not treated|15
361321|NCT02176421|888344|P1|NOT COMPLETED|Overall Study||5
361322|NCT02176421|888344|P1|COMPLETED|Overall Study||75
361323|NCT02176421|888344|P1|STARTED|Overall Study||80
361324|NCT02176356|888353|P1|NOT COMPLETED|Overall Study||23
361325|NCT02176356|888353|P1|COMPLETED|Overall Study||93
361326|NCT02176356|888353|P1|Eligible and Received Treatment|Overall Study||100
361327|NCT02176356|888353|P1|STARTED|Overall Study||116
361328|NCT02176343|888370|P1|NOT COMPLETED|Overall Study||0
361329|NCT02176343|888370|P1|COMPLETED|Overall Study||31
361330|NCT02176343|888370|P1|STARTED|Overall Study||31
361331|NCT02176018|888383|P2|NOT COMPLETED|Overall Study||6
361332|NCT02176018|888384|P1|NOT COMPLETED|Overall Study||5
361333|NCT02176018|888383|P2|COMPLETED|Overall Study||17
361334|NCT02176018|888384|P1|COMPLETED|Overall Study||17
361335|NCT02176018|888383|P2|STARTED|Overall Study||23
361336|NCT02176018|888384|P1|STARTED|Overall Study||22
361337|NCT02175771|888416|P9|NOT COMPLETED|Treatment Period||6
361338|NCT02175771|888417|P8|NOT COMPLETED|Treatment Period||17
361339|NCT02175771|888418|P7|NOT COMPLETED|Treatment Period||5
361340|NCT02175771|888419|P6|NOT COMPLETED|Treatment Period||10
361341|NCT02175771|888420|P5|NOT COMPLETED|Treatment Period||5
361342|NCT02175771|888421|P4|NOT COMPLETED|Treatment Period||13
361343|NCT02175771|888422|P3|NOT COMPLETED|Treatment Period||7
361344|NCT02175771|888423|P2|NOT COMPLETED|Treatment Period||16
361345|NCT02175771|888424|P1|NOT COMPLETED|Treatment Period||0
361346|NCT02175771|888416|P9|COMPLETED|Treatment Period||38
361347|NCT02175771|888417|P8|COMPLETED|Treatment Period||116
361348|NCT02175771|888418|P7|COMPLETED|Treatment Period||36
361349|NCT02175771|888419|P6|COMPLETED|Treatment Period||110
361350|NCT02175771|888420|P5|COMPLETED|Treatment Period||36
361351|NCT02175771|888421|P4|COMPLETED|Treatment Period||113
361352|NCT02175771|888422|P3|COMPLETED|Treatment Period||35
361353|NCT02175771|888423|P2|COMPLETED|Treatment Period||111
361354|NCT02175771|888424|P1|COMPLETED|Treatment Period||0
361355|NCT02175771|888416|P9|STARTED|Treatment Period||44
361356|NCT02175771|888417|P8|STARTED|Treatment Period||133
361357|NCT02175771|888418|P7|STARTED|Treatment Period||41
361358|NCT02175771|888419|P6|STARTED|Treatment Period||120
361359|NCT02175771|888420|P5|STARTED|Treatment Period||41
361360|NCT02175771|888421|P4|STARTED|Treatment Period||126
361361|NCT02175771|888422|P3|STARTED|Treatment Period||42
361362|NCT02175771|888423|P2|STARTED|Treatment Period||127
361363|NCT02175771|888424|P1|STARTED|Treatment Period||0
361364|NCT02175771|888416|P9|NOT COMPLETED|Run-In Period (Pre-assignment)||0
361365|NCT02175771|888417|P8|NOT COMPLETED|Run-In Period (Pre-assignment)||0
361366|NCT02175771|888418|P7|NOT COMPLETED|Run-In Period (Pre-assignment)||0
361367|NCT02175771|888419|P6|NOT COMPLETED|Run-In Period (Pre-assignment)||0
361368|NCT02175771|888420|P5|NOT COMPLETED|Run-In Period (Pre-assignment)||0
361369|NCT02175771|888421|P4|NOT COMPLETED|Run-In Period (Pre-assignment)||0
361370|NCT02175771|888422|P3|NOT COMPLETED|Run-In Period (Pre-assignment)||0
361371|NCT02175771|888423|P2|NOT COMPLETED|Run-In Period (Pre-assignment)||0
361372|NCT02175771|888424|P1|NOT COMPLETED|Run-In Period (Pre-assignment)||84
361373|NCT02175771|888416|P9|COMPLETED|Run-In Period (Pre-assignment)||0
361374|NCT02175771|888417|P8|COMPLETED|Run-In Period (Pre-assignment)||0
361375|NCT02175771|888418|P7|COMPLETED|Run-In Period (Pre-assignment)||0
361376|NCT02175771|888419|P6|COMPLETED|Run-In Period (Pre-assignment)||0
361377|NCT02175771|888420|P5|COMPLETED|Run-In Period (Pre-assignment)||0
361378|NCT02175771|888421|P4|COMPLETED|Run-In Period (Pre-assignment)||0
361379|NCT02175771|888422|P3|COMPLETED|Run-In Period (Pre-assignment)||0
361380|NCT02175771|888423|P2|COMPLETED|Run-In Period (Pre-assignment)||0
361381|NCT02175771|888424|P1|COMPLETED|Run-In Period (Pre-assignment)||674
361382|NCT02175771|888416|P9|STARTED|Run-In Period (Pre-assignment)||0
361383|NCT02175771|888417|P8|STARTED|Run-In Period (Pre-assignment)||0
361384|NCT02175771|888418|P7|STARTED|Run-In Period (Pre-assignment)||0
361385|NCT02175771|888419|P6|STARTED|Run-In Period (Pre-assignment)||0
361386|NCT02175771|888420|P5|STARTED|Run-In Period (Pre-assignment)||0
361387|NCT02175771|888421|P4|STARTED|Run-In Period (Pre-assignment)||0
361388|NCT02175771|888422|P3|STARTED|Run-In Period (Pre-assignment)||0
361389|NCT02175771|888423|P2|STARTED|Run-In Period (Pre-assignment)||0
361390|NCT02175771|888424|P1|STARTED|Run-In Period (Pre-assignment)|Enrolled; two participants were enrolled but had no enrollment date in their records.|758
361391|NCT02175745|888482|P1|NOT COMPLETED|Overall Study||1
361392|NCT02175745|888482|P1|COMPLETED|Overall Study||1
361393|NCT02175745|888482|P1|STARTED|Overall Study||2
361394|NCT02175368|888487|P1|NOT COMPLETED|Overall Study||1
361395|NCT02175368|888487|P1|COMPLETED|Overall Study||27
361396|NCT02175368|888487|P1|STARTED|Overall Study||28
361397|NCT02175212|888493|P2|NOT COMPLETED|Overall Study||147
361398|NCT02175212|888494|P1|NOT COMPLETED|Overall Study||163
361399|NCT02175212|888493|P2|COMPLETED|Overall Study||31
361400|NCT02175212|888494|P1|COMPLETED|Overall Study||14
361401|NCT02175212|888493|P2|STARTED|Overall Study||178
361402|NCT02175212|888494|P1|STARTED|Overall Study||177
361403|NCT02175199|888510|P2|NOT COMPLETED|Overall Study||5
361404|NCT02175199|888511|P1|NOT COMPLETED|Overall Study||3
361405|NCT02175199|888510|P2|COMPLETED|Overall Study||71
361406|NCT02175199|888511|P1|COMPLETED|Overall Study||71
361407|NCT02175199|888510|P2|Dispensed|Overall Study|Two subjects were randomized but never dispensed study lenses.|74
361408|NCT02175199|888511|P1|Dispensed|Overall Study|Two subjects were randomized but never dispensed study lenses.|72
361409|NCT02175199|888510|P2|STARTED|Overall Study||76
361410|NCT02175199|888511|P1|STARTED|Overall Study||74
361411|NCT02175121|888525|P5|NOT COMPLETED|Overall Study||1
361412|NCT02175121|888526|P4|NOT COMPLETED|Overall Study||1
361413|NCT02175121|888527|P3|NOT COMPLETED|Overall Study||2
361414|NCT02175121|888528|P2|NOT COMPLETED|Overall Study||1
361415|NCT02175121|888529|P1|NOT COMPLETED|Overall Study||1
361416|NCT02175121|888525|P5|COMPLETED|Overall Study||33
361417|NCT02175121|888526|P4|COMPLETED|Overall Study||34
361418|NCT02175121|888527|P3|COMPLETED|Overall Study||32
361419|NCT02175121|888528|P2|COMPLETED|Overall Study||34
361420|NCT02175121|888529|P1|COMPLETED|Overall Study||33
361421|NCT02175121|888525|P5|STARTED|Overall Study||34
361422|NCT02175121|888526|P4|STARTED|Overall Study||35
361423|NCT02175121|888527|P3|STARTED|Overall Study||34
361424|NCT02175121|888528|P2|STARTED|Overall Study||35
361425|NCT02175121|888529|P1|STARTED|Overall Study||34
361426|NCT02174861|888656|P1|NOT COMPLETED|Overall Study||158
361427|NCT02174861|888656|P1|COMPLETED|Overall Study||451
361428|NCT02174861|888656|P1|Enrolled in CHU Substudy|Overall Study||53
361429|NCT02174861|888656|P1|STARTED|Overall Study||609
361430|NCT02173769|888668|P1|NOT COMPLETED|Overall Study||4
361431|NCT02173769|888668|P1|COMPLETED|Overall Study||1854
361432|NCT02173769|888668|P1|STARTED|Overall Study||1858
361433|NCT02173704|888681|P2|NOT COMPLETED|Overall Study||4
361434|NCT02173704|888682|P1|NOT COMPLETED|Overall Study||13
361435|NCT02173704|888681|P2|COMPLETED|Overall Study||71
361436|NCT02173704|888682|P1|COMPLETED|Overall Study||137
361437|NCT02173704|888681|P2|STARTED|Overall Study||75
361438|NCT02173704|888682|P1|STARTED|Overall Study||150
361439|NCT02173548|888708|P2|NOT COMPLETED|Overall Study||2
361440|NCT02173548|888709|P1|NOT COMPLETED|Overall Study||1
361441|NCT02173548|888708|P2|COMPLETED|Overall Study||8
361442|NCT02173548|888709|P1|COMPLETED|Overall Study||20
361443|NCT02173548|888708|P2|STARTED|Overall Study||10
361444|NCT02173548|888709|P1|STARTED|Overall Study||21
361445|NCT02173535|888749|P20|NOT COMPLETED|Period 5||0
361446|NCT02173535|888750|P19|NOT COMPLETED|Period 5||0
361447|NCT02173535|888751|P18|NOT COMPLETED|Period 5||0
361448|NCT02173535|888752|P17|NOT COMPLETED|Period 5||0
361449|NCT02173535|888753|P16|NOT COMPLETED|Period 5||0
361450|NCT02173535|888754|P15|NOT COMPLETED|Period 5||0
361451|NCT02173535|888755|P14|NOT COMPLETED|Period 5||0
361452|NCT02173535|888756|P13|NOT COMPLETED|Period 5||0
361453|NCT02173535|888757|P12|NOT COMPLETED|Period 5||0
361454|NCT02173535|888758|P11|NOT COMPLETED|Period 5||0
361455|NCT02173535|888759|P10|NOT COMPLETED|Period 5||0
361456|NCT02173535|888760|P9|NOT COMPLETED|Period 5||0
361457|NCT02173535|888761|P8|NOT COMPLETED|Period 5||0
361458|NCT02173535|888762|P7|NOT COMPLETED|Period 5||0
361459|NCT02173535|888763|P6|NOT COMPLETED|Period 5||0
361460|NCT02173535|888764|P5|NOT COMPLETED|Period 5||0
361461|NCT02173535|888765|P4|NOT COMPLETED|Period 5||0
361462|NCT02173535|888766|P3|NOT COMPLETED|Period 5||0
361463|NCT02173535|888767|P2|NOT COMPLETED|Period 5||0
361464|NCT02173535|888768|P1|NOT COMPLETED|Period 5||0
361465|NCT02173535|888749|P20|COMPLETED|Period 5||12
361466|NCT02173535|888750|P19|COMPLETED|Period 5||12
361467|NCT02173535|888751|P18|COMPLETED|Period 5||12
361468|NCT02173535|888752|P17|COMPLETED|Period 5||12
361469|NCT02173535|888753|P16|COMPLETED|Period 5||12
361470|NCT02173535|888754|P15|COMPLETED|Period 5||12
361471|NCT02173535|888755|P14|COMPLETED|Period 5||12
361472|NCT02173535|888756|P13|COMPLETED|Period 5||12
361473|NCT02173535|888757|P12|COMPLETED|Period 5||12
361474|NCT02173535|888758|P11|COMPLETED|Period 5||12
361475|NCT02173535|888759|P10|COMPLETED|Period 5||12
361476|NCT02173535|888760|P9|COMPLETED|Period 5||12
361477|NCT02173535|888761|P8|COMPLETED|Period 5||12
361478|NCT02173535|888762|P7|COMPLETED|Period 5||12
361479|NCT02173535|888763|P6|COMPLETED|Period 5||12
361480|NCT02173535|888764|P5|COMPLETED|Period 5||12
361481|NCT02173535|888765|P4|COMPLETED|Period 5||12
361482|NCT02173535|888766|P3|COMPLETED|Period 5||12
361483|NCT02173535|888767|P2|COMPLETED|Period 5||12
361484|NCT02173535|888768|P1|COMPLETED|Period 5||12
361485|NCT02173535|888749|P20|STARTED|Period 5||12
361486|NCT02173535|888750|P19|STARTED|Period 5||12
361487|NCT02173535|888751|P18|STARTED|Period 5||12
361488|NCT02173535|888752|P17|STARTED|Period 5||12
361489|NCT02173535|888753|P16|STARTED|Period 5||12
361490|NCT02173535|888754|P15|STARTED|Period 5||12
361491|NCT02173535|888755|P14|STARTED|Period 5||12
361492|NCT02173535|888756|P13|STARTED|Period 5||12
361493|NCT02173535|888757|P12|STARTED|Period 5||12
361494|NCT02173535|888758|P11|STARTED|Period 5||12
361495|NCT02173535|888759|P10|STARTED|Period 5||12
361496|NCT02173535|888760|P9|STARTED|Period 5||12
361497|NCT02173535|888761|P8|STARTED|Period 5||12
361498|NCT02173535|888762|P7|STARTED|Period 5||12
361499|NCT02173535|888763|P6|STARTED|Period 5||12
361500|NCT02173535|888764|P5|STARTED|Period 5||12
361501|NCT02173535|888765|P4|STARTED|Period 5||12
361502|NCT02173535|888766|P3|STARTED|Period 5||12
361503|NCT02173535|888767|P2|STARTED|Period 5||12
361504|NCT02173535|888768|P1|STARTED|Period 5||12
361505|NCT02173535|888749|P20|NOT COMPLETED|Period 4||0
361506|NCT02173535|888750|P19|NOT COMPLETED|Period 4||0
361507|NCT02173535|888751|P18|NOT COMPLETED|Period 4||0
361508|NCT02173535|888752|P17|NOT COMPLETED|Period 4||0
361509|NCT02173535|888753|P16|NOT COMPLETED|Period 4||0
361510|NCT02173535|888754|P15|NOT COMPLETED|Period 4||0
361511|NCT02173535|888755|P14|NOT COMPLETED|Period 4||0
361512|NCT02173535|888756|P13|NOT COMPLETED|Period 4||0
361513|NCT02173535|888757|P12|NOT COMPLETED|Period 4||0
361514|NCT02173535|888758|P11|NOT COMPLETED|Period 4||0
361515|NCT02173535|888759|P10|NOT COMPLETED|Period 4||0
361516|NCT02173535|888760|P9|NOT COMPLETED|Period 4||0
361517|NCT02173535|888761|P8|NOT COMPLETED|Period 4||0
361518|NCT02173535|888762|P7|NOT COMPLETED|Period 4||0
361519|NCT02173535|888763|P6|NOT COMPLETED|Period 4||0
361520|NCT02173535|888764|P5|NOT COMPLETED|Period 4||0
361521|NCT02173535|888765|P4|NOT COMPLETED|Period 4||0
361522|NCT02173535|888766|P3|NOT COMPLETED|Period 4||0
361523|NCT02173535|888767|P2|NOT COMPLETED|Period 4||0
361524|NCT02173535|888768|P1|NOT COMPLETED|Period 4||0
361525|NCT02173535|888749|P20|COMPLETED|Period 4||12
361526|NCT02173535|888750|P19|COMPLETED|Period 4||12
361527|NCT02173535|888751|P18|COMPLETED|Period 4||12
361528|NCT02173535|888752|P17|COMPLETED|Period 4||12
361529|NCT02173535|888753|P16|COMPLETED|Period 4||12
361530|NCT02173535|888754|P15|COMPLETED|Period 4||12
361531|NCT02173535|888755|P14|COMPLETED|Period 4||12
361532|NCT02173535|888756|P13|COMPLETED|Period 4||12
361533|NCT02173535|888757|P12|COMPLETED|Period 4||12
361534|NCT02173535|888758|P11|COMPLETED|Period 4||12
361535|NCT02173535|888759|P10|COMPLETED|Period 4||12
361536|NCT02173535|888760|P9|COMPLETED|Period 4||12
361537|NCT02173535|888761|P8|COMPLETED|Period 4||12
361538|NCT02173535|888762|P7|COMPLETED|Period 4||12
361539|NCT02173535|888763|P6|COMPLETED|Period 4||12
361540|NCT02173535|888764|P5|COMPLETED|Period 4||12
361541|NCT02173535|888765|P4|COMPLETED|Period 4||12
361542|NCT02173535|888766|P3|COMPLETED|Period 4||12
361543|NCT02173535|888767|P2|COMPLETED|Period 4||12
361544|NCT02173535|888768|P1|COMPLETED|Period 4||12
361545|NCT02173535|888749|P20|STARTED|Period 4||12
361546|NCT02173535|888750|P19|STARTED|Period 4||12
361547|NCT02173535|888751|P18|STARTED|Period 4||12
361548|NCT02173535|888752|P17|STARTED|Period 4||12
361549|NCT02173535|888753|P16|STARTED|Period 4||12
361550|NCT02173535|888754|P15|STARTED|Period 4||12
361551|NCT02173535|888755|P14|STARTED|Period 4||12
361552|NCT02173535|888756|P13|STARTED|Period 4||12
361553|NCT02173535|888757|P12|STARTED|Period 4||12
361554|NCT02173535|888758|P11|STARTED|Period 4||12
361555|NCT02173535|888759|P10|STARTED|Period 4||12
361556|NCT02173535|888760|P9|STARTED|Period 4||12
361557|NCT02173535|888761|P8|STARTED|Period 4||12
361558|NCT02173535|888762|P7|STARTED|Period 4||12
361559|NCT02173535|888763|P6|STARTED|Period 4||12
361560|NCT02173535|888764|P5|STARTED|Period 4||12
361561|NCT02173535|888765|P4|STARTED|Period 4||12
361562|NCT02173535|888766|P3|STARTED|Period 4||12
361563|NCT02173535|888767|P2|STARTED|Period 4||12
361564|NCT02173535|888768|P1|STARTED|Period 4||12
361565|NCT02173535|888749|P20|NOT COMPLETED|Period 3||0
361566|NCT02173535|888750|P19|NOT COMPLETED|Period 3||0
361567|NCT02173535|888751|P18|NOT COMPLETED|Period 3||0
361568|NCT02173535|888752|P17|NOT COMPLETED|Period 3||0
361569|NCT02173535|888753|P16|NOT COMPLETED|Period 3||0
361570|NCT02173535|888754|P15|NOT COMPLETED|Period 3||0
361571|NCT02173535|888755|P14|NOT COMPLETED|Period 3||0
361572|NCT02173535|888756|P13|NOT COMPLETED|Period 3||0
361573|NCT02173535|888757|P12|NOT COMPLETED|Period 3||0
361574|NCT02173535|888758|P11|NOT COMPLETED|Period 3||0
361575|NCT02173535|888759|P10|NOT COMPLETED|Period 3||0
361576|NCT02173535|888760|P9|NOT COMPLETED|Period 3||0
361577|NCT02173535|888761|P8|NOT COMPLETED|Period 3||0
361578|NCT02173535|888762|P7|NOT COMPLETED|Period 3||0
361579|NCT02173535|888763|P6|NOT COMPLETED|Period 3||0
361580|NCT02173535|888764|P5|NOT COMPLETED|Period 3||0
361581|NCT02173535|888765|P4|NOT COMPLETED|Period 3||0
361582|NCT02173535|888766|P3|NOT COMPLETED|Period 3||0
361583|NCT02173535|888767|P2|NOT COMPLETED|Period 3||0
361584|NCT02173535|888768|P1|NOT COMPLETED|Period 3||0
361585|NCT02173535|888749|P20|COMPLETED|Period 3||12
361586|NCT02173535|888750|P19|COMPLETED|Period 3||12
361587|NCT02173535|888751|P18|COMPLETED|Period 3||12
361588|NCT02173535|888752|P17|COMPLETED|Period 3||12
361589|NCT02173535|888753|P16|COMPLETED|Period 3||12
361590|NCT02173535|888754|P15|COMPLETED|Period 3||12
361591|NCT02173535|888755|P14|COMPLETED|Period 3||12
361592|NCT02173535|888756|P13|COMPLETED|Period 3||12
361593|NCT02173535|888757|P12|COMPLETED|Period 3||12
361594|NCT02173535|888758|P11|COMPLETED|Period 3||12
361595|NCT02173535|888759|P10|COMPLETED|Period 3||12
361596|NCT02173535|888760|P9|COMPLETED|Period 3||12
361597|NCT02173535|888761|P8|COMPLETED|Period 3||12
361598|NCT02173535|888762|P7|COMPLETED|Period 3||12
361599|NCT02173535|888763|P6|COMPLETED|Period 3||12
361600|NCT02173535|888764|P5|COMPLETED|Period 3||12
361601|NCT02173535|888765|P4|COMPLETED|Period 3||12
361602|NCT02173535|888766|P3|COMPLETED|Period 3||12
361603|NCT02173535|888767|P2|COMPLETED|Period 3||12
361604|NCT02173535|888768|P1|COMPLETED|Period 3||12
361605|NCT02173535|888749|P20|STARTED|Period 3||12
361606|NCT02173535|888750|P19|STARTED|Period 3||12
361607|NCT02173535|888751|P18|STARTED|Period 3||12
361608|NCT02173535|888752|P17|STARTED|Period 3||12
361609|NCT02173535|888753|P16|STARTED|Period 3||12
361610|NCT02173535|888754|P15|STARTED|Period 3||12
361611|NCT02173535|888755|P14|STARTED|Period 3||12
361612|NCT02173535|888756|P13|STARTED|Period 3||12
361613|NCT02173535|888757|P12|STARTED|Period 3||12
361614|NCT02173535|888758|P11|STARTED|Period 3||12
361615|NCT02173535|888759|P10|STARTED|Period 3||12
361616|NCT02173535|888760|P9|STARTED|Period 3||12
361617|NCT02173535|888761|P8|STARTED|Period 3||12
361618|NCT02173535|888762|P7|STARTED|Period 3||12
361619|NCT02173535|888763|P6|STARTED|Period 3||12
361620|NCT02173535|888764|P5|STARTED|Period 3||12
361621|NCT02173535|888765|P4|STARTED|Period 3||12
361622|NCT02173535|888766|P3|STARTED|Period 3||12
361623|NCT02173535|888767|P2|STARTED|Period 3||12
361624|NCT02173535|888768|P1|STARTED|Period 3||12
361625|NCT02173535|888749|P20|NOT COMPLETED|Period 2||0
361626|NCT02173535|888750|P19|NOT COMPLETED|Period 2||0
361627|NCT02173535|888751|P18|NOT COMPLETED|Period 2||0
361628|NCT02173535|888752|P17|NOT COMPLETED|Period 2||0
361629|NCT02173535|888753|P16|NOT COMPLETED|Period 2||0
361630|NCT02173535|888754|P15|NOT COMPLETED|Period 2||0
361631|NCT02173535|888755|P14|NOT COMPLETED|Period 2||0
361632|NCT02173535|888756|P13|NOT COMPLETED|Period 2||0
361633|NCT02173535|888757|P12|NOT COMPLETED|Period 2||0
361634|NCT02173535|888758|P11|NOT COMPLETED|Period 2||0
361635|NCT02173535|888759|P10|NOT COMPLETED|Period 2||0
361636|NCT02173535|888760|P9|NOT COMPLETED|Period 2||0
361637|NCT02173535|888761|P8|NOT COMPLETED|Period 2||0
361638|NCT02173535|888762|P7|NOT COMPLETED|Period 2||0
361639|NCT02173535|888763|P6|NOT COMPLETED|Period 2||0
361640|NCT02173535|888764|P5|NOT COMPLETED|Period 2||0
361641|NCT02173535|888765|P4|NOT COMPLETED|Period 2||0
361642|NCT02173535|888766|P3|NOT COMPLETED|Period 2||0
361643|NCT02173535|888767|P2|NOT COMPLETED|Period 2||0
361644|NCT02173535|888768|P1|NOT COMPLETED|Period 2||0
361645|NCT02173535|888749|P20|COMPLETED|Period 2||12
361646|NCT02173535|888750|P19|COMPLETED|Period 2||12
361647|NCT02173535|888751|P18|COMPLETED|Period 2||12
361648|NCT02173535|888752|P17|COMPLETED|Period 2||12
361649|NCT02173535|888753|P16|COMPLETED|Period 2||12
361650|NCT02173535|888754|P15|COMPLETED|Period 2||12
361651|NCT02173535|888755|P14|COMPLETED|Period 2||12
361652|NCT02173535|888756|P13|COMPLETED|Period 2||12
361653|NCT02173535|888757|P12|COMPLETED|Period 2||12
361654|NCT02173535|888758|P11|COMPLETED|Period 2||12
361655|NCT02173535|888759|P10|COMPLETED|Period 2||12
361656|NCT02173535|888760|P9|COMPLETED|Period 2||12
361657|NCT02173535|888761|P8|COMPLETED|Period 2||12
361658|NCT02173535|888762|P7|COMPLETED|Period 2||12
361659|NCT02173535|888763|P6|COMPLETED|Period 2||12
361660|NCT02173535|888764|P5|COMPLETED|Period 2||12
361661|NCT02173535|888765|P4|COMPLETED|Period 2||12
361662|NCT02173535|888766|P3|COMPLETED|Period 2||12
361663|NCT02173535|888767|P2|COMPLETED|Period 2||12
361664|NCT02173535|888768|P1|COMPLETED|Period 2||12
361665|NCT02173535|888749|P20|STARTED|Period 2||12
361666|NCT02173535|888750|P19|STARTED|Period 2||12
361667|NCT02173535|888751|P18|STARTED|Period 2||12
361668|NCT02173535|888752|P17|STARTED|Period 2||12
361669|NCT02173535|888753|P16|STARTED|Period 2||12
361670|NCT02173535|888754|P15|STARTED|Period 2||12
361671|NCT02173535|888755|P14|STARTED|Period 2||12
361672|NCT02173535|888756|P13|STARTED|Period 2||12
361673|NCT02173535|888757|P12|STARTED|Period 2||12
361674|NCT02173535|888758|P11|STARTED|Period 2||12
361675|NCT02173535|888759|P10|STARTED|Period 2||12
361676|NCT02173535|888760|P9|STARTED|Period 2||12
361677|NCT02173535|888761|P8|STARTED|Period 2||12
361678|NCT02173535|888762|P7|STARTED|Period 2||12
361679|NCT02173535|888763|P6|STARTED|Period 2||12
361680|NCT02173535|888764|P5|STARTED|Period 2||12
361681|NCT02173535|888765|P4|STARTED|Period 2||12
361682|NCT02173535|888766|P3|STARTED|Period 2||12
361683|NCT02173535|888767|P2|STARTED|Period 2||12
361684|NCT02173535|888768|P1|STARTED|Period 2||12
361685|NCT02173535|888749|P20|NOT COMPLETED|Period 1||0
361686|NCT02173535|888750|P19|NOT COMPLETED|Period 1||0
361687|NCT02173535|888751|P18|NOT COMPLETED|Period 1||0
361688|NCT02173535|888752|P17|NOT COMPLETED|Period 1||0
361689|NCT02173535|888753|P16|NOT COMPLETED|Period 1||0
361690|NCT02173535|888754|P15|NOT COMPLETED|Period 1||0
361691|NCT02173535|888755|P14|NOT COMPLETED|Period 1||0
361692|NCT02173535|888756|P13|NOT COMPLETED|Period 1||0
361693|NCT02173535|888757|P12|NOT COMPLETED|Period 1||0
361694|NCT02173535|888758|P11|NOT COMPLETED|Period 1||0
361695|NCT02173535|888759|P10|NOT COMPLETED|Period 1||0
361696|NCT02173535|888760|P9|NOT COMPLETED|Period 1||0
361697|NCT02173535|888761|P8|NOT COMPLETED|Period 1||0
361698|NCT02173535|888762|P7|NOT COMPLETED|Period 1||0
361699|NCT02173535|888763|P6|NOT COMPLETED|Period 1||0
361700|NCT02173535|888764|P5|NOT COMPLETED|Period 1||0
361701|NCT02173535|888765|P4|NOT COMPLETED|Period 1||0
361702|NCT02173535|888766|P3|NOT COMPLETED|Period 1||0
361703|NCT02173535|888767|P2|NOT COMPLETED|Period 1||0
361704|NCT02173535|888768|P1|NOT COMPLETED|Period 1||0
361705|NCT02173535|888749|P20|COMPLETED|Period 1||12
361706|NCT02173535|888750|P19|COMPLETED|Period 1||12
361707|NCT02173535|888751|P18|COMPLETED|Period 1||12
361708|NCT02173535|888752|P17|COMPLETED|Period 1||12
361709|NCT02173535|888753|P16|COMPLETED|Period 1||12
361710|NCT02173535|888754|P15|COMPLETED|Period 1||12
361711|NCT02173535|888755|P14|COMPLETED|Period 1||12
361712|NCT02173535|888756|P13|COMPLETED|Period 1||12
361713|NCT02173535|888757|P12|COMPLETED|Period 1||12
361714|NCT02173535|888758|P11|COMPLETED|Period 1||12
361715|NCT02173535|888759|P10|COMPLETED|Period 1||12
361716|NCT02173535|888760|P9|COMPLETED|Period 1||12
361717|NCT02173535|888761|P8|COMPLETED|Period 1||12
361718|NCT02173535|888762|P7|COMPLETED|Period 1||12
361719|NCT02173535|888763|P6|COMPLETED|Period 1||12
361720|NCT02173535|888764|P5|COMPLETED|Period 1||12
361721|NCT02173535|888765|P4|COMPLETED|Period 1||12
361722|NCT02173535|888766|P3|COMPLETED|Period 1||12
361723|NCT02173535|888767|P2|COMPLETED|Period 1||12
361724|NCT02173535|888768|P1|COMPLETED|Period 1||12
361725|NCT02173535|888749|P20|STARTED|Period 1||12
361726|NCT02173535|888750|P19|STARTED|Period 1||12
361727|NCT02173535|888751|P18|STARTED|Period 1||12
361728|NCT02173535|888752|P17|STARTED|Period 1||12
361729|NCT02173535|888753|P16|STARTED|Period 1||12
361730|NCT02173535|888754|P15|STARTED|Period 1||12
361731|NCT02173535|888755|P14|STARTED|Period 1||12
361732|NCT02173535|888756|P13|STARTED|Period 1||12
361733|NCT02173535|888757|P12|STARTED|Period 1||12
361734|NCT02173535|888758|P11|STARTED|Period 1||12
361735|NCT02173535|888759|P10|STARTED|Period 1||12
361736|NCT02173535|888760|P9|STARTED|Period 1||12
361737|NCT02173535|888761|P8|STARTED|Period 1||12
361738|NCT02173535|888762|P7|STARTED|Period 1||12
361739|NCT02173535|888763|P6|STARTED|Period 1||12
361740|NCT02173535|888764|P5|STARTED|Period 1||12
361741|NCT02173535|888765|P4|STARTED|Period 1||12
361742|NCT02173535|888766|P3|STARTED|Period 1||12
361743|NCT02173535|888767|P2|STARTED|Period 1||12
361744|NCT02173535|888768|P1|STARTED|Period 1||12
361745|NCT02173392|888807|P2|NOT COMPLETED|Overall Study||4
361746|NCT02173392|888808|P1|NOT COMPLETED|Overall Study||14
361747|NCT02173392|888807|P2|COMPLETED|Overall Study||68
361748|NCT02173392|888808|P1|COMPLETED|Overall Study||59
361749|NCT02173392|888807|P2|STARTED|Overall Study||72
361750|NCT02173392|888808|P1|STARTED|Overall Study||73
361751|NCT02173054|888821|P3|NOT COMPLETED|Overall Study||1
361752|NCT02173054|888822|P2|NOT COMPLETED|Overall Study||0
361753|NCT02173054|888823|P1|NOT COMPLETED|Overall Study||1
361754|NCT02173054|888821|P3|COMPLETED|Overall Study||39
361755|NCT02173054|888822|P2|COMPLETED|Overall Study||40
361756|NCT02173054|888823|P1|COMPLETED|Overall Study||39
361757|NCT02173054|888821|P3|STARTED|Overall Study||40
361758|NCT02173054|888822|P2|STARTED|Overall Study||40
361759|NCT02173054|888823|P1|STARTED|Overall Study||40
361760|NCT02172755|888845|P2|NOT COMPLETED|Overall Study||4
361761|NCT02172755|888846|P1|NOT COMPLETED|Overall Study||2
361762|NCT02172755|888845|P2|COMPLETED|Overall Study||12
361763|NCT02172755|888846|P1|COMPLETED|Overall Study||12
361764|NCT02172755|888845|P2|STARTED|Overall Study||16
361765|NCT02172755|888846|P1|STARTED|Overall Study||14
361766|NCT02172742|888858|P2|NOT COMPLETED|Overall Study||0
361767|NCT02172742|888859|P1|NOT COMPLETED|Overall Study||1
361768|NCT02172742|888858|P2|COMPLETED|Overall Study||6
361769|NCT02172742|888859|P1|COMPLETED|Overall Study||6
361770|NCT02172742|888858|P2|STARTED|Overall Study||6
361771|NCT02172742|888859|P1|STARTED|Overall Study||7
361772|NCT02172625|888868|P2|NOT COMPLETED|Overall Study||3
361773|NCT02172625|888869|P1|NOT COMPLETED|Overall Study||0
361774|NCT02172625|888868|P2|COMPLETED|Overall Study||16
361775|NCT02172625|888869|P1|COMPLETED|Overall Study||19
361776|NCT02172625|888868|P2|STARTED|Overall Study||19
361777|NCT02172625|888869|P1|STARTED|Overall Study||19
361778|NCT02172040|888891|P4|NOT COMPLETED|Overall Study||1
361779|NCT02172040|888892|P3|NOT COMPLETED|Overall Study||2
361780|NCT02172040|888893|P2|NOT COMPLETED|Overall Study||3
361781|NCT02172040|888894|P1|NOT COMPLETED|Overall Study||0
361782|NCT02172040|888891|P4|COMPLETED|Overall Study||26
361783|NCT02172040|888892|P3|COMPLETED|Overall Study||29
361784|NCT02172040|888893|P2|COMPLETED|Overall Study||42
361785|NCT02172040|888894|P1|COMPLETED|Overall Study||49
361786|NCT02172040|888891|P4|STARTED|Overall Study||27
361787|NCT02172040|888892|P3|STARTED|Overall Study||31
361788|NCT02172040|888893|P2|STARTED|Overall Study||45
361789|NCT02172040|888894|P1|STARTED|Overall Study||49
361790|NCT02171611|888940|P6|NOT COMPLETED|Overall Study||0
361791|NCT02171611|888941|P5|NOT COMPLETED|Overall Study||0
361792|NCT02171611|888942|P4|NOT COMPLETED|Overall Study||0
361793|NCT02171611|888943|P3|NOT COMPLETED|Overall Study||0
361794|NCT02171611|888944|P2|NOT COMPLETED|Overall Study||0
361795|NCT02171611|888945|P1|NOT COMPLETED|Overall Study||0
361796|NCT02171611|888940|P6|COMPLETED|Overall Study||5
361797|NCT02171611|888941|P5|COMPLETED|Overall Study||5
361798|NCT02171611|888942|P4|COMPLETED|Overall Study||5
361799|NCT02171611|888943|P3|COMPLETED|Overall Study||5
361800|NCT02171611|888944|P2|COMPLETED|Overall Study||5
361801|NCT02171611|888945|P1|COMPLETED|Overall Study||5
361802|NCT02171611|888940|P6|STARTED|Overall Study||5
361803|NCT02171611|888941|P5|STARTED|Overall Study||5
361804|NCT02171611|888942|P4|STARTED|Overall Study||5
361805|NCT02171611|888943|P3|STARTED|Overall Study||5
361806|NCT02171611|888944|P2|STARTED|Overall Study||5
361807|NCT02171611|888945|P1|STARTED|Overall Study||5
361808|NCT02171247|889015|P2|NOT COMPLETED|Overall Study||0
361809|NCT02171247|889016|P1|NOT COMPLETED|Overall Study||0
361810|NCT02171247|889015|P2|COMPLETED|Overall Study||17
361811|NCT02171247|889016|P1|COMPLETED|Overall Study||16
361812|NCT02171247|889015|P2|STARTED|Overall Study||17
361813|NCT02171247|889016|P1|STARTED|Overall Study||16
361814|NCT02171234|889033|P5|NOT COMPLETED|Overall Study||0
361815|NCT02171234|889034|P4|NOT COMPLETED|Overall Study||0
361816|NCT02171234|889035|P3|NOT COMPLETED|Overall Study||0
361817|NCT02171234|889036|P2|NOT COMPLETED|Overall Study||0
361818|NCT02171234|889037|P1|NOT COMPLETED|Overall Study||0
361819|NCT02171234|889033|P5|COMPLETED|Overall Study||6
361820|NCT02171234|889034|P4|COMPLETED|Overall Study||6
361821|NCT02171234|889035|P3|COMPLETED|Overall Study||6
361822|NCT02171234|889036|P2|COMPLETED|Overall Study||6
361823|NCT02171234|889037|P1|COMPLETED|Overall Study||8
361824|NCT02171234|889033|P5|STARTED|Overall Study||6
361825|NCT02171234|889034|P4|STARTED|Overall Study||6
361826|NCT02171234|889035|P3|STARTED|Overall Study||6
361827|NCT02171234|889036|P2|STARTED|Overall Study||6
361828|NCT02171234|889037|P1|STARTED|Overall Study||8
361829|NCT02171195|889066|P9|NOT COMPLETED|Overall Study||0
361830|NCT02171195|889067|P8|NOT COMPLETED|Overall Study||0
361831|NCT02171195|889068|P7|NOT COMPLETED|Overall Study||0
361832|NCT02171195|889069|P6|NOT COMPLETED|Overall Study||0
361833|NCT02171195|889070|P5|NOT COMPLETED|Overall Study||0
361834|NCT02171195|889071|P4|NOT COMPLETED|Overall Study||0
361835|NCT02171195|889072|P3|NOT COMPLETED|Overall Study||0
361836|NCT02171195|889073|P2|NOT COMPLETED|Overall Study||0
361837|NCT02171195|889074|P1|NOT COMPLETED|Overall Study||0
361838|NCT02171195|889066|P9|COMPLETED|Overall Study||6
361839|NCT02171195|889067|P8|COMPLETED|Overall Study||6
361840|NCT02171195|889068|P7|COMPLETED|Overall Study||6
361841|NCT02171195|889069|P6|COMPLETED|Overall Study||6
361842|NCT02171195|889070|P5|COMPLETED|Overall Study||6
361843|NCT02171195|889071|P4|COMPLETED|Overall Study||6
361844|NCT02171195|889072|P3|COMPLETED|Overall Study||6
361845|NCT02171195|889073|P2|COMPLETED|Overall Study||6
361846|NCT02171195|889074|P1|COMPLETED|Overall Study||16
361847|NCT02171195|889066|P9|STARTED|Overall Study||6
361848|NCT02171195|889067|P8|STARTED|Overall Study||6
361849|NCT02171195|889068|P7|STARTED|Overall Study||6
361850|NCT02171195|889069|P6|STARTED|Overall Study||6
361851|NCT02171195|889070|P5|STARTED|Overall Study||6
361852|NCT02171195|889071|P4|STARTED|Overall Study||6
361853|NCT02171195|889072|P3|STARTED|Overall Study||6
361854|NCT02171195|889073|P2|STARTED|Overall Study||6
361855|NCT02171195|889074|P1|STARTED|Overall Study||16
361856|NCT02170779|889096|P2|NOT COMPLETED|Overall Study||1
361857|NCT02170779|889097|P1|NOT COMPLETED|Overall Study||1
361858|NCT02170779|889096|P2|COMPLETED|Overall Study||19
361859|NCT02170779|889097|P1|COMPLETED|Overall Study||19
361860|NCT02170779|889096|P2|STARTED|Overall Study||20
361861|NCT02170779|889097|P1|STARTED|Overall Study||20
361862|NCT02170688|889124|P5|NOT COMPLETED|Overall Study||0
361863|NCT02170688|889125|P4|NOT COMPLETED|Overall Study||2
361864|NCT02170688|889126|P3|NOT COMPLETED|Overall Study||4
361865|NCT02170688|889127|P2|NOT COMPLETED|Overall Study||3
361866|NCT02170688|889128|P1|NOT COMPLETED|Overall Study||4
361867|NCT02170688|889124|P5|COMPLETED|Overall Study||25
361868|NCT02170688|889125|P4|COMPLETED|Overall Study||25
361869|NCT02170688|889126|P3|COMPLETED|Overall Study||25
361870|NCT02170688|889127|P2|COMPLETED|Overall Study||26
361871|NCT02170688|889128|P1|COMPLETED|Overall Study||25
361872|NCT02170688|889124|P5|STARTED|Overall Study||25
361873|NCT02170688|889125|P4|STARTED|Overall Study||27
361874|NCT02170688|889126|P3|STARTED|Overall Study||29
361875|NCT02170688|889127|P2|STARTED|Overall Study||29
361876|NCT02170688|889128|P1|STARTED|Overall Study||29
361877|NCT02170662|889147|P2|NOT COMPLETED|Overall Study||0
361878|NCT02170662|889148|P1|NOT COMPLETED|Overall Study||0
361879|NCT02170662|889147|P2|COMPLETED|Overall Study||6
361880|NCT02170662|889148|P1|COMPLETED|Overall Study||3
361881|NCT02170662|889147|P2|STARTED|Overall Study||6
361882|NCT02170662|889148|P1|STARTED|Overall Study||3
361883|NCT02170649|889160|P1|NOT COMPLETED|Fed Period||0
361884|NCT02170649|889160|P1|COMPLETED|Fed Period||12
361885|NCT02170649|889160|P1|STARTED|Fed Period||12
361886|NCT02170649|889160|P1|NOT COMPLETED|Fasting Period||0
361887|NCT02170649|889160|P1|COMPLETED|Fasting Period||12
361888|NCT02170649|889160|P1|STARTED|Fasting Period||12
361889|NCT02170532|889167|P1|NOT COMPLETED|Overall Study||0
361890|NCT02170532|889167|P1|COMPLETED|Overall Study||10
361891|NCT02170532|889167|P1|STARTED|Overall Study||10
361892|NCT02170519|889197|P2|NOT COMPLETED|Overall Study||0
361893|NCT02170519|889198|P1|NOT COMPLETED|Overall Study||0
361894|NCT02170519|889197|P2|COMPLETED|Overall Study||5
361895|NCT02170519|889198|P1|COMPLETED|Overall Study||22
361896|NCT02170519|889197|P2|STARTED|Overall Study||5
361897|NCT02170519|889198|P1|STARTED|Overall Study||22
361898|NCT02170376|889219|P5|NOT COMPLETED|Overall Study||0
361899|NCT02170376|889220|P4|NOT COMPLETED|Overall Study||0
361900|NCT02170376|889221|P3|NOT COMPLETED|Overall Study||0
361901|NCT02170376|889222|P2|NOT COMPLETED|Overall Study||1
361902|NCT02170376|889223|P1|NOT COMPLETED|Overall Study||0
361903|NCT02170376|889219|P5|COMPLETED|Overall Study||16
361904|NCT02170376|889220|P4|COMPLETED|Overall Study||16
361905|NCT02170376|889221|P3|COMPLETED|Overall Study||16
361906|NCT02170376|889222|P2|COMPLETED|Overall Study||15
361907|NCT02170376|889223|P1|COMPLETED|Overall Study||16
361908|NCT02170376|889219|P5|Pharmacokinetic Population|Overall Study||16
361909|NCT02170376|889220|P4|Pharmacokinetic Population|Overall Study||16
361910|NCT02170376|889221|P3|Pharmacokinetic Population|Overall Study||16
361911|NCT02170376|889222|P2|Pharmacokinetic Population|Overall Study||15
361912|NCT02170376|889223|P1|Pharmacokinetic Population|Overall Study||16
361913|NCT02170376|889219|P5|STARTED|Overall Study||16
361914|NCT02170376|889220|P4|STARTED|Overall Study||16
361915|NCT02170376|889221|P3|STARTED|Overall Study||16
361916|NCT02170376|889222|P2|STARTED|Overall Study||16
361917|NCT02170376|889223|P1|STARTED|Overall Study||16
361918|NCT02170363|889260|P1|NOT COMPLETED|Overall Study||0
361919|NCT02170363|889260|P1|COMPLETED|Overall Study|Followed to the 6-Month Primary Endpoint|50
361920|NCT02170363|889260|P1|STARTED|Overall Study||50
361921|NCT02170220|889274|P2|NOT COMPLETED|Overall Study||0
361922|NCT02170220|889275|P1|NOT COMPLETED|Overall Study||0
361923|NCT02170220|889274|P2|COMPLETED|Overall Study||6
361924|NCT02170220|889275|P1|COMPLETED|Overall Study||6
361925|NCT02170220|889274|P2|STARTED|Overall Study||6
361926|NCT02170220|889275|P1|STARTED|Overall Study||6
361927|NCT02170207|889301|P1|NOT COMPLETED|Overall Study||5
361928|NCT02170207|889301|P1|COMPLETED|Overall Study||58
361929|NCT02170207|889301|P1|STARTED|Overall Study||63
361930|NCT02170077|889312|P3|NOT COMPLETED|Overall Study||12
361931|NCT02170077|889313|P2|NOT COMPLETED|Overall Study||13
361932|NCT02170077|889314|P1|NOT COMPLETED|Overall Study||9
361933|NCT02170077|889312|P3|COMPLETED|Overall Study||35
361934|NCT02170077|889313|P2|COMPLETED|Overall Study||34
361935|NCT02170077|889314|P1|COMPLETED|Overall Study||41
361936|NCT02170077|889312|P3|Intent to Treat (ITT) Population|Overall Study||47
361937|NCT02170077|889313|P2|Intent to Treat (ITT) Population|Overall Study||46
361938|NCT02170077|889314|P1|Intent to Treat (ITT) Population|Overall Study||50
361939|NCT02170077|889312|P3|STARTED|Overall Study||47
361940|NCT02170077|889313|P2|STARTED|Overall Study||47
361941|NCT02170077|889314|P1|STARTED|Overall Study||50
361942|NCT02170064|889325|P3|NOT COMPLETED|Overall Study||1
361943|NCT02170064|889326|P2|NOT COMPLETED|Overall Study||2
361944|NCT02170064|889327|P1|NOT COMPLETED|Overall Study||6
361945|NCT02170064|889325|P3|COMPLETED|Overall Study||10
361946|NCT02170064|889326|P2|COMPLETED|Overall Study||7
361947|NCT02170064|889327|P1|COMPLETED|Overall Study||9
361948|NCT02170064|889325|P3|Efficacy Population (EP)|Overall Study||10
361949|NCT02170064|889326|P2|Efficacy Population (EP)|Overall Study||8
361950|NCT02170064|889327|P1|Efficacy Population (EP)|Overall Study||11
361951|NCT02170064|889325|P3|Pharmacokinetic Population (PKP)|Overall Study||10
361952|NCT02170064|889326|P2|Pharmacokinetic Population (PKP)|Overall Study||8
361953|NCT02170064|889327|P1|Pharmacokinetic Population (PKP)|Overall Study||11
361954|NCT02170064|889325|P3|Safety Population (SP)|Overall Study||11
361955|NCT02170064|889326|P2|Safety Population (SP)|Overall Study||8
361956|NCT02170064|889327|P1|Safety Population (SP)|Overall Study||12
361957|NCT02170064|889325|P3|STARTED|Overall Study||11
361958|NCT02170064|889326|P2|STARTED|Overall Study||9
361959|NCT02170064|889327|P1|STARTED|Overall Study||15
361960|NCT02170025|889343|P2|NOT COMPLETED|Overall Study||0
361961|NCT02170025|889344|P1|NOT COMPLETED|Overall Study||2
361962|NCT02170025|889343|P2|COMPLETED|Overall Study||7
361963|NCT02170025|889344|P1|COMPLETED|Overall Study||12
361964|NCT02170025|889343|P2|STARTED|Overall Study||7
361965|NCT02170025|889344|P1|STARTED|Overall Study||14
361966|NCT02169895|889354|P4|NOT COMPLETED|Overall Study||2
361967|NCT02169895|889355|P3|NOT COMPLETED|Overall Study||0
361968|NCT02169895|889356|P2|NOT COMPLETED|Overall Study||0
361969|NCT02169895|889357|P1|NOT COMPLETED|Overall Study||0
361970|NCT02169895|889354|P4|COMPLETED|Overall Study||2
361971|NCT02169895|889355|P3|COMPLETED|Overall Study||4
361972|NCT02169895|889356|P2|COMPLETED|Overall Study||4
361973|NCT02169895|889357|P1|COMPLETED|Overall Study||4
361974|NCT02169895|889354|P4|Placebo|Overall Study||4
361975|NCT02169895|889355|P3|Placebo|Overall Study||4
361976|NCT02169895|889356|P2|Placebo|Overall Study||4
361977|NCT02169895|889357|P1|Placebo|Overall Study||4
361978|NCT02169895|889354|P4|100 mg BIA 9-1067|Overall Study||2
361979|NCT02169895|889355|P3|100 mg BIA 9-1067|Overall Study||4
361980|NCT02169895|889356|P2|100 mg BIA 9-1067|Overall Study||4
361981|NCT02169895|889357|P1|100 mg BIA 9-1067|Overall Study||4
361982|NCT02169895|889354|P4|50 mg BIA 9-1067|Overall Study||4
361983|NCT02169895|889355|P3|50 mg BIA 9-1067|Overall Study||4
361984|NCT02169895|889356|P2|50 mg BIA 9-1067|Overall Study||4
361985|NCT02169895|889357|P1|50 mg BIA 9-1067|Overall Study||4
361986|NCT02169895|889354|P4|25 mg BIA 9-1067|Overall Study||4
361987|NCT02169895|889355|P3|25 mg BIA 9-1067|Overall Study||4
361988|NCT02169895|889356|P2|25 mg BIA 9-1067|Overall Study||4
361989|NCT02169895|889357|P1|25 mg BIA 9-1067|Overall Study||4
361990|NCT02169895|889354|P4|STARTED|Overall Study||4
361991|NCT02169895|889355|P3|STARTED|Overall Study||4
361992|NCT02169895|889356|P2|STARTED|Overall Study||4
361993|NCT02169895|889357|P1|STARTED|Overall Study||4
361994|NCT02169479|889379|P4|NOT COMPLETED|Overall Study||0
361995|NCT02169479|889380|P3|NOT COMPLETED|Overall Study||0
361996|NCT02169479|889381|P2|NOT COMPLETED|Overall Study||1
361997|NCT02169479|889382|P1|NOT COMPLETED|Overall Study||1
361998|NCT02169479|889379|P4|COMPLETED|Overall Study||4
361999|NCT02169479|889380|P3|COMPLETED|Overall Study||4
362000|NCT02169479|889381|P2|COMPLETED|Overall Study||3
362001|NCT02169479|889382|P1|COMPLETED|Overall Study||3
362002|NCT02169479|889379|P4|Placebo|Overall Study||4
362003|NCT02169479|889380|P3|Placebo|Overall Study||4
362004|NCT02169479|889381|P2|Placebo|Overall Study||3
362005|NCT02169479|889382|P1|Placebo|Overall Study||3
362006|NCT02169479|889379|P4|100 mg BIA 9-1067|Overall Study||4
362007|NCT02169479|889380|P3|100 mg BIA 9-1067|Overall Study||4
362008|NCT02169479|889381|P2|100 mg BIA 9-1067|Overall Study||4
362009|NCT02169479|889382|P1|100 mg BIA 9-1067|Overall Study||3
362010|NCT02169479|889379|P4|50 mg BIA 9-1067|Overall Study||4
362011|NCT02169479|889380|P3|50 mg BIA 9-1067|Overall Study||4
362012|NCT02169479|889381|P2|50 mg BIA 9-1067|Overall Study||4
362013|NCT02169479|889382|P1|50 mg BIA 9-1067|Overall Study||4
362014|NCT02169479|889379|P4|25 mg BIA 9-1067|Overall Study||4
362015|NCT02169479|889380|P3|25 mg BIA 9-1067|Overall Study||4
362016|NCT02169479|889381|P2|25 mg BIA 9-1067|Overall Study||3
362017|NCT02169479|889382|P1|25 mg BIA 9-1067|Overall Study||4
362018|NCT02169479|889379|P4|STARTED|Overall Study||4
362019|NCT02169479|889380|P3|STARTED|Overall Study||4
362020|NCT02169479|889381|P2|STARTED|Overall Study||4
362021|NCT02169479|889382|P1|STARTED|Overall Study||4
362022|NCT02169466|889404|P4|NOT COMPLETED|Overall Study||0
362023|NCT02169466|889405|P3|NOT COMPLETED|Overall Study||0
362024|NCT02169466|889406|P2|NOT COMPLETED|Overall Study||1
362025|NCT02169466|889407|P1|NOT COMPLETED|Overall Study||1
362026|NCT02169466|889404|P4|COMPLETED|Overall Study||5
362027|NCT02169466|889405|P3|COMPLETED|Overall Study||5
362028|NCT02169466|889406|P2|COMPLETED|Overall Study||5
362029|NCT02169466|889407|P1|COMPLETED|Overall Study||5
362030|NCT02169466|889404|P4|Placebo|Overall Study||5
362031|NCT02169466|889405|P3|Placebo|Overall Study||5
362032|NCT02169466|889406|P2|Placebo|Overall Study||6
362033|NCT02169466|889407|P1|Placebo|Overall Study||5
362034|NCT02169466|889404|P4|100 mg BIA 9-1067|Overall Study||5
362035|NCT02169466|889405|P3|100 mg BIA 9-1067|Overall Study||5
362036|NCT02169466|889406|P2|100 mg BIA 9-1067|Overall Study||6
362037|NCT02169466|889407|P1|100 mg BIA 9-1067|Overall Study||6
362038|NCT02169466|889404|P4|50 mg BIA 9-1067|Overall Study||5
362039|NCT02169466|889405|P3|50 mg BIA 9-1067|Overall Study||5
362040|NCT02169466|889406|P2|50 mg BIA 9-1067|Overall Study||6
362041|NCT02169466|889407|P1|50 mg BIA 9-1067|Overall Study||6
362042|NCT02169466|889404|P4|25 mg BIA 9-1067|Overall Study||5
362043|NCT02169466|889405|P3|25 mg BIA 9-1067|Overall Study||5
362044|NCT02169466|889406|P2|25 mg BIA 9-1067|Overall Study||5
362045|NCT02169466|889407|P1|25 mg BIA 9-1067|Overall Study||6
362046|NCT02169466|889404|P4|STARTED|Overall Study||5
362047|NCT02169466|889405|P3|STARTED|Overall Study||5
362048|NCT02169466|889406|P2|STARTED|Overall Study||6
362049|NCT02169466|889407|P1|STARTED|Overall Study||6
362050|NCT02169453|889433|P4|NOT COMPLETED|Overall Study||0
362051|NCT02169453|889434|P3|NOT COMPLETED|Overall Study||1
362052|NCT02169453|889435|P2|NOT COMPLETED|Overall Study||0
362053|NCT02169453|889436|P1|NOT COMPLETED|Overall Study||0
362054|NCT02169453|889433|P4|COMPLETED|Overall Study||3
362055|NCT02169453|889434|P3|COMPLETED|Overall Study||2
362056|NCT02169453|889435|P2|COMPLETED|Overall Study||3
362057|NCT02169453|889436|P1|COMPLETED|Overall Study||3
362058|NCT02169453|889433|P4|Placebo|Overall Study||3
362059|NCT02169453|889434|P3|Placebo|Overall Study||3
362060|NCT02169453|889435|P2|Placebo|Overall Study||3
362061|NCT02169453|889436|P1|Placebo|Overall Study||3
362062|NCT02169453|889433|P4|100 mg BIA 9-1067|Overall Study||3
362063|NCT02169453|889434|P3|100 mg BIA 9-1067|Overall Study||3
362064|NCT02169453|889435|P2|100 mg BIA 9-1067|Overall Study||3
362065|NCT02169453|889436|P1|100 mg BIA 9-1067|Overall Study||3
362066|NCT02169453|889433|P4|50 mg BIA 9-1067|Overall Study||3
362067|NCT02169453|889434|P3|50 mg BIA 9-1067|Overall Study||2
362068|NCT02169453|889435|P2|50 mg BIA 9-1067|Overall Study||3
362069|NCT02169453|889436|P1|50 mg BIA 9-1067|Overall Study||3
362070|NCT02169453|889433|P4|25 mg BIA 9-1067|Overall Study||3
362071|NCT02169453|889434|P3|25 mg BIA 9-1067|Overall Study||3
362072|NCT02169453|889435|P2|25 mg BIA 9-1067|Overall Study||3
362073|NCT02169453|889436|P1|25 mg BIA 9-1067|Overall Study||3
362074|NCT02169453|889433|P4|STARTED|Overall Study||3
362075|NCT02169453|889434|P3|STARTED|Overall Study||3
362076|NCT02169453|889435|P2|STARTED|Overall Study||3
362077|NCT02169453|889436|P1|STARTED|Overall Study||3
362078|NCT02169440|889468|P2|NOT COMPLETED|Overall Study||0
362079|NCT02169440|889469|P1|NOT COMPLETED|Overall Study||0
362080|NCT02169440|889468|P2|COMPLETED|Overall Study||10
362081|NCT02169440|889469|P1|COMPLETED|Overall Study||10
362082|NCT02169440|889468|P2|STARTED|Overall Study||10
362083|NCT02169440|889469|P1|STARTED|Overall Study||10
362084|NCT02169427|889482|P1|NOT COMPLETED|Overall Study||0
362085|NCT02169427|889482|P1|COMPLETED|Overall Study||6
362086|NCT02169427|889482|P1|STARTED|Overall Study||6
362087|NCT02169414|889492|P4|NOT COMPLETED|Overall Study||0
362088|NCT02169414|889493|P3|NOT COMPLETED|Overall Study||0
362089|NCT02169414|889494|P2|NOT COMPLETED|Overall Study||1
362090|NCT02169414|889495|P1|NOT COMPLETED|Overall Study||1
362091|NCT02169414|889492|P4|COMPLETED|Overall Study||18
362092|NCT02169414|889493|P3|COMPLETED|Overall Study||18
362093|NCT02169414|889494|P2|COMPLETED|Overall Study||18
362094|NCT02169414|889495|P1|COMPLETED|Overall Study||18
362095|NCT02169414|889492|P4|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
362096|NCT02169414|889493|P3|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
362097|NCT02169414|889494|P2|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
362098|NCT02169414|889495|P1|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
362099|NCT02169414|889492|P4|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
362100|NCT02169414|889493|P3|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
362101|NCT02169414|889494|P2|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||19
362102|NCT02169414|889495|P1|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
362103|NCT02169414|889492|P4|STARTED|Overall Study||18
362104|NCT02169414|889493|P3|STARTED|Overall Study||18
362105|NCT02169414|889494|P2|STARTED|Overall Study||19
362106|NCT02169414|889495|P1|STARTED|Overall Study||19
362107|NCT02169336|889536|P3|NOT COMPLETED|Overall Study||3
362108|NCT02169336|889537|P2|NOT COMPLETED|Overall Study||4
362109|NCT02169336|889538|P1|NOT COMPLETED|Overall Study||4
362110|NCT02169336|889536|P3|COMPLETED|Overall Study||29
362111|NCT02169336|889537|P2|COMPLETED|Overall Study||28
362112|NCT02169336|889538|P1|COMPLETED|Overall Study||27
362113|NCT02169336|889536|P3|STARTED|Overall Study||32
362114|NCT02169336|889537|P2|STARTED|Overall Study||32
362115|NCT02169336|889538|P1|STARTED|Overall Study||31
362116|NCT02169115|889549|P3|NOT COMPLETED|Overall Study||0
362117|NCT02169115|889550|P2|NOT COMPLETED|Overall Study||0
362118|NCT02169115|889551|P1|NOT COMPLETED|Overall Study||0
362119|NCT02169115|889549|P3|COMPLETED|Overall Study||21
362120|NCT02169115|889550|P2|COMPLETED|Overall Study||21
362121|NCT02169115|889551|P1|COMPLETED|Overall Study||19
362122|NCT02169115|889549|P3|STARTED|Overall Study||21
362123|NCT02169115|889550|P2|STARTED|Overall Study||21
362124|NCT02169115|889551|P1|STARTED|Overall Study||19
362125|NCT02168816|889561|P2|NOT COMPLETED|Overall Study||2
362126|NCT02168816|889562|P1|NOT COMPLETED|Overall Study||2
362127|NCT02168816|889561|P2|COMPLETED|Overall Study||5
362128|NCT02168816|889562|P1|COMPLETED|Overall Study||3
362129|NCT02168816|889561|P2|STARTED|Overall Study||7
362130|NCT02168816|889562|P1|STARTED|Overall Study||5
362131|NCT02168777|889573|P3|NOT COMPLETED|Overall Study||11
362132|NCT02168777|889574|P2|NOT COMPLETED|Overall Study||7
362133|NCT02168777|889575|P1|NOT COMPLETED|Overall Study||2
362134|NCT02168777|889573|P3|COMPLETED|Overall Study||0
362135|NCT02168777|889574|P2|COMPLETED|Overall Study||0
362136|NCT02168777|889575|P1|COMPLETED|Overall Study||0
362137|NCT02168777|889573|P3|STARTED|Overall Study||11
362138|NCT02168777|889574|P2|STARTED|Overall Study||7
362139|NCT02168777|889575|P1|STARTED|Overall Study||2
362140|NCT02168491|889652|P1|NOT COMPLETED|Overall Study||1
362141|NCT02168491|889652|P1|COMPLETED|Overall Study||8
362142|NCT02168491|889652|P1|STARTED|Overall Study||9
362143|NCT02168478|889658|P1|NOT COMPLETED|Overall Study||4
362144|NCT02168478|889658|P1|COMPLETED|Overall Study||202
362145|NCT02168478|889658|P1|STARTED|Overall Study||206
362146|NCT02168439|889664|P2|NOT COMPLETED|Overall Study||2
362147|NCT02168439|889665|P1|NOT COMPLETED|Overall Study||0
362148|NCT02168439|889664|P2|COMPLETED|Overall Study||18
362149|NCT02168439|889665|P1|COMPLETED|Overall Study||20
362150|NCT02168439|889664|P2|STARTED|Overall Study||20
362151|NCT02168439|889665|P1|STARTED|Overall Study||20
362152|NCT02168387|889683|P2|NOT COMPLETED|Overall Study||3
362153|NCT02168387|889684|P1|NOT COMPLETED|Overall Study||7
362154|NCT02168387|889683|P2|COMPLETED|Overall Study||16
362155|NCT02168387|889684|P1|COMPLETED|Overall Study||13
362156|NCT02168387|889683|P2|STARTED|Overall Study||19
362157|NCT02168387|889684|P1|STARTED|Overall Study||20
362158|NCT02168361|889696|P2|NOT COMPLETED|Overall Study||10
362159|NCT02168361|889697|P1|NOT COMPLETED|Overall Study||5
362160|NCT02168361|889696|P2|COMPLETED|Overall Study||21
362161|NCT02168361|889697|P1|COMPLETED|Overall Study||57
362162|NCT02168361|889696|P2|STARTED|Overall Study||31
362163|NCT02168361|889697|P1|STARTED|Overall Study||62
362164|NCT02168309|889707|P2|NOT COMPLETED|Overall Study||0
362165|NCT02168309|889708|P1|NOT COMPLETED|Overall Study||0
362166|NCT02168309|889707|P2|COMPLETED|Overall Study||25
362167|NCT02168309|889708|P1|COMPLETED|Overall Study||25
362168|NCT02168309|889707|P2|STARTED|Overall Study||25
362169|NCT02168309|889708|P1|STARTED|Overall Study||25
362170|NCT02168270|889716|P1|NOT COMPLETED|Overall Study||4
362171|NCT02168270|889716|P1|COMPLETED|Overall Study||0
362172|NCT02168270|889716|P1|STARTED|Overall Study||4
362173|NCT02167893|889723|P1|NOT COMPLETED|Overall Study||163
362174|NCT02167893|889723|P1|COMPLETED|Overall Study||11125
362175|NCT02167893|889723|P1|STARTED|Overall Study||11288
362176|NCT02167867|889734|P2|NOT COMPLETED|Overall Study||0
362177|NCT02167867|889735|P1|NOT COMPLETED|Overall Study||0
362178|NCT02167867|889734|P2|COMPLETED|Overall Study||22
362179|NCT02167867|889735|P1|COMPLETED|Overall Study||22
362180|NCT02167867|889734|P2|STARTED|Overall Study||22
362181|NCT02167867|889735|P1|STARTED|Overall Study||22
362182|NCT02167815|889743|P2|NOT COMPLETED|Overall Study||0
362183|NCT02167815|889744|P1|NOT COMPLETED|Overall Study||0
362184|NCT02167815|889743|P2|COMPLETED|Overall Study||21
362185|NCT02167815|889744|P1|COMPLETED|Overall Study||9
362186|NCT02167815|889743|P2|STARTED|Overall Study||21
362187|NCT02167815|889744|P1|STARTED|Overall Study||9
362188|NCT02167217|889755|P1|NOT COMPLETED|Overall Study||2
362189|NCT02167217|889755|P1|COMPLETED|Overall Study||23
362190|NCT02167217|889755|P1|STARTED|Overall Study||25
362191|NCT02167139|889761|P4|NOT COMPLETED|Transition-extension||5
362192|NCT02167139|889762|P3|NOT COMPLETED|Transition-extension||8
362193|NCT02167139|889763|P2|NOT COMPLETED|Transition-extension||0
362194|NCT02167139|889764|P1|NOT COMPLETED|Transition-extension||6
362195|NCT02167139|889761|P4|COMPLETED|Transition-extension||124
362196|NCT02167139|889762|P3|COMPLETED|Transition-extension||117
362197|NCT02167139|889763|P2|COMPLETED|Transition-extension||0
362198|NCT02167139|889764|P1|COMPLETED|Transition-extension||248
362199|NCT02167139|889761|P4|STARTED|Transition-extension||129
362200|NCT02167139|889762|P3|STARTED|Transition-extension||125
362201|NCT02167139|889763|P2|STARTED|Transition-extension||0
362202|NCT02167139|889764|P1|STARTED|Transition-extension||254
362203|NCT02167139|889761|P4|NOT COMPLETED|Randomised, Double-blind||0
362204|NCT02167139|889762|P3|NOT COMPLETED|Randomised, Double-blind||0
362205|NCT02167139|889763|P2|NOT COMPLETED|Randomised, Double-blind||19
362206|NCT02167139|889764|P1|NOT COMPLETED|Randomised, Double-blind||17
362207|NCT02167139|889761|P4|COMPLETED|Randomised, Double-blind||0
362208|NCT02167139|889762|P3|COMPLETED|Randomised, Double-blind||0
362209|NCT02167139|889763|P2|COMPLETED|Randomised, Double-blind||254
362210|NCT02167139|889764|P1|COMPLETED|Randomised, Double-blind||254
362211|NCT02167139|889761|P4|STARTED|Randomised, Double-blind||0
362212|NCT02167139|889762|P3|STARTED|Randomised, Double-blind||0
362213|NCT02167139|889763|P2|STARTED|Randomised, Double-blind||273
362214|NCT02167139|889764|P1|STARTED|Randomised, Double-blind||271
362215|NCT02166697|889778|P1|NOT COMPLETED|Overall Study||347
362216|NCT02166697|889778|P1|COMPLETED|Overall Study||13804
362217|NCT02166697|889778|P1|STARTED|Overall Study||14151
362218|NCT02166476|889789|P2|NOT COMPLETED|Overall Study||23
362219|NCT02166476|889790|P1|NOT COMPLETED|Overall Study||14
362220|NCT02166476|889789|P2|COMPLETED|Overall Study||250
362221|NCT02166476|889790|P1|COMPLETED|Overall Study||258
362222|NCT02166476|889789|P2|Received at Least 1 Dose of Study Drug|Overall Study||273
362223|NCT02166476|889790|P1|Received at Least 1 Dose of Study Drug|Overall Study||272
362224|NCT02166476|889789|P2|STARTED|Overall Study||273
362225|NCT02166476|889790|P1|STARTED|Overall Study||272
362226|NCT02166346|889823|P2|NOT COMPLETED|Intervention - Phase 2 (After Crossover)||0
362227|NCT02166346|889824|P1|NOT COMPLETED|Intervention - Phase 2 (After Crossover)||1
362228|NCT02166346|889823|P2|COMPLETED|Intervention - Phase 2 (After Crossover)||6
362229|NCT02166346|889824|P1|COMPLETED|Intervention - Phase 2 (After Crossover)||7
362230|NCT02166346|889823|P2|STARTED|Intervention - Phase 2 (After Crossover)||6
362231|NCT02166346|889824|P1|STARTED|Intervention - Phase 2 (After Crossover)||8
362232|NCT02166346|889823|P2|NOT COMPLETED|Intervention - Phase 1||2
362233|NCT02166346|889824|P1|NOT COMPLETED|Intervention - Phase 1||0
362234|NCT02166346|889823|P2|COMPLETED|Intervention - Phase 1||6
362235|NCT02166346|889824|P1|COMPLETED|Intervention - Phase 1||8
362236|NCT02166346|889823|P2|STARTED|Intervention - Phase 1||8
362237|NCT02166346|889824|P1|STARTED|Intervention - Phase 1||8
362238|NCT02166346|889823|P2|NOT COMPLETED|Screening and Randomization||4
362239|NCT02166346|889824|P1|NOT COMPLETED|Screening and Randomization||4
362240|NCT02166346|889823|P2|COMPLETED|Screening and Randomization||8
362241|NCT02166346|889824|P1|COMPLETED|Screening and Randomization||8
362242|NCT02166346|889823|P2|STARTED|Screening and Randomization||12
362243|NCT02166346|889824|P1|STARTED|Screening and Randomization||12
362244|NCT02165826|889835|P3|NOT COMPLETED|Down-Titration Period||7
362245|NCT02165826|889836|P2|NOT COMPLETED|Down-Titration Period||11
362246|NCT02165826|889837|P1|NOT COMPLETED|Down-Titration Period||7
362247|NCT02165826|889835|P3|COMPLETED|Down-Titration Period||31
362248|NCT02165826|889836|P2|COMPLETED|Down-Titration Period||28
362249|NCT02165826|889837|P1|COMPLETED|Down-Titration Period||20
362250|NCT02165826|889835|P3|Safety Analysis Set: Received Study Drug|Down-Titration Period||38
362251|NCT02165826|889836|P2|Safety Analysis Set: Received Study Drug|Down-Titration Period||39
362252|NCT02165826|889837|P1|Safety Analysis Set: Received Study Drug|Down-Titration Period||27
362253|NCT02165826|889835|P3|STARTED|Down-Titration Period||38
362254|NCT02165826|889836|P2|STARTED|Down-Titration Period||39
362255|NCT02165826|889837|P1|STARTED|Down-Titration Period||27
362256|NCT02165826|889835|P3|NOT COMPLETED|Main Treatment Period||109
362257|NCT02165826|889836|P2|NOT COMPLETED|Main Treatment Period||90
362258|NCT02165826|889837|P1|NOT COMPLETED|Main Treatment Period||81
362259|NCT02165826|889835|P3|COMPLETED|Main Treatment Period||334
362260|NCT02165826|889836|P2|COMPLETED|Main Treatment Period||349
362261|NCT02165826|889837|P1|COMPLETED|Main Treatment Period||360
362262|NCT02165826|889835|P3|Safety Analysis Set: Received Study Drug|Main Treatment Period||443
362263|NCT02165826|889836|P2|Safety Analysis Set: Received Study Drug|Main Treatment Period||437
362264|NCT02165826|889837|P1|Safety Analysis Set: Received Study Drug|Main Treatment Period||441
362265|NCT02165826|889835|P3|STARTED|Main Treatment Period||443
362266|NCT02165826|889836|P2|STARTED|Main Treatment Period||439
362267|NCT02165826|889837|P1|STARTED|Main Treatment Period||441
362268|NCT02165761|889896|P2|NOT COMPLETED|Overall Study||14
362269|NCT02165761|889897|P1|NOT COMPLETED|Overall Study||19
362270|NCT02165761|889896|P2|COMPLETED|Overall Study||5
362271|NCT02165761|889897|P1|COMPLETED|Overall Study||4
362272|NCT02165761|889896|P2|STARTED|Overall Study||19
362273|NCT02165761|889897|P1|STARTED|Overall Study||23
362274|NCT02165462|889903|P1|NOT COMPLETED|Overall Study||0
362275|NCT02165462|889903|P1|COMPLETED|Overall Study||17
362276|NCT02165462|889903|P1|STARTED|Overall Study||17
362277|NCT02165111|889922|P2|NOT COMPLETED|Overall Study||0
362278|NCT02165111|889923|P1|NOT COMPLETED|Overall Study||0
362279|NCT02165111|889922|P2|COMPLETED|Overall Study||40
362280|NCT02165111|889923|P1|COMPLETED|Overall Study||40
362281|NCT02165111|889922|P2|STARTED|Overall Study||40
362282|NCT02165111|889923|P1|STARTED|Overall Study||40
362283|NCT02165072|889939|P1|NOT COMPLETED|Overall Study||0
362284|NCT02165072|889939|P1|COMPLETED|Overall Study||30
362285|NCT02165072|889939|P1|STARTED|Overall Study||30
362286|NCT02164929|889948|P4|NOT COMPLETED|Overall Study||2
362287|NCT02164929|889949|P3|NOT COMPLETED|Overall Study||1
362288|NCT02164929|889950|P2|NOT COMPLETED|Overall Study||0
362289|NCT02164929|889951|P1|NOT COMPLETED|Overall Study||1
362290|NCT02164929|889948|P4|COMPLETED|Overall Study||2
362291|NCT02164929|889949|P3|COMPLETED|Overall Study||4
362292|NCT02164929|889950|P2|COMPLETED|Overall Study||3
362293|NCT02164929|889951|P1|COMPLETED|Overall Study||3
362294|NCT02164929|889948|P4|STARTED|Overall Study||4
362295|NCT02164929|889949|P3|STARTED|Overall Study||5
362296|NCT02164929|889950|P2|STARTED|Overall Study||3
362297|NCT02164929|889951|P1|STARTED|Overall Study||4
362298|NCT02164916|889995|P2|NOT COMPLETED|Overall Study||54
362299|NCT02164916|889996|P1|NOT COMPLETED|Overall Study||52
362300|NCT02164916|889995|P2|COMPLETED|Overall Study||0
362301|NCT02164916|889996|P1|COMPLETED|Overall Study||0
362302|NCT02164916|889995|P2|Cross-over to Arm II|Overall Study||0
362303|NCT02164916|889996|P1|Cross-over to Arm II|Overall Study|Following disease progression on Arm 1. Note: these patients are also counted in 'Not Completed'.|24
362304|NCT02164916|889995|P2|Eligible|Overall Study||49
362305|NCT02164916|889996|P1|Eligible|Overall Study||50
362306|NCT02164916|889995|P2|STARTED|Overall Study||54
362307|NCT02164916|889996|P1|STARTED|Overall Study||52
362308|NCT02164539|890019|P7|NOT COMPLETED|Treatment Phase C (1 Week)||2
362309|NCT02164539|890020|P6|NOT COMPLETED|Treatment Phase C (1 Week)||0
362310|NCT02164539|890021|P5|NOT COMPLETED|Treatment Phase C (1 Week)||0
362311|NCT02164539|890022|P4|NOT COMPLETED|Treatment Phase C (1 Week)||0
362312|NCT02164539|890023|P3|NOT COMPLETED|Treatment Phase C (1 Week)||0
362313|NCT02164539|890024|P2|NOT COMPLETED|Treatment Phase C (1 Week)||0
362314|NCT02164539|890025|P1|NOT COMPLETED|Treatment Phase C (1 Week)||1
362315|NCT02164539|890019|P7|COMPLETED|Treatment Phase C (1 Week)||78
362316|NCT02164539|890020|P6|COMPLETED|Treatment Phase C (1 Week)||82
362317|NCT02164539|890021|P5|COMPLETED|Treatment Phase C (1 Week)||84
362318|NCT02164539|890022|P4|COMPLETED|Treatment Phase C (1 Week)||0
362319|NCT02164539|890023|P3|COMPLETED|Treatment Phase C (1 Week)||0
362320|NCT02164539|890024|P2|COMPLETED|Treatment Phase C (1 Week)||0
362321|NCT02164539|890025|P1|COMPLETED|Treatment Phase C (1 Week)||78
362322|NCT02164539|890019|P7|STARTED|Treatment Phase C (1 Week)||80
362323|NCT02164539|890020|P6|STARTED|Treatment Phase C (1 Week)||82
362324|NCT02164539|890021|P5|STARTED|Treatment Phase C (1 Week)||84
362325|NCT02164539|890022|P4|STARTED|Treatment Phase C (1 Week)||0
362326|NCT02164539|890023|P3|STARTED|Treatment Phase C (1 Week)||0
362327|NCT02164539|890024|P2|STARTED|Treatment Phase C (1 Week)||0
362328|NCT02164539|890025|P1|STARTED|Treatment Phase C (1 Week)||79
362329|NCT02164539|890019|P7|NOT COMPLETED|Treatment Phase B (1 Week)||1
362330|NCT02164539|890020|P6|NOT COMPLETED|Treatment Phase B (1 Week)||0
362331|NCT02164539|890021|P5|NOT COMPLETED|Treatment Phase B (1 Week)||3
362332|NCT02164539|890022|P4|NOT COMPLETED|Treatment Phase B (1 Week)||0
362333|NCT02164539|890023|P3|NOT COMPLETED|Treatment Phase B (1 Week)||0
362334|NCT02164539|890024|P2|NOT COMPLETED|Treatment Phase B (1 Week)||0
362335|NCT02164539|890025|P1|NOT COMPLETED|Treatment Phase B (1 Week)||0
362336|NCT02164539|890019|P7|COMPLETED|Treatment Phase B (1 Week)||162
362337|NCT02164539|890020|P6|COMPLETED|Treatment Phase B (1 Week)||0
362338|NCT02164539|890021|P5|COMPLETED|Treatment Phase B (1 Week)||163
362339|NCT02164539|890022|P4|COMPLETED|Treatment Phase B (1 Week)||0
362340|NCT02164539|890023|P3|COMPLETED|Treatment Phase B (1 Week)||0
362341|NCT02164539|890024|P2|COMPLETED|Treatment Phase B (1 Week)||0
362342|NCT02164539|890025|P1|COMPLETED|Treatment Phase B (1 Week)||0
362343|NCT02164539|890019|P7|STARTED|Treatment Phase B (1 Week)||163
362344|NCT02164539|890020|P6|STARTED|Treatment Phase B (1 Week)||0
362345|NCT02164539|890021|P5|STARTED|Treatment Phase B (1 Week)||166
362346|NCT02164539|890022|P4|STARTED|Treatment Phase B (1 Week)||0
362347|NCT02164539|890023|P3|STARTED|Treatment Phase B (1 Week)||0
362348|NCT02164539|890024|P2|STARTED|Treatment Phase B (1 Week)||0
362349|NCT02164539|890025|P1|STARTED|Treatment Phase B (1 Week)||0
362350|NCT02164539|890019|P7|NOT COMPLETED|Treatment Phase A (4 Weeks)||0
362351|NCT02164539|890020|P6|NOT COMPLETED|Treatment Phase A (4 Weeks)||1
362352|NCT02164539|890021|P5|NOT COMPLETED|Treatment Phase A (4 Weeks)||3
362353|NCT02164539|890022|P4|NOT COMPLETED|Treatment Phase A (4 Weeks)||2
362354|NCT02164539|890023|P3|NOT COMPLETED|Treatment Phase A (4 Weeks)||1
362355|NCT02164539|890024|P2|NOT COMPLETED|Treatment Phase A (4 Weeks)||0
362356|NCT02164539|890025|P1|NOT COMPLETED|Treatment Phase A (4 Weeks)||2
362357|NCT02164539|890019|P7|COMPLETED|Treatment Phase A (4 Weeks)||0
362358|NCT02164539|890020|P6|COMPLETED|Treatment Phase A (4 Weeks)||83
362359|NCT02164539|890021|P5|COMPLETED|Treatment Phase A (4 Weeks)||82
362360|NCT02164539|890022|P4|COMPLETED|Treatment Phase A (4 Weeks)||44
362361|NCT02164539|890023|P3|COMPLETED|Treatment Phase A (4 Weeks)||39
362362|NCT02164539|890024|P2|COMPLETED|Treatment Phase A (4 Weeks)||42
362363|NCT02164539|890025|P1|COMPLETED|Treatment Phase A (4 Weeks)||39
362364|NCT02164539|890019|P7|STARTED|Treatment Phase A (4 Weeks)||0
362365|NCT02164539|890020|P6|STARTED|Treatment Phase A (4 Weeks)||84
362366|NCT02164539|890021|P5|STARTED|Treatment Phase A (4 Weeks)||85
362367|NCT02164539|890022|P4|STARTED|Treatment Phase A (4 Weeks)||46
362368|NCT02164539|890023|P3|STARTED|Treatment Phase A (4 Weeks)||40
362369|NCT02164539|890024|P2|STARTED|Treatment Phase A (4 Weeks)||42
362370|NCT02164539|890025|P1|STARTED|Treatment Phase A (4 Weeks)||41
362371|NCT02164396|890073|P3|NOT COMPLETED|Overall Study||0
362372|NCT02164396|890074|P2|NOT COMPLETED|Overall Study||0
362373|NCT02164396|890075|P1|NOT COMPLETED|Overall Study||0
362374|NCT02164396|890073|P3|COMPLETED|Overall Study||10
362375|NCT02164396|890074|P2|COMPLETED|Overall Study||10
362376|NCT02164396|890075|P1|COMPLETED|Overall Study||10
362377|NCT02164396|890073|P3|STARTED|Overall Study||10
362378|NCT02164396|890074|P2|STARTED|Overall Study||10
362379|NCT02164396|890075|P1|STARTED|Overall Study||10
362380|NCT02164318|890087|P4|NOT COMPLETED|Overall Study||1
362381|NCT02164318|890088|P3|NOT COMPLETED|Overall Study||0
362382|NCT02164318|890089|P2|NOT COMPLETED|Overall Study||1
362383|NCT02164318|890090|P1|NOT COMPLETED|Overall Study||0
362384|NCT02164318|890087|P4|COMPLETED|Overall Study||2
362385|NCT02164318|890088|P3|COMPLETED|Overall Study||1
362386|NCT02164318|890089|P2|COMPLETED|Overall Study||2
362387|NCT02164318|890090|P1|COMPLETED|Overall Study||4
362388|NCT02164318|890087|P4|STARTED|Overall Study||3
362389|NCT02164318|890088|P3|STARTED|Overall Study||1
362390|NCT02164318|890089|P2|STARTED|Overall Study||3
362391|NCT02164318|890090|P1|STARTED|Overall Study||4
362392|NCT02163915|890113|P5|NOT COMPLETED|Overall Study||4
362393|NCT02163915|890114|P4|NOT COMPLETED|Overall Study||3
362394|NCT02163915|890115|P3|NOT COMPLETED|Overall Study||2
362395|NCT02163915|890116|P2|NOT COMPLETED|Overall Study||0
362396|NCT02163915|890117|P1|NOT COMPLETED|Overall Study||3
362397|NCT02163915|890113|P5|COMPLETED|Overall Study||6
362398|NCT02163915|890114|P4|COMPLETED|Overall Study||6
362399|NCT02163915|890115|P3|COMPLETED|Overall Study||8
362400|NCT02163915|890116|P2|COMPLETED|Overall Study||8
362401|NCT02163915|890117|P1|COMPLETED|Overall Study||7
362402|NCT02163915|890113|P5|STARTED|Overall Study||10
362403|NCT02163915|890114|P4|STARTED|Overall Study||9
362404|NCT02163915|890115|P3|STARTED|Overall Study||10
362405|NCT02163915|890116|P2|STARTED|Overall Study||8
362406|NCT02163915|890117|P1|STARTED|Overall Study||10
362407|NCT02163733|890172|P3|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||24
362408|NCT02163733|890173|P2|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
362409|NCT02163733|890174|P1|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
362410|NCT02163733|890172|P3|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||14
362411|NCT02163733|890173|P2|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
362412|NCT02163733|890174|P1|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
362413|NCT02163733|890172|P3|STARTED|Part B: Day 15 to End Part B (AZD9291)|No patients completed previous period as relates to Part A and arm is applicable only for Part B.|38
362414|NCT02163733|890173|P2|STARTED|Part B: Day 15 to End Part B (AZD9291)|Only the AZD9291 once daily (Part B) arm is applicable for this period.|0
362415|NCT02163733|890174|P1|STARTED|Part B: Day 15 to End Part B (AZD9291)|Only the AZD9291 once daily (Part B) arm is applicable for this period.|0
362416|NCT02163733|890172|P3|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
362417|NCT02163733|890173|P2|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
362418|NCT02163733|890174|P1|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
362419|NCT02163733|890172|P3|COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
362420|NCT02163733|890173|P2|COMPLETED|Part A: Day 10-15 (2nd Intervention)||20
362421|NCT02163733|890174|P1|COMPLETED|Part A: Day 10-15 (2nd Intervention)||18
362422|NCT02163733|890172|P3|STARTED|Part A: Day 10-15 (2nd Intervention)||0
362423|NCT02163733|890173|P2|STARTED|Part A: Day 10-15 (2nd Intervention)||20
362424|NCT02163733|890174|P1|STARTED|Part A: Day 10-15 (2nd Intervention)||18
362425|NCT02163733|890172|P3|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
362426|NCT02163733|890173|P2|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
362427|NCT02163733|890174|P1|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
362428|NCT02163733|890172|P3|COMPLETED|Part A: Day 1-9 (1st Intervention)||0
362429|NCT02163733|890173|P2|COMPLETED|Part A: Day 1-9 (1st Intervention)||20
362430|NCT02163733|890174|P1|COMPLETED|Part A: Day 1-9 (1st Intervention)||18
362431|NCT02163733|890172|P3|STARTED|Part A: Day 1-9 (1st Intervention)||0
362432|NCT02163733|890173|P2|STARTED|Part A: Day 1-9 (1st Intervention)||20
362433|NCT02163733|890174|P1|STARTED|Part A: Day 1-9 (1st Intervention)||18
362434|NCT02163538|890211|P2|NOT COMPLETED|Overall Study||1
362435|NCT02163538|890212|P1|NOT COMPLETED|Overall Study||1
362436|NCT02163538|890211|P2|COMPLETED|Overall Study||70
362437|NCT02163538|890212|P1|COMPLETED|Overall Study||70
362438|NCT02163538|890211|P2|STARTED|Overall Study||71
362439|NCT02163538|890212|P1|STARTED|Overall Study||71
362440|NCT02163499|890228|P1|NOT COMPLETED|Extended Dosing Phase: ZS||280
362441|NCT02163499|890228|P1|COMPLETED|Extended Dosing Phase: ZS||466
362442|NCT02163499|890228|P1|STARTED|Extended Dosing Phase: ZS||746
362443|NCT02163499|890228|P1|NOT COMPLETED|Acute Phase: ZS 10 g TID||5
362444|NCT02163499|890228|P1|COMPLETED|Acute Phase: ZS 10 g TID||746
362445|NCT02163499|890228|P1|STARTED|Acute Phase: ZS 10 g TID||751
362446|NCT02163421|890240|P4|NOT COMPLETED|Overall Study||0
362447|NCT02163421|890241|P3|NOT COMPLETED|Overall Study||0
362448|NCT02163421|890242|P2|NOT COMPLETED|Overall Study||0
362449|NCT02163421|890243|P1|NOT COMPLETED|Overall Study||0
362450|NCT02163421|890240|P4|COMPLETED|Overall Study||12
362451|NCT02163421|890241|P3|COMPLETED|Overall Study||12
362452|NCT02163421|890242|P2|COMPLETED|Overall Study||12
362453|NCT02163421|890243|P1|COMPLETED|Overall Study||12
362454|NCT02163421|890240|P4|STARTED|Overall Study||12
362455|NCT02163421|890241|P3|STARTED|Overall Study||12
362456|NCT02163421|890242|P2|STARTED|Overall Study||12
362457|NCT02163421|890243|P1|STARTED|Overall Study||12
362458|NCT02163395|890250|P1|NOT COMPLETED|Overall Study||5
362459|NCT02163395|890250|P1|COMPLETED|Overall Study||39
362460|NCT02163395|890250|P1|STARTED|Overall Study||44
362461|NCT02163187|890259|P2|NOT COMPLETED|Overall Study||0
362462|NCT02163187|890260|P1|NOT COMPLETED|Overall Study||2
362463|NCT02163187|890259|P2|COMPLETED|Overall Study||0
362464|NCT02163187|890260|P1|COMPLETED|Overall Study||2
362465|NCT02163187|890259|P2|Treatment|Overall Study||0
362466|NCT02163187|890260|P1|Treatment|Overall Study||2
362467|NCT02163187|890259|P2|STARTED|Overall Study||0
362468|NCT02163187|890260|P1|STARTED|Overall Study||4
362469|NCT02162979|890270|P2|NOT COMPLETED|Overall Study||0
362470|NCT02162979|890271|P1|NOT COMPLETED|Overall Study||0
362471|NCT02162979|890270|P2|COMPLETED|Overall Study||0
362472|NCT02162979|890271|P1|COMPLETED|Overall Study||0
362473|NCT02162979|890270|P2|STARTED|Overall Study||0
362474|NCT02162979|890271|P1|STARTED|Overall Study||0
362475|NCT02162862|890284|P3|NOT COMPLETED|Overall Study||4
362476|NCT02162862|890285|P2|NOT COMPLETED|Overall Study||11
362477|NCT02162862|890286|P1|NOT COMPLETED|Overall Study||0
362478|NCT02162862|890284|P3|COMPLETED|Overall Study||29
362479|NCT02162862|890285|P2|COMPLETED|Overall Study||24
362480|NCT02162862|890286|P1|COMPLETED|Overall Study||31
362481|NCT02162862|890284|P3|STARTED|Overall Study||33
362482|NCT02162862|890285|P2|STARTED|Overall Study||35
362483|NCT02162862|890286|P1|STARTED|Overall Study||31
362484|NCT02162758|890299|P2|NOT COMPLETED|Overall Study||1
362485|NCT02162758|890300|P1|NOT COMPLETED|Overall Study||0
362486|NCT02162758|890299|P2|COMPLETED|Overall Study||2
362487|NCT02162758|890300|P1|COMPLETED|Overall Study||3
362488|NCT02162758|890299|P2|STARTED|Overall Study||3
362489|NCT02162758|890300|P1|STARTED|Overall Study||3
362490|NCT02162680|890315|P3|NOT COMPLETED|Overall Study||0
362491|NCT02162680|890316|P2|NOT COMPLETED|Overall Study||0
362492|NCT02162680|890317|P1|NOT COMPLETED|Overall Study||0
362493|NCT02162680|890315|P3|COMPLETED|Overall Study||32
362494|NCT02162680|890316|P2|COMPLETED|Overall Study||33
362495|NCT02162680|890317|P1|COMPLETED|Overall Study||33
362496|NCT02162680|890315|P3|STARTED|Overall Study||32
362497|NCT02162680|890316|P2|STARTED|Overall Study||33
362498|NCT02162680|890317|P1|STARTED|Overall Study||33
362499|NCT02162576|890325|P1|NOT COMPLETED|Overall Study||0
362500|NCT02162576|890325|P1|COMPLETED|Overall Study||95
362501|NCT02162576|890325|P1|STARTED|Overall Study||95
362502|NCT02161757|890334|P3|NOT COMPLETED|Treatment Through Study Completion||40
362503|NCT02161757|890335|P2|NOT COMPLETED|Treatment Through Study Completion||49
362504|NCT02161757|890336|P1|NOT COMPLETED|Treatment Through Study Completion||66
362505|NCT02161757|890334|P3|COMPLETED|Treatment Through Study Completion||360
362506|NCT02161757|890335|P2|COMPLETED|Treatment Through Study Completion||355
362507|NCT02161757|890336|P1|COMPLETED|Treatment Through Study Completion||332
362508|NCT02161757|890334|P3|STARTED|Treatment Through Study Completion||400
362509|NCT02161757|890335|P2|STARTED|Treatment Through Study Completion||404
362510|NCT02161757|890336|P1|STARTED|Treatment Through Study Completion||398
362511|NCT02161757|890334|P3|NOT COMPLETED|Randomised Through Start Treatment||0
362512|NCT02161757|890335|P2|NOT COMPLETED|Randomised Through Start Treatment||2
362513|NCT02161757|890336|P1|NOT COMPLETED|Randomised Through Start Treatment||3
362514|NCT02161757|890334|P3|COMPLETED|Randomised Through Start Treatment||400
362515|NCT02161757|890335|P2|COMPLETED|Randomised Through Start Treatment||404
362516|NCT02161757|890336|P1|COMPLETED|Randomised Through Start Treatment||398
362517|NCT02161757|890334|P3|STARTED|Randomised Through Start Treatment||400
362518|NCT02161757|890335|P2|STARTED|Randomised Through Start Treatment||406
362519|NCT02161757|890336|P1|STARTED|Randomised Through Start Treatment||401
362520|NCT02161549|890393|P2|NOT COMPLETED|Overall Study||2
362521|NCT02161549|890394|P1|NOT COMPLETED|Overall Study||6
362522|NCT02161549|890393|P2|COMPLETED|Overall Study||29
362523|NCT02161549|890394|P1|COMPLETED|Overall Study||34
362524|NCT02161549|890393|P2|STARTED|Overall Study||31
362525|NCT02161549|890394|P1|STARTED|Overall Study||40
362526|NCT02161484|890402|P2|NOT COMPLETED|Overall Study||3
362527|NCT02161484|890403|P1|NOT COMPLETED|Overall Study||4
362528|NCT02161484|890402|P2|COMPLETED|Overall Study||2
362529|NCT02161484|890403|P1|COMPLETED|Overall Study||1
362530|NCT02161484|890402|P2|STARTED|Overall Study||5
362531|NCT02161484|890403|P1|STARTED|Overall Study||5
362532|NCT02161146|890430|P5|NOT COMPLETED|Overall Study||1
362533|NCT02161146|890431|P4|NOT COMPLETED|Overall Study||3
362534|NCT02161146|890432|P3|NOT COMPLETED|Overall Study||0
362535|NCT02161146|890433|P2|NOT COMPLETED|Overall Study||4
362536|NCT02161146|890434|P1|NOT COMPLETED|Overall Study||1
362537|NCT02161146|890430|P5|COMPLETED|Overall Study||48
362538|NCT02161146|890431|P4|COMPLETED|Overall Study||45
362539|NCT02161146|890432|P3|COMPLETED|Overall Study||49
362540|NCT02161146|890433|P2|COMPLETED|Overall Study||43
362541|NCT02161146|890434|P1|COMPLETED|Overall Study||46
362542|NCT02161146|890430|P5|STARTED|Overall Study||49
362543|NCT02161146|890431|P4|STARTED|Overall Study||48
362544|NCT02161146|890432|P3|STARTED|Overall Study||49
362545|NCT02161146|890433|P2|STARTED|Overall Study||47
362546|NCT02161146|890434|P1|STARTED|Overall Study||47
362547|NCT02161016|890447|P1|NOT COMPLETED|Overall Study||1
362548|NCT02161016|890447|P1|COMPLETED|Overall Study||0
362549|NCT02161016|890447|P1|STARTED|Overall Study||1
362550|NCT02160990|890457|P2|NOT COMPLETED|Overall Study||0
362551|NCT02160990|890458|P1|NOT COMPLETED|Overall Study||0
362552|NCT02160990|890457|P2|COMPLETED|Overall Study||10
362553|NCT02160990|890458|P1|COMPLETED|Overall Study||10
362554|NCT02160990|890457|P2|STARTED|Overall Study||10
362555|NCT02160990|890458|P1|STARTED|Overall Study||10
362556|NCT02160977|890478|P2|NOT COMPLETED|Six Months After Surgery||1
362557|NCT02160977|890479|P1|NOT COMPLETED|Six Months After Surgery||2
362558|NCT02160977|890478|P2|COMPLETED|Six Months After Surgery||42
362559|NCT02160977|890479|P1|COMPLETED|Six Months After Surgery||42
362560|NCT02160977|890478|P2|STARTED|Six Months After Surgery||43
362561|NCT02160977|890479|P1|STARTED|Six Months After Surgery||44
362562|NCT02160977|890478|P2|NOT COMPLETED|Three Months After Surgery||2
362563|NCT02160977|890479|P1|NOT COMPLETED|Three Months After Surgery||0
362564|NCT02160977|890478|P2|COMPLETED|Three Months After Surgery||43
362565|NCT02160977|890479|P1|COMPLETED|Three Months After Surgery||44
362566|NCT02160977|890478|P2|STARTED|Three Months After Surgery||45
362567|NCT02160977|890479|P1|STARTED|Three Months After Surgery||44
362568|NCT02160977|890478|P2|NOT COMPLETED|Six Weeks After Surgery||0
362569|NCT02160977|890479|P1|NOT COMPLETED|Six Weeks After Surgery||1
362570|NCT02160977|890478|P2|COMPLETED|Six Weeks After Surgery||45
362571|NCT02160977|890479|P1|COMPLETED|Six Weeks After Surgery||44
362572|NCT02160977|890478|P2|STARTED|Six Weeks After Surgery||45
362573|NCT02160977|890479|P1|STARTED|Six Weeks After Surgery||45
362574|NCT02160977|890478|P2|NOT COMPLETED|One Week After Surgery||0
362575|NCT02160977|890479|P1|NOT COMPLETED|One Week After Surgery||0
362576|NCT02160977|890478|P2|COMPLETED|One Week After Surgery||45
362577|NCT02160977|890479|P1|COMPLETED|One Week After Surgery||45
362578|NCT02160977|890478|P2|STARTED|One Week After Surgery||45
362579|NCT02160977|890479|P1|STARTED|One Week After Surgery||45
362580|NCT02160873|890491|P2|NOT COMPLETED|Overall Study||0
362581|NCT02160873|890492|P1|NOT COMPLETED|Overall Study||0
362582|NCT02160873|890491|P2|COMPLETED|Overall Study||6
362583|NCT02160873|890492|P1|COMPLETED|Overall Study||6
362584|NCT02160873|890491|P2|STARTED|Overall Study||6
362585|NCT02160873|890492|P1|STARTED|Overall Study||6
362586|NCT02160314|890506|P2|NOT COMPLETED|Overall Study||13
362587|NCT02160314|890507|P1|NOT COMPLETED|Overall Study||1
362588|NCT02160314|890506|P2|COMPLETED|Overall Study||59
362589|NCT02160314|890507|P1|COMPLETED|Overall Study||72
362590|NCT02160314|890506|P2|STARTED|Overall Study||72
362591|NCT02160314|890507|P1|STARTED|Overall Study||73
362592|NCT02160002|890515|P2|NOT COMPLETED|Overall Study||1
362593|NCT02160002|890516|P1|NOT COMPLETED|Overall Study||2
362594|NCT02160002|890515|P2|COMPLETED|Overall Study||178
362595|NCT02160002|890516|P1|COMPLETED|Overall Study||185
362596|NCT02160002|890515|P2|Primary Outcome|Overall Study||178
362597|NCT02160002|890516|P1|Primary Outcome|Overall Study||185
362598|NCT02160002|890515|P2|STARTED|Overall Study||179
362599|NCT02160002|890516|P1|STARTED|Overall Study||187
362600|NCT02159950|890548|P2|NOT COMPLETED|Overall Study||2
362601|NCT02159950|890549|P1|NOT COMPLETED|Overall Study||0
362602|NCT02159950|890548|P2|COMPLETED|Overall Study||0
362603|NCT02159950|890549|P1|COMPLETED|Overall Study||0
362604|NCT02159950|890548|P2|STARTED|Overall Study||2
362605|NCT02159950|890549|P1|STARTED|Overall Study||0
362606|NCT02159898|890583|P2|NOT COMPLETED|Overall Study||0
362607|NCT02159898|890584|P1|NOT COMPLETED|Overall Study||1
362608|NCT02159898|890583|P2|COMPLETED|Overall Study||30
362609|NCT02159898|890584|P1|COMPLETED|Overall Study||29
362610|NCT02159898|890583|P2|STARTED|Overall Study||30
362611|NCT02159898|890584|P1|STARTED|Overall Study||30
362612|NCT02159859|890592|P1|NOT COMPLETED|Overall Study||0
362613|NCT02159859|890592|P1|COMPLETED|Overall Study||7
362614|NCT02159859|890592|P1|STARTED|Overall Study||7
362615|NCT02159768|890605|P1|NOT COMPLETED|Overall Study||0
362616|NCT02159768|890605|P1|COMPLETED|Overall Study|Completed 27 July 2015|30
362617|NCT02159768|890605|P1|STARTED|Overall Study|Started 16 July 2014|30
362618|NCT02159547|890612|P2|NOT COMPLETED|Overall Study||0
362619|NCT02159547|890613|P1|NOT COMPLETED|Overall Study||0
362620|NCT02159547|890612|P2|COMPLETED|Overall Study||112
362621|NCT02159547|890613|P1|COMPLETED|Overall Study||112
362622|NCT02159547|890612|P2|STARTED|Overall Study||112
362623|NCT02159547|890613|P1|STARTED|Overall Study||112
362624|NCT02159482|890621|P1|NOT COMPLETED|Overall Study||5
362625|NCT02159482|890621|P1|COMPLETED|Overall Study||6
362626|NCT02159482|890621|P1|STARTED|Overall Study||11
362627|NCT02159469|890626|P1|NOT COMPLETED|Overall Study||53
362628|NCT02159469|890626|P1|COMPLETED|Overall Study||97
362629|NCT02159469|890626|P1|Completed 12 Week|Overall Study||137
362630|NCT02159469|890626|P1|STARTED|Overall Study||150
362631|NCT02159365|890631|P1|NOT COMPLETED|Overall Study||22
362632|NCT02159365|890631|P1|COMPLETED|Overall Study|Completed = Still on Treatment|48
362633|NCT02159365|890631|P1|STARTED|Overall Study||70
362634|NCT02159352|890637|P2|NOT COMPLETED|Overall Study||2
362635|NCT02159352|890638|P1|NOT COMPLETED|Overall Study||3
362636|NCT02159352|890637|P2|COMPLETED|Overall Study||12
362637|NCT02159352|890638|P1|COMPLETED|Overall Study||11
362638|NCT02159352|890637|P2|Phase 2 (Day 5-14)|Overall Study||12
362639|NCT02159352|890638|P1|Phase 2 (Day 5-14)|Overall Study||11
362640|NCT02159352|890637|P2|Phase 1 (Day 1- 4)|Overall Study||14
362641|NCT02159352|890638|P1|Phase 1 (Day 1- 4)|Overall Study||14
362642|NCT02159352|890637|P2|STARTED|Overall Study||14
362643|NCT02159352|890638|P1|STARTED|Overall Study||14
362644|NCT02159118|890690|P2|NOT COMPLETED|Overall Study||0
362645|NCT02159118|890691|P1|NOT COMPLETED|Overall Study||0
362646|NCT02159118|890690|P2|COMPLETED|Overall Study||22
362647|NCT02159118|890691|P1|COMPLETED|Overall Study||22
362648|NCT02159118|890690|P2|STARTED|Overall Study||22
362649|NCT02159118|890691|P1|STARTED|Overall Study||22
362650|NCT02159040|890713|P1|NOT COMPLETED|Overall Study||1
362651|NCT02159040|890713|P1|COMPLETED|Overall Study||0
362652|NCT02159040|890713|P1|STARTED|Overall Study||1
362653|NCT02158975|890726|P1|NOT COMPLETED|Overall Study||1
362654|NCT02158975|890726|P1|COMPLETED|Overall Study||12
362655|NCT02158975|890726|P1|STARTED|Overall Study||13
362656|NCT02158936|890736|P2|NOT COMPLETED|Overall Study||177
362657|NCT02158936|890737|P1|NOT COMPLETED|Overall Study||179
362658|NCT02158936|890736|P2|COMPLETED|Overall Study||0
362659|NCT02158936|890737|P1|COMPLETED|Overall Study||0
362660|NCT02158936|890736|P2|Untreated|Overall Study||0
362661|NCT02158936|890737|P1|Untreated|Overall Study||2
362662|NCT02158936|890736|P2|Treated|Overall Study||177
362663|NCT02158936|890737|P1|Treated|Overall Study||177
362664|NCT02158936|890736|P2|STARTED|Overall Study||177
362665|NCT02158936|890737|P1|STARTED|Overall Study||179
362666|NCT02158728|890779|P1|NOT COMPLETED|Overall Study||27
362667|NCT02158728|890779|P1|COMPLETED|Overall Study||53
362668|NCT02158728|890779|P1|STARTED|Overall Study||80
362669|NCT02158572|890783|P1|NOT COMPLETED|Overall Study||1043
362670|NCT02158572|890783|P1|COMPLETED|Overall Study||989
362671|NCT02158572|890783|P1|STARTED|Overall Study||2032
362672|NCT02158442|890796|P2|NOT COMPLETED|Overall Study||0
362673|NCT02158442|890797|P1|NOT COMPLETED|Overall Study||2
362674|NCT02158442|890796|P2|COMPLETED|Overall Study||7
362675|NCT02158442|890797|P1|COMPLETED|Overall Study||6
362676|NCT02158442|890796|P2|STARTED|Overall Study||7
362677|NCT02158442|890797|P1|STARTED|Overall Study||8
362678|NCT02158364|890803|P1|NOT COMPLETED|Overall Study||60
362679|NCT02158364|890803|P1|COMPLETED|Overall Study||3271
362680|NCT02158364|890803|P1|STARTED|Overall Study||3331
362681|NCT02158273|890810|P2|NOT COMPLETED|Overall Study||3
362682|NCT02158273|890811|P1|NOT COMPLETED|Overall Study||3
362683|NCT02158273|890810|P2|COMPLETED|Overall Study||22
362684|NCT02158273|890811|P1|COMPLETED|Overall Study||22
362685|NCT02158273|890810|P2|STARTED|Overall Study||25
362686|NCT02158273|890811|P1|STARTED|Overall Study||25
362687|NCT02158247|890821|P1|NOT COMPLETED|Overall Study||5
362688|NCT02158247|890821|P1|COMPLETED|Overall Study||176
362689|NCT02158247|890821|P1|STARTED|Overall Study||181
362690|NCT02158039|890837|P1|NOT COMPLETED|Overall Study||10
362691|NCT02158039|890837|P1|COMPLETED|Overall Study||23
362692|NCT02158039|890837|P1|STARTED|Overall Study||33
362693|NCT02157948|890844|P2|NOT COMPLETED|Overall Study||9
362694|NCT02157948|890845|P1|NOT COMPLETED|Overall Study||9
362695|NCT02157948|890844|P2|COMPLETED|Overall Study||188
362696|NCT02157948|890845|P1|COMPLETED|Overall Study||188
362697|NCT02157948|890844|P2|Received Treatment|Overall Study||196
362698|NCT02157948|890845|P1|Received Treatment|Overall Study||196
362699|NCT02157948|890844|P2|STARTED|Overall Study||197
362700|NCT02157948|890845|P1|STARTED|Overall Study||197
362701|NCT02157935|890857|P2|NOT COMPLETED|Overall Study||65
362702|NCT02157935|890858|P1|NOT COMPLETED|Overall Study||39
362703|NCT02157935|890857|P2|COMPLETED|Overall Study||548
362704|NCT02157935|890858|P1|COMPLETED|Overall Study||567
362705|NCT02157935|890857|P2|STARTED|Overall Study||613
362706|NCT02157935|890858|P1|STARTED|Overall Study||606
362707|NCT02157909|890876|P2|NOT COMPLETED|Overall Study||0
362708|NCT02157909|890877|P1|NOT COMPLETED|Overall Study||0
362709|NCT02157909|890876|P2|COMPLETED|Overall Study||66
362710|NCT02157909|890877|P1|COMPLETED|Overall Study||66
362711|NCT02157909|890876|P2|STARTED|Overall Study||66
362712|NCT02157909|890877|P1|STARTED|Overall Study||66
362713|NCT02157883|890884|P1|NOT COMPLETED|Part B: Day 19 to End Part B (AZD9291)||22
362714|NCT02157883|890884|P1|COMPLETED|Part B: Day 19 to End Part B (AZD9291)||16
362715|NCT02157883|890884|P1|STARTED|Part B: Day 19 to End Part B (AZD9291)||38
362716|NCT02157883|890884|P1|NOT COMPLETED|Part A: Day 6-18 (AZD9291+Itraconozole)||1
362717|NCT02157883|890884|P1|COMPLETED|Part A: Day 6-18 (AZD9291+Itraconozole)||38
362718|NCT02157883|890884|P1|STARTED|Part A: Day 6-18 (AZD9291+Itraconozole)||39
362719|NCT02157883|890884|P1|NOT COMPLETED|Part A: Day 1-5 (AZD9291 Alone)||0
362720|NCT02157883|890884|P1|COMPLETED|Part A: Day 1-5 (AZD9291 Alone)||39
362721|NCT02157883|890884|P1|STARTED|Part A: Day 1-5 (AZD9291 Alone)||39
362722|NCT02157623|890915|P2|NOT COMPLETED|Overall Study||3
362723|NCT02157623|890916|P1|NOT COMPLETED|Overall Study||4
362724|NCT02157623|890915|P2|COMPLETED|Overall Study||0
362725|NCT02157623|890916|P1|COMPLETED|Overall Study||0
362726|NCT02157623|890915|P2|STARTED|Overall Study||3
362727|NCT02157623|890916|P1|STARTED|Overall Study||4
362728|NCT02157376|890924|P2|NOT COMPLETED|Overall Study||18
362729|NCT02157376|890925|P1|NOT COMPLETED|Overall Study||22
362730|NCT02157376|890924|P2|COMPLETED|Overall Study||138
362731|NCT02157376|890925|P1|COMPLETED|Overall Study||133
362732|NCT02157376|890924|P2|STARTED|Overall Study||156
362733|NCT02157376|890925|P1|STARTED|Overall Study||155
362734|NCT02157298|890935|P2|NOT COMPLETED|Overall Study||2
362735|NCT02157298|890936|P1|NOT COMPLETED|Overall Study||4
362736|NCT02157298|890935|P2|COMPLETED|Overall Study||58
362737|NCT02157298|890936|P1|COMPLETED|Overall Study||119
362738|NCT02157298|890935|P2|STARTED|Overall Study||60
362739|NCT02157298|890936|P1|STARTED|Overall Study||123
362740|NCT02157168|890953|P3|NOT COMPLETED|Overall Study||0
362741|NCT02157168|890954|P2|NOT COMPLETED|Overall Study||0
362742|NCT02157168|890955|P1|NOT COMPLETED|Overall Study||0
362743|NCT02157168|890953|P3|COMPLETED|Overall Study||1362
362744|NCT02157168|890954|P2|COMPLETED|Overall Study||159
362745|NCT02157168|890955|P1|COMPLETED|Overall Study||746
362746|NCT02157168|890953|P3|STARTED|Overall Study||1362
362747|NCT02157168|890954|P2|STARTED|Overall Study||159
362748|NCT02157168|890955|P1|STARTED|Overall Study||746
362749|NCT02157116|890975|P1|NOT COMPLETED|Overall Study||9
362750|NCT02157116|890975|P1|COMPLETED|Overall Study||4
362751|NCT02157116|890975|P1|STARTED|Overall Study|signed consent form|13
362752|NCT02157103|890984|P1|NOT COMPLETED|Overall Study||0
362753|NCT02157103|890984|P1|COMPLETED|Overall Study||3
362754|NCT02157103|890984|P1|STARTED|Overall Study||3
362755|NCT02156466|890995|P5|NOT COMPLETED|Overall Study||0
362756|NCT02156466|890996|P4|NOT COMPLETED|Overall Study||2
362757|NCT02156466|890997|P3|NOT COMPLETED|Overall Study||1
362758|NCT02156466|890998|P2|NOT COMPLETED|Overall Study||0
362759|NCT02156466|890999|P1|NOT COMPLETED|Overall Study||0
362760|NCT02156466|890995|P5|COMPLETED|Overall Study||8
362761|NCT02156466|890996|P4|COMPLETED|Overall Study||7
362762|NCT02156466|890997|P3|COMPLETED|Overall Study||7
362763|NCT02156466|890998|P2|COMPLETED|Overall Study||8
362764|NCT02156466|890999|P1|COMPLETED|Overall Study||8
362765|NCT02156466|890995|P5|STARTED|Overall Study||8
362766|NCT02156466|890996|P4|STARTED|Overall Study||9
362767|NCT02156466|890997|P3|STARTED|Overall Study||8
362768|NCT02156466|890998|P2|STARTED|Overall Study||8
362769|NCT02156466|890999|P1|STARTED|Overall Study||8
362770|NCT02156271|891180|P2|NOT COMPLETED|Overall Study||3
362771|NCT02156271|891181|P1|NOT COMPLETED|Overall Study||4
362772|NCT02156271|891180|P2|COMPLETED|Overall Study||10
362773|NCT02156271|891181|P1|COMPLETED|Overall Study||22
362774|NCT02156271|891180|P2|STARTED|Overall Study||13
362775|NCT02156271|891181|P1|STARTED|Overall Study||26
362776|NCT02156167|891213|P1|NOT COMPLETED|Overall Study||0
362777|NCT02156167|891213|P1|COMPLETED|Overall Study||15
362778|NCT02156167|891213|P1|STARTED|Overall Study||15
362779|NCT02155985|891220|P3|NOT COMPLETED|Overall Study||1
362780|NCT02155985|891221|P2|NOT COMPLETED|Overall Study||0
362781|NCT02155985|891222|P1|NOT COMPLETED|Overall Study||1
362782|NCT02155985|891220|P3|COMPLETED|Overall Study||39
362783|NCT02155985|891221|P2|COMPLETED|Overall Study||41
362784|NCT02155985|891222|P1|COMPLETED|Overall Study||39
362785|NCT02155985|891220|P3|STARTED|Overall Study||40
362786|NCT02155985|891221|P2|STARTED|Overall Study||41
362787|NCT02155985|891222|P1|STARTED|Overall Study||40
362788|NCT02155881|891289|P2|NOT COMPLETED|Overall Study||4
362789|NCT02155881|891290|P1|NOT COMPLETED|Overall Study||2
362790|NCT02155881|891289|P2|COMPLETED|Overall Study||36
362791|NCT02155881|891290|P1|COMPLETED|Overall Study||38
362792|NCT02155881|891289|P2|STARTED|Overall Study||40
362793|NCT02155881|891290|P1|STARTED|Overall Study||40
362794|NCT02155543|891317|P7|NOT COMPLETED|Overall Study||0
362795|NCT02155543|891318|P6|NOT COMPLETED|Overall Study||0
362796|NCT02155543|891319|P5|NOT COMPLETED|Overall Study||0
362797|NCT02155543|891320|P4|NOT COMPLETED|Overall Study||0
362798|NCT02155543|891321|P3|NOT COMPLETED|Overall Study||0
362799|NCT02155543|891322|P2|NOT COMPLETED|Overall Study||0
362800|NCT02155543|891323|P1|NOT COMPLETED|Overall Study||0
362801|NCT02155543|891317|P7|COMPLETED|Overall Study||9
362802|NCT02155543|891318|P6|COMPLETED|Overall Study||3
362803|NCT02155543|891319|P5|COMPLETED|Overall Study||3
362804|NCT02155543|891320|P4|COMPLETED|Overall Study||9
362805|NCT02155543|891321|P3|COMPLETED|Overall Study||9
362806|NCT02155543|891322|P2|COMPLETED|Overall Study||9
362807|NCT02155543|891323|P1|COMPLETED|Overall Study||9
362808|NCT02155543|891317|P7|STARTED|Overall Study||9
362809|NCT02155543|891318|P6|STARTED|Overall Study||3
362810|NCT02155543|891319|P5|STARTED|Overall Study||3
362811|NCT02155543|891320|P4|STARTED|Overall Study||9
362812|NCT02155543|891321|P3|STARTED|Overall Study||9
362813|NCT02155543|891322|P2|STARTED|Overall Study||9
362814|NCT02155543|891323|P1|STARTED|Overall Study||9
362815|NCT02155335|891336|P2|NOT COMPLETED|Period 2||0
362816|NCT02155335|891337|P1|NOT COMPLETED|Period 2||0
362817|NCT02155335|891336|P2|COMPLETED|Period 2||49
362818|NCT02155335|891337|P1|COMPLETED|Period 2||50
362819|NCT02155335|891336|P2|STARTED|Period 2||49
362820|NCT02155335|891337|P1|STARTED|Period 2||50
362821|NCT02155335|891336|P2|NOT COMPLETED|Period 1||1
362822|NCT02155335|891337|P1|NOT COMPLETED|Period 1||0
362823|NCT02155335|891336|P2|COMPLETED|Period 1||49
362824|NCT02155335|891337|P1|COMPLETED|Period 1||50
362825|NCT02155335|891336|P2|Treated|Period 1||49
362826|NCT02155335|891337|P1|Treated|Period 1||50
362827|NCT02155335|891336|P2|STARTED|Period 1||50
362828|NCT02155335|891337|P1|STARTED|Period 1||50
362829|NCT02155322|891342|P1|NOT COMPLETED|Overall Study||14
362830|NCT02155322|891342|P1|COMPLETED|Overall Study||19
362831|NCT02155322|891342|P1|Treated|Overall Study|32 of 33 participants treated. 1 participant not treated at the discretion of the investigator.|32
362832|NCT02155322|891342|P1|STARTED|Overall Study||33
362833|NCT02155309|891349|P3|NOT COMPLETED|Overall Study||1
362834|NCT02155309|891350|P2|NOT COMPLETED|Overall Study||0
362835|NCT02155309|891351|P1|NOT COMPLETED|Overall Study||0
362836|NCT02155309|891349|P3|COMPLETED|Overall Study||12
362837|NCT02155309|891350|P2|COMPLETED|Overall Study||10
362838|NCT02155309|891351|P1|COMPLETED|Overall Study||13
362839|NCT02155309|891349|P3|STARTED|Overall Study||13
362840|NCT02155309|891350|P2|STARTED|Overall Study||10
362841|NCT02155309|891351|P1|STARTED|Overall Study||13
362842|NCT02155283|891358|P1|NOT COMPLETED|Overall Study||7
362843|NCT02155283|891358|P1|COMPLETED|Overall Study||9
362844|NCT02155283|891358|P1|STARTED|Overall Study||16
362845|NCT02155010|891365|P2|NOT COMPLETED|Overall Study||6
362846|NCT02155010|891366|P1|NOT COMPLETED|Overall Study||6
362847|NCT02155010|891365|P2|COMPLETED|Overall Study||31
362848|NCT02155010|891366|P1|COMPLETED|Overall Study||31
362849|NCT02155010|891365|P2|STARTED|Overall Study||37
362850|NCT02155010|891366|P1|STARTED|Overall Study||37
362851|NCT02154906|891376|P2|NOT COMPLETED|Overall Study||3
362852|NCT02154906|891377|P1|NOT COMPLETED|Overall Study||2
362853|NCT02154906|891376|P2|COMPLETED|Overall Study||17
362854|NCT02154906|891377|P1|COMPLETED|Overall Study||19
362855|NCT02154906|891376|P2|STARTED|Overall Study||20
362856|NCT02154906|891377|P1|STARTED|Overall Study||21
362857|NCT02154425|891385|P1|NOT COMPLETED|Sampling Period||0
362858|NCT02154425|891385|P1|COMPLETED|Sampling Period||17
362859|NCT02154425|891385|P1|STARTED|Sampling Period||17
362860|NCT02154425|891385|P1|NOT COMPLETED|Screening Period||1
362861|NCT02154425|891385|P1|COMPLETED|Screening Period||17
362862|NCT02154425|891385|P1|STARTED|Screening Period||18
362863|NCT02154386|891417|P2|NOT COMPLETED|Overall Study||2
362864|NCT02154386|891418|P1|NOT COMPLETED|Overall Study||1
362865|NCT02154386|891417|P2|COMPLETED|Overall Study||21
362866|NCT02154386|891418|P1|COMPLETED|Overall Study||22
362867|NCT02154386|891417|P2|STARTED|Overall Study||23
362868|NCT02154386|891418|P1|STARTED|Overall Study||23
362869|NCT02154243|891431|P3|NOT COMPLETED|Overall Study||0
362870|NCT02154243|891432|P2|NOT COMPLETED|Overall Study||0
362871|NCT02154243|891433|P1|NOT COMPLETED|Overall Study||0
362872|NCT02154243|891431|P3|COMPLETED|Overall Study||4
362873|NCT02154243|891432|P2|COMPLETED|Overall Study||4
362874|NCT02154243|891433|P1|COMPLETED|Overall Study||5
362875|NCT02154243|891431|P3|STARTED|Overall Study||4
362876|NCT02154243|891432|P2|STARTED|Overall Study||4
362877|NCT02154243|891433|P1|STARTED|Overall Study||5
362878|NCT02154139|891444|P1|NOT COMPLETED|Overall Study||7
362879|NCT02154139|891444|P1|COMPLETED|Overall Study||644
362880|NCT02154139|891444|P1|STARTED|Overall Study||651
362881|NCT02154087|891452|P1|NOT COMPLETED|Overall Study||1
362882|NCT02154087|891452|P1|COMPLETED|Overall Study||0
362883|NCT02154087|891452|P1|STARTED|Overall Study||1
362884|NCT02154061|891458|P2|NOT COMPLETED|Overall Study||0
362885|NCT02154061|891459|P1|NOT COMPLETED|Overall Study||2
362886|NCT02154061|891458|P2|COMPLETED|Overall Study||17
362887|NCT02154061|891459|P1|COMPLETED|Overall Study||14
362888|NCT02154061|891458|P2|STARTED|Overall Study||17
362889|NCT02154061|891459|P1|STARTED|Overall Study||16
362890|NCT02154048|891468|P3|NOT COMPLETED|Overall Study||0
362891|NCT02154048|891469|P2|NOT COMPLETED|Overall Study||0
362892|NCT02154048|891470|P1|NOT COMPLETED|Overall Study||0
362893|NCT02154048|891468|P3|COMPLETED|Overall Study||1
362894|NCT02154048|891469|P2|COMPLETED|Overall Study||2
362895|NCT02154048|891470|P1|COMPLETED|Overall Study||2
362896|NCT02154048|891468|P3|STARTED|Overall Study||1
362897|NCT02154048|891469|P2|STARTED|Overall Study||2
362898|NCT02154048|891470|P1|STARTED|Overall Study||2
362899|NCT02153827|891480|P2|NOT COMPLETED|Overall Study||9
362900|NCT02153827|891481|P1|NOT COMPLETED|Overall Study||3
362901|NCT02153827|891480|P2|COMPLETED|Overall Study||14
362902|NCT02153827|891481|P1|COMPLETED|Overall Study||22
362903|NCT02153827|891480|P2|STARTED|Overall Study||23
362904|NCT02153827|891481|P1|STARTED|Overall Study||25
362905|NCT02153788|891497|P2|NOT COMPLETED|Overall Study||1
362906|NCT02153788|891498|P1|NOT COMPLETED|Overall Study||2
362907|NCT02153788|891497|P2|COMPLETED|Overall Study||18
362908|NCT02153788|891498|P1|COMPLETED|Overall Study||23
362909|NCT02153788|891497|P2|STARTED|Overall Study||19
362910|NCT02153788|891498|P1|STARTED|Overall Study||25
362911|NCT02153736|891518|P2|NOT COMPLETED|Overall Study||2
362912|NCT02153736|891519|P1|NOT COMPLETED|Overall Study||2
362913|NCT02153736|891518|P2|COMPLETED|Overall Study||5
362914|NCT02153736|891519|P1|COMPLETED|Overall Study||5
362915|NCT02153736|891518|P2|STARTED|Overall Study||7
362916|NCT02153736|891519|P1|STARTED|Overall Study||7
362917|NCT02153489|891535|P2|NOT COMPLETED|Period 2||0
362918|NCT02153489|891536|P1|NOT COMPLETED|Period 2||0
362919|NCT02153489|891535|P2|COMPLETED|Period 2||15
362920|NCT02153489|891536|P1|COMPLETED|Period 2||15
362921|NCT02153489|891535|P2|STARTED|Period 2||15
362922|NCT02153489|891536|P1|STARTED|Period 2||15
362923|NCT02153489|891535|P2|NOT COMPLETED|Period 1||0
362924|NCT02153489|891536|P1|NOT COMPLETED|Period 1||0
362925|NCT02153489|891535|P2|COMPLETED|Period 1||15
362926|NCT02153489|891536|P1|COMPLETED|Period 1||15
362927|NCT02153489|891535|P2|STARTED|Period 1||15
362928|NCT02153489|891536|P1|STARTED|Period 1||15
362929|NCT02153398|891579|P5|NOT COMPLETED|Overall Study||0
362930|NCT02153398|891580|P4|NOT COMPLETED|Overall Study||1
362931|NCT02153398|891581|P3|NOT COMPLETED|Overall Study||1
362932|NCT02153398|891582|P2|NOT COMPLETED|Overall Study||0
362933|NCT02153398|891583|P1|NOT COMPLETED|Overall Study||1
362934|NCT02153398|891579|P5|COMPLETED|Overall Study||10
362935|NCT02153398|891580|P4|COMPLETED|Overall Study||9
362936|NCT02153398|891581|P3|COMPLETED|Overall Study||9
362937|NCT02153398|891582|P2|COMPLETED|Overall Study||10
362938|NCT02153398|891583|P1|COMPLETED|Overall Study||9
362939|NCT02153398|891579|P5|STARTED|Overall Study||10
362940|NCT02153398|891580|P4|STARTED|Overall Study||10
362941|NCT02153398|891581|P3|STARTED|Overall Study||10
362942|NCT02153398|891582|P2|STARTED|Overall Study||10
362943|NCT02153398|891583|P1|STARTED|Overall Study||10
362944|NCT02153346|891705|P1|NOT COMPLETED|Overall Study||11
362945|NCT02153346|891705|P1|COMPLETED|Overall Study||90
362946|NCT02153346|891705|P1|STARTED|Overall Study||101
362947|NCT02153099|891719|P7|NOT COMPLETED|Overall Study||0
362948|NCT02153099|891720|P6|NOT COMPLETED|Overall Study||0
362949|NCT02153099|891721|P5|NOT COMPLETED|Overall Study||0
362950|NCT02153099|891722|P4|NOT COMPLETED|Overall Study||0
362951|NCT02153099|891723|P3|NOT COMPLETED|Overall Study||0
362952|NCT02153099|891724|P2|NOT COMPLETED|Overall Study||0
362953|NCT02153099|891725|P1|NOT COMPLETED|Overall Study||0
362954|NCT02153099|891719|P7|COMPLETED|Overall Study||12
362955|NCT02153099|891720|P6|COMPLETED|Overall Study||6
362956|NCT02153099|891721|P5|COMPLETED|Overall Study||6
362957|NCT02153099|891722|P4|COMPLETED|Overall Study||6
362958|NCT02153099|891723|P3|COMPLETED|Overall Study||6
362959|NCT02153099|891724|P2|COMPLETED|Overall Study||6
362960|NCT02153099|891725|P1|COMPLETED|Overall Study||6
362961|NCT02153099|891719|P7|STARTED|Overall Study||12
362962|NCT02153099|891720|P6|STARTED|Overall Study||6
362963|NCT02153099|891721|P5|STARTED|Overall Study||6
362964|NCT02153099|891722|P4|STARTED|Overall Study||6
362965|NCT02153099|891723|P3|STARTED|Overall Study||6
362966|NCT02153099|891724|P2|STARTED|Overall Study||6
362967|NCT02153099|891725|P1|STARTED|Overall Study||6
362968|NCT02153086|891779|P1|NOT COMPLETED|Overall Study||4
362969|NCT02153086|891779|P1|COMPLETED|Overall Study||232
362970|NCT02153086|891779|P1|STARTED|Overall Study||236
362971|NCT02152605|891795|P2|NOT COMPLETED|Overall Study||18
362972|NCT02152605|891796|P1|NOT COMPLETED|Overall Study||19
362973|NCT02152605|891795|P2|COMPLETED|Overall Study||230
362974|NCT02152605|891796|P1|COMPLETED|Overall Study||229
362975|NCT02152605|891795|P2|STARTED|Overall Study||248
362976|NCT02152605|891796|P1|STARTED|Overall Study||248
362977|NCT02152566|891806|P1|NOT COMPLETED|Overall Study||3
362978|NCT02152566|891806|P1|COMPLETED|Overall Study||3
362979|NCT02152566|891806|P1|STARTED|Overall Study||6
362980|NCT02152371|891812|P2|NOT COMPLETED|Overall Study||16
362981|NCT02152371|891813|P1|NOT COMPLETED|Overall Study||12
362982|NCT02152371|891812|P2|COMPLETED|Overall Study||134
362983|NCT02152371|891813|P1|COMPLETED|Overall Study||138
362984|NCT02152371|891812|P2|Received at Least 1 Dose of Study Drug.|Overall Study||150
362985|NCT02152371|891813|P1|Received at Least 1 Dose of Study Drug.|Overall Study||150
362986|NCT02152371|891812|P2|STARTED|Overall Study||150
362987|NCT02152371|891813|P1|STARTED|Overall Study||150
362988|NCT02152007|891849|P1|NOT COMPLETED|Overall Study||1
362989|NCT02152007|891849|P1|COMPLETED|Overall Study||14
362990|NCT02152007|891849|P1|STARTED|Overall Study||15
362991|NCT02151994|891858|P13|NOT COMPLETED|Food Effect (FE): Fed||0
362992|NCT02151994|891859|P12|NOT COMPLETED|Food Effect (FE): Fed||0
362993|NCT02151994|891860|P11|NOT COMPLETED|Food Effect (FE): Fed||0
362994|NCT02151994|891861|P10|NOT COMPLETED|Food Effect (FE): Fed||0
362995|NCT02151994|891862|P9|NOT COMPLETED|Food Effect (FE): Fed||0
362996|NCT02151994|891863|P8|NOT COMPLETED|Food Effect (FE): Fed||0
362997|NCT02151994|891864|P7|NOT COMPLETED|Food Effect (FE): Fed||0
362998|NCT02151994|891865|P6|NOT COMPLETED|Food Effect (FE): Fed||0
362999|NCT02151994|891866|P5|NOT COMPLETED|Food Effect (FE): Fed||0
363000|NCT02151994|891867|P4|NOT COMPLETED|Food Effect (FE): Fed||0
363001|NCT02151994|891868|P3|NOT COMPLETED|Food Effect (FE): Fed||0
363002|NCT02151994|891869|P2|NOT COMPLETED|Food Effect (FE): Fed||0
363003|NCT02151994|891870|P1|NOT COMPLETED|Food Effect (FE): Fed||0
363004|NCT02151994|891858|P13|COMPLETED|Food Effect (FE): Fed||12
363005|NCT02151994|891859|P12|COMPLETED|Food Effect (FE): Fed||0
363006|NCT02151994|891860|P11|COMPLETED|Food Effect (FE): Fed||0
363007|NCT02151994|891861|P10|COMPLETED|Food Effect (FE): Fed||0
363008|NCT02151994|891862|P9|COMPLETED|Food Effect (FE): Fed||0
363009|NCT02151994|891863|P8|COMPLETED|Food Effect (FE): Fed||0
363010|NCT02151994|891864|P7|COMPLETED|Food Effect (FE): Fed||0
363011|NCT02151994|891865|P6|COMPLETED|Food Effect (FE): Fed||0
363012|NCT02151994|891866|P5|COMPLETED|Food Effect (FE): Fed||0
363013|NCT02151994|891867|P4|COMPLETED|Food Effect (FE): Fed||0
363014|NCT02151994|891868|P3|COMPLETED|Food Effect (FE): Fed||0
363015|NCT02151994|891869|P2|COMPLETED|Food Effect (FE): Fed||0
363016|NCT02151994|891870|P1|COMPLETED|Food Effect (FE): Fed||0
363017|NCT02151994|891858|P13|STARTED|Food Effect (FE): Fed||12
363018|NCT02151994|891859|P12|STARTED|Food Effect (FE): Fed||0
363019|NCT02151994|891860|P11|STARTED|Food Effect (FE): Fed||0
363020|NCT02151994|891861|P10|STARTED|Food Effect (FE): Fed||0
363021|NCT02151994|891862|P9|STARTED|Food Effect (FE): Fed||0
363022|NCT02151994|891863|P8|STARTED|Food Effect (FE): Fed||0
363023|NCT02151994|891864|P7|STARTED|Food Effect (FE): Fed||0
363024|NCT02151994|891865|P6|STARTED|Food Effect (FE): Fed||0
363025|NCT02151994|891866|P5|STARTED|Food Effect (FE): Fed||0
363026|NCT02151994|891867|P4|STARTED|Food Effect (FE): Fed||0
363027|NCT02151994|891868|P3|STARTED|Food Effect (FE): Fed||0
363028|NCT02151994|891869|P2|STARTED|Food Effect (FE): Fed||0
363029|NCT02151994|891870|P1|STARTED|Food Effect (FE): Fed||0
363030|NCT02151994|891858|P13|NOT COMPLETED|Food Effect (FE): Fasted||0
363031|NCT02151994|891859|P12|NOT COMPLETED|Food Effect (FE): Fasted||0
363032|NCT02151994|891860|P11|NOT COMPLETED|Food Effect (FE): Fasted||0
363033|NCT02151994|891861|P10|NOT COMPLETED|Food Effect (FE): Fasted||0
363034|NCT02151994|891862|P9|NOT COMPLETED|Food Effect (FE): Fasted||0
363035|NCT02151994|891863|P8|NOT COMPLETED|Food Effect (FE): Fasted||0
363036|NCT02151994|891864|P7|NOT COMPLETED|Food Effect (FE): Fasted||0
363037|NCT02151994|891865|P6|NOT COMPLETED|Food Effect (FE): Fasted||0
363038|NCT02151994|891866|P5|NOT COMPLETED|Food Effect (FE): Fasted||0
363039|NCT02151994|891867|P4|NOT COMPLETED|Food Effect (FE): Fasted||0
363040|NCT02151994|891868|P3|NOT COMPLETED|Food Effect (FE): Fasted||0
363041|NCT02151994|891869|P2|NOT COMPLETED|Food Effect (FE): Fasted||0
363042|NCT02151994|891870|P1|NOT COMPLETED|Food Effect (FE): Fasted||0
363043|NCT02151994|891858|P13|COMPLETED|Food Effect (FE): Fasted||0
363044|NCT02151994|891859|P12|COMPLETED|Food Effect (FE): Fasted||12
363045|NCT02151994|891860|P11|COMPLETED|Food Effect (FE): Fasted||0
363046|NCT02151994|891861|P10|COMPLETED|Food Effect (FE): Fasted||0
363047|NCT02151994|891862|P9|COMPLETED|Food Effect (FE): Fasted||0
363048|NCT02151994|891863|P8|COMPLETED|Food Effect (FE): Fasted||0
363049|NCT02151994|891864|P7|COMPLETED|Food Effect (FE): Fasted||0
363050|NCT02151994|891865|P6|COMPLETED|Food Effect (FE): Fasted||0
363051|NCT02151994|891866|P5|COMPLETED|Food Effect (FE): Fasted||0
363052|NCT02151994|891867|P4|COMPLETED|Food Effect (FE): Fasted||0
363053|NCT02151994|891868|P3|COMPLETED|Food Effect (FE): Fasted||0
363054|NCT02151994|891869|P2|COMPLETED|Food Effect (FE): Fasted||0
363055|NCT02151994|891870|P1|COMPLETED|Food Effect (FE): Fasted||0
363056|NCT02151994|891858|P13|STARTED|Food Effect (FE): Fasted||0
363057|NCT02151994|891859|P12|STARTED|Food Effect (FE): Fasted||12
363058|NCT02151994|891860|P11|STARTED|Food Effect (FE): Fasted||0
363059|NCT02151994|891861|P10|STARTED|Food Effect (FE): Fasted||0
363060|NCT02151994|891862|P9|STARTED|Food Effect (FE): Fasted||0
363061|NCT02151994|891863|P8|STARTED|Food Effect (FE): Fasted||0
363062|NCT02151994|891864|P7|STARTED|Food Effect (FE): Fasted||0
363063|NCT02151994|891865|P6|STARTED|Food Effect (FE): Fasted||0
363064|NCT02151994|891866|P5|STARTED|Food Effect (FE): Fasted||0
363065|NCT02151994|891867|P4|STARTED|Food Effect (FE): Fasted||0
363066|NCT02151994|891868|P3|STARTED|Food Effect (FE): Fasted||0
363067|NCT02151994|891869|P2|STARTED|Food Effect (FE): Fasted||0
363068|NCT02151994|891870|P1|STARTED|Food Effect (FE): Fasted||0
363069|NCT02151994|891858|P13|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
363070|NCT02151994|891859|P12|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
363071|NCT02151994|891860|P11|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
363072|NCT02151994|891861|P10|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
363073|NCT02151994|891862|P9|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
363074|NCT02151994|891863|P8|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
363075|NCT02151994|891864|P7|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
363076|NCT02151994|891865|P6|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
363077|NCT02151994|891866|P5|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
363078|NCT02151994|891867|P4|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
363079|NCT02151994|891868|P3|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
363080|NCT02151994|891869|P2|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
363081|NCT02151994|891870|P1|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
363082|NCT02151994|891858|P13|COMPLETED|Multiple Ascending Dose (MAD)||0
363083|NCT02151994|891859|P12|COMPLETED|Multiple Ascending Dose (MAD)||0
363084|NCT02151994|891860|P11|COMPLETED|Multiple Ascending Dose (MAD)||0
363085|NCT02151994|891861|P10|COMPLETED|Multiple Ascending Dose (MAD)||0
363086|NCT02151994|891862|P9|COMPLETED|Multiple Ascending Dose (MAD)||6
363087|NCT02151994|891863|P8|COMPLETED|Multiple Ascending Dose (MAD)||0
363088|NCT02151994|891864|P7|COMPLETED|Multiple Ascending Dose (MAD)||6
363089|NCT02151994|891865|P6|COMPLETED|Multiple Ascending Dose (MAD)||6
363090|NCT02151994|891866|P5|COMPLETED|Multiple Ascending Dose (MAD)||6
363091|NCT02151994|891867|P4|COMPLETED|Multiple Ascending Dose (MAD)||6
363092|NCT02151994|891868|P3|COMPLETED|Multiple Ascending Dose (MAD)||0
363093|NCT02151994|891869|P2|COMPLETED|Multiple Ascending Dose (MAD)||0
363094|NCT02151994|891870|P1|COMPLETED|Multiple Ascending Dose (MAD)||10
363095|NCT02151994|891858|P13|STARTED|Multiple Ascending Dose (MAD)||0
363096|NCT02151994|891859|P12|STARTED|Multiple Ascending Dose (MAD)||0
363097|NCT02151994|891860|P11|STARTED|Multiple Ascending Dose (MAD)||0
363098|NCT02151994|891861|P10|STARTED|Multiple Ascending Dose (MAD)||0
363099|NCT02151994|891862|P9|STARTED|Multiple Ascending Dose (MAD)||6
363100|NCT02151994|891863|P8|STARTED|Multiple Ascending Dose (MAD)||0
363101|NCT02151994|891864|P7|STARTED|Multiple Ascending Dose (MAD)||6
363102|NCT02151994|891865|P6|STARTED|Multiple Ascending Dose (MAD)||6
363103|NCT02151994|891866|P5|STARTED|Multiple Ascending Dose (MAD)||6
363104|NCT02151994|891867|P4|STARTED|Multiple Ascending Dose (MAD)||6
363105|NCT02151994|891868|P3|STARTED|Multiple Ascending Dose (MAD)||0
363106|NCT02151994|891869|P2|STARTED|Multiple Ascending Dose (MAD)||0
363107|NCT02151994|891870|P1|STARTED|Multiple Ascending Dose (MAD)||10
363108|NCT02151994|891858|P13|NOT COMPLETED|Single Ascending Dose (SAD)||0
363109|NCT02151994|891859|P12|NOT COMPLETED|Single Ascending Dose (SAD)||0
363110|NCT02151994|891860|P11|NOT COMPLETED|Single Ascending Dose (SAD)||0
363111|NCT02151994|891861|P10|NOT COMPLETED|Single Ascending Dose (SAD)||0
363112|NCT02151994|891862|P9|NOT COMPLETED|Single Ascending Dose (SAD)||0
363113|NCT02151994|891863|P8|NOT COMPLETED|Single Ascending Dose (SAD)||0
363114|NCT02151994|891864|P7|NOT COMPLETED|Single Ascending Dose (SAD)||0
363115|NCT02151994|891865|P6|NOT COMPLETED|Single Ascending Dose (SAD)||0
363116|NCT02151994|891866|P5|NOT COMPLETED|Single Ascending Dose (SAD)||0
363117|NCT02151994|891867|P4|NOT COMPLETED|Single Ascending Dose (SAD)||0
363118|NCT02151994|891868|P3|NOT COMPLETED|Single Ascending Dose (SAD)||0
363119|NCT02151994|891869|P2|NOT COMPLETED|Single Ascending Dose (SAD)||0
363120|NCT02151994|891870|P1|NOT COMPLETED|Single Ascending Dose (SAD)||0
363121|NCT02151994|891858|P13|COMPLETED|Single Ascending Dose (SAD)||0
363122|NCT02151994|891859|P12|COMPLETED|Single Ascending Dose (SAD)||0
363123|NCT02151994|891860|P11|COMPLETED|Single Ascending Dose (SAD)||6
363124|NCT02151994|891861|P10|COMPLETED|Single Ascending Dose (SAD)||6
363125|NCT02151994|891862|P9|COMPLETED|Single Ascending Dose (SAD)||0
363126|NCT02151994|891863|P8|COMPLETED|Single Ascending Dose (SAD)||6
363127|NCT02151994|891864|P7|COMPLETED|Single Ascending Dose (SAD)||6
363128|NCT02151994|891865|P6|COMPLETED|Single Ascending Dose (SAD)||6
363129|NCT02151994|891866|P5|COMPLETED|Single Ascending Dose (SAD)||6
363130|NCT02151994|891867|P4|COMPLETED|Single Ascending Dose (SAD)||6
363131|NCT02151994|891868|P3|COMPLETED|Single Ascending Dose (SAD)||6
363132|NCT02151994|891869|P2|COMPLETED|Single Ascending Dose (SAD)||6
363133|NCT02151994|891870|P1|COMPLETED|Single Ascending Dose (SAD)||18
363134|NCT02151994|891858|P13|STARTED|Single Ascending Dose (SAD)||0
363135|NCT02151994|891859|P12|STARTED|Single Ascending Dose (SAD)||0
363136|NCT02151994|891860|P11|STARTED|Single Ascending Dose (SAD)||6
363137|NCT02151994|891861|P10|STARTED|Single Ascending Dose (SAD)||6
363138|NCT02151994|891862|P9|STARTED|Single Ascending Dose (SAD)||0
363139|NCT02151994|891863|P8|STARTED|Single Ascending Dose (SAD)||6
363140|NCT02151994|891864|P7|STARTED|Single Ascending Dose (SAD)||6
363141|NCT02151994|891865|P6|STARTED|Single Ascending Dose (SAD)||6
363142|NCT02151994|891866|P5|STARTED|Single Ascending Dose (SAD)||6
363143|NCT02151994|891867|P4|STARTED|Single Ascending Dose (SAD)||6
363144|NCT02151994|891868|P3|STARTED|Single Ascending Dose (SAD)||6
363145|NCT02151994|891869|P2|STARTED|Single Ascending Dose (SAD)||6
363146|NCT02151994|891870|P1|STARTED|Single Ascending Dose (SAD)||18
363147|NCT02151981|891910|P2|NOT COMPLETED|Overall Study||140
363148|NCT02151981|891911|P1|NOT COMPLETED|Overall Study||279
363149|NCT02151981|891910|P2|COMPLETED|Overall Study||0
363150|NCT02151981|891911|P1|COMPLETED|Overall Study||0
363151|NCT02151981|891910|P2|Crossed Over AZD9291|Overall Study|Patients randomised to chemotherapy were allowed to crossover to AZD9291 after progression|82
363152|NCT02151981|891911|P1|Crossed Over AZD9291|Overall Study||0
363153|NCT02151981|891910|P2|Did Not Receive Treatment|Overall Study||4
363154|NCT02151981|891911|P1|Did Not Receive Treatment|Overall Study||0
363155|NCT02151981|891910|P2|Received Randomised Treatment Only|Overall Study||54
363156|NCT02151981|891911|P1|Received Randomised Treatment Only|Overall Study||279
363157|NCT02151981|891910|P2|STARTED|Overall Study||140
363158|NCT02151981|891911|P1|STARTED|Overall Study||279
363159|NCT02151851|891929|P2|NOT COMPLETED|Overall Study||130
363160|NCT02151851|891930|P1|NOT COMPLETED|Overall Study||76
363161|NCT02151851|891929|P2|COMPLETED|Overall Study||186
363162|NCT02151851|891930|P1|COMPLETED|Overall Study||38
363163|NCT02151851|891929|P2|Included in the Safety Set|Overall Study||316
363164|NCT02151851|891930|P1|Included in the Safety Set|Overall Study||113
363165|NCT02151851|891929|P2|STARTED|Overall Study||316
363166|NCT02151851|891930|P1|STARTED|Overall Study||114
363167|NCT02151786|891942|P1|NOT COMPLETED|Overall Study||36
363168|NCT02151786|891942|P1|COMPLETED|Overall Study||1084
363169|NCT02151786|891942|P1|STARTED|Overall Study||1120
363170|NCT02151773|891953|P1|NOT COMPLETED|Overall Study||64
363171|NCT02151773|891953|P1|COMPLETED|Overall Study||3429
363172|NCT02151773|891953|P1|STARTED|Overall Study||3493
363173|NCT02151643|891963|P5|NOT COMPLETED|Overall Study||3
363174|NCT02151643|891964|P4|NOT COMPLETED|Overall Study||7
363175|NCT02151643|891965|P3|NOT COMPLETED|Overall Study||4
363176|NCT02151643|891966|P2|NOT COMPLETED|Overall Study||4
363177|NCT02151643|891967|P1|NOT COMPLETED|Overall Study||6
363178|NCT02151643|891963|P5|COMPLETED|Overall Study||35
363179|NCT02151643|891964|P4|COMPLETED|Overall Study||32
363180|NCT02151643|891965|P3|COMPLETED|Overall Study||21
363181|NCT02151643|891966|P2|COMPLETED|Overall Study||21
363182|NCT02151643|891967|P1|COMPLETED|Overall Study||20
363183|NCT02151643|891963|P5|STARTED|Overall Study||38
363184|NCT02151643|891964|P4|STARTED|Overall Study||39
363185|NCT02151643|891965|P3|STARTED|Overall Study||25
363186|NCT02151643|891966|P2|STARTED|Overall Study||25
363187|NCT02151643|891967|P1|STARTED|Overall Study||26
363188|NCT02151461|892008|P4|NOT COMPLETED|Overall Study||4
363189|NCT02151461|892009|P3|NOT COMPLETED|Overall Study||3
363190|NCT02151461|892010|P2|NOT COMPLETED|Overall Study||1
363191|NCT02151461|892011|P1|NOT COMPLETED|Overall Study||6
363192|NCT02151461|892008|P4|COMPLETED|Overall Study||19
363193|NCT02151461|892009|P3|COMPLETED|Overall Study||21
363194|NCT02151461|892010|P2|COMPLETED|Overall Study||24
363195|NCT02151461|892011|P1|COMPLETED|Overall Study||18
363196|NCT02151461|892008|P4|STARTED|Overall Study||23
363197|NCT02151461|892009|P3|STARTED|Overall Study||24
363198|NCT02151461|892010|P2|STARTED|Overall Study||25
363199|NCT02151461|892011|P1|STARTED|Overall Study||24
363200|NCT02151253|892049|P2|NOT COMPLETED|Overall Study||0
363201|NCT02151253|892050|P1|NOT COMPLETED|Overall Study||0
363202|NCT02151253|892049|P2|COMPLETED|Overall Study||15
363203|NCT02151253|892050|P1|COMPLETED|Overall Study||13
363204|NCT02151253|892049|P2|STARTED|Overall Study||15
363205|NCT02151253|892050|P1|STARTED|Overall Study||13
363206|NCT02151058|892067|P3|NOT COMPLETED|Overall Study||5
363207|NCT02151058|892068|P2|NOT COMPLETED|Overall Study||1
363208|NCT02151058|892069|P1|NOT COMPLETED|Overall Study||2
363209|NCT02151058|892067|P3|COMPLETED|Overall Study||86
363210|NCT02151058|892068|P2|COMPLETED|Overall Study||90
363211|NCT02151058|892069|P1|COMPLETED|Overall Study||43
363212|NCT02151058|892067|P3|STARTED|Overall Study||91
363213|NCT02151058|892068|P2|STARTED|Overall Study||91
363214|NCT02151058|892069|P1|STARTED|Overall Study||45
363215|NCT02150954|892103|P2|NOT COMPLETED|Overall Study||0
363216|NCT02150954|892104|P1|NOT COMPLETED|Overall Study||1
363217|NCT02150954|892103|P2|COMPLETED|Overall Study||59
363218|NCT02150954|892104|P1|COMPLETED|Overall Study||57
363219|NCT02150954|892103|P2|STARTED|Overall Study||59
363220|NCT02150954|892104|P1|STARTED|Overall Study||58
363221|NCT02150499|892128|P2|NOT COMPLETED|Overall Study||0
363222|NCT02150499|892129|P1|NOT COMPLETED|Overall Study||0
363223|NCT02150499|892128|P2|COMPLETED|Overall Study||9
363224|NCT02150499|892129|P1|COMPLETED|Overall Study||9
363225|NCT02150499|892128|P2|STARTED|Overall Study||9
363226|NCT02150499|892129|P1|STARTED|Overall Study||9
363227|NCT02150460|892151|P2|NOT COMPLETED|Overall Study||0
363228|NCT02150460|892152|P1|NOT COMPLETED|Overall Study||0
363229|NCT02150460|892151|P2|COMPLETED|Overall Study||50
363230|NCT02150460|892152|P1|COMPLETED|Overall Study||50
363231|NCT02150460|892151|P2|STARTED|Overall Study||50
363232|NCT02150460|892152|P1|STARTED|Overall Study||50
363233|NCT02150343|892180|P4|NOT COMPLETED|Overall Study||10
363234|NCT02150343|892181|P3|NOT COMPLETED|Overall Study||12
363235|NCT02150343|892182|P2|NOT COMPLETED|Overall Study||20
363236|NCT02150343|892183|P1|NOT COMPLETED|Overall Study||21
363237|NCT02150343|892180|P4|COMPLETED|Overall Study||168
363238|NCT02150343|892181|P3|COMPLETED|Overall Study||166
363239|NCT02150343|892182|P2|COMPLETED|Overall Study||158
363240|NCT02150343|892183|P1|COMPLETED|Overall Study||159
363241|NCT02150343|892180|P4|STARTED|Overall Study||178
363242|NCT02150343|892181|P3|STARTED|Overall Study||178
363243|NCT02150343|892182|P2|STARTED|Overall Study||178
363244|NCT02150343|892183|P1|STARTED|Overall Study||180
363245|NCT02150213|892221|P1|NOT COMPLETED|Overall Study||2
363246|NCT02150213|892221|P1|COMPLETED|Overall Study||57
363247|NCT02150213|892221|P1|STARTED|Overall Study||59
363248|NCT02150109|892226|P1|NOT COMPLETED|Overall Study||0
363249|NCT02150109|892226|P1|COMPLETED|Overall Study||372
363250|NCT02150109|892226|P1|STARTED|Overall Study||372
363251|NCT02150044|892238|P1|NOT COMPLETED|Overall Study||0
363252|NCT02150044|892238|P1|COMPLETED|Overall Study||29
363253|NCT02150044|892238|P1|Study Cohort|Overall Study||13
363254|NCT02150044|892238|P1|Lead-In Subjects|Overall Study||16
363255|NCT02150044|892238|P1|STARTED|Overall Study||29
363256|NCT02149875|892247|P3|NOT COMPLETED|Overall Study||9
363257|NCT02149875|892248|P2|NOT COMPLETED|Overall Study||8
363258|NCT02149875|892249|P1|NOT COMPLETED|Overall Study||7
363259|NCT02149875|892247|P3|COMPLETED|Overall Study||20
363260|NCT02149875|892248|P2|COMPLETED|Overall Study||20
363261|NCT02149875|892249|P1|COMPLETED|Overall Study||20
363262|NCT02149875|892247|P3|STARTED|Overall Study||29
363263|NCT02149875|892248|P2|STARTED|Overall Study||28
363264|NCT02149875|892249|P1|STARTED|Overall Study||27
363265|NCT02149342|892260|P1|NOT COMPLETED|Overall Study||0
363266|NCT02149342|892260|P1|COMPLETED|Overall Study|14 patients|14
363267|NCT02149342|892260|P1|STARTED|Overall Study|14 patients|14
363268|NCT02149303|892272|P1|NOT COMPLETED|Overall Study||0
363269|NCT02149303|892272|P1|COMPLETED|Overall Study||191
363270|NCT02149303|892272|P1|STARTED|Overall Study||191
363271|NCT02149264|892278|P1|NOT COMPLETED|Overall Study||20
363272|NCT02149264|892278|P1|COMPLETED|Overall Study||139
363273|NCT02149264|892278|P1|STARTED|Overall Study|Of the 160 enrolled subjects, one discontinued before receiving treatment.|159
363274|NCT02149108|892293|P2|NOT COMPLETED|Overall Study||383
363275|NCT02149108|892294|P1|NOT COMPLETED|Overall Study||380
363276|NCT02149108|892293|P2|COMPLETED|Overall Study|On-treatment at analysis cut-off date (14JUN2016).|3
363277|NCT02149108|892294|P1|COMPLETED|Overall Study|On-treatment at analysis cut-off date (14JUN2016).|2
363278|NCT02149108|892293|P2|STARTED|Overall Study|Randomised patients.|386
363279|NCT02149108|892294|P1|STARTED|Overall Study|Randomised patients.|382
363280|NCT02148809|892306|P1|NOT COMPLETED|Overall Study||0
363281|NCT02148809|892306|P1|COMPLETED|Overall Study||14
363282|NCT02148809|892306|P1|STARTED|Overall Study||14
363283|NCT02148718|892311|P1|NOT COMPLETED|Overall Study||31
363284|NCT02148718|892311|P1|COMPLETED|Overall Study||55
363285|NCT02148718|892311|P1|STARTED|Overall Study||86
363286|NCT02148588|892332|P1|NOT COMPLETED|Overall Study||0
363287|NCT02148588|892332|P1|COMPLETED|Overall Study||8
363288|NCT02148588|892332|P1|STARTED|Overall Study||8
363289|NCT02148523|892344|P3|NOT COMPLETED|Overall Study||0
363290|NCT02148523|892345|P2|NOT COMPLETED|Overall Study||0
363291|NCT02148523|892346|P1|NOT COMPLETED|Overall Study||0
363292|NCT02148523|892344|P3|COMPLETED|Overall Study||67
363293|NCT02148523|892345|P2|COMPLETED|Overall Study||67
363294|NCT02148523|892346|P1|COMPLETED|Overall Study||67
363295|NCT02148523|892344|P3|STARTED|Overall Study||67
363296|NCT02148523|892345|P2|STARTED|Overall Study||67
363297|NCT02148523|892346|P1|STARTED|Overall Study||67
363298|NCT02148445|892359|P2|NOT COMPLETED|Overall Study||3
363299|NCT02148445|892360|P1|NOT COMPLETED|Overall Study||1
363300|NCT02148445|892359|P2|COMPLETED|Overall Study||197
363301|NCT02148445|892360|P1|COMPLETED|Overall Study||197
363302|NCT02148445|892359|P2|STARTED|Overall Study||200
363303|NCT02148445|892360|P1|STARTED|Overall Study||198
363304|NCT02148107|892399|P3|NOT COMPLETED|Overall Study||0
363305|NCT02148107|892400|P2|NOT COMPLETED|Overall Study||0
363306|NCT02148107|892401|P1|NOT COMPLETED|Overall Study||0
363307|NCT02148107|892399|P3|COMPLETED|Overall Study||3
363308|NCT02148107|892400|P2|COMPLETED|Overall Study||7
363309|NCT02148107|892401|P1|COMPLETED|Overall Study||8
363310|NCT02148107|892399|P3|STARTED|Overall Study||3
363311|NCT02148107|892400|P2|STARTED|Overall Study||7
363312|NCT02148107|892401|P1|STARTED|Overall Study||8
363313|NCT02147899|892420|P3|NOT COMPLETED|Overall Study||0
363314|NCT02147899|892421|P2|NOT COMPLETED|Overall Study||0
363315|NCT02147899|892422|P1|NOT COMPLETED|Overall Study||0
363316|NCT02147899|892420|P3|COMPLETED|Overall Study||72
363317|NCT02147899|892421|P2|COMPLETED|Overall Study||72
363318|NCT02147899|892422|P1|COMPLETED|Overall Study||71
363319|NCT02147899|892420|P3|STARTED|Overall Study||72
363320|NCT02147899|892421|P2|STARTED|Overall Study||72
363321|NCT02147899|892422|P1|STARTED|Overall Study||71
363322|NCT02147691|892435|P2|NOT COMPLETED|Overall Study||1
363323|NCT02147691|892436|P1|NOT COMPLETED|Overall Study||4
363324|NCT02147691|892435|P2|COMPLETED|Overall Study||11
363325|NCT02147691|892436|P1|COMPLETED|Overall Study||6
363326|NCT02147691|892435|P2|STARTED|Overall Study||12
363327|NCT02147691|892436|P1|STARTED|Overall Study||10
363328|NCT02147587|892482|P2|NOT COMPLETED|Overall Study||5
363329|NCT02147587|892483|P1|NOT COMPLETED|Overall Study||11
363330|NCT02147587|892482|P2|COMPLETED|Overall Study||50
363331|NCT02147587|892483|P1|COMPLETED|Overall Study||46
363332|NCT02147587|892482|P2|STARTED|Overall Study||55
363333|NCT02147587|892483|P1|STARTED|Overall Study||57
363334|NCT02147561|892503|P1|NOT COMPLETED|Overall Study||4
363335|NCT02147561|892503|P1|COMPLETED|Overall Study||276
363336|NCT02147561|892503|P1|STARTED|Overall Study||280
363337|NCT02147522|892511|P2|NOT COMPLETED|Overall Study||48
363338|NCT02147522|892512|P1|NOT COMPLETED|Overall Study||56
363339|NCT02147522|892511|P2|COMPLETED|Overall Study||122
363340|NCT02147522|892512|P1|COMPLETED|Overall Study||122
363341|NCT02147522|892511|P2|STARTED|Overall Study||170
363342|NCT02147522|892512|P1|STARTED|Overall Study||178
363343|NCT02147288|892524|P10|NOT COMPLETED|Overall Study||0
363344|NCT02147288|892525|P9|NOT COMPLETED|Overall Study||0
363345|NCT02147288|892526|P8|NOT COMPLETED|Overall Study||0
363346|NCT02147288|892527|P7|NOT COMPLETED|Overall Study||0
363347|NCT02147288|892528|P6|NOT COMPLETED|Overall Study||0
363348|NCT02147288|892529|P5|NOT COMPLETED|Overall Study||0
363349|NCT02147288|892530|P4|NOT COMPLETED|Overall Study||0
363350|NCT02147288|892531|P3|NOT COMPLETED|Overall Study||0
363351|NCT02147288|892532|P2|NOT COMPLETED|Overall Study||2
363352|NCT02147288|892533|P1|NOT COMPLETED|Overall Study||1
363353|NCT02147288|892524|P10|COMPLETED|Overall Study||0
363354|NCT02147288|892525|P9|COMPLETED|Overall Study||0
363355|NCT02147288|892526|P8|COMPLETED|Overall Study||0
363356|NCT02147288|892527|P7|COMPLETED|Overall Study||0
363357|NCT02147288|892528|P6|COMPLETED|Overall Study||0
363358|NCT02147288|892529|P5|COMPLETED|Overall Study||0
363359|NCT02147288|892530|P4|COMPLETED|Overall Study||0
363360|NCT02147288|892531|P3|COMPLETED|Overall Study||0
363361|NCT02147288|892532|P2|COMPLETED|Overall Study||22
363362|NCT02147288|892533|P1|COMPLETED|Overall Study||21
363363|NCT02147288|892524|P10|STARTED|Overall Study||0
363364|NCT02147288|892525|P9|STARTED|Overall Study||0
363365|NCT02147288|892526|P8|STARTED|Overall Study||0
363366|NCT02147288|892527|P7|STARTED|Overall Study||0
363367|NCT02147288|892528|P6|STARTED|Overall Study||0
363368|NCT02147288|892529|P5|STARTED|Overall Study||0
363369|NCT02147288|892530|P4|STARTED|Overall Study||0
363370|NCT02147288|892531|P3|STARTED|Overall Study||0
363371|NCT02147288|892532|P2|STARTED|Overall Study||24
363372|NCT02147288|892533|P1|STARTED|Overall Study||22
363373|NCT02147184|892541|P2|NOT COMPLETED|Overall Study||27
363374|NCT02147184|892542|P1|NOT COMPLETED|Overall Study||49
363375|NCT02147184|892541|P2|COMPLETED|Overall Study||110
363376|NCT02147184|892542|P1|COMPLETED|Overall Study||78
363377|NCT02147184|892541|P2|STARTED|Overall Study||137
363378|NCT02147184|892542|P1|STARTED|Overall Study||127
363379|NCT02147093|892562|P2|NOT COMPLETED|Period 2||0
363380|NCT02147093|892563|P1|NOT COMPLETED|Period 2||2
363381|NCT02147093|892562|P2|COMPLETED|Period 2||19
363382|NCT02147093|892563|P1|COMPLETED|Period 2||18
363383|NCT02147093|892562|P2|STARTED|Period 2||19
363384|NCT02147093|892563|P1|STARTED|Period 2||20
363385|NCT02147093|892562|P2|NOT COMPLETED|Period 1||1
363386|NCT02147093|892563|P1|NOT COMPLETED|Period 1||0
363387|NCT02147093|892562|P2|COMPLETED|Period 1||19
363388|NCT02147093|892563|P1|COMPLETED|Period 1||20
363389|NCT02147093|892562|P2|STARTED|Period 1||20
363390|NCT02147093|892563|P1|STARTED|Period 1||20
363391|NCT02146599|892571|P1|NOT COMPLETED|Overall Study||5
363392|NCT02146599|892571|P1|COMPLETED|Overall Study||296
363393|NCT02146599|892571|P1|STARTED|Overall Study||301
363394|NCT02146482|892577|P2|NOT COMPLETED|Overall Study||0
363395|NCT02146482|892578|P1|NOT COMPLETED|Overall Study||0
363396|NCT02146482|892577|P2|COMPLETED|Overall Study||25
363397|NCT02146482|892578|P1|COMPLETED|Overall Study||21
363398|NCT02146482|892577|P2|STARTED|Overall Study|11 participants total enrolled in study but withdrew prior to randomization|25
363399|NCT02146482|892578|P1|STARTED|Overall Study|11 participants total enrolled in study but withdrew prior to randomization|21
363400|NCT02146352|892584|P1|NOT COMPLETED|Overall Study||2
363401|NCT02146352|892584|P1|COMPLETED|Overall Study||28
363402|NCT02146352|892584|P1|7 Days Post-stent Removal|Overall Study||28
363403|NCT02146352|892584|P1|30 or 60 Days Post-procedure|Overall Study||30
363404|NCT02146352|892584|P1|STARTED|Overall Study||30
363405|NCT02146326|892602|P4|NOT COMPLETED|Overall Study||48
363406|NCT02146326|892603|P3|NOT COMPLETED|Overall Study||43
363407|NCT02146326|892604|P2|NOT COMPLETED|Overall Study||37
363408|NCT02146326|892605|P1|NOT COMPLETED|Overall Study||28
363409|NCT02146326|892602|P4|COMPLETED|Overall Study||210
363410|NCT02146326|892603|P3|COMPLETED|Overall Study||168
363411|NCT02146326|892604|P2|COMPLETED|Overall Study||66
363412|NCT02146326|892605|P1|COMPLETED|Overall Study||61
363413|NCT02146326|892602|P4|12 Months|Overall Study||210
363414|NCT02146326|892603|P3|12 Months|Overall Study||168
363415|NCT02146326|892604|P2|12 Months|Overall Study||66
363416|NCT02146326|892605|P1|12 Months|Overall Study||61
363417|NCT02146326|892602|P4|6 Months|Overall Study||235
363418|NCT02146326|892603|P3|6 Months|Overall Study||186
363419|NCT02146326|892604|P2|6 Months|Overall Study||71
363420|NCT02146326|892605|P1|6 Months|Overall Study||71
363421|NCT02146326|892602|P4|3 Months|Overall Study||0
363422|NCT02146326|892603|P3|3 Months|Overall Study||0
363423|NCT02146326|892604|P2|3 Months|Overall Study||83
363424|NCT02146326|892605|P1|3 Months|Overall Study||71
363425|NCT02146326|892602|P4|Baseline|Overall Study||258
363426|NCT02146326|892603|P3|Baseline|Overall Study||211
363427|NCT02146326|892604|P2|Baseline|Overall Study||103
363428|NCT02146326|892605|P1|Baseline|Overall Study||89
363429|NCT02146326|892602|P4|STARTED|Overall Study||258
363430|NCT02146326|892603|P3|STARTED|Overall Study||211
363431|NCT02146326|892604|P2|STARTED|Overall Study||103
363432|NCT02146326|892605|P1|STARTED|Overall Study||89
363433|NCT02146248|892767|P1|NOT COMPLETED|Overall Study||2
363434|NCT02146248|892767|P1|COMPLETED|Overall Study||9
363435|NCT02146248|892767|P1|HSG 5|Overall Study||1
363436|NCT02146248|892767|P1|HSG 4|Overall Study||7
363437|NCT02146248|892767|P1|HSG 3|Overall Study||9
363438|NCT02146248|892767|P1|HSG 2|Overall Study||10
363439|NCT02146248|892767|P1|HSG 1|Overall Study||10
363440|NCT02146248|892767|P1|Uterine Sounding|Overall Study|one subject dropped out after uterine sound before HSG #1|11
363441|NCT02146248|892767|P1|Enrolled|Overall Study||11
363442|NCT02146248|892767|P1|STARTED|Overall Study||11
363443|NCT02146105|892775|P1|NOT COMPLETED|Overall Study||6
363444|NCT02146105|892775|P1|COMPLETED|Overall Study||39
363445|NCT02146105|892775|P1|STARTED|Overall Study||45
363446|NCT02146001|892781|P2|NOT COMPLETED|Overall Study||0
363447|NCT02146001|892782|P1|NOT COMPLETED|Overall Study||0
363448|NCT02146001|892781|P2|COMPLETED|Overall Study||19
363449|NCT02146001|892782|P1|COMPLETED|Overall Study||19
363450|NCT02146001|892781|P2|STARTED|Overall Study||19
363451|NCT02146001|892782|P1|STARTED|Overall Study||19
363452|NCT02145754|892792|P1|NOT COMPLETED|Overall Study||0
363453|NCT02145754|892792|P1|COMPLETED|Overall Study||235
363454|NCT02145754|892792|P1|STARTED|Overall Study||235
363455|NCT02145676|892799|P3|NOT COMPLETED|Overall Study||0
363456|NCT02145676|892800|P2|NOT COMPLETED|Overall Study||0
363457|NCT02145676|892801|P1|NOT COMPLETED|Overall Study||0
363458|NCT02145676|892799|P3|COMPLETED|Overall Study||18
363459|NCT02145676|892800|P2|COMPLETED|Overall Study||18
363460|NCT02145676|892801|P1|COMPLETED|Overall Study||17
363461|NCT02145676|892799|P3|STARTED|Overall Study||18
363462|NCT02145676|892800|P2|STARTED|Overall Study||18
363463|NCT02145676|892801|P1|STARTED|Overall Study||17
363464|NCT02145468|892826|P2|NOT COMPLETED|Overall Study||8
363465|NCT02145468|892827|P1|NOT COMPLETED|Overall Study||5
363466|NCT02145468|892826|P2|COMPLETED|Overall Study||1723
363467|NCT02145468|892827|P1|COMPLETED|Overall Study||1753
363468|NCT02145468|892826|P2|STARTED|Overall Study||1731
363469|NCT02145468|892827|P1|STARTED|Overall Study||1758
363470|NCT02145299|892885|P2|NOT COMPLETED|Overall Study||0
363471|NCT02145299|892886|P1|NOT COMPLETED|Overall Study||0
363472|NCT02145299|892885|P2|COMPLETED|Overall Study||2
363473|NCT02145299|892886|P1|COMPLETED|Overall Study||6
363474|NCT02145299|892885|P2|STARTED|Overall Study||2
363475|NCT02145299|892886|P1|STARTED|Overall Study||6
363476|NCT02145156|892915|P3|NOT COMPLETED|Overall Study||41
363477|NCT02145156|892916|P2|NOT COMPLETED|Overall Study||52
363478|NCT02145156|892917|P1|NOT COMPLETED|Overall Study||60
363479|NCT02145156|892915|P3|COMPLETED|Overall Study||398
363480|NCT02145156|892916|P2|COMPLETED|Overall Study||373
363481|NCT02145156|892917|P1|COMPLETED|Overall Study||370
363482|NCT02145156|892915|P3|STARTED|Overall Study||439
363483|NCT02145156|892916|P2|STARTED|Overall Study||425
363484|NCT02145156|892917|P1|STARTED|Overall Study||430
363485|NCT02144519|892960|P2|NOT COMPLETED|Year 3||0
363486|NCT02144519|892961|P1|NOT COMPLETED|Year 3||0
363487|NCT02144519|892960|P2|COMPLETED|Year 3||760
363488|NCT02144519|892961|P1|COMPLETED|Year 3||894
363489|NCT02144519|892960|P2|STARTED|Year 3||760
363490|NCT02144519|892961|P1|STARTED|Year 3||894
363491|NCT02144519|892960|P2|NOT COMPLETED|Year 2||0
363492|NCT02144519|892961|P1|NOT COMPLETED|Year 2||0
363493|NCT02144519|892960|P2|COMPLETED|Year 2||864
363494|NCT02144519|892961|P1|COMPLETED|Year 2||763
363495|NCT02144519|892960|P2|STARTED|Year 2||864
363496|NCT02144519|892961|P1|STARTED|Year 2||763
363497|NCT02144519|892960|P2|NOT COMPLETED|Year 1||0
363498|NCT02144519|892961|P1|NOT COMPLETED|Year 1||0
363499|NCT02144519|892960|P2|COMPLETED|Year 1||870
363500|NCT02144519|892961|P1|COMPLETED|Year 1||895
363501|NCT02144519|892960|P2|STARTED|Year 1||870
363502|NCT02144519|892961|P1|STARTED|Year 1||895
363503|NCT02144337|892971|P2|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||0
363504|NCT02144337|892972|P1|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||3
363505|NCT02144337|892971|P2|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5
363506|NCT02144337|892972|P1|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5
363507|NCT02144337|892971|P2|STARTED|T3 Follow-up (3 Month Post-intervention)|Number not the same as number who completed previous period due to absence/loss of data at T2|5
363508|NCT02144337|892972|P1|STARTED|T3 Follow-up (3 Month Post-intervention)|Number not the same as number who completed previous period due to absence/loss of data at T2|8
363509|NCT02144337|892971|P2|NOT COMPLETED|T2 Follow-up (Post-intervention)||1
363510|NCT02144337|892972|P1|NOT COMPLETED|T2 Follow-up (Post-intervention)||4
363511|NCT02144337|892971|P2|COMPLETED|T2 Follow-up (Post-intervention)||4
363512|NCT02144337|892972|P1|COMPLETED|T2 Follow-up (Post-intervention)||4
363513|NCT02144337|892971|P2|STARTED|T2 Follow-up (Post-intervention)||5
363514|NCT02144337|892972|P1|STARTED|T2 Follow-up (Post-intervention)||8
363515|NCT02144337|892971|P2|NOT COMPLETED|Baseline 0 Months||0
363516|NCT02144337|892972|P1|NOT COMPLETED|Baseline 0 Months||0
363517|NCT02144337|892971|P2|COMPLETED|Baseline 0 Months||5
363518|NCT02144337|892972|P1|COMPLETED|Baseline 0 Months||8
363519|NCT02144337|892971|P2|STARTED|Baseline 0 Months||5
363520|NCT02144337|892972|P1|STARTED|Baseline 0 Months||8
363521|NCT02144259|892985|P3|NOT COMPLETED|Overall Study||18
363522|NCT02144259|892986|P2|NOT COMPLETED|Overall Study||5
363523|NCT02144259|892987|P1|NOT COMPLETED|Overall Study||10
363524|NCT02144259|892985|P3|COMPLETED|Overall Study||16
363525|NCT02144259|892986|P2|COMPLETED|Overall Study||28
363526|NCT02144259|892987|P1|COMPLETED|Overall Study||23
363527|NCT02144259|892985|P3|STARTED|Overall Study||34
363528|NCT02144259|892986|P2|STARTED|Overall Study||33
363529|NCT02144259|892987|P1|STARTED|Overall Study||33
363530|NCT02144220|893001|P1|NOT COMPLETED|Overall Study||19
363531|NCT02144220|893001|P1|COMPLETED|Overall Study||258
363532|NCT02144220|893001|P1|STARTED|Overall Study||277
363533|NCT02144012|893011|P2|NOT COMPLETED|Overall Study||15
363534|NCT02144012|893012|P1|NOT COMPLETED|Overall Study||34
363535|NCT02144012|893011|P2|COMPLETED|Overall Study||0
363536|NCT02144012|893012|P1|COMPLETED|Overall Study||0
363537|NCT02144012|893011|P2|STARTED|Overall Study||15
363538|NCT02144012|893012|P1|STARTED|Overall Study||34
363539|NCT02143947|893049|P2|NOT COMPLETED|Overall Study||2
363540|NCT02143947|893050|P1|NOT COMPLETED|Overall Study||4
363541|NCT02143947|893049|P2|COMPLETED|Overall Study||42
363542|NCT02143947|893050|P1|COMPLETED|Overall Study||32
363543|NCT02143947|893049|P2|STARTED|Overall Study||44
363544|NCT02143947|893050|P1|STARTED|Overall Study||36
363545|NCT02143583|893065|P3|NOT COMPLETED|Overall Study||2
363546|NCT02143583|893066|P2|NOT COMPLETED|Overall Study||0
363547|NCT02143583|893067|P1|NOT COMPLETED|Overall Study||1
363548|NCT02143583|893065|P3|COMPLETED|Overall Study||66
363549|NCT02143583|893066|P2|COMPLETED|Overall Study||66
363550|NCT02143583|893067|P1|COMPLETED|Overall Study||61
363551|NCT02143583|893065|P3|STARTED|Overall Study||68
363552|NCT02143583|893066|P2|STARTED|Overall Study||66
363553|NCT02143583|893067|P1|STARTED|Overall Study||62
363554|NCT02143141|893080|P2|NOT COMPLETED|Overall Study||0
363555|NCT02143141|893081|P1|NOT COMPLETED|Overall Study||1
363556|NCT02143141|893080|P2|COMPLETED|Overall Study||6
363557|NCT02143141|893081|P1|COMPLETED|Overall Study||6
363558|NCT02143141|893080|P2|STARTED|Overall Study||6
363559|NCT02143141|893081|P1|STARTED|Overall Study||7
363560|NCT02142738|893093|P2|NOT COMPLETED|Overall Study||151
363561|NCT02142738|893094|P1|NOT COMPLETED|Overall Study||154
363562|NCT02142738|893093|P2|COMPLETED|Overall Study||0
363563|NCT02142738|893094|P1|COMPLETED|Overall Study||0
363564|NCT02142738|893093|P2|Treated|Overall Study||150
363565|NCT02142738|893094|P1|Treated|Overall Study||154
363566|NCT02142738|893093|P2|STARTED|Overall Study||151
363567|NCT02142738|893094|P1|STARTED|Overall Study||154
363568|NCT02142712|893107|P4|NOT COMPLETED|Overall Study||0
363569|NCT02142712|893108|P3|NOT COMPLETED|Overall Study||1
363570|NCT02142712|893109|P2|NOT COMPLETED|Overall Study||1
363571|NCT02142712|893110|P1|NOT COMPLETED|Overall Study||1
363572|NCT02142712|893107|P4|COMPLETED|Overall Study||0
363573|NCT02142712|893108|P3|COMPLETED|Overall Study||0
363574|NCT02142712|893109|P2|COMPLETED|Overall Study||0
363575|NCT02142712|893110|P1|COMPLETED|Overall Study||0
363576|NCT02142712|893107|P4|STARTED|Overall Study||0
363577|NCT02142712|893108|P3|STARTED|Overall Study||1
363578|NCT02142712|893109|P2|STARTED|Overall Study||1
363579|NCT02142712|893110|P1|STARTED|Overall Study||1
363580|NCT02142504|893133|P3|NOT COMPLETED|Overall Study||43
363581|NCT02142504|893134|P2|NOT COMPLETED|Overall Study||42
363582|NCT02142504|893135|P1|NOT COMPLETED|Overall Study||31
363583|NCT02142504|893133|P3|COMPLETED|Overall Study||111
363584|NCT02142504|893134|P2|COMPLETED|Overall Study||105
363585|NCT02142504|893135|P1|COMPLETED|Overall Study||122
363586|NCT02142504|893133|P3|Received Booster (Second Vaccination)|Overall Study||116
363587|NCT02142504|893134|P2|Received Booster (Second Vaccination)|Overall Study||109
363588|NCT02142504|893135|P1|Received Booster (Second Vaccination)|Overall Study||126
363589|NCT02142504|893133|P3|Randomized and Received Treatment|Overall Study||154
363590|NCT02142504|893134|P2|Randomized and Received Treatment|Overall Study||145
363591|NCT02142504|893135|P1|Randomized and Received Treatment|Overall Study||153
363592|NCT02142504|893133|P3|STARTED|Overall Study||154
363593|NCT02142504|893134|P2|STARTED|Overall Study||147
363594|NCT02142504|893135|P1|STARTED|Overall Study||153
363595|NCT02142361|893221|P3|NOT COMPLETED|Overall Study||0
363596|NCT02142361|893222|P2|NOT COMPLETED|Overall Study||0
363597|NCT02142361|893223|P1|NOT COMPLETED|Overall Study||0
363598|NCT02142361|893221|P3|COMPLETED|Overall Study||20
363599|NCT02142361|893222|P2|COMPLETED|Overall Study||20
363600|NCT02142361|893223|P1|COMPLETED|Overall Study||20
363601|NCT02142361|893221|P3|STARTED|Overall Study||20
363602|NCT02142361|893222|P2|STARTED|Overall Study||20
363603|NCT02142361|893223|P1|STARTED|Overall Study||20
363604|NCT02142153|893332|P10|NOT COMPLETED|Overall Study||0
363605|NCT02142153|893333|P9|NOT COMPLETED|Overall Study||0
363606|NCT02142153|893334|P8|NOT COMPLETED|Overall Study||0
363607|NCT02142153|893335|P7|NOT COMPLETED|Overall Study||0
363608|NCT02142153|893336|P6|NOT COMPLETED|Overall Study||0
363609|NCT02142153|893337|P5|NOT COMPLETED|Overall Study||0
363610|NCT02142153|893338|P4|NOT COMPLETED|Overall Study||0
363611|NCT02142153|893339|P3|NOT COMPLETED|Overall Study||0
363612|NCT02142153|893340|P2|NOT COMPLETED|Overall Study||0
363613|NCT02142153|893341|P1|NOT COMPLETED|Overall Study||0
363614|NCT02142153|893332|P10|COMPLETED|Overall Study||2
363615|NCT02142153|893333|P9|COMPLETED|Overall Study||6
363616|NCT02142153|893334|P8|COMPLETED|Overall Study||2
363617|NCT02142153|893335|P7|COMPLETED|Overall Study||6
363618|NCT02142153|893336|P6|COMPLETED|Overall Study||2
363619|NCT02142153|893337|P5|COMPLETED|Overall Study||6
363620|NCT02142153|893338|P4|COMPLETED|Overall Study||2
363621|NCT02142153|893339|P3|COMPLETED|Overall Study||6
363622|NCT02142153|893340|P2|COMPLETED|Overall Study||2
363623|NCT02142153|893341|P1|COMPLETED|Overall Study||6
363624|NCT02142153|893332|P10|STARTED|Overall Study||2
363625|NCT02142153|893333|P9|STARTED|Overall Study||6
363626|NCT02142153|893334|P8|STARTED|Overall Study||2
363627|NCT02142153|893335|P7|STARTED|Overall Study||6
363628|NCT02142153|893336|P6|STARTED|Overall Study||2
363629|NCT02142153|893337|P5|STARTED|Overall Study||6
363630|NCT02142153|893338|P4|STARTED|Overall Study||2
363631|NCT02142153|893339|P3|STARTED|Overall Study||6
363632|NCT02142153|893340|P2|STARTED|Overall Study||2
363633|NCT02142153|893341|P1|STARTED|Overall Study||6
363634|NCT02141997|893377|P4|NOT COMPLETED|Overall Study||1
363635|NCT02141997|893378|P3|NOT COMPLETED|Overall Study||3
363636|NCT02141997|893379|P2|NOT COMPLETED|Overall Study||6
363637|NCT02141997|893380|P1|NOT COMPLETED|Overall Study||3
363638|NCT02141997|893377|P4|COMPLETED|Overall Study||54
363639|NCT02141997|893378|P3|COMPLETED|Overall Study||53
363640|NCT02141997|893379|P2|COMPLETED|Overall Study||49
363641|NCT02141997|893380|P1|COMPLETED|Overall Study||53
363642|NCT02141997|893377|P4|STARTED|Overall Study||55
363643|NCT02141997|893378|P3|STARTED|Overall Study||56
363644|NCT02141997|893379|P2|STARTED|Overall Study||55
363645|NCT02141997|893380|P1|STARTED|Overall Study||56
363646|NCT02141984|893418|P1|NOT COMPLETED|Overall Study||2
363647|NCT02141984|893418|P1|COMPLETED|Overall Study||26
363648|NCT02141984|893418|P1|STARTED|Overall Study||28
363649|NCT02141867|893425|P1|NOT COMPLETED|Overall Study||94
363650|NCT02141867|893425|P1|COMPLETED|Overall Study||3927
363651|NCT02141867|893425|P1|STARTED|Overall Study||4021
363652|NCT02141854|893437|P6|NOT COMPLETED|Treatment Period||38
363653|NCT02141854|893438|P5|NOT COMPLETED|Treatment Period||10
363654|NCT02141854|893439|P4|NOT COMPLETED|Treatment Period||11
363655|NCT02141854|893440|P3|NOT COMPLETED|Treatment Period||9
363656|NCT02141854|893441|P2|NOT COMPLETED|Treatment Period||10
363657|NCT02141854|893442|P1|NOT COMPLETED|Treatment Period||0
363658|NCT02141854|893437|P6|COMPLETED|Treatment Period||107
363659|NCT02141854|893438|P5|COMPLETED|Treatment Period||136
363660|NCT02141854|893439|P4|COMPLETED|Treatment Period||135
363661|NCT02141854|893440|P3|COMPLETED|Treatment Period||136
363662|NCT02141854|893441|P2|COMPLETED|Treatment Period||136
363663|NCT02141854|893442|P1|COMPLETED|Treatment Period||0
363664|NCT02141854|893437|P6|Full Analysis Set|Treatment Period||143
363665|NCT02141854|893438|P5|Full Analysis Set|Treatment Period||145
363666|NCT02141854|893439|P4|Full Analysis Set|Treatment Period||146
363667|NCT02141854|893440|P3|Full Analysis Set|Treatment Period||141
363668|NCT02141854|893441|P2|Full Analysis Set|Treatment Period||145
363669|NCT02141854|893442|P1|Full Analysis Set|Treatment Period||0
363670|NCT02141854|893437|P6|Safety Population|Treatment Period||144
363671|NCT02141854|893438|P5|Safety Population|Treatment Period||145
363672|NCT02141854|893439|P4|Safety Population|Treatment Period||146
363673|NCT02141854|893440|P3|Safety Population|Treatment Period||143
363674|NCT02141854|893441|P2|Safety Population|Treatment Period||145
363675|NCT02141854|893442|P1|Safety Population|Treatment Period||0
363676|NCT02141854|893437|P6|Intent to Treat Population|Treatment Period||145
363677|NCT02141854|893438|P5|Intent to Treat Population|Treatment Period||146
363678|NCT02141854|893439|P4|Intent to Treat Population|Treatment Period||146
363679|NCT02141854|893440|P3|Intent to Treat Population|Treatment Period||145
363680|NCT02141854|893441|P2|Intent to Treat Population|Treatment Period||146
363681|NCT02141854|893442|P1|Intent to Treat Population|Treatment Period||0
363682|NCT02141854|893437|P6|STARTED|Treatment Period||145
363683|NCT02141854|893438|P5|STARTED|Treatment Period||146
363684|NCT02141854|893439|P4|STARTED|Treatment Period||146
363685|NCT02141854|893440|P3|STARTED|Treatment Period||145
363686|NCT02141854|893441|P2|STARTED|Treatment Period||146
363687|NCT02141854|893442|P1|STARTED|Treatment Period||0
363688|NCT02141854|893437|P6|NOT COMPLETED|Run-In Period (Pre-assignment)||0
363689|NCT02141854|893438|P5|NOT COMPLETED|Run-In Period (Pre-assignment)||0
363690|NCT02141854|893439|P4|NOT COMPLETED|Run-In Period (Pre-assignment)||0
363691|NCT02141854|893440|P3|NOT COMPLETED|Run-In Period (Pre-assignment)||0
363692|NCT02141854|893441|P2|NOT COMPLETED|Run-In Period (Pre-assignment)||0
363693|NCT02141854|893442|P1|NOT COMPLETED|Run-In Period (Pre-assignment)||154
363694|NCT02141854|893437|P6|COMPLETED|Run-In Period (Pre-assignment)||0
363695|NCT02141854|893438|P5|COMPLETED|Run-In Period (Pre-assignment)||0
363696|NCT02141854|893439|P4|COMPLETED|Run-In Period (Pre-assignment)||0
363697|NCT02141854|893440|P3|COMPLETED|Run-In Period (Pre-assignment)||0
363698|NCT02141854|893441|P2|COMPLETED|Run-In Period (Pre-assignment)||0
363699|NCT02141854|893442|P1|COMPLETED|Run-In Period (Pre-assignment)||728
363700|NCT02141854|893437|P6|STARTED|Run-In Period (Pre-assignment)||0
363701|NCT02141854|893438|P5|STARTED|Run-In Period (Pre-assignment)||0
363702|NCT02141854|893439|P4|STARTED|Run-In Period (Pre-assignment)||0
363703|NCT02141854|893440|P3|STARTED|Run-In Period (Pre-assignment)||0
363704|NCT02141854|893441|P2|STARTED|Run-In Period (Pre-assignment)||0
363705|NCT02141854|893442|P1|STARTED|Run-In Period (Pre-assignment)||882
363706|NCT02141633|893496|P2|NOT COMPLETED|Overall Study||0
363707|NCT02141633|893497|P1|NOT COMPLETED|Overall Study||1
363708|NCT02141633|893496|P2|COMPLETED|Overall Study||15
363709|NCT02141633|893497|P1|COMPLETED|Overall Study||15
363710|NCT02141633|893496|P2|STARTED|Overall Study||15
363711|NCT02141633|893497|P1|STARTED|Overall Study||16
363712|NCT02141620|893505|P2|NOT COMPLETED|Treatment Condition 2 (7 Days)||0
363713|NCT02141620|893506|P1|NOT COMPLETED|Treatment Condition 2 (7 Days)||0
363714|NCT02141620|893505|P2|COMPLETED|Treatment Condition 2 (7 Days)||7
363715|NCT02141620|893506|P1|COMPLETED|Treatment Condition 2 (7 Days)||7
363716|NCT02141620|893505|P2|STARTED|Treatment Condition 2 (7 Days)||7
363717|NCT02141620|893506|P1|STARTED|Treatment Condition 2 (7 Days)||7
363718|NCT02141620|893505|P2|NOT COMPLETED|Treatment Condition 1 (7 Days)||0
363719|NCT02141620|893506|P1|NOT COMPLETED|Treatment Condition 1 (7 Days)||1
363720|NCT02141620|893505|P2|COMPLETED|Treatment Condition 1 (7 Days)|7 completing subjects switched to placebo for Condition 2.|7
363721|NCT02141620|893506|P1|COMPLETED|Treatment Condition 1 (7 Days)|7 completing subjects switched to n-acetylcysteine for Condition 2.|7
363722|NCT02141620|893505|P2|STARTED|Treatment Condition 1 (7 Days)||7
363723|NCT02141620|893506|P1|STARTED|Treatment Condition 1 (7 Days)||8
363724|NCT02141581|893567|P3|NOT COMPLETED|Overall Study||0
363725|NCT02141581|893568|P2|NOT COMPLETED|Overall Study||0
363726|NCT02141581|893569|P1|NOT COMPLETED|Overall Study||0
363727|NCT02141581|893567|P3|COMPLETED|Overall Study||25
363728|NCT02141581|893568|P2|COMPLETED|Overall Study||19
363729|NCT02141581|893569|P1|COMPLETED|Overall Study||42
363730|NCT02141581|893567|P3|STARTED|Overall Study||25
363731|NCT02141581|893568|P2|STARTED|Overall Study||19
363732|NCT02141581|893569|P1|STARTED|Overall Study||42
363733|NCT02141516|893583|P3|NOT COMPLETED|Overall Study||0
363734|NCT02141516|893584|P2|NOT COMPLETED|Overall Study||5
363735|NCT02141516|893585|P1|NOT COMPLETED|Overall Study||0
363736|NCT02141516|893583|P3|COMPLETED|Overall Study||87
363737|NCT02141516|893584|P2|COMPLETED|Overall Study||107
363738|NCT02141516|893585|P1|COMPLETED|Overall Study||40
363739|NCT02141516|893583|P3|STARTED|Overall Study||87
363740|NCT02141516|893584|P2|STARTED|Overall Study||112
363741|NCT02141516|893585|P1|STARTED|Overall Study||40
363742|NCT02141360|893635|P3|NOT COMPLETED|Overall Study||0
363743|NCT02141360|893636|P2|NOT COMPLETED|Overall Study||0
363744|NCT02141360|893637|P1|NOT COMPLETED|Overall Study||7
363745|NCT02141360|893635|P3|COMPLETED|Overall Study||6
363746|NCT02141360|893636|P2|COMPLETED|Overall Study||6
363747|NCT02141360|893637|P1|COMPLETED|Overall Study||4
363748|NCT02141360|893635|P3|STARTED|Overall Study||6
363749|NCT02141360|893636|P2|STARTED|Overall Study||6
363750|NCT02141360|893637|P1|STARTED|Overall Study||11
363751|NCT02141217|893647|P2|NOT COMPLETED|Overall Study||8
363752|NCT02141217|893648|P1|NOT COMPLETED|Overall Study||11
363753|NCT02141217|893647|P2|COMPLETED|Overall Study||229
363754|NCT02141217|893648|P1|COMPLETED|Overall Study||223
363755|NCT02141217|893647|P2|ITT Population-Actual Treatment Received|Overall Study||235
363756|NCT02141217|893648|P1|ITT Population-Actual Treatment Received|Overall Study||236
363757|NCT02141217|893647|P2|ITT Population-Randomized Treatment Arm|Overall Study||237
363758|NCT02141217|893648|P1|ITT Population-Randomized Treatment Arm|Overall Study||234
363759|NCT02141217|893647|P2|STARTED|Overall Study||237
363760|NCT02141217|893648|P1|STARTED|Overall Study||234
363761|NCT02140957|893668|P2|NOT COMPLETED|Overall Study||23
363762|NCT02140957|893669|P1|NOT COMPLETED|Overall Study||27
363763|NCT02140957|893668|P2|COMPLETED|Overall Study||99
363764|NCT02140957|893669|P1|COMPLETED|Overall Study||102
363765|NCT02140957|893668|P2|STARTED|Overall Study||122
363766|NCT02140957|893669|P1|STARTED|Overall Study||129
363767|NCT02140788|893679|P4|NOT COMPLETED|Overall Study||0
363768|NCT02140788|893680|P3|NOT COMPLETED|Overall Study||0
363769|NCT02140788|893681|P2|NOT COMPLETED|Overall Study||0
363770|NCT02140788|893682|P1|NOT COMPLETED|Overall Study||0
363771|NCT02140788|893679|P4|COMPLETED|Overall Study||0
363772|NCT02140788|893680|P3|COMPLETED|Overall Study||0
363773|NCT02140788|893681|P2|COMPLETED|Overall Study||0
363774|NCT02140788|893682|P1|COMPLETED|Overall Study||0
363775|NCT02140788|893679|P4|STARTED|Overall Study||0
363776|NCT02140788|893680|P3|STARTED|Overall Study||0
363777|NCT02140788|893681|P2|STARTED|Overall Study||0
363778|NCT02140788|893682|P1|STARTED|Overall Study||0
363779|NCT02140762|893710|P2|NOT COMPLETED|Overall Study||12
363780|NCT02140762|893711|P1|NOT COMPLETED|Overall Study||17
363781|NCT02140762|893710|P2|COMPLETED|Overall Study||139
363782|NCT02140762|893711|P1|COMPLETED|Overall Study||137
363783|NCT02140762|893710|P2|STARTED|Overall Study||151
363784|NCT02140762|893711|P1|STARTED|Overall Study||154
363785|NCT02140645|893757|P6|NOT COMPLETED|Overall Study||70896
363786|NCT02140645|893758|P5|NOT COMPLETED|Overall Study||3286
363787|NCT02140645|893759|P4|NOT COMPLETED|Overall Study||13833
363788|NCT02140645|893760|P3|NOT COMPLETED|Overall Study||4236
363789|NCT02140645|893761|P2|NOT COMPLETED|Overall Study||61654
363790|NCT02140645|893762|P1|NOT COMPLETED|Overall Study||5489
363791|NCT02140645|893757|P6|COMPLETED|Overall Study||3050
363792|NCT02140645|893758|P5|COMPLETED|Overall Study||150
363793|NCT02140645|893759|P4|COMPLETED|Overall Study||530
363794|NCT02140645|893760|P3|COMPLETED|Overall Study||205
363795|NCT02140645|893761|P2|COMPLETED|Overall Study||3041
363796|NCT02140645|893762|P1|COMPLETED|Overall Study||243
363797|NCT02140645|893757|P6|STARTED|Overall Study||73946
363798|NCT02140645|893758|P5|STARTED|Overall Study||3436
363799|NCT02140645|893759|P4|STARTED|Overall Study||14363
363800|NCT02140645|893760|P3|STARTED|Overall Study||4441
363801|NCT02140645|893761|P2|STARTED|Overall Study||64695
363802|NCT02140645|893762|P1|STARTED|Overall Study||5732
363803|NCT02140593|893851|P2|NOT COMPLETED|Overall Study||0
363804|NCT02140593|893852|P1|NOT COMPLETED|Overall Study||0
363805|NCT02140593|893851|P2|COMPLETED|Overall Study||65
363806|NCT02140593|893852|P1|COMPLETED|Overall Study||63
363807|NCT02140593|893851|P2|STARTED|Overall Study||65
363808|NCT02140593|893852|P1|STARTED|Overall Study||63
363809|NCT02140372|893860|P1|NOT COMPLETED|Overall Study||0
363810|NCT02140372|893860|P1|COMPLETED|Overall Study||10
363811|NCT02140372|893860|P1|STARTED|Overall Study||10
363812|NCT02140164|893871|P1|NOT COMPLETED|Overall Study||2
363813|NCT02140164|893871|P1|COMPLETED|Overall Study||5
363814|NCT02140164|893871|P1|STARTED|Overall Study||7
363815|NCT02140060|893892|P6|NOT COMPLETED|Overall Study||1
363816|NCT02140060|893893|P5|NOT COMPLETED|Overall Study||1
363817|NCT02140060|893894|P4|NOT COMPLETED|Overall Study||2
363818|NCT02140060|893895|P3|NOT COMPLETED|Overall Study||0
363819|NCT02140060|893896|P2|NOT COMPLETED|Overall Study||0
363820|NCT02140060|893897|P1|NOT COMPLETED|Overall Study||0
363821|NCT02140060|893892|P6|COMPLETED|Overall Study||43
363822|NCT02140060|893893|P5|COMPLETED|Overall Study||44
363823|NCT02140060|893894|P4|COMPLETED|Overall Study||43
363824|NCT02140060|893895|P3|COMPLETED|Overall Study||44
363825|NCT02140060|893896|P2|COMPLETED|Overall Study||44
363826|NCT02140060|893897|P1|COMPLETED|Overall Study||44
363827|NCT02140060|893892|P6|STARTED|Overall Study||44
363828|NCT02140060|893893|P5|STARTED|Overall Study||45
363829|NCT02140060|893894|P4|STARTED|Overall Study||45
363830|NCT02140060|893895|P3|STARTED|Overall Study||44
363831|NCT02140060|893896|P2|STARTED|Overall Study||44
363832|NCT02140060|893897|P1|STARTED|Overall Study||44
363833|NCT02139982|893922|P10|NOT COMPLETED|Overall Study||0
363834|NCT02139982|893923|P9|NOT COMPLETED|Overall Study||0
363835|NCT02139982|893924|P8|NOT COMPLETED|Overall Study||0
363836|NCT02139982|893925|P7|NOT COMPLETED|Overall Study||0
363837|NCT02139982|893926|P6|NOT COMPLETED|Overall Study||0
363838|NCT02139982|893927|P5|NOT COMPLETED|Overall Study||0
363839|NCT02139982|893928|P4|NOT COMPLETED|Overall Study||1
363840|NCT02139982|893929|P3|NOT COMPLETED|Overall Study||0
363841|NCT02139982|893930|P2|NOT COMPLETED|Overall Study||1
363842|NCT02139982|893931|P1|NOT COMPLETED|Overall Study||0
363843|NCT02139982|893922|P10|COMPLETED|Overall Study||13
363844|NCT02139982|893923|P9|COMPLETED|Overall Study||13
363845|NCT02139982|893924|P8|COMPLETED|Overall Study||13
363846|NCT02139982|893925|P7|COMPLETED|Overall Study||13
363847|NCT02139982|893926|P6|COMPLETED|Overall Study||13
363848|NCT02139982|893927|P5|COMPLETED|Overall Study||13
363849|NCT02139982|893928|P4|COMPLETED|Overall Study||7
363850|NCT02139982|893929|P3|COMPLETED|Overall Study||8
363851|NCT02139982|893930|P2|COMPLETED|Overall Study||7
363852|NCT02139982|893931|P1|COMPLETED|Overall Study||8
363853|NCT02139982|893922|P10|STARTED|Overall Study||13
363854|NCT02139982|893923|P9|STARTED|Overall Study||13
363855|NCT02139982|893924|P8|STARTED|Overall Study||13
363856|NCT02139982|893925|P7|STARTED|Overall Study||13
363857|NCT02139982|893926|P6|STARTED|Overall Study||13
363858|NCT02139982|893927|P5|STARTED|Overall Study||13
363859|NCT02139982|893928|P4|STARTED|Overall Study||8
363860|NCT02139982|893929|P3|STARTED|Overall Study||8
363861|NCT02139982|893930|P2|STARTED|Overall Study||8
363862|NCT02139982|893931|P1|STARTED|Overall Study||8
363863|NCT02139943|893976|P3|NOT COMPLETED|Overall Study||7
363864|NCT02139943|893977|P2|NOT COMPLETED|Overall Study||6
363865|NCT02139943|893978|P1|NOT COMPLETED|Overall Study||10
363866|NCT02139943|893976|P3|COMPLETED|Overall Study||110
363867|NCT02139943|893977|P2|COMPLETED|Overall Study||111
363868|NCT02139943|893978|P1|COMPLETED|Overall Study||107
363869|NCT02139943|893976|P3|STARTED|Overall Study||117
363870|NCT02139943|893977|P2|STARTED|Overall Study||117
363871|NCT02139943|893978|P1|STARTED|Overall Study||117
363872|NCT02139878|893989|P2|NOT COMPLETED|Second Intervention (7 Days)||0
363873|NCT02139878|893990|P1|NOT COMPLETED|Second Intervention (7 Days)||0
363874|NCT02139878|893989|P2|COMPLETED|Second Intervention (7 Days)||10
363875|NCT02139878|893990|P1|COMPLETED|Second Intervention (7 Days)||9
363876|NCT02139878|893989|P2|STARTED|Second Intervention (7 Days)||10
363877|NCT02139878|893990|P1|STARTED|Second Intervention (7 Days)||9
363878|NCT02139878|893989|P2|NOT COMPLETED|Washout Period (8 Days)||0
363879|NCT02139878|893990|P1|NOT COMPLETED|Washout Period (8 Days)||0
363880|NCT02139878|893989|P2|COMPLETED|Washout Period (8 Days)||10
363881|NCT02139878|893990|P1|COMPLETED|Washout Period (8 Days)||9
363882|NCT02139878|893989|P2|STARTED|Washout Period (8 Days)||10
363883|NCT02139878|893990|P1|STARTED|Washout Period (8 Days)||9
363884|NCT02139878|893989|P2|NOT COMPLETED|First Intervention (7 Days)||0
363885|NCT02139878|893990|P1|NOT COMPLETED|First Intervention (7 Days)||1
363886|NCT02139878|893989|P2|COMPLETED|First Intervention (7 Days)||10
363887|NCT02139878|893990|P1|COMPLETED|First Intervention (7 Days)||9
363888|NCT02139878|893989|P2|STARTED|First Intervention (7 Days)||10
363889|NCT02139878|893990|P1|STARTED|First Intervention (7 Days)||10
363890|NCT02139644|894003|P6|NOT COMPLETED|Treatment Period||17
363891|NCT02139644|894004|P5|NOT COMPLETED|Treatment Period||8
363892|NCT02139644|894005|P4|NOT COMPLETED|Treatment Period||9
363893|NCT02139644|894006|P3|NOT COMPLETED|Treatment Period||8
363894|NCT02139644|894007|P2|NOT COMPLETED|Treatment Period||3
363895|NCT02139644|894008|P1|NOT COMPLETED|Treatment Period||0
363896|NCT02139644|894003|P6|COMPLETED|Treatment Period||113
363897|NCT02139644|894004|P5|COMPLETED|Treatment Period||121
363898|NCT02139644|894005|P4|COMPLETED|Treatment Period||121
363899|NCT02139644|894006|P3|COMPLETED|Treatment Period||121
363900|NCT02139644|894007|P2|COMPLETED|Treatment Period||126
363901|NCT02139644|894008|P1|COMPLETED|Treatment Period||0
363902|NCT02139644|894003|P6|STARTED|Treatment Period|Randomized|130
363903|NCT02139644|894004|P5|STARTED|Treatment Period|Randomized|129
363904|NCT02139644|894005|P4|STARTED|Treatment Period|Randomized|130
363905|NCT02139644|894006|P3|STARTED|Treatment Period|Randomized|129
363906|NCT02139644|894007|P2|STARTED|Treatment Period|Randomized|129
363907|NCT02139644|894008|P1|STARTED|Treatment Period||0
363908|NCT02139644|894003|P6|NOT COMPLETED|Run-In Period (Pre-assignment)||0
363909|NCT02139644|894004|P5|NOT COMPLETED|Run-In Period (Pre-assignment)||0
363910|NCT02139644|894005|P4|NOT COMPLETED|Run-In Period (Pre-assignment)||0
363911|NCT02139644|894006|P3|NOT COMPLETED|Run-In Period (Pre-assignment)||0
363912|NCT02139644|894007|P2|NOT COMPLETED|Run-In Period (Pre-assignment)||0
363913|NCT02139644|894008|P1|NOT COMPLETED|Run-In Period (Pre-assignment)||140
363914|NCT02139644|894003|P6|COMPLETED|Run-In Period (Pre-assignment)||0
363915|NCT02139644|894004|P5|COMPLETED|Run-In Period (Pre-assignment)||0
363916|NCT02139644|894005|P4|COMPLETED|Run-In Period (Pre-assignment)||0
363917|NCT02139644|894006|P3|COMPLETED|Run-In Period (Pre-assignment)||0
363918|NCT02139644|894007|P2|COMPLETED|Run-In Period (Pre-assignment)||0
363919|NCT02139644|894008|P1|COMPLETED|Run-In Period (Pre-assignment)||647
363920|NCT02139644|894003|P6|STARTED|Run-In Period (Pre-assignment)||0
363921|NCT02139644|894004|P5|STARTED|Run-In Period (Pre-assignment)||0
363922|NCT02139644|894005|P4|STARTED|Run-In Period (Pre-assignment)||0
363923|NCT02139644|894006|P3|STARTED|Run-In Period (Pre-assignment)||0
363924|NCT02139644|894007|P2|STARTED|Run-In Period (Pre-assignment)||0
363925|NCT02139644|894008|P1|STARTED|Run-In Period (Pre-assignment)|Enrolled|787
363926|NCT02139228|894062|P2|NOT COMPLETED|Overall Study||0
363927|NCT02139228|894063|P1|NOT COMPLETED|Overall Study||0
363928|NCT02139228|894062|P2|COMPLETED|Overall Study||211
363929|NCT02139228|894063|P1|COMPLETED|Overall Study||215
363930|NCT02139228|894062|P2|STARTED|Overall Study||211
363931|NCT02139228|894063|P1|STARTED|Overall Study||215
363932|NCT02139176|894073|P2|NOT COMPLETED|Overall Study||0
363933|NCT02139176|894074|P1|NOT COMPLETED|Overall Study||0
363934|NCT02139176|894073|P2|COMPLETED|Overall Study||100
363935|NCT02139176|894074|P1|COMPLETED|Overall Study||100
363936|NCT02139176|894073|P2|STARTED|Overall Study||100
363937|NCT02139176|894074|P1|STARTED|Overall Study||100
363938|NCT02139137|894086|P2|NOT COMPLETED|Overall Study||10
363939|NCT02139137|894087|P1|NOT COMPLETED|Overall Study||7
363940|NCT02139137|894086|P2|COMPLETED|Overall Study||10
363941|NCT02139137|894087|P1|COMPLETED|Overall Study||15
363942|NCT02139137|894086|P2|STARTED|Overall Study||20
363943|NCT02139137|894087|P1|STARTED|Overall Study||22
363944|NCT02139046|894106|P5|NOT COMPLETED|Overall Study||57
363945|NCT02139046|894107|P4|NOT COMPLETED|Overall Study||68
363946|NCT02139046|894108|P3|NOT COMPLETED|Overall Study||59
363947|NCT02139046|894109|P2|NOT COMPLETED|Overall Study||54
363948|NCT02139046|894110|P1|NOT COMPLETED|Overall Study||62
363949|NCT02139046|894106|P5|COMPLETED|Overall Study||301
363950|NCT02139046|894107|P4|COMPLETED|Overall Study||290
363951|NCT02139046|894108|P3|COMPLETED|Overall Study||298
363952|NCT02139046|894109|P2|COMPLETED|Overall Study||305
363953|NCT02139046|894110|P1|COMPLETED|Overall Study|Completed=Completed Study Drug|296
363954|NCT02139046|894106|P5|Full Analysis Set|Overall Study||357
363955|NCT02139046|894107|P4|Full Analysis Set|Overall Study||357
363956|NCT02139046|894108|P3|Full Analysis Set|Overall Study||355
363957|NCT02139046|894109|P2|Full Analysis Set|Overall Study||357
363958|NCT02139046|894110|P1|Full Analysis Set|Overall Study||357
363959|NCT02139046|894106|P5|Safety Analysis Set|Overall Study||357
363960|NCT02139046|894107|P4|Safety Analysis Set|Overall Study||357
363961|NCT02139046|894108|P3|Safety Analysis Set|Overall Study||355
363962|NCT02139046|894109|P2|Safety Analysis Set|Overall Study||358
363963|NCT02139046|894110|P1|Safety Analysis Set|Overall Study||356
363964|NCT02139046|894106|P5|STARTED|Overall Study||358
363965|NCT02139046|894107|P4|STARTED|Overall Study||358
363966|NCT02139046|894108|P3|STARTED|Overall Study||357
363967|NCT02139046|894109|P2|STARTED|Overall Study||359
363968|NCT02139046|894110|P1|STARTED|Overall Study||358
363969|NCT02139007|894134|P2|NOT COMPLETED|Patient Participant Recruitment||1
363970|NCT02139007|894135|P1|NOT COMPLETED|Patient Participant Recruitment||2
363971|NCT02139007|894134|P2|COMPLETED|Patient Participant Recruitment||13
363972|NCT02139007|894135|P1|COMPLETED|Patient Participant Recruitment||11
363973|NCT02139007|894134|P2|STARTED|Patient Participant Recruitment||14
363974|NCT02139007|894135|P1|STARTED|Patient Participant Recruitment||13
363975|NCT02139007|894134|P2|NOT COMPLETED|Study Site Recruitment||4
363976|NCT02139007|894135|P1|NOT COMPLETED|Study Site Recruitment||3
363977|NCT02139007|894134|P2|COMPLETED|Study Site Recruitment||1
363978|NCT02139007|894135|P1|COMPLETED|Study Site Recruitment||1
363979|NCT02139007|894134|P2|STARTED|Study Site Recruitment||5
363980|NCT02139007|894135|P1|STARTED|Study Site Recruitment||4
363981|NCT02138838|894150|P2|NOT COMPLETED|Overall Study||11
363982|NCT02138838|894151|P1|NOT COMPLETED|Overall Study||8
363983|NCT02138838|894150|P2|COMPLETED|Overall Study||16
363984|NCT02138838|894151|P1|COMPLETED|Overall Study||20
363985|NCT02138838|894150|P2|Received Study Drug|Overall Study||25
363986|NCT02138838|894151|P1|Received Study Drug|Overall Study||28
363987|NCT02138838|894150|P2|STARTED|Overall Study||27
363988|NCT02138838|894151|P1|STARTED|Overall Study||28
363989|NCT02138825|894169|P2|NOT COMPLETED|Safety Follow-up||17
363990|NCT02138825|894170|P1|NOT COMPLETED|Safety Follow-up||22
363991|NCT02138825|894169|P2|COMPLETED|Safety Follow-up||47
363992|NCT02138825|894170|P1|COMPLETED|Safety Follow-up||50
363993|NCT02138825|894169|P2|STARTED|Safety Follow-up|Participants from main study treatment and LTE phase entered safety follow-up|64
363994|NCT02138825|894170|P1|STARTED|Safety Follow-up|Participants from main study treatment and LTE phase entered safety follow-up|72
363995|NCT02138825|894169|P2|NOT COMPLETED|Long-term Extension||38
363996|NCT02138825|894170|P1|NOT COMPLETED|Long-term Extension||32
363997|NCT02138825|894169|P2|COMPLETED|Long-term Extension|no participants were considered as completed LTE phase at time of study termination|0
363998|NCT02138825|894170|P1|COMPLETED|Long-term Extension|no participants were considered as completed LTE phase at time of study termination|0
363999|NCT02138825|894169|P2|STARTED|Long-term Extension||38
364000|NCT02138825|894170|P1|STARTED|Long-term Extension||32
364001|NCT02138825|894169|P2|NOT COMPLETED|Main Study Treatment||35
364002|NCT02138825|894170|P1|NOT COMPLETED|Main Study Treatment||40
364003|NCT02138825|894169|P2|COMPLETED|Main Study Treatment||39
364004|NCT02138825|894170|P1|COMPLETED|Main Study Treatment||33
364005|NCT02138825|894169|P2|STARTED|Main Study Treatment|safety population|74
364006|NCT02138825|894170|P1|STARTED|Main Study Treatment|safety population|73
364007|NCT02138747|894188|P4|NOT COMPLETED|Treatment Period 2||3
364008|NCT02138747|894189|P3|NOT COMPLETED|Treatment Period 2||2
364009|NCT02138747|894190|P2|NOT COMPLETED|Treatment Period 2||7
364010|NCT02138747|894191|P1|NOT COMPLETED|Treatment Period 2||17
364011|NCT02138747|894188|P4|COMPLETED|Treatment Period 2||24
364012|NCT02138747|894189|P3|COMPLETED|Treatment Period 2||24
364013|NCT02138747|894190|P2|COMPLETED|Treatment Period 2||125
364014|NCT02138747|894191|P1|COMPLETED|Treatment Period 2||121
364015|NCT02138747|894188|P4|STARTED|Treatment Period 2|One participant completed treatment in period 1.|27
364016|NCT02138747|894189|P3|STARTED|Treatment Period 2|One participant completed treatment in period 1.|26
364017|NCT02138747|894190|P2|STARTED|Treatment Period 2||132
364111|NCT02137226|894709|P2|NOT COMPLETED|Period 2 (Re - Randomization)||0
364018|NCT02138747|894191|P1|STARTED|Treatment Period 2|Two participants who discontinued treatment in period 1 entered period 2.|138
364019|NCT02138747|894188|P4|NOT COMPLETED|Treatment Period 1||4
364020|NCT02138747|894189|P3|NOT COMPLETED|Treatment Period 1||4
364021|NCT02138747|894190|P2|NOT COMPLETED|Treatment Period 1||25
364022|NCT02138747|894191|P1|NOT COMPLETED|Treatment Period 1||20
364023|NCT02138747|894188|P4|COMPLETED|Treatment Period 1||28
364024|NCT02138747|894189|P3|COMPLETED|Treatment Period 1||27
364025|NCT02138747|894190|P2|COMPLETED|Treatment Period 1||132
364026|NCT02138747|894191|P1|COMPLETED|Treatment Period 1||136
364027|NCT02138747|894188|P4|STARTED|Treatment Period 1||32
364028|NCT02138747|894189|P3|STARTED|Treatment Period 1||31
364029|NCT02138747|894190|P2|STARTED|Treatment Period 1||157
364030|NCT02138747|894191|P1|STARTED|Treatment Period 1||156
364031|NCT02138578|894226|P3|NOT COMPLETED|Overall Study||0
364032|NCT02138578|894227|P2|NOT COMPLETED|Overall Study||0
364033|NCT02138578|894228|P1|NOT COMPLETED|Overall Study||0
364034|NCT02138578|894226|P3|COMPLETED|Overall Study||3
364035|NCT02138578|894227|P2|COMPLETED|Overall Study||0
364036|NCT02138578|894228|P1|COMPLETED|Overall Study||1
364037|NCT02138578|894226|P3|STARTED|Overall Study||3
364038|NCT02138578|894227|P2|STARTED|Overall Study||0
364039|NCT02138578|894228|P1|STARTED|Overall Study||1
364040|NCT02138461|894256|P2|NOT COMPLETED|Overall Study||0
364041|NCT02138461|894257|P1|NOT COMPLETED|Overall Study||0
364042|NCT02138461|894256|P2|COMPLETED|Overall Study||110
364043|NCT02138461|894257|P1|COMPLETED|Overall Study||101
364044|NCT02138461|894256|P2|STARTED|Overall Study||110
364045|NCT02138461|894257|P1|STARTED|Overall Study||101
364046|NCT02138227|894265|P2|NOT COMPLETED|Overall Study||0
364047|NCT02138227|894266|P1|NOT COMPLETED|Overall Study||0
364048|NCT02138227|894265|P2|COMPLETED|Overall Study||218
364049|NCT02138227|894266|P1|COMPLETED|Overall Study||55
364050|NCT02138227|894265|P2|STARTED|Overall Study||218
364051|NCT02138227|894266|P1|STARTED|Overall Study||55
364052|NCT02138097|894315|P2|NOT COMPLETED|Overall Study||0
364053|NCT02138097|894316|P1|NOT COMPLETED|Overall Study||0
364054|NCT02138097|894315|P2|COMPLETED|Overall Study||459722
364055|NCT02138097|894316|P1|COMPLETED|Overall Study||155345
364056|NCT02138097|894315|P2|STARTED|Overall Study||459722
364057|NCT02138097|894316|P1|STARTED|Overall Study||155345
364058|NCT02138006|894508|P2|NOT COMPLETED|Overall Study||0
364059|NCT02138006|894509|P1|NOT COMPLETED|Overall Study||0
364060|NCT02138006|894508|P2|COMPLETED|Overall Study||54
364061|NCT02138006|894509|P1|COMPLETED|Overall Study||48
364062|NCT02138006|894508|P2|STARTED|Overall Study||54
364063|NCT02138006|894509|P1|STARTED|Overall Study||48
364064|NCT02137785|894519|P2|NOT COMPLETED|Overall Study||4
364065|NCT02137785|894520|P1|NOT COMPLETED|Overall Study||3
364066|NCT02137785|894519|P2|COMPLETED|Overall Study||130
364067|NCT02137785|894520|P1|COMPLETED|Overall Study||132
364068|NCT02137785|894519|P2|STARTED|Overall Study||134
364069|NCT02137785|894520|P1|STARTED|Overall Study||135
364070|NCT02137772|894628|P2|NOT COMPLETED|Overall Study||75
364071|NCT02137772|894629|P1|NOT COMPLETED|Overall Study||132
364072|NCT02137772|894628|P2|COMPLETED|Overall Study||119
364073|NCT02137772|894629|P1|COMPLETED|Overall Study||244
364074|NCT02137772|894628|P2|Treated Participants|Overall Study||192
364075|NCT02137772|894629|P1|Treated Participants|Overall Study||373
364076|NCT02137772|894628|P2|STARTED|Overall Study|Randomized participants|194
364077|NCT02137772|894629|P1|STARTED|Overall Study|Randomized participants|376
364078|NCT02137603|894655|P2|NOT COMPLETED|Overall Study||0
364079|NCT02137603|894656|P1|NOT COMPLETED|Overall Study||2
364080|NCT02137603|894655|P2|COMPLETED|Overall Study||18
364081|NCT02137603|894656|P1|COMPLETED|Overall Study||16
364082|NCT02137603|894655|P2|STARTED|Overall Study||18
364083|NCT02137603|894656|P1|STARTED|Overall Study||18
364084|NCT02137512|894664|P1|NOT COMPLETED|Overall Study||0
364085|NCT02137512|894664|P1|COMPLETED|Overall Study||30
364086|NCT02137512|894664|P1|STARTED|Overall Study||30
364087|NCT02137447|894680|P1|NOT COMPLETED|Overall Study||0
364088|NCT02137447|894680|P1|COMPLETED|Overall Study||10
364089|NCT02137447|894680|P1|STARTED|Overall Study||10
364090|NCT02137382|894685|P2|NOT COMPLETED|Cross-over Period 2||0
364091|NCT02137382|894686|P1|NOT COMPLETED|Cross-over Period 2||0
364092|NCT02137382|894685|P2|COMPLETED|Cross-over Period 2||21
364093|NCT02137382|894686|P1|COMPLETED|Cross-over Period 2||18
364094|NCT02137382|894685|P2|STARTED|Cross-over Period 2||21
364095|NCT02137382|894686|P1|STARTED|Cross-over Period 2||18
364096|NCT02137382|894685|P2|NOT COMPLETED|Wash Out||0
364097|NCT02137382|894686|P1|NOT COMPLETED|Wash Out||0
364098|NCT02137382|894685|P2|COMPLETED|Wash Out||21
364099|NCT02137382|894686|P1|COMPLETED|Wash Out||18
364100|NCT02137382|894685|P2|STARTED|Wash Out||21
364101|NCT02137382|894686|P1|STARTED|Wash Out||18
364102|NCT02137382|894685|P2|NOT COMPLETED|Cross-over Period 1||0
364103|NCT02137382|894686|P1|NOT COMPLETED|Cross-over Period 1||2
364104|NCT02137382|894685|P2|COMPLETED|Cross-over Period 1||21
364105|NCT02137382|894686|P1|COMPLETED|Cross-over Period 1||18
364106|NCT02137382|894685|P2|STARTED|Cross-over Period 1||21
364107|NCT02137382|894686|P1|STARTED|Cross-over Period 1||20
364108|NCT02137226|894706|P5|NOT COMPLETED|Period 2 (Re - Randomization)||9
364109|NCT02137226|894707|P4|NOT COMPLETED|Period 2 (Re - Randomization)||8
364110|NCT02137226|894708|P3|NOT COMPLETED|Period 2 (Re - Randomization)||17
364112|NCT02137226|894710|P1|NOT COMPLETED|Period 2 (Re - Randomization)||0
364113|NCT02137226|894706|P5|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|138
364114|NCT02137226|894707|P4|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|140
364115|NCT02137226|894708|P3|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|281
364116|NCT02137226|894709|P2|COMPLETED|Period 2 (Re - Randomization)||0
364117|NCT02137226|894710|P1|COMPLETED|Period 2 (Re - Randomization)||0
364118|NCT02137226|894706|P5|STARTED|Period 2 (Re - Randomization)||147
364119|NCT02137226|894707|P4|STARTED|Period 2 (Re - Randomization)||148
364120|NCT02137226|894708|P3|STARTED|Period 2 (Re - Randomization)||298
364121|NCT02137226|894709|P2|STARTED|Period 2 (Re - Randomization)||0
364122|NCT02137226|894710|P1|STARTED|Period 2 (Re - Randomization)||0
364123|NCT02137226|894706|P5|NOT COMPLETED|Period 1 (Initial Randomization)||0
364124|NCT02137226|894707|P4|NOT COMPLETED|Period 1 (Initial Randomization)||0
364125|NCT02137226|894708|P3|NOT COMPLETED|Period 1 (Initial Randomization)||0
364126|NCT02137226|894709|P2|NOT COMPLETED|Period 1 (Initial Randomization)||16
364127|NCT02137226|894710|P1|NOT COMPLETED|Period 1 (Initial Randomization)||20
364128|NCT02137226|894706|P5|COMPLETED|Period 1 (Initial Randomization)||0
364129|NCT02137226|894707|P4|COMPLETED|Period 1 (Initial Randomization)||0
364130|NCT02137226|894708|P3|COMPLETED|Period 1 (Initial Randomization)||0
364131|NCT02137226|894709|P2|COMPLETED|Period 1 (Initial Randomization)|Not completed are discontinued from study|305
364132|NCT02137226|894710|P1|COMPLETED|Period 1 (Initial Randomization)|Not completed are discontinued from study|304
364133|NCT02137226|894706|P5|STARTED|Period 1 (Initial Randomization)||0
364134|NCT02137226|894707|P4|STARTED|Period 1 (Initial Randomization)||0
364135|NCT02137226|894708|P3|STARTED|Period 1 (Initial Randomization)||0
364136|NCT02137226|894709|P2|STARTED|Period 1 (Initial Randomization)||321
364137|NCT02137226|894710|P1|STARTED|Period 1 (Initial Randomization)||324
364138|NCT02136914|894724|P2|NOT COMPLETED|Overall Study||21
364139|NCT02136914|894725|P1|NOT COMPLETED|Overall Study||21
364140|NCT02136914|894724|P2|COMPLETED|Overall Study||42
364141|NCT02136914|894725|P1|COMPLETED|Overall Study||42
364142|NCT02136914|894724|P2|Received Study Drug|Overall Study||63
364143|NCT02136914|894725|P1|Received Study Drug|Overall Study||60
364144|NCT02136914|894724|P2|STARTED|Overall Study||63
364145|NCT02136914|894725|P1|STARTED|Overall Study||63
364146|NCT02136498|894741|P2|NOT COMPLETED|Overall Study||0
364147|NCT02136498|894742|P1|NOT COMPLETED|Overall Study||0
364148|NCT02136498|894741|P2|COMPLETED|Overall Study||33
364149|NCT02136498|894742|P1|COMPLETED|Overall Study||33
364150|NCT02136498|894741|P2|STARTED|Overall Study||33
364151|NCT02136498|894742|P1|STARTED|Overall Study||33
364152|NCT02136420|894754|P10|NOT COMPLETED|Overall Study||0
364153|NCT02136420|894755|P9|NOT COMPLETED|Overall Study||0
364154|NCT02136420|894756|P8|NOT COMPLETED|Overall Study||0
364155|NCT02136420|894757|P7|NOT COMPLETED|Overall Study||0
364156|NCT02136420|894758|P6|NOT COMPLETED|Overall Study||0
364157|NCT02136420|894759|P5|NOT COMPLETED|Overall Study||0
364158|NCT02136420|894760|P4|NOT COMPLETED|Overall Study||0
364159|NCT02136420|894761|P3|NOT COMPLETED|Overall Study||0
364160|NCT02136420|894762|P2|NOT COMPLETED|Overall Study||0
364161|NCT02136420|894763|P1|NOT COMPLETED|Overall Study||1
364162|NCT02136420|894754|P10|COMPLETED|Overall Study||5
364163|NCT02136420|894755|P9|COMPLETED|Overall Study||5
364164|NCT02136420|894756|P8|COMPLETED|Overall Study||0
364165|NCT02136420|894757|P7|COMPLETED|Overall Study||0
364166|NCT02136420|894758|P6|COMPLETED|Overall Study||0
364167|NCT02136420|894759|P5|COMPLETED|Overall Study||10
364168|NCT02136420|894760|P4|COMPLETED|Overall Study||0
364169|NCT02136420|894761|P3|COMPLETED|Overall Study||0
364170|NCT02136420|894762|P2|COMPLETED|Overall Study||0
364171|NCT02136420|894763|P1|COMPLETED|Overall Study||9
364172|NCT02136420|894754|P10|STARTED|Overall Study||5
364173|NCT02136420|894755|P9|STARTED|Overall Study||5
364174|NCT02136420|894756|P8|STARTED|Overall Study||0
364175|NCT02136420|894757|P7|STARTED|Overall Study||0
364176|NCT02136420|894758|P6|STARTED|Overall Study||0
364177|NCT02136420|894759|P5|STARTED|Overall Study||10
364178|NCT02136420|894760|P4|STARTED|Overall Study||0
364179|NCT02136420|894761|P3|STARTED|Overall Study||0
364180|NCT02136420|894762|P2|STARTED|Overall Study||0
364181|NCT02136420|894763|P1|STARTED|Overall Study||10
364182|NCT02136238|894785|P3|NOT COMPLETED|Overall Study||0
364183|NCT02136238|894786|P2|NOT COMPLETED|Overall Study||0
364184|NCT02136238|894787|P1|NOT COMPLETED|Overall Study||0
364185|NCT02136238|894785|P3|COMPLETED|Overall Study||10
364186|NCT02136238|894786|P2|COMPLETED|Overall Study||4
364187|NCT02136238|894787|P1|COMPLETED|Overall Study||4
364188|NCT02136238|894785|P3|STARTED|Overall Study||10
364189|NCT02136238|894786|P2|STARTED|Overall Study||4
364190|NCT02136238|894787|P1|STARTED|Overall Study||4
364191|NCT02136134|894800|P2|NOT COMPLETED|Overall Study||251
364192|NCT02136134|894801|P1|NOT COMPLETED|Overall Study||247
364193|NCT02136134|894800|P2|COMPLETED|Overall Study||0
364194|NCT02136134|894801|P1|COMPLETED|Overall Study||0
364195|NCT02136134|894800|P2|Treated|Overall Study||243
364196|NCT02136134|894801|P1|Treated|Overall Study||237
364197|NCT02136134|894800|P2|STARTED|Overall Study||251
364198|NCT02136134|894801|P1|STARTED|Overall Study||247
364199|NCT02136004|894819|P1|NOT COMPLETED|Overall Study||1
364200|NCT02136004|894819|P1|COMPLETED|Overall Study||219
364201|NCT02136004|894819|P1|STARTED|Overall Study|Enrollment commenced on May 20, 2014 and the last subject completed follow-up on February 28, 2015|220
364202|NCT02135900|894830|P1|NOT COMPLETED|Overall Study||0
364203|NCT02135900|894830|P1|COMPLETED|Overall Study||32
364204|NCT02135900|894830|P1|STARTED|Overall Study|32 subjects started the study. 50 subjects were screened.|32
364205|NCT02135848|894839|P2|NOT COMPLETED|Overall Study||1
364206|NCT02135848|894840|P1|NOT COMPLETED|Overall Study||3
364207|NCT02135848|894839|P2|COMPLETED|Overall Study||19
364208|NCT02135848|894840|P1|COMPLETED|Overall Study||23
364209|NCT02135848|894839|P2|STARTED|Overall Study||20
364210|NCT02135848|894840|P1|STARTED|Overall Study||26
364211|NCT02135692|894898|P1|NOT COMPLETED|Overall Study||339
364212|NCT02135692|894898|P1|COMPLETED|Overall Study||0
364213|NCT02135692|894898|P1|STARTED|Overall Study||339
364214|NCT02135614|894917|P2|NOT COMPLETED|Overall Study||5
364215|NCT02135614|894918|P1|NOT COMPLETED|Overall Study||8
364216|NCT02135614|894917|P2|COMPLETED|Overall Study||90
364217|NCT02135614|894918|P1|COMPLETED|Overall Study||86
364218|NCT02135614|894917|P2|STARTED|Overall Study||95
364219|NCT02135614|894918|P1|STARTED|Overall Study||94
364220|NCT02135445|894932|P2|NOT COMPLETED|Overall Study||0
364221|NCT02135445|894933|P1|NOT COMPLETED|Overall Study||2
364222|NCT02135445|894932|P2|COMPLETED|Overall Study||38
364223|NCT02135445|894933|P1|COMPLETED|Overall Study||63
364224|NCT02135445|894932|P2|STARTED|Overall Study||38
364225|NCT02135445|894933|P1|STARTED|Overall Study||65
364226|NCT02135432|894984|P2|NOT COMPLETED|Overall Study||0
364227|NCT02135432|894985|P1|NOT COMPLETED|Overall Study||0
364228|NCT02135432|894984|P2|COMPLETED|Overall Study||4
364229|NCT02135432|894985|P1|COMPLETED|Overall Study||8
364230|NCT02135432|894984|P2|STARTED|Overall Study||4
364231|NCT02135432|894985|P1|STARTED|Overall Study||8
364232|NCT02135094|894999|P2|NOT COMPLETED|Overall Study||0
364233|NCT02135094|895000|P1|NOT COMPLETED|Overall Study||0
364234|NCT02135094|894999|P2|COMPLETED|Overall Study||8
364235|NCT02135094|895000|P1|COMPLETED|Overall Study||25
364236|NCT02135094|894999|P2|Week 4|Overall Study||8
364237|NCT02135094|895000|P1|Week 4|Overall Study||25
364238|NCT02135094|894999|P2|Week 3|Overall Study||8
364239|NCT02135094|895000|P1|Week 3|Overall Study||25
364240|NCT02135094|894999|P2|Week 2|Overall Study||8
364241|NCT02135094|895000|P1|Week 2|Overall Study||25
364242|NCT02135094|894999|P2|STARTED|Overall Study||8
364243|NCT02135094|895000|P1|STARTED|Overall Study||25
364244|NCT02135029|895017|P3|NOT COMPLETED|Overall Study||3
364245|NCT02135029|895018|P2|NOT COMPLETED|Overall Study||5
364246|NCT02135029|895019|P1|NOT COMPLETED|Overall Study||4
364247|NCT02135029|895017|P3|COMPLETED|Overall Study||34
364248|NCT02135029|895018|P2|COMPLETED|Overall Study||69
364249|NCT02135029|895019|P1|COMPLETED|Overall Study||69
364250|NCT02135029|895017|P3|Treated|Overall Study||36
364251|NCT02135029|895018|P2|Treated|Overall Study||74
364252|NCT02135029|895019|P1|Treated|Overall Study||73
364253|NCT02135029|895017|P3|STARTED|Overall Study||37
364254|NCT02135029|895018|P2|STARTED|Overall Study||74
364255|NCT02135029|895019|P1|STARTED|Overall Study||73
364256|NCT02135016|895102|P3|NOT COMPLETED|Overall Study||0
364257|NCT02135016|895103|P2|NOT COMPLETED|Overall Study||0
364258|NCT02135016|895104|P1|NOT COMPLETED|Overall Study||0
364259|NCT02135016|895102|P3|COMPLETED|Overall Study||15
364260|NCT02135016|895103|P2|COMPLETED|Overall Study||15
364261|NCT02135016|895104|P1|COMPLETED|Overall Study||15
364262|NCT02135016|895102|P3|STARTED|Overall Study||15
364263|NCT02135016|895103|P2|STARTED|Overall Study||15
364264|NCT02135016|895104|P1|STARTED|Overall Study||15
364265|NCT02134977|895124|P1|NOT COMPLETED|Overall Study||102
364266|NCT02134977|895124|P1|COMPLETED|Overall Study||2714
364267|NCT02134977|895124|P1|STARTED|Overall Study||2816
364268|NCT02134951|895147|P2|NOT COMPLETED|Overall Study||0
364269|NCT02134951|895148|P1|NOT COMPLETED|Overall Study||0
364270|NCT02134951|895147|P2|COMPLETED|Overall Study|number of subjects with at least one valid scan|20
364271|NCT02134951|895148|P1|COMPLETED|Overall Study|number of subjects with at least one valid scan|39
364272|NCT02134951|895147|P2|STARTED|Overall Study||20
364273|NCT02134951|895148|P1|STARTED|Overall Study||39
364274|NCT02134925|895158|P2|NOT COMPLETED|Overall Study||6
364275|NCT02134925|895159|P1|NOT COMPLETED|Overall Study||2
364276|NCT02134925|895158|P2|COMPLETED|Overall Study||50
364277|NCT02134925|895159|P1|COMPLETED|Overall Study||52
364278|NCT02134925|895158|P2|STARTED|Overall Study||56
364279|NCT02134925|895159|P1|STARTED|Overall Study||54
364280|NCT02134717|895167|P1|NOT COMPLETED|Overall Study||0
364281|NCT02134717|895167|P1|COMPLETED|Overall Study||3
364282|NCT02134717|895167|P1|STARTED|Overall Study||3
364283|NCT02134587|895173|P1|NOT COMPLETED|Overall Study||30
364284|NCT02134587|895173|P1|COMPLETED|Overall Study||173
364285|NCT02134587|895173|P1|STARTED|Overall Study||203
364286|NCT02134522|895182|P1|NOT COMPLETED|Overall Study||0
364287|NCT02134522|895182|P1|COMPLETED|Overall Study||1
364288|NCT02134522|895182|P1|STARTED|Overall Study||1
364289|NCT02134314|895189|P2|NOT COMPLETED|Overall Study||1
364290|NCT02134314|895190|P1|NOT COMPLETED|Overall Study||1
364291|NCT02134314|895189|P2|COMPLETED|Overall Study||34
364292|NCT02134314|895190|P1|COMPLETED|Overall Study||34
364293|NCT02134314|895189|P2|STARTED|Overall Study||35
364294|NCT02134314|895190|P1|STARTED|Overall Study||35
364295|NCT02134184|895223|P3|NOT COMPLETED|Overall Study||0
364296|NCT02134184|895224|P2|NOT COMPLETED|Overall Study||0
364297|NCT02134184|895225|P1|NOT COMPLETED|Overall Study||0
364298|NCT02134184|895223|P3|COMPLETED|Overall Study||8
364299|NCT02134184|895224|P2|COMPLETED|Overall Study||37
364300|NCT02134184|895225|P1|COMPLETED|Overall Study||33
364301|NCT02134184|895223|P3|STARTED|Overall Study||8
364302|NCT02134184|895224|P2|STARTED|Overall Study||37
364303|NCT02134184|895225|P1|STARTED|Overall Study||33
364304|NCT02134119|895238|P2|NOT COMPLETED|Overall Study||0
364305|NCT02134119|895239|P1|NOT COMPLETED|Overall Study||0
364306|NCT02134119|895238|P2|COMPLETED|Overall Study||15
364307|NCT02134119|895239|P1|COMPLETED|Overall Study||30
364308|NCT02134119|895238|P2|STARTED|Overall Study||15
364309|NCT02134119|895239|P1|STARTED|Overall Study||30
364310|NCT02134015|895279|P2|NOT COMPLETED|Overall Study||74
364311|NCT02134015|895280|P1|NOT COMPLETED|Overall Study||71
364312|NCT02134015|895279|P2|COMPLETED|Overall Study||0
364313|NCT02134015|895280|P1|COMPLETED|Overall Study||0
364314|NCT02134015|895279|P2|STARTED|Overall Study||74
364315|NCT02134015|895280|P1|STARTED|Overall Study||71
364316|NCT02133781|895303|P3|NOT COMPLETED|Overall Study||0
364317|NCT02133781|895304|P2|NOT COMPLETED|Overall Study||0
364318|NCT02133781|895305|P1|NOT COMPLETED|Overall Study||0
364319|NCT02133781|895303|P3|COMPLETED|Overall Study||21
364320|NCT02133781|895304|P2|COMPLETED|Overall Study||24
364321|NCT02133781|895305|P1|COMPLETED|Overall Study||6
364322|NCT02133781|895303|P3|STARTED|Overall Study||21
364323|NCT02133781|895304|P2|STARTED|Overall Study||24
364324|NCT02133781|895305|P1|STARTED|Overall Study||6
364325|NCT02133664|895318|P2|NOT COMPLETED|Overall Study||7
364326|NCT02133664|895319|P1|NOT COMPLETED|Overall Study||5
364327|NCT02133664|895318|P2|COMPLETED|Overall Study||21
364328|NCT02133664|895319|P1|COMPLETED|Overall Study||21
364329|NCT02133664|895318|P2|STARTED|Overall Study||28
364330|NCT02133664|895319|P1|STARTED|Overall Study||26
364331|NCT02133534|895331|P1|NOT COMPLETED|Overall Study||0
364332|NCT02133534|895331|P1|COMPLETED|Overall Study||1
364333|NCT02133534|895331|P1|STARTED|Overall Study||1
364334|NCT02133508|895335|P1|NOT COMPLETED|Overall Study||15
364335|NCT02133508|895335|P1|COMPLETED|Overall Study||141
364336|NCT02133508|895335|P1|STARTED|Overall Study||156
364337|NCT02133352|895343|P1|NOT COMPLETED|Longer Term Extension||6
364338|NCT02133352|895343|P1|COMPLETED|Longer Term Extension||4
364339|NCT02133352|895343|P1|STARTED|Longer Term Extension||10
364340|NCT02133352|895343|P1|NOT COMPLETED|Main Study (180 Day)||0
364341|NCT02133352|895343|P1|COMPLETED|Main Study (180 Day)||10
364342|NCT02133352|895343|P1|STARTED|Main Study (180 Day)||10
364343|NCT02133235|895354|P2|NOT COMPLETED|Overall Study||0
364344|NCT02133235|895355|P1|NOT COMPLETED|Overall Study||0
364345|NCT02133235|895354|P2|COMPLETED|Overall Study||57
364346|NCT02133235|895355|P1|COMPLETED|Overall Study||55
364347|NCT02133235|895354|P2|STARTED|Overall Study||57
364348|NCT02133235|895355|P1|STARTED|Overall Study||55
364349|NCT02133131|895374|P7|NOT COMPLETED|Overall Study||12
364350|NCT02133131|895375|P6|NOT COMPLETED|Overall Study||14
364351|NCT02133131|895376|P5|NOT COMPLETED|Overall Study||15
364352|NCT02133131|895377|P4|NOT COMPLETED|Overall Study||6
364353|NCT02133131|895378|P3|NOT COMPLETED|Overall Study||1
364354|NCT02133131|895379|P2|NOT COMPLETED|Overall Study||5
364355|NCT02133131|895380|P1|NOT COMPLETED|Overall Study||5
364356|NCT02133131|895374|P7|COMPLETED|Overall Study||0
364357|NCT02133131|895375|P6|COMPLETED|Overall Study||0
364358|NCT02133131|895376|P5|COMPLETED|Overall Study||0
364359|NCT02133131|895377|P4|COMPLETED|Overall Study||15
364360|NCT02133131|895378|P3|COMPLETED|Overall Study||19
364361|NCT02133131|895379|P2|COMPLETED|Overall Study||25
364362|NCT02133131|895380|P1|COMPLETED|Overall Study||26
364363|NCT02133131|895374|P7|STARTED|Overall Study||12
364364|NCT02133131|895375|P6|STARTED|Overall Study||14
364365|NCT02133131|895376|P5|STARTED|Overall Study||15
364366|NCT02133131|895377|P4|STARTED|Overall Study||21
364367|NCT02133131|895378|P3|STARTED|Overall Study||20
364368|NCT02133131|895379|P2|STARTED|Overall Study||30
364369|NCT02133131|895380|P1|STARTED|Overall Study||31
364370|NCT02133066|895419|P2|NOT COMPLETED|Overall Study||0
364371|NCT02133066|895420|P1|NOT COMPLETED|Overall Study||0
364372|NCT02133066|895419|P2|COMPLETED|Overall Study||64
364373|NCT02133066|895420|P1|COMPLETED|Overall Study||64
364374|NCT02133066|895419|P2|STARTED|Overall Study||64
364375|NCT02133066|895420|P1|STARTED|Overall Study||64
364376|NCT02132949|895434|P2|NOT COMPLETED|Adjuvant Treatment Period||167
364377|NCT02132949|895435|P1|NOT COMPLETED|Adjuvant Treatment Period||149
364378|NCT02132949|895434|P2|COMPLETED|Adjuvant Treatment Period||23
364379|NCT02132949|895435|P1|COMPLETED|Adjuvant Treatment Period||29
364380|NCT02132949|895434|P2|STARTED|Adjuvant Treatment Period|Includes a participant who did not complete neoadjuvant treatment but started adjuvant treatment.|190
364381|NCT02132949|895435|P1|STARTED|Adjuvant Treatment Period|At clinical cutoff (03 March 2016), some participants had not yet received adjuvant treatment.|178
364382|NCT02132949|895434|P2|NOT COMPLETED|Neoadjuvant Treatment Period||12
364383|NCT02132949|895435|P1|NOT COMPLETED|Neoadjuvant Treatment Period||17
364384|NCT02132949|895434|P2|COMPLETED|Neoadjuvant Treatment Period||189
364385|NCT02132949|895435|P1|COMPLETED|Neoadjuvant Treatment Period||182
364386|NCT02132949|895434|P2|No Treatment|Neoadjuvant Treatment Period||3
364387|NCT02132949|895435|P1|No Treatment|Neoadjuvant Treatment Period||1
364388|NCT02132949|895434|P2|STARTED|Neoadjuvant Treatment Period||201
364389|NCT02132949|895435|P1|STARTED|Neoadjuvant Treatment Period|A participant enrolled in Cohort B received Cohort A treatment, hence counted under Cohort A.|199
364390|NCT02132936|895467|P4|NOT COMPLETED|Overall Study||14
364391|NCT02132936|895468|P3|NOT COMPLETED|Overall Study||14
364392|NCT02132936|895469|P2|NOT COMPLETED|Overall Study||9
364393|NCT02132936|895470|P1|NOT COMPLETED|Overall Study||10
364394|NCT02132936|895467|P4|COMPLETED|Overall Study||29
364395|NCT02132936|895468|P3|COMPLETED|Overall Study||174
364396|NCT02132936|895469|P2|COMPLETED|Overall Study||38
364397|NCT02132936|895470|P1|COMPLETED|Overall Study||175
364398|NCT02132936|895467|P4|STARTED|Overall Study||43
364399|NCT02132936|895468|P3|STARTED|Overall Study||188
364400|NCT02132936|895469|P2|STARTED|Overall Study||47
364401|NCT02132936|895470|P1|STARTED|Overall Study||185
364402|NCT02132884|895488|P2|NOT COMPLETED|Overall Study||0
364403|NCT02132884|895489|P1|NOT COMPLETED|Overall Study||0
364404|NCT02132884|895488|P2|COMPLETED|Overall Study||0
364405|NCT02132884|895489|P1|COMPLETED|Overall Study||0
364406|NCT02132884|895488|P2|STARTED|Overall Study||0
364407|NCT02132884|895489|P1|STARTED|Overall Study||0
364408|NCT02132832|895497|P2|NOT COMPLETED|Overall Study||7
364409|NCT02132832|895498|P1|NOT COMPLETED|Overall Study||3
364410|NCT02132832|895497|P2|COMPLETED|Overall Study||16
364411|NCT02132832|895498|P1|COMPLETED|Overall Study||16
364412|NCT02132832|895497|P2|STARTED|Overall Study||23
364413|NCT02132832|895498|P1|STARTED|Overall Study||19
364414|NCT02132767|895528|P2|NOT COMPLETED|Overall Study||15
364415|NCT02132767|895529|P1|NOT COMPLETED|Overall Study||17
364416|NCT02132767|895528|P2|COMPLETED|Overall Study||246
364417|NCT02132767|895529|P1|COMPLETED|Overall Study||245
364418|NCT02132767|895528|P2|STARTED|Overall Study||261
364419|NCT02132767|895529|P1|STARTED|Overall Study||262
364420|NCT02132637|895551|P2|NOT COMPLETED|Study Period 2 (Crossover)||1
364421|NCT02132637|895552|P1|NOT COMPLETED|Study Period 2 (Crossover)||2
364422|NCT02132637|895551|P2|COMPLETED|Study Period 2 (Crossover)||29
364423|NCT02132637|895552|P1|COMPLETED|Study Period 2 (Crossover)||31
364424|NCT02132637|895551|P2|STARTED|Study Period 2 (Crossover)||30
364425|NCT02132637|895552|P1|STARTED|Study Period 2 (Crossover)||33
364426|NCT02132637|895551|P2|NOT COMPLETED|Study Period 1||4
364427|NCT02132637|895552|P1|NOT COMPLETED|Study Period 1||1
364428|NCT02132637|895551|P2|COMPLETED|Study Period 1||30
364429|NCT02132637|895552|P1|COMPLETED|Study Period 1||33
364430|NCT02132637|895551|P2|Received at Least One Dose of Study Drug|Study Period 1||34
364431|NCT02132637|895552|P1|Received at Least One Dose of Study Drug|Study Period 1||34
364432|NCT02132637|895551|P2|STARTED|Study Period 1||34
364433|NCT02132637|895552|P1|STARTED|Study Period 1||34
364434|NCT02132611|895576|P1|NOT COMPLETED|Overall Study||2
364435|NCT02132611|895576|P1|COMPLETED|Overall Study||98
364436|NCT02132611|895576|P1|STARTED|Overall Study||100
364437|NCT02132572|895581|P1|NOT COMPLETED|Overall Study||0
364438|NCT02132572|895581|P1|COMPLETED|Overall Study||201
364439|NCT02132572|895581|P1|STARTED|Overall Study||201
364440|NCT02132468|895585|P1|NOT COMPLETED|Overall Study||7
364441|NCT02132468|895585|P1|COMPLETED|Overall Study||11
364442|NCT02132468|895585|P1|STARTED|Overall Study||18
364443|NCT02132247|895594|P2|NOT COMPLETED|Overall Study||0
364444|NCT02132247|895595|P1|NOT COMPLETED|Overall Study||1
364445|NCT02132247|895594|P2|COMPLETED|Overall Study||52
364446|NCT02132247|895595|P1|COMPLETED|Overall Study||51
364447|NCT02132247|895594|P2|STARTED|Overall Study||52
364448|NCT02132247|895595|P1|STARTED|Overall Study||52
364449|NCT02132169|895609|P2|NOT COMPLETED|Overall Study||9
364450|NCT02132169|895610|P1|NOT COMPLETED|Overall Study||15
364451|NCT02132169|895609|P2|COMPLETED|Overall Study||162
364452|NCT02132169|895610|P1|COMPLETED|Overall Study||326
364453|NCT02132169|895609|P2|STARTED|Overall Study||171
364454|NCT02132169|895610|P1|STARTED|Overall Study||341
364455|NCT02132117|895624|P2|NOT COMPLETED|Overall Study||5
364456|NCT02132117|895625|P1|NOT COMPLETED|Overall Study||11
364457|NCT02132117|895624|P2|COMPLETED|Overall Study||216
364458|NCT02132117|895625|P1|COMPLETED|Overall Study||213
364459|NCT02132117|895624|P2|STARTED|Overall Study||221
364460|NCT02132117|895625|P1|STARTED|Overall Study||224
364461|NCT02131662|895646|P5|NOT COMPLETED|Overall Study||18
364462|NCT02131662|895647|P4|NOT COMPLETED|Overall Study||21
364463|NCT02131662|895648|P3|NOT COMPLETED|Overall Study||7
364464|NCT02131662|895649|P2|NOT COMPLETED|Overall Study||14
364465|NCT02131662|895650|P1|NOT COMPLETED|Overall Study||8
364466|NCT02131662|895646|P5|COMPLETED|Overall Study||43
364467|NCT02131662|895647|P4|COMPLETED|Overall Study||41
364468|NCT02131662|895648|P3|COMPLETED|Overall Study||56
364469|NCT02131662|895649|P2|COMPLETED|Overall Study||47
364470|NCT02131662|895650|P1|COMPLETED|Overall Study||54
364471|NCT02131662|895646|P5|Completed Follow-up|Overall Study||44
364472|NCT02131662|895647|P4|Completed Follow-up|Overall Study||42
364473|NCT02131662|895648|P3|Completed Follow-up|Overall Study||56
364474|NCT02131662|895649|P2|Completed Follow-up|Overall Study||47
364475|NCT02131662|895650|P1|Completed Follow-up|Overall Study||54
364476|NCT02131662|895646|P5|Completed Treatment|Overall Study||52
364477|NCT02131662|895647|P4|Completed Treatment|Overall Study||56
364478|NCT02131662|895648|P3|Completed Treatment|Overall Study||61
364479|NCT02131662|895649|P2|Completed Treatment|Overall Study||60
364480|NCT02131662|895650|P1|Completed Treatment|Overall Study||57
364481|NCT02131662|895646|P5|Treated|Overall Study||58
364482|NCT02131662|895647|P4|Treated|Overall Study||60
364483|NCT02131662|895648|P3|Treated|Overall Study||61
364484|NCT02131662|895649|P2|Treated|Overall Study||61
364485|NCT02131662|895650|P1|Treated|Overall Study||60
364486|NCT02131662|895646|P5|STARTED|Overall Study||61
364487|NCT02131662|895647|P4|STARTED|Overall Study||62
364488|NCT02131662|895648|P3|STARTED|Overall Study||63
364489|NCT02131662|895649|P2|STARTED|Overall Study||61
364490|NCT02131662|895650|P1|STARTED|Overall Study||62
364491|NCT02131636|895696|P2|NOT COMPLETED|Overall Study||5
364492|NCT02131636|895697|P1|NOT COMPLETED|Overall Study||12
364493|NCT02131636|895696|P2|COMPLETED|Overall Study||213
364494|NCT02131636|895697|P1|COMPLETED|Overall Study||210
364495|NCT02131636|895696|P2|STARTED|Overall Study||218
364496|NCT02131636|895697|P1|STARTED|Overall Study||222
364497|NCT02131532|895713|P1|NOT COMPLETED|Overall Study||4
364498|NCT02131532|895713|P1|COMPLETED|Overall Study||8
364499|NCT02131532|895713|P1|STARTED|Overall Study||12
364500|NCT02131402|895732|P1|NOT COMPLETED|Overall Study||0
364501|NCT02131402|895732|P1|COMPLETED|Overall Study||60
364502|NCT02131402|895732|P1|STARTED|Overall Study||60
364503|NCT02131324|895805|P2|NOT COMPLETED|Overall Study||3
364504|NCT02131324|895806|P1|NOT COMPLETED|Overall Study||2
364505|NCT02131324|895805|P2|COMPLETED|Overall Study||23
364506|NCT02131324|895806|P1|COMPLETED|Overall Study||22
364507|NCT02131324|895805|P2|Analyzed|Overall Study||24
364508|NCT02131324|895806|P1|Analyzed|Overall Study||22
364509|NCT02131324|895805|P2|STARTED|Overall Study|2 subjects randomized into DFD-06 not included in analysis as there was no post-baseline information|26
364510|NCT02131324|895806|P1|STARTED|Overall Study|2 subjects randomized into Comp01 not included in analysis as there was no post-baseline information|24
364511|NCT02131311|895812|P1|NOT COMPLETED|Overall Study||4
364512|NCT02131311|895812|P1|COMPLETED|Overall Study||86
364513|NCT02131311|895812|P1|STARTED|Overall Study||90
364514|NCT02131272|895824|P2|NOT COMPLETED|Overall Study||2
364515|NCT02131272|895825|P1|NOT COMPLETED|Overall Study||1
364516|NCT02131272|895824|P2|COMPLETED|Overall Study||20
364517|NCT02131272|895825|P1|COMPLETED|Overall Study||19
364518|NCT02131272|895824|P2|STARTED|Overall Study||22
364519|NCT02131272|895825|P1|STARTED|Overall Study||20
364520|NCT02131233|895845|P2|NOT COMPLETED|Overall Study||42
364521|NCT02131233|895846|P1|NOT COMPLETED|Overall Study||66
364522|NCT02131233|895845|P2|COMPLETED|Overall Study|Completed to Week 96|227
364523|NCT02131233|895846|P1|COMPLETED|Overall Study|Completed to Week 96|467
364524|NCT02131233|895845|P2|Treated|Overall Study||266
364525|NCT02131233|895846|P1|Treated|Overall Study||531
364526|NCT02131233|895845|P2|STARTED|Overall Study|Enrolled participants|269
364527|NCT02131233|895846|P1|STARTED|Overall Study|Enrolled participants|533
364528|NCT02131064|895880|P2|NOT COMPLETED|Overall Study||223
364529|NCT02131064|895881|P1|NOT COMPLETED|Overall Study||221
364530|NCT02131064|895880|P2|COMPLETED|Overall Study||0
364531|NCT02131064|895881|P1|COMPLETED|Overall Study||0
364532|NCT02131064|895880|P2|STARTED|Overall Study||223
364533|NCT02131064|895881|P1|STARTED|Overall Study||221
364534|NCT02130999|895913|P2|NOT COMPLETED|Overall Study||0
364535|NCT02130999|895914|P1|NOT COMPLETED|Overall Study||0
364536|NCT02130999|895913|P2|COMPLETED|Overall Study||8
364537|NCT02130999|895914|P1|COMPLETED|Overall Study||6
364538|NCT02130999|895913|P2|STARTED|Overall Study||8
364539|NCT02130999|895914|P1|STARTED|Overall Study||6
364540|NCT02130635|895949|P9|NOT COMPLETED|Part B-Dose-Response Relationship||0
364541|NCT02130635|895950|P8|NOT COMPLETED|Part B-Dose-Response Relationship||0
364542|NCT02130635|895951|P7|NOT COMPLETED|Part B-Dose-Response Relationship||0
364543|NCT02130635|895952|P6|NOT COMPLETED|Part B-Dose-Response Relationship||0
364544|NCT02130635|895953|P5|NOT COMPLETED|Part B-Dose-Response Relationship||0
364545|NCT02130635|895954|P4|NOT COMPLETED|Part B-Dose-Response Relationship||0
364546|NCT02130635|895955|P3|NOT COMPLETED|Part B-Dose-Response Relationship||0
364547|NCT02130635|895956|P2|NOT COMPLETED|Part B-Dose-Response Relationship||0
364548|NCT02130635|895957|P1|NOT COMPLETED|Part B-Dose-Response Relationship||0
364549|NCT02130635|895949|P9|COMPLETED|Part B-Dose-Response Relationship||5
364550|NCT02130635|895950|P8|COMPLETED|Part B-Dose-Response Relationship||5
364551|NCT02130635|895951|P7|COMPLETED|Part B-Dose-Response Relationship||6
364552|NCT02130635|895952|P6|COMPLETED|Part B-Dose-Response Relationship||5
364553|NCT02130635|895953|P5|COMPLETED|Part B-Dose-Response Relationship||5
364554|NCT02130635|895954|P4|COMPLETED|Part B-Dose-Response Relationship||5
364555|NCT02130635|895955|P3|COMPLETED|Part B-Dose-Response Relationship||5
364556|NCT02130635|895956|P2|COMPLETED|Part B-Dose-Response Relationship||0
364557|NCT02130635|895957|P1|COMPLETED|Part B-Dose-Response Relationship||0
364558|NCT02130635|895949|P9|STARTED|Part B-Dose-Response Relationship||5
364559|NCT02130635|895950|P8|STARTED|Part B-Dose-Response Relationship||5
364560|NCT02130635|895951|P7|STARTED|Part B-Dose-Response Relationship||6
364561|NCT02130635|895952|P6|STARTED|Part B-Dose-Response Relationship||5
364562|NCT02130635|895953|P5|STARTED|Part B-Dose-Response Relationship||5
364563|NCT02130635|895954|P4|STARTED|Part B-Dose-Response Relationship||5
364564|NCT02130635|895955|P3|STARTED|Part B-Dose-Response Relationship||5
364565|NCT02130635|895956|P2|STARTED|Part B-Dose-Response Relationship||0
364566|NCT02130635|895957|P1|STARTED|Part B-Dose-Response Relationship||0
364567|NCT02130635|895949|P9|NOT COMPLETED|Part A-Safety and Tolerability||0
364568|NCT02130635|895950|P8|NOT COMPLETED|Part A-Safety and Tolerability||0
364569|NCT02130635|895951|P7|NOT COMPLETED|Part A-Safety and Tolerability||0
364570|NCT02130635|895952|P6|NOT COMPLETED|Part A-Safety and Tolerability||0
364571|NCT02130635|895953|P5|NOT COMPLETED|Part A-Safety and Tolerability||0
364572|NCT02130635|895954|P4|NOT COMPLETED|Part A-Safety and Tolerability||0
364573|NCT02130635|895955|P3|NOT COMPLETED|Part A-Safety and Tolerability||0
364574|NCT02130635|895956|P2|NOT COMPLETED|Part A-Safety and Tolerability||0
364575|NCT02130635|895957|P1|NOT COMPLETED|Part A-Safety and Tolerability||0
364576|NCT02130635|895949|P9|COMPLETED|Part A-Safety and Tolerability||0
364577|NCT02130635|895950|P8|COMPLETED|Part A-Safety and Tolerability||0
364578|NCT02130635|895951|P7|COMPLETED|Part A-Safety and Tolerability||0
364579|NCT02130635|895952|P6|COMPLETED|Part A-Safety and Tolerability||0
364580|NCT02130635|895953|P5|COMPLETED|Part A-Safety and Tolerability||0
364581|NCT02130635|895954|P4|COMPLETED|Part A-Safety and Tolerability||0
364582|NCT02130635|895955|P3|COMPLETED|Part A-Safety and Tolerability||0
364583|NCT02130635|895956|P2|COMPLETED|Part A-Safety and Tolerability||21
364584|NCT02130635|895957|P1|COMPLETED|Part A-Safety and Tolerability||7
364585|NCT02130635|895949|P9|STARTED|Part A-Safety and Tolerability||0
364586|NCT02130635|895950|P8|STARTED|Part A-Safety and Tolerability||0
364587|NCT02130635|895951|P7|STARTED|Part A-Safety and Tolerability||0
364588|NCT02130635|895952|P6|STARTED|Part A-Safety and Tolerability||0
364589|NCT02130635|895953|P5|STARTED|Part A-Safety and Tolerability||0
364590|NCT02130635|895954|P4|STARTED|Part A-Safety and Tolerability||0
364591|NCT02130635|895955|P3|STARTED|Part A-Safety and Tolerability||0
364592|NCT02130635|895956|P2|STARTED|Part A-Safety and Tolerability||21
364593|NCT02130635|895957|P1|STARTED|Part A-Safety and Tolerability||7
364594|NCT02130622|896131|P2|NOT COMPLETED|Overall Study||0
364595|NCT02130622|896132|P1|NOT COMPLETED|Overall Study||0
364596|NCT02130622|896131|P2|COMPLETED|Overall Study||1
364597|NCT02130622|896132|P1|COMPLETED|Overall Study||2
364598|NCT02130622|896131|P2|STARTED|Overall Study||1
364599|NCT02130622|896132|P1|STARTED|Overall Study||2
364600|NCT02130284|896144|P1|NOT COMPLETED|Overall Study||9
364601|NCT02130284|896144|P1|COMPLETED|Overall Study||71
364602|NCT02130284|896144|P1|STARTED|Overall Study||80
364603|NCT02130258|896157|P2|NOT COMPLETED|Overall Study||0
364604|NCT02130258|896158|P1|NOT COMPLETED|Overall Study||0
364605|NCT02130258|896157|P2|COMPLETED|Overall Study||11
364606|NCT02130258|896158|P1|COMPLETED|Overall Study||9
364607|NCT02130258|896157|P2|STARTED|Overall Study||11
364608|NCT02130258|896158|P1|STARTED|Overall Study||9
364609|NCT02130193|896170|P3|NOT COMPLETED|Part B: 52-week Double-blind Period||8
364610|NCT02130193|896171|P2|NOT COMPLETED|Part B: 52-week Double-blind Period||10
364611|NCT02130193|896172|P1|NOT COMPLETED|Part B: 52-week Double-blind Period||0
364612|NCT02130193|896170|P3|COMPLETED|Part B: 52-week Double-blind Period||37
364613|NCT02130193|896171|P2|COMPLETED|Part B: 52-week Double-blind Period||38
364614|NCT02130193|896172|P1|COMPLETED|Part B: 52-week Double-blind Period||0
364615|NCT02130193|896170|P3|STARTED|Part B: 52-week Double-blind Period||45
364616|NCT02130193|896171|P2|STARTED|Part B: 52-week Double-blind Period||48
364617|NCT02130193|896172|P1|STARTED|Part B: 52-week Double-blind Period||0
364618|NCT02130193|896170|P3|NOT COMPLETED|Part A: 4-week Open-label Period||0
364619|NCT02130193|896171|P2|NOT COMPLETED|Part A: 4-week Open-label Period||0
364620|NCT02130193|896172|P1|NOT COMPLETED|Part A: 4-week Open-label Period||0
364621|NCT02130193|896170|P3|COMPLETED|Part A: 4-week Open-label Period||0
364622|NCT02130193|896171|P2|COMPLETED|Part A: 4-week Open-label Period||0
364623|NCT02130193|896172|P1|COMPLETED|Part A: 4-week Open-label Period||9
364624|NCT02130193|896170|P3|STARTED|Part A: 4-week Open-label Period||0
364625|NCT02130193|896171|P2|STARTED|Part A: 4-week Open-label Period||0
364626|NCT02130193|896172|P1|STARTED|Part A: 4-week Open-label Period||9
364627|NCT02130063|896238|P2|NOT COMPLETED|Overall Study||17
364628|NCT02130063|896239|P1|NOT COMPLETED|Overall Study||25
364629|NCT02130063|896238|P2|COMPLETED|Overall Study||152
364630|NCT02130063|896239|P1|COMPLETED|Overall Study||317
364631|NCT02130063|896238|P2|STARTED|Overall Study||169
364632|NCT02130063|896239|P1|STARTED|Overall Study||342
364633|NCT02129777|896256|P7|NOT COMPLETED|Open-Label Period||48
364634|NCT02129777|896257|P6|NOT COMPLETED|Open-Label Period||12
364635|NCT02129777|896258|P5|NOT COMPLETED|Open-Label Period||0
364636|NCT02129777|896259|P4|NOT COMPLETED|Open-Label Period||0
364637|NCT02129777|896260|P3|NOT COMPLETED|Open-Label Period||0
364638|NCT02129777|896261|P2|NOT COMPLETED|Open-Label Period||0
364639|NCT02129777|896262|P1|NOT COMPLETED|Open-Label Period||0
364640|NCT02129777|896256|P7|COMPLETED|Open-Label Period||0
364641|NCT02129777|896257|P6|COMPLETED|Open-Label Period||0
364642|NCT02129777|896258|P5|COMPLETED|Open-Label Period||0
364643|NCT02129777|896259|P4|COMPLETED|Open-Label Period||0
364644|NCT02129777|896260|P3|COMPLETED|Open-Label Period||0
364645|NCT02129777|896261|P2|COMPLETED|Open-Label Period||0
364646|NCT02129777|896262|P1|COMPLETED|Open-Label Period||0
364647|NCT02129777|896256|P7|STARTED|Open-Label Period||48
364648|NCT02129777|896257|P6|STARTED|Open-Label Period||12
364649|NCT02129777|896258|P5|STARTED|Open-Label Period||0
364650|NCT02129777|896259|P4|STARTED|Open-Label Period||0
364651|NCT02129777|896260|P3|STARTED|Open-Label Period||0
364652|NCT02129777|896261|P2|STARTED|Open-Label Period||0
364653|NCT02129777|896262|P1|STARTED|Open-Label Period||0
364654|NCT02129777|896256|P7|NOT COMPLETED|Double-Blind Period||0
364655|NCT02129777|896257|P6|NOT COMPLETED|Double-Blind Period||0
364656|NCT02129777|896258|P5|NOT COMPLETED|Double-Blind Period||7
364657|NCT02129777|896259|P4|NOT COMPLETED|Double-Blind Period||7
364658|NCT02129777|896260|P3|NOT COMPLETED|Double-Blind Period||4
364659|NCT02129777|896261|P2|NOT COMPLETED|Double-Blind Period||8
364660|NCT02129777|896262|P1|NOT COMPLETED|Double-Blind Period||7
364661|NCT02129777|896256|P7|COMPLETED|Double-Blind Period||0
364662|NCT02129777|896257|P6|COMPLETED|Double-Blind Period||0
364663|NCT02129777|896258|P5|COMPLETED|Double-Blind Period||18
364664|NCT02129777|896259|P4|COMPLETED|Double-Blind Period||18
364665|NCT02129777|896260|P3|COMPLETED|Double-Blind Period||20
364666|NCT02129777|896261|P2|COMPLETED|Double-Blind Period||16
364667|NCT02129777|896262|P1|COMPLETED|Double-Blind Period||17
364668|NCT02129777|896256|P7|STARTED|Double-Blind Period||0
364669|NCT02129777|896257|P6|STARTED|Double-Blind Period||0
364670|NCT02129777|896258|P5|STARTED|Double-Blind Period||25
364671|NCT02129777|896259|P4|STARTED|Double-Blind Period||25
364672|NCT02129777|896260|P3|STARTED|Double-Blind Period||24
364673|NCT02129777|896261|P2|STARTED|Double-Blind Period||24
364674|NCT02129777|896262|P1|STARTED|Double-Blind Period||24
364675|NCT02129725|896368|P2|NOT COMPLETED|Overall Study||3
364676|NCT02129725|896369|P1|NOT COMPLETED|Overall Study||2
364677|NCT02129725|896368|P2|COMPLETED|Overall Study||4
364678|NCT02129725|896369|P1|COMPLETED|Overall Study||6
364679|NCT02129725|896368|P2|STARTED|Overall Study||7
364680|NCT02129725|896369|P1|STARTED|Overall Study||8
364681|NCT02129608|896378|P3|NOT COMPLETED|Overall Study||3
364682|NCT02129608|896379|P2|NOT COMPLETED|Overall Study||1
364683|NCT02129608|896380|P1|NOT COMPLETED|Overall Study||0
364684|NCT02129608|896378|P3|COMPLETED|Overall Study||12
364685|NCT02129608|896379|P2|COMPLETED|Overall Study||13
364686|NCT02129608|896380|P1|COMPLETED|Overall Study||15
364687|NCT02129608|896378|P3|End of Treatment|Overall Study||12
364688|NCT02129608|896379|P2|End of Treatment|Overall Study||13
364689|NCT02129608|896380|P1|End of Treatment|Overall Study||15
364690|NCT02129608|896378|P3|STARTED|Overall Study||15
364691|NCT02129608|896379|P2|STARTED|Overall Study||14
364692|NCT02129608|896380|P1|STARTED|Overall Study||15
364693|NCT02129192|896393|P2|NOT COMPLETED|Period 5||0
364694|NCT02129192|896394|P1|NOT COMPLETED|Period 5||0
364695|NCT02129192|896393|P2|COMPLETED|Period 5||0
364696|NCT02129192|896394|P1|COMPLETED|Period 5||36
364697|NCT02129192|896393|P2|STARTED|Period 5|This sequence consists of only 4 periods.|0
364698|NCT02129192|896394|P1|STARTED|Period 5||36
364699|NCT02129192|896393|P2|NOT COMPLETED|Period 4 Including Washout Period||0
364700|NCT02129192|896394|P1|NOT COMPLETED|Period 4 Including Washout Period||0
364701|NCT02129192|896393|P2|COMPLETED|Period 4 Including Washout Period||35
364702|NCT02129192|896394|P1|COMPLETED|Period 4 Including Washout Period||36
364703|NCT02129192|896393|P2|STARTED|Period 4 Including Washout Period||35
364704|NCT02129192|896394|P1|STARTED|Period 4 Including Washout Period||36
364705|NCT02129192|896393|P2|NOT COMPLETED|Period 3 Including Washout Period||0
364706|NCT02129192|896394|P1|NOT COMPLETED|Period 3 Including Washout Period||0
364707|NCT02129192|896393|P2|COMPLETED|Period 3 Including Washout Period||35
364708|NCT02129192|896394|P1|COMPLETED|Period 3 Including Washout Period||36
364709|NCT02129192|896393|P2|STARTED|Period 3 Including Washout Period||35
364710|NCT02129192|896394|P1|STARTED|Period 3 Including Washout Period||36
364711|NCT02129192|896393|P2|NOT COMPLETED|Period 2 Including Washout Period||0
364712|NCT02129192|896394|P1|NOT COMPLETED|Period 2 Including Washout Period||0
364713|NCT02129192|896393|P2|COMPLETED|Period 2 Including Washout Period||35
364714|NCT02129192|896394|P1|COMPLETED|Period 2 Including Washout Period||36
364715|NCT02129192|896393|P2|STARTED|Period 2 Including Washout Period||35
364716|NCT02129192|896394|P1|STARTED|Period 2 Including Washout Period||36
364717|NCT02129192|896393|P2|NOT COMPLETED|Period 1 Including Washout Period||1
364718|NCT02129192|896394|P1|NOT COMPLETED|Period 1 Including Washout Period||0
364719|NCT02129192|896393|P2|COMPLETED|Period 1 Including Washout Period|Withdrawal by one subject in washout period|35
364720|NCT02129192|896394|P1|COMPLETED|Period 1 Including Washout Period||36
364721|NCT02129192|896393|P2|STARTED|Period 1 Including Washout Period||36
364722|NCT02129192|896394|P1|STARTED|Period 1 Including Washout Period||36
364723|NCT02129062|896411|P1|NOT COMPLETED|Overall Study||3
364724|NCT02129062|896411|P1|COMPLETED|Overall Study||0
364725|NCT02129062|896411|P1|STARTED|Overall Study||3
364726|NCT02128997|896418|P2|NOT COMPLETED|Overall Study||11
364727|NCT02128997|896419|P1|NOT COMPLETED|Overall Study||6
364728|NCT02128997|896418|P2|COMPLETED|Overall Study||58
364729|NCT02128997|896419|P1|COMPLETED|Overall Study||61
364730|NCT02128997|896418|P2|STARTED|Overall Study||69
364731|NCT02128997|896419|P1|STARTED|Overall Study||67
364732|NCT02128932|896434|P3|NOT COMPLETED|Overall Study||18
364733|NCT02128932|896435|P2|NOT COMPLETED|Overall Study||19
364734|NCT02128932|896436|P1|NOT COMPLETED|Overall Study||27
364735|NCT02128932|896434|P3|COMPLETED|Overall Study||342
364736|NCT02128932|896435|P2|COMPLETED|Overall Study||341
364737|NCT02128932|896436|P1|COMPLETED|Overall Study||335
364738|NCT02128932|896434|P3|STARTED|Overall Study||360
364739|NCT02128932|896435|P2|STARTED|Overall Study||360
364740|NCT02128932|896436|P1|STARTED|Overall Study||362
364741|NCT02128919|896467|P2|NOT COMPLETED|Overall Study||1
364742|NCT02128919|896468|P1|NOT COMPLETED|Overall Study||3
364743|NCT02128919|896467|P2|COMPLETED|Overall Study||15
364744|NCT02128919|896468|P1|COMPLETED|Overall Study||14
364745|NCT02128919|896467|P2|STARTED|Overall Study||16
364746|NCT02128919|896468|P1|STARTED|Overall Study||17
364747|NCT02128867|896481|P3|NOT COMPLETED|Overall Study||4
364748|NCT02128867|896482|P2|NOT COMPLETED|Overall Study||2
364749|NCT02128867|896483|P1|NOT COMPLETED|Overall Study||3
364750|NCT02128867|896481|P3|COMPLETED|Overall Study||50
364751|NCT02128867|896482|P2|COMPLETED|Overall Study||50
364752|NCT02128867|896483|P1|COMPLETED|Overall Study||50
364753|NCT02128867|896481|P3|STARTED|Overall Study||54
364754|NCT02128867|896482|P2|STARTED|Overall Study||52
364755|NCT02128867|896483|P1|STARTED|Overall Study||53
364756|NCT02128542|896493|P2|NOT COMPLETED|Overall Study||0
364757|NCT02128542|896494|P1|NOT COMPLETED|Overall Study||4
364758|NCT02128542|896493|P2|COMPLETED|Overall Study||19
364759|NCT02128542|896494|P1|COMPLETED|Overall Study||43
364760|NCT02128542|896493|P2|STARTED|Overall Study||19
364761|NCT02128542|896494|P1|STARTED|Overall Study||47
364762|NCT02128490|896512|P5|NOT COMPLETED|Overall Study||7
364763|NCT02128490|896513|P4|NOT COMPLETED|Overall Study||6
364764|NCT02128490|896514|P3|NOT COMPLETED|Overall Study||5
364765|NCT02128490|896515|P2|NOT COMPLETED|Overall Study||6
364766|NCT02128490|896516|P1|NOT COMPLETED|Overall Study||5
364767|NCT02128490|896512|P5|COMPLETED|Overall Study||31
364768|NCT02128490|896513|P4|COMPLETED|Overall Study||31
364769|NCT02128490|896514|P3|COMPLETED|Overall Study||34
364770|NCT02128490|896515|P2|COMPLETED|Overall Study||31
364771|NCT02128490|896516|P1|COMPLETED|Overall Study||33
364772|NCT02128490|896512|P5|STARTED|Overall Study||38
364773|NCT02128490|896513|P4|STARTED|Overall Study||37
364774|NCT02128490|896514|P3|STARTED|Overall Study||39
364775|NCT02128490|896515|P2|STARTED|Overall Study||37
364776|NCT02128490|896516|P1|STARTED|Overall Study||38
364777|NCT02128269|896538|P1|NOT COMPLETED|Follow-up||0
364778|NCT02128269|896538|P1|COMPLETED|Follow-up||9
364779|NCT02128269|896538|P1|STARTED|Follow-up|All enrolled patients were followed for 12 weeks after their last infusion of ALXN1007.|9
364780|NCT02128269|896538|P1|NOT COMPLETED|Treatment Period||2
364781|NCT02128269|896538|P1|COMPLETED|Treatment Period||7
364782|NCT02128269|896538|P1|STARTED|Treatment Period||9
364783|NCT02128217|896544|P2|NOT COMPLETED|Overall Study||1
364784|NCT02128217|896545|P1|NOT COMPLETED|Overall Study||0
364785|NCT02128217|896544|P2|COMPLETED|Overall Study||26
364786|NCT02128217|896545|P1|COMPLETED|Overall Study||17
364787|NCT02128217|896544|P2|STARTED|Overall Study||27
364788|NCT02128217|896545|P1|STARTED|Overall Study||17
364789|NCT02127892|896591|P4|NOT COMPLETED|Overall Study||0
364790|NCT02127892|896592|P3|NOT COMPLETED|Overall Study||0
364791|NCT02127892|896593|P2|NOT COMPLETED|Overall Study||1
364792|NCT02127892|896594|P1|NOT COMPLETED|Overall Study||1
364793|NCT02127892|896591|P4|COMPLETED|Overall Study||0
364794|NCT02127892|896592|P3|COMPLETED|Overall Study||0
364795|NCT02127892|896593|P2|COMPLETED|Overall Study||1
364796|NCT02127892|896594|P1|COMPLETED|Overall Study||6
364797|NCT02127892|896591|P4|STARTED|Overall Study||0
364798|NCT02127892|896592|P3|STARTED|Overall Study||0
364799|NCT02127892|896593|P2|STARTED|Overall Study||2
364800|NCT02127892|896594|P1|STARTED|Overall Study||7
364801|NCT02127710|896623|P3|NOT COMPLETED|Overall Study||0
364802|NCT02127710|896624|P2|NOT COMPLETED|Overall Study||0
364803|NCT02127710|896625|P1|NOT COMPLETED|Overall Study||0
364804|NCT02127710|896623|P3|COMPLETED|Overall Study||19
364805|NCT02127710|896624|P2|COMPLETED|Overall Study||46
364806|NCT02127710|896625|P1|COMPLETED|Overall Study||44
364807|NCT02127710|896623|P3|STARTED|Overall Study||19
364808|NCT02127710|896624|P2|STARTED|Overall Study||46
364809|NCT02127710|896625|P1|STARTED|Overall Study||44
364810|NCT02127632|896648|P2|NOT COMPLETED|Overall Study||0
364811|NCT02127632|896649|P1|NOT COMPLETED|Overall Study||0
364812|NCT02127632|896648|P2|COMPLETED|Overall Study||50
364813|NCT02127632|896649|P1|COMPLETED|Overall Study||50
364814|NCT02127632|896648|P2|STARTED|Overall Study||50
364815|NCT02127632|896649|P1|STARTED|Overall Study||50
364816|NCT02127567|896659|P1|NOT COMPLETED|Overall Study||0
364817|NCT02127567|896659|P1|COMPLETED|Overall Study||41
364818|NCT02127567|896659|P1|STARTED|Overall Study|41 participants completed 123 domains, 3 domains were completed with the tool per participant|41
364819|NCT02127372|896681|P2|NOT COMPLETED|Overall Study||0
364820|NCT02127372|896682|P1|NOT COMPLETED|Overall Study||1
364821|NCT02127372|896681|P2|COMPLETED|Overall Study||28
364822|NCT02127372|896682|P1|COMPLETED|Overall Study|Completed at least one cycle and were available for dose limiting toxicity (DLT) evaluation.|14
364823|NCT02127372|896681|P2|Started Study Treatment|Overall Study||28
364824|NCT02127372|896682|P1|Started Study Treatment|Overall Study||15
364825|NCT02127372|896681|P2|STARTED|Overall Study|Signed Consent|28
364826|NCT02127372|896682|P1|STARTED|Overall Study|Signed Consent|15
364827|NCT02127307|896692|P1|NOT COMPLETED|Overall Study||308
364828|NCT02127307|896692|P1|COMPLETED|Overall Study||656
364829|NCT02127307|896692|P1|STARTED|Overall Study||964
364830|NCT02127281|896698|P2|NOT COMPLETED|Overall Study||0
364831|NCT02127281|896699|P1|NOT COMPLETED|Overall Study||1
364832|NCT02127281|896698|P2|COMPLETED|Overall Study||80
364833|NCT02127281|896699|P1|COMPLETED|Overall Study||79
364834|NCT02127281|896698|P2|STARTED|Overall Study||80
364835|NCT02127281|896699|P1|STARTED|Overall Study||80
364836|NCT02126839|896727|P2|NOT COMPLETED|Overall Study||14
364837|NCT02126839|896728|P1|NOT COMPLETED|Overall Study||10
364838|NCT02126839|896727|P2|COMPLETED|Overall Study||80
364839|NCT02126839|896728|P1|COMPLETED|Overall Study||82
364840|NCT02126839|896727|P2|Full Analysis Set|Overall Study||92
364841|NCT02126839|896728|P1|Full Analysis Set|Overall Study||92
364842|NCT02126839|896727|P2|Safety Population|Overall Study||93
364843|NCT02126839|896728|P1|Safety Population|Overall Study||92
364844|NCT02126839|896727|P2|STARTED|Overall Study||94
364845|NCT02126839|896728|P1|STARTED|Overall Study||92
364846|NCT02126748|896741|P3|NOT COMPLETED|Overall Study||5
364847|NCT02126748|896742|P2|NOT COMPLETED|Overall Study||3
364848|NCT02126748|896743|P1|NOT COMPLETED|Overall Study||2
364849|NCT02126748|896741|P3|COMPLETED|Overall Study||31
364850|NCT02126748|896742|P2|COMPLETED|Overall Study||31
364851|NCT02126748|896743|P1|COMPLETED|Overall Study||31
364852|NCT02126748|896741|P3|STARTED|Overall Study||36
364853|NCT02126748|896742|P2|STARTED|Overall Study||34
364854|NCT02126748|896743|P1|STARTED|Overall Study||33
364855|NCT02126670|896755|P4|NOT COMPLETED|Overall Study||1
364856|NCT02126670|896756|P3|NOT COMPLETED|Overall Study||0
364857|NCT02126670|896757|P2|NOT COMPLETED|Overall Study||0
364858|NCT02126670|896758|P1|NOT COMPLETED|Overall Study||1
364859|NCT02126670|896755|P4|COMPLETED|Overall Study||24
364860|NCT02126670|896756|P3|COMPLETED|Overall Study||25
364861|NCT02126670|896757|P2|COMPLETED|Overall Study||24
364862|NCT02126670|896758|P1|COMPLETED|Overall Study||25
364863|NCT02126670|896755|P4|STARTED|Overall Study||25
364864|NCT02126670|896756|P3|STARTED|Overall Study||25
364865|NCT02126670|896757|P2|STARTED|Overall Study||24
364866|NCT02126670|896758|P1|STARTED|Overall Study||26
364867|NCT02126319|896774|P2|NOT COMPLETED|Overall Study||24
364868|NCT02126319|896775|P1|NOT COMPLETED|Overall Study||21
364869|NCT02126319|896774|P2|COMPLETED|Overall Study||43
364870|NCT02126319|896775|P1|COMPLETED|Overall Study||40
364871|NCT02126319|896774|P2|STARTED|Overall Study||67
364872|NCT02126319|896775|P1|STARTED|Overall Study||61
364873|NCT02126306|896801|P2|NOT COMPLETED|Overall Study||0
364874|NCT02126306|896802|P1|NOT COMPLETED|Overall Study||0
364875|NCT02126306|896801|P2|COMPLETED|Overall Study||13
364876|NCT02126306|896802|P1|COMPLETED|Overall Study||10
364877|NCT02126306|896801|P2|STARTED|Overall Study||13
364878|NCT02126306|896802|P1|STARTED|Overall Study||10
364879|NCT02125877|896810|P2|NOT COMPLETED|Overall Study||10
364880|NCT02125877|896811|P1|NOT COMPLETED|Overall Study||13
364881|NCT02125877|896810|P2|COMPLETED|Overall Study||77
364882|NCT02125877|896811|P1|COMPLETED|Overall Study||73
364883|NCT02125877|896810|P2|Safety Set|Overall Study||87
364884|NCT02125877|896811|P1|Safety Set|Overall Study||86
364885|NCT02125877|896810|P2|Pharmacokinetic Subset A|Overall Study||15
364886|NCT02125877|896811|P1|Pharmacokinetic Subset A|Overall Study||16
364887|NCT02125877|896810|P2|Pharmacokinetic Analysis Set|Overall Study||83
364888|NCT02125877|896811|P1|Pharmacokinetic Analysis Set|Overall Study||83
364889|NCT02125877|896810|P2|STARTED|Overall Study||87
364890|NCT02125877|896811|P1|STARTED|Overall Study||86
364891|NCT02125838|896841|P2|NOT COMPLETED|Overall Study||4
364892|NCT02125838|896842|P1|NOT COMPLETED|Overall Study||4
364893|NCT02125838|896841|P2|COMPLETED|Overall Study|Analysed (n=50 )|50
364894|NCT02125838|896842|P1|COMPLETED|Overall Study|Analysed (n=50 )|50
364895|NCT02125838|896841|P2|STARTED|Overall Study|Lost to follow-up (n= 4 ) Turned to laparotomy (Adhesions) (n= 2) NBA used (n= 2)|54
364896|NCT02125838|896842|P1|STARTED|Overall Study|Lost to follow-up (n= 4 ) Turned to laparotomy (Adhesions)(n= 2) NBA used (n= 2)|54
364897|NCT02125734|896860|P2|NOT COMPLETED|Period 2||1
364898|NCT02125734|896861|P1|NOT COMPLETED|Period 2||0
364899|NCT02125734|896860|P2|COMPLETED|Period 2||47
364900|NCT02125734|896861|P1|COMPLETED|Period 2||40
364901|NCT02125734|896860|P2|STARTED|Period 2||48
364902|NCT02125734|896861|P1|STARTED|Period 2||40
364903|NCT02125734|896860|P2|NOT COMPLETED|Period 1||0
364904|NCT02125734|896861|P1|NOT COMPLETED|Period 1||0
364905|NCT02125734|896860|P2|COMPLETED|Period 1||48
364906|NCT02125734|896861|P1|COMPLETED|Period 1||40
364907|NCT02125734|896860|P2|STARTED|Period 1||48
364908|NCT02125734|896861|P1|STARTED|Period 1||40
364909|NCT02125604|896871|P1|NOT COMPLETED|Overall Study||31
364910|NCT02125604|896871|P1|COMPLETED|Overall Study||180
364911|NCT02125604|896871|P1|STARTED|Overall Study|enrolled and received at least 1 dose of study drug|211
364912|NCT02125292|896885|P6|NOT COMPLETED|Third Intervention (1 Hour)||0
364913|NCT02125292|896886|P5|NOT COMPLETED|Third Intervention (1 Hour)||0
364914|NCT02125292|896887|P4|NOT COMPLETED|Third Intervention (1 Hour)||0
364915|NCT02125292|896888|P3|NOT COMPLETED|Third Intervention (1 Hour)||0
364916|NCT02125292|896889|P2|NOT COMPLETED|Third Intervention (1 Hour)||0
364917|NCT02125292|896890|P1|NOT COMPLETED|Third Intervention (1 Hour)||0
364918|NCT02125292|896885|P6|COMPLETED|Third Intervention (1 Hour)||3
364919|NCT02125292|896886|P5|COMPLETED|Third Intervention (1 Hour)||3
364920|NCT02125292|896887|P4|COMPLETED|Third Intervention (1 Hour)||3
364921|NCT02125292|896888|P3|COMPLETED|Third Intervention (1 Hour)||3
364922|NCT02125292|896889|P2|COMPLETED|Third Intervention (1 Hour)||3
364923|NCT02125292|896890|P1|COMPLETED|Third Intervention (1 Hour)||3
364924|NCT02125292|896885|P6|STARTED|Third Intervention (1 Hour)||3
364925|NCT02125292|896886|P5|STARTED|Third Intervention (1 Hour)||3
364926|NCT02125292|896887|P4|STARTED|Third Intervention (1 Hour)||3
364927|NCT02125292|896888|P3|STARTED|Third Intervention (1 Hour)||3
364928|NCT02125292|896889|P2|STARTED|Third Intervention (1 Hour)||3
364929|NCT02125292|896890|P1|STARTED|Third Intervention (1 Hour)||3
364930|NCT02125292|896885|P6|NOT COMPLETED|Washout (2 Hours)||0
364931|NCT02125292|896886|P5|NOT COMPLETED|Washout (2 Hours)||0
364932|NCT02125292|896887|P4|NOT COMPLETED|Washout (2 Hours)||0
364933|NCT02125292|896888|P3|NOT COMPLETED|Washout (2 Hours)||0
364934|NCT02125292|896889|P2|NOT COMPLETED|Washout (2 Hours)||0
364935|NCT02125292|896890|P1|NOT COMPLETED|Washout (2 Hours)||0
364936|NCT02125292|896885|P6|COMPLETED|Washout (2 Hours)||3
364937|NCT02125292|896886|P5|COMPLETED|Washout (2 Hours)||3
364938|NCT02125292|896887|P4|COMPLETED|Washout (2 Hours)||3
364939|NCT02125292|896888|P3|COMPLETED|Washout (2 Hours)||3
364940|NCT02125292|896889|P2|COMPLETED|Washout (2 Hours)||3
364941|NCT02125292|896890|P1|COMPLETED|Washout (2 Hours)||3
364942|NCT02125292|896885|P6|STARTED|Washout (2 Hours)||3
364943|NCT02125292|896886|P5|STARTED|Washout (2 Hours)||3
364944|NCT02125292|896887|P4|STARTED|Washout (2 Hours)||3
364945|NCT02125292|896888|P3|STARTED|Washout (2 Hours)||3
364946|NCT02125292|896889|P2|STARTED|Washout (2 Hours)||3
364947|NCT02125292|896890|P1|STARTED|Washout (2 Hours)||3
364948|NCT02125292|896885|P6|NOT COMPLETED|Second Intervention (1 Hour)||0
364949|NCT02125292|896886|P5|NOT COMPLETED|Second Intervention (1 Hour)||0
364950|NCT02125292|896887|P4|NOT COMPLETED|Second Intervention (1 Hour)||0
364951|NCT02125292|896888|P3|NOT COMPLETED|Second Intervention (1 Hour)||0
364952|NCT02125292|896889|P2|NOT COMPLETED|Second Intervention (1 Hour)||0
364953|NCT02125292|896890|P1|NOT COMPLETED|Second Intervention (1 Hour)||0
364954|NCT02125292|896885|P6|COMPLETED|Second Intervention (1 Hour)||3
364955|NCT02125292|896886|P5|COMPLETED|Second Intervention (1 Hour)||3
364956|NCT02125292|896887|P4|COMPLETED|Second Intervention (1 Hour)||3
364957|NCT02125292|896888|P3|COMPLETED|Second Intervention (1 Hour)||3
364958|NCT02125292|896889|P2|COMPLETED|Second Intervention (1 Hour)||3
364959|NCT02125292|896890|P1|COMPLETED|Second Intervention (1 Hour)||3
364960|NCT02125292|896885|P6|STARTED|Second Intervention (1 Hour)||3
364961|NCT02125292|896886|P5|STARTED|Second Intervention (1 Hour)||3
364962|NCT02125292|896887|P4|STARTED|Second Intervention (1 Hour)||3
364963|NCT02125292|896888|P3|STARTED|Second Intervention (1 Hour)||3
364964|NCT02125292|896889|P2|STARTED|Second Intervention (1 Hour)||3
364965|NCT02125292|896890|P1|STARTED|Second Intervention (1 Hour)||3
364966|NCT02125292|896885|P6|NOT COMPLETED|Washout (2 Hours)||0
364967|NCT02125292|896886|P5|NOT COMPLETED|Washout (2 Hours)||0
364968|NCT02125292|896887|P4|NOT COMPLETED|Washout (2 Hours)||0
364969|NCT02125292|896888|P3|NOT COMPLETED|Washout (2 Hours)||0
364970|NCT02125292|896889|P2|NOT COMPLETED|Washout (2 Hours)||0
364971|NCT02125292|896890|P1|NOT COMPLETED|Washout (2 Hours)||0
364972|NCT02125292|896885|P6|COMPLETED|Washout (2 Hours)||3
364973|NCT02125292|896886|P5|COMPLETED|Washout (2 Hours)||3
364974|NCT02125292|896887|P4|COMPLETED|Washout (2 Hours)||3
364975|NCT02125292|896888|P3|COMPLETED|Washout (2 Hours)||3
364976|NCT02125292|896889|P2|COMPLETED|Washout (2 Hours)||3
364977|NCT02125292|896890|P1|COMPLETED|Washout (2 Hours)||3
364978|NCT02125292|896885|P6|STARTED|Washout (2 Hours)||3
364979|NCT02125292|896886|P5|STARTED|Washout (2 Hours)||3
364980|NCT02125292|896887|P4|STARTED|Washout (2 Hours)||3
364981|NCT02125292|896888|P3|STARTED|Washout (2 Hours)||3
364982|NCT02125292|896889|P2|STARTED|Washout (2 Hours)||3
364983|NCT02125292|896890|P1|STARTED|Washout (2 Hours)||3
364984|NCT02125292|896885|P6|NOT COMPLETED|First Intervention (1 Hour)||0
364985|NCT02125292|896886|P5|NOT COMPLETED|First Intervention (1 Hour)||0
364986|NCT02125292|896887|P4|NOT COMPLETED|First Intervention (1 Hour)||0
364987|NCT02125292|896888|P3|NOT COMPLETED|First Intervention (1 Hour)||0
364988|NCT02125292|896889|P2|NOT COMPLETED|First Intervention (1 Hour)||0
364989|NCT02125292|896890|P1|NOT COMPLETED|First Intervention (1 Hour)||0
364990|NCT02125292|896885|P6|COMPLETED|First Intervention (1 Hour)||3
364991|NCT02125292|896886|P5|COMPLETED|First Intervention (1 Hour)||3
364992|NCT02125292|896887|P4|COMPLETED|First Intervention (1 Hour)||3
364993|NCT02125292|896888|P3|COMPLETED|First Intervention (1 Hour)||3
364994|NCT02125292|896889|P2|COMPLETED|First Intervention (1 Hour)||3
364995|NCT02125292|896890|P1|COMPLETED|First Intervention (1 Hour)||3
364996|NCT02125292|896885|P6|STARTED|First Intervention (1 Hour)||3
364997|NCT02125292|896886|P5|STARTED|First Intervention (1 Hour)||3
364998|NCT02125292|896887|P4|STARTED|First Intervention (1 Hour)||3
364999|NCT02125292|896888|P3|STARTED|First Intervention (1 Hour)||3
365000|NCT02125292|896889|P2|STARTED|First Intervention (1 Hour)||3
365001|NCT02125292|896890|P1|STARTED|First Intervention (1 Hour)||3
365002|NCT02124863|896911|P1|NOT COMPLETED|Overall Study||17
365003|NCT02124863|896911|P1|COMPLETED|Overall Study||50
365004|NCT02124863|896911|P1|STARTED|Overall Study||67
365005|NCT02124798|896917|P1|NOT COMPLETED|Overall Study||4
365006|NCT02124798|896917|P1|COMPLETED|Overall Study||91
365007|NCT02124798|896917|P1|STARTED|Overall Study||95
365008|NCT02124603|896923|P1|NOT COMPLETED|Overall Study||0
365009|NCT02124603|896923|P1|COMPLETED|Overall Study||120
365010|NCT02124603|896923|P1|STARTED|Overall Study||120
365011|NCT02124460|896931|P2|NOT COMPLETED|Overall Study||24
365012|NCT02124460|896932|P1|NOT COMPLETED|Overall Study||33
365013|NCT02124460|896931|P2|COMPLETED|Overall Study||336
365014|NCT02124460|896932|P1|COMPLETED|Overall Study||328
365015|NCT02124460|896931|P2|STARTED|Overall Study||360
365016|NCT02124460|896932|P1|STARTED|Overall Study||361
365017|NCT02124304|896964|P2|NOT COMPLETED|Overall Study||0
365018|NCT02124304|896965|P1|NOT COMPLETED|Overall Study||0
365019|NCT02124304|896964|P2|COMPLETED|Overall Study||15
365020|NCT02124304|896965|P1|COMPLETED|Overall Study||15
365021|NCT02124304|896964|P2|STARTED|Overall Study||15
365022|NCT02124304|896965|P1|STARTED|Overall Study||15
365023|NCT02124161|896975|P2|NOT COMPLETED|Overall Study||15
365024|NCT02124161|896976|P1|NOT COMPLETED|Overall Study||16
365025|NCT02124161|896975|P2|COMPLETED|Overall Study||426
365026|NCT02124161|896976|P1|COMPLETED|Overall Study||425
365027|NCT02124161|896975|P2|Vaccination 2|Overall Study||432
365028|NCT02124161|896976|P1|Vaccination 2|Overall Study||431
365029|NCT02124161|896975|P2|Vaccination 1|Overall Study||437
365030|NCT02124161|896976|P1|Vaccination 1|Overall Study||439
365031|NCT02124161|896975|P2|STARTED|Overall Study||441
365032|NCT02124161|896976|P1|STARTED|Overall Study||441
365033|NCT02124122|897008|P2|NOT COMPLETED|Overall Study||0
365034|NCT02124122|897009|P1|NOT COMPLETED|Overall Study||0
365035|NCT02124122|897008|P2|COMPLETED|Overall Study||19
365036|NCT02124122|897009|P1|COMPLETED|Overall Study||41
365037|NCT02124122|897008|P2|STARTED|Overall Study||19
365038|NCT02124122|897009|P1|STARTED|Overall Study||41
365039|NCT02124083|897017|P1|NOT COMPLETED|Overall Study||1
365040|NCT02124083|897017|P1|COMPLETED|Overall Study||11
365041|NCT02124083|897017|P1|STARTED|Overall Study||12
365042|NCT02124044|897028|P2|NOT COMPLETED|Overall Study||1
365043|NCT02124044|897029|P1|NOT COMPLETED|Overall Study||0
365044|NCT02124044|897028|P2|COMPLETED|Overall Study||9
365045|NCT02124044|897029|P1|COMPLETED|Overall Study||20
365046|NCT02124044|897028|P2|STARTED|Overall Study||10
365047|NCT02124044|897029|P1|STARTED|Overall Study||20
365048|NCT02123745|897035|P1|NOT COMPLETED|Overall Study||0
365049|NCT02123745|897035|P1|COMPLETED|Overall Study||71
365050|NCT02123745|897035|P1|STARTED|Overall Study||71
365051|NCT02123472|897043|P2|NOT COMPLETED|Period 2 (7 Days)||1
365052|NCT02123472|897044|P1|NOT COMPLETED|Period 2 (7 Days)||0
365053|NCT02123472|897043|P2|COMPLETED|Period 2 (7 Days)||13
365054|NCT02123472|897044|P1|COMPLETED|Period 2 (7 Days)||14
365055|NCT02123472|897043|P2|STARTED|Period 2 (7 Days)||14
365056|NCT02123472|897044|P1|STARTED|Period 2 (7 Days)||14
365057|NCT02123472|897043|P2|NOT COMPLETED|Washout Period (1 Day)||0
365058|NCT02123472|897044|P1|NOT COMPLETED|Washout Period (1 Day)||0
365059|NCT02123472|897043|P2|COMPLETED|Washout Period (1 Day)||14
365060|NCT02123472|897044|P1|COMPLETED|Washout Period (1 Day)||14
365061|NCT02123472|897043|P2|STARTED|Washout Period (1 Day)||14
365062|NCT02123472|897044|P1|STARTED|Washout Period (1 Day)||14
365063|NCT02123472|897043|P2|NOT COMPLETED|Period 1 (7 Days)||0
365064|NCT02123472|897044|P1|NOT COMPLETED|Period 1 (7 Days)||0
365065|NCT02123472|897043|P2|COMPLETED|Period 1 (7 Days)||14
365066|NCT02123472|897044|P1|COMPLETED|Period 1 (7 Days)||14
365067|NCT02123472|897043|P2|STARTED|Period 1 (7 Days)||14
365068|NCT02123472|897044|P1|STARTED|Period 1 (7 Days)||14
365069|NCT02123459|897054|P2|NOT COMPLETED|Period 2 (7 Days)||0
365070|NCT02123459|897055|P1|NOT COMPLETED|Period 2 (7 Days)||0
365071|NCT02123459|897054|P2|COMPLETED|Period 2 (7 Days)||14
365072|NCT02123459|897055|P1|COMPLETED|Period 2 (7 Days)||13
365073|NCT02123459|897054|P2|STARTED|Period 2 (7 Days)||14
365074|NCT02123459|897055|P1|STARTED|Period 2 (7 Days)||13
365075|NCT02123459|897054|P2|NOT COMPLETED|Washout Period (1 Day)||0
365076|NCT02123459|897055|P1|NOT COMPLETED|Washout Period (1 Day)||1
365077|NCT02123459|897054|P2|COMPLETED|Washout Period (1 Day)||14
365078|NCT02123459|897055|P1|COMPLETED|Washout Period (1 Day)||13
365079|NCT02123459|897054|P2|STARTED|Washout Period (1 Day)||14
365080|NCT02123459|897055|P1|STARTED|Washout Period (1 Day)||14
365081|NCT02123459|897054|P2|NOT COMPLETED|Period 1 (7 Days)||0
365082|NCT02123459|897055|P1|NOT COMPLETED|Period 1 (7 Days)||0
365083|NCT02123459|897054|P2|COMPLETED|Period 1 (7 Days)||14
365084|NCT02123459|897055|P1|COMPLETED|Period 1 (7 Days)||14
365085|NCT02123459|897054|P2|STARTED|Period 1 (7 Days)||14
365086|NCT02123459|897055|P1|STARTED|Period 1 (7 Days)||14
365087|NCT02123446|897065|P2|NOT COMPLETED|Period 2 (7 Days)||0
365088|NCT02123446|897066|P1|NOT COMPLETED|Period 2 (7 Days)||0
365089|NCT02123446|897065|P2|COMPLETED|Period 2 (7 Days)||14
365090|NCT02123446|897066|P1|COMPLETED|Period 2 (7 Days)||13
365091|NCT02123446|897065|P2|STARTED|Period 2 (7 Days)||14
365092|NCT02123446|897066|P1|STARTED|Period 2 (7 Days)||13
365093|NCT02123446|897065|P2|NOT COMPLETED|Washout Period (1 Day)||0
365094|NCT02123446|897066|P1|NOT COMPLETED|Washout Period (1 Day)||1
365095|NCT02123446|897065|P2|COMPLETED|Washout Period (1 Day)||14
365096|NCT02123446|897066|P1|COMPLETED|Washout Period (1 Day)||13
365097|NCT02123446|897065|P2|STARTED|Washout Period (1 Day)||14
365098|NCT02123446|897066|P1|STARTED|Washout Period (1 Day)||14
365099|NCT02123446|897065|P2|NOT COMPLETED|Period 1 (7 Days)||0
365100|NCT02123446|897066|P1|NOT COMPLETED|Period 1 (7 Days)||0
365101|NCT02123446|897065|P2|COMPLETED|Period 1 (7 Days)||14
365102|NCT02123446|897066|P1|COMPLETED|Period 1 (7 Days)||14
365103|NCT02123446|897065|P2|STARTED|Period 1 (7 Days)||14
365104|NCT02123446|897066|P1|STARTED|Period 1 (7 Days)||14
365105|NCT02123329|897078|P2|NOT COMPLETED|12 Month Outcome Measure||79
365106|NCT02123329|897079|P1|NOT COMPLETED|12 Month Outcome Measure||64
365107|NCT02123329|897078|P2|COMPLETED|12 Month Outcome Measure||88
365108|NCT02123329|897079|P1|COMPLETED|12 Month Outcome Measure||83
365109|NCT02123329|897078|P2|STARTED|12 Month Outcome Measure||167
365110|NCT02123329|897079|P1|STARTED|12 Month Outcome Measure||147
365111|NCT02123329|897078|P2|NOT COMPLETED|6 Month Outcome Measure||67
365112|NCT02123329|897079|P1|NOT COMPLETED|6 Month Outcome Measure||48
365113|NCT02123329|897078|P2|COMPLETED|6 Month Outcome Measure||100
365114|NCT02123329|897079|P1|COMPLETED|6 Month Outcome Measure||99
365115|NCT02123329|897078|P2|STARTED|6 Month Outcome Measure||167
365116|NCT02123329|897079|P1|STARTED|6 Month Outcome Measure||147
365117|NCT02123329|897078|P2|NOT COMPLETED|3 Month Outcome Measure||66
365118|NCT02123329|897079|P1|NOT COMPLETED|3 Month Outcome Measure||49
365119|NCT02123329|897078|P2|COMPLETED|3 Month Outcome Measure||101
365120|NCT02123329|897079|P1|COMPLETED|3 Month Outcome Measure||98
365121|NCT02123329|897078|P2|STARTED|3 Month Outcome Measure||167
365122|NCT02123329|897079|P1|STARTED|3 Month Outcome Measure||147
365123|NCT02123017|897108|P3|NOT COMPLETED|Overall Study||0
365124|NCT02123017|897109|P2|NOT COMPLETED|Overall Study||0
365125|NCT02123017|897110|P1|NOT COMPLETED|Overall Study||0
365126|NCT02123017|897108|P3|COMPLETED|Overall Study||12
365127|NCT02123017|897109|P2|COMPLETED|Overall Study||12
365128|NCT02123017|897110|P1|COMPLETED|Overall Study||8
365129|NCT02123017|897108|P3|STARTED|Overall Study||12
365130|NCT02123017|897109|P2|STARTED|Overall Study||12
365131|NCT02123017|897110|P1|STARTED|Overall Study||8
365132|NCT02122796|897129|P2|NOT COMPLETED|Visit 2||1
365133|NCT02122796|897130|P1|NOT COMPLETED|Visit 2||3
365134|NCT02122796|897129|P2|COMPLETED|Visit 2||14
365135|NCT02122796|897130|P1|COMPLETED|Visit 2||12
365136|NCT02122796|897129|P2|STARTED|Visit 2||15
365137|NCT02122796|897130|P1|STARTED|Visit 2||15
365138|NCT02122796|897129|P2|NOT COMPLETED|Visit 1||0
365139|NCT02122796|897130|P1|NOT COMPLETED|Visit 1||0
365140|NCT02122796|897129|P2|COMPLETED|Visit 1||15
365141|NCT02122796|897130|P1|COMPLETED|Visit 1||15
365142|NCT02122796|897129|P2|STARTED|Visit 1||15
365143|NCT02122796|897130|P1|STARTED|Visit 1||15
365144|NCT02122549|897143|P1|NOT COMPLETED|Overall Study||0
365145|NCT02122549|897143|P1|COMPLETED|Overall Study||59
365146|NCT02122549|897143|P1|STARTED|Overall Study||59
365147|NCT02122445|897147|P1|NOT COMPLETED|Overall Study||0
365148|NCT02122445|897147|P1|COMPLETED|Overall Study||20
365149|NCT02122445|897147|P1|STARTED|Overall Study||20
365150|NCT02122406|897152|P1|NOT COMPLETED|Overall Study||0
365151|NCT02122406|897152|P1|COMPLETED|Overall Study||200
365152|NCT02122406|897152|P1|STARTED|Overall Study||200
365153|NCT02122146|897164|P8|NOT COMPLETED|Part 3: Expansion||0
365154|NCT02122146|897165|P7|NOT COMPLETED|Part 3: Expansion||0
365155|NCT02122146|897166|P6|NOT COMPLETED|Part 3: Expansion||0
365156|NCT02122146|897167|P5|NOT COMPLETED|Part 3: Expansion||0
365157|NCT02122146|897168|P4|NOT COMPLETED|Part 3: Expansion||0
365158|NCT02122146|897169|P3|NOT COMPLETED|Part 3: Expansion||0
365159|NCT02122146|897170|P2|NOT COMPLETED|Part 3: Expansion||0
365160|NCT02122146|897171|P1|NOT COMPLETED|Part 3: Expansion||0
365161|NCT02122146|897164|P8|COMPLETED|Part 3: Expansion||0
365162|NCT02122146|897165|P7|COMPLETED|Part 3: Expansion||0
365163|NCT02122146|897166|P6|COMPLETED|Part 3: Expansion||0
365164|NCT02122146|897167|P5|COMPLETED|Part 3: Expansion||0
365165|NCT02122146|897168|P4|COMPLETED|Part 3: Expansion||0
365166|NCT02122146|897169|P3|COMPLETED|Part 3: Expansion||0
365167|NCT02122146|897170|P2|COMPLETED|Part 3: Expansion||0
365168|NCT02122146|897171|P1|COMPLETED|Part 3: Expansion||0
365169|NCT02122146|897164|P8|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
365170|NCT02122146|897165|P7|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
365171|NCT02122146|897166|P6|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
365172|NCT02122146|897167|P5|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
365173|NCT02122146|897168|P4|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
365174|NCT02122146|897169|P3|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
365175|NCT02122146|897170|P2|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
365176|NCT02122146|897171|P1|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
365177|NCT02122146|897164|P8|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
365178|NCT02122146|897165|P7|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
365179|NCT02122146|897166|P6|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
365180|NCT02122146|897167|P5|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
365181|NCT02122146|897168|P4|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
365182|NCT02122146|897169|P3|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
365183|NCT02122146|897170|P2|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
365184|NCT02122146|897171|P1|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
365185|NCT02122146|897164|P8|COMPLETED|Part 2: Maximum Tolerated Dose||0
365186|NCT02122146|897165|P7|COMPLETED|Part 2: Maximum Tolerated Dose||0
365187|NCT02122146|897166|P6|COMPLETED|Part 2: Maximum Tolerated Dose||0
365188|NCT02122146|897167|P5|COMPLETED|Part 2: Maximum Tolerated Dose||0
365189|NCT02122146|897168|P4|COMPLETED|Part 2: Maximum Tolerated Dose||0
365190|NCT02122146|897169|P3|COMPLETED|Part 2: Maximum Tolerated Dose||0
365191|NCT02122146|897170|P2|COMPLETED|Part 2: Maximum Tolerated Dose||0
365192|NCT02122146|897171|P1|COMPLETED|Part 2: Maximum Tolerated Dose||0
365193|NCT02122146|897164|P8|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
365194|NCT02122146|897165|P7|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
365195|NCT02122146|897166|P6|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
365196|NCT02122146|897167|P5|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
365197|NCT02122146|897168|P4|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
365198|NCT02122146|897169|P3|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
365199|NCT02122146|897170|P2|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
365200|NCT02122146|897171|P1|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
365201|NCT02122146|897164|P8|NOT COMPLETED|Part 1: Dose Escalation||2
365202|NCT02122146|897165|P7|NOT COMPLETED|Part 1: Dose Escalation||1
365203|NCT02122146|897166|P6|NOT COMPLETED|Part 1: Dose Escalation||1
365204|NCT02122146|897167|P5|NOT COMPLETED|Part 1: Dose Escalation||1
365205|NCT02122146|897168|P4|NOT COMPLETED|Part 1: Dose Escalation||1
365206|NCT02122146|897169|P3|NOT COMPLETED|Part 1: Dose Escalation||2
365207|NCT02122146|897170|P2|NOT COMPLETED|Part 1: Dose Escalation||1
365208|NCT02122146|897171|P1|NOT COMPLETED|Part 1: Dose Escalation||1
365209|NCT02122146|897164|P8|COMPLETED|Part 1: Dose Escalation||6
365210|NCT02122146|897165|P7|COMPLETED|Part 1: Dose Escalation||0
365211|NCT02122146|897166|P6|COMPLETED|Part 1: Dose Escalation||5
365212|NCT02122146|897167|P5|COMPLETED|Part 1: Dose Escalation||3
365213|NCT02122146|897168|P4|COMPLETED|Part 1: Dose Escalation||3
365214|NCT02122146|897169|P3|COMPLETED|Part 1: Dose Escalation||2
365215|NCT02122146|897170|P2|COMPLETED|Part 1: Dose Escalation||1
365216|NCT02122146|897171|P1|COMPLETED|Part 1: Dose Escalation||1
365217|NCT02122146|897164|P8|STARTED|Part 1: Dose Escalation||8
365218|NCT02122146|897165|P7|STARTED|Part 1: Dose Escalation||1
365219|NCT02122146|897166|P6|STARTED|Part 1: Dose Escalation||6
365220|NCT02122146|897167|P5|STARTED|Part 1: Dose Escalation||4
365221|NCT02122146|897168|P4|STARTED|Part 1: Dose Escalation||4
365222|NCT02122146|897169|P3|STARTED|Part 1: Dose Escalation||4
365223|NCT02122146|897170|P2|STARTED|Part 1: Dose Escalation||2
365224|NCT02122146|897171|P1|STARTED|Part 1: Dose Escalation||2
365225|NCT02121860|897410|P4|NOT COMPLETED|Overall Study||0
365226|NCT02121860|897411|P3|NOT COMPLETED|Overall Study||0
365227|NCT02121860|897412|P2|NOT COMPLETED|Overall Study||0
365228|NCT02121860|897413|P1|NOT COMPLETED|Overall Study||0
365229|NCT02121860|897410|P4|COMPLETED|Overall Study||8
365230|NCT02121860|897411|P3|COMPLETED|Overall Study||8
365231|NCT02121860|897412|P2|COMPLETED|Overall Study||12
365232|NCT02121860|897413|P1|COMPLETED|Overall Study||8
365233|NCT02121860|897410|P4|STARTED|Overall Study||8
365234|NCT02121860|897411|P3|STARTED|Overall Study||8
365235|NCT02121860|897412|P2|STARTED|Overall Study||12
365236|NCT02121860|897413|P1|STARTED|Overall Study||8
365237|NCT02121847|897432|P1|NOT COMPLETED|Overall Study||3
365238|NCT02121847|897432|P1|COMPLETED|Overall Study||37
365239|NCT02121847|897432|P1|STARTED|Overall Study||40
365240|NCT02121808|897451|P1|NOT COMPLETED|Overall Study||3
365241|NCT02121808|897451|P1|COMPLETED|Overall Study||17
365242|NCT02121808|897451|P1|STARTED|Overall Study||20
365243|NCT02121795|897462|P2|NOT COMPLETED|Overall Study||334
365244|NCT02121795|897463|P1|NOT COMPLETED|Overall Study||334
365245|NCT02121795|897462|P2|COMPLETED|Overall Study||0
365246|NCT02121795|897463|P1|COMPLETED|Overall Study||0
365247|NCT02121795|897462|P2|STARTED|Overall Study||334
365248|NCT02121795|897463|P1|STARTED|Overall Study||334
365249|NCT02121535|897479|P2|NOT COMPLETED|Period 4 (8 Trial Days)||0
365250|NCT02121535|897480|P1|NOT COMPLETED|Period 4 (8 Trial Days)||0
365251|NCT02121535|897479|P2|COMPLETED|Period 4 (8 Trial Days)||35
365252|NCT02121535|897480|P1|COMPLETED|Period 4 (8 Trial Days)||35
365253|NCT02121535|897479|P2|STARTED|Period 4 (8 Trial Days)||35
365254|NCT02121535|897480|P1|STARTED|Period 4 (8 Trial Days)||35
365255|NCT02121535|897479|P2|NOT COMPLETED|Period 3 (8 Trial Days)||0
365256|NCT02121535|897480|P1|NOT COMPLETED|Period 3 (8 Trial Days)||1
365257|NCT02121535|897479|P2|COMPLETED|Period 3 (8 Trial Days)||35
365258|NCT02121535|897480|P1|COMPLETED|Period 3 (8 Trial Days)|1 subject withdrew consent during the washout period between Period 3 and 4.|35
365259|NCT02121535|897479|P2|STARTED|Period 3 (8 Trial Days)||35
365260|NCT02121535|897480|P1|STARTED|Period 3 (8 Trial Days)||36
365261|NCT02121535|897479|P2|NOT COMPLETED|Period 2 (8 Trial Days)||0
365262|NCT02121535|897480|P1|NOT COMPLETED|Period 2 (8 Trial Days)||0
365263|NCT02121535|897479|P2|COMPLETED|Period 2 (8 Trial Days)||35
365264|NCT02121535|897480|P1|COMPLETED|Period 2 (8 Trial Days)||36
365265|NCT02121535|897479|P2|STARTED|Period 2 (8 Trial Days)||35
365266|NCT02121535|897480|P1|STARTED|Period 2 (8 Trial Days)||36
365267|NCT02121535|897479|P2|NOT COMPLETED|Period 1 (8 Trial Days)||1
365268|NCT02121535|897480|P1|NOT COMPLETED|Period 1 (8 Trial Days)||0
365269|NCT02121535|897479|P2|COMPLETED|Period 1 (8 Trial Days)|1 subject withdrew his consent during the washout period between Period 1 and 2.|35
365270|NCT02121535|897480|P1|COMPLETED|Period 1 (8 Trial Days)||36
365271|NCT02121535|897479|P2|STARTED|Period 1 (8 Trial Days)||36
365272|NCT02121535|897480|P1|STARTED|Period 1 (8 Trial Days)||36
365273|NCT02121522|897503|P1|NOT COMPLETED|Overall Study||1
365274|NCT02121522|897503|P1|COMPLETED|Overall Study||13
365275|NCT02121522|897503|P1|STARTED|Overall Study||14
365276|NCT02121509|897510|P4|NOT COMPLETED|Treatment Period-2 (4 Days)||0
365277|NCT02121509|897511|P3|NOT COMPLETED|Treatment Period-2 (4 Days)||0
365278|NCT02121509|897512|P2|NOT COMPLETED|Treatment Period-2 (4 Days)||0
365279|NCT02121509|897513|P1|NOT COMPLETED|Treatment Period-2 (4 Days)||0
365280|NCT02121509|897510|P4|COMPLETED|Treatment Period-2 (4 Days)||8
365281|NCT02121509|897511|P3|COMPLETED|Treatment Period-2 (4 Days)||8
365282|NCT02121509|897512|P2|COMPLETED|Treatment Period-2 (4 Days)||24
365283|NCT02121509|897513|P1|COMPLETED|Treatment Period-2 (4 Days)||28
365284|NCT02121509|897510|P4|STARTED|Treatment Period-2 (4 Days)||8
365285|NCT02121509|897511|P3|STARTED|Treatment Period-2 (4 Days)||8
365286|NCT02121509|897512|P2|STARTED|Treatment Period-2 (4 Days)||24
365287|NCT02121509|897513|P1|STARTED|Treatment Period-2 (4 Days)||28
365288|NCT02121509|897510|P4|NOT COMPLETED|Washout Period (35 Days)||0
365289|NCT02121509|897511|P3|NOT COMPLETED|Washout Period (35 Days)||0
365290|NCT02121509|897512|P2|NOT COMPLETED|Washout Period (35 Days)||4
365291|NCT02121509|897513|P1|NOT COMPLETED|Washout Period (35 Days)||2
365292|NCT02121509|897510|P4|COMPLETED|Washout Period (35 Days)||8
365293|NCT02121509|897511|P3|COMPLETED|Washout Period (35 Days)||8
365294|NCT02121509|897512|P2|COMPLETED|Washout Period (35 Days)||24
365295|NCT02121509|897513|P1|COMPLETED|Washout Period (35 Days)||28
365296|NCT02121509|897510|P4|STARTED|Washout Period (35 Days)||8
365297|NCT02121509|897511|P3|STARTED|Washout Period (35 Days)||8
365298|NCT02121509|897512|P2|STARTED|Washout Period (35 Days)||28
365299|NCT02121509|897513|P1|STARTED|Washout Period (35 Days)||30
365300|NCT02121509|897510|P4|NOT COMPLETED|Treatment Period-1 (4 Days)||0
365301|NCT02121509|897511|P3|NOT COMPLETED|Treatment Period-1 (4 Days)||0
365302|NCT02121509|897512|P2|NOT COMPLETED|Treatment Period-1 (4 Days)||0
365303|NCT02121509|897513|P1|NOT COMPLETED|Treatment Period-1 (4 Days)||0
365304|NCT02121509|897510|P4|COMPLETED|Treatment Period-1 (4 Days)||8
365305|NCT02121509|897511|P3|COMPLETED|Treatment Period-1 (4 Days)||8
365306|NCT02121509|897512|P2|COMPLETED|Treatment Period-1 (4 Days)||28
365307|NCT02121509|897513|P1|COMPLETED|Treatment Period-1 (4 Days)||30
365308|NCT02121509|897510|P4|STARTED|Treatment Period-1 (4 Days)||8
365309|NCT02121509|897511|P3|STARTED|Treatment Period-1 (4 Days)||8
365310|NCT02121509|897512|P2|STARTED|Treatment Period-1 (4 Days)||28
365311|NCT02121509|897513|P1|STARTED|Treatment Period-1 (4 Days)||30
365312|NCT02121483|897546|P3|NOT COMPLETED|Overall Study||0
365313|NCT02121483|897547|P2|NOT COMPLETED|Overall Study||0
365314|NCT02121483|897548|P1|NOT COMPLETED|Overall Study||0
365315|NCT02121483|897546|P3|COMPLETED|Overall Study||10
365316|NCT02121483|897547|P2|COMPLETED|Overall Study||8
365317|NCT02121483|897548|P1|COMPLETED|Overall Study||9
365318|NCT02121483|897546|P3|STARTED|Overall Study||10
365319|NCT02121483|897547|P2|STARTED|Overall Study||8
365320|NCT02121483|897548|P1|STARTED|Overall Study||9
365321|NCT02121418|897577|P1|NOT COMPLETED|Overall Study||0
365322|NCT02121418|897577|P1|COMPLETED|Overall Study||12
365323|NCT02121418|897577|P1|STARTED|Overall Study||12
365324|NCT02121210|897584|P2|NOT COMPLETED|Overall Study||9
365325|NCT02121210|897585|P1|NOT COMPLETED|Overall Study||7
365326|NCT02121210|897584|P2|COMPLETED|Overall Study||58
365327|NCT02121210|897585|P1|COMPLETED|Overall Study||58
365328|NCT02121210|897584|P2|STARTED|Overall Study||67
365329|NCT02121210|897585|P1|STARTED|Overall Study||65
365330|NCT02121067|897593|P1|NOT COMPLETED|Overall Study||0
365331|NCT02121067|897593|P1|COMPLETED|Overall Study||50
365332|NCT02121067|897593|P1|STARTED|Overall Study||50
365333|NCT02121041|897601|P2|NOT COMPLETED|Overall Study||6
365334|NCT02121041|897602|P1|NOT COMPLETED|Overall Study||1
365335|NCT02121041|897601|P2|COMPLETED|Overall Study||8
365336|NCT02121041|897602|P1|COMPLETED|Overall Study||13
365337|NCT02121041|897601|P2|STARTED|Overall Study||14
365338|NCT02121041|897602|P1|STARTED|Overall Study||14
365339|NCT02120833|897610|P2|NOT COMPLETED|Overall Study||1
365340|NCT02120833|897611|P1|NOT COMPLETED|Overall Study||4
365341|NCT02120833|897610|P2|COMPLETED|Overall Study||11
365342|NCT02120833|897611|P1|COMPLETED|Overall Study||35
365343|NCT02120833|897610|P2|STARTED|Overall Study||12
365344|NCT02120833|897611|P1|STARTED|Overall Study||39
365345|NCT02120664|897770|P5|NOT COMPLETED|Overall Study||0
365346|NCT02120664|897771|P4|NOT COMPLETED|Overall Study||1
365347|NCT02120664|897772|P3|NOT COMPLETED|Overall Study||0
365348|NCT02120664|897773|P2|NOT COMPLETED|Overall Study||0
365349|NCT02120664|897774|P1|NOT COMPLETED|Overall Study||0
365350|NCT02120664|897770|P5|COMPLETED|Overall Study||10
365351|NCT02120664|897771|P4|COMPLETED|Overall Study||3
365352|NCT02120664|897772|P3|COMPLETED|Overall Study||7
365353|NCT02120664|897773|P2|COMPLETED|Overall Study||4
365354|NCT02120664|897774|P1|COMPLETED|Overall Study||10
365355|NCT02120664|897770|P5|STARTED|Overall Study||10
365356|NCT02120664|897771|P4|STARTED|Overall Study||4
365357|NCT02120664|897772|P3|STARTED|Overall Study||7
365358|NCT02120664|897773|P2|STARTED|Overall Study||4
365359|NCT02120664|897774|P1|STARTED|Overall Study||10
365360|NCT02120625|897792|P1|NOT COMPLETED|Overall Study||2
365361|NCT02120625|897792|P1|COMPLETED|Overall Study||6
365362|NCT02120625|897792|P1|STARTED|Overall Study||8
365363|NCT02120443|897799|P1|NOT COMPLETED|Overall Study||0
365364|NCT02120443|897799|P1|COMPLETED|Overall Study||43
365365|NCT02120443|897799|P1|STARTED|Overall Study||43
365366|NCT02120417|897807|P2|NOT COMPLETED|Overall Study||68
365367|NCT02120417|897808|P1|NOT COMPLETED|Overall Study||60
365368|NCT02120417|897807|P2|COMPLETED|Overall Study||5
365369|NCT02120417|897808|P1|COMPLETED|Overall Study||16
365370|NCT02120417|897807|P2|STARTED|Overall Study||73
365371|NCT02120417|897808|P1|STARTED|Overall Study||76
365372|NCT02120300|897830|P4|NOT COMPLETED|Overall Study||1
365373|NCT02120300|897831|P3|NOT COMPLETED|Overall Study||0
365374|NCT02120300|897832|P2|NOT COMPLETED|Overall Study||0
365375|NCT02120300|897833|P1|NOT COMPLETED|Overall Study||3
365376|NCT02120300|897830|P4|COMPLETED|Overall Study||5
365377|NCT02120300|897831|P3|COMPLETED|Overall Study||10
365378|NCT02120300|897832|P2|COMPLETED|Overall Study||5
365379|NCT02120300|897833|P1|COMPLETED|Overall Study||98
365380|NCT02120300|897830|P4|STARTED|Overall Study||6
365381|NCT02120300|897831|P3|STARTED|Overall Study||10
365382|NCT02120300|897832|P2|STARTED|Overall Study||5
365383|NCT02120300|897833|P1|STARTED|Overall Study||101
365384|NCT02120027|897871|P2|NOT COMPLETED|Overall Study||119
365385|NCT02120027|897872|P1|NOT COMPLETED|Overall Study||116
365386|NCT02120027|897871|P2|COMPLETED|Overall Study||160
365387|NCT02120027|897872|P1|COMPLETED|Overall Study||161
365388|NCT02120027|897871|P2|STARTED|Overall Study||279
365389|NCT02120027|897872|P1|STARTED|Overall Study||277
365390|NCT02120001|897888|P2|NOT COMPLETED|Overall Study||0
365391|NCT02120001|897889|P1|NOT COMPLETED|Overall Study||0
365392|NCT02120001|897888|P2|COMPLETED|Overall Study||19
365393|NCT02120001|897889|P1|COMPLETED|Overall Study||17
365394|NCT02120001|897888|P2|STARTED|Overall Study||19
365395|NCT02120001|897889|P1|STARTED|Overall Study||17
365396|NCT02119936|897897|P1|NOT COMPLETED|Overall Study||10
365397|NCT02119936|897897|P1|COMPLETED|Overall Study||0
365398|NCT02119936|897897|P1|STARTED|Overall Study||10
365399|NCT02119871|897908|P2|NOT COMPLETED|Overall Study||0
365400|NCT02119871|897909|P1|NOT COMPLETED|Overall Study||0
365401|NCT02119871|897908|P2|COMPLETED|Overall Study||10
365402|NCT02119871|897909|P1|COMPLETED|Overall Study||10
365403|NCT02119871|897908|P2|STARTED|Overall Study||10
365404|NCT02119871|897909|P1|STARTED|Overall Study||10
365405|NCT02119676|897931|P4|NOT COMPLETED|Overall Study||101
365406|NCT02119676|897932|P3|NOT COMPLETED|Overall Study||97
365407|NCT02119676|897933|P2|NOT COMPLETED|Overall Study||86
365408|NCT02119676|897934|P1|NOT COMPLETED|Overall Study||83
365409|NCT02119676|897931|P4|COMPLETED|Overall Study||10
365410|NCT02119676|897932|P3|COMPLETED|Overall Study||13
365411|NCT02119676|897933|P2|COMPLETED|Overall Study||2
365412|NCT02119676|897934|P1|COMPLETED|Overall Study||4
365413|NCT02119676|897931|P4|Treated Patients|Overall Study||106
365414|NCT02119676|897932|P3|Treated Patients|Overall Study||106
365415|NCT02119676|897933|P2|Treated Patients|Overall Study||86
365416|NCT02119676|897934|P1|Treated Patients|Overall Study||85
365417|NCT02119676|897931|P4|STARTED|Overall Study||111
365418|NCT02119676|897932|P3|STARTED|Overall Study||110
365419|NCT02119676|897933|P2|STARTED|Overall Study||88
365420|NCT02119676|897934|P1|STARTED|Overall Study||87
365421|NCT02119663|897966|P2|NOT COMPLETED|Overall Study||41
365422|NCT02119663|897967|P1|NOT COMPLETED|Overall Study||40
365423|NCT02119663|897966|P2|COMPLETED|Overall Study|Treatment ongoing as of 13APR2016 for remaining participants in the study.|2
365424|NCT02119663|897967|P1|COMPLETED|Overall Study|Treatment ongoing as of 13APR2016 for remaining participants in the study.|3
365425|NCT02119663|897966|P2|STARTED|Overall Study||43
365426|NCT02119663|897967|P1|STARTED|Overall Study||43
365427|NCT02119650|897985|P2|NOT COMPLETED|Overall Study||26
365428|NCT02119650|897986|P1|NOT COMPLETED|Overall Study||25
365429|NCT02119650|897985|P2|COMPLETED|Overall Study|Participants with treatment ongoing when the study was terminated.|11
365430|NCT02119650|897986|P1|COMPLETED|Overall Study|Participants with treatment ongoing when the study was terminated.|14
365431|NCT02119650|897985|P2|STARTED|Overall Study||37
365432|NCT02119650|897986|P1|STARTED|Overall Study||39
365433|NCT02119325|898000|P2|NOT COMPLETED|Period 2||0
365434|NCT02119325|898001|P1|NOT COMPLETED|Period 2||0
365435|NCT02119325|898000|P2|COMPLETED|Period 2||47
365436|NCT02119325|898001|P1|COMPLETED|Period 2||48
365437|NCT02119325|898000|P2|STARTED|Period 2||47
365438|NCT02119325|898001|P1|STARTED|Period 2||48
365439|NCT02119325|898000|P2|NOT COMPLETED|Washout Period 1||1
365440|NCT02119325|898001|P1|NOT COMPLETED|Washout Period 1||0
365441|NCT02119325|898000|P2|COMPLETED|Washout Period 1||47
365442|NCT02119325|898001|P1|COMPLETED|Washout Period 1||48
365443|NCT02119325|898000|P2|STARTED|Washout Period 1||48
365444|NCT02119325|898001|P1|STARTED|Washout Period 1||48
365445|NCT02119325|898000|P2|NOT COMPLETED|Period 1||0
365446|NCT02119325|898001|P1|NOT COMPLETED|Period 1||0
365447|NCT02119325|898000|P2|COMPLETED|Period 1||48
365448|NCT02119325|898001|P1|COMPLETED|Period 1||48
365449|NCT02119325|898000|P2|STARTED|Period 1||48
365450|NCT02119325|898001|P1|STARTED|Period 1||48
365451|NCT02119299|898045|P1|NOT COMPLETED|Overall Study||9
365452|NCT02119299|898045|P1|COMPLETED|Overall Study||67
365453|NCT02119299|898045|P1|STARTED|Overall Study||76
365454|NCT02119286|898059|P3|NOT COMPLETED|Overall Study||7
365455|NCT02119286|898060|P2|NOT COMPLETED|Overall Study||11
365456|NCT02119286|898061|P1|NOT COMPLETED|Overall Study||26
365457|NCT02119286|898059|P3|COMPLETED|Overall Study||200
365458|NCT02119286|898060|P2|COMPLETED|Overall Study||195
365459|NCT02119286|898061|P1|COMPLETED|Overall Study||180
365460|NCT02119286|898059|P3|STARTED|Overall Study||207
365461|NCT02119286|898060|P2|STARTED|Overall Study||206
365462|NCT02119286|898061|P1|STARTED|Overall Study||206
365463|NCT02119104|898072|P1|NOT COMPLETED|Overall Study||16
365464|NCT02119104|898072|P1|COMPLETED|Overall Study||1071
365465|NCT02119104|898072|P1|STARTED|Overall Study||1087
365466|NCT02118961|898078|P2|NOT COMPLETED|Overall Study||0
365467|NCT02118961|898079|P1|NOT COMPLETED|Overall Study||1
365468|NCT02118961|898078|P2|COMPLETED|Overall Study||222
365469|NCT02118961|898079|P1|COMPLETED|Overall Study||223
365470|NCT02118961|898078|P2|STARTED|Overall Study||222
365471|NCT02118961|898079|P1|STARTED|Overall Study||224
365472|NCT02118896|898107|P10|NOT COMPLETED|Overall Study||2
365473|NCT02118896|898108|P9|NOT COMPLETED|Overall Study||4
365474|NCT02118896|898109|P8|NOT COMPLETED|Overall Study||2
365475|NCT02118896|898110|P7|NOT COMPLETED|Overall Study||2
365476|NCT02118896|898111|P6|NOT COMPLETED|Overall Study||28
365477|NCT02118896|898112|P5|NOT COMPLETED|Overall Study||17
365478|NCT02118896|898113|P4|NOT COMPLETED|Overall Study||24
365479|NCT02118896|898114|P3|NOT COMPLETED|Overall Study||14
365480|NCT02118896|898115|P2|NOT COMPLETED|Overall Study||15
365481|NCT02118896|898116|P1|NOT COMPLETED|Overall Study||17
365482|NCT02118896|898107|P10|COMPLETED|Overall Study||7
365483|NCT02118896|898108|P9|COMPLETED|Overall Study||84
365484|NCT02118896|898109|P8|COMPLETED|Overall Study||105
365485|NCT02118896|898110|P7|COMPLETED|Overall Study||83
365486|NCT02118896|898111|P6|COMPLETED|Overall Study||163
365487|NCT02118896|898112|P5|COMPLETED|Overall Study||113
365488|NCT02118896|898113|P4|COMPLETED|Overall Study||55
365489|NCT02118896|898114|P3|COMPLETED|Overall Study||53
365490|NCT02118896|898115|P2|COMPLETED|Overall Study||32
365491|NCT02118896|898116|P1|COMPLETED|Overall Study||30
365492|NCT02118896|898107|P10|STARTED|Overall Study||9
365493|NCT02118896|898108|P9|STARTED|Overall Study||88
365494|NCT02118896|898109|P8|STARTED|Overall Study||107
365495|NCT02118896|898110|P7|STARTED|Overall Study||85
365496|NCT02118896|898111|P6|STARTED|Overall Study||191
365497|NCT02118896|898112|P5|STARTED|Overall Study||130
365498|NCT02118896|898113|P4|STARTED|Overall Study||79
365499|NCT02118896|898114|P3|STARTED|Overall Study||67
365500|NCT02118896|898115|P2|STARTED|Overall Study||47
365501|NCT02118896|898116|P1|STARTED|Overall Study||47
365502|NCT02118831|898191|P3|NOT COMPLETED|Overall Study||0
365503|NCT02118831|898192|P2|NOT COMPLETED|Overall Study||0
365504|NCT02118831|898193|P1|NOT COMPLETED|Overall Study||0
365505|NCT02118831|898191|P3|COMPLETED|Overall Study||20
365506|NCT02118831|898192|P2|COMPLETED|Overall Study||15
365507|NCT02118831|898193|P1|COMPLETED|Overall Study||21
365508|NCT02118831|898191|P3|STARTED|Overall Study||20
365509|NCT02118831|898192|P2|STARTED|Overall Study||15
365510|NCT02118831|898193|P1|STARTED|Overall Study||21
365511|NCT02118792|898206|P2|NOT COMPLETED|Overall Study||37
365512|NCT02118792|898207|P1|NOT COMPLETED|Overall Study||31
365513|NCT02118792|898206|P2|COMPLETED|Overall Study||213
365514|NCT02118792|898207|P1|COMPLETED|Overall Study||483
365515|NCT02118792|898206|P2|Treated|Overall Study||250
365516|NCT02118792|898207|P1|Treated|Overall Study||513
365517|NCT02118792|898206|P2|STARTED|Overall Study||250
365518|NCT02118792|898207|P1|STARTED|Overall Study||514
365519|NCT02118766|898249|P2|NOT COMPLETED|Overall Study||31
365520|NCT02118766|898250|P1|NOT COMPLETED|Overall Study||30
365521|NCT02118766|898249|P2|COMPLETED|Overall Study||225
365522|NCT02118766|898250|P1|COMPLETED|Overall Study||477
365523|NCT02118766|898249|P2|Treated|Overall Study||256
365524|NCT02118766|898250|P1|Treated|Overall Study||503
365525|NCT02118766|898249|P2|STARTED|Overall Study||256
365526|NCT02118766|898250|P1|STARTED|Overall Study||507
365527|NCT02118597|898272|P1|NOT COMPLETED|Overall Study||16
365528|NCT02118597|898272|P1|COMPLETED|Overall Study||3
365529|NCT02118597|898272|P1|STARTED|Overall Study||19
365530|NCT02118441|898288|P2|NOT COMPLETED|Overall Study||1
365531|NCT02118441|898289|P1|NOT COMPLETED|Overall Study||3
365532|NCT02118441|898288|P2|COMPLETED|Overall Study||63
365533|NCT02118441|898289|P1|COMPLETED|Overall Study||62
365534|NCT02118441|898288|P2|STARTED|Overall Study||64
365535|NCT02118441|898289|P1|STARTED|Overall Study||65
365536|NCT02117934|898303|P2|NOT COMPLETED|Overall Study||215
365537|NCT02117934|898304|P1|NOT COMPLETED|Overall Study||500
365538|NCT02117934|898303|P2|COMPLETED|Overall Study||2567
365539|NCT02117934|898304|P1|COMPLETED|Overall Study||5092
365540|NCT02117934|898303|P2|STARTED|Overall Study||2782
365541|NCT02117934|898304|P1|STARTED|Overall Study||5592
365542|NCT02117687|898314|P2|NOT COMPLETED|Overall Study||4
365543|NCT02117687|898315|P1|NOT COMPLETED|Overall Study||1
365544|NCT02117687|898314|P2|COMPLETED|Overall Study||36
365545|NCT02117687|898315|P1|COMPLETED|Overall Study||39
365546|NCT02117687|898314|P2|STARTED|Overall Study||40
365547|NCT02117687|898315|P1|STARTED|Overall Study||40
365548|NCT02117570|898350|P3|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||6
365549|NCT02117570|898351|P2|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||3
365550|NCT02117570|898352|P1|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||1
365551|NCT02117570|898350|P3|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||54
365552|NCT02117570|898351|P2|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||59
365553|NCT02117570|898352|P1|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||20
365554|NCT02117570|898350|P3|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12
365555|NCT02117570|898351|P2|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12
365556|NCT02117570|898352|P1|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||4
365557|NCT02117570|898350|P3|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||50
365558|NCT02117570|898351|P2|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||53
365559|NCT02117570|898352|P1|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||17
365560|NCT02117570|898350|P3|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||60
365561|NCT02117570|898351|P2|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||61
365562|NCT02117570|898352|P1|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||21
365563|NCT02117570|898350|P3|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|60
365564|NCT02117570|898351|P2|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|62
365565|NCT02117570|898352|P1|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|21
365566|NCT02117570|898350|P3|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1
365567|NCT02117570|898351|P2|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||3
365568|NCT02117570|898352|P1|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1
365569|NCT02117570|898350|P3|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||17
365570|NCT02117570|898351|P2|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||15
365571|NCT02117570|898352|P1|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||5
365572|NCT02117570|898350|P3|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||18
365573|NCT02117570|898351|P2|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||17
365574|NCT02117570|898352|P1|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||6
365575|NCT02117570|898350|P3|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18
365576|NCT02117570|898351|P2|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18
365577|NCT02117570|898352|P1|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||6
365578|NCT02117570|898350|P3|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18
365579|NCT02117570|898351|P2|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18
365580|NCT02117570|898352|P1|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||6
365581|NCT02117570|898350|P3|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|18
365582|NCT02117570|898351|P2|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|18
365583|NCT02117570|898352|P1|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|6
365584|NCT02117544|898402|P2|NOT COMPLETED|Period 2||0
365585|NCT02117544|898403|P1|NOT COMPLETED|Period 2||0
365586|NCT02117544|898402|P2|COMPLETED|Period 2||55
365587|NCT02117544|898403|P1|COMPLETED|Period 2||52
365588|NCT02117544|898402|P2|STARTED|Period 2||55
365589|NCT02117544|898403|P1|STARTED|Period 2||52
365590|NCT02117544|898402|P2|NOT COMPLETED|Period 1||0
365591|NCT02117544|898403|P1|NOT COMPLETED|Period 1||2
365592|NCT02117544|898402|P2|COMPLETED|Period 1||55
365593|NCT02117544|898403|P1|COMPLETED|Period 1||52
365594|NCT02117544|898402|P2|Treated|Period 1||55
365595|NCT02117544|898403|P1|Treated|Period 1||52
365596|NCT02117544|898402|P2|STARTED|Period 1||55
365597|NCT02117544|898403|P1|STARTED|Period 1||54
365598|NCT02117479|898418|P2|NOT COMPLETED|Overall Study||156
365599|NCT02117479|898419|P1|NOT COMPLETED|Overall Study||156
365600|NCT02117479|898418|P2|COMPLETED|Overall Study|Treatment ongoing as of 20APR2016 for remaining participants in the study.|4
365601|NCT02117479|898419|P1|COMPLETED|Overall Study|Treatment ongoing as of 20APR2016 for remaining participants in the study.|5
365602|NCT02117479|898418|P2|STARTED|Overall Study||160
365603|NCT02117479|898419|P1|STARTED|Overall Study||161
365604|NCT02117414|898437|P2|NOT COMPLETED|Overall Study||6
365605|NCT02117414|898438|P1|NOT COMPLETED|Overall Study||15
365606|NCT02117414|898437|P2|COMPLETED|Overall Study|Subject followed up at least to the one-month post MRI/Waiting period visit in the Control group.|82
365607|NCT02117414|898438|P1|COMPLETED|Overall Study|Subject followed up at least to the one-month post MRI/Waiting period visit in the MRI group.|160
365608|NCT02117414|898437|P2|STARTED|Overall Study|Subjects randomized to the Control group.|88
365609|NCT02117414|898438|P1|STARTED|Overall Study|Subjects randomized to the MRI group.|175
365610|NCT02117310|898456|P1|NOT COMPLETED|Overall Study||0
365611|NCT02117310|898456|P1|COMPLETED|Overall Study||5
365612|NCT02117310|898456|P1|STARTED|Overall Study||5
365613|NCT02117193|898460|P1|NOT COMPLETED|Overall Study||0
365614|NCT02117193|898460|P1|COMPLETED|Overall Study||10
365615|NCT02117193|898460|P1|Placebo Intake + Sleep Deprivation|Overall Study||10
365616|NCT02117193|898460|P1|Alcohol Intake + Sleep Deprivation|Overall Study||10
365617|NCT02117193|898460|P1|Placebo Intake + Normal Sleep|Overall Study||10
365618|NCT02117193|898460|P1|Alcohol Intake + Normal Sleep|Overall Study||10
365619|NCT02117193|898460|P1|STARTED|Overall Study||10
365620|NCT02117050|898482|P1|NOT COMPLETED|Overall Study||1
365621|NCT02117050|898482|P1|COMPLETED|Overall Study||0
365622|NCT02117050|898482|P1|STARTED|Overall Study||1
365623|NCT02116972|898497|P3|NOT COMPLETED|Overall Study||19
365624|NCT02116972|898498|P2|NOT COMPLETED|Overall Study||17
365625|NCT02116972|898499|P1|NOT COMPLETED|Overall Study||19
365626|NCT02116972|898497|P3|COMPLETED|Overall Study||85
365627|NCT02116972|898498|P2|COMPLETED|Overall Study||87
365628|NCT02116972|898499|P1|COMPLETED|Overall Study||83
365629|NCT02116972|898497|P3|STARTED|Overall Study||104
365630|NCT02116972|898498|P2|STARTED|Overall Study||104
365631|NCT02116972|898499|P1|STARTED|Overall Study||102
365632|NCT02116803|898531|P2|NOT COMPLETED|Overall Study||2
365633|NCT02116803|898532|P1|NOT COMPLETED|Overall Study||10
365634|NCT02116803|898531|P2|COMPLETED|Overall Study||0
365635|NCT02116803|898532|P1|COMPLETED|Overall Study||0
365636|NCT02116803|898531|P2|STARTED|Overall Study||2
365637|NCT02116803|898532|P1|STARTED|Overall Study||10
365638|NCT02116621|898540|P2|NOT COMPLETED|Twelve Month Follow-up||12
365639|NCT02116621|898541|P1|NOT COMPLETED|Twelve Month Follow-up||16
365640|NCT02116621|898540|P2|COMPLETED|Twelve Month Follow-up||86
365641|NCT02116621|898541|P1|COMPLETED|Twelve Month Follow-up||84
365642|NCT02116621|898540|P2|STARTED|Twelve Month Follow-up|Patients who didn't complete 6mo survey but didn't drop from study were contacted for 12mo follow-up|98
365643|NCT02116621|898541|P1|STARTED|Twelve Month Follow-up|Patients who didn't complete 6mo survey but didn't drop from study were contacted for 12mo follow-up|100
365644|NCT02116621|898540|P2|NOT COMPLETED|Six Month Follow-up||3
365645|NCT02116621|898541|P1|NOT COMPLETED|Six Month Follow-up||4
365646|NCT02116621|898540|P2|COMPLETED|Six Month Follow-up||97
365647|NCT02116621|898541|P1|COMPLETED|Six Month Follow-up||99
365648|NCT02116621|898540|P2|STARTED|Six Month Follow-up|Patients who didn't complete 3mo survey but didn't drop from study were contacted for 6mo follow-up|100
365649|NCT02116621|898541|P1|STARTED|Six Month Follow-up|Patients who didn't complete 3mo survey but didn't drop from study were contacted for 6mo follow-up.|103
365650|NCT02116621|898540|P2|NOT COMPLETED|Three Month Follow-up||7
365651|NCT02116621|898541|P1|NOT COMPLETED|Three Month Follow-up||19
365652|NCT02116621|898540|P2|COMPLETED|Three Month Follow-up||96
365653|NCT02116621|898541|P1|COMPLETED|Three Month Follow-up||89
365654|NCT02116621|898540|P2|STARTED|Three Month Follow-up||103
365655|NCT02116621|898541|P1|STARTED|Three Month Follow-up||108
365656|NCT02116621|898540|P2|NOT COMPLETED|Baseline||4
365657|NCT02116621|898541|P1|NOT COMPLETED|Baseline||0
365658|NCT02116621|898540|P2|COMPLETED|Baseline||103
365659|NCT02116621|898541|P1|COMPLETED|Baseline||108
365660|NCT02116621|898540|P2|Completed Intervention Period|Baseline||103
365661|NCT02116621|898541|P1|Completed Intervention Period|Baseline||95
365662|NCT02116621|898540|P2|Completed Baseline Visit|Baseline||103
365663|NCT02116621|898541|P1|Completed Baseline Visit|Baseline||108
365664|NCT02116621|898540|P2|STARTED|Baseline||107
365665|NCT02116621|898541|P1|STARTED|Baseline||108
365666|NCT02116582|898629|P1|NOT COMPLETED|Overall Study||185
365667|NCT02116582|898629|P1|COMPLETED|Overall Study|Completed indicates participants were still on study drug at the time of the data cut-off.|30
365668|NCT02116582|898629|P1|Treated|Overall Study||214
365669|NCT02116582|898629|P1|STARTED|Overall Study||215
365670|NCT02116530|898639|P2|NOT COMPLETED|Overall Study||4
365671|NCT02116530|898640|P1|NOT COMPLETED|Overall Study||9
365672|NCT02116530|898639|P2|COMPLETED|Overall Study||184
365673|NCT02116530|898640|P1|COMPLETED|Overall Study||183
365674|NCT02116530|898639|P2|STARTED|Overall Study||188
365675|NCT02116530|898640|P1|STARTED|Overall Study||192
365676|NCT02116361|898658|P4|NOT COMPLETED|Overall Study||31
365677|NCT02116361|898659|P3|NOT COMPLETED|Overall Study||26
365678|NCT02116361|898660|P2|NOT COMPLETED|Overall Study||31
365679|NCT02116361|898661|P1|NOT COMPLETED|Overall Study||31
365680|NCT02116361|898658|P4|COMPLETED|Overall Study||34
365681|NCT02116361|898659|P3|COMPLETED|Overall Study||33
365682|NCT02116361|898660|P2|COMPLETED|Overall Study||34
365683|NCT02116361|898661|P1|COMPLETED|Overall Study||38
365684|NCT02116361|898658|P4|STARTED|Overall Study||65
365685|NCT02116361|898659|P3|STARTED|Overall Study||59
365686|NCT02116361|898660|P2|STARTED|Overall Study||65
365687|NCT02116361|898661|P1|STARTED|Overall Study||69
365688|NCT02116322|898691|P1|NOT COMPLETED|Overall Study||0
365689|NCT02116322|898691|P1|COMPLETED|Overall Study||1
365690|NCT02116322|898691|P1|STARTED|Overall Study||1
365691|NCT02116309|898698|P2|NOT COMPLETED|Overall Study||1
365692|NCT02116309|898699|P1|NOT COMPLETED|Overall Study||0
365693|NCT02116309|898698|P2|COMPLETED|Overall Study||477
365694|NCT02116309|898699|P1|COMPLETED|Overall Study||482
365695|NCT02116309|898698|P2|STARTED|Overall Study||478
365696|NCT02116309|898699|P1|STARTED|Overall Study||482
365697|NCT02115984|898709|P2|NOT COMPLETED|Overall Study||7
365698|NCT02115984|898710|P1|NOT COMPLETED|Overall Study||6
365699|NCT02115984|898709|P2|COMPLETED|Overall Study||16
365700|NCT02115984|898710|P1|COMPLETED|Overall Study||51
365701|NCT02115984|898709|P2|STARTED|Overall Study||23
365702|NCT02115984|898710|P1|STARTED|Overall Study||57
365703|NCT02115815|898723|P7|NOT COMPLETED|Overall Study||0
365704|NCT02115815|898724|P6|NOT COMPLETED|Overall Study||2
365705|NCT02115815|898725|P5|NOT COMPLETED|Overall Study||0
365706|NCT02115815|898726|P4|NOT COMPLETED|Overall Study||0
365707|NCT02115815|898727|P3|NOT COMPLETED|Overall Study||0
365708|NCT02115815|898728|P2|NOT COMPLETED|Overall Study||0
365709|NCT02115815|898729|P1|NOT COMPLETED|Overall Study||2
365710|NCT02115815|898723|P7|COMPLETED|Overall Study||20
365711|NCT02115815|898724|P6|COMPLETED|Overall Study||20
365712|NCT02115815|898725|P5|COMPLETED|Overall Study||20
365713|NCT02115815|898726|P4|COMPLETED|Overall Study||20
365714|NCT02115815|898727|P3|COMPLETED|Overall Study||20
365715|NCT02115815|898728|P2|COMPLETED|Overall Study||20
365716|NCT02115815|898729|P1|COMPLETED|Overall Study||22
365717|NCT02115815|898723|P7|STARTED|Overall Study||20
365718|NCT02115815|898724|P6|STARTED|Overall Study||22
365719|NCT02115815|898725|P5|STARTED|Overall Study||20
365720|NCT02115815|898726|P4|STARTED|Overall Study||20
365721|NCT02115815|898727|P3|STARTED|Overall Study||20
365722|NCT02115815|898728|P2|STARTED|Overall Study||20
365723|NCT02115815|898729|P1|STARTED|Overall Study||24
365724|NCT02115646|898822|P1|NOT COMPLETED|Overall Study||7
365725|NCT02115646|898822|P1|COMPLETED|Overall Study||22
365726|NCT02115646|898822|P1|STARTED|Overall Study||29
365727|NCT02115581|898837|P2|NOT COMPLETED|Overall Study||0
365728|NCT02115581|898838|P1|NOT COMPLETED|Overall Study||0
365729|NCT02115581|898837|P2|COMPLETED|Overall Study||21
365730|NCT02115581|898838|P1|COMPLETED|Overall Study||17
365731|NCT02115581|898837|P2|STARTED|Overall Study||21
365732|NCT02115581|898838|P1|STARTED|Overall Study||17
365733|NCT02115321|898850|P2|NOT COMPLETED|Overall Study||0
365734|NCT02115321|898851|P1|NOT COMPLETED|Overall Study||1
365735|NCT02115321|898850|P2|COMPLETED|Overall Study||10
365736|NCT02115321|898851|P1|COMPLETED|Overall Study||29
365737|NCT02115321|898850|P2|STARTED|Overall Study||10
365738|NCT02115321|898851|P1|STARTED|Overall Study||30
365739|NCT02115269|898871|P1|NOT COMPLETED|Overall Study||57
365740|NCT02115269|898871|P1|COMPLETED|Overall Study||702
365741|NCT02115269|898871|P1|STARTED|Overall Study||759
365742|NCT02115256|898891|P2|NOT COMPLETED|Overall Study||1
365743|NCT02115256|898892|P1|NOT COMPLETED|Overall Study||0
365744|NCT02115256|898891|P2|COMPLETED|Overall Study||2
365745|NCT02115256|898892|P1|COMPLETED|Overall Study||3
365746|NCT02115256|898891|P2|STARTED|Overall Study||3
365747|NCT02115256|898892|P1|STARTED|Overall Study||3
365748|NCT02114931|898906|P2|NOT COMPLETED|Overall Study||30
365749|NCT02114931|898907|P1|NOT COMPLETED|Overall Study||25
365750|NCT02114931|898906|P2|COMPLETED|Overall Study||207
365751|NCT02114931|898907|P1|COMPLETED|Overall Study||205
365752|NCT02114931|898906|P2|Received Treatment|Overall Study||237
365753|NCT02114931|898907|P1|Received Treatment|Overall Study|One participant was enrolled in error and did not receive treatment in the extension study|229
365754|NCT02114931|898906|P2|STARTED|Overall Study||237
365755|NCT02114931|898907|P1|STARTED|Overall Study||230
365756|NCT02114892|898923|P2|NOT COMPLETED|Overall Study||2
365757|NCT02114892|898924|P1|NOT COMPLETED|Overall Study||1
365758|NCT02114892|898923|P2|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawl|10
365759|NCT02114892|898924|P1|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
365760|NCT02114892|898923|P2|STARTED|Overall Study||12
365761|NCT02114892|898924|P1|STARTED|Overall Study||12
365762|NCT02114268|898964|P6|NOT COMPLETED|Overall Study||3
365763|NCT02114268|898965|P5|NOT COMPLETED|Overall Study||0
365764|NCT02114268|898966|P4|NOT COMPLETED|Overall Study||0
365765|NCT02114268|898967|P3|NOT COMPLETED|Overall Study||1
365766|NCT02114268|898968|P2|NOT COMPLETED|Overall Study||1
365767|NCT02114268|898969|P1|NOT COMPLETED|Overall Study||6
365768|NCT02114268|898964|P6|COMPLETED|Overall Study||75
365769|NCT02114268|898965|P5|COMPLETED|Overall Study||6
365770|NCT02114268|898966|P4|COMPLETED|Overall Study||6
365771|NCT02114268|898967|P3|COMPLETED|Overall Study||5
365772|NCT02114268|898968|P2|COMPLETED|Overall Study||5
365773|NCT02114268|898969|P1|COMPLETED|Overall Study||28
365774|NCT02114268|898964|P6|STARTED|Overall Study||78
365775|NCT02114268|898965|P5|STARTED|Overall Study||6
365776|NCT02114268|898966|P4|STARTED|Overall Study||6
365777|NCT02114268|898967|P3|STARTED|Overall Study||6
365778|NCT02114268|898968|P2|STARTED|Overall Study||6
365779|NCT02114268|898969|P1|STARTED|Overall Study||34
365780|NCT02114216|899022|P3|NOT COMPLETED|Overall Study||0
365781|NCT02114216|899023|P2|NOT COMPLETED|Overall Study||0
365782|NCT02114216|899024|P1|NOT COMPLETED|Overall Study||0
365783|NCT02114216|899022|P3|COMPLETED|Overall Study||14
365784|NCT02114216|899023|P2|COMPLETED|Overall Study||45
365785|NCT02114216|899024|P1|COMPLETED|Overall Study||16
365786|NCT02114216|899022|P3|STARTED|Overall Study||14
365787|NCT02114216|899023|P2|STARTED|Overall Study||45
365788|NCT02114216|899024|P1|STARTED|Overall Study||16
365789|NCT02114203|899038|P3|NOT COMPLETED|Overall Study||0
365790|NCT02114203|899039|P2|NOT COMPLETED|Overall Study||2
365791|NCT02114203|899040|P1|NOT COMPLETED|Overall Study||0
365792|NCT02114203|899038|P3|COMPLETED|Overall Study||7
365793|NCT02114203|899039|P2|COMPLETED|Overall Study||14
365794|NCT02114203|899040|P1|COMPLETED|Overall Study||7
365795|NCT02114203|899038|P3|STARTED|Overall Study||7
365796|NCT02114203|899039|P2|STARTED|Overall Study||16
365797|NCT02114203|899040|P1|STARTED|Overall Study||7
365798|NCT02114177|899074|P2|NOT COMPLETED|Overall Study||4
365799|NCT02114177|899075|P1|NOT COMPLETED|Overall Study||9
365800|NCT02114177|899074|P2|COMPLETED|Overall Study||151
365801|NCT02114177|899075|P1|COMPLETED|Overall Study||146
365802|NCT02114177|899074|P2|STARTED|Overall Study||155
365803|NCT02114177|899075|P1|STARTED|Overall Study||155
365804|NCT02114151|899099|P1|NOT COMPLETED|Overall Study||7
365805|NCT02114151|899099|P1|COMPLETED|Overall Study||96
365806|NCT02114151|899099|P1|STARTED|Overall Study||103
365807|NCT02113579|899116|P2|NOT COMPLETED|Overall Study||4
365808|NCT02113579|899117|P1|NOT COMPLETED|Overall Study||10
365809|NCT02113579|899116|P2|COMPLETED|Overall Study||185
365810|NCT02113579|899117|P1|COMPLETED|Overall Study||176
365811|NCT02113579|899116|P2|STARTED|Overall Study||189
365812|NCT02113579|899117|P1|STARTED|Overall Study||186
365813|NCT02113449|899141|P1|NOT COMPLETED|Overall Study||4
365814|NCT02113449|899141|P1|COMPLETED|Overall Study||143
365815|NCT02113449|899141|P1|STARTED|Overall Study||147
365816|NCT02113436|899157|P4|NOT COMPLETED|Period 2: 16 Weeks||11
365817|NCT02113436|899158|P3|NOT COMPLETED|Period 2: 16 Weeks||9
365818|NCT02113436|899159|P2|NOT COMPLETED|Period 2: 16 Weeks||0
365819|NCT02113436|899160|P1|NOT COMPLETED|Period 2: 16 Weeks||0
365820|NCT02113436|899157|P4|COMPLETED|Period 2: 16 Weeks||136
365821|NCT02113436|899158|P3|COMPLETED|Period 2: 16 Weeks||132
365822|NCT02113436|899159|P2|COMPLETED|Period 2: 16 Weeks||0
365823|NCT02113436|899160|P1|COMPLETED|Period 2: 16 Weeks||0
365824|NCT02113436|899157|P4|STARTED|Period 2: 16 Weeks|Par. started TP2 are not equal to that completed TP1 as 1 par. in each arm didn’t transfer to TP2.|147
365825|NCT02113436|899158|P3|STARTED|Period 2: 16 Weeks|Par. started TP2 are not equal to that completed TP1 as 1 par. in each arm didn’t transfer to TP2.|141
365826|NCT02113436|899159|P2|STARTED|Period 2: 16 Weeks||0
365827|NCT02113436|899160|P1|STARTED|Period 2: 16 Weeks||0
365828|NCT02113436|899157|P4|NOT COMPLETED|Period 1: 8 Weeks||0
365829|NCT02113436|899158|P3|NOT COMPLETED|Period 1: 8 Weeks||0
365830|NCT02113436|899159|P2|NOT COMPLETED|Period 1: 8 Weeks||2
365831|NCT02113436|899160|P1|NOT COMPLETED|Period 1: 8 Weeks||8
365832|NCT02113436|899157|P4|COMPLETED|Period 1: 8 Weeks||0
365833|NCT02113436|899158|P3|COMPLETED|Period 1: 8 Weeks||0
365834|NCT02113436|899159|P2|COMPLETED|Period 1: 8 Weeks||148
365835|NCT02113436|899160|P1|COMPLETED|Period 1: 8 Weeks||142
365836|NCT02113436|899157|P4|STARTED|Period 1: 8 Weeks||0
365837|NCT02113436|899158|P3|STARTED|Period 1: 8 Weeks||0
365838|NCT02113436|899159|P2|STARTED|Period 1: 8 Weeks||150
365839|NCT02113436|899160|P1|STARTED|Period 1: 8 Weeks||150
365840|NCT02113124|899183|P2|NOT COMPLETED|Overall Study||1
365841|NCT02113124|899184|P1|NOT COMPLETED|Overall Study||1
365842|NCT02113124|899183|P2|COMPLETED|Overall Study||24
365843|NCT02113124|899184|P1|COMPLETED|Overall Study||17
365844|NCT02113124|899183|P2|STARTED|Overall Study||25
365845|NCT02113124|899184|P1|STARTED|Overall Study||18
365846|NCT02113007|899190|P1|NOT COMPLETED|Overall Study||2
365847|NCT02113007|899190|P1|COMPLETED|Overall Study||0
365848|NCT02113007|899190|P1|STARTED|Overall Study||2
365849|NCT02112448|899198|P2|NOT COMPLETED|Overall Study||10
365850|NCT02112448|899199|P1|NOT COMPLETED|Overall Study||8
365851|NCT02112448|899198|P2|COMPLETED|Overall Study||30
365852|NCT02112448|899199|P1|COMPLETED|Overall Study||30
365853|NCT02112448|899198|P2|STARTED|Overall Study||40
365854|NCT02112448|899199|P1|STARTED|Overall Study||38
365855|NCT02112370|899209|P2|NOT COMPLETED|Overall Study||0
365856|NCT02112370|899210|P1|NOT COMPLETED|Overall Study||0
365857|NCT02112370|899209|P2|COMPLETED|Overall Study||74
365858|NCT02112370|899210|P1|COMPLETED|Overall Study||74
365859|NCT02112370|899209|P2|STARTED|Overall Study||74
365860|NCT02112370|899210|P1|STARTED|Overall Study||74
365861|NCT02111863|899230|P1|NOT COMPLETED|Overall Study||0
365862|NCT02111863|899230|P1|COMPLETED|Overall Study||6
365863|NCT02111863|899230|P1|STARTED|Overall Study||6
365864|NCT02111772|899238|P2|NOT COMPLETED|Overall Study||0
365865|NCT02111772|899239|P1|NOT COMPLETED|Overall Study||0
365866|NCT02111772|899238|P2|COMPLETED|Overall Study||14
365867|NCT02111772|899239|P1|COMPLETED|Overall Study||12
365868|NCT02111772|899238|P2|STARTED|Overall Study||14
365869|NCT02111772|899239|P1|STARTED|Overall Study||12
365870|NCT02111603|899247|P1|NOT COMPLETED|Overall Study||1
365871|NCT02111603|899247|P1|COMPLETED|Overall Study||12
365872|NCT02111603|899247|P1|STARTED|Overall Study||13
365873|NCT02111369|899256|P1|NOT COMPLETED|Overall Study||3
365874|NCT02111369|899256|P1|COMPLETED|Overall Study||15
365875|NCT02111369|899256|P1|STARTED|Overall Study||18
365876|NCT02111252|899264|P1|NOT COMPLETED|Overall Study||0
365877|NCT02111252|899264|P1|COMPLETED|Overall Study||55
365878|NCT02111252|899264|P1|STARTED|Overall Study||55
365879|NCT02111200|899282|P4|NOT COMPLETED|Overall Study||0
365880|NCT02111200|899283|P3|NOT COMPLETED|Overall Study||0
365881|NCT02111200|899284|P2|NOT COMPLETED|Overall Study||0
365882|NCT02111200|899285|P1|NOT COMPLETED|Overall Study||0
365883|NCT02111200|899282|P4|COMPLETED|Overall Study||1
365884|NCT02111200|899283|P3|COMPLETED|Overall Study||1
365885|NCT02111200|899284|P2|COMPLETED|Overall Study||2
365886|NCT02111200|899285|P1|COMPLETED|Overall Study||3
365887|NCT02111200|899282|P4|STARTED|Overall Study||1
365888|NCT02111200|899283|P3|STARTED|Overall Study||1
365889|NCT02111200|899284|P2|STARTED|Overall Study||2
365890|NCT02111200|899285|P1|STARTED|Overall Study||3
365891|NCT02111096|899302|P3|NOT COMPLETED|Overall Study||66
365892|NCT02111096|899303|P2|NOT COMPLETED|Overall Study||41
365893|NCT02111096|899304|P1|NOT COMPLETED|Overall Study||64
365894|NCT02111096|899302|P3|COMPLETED|Overall Study||2
365895|NCT02111096|899303|P2|COMPLETED|Overall Study||0
365896|NCT02111096|899304|P1|COMPLETED|Overall Study||1
365897|NCT02111096|899302|P3|Received at Least 1 Dose of Study Drug|Overall Study||68
365898|NCT02111096|899303|P2|Received at Least 1 Dose of Study Drug|Overall Study||41
365899|NCT02111096|899304|P1|Received at Least 1 Dose of Study Drug|Overall Study||65
365900|NCT02111096|899302|P3|STARTED|Overall Study||68
365901|NCT02111096|899303|P2|STARTED|Overall Study||41
365902|NCT02111096|899304|P1|STARTED|Overall Study||65
365903|NCT02111083|899352|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
365904|NCT02111083|899353|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
365905|NCT02111083|899352|P2|COMPLETED|Fourth Intervention (1 Day)||18
365906|NCT02111083|899353|P1|COMPLETED|Fourth Intervention (1 Day)||18
365907|NCT02111083|899352|P2|STARTED|Fourth Intervention (1 Day)||18
365908|NCT02111083|899353|P1|STARTED|Fourth Intervention (1 Day)||18
365909|NCT02111083|899352|P2|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1
365910|NCT02111083|899353|P1|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1
365911|NCT02111083|899352|P2|COMPLETED|Interval Between Dosing (7-8 Days)||18
365912|NCT02111083|899353|P1|COMPLETED|Interval Between Dosing (7-8 Days)||18
365913|NCT02111083|899352|P2|STARTED|Interval Between Dosing (7-8 Days)||19
365914|NCT02111083|899353|P1|STARTED|Interval Between Dosing (7-8 Days)||19
365915|NCT02111083|899352|P2|NOT COMPLETED|Third Intervention (1 Day)||0
365916|NCT02111083|899353|P1|NOT COMPLETED|Third Intervention (1 Day)||0
365917|NCT02111083|899352|P2|COMPLETED|Third Intervention (1 Day)||19
365918|NCT02111083|899353|P1|COMPLETED|Third Intervention (1 Day)||19
365919|NCT02111083|899352|P2|STARTED|Third Intervention (1 Day)||19
365920|NCT02111083|899353|P1|STARTED|Third Intervention (1 Day)||19
365921|NCT02111083|899352|P2|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
365922|NCT02111083|899353|P1|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
365923|NCT02111083|899352|P2|COMPLETED|Interval Between Dosing (7-8 Days)||19
365924|NCT02111083|899353|P1|COMPLETED|Interval Between Dosing (7-8 Days)||19
365925|NCT02111083|899352|P2|STARTED|Interval Between Dosing (7-8 Days)||19
365926|NCT02111083|899353|P1|STARTED|Interval Between Dosing (7-8 Days)||19
365927|NCT02111083|899352|P2|NOT COMPLETED|Second Intervention (1 Day)||0
365928|NCT02111083|899353|P1|NOT COMPLETED|Second Intervention (1 Day)||0
365929|NCT02111083|899352|P2|COMPLETED|Second Intervention (1 Day)||19
365930|NCT02111083|899353|P1|COMPLETED|Second Intervention (1 Day)||19
365931|NCT02111083|899352|P2|STARTED|Second Intervention (1 Day)||19
365932|NCT02111083|899353|P1|STARTED|Second Intervention (1 Day)||19
365933|NCT02111083|899352|P2|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
365934|NCT02111083|899353|P1|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
365935|NCT02111083|899352|P2|COMPLETED|Interval Between Dosing (7-8 Days)||19
365936|NCT02111083|899353|P1|COMPLETED|Interval Between Dosing (7-8 Days)||19
365937|NCT02111083|899352|P2|STARTED|Interval Between Dosing (7-8 Days)||19
365938|NCT02111083|899353|P1|STARTED|Interval Between Dosing (7-8 Days)||19
365939|NCT02111083|899352|P2|NOT COMPLETED|First Intervention (1 Day)||0
365940|NCT02111083|899353|P1|NOT COMPLETED|First Intervention (1 Day)||0
365941|NCT02111083|899352|P2|COMPLETED|First Intervention (1 Day)||19
365942|NCT02111083|899353|P1|COMPLETED|First Intervention (1 Day)||19
365943|NCT02111083|899352|P2|STARTED|First Intervention (1 Day)||19
365944|NCT02111083|899353|P1|STARTED|First Intervention (1 Day)||19
365945|NCT02110693|899371|P2|NOT COMPLETED|Overall Study||29
365946|NCT02110693|899372|P1|NOT COMPLETED|Overall Study||28
365947|NCT02110693|899371|P2|COMPLETED|Overall Study||1002
365948|NCT02110693|899372|P1|COMPLETED|Overall Study||998
365949|NCT02110693|899371|P2|STARTED|Overall Study||1031
365950|NCT02110693|899372|P1|STARTED|Overall Study||1026
365951|NCT02110381|899399|P2|NOT COMPLETED|Dual Modality||1
365952|NCT02110381|899400|P1|NOT COMPLETED|Dual Modality||2
365953|NCT02110381|899399|P2|COMPLETED|Dual Modality||7
365954|NCT02110381|899400|P1|COMPLETED|Dual Modality||5
365955|NCT02110381|899399|P2|Began Active Treatment|Dual Modality||7
365956|NCT02110381|899400|P1|Began Active Treatment|Dual Modality||7
365957|NCT02110381|899399|P2|STARTED|Dual Modality||8
365958|NCT02110381|899400|P1|STARTED|Dual Modality||7
365959|NCT02110381|899399|P2|NOT COMPLETED|Single Modality||1
365960|NCT02110381|899400|P1|NOT COMPLETED|Single Modality||2
365961|NCT02110381|899399|P2|COMPLETED|Single Modality||8
365962|NCT02110381|899400|P1|COMPLETED|Single Modality||7
365963|NCT02110381|899399|P2|STARTED|Single Modality||9
365964|NCT02110381|899400|P1|STARTED|Single Modality||9
365965|NCT02110277|899411|P1|NOT COMPLETED|Overall Study||2
365966|NCT02110277|899411|P1|COMPLETED|Overall Study||0
365967|NCT02110277|899411|P1|STARTED|Overall Study||2
365968|NCT02110238|899418|P2|NOT COMPLETED|14 Week Blinded Extension Phase||12
365969|NCT02110238|899419|P1|NOT COMPLETED|14 Week Blinded Extension Phase||12
365970|NCT02110238|899418|P2|COMPLETED|14 Week Blinded Extension Phase||188
365971|NCT02110238|899419|P1|COMPLETED|14 Week Blinded Extension Phase||190
365972|NCT02110238|899418|P2|STARTED|14 Week Blinded Extension Phase||200
365973|NCT02110238|899419|P1|STARTED|14 Week Blinded Extension Phase||202
365974|NCT02110238|899418|P2|NOT COMPLETED|12 Week Pivotal Phase||9
365975|NCT02110238|899419|P1|NOT COMPLETED|12 Week Pivotal Phase||10
365976|NCT02110238|899418|P2|COMPLETED|12 Week Pivotal Phase||200
365977|NCT02110238|899419|P1|COMPLETED|12 Week Pivotal Phase||202
365978|NCT02110238|899418|P2|STARTED|12 Week Pivotal Phase||209
365979|NCT02110238|899419|P1|STARTED|12 Week Pivotal Phase|One subject was randomized but not treated. As a result there were 211 safety subjects|212
365980|NCT02110147|899425|P1|NOT COMPLETED|Overall Study||0
365981|NCT02110147|899425|P1|COMPLETED|Overall Study||4
365982|NCT02110147|899425|P1|STARTED|Overall Study||4
365983|NCT02109731|899431|P1|NOT COMPLETED|Overall Study||0
365984|NCT02109731|899431|P1|COMPLETED|Overall Study||15
365985|NCT02109731|899431|P1|STARTED|Overall Study||15
365986|NCT02109640|899437|P2|NOT COMPLETED|Overall Study||0
365987|NCT02109640|899438|P1|NOT COMPLETED|Overall Study||0
365988|NCT02109640|899437|P2|COMPLETED|Overall Study||23
365989|NCT02109640|899438|P1|COMPLETED|Overall Study||27
365990|NCT02109640|899437|P2|STARTED|Overall Study||23
365991|NCT02109640|899438|P1|STARTED|Overall Study||27
365992|NCT02109497|899448|P1|NOT COMPLETED|Overall Study||1
365993|NCT02109497|899448|P1|COMPLETED|Overall Study|One participant completed the safety assessments but did not complete all doses of the study drugs.|17
365994|NCT02109497|899448|P1|STARTED|Overall Study||18
365995|NCT02109484|899461|P8|NOT COMPLETED|Overall Study||3
365996|NCT02109484|899462|P7|NOT COMPLETED|Overall Study||3
365997|NCT02109484|899463|P6|NOT COMPLETED|Overall Study||1
365998|NCT02109484|899464|P5|NOT COMPLETED|Overall Study||4
365999|NCT02109484|899465|P4|NOT COMPLETED|Overall Study||1
366000|NCT02109484|899466|P3|NOT COMPLETED|Overall Study||0
366001|NCT02109484|899467|P2|NOT COMPLETED|Overall Study||0
366002|NCT02109484|899468|P1|NOT COMPLETED|Overall Study||0
366003|NCT02109484|899461|P8|COMPLETED|Overall Study||47
366004|NCT02109484|899462|P7|COMPLETED|Overall Study||47
366005|NCT02109484|899463|P6|COMPLETED|Overall Study||11
366006|NCT02109484|899464|P5|COMPLETED|Overall Study||46
366007|NCT02109484|899465|P4|COMPLETED|Overall Study||11
366008|NCT02109484|899466|P3|COMPLETED|Overall Study||12
366009|NCT02109484|899467|P2|COMPLETED|Overall Study||13
366010|NCT02109484|899468|P1|COMPLETED|Overall Study||5
366011|NCT02109484|899461|P8|STARTED|Overall Study||50
366012|NCT02109484|899462|P7|STARTED|Overall Study||50
366013|NCT02109484|899463|P6|STARTED|Overall Study||12
366014|NCT02109484|899464|P5|STARTED|Overall Study||50
366015|NCT02109484|899465|P4|STARTED|Overall Study||12
366016|NCT02109484|899466|P3|STARTED|Overall Study||12
366017|NCT02109484|899467|P2|STARTED|Overall Study||13
366018|NCT02109484|899468|P1|STARTED|Overall Study||5
366019|NCT02109458|899517|P1|NOT COMPLETED|Overall Study||0
366020|NCT02109458|899517|P1|COMPLETED|Overall Study||24
366021|NCT02109458|899517|P1|STARTED|Overall Study||24
366022|NCT02109445|899524|P1|NOT COMPLETED|Overall Study||3
366023|NCT02109445|899524|P1|COMPLETED|Overall Study||0
366024|NCT02109445|899524|P1|STARTED|Overall Study||3
366025|NCT02109172|899557|P6|NOT COMPLETED|Overall Study||1
366026|NCT02109172|899558|P5|NOT COMPLETED|Overall Study||1
366027|NCT02109172|899559|P4|NOT COMPLETED|Overall Study||1
366028|NCT02109172|899560|P3|NOT COMPLETED|Overall Study||1
366029|NCT02109172|899561|P2|NOT COMPLETED|Overall Study||0
366030|NCT02109172|899562|P1|NOT COMPLETED|Overall Study||1
366031|NCT02109172|899557|P6|COMPLETED|Overall Study||10
366032|NCT02109172|899558|P5|COMPLETED|Overall Study||9
366033|NCT02109172|899559|P4|COMPLETED|Overall Study||10
366034|NCT02109172|899560|P3|COMPLETED|Overall Study||9
366035|NCT02109172|899561|P2|COMPLETED|Overall Study||11
366036|NCT02109172|899562|P1|COMPLETED|Overall Study||10
366037|NCT02109172|899557|P6|STARTED|Overall Study||11
366038|NCT02109172|899558|P5|STARTED|Overall Study||10
366039|NCT02109172|899559|P4|STARTED|Overall Study||11
366040|NCT02109172|899560|P3|STARTED|Overall Study||10
366041|NCT02109172|899561|P2|STARTED|Overall Study||11
366042|NCT02109172|899562|P1|STARTED|Overall Study||11
366043|NCT02109159|899572|P2|NOT COMPLETED|Overall Study||0
366044|NCT02109159|899573|P1|NOT COMPLETED|Overall Study||0
366045|NCT02109159|899572|P2|COMPLETED|Overall Study||4175
366046|NCT02109159|899573|P1|COMPLETED|Overall Study||4178
366047|NCT02109159|899572|P2|STARTED|Overall Study||4175
366048|NCT02109159|899573|P1|STARTED|Overall Study||4178
366049|NCT02109133|899583|P2|NOT COMPLETED|Overall Study||0
366050|NCT02109133|899584|P1|NOT COMPLETED|Overall Study||1
366051|NCT02109133|899583|P2|COMPLETED|Overall Study||34
366052|NCT02109133|899584|P1|COMPLETED|Overall Study||32
366053|NCT02109133|899583|P2|STARTED|Overall Study||34
366054|NCT02109133|899584|P1|STARTED|Overall Study||33
366055|NCT02109107|899596|P1|NOT COMPLETED|Overall Study||2
366056|NCT02109107|899596|P1|COMPLETED|Overall Study||52
366057|NCT02109107|899596|P1|STARTED|Overall Study||54
366058|NCT02108977|899605|P2|NOT COMPLETED|Overall Study||1
366059|NCT02108977|899606|P1|NOT COMPLETED|Overall Study||10
366060|NCT02108977|899605|P2|COMPLETED|Overall Study||19
366061|NCT02108977|899606|P1|COMPLETED|Overall Study||8
366062|NCT02108977|899605|P2|STARTED|Overall Study||20
366063|NCT02108977|899606|P1|STARTED|Overall Study||18
366064|NCT02108951|899618|P1|NOT COMPLETED|Overall Study||16
366065|NCT02108951|899618|P1|COMPLETED|Overall Study||4
366066|NCT02108951|899618|P1|STARTED|Overall Study|Indicates patients in enrolled, full analysis and safety set|20
366067|NCT02108691|899637|P2|NOT COMPLETED|Overall Study||9
366068|NCT02108691|899638|P1|NOT COMPLETED|Overall Study||8
366069|NCT02108691|899637|P2|COMPLETED|Overall Study||31
366070|NCT02108691|899638|P1|COMPLETED|Overall Study||32
366071|NCT02108691|899637|P2|STARTED|Overall Study||40
366072|NCT02108691|899638|P1|STARTED|Overall Study||40
366073|NCT02108652|899656|P1|NOT COMPLETED|Overall Study||310
366074|NCT02108652|899656|P1|COMPLETED|Overall Study||0
366075|NCT02108652|899656|P1|STARTED|Overall Study||310
366076|NCT02108288|899680|P3|NOT COMPLETED|Overall Study||0
366077|NCT02108288|899681|P2|NOT COMPLETED|Overall Study||0
366078|NCT02108288|899682|P1|NOT COMPLETED|Overall Study||0
366079|NCT02108288|899680|P3|COMPLETED|Overall Study||10
366080|NCT02108288|899681|P2|COMPLETED|Overall Study||10
366081|NCT02108288|899682|P1|COMPLETED|Overall Study||10
366082|NCT02108288|899680|P3|STARTED|Overall Study||10
366083|NCT02108288|899681|P2|STARTED|Overall Study||10
366084|NCT02108288|899682|P1|STARTED|Overall Study||10
366085|NCT02108223|899698|P3|NOT COMPLETED|Overall Study||0
366086|NCT02108223|899699|P2|NOT COMPLETED|Overall Study||0
366087|NCT02108223|899700|P1|NOT COMPLETED|Overall Study||0
366088|NCT02108223|899698|P3|COMPLETED|Overall Study||35
366089|NCT02108223|899699|P2|COMPLETED|Overall Study||50
366090|NCT02108223|899700|P1|COMPLETED|Overall Study||52
366091|NCT02108223|899698|P3|STARTED|Overall Study||35
366092|NCT02108223|899699|P2|STARTED|Overall Study||50
366093|NCT02108223|899700|P1|STARTED|Overall Study||52
366094|NCT02108171|899722|P2|NOT COMPLETED|Overall Study||0
366095|NCT02108171|899723|P1|NOT COMPLETED|Overall Study||0
366096|NCT02108171|899722|P2|COMPLETED|Overall Study||41
366097|NCT02108171|899723|P1|COMPLETED|Overall Study||40
366098|NCT02108171|899722|P2|STARTED|Overall Study||41
366099|NCT02108171|899723|P1|STARTED|Overall Study||40
366100|NCT02107898|899825|P2|NOT COMPLETED|Overall Study||12
366101|NCT02107898|899826|P1|NOT COMPLETED|Overall Study||6
366102|NCT02107898|899825|P2|COMPLETED|Overall Study||132
366103|NCT02107898|899826|P1|COMPLETED|Overall Study||66
366104|NCT02107898|899825|P2|Treated|Overall Study||143
366105|NCT02107898|899826|P1|Treated|Overall Study||72
366106|NCT02107898|899825|P2|STARTED|Overall Study|Randomized|144
366107|NCT02107898|899826|P1|STARTED|Overall Study|Randomized|72
366108|NCT02107703|899880|P2|NOT COMPLETED|Overall Study||175
366109|NCT02107703|899881|P1|NOT COMPLETED|Overall Study||361
366110|NCT02107703|899880|P2|COMPLETED|Overall Study||48
366111|NCT02107703|899881|P1|COMPLETED|Overall Study||85
366112|NCT02107703|899880|P2|Received at Least 1 Dose of Study Drug|Overall Study||223
366113|NCT02107703|899881|P1|Received at Least 1 Dose of Study Drug|Overall Study||441
366114|NCT02107703|899880|P2|STARTED|Overall Study||223
366115|NCT02107703|899881|P1|STARTED|Overall Study||446
366116|NCT02107599|899906|P1|NOT COMPLETED|Overall Study||0
366117|NCT02107599|899906|P1|COMPLETED|Overall Study||96
366118|NCT02107599|899906|P1|STARTED|Overall Study||96
366119|NCT02107482|899913|P1|NOT COMPLETED|Overall Study||4
366120|NCT02107482|899913|P1|COMPLETED|Overall Study||17
366121|NCT02107482|899913|P1|STARTED|Overall Study|21 participants enrolled. Total of 21 participants recvd both active and sham|21
366122|NCT02107339|899921|P2|NOT COMPLETED|Overall Study||4
366123|NCT02107339|899922|P1|NOT COMPLETED|Overall Study||1
366124|NCT02107339|899921|P2|COMPLETED|Overall Study||53
366125|NCT02107339|899922|P1|COMPLETED|Overall Study||62
366126|NCT02107339|899921|P2|STARTED|Overall Study||57
366127|NCT02107339|899922|P1|STARTED|Overall Study||63
366128|NCT02107313|899950|P2|NOT COMPLETED|Overall Study||1
366129|NCT02107313|899951|P1|NOT COMPLETED|Overall Study||0
366130|NCT02107313|899950|P2|COMPLETED|Overall Study||8
366131|NCT02107313|899951|P1|COMPLETED|Overall Study||9
366132|NCT02107313|899950|P2|STARTED|Overall Study|One participant from the study did not cross over and participate in the FED cohort|9
366133|NCT02107313|899951|P1|STARTED|Overall Study||9
366134|NCT02107274|899961|P2|NOT COMPLETED|Control Phase||2
366135|NCT02107274|899962|P1|NOT COMPLETED|Control Phase||3
366136|NCT02107274|899961|P2|COMPLETED|Control Phase||35
366137|NCT02107274|899962|P1|COMPLETED|Control Phase||33
366138|NCT02107274|899961|P2|STARTED|Control Phase||37
366139|NCT02107274|899962|P1|STARTED|Control Phase||36
366140|NCT02107274|899961|P2|NOT COMPLETED|Treatment vs. Placebo||2
366141|NCT02107274|899962|P1|NOT COMPLETED|Treatment vs. Placebo||3
366142|NCT02107274|899961|P2|COMPLETED|Treatment vs. Placebo||37
366143|NCT02107274|899962|P1|COMPLETED|Treatment vs. Placebo||36
366144|NCT02107274|899961|P2|STARTED|Treatment vs. Placebo||39
366145|NCT02107274|899962|P1|STARTED|Treatment vs. Placebo||39
366146|NCT02107196|899976|P2|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||5
366147|NCT02107196|899977|P1|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||23
366148|NCT02107196|899976|P2|COMPLETED|4-week Randomized Withdrawal (RW) Period||109
366149|NCT02107196|899977|P1|COMPLETED|4-week Randomized Withdrawal (RW) Period||315
366150|NCT02107196|899976|P2|Modified RW Population|4-week Randomized Withdrawal (RW) Period|all RW patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|90
366151|NCT02107196|899977|P1|Modified RW Population|4-week Randomized Withdrawal (RW) Period|all RW patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|272
366152|NCT02107196|899976|P2|RW Population|4-week Randomized Withdrawal (RW) Period|All re-randomized ITT patients,who received at least 1 dose of placebo during RW period|114
366153|NCT02107196|899977|P1|RW Population|4-week Randomized Withdrawal (RW) Period|All re-randomized ITT patients,who received at least 1 dose of ibodutant during RW period|338
366154|NCT02107196|899976|P2|STARTED|4-week Randomized Withdrawal (RW) Period|all re-randomized patients at Visit 6 [Day85]|114
366155|NCT02107196|899977|P1|STARTED|4-week Randomized Withdrawal (RW) Period|all re-randomized patients at Visit 6 [Day85]|338
366156|NCT02107196|899976|P2|NOT COMPLETED|12-week Treatment Period||39
366157|NCT02107196|899977|P1|NOT COMPLETED|12-week Treatment Period||44
366158|NCT02107196|899976|P2|COMPLETED|12-week Treatment Period||225
366159|NCT02107196|899977|P1|COMPLETED|12-week Treatment Period||227
366160|NCT02107196|899976|P2|Modified ITT|12-week Treatment Period|All ITT patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|216
366161|NCT02107196|899977|P1|Modified ITT|12-week Treatment Period|All ITT patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|221
366162|NCT02107196|899976|P2|Intention To Treat (ITT)|12-week Treatment Period|All randomised patients who took at least one dose of study drug during 12-week treatment period|264
366163|NCT02107196|899977|P1|Intention To Treat (ITT)|12-week Treatment Period|All randomised patients who took at least one dose of study drug during 12-week treatment period|271
366164|NCT02107196|899976|P2|STARTED|12-week Treatment Period|Safety population, all enrolled patients who received at least one dose of study drug|264
366165|NCT02107196|899977|P1|STARTED|12-week Treatment Period|Safety population, all enrolled patients who received at least one dose of study drug|271
366166|NCT02107014|899990|P1|NOT COMPLETED|Overall Study||1
366167|NCT02107014|899990|P1|COMPLETED|Overall Study||8
366168|NCT02107014|899990|P1|STARTED|Overall Study||9
366169|NCT02106962|900060|P2|NOT COMPLETED|Overall Study||0
366170|NCT02106962|900061|P1|NOT COMPLETED|Overall Study||0
366171|NCT02106962|900060|P2|COMPLETED|Overall Study||9
366172|NCT02106962|900061|P1|COMPLETED|Overall Study||8
366173|NCT02106962|900060|P2|STARTED|Overall Study||9
366174|NCT02106962|900061|P1|STARTED|Overall Study||8
366175|NCT02106923|900072|P6|NOT COMPLETED|Overall Study||1
366176|NCT02106923|900073|P5|NOT COMPLETED|Overall Study||0
366177|NCT02106923|900074|P4|NOT COMPLETED|Overall Study||0
366178|NCT02106923|900075|P3|NOT COMPLETED|Overall Study||0
366179|NCT02106923|900076|P2|NOT COMPLETED|Overall Study||0
366180|NCT02106923|900077|P1|NOT COMPLETED|Overall Study||0
366181|NCT02106923|900072|P6|COMPLETED|Overall Study||11
366182|NCT02106923|900073|P5|COMPLETED|Overall Study||12
366183|NCT02106923|900074|P4|COMPLETED|Overall Study||12
366184|NCT02106923|900075|P3|COMPLETED|Overall Study||12
366185|NCT02106923|900076|P2|COMPLETED|Overall Study||12
366186|NCT02106923|900077|P1|COMPLETED|Overall Study||12
366187|NCT02106923|900072|P6|STARTED|Overall Study||12
366188|NCT02106923|900073|P5|STARTED|Overall Study||12
366189|NCT02106923|900074|P4|STARTED|Overall Study||12
366190|NCT02106923|900075|P3|STARTED|Overall Study||12
366191|NCT02106923|900076|P2|STARTED|Overall Study||12
366192|NCT02106923|900077|P1|STARTED|Overall Study||12
366193|NCT02106832|900125|P4|NOT COMPLETED|Overall Study||15
366194|NCT02106832|900126|P3|NOT COMPLETED|Overall Study||16
366195|NCT02106832|900127|P2|NOT COMPLETED|Overall Study||25
366196|NCT02106832|900128|P1|NOT COMPLETED|Overall Study||23
366197|NCT02106832|900125|P4|COMPLETED|Overall Study||73
366198|NCT02106832|900126|P3|COMPLETED|Overall Study||70
366199|NCT02106832|900127|P2|COMPLETED|Overall Study||151
366200|NCT02106832|900128|P1|COMPLETED|Overall Study||148
366201|NCT02106832|900125|P4|Participants Received Treatment|Overall Study||88
366202|NCT02106832|900126|P3|Participants Received Treatment|Overall Study||86
366203|NCT02106832|900127|P2|Participants Received Treatment|Overall Study||174
366204|NCT02106832|900128|P1|Participants Received Treatment|Overall Study||171
366205|NCT02106832|900125|P4|STARTED|Overall Study||88
366206|NCT02106832|900126|P3|STARTED|Overall Study||86
366207|NCT02106832|900127|P2|STARTED|Overall Study||176
366208|NCT02106832|900128|P1|STARTED|Overall Study||171
366209|NCT02106728|900163|P2|NOT COMPLETED|Overall Study||0
366210|NCT02106728|900164|P1|NOT COMPLETED|Overall Study||0
366211|NCT02106728|900163|P2|COMPLETED|Overall Study||47
366212|NCT02106728|900164|P1|COMPLETED|Overall Study||70
366213|NCT02106728|900163|P2|STARTED|Overall Study||47
366214|NCT02106728|900164|P1|STARTED|Overall Study||70
366215|NCT02106494|900180|P2|NOT COMPLETED|Overall Study||25
366216|NCT02106494|900181|P1|NOT COMPLETED|Overall Study||26
366217|NCT02106494|900180|P2|COMPLETED|Overall Study||446
366218|NCT02106494|900181|P1|COMPLETED|Overall Study||445
366219|NCT02106494|900180|P2|Efficacy Population|Overall Study||452
366220|NCT02106494|900181|P1|Efficacy Population|Overall Study||450
366221|NCT02106494|900180|P2|Safety Population|Overall Study||459
366222|NCT02106494|900181|P1|Safety Population|Overall Study||456
366223|NCT02106494|900180|P2|STARTED|Overall Study||471
366224|NCT02106494|900181|P1|STARTED|Overall Study||471
366225|NCT02106403|900195|P6|NOT COMPLETED|Follow-Up Visit 3||1
366226|NCT02106403|900196|P5|NOT COMPLETED|Follow-Up Visit 3||0
366227|NCT02106403|900197|P4|NOT COMPLETED|Follow-Up Visit 3||0
366228|NCT02106403|900198|P3|NOT COMPLETED|Follow-Up Visit 3||0
366229|NCT02106403|900199|P2|NOT COMPLETED|Follow-Up Visit 3||0
366230|NCT02106403|900200|P1|NOT COMPLETED|Follow-Up Visit 3||0
366231|NCT02106403|900195|P6|COMPLETED|Follow-Up Visit 3||8
366232|NCT02106403|900196|P5|COMPLETED|Follow-Up Visit 3||8
366233|NCT02106403|900197|P4|COMPLETED|Follow-Up Visit 3||8
366234|NCT02106403|900198|P3|COMPLETED|Follow-Up Visit 3||9
366235|NCT02106403|900199|P2|COMPLETED|Follow-Up Visit 3||8
366236|NCT02106403|900200|P1|COMPLETED|Follow-Up Visit 3||8
366237|NCT02106403|900195|P6|STARTED|Follow-Up Visit 3||9
366238|NCT02106403|900196|P5|STARTED|Follow-Up Visit 3||8
366239|NCT02106403|900197|P4|STARTED|Follow-Up Visit 3||8
366240|NCT02106403|900198|P3|STARTED|Follow-Up Visit 3||9
366241|NCT02106403|900199|P2|STARTED|Follow-Up Visit 3||8
366242|NCT02106403|900200|P1|STARTED|Follow-Up Visit 3||8
366243|NCT02106403|900195|P6|NOT COMPLETED|Follow-Up Visit 2||0
366244|NCT02106403|900196|P5|NOT COMPLETED|Follow-Up Visit 2||0
366245|NCT02106403|900197|P4|NOT COMPLETED|Follow-Up Visit 2||0
366246|NCT02106403|900198|P3|NOT COMPLETED|Follow-Up Visit 2||0
366247|NCT02106403|900199|P2|NOT COMPLETED|Follow-Up Visit 2||0
366248|NCT02106403|900200|P1|NOT COMPLETED|Follow-Up Visit 2||0
366249|NCT02106403|900195|P6|COMPLETED|Follow-Up Visit 2||9
366250|NCT02106403|900196|P5|COMPLETED|Follow-Up Visit 2||8
366251|NCT02106403|900197|P4|COMPLETED|Follow-Up Visit 2||8
366252|NCT02106403|900198|P3|COMPLETED|Follow-Up Visit 2||9
366253|NCT02106403|900199|P2|COMPLETED|Follow-Up Visit 2||8
366254|NCT02106403|900200|P1|COMPLETED|Follow-Up Visit 2||8
366255|NCT02106403|900195|P6|STARTED|Follow-Up Visit 2||9
366256|NCT02106403|900196|P5|STARTED|Follow-Up Visit 2||8
366257|NCT02106403|900197|P4|STARTED|Follow-Up Visit 2||8
366258|NCT02106403|900198|P3|STARTED|Follow-Up Visit 2||9
366259|NCT02106403|900199|P2|STARTED|Follow-Up Visit 2||8
366260|NCT02106403|900200|P1|STARTED|Follow-Up Visit 2||8
366261|NCT02106403|900195|P6|NOT COMPLETED|Visit 1, Treatment Period 3||0
366262|NCT02106403|900196|P5|NOT COMPLETED|Visit 1, Treatment Period 3||0
366263|NCT02106403|900197|P4|NOT COMPLETED|Visit 1, Treatment Period 3||0
366264|NCT02106403|900198|P3|NOT COMPLETED|Visit 1, Treatment Period 3||0
366265|NCT02106403|900199|P2|NOT COMPLETED|Visit 1, Treatment Period 3||0
366266|NCT02106403|900200|P1|NOT COMPLETED|Visit 1, Treatment Period 3||0
366267|NCT02106403|900195|P6|COMPLETED|Visit 1, Treatment Period 3||9
366268|NCT02106403|900196|P5|COMPLETED|Visit 1, Treatment Period 3||8
366269|NCT02106403|900197|P4|COMPLETED|Visit 1, Treatment Period 3||8
366270|NCT02106403|900198|P3|COMPLETED|Visit 1, Treatment Period 3||9
366271|NCT02106403|900199|P2|COMPLETED|Visit 1, Treatment Period 3||8
366272|NCT02106403|900200|P1|COMPLETED|Visit 1, Treatment Period 3||8
366273|NCT02106403|900195|P6|STARTED|Visit 1, Treatment Period 3||9
366274|NCT02106403|900196|P5|STARTED|Visit 1, Treatment Period 3||8
366275|NCT02106403|900197|P4|STARTED|Visit 1, Treatment Period 3||8
366276|NCT02106403|900198|P3|STARTED|Visit 1, Treatment Period 3||9
366277|NCT02106403|900199|P2|STARTED|Visit 1, Treatment Period 3||8
366278|NCT02106403|900200|P1|STARTED|Visit 1, Treatment Period 3||8
366279|NCT02106403|900195|P6|NOT COMPLETED|Visit 1, Treatment Period 2||0
366280|NCT02106403|900196|P5|NOT COMPLETED|Visit 1, Treatment Period 2||0
366281|NCT02106403|900197|P4|NOT COMPLETED|Visit 1, Treatment Period 2||0
366282|NCT02106403|900198|P3|NOT COMPLETED|Visit 1, Treatment Period 2||0
366283|NCT02106403|900199|P2|NOT COMPLETED|Visit 1, Treatment Period 2||0
366284|NCT02106403|900200|P1|NOT COMPLETED|Visit 1, Treatment Period 2||0
366285|NCT02106403|900195|P6|COMPLETED|Visit 1, Treatment Period 2||9
366286|NCT02106403|900196|P5|COMPLETED|Visit 1, Treatment Period 2||8
366287|NCT02106403|900197|P4|COMPLETED|Visit 1, Treatment Period 2||8
366288|NCT02106403|900198|P3|COMPLETED|Visit 1, Treatment Period 2||9
366289|NCT02106403|900199|P2|COMPLETED|Visit 1, Treatment Period 2||8
366290|NCT02106403|900200|P1|COMPLETED|Visit 1, Treatment Period 2||8
366291|NCT02106403|900195|P6|STARTED|Visit 1, Treatment Period 2||9
366292|NCT02106403|900196|P5|STARTED|Visit 1, Treatment Period 2||8
366293|NCT02106403|900197|P4|STARTED|Visit 1, Treatment Period 2||8
366294|NCT02106403|900198|P3|STARTED|Visit 1, Treatment Period 2||9
366295|NCT02106403|900199|P2|STARTED|Visit 1, Treatment Period 2||8
366296|NCT02106403|900200|P1|STARTED|Visit 1, Treatment Period 2||8
366297|NCT02106403|900195|P6|NOT COMPLETED|Visit 1, Treatment Period 1||0
366298|NCT02106403|900196|P5|NOT COMPLETED|Visit 1, Treatment Period 1||0
366299|NCT02106403|900197|P4|NOT COMPLETED|Visit 1, Treatment Period 1||0
366300|NCT02106403|900198|P3|NOT COMPLETED|Visit 1, Treatment Period 1||0
366301|NCT02106403|900199|P2|NOT COMPLETED|Visit 1, Treatment Period 1||0
366302|NCT02106403|900200|P1|NOT COMPLETED|Visit 1, Treatment Period 1||0
366303|NCT02106403|900195|P6|COMPLETED|Visit 1, Treatment Period 1||9
366304|NCT02106403|900196|P5|COMPLETED|Visit 1, Treatment Period 1||8
366305|NCT02106403|900197|P4|COMPLETED|Visit 1, Treatment Period 1||8
366306|NCT02106403|900198|P3|COMPLETED|Visit 1, Treatment Period 1||9
366307|NCT02106403|900199|P2|COMPLETED|Visit 1, Treatment Period 1||8
366308|NCT02106403|900200|P1|COMPLETED|Visit 1, Treatment Period 1||8
366309|NCT02106403|900195|P6|STARTED|Visit 1, Treatment Period 1||9
366310|NCT02106403|900196|P5|STARTED|Visit 1, Treatment Period 1||8
366311|NCT02106403|900197|P4|STARTED|Visit 1, Treatment Period 1||8
366312|NCT02106403|900198|P3|STARTED|Visit 1, Treatment Period 1||9
366313|NCT02106403|900199|P2|STARTED|Visit 1, Treatment Period 1||8
366314|NCT02106403|900200|P1|STARTED|Visit 1, Treatment Period 1||8
366315|NCT02106156|900223|P3|NOT COMPLETED|Overall Study||0
366316|NCT02106156|900224|P2|NOT COMPLETED|Overall Study||40
366317|NCT02106156|900225|P1|NOT COMPLETED|Overall Study||2549
366318|NCT02106156|900223|P3|COMPLETED|Overall Study||518
366319|NCT02106156|900224|P2|COMPLETED|Overall Study||50
366320|NCT02106156|900225|P1|COMPLETED|Overall Study||7071
366321|NCT02106156|900223|P3|STARTED|Overall Study||518
366322|NCT02106156|900224|P2|STARTED|Overall Study||90
366323|NCT02106156|900225|P1|STARTED|Overall Study||9620
366324|NCT02105987|900249|P6|NOT COMPLETED|Continuation Phase||0
366325|NCT02105987|900250|P5|NOT COMPLETED|Continuation Phase||1
366326|NCT02105987|900251|P4|NOT COMPLETED|Continuation Phase||0
366327|NCT02105987|900252|P3|NOT COMPLETED|Continuation Phase||0
366328|NCT02105987|900253|P2|NOT COMPLETED|Continuation Phase||0
366329|NCT02105987|900254|P1|NOT COMPLETED|Continuation Phase||0
366330|NCT02105987|900249|P6|COMPLETED|Continuation Phase||23
366331|NCT02105987|900250|P5|COMPLETED|Continuation Phase||13
366332|NCT02105987|900251|P4|COMPLETED|Continuation Phase||0
366333|NCT02105987|900252|P3|COMPLETED|Continuation Phase||0
366334|NCT02105987|900253|P2|COMPLETED|Continuation Phase||0
366335|NCT02105987|900254|P1|COMPLETED|Continuation Phase||0
366336|NCT02105987|900249|P6|STARTED|Continuation Phase||23
366337|NCT02105987|900250|P5|STARTED|Continuation Phase||14
366338|NCT02105987|900251|P4|STARTED|Continuation Phase||0
366339|NCT02105987|900252|P3|STARTED|Continuation Phase||0
366340|NCT02105987|900253|P2|STARTED|Continuation Phase||0
366341|NCT02105987|900254|P1|STARTED|Continuation Phase||0
366342|NCT02105987|900249|P6|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
366343|NCT02105987|900250|P5|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
366344|NCT02105987|900251|P4|NOT COMPLETED|Late Switch Phase (24 Weeks)||14
366345|NCT02105987|900252|P3|NOT COMPLETED|Late Switch Phase (24 Weeks)||45
366346|NCT02105987|900253|P2|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
366347|NCT02105987|900254|P1|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
366348|NCT02105987|900249|P6|COMPLETED|Late Switch Phase (24 Weeks)||0
366349|NCT02105987|900250|P5|COMPLETED|Late Switch Phase (24 Weeks)||0
366350|NCT02105987|900251|P4|COMPLETED|Late Switch Phase (24 Weeks)||230
366351|NCT02105987|900252|P3|COMPLETED|Late Switch Phase (24 Weeks)||230
366352|NCT02105987|900253|P2|COMPLETED|Late Switch Phase (24 Weeks)||0
366353|NCT02105987|900254|P1|COMPLETED|Late Switch Phase (24 Weeks)||0
366354|NCT02105987|900249|P6|STARTED|Late Switch Phase (24 Weeks)||0
366355|NCT02105987|900250|P5|STARTED|Late Switch Phase (24 Weeks)||0
366356|NCT02105987|900251|P4|STARTED|Late Switch Phase (24 Weeks)||244
366357|NCT02105987|900252|P3|STARTED|Late Switch Phase (24 Weeks)||275
366358|NCT02105987|900253|P2|STARTED|Late Switch Phase (24 Weeks)||0
366359|NCT02105987|900254|P1|STARTED|Late Switch Phase (24 Weeks)||0
366360|NCT02105987|900249|P6|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
366361|NCT02105987|900250|P5|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
366362|NCT02105987|900251|P4|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
366363|NCT02105987|900252|P3|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
366364|NCT02105987|900253|P2|NOT COMPLETED|Early Switch Phase (24 Weeks)||34
366365|NCT02105987|900254|P1|NOT COMPLETED|Early Switch Phase (24 Weeks)||36
366366|NCT02105987|900249|P6|COMPLETED|Early Switch Phase (24 Weeks)||0
366367|NCT02105987|900250|P5|COMPLETED|Early Switch Phase (24 Weeks)||0
366368|NCT02105987|900251|P4|COMPLETED|Early Switch Phase (24 Weeks)||0
366369|NCT02105987|900252|P3|COMPLETED|Early Switch Phase (24 Weeks)||0
366370|NCT02105987|900253|P2|COMPLETED|Early Switch Phase (24 Weeks)||244
366371|NCT02105987|900254|P1|COMPLETED|Early Switch Phase (24 Weeks)||239
366372|NCT02105987|900249|P6|STARTED|Early Switch Phase (24 Weeks)||0
366373|NCT02105987|900250|P5|STARTED|Early Switch Phase (24 Weeks)||0
366374|NCT02105987|900251|P4|STARTED|Early Switch Phase (24 Weeks)||0
366375|NCT02105987|900252|P3|STARTED|Early Switch Phase (24 Weeks)||0
366376|NCT02105987|900253|P2|STARTED|Early Switch Phase (24 Weeks)|Number Started represents the number of par. in the Intent-To-Treat Exposed (ITT-E) Population.|278
366377|NCT02105987|900254|P1|STARTED|Early Switch Phase (24 Weeks)|Number Started represents the number of par. in the Intent-To-Treat Exposed (ITT-E) Population.|275
366378|NCT02105974|900308|P3|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||58
366379|NCT02105974|900309|P2|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||42
366380|NCT02105974|900310|P1|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||0
366381|NCT02105974|900308|P3|COMPLETED|12 Week (Wk) Treatment Period (TP)|Par. completed study if attended visit 7, had follow-up contact and no early withdrawal|756
366382|NCT02105974|900309|P2|COMPLETED|12 Week (Wk) Treatment Period (TP)|Par. completed study if attended visit 7, had follow-up contact and no early withdrawal|764
366383|NCT02105974|900310|P1|COMPLETED|12 Week (Wk) Treatment Period (TP)||0
366384|NCT02105974|900308|P3|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)|Par completed TP if attended Visit (V7, Wk12), did not withdraw at V7 and did not stop trt before V7|754
366385|NCT02105974|900309|P2|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)|Par completed TP if attended Visit (V7, Wk12), did not withdraw at V7 and did not stop trt before V7|764
366386|NCT02105974|900310|P1|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)||0
366387|NCT02105974|900308|P3|STARTED|12 Week (Wk) Treatment Period (TP)||814
366388|NCT02105974|900309|P2|STARTED|12 Week (Wk) Treatment Period (TP)||806
366389|NCT02105974|900310|P1|STARTED|12 Week (Wk) Treatment Period (TP)||0
366390|NCT02105974|900308|P3|NOT COMPLETED|2 Week Run-in Period||0
366391|NCT02105974|900309|P2|NOT COMPLETED|2 Week Run-in Period||0
366392|NCT02105974|900310|P1|NOT COMPLETED|2 Week Run-in Period||801
366393|NCT02105974|900308|P3|COMPLETED|2 Week Run-in Period||0
366394|NCT02105974|900309|P2|COMPLETED|2 Week Run-in Period||0
366395|NCT02105974|900310|P1|COMPLETED|2 Week Run-in Period||1622
366396|NCT02105974|900308|P3|STARTED|2 Week Run-in Period||0
366397|NCT02105974|900309|P2|STARTED|2 Week Run-in Period||0
366398|NCT02105974|900310|P1|STARTED|2 Week Run-in Period||2423
366399|NCT02105961|900323|P3|NOT COMPLETED|Overall Study||30
366400|NCT02105961|900324|P2|NOT COMPLETED|Overall Study||17
366401|NCT02105961|900325|P1|NOT COMPLETED|Overall Study||41
366402|NCT02105961|900323|P3|COMPLETED|Overall Study||195
366403|NCT02105961|900324|P2|COMPLETED|Overall Study||206
366404|NCT02105961|900325|P1|COMPLETED|Overall Study||185
366405|NCT02105961|900323|P3|Withdrew IP Due to: Site Closed|Overall Study||1
366406|NCT02105961|900324|P2|Withdrew IP Due to: Site Closed|Overall Study||0
366407|NCT02105961|900325|P1|Withdrew IP Due to: Site Closed|Overall Study||1
366408|NCT02105961|900323|P3|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
366409|NCT02105961|900324|P2|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
366410|NCT02105961|900325|P1|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||16
366411|NCT02105961|900323|P3|Withdrew IP Due to: Physician Decision|Overall Study||1
366412|NCT02105961|900324|P2|Withdrew IP Due to: Physician Decision|Overall Study||3
366413|NCT02105961|900325|P1|Withdrew IP Due to: Physician Decision|Overall Study||2
366414|NCT02105961|900323|P3|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
366415|NCT02105961|900324|P2|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
366416|NCT02105961|900325|P1|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
366417|NCT02105961|900323|P3|Withdrew IP Due to: Protocol Deviation|Overall Study||1
366418|NCT02105961|900324|P2|Withdrew IP Due to: Protocol Deviation|Overall Study||0
366419|NCT02105961|900325|P1|Withdrew IP Due to: Protocol Deviation|Overall Study||2
366420|NCT02105961|900323|P3|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
366421|NCT02105961|900324|P2|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
366422|NCT02105961|900325|P1|Withdrew IP Due to: Lack of Efficacy|Overall Study||6
366423|NCT02105961|900323|P3|Withdrew IP Due to: Stopping Criteria|Overall Study||0
366424|NCT02105961|900324|P2|Withdrew IP Due to: Stopping Criteria|Overall Study||1
366425|NCT02105961|900325|P1|Withdrew IP Due to: Stopping Criteria|Overall Study||1
366426|NCT02105961|900323|P3|Withdrew IP Due to: Adverse Event|Overall Study||25
366427|NCT02105961|900324|P2|Withdrew IP Due to: Adverse Event|Overall Study||9
366428|NCT02105961|900325|P1|Withdrew IP Due to: Adverse Event|Overall Study||27
366429|NCT02105961|900323|P3|Not Completed IP|Overall Study||42
366430|NCT02105961|900324|P2|Not Completed IP|Overall Study||27
366431|NCT02105961|900325|P1|Not Completed IP|Overall Study||56
366432|NCT02105961|900323|P3|Completed Investigational Product (IP)|Overall Study||183
366433|NCT02105961|900324|P2|Completed Investigational Product (IP)|Overall Study||196
366434|NCT02105961|900325|P1|Completed Investigational Product (IP)|Overall Study||170
366435|NCT02105961|900323|P3|STARTED|Overall Study||225
366436|NCT02105961|900324|P2|STARTED|Overall Study||223
366437|NCT02105961|900325|P1|STARTED|Overall Study||226
366438|NCT02105948|900349|P4|NOT COMPLETED|Overall Study||27
366439|NCT02105948|900350|P3|NOT COMPLETED|Overall Study||28
366440|NCT02105948|900351|P2|NOT COMPLETED|Overall Study||20
366441|NCT02105948|900352|P1|NOT COMPLETED|Overall Study||27
366442|NCT02105948|900349|P4|COMPLETED|Overall Study||157
366443|NCT02105948|900350|P3|COMPLETED|Overall Study||162
366444|NCT02105948|900351|P2|COMPLETED|Overall Study||213
366445|NCT02105948|900352|P1|COMPLETED|Overall Study||202
366446|NCT02105948|900349|P4|Withdrew IP Due to: Stopping Criteria|Overall Study||1
366447|NCT02105948|900350|P3|Withdrew IP Due to: Stopping Criteria|Overall Study||0
366448|NCT02105948|900351|P2|Withdrew IP Due to: Stopping Criteria|Overall Study||0
366449|NCT02105948|900352|P1|Withdrew IP Due to: Stopping Criteria|Overall Study||0
366450|NCT02105948|900349|P4|Withdrew IP Due to: Physician Decision|Overall Study||2
366451|NCT02105948|900350|P3|Withdrew IP Due to: Physician Decision|Overall Study||4
366452|NCT02105948|900351|P2|Withdrew IP Due to: Physician Decision|Overall Study||1
366453|NCT02105948|900352|P1|Withdrew IP Due to: Physician Decision|Overall Study||2
366454|NCT02105948|900349|P4|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||15
366455|NCT02105948|900350|P3|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
366456|NCT02105948|900351|P2|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||8
366457|NCT02105948|900352|P1|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||16
366458|NCT02105948|900349|P4|Withdrew IP Due to: Lost to Follow-up|Overall Study||2
366459|NCT02105948|900350|P3|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
366460|NCT02105948|900351|P2|Withdrew IP Due to: Lost to Follow-up|Overall Study||0
366461|NCT02105948|900352|P1|Withdrew IP Due to: Lost to Follow-up|Overall Study||0
366462|NCT02105948|900349|P4|Withdrew IP Due to: Protocol Deviation|Overall Study||0
366463|NCT02105948|900350|P3|Withdrew IP Due to: Protocol Deviation|Overall Study||3
366464|NCT02105948|900351|P2|Withdrew IP Due to: Protocol Deviation|Overall Study||3
366465|NCT02105948|900352|P1|Withdrew IP Due to: Protocol Deviation|Overall Study||1
366466|NCT02105948|900349|P4|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
366467|NCT02105948|900350|P3|Withdrew IP Due to: Lack of Efficacy|Overall Study||8
366468|NCT02105948|900351|P2|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
366469|NCT02105948|900352|P1|Withdrew IP Due to: Lack of Efficacy|Overall Study||5
366470|NCT02105948|900349|P4|Withdrew IP Due to: Adverse Event|Overall Study||13
366471|NCT02105948|900350|P3|Withdrew IP Due to: Adverse Event|Overall Study||15
366472|NCT02105948|900351|P2|Withdrew IP Due to: Adverse Event|Overall Study||16
366473|NCT02105948|900352|P1|Withdrew IP Due to: Adverse Event|Overall Study||20
366474|NCT02105948|900349|P4|Not Completed IP|Overall Study||35
366475|NCT02105948|900350|P3|Not Completed IP|Overall Study||42
366476|NCT02105948|900351|P2|Not Completed IP|Overall Study||30
366477|NCT02105948|900352|P1|Not Completed IP|Overall Study||44
366478|NCT02105948|900349|P4|Completed Investigational Product (IP)|Overall Study||149
366479|NCT02105948|900350|P3|Completed Investigational Product (IP)|Overall Study||148
366480|NCT02105948|900351|P2|Completed Investigational Product (IP)|Overall Study||203
366481|NCT02105948|900352|P1|Completed Investigational Product (IP)|Overall Study||185
366482|NCT02105948|900349|P4|STARTED|Overall Study||184
366483|NCT02105948|900350|P3|STARTED|Overall Study||190
366484|NCT02105948|900351|P2|STARTED|Overall Study||233
366485|NCT02105948|900352|P1|STARTED|Overall Study||229
366486|NCT02105740|900380|P2|NOT COMPLETED|Overall Study||1
366487|NCT02105740|900381|P1|NOT COMPLETED|Overall Study||0
366488|NCT02105740|900380|P2|COMPLETED|Overall Study|Application of EVA and HADS scales and data analysis|11
366489|NCT02105740|900381|P1|COMPLETED|Overall Study|Application of EVA and HADS scales and data analysis|12
366490|NCT02105740|900380|P2|Second|Overall Study|Application of EVA and HADS scales. One accompanying lost|11
366491|NCT02105740|900381|P1|Second|Overall Study|Intervention with hypnosis and application of EVA scales and HADS (n = 12)|12
366492|NCT02105740|900380|P2|STARTED|Overall Study|Application of EVA and HADS scales|12
366493|NCT02105740|900381|P1|STARTED|Overall Study|Application of EVA and HADS scales and after that application of hypnosis intervention|12
366494|NCT02105701|900393|P4|NOT COMPLETED|Overall Study||2
366495|NCT02105701|900394|P3|NOT COMPLETED|Overall Study||3
366496|NCT02105701|900395|P2|NOT COMPLETED|Overall Study||1
366497|NCT02105701|900396|P1|NOT COMPLETED|Overall Study||4
366498|NCT02105701|900393|P4|COMPLETED|Overall Study||104
366499|NCT02105701|900394|P3|COMPLETED|Overall Study||102
366500|NCT02105701|900395|P2|COMPLETED|Overall Study||103
366501|NCT02105701|900396|P1|COMPLETED|Overall Study||101
366502|NCT02105701|900393|P4|STARTED|Overall Study||106
366503|NCT02105701|900394|P3|STARTED|Overall Study||105
366504|NCT02105701|900395|P2|STARTED|Overall Study||104
366505|NCT02105701|900396|P1|STARTED|Overall Study||105
366506|NCT02105688|900420|P2|NOT COMPLETED|Overall Study||99
366507|NCT02105688|900421|P1|NOT COMPLETED|Overall Study||26
366508|NCT02105688|900420|P2|COMPLETED|Overall Study|Completed means participant completed Follow-Up Week 24 visit|1
366509|NCT02105688|900421|P1|COMPLETED|Overall Study|Completed means participant completed Follow-Up Week 24 visit|175
366510|NCT02105688|900420|P2|Not Reached FU Week 12 Visit|Overall Study||15
366511|NCT02105688|900421|P1|Not Reached FU Week 12 Visit|Overall Study||2
366512|NCT02105688|900420|P2|Completed FU Week 12 Visit, Still in FU|Overall Study||75
366513|NCT02105688|900421|P1|Completed FU Week 12 Visit, Still in FU|Overall Study||10
366514|NCT02105688|900420|P2|STARTED|Overall Study||100
366515|NCT02105688|900421|P1|STARTED|Overall Study||201
366516|NCT02105662|900431|P1|NOT COMPLETED|Overall Study||6
366517|NCT02105662|900431|P1|COMPLETED|Overall Study||212
366518|NCT02105662|900431|P1|STARTED|Overall Study||218
366519|NCT02105636|900440|P2|NOT COMPLETED|Overall Study||108
366520|NCT02105636|900441|P1|NOT COMPLETED|Overall Study||195
366521|NCT02105636|900440|P2|COMPLETED|Overall Study|Completed=Still on Treatment|3
366522|NCT02105636|900441|P1|COMPLETED|Overall Study|Completed=Still on Treatment|41
366523|NCT02105636|900440|P2|STARTED|Overall Study||111
366524|NCT02105636|900441|P1|STARTED|Overall Study||236
366525|NCT02105467|900453|P2|NOT COMPLETED|Period 3||1
366526|NCT02105467|900454|P1|NOT COMPLETED|Period 3||0
366527|NCT02105467|900453|P2|COMPLETED|Period 3||102
366528|NCT02105467|900454|P1|COMPLETED|Period 3||0
366529|NCT02105467|900453|P2|STARTED|Period 3|One participant did not receive deferred treatment (Period 2) but proceeded directly to Period 3|103
366530|NCT02105467|900454|P1|STARTED|Period 3|The Immediate Treatment Group completed the study with Period 2|0
366531|NCT02105467|900453|P2|NOT COMPLETED|Period 2||2
366532|NCT02105467|900454|P1|NOT COMPLETED|Period 2||2
366533|NCT02105467|900453|P2|COMPLETED|Period 2||102
366534|NCT02105467|900454|P1|COMPLETED|Period 2||312
366535|NCT02105467|900453|P2|STARTED|Period 2|One participant did not receive deferred treatment (Period 2) but proceeded directly to Period 3|104
366536|NCT02105467|900454|P1|STARTED|Period 2||314
366537|NCT02105467|900453|P2|NOT COMPLETED|Period 1||0
366538|NCT02105467|900454|P1|NOT COMPLETED|Period 1||2
366539|NCT02105467|900453|P2|COMPLETED|Period 1||105
366540|NCT02105467|900454|P1|COMPLETED|Period 1||314
366541|NCT02105467|900453|P2|STARTED|Period 1||105
366542|NCT02105467|900454|P1|STARTED|Period 1||316
366543|NCT02105454|900466|P1|NOT COMPLETED|Overall Study||1
366544|NCT02105454|900466|P1|COMPLETED|Overall Study||78
366545|NCT02105454|900466|P1|STARTED|Overall Study||79
366546|NCT02105324|900473|P2|NOT COMPLETED|Period 2||0
366547|NCT02105324|900474|P1|NOT COMPLETED|Period 2||0
366548|NCT02105324|900473|P2|COMPLETED|Period 2||10
366549|NCT02105324|900474|P1|COMPLETED|Period 2||9
366550|NCT02105324|900473|P2|STARTED|Period 2||10
366551|NCT02105324|900474|P1|STARTED|Period 2||9
366552|NCT02105324|900473|P2|NOT COMPLETED|Period 1||0
366553|NCT02105324|900474|P1|NOT COMPLETED|Period 1||0
366554|NCT02105324|900473|P2|COMPLETED|Period 1||10
366555|NCT02105324|900474|P1|COMPLETED|Period 1||9
366556|NCT02105324|900473|P2|STARTED|Period 1||10
366557|NCT02105324|900474|P1|STARTED|Period 1||9
366558|NCT02105285|900553|P3|NOT COMPLETED|Overall Study||0
366559|NCT02105285|900554|P2|NOT COMPLETED|Overall Study||2
366560|NCT02105285|900555|P1|NOT COMPLETED|Overall Study||2
366561|NCT02105285|900553|P3|COMPLETED|Overall Study||37
366562|NCT02105285|900554|P2|COMPLETED|Overall Study||76
366563|NCT02105285|900555|P1|COMPLETED|Overall Study||76
366564|NCT02105285|900553|P3|STARTED|Overall Study||37
366565|NCT02105285|900554|P2|STARTED|Overall Study||78
366566|NCT02105285|900555|P1|STARTED|Overall Study||78
366567|NCT02105272|900574|P2|NOT COMPLETED|Overall Study||3
366568|NCT02105272|900575|P1|NOT COMPLETED|Overall Study||5
366569|NCT02105272|900574|P2|COMPLETED|Overall Study||116
366570|NCT02105272|900575|P1|COMPLETED|Overall Study||113
366571|NCT02105272|900574|P2|STARTED|Overall Study||119
366572|NCT02105272|900575|P1|STARTED|Overall Study||118
366573|NCT02105012|900591|P1|NOT COMPLETED|Overall Study||33
366574|NCT02105012|900591|P1|COMPLETED|Overall Study||114
366575|NCT02105012|900591|P1|Placebo MDI|Overall Study||127
366576|NCT02105012|900591|P1|BD MDI 40 µg|Overall Study||63
366577|NCT02105012|900591|P1|BD MDI 80 µg|Overall Study||64
366578|NCT02105012|900591|P1|BD MDI 160 µg|Overall Study||132
366579|NCT02105012|900591|P1|BD MDI 320 µg|Overall Study||124
366580|NCT02105012|900591|P1|STARTED|Overall Study||147
366581|NCT02104947|900625|P2|NOT COMPLETED|Overall Study||56
366582|NCT02104947|900626|P1|NOT COMPLETED|Overall Study||79
366583|NCT02104947|900625|P2|COMPLETED|Overall Study||146
366584|NCT02104947|900626|P1|COMPLETED|Overall Study||222
366585|NCT02104947|900625|P2|STARTED|Overall Study||202
366586|NCT02104947|900626|P1|STARTED|Overall Study||301
366587|NCT02104895|900644|P2|NOT COMPLETED|Overall Study||14
366588|NCT02104895|900645|P1|NOT COMPLETED|Overall Study||0
366589|NCT02104895|900644|P2|COMPLETED|Overall Study||246
366590|NCT02104895|900645|P1|COMPLETED|Overall Study||260
366591|NCT02104895|900644|P2|STARTED|Overall Study||260
366592|NCT02104895|900645|P1|STARTED|Overall Study||260
366593|NCT02104830|900658|P3|NOT COMPLETED|Overall Study||7
366594|NCT02104830|900659|P2|NOT COMPLETED|Overall Study||7
366595|NCT02104830|900660|P1|NOT COMPLETED|Overall Study||4
366596|NCT02104830|900658|P3|COMPLETED|Overall Study||36
366597|NCT02104830|900659|P2|COMPLETED|Overall Study||36
366598|NCT02104830|900660|P1|COMPLETED|Overall Study||38
366599|NCT02104830|900658|P3|STARTED|Overall Study||43
366600|NCT02104830|900659|P2|STARTED|Overall Study||43
366601|NCT02104830|900660|P1|STARTED|Overall Study||42
366602|NCT02104804|900685|P2|NOT COMPLETED|Overall Study||19
366603|NCT02104804|900686|P1|NOT COMPLETED|Overall Study||16
366604|NCT02104804|900685|P2|COMPLETED|Overall Study|Of the 19 who did not complete, 1 did not take study medication after randomization.|213
366605|NCT02104804|900686|P1|COMPLETED|Overall Study|Number of patients who completed 24 weeks of treatment|218
366606|NCT02104804|900685|P2|STARTED|Overall Study|Number of patients who were randomized|232
366607|NCT02104804|900686|P1|STARTED|Overall Study|Number of patients who were randomized|234
366608|NCT02104505|900704|P2|NOT COMPLETED|Second Intervention (14 Days)||1
366609|NCT02104505|900705|P1|NOT COMPLETED|Second Intervention (14 Days)||2
366610|NCT02104505|900704|P2|COMPLETED|Second Intervention (14 Days)||7
366611|NCT02104505|900705|P1|COMPLETED|Second Intervention (14 Days)||8
366612|NCT02104505|900704|P2|STARTED|Second Intervention (14 Days)||8
366613|NCT02104505|900705|P1|STARTED|Second Intervention (14 Days)||10
366614|NCT02104505|900704|P2|NOT COMPLETED|Washout (Minimum 3 Weeks)||0
366615|NCT02104505|900705|P1|NOT COMPLETED|Washout (Minimum 3 Weeks)||0
366616|NCT02104505|900704|P2|COMPLETED|Washout (Minimum 3 Weeks)||8
366617|NCT02104505|900705|P1|COMPLETED|Washout (Minimum 3 Weeks)||10
366618|NCT02104505|900704|P2|STARTED|Washout (Minimum 3 Weeks)||8
366619|NCT02104505|900705|P1|STARTED|Washout (Minimum 3 Weeks)||10
366620|NCT02104505|900704|P2|NOT COMPLETED|First Intervention (14 Days)||3
366621|NCT02104505|900705|P1|NOT COMPLETED|First Intervention (14 Days)||2
366622|NCT02104505|900704|P2|COMPLETED|First Intervention (14 Days)||8
366623|NCT02104505|900705|P1|COMPLETED|First Intervention (14 Days)||10
366624|NCT02104505|900704|P2|STARTED|First Intervention (14 Days)|one participant withdrew prior to receiving study drug|11
366625|NCT02104505|900705|P1|STARTED|First Intervention (14 Days)||12
366626|NCT02104427|900717|P1|NOT COMPLETED|Overall Study||0
366627|NCT02104427|900717|P1|COMPLETED|Overall Study||12
366628|NCT02104427|900717|P1|STARTED|Overall Study||12
366629|NCT02104219|900740|P1|NOT COMPLETED|Overall Study||0
366630|NCT02104219|900740|P1|COMPLETED|Overall Study||32
366631|NCT02104219|900740|P1|STARTED|Overall Study||32
366632|NCT02103855|900747|P1|NOT COMPLETED|Overall Study||2
366633|NCT02103855|900747|P1|COMPLETED|Overall Study||4
366634|NCT02103855|900747|P1|STARTED|Overall Study||6
366635|NCT02103439|900757|P2|NOT COMPLETED|Overall Study||3
366636|NCT02103439|900758|P1|NOT COMPLETED|Overall Study||3
366637|NCT02103439|900757|P2|COMPLETED|Overall Study||67
366638|NCT02103439|900758|P1|COMPLETED|Overall Study||67
366639|NCT02103439|900757|P2|STARTED|Overall Study||70
366640|NCT02103439|900758|P1|STARTED|Overall Study||70
366641|NCT02103309|900778|P2|NOT COMPLETED|Overall Study||0
366642|NCT02103309|900779|P1|NOT COMPLETED|Overall Study||0
366643|NCT02103309|900778|P2|COMPLETED|Overall Study||22
366644|NCT02103309|900779|P1|COMPLETED|Overall Study||20
366645|NCT02103309|900778|P2|STARTED|Overall Study||22
366646|NCT02103309|900779|P1|STARTED|Overall Study||20
366647|NCT02103114|900793|P2|NOT COMPLETED|Overall Study||1
366648|NCT02103114|900794|P1|NOT COMPLETED|Overall Study||0
366649|NCT02103114|900793|P2|COMPLETED|Overall Study||19
366650|NCT02103114|900794|P1|COMPLETED|Overall Study||20
366651|NCT02103114|900793|P2|STARTED|Overall Study||20
366652|NCT02103114|900794|P1|STARTED|Overall Study||20
366653|NCT02103062|900850|P2|NOT COMPLETED|Overall Study||23
366654|NCT02103062|900851|P1|NOT COMPLETED|Overall Study||18
366655|NCT02103062|900850|P2|COMPLETED|Overall Study||0
366656|NCT02103062|900851|P1|COMPLETED|Overall Study||0
366657|NCT02103062|900850|P2|Intent to Treat Population|Overall Study|Includes participants who met all eligibility criteria and received at least one dose of study drug.|20
366658|NCT02103062|900851|P1|Intent to Treat Population|Overall Study|Includes participants who met all eligibility criteria and received at least one dose of study drug.|17
366659|NCT02103062|900850|P2|Safety Population|Overall Study|Includes participants who received at least one dose of study drug.|23
366660|NCT02103062|900851|P1|Safety Population|Overall Study|Includes participants who received at least one dose of study drug.|18
366661|NCT02103062|900850|P2|STARTED|Overall Study||23
366662|NCT02103062|900851|P1|STARTED|Overall Study||18
366663|NCT02102932|900877|P8|NOT COMPLETED|Overall Study||0
366664|NCT02102932|900878|P7|NOT COMPLETED|Overall Study||0
366665|NCT02102932|900879|P6|NOT COMPLETED|Overall Study||0
366666|NCT02102932|900880|P5|NOT COMPLETED|Overall Study||0
366667|NCT02102932|900881|P4|NOT COMPLETED|Overall Study||0
366668|NCT02102932|900882|P3|NOT COMPLETED|Overall Study||0
366669|NCT02102932|900883|P2|NOT COMPLETED|Overall Study||0
366670|NCT02102932|900884|P1|NOT COMPLETED|Overall Study||0
366671|NCT02102932|900877|P8|COMPLETED|Overall Study||12
366672|NCT02102932|900878|P7|COMPLETED|Overall Study||12
366673|NCT02102932|900879|P6|COMPLETED|Overall Study||12
366674|NCT02102932|900880|P5|COMPLETED|Overall Study||12
366675|NCT02102932|900881|P4|COMPLETED|Overall Study||12
366676|NCT02102932|900882|P3|COMPLETED|Overall Study||12
366677|NCT02102932|900883|P2|COMPLETED|Overall Study||12
366678|NCT02102932|900884|P1|COMPLETED|Overall Study||12
366679|NCT02102932|900877|P8|STARTED|Overall Study||12
366680|NCT02102932|900878|P7|STARTED|Overall Study||12
366681|NCT02102932|900879|P6|STARTED|Overall Study||12
366682|NCT02102932|900880|P5|STARTED|Overall Study||12
366683|NCT02102932|900881|P4|STARTED|Overall Study||12
366684|NCT02102932|900882|P3|STARTED|Overall Study||12
366685|NCT02102932|900883|P2|STARTED|Overall Study||12
366686|NCT02102932|900884|P1|STARTED|Overall Study||12
366687|NCT02102490|900942|P1|NOT COMPLETED|Overall Study||9
366688|NCT02102490|900942|P1|COMPLETED|Overall Study||123
366689|NCT02102490|900942|P1|Received at Least 1 Dose of Study Drug|Overall Study||132
366690|NCT02102490|900942|P1|STARTED|Overall Study||132
366691|NCT02102464|900956|P3|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
366692|NCT02102464|900957|P2|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
366693|NCT02102464|900958|P1|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
366694|NCT02102464|900956|P3|COMPLETED|Crossover LipiFlow Treatment of Control||25
366695|NCT02102464|900957|P2|COMPLETED|Crossover LipiFlow Treatment of Control||0
366696|NCT02102464|900958|P1|COMPLETED|Crossover LipiFlow Treatment of Control||0
366697|NCT02102464|900956|P3|STARTED|Crossover LipiFlow Treatment of Control||25
366698|NCT02102464|900957|P2|STARTED|Crossover LipiFlow Treatment of Control||0
366699|NCT02102464|900958|P1|STARTED|Crossover LipiFlow Treatment of Control||0
366700|NCT02102464|900956|P3|NOT COMPLETED|Randomized Study||0
366701|NCT02102464|900957|P2|NOT COMPLETED|Randomized Study||1
366702|NCT02102464|900958|P1|NOT COMPLETED|Randomized Study||0
366703|NCT02102464|900956|P3|COMPLETED|Randomized Study||0
366704|NCT02102464|900957|P2|COMPLETED|Randomized Study||25
366705|NCT02102464|900958|P1|COMPLETED|Randomized Study||29
366706|NCT02102464|900956|P3|STARTED|Randomized Study||0
366707|NCT02102464|900957|P2|STARTED|Randomized Study||26
366708|NCT02102464|900958|P1|STARTED|Randomized Study||29
366709|NCT02102399|900977|P2|NOT COMPLETED|Overall Study||4
366710|NCT02102399|900978|P1|NOT COMPLETED|Overall Study||6
366711|NCT02102399|900977|P2|COMPLETED|Overall Study||17
366712|NCT02102399|900978|P1|COMPLETED|Overall Study||14
366713|NCT02102399|900977|P2|STARTED|Overall Study||21
366714|NCT02102399|900978|P1|STARTED|Overall Study||20
366715|NCT02102204|901026|P1|NOT COMPLETED|Overall Study||304
366716|NCT02102204|901026|P1|COMPLETED|Overall Study||598
366717|NCT02102204|901026|P1|Received Etelcalcetide|Overall Study||884
366718|NCT02102204|901026|P1|STARTED|Overall Study||902
366719|NCT02101983|901037|P2|NOT COMPLETED|Overall Study||0
366720|NCT02101983|901038|P1|NOT COMPLETED|Overall Study||1
366721|NCT02101983|901037|P2|COMPLETED|Overall Study||6
366722|NCT02101983|901038|P1|COMPLETED|Overall Study||4
366723|NCT02101983|901037|P2|STARTED|Overall Study||6
366724|NCT02101983|901038|P1|STARTED|Overall Study||5
366725|NCT02101359|901050|P2|NOT COMPLETED|Overall Study||19
366726|NCT02101359|901051|P1|NOT COMPLETED|Overall Study||29
366727|NCT02101359|901050|P2|COMPLETED|Overall Study||277
366728|NCT02101359|901051|P1|COMPLETED|Overall Study||266
366729|NCT02101359|901050|P2|STARTED|Overall Study||296
366730|NCT02101359|901051|P1|STARTED|Overall Study||295
366731|NCT02101294|901057|P1|NOT COMPLETED|Overall Study||11
366732|NCT02101294|901057|P1|COMPLETED|Overall Study||20
366733|NCT02101294|901057|P1|STARTED|Overall Study||31
366734|NCT02101190|901066|P2|NOT COMPLETED|Overall Study||0
366735|NCT02101190|901067|P1|NOT COMPLETED|Overall Study||0
366736|NCT02101190|901066|P2|COMPLETED|Overall Study||8
366737|NCT02101190|901067|P1|COMPLETED|Overall Study||8
366738|NCT02101190|901066|P2|STARTED|Overall Study||8
366739|NCT02101190|901067|P1|STARTED|Overall Study||8
366740|NCT02101112|901077|P6|NOT COMPLETED|Overall Study||0
366741|NCT02101112|901078|P5|NOT COMPLETED|Overall Study||1
366742|NCT02101112|901079|P4|NOT COMPLETED|Overall Study||0
366743|NCT02101112|901080|P3|NOT COMPLETED|Overall Study||1
366744|NCT02101112|901081|P2|NOT COMPLETED|Overall Study||0
366745|NCT02101112|901082|P1|NOT COMPLETED|Overall Study||0
366746|NCT02101112|901077|P6|COMPLETED|Overall Study||5
366747|NCT02101112|901078|P5|COMPLETED|Overall Study||5
366748|NCT02101112|901079|P4|COMPLETED|Overall Study||5
366749|NCT02101112|901080|P3|COMPLETED|Overall Study||5
366750|NCT02101112|901081|P2|COMPLETED|Overall Study||5
366751|NCT02101112|901082|P1|COMPLETED|Overall Study||6
366752|NCT02101112|901077|P6|STARTED|Overall Study||5
366753|NCT02101112|901078|P5|STARTED|Overall Study||6
366754|NCT02101112|901079|P4|STARTED|Overall Study||5
366755|NCT02101112|901080|P3|STARTED|Overall Study||6
366756|NCT02101112|901081|P2|STARTED|Overall Study||5
366757|NCT02101112|901082|P1|STARTED|Overall Study||6
366758|NCT02101021|901112|P5|NOT COMPLETED|Overall Study||4
366759|NCT02101021|901113|P4|NOT COMPLETED|Overall Study||3
366760|NCT02101021|901114|P3|NOT COMPLETED|Overall Study||7
366761|NCT02101021|901115|P2|NOT COMPLETED|Overall Study||4
366762|NCT02101021|901116|P1|NOT COMPLETED|Overall Study||7
366763|NCT02101021|901112|P5|COMPLETED|Overall Study||0
366764|NCT02101021|901113|P4|COMPLETED|Overall Study||0
366765|NCT02101021|901114|P3|COMPLETED|Overall Study||0
366766|NCT02101021|901115|P2|COMPLETED|Overall Study||0
366767|NCT02101021|901116|P1|COMPLETED|Overall Study||0
366768|NCT02101021|901112|P5|STARTED|Overall Study||4
366769|NCT02101021|901113|P4|STARTED|Overall Study||3
366770|NCT02101021|901114|P3|STARTED|Overall Study||7
366771|NCT02101021|901115|P2|STARTED|Overall Study||4
366772|NCT02101021|901116|P1|STARTED|Overall Study||7
366773|NCT02101008|901158|P1|NOT COMPLETED|Overall Study||0
366774|NCT02101008|901158|P1|COMPLETED|Overall Study||12
366775|NCT02101008|901158|P1|STARTED|Overall Study||12
366776|NCT02100839|901165|P2|NOT COMPLETED|Multiple Ascending Dose||0
366777|NCT02100839|901166|P1|NOT COMPLETED|Multiple Ascending Dose||4
366778|NCT02100839|901165|P2|COMPLETED|Multiple Ascending Dose||3
366779|NCT02100839|901166|P1|COMPLETED|Multiple Ascending Dose||9
366780|NCT02100839|901165|P2|STARTED|Multiple Ascending Dose||3
366781|NCT02100839|901166|P1|STARTED|Multiple Ascending Dose||13
366782|NCT02100839|901165|P2|NOT COMPLETED|Single Ascending Dose||0
366783|NCT02100839|901166|P1|NOT COMPLETED|Single Ascending Dose||0
366784|NCT02100839|901165|P2|COMPLETED|Single Ascending Dose||12
366785|NCT02100839|901166|P1|COMPLETED|Single Ascending Dose||24
366786|NCT02100839|901165|P2|STARTED|Single Ascending Dose||12
366787|NCT02100839|901166|P1|STARTED|Single Ascending Dose||24
366788|NCT02100826|901178|P2|NOT COMPLETED|Period 2 (7 Days)||0
366789|NCT02100826|901179|P1|NOT COMPLETED|Period 2 (7 Days)||0
366790|NCT02100826|901178|P2|COMPLETED|Period 2 (7 Days)||14
366791|NCT02100826|901179|P1|COMPLETED|Period 2 (7 Days)||14
366792|NCT02100826|901178|P2|STARTED|Period 2 (7 Days)||14
366793|NCT02100826|901179|P1|STARTED|Period 2 (7 Days)||14
366794|NCT02100826|901178|P2|NOT COMPLETED|Washout Period (1 Day)||0
366795|NCT02100826|901179|P1|NOT COMPLETED|Washout Period (1 Day)||0
366796|NCT02100826|901178|P2|COMPLETED|Washout Period (1 Day)||14
366797|NCT02100826|901179|P1|COMPLETED|Washout Period (1 Day)||14
366798|NCT02100826|901178|P2|STARTED|Washout Period (1 Day)||14
366799|NCT02100826|901179|P1|STARTED|Washout Period (1 Day)||14
366800|NCT02100826|901178|P2|NOT COMPLETED|Period 1 (7 Days)||0
366801|NCT02100826|901179|P1|NOT COMPLETED|Period 1 (7 Days)||0
366802|NCT02100826|901178|P2|COMPLETED|Period 1 (7 Days)||14
366803|NCT02100826|901179|P1|COMPLETED|Period 1 (7 Days)||14
366804|NCT02100826|901178|P2|STARTED|Period 1 (7 Days)||14
366805|NCT02100826|901179|P1|STARTED|Period 1 (7 Days)||14
366806|NCT02100670|901193|P4|NOT COMPLETED|Overall Study||1
366807|NCT02100670|901194|P3|NOT COMPLETED|Overall Study||4
366808|NCT02100670|901195|P2|NOT COMPLETED|Overall Study||7
366809|NCT02100670|901196|P1|NOT COMPLETED|Overall Study||13
366810|NCT02100670|901193|P4|COMPLETED|Overall Study||75
366811|NCT02100670|901194|P3|COMPLETED|Overall Study||74
366812|NCT02100670|901195|P2|COMPLETED|Overall Study||106
366813|NCT02100670|901196|P1|COMPLETED|Overall Study||105
366814|NCT02100670|901193|P4|STARTED|Overall Study||76
366815|NCT02100670|901194|P3|STARTED|Overall Study||78
366816|NCT02100670|901195|P2|STARTED|Overall Study||113
366817|NCT02100670|901196|P1|STARTED|Overall Study||118
366818|NCT02100644|901256|P3|NOT COMPLETED|LTG and VPA Maintenance Phase||0
366819|NCT02100644|901257|P2|NOT COMPLETED|LTG and VPA Maintenance Phase||0
366820|NCT02100644|901258|P1|NOT COMPLETED|LTG and VPA Maintenance Phase||0
366821|NCT02100644|901256|P3|COMPLETED|LTG and VPA Maintenance Phase||20
366822|NCT02100644|901257|P2|COMPLETED|LTG and VPA Maintenance Phase||0
366823|NCT02100644|901258|P1|COMPLETED|LTG and VPA Maintenance Phase||0
366824|NCT02100644|901256|P3|STARTED|LTG and VPA Maintenance Phase||20
366825|NCT02100644|901257|P2|STARTED|LTG and VPA Maintenance Phase||0
366826|NCT02100644|901258|P1|STARTED|LTG and VPA Maintenance Phase||0
366827|NCT02100644|901256|P3|NOT COMPLETED|VPA Reduction Phase||0
366828|NCT02100644|901257|P2|NOT COMPLETED|VPA Reduction Phase||0
366829|NCT02100644|901258|P1|NOT COMPLETED|VPA Reduction Phase||0
366830|NCT02100644|901256|P3|COMPLETED|VPA Reduction Phase||0
366831|NCT02100644|901257|P2|COMPLETED|VPA Reduction Phase||20
366832|NCT02100644|901258|P1|COMPLETED|VPA Reduction Phase||0
366833|NCT02100644|901256|P3|STARTED|VPA Reduction Phase||0
366834|NCT02100644|901257|P2|STARTED|VPA Reduction Phase||20
366835|NCT02100644|901258|P1|STARTED|VPA Reduction Phase||0
366836|NCT02100644|901256|P3|NOT COMPLETED|LTG Escalation Phase||0
366837|NCT02100644|901257|P2|NOT COMPLETED|LTG Escalation Phase||0
366838|NCT02100644|901258|P1|NOT COMPLETED|LTG Escalation Phase||13
366839|NCT02100644|901256|P3|COMPLETED|LTG Escalation Phase||0
366840|NCT02100644|901257|P2|COMPLETED|LTG Escalation Phase||0
366841|NCT02100644|901258|P1|COMPLETED|LTG Escalation Phase||20
366842|NCT02100644|901256|P3|STARTED|LTG Escalation Phase||0
366843|NCT02100644|901257|P2|STARTED|LTG Escalation Phase||0
366844|NCT02100644|901258|P1|STARTED|LTG Escalation Phase||33
366845|NCT02100579|901270|P2|NOT COMPLETED|Overall Study||0
366846|NCT02100579|901271|P1|NOT COMPLETED|Overall Study||0
366847|NCT02100579|901270|P2|COMPLETED|Overall Study||20
366848|NCT02100579|901271|P1|COMPLETED|Overall Study||20
366849|NCT02100579|901270|P2|STARTED|Overall Study||20
366850|NCT02100579|901271|P1|STARTED|Overall Study||20
366851|NCT02100514|901283|P2|NOT COMPLETED|Overall Study||74
366852|NCT02100514|901284|P1|NOT COMPLETED|Overall Study||29
366853|NCT02100514|901283|P2|COMPLETED|Overall Study||425
366854|NCT02100514|901284|P1|COMPLETED|Overall Study||218
366855|NCT02100514|901283|P2|STARTED|Overall Study||499
366856|NCT02100514|901284|P1|STARTED|Overall Study||247
366857|NCT02100475|901344|P2|NOT COMPLETED|Overall Study||2
366858|NCT02100475|901345|P1|NOT COMPLETED|Overall Study||2
366859|NCT02100475|901344|P2|COMPLETED|Overall Study||13
366860|NCT02100475|901345|P1|COMPLETED|Overall Study||14
366861|NCT02100475|901344|P2|STARTED|Overall Study||15
366862|NCT02100475|901345|P1|STARTED|Overall Study||16
366863|NCT02100410|901355|P6|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
366864|NCT02100410|901356|P5|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
366865|NCT02100410|901357|P4|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
366866|NCT02100410|901358|P3|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
366867|NCT02100410|901359|P2|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
366868|NCT02100410|901360|P1|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
366869|NCT02100410|901355|P6|COMPLETED|Exposure Pair 3, 30 Minutes||9
366870|NCT02100410|901356|P5|COMPLETED|Exposure Pair 3, 30 Minutes||8
366871|NCT02100410|901357|P4|COMPLETED|Exposure Pair 3, 30 Minutes||8
366872|NCT02100410|901358|P3|COMPLETED|Exposure Pair 3, 30 Minutes||8
366873|NCT02100410|901359|P2|COMPLETED|Exposure Pair 3, 30 Minutes||8
366874|NCT02100410|901360|P1|COMPLETED|Exposure Pair 3, 30 Minutes||8
366875|NCT02100410|901355|P6|STARTED|Exposure Pair 3, 30 Minutes||9
366876|NCT02100410|901356|P5|STARTED|Exposure Pair 3, 30 Minutes||8
366877|NCT02100410|901357|P4|STARTED|Exposure Pair 3, 30 Minutes||8
366878|NCT02100410|901358|P3|STARTED|Exposure Pair 3, 30 Minutes||8
366879|NCT02100410|901359|P2|STARTED|Exposure Pair 3, 30 Minutes||8
366880|NCT02100410|901360|P1|STARTED|Exposure Pair 3, 30 Minutes||8
366881|NCT02100410|901355|P6|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
366882|NCT02100410|901356|P5|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
366883|NCT02100410|901357|P4|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
366884|NCT02100410|901358|P3|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
366885|NCT02100410|901359|P2|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
366886|NCT02100410|901360|P1|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
366887|NCT02100410|901355|P6|COMPLETED|Exposure Pair 2, 30 Minutes||9
366888|NCT02100410|901356|P5|COMPLETED|Exposure Pair 2, 30 Minutes||8
366889|NCT02100410|901357|P4|COMPLETED|Exposure Pair 2, 30 Minutes||8
366890|NCT02100410|901358|P3|COMPLETED|Exposure Pair 2, 30 Minutes||8
366891|NCT02100410|901359|P2|COMPLETED|Exposure Pair 2, 30 Minutes||8
366892|NCT02100410|901360|P1|COMPLETED|Exposure Pair 2, 30 Minutes||8
366893|NCT02100410|901355|P6|STARTED|Exposure Pair 2, 30 Minutes||9
366894|NCT02100410|901356|P5|STARTED|Exposure Pair 2, 30 Minutes||8
366895|NCT02100410|901357|P4|STARTED|Exposure Pair 2, 30 Minutes||8
366896|NCT02100410|901358|P3|STARTED|Exposure Pair 2, 30 Minutes||8
366897|NCT02100410|901359|P2|STARTED|Exposure Pair 2, 30 Minutes||8
366898|NCT02100410|901360|P1|STARTED|Exposure Pair 2, 30 Minutes||8
366899|NCT02100410|901355|P6|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
366900|NCT02100410|901356|P5|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
366901|NCT02100410|901357|P4|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
366902|NCT02100410|901358|P3|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
366903|NCT02100410|901359|P2|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
366904|NCT02100410|901360|P1|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
366905|NCT02100410|901355|P6|COMPLETED|Exposure Pair 1, 30 Minutes||9
366906|NCT02100410|901356|P5|COMPLETED|Exposure Pair 1, 30 Minutes||8
366907|NCT02100410|901357|P4|COMPLETED|Exposure Pair 1, 30 Minutes||8
366908|NCT02100410|901358|P3|COMPLETED|Exposure Pair 1, 30 Minutes||8
366909|NCT02100410|901359|P2|COMPLETED|Exposure Pair 1, 30 Minutes||8
366910|NCT02100410|901360|P1|COMPLETED|Exposure Pair 1, 30 Minutes||8
366911|NCT02100410|901355|P6|STARTED|Exposure Pair 1, 30 Minutes||9
366912|NCT02100410|901356|P5|STARTED|Exposure Pair 1, 30 Minutes||8
366913|NCT02100410|901357|P4|STARTED|Exposure Pair 1, 30 Minutes||8
366914|NCT02100410|901358|P3|STARTED|Exposure Pair 1, 30 Minutes||8
366915|NCT02100410|901359|P2|STARTED|Exposure Pair 1, 30 Minutes||8
366916|NCT02100410|901360|P1|STARTED|Exposure Pair 1, 30 Minutes||8
366917|NCT02100280|901378|P2|NOT COMPLETED|Overall Study||4
366918|NCT02100280|901379|P1|NOT COMPLETED|Overall Study||4
366919|NCT02100280|901378|P2|COMPLETED|Overall Study||44
366920|NCT02100280|901379|P1|COMPLETED|Overall Study||44
366921|NCT02100280|901378|P2|STARTED|Overall Study||48
366922|NCT02100280|901379|P1|STARTED|Overall Study||48
366923|NCT02100228|901395|P2|NOT COMPLETED|Overall Study||90
366924|NCT02100228|901396|P1|NOT COMPLETED|Overall Study||75
366925|NCT02100228|901395|P2|COMPLETED|Overall Study||657
366926|NCT02100228|901396|P1|COMPLETED|Overall Study||678
366927|NCT02100228|901395|P2|STARTED|Overall Study|721 treated with Usual Care|747
366928|NCT02100228|901396|P1|STARTED|Overall Study|735 treated with Apixaban|753
366929|NCT02100189|901422|P1|NOT COMPLETED|Overall Study||0
366930|NCT02100189|901422|P1|COMPLETED|Overall Study||50
366931|NCT02100189|901422|P1|STARTED|Overall Study||50
366932|NCT02100007|901429|P1|NOT COMPLETED|Overall Study||0
366933|NCT02100007|901429|P1|COMPLETED|Overall Study||46
366934|NCT02100007|901429|P1|STARTED|Overall Study||46
366935|NCT02099838|901442|P2|NOT COMPLETED|Overall Study||2
366936|NCT02099838|901443|P1|NOT COMPLETED|Overall Study||4
366937|NCT02099838|901442|P2|COMPLETED|Overall Study||49
366938|NCT02099838|901443|P1|COMPLETED|Overall Study||43
366939|NCT02099838|901442|P2|STARTED|Overall Study||51
366940|NCT02099838|901443|P1|STARTED|Overall Study||47
366941|NCT02099708|901473|P1|NOT COMPLETED|Overall Study||200
366942|NCT02099708|901473|P1|COMPLETED|Overall Study||3302
366943|NCT02099708|901473|P1|Safety Analysis Set (SAS)|Overall Study|All participants who took the study drug at least once.|3302
366944|NCT02099708|901473|P1|STARTED|Overall Study|Number of cases.|3502
366945|NCT02099682|901484|P1|NOT COMPLETED|Overall Study||111
366946|NCT02099682|901484|P1|COMPLETED|Overall Study||3255
366947|NCT02099682|901484|P1|Safety Analysis Set (SAS)|Overall Study|All participants who took the study drug at least once.|3255
366948|NCT02099682|901484|P1|STARTED|Overall Study|Number of cases.|3366
366949|NCT02099461|901498|P3|NOT COMPLETED|Overall Study||0
366950|NCT02099461|901499|P2|NOT COMPLETED|Overall Study||0
366951|NCT02099461|901500|P1|NOT COMPLETED|Overall Study||0
366952|NCT02099461|901498|P3|COMPLETED|Overall Study||28
366953|NCT02099461|901499|P2|COMPLETED|Overall Study||27
366954|NCT02099461|901500|P1|COMPLETED|Overall Study||27
366955|NCT02099461|901498|P3|STARTED|Overall Study||28
366956|NCT02099461|901499|P2|STARTED|Overall Study||27
366957|NCT02099461|901500|P1|STARTED|Overall Study||27
366958|NCT02099344|901510|P2|NOT COMPLETED|Overall Study||0
366959|NCT02099344|901511|P1|NOT COMPLETED|Overall Study||1
366960|NCT02099344|901510|P2|COMPLETED|Overall Study||0
366961|NCT02099344|901511|P1|COMPLETED|Overall Study||0
366962|NCT02099344|901510|P2|STARTED|Overall Study||0
366963|NCT02099344|901511|P1|STARTED|Overall Study||1
366964|NCT02099318|901519|P2|NOT COMPLETED|Overall Study||0
366965|NCT02099318|901520|P1|NOT COMPLETED|Overall Study||0
366966|NCT02099318|901519|P2|COMPLETED|Overall Study||20
366967|NCT02099318|901520|P1|COMPLETED|Overall Study||20
366968|NCT02099318|901519|P2|STARTED|Overall Study||20
366969|NCT02099318|901520|P1|STARTED|Overall Study||20
366970|NCT02099266|901534|P1|NOT COMPLETED|Overall Study||0
366971|NCT02099266|901534|P1|COMPLETED|Overall Study||15
366972|NCT02099266|901534|P1|STARTED|Overall Study||15
366973|NCT02099110|901546|P5|NOT COMPLETED|Overall Study||27
366974|NCT02099110|901547|P4|NOT COMPLETED|Overall Study||22
366975|NCT02099110|901548|P3|NOT COMPLETED|Overall Study||28
366976|NCT02099110|901549|P2|NOT COMPLETED|Overall Study||31
366977|NCT02099110|901550|P1|NOT COMPLETED|Overall Study||24
366978|NCT02099110|901546|P5|COMPLETED|Overall Study||218
366979|NCT02099110|901547|P4|COMPLETED|Overall Study||221
366980|NCT02099110|901548|P3|COMPLETED|Overall Study||219
366981|NCT02099110|901549|P2|COMPLETED|Overall Study||217
366982|NCT02099110|901550|P1|COMPLETED|Overall Study||226
366983|NCT02099110|901546|P5|Treated|Overall Study||244
366984|NCT02099110|901547|P4|Treated|Overall Study||243
366985|NCT02099110|901548|P3|Treated|Overall Study||247
366986|NCT02099110|901549|P2|Treated|Overall Study||248
366987|NCT02099110|901550|P1|Treated|Overall Study||250
366988|NCT02099110|901546|P5|STARTED|Overall Study||245
366989|NCT02099110|901547|P4|STARTED|Overall Study||243
366990|NCT02099110|901548|P3|STARTED|Overall Study||247
366991|NCT02099110|901549|P2|STARTED|Overall Study||248
366992|NCT02099110|901550|P1|STARTED|Overall Study||250
366993|NCT02099084|901597|P2|NOT COMPLETED|Second Intervention||0
366994|NCT02099084|901598|P1|NOT COMPLETED|Second Intervention||0
366995|NCT02099084|901597|P2|COMPLETED|Second Intervention||4
366996|NCT02099084|901598|P1|COMPLETED|Second Intervention||4
366997|NCT02099084|901597|P2|STARTED|Second Intervention||4
366998|NCT02099084|901598|P1|STARTED|Second Intervention||4
366999|NCT02099084|901597|P2|NOT COMPLETED|Washout Period of 14 Days||0
367000|NCT02099084|901598|P1|NOT COMPLETED|Washout Period of 14 Days||0
367001|NCT02099084|901597|P2|COMPLETED|Washout Period of 14 Days||4
367002|NCT02099084|901598|P1|COMPLETED|Washout Period of 14 Days||4
367003|NCT02099084|901597|P2|STARTED|Washout Period of 14 Days||4
367004|NCT02099084|901598|P1|STARTED|Washout Period of 14 Days||4
367005|NCT02099084|901597|P2|NOT COMPLETED|First Intervention||0
367006|NCT02099084|901598|P1|NOT COMPLETED|First Intervention||0
367007|NCT02099084|901597|P2|COMPLETED|First Intervention||4
367008|NCT02099084|901598|P1|COMPLETED|First Intervention||4
367009|NCT02099084|901597|P2|STARTED|First Intervention||4
367010|NCT02099084|901598|P1|STARTED|First Intervention||4
367011|NCT02099006|901616|P1|NOT COMPLETED|Overall Study||1
367012|NCT02099006|901616|P1|COMPLETED|Overall Study||8
367013|NCT02099006|901616|P1|Received Gabapentin|Overall Study||8
367014|NCT02099006|901616|P1|Received Ketamine|Overall Study||6
367015|NCT02099006|901616|P1|Received Loperamide|Overall Study||7
367016|NCT02099006|901616|P1|Received Ketoprofen|Overall Study||3
367017|NCT02099006|901616|P1|Received Amitriptyline/ Baclofen|Overall Study||7
367018|NCT02099006|901616|P1|Received Placebo|Overall Study||9
367019|NCT02099006|901616|P1|STARTED|Overall Study||9
367020|NCT02098746|901624|P1|NOT COMPLETED|Overall Study||5
367021|NCT02098746|901624|P1|COMPLETED|Overall Study||289
367022|NCT02098746|901624|P1|STARTED|Overall Study||294
367023|NCT02098733|901632|P1|NOT COMPLETED|Overall Study||10
367024|NCT02098733|901632|P1|COMPLETED|Overall Study||1158
367025|NCT02098733|901632|P1|STARTED|Overall Study||1168
367026|NCT02098395|901646|P4|NOT COMPLETED|Overall Study||27
367027|NCT02098395|901647|P3|NOT COMPLETED|Overall Study||42
367028|NCT02098395|901648|P2|NOT COMPLETED|Overall Study||32
367029|NCT02098395|901649|P1|NOT COMPLETED|Overall Study||26
367030|NCT02098395|901646|P4|COMPLETED|Overall Study||180
367031|NCT02098395|901647|P3|COMPLETED|Overall Study||165
367032|NCT02098395|901648|P2|COMPLETED|Overall Study||177
367033|NCT02098395|901649|P1|COMPLETED|Overall Study||186
367034|NCT02098395|901646|P4|Exposed|Overall Study||206
367035|NCT02098395|901647|P3|Exposed|Overall Study||206
367036|NCT02098395|901648|P2|Exposed|Overall Study||209
367037|NCT02098395|901649|P1|Exposed|Overall Study||211
367038|NCT02098395|901646|P4|STARTED|Overall Study||207
367039|NCT02098395|901647|P3|STARTED|Overall Study||207
367040|NCT02098395|901648|P2|STARTED|Overall Study||209
367041|NCT02098395|901649|P1|STARTED|Overall Study||212
367042|NCT02098304|901667|P1|NOT COMPLETED|Overall Study||0
367043|NCT02098304|901667|P1|COMPLETED|Overall Study||42
367044|NCT02098304|901667|P1|STARTED|Overall Study||42
367045|NCT02098109|901676|P2|NOT COMPLETED|Overall Study||0
367046|NCT02098109|901677|P1|NOT COMPLETED|Overall Study||3
367047|NCT02098109|901676|P2|COMPLETED|Overall Study||51
367048|NCT02098109|901677|P1|COMPLETED|Overall Study||46
367049|NCT02098109|901676|P2|STARTED|Overall Study||51
367050|NCT02098109|901677|P1|STARTED|Overall Study||49
367051|NCT02097992|901703|P4|NOT COMPLETED|Treatment 3 (4 Weeks)||0
367052|NCT02097992|901704|P3|NOT COMPLETED|Treatment 3 (4 Weeks)||0
367053|NCT02097992|901705|P2|NOT COMPLETED|Treatment 3 (4 Weeks)||0
367054|NCT02097992|901706|P1|NOT COMPLETED|Treatment 3 (4 Weeks)||0
367055|NCT02097992|901703|P4|COMPLETED|Treatment 3 (4 Weeks)||2
367056|NCT02097992|901704|P3|COMPLETED|Treatment 3 (4 Weeks)||4
367057|NCT02097992|901705|P2|COMPLETED|Treatment 3 (4 Weeks)||3
367058|NCT02097992|901706|P1|COMPLETED|Treatment 3 (4 Weeks)||2
367059|NCT02097992|901703|P4|STARTED|Treatment 3 (4 Weeks)||2
367060|NCT02097992|901704|P3|STARTED|Treatment 3 (4 Weeks)||4
367061|NCT02097992|901705|P2|STARTED|Treatment 3 (4 Weeks)||3
367062|NCT02097992|901706|P1|STARTED|Treatment 3 (4 Weeks)||2
367063|NCT02097992|901703|P4|NOT COMPLETED|Washout (4 Weeks)||0
367064|NCT02097992|901704|P3|NOT COMPLETED|Washout (4 Weeks)||0
367065|NCT02097992|901705|P2|NOT COMPLETED|Washout (4 Weeks)||0
367066|NCT02097992|901706|P1|NOT COMPLETED|Washout (4 Weeks)||0
367067|NCT02097992|901703|P4|COMPLETED|Washout (4 Weeks)||2
367068|NCT02097992|901704|P3|COMPLETED|Washout (4 Weeks)||4
367069|NCT02097992|901705|P2|COMPLETED|Washout (4 Weeks)||3
367070|NCT02097992|901706|P1|COMPLETED|Washout (4 Weeks)||2
367071|NCT02097992|901703|P4|STARTED|Washout (4 Weeks)||2
367072|NCT02097992|901704|P3|STARTED|Washout (4 Weeks)||4
367073|NCT02097992|901705|P2|STARTED|Washout (4 Weeks)||3
367074|NCT02097992|901706|P1|STARTED|Washout (4 Weeks)||2
367075|NCT02097992|901703|P4|NOT COMPLETED|Treatment 2 (4 Weeks)||0
367076|NCT02097992|901704|P3|NOT COMPLETED|Treatment 2 (4 Weeks)||0
367077|NCT02097992|901705|P2|NOT COMPLETED|Treatment 2 (4 Weeks)||0
367078|NCT02097992|901706|P1|NOT COMPLETED|Treatment 2 (4 Weeks)||0
367079|NCT02097992|901703|P4|COMPLETED|Treatment 2 (4 Weeks)||2
367080|NCT02097992|901704|P3|COMPLETED|Treatment 2 (4 Weeks)||4
367081|NCT02097992|901705|P2|COMPLETED|Treatment 2 (4 Weeks)||3
367082|NCT02097992|901706|P1|COMPLETED|Treatment 2 (4 Weeks)||2
367083|NCT02097992|901703|P4|STARTED|Treatment 2 (4 Weeks)||2
367084|NCT02097992|901704|P3|STARTED|Treatment 2 (4 Weeks)||4
367085|NCT02097992|901705|P2|STARTED|Treatment 2 (4 Weeks)||3
367086|NCT02097992|901706|P1|STARTED|Treatment 2 (4 Weeks)||2
367087|NCT02097992|901703|P4|NOT COMPLETED|Treatment 1 (1 Day)||0
367088|NCT02097992|901704|P3|NOT COMPLETED|Treatment 1 (1 Day)||0
367089|NCT02097992|901705|P2|NOT COMPLETED|Treatment 1 (1 Day)||0
367090|NCT02097992|901706|P1|NOT COMPLETED|Treatment 1 (1 Day)||0
367091|NCT02097992|901703|P4|COMPLETED|Treatment 1 (1 Day)||2
367092|NCT02097992|901704|P3|COMPLETED|Treatment 1 (1 Day)||4
367093|NCT02097992|901705|P2|COMPLETED|Treatment 1 (1 Day)||3
367094|NCT02097992|901706|P1|COMPLETED|Treatment 1 (1 Day)||2
367095|NCT02097992|901703|P4|STARTED|Treatment 1 (1 Day)||2
367096|NCT02097992|901704|P3|STARTED|Treatment 1 (1 Day)||4
367097|NCT02097992|901705|P2|STARTED|Treatment 1 (1 Day)||3
367098|NCT02097992|901706|P1|STARTED|Treatment 1 (1 Day)||2
367099|NCT02097849|901716|P2|NOT COMPLETED|Overall Study||0
367100|NCT02097849|901717|P1|NOT COMPLETED|Overall Study||0
367101|NCT02097849|901716|P2|COMPLETED|Overall Study||38
367102|NCT02097849|901717|P1|COMPLETED|Overall Study||33
367103|NCT02097849|901716|P2|STARTED|Overall Study||38
367104|NCT02097849|901717|P1|STARTED|Overall Study||33
367105|NCT02097823|901755|P2|NOT COMPLETED|Overall Study||1
367106|NCT02097823|901756|P1|NOT COMPLETED|Overall Study||1
367107|NCT02097823|901755|P2|COMPLETED|Overall Study||3
367108|NCT02097823|901756|P1|COMPLETED|Overall Study||10
367109|NCT02097823|901755|P2|STARTED|Overall Study||4
367110|NCT02097823|901756|P1|STARTED|Overall Study||11
367111|NCT02097745|901771|P1|NOT COMPLETED|Overall Study||178
367112|NCT02097745|901771|P1|COMPLETED|Overall Study||157
367113|NCT02097745|901771|P1|STARTED|Overall Study|Six participants did not receive any treatment and were not included in any analyses.|335
367114|NCT02097732|901795|P2|NOT COMPLETED|Overall Study||0
367115|NCT02097732|901796|P1|NOT COMPLETED|Overall Study||0
367116|NCT02097732|901795|P2|COMPLETED|Overall Study||3
367117|NCT02097732|901796|P1|COMPLETED|Overall Study||1
367118|NCT02097732|901795|P2|STARTED|Overall Study||3
367119|NCT02097732|901796|P1|STARTED|Overall Study||1
367120|NCT02097719|901807|P2|NOT COMPLETED|Overall Study||1
367121|NCT02097719|901808|P1|NOT COMPLETED|Overall Study||3
367122|NCT02097719|901807|P2|COMPLETED|Overall Study||50
367123|NCT02097719|901808|P1|COMPLETED|Overall Study||46
367124|NCT02097719|901807|P2|STARTED|Overall Study||51
367125|NCT02097719|901808|P1|STARTED|Overall Study||49
367126|NCT02097537|901814|P1|NOT COMPLETED|Overall Study||0
367127|NCT02097537|901814|P1|COMPLETED|Overall Study||10
367128|NCT02097537|901814|P1|Follow-Up|Overall Study||10
367129|NCT02097537|901814|P1|Enrollment|Overall Study|Inhalation of Methacholine Chloride|10
367130|NCT02097537|901814|P1|STARTED|Overall Study||10
367131|NCT02097472|901828|P8|NOT COMPLETED|Assessed for Immunogenicity||1
367132|NCT02097472|901829|P7|NOT COMPLETED|Assessed for Immunogenicity||2
367133|NCT02097472|901830|P6|NOT COMPLETED|Assessed for Immunogenicity||2
367134|NCT02097472|901831|P5|NOT COMPLETED|Assessed for Immunogenicity||0
367135|NCT02097472|901832|P4|NOT COMPLETED|Assessed for Immunogenicity||2
367136|NCT02097472|901833|P3|NOT COMPLETED|Assessed for Immunogenicity||1
367137|NCT02097472|901834|P2|NOT COMPLETED|Assessed for Immunogenicity||0
367138|NCT02097472|901835|P1|NOT COMPLETED|Assessed for Immunogenicity||0
367139|NCT02097472|901828|P8|COMPLETED|Assessed for Immunogenicity||49
367140|NCT02097472|901829|P7|COMPLETED|Assessed for Immunogenicity||47
367141|NCT02097472|901830|P6|COMPLETED|Assessed for Immunogenicity||48
367142|NCT02097472|901831|P5|COMPLETED|Assessed for Immunogenicity||50
367143|NCT02097472|901832|P4|COMPLETED|Assessed for Immunogenicity||48
367144|NCT02097472|901833|P3|COMPLETED|Assessed for Immunogenicity||17
367145|NCT02097472|901834|P2|COMPLETED|Assessed for Immunogenicity||18
367146|NCT02097472|901835|P1|COMPLETED|Assessed for Immunogenicity||18
367147|NCT02097472|901828|P8|STARTED|Assessed for Immunogenicity||50
367148|NCT02097472|901829|P7|STARTED|Assessed for Immunogenicity||49
367149|NCT02097472|901830|P6|STARTED|Assessed for Immunogenicity||50
367150|NCT02097472|901831|P5|STARTED|Assessed for Immunogenicity||50
367151|NCT02097472|901832|P4|STARTED|Assessed for Immunogenicity||50
367152|NCT02097472|901833|P3|STARTED|Assessed for Immunogenicity||18
367153|NCT02097472|901834|P2|STARTED|Assessed for Immunogenicity||18
367154|NCT02097472|901835|P1|STARTED|Assessed for Immunogenicity||18
367155|NCT02097472|901828|P8|NOT COMPLETED|Received Vaccination 2||0
367156|NCT02097472|901829|P7|NOT COMPLETED|Received Vaccination 2||1
367157|NCT02097472|901830|P6|NOT COMPLETED|Received Vaccination 2||0
367158|NCT02097472|901831|P5|NOT COMPLETED|Received Vaccination 2||0
367159|NCT02097472|901832|P4|NOT COMPLETED|Received Vaccination 2||0
367160|NCT02097472|901833|P3|NOT COMPLETED|Received Vaccination 2||0
367161|NCT02097472|901834|P2|NOT COMPLETED|Received Vaccination 2||0
367162|NCT02097472|901835|P1|NOT COMPLETED|Received Vaccination 2||0
367163|NCT02097472|901828|P8|COMPLETED|Received Vaccination 2||50
367164|NCT02097472|901829|P7|COMPLETED|Received Vaccination 2||49
367165|NCT02097472|901830|P6|COMPLETED|Received Vaccination 2||50
367166|NCT02097472|901831|P5|COMPLETED|Received Vaccination 2||50
367167|NCT02097472|901832|P4|COMPLETED|Received Vaccination 2||50
367168|NCT02097472|901833|P3|COMPLETED|Received Vaccination 2||18
367169|NCT02097472|901834|P2|COMPLETED|Received Vaccination 2||18
367170|NCT02097472|901835|P1|COMPLETED|Received Vaccination 2||18
367171|NCT02097472|901828|P8|STARTED|Received Vaccination 2||50
367172|NCT02097472|901829|P7|STARTED|Received Vaccination 2||50
367173|NCT02097472|901830|P6|STARTED|Received Vaccination 2||50
367174|NCT02097472|901831|P5|STARTED|Received Vaccination 2||50
367175|NCT02097472|901832|P4|STARTED|Received Vaccination 2||50
367176|NCT02097472|901833|P3|STARTED|Received Vaccination 2||18
367177|NCT02097472|901834|P2|STARTED|Received Vaccination 2||18
367178|NCT02097472|901835|P1|STARTED|Received Vaccination 2||18
367179|NCT02097472|901828|P8|NOT COMPLETED|Received Vaccination 1||0
367180|NCT02097472|901829|P7|NOT COMPLETED|Received Vaccination 1||0
367181|NCT02097472|901830|P6|NOT COMPLETED|Received Vaccination 1||0
367182|NCT02097472|901831|P5|NOT COMPLETED|Received Vaccination 1||0
367183|NCT02097472|901832|P4|NOT COMPLETED|Received Vaccination 1||0
367184|NCT02097472|901833|P3|NOT COMPLETED|Received Vaccination 1||0
367185|NCT02097472|901834|P2|NOT COMPLETED|Received Vaccination 1||0
367186|NCT02097472|901835|P1|NOT COMPLETED|Received Vaccination 1||0
367187|NCT02097472|901828|P8|COMPLETED|Received Vaccination 1||50
367188|NCT02097472|901829|P7|COMPLETED|Received Vaccination 1||50
367189|NCT02097472|901830|P6|COMPLETED|Received Vaccination 1||50
367190|NCT02097472|901831|P5|COMPLETED|Received Vaccination 1||50
367191|NCT02097472|901832|P4|COMPLETED|Received Vaccination 1||50
367192|NCT02097472|901833|P3|COMPLETED|Received Vaccination 1||18
367193|NCT02097472|901834|P2|COMPLETED|Received Vaccination 1||18
367194|NCT02097472|901835|P1|COMPLETED|Received Vaccination 1||18
367195|NCT02097472|901828|P8|STARTED|Received Vaccination 1||50
367196|NCT02097472|901829|P7|STARTED|Received Vaccination 1||50
367197|NCT02097472|901830|P6|STARTED|Received Vaccination 1||50
367198|NCT02097472|901831|P5|STARTED|Received Vaccination 1||50
367199|NCT02097472|901832|P4|STARTED|Received Vaccination 1||50
367200|NCT02097472|901833|P3|STARTED|Received Vaccination 1||18
367201|NCT02097472|901834|P2|STARTED|Received Vaccination 1||18
367202|NCT02097472|901835|P1|STARTED|Received Vaccination 1||18
367203|NCT02097303|902256|P1|NOT COMPLETED|Overall Study||5
367204|NCT02097303|902256|P1|COMPLETED|Overall Study||31
367205|NCT02097303|902256|P1|STARTED|Overall Study||36
367206|NCT02097290|902266|P1|NOT COMPLETED|Overall Study||17
367207|NCT02097290|902266|P1|COMPLETED|Overall Study|Active subjects at the end of 3 month follow up visit for primary end point data collection|193
367208|NCT02097290|902266|P1|STARTED|Overall Study||210
367209|NCT02097238|902276|P1|NOT COMPLETED|Overall Study||19
367210|NCT02097238|902276|P1|COMPLETED|Overall Study||0
367211|NCT02097238|902276|P1|STARTED|Overall Study||19
367212|NCT02097134|902282|P1|NOT COMPLETED|Overall Study||9
367213|NCT02097134|902282|P1|COMPLETED|Overall Study||5
367214|NCT02097134|902282|P1|STARTED|Overall Study||14
367215|NCT02097108|902286|P1|NOT COMPLETED|Overall Study||2
367216|NCT02097108|902286|P1|COMPLETED|Overall Study||9
367217|NCT02097108|902286|P1|STARTED|Overall Study||11
367218|NCT02097056|902293|P1|NOT COMPLETED|Overall Study||58
367219|NCT02097056|902293|P1|COMPLETED|Overall Study||113
367220|NCT02097056|902293|P1|ParticipantsTreated|Overall Study||170
367221|NCT02097056|902293|P1|STARTED|Overall Study||171
367222|NCT02097030|902301|P2|NOT COMPLETED|Second Intervention (3 Days)||0
367223|NCT02097030|902302|P1|NOT COMPLETED|Second Intervention (3 Days)||0
367224|NCT02097030|902301|P2|COMPLETED|Second Intervention (3 Days)||16
367225|NCT02097030|902302|P1|COMPLETED|Second Intervention (3 Days)||14
367226|NCT02097030|902301|P2|STARTED|Second Intervention (3 Days)||16
367227|NCT02097030|902302|P1|STARTED|Second Intervention (3 Days)||14
367228|NCT02097030|902301|P2|NOT COMPLETED|First Intervention (3 Days)||1
367229|NCT02097030|902302|P1|NOT COMPLETED|First Intervention (3 Days)||1
367230|NCT02097030|902301|P2|COMPLETED|First Intervention (3 Days)||16
367231|NCT02097030|902302|P1|COMPLETED|First Intervention (3 Days)||14
367232|NCT02097030|902301|P2|STARTED|First Intervention (3 Days)||17
367233|NCT02097030|902302|P1|STARTED|First Intervention (3 Days)||15
367234|NCT02096952|902363|P1|NOT COMPLETED|Overall Study||1
367235|NCT02096952|902363|P1|COMPLETED|Overall Study||14
367236|NCT02096952|902363|P1|STARTED|Overall Study||15
367237|NCT02096900|902369|P2|NOT COMPLETED|Overall Study||2
367238|NCT02096900|902370|P1|NOT COMPLETED|Overall Study||4
367239|NCT02096900|902369|P2|COMPLETED|Overall Study||42
367240|NCT02096900|902370|P1|COMPLETED|Overall Study||38
367241|NCT02096900|902369|P2|STARTED|Overall Study|Allocated to Zolpidem|44
367242|NCT02096900|902370|P1|STARTED|Overall Study|Allocated to Midazolam|42
367243|NCT02096861|902388|P4|NOT COMPLETED|Overall Study||10
367244|NCT02096861|902389|P3|NOT COMPLETED|Overall Study||17
367245|NCT02096861|902390|P2|NOT COMPLETED|Overall Study||15
367246|NCT02096861|902391|P1|NOT COMPLETED|Overall Study||12
367247|NCT02096861|902388|P4|COMPLETED|Overall Study||45
367248|NCT02096861|902389|P3|COMPLETED|Overall Study||37
367249|NCT02096861|902390|P2|COMPLETED|Overall Study||40
367250|NCT02096861|902391|P1|COMPLETED|Overall Study||44
367251|NCT02096861|902388|P4|Drug Switching at Week 30|Overall Study||47
367252|NCT02096861|902389|P3|Drug Switching at Week 30|Overall Study||41
367253|NCT02096861|902390|P2|Drug Switching at Week 30|Overall Study||44
367254|NCT02096861|902391|P1|Drug Switching at Week 30|Overall Study||48
367255|NCT02096861|902388|P4|STARTED|Overall Study|Remicade followed by CT-P13 from Week 30|55
367256|NCT02096861|902389|P3|STARTED|Overall Study|Remicade followed by Remicade from Week 30|54
367257|NCT02096861|902390|P2|STARTED|Overall Study|CT-P13 followed by Remicade from Week 30|55
367258|NCT02096861|902391|P1|STARTED|Overall Study|CT-P13 followed by CT-P13 from Week 30|56
367259|NCT02096835|902422|P3|NOT COMPLETED|Overall Study||1
367260|NCT02096835|902423|P2|NOT COMPLETED|Overall Study||0
367261|NCT02096835|902424|P1|NOT COMPLETED|Overall Study||3
367262|NCT02096835|902422|P3|COMPLETED|Overall Study||50
367263|NCT02096835|902423|P2|COMPLETED|Overall Study||53
367264|NCT02096835|902424|P1|COMPLETED|Overall Study||50
367265|NCT02096835|902422|P3|STARTED|Overall Study||51
367266|NCT02096835|902423|P2|STARTED|Overall Study||53
367267|NCT02096835|902424|P1|STARTED|Overall Study||53
367268|NCT02096744|902441|P2|NOT COMPLETED|Treatment Period 3 (7 Days)||1
367269|NCT02096744|902442|P1|NOT COMPLETED|Treatment Period 3 (7 Days)||0
367270|NCT02096744|902441|P2|COMPLETED|Treatment Period 3 (7 Days)||27
367271|NCT02096744|902442|P1|COMPLETED|Treatment Period 3 (7 Days)||28
367272|NCT02096744|902441|P2|STARTED|Treatment Period 3 (7 Days)||28
367273|NCT02096744|902442|P1|STARTED|Treatment Period 3 (7 Days)||28
367274|NCT02096744|902441|P2|NOT COMPLETED|Washout Period 2 (3 Days)||0
367275|NCT02096744|902442|P1|NOT COMPLETED|Washout Period 2 (3 Days)||0
367276|NCT02096744|902441|P2|COMPLETED|Washout Period 2 (3 Days)||28
367277|NCT02096744|902442|P1|COMPLETED|Washout Period 2 (3 Days)||28
367278|NCT02096744|902441|P2|STARTED|Washout Period 2 (3 Days)||28
367279|NCT02096744|902442|P1|STARTED|Washout Period 2 (3 Days)||28
367280|NCT02096744|902441|P2|NOT COMPLETED|Treatment Period 2 (7 Days)||0
367281|NCT02096744|902442|P1|NOT COMPLETED|Treatment Period 2 (7 Days)||0
367282|NCT02096744|902441|P2|COMPLETED|Treatment Period 2 (7 Days)||28
367283|NCT02096744|902442|P1|COMPLETED|Treatment Period 2 (7 Days)||28
367284|NCT02096744|902441|P2|STARTED|Treatment Period 2 (7 Days)||28
367285|NCT02096744|902442|P1|STARTED|Treatment Period 2 (7 Days)||28
367286|NCT02096744|902441|P2|NOT COMPLETED|Washout Period 1(7 Days)||0
367287|NCT02096744|902442|P1|NOT COMPLETED|Washout Period 1(7 Days)||0
367288|NCT02096744|902441|P2|COMPLETED|Washout Period 1(7 Days)||28
367289|NCT02096744|902442|P1|COMPLETED|Washout Period 1(7 Days)||28
367290|NCT02096744|902441|P2|STARTED|Washout Period 1(7 Days)||28
367291|NCT02096744|902442|P1|STARTED|Washout Period 1(7 Days)||28
367292|NCT02096744|902441|P2|NOT COMPLETED|Treatment Period 1(7 Days)||1
367293|NCT02096744|902442|P1|NOT COMPLETED|Treatment Period 1(7 Days)||1
367294|NCT02096744|902441|P2|COMPLETED|Treatment Period 1(7 Days)||28
367295|NCT02096744|902442|P1|COMPLETED|Treatment Period 1(7 Days)||28
367296|NCT02096744|902441|P2|STARTED|Treatment Period 1(7 Days)||29
367297|NCT02096744|902442|P1|STARTED|Treatment Period 1(7 Days)||29
367298|NCT02096731|902457|P2|NOT COMPLETED|Overall Study||0
367299|NCT02096731|902458|P1|NOT COMPLETED|Overall Study||0
367300|NCT02096731|902457|P2|COMPLETED|Overall Study||88955
367301|NCT02096731|902458|P1|COMPLETED|Overall Study||26442
367302|NCT02096731|902457|P2|STARTED|Overall Study||88955
367303|NCT02096731|902458|P1|STARTED|Overall Study||26442
367304|NCT02096718|902475|P3|NOT COMPLETED|Overall Study||0
367305|NCT02096718|902476|P2|NOT COMPLETED|Overall Study||0
367306|NCT02096718|902477|P1|NOT COMPLETED|Overall Study||0
367307|NCT02096718|902475|P3|COMPLETED|Overall Study||14
367308|NCT02096718|902476|P2|COMPLETED|Overall Study||8
367309|NCT02096718|902477|P1|COMPLETED|Overall Study||8
367310|NCT02096718|902475|P3|STARTED|Overall Study||14
367311|NCT02096718|902476|P2|STARTED|Overall Study||8
367312|NCT02096718|902477|P1|STARTED|Overall Study||8
367313|NCT02096705|902496|P2|NOT COMPLETED|Follow-up||4
367314|NCT02096705|902497|P1|NOT COMPLETED|Follow-up||4
367315|NCT02096705|902496|P2|COMPLETED|Follow-up||135
367316|NCT02096705|902497|P1|COMPLETED|Follow-up||125
367317|NCT02096705|902496|P2|STARTED|Follow-up|5 participants in this arm did not complete the treatment period and rejoined for follow-up|139
367318|NCT02096705|902497|P1|STARTED|Follow-up|5 participants in this arm did not complete the treatment period and rejoined for follow-up|129
367319|NCT02096705|902496|P2|NOT COMPLETED|Treatment||5
367320|NCT02096705|902497|P1|NOT COMPLETED|Treatment||9
367321|NCT02096705|902496|P2|COMPLETED|Treatment||134
367322|NCT02096705|902497|P1|COMPLETED|Treatment||124
367323|NCT02096705|902496|P2|STARTED|Treatment||139
367324|NCT02096705|902497|P1|STARTED|Treatment||133
367325|NCT02096692|902509|P1|NOT COMPLETED|Overall Study||4
367326|NCT02096692|902509|P1|COMPLETED|Overall Study||150
367327|NCT02096692|902509|P1|STARTED|Overall Study||154
367328|NCT02096679|902515|P1|NOT COMPLETED|Overall Study||0
367329|NCT02096679|902515|P1|COMPLETED|Overall Study||8
367330|NCT02096679|902515|P1|STARTED|Overall Study||8
367331|NCT02096575|902540|P3|NOT COMPLETED|Overall Study||5
367332|NCT02096575|902541|P2|NOT COMPLETED|Overall Study||0
367333|NCT02096575|902542|P1|NOT COMPLETED|Overall Study||0
367334|NCT02096575|902540|P3|COMPLETED|Overall Study||0
367335|NCT02096575|902541|P2|COMPLETED|Overall Study||67
367336|NCT02096575|902542|P1|COMPLETED|Overall Study||68
367337|NCT02096575|902540|P3|STARTED|Overall Study||5
367338|NCT02096575|902541|P2|STARTED|Overall Study||67
367339|NCT02096575|902542|P1|STARTED|Overall Study||68
367340|NCT02096458|902556|P1|NOT COMPLETED|Overall Study||0
367341|NCT02096458|902556|P1|COMPLETED|Overall Study||8
367342|NCT02096458|902556|P1|STARTED|Overall Study||8
367343|NCT02096081|902562|P2|NOT COMPLETED|Overall Study||4
367344|NCT02096081|902563|P1|NOT COMPLETED|Overall Study||3
367345|NCT02096081|902562|P2|COMPLETED|Overall Study||124
367346|NCT02096081|902563|P1|COMPLETED|Overall Study||119
367347|NCT02096081|902562|P2|STARTED|Overall Study||128
367348|NCT02096081|902563|P1|STARTED|Overall Study||122
367349|NCT02096042|902595|P3|NOT COMPLETED|Overall Study||0
367350|NCT02096042|902596|P2|NOT COMPLETED|Overall Study||0
367351|NCT02096042|902597|P1|NOT COMPLETED|Overall Study||1
367352|NCT02096042|902595|P3|COMPLETED|Overall Study||0
367353|NCT02096042|902596|P2|COMPLETED|Overall Study||0
367354|NCT02096042|902597|P1|COMPLETED|Overall Study||0
367355|NCT02096042|902595|P3|STARTED|Overall Study||0
367356|NCT02096042|902596|P2|STARTED|Overall Study||0
367357|NCT02096042|902597|P1|STARTED|Overall Study||1
367358|NCT02095873|902606|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
367359|NCT02095873|902607|P1|NOT COMPLETED|Second Intervention (8 Weeks)||2
367360|NCT02095873|902606|P2|COMPLETED|Second Intervention (8 Weeks)||16
367361|NCT02095873|902607|P1|COMPLETED|Second Intervention (8 Weeks)||13
367362|NCT02095873|902606|P2|STARTED|Second Intervention (8 Weeks)||16
367363|NCT02095873|902607|P1|STARTED|Second Intervention (8 Weeks)||15
367364|NCT02095873|902606|P2|NOT COMPLETED|First Intervention (8 Weeks)||0
367365|NCT02095873|902607|P1|NOT COMPLETED|First Intervention (8 Weeks)||1
367366|NCT02095873|902606|P2|COMPLETED|First Intervention (8 Weeks)||16
367367|NCT02095873|902607|P1|COMPLETED|First Intervention (8 Weeks)||15
367368|NCT02095873|902606|P2|STARTED|First Intervention (8 Weeks)||16
367369|NCT02095873|902607|P1|STARTED|First Intervention (8 Weeks)||16
367370|NCT02095691|902619|P1|NOT COMPLETED|Overall Study||1
367371|NCT02095691|902619|P1|COMPLETED|Overall Study|Subjects with follow up available at 12 months.|18
367372|NCT02095691|902619|P1|STARTED|Overall Study|Subjects who were consented and treated with study ablation catheter.|19
367373|NCT02095561|902638|P2|NOT COMPLETED|Overall Study||0
367374|NCT02095561|902639|P1|NOT COMPLETED|Overall Study||0
367375|NCT02095561|902638|P2|COMPLETED|Overall Study|All women are part of the study, independently of whether they were tested or not.|2964
367376|NCT02095561|902639|P1|COMPLETED|Overall Study|All women are part of the study, independently of whether they were tested or not.|3049
367377|NCT02095561|902638|P2|HPV Tested at Health Centers|Overall Study||599
367378|NCT02095561|902639|P1|HPV Tested at Health Centers|Overall Study||99
367379|NCT02095561|902638|P2|HPV Self-tested Women|Overall Study|HPV self-testing only applies to the HPV self-testing arm|0
367380|NCT02095561|902639|P1|HPV Self-tested Women|Overall Study||2519
367381|NCT02095561|902638|P2|Self-testing Acceptability|Overall Study|Acceptablity only applies to the group of women being offered self-testing.|0
367382|NCT02095561|902639|P1|Self-testing Acceptability|Overall Study||2616
367383|NCT02095561|902638|P2|STARTED|Overall Study||2964
367384|NCT02095561|902639|P1|STARTED|Overall Study||3049
367385|NCT02095535|902651|P1|NOT COMPLETED|Analysis||0
367386|NCT02095535|902651|P1|COMPLETED|Analysis||18
367387|NCT02095535|902651|P1|STARTED|Analysis||18
367388|NCT02095535|902651|P1|NOT COMPLETED|Recruitment||2
367389|NCT02095535|902651|P1|COMPLETED|Recruitment||18
367390|NCT02095535|902651|P1|STARTED|Recruitment||20
367391|NCT02095223|902657|P2|NOT COMPLETED|Overall Study||0
367392|NCT02095223|902658|P1|NOT COMPLETED|Overall Study||1
367393|NCT02095223|902657|P2|COMPLETED|Overall Study||2
367394|NCT02095223|902658|P1|COMPLETED|Overall Study|1 participant dropped out of this study due to the time commitment associated with participation.|1
367395|NCT02095223|902657|P2|STARTED|Overall Study||2
367396|NCT02095223|902658|P1|STARTED|Overall Study||2
367397|NCT02095197|902668|P2|NOT COMPLETED|Overall Study||3
367398|NCT02095197|902669|P1|NOT COMPLETED|Overall Study||0
367399|NCT02095197|902668|P2|COMPLETED|Overall Study||36
367400|NCT02095197|902669|P1|COMPLETED|Overall Study||40
367401|NCT02095197|902668|P2|STARTED|Overall Study||39
367402|NCT02095197|902669|P1|STARTED|Overall Study||40
367403|NCT02095158|902681|P1|NOT COMPLETED|Overall Study||75
367404|NCT02095158|902681|P1|COMPLETED|Overall Study||365
367405|NCT02095158|902681|P1|STARTED|Overall Study||440
367406|NCT02095106|902688|P2|NOT COMPLETED|Second Intervention (14 Days)||1
367407|NCT02095106|902689|P1|NOT COMPLETED|Second Intervention (14 Days)||0
367408|NCT02095106|902688|P2|COMPLETED|Second Intervention (14 Days)||12
367409|NCT02095106|902689|P1|COMPLETED|Second Intervention (14 Days)||14
367410|NCT02095106|902688|P2|STARTED|Second Intervention (14 Days)||13
367411|NCT02095106|902689|P1|STARTED|Second Intervention (14 Days)||14
367412|NCT02095106|902688|P2|NOT COMPLETED|First Intervention (14 Days)||0
367413|NCT02095106|902689|P1|NOT COMPLETED|First Intervention (14 Days)||0
367414|NCT02095106|902688|P2|COMPLETED|First Intervention (14 Days)||13
367415|NCT02095106|902689|P1|COMPLETED|First Intervention (14 Days)||14
367416|NCT02095106|902688|P2|STARTED|First Intervention (14 Days)||13
367417|NCT02095106|902689|P1|STARTED|First Intervention (14 Days)||14
367418|NCT02094937|902705|P4|NOT COMPLETED|12 Weeks in Period 2||12
367419|NCT02094937|902706|P3|NOT COMPLETED|12 Weeks in Period 2||12
367420|NCT02094937|902707|P2|NOT COMPLETED|12 Weeks in Period 2||11
367421|NCT02094937|902708|P1|NOT COMPLETED|12 Weeks in Period 2||0
367422|NCT02094937|902705|P4|COMPLETED|12 Weeks in Period 2||112
367423|NCT02094937|902706|P3|COMPLETED|12 Weeks in Period 2||112
367424|NCT02094937|902707|P2|COMPLETED|12 Weeks in Period 2||112
367425|NCT02094937|902708|P1|COMPLETED|12 Weeks in Period 2||0
367426|NCT02094937|902705|P4|STARTED|12 Weeks in Period 2||124
367427|NCT02094937|902706|P3|STARTED|12 Weeks in Period 2||124
367428|NCT02094937|902707|P2|STARTED|12 Weeks in Period 2||123
367429|NCT02094937|902708|P1|STARTED|12 Weeks in Period 2||0
367430|NCT02094937|902705|P4|NOT COMPLETED|8 Weeks in Period 1||0
367431|NCT02094937|902706|P3|NOT COMPLETED|8 Weeks in Period 1||0
367432|NCT02094937|902707|P2|NOT COMPLETED|8 Weeks in Period 1||0
367433|NCT02094937|902708|P1|NOT COMPLETED|8 Weeks in Period 1||60
367434|NCT02094937|902705|P4|COMPLETED|8 Weeks in Period 1||0
367435|NCT02094937|902706|P3|COMPLETED|8 Weeks in Period 1||0
367436|NCT02094937|902707|P2|COMPLETED|8 Weeks in Period 1||0
367437|NCT02094937|902708|P1|COMPLETED|8 Weeks in Period 1||370
367438|NCT02094937|902705|P4|STARTED|8 Weeks in Period 1||0
367439|NCT02094937|902706|P3|STARTED|8 Weeks in Period 1||0
367440|NCT02094937|902707|P2|STARTED|8 Weeks in Period 1||0
367441|NCT02094937|902708|P1|STARTED|8 Weeks in Period 1||430
367442|NCT02094898|902738|P1|NOT COMPLETED|Overall Study||5
367443|NCT02094898|902738|P1|COMPLETED|Overall Study||7
367444|NCT02094898|902738|P1|STARTED|Overall Study||12
367445|NCT02094885|902785|P2|NOT COMPLETED|Overall Study||5
367446|NCT02094885|902786|P1|NOT COMPLETED|Overall Study||2
367447|NCT02094885|902785|P2|COMPLETED|Overall Study||122
367448|NCT02094885|902786|P1|COMPLETED|Overall Study||123
367449|NCT02094885|902785|P2|STARTED|Overall Study||127
367450|NCT02094885|902786|P1|STARTED|Overall Study||125
367451|NCT02094677|902800|P2|NOT COMPLETED|Overall Study||1
367452|NCT02094677|902801|P1|NOT COMPLETED|Overall Study||3
367453|NCT02094677|902800|P2|COMPLETED|Overall Study||30
367454|NCT02094677|902801|P1|COMPLETED|Overall Study||40
367455|NCT02094677|902800|P2|STARTED|Overall Study||31
367456|NCT02094677|902801|P1|STARTED|Overall Study||43
367457|NCT02094664|902865|P2|NOT COMPLETED|Overall Study||0
367458|NCT02094664|902866|P1|NOT COMPLETED|Overall Study||0
367459|NCT02094664|902865|P2|COMPLETED|Overall Study||16
367460|NCT02094664|902866|P1|COMPLETED|Overall Study||16
367461|NCT02094664|902865|P2|STARTED|Overall Study||16
367462|NCT02094664|902866|P1|STARTED|Overall Study||16
367463|NCT02094612|902880|P2|NOT COMPLETED|Overall Study||70
367464|NCT02094612|902881|P1|NOT COMPLETED|Overall Study||79
367465|NCT02094612|902880|P2|COMPLETED|Overall Study||25
367466|NCT02094612|902881|P1|COMPLETED|Overall Study||33
367467|NCT02094612|902880|P2|6 Month Follow up|Overall Study||25
367468|NCT02094612|902881|P1|6 Month Follow up|Overall Study||33
367469|NCT02094612|902880|P2|3 Month Follow up|Overall Study||43
367470|NCT02094612|902881|P1|3 Month Follow up|Overall Study||50
367471|NCT02094612|902880|P2|1 Month Follow up|Overall Study||50
367472|NCT02094612|902881|P1|1 Month Follow up|Overall Study||67
367473|NCT02094612|902880|P2|STARTED|Overall Study||95
367474|NCT02094612|902881|P1|STARTED|Overall Study||112
367475|NCT02094573|902901|P2|NOT COMPLETED|Overall Study||110
367476|NCT02094573|902902|P1|NOT COMPLETED|Overall Study||112
367477|NCT02094573|902901|P2|COMPLETED|Overall Study||0
367478|NCT02094573|902902|P1|COMPLETED|Overall Study||0
367479|NCT02094573|902901|P2|Treated|Overall Study||110
367480|NCT02094573|902902|P1|Treated|Overall Study||109
367481|NCT02094573|902901|P2|STARTED|Overall Study||110
367482|NCT02094573|902902|P1|STARTED|Overall Study||112
367483|NCT02094534|902936|P2|NOT COMPLETED|Overall Study||0
367484|NCT02094534|902937|P1|NOT COMPLETED|Overall Study||0
367485|NCT02094534|902936|P2|COMPLETED|Overall Study||10
367486|NCT02094534|902937|P1|COMPLETED|Overall Study||15
367487|NCT02094534|902936|P2|STARTED|Overall Study||10
367488|NCT02094534|902937|P1|STARTED|Overall Study||15
367489|NCT02094443|902947|P2|NOT COMPLETED|Overall Study||17
367490|NCT02094443|902948|P1|NOT COMPLETED|Overall Study||15
367491|NCT02094443|902947|P2|COMPLETED|Overall Study||9
367492|NCT02094443|902948|P1|COMPLETED|Overall Study||11
367493|NCT02094443|902947|P2|Completed at Week 24|Overall Study||8
367494|NCT02094443|902948|P1|Completed at Week 24|Overall Study||11
367495|NCT02094443|902947|P2|Completed at Week 12|Overall Study||1
367496|NCT02094443|902948|P1|Completed at Week 12|Overall Study||0
367497|NCT02094443|902947|P2|STARTED|Overall Study||26
367498|NCT02094443|902948|P1|STARTED|Overall Study||26
367499|NCT02094352|902968|P2|NOT COMPLETED|Overall Study||0
367500|NCT02094352|902969|P1|NOT COMPLETED|Overall Study||0
367501|NCT02094352|902968|P2|COMPLETED|Overall Study||1
367502|NCT02094352|902969|P1|COMPLETED|Overall Study||2
367503|NCT02094352|902968|P2|STARTED|Overall Study||1
367504|NCT02094352|902969|P1|STARTED|Overall Study||2
367505|NCT02094326|902975|P1|NOT COMPLETED|Overall Study||0
367506|NCT02094326|902975|P1|COMPLETED|Overall Study||301
367507|NCT02094326|902975|P1|STARTED|Overall Study||301
367508|NCT02094300|902984|P1|NOT COMPLETED|Overall Study||20
367509|NCT02094300|902984|P1|COMPLETED|Overall Study||6
367510|NCT02094300|902984|P1|30 Days|Overall Study||24
367511|NCT02094300|902984|P1|STARTED|Overall Study||26
367512|NCT02094261|902988|P1|NOT COMPLETED|Overall Study||210
367513|NCT02094261|902988|P1|COMPLETED|Overall Study||0
367514|NCT02094261|902988|P1|STARTED|Overall Study||210
367515|NCT02093962|902997|P2|NOT COMPLETED|Overall Study||131
367516|NCT02093962|902998|P1|NOT COMPLETED|Overall Study||134
367517|NCT02093962|902997|P2|COMPLETED|Overall Study||0
367518|NCT02093962|902998|P1|COMPLETED|Overall Study||0
367519|NCT02093962|902997|P2|Received Treatment|Overall Study||130
367520|NCT02093962|902998|P1|Received Treatment|Overall Study||130
367521|NCT02093962|902997|P2|STARTED|Overall Study||131
367522|NCT02093962|902998|P1|STARTED|Overall Study||134
367523|NCT02093949|903006|P2|NOT COMPLETED|Overall Study||0
367524|NCT02093949|903007|P1|NOT COMPLETED|Overall Study||0
367525|NCT02093949|903006|P2|COMPLETED|Overall Study||47
367526|NCT02093949|903007|P1|COMPLETED|Overall Study||105
367527|NCT02093949|903006|P2|STARTED|Overall Study||47
367528|NCT02093949|903007|P1|STARTED|Overall Study||105
367529|NCT02093923|903030|P5|NOT COMPLETED|Overall Study||0
367530|NCT02093923|903031|P4|NOT COMPLETED|Overall Study||2
367531|NCT02093923|903032|P3|NOT COMPLETED|Overall Study||0
367532|NCT02093923|903033|P2|NOT COMPLETED|Overall Study||0
367533|NCT02093923|903034|P1|NOT COMPLETED|Overall Study||0
367534|NCT02093923|903030|P5|COMPLETED|Overall Study||13
367535|NCT02093923|903031|P4|COMPLETED|Overall Study||10
367536|NCT02093923|903032|P3|COMPLETED|Overall Study||5
367537|NCT02093923|903033|P2|COMPLETED|Overall Study||4
367538|NCT02093923|903034|P1|COMPLETED|Overall Study||4
367539|NCT02093923|903030|P5|Treated - 2 Doses:|Overall Study||13
367540|NCT02093923|903031|P4|Treated - 2 Doses:|Overall Study||10
367541|NCT02093923|903032|P3|Treated - 2 Doses:|Overall Study||5
367542|NCT02093923|903033|P2|Treated - 2 Doses:|Overall Study||4
367543|NCT02093923|903034|P1|Treated - 2 Doses:|Overall Study||4
367544|NCT02093923|903030|P5|Treated - 1 Dose Only:|Overall Study||0
367545|NCT02093923|903031|P4|Treated - 1 Dose Only:|Overall Study||1
367546|NCT02093923|903032|P3|Treated - 1 Dose Only:|Overall Study||0
367547|NCT02093923|903033|P2|Treated - 1 Dose Only:|Overall Study||0
367548|NCT02093923|903034|P1|Treated - 1 Dose Only:|Overall Study||0
367549|NCT02093923|903030|P5|Total Treated|Overall Study||13
367550|NCT02093923|903031|P4|Total Treated|Overall Study||11
367551|NCT02093923|903032|P3|Total Treated|Overall Study||5
367552|NCT02093923|903033|P2|Total Treated|Overall Study||4
367553|NCT02093923|903034|P1|Total Treated|Overall Study||4
367554|NCT02093923|903030|P5|STARTED|Overall Study||13
367555|NCT02093923|903031|P4|STARTED|Overall Study||12
367556|NCT02093923|903032|P3|STARTED|Overall Study||5
367557|NCT02093923|903033|P2|STARTED|Overall Study||4
367558|NCT02093923|903034|P1|STARTED|Overall Study||4
367559|NCT02093897|903089|P1|NOT COMPLETED|Overall Study||19
367560|NCT02093897|903089|P1|COMPLETED|Overall Study||65
367561|NCT02093897|903089|P1|STARTED|Overall Study||84
367562|NCT02093819|903117|P8|NOT COMPLETED|Overall Study||0
367563|NCT02093819|903118|P7|NOT COMPLETED|Overall Study||0
367564|NCT02093819|903119|P6|NOT COMPLETED|Overall Study||0
367565|NCT02093819|903120|P5|NOT COMPLETED|Overall Study||0
367566|NCT02093819|903121|P4|NOT COMPLETED|Overall Study||0
367567|NCT02093819|903122|P3|NOT COMPLETED|Overall Study||0
367568|NCT02093819|903123|P2|NOT COMPLETED|Overall Study||0
367569|NCT02093819|903124|P1|NOT COMPLETED|Overall Study||0
367570|NCT02093819|903117|P8|COMPLETED|Overall Study||6
367571|NCT02093819|903118|P7|COMPLETED|Overall Study||5
367572|NCT02093819|903119|P6|COMPLETED|Overall Study||6
367573|NCT02093819|903120|P5|COMPLETED|Overall Study||6
367574|NCT02093819|903121|P4|COMPLETED|Overall Study||6
367575|NCT02093819|903122|P3|COMPLETED|Overall Study||10
367576|NCT02093819|903123|P2|COMPLETED|Overall Study||6
367577|NCT02093819|903124|P1|COMPLETED|Overall Study||15
367578|NCT02093819|903117|P8|STARTED|Overall Study||6
367579|NCT02093819|903118|P7|STARTED|Overall Study||5
367580|NCT02093819|903119|P6|STARTED|Overall Study||6
367581|NCT02093819|903120|P5|STARTED|Overall Study||6
367582|NCT02093819|903121|P4|STARTED|Overall Study||6
367583|NCT02093819|903122|P3|STARTED|Overall Study||10
367584|NCT02093819|903123|P2|STARTED|Overall Study||6
367585|NCT02093819|903124|P1|STARTED|Overall Study||15
367586|NCT02093702|903160|P2|NOT COMPLETED|Overall Study||0
367587|NCT02093702|903161|P1|NOT COMPLETED|Overall Study||0
367588|NCT02093702|903160|P2|COMPLETED|Overall Study||3
367589|NCT02093702|903161|P1|COMPLETED|Overall Study||2
367590|NCT02093702|903160|P2|STARTED|Overall Study||3
367591|NCT02093702|903161|P1|STARTED|Overall Study||2
367592|NCT02093689|903192|P3|NOT COMPLETED|Overall Study||0
367593|NCT02093689|903193|P2|NOT COMPLETED|Overall Study||0
367594|NCT02093689|903194|P1|NOT COMPLETED|Overall Study||4
367595|NCT02093689|903192|P3|COMPLETED|Overall Study||0
367596|NCT02093689|903193|P2|COMPLETED|Overall Study||0
367597|NCT02093689|903194|P1|COMPLETED|Overall Study||14
367598|NCT02093689|903192|P3|STARTED|Overall Study||0
367599|NCT02093689|903193|P2|STARTED|Overall Study||0
367600|NCT02093689|903194|P1|STARTED|Overall Study||18
367601|NCT02093520|903202|P2|NOT COMPLETED|Overall Study||22
367602|NCT02093520|903203|P1|NOT COMPLETED|Overall Study||6
367603|NCT02093520|903202|P2|COMPLETED|Overall Study||131
367604|NCT02093520|903203|P1|COMPLETED|Overall Study||143
367605|NCT02093520|903202|P2|STARTED|Overall Study||153
367606|NCT02093520|903203|P1|STARTED|Overall Study||149
367607|NCT02093390|903215|P2|NOT COMPLETED|Overall Study||1
367608|NCT02093390|903216|P1|NOT COMPLETED|Overall Study||0
367609|NCT02093390|903215|P2|COMPLETED|Overall Study||19
367610|NCT02093390|903216|P1|COMPLETED|Overall Study||20
367611|NCT02093390|903215|P2|STARTED|Overall Study||20
367612|NCT02093390|903216|P1|STARTED|Overall Study||20
367613|NCT02093351|903255|P3|NOT COMPLETED|Overall Study||3
367614|NCT02093351|903256|P2|NOT COMPLETED|Overall Study||2
367615|NCT02093351|903257|P1|NOT COMPLETED|Overall Study||2
367616|NCT02093351|903255|P3|COMPLETED|Overall Study||23
367617|NCT02093351|903256|P2|COMPLETED|Overall Study||21
367618|NCT02093351|903257|P1|COMPLETED|Overall Study||28
367619|NCT02093351|903255|P3|Completing Treatment Period 3|Overall Study||23
367620|NCT02093351|903256|P2|Completing Treatment Period 3|Overall Study||21
367621|NCT02093351|903257|P1|Completing Treatment Period 3|Overall Study||28
367622|NCT02093351|903255|P3|Completing Treatment Period 2|Overall Study||23
367623|NCT02093351|903256|P2|Completing Treatment Period 2|Overall Study||21
367624|NCT02093351|903257|P1|Completing Treatment Period 2|Overall Study||29
367625|NCT02093351|903255|P3|Completing Treatment Period 1|Overall Study||23
367626|NCT02093351|903256|P2|Completing Treatment Period 1|Overall Study||22
367627|NCT02093351|903257|P1|Completing Treatment Period 1|Overall Study||29
367628|NCT02093351|903255|P3|STARTED|Overall Study||26
367629|NCT02093351|903256|P2|STARTED|Overall Study||23
367630|NCT02093351|903257|P1|STARTED|Overall Study||30
367631|NCT02093234|903289|P3|NOT COMPLETED|Overall Study||4
367632|NCT02093234|903290|P2|NOT COMPLETED|Overall Study||4
367633|NCT02093234|903291|P1|NOT COMPLETED|Overall Study||3
367634|NCT02093234|903289|P3|COMPLETED|Overall Study||50
367635|NCT02093234|903290|P2|COMPLETED|Overall Study||52
367636|NCT02093234|903291|P1|COMPLETED|Overall Study||53
367637|NCT02093234|903289|P3|STARTED|Overall Study||54
367638|NCT02093234|903290|P2|STARTED|Overall Study||56
367639|NCT02093234|903291|P1|STARTED|Overall Study||56
367640|NCT02093221|903313|P5|NOT COMPLETED|Overall Study||8
367641|NCT02093221|903314|P4|NOT COMPLETED|Overall Study||8
367642|NCT02093221|903315|P3|NOT COMPLETED|Overall Study||9
367643|NCT02093221|903316|P2|NOT COMPLETED|Overall Study||8
367644|NCT02093221|903317|P1|NOT COMPLETED|Overall Study||10
367645|NCT02093221|903313|P5|COMPLETED|Overall Study||7
367646|NCT02093221|903314|P4|COMPLETED|Overall Study||7
367647|NCT02093221|903315|P3|COMPLETED|Overall Study||6
367648|NCT02093221|903316|P2|COMPLETED|Overall Study||8
367649|NCT02093221|903317|P1|COMPLETED|Overall Study||5
367650|NCT02093221|903313|P5|STARTED|Overall Study||15
367651|NCT02093221|903314|P4|STARTED|Overall Study||15
367652|NCT02093221|903315|P3|STARTED|Overall Study||15
367653|NCT02093221|903316|P2|STARTED|Overall Study||16
367654|NCT02093221|903317|P1|STARTED|Overall Study||15
367655|NCT02093026|903354|P1|NOT COMPLETED|Overall Study||193
367656|NCT02093026|903354|P1|COMPLETED|Overall Study|At predefined end-of-treatment date, 272 ongoing participants were designated as completed study.|272
367657|NCT02093026|903354|P1|STARTED|Overall Study||465
367658|NCT02092961|903376|P3|NOT COMPLETED|Overall Study||16
367659|NCT02092961|903377|P2|NOT COMPLETED|Overall Study||14
367660|NCT02092961|903378|P1|NOT COMPLETED|Overall Study||21
367661|NCT02092961|903376|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|13
367662|NCT02092961|903377|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|14
367663|NCT02092961|903378|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|12
367664|NCT02092961|903376|P3|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled|1
367665|NCT02092961|903377|P2|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/study stopped|5
367666|NCT02092961|903378|P1|Randomised But Did Not Receive Treatment|Overall Study|Study stopped|1
367667|NCT02092961|903376|P3|STARTED|Overall Study|Patients who received treatment|29
367668|NCT02092961|903377|P2|STARTED|Overall Study|Patients who received treatment|28
367853|NCT02090413|903800|P2|NOT COMPLETED|Overall Study||20
367669|NCT02092961|903378|P1|STARTED|Overall Study|Patients who received treatment|33
367670|NCT02092857|903402|P3|NOT COMPLETED|Overall Study||13
367671|NCT02092857|903403|P2|NOT COMPLETED|Overall Study||12
367672|NCT02092857|903404|P1|NOT COMPLETED|Overall Study||10
367673|NCT02092857|903402|P3|COMPLETED|Overall Study||16
367674|NCT02092857|903403|P2|COMPLETED|Overall Study||18
367675|NCT02092857|903404|P1|COMPLETED|Overall Study||20
367676|NCT02092857|903402|P3|STARTED|Overall Study||29
367677|NCT02092857|903403|P2|STARTED|Overall Study||30
367678|NCT02092857|903404|P1|STARTED|Overall Study||30
367679|NCT02092662|903414|P2|NOT COMPLETED|Overall Study||0
367680|NCT02092662|903415|P1|NOT COMPLETED|Overall Study||13
367681|NCT02092662|903414|P2|COMPLETED|Overall Study||19
367682|NCT02092662|903415|P1|COMPLETED|Overall Study||25
367683|NCT02092662|903414|P2|Recruited|Overall Study||19
367684|NCT02092662|903415|P1|Recruited|Overall Study||38
367685|NCT02092662|903414|P2|STARTED|Overall Study||19
367686|NCT02092662|903415|P1|STARTED|Overall Study||38
367687|NCT02092649|903424|P2|NOT COMPLETED|Overall Study||0
367688|NCT02092649|903425|P1|NOT COMPLETED|Overall Study||0
367689|NCT02092649|903424|P2|COMPLETED|Overall Study|13 participants finished study|13
367690|NCT02092649|903425|P1|COMPLETED|Overall Study|13 participants finished study|13
367691|NCT02092649|903424|P2|STARTED|Overall Study|13 participants recruited|13
367692|NCT02092649|903425|P1|STARTED|Overall Study|13 participants recruited|13
367693|NCT02092610|903443|P2|NOT COMPLETED|Overall Study||12
367694|NCT02092610|903444|P1|NOT COMPLETED|Overall Study||8
367695|NCT02092610|903443|P2|COMPLETED|Overall Study||40
367696|NCT02092610|903444|P1|COMPLETED|Overall Study||17
367697|NCT02092610|903443|P2|STARTED|Overall Study||52
367698|NCT02092610|903444|P1|STARTED|Overall Study||25
367699|NCT02092441|903458|P2|NOT COMPLETED|Overall Study||0
367700|NCT02092441|903459|P1|NOT COMPLETED|Overall Study||0
367701|NCT02092441|903458|P2|COMPLETED|Overall Study||43
367702|NCT02092441|903459|P1|COMPLETED|Overall Study||37
367703|NCT02092441|903458|P2|STARTED|Overall Study||43
367704|NCT02092441|903459|P1|STARTED|Overall Study||37
367705|NCT02092415|903469|P1|NOT COMPLETED|Overall Study||0
367706|NCT02092415|903469|P1|COMPLETED|Overall Study||10
367707|NCT02092415|903469|P1|STARTED|Overall Study||10
367708|NCT02092389|903474|P1|NOT COMPLETED|Overall Study||6
367709|NCT02092389|903474|P1|COMPLETED|Overall Study||4
367710|NCT02092389|903474|P1|STARTED|Overall Study||10
367711|NCT02092350|903486|P2|NOT COMPLETED|Overall Study||12
367712|NCT02092350|903487|P1|NOT COMPLETED|Overall Study||10
367713|NCT02092350|903486|P2|COMPLETED|Overall Study||102
367714|NCT02092350|903487|P1|COMPLETED|Overall Study||113
367715|NCT02092350|903486|P2|STARTED|Overall Study||114
367716|NCT02092350|903487|P1|STARTED|Overall Study||123
367717|NCT02092311|903504|P2|NOT COMPLETED|Overall Study||0
367718|NCT02092311|903505|P1|NOT COMPLETED|Overall Study||0
367719|NCT02092311|903504|P2|COMPLETED|Overall Study||285
367720|NCT02092311|903505|P1|COMPLETED|Overall Study||285
367721|NCT02092311|903504|P2|STARTED|Overall Study||285
367722|NCT02092311|903505|P1|STARTED|Overall Study||285
367723|NCT02092285|903515|P1|NOT COMPLETED|Maintenance Phase & Follow-up||110
367724|NCT02092285|903515|P1|COMPLETED|Maintenance Phase & Follow-up||60
367725|NCT02092285|903515|P1|STARTED|Maintenance Phase & Follow-up||170
367726|NCT02092285|903515|P1|NOT COMPLETED|Induction Phase||35
367727|NCT02092285|903515|P1|COMPLETED|Induction Phase||170
367728|NCT02092285|903515|P1|STARTED|Induction Phase||205
367729|NCT02092220|903519|P2|NOT COMPLETED|Period 2||1
367730|NCT02092220|903520|P1|NOT COMPLETED|Period 2||1
367731|NCT02092220|903519|P2|COMPLETED|Period 2||19
367732|NCT02092220|903520|P1|COMPLETED|Period 2||20
367733|NCT02092220|903519|P2|STARTED|Period 2||20
367734|NCT02092220|903520|P1|STARTED|Period 2||21
367735|NCT02092220|903519|P2|NOT COMPLETED|Period 1||2
367736|NCT02092220|903520|P1|NOT COMPLETED|Period 1||0
367737|NCT02092220|903519|P2|COMPLETED|Period 1||20
367738|NCT02092220|903520|P1|COMPLETED|Period 1||21
367739|NCT02092220|903519|P2|STARTED|Period 1||22
367740|NCT02092220|903520|P1|STARTED|Period 1||21
367741|NCT02092168|903580|P2|NOT COMPLETED|Overall Study||0
367742|NCT02092168|903581|P1|NOT COMPLETED|Overall Study||0
367743|NCT02092168|903580|P2|COMPLETED|Overall Study||12
367744|NCT02092168|903581|P1|COMPLETED|Overall Study||12
367745|NCT02092168|903580|P2|STARTED|Overall Study||12
367746|NCT02092168|903581|P1|STARTED|Overall Study||12
367747|NCT02092116|903593|P2|NOT COMPLETED|Overall Study||4
367748|NCT02092116|903594|P1|NOT COMPLETED|Overall Study||0
367749|NCT02092116|903593|P2|COMPLETED|Overall Study||16
367750|NCT02092116|903594|P1|COMPLETED|Overall Study||6
367751|NCT02092116|903593|P2|STARTED|Overall Study||20
367752|NCT02092116|903594|P1|STARTED|Overall Study||6
367753|NCT02091986|903606|P3|NOT COMPLETED|Overall Study||8
367754|NCT02091986|903607|P2|NOT COMPLETED|Overall Study||11
367755|NCT02091986|903608|P1|NOT COMPLETED|Overall Study||7
367756|NCT02091986|903606|P3|COMPLETED|Overall Study||84
367757|NCT02091986|903607|P2|COMPLETED|Overall Study||84
367758|NCT02091986|903608|P1|COMPLETED|Overall Study||85
367759|NCT02091986|903606|P3|STARTED|Overall Study||92
367760|NCT02091986|903607|P2|STARTED|Overall Study||95
367761|NCT02091986|903608|P1|STARTED|Overall Study||92
367762|NCT02091960|903655|P1|NOT COMPLETED|Overall Study||51
367854|NCT02090413|903801|P1|NOT COMPLETED|Overall Study||19
367763|NCT02091960|903655|P1|COMPLETED|Overall Study|Completed indicates participants with disease progression|52
367764|NCT02091960|903655|P1|Received Treatment|Overall Study||103
367765|NCT02091960|903655|P1|STARTED|Overall Study||103
367772|NCT02091856|903684|P3|NOT COMPLETED|Follow-up Assessment||0
367773|NCT02091856|903685|P2|NOT COMPLETED|Follow-up Assessment||3
367774|NCT02091856|903686|P1|NOT COMPLETED|Follow-up Assessment||5
367775|NCT02091856|903684|P3|COMPLETED|Follow-up Assessment||0
367776|NCT02091856|903685|P2|COMPLETED|Follow-up Assessment||9
367777|NCT02091856|903686|P1|COMPLETED|Follow-up Assessment||10
367778|NCT02091856|903684|P3|STARTED|Follow-up Assessment|WLCG participants were lost at follow-up.|0
367779|NCT02091856|903685|P2|STARTED|Follow-up Assessment|Only a subset of R-CBT participants responded to our request to complete the follow-up assessment.|12
367780|NCT02091856|903686|P1|STARTED|Follow-up Assessment|Only a subset of C-CBT participants responded to our request to complete the follow-up assessment.|15
367781|NCT02091856|903684|P3|NOT COMPLETED|Active Intervention Interval||7
367782|NCT02091856|903685|P2|NOT COMPLETED|Active Intervention Interval||7
367783|NCT02091856|903686|P1|NOT COMPLETED|Active Intervention Interval||19
367784|NCT02091856|903684|P3|COMPLETED|Active Intervention Interval||19
367785|NCT02091856|903685|P2|COMPLETED|Active Intervention Interval||12
367786|NCT02091856|903686|P1|COMPLETED|Active Intervention Interval||15
367787|NCT02091856|903684|P3|STARTED|Active Intervention Interval||26
367788|NCT02091856|903685|P2|STARTED|Active Intervention Interval||19
367789|NCT02091856|903686|P1|STARTED|Active Intervention Interval||34
367790|NCT02091778|903706|P1|NOT COMPLETED|Overall Study||1
367791|NCT02091778|903706|P1|COMPLETED|Overall Study||20
367792|NCT02091778|903706|P1|STARTED|Overall Study||21
367793|NCT02091752|903710|P1|NOT COMPLETED|Overall Study||3
367794|NCT02091752|903710|P1|COMPLETED|Overall Study||0
367795|NCT02091752|903710|P1|STARTED|Overall Study||3
367796|NCT02091739|903724|P5|NOT COMPLETED|EP: 48 Weeks||14
367797|NCT02091739|903725|P4|NOT COMPLETED|EP: 48 Weeks||8
367798|NCT02091739|903726|P3|NOT COMPLETED|EP: 48 Weeks||0
367799|NCT02091739|903727|P2|NOT COMPLETED|EP: 48 Weeks||0
367800|NCT02091739|903728|P1|NOT COMPLETED|EP: 48 Weeks||0
367801|NCT02091739|903724|P5|COMPLETED|EP: 48 Weeks||75
367802|NCT02091739|903725|P4|COMPLETED|EP: 48 Weeks||76
367803|NCT02091739|903726|P3|COMPLETED|EP: 48 Weeks||0
367804|NCT02091739|903727|P2|COMPLETED|EP: 48 Weeks||0
367805|NCT02091739|903728|P1|COMPLETED|EP: 48 Weeks||0
367806|NCT02091739|903724|P5|STARTED|EP: 48 Weeks||89
367807|NCT02091739|903725|P4|STARTED|EP: 48 Weeks||84
367808|NCT02091739|903726|P3|STARTED|EP: 48 Weeks||0
367809|NCT02091739|903727|P2|STARTED|EP: 48 Weeks||0
367810|NCT02091739|903728|P1|STARTED|EP: 48 Weeks||0
367811|NCT02091739|903724|P5|NOT COMPLETED|MP: 16 Weeks||0
367812|NCT02091739|903725|P4|NOT COMPLETED|MP: 16 Weeks||0
367813|NCT02091739|903726|P3|NOT COMPLETED|MP: 16 Weeks||2
367814|NCT02091739|903727|P2|NOT COMPLETED|MP: 16 Weeks||5
367815|NCT02091739|903728|P1|NOT COMPLETED|MP: 16 Weeks||4
367816|NCT02091739|903724|P5|COMPLETED|MP: 16 Weeks||0
367817|NCT02091739|903725|P4|COMPLETED|MP: 16 Weeks||0
367818|NCT02091739|903726|P3|COMPLETED|MP: 16 Weeks||72
367819|NCT02091739|903727|P2|COMPLETED|MP: 16 Weeks||69
367820|NCT02091739|903728|P1|COMPLETED|MP: 16 Weeks||32
367821|NCT02091739|903724|P5|STARTED|MP: 16 Weeks||0
367822|NCT02091739|903725|P4|STARTED|MP: 16 Weeks||0
367823|NCT02091739|903726|P3|STARTED|MP: 16 Weeks||74
367824|NCT02091739|903727|P2|STARTED|MP: 16 Weeks||74
367825|NCT02091739|903728|P1|STARTED|MP: 16 Weeks||36
367826|NCT02091726|903747|P1|NOT COMPLETED|Overall Study||6
367827|NCT02091726|903747|P1|COMPLETED|Overall Study||104
367828|NCT02091726|903747|P1|4 Week Followup|Overall Study||104
367829|NCT02091726|903747|P1|1 Week Followup|Overall Study||110
367830|NCT02091726|903747|P1|STARTED|Overall Study||110
367831|NCT02091466|903757|P2|NOT COMPLETED|Overall Study||0
367832|NCT02091466|903758|P1|NOT COMPLETED|Overall Study||0
367833|NCT02091466|903757|P2|COMPLETED|Overall Study||20
367834|NCT02091466|903758|P1|COMPLETED|Overall Study||20
367835|NCT02091466|903757|P2|STARTED|Overall Study||20
367836|NCT02091466|903758|P1|STARTED|Overall Study||20
367837|NCT02091414|903764|P1|NOT COMPLETED|Overall Study||4
367838|NCT02091414|903764|P1|COMPLETED|Overall Study||32
367839|NCT02091414|903764|P1|STARTED|Overall Study||36
367840|NCT02090855|903776|P1|NOT COMPLETED|Overall Study||2
367841|NCT02090855|903776|P1|COMPLETED|Overall Study||106
367842|NCT02090855|903776|P1|STARTED|Overall Study||108
367843|NCT02090777|903783|P1|NOT COMPLETED|Overall Study||0
367844|NCT02090777|903783|P1|COMPLETED|Overall Study||4
367845|NCT02090777|903783|P1|STARTED|Overall Study||4
367846|NCT02090764|903789|P2|NOT COMPLETED|Overall Study||20
367847|NCT02090764|903790|P1|NOT COMPLETED|Overall Study||6
367848|NCT02090764|903789|P2|COMPLETED|Overall Study||186
367849|NCT02090764|903790|P1|COMPLETED|Overall Study||200
367850|NCT02090764|903789|P2|STARTED|Overall Study||206
367851|NCT02090764|903790|P1|STARTED|Overall Study||206
367852|NCT02090413|903799|P3|NOT COMPLETED|Overall Study||23
367855|NCT02090413|903799|P3|COMPLETED|Overall Study||57
367856|NCT02090413|903800|P2|COMPLETED|Overall Study||60
367857|NCT02090413|903801|P1|COMPLETED|Overall Study||62
367858|NCT02090413|903799|P3|STARTED|Overall Study||80
367859|NCT02090413|903800|P2|STARTED|Overall Study||80
367860|NCT02090413|903801|P1|STARTED|Overall Study||81
367861|NCT02090088|903875|P1|NOT COMPLETED|Overall Study||0
367862|NCT02090088|903875|P1|COMPLETED|Overall Study||4
367863|NCT02090088|903875|P1|Gave Birth|Overall Study||4
367864|NCT02090088|903875|P1|STARTED|Overall Study||4
367865|NCT02089737|903887|P1|NOT COMPLETED|Overall Study||6
367866|NCT02089737|903887|P1|COMPLETED|Overall Study||3085
367867|NCT02089737|903887|P1|STARTED|Overall Study||3091
367868|NCT02089347|903896|P2|NOT COMPLETED|Overall Study||0
367869|NCT02089347|903897|P1|NOT COMPLETED|Overall Study||1
367870|NCT02089347|903896|P2|COMPLETED|Overall Study||178
367871|NCT02089347|903897|P1|COMPLETED|Overall Study||355
367872|NCT02089347|903896|P2|STARTED|Overall Study||178
367873|NCT02089347|903897|P1|STARTED|Overall Study||356
367874|NCT02089191|903919|P2|NOT COMPLETED|Period 2, Second 12 Hours||0
367875|NCT02089191|903920|P1|NOT COMPLETED|Period 2, Second 12 Hours||0
367876|NCT02089191|903919|P2|COMPLETED|Period 2, Second 12 Hours||15
367877|NCT02089191|903920|P1|COMPLETED|Period 2, Second 12 Hours||15
367878|NCT02089191|903919|P2|STARTED|Period 2, Second 12 Hours||15
367879|NCT02089191|903920|P1|STARTED|Period 2, Second 12 Hours|One participant discontinued between Period 1 and Period 2 due to availability|15
367880|NCT02089191|903919|P2|NOT COMPLETED|Period 1, First 12 Hours||0
367881|NCT02089191|903920|P1|NOT COMPLETED|Period 1, First 12 Hours||0
367882|NCT02089191|903919|P2|COMPLETED|Period 1, First 12 Hours||15
367883|NCT02089191|903920|P1|COMPLETED|Period 1, First 12 Hours||16
367884|NCT02089191|903919|P2|STARTED|Period 1, First 12 Hours||15
367885|NCT02089191|903920|P1|STARTED|Period 1, First 12 Hours||16
367886|NCT02089113|903930|P2|NOT COMPLETED|Overall Study||0
367887|NCT02089113|903931|P1|NOT COMPLETED|Overall Study||1
367888|NCT02089113|903930|P2|COMPLETED|Overall Study||80
367889|NCT02089113|903931|P1|COMPLETED|Overall Study||160
367890|NCT02089113|903930|P2|STARTED|Overall Study||80
367891|NCT02089113|903931|P1|STARTED|Overall Study||161
367892|NCT02088957|903937|P2|NOT COMPLETED|Overall Study||0
367893|NCT02088957|903938|P1|NOT COMPLETED|Overall Study||1
367894|NCT02088957|903937|P2|COMPLETED|Overall Study||0
367895|NCT02088957|903938|P1|COMPLETED|Overall Study||0
367896|NCT02088957|903937|P2|STARTED|Overall Study||0
367897|NCT02088957|903938|P1|STARTED|Overall Study||1
367898|NCT02088177|903954|P1|NOT COMPLETED|Overall Study||3
367899|NCT02088177|903954|P1|COMPLETED|Overall Study||9
367900|NCT02088177|903954|P1|STARTED|Overall Study||12
367901|NCT02087995|903959|P1|NOT COMPLETED|Overall Study||0
367902|NCT02087995|903959|P1|COMPLETED|Overall Study||51
367903|NCT02087995|903959|P1|STARTED|Overall Study||51
367904|NCT02087943|903966|P5|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1
367905|NCT02087943|903967|P4|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1
367906|NCT02087943|903968|P3|NOT COMPLETED|Observational Follow-up Phase Week 24-30||3
367907|NCT02087943|903969|P2|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0
367908|NCT02087943|903970|P1|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0
367909|NCT02087943|903966|P5|COMPLETED|Observational Follow-up Phase Week 24-30||22
367910|NCT02087943|903967|P4|COMPLETED|Observational Follow-up Phase Week 24-30||23
367911|NCT02087943|903968|P3|COMPLETED|Observational Follow-up Phase Week 24-30||45
367912|NCT02087943|903969|P2|COMPLETED|Observational Follow-up Phase Week 24-30||46
367913|NCT02087943|903970|P1|COMPLETED|Observational Follow-up Phase Week 24-30||0
367914|NCT02087943|903966|P5|STARTED|Observational Follow-up Phase Week 24-30||23
367915|NCT02087943|903967|P4|STARTED|Observational Follow-up Phase Week 24-30||24
367916|NCT02087943|903968|P3|STARTED|Observational Follow-up Phase Week 24-30||48
367917|NCT02087943|903969|P2|STARTED|Observational Follow-up Phase Week 24-30||46
367918|NCT02087943|903970|P1|STARTED|Observational Follow-up Phase Week 24-30||0
367919|NCT02087943|903966|P5|NOT COMPLETED|Active Treatment Phase Week 12-24||2
367920|NCT02087943|903967|P4|NOT COMPLETED|Active Treatment Phase Week 12-24||2
367921|NCT02087943|903968|P3|NOT COMPLETED|Active Treatment Phase Week 12-24||5
367922|NCT02087943|903969|P2|NOT COMPLETED|Active Treatment Phase Week 12-24||4
367923|NCT02087943|903970|P1|NOT COMPLETED|Active Treatment Phase Week 12-24||0
367924|NCT02087943|903966|P5|COMPLETED|Active Treatment Phase Week 12-24||21
367925|NCT02087943|903967|P4|COMPLETED|Active Treatment Phase Week 12-24||22
367926|NCT02087943|903968|P3|COMPLETED|Active Treatment Phase Week 12-24||44
367927|NCT02087943|903969|P2|COMPLETED|Active Treatment Phase Week 12-24||42
367928|NCT02087943|903970|P1|COMPLETED|Active Treatment Phase Week 12-24||0
367929|NCT02087943|903966|P5|STARTED|Active Treatment Phase Week 12-24||23
367930|NCT02087943|903967|P4|STARTED|Active Treatment Phase Week 12-24||24
367931|NCT02087943|903968|P3|STARTED|Active Treatment Phase Week 12-24||49
367932|NCT02087943|903969|P2|STARTED|Active Treatment Phase Week 12-24||46
367933|NCT02087943|903970|P1|STARTED|Active Treatment Phase Week 12-24||0
367934|NCT02087943|903966|P5|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0
367935|NCT02087943|903967|P4|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0
367936|NCT02087943|903968|P3|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||13
367937|NCT02087943|903969|P2|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||12
367938|NCT02087943|903970|P1|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||14
368025|NCT02086591|904161|P1|STARTED|Overall Study||7
367939|NCT02087943|903966|P5|COMPLETED|Placebo-Controlled Phase Week 0-12||0
367940|NCT02087943|903967|P4|COMPLETED|Placebo-Controlled Phase Week 0-12||0
367941|NCT02087943|903968|P3|COMPLETED|Placebo-Controlled Phase Week 0-12|1 participant who completed week 12 did not enter the active treatment phase.|50
367942|NCT02087943|903969|P2|COMPLETED|Placebo-Controlled Phase Week 0-12||46
367943|NCT02087943|903970|P1|COMPLETED|Placebo-Controlled Phase Week 0-12|3 participants who completed week 12 did not enter the active treatment phase.|50
367944|NCT02087943|903966|P5|Safety Population|Placebo-Controlled Phase Week 0-12||0
367945|NCT02087943|903967|P4|Safety Population|Placebo-Controlled Phase Week 0-12||0
367946|NCT02087943|903968|P3|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|63
367947|NCT02087943|903969|P2|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|58
367948|NCT02087943|903970|P1|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|64
367949|NCT02087943|903966|P5|STARTED|Placebo-Controlled Phase Week 0-12||0
367950|NCT02087943|903967|P4|STARTED|Placebo-Controlled Phase Week 0-12||0
367951|NCT02087943|903968|P3|STARTED|Placebo-Controlled Phase Week 0-12||63
367952|NCT02087943|903969|P2|STARTED|Placebo-Controlled Phase Week 0-12||58
367953|NCT02087943|903970|P1|STARTED|Placebo-Controlled Phase Week 0-12||64
367954|NCT02087774|903996|P2|NOT COMPLETED|Overall Study||20
367955|NCT02087774|903997|P1|NOT COMPLETED|Overall Study||8
367956|NCT02087774|903996|P2|COMPLETED|Overall Study||130
367957|NCT02087774|903997|P1|COMPLETED|Overall Study||142
367958|NCT02087774|903996|P2|STARTED|Overall Study||150
367959|NCT02087774|903997|P1|STARTED|Overall Study||150
367960|NCT02087748|904005|P1|NOT COMPLETED|Overall Study||0
367961|NCT02087748|904005|P1|COMPLETED|Overall Study||24
367962|NCT02087748|904005|P1|STARTED|Overall Study||24
367963|NCT02087670|904017|P2|NOT COMPLETED|Overall Study||2
367964|NCT02087670|904018|P1|NOT COMPLETED|Overall Study||3
367965|NCT02087670|904017|P2|COMPLETED|Overall Study||20
367966|NCT02087670|904018|P1|COMPLETED|Overall Study||17
367967|NCT02087670|904017|P2|STARTED|Overall Study||22
367968|NCT02087670|904018|P1|STARTED|Overall Study||20
367969|NCT02087514|904032|P6|NOT COMPLETED|Overall Study||1
367970|NCT02087514|904033|P5|NOT COMPLETED|Overall Study||0
367971|NCT02087514|904034|P4|NOT COMPLETED|Overall Study||2
367972|NCT02087514|904035|P3|NOT COMPLETED|Overall Study||3
367973|NCT02087514|904036|P2|NOT COMPLETED|Overall Study||0
367974|NCT02087514|904037|P1|NOT COMPLETED|Overall Study||2
367975|NCT02087514|904032|P6|COMPLETED|Overall Study||9
367976|NCT02087514|904033|P5|COMPLETED|Overall Study||10
367977|NCT02087514|904034|P4|COMPLETED|Overall Study||8
367978|NCT02087514|904035|P3|COMPLETED|Overall Study||7
367979|NCT02087514|904036|P2|COMPLETED|Overall Study||10
367980|NCT02087514|904037|P1|COMPLETED|Overall Study||8
367981|NCT02087514|904032|P6|STARTED|Overall Study||10
367982|NCT02087514|904033|P5|STARTED|Overall Study||10
367983|NCT02087514|904034|P4|STARTED|Overall Study||10
367984|NCT02087514|904035|P3|STARTED|Overall Study||10
367985|NCT02087514|904036|P2|STARTED|Overall Study||10
367986|NCT02087514|904037|P1|STARTED|Overall Study||10
367987|NCT02087423|904054|P3|NOT COMPLETED|Overall Study||58
367988|NCT02087423|904055|P2|NOT COMPLETED|Overall Study||205
367989|NCT02087423|904056|P1|NOT COMPLETED|Overall Study||103
367990|NCT02087423|904054|P3|COMPLETED|Overall Study|Completed maximum 12-month treatment period|10
367991|NCT02087423|904055|P2|COMPLETED|Overall Study|Completed maximum 12-month treatment period|60
367992|NCT02087423|904056|P1|COMPLETED|Overall Study|Completed maximum 12-month treatment period|8
367993|NCT02087423|904054|P3|STARTED|Overall Study|Treated|68
367994|NCT02087423|904055|P2|STARTED|Overall Study|Treated|265
367995|NCT02087423|904056|P1|STARTED|Overall Study|Treated|111
367996|NCT02087241|904080|P4|NOT COMPLETED|Overall Study||7
367997|NCT02087241|904081|P3|NOT COMPLETED|Overall Study||1
367998|NCT02087241|904082|P2|NOT COMPLETED|Overall Study||3
367999|NCT02087241|904083|P1|NOT COMPLETED|Overall Study||3
368000|NCT02087241|904080|P4|COMPLETED|Overall Study||0
368001|NCT02087241|904081|P3|COMPLETED|Overall Study||0
368002|NCT02087241|904082|P2|COMPLETED|Overall Study||0
368003|NCT02087241|904083|P1|COMPLETED|Overall Study||0
368004|NCT02087241|904080|P4|STARTED|Overall Study||7
368005|NCT02087241|904081|P3|STARTED|Overall Study||1
368006|NCT02087241|904082|P2|STARTED|Overall Study||3
368007|NCT02087241|904083|P1|STARTED|Overall Study||3
368008|NCT02087176|904109|P1|NOT COMPLETED|Overall Study||32
368009|NCT02087176|904109|P1|COMPLETED|Overall Study|The sponsor terminated the study early.|0
368010|NCT02087176|904109|P1|STARTED|Overall Study||32
368011|NCT02087059|904114|P1|NOT COMPLETED|Overall Study||7
368012|NCT02087059|904114|P1|COMPLETED|Overall Study||44
368013|NCT02087059|904114|P1|STARTED|Overall Study||51
368014|NCT02086786|904124|P2|NOT COMPLETED|Overall Study||16
368015|NCT02086786|904125|P1|NOT COMPLETED|Overall Study||18
368016|NCT02086786|904124|P2|COMPLETED|Overall Study||19
368017|NCT02086786|904125|P1|COMPLETED|Overall Study||17
368018|NCT02086786|904124|P2|STARTED|Overall Study||35
368019|NCT02086786|904125|P1|STARTED|Overall Study||35
368020|NCT02086708|904149|P1|NOT COMPLETED|Overall Study||0
368021|NCT02086708|904149|P1|COMPLETED|Overall Study||24
368022|NCT02086708|904149|P1|STARTED|Overall Study||24
368023|NCT02086591|904161|P1|NOT COMPLETED|Overall Study||5
368024|NCT02086591|904161|P1|COMPLETED|Overall Study||2
368032|NCT02085720|904182|P1|NOT COMPLETED|Overall Study||0
368033|NCT02085720|904182|P1|COMPLETED|Overall Study||819
368034|NCT02085720|904182|P1|STARTED|Overall Study||819
368035|NCT02085161|904194|P4|NOT COMPLETED|Overall Study||10
368036|NCT02085161|904195|P3|NOT COMPLETED|Overall Study||5
368037|NCT02085161|904196|P2|NOT COMPLETED|Overall Study||10
368038|NCT02085161|904197|P1|NOT COMPLETED|Overall Study||12
368039|NCT02085161|904194|P4|COMPLETED|Overall Study||66
368040|NCT02085161|904195|P3|COMPLETED|Overall Study||71
368041|NCT02085161|904196|P2|COMPLETED|Overall Study||66
368042|NCT02085161|904197|P1|COMPLETED|Overall Study||64
368043|NCT02085161|904194|P4|STARTED|Overall Study||76
368044|NCT02085161|904195|P3|STARTED|Overall Study||76
368045|NCT02085161|904196|P2|STARTED|Overall Study||76
368046|NCT02085161|904197|P1|STARTED|Overall Study||76
368047|NCT02084797|904236|P1|NOT COMPLETED|Overall Study||0
368048|NCT02084797|904236|P1|COMPLETED|Overall Study||10
368049|NCT02084797|904236|P1|STARTED|Overall Study||10
368050|NCT02084706|904245|P2|NOT COMPLETED|Overall Study||0
368051|NCT02084706|904246|P1|NOT COMPLETED|Overall Study||0
368052|NCT02084706|904245|P2|COMPLETED|Overall Study||31
368053|NCT02084706|904246|P1|COMPLETED|Overall Study||29
368054|NCT02084706|904245|P2|STARTED|Overall Study||31
368055|NCT02084706|904246|P1|STARTED|Overall Study||29
368056|NCT02084628|904252|P1|NOT COMPLETED|Overall Study||0
368057|NCT02084628|904252|P1|COMPLETED|Overall Study||1
368058|NCT02084628|904252|P1|STARTED|Overall Study||1
368059|NCT02084238|904265|P1|NOT COMPLETED|Overall Study||2
368060|NCT02084238|904265|P1|COMPLETED|Overall Study||38
368061|NCT02084238|904265|P1|STARTED|Overall Study||40
368062|NCT02084134|904278|P2|NOT COMPLETED|Overall Study||3
368063|NCT02084134|904279|P1|NOT COMPLETED|Overall Study||4
368064|NCT02084134|904278|P2|COMPLETED|Overall Study||17
368065|NCT02084134|904279|P1|COMPLETED|Overall Study||19
368066|NCT02084134|904278|P2|STARTED|Overall Study||20
368067|NCT02084134|904279|P1|STARTED|Overall Study||23
368068|NCT02084082|904289|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
368069|NCT02084082|904290|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
368070|NCT02084082|904291|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
368071|NCT02084082|904292|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
368072|NCT02084082|904289|P4|COMPLETED|Treatment Period 2 (4 Days)||6
368073|NCT02084082|904290|P3|COMPLETED|Treatment Period 2 (4 Days)||7
368074|NCT02084082|904291|P2|COMPLETED|Treatment Period 2 (4 Days)||26
368075|NCT02084082|904292|P1|COMPLETED|Treatment Period 2 (4 Days)||26
368076|NCT02084082|904289|P4|STARTED|Treatment Period 2 (4 Days)||6
368077|NCT02084082|904290|P3|STARTED|Treatment Period 2 (4 Days)||7
368078|NCT02084082|904291|P2|STARTED|Treatment Period 2 (4 Days)||26
368079|NCT02084082|904292|P1|STARTED|Treatment Period 2 (4 Days)||26
368080|NCT02084082|904289|P4|NOT COMPLETED|Washout Period 1 (35 Days)||2
368081|NCT02084082|904290|P3|NOT COMPLETED|Washout Period 1 (35 Days)||1
368082|NCT02084082|904291|P2|NOT COMPLETED|Washout Period 1 (35 Days)||0
368083|NCT02084082|904292|P1|NOT COMPLETED|Washout Period 1 (35 Days)||0
368084|NCT02084082|904289|P4|COMPLETED|Washout Period 1 (35 Days)||6
368085|NCT02084082|904290|P3|COMPLETED|Washout Period 1 (35 Days)||7
368086|NCT02084082|904291|P2|COMPLETED|Washout Period 1 (35 Days)||26
368087|NCT02084082|904292|P1|COMPLETED|Washout Period 1 (35 Days)||26
368088|NCT02084082|904289|P4|STARTED|Washout Period 1 (35 Days)||8
368089|NCT02084082|904290|P3|STARTED|Washout Period 1 (35 Days)||8
368090|NCT02084082|904291|P2|STARTED|Washout Period 1 (35 Days)||26
368091|NCT02084082|904292|P1|STARTED|Washout Period 1 (35 Days)||26
368092|NCT02084082|904289|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
368093|NCT02084082|904290|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
368094|NCT02084082|904291|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
368095|NCT02084082|904292|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||0
368096|NCT02084082|904289|P4|COMPLETED|Treatment Period 1 (4 Days)||8
368097|NCT02084082|904290|P3|COMPLETED|Treatment Period 1 (4 Days)||8
368098|NCT02084082|904291|P2|COMPLETED|Treatment Period 1 (4 Days)||26
368099|NCT02084082|904292|P1|COMPLETED|Treatment Period 1 (4 Days)||26
368100|NCT02084082|904289|P4|STARTED|Treatment Period 1 (4 Days)||8
368101|NCT02084082|904290|P3|STARTED|Treatment Period 1 (4 Days)||8
368102|NCT02084082|904291|P2|STARTED|Treatment Period 1 (4 Days)||26
368103|NCT02084082|904292|P1|STARTED|Treatment Period 1 (4 Days)||26
368104|NCT02084069|904324|P2|NOT COMPLETED|Overall Study||0
368105|NCT02084069|904325|P1|NOT COMPLETED|Overall Study||0
368106|NCT02084069|904324|P2|COMPLETED|Overall Study||29
368107|NCT02084069|904325|P1|COMPLETED|Overall Study||29
368108|NCT02084069|904324|P2|STARTED|Overall Study||29
368109|NCT02084069|904325|P1|STARTED|Overall Study||29
368110|NCT02084056|904333|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
368111|NCT02084056|904334|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
368112|NCT02084056|904335|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
368113|NCT02084056|904336|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
368114|NCT02084056|904333|P4|COMPLETED|Treatment Period 2 (4 Days)||8
368115|NCT02084056|904334|P3|COMPLETED|Treatment Period 2 (4 Days)||8
368116|NCT02084056|904335|P2|COMPLETED|Treatment Period 2 (4 Days)||30
368117|NCT02084056|904336|P1|COMPLETED|Treatment Period 2 (4 Days)||26
368118|NCT02084056|904333|P4|STARTED|Treatment Period 2 (4 Days)||8
368119|NCT02084056|904334|P3|STARTED|Treatment Period 2 (4 Days)||8
368120|NCT02084056|904335|P2|STARTED|Treatment Period 2 (4 Days)||30
368121|NCT02084056|904336|P1|STARTED|Treatment Period 2 (4 Days)||26
368122|NCT02084056|904333|P4|NOT COMPLETED|Washout Period 1 (35 Days)||0
368123|NCT02084056|904334|P3|NOT COMPLETED|Washout Period 1 (35 Days)||0
368124|NCT02084056|904335|P2|NOT COMPLETED|Washout Period 1 (35 Days)||0
368125|NCT02084056|904336|P1|NOT COMPLETED|Washout Period 1 (35 Days)||1
368126|NCT02084056|904333|P4|COMPLETED|Washout Period 1 (35 Days)||8
368127|NCT02084056|904334|P3|COMPLETED|Washout Period 1 (35 Days)||8
368128|NCT02084056|904335|P2|COMPLETED|Washout Period 1 (35 Days)||30
368129|NCT02084056|904336|P1|COMPLETED|Washout Period 1 (35 Days)||26
368130|NCT02084056|904333|P4|STARTED|Washout Period 1 (35 Days)||8
368131|NCT02084056|904334|P3|STARTED|Washout Period 1 (35 Days)||8
368132|NCT02084056|904335|P2|STARTED|Washout Period 1 (35 Days)||30
368133|NCT02084056|904336|P1|STARTED|Washout Period 1 (35 Days)||27
368134|NCT02084056|904333|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
368135|NCT02084056|904334|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
368136|NCT02084056|904335|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
368137|NCT02084056|904336|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||1
368138|NCT02084056|904333|P4|COMPLETED|Treatment Period 1 (4 Days)||8
368139|NCT02084056|904334|P3|COMPLETED|Treatment Period 1 (4 Days)||8
368140|NCT02084056|904335|P2|COMPLETED|Treatment Period 1 (4 Days)||30
368141|NCT02084056|904336|P1|COMPLETED|Treatment Period 1 (4 Days)||27
368142|NCT02084056|904333|P4|STARTED|Treatment Period 1 (4 Days)||8
368143|NCT02084056|904334|P3|STARTED|Treatment Period 1 (4 Days)||8
368144|NCT02084056|904335|P2|STARTED|Treatment Period 1 (4 Days)||30
368145|NCT02084056|904336|P1|STARTED|Treatment Period 1 (4 Days)||28
368146|NCT02083965|904368|P2|NOT COMPLETED|Treatment Period||0
368147|NCT02083965|904369|P1|NOT COMPLETED|Treatment Period||1
368148|NCT02083965|904368|P2|COMPLETED|Treatment Period||8
368149|NCT02083965|904369|P1|COMPLETED|Treatment Period||9
368150|NCT02083965|904368|P2|STARTED|Treatment Period|1 participant completed PK period 1 and 2, then chose to withdraw and did not enter treatment period|8
368151|NCT02083965|904369|P1|STARTED|Treatment Period||10
368152|NCT02083965|904368|P2|NOT COMPLETED|PK Period 2||0
368153|NCT02083965|904369|P1|NOT COMPLETED|PK Period 2||0
368154|NCT02083965|904368|P2|COMPLETED|PK Period 2||9
368155|NCT02083965|904369|P1|COMPLETED|PK Period 2||10
368156|NCT02083965|904368|P2|STARTED|PK Period 2||9
368157|NCT02083965|904369|P1|STARTED|PK Period 2||10
368158|NCT02083965|904368|P2|NOT COMPLETED|Washout Period||0
368159|NCT02083965|904369|P1|NOT COMPLETED|Washout Period||0
368160|NCT02083965|904368|P2|COMPLETED|Washout Period||9
368161|NCT02083965|904369|P1|COMPLETED|Washout Period||10
368162|NCT02083965|904368|P2|STARTED|Washout Period||9
368163|NCT02083965|904369|P1|STARTED|Washout Period||10
368164|NCT02083965|904368|P2|NOT COMPLETED|PK Period 1||0
368165|NCT02083965|904369|P1|NOT COMPLETED|PK Period 1||0
368166|NCT02083965|904368|P2|COMPLETED|PK Period 1||9
368167|NCT02083965|904369|P1|COMPLETED|PK Period 1||10
368168|NCT02083965|904368|P2|STARTED|PK Period 1||9
368169|NCT02083965|904369|P1|STARTED|PK Period 1||10
368170|NCT02083861|904427|P2|NOT COMPLETED|Overall Study||3
368171|NCT02083861|904428|P1|NOT COMPLETED|Overall Study||6
368172|NCT02083861|904427|P2|COMPLETED|Overall Study||33
368173|NCT02083861|904428|P1|COMPLETED|Overall Study||51
368174|NCT02083861|904427|P2|Treated|Overall Study||35
368175|NCT02083861|904428|P1|Treated|Overall Study||55
368176|NCT02083861|904427|P2|STARTED|Overall Study||36
368177|NCT02083861|904428|P1|STARTED|Overall Study||57
368178|NCT02083679|904444|P4|NOT COMPLETED|Overall Study||0
368179|NCT02083679|904445|P3|NOT COMPLETED|Overall Study||0
368180|NCT02083679|904446|P2|NOT COMPLETED|Overall Study||0
368181|NCT02083679|904447|P1|NOT COMPLETED|Overall Study||0
368182|NCT02083679|904444|P4|COMPLETED|Overall Study||3
368183|NCT02083679|904445|P3|COMPLETED|Overall Study||3
368184|NCT02083679|904446|P2|COMPLETED|Overall Study||6
368185|NCT02083679|904447|P1|COMPLETED|Overall Study||3
368186|NCT02083679|904444|P4|STARTED|Overall Study||3
368187|NCT02083679|904445|P3|STARTED|Overall Study||3
368188|NCT02083679|904446|P2|STARTED|Overall Study||6
368189|NCT02083679|904447|P1|STARTED|Overall Study||3
368190|NCT02083406|904464|P3|NOT COMPLETED|Overall Study||0
368191|NCT02083406|904465|P2|NOT COMPLETED|Overall Study||0
368192|NCT02083406|904466|P1|NOT COMPLETED|Overall Study||0
368193|NCT02083406|904464|P3|COMPLETED|Overall Study||7
368194|NCT02083406|904465|P2|COMPLETED|Overall Study||8
368195|NCT02083406|904466|P1|COMPLETED|Overall Study||7
368196|NCT02083406|904464|P3|STARTED|Overall Study||7
368197|NCT02083406|904465|P2|STARTED|Overall Study||8
368198|NCT02083406|904466|P1|STARTED|Overall Study||7
368199|NCT02083380|904486|P3|NOT COMPLETED|Overall Study||84
368200|NCT02083380|904487|P2|NOT COMPLETED|Overall Study||95
368201|NCT02083380|904488|P1|NOT COMPLETED|Overall Study||91
368202|NCT02083380|904486|P3|COMPLETED|Overall Study||65
368203|NCT02083380|904487|P2|COMPLETED|Overall Study||56
368204|NCT02083380|904488|P1|COMPLETED|Overall Study||57
368205|NCT02083380|904486|P3|STARTED|Overall Study|3 subjects excluded from safety / ITT population - no drug administered|149
368206|NCT02083380|904487|P2|STARTED|Overall Study|3 subjects excluded from safety / ITT population - no drug administered|151
368207|NCT02083380|904488|P1|STARTED|Overall Study|5 subjects excluded from safety / ITT population - no drug administered|148
368208|NCT02083263|904583|P2|NOT COMPLETED|Overall Study||0
368209|NCT02083263|904584|P1|NOT COMPLETED|Overall Study||0
368210|NCT02083263|904583|P2|COMPLETED|Overall Study||16
368211|NCT02083263|904584|P1|COMPLETED|Overall Study||16
368212|NCT02083263|904583|P2|STARTED|Overall Study||16
368213|NCT02083263|904584|P1|STARTED|Overall Study||16
368214|NCT02083185|904593|P3|NOT COMPLETED|Overall Study||7
368215|NCT02083185|904594|P2|NOT COMPLETED|Overall Study||29
368216|NCT02083185|904595|P1|NOT COMPLETED|Overall Study||20
368217|NCT02083185|904593|P3|COMPLETED|Overall Study||17
368218|NCT02083185|904594|P2|COMPLETED|Overall Study||27
368219|NCT02083185|904595|P1|COMPLETED|Overall Study||36
368220|NCT02083185|904593|P3|Safety Population|Overall Study||24
368221|NCT02083185|904594|P2|Safety Population|Overall Study||54
368222|NCT02083185|904595|P1|Safety Population|Overall Study||56
368223|NCT02083185|904593|P3|STARTED|Overall Study||24
368224|NCT02083185|904594|P2|STARTED|Overall Study||56
368225|NCT02083185|904595|P1|STARTED|Overall Study||56
368226|NCT02083107|904653|P3|NOT COMPLETED|Overall Study||0
368227|NCT02083107|904654|P2|NOT COMPLETED|Overall Study||0
368228|NCT02083107|904655|P1|NOT COMPLETED|Overall Study||0
368229|NCT02083107|904653|P3|COMPLETED|Overall Study|212 women received 2 tablets of Misotac® rectally and 2 placebo tablets sublingually.|212
368230|NCT02083107|904654|P2|COMPLETED|Overall Study|212 women received 2 tablets of placebo sublingually and 2 placebo tablets rectally.|212
368231|NCT02083107|904655|P1|COMPLETED|Overall Study|212 women received 2 tablets of Misotac® sublingually and 2 placebo tablets rectally.|212
368232|NCT02083107|904653|P3|STARTED|Overall Study|212 women received 2 tablets of Misotac® rectally and 2 placebo tablets sublingually.|212
368233|NCT02083107|904654|P2|STARTED|Overall Study|212 women received 2 tablets of placebo sublingually and 2 placebo tablets rectally.|212
368234|NCT02083107|904655|P1|STARTED|Overall Study|212 women received 2 tablets of Misotac® sublingually and 2 placebo tablets rectally.|212
368235|NCT02082912|904692|P2|NOT COMPLETED|Overall Study||1
368236|NCT02082912|904693|P1|NOT COMPLETED|Overall Study||0
368237|NCT02082912|904692|P2|COMPLETED|Overall Study||6
368238|NCT02082912|904693|P1|COMPLETED|Overall Study||7
368239|NCT02082912|904692|P2|STARTED|Overall Study||7
368240|NCT02082912|904693|P1|STARTED|Overall Study||7
368241|NCT02082769|904702|P3|NOT COMPLETED|Overall Study||36
368242|NCT02082769|904703|P2|NOT COMPLETED|Overall Study||27
368243|NCT02082769|904704|P1|NOT COMPLETED|Overall Study||24
368244|NCT02082769|904702|P3|COMPLETED|Overall Study||132
368245|NCT02082769|904703|P2|COMPLETED|Overall Study||141
368246|NCT02082769|904704|P1|COMPLETED|Overall Study||144
368247|NCT02082769|904702|P3|STARTED|Overall Study||168
368248|NCT02082769|904703|P2|STARTED|Overall Study||168
368249|NCT02082769|904704|P1|STARTED|Overall Study||168
368250|NCT02082392|904720|P2|NOT COMPLETED|Overall Study||0
368251|NCT02082392|904721|P1|NOT COMPLETED|Overall Study||0
368252|NCT02082392|904720|P2|COMPLETED|Overall Study||1
368253|NCT02082392|904721|P1|COMPLETED|Overall Study||2
368254|NCT02082392|904720|P2|STARTED|Overall Study||1
368255|NCT02082392|904721|P1|STARTED|Overall Study||2
368256|NCT02082288|904753|P1|NOT COMPLETED|Overall Study||0
368257|NCT02082288|904753|P1|COMPLETED|Overall Study||243
368258|NCT02082288|904753|P1|STARTED|Overall Study||243
368259|NCT02082262|904757|P1|NOT COMPLETED|Overall Study||51
368260|NCT02082262|904757|P1|COMPLETED|Overall Study||89
368261|NCT02082262|904757|P1|STARTED|Overall Study||140
368262|NCT02082184|904763|P2|NOT COMPLETED|Overall Study||13
368263|NCT02082184|904764|P1|NOT COMPLETED|Overall Study||10
368264|NCT02082184|904763|P2|COMPLETED|Overall Study||62
368265|NCT02082184|904764|P1|COMPLETED|Overall Study||139
368266|NCT02082184|904763|P2|STARTED|Overall Study||75
368267|NCT02082184|904764|P1|STARTED|Overall Study||149
368268|NCT02082158|904789|P6|NOT COMPLETED|Overall Study||7
368269|NCT02082158|904790|P5|NOT COMPLETED|Overall Study||4
368270|NCT02082158|904791|P4|NOT COMPLETED|Overall Study||4
368271|NCT02082158|904792|P3|NOT COMPLETED|Overall Study||14
368272|NCT02082158|904793|P2|NOT COMPLETED|Overall Study||8
368273|NCT02082158|904794|P1|NOT COMPLETED|Overall Study||8
368274|NCT02082158|904789|P6|COMPLETED|Overall Study||56
368275|NCT02082158|904790|P5|COMPLETED|Overall Study||64
368276|NCT02082158|904791|P4|COMPLETED|Overall Study|Includes completion with respirator from secondary randomization after fit-test failure of 1st model|68
368277|NCT02082158|904792|P3|COMPLETED|Overall Study||38
368278|NCT02082158|904793|P2|COMPLETED|Overall Study||53
368279|NCT02082158|904794|P1|COMPLETED|Overall Study||58
368280|NCT02082158|904789|P6|STARTED|Overall Study||63
368281|NCT02082158|904790|P5|STARTED|Overall Study||68
368282|NCT02082158|904791|P4|STARTED|Overall Study||72
368283|NCT02082158|904792|P3|STARTED|Overall Study||52
368284|NCT02082158|904793|P2|STARTED|Overall Study||61
368285|NCT02082158|904794|P1|STARTED|Overall Study||66
368286|NCT02081859|904816|P2|NOT COMPLETED|Overall Study||31
368287|NCT02081859|904817|P1|NOT COMPLETED|Overall Study||34
368288|NCT02081859|904816|P2|COMPLETED|Overall Study||119
368289|NCT02081859|904817|P1|COMPLETED|Overall Study||116
368290|NCT02081859|904816|P2|STARTED|Overall Study||150
368291|NCT02081859|904817|P1|STARTED|Overall Study||150
368292|NCT02081690|904825|P1|NOT COMPLETED|Overall Study||7
368293|NCT02081690|904825|P1|COMPLETED|Overall Study||81
368294|NCT02081690|904825|P1|STARTED|Overall Study||88
368295|NCT02081677|904836|P4|NOT COMPLETED|Overall Study||0
368296|NCT02081677|904837|P3|NOT COMPLETED|Overall Study||2
368297|NCT02081677|904838|P2|NOT COMPLETED|Overall Study||1
368298|NCT02081677|904839|P1|NOT COMPLETED|Overall Study||1
368299|NCT02081677|904836|P4|COMPLETED|Overall Study||19
368300|NCT02081677|904837|P3|COMPLETED|Overall Study||17
368301|NCT02081677|904838|P2|COMPLETED|Overall Study||18
368302|NCT02081677|904839|P1|COMPLETED|Overall Study||18
368303|NCT02081677|904836|P4|STARTED|Overall Study||19
368304|NCT02081677|904837|P3|STARTED|Overall Study||19
368305|NCT02081677|904838|P2|STARTED|Overall Study||19
368306|NCT02081677|904839|P1|STARTED|Overall Study||19
368307|NCT02081599|904931|P2|NOT COMPLETED|Period 2：Open-label Period||4
368308|NCT02081599|904932|P1|NOT COMPLETED|Period 2：Open-label Period||6
368309|NCT02081599|904931|P2|COMPLETED|Period 2：Open-label Period||71
368310|NCT02081599|904932|P1|COMPLETED|Period 2：Open-label Period||57
368311|NCT02081599|904931|P2|STARTED|Period 2：Open-label Period||75
368312|NCT02081599|904932|P1|STARTED|Period 2：Open-label Period||63
368313|NCT02081599|904931|P2|NOT COMPLETED|Period 1：Double-blind Period||2
368314|NCT02081599|904932|P1|NOT COMPLETED|Period 1：Double-blind Period||8
368315|NCT02081599|904931|P2|COMPLETED|Period 1：Double-blind Period||75
368316|NCT02081599|904932|P1|COMPLETED|Period 1：Double-blind Period||63
368317|NCT02081599|904931|P2|STARTED|Period 1：Double-blind Period||77
368318|NCT02081599|904932|P1|STARTED|Period 1：Double-blind Period||71
368319|NCT02081586|904950|P4|NOT COMPLETED|Overall Study||1
368320|NCT02081586|904951|P3|NOT COMPLETED|Overall Study||1
368321|NCT02081586|904952|P2|NOT COMPLETED|Overall Study||1
368322|NCT02081586|904953|P1|NOT COMPLETED|Overall Study||0
368323|NCT02081586|904950|P4|COMPLETED|Overall Study||2
368324|NCT02081586|904951|P3|COMPLETED|Overall Study||3
368325|NCT02081586|904952|P2|COMPLETED|Overall Study||2
368326|NCT02081586|904953|P1|COMPLETED|Overall Study||3
368327|NCT02081586|904950|P4|STARTED|Overall Study||3
368328|NCT02081586|904951|P3|STARTED|Overall Study||4
368329|NCT02081586|904952|P2|STARTED|Overall Study||3
368330|NCT02081586|904953|P1|STARTED|Overall Study||3
368331|NCT02081573|904980|P1|NOT COMPLETED|Overall Study||0
368332|NCT02081573|904980|P1|COMPLETED|Overall Study||10
368333|NCT02081573|904980|P1|STARTED|Overall Study||10
368334|NCT02081443|904991|P2|NOT COMPLETED|Overall Study||0
368335|NCT02081443|904992|P1|NOT COMPLETED|Overall Study||0
368336|NCT02081443|904991|P2|COMPLETED|Overall Study||30
368337|NCT02081443|904992|P1|COMPLETED|Overall Study||30
368338|NCT02081443|904991|P2|STARTED|Overall Study||30
368339|NCT02081443|904992|P1|STARTED|Overall Study||30
368340|NCT02081365|905004|P2|NOT COMPLETED|Overall Study||23
368341|NCT02081365|905005|P1|NOT COMPLETED|Overall Study||30
368342|NCT02081365|905004|P2|COMPLETED|Overall Study||54
368343|NCT02081365|905005|P1|COMPLETED|Overall Study||44
368344|NCT02081365|905004|P2|Received Allocated Intervention|Overall Study||59
368345|NCT02081365|905005|P1|Received Allocated Intervention|Overall Study||46
368346|NCT02081365|905004|P2|STARTED|Overall Study||77
368347|NCT02081365|905005|P1|STARTED|Overall Study||74
368348|NCT02081248|905019|P2|NOT COMPLETED|Overall Study||13
368349|NCT02081248|905020|P1|NOT COMPLETED|Overall Study||22
368350|NCT02081248|905019|P2|COMPLETED|Overall Study||87
368351|NCT02081248|905020|P1|COMPLETED|Overall Study||76
368352|NCT02081248|905019|P2|STARTED|Overall Study||100
368353|NCT02081248|905020|P1|STARTED|Overall Study||98
368354|NCT02081183|905044|P2|NOT COMPLETED|Overall Study||4
368355|NCT02081183|905045|P1|NOT COMPLETED|Overall Study||4
368356|NCT02081183|905044|P2|COMPLETED|Overall Study||2
368357|NCT02081183|905045|P1|COMPLETED|Overall Study||1
368358|NCT02081183|905044|P2|STARTED|Overall Study||6
368359|NCT02081183|905045|P1|STARTED|Overall Study||5
368360|NCT02081079|905061|P2|NOT COMPLETED|Overall Study||2
368361|NCT02081079|905062|P1|NOT COMPLETED|Overall Study||4
368362|NCT02081079|905061|P2|COMPLETED|Overall Study||39
368363|NCT02081079|905062|P1|COMPLETED|Overall Study||40
368364|NCT02081079|905061|P2|STARTED|Overall Study||41
368365|NCT02081079|905062|P1|STARTED|Overall Study||44
368366|NCT02081014|905084|P6|NOT COMPLETED|Overall Study||0
368367|NCT02081014|905085|P5|NOT COMPLETED|Overall Study||0
368368|NCT02081014|905086|P4|NOT COMPLETED|Overall Study||0
368369|NCT02081014|905087|P3|NOT COMPLETED|Overall Study||0
368370|NCT02081014|905088|P2|NOT COMPLETED|Overall Study||0
368371|NCT02081014|905089|P1|NOT COMPLETED|Overall Study||0
368372|NCT02081014|905084|P6|COMPLETED|Overall Study||2
368373|NCT02081014|905085|P5|COMPLETED|Overall Study||2
368374|NCT02081014|905086|P4|COMPLETED|Overall Study||2
368375|NCT02081014|905087|P3|COMPLETED|Overall Study||2
368376|NCT02081014|905088|P2|COMPLETED|Overall Study||2
368377|NCT02081014|905089|P1|COMPLETED|Overall Study||2
368378|NCT02081014|905084|P6|STARTED|Overall Study||2
368379|NCT02081014|905085|P5|STARTED|Overall Study||2
368380|NCT02081014|905086|P4|STARTED|Overall Study||2
368381|NCT02081014|905087|P3|STARTED|Overall Study||2
368382|NCT02081014|905088|P2|STARTED|Overall Study||2
368383|NCT02081014|905089|P1|STARTED|Overall Study||2
368384|NCT02081001|905135|P12|NOT COMPLETED|Overall Study||0
368385|NCT02081001|905136|P11|NOT COMPLETED|Overall Study||0
368386|NCT02081001|905137|P10|NOT COMPLETED|Overall Study||0
368387|NCT02081001|905138|P9|NOT COMPLETED|Overall Study||0
368388|NCT02081001|905139|P8|NOT COMPLETED|Overall Study||0
368389|NCT02081001|905140|P7|NOT COMPLETED|Overall Study||0
368390|NCT02081001|905141|P6|NOT COMPLETED|Overall Study||0
368391|NCT02081001|905142|P5|NOT COMPLETED|Overall Study||1
368392|NCT02081001|905143|P4|NOT COMPLETED|Overall Study||0
368393|NCT02081001|905144|P3|NOT COMPLETED|Overall Study||0
368394|NCT02081001|905145|P2|NOT COMPLETED|Overall Study||0
368395|NCT02081001|905146|P1|NOT COMPLETED|Overall Study||0
368396|NCT02081001|905135|P12|COMPLETED|Overall Study||1
368397|NCT02081001|905136|P11|COMPLETED|Overall Study||2
368398|NCT02081001|905137|P10|COMPLETED|Overall Study||1
368399|NCT02081001|905138|P9|COMPLETED|Overall Study||2
368400|NCT02081001|905139|P8|COMPLETED|Overall Study||1
368401|NCT02081001|905140|P7|COMPLETED|Overall Study||2
368402|NCT02081001|905141|P6|COMPLETED|Overall Study||1
368403|NCT02081001|905142|P5|COMPLETED|Overall Study||2
368404|NCT02081001|905143|P4|COMPLETED|Overall Study||1
368405|NCT02081001|905144|P3|COMPLETED|Overall Study||2
368406|NCT02081001|905145|P2|COMPLETED|Overall Study||1
368407|NCT02081001|905146|P1|COMPLETED|Overall Study||2
368408|NCT02081001|905135|P12|STARTED|Overall Study||1
368409|NCT02081001|905136|P11|STARTED|Overall Study||2
368410|NCT02081001|905137|P10|STARTED|Overall Study||1
368411|NCT02081001|905138|P9|STARTED|Overall Study||2
368412|NCT02081001|905139|P8|STARTED|Overall Study||1
368413|NCT02081001|905140|P7|STARTED|Overall Study||2
368414|NCT02081001|905141|P6|STARTED|Overall Study||1
368415|NCT02081001|905142|P5|STARTED|Overall Study||3
368416|NCT02081001|905143|P4|STARTED|Overall Study||1
368417|NCT02081001|905144|P3|STARTED|Overall Study||2
368418|NCT02081001|905145|P2|STARTED|Overall Study||1
368419|NCT02081001|905146|P1|STARTED|Overall Study||2
368420|NCT02080832|905213|P3|NOT COMPLETED|Overall Study||16
368421|NCT02080832|905214|P2|NOT COMPLETED|Overall Study||12
368422|NCT02080832|905215|P1|NOT COMPLETED|Overall Study||9
368423|NCT02080832|905213|P3|COMPLETED|Overall Study||6
368424|NCT02080832|905214|P2|COMPLETED|Overall Study||5
368425|NCT02080832|905215|P1|COMPLETED|Overall Study||6
368426|NCT02080832|905213|P3|STARTED|Overall Study||22
368427|NCT02080832|905214|P2|STARTED|Overall Study||17
368428|NCT02080832|905215|P1|STARTED|Overall Study||15
368429|NCT02080819|905232|P3|NOT COMPLETED|Overall Study||22
368430|NCT02080819|905233|P2|NOT COMPLETED|Overall Study||26
368431|NCT02080819|905234|P1|NOT COMPLETED|Overall Study||25
368432|NCT02080819|905232|P3|COMPLETED|Overall Study||11
368433|NCT02080819|905233|P2|COMPLETED|Overall Study||9
368434|NCT02080819|905234|P1|COMPLETED|Overall Study||38
368435|NCT02080819|905232|P3|STARTED|Overall Study||33
368436|NCT02080819|905233|P2|STARTED|Overall Study||35
368437|NCT02080819|905234|P1|STARTED|Overall Study||63
368438|NCT02080780|905242|P1|NOT COMPLETED|Overall Study||0
368439|NCT02080780|905242|P1|COMPLETED|Overall Study||24
368440|NCT02080780|905242|P1|STARTED|Overall Study||24
368441|NCT02080546|905251|P2|NOT COMPLETED|Overall Study||11
368442|NCT02080546|905252|P1|NOT COMPLETED|Overall Study||8
368443|NCT02080546|905251|P2|COMPLETED|Overall Study||52
368444|NCT02080546|905252|P1|COMPLETED|Overall Study||49
368445|NCT02080546|905251|P2|STARTED|Overall Study||63
368446|NCT02080546|905252|P1|STARTED|Overall Study||57
368447|NCT02080507|905262|P2|NOT COMPLETED|Overall Study||0
368448|NCT02080507|905263|P1|NOT COMPLETED|Overall Study||0
368449|NCT02080507|905262|P2|COMPLETED|Overall Study||7
368450|NCT02080507|905263|P1|COMPLETED|Overall Study||5
368451|NCT02080507|905262|P2|STARTED|Overall Study||7
368452|NCT02080507|905263|P1|STARTED|Overall Study||5
368453|NCT02080481|905273|P2|NOT COMPLETED|Overall Study||0
368454|NCT02080481|905274|P1|NOT COMPLETED|Overall Study||1
368455|NCT02080481|905273|P2|COMPLETED|Overall Study||67
368456|NCT02080481|905274|P1|COMPLETED|Overall Study||67
368457|NCT02080481|905273|P2|STARTED|Overall Study||67
368458|NCT02080481|905274|P1|STARTED|Overall Study||68
368459|NCT02080312|905286|P1|NOT COMPLETED|Overall Study||0
368460|NCT02080312|905286|P1|COMPLETED|Overall Study||6
368461|NCT02080312|905286|P1|STARTED|Overall Study||6
368462|NCT02080091|905292|P1|NOT COMPLETED|Overall Study||25
368463|NCT02080091|905292|P1|COMPLETED|Overall Study||0
368464|NCT02080091|905292|P1|STARTED|Overall Study||25
368465|NCT02079844|905301|P3|NOT COMPLETED|Treatment Period 3||0
368466|NCT02079844|905302|P2|NOT COMPLETED|Treatment Period 3||0
368467|NCT02079844|905303|P1|NOT COMPLETED|Treatment Period 3||0
368468|NCT02079844|905301|P3|COMPLETED|Treatment Period 3||5
368469|NCT02079844|905302|P2|COMPLETED|Treatment Period 3||5
368470|NCT02079844|905303|P1|COMPLETED|Treatment Period 3||5
368471|NCT02079844|905301|P3|STARTED|Treatment Period 3||5
368472|NCT02079844|905302|P2|STARTED|Treatment Period 3|1 Participant Voluntarily Withdrew after completing Period 2.|5
368473|NCT02079844|905303|P1|STARTED|Treatment Period 3||5
368474|NCT02079844|905301|P3|NOT COMPLETED|Treatment Period 2||0
368475|NCT02079844|905302|P2|NOT COMPLETED|Treatment Period 2||1
368476|NCT02079844|905303|P1|NOT COMPLETED|Treatment Period 2||0
368477|NCT02079844|905301|P3|COMPLETED|Treatment Period 2||5
368478|NCT02079844|905302|P2|COMPLETED|Treatment Period 2||6
368479|NCT02079844|905303|P1|COMPLETED|Treatment Period 2||5
368480|NCT02079844|905301|P3|STARTED|Treatment Period 2||5
368481|NCT02079844|905302|P2|STARTED|Treatment Period 2||7
368482|NCT02079844|905303|P1|STARTED|Treatment Period 2|1 Participant was withdrawn due to an Adverse Event after completing Period 1.|5
368483|NCT02079844|905301|P3|NOT COMPLETED|Treatment Period 1||2
368484|NCT02079844|905302|P2|NOT COMPLETED|Treatment Period 1||0
368485|NCT02079844|905303|P1|NOT COMPLETED|Treatment Period 1||0
368486|NCT02079844|905301|P3|COMPLETED|Treatment Period 1||5
368487|NCT02079844|905302|P2|COMPLETED|Treatment Period 1||7
368488|NCT02079844|905303|P1|COMPLETED|Treatment Period 1||6
368489|NCT02079844|905301|P3|STARTED|Treatment Period 1||7
368490|NCT02079844|905302|P2|STARTED|Treatment Period 1||7
368491|NCT02079844|905303|P1|STARTED|Treatment Period 1||6
368492|NCT02079805|905361|P2|NOT COMPLETED|Overall Study||2
368493|NCT02079805|905362|P1|NOT COMPLETED|Overall Study||0
368494|NCT02079805|905361|P2|COMPLETED|Overall Study||15
368495|NCT02079805|905362|P1|COMPLETED|Overall Study||16
368496|NCT02079805|905361|P2|STARTED|Overall Study||17
368497|NCT02079805|905362|P1|STARTED|Overall Study||16
368498|NCT02079649|905384|P4|NOT COMPLETED|Overall Study||2
368499|NCT02079649|905385|P3|NOT COMPLETED|Overall Study||1
368500|NCT02079649|905386|P2|NOT COMPLETED|Overall Study||0
368501|NCT02079649|905387|P1|NOT COMPLETED|Overall Study||1
368502|NCT02079649|905384|P4|COMPLETED|Overall Study||38
368503|NCT02079649|905385|P3|COMPLETED|Overall Study||40
368504|NCT02079649|905386|P2|COMPLETED|Overall Study||41
368505|NCT02079649|905387|P1|COMPLETED|Overall Study||41
368506|NCT02079649|905384|P4|Treated|Overall Study||40
368507|NCT02079649|905385|P3|Treated|Overall Study||40
368508|NCT02079649|905386|P2|Treated|Overall Study||41
368509|NCT02079649|905387|P1|Treated|Overall Study||41
368510|NCT02079649|905384|P4|STARTED|Overall Study||40
368511|NCT02079649|905385|P3|STARTED|Overall Study||41
368512|NCT02079649|905386|P2|STARTED|Overall Study||41
368513|NCT02079649|905387|P1|STARTED|Overall Study||42
368514|NCT02079610|905404|P2|NOT COMPLETED|Overall Study||1
368515|NCT02079610|905405|P1|NOT COMPLETED|Overall Study||1
368516|NCT02079610|905404|P2|COMPLETED|Overall Study||16
368517|NCT02079610|905405|P1|COMPLETED|Overall Study||18
368518|NCT02079610|905404|P2|STARTED|Overall Study||17
368519|NCT02079610|905405|P1|STARTED|Overall Study||19
368520|NCT02079532|905415|P1|NOT COMPLETED|Overall Study||29
368521|NCT02079532|905415|P1|COMPLETED|Overall Study||273
368522|NCT02079532|905415|P1|STARTED|Overall Study||302
368523|NCT02079519|905437|P1|NOT COMPLETED|Overall Study||10
368524|NCT02079519|905437|P1|COMPLETED|Overall Study||0
368525|NCT02079519|905437|P1|STARTED|Overall Study||10
368526|NCT02079311|905443|P2|NOT COMPLETED|Overall Study||1
368527|NCT02079311|905444|P1|NOT COMPLETED|Overall Study||0
368528|NCT02079311|905443|P2|COMPLETED|Overall Study||26
368529|NCT02079311|905444|P1|COMPLETED|Overall Study||28
368530|NCT02079311|905443|P2|STARTED|Overall Study||27
368531|NCT02079311|905444|P1|STARTED|Overall Study||28
368532|NCT02078492|905453|P3|NOT COMPLETED|Overall Study||0
368533|NCT02078492|905454|P2|NOT COMPLETED|Overall Study||0
368534|NCT02078492|905455|P1|NOT COMPLETED|Overall Study||0
368535|NCT02078492|905453|P3|COMPLETED|Overall Study||80
368536|NCT02078492|905454|P2|COMPLETED|Overall Study||80
368537|NCT02078492|905455|P1|COMPLETED|Overall Study||80
368538|NCT02078492|905453|P3|STARTED|Overall Study||80
368539|NCT02078492|905454|P2|STARTED|Overall Study||80
368540|NCT02078492|905455|P1|STARTED|Overall Study||80
368541|NCT02078193|905472|P1|NOT COMPLETED|Overall Study||0
368542|NCT02078193|905472|P1|COMPLETED|Overall Study||3
368543|NCT02078193|905472|P1|STARTED|Overall Study||3
368544|NCT02078180|905478|P1|NOT COMPLETED|Overall Study||5
368545|NCT02078180|905478|P1|COMPLETED|Overall Study||29
368546|NCT02078180|905478|P1|XL 300|Overall Study||32
368547|NCT02078180|905478|P1|XL 150|Overall Study||31
368548|NCT02078180|905478|P1|SR150|Overall Study||32
368549|NCT02078180|905478|P1|SR100|Overall Study||31
368550|NCT02078180|905478|P1|IR100|Overall Study||31
368551|NCT02078180|905478|P1|IR75|Overall Study||30
368552|NCT02078180|905478|P1|STARTED|Overall Study||34
368553|NCT02077374|905495|P2|NOT COMPLETED|Overall Study||2
368554|NCT02077374|905496|P1|NOT COMPLETED|Overall Study||0
368555|NCT02077374|905495|P2|COMPLETED|Overall Study||17
368556|NCT02077374|905496|P1|COMPLETED|Overall Study||19
368557|NCT02077374|905495|P2|STARTED|Overall Study||19
368558|NCT02077374|905496|P1|STARTED|Overall Study||19
368559|NCT02077140|905517|P5|NOT COMPLETED|Overall Study||5
368560|NCT02077140|905518|P4|NOT COMPLETED|Overall Study||4
368561|NCT02077140|905519|P3|NOT COMPLETED|Overall Study||2
368562|NCT02077140|905520|P2|NOT COMPLETED|Overall Study||2
368563|NCT02077140|905521|P1|NOT COMPLETED|Overall Study||4
368564|NCT02077140|905517|P5|COMPLETED|Overall Study||43
368565|NCT02077140|905518|P4|COMPLETED|Overall Study||32
368566|NCT02077140|905519|P3|COMPLETED|Overall Study||34
368567|NCT02077140|905520|P2|COMPLETED|Overall Study||34
368568|NCT02077140|905521|P1|COMPLETED|Overall Study||32
368569|NCT02077140|905517|P5|STARTED|Overall Study||48
368570|NCT02077140|905518|P4|STARTED|Overall Study||36
368571|NCT02077140|905519|P3|STARTED|Overall Study||36
368572|NCT02077140|905520|P2|STARTED|Overall Study||36
368573|NCT02077140|905521|P1|STARTED|Overall Study||36
368574|NCT02076919|905620|P4|NOT COMPLETED|Overall Study||0
368575|NCT02076919|905621|P3|NOT COMPLETED|Overall Study||0
368576|NCT02076919|905622|P2|NOT COMPLETED|Overall Study||0
368577|NCT02076919|905623|P1|NOT COMPLETED|Overall Study||0
368578|NCT02076919|905620|P4|COMPLETED|Overall Study||12
368579|NCT02076919|905621|P3|COMPLETED|Overall Study||36
368580|NCT02076919|905622|P2|COMPLETED|Overall Study||8
368581|NCT02076919|905623|P1|COMPLETED|Overall Study||24
368582|NCT02076919|905620|P4|STARTED|Overall Study||12
368583|NCT02076919|905621|P3|STARTED|Overall Study||36
368584|NCT02076919|905622|P2|STARTED|Overall Study||8
368585|NCT02076919|905623|P1|STARTED|Overall Study||24
368586|NCT02076334|905725|P4|NOT COMPLETED|Overall Study||1
368587|NCT02076334|905726|P3|NOT COMPLETED|Overall Study||1
368588|NCT02076334|905727|P2|NOT COMPLETED|Overall Study||1
368589|NCT02076334|905728|P1|NOT COMPLETED|Overall Study||1
368590|NCT02076334|905725|P4|COMPLETED|Overall Study||20
368591|NCT02076334|905726|P3|COMPLETED|Overall Study||20
368592|NCT02076334|905727|P2|COMPLETED|Overall Study||20
368593|NCT02076334|905728|P1|COMPLETED|Overall Study||20
368594|NCT02076334|905725|P4|STARTED|Overall Study||21
368595|NCT02076334|905726|P3|STARTED|Overall Study||21
368596|NCT02076334|905727|P2|STARTED|Overall Study||21
368597|NCT02076334|905728|P1|STARTED|Overall Study||21
368598|NCT02076321|905744|P2|NOT COMPLETED|Overall Study||2
368599|NCT02076321|905745|P1|NOT COMPLETED|Overall Study||5
368600|NCT02076321|905744|P2|COMPLETED|Overall Study||49
368601|NCT02076321|905745|P1|COMPLETED|Overall Study||46
368602|NCT02076321|905744|P2|STARTED|Overall Study||51
368603|NCT02076321|905745|P1|STARTED|Overall Study||51
368604|NCT02076243|905751|P1|NOT COMPLETED|Overall Study||2
368605|NCT02076243|905751|P1|COMPLETED|Overall Study||0
368606|NCT02076243|905751|P1|STARTED|Overall Study||2
368607|NCT02076178|905761|P2|NOT COMPLETED|Injection Phase||7
368608|NCT02076178|905762|P1|NOT COMPLETED|Injection Phase||1
368609|NCT02076178|905761|P2|COMPLETED|Injection Phase||87
368610|NCT02076178|905762|P1|COMPLETED|Injection Phase||20
368611|NCT02076178|905761|P2|STARTED|Injection Phase||94
368612|NCT02076178|905762|P1|STARTED|Injection Phase||21
368613|NCT02076178|905761|P2|NOT COMPLETED|Oral Phase||12
368614|NCT02076178|905762|P1|NOT COMPLETED|Oral Phase||0
368615|NCT02076178|905761|P2|COMPLETED|Oral Phase||94
368616|NCT02076178|905762|P1|COMPLETED|Oral Phase||21
368617|NCT02076178|905761|P2|STARTED|Oral Phase||106
368618|NCT02076178|905762|P1|STARTED|Oral Phase||21
368619|NCT02076009|905796|P2|NOT COMPLETED|Overall Study||286
368620|NCT02076009|905797|P1|NOT COMPLETED|Overall Study||283
368621|NCT02076009|905796|P2|COMPLETED|Overall Study||0
368622|NCT02076009|905797|P1|COMPLETED|Overall Study||0
368623|NCT02076009|905796|P2|Treated|Overall Study||283
368624|NCT02076009|905797|P1|Treated|Overall Study||281
368625|NCT02076009|905796|P2|STARTED|Overall Study||286
368626|NCT02076009|905797|P1|STARTED|Overall Study||283
368627|NCT02075840|905819|P2|NOT COMPLETED|Overall Study||151
368628|NCT02075840|905820|P1|NOT COMPLETED|Overall Study||152
368629|NCT02075840|905819|P2|COMPLETED|Overall Study||0
368630|NCT02075840|905820|P1|COMPLETED|Overall Study||0
368631|NCT02075840|905819|P2|STARTED|Overall Study||151
368632|NCT02075840|905820|P1|STARTED|Overall Study||152
368633|NCT02075658|905876|P2|NOT COMPLETED|Overall Study||2
368634|NCT02075658|905877|P1|NOT COMPLETED|Overall Study||2
368635|NCT02075658|905876|P2|COMPLETED|Overall Study||28
368636|NCT02075658|905877|P1|COMPLETED|Overall Study||28
368637|NCT02075658|905876|P2|STARTED|Overall Study||30
368638|NCT02075658|905877|P1|STARTED|Overall Study||30
368639|NCT02075632|905887|P2|NOT COMPLETED|Overall Study||5
368640|NCT02075632|905888|P1|NOT COMPLETED|Overall Study||1
368641|NCT02075632|905887|P2|COMPLETED|Overall Study||143
368642|NCT02075632|905888|P1|COMPLETED|Overall Study||161
368643|NCT02075632|905887|P2|STARTED|Overall Study||148
368644|NCT02075632|905888|P1|STARTED|Overall Study||162
368645|NCT02075515|905901|P3|NOT COMPLETED|Overall Study||8
368646|NCT02075515|905902|P2|NOT COMPLETED|Overall Study||5
368647|NCT02075515|905903|P1|NOT COMPLETED|Overall Study||4
368648|NCT02075515|905901|P3|COMPLETED|Overall Study||208
368649|NCT02075515|905902|P2|COMPLETED|Overall Study||212
368650|NCT02075515|905903|P1|COMPLETED|Overall Study||214
368651|NCT02075515|905901|P3|STARTED|Overall Study||216
368652|NCT02075515|905902|P2|STARTED|Overall Study||217
368653|NCT02075515|905903|P1|STARTED|Overall Study||218
368654|NCT02075463|905938|P1|NOT COMPLETED|Overall Study||8
368655|NCT02075463|905938|P1|COMPLETED|Overall Study||7
368656|NCT02075463|905938|P1|STARTED|Overall Study||15
368657|NCT02075411|905967|P4|NOT COMPLETED|Overall Study||0
368658|NCT02075411|905968|P3|NOT COMPLETED|Overall Study||0
368659|NCT02075411|905969|P2|NOT COMPLETED|Overall Study||0
368660|NCT02075411|905970|P1|NOT COMPLETED|Overall Study||0
368661|NCT02075411|905967|P4|COMPLETED|Overall Study||1
368662|NCT02075411|905968|P3|COMPLETED|Overall Study||0
368663|NCT02075411|905969|P2|COMPLETED|Overall Study||0
368664|NCT02075411|905970|P1|COMPLETED|Overall Study||0
368665|NCT02075411|905967|P4|STARTED|Overall Study||1
368666|NCT02075411|905968|P3|STARTED|Overall Study||0
368667|NCT02075411|905969|P2|STARTED|Overall Study||0
368668|NCT02075411|905970|P1|STARTED|Overall Study||0
368669|NCT02075320|905988|P1|NOT COMPLETED|Overall Study||2
368670|NCT02075320|905988|P1|COMPLETED|Overall Study||48
368671|NCT02075320|905988|P1|STARTED|Overall Study||50
368672|NCT02075255|905998|P3|NOT COMPLETED|Overall Study||3
368673|NCT02075255|905999|P2|NOT COMPLETED|Overall Study||4
368674|NCT02075255|906000|P1|NOT COMPLETED|Overall Study||4
368675|NCT02075255|905998|P3|COMPLETED|Overall Study||72
368676|NCT02075255|905999|P2|COMPLETED|Overall Study||69
368677|NCT02075255|906000|P1|COMPLETED|Overall Study||68
368678|NCT02075255|905998|P3|STARTED|Overall Study||75
368679|NCT02075255|905999|P2|STARTED|Overall Study||73
368680|NCT02075255|906000|P1|STARTED|Overall Study||72
368681|NCT02075125|906109|P2|NOT COMPLETED|Overall Study||1
368682|NCT02075125|906110|P1|NOT COMPLETED|Overall Study||0
368683|NCT02075125|906109|P2|COMPLETED|Overall Study|One patient switched to clopidogrel treatment after 18 days of ticagrelor treatment.|19
368684|NCT02075125|906110|P1|COMPLETED|Overall Study||19
368685|NCT02075125|906109|P2|STARTED|Overall Study||20
368686|NCT02075125|906110|P1|STARTED|Overall Study||19
368687|NCT02075073|906131|P3|NOT COMPLETED|Overall Study||0
368688|NCT02075073|906132|P2|NOT COMPLETED|Overall Study||1
368689|NCT02075073|906133|P1|NOT COMPLETED|Overall Study||0
368690|NCT02075073|906131|P3|COMPLETED|Overall Study||36
368691|NCT02075073|906132|P2|COMPLETED|Overall Study||36
368692|NCT02075073|906133|P1|COMPLETED|Overall Study||36
368693|NCT02075073|906131|P3|STARTED|Overall Study||36
368694|NCT02075073|906132|P2|STARTED|Overall Study||37
368695|NCT02075073|906133|P1|STARTED|Overall Study||36
368696|NCT02075021|906150|P1|NOT COMPLETED|Overall Study||0
368697|NCT02075021|906150|P1|COMPLETED|Overall Study||3
368698|NCT02075021|906150|P1|STARTED|Overall Study||3
368699|NCT02075008|906155|P1|NOT COMPLETED|Overall Study||176
368700|NCT02075008|906155|P1|COMPLETED|Overall Study||94
368701|NCT02075008|906155|P1|STARTED|Overall Study||270
368702|NCT02074995|906159|P3|NOT COMPLETED|Overall Study||0
368703|NCT02074995|906160|P2|NOT COMPLETED|Overall Study||0
368704|NCT02074995|906161|P1|NOT COMPLETED|Overall Study||0
368705|NCT02074995|906159|P3|COMPLETED|Overall Study||0
368706|NCT02074995|906160|P2|COMPLETED|Overall Study||0
368707|NCT02074995|906161|P1|COMPLETED|Overall Study||1
368708|NCT02074995|906159|P3|STARTED|Overall Study||0
368709|NCT02074995|906160|P2|STARTED|Overall Study||0
368710|NCT02074995|906161|P1|STARTED|Overall Study||1
368711|NCT02074982|906178|P2|NOT COMPLETED|Overall Study||54
368712|NCT02074982|906179|P1|NOT COMPLETED|Overall Study||51
368713|NCT02074982|906178|P2|COMPLETED|Overall Study||285
368714|NCT02074982|906179|P1|COMPLETED|Overall Study||286
368715|NCT02074982|906178|P2|Safety Set (SF)|Overall Study||336
368716|NCT02074982|906179|P1|Safety Set (SF)|Overall Study||335
368717|NCT02074982|906178|P2|Full Analysis Set (FAS)|Overall Study||339
368718|NCT02074982|906179|P1|Full Analysis Set (FAS)|Overall Study||336
368719|NCT02074982|906178|P2|STARTED|Overall Study||339
368720|NCT02074982|906179|P1|STARTED|Overall Study||337
368721|NCT02074904|906191|P2|NOT COMPLETED|Overall Study||0
368722|NCT02074904|906192|P1|NOT COMPLETED|Overall Study||0
368723|NCT02074904|906191|P2|COMPLETED|Overall Study||0
368724|NCT02074904|906192|P1|COMPLETED|Overall Study||1
368725|NCT02074904|906191|P2|STARTED|Overall Study||0
368726|NCT02074904|906192|P1|STARTED|Overall Study||1
368727|NCT02074709|906208|P2|NOT COMPLETED|Overall Study||1
368728|NCT02074709|906209|P1|NOT COMPLETED|Overall Study||1
368729|NCT02074709|906208|P2|COMPLETED|Overall Study||29
368730|NCT02074709|906209|P1|COMPLETED|Overall Study||29
368731|NCT02074709|906208|P2|STARTED|Overall Study||30
368732|NCT02074709|906209|P1|STARTED|Overall Study||30
368733|NCT02074553|906217|P8|NOT COMPLETED|Intervention Period 4||0
368734|NCT02074553|906218|P7|NOT COMPLETED|Intervention Period 4||0
368735|NCT02074553|906219|P6|NOT COMPLETED|Intervention Period 4||0
368736|NCT02074553|906220|P5|NOT COMPLETED|Intervention Period 4||0
368737|NCT02074553|906221|P4|NOT COMPLETED|Intervention Period 4||0
368738|NCT02074553|906222|P3|NOT COMPLETED|Intervention Period 4||0
368739|NCT02074553|906223|P2|NOT COMPLETED|Intervention Period 4||0
368740|NCT02074553|906224|P1|NOT COMPLETED|Intervention Period 4||0
368741|NCT02074553|906217|P8|COMPLETED|Intervention Period 4||11
368742|NCT02074553|906218|P7|COMPLETED|Intervention Period 4||11
368743|NCT02074553|906219|P6|COMPLETED|Intervention Period 4||10
368744|NCT02074553|906220|P5|COMPLETED|Intervention Period 4||12
368745|NCT02074553|906221|P4|COMPLETED|Intervention Period 4||11
368746|NCT02074553|906222|P3|COMPLETED|Intervention Period 4||11
368747|NCT02074553|906223|P2|COMPLETED|Intervention Period 4||12
368748|NCT02074553|906224|P1|COMPLETED|Intervention Period 4||11
368749|NCT02074553|906217|P8|STARTED|Intervention Period 4||11
368750|NCT02074553|906218|P7|STARTED|Intervention Period 4||11
368751|NCT02074553|906219|P6|STARTED|Intervention Period 4||10
368752|NCT02074553|906220|P5|STARTED|Intervention Period 4||12
368753|NCT02074553|906221|P4|STARTED|Intervention Period 4||11
368754|NCT02074553|906222|P3|STARTED|Intervention Period 4||11
368755|NCT02074553|906223|P2|STARTED|Intervention Period 4||12
368756|NCT02074553|906224|P1|STARTED|Intervention Period 4||11
368757|NCT02074553|906217|P8|NOT COMPLETED|Washout Period 3||1
368758|NCT02074553|906218|P7|NOT COMPLETED|Washout Period 3||0
368759|NCT02074553|906219|P6|NOT COMPLETED|Washout Period 3||0
368760|NCT02074553|906220|P5|NOT COMPLETED|Washout Period 3||0
368761|NCT02074553|906221|P4|NOT COMPLETED|Washout Period 3||0
368762|NCT02074553|906222|P3|NOT COMPLETED|Washout Period 3||0
368763|NCT02074553|906223|P2|NOT COMPLETED|Washout Period 3||0
368764|NCT02074553|906224|P1|NOT COMPLETED|Washout Period 3||0
368765|NCT02074553|906217|P8|COMPLETED|Washout Period 3||11
368766|NCT02074553|906218|P7|COMPLETED|Washout Period 3||11
368767|NCT02074553|906219|P6|COMPLETED|Washout Period 3||10
368768|NCT02074553|906220|P5|COMPLETED|Washout Period 3||12
368769|NCT02074553|906221|P4|COMPLETED|Washout Period 3||11
368770|NCT02074553|906222|P3|COMPLETED|Washout Period 3||11
368771|NCT02074553|906223|P2|COMPLETED|Washout Period 3||12
368772|NCT02074553|906224|P1|COMPLETED|Washout Period 3||11
368773|NCT02074553|906217|P8|STARTED|Washout Period 3||12
368774|NCT02074553|906218|P7|STARTED|Washout Period 3||11
368775|NCT02074553|906219|P6|STARTED|Washout Period 3||10
368776|NCT02074553|906220|P5|STARTED|Washout Period 3||12
368777|NCT02074553|906221|P4|STARTED|Washout Period 3||11
368778|NCT02074553|906222|P3|STARTED|Washout Period 3||11
368779|NCT02074553|906223|P2|STARTED|Washout Period 3||12
368780|NCT02074553|906224|P1|STARTED|Washout Period 3||11
368781|NCT02074553|906217|P8|NOT COMPLETED|Intervention Period 3||0
368782|NCT02074553|906218|P7|NOT COMPLETED|Intervention Period 3||0
368783|NCT02074553|906219|P6|NOT COMPLETED|Intervention Period 3||0
368784|NCT02074553|906220|P5|NOT COMPLETED|Intervention Period 3||0
368785|NCT02074553|906221|P4|NOT COMPLETED|Intervention Period 3||0
368786|NCT02074553|906222|P3|NOT COMPLETED|Intervention Period 3||0
368787|NCT02074553|906223|P2|NOT COMPLETED|Intervention Period 3||0
368788|NCT02074553|906224|P1|NOT COMPLETED|Intervention Period 3||0
368789|NCT02074553|906217|P8|COMPLETED|Intervention Period 3||12
368790|NCT02074553|906218|P7|COMPLETED|Intervention Period 3||11
368791|NCT02074553|906219|P6|COMPLETED|Intervention Period 3||10
368792|NCT02074553|906220|P5|COMPLETED|Intervention Period 3||12
368793|NCT02074553|906221|P4|COMPLETED|Intervention Period 3||11
368794|NCT02074553|906222|P3|COMPLETED|Intervention Period 3||11
368795|NCT02074553|906223|P2|COMPLETED|Intervention Period 3||12
368796|NCT02074553|906224|P1|COMPLETED|Intervention Period 3||11
368797|NCT02074553|906217|P8|STARTED|Intervention Period 3||12
368798|NCT02074553|906218|P7|STARTED|Intervention Period 3||11
368799|NCT02074553|906219|P6|STARTED|Intervention Period 3||10
368800|NCT02074553|906220|P5|STARTED|Intervention Period 3||12
368801|NCT02074553|906221|P4|STARTED|Intervention Period 3||11
368802|NCT02074553|906222|P3|STARTED|Intervention Period 3||11
368803|NCT02074553|906223|P2|STARTED|Intervention Period 3||12
368804|NCT02074553|906224|P1|STARTED|Intervention Period 3||11
368805|NCT02074553|906217|P8|NOT COMPLETED|Washout Period 2||0
368806|NCT02074553|906218|P7|NOT COMPLETED|Washout Period 2||1
368807|NCT02074553|906219|P6|NOT COMPLETED|Washout Period 2||1
368808|NCT02074553|906220|P5|NOT COMPLETED|Washout Period 2||0
368809|NCT02074553|906221|P4|NOT COMPLETED|Washout Period 2||0
368810|NCT02074553|906222|P3|NOT COMPLETED|Washout Period 2||1
368811|NCT02074553|906223|P2|NOT COMPLETED|Washout Period 2||0
368812|NCT02074553|906224|P1|NOT COMPLETED|Washout Period 2||0
368813|NCT02074553|906217|P8|COMPLETED|Washout Period 2||12
368814|NCT02074553|906218|P7|COMPLETED|Washout Period 2||11
368815|NCT02074553|906219|P6|COMPLETED|Washout Period 2||10
368816|NCT02074553|906220|P5|COMPLETED|Washout Period 2||12
368817|NCT02074553|906221|P4|COMPLETED|Washout Period 2||11
368818|NCT02074553|906222|P3|COMPLETED|Washout Period 2||11
368819|NCT02074553|906223|P2|COMPLETED|Washout Period 2||12
368820|NCT02074553|906224|P1|COMPLETED|Washout Period 2||11
368821|NCT02074553|906217|P8|STARTED|Washout Period 2||12
368822|NCT02074553|906218|P7|STARTED|Washout Period 2||12
368823|NCT02074553|906219|P6|STARTED|Washout Period 2||11
368824|NCT02074553|906220|P5|STARTED|Washout Period 2||12
368825|NCT02074553|906221|P4|STARTED|Washout Period 2||11
368826|NCT02074553|906222|P3|STARTED|Washout Period 2||12
368827|NCT02074553|906223|P2|STARTED|Washout Period 2||12
368828|NCT02074553|906224|P1|STARTED|Washout Period 2||11
368829|NCT02074553|906217|P8|NOT COMPLETED|Intervention Period 2||0
368830|NCT02074553|906218|P7|NOT COMPLETED|Intervention Period 2||0
368831|NCT02074553|906219|P6|NOT COMPLETED|Intervention Period 2||0
368832|NCT02074553|906220|P5|NOT COMPLETED|Intervention Period 2||0
368833|NCT02074553|906221|P4|NOT COMPLETED|Intervention Period 2||0
368834|NCT02074553|906222|P3|NOT COMPLETED|Intervention Period 2||0
368835|NCT02074553|906223|P2|NOT COMPLETED|Intervention Period 2||0
368836|NCT02074553|906224|P1|NOT COMPLETED|Intervention Period 2||0
368837|NCT02074553|906217|P8|COMPLETED|Intervention Period 2||12
368838|NCT02074553|906218|P7|COMPLETED|Intervention Period 2||12
368839|NCT02074553|906219|P6|COMPLETED|Intervention Period 2||11
368840|NCT02074553|906220|P5|COMPLETED|Intervention Period 2||12
368841|NCT02074553|906221|P4|COMPLETED|Intervention Period 2||11
368842|NCT02074553|906222|P3|COMPLETED|Intervention Period 2||12
368843|NCT02074553|906223|P2|COMPLETED|Intervention Period 2||12
368844|NCT02074553|906224|P1|COMPLETED|Intervention Period 2||11
368845|NCT02074553|906217|P8|STARTED|Intervention Period 2||12
368846|NCT02074553|906218|P7|STARTED|Intervention Period 2||12
368847|NCT02074553|906219|P6|STARTED|Intervention Period 2||11
368848|NCT02074553|906220|P5|STARTED|Intervention Period 2||12
368849|NCT02074553|906221|P4|STARTED|Intervention Period 2||11
368850|NCT02074553|906222|P3|STARTED|Intervention Period 2||12
368851|NCT02074553|906223|P2|STARTED|Intervention Period 2||12
368852|NCT02074553|906224|P1|STARTED|Intervention Period 2||11
368853|NCT02074553|906217|P8|NOT COMPLETED|Washout Period 1||0
368854|NCT02074553|906218|P7|NOT COMPLETED|Washout Period 1||0
368855|NCT02074553|906219|P6|NOT COMPLETED|Washout Period 1||1
368856|NCT02074553|906220|P5|NOT COMPLETED|Washout Period 1||0
368857|NCT02074553|906221|P4|NOT COMPLETED|Washout Period 1||1
368858|NCT02074553|906222|P3|NOT COMPLETED|Washout Period 1||0
368859|NCT02074553|906223|P2|NOT COMPLETED|Washout Period 1||0
368860|NCT02074553|906224|P1|NOT COMPLETED|Washout Period 1||1
368861|NCT02074553|906217|P8|COMPLETED|Washout Period 1||12
368862|NCT02074553|906218|P7|COMPLETED|Washout Period 1||12
368863|NCT02074553|906219|P6|COMPLETED|Washout Period 1||11
368864|NCT02074553|906220|P5|COMPLETED|Washout Period 1||12
368865|NCT02074553|906221|P4|COMPLETED|Washout Period 1||11
368866|NCT02074553|906222|P3|COMPLETED|Washout Period 1||12
368867|NCT02074553|906223|P2|COMPLETED|Washout Period 1||12
368868|NCT02074553|906224|P1|COMPLETED|Washout Period 1||11
368869|NCT02074553|906217|P8|STARTED|Washout Period 1||12
368870|NCT02074553|906218|P7|STARTED|Washout Period 1||12
368871|NCT02074553|906219|P6|STARTED|Washout Period 1||12
368872|NCT02074553|906220|P5|STARTED|Washout Period 1||12
368873|NCT02074553|906221|P4|STARTED|Washout Period 1||12
368874|NCT02074553|906222|P3|STARTED|Washout Period 1||12
368875|NCT02074553|906223|P2|STARTED|Washout Period 1||12
368876|NCT02074553|906224|P1|STARTED|Washout Period 1||12
368877|NCT02074553|906217|P8|NOT COMPLETED|Intervention Period 1||0
368878|NCT02074553|906218|P7|NOT COMPLETED|Intervention Period 1||0
368879|NCT02074553|906219|P6|NOT COMPLETED|Intervention Period 1||0
368880|NCT02074553|906220|P5|NOT COMPLETED|Intervention Period 1||0
368881|NCT02074553|906221|P4|NOT COMPLETED|Intervention Period 1||1
368882|NCT02074553|906222|P3|NOT COMPLETED|Intervention Period 1||0
368883|NCT02074553|906223|P2|NOT COMPLETED|Intervention Period 1||0
368884|NCT02074553|906224|P1|NOT COMPLETED|Intervention Period 1||0
368885|NCT02074553|906217|P8|COMPLETED|Intervention Period 1||12
368886|NCT02074553|906218|P7|COMPLETED|Intervention Period 1||12
368887|NCT02074553|906219|P6|COMPLETED|Intervention Period 1||12
368888|NCT02074553|906220|P5|COMPLETED|Intervention Period 1||12
368889|NCT02074553|906221|P4|COMPLETED|Intervention Period 1||12
368890|NCT02074553|906222|P3|COMPLETED|Intervention Period 1||12
368891|NCT02074553|906223|P2|COMPLETED|Intervention Period 1||12
368892|NCT02074553|906224|P1|COMPLETED|Intervention Period 1||12
368893|NCT02074553|906217|P8|STARTED|Intervention Period 1||12
368894|NCT02074553|906218|P7|STARTED|Intervention Period 1||12
368895|NCT02074553|906219|P6|STARTED|Intervention Period 1||12
368896|NCT02074553|906220|P5|STARTED|Intervention Period 1||12
368897|NCT02074553|906221|P4|STARTED|Intervention Period 1||13
368898|NCT02074553|906222|P3|STARTED|Intervention Period 1||12
368899|NCT02074553|906223|P2|STARTED|Intervention Period 1||12
368900|NCT02074553|906224|P1|STARTED|Intervention Period 1||12
368901|NCT02074514|906406|P2|NOT COMPLETED|Overall Study||4
368902|NCT02074514|906407|P1|NOT COMPLETED|Overall Study||3
368903|NCT02074514|906406|P2|COMPLETED|Overall Study||54
368904|NCT02074514|906407|P1|COMPLETED|Overall Study||56
368905|NCT02074514|906406|P2|STARTED|Overall Study||58
368906|NCT02074514|906407|P1|STARTED|Overall Study||59
368907|NCT02074384|906428|P3|NOT COMPLETED|Overall Study||0
368908|NCT02074384|906429|P2|NOT COMPLETED|Overall Study||0
368909|NCT02074384|906430|P1|NOT COMPLETED|Overall Study||0
368910|NCT02074384|906428|P3|COMPLETED|Overall Study||17
368911|NCT02074384|906429|P2|COMPLETED|Overall Study||70
368912|NCT02074384|906430|P1|COMPLETED|Overall Study||74
368913|NCT02074384|906428|P3|STARTED|Overall Study||17
368914|NCT02074384|906429|P2|STARTED|Overall Study||70
368915|NCT02074384|906430|P1|STARTED|Overall Study||74
368916|NCT02074358|906438|P6|NOT COMPLETED|Overall Study||0
368917|NCT02074358|906439|P5|NOT COMPLETED|Overall Study||0
368918|NCT02074358|906440|P4|NOT COMPLETED|Overall Study||0
368919|NCT02074358|906441|P3|NOT COMPLETED|Overall Study||0
368920|NCT02074358|906442|P2|NOT COMPLETED|Overall Study||0
368921|NCT02074358|906443|P1|NOT COMPLETED|Overall Study||0
368922|NCT02074358|906438|P6|COMPLETED|Overall Study||2
368923|NCT02074358|906439|P5|COMPLETED|Overall Study||3
368924|NCT02074358|906440|P4|COMPLETED|Overall Study||2
368925|NCT02074358|906441|P3|COMPLETED|Overall Study||2
368926|NCT02074358|906442|P2|COMPLETED|Overall Study||3
368927|NCT02074358|906443|P1|COMPLETED|Overall Study||3
368928|NCT02074358|906438|P6|STARTED|Overall Study||2
368929|NCT02074358|906439|P5|STARTED|Overall Study||3
368930|NCT02074358|906440|P4|STARTED|Overall Study||2
368931|NCT02074358|906441|P3|STARTED|Overall Study||2
368932|NCT02074358|906442|P2|STARTED|Overall Study||3
368933|NCT02074358|906443|P1|STARTED|Overall Study||3
368934|NCT02074345|906532|P1|NOT COMPLETED|Overall Study||0
368935|NCT02074345|906532|P1|COMPLETED|Overall Study||31
368936|NCT02074345|906532|P1|STARTED|Overall Study||31
368937|NCT02074059|906548|P6|NOT COMPLETED|Overall Study||1
368938|NCT02074059|906549|P5|NOT COMPLETED|Overall Study||1
368939|NCT02074059|906550|P4|NOT COMPLETED|Overall Study||0
368940|NCT02074059|906551|P3|NOT COMPLETED|Overall Study||0
368941|NCT02074059|906552|P2|NOT COMPLETED|Overall Study||0
368942|NCT02074059|906553|P1|NOT COMPLETED|Overall Study||0
368943|NCT02074059|906548|P6|COMPLETED|Overall Study||39
368944|NCT02074059|906549|P5|COMPLETED|Overall Study||7
368945|NCT02074059|906550|P4|COMPLETED|Overall Study||8
368946|NCT02074059|906551|P3|COMPLETED|Overall Study||8
368947|NCT02074059|906552|P2|COMPLETED|Overall Study||8
368948|NCT02074059|906553|P1|COMPLETED|Overall Study||8
368949|NCT02074059|906548|P6|STARTED|Overall Study||40
368950|NCT02074059|906549|P5|STARTED|Overall Study||8
368951|NCT02074059|906550|P4|STARTED|Overall Study||8
368952|NCT02074059|906551|P3|STARTED|Overall Study||8
368953|NCT02074059|906552|P2|STARTED|Overall Study||8
368954|NCT02074059|906553|P1|STARTED|Overall Study||8
368955|NCT02073747|906593|P2|NOT COMPLETED|Overall Study||1
368956|NCT02073747|906594|P1|NOT COMPLETED|Overall Study||1
368957|NCT02073747|906593|P2|COMPLETED|Overall Study||14
368958|NCT02073747|906594|P1|COMPLETED|Overall Study||14
368959|NCT02073747|906593|P2|STARTED|Overall Study||15
368960|NCT02073747|906594|P1|STARTED|Overall Study||15
368961|NCT02073656|906600|P1|NOT COMPLETED|Retreatment Substudy||0
368962|NCT02073656|906600|P1|COMPLETED|Retreatment Substudy||9
368963|NCT02073656|906600|P1|STARTED|Retreatment Substudy|Only participants experiencing virologic relapse in the Primary Study were eligible for retreatment.|9
368964|NCT02073656|906600|P1|NOT COMPLETED|Primary Study||8
368965|NCT02073656|906600|P1|COMPLETED|Primary Study||327
368966|NCT02073656|906600|P1|STARTED|Primary Study||335
368967|NCT02073461|906619|P3|NOT COMPLETED|Overall Study||1
368968|NCT02073461|906620|P2|NOT COMPLETED|Overall Study||1
368969|NCT02073461|906621|P1|NOT COMPLETED|Overall Study||4
368970|NCT02073461|906619|P3|COMPLETED|Overall Study||78
368971|NCT02073461|906620|P2|COMPLETED|Overall Study||77
368972|NCT02073461|906621|P1|COMPLETED|Overall Study||75
368973|NCT02073461|906619|P3|STARTED|Overall Study||79
368974|NCT02073461|906620|P2|STARTED|Overall Study||78
368975|NCT02073461|906621|P1|STARTED|Overall Study||79
368976|NCT02073448|906650|P3|NOT COMPLETED|Overall Study||5
368977|NCT02073448|906651|P2|NOT COMPLETED|Overall Study||12
368978|NCT02073448|906652|P1|NOT COMPLETED|Overall Study||2
368979|NCT02073448|906650|P3|COMPLETED|Overall Study||99
368980|NCT02073448|906651|P2|COMPLETED|Overall Study||200
368981|NCT02073448|906652|P1|COMPLETED|Overall Study||99
368982|NCT02073448|906650|P3|STARTED|Overall Study||104
368983|NCT02073448|906651|P2|STARTED|Overall Study||212
368984|NCT02073448|906652|P1|STARTED|Overall Study||101
368985|NCT02072980|906678|P2|NOT COMPLETED|Period 2, Second Wear||1
368986|NCT02072980|906679|P1|NOT COMPLETED|Period 2, Second Wear||0
368987|NCT02072980|906678|P2|COMPLETED|Period 2, Second Wear||7
368988|NCT02072980|906679|P1|COMPLETED|Period 2, Second Wear||7
368989|NCT02072980|906678|P2|STARTED|Period 2, Second Wear||8
368990|NCT02072980|906679|P1|STARTED|Period 2, Second Wear||7
368991|NCT02072980|906678|P2|NOT COMPLETED|Period 1, First Wear||0
368992|NCT02072980|906679|P1|NOT COMPLETED|Period 1, First Wear||0
368993|NCT02072980|906678|P2|COMPLETED|Period 1, First Wear||8
368994|NCT02072980|906679|P1|COMPLETED|Period 1, First Wear||7
368995|NCT02072980|906678|P2|STARTED|Period 1, First Wear||8
368996|NCT02072980|906679|P1|STARTED|Period 1, First Wear||7
368997|NCT02072928|906685|P1|NOT COMPLETED|Overall Study||0
368998|NCT02072928|906685|P1|COMPLETED|Overall Study||55
368999|NCT02072928|906685|P1|STARTED|Overall Study||55
369000|NCT02072421|906689|P1|NOT COMPLETED|Overall Study||390
369001|NCT02072421|906689|P1|COMPLETED|Overall Study||2489
369002|NCT02072421|906689|P1|STARTED|Overall Study||2879
369003|NCT02072200|906697|P1|NOT COMPLETED|Overall Study||2
369004|NCT02072200|906697|P1|COMPLETED|Overall Study||145
369005|NCT02072200|906697|P1|STARTED|Overall Study||147
369006|NCT02072096|906705|P2|NOT COMPLETED|Overall Study||78
369007|NCT02072096|906706|P1|NOT COMPLETED|Overall Study||85
369008|NCT02072096|906705|P2|COMPLETED|Overall Study||15
369009|NCT02072096|906706|P1|COMPLETED|Overall Study||14
369010|NCT02072096|906705|P2|Received at Least One Dose of Study Drug|Overall Study||93
369011|NCT02072096|906706|P1|Received at Least One Dose of Study Drug|Overall Study||98
369012|NCT02072096|906705|P2|STARTED|Overall Study||93
369013|NCT02072096|906706|P1|STARTED|Overall Study||99
369014|NCT02071849|906728|P1|NOT COMPLETED|2-year Extended Follow-up||1
369015|NCT02071849|906728|P1|COMPLETED|2-year Extended Follow-up||14
369016|NCT02071849|906728|P1|STARTED|2-year Extended Follow-up||15
369017|NCT02071849|906728|P1|NOT COMPLETED|6-month Primary Endpoint||5
369018|NCT02071849|906728|P1|COMPLETED|6-month Primary Endpoint||15
369019|NCT02071849|906728|P1|STARTED|6-month Primary Endpoint||20
369020|NCT02071823|906762|P2|NOT COMPLETED|Overall Study||0
369021|NCT02071823|906763|P1|NOT COMPLETED|Overall Study||1
369022|NCT02071823|906762|P2|COMPLETED|Overall Study||6
369023|NCT02071823|906763|P1|COMPLETED|Overall Study||5
369024|NCT02071823|906762|P2|STARTED|Overall Study||6
369025|NCT02071823|906763|P1|STARTED|Overall Study||6
369026|NCT02071810|906778|P5|NOT COMPLETED|Overall Study||1
369027|NCT02071810|906779|P4|NOT COMPLETED|Overall Study||1
369028|NCT02071810|906780|P3|NOT COMPLETED|Overall Study||0
369029|NCT02071810|906781|P2|NOT COMPLETED|Overall Study||0
369030|NCT02071810|906782|P1|NOT COMPLETED|Overall Study||0
369031|NCT02071810|906778|P5|COMPLETED|Overall Study||8
369032|NCT02071810|906779|P4|COMPLETED|Overall Study||6
369033|NCT02071810|906780|P3|COMPLETED|Overall Study||6
369034|NCT02071810|906781|P2|COMPLETED|Overall Study||6
369035|NCT02071810|906782|P1|COMPLETED|Overall Study||6
369036|NCT02071810|906778|P5|STARTED|Overall Study||9
369037|NCT02071810|906779|P4|STARTED|Overall Study||7
369038|NCT02071810|906780|P3|STARTED|Overall Study||6
369039|NCT02071810|906781|P2|STARTED|Overall Study||6
369040|NCT02071810|906782|P1|STARTED|Overall Study||6
369041|NCT02071771|906794|P2|NOT COMPLETED|Period 2: Second 10 Days||0
369042|NCT02071771|906795|P1|NOT COMPLETED|Period 2: Second 10 Days||0
369043|NCT02071771|906794|P2|COMPLETED|Period 2: Second 10 Days||38
369044|NCT02071771|906795|P1|COMPLETED|Period 2: Second 10 Days||39
369045|NCT02071771|906794|P2|STARTED|Period 2: Second 10 Days|One participant completed Period 1 but did not start Period 2 due to unacceptable fit with DACP T.|38
369046|NCT02071771|906795|P1|STARTED|Period 2: Second 10 Days||39
369047|NCT02071771|906794|P2|NOT COMPLETED|Period 1: First 10 Days||0
369048|NCT02071771|906795|P1|NOT COMPLETED|Period 1: First 10 Days||2
369049|NCT02071771|906794|P2|COMPLETED|Period 1: First 10 Days||39
369050|NCT02071771|906795|P1|COMPLETED|Period 1: First 10 Days||39
369051|NCT02071771|906794|P2|Dispensed|Period 1: First 10 Days||39
369052|NCT02071771|906795|P1|Dispensed|Period 1: First 10 Days||39
369053|NCT02071771|906794|P2|STARTED|Period 1: First 10 Days||39
369054|NCT02071771|906795|P1|STARTED|Period 1: First 10 Days||41
369055|NCT02071420|906805|P2|NOT COMPLETED|Overall Study||3
369056|NCT02071420|906806|P1|NOT COMPLETED|Overall Study||3
369057|NCT02071420|906805|P2|COMPLETED|Overall Study||27
369058|NCT02071420|906806|P1|COMPLETED|Overall Study||27
369059|NCT02071420|906805|P2|STARTED|Overall Study||30
369060|NCT02071420|906806|P1|STARTED|Overall Study||30
369061|NCT02071108|906812|P1|NOT COMPLETED|Overall Study||0
369062|NCT02071108|906812|P1|COMPLETED|Overall Study||35
369063|NCT02071108|906812|P1|STARTED|Overall Study||35
369064|NCT02071095|906833|P2|NOT COMPLETED|Overall Study||0
369065|NCT02071095|906834|P1|NOT COMPLETED|Overall Study||0
369066|NCT02071095|906833|P2|COMPLETED|Overall Study||3
369067|NCT02071095|906834|P1|COMPLETED|Overall Study||12
369068|NCT02071095|906833|P2|STARTED|Overall Study||3
369069|NCT02071095|906834|P1|STARTED|Overall Study||12
369070|NCT02071082|906850|P2|NOT COMPLETED|Overall Study||7
369071|NCT02071082|906851|P1|NOT COMPLETED|Overall Study||2
369072|NCT02071082|906850|P2|COMPLETED|Overall Study||68
369073|NCT02071082|906851|P1|COMPLETED|Overall Study||2
369074|NCT02071082|906850|P2|STARTED|Overall Study||75
369075|NCT02071082|906851|P1|STARTED|Overall Study||4
369076|NCT02070965|906882|P3|NOT COMPLETED|Overall Study||1
369077|NCT02070965|906883|P2|NOT COMPLETED|Overall Study||2
369078|NCT02070965|906884|P1|NOT COMPLETED|Overall Study||2
369079|NCT02070965|906882|P3|COMPLETED|Overall Study||24
369080|NCT02070965|906883|P2|COMPLETED|Overall Study||21
369081|NCT02070965|906884|P1|COMPLETED|Overall Study||25
369082|NCT02070965|906882|P3|STARTED|Overall Study||25
369083|NCT02070965|906883|P2|STARTED|Overall Study||23
369084|NCT02070965|906884|P1|STARTED|Overall Study||27
369085|NCT02070744|906896|P5|NOT COMPLETED|OLE Phase (48 Weeks)||3
369086|NCT02070744|906897|P4|NOT COMPLETED|OLE Phase (48 Weeks)||0
369087|NCT02070744|906898|P3|NOT COMPLETED|OLE Phase (48 Weeks)||0
369088|NCT02070744|906899|P2|NOT COMPLETED|OLE Phase (48 Weeks)||0
369089|NCT02070744|906900|P1|NOT COMPLETED|OLE Phase (48 Weeks)||0
369090|NCT02070744|906896|P5|COMPLETED|OLE Phase (48 Weeks)||24
369091|NCT02070744|906897|P4|COMPLETED|OLE Phase (48 Weeks)||0
369092|NCT02070744|906898|P3|COMPLETED|OLE Phase (48 Weeks)||0
369093|NCT02070744|906899|P2|COMPLETED|OLE Phase (48 Weeks)||0
369094|NCT02070744|906900|P1|COMPLETED|OLE Phase (48 Weeks)||0
369095|NCT02070744|906896|P5|STARTED|OLE Phase (48 Weeks)|12 participants completed PC phase, but did not enter OLE phase.|27
369096|NCT02070744|906897|P4|STARTED|OLE Phase (48 Weeks)||0
369097|NCT02070744|906898|P3|STARTED|OLE Phase (48 Weeks)||0
369098|NCT02070744|906899|P2|STARTED|OLE Phase (48 Weeks)||0
369099|NCT02070744|906900|P1|STARTED|OLE Phase (48 Weeks)||0
369100|NCT02070744|906896|P5|NOT COMPLETED|PC Phase (12 Weeks)||0
369101|NCT02070744|906897|P4|NOT COMPLETED|PC Phase (12 Weeks)||1
369102|NCT02070744|906898|P3|NOT COMPLETED|PC Phase (12 Weeks)||0
369103|NCT02070744|906899|P2|NOT COMPLETED|PC Phase (12 Weeks)||0
369104|NCT02070744|906900|P1|NOT COMPLETED|PC Phase (12 Weeks)||0
369105|NCT02070744|906896|P5|COMPLETED|PC Phase (12 Weeks)||0
369106|NCT02070744|906897|P4|COMPLETED|PC Phase (12 Weeks)||13
369107|NCT02070744|906898|P3|COMPLETED|PC Phase (12 Weeks)||15
369108|NCT02070744|906899|P2|COMPLETED|PC Phase (12 Weeks)||5
369109|NCT02070744|906900|P1|COMPLETED|PC Phase (12 Weeks)||6
369110|NCT02070744|906896|P5|Treated|PC Phase (12 Weeks)||0
369111|NCT02070744|906897|P4|Treated|PC Phase (12 Weeks)||13
369112|NCT02070744|906898|P3|Treated|PC Phase (12 Weeks)||15
369113|NCT02070744|906899|P2|Treated|PC Phase (12 Weeks)||5
369114|NCT02070744|906900|P1|Treated|PC Phase (12 Weeks)||6
369115|NCT02070744|906896|P5|STARTED|PC Phase (12 Weeks)||0
369116|NCT02070744|906897|P4|STARTED|PC Phase (12 Weeks)||14
369117|NCT02070744|906898|P3|STARTED|PC Phase (12 Weeks)||15
369118|NCT02070744|906899|P2|STARTED|PC Phase (12 Weeks)||5
369119|NCT02070744|906900|P1|STARTED|PC Phase (12 Weeks)||6
369120|NCT02070692|906952|P2|NOT COMPLETED|Overall Study||12
369121|NCT02070692|906953|P1|NOT COMPLETED|Overall Study||10
369122|NCT02070692|906952|P2|COMPLETED|Overall Study||16
369123|NCT02070692|906953|P1|COMPLETED|Overall Study||18
369124|NCT02070692|906952|P2|STARTED|Overall Study||28
369125|NCT02070692|906953|P1|STARTED|Overall Study||28
369126|NCT02070640|906969|P2|NOT COMPLETED|Overall Study||0
369127|NCT02070640|906970|P1|NOT COMPLETED|Overall Study||11
369128|NCT02070640|906969|P2|COMPLETED|Overall Study||6
369129|NCT02070640|906970|P1|COMPLETED|Overall Study||82
369130|NCT02070640|906969|P2|STARTED|Overall Study||6
369131|NCT02070640|906970|P1|STARTED|Overall Study||93
369132|NCT02070588|906983|P3|NOT COMPLETED|Overall Study||0
369133|NCT02070588|906984|P2|NOT COMPLETED|Overall Study||1
369134|NCT02070588|906985|P1|NOT COMPLETED|Overall Study||39
369135|NCT02070588|906983|P3|COMPLETED|Overall Study||0
369136|NCT02070588|906984|P2|COMPLETED|Overall Study||25
369137|NCT02070588|906985|P1|COMPLETED|Overall Study||47
369138|NCT02070588|906983|P3|STARTED|Overall Study||0
369139|NCT02070588|906984|P2|STARTED|Overall Study||26
369140|NCT02070588|906985|P1|STARTED|Overall Study||86
369141|NCT02070380|907003|P4|NOT COMPLETED|Second Injection||5
369142|NCT02070380|907004|P3|NOT COMPLETED|Second Injection||1
369143|NCT02070380|907005|P2|NOT COMPLETED|Second Injection||2
369144|NCT02070380|907006|P1|NOT COMPLETED|Second Injection||0
369145|NCT02070380|907003|P4|COMPLETED|Second Injection||46
369146|NCT02070380|907004|P3|COMPLETED|Second Injection||50
369147|NCT02070380|907005|P2|COMPLETED|Second Injection||32
369148|NCT02070380|907006|P1|COMPLETED|Second Injection||31
369149|NCT02070380|907003|P4|STARTED|Second Injection||51
369150|NCT02070380|907004|P3|STARTED|Second Injection||51
369151|NCT02070380|907005|P2|STARTED|Second Injection||34
369152|NCT02070380|907006|P1|STARTED|Second Injection||31
369153|NCT02070380|907003|P4|NOT COMPLETED|Washout (no Second Injection/MRI)||3
369154|NCT02070380|907004|P3|NOT COMPLETED|Washout (no Second Injection/MRI)||2
369155|NCT02070380|907005|P2|NOT COMPLETED|Washout (no Second Injection/MRI)||5
369156|NCT02070380|907006|P1|NOT COMPLETED|Washout (no Second Injection/MRI)||0
369157|NCT02070380|907003|P4|COMPLETED|Washout (no Second Injection/MRI)||51
369158|NCT02070380|907004|P3|COMPLETED|Washout (no Second Injection/MRI)||51
369159|NCT02070380|907005|P2|COMPLETED|Washout (no Second Injection/MRI)||34
369160|NCT02070380|907006|P1|COMPLETED|Washout (no Second Injection/MRI)||31
369161|NCT02070380|907003|P4|STARTED|Washout (no Second Injection/MRI)||54
369162|NCT02070380|907004|P3|STARTED|Washout (no Second Injection/MRI)||53
369163|NCT02070380|907005|P2|STARTED|Washout (no Second Injection/MRI)||39
369164|NCT02070380|907006|P1|STARTED|Washout (no Second Injection/MRI)||31
369165|NCT02070380|907003|P4|NOT COMPLETED|First Injection||0
369166|NCT02070380|907004|P3|NOT COMPLETED|First Injection||0
369167|NCT02070380|907005|P2|NOT COMPLETED|First Injection||0
369168|NCT02070380|907006|P1|NOT COMPLETED|First Injection||0
369169|NCT02070380|907003|P4|COMPLETED|First Injection||54
369170|NCT02070380|907004|P3|COMPLETED|First Injection||53
369171|NCT02070380|907005|P2|COMPLETED|First Injection||39
369172|NCT02070380|907006|P1|COMPLETED|First Injection||31
369173|NCT02070380|907003|P4|STARTED|First Injection||54
369174|NCT02070380|907004|P3|STARTED|First Injection||53
369175|NCT02070380|907005|P2|STARTED|First Injection||39
369176|NCT02070380|907006|P1|STARTED|First Injection||31
369177|NCT02070302|907056|P2|NOT COMPLETED|Overall Study||0
369178|NCT02070302|907057|P1|NOT COMPLETED|Overall Study||0
369179|NCT02070302|907056|P2|COMPLETED|Overall Study||5
369180|NCT02070302|907057|P1|COMPLETED|Overall Study||5
369181|NCT02070302|907056|P2|STARTED|Overall Study||5
369182|NCT02070302|907057|P1|STARTED|Overall Study||5
369183|NCT02070237|907075|P2|NOT COMPLETED|Overall Study||3
369184|NCT02070237|907076|P1|NOT COMPLETED|Overall Study||3
369185|NCT02070237|907075|P2|COMPLETED|Overall Study||42
369186|NCT02070237|907076|P1|COMPLETED|Overall Study||42
369187|NCT02070237|907075|P2|STARTED|Overall Study||45
369188|NCT02070237|907076|P1|STARTED|Overall Study||45
369189|NCT02069093|907084|P1|NOT COMPLETED|Overall Study||30
369190|NCT02069093|907084|P1|COMPLETED|Overall Study||56
369191|NCT02069093|907084|P1|Pharmacokinetic Analysis Set|Overall Study||50
369192|NCT02069093|907084|P1|STARTED|Overall Study||86
369193|NCT02068547|907095|P2|NOT COMPLETED|Overall Study||3
369194|NCT02068547|907096|P1|NOT COMPLETED|Overall Study||4
369195|NCT02068547|907095|P2|COMPLETED|Overall Study||1
369196|NCT02068547|907096|P1|COMPLETED|Overall Study||0
369197|NCT02068547|907095|P2|STARTED|Overall Study||4
369198|NCT02068547|907096|P1|STARTED|Overall Study||4
369199|NCT02068443|907109|P3|NOT COMPLETED|Overall Study||3
369200|NCT02068443|907110|P2|NOT COMPLETED|Overall Study||6
369201|NCT02068443|907111|P1|NOT COMPLETED|Overall Study||7
369202|NCT02068443|907109|P3|COMPLETED|Overall Study||148
369203|NCT02068443|907110|P2|COMPLETED|Overall Study||146
369204|NCT02068443|907111|P1|COMPLETED|Overall Study||64
369205|NCT02068443|907109|P3|STARTED|Overall Study||151
369206|NCT02068443|907110|P2|STARTED|Overall Study||152
369207|NCT02068443|907111|P1|STARTED|Overall Study||71
369208|NCT02068222|907146|P1|NOT COMPLETED|Overall Study||1
369209|NCT02068222|907146|P1|COMPLETED|Overall Study||9
369210|NCT02068222|907146|P1|STARTED|Overall Study||10
369211|NCT02068157|907153|P1|NOT COMPLETED|Overall Study||0
369212|NCT02068157|907153|P1|COMPLETED|Overall Study||3
369213|NCT02068157|907153|P1|STARTED|Overall Study||3
369214|NCT02068027|907160|P2|NOT COMPLETED|Overall Study||16
369215|NCT02068027|907161|P1|NOT COMPLETED|Overall Study||13
369216|NCT02068027|907160|P2|COMPLETED|Overall Study||114
369217|NCT02068027|907161|P1|COMPLETED|Overall Study||117
369218|NCT02068027|907160|P2|STARTED|Overall Study||130
369219|NCT02068027|907161|P1|STARTED|Overall Study||130
369220|NCT02067728|907171|P2|NOT COMPLETED|6 Month Measurements||97
369221|NCT02067728|907172|P1|NOT COMPLETED|6 Month Measurements||114
369222|NCT02067728|907171|P2|COMPLETED|6 Month Measurements|Number includes 6 month measurements & chart review for visits at 6 months +/- 2 months from initial|113
369223|NCT02067728|907172|P1|COMPLETED|6 Month Measurements|Number includes 6 month measurements & chart review for visits at 6 months +/- 2 months from initial|106
369224|NCT02067728|907171|P2|STARTED|6 Month Measurements||210
369225|NCT02067728|907172|P1|STARTED|6 Month Measurements||220
369226|NCT02067728|907171|P2|NOT COMPLETED|6 Month Follow up Survey||60
369227|NCT02067728|907172|P1|NOT COMPLETED|6 Month Follow up Survey||48
369228|NCT02067728|907171|P2|COMPLETED|6 Month Follow up Survey|150 parent/guardians completed surveys at this time point, along with 69 teens.|150
369229|NCT02067728|907172|P1|COMPLETED|6 Month Follow up Survey|172 parent/guardians completed surveys at this time point, along with 71 teens.|172
369230|NCT02067728|907171|P2|STARTED|6 Month Follow up Survey|Participants completed the 6 month follow up even if 1 month data wasn't able to be collected.|210
369231|NCT02067728|907172|P1|STARTED|6 Month Follow up Survey|Participants completed the 6 month follow up even if 1 month data wasn't able to be collected.|220
369232|NCT02067728|907171|P2|NOT COMPLETED|Baseline - 1 Month Follow up Survey||28
369233|NCT02067728|907172|P1|NOT COMPLETED|Baseline - 1 Month Follow up Survey||7
369234|NCT02067728|907171|P2|COMPLETED|Baseline - 1 Month Follow up Survey|182 parent/guardians completed the surveys, along with 75 teens.|182
369235|NCT02067728|907172|P1|COMPLETED|Baseline - 1 Month Follow up Survey|213 parents/guardians completed the surveys, along with 82 teens.|213
369236|NCT02067728|907171|P2|STARTED|Baseline - 1 Month Follow up Survey||210
369237|NCT02067728|907172|P1|STARTED|Baseline - 1 Month Follow up Survey||220
369238|NCT02067676|907206|P6|NOT COMPLETED|Overall Study||0
369239|NCT02067676|907207|P5|NOT COMPLETED|Overall Study||0
369240|NCT02067676|907208|P4|NOT COMPLETED|Overall Study||0
369241|NCT02067676|907209|P3|NOT COMPLETED|Overall Study||0
369242|NCT02067676|907210|P2|NOT COMPLETED|Overall Study||0
369243|NCT02067676|907211|P1|NOT COMPLETED|Overall Study||1
369244|NCT02067676|907206|P6|COMPLETED|Overall Study||8
369245|NCT02067676|907207|P5|COMPLETED|Overall Study||8
369246|NCT02067676|907208|P4|COMPLETED|Overall Study||8
369247|NCT02067676|907209|P3|COMPLETED|Overall Study||8
369248|NCT02067676|907210|P2|COMPLETED|Overall Study||8
369249|NCT02067676|907211|P1|COMPLETED|Overall Study||7
369250|NCT02067676|907206|P6|STARTED|Overall Study||8
369251|NCT02067676|907207|P5|STARTED|Overall Study||8
369252|NCT02067676|907208|P4|STARTED|Overall Study||8
369253|NCT02067676|907209|P3|STARTED|Overall Study||8
369254|NCT02067676|907210|P2|STARTED|Overall Study||8
369255|NCT02067676|907211|P1|STARTED|Overall Study||8
369256|NCT02067611|907249|P3|NOT COMPLETED|Overall Study||4
369257|NCT02067611|907250|P2|NOT COMPLETED|Overall Study||6
369258|NCT02067611|907251|P1|NOT COMPLETED|Overall Study||6
369259|NCT02067611|907249|P3|COMPLETED|Overall Study||68
369260|NCT02067611|907250|P2|COMPLETED|Overall Study||66
369261|NCT02067611|907251|P1|COMPLETED|Overall Study||66
369262|NCT02067611|907249|P3|STARTED|Overall Study||72
369263|NCT02067611|907250|P2|STARTED|Overall Study||72
369264|NCT02067611|907251|P1|STARTED|Overall Study||72
369265|NCT02067585|907289|P3|NOT COMPLETED|Overall Study||0
369266|NCT02067585|907290|P2|NOT COMPLETED|Overall Study||0
369267|NCT02067585|907291|P1|NOT COMPLETED|Overall Study||0
369268|NCT02067585|907289|P3|COMPLETED|Overall Study||16
369269|NCT02067585|907290|P2|COMPLETED|Overall Study||16
369270|NCT02067585|907291|P1|COMPLETED|Overall Study||16
369271|NCT02067585|907289|P3|STARTED|Overall Study||16
369272|NCT02067585|907290|P2|STARTED|Overall Study||16
369273|NCT02067585|907291|P1|STARTED|Overall Study||16
369274|NCT02067533|907328|P2|NOT COMPLETED|Overall Study||2
369275|NCT02067533|907329|P1|NOT COMPLETED|Overall Study||4
369276|NCT02067533|907328|P2|COMPLETED|Overall Study||44
369277|NCT02067533|907329|P1|COMPLETED|Overall Study||41
369278|NCT02067533|907328|P2|STARTED|Overall Study||46
369279|NCT02067533|907329|P1|STARTED|Overall Study||45
369280|NCT02067273|907337|P2|NOT COMPLETED|Overall Study||3
369281|NCT02067273|907338|P1|NOT COMPLETED|Overall Study||0
369282|NCT02067273|907337|P2|COMPLETED|Overall Study||12
369283|NCT02067273|907338|P1|COMPLETED|Overall Study||5
369284|NCT02067273|907337|P2|STARTED|Overall Study||15
369285|NCT02067273|907338|P1|STARTED|Overall Study||5
369286|NCT02066922|907344|P1|NOT COMPLETED|Overall Study||1
369287|NCT02066922|907344|P1|COMPLETED|Overall Study||14
369288|NCT02066922|907344|P1|STARTED|Overall Study||15
369289|NCT02066896|907354|P2|NOT COMPLETED|Overall Study||0
369290|NCT02066896|907355|P1|NOT COMPLETED|Overall Study||0
369291|NCT02066896|907354|P2|COMPLETED|Overall Study||33
369292|NCT02066896|907355|P1|COMPLETED|Overall Study||33
369293|NCT02066896|907354|P2|STARTED|Overall Study||33
369294|NCT02066896|907355|P1|STARTED|Overall Study||33
369295|NCT02066857|907367|P2|NOT COMPLETED|Overall Study||1
369296|NCT02066857|907368|P1|NOT COMPLETED|Overall Study||1
369297|NCT02066857|907367|P2|COMPLETED|Overall Study||3
369298|NCT02066857|907368|P1|COMPLETED|Overall Study||0
369299|NCT02066857|907367|P2|STARTED|Overall Study||4
369300|NCT02066857|907368|P1|STARTED|Overall Study||1
369301|NCT02066740|907382|P1|NOT COMPLETED|Overall Study||2
369302|NCT02066740|907382|P1|COMPLETED|Overall Study||32
369303|NCT02066740|907382|P1|STARTED|Overall Study||34
369304|NCT02066727|907389|P2|NOT COMPLETED|Overall Study||0
369305|NCT02066727|907390|P1|NOT COMPLETED|Overall Study||0
369306|NCT02066727|907389|P2|COMPLETED|Overall Study||30
369307|NCT02066727|907390|P1|COMPLETED|Overall Study||30
369308|NCT02066727|907389|P2|STARTED|Overall Study||30
369309|NCT02066727|907390|P1|STARTED|Overall Study||30
369310|NCT02066415|907399|P3|NOT COMPLETED|Overall Study||8
369311|NCT02066415|907400|P2|NOT COMPLETED|Overall Study||7
369312|NCT02066415|907401|P1|NOT COMPLETED|Overall Study||21
369313|NCT02066415|907399|P3|COMPLETED|Overall Study||182
369314|NCT02066415|907400|P2|COMPLETED|Overall Study||184
369315|NCT02066415|907401|P1|COMPLETED|Overall Study||265
369316|NCT02066415|907399|P3|Received Study Drug|Overall Study||188
369317|NCT02066415|907400|P2|Received Study Drug|Overall Study||190
369318|NCT02066415|907401|P1|Received Study Drug|Overall Study||282
369319|NCT02066415|907399|P3|STARTED|Overall Study||190
369320|NCT02066415|907400|P2|STARTED|Overall Study||191
369321|NCT02066415|907401|P1|STARTED|Overall Study||286
369322|NCT02066402|907426|P2|NOT COMPLETED|Overall Study||23
369323|NCT02066402|907427|P1|NOT COMPLETED|Overall Study||26
369324|NCT02066402|907426|P2|COMPLETED|Overall Study||275
369325|NCT02066402|907427|P1|COMPLETED|Overall Study||274
369326|NCT02066402|907426|P2|Completed Study Treatment Period|Overall Study||256
369327|NCT02066402|907427|P1|Completed Study Treatment Period|Overall Study||261
369328|NCT02066402|907426|P2|Participants Received Treatment|Overall Study||297
369329|NCT02066402|907427|P1|Participants Received Treatment|Overall Study||292
369330|NCT02066402|907426|P2|STARTED|Overall Study||298
369331|NCT02066402|907427|P1|STARTED|Overall Study||300
369332|NCT02066233|907455|P2|NOT COMPLETED|Standard Endoscopy (Day 2)||0
369333|NCT02066233|907456|P1|NOT COMPLETED|Standard Endoscopy (Day 2)||0
369334|NCT02066233|907455|P2|COMPLETED|Standard Endoscopy (Day 2)||44
369335|NCT02066233|907456|P1|COMPLETED|Standard Endoscopy (Day 2)||44
369336|NCT02066233|907455|P2|STARTED|Standard Endoscopy (Day 2)||44
369337|NCT02066233|907456|P1|STARTED|Standard Endoscopy (Day 2)||44
369338|NCT02066233|907455|P2|NOT COMPLETED|EG Scan II (Day 1)||6
369339|NCT02066233|907456|P1|NOT COMPLETED|EG Scan II (Day 1)||6
369340|NCT02066233|907455|P2|COMPLETED|EG Scan II (Day 1)||44
369341|NCT02066233|907456|P1|COMPLETED|EG Scan II (Day 1)||44
369342|NCT02066233|907455|P2|STARTED|EG Scan II (Day 1)||50
369343|NCT02066233|907456|P1|STARTED|EG Scan II (Day 1)||50
369344|NCT02066051|907464|P1|NOT COMPLETED|Overall Study||1
369345|NCT02066051|907464|P1|COMPLETED|Overall Study||7
369346|NCT02066051|907464|P1|STARTED|Overall Study||8
369347|NCT02065895|907469|P6|NOT COMPLETED|Overall Study||0
369348|NCT02065895|907470|P5|NOT COMPLETED|Overall Study||0
369349|NCT02065895|907471|P4|NOT COMPLETED|Overall Study||1
369350|NCT02065895|907472|P3|NOT COMPLETED|Overall Study||0
369351|NCT02065895|907473|P2|NOT COMPLETED|Overall Study||1
369352|NCT02065895|907474|P1|NOT COMPLETED|Overall Study||1
369353|NCT02065895|907469|P6|COMPLETED|Overall Study||1
369354|NCT02065895|907470|P5|COMPLETED|Overall Study||1
369355|NCT02065895|907471|P4|COMPLETED|Overall Study||0
369356|NCT02065895|907472|P3|COMPLETED|Overall Study||1
369357|NCT02065895|907473|P2|COMPLETED|Overall Study||2
369358|NCT02065895|907474|P1|COMPLETED|Overall Study||0
369359|NCT02065895|907469|P6|STARTED|Overall Study||1
369360|NCT02065895|907470|P5|STARTED|Overall Study||1
369361|NCT02065895|907471|P4|STARTED|Overall Study||1
369362|NCT02065895|907472|P3|STARTED|Overall Study||1
369363|NCT02065895|907473|P2|STARTED|Overall Study||3
369364|NCT02065895|907474|P1|STARTED|Overall Study||1
369365|NCT02065453|907493|P2|NOT COMPLETED|Overall Study||4
369366|NCT02065453|907494|P1|NOT COMPLETED|Overall Study||3
369367|NCT02065453|907493|P2|COMPLETED|Overall Study||21
369368|NCT02065453|907494|P1|COMPLETED|Overall Study||24
369369|NCT02065453|907493|P2|STARTED|Overall Study||25
369370|NCT02065453|907494|P1|STARTED|Overall Study||27
369371|NCT02064985|907502|P3|NOT COMPLETED|Overall Study||0
369372|NCT02064985|907503|P2|NOT COMPLETED|Overall Study||0
369373|NCT02064985|907504|P1|NOT COMPLETED|Overall Study||0
369374|NCT02064985|907502|P3|COMPLETED|Overall Study||12
369375|NCT02064985|907503|P2|COMPLETED|Overall Study||12
369376|NCT02064985|907504|P1|COMPLETED|Overall Study||12
369377|NCT02064985|907502|P3|STARTED|Overall Study||12
369378|NCT02064985|907503|P2|STARTED|Overall Study||12
369379|NCT02064985|907504|P1|STARTED|Overall Study||12
369380|NCT02064920|907667|P2|NOT COMPLETED|Overall Study||9
369381|NCT02064920|907668|P1|NOT COMPLETED|Overall Study||1
369382|NCT02064920|907667|P2|COMPLETED|Overall Study||21
369383|NCT02064920|907668|P1|COMPLETED|Overall Study||5
369384|NCT02064920|907667|P2|Treated|Overall Study|Two participants discontinued from study prior to treatment|28
369385|NCT02064920|907668|P1|Treated|Overall Study||6
369386|NCT02064920|907667|P2|STARTED|Overall Study||30
369387|NCT02064920|907668|P1|STARTED|Overall Study||6
369388|NCT02064907|907678|P2|NOT COMPLETED|Period 2||0
369389|NCT02064907|907679|P1|NOT COMPLETED|Period 2||0
369390|NCT02064907|907678|P2|COMPLETED|Period 2||26
369391|NCT02064907|907679|P1|COMPLETED|Period 2||26
369392|NCT02064907|907678|P2|STARTED|Period 2||26
369393|NCT02064907|907679|P1|STARTED|Period 2||26
369394|NCT02064907|907678|P2|NOT COMPLETED|Period 1||0
369395|NCT02064907|907679|P1|NOT COMPLETED|Period 1||0
369396|NCT02064907|907678|P2|COMPLETED|Period 1||26
369397|NCT02064907|907679|P1|COMPLETED|Period 1||26
369398|NCT02064907|907678|P2|STARTED|Period 1||26
369399|NCT02064907|907679|P1|STARTED|Period 1||26
369400|NCT02064894|907698|P3|NOT COMPLETED|Overall Study||115
369401|NCT02064894|907699|P2|NOT COMPLETED|Overall Study||102
369402|NCT02064894|907700|P1|NOT COMPLETED|Overall Study||43
369403|NCT02064894|907698|P3|COMPLETED|Overall Study||86
369404|NCT02064894|907699|P2|COMPLETED|Overall Study||99
369405|NCT02064894|907700|P1|COMPLETED|Overall Study||56
369406|NCT02064894|907698|P3|Avalaible at T-90|Overall Study||129
369407|NCT02064894|907699|P2|Avalaible at T-90|Overall Study||134
369408|NCT02064894|907700|P1|Avalaible at T-90|Overall Study||74
369409|NCT02064894|907698|P3|Available at T-60|Overall Study||177
369410|NCT02064894|907699|P2|Available at T-60|Overall Study||188
369411|NCT02064894|907700|P1|Available at T-60|Overall Study||91
369412|NCT02064894|907698|P3|STARTED|Overall Study|"Received allocated intervention (n=199)~Did not receive allocated intervention (n=2)"|201
369413|NCT02064894|907699|P2|STARTED|Overall Study|"Received allocated intervention (n=198)~Did not receive allocated intervention (n=3)"|201
369414|NCT02064894|907700|P1|STARTED|Overall Study|"Received allocated intervention (n=98)~Did not receive intervention (n=1)"|99
369415|NCT02064439|907714|P3|NOT COMPLETED|Overall Study||182
369416|NCT02064439|907715|P2|NOT COMPLETED|Overall Study||138
369417|NCT02064439|907716|P1|NOT COMPLETED|Overall Study||143
369418|NCT02064439|907714|P3|COMPLETED|Overall Study||949
369419|NCT02064439|907715|P2|COMPLETED|Overall Study||969
369420|NCT02064439|907716|P1|COMPLETED|Overall Study||984
369421|NCT02064439|907714|P3|STARTED|Overall Study|FAS, randomized and received study medication|1131
369422|NCT02064439|907715|P2|STARTED|Overall Study|FAS, randomized and received study medication|1107
369423|NCT02064439|907716|P1|STARTED|Overall Study|Full Analysis Set (FAS), randomized and received study medication|1127
369424|NCT02064270|907735|P2|NOT COMPLETED|Overall Study||32
369425|NCT02064270|907736|P1|NOT COMPLETED|Overall Study||62
369426|NCT02064270|907735|P2|COMPLETED|Overall Study||231
369427|NCT02064270|907736|P1|COMPLETED|Overall Study||201
369428|NCT02064270|907735|P2|STARTED|Overall Study||263
369429|NCT02064270|907736|P1|STARTED|Overall Study||263
369430|NCT02064231|907751|P4|NOT COMPLETED|Third Test Period (Own Product)||0
369431|NCT02064231|907752|P3|NOT COMPLETED|Third Test Period (Own Product)||0
369432|NCT02064231|907753|P2|NOT COMPLETED|Third Test Period (Own Product)||0
369433|NCT02064231|907754|P1|NOT COMPLETED|Third Test Period (Own Product)||0
369434|NCT02064231|907751|P4|COMPLETED|Third Test Period (Own Product)||1
369435|NCT02064231|907752|P3|COMPLETED|Third Test Period (Own Product)||0
369436|NCT02064231|907753|P2|COMPLETED|Third Test Period (Own Product)||8
369437|NCT02064231|907754|P1|COMPLETED|Third Test Period (Own Product)||8
369438|NCT02064231|907751|P4|STARTED|Third Test Period (Own Product)||1
369439|NCT02064231|907752|P3|STARTED|Third Test Period (Own Product)||0
369440|NCT02064231|907753|P2|STARTED|Third Test Period (Own Product)|One subject who discontinued testing Test C proceeded to test Own product afterwards|8
369441|NCT02064231|907754|P1|STARTED|Third Test Period (Own Product)|One subject who discontinued testing Test A proceeded to test Own product afterwards.|8
369442|NCT02064231|907751|P4|NOT COMPLETED|Second Test Period (Test B or Test D)||0
369443|NCT02064231|907752|P3|NOT COMPLETED|Second Test Period (Test B or Test D)||0
369444|NCT02064231|907753|P2|NOT COMPLETED|Second Test Period (Test B or Test D)||1
369445|NCT02064231|907754|P1|NOT COMPLETED|Second Test Period (Test B or Test D)||1
369446|NCT02064231|907751|P4|COMPLETED|Second Test Period (Test B or Test D)||1
369447|NCT02064231|907752|P3|COMPLETED|Second Test Period (Test B or Test D)||0
369448|NCT02064231|907753|P2|COMPLETED|Second Test Period (Test B or Test D)||7
369449|NCT02064231|907754|P1|COMPLETED|Second Test Period (Test B or Test D)||6
369450|NCT02064231|907751|P4|STARTED|Second Test Period (Test B or Test D)||1
369451|NCT02064231|907752|P3|STARTED|Second Test Period (Test B or Test D)||0
369452|NCT02064231|907753|P2|STARTED|Second Test Period (Test B or Test D)||8
369453|NCT02064231|907754|P1|STARTED|Second Test Period (Test B or Test D)||7
369454|NCT02064231|907751|P4|NOT COMPLETED|First Test Period (Test A or Test C)||0
369455|NCT02064231|907752|P3|NOT COMPLETED|First Test Period (Test A or Test C)||1
369456|NCT02064231|907753|P2|NOT COMPLETED|First Test Period (Test A or Test C)||4
369457|NCT02064231|907754|P1|NOT COMPLETED|First Test Period (Test A or Test C)||7
369458|NCT02064231|907751|P4|COMPLETED|First Test Period (Test A or Test C)||1
369459|NCT02064231|907752|P3|COMPLETED|First Test Period (Test A or Test C)||0
369460|NCT02064231|907753|P2|COMPLETED|First Test Period (Test A or Test C)||8
369461|NCT02064231|907754|P1|COMPLETED|First Test Period (Test A or Test C)||7
369462|NCT02064231|907751|P4|STARTED|First Test Period (Test A or Test C)||1
369463|NCT02064231|907752|P3|STARTED|First Test Period (Test A or Test C)||1
369464|NCT02064231|907753|P2|STARTED|First Test Period (Test A or Test C)||12
369465|NCT02064231|907754|P1|STARTED|First Test Period (Test A or Test C)||14
369466|NCT02064205|907766|P1|NOT COMPLETED|Overall Study||1
369467|NCT02064205|907766|P1|COMPLETED|Overall Study||31
369468|NCT02064205|907766|P1|Condition D|Overall Study||32
369469|NCT02064205|907766|P1|Condition C|Overall Study||31
369470|NCT02064205|907766|P1|Condition B|Overall Study||32
369471|NCT02064205|907766|P1|Condition A|Overall Study||32
369472|NCT02064205|907766|P1|STARTED|Overall Study||32
369473|NCT02063880|907784|P2|NOT COMPLETED|Overall Study||27
369474|NCT02063880|907785|P1|NOT COMPLETED|Overall Study||28
369475|NCT02063880|907784|P2|COMPLETED|Overall Study||66
369476|NCT02063880|907785|P1|COMPLETED|Overall Study||62
369477|NCT02063880|907784|P2|STARTED|Overall Study||93
369478|NCT02063880|907785|P1|STARTED|Overall Study||90
369479|NCT02063854|907802|P7|NOT COMPLETED|Overall Study||6
369480|NCT02063854|907803|P6|NOT COMPLETED|Overall Study||31
369481|NCT02063854|907804|P5|NOT COMPLETED|Overall Study||11
369482|NCT02063854|907805|P4|NOT COMPLETED|Overall Study||10
369483|NCT02063854|907806|P3|NOT COMPLETED|Overall Study||30
369484|NCT02063854|907807|P2|NOT COMPLETED|Overall Study||12
369485|NCT02063854|907808|P1|NOT COMPLETED|Overall Study||21
369486|NCT02063854|907802|P7|COMPLETED|Overall Study||60
369487|NCT02063854|907803|P6|COMPLETED|Overall Study||170
369488|NCT02063854|907804|P5|COMPLETED|Overall Study||54
369489|NCT02063854|907805|P4|COMPLETED|Overall Study||58
369490|NCT02063854|907806|P3|COMPLETED|Overall Study||176
369491|NCT02063854|907807|P2|COMPLETED|Overall Study||54
369492|NCT02063854|907808|P1|COMPLETED|Overall Study||178
369493|NCT02063854|907802|P7|Full Analysis Set: Received Study Drug|Overall Study||66
369494|NCT02063854|907803|P6|Full Analysis Set: Received Study Drug|Overall Study||200
369495|NCT02063854|907804|P5|Full Analysis Set: Received Study Drug|Overall Study||65
369496|NCT02063854|907805|P4|Full Analysis Set: Received Study Drug|Overall Study||68
369497|NCT02063854|907806|P3|Full Analysis Set: Received Study Drug|Overall Study||206
369498|NCT02063854|907807|P2|Full Analysis Set: Received Study Drug|Overall Study||66
369499|NCT02063854|907808|P1|Full Analysis Set: Received Study Drug|Overall Study||199
369500|NCT02063854|907802|P7|STARTED|Overall Study||66
369501|NCT02063854|907803|P6|STARTED|Overall Study||201
369502|NCT02063854|907804|P5|STARTED|Overall Study||65
369503|NCT02063854|907805|P4|STARTED|Overall Study||68
369504|NCT02063854|907806|P3|STARTED|Overall Study||206
369505|NCT02063854|907807|P2|STARTED|Overall Study||66
369506|NCT02063854|907808|P1|STARTED|Overall Study||199
369507|NCT02063737|907892|P2|NOT COMPLETED|Overall Study||4
369508|NCT02063737|907893|P1|NOT COMPLETED|Overall Study||11
369509|NCT02063737|907892|P2|COMPLETED|Overall Study||44
369510|NCT02063737|907893|P1|COMPLETED|Overall Study||41
369511|NCT02063737|907892|P2|STARTED|Overall Study||48
369512|NCT02063737|907893|P1|STARTED|Overall Study||52
369513|NCT02063672|907927|P2|NOT COMPLETED|Overall Study||22
369514|NCT02063672|907928|P1|NOT COMPLETED|Overall Study||35
369515|NCT02063672|907927|P2|COMPLETED|Overall Study||7
369516|NCT02063672|907928|P1|COMPLETED|Overall Study||18
369517|NCT02063672|907927|P2|STARTED|Overall Study||29
369518|NCT02063672|907928|P1|STARTED|Overall Study||53
369519|NCT02063659|907975|P4|NOT COMPLETED|Open-Label Extension Period (OLE)||20
369520|NCT02063659|907976|P3|NOT COMPLETED|Open-Label Extension Period (OLE)||0
369521|NCT02063659|907977|P2|NOT COMPLETED|Open-Label Extension Period (OLE)||0
369522|NCT02063659|907978|P1|NOT COMPLETED|Open-Label Extension Period (OLE)||0
369523|NCT02063659|907975|P4|COMPLETED|Open-Label Extension Period (OLE)||47
369524|NCT02063659|907976|P3|COMPLETED|Open-Label Extension Period (OLE)||0
369525|NCT02063659|907977|P2|COMPLETED|Open-Label Extension Period (OLE)||0
369526|NCT02063659|907978|P1|COMPLETED|Open-Label Extension Period (OLE)||0
369527|NCT02063659|907975|P4|STARTED|Open-Label Extension Period (OLE)||67
369528|NCT02063659|907976|P3|STARTED|Open-Label Extension Period (OLE)||0
369529|NCT02063659|907977|P2|STARTED|Open-Label Extension Period (OLE)||0
369530|NCT02063659|907978|P1|STARTED|Open-Label Extension Period (OLE)||0
369531|NCT02063659|907975|P4|NOT COMPLETED|Double-Blind Treatment Period||0
369532|NCT02063659|907976|P3|NOT COMPLETED|Double-Blind Treatment Period||3
369533|NCT02063659|907977|P2|NOT COMPLETED|Double-Blind Treatment Period||3
369534|NCT02063659|907978|P1|NOT COMPLETED|Double-Blind Treatment Period||2
369535|NCT02063659|907975|P4|COMPLETED|Double-Blind Treatment Period||0
369536|NCT02063659|907976|P3|COMPLETED|Double-Blind Treatment Period||22
369537|NCT02063659|907977|P2|COMPLETED|Double-Blind Treatment Period||22
369538|NCT02063659|907978|P1|COMPLETED|Double-Blind Treatment Period||24
369539|NCT02063659|907975|P4|STARTED|Double-Blind Treatment Period||0
369540|NCT02063659|907976|P3|STARTED|Double-Blind Treatment Period||25
369541|NCT02063659|907977|P2|STARTED|Double-Blind Treatment Period||25
369542|NCT02063659|907978|P1|STARTED|Double-Blind Treatment Period||26
369543|NCT02063516|908010|P2|NOT COMPLETED|Overall Study||0
369544|NCT02063516|908011|P1|NOT COMPLETED|Overall Study||0
369545|NCT02063516|908010|P2|COMPLETED|Overall Study||40
369546|NCT02063516|908011|P1|COMPLETED|Overall Study||40
369547|NCT02063516|908010|P2|STARTED|Overall Study||40
369548|NCT02063516|908011|P1|STARTED|Overall Study||40
369549|NCT02063230|908025|P4|NOT COMPLETED|Overall Study||0
369550|NCT02063230|908026|P3|NOT COMPLETED|Overall Study||0
369551|NCT02063230|908027|P2|NOT COMPLETED|Overall Study||0
369552|NCT02063230|908028|P1|NOT COMPLETED|Overall Study||0
369553|NCT02063230|908025|P4|COMPLETED|Overall Study||8
369554|NCT02063230|908026|P3|COMPLETED|Overall Study||8
369555|NCT02063230|908027|P2|COMPLETED|Overall Study||8
369556|NCT02063230|908028|P1|COMPLETED|Overall Study||8
369557|NCT02063230|908025|P4|Received Treatment|Overall Study||8
369558|NCT02063230|908026|P3|Received Treatment|Overall Study||8
369559|NCT02063230|908027|P2|Received Treatment|Overall Study||8
369560|NCT02063230|908028|P1|Received Treatment|Overall Study||8
369561|NCT02063230|908025|P4|STARTED|Overall Study||8
369562|NCT02063230|908026|P3|STARTED|Overall Study||8
369563|NCT02063230|908027|P2|STARTED|Overall Study||8
369564|NCT02063230|908028|P1|STARTED|Overall Study||8
369565|NCT02063217|908061|P3|NOT COMPLETED|Overall Study||0
369566|NCT02063217|908062|P2|NOT COMPLETED|Overall Study||0
369567|NCT02063217|908063|P1|NOT COMPLETED|Overall Study||1
369568|NCT02063217|908061|P3|COMPLETED|Overall Study||12
369569|NCT02063217|908062|P2|COMPLETED|Overall Study||12
369570|NCT02063217|908063|P1|COMPLETED|Overall Study||11
369571|NCT02063217|908061|P3|STARTED|Overall Study||12
369572|NCT02063217|908062|P2|STARTED|Overall Study||12
369573|NCT02063217|908063|P1|STARTED|Overall Study||12
369574|NCT02063035|908073|P2|NOT COMPLETED|Overall Study||0
369575|NCT02063035|908074|P1|NOT COMPLETED|Overall Study||0
369576|NCT02063035|908073|P2|COMPLETED|Overall Study||17
369577|NCT02063035|908074|P1|COMPLETED|Overall Study||12
369578|NCT02063035|908073|P2|STARTED|Overall Study||17
369579|NCT02063035|908074|P1|STARTED|Overall Study||12
369580|NCT02062905|908088|P2|NOT COMPLETED|Overall Study||2
369581|NCT02062905|908089|P1|NOT COMPLETED|Overall Study||7
369582|NCT02062905|908088|P2|COMPLETED|Overall Study||31
369583|NCT02062905|908089|P1|COMPLETED|Overall Study||28
369584|NCT02062905|908088|P2|STARTED|Overall Study||33
369585|NCT02062905|908089|P1|STARTED|Overall Study||35
369586|NCT02062879|908099|P2|NOT COMPLETED|Overall Study||1
369587|NCT02062879|908100|P1|NOT COMPLETED|Overall Study||4
369588|NCT02062879|908099|P2|COMPLETED|Overall Study||9
369589|NCT02062879|908100|P1|COMPLETED|Overall Study||6
369590|NCT02062879|908099|P2|STARTED|Overall Study||10
369591|NCT02062879|908100|P1|STARTED|Overall Study||10
369592|NCT02062801|908112|P2|NOT COMPLETED|Overall Study||4
369593|NCT02062801|908113|P1|NOT COMPLETED|Overall Study||2
369594|NCT02062801|908112|P2|COMPLETED|Overall Study||297
369595|NCT02062801|908113|P1|COMPLETED|Overall Study||299
369596|NCT02062801|908112|P2|STARTED|Overall Study||301
369597|NCT02062801|908113|P1|STARTED|Overall Study||301
369598|NCT02062710|908123|P6|NOT COMPLETED|Overall Study||0
369599|NCT02062710|908124|P5|NOT COMPLETED|Overall Study||0
369600|NCT02062710|908125|P4|NOT COMPLETED|Overall Study||0
369601|NCT02062710|908126|P3|NOT COMPLETED|Overall Study||0
369602|NCT02062710|908127|P2|NOT COMPLETED|Overall Study||0
369603|NCT02062710|908128|P1|NOT COMPLETED|Overall Study||0
369604|NCT02062710|908123|P6|COMPLETED|Overall Study||4
369605|NCT02062710|908124|P5|COMPLETED|Overall Study||3
369606|NCT02062710|908125|P4|COMPLETED|Overall Study||3
369607|NCT02062710|908126|P3|COMPLETED|Overall Study||5
369608|NCT02062710|908127|P2|COMPLETED|Overall Study||4
369609|NCT02062710|908128|P1|COMPLETED|Overall Study||3
369610|NCT02062710|908123|P6|STARTED|Overall Study|4 of 22 subjects randomized to receive the 3 study drugs in this particular sequence|4
369611|NCT02062710|908124|P5|STARTED|Overall Study|3 of 22 subjects randomized to receive the 3 study drugs in this aprticular sequence|3
369612|NCT02062710|908125|P4|STARTED|Overall Study|3 of 22 subjects randomized to receive the 3 study drugs in this particular sequence|3
369613|NCT02062710|908126|P3|STARTED|Overall Study|5 of total of 22 subjects randomized to receive the 3 study drugs in this particular sequence|5
369614|NCT02062710|908127|P2|STARTED|Overall Study|4 of the total 22 subjects randomized to receive the 3 study drugs in this particular sequence|4
369615|NCT02062710|908128|P1|STARTED|Overall Study|3 of total 22 subjects randomized to receive the 3 study drugs in this particular sequence|3
369616|NCT02062658|908136|P1|NOT COMPLETED|Overall Study||2
369617|NCT02062658|908136|P1|COMPLETED|Overall Study||8
369618|NCT02062658|908136|P1|STARTED|Overall Study||10
369619|NCT02062645|908140|P1|NOT COMPLETED|Overall Study||15
369620|NCT02062645|908140|P1|COMPLETED|Overall Study||100
369621|NCT02062645|908140|P1|STARTED|Overall Study||115
369622|NCT02062580|908150|P2|NOT COMPLETED|Overall Study||13
369623|NCT02062580|908151|P1|NOT COMPLETED|Overall Study||12
369624|NCT02062580|908150|P2|COMPLETED|Overall Study||65
369625|NCT02062580|908151|P1|COMPLETED|Overall Study||59
369626|NCT02062580|908150|P2|STARTED|Overall Study||78
369627|NCT02062580|908151|P1|STARTED|Overall Study||71
369628|NCT02062502|908161|P2|NOT COMPLETED|Overall Study||35
369629|NCT02062502|908162|P1|NOT COMPLETED|Overall Study||43
369630|NCT02062502|908161|P2|COMPLETED|Overall Study||270
369631|NCT02062502|908162|P1|COMPLETED|Overall Study||263
369632|NCT02062502|908161|P2|Vaccinated Dose 1|Overall Study||305
369633|NCT02062502|908162|P1|Vaccinated Dose 1|Overall Study||306
369634|NCT02062502|908161|P2|STARTED|Overall Study||305
369635|NCT02062502|908162|P1|STARTED|Overall Study||306
369636|NCT02062450|908182|P1|NOT COMPLETED|Overall Study||124
369637|NCT02062450|908182|P1|COMPLETED|Overall Study||255
369638|NCT02062450|908182|P1|Per Protocol Cohort|Overall Study|255 patients attended their 2-year follow-up visit.|255
369639|NCT02062450|908182|P1|STARTED|Overall Study|379 patients were successfully reached by phone and convoked for the 2-year follow-up visit.|379
369640|NCT02062437|908196|P1|NOT COMPLETED|Overall Study||52
369641|NCT02062437|908196|P1|COMPLETED|Overall Study|80 patients were effectively enrolled, when coming back for their 2-year follow-up visit.|80
369642|NCT02062437|908196|P1|STARTED|Overall Study|132 patients who undergone THR (July-Oct 2010), complying with in/exclusion criteria were identified|132
369643|NCT02062385|908209|P4|NOT COMPLETED|Overall Study||9
369644|NCT02062385|908210|P3|NOT COMPLETED|Overall Study||12
369645|NCT02062385|908211|P2|NOT COMPLETED|Overall Study||65
369646|NCT02062385|908212|P1|NOT COMPLETED|Overall Study||78
369647|NCT02062385|908209|P4|COMPLETED|Overall Study||391
369648|NCT02062385|908210|P3|COMPLETED|Overall Study||388
369649|NCT02062385|908211|P2|COMPLETED|Overall Study||1555
369650|NCT02062385|908212|P1|COMPLETED|Overall Study||1542
369651|NCT02062385|908209|P4|Received Vaccination 3|Overall Study||392
369652|NCT02062385|908210|P3|Received Vaccination 3|Overall Study||389
369653|NCT02062385|908211|P2|Received Vaccination 3|Overall Study||1554
369654|NCT02062385|908212|P1|Received Vaccination 3|Overall Study||1543
369655|NCT02062385|908209|P4|Received Vaccination 2|Overall Study||393
369656|NCT02062385|908210|P3|Received Vaccination 2|Overall Study||392
369657|NCT02062385|908211|P2|Received Vaccination 2|Overall Study||1566
369658|NCT02062385|908212|P1|Received Vaccination 2|Overall Study||1554
369659|NCT02062385|908209|P4|Received Vaccination 1|Overall Study||400
369660|NCT02062385|908210|P3|Received Vaccination 1|Overall Study||400
369661|NCT02062385|908211|P2|Received Vaccination 1|Overall Study||1619
369662|NCT02062385|908212|P1|Received Vaccination 1|Overall Study||1618
369663|NCT02062385|908209|P4|STARTED|Overall Study||400
369664|NCT02062385|908210|P3|STARTED|Overall Study||400
369665|NCT02062385|908211|P2|STARTED|Overall Study||1620
369666|NCT02062385|908212|P1|STARTED|Overall Study||1620
369667|NCT02062359|908232|P1|NOT COMPLETED|Overall Study||0
369668|NCT02062359|908232|P1|COMPLETED|Overall Study||2
369669|NCT02062359|908232|P1|STARTED|Overall Study||2
369670|NCT02062294|908238|P1|NOT COMPLETED|Overall Study||0
369671|NCT02062294|908238|P1|COMPLETED|Overall Study||14
369672|NCT02062294|908238|P1|STARTED|Overall Study||14
369673|NCT02062177|908245|P2|NOT COMPLETED|Overall Study||0
369674|NCT02062177|908246|P1|NOT COMPLETED|Overall Study||0
369675|NCT02062177|908245|P2|COMPLETED|Overall Study||70
369676|NCT02062177|908246|P1|COMPLETED|Overall Study||70
369677|NCT02062177|908245|P2|STARTED|Overall Study||70
369678|NCT02062177|908246|P1|STARTED|Overall Study||70
369679|NCT02061748|908258|P2|NOT COMPLETED|Overall Study||0
369680|NCT02061748|908259|P1|NOT COMPLETED|Overall Study||0
369681|NCT02061748|908258|P2|COMPLETED|Overall Study||30853
369682|NCT02061748|908259|P1|COMPLETED|Overall Study||7646
369683|NCT02061748|908258|P2|STARTED|Overall Study||30853
369684|NCT02061748|908259|P1|STARTED|Overall Study||7646
369685|NCT02061696|908333|P2|NOT COMPLETED|Overall Study||0
369686|NCT02061696|908334|P1|NOT COMPLETED|Overall Study||0
369687|NCT02061696|908333|P2|COMPLETED|Overall Study||22
369688|NCT02061696|908334|P1|COMPLETED|Overall Study||17
369689|NCT02061696|908333|P2|STARTED|Overall Study||22
369690|NCT02061696|908334|P1|STARTED|Overall Study||17
369691|NCT02061683|908358|P1|NOT COMPLETED|Overall Study||60
369692|NCT02061683|908358|P1|COMPLETED|Overall Study||203
369693|NCT02061683|908358|P1|STARTED|Overall Study||263
369694|NCT02061592|908365|P2|NOT COMPLETED|Period 2||1
369695|NCT02061592|908366|P1|NOT COMPLETED|Period 2||0
369696|NCT02061592|908365|P2|COMPLETED|Period 2||61
369697|NCT02061592|908366|P1|COMPLETED|Period 2||64
369698|NCT02061592|908365|P2|STARTED|Period 2||62
369699|NCT02061592|908366|P1|STARTED|Period 2||64
369700|NCT02061592|908365|P2|NOT COMPLETED|Period 1||0
369701|NCT02061592|908366|P1|NOT COMPLETED|Period 1||2
369702|NCT02061592|908365|P2|COMPLETED|Period 1||62
369703|NCT02061592|908366|P1|COMPLETED|Period 1||64
369704|NCT02061592|908365|P2|STARTED|Period 1||62
369705|NCT02061592|908366|P1|STARTED|Period 1||66
369706|NCT02061540|908378|P1|NOT COMPLETED|Overall Study||4
369707|NCT02061540|908378|P1|COMPLETED|Overall Study||23
369708|NCT02061540|908378|P1|Down-Titrated on LUM001 During the Study|Overall Study||5
369709|NCT02061540|908378|P1|STARTED|Overall Study||27
369710|NCT02061358|908400|P9|NOT COMPLETED|Overall Study||0
369711|NCT02061358|908401|P8|NOT COMPLETED|Overall Study||0
369712|NCT02061358|908402|P7|NOT COMPLETED|Overall Study||0
369713|NCT02061358|908403|P6|NOT COMPLETED|Overall Study||0
369714|NCT02061358|908404|P5|NOT COMPLETED|Overall Study||0
369715|NCT02061358|908405|P4|NOT COMPLETED|Overall Study||0
369716|NCT02061358|908406|P3|NOT COMPLETED|Overall Study||0
369717|NCT02061358|908407|P2|NOT COMPLETED|Overall Study||0
369718|NCT02061358|908408|P1|NOT COMPLETED|Overall Study||0
369719|NCT02061358|908400|P9|COMPLETED|Overall Study||16
369720|NCT02061358|908401|P8|COMPLETED|Overall Study||6
369721|NCT02061358|908402|P7|COMPLETED|Overall Study||6
369722|NCT02061358|908403|P6|COMPLETED|Overall Study||6
369723|NCT02061358|908404|P5|COMPLETED|Overall Study||6
369724|NCT02061358|908405|P4|COMPLETED|Overall Study||6
369725|NCT02061358|908406|P3|COMPLETED|Overall Study||6
369726|NCT02061358|908407|P2|COMPLETED|Overall Study||6
369727|NCT02061358|908408|P1|COMPLETED|Overall Study||6
369728|NCT02061358|908400|P9|STARTED|Overall Study||16
369729|NCT02061358|908401|P8|STARTED|Overall Study||6
369730|NCT02061358|908402|P7|STARTED|Overall Study||6
369731|NCT02061358|908403|P6|STARTED|Overall Study||6
369732|NCT02061358|908404|P5|STARTED|Overall Study||6
369733|NCT02061358|908405|P4|STARTED|Overall Study||6
369734|NCT02061358|908406|P3|STARTED|Overall Study||6
369735|NCT02061358|908407|P2|STARTED|Overall Study||6
369736|NCT02061358|908408|P1|STARTED|Overall Study||6
369737|NCT02061280|908546|P2|NOT COMPLETED|Overall Study||12
369738|NCT02061280|908547|P1|NOT COMPLETED|Overall Study||18
369739|NCT02061280|908546|P2|COMPLETED|Overall Study||25
369740|NCT02061280|908547|P1|COMPLETED|Overall Study||53
369741|NCT02061280|908546|P2|Randomized to Treatment|Overall Study||25
369742|NCT02061280|908547|P1|Randomized to Treatment|Overall Study||54
369743|NCT02061280|908546|P2|STARTED|Overall Study||37
369744|NCT02061280|908547|P1|STARTED|Overall Study||71
369745|NCT02060890|908559|P1|NOT COMPLETED|Overall Study||4
369746|NCT02060890|908559|P1|COMPLETED|Overall Study||16
369747|NCT02060890|908559|P1|STARTED|Overall Study||20
369748|NCT02060838|908568|P2|NOT COMPLETED|Overall Study||0
369749|NCT02060838|908569|P1|NOT COMPLETED|Overall Study||0
369750|NCT02060838|908568|P2|COMPLETED|Overall Study||22
369751|NCT02060838|908569|P1|COMPLETED|Overall Study||28
369752|NCT02060838|908568|P2|STARTED|Overall Study||22
369753|NCT02060838|908569|P1|STARTED|Overall Study||28
369754|NCT02060539|908577|P1|NOT COMPLETED|Overall Study||0
369755|NCT02060539|908577|P1|COMPLETED|Overall Study||19
369756|NCT02060539|908577|P1|STARTED|Overall Study||19
369757|NCT02060526|908625|P3|NOT COMPLETED|Overall Study||0
369758|NCT02060526|908626|P2|NOT COMPLETED|Overall Study||0
369759|NCT02060526|908627|P1|NOT COMPLETED|Overall Study||0
369760|NCT02060526|908625|P3|COMPLETED|Overall Study||7
369761|NCT02060526|908626|P2|COMPLETED|Overall Study||7
369762|NCT02060526|908627|P1|COMPLETED|Overall Study||7
369763|NCT02060526|908625|P3|STARTED|Overall Study||7
369764|NCT02060526|908626|P2|STARTED|Overall Study||7
369765|NCT02060526|908627|P1|STARTED|Overall Study||7
369766|NCT02060461|908663|P1|NOT COMPLETED|Overall Study||0
369767|NCT02060461|908663|P1|COMPLETED|Overall Study||33
369768|NCT02060461|908663|P1|STARTED|Overall Study||33
369769|NCT02060058|908672|P3|NOT COMPLETED|Overall Study||0
369770|NCT02060058|908673|P2|NOT COMPLETED|Overall Study||0
369771|NCT02060058|908674|P1|NOT COMPLETED|Overall Study||0
369772|NCT02060058|908672|P3|COMPLETED|Overall Study||8
369773|NCT02060058|908673|P2|COMPLETED|Overall Study||0
369774|NCT02060058|908674|P1|COMPLETED|Overall Study||4
369775|NCT02060058|908672|P3|STARTED|Overall Study||8
369776|NCT02060058|908673|P2|STARTED|Overall Study||0
369777|NCT02060058|908674|P1|STARTED|Overall Study||4
369778|NCT02059993|908690|P2|NOT COMPLETED|Overall Study||4
369779|NCT02059993|908691|P1|NOT COMPLETED|Overall Study||2
369780|NCT02059993|908690|P2|COMPLETED|Overall Study||37
369781|NCT02059993|908691|P1|COMPLETED|Overall Study||40
369782|NCT02059993|908690|P2|STARTED|Overall Study||41
369783|NCT02059993|908691|P1|STARTED|Overall Study||42
369784|NCT02059928|908697|P1|NOT COMPLETED|Overall Study||0
369785|NCT02059928|908697|P1|COMPLETED|Overall Study||20
369786|NCT02059928|908697|P1|STARTED|Overall Study||20
369787|NCT02059902|908703|P2|NOT COMPLETED|Overall Study||4
369788|NCT02059902|908704|P1|NOT COMPLETED|Overall Study||4
369789|NCT02059902|908703|P2|COMPLETED|Overall Study||14
369790|NCT02059902|908704|P1|COMPLETED|Overall Study||14
369791|NCT02059902|908703|P2|STARTED|Overall Study||18
369792|NCT02059902|908704|P1|STARTED|Overall Study||18
369793|NCT02059642|908712|P2|NOT COMPLETED|Overall Study||24
369794|NCT02059642|908713|P1|NOT COMPLETED|Overall Study||27
369795|NCT02059642|908712|P2|COMPLETED|Overall Study||128
369796|NCT02059642|908713|P1|COMPLETED|Overall Study||121
369797|NCT02059642|908712|P2|STARTED|Overall Study||152
369798|NCT02059642|908713|P1|STARTED|Overall Study||148
369799|NCT02059395|908723|P2|NOT COMPLETED|Overall Study||4
369800|NCT02059395|908724|P1|NOT COMPLETED|Overall Study||2
369801|NCT02059395|908723|P2|COMPLETED|Overall Study||23
369802|NCT02059395|908724|P1|COMPLETED|Overall Study||20
369803|NCT02059395|908723|P2|STARTED|Overall Study||27
369804|NCT02059395|908724|P1|STARTED|Overall Study||22
369805|NCT02059291|908739|P25|NOT COMPLETED|Epoch 4||0
369806|NCT02059291|908740|P24|NOT COMPLETED|Epoch 4||1
369807|NCT02059291|908741|P23|NOT COMPLETED|Epoch 4||1
369808|NCT02059291|908742|P22|NOT COMPLETED|Epoch 4||0
369809|NCT02059291|908743|P21|NOT COMPLETED|Epoch 4||1
369810|NCT02059291|908744|P20|NOT COMPLETED|Epoch 4||0
369811|NCT02059291|908745|P19|NOT COMPLETED|Epoch 4||0
369812|NCT02059291|908746|P18|NOT COMPLETED|Epoch 4||0
369813|NCT02059291|908747|P17|NOT COMPLETED|Epoch 4||2
369814|NCT02059291|908748|P16|NOT COMPLETED|Epoch 4||0
369815|NCT02059291|908749|P15|NOT COMPLETED|Epoch 4||0
369816|NCT02059291|908750|P14|NOT COMPLETED|Epoch 4||0
369817|NCT02059291|908751|P13|NOT COMPLETED|Epoch 4||0
369818|NCT02059291|908752|P12|NOT COMPLETED|Epoch 4||0
369819|NCT02059291|908753|P11|NOT COMPLETED|Epoch 4||0
369820|NCT02059291|908754|P10|NOT COMPLETED|Epoch 4||0
369821|NCT02059291|908755|P9|NOT COMPLETED|Epoch 4||0
369822|NCT02059291|908756|P8|NOT COMPLETED|Epoch 4||0
369823|NCT02059291|908757|P7|NOT COMPLETED|Epoch 4||0
369824|NCT02059291|908758|P6|NOT COMPLETED|Epoch 4||0
369825|NCT02059291|908759|P5|NOT COMPLETED|Epoch 4||0
369826|NCT02059291|908760|P4|NOT COMPLETED|Epoch 4||0
369827|NCT02059291|908761|P3|NOT COMPLETED|Epoch 4||0
369828|NCT02059291|908762|P2|NOT COMPLETED|Epoch 4||0
369829|NCT02059291|908763|P1|NOT COMPLETED|Epoch 4||0
369830|NCT02059291|908739|P25|COMPLETED|Epoch 4||0
369831|NCT02059291|908740|P24|COMPLETED|Epoch 4||21
369832|NCT02059291|908741|P23|COMPLETED|Epoch 4||30
369833|NCT02059291|908742|P22|COMPLETED|Epoch 4||14
369834|NCT02059291|908743|P21|COMPLETED|Epoch 4||33
369835|NCT02059291|908744|P20|COMPLETED|Epoch 4||18
369836|NCT02059291|908745|P19|COMPLETED|Epoch 4||2
369837|NCT02059291|908746|P18|COMPLETED|Epoch 4||14
369838|NCT02059291|908747|P17|COMPLETED|Epoch 4||41
369839|NCT02059291|908748|P16|COMPLETED|Epoch 4||0
369840|NCT02059291|908749|P15|COMPLETED|Epoch 4||0
369841|NCT02059291|908750|P14|COMPLETED|Epoch 4||0
369842|NCT02059291|908751|P13|COMPLETED|Epoch 4||0
369843|NCT02059291|908752|P12|COMPLETED|Epoch 4||0
369844|NCT02059291|908753|P11|COMPLETED|Epoch 4||0
369845|NCT02059291|908754|P10|COMPLETED|Epoch 4||0
369846|NCT02059291|908755|P9|COMPLETED|Epoch 4||0
369847|NCT02059291|908756|P8|COMPLETED|Epoch 4||0
369848|NCT02059291|908757|P7|COMPLETED|Epoch 4||0
369849|NCT02059291|908758|P6|COMPLETED|Epoch 4||0
369850|NCT02059291|908759|P5|COMPLETED|Epoch 4||0
369851|NCT02059291|908760|P4|COMPLETED|Epoch 4||0
369852|NCT02059291|908761|P3|COMPLETED|Epoch 4||0
369853|NCT02059291|908762|P2|COMPLETED|Epoch 4||0
369854|NCT02059291|908763|P1|COMPLETED|Epoch 4||0
369855|NCT02059291|908739|P25|STARTED|Epoch 4||0
369856|NCT02059291|908740|P24|STARTED|Epoch 4||22
369857|NCT02059291|908741|P23|STARTED|Epoch 4||31
369858|NCT02059291|908742|P22|STARTED|Epoch 4||14
369859|NCT02059291|908743|P21|STARTED|Epoch 4||34
369860|NCT02059291|908744|P20|STARTED|Epoch 4||18
369861|NCT02059291|908745|P19|STARTED|Epoch 4||2
369862|NCT02059291|908746|P18|STARTED|Epoch 4||14
369863|NCT02059291|908747|P17|STARTED|Epoch 4||43
369864|NCT02059291|908748|P16|STARTED|Epoch 4||0
369865|NCT02059291|908749|P15|STARTED|Epoch 4||0
369866|NCT02059291|908750|P14|STARTED|Epoch 4||0
369867|NCT02059291|908751|P13|STARTED|Epoch 4||0
369868|NCT02059291|908752|P12|STARTED|Epoch 4||0
369869|NCT02059291|908753|P11|STARTED|Epoch 4||0
369870|NCT02059291|908754|P10|STARTED|Epoch 4||0
369871|NCT02059291|908755|P9|STARTED|Epoch 4||0
369872|NCT02059291|908756|P8|STARTED|Epoch 4||0
369873|NCT02059291|908757|P7|STARTED|Epoch 4||0
369874|NCT02059291|908758|P6|STARTED|Epoch 4||0
369875|NCT02059291|908759|P5|STARTED|Epoch 4||0
369876|NCT02059291|908760|P4|STARTED|Epoch 4||0
369877|NCT02059291|908761|P3|STARTED|Epoch 4||0
369878|NCT02059291|908762|P2|STARTED|Epoch 4||0
369879|NCT02059291|908763|P1|STARTED|Epoch 4||0
369880|NCT02059291|908739|P25|NOT COMPLETED|Epoch 3||0
369881|NCT02059291|908740|P24|NOT COMPLETED|Epoch 3||0
369882|NCT02059291|908741|P23|NOT COMPLETED|Epoch 3||0
369883|NCT02059291|908742|P22|NOT COMPLETED|Epoch 3||0
369884|NCT02059291|908743|P21|NOT COMPLETED|Epoch 3||0
369885|NCT02059291|908744|P20|NOT COMPLETED|Epoch 3||0
369886|NCT02059291|908745|P19|NOT COMPLETED|Epoch 3||0
369887|NCT02059291|908746|P18|NOT COMPLETED|Epoch 3||0
369888|NCT02059291|908747|P17|NOT COMPLETED|Epoch 3||0
369889|NCT02059291|908748|P16|NOT COMPLETED|Epoch 3||6
369890|NCT02059291|908749|P15|NOT COMPLETED|Epoch 3||0
369891|NCT02059291|908750|P14|NOT COMPLETED|Epoch 3||1
369892|NCT02059291|908751|P13|NOT COMPLETED|Epoch 3||0
369893|NCT02059291|908752|P12|NOT COMPLETED|Epoch 3||0
369894|NCT02059291|908753|P11|NOT COMPLETED|Epoch 3||0
369895|NCT02059291|908754|P10|NOT COMPLETED|Epoch 3||0
369896|NCT02059291|908755|P9|NOT COMPLETED|Epoch 3||0
369897|NCT02059291|908756|P8|NOT COMPLETED|Epoch 3||0
369898|NCT02059291|908757|P7|NOT COMPLETED|Epoch 3||0
369899|NCT02059291|908758|P6|NOT COMPLETED|Epoch 3||0
369900|NCT02059291|908759|P5|NOT COMPLETED|Epoch 3||0
369901|NCT02059291|908760|P4|NOT COMPLETED|Epoch 3||0
369902|NCT02059291|908761|P3|NOT COMPLETED|Epoch 3||0
369903|NCT02059291|908762|P2|NOT COMPLETED|Epoch 3||0
369904|NCT02059291|908763|P1|NOT COMPLETED|Epoch 3||0
369905|NCT02059291|908739|P25|COMPLETED|Epoch 3||0
369906|NCT02059291|908740|P24|COMPLETED|Epoch 3||0
369907|NCT02059291|908741|P23|COMPLETED|Epoch 3||0
369908|NCT02059291|908742|P22|COMPLETED|Epoch 3||0
369909|NCT02059291|908743|P21|COMPLETED|Epoch 3||0
369910|NCT02059291|908744|P20|COMPLETED|Epoch 3||0
369911|NCT02059291|908745|P19|COMPLETED|Epoch 3||0
369912|NCT02059291|908746|P18|COMPLETED|Epoch 3||0
369913|NCT02059291|908747|P17|COMPLETED|Epoch 3||0
369914|NCT02059291|908748|P16|COMPLETED|Epoch 3||120
369915|NCT02059291|908749|P15|COMPLETED|Epoch 3||5
369916|NCT02059291|908750|P14|COMPLETED|Epoch 3||3
369917|NCT02059291|908751|P13|COMPLETED|Epoch 3||7
369918|NCT02059291|908752|P12|COMPLETED|Epoch 3||6
369919|NCT02059291|908753|P11|COMPLETED|Epoch 3||10
369920|NCT02059291|908754|P10|COMPLETED|Epoch 3||9
369921|NCT02059291|908755|P9|COMPLETED|Epoch 3||0
369922|NCT02059291|908756|P8|COMPLETED|Epoch 3||1
369923|NCT02059291|908757|P7|COMPLETED|Epoch 3||2
369924|NCT02059291|908758|P6|COMPLETED|Epoch 3||0
369925|NCT02059291|908759|P5|COMPLETED|Epoch 3||0
369926|NCT02059291|908760|P4|COMPLETED|Epoch 3||0
369927|NCT02059291|908761|P3|COMPLETED|Epoch 3||0
369928|NCT02059291|908762|P2|COMPLETED|Epoch 3||0
369929|NCT02059291|908763|P1|COMPLETED|Epoch 3||0
369930|NCT02059291|908739|P25|STARTED|Epoch 3||0
369931|NCT02059291|908740|P24|STARTED|Epoch 3||0
369932|NCT02059291|908741|P23|STARTED|Epoch 3||0
369933|NCT02059291|908742|P22|STARTED|Epoch 3||0
369934|NCT02059291|908743|P21|STARTED|Epoch 3||0
369935|NCT02059291|908744|P20|STARTED|Epoch 3||0
369936|NCT02059291|908745|P19|STARTED|Epoch 3||0
369937|NCT02059291|908746|P18|STARTED|Epoch 3||0
369938|NCT02059291|908747|P17|STARTED|Epoch 3||0
369939|NCT02059291|908748|P16|STARTED|Epoch 3||126
369940|NCT02059291|908749|P15|STARTED|Epoch 3||5
369941|NCT02059291|908750|P14|STARTED|Epoch 3||4
369942|NCT02059291|908751|P13|STARTED|Epoch 3||7
369943|NCT02059291|908752|P12|STARTED|Epoch 3||6
369944|NCT02059291|908753|P11|STARTED|Epoch 3||10
369945|NCT02059291|908754|P10|STARTED|Epoch 3||9
369946|NCT02059291|908755|P9|STARTED|Epoch 3|Presented in Epoch 2.|0
369947|NCT02059291|908756|P8|STARTED|Epoch 3||1
369948|NCT02059291|908757|P7|STARTED|Epoch 3||2
369949|NCT02059291|908758|P6|STARTED|Epoch 3||0
369950|NCT02059291|908759|P5|STARTED|Epoch 3||0
369951|NCT02059291|908760|P4|STARTED|Epoch 3||0
369952|NCT02059291|908761|P3|STARTED|Epoch 3||0
369953|NCT02059291|908762|P2|STARTED|Epoch 3||0
369954|NCT02059291|908763|P1|STARTED|Epoch 3||0
369955|NCT02059291|908739|P25|NOT COMPLETED|Epoch 2||0
369956|NCT02059291|908740|P24|NOT COMPLETED|Epoch 2||0
369957|NCT02059291|908741|P23|NOT COMPLETED|Epoch 2||0
369958|NCT02059291|908742|P22|NOT COMPLETED|Epoch 2||0
369959|NCT02059291|908743|P21|NOT COMPLETED|Epoch 2||0
369960|NCT02059291|908744|P20|NOT COMPLETED|Epoch 2||0
369961|NCT02059291|908745|P19|NOT COMPLETED|Epoch 2||0
369962|NCT02059291|908746|P18|NOT COMPLETED|Epoch 2||0
369963|NCT02059291|908747|P17|NOT COMPLETED|Epoch 2||0
369964|NCT02059291|908748|P16|NOT COMPLETED|Epoch 2||0
369965|NCT02059291|908749|P15|NOT COMPLETED|Epoch 2||0
369966|NCT02059291|908750|P14|NOT COMPLETED|Epoch 2||0
369967|NCT02059291|908751|P13|NOT COMPLETED|Epoch 2||0
369968|NCT02059291|908752|P12|NOT COMPLETED|Epoch 2||0
369969|NCT02059291|908753|P11|NOT COMPLETED|Epoch 2||0
369970|NCT02059291|908754|P10|NOT COMPLETED|Epoch 2||0
369971|NCT02059291|908755|P9|NOT COMPLETED|Epoch 2||2
369972|NCT02059291|908756|P8|NOT COMPLETED|Epoch 2||1
369973|NCT02059291|908757|P7|NOT COMPLETED|Epoch 2||0
369974|NCT02059291|908758|P6|NOT COMPLETED|Epoch 2||2
369975|NCT02059291|908759|P5|NOT COMPLETED|Epoch 2||0
369976|NCT02059291|908760|P4|NOT COMPLETED|Epoch 2||2
369977|NCT02059291|908761|P3|NOT COMPLETED|Epoch 2||1
369978|NCT02059291|908762|P2|NOT COMPLETED|Epoch 2||1
369979|NCT02059291|908763|P1|NOT COMPLETED|Epoch 2||0
369980|NCT02059291|908739|P25|COMPLETED|Epoch 2||0
369981|NCT02059291|908740|P24|COMPLETED|Epoch 2||0
369982|NCT02059291|908741|P23|COMPLETED|Epoch 2||0
369983|NCT02059291|908742|P22|COMPLETED|Epoch 2||0
369984|NCT02059291|908743|P21|COMPLETED|Epoch 2||0
369985|NCT02059291|908744|P20|COMPLETED|Epoch 2||0
369986|NCT02059291|908745|P19|COMPLETED|Epoch 2||0
369987|NCT02059291|908746|P18|COMPLETED|Epoch 2||0
369988|NCT02059291|908747|P17|COMPLETED|Epoch 2||0
369989|NCT02059291|908748|P16|COMPLETED|Epoch 2||0
369990|NCT02059291|908749|P15|COMPLETED|Epoch 2||0
369991|NCT02059291|908750|P14|COMPLETED|Epoch 2||0
369992|NCT02059291|908751|P13|COMPLETED|Epoch 2||0
369993|NCT02059291|908752|P12|COMPLETED|Epoch 2||0
369994|NCT02059291|908753|P11|COMPLETED|Epoch 2||0
369995|NCT02059291|908754|P10|COMPLETED|Epoch 2||0
369996|NCT02059291|908755|P9|COMPLETED|Epoch 2||16
369997|NCT02059291|908756|P8|COMPLETED|Epoch 2||1
369998|NCT02059291|908757|P7|COMPLETED|Epoch 2||2
369999|NCT02059291|908758|P6|COMPLETED|Epoch 2||22
370000|NCT02059291|908759|P5|COMPLETED|Epoch 2||22
370001|NCT02059291|908760|P4|COMPLETED|Epoch 2||33
370002|NCT02059291|908761|P3|COMPLETED|Epoch 2||36
370003|NCT02059291|908762|P2|COMPLETED|Epoch 2||31
370004|NCT02059291|908763|P1|COMPLETED|Epoch 2||31
370005|NCT02059291|908739|P25|STARTED|Epoch 2||0
370006|NCT02059291|908740|P24|STARTED|Epoch 2||0
370007|NCT02059291|908741|P23|STARTED|Epoch 2||0
370008|NCT02059291|908742|P22|STARTED|Epoch 2||0
370009|NCT02059291|908743|P21|STARTED|Epoch 2||0
370010|NCT02059291|908744|P20|STARTED|Epoch 2||0
370011|NCT02059291|908745|P19|STARTED|Epoch 2||0
370012|NCT02059291|908746|P18|STARTED|Epoch 2||0
370013|NCT02059291|908747|P17|STARTED|Epoch 2||0
370014|NCT02059291|908748|P16|STARTED|Epoch 2||0
370015|NCT02059291|908749|P15|STARTED|Epoch 2||0
370016|NCT02059291|908750|P14|STARTED|Epoch 2||0
370017|NCT02059291|908751|P13|STARTED|Epoch 2||0
370018|NCT02059291|908752|P12|STARTED|Epoch 2||0
370019|NCT02059291|908753|P11|STARTED|Epoch 2||0
370020|NCT02059291|908754|P10|STARTED|Epoch 2||0
370021|NCT02059291|908755|P9|STARTED|Epoch 2|This Epoch 3 group is shown in Epoch 2 to account for the 203 patients enrolled in the study.|18
370022|NCT02059291|908756|P8|STARTED|Epoch 2||2
370023|NCT02059291|908757|P7|STARTED|Epoch 2||2
370024|NCT02059291|908758|P6|STARTED|Epoch 2||24
370025|NCT02059291|908759|P5|STARTED|Epoch 2||22
370026|NCT02059291|908760|P4|STARTED|Epoch 2||35
370027|NCT02059291|908761|P3|STARTED|Epoch 2||37
370028|NCT02059291|908762|P2|STARTED|Epoch 2||32
370029|NCT02059291|908763|P1|STARTED|Epoch 2||31
370030|NCT02059187|908817|P2|NOT COMPLETED|Overall Study||22
370031|NCT02059187|908818|P1|NOT COMPLETED|Overall Study||25
370032|NCT02059187|908817|P2|COMPLETED|Overall Study||244
370033|NCT02059187|908818|P1|COMPLETED|Overall Study||240
370034|NCT02059187|908817|P2|STARTED|Overall Study||266
370035|NCT02059187|908818|P1|STARTED|Overall Study||265
370036|NCT02059174|908844|P2|NOT COMPLETED|Period 4||0
370037|NCT02059174|908845|P1|NOT COMPLETED|Period 4||0
370038|NCT02059174|908844|P2|COMPLETED|Period 4||35
370039|NCT02059174|908845|P1|COMPLETED|Period 4||35
370040|NCT02059174|908844|P2|STARTED|Period 4||35
370041|NCT02059174|908845|P1|STARTED|Period 4||35
370042|NCT02059174|908844|P2|NOT COMPLETED|Period 3||0
370043|NCT02059174|908845|P1|NOT COMPLETED|Period 3||1
370044|NCT02059174|908844|P2|COMPLETED|Period 3||35
370045|NCT02059174|908845|P1|COMPLETED|Period 3||35
370046|NCT02059174|908844|P2|STARTED|Period 3||35
370047|NCT02059174|908845|P1|STARTED|Period 3||36
370048|NCT02059174|908844|P2|NOT COMPLETED|Period 2||2
370049|NCT02059174|908845|P1|NOT COMPLETED|Period 2||1
370050|NCT02059174|908844|P2|COMPLETED|Period 2||35
370051|NCT02059174|908845|P1|COMPLETED|Period 2||36
370052|NCT02059174|908844|P2|STARTED|Period 2||37
370053|NCT02059174|908845|P1|STARTED|Period 2||37
370054|NCT02059174|908844|P2|NOT COMPLETED|Period 1||2
370055|NCT02059174|908845|P1|NOT COMPLETED|Period 1||0
370056|NCT02059174|908844|P2|COMPLETED|Period 1||37
370057|NCT02059174|908845|P1|COMPLETED|Period 1||37
370058|NCT02059174|908844|P2|STARTED|Period 1||39
370059|NCT02059174|908845|P1|STARTED|Period 1||37
370060|NCT02059161|908869|P2|NOT COMPLETED|Overall Study||41
370061|NCT02059161|908870|P1|NOT COMPLETED|Overall Study||49
370062|NCT02059161|908869|P2|COMPLETED|Overall Study||222
370063|NCT02059161|908870|P1|COMPLETED|Overall Study||196
370064|NCT02059161|908869|P2|Treated|Overall Study||258
370065|NCT02059161|908870|P1|Treated|Overall Study||241
370066|NCT02059161|908869|P2|STARTED|Overall Study||263
370067|NCT02059161|908870|P1|STARTED|Overall Study||245
370068|NCT02059135|908932|P2|NOT COMPLETED|Neonatal Follow-up (Safety Population)||4
370069|NCT02059135|908933|P1|NOT COMPLETED|Neonatal Follow-up (Safety Population)||4
370070|NCT02059135|908932|P2|COMPLETED|Neonatal Follow-up (Safety Population)||50
370071|NCT02059135|908933|P1|COMPLETED|Neonatal Follow-up (Safety Population)||56
370072|NCT02059135|908932|P2|STARTED|Neonatal Follow-up (Safety Population)||54
370073|NCT02059135|908933|P1|STARTED|Neonatal Follow-up (Safety Population)||60
370074|NCT02059135|908932|P2|NOT COMPLETED|Maternal Follow-up (ITT Population)||7
370075|NCT02059135|908933|P1|NOT COMPLETED|Maternal Follow-up (ITT Population)||3
370076|NCT02059135|908932|P2|COMPLETED|Maternal Follow-up (ITT Population)||51
370077|NCT02059135|908933|P1|COMPLETED|Maternal Follow-up (ITT Population)||59
370078|NCT02059135|908932|P2|STARTED|Maternal Follow-up (ITT Population)||58
370079|NCT02059135|908933|P1|STARTED|Maternal Follow-up (ITT Population)||62
370080|NCT02059070|908947|P2|NOT COMPLETED|Overall Study||4
370081|NCT02059070|908948|P1|NOT COMPLETED|Overall Study||5
370082|NCT02059070|908947|P2|COMPLETED|Overall Study||16
370083|NCT02059070|908948|P1|COMPLETED|Overall Study||14
370084|NCT02059070|908947|P2|STARTED|Overall Study||20
370085|NCT02059070|908948|P1|STARTED|Overall Study||19
370086|NCT02058992|908960|P1|NOT COMPLETED|Overall Study||116
370087|NCT02058992|908960|P1|COMPLETED|Overall Study||3223
370088|NCT02058992|908960|P1|STARTED|Overall Study||3339
370089|NCT02058836|908971|P2|NOT COMPLETED|Overall Study||1
370090|NCT02058836|908972|P1|NOT COMPLETED|Overall Study||1
370091|NCT02058836|908971|P2|COMPLETED|Overall Study||3
370092|NCT02058836|908972|P1|COMPLETED|Overall Study||3
370093|NCT02058836|908971|P2|STARTED|Overall Study||4
370094|NCT02058836|908972|P1|STARTED|Overall Study||4
370095|NCT02058628|909002|P2|NOT COMPLETED|Overall Study||8
370096|NCT02058628|909003|P1|NOT COMPLETED|Overall Study||7
370097|NCT02058628|909002|P2|COMPLETED|Overall Study||102
370098|NCT02058628|909003|P1|COMPLETED|Overall Study||104
370099|NCT02058628|909002|P2|STARTED|Overall Study||110
370100|NCT02058628|909003|P1|STARTED|Overall Study||111
370101|NCT02058563|909035|P2|NOT COMPLETED|Overall Study||24
370102|NCT02058563|909036|P1|NOT COMPLETED|Overall Study||28
370103|NCT02058563|909035|P2|COMPLETED|Overall Study||433
370104|NCT02058563|909036|P1|COMPLETED|Overall Study||426
370105|NCT02058563|909035|P2|STARTED|Overall Study||457
370106|NCT02058563|909036|P1|STARTED|Overall Study||454
370107|NCT02058537|909072|P1|NOT COMPLETED|Overall Study||1
370108|NCT02058537|909072|P1|COMPLETED|Overall Study||2
370109|NCT02058537|909072|P1|STARTED|Overall Study||3
370110|NCT02058498|909078|P1|NOT COMPLETED|Overall Study||4
370111|NCT02058498|909078|P1|COMPLETED|Overall Study||8
370112|NCT02058498|909078|P1|6 Weeks|Overall Study||8
370113|NCT02058498|909078|P1|STARTED|Overall Study||12
370114|NCT02058290|909086|P2|NOT COMPLETED|Overall Study||9
370115|NCT02058290|909087|P1|NOT COMPLETED|Overall Study||11
370116|NCT02058290|909086|P2|COMPLETED|Overall Study||36
370117|NCT02058290|909087|P1|COMPLETED|Overall Study||66
370118|NCT02058290|909086|P2|STARTED|Overall Study||45
370119|NCT02058290|909087|P1|STARTED|Overall Study||77
370120|NCT02058160|909103|P2|NOT COMPLETED|Overall Study||14
370121|NCT02058160|909104|P1|NOT COMPLETED|Overall Study||31
370122|NCT02058160|909103|P2|COMPLETED|Overall Study||355
370123|NCT02058160|909104|P1|COMPLETED|Overall Study||336
370124|NCT02058160|909103|P2|Treated|Overall Study||365
370125|NCT02058160|909104|P1|Treated|Overall Study||365
370126|NCT02058160|909103|P2|STARTED|Overall Study||369
370127|NCT02058160|909104|P1|STARTED|Overall Study||367
370128|NCT02058147|909141|P3|NOT COMPLETED|Overall Study||29
370129|NCT02058147|909142|P2|NOT COMPLETED|Overall Study||27
370130|NCT02058147|909143|P1|NOT COMPLETED|Overall Study||29
370131|NCT02058147|909141|P3|COMPLETED|Overall Study||205
370132|NCT02058147|909142|P2|COMPLETED|Overall Study||440
370133|NCT02058147|909143|P1|COMPLETED|Overall Study||440
370134|NCT02058147|909141|P3|Treated|Overall Study||233
370135|NCT02058147|909142|P2|Treated|Overall Study||467
370136|NCT02058147|909143|P1|Treated|Overall Study||469
370137|NCT02058147|909141|P3|STARTED|Overall Study||234
370138|NCT02058147|909142|P2|STARTED|Overall Study||467
370139|NCT02058147|909143|P1|STARTED|Overall Study||469
370140|NCT02058069|909192|P1|NOT COMPLETED|Overall Study||11
370141|NCT02058069|909192|P1|COMPLETED|Overall Study||89
370142|NCT02058069|909192|P1|STARTED|Overall Study||100
370143|NCT02057952|909204|P3|NOT COMPLETED|Overall Study||22
370144|NCT02057952|909205|P2|NOT COMPLETED|Overall Study||10
370145|NCT02057952|909206|P1|NOT COMPLETED|Overall Study||8
370146|NCT02057952|909204|P3|COMPLETED|Overall Study||28
370147|NCT02057952|909205|P2|COMPLETED|Overall Study||39
370148|NCT02057952|909206|P1|COMPLETED|Overall Study||43
370149|NCT02057952|909204|P3|STARTED|Overall Study||50
370150|NCT02057952|909205|P2|STARTED|Overall Study||49
370151|NCT02057952|909206|P1|STARTED|Overall Study||51
370152|NCT02057835|909251|P10|NOT COMPLETED|Overall Study||0
370153|NCT02057835|909252|P9|NOT COMPLETED|Overall Study||0
370154|NCT02057835|909253|P8|NOT COMPLETED|Overall Study||0
370155|NCT02057835|909254|P7|NOT COMPLETED|Overall Study||0
370156|NCT02057835|909255|P6|NOT COMPLETED|Overall Study||0
370157|NCT02057835|909256|P5|NOT COMPLETED|Overall Study||0
370158|NCT02057835|909257|P4|NOT COMPLETED|Overall Study||0
370159|NCT02057835|909258|P3|NOT COMPLETED|Overall Study||0
370160|NCT02057835|909259|P2|NOT COMPLETED|Overall Study||2
370161|NCT02057835|909260|P1|NOT COMPLETED|Overall Study||0
370162|NCT02057835|909251|P10|COMPLETED|Overall Study||6
370163|NCT02057835|909252|P9|COMPLETED|Overall Study||6
370164|NCT02057835|909253|P8|COMPLETED|Overall Study||6
370165|NCT02057835|909254|P7|COMPLETED|Overall Study||6
370166|NCT02057835|909255|P6|COMPLETED|Overall Study||8
370167|NCT02057835|909256|P5|COMPLETED|Overall Study||6
370168|NCT02057835|909257|P4|COMPLETED|Overall Study||6
370169|NCT02057835|909258|P3|COMPLETED|Overall Study||6
370170|NCT02057835|909259|P2|COMPLETED|Overall Study||4
370171|NCT02057835|909260|P1|COMPLETED|Overall Study||8
370172|NCT02057835|909251|P10|STARTED|Overall Study||6
370173|NCT02057835|909252|P9|STARTED|Overall Study||6
370174|NCT02057835|909253|P8|STARTED|Overall Study||6
370175|NCT02057835|909254|P7|STARTED|Overall Study||6
370176|NCT02057835|909255|P6|STARTED|Overall Study||8
370177|NCT02057835|909256|P5|STARTED|Overall Study||6
370178|NCT02057835|909257|P4|STARTED|Overall Study||6
370179|NCT02057835|909258|P3|STARTED|Overall Study||6
370180|NCT02057835|909259|P2|STARTED|Overall Study||6
370181|NCT02057835|909260|P1|STARTED|Overall Study||8
370182|NCT02057692|909341|P4|NOT COMPLETED|Overall Study||1
370183|NCT02057692|909342|P3|NOT COMPLETED|Overall Study||0
370184|NCT02057692|909343|P2|NOT COMPLETED|Overall Study||0
370185|NCT02057692|909344|P1|NOT COMPLETED|Overall Study||1
370186|NCT02057692|909341|P4|COMPLETED|Overall Study||11
370187|NCT02057692|909342|P3|COMPLETED|Overall Study||6
370188|NCT02057692|909343|P2|COMPLETED|Overall Study||11
370189|NCT02057692|909344|P1|COMPLETED|Overall Study||7
370190|NCT02057692|909341|P4|STARTED|Overall Study||12
370191|NCT02057692|909342|P3|STARTED|Overall Study||6
370192|NCT02057692|909343|P2|STARTED|Overall Study||11
370193|NCT02057692|909344|P1|STARTED|Overall Study||8
370194|NCT02057549|909370|P2|NOT COMPLETED|Overall Study||0
370195|NCT02057549|909371|P1|NOT COMPLETED|Overall Study||3
370196|NCT02057549|909370|P2|COMPLETED|Overall Study||18
370197|NCT02057549|909371|P1|COMPLETED|Overall Study||15
370198|NCT02057549|909370|P2|STARTED|Overall Study||18
370199|NCT02057549|909371|P1|STARTED|Overall Study||18
370200|NCT02057406|909394|P3|NOT COMPLETED|Overall Study||4
370201|NCT02057406|909395|P2|NOT COMPLETED|Overall Study||3
370202|NCT02057406|909396|P1|NOT COMPLETED|Overall Study||1
370203|NCT02057406|909394|P3|COMPLETED|Overall Study||32
370204|NCT02057406|909395|P2|COMPLETED|Overall Study||33
370205|NCT02057406|909396|P1|COMPLETED|Overall Study||35
370206|NCT02057406|909394|P3|STARTED|Overall Study||36
370207|NCT02057406|909395|P2|STARTED|Overall Study||36
370208|NCT02057406|909396|P1|STARTED|Overall Study||36
370209|NCT02057393|909407|P1|NOT COMPLETED|Overall Study||2
370210|NCT02057393|909407|P1|COMPLETED|Overall Study||87
370211|NCT02057393|909407|P1|STARTED|Overall Study||89
370212|NCT02057276|909413|P2|NOT COMPLETED|Overall Study||0
370213|NCT02057276|909414|P1|NOT COMPLETED|Overall Study||0
370214|NCT02057276|909413|P2|COMPLETED|Overall Study||0
370215|NCT02057276|909414|P1|COMPLETED|Overall Study||0
370216|NCT02057276|909413|P2|STARTED|Overall Study||0
370217|NCT02057276|909414|P1|STARTED|Overall Study||0
370218|NCT02057250|909428|P5|NOT COMPLETED|Extension Phase||36
370219|NCT02057250|909429|P4|NOT COMPLETED|Extension Phase||0
370220|NCT02057250|909430|P3|NOT COMPLETED|Extension Phase||0
370221|NCT02057250|909431|P2|NOT COMPLETED|Extension Phase||0
370222|NCT02057250|909432|P1|NOT COMPLETED|Extension Phase||0
370223|NCT02057250|909428|P5|COMPLETED|Extension Phase||156
370224|NCT02057250|909429|P4|COMPLETED|Extension Phase||0
370225|NCT02057250|909430|P3|COMPLETED|Extension Phase||0
370226|NCT02057250|909431|P2|COMPLETED|Extension Phase||0
370227|NCT02057250|909432|P1|COMPLETED|Extension Phase||0
370228|NCT02057250|909428|P5|Treated|Extension Phase||188
370229|NCT02057250|909429|P4|Treated|Extension Phase||0
370230|NCT02057250|909430|P3|Treated|Extension Phase||0
370231|NCT02057250|909431|P2|Treated|Extension Phase||0
370232|NCT02057250|909432|P1|Treated|Extension Phase||0
370233|NCT02057250|909428|P5|STARTED|Extension Phase|9 participants who completed AID Assessment phase did not enter extension phase.|192
370234|NCT02057250|909429|P4|STARTED|Extension Phase||0
370235|NCT02057250|909430|P3|STARTED|Extension Phase||0
370236|NCT02057250|909431|P2|STARTED|Extension Phase||0
370237|NCT02057250|909432|P1|STARTED|Extension Phase||0
370238|NCT02057250|909428|P5|NOT COMPLETED|AID Assessment Phase||0
370239|NCT02057250|909429|P4|NOT COMPLETED|AID Assessment Phase||2
370240|NCT02057250|909430|P3|NOT COMPLETED|AID Assessment Phase||7
370241|NCT02057250|909431|P2|NOT COMPLETED|AID Assessment Phase||3
370242|NCT02057250|909432|P1|NOT COMPLETED|AID Assessment Phase||4
370243|NCT02057250|909428|P5|COMPLETED|AID Assessment Phase||0
370244|NCT02057250|909429|P4|COMPLETED|AID Assessment Phase||54
370245|NCT02057250|909430|P3|COMPLETED|AID Assessment Phase||45
370246|NCT02057250|909431|P2|COMPLETED|AID Assessment Phase||50
370247|NCT02057250|909432|P1|COMPLETED|AID Assessment Phase||52
370248|NCT02057250|909428|P5|STARTED|AID Assessment Phase||0
370249|NCT02057250|909429|P4|STARTED|AID Assessment Phase||56
370250|NCT02057250|909430|P3|STARTED|AID Assessment Phase||52
370251|NCT02057250|909431|P2|STARTED|AID Assessment Phase||53
370252|NCT02057250|909432|P1|STARTED|AID Assessment Phase||56
370253|NCT02057237|909445|P1|NOT COMPLETED|Overall Study||0
370254|NCT02057237|909445|P1|COMPLETED|Overall Study||1
370255|NCT02057237|909445|P1|STARTED|Overall Study||1
370256|NCT02057068|909452|P2|NOT COMPLETED|Overall Study||8
370257|NCT02057068|909453|P1|NOT COMPLETED|Overall Study||8
370258|NCT02057068|909452|P2|COMPLETED|Overall Study||28
370259|NCT02057068|909453|P1|COMPLETED|Overall Study||52
370260|NCT02057068|909452|P2|STARTED|Overall Study||36
370261|NCT02057068|909453|P1|STARTED|Overall Study||60
370262|NCT02056834|909463|P1|NOT COMPLETED|Overall Study||7
370263|NCT02056834|909463|P1|COMPLETED|Overall Study||29
370264|NCT02056834|909463|P1|6 Months|Overall Study||31
370265|NCT02056834|909463|P1|6 Weeks|Overall Study||34
370266|NCT02056834|909463|P1|STARTED|Overall Study||36
370267|NCT02056652|909484|P2|NOT COMPLETED|Overall Study||3
370268|NCT02056652|909485|P1|NOT COMPLETED|Overall Study||1
370269|NCT02056652|909484|P2|COMPLETED|Overall Study||58
370270|NCT02056652|909485|P1|COMPLETED|Overall Study||60
370271|NCT02056652|909484|P2|STARTED|Overall Study||61
370272|NCT02056652|909485|P1|STARTED|Overall Study||61
370273|NCT02056639|909503|P2|NOT COMPLETED|Overall Study||0
370274|NCT02056639|909504|P1|NOT COMPLETED|Overall Study||0
370275|NCT02056639|909503|P2|COMPLETED|Overall Study||23
370276|NCT02056639|909504|P1|COMPLETED|Overall Study||23
370277|NCT02056639|909503|P2|STARTED|Overall Study||23
370278|NCT02056639|909504|P1|STARTED|Overall Study||23
370279|NCT02056431|909520|P2|NOT COMPLETED|Overall Study||47
370280|NCT02056431|909521|P1|NOT COMPLETED|Overall Study||44
370281|NCT02056431|909520|P2|COMPLETED|Overall Study||619
370282|NCT02056431|909521|P1|COMPLETED|Overall Study||560
370283|NCT02056431|909520|P2|STARTED|Overall Study||666
370284|NCT02056431|909521|P1|STARTED|Overall Study||604
370285|NCT02056392|909535|P6|NOT COMPLETED|Overall Study||0
370286|NCT02056392|909536|P5|NOT COMPLETED|Overall Study||1
370287|NCT02056392|909537|P4|NOT COMPLETED|Overall Study||0
370288|NCT02056392|909538|P3|NOT COMPLETED|Overall Study||3
370289|NCT02056392|909539|P2|NOT COMPLETED|Overall Study||1
370290|NCT02056392|909540|P1|NOT COMPLETED|Overall Study||2
370291|NCT02056392|909535|P6|COMPLETED|Overall Study||9
370292|NCT02056392|909536|P5|COMPLETED|Overall Study||7
370293|NCT02056392|909537|P4|COMPLETED|Overall Study||9
370294|NCT02056392|909538|P3|COMPLETED|Overall Study||6
370295|NCT02056392|909539|P2|COMPLETED|Overall Study||8
370296|NCT02056392|909540|P1|COMPLETED|Overall Study||8
370297|NCT02056392|909535|P6|STARTED|Overall Study||9
370298|NCT02056392|909536|P5|STARTED|Overall Study||8
370299|NCT02056392|909537|P4|STARTED|Overall Study||9
370300|NCT02056392|909538|P3|STARTED|Overall Study||9
370301|NCT02056392|909539|P2|STARTED|Overall Study||9
370302|NCT02056392|909540|P1|STARTED|Overall Study||10
370303|NCT02056171|909577|P2|NOT COMPLETED|Overall Study||0
370304|NCT02056171|909578|P1|NOT COMPLETED|Overall Study||0
370305|NCT02056171|909577|P2|COMPLETED|Overall Study||3
370306|NCT02056171|909578|P1|COMPLETED|Overall Study||3
370307|NCT02056171|909577|P2|STARTED|Overall Study||3
370308|NCT02056171|909578|P1|STARTED|Overall Study||3
370309|NCT02055430|909590|P2|NOT COMPLETED|Overall Study||0
370310|NCT02055430|909591|P1|NOT COMPLETED|Overall Study||0
370311|NCT02055430|909590|P2|COMPLETED|Overall Study||45
370312|NCT02055430|909591|P1|COMPLETED|Overall Study||45
370313|NCT02055430|909590|P2|STARTED|Overall Study||45
370314|NCT02055430|909591|P1|STARTED|Overall Study||45
370315|NCT02055404|909597|P1|NOT COMPLETED|Overall Study||0
370316|NCT02055404|909597|P1|COMPLETED|Overall Study||3
370317|NCT02055404|909597|P1|STARTED|Overall Study||3
370318|NCT02055365|909610|P1|NOT COMPLETED|Overall Study||1
370319|NCT02055365|909610|P1|COMPLETED|Overall Study||9
370320|NCT02055365|909610|P1|STARTED|Overall Study||10
370321|NCT02055352|909623|P2|NOT COMPLETED|Overall Study||17
370322|NCT02055352|909624|P1|NOT COMPLETED|Overall Study||6
370323|NCT02055352|909623|P2|COMPLETED|Overall Study||96
370324|NCT02055352|909624|P1|COMPLETED|Overall Study||103
370325|NCT02055352|909623|P2|Per-Protocol Set (PPS)|Overall Study||111
370326|NCT02055352|909624|P1|Per-Protocol Set (PPS)|Overall Study||108
370327|NCT02055352|909623|P2|STARTED|Overall Study||113
370328|NCT02055352|909624|P1|STARTED|Overall Study||109
370329|NCT02054910|909640|P2|NOT COMPLETED|Overall Study||1
370330|NCT02054910|909641|P1|NOT COMPLETED|Overall Study||4
370331|NCT02054910|909640|P2|COMPLETED|Overall Study||0
370332|NCT02054910|909641|P1|COMPLETED|Overall Study||0
370333|NCT02054910|909640|P2|STARTED|Overall Study||1
370334|NCT02054910|909641|P1|STARTED|Overall Study||4
370335|NCT02054897|909660|P3|NOT COMPLETED|Overall Study||12
370336|NCT02054897|909661|P2|NOT COMPLETED|Overall Study||7
370337|NCT02054897|909662|P1|NOT COMPLETED|Overall Study||10
370338|NCT02054897|909660|P3|COMPLETED|Overall Study||117
370339|NCT02054897|909661|P2|COMPLETED|Overall Study||123
370340|NCT02054897|909662|P1|COMPLETED|Overall Study||119
370341|NCT02054897|909660|P3|Exposed|Overall Study||129
370342|NCT02054897|909661|P2|Exposed|Overall Study||130
370343|NCT02054897|909662|P1|Exposed|Overall Study||128
370344|NCT02054897|909660|P3|STARTED|Overall Study||129
370345|NCT02054897|909661|P2|STARTED|Overall Study||130
370346|NCT02054897|909662|P1|STARTED|Overall Study||129
370347|NCT02054754|909687|P6|NOT COMPLETED|Overall Study||0
370348|NCT02054754|909688|P5|NOT COMPLETED|Overall Study||0
370349|NCT02054754|909689|P4|NOT COMPLETED|Overall Study||0
370350|NCT02054754|909690|P3|NOT COMPLETED|Overall Study||0
370351|NCT02054754|909691|P2|NOT COMPLETED|Overall Study||0
370352|NCT02054754|909692|P1|NOT COMPLETED|Overall Study||0
370353|NCT02054754|909687|P6|COMPLETED|Overall Study||10
370354|NCT02054754|909688|P5|COMPLETED|Overall Study||6
370355|NCT02054754|909689|P4|COMPLETED|Overall Study||6
370356|NCT02054754|909690|P3|COMPLETED|Overall Study||6
370357|NCT02054754|909691|P2|COMPLETED|Overall Study||6
370358|NCT02054754|909692|P1|COMPLETED|Overall Study||6
370359|NCT02054754|909687|P6|STARTED|Overall Study||10
370360|NCT02054754|909688|P5|STARTED|Overall Study||6
370361|NCT02054754|909689|P4|STARTED|Overall Study||6
370362|NCT02054754|909690|P3|STARTED|Overall Study||6
370363|NCT02054754|909691|P2|STARTED|Overall Study||6
370364|NCT02054754|909692|P1|STARTED|Overall Study||6
370365|NCT02054715|909709|P2|NOT COMPLETED|Follow-up 2||19
370366|NCT02054715|909710|P1|NOT COMPLETED|Follow-up 2||19
370367|NCT02054715|909709|P2|COMPLETED|Follow-up 2||173
370368|NCT02054715|909710|P1|COMPLETED|Follow-up 2||192
370369|NCT02054715|909709|P2|STARTED|Follow-up 2||192
370370|NCT02054715|909710|P1|STARTED|Follow-up 2||211
370371|NCT02054715|909709|P2|NOT COMPLETED|Baseline/Follow-up 1||7
370372|NCT02054715|909710|P1|NOT COMPLETED|Baseline/Follow-up 1||8
370373|NCT02054715|909709|P2|COMPLETED|Baseline/Follow-up 1||192
370374|NCT02054715|909710|P1|COMPLETED|Baseline/Follow-up 1||211
370375|NCT02054715|909709|P2|STARTED|Baseline/Follow-up 1||199
370376|NCT02054715|909710|P1|STARTED|Baseline/Follow-up 1||219
370377|NCT02054702|909724|P2|NOT COMPLETED|Overall Study||12
370378|NCT02054702|909725|P1|NOT COMPLETED|Overall Study||24
370379|NCT02054702|909724|P2|COMPLETED|Overall Study||21
370380|NCT02054702|909725|P1|COMPLETED|Overall Study||40
370381|NCT02054702|909724|P2|STARTED|Overall Study||33
370382|NCT02054702|909725|P1|STARTED|Overall Study||64
370383|NCT02054572|909753|P1|NOT COMPLETED|Overall Study||0
370384|NCT02054572|909753|P1|COMPLETED|Overall Study||6
370385|NCT02054572|909753|P1|STARTED|Overall Study||6
370386|NCT02054481|909780|P4|NOT COMPLETED|Overall Study||1
370387|NCT02054481|909781|P3|NOT COMPLETED|Overall Study||2
370388|NCT02054481|909782|P2|NOT COMPLETED|Overall Study||2
370389|NCT02054481|909783|P1|NOT COMPLETED|Overall Study||4
370390|NCT02054481|909780|P4|COMPLETED|Overall Study||39
370391|NCT02054481|909781|P3|COMPLETED|Overall Study||40
370392|NCT02054481|909782|P2|COMPLETED|Overall Study||39
370393|NCT02054481|909783|P1|COMPLETED|Overall Study||39
370394|NCT02054481|909780|P4|STARTED|Overall Study||40
370395|NCT02054481|909781|P3|STARTED|Overall Study||42
370396|NCT02054481|909782|P2|STARTED|Overall Study||41
370397|NCT02054481|909783|P1|STARTED|Overall Study||43
370398|NCT02054325|909831|P2|NOT COMPLETED|Overall Study||5
370399|NCT02054325|909832|P1|NOT COMPLETED|Overall Study||8
370400|NCT02054325|909831|P2|COMPLETED|Overall Study||50
370401|NCT02054325|909832|P1|COMPLETED|Overall Study||43
370402|NCT02054325|909831|P2|STARTED|Overall Study||55
370403|NCT02054325|909832|P1|STARTED|Overall Study||51
370404|NCT02053753|909842|P2|NOT COMPLETED|Overall Study||8
370405|NCT02053753|909843|P1|NOT COMPLETED|Overall Study||7
370406|NCT02053753|909842|P2|COMPLETED|Overall Study||66
370407|NCT02053753|909843|P1|COMPLETED|Overall Study||65
370408|NCT02053753|909842|P2|Received Treatment|Overall Study||71
370409|NCT02053753|909843|P1|Received Treatment|Overall Study||71
370410|NCT02053753|909842|P2|STARTED|Overall Study||74
370411|NCT02053753|909843|P1|STARTED|Overall Study||72
370412|NCT02053610|909867|P2|NOT COMPLETED|Overall Study||174
370413|NCT02053610|909868|P1|NOT COMPLETED|Overall Study||235
370414|NCT02053610|909867|P2|COMPLETED|Overall Study|Completed=Completed Treatment|159
370415|NCT02053610|909868|P1|COMPLETED|Overall Study|Completed=Completed Treatment|95
370416|NCT02053610|909867|P2|Received Study Drug|Overall Study||331
370417|NCT02053610|909868|P1|Received Study Drug|Overall Study||326
370418|NCT02053610|909867|P2|STARTED|Overall Study||333
370419|NCT02053610|909868|P1|STARTED|Overall Study||330
370420|NCT02053493|909900|P2|NOT COMPLETED|Overall Study||1
370421|NCT02053493|909901|P1|NOT COMPLETED|Overall Study||1
370422|NCT02053493|909900|P2|COMPLETED|Overall Study||58
370423|NCT02053493|909901|P1|COMPLETED|Overall Study||50
370424|NCT02053493|909900|P2|STARTED|Overall Study||59
370425|NCT02053493|909901|P1|STARTED|Overall Study||51
370426|NCT02053168|909939|P1|NOT COMPLETED|Overall Study||3
370427|NCT02053168|909939|P1|COMPLETED|Overall Study||22
370428|NCT02053168|909939|P1|STARTED|Overall Study||25
370429|NCT02052895|909956|P3|NOT COMPLETED|Overall Study||0
370430|NCT02052895|909957|P2|NOT COMPLETED|Overall Study||0
370431|NCT02052895|909958|P1|NOT COMPLETED|Overall Study||0
370432|NCT02052895|909956|P3|COMPLETED|Overall Study||15
370433|NCT02052895|909957|P2|COMPLETED|Overall Study||15
370434|NCT02052895|909958|P1|COMPLETED|Overall Study||196
370435|NCT02052895|909956|P3|STARTED|Overall Study||15
370436|NCT02052895|909957|P2|STARTED|Overall Study||15
370437|NCT02052895|909958|P1|STARTED|Overall Study||196
370438|NCT02052752|909968|P3|NOT COMPLETED|Overall Study||0
370439|NCT02052752|909969|P2|NOT COMPLETED|Overall Study||0
370440|NCT02052752|909970|P1|NOT COMPLETED|Overall Study||0
370441|NCT02052752|909968|P3|COMPLETED|Overall Study||30
370442|NCT02052752|909969|P2|COMPLETED|Overall Study||30
370443|NCT02052752|909970|P1|COMPLETED|Overall Study||30
370444|NCT02052752|909968|P3|STARTED|Overall Study||30
370445|NCT02052752|909969|P2|STARTED|Overall Study||30
370446|NCT02052752|909970|P1|STARTED|Overall Study||30
370447|NCT02052661|909993|P1|NOT COMPLETED|Overall Study||0
370448|NCT02052661|909993|P1|COMPLETED|Overall Study||300
370449|NCT02052661|909993|P1|STARTED|Overall Study||300
370450|NCT02052635|910007|P2|NOT COMPLETED|Overall Study||0
370451|NCT02052635|910008|P1|NOT COMPLETED|Overall Study||0
370452|NCT02052635|910007|P2|COMPLETED|Overall Study||6
370453|NCT02052635|910008|P1|COMPLETED|Overall Study||7
370454|NCT02052635|910007|P2|STARTED|Overall Study||6
370455|NCT02052635|910008|P1|STARTED|Overall Study||7
370456|NCT02052596|910018|P2|NOT COMPLETED|Safety Phase||35
370457|NCT02052596|910019|P1|NOT COMPLETED|Safety Phase||27
370458|NCT02052596|910018|P2|COMPLETED|Safety Phase||383
370459|NCT02052596|910019|P1|COMPLETED|Safety Phase||385
370460|NCT02052596|910018|P2|STARTED|Safety Phase||418
370461|NCT02052596|910019|P1|STARTED|Safety Phase||412
370462|NCT02052596|910018|P2|NOT COMPLETED|Active Phase||20
370463|NCT02052596|910019|P1|NOT COMPLETED|Active Phase||16
370464|NCT02052596|910018|P2|COMPLETED|Active Phase||398
370465|NCT02052596|910019|P1|COMPLETED|Active Phase||396
370466|NCT02052596|910018|P2|STARTED|Active Phase||418
370467|NCT02052596|910019|P1|STARTED|Active Phase||412
370468|NCT02052544|910044|P1|NOT COMPLETED|Overall Study||0
370469|NCT02052544|910044|P1|COMPLETED|Overall Study|Last Subject Out|123
370470|NCT02052544|910044|P1|STARTED|Overall Study|First Subject In|123
370471|NCT02052466|910049|P1|NOT COMPLETED|Overall Study||2
370472|NCT02052466|910049|P1|COMPLETED|Overall Study||30
370473|NCT02052466|910049|P1|STARTED|Overall Study||32
370474|NCT02052440|910066|P2|NOT COMPLETED|Overall Study||1
370475|NCT02052440|910067|P1|NOT COMPLETED|Overall Study||0
370476|NCT02052440|910066|P2|COMPLETED|Overall Study||51
370477|NCT02052440|910067|P1|COMPLETED|Overall Study||50
370478|NCT02052440|910066|P2|STARTED|Overall Study||52
370479|NCT02052440|910067|P1|STARTED|Overall Study||50
370480|NCT02052414|910079|P1|NOT COMPLETED|Overall Study||17
370481|NCT02052414|910079|P1|COMPLETED|Overall Study||17
370482|NCT02052414|910079|P1|STARTED|Overall Study||34
370483|NCT02052011|910089|P2|NOT COMPLETED|Overall Study||2
370484|NCT02052011|910090|P1|NOT COMPLETED|Overall Study||4
370485|NCT02052011|910089|P2|COMPLETED|Overall Study||8
370486|NCT02052011|910090|P1|COMPLETED|Overall Study||17
370487|NCT02052011|910089|P2|STARTED|Overall Study||10
370488|NCT02052011|910090|P1|STARTED|Overall Study||21
370489|NCT02051816|910100|P4|NOT COMPLETED|Overall Study||0
370490|NCT02051816|910101|P3|NOT COMPLETED|Overall Study||0
370491|NCT02051816|910102|P2|NOT COMPLETED|Overall Study||0
370492|NCT02051816|910103|P1|NOT COMPLETED|Overall Study||0
370493|NCT02051816|910100|P4|COMPLETED|Overall Study||36
370494|NCT02051816|910101|P3|COMPLETED|Overall Study||37
370495|NCT02051816|910102|P2|COMPLETED|Overall Study||40
370496|NCT02051816|910103|P1|COMPLETED|Overall Study||37
370497|NCT02051816|910100|P4|STARTED|Overall Study||36
370498|NCT02051816|910101|P3|STARTED|Overall Study||37
370499|NCT02051816|910102|P2|STARTED|Overall Study||40
370500|NCT02051816|910103|P1|STARTED|Overall Study||37
370501|NCT02051790|910141|P1|NOT COMPLETED|Overall Study||0
370502|NCT02051790|910141|P1|COMPLETED|Overall Study||241
370503|NCT02051790|910141|P1|STARTED|Overall Study||241
370504|NCT02051686|910147|P2|NOT COMPLETED|Overall Study||0
370505|NCT02051686|910148|P1|NOT COMPLETED|Overall Study||0
370506|NCT02051686|910147|P2|COMPLETED|Overall Study||46
370507|NCT02051686|910148|P1|COMPLETED|Overall Study||42
370508|NCT02051686|910147|P2|STARTED|Overall Study||46
370509|NCT02051686|910148|P1|STARTED|Overall Study||42
370510|NCT02051595|910156|P1|NOT COMPLETED|Overall Study||0
370511|NCT02051595|910156|P1|COMPLETED|Overall Study||25
370512|NCT02051595|910156|P1|STARTED|Overall Study||25
370513|NCT02051426|910162|P2|NOT COMPLETED|Second Intervention||0
370514|NCT02051426|910163|P1|NOT COMPLETED|Second Intervention||0
370515|NCT02051426|910162|P2|COMPLETED|Second Intervention||19
370516|NCT02051426|910163|P1|COMPLETED|Second Intervention||16
370517|NCT02051426|910162|P2|STARTED|Second Intervention||19
370518|NCT02051426|910163|P1|STARTED|Second Intervention||16
370519|NCT02051426|910162|P2|NOT COMPLETED|Washout Period of 1 Month||0
370520|NCT02051426|910163|P1|NOT COMPLETED|Washout Period of 1 Month||0
370521|NCT02051426|910162|P2|COMPLETED|Washout Period of 1 Month||19
370522|NCT02051426|910163|P1|COMPLETED|Washout Period of 1 Month||16
370523|NCT02051426|910162|P2|STARTED|Washout Period of 1 Month||19
370524|NCT02051426|910163|P1|STARTED|Washout Period of 1 Month||16
370525|NCT02051426|910162|P2|NOT COMPLETED|First Intervention||0
370526|NCT02051426|910163|P1|NOT COMPLETED|First Intervention||0
370527|NCT02051426|910162|P2|COMPLETED|First Intervention||19
370528|NCT02051426|910163|P1|COMPLETED|First Intervention||16
370529|NCT02051426|910162|P2|STARTED|First Intervention||19
370530|NCT02051426|910163|P1|STARTED|First Intervention||16
370531|NCT02051335|910177|P4|NOT COMPLETED|Period 4||0
370532|NCT02051335|910178|P3|NOT COMPLETED|Period 4||0
370533|NCT02051335|910179|P2|NOT COMPLETED|Period 4||0
370534|NCT02051335|910180|P1|NOT COMPLETED|Period 4||0
370535|NCT02051335|910177|P4|COMPLETED|Period 4||4
370536|NCT02051335|910178|P3|COMPLETED|Period 4||5
370537|NCT02051335|910179|P2|COMPLETED|Period 4||7
370538|NCT02051335|910180|P1|COMPLETED|Period 4||7
370539|NCT02051335|910177|P4|STARTED|Period 4||4
370540|NCT02051335|910178|P3|STARTED|Period 4||5
370541|NCT02051335|910179|P2|STARTED|Period 4||7
370542|NCT02051335|910180|P1|STARTED|Period 4||7
370543|NCT02051335|910177|P4|NOT COMPLETED|Period 3||0
370544|NCT02051335|910178|P3|NOT COMPLETED|Period 3||0
370545|NCT02051335|910179|P2|NOT COMPLETED|Period 3||0
370546|NCT02051335|910180|P1|NOT COMPLETED|Period 3||0
370547|NCT02051335|910177|P4|COMPLETED|Period 3||4
370548|NCT02051335|910178|P3|COMPLETED|Period 3||5
370549|NCT02051335|910179|P2|COMPLETED|Period 3||7
370550|NCT02051335|910180|P1|COMPLETED|Period 3||7
370551|NCT02051335|910177|P4|STARTED|Period 3||4
370552|NCT02051335|910178|P3|STARTED|Period 3|2 Participants received treatment in Period 2 but discontinued prior to Period 3.|5
370553|NCT02051335|910179|P2|STARTED|Period 3||7
370554|NCT02051335|910180|P1|STARTED|Period 3||7
370555|NCT02051335|910177|P4|NOT COMPLETED|Period 2||0
370556|NCT02051335|910178|P3|NOT COMPLETED|Period 2||0
370557|NCT02051335|910179|P2|NOT COMPLETED|Period 2||0
370558|NCT02051335|910180|P1|NOT COMPLETED|Period 2||0
370559|NCT02051335|910177|P4|COMPLETED|Period 2||4
370560|NCT02051335|910178|P3|COMPLETED|Period 2||7
370561|NCT02051335|910179|P2|COMPLETED|Period 2||7
370562|NCT02051335|910180|P1|COMPLETED|Period 2||7
370563|NCT02051335|910177|P4|STARTED|Period 2|2 Participants received treatment in Period 1 but discontinued prior to Period 2.|4
370564|NCT02051335|910178|P3|STARTED|Period 2||7
370565|NCT02051335|910179|P2|STARTED|Period 2||7
370566|NCT02051335|910180|P1|STARTED|Period 2||7
370567|NCT02051335|910177|P4|NOT COMPLETED|Period 1||0
370568|NCT02051335|910178|P3|NOT COMPLETED|Period 1||0
370569|NCT02051335|910179|P2|NOT COMPLETED|Period 1||0
370570|NCT02051335|910180|P1|NOT COMPLETED|Period 1||0
370571|NCT02051335|910177|P4|COMPLETED|Period 1||6
370572|NCT02051335|910178|P3|COMPLETED|Period 1||7
370573|NCT02051335|910179|P2|COMPLETED|Period 1||7
370574|NCT02051335|910180|P1|COMPLETED|Period 1||7
370575|NCT02051335|910177|P4|STARTED|Period 1||6
370576|NCT02051335|910178|P3|STARTED|Period 1||7
370577|NCT02051335|910179|P2|STARTED|Period 1||7
370578|NCT02051335|910180|P1|STARTED|Period 1||7
370579|NCT02051296|910232|P2|NOT COMPLETED|Overall Study||9
370580|NCT02051296|910233|P1|NOT COMPLETED|Overall Study||8
370581|NCT02051296|910232|P2|COMPLETED|Overall Study||56
370582|NCT02051296|910233|P1|COMPLETED|Overall Study||58
370583|NCT02051296|910232|P2|Received Allocated Intervention|Overall Study||58
370584|NCT02051296|910233|P1|Received Allocated Intervention|Overall Study||59
370585|NCT02051296|910232|P2|STARTED|Overall Study||65
370586|NCT02051296|910233|P1|STARTED|Overall Study||66
370587|NCT02050334|910241|P2|NOT COMPLETED|Overall Study||0
370588|NCT02050334|910242|P1|NOT COMPLETED|Overall Study||0
370589|NCT02050334|910241|P2|COMPLETED|Overall Study||9
370590|NCT02050334|910242|P1|COMPLETED|Overall Study||9
370591|NCT02050334|910241|P2|STARTED|Overall Study||9
370592|NCT02050334|910242|P1|STARTED|Overall Study||9
370593|NCT02050321|910250|P1|NOT COMPLETED|Overall Study||2
370594|NCT02050321|910250|P1|COMPLETED|Overall Study||0
370595|NCT02050321|910250|P1|STARTED|Overall Study||2
370596|NCT02050048|910257|P2|NOT COMPLETED|Overall Study||2
370597|NCT02050048|910258|P1|NOT COMPLETED|Overall Study||5
370598|NCT02050048|910257|P2|COMPLETED|Overall Study||10
370599|NCT02050048|910258|P1|COMPLETED|Overall Study||9
370600|NCT02050048|910257|P2|STARTED|Overall Study||12
370601|NCT02050048|910258|P1|STARTED|Overall Study||14
370602|NCT02049931|910267|P3|NOT COMPLETED|Overall Study||3
370603|NCT02049931|910268|P2|NOT COMPLETED|Overall Study||5
370604|NCT02049931|910269|P1|NOT COMPLETED|Overall Study||3
370605|NCT02049931|910267|P3|COMPLETED|Overall Study||17
370606|NCT02049931|910268|P2|COMPLETED|Overall Study||15
370607|NCT02049931|910269|P1|COMPLETED|Overall Study||17
370608|NCT02049931|910267|P3|STARTED|Overall Study||20
370609|NCT02049931|910268|P2|STARTED|Overall Study||20
370610|NCT02049931|910269|P1|STARTED|Overall Study||20
370611|NCT02049450|910277|P1|NOT COMPLETED|Overall Study||4
370612|NCT02049450|910277|P1|COMPLETED|Overall Study|Completed = Completed Core phase of study|26
370613|NCT02049450|910277|P1|Entered Extension Phase|Overall Study|Of 26 who completed Core phase 18 moved into Ext. phase; All 18 eventually discontinued Ext. phase|18
370614|NCT02049450|910277|P1|Discontinued Treatment Prior to Week 30|Overall Study||4
370615|NCT02049450|910277|P1|STARTED|Overall Study||30
370616|NCT02049385|910291|P2|NOT COMPLETED|Second Intervention||2
370617|NCT02049385|910292|P1|NOT COMPLETED|Second Intervention||0
370618|NCT02049385|910291|P2|COMPLETED|Second Intervention||0
370619|NCT02049385|910292|P1|COMPLETED|Second Intervention||1
370620|NCT02049385|910291|P2|STARTED|Second Intervention||2
370621|NCT02049385|910292|P1|STARTED|Second Intervention||1
370622|NCT02049385|910291|P2|NOT COMPLETED|First Intervention||0
370623|NCT02049385|910292|P1|NOT COMPLETED|First Intervention||3
370624|NCT02049385|910291|P2|COMPLETED|First Intervention||2
370625|NCT02049385|910292|P1|COMPLETED|First Intervention||1
370626|NCT02049385|910291|P2|STARTED|First Intervention||2
370627|NCT02049385|910292|P1|STARTED|First Intervention||4
370628|NCT02049151|910300|P2|NOT COMPLETED|Overall Study||0
370629|NCT02049151|910301|P1|NOT COMPLETED|Overall Study||0
370630|NCT02049151|910300|P2|COMPLETED|Overall Study||17
370631|NCT02049151|910301|P1|COMPLETED|Overall Study||15
370632|NCT02049151|910300|P2|STARTED|Overall Study|1 subject did not receive treatment|17
370633|NCT02049151|910301|P1|STARTED|Overall Study|2 subjects did not receive treatment|15
370634|NCT02048904|910315|P1|NOT COMPLETED|Overall Study||77
370635|NCT02048904|910315|P1|COMPLETED|Overall Study||65
370636|NCT02048904|910315|P1|STARTED|Overall Study||142
370637|NCT02048891|910321|P2|NOT COMPLETED|Overall Study||0
370638|NCT02048891|910322|P1|NOT COMPLETED|Overall Study||0
370639|NCT02048891|910321|P2|COMPLETED|Overall Study||1
370640|NCT02048891|910322|P1|COMPLETED|Overall Study||2
370641|NCT02048891|910321|P2|STARTED|Overall Study||1
370642|NCT02048891|910322|P1|STARTED|Overall Study||2
370643|NCT02048241|910330|P2|NOT COMPLETED|Overall Study||1
370644|NCT02048241|910331|P1|NOT COMPLETED|Overall Study||0
370645|NCT02048241|910330|P2|COMPLETED|Overall Study||5
370646|NCT02048241|910331|P1|COMPLETED|Overall Study||5
370647|NCT02048241|910330|P2|STARTED|Overall Study||6
370648|NCT02048241|910331|P1|STARTED|Overall Study||5
370649|NCT02048072|910337|P1|NOT COMPLETED|Overall Study||4
370650|NCT02048072|910337|P1|COMPLETED|Overall Study||29
370651|NCT02048072|910337|P1|STARTED|Overall Study||33
370652|NCT02047747|910341|P1|NOT COMPLETED|Overall Study||3
370653|NCT02047747|910341|P1|COMPLETED|Overall Study||1
370654|NCT02047747|910341|P1|STARTED|Overall Study||4
370655|NCT02047500|910346|P1|NOT COMPLETED|Overall Study||19
370656|NCT02047500|910346|P1|COMPLETED|Overall Study||0
370657|NCT02047500|910346|P1|STARTED|Overall Study||19
370658|NCT02047227|910352|P2|NOT COMPLETED|Overall Study||130
370659|NCT02047227|910353|P1|NOT COMPLETED|Overall Study||144
370660|NCT02047227|910352|P2|COMPLETED|Overall Study||347
370661|NCT02047227|910353|P1|COMPLETED|Overall Study||318
370662|NCT02047227|910352|P2|Completed Ovarian Stimulation Phase|Overall Study||440
370663|NCT02047227|910353|P1|Completed Ovarian Stimulation Phase|Overall Study||424
370664|NCT02047227|910352|P2|STARTED|Overall Study||477
370665|NCT02047227|910353|P1|STARTED|Overall Study||462
370666|NCT02046993|910371|P2|NOT COMPLETED|Overall Study||11
370667|NCT02046993|910372|P1|NOT COMPLETED|Overall Study||3
370668|NCT02046993|910371|P2|COMPLETED|Overall Study||94
370669|NCT02046993|910372|P1|COMPLETED|Overall Study||102
370670|NCT02046993|910371|P2|6th Month|Overall Study||94
370671|NCT02046993|910372|P1|6th Month|Overall Study||102
370672|NCT02046993|910371|P2|3rd Month|Overall Study||97
370673|NCT02046993|910372|P1|3rd Month|Overall Study||104
370674|NCT02046993|910371|P2|STARTED|Overall Study||105
370675|NCT02046993|910372|P1|STARTED|Overall Study||105
370676|NCT02046980|910391|P3|NOT COMPLETED|Overall Study||1
370677|NCT02046980|910392|P2|NOT COMPLETED|Overall Study||5
370678|NCT02046980|910393|P1|NOT COMPLETED|Overall Study||2
370679|NCT02046980|910391|P3|COMPLETED|Overall Study||72
370680|NCT02046980|910392|P2|COMPLETED|Overall Study||67
370681|NCT02046980|910393|P1|COMPLETED|Overall Study||70
370682|NCT02046980|910391|P3|STARTED|Overall Study||73
370683|NCT02046980|910392|P2|STARTED|Overall Study||72
370684|NCT02046980|910393|P1|STARTED|Overall Study||72
370685|NCT02046863|910401|P1|NOT COMPLETED|Overall Study||0
370686|NCT02046863|910401|P1|COMPLETED|Overall Study||7
370687|NCT02046863|910401|P1|STARTED|Overall Study||7
370688|NCT02046772|910407|P2|NOT COMPLETED|Overall Study||0
370689|NCT02046772|910408|P1|NOT COMPLETED|Overall Study||0
370690|NCT02046772|910407|P2|COMPLETED|Overall Study||33
370691|NCT02046772|910408|P1|COMPLETED|Overall Study||30
370692|NCT02046772|910407|P2|STARTED|Overall Study||33
370693|NCT02046772|910408|P1|STARTED|Overall Study||30
370694|NCT02046616|910422|P1|NOT COMPLETED|8-Week FU Period||1
370695|NCT02046616|910422|P1|COMPLETED|8-Week FU Period||113
370696|NCT02046616|910422|P1|STARTED|8-Week FU Period||114
370697|NCT02046616|910422|P1|NOT COMPLETED|24-Week Treatment Period||19
370698|NCT02046616|910422|P1|COMPLETED|24-Week Treatment Period||114
370699|NCT02046616|910422|P1|STARTED|24-Week Treatment Period||133
370700|NCT02046564|910444|P2|NOT COMPLETED|Overall Study||20
370701|NCT02046564|910445|P1|NOT COMPLETED|Overall Study||15
370702|NCT02046564|910444|P2|COMPLETED|Overall Study||183
370703|NCT02046564|910445|P1|COMPLETED|Overall Study||194
370704|NCT02046564|910444|P2|STARTED|Overall Study||203
370705|NCT02046564|910445|P1|STARTED|Overall Study||209
370706|NCT02046382|910469|P2|NOT COMPLETED|Overall Study||20
370707|NCT02046382|910470|P1|NOT COMPLETED|Overall Study||8
370708|NCT02046382|910469|P2|COMPLETED|Overall Study||47
370709|NCT02046382|910470|P1|COMPLETED|Overall Study||57
370710|NCT02046382|910469|P2|STARTED|Overall Study||67
370711|NCT02046382|910470|P1|STARTED|Overall Study||65
370712|NCT02046369|910484|P2|NOT COMPLETED|Overall Study||18
370713|NCT02046369|910485|P1|NOT COMPLETED|Overall Study||14
370714|NCT02046369|910484|P2|COMPLETED|Overall Study||156
370715|NCT02046369|910485|P1|COMPLETED|Overall Study||162
370716|NCT02046369|910484|P2|STARTED|Overall Study||174
370717|NCT02046369|910485|P1|STARTED|Overall Study||176
370718|NCT02046265|910505|P4|NOT COMPLETED|Overall Study||2
370719|NCT02046265|910506|P3|NOT COMPLETED|Overall Study||2
370720|NCT02046265|910507|P2|NOT COMPLETED|Overall Study||2
370721|NCT02046265|910508|P1|NOT COMPLETED|Overall Study||1
370722|NCT02046265|910505|P4|COMPLETED|Overall Study||12
370723|NCT02046265|910506|P3|COMPLETED|Overall Study||10
370724|NCT02046265|910507|P2|COMPLETED|Overall Study||15
370725|NCT02046265|910508|P1|COMPLETED|Overall Study||16
370726|NCT02046265|910505|P4|STARTED|Overall Study||14
370727|NCT02046265|910506|P3|STARTED|Overall Study||12
370728|NCT02046265|910507|P2|STARTED|Overall Study||17
370729|NCT02046265|910508|P1|STARTED|Overall Study||17
370730|NCT02046226|910518|P1|NOT COMPLETED|Overall Study||7
370731|NCT02046226|910518|P1|COMPLETED|Overall Study||0
370732|NCT02046226|910518|P1|STARTED|Overall Study||7
370733|NCT02046200|910525|P2|NOT COMPLETED|Second Intervention (1 Day)||0
370734|NCT02046200|910526|P1|NOT COMPLETED|Second Intervention (1 Day)||0
370735|NCT02046200|910525|P2|COMPLETED|Second Intervention (1 Day)||6
370736|NCT02046200|910526|P1|COMPLETED|Second Intervention (1 Day)||5
370737|NCT02046200|910525|P2|STARTED|Second Intervention (1 Day)||6
370738|NCT02046200|910526|P1|STARTED|Second Intervention (1 Day)||5
370739|NCT02046200|910525|P2|NOT COMPLETED|First Intervention (1 Day)||0
370740|NCT02046200|910526|P1|NOT COMPLETED|First Intervention (1 Day)||0
370741|NCT02046200|910525|P2|COMPLETED|First Intervention (1 Day)||6
370742|NCT02046200|910526|P1|COMPLETED|First Intervention (1 Day)||5
370743|NCT02046200|910525|P2|STARTED|First Intervention (1 Day)||6
370744|NCT02046200|910526|P1|STARTED|First Intervention (1 Day)||5
370745|NCT02046148|910566|P2|NOT COMPLETED|Overall Study||3
370746|NCT02046148|910567|P1|NOT COMPLETED|Overall Study||1
370747|NCT02046148|910566|P2|COMPLETED|Overall Study||23
370748|NCT02046148|910567|P1|COMPLETED|Overall Study||48
370749|NCT02046148|910566|P2|STARTED|Overall Study||26
370750|NCT02046148|910567|P1|STARTED|Overall Study||49
370751|NCT02046005|910614|P3|NOT COMPLETED|Overall Study||10
370752|NCT02046005|910615|P2|NOT COMPLETED|Overall Study||7
370753|NCT02046005|910616|P1|NOT COMPLETED|Overall Study||8
370754|NCT02046005|910614|P3|COMPLETED|Overall Study||70
370755|NCT02046005|910615|P2|COMPLETED|Overall Study||71
370756|NCT02046005|910616|P1|COMPLETED|Overall Study||72
370757|NCT02046005|910614|P3|STARTED|Overall Study||80
370758|NCT02046005|910615|P2|STARTED|Overall Study||78
370759|NCT02046005|910616|P1|STARTED|Overall Study||80
370760|NCT02045979|910627|P3|NOT COMPLETED|Overall Study||1
370761|NCT02045979|910628|P2|NOT COMPLETED|Overall Study||1
370762|NCT02045979|910629|P1|NOT COMPLETED|Overall Study||2
370763|NCT02045979|910627|P3|COMPLETED|Overall Study||107
370764|NCT02045979|910628|P2|COMPLETED|Overall Study||107
370765|NCT02045979|910629|P1|COMPLETED|Overall Study||106
370766|NCT02045979|910627|P3|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication.|108
370767|NCT02045979|910628|P2|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication..|108
370768|NCT02045979|910629|P1|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication.|108
370769|NCT02045875|910666|P2|NOT COMPLETED|Overall Study||3
370770|NCT02045875|910667|P1|NOT COMPLETED|Overall Study||7
370771|NCT02045875|910666|P2|COMPLETED|Overall Study||20
370772|NCT02045875|910667|P1|COMPLETED|Overall Study||20
370773|NCT02045875|910666|P2|STARTED|Overall Study||23
370774|NCT02045875|910667|P1|STARTED|Overall Study||27
370775|NCT02045862|910678|P3|NOT COMPLETED|Overall Study||126
370776|NCT02045862|910679|P2|NOT COMPLETED|Overall Study||40
370777|NCT02045862|910680|P1|NOT COMPLETED|Overall Study||39
370778|NCT02045862|910678|P3|COMPLETED|Overall Study||1092
370779|NCT02045862|910679|P2|COMPLETED|Overall Study||265
370780|NCT02045862|910680|P1|COMPLETED|Overall Study||267
370781|NCT02045862|910678|P3|Treated|Overall Study||1210
370782|NCT02045862|910679|P2|Treated|Overall Study||303
370783|NCT02045862|910680|P1|Treated|Overall Study||306
370784|NCT02045862|910678|P3|STARTED|Overall Study||1218
370785|NCT02045862|910679|P2|STARTED|Overall Study||305
370786|NCT02045862|910680|P1|STARTED|Overall Study||306
370787|NCT02045836|910861|P2|NOT COMPLETED|Overall Study||14
370788|NCT02045836|910862|P1|NOT COMPLETED|Overall Study||9
370789|NCT02045836|910861|P2|COMPLETED|Overall Study||419
370790|NCT02045836|910862|P1|COMPLETED|Overall Study||423
370791|NCT02045836|910861|P2|STARTED|Overall Study||433
370792|NCT02045836|910862|P1|STARTED|Overall Study||432
370793|NCT02045797|910894|P3|NOT COMPLETED|Overall Study||1
370794|NCT02045797|910895|P2|NOT COMPLETED|Overall Study||7
370795|NCT02045797|910896|P1|NOT COMPLETED|Overall Study||7
370796|NCT02045797|910894|P3|COMPLETED|Overall Study||24
370797|NCT02045797|910895|P2|COMPLETED|Overall Study||32
370798|NCT02045797|910896|P1|COMPLETED|Overall Study||51
370799|NCT02045797|910894|P3|STARTED|Overall Study||25
370800|NCT02045797|910895|P2|STARTED|Overall Study||39
370801|NCT02045797|910896|P1|STARTED|Overall Study||58
370802|NCT02045732|911041|P2|NOT COMPLETED|Overall Study||1
370803|NCT02045732|911042|P1|NOT COMPLETED|Overall Study||1
370804|NCT02045732|911041|P2|COMPLETED|Overall Study||2
370805|NCT02045732|911042|P1|COMPLETED|Overall Study||0
370806|NCT02045732|911041|P2|STARTED|Overall Study||3
370807|NCT02045732|911042|P1|STARTED|Overall Study||1
370808|NCT02045511|911062|P2|NOT COMPLETED|Overall Study||0
370809|NCT02045511|911063|P1|NOT COMPLETED|Overall Study||0
370810|NCT02045511|911062|P2|COMPLETED|Overall Study||7
370811|NCT02045511|911063|P1|COMPLETED|Overall Study||8
370812|NCT02045511|911062|P2|STARTED|Overall Study||7
370813|NCT02045511|911063|P1|STARTED|Overall Study||8
370814|NCT02045264|911079|P1|NOT COMPLETED|Overall Study||0
370815|NCT02045264|911079|P1|COMPLETED|Overall Study||12
370816|NCT02045264|911079|P1|STARTED|Overall Study||12
370817|NCT02045238|911096|P2|NOT COMPLETED|Overall Study||1
370818|NCT02045238|911097|P1|NOT COMPLETED|Overall Study||7
370819|NCT02045238|911096|P2|COMPLETED|Overall Study||14
370820|NCT02045238|911097|P1|COMPLETED|Overall Study||9
370821|NCT02045238|911096|P2|STARTED|Overall Study||15
370822|NCT02045238|911097|P1|STARTED|Overall Study||16
370823|NCT02045108|911109|P4|NOT COMPLETED|Overall Study||1
370824|NCT02045108|911110|P3|NOT COMPLETED|Overall Study||2
370825|NCT02045108|911111|P2|NOT COMPLETED|Overall Study||3
370826|NCT02045108|911112|P1|NOT COMPLETED|Overall Study||1
370827|NCT02045108|911109|P4|COMPLETED|Overall Study||19
370828|NCT02045108|911110|P3|COMPLETED|Overall Study||18
370829|NCT02045108|911111|P2|COMPLETED|Overall Study||12
370830|NCT02045108|911112|P1|COMPLETED|Overall Study||21
370831|NCT02045108|911109|P4|STARTED|Overall Study||20
370832|NCT02045108|911110|P3|STARTED|Overall Study||20
370833|NCT02045108|911111|P2|STARTED|Overall Study||15
370834|NCT02045108|911112|P1|STARTED|Overall Study||22
370835|NCT02044991|911160|P2|NOT COMPLETED|Overall Study||0
370836|NCT02044991|911161|P1|NOT COMPLETED|Overall Study||0
370837|NCT02044991|911160|P2|COMPLETED|Overall Study||0
370838|NCT02044991|911161|P1|COMPLETED|Overall Study||2
370839|NCT02044991|911160|P2|STARTED|Overall Study||0
370840|NCT02044991|911161|P1|STARTED|Overall Study||2
370841|NCT02044848|911173|P2|NOT COMPLETED|Overall Study||3
370842|NCT02044848|911174|P1|NOT COMPLETED|Overall Study||2
370843|NCT02044848|911173|P2|COMPLETED|Overall Study||0
370844|NCT02044848|911174|P1|COMPLETED|Overall Study||0
370845|NCT02044848|911173|P2|STARTED|Overall Study||3
370846|NCT02044848|911174|P1|STARTED|Overall Study||2
370847|NCT02044822|911180|P1|NOT COMPLETED|Overall Study||93
370848|NCT02044822|911180|P1|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|9
370849|NCT02044822|911180|P1|STARTED|Overall Study||102
370850|NCT02044458|911192|P2|NOT COMPLETED|Overall Study||8
370851|NCT02044458|911193|P1|NOT COMPLETED|Overall Study||3
370852|NCT02044458|911192|P2|COMPLETED|Overall Study||61
370853|NCT02044458|911193|P1|COMPLETED|Overall Study||62
370854|NCT02044458|911192|P2|STARTED|Overall Study||69
370855|NCT02044458|911193|P1|STARTED|Overall Study||65
370856|NCT02044419|911206|P3|NOT COMPLETED|Third Intervention||0
370857|NCT02044419|911207|P2|NOT COMPLETED|Third Intervention||0
370858|NCT02044419|911208|P1|NOT COMPLETED|Third Intervention||0
370859|NCT02044419|911206|P3|COMPLETED|Third Intervention||10
370860|NCT02044419|911207|P2|COMPLETED|Third Intervention||9
370861|NCT02044419|911208|P1|COMPLETED|Third Intervention||11
370862|NCT02044419|911206|P3|STARTED|Third Intervention||10
370863|NCT02044419|911207|P2|STARTED|Third Intervention||9
370864|NCT02044419|911208|P1|STARTED|Third Intervention||11
370865|NCT02044419|911206|P3|NOT COMPLETED|Second Intervention||0
370866|NCT02044419|911207|P2|NOT COMPLETED|Second Intervention||0
370867|NCT02044419|911208|P1|NOT COMPLETED|Second Intervention||0
370868|NCT02044419|911206|P3|COMPLETED|Second Intervention||10
370869|NCT02044419|911207|P2|COMPLETED|Second Intervention||9
370870|NCT02044419|911208|P1|COMPLETED|Second Intervention||11
370871|NCT02044419|911206|P3|STARTED|Second Intervention||10
370872|NCT02044419|911207|P2|STARTED|Second Intervention||9
370873|NCT02044419|911208|P1|STARTED|Second Intervention||11
370874|NCT02044419|911206|P3|NOT COMPLETED|First Intervention||1
370875|NCT02044419|911207|P2|NOT COMPLETED|First Intervention||1
370876|NCT02044419|911208|P1|NOT COMPLETED|First Intervention||0
370877|NCT02044419|911206|P3|COMPLETED|First Intervention||10
370878|NCT02044419|911207|P2|COMPLETED|First Intervention||9
370879|NCT02044419|911208|P1|COMPLETED|First Intervention||11
370880|NCT02044419|911206|P3|STARTED|First Intervention||11
370881|NCT02044419|911207|P2|STARTED|First Intervention||10
370882|NCT02044419|911208|P1|STARTED|First Intervention||11
370883|NCT02044393|911233|P2|NOT COMPLETED|Period 2||0
370884|NCT02044393|911234|P1|NOT COMPLETED|Period 2||0
370885|NCT02044393|911233|P2|COMPLETED|Period 2||10
370886|NCT02044393|911234|P1|COMPLETED|Period 2||10
370887|NCT02044393|911233|P2|STARTED|Period 2||10
370888|NCT02044393|911234|P1|STARTED|Period 2||10
370889|NCT02044393|911233|P2|NOT COMPLETED|Period 1||0
370890|NCT02044393|911234|P1|NOT COMPLETED|Period 1||0
370891|NCT02044393|911233|P2|COMPLETED|Period 1||10
370892|NCT02044393|911234|P1|COMPLETED|Period 1||10
370893|NCT02044393|911233|P2|STARTED|Period 1||10
370894|NCT02044393|911234|P1|STARTED|Period 1||10
370895|NCT02044380|911247|P1|NOT COMPLETED|Overall Study||0
370896|NCT02044380|911247|P1|COMPLETED|Overall Study||14
370897|NCT02044380|911247|P1|STARTED|Overall Study|Started are the treated patients|14
370898|NCT02044367|911251|P6|NOT COMPLETED|Overall Study||0
370899|NCT02044367|911252|P5|NOT COMPLETED|Overall Study||0
370900|NCT02044367|911253|P4|NOT COMPLETED|Overall Study||0
370901|NCT02044367|911254|P3|NOT COMPLETED|Overall Study||0
370902|NCT02044367|911255|P2|NOT COMPLETED|Overall Study||0
370903|NCT02044367|911256|P1|NOT COMPLETED|Overall Study||0
370904|NCT02044367|911251|P6|COMPLETED|Overall Study||9
370905|NCT02044367|911252|P5|COMPLETED|Overall Study||9
370906|NCT02044367|911253|P4|COMPLETED|Overall Study||9
370907|NCT02044367|911254|P3|COMPLETED|Overall Study||9
370908|NCT02044367|911255|P2|COMPLETED|Overall Study||9
370909|NCT02044367|911256|P1|COMPLETED|Overall Study||9
370910|NCT02044367|911251|P6|STARTED|Overall Study||9
370911|NCT02044367|911252|P5|STARTED|Overall Study||9
370912|NCT02044367|911253|P4|STARTED|Overall Study||9
370913|NCT02044367|911254|P3|STARTED|Overall Study||9
370914|NCT02044367|911255|P2|STARTED|Overall Study||9
370915|NCT02044367|911256|P1|STARTED|Overall Study||9
370916|NCT02044302|911279|P2|NOT COMPLETED|Overall Study||0
370917|NCT02044302|911280|P1|NOT COMPLETED|Overall Study||2
370918|NCT02044302|911279|P2|COMPLETED|Overall Study||0
370919|NCT02044302|911280|P1|COMPLETED|Overall Study||0
370920|NCT02044302|911279|P2|STARTED|Overall Study||0
370921|NCT02044302|911280|P1|STARTED|Overall Study||2
370922|NCT02044094|911286|P1|NOT COMPLETED|RBP-6000 Injection 2 (Day 29 to Week 12)||13
370923|NCT02044094|911286|P1|COMPLETED|RBP-6000 Injection 2 (Day 29 to Week 12)||17
370924|NCT02044094|911286|P1|STARTED|RBP-6000 Injection 2 (Day 29 to Week 12)||30
370925|NCT02044094|911286|P1|NOT COMPLETED|RBP-6000 Injection 1 (Day 1 to Day 28)||9
370926|NCT02044094|911286|P1|COMPLETED|RBP-6000 Injection 1 (Day 1 to Day 28)||30
370927|NCT02044094|911286|P1|Completers Population|RBP-6000 Injection 1 (Day 1 to Day 28)|Subjects that reached Day 28 + completed all challenges at Week 4 were considered study completers.|30
370928|NCT02044094|911286|P1|Intent to Treat Population|RBP-6000 Injection 1 (Day 1 to Day 28)|Subjects who receive >=1 dose of RBP-6000 and have >=1 complete sequence of hydromorphone challenges|38
370929|NCT02044094|911286|P1|STARTED|RBP-6000 Injection 1 (Day 1 to Day 28)||39
370930|NCT02043938|911343|P1|NOT COMPLETED|Overall Study||10
370931|NCT02043938|911343|P1|COMPLETED|Overall Study||36
370932|NCT02043938|911343|P1|STARTED|Overall Study||46
370933|NCT02043808|911355|P2|NOT COMPLETED|Overall Study||0
370934|NCT02043808|911356|P1|NOT COMPLETED|Overall Study||0
370935|NCT02043808|911355|P2|COMPLETED|Overall Study||12793
370936|NCT02043808|911356|P1|COMPLETED|Overall Study||12793
370937|NCT02043808|911355|P2|STARTED|Overall Study||12793
370938|NCT02043808|911356|P1|STARTED|Overall Study||12793
370939|NCT02043782|911394|P6|NOT COMPLETED|Period 3||0
370940|NCT02043782|911395|P5|NOT COMPLETED|Period 3||0
370941|NCT02043782|911396|P4|NOT COMPLETED|Period 3||0
370942|NCT02043782|911397|P3|NOT COMPLETED|Period 3||0
370943|NCT02043782|911398|P2|NOT COMPLETED|Period 3||0
370944|NCT02043782|911399|P1|NOT COMPLETED|Period 3||0
370945|NCT02043782|911394|P6|COMPLETED|Period 3||6
370946|NCT02043782|911395|P5|COMPLETED|Period 3||6
370947|NCT02043782|911396|P4|COMPLETED|Period 3||6
370948|NCT02043782|911397|P3|COMPLETED|Period 3||6
370949|NCT02043782|911398|P2|COMPLETED|Period 3||6
370950|NCT02043782|911399|P1|COMPLETED|Period 3||7
370951|NCT02043782|911394|P6|STARTED|Period 3||6
370952|NCT02043782|911395|P5|STARTED|Period 3||6
370953|NCT02043782|911396|P4|STARTED|Period 3||6
370954|NCT02043782|911397|P3|STARTED|Period 3||6
370955|NCT02043782|911398|P2|STARTED|Period 3||6
370956|NCT02043782|911399|P1|STARTED|Period 3||7
370957|NCT02043782|911394|P6|NOT COMPLETED|Period 2||0
370958|NCT02043782|911395|P5|NOT COMPLETED|Period 2||0
370959|NCT02043782|911396|P4|NOT COMPLETED|Period 2||0
370960|NCT02043782|911397|P3|NOT COMPLETED|Period 2||0
370961|NCT02043782|911398|P2|NOT COMPLETED|Period 2||0
370962|NCT02043782|911399|P1|NOT COMPLETED|Period 2||0
370963|NCT02043782|911394|P6|COMPLETED|Period 2||6
370964|NCT02043782|911395|P5|COMPLETED|Period 2||6
370965|NCT02043782|911396|P4|COMPLETED|Period 2||6
370966|NCT02043782|911397|P3|COMPLETED|Period 2||6
370967|NCT02043782|911398|P2|COMPLETED|Period 2||6
370968|NCT02043782|911399|P1|COMPLETED|Period 2||7
370969|NCT02043782|911394|P6|STARTED|Period 2||6
370970|NCT02043782|911395|P5|STARTED|Period 2||6
370971|NCT02043782|911396|P4|STARTED|Period 2||6
370972|NCT02043782|911397|P3|STARTED|Period 2||6
370973|NCT02043782|911398|P2|STARTED|Period 2||6
370974|NCT02043782|911399|P1|STARTED|Period 2||7
370975|NCT02043782|911394|P6|NOT COMPLETED|Period 1||0
370976|NCT02043782|911395|P5|NOT COMPLETED|Period 1||0
370977|NCT02043782|911396|P4|NOT COMPLETED|Period 1||0
370978|NCT02043782|911397|P3|NOT COMPLETED|Period 1||1
370979|NCT02043782|911398|P2|NOT COMPLETED|Period 1||0
370980|NCT02043782|911399|P1|NOT COMPLETED|Period 1||0
370981|NCT02043782|911394|P6|COMPLETED|Period 1||6
370982|NCT02043782|911395|P5|COMPLETED|Period 1||6
370983|NCT02043782|911396|P4|COMPLETED|Period 1||6
370984|NCT02043782|911397|P3|COMPLETED|Period 1|One subject discontinued due to an adverse event while testing own product|6
370985|NCT02043782|911398|P2|COMPLETED|Period 1||6
370986|NCT02043782|911399|P1|COMPLETED|Period 1||7
370987|NCT02043782|911394|P6|STARTED|Period 1||6
370988|NCT02043782|911395|P5|STARTED|Period 1||6
370989|NCT02043782|911396|P4|STARTED|Period 1||6
370990|NCT02043782|911397|P3|STARTED|Period 1||7
370991|NCT02043782|911398|P2|STARTED|Period 1||6
370992|NCT02043782|911399|P1|STARTED|Period 1||7
370993|NCT02043704|911409|P2|NOT COMPLETED|Overall Study||7
370994|NCT02043704|911410|P1|NOT COMPLETED|Overall Study||3
370995|NCT02043704|911409|P2|COMPLETED|Overall Study||43
370996|NCT02043704|911410|P1|COMPLETED|Overall Study||47
370997|NCT02043704|911409|P2|STARTED|Overall Study||50
370998|NCT02043704|911410|P1|STARTED|Overall Study||50
370999|NCT02043652|911440|P1|NOT COMPLETED|Overall Study||26
371000|NCT02043652|911440|P1|COMPLETED|Overall Study||93
371001|NCT02043652|911440|P1|STARTED|Overall Study||119
371002|NCT02043379|911447|P2|NOT COMPLETED|Overall Study||0
371003|NCT02043379|911448|P1|NOT COMPLETED|Overall Study||0
371004|NCT02043379|911447|P2|COMPLETED|Overall Study||20
371005|NCT02043379|911448|P1|COMPLETED|Overall Study||30
371006|NCT02043379|911447|P2|STARTED|Overall Study||20
371007|NCT02043379|911448|P1|STARTED|Overall Study||30
371008|NCT02043366|911510|P6|NOT COMPLETED|Overall Study||2
371009|NCT02043366|911511|P5|NOT COMPLETED|Overall Study||2
371010|NCT02043366|911512|P4|NOT COMPLETED|Overall Study||2
371011|NCT02043366|911513|P3|NOT COMPLETED|Overall Study||2
371012|NCT02043366|911514|P2|NOT COMPLETED|Overall Study||2
371013|NCT02043366|911515|P1|NOT COMPLETED|Overall Study||2
371014|NCT02043366|911510|P6|COMPLETED|Overall Study||28
371015|NCT02043366|911511|P5|COMPLETED|Overall Study||28
371016|NCT02043366|911512|P4|COMPLETED|Overall Study||28
371017|NCT02043366|911513|P3|COMPLETED|Overall Study||28
371018|NCT02043366|911514|P2|COMPLETED|Overall Study||28
371019|NCT02043366|911515|P1|COMPLETED|Overall Study||28
371020|NCT02043366|911510|P6|STARTED|Overall Study||30
371021|NCT02043366|911511|P5|STARTED|Overall Study||30
371022|NCT02043366|911512|P4|STARTED|Overall Study||30
371023|NCT02043366|911513|P3|STARTED|Overall Study||30
371024|NCT02043366|911514|P2|STARTED|Overall Study||30
371025|NCT02043366|911515|P1|STARTED|Overall Study||30
371026|NCT02043145|911538|P3|NOT COMPLETED|Overall Study||0
371027|NCT02043145|911539|P2|NOT COMPLETED|Overall Study||0
371028|NCT02043145|911540|P1|NOT COMPLETED|Overall Study||0
371029|NCT02043145|911538|P3|COMPLETED|Overall Study||425
371030|NCT02043145|911539|P2|COMPLETED|Overall Study||247
371031|NCT02043145|911540|P1|COMPLETED|Overall Study||55
371032|NCT02043145|911538|P3|STARTED|Overall Study||425
371033|NCT02043145|911539|P2|STARTED|Overall Study||247
371034|NCT02043145|911540|P1|STARTED|Overall Study||55
371035|NCT02043132|911553|P2|NOT COMPLETED|Overall Study||9
371036|NCT02043132|911554|P1|NOT COMPLETED|Overall Study||5
371037|NCT02043132|911553|P2|COMPLETED|Overall Study||49
371038|NCT02043132|911554|P1|COMPLETED|Overall Study||53
371039|NCT02043132|911553|P2|STARTED|Overall Study||58
371040|NCT02043132|911554|P1|STARTED|Overall Study||58
371041|NCT02043015|911574|P1|NOT COMPLETED|Overall Study||28
371042|NCT02043015|911574|P1|COMPLETED|Overall Study||87
371043|NCT02043015|911574|P1|STARTED|Overall Study||115
371044|NCT02042924|911587|P1|NOT COMPLETED|Overall Study||1
371045|NCT02042924|911587|P1|COMPLETED|Overall Study||1
371046|NCT02042924|911587|P1|STARTED|Overall Study||2
371047|NCT02042911|911593|P1|NOT COMPLETED|Overall Study||1
371048|NCT02042911|911593|P1|COMPLETED|Overall Study||9
371049|NCT02042911|911593|P1|STARTED|Overall Study||10
371050|NCT02042872|911607|P2|NOT COMPLETED|Overall Study||5
371051|NCT02042872|911608|P1|NOT COMPLETED|Overall Study||0
371052|NCT02042872|911607|P2|COMPLETED|Overall Study||8
371053|NCT02042872|911608|P1|COMPLETED|Overall Study||8
371054|NCT02042872|911607|P2|STARTED|Overall Study||13
371055|NCT02042872|911608|P1|STARTED|Overall Study||8
371056|NCT02042534|911618|P2|NOT COMPLETED|Overall Study||0
371057|NCT02042534|911619|P1|NOT COMPLETED|Overall Study||0
371058|NCT02042534|911618|P2|COMPLETED|Overall Study||94
371059|NCT02042534|911619|P1|COMPLETED|Overall Study||101
371060|NCT02042534|911618|P2|STARTED|Overall Study||94
371061|NCT02042534|911619|P1|STARTED|Overall Study||101
371062|NCT02042443|911635|P2|NOT COMPLETED|Overall Study||26
371063|NCT02042443|911636|P1|NOT COMPLETED|Overall Study||27
371064|NCT02042443|911635|P2|COMPLETED|Overall Study||0
371065|NCT02042443|911636|P1|COMPLETED|Overall Study||0
371066|NCT02042443|911635|P2|Eligible and Analyzable|Overall Study||20
371067|NCT02042443|911636|P1|Eligible and Analyzable|Overall Study||24
371068|NCT02042443|911635|P2|STARTED|Overall Study||26
371069|NCT02042443|911636|P1|STARTED|Overall Study||27
371070|NCT02042404|911648|P2|NOT COMPLETED|Overall Study||0
371071|NCT02042404|911649|P1|NOT COMPLETED|Overall Study||5
371072|NCT02042404|911648|P2|COMPLETED|Overall Study||5
371073|NCT02042404|911649|P1|COMPLETED|Overall Study|39 subjects completed 30 days evaluation. 38 subjects completed 120 days evaluation.|38
371074|NCT02042404|911648|P2|STARTED|Overall Study||5
371075|NCT02042404|911649|P1|STARTED|Overall Study|Enrollment was stopped after 43 were enrolled, had approval to enroll 45 primary cohort subjects|43
371076|NCT02042274|911660|P1|NOT COMPLETED|Overall Study||0
371077|NCT02042274|911660|P1|COMPLETED|Overall Study||12
371078|NCT02042274|911660|P1|STARTED|Overall Study||12
371079|NCT02042131|911668|P3|NOT COMPLETED|Overall Study||0
371080|NCT02042131|911669|P2|NOT COMPLETED|Overall Study||0
371081|NCT02042131|911670|P1|NOT COMPLETED|Overall Study||0
371082|NCT02042131|911668|P3|COMPLETED|Overall Study||33
371083|NCT02042131|911669|P2|COMPLETED|Overall Study||32
371084|NCT02042131|911670|P1|COMPLETED|Overall Study||32
371085|NCT02042131|911668|P3|STARTED|Overall Study||33
371086|NCT02042131|911669|P2|STARTED|Overall Study||32
371087|NCT02042131|911670|P1|STARTED|Overall Study||32
371088|NCT02041533|911689|P2|NOT COMPLETED|Overall Study||258
371089|NCT02041533|911690|P1|NOT COMPLETED|Overall Study||228
371090|NCT02041533|911689|P2|COMPLETED|Overall Study|Completed = Participants continuing in the treatment period|12
371091|NCT02041533|911690|P1|COMPLETED|Overall Study|Completed = Participants continuing in the treatment period|43
371092|NCT02041533|911689|P2|Began Treatment|Overall Study||263
371093|NCT02041533|911690|P1|Began Treatment|Overall Study||267
371094|NCT02041533|911689|P2|STARTED|Overall Study||270
371095|NCT02041533|911690|P1|STARTED|Overall Study||271
371096|NCT02041520|911712|P2|NOT COMPLETED|Overall Study||7
371097|NCT02041520|911713|P1|NOT COMPLETED|Overall Study||6
371098|NCT02041520|911712|P2|COMPLETED|Overall Study||28
371099|NCT02041520|911713|P1|COMPLETED|Overall Study||29
371100|NCT02041520|911712|P2|STARTED|Overall Study|35 patients randomly assigned to placebo|35
371101|NCT02041520|911713|P1|STARTED|Overall Study|35 patients randomly assigned to omega 3 fatty acids|35
371102|NCT02041377|911733|P1|NOT COMPLETED|Overall Study||0
371103|NCT02041377|911733|P1|COMPLETED|Overall Study||134
371104|NCT02041377|911733|P1|STARTED|Overall Study||134
371105|NCT02041325|911743|P2|NOT COMPLETED|Overall Study||3
371106|NCT02041325|911744|P1|NOT COMPLETED|Overall Study||3
371107|NCT02041325|911743|P2|COMPLETED|Overall Study||13
371108|NCT02041325|911744|P1|COMPLETED|Overall Study||19
371109|NCT02041325|911743|P2|STARTED|Overall Study||16
371110|NCT02041325|911744|P1|STARTED|Overall Study||22
371111|NCT02041286|911756|P1|NOT COMPLETED|Overall Study||1
371112|NCT02041286|911756|P1|COMPLETED|Overall Study|One subject discontinued from testing after low BG fingerstick result (hypoglycemia AE).|135
371113|NCT02041286|911756|P1|STARTED|Overall Study||136
371114|NCT02041221|911770|P6|NOT COMPLETED|Part 2||0
371115|NCT02041221|911771|P5|NOT COMPLETED|Part 2||0
371116|NCT02041221|911772|P4|NOT COMPLETED|Part 2||0
371117|NCT02041221|911773|P3|NOT COMPLETED|Part 2||1
371118|NCT02041221|911774|P2|NOT COMPLETED|Part 2||0
371119|NCT02041221|911775|P1|NOT COMPLETED|Part 2||0
371120|NCT02041221|911770|P6|COMPLETED|Part 2||6
371121|NCT02041221|911771|P5|COMPLETED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
371122|NCT02041221|911772|P4|COMPLETED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
371123|NCT02041221|911773|P3|COMPLETED|Part 2||5
371124|NCT02041221|911774|P2|COMPLETED|Part 2||6
371125|NCT02041221|911775|P1|COMPLETED|Part 2||6
371126|NCT02041221|911770|P6|STARTED|Part 2||6
371127|NCT02041221|911771|P5|STARTED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
371128|NCT02041221|911772|P4|STARTED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually.|0
371129|NCT02041221|911773|P3|STARTED|Part 2||6
371130|NCT02041221|911774|P2|STARTED|Part 2||6
371131|NCT02041221|911775|P1|STARTED|Part 2||6
371132|NCT02041221|911770|P6|NOT COMPLETED|Part 1||0
371133|NCT02041221|911771|P5|NOT COMPLETED|Part 1||0
371134|NCT02041221|911772|P4|NOT COMPLETED|Part 1||0
371135|NCT02041221|911773|P3|NOT COMPLETED|Part 1||0
371136|NCT02041221|911774|P2|NOT COMPLETED|Part 1||0
371137|NCT02041221|911775|P1|NOT COMPLETED|Part 1||0
371138|NCT02041221|911770|P6|COMPLETED|Part 1||10
371139|NCT02041221|911771|P5|COMPLETED|Part 1||6
371140|NCT02041221|911772|P4|COMPLETED|Part 1||6
371141|NCT02041221|911773|P3|COMPLETED|Part 1||6
371142|NCT02041221|911774|P2|COMPLETED|Part 1||6
371143|NCT02041221|911775|P1|COMPLETED|Part 1||6
371144|NCT02041221|911770|P6|STARTED|Part 1||10
371145|NCT02041221|911771|P5|STARTED|Part 1||6
371146|NCT02041221|911772|P4|STARTED|Part 1||6
371147|NCT02041221|911773|P3|STARTED|Part 1||6
371148|NCT02041221|911774|P2|STARTED|Part 1||6
371149|NCT02041221|911775|P1|STARTED|Part 1||6
371150|NCT02041091|911791|P2|NOT COMPLETED|Optional Safety Extension Period||82
371151|NCT02041091|911792|P1|NOT COMPLETED|Optional Safety Extension Period||85
371152|NCT02041091|911791|P2|COMPLETED|Optional Safety Extension Period||0
371153|NCT02041091|911792|P1|COMPLETED|Optional Safety Extension Period||0
371154|NCT02041091|911791|P2|STARTED|Optional Safety Extension Period|Participation was optional for the Safety Extension Period.|82
371155|NCT02041091|911792|P1|STARTED|Optional Safety Extension Period|Participation was optional for the Safety Extension Period.|85
371156|NCT02041091|911791|P2|NOT COMPLETED|Treatment||23
371157|NCT02041091|911792|P1|NOT COMPLETED|Treatment||22
371158|NCT02041091|911791|P2|COMPLETED|Treatment||91
371159|NCT02041091|911792|P1|COMPLETED|Treatment||90
371160|NCT02041091|911791|P2|Participated in Follow Up|Treatment||96
371161|NCT02041091|911792|P1|Participated in Follow Up|Treatment||106
371162|NCT02041091|911791|P2|Received At Least One Dose of Study Drug|Treatment||114
371163|NCT02041091|911792|P1|Received At Least One Dose of Study Drug|Treatment||112
371164|NCT02041091|911791|P2|STARTED|Treatment||114
371165|NCT02041091|911792|P1|STARTED|Treatment||112
371166|NCT02040844|911817|P3|NOT COMPLETED|Overall Study||47
371167|NCT02040844|911818|P2|NOT COMPLETED|Overall Study||39
371168|NCT02040844|911819|P1|NOT COMPLETED|Overall Study||50
371169|NCT02040844|911817|P3|COMPLETED|Overall Study||97
371170|NCT02040844|911818|P2|COMPLETED|Overall Study||109
371171|NCT02040844|911819|P1|COMPLETED|Overall Study||88
371172|NCT02040844|911817|P3|STARTED|Overall Study||144
371173|NCT02040844|911818|P2|STARTED|Overall Study||148
371174|NCT02040844|911819|P1|STARTED|Overall Study||138
371175|NCT02040792|911847|P5|NOT COMPLETED|Overall Study||7
371176|NCT02040792|911848|P4|NOT COMPLETED|Overall Study||7
371177|NCT02040792|911849|P3|NOT COMPLETED|Overall Study||3
371178|NCT02040792|911850|P2|NOT COMPLETED|Overall Study||3
371179|NCT02040792|911851|P1|NOT COMPLETED|Overall Study||6
371180|NCT02040792|911847|P5|COMPLETED|Overall Study||67
371181|NCT02040792|911848|P4|COMPLETED|Overall Study||64
371182|NCT02040792|911849|P3|COMPLETED|Overall Study||68
371183|NCT02040792|911850|P2|COMPLETED|Overall Study||65
371184|NCT02040792|911851|P1|COMPLETED|Overall Study||64
371185|NCT02040792|911847|P5|STARTED|Overall Study||74
371186|NCT02040792|911848|P4|STARTED|Overall Study||71
371187|NCT02040792|911849|P3|STARTED|Overall Study||71
371188|NCT02040792|911850|P2|STARTED|Overall Study||68
371189|NCT02040792|911851|P1|STARTED|Overall Study||70
371190|NCT02040779|911866|P3|NOT COMPLETED|Overall Study||4
371191|NCT02040779|911867|P2|NOT COMPLETED|Overall Study||7
371192|NCT02040779|911868|P1|NOT COMPLETED|Overall Study||12
371193|NCT02040779|911866|P3|COMPLETED|Overall Study||88
371194|NCT02040779|911867|P2|COMPLETED|Overall Study||83
371195|NCT02040779|911868|P1|COMPLETED|Overall Study||79
371196|NCT02040779|911866|P3|Full Analysis Set (FAS)|Overall Study||92
371197|NCT02040779|911867|P2|Full Analysis Set (FAS)|Overall Study||88
371198|NCT02040779|911868|P1|Full Analysis Set (FAS)|Overall Study||90
371199|NCT02040779|911866|P3|STARTED|Overall Study||92
371200|NCT02040779|911867|P2|STARTED|Overall Study||90
371201|NCT02040779|911868|P1|STARTED|Overall Study||91
371202|NCT02040766|911908|P5|NOT COMPLETED|Overall Study||13
371203|NCT02040766|911909|P4|NOT COMPLETED|Overall Study||13
371204|NCT02040766|911910|P3|NOT COMPLETED|Overall Study||12
371205|NCT02040766|911911|P2|NOT COMPLETED|Overall Study||10
371206|NCT02040766|911912|P1|NOT COMPLETED|Overall Study||18
371207|NCT02040766|911908|P5|COMPLETED|Overall Study||112
371208|NCT02040766|911909|P4|COMPLETED|Overall Study||112
371209|NCT02040766|911910|P3|COMPLETED|Overall Study||113
371210|NCT02040766|911911|P2|COMPLETED|Overall Study||116
371211|NCT02040766|911912|P1|COMPLETED|Overall Study||109
371212|NCT02040766|911908|P5|STARTED|Overall Study||125
371213|NCT02040766|911909|P4|STARTED|Overall Study||125
371214|NCT02040766|911910|P3|STARTED|Overall Study||125
371215|NCT02040766|911911|P2|STARTED|Overall Study||126
371216|NCT02040766|911912|P1|STARTED|Overall Study||127
371217|NCT02040623|911953|P3|NOT COMPLETED|Overall Study||2
371218|NCT02040623|911954|P2|NOT COMPLETED|Overall Study||6
371219|NCT02040623|911955|P1|NOT COMPLETED|Overall Study||4
371220|NCT02040623|911953|P3|COMPLETED|Overall Study||10
371221|NCT02040623|911954|P2|COMPLETED|Overall Study||6
371222|NCT02040623|911955|P1|COMPLETED|Overall Study||7
371223|NCT02040623|911953|P3|STARTED|Overall Study||12
371224|NCT02040623|911954|P2|STARTED|Overall Study||12
371225|NCT02040623|911955|P1|STARTED|Overall Study||11
371226|NCT02040532|911963|P1|NOT COMPLETED|Overall Study||12
371227|NCT02040532|911963|P1|COMPLETED|Overall Study||20
371228|NCT02040532|911963|P1|Received at Least One Dose of Medication|Overall Study||26
371229|NCT02040532|911963|P1|STARTED|Overall Study||32
371230|NCT02040428|911976|P2|NOT COMPLETED|Overall Study||4
371231|NCT02040428|911977|P1|NOT COMPLETED|Overall Study||5
371232|NCT02040428|911976|P2|COMPLETED|Overall Study||77
371233|NCT02040428|911977|P1|COMPLETED|Overall Study||70
371234|NCT02040428|911976|P2|Intent to Treat (Randomized Subjects)|Overall Study||80
371235|NCT02040428|911977|P1|Intent to Treat (Randomized Subjects)|Overall Study||76
371236|NCT02040428|911976|P2|STARTED|Overall Study||81
371237|NCT02040428|911977|P1|STARTED|Overall Study||75
371238|NCT02040116|911989|P1|NOT COMPLETED|Overall Study||0
371239|NCT02040116|911989|P1|COMPLETED|Overall Study||19
371240|NCT02040116|911989|P1|STARTED|Overall Study||19
371241|NCT02040077|912000|P3|NOT COMPLETED|Overall Study||0
371242|NCT02040077|912001|P2|NOT COMPLETED|Overall Study||0
371243|NCT02040077|912002|P1|NOT COMPLETED|Overall Study||0
371244|NCT02040077|912000|P3|COMPLETED|Overall Study||25
371245|NCT02040077|912001|P2|COMPLETED|Overall Study||24
371246|NCT02040077|912002|P1|COMPLETED|Overall Study||27
371247|NCT02040077|912000|P3|STARTED|Overall Study||25
371248|NCT02040077|912001|P2|STARTED|Overall Study||24
371249|NCT02040077|912002|P1|STARTED|Overall Study||27
371250|NCT02039817|912015|P2|NOT COMPLETED|Overall Study||0
371251|NCT02039817|912016|P1|NOT COMPLETED|Overall Study||0
371252|NCT02039817|912015|P2|COMPLETED|Overall Study||8
371253|NCT02039817|912016|P1|COMPLETED|Overall Study||8
371254|NCT02039817|912015|P2|STARTED|Overall Study||8
371255|NCT02039817|912016|P1|STARTED|Overall Study||8
371256|NCT02039778|912025|P1|NOT COMPLETED|Overall Study||4
371257|NCT02039778|912025|P1|COMPLETED|Overall Study||0
371258|NCT02039778|912025|P1|STARTED|Overall Study||4
371259|NCT02039687|912037|P4|NOT COMPLETED|Overall Study||0
371260|NCT02039687|912038|P3|NOT COMPLETED|Overall Study||3
371261|NCT02039687|912039|P2|NOT COMPLETED|Overall Study||1
371262|NCT02039687|912040|P1|NOT COMPLETED|Overall Study||0
371263|NCT02039687|912037|P4|COMPLETED|Overall Study||16
371264|NCT02039687|912038|P3|COMPLETED|Overall Study||13
371265|NCT02039687|912039|P2|COMPLETED|Overall Study||15
371266|NCT02039687|912040|P1|COMPLETED|Overall Study||16
371267|NCT02039687|912037|P4|STARTED|Overall Study||16
371268|NCT02039687|912038|P3|STARTED|Overall Study||16
371269|NCT02039687|912039|P2|STARTED|Overall Study||16
371270|NCT02039687|912040|P1|STARTED|Overall Study||16
371271|NCT02039674|912075|P9|NOT COMPLETED|Overall Study||45
371272|NCT02039674|912076|P8|NOT COMPLETED|Overall Study||63
371273|NCT02039674|912077|P7|NOT COMPLETED|Overall Study||60
371274|NCT02039674|912078|P6|NOT COMPLETED|Overall Study||7
371275|NCT02039674|912079|P5|NOT COMPLETED|Overall Study||12
371276|NCT02039674|912080|P4|NOT COMPLETED|Overall Study||6
371277|NCT02039674|912081|P3|NOT COMPLETED|Overall Study||24
371278|NCT02039674|912082|P2|NOT COMPLETED|Overall Study||25
371279|NCT02039674|912083|P1|NOT COMPLETED|Overall Study||24
371280|NCT02039674|912075|P9|COMPLETED|Overall Study||0
371281|NCT02039674|912076|P8|COMPLETED|Overall Study||0
371282|NCT02039674|912077|P7|COMPLETED|Overall Study||0
371283|NCT02039674|912078|P6|COMPLETED|Overall Study||0
371284|NCT02039674|912079|P5|COMPLETED|Overall Study||0
371285|NCT02039674|912080|P4|COMPLETED|Overall Study||0
371286|NCT02039674|912081|P3|COMPLETED|Overall Study||0
371287|NCT02039674|912082|P2|COMPLETED|Overall Study||0
371288|NCT02039674|912083|P1|COMPLETED|Overall Study||1
371289|NCT02039674|912075|P9|Treated|Overall Study||45
371290|NCT02039674|912076|P8|Treated|Overall Study|One participant was randomized but did not receive study treatment|62
371291|NCT02039674|912077|P7|Treated|Overall Study|One participant was randomized but did not receive study treatment.|59
371292|NCT02039674|912078|P6|Treated|Overall Study||7
371293|NCT02039674|912079|P5|Treated|Overall Study||12
371294|NCT02039674|912080|P4|Treated|Overall Study||6
371295|NCT02039674|912081|P3|Treated|Overall Study||24
371296|NCT02039674|912082|P2|Treated|Overall Study|One participant was randomized but did not receive study treatment.|24
371297|NCT02039674|912083|P1|Treated|Overall Study||25
371298|NCT02039674|912075|P9|STARTED|Overall Study||45
371299|NCT02039674|912076|P8|STARTED|Overall Study||63
371300|NCT02039674|912077|P7|STARTED|Overall Study||60
371301|NCT02039674|912078|P6|STARTED|Overall Study||7
371302|NCT02039674|912079|P5|STARTED|Overall Study||12
371303|NCT02039674|912080|P4|STARTED|Overall Study||6
371304|NCT02039674|912081|P3|STARTED|Overall Study||24
371305|NCT02039674|912082|P2|STARTED|Overall Study||25
371306|NCT02039674|912083|P1|STARTED|Overall Study||25
371307|NCT02039427|912119|P4|NOT COMPLETED|Overall Study||5
371308|NCT02039427|912120|P3|NOT COMPLETED|Overall Study||3
371309|NCT02039427|912121|P2|NOT COMPLETED|Overall Study||1
371310|NCT02039427|912122|P1|NOT COMPLETED|Overall Study||3
371311|NCT02039427|912119|P4|COMPLETED|Overall Study||43
371312|NCT02039427|912120|P3|COMPLETED|Overall Study||45
371313|NCT02039427|912121|P2|COMPLETED|Overall Study||47
371314|NCT02039427|912122|P1|COMPLETED|Overall Study||45
371315|NCT02039427|912119|P4|STARTED|Overall Study||48
371316|NCT02039427|912120|P3|STARTED|Overall Study||48
371317|NCT02039427|912121|P2|STARTED|Overall Study||48
371318|NCT02039427|912122|P1|STARTED|Overall Study||48
371319|NCT02039414|912142|P2|NOT COMPLETED|Overall Study||2
371320|NCT02039414|912143|P1|NOT COMPLETED|Overall Study||6
371321|NCT02039414|912142|P2|COMPLETED|Overall Study||16
371322|NCT02039414|912143|P1|COMPLETED|Overall Study||16
371323|NCT02039414|912142|P2|STARTED|Overall Study||18
371324|NCT02039414|912143|P1|STARTED|Overall Study||22
371325|NCT02039115|912157|P2|NOT COMPLETED|Overall Study||0
371326|NCT02039115|912158|P1|NOT COMPLETED|Overall Study||0
371327|NCT02039115|912157|P2|COMPLETED|Overall Study||0
371328|NCT02039115|912158|P1|COMPLETED|Overall Study||1
371329|NCT02039115|912157|P2|STARTED|Overall Study||0
371330|NCT02039115|912158|P1|STARTED|Overall Study||1
371331|NCT02038959|912166|P2|NOT COMPLETED|Overall Study||8
371332|NCT02038959|912167|P1|NOT COMPLETED|Overall Study||6
371333|NCT02038959|912166|P2|COMPLETED|Overall Study||89
371334|NCT02038959|912167|P1|COMPLETED|Overall Study||92
371335|NCT02038959|912166|P2|STARTED|Overall Study||97
371336|NCT02038959|912167|P1|STARTED|Overall Study||98
371337|NCT02038946|912193|P1|NOT COMPLETED|Overall Study||11
371338|NCT02038946|912193|P1|COMPLETED|Overall Study||81
371339|NCT02038946|912193|P1|STARTED|Overall Study||92
371340|NCT02038933|912204|P1|NOT COMPLETED|Follow-up||19
371341|NCT02038933|912204|P1|COMPLETED|Follow-up|Includes subjects still on-treatment and subjects off-treatment continuing in the Follow-up period.|102
371342|NCT02038933|912204|P1|STARTED|Follow-up||121
371343|NCT02038933|912204|P1|NOT COMPLETED|Treatment||114
371344|NCT02038933|912204|P1|COMPLETED|Treatment|Subjects continuing in the treatment period|7
371345|NCT02038933|912204|P1|STARTED|Treatment||121
371346|NCT02038907|912237|P14|NOT COMPLETED|Overall Study||0
371347|NCT02038907|912238|P13|NOT COMPLETED|Overall Study||0
371348|NCT02038907|912239|P12|NOT COMPLETED|Overall Study||0
371349|NCT02038907|912240|P11|NOT COMPLETED|Overall Study||2
371350|NCT02038907|912241|P10|NOT COMPLETED|Overall Study||0
371351|NCT02038907|912242|P9|NOT COMPLETED|Overall Study||0
371352|NCT02038907|912243|P8|NOT COMPLETED|Overall Study||0
371353|NCT02038907|912244|P7|NOT COMPLETED|Overall Study||0
371354|NCT02038907|912245|P6|NOT COMPLETED|Overall Study||0
371355|NCT02038907|912246|P5|NOT COMPLETED|Overall Study||0
371356|NCT02038907|912247|P4|NOT COMPLETED|Overall Study||0
371357|NCT02038907|912248|P3|NOT COMPLETED|Overall Study||0
371358|NCT02038907|912249|P2|NOT COMPLETED|Overall Study||0
371359|NCT02038907|912250|P1|NOT COMPLETED|Overall Study||0
371360|NCT02038907|912237|P14|COMPLETED|Overall Study||31
371361|NCT02038907|912238|P13|COMPLETED|Overall Study||29
371362|NCT02038907|912239|P12|COMPLETED|Overall Study||28
371363|NCT02038907|912240|P11|COMPLETED|Overall Study||27
371364|NCT02038907|912241|P10|COMPLETED|Overall Study||30
371365|NCT02038907|912242|P9|COMPLETED|Overall Study||29
371366|NCT02038907|912243|P8|COMPLETED|Overall Study||32
371367|NCT02038907|912244|P7|COMPLETED|Overall Study||30
371368|NCT02038907|912245|P6|COMPLETED|Overall Study||31
371369|NCT02038907|912246|P5|COMPLETED|Overall Study||30
371370|NCT02038907|912247|P4|COMPLETED|Overall Study||31
371371|NCT02038907|912248|P3|COMPLETED|Overall Study||30
371372|NCT02038907|912249|P2|COMPLETED|Overall Study||30
371373|NCT02038907|912250|P1|COMPLETED|Overall Study||30
371374|NCT02038907|912237|P14|STARTED|Overall Study||31
371375|NCT02038907|912238|P13|STARTED|Overall Study||29
371376|NCT02038907|912239|P12|STARTED|Overall Study||28
371377|NCT02038907|912240|P11|STARTED|Overall Study||29
371378|NCT02038907|912241|P10|STARTED|Overall Study||30
371379|NCT02038907|912242|P9|STARTED|Overall Study||29
371380|NCT02038907|912243|P8|STARTED|Overall Study||32
371381|NCT02038907|912244|P7|STARTED|Overall Study||30
371382|NCT02038907|912245|P6|STARTED|Overall Study||31
371383|NCT02038907|912246|P5|STARTED|Overall Study||30
371384|NCT02038907|912247|P4|STARTED|Overall Study||31
371385|NCT02038907|912248|P3|STARTED|Overall Study||30
371386|NCT02038907|912249|P2|STARTED|Overall Study||30
371387|NCT02038907|912250|P1|STARTED|Overall Study||30
371388|NCT02038829|912778|P12|NOT COMPLETED|Treatment Period 6||0
371389|NCT02038829|912779|P11|NOT COMPLETED|Treatment Period 6||0
371390|NCT02038829|912780|P10|NOT COMPLETED|Treatment Period 6||0
371391|NCT02038829|912781|P9|NOT COMPLETED|Treatment Period 6||0
371392|NCT02038829|912782|P8|NOT COMPLETED|Treatment Period 6||0
371393|NCT02038829|912783|P7|NOT COMPLETED|Treatment Period 6||0
371394|NCT02038829|912784|P6|NOT COMPLETED|Treatment Period 6||0
371395|NCT02038829|912785|P5|NOT COMPLETED|Treatment Period 6||0
371396|NCT02038829|912786|P4|NOT COMPLETED|Treatment Period 6||0
371397|NCT02038829|912787|P3|NOT COMPLETED|Treatment Period 6||1
371398|NCT02038829|912788|P2|NOT COMPLETED|Treatment Period 6||0
371399|NCT02038829|912789|P1|NOT COMPLETED|Treatment Period 6||0
371400|NCT02038829|912778|P12|COMPLETED|Treatment Period 6||8
371401|NCT02038829|912779|P11|COMPLETED|Treatment Period 6||7
371402|NCT02038829|912780|P10|COMPLETED|Treatment Period 6||8
371403|NCT02038829|912781|P9|COMPLETED|Treatment Period 6||7
371404|NCT02038829|912782|P8|COMPLETED|Treatment Period 6||8
371405|NCT02038829|912783|P7|COMPLETED|Treatment Period 6||7
371406|NCT02038829|912784|P6|COMPLETED|Treatment Period 6||7
371407|NCT02038829|912785|P5|COMPLETED|Treatment Period 6||7
371408|NCT02038829|912786|P4|COMPLETED|Treatment Period 6||8
371409|NCT02038829|912787|P3|COMPLETED|Treatment Period 6||7
371410|NCT02038829|912788|P2|COMPLETED|Treatment Period 6||7
371411|NCT02038829|912789|P1|COMPLETED|Treatment Period 6||7
371412|NCT02038829|912778|P12|STARTED|Treatment Period 6||8
371413|NCT02038829|912779|P11|STARTED|Treatment Period 6||7
371414|NCT02038829|912780|P10|STARTED|Treatment Period 6||8
371415|NCT02038829|912781|P9|STARTED|Treatment Period 6||7
371416|NCT02038829|912782|P8|STARTED|Treatment Period 6||8
371417|NCT02038829|912783|P7|STARTED|Treatment Period 6||7
371418|NCT02038829|912784|P6|STARTED|Treatment Period 6||7
371419|NCT02038829|912785|P5|STARTED|Treatment Period 6||7
371420|NCT02038829|912786|P4|STARTED|Treatment Period 6||8
371421|NCT02038829|912787|P3|STARTED|Treatment Period 6||8
371422|NCT02038829|912788|P2|STARTED|Treatment Period 6||7
371423|NCT02038829|912789|P1|STARTED|Treatment Period 6||7
371424|NCT02038829|912778|P12|NOT COMPLETED|Washout Period 5||0
371425|NCT02038829|912779|P11|NOT COMPLETED|Washout Period 5||0
371426|NCT02038829|912780|P10|NOT COMPLETED|Washout Period 5||0
371427|NCT02038829|912781|P9|NOT COMPLETED|Washout Period 5||0
371428|NCT02038829|912782|P8|NOT COMPLETED|Washout Period 5||0
371429|NCT02038829|912783|P7|NOT COMPLETED|Washout Period 5||0
371430|NCT02038829|912784|P6|NOT COMPLETED|Washout Period 5||0
371431|NCT02038829|912785|P5|NOT COMPLETED|Washout Period 5||0
371432|NCT02038829|912786|P4|NOT COMPLETED|Washout Period 5||0
371433|NCT02038829|912787|P3|NOT COMPLETED|Washout Period 5||0
371434|NCT02038829|912788|P2|NOT COMPLETED|Washout Period 5||0
371435|NCT02038829|912789|P1|NOT COMPLETED|Washout Period 5||0
371436|NCT02038829|912778|P12|COMPLETED|Washout Period 5||8
371437|NCT02038829|912779|P11|COMPLETED|Washout Period 5||7
371438|NCT02038829|912780|P10|COMPLETED|Washout Period 5||8
371439|NCT02038829|912781|P9|COMPLETED|Washout Period 5||7
371440|NCT02038829|912782|P8|COMPLETED|Washout Period 5||8
371441|NCT02038829|912783|P7|COMPLETED|Washout Period 5||7
371442|NCT02038829|912784|P6|COMPLETED|Washout Period 5||7
371443|NCT02038829|912785|P5|COMPLETED|Washout Period 5||7
371444|NCT02038829|912786|P4|COMPLETED|Washout Period 5||8
371445|NCT02038829|912787|P3|COMPLETED|Washout Period 5||8
371446|NCT02038829|912788|P2|COMPLETED|Washout Period 5||7
371447|NCT02038829|912789|P1|COMPLETED|Washout Period 5||7
371448|NCT02038829|912778|P12|STARTED|Washout Period 5||8
371449|NCT02038829|912779|P11|STARTED|Washout Period 5||7
371450|NCT02038829|912780|P10|STARTED|Washout Period 5||8
371451|NCT02038829|912781|P9|STARTED|Washout Period 5||7
371452|NCT02038829|912782|P8|STARTED|Washout Period 5||8
371453|NCT02038829|912783|P7|STARTED|Washout Period 5||7
371454|NCT02038829|912784|P6|STARTED|Washout Period 5||7
371455|NCT02038829|912785|P5|STARTED|Washout Period 5||7
371456|NCT02038829|912786|P4|STARTED|Washout Period 5||8
371457|NCT02038829|912787|P3|STARTED|Washout Period 5||8
371458|NCT02038829|912788|P2|STARTED|Washout Period 5||7
371459|NCT02038829|912789|P1|STARTED|Washout Period 5||7
371460|NCT02038829|912778|P12|NOT COMPLETED|Treatment Period 5||0
371461|NCT02038829|912779|P11|NOT COMPLETED|Treatment Period 5||0
371462|NCT02038829|912780|P10|NOT COMPLETED|Treatment Period 5||0
371463|NCT02038829|912781|P9|NOT COMPLETED|Treatment Period 5||0
371464|NCT02038829|912782|P8|NOT COMPLETED|Treatment Period 5||0
371465|NCT02038829|912783|P7|NOT COMPLETED|Treatment Period 5||0
371466|NCT02038829|912784|P6|NOT COMPLETED|Treatment Period 5||0
371467|NCT02038829|912785|P5|NOT COMPLETED|Treatment Period 5||0
371468|NCT02038829|912786|P4|NOT COMPLETED|Treatment Period 5||0
371469|NCT02038829|912787|P3|NOT COMPLETED|Treatment Period 5||0
371470|NCT02038829|912788|P2|NOT COMPLETED|Treatment Period 5||0
371471|NCT02038829|912789|P1|NOT COMPLETED|Treatment Period 5||0
371472|NCT02038829|912778|P12|COMPLETED|Treatment Period 5||8
371473|NCT02038829|912779|P11|COMPLETED|Treatment Period 5||7
371474|NCT02038829|912780|P10|COMPLETED|Treatment Period 5||8
371475|NCT02038829|912781|P9|COMPLETED|Treatment Period 5||7
371476|NCT02038829|912782|P8|COMPLETED|Treatment Period 5||8
371477|NCT02038829|912783|P7|COMPLETED|Treatment Period 5||7
371478|NCT02038829|912784|P6|COMPLETED|Treatment Period 5||7
371479|NCT02038829|912785|P5|COMPLETED|Treatment Period 5||7
371480|NCT02038829|912786|P4|COMPLETED|Treatment Period 5||8
371481|NCT02038829|912787|P3|COMPLETED|Treatment Period 5||8
371482|NCT02038829|912788|P2|COMPLETED|Treatment Period 5||7
371483|NCT02038829|912789|P1|COMPLETED|Treatment Period 5||7
371484|NCT02038829|912778|P12|STARTED|Treatment Period 5||8
371485|NCT02038829|912779|P11|STARTED|Treatment Period 5||7
371486|NCT02038829|912780|P10|STARTED|Treatment Period 5||8
371487|NCT02038829|912781|P9|STARTED|Treatment Period 5||7
371488|NCT02038829|912782|P8|STARTED|Treatment Period 5||8
371489|NCT02038829|912783|P7|STARTED|Treatment Period 5||7
371490|NCT02038829|912784|P6|STARTED|Treatment Period 5||7
371491|NCT02038829|912785|P5|STARTED|Treatment Period 5||7
371492|NCT02038829|912786|P4|STARTED|Treatment Period 5||8
371493|NCT02038829|912787|P3|STARTED|Treatment Period 5||8
371494|NCT02038829|912788|P2|STARTED|Treatment Period 5||7
371495|NCT02038829|912789|P1|STARTED|Treatment Period 5||7
371496|NCT02038829|912778|P12|NOT COMPLETED|Washout Period 4||0
371497|NCT02038829|912779|P11|NOT COMPLETED|Washout Period 4||0
371498|NCT02038829|912780|P10|NOT COMPLETED|Washout Period 4||0
371499|NCT02038829|912781|P9|NOT COMPLETED|Washout Period 4||0
371500|NCT02038829|912782|P8|NOT COMPLETED|Washout Period 4||0
371501|NCT02038829|912783|P7|NOT COMPLETED|Washout Period 4||1
371502|NCT02038829|912784|P6|NOT COMPLETED|Washout Period 4||0
371503|NCT02038829|912785|P5|NOT COMPLETED|Washout Period 4||0
371504|NCT02038829|912786|P4|NOT COMPLETED|Washout Period 4||0
371505|NCT02038829|912787|P3|NOT COMPLETED|Washout Period 4||0
371506|NCT02038829|912788|P2|NOT COMPLETED|Washout Period 4||0
371507|NCT02038829|912789|P1|NOT COMPLETED|Washout Period 4||0
371508|NCT02038829|912778|P12|COMPLETED|Washout Period 4||8
371509|NCT02038829|912779|P11|COMPLETED|Washout Period 4||7
371510|NCT02038829|912780|P10|COMPLETED|Washout Period 4||8
371511|NCT02038829|912781|P9|COMPLETED|Washout Period 4||7
371512|NCT02038829|912782|P8|COMPLETED|Washout Period 4||8
371513|NCT02038829|912783|P7|COMPLETED|Washout Period 4||7
371514|NCT02038829|912784|P6|COMPLETED|Washout Period 4||7
371515|NCT02038829|912785|P5|COMPLETED|Washout Period 4||7
371516|NCT02038829|912786|P4|COMPLETED|Washout Period 4||8
371517|NCT02038829|912787|P3|COMPLETED|Washout Period 4||8
371518|NCT02038829|912788|P2|COMPLETED|Washout Period 4||7
371519|NCT02038829|912789|P1|COMPLETED|Washout Period 4||7
371520|NCT02038829|912778|P12|STARTED|Washout Period 4||8
371521|NCT02038829|912779|P11|STARTED|Washout Period 4||7
371522|NCT02038829|912780|P10|STARTED|Washout Period 4||8
371523|NCT02038829|912781|P9|STARTED|Washout Period 4||7
371524|NCT02038829|912782|P8|STARTED|Washout Period 4||8
371525|NCT02038829|912783|P7|STARTED|Washout Period 4||8
371526|NCT02038829|912784|P6|STARTED|Washout Period 4||7
371527|NCT02038829|912785|P5|STARTED|Washout Period 4||7
371528|NCT02038829|912786|P4|STARTED|Washout Period 4||8
371529|NCT02038829|912787|P3|STARTED|Washout Period 4||8
371530|NCT02038829|912788|P2|STARTED|Washout Period 4||7
371531|NCT02038829|912789|P1|STARTED|Washout Period 4||7
371532|NCT02038829|912778|P12|NOT COMPLETED|Treatment Period 4||0
371533|NCT02038829|912779|P11|NOT COMPLETED|Treatment Period 4||0
371534|NCT02038829|912780|P10|NOT COMPLETED|Treatment Period 4||0
371535|NCT02038829|912781|P9|NOT COMPLETED|Treatment Period 4||0
371536|NCT02038829|912782|P8|NOT COMPLETED|Treatment Period 4||0
371537|NCT02038829|912783|P7|NOT COMPLETED|Treatment Period 4||0
371538|NCT02038829|912784|P6|NOT COMPLETED|Treatment Period 4||0
371539|NCT02038829|912785|P5|NOT COMPLETED|Treatment Period 4||0
371540|NCT02038829|912786|P4|NOT COMPLETED|Treatment Period 4||0
371541|NCT02038829|912787|P3|NOT COMPLETED|Treatment Period 4||0
371542|NCT02038829|912788|P2|NOT COMPLETED|Treatment Period 4||1
371543|NCT02038829|912789|P1|NOT COMPLETED|Treatment Period 4||0
371544|NCT02038829|912778|P12|COMPLETED|Treatment Period 4||8
371545|NCT02038829|912779|P11|COMPLETED|Treatment Period 4||7
371546|NCT02038829|912780|P10|COMPLETED|Treatment Period 4||8
371547|NCT02038829|912781|P9|COMPLETED|Treatment Period 4||7
371548|NCT02038829|912782|P8|COMPLETED|Treatment Period 4||8
371549|NCT02038829|912783|P7|COMPLETED|Treatment Period 4||8
371550|NCT02038829|912784|P6|COMPLETED|Treatment Period 4||7
371551|NCT02038829|912785|P5|COMPLETED|Treatment Period 4||7
371552|NCT02038829|912786|P4|COMPLETED|Treatment Period 4||8
371553|NCT02038829|912787|P3|COMPLETED|Treatment Period 4||8
371554|NCT02038829|912788|P2|COMPLETED|Treatment Period 4||7
371555|NCT02038829|912789|P1|COMPLETED|Treatment Period 4||7
371556|NCT02038829|912778|P12|STARTED|Treatment Period 4||8
371557|NCT02038829|912779|P11|STARTED|Treatment Period 4||7
371558|NCT02038829|912780|P10|STARTED|Treatment Period 4||8
371559|NCT02038829|912781|P9|STARTED|Treatment Period 4||7
371560|NCT02038829|912782|P8|STARTED|Treatment Period 4||8
371561|NCT02038829|912783|P7|STARTED|Treatment Period 4||8
371562|NCT02038829|912784|P6|STARTED|Treatment Period 4||7
371563|NCT02038829|912785|P5|STARTED|Treatment Period 4||7
371564|NCT02038829|912786|P4|STARTED|Treatment Period 4||8
371565|NCT02038829|912787|P3|STARTED|Treatment Period 4||8
371566|NCT02038829|912788|P2|STARTED|Treatment Period 4||8
371567|NCT02038829|912789|P1|STARTED|Treatment Period 4||7
371568|NCT02038829|912778|P12|NOT COMPLETED|Washout Period 3||0
371569|NCT02038829|912779|P11|NOT COMPLETED|Washout Period 3||0
371570|NCT02038829|912780|P10|NOT COMPLETED|Washout Period 3||0
371571|NCT02038829|912781|P9|NOT COMPLETED|Washout Period 3||0
371572|NCT02038829|912782|P8|NOT COMPLETED|Washout Period 3||0
371573|NCT02038829|912783|P7|NOT COMPLETED|Washout Period 3||0
371574|NCT02038829|912784|P6|NOT COMPLETED|Washout Period 3||0
371575|NCT02038829|912785|P5|NOT COMPLETED|Washout Period 3||0
371576|NCT02038829|912786|P4|NOT COMPLETED|Washout Period 3||0
371577|NCT02038829|912787|P3|NOT COMPLETED|Washout Period 3||0
371578|NCT02038829|912788|P2|NOT COMPLETED|Washout Period 3||0
371579|NCT02038829|912789|P1|NOT COMPLETED|Washout Period 3||0
371580|NCT02038829|912778|P12|COMPLETED|Washout Period 3||8
371581|NCT02038829|912779|P11|COMPLETED|Washout Period 3||7
371582|NCT02038829|912780|P10|COMPLETED|Washout Period 3||8
371583|NCT02038829|912781|P9|COMPLETED|Washout Period 3||7
371584|NCT02038829|912782|P8|COMPLETED|Washout Period 3||8
371585|NCT02038829|912783|P7|COMPLETED|Washout Period 3||8
371586|NCT02038829|912784|P6|COMPLETED|Washout Period 3||7
371587|NCT02038829|912785|P5|COMPLETED|Washout Period 3||7
371588|NCT02038829|912786|P4|COMPLETED|Washout Period 3||8
371589|NCT02038829|912787|P3|COMPLETED|Washout Period 3||8
371590|NCT02038829|912788|P2|COMPLETED|Washout Period 3||8
371591|NCT02038829|912789|P1|COMPLETED|Washout Period 3||7
371592|NCT02038829|912778|P12|STARTED|Washout Period 3||8
371593|NCT02038829|912779|P11|STARTED|Washout Period 3||7
371594|NCT02038829|912780|P10|STARTED|Washout Period 3||8
371595|NCT02038829|912781|P9|STARTED|Washout Period 3||7
371596|NCT02038829|912782|P8|STARTED|Washout Period 3||8
371597|NCT02038829|912783|P7|STARTED|Washout Period 3||8
371598|NCT02038829|912784|P6|STARTED|Washout Period 3||7
371599|NCT02038829|912785|P5|STARTED|Washout Period 3||7
371600|NCT02038829|912786|P4|STARTED|Washout Period 3||8
371601|NCT02038829|912787|P3|STARTED|Washout Period 3||8
371602|NCT02038829|912788|P2|STARTED|Washout Period 3||8
371603|NCT02038829|912789|P1|STARTED|Washout Period 3||7
371604|NCT02038829|912778|P12|NOT COMPLETED|Treatment Period 3||0
371605|NCT02038829|912779|P11|NOT COMPLETED|Treatment Period 3||0
371606|NCT02038829|912780|P10|NOT COMPLETED|Treatment Period 3||0
371607|NCT02038829|912781|P9|NOT COMPLETED|Treatment Period 3||0
371608|NCT02038829|912782|P8|NOT COMPLETED|Treatment Period 3||0
371609|NCT02038829|912783|P7|NOT COMPLETED|Treatment Period 3||0
371610|NCT02038829|912784|P6|NOT COMPLETED|Treatment Period 3||0
371611|NCT02038829|912785|P5|NOT COMPLETED|Treatment Period 3||0
371612|NCT02038829|912786|P4|NOT COMPLETED|Treatment Period 3||0
371613|NCT02038829|912787|P3|NOT COMPLETED|Treatment Period 3||0
371614|NCT02038829|912788|P2|NOT COMPLETED|Treatment Period 3||0
371615|NCT02038829|912789|P1|NOT COMPLETED|Treatment Period 3||0
371616|NCT02038829|912778|P12|COMPLETED|Treatment Period 3||8
371617|NCT02038829|912779|P11|COMPLETED|Treatment Period 3||7
371618|NCT02038829|912780|P10|COMPLETED|Treatment Period 3||8
371619|NCT02038829|912781|P9|COMPLETED|Treatment Period 3||7
371620|NCT02038829|912782|P8|COMPLETED|Treatment Period 3||8
371621|NCT02038829|912783|P7|COMPLETED|Treatment Period 3||8
371622|NCT02038829|912784|P6|COMPLETED|Treatment Period 3||7
371623|NCT02038829|912785|P5|COMPLETED|Treatment Period 3||7
371624|NCT02038829|912786|P4|COMPLETED|Treatment Period 3||8
371625|NCT02038829|912787|P3|COMPLETED|Treatment Period 3||8
371626|NCT02038829|912788|P2|COMPLETED|Treatment Period 3||8
371627|NCT02038829|912789|P1|COMPLETED|Treatment Period 3||7
371628|NCT02038829|912778|P12|STARTED|Treatment Period 3||8
371629|NCT02038829|912779|P11|STARTED|Treatment Period 3||7
371630|NCT02038829|912780|P10|STARTED|Treatment Period 3||8
371631|NCT02038829|912781|P9|STARTED|Treatment Period 3||7
371632|NCT02038829|912782|P8|STARTED|Treatment Period 3||8
371633|NCT02038829|912783|P7|STARTED|Treatment Period 3||8
371634|NCT02038829|912784|P6|STARTED|Treatment Period 3||7
371635|NCT02038829|912785|P5|STARTED|Treatment Period 3||7
371636|NCT02038829|912786|P4|STARTED|Treatment Period 3||8
371637|NCT02038829|912787|P3|STARTED|Treatment Period 3||8
371638|NCT02038829|912788|P2|STARTED|Treatment Period 3||8
371639|NCT02038829|912789|P1|STARTED|Treatment Period 3||7
371640|NCT02038829|912778|P12|NOT COMPLETED|Washout Period 2||0
371641|NCT02038829|912779|P11|NOT COMPLETED|Washout Period 2||0
371642|NCT02038829|912780|P10|NOT COMPLETED|Washout Period 2||0
371643|NCT02038829|912781|P9|NOT COMPLETED|Washout Period 2||1
371644|NCT02038829|912782|P8|NOT COMPLETED|Washout Period 2||0
371645|NCT02038829|912783|P7|NOT COMPLETED|Washout Period 2||0
371646|NCT02038829|912784|P6|NOT COMPLETED|Washout Period 2||1
371647|NCT02038829|912785|P5|NOT COMPLETED|Washout Period 2||0
371648|NCT02038829|912786|P4|NOT COMPLETED|Washout Period 2||0
371649|NCT02038829|912787|P3|NOT COMPLETED|Washout Period 2||0
371650|NCT02038829|912788|P2|NOT COMPLETED|Washout Period 2||0
371651|NCT02038829|912789|P1|NOT COMPLETED|Washout Period 2||0
371652|NCT02038829|912778|P12|COMPLETED|Washout Period 2||8
371653|NCT02038829|912779|P11|COMPLETED|Washout Period 2||7
371654|NCT02038829|912780|P10|COMPLETED|Washout Period 2||8
371655|NCT02038829|912781|P9|COMPLETED|Washout Period 2||7
371656|NCT02038829|912782|P8|COMPLETED|Washout Period 2||8
371657|NCT02038829|912783|P7|COMPLETED|Washout Period 2||8
371658|NCT02038829|912784|P6|COMPLETED|Washout Period 2||7
371659|NCT02038829|912785|P5|COMPLETED|Washout Period 2||7
371660|NCT02038829|912786|P4|COMPLETED|Washout Period 2||8
371661|NCT02038829|912787|P3|COMPLETED|Washout Period 2||8
371662|NCT02038829|912788|P2|COMPLETED|Washout Period 2||8
371663|NCT02038829|912789|P1|COMPLETED|Washout Period 2||7
371664|NCT02038829|912778|P12|STARTED|Washout Period 2||8
371665|NCT02038829|912779|P11|STARTED|Washout Period 2||7
371666|NCT02038829|912780|P10|STARTED|Washout Period 2||8
371667|NCT02038829|912781|P9|STARTED|Washout Period 2||8
371668|NCT02038829|912782|P8|STARTED|Washout Period 2||8
371669|NCT02038829|912783|P7|STARTED|Washout Period 2||8
371670|NCT02038829|912784|P6|STARTED|Washout Period 2||8
371671|NCT02038829|912785|P5|STARTED|Washout Period 2||7
371672|NCT02038829|912786|P4|STARTED|Washout Period 2||8
371673|NCT02038829|912787|P3|STARTED|Washout Period 2||8
371674|NCT02038829|912788|P2|STARTED|Washout Period 2||8
371675|NCT02038829|912789|P1|STARTED|Washout Period 2||7
371676|NCT02038829|912778|P12|NOT COMPLETED|Treatment Period 2||0
371677|NCT02038829|912779|P11|NOT COMPLETED|Treatment Period 2||1
371678|NCT02038829|912780|P10|NOT COMPLETED|Treatment Period 2||0
371679|NCT02038829|912781|P9|NOT COMPLETED|Treatment Period 2||0
371680|NCT02038829|912782|P8|NOT COMPLETED|Treatment Period 2||0
371681|NCT02038829|912783|P7|NOT COMPLETED|Treatment Period 2||0
371682|NCT02038829|912784|P6|NOT COMPLETED|Treatment Period 2||0
371683|NCT02038829|912785|P5|NOT COMPLETED|Treatment Period 2||0
371684|NCT02038829|912786|P4|NOT COMPLETED|Treatment Period 2||0
371685|NCT02038829|912787|P3|NOT COMPLETED|Treatment Period 2||0
371686|NCT02038829|912788|P2|NOT COMPLETED|Treatment Period 2||0
371687|NCT02038829|912789|P1|NOT COMPLETED|Treatment Period 2||1
371688|NCT02038829|912778|P12|COMPLETED|Treatment Period 2||8
371689|NCT02038829|912779|P11|COMPLETED|Treatment Period 2||7
371690|NCT02038829|912780|P10|COMPLETED|Treatment Period 2||8
371691|NCT02038829|912781|P9|COMPLETED|Treatment Period 2||8
371692|NCT02038829|912782|P8|COMPLETED|Treatment Period 2||8
371693|NCT02038829|912783|P7|COMPLETED|Treatment Period 2||8
371694|NCT02038829|912784|P6|COMPLETED|Treatment Period 2||8
371695|NCT02038829|912785|P5|COMPLETED|Treatment Period 2||7
371696|NCT02038829|912786|P4|COMPLETED|Treatment Period 2||8
371697|NCT02038829|912787|P3|COMPLETED|Treatment Period 2||8
371698|NCT02038829|912788|P2|COMPLETED|Treatment Period 2||8
371699|NCT02038829|912789|P1|COMPLETED|Treatment Period 2||7
371700|NCT02038829|912778|P12|STARTED|Treatment Period 2||8
371701|NCT02038829|912779|P11|STARTED|Treatment Period 2||8
371702|NCT02038829|912780|P10|STARTED|Treatment Period 2||8
371703|NCT02038829|912781|P9|STARTED|Treatment Period 2||8
371704|NCT02038829|912782|P8|STARTED|Treatment Period 2||8
371705|NCT02038829|912783|P7|STARTED|Treatment Period 2||8
371706|NCT02038829|912784|P6|STARTED|Treatment Period 2||8
371707|NCT02038829|912785|P5|STARTED|Treatment Period 2||7
371708|NCT02038829|912786|P4|STARTED|Treatment Period 2||8
371709|NCT02038829|912787|P3|STARTED|Treatment Period 2||8
371710|NCT02038829|912788|P2|STARTED|Treatment Period 2||8
371711|NCT02038829|912789|P1|STARTED|Treatment Period 2||8
371712|NCT02038829|912778|P12|NOT COMPLETED|Washout Period 1||0
371713|NCT02038829|912779|P11|NOT COMPLETED|Washout Period 1||0
371714|NCT02038829|912780|P10|NOT COMPLETED|Washout Period 1||0
371715|NCT02038829|912781|P9|NOT COMPLETED|Washout Period 1||0
371716|NCT02038829|912782|P8|NOT COMPLETED|Washout Period 1||0
371717|NCT02038829|912783|P7|NOT COMPLETED|Washout Period 1||0
371718|NCT02038829|912784|P6|NOT COMPLETED|Washout Period 1||0
371719|NCT02038829|912785|P5|NOT COMPLETED|Washout Period 1||1
371720|NCT02038829|912786|P4|NOT COMPLETED|Washout Period 1||0
371721|NCT02038829|912787|P3|NOT COMPLETED|Washout Period 1||0
371722|NCT02038829|912788|P2|NOT COMPLETED|Washout Period 1||0
371723|NCT02038829|912789|P1|NOT COMPLETED|Washout Period 1||0
371724|NCT02038829|912778|P12|COMPLETED|Washout Period 1||8
371725|NCT02038829|912779|P11|COMPLETED|Washout Period 1||8
371726|NCT02038829|912780|P10|COMPLETED|Washout Period 1||8
371727|NCT02038829|912781|P9|COMPLETED|Washout Period 1||8
371728|NCT02038829|912782|P8|COMPLETED|Washout Period 1||8
371729|NCT02038829|912783|P7|COMPLETED|Washout Period 1||8
371730|NCT02038829|912784|P6|COMPLETED|Washout Period 1||8
371731|NCT02038829|912785|P5|COMPLETED|Washout Period 1||7
371732|NCT02038829|912786|P4|COMPLETED|Washout Period 1||8
371733|NCT02038829|912787|P3|COMPLETED|Washout Period 1||8
371734|NCT02038829|912788|P2|COMPLETED|Washout Period 1||8
371735|NCT02038829|912789|P1|COMPLETED|Washout Period 1||8
371736|NCT02038829|912778|P12|STARTED|Washout Period 1||8
371737|NCT02038829|912779|P11|STARTED|Washout Period 1||8
371738|NCT02038829|912780|P10|STARTED|Washout Period 1||8
371739|NCT02038829|912781|P9|STARTED|Washout Period 1||8
371740|NCT02038829|912782|P8|STARTED|Washout Period 1||8
371741|NCT02038829|912783|P7|STARTED|Washout Period 1||8
371742|NCT02038829|912784|P6|STARTED|Washout Period 1||8
371743|NCT02038829|912785|P5|STARTED|Washout Period 1||8
371744|NCT02038829|912786|P4|STARTED|Washout Period 1||8
371745|NCT02038829|912787|P3|STARTED|Washout Period 1||8
371746|NCT02038829|912788|P2|STARTED|Washout Period 1||8
371747|NCT02038829|912789|P1|STARTED|Washout Period 1||8
371748|NCT02038829|912778|P12|NOT COMPLETED|Treatment Period 1||0
371749|NCT02038829|912779|P11|NOT COMPLETED|Treatment Period 1||0
371750|NCT02038829|912780|P10|NOT COMPLETED|Treatment Period 1||0
371751|NCT02038829|912781|P9|NOT COMPLETED|Treatment Period 1||0
371752|NCT02038829|912782|P8|NOT COMPLETED|Treatment Period 1||0
371753|NCT02038829|912783|P7|NOT COMPLETED|Treatment Period 1||0
371754|NCT02038829|912784|P6|NOT COMPLETED|Treatment Period 1||0
371755|NCT02038829|912785|P5|NOT COMPLETED|Treatment Period 1||0
371756|NCT02038829|912786|P4|NOT COMPLETED|Treatment Period 1||0
371757|NCT02038829|912787|P3|NOT COMPLETED|Treatment Period 1||0
371758|NCT02038829|912788|P2|NOT COMPLETED|Treatment Period 1||0
371759|NCT02038829|912789|P1|NOT COMPLETED|Treatment Period 1||0
371760|NCT02038829|912778|P12|COMPLETED|Treatment Period 1||8
371761|NCT02038829|912779|P11|COMPLETED|Treatment Period 1||8
371762|NCT02038829|912780|P10|COMPLETED|Treatment Period 1||8
371763|NCT02038829|912781|P9|COMPLETED|Treatment Period 1||8
371764|NCT02038829|912782|P8|COMPLETED|Treatment Period 1||8
371765|NCT02038829|912783|P7|COMPLETED|Treatment Period 1||8
371766|NCT02038829|912784|P6|COMPLETED|Treatment Period 1||8
371767|NCT02038829|912785|P5|COMPLETED|Treatment Period 1||8
371768|NCT02038829|912786|P4|COMPLETED|Treatment Period 1||8
371769|NCT02038829|912787|P3|COMPLETED|Treatment Period 1||8
371770|NCT02038829|912788|P2|COMPLETED|Treatment Period 1||8
371771|NCT02038829|912789|P1|COMPLETED|Treatment Period 1||8
371772|NCT02038829|912778|P12|STARTED|Treatment Period 1||8
371773|NCT02038829|912779|P11|STARTED|Treatment Period 1||8
371774|NCT02038829|912780|P10|STARTED|Treatment Period 1||8
371775|NCT02038829|912781|P9|STARTED|Treatment Period 1||8
371776|NCT02038829|912782|P8|STARTED|Treatment Period 1||8
371777|NCT02038829|912783|P7|STARTED|Treatment Period 1||8
371778|NCT02038829|912784|P6|STARTED|Treatment Period 1||8
371779|NCT02038829|912785|P5|STARTED|Treatment Period 1||8
371780|NCT02038829|912786|P4|STARTED|Treatment Period 1||8
371781|NCT02038829|912787|P3|STARTED|Treatment Period 1||8
371782|NCT02038829|912788|P2|STARTED|Treatment Period 1||8
371783|NCT02038829|912789|P1|STARTED|Treatment Period 1||8
371784|NCT02038790|912823|P2|NOT COMPLETED|Day 1 - Second Treatment||0
371785|NCT02038790|912824|P1|NOT COMPLETED|Day 1 - Second Treatment||0
371786|NCT02038790|912823|P2|COMPLETED|Day 1 - Second Treatment||16
371787|NCT02038790|912824|P1|COMPLETED|Day 1 - Second Treatment||15
371788|NCT02038790|912823|P2|STARTED|Day 1 - Second Treatment||16
371789|NCT02038790|912824|P1|STARTED|Day 1 - Second Treatment||15
371790|NCT02038790|912823|P2|NOT COMPLETED|Day 0 - First Treatment||1
371791|NCT02038790|912824|P1|NOT COMPLETED|Day 0 - First Treatment||1
371792|NCT02038790|912823|P2|COMPLETED|Day 0 - First Treatment||16
371793|NCT02038790|912824|P1|COMPLETED|Day 0 - First Treatment||15
371794|NCT02038790|912823|P2|STARTED|Day 0 - First Treatment||17
371795|NCT02038790|912824|P1|STARTED|Day 0 - First Treatment||16
371796|NCT02038543|912859|P4|NOT COMPLETED|Overall Study||2
371797|NCT02038543|912860|P3|NOT COMPLETED|Overall Study||0
371798|NCT02038543|912861|P2|NOT COMPLETED|Overall Study||0
371799|NCT02038543|912862|P1|NOT COMPLETED|Overall Study||0
371800|NCT02038543|912859|P4|COMPLETED|Overall Study||1
371801|NCT02038543|912860|P3|COMPLETED|Overall Study||8
371802|NCT02038543|912861|P2|COMPLETED|Overall Study||4
371803|NCT02038543|912862|P1|COMPLETED|Overall Study||7
371804|NCT02038543|912859|P4|STARTED|Overall Study||3
371805|NCT02038543|912860|P3|STARTED|Overall Study||8
371806|NCT02038543|912861|P2|STARTED|Overall Study||4
371807|NCT02038543|912862|P1|STARTED|Overall Study||7
371808|NCT02038075|912878|P2|NOT COMPLETED|Overall Study||0
371809|NCT02038075|912879|P1|NOT COMPLETED|Overall Study||3
371810|NCT02038075|912878|P2|COMPLETED|Overall Study||76
371811|NCT02038075|912879|P1|COMPLETED|Overall Study||73
371812|NCT02038075|912878|P2|STARTED|Overall Study||76
371813|NCT02038075|912879|P1|STARTED|Overall Study||76
371814|NCT02038023|912885|P1|NOT COMPLETED|Overall Study||1
371815|NCT02038023|912885|P1|COMPLETED|Overall Study||73
371816|NCT02038023|912885|P1|STARTED|Overall Study||74
371817|NCT02037776|912894|P2|NOT COMPLETED|Overall Study||4
371818|NCT02037776|912895|P1|NOT COMPLETED|Overall Study||5
371819|NCT02037776|912894|P2|COMPLETED|Overall Study||60
371820|NCT02037776|912895|P1|COMPLETED|Overall Study||56
371821|NCT02037776|912894|P2|STARTED|Overall Study||64
371822|NCT02037776|912895|P1|STARTED|Overall Study||61
371823|NCT02037607|912911|P1|NOT COMPLETED|Overall Study||9
371824|NCT02037607|912911|P1|COMPLETED|Overall Study||91
371825|NCT02037607|912911|P1|STARTED|Overall Study||100
371826|NCT02037568|912917|P2|NOT COMPLETED|Overall Study||39
371827|NCT02037568|912918|P1|NOT COMPLETED|Overall Study||36
371828|NCT02037568|912917|P2|COMPLETED|Overall Study||37
371829|NCT02037568|912918|P1|COMPLETED|Overall Study||47
371830|NCT02037568|912917|P2|Month 6 (Post Transplantation)|Overall Study||52
371831|NCT02037568|912918|P1|Month 6 (Post Transplantation)|Overall Study||63
371832|NCT02037568|912917|P2|Month 3 (Post Transplantation)|Overall Study||62
371833|NCT02037568|912918|P1|Month 3 (Post Transplantation)|Overall Study||66
371834|NCT02037568|912917|P2|Month 1.5 (Post Transplantation)|Overall Study||76
371835|NCT02037568|912918|P1|Month 1.5 (Post Transplantation)|Overall Study||79
371836|NCT02037568|912917|P2|STARTED|Overall Study||76
371837|NCT02037568|912918|P1|STARTED|Overall Study||83
371838|NCT02037477|912944|P4|NOT COMPLETED|Treatment Period 2||0
371839|NCT02037477|912945|P3|NOT COMPLETED|Treatment Period 2||0
371840|NCT02037477|912946|P2|NOT COMPLETED|Treatment Period 2||0
371841|NCT02037477|912947|P1|NOT COMPLETED|Treatment Period 2||0
371842|NCT02037477|912944|P4|COMPLETED|Treatment Period 2||5
371843|NCT02037477|912945|P3|COMPLETED|Treatment Period 2||4
371844|NCT02037477|912946|P2|COMPLETED|Treatment Period 2||5
371845|NCT02037477|912947|P1|COMPLETED|Treatment Period 2||5
371846|NCT02037477|912944|P4|STARTED|Treatment Period 2||5
371847|NCT02037477|912945|P3|STARTED|Treatment Period 2||4
371848|NCT02037477|912946|P2|STARTED|Treatment Period 2||5
371849|NCT02037477|912947|P1|STARTED|Treatment Period 2||5
371850|NCT02037477|912944|P4|NOT COMPLETED|Treatment Period 1||0
371851|NCT02037477|912945|P3|NOT COMPLETED|Treatment Period 1||1
371852|NCT02037477|912946|P2|NOT COMPLETED|Treatment Period 1||0
371853|NCT02037477|912947|P1|NOT COMPLETED|Treatment Period 1||0
371854|NCT02037477|912944|P4|COMPLETED|Treatment Period 1||5
371855|NCT02037477|912945|P3|COMPLETED|Treatment Period 1||4
371856|NCT02037477|912946|P2|COMPLETED|Treatment Period 1||5
371857|NCT02037477|912947|P1|COMPLETED|Treatment Period 1||5
371858|NCT02037477|912944|P4|STARTED|Treatment Period 1||5
371859|NCT02037477|912945|P3|STARTED|Treatment Period 1||5
371860|NCT02037477|912946|P2|STARTED|Treatment Period 1||5
371861|NCT02037477|912947|P1|STARTED|Treatment Period 1||5
371862|NCT02037425|912973|P1|NOT COMPLETED|Overall Study||26
371863|NCT02037425|912973|P1|COMPLETED|Overall Study||18
371864|NCT02037425|912973|P1|Randomized to Treatment|Overall Study||32
371865|NCT02037425|912973|P1|STARTED|Overall Study||44
371866|NCT02037347|913015|P1|NOT COMPLETED|Overall Study||0
371867|NCT02037347|913015|P1|COMPLETED|Overall Study||1
371868|NCT02037347|913015|P1|STARTED|Overall Study||1
371869|NCT02036840|913021|P1|NOT COMPLETED|Overall Study||0
371870|NCT02036840|913021|P1|COMPLETED|Overall Study||513
371871|NCT02036840|913021|P1|STARTED|Overall Study||513
371872|NCT02036775|913025|P6|NOT COMPLETED|Treatment Period 3 (6 Days)||0
371873|NCT02036775|913026|P5|NOT COMPLETED|Treatment Period 3 (6 Days)||0
371874|NCT02036775|913027|P4|NOT COMPLETED|Treatment Period 3 (6 Days)||0
371875|NCT02036775|913028|P3|NOT COMPLETED|Treatment Period 3 (6 Days)||0
371876|NCT02036775|913029|P2|NOT COMPLETED|Treatment Period 3 (6 Days)||0
371877|NCT02036775|913030|P1|NOT COMPLETED|Treatment Period 3 (6 Days)||0
371878|NCT02036775|913025|P6|COMPLETED|Treatment Period 3 (6 Days)||3
371879|NCT02036775|913026|P5|COMPLETED|Treatment Period 3 (6 Days)||4
371880|NCT02036775|913027|P4|COMPLETED|Treatment Period 3 (6 Days)||4
371881|NCT02036775|913028|P3|COMPLETED|Treatment Period 3 (6 Days)||4
371882|NCT02036775|913029|P2|COMPLETED|Treatment Period 3 (6 Days)||4
371883|NCT02036775|913030|P1|COMPLETED|Treatment Period 3 (6 Days)||4
371884|NCT02036775|913025|P6|STARTED|Treatment Period 3 (6 Days)||3
371885|NCT02036775|913026|P5|STARTED|Treatment Period 3 (6 Days)||4
371886|NCT02036775|913027|P4|STARTED|Treatment Period 3 (6 Days)||4
371887|NCT02036775|913028|P3|STARTED|Treatment Period 3 (6 Days)||4
371888|NCT02036775|913029|P2|STARTED|Treatment Period 3 (6 Days)||4
371889|NCT02036775|913030|P1|STARTED|Treatment Period 3 (6 Days)||4
371890|NCT02036775|913025|P6|NOT COMPLETED|Treatment Period 2 (6 Days)||1
371891|NCT02036775|913026|P5|NOT COMPLETED|Treatment Period 2 (6 Days)||0
371892|NCT02036775|913027|P4|NOT COMPLETED|Treatment Period 2 (6 Days)||0
371893|NCT02036775|913028|P3|NOT COMPLETED|Treatment Period 2 (6 Days)||0
371894|NCT02036775|913029|P2|NOT COMPLETED|Treatment Period 2 (6 Days)||0
371895|NCT02036775|913030|P1|NOT COMPLETED|Treatment Period 2 (6 Days)||0
371896|NCT02036775|913025|P6|COMPLETED|Treatment Period 2 (6 Days)||3
371897|NCT02036775|913026|P5|COMPLETED|Treatment Period 2 (6 Days)||4
371898|NCT02036775|913027|P4|COMPLETED|Treatment Period 2 (6 Days)||4
371899|NCT02036775|913028|P3|COMPLETED|Treatment Period 2 (6 Days)||4
371900|NCT02036775|913029|P2|COMPLETED|Treatment Period 2 (6 Days)||4
371901|NCT02036775|913030|P1|COMPLETED|Treatment Period 2 (6 Days)||4
371902|NCT02036775|913025|P6|STARTED|Treatment Period 2 (6 Days)||4
371903|NCT02036775|913026|P5|STARTED|Treatment Period 2 (6 Days)||4
371904|NCT02036775|913027|P4|STARTED|Treatment Period 2 (6 Days)||4
371905|NCT02036775|913028|P3|STARTED|Treatment Period 2 (6 Days)||4
371906|NCT02036775|913029|P2|STARTED|Treatment Period 2 (6 Days)||4
371907|NCT02036775|913030|P1|STARTED|Treatment Period 2 (6 Days)||4
371908|NCT02036775|913025|P6|NOT COMPLETED|Treatment Period 1 (6 Days)||0
371909|NCT02036775|913026|P5|NOT COMPLETED|Treatment Period 1 (6 Days)||0
371910|NCT02036775|913027|P4|NOT COMPLETED|Treatment Period 1 (6 Days)||0
371911|NCT02036775|913028|P3|NOT COMPLETED|Treatment Period 1 (6 Days)||0
371912|NCT02036775|913029|P2|NOT COMPLETED|Treatment Period 1 (6 Days)||0
371913|NCT02036775|913030|P1|NOT COMPLETED|Treatment Period 1 (6 Days)||0
371914|NCT02036775|913025|P6|COMPLETED|Treatment Period 1 (6 Days)||4
371915|NCT02036775|913026|P5|COMPLETED|Treatment Period 1 (6 Days)||4
371916|NCT02036775|913027|P4|COMPLETED|Treatment Period 1 (6 Days)||4
371917|NCT02036775|913028|P3|COMPLETED|Treatment Period 1 (6 Days)||4
371918|NCT02036775|913029|P2|COMPLETED|Treatment Period 1 (6 Days)||4
371919|NCT02036775|913030|P1|COMPLETED|Treatment Period 1 (6 Days)||4
371920|NCT02036775|913025|P6|STARTED|Treatment Period 1 (6 Days)||4
371921|NCT02036775|913026|P5|STARTED|Treatment Period 1 (6 Days)||4
371922|NCT02036775|913027|P4|STARTED|Treatment Period 1 (6 Days)||4
371923|NCT02036775|913028|P3|STARTED|Treatment Period 1 (6 Days)||4
371924|NCT02036775|913029|P2|STARTED|Treatment Period 1 (6 Days)||4
371925|NCT02036775|913030|P1|STARTED|Treatment Period 1 (6 Days)||4
371926|NCT02036580|913071|P3|NOT COMPLETED|Overall Study||0
371927|NCT02036580|913072|P2|NOT COMPLETED|Overall Study||1
371928|NCT02036580|913073|P1|NOT COMPLETED|Overall Study||1
371929|NCT02036580|913071|P3|COMPLETED|Overall Study||4
371930|NCT02036580|913072|P2|COMPLETED|Overall Study||7
371931|NCT02036580|913073|P1|COMPLETED|Overall Study||7
371932|NCT02036580|913071|P3|STARTED|Overall Study||4
371933|NCT02036580|913072|P2|STARTED|Overall Study||8
371934|NCT02036580|913073|P1|STARTED|Overall Study||8
371935|NCT02036541|913086|P1|NOT COMPLETED|Overall Study||16
371936|NCT02036541|913086|P1|COMPLETED|Overall Study||49
371937|NCT02036541|913086|P1|Completed Endpoint Visit|Overall Study||54
371938|NCT02036541|913086|P1|STARTED|Overall Study||65
371939|NCT02036515|913094|P3|NOT COMPLETED|Overall Study||14
371940|NCT02036515|913095|P2|NOT COMPLETED|Overall Study||12
371941|NCT02036515|913096|P1|NOT COMPLETED|Overall Study||5
371942|NCT02036515|913094|P3|COMPLETED|Overall Study||139
371943|NCT02036515|913095|P2|COMPLETED|Overall Study||143
371944|NCT02036515|913096|P1|COMPLETED|Overall Study||151
371945|NCT02036515|913094|P3|Treated|Overall Study||153
371946|NCT02036515|913095|P2|Treated|Overall Study||153
371947|NCT02036515|913096|P1|Treated|Overall Study||156
371948|NCT02036515|913094|P3|STARTED|Overall Study||153
371949|NCT02036515|913095|P2|STARTED|Overall Study||155
371950|NCT02036515|913096|P1|STARTED|Overall Study||156
371951|NCT02036424|913175|P2|NOT COMPLETED|Overall Study||0
371952|NCT02036424|913176|P1|NOT COMPLETED|Overall Study||0
371953|NCT02036424|913175|P2|COMPLETED|Overall Study|27 study eyes, not number of subjects|27
371954|NCT02036424|913176|P1|COMPLETED|Overall Study|23 study eyes, not number of subjects|23
371955|NCT02036424|913175|P2|STARTED|Overall Study|27 study eyes, not number of subjects|27
371956|NCT02036424|913176|P1|STARTED|Overall Study|23 study eyes, not number of subjects|23
371957|NCT02036320|913184|P2|NOT COMPLETED|Period 2||0
371958|NCT02036320|913185|P1|NOT COMPLETED|Period 2||0
371959|NCT02036320|913184|P2|COMPLETED|Period 2||95
371960|NCT02036320|913185|P1|COMPLETED|Period 2||95
371961|NCT02036320|913184|P2|STARTED|Period 2||95
371962|NCT02036320|913185|P1|STARTED|Period 2||95
371963|NCT02036320|913184|P2|NOT COMPLETED|Period 1||0
371964|NCT02036320|913185|P1|NOT COMPLETED|Period 1||0
371965|NCT02036320|913184|P2|COMPLETED|Period 1||95
371966|NCT02036320|913185|P1|COMPLETED|Period 1||95
371967|NCT02036320|913184|P2|STARTED|Period 1||95
371968|NCT02036320|913185|P1|STARTED|Period 1||95
371969|NCT02035748|913195|P1|NOT COMPLETED|Overall Study||20
371970|NCT02035748|913195|P1|COMPLETED|Overall Study||448
371971|NCT02035748|913195|P1|STARTED|Overall Study||468
371972|NCT02035696|913209|P4|NOT COMPLETED|Overall Study||3
371973|NCT02035696|913210|P3|NOT COMPLETED|Overall Study||3
371974|NCT02035696|913211|P2|NOT COMPLETED|Overall Study||3
371975|NCT02035696|913212|P1|NOT COMPLETED|Overall Study||3
371976|NCT02035696|913209|P4|COMPLETED|Overall Study||161
371977|NCT02035696|913210|P3|COMPLETED|Overall Study||164
371978|NCT02035696|913211|P2|COMPLETED|Overall Study||163
371979|NCT02035696|913212|P1|COMPLETED|Overall Study||171
371980|NCT02035696|913209|P4|STARTED|Overall Study||164
371981|NCT02035696|913210|P3|STARTED|Overall Study||167
371982|NCT02035696|913211|P2|STARTED|Overall Study||166
371983|NCT02035696|913212|P1|STARTED|Overall Study||174
371984|NCT02035553|913268|P2|NOT COMPLETED|Overall Study||23
371985|NCT02035553|913269|P1|NOT COMPLETED|Overall Study||18
371986|NCT02035553|913268|P2|COMPLETED|Overall Study||67
371987|NCT02035553|913269|P1|COMPLETED|Overall Study||73
371988|NCT02035553|913268|P2|STARTED|Overall Study||90
371989|NCT02035553|913269|P1|STARTED|Overall Study||91
371990|NCT02035475|913275|P1|NOT COMPLETED|Overall Study||6
371991|NCT02035475|913275|P1|COMPLETED|Overall Study|Six subjects did not complete the study due to withdrawal of consent.|114
371992|NCT02035475|913275|P1|STARTED|Overall Study|120 subjects were consented for participation in the study.|120
371993|NCT02035345|913281|P1|NOT COMPLETED|Overall Study||0
371994|NCT02035345|913281|P1|COMPLETED|Overall Study||15
371995|NCT02035345|913281|P1|STARTED|Overall Study||15
371996|NCT02035332|913286|P1|NOT COMPLETED|Overall Study||1
371997|NCT02035332|913286|P1|COMPLETED|Overall Study|Completed 12 Month Follow-up|20
371998|NCT02035332|913286|P1|Treated|Overall Study|Treatment Completed|20
371999|NCT02035332|913286|P1|STARTED|Overall Study|Treatment Attempted|21
372000|NCT02034916|913294|P2|NOT COMPLETED|Overall Study||35
372001|NCT02034916|913295|P1|NOT COMPLETED|Overall Study||49
372002|NCT02034916|913294|P2|COMPLETED|Overall Study||0
372003|NCT02034916|913295|P1|COMPLETED|Overall Study||0
372004|NCT02034916|913294|P2|Treated|Overall Study||35
372005|NCT02034916|913295|P1|Treated|Overall Study||48
372006|NCT02034916|913294|P2|STARTED|Overall Study||35
372007|NCT02034916|913295|P1|STARTED|Overall Study||49
372008|NCT02034877|913330|P2|NOT COMPLETED|Overall Study||6
372009|NCT02034877|913331|P1|NOT COMPLETED|Overall Study||0
372010|NCT02034877|913330|P2|COMPLETED|Overall Study||993
372011|NCT02034877|913331|P1|COMPLETED|Overall Study||200
372012|NCT02034877|913330|P2|STARTED|Overall Study||999
372013|NCT02034877|913331|P1|STARTED|Overall Study||200
372014|NCT02034799|913349|P2|NOT COMPLETED|Overall Study||4
372015|NCT02034799|913350|P1|NOT COMPLETED|Overall Study||2
372016|NCT02034799|913349|P2|COMPLETED|Overall Study||123
372017|NCT02034799|913350|P1|COMPLETED|Overall Study||127
372018|NCT02034799|913349|P2|STARTED|Overall Study||127
372019|NCT02034799|913350|P1|STARTED|Overall Study||129
372020|NCT02034708|913364|P2|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0
372021|NCT02034708|913365|P1|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0
372022|NCT02034708|913364|P2|COMPLETED|Second Contrast Agent Injection (1 Day)||120
372023|NCT02034708|913365|P1|COMPLETED|Second Contrast Agent Injection (1 Day)||129
372024|NCT02034708|913364|P2|STARTED|Second Contrast Agent Injection (1 Day)||120
372025|NCT02034708|913365|P1|STARTED|Second Contrast Agent Injection (1 Day)||129
372026|NCT02034708|913364|P2|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||10
372027|NCT02034708|913365|P1|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||9
372028|NCT02034708|913364|P2|COMPLETED|Wash-out (From 2 Days up to 14 Days)||120
372029|NCT02034708|913365|P1|COMPLETED|Wash-out (From 2 Days up to 14 Days)||129
372030|NCT02034708|913364|P2|STARTED|Wash-out (From 2 Days up to 14 Days)||130
372031|NCT02034708|913365|P1|STARTED|Wash-out (From 2 Days up to 14 Days)||138
372032|NCT02034708|913364|P2|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0
372033|NCT02034708|913365|P1|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0
372034|NCT02034708|913364|P2|COMPLETED|First Contrast Agent Injection (1 Day)||130
372035|NCT02034708|913365|P1|COMPLETED|First Contrast Agent Injection (1 Day)||138
372036|NCT02034708|913364|P2|STARTED|First Contrast Agent Injection (1 Day)||130
372037|NCT02034708|913365|P1|STARTED|First Contrast Agent Injection (1 Day)||138
372038|NCT02034591|913376|P6|NOT COMPLETED|Overall Study||0
372039|NCT02034591|913377|P5|NOT COMPLETED|Overall Study||1
372040|NCT02034591|913378|P4|NOT COMPLETED|Overall Study||0
372041|NCT02034591|913379|P3|NOT COMPLETED|Overall Study||0
372042|NCT02034591|913380|P2|NOT COMPLETED|Overall Study||0
372043|NCT02034591|913381|P1|NOT COMPLETED|Overall Study||0
372044|NCT02034591|913376|P6|COMPLETED|Overall Study||3
372045|NCT02034591|913377|P5|COMPLETED|Overall Study||3
372046|NCT02034591|913378|P4|COMPLETED|Overall Study||3
372047|NCT02034591|913379|P3|COMPLETED|Overall Study||4
372048|NCT02034591|913380|P2|COMPLETED|Overall Study||3
372049|NCT02034591|913381|P1|COMPLETED|Overall Study||4
372050|NCT02034591|913376|P6|STARTED|Overall Study||3
372051|NCT02034591|913377|P5|STARTED|Overall Study||4
372052|NCT02034591|913378|P4|STARTED|Overall Study||3
372053|NCT02034591|913379|P3|STARTED|Overall Study||4
372054|NCT02034591|913380|P2|STARTED|Overall Study||3
372055|NCT02034591|913381|P1|STARTED|Overall Study||4
372056|NCT02034578|913404|P6|NOT COMPLETED|Overall Study||0
372057|NCT02034578|913405|P5|NOT COMPLETED|Overall Study||0
372058|NCT02034578|913406|P4|NOT COMPLETED|Overall Study||0
372059|NCT02034578|913407|P3|NOT COMPLETED|Overall Study||0
372060|NCT02034578|913408|P2|NOT COMPLETED|Overall Study||0
372061|NCT02034578|913409|P1|NOT COMPLETED|Overall Study||0
372062|NCT02034578|913404|P6|COMPLETED|Overall Study||3
372063|NCT02034578|913405|P5|COMPLETED|Overall Study||4
372064|NCT02034578|913406|P4|COMPLETED|Overall Study||3
372065|NCT02034578|913407|P3|COMPLETED|Overall Study||4
372066|NCT02034578|913408|P2|COMPLETED|Overall Study||3
372067|NCT02034578|913409|P1|COMPLETED|Overall Study||4
372068|NCT02034578|913404|P6|STARTED|Overall Study||3
372069|NCT02034578|913405|P5|STARTED|Overall Study||4
372070|NCT02034578|913406|P4|STARTED|Overall Study||3
372071|NCT02034578|913407|P3|STARTED|Overall Study||4
372072|NCT02034578|913408|P2|STARTED|Overall Study||3
372073|NCT02034578|913409|P1|STARTED|Overall Study||4
372074|NCT02034565|913436|P2|NOT COMPLETED|Overall Study||0
372075|NCT02034565|913437|P1|NOT COMPLETED|Overall Study||1
372076|NCT02034565|913436|P2|COMPLETED|Overall Study||7
372077|NCT02034565|913437|P1|COMPLETED|Overall Study||6
372078|NCT02034565|913436|P2|STARTED|Overall Study||7
372079|NCT02034565|913437|P1|STARTED|Overall Study||7
372080|NCT02034552|913454|P3|NOT COMPLETED|Overall Study||15
372081|NCT02034552|913455|P2|NOT COMPLETED|Overall Study||17
372082|NCT02034552|913456|P1|NOT COMPLETED|Overall Study||6
372083|NCT02034552|913454|P3|COMPLETED|Overall Study||7
372084|NCT02034552|913455|P2|COMPLETED|Overall Study||7
372085|NCT02034552|913456|P1|COMPLETED|Overall Study||16
372086|NCT02034552|913454|P3|Received Treatment|Overall Study||22
372087|NCT02034552|913455|P2|Received Treatment|Overall Study||22
372088|NCT02034552|913456|P1|Received Treatment|Overall Study||19
372089|NCT02034552|913454|P3|STARTED|Overall Study||22
372090|NCT02034552|913455|P2|STARTED|Overall Study||24
372091|NCT02034552|913456|P1|STARTED|Overall Study||22
372092|NCT02034513|913481|P2|NOT COMPLETED|Overall Study||57
372093|NCT02034513|913482|P1|NOT COMPLETED|Overall Study||49
372094|NCT02034513|913481|P2|COMPLETED|Overall Study||195
372095|NCT02034513|913482|P1|COMPLETED|Overall Study||200
372096|NCT02034513|913481|P2|Exposed|Overall Study||251
372097|NCT02034513|913482|P1|Exposed|Overall Study||249
372098|NCT02034513|913481|P2|STARTED|Overall Study||252
372099|NCT02034513|913482|P1|STARTED|Overall Study||249
372100|NCT02034162|913500|P3|NOT COMPLETED|Open-label||0
372101|NCT02034162|913501|P2|NOT COMPLETED|Open-label||0
372102|NCT02034162|913502|P1|NOT COMPLETED|Open-label||0
372103|NCT02034162|913500|P3|COMPLETED|Open-label||278
372104|NCT02034162|913501|P2|COMPLETED|Open-label||0
372105|NCT02034162|913502|P1|COMPLETED|Open-label||0
372106|NCT02034162|913500|P3|STARTED|Open-label||278
372107|NCT02034162|913501|P2|STARTED|Open-label||0
372108|NCT02034162|913502|P1|STARTED|Open-label||0
372109|NCT02034162|913500|P3|NOT COMPLETED|Double-blind||0
372110|NCT02034162|913501|P2|NOT COMPLETED|Double-blind||8
372111|NCT02034162|913502|P1|NOT COMPLETED|Double-blind||9
372112|NCT02034162|913500|P3|COMPLETED|Double-blind||0
372113|NCT02034162|913501|P2|COMPLETED|Double-blind||141
372114|NCT02034162|913502|P1|COMPLETED|Double-blind||137
372115|NCT02034162|913500|P3|STARTED|Double-blind||0
372116|NCT02034162|913501|P2|STARTED|Double-blind||149
372117|NCT02034162|913502|P1|STARTED|Double-blind||146
372118|NCT02033499|913533|P3|NOT COMPLETED|Overall Study||9
372119|NCT02033499|913534|P2|NOT COMPLETED|Overall Study||8
372120|NCT02033499|913535|P1|NOT COMPLETED|Overall Study||5
372121|NCT02033499|913533|P3|COMPLETED|Overall Study||139
372122|NCT02033499|913534|P2|COMPLETED|Overall Study||142
372123|NCT02033499|913535|P1|COMPLETED|Overall Study||147
372124|NCT02033499|913533|P3|STARTED|Overall Study||148
372125|NCT02033499|913534|P2|STARTED|Overall Study||150
372126|NCT02033499|913535|P1|STARTED|Overall Study||152
372127|NCT02033369|913575|P2|NOT COMPLETED|Overall Study||5
372128|NCT02033369|913576|P1|NOT COMPLETED|Overall Study||5
372129|NCT02033369|913575|P2|COMPLETED|Overall Study||21
372130|NCT02033369|913576|P1|COMPLETED|Overall Study||21
372131|NCT02033369|913575|P2|STARTED|Overall Study||26
372132|NCT02033369|913576|P1|STARTED|Overall Study||26
372133|NCT02033317|913586|P1|NOT COMPLETED|Overall Study||0
372134|NCT02033317|913586|P1|COMPLETED|Overall Study||6
372135|NCT02033317|913586|P1|STARTED|Overall Study||6
372136|NCT02033213|913593|P2|NOT COMPLETED|Overall Study||0
372137|NCT02033213|913594|P1|NOT COMPLETED|Overall Study||0
372138|NCT02033213|913593|P2|COMPLETED|Overall Study||8
372139|NCT02033213|913594|P1|COMPLETED|Overall Study||8
372140|NCT02033213|913593|P2|STARTED|Overall Study||8
372141|NCT02033213|913594|P1|STARTED|Overall Study||8
372142|NCT02033200|913612|P2|NOT COMPLETED|Overall Study||0
372143|NCT02033200|913613|P1|NOT COMPLETED|Overall Study||0
372144|NCT02033200|913612|P2|COMPLETED|Overall Study||40
372145|NCT02033200|913613|P1|COMPLETED|Overall Study||40
372146|NCT02033200|913612|P2|STARTED|Overall Study||40
372147|NCT02033200|913613|P1|STARTED|Overall Study||40
372148|NCT02033174|913633|P2|NOT COMPLETED|Second Intervention||0
372149|NCT02033174|913634|P1|NOT COMPLETED|Second Intervention||0
372150|NCT02033174|913633|P2|COMPLETED|Second Intervention||8
372151|NCT02033174|913634|P1|COMPLETED|Second Intervention||8
372152|NCT02033174|913633|P2|STARTED|Second Intervention||8
372153|NCT02033174|913634|P1|STARTED|Second Intervention||8
372154|NCT02033174|913633|P2|NOT COMPLETED|Washout (1 Week)||0
372155|NCT02033174|913634|P1|NOT COMPLETED|Washout (1 Week)||0
372156|NCT02033174|913633|P2|COMPLETED|Washout (1 Week)||8
372157|NCT02033174|913634|P1|COMPLETED|Washout (1 Week)||8
372158|NCT02033174|913633|P2|STARTED|Washout (1 Week)||8
372159|NCT02033174|913634|P1|STARTED|Washout (1 Week)||8
372160|NCT02033174|913633|P2|NOT COMPLETED|First Intervention||0
372161|NCT02033174|913634|P1|NOT COMPLETED|First Intervention||0
372162|NCT02033174|913633|P2|COMPLETED|First Intervention||8
372163|NCT02033174|913634|P1|COMPLETED|First Intervention||8
372164|NCT02033174|913633|P2|STARTED|First Intervention||8
372165|NCT02033174|913634|P1|STARTED|First Intervention||8
372166|NCT02032901|913642|P2|NOT COMPLETED|Follow-Up Period (24 Weeks)||1
372167|NCT02032901|913643|P1|NOT COMPLETED|Follow-Up Period (24 Weeks)||0
372168|NCT02032901|913642|P2|COMPLETED|Follow-Up Period (24 Weeks)||50
372169|NCT02032901|913643|P1|COMPLETED|Follow-Up Period (24 Weeks)||101
372170|NCT02032901|913642|P2|STARTED|Follow-Up Period (24 Weeks)||51
372171|NCT02032901|913643|P1|STARTED|Follow-Up Period (24 Weeks)|Participant could enter follow up period even if the treatment period was not completed.|101
372172|NCT02032901|913642|P2|NOT COMPLETED|Treatment Period (12 Weeks)||0
372173|NCT02032901|913643|P1|NOT COMPLETED|Treatment Period (12 Weeks)||1
372174|NCT02032901|913642|P2|COMPLETED|Treatment Period (12 Weeks)||51
372175|NCT02032901|913643|P1|COMPLETED|Treatment Period (12 Weeks)||100
372176|NCT02032901|913642|P2|STARTED|Treatment Period (12 Weeks)||51
372177|NCT02032901|913643|P1|STARTED|Treatment Period (12 Weeks)||101
372178|NCT02032888|913667|P3|NOT COMPLETED|Follow-up Period||0
372179|NCT02032888|913668|P2|NOT COMPLETED|Follow-up Period||2
372180|NCT02032888|913669|P1|NOT COMPLETED|Follow-up Period||3
372181|NCT02032888|913667|P3|COMPLETED|Follow-up Period||52
372182|NCT02032888|913668|P2|COMPLETED|Follow-up Period||47
372183|NCT02032888|913669|P1|COMPLETED|Follow-up Period||97
372184|NCT02032888|913667|P3|STARTED|Follow-up Period||52
372185|NCT02032888|913668|P2|STARTED|Follow-up Period|All patients who received study drug and not a nonstudy HCV therapy before treatment Week 4|49
372186|NCT02032888|913669|P1|STARTED|Follow-up Period|All patients who received study drug and not a nonstudy HCV therapy before treatment Week 4|100
372187|NCT02032888|913667|P3|NOT COMPLETED|Treatment Period||0
372188|NCT02032888|913668|P2|NOT COMPLETED|Treatment Period||2
372189|NCT02032888|913669|P1|NOT COMPLETED|Treatment Period||2
372190|NCT02032888|913667|P3|COMPLETED|Treatment Period||52
372191|NCT02032888|913668|P2|COMPLETED|Treatment Period||48
372192|NCT02032888|913669|P1|COMPLETED|Treatment Period||99
372193|NCT02032888|913667|P3|STARTED|Treatment Period||52
372194|NCT02032888|913668|P2|STARTED|Treatment Period||50
372195|NCT02032888|913669|P1|STARTED|Treatment Period||101
372196|NCT02032875|913700|P2|NOT COMPLETED|Follow-up Period||11
372197|NCT02032875|913701|P1|NOT COMPLETED|Follow-up Period||3
372198|NCT02032875|913700|P2|COMPLETED|Follow-up Period||46
372199|NCT02032875|913701|P1|COMPLETED|Follow-up Period||50
372200|NCT02032875|913700|P2|STARTED|Follow-up Period|Of 60 participants in treatment period, 57 continued in follow-up, 3 entered treatment extension.|57
372201|NCT02032875|913701|P1|STARTED|Follow-up Period|Out of 53 participants who entered the treatment period, all 53 continued in the follow-up period.|53
372202|NCT02032875|913700|P2|NOT COMPLETED|Treatment Period||4
372203|NCT02032875|913701|P1|NOT COMPLETED|Treatment Period||1
372204|NCT02032875|913700|P2|COMPLETED|Treatment Period||56
372205|NCT02032875|913701|P1|COMPLETED|Treatment Period||52
372206|NCT02032875|913700|P2|STARTED|Treatment Period||60
372207|NCT02032875|913701|P1|STARTED|Treatment Period||53
372208|NCT02032758|913721|P2|NOT COMPLETED|Overall Study||0
372209|NCT02032758|913722|P1|NOT COMPLETED|Overall Study||0
372210|NCT02032758|913721|P2|COMPLETED|Overall Study||11
372211|NCT02032758|913722|P1|COMPLETED|Overall Study||27
372212|NCT02032758|913721|P2|STARTED|Overall Study||11
372213|NCT02032758|913722|P1|STARTED|Overall Study||27
372214|NCT02032706|913730|P1|NOT COMPLETED|Overall Study||6
372215|NCT02032706|913730|P1|COMPLETED|Overall Study||30
372216|NCT02032706|913730|P1|STARTED|Overall Study||36
372217|NCT02032641|913743|P1|NOT COMPLETED|Overall Study||1
372218|NCT02032641|913743|P1|COMPLETED|Overall Study|16 brows completed study (half underwent treatment, half were control)|8
372219|NCT02032641|913743|P1|STARTED|Overall Study|18 Brows enrolled for evaluation|9
372220|NCT02032433|913755|P2|NOT COMPLETED|Overall Study||0
372221|NCT02032433|913756|P1|NOT COMPLETED|Overall Study||0
372222|NCT02032433|913755|P2|COMPLETED|Overall Study||287
372223|NCT02032433|913756|P1|COMPLETED|Overall Study||283
372224|NCT02032433|913755|P2|STARTED|Overall Study||287
372225|NCT02032433|913756|P1|STARTED|Overall Study||283
372226|NCT02032420|913774|P2|NOT COMPLETED|Overall Study||0
372227|NCT02032420|913775|P1|NOT COMPLETED|Overall Study||0
372228|NCT02032420|913774|P2|COMPLETED|Overall Study||17
372229|NCT02032420|913775|P1|COMPLETED|Overall Study||18
372230|NCT02032420|913774|P2|STARTED|Overall Study||17
372231|NCT02032420|913775|P1|STARTED|Overall Study||18
372232|NCT02032407|913787|P1|NOT COMPLETED|Overall Study||5
372233|NCT02032407|913787|P1|COMPLETED|Overall Study||63
372234|NCT02032407|913787|P1|STARTED|Overall Study||68
372235|NCT02032238|913800|P2|NOT COMPLETED|Overall Study||0
372236|NCT02032238|913801|P1|NOT COMPLETED|Overall Study||2
372237|NCT02032238|913800|P2|COMPLETED|Overall Study||0
372238|NCT02032238|913801|P1|COMPLETED|Overall Study||10
372239|NCT02032238|913800|P2|STARTED|Overall Study|Study Terminated due to slow enrollment, no subjects enrolled in this study arm|0
372240|NCT02032238|913801|P1|STARTED|Overall Study||12
372241|NCT02032212|913811|P4|NOT COMPLETED|Overall Study||0
372242|NCT02032212|913812|P3|NOT COMPLETED|Overall Study||0
372243|NCT02032212|913813|P2|NOT COMPLETED|Overall Study||0
372244|NCT02032212|913814|P1|NOT COMPLETED|Overall Study||0
372245|NCT02032212|913811|P4|COMPLETED|Overall Study||3
372246|NCT02032212|913812|P3|COMPLETED|Overall Study||3
372247|NCT02032212|913813|P2|COMPLETED|Overall Study||3
372248|NCT02032212|913814|P1|COMPLETED|Overall Study||3
372249|NCT02032212|913811|P4|STARTED|Overall Study||3
372250|NCT02032212|913812|P3|STARTED|Overall Study||3
372251|NCT02032212|913813|P2|STARTED|Overall Study||3
372252|NCT02032212|913814|P1|STARTED|Overall Study||3
372253|NCT02031679|913842|P2|NOT COMPLETED|Overall Study||2
372254|NCT02031679|913843|P1|NOT COMPLETED|Overall Study||0
372255|NCT02031679|913842|P2|COMPLETED|Overall Study||12
372256|NCT02031679|913843|P1|COMPLETED|Overall Study||14
372257|NCT02031679|913842|P2|STARTED|Overall Study||14
372258|NCT02031679|913843|P1|STARTED|Overall Study||14
372259|NCT02031640|913858|P6|NOT COMPLETED|Double-blind Treatment Period||3
372260|NCT02031640|913859|P5|NOT COMPLETED|Double-blind Treatment Period||11
372261|NCT02031640|913860|P4|NOT COMPLETED|Double-blind Treatment Period||7
372262|NCT02031640|913861|P3|NOT COMPLETED|Double-blind Treatment Period||6
372263|NCT02031640|913862|P2|NOT COMPLETED|Double-blind Treatment Period||22
372264|NCT02031640|913863|P1|NOT COMPLETED|Double-blind Treatment Period||0
372265|NCT02031640|913858|P6|COMPLETED|Double-blind Treatment Period||104
372266|NCT02031640|913859|P5|COMPLETED|Double-blind Treatment Period||96
372267|NCT02031640|913860|P4|COMPLETED|Double-blind Treatment Period||99
372268|NCT02031640|913861|P3|COMPLETED|Double-blind Treatment Period||100
372269|NCT02031640|913862|P2|COMPLETED|Double-blind Treatment Period||84
372270|NCT02031640|913863|P1|COMPLETED|Double-blind Treatment Period||0
372271|NCT02031640|913858|P6|Full Analysis Set|Double-blind Treatment Period||107
372272|NCT02031640|913859|P5|Full Analysis Set|Double-blind Treatment Period||106
372273|NCT02031640|913860|P4|Full Analysis Set|Double-blind Treatment Period||106
372274|NCT02031640|913861|P3|Full Analysis Set|Double-blind Treatment Period||104
372275|NCT02031640|913862|P2|Full Analysis Set|Double-blind Treatment Period||106
372276|NCT02031640|913863|P1|Full Analysis Set|Double-blind Treatment Period||0
372277|NCT02031640|913858|P6|STARTED|Double-blind Treatment Period||107
372278|NCT02031640|913859|P5|STARTED|Double-blind Treatment Period||107
372279|NCT02031640|913860|P4|STARTED|Double-blind Treatment Period||106
372280|NCT02031640|913861|P3|STARTED|Double-blind Treatment Period||106
372281|NCT02031640|913862|P2|STARTED|Double-blind Treatment Period||106
372282|NCT02031640|913863|P1|STARTED|Double-blind Treatment Period||0
372283|NCT02031640|913858|P6|NOT COMPLETED|Run-In Period||0
372284|NCT02031640|913859|P5|NOT COMPLETED|Run-In Period||0
372285|NCT02031640|913860|P4|NOT COMPLETED|Run-In Period||0
372286|NCT02031640|913861|P3|NOT COMPLETED|Run-In Period||0
372287|NCT02031640|913862|P2|NOT COMPLETED|Run-In Period||0
372288|NCT02031640|913863|P1|NOT COMPLETED|Run-In Period||169
372289|NCT02031640|913858|P6|COMPLETED|Run-In Period||0
372290|NCT02031640|913859|P5|COMPLETED|Run-In Period||0
372291|NCT02031640|913860|P4|COMPLETED|Run-In Period||0
372292|NCT02031640|913861|P3|COMPLETED|Run-In Period||0
372293|NCT02031640|913862|P2|COMPLETED|Run-In Period||0
372294|NCT02031640|913863|P1|COMPLETED|Run-In Period||532
372295|NCT02031640|913858|P6|STARTED|Run-In Period||0
372296|NCT02031640|913859|P5|STARTED|Run-In Period||0
372297|NCT02031640|913860|P4|STARTED|Run-In Period||0
372298|NCT02031640|913861|P3|STARTED|Run-In Period||0
372299|NCT02031640|913862|P2|STARTED|Run-In Period||0
372300|NCT02031640|913863|P1|STARTED|Run-In Period||701
372301|NCT02031640|913858|P6|NOT COMPLETED|Screening Period||0
372302|NCT02031640|913859|P5|NOT COMPLETED|Screening Period||0
372303|NCT02031640|913860|P4|NOT COMPLETED|Screening Period||0
372304|NCT02031640|913861|P3|NOT COMPLETED|Screening Period||0
372305|NCT02031640|913862|P2|NOT COMPLETED|Screening Period||0
372306|NCT02031640|913863|P1|NOT COMPLETED|Screening Period||412
372307|NCT02031640|913858|P6|COMPLETED|Screening Period||0
372308|NCT02031640|913859|P5|COMPLETED|Screening Period||0
372309|NCT02031640|913860|P4|COMPLETED|Screening Period||0
372310|NCT02031640|913861|P3|COMPLETED|Screening Period||0
372311|NCT02031640|913862|P2|COMPLETED|Screening Period||0
372312|NCT02031640|913863|P1|COMPLETED|Screening Period||701
372313|NCT02031640|913858|P6|STARTED|Screening Period||0
372314|NCT02031640|913859|P5|STARTED|Screening Period||0
372315|NCT02031640|913860|P4|STARTED|Screening Period||0
372316|NCT02031640|913861|P3|STARTED|Screening Period||0
372317|NCT02031640|913862|P2|STARTED|Screening Period||0
372318|NCT02031640|913863|P1|STARTED|Screening Period|Consented|1113
372319|NCT02031471|913906|P1|NOT COMPLETED|Long Term Extension (LTE) Period||2
372320|NCT02031471|913906|P1|COMPLETED|Long Term Extension (LTE) Period||37
372321|NCT02031471|913906|P1|STARTED|Long Term Extension (LTE) Period|Only participants who achieved at least a moderate EULAR response at Week 24 entered the LTE Period.|39
372322|NCT02031471|913906|P1|NOT COMPLETED|24 Week Treatment Period||11
372323|NCT02031471|913906|P1|COMPLETED|24 Week Treatment Period||46
372324|NCT02031471|913906|P1|STARTED|24 Week Treatment Period||57
372325|NCT02031458|913939|P3|NOT COMPLETED|Overall Study||253
372326|NCT02031458|913940|P2|NOT COMPLETED|Overall Study||267
372327|NCT02031458|913941|P1|NOT COMPLETED|Overall Study||139
372328|NCT02031458|913939|P3|COMPLETED|Overall Study||0
372329|NCT02031458|913940|P2|COMPLETED|Overall Study||0
372330|NCT02031458|913941|P1|COMPLETED|Overall Study||0
372331|NCT02031458|913939|P3|STARTED|Overall Study||253
372332|NCT02031458|913940|P2|STARTED|Overall Study||267
372333|NCT02031458|913941|P1|STARTED|Overall Study||139
372334|NCT02030600|914037|P2|NOT COMPLETED|Treatment Period 2||18
372335|NCT02030600|914038|P1|NOT COMPLETED|Treatment Period 2||25
372336|NCT02030600|914037|P2|COMPLETED|Treatment Period 2||297
372337|NCT02030600|914038|P1|COMPLETED|Treatment Period 2||283
372338|NCT02030600|914037|P2|STARTED|Treatment Period 2||315
372339|NCT02030600|914038|P1|STARTED|Treatment Period 2||308
372340|NCT02030600|914037|P2|NOT COMPLETED|Treatment Period 1||45
372341|NCT02030600|914038|P1|NOT COMPLETED|Treatment Period 1||53
372342|NCT02030600|914037|P2|COMPLETED|Treatment Period 1||315
372343|NCT02030600|914038|P1|COMPLETED|Treatment Period 1||308
372344|NCT02030600|914037|P2|Exposed|Treatment Period 1||357
372345|NCT02030600|914038|P1|Exposed|Treatment Period 1||356
372346|NCT02030600|914037|P2|STARTED|Treatment Period 1||360
372347|NCT02030600|914038|P1|STARTED|Treatment Period 1||361
372348|NCT02030574|914054|P1|NOT COMPLETED|Overall Study||0
372349|NCT02030574|914054|P1|COMPLETED|Overall Study||2
372350|NCT02030574|914054|P1|STARTED|Overall Study||2
372351|NCT02030535|914059|P1|NOT COMPLETED|Treatment Period 3 (1 Day)||0
372352|NCT02030535|914059|P1|COMPLETED|Treatment Period 3 (1 Day)||52
372353|NCT02030535|914059|P1|STARTED|Treatment Period 3 (1 Day)||52
372354|NCT02030535|914059|P1|NOT COMPLETED|Washout Period 2 (21 Days)||0
372355|NCT02030535|914059|P1|COMPLETED|Washout Period 2 (21 Days)||52
372356|NCT02030535|914059|P1|STARTED|Washout Period 2 (21 Days)||52
372357|NCT02030535|914059|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
372358|NCT02030535|914059|P1|COMPLETED|Treatment Period 2 (1 Day)||52
372359|NCT02030535|914059|P1|STARTED|Treatment Period 2 (1 Day)||52
372360|NCT02030535|914059|P1|NOT COMPLETED|Washout Period 1 (21 Days)||1
372361|NCT02030535|914059|P1|COMPLETED|Washout Period 1 (21 Days)||52
372362|NCT02030535|914059|P1|STARTED|Washout Period 1 (21 Days)||53
372363|NCT02030535|914059|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
372364|NCT02030535|914059|P1|COMPLETED|Treatment Period 1 (1 Day)||53
372365|NCT02030535|914059|P1|STARTED|Treatment Period 1 (1 Day)||53
372366|NCT02030405|914127|P1|NOT COMPLETED|Overall Study||2
372367|NCT02030405|914127|P1|COMPLETED|Overall Study||2
372368|NCT02030405|914127|P1|STARTED|Overall Study||4
372369|NCT02030119|914136|P4|NOT COMPLETED|Overall Study||3
372370|NCT02030119|914137|P3|NOT COMPLETED|Overall Study||6
372371|NCT02030119|914138|P2|NOT COMPLETED|Overall Study||2
372372|NCT02030119|914139|P1|NOT COMPLETED|Overall Study||3
372373|NCT02030119|914136|P4|COMPLETED|Overall Study||67
372374|NCT02030119|914137|P3|COMPLETED|Overall Study||65
372375|NCT02030119|914138|P2|COMPLETED|Overall Study||68
372376|NCT02030119|914139|P1|COMPLETED|Overall Study||67
372377|NCT02030119|914136|P4|STARTED|Overall Study||70
372378|NCT02030119|914137|P3|STARTED|Overall Study||71
372379|NCT02030119|914138|P2|STARTED|Overall Study||70
372380|NCT02030119|914139|P1|STARTED|Overall Study||70
372381|NCT02030080|914157|P4|NOT COMPLETED|Overall Study||2
372382|NCT02030080|914158|P3|NOT COMPLETED|Overall Study||0
372383|NCT02030080|914159|P2|NOT COMPLETED|Overall Study||0
372384|NCT02030080|914160|P1|NOT COMPLETED|Overall Study||0
372385|NCT02030080|914157|P4|COMPLETED|Overall Study||42
372386|NCT02030080|914158|P3|COMPLETED|Overall Study||80
372387|NCT02030080|914159|P2|COMPLETED|Overall Study||64
372388|NCT02030080|914160|P1|COMPLETED|Overall Study||100
372389|NCT02030080|914157|P4|STARTED|Overall Study|11 teams|44
372390|NCT02030080|914158|P3|STARTED|Overall Study|20 teams|80
372391|NCT02030080|914159|P2|STARTED|Overall Study|16 teams|64
372392|NCT02030080|914160|P1|STARTED|Overall Study|25 teams|100
372393|NCT02030041|914177|P3|NOT COMPLETED|Overall Study||1
372394|NCT02030041|914178|P2|NOT COMPLETED|Overall Study||2
372395|NCT02030041|914179|P1|NOT COMPLETED|Overall Study||2
372396|NCT02030041|914177|P3|COMPLETED|Overall Study||10
372397|NCT02030041|914178|P2|COMPLETED|Overall Study||9
372398|NCT02030041|914179|P1|COMPLETED|Overall Study||9
372399|NCT02030041|914177|P3|STARTED|Overall Study||11
372400|NCT02030041|914178|P2|STARTED|Overall Study||11
372401|NCT02030041|914179|P1|STARTED|Overall Study||11
372402|NCT02029989|914192|P2|NOT COMPLETED|Overall Study||11
372403|NCT02029989|914193|P1|NOT COMPLETED|Overall Study||16
372404|NCT02029989|914192|P2|COMPLETED|Overall Study||49
372405|NCT02029989|914193|P1|COMPLETED|Overall Study||45
372406|NCT02029989|914192|P2|STARTED|Overall Study||60
372407|NCT02029989|914193|P1|STARTED|Overall Study|A subject was given the same ID# as withdrawn subject (ID # counted twice) causing N=61 discrepancy.|61
372408|NCT02029911|914199|P1|NOT COMPLETED|Overall Study||0
372409|NCT02029911|914199|P1|COMPLETED|Overall Study|Completed 12 Month Follow-up|60
372410|NCT02029911|914199|P1|Treated|Overall Study|Treatment Completed|60
372411|NCT02029911|914199|P1|STARTED|Overall Study|Treatment Attempted|60
372412|NCT02029872|914207|P2|NOT COMPLETED|Overall Study||3
372413|NCT02029872|914208|P1|NOT COMPLETED|Overall Study||2
372414|NCT02029872|914207|P2|COMPLETED|Overall Study||6
372415|NCT02029872|914208|P1|COMPLETED|Overall Study||7
372416|NCT02029872|914207|P2|STARTED|Overall Study||9
372417|NCT02029872|914208|P1|STARTED|Overall Study||9
372418|NCT02029846|914216|P2|NOT COMPLETED|Overall Study||1
372419|NCT02029846|914217|P1|NOT COMPLETED|Overall Study||1
372420|NCT02029846|914216|P2|COMPLETED|Overall Study||0
372421|NCT02029846|914217|P1|COMPLETED|Overall Study||0
372422|NCT02029846|914216|P2|STARTED|Overall Study||1
372423|NCT02029846|914217|P1|STARTED|Overall Study||1
372424|NCT02029755|914230|P3|NOT COMPLETED|Overall Study||0
372425|NCT02029755|914231|P2|NOT COMPLETED|Overall Study||0
372426|NCT02029755|914232|P1|NOT COMPLETED|Overall Study||0
372427|NCT02029755|914230|P3|COMPLETED|Overall Study||36
372428|NCT02029755|914231|P2|COMPLETED|Overall Study||36
372429|NCT02029755|914232|P1|COMPLETED|Overall Study||36
372430|NCT02029755|914230|P3|STARTED|Overall Study||36
372431|NCT02029755|914231|P2|STARTED|Overall Study||36
372432|NCT02029755|914232|P1|STARTED|Overall Study||36
372433|NCT02029703|914245|P2|NOT COMPLETED|Overall Study||0
372434|NCT02029703|914246|P1|NOT COMPLETED|Overall Study||0
372435|NCT02029703|914245|P2|COMPLETED|Overall Study||22
372436|NCT02029703|914246|P1|COMPLETED|Overall Study||20
372437|NCT02029703|914245|P2|STARTED|Overall Study||22
372438|NCT02029703|914246|P1|STARTED|Overall Study||20
372439|NCT02029521|914254|P2|NOT COMPLETED|Overall Study||1
372440|NCT02029521|914255|P1|NOT COMPLETED|Overall Study||2
372441|NCT02029521|914254|P2|COMPLETED|Overall Study||22
372442|NCT02029521|914255|P1|COMPLETED|Overall Study||22
372443|NCT02029521|914254|P2|STARTED|Overall Study||23
372444|NCT02029521|914255|P1|STARTED|Overall Study||24
372445|NCT02029495|914340|P3|NOT COMPLETED|Overall Study||2
372446|NCT02029495|914341|P2|NOT COMPLETED|Overall Study||0
372447|NCT02029495|914342|P1|NOT COMPLETED|Overall Study||1
372448|NCT02029495|914340|P3|COMPLETED|Overall Study||159
372449|NCT02029495|914341|P2|COMPLETED|Overall Study||158
372450|NCT02029495|914342|P1|COMPLETED|Overall Study||158
372451|NCT02029495|914340|P3|STARTED|Overall Study||161
372452|NCT02029495|914341|P2|STARTED|Overall Study||158
372453|NCT02029495|914342|P1|STARTED|Overall Study||159
372454|NCT02029417|914353|P1|NOT COMPLETED|Overall Study||2
372455|NCT02029417|914353|P1|COMPLETED|Overall Study||0
372456|NCT02029417|914353|P1|STARTED|Overall Study||2
372457|NCT02029196|914360|P2|NOT COMPLETED|Overall Study||1
372458|NCT02029196|914361|P1|NOT COMPLETED|Overall Study||20
372459|NCT02029196|914360|P2|COMPLETED|Overall Study||101
372460|NCT02029196|914361|P1|COMPLETED|Overall Study||286
372461|NCT02029196|914360|P2|STARTED|Overall Study||102
372462|NCT02029196|914361|P1|STARTED|Overall Study||306
372463|NCT02028780|914381|P12|NOT COMPLETED|Follow up Phase||0
372464|NCT02028780|914382|P11|NOT COMPLETED|Follow up Phase||0
372465|NCT02028780|914383|P10|NOT COMPLETED|Follow up Phase||0
372466|NCT02028780|914384|P9|NOT COMPLETED|Follow up Phase||0
372467|NCT02028780|914385|P8|NOT COMPLETED|Follow up Phase||0
372468|NCT02028780|914386|P7|NOT COMPLETED|Follow up Phase||0
372469|NCT02028780|914387|P6|NOT COMPLETED|Follow up Phase||0
372470|NCT02028780|914388|P5|NOT COMPLETED|Follow up Phase||0
372471|NCT02028780|914389|P4|NOT COMPLETED|Follow up Phase||0
372472|NCT02028780|914390|P3|NOT COMPLETED|Follow up Phase||0
372473|NCT02028780|914391|P2|NOT COMPLETED|Follow up Phase||0
372474|NCT02028780|914392|P1|NOT COMPLETED|Follow up Phase||0
372475|NCT02028780|914381|P12|COMPLETED|Follow up Phase||9
372476|NCT02028780|914382|P11|COMPLETED|Follow up Phase||9
372477|NCT02028780|914383|P10|COMPLETED|Follow up Phase||9
372478|NCT02028780|914384|P9|COMPLETED|Follow up Phase||9
372479|NCT02028780|914385|P8|COMPLETED|Follow up Phase||3
372480|NCT02028780|914386|P7|COMPLETED|Follow up Phase||9
372481|NCT02028780|914387|P6|COMPLETED|Follow up Phase||6
372482|NCT02028780|914388|P5|COMPLETED|Follow up Phase||6
372483|NCT02028780|914389|P4|COMPLETED|Follow up Phase||6
372484|NCT02028780|914390|P3|COMPLETED|Follow up Phase||6
372485|NCT02028780|914391|P2|COMPLETED|Follow up Phase||2
372486|NCT02028780|914392|P1|COMPLETED|Follow up Phase||6
372487|NCT02028780|914381|P12|STARTED|Follow up Phase||9
372488|NCT02028780|914382|P11|STARTED|Follow up Phase||9
372489|NCT02028780|914383|P10|STARTED|Follow up Phase||9
372490|NCT02028780|914384|P9|STARTED|Follow up Phase||9
372491|NCT02028780|914385|P8|STARTED|Follow up Phase||3
372492|NCT02028780|914386|P7|STARTED|Follow up Phase||9
372493|NCT02028780|914387|P6|STARTED|Follow up Phase||6
372494|NCT02028780|914388|P5|STARTED|Follow up Phase||6
372495|NCT02028780|914389|P4|STARTED|Follow up Phase||6
372496|NCT02028780|914390|P3|STARTED|Follow up Phase||6
372497|NCT02028780|914391|P2|STARTED|Follow up Phase||2
372498|NCT02028780|914392|P1|STARTED|Follow up Phase||6
372499|NCT02028780|914381|P12|NOT COMPLETED|Observation Phase||0
372500|NCT02028780|914382|P11|NOT COMPLETED|Observation Phase||0
372501|NCT02028780|914383|P10|NOT COMPLETED|Observation Phase||0
372502|NCT02028780|914384|P9|NOT COMPLETED|Observation Phase||0
372503|NCT02028780|914385|P8|NOT COMPLETED|Observation Phase||0
372504|NCT02028780|914386|P7|NOT COMPLETED|Observation Phase||0
372505|NCT02028780|914387|P6|NOT COMPLETED|Observation Phase||0
372506|NCT02028780|914388|P5|NOT COMPLETED|Observation Phase||0
372507|NCT02028780|914389|P4|NOT COMPLETED|Observation Phase||0
372508|NCT02028780|914390|P3|NOT COMPLETED|Observation Phase||0
372509|NCT02028780|914391|P2|NOT COMPLETED|Observation Phase||0
372510|NCT02028780|914392|P1|NOT COMPLETED|Observation Phase||0
372511|NCT02028780|914381|P12|COMPLETED|Observation Phase||9
372512|NCT02028780|914382|P11|COMPLETED|Observation Phase||9
372513|NCT02028780|914383|P10|COMPLETED|Observation Phase||9
372514|NCT02028780|914384|P9|COMPLETED|Observation Phase||9
372515|NCT02028780|914385|P8|COMPLETED|Observation Phase||3
372516|NCT02028780|914386|P7|COMPLETED|Observation Phase||9
372517|NCT02028780|914387|P6|COMPLETED|Observation Phase||6
372518|NCT02028780|914388|P5|COMPLETED|Observation Phase||6
372519|NCT02028780|914389|P4|COMPLETED|Observation Phase||6
372520|NCT02028780|914390|P3|COMPLETED|Observation Phase||6
372521|NCT02028780|914391|P2|COMPLETED|Observation Phase||2
372522|NCT02028780|914392|P1|COMPLETED|Observation Phase||6
372523|NCT02028780|914381|P12|STARTED|Observation Phase||9
372524|NCT02028780|914382|P11|STARTED|Observation Phase||9
372525|NCT02028780|914383|P10|STARTED|Observation Phase||9
372526|NCT02028780|914384|P9|STARTED|Observation Phase||9
372527|NCT02028780|914385|P8|STARTED|Observation Phase||3
372528|NCT02028780|914386|P7|STARTED|Observation Phase||9
372529|NCT02028780|914387|P6|STARTED|Observation Phase||6
372530|NCT02028780|914388|P5|STARTED|Observation Phase||6
372531|NCT02028780|914389|P4|STARTED|Observation Phase||6
372532|NCT02028780|914390|P3|STARTED|Observation Phase||6
372533|NCT02028780|914391|P2|STARTED|Observation Phase||2
372534|NCT02028780|914392|P1|STARTED|Observation Phase||6
372535|NCT02028767|914457|P2|NOT COMPLETED|Treatment Period 2||0
372536|NCT02028767|914458|P1|NOT COMPLETED|Treatment Period 2||2
372537|NCT02028767|914457|P2|COMPLETED|Treatment Period 2||16
372538|NCT02028767|914458|P1|COMPLETED|Treatment Period 2||14
372539|NCT02028767|914457|P2|STARTED|Treatment Period 2||16
372540|NCT02028767|914458|P1|STARTED|Treatment Period 2||16
372541|NCT02028767|914457|P2|NOT COMPLETED|Treatment Period 1||0
372542|NCT02028767|914458|P1|NOT COMPLETED|Treatment Period 1||0
372543|NCT02028767|914457|P2|COMPLETED|Treatment Period 1||16
372544|NCT02028767|914458|P1|COMPLETED|Treatment Period 1||16
372545|NCT02028767|914457|P2|STARTED|Treatment Period 1||16
372546|NCT02028767|914458|P1|STARTED|Treatment Period 1||16
372547|NCT02028754|914470|P2|NOT COMPLETED|Overall Study||8
372548|NCT02028754|914471|P1|NOT COMPLETED|Overall Study||7
372549|NCT02028754|914470|P2|COMPLETED|Overall Study||82
372550|NCT02028754|914471|P1|COMPLETED|Overall Study||83
372551|NCT02028754|914470|P2|STARTED|Overall Study||90
372552|NCT02028754|914471|P1|STARTED|Overall Study||90
372553|NCT02028676|914498|P9|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
372554|NCT02028676|914499|P8|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
372555|NCT02028676|914500|P7|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
372556|NCT02028676|914501|P6|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
372557|NCT02028676|914502|P5|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
372558|NCT02028676|914503|P4|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
372559|NCT02028676|914504|P3|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
372560|NCT02028676|914505|P2|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
372561|NCT02028676|914506|P1|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
372562|NCT02028676|914498|P9|COMPLETED|Subsequent Cotrimoxazole Randomization||382
372563|NCT02028676|914499|P8|COMPLETED|Subsequent Cotrimoxazole Randomization||376
372564|NCT02028676|914500|P7|COMPLETED|Subsequent Cotrimoxazole Randomization||0
372565|NCT02028676|914501|P6|COMPLETED|Subsequent Cotrimoxazole Randomization||0
372566|NCT02028676|914502|P5|COMPLETED|Subsequent Cotrimoxazole Randomization||0
372567|NCT02028676|914503|P4|COMPLETED|Subsequent Cotrimoxazole Randomization||0
372568|NCT02028676|914504|P3|COMPLETED|Subsequent Cotrimoxazole Randomization||0
372569|NCT02028676|914505|P2|COMPLETED|Subsequent Cotrimoxazole Randomization||0
372570|NCT02028676|914506|P1|COMPLETED|Subsequent Cotrimoxazole Randomization||0
372571|NCT02028676|914498|P9|STARTED|Subsequent Cotrimoxazole Randomization||382
372572|NCT02028676|914499|P8|STARTED|Subsequent Cotrimoxazole Randomization||376
372573|NCT02028676|914500|P7|STARTED|Subsequent Cotrimoxazole Randomization||0
372574|NCT02028676|914501|P6|STARTED|Subsequent Cotrimoxazole Randomization||0
372575|NCT02028676|914502|P5|STARTED|Subsequent Cotrimoxazole Randomization||0
372576|NCT02028676|914503|P4|STARTED|Subsequent Cotrimoxazole Randomization||0
372577|NCT02028676|914504|P3|STARTED|Subsequent Cotrimoxazole Randomization||0
372578|NCT02028676|914505|P2|STARTED|Subsequent Cotrimoxazole Randomization||0
372579|NCT02028676|914506|P1|STARTED|Subsequent Cotrimoxazole Randomization||0
372580|NCT02028676|914498|P9|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
372581|NCT02028676|914499|P8|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
372582|NCT02028676|914500|P7|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
372583|NCT02028676|914501|P6|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
372584|NCT02028676|914502|P5|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
372585|NCT02028676|914503|P4|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
372586|NCT02028676|914504|P3|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
372587|NCT02028676|914505|P2|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
372588|NCT02028676|914506|P1|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
372589|NCT02028676|914498|P9|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
372590|NCT02028676|914499|P8|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
372591|NCT02028676|914500|P7|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||333
372592|NCT02028676|914501|P6|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||336
372593|NCT02028676|914502|P5|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
372594|NCT02028676|914503|P4|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
372595|NCT02028676|914504|P3|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
372596|NCT02028676|914505|P2|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
372597|NCT02028676|914506|P1|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
372598|NCT02028676|914498|P9|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
372599|NCT02028676|914499|P8|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
372600|NCT02028676|914500|P7|STARTED|Subsequent Once vs Twice Daily ABC+3TC||333
372601|NCT02028676|914501|P6|STARTED|Subsequent Once vs Twice Daily ABC+3TC||336
372602|NCT02028676|914502|P5|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
372603|NCT02028676|914503|P4|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
372604|NCT02028676|914504|P3|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
372605|NCT02028676|914505|P2|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
372606|NCT02028676|914506|P1|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
372607|NCT02028676|914498|P9|NOT COMPLETED|Initial Enrolment: Induction ART||0
372608|NCT02028676|914499|P8|NOT COMPLETED|Initial Enrolment: Induction ART||0
372609|NCT02028676|914500|P7|NOT COMPLETED|Initial Enrolment: Induction ART||0
372610|NCT02028676|914501|P6|NOT COMPLETED|Initial Enrolment: Induction ART||0
372611|NCT02028676|914502|P5|NOT COMPLETED|Initial Enrolment: Induction ART||0
372612|NCT02028676|914503|P4|NOT COMPLETED|Initial Enrolment: Induction ART||0
372613|NCT02028676|914504|P3|NOT COMPLETED|Initial Enrolment: Induction ART||0
372614|NCT02028676|914505|P2|NOT COMPLETED|Initial Enrolment: Induction ART||0
372615|NCT02028676|914506|P1|NOT COMPLETED|Initial Enrolment: Induction ART||0
372616|NCT02028676|914498|P9|COMPLETED|Initial Enrolment: Induction ART||0
372617|NCT02028676|914499|P8|COMPLETED|Initial Enrolment: Induction ART||0
372618|NCT02028676|914500|P7|COMPLETED|Initial Enrolment: Induction ART||0
372619|NCT02028676|914501|P6|COMPLETED|Initial Enrolment: Induction ART||0
372620|NCT02028676|914502|P5|COMPLETED|Initial Enrolment: Induction ART||405
372621|NCT02028676|914503|P4|COMPLETED|Initial Enrolment: Induction ART||404
372622|NCT02028676|914504|P3|COMPLETED|Initial Enrolment: Induction ART||397
372623|NCT02028676|914505|P2|COMPLETED|Initial Enrolment: Induction ART||0
372624|NCT02028676|914506|P1|COMPLETED|Initial Enrolment: Induction ART||0
372625|NCT02028676|914498|P9|STARTED|Initial Enrolment: Induction ART||0
372626|NCT02028676|914499|P8|STARTED|Initial Enrolment: Induction ART||0
372627|NCT02028676|914500|P7|STARTED|Initial Enrolment: Induction ART||0
372628|NCT02028676|914501|P6|STARTED|Initial Enrolment: Induction ART||0
372629|NCT02028676|914502|P5|STARTED|Initial Enrolment: Induction ART||405
372630|NCT02028676|914503|P4|STARTED|Initial Enrolment: Induction ART||404
372631|NCT02028676|914504|P3|STARTED|Initial Enrolment: Induction ART||397
372632|NCT02028676|914505|P2|STARTED|Initial Enrolment: Induction ART||0
372633|NCT02028676|914506|P1|STARTED|Initial Enrolment: Induction ART||0
372634|NCT02028676|914498|P9|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
372635|NCT02028676|914499|P8|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
372636|NCT02028676|914500|P7|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
372637|NCT02028676|914501|P6|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
372638|NCT02028676|914502|P5|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
372639|NCT02028676|914503|P4|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
372640|NCT02028676|914504|P3|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
372641|NCT02028676|914505|P2|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
372642|NCT02028676|914506|P1|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
372643|NCT02028676|914498|P9|COMPLETED|Initial Enrolment: CDM vs LCM||0
372644|NCT02028676|914499|P8|COMPLETED|Initial Enrolment: CDM vs LCM||0
372645|NCT02028676|914500|P7|COMPLETED|Initial Enrolment: CDM vs LCM||0
372646|NCT02028676|914501|P6|COMPLETED|Initial Enrolment: CDM vs LCM||0
372647|NCT02028676|914502|P5|COMPLETED|Initial Enrolment: CDM vs LCM||0
372648|NCT02028676|914503|P4|COMPLETED|Initial Enrolment: CDM vs LCM||0
372649|NCT02028676|914504|P3|COMPLETED|Initial Enrolment: CDM vs LCM||0
372650|NCT02028676|914505|P2|COMPLETED|Initial Enrolment: CDM vs LCM||600
372651|NCT02028676|914506|P1|COMPLETED|Initial Enrolment: CDM vs LCM||606
372652|NCT02028676|914498|P9|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
372653|NCT02028676|914499|P8|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
372654|NCT02028676|914500|P7|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
372655|NCT02028676|914501|P6|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
372656|NCT02028676|914502|P5|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
372657|NCT02028676|914503|P4|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
372658|NCT02028676|914504|P3|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
372659|NCT02028676|914505|P2|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|600
372660|NCT02028676|914506|P1|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|606
372661|NCT02028325|914679|P1|NOT COMPLETED|Overall Study||10
372662|NCT02028325|914679|P1|COMPLETED|Overall Study||126
372663|NCT02028325|914679|P1|STARTED|Overall Study||136
372664|NCT02028169|914683|P1|NOT COMPLETED|Overall Study||28
372665|NCT02028169|914683|P1|COMPLETED|Overall Study||92
372666|NCT02028169|914683|P1|STARTED|Overall Study||120
372667|NCT02028065|914709|P3|NOT COMPLETED|Treatment Through Study Completion||14
372668|NCT02028065|914710|P2|NOT COMPLETED|Treatment Through Study Completion||15
372669|NCT02028065|914711|P1|NOT COMPLETED|Treatment Through Study Completion||12
372670|NCT02028065|914709|P3|COMPLETED|Treatment Through Study Completion||134
372671|NCT02028065|914710|P2|COMPLETED|Treatment Through Study Completion||136
372672|NCT02028065|914711|P1|COMPLETED|Treatment Through Study Completion||64
372673|NCT02028065|914709|P3|Received Third Dose|Treatment Through Study Completion||134
372674|NCT02028065|914710|P2|Received Third Dose|Treatment Through Study Completion||136
372675|NCT02028065|914711|P1|Received Third Dose|Treatment Through Study Completion||64
372676|NCT02028065|914709|P3|Received Second Dose|Treatment Through Study Completion||138
372677|NCT02028065|914710|P2|Received Second Dose|Treatment Through Study Completion||140
372678|NCT02028065|914711|P1|Received Second Dose|Treatment Through Study Completion||69
372679|NCT02028065|914709|P3|Received First Dose|Treatment Through Study Completion||148
372680|NCT02028065|914710|P2|Received First Dose|Treatment Through Study Completion||151
372681|NCT02028065|914711|P1|Received First Dose|Treatment Through Study Completion||76
372682|NCT02028065|914709|P3|STARTED|Treatment Through Study Completion|Does not include the 1 participant randomized to sugammadex 16 mg/kg who actually received placebo|148
372683|NCT02028065|914710|P2|STARTED|Treatment Through Study Completion||151
372684|NCT02028065|914711|P1|STARTED|Treatment Through Study Completion|Includes 1 participant randomized to sugammadex 16 mg/kg who actually received placebo|76
372685|NCT02028065|914709|P3|NOT COMPLETED|Randomization Through Start Treatment||3
372686|NCT02028065|914710|P2|NOT COMPLETED|Randomization Through Start Treatment||3
372687|NCT02028065|914711|P1|NOT COMPLETED|Randomization Through Start Treatment||1
372688|NCT02028065|914709|P3|COMPLETED|Randomization Through Start Treatment||149
372689|NCT02028065|914710|P2|COMPLETED|Randomization Through Start Treatment||151
372690|NCT02028065|914711|P1|COMPLETED|Randomization Through Start Treatment||75
372691|NCT02028065|914709|P3|STARTED|Randomization Through Start Treatment|Randomized|152
372692|NCT02028065|914710|P2|STARTED|Randomization Through Start Treatment|Randomized|154
372693|NCT02028065|914711|P1|STARTED|Randomization Through Start Treatment|Randomized|76
372694|NCT02027883|914724|P2|NOT COMPLETED|Overall Study||0
372695|NCT02027883|914725|P1|NOT COMPLETED|Overall Study||0
372696|NCT02027883|914724|P2|COMPLETED|Overall Study||50
372697|NCT02027883|914725|P1|COMPLETED|Overall Study||50
372698|NCT02027883|914724|P2|STARTED|Overall Study||50
372699|NCT02027883|914725|P1|STARTED|Overall Study||50
372700|NCT02027844|914738|P3|NOT COMPLETED|Overall Study||2
372701|NCT02027844|914739|P2|NOT COMPLETED|Overall Study||6
372702|NCT02027844|914740|P1|NOT COMPLETED|Overall Study||5
372703|NCT02027844|914738|P3|COMPLETED|Overall Study||37
372704|NCT02027844|914739|P2|COMPLETED|Overall Study||33
372705|NCT02027844|914740|P1|COMPLETED|Overall Study||34
372706|NCT02027844|914738|P3|STARTED|Overall Study||39
372707|NCT02027844|914739|P2|STARTED|Overall Study||39
372708|NCT02027844|914740|P1|STARTED|Overall Study||39
372709|NCT02027402|914759|P2|NOT COMPLETED|Overall Study||1
372710|NCT02027402|914760|P1|NOT COMPLETED|Overall Study||4
372711|NCT02027402|914759|P2|COMPLETED|Overall Study||99
372712|NCT02027402|914760|P1|COMPLETED|Overall Study||94
372713|NCT02027402|914759|P2|STARTED|Overall Study||100
372714|NCT02027402|914760|P1|STARTED|Overall Study||98
372715|NCT02027311|914774|P2|NOT COMPLETED|Overall Study||2
372716|NCT02027311|914775|P1|NOT COMPLETED|Overall Study||3
372717|NCT02027311|914774|P2|COMPLETED|Overall Study|1 cases was dropped due to tachycardia and 1 were desaturation.|33
372718|NCT02027311|914775|P1|COMPLETED|Overall Study|1 case was dropped due to hypotension and 2 were desaturation.|30
372719|NCT02027311|914774|P2|STARTED|Overall Study||35
372720|NCT02027311|914775|P1|STARTED|Overall Study||33
372721|NCT02027272|914785|P2|NOT COMPLETED|Overall Study||1
372722|NCT02027272|914786|P1|NOT COMPLETED|Overall Study||0
372723|NCT02027272|914785|P2|COMPLETED|Overall Study||0
372724|NCT02027272|914786|P1|COMPLETED|Overall Study||0
372725|NCT02027272|914785|P2|STARTED|Overall Study||1
372726|NCT02027272|914786|P1|STARTED|Overall Study||0
372727|NCT02026453|914795|P3|NOT COMPLETED|Overall Study||13
372728|NCT02026453|914796|P2|NOT COMPLETED|Overall Study||9
372729|NCT02026453|914797|P1|NOT COMPLETED|Overall Study||6
372730|NCT02026453|914795|P3|COMPLETED|Overall Study||89
372731|NCT02026453|914796|P2|COMPLETED|Overall Study||94
372732|NCT02026453|914797|P1|COMPLETED|Overall Study||95
372733|NCT02026453|914795|P3|STARTED|Overall Study||102
372734|NCT02026453|914796|P2|STARTED|Overall Study||103
372735|NCT02026453|914797|P1|STARTED|Overall Study||101
372736|NCT02026258|914810|P2|NOT COMPLETED|Recieved Allocated Intervention||2
372737|NCT02026258|914811|P1|NOT COMPLETED|Recieved Allocated Intervention||1
372738|NCT02026258|914810|P2|COMPLETED|Recieved Allocated Intervention||17
372739|NCT02026258|914811|P1|COMPLETED|Recieved Allocated Intervention||15
372740|NCT02026258|914810|P2|STARTED|Recieved Allocated Intervention||19
372741|NCT02026258|914811|P1|STARTED|Recieved Allocated Intervention||16
372742|NCT02026258|914810|P2|NOT COMPLETED|Randomized||2
372743|NCT02026258|914811|P1|NOT COMPLETED|Randomized||4
372744|NCT02026258|914810|P2|COMPLETED|Randomized||19
372745|NCT02026258|914811|P1|COMPLETED|Randomized||16
372746|NCT02026258|914810|P2|STARTED|Randomized||21
372747|NCT02026258|914811|P1|STARTED|Randomized||20
372748|NCT02026206|914825|P2|NOT COMPLETED|Overall Study||8
372749|NCT02026206|914826|P1|NOT COMPLETED|Overall Study||4
372750|NCT02026206|914825|P2|COMPLETED|Overall Study||36
372751|NCT02026206|914826|P1|COMPLETED|Overall Study||40
372752|NCT02026206|914825|P2|STARTED|Overall Study||44
372753|NCT02026206|914826|P1|STARTED|Overall Study||44
372754|NCT02026193|914836|P2|NOT COMPLETED|Overall Study||0
372755|NCT02026193|914837|P1|NOT COMPLETED|Overall Study||0
372756|NCT02026193|914836|P2|COMPLETED|Overall Study||8
372757|NCT02026193|914837|P1|COMPLETED|Overall Study||3
372758|NCT02026193|914836|P2|STARTED|Overall Study||8
372759|NCT02026193|914837|P1|STARTED|Overall Study||3
372760|NCT02026141|914845|P2|NOT COMPLETED|Overall Study||1
372761|NCT02026141|914846|P1|NOT COMPLETED|Overall Study||0
372762|NCT02026141|914845|P2|COMPLETED|Overall Study||19
372763|NCT02026141|914846|P1|COMPLETED|Overall Study||20
372764|NCT02026141|914845|P2|STARTED|Overall Study||20
372765|NCT02026141|914846|P1|STARTED|Overall Study||20
372766|NCT02025907|914854|P2|NOT COMPLETED|Overall Study||12
372767|NCT02025907|914855|P1|NOT COMPLETED|Overall Study||27
372768|NCT02025907|914854|P2|COMPLETED|Overall Study||96
372769|NCT02025907|914855|P1|COMPLETED|Overall Study||81
372770|NCT02025907|914854|P2|STARTED|Overall Study|Participant flow is presented for safety population.|108
372771|NCT02025907|914855|P1|STARTED|Overall Study|Participant flow is presented for safety population.|108
372772|NCT02025829|914871|P2|NOT COMPLETED|Overall Study||0
372773|NCT02025829|914872|P1|NOT COMPLETED|Overall Study||0
372774|NCT02025829|914871|P2|COMPLETED|Overall Study||11
372775|NCT02025829|914872|P1|COMPLETED|Overall Study||3
372776|NCT02025829|914871|P2|STARTED|Overall Study||11
372777|NCT02025829|914872|P1|STARTED|Overall Study||3
372778|NCT02025647|914881|P1|NOT COMPLETED|Overall Study||0
372779|NCT02025647|914881|P1|COMPLETED|Overall Study||139
372780|NCT02025647|914881|P1|Session 3 (Rating Module: 30-45 Days)|Overall Study|"27 did not generate IRS~36 lost to follow up"|76
372781|NCT02025647|914881|P1|Session 2 (Narrative Module: 24-48 Hrs)|Overall Study|"19 lost to follow up or technology issues~3 administered wrong session"|117
372782|NCT02025647|914881|P1|Immediate Retest (Rating Module: 5 Min)|Overall Study|"27 did not generate IRS~15 technology issues or administered wrong session"|97
372783|NCT02025647|914881|P1|Session 1 (Narrative Module)|Overall Study||139
372784|NCT02025647|914881|P1|STARTED|Overall Study||139
372785|NCT02025621|914912|P2|NOT COMPLETED|Overall Study||19
372786|NCT02025621|914913|P1|NOT COMPLETED|Overall Study||14
372787|NCT02025621|914912|P2|COMPLETED|Overall Study||421
372788|NCT02025621|914913|P1|COMPLETED|Overall Study||428
372789|NCT02025621|914912|P2|STARTED|Overall Study||440
372790|NCT02025621|914913|P1|STARTED|Overall Study||442
372791|NCT02025075|914933|P2|NOT COMPLETED|Overall Study||2
372792|NCT02025075|914934|P1|NOT COMPLETED|Overall Study||0
372793|NCT02025075|914933|P2|COMPLETED|Overall Study||19
372794|NCT02025075|914934|P1|COMPLETED|Overall Study||16
372795|NCT02025075|914933|P2|STARTED|Overall Study||21
372796|NCT02025075|914934|P1|STARTED|Overall Study||16
372797|NCT02024971|914958|P1|NOT COMPLETED|Overall Study||36
372798|NCT02024971|914958|P1|COMPLETED|Overall Study|Including 162 patients with missing efficacy data at two or more time points.|1067
372799|NCT02024971|914958|P1|Safety Analysis Set|Overall Study|All participants with available data who were enrolled prior to Day 15 of the start of treatment.|1067
372800|NCT02024971|914958|P1|STARTED|Overall Study||1103
372801|NCT02024932|914971|P6|NOT COMPLETED|Overall Study||0
372802|NCT02024932|914972|P5|NOT COMPLETED|Overall Study||2
372803|NCT02024932|914973|P4|NOT COMPLETED|Overall Study||2
372804|NCT02024932|914974|P3|NOT COMPLETED|Overall Study||0
372805|NCT02024932|914975|P2|NOT COMPLETED|Overall Study||3
372806|NCT02024932|914976|P1|NOT COMPLETED|Overall Study||2
372807|NCT02024932|914971|P6|COMPLETED|Overall Study||9
372808|NCT02024932|914972|P5|COMPLETED|Overall Study||16
372809|NCT02024932|914973|P4|COMPLETED|Overall Study||0
372810|NCT02024932|914974|P3|COMPLETED|Overall Study||2
372811|NCT02024932|914975|P2|COMPLETED|Overall Study||1
372812|NCT02024932|914976|P1|COMPLETED|Overall Study||0
372813|NCT02024932|914971|P6|Pharmacodynamic (PD) Analysis Set|Overall Study||9
372814|NCT02024932|914972|P5|Pharmacodynamic (PD) Analysis Set|Overall Study||18
372815|NCT02024932|914973|P4|Pharmacodynamic (PD) Analysis Set|Overall Study||2
372816|NCT02024932|914974|P3|Pharmacodynamic (PD) Analysis Set|Overall Study||2
372817|NCT02024932|914975|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||4
372818|NCT02024932|914976|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||2
372819|NCT02024932|914971|P6|Pharmacokinetic (PK) Analysis Set|Overall Study||0
372820|NCT02024932|914972|P5|Pharmacokinetic (PK) Analysis Set|Overall Study||18
372821|NCT02024932|914973|P4|Pharmacokinetic (PK) Analysis Set|Overall Study||2
372822|NCT02024932|914974|P3|Pharmacokinetic (PK) Analysis Set|Overall Study||0
372823|NCT02024932|914975|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||4
372824|NCT02024932|914976|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||2
372825|NCT02024932|914971|P6|Safety Analysis Set|Overall Study||9
372826|NCT02024932|914972|P5|Safety Analysis Set|Overall Study||18
372827|NCT02024932|914973|P4|Safety Analysis Set|Overall Study||2
372828|NCT02024932|914974|P3|Safety Analysis Set|Overall Study||2
372829|NCT02024932|914975|P2|Safety Analysis Set|Overall Study||4
372830|NCT02024932|914976|P1|Safety Analysis Set|Overall Study||2
372831|NCT02024932|914971|P6|STARTED|Overall Study||9
372832|NCT02024932|914972|P5|STARTED|Overall Study||18
372833|NCT02024932|914973|P4|STARTED|Overall Study||2
372834|NCT02024932|914974|P3|STARTED|Overall Study||2
372835|NCT02024932|914975|P2|STARTED|Overall Study||4
372836|NCT02024932|914976|P1|STARTED|Overall Study||2
372837|NCT02024867|915035|P2|NOT COMPLETED|Overall Study||7
372838|NCT02024867|915036|P1|NOT COMPLETED|Overall Study||9
372839|NCT02024867|915035|P2|COMPLETED|Overall Study||124
372840|NCT02024867|915036|P1|COMPLETED|Overall Study||125
372841|NCT02024867|915035|P2|STARTED|Overall Study||131
372842|NCT02024867|915036|P1|STARTED|Overall Study||134
372843|NCT02024724|915054|P2|NOT COMPLETED|Overall Study||0
372844|NCT02024724|915055|P1|NOT COMPLETED|Overall Study||1
372845|NCT02024724|915054|P2|COMPLETED|Overall Study||30
372846|NCT02024724|915055|P1|COMPLETED|Overall Study||29
372847|NCT02024724|915054|P2|STARTED|Overall Study||30
372848|NCT02024724|915055|P1|STARTED|Overall Study||30
372849|NCT02024698|915061|P2|NOT COMPLETED|Second Intervention (7 Days)||0
372850|NCT02024698|915062|P1|NOT COMPLETED|Second Intervention (7 Days)||0
372851|NCT02024698|915061|P2|COMPLETED|Second Intervention (7 Days)||26
372852|NCT02024698|915062|P1|COMPLETED|Second Intervention (7 Days)||16
372853|NCT02024698|915061|P2|Received Etafilcon A Twice|Second Intervention (7 Days)||0
372854|NCT02024698|915062|P1|Received Etafilcon A Twice|Second Intervention (7 Days)||1
372855|NCT02024698|915061|P2|STARTED|Second Intervention (7 Days)||26
372856|NCT02024698|915062|P1|STARTED|Second Intervention (7 Days)||16
372857|NCT02024698|915061|P2|NOT COMPLETED|First Intervention (7 Days)||1
372858|NCT02024698|915062|P1|NOT COMPLETED|First Intervention (7 Days)||0
372859|NCT02024698|915061|P2|COMPLETED|First Intervention (7 Days)||26
372860|NCT02024698|915062|P1|COMPLETED|First Intervention (7 Days)||16
372861|NCT02024698|915061|P2|STARTED|First Intervention (7 Days)||27
372862|NCT02024698|915062|P1|STARTED|First Intervention (7 Days)||16
372863|NCT02024386|915091|P3|NOT COMPLETED|Overall Study||0
372864|NCT02024386|915092|P2|NOT COMPLETED|Overall Study||0
372865|NCT02024386|915093|P1|NOT COMPLETED|Overall Study||0
372866|NCT02024386|915091|P3|COMPLETED|Overall Study||5
372867|NCT02024386|915092|P2|COMPLETED|Overall Study||11
372868|NCT02024386|915093|P1|COMPLETED|Overall Study||6
372869|NCT02024386|915091|P3|STARTED|Overall Study||5
372870|NCT02024386|915092|P2|STARTED|Overall Study||11
372871|NCT02024386|915093|P1|STARTED|Overall Study||6
372872|NCT02024165|915116|P1|NOT COMPLETED|Overall Study||0
372873|NCT02024165|915116|P1|COMPLETED|Overall Study||71
372874|NCT02024165|915116|P1|STARTED|Overall Study||71
372875|NCT02023983|915123|P2|NOT COMPLETED|Overall Study||0
372876|NCT02023983|915124|P1|NOT COMPLETED|Overall Study||0
372877|NCT02023983|915123|P2|COMPLETED|Overall Study||75
372878|NCT02023983|915124|P1|COMPLETED|Overall Study||76
372879|NCT02023983|915123|P2|STARTED|Overall Study||75
372880|NCT02023983|915124|P1|STARTED|Overall Study||76
372881|NCT02023918|915132|P1|NOT COMPLETED|Overall Study||0
372882|NCT02023918|915132|P1|COMPLETED|Overall Study||6
372883|NCT02023918|915132|P1|STARTED|Overall Study||6
372884|NCT02023879|915140|P3|NOT COMPLETED|Overall Study||9
372885|NCT02023879|915141|P2|NOT COMPLETED|Overall Study||9
372886|NCT02023879|915142|P1|NOT COMPLETED|Overall Study||4
372887|NCT02023879|915140|P3|COMPLETED|Overall Study|48 participants entered open-label extension treatment period.|50
372888|NCT02023879|915141|P2|COMPLETED|Overall Study|106 participants entered open-label extension treatment period.|107
372889|NCT02023879|915142|P1|COMPLETED|Overall Study|51 participants entered open-label extension treatment period.|54
372890|NCT02023879|915140|P3|Treated|Overall Study||58
372891|NCT02023879|915141|P2|Treated|Overall Study||115
372892|NCT02023879|915142|P1|Treated|Overall Study||58
372893|NCT02023879|915140|P3|STARTED|Overall Study||59
372894|NCT02023879|915141|P2|STARTED|Overall Study||116
372895|NCT02023879|915142|P1|STARTED|Overall Study||58
372896|NCT02023866|915225|P1|NOT COMPLETED|Overall Study||6
372897|NCT02023866|915225|P1|COMPLETED|Overall Study||30
372898|NCT02023866|915225|P1|STARTED|Overall Study||36
372899|NCT02023801|915238|P1|NOT COMPLETED|Overall Study||0
372900|NCT02023801|915238|P1|COMPLETED|Overall Study|Completed 12 Month Follow-up|24
372901|NCT02023801|915238|P1|Treated|Overall Study|Treatment Completed|24
372902|NCT02023801|915238|P1|STARTED|Overall Study|Treatment Attempted|24
372903|NCT02023515|915246|P2|NOT COMPLETED|Overall Study||3
372904|NCT02023515|915247|P1|NOT COMPLETED|Overall Study||1
372905|NCT02023515|915246|P2|COMPLETED|Overall Study||22
372906|NCT02023515|915247|P1|COMPLETED|Overall Study||23
372907|NCT02023515|915246|P2|STARTED|Overall Study||25
372908|NCT02023515|915247|P1|STARTED|Overall Study||24
372909|NCT02023268|915257|P2|NOT COMPLETED|Overall Study||4
372910|NCT02023268|915258|P1|NOT COMPLETED|Overall Study||0
372911|NCT02023268|915257|P2|COMPLETED|Overall Study||49
372912|NCT02023268|915258|P1|COMPLETED|Overall Study||52
372913|NCT02023268|915257|P2|STARTED|Overall Study||53
372914|NCT02023268|915258|P1|STARTED|Overall Study||52
372915|NCT02023151|915264|P1|NOT COMPLETED|Overall Study||4
372916|NCT02023151|915264|P1|COMPLETED|Overall Study||13
372917|NCT02023151|915264|P1|STARTED|Overall Study||17
372918|NCT02023125|915271|P3|NOT COMPLETED|Period 2||0
372919|NCT02023125|915272|P2|NOT COMPLETED|Period 2||0
372920|NCT02023125|915273|P1|NOT COMPLETED|Period 2||0
372921|NCT02023125|915271|P3|COMPLETED|Period 2||24
372922|NCT02023125|915272|P2|COMPLETED|Period 2||9
372923|NCT02023125|915273|P1|COMPLETED|Period 2||9
372924|NCT02023125|915271|P3|STARTED|Period 2||24
372925|NCT02023125|915272|P2|STARTED|Period 2||9
372926|NCT02023125|915273|P1|STARTED|Period 2||9
372927|NCT02023125|915271|P3|NOT COMPLETED|Washout Period||0
372928|NCT02023125|915272|P2|NOT COMPLETED|Washout Period||0
372929|NCT02023125|915273|P1|NOT COMPLETED|Washout Period||0
372930|NCT02023125|915271|P3|COMPLETED|Washout Period||24
372931|NCT02023125|915272|P2|COMPLETED|Washout Period||9
372932|NCT02023125|915273|P1|COMPLETED|Washout Period||9
372933|NCT02023125|915271|P3|STARTED|Washout Period||24
372934|NCT02023125|915272|P2|STARTED|Washout Period||9
372935|NCT02023125|915273|P1|STARTED|Washout Period||9
372936|NCT02023125|915271|P3|NOT COMPLETED|Period 1||0
372937|NCT02023125|915272|P2|NOT COMPLETED|Period 1||0
372938|NCT02023125|915273|P1|NOT COMPLETED|Period 1||0
372939|NCT02023125|915271|P3|COMPLETED|Period 1||24
372940|NCT02023125|915272|P2|COMPLETED|Period 1||9
372941|NCT02023125|915273|P1|COMPLETED|Period 1||9
372942|NCT02023125|915271|P3|STARTED|Period 1||24
372943|NCT02023125|915272|P2|STARTED|Period 1||9
372944|NCT02023125|915273|P1|STARTED|Period 1||9
372945|NCT02023112|915334|P2|NOT COMPLETED|Overall Study||1
372946|NCT02023112|915335|P1|NOT COMPLETED|Overall Study||2
372947|NCT02023112|915334|P2|COMPLETED|Overall Study||85
372948|NCT02023112|915335|P1|COMPLETED|Overall Study||83
372949|NCT02023112|915334|P2|STARTED|Overall Study||86
372950|NCT02023112|915335|P1|STARTED|Overall Study||85
372951|NCT02023099|915356|P3|NOT COMPLETED|Overall Study||3
372952|NCT02023099|915357|P2|NOT COMPLETED|Overall Study||0
372953|NCT02023099|915358|P1|NOT COMPLETED|Overall Study||3
372954|NCT02023099|915356|P3|COMPLETED|Overall Study||39
372955|NCT02023099|915357|P2|COMPLETED|Overall Study||106
372956|NCT02023099|915358|P1|COMPLETED|Overall Study||212
372957|NCT02023099|915356|P3|STARTED|Overall Study||42
372958|NCT02023099|915357|P2|STARTED|Overall Study||106
372959|NCT02023099|915358|P1|STARTED|Overall Study||215
372960|NCT02022826|915374|P1|NOT COMPLETED|Overall Study||28
372961|NCT02022826|915374|P1|COMPLETED|Overall Study||139
372962|NCT02022826|915374|P1|STARTED|Overall Study||167
372963|NCT02022748|915381|P3|NOT COMPLETED|Overall Study||0
372964|NCT02022748|915382|P2|NOT COMPLETED|Overall Study||2
372965|NCT02022748|915383|P1|NOT COMPLETED|Overall Study||1
372966|NCT02022748|915381|P3|COMPLETED|Overall Study||13
372967|NCT02022748|915382|P2|COMPLETED|Overall Study||4
372968|NCT02022748|915383|P1|COMPLETED|Overall Study||7
372969|NCT02022748|915381|P3|Subjects Who Completed Treatment|Overall Study||13
372970|NCT02022748|915382|P2|Subjects Who Completed Treatment|Overall Study||4
372971|NCT02022748|915383|P1|Subjects Who Completed Treatment|Overall Study||7
372972|NCT02022748|915381|P3|Subject Who Started Treatment|Overall Study||13
372973|NCT02022748|915382|P2|Subject Who Started Treatment|Overall Study||6
372974|NCT02022748|915383|P1|Subject Who Started Treatment|Overall Study||8
372975|NCT02022748|915381|P3|STARTED|Overall Study||13
372976|NCT02022748|915382|P2|STARTED|Overall Study||6
372977|NCT02022748|915383|P1|STARTED|Overall Study||8
372978|NCT02022670|915409|P3|NOT COMPLETED|Overall Study||1
372979|NCT02022670|915410|P2|NOT COMPLETED|Overall Study||0
372980|NCT02022670|915411|P1|NOT COMPLETED|Overall Study||1
372981|NCT02022670|915409|P3|COMPLETED|Overall Study||11
372982|NCT02022670|915410|P2|COMPLETED|Overall Study||10
372983|NCT02022670|915411|P1|COMPLETED|Overall Study||10
372984|NCT02022670|915409|P3|STARTED|Overall Study||12
372985|NCT02022670|915410|P2|STARTED|Overall Study||10
372986|NCT02022670|915411|P1|STARTED|Overall Study||11
372987|NCT02022085|915425|P1|NOT COMPLETED|Overall Study||1
372988|NCT02022085|915425|P1|COMPLETED|Overall Study||53
372989|NCT02022085|915425|P1|STARTED|Overall Study||54
372990|NCT02022020|915446|P1|NOT COMPLETED|Overall Study||0
372991|NCT02022020|915446|P1|COMPLETED|Overall Study||220
372992|NCT02022020|915446|P1|STARTED|Overall Study||220
372993|NCT02022007|915455|P3|NOT COMPLETED|Overall Study||2
372994|NCT02022007|915456|P2|NOT COMPLETED|Overall Study||1
372995|NCT02022007|915457|P1|NOT COMPLETED|Overall Study||1
372996|NCT02022007|915455|P3|COMPLETED|Overall Study||11
372997|NCT02022007|915456|P2|COMPLETED|Overall Study||11
372998|NCT02022007|915457|P1|COMPLETED|Overall Study||12
372999|NCT02022007|915455|P3|STARTED|Overall Study||13
373000|NCT02022007|915456|P2|STARTED|Overall Study||12
373001|NCT02022007|915457|P1|STARTED|Overall Study||13
373002|NCT02021942|915498|P1|NOT COMPLETED|Overall Study||0
373003|NCT02021942|915498|P1|COMPLETED|Overall Study||16
373004|NCT02021942|915498|P1|STARTED|Overall Study||16
373005|NCT02021812|915508|P1|NOT COMPLETED|Overall Study||26
373006|NCT02021812|915508|P1|COMPLETED|Overall Study||5
373007|NCT02021812|915508|P1|STARTED|Overall Study||31
373008|NCT02021643|915522|P4|NOT COMPLETED|Overall Study||12
373009|NCT02021643|915523|P3|NOT COMPLETED|Overall Study||0
373010|NCT02021643|915524|P2|NOT COMPLETED|Overall Study||10
373011|NCT02021643|915525|P1|NOT COMPLETED|Overall Study||9
373012|NCT02021643|915522|P4|COMPLETED|Overall Study||218
373013|NCT02021643|915523|P3|COMPLETED|Overall Study||11
373014|NCT02021643|915524|P2|COMPLETED|Overall Study||280
373015|NCT02021643|915525|P1|COMPLETED|Overall Study||147
373016|NCT02021643|915522|P4|STARTED|Overall Study||230
373017|NCT02021643|915523|P3|STARTED|Overall Study||11
373018|NCT02021643|915524|P2|STARTED|Overall Study||290
373019|NCT02021643|915525|P1|STARTED|Overall Study||156
373020|NCT02021565|915567|P2|NOT COMPLETED|3-month Follow-up||2
373021|NCT02021565|915568|P1|NOT COMPLETED|3-month Follow-up||10
373022|NCT02021565|915567|P2|COMPLETED|3-month Follow-up||34
373023|NCT02021565|915568|P1|COMPLETED|3-month Follow-up||50
373024|NCT02021565|915567|P2|Care Recipients|3-month Follow-up||18
373025|NCT02021565|915568|P1|Care Recipients|3-month Follow-up||30
373026|NCT02021565|915567|P2|Caregivers|3-month Follow-up||18
373027|NCT02021565|915568|P1|Caregivers|3-month Follow-up||30
373028|NCT02021565|915567|P2|STARTED|3-month Follow-up||36
373029|NCT02021565|915568|P1|STARTED|3-month Follow-up||60
373030|NCT02021565|915567|P2|NOT COMPLETED|Baseline Through Intervention||18
373031|NCT02021565|915568|P1|NOT COMPLETED|Baseline Through Intervention||12
373032|NCT02021565|915567|P2|COMPLETED|Baseline Through Intervention||36
373033|NCT02021565|915568|P1|COMPLETED|Baseline Through Intervention||60
373034|NCT02021565|915567|P2|Care Recipients|Baseline Through Intervention||27
373035|NCT02021565|915568|P1|Care Recipients|Baseline Through Intervention||36
373036|NCT02021565|915567|P2|Caregivers|Baseline Through Intervention||27
373037|NCT02021565|915568|P1|Caregivers|Baseline Through Intervention||36
373038|NCT02021565|915567|P2|STARTED|Baseline Through Intervention||54
373039|NCT02021565|915568|P1|STARTED|Baseline Through Intervention||72
373040|NCT02021461|915580|P1|NOT COMPLETED|Overall Study||0
373041|NCT02021461|915580|P1|COMPLETED|Overall Study||38
373042|NCT02021461|915580|P1|STARTED|Overall Study||38
373043|NCT02021331|915588|P2|NOT COMPLETED|Overall Study||2
373044|NCT02021331|915589|P1|NOT COMPLETED|Overall Study||0
373045|NCT02021331|915588|P2|COMPLETED|Overall Study||1
373046|NCT02021331|915589|P1|COMPLETED|Overall Study||2
373047|NCT02021331|915588|P2|STARTED|Overall Study||3
373048|NCT02021331|915589|P1|STARTED|Overall Study||2
373049|NCT02021292|915601|P2|NOT COMPLETED|Overall Study||3
373050|NCT02021292|915602|P1|NOT COMPLETED|Overall Study||0
373051|NCT02021292|915601|P2|COMPLETED|Overall Study||37
373052|NCT02021292|915602|P1|COMPLETED|Overall Study||40
373053|NCT02021292|915601|P2|STARTED|Overall Study||40
373054|NCT02021292|915602|P1|STARTED|Overall Study||40
373055|NCT02021071|915616|P2|NOT COMPLETED|Overall Study||0
373056|NCT02021071|915617|P1|NOT COMPLETED|Overall Study||0
373057|NCT02021071|915616|P2|COMPLETED|Overall Study||12
373058|NCT02021071|915617|P1|COMPLETED|Overall Study||12
373059|NCT02021071|915616|P2|STARTED|Overall Study||12
373060|NCT02021071|915617|P1|STARTED|Overall Study||12
373061|NCT02020941|915624|P1|NOT COMPLETED|Overall Study||8
373062|NCT02020941|915624|P1|COMPLETED|Overall Study||2
373063|NCT02020941|915624|P1|STARTED|Overall Study||10
373064|NCT02020889|915635|P2|NOT COMPLETED|Overall Study||3
373065|NCT02020889|915636|P1|NOT COMPLETED|Overall Study||7
373066|NCT02020889|915635|P2|COMPLETED|Overall Study||65
373067|NCT02020889|915636|P1|COMPLETED|Overall Study||61
373068|NCT02020889|915635|P2|STARTED|Overall Study||68
373069|NCT02020889|915636|P1|STARTED|Overall Study||68
373070|NCT02020863|915690|P1|NOT COMPLETED|Overall Study||5
373071|NCT02020863|915690|P1|COMPLETED|Overall Study||35
373072|NCT02020863|915690|P1|STARTED|Overall Study||40
373073|NCT02020837|915694|P1|NOT COMPLETED|Overall Study||0
373074|NCT02020837|915694|P1|COMPLETED|Overall Study||2
373075|NCT02020837|915694|P1|STARTED|Overall Study||2
373076|NCT02020616|915705|P7|NOT COMPLETED|Overall Study||4
373077|NCT02020616|915706|P6|NOT COMPLETED|Overall Study||5
373078|NCT02020616|915707|P5|NOT COMPLETED|Overall Study||2
373079|NCT02020616|915708|P4|NOT COMPLETED|Overall Study||2
373080|NCT02020616|915709|P3|NOT COMPLETED|Overall Study||2
373081|NCT02020616|915710|P2|NOT COMPLETED|Overall Study||1
373082|NCT02020616|915711|P1|NOT COMPLETED|Overall Study||0
373083|NCT02020616|915705|P7|COMPLETED|Overall Study||6
373084|NCT02020616|915706|P6|COMPLETED|Overall Study||3
373085|NCT02020616|915707|P5|COMPLETED|Overall Study||6
373086|NCT02020616|915708|P4|COMPLETED|Overall Study||6
373087|NCT02020616|915709|P3|COMPLETED|Overall Study||6
373088|NCT02020616|915710|P2|COMPLETED|Overall Study||7
373089|NCT02020616|915711|P1|COMPLETED|Overall Study||10
373090|NCT02020616|915705|P7|Received at Least One Dose of Study Drug|Overall Study||10
373091|NCT02020616|915706|P6|Received at Least One Dose of Study Drug|Overall Study||8
373092|NCT02020616|915707|P5|Received at Least One Dose of Study Drug|Overall Study||8
373093|NCT02020616|915708|P4|Received at Least One Dose of Study Drug|Overall Study||7
373094|NCT02020616|915709|P3|Received at Least One Dose of Study Drug|Overall Study||8
373095|NCT02020616|915710|P2|Received at Least One Dose of Study Drug|Overall Study||8
373096|NCT02020616|915711|P1|Received at Least One Dose of Study Drug|Overall Study||10
373097|NCT02020616|915705|P7|STARTED|Overall Study||10
373098|NCT02020616|915706|P6|STARTED|Overall Study||8
373099|NCT02020616|915707|P5|STARTED|Overall Study||8
373100|NCT02020616|915708|P4|STARTED|Overall Study||8
373101|NCT02020616|915709|P3|STARTED|Overall Study||8
373102|NCT02020616|915710|P2|STARTED|Overall Study||8
373103|NCT02020616|915711|P1|STARTED|Overall Study||10
373104|NCT02020577|915804|P2|NOT COMPLETED|Overall Study||55
373105|NCT02020577|915805|P1|NOT COMPLETED|Overall Study||3
373106|NCT02020577|915804|P2|COMPLETED|Overall Study||0
373107|NCT02020577|915805|P1|COMPLETED|Overall Study||0
373108|NCT02020577|915804|P2|STARTED|Overall Study||55
373109|NCT02020577|915805|P1|STARTED|Overall Study||3
373110|NCT02020512|915832|P1|NOT COMPLETED|Overall Study||8
373111|NCT02020512|915832|P1|COMPLETED|Overall Study||79
373112|NCT02020512|915832|P1|STARTED|Overall Study||87
373113|NCT02020369|915838|P2|NOT COMPLETED|Overall Study||2
373114|NCT02020369|915839|P1|NOT COMPLETED|Overall Study||3
373115|NCT02020369|915838|P2|COMPLETED|Overall Study||11
373116|NCT02020369|915839|P1|COMPLETED|Overall Study||11
373117|NCT02020369|915838|P2|STARTED|Overall Study||13
373118|NCT02020369|915839|P1|STARTED|Overall Study||14
373119|NCT02020304|915855|P2|NOT COMPLETED|Overall Study||2
373120|NCT02020304|915856|P1|NOT COMPLETED|Overall Study||3
373121|NCT02020304|915855|P2|COMPLETED|Overall Study||26
373122|NCT02020304|915856|P1|COMPLETED|Overall Study||27
373123|NCT02020304|915855|P2|STARTED|Overall Study||28
373124|NCT02020304|915856|P1|STARTED|Overall Study||30
373125|NCT02020135|915872|P1|NOT COMPLETED|Overall Study||9
373126|NCT02020135|915872|P1|COMPLETED|Overall Study||0
373127|NCT02020135|915872|P1|STARTED|Overall Study||9
373128|NCT02020031|915884|P2|NOT COMPLETED|Overall Study||1
373129|NCT02020031|915885|P1|NOT COMPLETED|Overall Study||1
373130|NCT02020031|915884|P2|COMPLETED|Overall Study||10
373131|NCT02020031|915885|P1|COMPLETED|Overall Study||10
373132|NCT02020031|915884|P2|STARTED|Overall Study||11
373133|NCT02020031|915885|P1|STARTED|Overall Study||11
373134|NCT02019979|915893|P1|NOT COMPLETED|Overall Study||14
373135|NCT02019979|915893|P1|COMPLETED|Overall Study||0
373136|NCT02019979|915893|P1|STARTED|Overall Study||14
373137|NCT02019719|915904|P5|NOT COMPLETED|Overall Study||2
373138|NCT02019719|915905|P4|NOT COMPLETED|Overall Study||2
373139|NCT02019719|915906|P3|NOT COMPLETED|Overall Study||0
373140|NCT02019719|915907|P2|NOT COMPLETED|Overall Study||1
373141|NCT02019719|915908|P1|NOT COMPLETED|Overall Study||6
373142|NCT02019719|915904|P5|COMPLETED|Overall Study||18
373143|NCT02019719|915905|P4|COMPLETED|Overall Study||17
373144|NCT02019719|915906|P3|COMPLETED|Overall Study||20
373145|NCT02019719|915907|P2|COMPLETED|Overall Study||18
373146|NCT02019719|915908|P1|COMPLETED|Overall Study||13
373147|NCT02019719|915904|P5|STARTED|Overall Study||20
373148|NCT02019719|915905|P4|STARTED|Overall Study||19
373149|NCT02019719|915906|P3|STARTED|Overall Study||20
373150|NCT02019719|915907|P2|STARTED|Overall Study||19
373151|NCT02019719|915908|P1|STARTED|Overall Study||19
373152|NCT02019563|916007|P2|NOT COMPLETED|Overall Study||0
373153|NCT02019563|916008|P1|NOT COMPLETED|Overall Study||0
373154|NCT02019563|916007|P2|COMPLETED|Overall Study|72 incisors were treated in the RCT group|30
373155|NCT02019563|916008|P1|COMPLETED|Overall Study|100 incisors were treated in the MTA/FS pulpotomy group|40
373156|NCT02019563|916007|P2|STARTED|Overall Study|72 incisors were treated in the RCT group|30
373157|NCT02019563|916008|P1|STARTED|Overall Study|100 incisors were treated in the MTA/FS pulpotomy group|40
373158|NCT02019550|916024|P2|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
373159|NCT02019550|916025|P1|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
373160|NCT02019550|916024|P2|COMPLETED|Treatment Period 2 (4 Weeks)||50
373161|NCT02019550|916025|P1|COMPLETED|Treatment Period 2 (4 Weeks)||46
373162|NCT02019550|916024|P2|STARTED|Treatment Period 2 (4 Weeks)||50
373163|NCT02019550|916025|P1|STARTED|Treatment Period 2 (4 Weeks)||46
373164|NCT02019550|916024|P2|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
373165|NCT02019550|916025|P1|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
373166|NCT02019550|916024|P2|COMPLETED|Treatment Period 1 (4 Weeks)||50
373167|NCT02019550|916025|P1|COMPLETED|Treatment Period 1 (4 Weeks)||46
373168|NCT02019550|916024|P2|STARTED|Treatment Period 1 (4 Weeks)||51
373169|NCT02019550|916025|P1|STARTED|Treatment Period 1 (4 Weeks)||46
373170|NCT02019472|916066|P3|NOT COMPLETED|Overall Study||42
373171|NCT02019472|916067|P2|NOT COMPLETED|Overall Study||52
373172|NCT02019472|916068|P1|NOT COMPLETED|Overall Study||37
373173|NCT02019472|916066|P3|COMPLETED|Overall Study||145
373174|NCT02019472|916067|P2|COMPLETED|Overall Study||134
373175|NCT02019472|916068|P1|COMPLETED|Overall Study||149
373176|NCT02019472|916066|P3|STARTED|Overall Study||187
373177|NCT02019472|916067|P2|STARTED|Overall Study||186
373178|NCT02019472|916068|P1|STARTED|Overall Study||186
373179|NCT02018809|916093|P4|NOT COMPLETED|Overall Study||0
373180|NCT02018809|916094|P3|NOT COMPLETED|Overall Study||0
373181|NCT02018809|916095|P2|NOT COMPLETED|Overall Study||0
373182|NCT02018809|916096|P1|NOT COMPLETED|Overall Study||0
373183|NCT02018809|916093|P4|COMPLETED|Overall Study||50
373184|NCT02018809|916094|P3|COMPLETED|Overall Study||50
373185|NCT02018809|916095|P2|COMPLETED|Overall Study||50
373186|NCT02018809|916096|P1|COMPLETED|Overall Study||50
373187|NCT02018809|916093|P4|STARTED|Overall Study||50
373188|NCT02018809|916094|P3|STARTED|Overall Study||50
373189|NCT02018809|916095|P2|STARTED|Overall Study||50
373190|NCT02018809|916096|P1|STARTED|Overall Study||50
373191|NCT02018562|916112|P2|NOT COMPLETED|Overall Study||0
373192|NCT02018562|916113|P1|NOT COMPLETED|Overall Study||3
373193|NCT02018562|916112|P2|COMPLETED|Overall Study||25
373194|NCT02018562|916113|P1|COMPLETED|Overall Study||22
373195|NCT02018562|916112|P2|STARTED|Overall Study||25
373196|NCT02018562|916113|P1|STARTED|Overall Study||25
373197|NCT02017574|916133|P2|NOT COMPLETED|Overall Study||0
373198|NCT02017574|916134|P1|NOT COMPLETED|Overall Study||0
373199|NCT02017574|916133|P2|COMPLETED|Overall Study||12
373200|NCT02017574|916134|P1|COMPLETED|Overall Study||12
373201|NCT02017574|916133|P2|STARTED|Overall Study||12
373202|NCT02017574|916134|P1|STARTED|Overall Study||12
373203|NCT02017093|916144|P2|NOT COMPLETED|Overall Study||0
373204|NCT02017093|916145|P1|NOT COMPLETED|Overall Study||0
373205|NCT02017093|916144|P2|COMPLETED|Overall Study||3
373206|NCT02017093|916145|P1|COMPLETED|Overall Study||4
373207|NCT02017093|916144|P2|STARTED|Overall Study||3
373208|NCT02017093|916145|P1|STARTED|Overall Study||4
373209|NCT02017015|916153|P1|NOT COMPLETED|Overall Study||69
373210|NCT02017015|916153|P1|COMPLETED|Overall Study|Completed = Participants remaining on treatment at the time of the data cut-off of 01 Jun 2015|14
373211|NCT02017015|916153|P1|Safety Population|Overall Study||83
373212|NCT02017015|916153|P1|STARTED|Overall Study||83
373213|NCT02016963|916160|P1|NOT COMPLETED|Overall Study||0
373214|NCT02016963|916160|P1|COMPLETED|Overall Study||20
373215|NCT02016963|916160|P1|STARTED|Overall Study||20
373216|NCT02016898|916178|P2|NOT COMPLETED|Overall Study||5
373217|NCT02016898|916179|P1|NOT COMPLETED|Overall Study||5
373218|NCT02016898|916178|P2|COMPLETED|Overall Study||40
373219|NCT02016898|916179|P1|COMPLETED|Overall Study||45
373220|NCT02016898|916178|P2|STARTED|Overall Study||45
373221|NCT02016898|916179|P1|STARTED|Overall Study||50
373222|NCT02016690|916187|P1|NOT COMPLETED|Overall Study||24
373223|NCT02016690|916187|P1|COMPLETED|Overall Study|(Effectiveness analysis set)|288
373224|NCT02016690|916187|P1|Safety Analysis Set (SAS)|Overall Study||304
373225|NCT02016690|916187|P1|Treated|Overall Study||312
373226|NCT02016690|916187|P1|STARTED|Overall Study||312
373227|NCT02016625|916200|P2|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||0
373228|NCT02016625|916201|P1|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||3
373229|NCT02016625|916200|P2|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15
373230|NCT02016625|916201|P1|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||13
373231|NCT02016625|916200|P2|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15
373232|NCT02016625|916201|P1|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||16
373233|NCT02016625|916200|P2|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||1
373234|NCT02016625|916201|P1|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||0
373235|NCT02016625|916200|P2|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||15
373236|NCT02016625|916201|P1|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||16
373237|NCT02016625|916200|P2|STARTED|Cyclo or Tac (Single Dose, Day 1)||16
373238|NCT02016625|916201|P1|STARTED|Cyclo or Tac (Single Dose, Day 1)||16
373239|NCT02016612|916237|P4|NOT COMPLETED|Overall Study||0
373240|NCT02016612|916238|P3|NOT COMPLETED|Overall Study||0
373241|NCT02016612|916239|P2|NOT COMPLETED|Overall Study||0
373242|NCT02016612|916240|P1|NOT COMPLETED|Overall Study||0
373243|NCT02016612|916237|P4|COMPLETED|Overall Study||61
373244|NCT02016612|916238|P3|COMPLETED|Overall Study||26
373245|NCT02016612|916239|P2|COMPLETED|Overall Study||25
373246|NCT02016612|916240|P1|COMPLETED|Overall Study||25
373247|NCT02016612|916237|P4|STARTED|Overall Study||61
373248|NCT02016612|916238|P3|STARTED|Overall Study||26
373249|NCT02016612|916239|P2|STARTED|Overall Study||25
373250|NCT02016612|916240|P1|STARTED|Overall Study||25
373251|NCT02016482|916256|P2|NOT COMPLETED|Period B||7
373252|NCT02016482|916257|P1|NOT COMPLETED|Period B||13
373253|NCT02016482|916256|P2|COMPLETED|Period B||87
373254|NCT02016482|916257|P1|COMPLETED|Period B||81
373255|NCT02016482|916256|P2|STARTED|Period B||94
373256|NCT02016482|916257|P1|STARTED|Period B||94
373257|NCT02016482|916256|P2|NOT COMPLETED|Period A||15
373258|NCT02016482|916257|P1|NOT COMPLETED|Period A||14
373259|NCT02016482|916256|P2|COMPLETED|Period A|8 participants early escaped to the end of Period A and 86 continued to the end of Period A.|94
373260|NCT02016482|916257|P1|COMPLETED|Period A|56 participants early escaped to the end of Period A and 38 continued to the end of Period A.|94
373261|NCT02016482|916256|P2|STARTED|Period A||109
373262|NCT02016482|916257|P1|STARTED|Period A||108
373263|NCT02016170|916348|P3|NOT COMPLETED|Overall Study||0
373264|NCT02016170|916349|P2|NOT COMPLETED|Overall Study||1
373265|NCT02016170|916350|P1|NOT COMPLETED|Overall Study||2
373266|NCT02016170|916348|P3|COMPLETED|Overall Study||27
373267|NCT02016170|916349|P2|COMPLETED|Overall Study||27
373268|NCT02016170|916350|P1|COMPLETED|Overall Study||25
373269|NCT02016170|916348|P3|STARTED|Overall Study||27
373270|NCT02016170|916349|P2|STARTED|Overall Study||28
373271|NCT02016170|916350|P1|STARTED|Overall Study||27
373272|NCT02016105|916361|P6|NOT COMPLETED|EXTENSION PERIOD||6
373273|NCT02016105|916362|P5|NOT COMPLETED|EXTENSION PERIOD||6
373274|NCT02016105|916363|P4|NOT COMPLETED|EXTENSION PERIOD||5
373275|NCT02016105|916364|P3|NOT COMPLETED|EXTENSION PERIOD||5
373276|NCT02016105|916365|P2|NOT COMPLETED|EXTENSION PERIOD||0
373277|NCT02016105|916366|P1|NOT COMPLETED|EXTENSION PERIOD||0
373278|NCT02016105|916361|P6|COMPLETED|EXTENSION PERIOD||100
373279|NCT02016105|916362|P5|COMPLETED|EXTENSION PERIOD||50
373280|NCT02016105|916363|P4|COMPLETED|EXTENSION PERIOD||104
373281|NCT02016105|916364|P3|COMPLETED|EXTENSION PERIOD||47
373282|NCT02016105|916365|P2|COMPLETED|EXTENSION PERIOD||0
373283|NCT02016105|916366|P1|COMPLETED|EXTENSION PERIOD||0
373284|NCT02016105|916361|P6|STARTED|EXTENSION PERIOD|6 patients did not proceed from Treatment Period 2 into Extension Period|106
373285|NCT02016105|916362|P5|STARTED|EXTENSION PERIOD|3 patients did not proceed from Treatment Period 2 into Extension Period|56
373286|NCT02016105|916363|P4|STARTED|EXTENSION PERIOD|7 patients did not proceed from Treatment Period 2 into Extension Period|109
373287|NCT02016105|916364|P3|STARTED|EXTENSION PERIOD|5 patients did not proceed from Treatment Period 2 into Extension Period|52
373288|NCT02016105|916365|P2|STARTED|EXTENSION PERIOD||0
373289|NCT02016105|916366|P1|STARTED|EXTENSION PERIOD||0
373290|NCT02016105|916361|P6|NOT COMPLETED|TREATMENT PERIOD 2||14
373291|NCT02016105|916362|P5|NOT COMPLETED|TREATMENT PERIOD 2||4
373292|NCT02016105|916363|P4|NOT COMPLETED|TREATMENT PERIOD 2||11
373293|NCT02016105|916364|P3|NOT COMPLETED|TREATMENT PERIOD 2||6
373294|NCT02016105|916365|P2|NOT COMPLETED|TREATMENT PERIOD 2||0
373295|NCT02016105|916366|P1|NOT COMPLETED|TREATMENT PERIOD 2||0
373296|NCT02016105|916361|P6|COMPLETED|TREATMENT PERIOD 2||112
373297|NCT02016105|916362|P5|COMPLETED|TREATMENT PERIOD 2||59
373298|NCT02016105|916363|P4|COMPLETED|TREATMENT PERIOD 2||116
373299|NCT02016105|916364|P3|COMPLETED|TREATMENT PERIOD 2||57
373300|NCT02016105|916365|P2|COMPLETED|TREATMENT PERIOD 2||0
373301|NCT02016105|916366|P1|COMPLETED|TREATMENT PERIOD 2||0
373302|NCT02016105|916361|P6|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from GP2017 adalimumab treatment arm in Treatment Period 1"|126
373303|NCT02016105|916362|P5|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from GP2017 adalimumab treatment arm in Treatment Period 1"|63
373304|NCT02016105|916363|P4|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from Humira ® adalimumab treatment arm in Treatment Period 1"|127
373305|NCT02016105|916364|P3|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from Humira ® adalimumab treatment arm in Treatment Period 1"|63
373306|NCT02016105|916365|P2|STARTED|TREATMENT PERIOD 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
373307|NCT02016105|916366|P1|STARTED|TREATMENT PERIOD 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
373308|NCT02016105|916361|P6|NOT COMPLETED|TREATMENT PERIOD 1||0
373309|NCT02016105|916362|P5|NOT COMPLETED|TREATMENT PERIOD 1||0
373310|NCT02016105|916363|P4|NOT COMPLETED|TREATMENT PERIOD 1||0
373311|NCT02016105|916364|P3|NOT COMPLETED|TREATMENT PERIOD 1||0
373312|NCT02016105|916365|P2|NOT COMPLETED|TREATMENT PERIOD 1||33
373313|NCT02016105|916366|P1|NOT COMPLETED|TREATMENT PERIOD 1||30
373314|NCT02016105|916361|P6|COMPLETED|TREATMENT PERIOD 1||0
373315|NCT02016105|916362|P5|COMPLETED|TREATMENT PERIOD 1||0
373316|NCT02016105|916363|P4|COMPLETED|TREATMENT PERIOD 1||0
373317|NCT02016105|916364|P3|COMPLETED|TREATMENT PERIOD 1||0
373318|NCT02016105|916365|P2|COMPLETED|TREATMENT PERIOD 1|11 patients did not proceed into Treatment Period 2|201
373319|NCT02016105|916366|P1|COMPLETED|TREATMENT PERIOD 1|12 patients did not proceed into Treatment Period 2|201
373320|NCT02016105|916361|P6|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
373321|NCT02016105|916362|P5|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
373322|NCT02016105|916363|P4|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
373323|NCT02016105|916364|P3|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
373324|NCT02016105|916365|P2|STARTED|TREATMENT PERIOD 1||234
373325|NCT02016105|916366|P1|STARTED|TREATMENT PERIOD 1||231
373326|NCT02015910|916416|P2|NOT COMPLETED|Overall Study||0
373327|NCT02015910|916417|P1|NOT COMPLETED|Overall Study||0
373328|NCT02015910|916416|P2|COMPLETED|Overall Study||1
373329|NCT02015910|916417|P1|COMPLETED|Overall Study||0
373330|NCT02015910|916416|P2|STARTED|Overall Study||1
373331|NCT02015910|916417|P1|STARTED|Overall Study||0
373332|NCT02015793|916425|P2|NOT COMPLETED|Overall Study||4
373333|NCT02015793|916426|P1|NOT COMPLETED|Overall Study||4
373334|NCT02015793|916425|P2|COMPLETED|Overall Study||11
373335|NCT02015793|916426|P1|COMPLETED|Overall Study||11
373336|NCT02015793|916425|P2|Entered Open-label Extension Period|Overall Study||14
373337|NCT02015793|916426|P1|Entered Open-label Extension Period|Overall Study||13
373338|NCT02015793|916425|P2|Completed Double-Blind Period|Overall Study||14
373339|NCT02015793|916426|P1|Completed Double-Blind Period|Overall Study||14
373340|NCT02015793|916425|P2|STARTED|Overall Study||15
373341|NCT02015793|916426|P1|STARTED|Overall Study||15
373342|NCT02015754|916456|P1|NOT COMPLETED|Overall Study||11
373343|NCT02015754|916456|P1|COMPLETED|Overall Study||3
373344|NCT02015754|916456|P1|Completed First Clinical and Imaging|Overall Study|1 patient exited prior to follow-up|13
373345|NCT02015754|916456|P1|Completed First TACE|Overall Study||14
373346|NCT02015754|916456|P1|STARTED|Overall Study|17 participants were consented, but 3 participants were screened out prior to treatment|14
373347|NCT02015676|916476|P3|NOT COMPLETED|Overall Study||3
373348|NCT02015676|916477|P2|NOT COMPLETED|Overall Study||34
373349|NCT02015676|916478|P1|NOT COMPLETED|Overall Study||9
373350|NCT02015676|916476|P3|COMPLETED|Overall Study||3
373351|NCT02015676|916477|P2|COMPLETED|Overall Study||14
373352|NCT02015676|916478|P1|COMPLETED|Overall Study||6
373353|NCT02015676|916476|P3|STARTED|Overall Study||6
373354|NCT02015676|916477|P2|STARTED|Overall Study||48
373355|NCT02015676|916478|P1|STARTED|Overall Study||15
373356|NCT02015663|916494|P2|NOT COMPLETED|Overall Study||12
373357|NCT02015663|916495|P1|NOT COMPLETED|Overall Study||15
373358|NCT02015663|916494|P2|COMPLETED|Overall Study||4
373359|NCT02015663|916495|P1|COMPLETED|Overall Study||1
373360|NCT02015663|916494|P2|STARTED|Overall Study||16
373361|NCT02015663|916495|P1|STARTED|Overall Study||16
373362|NCT02015637|916526|P2|NOT COMPLETED|Overall Study||5
373363|NCT02015637|916527|P1|NOT COMPLETED|Overall Study||8
373364|NCT02015637|916526|P2|COMPLETED|Overall Study||149
373365|NCT02015637|916527|P1|COMPLETED|Overall Study||298
373366|NCT02015637|916526|P2|STARTED|Overall Study||154
373367|NCT02015637|916527|P1|STARTED|Overall Study||306
373368|NCT02015546|916538|P3|NOT COMPLETED|Overall Study||4
373369|NCT02015546|916539|P2|NOT COMPLETED|Overall Study||2
373370|NCT02015546|916540|P1|NOT COMPLETED|Overall Study||3
373371|NCT02015546|916538|P3|COMPLETED|Overall Study||22
373372|NCT02015546|916539|P2|COMPLETED|Overall Study||19
373373|NCT02015546|916540|P1|COMPLETED|Overall Study||20
373374|NCT02015546|916538|P3|STARTED|Overall Study||26
373375|NCT02015546|916539|P2|STARTED|Overall Study||21
373376|NCT02015546|916540|P1|STARTED|Overall Study||23
373377|NCT02015481|916572|P1|NOT COMPLETED|Overall Study||1
373378|NCT02015481|916572|P1|COMPLETED|Overall Study||24
373379|NCT02015481|916572|P1|STARTED|Overall Study||25
373380|NCT02015234|916581|P2|NOT COMPLETED|Overall Study||25
373381|NCT02015234|916582|P1|NOT COMPLETED|Overall Study||36
373382|NCT02015234|916581|P2|COMPLETED|Overall Study||54
373383|NCT02015234|916582|P1|COMPLETED|Overall Study||43
373384|NCT02015234|916581|P2|STARTED|Overall Study||79
373385|NCT02015234|916582|P1|STARTED|Overall Study||79
373386|NCT02015221|916596|P2|NOT COMPLETED|Overall Study||6
373387|NCT02015221|916597|P1|NOT COMPLETED|Overall Study||9
373388|NCT02015221|916596|P2|COMPLETED|Overall Study||34
373389|NCT02015221|916597|P1|COMPLETED|Overall Study||32
373390|NCT02015221|916596|P2|STARTED|Overall Study||40
373391|NCT02015221|916597|P1|STARTED|Overall Study||41
373392|NCT02015195|916610|P7|NOT COMPLETED|Overall Study||0
373393|NCT02015195|916611|P6|NOT COMPLETED|Overall Study||0
373394|NCT02015195|916612|P5|NOT COMPLETED|Overall Study||0
373395|NCT02015195|916613|P4|NOT COMPLETED|Overall Study||1
373396|NCT02015195|916614|P3|NOT COMPLETED|Overall Study||0
373397|NCT02015195|916615|P2|NOT COMPLETED|Overall Study||0
373398|NCT02015195|916616|P1|NOT COMPLETED|Overall Study||0
373399|NCT02015195|916610|P7|COMPLETED|Overall Study||16
373400|NCT02015195|916611|P6|COMPLETED|Overall Study||16
373401|NCT02015195|916612|P5|COMPLETED|Overall Study||16
373402|NCT02015195|916613|P4|COMPLETED|Overall Study||0
373403|NCT02015195|916614|P3|COMPLETED|Overall Study||16
373404|NCT02015195|916615|P2|COMPLETED|Overall Study||16
373405|NCT02015195|916616|P1|COMPLETED|Overall Study||16
373406|NCT02015195|916610|P7|STARTED|Overall Study||16
373407|NCT02015195|916611|P6|STARTED|Overall Study||16
373408|NCT02015195|916612|P5|STARTED|Overall Study||16
373409|NCT02015195|916613|P4|STARTED|Overall Study||1
373410|NCT02015195|916614|P3|STARTED|Overall Study||16
373411|NCT02015195|916615|P2|STARTED|Overall Study||16
373412|NCT02015195|916616|P1|STARTED|Overall Study||16
373413|NCT02015039|916639|P2|NOT COMPLETED|Overall Study||1
373414|NCT02015039|916640|P1|NOT COMPLETED|Overall Study||0
373415|NCT02015039|916639|P2|COMPLETED|Overall Study||6
373416|NCT02015039|916640|P1|COMPLETED|Overall Study||6
373417|NCT02015039|916639|P2|STARTED|Overall Study||7
373418|NCT02015039|916640|P1|STARTED|Overall Study||6
373419|NCT02014740|916660|P2|NOT COMPLETED|Overall Study||5
373420|NCT02014740|916661|P1|NOT COMPLETED|Overall Study||6
373421|NCT02014740|916660|P2|COMPLETED|Overall Study||40
373422|NCT02014740|916661|P1|COMPLETED|Overall Study||49
373423|NCT02014740|916660|P2|STARTED|Overall Study||45
373424|NCT02014740|916661|P1|STARTED|Overall Study||55
373425|NCT02014584|916669|P6|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
373426|NCT02014584|916670|P5|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||1
373427|NCT02014584|916671|P4|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
373428|NCT02014584|916672|P3|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
373429|NCT02014584|916673|P2|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
373430|NCT02014584|916674|P1|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
373431|NCT02014584|916669|P6|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||2
373432|NCT02014584|916670|P5|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||2
373433|NCT02014584|916671|P4|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
373434|NCT02014584|916672|P3|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
373435|NCT02014584|916673|P2|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
373436|NCT02014584|916674|P1|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
373437|NCT02014584|916669|P6|STARTED|Target Follow-up (F/U) Period (24 Weeks)||2
373438|NCT02014584|916670|P5|STARTED|Target Follow-up (F/U) Period (24 Weeks)||3
373439|NCT02014584|916671|P4|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
373440|NCT02014584|916672|P3|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
373441|NCT02014584|916673|P2|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
373442|NCT02014584|916674|P1|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
373443|NCT02014584|916669|P6|NOT COMPLETED|Open-Label Period (24 Weeks)||0
373444|NCT02014584|916670|P5|NOT COMPLETED|Open-Label Period (24 Weeks)||0
373445|NCT02014584|916671|P4|NOT COMPLETED|Open-Label Period (24 Weeks)||1
373446|NCT02014584|916672|P3|NOT COMPLETED|Open-Label Period (24 Weeks)||5
373447|NCT02014584|916673|P2|NOT COMPLETED|Open-Label Period (24 Weeks)||0
373448|NCT02014584|916674|P1|NOT COMPLETED|Open-Label Period (24 Weeks)||0
373449|NCT02014584|916669|P6|COMPLETED|Open-Label Period (24 Weeks)||0
373450|NCT02014584|916670|P5|COMPLETED|Open-Label Period (24 Weeks)||0
373451|NCT02014584|916671|P4|COMPLETED|Open-Label Period (24 Weeks)||47
373452|NCT02014584|916672|P3|COMPLETED|Open-Label Period (24 Weeks)||44
373453|NCT02014584|916673|P2|COMPLETED|Open-Label Period (24 Weeks)||0
373454|NCT02014584|916674|P1|COMPLETED|Open-Label Period (24 Weeks)||0
373455|NCT02014584|916669|P6|STARTED|Open-Label Period (24 Weeks)||0
373456|NCT02014584|916670|P5|STARTED|Open-Label Period (24 Weeks)||0
373457|NCT02014584|916671|P4|STARTED|Open-Label Period (24 Weeks)||48
373458|NCT02014584|916672|P3|STARTED|Open-Label Period (24 Weeks)||49
373459|NCT02014584|916673|P2|STARTED|Open-Label Period (24 Weeks)||0
373460|NCT02014584|916674|P1|STARTED|Open-Label Period (24 Weeks)||0
373461|NCT02014584|916669|P6|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
373462|NCT02014584|916670|P5|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
373463|NCT02014584|916671|P4|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
373464|NCT02014584|916672|P3|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
373465|NCT02014584|916673|P2|NOT COMPLETED|Double-Blind Period (24 Weeks)||6
373466|NCT02014584|916674|P1|NOT COMPLETED|Double-Blind Period (24 Weeks)||2
373467|NCT02014584|916669|P6|COMPLETED|Double-Blind Period (24 Weeks)||0
373468|NCT02014584|916670|P5|COMPLETED|Double-Blind Period (24 Weeks)||0
373469|NCT02014584|916671|P4|COMPLETED|Double-Blind Period (24 Weeks)||0
373470|NCT02014584|916672|P3|COMPLETED|Double-Blind Period (24 Weeks)||0
373471|NCT02014584|916673|P2|COMPLETED|Double-Blind Period (24 Weeks)||52
373472|NCT02014584|916674|P1|COMPLETED|Double-Blind Period (24 Weeks)||57
373473|NCT02014584|916669|P6|STARTED|Double-Blind Period (24 Weeks)||0
373474|NCT02014584|916670|P5|STARTED|Double-Blind Period (24 Weeks)||0
373475|NCT02014584|916671|P4|STARTED|Double-Blind Period (24 Weeks)||0
373476|NCT02014584|916672|P3|STARTED|Double-Blind Period (24 Weeks)||0
373477|NCT02014584|916673|P2|STARTED|Double-Blind Period (24 Weeks)||58
373478|NCT02014584|916674|P1|STARTED|Double-Blind Period (24 Weeks)||59
373479|NCT02014480|916791|P6|NOT COMPLETED|Treatment Period 3 (14 Days)||2
373480|NCT02014480|916792|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||0
373481|NCT02014480|916793|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
373482|NCT02014480|916794|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||1
373483|NCT02014480|916795|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||1
373484|NCT02014480|916796|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
373485|NCT02014480|916791|P6|COMPLETED|Treatment Period 3 (14 Days)||32
373486|NCT02014480|916792|P5|COMPLETED|Treatment Period 3 (14 Days)||34
373487|NCT02014480|916793|P4|COMPLETED|Treatment Period 3 (14 Days)||31
373488|NCT02014480|916794|P3|COMPLETED|Treatment Period 3 (14 Days)||29
373489|NCT02014480|916795|P2|COMPLETED|Treatment Period 3 (14 Days)||32
373490|NCT02014480|916796|P1|COMPLETED|Treatment Period 3 (14 Days)||34
373491|NCT02014480|916791|P6|STARTED|Treatment Period 3 (14 Days)||34
373492|NCT02014480|916792|P5|STARTED|Treatment Period 3 (14 Days)||34
373493|NCT02014480|916793|P4|STARTED|Treatment Period 3 (14 Days)||31
373494|NCT02014480|916794|P3|STARTED|Treatment Period 3 (14 Days)||30
373495|NCT02014480|916795|P2|STARTED|Treatment Period 3 (14 Days)||33
373496|NCT02014480|916796|P1|STARTED|Treatment Period 3 (14 Days)||34
373497|NCT02014480|916791|P6|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
373498|NCT02014480|916792|P5|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
373499|NCT02014480|916793|P4|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
373500|NCT02014480|916794|P3|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
373501|NCT02014480|916795|P2|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
373502|NCT02014480|916796|P1|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
373503|NCT02014480|916791|P6|COMPLETED|Washout Period 2 (10 to 14 Days)||34
373504|NCT02014480|916792|P5|COMPLETED|Washout Period 2 (10 to 14 Days)||34
373505|NCT02014480|916793|P4|COMPLETED|Washout Period 2 (10 to 14 Days)||31
373506|NCT02014480|916794|P3|COMPLETED|Washout Period 2 (10 to 14 Days)||30
373507|NCT02014480|916795|P2|COMPLETED|Washout Period 2 (10 to 14 Days)||33
373508|NCT02014480|916796|P1|COMPLETED|Washout Period 2 (10 to 14 Days)||34
373509|NCT02014480|916791|P6|STARTED|Washout Period 2 (10 to 14 Days)||34
373510|NCT02014480|916792|P5|STARTED|Washout Period 2 (10 to 14 Days)||34
373511|NCT02014480|916793|P4|STARTED|Washout Period 2 (10 to 14 Days)||31
373512|NCT02014480|916794|P3|STARTED|Washout Period 2 (10 to 14 Days)||30
373513|NCT02014480|916795|P2|STARTED|Washout Period 2 (10 to 14 Days)||33
373514|NCT02014480|916796|P1|STARTED|Washout Period 2 (10 to 14 Days)||34
373515|NCT02014480|916791|P6|NOT COMPLETED|Treatment Period 2 (14 Days)||0
373516|NCT02014480|916792|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||0
373517|NCT02014480|916793|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||1
373518|NCT02014480|916794|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||2
373519|NCT02014480|916795|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||1
373520|NCT02014480|916796|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||1
373521|NCT02014480|916791|P6|COMPLETED|Treatment Period 2 (14 Days)||34
373522|NCT02014480|916792|P5|COMPLETED|Treatment Period 2 (14 Days)||34
373523|NCT02014480|916793|P4|COMPLETED|Treatment Period 2 (14 Days)||31
373524|NCT02014480|916794|P3|COMPLETED|Treatment Period 2 (14 Days)||30
373525|NCT02014480|916795|P2|COMPLETED|Treatment Period 2 (14 Days)||33
373526|NCT02014480|916796|P1|COMPLETED|Treatment Period 2 (14 Days)||34
373527|NCT02014480|916791|P6|STARTED|Treatment Period 2 (14 Days)||34
373528|NCT02014480|916792|P5|STARTED|Treatment Period 2 (14 Days)||34
373529|NCT02014480|916793|P4|STARTED|Treatment Period 2 (14 Days)||32
373530|NCT02014480|916794|P3|STARTED|Treatment Period 2 (14 Days)||32
373531|NCT02014480|916795|P2|STARTED|Treatment Period 2 (14 Days)||34
373532|NCT02014480|916796|P1|STARTED|Treatment Period 2 (14 Days)||35
373533|NCT02014480|916791|P6|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
373534|NCT02014480|916792|P5|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
373535|NCT02014480|916793|P4|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
373536|NCT02014480|916794|P3|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
373537|NCT02014480|916795|P2|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
373538|NCT02014480|916796|P1|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
373539|NCT02014480|916791|P6|COMPLETED|Washout Period 1 (10 to 14 Days)||34
373540|NCT02014480|916792|P5|COMPLETED|Washout Period 1 (10 to 14 Days)||34
373541|NCT02014480|916793|P4|COMPLETED|Washout Period 1 (10 to 14 Days)||32
373542|NCT02014480|916794|P3|COMPLETED|Washout Period 1 (10 to 14 Days)||32
373543|NCT02014480|916795|P2|COMPLETED|Washout Period 1 (10 to 14 Days)||34
373544|NCT02014480|916796|P1|COMPLETED|Washout Period 1 (10 to 14 Days)||35
373545|NCT02014480|916791|P6|STARTED|Washout Period 1 (10 to 14 Days)||34
373546|NCT02014480|916792|P5|STARTED|Washout Period 1 (10 to 14 Days)||34
373547|NCT02014480|916793|P4|STARTED|Washout Period 1 (10 to 14 Days)||32
373548|NCT02014480|916794|P3|STARTED|Washout Period 1 (10 to 14 Days)||33
373549|NCT02014480|916795|P2|STARTED|Washout Period 1 (10 to 14 Days)||34
373550|NCT02014480|916796|P1|STARTED|Washout Period 1 (10 to 14 Days)||35
373551|NCT02014480|916791|P6|NOT COMPLETED|Treatment Period 1 (14 Days)||0
373552|NCT02014480|916792|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||1
373553|NCT02014480|916793|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||2
373554|NCT02014480|916794|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||1
373555|NCT02014480|916795|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
373556|NCT02014480|916796|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||0
373557|NCT02014480|916791|P6|COMPLETED|Treatment Period 1 (14 Days)||34
373558|NCT02014480|916792|P5|COMPLETED|Treatment Period 1 (14 Days)||34
373559|NCT02014480|916793|P4|COMPLETED|Treatment Period 1 (14 Days)||32
373560|NCT02014480|916794|P3|COMPLETED|Treatment Period 1 (14 Days)||33
373561|NCT02014480|916795|P2|COMPLETED|Treatment Period 1 (14 Days)||34
373562|NCT02014480|916796|P1|COMPLETED|Treatment Period 1 (14 Days)||35
373563|NCT02014480|916791|P6|STARTED|Treatment Period 1 (14 Days)|One participant randomized to Sequence 6 actually received UMEC in Treatment Periods 2 and 3.|34
373564|NCT02014480|916792|P5|STARTED|Treatment Period 1 (14 Days)||35
373565|NCT02014480|916793|P4|STARTED|Treatment Period 1 (14 Days)||34
373566|NCT02014480|916794|P3|STARTED|Treatment Period 1 (14 Days)||34
373567|NCT02014480|916795|P2|STARTED|Treatment Period 1 (14 Days)||35
373568|NCT02014480|916796|P1|STARTED|Treatment Period 1 (14 Days)||35
373569|NCT02014467|916815|P2|NOT COMPLETED|Overall Study||7
373570|NCT02014467|916816|P1|NOT COMPLETED|Overall Study||25
373571|NCT02014467|916815|P2|COMPLETED|Overall Study||112
373572|NCT02014467|916816|P1|COMPLETED|Overall Study||340
373573|NCT02014467|916815|P2|STARTED|Overall Study||119
373574|NCT02014467|916816|P1|STARTED|Overall Study||365
373575|NCT02014441|916876|P1|NOT COMPLETED|Overall Study||30
373576|NCT02014441|916876|P1|COMPLETED|Overall Study||31
373577|NCT02014441|916876|P1|Received Treatment|Overall Study||60
373578|NCT02014441|916876|P1|STARTED|Overall Study||61
373579|NCT02014402|916972|P4|NOT COMPLETED|Overall Study||3
373580|NCT02014402|916973|P3|NOT COMPLETED|Overall Study||3
373581|NCT02014402|916974|P2|NOT COMPLETED|Overall Study||3
373582|NCT02014402|916975|P1|NOT COMPLETED|Overall Study||2
373583|NCT02014402|916972|P4|COMPLETED|Overall Study||82
373584|NCT02014402|916973|P3|COMPLETED|Overall Study||32
373585|NCT02014402|916974|P2|COMPLETED|Overall Study||27
373586|NCT02014402|916975|P1|COMPLETED|Overall Study||29
373587|NCT02014402|916972|P4|Bovine Thrombin|Overall Study||28
373588|NCT02014402|916973|P3|Bovine Thrombin|Overall Study||12
373589|NCT02014402|916974|P2|Bovine Thrombin|Overall Study||10
373590|NCT02014402|916975|P1|Bovine Thrombin|Overall Study||11
373591|NCT02014402|916972|P4|Human Thrombin|Overall Study||57
373592|NCT02014402|916973|P3|Human Thrombin|Overall Study||23
373593|NCT02014402|916974|P2|Human Thrombin|Overall Study||20
373594|NCT02014402|916975|P1|Human Thrombin|Overall Study||20
373595|NCT02014402|916972|P4|STARTED|Overall Study||85
373596|NCT02014402|916973|P3|STARTED|Overall Study||35
373597|NCT02014402|916974|P2|STARTED|Overall Study||30
373598|NCT02014402|916975|P1|STARTED|Overall Study||31
373599|NCT02014363|917005|P3|NOT COMPLETED|Overall Study||24
373600|NCT02014363|917006|P2|NOT COMPLETED|Overall Study||19
373601|NCT02014363|917007|P1|NOT COMPLETED|Overall Study||17
373602|NCT02014363|917005|P3|COMPLETED|Overall Study||31
373603|NCT02014363|917006|P2|COMPLETED|Overall Study||35
373604|NCT02014363|917007|P1|COMPLETED|Overall Study||38
373605|NCT02014363|917005|P3|STARTED|Overall Study||55
373606|NCT02014363|917006|P2|STARTED|Overall Study||54
373607|NCT02014363|917007|P1|STARTED|Overall Study||55
373608|NCT02014272|917015|P2|NOT COMPLETED|Intervention Period 2||0
373609|NCT02014272|917016|P1|NOT COMPLETED|Intervention Period 2||0
373610|NCT02014272|917015|P2|COMPLETED|Intervention Period 2||13
373611|NCT02014272|917016|P1|COMPLETED|Intervention Period 2||13
373612|NCT02014272|917015|P2|STARTED|Intervention Period 2||13
373613|NCT02014272|917016|P1|STARTED|Intervention Period 2||13
373614|NCT02014272|917015|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
373615|NCT02014272|917016|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
373616|NCT02014272|917015|P2|COMPLETED|Washout Period 1 (7 Days)||13
373617|NCT02014272|917016|P1|COMPLETED|Washout Period 1 (7 Days)||13
373618|NCT02014272|917015|P2|STARTED|Washout Period 1 (7 Days)||13
373619|NCT02014272|917016|P1|STARTED|Washout Period 1 (7 Days)||13
373620|NCT02014272|917015|P2|NOT COMPLETED|Intervention Period 1||1
373621|NCT02014272|917016|P1|NOT COMPLETED|Intervention Period 1||1
373622|NCT02014272|917015|P2|COMPLETED|Intervention Period 1||13
373623|NCT02014272|917016|P1|COMPLETED|Intervention Period 1||13
373624|NCT02014272|917015|P2|STARTED|Intervention Period 1||14
373625|NCT02014272|917016|P1|STARTED|Intervention Period 1||14
373626|NCT02014051|917034|P2|NOT COMPLETED|Overall Study||1
373627|NCT02014051|917035|P1|NOT COMPLETED|Overall Study||1
373628|NCT02014051|917034|P2|COMPLETED|Overall Study||5
373629|NCT02014051|917035|P1|COMPLETED|Overall Study||2
373630|NCT02014051|917034|P2|STARTED|Overall Study||6
373631|NCT02014051|917035|P1|STARTED|Overall Study||3
373632|NCT02013830|917048|P1|NOT COMPLETED|Overall Study||30
373633|NCT02013830|917048|P1|COMPLETED|Overall Study||15
373634|NCT02013830|917048|P1|STARTED|Overall Study||45
373635|NCT02013817|917059|P1|NOT COMPLETED|Overall Study||27
373636|NCT02013817|917059|P1|COMPLETED|Overall Study||16
373637|NCT02013817|917059|P1|STARTED|Overall Study||43
373638|NCT02013791|917077|P9|NOT COMPLETED|Period 2||0
373639|NCT02013791|917078|P8|NOT COMPLETED|Period 2||0
373640|NCT02013791|917079|P7|NOT COMPLETED|Period 2||0
373641|NCT02013791|917080|P6|NOT COMPLETED|Period 2||0
373642|NCT02013791|917081|P5|NOT COMPLETED|Period 2||0
373643|NCT02013791|917082|P4|NOT COMPLETED|Period 2||0
373644|NCT02013791|917083|P3|NOT COMPLETED|Period 2||0
373645|NCT02013791|917084|P2|NOT COMPLETED|Period 2||0
373646|NCT02013791|917085|P1|NOT COMPLETED|Period 2||0
373647|NCT02013791|917077|P9|COMPLETED|Period 2||0
373648|NCT02013791|917078|P8|COMPLETED|Period 2||0
373649|NCT02013791|917079|P7|COMPLETED|Period 2||3
373650|NCT02013791|917080|P6|COMPLETED|Period 2||0
373651|NCT02013791|917081|P5|COMPLETED|Period 2||0
373652|NCT02013791|917082|P4|COMPLETED|Period 2||0
373653|NCT02013791|917083|P3|COMPLETED|Period 2||2
373654|NCT02013791|917084|P2|COMPLETED|Period 2||0
373655|NCT02013791|917085|P1|COMPLETED|Period 2||0
373656|NCT02013791|917077|P9|STARTED|Period 2||0
373657|NCT02013791|917078|P8|STARTED|Period 2||0
373658|NCT02013791|917079|P7|STARTED|Period 2||3
373659|NCT02013791|917080|P6|STARTED|Period 2||0
373660|NCT02013791|917081|P5|STARTED|Period 2||0
373661|NCT02013791|917082|P4|STARTED|Period 2||0
373662|NCT02013791|917083|P3|STARTED|Period 2||2
373663|NCT02013791|917084|P2|STARTED|Period 2||0
373664|NCT02013791|917085|P1|STARTED|Period 2||0
373665|NCT02013791|917077|P9|NOT COMPLETED|Period 1||0
373666|NCT02013791|917078|P8|NOT COMPLETED|Period 1||1
373667|NCT02013791|917079|P7|NOT COMPLETED|Period 1||1
373668|NCT02013791|917080|P6|NOT COMPLETED|Period 1||0
373669|NCT02013791|917081|P5|NOT COMPLETED|Period 1||0
373670|NCT02013791|917082|P4|NOT COMPLETED|Period 1||1
373671|NCT02013791|917083|P3|NOT COMPLETED|Period 1||0
373672|NCT02013791|917084|P2|NOT COMPLETED|Period 1||2
373673|NCT02013791|917085|P1|NOT COMPLETED|Period 1||0
373674|NCT02013791|917077|P9|COMPLETED|Period 1||3
373675|NCT02013791|917078|P8|COMPLETED|Period 1||7
373676|NCT02013791|917079|P7|COMPLETED|Period 1||3
373677|NCT02013791|917080|P6|COMPLETED|Period 1||8
373678|NCT02013791|917081|P5|COMPLETED|Period 1||4
373679|NCT02013791|917082|P4|COMPLETED|Period 1||7
373680|NCT02013791|917083|P3|COMPLETED|Period 1||4
373681|NCT02013791|917084|P2|COMPLETED|Period 1||6
373682|NCT02013791|917085|P1|COMPLETED|Period 1||8
373683|NCT02013791|917077|P9|STARTED|Period 1||3
373684|NCT02013791|917078|P8|STARTED|Period 1||8
373685|NCT02013791|917079|P7|STARTED|Period 1||4
373686|NCT02013791|917080|P6|STARTED|Period 1||8
373687|NCT02013791|917081|P5|STARTED|Period 1||4
373688|NCT02013791|917082|P4|STARTED|Period 1||8
373689|NCT02013791|917083|P3|STARTED|Period 1||4
373690|NCT02013791|917084|P2|STARTED|Period 1||8
373691|NCT02013791|917085|P1|STARTED|Period 1||8
373692|NCT02013765|917106|P1|NOT COMPLETED|Overall Study||1
373693|NCT02013765|917106|P1|COMPLETED|Overall Study||4
373694|NCT02013765|917106|P1|STARTED|Overall Study||5
373695|NCT02013687|917120|P4|NOT COMPLETED|Overall Study||2
373696|NCT02013687|917121|P3|NOT COMPLETED|Overall Study||2
373697|NCT02013687|917122|P2|NOT COMPLETED|Overall Study||0
373698|NCT02013687|917123|P1|NOT COMPLETED|Overall Study||0
373699|NCT02013687|917120|P4|COMPLETED|Overall Study||14
373700|NCT02013687|917121|P3|COMPLETED|Overall Study||14
373701|NCT02013687|917122|P2|COMPLETED|Overall Study||6
373702|NCT02013687|917123|P1|COMPLETED|Overall Study||6
373703|NCT02013687|917120|P4|STARTED|Overall Study||16
373704|NCT02013687|917121|P3|STARTED|Overall Study||16
373705|NCT02013687|917122|P2|STARTED|Overall Study||6
373706|NCT02013687|917123|P1|STARTED|Overall Study||6
373707|NCT02013622|917153|P1|NOT COMPLETED|Overall Study||24
373708|NCT02013622|917153|P1|COMPLETED|Overall Study||25
373709|NCT02013622|917153|P1|STARTED|Overall Study||49
373710|NCT02013609|917173|P1|NOT COMPLETED|Overall Study||18
373711|NCT02013609|917173|P1|COMPLETED|Overall Study||29
373712|NCT02013609|917173|P1|STARTED|Overall Study|One participant out of 48 participants enrolled had discontinued before receiving study medication.|47
373713|NCT02013544|917198|P2|NOT COMPLETED|Overall Study||20
373714|NCT02013544|917199|P1|NOT COMPLETED|Overall Study||11
373715|NCT02013544|917198|P2|COMPLETED|Overall Study||356
373716|NCT02013544|917199|P1|COMPLETED|Overall Study||171
373717|NCT02013544|917198|P2|ITT Population|Overall Study||325
373718|NCT02013544|917199|P1|ITT Population|Overall Study||157
373719|NCT02013544|917198|P2|Safety Population|Overall Study||374
373720|NCT02013544|917199|P1|Safety Population|Overall Study||180
373721|NCT02013544|917198|P2|STARTED|Overall Study||376
373722|NCT02013544|917199|P1|STARTED|Overall Study||182
373723|NCT02013531|917221|P1|NOT COMPLETED|Overall Study||5
373724|NCT02013531|917221|P1|COMPLETED|Overall Study||32
373725|NCT02013531|917221|P1|STARTED|Overall Study||37
373726|NCT02013388|917251|P8|NOT COMPLETED|Overall Study||0
373727|NCT02013388|917252|P7|NOT COMPLETED|Overall Study||0
373728|NCT02013388|917253|P6|NOT COMPLETED|Overall Study||0
373729|NCT02013388|917254|P5|NOT COMPLETED|Overall Study||1
373730|NCT02013388|917255|P4|NOT COMPLETED|Overall Study||0
373731|NCT02013388|917256|P3|NOT COMPLETED|Overall Study||0
373732|NCT02013388|917257|P2|NOT COMPLETED|Overall Study||0
373733|NCT02013388|917258|P1|NOT COMPLETED|Overall Study||1
373734|NCT02013388|917251|P8|COMPLETED|Overall Study||4
373735|NCT02013388|917252|P7|COMPLETED|Overall Study||6
373736|NCT02013388|917253|P6|COMPLETED|Overall Study||6
373737|NCT02013388|917254|P5|COMPLETED|Overall Study||5
373738|NCT02013388|917255|P4|COMPLETED|Overall Study||6
373739|NCT02013388|917256|P3|COMPLETED|Overall Study||6
373740|NCT02013388|917257|P2|COMPLETED|Overall Study||6
373741|NCT02013388|917258|P1|COMPLETED|Overall Study||8
373742|NCT02013388|917251|P8|STARTED|Overall Study||4
373743|NCT02013388|917252|P7|STARTED|Overall Study||6
373744|NCT02013388|917253|P6|STARTED|Overall Study||6
373745|NCT02013388|917254|P5|STARTED|Overall Study||6
373746|NCT02013388|917255|P4|STARTED|Overall Study||6
373747|NCT02013388|917256|P3|STARTED|Overall Study||6
373748|NCT02013388|917257|P2|STARTED|Overall Study||6
373749|NCT02013388|917258|P1|STARTED|Overall Study||9
373750|NCT02013245|917296|P4|NOT COMPLETED|Overall Study||0
373751|NCT02013245|917297|P3|NOT COMPLETED|Overall Study||0
373752|NCT02013245|917298|P2|NOT COMPLETED|Overall Study||1
373753|NCT02013245|917299|P1|NOT COMPLETED|Overall Study||0
373754|NCT02013245|917296|P4|COMPLETED|Overall Study||9
373755|NCT02013245|917297|P3|COMPLETED|Overall Study||9
373756|NCT02013245|917298|P2|COMPLETED|Overall Study||8
373757|NCT02013245|917299|P1|COMPLETED|Overall Study||9
373758|NCT02013245|917296|P4|STARTED|Overall Study||9
373759|NCT02013245|917297|P3|STARTED|Overall Study||9
373760|NCT02013245|917298|P2|STARTED|Overall Study||9
373761|NCT02013245|917299|P1|STARTED|Overall Study||9
373762|NCT02013206|917315|P2|NOT COMPLETED|Overall Study||22
373763|NCT02013206|917316|P1|NOT COMPLETED|Overall Study||27
373764|NCT02013206|917315|P2|COMPLETED|Overall Study||1
373765|NCT02013206|917316|P1|COMPLETED|Overall Study|3 Patients were on-going at clinical cut-off. Not Completed=patients who discontinued treatment.|2
373766|NCT02013206|917315|P2|Received Study Drug|Overall Study||23
373767|NCT02013206|917316|P1|Received Study Drug|Overall Study||26
373768|NCT02013206|917315|P2|STARTED|Overall Study||23
373769|NCT02013206|917316|P1|STARTED|Overall Study||29
373770|NCT02013167|917338|P2|NOT COMPLETED|Overall Study||178
373771|NCT02013167|917339|P1|NOT COMPLETED|Overall Study||101
373772|NCT02013167|917338|P2|COMPLETED|Overall Study|Indicates participants continuing study at time of data cut-off; 22 were receiving treatment|93
373773|NCT02013167|917339|P1|COMPLETED|Overall Study|Indicates participants continuing study at time of data cut-off|33
373774|NCT02013167|917338|P2|Received Treatment|Overall Study||267
373775|NCT02013167|917339|P1|Received Treatment|Overall Study||109
373776|NCT02013167|917338|P2|STARTED|Overall Study||271
373777|NCT02013167|917339|P1|STARTED|Overall Study||134
373778|NCT02013050|917370|P4|NOT COMPLETED|Overall Study||4
373779|NCT02013050|917371|P3|NOT COMPLETED|Overall Study||0
373780|NCT02013050|917372|P2|NOT COMPLETED|Overall Study||5
373781|NCT02013050|917373|P1|NOT COMPLETED|Overall Study||4
373782|NCT02013050|917370|P4|COMPLETED|Overall Study||19
373783|NCT02013050|917371|P3|COMPLETED|Overall Study||3
373784|NCT02013050|917372|P2|COMPLETED|Overall Study||36
373785|NCT02013050|917373|P1|COMPLETED|Overall Study||38
373786|NCT02013050|917370|P4|STARTED|Overall Study||23
373787|NCT02013050|917371|P3|STARTED|Overall Study||3
373788|NCT02013050|917372|P2|STARTED|Overall Study||41
373789|NCT02013050|917373|P1|STARTED|Overall Study||42
373790|NCT02012686|917417|P2|NOT COMPLETED|Overall Study||2
373791|NCT02012686|917418|P1|NOT COMPLETED|Overall Study||0
373792|NCT02012686|917417|P2|COMPLETED|Overall Study||48
373793|NCT02012686|917418|P1|COMPLETED|Overall Study||50
373794|NCT02012686|917417|P2|STARTED|Overall Study||50
373795|NCT02012686|917418|P1|STARTED|Overall Study||50
373796|NCT02012582|917434|P4|NOT COMPLETED|Overall Study||1
373797|NCT02012582|917435|P3|NOT COMPLETED|Overall Study||0
373798|NCT02012582|917436|P2|NOT COMPLETED|Overall Study||0
373799|NCT02012582|917437|P1|NOT COMPLETED|Overall Study||0
373800|NCT02012582|917434|P4|COMPLETED|Overall Study||7
373801|NCT02012582|917435|P3|COMPLETED|Overall Study||8
373802|NCT02012582|917436|P2|COMPLETED|Overall Study||8
373803|NCT02012582|917437|P1|COMPLETED|Overall Study||8
373804|NCT02012582|917434|P4|STARTED|Overall Study||8
373805|NCT02012582|917435|P3|STARTED|Overall Study||8
373806|NCT02012582|917436|P2|STARTED|Overall Study||8
373807|NCT02012582|917437|P1|STARTED|Overall Study||8
373808|NCT02012452|917465|P2|NOT COMPLETED|Overall Study||1
373809|NCT02012452|917466|P1|NOT COMPLETED|Overall Study||6
373810|NCT02012452|917465|P2|COMPLETED|Overall Study||1
373811|NCT02012452|917466|P1|COMPLETED|Overall Study||1
373812|NCT02012452|917465|P2|STARTED|Overall Study||2
373813|NCT02012452|917466|P1|STARTED|Overall Study||7
373814|NCT02012218|917479|P5|NOT COMPLETED|Overall Study||1
373815|NCT02012218|917480|P4|NOT COMPLETED|Overall Study||2
373816|NCT02012218|917481|P3|NOT COMPLETED|Overall Study||2
373817|NCT02012218|917482|P2|NOT COMPLETED|Overall Study||1
373818|NCT02012218|917483|P1|NOT COMPLETED|Overall Study||4
373819|NCT02012218|917479|P5|COMPLETED|Overall Study||5
373820|NCT02012218|917480|P4|COMPLETED|Overall Study||17
373821|NCT02012218|917481|P3|COMPLETED|Overall Study||11
373822|NCT02012218|917482|P2|COMPLETED|Overall Study||10
373823|NCT02012218|917483|P1|COMPLETED|Overall Study||8
373824|NCT02012218|917479|P5|STARTED|Overall Study||6
373825|NCT02012218|917480|P4|STARTED|Overall Study||19
373826|NCT02012218|917481|P3|STARTED|Overall Study||13
373827|NCT02012218|917482|P2|STARTED|Overall Study||11
373828|NCT02012218|917483|P1|STARTED|Overall Study||12
373829|NCT02011893|917495|P3|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||1
373830|NCT02011893|917496|P2|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
373831|NCT02011893|917497|P1|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
373832|NCT02011893|917495|P3|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||51
373833|NCT02011893|917496|P2|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||45
373834|NCT02011893|917497|P1|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
373835|NCT02011893|917495|P3|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||51
373836|NCT02011893|917496|P2|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||45
373837|NCT02011893|917497|P1|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||0
373838|NCT02011893|917495|P3|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||51
373839|NCT02011893|917496|P2|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||44
373840|NCT02011893|917497|P1|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||0
373841|NCT02011893|917495|P3|STARTED|Period 2 (12 Weeks to 24 Weeks)||52
373842|NCT02011893|917496|P2|STARTED|Period 2 (12 Weeks to 24 Weeks)||45
373843|NCT02011893|917497|P1|STARTED|Period 2 (12 Weeks to 24 Weeks)||0
373844|NCT02011893|917495|P3|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||3
373845|NCT02011893|917496|P2|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||0
373846|NCT02011893|917497|P1|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||0
373847|NCT02011893|917495|P3|COMPLETED|Period 1 (Randomization to 12 Weeks)||52
373848|NCT02011893|917496|P2|COMPLETED|Period 1 (Randomization to 12 Weeks)||45
373849|NCT02011893|917497|P1|COMPLETED|Period 1 (Randomization to 12 Weeks)||0
373850|NCT02011893|917495|P3|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||52
373851|NCT02011893|917496|P2|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||45
373852|NCT02011893|917497|P1|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||0
373853|NCT02011893|917495|P3|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||52
373854|NCT02011893|917496|P2|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||45
373855|NCT02011893|917497|P1|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||0
373856|NCT02011893|917495|P3|STARTED|Period 1 (Randomization to 12 Weeks)||55
373857|NCT02011893|917496|P2|STARTED|Period 1 (Randomization to 12 Weeks)||45
373858|NCT02011893|917497|P1|STARTED|Period 1 (Randomization to 12 Weeks)||0
373859|NCT02011893|917495|P3|NOT COMPLETED|Enrollment to Randomization||0
373860|NCT02011893|917496|P2|NOT COMPLETED|Enrollment to Randomization||0
373861|NCT02011893|917497|P1|NOT COMPLETED|Enrollment to Randomization||73
373862|NCT02011893|917495|P3|COMPLETED|Enrollment to Randomization||0
373863|NCT02011893|917496|P2|COMPLETED|Enrollment to Randomization||0
373864|NCT02011893|917497|P1|COMPLETED|Enrollment to Randomization||100
373865|NCT02011893|917495|P3|Randomization|Enrollment to Randomization||0
373866|NCT02011893|917496|P2|Randomization|Enrollment to Randomization||0
373867|NCT02011893|917497|P1|Randomization|Enrollment to Randomization||100
373868|NCT02011893|917495|P3|Permanent Stimulation Implant|Enrollment to Randomization||0
373869|NCT02011893|917496|P2|Permanent Stimulation Implant|Enrollment to Randomization||0
373870|NCT02011893|917497|P1|Permanent Stimulation Implant|Enrollment to Randomization||101
373871|NCT02011893|917495|P3|Trial Stimulation Implant|Enrollment to Randomization||0
373872|NCT02011893|917496|P2|Trial Stimulation Implant|Enrollment to Randomization||0
373873|NCT02011893|917497|P1|Trial Stimulation Implant|Enrollment to Randomization||121
373874|NCT02011893|917495|P3|Baseline|Enrollment to Randomization||0
373875|NCT02011893|917496|P2|Baseline|Enrollment to Randomization||0
373876|NCT02011893|917497|P1|Baseline|Enrollment to Randomization||141
373877|NCT02011893|917495|P3|STARTED|Enrollment to Randomization||0
373878|NCT02011893|917496|P2|STARTED|Enrollment to Randomization||0
373879|NCT02011893|917497|P1|STARTED|Enrollment to Randomization||173
373880|NCT02011542|917508|P1|NOT COMPLETED|Overall Study||1
373881|NCT02011542|917508|P1|COMPLETED|Overall Study||29
373882|NCT02011542|917508|P1|STARTED|Overall Study||30
373883|NCT02011516|917515|P2|NOT COMPLETED|Overall Study||2
373884|NCT02011516|917516|P1|NOT COMPLETED|Overall Study||4
373885|NCT02011516|917515|P2|COMPLETED|Overall Study||6
373886|NCT02011516|917516|P1|COMPLETED|Overall Study||4
373887|NCT02011516|917515|P2|STARTED|Overall Study||8
373888|NCT02011516|917516|P1|STARTED|Overall Study||8
373889|NCT02011490|917525|P6|NOT COMPLETED|Part 2||0
373890|NCT02011490|917526|P5|NOT COMPLETED|Part 2||0
373891|NCT02011490|917527|P4|NOT COMPLETED|Part 2||0
373892|NCT02011490|917528|P3|NOT COMPLETED|Part 2||0
373893|NCT02011490|917529|P2|NOT COMPLETED|Part 2||0
373894|NCT02011490|917530|P1|NOT COMPLETED|Part 2||0
373895|NCT02011490|917525|P6|COMPLETED|Part 2||6
373896|NCT02011490|917526|P5|COMPLETED|Part 2||6
373897|NCT02011490|917527|P4|COMPLETED|Part 2||6
373898|NCT02011490|917528|P3|COMPLETED|Part 2||0
373899|NCT02011490|917529|P2|COMPLETED|Part 2||0
373900|NCT02011490|917530|P1|COMPLETED|Part 2||0
373901|NCT02011490|917525|P6|STARTED|Part 2|2 had also participated in Part 1 (both in healthy group)|6
373902|NCT02011490|917526|P5|STARTED|Part 2|3 had also participated in Part 1 (2 in moderate, 1 in severe groups)|6
373903|NCT02011490|917527|P4|STARTED|Part 2|4 had also participated in Part 1 (all in severe group)|6
373904|NCT02011490|917528|P3|STARTED|Part 2||0
373905|NCT02011490|917529|P2|STARTED|Part 2||0
373906|NCT02011490|917530|P1|STARTED|Part 2||0
373907|NCT02011490|917525|P6|NOT COMPLETED|Part 1||0
373908|NCT02011490|917526|P5|NOT COMPLETED|Part 1||0
373909|NCT02011490|917527|P4|NOT COMPLETED|Part 1||0
373910|NCT02011490|917528|P3|NOT COMPLETED|Part 1||0
373911|NCT02011490|917529|P2|NOT COMPLETED|Part 1||0
373912|NCT02011490|917530|P1|NOT COMPLETED|Part 1||0
373913|NCT02011490|917525|P6|COMPLETED|Part 1||0
373914|NCT02011490|917526|P5|COMPLETED|Part 1||0
373915|NCT02011490|917527|P4|COMPLETED|Part 1||0
373916|NCT02011490|917528|P3|COMPLETED|Part 1||8
373917|NCT02011490|917529|P2|COMPLETED|Part 1||8
373918|NCT02011490|917530|P1|COMPLETED|Part 1||8
373919|NCT02011490|917525|P6|STARTED|Part 1||0
373920|NCT02011490|917526|P5|STARTED|Part 1||0
373921|NCT02011490|917527|P4|STARTED|Part 1||0
373922|NCT02011490|917528|P3|STARTED|Part 1||8
373923|NCT02011490|917529|P2|STARTED|Part 1||8
373924|NCT02011490|917530|P1|STARTED|Part 1||8
373925|NCT02011464|917618|P2|NOT COMPLETED|Overall Study||0
373926|NCT02011464|917619|P1|NOT COMPLETED|Overall Study||0
373927|NCT02011464|917618|P2|COMPLETED|Overall Study||10
373928|NCT02011464|917619|P1|COMPLETED|Overall Study||10
373929|NCT02011464|917618|P2|STARTED|Overall Study||10
373930|NCT02011464|917619|P1|STARTED|Overall Study||10
373931|NCT02011113|917639|P1|NOT COMPLETED|Overall Study||36
373932|NCT02011113|917639|P1|COMPLETED|Overall Study|Completed = participants with progressive disease were considered as completed.|0
373933|NCT02011113|917639|P1|STARTED|Overall Study||36
373934|NCT02010996|917655|P2|NOT COMPLETED|Overall Study||0
373935|NCT02010996|917656|P1|NOT COMPLETED|Overall Study||0
373936|NCT02010996|917655|P2|COMPLETED|Overall Study||36
373937|NCT02010996|917656|P1|COMPLETED|Overall Study||36
373938|NCT02010996|917655|P2|STARTED|Overall Study||36
373939|NCT02010996|917656|P1|STARTED|Overall Study||36
373940|NCT02010684|917668|P2|NOT COMPLETED|Overall Study||23
373941|NCT02010684|917669|P1|NOT COMPLETED|Overall Study||12
373942|NCT02010684|917668|P2|COMPLETED|Overall Study||59
373943|NCT02010684|917669|P1|COMPLETED|Overall Study||27
373944|NCT02010684|917668|P2|STARTED|Overall Study||82
373945|NCT02010684|917669|P1|STARTED|Overall Study||39
373946|NCT02010632|917687|P2|NOT COMPLETED|Second Intervention (7 Days)||0
373947|NCT02010632|917688|P1|NOT COMPLETED|Second Intervention (7 Days)||1
373948|NCT02010632|917687|P2|COMPLETED|Second Intervention (7 Days)||16
373949|NCT02010632|917688|P1|COMPLETED|Second Intervention (7 Days)||15
373950|NCT02010632|917687|P2|STARTED|Second Intervention (7 Days)||16
373951|NCT02010632|917688|P1|STARTED|Second Intervention (7 Days)||16
373952|NCT02010632|917687|P2|NOT COMPLETED|Wash Out Period (14 Days)||0
373953|NCT02010632|917688|P1|NOT COMPLETED|Wash Out Period (14 Days)||0
373954|NCT02010632|917687|P2|COMPLETED|Wash Out Period (14 Days)||16
373955|NCT02010632|917688|P1|COMPLETED|Wash Out Period (14 Days)||16
373956|NCT02010632|917687|P2|STARTED|Wash Out Period (14 Days)||16
373957|NCT02010632|917688|P1|STARTED|Wash Out Period (14 Days)||16
373958|NCT02010632|917687|P2|NOT COMPLETED|First Intervention (7 Days)||0
373959|NCT02010632|917688|P1|NOT COMPLETED|First Intervention (7 Days)||0
373960|NCT02010632|917687|P2|COMPLETED|First Intervention (7 Days)||16
373961|NCT02010632|917688|P1|COMPLETED|First Intervention (7 Days)||16
373962|NCT02010632|917687|P2|STARTED|First Intervention (7 Days)||16
373963|NCT02010632|917688|P1|STARTED|First Intervention (7 Days)||16
373964|NCT02010567|917699|P5|NOT COMPLETED|Overall Study||1
373965|NCT02010567|917700|P4|NOT COMPLETED|Overall Study||0
373966|NCT02010567|917701|P3|NOT COMPLETED|Overall Study||1
373967|NCT02010567|917702|P2|NOT COMPLETED|Overall Study||0
373968|NCT02010567|917703|P1|NOT COMPLETED|Overall Study||0
373969|NCT02010567|917699|P5|COMPLETED|Overall Study||5
373970|NCT02010567|917700|P4|COMPLETED|Overall Study||3
373971|NCT02010567|917701|P3|COMPLETED|Overall Study||13
373972|NCT02010567|917702|P2|COMPLETED|Overall Study||6
373973|NCT02010567|917703|P1|COMPLETED|Overall Study||3
373974|NCT02010567|917699|P5|STARTED|Overall Study||6
373975|NCT02010567|917700|P4|STARTED|Overall Study||3
373976|NCT02010567|917701|P3|STARTED|Overall Study||14
373977|NCT02010567|917702|P2|STARTED|Overall Study||6
373978|NCT02010567|917703|P1|STARTED|Overall Study||3
373979|NCT02010255|917728|P14|NOT COMPLETED|Overall Study||1
373980|NCT02010255|917729|P13|NOT COMPLETED|Overall Study||0
373981|NCT02010255|917730|P12|NOT COMPLETED|Overall Study||1
373982|NCT02010255|917731|P11|NOT COMPLETED|Overall Study||2
373983|NCT02010255|917732|P10|NOT COMPLETED|Overall Study||0
373984|NCT02010255|917733|P9|NOT COMPLETED|Overall Study||1
373985|NCT02010255|917734|P8|NOT COMPLETED|Overall Study||1
373986|NCT02010255|917735|P7|NOT COMPLETED|Overall Study||1
373987|NCT02010255|917736|P6|NOT COMPLETED|Overall Study||0
373988|NCT02010255|917737|P5|NOT COMPLETED|Overall Study||4
373989|NCT02010255|917738|P4|NOT COMPLETED|Overall Study||6
373990|NCT02010255|917739|P3|NOT COMPLETED|Overall Study||7
373991|NCT02010255|917740|P2|NOT COMPLETED|Overall Study||2
373992|NCT02010255|917741|P1|NOT COMPLETED|Overall Study||6
373993|NCT02010255|917728|P14|COMPLETED|Overall Study||2
373994|NCT02010255|917729|P13|COMPLETED|Overall Study||3
373995|NCT02010255|917730|P12|COMPLETED|Overall Study||4
373996|NCT02010255|917731|P11|COMPLETED|Overall Study||1
373997|NCT02010255|917732|P10|COMPLETED|Overall Study||23
373998|NCT02010255|917733|P9|COMPLETED|Overall Study||21
373999|NCT02010255|917734|P8|COMPLETED|Overall Study||32
374000|NCT02010255|917735|P7|COMPLETED|Overall Study||33
374001|NCT02010255|917736|P6|COMPLETED|Overall Study||49
374002|NCT02010255|917737|P5|COMPLETED|Overall Study||48
374003|NCT02010255|917738|P4|COMPLETED|Overall Study||20
374004|NCT02010255|917739|P3|COMPLETED|Overall Study||18
374005|NCT02010255|917740|P2|COMPLETED|Overall Study||26
374006|NCT02010255|917741|P1|COMPLETED|Overall Study||22
374007|NCT02010255|917728|P14|STARTED|Overall Study||3
374008|NCT02010255|917729|P13|STARTED|Overall Study||3
374009|NCT02010255|917730|P12|STARTED|Overall Study||5
374010|NCT02010255|917731|P11|STARTED|Overall Study||3
374011|NCT02010255|917732|P10|STARTED|Overall Study||23
374012|NCT02010255|917733|P9|STARTED|Overall Study||22
374013|NCT02010255|917734|P8|STARTED|Overall Study||33
374014|NCT02010255|917735|P7|STARTED|Overall Study||34
374015|NCT02010255|917736|P6|STARTED|Overall Study||49
374016|NCT02010255|917737|P5|STARTED|Overall Study||52
374017|NCT02010255|917738|P4|STARTED|Overall Study||26
374018|NCT02010255|917739|P3|STARTED|Overall Study||25
374019|NCT02010255|917740|P2|STARTED|Overall Study||28
374020|NCT02010255|917741|P1|STARTED|Overall Study||28
374021|NCT02010216|918065|P1|NOT COMPLETED|Overall Study||0
374022|NCT02010216|918065|P1|COMPLETED|Overall Study||23
374023|NCT02010216|918065|P1|STARTED|Overall Study||23
374024|NCT02009982|918073|P2|NOT COMPLETED|Overall Study||0
374025|NCT02009982|918074|P1|NOT COMPLETED|Overall Study||0
374026|NCT02009982|918073|P2|COMPLETED|Overall Study||2
374027|NCT02009982|918074|P1|COMPLETED|Overall Study||1
374028|NCT02009982|918073|P2|STARTED|Overall Study||2
374029|NCT02009982|918074|P1|STARTED|Overall Study||1
374030|NCT02009878|918085|P3|NOT COMPLETED|Overall Study||0
374031|NCT02009878|918086|P2|NOT COMPLETED|Overall Study||1
374032|NCT02009878|918087|P1|NOT COMPLETED|Overall Study||0
374033|NCT02009878|918085|P3|COMPLETED|Overall Study||9
374034|NCT02009878|918086|P2|COMPLETED|Overall Study||10
374035|NCT02009878|918087|P1|COMPLETED|Overall Study||10
374036|NCT02009878|918085|P3|STARTED|Overall Study||9
374037|NCT02009878|918086|P2|STARTED|Overall Study||11
374038|NCT02009878|918087|P1|STARTED|Overall Study||10
374039|NCT02009865|918121|P2|NOT COMPLETED|Overall Study||5
374040|NCT02009865|918122|P1|NOT COMPLETED|Overall Study||1
374041|NCT02009865|918121|P2|COMPLETED|Overall Study||76
374042|NCT02009865|918122|P1|COMPLETED|Overall Study||80
374043|NCT02009865|918121|P2|STARTED|Overall Study||81
374044|NCT02009865|918122|P1|STARTED|Overall Study||81
374045|NCT02009722|918138|P2|NOT COMPLETED|Overall Study||3
374046|NCT02009722|918139|P1|NOT COMPLETED|Overall Study||1
374047|NCT02009722|918138|P2|COMPLETED|Overall Study||40
374048|NCT02009722|918139|P1|COMPLETED|Overall Study||40
374049|NCT02009722|918138|P2|Received Intervention|Overall Study||42
374050|NCT02009722|918139|P1|Received Intervention|Overall Study||41
374051|NCT02009722|918138|P2|STARTED|Overall Study||43
374052|NCT02009722|918139|P1|STARTED|Overall Study||41
374053|NCT02009696|918163|P1|NOT COMPLETED|Overall Study||2
374054|NCT02009696|918163|P1|COMPLETED|Overall Study||219
374055|NCT02009696|918163|P1|STARTED|Overall Study||221
374056|NCT02009163|918171|P3|NOT COMPLETED|Randomized-withdrawal Period||35
374057|NCT02009163|918172|P2|NOT COMPLETED|Randomized-withdrawal Period||88
374058|NCT02009163|918173|P1|NOT COMPLETED|Randomized-withdrawal Period||0
374059|NCT02009163|918171|P3|COMPLETED|Randomized-withdrawal Period||102
374060|NCT02009163|918172|P2|COMPLETED|Randomized-withdrawal Period||50
374061|NCT02009163|918173|P1|COMPLETED|Randomized-withdrawal Period||0
374062|NCT02009163|918171|P3|STARTED|Randomized-withdrawal Period|The total who started the Placebo and SPD489 arms equals those who completed the open-label period.|137
374063|NCT02009163|918172|P2|STARTED|Randomized-withdrawal Period|The total who started the Placebo and SPD489 arms equals those who completed the open-label period.|138
374064|NCT02009163|918173|P1|STARTED|Randomized-withdrawal Period|The open-label treatment group is not an arm of the randomized-withdrawal period.|0
374065|NCT02009163|918171|P3|NOT COMPLETED|Open-label Period (Non-randomized)||0
374066|NCT02009163|918172|P2|NOT COMPLETED|Open-label Period (Non-randomized)||0
374067|NCT02009163|918173|P1|NOT COMPLETED|Open-label Period (Non-randomized)||143
374068|NCT02009163|918171|P3|COMPLETED|Open-label Period (Non-randomized)||0
374069|NCT02009163|918172|P2|COMPLETED|Open-label Period (Non-randomized)||0
374070|NCT02009163|918173|P1|COMPLETED|Open-label Period (Non-randomized)||275
374071|NCT02009163|918171|P3|STARTED|Open-label Period (Non-randomized)||0
374072|NCT02009163|918172|P2|STARTED|Open-label Period (Non-randomized)||0
374073|NCT02009163|918173|P1|STARTED|Open-label Period (Non-randomized)||418
374074|NCT02008942|918206|P2|NOT COMPLETED|Second Intervention||0
374075|NCT02008942|918207|P1|NOT COMPLETED|Second Intervention||1
374076|NCT02008942|918206|P2|COMPLETED|Second Intervention||30
374077|NCT02008942|918207|P1|COMPLETED|Second Intervention||25
374078|NCT02008942|918206|P2|STARTED|Second Intervention||30
374079|NCT02008942|918207|P1|STARTED|Second Intervention||26
374080|NCT02008942|918206|P2|NOT COMPLETED|First Intervention||0
374081|NCT02008942|918207|P1|NOT COMPLETED|First Intervention||0
374082|NCT02008942|918206|P2|COMPLETED|First Intervention||30
374083|NCT02008942|918207|P1|COMPLETED|First Intervention||27
374084|NCT02008942|918206|P2|STARTED|First Intervention||30
374085|NCT02008942|918207|P1|STARTED|First Intervention||27
374086|NCT02008682|918215|P2|NOT COMPLETED|Overall Study||14
374087|NCT02008682|918216|P1|NOT COMPLETED|Overall Study||27
374088|NCT02008682|918215|P2|COMPLETED|Overall Study|Completed without discontinuation of trial product|170
374089|NCT02008682|918216|P1|COMPLETED|Overall Study|Completed without discontinuation of trial product|157
374090|NCT02008682|918215|P2|Exposed|Overall Study||184
374091|NCT02008682|918216|P1|Exposed|Overall Study|1 subject withdrawn before exposure to trial product|183
374092|NCT02008682|918215|P2|STARTED|Overall Study||184
374093|NCT02008682|918216|P1|STARTED|Overall Study||184
374094|NCT02008617|918234|P2|NOT COMPLETED|Overall Study||0
374095|NCT02008617|918235|P1|NOT COMPLETED|Overall Study||0
374096|NCT02008617|918234|P2|COMPLETED|Overall Study||10
374097|NCT02008617|918235|P1|COMPLETED|Overall Study||8
374098|NCT02008617|918234|P2|STARTED|Overall Study||10
374099|NCT02008617|918235|P1|STARTED|Overall Study||8
374100|NCT02008526|918250|P3|NOT COMPLETED|Overall Study||9
374101|NCT02008526|918251|P2|NOT COMPLETED|Overall Study||14
374102|NCT02008526|918252|P1|NOT COMPLETED|Overall Study||8
374103|NCT02008526|918250|P3|COMPLETED|Overall Study||84
374104|NCT02008526|918251|P2|COMPLETED|Overall Study||85
374105|NCT02008526|918252|P1|COMPLETED|Overall Study||86
374106|NCT02008526|918250|P3|STARTED|Overall Study||93
374107|NCT02008526|918251|P2|STARTED|Overall Study||99
374108|NCT02008526|918252|P1|STARTED|Overall Study||94
374109|NCT02008227|918265|P2|NOT COMPLETED|Overall Study||613
374110|NCT02008227|918266|P1|NOT COMPLETED|Overall Study||612
374111|NCT02008227|918265|P2|COMPLETED|Overall Study||0
374112|NCT02008227|918266|P1|COMPLETED|Overall Study||0
374113|NCT02008227|918265|P2|Treated|Overall Study||608
374114|NCT02008227|918266|P1|Treated|Overall Study||579
374115|NCT02008227|918265|P2|STARTED|Overall Study||613
374116|NCT02008227|918266|P1|STARTED|Overall Study||612
374117|NCT02007954|918327|P1|NOT COMPLETED|Overall Study||7
374118|NCT02007954|918327|P1|COMPLETED|Overall Study||17
374119|NCT02007954|918327|P1|Completed First Clinical and Imaging|Overall Study|1 patient exited prior to first imaging follow-up due to unrelated serious adverse event and death|23
374120|NCT02007954|918327|P1|Completed First TACE|Overall Study||24
374121|NCT02007954|918327|P1|STARTED|Overall Study|A total of 32 participants were consented, with 8 patients screened out prior to treatment.|24
374122|NCT02007863|918340|P1|NOT COMPLETED|Overall Study||0
374123|NCT02007863|918340|P1|COMPLETED|Overall Study||2
374124|NCT02007863|918340|P1|STARTED|Overall Study||2
374125|NCT02007577|918346|P2|NOT COMPLETED|Overall Study||1
374126|NCT02007577|918347|P1|NOT COMPLETED|Overall Study||1
374127|NCT02007577|918346|P2|COMPLETED|Overall Study||13
374128|NCT02007577|918347|P1|COMPLETED|Overall Study||26
374129|NCT02007577|918346|P2|STARTED|Overall Study||14
374130|NCT02007577|918347|P1|STARTED|Overall Study||27
374131|NCT02007512|918359|P4|NOT COMPLETED|Open Label Treatment Period||12
374132|NCT02007512|918360|P3|NOT COMPLETED|Open Label Treatment Period||0
374133|NCT02007512|918361|P2|NOT COMPLETED|Open Label Treatment Period||21
374134|NCT02007512|918362|P1|NOT COMPLETED|Open Label Treatment Period||0
374135|NCT02007512|918359|P4|COMPLETED|Open Label Treatment Period||0
374136|NCT02007512|918360|P3|COMPLETED|Open Label Treatment Period||0
374137|NCT02007512|918361|P2|COMPLETED|Open Label Treatment Period||0
374138|NCT02007512|918362|P1|COMPLETED|Open Label Treatment Period||0
374139|NCT02007512|918359|P4|STARTED|Open Label Treatment Period|Of the participants with disease progression in double blind period, 12 entered open label period.|12
374140|NCT02007512|918360|P3|STARTED|Open Label Treatment Period||0
374141|NCT02007512|918361|P2|STARTED|Open Label Treatment Period|Of the participants with disease progression in double blind period, 21 entered open label period.|21
374142|NCT02007512|918362|P1|STARTED|Open Label Treatment Period||0
374143|NCT02007512|918359|P4|NOT COMPLETED|Double Blind Treatment Period||60
374144|NCT02007512|918360|P3|NOT COMPLETED|Double Blind Treatment Period||60
374145|NCT02007512|918361|P2|NOT COMPLETED|Double Blind Treatment Period||64
374146|NCT02007512|918362|P1|NOT COMPLETED|Double Blind Treatment Period||63
374147|NCT02007512|918359|P4|COMPLETED|Double Blind Treatment Period||0
374148|NCT02007512|918360|P3|COMPLETED|Double Blind Treatment Period||0
374149|NCT02007512|918361|P2|COMPLETED|Double Blind Treatment Period||0
374150|NCT02007512|918362|P1|COMPLETED|Double Blind Treatment Period||0
374151|NCT02007512|918359|P4|Treated|Double Blind Treatment Period||60
374152|NCT02007512|918360|P3|Treated|Double Blind Treatment Period||60
374153|NCT02007512|918361|P2|Treated|Double Blind Treatment Period||63
374154|NCT02007512|918362|P1|Treated|Double Blind Treatment Period||62
374155|NCT02007512|918359|P4|STARTED|Double Blind Treatment Period||60
374156|NCT02007512|918360|P3|STARTED|Double Blind Treatment Period||60
374157|NCT02007512|918361|P2|STARTED|Double Blind Treatment Period||64
374158|NCT02007512|918362|P1|STARTED|Double Blind Treatment Period||63
374159|NCT02007434|918432|P8|NOT COMPLETED|Overall Study||0
374160|NCT02007434|918433|P7|NOT COMPLETED|Overall Study||0
374161|NCT02007434|918434|P6|NOT COMPLETED|Overall Study||0
374162|NCT02007434|918435|P5|NOT COMPLETED|Overall Study||0
374163|NCT02007434|918436|P4|NOT COMPLETED|Overall Study||0
374164|NCT02007434|918437|P3|NOT COMPLETED|Overall Study||1
374165|NCT02007434|918438|P2|NOT COMPLETED|Overall Study||1
374166|NCT02007434|918439|P1|NOT COMPLETED|Overall Study||1
374167|NCT02007434|918432|P8|COMPLETED|Overall Study||4
374168|NCT02007434|918433|P7|COMPLETED|Overall Study||18
374169|NCT02007434|918434|P6|COMPLETED|Overall Study||4
374170|NCT02007434|918435|P5|COMPLETED|Overall Study||16
374171|NCT02007434|918436|P4|COMPLETED|Overall Study||4
374172|NCT02007434|918437|P3|COMPLETED|Overall Study||16
374173|NCT02007434|918438|P2|COMPLETED|Overall Study||3
374174|NCT02007434|918439|P1|COMPLETED|Overall Study||16
374175|NCT02007434|918432|P8|Received Treatment|Overall Study||4
374176|NCT02007434|918433|P7|Received Treatment|Overall Study||18
374177|NCT02007434|918434|P6|Received Treatment|Overall Study||4
374178|NCT02007434|918435|P5|Received Treatment|Overall Study||16
374179|NCT02007434|918436|P4|Received Treatment|Overall Study||4
374180|NCT02007434|918437|P3|Received Treatment|Overall Study||17
374181|NCT02007434|918438|P2|Received Treatment|Overall Study||3
374182|NCT02007434|918439|P1|Received Treatment|Overall Study||17
374183|NCT02007434|918432|P8|STARTED|Overall Study||4
374184|NCT02007434|918433|P7|STARTED|Overall Study||18
374185|NCT02007434|918434|P6|STARTED|Overall Study||4
374186|NCT02007434|918435|P5|STARTED|Overall Study||16
374187|NCT02007434|918436|P4|STARTED|Overall Study||4
374188|NCT02007434|918437|P3|STARTED|Overall Study||17
374189|NCT02007434|918438|P2|STARTED|Overall Study||4
374190|NCT02007434|918439|P1|STARTED|Overall Study||17
374191|NCT02007369|918540|P3|NOT COMPLETED|Overall Study||0
374192|NCT02007369|918541|P2|NOT COMPLETED|Overall Study||0
374193|NCT02007369|918542|P1|NOT COMPLETED|Overall Study||0
374194|NCT02007369|918540|P3|COMPLETED|Overall Study||54
374195|NCT02007369|918541|P2|COMPLETED|Overall Study||40
374196|NCT02007369|918542|P1|COMPLETED|Overall Study||42
374197|NCT02007369|918540|P3|STARTED|Overall Study||54
374198|NCT02007369|918541|P2|STARTED|Overall Study||40
374199|NCT02007369|918542|P1|STARTED|Overall Study||42
374200|NCT02007291|918559|P2|NOT COMPLETED|Overall Study||0
374201|NCT02007291|918560|P1|NOT COMPLETED|Overall Study||0
374202|NCT02007291|918559|P2|COMPLETED|Overall Study||23
374203|NCT02007291|918560|P1|COMPLETED|Overall Study||48
374204|NCT02007291|918559|P2|STARTED|Overall Study||23
374205|NCT02007291|918560|P1|STARTED|Overall Study||48
374206|NCT02007278|918570|P2|NOT COMPLETED|Overall Study||3
374207|NCT02007278|918571|P1|NOT COMPLETED|Overall Study||2
374208|NCT02007278|918570|P2|COMPLETED|Overall Study||17
374209|NCT02007278|918571|P1|COMPLETED|Overall Study||18
374210|NCT02007278|918570|P2|STARTED|Overall Study||20
374211|NCT02007278|918571|P1|STARTED|Overall Study||20
374212|NCT02007252|918593|P2|NOT COMPLETED|Overall Study||11
374213|NCT02007252|918594|P1|NOT COMPLETED|Overall Study||11
374214|NCT02007252|918593|P2|COMPLETED|Overall Study||22
374215|NCT02007252|918594|P1|COMPLETED|Overall Study||20
374216|NCT02007252|918593|P2|Pharmacodynamic Analysis Set|Overall Study||33
374217|NCT02007252|918594|P1|Pharmacodynamic Analysis Set|Overall Study||31
374218|NCT02007252|918593|P2|Safety Analysis Set|Overall Study||33
374219|NCT02007252|918594|P1|Safety Analysis Set|Overall Study||31
374220|NCT02007252|918593|P2|STARTED|Overall Study||33
374221|NCT02007252|918594|P1|STARTED|Overall Study||31
374222|NCT02007200|918600|P1|NOT COMPLETED|Overall Study||0
374223|NCT02007200|918600|P1|COMPLETED|Overall Study||55
374224|NCT02007200|918600|P1|STARTED|Overall Study||55
374225|NCT02007096|918609|P2|NOT COMPLETED|Overall Study||16
374226|NCT02007096|918610|P1|NOT COMPLETED|Overall Study||11
374227|NCT02007096|918609|P2|COMPLETED|Overall Study||48
374228|NCT02007096|918610|P1|COMPLETED|Overall Study||52
374229|NCT02007096|918609|P2|STARTED|Overall Study||64
374230|NCT02007096|918610|P1|STARTED|Overall Study||63
374231|NCT02007070|918622|P1|NOT COMPLETED|Overall Study||33
374232|NCT02007070|918622|P1|COMPLETED|Overall Study|Completed 2 years of treatment.|5
374233|NCT02007070|918622|P1|STARTED|Overall Study||38
374234|NCT02006888|918644|P3|NOT COMPLETED|Overall Study||22
374235|NCT02006888|918645|P2|NOT COMPLETED|Overall Study||34
374236|NCT02006888|918646|P1|NOT COMPLETED|Overall Study||36
374237|NCT02006888|918644|P3|COMPLETED|Overall Study||58
374238|NCT02006888|918645|P2|COMPLETED|Overall Study||122
374239|NCT02006888|918646|P1|COMPLETED|Overall Study||122
374240|NCT02006888|918644|P3|STARTED|Overall Study||80
374241|NCT02006888|918645|P2|STARTED|Overall Study||156
374242|NCT02006888|918646|P1|STARTED|Overall Study||158
374243|NCT02006836|918657|P3|NOT COMPLETED|Self-control Period: Month 7-month 12||0
374244|NCT02006836|918658|P2|NOT COMPLETED|Self-control Period: Month 7-month 12||0
374245|NCT02006836|918659|P1|NOT COMPLETED|Self-control Period: Month 7-month 12||0
374246|NCT02006836|918657|P3|COMPLETED|Self-control Period: Month 7-month 12||19
374247|NCT02006836|918658|P2|COMPLETED|Self-control Period: Month 7-month 12||0
374248|NCT02006836|918659|P1|COMPLETED|Self-control Period: Month 7-month 12||0
374249|NCT02006836|918657|P3|STARTED|Self-control Period: Month 7-month 12||19
374250|NCT02006836|918658|P2|STARTED|Self-control Period: Month 7-month 12||0
374251|NCT02006836|918659|P1|STARTED|Self-control Period: Month 7-month 12||0
374252|NCT02006836|918657|P3|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
374253|NCT02006836|918658|P2|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
374254|NCT02006836|918659|P1|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
374255|NCT02006836|918657|P3|COMPLETED|Case-control Period: Month 1- Month 6||0
374256|NCT02006836|918658|P2|COMPLETED|Case-control Period: Month 1- Month 6||20
374257|NCT02006836|918659|P1|COMPLETED|Case-control Period: Month 1- Month 6||20
374258|NCT02006836|918657|P3|STARTED|Case-control Period: Month 1- Month 6||0
374259|NCT02006836|918658|P2|STARTED|Case-control Period: Month 1- Month 6||20
374260|NCT02006836|918659|P1|STARTED|Case-control Period: Month 1- Month 6||20
374261|NCT02006732|918679|P4|NOT COMPLETED|Overall Study||4
374262|NCT02006732|918680|P3|NOT COMPLETED|Overall Study||9
374263|NCT02006732|918681|P2|NOT COMPLETED|Overall Study||12
374264|NCT02006732|918682|P1|NOT COMPLETED|Overall Study||20
374265|NCT02006732|918679|P4|COMPLETED|Overall Study||198
374266|NCT02006732|918680|P3|COMPLETED|Overall Study||193
374267|NCT02006732|918681|P2|COMPLETED|Overall Study||191
374268|NCT02006732|918682|P1|COMPLETED|Overall Study||182
374269|NCT02006732|918679|P4|STARTED|Overall Study||202
374270|NCT02006732|918680|P3|STARTED|Overall Study||202
374271|NCT02006732|918681|P2|STARTED|Overall Study||203
374272|NCT02006732|918682|P1|STARTED|Overall Study||202
374273|NCT02006719|918722|P2|NOT COMPLETED|Overall Study||5
374274|NCT02006719|918723|P1|NOT COMPLETED|Overall Study||18
374275|NCT02006719|918722|P2|COMPLETED|Overall Study||80
374276|NCT02006719|918723|P1|COMPLETED|Overall Study||219
374277|NCT02006719|918722|P2|STARTED|Overall Study||85
374278|NCT02006719|918723|P1|STARTED|Overall Study||237
374279|NCT02006706|918753|P1|NOT COMPLETED|Overall Study||1
374280|NCT02006706|918753|P1|COMPLETED|Overall Study||14
374281|NCT02006706|918753|P1|STARTED|Overall Study||15
374282|NCT02006667|918758|P1|NOT COMPLETED|Overall Study||6
374283|NCT02006667|918758|P1|COMPLETED|Overall Study||7
374284|NCT02006667|918758|P1|STARTED|Overall Study||13
374285|NCT02006654|918770|P2|NOT COMPLETED|Overall Study||44
374286|NCT02006654|918771|P1|NOT COMPLETED|Overall Study||45
374287|NCT02006654|918770|P2|COMPLETED|Overall Study||321
374288|NCT02006654|918771|P1|COMPLETED|Overall Study||324
374289|NCT02006654|918770|P2|Treated|Overall Study||363
374290|NCT02006654|918771|P1|Treated|Overall Study||365
374291|NCT02006654|918770|P2|STARTED|Overall Study||365
374292|NCT02006654|918771|P1|STARTED|Overall Study||369
374293|NCT02006641|918800|P3|NOT COMPLETED|Overall Study||36
374294|NCT02006641|918801|P2|NOT COMPLETED|Overall Study||33
374295|NCT02006641|918802|P1|NOT COMPLETED|Overall Study||26
374296|NCT02006641|918800|P3|COMPLETED|Overall Study||248
374297|NCT02006641|918801|P2|COMPLETED|Overall Study||257
374298|NCT02006641|918802|P1|COMPLETED|Overall Study||258
374299|NCT02006641|918800|P3|Treated|Overall Study||281
374300|NCT02006641|918801|P2|Treated|Overall Study||285
374301|NCT02006641|918802|P1|Treated|Overall Study||282
374302|NCT02006641|918800|P3|STARTED|Overall Study||284
374303|NCT02006641|918801|P2|STARTED|Overall Study||290
374304|NCT02006641|918802|P1|STARTED|Overall Study||284
374305|NCT02006407|918840|P1|NOT COMPLETED|Overall Study||0
374306|NCT02006407|918840|P1|COMPLETED|Overall Study||5
374307|NCT02006407|918840|P1|STARTED|Overall Study||5
374308|NCT02006342|918848|P2|NOT COMPLETED|Overall Study||0
374309|NCT02006342|918849|P1|NOT COMPLETED|Overall Study||1
374310|NCT02006342|918848|P2|COMPLETED|Overall Study||20
374311|NCT02006342|918849|P1|COMPLETED|Overall Study||19
374312|NCT02006342|918848|P2|STARTED|Overall Study||20
374313|NCT02006342|918849|P1|STARTED|Overall Study||20
374314|NCT02006108|918863|P1|NOT COMPLETED|Overall Study||2
374315|NCT02006108|918863|P1|COMPLETED|Overall Study||19
374316|NCT02006108|918863|P1|MR Imaging|Overall Study||19
374317|NCT02006108|918863|P1|STARTED|Overall Study||21
374318|NCT02005692|918868|P1|NOT COMPLETED|Overall Study||7
374319|NCT02005692|918868|P1|COMPLETED|Overall Study||63
374320|NCT02005692|918868|P1|STARTED|Overall Study||70
374321|NCT02005601|918875|P2|NOT COMPLETED|Overall Study||0
374322|NCT02005601|918876|P1|NOT COMPLETED|Overall Study||0
374323|NCT02005601|918875|P2|COMPLETED|Overall Study||53
374324|NCT02005601|918876|P1|COMPLETED|Overall Study||53
374325|NCT02005601|918875|P2|STARTED|Overall Study||53
374326|NCT02005601|918876|P1|STARTED|Overall Study||53
374327|NCT02005562|918888|P2|NOT COMPLETED|Overall Study||15
374328|NCT02005562|918889|P1|NOT COMPLETED|Overall Study||12
374329|NCT02005562|918888|P2|COMPLETED|Overall Study||110
374330|NCT02005562|918889|P1|COMPLETED|Overall Study||115
374331|NCT02005562|918888|P2|Transplanted|Overall Study||121
374332|NCT02005562|918889|P1|Transplanted|Overall Study||126
374333|NCT02005562|918888|P2|STARTED|Overall Study||125
374334|NCT02005562|918889|P1|STARTED|Overall Study||127
374335|NCT02005549|918917|P1|NOT COMPLETED|Overall Study||0
374336|NCT02005549|918917|P1|COMPLETED|Overall Study||18
374337|NCT02005549|918917|P1|STARTED|Overall Study||18
374338|NCT02005536|918923|P1|NOT COMPLETED|Overall Study||0
374339|NCT02005536|918923|P1|COMPLETED|Overall Study||60
374340|NCT02005536|918923|P1|STARTED|Overall Study||60
374341|NCT02005484|918931|P1|NOT COMPLETED|Overall Study||4
374342|NCT02005484|918931|P1|COMPLETED|Overall Study||2
374343|NCT02005484|918931|P1|STARTED|Overall Study||6
374344|NCT02005393|918941|P1|NOT COMPLETED|Overall Study||0
374345|NCT02005393|918941|P1|COMPLETED|Overall Study||20
374346|NCT02005393|918941|P1|STARTED|Overall Study||20
374347|NCT02005211|918952|P7|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
374348|NCT02005211|918953|P6|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
374349|NCT02005211|918954|P5|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||1
374350|NCT02005211|918955|P4|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
374351|NCT02005211|918956|P3|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
374352|NCT02005211|918957|P2|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
374353|NCT02005211|918958|P1|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
374354|NCT02005211|918952|P7|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||4
374355|NCT02005211|918953|P6|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
374356|NCT02005211|918954|P5|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||5
374357|NCT02005211|918955|P4|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
374358|NCT02005211|918956|P3|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
374359|NCT02005211|918957|P2|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
374360|NCT02005211|918958|P1|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
374361|NCT02005211|918952|P7|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||4
374362|NCT02005211|918953|P6|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
374363|NCT02005211|918954|P5|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
374364|NCT02005211|918955|P4|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
374365|NCT02005211|918956|P3|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
374366|NCT02005211|918957|P2|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
374367|NCT02005211|918958|P1|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
374368|NCT02005211|918952|P7|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
374369|NCT02005211|918953|P6|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
374370|NCT02005211|918954|P5|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
374371|NCT02005211|918955|P4|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
374372|NCT02005211|918956|P3|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
374373|NCT02005211|918957|P2|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
374374|NCT02005211|918958|P1|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
374375|NCT02005211|918952|P7|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
374376|NCT02005211|918953|P6|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
374377|NCT02005211|918954|P5|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
374378|NCT02005211|918955|P4|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
374379|NCT02005211|918956|P3|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
374380|NCT02005211|918957|P2|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
374381|NCT02005211|918958|P1|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
374382|NCT02005211|918952|P7|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
374383|NCT02005211|918953|P6|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
374384|NCT02005211|918954|P5|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
374385|NCT02005211|918955|P4|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
374386|NCT02005211|918956|P3|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
374387|NCT02005211|918957|P2|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
374388|NCT02005211|918958|P1|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
374389|NCT02005029|918993|P2|NOT COMPLETED|Second Intervention (1 Day)||0
374390|NCT02005029|918994|P1|NOT COMPLETED|Second Intervention (1 Day)||0
374391|NCT02005029|918993|P2|COMPLETED|Second Intervention (1 Day)||5
374392|NCT02005029|918994|P1|COMPLETED|Second Intervention (1 Day)||4
374393|NCT02005029|918993|P2|STARTED|Second Intervention (1 Day)||5
374394|NCT02005029|918994|P1|STARTED|Second Intervention (1 Day)||4
374395|NCT02005029|918993|P2|NOT COMPLETED|Washout (2 Weeks)||0
374396|NCT02005029|918994|P1|NOT COMPLETED|Washout (2 Weeks)||0
374397|NCT02005029|918993|P2|COMPLETED|Washout (2 Weeks)||5
374398|NCT02005029|918994|P1|COMPLETED|Washout (2 Weeks)||4
374399|NCT02005029|918993|P2|STARTED|Washout (2 Weeks)||5
374400|NCT02005029|918994|P1|STARTED|Washout (2 Weeks)||4
374401|NCT02005029|918993|P2|NOT COMPLETED|First Intervention (1 Day)||0
374402|NCT02005029|918994|P1|NOT COMPLETED|First Intervention (1 Day)||1
374403|NCT02005029|918993|P2|COMPLETED|First Intervention (1 Day)||5
374404|NCT02005029|918994|P1|COMPLETED|First Intervention (1 Day)||4
374405|NCT02005029|918993|P2|STARTED|First Intervention (1 Day)||5
374406|NCT02005029|918994|P1|STARTED|First Intervention (1 Day)||5
374407|NCT02004990|919020|P1|NOT COMPLETED|Overall Study||0
374408|NCT02004990|919020|P1|COMPLETED|Overall Study||12
374409|NCT02004990|919020|P1|STARTED|Overall Study||12
374410|NCT02004977|919027|P2|NOT COMPLETED|Overall Study||5
374411|NCT02004977|919028|P1|NOT COMPLETED|Overall Study||54
374412|NCT02004977|919027|P2|COMPLETED|Overall Study||436
374413|NCT02004977|919028|P1|COMPLETED|Overall Study||409
374414|NCT02004977|919027|P2|STARTED|Overall Study||441
374415|NCT02004977|919028|P1|STARTED|Overall Study||463
374416|NCT02004886|919046|P4|NOT COMPLETED|Overall Study||0
374417|NCT02004886|919047|P3|NOT COMPLETED|Overall Study||0
374418|NCT02004886|919048|P2|NOT COMPLETED|Overall Study||1
374419|NCT02004886|919049|P1|NOT COMPLETED|Overall Study||1
374420|NCT02004886|919046|P4|COMPLETED|Overall Study||19
374421|NCT02004886|919047|P3|COMPLETED|Overall Study||18
374422|NCT02004886|919048|P2|COMPLETED|Overall Study||17
374423|NCT02004886|919049|P1|COMPLETED|Overall Study||18
374424|NCT02004886|919046|P4|STARTED|Overall Study||19
374425|NCT02004886|919047|P3|STARTED|Overall Study||18
374426|NCT02004886|919048|P2|STARTED|Overall Study||18
374427|NCT02004886|919049|P1|STARTED|Overall Study||19
374428|NCT02004873|919099|P1|NOT COMPLETED|Overall Study||424
374429|NCT02004873|919099|P1|COMPLETED|Overall Study|6-Month Follow-up|301
374430|NCT02004873|919099|P1|Micra Implant Success|Overall Study||719
374431|NCT02004873|919099|P1|STARTED|Overall Study|Micra Implant Attempt|725
374432|NCT02004847|919108|P2|NOT COMPLETED|Overall Study||1
374433|NCT02004847|919109|P1|NOT COMPLETED|Overall Study||1
374434|NCT02004847|919108|P2|COMPLETED|Overall Study||22
374435|NCT02004847|919109|P1|COMPLETED|Overall Study||23
374436|NCT02004847|919108|P2|STARTED|Overall Study||23
374437|NCT02004847|919109|P1|STARTED|Overall Study||24
374438|NCT02004262|919159|P6|NOT COMPLETED|Overall Study||30
374439|NCT02004262|919160|P5|NOT COMPLETED|Overall Study||31
374440|NCT02004262|919161|P4|NOT COMPLETED|Overall Study||29
374441|NCT02004262|919162|P3|NOT COMPLETED|Overall Study||72
374442|NCT02004262|919163|P2|NOT COMPLETED|Overall Study||68
374443|NCT02004262|919164|P1|NOT COMPLETED|Overall Study||73
374444|NCT02004262|919159|P6|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
374445|NCT02004262|919160|P5|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
374446|NCT02004262|919161|P4|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
374447|NCT02004262|919162|P3|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
374448|NCT02004262|919163|P2|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
374449|NCT02004262|919164|P1|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
374450|NCT02004262|919159|P6|Treated|Overall Study||11
374451|NCT02004262|919160|P5|Treated|Overall Study||29
374452|NCT02004262|919161|P4|Treated|Overall Study||26
374453|NCT02004262|919162|P3|Treated|Overall Study||43
374454|NCT02004262|919163|P2|Treated|Overall Study||58
374455|NCT02004262|919164|P1|Treated|Overall Study||68
374456|NCT02004262|919159|P6|STARTED|Overall Study||30
374457|NCT02004262|919160|P5|STARTED|Overall Study||31
374458|NCT02004262|919161|P4|STARTED|Overall Study||29
374459|NCT02004262|919162|P3|STARTED|Overall Study||72
374460|NCT02004262|919163|P2|STARTED|Overall Study||68
374461|NCT02004262|919164|P1|STARTED|Overall Study||73
374462|NCT02004236|919184|P3|NOT COMPLETED|Overall Study||16
374463|NCT02004236|919185|P2|NOT COMPLETED|Overall Study||0
374464|NCT02004236|919186|P1|NOT COMPLETED|Overall Study||0
374465|NCT02004236|919184|P3|COMPLETED|Overall Study|Leave the group because the parents does't find any clinical improvement.|59
374466|NCT02004236|919185|P2|COMPLETED|Overall Study||75
374467|NCT02004236|919186|P1|COMPLETED|Overall Study||75
374468|NCT02004236|919184|P3|STARTED|Overall Study||75
374469|NCT02004236|919185|P2|STARTED|Overall Study||75
374470|NCT02004236|919186|P1|STARTED|Overall Study||75
374471|NCT02004158|919230|P1|NOT COMPLETED|Overall Study||3
374472|NCT02004158|919230|P1|COMPLETED|Overall Study||20
374473|NCT02004158|919230|P1|STARTED|Overall Study||23
374474|NCT02004132|919238|P1|NOT COMPLETED|Overall Study||0
374475|NCT02004132|919238|P1|COMPLETED|Overall Study||12
374476|NCT02004132|919238|P1|Received Study Drug|Overall Study||12
374477|NCT02004132|919238|P1|STARTED|Overall Study||12
374478|NCT02004093|919246|P2|NOT COMPLETED|Overall Study||73
374479|NCT02004093|919247|P1|NOT COMPLETED|Overall Study||74
374480|NCT02004093|919246|P2|COMPLETED|Overall Study||1
374481|NCT02004093|919247|P1|COMPLETED|Overall Study||1
374482|NCT02004093|919246|P2|STARTED|Overall Study||74
374483|NCT02004093|919247|P1|STARTED|Overall Study|Includes 1 participant who was randomized to chemotherapy group but received pertuzumab+chemotherapy|75
374484|NCT02003963|919279|P2|NOT COMPLETED|Overall Study||1
374485|NCT02003963|919280|P1|NOT COMPLETED|Overall Study||2
374486|NCT02003963|919279|P2|COMPLETED|Overall Study|1 participant was removed from analysis for completing final visit outside of visit window.|18
374487|NCT02003963|919280|P1|COMPLETED|Overall Study|2 participants dropped out: 1 due to lack of interest and 1 due to a mental health hospitalization.|20
374488|NCT02003963|919279|P2|STARTED|Overall Study||19
374489|NCT02003963|919280|P1|STARTED|Overall Study||22
374490|NCT02003638|919302|P2|NOT COMPLETED|Overall Study||0
374491|NCT02003638|919303|P1|NOT COMPLETED|Overall Study||1
374492|NCT02003638|919302|P2|COMPLETED|Overall Study||3
374493|NCT02003638|919303|P1|COMPLETED|Overall Study|1 withdrew after developing bacterial pharyngitis. Not considered treatment-emergent.|5
374494|NCT02003638|919302|P2|STARTED|Overall Study||3
374495|NCT02003638|919303|P1|STARTED|Overall Study||6
374496|NCT02003534|919309|P1|NOT COMPLETED|Overall Study||47
374497|NCT02003534|919309|P1|COMPLETED|Overall Study||329
374498|NCT02003534|919309|P1|STARTED|Overall Study||376
374499|NCT02003404|919313|P1|NOT COMPLETED|Overall Study||0
374500|NCT02003404|919313|P1|COMPLETED|Overall Study||17
374501|NCT02003404|919313|P1|STARTED|Overall Study||17
374502|NCT02003391|919321|P2|NOT COMPLETED|Overall Study||2
374503|NCT02003391|919322|P1|NOT COMPLETED|Overall Study||3
374504|NCT02003391|919321|P2|COMPLETED|Overall Study||73
374505|NCT02003391|919322|P1|COMPLETED|Overall Study||78
374506|NCT02003391|919321|P2|Intent to Treat Population|Overall Study||73
374507|NCT02003391|919322|P1|Intent to Treat Population|Overall Study||78
374508|NCT02003391|919321|P2|Safety Population|Overall Study||75
374509|NCT02003391|919322|P1|Safety Population|Overall Study||81
374510|NCT02003391|919321|P2|STARTED|Overall Study||75
374511|NCT02003391|919322|P1|STARTED|Overall Study||81
374512|NCT02003365|919335|P3|NOT COMPLETED|Overall Study||1
374513|NCT02003365|919336|P2|NOT COMPLETED|Overall Study||0
374514|NCT02003365|919337|P1|NOT COMPLETED|Overall Study||0
374515|NCT02003365|919335|P3|COMPLETED|Overall Study||9
374516|NCT02003365|919336|P2|COMPLETED|Overall Study||30
374517|NCT02003365|919337|P1|COMPLETED|Overall Study||10
374518|NCT02003365|919335|P3|STARTED|Overall Study||10
374519|NCT02003365|919336|P2|STARTED|Overall Study||30
374520|NCT02003365|919337|P1|STARTED|Overall Study||10
374521|NCT02003352|919348|P1|NOT COMPLETED|Overall Study||0
374522|NCT02003352|919348|P1|COMPLETED|Overall Study||98
374523|NCT02003352|919348|P1|STARTED|Overall Study||98
374524|NCT02003053|919354|P2|NOT COMPLETED|Overall Study||0
374525|NCT02003053|919355|P1|NOT COMPLETED|Overall Study||0
374526|NCT02003053|919354|P2|COMPLETED|Overall Study||3
374527|NCT02003053|919355|P1|COMPLETED|Overall Study||4
374528|NCT02003053|919354|P2|STARTED|Overall Study||3
374529|NCT02003053|919355|P1|STARTED|Overall Study||4
374530|NCT02003014|919361|P1|NOT COMPLETED|Overall Study||19
374531|NCT02003014|919361|P1|COMPLETED|Overall Study||880
374532|NCT02003014|919361|P1|STARTED|Overall Study||899
374533|NCT02002936|919371|P1|NOT COMPLETED|Overall Study||0
374534|NCT02002936|919371|P1|COMPLETED|Overall Study||1
374535|NCT02002936|919371|P1|STARTED|Overall Study||1
374536|NCT02002871|919380|P1|NOT COMPLETED|Overall Study||1
374537|NCT02002871|919380|P1|COMPLETED|Overall Study||20
374538|NCT02002871|919380|P1|STARTED|Overall Study||21
374539|NCT02002702|919409|P3|NOT COMPLETED|Overall Study||0
374540|NCT02002702|919410|P2|NOT COMPLETED|Overall Study||0
374541|NCT02002702|919411|P1|NOT COMPLETED|Overall Study||0
374542|NCT02002702|919409|P3|COMPLETED|Overall Study||15
374543|NCT02002702|919410|P2|COMPLETED|Overall Study||15
374544|NCT02002702|919411|P1|COMPLETED|Overall Study||16
374545|NCT02002702|919409|P3|STARTED|Overall Study||15
374546|NCT02002702|919410|P2|STARTED|Overall Study||15
374547|NCT02002702|919411|P1|STARTED|Overall Study||16
374548|NCT02002689|919443|P1|NOT COMPLETED|Overall Study||10
374549|NCT02002689|919443|P1|COMPLETED|Overall Study||0
374550|NCT02002689|919443|P1|STARTED|Overall Study||10
374551|NCT02002650|919451|P2|NOT COMPLETED|Overall Study||0
374552|NCT02002650|919452|P1|NOT COMPLETED|Overall Study||0
374553|NCT02002650|919451|P2|COMPLETED|Overall Study||1303
374554|NCT02002650|919452|P1|COMPLETED|Overall Study||1297
374555|NCT02002650|919451|P2|STARTED|Overall Study||1303
374556|NCT02002650|919452|P1|STARTED|Overall Study||1297
374557|NCT02002533|919462|P2|NOT COMPLETED|Overall Study||18
374558|NCT02002533|919463|P1|NOT COMPLETED|Overall Study||6
374559|NCT02002533|919462|P2|COMPLETED|Overall Study||19
374560|NCT02002533|919463|P1|COMPLETED|Overall Study||28
374561|NCT02002533|919462|P2|STARTED|Overall Study||37
374562|NCT02002533|919463|P1|STARTED|Overall Study||34
374563|NCT02002221|919488|P2|NOT COMPLETED|Overall Study||3
374564|NCT02002221|919489|P1|NOT COMPLETED|Overall Study||2
374565|NCT02002221|919488|P2|COMPLETED|Overall Study||75
374566|NCT02002221|919489|P1|COMPLETED|Overall Study||76
374567|NCT02002221|919488|P2|STARTED|Overall Study||78
374568|NCT02002221|919489|P1|STARTED|Overall Study||78
374569|NCT02002208|919505|P2|NOT COMPLETED|Overall Study||40
374570|NCT02002208|919506|P1|NOT COMPLETED|Overall Study||37
374571|NCT02002208|919505|P2|COMPLETED|Overall Study||30
374572|NCT02002208|919506|P1|COMPLETED|Overall Study||32
374573|NCT02002208|919505|P2|STARTED|Overall Study||70
374574|NCT02002208|919506|P1|STARTED|Overall Study||69
374575|NCT02001714|919516|P2|NOT COMPLETED|Overall Study||12
374576|NCT02001714|919517|P1|NOT COMPLETED|Overall Study||22
374577|NCT02001714|919516|P2|COMPLETED|Overall Study||219
374578|NCT02001714|919517|P1|COMPLETED|Overall Study||210
374579|NCT02001714|919516|P2|STARTED|Overall Study||231
374580|NCT02001714|919517|P1|STARTED|Overall Study||232
374581|NCT02001181|919525|P2|NOT COMPLETED|Overall Study||3
374582|NCT02001181|919526|P1|NOT COMPLETED|Overall Study||1
374583|NCT02001181|919525|P2|COMPLETED|Overall Study||31
374584|NCT02001181|919526|P1|COMPLETED|Overall Study||34
374585|NCT02001181|919525|P2|STARTED|Overall Study||34
374586|NCT02001181|919526|P1|STARTED|Overall Study||35
374587|NCT02001051|919542|P2|NOT COMPLETED|Overall Study||1
374588|NCT02001051|919543|P1|NOT COMPLETED|Overall Study||0
374589|NCT02001051|919542|P2|COMPLETED|Overall Study||1
374590|NCT02001051|919543|P1|COMPLETED|Overall Study||2
374591|NCT02001051|919542|P2|STARTED|Overall Study||2
374592|NCT02001051|919543|P1|STARTED|Overall Study||2
374593|NCT02000973|919567|P4|NOT COMPLETED|Overall Study||0
374594|NCT02000973|919568|P3|NOT COMPLETED|Overall Study||0
374595|NCT02000973|919569|P2|NOT COMPLETED|Overall Study||0
374596|NCT02000973|919570|P1|NOT COMPLETED|Overall Study||0
374597|NCT02000973|919567|P4|COMPLETED|Overall Study||20
374598|NCT02000973|919568|P3|COMPLETED|Overall Study||20
374599|NCT02000973|919569|P2|COMPLETED|Overall Study||20
374600|NCT02000973|919570|P1|COMPLETED|Overall Study||20
374601|NCT02000973|919567|P4|STARTED|Overall Study||20
374602|NCT02000973|919568|P3|STARTED|Overall Study||20
374603|NCT02000973|919569|P2|STARTED|Overall Study||20
374604|NCT02000973|919570|P1|STARTED|Overall Study||20
374605|NCT02000921|919595|P3|NOT COMPLETED|Overall Study||10
374606|NCT02000921|919596|P2|NOT COMPLETED|Overall Study||16
374607|NCT02000921|919597|P1|NOT COMPLETED|Overall Study||5
374608|NCT02000921|919595|P3|COMPLETED|Overall Study||46
374609|NCT02000921|919596|P2|COMPLETED|Overall Study||37
374610|NCT02000921|919597|P1|COMPLETED|Overall Study||22
374611|NCT02000921|919595|P3|STARTED|Overall Study||56
374612|NCT02000921|919596|P2|STARTED|Overall Study||53
374613|NCT02000921|919597|P1|STARTED|Overall Study||27
374614|NCT02000752|919616|P2|NOT COMPLETED|Overall Study||13
374615|NCT02000752|919617|P1|NOT COMPLETED|Overall Study||31
374616|NCT02000752|919616|P2|COMPLETED|Overall Study||47
374617|NCT02000752|919617|P1|COMPLETED|Overall Study||29
374618|NCT02000752|919616|P2|STARTED|Overall Study||60
374619|NCT02000752|919617|P1|STARTED|Overall Study||60
374620|NCT02000622|919631|P2|NOT COMPLETED|Overall Study||53
374621|NCT02000622|919632|P1|NOT COMPLETED|Overall Study||101
374622|NCT02000622|919631|P2|COMPLETED|Overall Study|Patients were ongoing on the study at the data cut-off.|44
374623|NCT02000622|919632|P1|COMPLETED|Overall Study|Patients were ongoing on the study at the data cut-off.|104
374624|NCT02000622|919631|P2|STARTED|Overall Study||97
374625|NCT02000622|919632|P1|STARTED|Overall Study||205
374626|NCT02000531|919654|P2|NOT COMPLETED|Overall Study||8
374627|NCT02000531|919655|P1|NOT COMPLETED|Overall Study||4
374628|NCT02000531|919654|P2|COMPLETED|Overall Study||16
374629|NCT02000531|919655|P1|COMPLETED|Overall Study||17
374630|NCT02000531|919654|P2|Safety Population|Overall Study||24
374631|NCT02000531|919655|P1|Safety Population|Overall Study||21
374632|NCT02000531|919654|P2|STARTED|Overall Study||24
374633|NCT02000531|919655|P1|STARTED|Overall Study||21
374634|NCT02000440|919663|P1|NOT COMPLETED|Overall Study||4
374635|NCT02000440|919663|P1|COMPLETED|Overall Study||13
374636|NCT02000440|919663|P1|STARTED|Overall Study||17
374637|NCT02000427|919683|P1|NOT COMPLETED|Overall Study||22
374638|NCT02000427|919683|P1|COMPLETED|Overall Study|Indicates participants ongoing in study as of the data cut-off date of 20 May 2015.|23
374639|NCT02000427|919683|P1|STARTED|Overall Study||45
374640|NCT02000180|919700|P2|NOT COMPLETED|Overall Study||0
374641|NCT02000180|919701|P1|NOT COMPLETED|Overall Study||0
374642|NCT02000180|919700|P2|COMPLETED|Overall Study||19
374643|NCT02000180|919701|P1|COMPLETED|Overall Study||18
374644|NCT02000180|919700|P2|STARTED|Overall Study||19
374645|NCT02000180|919701|P1|STARTED|Overall Study||18
374646|NCT02000154|919713|P1|NOT COMPLETED|Overall Study||0
374647|NCT02000154|919713|P1|COMPLETED|Overall Study||1
374648|NCT02000154|919713|P1|STARTED|Overall Study||1
374649|NCT01999920|919723|P2|NOT COMPLETED|Overall Study||2
374650|NCT01999920|919724|P1|NOT COMPLETED|Overall Study||6
374651|NCT01999920|919723|P2|COMPLETED|Overall Study||9
374652|NCT01999920|919724|P1|COMPLETED|Overall Study||7
374653|NCT01999920|919723|P2|STARTED|Overall Study||11
374654|NCT01999920|919724|P1|STARTED|Overall Study||13
374655|NCT01999894|919740|P1|NOT COMPLETED|Overall Study||36
374656|NCT01999894|919740|P1|COMPLETED|Overall Study||66
374657|NCT01999894|919740|P1|STARTED|Overall Study||102
374658|NCT01999400|919745|P6|NOT COMPLETED|Fourth Intervention (1 Day)||0
374659|NCT01999400|919746|P5|NOT COMPLETED|Fourth Intervention (1 Day)||0
374660|NCT01999400|919747|P4|NOT COMPLETED|Fourth Intervention (1 Day)||0
374661|NCT01999400|919748|P3|NOT COMPLETED|Fourth Intervention (1 Day)||0
374662|NCT01999400|919749|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
374663|NCT01999400|919750|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
374664|NCT01999400|919745|P6|COMPLETED|Fourth Intervention (1 Day)||0
374665|NCT01999400|919746|P5|COMPLETED|Fourth Intervention (1 Day)||0
374666|NCT01999400|919747|P4|COMPLETED|Fourth Intervention (1 Day)||0
374667|NCT01999400|919748|P3|COMPLETED|Fourth Intervention (1 Day)||1
374668|NCT01999400|919749|P2|COMPLETED|Fourth Intervention (1 Day)||0
374669|NCT01999400|919750|P1|COMPLETED|Fourth Intervention (1 Day)||1
374670|NCT01999400|919745|P6|STARTED|Fourth Intervention (1 Day)||0
374671|NCT01999400|919746|P5|STARTED|Fourth Intervention (1 Day)||0
374672|NCT01999400|919747|P4|STARTED|Fourth Intervention (1 Day)||0
374673|NCT01999400|919748|P3|STARTED|Fourth Intervention (1 Day)||1
374674|NCT01999400|919749|P2|STARTED|Fourth Intervention (1 Day)||0
374675|NCT01999400|919750|P1|STARTED|Fourth Intervention (1 Day)||1
374676|NCT01999400|919745|P6|NOT COMPLETED|Washout (10 Days)||0
374677|NCT01999400|919746|P5|NOT COMPLETED|Washout (10 Days)||0
374678|NCT01999400|919747|P4|NOT COMPLETED|Washout (10 Days)||0
374679|NCT01999400|919748|P3|NOT COMPLETED|Washout (10 Days)||0
374680|NCT01999400|919749|P2|NOT COMPLETED|Washout (10 Days)||0
374681|NCT01999400|919750|P1|NOT COMPLETED|Washout (10 Days)||0
374682|NCT01999400|919745|P6|COMPLETED|Washout (10 Days)||0
374683|NCT01999400|919746|P5|COMPLETED|Washout (10 Days)||0
374684|NCT01999400|919747|P4|COMPLETED|Washout (10 Days)||0
374685|NCT01999400|919748|P3|COMPLETED|Washout (10 Days)||1
374686|NCT01999400|919749|P2|COMPLETED|Washout (10 Days)||0
374687|NCT01999400|919750|P1|COMPLETED|Washout (10 Days)||1
374688|NCT01999400|919745|P6|STARTED|Washout (10 Days)||0
374689|NCT01999400|919746|P5|STARTED|Washout (10 Days)||0
374690|NCT01999400|919747|P4|STARTED|Washout (10 Days)||0
374691|NCT01999400|919748|P3|STARTED|Washout (10 Days)||1
374692|NCT01999400|919749|P2|STARTED|Washout (10 Days)||0
374693|NCT01999400|919750|P1|STARTED|Washout (10 Days)||1
374694|NCT01999400|919745|P6|NOT COMPLETED|Third Intervention (1 Day)||1
374695|NCT01999400|919746|P5|NOT COMPLETED|Third Intervention (1 Day)||0
374696|NCT01999400|919747|P4|NOT COMPLETED|Third Intervention (1 Day)||0
374697|NCT01999400|919748|P3|NOT COMPLETED|Third Intervention (1 Day)||0
374698|NCT01999400|919749|P2|NOT COMPLETED|Third Intervention (1 Day)||0
374699|NCT01999400|919750|P1|NOT COMPLETED|Third Intervention (1 Day)||0
374700|NCT01999400|919745|P6|COMPLETED|Third Intervention (1 Day)||0
374701|NCT01999400|919746|P5|COMPLETED|Third Intervention (1 Day)||1
374702|NCT01999400|919747|P4|COMPLETED|Third Intervention (1 Day)||1
374703|NCT01999400|919748|P3|COMPLETED|Third Intervention (1 Day)||1
374704|NCT01999400|919749|P2|COMPLETED|Third Intervention (1 Day)||0
374705|NCT01999400|919750|P1|COMPLETED|Third Intervention (1 Day)||2
374706|NCT01999400|919745|P6|STARTED|Third Intervention (1 Day)||1
374707|NCT01999400|919746|P5|STARTED|Third Intervention (1 Day)||1
374708|NCT01999400|919747|P4|STARTED|Third Intervention (1 Day)||1
374709|NCT01999400|919748|P3|STARTED|Third Intervention (1 Day)||1
374710|NCT01999400|919749|P2|STARTED|Third Intervention (1 Day)||0
374711|NCT01999400|919750|P1|STARTED|Third Intervention (1 Day)||2
374712|NCT01999400|919745|P6|NOT COMPLETED|Washout (10 Days)||0
374713|NCT01999400|919746|P5|NOT COMPLETED|Washout (10 Days)||0
374714|NCT01999400|919747|P4|NOT COMPLETED|Washout (10 Days)||0
374715|NCT01999400|919748|P3|NOT COMPLETED|Washout (10 Days)||0
374716|NCT01999400|919749|P2|NOT COMPLETED|Washout (10 Days)||0
374717|NCT01999400|919750|P1|NOT COMPLETED|Washout (10 Days)||0
374718|NCT01999400|919745|P6|COMPLETED|Washout (10 Days)||1
374719|NCT01999400|919746|P5|COMPLETED|Washout (10 Days)||1
374720|NCT01999400|919747|P4|COMPLETED|Washout (10 Days)||1
374721|NCT01999400|919748|P3|COMPLETED|Washout (10 Days)||1
374722|NCT01999400|919749|P2|COMPLETED|Washout (10 Days)||0
374723|NCT01999400|919750|P1|COMPLETED|Washout (10 Days)||2
374724|NCT01999400|919745|P6|STARTED|Washout (10 Days)||1
374725|NCT01999400|919746|P5|STARTED|Washout (10 Days)||1
374726|NCT01999400|919747|P4|STARTED|Washout (10 Days)||1
374727|NCT01999400|919748|P3|STARTED|Washout (10 Days)||1
374728|NCT01999400|919749|P2|STARTED|Washout (10 Days)||0
374729|NCT01999400|919750|P1|STARTED|Washout (10 Days)||2
374730|NCT01999400|919745|P6|NOT COMPLETED|Second Intervention (1 Day)||0
374731|NCT01999400|919746|P5|NOT COMPLETED|Second Intervention (1 Day)||0
374732|NCT01999400|919747|P4|NOT COMPLETED|Second Intervention (1 Day)||0
374733|NCT01999400|919748|P3|NOT COMPLETED|Second Intervention (1 Day)||0
374734|NCT01999400|919749|P2|NOT COMPLETED|Second Intervention (1 Day)||0
374735|NCT01999400|919750|P1|NOT COMPLETED|Second Intervention (1 Day)||0
374736|NCT01999400|919745|P6|COMPLETED|Second Intervention (1 Day)||3
374737|NCT01999400|919746|P5|COMPLETED|Second Intervention (1 Day)||3
374738|NCT01999400|919747|P4|COMPLETED|Second Intervention (1 Day)||2
374739|NCT01999400|919748|P3|COMPLETED|Second Intervention (1 Day)||3
374740|NCT01999400|919749|P2|COMPLETED|Second Intervention (1 Day)||4
374741|NCT01999400|919750|P1|COMPLETED|Second Intervention (1 Day)||5
374742|NCT01999400|919745|P6|STARTED|Second Intervention (1 Day)||3
374743|NCT01999400|919746|P5|STARTED|Second Intervention (1 Day)||3
374744|NCT01999400|919747|P4|STARTED|Second Intervention (1 Day)||2
374745|NCT01999400|919748|P3|STARTED|Second Intervention (1 Day)||3
374746|NCT01999400|919749|P2|STARTED|Second Intervention (1 Day)||4
374747|NCT01999400|919750|P1|STARTED|Second Intervention (1 Day)||5
374748|NCT01999400|919745|P6|NOT COMPLETED|Washout (10 Days)||0
374749|NCT01999400|919746|P5|NOT COMPLETED|Washout (10 Days)||0
374750|NCT01999400|919747|P4|NOT COMPLETED|Washout (10 Days)||0
374751|NCT01999400|919748|P3|NOT COMPLETED|Washout (10 Days)||0
374752|NCT01999400|919749|P2|NOT COMPLETED|Washout (10 Days)||0
374753|NCT01999400|919750|P1|NOT COMPLETED|Washout (10 Days)||0
374754|NCT01999400|919745|P6|COMPLETED|Washout (10 Days)||3
374755|NCT01999400|919746|P5|COMPLETED|Washout (10 Days)||3
374756|NCT01999400|919747|P4|COMPLETED|Washout (10 Days)||2
374757|NCT01999400|919748|P3|COMPLETED|Washout (10 Days)||3
374758|NCT01999400|919749|P2|COMPLETED|Washout (10 Days)||4
374759|NCT01999400|919750|P1|COMPLETED|Washout (10 Days)||5
374760|NCT01999400|919745|P6|STARTED|Washout (10 Days)||3
374761|NCT01999400|919746|P5|STARTED|Washout (10 Days)||3
374762|NCT01999400|919747|P4|STARTED|Washout (10 Days)||2
374763|NCT01999400|919748|P3|STARTED|Washout (10 Days)||3
374764|NCT01999400|919749|P2|STARTED|Washout (10 Days)||4
374765|NCT01999400|919750|P1|STARTED|Washout (10 Days)||5
374766|NCT01999400|919745|P6|NOT COMPLETED|First Intervention (1 Day)||1
374767|NCT01999400|919746|P5|NOT COMPLETED|First Intervention (1 Day)||0
374768|NCT01999400|919747|P4|NOT COMPLETED|First Intervention (1 Day)||3
374769|NCT01999400|919748|P3|NOT COMPLETED|First Intervention (1 Day)||2
374770|NCT01999400|919749|P2|NOT COMPLETED|First Intervention (1 Day)||2
374771|NCT01999400|919750|P1|NOT COMPLETED|First Intervention (1 Day)||2
374772|NCT01999400|919745|P6|COMPLETED|First Intervention (1 Day)||3
374773|NCT01999400|919746|P5|COMPLETED|First Intervention (1 Day)||4
374774|NCT01999400|919747|P4|COMPLETED|First Intervention (1 Day)||2
374775|NCT01999400|919748|P3|COMPLETED|First Intervention (1 Day)||3
374776|NCT01999400|919749|P2|COMPLETED|First Intervention (1 Day)||4
374777|NCT01999400|919750|P1|COMPLETED|First Intervention (1 Day)||4
374778|NCT01999400|919745|P6|STARTED|First Intervention (1 Day)||4
374779|NCT01999400|919746|P5|STARTED|First Intervention (1 Day)||4
374780|NCT01999400|919747|P4|STARTED|First Intervention (1 Day)||5
374781|NCT01999400|919748|P3|STARTED|First Intervention (1 Day)||5
374782|NCT01999400|919749|P2|STARTED|First Intervention (1 Day)||6
374783|NCT01999400|919750|P1|STARTED|First Intervention (1 Day)||6
374784|NCT01999348|919770|P1|NOT COMPLETED|Overall Study||120
374785|NCT01999348|919770|P1|COMPLETED|Overall Study||1433
374786|NCT01999348|919770|P1|STARTED|Overall Study||1553
374787|NCT01999322|919782|P2|NOT COMPLETED|Overall Study||0
374788|NCT01999322|919783|P1|NOT COMPLETED|Overall Study||1
374789|NCT01999322|919782|P2|COMPLETED|Overall Study||12
374790|NCT01999322|919783|P1|COMPLETED|Overall Study||24
374791|NCT01999322|919782|P2|STARTED|Overall Study||12
374792|NCT01999322|919783|P1|STARTED|Overall Study||25
374793|NCT01999231|919799|P4|NOT COMPLETED|Overall Study||0
374794|NCT01999231|919800|P3|NOT COMPLETED|Overall Study||0
374795|NCT01999231|919801|P2|NOT COMPLETED|Overall Study||0
374796|NCT01999231|919802|P1|NOT COMPLETED|Overall Study||0
374797|NCT01999231|919799|P4|COMPLETED|Overall Study||6
374798|NCT01999231|919800|P3|COMPLETED|Overall Study||6
374799|NCT01999231|919801|P2|COMPLETED|Overall Study||6
374800|NCT01999231|919802|P1|COMPLETED|Overall Study||6
374801|NCT01999231|919799|P4|STARTED|Overall Study||6
374802|NCT01999231|919800|P3|STARTED|Overall Study||6
374803|NCT01999231|919801|P2|STARTED|Overall Study||6
374804|NCT01999231|919802|P1|STARTED|Overall Study||6
374805|NCT01999218|919835|P3|NOT COMPLETED|Overall Study||110
374806|NCT01999218|919836|P2|NOT COMPLETED|Overall Study||101
374807|NCT01999218|919837|P1|NOT COMPLETED|Overall Study||109
374808|NCT01999218|919835|P3|COMPLETED|Overall Study||327
374809|NCT01999218|919836|P2|COMPLETED|Overall Study||340
374810|NCT01999218|919837|P1|COMPLETED|Overall Study||339
374811|NCT01999218|919835|P3|Site Issue|Overall Study||435
374812|NCT01999218|919836|P2|Site Issue|Overall Study||435
374813|NCT01999218|919837|P1|Site Issue|Overall Study||445
374814|NCT01999218|919835|P3|Treated|Overall Study||437
374815|NCT01999218|919836|P2|Treated|Overall Study||440
374816|NCT01999218|919837|P1|Treated|Overall Study||448
374817|NCT01999218|919835|P3|STARTED|Overall Study||437
374818|NCT01999218|919836|P2|STARTED|Overall Study||441
374819|NCT01999218|919837|P1|STARTED|Overall Study||448
374820|NCT01999192|919864|P4|NOT COMPLETED|Extension Phase||0
374821|NCT01999192|919865|P3|NOT COMPLETED|Extension Phase||24
374822|NCT01999192|919866|P2|NOT COMPLETED|Extension Phase||18
374823|NCT01999192|919867|P1|NOT COMPLETED|Extension Phase||13
374824|NCT01999192|919864|P4|COMPLETED|Extension Phase||0
374825|NCT01999192|919865|P3|COMPLETED|Extension Phase||44
374826|NCT01999192|919866|P2|COMPLETED|Extension Phase||38
374827|NCT01999192|919867|P1|COMPLETED|Extension Phase||41
374828|NCT01999192|919864|P4|STARTED|Extension Phase|No Placebo arm for Extension Phase, all patients terminated or were switched to tregalizumab Groups.|0
374829|NCT01999192|919865|P3|STARTED|Extension Phase|Some patients terminated after Main Phase 2.|68
374830|NCT01999192|919866|P2|STARTED|Extension Phase|Some patients terminated or were switched to higher dose Level after Main Phase 2.|56
374831|NCT01999192|919867|P1|STARTED|Extension Phase|Some patients terminated or were switched to higher dose Level after Main Phase 2.|54
374832|NCT01999192|919864|P4|NOT COMPLETED|Main Phase II||1
374833|NCT01999192|919865|P3|NOT COMPLETED|Main Phase II||22
374834|NCT01999192|919866|P2|NOT COMPLETED|Main Phase II||9
374835|NCT01999192|919867|P1|NOT COMPLETED|Main Phase II||9
374836|NCT01999192|919864|P4|COMPLETED|Main Phase II||43
374837|NCT01999192|919865|P3|COMPLETED|Main Phase II||76
374838|NCT01999192|919866|P2|COMPLETED|Main Phase II||66
374839|NCT01999192|919867|P1|COMPLETED|Main Phase II||55
374840|NCT01999192|919864|P4|STARTED|Main Phase II|non-responders were switched to higher dose Level after Main Phase 1, started = completed -switched|44
374841|NCT01999192|919865|P3|STARTED|Main Phase II|started Patient = completed patients + switched patients (non-responder) from other arms.|98
374932|NCT01997905|920123|P1|NOT COMPLETED|Overall Study||3
374842|NCT01999192|919866|P2|STARTED|Main Phase II|started Patient = completed patients + switched patients (non-responder) from other arms.|75
374843|NCT01999192|919867|P1|STARTED|Main Phase II|Non-responders were switched to higher dose Level after Main Phase 1, started = completed -switched.|64
374844|NCT01999192|919864|P4|NOT COMPLETED|Main Phase I||8
374845|NCT01999192|919865|P3|NOT COMPLETED|Main Phase I||8
374846|NCT01999192|919866|P2|NOT COMPLETED|Main Phase I||10
374847|NCT01999192|919867|P1|NOT COMPLETED|Main Phase I||11
374848|NCT01999192|919864|P4|COMPLETED|Main Phase I||72
374849|NCT01999192|919865|P3|COMPLETED|Main Phase I||70
374850|NCT01999192|919866|P2|COMPLETED|Main Phase I||70
374851|NCT01999192|919867|P1|COMPLETED|Main Phase I||72
374852|NCT01999192|919864|P4|STARTED|Main Phase I||80
374853|NCT01999192|919865|P3|STARTED|Main Phase I||78
374854|NCT01999192|919866|P2|STARTED|Main Phase I||80
374855|NCT01999192|919867|P1|STARTED|Main Phase I||83
374856|NCT01998919|919879|P2|NOT COMPLETED|Overall Study||35
374857|NCT01998919|919880|P1|NOT COMPLETED|Overall Study||42
374858|NCT01998919|919879|P2|COMPLETED|Overall Study||39
374859|NCT01998919|919880|P1|COMPLETED|Overall Study||37
374860|NCT01998919|919879|P2|Randomized|Overall Study|One participant withdrew consent prior to 1st dose and was excluded from safety analysis population.|76
374861|NCT01998919|919880|P1|Randomized|Overall Study|1 participant randomized to erlotinib didn't receive study drug; analyzed in placebo for safety|78
374862|NCT01998919|919879|P2|STARTED|Overall Study||74
374863|NCT01998919|919880|P1|STARTED|Overall Study||79
374864|NCT01998906|919901|P3|NOT COMPLETED|Overall Study||98
374865|NCT01998906|919902|P2|NOT COMPLETED|Overall Study||114
374866|NCT01998906|919903|P1|NOT COMPLETED|Overall Study||114
374867|NCT01998906|919901|P3|COMPLETED|Overall Study||1
374868|NCT01998906|919902|P2|COMPLETED|Overall Study||2
374869|NCT01998906|919903|P1|COMPLETED|Overall Study||1
374870|NCT01998906|919901|P3|STARTED|Overall Study||99
374871|NCT01998906|919902|P2|STARTED|Overall Study||116
374872|NCT01998906|919903|P1|STARTED|Overall Study||115
374873|NCT01998893|919947|P1|NOT COMPLETED|Overall Study||17
374874|NCT01998893|919947|P1|COMPLETED|Overall Study||21
374875|NCT01998893|919947|P1|2nd Treatment Cycle Completed Until PD|Overall Study||3
374876|NCT01998893|919947|P1|2nd Treatment Cycle Started|Overall Study||5
374877|NCT01998893|919947|P1|1st Treatment Cycle Completed Until PD|Overall Study|Progressive disease (PD)|30
374878|NCT01998893|919947|P1|STARTED|Overall Study||38
374879|NCT01998880|919959|P2|NOT COMPLETED|Overall Study||40
374880|NCT01998880|919960|P1|NOT COMPLETED|Overall Study||29
374881|NCT01998880|919959|P2|COMPLETED|Overall Study||78
374882|NCT01998880|919960|P1|COMPLETED|Overall Study|Completed=Completed treatment.|204
374883|NCT01998880|919959|P2|Received Study Drug|Overall Study||116
374884|NCT01998880|919960|P1|Received Study Drug|Overall Study||230
374885|NCT01998880|919959|P2|STARTED|Overall Study||118
374886|NCT01998880|919960|P1|STARTED|Overall Study||233
374887|NCT01998737|919978|P2|NOT COMPLETED|Overall Study||0
374888|NCT01998737|919979|P1|NOT COMPLETED|Overall Study||23
374889|NCT01998737|919978|P2|COMPLETED|Overall Study||100
374890|NCT01998737|919979|P1|COMPLETED|Overall Study||888
374891|NCT01998737|919978|P2|STARTED|Overall Study||100
374892|NCT01998737|919979|P1|STARTED|Overall Study||911
374893|NCT01998633|919991|P1|NOT COMPLETED|Overall Study||1
374894|NCT01998633|919991|P1|COMPLETED|Overall Study||46
374895|NCT01998633|919991|P1|STARTED|Overall Study||47
374896|NCT01998581|920009|P2|NOT COMPLETED|Overall Study||12
374897|NCT01998581|920010|P1|NOT COMPLETED|Overall Study||46
374898|NCT01998581|920009|P2|COMPLETED|Overall Study||44
374899|NCT01998581|920010|P1|COMPLETED|Overall Study||123
374900|NCT01998581|920009|P2|STARTED|Overall Study||56
374901|NCT01998581|920010|P1|STARTED|Overall Study||169
374902|NCT01998477|920022|P2|NOT COMPLETED|Overall Study||5
374903|NCT01998477|920023|P1|NOT COMPLETED|Overall Study||10
374904|NCT01998477|920022|P2|COMPLETED|Overall Study||143
374905|NCT01998477|920023|P1|COMPLETED|Overall Study||272
374906|NCT01998477|920022|P2|STARTED|Overall Study||148
374907|NCT01998477|920023|P1|STARTED|Overall Study||282
374908|NCT01998438|920057|P3|NOT COMPLETED|Overall Study||0
374909|NCT01998438|920058|P2|NOT COMPLETED|Overall Study||0
374910|NCT01998438|920059|P1|NOT COMPLETED|Overall Study||0
374911|NCT01998438|920057|P3|COMPLETED|Overall Study||318
374912|NCT01998438|920058|P2|COMPLETED|Overall Study||318
374913|NCT01998438|920059|P1|COMPLETED|Overall Study||319
374914|NCT01998438|920057|P3|STARTED|Overall Study||318
374915|NCT01998438|920058|P2|STARTED|Overall Study||318
374916|NCT01998438|920059|P1|STARTED|Overall Study||319
374917|NCT01998399|920069|P2|NOT COMPLETED|Overall Study||9
374918|NCT01998399|920070|P1|NOT COMPLETED|Overall Study||8
374919|NCT01998399|920069|P2|COMPLETED|Overall Study||4
374920|NCT01998399|920070|P1|COMPLETED|Overall Study||4
374921|NCT01998399|920069|P2|STARTED|Overall Study||13
374922|NCT01998399|920070|P1|STARTED|Overall Study||12
374923|NCT01998360|920104|P2|NOT COMPLETED|Overall Study||0
374924|NCT01998360|920105|P1|NOT COMPLETED|Overall Study||0
374925|NCT01998360|920104|P2|COMPLETED|Overall Study||50
374926|NCT01998360|920105|P1|COMPLETED|Overall Study||50
374927|NCT01998360|920104|P2|STARTED|Overall Study||50
374928|NCT01998360|920105|P1|STARTED|Overall Study||50
374929|NCT01998269|920119|P1|NOT COMPLETED|Overall Study||0
374930|NCT01998269|920119|P1|COMPLETED|Overall Study||193
374931|NCT01998269|920119|P1|STARTED|Overall Study||193
374933|NCT01997905|920123|P1|COMPLETED|Overall Study||10
374934|NCT01997905|920123|P1|Baseline Completed|Overall Study||11
374935|NCT01997905|920123|P1|STARTED|Overall Study||13
374936|NCT01997892|920132|P1|NOT COMPLETED|Overall Study||68
374937|NCT01997892|920132|P1|COMPLETED|Overall Study||959
374938|NCT01997892|920132|P1|Received Darbepoetin Alfa|Overall Study||987
374939|NCT01997892|920132|P1|STARTED|Overall Study||1027
374940|NCT01997723|920144|P1|NOT COMPLETED|Overall Study||0
374941|NCT01997723|920144|P1|COMPLETED|Overall Study||75
374942|NCT01997723|920144|P1|STARTED|Overall Study||75
374943|NCT01997567|920152|P2|NOT COMPLETED|Overall Study||0
374944|NCT01997567|920153|P1|NOT COMPLETED|Overall Study||0
374945|NCT01997567|920152|P2|COMPLETED|Overall Study||0
374946|NCT01997567|920153|P1|COMPLETED|Overall Study||0
374947|NCT01997567|920152|P2|STARTED|Overall Study||0
374948|NCT01997567|920153|P1|STARTED|Overall Study||0
374949|NCT01997437|920159|P1|NOT COMPLETED|Overall Study||0
374950|NCT01997437|920159|P1|COMPLETED|Overall Study||6
374951|NCT01997437|920159|P1|STARTED|Overall Study||6
374952|NCT01997411|920171|P8|NOT COMPLETED|Overall Study||0
374953|NCT01997411|920172|P7|NOT COMPLETED|Overall Study||0
374954|NCT01997411|920173|P6|NOT COMPLETED|Overall Study||1
374955|NCT01997411|920174|P5|NOT COMPLETED|Overall Study||0
374956|NCT01997411|920175|P4|NOT COMPLETED|Overall Study||0
374957|NCT01997411|920176|P3|NOT COMPLETED|Overall Study||0
374958|NCT01997411|920177|P2|NOT COMPLETED|Overall Study||0
374959|NCT01997411|920178|P1|NOT COMPLETED|Overall Study||0
374960|NCT01997411|920171|P8|COMPLETED|Overall Study||6
374961|NCT01997411|920172|P7|COMPLETED|Overall Study||6
374962|NCT01997411|920173|P6|COMPLETED|Overall Study||5
374963|NCT01997411|920174|P5|COMPLETED|Overall Study||6
374964|NCT01997411|920175|P4|COMPLETED|Overall Study||6
374965|NCT01997411|920176|P3|COMPLETED|Overall Study||6
374966|NCT01997411|920177|P2|COMPLETED|Overall Study||6
374967|NCT01997411|920178|P1|COMPLETED|Overall Study||6
374968|NCT01997411|920171|P8|STARTED|Overall Study||6
374969|NCT01997411|920172|P7|STARTED|Overall Study||6
374970|NCT01997411|920173|P6|STARTED|Overall Study||6
374971|NCT01997411|920174|P5|STARTED|Overall Study||6
374972|NCT01997411|920175|P4|STARTED|Overall Study||6
374973|NCT01997411|920176|P3|STARTED|Overall Study||6
374974|NCT01997411|920177|P2|STARTED|Overall Study||6
374975|NCT01997411|920178|P1|STARTED|Overall Study||6
374976|NCT01997398|920268|P1|NOT COMPLETED|Overall Study||1
374977|NCT01997398|920268|P1|COMPLETED|Overall Study|One patient took PD meds 3 hours prior to 6 mo. UPDRS testing and was excluded from the analysis.|34
374978|NCT01997398|920268|P1|STARTED|Overall Study||35
374979|NCT01997229|920279|P2|NOT COMPLETED|Overall Study||2
374980|NCT01997229|920280|P1|NOT COMPLETED|Overall Study||5
374981|NCT01997229|920279|P2|COMPLETED|Overall Study||61
374982|NCT01997229|920280|P1|COMPLETED|Overall Study||57
374983|NCT01997229|920279|P2|STARTED|Overall Study||63
374984|NCT01997229|920280|P1|STARTED|Overall Study||62
374985|NCT01997216|920286|P2|NOT COMPLETED|Second 9 Hours||0
374986|NCT01997216|920287|P1|NOT COMPLETED|Second 9 Hours||0
374987|NCT01997216|920286|P2|COMPLETED|Second 9 Hours||21
374988|NCT01997216|920287|P1|COMPLETED|Second 9 Hours||19
374989|NCT01997216|920286|P2|STARTED|Second 9 Hours||21
374990|NCT01997216|920287|P1|STARTED|Second 9 Hours|One participant was not exposed to Pair 1 due to product unavailability, but was exposed to Pair 2.|19
374991|NCT01997216|920286|P2|NOT COMPLETED|First 9 Hours||0
374992|NCT01997216|920287|P1|NOT COMPLETED|First 9 Hours||0
374993|NCT01997216|920286|P2|COMPLETED|First 9 Hours||21
374994|NCT01997216|920287|P1|COMPLETED|First 9 Hours||18
374995|NCT01997216|920286|P2|STARTED|First 9 Hours||21
374996|NCT01997216|920287|P1|STARTED|First 9 Hours||18
374997|NCT01996904|920299|P2|NOT COMPLETED|Overall Study||27
374998|NCT01996904|920300|P1|NOT COMPLETED|Overall Study||38
374999|NCT01996904|920299|P2|COMPLETED|Overall Study||90
375000|NCT01996904|920300|P1|COMPLETED|Overall Study||101
375001|NCT01996904|920299|P2|STARTED|Overall Study||117
375002|NCT01996904|920300|P1|STARTED|Overall Study||139
375003|NCT01996813|920308|P2|NOT COMPLETED|Overall Study||0
375004|NCT01996813|920309|P1|NOT COMPLETED|Overall Study||0
375005|NCT01996813|920308|P2|COMPLETED|Overall Study||24
375006|NCT01996813|920309|P1|COMPLETED|Overall Study||23
375007|NCT01996813|920308|P2|STARTED|Overall Study||24
375008|NCT01996813|920309|P1|STARTED|Overall Study||23
375009|NCT01996748|920319|P2|NOT COMPLETED|Overall Study||6
375010|NCT01996748|920320|P1|NOT COMPLETED|Overall Study||8
375011|NCT01996748|920319|P2|COMPLETED|Overall Study||63
375012|NCT01996748|920320|P1|COMPLETED|Overall Study||58
375013|NCT01996748|920319|P2|STARTED|Overall Study||69
375014|NCT01996748|920320|P1|STARTED|Overall Study||66
375015|NCT01996709|920334|P2|NOT COMPLETED|Overall Study||1
375016|NCT01996709|920335|P1|NOT COMPLETED|Overall Study||5
375017|NCT01996709|920334|P2|COMPLETED|Overall Study||67
375018|NCT01996709|920335|P1|COMPLETED|Overall Study||61
375019|NCT01996709|920334|P2|STARTED|Overall Study||68
375020|NCT01996709|920335|P1|STARTED|Overall Study||66
375021|NCT01996657|920352|P3|NOT COMPLETED|Overall Study||14
375022|NCT01996657|920353|P2|NOT COMPLETED|Overall Study||11
375023|NCT01996657|920354|P1|NOT COMPLETED|Overall Study||13
375024|NCT01996657|920352|P3|COMPLETED|Overall Study||234
375025|NCT01996657|920353|P2|COMPLETED|Overall Study||239
375026|NCT01996657|920354|P1|COMPLETED|Overall Study||237
375027|NCT01996657|920352|P3|STARTED|Overall Study||248
375028|NCT01996657|920353|P2|STARTED|Overall Study||250
375029|NCT01996657|920354|P1|STARTED|Overall Study||250
375030|NCT01996644|920370|P2|NOT COMPLETED|Overall Study||0
375031|NCT01996644|920371|P1|NOT COMPLETED|Overall Study||0
375032|NCT01996644|920370|P2|COMPLETED|Overall Study||16
375033|NCT01996644|920371|P1|COMPLETED|Overall Study||20
375034|NCT01996644|920370|P2|STARTED|Overall Study||16
375035|NCT01996644|920371|P1|STARTED|Overall Study||20
375036|NCT01996410|920390|P8|NOT COMPLETED|Overall Study||0
375037|NCT01996410|920391|P7|NOT COMPLETED|Overall Study||0
375038|NCT01996410|920392|P6|NOT COMPLETED|Overall Study||0
375039|NCT01996410|920393|P5|NOT COMPLETED|Overall Study||0
375040|NCT01996410|920394|P4|NOT COMPLETED|Overall Study||0
375041|NCT01996410|920395|P3|NOT COMPLETED|Overall Study||0
375042|NCT01996410|920396|P2|NOT COMPLETED|Overall Study||0
375043|NCT01996410|920397|P1|NOT COMPLETED|Overall Study||0
375044|NCT01996410|920390|P8|COMPLETED|Overall Study||0
375045|NCT01996410|920391|P7|COMPLETED|Overall Study||0
375046|NCT01996410|920392|P6|COMPLETED|Overall Study||2
375047|NCT01996410|920393|P5|COMPLETED|Overall Study||2
375048|NCT01996410|920394|P4|COMPLETED|Overall Study||0
375049|NCT01996410|920395|P3|COMPLETED|Overall Study||0
375050|NCT01996410|920396|P2|COMPLETED|Overall Study||3
375051|NCT01996410|920397|P1|COMPLETED|Overall Study||3
375052|NCT01996410|920390|P8|STARTED|Overall Study||0
375053|NCT01996410|920391|P7|STARTED|Overall Study||0
375054|NCT01996410|920392|P6|STARTED|Overall Study||2
375055|NCT01996410|920393|P5|STARTED|Overall Study||2
375056|NCT01996410|920394|P4|STARTED|Overall Study||0
375057|NCT01996410|920395|P3|STARTED|Overall Study||0
375058|NCT01996410|920396|P2|STARTED|Overall Study||3
375059|NCT01996410|920397|P1|STARTED|Overall Study||3
375060|NCT01996332|920409|P1|NOT COMPLETED|Overall Study||1805
375061|NCT01996332|920409|P1|COMPLETED|Overall Study||0
375062|NCT01996332|920409|P1|STARTED|Overall Study||1805
375063|NCT01996319|920417|P2|NOT COMPLETED|Overall Study||3
375064|NCT01996319|920418|P1|NOT COMPLETED|Overall Study||8
375065|NCT01996319|920417|P2|COMPLETED|Overall Study||95
375066|NCT01996319|920418|P1|COMPLETED|Overall Study||88
375067|NCT01996319|920417|P2|STARTED|Overall Study||98
375068|NCT01996319|920418|P1|STARTED|Overall Study||96
375069|NCT01995513|920438|P3|NOT COMPLETED|Double Blind Treatment Period||125
375070|NCT01995513|920439|P2|NOT COMPLETED|Double Blind Treatment Period||126
375071|NCT01995513|920440|P1|NOT COMPLETED|Double Blind Treatment Period||0
375072|NCT01995513|920438|P3|COMPLETED|Double Blind Treatment Period||0
375073|NCT01995513|920439|P2|COMPLETED|Double Blind Treatment Period||0
375074|NCT01995513|920440|P1|COMPLETED|Double Blind Treatment Period||0
375075|NCT01995513|920438|P3|Treated|Double Blind Treatment Period||124
375076|NCT01995513|920439|P2|Treated|Double Blind Treatment Period||125
375077|NCT01995513|920440|P1|Treated|Double Blind Treatment Period||0
375078|NCT01995513|920438|P3|STARTED|Double Blind Treatment Period||125
375079|NCT01995513|920439|P2|STARTED|Double Blind Treatment Period||126
375080|NCT01995513|920440|P1|STARTED|Double Blind Treatment Period||0
375081|NCT01995513|920438|P3|NOT COMPLETED|Open Label Treatment Period||0
375082|NCT01995513|920439|P2|NOT COMPLETED|Open Label Treatment Period||0
375083|NCT01995513|920440|P1|NOT COMPLETED|Open Label Treatment Period||258
375084|NCT01995513|920438|P3|COMPLETED|Open Label Treatment Period||0
375085|NCT01995513|920439|P2|COMPLETED|Open Label Treatment Period||0
375086|NCT01995513|920440|P1|COMPLETED|Open Label Treatment Period||251
375087|NCT01995513|920438|P3|STARTED|Open Label Treatment Period||0
375088|NCT01995513|920439|P2|STARTED|Open Label Treatment Period||0
375089|NCT01995513|920440|P1|STARTED|Open Label Treatment Period||509
375090|NCT01995461|920483|P1|NOT COMPLETED|Overall Study||5
375091|NCT01995461|920483|P1|COMPLETED|Overall Study||21
375092|NCT01995461|920483|P1|STARTED|Overall Study||26
375093|NCT01995357|920489|P6|NOT COMPLETED|Period 5||0
375094|NCT01995357|920490|P5|NOT COMPLETED|Period 5||0
375095|NCT01995357|920491|P4|NOT COMPLETED|Period 5||0
375096|NCT01995357|920492|P3|NOT COMPLETED|Period 5||1
375097|NCT01995357|920493|P2|NOT COMPLETED|Period 5||0
375098|NCT01995357|920494|P1|NOT COMPLETED|Period 5||2
375099|NCT01995357|920489|P6|COMPLETED|Period 5||4
375100|NCT01995357|920490|P5|COMPLETED|Period 5||4
375101|NCT01995357|920491|P4|COMPLETED|Period 5||3
375102|NCT01995357|920492|P3|COMPLETED|Period 5||3
375103|NCT01995357|920493|P2|COMPLETED|Period 5||3
375104|NCT01995357|920494|P1|COMPLETED|Period 5||2
375105|NCT01995357|920489|P6|STARTED|Period 5||4
375106|NCT01995357|920490|P5|STARTED|Period 5|1 subject terminated due to an adverse event. Subject counted as completed as some B products tested|4
375107|NCT01995357|920491|P4|STARTED|Period 5||3
375108|NCT01995357|920492|P3|STARTED|Period 5||4
375109|NCT01995357|920493|P2|STARTED|Period 5||3
375110|NCT01995357|920494|P1|STARTED|Period 5|The two discontinued subjects tested zero planned B products in period 5.|4
375111|NCT01995357|920489|P6|NOT COMPLETED|Period 4||0
375112|NCT01995357|920490|P5|NOT COMPLETED|Period 4||0
375113|NCT01995357|920491|P4|NOT COMPLETED|Period 4||0
375114|NCT01995357|920492|P3|NOT COMPLETED|Period 4||0
375115|NCT01995357|920493|P2|NOT COMPLETED|Period 4||0
375116|NCT01995357|920494|P1|NOT COMPLETED|Period 4||0
375117|NCT01995357|920489|P6|COMPLETED|Period 4||4
375118|NCT01995357|920490|P5|COMPLETED|Period 4||4
375119|NCT01995357|920491|P4|COMPLETED|Period 4||3
375120|NCT01995357|920492|P3|COMPLETED|Period 4||4
375121|NCT01995357|920493|P2|COMPLETED|Period 4||3
375122|NCT01995357|920494|P1|COMPLETED|Period 4||4
375123|NCT01995357|920489|P6|STARTED|Period 4||4
375124|NCT01995357|920490|P5|STARTED|Period 4||4
375125|NCT01995357|920491|P4|STARTED|Period 4||3
375126|NCT01995357|920492|P3|STARTED|Period 4|The subject who did not complete period 5, erroneously used product A when B should have been used.|4
375127|NCT01995357|920493|P2|STARTED|Period 4||3
375128|NCT01995357|920494|P1|STARTED|Period 4||4
375129|NCT01995357|920489|P6|NOT COMPLETED|Period 3||0
375130|NCT01995357|920490|P5|NOT COMPLETED|Period 3||0
375131|NCT01995357|920491|P4|NOT COMPLETED|Period 3||0
375132|NCT01995357|920492|P3|NOT COMPLETED|Period 3||0
375133|NCT01995357|920493|P2|NOT COMPLETED|Period 3||0
375134|NCT01995357|920494|P1|NOT COMPLETED|Period 3||0
375135|NCT01995357|920489|P6|COMPLETED|Period 3||4
375136|NCT01995357|920490|P5|COMPLETED|Period 3||4
375137|NCT01995357|920491|P4|COMPLETED|Period 3||3
375138|NCT01995357|920492|P3|COMPLETED|Period 3||4
375139|NCT01995357|920493|P2|COMPLETED|Period 3||3
375140|NCT01995357|920494|P1|COMPLETED|Period 3||4
375141|NCT01995357|920489|P6|STARTED|Period 3||4
375142|NCT01995357|920490|P5|STARTED|Period 3||4
375143|NCT01995357|920491|P4|STARTED|Period 3||3
375144|NCT01995357|920492|P3|STARTED|Period 3||4
375145|NCT01995357|920493|P2|STARTED|Period 3||3
375146|NCT01995357|920494|P1|STARTED|Period 3||4
375147|NCT01995357|920489|P6|NOT COMPLETED|Period 2||0
375148|NCT01995357|920490|P5|NOT COMPLETED|Period 2||0
375149|NCT01995357|920491|P4|NOT COMPLETED|Period 2||0
375150|NCT01995357|920492|P3|NOT COMPLETED|Period 2||0
375151|NCT01995357|920493|P2|NOT COMPLETED|Period 2||0
375152|NCT01995357|920494|P1|NOT COMPLETED|Period 2||0
375153|NCT01995357|920489|P6|COMPLETED|Period 2||4
375154|NCT01995357|920490|P5|COMPLETED|Period 2||4
375155|NCT01995357|920491|P4|COMPLETED|Period 2||3
375156|NCT01995357|920492|P3|COMPLETED|Period 2||4
375157|NCT01995357|920493|P2|COMPLETED|Period 2||3
375158|NCT01995357|920494|P1|COMPLETED|Period 2||4
375159|NCT01995357|920489|P6|STARTED|Period 2||4
375160|NCT01995357|920490|P5|STARTED|Period 2||4
375161|NCT01995357|920491|P4|STARTED|Period 2||3
375162|NCT01995357|920492|P3|STARTED|Period 2||4
375163|NCT01995357|920493|P2|STARTED|Period 2||3
375164|NCT01995357|920494|P1|STARTED|Period 2||4
375165|NCT01995357|920489|P6|NOT COMPLETED|Period 1||0
375166|NCT01995357|920490|P5|NOT COMPLETED|Period 1||0
375167|NCT01995357|920491|P4|NOT COMPLETED|Period 1||0
375168|NCT01995357|920492|P3|NOT COMPLETED|Period 1||0
375169|NCT01995357|920493|P2|NOT COMPLETED|Period 1||0
375170|NCT01995357|920494|P1|NOT COMPLETED|Period 1||0
375171|NCT01995357|920489|P6|COMPLETED|Period 1||4
375172|NCT01995357|920490|P5|COMPLETED|Period 1||4
375173|NCT01995357|920491|P4|COMPLETED|Period 1||3
375174|NCT01995357|920492|P3|COMPLETED|Period 1||4
375175|NCT01995357|920493|P2|COMPLETED|Period 1||3
375176|NCT01995357|920494|P1|COMPLETED|Period 1||4
375177|NCT01995357|920489|P6|STARTED|Period 1||4
375178|NCT01995357|920490|P5|STARTED|Period 1||4
375179|NCT01995357|920491|P4|STARTED|Period 1||3
375180|NCT01995357|920492|P3|STARTED|Period 1||4
375181|NCT01995357|920493|P2|STARTED|Period 1||3
375182|NCT01995357|920494|P1|STARTED|Period 1||4
375183|NCT01995201|920512|P7|NOT COMPLETED|From Week 24 Until Week 48||2
375184|NCT01995201|920513|P6|NOT COMPLETED|From Week 24 Until Week 48||8
375185|NCT01995201|920514|P5|NOT COMPLETED|From Week 24 Until Week 48||6
375186|NCT01995201|920515|P4|NOT COMPLETED|From Week 24 Until Week 48||1
375187|NCT01995201|920516|P3|NOT COMPLETED|From Week 24 Until Week 48||5
375188|NCT01995201|920517|P2|NOT COMPLETED|From Week 24 Until Week 48||0
375189|NCT01995201|920518|P1|NOT COMPLETED|From Week 24 Until Week 48||0
375190|NCT01995201|920512|P7|COMPLETED|From Week 24 Until Week 48||0
375191|NCT01995201|920513|P6|COMPLETED|From Week 24 Until Week 48||59
375192|NCT01995201|920514|P5|COMPLETED|From Week 24 Until Week 48||89
375193|NCT01995201|920515|P4|COMPLETED|From Week 24 Until Week 48||89
375194|NCT01995201|920516|P3|COMPLETED|From Week 24 Until Week 48||84
375195|NCT01995201|920517|P2|COMPLETED|From Week 24 Until Week 48||0
375196|NCT01995201|920518|P1|COMPLETED|From Week 24 Until Week 48||0
375197|NCT01995201|920512|P7|STARTED|From Week 24 Until Week 48||2
375198|NCT01995201|920513|P6|STARTED|From Week 24 Until Week 48||67
375199|NCT01995201|920514|P5|STARTED|From Week 24 Until Week 48||95
375200|NCT01995201|920515|P4|STARTED|From Week 24 Until Week 48||90
375201|NCT01995201|920516|P3|STARTED|From Week 24 Until Week 48||89
375202|NCT01995201|920517|P2|STARTED|From Week 24 Until Week 48||0
375203|NCT01995201|920518|P1|STARTED|From Week 24 Until Week 48||0
375204|NCT01995201|920512|P7|NOT COMPLETED|From Baseline Until Week 24||0
375205|NCT01995201|920513|P6|NOT COMPLETED|From Baseline Until Week 24||0
375206|NCT01995201|920514|P5|NOT COMPLETED|From Baseline Until Week 24||0
375207|NCT01995201|920515|P4|NOT COMPLETED|From Baseline Until Week 24||0
375208|NCT01995201|920516|P3|NOT COMPLETED|From Baseline Until Week 24||0
375209|NCT01995201|920517|P2|NOT COMPLETED|From Baseline Until Week 24||46
375210|NCT01995201|920518|P1|NOT COMPLETED|From Baseline Until Week 24||10
375211|NCT01995201|920512|P7|COMPLETED|From Baseline Until Week 24||0
375212|NCT01995201|920513|P6|COMPLETED|From Baseline Until Week 24||0
375213|NCT01995201|920514|P5|COMPLETED|From Baseline Until Week 24||0
375214|NCT01995201|920515|P4|COMPLETED|From Baseline Until Week 24||0
375215|NCT01995201|920516|P3|COMPLETED|From Baseline Until Week 24||0
375216|NCT01995201|920517|P2|COMPLETED|From Baseline Until Week 24||281
375217|NCT01995201|920518|P1|COMPLETED|From Baseline Until Week 24||64
375218|NCT01995201|920512|P7|STARTED|From Baseline Until Week 24||0
375219|NCT01995201|920513|P6|STARTED|From Baseline Until Week 24||0
375220|NCT01995201|920514|P5|STARTED|From Baseline Until Week 24||0
375221|NCT01995201|920515|P4|STARTED|From Baseline Until Week 24||0
375222|NCT01995201|920516|P3|STARTED|From Baseline Until Week 24||0
375223|NCT01995201|920517|P2|STARTED|From Baseline Until Week 24||327
375224|NCT01995201|920518|P1|STARTED|From Baseline Until Week 24||74
375225|NCT01995136|920627|P1|NOT COMPLETED|Overall Study||1
375226|NCT01995136|920627|P1|COMPLETED|Overall Study||31
375227|NCT01995136|920627|P1|STARTED|Overall Study||32
375228|NCT01995071|920643|P12|NOT COMPLETED|Overall Study||0
375229|NCT01995071|920644|P11|NOT COMPLETED|Overall Study||1
375230|NCT01995071|920645|P10|NOT COMPLETED|Overall Study||0
375231|NCT01995071|920646|P9|NOT COMPLETED|Overall Study||1
375232|NCT01995071|920647|P8|NOT COMPLETED|Overall Study||2
375233|NCT01995071|920648|P7|NOT COMPLETED|Overall Study||1
375234|NCT01995071|920649|P6|NOT COMPLETED|Overall Study||0
375235|NCT01995071|920650|P5|NOT COMPLETED|Overall Study||1
375236|NCT01995071|920651|P4|NOT COMPLETED|Overall Study||0
375237|NCT01995071|920652|P3|NOT COMPLETED|Overall Study||1
375238|NCT01995071|920653|P2|NOT COMPLETED|Overall Study||0
375239|NCT01995071|920654|P1|NOT COMPLETED|Overall Study||1
375240|NCT01995071|920643|P12|COMPLETED|Overall Study||0
375241|NCT01995071|920644|P11|COMPLETED|Overall Study||7
375242|NCT01995071|920645|P10|COMPLETED|Overall Study||8
375243|NCT01995071|920646|P9|COMPLETED|Overall Study||7
375244|NCT01995071|920647|P8|COMPLETED|Overall Study||6
375245|NCT01995071|920648|P7|COMPLETED|Overall Study||7
375246|NCT01995071|920649|P6|COMPLETED|Overall Study||8
375247|NCT01995071|920650|P5|COMPLETED|Overall Study||7
375248|NCT01995071|920651|P4|COMPLETED|Overall Study||8
375249|NCT01995071|920652|P3|COMPLETED|Overall Study||8
375250|NCT01995071|920653|P2|COMPLETED|Overall Study||8
375251|NCT01995071|920654|P1|COMPLETED|Overall Study||7
375252|NCT01995071|920643|P12|STARTED|Overall Study||0
375253|NCT01995071|920644|P11|STARTED|Overall Study||8
375254|NCT01995071|920645|P10|STARTED|Overall Study||8
375255|NCT01995071|920646|P9|STARTED|Overall Study||8
375256|NCT01995071|920647|P8|STARTED|Overall Study||8
375257|NCT01995071|920648|P7|STARTED|Overall Study||8
375258|NCT01995071|920649|P6|STARTED|Overall Study||8
375259|NCT01995071|920650|P5|STARTED|Overall Study||8
375260|NCT01995071|920651|P4|STARTED|Overall Study||8
375261|NCT01995071|920652|P3|STARTED|Overall Study||9
375262|NCT01995071|920653|P2|STARTED|Overall Study||8
375263|NCT01995071|920654|P1|STARTED|Overall Study||8
375264|NCT01995045|920715|P2|NOT COMPLETED|Overall Study||0
375265|NCT01995045|920716|P1|NOT COMPLETED|Overall Study||0
375266|NCT01995045|920715|P2|COMPLETED|Overall Study||28
375267|NCT01995045|920716|P1|COMPLETED|Overall Study||29
375268|NCT01995045|920715|P2|STARTED|Overall Study||28
375269|NCT01995045|920716|P1|STARTED|Overall Study||29
375270|NCT01994993|920733|P5|NOT COMPLETED|Overall Study||2
375271|NCT01994993|920734|P4|NOT COMPLETED|Overall Study||46
375272|NCT01994993|920735|P3|NOT COMPLETED|Overall Study||47
375273|NCT01994993|920736|P2|NOT COMPLETED|Overall Study||35
375274|NCT01994993|920737|P1|NOT COMPLETED|Overall Study||35
375275|NCT01994993|920733|P5|COMPLETED|Overall Study||22
375276|NCT01994993|920734|P4|COMPLETED|Overall Study||9
375277|NCT01994993|920735|P3|COMPLETED|Overall Study||23
375278|NCT01994993|920736|P2|COMPLETED|Overall Study||12
375279|NCT01994993|920737|P1|COMPLETED|Overall Study||28
375280|NCT01994993|920733|P5|STARTED|Overall Study||24
375281|NCT01994993|920734|P4|STARTED|Overall Study||55
375282|NCT01994993|920735|P3|STARTED|Overall Study||70
375283|NCT01994993|920736|P2|STARTED|Overall Study||47
375284|NCT01994993|920737|P1|STARTED|Overall Study||63
375285|NCT01994902|920789|P2|NOT COMPLETED|Test Period 2||6
375286|NCT01994902|920790|P1|NOT COMPLETED|Test Period 2||0
375287|NCT01994902|920789|P2|COMPLETED|Test Period 2||55
375288|NCT01994902|920790|P1|COMPLETED|Test Period 2||57
375289|NCT01994902|920789|P2|STARTED|Test Period 2||61
375290|NCT01994902|920790|P1|STARTED|Test Period 2||57
375291|NCT01994902|920789|P2|NOT COMPLETED|Test Period 1||3
375292|NCT01994902|920790|P1|NOT COMPLETED|Test Period 1||6
375293|NCT01994902|920789|P2|COMPLETED|Test Period 1|The subject testing Coloplast test product discontinued due to device deficiency with adverse event|61
375294|NCT01994902|920790|P1|COMPLETED|Test Period 1||57
375295|NCT01994902|920789|P2|STARTED|Test Period 1|Randomisation mistake:a subject randomised to SenSura Convex Light but tested Coloplast test product|64
375296|NCT01994902|920790|P1|STARTED|Test Period 1||63
375297|NCT01994876|920796|P2|NOT COMPLETED|Test Period 2||1
375298|NCT01994876|920797|P1|NOT COMPLETED|Test Period 2||1
375299|NCT01994876|920796|P2|COMPLETED|Test Period 2||6
375300|NCT01994876|920797|P1|COMPLETED|Test Period 2||8
375301|NCT01994876|920796|P2|STARTED|Test Period 2||7
375302|NCT01994876|920797|P1|STARTED|Test Period 2||9
375303|NCT01994876|920796|P2|NOT COMPLETED|Test Period 1||2
375304|NCT01994876|920797|P1|NOT COMPLETED|Test Period 1||0
375305|NCT01994876|920796|P2|COMPLETED|Test Period 1||7
375306|NCT01994876|920797|P1|COMPLETED|Test Period 1||9
375307|NCT01994876|920796|P2|STARTED|Test Period 1||9
375308|NCT01994876|920797|P1|STARTED|Test Period 1||9
375309|NCT01994876|920796|P2|NOT COMPLETED|Baseline - Own Product||0
375310|NCT01994876|920797|P1|NOT COMPLETED|Baseline - Own Product||0
375311|NCT01994876|920796|P2|COMPLETED|Baseline - Own Product||9
375312|NCT01994876|920797|P1|COMPLETED|Baseline - Own Product||9
375313|NCT01994876|920796|P2|STARTED|Baseline - Own Product||9
375314|NCT01994876|920797|P1|STARTED|Baseline - Own Product||9
375315|NCT01994863|920805|P2|NOT COMPLETED|Period 2||4
375316|NCT01994863|920806|P1|NOT COMPLETED|Period 2||1
375317|NCT01994863|920805|P2|COMPLETED|Period 2||5
375318|NCT01994863|920806|P1|COMPLETED|Period 2||7
375319|NCT01994863|920805|P2|STARTED|Period 2||9
375320|NCT01994863|920806|P1|STARTED|Period 2||8
375321|NCT01994863|920805|P2|NOT COMPLETED|Period 1||3
375322|NCT01994863|920806|P1|NOT COMPLETED|Period 1||7
375323|NCT01994863|920805|P2|COMPLETED|Period 1||9
375324|NCT01994863|920806|P1|COMPLETED|Period 1||4
375325|NCT01994863|920805|P2|STARTED|Period 1||12
375326|NCT01994863|920806|P1|STARTED|Period 1||11
375327|NCT01994837|920812|P1|NOT COMPLETED|Overall Study||32
375328|NCT01994837|920812|P1|COMPLETED|Overall Study||0
375329|NCT01994837|920812|P1|Treated|Overall Study||32
375330|NCT01994837|920812|P1|STARTED|Overall Study||32
375331|NCT01994785|920829|P4|NOT COMPLETED|Overall Study||3
375332|NCT01994785|920830|P3|NOT COMPLETED|Overall Study||0
375333|NCT01994785|920831|P2|NOT COMPLETED|Overall Study||1
375334|NCT01994785|920832|P1|NOT COMPLETED|Overall Study||8
375335|NCT01994785|920829|P4|COMPLETED|Overall Study||114
375336|NCT01994785|920830|P3|COMPLETED|Overall Study||117
375337|NCT01994785|920831|P2|COMPLETED|Overall Study||108
375338|NCT01994785|920832|P1|COMPLETED|Overall Study||101
375339|NCT01994785|920829|P4|STARTED|Overall Study||117
375340|NCT01994785|920830|P3|STARTED|Overall Study||117
375341|NCT01994785|920831|P2|STARTED|Overall Study||109
375342|NCT01994785|920832|P1|STARTED|Overall Study||109
375343|NCT01994746|920842|P2|NOT COMPLETED|Second Visit||0
375344|NCT01994746|920843|P1|NOT COMPLETED|Second Visit||0
375345|NCT01994746|920842|P2|COMPLETED|Second Visit||38
375346|NCT01994746|920843|P1|COMPLETED|Second Visit|Safety population|38
375347|NCT01994746|920842|P2|Efficacy|Second Visit||38
375348|NCT01994746|920843|P1|Efficacy|Second Visit|Those who completed both visits were included in the efficacy population.|37
375349|NCT01994746|920842|P2|STARTED|Second Visit||38
375350|NCT01994746|920843|P1|STARTED|Second Visit|One participant requested to withdraw after completing the first dosing visit.|38
375351|NCT01994746|920842|P2|NOT COMPLETED|First Visit||0
375352|NCT01994746|920843|P1|NOT COMPLETED|First Visit||0
375353|NCT01994746|920842|P2|COMPLETED|First Visit||38
375354|NCT01994746|920843|P1|COMPLETED|First Visit|Safety population|39
375355|NCT01994746|920842|P2|Efficacy|First Visit||38
375356|NCT01994746|920843|P1|Efficacy|First Visit|Those who completed both visits were included in the efficacy population.|37
375357|NCT01994746|920842|P2|STARTED|First Visit||38
375358|NCT01994746|920843|P1|STARTED|First Visit||39
375359|NCT01994720|920851|P2|NOT COMPLETED|Overall Study||56
375360|NCT01994720|920852|P1|NOT COMPLETED|Overall Study||46
375361|NCT01994720|920851|P2|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the Study Closure Visit|6554
375362|NCT01994720|920852|P1|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the Study Closure Visit|6543
375363|NCT01994720|920851|P2|STARTED|Overall Study||6610
375364|NCT01994720|920852|P1|STARTED|Overall Study||6589
375365|NCT01994629|920894|P2|NOT COMPLETED|Overall Study||3
375366|NCT01994629|920895|P1|NOT COMPLETED|Overall Study||1
375367|NCT01994629|920894|P2|COMPLETED|Overall Study||99
375368|NCT01994629|920895|P1|COMPLETED|Overall Study||99
375369|NCT01994629|920894|P2|STARTED|Overall Study||102
375370|NCT01994629|920895|P1|STARTED|Overall Study||100
375371|NCT01994486|920919|P1|NOT COMPLETED|Overall Study||0
375372|NCT01994486|920919|P1|COMPLETED|Overall Study||20
375373|NCT01994486|920919|P1|STARTED|Overall Study||20
375374|NCT01994395|920930|P2|NOT COMPLETED|Overall Study||2
375375|NCT01994395|920931|P1|NOT COMPLETED|Overall Study||1
375376|NCT01994395|920930|P2|COMPLETED|Overall Study||25
375377|NCT01994395|920931|P1|COMPLETED|Overall Study||25
375378|NCT01994395|920930|P2|STARTED|Overall Study||27
375379|NCT01994395|920931|P1|STARTED|Overall Study||26
375380|NCT01994291|920956|P3|NOT COMPLETED|Overall Study||9
375381|NCT01994291|920957|P2|NOT COMPLETED|Overall Study||7
375382|NCT01994291|920958|P1|NOT COMPLETED|Overall Study||15
375383|NCT01994291|920956|P3|COMPLETED|Overall Study||47
375384|NCT01994291|920957|P2|COMPLETED|Overall Study||36
375385|NCT01994291|920958|P1|COMPLETED|Overall Study||84
375386|NCT01994291|920956|P3|Received Treatment|Overall Study||56
375387|NCT01994291|920957|P2|Received Treatment|Overall Study||43
375388|NCT01994291|920958|P1|Received Treatment|Overall Study||99
375389|NCT01994291|920956|P3|STARTED|Overall Study||56
375390|NCT01994291|920957|P2|STARTED|Overall Study||43
375391|NCT01994291|920958|P1|STARTED|Overall Study||99
375392|NCT01994226|921014|P2|NOT COMPLETED|Overall Study||21
375393|NCT01994226|921015|P1|NOT COMPLETED|Overall Study||19
375394|NCT01994226|921014|P2|COMPLETED|Overall Study||179
375395|NCT01994226|921015|P1|COMPLETED|Overall Study||180
375396|NCT01994226|921014|P2|STARTED|Overall Study||200
375397|NCT01994226|921015|P1|STARTED|Overall Study||199
375398|NCT01993940|921023|P2|NOT COMPLETED|Overall Study||44
375399|NCT01993940|921024|P1|NOT COMPLETED|Overall Study||40
375400|NCT01993940|921023|P2|COMPLETED|Overall Study||232
375401|NCT01993940|921024|P1|COMPLETED|Overall Study||237
375402|NCT01993940|921023|P2|Received Treatment|Overall Study||276
375403|NCT01993940|921024|P1|Received Treatment|Overall Study||272
375404|NCT01993940|921023|P2|STARTED|Overall Study|Includes two participants who each enrolled at two different sites|276
375405|NCT01993940|921024|P1|STARTED|Overall Study|Includes one participant who enrolled at two different sites|277
375406|NCT01993888|921040|P2|NOT COMPLETED|Overall Study||3
375407|NCT01993888|921041|P1|NOT COMPLETED|Overall Study||2
375408|NCT01993888|921040|P2|COMPLETED|Overall Study||49
375409|NCT01993888|921041|P1|COMPLETED|Overall Study||48
375410|NCT01993888|921040|P2|STARTED|Overall Study||52
375411|NCT01993888|921041|P1|STARTED|Overall Study||50
375412|NCT01993823|921059|P2|NOT COMPLETED|Overall Study||16
375413|NCT01993823|921060|P1|NOT COMPLETED|Overall Study||7
375414|NCT01993823|921059|P2|COMPLETED|Overall Study||79
375415|NCT01993823|921060|P1|COMPLETED|Overall Study||88
375416|NCT01993823|921059|P2|STARTED|Overall Study||95
375417|NCT01993823|921060|P1|STARTED|Overall Study||95
375418|NCT01993238|921068|P1|NOT COMPLETED|Overall Study||0
375419|NCT01993238|921068|P1|COMPLETED|Overall Study||11
375420|NCT01993238|921068|P1|STARTED|Overall Study||11
375421|NCT01993108|921075|P2|NOT COMPLETED|Overall Study||0
375422|NCT01993108|921076|P1|NOT COMPLETED|Overall Study||0
375423|NCT01993108|921075|P2|COMPLETED|Overall Study||12
375424|NCT01993108|921076|P1|COMPLETED|Overall Study||11
375425|NCT01993108|921075|P2|STARTED|Overall Study||12
375426|NCT01993108|921076|P1|STARTED|Overall Study||11
375427|NCT01993030|921107|P2|NOT COMPLETED|Overall Study||4
375428|NCT01993030|921108|P1|NOT COMPLETED|Overall Study||0
375429|NCT01993030|921107|P2|COMPLETED|Overall Study||31
375430|NCT01993030|921108|P1|COMPLETED|Overall Study||36
375431|NCT01993030|921107|P2|STARTED|Overall Study||35
375432|NCT01993030|921108|P1|STARTED|Overall Study||36
375433|NCT01992874|921122|P3|NOT COMPLETED|Part B||0
375434|NCT01992874|921123|P2|NOT COMPLETED|Part B||0
375435|NCT01992874|921124|P1|NOT COMPLETED|Part B||0
375436|NCT01992874|921122|P3|COMPLETED|Part B||38
375437|NCT01992874|921123|P2|COMPLETED|Part B||0
375438|NCT01992874|921124|P1|COMPLETED|Part B||0
375439|NCT01992874|921122|P3|STARTED|Part B||38
375440|NCT01992874|921123|P2|STARTED|Part B||0
375441|NCT01992874|921124|P1|STARTED|Part B||0
375442|NCT01992874|921122|P3|NOT COMPLETED|Part A||0
375443|NCT01992874|921123|P2|NOT COMPLETED|Part A||0
375444|NCT01992874|921124|P1|NOT COMPLETED|Part A||0
375445|NCT01992874|921122|P3|COMPLETED|Part A||0
375446|NCT01992874|921123|P2|COMPLETED|Part A||17
375447|NCT01992874|921124|P1|COMPLETED|Part A||21
375448|NCT01992874|921122|P3|STARTED|Part A||0
375449|NCT01992874|921123|P2|STARTED|Part A||17
375450|NCT01992874|921124|P1|STARTED|Part A||21
375451|NCT01992536|921162|P10|NOT COMPLETED|Overall Study||1
375452|NCT01992536|921163|P9|NOT COMPLETED|Overall Study||1
375453|NCT01992536|921164|P8|NOT COMPLETED|Overall Study||0
375454|NCT01992536|921165|P7|NOT COMPLETED|Overall Study||7
375455|NCT01992536|921166|P6|NOT COMPLETED|Overall Study||1
375456|NCT01992536|921167|P5|NOT COMPLETED|Overall Study||0
375457|NCT01992536|921168|P4|NOT COMPLETED|Overall Study||2
375458|NCT01992536|921169|P3|NOT COMPLETED|Overall Study||1
375459|NCT01992536|921170|P2|NOT COMPLETED|Overall Study||3
375460|NCT01992536|921171|P1|NOT COMPLETED|Overall Study||4
375461|NCT01992536|921162|P10|COMPLETED|Overall Study||18
375462|NCT01992536|921163|P9|COMPLETED|Overall Study||18
375463|NCT01992536|921164|P8|COMPLETED|Overall Study||21
375464|NCT01992536|921165|P7|COMPLETED|Overall Study||0
375465|NCT01992536|921166|P6|COMPLETED|Overall Study||20
375466|NCT01992536|921167|P5|COMPLETED|Overall Study||11
375467|NCT01992536|921168|P4|COMPLETED|Overall Study||22
375468|NCT01992536|921169|P3|COMPLETED|Overall Study||16
375469|NCT01992536|921170|P2|COMPLETED|Overall Study||22
375470|NCT01992536|921171|P1|COMPLETED|Overall Study||22
375471|NCT01992536|921162|P10|STARTED|Overall Study||19
375472|NCT01992536|921163|P9|STARTED|Overall Study||19
375473|NCT01992536|921164|P8|STARTED|Overall Study||21
375474|NCT01992536|921165|P7|STARTED|Overall Study||7
375475|NCT01992536|921166|P6|STARTED|Overall Study||21
375476|NCT01992536|921167|P5|STARTED|Overall Study||11
375477|NCT01992536|921168|P4|STARTED|Overall Study||24
375478|NCT01992536|921169|P3|STARTED|Overall Study||17
375479|NCT01992536|921170|P2|STARTED|Overall Study||25
375480|NCT01992536|921171|P1|STARTED|Overall Study||26
375481|NCT01992523|921388|P2|NOT COMPLETED|Overall Study||0
375482|NCT01992523|921389|P1|NOT COMPLETED|Overall Study||0
375483|NCT01992523|921388|P2|COMPLETED|Overall Study||41
375484|NCT01992523|921389|P1|COMPLETED|Overall Study||41
375485|NCT01992523|921388|P2|STARTED|Overall Study||41
375486|NCT01992523|921389|P1|STARTED|Overall Study||41
375487|NCT01992185|921403|P2|NOT COMPLETED|Overall Study||0
375488|NCT01992185|921404|P1|NOT COMPLETED|Overall Study||0
375489|NCT01992185|921403|P2|COMPLETED|Overall Study||8
375490|NCT01992185|921404|P1|COMPLETED|Overall Study||7
375491|NCT01992185|921403|P2|STARTED|Overall Study||8
375492|NCT01992185|921404|P1|STARTED|Overall Study||7
375493|NCT01992172|921412|P2|NOT COMPLETED|Overall Study||0
375494|NCT01992172|921413|P1|NOT COMPLETED|Overall Study||0
375495|NCT01992172|921412|P2|COMPLETED|Overall Study||0
375496|NCT01992172|921413|P1|COMPLETED|Overall Study||7
375497|NCT01992172|921412|P2|STARTED|Overall Study||0
375498|NCT01992172|921413|P1|STARTED|Overall Study||7
375499|NCT01992107|921422|P3|NOT COMPLETED|Overall Study||36
375500|NCT01992107|921423|P2|NOT COMPLETED|Overall Study||33
375501|NCT01992107|921424|P1|NOT COMPLETED|Overall Study||68
375502|NCT01992107|921422|P3|COMPLETED|Overall Study||545
375503|NCT01992107|921423|P2|COMPLETED|Overall Study||560
375504|NCT01992107|921424|P1|COMPLETED|Overall Study||1091
375505|NCT01992107|921422|P3|STARTED|Overall Study||581
375506|NCT01992107|921423|P2|STARTED|Overall Study||593
375507|NCT01992107|921424|P1|STARTED|Overall Study||1159
375508|NCT01992094|921480|P3|NOT COMPLETED|Overall Study||21
375509|NCT01992094|921481|P2|NOT COMPLETED|Overall Study||24
375510|NCT01992094|921482|P1|NOT COMPLETED|Overall Study||50
375511|NCT01992094|921480|P3|COMPLETED|Overall Study||648
375512|NCT01992094|921481|P2|COMPLETED|Overall Study||652
375513|NCT01992094|921482|P1|COMPLETED|Overall Study||1285
375514|NCT01992094|921480|P3|STARTED|Overall Study||669
375515|NCT01992094|921481|P2|STARTED|Overall Study||676
375516|NCT01992094|921482|P1|STARTED|Overall Study||1335
375517|NCT01992016|921540|P2|NOT COMPLETED|Overall Study||0
375518|NCT01992016|921541|P1|NOT COMPLETED|Overall Study||0
375519|NCT01992016|921540|P2|COMPLETED|Overall Study||7
375520|NCT01992016|921541|P1|COMPLETED|Overall Study||4
375521|NCT01992016|921540|P2|STARTED|Overall Study||7
375522|NCT01992016|921541|P1|STARTED|Overall Study||4
375523|NCT01991990|921549|P2|NOT COMPLETED|Overall Study||0
375524|NCT01991990|921550|P1|NOT COMPLETED|Overall Study||0
375525|NCT01991990|921549|P2|COMPLETED|Overall Study||12
375526|NCT01991990|921550|P1|COMPLETED|Overall Study||6
375527|NCT01991990|921549|P2|STARTED|Overall Study||12
375528|NCT01991990|921550|P1|STARTED|Overall Study||6
375529|NCT01991548|921590|P1|NOT COMPLETED|Overall Study||1
375530|NCT01991548|921590|P1|COMPLETED|Overall Study||39
375531|NCT01991548|921590|P1|STARTED|Overall Study||40
375532|NCT01991314|921596|P2|NOT COMPLETED|Overall Study||11
375533|NCT01991314|921597|P1|NOT COMPLETED|Overall Study||11
375534|NCT01991314|921596|P2|COMPLETED|Overall Study||32
375535|NCT01991314|921597|P1|COMPLETED|Overall Study||34
375536|NCT01991314|921596|P2|STARTED|Overall Study||43
375537|NCT01991314|921597|P1|STARTED|Overall Study||45
375538|NCT01990898|921615|P1|NOT COMPLETED|Overall Study||4
375539|NCT01990898|921615|P1|COMPLETED|Overall Study||22
375540|NCT01990898|921615|P1|3 Months|Overall Study||22
375541|NCT01990898|921615|P1|STARTED|Overall Study||26
375542|NCT01990859|921619|P1|NOT COMPLETED|90 Day Follow Up for All Participants||0
375543|NCT01990859|921619|P1|COMPLETED|90 Day Follow Up for All Participants||20
375544|NCT01990859|921619|P1|STARTED|90 Day Follow Up for All Participants|All entered into 90 day follow-up whether treatment and/or post dose follow up was completed or not.|20
375545|NCT01990859|921619|P1|NOT COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||17
375546|NCT01990859|921619|P1|COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||3
375547|NCT01990859|921619|P1|STARTED|Week 12 to Week 24 Post Dosing Follow Up|All were entered into follow-up whether dosing was completed or not.|20
375548|NCT01990859|921619|P1|NOT COMPLETED|Treatment (4 Doses Over 12 Weeks)||5
375549|NCT01990859|921619|P1|COMPLETED|Treatment (4 Doses Over 12 Weeks)||15
375550|NCT01990859|921619|P1|STARTED|Treatment (4 Doses Over 12 Weeks)||20
375551|NCT01990794|921630|P1|NOT COMPLETED|Overall Study||3
375552|NCT01990794|921630|P1|COMPLETED|Overall Study||10
375553|NCT01990794|921630|P1|One Month Into Study|Overall Study||10
375554|NCT01990794|921630|P1|STARTED|Overall Study||13
375555|NCT01990703|921744|P2|NOT COMPLETED|Overall Study||45
375556|NCT01990703|921745|P1|NOT COMPLETED|Overall Study||39
375557|NCT01990703|921744|P2|COMPLETED|Overall Study||93
375558|NCT01990703|921745|P1|COMPLETED|Overall Study||108
375559|NCT01990703|921744|P2|STARTED|Overall Study||138
375560|NCT01990703|921745|P1|STARTED|Overall Study||147
375561|NCT01990677|921755|P2|NOT COMPLETED|Overall Study||1
375562|NCT01990677|921756|P1|NOT COMPLETED|Overall Study||2
375563|NCT01990677|921755|P2|COMPLETED|Overall Study||5
375564|NCT01990677|921756|P1|COMPLETED|Overall Study||10
375565|NCT01990677|921755|P2|STARTED|Overall Study||6
375566|NCT01990677|921756|P1|STARTED|Overall Study||12
375567|NCT01990664|921768|P2|NOT COMPLETED|Overall Study||11
375568|NCT01990664|921769|P1|NOT COMPLETED|Overall Study||7
375569|NCT01990664|921768|P2|COMPLETED|Overall Study||79
375570|NCT01990664|921769|P1|COMPLETED|Overall Study||95
375571|NCT01990664|921768|P2|STARTED|Overall Study||90
375572|NCT01990664|921769|P1|STARTED|Overall Study||102
375573|NCT01990560|921775|P1|NOT COMPLETED|Overall Study||1
375574|NCT01990560|921775|P1|COMPLETED|Overall Study||7
375575|NCT01990560|921775|P1|STARTED|Overall Study||8
375576|NCT01990534|921789|P1|NOT COMPLETED|Overall Study||60
375577|NCT01990534|921789|P1|COMPLETED|Overall Study||0
375578|NCT01990534|921789|P1|Ongoing|Overall Study||36
375579|NCT01990534|921789|P1|STARTED|Overall Study||60
375580|NCT01990339|921805|P1|NOT COMPLETED|Overall Study||2312
375581|NCT01990339|921805|P1|COMPLETED|Overall Study||12653
375582|NCT01990339|921805|P1|STARTED|Overall Study||14965
375583|NCT01990313|921810|P1|NOT COMPLETED|Overall Study||1
375584|NCT01990313|921810|P1|COMPLETED|Overall Study||14
375585|NCT01990313|921810|P1|STARTED|Overall Study||15
375586|NCT01990261|921815|P1|NOT COMPLETED|Overall Study||25
375587|NCT01990261|921815|P1|COMPLETED|Overall Study||8
375588|NCT01990261|921815|P1|Treated|Overall Study||29
375589|NCT01990261|921815|P1|STARTED|Overall Study||33
375590|NCT01989793|921827|P2|NOT COMPLETED|Overall Study||4
375591|NCT01989793|921828|P1|NOT COMPLETED|Overall Study||8
375592|NCT01989793|921827|P2|COMPLETED|Overall Study||15
375593|NCT01989793|921828|P1|COMPLETED|Overall Study||10
375594|NCT01989793|921827|P2|STARTED|Overall Study||19
375595|NCT01989793|921828|P1|STARTED|Overall Study||18
375596|NCT01989689|921852|P2|NOT COMPLETED|Treatment Period ( 3 Months)||0
375597|NCT01989689|921853|P1|NOT COMPLETED|Treatment Period ( 3 Months)||0
375598|NCT01989689|921852|P2|COMPLETED|Treatment Period ( 3 Months)||10
375599|NCT01989689|921853|P1|COMPLETED|Treatment Period ( 3 Months)||11
375600|NCT01989689|921852|P2|STARTED|Treatment Period ( 3 Months)||10
375601|NCT01989689|921853|P1|STARTED|Treatment Period ( 3 Months)||11
375602|NCT01989689|921852|P2|NOT COMPLETED|Treatment Period 1 ( 3 Months)||3
375603|NCT01989689|921853|P1|NOT COMPLETED|Treatment Period 1 ( 3 Months)||0
375604|NCT01989689|921852|P2|COMPLETED|Treatment Period 1 ( 3 Months)||10
375605|NCT01989689|921853|P1|COMPLETED|Treatment Period 1 ( 3 Months)||11
375606|NCT01989689|921852|P2|STARTED|Treatment Period 1 ( 3 Months)||13
375607|NCT01989689|921853|P1|STARTED|Treatment Period 1 ( 3 Months)||11
375608|NCT01989689|921852|P2|NOT COMPLETED|Baseline||0
375609|NCT01989689|921853|P1|NOT COMPLETED|Baseline||0
375610|NCT01989689|921852|P2|COMPLETED|Baseline||13
375611|NCT01989689|921853|P1|COMPLETED|Baseline||11
375612|NCT01989689|921852|P2|STARTED|Baseline||13
375613|NCT01989689|921853|P1|STARTED|Baseline||11
375614|NCT01989676|921865|P2|NOT COMPLETED|Overall Study||347
375615|NCT01989676|921866|P1|NOT COMPLETED|Overall Study||338
375616|NCT01989676|921865|P2|COMPLETED|Overall Study||6
375617|NCT01989676|921866|P1|COMPLETED|Overall Study||11
375618|NCT01989676|921865|P2|STARTED|Overall Study|Treated (355 randomized)|353
375619|NCT01989676|921866|P1|STARTED|Overall Study|Treated (352 randomized)|349
375620|NCT01989572|921892|P6|NOT COMPLETED|Overall Study||110
375621|NCT01989572|921893|P5|NOT COMPLETED|Overall Study||98
375622|NCT01989572|921894|P4|NOT COMPLETED|Overall Study||51
375623|NCT01989572|921895|P3|NOT COMPLETED|Overall Study||62
375624|NCT01989572|921896|P2|NOT COMPLETED|Overall Study||58
375625|NCT01989572|921897|P1|NOT COMPLETED|Overall Study||55
375626|NCT01989572|921892|P6|COMPLETED|Overall Study||79
375627|NCT01989572|921893|P5|COMPLETED|Overall Study||92
375628|NCT01989572|921894|P4|COMPLETED|Overall Study||56
375629|NCT01989572|921895|P3|COMPLETED|Overall Study||47
375630|NCT01989572|921896|P2|COMPLETED|Overall Study||53
375631|NCT01989572|921897|P1|COMPLETED|Overall Study||54
375632|NCT01989572|921892|P6|Treated|Overall Study||171
375633|NCT01989572|921893|P5|Treated|Overall Study||186
375634|NCT01989572|921894|P4|Treated|Overall Study||104
375635|NCT01989572|921895|P3|Treated|Overall Study||107
375636|NCT01989572|921896|P2|Treated|Overall Study||110
375637|NCT01989572|921897|P1|Treated|Overall Study||104
375638|NCT01989572|921892|P6|STARTED|Overall Study||189
375639|NCT01989572|921893|P5|STARTED|Overall Study||190
375640|NCT01989572|921894|P4|STARTED|Overall Study||107
375641|NCT01989572|921895|P3|STARTED|Overall Study||109
375642|NCT01989572|921896|P2|STARTED|Overall Study||111
375643|NCT01989572|921897|P1|STARTED|Overall Study||109
375644|NCT01989455|921930|P5|NOT COMPLETED|Overall Study||1
375645|NCT01989455|921931|P4|NOT COMPLETED|Overall Study||0
375646|NCT01989455|921932|P3|NOT COMPLETED|Overall Study||1
375647|NCT01989455|921933|P2|NOT COMPLETED|Overall Study||2
375648|NCT01989455|921934|P1|NOT COMPLETED|Overall Study||0
375649|NCT01989455|921930|P5|COMPLETED|Overall Study||7
375650|NCT01989455|921931|P4|COMPLETED|Overall Study||14
375651|NCT01989455|921932|P3|COMPLETED|Overall Study||13
375652|NCT01989455|921933|P2|COMPLETED|Overall Study||12
375653|NCT01989455|921934|P1|COMPLETED|Overall Study||14
375654|NCT01989455|921930|P5|STARTED|Overall Study||8
375655|NCT01989455|921931|P4|STARTED|Overall Study||14
375656|NCT01989455|921932|P3|STARTED|Overall Study||14
375657|NCT01989455|921933|P2|STARTED|Overall Study||14
375658|NCT01989455|921934|P1|STARTED|Overall Study||14
375659|NCT01989195|921968|P1|NOT COMPLETED|Overall Study||0
375660|NCT01989195|921968|P1|COMPLETED|Overall Study||6
375661|NCT01989195|921968|P1|STARTED|Overall Study||6
375662|NCT01989169|921978|P2|NOT COMPLETED|Period 2||1
375663|NCT01989169|921979|P1|NOT COMPLETED|Period 2||0
375664|NCT01989169|921978|P2|COMPLETED|Period 2||14
375665|NCT01989169|921979|P1|COMPLETED|Period 2||15
375666|NCT01989169|921978|P2|STARTED|Period 2||15
375667|NCT01989169|921979|P1|STARTED|Period 2||15
375668|NCT01989169|921978|P2|NOT COMPLETED|Period 1||0
375669|NCT01989169|921979|P1|NOT COMPLETED|Period 1||0
375670|NCT01989169|921978|P2|COMPLETED|Period 1||15
375671|NCT01989169|921979|P1|COMPLETED|Period 1||15
375672|NCT01989169|921978|P2|STARTED|Period 1||15
375673|NCT01989169|921979|P1|STARTED|Period 1||15
375674|NCT01989156|921992|P3|NOT COMPLETED|End of Study (Population at Day 90)||3
375675|NCT01989156|921993|P2|NOT COMPLETED|End of Study (Population at Day 90)||5
375676|NCT01989156|921994|P1|NOT COMPLETED|End of Study (Population at Day 90)||7
375677|NCT01989156|921992|P3|COMPLETED|End of Study (Population at Day 90)||31
375678|NCT01989156|921993|P2|COMPLETED|End of Study (Population at Day 90)||35
375679|NCT01989156|921994|P1|COMPLETED|End of Study (Population at Day 90)||73
375680|NCT01989156|921992|P3|STARTED|End of Study (Population at Day 90)||34
375681|NCT01989156|921993|P2|STARTED|End of Study (Population at Day 90)||40
375682|NCT01989156|921994|P1|STARTED|End of Study (Population at Day 90)||80
375683|NCT01989156|921992|P3|NOT COMPLETED|Confinement Period (Population at Day 5)||5
375684|NCT01989156|921993|P2|NOT COMPLETED|Confinement Period (Population at Day 5)||1
375685|NCT01989156|921994|P1|NOT COMPLETED|Confinement Period (Population at Day 5)||0
375686|NCT01989156|921992|P3|COMPLETED|Confinement Period (Population at Day 5)||34
375687|NCT01989156|921993|P2|COMPLETED|Confinement Period (Population at Day 5)||40
375688|NCT01989156|921994|P1|COMPLETED|Confinement Period (Population at Day 5)||80
375689|NCT01989156|921992|P3|STARTED|Confinement Period (Population at Day 5)||39
375690|NCT01989156|921993|P2|STARTED|Confinement Period (Population at Day 5)||41
375691|NCT01989156|921994|P1|STARTED|Confinement Period (Population at Day 5)||80
375692|NCT01989130|922016|P2|NOT COMPLETED|Overall Study||0
375693|NCT01989130|922017|P1|NOT COMPLETED|Overall Study||0
375694|NCT01989130|922016|P2|COMPLETED|Overall Study||27
375695|NCT01989130|922017|P1|COMPLETED|Overall Study||43
375696|NCT01989130|922016|P2|STARTED|Overall Study||27
375697|NCT01989130|922017|P1|STARTED|Overall Study||43
375698|NCT01988922|922032|P3|NOT COMPLETED|Overall Study||0
375699|NCT01988922|922033|P2|NOT COMPLETED|Overall Study||0
375700|NCT01988922|922034|P1|NOT COMPLETED|Overall Study||0
375701|NCT01988922|922032|P3|COMPLETED|Overall Study||10
375702|NCT01988922|922033|P2|COMPLETED|Overall Study||10
375703|NCT01988922|922034|P1|COMPLETED|Overall Study||10
375704|NCT01988922|922032|P3|STARTED|Overall Study||10
375705|NCT01988922|922033|P2|STARTED|Overall Study||10
375706|NCT01988922|922034|P1|STARTED|Overall Study||10
375707|NCT01988857|922045|P1|NOT COMPLETED|Overall Study||0
375708|NCT01988857|922045|P1|COMPLETED|Overall Study||300
375709|NCT01988857|922045|P1|STARTED|Overall Study||300
375710|NCT01988662|922054|P2|NOT COMPLETED|Overall Study||2
375711|NCT01988662|922055|P1|NOT COMPLETED|Overall Study||4
375712|NCT01988662|922054|P2|COMPLETED|Overall Study||99
375713|NCT01988662|922055|P1|COMPLETED|Overall Study||100
375714|NCT01988662|922054|P2|STARTED|Overall Study||101
375715|NCT01988662|922055|P1|STARTED|Overall Study||104
375716|NCT01988415|922072|P1|NOT COMPLETED|Overall Study||0
375717|NCT01988415|922072|P1|COMPLETED|Overall Study||26
375718|NCT01988415|922072|P1|STARTED|Overall Study|52 eyes of 26 subjects (paired-eyes: commercial and investigational software)|26
375719|NCT01988402|922082|P2|NOT COMPLETED|Overall Study||2
375720|NCT01988402|922083|P1|NOT COMPLETED|Overall Study||2
375721|NCT01988402|922082|P2|COMPLETED|Overall Study||17
375722|NCT01988402|922083|P1|COMPLETED|Overall Study||14
375723|NCT01988402|922082|P2|STARTED|Overall Study||19
375724|NCT01988402|922083|P1|STARTED|Overall Study||16
375725|NCT01988129|922097|P2|NOT COMPLETED|Overall Study||0
375726|NCT01988129|922098|P1|NOT COMPLETED|Overall Study||0
375727|NCT01988129|922097|P2|COMPLETED|Overall Study||588
375728|NCT01988129|922098|P1|COMPLETED|Overall Study||601
375729|NCT01988129|922097|P2|Completed 1-year Follow-up Survey|Overall Study||4
375730|NCT01988129|922098|P1|Completed 1-year Follow-up Survey|Overall Study||100
375731|NCT01988129|922097|P2|Screened for Sleep Disorders|Overall Study||15
375732|NCT01988129|922098|P1|Screened for Sleep Disorders|Overall Study||416
375733|NCT01988129|922097|P2|Attended Education Session|Overall Study||18
375734|NCT01988129|922098|P1|Attended Education Session|Overall Study||542
375735|NCT01988129|922097|P2|STARTED|Overall Study|Control participant data obtained from department. Individuals were not enrolled.|588
375736|NCT01988129|922098|P1|STARTED|Overall Study|Intervention participant data obtained from department. Individuals not enrolled for primary aim.|601
375737|NCT01988012|922125|P1|NOT COMPLETED|Overall Study||15
375738|NCT01988012|922125|P1|COMPLETED|Overall Study||85
375739|NCT01988012|922125|P1|STARTED|Overall Study||100
375740|NCT01987986|922151|P4|NOT COMPLETED|Overall Study||0
375741|NCT01987986|922152|P3|NOT COMPLETED|Overall Study||2
375742|NCT01987986|922153|P2|NOT COMPLETED|Overall Study||0
375743|NCT01987986|922154|P1|NOT COMPLETED|Overall Study||2
375744|NCT01987986|922151|P4|COMPLETED|Overall Study||24
375745|NCT01987986|922152|P3|COMPLETED|Overall Study||38
375746|NCT01987986|922153|P2|COMPLETED|Overall Study||43
375747|NCT01987986|922154|P1|COMPLETED|Overall Study||41
375748|NCT01987986|922151|P4|STARTED|Overall Study||24
375749|NCT01987986|922152|P3|STARTED|Overall Study||40
375750|NCT01987986|922153|P2|STARTED|Overall Study||43
375751|NCT01987986|922154|P1|STARTED|Overall Study||43
375752|NCT01987960|922194|P4|NOT COMPLETED|Period 3||71
375753|NCT01987960|922195|P3|NOT COMPLETED|Period 3||0
375754|NCT01987960|922196|P2|NOT COMPLETED|Period 3||0
375755|NCT01987960|922197|P1|NOT COMPLETED|Period 3||0
375756|NCT01987960|922194|P4|COMPLETED|Period 3||119
375757|NCT01987960|922195|P3|COMPLETED|Period 3||0
375758|NCT01987960|922196|P2|COMPLETED|Period 3||0
375759|NCT01987960|922197|P1|COMPLETED|Period 3||0
375760|NCT01987960|922194|P4|STARTED|Period 3||190
375761|NCT01987960|922195|P3|STARTED|Period 3||0
375762|NCT01987960|922196|P2|STARTED|Period 3||0
375763|NCT01987960|922197|P1|STARTED|Period 3||0
375764|NCT01987960|922194|P4|NOT COMPLETED|Period 2||0
375765|NCT01987960|922195|P3|NOT COMPLETED|Period 2||9
375766|NCT01987960|922196|P2|NOT COMPLETED|Period 2||5
375767|NCT01987960|922197|P1|NOT COMPLETED|Period 2||0
375768|NCT01987960|922194|P4|COMPLETED|Period 2||0
375769|NCT01987960|922195|P3|COMPLETED|Period 2||14
375770|NCT01987960|922196|P2|COMPLETED|Period 2||12
375771|NCT01987960|922197|P1|COMPLETED|Period 2||0
375772|NCT01987960|922194|P4|STARTED|Period 2||0
375773|NCT01987960|922195|P3|STARTED|Period 2||23
375774|NCT01987960|922196|P2|STARTED|Period 2||17
375775|NCT01987960|922197|P1|STARTED|Period 2||0
375776|NCT01987960|922194|P4|NOT COMPLETED|Period 1||0
375777|NCT01987960|922195|P3|NOT COMPLETED|Period 1||0
375778|NCT01987960|922196|P2|NOT COMPLETED|Period 1||0
375779|NCT01987960|922197|P1|NOT COMPLETED|Period 1||186
375780|NCT01987960|922194|P4|COMPLETED|Period 1||0
375781|NCT01987960|922195|P3|COMPLETED|Period 1||0
375782|NCT01987960|922196|P2|COMPLETED|Period 1||0
375783|NCT01987960|922197|P1|COMPLETED|Period 1||231
375784|NCT01987960|922194|P4|STARTED|Period 1||0
375785|NCT01987960|922195|P3|STARTED|Period 1||0
375786|NCT01987960|922196|P2|STARTED|Period 1||0
375787|NCT01987960|922197|P1|STARTED|Period 1||417
375788|NCT01987908|922209|P3|NOT COMPLETED|Post-Treatment Observation Period||0
375789|NCT01987908|922210|P2|NOT COMPLETED|Post-Treatment Observation Period||3
375790|NCT01987908|922211|P1|NOT COMPLETED|Post-Treatment Observation Period||0
375791|NCT01987908|922209|P3|COMPLETED|Post-Treatment Observation Period||2
375792|NCT01987908|922210|P2|COMPLETED|Post-Treatment Observation Period||7
375793|NCT01987908|922211|P1|COMPLETED|Post-Treatment Observation Period||0
375794|NCT01987908|922209|P3|STARTED|Post-Treatment Observation Period||2
375795|NCT01987908|922210|P2|STARTED|Post-Treatment Observation Period||10
375796|NCT01987908|922211|P1|STARTED|Post-Treatment Observation Period||0
375797|NCT01987908|922209|P3|NOT COMPLETED|Treatment Period||1
375798|NCT01987908|922210|P2|NOT COMPLETED|Treatment Period||1
375799|NCT01987908|922211|P1|NOT COMPLETED|Treatment Period||0
375800|NCT01987908|922209|P3|COMPLETED|Treatment Period||2
375801|NCT01987908|922210|P2|COMPLETED|Treatment Period||10
375802|NCT01987908|922211|P1|COMPLETED|Treatment Period||0
375803|NCT01987908|922209|P3|STARTED|Treatment Period||3
375804|NCT01987908|922210|P2|STARTED|Treatment Period||11
375805|NCT01987908|922211|P1|STARTED|Treatment Period||0
375806|NCT01987908|922209|P3|NOT COMPLETED|Placebo Lead-in Period||0
375807|NCT01987908|922210|P2|NOT COMPLETED|Placebo Lead-in Period||0
375808|NCT01987908|922211|P1|NOT COMPLETED|Placebo Lead-in Period||9
375809|NCT01987908|922209|P3|COMPLETED|Placebo Lead-in Period||0
375810|NCT01987908|922210|P2|COMPLETED|Placebo Lead-in Period||0
375811|NCT01987908|922211|P1|COMPLETED|Placebo Lead-in Period||14
375812|NCT01987908|922209|P3|STARTED|Placebo Lead-in Period||0
375813|NCT01987908|922210|P2|STARTED|Placebo Lead-in Period||0
375814|NCT01987908|922211|P1|STARTED|Placebo Lead-in Period||23
375815|NCT01987895|922294|P2|NOT COMPLETED|Overall Study||30
375816|NCT01987895|922295|P1|NOT COMPLETED|Overall Study||30
375817|NCT01987895|922294|P2|COMPLETED|Overall Study||296
375818|NCT01987895|922295|P1|COMPLETED|Overall Study||276
375819|NCT01987895|922294|P2|STARTED|Overall Study||326
375820|NCT01987895|922295|P1|STARTED|Overall Study||306
375821|NCT01987765|922319|P1|NOT COMPLETED|Overall Study||102
375822|NCT01987765|922319|P1|COMPLETED|Overall Study||745
375823|NCT01987765|922319|P1|STARTED|Overall Study||847
375824|NCT01987752|922324|P1|NOT COMPLETED|Overall Study||0
375825|NCT01987752|922324|P1|COMPLETED|Overall Study||732
375826|NCT01987752|922324|P1|STARTED|Overall Study||732
375827|NCT01987583|922331|P2|NOT COMPLETED|Overall Study||2
375828|NCT01987583|922332|P1|NOT COMPLETED|Overall Study||3
375829|NCT01987583|922331|P2|COMPLETED|Overall Study||38
375830|NCT01987583|922332|P1|COMPLETED|Overall Study||37
375831|NCT01987583|922331|P2|STARTED|Overall Study||40
375832|NCT01987583|922332|P1|STARTED|Overall Study||40
375833|NCT01987557|922343|P3|NOT COMPLETED|Overall Study||3
375834|NCT01987557|922344|P2|NOT COMPLETED|Overall Study||3
375835|NCT01987557|922345|P1|NOT COMPLETED|Overall Study||3
375836|NCT01987557|922343|P3|COMPLETED|Overall Study||13
375837|NCT01987557|922344|P2|COMPLETED|Overall Study||13
375838|NCT01987557|922345|P1|COMPLETED|Overall Study||13
375839|NCT01987557|922343|P3|STARTED|Overall Study||16
375840|NCT01987557|922344|P2|STARTED|Overall Study||16
375841|NCT01987557|922345|P1|STARTED|Overall Study||16
375842|NCT01987479|922353|P1|NOT COMPLETED|Overall Study||17
375843|NCT01987479|922353|P1|COMPLETED|Overall Study||133
375844|NCT01987479|922353|P1|STARTED|Overall Study||150
375845|NCT01987453|922381|P3|NOT COMPLETED|Overall Study||1
375846|NCT01987453|922382|P2|NOT COMPLETED|Overall Study||12
375847|NCT01987453|922383|P1|NOT COMPLETED|Overall Study||1
375848|NCT01987453|922381|P3|COMPLETED|Overall Study||7
375849|NCT01987453|922382|P2|COMPLETED|Overall Study||29
375850|NCT01987453|922383|P1|COMPLETED|Overall Study||50
375851|NCT01987453|922381|P3|STARTED|Overall Study||8
375852|NCT01987453|922382|P2|STARTED|Overall Study||41
375853|NCT01987453|922383|P1|STARTED|Overall Study||51
375854|NCT01987349|922414|P8|NOT COMPLETED|Overall Study||1
375855|NCT01987349|922415|P7|NOT COMPLETED|Overall Study||0
375856|NCT01987349|922416|P6|NOT COMPLETED|Overall Study||0
375857|NCT01987349|922417|P5|NOT COMPLETED|Overall Study||0
375858|NCT01987349|922418|P4|NOT COMPLETED|Overall Study||0
375859|NCT01987349|922419|P3|NOT COMPLETED|Overall Study||0
375860|NCT01987349|922420|P2|NOT COMPLETED|Overall Study||0
375861|NCT01987349|922421|P1|NOT COMPLETED|Overall Study||0
375862|NCT01987349|922414|P8|COMPLETED|Overall Study||24
375863|NCT01987349|922415|P7|COMPLETED|Overall Study||10
375864|NCT01987349|922416|P6|COMPLETED|Overall Study||6
375865|NCT01987349|922417|P5|COMPLETED|Overall Study||6
375866|NCT01987349|922418|P4|COMPLETED|Overall Study||6
375867|NCT01987349|922419|P3|COMPLETED|Overall Study||8
375868|NCT01987349|922420|P2|COMPLETED|Overall Study||6
375869|NCT01987349|922421|P1|COMPLETED|Overall Study||6
375870|NCT01987349|922414|P8|STARTED|Overall Study||25
375871|NCT01987349|922415|P7|STARTED|Overall Study||10
375872|NCT01987349|922416|P6|STARTED|Overall Study||6
375873|NCT01987349|922417|P5|STARTED|Overall Study||6
375874|NCT01987349|922418|P4|STARTED|Overall Study||6
375875|NCT01987349|922419|P3|STARTED|Overall Study||8
375876|NCT01987349|922420|P2|STARTED|Overall Study||6
375877|NCT01987349|922421|P1|STARTED|Overall Study||6
375878|NCT01987232|922452|P5|NOT COMPLETED|Overall Study||0
375879|NCT01987232|922453|P4|NOT COMPLETED|Overall Study||1
375880|NCT01987232|922454|P3|NOT COMPLETED|Overall Study||0
375881|NCT01987232|922455|P2|NOT COMPLETED|Overall Study||0
375882|NCT01987232|922456|P1|NOT COMPLETED|Overall Study||0
375883|NCT01987232|922452|P5|COMPLETED|Overall Study||6
375884|NCT01987232|922453|P4|COMPLETED|Overall Study||14
375885|NCT01987232|922454|P3|COMPLETED|Overall Study||3
375886|NCT01987232|922455|P2|COMPLETED|Overall Study||3
375887|NCT01987232|922456|P1|COMPLETED|Overall Study||5
375888|NCT01987232|922452|P5|STARTED|Overall Study||6
375889|NCT01987232|922453|P4|STARTED|Overall Study||15
375890|NCT01987232|922454|P3|STARTED|Overall Study||3
375891|NCT01987232|922455|P2|STARTED|Overall Study||3
375892|NCT01987232|922456|P1|STARTED|Overall Study||5
375893|NCT01987219|922521|P6|NOT COMPLETED|Overall Study||0
375894|NCT01987219|922522|P5|NOT COMPLETED|Overall Study||0
375895|NCT01987219|922523|P4|NOT COMPLETED|Overall Study||0
375896|NCT01987219|922524|P3|NOT COMPLETED|Overall Study||1
375897|NCT01987219|922525|P2|NOT COMPLETED|Overall Study||0
375898|NCT01987219|922526|P1|NOT COMPLETED|Overall Study||0
375899|NCT01987219|922521|P6|COMPLETED|Overall Study||1
375900|NCT01987219|922522|P5|COMPLETED|Overall Study||1
375901|NCT01987219|922523|P4|COMPLETED|Overall Study||2
375902|NCT01987219|922524|P3|COMPLETED|Overall Study||6
375903|NCT01987219|922525|P2|COMPLETED|Overall Study||2
375904|NCT01987219|922526|P1|COMPLETED|Overall Study||2
375905|NCT01987219|922521|P6|STARTED|Overall Study||1
375906|NCT01987219|922522|P5|STARTED|Overall Study||1
375907|NCT01987219|922523|P4|STARTED|Overall Study||2
375908|NCT01987219|922524|P3|STARTED|Overall Study||7
375909|NCT01987219|922525|P2|STARTED|Overall Study||2
375910|NCT01987219|922526|P1|STARTED|Overall Study||2
375911|NCT01986985|922543|P1|NOT COMPLETED|Overall Study||7
375912|NCT01986985|922543|P1|COMPLETED|Overall Study||51
375913|NCT01986985|922543|P1|STARTED|Overall Study||58
375914|NCT01986946|922549|P2|NOT COMPLETED|Overall Study||0
375915|NCT01986946|922550|P1|NOT COMPLETED|Overall Study||0
375916|NCT01986946|922549|P2|COMPLETED|Overall Study||9
375917|NCT01986946|922550|P1|COMPLETED|Overall Study||5
375918|NCT01986946|922549|P2|STARTED|Overall Study||9
375919|NCT01986946|922550|P1|STARTED|Overall Study||5
375920|NCT01986855|922583|P3|NOT COMPLETED|Overall Study||11
375921|NCT01986855|922584|P2|NOT COMPLETED|Overall Study||14
375922|NCT01986855|922585|P1|NOT COMPLETED|Overall Study||13
375923|NCT01986855|922583|P3|COMPLETED|Overall Study||143
375924|NCT01986855|922584|P2|COMPLETED|Overall Study||142
375925|NCT01986855|922585|P1|COMPLETED|Overall Study||145
375926|NCT01986855|922583|P3|Treated|Overall Study||154
375927|NCT01986855|922584|P2|Treated|Overall Study||155
375928|NCT01986855|922585|P1|Treated|Overall Study||158
375929|NCT01986855|922583|P3|STARTED|Overall Study||154
375930|NCT01986855|922584|P2|STARTED|Overall Study||156
375931|NCT01986855|922585|P1|STARTED|Overall Study||158
375932|NCT01986790|922617|P3|NOT COMPLETED|Overall Study||0
375933|NCT01986790|922618|P2|NOT COMPLETED|Overall Study||0
375934|NCT01986790|922619|P1|NOT COMPLETED|Overall Study||0
375935|NCT01986790|922617|P3|COMPLETED|Overall Study||98
375936|NCT01986790|922618|P2|COMPLETED|Overall Study||154
375937|NCT01986790|922619|P1|COMPLETED|Overall Study||91
375938|NCT01986790|922617|P3|STARTED|Overall Study||98
375939|NCT01986790|922618|P2|STARTED|Overall Study||154
375940|NCT01986790|922619|P1|STARTED|Overall Study||91
375941|NCT01986751|922635|P2|NOT COMPLETED|Overall Study||2
375942|NCT01986751|922636|P1|NOT COMPLETED|Overall Study||10
375943|NCT01986751|922635|P2|COMPLETED|Overall Study||2
375944|NCT01986751|922636|P1|COMPLETED|Overall Study||0
375945|NCT01986751|922635|P2|STARTED|Overall Study||4
375946|NCT01986751|922636|P1|STARTED|Overall Study||10
375947|NCT01986686|922658|P2|NOT COMPLETED|Overall Study||0
375948|NCT01986686|922659|P1|NOT COMPLETED|Overall Study||0
375949|NCT01986686|922658|P2|COMPLETED|Overall Study||26
375950|NCT01986686|922659|P1|COMPLETED|Overall Study||81
375951|NCT01986686|922658|P2|STARTED|Overall Study||26
375952|NCT01986686|922659|P1|STARTED|Overall Study||81
375953|NCT01986361|922667|P2|NOT COMPLETED|Overall Study||0
375954|NCT01986361|922668|P1|NOT COMPLETED|Overall Study||0
375955|NCT01986361|922667|P2|COMPLETED|Overall Study||21
375956|NCT01986361|922668|P1|COMPLETED|Overall Study||101
375957|NCT01986361|922667|P2|STARTED|Overall Study||21
375958|NCT01986361|922668|P1|STARTED|Overall Study||101
375959|NCT01986231|922690|P1|NOT COMPLETED|Overall Study||1
375960|NCT01986231|922690|P1|COMPLETED|Overall Study||11
375961|NCT01986231|922690|P1|STARTED|Overall Study||12
375962|NCT01986062|922697|P2|NOT COMPLETED|Overall Study||1
375963|NCT01986062|922698|P1|NOT COMPLETED|Overall Study||1
375964|NCT01986062|922697|P2|COMPLETED|Overall Study||49
375965|NCT01986062|922698|P1|COMPLETED|Overall Study||46
375966|NCT01986062|922697|P2|STARTED|Overall Study||50
375967|NCT01986062|922698|P1|STARTED|Overall Study||47
375968|NCT01985685|922716|P2|NOT COMPLETED|Overall Study||0
375969|NCT01985685|922717|P1|NOT COMPLETED|Overall Study||0
375970|NCT01985685|922716|P2|COMPLETED|Overall Study||29
375971|NCT01985685|922717|P1|COMPLETED|Overall Study||27
375972|NCT01985685|922716|P2|STARTED|Overall Study||29
375973|NCT01985685|922717|P1|STARTED|Overall Study||27
375974|NCT01985581|922729|P2|NOT COMPLETED|Second Intervention||4
375975|NCT01985581|922730|P1|NOT COMPLETED|Second Intervention||2
375976|NCT01985581|922729|P2|COMPLETED|Second Intervention||19
375977|NCT01985581|922730|P1|COMPLETED|Second Intervention||20
375978|NCT01985581|922729|P2|STARTED|Second Intervention||23
375979|NCT01985581|922730|P1|STARTED|Second Intervention||22
375980|NCT01985581|922729|P2|NOT COMPLETED|First Intervention||2
375981|NCT01985581|922730|P1|NOT COMPLETED|First Intervention||3
375982|NCT01985581|922729|P2|COMPLETED|First Intervention||23
375983|NCT01985581|922730|P1|COMPLETED|First Intervention||22
375984|NCT01985581|922729|P2|STARTED|First Intervention||25
375985|NCT01985581|922730|P1|STARTED|First Intervention||25
375986|NCT01985425|922750|P2|NOT COMPLETED|Overall Study||0
375987|NCT01985425|922751|P1|NOT COMPLETED|Overall Study||0
375988|NCT01985425|922750|P2|COMPLETED|Overall Study||51
375989|NCT01985425|922751|P1|COMPLETED|Overall Study||49
375990|NCT01985425|922750|P2|STARTED|Overall Study||51
375991|NCT01985425|922751|P1|STARTED|Overall Study||49
375992|NCT01985321|922771|P2|NOT COMPLETED|Overall Study||5
375993|NCT01985321|922772|P1|NOT COMPLETED|Overall Study||11
375994|NCT01985321|922771|P2|COMPLETED|Overall Study||78
375995|NCT01985321|922772|P1|COMPLETED|Overall Study||79
375996|NCT01985321|922771|P2|STARTED|Overall Study|This is treatment eligible subjects only|83
375997|NCT01985321|922772|P1|STARTED|Overall Study|This is Treatment Eligible Subjects only|90
375998|NCT01985126|922782|P2|NOT COMPLETED|Overall Study||106
375999|NCT01985126|922783|P1|NOT COMPLETED|Overall Study||18
376000|NCT01985126|922782|P2|COMPLETED|Overall Study||0
376001|NCT01985126|922783|P1|COMPLETED|Overall Study||0
376002|NCT01985126|922782|P2|STARTED|Overall Study||106
376003|NCT01985126|922783|P1|STARTED|Overall Study||18
376004|NCT01984892|922801|P1|NOT COMPLETED|Overall Study||7
376005|NCT01984892|922801|P1|COMPLETED|Overall Study|1 completed all study visits up until the termination of the study, last study visit not done.|1
376006|NCT01984892|922801|P1|STARTED|Overall Study||8
376007|NCT01984697|922812|P5|NOT COMPLETED|Overall Study||314
376008|NCT01984697|922813|P4|NOT COMPLETED|Overall Study||301
376009|NCT01984697|922814|P3|NOT COMPLETED|Overall Study||301
376010|NCT01984697|922815|P2|NOT COMPLETED|Overall Study||301
376011|NCT01984697|922816|P1|NOT COMPLETED|Overall Study||301
376012|NCT01984697|922812|P5|COMPLETED|Overall Study|Follow-up continues for participants not discontinued|0
376013|NCT01984697|922813|P4|COMPLETED|Overall Study|Follow-up continues for participants not discontinued|0
376014|NCT01984697|922814|P3|COMPLETED|Overall Study|Follow-up continues for participants not discontinued|0
376015|NCT01984697|922815|P2|COMPLETED|Overall Study|Follow-up continues for participants not discontinued|0
376016|NCT01984697|922816|P1|COMPLETED|Overall Study|Follow-up continues for participants not discontinued|0
376017|NCT01984697|922812|P5|Vaccination 3|Overall Study||311
376018|NCT01984697|922813|P4|Vaccination 3|Overall Study||293
376019|NCT01984697|922814|P3|Vaccination 3|Overall Study||0
376020|NCT01984697|922815|P2|Vaccination 3|Overall Study||0
376021|NCT01984697|922816|P1|Vaccination 3|Overall Study||0
376022|NCT01984697|922812|P5|Vaccination 2|Overall Study||313
376023|NCT01984697|922813|P4|Vaccination 2|Overall Study||298
376024|NCT01984697|922814|P3|Vaccination 2|Overall Study||291
376025|NCT01984697|922815|P2|Vaccination 2|Overall Study||296
376026|NCT01984697|922816|P1|Vaccination 2|Overall Study||293
376027|NCT01984697|922812|P5|Vaccination 1|Overall Study||314
376028|NCT01984697|922813|P4|Vaccination 1|Overall Study||300
376029|NCT01984697|922814|P3|Vaccination 1|Overall Study||300
376030|NCT01984697|922815|P2|Vaccination 1|Overall Study||301
376031|NCT01984697|922816|P1|Vaccination 1|Overall Study||301
376032|NCT01984697|922812|P5|STARTED|Overall Study||314
376033|NCT01984697|922813|P4|STARTED|Overall Study||301
376034|NCT01984697|922814|P3|STARTED|Overall Study||301
376035|NCT01984697|922815|P2|STARTED|Overall Study||301
376036|NCT01984697|922816|P1|STARTED|Overall Study||301
376037|NCT01984684|922915|P2|NOT COMPLETED|Overall Study||59
376038|NCT01984684|922916|P1|NOT COMPLETED|Overall Study||57
376039|NCT01984684|922915|P2|COMPLETED|Overall Study||368
376040|NCT01984684|922916|P1|COMPLETED|Overall Study||366
376041|NCT01984684|922915|P2|STARTED|Overall Study||427
376042|NCT01984684|922916|P1|STARTED|Overall Study||423
376043|NCT01984515|922926|P1|NOT COMPLETED|Overall Study||19
376044|NCT01984515|922926|P1|COMPLETED|Overall Study||40
376045|NCT01984515|922926|P1|Received CBT Session|Overall Study||40
376046|NCT01984515|922926|P1|STARTED|Overall Study||59
376047|NCT01984424|922934|P2|NOT COMPLETED|Overall Study||7
376048|NCT01984424|922935|P1|NOT COMPLETED|Overall Study||3
376049|NCT01984424|922934|P2|COMPLETED|Overall Study||138
376050|NCT01984424|922935|P1|COMPLETED|Overall Study||70
376051|NCT01984424|922934|P2|STARTED|Overall Study||145
376052|NCT01984424|922935|P1|STARTED|Overall Study||73
376053|NCT01984294|922990|P3|NOT COMPLETED|Overall Study||7
376054|NCT01984294|922991|P2|NOT COMPLETED|Overall Study||3
376055|NCT01984294|922992|P1|NOT COMPLETED|Overall Study||4
376056|NCT01984294|922990|P3|COMPLETED|Overall Study||27
376057|NCT01984294|922991|P2|COMPLETED|Overall Study||29
376058|NCT01984294|922992|P1|COMPLETED|Overall Study||31
376059|NCT01984294|922990|P3|STARTED|Overall Study||34
376060|NCT01984294|922991|P2|STARTED|Overall Study||32
376061|NCT01984294|922992|P1|STARTED|Overall Study||35
376062|NCT01984242|923015|P3|NOT COMPLETED|Overall Study||101
376063|NCT01984242|923016|P2|NOT COMPLETED|Overall Study||103
376064|NCT01984242|923017|P1|NOT COMPLETED|Overall Study||101
376065|NCT01984242|923015|P3|COMPLETED|Overall Study||0
376066|NCT01984242|923016|P2|COMPLETED|Overall Study||0
376067|NCT01984242|923017|P1|COMPLETED|Overall Study||0
376068|NCT01984242|923015|P3|Crossover Population|Overall Study||57
376069|NCT01984242|923016|P2|Crossover Population|Overall Study||44
376070|NCT01984242|923017|P1|Crossover Population|Overall Study||0
376071|NCT01984242|923015|P3|Treated|Overall Study||100
376072|NCT01984242|923016|P2|Treated|Overall Study||103
376073|NCT01984242|923017|P1|Treated|Overall Study||101
376074|NCT01984242|923015|P3|STARTED|Overall Study||101
376075|NCT01984242|923016|P2|STARTED|Overall Study||103
376076|NCT01984242|923017|P1|STARTED|Overall Study||101
376077|NCT01984229|923167|P2|NOT COMPLETED|Safety Follow-up Period||1
376078|NCT01984229|923168|P1|NOT COMPLETED|Safety Follow-up Period||2
376079|NCT01984229|923167|P2|COMPLETED|Safety Follow-up Period||16
376080|NCT01984229|923168|P1|COMPLETED|Safety Follow-up Period||4
376081|NCT01984229|923167|P2|STARTED|Safety Follow-up Period||17
376082|NCT01984229|923168|P1|STARTED|Safety Follow-up Period||6
376083|NCT01984229|923167|P2|NOT COMPLETED|Period 3||0
376084|NCT01984229|923168|P1|NOT COMPLETED|Period 3||0
376085|NCT01984229|923167|P2|COMPLETED|Period 3||17
376086|NCT01984229|923168|P1|COMPLETED|Period 3||6
376087|NCT01984229|923167|P2|STARTED|Period 3||17
376088|NCT01984229|923168|P1|STARTED|Period 3||6
376089|NCT01984229|923167|P2|NOT COMPLETED|Period 2||0
376090|NCT01984229|923168|P1|NOT COMPLETED|Period 2||0
376091|NCT01984229|923167|P2|COMPLETED|Period 2||17
376092|NCT01984229|923168|P1|COMPLETED|Period 2||6
376093|NCT01984229|923167|P2|STARTED|Period 2||17
376094|NCT01984229|923168|P1|STARTED|Period 2||6
376095|NCT01984229|923167|P2|NOT COMPLETED|Period 1||0
376096|NCT01984229|923168|P1|NOT COMPLETED|Period 1||0
376097|NCT01984229|923167|P2|COMPLETED|Period 1||17
376098|NCT01984229|923168|P1|COMPLETED|Period 1||6
376099|NCT01984229|923167|P2|STARTED|Period 1||17
376100|NCT01984229|923168|P1|STARTED|Period 1||6
376101|NCT01983878|923218|P1|NOT COMPLETED|Overall Study||0
376102|NCT01983878|923218|P1|COMPLETED|Overall Study||36
376103|NCT01983878|923218|P1|Received At Least One Dose of Study Drug|Overall Study||36
376104|NCT01983878|923218|P1|STARTED|Overall Study||36
376105|NCT01983839|923229|P1|NOT COMPLETED|Overall Study||0
376106|NCT01983839|923229|P1|COMPLETED|Overall Study||18
376107|NCT01983839|923229|P1|STARTED|Overall Study||18
376108|NCT01983787|923234|P1|NOT COMPLETED|Overall Study||0
376109|NCT01983787|923234|P1|COMPLETED|Overall Study||10
376110|NCT01983787|923234|P1|STARTED|Overall Study||10
376111|NCT01983683|923259|P2|NOT COMPLETED|Overall Study||51
376112|NCT01983683|923260|P1|NOT COMPLETED|Overall Study||38
376113|NCT01983683|923259|P2|COMPLETED|Overall Study||260
376114|NCT01983683|923260|P1|COMPLETED|Overall Study||260
376115|NCT01983683|923259|P2|STARTED|Overall Study||311
376116|NCT01983683|923260|P1|STARTED|Overall Study||298
376117|NCT01983566|923288|P4|NOT COMPLETED|Test Period 4||0
376118|NCT01983566|923289|P3|NOT COMPLETED|Test Period 4||0
376119|NCT01983566|923290|P2|NOT COMPLETED|Test Period 4||0
376120|NCT01983566|923291|P1|NOT COMPLETED|Test Period 4||0
376121|NCT01983566|923288|P4|COMPLETED|Test Period 4||0
376122|NCT01983566|923289|P3|COMPLETED|Test Period 4||0
376123|NCT01983566|923290|P2|COMPLETED|Test Period 4||0
376124|NCT01983566|923291|P1|COMPLETED|Test Period 4||0
376125|NCT01983566|923288|P4|STARTED|Test Period 4||0
376126|NCT01983566|923289|P3|STARTED|Test Period 4||0
376127|NCT01983566|923290|P2|STARTED|Test Period 4||0
376128|NCT01983566|923291|P1|STARTED|Test Period 4||0
376129|NCT01983566|923288|P4|NOT COMPLETED|Wash-Out 3||0
376130|NCT01983566|923289|P3|NOT COMPLETED|Wash-Out 3||0
376131|NCT01983566|923290|P2|NOT COMPLETED|Wash-Out 3||0
376132|NCT01983566|923291|P1|NOT COMPLETED|Wash-Out 3||0
376133|NCT01983566|923288|P4|COMPLETED|Wash-Out 3||0
376134|NCT01983566|923289|P3|COMPLETED|Wash-Out 3||0
376135|NCT01983566|923290|P2|COMPLETED|Wash-Out 3||0
376136|NCT01983566|923291|P1|COMPLETED|Wash-Out 3||0
376137|NCT01983566|923288|P4|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
376138|NCT01983566|923289|P3|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
376139|NCT01983566|923290|P2|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
376140|NCT01983566|923291|P1|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
376141|NCT01983566|923288|P4|NOT COMPLETED|Test Period 3||0
376142|NCT01983566|923289|P3|NOT COMPLETED|Test Period 3||0
376143|NCT01983566|923290|P2|NOT COMPLETED|Test Period 3||0
376144|NCT01983566|923291|P1|NOT COMPLETED|Test Period 3||0
376145|NCT01983566|923288|P4|COMPLETED|Test Period 3||4
376146|NCT01983566|923289|P3|COMPLETED|Test Period 3||2
376147|NCT01983566|923290|P2|COMPLETED|Test Period 3||3
376148|NCT01983566|923291|P1|COMPLETED|Test Period 3||2
376149|NCT01983566|923288|P4|STARTED|Test Period 3||4
376150|NCT01983566|923289|P3|STARTED|Test Period 3||2
376151|NCT01983566|923290|P2|STARTED|Test Period 3||3
376152|NCT01983566|923291|P1|STARTED|Test Period 3||2
376153|NCT01983566|923288|P4|NOT COMPLETED|Wash-Out 2||0
376154|NCT01983566|923289|P3|NOT COMPLETED|Wash-Out 2||0
376155|NCT01983566|923290|P2|NOT COMPLETED|Wash-Out 2||0
376156|NCT01983566|923291|P1|NOT COMPLETED|Wash-Out 2||0
376157|NCT01983566|923288|P4|COMPLETED|Wash-Out 2||4
376158|NCT01983566|923289|P3|COMPLETED|Wash-Out 2||2
376159|NCT01983566|923290|P2|COMPLETED|Wash-Out 2||3
376160|NCT01983566|923291|P1|COMPLETED|Wash-Out 2||2
376161|NCT01983566|923288|P4|STARTED|Wash-Out 2||4
376162|NCT01983566|923289|P3|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|2
376163|NCT01983566|923290|P2|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|3
376164|NCT01983566|923291|P1|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|2
376165|NCT01983566|923288|P4|NOT COMPLETED|Test Period 2||0
376166|NCT01983566|923289|P3|NOT COMPLETED|Test Period 2||0
376167|NCT01983566|923290|P2|NOT COMPLETED|Test Period 2||0
376168|NCT01983566|923291|P1|NOT COMPLETED|Test Period 2||0
376169|NCT01983566|923288|P4|COMPLETED|Test Period 2||4
376170|NCT01983566|923289|P3|COMPLETED|Test Period 2||4
376171|NCT01983566|923290|P2|COMPLETED|Test Period 2||4
376172|NCT01983566|923291|P1|COMPLETED|Test Period 2||4
376173|NCT01983566|923288|P4|STARTED|Test Period 2||4
376174|NCT01983566|923289|P3|STARTED|Test Period 2||4
376175|NCT01983566|923290|P2|STARTED|Test Period 2||4
376176|NCT01983566|923291|P1|STARTED|Test Period 2||4
376177|NCT01983566|923288|P4|NOT COMPLETED|Wash-Out 1||0
376178|NCT01983566|923289|P3|NOT COMPLETED|Wash-Out 1||0
376179|NCT01983566|923290|P2|NOT COMPLETED|Wash-Out 1||0
376180|NCT01983566|923291|P1|NOT COMPLETED|Wash-Out 1||0
376181|NCT01983566|923288|P4|COMPLETED|Wash-Out 1||4
376182|NCT01983566|923289|P3|COMPLETED|Wash-Out 1||4
376183|NCT01983566|923290|P2|COMPLETED|Wash-Out 1||4
376184|NCT01983566|923291|P1|COMPLETED|Wash-Out 1||4
376185|NCT01983566|923288|P4|STARTED|Wash-Out 1||4
376186|NCT01983566|923289|P3|STARTED|Wash-Out 1||4
376187|NCT01983566|923290|P2|STARTED|Wash-Out 1||4
376188|NCT01983566|923291|P1|STARTED|Wash-Out 1||4
376189|NCT01983566|923288|P4|NOT COMPLETED|Test Period 1||0
376190|NCT01983566|923289|P3|NOT COMPLETED|Test Period 1||0
376191|NCT01983566|923290|P2|NOT COMPLETED|Test Period 1||0
376192|NCT01983566|923291|P1|NOT COMPLETED|Test Period 1||0
376193|NCT01983566|923288|P4|COMPLETED|Test Period 1||4
376194|NCT01983566|923289|P3|COMPLETED|Test Period 1||4
376195|NCT01983566|923290|P2|COMPLETED|Test Period 1||4
376196|NCT01983566|923291|P1|COMPLETED|Test Period 1||4
376197|NCT01983566|923288|P4|STARTED|Test Period 1||4
376198|NCT01983566|923289|P3|STARTED|Test Period 1||4
376199|NCT01983566|923290|P2|STARTED|Test Period 1||4
376200|NCT01983566|923291|P1|STARTED|Test Period 1||4
376201|NCT01983254|923312|P2|NOT COMPLETED|Overall Study||30
376202|NCT01983254|923313|P1|NOT COMPLETED|Overall Study||34
376203|NCT01983254|923312|P2|COMPLETED|Overall Study|69 patients, 37 caregivers|106
376204|NCT01983254|923313|P1|COMPLETED|Overall Study|62 patients, 29 caregivers|91
376205|NCT01983254|923312|P2|Interview 3|Overall Study|69 patients, 37 caregivers|106
376206|NCT01983254|923313|P1|Interview 3|Overall Study|62 patients, 29 caregivers|91
376207|NCT01983254|923312|P2|Interview 2|Overall Study|71 patients, 39 caregivers|110
376208|NCT01983254|923313|P1|Interview 2|Overall Study|65 patients, 30 caregivers|95
376209|NCT01983254|923312|P2|Interview 1|Overall Study|89 patients, 47 caregivers|136
376210|NCT01983254|923313|P1|Interview 1|Overall Study|86 patients, 39 caregivers|125
376211|NCT01983254|923312|P2|STARTED|Overall Study|89 patients, 47 caregivers|136
376212|NCT01983254|923313|P1|STARTED|Overall Study|86 patients, 39 caregivers|125
376213|NCT01983111|923325|P2|NOT COMPLETED|Overall Study||7
376214|NCT01983111|923326|P1|NOT COMPLETED|Overall Study||12
376215|NCT01983111|923325|P2|COMPLETED|Overall Study||59
376216|NCT01983111|923326|P1|COMPLETED|Overall Study||58
376217|NCT01983111|923325|P2|STARTED|Overall Study||66
376218|NCT01983111|923326|P1|STARTED|Overall Study||70
376219|NCT01983020|923346|P4|NOT COMPLETED|Overall Study||0
376220|NCT01983020|923347|P3|NOT COMPLETED|Overall Study||0
376221|NCT01983020|923348|P2|NOT COMPLETED|Overall Study||0
376222|NCT01983020|923349|P1|NOT COMPLETED|Overall Study||0
376223|NCT01983020|923346|P4|COMPLETED|Overall Study||11
376224|NCT01983020|923347|P3|COMPLETED|Overall Study||12
376225|NCT01983020|923348|P2|COMPLETED|Overall Study||11
376226|NCT01983020|923349|P1|COMPLETED|Overall Study||12
376227|NCT01983020|923346|P4|STARTED|Overall Study||11
376228|NCT01983020|923347|P3|STARTED|Overall Study||12
376229|NCT01983020|923348|P2|STARTED|Overall Study||11
376230|NCT01983020|923349|P1|STARTED|Overall Study||12
376231|NCT01982812|923361|P2|NOT COMPLETED|Overall Study||10
376232|NCT01982812|923362|P1|NOT COMPLETED|Overall Study||1
376233|NCT01982812|923361|P2|COMPLETED|Overall Study||11
376234|NCT01982812|923362|P1|COMPLETED|Overall Study||22
376235|NCT01982812|923361|P2|STARTED|Overall Study||21
376236|NCT01982812|923362|P1|STARTED|Overall Study||23
376237|NCT01982773|923376|P2|NOT COMPLETED|Overall Study||4
376238|NCT01982773|923377|P1|NOT COMPLETED|Overall Study||8
376239|NCT01982773|923376|P2|COMPLETED|Overall Study||56
376240|NCT01982773|923377|P1|COMPLETED|Overall Study||50
376241|NCT01982773|923376|P2|STARTED|Overall Study||60
376242|NCT01982773|923377|P1|STARTED|Overall Study||58
376243|NCT01982695|923391|P2|NOT COMPLETED|Overall Study||1
376244|NCT01982695|923392|P1|NOT COMPLETED|Overall Study||0
376245|NCT01982695|923391|P2|COMPLETED|Overall Study||10
376246|NCT01982695|923392|P1|COMPLETED|Overall Study||12
376247|NCT01982695|923391|P2|STARTED|Overall Study||11
376248|NCT01982695|923392|P1|STARTED|Overall Study||12
376249|NCT01982682|923398|P1|NOT COMPLETED|Overall Study||1
376250|NCT01982682|923398|P1|COMPLETED|Overall Study||40
376251|NCT01982682|923398|P1|STARTED|Overall Study||41
376252|NCT01982539|923406|P1|NOT COMPLETED|Overall Study||0
376253|NCT01982539|923406|P1|COMPLETED|Overall Study||25
376254|NCT01982539|923406|P1|STARTED|Overall Study||25
376255|NCT01982435|923412|P2|NOT COMPLETED|Overall Study||0
376256|NCT01982435|923413|P1|NOT COMPLETED|Overall Study||1
376257|NCT01982435|923412|P2|COMPLETED|Overall Study||12
376258|NCT01982435|923413|P1|COMPLETED|Overall Study||14
376259|NCT01982435|923412|P2|STARTED|Overall Study||12
376260|NCT01982435|923413|P1|STARTED|Overall Study||15
376261|NCT01982383|923443|P2|NOT COMPLETED|Overall Study||0
376262|NCT01982383|923444|P1|NOT COMPLETED|Overall Study||0
376263|NCT01982383|923443|P2|COMPLETED|Overall Study||0
376264|NCT01982383|923444|P1|COMPLETED|Overall Study||2
376265|NCT01982383|923443|P2|STARTED|Overall Study||0
376266|NCT01982383|923444|P1|STARTED|Overall Study||2
376267|NCT01982292|923452|P2|NOT COMPLETED|Overall Study||1
376268|NCT01982292|923453|P1|NOT COMPLETED|Overall Study||12
376269|NCT01982292|923452|P2|COMPLETED|Overall Study||107
376270|NCT01982292|923453|P1|COMPLETED|Overall Study||203
376271|NCT01982292|923452|P2|Safety Set|Overall Study||108
376272|NCT01982292|923453|P1|Safety Set|Overall Study||212
376273|NCT01982292|923452|P2|Full Analaysis Set (FAS)|Overall Study||108
376274|NCT01982292|923453|P1|Full Analaysis Set (FAS)|Overall Study|FAS excludes mis-randomized patients|213
376275|NCT01982292|923452|P2|STARTED|Overall Study||108
376276|NCT01982292|923453|P1|STARTED|Overall Study|"Started indicates Randomized set"|215
376277|NCT01982253|923474|P3|NOT COMPLETED|Overall Study||4
376278|NCT01982253|923475|P2|NOT COMPLETED|Overall Study||4
376279|NCT01982253|923476|P1|NOT COMPLETED|Overall Study||2
376280|NCT01982253|923474|P3|COMPLETED|Overall Study||0
376281|NCT01982253|923475|P2|COMPLETED|Overall Study||0
376282|NCT01982253|923476|P1|COMPLETED|Overall Study||0
376283|NCT01982253|923474|P3|STARTED|Overall Study||4
376284|NCT01982253|923475|P2|STARTED|Overall Study||4
376285|NCT01982253|923476|P1|STARTED|Overall Study||2
376286|NCT01981967|923489|P2|NOT COMPLETED|Overall Study||0
376287|NCT01981967|923490|P1|NOT COMPLETED|Overall Study||0
376288|NCT01981967|923489|P2|COMPLETED|Overall Study||3149
376289|NCT01981967|923490|P1|COMPLETED|Overall Study||6851
376290|NCT01981967|923489|P2|STARTED|Overall Study||3149
376291|NCT01981967|923490|P1|STARTED|Overall Study||6851
376292|NCT01981954|923500|P1|NOT COMPLETED|Fixed-Dose Assessment Period||1
376293|NCT01981954|923500|P1|COMPLETED|Fixed-Dose Assessment Period||21
376294|NCT01981954|923500|P1|Treated|Fixed-Dose Assessment Period||22
376295|NCT01981954|923500|P1|STARTED|Fixed-Dose Assessment Period||22
376296|NCT01981954|923500|P1|NOT COMPLETED|Titration Period||1
376297|NCT01981954|923500|P1|COMPLETED|Titration Period||22
376298|NCT01981954|923500|P1|Treated|Titration Period||23
376299|NCT01981954|923500|P1|STARTED|Titration Period||23
376300|NCT01981863|923547|P2|NOT COMPLETED|Overall Study||0
376301|NCT01981863|923548|P1|NOT COMPLETED|Overall Study||0
376302|NCT01981863|923547|P2|COMPLETED|Overall Study||20
376303|NCT01981863|923548|P1|COMPLETED|Overall Study||20
376304|NCT01981863|923547|P2|STARTED|Overall Study||20
376305|NCT01981863|923548|P1|STARTED|Overall Study||20
376306|NCT01981616|923560|P2|NOT COMPLETED|Overall Study||1
376307|NCT01981616|923561|P1|NOT COMPLETED|Overall Study||1
376308|NCT01981616|923560|P2|COMPLETED|Overall Study||62
376309|NCT01981616|923561|P1|COMPLETED|Overall Study||63
376310|NCT01981616|923560|P2|STARTED|Overall Study||63
376311|NCT01981616|923561|P1|STARTED|Overall Study||64
376312|NCT01981564|923575|P2|NOT COMPLETED|Overall Study||9
376313|NCT01981564|923576|P1|NOT COMPLETED|Overall Study||9
376314|NCT01981564|923575|P2|COMPLETED|Overall Study||106
376315|NCT01981564|923576|P1|COMPLETED|Overall Study||98
376316|NCT01981564|923575|P2|STARTED|Overall Study||115
376317|NCT01981564|923576|P1|STARTED|Overall Study||107
376318|NCT01981473|923587|P3|NOT COMPLETED|Overall Study||8
376319|NCT01981473|923588|P2|NOT COMPLETED|Overall Study||0
376320|NCT01981473|923589|P1|NOT COMPLETED|Overall Study||2
376321|NCT01981473|923587|P3|COMPLETED|Overall Study||196
376322|NCT01981473|923588|P2|COMPLETED|Overall Study||199
376323|NCT01981473|923589|P1|COMPLETED|Overall Study||200
376324|NCT01981473|923587|P3|STARTED|Overall Study||204
376325|NCT01981473|923588|P2|STARTED|Overall Study||199
376326|NCT01981473|923589|P1|STARTED|Overall Study||202
376327|NCT01981356|923630|P2|NOT COMPLETED|Overall Study||2
376328|NCT01981356|923631|P1|NOT COMPLETED|Overall Study||7
376329|NCT01981356|923630|P2|COMPLETED|Overall Study||4
376330|NCT01981356|923631|P1|COMPLETED|Overall Study||5
376331|NCT01981356|923630|P2|STARTED|Overall Study||6
376332|NCT01981356|923631|P1|STARTED|Overall Study||12
376333|NCT01981057|923658|P2|NOT COMPLETED|Overall Study||0
376334|NCT01981057|923659|P1|NOT COMPLETED|Overall Study||0
376335|NCT01981057|923658|P2|COMPLETED|Overall Study||50
376336|NCT01981057|923659|P1|COMPLETED|Overall Study||50
376337|NCT01981057|923658|P2|STARTED|Overall Study||50
376338|NCT01981057|923659|P1|STARTED|Overall Study||50
376339|NCT01980992|923667|P2|NOT COMPLETED|52 Weeks Open Label Active Wheat OIT||1
376340|NCT01980992|923668|P1|NOT COMPLETED|52 Weeks Open Label Active Wheat OIT||3
376341|NCT01980992|923667|P2|COMPLETED|52 Weeks Open Label Active Wheat OIT||18
376342|NCT01980992|923668|P1|COMPLETED|52 Weeks Open Label Active Wheat OIT||18
376343|NCT01980992|923667|P2|STARTED|52 Weeks Open Label Active Wheat OIT||19
376344|NCT01980992|923668|P1|STARTED|52 Weeks Open Label Active Wheat OIT||21
376345|NCT01980992|923667|P2|NOT COMPLETED|52 Weeks Blinded Study Treatment||4
376346|NCT01980992|923668|P1|NOT COMPLETED|52 Weeks Blinded Study Treatment||2
376347|NCT01980992|923667|P2|COMPLETED|52 Weeks Blinded Study Treatment||19
376348|NCT01980992|923668|P1|COMPLETED|52 Weeks Blinded Study Treatment||21
376349|NCT01980992|923667|P2|STARTED|52 Weeks Blinded Study Treatment||23
376350|NCT01980992|923668|P1|STARTED|52 Weeks Blinded Study Treatment||23
376351|NCT01980940|923693|P8|NOT COMPLETED|Overall Study||0
376352|NCT01980940|923694|P7|NOT COMPLETED|Overall Study||0
376353|NCT01980940|923695|P6|NOT COMPLETED|Overall Study||2
376354|NCT01980940|923696|P5|NOT COMPLETED|Overall Study||0
376355|NCT01980940|923697|P4|NOT COMPLETED|Overall Study||0
376356|NCT01980940|923698|P3|NOT COMPLETED|Overall Study||0
376357|NCT01980940|923699|P2|NOT COMPLETED|Overall Study||0
376358|NCT01980940|923700|P1|NOT COMPLETED|Overall Study||0
376359|NCT01980940|923693|P8|COMPLETED|Overall Study||24
376360|NCT01980940|923694|P7|COMPLETED|Overall Study||24
376361|NCT01980940|923695|P6|COMPLETED|Overall Study||0
376362|NCT01980940|923696|P5|COMPLETED|Overall Study||2
376363|NCT01980940|923697|P4|COMPLETED|Overall Study||3
376364|NCT01980940|923698|P3|COMPLETED|Overall Study||5
376365|NCT01980940|923699|P2|COMPLETED|Overall Study||5
376366|NCT01980940|923700|P1|COMPLETED|Overall Study||5
376367|NCT01980940|923693|P8|Treated|Overall Study||24
376368|NCT01980940|923694|P7|Treated|Overall Study||24
376369|NCT01980940|923695|P6|Treated|Overall Study||2
376370|NCT01980940|923696|P5|Treated|Overall Study||2
376371|NCT01980940|923697|P4|Treated|Overall Study||3
376372|NCT01980940|923698|P3|Treated|Overall Study||5
376373|NCT01980940|923699|P2|Treated|Overall Study||5
376374|NCT01980940|923700|P1|Treated|Overall Study||5
376375|NCT01980940|923693|P8|STARTED|Overall Study||24
376376|NCT01980940|923694|P7|STARTED|Overall Study||24
376377|NCT01980940|923695|P6|STARTED|Overall Study||2
376378|NCT01980940|923696|P5|STARTED|Overall Study||2
376379|NCT01980940|923697|P4|STARTED|Overall Study||3
376380|NCT01980940|923698|P3|STARTED|Overall Study||5
376381|NCT01980940|923699|P2|STARTED|Overall Study||5
376382|NCT01980940|923700|P1|STARTED|Overall Study||5
376383|NCT01980888|923754|P2|NOT COMPLETED|Overall Study||133
376384|NCT01980888|923755|P1|NOT COMPLETED|Overall Study||144
376385|NCT01980888|923754|P2|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|21
376386|NCT01980888|923755|P1|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|13
376387|NCT01980888|923754|P2|STARTED|Overall Study||154
376388|NCT01980888|923755|P1|STARTED|Overall Study||157
376389|NCT01980875|923774|P3|NOT COMPLETED|Overall Study||24
376390|NCT01980875|923775|P2|NOT COMPLETED|Overall Study||25
376391|NCT01980875|923776|P1|NOT COMPLETED|Overall Study||8
376392|NCT01980875|923774|P3|COMPLETED|Overall Study||0
376393|NCT01980875|923775|P2|COMPLETED|Overall Study||0
376394|NCT01980875|923776|P1|COMPLETED|Overall Study||0
376395|NCT01980875|923774|P3|STARTED|Overall Study||24
376396|NCT01980875|923775|P2|STARTED|Overall Study||25
376397|NCT01980875|923776|P1|STARTED|Overall Study||8
376398|NCT01980628|923799|P1|NOT COMPLETED|Overall Study||39
376399|NCT01980628|923799|P1|COMPLETED|Overall Study|Participants who remain on treatment at Primary Completion.|24
376400|NCT01980628|923799|P1|STARTED|Overall Study|Total number of patients enrolled to the study and received study treatment|63
376401|NCT01980589|923807|P3|NOT COMPLETED|Overall Study||0
376402|NCT01980589|923808|P2|NOT COMPLETED|Overall Study||0
376403|NCT01980589|923809|P1|NOT COMPLETED|Overall Study||0
376404|NCT01980589|923807|P3|COMPLETED|Overall Study||16
376405|NCT01980589|923808|P2|COMPLETED|Overall Study||3
376406|NCT01980589|923809|P1|COMPLETED|Overall Study||3
376407|NCT01980589|923807|P3|STARTED|Overall Study||16
376408|NCT01980589|923808|P2|STARTED|Overall Study||3
376409|NCT01980589|923809|P1|STARTED|Overall Study||3
376410|NCT01980524|923826|P2|NOT COMPLETED|Study Day 2||0
376411|NCT01980524|923827|P1|NOT COMPLETED|Study Day 2||0
376412|NCT01980524|923826|P2|COMPLETED|Study Day 2||4
376413|NCT01980524|923827|P1|COMPLETED|Study Day 2||4
376414|NCT01980524|923826|P2|STARTED|Study Day 2||4
376415|NCT01980524|923827|P1|STARTED|Study Day 2||4
376416|NCT01980524|923826|P2|NOT COMPLETED|Washout (at Least 2 Weeks)||0
376417|NCT01980524|923827|P1|NOT COMPLETED|Washout (at Least 2 Weeks)||0
376418|NCT01980524|923826|P2|COMPLETED|Washout (at Least 2 Weeks)||4
376419|NCT01980524|923827|P1|COMPLETED|Washout (at Least 2 Weeks)||4
376420|NCT01980524|923826|P2|STARTED|Washout (at Least 2 Weeks)||4
376421|NCT01980524|923827|P1|STARTED|Washout (at Least 2 Weeks)||4
376422|NCT01980524|923826|P2|NOT COMPLETED|Study Day 1||0
376423|NCT01980524|923827|P1|NOT COMPLETED|Study Day 1||0
376424|NCT01980524|923826|P2|COMPLETED|Study Day 1||4
376425|NCT01980524|923827|P1|COMPLETED|Study Day 1||4
376426|NCT01980524|923826|P2|STARTED|Study Day 1||4
376427|NCT01980524|923827|P1|STARTED|Study Day 1||4
376428|NCT01980342|923837|P1|NOT COMPLETED|Overall Study||1
376429|NCT01980342|923837|P1|COMPLETED|Overall Study||0
376430|NCT01980342|923837|P1|STARTED|Overall Study||1
376431|NCT01980095|923847|P2|NOT COMPLETED|Overall Study||11
376432|NCT01980095|923848|P1|NOT COMPLETED|Overall Study||14
376433|NCT01980095|923847|P2|COMPLETED|Overall Study||30
376434|NCT01980095|923848|P1|COMPLETED|Overall Study||63
376435|NCT01980095|923847|P2|Treated|Overall Study||41
376436|NCT01980095|923848|P1|Treated|Overall Study|Of 78 patients randomized, 1 patient erroneously randomized and not treated|77
376437|NCT01980095|923847|P2|STARTED|Overall Study|Protocol planned for 90 patients, protocol amendment increase up to 120 patients.|41
376438|NCT01980095|923848|P1|STARTED|Overall Study|Protocol planned for 90 patients, protocol amendment increase up to 120 patients.|77
376439|NCT01979952|923858|P2|NOT COMPLETED|Overall Study||6
376440|NCT01979952|923859|P1|NOT COMPLETED|Overall Study||8
376441|NCT01979952|923858|P2|COMPLETED|Overall Study||51
376442|NCT01979952|923859|P1|COMPLETED|Overall Study||48
376443|NCT01979952|923858|P2|STARTED|Overall Study||57
376444|NCT01979952|923859|P1|STARTED|Overall Study||56
376445|NCT01979445|923889|P4|NOT COMPLETED|Overall Study||0
376446|NCT01979445|923890|P3|NOT COMPLETED|Overall Study||0
376447|NCT01979445|923891|P2|NOT COMPLETED|Overall Study||0
376448|NCT01979445|923892|P1|NOT COMPLETED|Overall Study||0
376449|NCT01979445|923889|P4|COMPLETED|Overall Study||3
376450|NCT01979445|923890|P3|COMPLETED|Overall Study||6
376451|NCT01979445|923891|P2|COMPLETED|Overall Study||3
376452|NCT01979445|923892|P1|COMPLETED|Overall Study||3
376453|NCT01979445|923889|P4|ITT Population|Overall Study||3
376454|NCT01979445|923890|P3|ITT Population|Overall Study||6
376455|NCT01979445|923891|P2|ITT Population|Overall Study||3
376456|NCT01979445|923892|P1|ITT Population|Overall Study||3
376457|NCT01979445|923889|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
376458|NCT01979445|923890|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
376459|NCT01979445|923891|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
376460|NCT01979445|923892|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
376461|NCT01979445|923889|P4|STARTED|Overall Study||3
376462|NCT01979445|923890|P3|STARTED|Overall Study||6
376463|NCT01979445|923891|P2|STARTED|Overall Study||3
376464|NCT01979445|923892|P1|STARTED|Overall Study||3
376465|NCT01979276|923918|P1|NOT COMPLETED|Overall Study||0
376466|NCT01979276|923918|P1|COMPLETED|Overall Study||2
376467|NCT01979276|923918|P1|STARTED|Overall Study||2
376468|NCT01979185|923926|P2|NOT COMPLETED|Period 2||1
376469|NCT01979185|923927|P1|NOT COMPLETED|Period 2||0
376470|NCT01979185|923926|P2|COMPLETED|Period 2|1 subject discontinued due to a positive drug test prior to receiving Simvastatin alone in Period 2.|14
376471|NCT01979185|923927|P1|COMPLETED|Period 2||15
376472|NCT01979185|923926|P2|STARTED|Period 2||15
376473|NCT01979185|923927|P1|STARTED|Period 2||15
376474|NCT01979185|923926|P2|NOT COMPLETED|Period 1||0
376475|NCT01979185|923927|P1|NOT COMPLETED|Period 1||0
376476|NCT01979185|923926|P2|COMPLETED|Period 1||15
376477|NCT01979185|923927|P1|COMPLETED|Period 1||15
376478|NCT01979185|923926|P2|STARTED|Period 1||15
376479|NCT01979185|923927|P1|STARTED|Period 1||15
376480|NCT01979133|923937|P1|NOT COMPLETED|Overall Study||3
376481|NCT01979133|923937|P1|COMPLETED|Overall Study||7
376482|NCT01979133|923937|P1|STARTED|Overall Study||10
376483|NCT01979029|923956|P2|NOT COMPLETED|Overall Study||0
376484|NCT01979029|923957|P1|NOT COMPLETED|Overall Study||0
376485|NCT01979029|923956|P2|COMPLETED|Overall Study||28
376486|NCT01979029|923957|P1|COMPLETED|Overall Study||29
376487|NCT01979029|923956|P2|STARTED|Overall Study||28
376488|NCT01979029|923957|P1|STARTED|Overall Study||29
376489|NCT01978743|923967|P1|NOT COMPLETED|Overall Study||0
376490|NCT01978743|923967|P1|COMPLETED|Overall Study||10
376491|NCT01978743|923967|P1|STARTED|Overall Study||10
376492|NCT01978600|923981|P2|NOT COMPLETED|Overall Study||0
376493|NCT01978600|923982|P1|NOT COMPLETED|Overall Study||0
376494|NCT01978600|923981|P2|COMPLETED|Overall Study||42
376495|NCT01978600|923982|P1|COMPLETED|Overall Study||44
376496|NCT01978600|923981|P2|STARTED|Overall Study||42
376497|NCT01978600|923982|P1|STARTED|Overall Study||44
376498|NCT01978535|923994|P2|NOT COMPLETED|Overall Study||0
376499|NCT01978535|923995|P1|NOT COMPLETED|Overall Study||0
376500|NCT01978535|923994|P2|COMPLETED|Overall Study||2
376501|NCT01978535|923995|P1|COMPLETED|Overall Study||1
376502|NCT01978535|923994|P2|STARTED|Overall Study||2
376503|NCT01978535|923995|P1|STARTED|Overall Study||1
376504|NCT01978314|924006|P5|NOT COMPLETED|Overall Study||0
376505|NCT01978314|924007|P4|NOT COMPLETED|Overall Study||0
376506|NCT01978314|924008|P3|NOT COMPLETED|Overall Study||0
376507|NCT01978314|924009|P2|NOT COMPLETED|Overall Study||0
376508|NCT01978314|924010|P1|NOT COMPLETED|Overall Study||0
376509|NCT01978314|924006|P5|COMPLETED|Overall Study||8
376510|NCT01978314|924007|P4|COMPLETED|Overall Study||1
376511|NCT01978314|924008|P3|COMPLETED|Overall Study||8
376512|NCT01978314|924009|P2|COMPLETED|Overall Study||8
376513|NCT01978314|924010|P1|COMPLETED|Overall Study||8
376514|NCT01978314|924006|P5|STARTED|Overall Study||8
376515|NCT01978314|924007|P4|STARTED|Overall Study||1
376516|NCT01978314|924008|P3|STARTED|Overall Study||8
376517|NCT01978314|924009|P2|STARTED|Overall Study||8
376518|NCT01978314|924010|P1|STARTED|Overall Study||8
376519|NCT01978145|924092|P2|NOT COMPLETED|Treatment Period 2||14
376520|NCT01978145|924093|P1|NOT COMPLETED|Treatment Period 2||19
376521|NCT01978145|924092|P2|COMPLETED|Treatment Period 2||179
376522|NCT01978145|924093|P1|COMPLETED|Treatment Period 2||185
376523|NCT01978145|924092|P2|STARTED|Treatment Period 2||193
376524|NCT01978145|924093|P1|STARTED|Treatment Period 2||204
376525|NCT01978145|924092|P2|NOT COMPLETED|Washout Period 1||3
376526|NCT01978145|924093|P1|NOT COMPLETED|Washout Period 1||1
376527|NCT01978145|924092|P2|COMPLETED|Washout Period 1||193
376528|NCT01978145|924093|P1|COMPLETED|Washout Period 1||204
376529|NCT01978145|924092|P2|STARTED|Washout Period 1||196
376530|NCT01978145|924093|P1|STARTED|Washout Period 1||205
376531|NCT01978145|924092|P2|NOT COMPLETED|Treatment Period 1||16
376532|NCT01978145|924093|P1|NOT COMPLETED|Treatment Period 1||9
376533|NCT01978145|924092|P2|COMPLETED|Treatment Period 1||196
376534|NCT01978145|924093|P1|COMPLETED|Treatment Period 1||205
376535|NCT01978145|924092|P2|STARTED|Treatment Period 1||212
376536|NCT01978145|924093|P1|STARTED|Treatment Period 1||214
376537|NCT01978119|924109|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||2
376538|NCT01978119|924110|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||0
376539|NCT01978119|924109|P2|COMPLETED|Treatment Period 2 (12 Weeks)||40
376540|NCT01978119|924110|P1|COMPLETED|Treatment Period 2 (12 Weeks)||38
376541|NCT01978119|924109|P2|STARTED|Treatment Period 2 (12 Weeks)||42
376542|NCT01978119|924110|P1|STARTED|Treatment Period 2 (12 Weeks)||38
376543|NCT01978119|924109|P2|NOT COMPLETED|Washout Period 1 (3 Weeks)||0
376544|NCT01978119|924110|P1|NOT COMPLETED|Washout Period 1 (3 Weeks)||0
376545|NCT01978119|924109|P2|COMPLETED|Washout Period 1 (3 Weeks)||42
376546|NCT01978119|924110|P1|COMPLETED|Washout Period 1 (3 Weeks)||38
376547|NCT01978119|924109|P2|STARTED|Washout Period 1 (3 Weeks)||42
376548|NCT01978119|924110|P1|STARTED|Washout Period 1 (3 Weeks)||38
376549|NCT01978119|924109|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||0
376550|NCT01978119|924110|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2
376551|NCT01978119|924109|P2|COMPLETED|Treatment Period 1 (12 Weeks)||42
376552|NCT01978119|924110|P1|COMPLETED|Treatment Period 1 (12 Weeks)||38
376553|NCT01978119|924109|P2|STARTED|Treatment Period 1 (12 Weeks)||42
376554|NCT01978119|924110|P1|STARTED|Treatment Period 1 (12 Weeks)||40
376555|NCT01978093|924136|P2|NOT COMPLETED|Overall Study||73
376556|NCT01978093|924137|P1|NOT COMPLETED|Overall Study||65
376557|NCT01978093|924136|P2|COMPLETED|Overall Study||230
376558|NCT01978093|924137|P1|COMPLETED|Overall Study||232
376559|NCT01978093|924136|P2|STARTED|Overall Study||303
376560|NCT01978093|924137|P1|STARTED|Overall Study||297
376561|NCT01977820|924181|P2|NOT COMPLETED|Overall Study||1
376562|NCT01977820|924182|P1|NOT COMPLETED|Overall Study||1
376563|NCT01977820|924181|P2|COMPLETED|Overall Study||0
376564|NCT01977820|924182|P1|COMPLETED|Overall Study||0
376565|NCT01977820|924181|P2|STARTED|Overall Study||1
376566|NCT01977820|924182|P1|STARTED|Overall Study||1
376567|NCT01977794|924190|P2|NOT COMPLETED|Overall Study||6
376568|NCT01977794|924191|P1|NOT COMPLETED|Overall Study||8
376569|NCT01977794|924190|P2|COMPLETED|Overall Study||94
376570|NCT01977794|924191|P1|COMPLETED|Overall Study||92
376571|NCT01977794|924190|P2|STARTED|Overall Study||100
376572|NCT01977794|924191|P1|STARTED|Overall Study||100
376573|NCT01977781|924207|P2|NOT COMPLETED|Overall Study||1
376574|NCT01977781|924208|P1|NOT COMPLETED|Overall Study||6
376575|NCT01977781|924207|P2|COMPLETED|Overall Study||15
376576|NCT01977781|924208|P1|COMPLETED|Overall Study||18
376577|NCT01977781|924207|P2|STARTED|Overall Study||16
376578|NCT01977781|924208|P1|STARTED|Overall Study||24
376579|NCT01977729|924226|P1|NOT COMPLETED|Overall Study||1
376580|NCT01977729|924226|P1|COMPLETED|Overall Study||0
376581|NCT01977729|924226|P1|STARTED|Overall Study||1
376582|NCT01977690|924238|P2|NOT COMPLETED|Overall Study||4
376583|NCT01977690|924239|P1|NOT COMPLETED|Overall Study||0
376584|NCT01977690|924238|P2|COMPLETED|Overall Study||11
376585|NCT01977690|924239|P1|COMPLETED|Overall Study||15
376586|NCT01977690|924238|P2|STARTED|Overall Study||15
376587|NCT01977690|924239|P1|STARTED|Overall Study||15
376588|NCT01977625|924245|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
376589|NCT01977625|924246|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
376590|NCT01977625|924245|P2|COMPLETED|Second Intervention (4 Weeks)||7
376591|NCT01977625|924246|P1|COMPLETED|Second Intervention (4 Weeks)||7
376592|NCT01977625|924245|P2|STARTED|Second Intervention (4 Weeks)||7
376593|NCT01977625|924246|P1|STARTED|Second Intervention (4 Weeks)||8
376594|NCT01977625|924245|P2|NOT COMPLETED|Washout (2 Weeks)||0
376595|NCT01977625|924246|P1|NOT COMPLETED|Washout (2 Weeks)||0
376596|NCT01977625|924245|P2|COMPLETED|Washout (2 Weeks)||7
376597|NCT01977625|924246|P1|COMPLETED|Washout (2 Weeks)||8
376598|NCT01977625|924245|P2|STARTED|Washout (2 Weeks)||7
376599|NCT01977625|924246|P1|STARTED|Washout (2 Weeks)||8
376600|NCT01977625|924245|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
376601|NCT01977625|924246|P1|NOT COMPLETED|First Intervention (4 Weeks)||3
376602|NCT01977625|924245|P2|COMPLETED|First Intervention (4 Weeks)||7
376603|NCT01977625|924246|P1|COMPLETED|First Intervention (4 Weeks)||8
376604|NCT01977625|924245|P2|STARTED|First Intervention (4 Weeks)||7
376605|NCT01977625|924246|P1|STARTED|First Intervention (4 Weeks)||11
376606|NCT01977612|924256|P2|NOT COMPLETED|Overall Study||1
376607|NCT01977612|924257|P1|NOT COMPLETED|Overall Study||1
376608|NCT01977612|924256|P2|COMPLETED|Overall Study||79
376609|NCT01977612|924257|P1|COMPLETED|Overall Study||84
376610|NCT01977612|924256|P2|STARTED|Overall Study||80
376611|NCT01977612|924257|P1|STARTED|Overall Study||85
376612|NCT01977573|924279|P4|NOT COMPLETED|Overall Study||3
376613|NCT01977573|924280|P3|NOT COMPLETED|Overall Study||4
376614|NCT01977573|924281|P2|NOT COMPLETED|Overall Study||3
376615|NCT01977573|924282|P1|NOT COMPLETED|Overall Study||20
376616|NCT01977573|924279|P4|COMPLETED|Overall Study||33
376617|NCT01977573|924280|P3|COMPLETED|Overall Study||32
376618|NCT01977573|924281|P2|COMPLETED|Overall Study||41
376619|NCT01977573|924282|P1|COMPLETED|Overall Study||116
376620|NCT01977573|924279|P4|STARTED|Overall Study||36
376621|NCT01977573|924280|P3|STARTED|Overall Study||36
376622|NCT01977573|924281|P2|STARTED|Overall Study||44
376623|NCT01977573|924282|P1|STARTED|Overall Study||136
376624|NCT01977482|924396|P6|NOT COMPLETED|Overall Study||5
376625|NCT01977482|924397|P5|NOT COMPLETED|Overall Study||3
376626|NCT01977482|924398|P4|NOT COMPLETED|Overall Study||4
376627|NCT01977482|924399|P3|NOT COMPLETED|Overall Study||5
376628|NCT01977482|924400|P2|NOT COMPLETED|Overall Study||9
376629|NCT01977482|924401|P1|NOT COMPLETED|Overall Study||3
376630|NCT01977482|924396|P6|COMPLETED|Overall Study||14
376631|NCT01977482|924397|P5|COMPLETED|Overall Study||37
376632|NCT01977482|924398|P4|COMPLETED|Overall Study||35
376633|NCT01977482|924399|P3|COMPLETED|Overall Study||35
376634|NCT01977482|924400|P2|COMPLETED|Overall Study||30
376635|NCT01977482|924401|P1|COMPLETED|Overall Study||36
376636|NCT01977482|924396|P6|STARTED|Overall Study||19
376637|NCT01977482|924397|P5|STARTED|Overall Study||40
376638|NCT01977482|924398|P4|STARTED|Overall Study||39
376639|NCT01977482|924399|P3|STARTED|Overall Study||40
376640|NCT01977482|924400|P2|STARTED|Overall Study||39
376641|NCT01977482|924401|P1|STARTED|Overall Study||39
376642|NCT01977456|924516|P1|NOT COMPLETED|Overall Study||5
376643|NCT01977456|924516|P1|COMPLETED|Overall Study||22
376644|NCT01977456|924516|P1|STARTED|Overall Study||27
376645|NCT01977352|924525|P2|NOT COMPLETED|Overall Study||2
376646|NCT01977352|924526|P1|NOT COMPLETED|Overall Study||1
376647|NCT01977352|924525|P2|COMPLETED|Overall Study||19
376648|NCT01977352|924526|P1|COMPLETED|Overall Study||20
376649|NCT01977352|924525|P2|STARTED|Overall Study||21
376650|NCT01977352|924526|P1|STARTED|Overall Study||21
376651|NCT01977222|924544|P1|NOT COMPLETED|Overall Study||1
376652|NCT01977222|924544|P1|COMPLETED|Overall Study||11
376653|NCT01977222|924544|P1|STARTED|Overall Study||12
376654|NCT01976988|924557|P2|NOT COMPLETED|Overall Study||18
376655|NCT01976988|924558|P1|NOT COMPLETED|Overall Study||16
376656|NCT01976988|924557|P2|COMPLETED|Overall Study||184
376657|NCT01976988|924558|P1|COMPLETED|Overall Study||192
376658|NCT01976988|924557|P2|STARTED|Overall Study||202
376659|NCT01976988|924558|P1|STARTED|Overall Study||208
376660|NCT01976871|924574|P1|NOT COMPLETED|Overall Study||1
376661|NCT01976871|924574|P1|COMPLETED|Overall Study||20
376662|NCT01976871|924574|P1|STARTED|Overall Study||21
376663|NCT01976845|924586|P3|NOT COMPLETED|Overall Study||3
376664|NCT01976845|924587|P2|NOT COMPLETED|Overall Study||8
376665|NCT01976845|924588|P1|NOT COMPLETED|Overall Study||8
376666|NCT01976845|924586|P3|COMPLETED|Overall Study||40
376667|NCT01976845|924587|P2|COMPLETED|Overall Study||40
376668|NCT01976845|924588|P1|COMPLETED|Overall Study||40
376669|NCT01976845|924586|P3|STARTED|Overall Study||43
376670|NCT01976845|924587|P2|STARTED|Overall Study||48
376671|NCT01976845|924588|P1|STARTED|Overall Study||48
376672|NCT01976819|924602|P1|NOT COMPLETED|Overall Study||5
376673|NCT01976819|924602|P1|COMPLETED|Overall Study||11
376674|NCT01976819|924602|P1|STARTED|Overall Study||16
376675|NCT01976806|924613|P2|NOT COMPLETED|Overall Study||6
376676|NCT01976806|924614|P1|NOT COMPLETED|Overall Study||3
376677|NCT01976806|924613|P2|COMPLETED|Overall Study||22
376678|NCT01976806|924614|P1|COMPLETED|Overall Study||24
376679|NCT01976806|924613|P2|STARTED|Overall Study||28
376680|NCT01976806|924614|P1|STARTED|Overall Study||27
376681|NCT01976663|924642|P1|NOT COMPLETED|Overall Study||42
376682|NCT01976663|924642|P1|COMPLETED|Overall Study||84
376683|NCT01976663|924642|P1|STARTED|Overall Study||126
376684|NCT01976650|924656|P1|NOT COMPLETED|Overall Study||6
376685|NCT01976650|924656|P1|COMPLETED|Overall Study||718
376686|NCT01976650|924656|P1|STARTED|Overall Study||724
376687|NCT01976624|924661|P1|NOT COMPLETED|Overall Study||14
376688|NCT01976624|924661|P1|COMPLETED|Overall Study||742
376689|NCT01976624|924661|P1|STARTED|Overall Study||756
376690|NCT01976572|924666|P3|NOT COMPLETED|Overall Study||0
376691|NCT01976572|924667|P2|NOT COMPLETED|Overall Study||0
376692|NCT01976572|924668|P1|NOT COMPLETED|Overall Study||0
376693|NCT01976572|924666|P3|COMPLETED|Overall Study||6
376694|NCT01976572|924667|P2|COMPLETED|Overall Study||6
376695|NCT01976572|924668|P1|COMPLETED|Overall Study||6
376696|NCT01976572|924666|P3|STARTED|Overall Study||6
376697|NCT01976572|924667|P2|STARTED|Overall Study||6
376698|NCT01976572|924668|P1|STARTED|Overall Study||6
376699|NCT01976507|924689|P1|NOT COMPLETED|Overall Study||7
376700|NCT01976507|924689|P1|COMPLETED|Overall Study||94
376701|NCT01976507|924689|P1|Received Initial Dose of Dabigatran|Overall Study||100
376702|NCT01976507|924689|P1|STARTED|Overall Study||101
376703|NCT01976442|924698|P2|NOT COMPLETED|Overall Study||0
376704|NCT01976442|924699|P1|NOT COMPLETED|Overall Study||0
376705|NCT01976442|924698|P2|COMPLETED|Overall Study||31
376706|NCT01976442|924699|P1|COMPLETED|Overall Study||69
376707|NCT01976442|924698|P2|STARTED|Overall Study||31
376708|NCT01976442|924699|P1|STARTED|Overall Study||69
376709|NCT01976338|924713|P2|NOT COMPLETED|Overall Study||4
376710|NCT01976338|924714|P1|NOT COMPLETED|Overall Study||13
376711|NCT01976338|924713|P2|COMPLETED|Overall Study|12 months|89
376712|NCT01976338|924714|P1|COMPLETED|Overall Study|12 months|177
376713|NCT01976338|924713|P2|Discontinued Study Prior to 6 Months|Overall Study||2
376714|NCT01976338|924714|P1|Discontinued Study Prior to 6 Months|Overall Study||5
376715|NCT01976338|924713|P2|Completed 6 Months|Overall Study||91
376716|NCT01976338|924714|P1|Completed 6 Months|Overall Study||185
376717|NCT01976338|924713|P2|STARTED|Overall Study||93
376718|NCT01976338|924714|P1|STARTED|Overall Study||190
376719|NCT01976312|924741|P2|NOT COMPLETED|Overall Study||9
376720|NCT01976312|924742|P1|NOT COMPLETED|Overall Study||17
376721|NCT01976312|924741|P2|COMPLETED|Overall Study|Completed study at 12 months|53
376722|NCT01976312|924742|P1|COMPLETED|Overall Study|Completed study at 12 months|173
376723|NCT01976312|924741|P2|Discontinued Study Prior to 3 Months|Overall Study||2
376724|NCT01976312|924742|P1|Discontinued Study Prior to 3 Months|Overall Study||4
376725|NCT01976312|924741|P2|Completed 3 Months|Overall Study||60
376726|NCT01976312|924742|P1|Completed 3 Months|Overall Study||186
376727|NCT01976312|924741|P2|STARTED|Overall Study||62
376728|NCT01976312|924742|P1|STARTED|Overall Study||190
376729|NCT01976299|924763|P2|NOT COMPLETED|Overall Study||6
376730|NCT01976299|924764|P1|NOT COMPLETED|Overall Study||23
376731|NCT01976299|924763|P2|COMPLETED|Overall Study|2 subjects did not proceed onto procedure in this arm.|280
376732|NCT01976299|924764|P1|COMPLETED|Overall Study|9 subjects did not proceed onto procedure in this arm.|269
376733|NCT01976299|924763|P2|Completed Procedure|Overall Study||284
376734|NCT01976299|924764|P1|Completed Procedure|Overall Study||283
376735|NCT01976299|924763|P2|STARTED|Overall Study||286
376736|NCT01976299|924764|P1|STARTED|Overall Study||292
376737|NCT01976273|924780|P2|NOT COMPLETED|Overall Study||1
376738|NCT01976273|924781|P1|NOT COMPLETED|Overall Study||1
376739|NCT01976273|924780|P2|COMPLETED|Overall Study||9
376740|NCT01976273|924781|P1|COMPLETED|Overall Study||9
376741|NCT01976273|924780|P2|STARTED|Overall Study||10
376742|NCT01976273|924781|P1|STARTED|Overall Study||10
376743|NCT01976104|924791|P4|NOT COMPLETED|Overall Study||3
376744|NCT01976104|924792|P3|NOT COMPLETED|Overall Study||2
376745|NCT01976104|924793|P2|NOT COMPLETED|Overall Study||2
376746|NCT01976104|924794|P1|NOT COMPLETED|Overall Study||6
376747|NCT01976104|924791|P4|COMPLETED|Overall Study||55
376748|NCT01976104|924792|P3|COMPLETED|Overall Study||31
376749|NCT01976104|924793|P2|COMPLETED|Overall Study||68
376750|NCT01976104|924794|P1|COMPLETED|Overall Study||37
376751|NCT01976104|924791|P4|STARTED|Overall Study||58
376752|NCT01976104|924792|P3|STARTED|Overall Study||33
376753|NCT01976104|924793|P2|STARTED|Overall Study||70
376754|NCT01976104|924794|P1|STARTED|Overall Study||43
376755|NCT01975974|924820|P1|NOT COMPLETED|Overall Study||0
376756|NCT01975974|924820|P1|COMPLETED|Overall Study||100
376757|NCT01975974|924820|P1|STARTED|Overall Study||100
376758|NCT01975948|924828|P4|NOT COMPLETED|Overall Study||6
376759|NCT01975948|924829|P3|NOT COMPLETED|Overall Study||7
376760|NCT01975948|924830|P2|NOT COMPLETED|Overall Study||21
376761|NCT01975948|924831|P1|NOT COMPLETED|Overall Study||17
376762|NCT01975948|924828|P4|COMPLETED|Overall Study||51
376763|NCT01975948|924829|P3|COMPLETED|Overall Study||65
376764|NCT01975948|924830|P2|COMPLETED|Overall Study||34
376765|NCT01975948|924831|P1|COMPLETED|Overall Study||39
376766|NCT01975948|924828|P4|STARTED|Overall Study||57
376767|NCT01975948|924829|P3|STARTED|Overall Study||72
376768|NCT01975948|924830|P2|STARTED|Overall Study||55
376769|NCT01975948|924831|P1|STARTED|Overall Study||56
376770|NCT01975935|924857|P2|NOT COMPLETED|Overall Study||1
376771|NCT01975935|924858|P1|NOT COMPLETED|Overall Study||3
376772|NCT01975935|924857|P2|COMPLETED|Overall Study||20
376773|NCT01975935|924858|P1|COMPLETED|Overall Study||18
376774|NCT01975935|924857|P2|STARTED|Overall Study||21
376775|NCT01975935|924858|P1|STARTED|Overall Study||21
376776|NCT01975922|924870|P2|NOT COMPLETED|Overall Study||9
376777|NCT01975922|924871|P1|NOT COMPLETED|Overall Study||0
376778|NCT01975922|924870|P2|COMPLETED|Overall Study||43
376779|NCT01975922|924871|P1|COMPLETED|Overall Study||45
376780|NCT01975922|924870|P2|STARTED|Overall Study||52
376781|NCT01975922|924871|P1|STARTED|Overall Study||45
376782|NCT01975909|924881|P2|NOT COMPLETED|Overall Study||0
376783|NCT01975909|924882|P1|NOT COMPLETED|Overall Study||0
376784|NCT01975909|924881|P2|COMPLETED|Overall Study||10
376785|NCT01975909|924882|P1|COMPLETED|Overall Study||10
376786|NCT01975909|924881|P2|STARTED|Overall Study||10
376787|NCT01975909|924882|P1|STARTED|Overall Study||10
376788|NCT01975675|924902|P4|NOT COMPLETED|Overall Study||0
376789|NCT01975675|924903|P3|NOT COMPLETED|Overall Study||0
376790|NCT01975675|924904|P2|NOT COMPLETED|Overall Study||1
376791|NCT01975675|924905|P1|NOT COMPLETED|Overall Study||0
376792|NCT01975675|924902|P4|COMPLETED|Overall Study||87
376793|NCT01975675|924903|P3|COMPLETED|Overall Study||88
376794|NCT01975675|924904|P2|COMPLETED|Overall Study||82
376795|NCT01975675|924905|P1|COMPLETED|Overall Study||83
376796|NCT01975675|924902|P4|STARTED|Overall Study||87
376797|NCT01975675|924903|P3|STARTED|Overall Study||88
376798|NCT01975675|924904|P2|STARTED|Overall Study||83
376799|NCT01975675|924905|P1|STARTED|Overall Study||83
376800|NCT01975467|924927|P2|NOT COMPLETED|Overall Study||0
376801|NCT01975467|924928|P1|NOT COMPLETED|Overall Study||0
376802|NCT01975467|924927|P2|COMPLETED|Overall Study||0
376803|NCT01975467|924928|P1|COMPLETED|Overall Study||0
376804|NCT01975467|924927|P2|STARTED|Overall Study|Study terminated before enrollment|0
376805|NCT01975467|924928|P1|STARTED|Overall Study|Study terminated before enrollment|0
376806|NCT01975389|924938|P2|NOT COMPLETED|Overall Study||236
376807|NCT01975389|924939|P1|NOT COMPLETED|Overall Study||252
376808|NCT01975389|924938|P2|COMPLETED|Overall Study||5045
376809|NCT01975389|924939|P1|COMPLETED|Overall Study||5031
376810|NCT01975389|924938|P2|Treated|Overall Study||5276
376811|NCT01975389|924939|P1|Treated|Overall Study||5279
376812|NCT01975389|924938|P2|STARTED|Overall Study||5281
376813|NCT01975389|924939|P1|STARTED|Overall Study||5283
376814|NCT01975376|924999|P2|NOT COMPLETED|Overall Study||217
376815|NCT01975376|925000|P1|NOT COMPLETED|Overall Study||226
376816|NCT01975376|924999|P2|COMPLETED|Overall Study||8177
376817|NCT01975376|925000|P1|COMPLETED|Overall Study||8164
376818|NCT01975376|924999|P2|Treated|Overall Study||8386
376819|NCT01975376|925000|P1|Treated|Overall Study||8374
376820|NCT01975376|924999|P2|STARTED|Overall Study||8394
376821|NCT01975376|925000|P1|STARTED|Overall Study||8390
376822|NCT01975285|925060|P2|NOT COMPLETED|Overall Study||2
376823|NCT01975285|925061|P1|NOT COMPLETED|Overall Study||2
376824|NCT01975285|925060|P2|COMPLETED|Overall Study||28
376825|NCT01975285|925061|P1|COMPLETED|Overall Study||28
376826|NCT01975285|925060|P2|STARTED|Overall Study||30
376827|NCT01975285|925061|P1|STARTED|Overall Study||30
376828|NCT01975246|925077|P2|NOT COMPLETED|Overall Study||2
376829|NCT01975246|925078|P1|NOT COMPLETED|Overall Study||4
376830|NCT01975246|925077|P2|COMPLETED|Overall Study||158
376831|NCT01975246|925078|P1|COMPLETED|Overall Study||145
376832|NCT01975246|925077|P2|STARTED|Overall Study||160
376833|NCT01975246|925078|P1|STARTED|Overall Study||149
376834|NCT01975220|925091|P6|NOT COMPLETED|Test Period 2||0
376835|NCT01975220|925092|P5|NOT COMPLETED|Test Period 2||0
376836|NCT01975220|925093|P4|NOT COMPLETED|Test Period 2||0
376837|NCT01975220|925094|P3|NOT COMPLETED|Test Period 2||0
376838|NCT01975220|925095|P2|NOT COMPLETED|Test Period 2||0
376839|NCT01975220|925096|P1|NOT COMPLETED|Test Period 2||0
376840|NCT01975220|925091|P6|COMPLETED|Test Period 2||12
376841|NCT01975220|925092|P5|COMPLETED|Test Period 2||12
376842|NCT01975220|925093|P4|COMPLETED|Test Period 2||12
376843|NCT01975220|925094|P3|COMPLETED|Test Period 2||12
376844|NCT01975220|925095|P2|COMPLETED|Test Period 2||11
376845|NCT01975220|925096|P1|COMPLETED|Test Period 2||12
376846|NCT01975220|925091|P6|STARTED|Test Period 2||12
376847|NCT01975220|925092|P5|STARTED|Test Period 2||12
376848|NCT01975220|925093|P4|STARTED|Test Period 2||12
376849|NCT01975220|925094|P3|STARTED|Test Period 2||12
376850|NCT01975220|925095|P2|STARTED|Test Period 2||11
376851|NCT01975220|925096|P1|STARTED|Test Period 2||12
376852|NCT01975220|925091|P6|NOT COMPLETED|Test Period 1||0
376853|NCT01975220|925092|P5|NOT COMPLETED|Test Period 1||0
376854|NCT01975220|925093|P4|NOT COMPLETED|Test Period 1||0
376855|NCT01975220|925094|P3|NOT COMPLETED|Test Period 1||0
376856|NCT01975220|925095|P2|NOT COMPLETED|Test Period 1||1
376857|NCT01975220|925096|P1|NOT COMPLETED|Test Period 1||0
376858|NCT01975220|925091|P6|COMPLETED|Test Period 1||12
376859|NCT01975220|925092|P5|COMPLETED|Test Period 1||12
376860|NCT01975220|925093|P4|COMPLETED|Test Period 1||12
376861|NCT01975220|925094|P3|COMPLETED|Test Period 1||12
376862|NCT01975220|925095|P2|COMPLETED|Test Period 1||11
376863|NCT01975220|925096|P1|COMPLETED|Test Period 1||12
376864|NCT01975220|925091|P6|STARTED|Test Period 1||12
376865|NCT01975220|925092|P5|STARTED|Test Period 1||12
376866|NCT01975220|925093|P4|STARTED|Test Period 1||12
376867|NCT01975220|925094|P3|STARTED|Test Period 1||12
376868|NCT01975220|925095|P2|STARTED|Test Period 1||12
376869|NCT01975220|925096|P1|STARTED|Test Period 1||12
376870|NCT01975090|925140|P1|NOT COMPLETED|Overall Study||12
376871|NCT01975090|925140|P1|COMPLETED|Overall Study||117
376872|NCT01975090|925140|P1|6-month Follow-up|Overall Study||117
376873|NCT01975090|925140|P1|STARTED|Overall Study||129
376874|NCT01974895|925152|P2|NOT COMPLETED|Overall Study||15
376875|NCT01974895|925153|P1|NOT COMPLETED|Overall Study||15
376876|NCT01974895|925152|P2|COMPLETED|Overall Study||141
376877|NCT01974895|925153|P1|COMPLETED|Overall Study||143
376878|NCT01974895|925152|P2|STARTED|Overall Study||156
376879|NCT01974895|925153|P1|STARTED|Overall Study||158
376880|NCT01974817|925183|P1|NOT COMPLETED|Overall Study||8
376881|NCT01974817|925183|P1|COMPLETED|Overall Study||17
376882|NCT01974817|925183|P1|STARTED|Overall Study||25
376883|NCT01974752|925189|P2|NOT COMPLETED|Overall Study||15
376884|NCT01974752|925190|P1|NOT COMPLETED|Overall Study||37
376885|NCT01974752|925189|P2|COMPLETED|Overall Study||17
376886|NCT01974752|925190|P1|COMPLETED|Overall Study||60
376887|NCT01974752|925189|P2|STARTED|Overall Study||32
376888|NCT01974752|925190|P1|STARTED|Overall Study||97
376889|NCT01974700|925204|P2|NOT COMPLETED|Overall Study||0
376890|NCT01974700|925205|P1|NOT COMPLETED|Overall Study||0
376891|NCT01974700|925204|P2|COMPLETED|Overall Study||3
376892|NCT01974700|925205|P1|COMPLETED|Overall Study||5
376893|NCT01974700|925204|P2|STARTED|Overall Study||3
376894|NCT01974700|925205|P1|STARTED|Overall Study||5
376895|NCT01974323|925217|P2|NOT COMPLETED|Overall Study||93
376896|NCT01974323|925218|P1|NOT COMPLETED|Overall Study||92
376897|NCT01974323|925217|P2|COMPLETED|Overall Study||1027
376898|NCT01974323|925218|P1|COMPLETED|Overall Study||1026
376899|NCT01974323|925217|P2|STARTED|Overall Study||1120
376900|NCT01974323|925218|P1|STARTED|Overall Study||1118
376901|NCT01974245|925242|P2|NOT COMPLETED|Overall Study||8
376902|NCT01974245|925243|P1|NOT COMPLETED|Overall Study||9
376903|NCT01974245|925242|P2|COMPLETED|Overall Study||20
376904|NCT01974245|925243|P1|COMPLETED|Overall Study||18
376905|NCT01974245|925242|P2|STARTED|Overall Study||28
376906|NCT01974245|925243|P1|STARTED|Overall Study||27
376907|NCT01974141|925251|P2|NOT COMPLETED|Overall Study||82
376908|NCT01974141|925252|P1|NOT COMPLETED|Overall Study||96
376909|NCT01974141|925251|P2|COMPLETED|Overall Study||976
376910|NCT01974141|925252|P1|COMPLETED|Overall Study||948
376911|NCT01974141|925251|P2|STARTED|Overall Study||1058
376912|NCT01974141|925252|P1|STARTED|Overall Study||1044
376913|NCT01974050|925274|P1|NOT COMPLETED|Overall Study||25
376914|NCT01974050|925274|P1|COMPLETED|Overall Study||141
376915|NCT01974050|925274|P1|STARTED|Overall Study||166
376916|NCT01973777|925281|P1|NOT COMPLETED|Overall Study||7
376917|NCT01973777|925281|P1|COMPLETED|Overall Study||44
376918|NCT01973777|925281|P1|One Year Follow-up|Overall Study||44
376919|NCT01973777|925281|P1|STARTED|Overall Study|January 2014|51
376920|NCT01973608|925291|P4|NOT COMPLETED|Overall Study||0
376921|NCT01973608|925292|P3|NOT COMPLETED|Overall Study||0
376922|NCT01973608|925293|P2|NOT COMPLETED|Overall Study||0
376923|NCT01973608|925294|P1|NOT COMPLETED|Overall Study||0
376924|NCT01973608|925291|P4|COMPLETED|Overall Study||2
376925|NCT01973608|925292|P3|COMPLETED|Overall Study||6
376926|NCT01973608|925293|P2|COMPLETED|Overall Study||2
376927|NCT01973608|925294|P1|COMPLETED|Overall Study||2
376928|NCT01973608|925291|P4|STARTED|Overall Study||2
376929|NCT01973608|925292|P3|STARTED|Overall Study||6
376930|NCT01973608|925293|P2|STARTED|Overall Study||2
376931|NCT01973608|925294|P1|STARTED|Overall Study||2
376932|NCT01973595|925316|P4|NOT COMPLETED|Intervention Phase 2||0
376933|NCT01973595|925317|P3|NOT COMPLETED|Intervention Phase 2||0
376934|NCT01973595|925318|P2|NOT COMPLETED|Intervention Phase 2||0
376935|NCT01973595|925319|P1|NOT COMPLETED|Intervention Phase 2||0
376936|NCT01973595|925316|P4|COMPLETED|Intervention Phase 2||14
376937|NCT01973595|925317|P3|COMPLETED|Intervention Phase 2||14
376938|NCT01973595|925318|P2|COMPLETED|Intervention Phase 2||14
376939|NCT01973595|925319|P1|COMPLETED|Intervention Phase 2||14
376940|NCT01973595|925316|P4|STARTED|Intervention Phase 2||14
376941|NCT01973595|925317|P3|STARTED|Intervention Phase 2||14
376942|NCT01973595|925318|P2|STARTED|Intervention Phase 2||14
376943|NCT01973595|925319|P1|STARTED|Intervention Phase 2||14
376944|NCT01973595|925316|P4|NOT COMPLETED|Washout||0
376945|NCT01973595|925317|P3|NOT COMPLETED|Washout||1
376946|NCT01973595|925318|P2|NOT COMPLETED|Washout||0
376947|NCT01973595|925319|P1|NOT COMPLETED|Washout||1
376948|NCT01973595|925316|P4|COMPLETED|Washout||14
376949|NCT01973595|925317|P3|COMPLETED|Washout||14
376950|NCT01973595|925318|P2|COMPLETED|Washout||14
376951|NCT01973595|925319|P1|COMPLETED|Washout||14
376952|NCT01973595|925316|P4|STARTED|Washout||14
376953|NCT01973595|925317|P3|STARTED|Washout||15
376954|NCT01973595|925318|P2|STARTED|Washout||14
376955|NCT01973595|925319|P1|STARTED|Washout||15
376956|NCT01973595|925316|P4|NOT COMPLETED|Intervention Phase 1||0
376957|NCT01973595|925317|P3|NOT COMPLETED|Intervention Phase 1||0
376958|NCT01973595|925318|P2|NOT COMPLETED|Intervention Phase 1||0
376959|NCT01973595|925319|P1|NOT COMPLETED|Intervention Phase 1||0
376960|NCT01973595|925316|P4|COMPLETED|Intervention Phase 1||14
376961|NCT01973595|925317|P3|COMPLETED|Intervention Phase 1||15
376962|NCT01973595|925318|P2|COMPLETED|Intervention Phase 1||14
376963|NCT01973595|925319|P1|COMPLETED|Intervention Phase 1||15
376964|NCT01973595|925316|P4|STARTED|Intervention Phase 1||14
376965|NCT01973595|925317|P3|STARTED|Intervention Phase 1||15
376966|NCT01973595|925318|P2|STARTED|Intervention Phase 1||14
376967|NCT01973595|925319|P1|STARTED|Intervention Phase 1||15
376968|NCT01973491|925333|P1|NOT COMPLETED|Treatment Period (16 Weeks)||1
376969|NCT01973491|925333|P1|COMPLETED|Treatment Period (16 Weeks)||18
376970|NCT01973491|925333|P1|STARTED|Treatment Period (16 Weeks)||19
376971|NCT01973491|925333|P1|NOT COMPLETED|Titration Period(4 Weeks)||0
376972|NCT01973491|925333|P1|COMPLETED|Titration Period(4 Weeks)||19
376973|NCT01973491|925333|P1|STARTED|Titration Period(4 Weeks)||19
376974|NCT01973491|925333|P1|NOT COMPLETED|Baseline Control Period (8 Weeks)||18
376975|NCT01973491|925333|P1|COMPLETED|Baseline Control Period (8 Weeks)||19
376976|NCT01973491|925333|P1|STARTED|Baseline Control Period (8 Weeks)||37
376977|NCT01973439|925349|P1|NOT COMPLETED|Overall Study||5
376978|NCT01973439|925349|P1|COMPLETED|Overall Study||18
376979|NCT01973439|925349|P1|One Evaluable PK Day Only|Overall Study|5 children had only one evaluable PK day.|5
377078|NCT01972776|925916|P2|STARTED|Part 1||6
376980|NCT01973439|925349|P1|Two Evaluable PK Days|Overall Study|18 Children had two evaluable PK days|18
376981|NCT01973439|925349|P1|STARTED|Overall Study||23
376982|NCT01973413|925358|P2|NOT COMPLETED|Overall Study||0
376983|NCT01973413|925359|P1|NOT COMPLETED|Overall Study||1
376984|NCT01973413|925358|P2|COMPLETED|Overall Study||20
376985|NCT01973413|925359|P1|COMPLETED|Overall Study||11
376986|NCT01973413|925358|P2|STARTED|Overall Study||20
376987|NCT01973413|925359|P1|STARTED|Overall Study||12
376988|NCT01973387|925371|P2|NOT COMPLETED|Overall Study||18
376989|NCT01973387|925372|P1|NOT COMPLETED|Overall Study||106
376990|NCT01973387|925371|P2|COMPLETED|Overall Study||36
376991|NCT01973387|925372|P1|COMPLETED|Overall Study||0
376992|NCT01973387|925371|P2|Treated|Overall Study||52
376993|NCT01973387|925372|P1|Treated|Overall Study||104
376994|NCT01973387|925371|P2|STARTED|Overall Study||54
376995|NCT01973387|925372|P1|STARTED|Overall Study||106
376996|NCT01973348|925386|P4|NOT COMPLETED|Overall Study||0
376997|NCT01973348|925387|P3|NOT COMPLETED|Overall Study||0
376998|NCT01973348|925388|P2|NOT COMPLETED|Overall Study||3
376999|NCT01973348|925389|P1|NOT COMPLETED|Overall Study||8
377000|NCT01973348|925386|P4|COMPLETED|Overall Study||0
377001|NCT01973348|925387|P3|COMPLETED|Overall Study||0
377002|NCT01973348|925388|P2|COMPLETED|Overall Study||15
377003|NCT01973348|925389|P1|COMPLETED|Overall Study||19
377004|NCT01973348|925386|P4|STARTED|Overall Study||0
377005|NCT01973348|925387|P3|STARTED|Overall Study||0
377006|NCT01973348|925388|P2|STARTED|Overall Study||18
377007|NCT01973348|925389|P1|STARTED|Overall Study||27
377008|NCT01973231|925409|P2|NOT COMPLETED|Overall Study||12
377009|NCT01973231|925410|P1|NOT COMPLETED|Overall Study||11
377010|NCT01973231|925409|P2|COMPLETED|Overall Study||190
377011|NCT01973231|925410|P1|COMPLETED|Overall Study||191
377012|NCT01973231|925409|P2|STARTED|Overall Study||202
377013|NCT01973231|925410|P1|STARTED|Overall Study||202
377014|NCT01973218|925430|P2|NOT COMPLETED|Overall Study||0
377015|NCT01973218|925431|P1|NOT COMPLETED|Overall Study||2
377016|NCT01973218|925430|P2|COMPLETED|Overall Study||88
377017|NCT01973218|925431|P1|COMPLETED|Overall Study||174
377018|NCT01973218|925430|P2|STARTED|Overall Study||88
377019|NCT01973218|925431|P1|STARTED|Overall Study||176
377020|NCT01973205|925454|P2|NOT COMPLETED|Overall Study||22
377021|NCT01973205|925455|P1|NOT COMPLETED|Overall Study||30
377022|NCT01973205|925454|P2|COMPLETED|Overall Study||425
377023|NCT01973205|925455|P1|COMPLETED|Overall Study||423
377024|NCT01973205|925454|P2|STARTED|Overall Study||447
377025|NCT01973205|925455|P1|STARTED|Overall Study||453
377026|NCT01972841|925473|P6|NOT COMPLETED|Overall Study||85
377027|NCT01972841|925474|P5|NOT COMPLETED|Overall Study||83
377028|NCT01972841|925475|P4|NOT COMPLETED|Overall Study||37
377029|NCT01972841|925476|P3|NOT COMPLETED|Overall Study||50
377030|NCT01972841|925477|P2|NOT COMPLETED|Overall Study||44
377031|NCT01972841|925478|P1|NOT COMPLETED|Overall Study||43
377032|NCT01972841|925473|P6|COMPLETED|Overall Study||798
377033|NCT01972841|925474|P5|COMPLETED|Overall Study||802
377034|NCT01972841|925475|P4|COMPLETED|Overall Study||397
377035|NCT01972841|925476|P3|COMPLETED|Overall Study||387
377036|NCT01972841|925477|P2|COMPLETED|Overall Study||397
377037|NCT01972841|925478|P1|COMPLETED|Overall Study||404
377038|NCT01972841|925473|P6|STARTED|Overall Study||883
377039|NCT01972841|925474|P5|STARTED|Overall Study||885
377040|NCT01972841|925475|P4|STARTED|Overall Study||434
377041|NCT01972841|925476|P3|STARTED|Overall Study||437
377042|NCT01972841|925477|P2|STARTED|Overall Study||441
377043|NCT01972841|925478|P1|STARTED|Overall Study||447
377044|NCT01972776|925912|P6|NOT COMPLETED|Part 2||7
377045|NCT01972776|925913|P5|NOT COMPLETED|Part 2||13
377046|NCT01972776|925914|P4|NOT COMPLETED|Part 2||0
377047|NCT01972776|925915|P3|NOT COMPLETED|Part 2||0
377048|NCT01972776|925916|P2|NOT COMPLETED|Part 2||0
377049|NCT01972776|925917|P1|NOT COMPLETED|Part 2||0
377050|NCT01972776|925912|P6|COMPLETED|Part 2||0
377051|NCT01972776|925913|P5|COMPLETED|Part 2||1
377052|NCT01972776|925914|P4|COMPLETED|Part 2||0
377053|NCT01972776|925915|P3|COMPLETED|Part 2||0
377054|NCT01972776|925916|P2|COMPLETED|Part 2||0
377055|NCT01972776|925917|P1|COMPLETED|Part 2||0
377056|NCT01972776|925912|P6|STARTED|Part 2||7
377057|NCT01972776|925913|P5|STARTED|Part 2||14
377058|NCT01972776|925914|P4|STARTED|Part 2||0
377059|NCT01972776|925915|P3|STARTED|Part 2||0
377060|NCT01972776|925916|P2|STARTED|Part 2||0
377061|NCT01972776|925917|P1|STARTED|Part 2||0
377062|NCT01972776|925912|P6|NOT COMPLETED|Part 1||0
377063|NCT01972776|925913|P5|NOT COMPLETED|Part 1||0
377064|NCT01972776|925914|P4|NOT COMPLETED|Part 1||1
377065|NCT01972776|925915|P3|NOT COMPLETED|Part 1||2
377066|NCT01972776|925916|P2|NOT COMPLETED|Part 1||0
377067|NCT01972776|925917|P1|NOT COMPLETED|Part 1||0
377068|NCT01972776|925912|P6|COMPLETED|Part 1||0
377069|NCT01972776|925913|P5|COMPLETED|Part 1||0
377070|NCT01972776|925914|P4|COMPLETED|Part 1||6
377071|NCT01972776|925915|P3|COMPLETED|Part 1||6
377072|NCT01972776|925916|P2|COMPLETED|Part 1||6
377073|NCT01972776|925917|P1|COMPLETED|Part 1||6
377074|NCT01972776|925912|P6|STARTED|Part 1||0
377075|NCT01972776|925913|P5|STARTED|Part 1||0
377076|NCT01972776|925914|P4|STARTED|Part 1||7
377077|NCT01972776|925915|P3|STARTED|Part 1||8
377079|NCT01972776|925917|P1|STARTED|Part 1||6
377080|NCT01972659|925987|P2|NOT COMPLETED|Overall Study||3
377081|NCT01972659|925988|P1|NOT COMPLETED|Overall Study||4
377082|NCT01972659|925987|P2|COMPLETED|Overall Study||37
377083|NCT01972659|925988|P1|COMPLETED|Overall Study||36
377084|NCT01972659|925987|P2|STARTED|Overall Study||40
377085|NCT01972659|925988|P1|STARTED|Overall Study||40
377086|NCT01972568|925997|P3|NOT COMPLETED|Overall Study||16
377087|NCT01972568|925998|P2|NOT COMPLETED|Overall Study||12
377088|NCT01972568|925999|P1|NOT COMPLETED|Overall Study||16
377089|NCT01972568|925997|P3|COMPLETED|Overall Study||84
377090|NCT01972568|925998|P2|COMPLETED|Overall Study||92
377091|NCT01972568|925999|P1|COMPLETED|Overall Study||86
377092|NCT01972568|925997|P3|STARTED|Overall Study||100
377093|NCT01972568|925998|P2|STARTED|Overall Study||104
377094|NCT01972568|925999|P1|STARTED|Overall Study||102
377095|NCT01972529|926038|P4|NOT COMPLETED|Overall Study||4
377096|NCT01972529|926039|P3|NOT COMPLETED|Overall Study||2
377097|NCT01972529|926040|P2|NOT COMPLETED|Overall Study||5
377098|NCT01972529|926041|P1|NOT COMPLETED|Overall Study||2
377099|NCT01972529|926038|P4|COMPLETED|Overall Study||55
377100|NCT01972529|926039|P3|COMPLETED|Overall Study||32
377101|NCT01972529|926040|P2|COMPLETED|Overall Study||85
377102|NCT01972529|926041|P1|COMPLETED|Overall Study||46
377103|NCT01972529|926038|P4|STARTED|Overall Study||59
377104|NCT01972529|926039|P3|STARTED|Overall Study||34
377105|NCT01972529|926040|P2|STARTED|Overall Study||90
377106|NCT01972529|926041|P1|STARTED|Overall Study||48
377107|NCT01972516|926069|P2|NOT COMPLETED|Overall Study||0
377108|NCT01972516|926070|P1|NOT COMPLETED|Overall Study||0
377109|NCT01972516|926069|P2|COMPLETED|Overall Study||1
377110|NCT01972516|926070|P1|COMPLETED|Overall Study||3
377111|NCT01972516|926069|P2|STARTED|Overall Study||1
377112|NCT01972516|926070|P1|STARTED|Overall Study||3
377113|NCT01972464|926086|P2|NOT COMPLETED|3-Month Follow-Up (Week 20)||1
377114|NCT01972464|926087|P1|NOT COMPLETED|3-Month Follow-Up (Week 20)||1
377115|NCT01972464|926086|P2|COMPLETED|3-Month Follow-Up (Week 20)||17
377116|NCT01972464|926087|P1|COMPLETED|3-Month Follow-Up (Week 20)||15
377117|NCT01972464|926086|P2|STARTED|3-Month Follow-Up (Week 20)||18
377118|NCT01972464|926087|P1|STARTED|3-Month Follow-Up (Week 20)||16
377119|NCT01972464|926086|P2|NOT COMPLETED|Treatment Period (Week 1 Through Week 8)||4
377120|NCT01972464|926087|P1|NOT COMPLETED|Treatment Period (Week 1 Through Week 8)||3
377121|NCT01972464|926086|P2|COMPLETED|Treatment Period (Week 1 Through Week 8)||18
377122|NCT01972464|926087|P1|COMPLETED|Treatment Period (Week 1 Through Week 8)||16
377123|NCT01972464|926086|P2|STARTED|Treatment Period (Week 1 Through Week 8)||22
377124|NCT01972464|926087|P1|STARTED|Treatment Period (Week 1 Through Week 8)||19
377125|NCT01972438|926103|P2|NOT COMPLETED|Post Month 12 Study Period||4
377126|NCT01972438|926104|P1|NOT COMPLETED|Post Month 12 Study Period||3
377127|NCT01972438|926103|P2|COMPLETED|Post Month 12 Study Period||0
377128|NCT01972438|926104|P1|COMPLETED|Post Month 12 Study Period||0
377129|NCT01972438|926103|P2|STARTED|Post Month 12 Study Period||4
377130|NCT01972438|926104|P1|STARTED|Post Month 12 Study Period||3
377131|NCT01972438|926103|P2|NOT COMPLETED|Months 6-12 Study Period||2
377132|NCT01972438|926104|P1|NOT COMPLETED|Months 6-12 Study Period||3
377133|NCT01972438|926103|P2|COMPLETED|Months 6-12 Study Period||4
377134|NCT01972438|926104|P1|COMPLETED|Months 6-12 Study Period||3
377135|NCT01972438|926103|P2|STARTED|Months 6-12 Study Period||6
377136|NCT01972438|926104|P1|STARTED|Months 6-12 Study Period||6
377137|NCT01972438|926103|P2|NOT COMPLETED|Months 3-6 Crossover Period||1
377138|NCT01972438|926104|P1|NOT COMPLETED|Months 3-6 Crossover Period||0
377139|NCT01972438|926103|P2|COMPLETED|Months 3-6 Crossover Period||6
377140|NCT01972438|926104|P1|COMPLETED|Months 3-6 Crossover Period||6
377141|NCT01972438|926103|P2|STARTED|Months 3-6 Crossover Period|Two participants who missed Month 3 visit completed this pd but one who completed Month 3 didn't|7
377142|NCT01972438|926104|P1|STARTED|Months 3-6 Crossover Period||6
377143|NCT01972438|926103|P2|NOT COMPLETED|Baseline-Month 3 Crossover Period||3
377144|NCT01972438|926104|P1|NOT COMPLETED|Baseline-Month 3 Crossover Period||3
377145|NCT01972438|926103|P2|COMPLETED|Baseline-Month 3 Crossover Period||6
377146|NCT01972438|926104|P1|COMPLETED|Baseline-Month 3 Crossover Period||6
377147|NCT01972438|926103|P2|STARTED|Baseline-Month 3 Crossover Period|One participant never started IP, as unable to donate blood for preparation of ASEDs|9
377148|NCT01972438|926104|P1|STARTED|Baseline-Month 3 Crossover Period|Two participants never started IP: one died and one did not meet the inclusion criteria|9
377149|NCT01972152|926156|P6|NOT COMPLETED|Third Treatment Visit||0
377150|NCT01972152|926157|P5|NOT COMPLETED|Third Treatment Visit||0
377151|NCT01972152|926158|P4|NOT COMPLETED|Third Treatment Visit||0
377152|NCT01972152|926159|P3|NOT COMPLETED|Third Treatment Visit||0
377153|NCT01972152|926160|P2|NOT COMPLETED|Third Treatment Visit||0
377154|NCT01972152|926161|P1|NOT COMPLETED|Third Treatment Visit||0
377155|NCT01972152|926156|P6|COMPLETED|Third Treatment Visit||5
377156|NCT01972152|926157|P5|COMPLETED|Third Treatment Visit||5
377157|NCT01972152|926158|P4|COMPLETED|Third Treatment Visit||5
377158|NCT01972152|926159|P3|COMPLETED|Third Treatment Visit||5
377159|NCT01972152|926160|P2|COMPLETED|Third Treatment Visit||3
377160|NCT01972152|926161|P1|COMPLETED|Third Treatment Visit||5
377161|NCT01972152|926156|P6|STARTED|Third Treatment Visit||5
377162|NCT01972152|926157|P5|STARTED|Third Treatment Visit||5
377163|NCT01972152|926158|P4|STARTED|Third Treatment Visit||5
377164|NCT01972152|926159|P3|STARTED|Third Treatment Visit||5
377165|NCT01972152|926160|P2|STARTED|Third Treatment Visit||3
377166|NCT01972152|926161|P1|STARTED|Third Treatment Visit||5
377167|NCT01972152|926156|P6|NOT COMPLETED|Second Treatment Visit||0
377168|NCT01972152|926157|P5|NOT COMPLETED|Second Treatment Visit||0
377169|NCT01972152|926158|P4|NOT COMPLETED|Second Treatment Visit||0
377170|NCT01972152|926159|P3|NOT COMPLETED|Second Treatment Visit||0
377171|NCT01972152|926160|P2|NOT COMPLETED|Second Treatment Visit||1
377172|NCT01972152|926161|P1|NOT COMPLETED|Second Treatment Visit||0
377173|NCT01972152|926156|P6|COMPLETED|Second Treatment Visit||5
377174|NCT01972152|926157|P5|COMPLETED|Second Treatment Visit||5
377175|NCT01972152|926158|P4|COMPLETED|Second Treatment Visit||5
377176|NCT01972152|926159|P3|COMPLETED|Second Treatment Visit||5
377177|NCT01972152|926160|P2|COMPLETED|Second Treatment Visit||3
377178|NCT01972152|926161|P1|COMPLETED|Second Treatment Visit||5
377179|NCT01972152|926156|P6|STARTED|Second Treatment Visit||5
377180|NCT01972152|926157|P5|STARTED|Second Treatment Visit||5
377181|NCT01972152|926158|P4|STARTED|Second Treatment Visit||5
377182|NCT01972152|926159|P3|STARTED|Second Treatment Visit||5
377183|NCT01972152|926160|P2|STARTED|Second Treatment Visit||4
377184|NCT01972152|926161|P1|STARTED|Second Treatment Visit||5
377185|NCT01972152|926156|P6|NOT COMPLETED|First Treatment Visit||0
377186|NCT01972152|926157|P5|NOT COMPLETED|First Treatment Visit||0
377187|NCT01972152|926158|P4|NOT COMPLETED|First Treatment Visit||0
377188|NCT01972152|926159|P3|NOT COMPLETED|First Treatment Visit||0
377189|NCT01972152|926160|P2|NOT COMPLETED|First Treatment Visit||1
377190|NCT01972152|926161|P1|NOT COMPLETED|First Treatment Visit||0
377191|NCT01972152|926156|P6|COMPLETED|First Treatment Visit||5
377192|NCT01972152|926157|P5|COMPLETED|First Treatment Visit||5
377193|NCT01972152|926158|P4|COMPLETED|First Treatment Visit||5
377194|NCT01972152|926159|P3|COMPLETED|First Treatment Visit||5
377195|NCT01972152|926160|P2|COMPLETED|First Treatment Visit||4
377196|NCT01972152|926161|P1|COMPLETED|First Treatment Visit||5
377197|NCT01972152|926156|P6|STARTED|First Treatment Visit||5
377198|NCT01972152|926157|P5|STARTED|First Treatment Visit||5
377199|NCT01972152|926158|P4|STARTED|First Treatment Visit||5
377200|NCT01972152|926159|P3|STARTED|First Treatment Visit||5
377201|NCT01972152|926160|P2|STARTED|First Treatment Visit||5
377202|NCT01972152|926161|P1|STARTED|First Treatment Visit||5
377203|NCT01971723|926198|P2|NOT COMPLETED|Overall Study||3
377204|NCT01971723|926199|P1|NOT COMPLETED|Overall Study||2
377205|NCT01971723|926198|P2|COMPLETED|Overall Study||13
377206|NCT01971723|926199|P1|COMPLETED|Overall Study||14
377207|NCT01971723|926198|P2|STARTED|Overall Study||16
377208|NCT01971723|926199|P1|STARTED|Overall Study||16
377209|NCT01971645|926232|P3|NOT COMPLETED|Overall Study||2
377210|NCT01971645|926233|P2|NOT COMPLETED|Overall Study||0
377211|NCT01971645|926234|P1|NOT COMPLETED|Overall Study||2
377212|NCT01971645|926232|P3|COMPLETED|Overall Study||23
377213|NCT01971645|926233|P2|COMPLETED|Overall Study||27
377214|NCT01971645|926234|P1|COMPLETED|Overall Study||23
377215|NCT01971645|926232|P3|STARTED|Overall Study||25
377216|NCT01971645|926233|P2|STARTED|Overall Study||27
377217|NCT01971645|926234|P1|STARTED|Overall Study||25
377218|NCT01971593|926245|P2|NOT COMPLETED|Overall Study||4
377219|NCT01971593|926246|P1|NOT COMPLETED|Overall Study||5
377220|NCT01971593|926245|P2|COMPLETED|Overall Study||8
377221|NCT01971593|926246|P1|COMPLETED|Overall Study||9
377222|NCT01971593|926245|P2|STARTED|Overall Study||12
377223|NCT01971593|926246|P1|STARTED|Overall Study||14
377224|NCT01971580|926257|P2|NOT COMPLETED|Overall Study||5
377225|NCT01971580|926258|P1|NOT COMPLETED|Overall Study||4
377226|NCT01971580|926257|P2|COMPLETED|Overall Study||9
377227|NCT01971580|926258|P1|COMPLETED|Overall Study||10
377228|NCT01971580|926257|P2|STARTED|Overall Study||14
377229|NCT01971580|926258|P1|STARTED|Overall Study||14
377230|NCT01971567|926268|P2|NOT COMPLETED|Overall Study||2
377231|NCT01971567|926269|P1|NOT COMPLETED|Overall Study||4
377232|NCT01971567|926268|P2|COMPLETED|Overall Study||49
377233|NCT01971567|926269|P1|COMPLETED|Overall Study||52
377234|NCT01971567|926268|P2|STARTED|Overall Study||51
377235|NCT01971567|926269|P1|STARTED|Overall Study||56
377236|NCT01971554|926295|P4|NOT COMPLETED|Overall Study||0
377237|NCT01971554|926296|P3|NOT COMPLETED|Overall Study||0
377238|NCT01971554|926297|P2|NOT COMPLETED|Overall Study||0
377239|NCT01971554|926298|P1|NOT COMPLETED|Overall Study||1
377240|NCT01971554|926295|P4|COMPLETED|Overall Study||18
377241|NCT01971554|926296|P3|COMPLETED|Overall Study||18
377242|NCT01971554|926297|P2|COMPLETED|Overall Study||18
377243|NCT01971554|926298|P1|COMPLETED|Overall Study||8
377244|NCT01971554|926295|P4|STARTED|Overall Study||18
377245|NCT01971554|926296|P3|STARTED|Overall Study||18
377246|NCT01971554|926297|P2|STARTED|Overall Study||18
377247|NCT01971554|926298|P1|STARTED|Overall Study||9
377248|NCT01971385|926335|P3|NOT COMPLETED|Overall Study||4
377249|NCT01971385|926336|P2|NOT COMPLETED|Overall Study||5
377250|NCT01971385|926337|P1|NOT COMPLETED|Overall Study||3
377251|NCT01971385|926335|P3|COMPLETED|Overall Study||15
377252|NCT01971385|926336|P2|COMPLETED|Overall Study||13
377253|NCT01971385|926337|P1|COMPLETED|Overall Study||14
377254|NCT01971385|926335|P3|STARTED|Overall Study||19
377255|NCT01971385|926336|P2|STARTED|Overall Study||18
377256|NCT01971385|926337|P1|STARTED|Overall Study||17
377257|NCT01971255|926346|P2|NOT COMPLETED|Overall Study||2
377258|NCT01971255|926347|P1|NOT COMPLETED|Overall Study||1
377259|NCT01971255|926346|P2|COMPLETED|Overall Study||40
377260|NCT01971255|926347|P1|COMPLETED|Overall Study||31
377261|NCT01971255|926346|P2|STARTED|Overall Study||42
377262|NCT01971255|926347|P1|STARTED|Overall Study||32
377263|NCT01971203|926365|P2|NOT COMPLETED|Overall Study||8
377264|NCT01971203|926366|P1|NOT COMPLETED|Overall Study||9
377265|NCT01971203|926365|P2|COMPLETED|Overall Study||21
377266|NCT01971203|926366|P1|COMPLETED|Overall Study||17
377267|NCT01971203|926365|P2|STARTED|Overall Study||29
377268|NCT01971203|926366|P1|STARTED|Overall Study||26
377269|NCT01971086|926378|P1|NOT COMPLETED|Overall Study||0
377270|NCT01971086|926378|P1|COMPLETED|Overall Study||300
377271|NCT01971086|926378|P1|STARTED|Overall Study||300
377272|NCT01970995|926393|P3|NOT COMPLETED|End of Study (Population at Day 90)||1
377273|NCT01970995|926394|P2|NOT COMPLETED|End of Study (Population at Day 90)||0
377274|NCT01970995|926395|P1|NOT COMPLETED|End of Study (Population at Day 90)||1
377275|NCT01970995|926393|P3|COMPLETED|End of Study (Population at Day 90)||38
377276|NCT01970995|926394|P2|COMPLETED|End of Study (Population at Day 90)||41
377277|NCT01970995|926395|P1|COMPLETED|End of Study (Population at Day 90)||76
377278|NCT01970995|926393|P3|STARTED|End of Study (Population at Day 90)||39
377279|NCT01970995|926394|P2|STARTED|End of Study (Population at Day 90)||41
377280|NCT01970995|926395|P1|STARTED|End of Study (Population at Day 90)||77
377281|NCT01970995|926393|P3|NOT COMPLETED|Confinement Period (Population at Day 5)||1
377282|NCT01970995|926394|P2|NOT COMPLETED|Confinement Period (Population at Day 5)||1
377283|NCT01970995|926395|P1|NOT COMPLETED|Confinement Period (Population at Day 5)||1
377284|NCT01970995|926393|P3|COMPLETED|Confinement Period (Population at Day 5)||39
377285|NCT01970995|926394|P2|COMPLETED|Confinement Period (Population at Day 5)||41
377286|NCT01970995|926395|P1|COMPLETED|Confinement Period (Population at Day 5)||77
377287|NCT01970995|926393|P3|STARTED|Confinement Period (Population at Day 5)||40
377288|NCT01970995|926394|P2|STARTED|Confinement Period (Population at Day 5)||42
377289|NCT01970995|926395|P1|STARTED|Confinement Period (Population at Day 5)||78
377290|NCT01970982|926418|P3|NOT COMPLETED|Overall Study||2
377291|NCT01970982|926419|P2|NOT COMPLETED|Overall Study||0
377292|NCT01970982|926420|P1|NOT COMPLETED|Overall Study||0
377293|NCT01970982|926418|P3|COMPLETED|Overall Study||38
377294|NCT01970982|926419|P2|COMPLETED|Overall Study||40
377295|NCT01970982|926420|P1|COMPLETED|Overall Study||80
377296|NCT01970982|926418|P3|STARTED|Overall Study||40
377297|NCT01970982|926419|P2|STARTED|Overall Study||40
377298|NCT01970982|926420|P1|STARTED|Overall Study||80
377299|NCT01970878|926442|P4|NOT COMPLETED|Overall Study||24
377300|NCT01970878|926443|P3|NOT COMPLETED|Overall Study||26
377301|NCT01970878|926444|P2|NOT COMPLETED|Overall Study||27
377302|NCT01970878|926445|P1|NOT COMPLETED|Overall Study||37
377303|NCT01970878|926442|P4|COMPLETED|Overall Study||147
377304|NCT01970878|926443|P3|COMPLETED|Overall Study||187
377305|NCT01970878|926444|P2|COMPLETED|Overall Study||191
377306|NCT01970878|926445|P1|COMPLETED|Overall Study||253
377307|NCT01970878|926442|P4|STARTED|Overall Study||171
377308|NCT01970878|926443|P3|STARTED|Overall Study||213
377309|NCT01970878|926444|P2|STARTED|Overall Study|218 subjects were reported in the CSR, 1 had no completion status|218
377310|NCT01970878|926445|P1|STARTED|Overall Study||290
377311|NCT01970865|926488|P17|NOT COMPLETED|Overall Study||3
377312|NCT01970865|926489|P16|NOT COMPLETED|Overall Study||47
377313|NCT01970865|926490|P15|NOT COMPLETED|Overall Study||46
377314|NCT01970865|926491|P14|NOT COMPLETED|Overall Study||66
377315|NCT01970865|926492|P13|NOT COMPLETED|Overall Study||60
377316|NCT01970865|926493|P12|NOT COMPLETED|Overall Study||27
377317|NCT01970865|926494|P11|NOT COMPLETED|Overall Study||30
377318|NCT01970865|926495|P10|NOT COMPLETED|Overall Study||4
377319|NCT01970865|926496|P9|NOT COMPLETED|Overall Study||3
377320|NCT01970865|926497|P8|NOT COMPLETED|Overall Study||3
377321|NCT01970865|926498|P7|NOT COMPLETED|Overall Study||3
377322|NCT01970865|926499|P6|NOT COMPLETED|Overall Study||3
377323|NCT01970865|926500|P5|NOT COMPLETED|Overall Study||17
377324|NCT01970865|926501|P4|NOT COMPLETED|Overall Study||13
377325|NCT01970865|926502|P3|NOT COMPLETED|Overall Study||3
377326|NCT01970865|926503|P2|NOT COMPLETED|Overall Study||3
377327|NCT01970865|926504|P1|NOT COMPLETED|Overall Study||3
377328|NCT01970865|926488|P17|COMPLETED|Overall Study||0
377329|NCT01970865|926489|P16|COMPLETED|Overall Study||0
377330|NCT01970865|926490|P15|COMPLETED|Overall Study||0
377331|NCT01970865|926491|P14|COMPLETED|Overall Study||0
377332|NCT01970865|926492|P13|COMPLETED|Overall Study||0
377333|NCT01970865|926493|P12|COMPLETED|Overall Study||0
377334|NCT01970865|926494|P11|COMPLETED|Overall Study||0
377335|NCT01970865|926495|P10|COMPLETED|Overall Study||0
377336|NCT01970865|926496|P9|COMPLETED|Overall Study||0
377337|NCT01970865|926497|P8|COMPLETED|Overall Study||0
377338|NCT01970865|926498|P7|COMPLETED|Overall Study||0
377339|NCT01970865|926499|P6|COMPLETED|Overall Study||0
377340|NCT01970865|926500|P5|COMPLETED|Overall Study||0
377341|NCT01970865|926501|P4|COMPLETED|Overall Study||0
377342|NCT01970865|926502|P3|COMPLETED|Overall Study||0
377343|NCT01970865|926503|P2|COMPLETED|Overall Study||0
377344|NCT01970865|926504|P1|COMPLETED|Overall Study||0
377345|NCT01970865|926488|P17|Received Treatment|Overall Study||3
377346|NCT01970865|926489|P16|Received Treatment|Overall Study||47
377347|NCT01970865|926490|P15|Received Treatment|Overall Study||46
377348|NCT01970865|926491|P14|Received Treatment|Overall Study||65
377349|NCT01970865|926492|P13|Received Treatment|Overall Study||60
377350|NCT01970865|926493|P12|Received Treatment|Overall Study||27
377351|NCT01970865|926494|P11|Received Treatment|Overall Study||30
377352|NCT01970865|926495|P10|Received Treatment|Overall Study||4
377353|NCT01970865|926496|P9|Received Treatment|Overall Study||3
377354|NCT01970865|926497|P8|Received Treatment|Overall Study||3
377355|NCT01970865|926498|P7|Received Treatment|Overall Study||3
377356|NCT01970865|926499|P6|Received Treatment|Overall Study||3
377357|NCT01970865|926500|P5|Received Treatment|Overall Study||17
377358|NCT01970865|926501|P4|Received Treatment|Overall Study||12
377359|NCT01970865|926502|P3|Received Treatment|Overall Study||3
377360|NCT01970865|926503|P2|Received Treatment|Overall Study||3
377361|NCT01970865|926504|P1|Received Treatment|Overall Study||3
377362|NCT01970865|926488|P17|STARTED|Overall Study||3
377363|NCT01970865|926489|P16|STARTED|Overall Study||47
377364|NCT01970865|926490|P15|STARTED|Overall Study||46
377365|NCT01970865|926491|P14|STARTED|Overall Study||66
377366|NCT01970865|926492|P13|STARTED|Overall Study||60
377367|NCT01970865|926493|P12|STARTED|Overall Study||27
377368|NCT01970865|926494|P11|STARTED|Overall Study||30
377369|NCT01970865|926495|P10|STARTED|Overall Study||4
377370|NCT01970865|926496|P9|STARTED|Overall Study||3
377371|NCT01970865|926497|P8|STARTED|Overall Study||3
377372|NCT01970865|926498|P7|STARTED|Overall Study||3
377373|NCT01970865|926499|P6|STARTED|Overall Study||3
377374|NCT01970865|926500|P5|STARTED|Overall Study||17
377375|NCT01970865|926501|P4|STARTED|Overall Study||13
377376|NCT01970865|926502|P3|STARTED|Overall Study||3
377377|NCT01970865|926503|P2|STARTED|Overall Study||3
377378|NCT01970865|926504|P1|STARTED|Overall Study||3
377379|NCT01970787|926928|P1|NOT COMPLETED|Overall Study||1
377380|NCT01970787|926928|P1|COMPLETED|Overall Study||21
377381|NCT01970787|926928|P1|STARTED|Overall Study||22
377382|NCT01970488|926938|P5|NOT COMPLETED|Part 2: Post Week 16||8
377383|NCT01970488|926939|P4|NOT COMPLETED|Part 2: Post Week 16||8
377384|NCT01970488|926940|P3|NOT COMPLETED|Part 2: Post Week 16||17
377385|NCT01970488|926941|P2|NOT COMPLETED|Part 2: Post Week 16||0
377386|NCT01970488|926942|P1|NOT COMPLETED|Part 2: Post Week 16||0
377387|NCT01970488|926938|P5|COMPLETED|Part 2: Post Week 16||69
377388|NCT01970488|926939|P4|COMPLETED|Part 2: Post Week 16||71
377389|NCT01970488|926940|P3|COMPLETED|Part 2: Post Week 16||135
377390|NCT01970488|926941|P2|COMPLETED|Part 2: Post Week 16||0
377391|NCT01970488|926942|P1|COMPLETED|Part 2: Post Week 16||0
377392|NCT01970488|926938|P5|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|77
377393|NCT01970488|926939|P4|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|79
377394|NCT01970488|926940|P3|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|152
377395|NCT01970488|926941|P2|STARTED|Part 2: Post Week 16||0
377396|NCT01970488|926942|P1|STARTED|Part 2: Post Week 16||0
377397|NCT01970488|926938|P5|NOT COMPLETED|Part 1: Through Week 16||0
377398|NCT01970488|926939|P4|NOT COMPLETED|Part 1: Through Week 16||0
377399|NCT01970488|926940|P3|NOT COMPLETED|Part 1: Through Week 16||0
377400|NCT01970488|926941|P2|NOT COMPLETED|Part 1: Through Week 16||13
377401|NCT01970488|926942|P1|NOT COMPLETED|Part 1: Through Week 16||11
377402|NCT01970488|926938|P5|COMPLETED|Part 1: Through Week 16||0
377403|NCT01970488|926939|P4|COMPLETED|Part 1: Through Week 16||0
377404|NCT01970488|926940|P3|COMPLETED|Part 1: Through Week 16||0
377405|NCT01970488|926941|P2|COMPLETED|Part 1: Through Week 16||162
377406|NCT01970488|926942|P1|COMPLETED|Part 1: Through Week 16||164
377407|NCT01970488|926938|P5|Received Treatment|Part 1: Through Week 16||0
377408|NCT01970488|926939|P4|Received Treatment|Part 1: Through Week 16||0
377409|NCT01970488|926940|P3|Received Treatment|Part 1: Through Week 16||0
377410|NCT01970488|926941|P2|Received Treatment|Part 1: Through Week 16||173
377411|NCT01970488|926942|P1|Received Treatment|Part 1: Through Week 16||174
377412|NCT01970488|926938|P5|STARTED|Part 1: Through Week 16||0
377413|NCT01970488|926939|P4|STARTED|Part 1: Through Week 16||0
377414|NCT01970488|926940|P3|STARTED|Part 1: Through Week 16||0
377415|NCT01970488|926941|P2|STARTED|Part 1: Through Week 16||175
377416|NCT01970488|926942|P1|STARTED|Part 1: Through Week 16||175
377417|NCT01970475|927009|P2|NOT COMPLETED|Overall Study||11
377418|NCT01970475|927010|P1|NOT COMPLETED|Overall Study||21
377419|NCT01970475|927009|P2|COMPLETED|Overall Study||251
377420|NCT01970475|927010|P1|COMPLETED|Overall Study||243
377421|NCT01970475|927009|P2|STARTED|Overall Study||262
377422|NCT01970475|927010|P1|STARTED|Overall Study||264
377423|NCT01970462|927030|P2|NOT COMPLETED|Overall Study||2
377424|NCT01970462|927031|P1|NOT COMPLETED|Overall Study||0
377425|NCT01970462|927030|P2|COMPLETED|Overall Study||2
377426|NCT01970462|927031|P1|COMPLETED|Overall Study||1
377427|NCT01970462|927030|P2|STARTED|Overall Study||4
377428|NCT01970462|927031|P1|STARTED|Overall Study||1
377429|NCT01970397|927045|P2|NOT COMPLETED|Overall Study||5
377430|NCT01970397|927046|P1|NOT COMPLETED|Overall Study||2
377431|NCT01970397|927045|P2|COMPLETED|Overall Study||64
377432|NCT01970397|927046|P1|COMPLETED|Overall Study||67
377433|NCT01970397|927045|P2|STARTED|Overall Study||69
377434|NCT01970397|927046|P1|STARTED|Overall Study||69
377435|NCT01969799|927058|P2|NOT COMPLETED|Overall Study||14
377436|NCT01969799|927059|P1|NOT COMPLETED|Overall Study||17
377437|NCT01969799|927058|P2|COMPLETED|Overall Study||58
377438|NCT01969799|927059|P1|COMPLETED|Overall Study||54
377439|NCT01969799|927058|P2|STARTED|Overall Study||72
377440|NCT01969799|927059|P1|STARTED|Overall Study||71
377441|NCT01969747|927083|P4|NOT COMPLETED|Overall Study||0
377442|NCT01969747|927084|P3|NOT COMPLETED|Overall Study||0
377443|NCT01969747|927085|P2|NOT COMPLETED|Overall Study||0
377444|NCT01969747|927086|P1|NOT COMPLETED|Overall Study||0
377445|NCT01969747|927083|P4|COMPLETED|Overall Study||18
377446|NCT01969747|927084|P3|COMPLETED|Overall Study||19
377447|NCT01969747|927085|P2|COMPLETED|Overall Study||19
377448|NCT01969747|927086|P1|COMPLETED|Overall Study||19
377449|NCT01969747|927083|P4|STARTED|Overall Study||18
377450|NCT01969747|927084|P3|STARTED|Overall Study||19
377451|NCT01969747|927085|P2|STARTED|Overall Study||19
377452|NCT01969747|927086|P1|STARTED|Overall Study||19
377453|NCT01969721|927096|P4|NOT COMPLETED|Overall Study||6
377454|NCT01969721|927097|P3|NOT COMPLETED|Overall Study||5
377455|NCT01969721|927098|P2|NOT COMPLETED|Overall Study||12
377456|NCT01969721|927099|P1|NOT COMPLETED|Overall Study||4
377457|NCT01969721|927096|P4|COMPLETED|Overall Study||46
377458|NCT01969721|927097|P3|COMPLETED|Overall Study||45
377459|NCT01969721|927098|P2|COMPLETED|Overall Study||57
377460|NCT01969721|927099|P1|COMPLETED|Overall Study||54
377461|NCT01969721|927096|P4|STARTED|Overall Study||52
377462|NCT01969721|927097|P3|STARTED|Overall Study||50
377463|NCT01969721|927098|P2|STARTED|Overall Study||69
377464|NCT01969721|927099|P1|STARTED|Overall Study||58
377465|NCT01969565|927125|P1|NOT COMPLETED|Overall Study||1
377466|NCT01969565|927125|P1|COMPLETED|Overall Study||0
377467|NCT01969565|927125|P1|STARTED|Overall Study||1
377468|NCT01969539|927131|P1|NOT COMPLETED|Overall Study||0
377469|NCT01969539|927131|P1|COMPLETED|Overall Study||11
377470|NCT01969539|927131|P1|STARTED|Overall Study||11
377471|NCT01969448|927140|P3|NOT COMPLETED|Overall Study||0
377472|NCT01969448|927141|P2|NOT COMPLETED|Overall Study||0
377473|NCT01969448|927142|P1|NOT COMPLETED|Overall Study||0
377474|NCT01969448|927140|P3|COMPLETED|Overall Study||0
377475|NCT01969448|927141|P2|COMPLETED|Overall Study||24
377476|NCT01969448|927142|P1|COMPLETED|Overall Study||55
377477|NCT01969448|927140|P3|STARTED|Overall Study||0
377478|NCT01969448|927141|P2|STARTED|Overall Study||24
377479|NCT01969448|927142|P1|STARTED|Overall Study||55
377480|NCT01969435|927165|P1|NOT COMPLETED|Overall Study||0
377481|NCT01969435|927165|P1|COMPLETED|Overall Study||50
377482|NCT01969435|927165|P1|STARTED|Overall Study||50
377483|NCT01969162|927179|P1|NOT COMPLETED|Overall Study||0
377484|NCT01969162|927179|P1|COMPLETED|Overall Study||35
377485|NCT01969162|927179|P1|STARTED|Overall Study||35
377486|NCT01969084|927185|P2|NOT COMPLETED|Overall Study||1
377487|NCT01969084|927186|P1|NOT COMPLETED|Overall Study||0
377488|NCT01969084|927185|P2|COMPLETED|Overall Study|One subject withdrew due to unrelated serious adverse event|21
377489|NCT01969084|927186|P1|COMPLETED|Overall Study||19
377490|NCT01969084|927185|P2|STARTED|Overall Study||22
377491|NCT01969084|927186|P1|STARTED|Overall Study||19
377492|NCT01969058|927202|P2|NOT COMPLETED|Overall Study||0
377493|NCT01969058|927203|P1|NOT COMPLETED|Overall Study||3
377494|NCT01969058|927202|P2|COMPLETED|Overall Study||26
377495|NCT01969058|927203|P1|COMPLETED|Overall Study||47
377496|NCT01969058|927202|P2|STARTED|Overall Study||26
377497|NCT01969058|927203|P1|STARTED|Overall Study||50
377498|NCT01968980|927239|P2|NOT COMPLETED|Overall Study||14
377499|NCT01968980|927240|P1|NOT COMPLETED|Overall Study||16
377500|NCT01968980|927239|P2|COMPLETED|Overall Study||171
377501|NCT01968980|927240|P1|COMPLETED|Overall Study||169
377502|NCT01968980|927239|P2|STARTED|Overall Study||185
377503|NCT01968980|927240|P1|STARTED|Overall Study||185
377504|NCT01968967|927302|P2|NOT COMPLETED|Overall Study||134
377505|NCT01968967|927303|P1|NOT COMPLETED|Overall Study||146
377506|NCT01968967|927302|P2|COMPLETED|Overall Study||934
377507|NCT01968967|927303|P1|COMPLETED|Overall Study||925
377508|NCT01968967|927302|P2|Treated|Overall Study||1063
377509|NCT01968967|927303|P1|Treated|Overall Study||1065
377510|NCT01968967|927302|P2|STARTED|Overall Study||1068
377511|NCT01968967|927303|P1|STARTED|Overall Study||1071
377512|NCT01968954|927364|P2|NOT COMPLETED|Overall Study||43
377513|NCT01968954|927365|P1|NOT COMPLETED|Overall Study||40
377514|NCT01968954|927364|P2|COMPLETED|Overall Study||314
377515|NCT01968954|927365|P1|COMPLETED|Overall Study||314
377516|NCT01968954|927364|P2|Treated|Overall Study||356
377517|NCT01968954|927365|P1|Treated|Overall Study||353
377518|NCT01968954|927364|P2|STARTED|Overall Study||357
377519|NCT01968954|927365|P1|STARTED|Overall Study||354
377520|NCT01968811|927429|P1|NOT COMPLETED|Overall Study||5
377521|NCT01968811|927429|P1|COMPLETED|Overall Study||5
377522|NCT01968811|927429|P1|STARTED|Overall Study||10
377523|NCT01968694|927436|P2|NOT COMPLETED|Visit 2 (1 Day)||0
377524|NCT01968694|927437|P1|NOT COMPLETED|Visit 2 (1 Day)||0
377525|NCT01968694|927436|P2|COMPLETED|Visit 2 (1 Day)||8
377526|NCT01968694|927437|P1|COMPLETED|Visit 2 (1 Day)||10
377527|NCT01968694|927436|P2|STARTED|Visit 2 (1 Day)||8
377528|NCT01968694|927437|P1|STARTED|Visit 2 (1 Day)||10
377529|NCT01968694|927436|P2|NOT COMPLETED|Washout (1 Month)||1
377530|NCT01968694|927437|P1|NOT COMPLETED|Washout (1 Month)||0
377531|NCT01968694|927436|P2|COMPLETED|Washout (1 Month)||8
377532|NCT01968694|927437|P1|COMPLETED|Washout (1 Month)||10
377533|NCT01968694|927436|P2|STARTED|Washout (1 Month)||9
377534|NCT01968694|927437|P1|STARTED|Washout (1 Month)||10
377535|NCT01968694|927436|P2|NOT COMPLETED|Visit 1 (1 Day)||0
377536|NCT01968694|927437|P1|NOT COMPLETED|Visit 1 (1 Day)||0
377537|NCT01968694|927436|P2|COMPLETED|Visit 1 (1 Day)||9
377538|NCT01968694|927437|P1|COMPLETED|Visit 1 (1 Day)||10
377539|NCT01968694|927436|P2|STARTED|Visit 1 (1 Day)||9
377540|NCT01968694|927437|P1|STARTED|Visit 1 (1 Day)||10
377541|NCT01968551|927454|P3|NOT COMPLETED|Extension Phase||4
377542|NCT01968551|927455|P2|NOT COMPLETED|Extension Phase||1
377543|NCT01968551|927456|P1|NOT COMPLETED|Extension Phase||1
377544|NCT01968551|927454|P3|COMPLETED|Extension Phase||30
377545|NCT01968551|927455|P2|COMPLETED|Extension Phase||86
377546|NCT01968551|927456|P1|COMPLETED|Extension Phase||19
377547|NCT01968551|927454|P3|STARTED|Extension Phase|7 participant completed the Open-Label Phase, but did not enter in the Extension Phase|34
377548|NCT01968551|927455|P2|STARTED|Extension Phase||87
377549|NCT01968551|927456|P1|STARTED|Extension Phase||20
377550|NCT01968551|927454|P3|NOT COMPLETED|Open Label Phase (48 Weeks)||5
377551|NCT01968551|927455|P2|NOT COMPLETED|Open Label Phase (48 Weeks)||3
377552|NCT01968551|927456|P1|NOT COMPLETED|Open Label Phase (48 Weeks)||2
377553|NCT01968551|927454|P3|COMPLETED|Open Label Phase (48 Weeks)||41
377554|NCT01968551|927455|P2|COMPLETED|Open Label Phase (48 Weeks)||87
377555|NCT01968551|927456|P1|COMPLETED|Open Label Phase (48 Weeks)||20
377556|NCT01968551|927454|P3|STARTED|Open Label Phase (48 Weeks)||46
377557|NCT01968551|927455|P2|STARTED|Open Label Phase (48 Weeks)||90
377558|NCT01968551|927456|P1|STARTED|Open Label Phase (48 Weeks)||22
377559|NCT01968434|927472|P2|NOT COMPLETED|Overall Study||6
377560|NCT01968434|927473|P1|NOT COMPLETED|Overall Study||3
377561|NCT01968434|927472|P2|COMPLETED|Overall Study||66
377562|NCT01968434|927473|P1|COMPLETED|Overall Study||75
377563|NCT01968434|927472|P2|STARTED|Overall Study||72
377564|NCT01968434|927473|P1|STARTED|Overall Study||78
377565|NCT01968226|927483|P1|NOT COMPLETED|Overall Study||2
377566|NCT01968226|927483|P1|COMPLETED|Overall Study||1
377567|NCT01968226|927483|P1|STARTED|Overall Study||3
377568|NCT01968135|927489|P2|NOT COMPLETED|Overall Study||0
377569|NCT01968135|927490|P1|NOT COMPLETED|Overall Study||0
377570|NCT01968135|927489|P2|COMPLETED|Overall Study||16
377571|NCT01968135|927490|P1|COMPLETED|Overall Study||16
377572|NCT01968135|927489|P2|STARTED|Overall Study||16
377573|NCT01968135|927490|P1|STARTED|Overall Study||16
377574|NCT01968057|927502|P1|NOT COMPLETED|Period 2 (At Dosing Day 4 to Day 7)||0
377575|NCT01968057|927502|P1|COMPLETED|Period 2 (At Dosing Day 4 to Day 7)||18
377576|NCT01968057|927502|P1|Received Baricitinib + Ciclosporin|Period 2 (At Dosing Day 4 to Day 7)||18
377577|NCT01968057|927502|P1|STARTED|Period 2 (At Dosing Day 4 to Day 7)||18
377578|NCT01968057|927502|P1|NOT COMPLETED|Period 1 (Day 1 to Predosing Day 4)||0
377579|NCT01968057|927502|P1|COMPLETED|Period 1 (Day 1 to Predosing Day 4)||18
377580|NCT01968057|927502|P1|Received Baricitinib|Period 1 (Day 1 to Predosing Day 4)||18
377581|NCT01968057|927502|P1|STARTED|Period 1 (Day 1 to Predosing Day 4)||18
377582|NCT01967940|927515|P3|NOT COMPLETED|Part 2||14
377583|NCT01967940|927516|P2|NOT COMPLETED|Part 2||16
377584|NCT01967940|927517|P1|NOT COMPLETED|Part 2||8
377585|NCT01967940|927515|P3|COMPLETED|Part 2||0
377586|NCT01967940|927516|P2|COMPLETED|Part 2||0
377587|NCT01967940|927517|P1|COMPLETED|Part 2||0
377588|NCT01967940|927515|P3|STARTED|Part 2|1 participant completed Part 1, but did not enter Part 2 of the study|14
377589|NCT01967940|927516|P2|STARTED|Part 2|12 participants completed Part 1, but did not enter Part 2 of the study|16
377590|NCT01967940|927517|P1|STARTED|Part 2|4 participants completed Part 1, but did not enter Part 2 of the study|8
377591|NCT01967940|927515|P3|NOT COMPLETED|Part 1||0
377592|NCT01967940|927516|P2|NOT COMPLETED|Part 1||0
377593|NCT01967940|927517|P1|NOT COMPLETED|Part 1||0
377594|NCT01967940|927515|P3|COMPLETED|Part 1||15
377595|NCT01967940|927516|P2|COMPLETED|Part 1||28
377596|NCT01967940|927517|P1|COMPLETED|Part 1||12
377597|NCT01967940|927515|P3|STARTED|Part 1||15
377598|NCT01967940|927516|P2|STARTED|Part 1||28
377599|NCT01967940|927517|P1|STARTED|Part 1||12
377600|NCT01967836|927528|P1|NOT COMPLETED|Overall Study||9
377601|NCT01967836|927528|P1|COMPLETED|Overall Study||11
377602|NCT01967836|927528|P1|STARTED|Overall Study||20
377603|NCT01967784|927534|P1|NOT COMPLETED|Overall Study||0
377604|NCT01967784|927534|P1|COMPLETED|Overall Study||100
377605|NCT01967784|927534|P1|STARTED|Overall Study||100
377606|NCT01967732|927544|P4|NOT COMPLETED|Second Intervention (Day 3)||0
377607|NCT01967732|927545|P3|NOT COMPLETED|Second Intervention (Day 3)||0
377608|NCT01967732|927546|P2|NOT COMPLETED|Second Intervention (Day 3)||0
377609|NCT01967732|927547|P1|NOT COMPLETED|Second Intervention (Day 3)||0
377610|NCT01967732|927544|P4|COMPLETED|Second Intervention (Day 3)||9
377611|NCT01967732|927545|P3|COMPLETED|Second Intervention (Day 3)||9
377612|NCT01967732|927546|P2|COMPLETED|Second Intervention (Day 3)||20
377613|NCT01967732|927547|P1|COMPLETED|Second Intervention (Day 3)||22
377614|NCT01967732|927544|P4|STARTED|Second Intervention (Day 3)||9
377615|NCT01967732|927545|P3|STARTED|Second Intervention (Day 3)||9
377616|NCT01967732|927546|P2|STARTED|Second Intervention (Day 3)||20
377617|NCT01967732|927547|P1|STARTED|Second Intervention (Day 3)||22
377618|NCT01967732|927544|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
377619|NCT01967732|927545|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
377620|NCT01967732|927546|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
377621|NCT01967732|927547|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
377622|NCT01967732|927544|P4|COMPLETED|Washout Period of 1 Day (Day 2)||9
377623|NCT01967732|927545|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
377624|NCT01967732|927546|P2|COMPLETED|Washout Period of 1 Day (Day 2)||20
377625|NCT01967732|927547|P1|COMPLETED|Washout Period of 1 Day (Day 2)||22
377626|NCT01967732|927544|P4|STARTED|Washout Period of 1 Day (Day 2)||9
377627|NCT01967732|927545|P3|STARTED|Washout Period of 1 Day (Day 2)||9
377628|NCT01967732|927546|P2|STARTED|Washout Period of 1 Day (Day 2)||20
377629|NCT01967732|927547|P1|STARTED|Washout Period of 1 Day (Day 2)||22
377630|NCT01967732|927544|P4|NOT COMPLETED|First Intervention (Day 1)||0
377631|NCT01967732|927545|P3|NOT COMPLETED|First Intervention (Day 1)||0
377632|NCT01967732|927546|P2|NOT COMPLETED|First Intervention (Day 1)||1
377633|NCT01967732|927547|P1|NOT COMPLETED|First Intervention (Day 1)||0
377634|NCT01967732|927544|P4|COMPLETED|First Intervention (Day 1)||9
377635|NCT01967732|927545|P3|COMPLETED|First Intervention (Day 1)||9
377636|NCT01967732|927546|P2|COMPLETED|First Intervention (Day 1)|Subject discontinued from the study prior to product use|20
377637|NCT01967732|927547|P1|COMPLETED|First Intervention (Day 1)||22
377638|NCT01967732|927544|P4|STARTED|First Intervention (Day 1)||9
377639|NCT01967732|927545|P3|STARTED|First Intervention (Day 1)||9
377640|NCT01967732|927546|P2|STARTED|First Intervention (Day 1)||21
377641|NCT01967732|927547|P1|STARTED|First Intervention (Day 1)||22
377642|NCT01967732|927544|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
377643|NCT01967732|927545|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
377644|NCT01967732|927546|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||1
377645|NCT01967732|927547|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
377646|NCT01967732|927544|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
377647|NCT01967732|927545|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
377648|NCT01967732|927546|P2|COMPLETED|Washout Period of 1 Day (Day 0)||21
377649|NCT01967732|927547|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
377650|NCT01967732|927544|P4|STARTED|Washout Period of 1 Day (Day 0)||9
377651|NCT01967732|927545|P3|STARTED|Washout Period of 1 Day (Day 0)||9
377652|NCT01967732|927546|P2|STARTED|Washout Period of 1 Day (Day 0)||22
377653|NCT01967732|927547|P1|STARTED|Washout Period of 1 Day (Day 0)||22
377654|NCT01967719|927561|P4|NOT COMPLETED|Second Intervention (Day 3)||0
377655|NCT01967719|927562|P3|NOT COMPLETED|Second Intervention (Day 3)||0
377656|NCT01967719|927563|P2|NOT COMPLETED|Second Intervention (Day 3)||1
377657|NCT01967719|927564|P1|NOT COMPLETED|Second Intervention (Day 3)||0
377658|NCT01967719|927561|P4|COMPLETED|Second Intervention (Day 3)||8
377659|NCT01967719|927562|P3|COMPLETED|Second Intervention (Day 3)||9
377660|NCT01967719|927563|P2|COMPLETED|Second Intervention (Day 3)||20
377661|NCT01967719|927564|P1|COMPLETED|Second Intervention (Day 3)||22
377662|NCT01967719|927561|P4|STARTED|Second Intervention (Day 3)||8
377663|NCT01967719|927562|P3|STARTED|Second Intervention (Day 3)||9
377664|NCT01967719|927563|P2|STARTED|Second Intervention (Day 3)||21
377665|NCT01967719|927564|P1|STARTED|Second Intervention (Day 3)||22
377666|NCT01967719|927561|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
377667|NCT01967719|927562|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
377668|NCT01967719|927563|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
377669|NCT01967719|927564|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
377670|NCT01967719|927561|P4|COMPLETED|Washout Period of 1 Day (Day 2)||8
377671|NCT01967719|927562|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
377672|NCT01967719|927563|P2|COMPLETED|Washout Period of 1 Day (Day 2)||21
377673|NCT01967719|927564|P1|COMPLETED|Washout Period of 1 Day (Day 2)||22
377674|NCT01967719|927561|P4|STARTED|Washout Period of 1 Day (Day 2)||8
377675|NCT01967719|927562|P3|STARTED|Washout Period of 1 Day (Day 2)||9
377676|NCT01967719|927563|P2|STARTED|Washout Period of 1 Day (Day 2)||21
377677|NCT01967719|927564|P1|STARTED|Washout Period of 1 Day (Day 2)||22
377678|NCT01967719|927561|P4|NOT COMPLETED|First Intervention (Day 1)||1
377679|NCT01967719|927562|P3|NOT COMPLETED|First Intervention (Day 1)||0
377680|NCT01967719|927563|P2|NOT COMPLETED|First Intervention (Day 1)||1
377681|NCT01967719|927564|P1|NOT COMPLETED|First Intervention (Day 1)||0
377682|NCT01967719|927561|P4|COMPLETED|First Intervention (Day 1)||8
377683|NCT01967719|927562|P3|COMPLETED|First Intervention (Day 1)||9
377684|NCT01967719|927563|P2|COMPLETED|First Intervention (Day 1)||21
377685|NCT01967719|927564|P1|COMPLETED|First Intervention (Day 1)||22
377686|NCT01967719|927561|P4|STARTED|First Intervention (Day 1)||9
377687|NCT01967719|927562|P3|STARTED|First Intervention (Day 1)||9
377688|NCT01967719|927563|P2|STARTED|First Intervention (Day 1)||22
377689|NCT01967719|927564|P1|STARTED|First Intervention (Day 1)||22
377690|NCT01967719|927561|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
377691|NCT01967719|927562|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
377692|NCT01967719|927563|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
377693|NCT01967719|927564|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
377694|NCT01967719|927561|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
377695|NCT01967719|927562|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
377696|NCT01967719|927563|P2|COMPLETED|Washout Period of 1 Day (Day 0)||22
377697|NCT01967719|927564|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
377698|NCT01967719|927561|P4|STARTED|Washout Period of 1 Day (Day 0)||9
377699|NCT01967719|927562|P3|STARTED|Washout Period of 1 Day (Day 0)||9
377700|NCT01967719|927563|P2|STARTED|Washout Period of 1 Day (Day 0)||22
377701|NCT01967719|927564|P1|STARTED|Washout Period of 1 Day (Day 0)||22
377702|NCT01967706|927579|P4|NOT COMPLETED|Second Intervention (Day 3)||0
377703|NCT01967706|927580|P3|NOT COMPLETED|Second Intervention (Day 3)||0
377704|NCT01967706|927581|P2|NOT COMPLETED|Second Intervention (Day 3)||0
377705|NCT01967706|927582|P1|NOT COMPLETED|Second Intervention (Day 3)||0
377706|NCT01967706|927579|P4|COMPLETED|Second Intervention (Day 3)||9
377707|NCT01967706|927580|P3|COMPLETED|Second Intervention (Day 3)||9
377708|NCT01967706|927581|P2|COMPLETED|Second Intervention (Day 3)||22
377709|NCT01967706|927582|P1|COMPLETED|Second Intervention (Day 3)||21
377710|NCT01967706|927579|P4|STARTED|Second Intervention (Day 3)||9
377711|NCT01967706|927580|P3|STARTED|Second Intervention (Day 3)||9
377712|NCT01967706|927581|P2|STARTED|Second Intervention (Day 3)||22
377713|NCT01967706|927582|P1|STARTED|Second Intervention (Day 3)||21
377714|NCT01967706|927579|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
377715|NCT01967706|927580|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
377716|NCT01967706|927581|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
377717|NCT01967706|927582|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
377718|NCT01967706|927579|P4|COMPLETED|Washout Period of 1 Day (Day 2)||9
377719|NCT01967706|927580|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
377720|NCT01967706|927581|P2|COMPLETED|Washout Period of 1 Day (Day 2)||22
377721|NCT01967706|927582|P1|COMPLETED|Washout Period of 1 Day (Day 2)||21
377722|NCT01967706|927579|P4|STARTED|Washout Period of 1 Day (Day 2)||9
377723|NCT01967706|927580|P3|STARTED|Washout Period of 1 Day (Day 2)||9
377724|NCT01967706|927581|P2|STARTED|Washout Period of 1 Day (Day 2)||22
377725|NCT01967706|927582|P1|STARTED|Washout Period of 1 Day (Day 2)||21
377726|NCT01967706|927579|P4|NOT COMPLETED|First Intervention (Day 1)||0
377727|NCT01967706|927580|P3|NOT COMPLETED|First Intervention (Day 1)||0
377728|NCT01967706|927581|P2|NOT COMPLETED|First Intervention (Day 1)||0
377729|NCT01967706|927582|P1|NOT COMPLETED|First Intervention (Day 1)||1
377730|NCT01967706|927579|P4|COMPLETED|First Intervention (Day 1)||9
377731|NCT01967706|927580|P3|COMPLETED|First Intervention (Day 1)||9
377732|NCT01967706|927581|P2|COMPLETED|First Intervention (Day 1)||22
377733|NCT01967706|927582|P1|COMPLETED|First Intervention (Day 1)||21
377734|NCT01967706|927579|P4|STARTED|First Intervention (Day 1)||9
377735|NCT01967706|927580|P3|STARTED|First Intervention (Day 1)||9
377736|NCT01967706|927581|P2|STARTED|First Intervention (Day 1)||22
377737|NCT01967706|927582|P1|STARTED|First Intervention (Day 1)||22
377738|NCT01967706|927579|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
377739|NCT01967706|927580|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
377740|NCT01967706|927581|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
377741|NCT01967706|927582|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
377742|NCT01967706|927579|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
377743|NCT01967706|927580|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
377744|NCT01967706|927581|P2|COMPLETED|Washout Period of 1 Day (Day 0)||22
377745|NCT01967706|927582|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
377746|NCT01967706|927579|P4|STARTED|Washout Period of 1 Day (Day 0)||9
377747|NCT01967706|927580|P3|STARTED|Washout Period of 1 Day (Day 0)||9
377748|NCT01967706|927581|P2|STARTED|Washout Period of 1 Day (Day 0)||22
377749|NCT01967706|927582|P1|STARTED|Washout Period of 1 Day (Day 0)||22
377750|NCT01967641|927595|P1|NOT COMPLETED|12-week Outpatient Phase||13
377751|NCT01967641|927595|P1|COMPLETED|12-week Outpatient Phase|Completed week 12 of outpatient phase|18
377752|NCT01967641|927595|P1|STARTED|12-week Outpatient Phase||31
377753|NCT01967641|927595|P1|NOT COMPLETED|Admission to Inpatient Phase||12
377754|NCT01967641|927595|P1|COMPLETED|Admission to Inpatient Phase|Completed 7 week inpatient phase|31
377755|NCT01967641|927595|P1|STARTED|Admission to Inpatient Phase||43
377756|NCT01967641|927595|P1|NOT COMPLETED|Randomized||8
377757|NCT01967641|927595|P1|COMPLETED|Randomized|Completed week 12|43
377758|NCT01967641|927595|P1|STARTED|Randomized||51
377759|NCT01967628|927603|P2|NOT COMPLETED|Overall Study||31
377760|NCT01967628|927604|P1|NOT COMPLETED|Overall Study||27
377761|NCT01967628|927603|P2|COMPLETED|Overall Study||19
377762|NCT01967628|927604|P1|COMPLETED|Overall Study||21
377763|NCT01967628|927603|P2|STARTED|Overall Study||50
377764|NCT01967628|927604|P1|STARTED|Overall Study||48
377765|NCT01967550|927612|P2|NOT COMPLETED|Overall Study||2
377766|NCT01967550|927613|P1|NOT COMPLETED|Overall Study||5
377767|NCT01967550|927612|P2|COMPLETED|Overall Study||149
377768|NCT01967550|927613|P1|COMPLETED|Overall Study||148
377769|NCT01967550|927612|P2|STARTED|Overall Study||151
377770|NCT01967550|927613|P1|STARTED|Overall Study||153
377771|NCT01967342|927622|P3|NOT COMPLETED|Overall Study||29
377772|NCT01967342|927623|P2|NOT COMPLETED|Overall Study||25
377773|NCT01967342|927624|P1|NOT COMPLETED|Overall Study||27
377774|NCT01967342|927622|P3|COMPLETED|Overall Study||68
377775|NCT01967342|927623|P2|COMPLETED|Overall Study||70
377776|NCT01967342|927624|P1|COMPLETED|Overall Study||71
377777|NCT01967342|927622|P3|10-week Follow-up|Overall Study||80
377778|NCT01967342|927623|P2|10-week Follow-up|Overall Study||83
377779|NCT01967342|927624|P1|10-week Follow-up|Overall Study||78
377780|NCT01967342|927622|P3|5-week Follow-up|Overall Study||76
377781|NCT01967342|927623|P2|5-week Follow-up|Overall Study||78
377782|NCT01967342|927624|P1|5-week Follow-up|Overall Study||83
377783|NCT01967342|927622|P3|STARTED|Overall Study||97
377784|NCT01967342|927623|P2|STARTED|Overall Study||95
377785|NCT01967342|927624|P1|STARTED|Overall Study||98
377786|NCT01967277|927643|P2|NOT COMPLETED|Overall Study||3
377787|NCT01967277|927644|P1|NOT COMPLETED|Overall Study||1
377788|NCT01967277|927643|P2|COMPLETED|Overall Study||19
377789|NCT01967277|927644|P1|COMPLETED|Overall Study||21
377790|NCT01967277|927643|P2|STARTED|Overall Study||22
377791|NCT01967277|927644|P1|STARTED|Overall Study||22
377792|NCT01967147|927654|P2|NOT COMPLETED|Overall Study||20
377793|NCT01967147|927655|P1|NOT COMPLETED|Overall Study||13
377794|NCT01967147|927654|P2|COMPLETED|Overall Study||82
377795|NCT01967147|927655|P1|COMPLETED|Overall Study||99
377796|NCT01967147|927654|P2|STARTED|Overall Study||102
377797|NCT01967147|927655|P1|STARTED|Overall Study||112
377798|NCT01967121|927673|P3|NOT COMPLETED|Overall Study||0
377799|NCT01967121|927674|P2|NOT COMPLETED|Overall Study||0
377800|NCT01967121|927675|P1|NOT COMPLETED|Overall Study||0
377801|NCT01967121|927673|P3|COMPLETED|Overall Study||25
377802|NCT01967121|927674|P2|COMPLETED|Overall Study||25
377803|NCT01967121|927675|P1|COMPLETED|Overall Study||25
377804|NCT01967121|927673|P3|STARTED|Overall Study||25
377805|NCT01967121|927674|P2|STARTED|Overall Study||25
377806|NCT01967121|927675|P1|STARTED|Overall Study||25
377807|NCT01967069|927685|P2|NOT COMPLETED|Overall Study||8
377808|NCT01967069|927686|P1|NOT COMPLETED|Overall Study||8
377809|NCT01967069|927685|P2|COMPLETED|Overall Study||87
377810|NCT01967069|927686|P1|COMPLETED|Overall Study||174
377811|NCT01967069|927685|P2|STARTED|Overall Study||95
377812|NCT01967069|927686|P1|STARTED|Overall Study||182
377813|NCT01966926|927694|P2|NOT COMPLETED|Overall Study||0
377814|NCT01966926|927695|P1|NOT COMPLETED|Overall Study||0
377815|NCT01966926|927694|P2|COMPLETED|Overall Study||15
377816|NCT01966926|927695|P1|COMPLETED|Overall Study||15
377817|NCT01966926|927694|P2|STARTED|Overall Study||15
377818|NCT01966926|927695|P1|STARTED|Overall Study||15
377819|NCT01966770|927711|P1|NOT COMPLETED|Overall Study||0
377820|NCT01966770|927711|P1|COMPLETED|Overall Study||20
377821|NCT01966770|927711|P1|STARTED|Overall Study||20
377822|NCT01966718|927820|P1|NOT COMPLETED|Overall Study||0
377823|NCT01966718|927820|P1|COMPLETED|Overall Study||8
377824|NCT01966718|927820|P1|STARTED|Overall Study||8
377825|NCT01966458|927830|P2|NOT COMPLETED|Overall Study||2
377826|NCT01966458|927831|P1|NOT COMPLETED|Overall Study||4
377827|NCT01966458|927830|P2|COMPLETED|Overall Study||155
377828|NCT01966458|927831|P1|COMPLETED|Overall Study||304
377829|NCT01966458|927830|P2|STARTED|Overall Study||157
377830|NCT01966458|927831|P1|STARTED|Overall Study||308
377831|NCT01966432|927843|P3|NOT COMPLETED|Overall Study||26
377832|NCT01966432|927844|P2|NOT COMPLETED|Overall Study||13
377833|NCT01966432|927845|P1|NOT COMPLETED|Overall Study||5
377834|NCT01966432|927843|P3|COMPLETED|Overall Study||28
377835|NCT01966432|927844|P2|COMPLETED|Overall Study||21
377836|NCT01966432|927845|P1|COMPLETED|Overall Study||5
377837|NCT01966432|927843|P3|STARTED|Overall Study||54
377838|NCT01966432|927844|P2|STARTED|Overall Study||34
377839|NCT01966432|927845|P1|STARTED|Overall Study||10
377840|NCT01966380|927865|P2|NOT COMPLETED|Overall Study||1
377841|NCT01966380|927866|P1|NOT COMPLETED|Overall Study||0
377842|NCT01966380|927865|P2|COMPLETED|Overall Study||2
377843|NCT01966380|927866|P1|COMPLETED|Overall Study||3
377844|NCT01966380|927865|P2|STARTED|Overall Study||3
377845|NCT01966380|927866|P1|STARTED|Overall Study||3
377846|NCT01966354|927875|P3|NOT COMPLETED|Overall Study||0
377847|NCT01966354|927876|P2|NOT COMPLETED|Overall Study||0
377848|NCT01966354|927877|P1|NOT COMPLETED|Overall Study||0
377849|NCT01966354|927875|P3|COMPLETED|Overall Study||72
377850|NCT01966354|927876|P2|COMPLETED|Overall Study||73
377851|NCT01966354|927877|P1|COMPLETED|Overall Study||75
377852|NCT01966354|927875|P3|STARTED|Overall Study||72
377853|NCT01966354|927876|P2|STARTED|Overall Study||73
377854|NCT01966354|927877|P1|STARTED|Overall Study||75
377855|NCT01966159|927902|P2|NOT COMPLETED|Overall Study||0
377856|NCT01966159|927903|P1|NOT COMPLETED|Overall Study||0
377857|NCT01966159|927902|P2|COMPLETED|Overall Study||207
377858|NCT01966159|927903|P1|COMPLETED|Overall Study||205
377859|NCT01966159|927902|P2|STARTED|Overall Study||207
377860|NCT01966159|927903|P1|STARTED|Overall Study||205
377861|NCT01966120|927915|P2|NOT COMPLETED|Overall Study||6
377862|NCT01966120|927916|P1|NOT COMPLETED|Overall Study||1
377863|NCT01966120|927915|P2|COMPLETED|Overall Study||26
377864|NCT01966120|927916|P1|COMPLETED|Overall Study||54
377865|NCT01966120|927915|P2|STARTED|Overall Study||32
377866|NCT01966120|927916|P1|STARTED|Overall Study||55
377867|NCT01966068|927940|P1|NOT COMPLETED|Overall Study||138
377868|NCT01966068|927940|P1|COMPLETED|Overall Study||156
377869|NCT01966068|927940|P1|Use the MyAsthma Portal More Than Once|Overall Study||156
377870|NCT01966068|927940|P1|Used the MyAsthma Portal at Least Once|Overall Study||237
377871|NCT01966068|927940|P1|STARTED|Overall Study||294
377872|NCT01966042|927945|P1|NOT COMPLETED|Overall Study||2
377873|NCT01966042|927945|P1|COMPLETED|Overall Study||11
377874|NCT01966042|927945|P1|STARTED|Overall Study||13
377875|NCT01966003|927954|P2|NOT COMPLETED|Overall Study||270
377876|NCT01966003|927955|P1|NOT COMPLETED|Overall Study||270
377877|NCT01966003|927954|P2|COMPLETED|Overall Study||44
377878|NCT01966003|927955|P1|COMPLETED|Overall Study||58
377879|NCT01966003|927954|P2|Received Study Drug|Overall Study||309
377880|NCT01966003|927955|P1|Received Study Drug|Overall Study||324
377881|NCT01966003|927954|P2|STARTED|Overall Study||314
377882|NCT01966003|927955|P1|STARTED|Overall Study||328
377883|NCT01965938|927973|P2|NOT COMPLETED|Overall Study||0
377884|NCT01965938|927974|P1|NOT COMPLETED|Overall Study||1
377885|NCT01965938|927973|P2|COMPLETED|Overall Study||20
377886|NCT01965938|927974|P1|COMPLETED|Overall Study||20
377887|NCT01965938|927973|P2|STARTED|Overall Study||20
377888|NCT01965938|927974|P1|STARTED|Overall Study||21
377889|NCT01965899|927994|P1|NOT COMPLETED|Overall Study||6
377890|NCT01965899|927994|P1|COMPLETED|Overall Study||145
377891|NCT01965899|927994|P1|STARTED|Overall Study||151
377892|NCT01965834|928005|P1|NOT COMPLETED|Overall Study||4
377893|NCT01965834|928005|P1|COMPLETED|Overall Study||2
377894|NCT01965834|928005|P1|STARTED|Overall Study||6
377895|NCT01965756|928013|P2|NOT COMPLETED|Overall Study||0
377896|NCT01965756|928014|P1|NOT COMPLETED|Overall Study||0
377897|NCT01965756|928013|P2|COMPLETED|Overall Study||10
377898|NCT01965756|928014|P1|COMPLETED|Overall Study||10
377899|NCT01965756|928013|P2|STARTED|Overall Study||10
377900|NCT01965756|928014|P1|STARTED|Overall Study||10
377901|NCT01965665|928028|P1|NOT COMPLETED|Overall Study||1
377902|NCT01965665|928028|P1|COMPLETED|Overall Study||19
377903|NCT01965665|928028|P1|STARTED|Overall Study||20
377904|NCT01965652|928036|P2|NOT COMPLETED|Overall Study||210
377905|NCT01965652|928037|P1|NOT COMPLETED|Overall Study||210
377906|NCT01965652|928036|P2|COMPLETED|Overall Study||413
377907|NCT01965652|928037|P1|COMPLETED|Overall Study||413
377908|NCT01965652|928036|P2|Received Treatment|Overall Study||623
377909|NCT01965652|928037|P1|Received Treatment|Overall Study||622
377910|NCT01965652|928036|P2|STARTED|Overall Study|Includes three participants who each enrolled at two different sites|623
377911|NCT01965652|928037|P1|STARTED|Overall Study|Includes two participants who each enrolled at two different sites|623
377912|NCT01965600|928067|P4|NOT COMPLETED|Second Intervention||2
377913|NCT01965600|928068|P3|NOT COMPLETED|Second Intervention||2
377914|NCT01965600|928069|P2|NOT COMPLETED|Second Intervention||0
377915|NCT01965600|928070|P1|NOT COMPLETED|Second Intervention||0
377916|NCT01965600|928067|P4|COMPLETED|Second Intervention||0
377917|NCT01965600|928068|P3|COMPLETED|Second Intervention||1
377918|NCT01965600|928069|P2|COMPLETED|Second Intervention||4
377919|NCT01965600|928070|P1|COMPLETED|Second Intervention||4
377920|NCT01965600|928067|P4|STARTED|Second Intervention||2
377921|NCT01965600|928068|P3|STARTED|Second Intervention||3
377922|NCT01965600|928069|P2|STARTED|Second Intervention||4
377923|NCT01965600|928070|P1|STARTED|Second Intervention||4
377924|NCT01965600|928067|P4|NOT COMPLETED|Washout Period of Approximately 15 Days||2
377925|NCT01965600|928068|P3|NOT COMPLETED|Washout Period of Approximately 15 Days||2
377926|NCT01965600|928069|P2|NOT COMPLETED|Washout Period of Approximately 15 Days||4
377927|NCT01965600|928070|P1|NOT COMPLETED|Washout Period of Approximately 15 Days||2
377928|NCT01965600|928067|P4|COMPLETED|Washout Period of Approximately 15 Days||2
377929|NCT01965600|928068|P3|COMPLETED|Washout Period of Approximately 15 Days||3
377930|NCT01965600|928069|P2|COMPLETED|Washout Period of Approximately 15 Days||4
377931|NCT01965600|928070|P1|COMPLETED|Washout Period of Approximately 15 Days||4
377932|NCT01965600|928067|P4|STARTED|Washout Period of Approximately 15 Days||4
377933|NCT01965600|928068|P3|STARTED|Washout Period of Approximately 15 Days||5
377934|NCT01965600|928069|P2|STARTED|Washout Period of Approximately 15 Days||8
377935|NCT01965600|928070|P1|STARTED|Washout Period of Approximately 15 Days||6
377936|NCT01965600|928067|P4|NOT COMPLETED|First Intervention||0
377937|NCT01965600|928068|P3|NOT COMPLETED|First Intervention||0
377938|NCT01965600|928069|P2|NOT COMPLETED|First Intervention||0
377939|NCT01965600|928070|P1|NOT COMPLETED|First Intervention||0
377940|NCT01965600|928067|P4|COMPLETED|First Intervention||4
377941|NCT01965600|928068|P3|COMPLETED|First Intervention||5
377942|NCT01965600|928069|P2|COMPLETED|First Intervention||8
377943|NCT01965600|928070|P1|COMPLETED|First Intervention||6
377944|NCT01965600|928067|P4|Received at Least One Dose of Drug|First Intervention||4
377945|NCT01965600|928068|P3|Received at Least One Dose of Drug|First Intervention||5
377946|NCT01965600|928069|P2|Received at Least One Dose of Drug|First Intervention||8
377947|NCT01965600|928070|P1|Received at Least One Dose of Drug|First Intervention||6
377948|NCT01965600|928067|P4|STARTED|First Intervention||4
377949|NCT01965600|928068|P3|STARTED|First Intervention||5
377950|NCT01965600|928069|P2|STARTED|First Intervention||8
377951|NCT01965600|928070|P1|STARTED|First Intervention||6
377952|NCT01965561|928114|P1|NOT COMPLETED|Overall Study||0
377953|NCT01965561|928114|P1|COMPLETED|Overall Study||10
377954|NCT01965561|928114|P1|STARTED|Overall Study||10
377955|NCT01965535|928127|P2|NOT COMPLETED|Overall Study||1
377956|NCT01965535|928128|P1|NOT COMPLETED|Overall Study||2
377957|NCT01965535|928127|P2|COMPLETED|Overall Study||76
377958|NCT01965535|928128|P1|COMPLETED|Overall Study||76
377959|NCT01965535|928127|P2|STARTED|Overall Study||77
377960|NCT01965535|928128|P1|STARTED|Overall Study||78
377961|NCT01965431|928142|P6|NOT COMPLETED|Overall Study||6
377962|NCT01965431|928143|P5|NOT COMPLETED|Overall Study||6
377963|NCT01965431|928144|P4|NOT COMPLETED|Overall Study||6
377964|NCT01965431|928145|P3|NOT COMPLETED|Overall Study||6
377965|NCT01965431|928146|P2|NOT COMPLETED|Overall Study||6
377966|NCT01965431|928147|P1|NOT COMPLETED|Overall Study||6
377967|NCT01965431|928142|P6|COMPLETED|Overall Study||2
377968|NCT01965431|928143|P5|COMPLETED|Overall Study||2
377969|NCT01965431|928144|P4|COMPLETED|Overall Study||2
377970|NCT01965431|928145|P3|COMPLETED|Overall Study||2
377971|NCT01965431|928146|P2|COMPLETED|Overall Study||2
377972|NCT01965431|928147|P1|COMPLETED|Overall Study||2
377973|NCT01965431|928142|P6|STARTED|Overall Study||8
377974|NCT01965431|928143|P5|STARTED|Overall Study||8
377975|NCT01965431|928144|P4|STARTED|Overall Study||8
377976|NCT01965431|928145|P3|STARTED|Overall Study||8
377977|NCT01965431|928146|P2|STARTED|Overall Study||8
377978|NCT01965431|928147|P1|STARTED|Overall Study|Started are actually Treated subjects|8
377979|NCT01965327|928160|P1|NOT COMPLETED|Overall Study||2
377980|NCT01965327|928160|P1|COMPLETED|Overall Study|Prior to completion, 2 subjects were withdrawn by the PI for failure to adhere to study protocol.|10
377981|NCT01965327|928160|P1|STARTED|Overall Study||12
377982|NCT01965288|928167|P2|NOT COMPLETED|Overall Study||0
377983|NCT01965288|928168|P1|NOT COMPLETED|Overall Study||0
377984|NCT01965288|928167|P2|COMPLETED|Overall Study||30
377985|NCT01965288|928168|P1|COMPLETED|Overall Study||30
377986|NCT01965288|928167|P2|STARTED|Overall Study||30
377987|NCT01965288|928168|P1|STARTED|Overall Study||30
377988|NCT01965262|928374|P2|NOT COMPLETED|Second Intervention (7 Days)||10
377989|NCT01965262|928375|P1|NOT COMPLETED|Second Intervention (7 Days)||1
377990|NCT01965262|928374|P2|COMPLETED|Second Intervention (7 Days)||5
377991|NCT01965262|928375|P1|COMPLETED|Second Intervention (7 Days)||14
377992|NCT01965262|928374|P2|STARTED|Second Intervention (7 Days)||15
377993|NCT01965262|928375|P1|STARTED|Second Intervention (7 Days)||15
377994|NCT01965262|928374|P2|NOT COMPLETED|First Intervention (7 Days)||0
377995|NCT01965262|928375|P1|NOT COMPLETED|First Intervention (7 Days)||0
377996|NCT01965262|928374|P2|COMPLETED|First Intervention (7 Days)||15
377997|NCT01965262|928375|P1|COMPLETED|First Intervention (7 Days)||15
377998|NCT01965262|928374|P2|STARTED|First Intervention (7 Days)||15
377999|NCT01965262|928375|P1|STARTED|First Intervention (7 Days)||15
378000|NCT01965158|928439|P2|NOT COMPLETED|Overall Study||35
378001|NCT01965158|928440|P1|NOT COMPLETED|Overall Study||41
378002|NCT01965158|928439|P2|COMPLETED|Overall Study||238
378003|NCT01965158|928440|P1|COMPLETED|Overall Study||233
378004|NCT01965158|928439|P2|Received Treatment|Overall Study||273
378005|NCT01965158|928440|P1|Received Treatment|Overall Study||272
378006|NCT01965158|928439|P2|STARTED|Overall Study|Includes 1 participant enrolled at 2 different sites simultaneously|273
378007|NCT01965158|928440|P1|STARTED|Overall Study|Includes 1 participant enrolled at 2 different sites simultaneously|274
378008|NCT01965067|928456|P2|NOT COMPLETED|Overall Study||0
378009|NCT01965067|928457|P1|NOT COMPLETED|Overall Study||0
378010|NCT01965067|928456|P2|COMPLETED|Overall Study||30
378011|NCT01965067|928457|P1|COMPLETED|Overall Study||30
378012|NCT01965067|928456|P2|STARTED|Overall Study||30
378013|NCT01965067|928457|P1|STARTED|Overall Study||30
378014|NCT01965002|928473|P1|NOT COMPLETED|Overall Study||0
378015|NCT01965002|928473|P1|COMPLETED|Overall Study||5
378016|NCT01965002|928473|P1|STARTED|Overall Study||5
378017|NCT01964976|928481|P1|NOT COMPLETED|Overall Study||31
378018|NCT01964976|928481|P1|COMPLETED|Overall Study||1065
378019|NCT01964976|928481|P1|STARTED|Overall Study|Data reports overall population,since data not collected separately per arm as specified in protocol|1096
378020|NCT01964950|928495|P1|NOT COMPLETED|Overall Study||25
378021|NCT01964950|928495|P1|COMPLETED|Overall Study||1076
378022|NCT01964950|928495|P1|STARTED|Overall Study|Data reports overall population,since data not collected separately per arm as specified in protocol|1101
378023|NCT01964898|928509|P2|NOT COMPLETED|Overall Study||7
378024|NCT01964898|928510|P1|NOT COMPLETED|Overall Study||7
378025|NCT01964898|928509|P2|COMPLETED|Overall Study||26
378026|NCT01964898|928510|P1|COMPLETED|Overall Study||24
378027|NCT01964898|928509|P2|12 Week Assessment|Overall Study||30
378028|NCT01964898|928510|P1|12 Week Assessment|Overall Study||25
378029|NCT01964898|928509|P2|STARTED|Overall Study||33
378030|NCT01964898|928510|P1|STARTED|Overall Study||31
378031|NCT01964716|928532|P2|NOT COMPLETED|Overall Study||6
378032|NCT01964716|928533|P1|NOT COMPLETED|Overall Study||5
378033|NCT01964716|928532|P2|COMPLETED|Overall Study||244
378034|NCT01964716|928533|P1|COMPLETED|Overall Study||245
378035|NCT01964716|928532|P2|Vaccinated Dose 3|Overall Study||244
378036|NCT01964716|928533|P1|Vaccinated Dose 3|Overall Study||247
378037|NCT01964716|928532|P2|Vaccinated Dose 2|Overall Study||248
378038|NCT01964716|928533|P1|Vaccinated Dose 2|Overall Study||249
378039|NCT01964716|928532|P2|Vaccinated Dose 1|Overall Study||250
378040|NCT01964716|928533|P1|Vaccinated Dose 1|Overall Study||250
378041|NCT01964716|928532|P2|STARTED|Overall Study||250
378042|NCT01964716|928533|P1|STARTED|Overall Study||250
378043|NCT01964547|928571|P2|NOT COMPLETED|Overall Study||11
378044|NCT01964547|928572|P1|NOT COMPLETED|Overall Study||12
378045|NCT01964547|928571|P2|COMPLETED|Overall Study||48
378046|NCT01964547|928572|P1|COMPLETED|Overall Study||50
378047|NCT01964547|928571|P2|STARTED|Overall Study||59
378048|NCT01964547|928572|P1|STARTED|Overall Study||62
378049|NCT01964352|928600|P4|NOT COMPLETED|Overall Study||8
378050|NCT01964352|928601|P3|NOT COMPLETED|Overall Study||6
378051|NCT01964352|928602|P2|NOT COMPLETED|Overall Study||11
378052|NCT01964352|928603|P1|NOT COMPLETED|Overall Study||26
378053|NCT01964352|928600|P4|COMPLETED|Overall Study||195
378054|NCT01964352|928601|P3|COMPLETED|Overall Study||196
378055|NCT01964352|928602|P2|COMPLETED|Overall Study||192
378056|NCT01964352|928603|P1|COMPLETED|Overall Study||178
378057|NCT01964352|928600|P4|STARTED|Overall Study||203
378058|NCT01964352|928601|P3|STARTED|Overall Study||202
378059|NCT01964352|928602|P2|STARTED|Overall Study||203
378060|NCT01964352|928603|P1|STARTED|Overall Study||204
378061|NCT01964326|928633|P1|NOT COMPLETED|Overall Study||297
378062|NCT01964326|928633|P1|COMPLETED|Overall Study||1014
378063|NCT01964326|928633|P1|STARTED|Overall Study||1311
378064|NCT01964222|928642|P2|NOT COMPLETED|Overall Study||11
378065|NCT01964222|928643|P1|NOT COMPLETED|Overall Study||15
378066|NCT01964222|928642|P2|COMPLETED|Overall Study||89
378067|NCT01964222|928643|P1|COMPLETED|Overall Study||86
378068|NCT01964222|928642|P2|STARTED|Overall Study||100
378069|NCT01964222|928643|P1|STARTED|Overall Study||101
378070|NCT01964105|928660|P3|NOT COMPLETED|Overall Study||0
378071|NCT01964105|928661|P2|NOT COMPLETED|Overall Study||13
378072|NCT01964105|928662|P1|NOT COMPLETED|Overall Study||2
378073|NCT01964105|928660|P3|COMPLETED|Overall Study||10
378074|NCT01964105|928661|P2|COMPLETED|Overall Study||62
378075|NCT01964105|928662|P1|COMPLETED|Overall Study||13
378076|NCT01964105|928660|P3|STARTED|Overall Study||10
378077|NCT01964105|928661|P2|STARTED|Overall Study||75
378078|NCT01964105|928662|P1|STARTED|Overall Study||15
378079|NCT01963845|928672|P2|NOT COMPLETED|Overall Study||0
378080|NCT01963845|928673|P1|NOT COMPLETED|Overall Study||0
378081|NCT01963845|928672|P2|COMPLETED|Overall Study||25
378082|NCT01963845|928673|P1|COMPLETED|Overall Study||25
378083|NCT01963845|928672|P2|STARTED|Overall Study||25
378084|NCT01963845|928673|P1|STARTED|Overall Study||25
378085|NCT01963767|928689|P2|NOT COMPLETED|Overall Study||2
378086|NCT01963767|928690|P1|NOT COMPLETED|Overall Study||6
378087|NCT01963767|928689|P2|COMPLETED|Overall Study||53
378088|NCT01963767|928690|P1|COMPLETED|Overall Study||52
378089|NCT01963767|928689|P2|STARTED|Overall Study||55
378090|NCT01963767|928690|P1|STARTED|Overall Study||58
378091|NCT01963676|928700|P2|NOT COMPLETED|Overall Study||0
378092|NCT01963676|928701|P1|NOT COMPLETED|Overall Study||1
378093|NCT01963676|928700|P2|COMPLETED|Overall Study||13
378094|NCT01963676|928701|P1|COMPLETED|Overall Study||13
378095|NCT01963676|928700|P2|STARTED|Overall Study||13
378096|NCT01963676|928701|P1|STARTED|Overall Study||14
378097|NCT01963611|928714|P5|NOT COMPLETED|Overall Study||51
378098|NCT01963611|928715|P4|NOT COMPLETED|Overall Study||52
378099|NCT01963611|928716|P3|NOT COMPLETED|Overall Study||52
378100|NCT01963611|928717|P2|NOT COMPLETED|Overall Study||49
378101|NCT01963611|928718|P1|NOT COMPLETED|Overall Study||51
378102|NCT01963611|928714|P5|COMPLETED|Overall Study||0
378103|NCT01963611|928715|P4|COMPLETED|Overall Study||0
378104|NCT01963611|928716|P3|COMPLETED|Overall Study||0
378105|NCT01963611|928717|P2|COMPLETED|Overall Study||0
378106|NCT01963611|928718|P1|COMPLETED|Overall Study||0
378107|NCT01963611|928714|P5|Safety Analysis Set|Overall Study||50
378108|NCT01963611|928715|P4|Safety Analysis Set|Overall Study||52
378109|NCT01963611|928716|P3|Safety Analysis Set|Overall Study||52
378110|NCT01963611|928717|P2|Safety Analysis Set|Overall Study||49
378111|NCT01963611|928718|P1|Safety Analysis Set|Overall Study||51
378112|NCT01963611|928714|P5|STARTED|Overall Study||51
378113|NCT01963611|928715|P4|STARTED|Overall Study||52
378114|NCT01963611|928716|P3|STARTED|Overall Study||52
378115|NCT01963611|928717|P2|STARTED|Overall Study||49
378116|NCT01963611|928718|P1|STARTED|Overall Study||51
378117|NCT01963403|928777|P2|NOT COMPLETED|Overall Study||4
378118|NCT01963403|928778|P1|NOT COMPLETED|Overall Study||2
378119|NCT01963403|928777|P2|COMPLETED|Overall Study|Follow-up over three months|9
378120|NCT01963403|928778|P1|COMPLETED|Overall Study|Follow-up over three months|11
378121|NCT01963403|928777|P2|STARTED|Overall Study||13
378122|NCT01963403|928778|P1|STARTED|Overall Study||13
378123|NCT01963260|928800|P10|NOT COMPLETED|Overall Study||0
378124|NCT01963260|928801|P9|NOT COMPLETED|Overall Study||0
378125|NCT01963260|928802|P8|NOT COMPLETED|Overall Study||0
378126|NCT01963260|928803|P7|NOT COMPLETED|Overall Study||0
378127|NCT01963260|928804|P6|NOT COMPLETED|Overall Study||0
378128|NCT01963260|928805|P5|NOT COMPLETED|Overall Study||2
378129|NCT01963260|928806|P4|NOT COMPLETED|Overall Study||1
378130|NCT01963260|928807|P3|NOT COMPLETED|Overall Study||0
378131|NCT01963260|928808|P2|NOT COMPLETED|Overall Study||0
378132|NCT01963260|928809|P1|NOT COMPLETED|Overall Study||2
378133|NCT01963260|928800|P10|COMPLETED|Overall Study||4
378134|NCT01963260|928801|P9|COMPLETED|Overall Study||1
378135|NCT01963260|928802|P8|COMPLETED|Overall Study||2
378136|NCT01963260|928803|P7|COMPLETED|Overall Study||3
378137|NCT01963260|928804|P6|COMPLETED|Overall Study||10
378138|NCT01963260|928805|P5|COMPLETED|Overall Study||4
378139|NCT01963260|928806|P4|COMPLETED|Overall Study||5
378140|NCT01963260|928807|P3|COMPLETED|Overall Study||6
378141|NCT01963260|928808|P2|COMPLETED|Overall Study||6
378142|NCT01963260|928809|P1|COMPLETED|Overall Study||4
378143|NCT01963260|928800|P10|Treated|Overall Study||4
378144|NCT01963260|928801|P9|Treated|Overall Study||1
378145|NCT01963260|928802|P8|Treated|Overall Study||2
378146|NCT01963260|928803|P7|Treated|Overall Study||3
378147|NCT01963260|928804|P6|Treated|Overall Study||10
378148|NCT01963260|928805|P5|Treated|Overall Study||6
378149|NCT01963260|928806|P4|Treated|Overall Study||6
378150|NCT01963260|928807|P3|Treated|Overall Study||6
378151|NCT01963260|928808|P2|Treated|Overall Study||6
378152|NCT01963260|928809|P1|Treated|Overall Study||6
378153|NCT01963260|928800|P10|STARTED|Overall Study||4
378154|NCT01963260|928801|P9|STARTED|Overall Study||1
378155|NCT01963260|928802|P8|STARTED|Overall Study||2
378156|NCT01963260|928803|P7|STARTED|Overall Study||3
378157|NCT01963260|928804|P6|STARTED|Overall Study||10
378158|NCT01963260|928805|P5|STARTED|Overall Study||6
378159|NCT01963260|928806|P4|STARTED|Overall Study||6
378160|NCT01963260|928807|P3|STARTED|Overall Study||6
378161|NCT01963260|928808|P2|STARTED|Overall Study||6
378162|NCT01963260|928809|P1|STARTED|Overall Study||6
378163|NCT01963143|928864|P3|NOT COMPLETED|Overall Study||1
378164|NCT01963143|928865|P2|NOT COMPLETED|Overall Study||1
378165|NCT01963143|928866|P1|NOT COMPLETED|Overall Study||0
378166|NCT01963143|928864|P3|COMPLETED|Overall Study||14
378167|NCT01963143|928865|P2|COMPLETED|Overall Study||18
378168|NCT01963143|928866|P1|COMPLETED|Overall Study||14
378169|NCT01963143|928864|P3|STARTED|Overall Study||15
378170|NCT01963143|928865|P2|STARTED|Overall Study||19
378171|NCT01963143|928866|P1|STARTED|Overall Study||14
378172|NCT01963091|928878|P2|NOT COMPLETED|Overall Study||0
378173|NCT01963091|928879|P1|NOT COMPLETED|Overall Study||0
378174|NCT01963091|928878|P2|COMPLETED|Overall Study||16
378175|NCT01963091|928879|P1|COMPLETED|Overall Study||17
378176|NCT01963091|928878|P2|STARTED|Overall Study||16
378177|NCT01963091|928879|P1|STARTED|Overall Study||17
378178|NCT01962974|928889|P1|NOT COMPLETED|Overall Study||7
378179|NCT01962974|928889|P1|COMPLETED|Overall Study||0
378180|NCT01962974|928889|P1|STARTED|Overall Study||7
378181|NCT01962961|928898|P3|NOT COMPLETED|Overall Study||1
378182|NCT01962961|928899|P2|NOT COMPLETED|Overall Study||1
378183|NCT01962961|928900|P1|NOT COMPLETED|Overall Study||0
378184|NCT01962961|928898|P3|COMPLETED|Overall Study||6
378185|NCT01962961|928899|P2|COMPLETED|Overall Study||7
378186|NCT01962961|928900|P1|COMPLETED|Overall Study||9
378187|NCT01962961|928898|P3|STARTED|Overall Study||7
378188|NCT01962961|928899|P2|STARTED|Overall Study||8
378189|NCT01962961|928900|P1|STARTED|Overall Study||9
378190|NCT01962922|928916|P2|NOT COMPLETED|Extendion Portion (up to Month 6)||3
378191|NCT01962922|928917|P1|NOT COMPLETED|Extendion Portion (up to Month 6)||5
378192|NCT01962922|928916|P2|COMPLETED|Extendion Portion (up to Month 6)||20
378193|NCT01962922|928917|P1|COMPLETED|Extendion Portion (up to Month 6)||18
378194|NCT01962922|928916|P2|STARTED|Extendion Portion (up to Month 6)||23
378195|NCT01962922|928917|P1|STARTED|Extendion Portion (up to Month 6)||23
378196|NCT01962922|928916|P2|NOT COMPLETED|PK Portion Day 21||0
378197|NCT01962922|928917|P1|NOT COMPLETED|PK Portion Day 21||0
378198|NCT01962922|928916|P2|COMPLETED|PK Portion Day 21||23
378199|NCT01962922|928917|P1|COMPLETED|PK Portion Day 21||23
378200|NCT01962922|928916|P2|STARTED|PK Portion Day 21||23
378201|NCT01962922|928917|P1|STARTED|PK Portion Day 21||23
378202|NCT01962922|928916|P2|NOT COMPLETED|PK Portion Day 14||0
378203|NCT01962922|928917|P1|NOT COMPLETED|PK Portion Day 14||0
378204|NCT01962922|928916|P2|COMPLETED|PK Portion Day 14||23
378205|NCT01962922|928917|P1|COMPLETED|PK Portion Day 14||23
378206|NCT01962922|928916|P2|STARTED|PK Portion Day 14||23
378207|NCT01962922|928917|P1|STARTED|PK Portion Day 14||23
378208|NCT01962922|928916|P2|NOT COMPLETED|PK Portion Day 7||0
378209|NCT01962922|928917|P1|NOT COMPLETED|PK Portion Day 7||4
378210|NCT01962922|928916|P2|COMPLETED|PK Portion Day 7||23
378211|NCT01962922|928917|P1|COMPLETED|PK Portion Day 7||23
378212|NCT01962922|928916|P2|STARTED|PK Portion Day 7||23
378213|NCT01962922|928917|P1|STARTED|PK Portion Day 7||27
378214|NCT01962688|928941|P2|NOT COMPLETED|Overall Study||0
378215|NCT01962688|928942|P1|NOT COMPLETED|Overall Study||0
378216|NCT01962688|928941|P2|COMPLETED|Overall Study||18
378217|NCT01962688|928942|P1|COMPLETED|Overall Study||19
378218|NCT01962688|928941|P2|STARTED|Overall Study||18
378219|NCT01962688|928942|P1|STARTED|Overall Study||19
378220|NCT01962675|928960|P2|NOT COMPLETED|Overall Study||0
378221|NCT01962675|928961|P1|NOT COMPLETED|Overall Study||0
378222|NCT01962675|928960|P2|COMPLETED|Overall Study||7
378223|NCT01962675|928961|P1|COMPLETED|Overall Study||7
378224|NCT01962675|928960|P2|STARTED|Overall Study||7
378225|NCT01962675|928961|P1|STARTED|Overall Study||7
378226|NCT01962558|928975|P2|NOT COMPLETED|Overall Study||0
378227|NCT01962558|928976|P1|NOT COMPLETED|Overall Study||0
378228|NCT01962558|928975|P2|COMPLETED|Overall Study||14
378229|NCT01962558|928976|P1|COMPLETED|Overall Study||16
378230|NCT01962558|928975|P2|12-Weeks|Overall Study||14
378231|NCT01962558|928976|P1|12-Weeks|Overall Study||16
378232|NCT01962558|928975|P2|Acute Study|Overall Study||14
378233|NCT01962558|928976|P1|Acute Study|Overall Study||16
378234|NCT01962558|928975|P2|STARTED|Overall Study||14
378235|NCT01962558|928976|P1|STARTED|Overall Study||16
378236|NCT01962493|928994|P2|NOT COMPLETED|Overall Study||5
378237|NCT01962493|928995|P1|NOT COMPLETED|Overall Study||5
378238|NCT01962493|928994|P2|COMPLETED|Overall Study||77
378239|NCT01962493|928995|P1|COMPLETED|Overall Study||73
378240|NCT01962493|928994|P2|STARTED|Overall Study||82
378241|NCT01962493|928995|P1|STARTED|Overall Study||78
378242|NCT01962441|929018|P3|NOT COMPLETED|Retreatment Substudy||0
378243|NCT01962441|929019|P2|NOT COMPLETED|Retreatment Substudy||0
378244|NCT01962441|929020|P1|NOT COMPLETED|Retreatment Substudy||2
378245|NCT01962441|929018|P3|COMPLETED|Retreatment Substudy||0
378246|NCT01962441|929019|P2|COMPLETED|Retreatment Substudy||10
378247|NCT01962441|929020|P1|COMPLETED|Retreatment Substudy||18
378248|NCT01962441|929018|P3|STARTED|Retreatment Substudy|Participants in the SOF+RBV+Peg-IFN group were not eligible to enroll in the Retreatment Substudy.|0
378249|NCT01962441|929019|P2|STARTED|Retreatment Substudy|10 participants who experienced virologic failure enrolled into the Retreatment Substudy.|10
378250|NCT01962441|929020|P1|STARTED|Retreatment Substudy|20 participants who experienced virologic failure enrolled into the Retreatment Substudy.|20
378251|NCT01962441|929018|P3|NOT COMPLETED|Randomized Period||11
378252|NCT01962441|929019|P2|NOT COMPLETED|Randomized Period||11
378253|NCT01962441|929020|P1|NOT COMPLETED|Randomized Period||10
378254|NCT01962441|929018|P3|COMPLETED|Randomized Period||189
378255|NCT01962441|929019|P2|COMPLETED|Randomized Period||190
378256|NCT01962441|929020|P1|COMPLETED|Randomized Period||190
378257|NCT01962441|929018|P3|STARTED|Randomized Period||200
378258|NCT01962441|929019|P2|STARTED|Randomized Period||201
378259|NCT01962441|929020|P1|STARTED|Randomized Period||200
378260|NCT01962428|929052|P2|NOT COMPLETED|Overall Study||6
378261|NCT01962428|929053|P1|NOT COMPLETED|Overall Study||10
378262|NCT01962428|929052|P2|COMPLETED|Overall Study||133
378263|NCT01962428|929053|P1|COMPLETED|Overall Study||129
378264|NCT01962428|929052|P2|STARTED|Overall Study||139
378265|NCT01962428|929053|P1|STARTED|Overall Study||139
378266|NCT01961544|929059|P1|NOT COMPLETED|Overall Study||13
378267|NCT01961544|929059|P1|COMPLETED|Overall Study||88
378268|NCT01961544|929059|P1|STARTED|Overall Study||101
378269|NCT01961349|929067|P3|NOT COMPLETED|Overall Study||2
378270|NCT01961349|929068|P2|NOT COMPLETED|Overall Study||6
378271|NCT01961349|929069|P1|NOT COMPLETED|Overall Study||3
378272|NCT01961349|929067|P3|COMPLETED|Overall Study||109
378273|NCT01961349|929068|P2|COMPLETED|Overall Study||101
378274|NCT01961349|929069|P1|COMPLETED|Overall Study||51
378275|NCT01961349|929067|P3|STARTED|Overall Study||111
378276|NCT01961349|929068|P2|STARTED|Overall Study||107
378277|NCT01961349|929069|P1|STARTED|Overall Study||54
378278|NCT01961323|929080|P1|NOT COMPLETED|Overall Study||49
378279|NCT01961323|929080|P1|COMPLETED|Overall Study||21
378280|NCT01961323|929080|P1|STARTED|Overall Study||70
378281|NCT01961297|929088|P2|NOT COMPLETED|Overall Study||1
378282|NCT01961297|929089|P1|NOT COMPLETED|Overall Study||2
378283|NCT01961297|929088|P2|COMPLETED|Overall Study||22
378284|NCT01961297|929089|P1|COMPLETED|Overall Study||28
378285|NCT01961297|929088|P2|STARTED|Overall Study||23
378286|NCT01961297|929089|P1|STARTED|Overall Study||30
378287|NCT01961271|929103|P1|NOT COMPLETED|Overall Study||50
378288|NCT01961271|929103|P1|COMPLETED|Overall Study||64
378289|NCT01961271|929103|P1|STARTED|Overall Study||114
378290|NCT01961115|929115|P3|NOT COMPLETED|Overall Study||4
378291|NCT01961115|929116|P2|NOT COMPLETED|Overall Study||0
378292|NCT01961115|929117|P1|NOT COMPLETED|Overall Study||2
378293|NCT01961115|929115|P3|COMPLETED|Overall Study||5
378294|NCT01961115|929116|P2|COMPLETED|Overall Study||0
378295|NCT01961115|929117|P1|COMPLETED|Overall Study||0
378296|NCT01961115|929115|P3|STARTED|Overall Study||9
378297|NCT01961115|929116|P2|STARTED|Overall Study||0
378298|NCT01961115|929117|P1|STARTED|Overall Study||2
378299|NCT01961089|929152|P1|NOT COMPLETED|Overall Study||0
378300|NCT01961089|929152|P1|COMPLETED|Overall Study||40
378301|NCT01961089|929152|P1|STARTED|Overall Study||40
378302|NCT01960907|929160|P2|NOT COMPLETED|Overall Study||45
378303|NCT01960907|929161|P1|NOT COMPLETED|Overall Study||36
378304|NCT01960907|929160|P2|COMPLETED|Overall Study||109
378305|NCT01960907|929161|P1|COMPLETED|Overall Study||122
378306|NCT01960907|929160|P2|STARTED|Overall Study||154
378307|NCT01960907|929161|P1|STARTED|Overall Study||158
378308|NCT01960855|929176|P5|NOT COMPLETED|Overall Study||5
378309|NCT01960855|929177|P4|NOT COMPLETED|Overall Study||4
378310|NCT01960855|929178|P3|NOT COMPLETED|Overall Study||9
378311|NCT01960855|929179|P2|NOT COMPLETED|Overall Study||4
378312|NCT01960855|929180|P1|NOT COMPLETED|Overall Study||11
378313|NCT01960855|929176|P5|COMPLETED|Overall Study||50
378314|NCT01960855|929177|P4|COMPLETED|Overall Study||51
378315|NCT01960855|929178|P3|COMPLETED|Overall Study||46
378316|NCT01960855|929179|P2|COMPLETED|Overall Study||51
378317|NCT01960855|929180|P1|COMPLETED|Overall Study||45
378318|NCT01960855|929176|P5|STARTED|Overall Study||55
378319|NCT01960855|929177|P4|STARTED|Overall Study||55
378320|NCT01960855|929178|P3|STARTED|Overall Study||55
378321|NCT01960855|929179|P2|STARTED|Overall Study||55
378322|NCT01960855|929180|P1|STARTED|Overall Study||56
378323|NCT01960842|929212|P1|NOT COMPLETED|Overall Study||3
378324|NCT01960842|929212|P1|COMPLETED|Overall Study||28
378325|NCT01960842|929212|P1|STARTED|Overall Study||31
378326|NCT01960816|929235|P1|NOT COMPLETED|Overall Study||1
378327|NCT01960816|929235|P1|COMPLETED|Overall Study||32
378328|NCT01960816|929235|P1|STARTED|Overall Study||33
378329|NCT01960725|929243|P2|NOT COMPLETED|Overall Study||5
378330|NCT01960725|929244|P1|NOT COMPLETED|Overall Study||6
378331|NCT01960725|929243|P2|COMPLETED|Overall Study||28
378332|NCT01960725|929244|P1|COMPLETED|Overall Study||27
378333|NCT01960725|929243|P2|Received Third Vaccine|Overall Study||32
378334|NCT01960725|929244|P1|Received Third Vaccine|Overall Study||32
378335|NCT01960725|929243|P2|Recieved Second Vaccine|Overall Study||33
378336|NCT01960725|929244|P1|Recieved Second Vaccine|Overall Study||33
378337|NCT01960725|929243|P2|Received First Vaccine|Overall Study||33
378338|NCT01960725|929244|P1|Received First Vaccine|Overall Study||33
378339|NCT01960725|929243|P2|STARTED|Overall Study||33
378340|NCT01960725|929244|P1|STARTED|Overall Study||33
378341|NCT01960530|929266|P1|NOT COMPLETED|Overall Study||0
378342|NCT01960530|929266|P1|COMPLETED|Overall Study||14
378343|NCT01960530|929266|P1|STARTED|Overall Study||14
378344|NCT01960400|929301|P2|NOT COMPLETED|Overall Study||0
378345|NCT01960400|929302|P1|NOT COMPLETED|Overall Study||0
378346|NCT01960400|929301|P2|COMPLETED|Overall Study||11
378347|NCT01960400|929302|P1|COMPLETED|Overall Study||11
378348|NCT01960400|929301|P2|STARTED|Overall Study||11
378349|NCT01960400|929302|P1|STARTED|Overall Study||11
378350|NCT01960387|929314|P1|NOT COMPLETED|Overall Study||0
378351|NCT01960387|929314|P1|COMPLETED|Overall Study||2
378352|NCT01960387|929314|P1|STARTED|Overall Study||2
378353|NCT01960296|929323|P2|NOT COMPLETED|Overall Study||3
378354|NCT01960296|929324|P1|NOT COMPLETED|Overall Study||2
378355|NCT01960296|929323|P2|COMPLETED|Overall Study||22
378356|NCT01960296|929324|P1|COMPLETED|Overall Study||21
378357|NCT01960296|929323|P2|STARTED|Overall Study||25
378358|NCT01960296|929324|P1|STARTED|Overall Study||23
378359|NCT01960140|929344|P1|NOT COMPLETED|Period 2 (Days 3-18)||2
378360|NCT01960140|929344|P1|COMPLETED|Period 2 (Days 3-18)||38
378361|NCT01960140|929344|P1|Received Simvastatin|Period 2 (Days 3-18)||38
378362|NCT01960140|929344|P1|Received At Least 1 Dose of Baricitinib|Period 2 (Days 3-18)||40
378363|NCT01960140|929344|P1|STARTED|Period 2 (Days 3-18)||40
378364|NCT01960140|929344|P1|NOT COMPLETED|Period 1 (Days 1-2)||0
378365|NCT01960140|929344|P1|COMPLETED|Period 1 (Days 1-2)||40
378366|NCT01960140|929344|P1|Received Simvastatin|Period 1 (Days 1-2)||40
378367|NCT01960140|929344|P1|STARTED|Period 1 (Days 1-2)||40
378368|NCT01960114|929355|P2|NOT COMPLETED|Overall Study||1
378369|NCT01960114|929356|P1|NOT COMPLETED|Overall Study||1
378370|NCT01960114|929355|P2|COMPLETED|Overall Study||268
378371|NCT01960114|929356|P1|COMPLETED|Overall Study||133
378372|NCT01960114|929355|P2|STARTED|Overall Study||269
378373|NCT01960114|929356|P1|STARTED|Overall Study||134
378374|NCT01959945|929374|P4|NOT COMPLETED|Overall Study||16
378375|NCT01959945|929375|P3|NOT COMPLETED|Overall Study||19
378376|NCT01959945|929376|P2|NOT COMPLETED|Overall Study||3
378377|NCT01959945|929377|P1|NOT COMPLETED|Overall Study||4
378378|NCT01959945|929374|P4|COMPLETED|Overall Study||15
378379|NCT01959945|929375|P3|COMPLETED|Overall Study||9
378380|NCT01959945|929376|P2|COMPLETED|Overall Study||75
378381|NCT01959945|929377|P1|COMPLETED|Overall Study||76
378382|NCT01959945|929374|P4|STARTED|Overall Study||31
378383|NCT01959945|929375|P3|STARTED|Overall Study||28
378384|NCT01959945|929376|P2|STARTED|Overall Study||78
378385|NCT01959945|929377|P1|STARTED|Overall Study||80
378386|NCT01959932|929402|P3|NOT COMPLETED|Overall Study||0
378387|NCT01959932|929403|P2|NOT COMPLETED|Overall Study||0
378388|NCT01959932|929404|P1|NOT COMPLETED|Overall Study||1
378389|NCT01959932|929402|P3|COMPLETED|Overall Study||39
378390|NCT01959932|929403|P2|COMPLETED|Overall Study||41
378391|NCT01959932|929404|P1|COMPLETED|Overall Study||79
378392|NCT01959932|929402|P3|STARTED|Overall Study||39
378393|NCT01959932|929403|P2|STARTED|Overall Study||41
378394|NCT01959932|929404|P1|STARTED|Overall Study||80
378395|NCT01959880|929426|P4|NOT COMPLETED|Overall Study||181
378396|NCT01959880|929427|P3|NOT COMPLETED|Overall Study||208
378397|NCT01959880|929428|P2|NOT COMPLETED|Overall Study||369
378398|NCT01959880|929429|P1|NOT COMPLETED|Overall Study||1132
378399|NCT01959880|929426|P4|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
378400|NCT01959880|929427|P3|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|1
378401|NCT01959880|929428|P2|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
378402|NCT01959880|929429|P1|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
378403|NCT01959880|929426|P4|STARTED|Overall Study||181
378404|NCT01959880|929427|P3|STARTED|Overall Study||209
378405|NCT01959880|929428|P2|STARTED|Overall Study||369
378406|NCT01959880|929429|P1|STARTED|Overall Study||1132
378407|NCT01959685|929451|P1|NOT COMPLETED|Overall Study||0
378408|NCT01959685|929451|P1|COMPLETED|Overall Study||9
378409|NCT01959685|929451|P1|STARTED|Overall Study||9
378410|NCT01959607|929458|P4|NOT COMPLETED|Second Intervention (Day 3)||0
378411|NCT01959607|929459|P3|NOT COMPLETED|Second Intervention (Day 3)||0
378412|NCT01959607|929460|P2|NOT COMPLETED|Second Intervention (Day 3)||0
378413|NCT01959607|929461|P1|NOT COMPLETED|Second Intervention (Day 3)||0
378414|NCT01959607|929458|P4|COMPLETED|Second Intervention (Day 3)||9
378415|NCT01959607|929459|P3|COMPLETED|Second Intervention (Day 3)||9
378416|NCT01959607|929460|P2|COMPLETED|Second Intervention (Day 3)||21
378417|NCT01959607|929461|P1|COMPLETED|Second Intervention (Day 3)||21
378418|NCT01959607|929458|P4|STARTED|Second Intervention (Day 3)||9
378419|NCT01959607|929459|P3|STARTED|Second Intervention (Day 3)||9
378420|NCT01959607|929460|P2|STARTED|Second Intervention (Day 3)||21
378421|NCT01959607|929461|P1|STARTED|Second Intervention (Day 3)||21
378422|NCT01959607|929458|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
378423|NCT01959607|929459|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
378424|NCT01959607|929460|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
378425|NCT01959607|929461|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
378426|NCT01959607|929458|P4|COMPLETED|Washout Period of 1 Day (Day 2)||9
378427|NCT01959607|929459|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
378428|NCT01959607|929460|P2|COMPLETED|Washout Period of 1 Day (Day 2)||21
378429|NCT01959607|929461|P1|COMPLETED|Washout Period of 1 Day (Day 2)||21
378430|NCT01959607|929458|P4|STARTED|Washout Period of 1 Day (Day 2)||9
378431|NCT01959607|929459|P3|STARTED|Washout Period of 1 Day (Day 2)||9
378432|NCT01959607|929460|P2|STARTED|Washout Period of 1 Day (Day 2)||21
378433|NCT01959607|929461|P1|STARTED|Washout Period of 1 Day (Day 2)||21
378434|NCT01959607|929458|P4|NOT COMPLETED|First Intervention (Day 1)||0
378435|NCT01959607|929459|P3|NOT COMPLETED|First Intervention (Day 1)||0
378436|NCT01959607|929460|P2|NOT COMPLETED|First Intervention (Day 1)||1
378437|NCT01959607|929461|P1|NOT COMPLETED|First Intervention (Day 1)||1
378438|NCT01959607|929458|P4|COMPLETED|First Intervention (Day 1)||9
378439|NCT01959607|929459|P3|COMPLETED|First Intervention (Day 1)||9
378440|NCT01959607|929460|P2|COMPLETED|First Intervention (Day 1)||21
378441|NCT01959607|929461|P1|COMPLETED|First Intervention (Day 1)||21
378442|NCT01959607|929458|P4|STARTED|First Intervention (Day 1)||9
378443|NCT01959607|929459|P3|STARTED|First Intervention (Day 1)||9
378444|NCT01959607|929460|P2|STARTED|First Intervention (Day 1)||22
378445|NCT01959607|929461|P1|STARTED|First Intervention (Day 1)||22
378446|NCT01959607|929458|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
378447|NCT01959607|929459|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
378448|NCT01959607|929460|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
378449|NCT01959607|929461|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
378450|NCT01959607|929458|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
378451|NCT01959607|929459|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
378452|NCT01959607|929460|P2|COMPLETED|Washout Period of 1 Day (Day 0)||22
378453|NCT01959607|929461|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
378454|NCT01959607|929458|P4|STARTED|Washout Period of 1 Day (Day 0)||9
378455|NCT01959607|929459|P3|STARTED|Washout Period of 1 Day (Day 0)||9
378456|NCT01959607|929460|P2|STARTED|Washout Period of 1 Day (Day 0)||22
378457|NCT01959607|929461|P1|STARTED|Washout Period of 1 Day (Day 0)||22
378458|NCT01959581|929474|P1|NOT COMPLETED|Overall Study||5
378459|NCT01959581|929474|P1|COMPLETED|Overall Study||25
378460|NCT01959581|929474|P1|STARTED|Overall Study||30
378461|NCT01959529|929480|P2|NOT COMPLETED|Overall Study||72
378462|NCT01959529|929481|P1|NOT COMPLETED|Overall Study||76
378463|NCT01959529|929480|P2|COMPLETED|Overall Study||3747
378464|NCT01959529|929481|P1|COMPLETED|Overall Study||3742
378465|NCT01959529|929480|P2|Exposed|Overall Study||3806
378466|NCT01959529|929481|P1|Exposed|Overall Study||3809
378467|NCT01959529|929480|P2|STARTED|Overall Study||3819
378468|NCT01959529|929481|P1|STARTED|Overall Study||3818
378469|NCT01959516|929493|P2|NOT COMPLETED|Epoch 2||1
378470|NCT01959516|929494|P1|NOT COMPLETED|Epoch 2||2
378471|NCT01959516|929493|P2|COMPLETED|Epoch 2||62
378472|NCT01959516|929494|P1|COMPLETED|Epoch 2||61
378473|NCT01959516|929493|P2|STARTED|Epoch 2||63
378474|NCT01959516|929494|P1|STARTED|Epoch 2||63
378475|NCT01959516|929493|P2|NOT COMPLETED|Epoch 1||5
378476|NCT01959516|929494|P1|NOT COMPLETED|Epoch 1||10
378477|NCT01959516|929493|P2|COMPLETED|Epoch 1||58
378478|NCT01959516|929494|P1|COMPLETED|Epoch 1||53
378479|NCT01959516|929493|P2|ITT Population|Epoch 1||62
378480|NCT01959516|929494|P1|ITT Population|Epoch 1||62
378481|NCT01959516|929493|P2|Safety Population|Epoch 1||62
378482|NCT01959516|929494|P1|Safety Population|Epoch 1||62
378483|NCT01959516|929493|P2|STARTED|Epoch 1||63
378484|NCT01959516|929494|P1|STARTED|Epoch 1||63
378485|NCT01959503|929504|P2|NOT COMPLETED|Overall Study||2
378486|NCT01959503|929505|P1|NOT COMPLETED|Overall Study||3
378487|NCT01959503|929504|P2|COMPLETED|Overall Study||49
378488|NCT01959503|929505|P1|COMPLETED|Overall Study||104
378489|NCT01959503|929504|P2|STARTED|Overall Study||51
378490|NCT01959503|929505|P1|STARTED|Overall Study||107
378491|NCT01959412|929525|P6|NOT COMPLETED|Overall Study||0
378492|NCT01959412|929526|P5|NOT COMPLETED|Overall Study||3
378493|NCT01959412|929527|P4|NOT COMPLETED|Overall Study||2
378494|NCT01959412|929528|P3|NOT COMPLETED|Overall Study||0
378495|NCT01959412|929529|P2|NOT COMPLETED|Overall Study||1
378496|NCT01959412|929530|P1|NOT COMPLETED|Overall Study||1
378497|NCT01959412|929525|P6|COMPLETED|Overall Study||15
378498|NCT01959412|929526|P5|COMPLETED|Overall Study||13
378499|NCT01959412|929527|P4|COMPLETED|Overall Study||13
378500|NCT01959412|929528|P3|COMPLETED|Overall Study||15
378501|NCT01959412|929529|P2|COMPLETED|Overall Study||14
378502|NCT01959412|929530|P1|COMPLETED|Overall Study||14
378503|NCT01959412|929525|P6|STARTED|Overall Study||15
378504|NCT01959412|929526|P5|STARTED|Overall Study||16
378505|NCT01959412|929527|P4|STARTED|Overall Study||15
378506|NCT01959412|929528|P3|STARTED|Overall Study||15
378507|NCT01959412|929529|P2|STARTED|Overall Study||15
378508|NCT01959412|929530|P1|STARTED|Overall Study||15
378509|NCT01959035|929568|P1|NOT COMPLETED|Overall Study||11
378510|NCT01959035|929568|P1|COMPLETED|Overall Study||77
378511|NCT01959035|929568|P1|STARTED|Overall Study||88
378512|NCT01958827|929594|P1|NOT COMPLETED|Overall Study||10
378513|NCT01958827|929594|P1|COMPLETED|Overall Study||18
378514|NCT01958827|929594|P1|STARTED|Overall Study||28
378515|NCT01958788|929612|P1|NOT COMPLETED|Overall Study||0
378516|NCT01958788|929612|P1|COMPLETED|Overall Study||7
378517|NCT01958788|929612|P1|STARTED|Overall Study||7
378518|NCT01958671|929625|P3|NOT COMPLETED|Overall Study||32
378519|NCT01958671|929626|P2|NOT COMPLETED|Overall Study||24
378520|NCT01958671|929627|P1|NOT COMPLETED|Overall Study||19
378521|NCT01958671|929625|P3|COMPLETED|Overall Study||121
378522|NCT01958671|929626|P2|COMPLETED|Overall Study||128
378523|NCT01958671|929627|P1|COMPLETED|Overall Study||137
378524|NCT01958671|929625|P3|STARTED|Overall Study||153
378525|NCT01958671|929626|P2|STARTED|Overall Study||152
378526|NCT01958671|929627|P1|STARTED|Overall Study||156
378527|NCT01958645|929671|P3|NOT COMPLETED|Overall Study||0
378528|NCT01958645|929672|P2|NOT COMPLETED|Overall Study||0
378529|NCT01958645|929673|P1|NOT COMPLETED|Overall Study||0
378530|NCT01958645|929671|P3|COMPLETED|Overall Study||4
378531|NCT01958645|929672|P2|COMPLETED|Overall Study||4
378532|NCT01958645|929673|P1|COMPLETED|Overall Study||4
378533|NCT01958645|929671|P3|STARTED|Overall Study||4
378534|NCT01958645|929672|P2|STARTED|Overall Study||4
378535|NCT01958645|929673|P1|STARTED|Overall Study||4
378536|NCT01958619|929701|P4|NOT COMPLETED|Overall Study||0
378537|NCT01958619|929702|P3|NOT COMPLETED|Overall Study||1
378538|NCT01958619|929703|P2|NOT COMPLETED|Overall Study||0
378539|NCT01958619|929704|P1|NOT COMPLETED|Overall Study||2
378540|NCT01958619|929701|P4|COMPLETED|Overall Study||12
378541|NCT01958619|929702|P3|COMPLETED|Overall Study||13
378542|NCT01958619|929703|P2|COMPLETED|Overall Study||14
378543|NCT01958619|929704|P1|COMPLETED|Overall Study||13
378544|NCT01958619|929701|P4|STARTED|Overall Study||12
378545|NCT01958619|929702|P3|STARTED|Overall Study||14
378546|NCT01958619|929703|P2|STARTED|Overall Study||14
378547|NCT01958619|929704|P1|STARTED|Overall Study||15
378548|NCT01958606|929726|P2|NOT COMPLETED|Overall Study||0
378549|NCT01958606|929727|P1|NOT COMPLETED|Overall Study||2
378550|NCT01958606|929726|P2|COMPLETED|Overall Study||5
378551|NCT01958606|929727|P1|COMPLETED|Overall Study||11
378552|NCT01958606|929726|P2|STARTED|Overall Study||5
378553|NCT01958606|929727|P1|STARTED|Overall Study||13
378554|NCT01958346|929767|P2|NOT COMPLETED|Overall Study||0
378555|NCT01958346|929768|P1|NOT COMPLETED|Overall Study||0
378556|NCT01958346|929767|P2|COMPLETED|Overall Study||39
378557|NCT01958346|929768|P1|COMPLETED|Overall Study||39
378558|NCT01958346|929767|P2|STARTED|Overall Study||39
378559|NCT01958346|929768|P1|STARTED|Overall Study||39
378560|NCT01958164|929778|P2|NOT COMPLETED|Overall Study||5
378561|NCT01958164|929779|P1|NOT COMPLETED|Overall Study||2
378562|NCT01958164|929778|P2|COMPLETED|Overall Study||5
378563|NCT01958164|929779|P1|COMPLETED|Overall Study||4
378564|NCT01958164|929778|P2|STARTED|Overall Study|Randomised and treated|10
378565|NCT01958164|929779|P1|STARTED|Overall Study|Randomised and treated|6
378566|NCT01958060|929798|P6|NOT COMPLETED|Overall Study||0
378567|NCT01958060|929799|P5|NOT COMPLETED|Overall Study||1
378568|NCT01958060|929800|P4|NOT COMPLETED|Overall Study||0
378569|NCT01958060|929801|P3|NOT COMPLETED|Overall Study||0
378570|NCT01958060|929802|P2|NOT COMPLETED|Overall Study||0
378571|NCT01958060|929803|P1|NOT COMPLETED|Overall Study||2
378572|NCT01958060|929798|P6|COMPLETED|Overall Study|One subject in the 100 mg iv dose group did not receive complete dose of trial medication.|1
378573|NCT01958060|929799|P5|COMPLETED|Overall Study|One subject in the 50 mg iv dose group did not receive complete dose of trial medication.|6
378574|NCT01958060|929800|P4|COMPLETED|Overall Study||5
378575|NCT01958060|929801|P3|COMPLETED|Overall Study||6
378576|NCT01958060|929802|P2|COMPLETED|Overall Study||6
378577|NCT01958060|929803|P1|COMPLETED|Overall Study||8
378578|NCT01958060|929798|P6|STARTED|Overall Study||1
378579|NCT01958060|929799|P5|STARTED|Overall Study||7
378580|NCT01958060|929800|P4|STARTED|Overall Study||5
378581|NCT01958060|929801|P3|STARTED|Overall Study||6
378582|NCT01958060|929802|P2|STARTED|Overall Study||6
378583|NCT01958060|929803|P1|STARTED|Overall Study||10
378584|NCT01958021|929828|P2|NOT COMPLETED|Overall Study||180
378585|NCT01958021|929829|P1|NOT COMPLETED|Overall Study||139
378586|NCT01958021|929828|P2|COMPLETED|Overall Study|Completed = Treatment ongoing|154
378587|NCT01958021|929829|P1|COMPLETED|Overall Study|Completed = Treatment ongoing|195
378588|NCT01958021|929828|P2|Patients Treated|Overall Study||330
378589|NCT01958021|929829|P1|Patients Treated|Overall Study||334
378590|NCT01958021|929828|P2|Patients Untreated|Overall Study||4
378591|NCT01958021|929829|P1|Patients Untreated|Overall Study||0
378592|NCT01958021|929828|P2|STARTED|Overall Study||334
378593|NCT01958021|929829|P1|STARTED|Overall Study||334
378594|NCT01958008|929841|P4|NOT COMPLETED|Overall Study||0
378595|NCT01958008|929842|P3|NOT COMPLETED|Overall Study||1
378596|NCT01958008|929843|P2|NOT COMPLETED|Overall Study||0
378597|NCT01958008|929844|P1|NOT COMPLETED|Overall Study||1
378598|NCT01958008|929841|P4|COMPLETED|Overall Study||21
378599|NCT01958008|929842|P3|COMPLETED|Overall Study||20
378600|NCT01958008|929843|P2|COMPLETED|Overall Study||21
378601|NCT01958008|929844|P1|COMPLETED|Overall Study||20
378602|NCT01958008|929841|P4|STARTED|Overall Study||21
378603|NCT01958008|929842|P3|STARTED|Overall Study||21
378604|NCT01958008|929843|P2|STARTED|Overall Study||21
378605|NCT01958008|929844|P1|STARTED|Overall Study||21
378606|NCT01957930|929874|P2|NOT COMPLETED|Overall Study||0
378607|NCT01957930|929875|P1|NOT COMPLETED|Overall Study||0
378608|NCT01957930|929874|P2|COMPLETED|Overall Study||37
378609|NCT01957930|929875|P1|COMPLETED|Overall Study||35
378610|NCT01957930|929874|P2|STARTED|Overall Study||37
378611|NCT01957930|929875|P1|STARTED|Overall Study||35
378612|NCT01957865|929884|P3|NOT COMPLETED|Overall Study||3
378613|NCT01957865|929885|P2|NOT COMPLETED|Overall Study||2
378614|NCT01957865|929886|P1|NOT COMPLETED|Overall Study||0
378615|NCT01957865|929884|P3|COMPLETED|Overall Study||19
378616|NCT01957865|929885|P2|COMPLETED|Overall Study||18
378617|NCT01957865|929886|P1|COMPLETED|Overall Study||21
378618|NCT01957865|929884|P3|STARTED|Overall Study||22
378619|NCT01957865|929885|P2|STARTED|Overall Study||20
378620|NCT01957865|929886|P1|STARTED|Overall Study||21
378621|NCT01957761|929897|P1|NOT COMPLETED|Overall Study||0
378622|NCT01957761|929897|P1|COMPLETED|Overall Study||189
378623|NCT01957761|929897|P1|STARTED|Overall Study||189
378624|NCT01957657|929901|P1|NOT COMPLETED|Overall Study||0
378625|NCT01957657|929901|P1|COMPLETED|Overall Study||4
378626|NCT01957657|929901|P1|STARTED|Overall Study||4
378627|NCT01957579|929919|P4|NOT COMPLETED|Overall Study||0
378628|NCT01957579|929920|P3|NOT COMPLETED|Overall Study||2
378629|NCT01957579|929921|P2|NOT COMPLETED|Overall Study||1
378630|NCT01957579|929922|P1|NOT COMPLETED|Overall Study||0
378631|NCT01957579|929919|P4|COMPLETED|Overall Study||6
378632|NCT01957579|929920|P3|COMPLETED|Overall Study||2
378633|NCT01957579|929921|P2|COMPLETED|Overall Study||6
378634|NCT01957579|929922|P1|COMPLETED|Overall Study||3
378635|NCT01957579|929919|P4|STARTED|Overall Study||6
378636|NCT01957579|929920|P3|STARTED|Overall Study||4
378637|NCT01957579|929921|P2|STARTED|Overall Study||7
378638|NCT01957579|929922|P1|STARTED|Overall Study||3
378639|NCT01957553|929989|P2|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||7
378640|NCT01957553|929990|P1|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||3
378641|NCT01957553|929989|P2|COMPLETED|Test Period 2 (21 +- 1 Days)||56
378642|NCT01957553|929990|P1|COMPLETED|Test Period 2 (21 +- 1 Days)||51
378643|NCT01957553|929989|P2|STARTED|Test Period 2 (21 +- 1 Days)||63
378644|NCT01957553|929990|P1|STARTED|Test Period 2 (21 +- 1 Days)||54
378645|NCT01957553|929989|P2|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||3
378646|NCT01957553|929990|P1|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||7
378647|NCT01957553|929989|P2|COMPLETED|Test Period 1 (21 +- 1 Days)||63
378648|NCT01957553|929990|P1|COMPLETED|Test Period 1 (21 +- 1 Days)||54
378649|NCT01957553|929989|P2|STARTED|Test Period 1 (21 +- 1 Days)||66
378650|NCT01957553|929990|P1|STARTED|Test Period 1 (21 +- 1 Days)||61
378651|NCT01957488|929996|P6|NOT COMPLETED|Test Period 3||0
378652|NCT01957488|929997|P5|NOT COMPLETED|Test Period 3||0
378653|NCT01957488|929998|P4|NOT COMPLETED|Test Period 3||0
378654|NCT01957488|929999|P3|NOT COMPLETED|Test Period 3||0
378655|NCT01957488|930000|P2|NOT COMPLETED|Test Period 3||1
378656|NCT01957488|930001|P1|NOT COMPLETED|Test Period 3||1
378657|NCT01957488|929996|P6|COMPLETED|Test Period 3||23
378658|NCT01957488|929997|P5|COMPLETED|Test Period 3||25
378659|NCT01957488|929998|P4|COMPLETED|Test Period 3||28
378660|NCT01957488|929999|P3|COMPLETED|Test Period 3||25
378661|NCT01957488|930000|P2|COMPLETED|Test Period 3||26
378662|NCT01957488|930001|P1|COMPLETED|Test Period 3||23
378663|NCT01957488|929996|P6|STARTED|Test Period 3||23
378664|NCT01957488|929997|P5|STARTED|Test Period 3||25
378665|NCT01957488|929998|P4|STARTED|Test Period 3||28
378666|NCT01957488|929999|P3|STARTED|Test Period 3||25
378667|NCT01957488|930000|P2|STARTED|Test Period 3||27
378668|NCT01957488|930001|P1|STARTED|Test Period 3||24
378669|NCT01957488|929996|P6|NOT COMPLETED|Test Period 2||1
378670|NCT01957488|929997|P5|NOT COMPLETED|Test Period 2||2
378671|NCT01957488|929998|P4|NOT COMPLETED|Test Period 2||1
378672|NCT01957488|929999|P3|NOT COMPLETED|Test Period 2||1
378673|NCT01957488|930000|P2|NOT COMPLETED|Test Period 2||1
378674|NCT01957488|930001|P1|NOT COMPLETED|Test Period 2||3
378675|NCT01957488|929996|P6|COMPLETED|Test Period 2||23
378676|NCT01957488|929997|P5|COMPLETED|Test Period 2||25
378677|NCT01957488|929998|P4|COMPLETED|Test Period 2||28
378678|NCT01957488|929999|P3|COMPLETED|Test Period 2||25
378679|NCT01957488|930000|P2|COMPLETED|Test Period 2||27
378680|NCT01957488|930001|P1|COMPLETED|Test Period 2||24
378681|NCT01957488|929996|P6|STARTED|Test Period 2||24
378682|NCT01957488|929997|P5|STARTED|Test Period 2||27
378683|NCT01957488|929998|P4|STARTED|Test Period 2||29
378684|NCT01957488|929999|P3|STARTED|Test Period 2||26
378685|NCT01957488|930000|P2|STARTED|Test Period 2||28
378686|NCT01957488|930001|P1|STARTED|Test Period 2||27
378687|NCT01957488|929996|P6|NOT COMPLETED|Test Period 1||6
378688|NCT01957488|929997|P5|NOT COMPLETED|Test Period 1||3
378689|NCT01957488|929998|P4|NOT COMPLETED|Test Period 1||3
378690|NCT01957488|929999|P3|NOT COMPLETED|Test Period 1||4
378691|NCT01957488|930000|P2|NOT COMPLETED|Test Period 1||3
378692|NCT01957488|930001|P1|NOT COMPLETED|Test Period 1||3
378693|NCT01957488|929996|P6|COMPLETED|Test Period 1||24
378694|NCT01957488|929997|P5|COMPLETED|Test Period 1||27
378695|NCT01957488|929998|P4|COMPLETED|Test Period 1||29
378696|NCT01957488|929999|P3|COMPLETED|Test Period 1||26
378697|NCT01957488|930000|P2|COMPLETED|Test Period 1||28
378698|NCT01957488|930001|P1|COMPLETED|Test Period 1||27
378699|NCT01957488|929996|P6|STARTED|Test Period 1||30
378700|NCT01957488|929997|P5|STARTED|Test Period 1||30
378701|NCT01957488|929998|P4|STARTED|Test Period 1||32
378702|NCT01957488|929999|P3|STARTED|Test Period 1||30
378703|NCT01957488|930000|P2|STARTED|Test Period 1||31
378704|NCT01957488|930001|P1|STARTED|Test Period 1||30
378705|NCT01957475|930009|P2|NOT COMPLETED|Test Period 2||0
378706|NCT01957475|930010|P1|NOT COMPLETED|Test Period 2||1
378707|NCT01957475|930009|P2|COMPLETED|Test Period 2||8
378708|NCT01957475|930010|P1|COMPLETED|Test Period 2||8
378709|NCT01957475|930009|P2|STARTED|Test Period 2||8
378710|NCT01957475|930010|P1|STARTED|Test Period 2||9
378711|NCT01957475|930009|P2|NOT COMPLETED|Test Period 1||1
378712|NCT01957475|930010|P1|NOT COMPLETED|Test Period 1||2
378713|NCT01957475|930009|P2|COMPLETED|Test Period 1||9
378714|NCT01957475|930010|P1|COMPLETED|Test Period 1||8
378715|NCT01957475|930009|P2|STARTED|Test Period 1||10
378716|NCT01957475|930010|P1|STARTED|Test Period 1||10
378717|NCT01957462|930016|P2|NOT COMPLETED|Test Period 2||0
378718|NCT01957462|930017|P1|NOT COMPLETED|Test Period 2||0
378719|NCT01957462|930016|P2|COMPLETED|Test Period 2||15
378720|NCT01957462|930017|P1|COMPLETED|Test Period 2||14
378721|NCT01957462|930016|P2|STARTED|Test Period 2||15
378722|NCT01957462|930017|P1|STARTED|Test Period 2||14
378723|NCT01957462|930016|P2|NOT COMPLETED|Test Period 1||0
378724|NCT01957462|930017|P1|NOT COMPLETED|Test Period 1||2
378725|NCT01957462|930016|P2|COMPLETED|Test Period 1||15
378726|NCT01957462|930017|P1|COMPLETED|Test Period 1||14
378727|NCT01957462|930016|P2|STARTED|Test Period 1||15
378728|NCT01957462|930017|P1|STARTED|Test Period 1||16
378729|NCT01957410|930023|P1|NOT COMPLETED|Optional Open Label||0
378730|NCT01957410|930023|P1|COMPLETED|Optional Open Label||13
378731|NCT01957410|930023|P1|STARTED|Optional Open Label||13
378732|NCT01957410|930023|P1|NOT COMPLETED|Open Label||0
378733|NCT01957410|930023|P1|COMPLETED|Open Label||13
378734|NCT01957410|930023|P1|STARTED|Open Label||13
378735|NCT01957397|930028|P2|NOT COMPLETED|Test Period 3||2
378736|NCT01957397|930029|P1|NOT COMPLETED|Test Period 3||2
378737|NCT01957397|930028|P2|COMPLETED|Test Period 3||9
378738|NCT01957397|930029|P1|COMPLETED|Test Period 3||9
378739|NCT01957397|930028|P2|STARTED|Test Period 3||11
378740|NCT01957397|930029|P1|STARTED|Test Period 3||11
378741|NCT01957397|930028|P2|NOT COMPLETED|Test Period 2||1
378742|NCT01957397|930029|P1|NOT COMPLETED|Test Period 2||0
378743|NCT01957397|930028|P2|COMPLETED|Test Period 2||11
378744|NCT01957397|930029|P1|COMPLETED|Test Period 2||11
378745|NCT01957397|930028|P2|STARTED|Test Period 2||12
378746|NCT01957397|930029|P1|STARTED|Test Period 2||11
378747|NCT01957397|930028|P2|NOT COMPLETED|Test Period 1||1
378748|NCT01957397|930029|P1|NOT COMPLETED|Test Period 1||2
378749|NCT01957397|930028|P2|COMPLETED|Test Period 1||12
378750|NCT01957397|930029|P1|COMPLETED|Test Period 1||11
378751|NCT01957397|930028|P2|STARTED|Test Period 1||13
378752|NCT01957397|930029|P1|STARTED|Test Period 1||13
378753|NCT01957397|930028|P2|NOT COMPLETED|Baseline Own Product||0
378754|NCT01957397|930029|P1|NOT COMPLETED|Baseline Own Product||0
378755|NCT01957397|930028|P2|COMPLETED|Baseline Own Product||13
378756|NCT01957397|930029|P1|COMPLETED|Baseline Own Product||13
378757|NCT01957397|930028|P2|STARTED|Baseline Own Product||13
378758|NCT01957397|930029|P1|STARTED|Baseline Own Product||13
378759|NCT01957384|930039|P6|NOT COMPLETED|Test Period 3 (14 Days)||0
378760|NCT01957384|930040|P5|NOT COMPLETED|Test Period 3 (14 Days)||0
378761|NCT01957384|930041|P4|NOT COMPLETED|Test Period 3 (14 Days)||0
378762|NCT01957384|930042|P3|NOT COMPLETED|Test Period 3 (14 Days)||0
378763|NCT01957384|930043|P2|NOT COMPLETED|Test Period 3 (14 Days)||0
378764|NCT01957384|930044|P1|NOT COMPLETED|Test Period 3 (14 Days)||0
378765|NCT01957384|930039|P6|COMPLETED|Test Period 3 (14 Days)||3
378766|NCT01957384|930040|P5|COMPLETED|Test Period 3 (14 Days)||3
378767|NCT01957384|930041|P4|COMPLETED|Test Period 3 (14 Days)||4
378768|NCT01957384|930042|P3|COMPLETED|Test Period 3 (14 Days)||4
378769|NCT01957384|930043|P2|COMPLETED|Test Period 3 (14 Days)||4
378770|NCT01957384|930044|P1|COMPLETED|Test Period 3 (14 Days)||4
378771|NCT01957384|930039|P6|STARTED|Test Period 3 (14 Days)||3
378772|NCT01957384|930040|P5|STARTED|Test Period 3 (14 Days)||3
378773|NCT01957384|930041|P4|STARTED|Test Period 3 (14 Days)||4
378774|NCT01957384|930042|P3|STARTED|Test Period 3 (14 Days)||4
378775|NCT01957384|930043|P2|STARTED|Test Period 3 (14 Days)||4
378776|NCT01957384|930044|P1|STARTED|Test Period 3 (14 Days)||4
378777|NCT01957384|930039|P6|NOT COMPLETED|Test Period 2 (14 Days)||0
378778|NCT01957384|930040|P5|NOT COMPLETED|Test Period 2 (14 Days)||0
378779|NCT01957384|930041|P4|NOT COMPLETED|Test Period 2 (14 Days)||0
378780|NCT01957384|930042|P3|NOT COMPLETED|Test Period 2 (14 Days)||0
378781|NCT01957384|930043|P2|NOT COMPLETED|Test Period 2 (14 Days)||0
378782|NCT01957384|930044|P1|NOT COMPLETED|Test Period 2 (14 Days)||0
378783|NCT01957384|930039|P6|COMPLETED|Test Period 2 (14 Days)||3
378784|NCT01957384|930040|P5|COMPLETED|Test Period 2 (14 Days)||3
378785|NCT01957384|930041|P4|COMPLETED|Test Period 2 (14 Days)||4
378786|NCT01957384|930042|P3|COMPLETED|Test Period 2 (14 Days)||4
378787|NCT01957384|930043|P2|COMPLETED|Test Period 2 (14 Days)||4
378788|NCT01957384|930044|P1|COMPLETED|Test Period 2 (14 Days)||4
378789|NCT01957384|930039|P6|STARTED|Test Period 2 (14 Days)||3
378790|NCT01957384|930040|P5|STARTED|Test Period 2 (14 Days)||3
378791|NCT01957384|930041|P4|STARTED|Test Period 2 (14 Days)||4
378792|NCT01957384|930042|P3|STARTED|Test Period 2 (14 Days)||4
378793|NCT01957384|930043|P2|STARTED|Test Period 2 (14 Days)||4
378794|NCT01957384|930044|P1|STARTED|Test Period 2 (14 Days)||4
378795|NCT01957384|930039|P6|NOT COMPLETED|Test Period 1 (14 Days)||0
378796|NCT01957384|930040|P5|NOT COMPLETED|Test Period 1 (14 Days)||0
378797|NCT01957384|930041|P4|NOT COMPLETED|Test Period 1 (14 Days)||0
378798|NCT01957384|930042|P3|NOT COMPLETED|Test Period 1 (14 Days)||0
378799|NCT01957384|930043|P2|NOT COMPLETED|Test Period 1 (14 Days)||0
378800|NCT01957384|930044|P1|NOT COMPLETED|Test Period 1 (14 Days)||0
378801|NCT01957384|930039|P6|COMPLETED|Test Period 1 (14 Days)||3
378802|NCT01957384|930040|P5|COMPLETED|Test Period 1 (14 Days)||3
378803|NCT01957384|930041|P4|COMPLETED|Test Period 1 (14 Days)||4
378804|NCT01957384|930042|P3|COMPLETED|Test Period 1 (14 Days)||4
378805|NCT01957384|930043|P2|COMPLETED|Test Period 1 (14 Days)||4
378806|NCT01957384|930044|P1|COMPLETED|Test Period 1 (14 Days)||4
378807|NCT01957384|930039|P6|STARTED|Test Period 1 (14 Days)||3
378808|NCT01957384|930040|P5|STARTED|Test Period 1 (14 Days)||3
378809|NCT01957384|930041|P4|STARTED|Test Period 1 (14 Days)||4
378810|NCT01957384|930042|P3|STARTED|Test Period 1 (14 Days)||4
378811|NCT01957384|930043|P2|STARTED|Test Period 1 (14 Days)||4
378812|NCT01957384|930044|P1|STARTED|Test Period 1 (14 Days)||4
378813|NCT01957215|930054|P2|NOT COMPLETED|Overall Study||12
378814|NCT01957215|930055|P1|NOT COMPLETED|Overall Study||13
378815|NCT01957215|930054|P2|COMPLETED|Overall Study||123
378816|NCT01957215|930055|P1|COMPLETED|Overall Study||122
378817|NCT01957215|930054|P2|STARTED|Overall Study||135
378818|NCT01957215|930055|P1|STARTED|Overall Study||135
378819|NCT01957202|930083|P18|NOT COMPLETED|Treatment Period 3 (8 Days)||0
378820|NCT01957202|930084|P17|NOT COMPLETED|Treatment Period 3 (8 Days)||1
378821|NCT01957202|930085|P16|NOT COMPLETED|Treatment Period 3 (8 Days)||0
378822|NCT01957202|930086|P15|NOT COMPLETED|Treatment Period 3 (8 Days)||0
378823|NCT01957202|930087|P14|NOT COMPLETED|Treatment Period 3 (8 Days)||0
378824|NCT01957202|930088|P13|NOT COMPLETED|Treatment Period 3 (8 Days)||0
378825|NCT01957202|930089|P12|NOT COMPLETED|Treatment Period 3 (8 Days)||0
378826|NCT01957202|930090|P11|NOT COMPLETED|Treatment Period 3 (8 Days)||0
378827|NCT01957202|930091|P10|NOT COMPLETED|Treatment Period 3 (8 Days)||0
378828|NCT01957202|930092|P9|NOT COMPLETED|Treatment Period 3 (8 Days)||0
378829|NCT01957202|930093|P8|NOT COMPLETED|Treatment Period 3 (8 Days)||0
378830|NCT01957202|930094|P7|NOT COMPLETED|Treatment Period 3 (8 Days)||0
378831|NCT01957202|930095|P6|NOT COMPLETED|Treatment Period 3 (8 Days)||0
378832|NCT01957202|930096|P5|NOT COMPLETED|Treatment Period 3 (8 Days)||0
378833|NCT01957202|930097|P4|NOT COMPLETED|Treatment Period 3 (8 Days)||0
378834|NCT01957202|930098|P3|NOT COMPLETED|Treatment Period 3 (8 Days)||0
378835|NCT01957202|930099|P2|NOT COMPLETED|Treatment Period 3 (8 Days)||0
378836|NCT01957202|930100|P1|NOT COMPLETED|Treatment Period 3 (8 Days)||0
378837|NCT01957202|930083|P18|COMPLETED|Treatment Period 3 (8 Days)||3
378838|NCT01957202|930084|P17|COMPLETED|Treatment Period 3 (8 Days)||4
378839|NCT01957202|930085|P16|COMPLETED|Treatment Period 3 (8 Days)||3
378840|NCT01957202|930086|P15|COMPLETED|Treatment Period 3 (8 Days)||6
378841|NCT01957202|930087|P14|COMPLETED|Treatment Period 3 (8 Days)||3
378842|NCT01957202|930088|P13|COMPLETED|Treatment Period 3 (8 Days)||3
378843|NCT01957202|930089|P12|COMPLETED|Treatment Period 3 (8 Days)||6
378844|NCT01957202|930090|P11|COMPLETED|Treatment Period 3 (8 Days)||3
378845|NCT01957202|930091|P10|COMPLETED|Treatment Period 3 (8 Days)||6
378846|NCT01957202|930092|P9|COMPLETED|Treatment Period 3 (8 Days)||3
378847|NCT01957202|930093|P8|COMPLETED|Treatment Period 3 (8 Days)||3
378848|NCT01957202|930094|P7|COMPLETED|Treatment Period 3 (8 Days)||3
378849|NCT01957202|930095|P6|COMPLETED|Treatment Period 3 (8 Days)||2
378850|NCT01957202|930096|P5|COMPLETED|Treatment Period 3 (8 Days)||3
378851|NCT01957202|930097|P4|COMPLETED|Treatment Period 3 (8 Days)||3
378852|NCT01957202|930098|P3|COMPLETED|Treatment Period 3 (8 Days)||6
378853|NCT01957202|930099|P2|COMPLETED|Treatment Period 3 (8 Days)||5
378854|NCT01957202|930100|P1|COMPLETED|Treatment Period 3 (8 Days)||3
378855|NCT01957202|930083|P18|STARTED|Treatment Period 3 (8 Days)||3
378856|NCT01957202|930084|P17|STARTED|Treatment Period 3 (8 Days)||5
378857|NCT01957202|930085|P16|STARTED|Treatment Period 3 (8 Days)||3
378858|NCT01957202|930086|P15|STARTED|Treatment Period 3 (8 Days)||6
378859|NCT01957202|930087|P14|STARTED|Treatment Period 3 (8 Days)||3
378860|NCT01957202|930088|P13|STARTED|Treatment Period 3 (8 Days)||3
378861|NCT01957202|930089|P12|STARTED|Treatment Period 3 (8 Days)||6
378862|NCT01957202|930090|P11|STARTED|Treatment Period 3 (8 Days)||3
378863|NCT01957202|930091|P10|STARTED|Treatment Period 3 (8 Days)||6
378864|NCT01957202|930092|P9|STARTED|Treatment Period 3 (8 Days)||3
378865|NCT01957202|930093|P8|STARTED|Treatment Period 3 (8 Days)||3
378866|NCT01957202|930094|P7|STARTED|Treatment Period 3 (8 Days)||3
378867|NCT01957202|930095|P6|STARTED|Treatment Period 3 (8 Days)||2
378868|NCT01957202|930096|P5|STARTED|Treatment Period 3 (8 Days)||3
378869|NCT01957202|930097|P4|STARTED|Treatment Period 3 (8 Days)||3
378870|NCT01957202|930098|P3|STARTED|Treatment Period 3 (8 Days)||6
378871|NCT01957202|930099|P2|STARTED|Treatment Period 3 (8 Days)||5
378872|NCT01957202|930100|P1|STARTED|Treatment Period 3 (8 Days)||3
378873|NCT01957202|930083|P18|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
378874|NCT01957202|930084|P17|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
378875|NCT01957202|930085|P16|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
378876|NCT01957202|930086|P15|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
378877|NCT01957202|930087|P14|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
378878|NCT01957202|930088|P13|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
378879|NCT01957202|930089|P12|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
378880|NCT01957202|930090|P11|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
378881|NCT01957202|930091|P10|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
378882|NCT01957202|930092|P9|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
378883|NCT01957202|930093|P8|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
378884|NCT01957202|930094|P7|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
378885|NCT01957202|930095|P6|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
378886|NCT01957202|930096|P5|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
378887|NCT01957202|930097|P4|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
378888|NCT01957202|930098|P3|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
378889|NCT01957202|930099|P2|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
378890|NCT01957202|930100|P1|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
378891|NCT01957202|930083|P18|COMPLETED|Washout Period 2 (14 to 28 Days)||3
378892|NCT01957202|930084|P17|COMPLETED|Washout Period 2 (14 to 28 Days)||5
378893|NCT01957202|930085|P16|COMPLETED|Washout Period 2 (14 to 28 Days)||3
378894|NCT01957202|930086|P15|COMPLETED|Washout Period 2 (14 to 28 Days)||6
378895|NCT01957202|930087|P14|COMPLETED|Washout Period 2 (14 to 28 Days)||3
378896|NCT01957202|930088|P13|COMPLETED|Washout Period 2 (14 to 28 Days)||3
378897|NCT01957202|930089|P12|COMPLETED|Washout Period 2 (14 to 28 Days)||6
378898|NCT01957202|930090|P11|COMPLETED|Washout Period 2 (14 to 28 Days)||3
378899|NCT01957202|930091|P10|COMPLETED|Washout Period 2 (14 to 28 Days)||6
378900|NCT01957202|930092|P9|COMPLETED|Washout Period 2 (14 to 28 Days)||3
378901|NCT01957202|930093|P8|COMPLETED|Washout Period 2 (14 to 28 Days)||3
378902|NCT01957202|930094|P7|COMPLETED|Washout Period 2 (14 to 28 Days)||3
378903|NCT01957202|930095|P6|COMPLETED|Washout Period 2 (14 to 28 Days)||2
378904|NCT01957202|930096|P5|COMPLETED|Washout Period 2 (14 to 28 Days)||3
378905|NCT01957202|930097|P4|COMPLETED|Washout Period 2 (14 to 28 Days)||3
378906|NCT01957202|930098|P3|COMPLETED|Washout Period 2 (14 to 28 Days)||6
378907|NCT01957202|930099|P2|COMPLETED|Washout Period 2 (14 to 28 Days)||5
378908|NCT01957202|930100|P1|COMPLETED|Washout Period 2 (14 to 28 Days)||3
378909|NCT01957202|930083|P18|STARTED|Washout Period 2 (14 to 28 Days)||3
378910|NCT01957202|930084|P17|STARTED|Washout Period 2 (14 to 28 Days)||5
378911|NCT01957202|930085|P16|STARTED|Washout Period 2 (14 to 28 Days)||3
378912|NCT01957202|930086|P15|STARTED|Washout Period 2 (14 to 28 Days)||6
378913|NCT01957202|930087|P14|STARTED|Washout Period 2 (14 to 28 Days)||3
378914|NCT01957202|930088|P13|STARTED|Washout Period 2 (14 to 28 Days)||3
378915|NCT01957202|930089|P12|STARTED|Washout Period 2 (14 to 28 Days)||6
378916|NCT01957202|930090|P11|STARTED|Washout Period 2 (14 to 28 Days)||3
378917|NCT01957202|930091|P10|STARTED|Washout Period 2 (14 to 28 Days)||6
378918|NCT01957202|930092|P9|STARTED|Washout Period 2 (14 to 28 Days)||3
378919|NCT01957202|930093|P8|STARTED|Washout Period 2 (14 to 28 Days)||3
378920|NCT01957202|930094|P7|STARTED|Washout Period 2 (14 to 28 Days)||3
378921|NCT01957202|930095|P6|STARTED|Washout Period 2 (14 to 28 Days)||2
378922|NCT01957202|930096|P5|STARTED|Washout Period 2 (14 to 28 Days)||3
378923|NCT01957202|930097|P4|STARTED|Washout Period 2 (14 to 28 Days)||3
378924|NCT01957202|930098|P3|STARTED|Washout Period 2 (14 to 28 Days)||6
378925|NCT01957202|930099|P2|STARTED|Washout Period 2 (14 to 28 Days)||5
378926|NCT01957202|930100|P1|STARTED|Washout Period 2 (14 to 28 Days)||3
378927|NCT01957202|930083|P18|NOT COMPLETED|Treatment Period 2 (8 Days)||0
378928|NCT01957202|930084|P17|NOT COMPLETED|Treatment Period 2 (8 Days)||1
378929|NCT01957202|930085|P16|NOT COMPLETED|Treatment Period 2 (8 Days)||0
378930|NCT01957202|930086|P15|NOT COMPLETED|Treatment Period 2 (8 Days)||0
378931|NCT01957202|930087|P14|NOT COMPLETED|Treatment Period 2 (8 Days)||0
378932|NCT01957202|930088|P13|NOT COMPLETED|Treatment Period 2 (8 Days)||0
378933|NCT01957202|930089|P12|NOT COMPLETED|Treatment Period 2 (8 Days)||0
378934|NCT01957202|930090|P11|NOT COMPLETED|Treatment Period 2 (8 Days)||0
378935|NCT01957202|930091|P10|NOT COMPLETED|Treatment Period 2 (8 Days)||0
378936|NCT01957202|930092|P9|NOT COMPLETED|Treatment Period 2 (8 Days)||0
378937|NCT01957202|930093|P8|NOT COMPLETED|Treatment Period 2 (8 Days)||0
378938|NCT01957202|930094|P7|NOT COMPLETED|Treatment Period 2 (8 Days)||0
378939|NCT01957202|930095|P6|NOT COMPLETED|Treatment Period 2 (8 Days)||0
378940|NCT01957202|930096|P5|NOT COMPLETED|Treatment Period 2 (8 Days)||0
378941|NCT01957202|930097|P4|NOT COMPLETED|Treatment Period 2 (8 Days)||0
378942|NCT01957202|930098|P3|NOT COMPLETED|Treatment Period 2 (8 Days)||0
378943|NCT01957202|930099|P2|NOT COMPLETED|Treatment Period 2 (8 Days)||1
378944|NCT01957202|930100|P1|NOT COMPLETED|Treatment Period 2 (8 Days)||0
378945|NCT01957202|930083|P18|COMPLETED|Treatment Period 2 (8 Days)||3
378946|NCT01957202|930084|P17|COMPLETED|Treatment Period 2 (8 Days)||5
378947|NCT01957202|930085|P16|COMPLETED|Treatment Period 2 (8 Days)||3
378948|NCT01957202|930086|P15|COMPLETED|Treatment Period 2 (8 Days)||6
378949|NCT01957202|930087|P14|COMPLETED|Treatment Period 2 (8 Days)||3
378950|NCT01957202|930088|P13|COMPLETED|Treatment Period 2 (8 Days)||3
378951|NCT01957202|930089|P12|COMPLETED|Treatment Period 2 (8 Days)||6
378952|NCT01957202|930090|P11|COMPLETED|Treatment Period 2 (8 Days)||3
378953|NCT01957202|930091|P10|COMPLETED|Treatment Period 2 (8 Days)||6
378954|NCT01957202|930092|P9|COMPLETED|Treatment Period 2 (8 Days)||3
378955|NCT01957202|930093|P8|COMPLETED|Treatment Period 2 (8 Days)||3
378956|NCT01957202|930094|P7|COMPLETED|Treatment Period 2 (8 Days)||3
378957|NCT01957202|930095|P6|COMPLETED|Treatment Period 2 (8 Days)||2
378958|NCT01957202|930096|P5|COMPLETED|Treatment Period 2 (8 Days)||3
378959|NCT01957202|930097|P4|COMPLETED|Treatment Period 2 (8 Days)||3
378960|NCT01957202|930098|P3|COMPLETED|Treatment Period 2 (8 Days)||6
378961|NCT01957202|930099|P2|COMPLETED|Treatment Period 2 (8 Days)||5
378962|NCT01957202|930100|P1|COMPLETED|Treatment Period 2 (8 Days)||3
378963|NCT01957202|930083|P18|STARTED|Treatment Period 2 (8 Days)||3
378964|NCT01957202|930084|P17|STARTED|Treatment Period 2 (8 Days)||6
378965|NCT01957202|930085|P16|STARTED|Treatment Period 2 (8 Days)||3
378966|NCT01957202|930086|P15|STARTED|Treatment Period 2 (8 Days)||6
378967|NCT01957202|930087|P14|STARTED|Treatment Period 2 (8 Days)||3
378968|NCT01957202|930088|P13|STARTED|Treatment Period 2 (8 Days)||3
378969|NCT01957202|930089|P12|STARTED|Treatment Period 2 (8 Days)||6
378970|NCT01957202|930090|P11|STARTED|Treatment Period 2 (8 Days)||3
378971|NCT01957202|930091|P10|STARTED|Treatment Period 2 (8 Days)||6
378972|NCT01957202|930092|P9|STARTED|Treatment Period 2 (8 Days)||3
378973|NCT01957202|930093|P8|STARTED|Treatment Period 2 (8 Days)||3
378974|NCT01957202|930094|P7|STARTED|Treatment Period 2 (8 Days)||3
378975|NCT01957202|930095|P6|STARTED|Treatment Period 2 (8 Days)||2
378976|NCT01957202|930096|P5|STARTED|Treatment Period 2 (8 Days)||3
378977|NCT01957202|930097|P4|STARTED|Treatment Period 2 (8 Days)||3
378978|NCT01957202|930098|P3|STARTED|Treatment Period 2 (8 Days)||6
378979|NCT01957202|930099|P2|STARTED|Treatment Period 2 (8 Days)||6
378980|NCT01957202|930100|P1|STARTED|Treatment Period 2 (8 Days)||3
378981|NCT01957202|930083|P18|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
378982|NCT01957202|930084|P17|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
378983|NCT01957202|930085|P16|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
378984|NCT01957202|930086|P15|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
378985|NCT01957202|930087|P14|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
378986|NCT01957202|930088|P13|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
378987|NCT01957202|930089|P12|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
378988|NCT01957202|930090|P11|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
378989|NCT01957202|930091|P10|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
378990|NCT01957202|930092|P9|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
378991|NCT01957202|930093|P8|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
378992|NCT01957202|930094|P7|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
378993|NCT01957202|930095|P6|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
378994|NCT01957202|930096|P5|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
378995|NCT01957202|930097|P4|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
378996|NCT01957202|930098|P3|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
378997|NCT01957202|930099|P2|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
378998|NCT01957202|930100|P1|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
378999|NCT01957202|930083|P18|COMPLETED|Washout Period 1 (14 to 28 Days)||3
379000|NCT01957202|930084|P17|COMPLETED|Washout Period 1 (14 to 28 Days)||6
379001|NCT01957202|930085|P16|COMPLETED|Washout Period 1 (14 to 28 Days)||3
379002|NCT01957202|930086|P15|COMPLETED|Washout Period 1 (14 to 28 Days)||6
379003|NCT01957202|930087|P14|COMPLETED|Washout Period 1 (14 to 28 Days)||3
379004|NCT01957202|930088|P13|COMPLETED|Washout Period 1 (14 to 28 Days)||3
379005|NCT01957202|930089|P12|COMPLETED|Washout Period 1 (14 to 28 Days)||6
379006|NCT01957202|930090|P11|COMPLETED|Washout Period 1 (14 to 28 Days)||3
379007|NCT01957202|930091|P10|COMPLETED|Washout Period 1 (14 to 28 Days)||6
379008|NCT01957202|930092|P9|COMPLETED|Washout Period 1 (14 to 28 Days)||3
379009|NCT01957202|930093|P8|COMPLETED|Washout Period 1 (14 to 28 Days)||3
379010|NCT01957202|930094|P7|COMPLETED|Washout Period 1 (14 to 28 Days)||3
379011|NCT01957202|930095|P6|COMPLETED|Washout Period 1 (14 to 28 Days)||2
379012|NCT01957202|930096|P5|COMPLETED|Washout Period 1 (14 to 28 Days)||3
379013|NCT01957202|930097|P4|COMPLETED|Washout Period 1 (14 to 28 Days)||3
379014|NCT01957202|930098|P3|COMPLETED|Washout Period 1 (14 to 28 Days)||6
379015|NCT01957202|930099|P2|COMPLETED|Washout Period 1 (14 to 28 Days)||6
379016|NCT01957202|930100|P1|COMPLETED|Washout Period 1 (14 to 28 Days)||3
379017|NCT01957202|930083|P18|STARTED|Washout Period 1 (14 to 28 Days)||3
379018|NCT01957202|930084|P17|STARTED|Washout Period 1 (14 to 28 Days)||6
379019|NCT01957202|930085|P16|STARTED|Washout Period 1 (14 to 28 Days)||3
379020|NCT01957202|930086|P15|STARTED|Washout Period 1 (14 to 28 Days)||6
379021|NCT01957202|930087|P14|STARTED|Washout Period 1 (14 to 28 Days)||3
379022|NCT01957202|930088|P13|STARTED|Washout Period 1 (14 to 28 Days)||3
379023|NCT01957202|930089|P12|STARTED|Washout Period 1 (14 to 28 Days)||6
379024|NCT01957202|930090|P11|STARTED|Washout Period 1 (14 to 28 Days)||3
379025|NCT01957202|930091|P10|STARTED|Washout Period 1 (14 to 28 Days)||6
379026|NCT01957202|930092|P9|STARTED|Washout Period 1 (14 to 28 Days)||3
379027|NCT01957202|930093|P8|STARTED|Washout Period 1 (14 to 28 Days)||3
379028|NCT01957202|930094|P7|STARTED|Washout Period 1 (14 to 28 Days)||3
379029|NCT01957202|930095|P6|STARTED|Washout Period 1 (14 to 28 Days)||2
379030|NCT01957202|930096|P5|STARTED|Washout Period 1 (14 to 28 Days)||3
379031|NCT01957202|930097|P4|STARTED|Washout Period 1 (14 to 28 Days)||3
379032|NCT01957202|930098|P3|STARTED|Washout Period 1 (14 to 28 Days)||6
379033|NCT01957202|930099|P2|STARTED|Washout Period 1 (14 to 28 Days)||6
379034|NCT01957202|930100|P1|STARTED|Washout Period 1 (14 to 28 Days)||3
379035|NCT01957202|930083|P18|NOT COMPLETED|Treatment Period 1 (8 Days)||0
379036|NCT01957202|930084|P17|NOT COMPLETED|Treatment Period 1 (8 Days)||0
379037|NCT01957202|930085|P16|NOT COMPLETED|Treatment Period 1 (8 Days)||0
379038|NCT01957202|930086|P15|NOT COMPLETED|Treatment Period 1 (8 Days)||0
379039|NCT01957202|930087|P14|NOT COMPLETED|Treatment Period 1 (8 Days)||0
379040|NCT01957202|930088|P13|NOT COMPLETED|Treatment Period 1 (8 Days)||0
379041|NCT01957202|930089|P12|NOT COMPLETED|Treatment Period 1 (8 Days)||0
379042|NCT01957202|930090|P11|NOT COMPLETED|Treatment Period 1 (8 Days)||0
379043|NCT01957202|930091|P10|NOT COMPLETED|Treatment Period 1 (8 Days)||0
379044|NCT01957202|930092|P9|NOT COMPLETED|Treatment Period 1 (8 Days)||0
379045|NCT01957202|930093|P8|NOT COMPLETED|Treatment Period 1 (8 Days)||0
379046|NCT01957202|930094|P7|NOT COMPLETED|Treatment Period 1 (8 Days)||0
379047|NCT01957202|930095|P6|NOT COMPLETED|Treatment Period 1 (8 Days)||0
379048|NCT01957202|930096|P5|NOT COMPLETED|Treatment Period 1 (8 Days)||0
379049|NCT01957202|930097|P4|NOT COMPLETED|Treatment Period 1 (8 Days)||0
379050|NCT01957202|930098|P3|NOT COMPLETED|Treatment Period 1 (8 Days)||0
379051|NCT01957202|930099|P2|NOT COMPLETED|Treatment Period 1 (8 Days)||0
379052|NCT01957202|930100|P1|NOT COMPLETED|Treatment Period 1 (8 Days)||0
379053|NCT01957202|930083|P18|COMPLETED|Treatment Period 1 (8 Days)||3
379054|NCT01957202|930084|P17|COMPLETED|Treatment Period 1 (8 Days)||6
379055|NCT01957202|930085|P16|COMPLETED|Treatment Period 1 (8 Days)||3
379056|NCT01957202|930086|P15|COMPLETED|Treatment Period 1 (8 Days)||6
379057|NCT01957202|930087|P14|COMPLETED|Treatment Period 1 (8 Days)||3
379058|NCT01957202|930088|P13|COMPLETED|Treatment Period 1 (8 Days)||3
379059|NCT01957202|930089|P12|COMPLETED|Treatment Period 1 (8 Days)||6
379060|NCT01957202|930090|P11|COMPLETED|Treatment Period 1 (8 Days)||3
379061|NCT01957202|930091|P10|COMPLETED|Treatment Period 1 (8 Days)||6
379062|NCT01957202|930092|P9|COMPLETED|Treatment Period 1 (8 Days)||3
379063|NCT01957202|930093|P8|COMPLETED|Treatment Period 1 (8 Days)||3
379064|NCT01957202|930094|P7|COMPLETED|Treatment Period 1 (8 Days)||3
379065|NCT01957202|930095|P6|COMPLETED|Treatment Period 1 (8 Days)||2
379066|NCT01957202|930096|P5|COMPLETED|Treatment Period 1 (8 Days)||3
379067|NCT01957202|930097|P4|COMPLETED|Treatment Period 1 (8 Days)||3
379068|NCT01957202|930098|P3|COMPLETED|Treatment Period 1 (8 Days)||6
379069|NCT01957202|930099|P2|COMPLETED|Treatment Period 1 (8 Days)||6
379070|NCT01957202|930100|P1|COMPLETED|Treatment Period 1 (8 Days)||3
379071|NCT01957202|930083|P18|STARTED|Treatment Period 1 (8 Days)||3
379072|NCT01957202|930084|P17|STARTED|Treatment Period 1 (8 Days)||6
379073|NCT01957202|930085|P16|STARTED|Treatment Period 1 (8 Days)||3
379074|NCT01957202|930086|P15|STARTED|Treatment Period 1 (8 Days)||6
379075|NCT01957202|930087|P14|STARTED|Treatment Period 1 (8 Days)||3
379076|NCT01957202|930088|P13|STARTED|Treatment Period 1 (8 Days)||3
379077|NCT01957202|930089|P12|STARTED|Treatment Period 1 (8 Days)||6
379078|NCT01957202|930090|P11|STARTED|Treatment Period 1 (8 Days)||3
379079|NCT01957202|930091|P10|STARTED|Treatment Period 1 (8 Days)||6
379080|NCT01957202|930092|P9|STARTED|Treatment Period 1 (8 Days)||3
379081|NCT01957202|930093|P8|STARTED|Treatment Period 1 (8 Days)||3
379082|NCT01957202|930094|P7|STARTED|Treatment Period 1 (8 Days)||3
379083|NCT01957202|930095|P6|STARTED|Treatment Period 1 (8 Days)||2
379084|NCT01957202|930096|P5|STARTED|Treatment Period 1 (8 Days)||3
379085|NCT01957202|930097|P4|STARTED|Treatment Period 1 (8 Days)||3
379086|NCT01957202|930098|P3|STARTED|Treatment Period 1 (8 Days)||6
379087|NCT01957202|930099|P2|STARTED|Treatment Period 1 (8 Days)||6
379088|NCT01957202|930100|P1|STARTED|Treatment Period 1 (8 Days)||3
379089|NCT01957163|930125|P3|NOT COMPLETED|Overall Study||18
379090|NCT01957163|930126|P2|NOT COMPLETED|Overall Study||11
379091|NCT01957163|930127|P1|NOT COMPLETED|Overall Study||15
379092|NCT01957163|930125|P3|COMPLETED|Overall Study||189
379093|NCT01957163|930126|P2|COMPLETED|Overall Study||195
379094|NCT01957163|930127|P1|COMPLETED|Overall Study||191
379095|NCT01957163|930125|P3|STARTED|Overall Study||207
379096|NCT01957163|930126|P2|STARTED|Overall Study||206
379097|NCT01957163|930127|P1|STARTED|Overall Study||206
379098|NCT01957137|930138|P1|NOT COMPLETED|No Stimulation||0
379099|NCT01957137|930138|P1|COMPLETED|No Stimulation||28
379100|NCT01957137|930138|P1|STARTED|No Stimulation|Following randomized portion, all subjects went through no stimulation for approximately 4 weeks.|28
379101|NCT01957137|930138|P1|NOT COMPLETED|Randomized Portion||2
379102|NCT01957137|930138|P1|COMPLETED|Randomized Portion||28
379103|NCT01957137|930138|P1|Cycling Parameter #3|Randomized Portion|Subjects received Cycling Parameter #3 for approximately 4 weeks.|28
379104|NCT01957137|930138|P1|Cycling Parameter #2|Randomized Portion|Subjects received Cycling Parameter #2 for approximately 4 weeks.|28
379105|NCT01957137|930138|P1|Cycling Parameter #1|Randomized Portion|Subjects received Cycling Parameter #1 for approximately 4 weeks.|30
379106|NCT01957137|930138|P1|Continuous Stimulation|Randomized Portion|Subjects received continuous stimulation for approximately 4 weeks.|29
379107|NCT01957137|930138|P1|STARTED|Randomized Portion||30
379108|NCT01957111|930168|P2|NOT COMPLETED|Overall Study||1
379109|NCT01957111|930169|P1|NOT COMPLETED|Overall Study||1
379110|NCT01957111|930168|P2|COMPLETED|Overall Study||15
379111|NCT01957111|930169|P1|COMPLETED|Overall Study||15
379112|NCT01957111|930168|P2|STARTED|Overall Study||16
379113|NCT01957111|930169|P1|STARTED|Overall Study||16
379114|NCT01956435|930177|P2|NOT COMPLETED|Overall Study||0
379115|NCT01956435|930178|P1|NOT COMPLETED|Overall Study||0
379116|NCT01956435|930177|P2|COMPLETED|Overall Study||3
379117|NCT01956435|930178|P1|COMPLETED|Overall Study||3
379118|NCT01956435|930177|P2|STARTED|Overall Study||3
379119|NCT01956435|930178|P1|STARTED|Overall Study||3
379120|NCT01956240|930187|P2|NOT COMPLETED|Overall Study||24
379121|NCT01956240|930188|P1|NOT COMPLETED|Overall Study||23
379122|NCT01956240|930187|P2|COMPLETED|Overall Study||25
379123|NCT01956240|930188|P1|COMPLETED|Overall Study||25
379124|NCT01956240|930187|P2|STARTED|Overall Study||49
379125|NCT01956240|930188|P1|STARTED|Overall Study||48
379126|NCT01956097|930199|P3|NOT COMPLETED|Overall Study||0
379127|NCT01956097|930200|P2|NOT COMPLETED|Overall Study||2
379128|NCT01956097|930201|P1|NOT COMPLETED|Overall Study||6
379129|NCT01956097|930199|P3|COMPLETED|Overall Study||15
379130|NCT01956097|930200|P2|COMPLETED|Overall Study||28
379131|NCT01956097|930201|P1|COMPLETED|Overall Study||24
379132|NCT01956097|930199|P3|STARTED|Overall Study||15
379133|NCT01956097|930200|P2|STARTED|Overall Study||30
379134|NCT01956097|930201|P1|STARTED|Overall Study||30
379135|NCT01956032|930218|P1|NOT COMPLETED|Overall Study||0
379136|NCT01956032|930218|P1|COMPLETED|Overall Study||15
379137|NCT01956032|930218|P1|STARTED|Overall Study||15
379138|NCT01955954|930265|P1|NOT COMPLETED|Overall Study||36
379139|NCT01955954|930265|P1|COMPLETED|Overall Study|12-months|33
379140|NCT01955954|930265|P1|Completed 6-month Assessement|Overall Study||42
379141|NCT01955954|930265|P1|Completed 2-month Assessment|Overall Study|Primary endpoint|46
379142|NCT01955954|930265|P1|Completed Post-treatment Assessement|Overall Study||48
379143|NCT01955954|930265|P1|Completed Treatment|Overall Study||53
379144|NCT01955954|930265|P1|Received Treatment|Overall Study||66
379145|NCT01955954|930265|P1|STARTED|Overall Study||69
379146|NCT01955733|930277|P3|NOT COMPLETED|Period 2||21
379147|NCT01955733|930278|P2|NOT COMPLETED|Period 2||19
379148|NCT01955733|930279|P1|NOT COMPLETED|Period 2||12
379149|NCT01955733|930277|P3|COMPLETED|Period 2||8
379150|NCT01955733|930278|P2|COMPLETED|Period 2||10
379151|NCT01955733|930279|P1|COMPLETED|Period 2||20
379152|NCT01955733|930277|P3|STARTED|Period 2||29
379153|NCT01955733|930278|P2|STARTED|Period 2||29
379154|NCT01955733|930279|P1|STARTED|Period 2||32
379155|NCT01955733|930277|P3|NOT COMPLETED|Period 1||0
379156|NCT01955733|930278|P2|NOT COMPLETED|Period 1||0
379157|NCT01955733|930279|P1|NOT COMPLETED|Period 1||1
379158|NCT01955733|930277|P3|COMPLETED|Period 1||29
379159|NCT01955733|930278|P2|COMPLETED|Period 1||29
379160|NCT01955733|930279|P1|COMPLETED|Period 1||32
379161|NCT01955733|930277|P3|STARTED|Period 1||29
379162|NCT01955733|930278|P2|STARTED|Period 1||29
379163|NCT01955733|930279|P1|STARTED|Period 1||33
379164|NCT01955720|930299|P6|NOT COMPLETED|Overall Study||0
379165|NCT01955720|930300|P5|NOT COMPLETED|Overall Study||0
379166|NCT01955720|930301|P4|NOT COMPLETED|Overall Study||0
379167|NCT01955720|930302|P3|NOT COMPLETED|Overall Study||0
379168|NCT01955720|930303|P2|NOT COMPLETED|Overall Study||0
379169|NCT01955720|930304|P1|NOT COMPLETED|Overall Study||0
379170|NCT01955720|930299|P6|COMPLETED|Overall Study||7
379171|NCT01955720|930300|P5|COMPLETED|Overall Study||7
379172|NCT01955720|930301|P4|COMPLETED|Overall Study||3
379173|NCT01955720|930302|P3|COMPLETED|Overall Study||3
379174|NCT01955720|930303|P2|COMPLETED|Overall Study||13
379175|NCT01955720|930304|P1|COMPLETED|Overall Study||13
379176|NCT01955720|930299|P6|Subjects With Moderate Renal Impairment|Overall Study||0
379177|NCT01955720|930300|P5|Subjects With Moderate Renal Impairment|Overall Study||0
379178|NCT01955720|930301|P4|Subjects With Moderate Renal Impairment|Overall Study||0
379179|NCT01955720|930302|P3|Subjects With Moderate Renal Impairment|Overall Study||0
379180|NCT01955720|930303|P2|Subjects With Moderate Renal Impairment|Overall Study||3
379181|NCT01955720|930304|P1|Subjects With Moderate Renal Impairment|Overall Study||3
379182|NCT01955720|930299|P6|Subjects With Mild Renal Impairment|Overall Study||3
379183|NCT01955720|930300|P5|Subjects With Mild Renal Impairment|Overall Study||3
379184|NCT01955720|930301|P4|Subjects With Mild Renal Impairment|Overall Study||0
379185|NCT01955720|930302|P3|Subjects With Mild Renal Impairment|Overall Study||0
379186|NCT01955720|930303|P2|Subjects With Mild Renal Impairment|Overall Study||3
379187|NCT01955720|930304|P1|Subjects With Mild Renal Impairment|Overall Study||3
379188|NCT01955720|930299|P6|Healthy Subjects Aged 65-80|Overall Study||4
379189|NCT01955720|930300|P5|Healthy Subjects Aged 65-80|Overall Study||4
379190|NCT01955720|930301|P4|Healthy Subjects Aged 65-80|Overall Study||0
379191|NCT01955720|930302|P3|Healthy Subjects Aged 65-80|Overall Study||0
379192|NCT01955720|930303|P2|Healthy Subjects Aged 65-80|Overall Study||4
379193|NCT01955720|930304|P1|Healthy Subjects Aged 65-80|Overall Study||4
379194|NCT01955720|930299|P6|Healthy Subjects Aged 45-64|Overall Study||0
379195|NCT01955720|930300|P5|Healthy Subjects Aged 45-64|Overall Study||0
379196|NCT01955720|930301|P4|Healthy Subjects Aged 45-64|Overall Study||3
379197|NCT01955720|930302|P3|Healthy Subjects Aged 45-64|Overall Study||3
379198|NCT01955720|930303|P2|Healthy Subjects Aged 45-64|Overall Study||3
379199|NCT01955720|930304|P1|Healthy Subjects Aged 45-64|Overall Study||3
379200|NCT01955720|930299|P6|STARTED|Overall Study||7
379201|NCT01955720|930300|P5|STARTED|Overall Study||7
379202|NCT01955720|930301|P4|STARTED|Overall Study||3
379203|NCT01955720|930302|P3|STARTED|Overall Study||3
379204|NCT01955720|930303|P2|STARTED|Overall Study||13
379205|NCT01955720|930304|P1|STARTED|Overall Study||13
379206|NCT01955707|930372|P2|NOT COMPLETED|Overall Study||22
379207|NCT01955707|930373|P1|NOT COMPLETED|Overall Study||20
379208|NCT01955707|930372|P2|COMPLETED|Overall Study||57
379209|NCT01955707|930373|P1|COMPLETED|Overall Study||62
379210|NCT01955707|930372|P2|Received Total Volume of Study Drug|Overall Study||77
379211|NCT01955707|930373|P1|Received Total Volume of Study Drug|Overall Study||82
379212|NCT01955707|930372|P2|Dosed|Overall Study||78
379213|NCT01955707|930373|P1|Dosed|Overall Study||82
379214|NCT01955707|930372|P2|Withdrew Prior to Dosing|Overall Study||1
379215|NCT01955707|930373|P1|Withdrew Prior to Dosing|Overall Study||0
379216|NCT01955707|930372|P2|STARTED|Overall Study||79
379217|NCT01955707|930373|P1|STARTED|Overall Study||82
379218|NCT01955629|930397|P1|NOT COMPLETED|Overall Study||0
379219|NCT01955629|930397|P1|COMPLETED|Overall Study|1 participant with DP and 3 with unacceptable toxicity were considered completed as per protocol.|4
379220|NCT01955629|930397|P1|STARTED|Overall Study||4
379221|NCT01955564|930416|P7|NOT COMPLETED|Overall Study||0
379222|NCT01955564|930417|P6|NOT COMPLETED|Overall Study||0
379223|NCT01955564|930418|P5|NOT COMPLETED|Overall Study||0
379224|NCT01955564|930419|P4|NOT COMPLETED|Overall Study||0
379225|NCT01955564|930420|P3|NOT COMPLETED|Overall Study||0
379226|NCT01955564|930421|P2|NOT COMPLETED|Overall Study||0
379227|NCT01955564|930422|P1|NOT COMPLETED|Overall Study||0
379228|NCT01955564|930416|P7|COMPLETED|Overall Study||6
379229|NCT01955564|930417|P6|COMPLETED|Overall Study||6
379230|NCT01955564|930418|P5|COMPLETED|Overall Study||6
379231|NCT01955564|930419|P4|COMPLETED|Overall Study||6
379232|NCT01955564|930420|P3|COMPLETED|Overall Study||6
379233|NCT01955564|930421|P2|COMPLETED|Overall Study||6
379234|NCT01955564|930422|P1|COMPLETED|Overall Study||18
379235|NCT01955564|930416|P7|STARTED|Overall Study||6
379236|NCT01955564|930417|P6|STARTED|Overall Study||6
379237|NCT01955564|930418|P5|STARTED|Overall Study||6
379238|NCT01955564|930419|P4|STARTED|Overall Study||6
379239|NCT01955564|930420|P3|STARTED|Overall Study||6
379240|NCT01955564|930421|P2|STARTED|Overall Study||6
379241|NCT01955564|930422|P1|STARTED|Overall Study||18
379242|NCT01955473|930455|P5|NOT COMPLETED|Overall Study||0
379243|NCT01955473|930456|P4|NOT COMPLETED|Overall Study||0
379244|NCT01955473|930457|P3|NOT COMPLETED|Overall Study||0
379245|NCT01955473|930458|P2|NOT COMPLETED|Overall Study||0
379246|NCT01955473|930459|P1|NOT COMPLETED|Overall Study||0
379247|NCT01955473|930455|P5|COMPLETED|Overall Study||30
379248|NCT01955473|930456|P4|COMPLETED|Overall Study||6
379249|NCT01955473|930457|P3|COMPLETED|Overall Study||6
379250|NCT01955473|930458|P2|COMPLETED|Overall Study||6
379251|NCT01955473|930459|P1|COMPLETED|Overall Study||3
379252|NCT01955473|930455|P5|STARTED|Overall Study||30
379253|NCT01955473|930456|P4|STARTED|Overall Study||6
379254|NCT01955473|930457|P3|STARTED|Overall Study||6
379255|NCT01955473|930458|P2|STARTED|Overall Study||6
379256|NCT01955473|930459|P1|STARTED|Overall Study||3
379257|NCT01955434|930613|P1|NOT COMPLETED|Overall Study||0
379258|NCT01955434|930613|P1|COMPLETED|Overall Study||25
379259|NCT01955434|930613|P1|STARTED|Overall Study||25
379260|NCT01955382|930623|P2|NOT COMPLETED|Overall Study||0
379261|NCT01955382|930624|P1|NOT COMPLETED|Overall Study||0
379262|NCT01955382|930623|P2|COMPLETED|Overall Study||35
379263|NCT01955382|930624|P1|COMPLETED|Overall Study||35
379264|NCT01955382|930623|P2|STARTED|Overall Study||35
379265|NCT01955382|930624|P1|STARTED|Overall Study||35
379266|NCT01955369|930632|P1|NOT COMPLETED|Overall Study||0
379267|NCT01955369|930632|P1|COMPLETED|Overall Study||200
379268|NCT01955369|930632|P1|STARTED|Overall Study||200
379269|NCT01955161|930641|P3|NOT COMPLETED|Overall Study||35
379270|NCT01955161|930642|P2|NOT COMPLETED|Overall Study||25
379271|NCT01955161|930643|P1|NOT COMPLETED|Overall Study||27
379272|NCT01955161|930641|P3|COMPLETED|Overall Study||275
379273|NCT01955161|930642|P2|COMPLETED|Overall Study||288
379274|NCT01955161|930643|P1|COMPLETED|Overall Study||283
379275|NCT01955161|930641|P3|Treated|Overall Study||309
379276|NCT01955161|930642|P2|Treated|Overall Study||313
379277|NCT01955161|930643|P1|Treated|Overall Study||308
379278|NCT01955161|930641|P3|STARTED|Overall Study||310
379279|NCT01955161|930642|P2|STARTED|Overall Study||313
379280|NCT01955161|930643|P1|STARTED|Overall Study||310
379281|NCT01955122|930683|P2|NOT COMPLETED|Overall Study||5
379282|NCT01955122|930684|P1|NOT COMPLETED|Overall Study||5
379283|NCT01955122|930683|P2|COMPLETED|Overall Study||57
379284|NCT01955122|930684|P1|COMPLETED|Overall Study||59
379285|NCT01955122|930683|P2|No. Patients Completed Double Procedure|Overall Study||57
379286|NCT01955122|930684|P1|No. Patients Completed Double Procedure|Overall Study||59
379287|NCT01955122|930683|P2|No.Patients Enrolled|Overall Study||62
379288|NCT01955122|930684|P1|No.Patients Enrolled|Overall Study||64
379289|NCT01955122|930683|P2|STARTED|Overall Study|"Excluded (n = 5)~Included in analysis (n = 57)"|62
379290|NCT01955122|930684|P1|STARTED|Overall Study|"Excluded (n = 5)~Included in analysis (n = 59)"|64
379291|NCT01955083|930704|P2|NOT COMPLETED|Overall Study||1
379292|NCT01955083|930705|P1|NOT COMPLETED|Overall Study||1
379293|NCT01955083|930704|P2|COMPLETED|Overall Study||14
379294|NCT01955083|930705|P1|COMPLETED|Overall Study||14
379295|NCT01955083|930704|P2|STARTED|Overall Study||15
379296|NCT01955083|930705|P1|STARTED|Overall Study||15
379297|NCT01955044|930738|P3|NOT COMPLETED|Overall Study||0
379298|NCT01955044|930739|P2|NOT COMPLETED|Overall Study||1
379299|NCT01955044|930740|P1|NOT COMPLETED|Overall Study||1
379300|NCT01955044|930738|P3|COMPLETED|Overall Study||10
379301|NCT01955044|930739|P2|COMPLETED|Overall Study||9
379302|NCT01955044|930740|P1|COMPLETED|Overall Study||9
379303|NCT01955044|930738|P3|STARTED|Overall Study||10
379304|NCT01955044|930739|P2|STARTED|Overall Study||10
379305|NCT01955044|930740|P1|STARTED|Overall Study||10
379306|NCT01955005|930753|P2|NOT COMPLETED|Overall Study||5
379307|NCT01955005|930754|P1|NOT COMPLETED|Overall Study||3
379308|NCT01955005|930753|P2|COMPLETED|Overall Study||25
379309|NCT01955005|930754|P1|COMPLETED|Overall Study||27
379310|NCT01955005|930753|P2|STARTED|Overall Study||30
379311|NCT01955005|930754|P1|STARTED|Overall Study||30
379312|NCT01954771|930767|P3|NOT COMPLETED|Overall Study||3
379313|NCT01954771|930768|P2|NOT COMPLETED|Overall Study||3
379314|NCT01954771|930769|P1|NOT COMPLETED|Overall Study||7
379315|NCT01954771|930767|P3|COMPLETED|Overall Study||25
379316|NCT01954771|930768|P2|COMPLETED|Overall Study||29
379317|NCT01954771|930769|P1|COMPLETED|Overall Study||22
379318|NCT01954771|930767|P3|STARTED|Overall Study||28
379319|NCT01954771|930768|P2|STARTED|Overall Study||32
379320|NCT01954771|930769|P1|STARTED|Overall Study||29
379321|NCT01954745|930786|P1|NOT COMPLETED|Overall Study||19
379322|NCT01954745|930786|P1|COMPLETED|Overall Study||0
379323|NCT01954745|930786|P1|STARTED|Overall Study||19
379324|NCT01954628|930795|P2|NOT COMPLETED|Overall Study||27
379325|NCT01954628|930796|P1|NOT COMPLETED|Overall Study||31
379326|NCT01954628|930795|P2|COMPLETED|Overall Study||173
379327|NCT01954628|930796|P1|COMPLETED|Overall Study||169
379328|NCT01954628|930795|P2|US 6 Month Ophthalmology Safety Visit|Overall Study||32
379329|NCT01954628|930796|P1|US 6 Month Ophthalmology Safety Visit|Overall Study||37
379330|NCT01954628|930795|P2|Pharmacokinetic Population|Overall Study||0
379331|NCT01954628|930796|P1|Pharmacokinetic Population|Overall Study||181
379332|NCT01954628|930795|P2|Safety Set|Overall Study||200
379333|NCT01954628|930796|P1|Safety Set|Overall Study||200
379334|NCT01954628|930795|P2|Full Analysis Set (FAS)|Overall Study||198
379335|NCT01954628|930796|P1|Full Analysis Set (FAS)|Overall Study||200
379336|NCT01954628|930795|P2|STARTED|Overall Study||200
379337|NCT01954628|930796|P1|STARTED|Overall Study||200
379338|NCT01954251|930817|P2|NOT COMPLETED|Overall Study||19
379339|NCT01954251|930818|P1|NOT COMPLETED|Overall Study||13
379340|NCT01954251|930817|P2|COMPLETED|Overall Study||396
379341|NCT01954251|930818|P1|COMPLETED|Overall Study||400
379342|NCT01954251|930817|P2|STARTED|Overall Study||415
379343|NCT01954251|930818|P1|STARTED|Overall Study||413
379344|NCT01954160|930854|P2|NOT COMPLETED|Overall Study||0
379345|NCT01954160|930855|P1|NOT COMPLETED|Overall Study||5
379346|NCT01954160|930854|P2|COMPLETED|Overall Study||0
379347|NCT01954160|930855|P1|COMPLETED|Overall Study|Only 4 subjects completed the first early denervation. No subjects completed the late denervation.|0
379348|NCT01954160|930854|P2|STARTED|Overall Study|Not started|0
379349|NCT01954160|930855|P1|STARTED|Overall Study||5
379350|NCT01954121|930915|P2|NOT COMPLETED|Overall Study||91
379351|NCT01954121|930916|P1|NOT COMPLETED|Overall Study||127
379352|NCT01954121|930915|P2|COMPLETED|Overall Study||125
379353|NCT01954121|930916|P1|COMPLETED|Overall Study||93
379354|NCT01954121|930915|P2|STARTED|Overall Study||216
379355|NCT01954121|930916|P1|STARTED|Overall Study||220
379356|NCT01953874|930932|P2|NOT COMPLETED|Overall Study||0
379357|NCT01953874|930933|P1|NOT COMPLETED|Overall Study||0
379358|NCT01953874|930932|P2|COMPLETED|Overall Study||61
379359|NCT01953874|930933|P1|COMPLETED|Overall Study||65
379360|NCT01953874|930932|P2|STARTED|Overall Study||61
379361|NCT01953874|930933|P1|STARTED|Overall Study||65
379362|NCT01953354|930978|P2|NOT COMPLETED|Overall Study||2
379363|NCT01953354|930979|P1|NOT COMPLETED|Overall Study||1
379364|NCT01953354|930978|P2|COMPLETED|Overall Study||5
379365|NCT01953354|930979|P1|COMPLETED|Overall Study||8
379366|NCT01953354|930978|P2|STARTED|Overall Study||7
379367|NCT01953354|930979|P1|STARTED|Overall Study||9
379368|NCT01953328|931007|P8|NOT COMPLETED|Overall Study||0
379369|NCT01953328|931008|P7|NOT COMPLETED|Overall Study||0
379370|NCT01953328|931009|P6|NOT COMPLETED|Overall Study||0
379371|NCT01953328|931010|P5|NOT COMPLETED|Overall Study||2
379372|NCT01953328|931011|P4|NOT COMPLETED|Overall Study||0
379373|NCT01953328|931012|P3|NOT COMPLETED|Overall Study||0
379374|NCT01953328|931013|P2|NOT COMPLETED|Overall Study||0
379375|NCT01953328|931014|P1|NOT COMPLETED|Overall Study||0
379376|NCT01953328|931007|P8|COMPLETED|Overall Study||51
379377|NCT01953328|931008|P7|COMPLETED|Overall Study||51
379378|NCT01953328|931009|P6|COMPLETED|Overall Study||51
379379|NCT01953328|931010|P5|COMPLETED|Overall Study||50
379380|NCT01953328|931011|P4|COMPLETED|Overall Study||50
379381|NCT01953328|931012|P3|COMPLETED|Overall Study||50
379382|NCT01953328|931013|P2|COMPLETED|Overall Study||50
379383|NCT01953328|931014|P1|COMPLETED|Overall Study||49
379384|NCT01953328|931007|P8|Received Treatment|Overall Study||51
379385|NCT01953328|931008|P7|Received Treatment|Overall Study||51
379386|NCT01953328|931009|P6|Received Treatment|Overall Study||51
379387|NCT01953328|931010|P5|Received Treatment|Overall Study||52
379388|NCT01953328|931011|P4|Received Treatment|Overall Study||50
379389|NCT01953328|931012|P3|Received Treatment|Overall Study||50
379390|NCT01953328|931013|P2|Received Treatment|Overall Study||50
379391|NCT01953328|931014|P1|Received Treatment|Overall Study||49
379392|NCT01953328|931007|P8|STARTED|Overall Study||51
379393|NCT01953328|931008|P7|STARTED|Overall Study||51
379394|NCT01953328|931009|P6|STARTED|Overall Study||51
379395|NCT01953328|931010|P5|STARTED|Overall Study||52
379396|NCT01953328|931011|P4|STARTED|Overall Study||50
379397|NCT01953328|931012|P3|STARTED|Overall Study||50
379398|NCT01953328|931013|P2|STARTED|Overall Study||50
379399|NCT01953328|931014|P1|STARTED|Overall Study||49
379400|NCT01953237|931218|P2|NOT COMPLETED|Overall Study||0
379401|NCT01953237|931219|P1|NOT COMPLETED|Overall Study||0
379402|NCT01953237|931218|P2|COMPLETED|Overall Study||21
379403|NCT01953237|931219|P1|COMPLETED|Overall Study||10
379404|NCT01953237|931218|P2|STARTED|Overall Study||21
379405|NCT01953237|931219|P1|STARTED|Overall Study||10
379406|NCT01953081|931227|P2|NOT COMPLETED|Overall Study||3
379407|NCT01953081|931228|P1|NOT COMPLETED|Overall Study||2
379408|NCT01953081|931227|P2|COMPLETED|Overall Study||3
379409|NCT01953081|931228|P1|COMPLETED|Overall Study||5
379410|NCT01953081|931227|P2|STARTED|Overall Study||6
379411|NCT01953081|931228|P1|STARTED|Overall Study||7
379412|NCT01952834|931244|P1|NOT COMPLETED|Overall Study||1
379413|NCT01952834|931244|P1|COMPLETED|Overall Study||20
379414|NCT01952834|931244|P1|STARTED|Overall Study||21
379415|NCT01952691|931251|P1|NOT COMPLETED|Overall Study||2
379416|NCT01952691|931251|P1|COMPLETED|Overall Study||20
379417|NCT01952691|931251|P1|STARTED|Overall Study||22
379418|NCT01952665|931259|P2|NOT COMPLETED|Overall Study||6
379419|NCT01952665|931260|P1|NOT COMPLETED|Overall Study||6
379420|NCT01952665|931259|P2|COMPLETED|Overall Study||20
379421|NCT01952665|931260|P1|COMPLETED|Overall Study||31
379422|NCT01952665|931259|P2|STARTED|Overall Study||26
379423|NCT01952665|931260|P1|STARTED|Overall Study||37
379424|NCT01952600|931401|P3|NOT COMPLETED|Overall Study||7
379425|NCT01952600|931402|P2|NOT COMPLETED|Overall Study||13
379426|NCT01952600|931403|P1|NOT COMPLETED|Overall Study||15
379427|NCT01952600|931401|P3|COMPLETED|Overall Study||38
379428|NCT01952600|931402|P2|COMPLETED|Overall Study||77
379429|NCT01952600|931403|P1|COMPLETED|Overall Study||65
379430|NCT01952600|931401|P3|STARTED|Overall Study||45
379431|NCT01952600|931402|P2|STARTED|Overall Study||90
379432|NCT01952600|931403|P1|STARTED|Overall Study||80
379433|NCT01952418|931413|P2|NOT COMPLETED|Overall Study||0
379434|NCT01952418|931414|P1|NOT COMPLETED|Overall Study||0
379435|NCT01952418|931413|P2|COMPLETED|Overall Study||895
379436|NCT01952418|931414|P1|COMPLETED|Overall Study||910
379437|NCT01952418|931413|P2|STARTED|Overall Study||895
379438|NCT01952418|931414|P1|STARTED|Overall Study||910
379439|NCT01952366|931426|P1|NOT COMPLETED|Overall Study||31
379440|NCT01952366|931426|P1|COMPLETED|Overall Study||138
379441|NCT01952366|931426|P1|STARTED|Overall Study||169
379442|NCT01952301|931433|P1|NOT COMPLETED|Overall Study||0
379443|NCT01952301|931433|P1|COMPLETED|Overall Study||30
379444|NCT01952301|931433|P1|STARTED|Overall Study|We designed and implemented a single-blind, randomized, controlled, split-mouth study of 30 subjects|30
379445|NCT01952145|931441|P2|NOT COMPLETED|Overall Study||14
379446|NCT01952145|931442|P1|NOT COMPLETED|Overall Study||28
379447|NCT01952145|931441|P2|COMPLETED|Overall Study||265
379448|NCT01952145|931442|P1|COMPLETED|Overall Study||250
379449|NCT01952145|931441|P2|STARTED|Overall Study||279
379450|NCT01952145|931442|P1|STARTED|Overall Study||278
379451|NCT01952080|931456|P4|NOT COMPLETED|Overall Study||1
379452|NCT01952080|931457|P3|NOT COMPLETED|Overall Study||0
379453|NCT01952080|931458|P2|NOT COMPLETED|Overall Study||1
379454|NCT01952080|931459|P1|NOT COMPLETED|Overall Study||0
379455|NCT01952080|931456|P4|COMPLETED|Overall Study||14
379456|NCT01952080|931457|P3|COMPLETED|Overall Study||14
379457|NCT01952080|931458|P2|COMPLETED|Overall Study||7
379458|NCT01952080|931459|P1|COMPLETED|Overall Study||5
379459|NCT01952080|931456|P4|Treated|Overall Study||15
379460|NCT01952080|931457|P3|Treated|Overall Study||14
379461|NCT01952080|931458|P2|Treated|Overall Study||8
379462|NCT01952080|931459|P1|Treated|Overall Study||5
379463|NCT01952080|931456|P4|STARTED|Overall Study||15
379464|NCT01952080|931457|P3|STARTED|Overall Study||14
379465|NCT01952080|931458|P2|STARTED|Overall Study||8
379466|NCT01952080|931459|P1|STARTED|Overall Study||5
379467|NCT01951963|931507|P2|NOT COMPLETED|Overall Study||0
379468|NCT01951963|931508|P1|NOT COMPLETED|Overall Study||0
379469|NCT01951963|931507|P2|COMPLETED|Overall Study||32
379470|NCT01951963|931508|P1|COMPLETED|Overall Study||31
379471|NCT01951963|931507|P2|STARTED|Overall Study||32
379472|NCT01951963|931508|P1|STARTED|Overall Study||31
379473|NCT01951950|931520|P2|NOT COMPLETED|Overall Study||6
379474|NCT01951950|931521|P1|NOT COMPLETED|Overall Study||6
379475|NCT01951950|931520|P2|COMPLETED|Overall Study||20
379476|NCT01951950|931521|P1|COMPLETED|Overall Study||20
379477|NCT01951950|931520|P2|STARTED|Overall Study||26
379478|NCT01951950|931521|P1|STARTED|Overall Study||26
379479|NCT01951820|931529|P2|NOT COMPLETED|Overall Study||0
379480|NCT01951820|931530|P1|NOT COMPLETED|Overall Study||0
379481|NCT01951820|931529|P2|COMPLETED|Overall Study||30
379482|NCT01951820|931530|P1|COMPLETED|Overall Study||34
379483|NCT01951820|931529|P2|STARTED|Overall Study||30
379484|NCT01951820|931530|P1|STARTED|Overall Study||34
379485|NCT01951703|931538|P2|NOT COMPLETED|Second Intervention||2
379486|NCT01951703|931539|P1|NOT COMPLETED|Second Intervention||0
379487|NCT01951703|931538|P2|COMPLETED|Second Intervention||60
379488|NCT01951703|931539|P1|COMPLETED|Second Intervention||61
379489|NCT01951703|931538|P2|STARTED|Second Intervention||62
379490|NCT01951703|931539|P1|STARTED|Second Intervention||61
379491|NCT01951703|931538|P2|NOT COMPLETED|First Intervention||1
379492|NCT01951703|931539|P1|NOT COMPLETED|First Intervention||3
379493|NCT01951703|931538|P2|COMPLETED|First Intervention||62
379494|NCT01951703|931539|P1|COMPLETED|First Intervention||61
379495|NCT01951703|931538|P2|STARTED|First Intervention||63
379496|NCT01951703|931539|P1|STARTED|First Intervention||64
379497|NCT01951651|931549|P2|NOT COMPLETED|Overall Study||2
379498|NCT01951651|931550|P1|NOT COMPLETED|Overall Study||4
379499|NCT01951651|931549|P2|COMPLETED|Overall Study||10
379500|NCT01951651|931550|P1|COMPLETED|Overall Study||8
379501|NCT01951651|931549|P2|STARTED|Overall Study||12
379502|NCT01951651|931550|P1|STARTED|Overall Study||12
379503|NCT01951586|931564|P2|NOT COMPLETED|Overall Study||113
379504|NCT01951586|931565|P1|NOT COMPLETED|Overall Study||59
379505|NCT01951586|931564|P2|COMPLETED|Overall Study||35
379506|NCT01951586|931565|P1|COMPLETED|Overall Study||19
379507|NCT01951586|931564|P2|Received Study Drug|Overall Study||145
379508|NCT01951586|931565|P1|Received Study Drug|Overall Study||76
379509|NCT01951586|931564|P2|STARTED|Overall Study||148
379510|NCT01951586|931565|P1|STARTED|Overall Study||78
379511|NCT01951573|931589|P2|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0
379512|NCT01951573|931590|P1|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0
379513|NCT01951573|931589|P2|COMPLETED|Period 2, Second 9 Hours of Wear||16
379514|NCT01951573|931590|P1|COMPLETED|Period 2, Second 9 Hours of Wear||17
379515|NCT01951573|931589|P2|STARTED|Period 2, Second 9 Hours of Wear||16
379516|NCT01951573|931590|P1|STARTED|Period 2, Second 9 Hours of Wear||17
379517|NCT01951573|931589|P2|NOT COMPLETED|Washout Period||1
379518|NCT01951573|931590|P1|NOT COMPLETED|Washout Period||0
379519|NCT01951573|931589|P2|COMPLETED|Washout Period||16
379520|NCT01951573|931590|P1|COMPLETED|Washout Period||17
379521|NCT01951573|931589|P2|STARTED|Washout Period||17
379522|NCT01951573|931590|P1|STARTED|Washout Period||17
379523|NCT01951573|931589|P2|NOT COMPLETED|Period 1, First 9 Hours of Wear||0
379524|NCT01951573|931590|P1|NOT COMPLETED|Period 1, First 9 Hours of Wear||0
379525|NCT01951573|931589|P2|COMPLETED|Period 1, First 9 Hours of Wear||17
379526|NCT01951573|931590|P1|COMPLETED|Period 1, First 9 Hours of Wear||17
379527|NCT01951573|931589|P2|STARTED|Period 1, First 9 Hours of Wear||17
379528|NCT01951573|931590|P1|STARTED|Period 1, First 9 Hours of Wear||17
379529|NCT01951417|931600|P1|NOT COMPLETED|Overall Study||9
379530|NCT01951417|931600|P1|COMPLETED|Overall Study||72
379531|NCT01951417|931600|P1|STARTED|Overall Study||81
379532|NCT01951170|931623|P1|NOT COMPLETED|Overall Study||1
379533|NCT01951170|931623|P1|COMPLETED|Overall Study||51
379534|NCT01951170|931623|P1|STARTED|Overall Study||52
379535|NCT01951092|931646|P1|NOT COMPLETED|Overall Study||12
379536|NCT01951092|931646|P1|COMPLETED|Overall Study||20
379537|NCT01951092|931646|P1|STARTED|Overall Study||32
379538|NCT01951066|931651|P2|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0
379539|NCT01951066|931652|P1|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0
379540|NCT01951066|931651|P2|COMPLETED|Second Intervention (Week 16 to Week 32)||10
379541|NCT01951066|931652|P1|COMPLETED|Second Intervention (Week 16 to Week 32)||10
379542|NCT01951066|931651|P2|STARTED|Second Intervention (Week 16 to Week 32)||10
379543|NCT01951066|931652|P1|STARTED|Second Intervention (Week 16 to Week 32)||10
379544|NCT01951066|931651|P2|NOT COMPLETED|First Intervention (Baseline to Week 16)||0
379545|NCT01951066|931652|P1|NOT COMPLETED|First Intervention (Baseline to Week 16)||0
379546|NCT01951066|931651|P2|COMPLETED|First Intervention (Baseline to Week 16)||10
379547|NCT01951066|931652|P1|COMPLETED|First Intervention (Baseline to Week 16)||10
379548|NCT01951066|931651|P2|STARTED|First Intervention (Baseline to Week 16)||10
379549|NCT01951066|931652|P1|STARTED|First Intervention (Baseline to Week 16)||10
379550|NCT01950741|931657|P1|NOT COMPLETED|Overall Study||3
379551|NCT01950741|931657|P1|COMPLETED|Overall Study||45
379552|NCT01950741|931657|P1|STARTED|Overall Study||48
379553|NCT01950663|931666|P1|NOT COMPLETED|Overall Study||1
379554|NCT01950663|931666|P1|COMPLETED|Overall Study||467
379555|NCT01950663|931666|P1|STARTED|Overall Study||468
379556|NCT01950364|931672|P2|NOT COMPLETED|Overall Study||10
379557|NCT01950364|931673|P1|NOT COMPLETED|Overall Study||10
379558|NCT01950364|931672|P2|COMPLETED|Overall Study||0
379559|NCT01950364|931673|P1|COMPLETED|Overall Study||0
379560|NCT01950364|931672|P2|STARTED|Overall Study||10
379561|NCT01950364|931673|P1|STARTED|Overall Study||10
379562|NCT01950078|931773|P2|NOT COMPLETED|Overall Study||12
379563|NCT01950078|931774|P1|NOT COMPLETED|Overall Study||20
379564|NCT01950078|931773|P2|COMPLETED|Overall Study||496
379565|NCT01950078|931774|P1|COMPLETED|Overall Study||1005
379566|NCT01950078|931773|P2|STARTED|Overall Study||508
379567|NCT01950078|931774|P1|STARTED|Overall Study||1025
379568|NCT01949870|931782|P1|NOT COMPLETED|Overall Study||6
379569|NCT01949870|931782|P1|COMPLETED|Overall Study||0
379570|NCT01949870|931782|P1|Received Treatment|Overall Study||4
379571|NCT01949870|931782|P1|STARTED|Overall Study||6
379572|NCT01949844|931786|P1|NOT COMPLETED|Overall Study||0
379573|NCT01949844|931786|P1|COMPLETED|Overall Study||44
379574|NCT01949844|931786|P1|STARTED|Overall Study||44
379575|NCT01949545|931794|P4|NOT COMPLETED|Overall Study||0
379576|NCT01949545|931795|P3|NOT COMPLETED|Overall Study||0
379577|NCT01949545|931796|P2|NOT COMPLETED|Overall Study||0
379578|NCT01949545|931797|P1|NOT COMPLETED|Overall Study||0
379579|NCT01949545|931794|P4|COMPLETED|Overall Study||4
379580|NCT01949545|931795|P3|COMPLETED|Overall Study||14
379581|NCT01949545|931796|P2|COMPLETED|Overall Study||17
379582|NCT01949545|931797|P1|COMPLETED|Overall Study||11
379583|NCT01949545|931794|P4|STARTED|Overall Study||4
379584|NCT01949545|931795|P3|STARTED|Overall Study||14
379585|NCT01949545|931796|P2|STARTED|Overall Study||17
379586|NCT01949545|931797|P1|STARTED|Overall Study||11
379587|NCT01949532|931945|P2|NOT COMPLETED|Overall Study||3
379588|NCT01949532|931946|P1|NOT COMPLETED|Overall Study||3
379589|NCT01949532|931945|P2|COMPLETED|Overall Study||8
379590|NCT01949532|931946|P1|COMPLETED|Overall Study||12
379591|NCT01949532|931945|P2|STARTED|Overall Study||11
379592|NCT01949532|931946|P1|STARTED|Overall Study||15
379593|NCT01949389|932014|P1|NOT COMPLETED|Overall Study||0
379594|NCT01949389|932014|P1|COMPLETED|Overall Study||51
379595|NCT01949389|932014|P1|STARTED|Overall Study||51
379596|NCT01949155|932021|P2|NOT COMPLETED|Overall Study||0
379597|NCT01949155|932022|P1|NOT COMPLETED|Overall Study||2
379598|NCT01949155|932021|P2|COMPLETED|Overall Study||88
379599|NCT01949155|932022|P1|COMPLETED|Overall Study||176
379600|NCT01949155|932021|P2|STARTED|Overall Study||88
379601|NCT01949155|932022|P1|STARTED|Overall Study||178
379602|NCT01949142|932034|P2|NOT COMPLETED|Overall Study||1
379603|NCT01949142|932035|P1|NOT COMPLETED|Overall Study||3
379604|NCT01949142|932034|P2|COMPLETED|Overall Study||86
379605|NCT01949142|932035|P1|COMPLETED|Overall Study||176
379606|NCT01949142|932034|P2|STARTED|Overall Study||87
379607|NCT01949142|932035|P1|STARTED|Overall Study||179
379608|NCT01949116|932047|P2|NOT COMPLETED|Overall Study||6
379609|NCT01949116|932048|P1|NOT COMPLETED|Overall Study||8
379610|NCT01949116|932047|P2|COMPLETED|Overall Study||84
379611|NCT01949116|932048|P1|COMPLETED|Overall Study||78
379612|NCT01949116|932047|P2|STARTED|Overall Study||90
379613|NCT01949116|932048|P1|STARTED|Overall Study||86
379614|NCT01949090|932085|P5|NOT COMPLETED|Overall Study||4
379615|NCT01949090|932086|P4|NOT COMPLETED|Overall Study||1
379616|NCT01949090|932087|P3|NOT COMPLETED|Overall Study||2
379617|NCT01949090|932088|P2|NOT COMPLETED|Overall Study||2
379618|NCT01949090|932089|P1|NOT COMPLETED|Overall Study||4
379619|NCT01949090|932085|P5|COMPLETED|Overall Study||116
379620|NCT01949090|932086|P4|COMPLETED|Overall Study||59
379621|NCT01949090|932087|P3|COMPLETED|Overall Study||58
379622|NCT01949090|932088|P2|COMPLETED|Overall Study||58
379623|NCT01949090|932089|P1|COMPLETED|Overall Study||56
379624|NCT01949090|932085|P5|STARTED|Overall Study||120
379625|NCT01949090|932086|P4|STARTED|Overall Study||60
379626|NCT01949090|932087|P3|STARTED|Overall Study||60
379627|NCT01949090|932088|P2|STARTED|Overall Study||60
379628|NCT01949090|932089|P1|STARTED|Overall Study||60
379629|NCT01949051|932266|P6|NOT COMPLETED|Treatment Period 3 (7 Days)||0
379630|NCT01949051|932267|P5|NOT COMPLETED|Treatment Period 3 (7 Days)||0
379631|NCT01949051|932268|P4|NOT COMPLETED|Treatment Period 3 (7 Days)||0
379632|NCT01949051|932269|P3|NOT COMPLETED|Treatment Period 3 (7 Days)||0
379633|NCT01949051|932270|P2|NOT COMPLETED|Treatment Period 3 (7 Days)||0
379634|NCT01949051|932271|P1|NOT COMPLETED|Treatment Period 3 (7 Days)||0
379635|NCT01949051|932266|P6|COMPLETED|Treatment Period 3 (7 Days)||12
379636|NCT01949051|932267|P5|COMPLETED|Treatment Period 3 (7 Days)||13
379637|NCT01949051|932268|P4|COMPLETED|Treatment Period 3 (7 Days)||12
379638|NCT01949051|932269|P3|COMPLETED|Treatment Period 3 (7 Days)||12
379639|NCT01949051|932270|P2|COMPLETED|Treatment Period 3 (7 Days)||12
379640|NCT01949051|932271|P1|COMPLETED|Treatment Period 3 (7 Days)||11
379641|NCT01949051|932266|P6|STARTED|Treatment Period 3 (7 Days)||12
379642|NCT01949051|932267|P5|STARTED|Treatment Period 3 (7 Days)||13
379643|NCT01949051|932268|P4|STARTED|Treatment Period 3 (7 Days)||12
379644|NCT01949051|932269|P3|STARTED|Treatment Period 3 (7 Days)||12
379645|NCT01949051|932270|P2|STARTED|Treatment Period 3 (7 Days)||12
379646|NCT01949051|932271|P1|STARTED|Treatment Period 3 (7 Days)||11
379647|NCT01949051|932266|P6|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
379648|NCT01949051|932267|P5|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
379649|NCT01949051|932268|P4|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
379650|NCT01949051|932269|P3|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
379651|NCT01949051|932270|P2|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
379652|NCT01949051|932271|P1|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
379653|NCT01949051|932266|P6|COMPLETED|Washout Period 2 (14 to 20 Days)||12
379654|NCT01949051|932267|P5|COMPLETED|Washout Period 2 (14 to 20 Days)||13
379655|NCT01949051|932268|P4|COMPLETED|Washout Period 2 (14 to 20 Days)||12
379656|NCT01949051|932269|P3|COMPLETED|Washout Period 2 (14 to 20 Days)||12
379657|NCT01949051|932270|P2|COMPLETED|Washout Period 2 (14 to 20 Days)||12
379658|NCT01949051|932271|P1|COMPLETED|Washout Period 2 (14 to 20 Days)||11
379659|NCT01949051|932266|P6|STARTED|Washout Period 2 (14 to 20 Days)||12
379660|NCT01949051|932267|P5|STARTED|Washout Period 2 (14 to 20 Days)||13
379661|NCT01949051|932268|P4|STARTED|Washout Period 2 (14 to 20 Days)||12
379662|NCT01949051|932269|P3|STARTED|Washout Period 2 (14 to 20 Days)||12
379663|NCT01949051|932270|P2|STARTED|Washout Period 2 (14 to 20 Days)||12
379664|NCT01949051|932271|P1|STARTED|Washout Period 2 (14 to 20 Days)||11
379665|NCT01949051|932266|P6|NOT COMPLETED|Treatment Period 2 (7 Days)||1
379666|NCT01949051|932267|P5|NOT COMPLETED|Treatment Period 2 (7 Days)||0
379667|NCT01949051|932268|P4|NOT COMPLETED|Treatment Period 2 (7 Days)||0
379668|NCT01949051|932269|P3|NOT COMPLETED|Treatment Period 2 (7 Days)||1
379669|NCT01949051|932270|P2|NOT COMPLETED|Treatment Period 2 (7 Days)||1
379670|NCT01949051|932271|P1|NOT COMPLETED|Treatment Period 2 (7 Days)||0
379671|NCT01949051|932266|P6|COMPLETED|Treatment Period 2 (7 Days)||12
379672|NCT01949051|932267|P5|COMPLETED|Treatment Period 2 (7 Days)||13
379673|NCT01949051|932268|P4|COMPLETED|Treatment Period 2 (7 Days)||12
379674|NCT01949051|932269|P3|COMPLETED|Treatment Period 2 (7 Days)||12
379675|NCT01949051|932270|P2|COMPLETED|Treatment Period 2 (7 Days)||12
379676|NCT01949051|932271|P1|COMPLETED|Treatment Period 2 (7 Days)||11
379677|NCT01949051|932266|P6|STARTED|Treatment Period 2 (7 Days)||13
379678|NCT01949051|932267|P5|STARTED|Treatment Period 2 (7 Days)||13
379679|NCT01949051|932268|P4|STARTED|Treatment Period 2 (7 Days)||12
379680|NCT01949051|932269|P3|STARTED|Treatment Period 2 (7 Days)||13
379681|NCT01949051|932270|P2|STARTED|Treatment Period 2 (7 Days)||13
379682|NCT01949051|932271|P1|STARTED|Treatment Period 2 (7 Days)||11
379683|NCT01949051|932266|P6|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
379684|NCT01949051|932267|P5|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
379685|NCT01949051|932268|P4|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
379686|NCT01949051|932269|P3|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
379687|NCT01949051|932270|P2|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
379688|NCT01949051|932271|P1|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
379689|NCT01949051|932266|P6|COMPLETED|Washout Period 1 (14 to 20 Days)||13
379690|NCT01949051|932267|P5|COMPLETED|Washout Period 1 (14 to 20 Days)||13
379691|NCT01949051|932268|P4|COMPLETED|Washout Period 1 (14 to 20 Days)||12
379692|NCT01949051|932269|P3|COMPLETED|Washout Period 1 (14 to 20 Days)||13
379693|NCT01949051|932270|P2|COMPLETED|Washout Period 1 (14 to 20 Days)||13
379694|NCT01949051|932271|P1|COMPLETED|Washout Period 1 (14 to 20 Days)||11
379695|NCT01949051|932266|P6|STARTED|Washout Period 1 (14 to 20 Days)||13
379696|NCT01949051|932267|P5|STARTED|Washout Period 1 (14 to 20 Days)||13
379697|NCT01949051|932268|P4|STARTED|Washout Period 1 (14 to 20 Days)||12
379698|NCT01949051|932269|P3|STARTED|Washout Period 1 (14 to 20 Days)||13
379699|NCT01949051|932270|P2|STARTED|Washout Period 1 (14 to 20 Days)||13
379700|NCT01949051|932271|P1|STARTED|Washout Period 1 (14 to 20 Days)||11
379701|NCT01949051|932266|P6|NOT COMPLETED|Treatment Period 1 (7 Days)||0
379702|NCT01949051|932267|P5|NOT COMPLETED|Treatment Period 1 (7 Days)||0
379703|NCT01949051|932268|P4|NOT COMPLETED|Treatment Period 1 (7 Days)||1
379704|NCT01949051|932269|P3|NOT COMPLETED|Treatment Period 1 (7 Days)||0
379705|NCT01949051|932270|P2|NOT COMPLETED|Treatment Period 1 (7 Days)||0
379706|NCT01949051|932271|P1|NOT COMPLETED|Treatment Period 1 (7 Days)||2
379707|NCT01949051|932266|P6|COMPLETED|Treatment Period 1 (7 Days)||13
379708|NCT01949051|932267|P5|COMPLETED|Treatment Period 1 (7 Days)||13
379709|NCT01949051|932268|P4|COMPLETED|Treatment Period 1 (7 Days)||12
379710|NCT01949051|932269|P3|COMPLETED|Treatment Period 1 (7 Days)||13
379711|NCT01949051|932270|P2|COMPLETED|Treatment Period 1 (7 Days)||13
379712|NCT01949051|932271|P1|COMPLETED|Treatment Period 1 (7 Days)||11
379713|NCT01949051|932266|P6|STARTED|Treatment Period 1 (7 Days)||13
379714|NCT01949051|932267|P5|STARTED|Treatment Period 1 (7 Days)||13
379715|NCT01949051|932268|P4|STARTED|Treatment Period 1 (7 Days)||13
379716|NCT01949051|932269|P3|STARTED|Treatment Period 1 (7 Days)||13
379717|NCT01949051|932270|P2|STARTED|Treatment Period 1 (7 Days)||13
379718|NCT01949051|932271|P1|STARTED|Treatment Period 1 (7 Days)||13
379719|NCT01948947|932284|P2|NOT COMPLETED|Overall Study||0
379720|NCT01948947|932285|P1|NOT COMPLETED|Overall Study||0
379721|NCT01948947|932284|P2|COMPLETED|Overall Study||15
379722|NCT01948947|932285|P1|COMPLETED|Overall Study||14
379723|NCT01948947|932284|P2|STARTED|Overall Study||15
379724|NCT01948947|932285|P1|STARTED|Overall Study||14
379725|NCT01948908|932300|P3|NOT COMPLETED|Overall Study||2
379726|NCT01948908|932301|P2|NOT COMPLETED|Overall Study||0
379727|NCT01948908|932302|P1|NOT COMPLETED|Overall Study||1
379728|NCT01948908|932300|P3|COMPLETED|Overall Study||31
379729|NCT01948908|932301|P2|COMPLETED|Overall Study||33
379730|NCT01948908|932302|P1|COMPLETED|Overall Study||32
379731|NCT01948908|932300|P3|STARTED|Overall Study||33
379732|NCT01948908|932301|P2|STARTED|Overall Study||33
379733|NCT01948908|932302|P1|STARTED|Overall Study||33
379734|NCT01948830|932318|P2|NOT COMPLETED|Overall Study||32
379735|NCT01948830|932319|P1|NOT COMPLETED|Overall Study||33
379736|NCT01948830|932318|P2|COMPLETED|Overall Study||295
379737|NCT01948830|932319|P1|COMPLETED|Overall Study||290
379738|NCT01948830|932318|P2|Safety Set|Overall Study||326
379739|NCT01948830|932319|P1|Safety Set|Overall Study||323
379740|NCT01948830|932318|P2|STARTED|Overall Study||327
379741|NCT01948830|932319|P1|STARTED|Overall Study||323
379742|NCT01948791|932351|P1|NOT COMPLETED|Overall Study||71
379743|NCT01948791|932351|P1|COMPLETED|Overall Study||151
379744|NCT01948791|932351|P1|STARTED|Overall Study||222
379745|NCT01948518|932359|P1|NOT COMPLETED|Overall Study||0
379746|NCT01948518|932359|P1|COMPLETED|Overall Study||15
379747|NCT01948518|932359|P1|STARTED|Overall Study||15
379748|NCT01948375|932366|P2|NOT COMPLETED|Overall Study||0
379749|NCT01948375|932367|P1|NOT COMPLETED|Overall Study||0
379750|NCT01948375|932366|P2|COMPLETED|Overall Study||30
379751|NCT01948375|932367|P1|COMPLETED|Overall Study||30
379752|NCT01948375|932366|P2|STARTED|Overall Study||30
379753|NCT01948375|932367|P1|STARTED|Overall Study||30
379754|NCT01948310|932383|P2|NOT COMPLETED|Overall Study||5
379755|NCT01948310|932384|P1|NOT COMPLETED|Overall Study||3
379756|NCT01948310|932383|P2|COMPLETED|Overall Study||13
379757|NCT01948310|932384|P1|COMPLETED|Overall Study||16
379758|NCT01948310|932383|P2|STARTED|Overall Study||18
379759|NCT01948310|932384|P1|STARTED|Overall Study||19
379760|NCT01948193|932394|P1|NOT COMPLETED|Overall Study||9
379761|NCT01948193|932394|P1|COMPLETED|Overall Study||168
379762|NCT01948193|932394|P1|STARTED|Overall Study||177
379763|NCT01948141|932403|P1|NOT COMPLETED|Overall Study||0
379764|NCT01948141|932403|P1|COMPLETED|Overall Study||6
379765|NCT01948141|932403|P1|STARTED|Overall Study||6
379766|NCT01948076|932416|P2|NOT COMPLETED|Overall Study||1
379767|NCT01948076|932417|P1|NOT COMPLETED|Overall Study||0
379768|NCT01948076|932416|P2|COMPLETED|Overall Study||19
379769|NCT01948076|932417|P1|COMPLETED|Overall Study||20
379770|NCT01948076|932416|P2|STARTED|Overall Study||20
379771|NCT01948076|932417|P1|STARTED|Overall Study||20
379772|NCT01948063|932427|P2|NOT COMPLETED|Overall Study||2
379773|NCT01948063|932428|P1|NOT COMPLETED|Overall Study||1
379774|NCT01948063|932427|P2|COMPLETED|Overall Study||19
379775|NCT01948063|932428|P1|COMPLETED|Overall Study||19
379776|NCT01948063|932427|P2|STARTED|Overall Study||21
379777|NCT01948063|932428|P1|STARTED|Overall Study||20
379778|NCT01948050|932436|P2|NOT COMPLETED|Overall Study||1
379779|NCT01948050|932437|P1|NOT COMPLETED|Overall Study||0
379780|NCT01948050|932436|P2|COMPLETED|Overall Study||7
379781|NCT01948050|932437|P1|COMPLETED|Overall Study||16
379782|NCT01948050|932436|P2|STARTED|Overall Study||8
379783|NCT01948050|932437|P1|STARTED|Overall Study||16
379784|NCT01947946|932446|P3|NOT COMPLETED|Overall Study||5
379785|NCT01947946|932447|P2|NOT COMPLETED|Overall Study||5
379786|NCT01947946|932448|P1|NOT COMPLETED|Overall Study||3
379787|NCT01947946|932446|P3|COMPLETED|Overall Study||0
379788|NCT01947946|932447|P2|COMPLETED|Overall Study||0
379789|NCT01947946|932448|P1|COMPLETED|Overall Study|Study Stopped|0
379790|NCT01947946|932446|P3|STARTED|Overall Study||5
379791|NCT01947946|932447|P2|STARTED|Overall Study||5
379792|NCT01947946|932448|P1|STARTED|Overall Study||3
379793|NCT01947907|932460|P4|NOT COMPLETED|Overall Study||0
379794|NCT01947907|932461|P3|NOT COMPLETED|Overall Study||0
379795|NCT01947907|932462|P2|NOT COMPLETED|Overall Study||0
379796|NCT01947907|932463|P1|NOT COMPLETED|Overall Study||0
379797|NCT01947907|932460|P4|COMPLETED|Overall Study||13
379798|NCT01947907|932461|P3|COMPLETED|Overall Study||14
379799|NCT01947907|932462|P2|COMPLETED|Overall Study||14
379800|NCT01947907|932463|P1|COMPLETED|Overall Study||12
379801|NCT01947907|932460|P4|STARTED|Overall Study||13
379802|NCT01947907|932461|P3|STARTED|Overall Study||14
379803|NCT01947907|932462|P2|STARTED|Overall Study||14
379804|NCT01947907|932463|P1|STARTED|Overall Study||12
379805|NCT01947855|932505|P3|NOT COMPLETED|Overall Study||0
379806|NCT01947855|932506|P2|NOT COMPLETED|Overall Study||0
379807|NCT01947855|932507|P1|NOT COMPLETED|Overall Study||1
379808|NCT01947855|932505|P3|COMPLETED|Overall Study||19
379809|NCT01947855|932506|P2|COMPLETED|Overall Study||20
379810|NCT01947855|932507|P1|COMPLETED|Overall Study||20
379811|NCT01947855|932505|P3|STARTED|Overall Study||19
379812|NCT01947855|932506|P2|STARTED|Overall Study||20
379813|NCT01947855|932507|P1|STARTED|Overall Study||21
379814|NCT01947582|932515|P1|NOT COMPLETED|Overall Study||1
379815|NCT01947582|932515|P1|COMPLETED|Overall Study||1
379816|NCT01947582|932515|P1|STARTED|Overall Study||2
379817|NCT01947517|932524|P2|NOT COMPLETED|Overall Study||1
379818|NCT01947517|932525|P1|NOT COMPLETED|Overall Study||1
379819|NCT01947517|932524|P2|COMPLETED|Overall Study||25
379820|NCT01947517|932525|P1|COMPLETED|Overall Study||25
379821|NCT01947517|932524|P2|STARTED|Overall Study||26
379822|NCT01947517|932525|P1|STARTED|Overall Study||26
379823|NCT01947491|932543|P4|NOT COMPLETED|Overall Study||5
379824|NCT01947491|932544|P3|NOT COMPLETED|Overall Study||2
379825|NCT01947491|932545|P2|NOT COMPLETED|Overall Study||6
379826|NCT01947491|932546|P1|NOT COMPLETED|Overall Study||8
379827|NCT01947491|932543|P4|COMPLETED|Overall Study||38
379828|NCT01947491|932544|P3|COMPLETED|Overall Study||88
379829|NCT01947491|932545|P2|COMPLETED|Overall Study||81
379830|NCT01947491|932546|P1|COMPLETED|Overall Study||166
379831|NCT01947491|932543|P4|STARTED|Overall Study||43
379832|NCT01947491|932544|P3|STARTED|Overall Study||90
379833|NCT01947491|932545|P2|STARTED|Overall Study||87
379834|NCT01947491|932546|P1|STARTED|Overall Study||174
379835|NCT01947335|932558|P2|NOT COMPLETED|Overall Study||0
379836|NCT01947335|932559|P1|NOT COMPLETED|Overall Study||0
379837|NCT01947335|932558|P2|COMPLETED|Overall Study||41
379838|NCT01947335|932559|P1|COMPLETED|Overall Study||42
379839|NCT01947335|932558|P2|STARTED|Overall Study||41
379840|NCT01947335|932559|P1|STARTED|Overall Study||42
379841|NCT01947153|932569|P2|NOT COMPLETED|Test Period 2||0
379842|NCT01947153|932570|P1|NOT COMPLETED|Test Period 2||0
379843|NCT01947153|932569|P2|COMPLETED|Test Period 2||18
379844|NCT01947153|932570|P1|COMPLETED|Test Period 2||18
379845|NCT01947153|932569|P2|STARTED|Test Period 2||18
379846|NCT01947153|932570|P1|STARTED|Test Period 2||18
379847|NCT01947153|932569|P2|NOT COMPLETED|Test Period 1||0
379848|NCT01947153|932570|P1|NOT COMPLETED|Test Period 1||0
379849|NCT01947153|932569|P2|COMPLETED|Test Period 1||18
379850|NCT01947153|932570|P1|COMPLETED|Test Period 1||18
379851|NCT01947153|932569|P2|STARTED|Test Period 1||18
379852|NCT01947153|932570|P1|STARTED|Test Period 1||18
379853|NCT01947127|932590|P2|NOT COMPLETED|Overall Study||43
379854|NCT01947127|932591|P1|NOT COMPLETED|Overall Study||23
379855|NCT01947127|932590|P2|COMPLETED|Overall Study||249
379856|NCT01947127|932591|P1|COMPLETED|Overall Study||143
379857|NCT01947127|932590|P2|STARTED|Overall Study||292
379858|NCT01947127|932591|P1|STARTED|Overall Study||166
379859|NCT01946542|932603|P2|NOT COMPLETED|Testing Visit 2||0
379860|NCT01946542|932604|P1|NOT COMPLETED|Testing Visit 2||0
379861|NCT01946542|932603|P2|COMPLETED|Testing Visit 2||1
379862|NCT01946542|932604|P1|COMPLETED|Testing Visit 2||1
379863|NCT01946542|932603|P2|STARTED|Testing Visit 2||1
379864|NCT01946542|932604|P1|STARTED|Testing Visit 2||1
379865|NCT01946542|932603|P2|NOT COMPLETED|Testing Visit 1||0
379866|NCT01946542|932604|P1|NOT COMPLETED|Testing Visit 1||0
379867|NCT01946542|932603|P2|COMPLETED|Testing Visit 1||1
379868|NCT01946542|932604|P1|COMPLETED|Testing Visit 1||1
379869|NCT01946542|932603|P2|STARTED|Testing Visit 1||1
379870|NCT01946542|932604|P1|STARTED|Testing Visit 1||1
379871|NCT01946529|932615|P3|NOT COMPLETED|Completion of All Therapy||6
379872|NCT01946529|932616|P2|NOT COMPLETED|Completion of All Therapy||16
379873|NCT01946529|932617|P1|NOT COMPLETED|Completion of All Therapy||1
379874|NCT01946529|932615|P3|COMPLETED|Completion of All Therapy||0
379875|NCT01946529|932616|P2|COMPLETED|Completion of All Therapy||0
379876|NCT01946529|932617|P1|COMPLETED|Completion of All Therapy||0
379877|NCT01946529|932615|P3|STARTED|Completion of All Therapy||6
379878|NCT01946529|932616|P2|STARTED|Completion of All Therapy||16
379879|NCT01946529|932617|P1|STARTED|Completion of All Therapy||1
379880|NCT01946529|932615|P3|NOT COMPLETED|End of Window Therapy (2 Courses)||0
379881|NCT01946529|932616|P2|NOT COMPLETED|End of Window Therapy (2 Courses)||1
379882|NCT01946529|932617|P1|NOT COMPLETED|End of Window Therapy (2 Courses)||0
379883|NCT01946529|932615|P3|COMPLETED|End of Window Therapy (2 Courses)||6
379884|NCT01946529|932616|P2|COMPLETED|End of Window Therapy (2 Courses)||16
379885|NCT01946529|932617|P1|COMPLETED|End of Window Therapy (2 Courses)||1
379886|NCT01946529|932615|P3|STARTED|End of Window Therapy (2 Courses)||6
379887|NCT01946529|932616|P2|STARTED|End of Window Therapy (2 Courses)||17
379888|NCT01946529|932617|P1|STARTED|End of Window Therapy (2 Courses)||1
379889|NCT01946438|932628|P4|NOT COMPLETED|Overall Study||1
379890|NCT01946438|932629|P3|NOT COMPLETED|Overall Study||1
379891|NCT01946438|932630|P2|NOT COMPLETED|Overall Study||0
379892|NCT01946438|932631|P1|NOT COMPLETED|Overall Study||2
379893|NCT01946438|932628|P4|COMPLETED|Overall Study||51
379894|NCT01946438|932629|P3|COMPLETED|Overall Study||51
379895|NCT01946438|932630|P2|COMPLETED|Overall Study||52
379896|NCT01946438|932631|P1|COMPLETED|Overall Study||50
379897|NCT01946438|932628|P4|STARTED|Overall Study||52
379898|NCT01946438|932629|P3|STARTED|Overall Study||52
379899|NCT01946438|932630|P2|STARTED|Overall Study||52
379900|NCT01946438|932631|P1|STARTED|Overall Study||52
379901|NCT01946425|932659|P2|NOT COMPLETED|Overall Study||0
379902|NCT01946425|932660|P1|NOT COMPLETED|Overall Study||2
379903|NCT01946425|932659|P2|COMPLETED|Overall Study||30
379904|NCT01946425|932660|P1|COMPLETED|Overall Study||28
379905|NCT01946425|932659|P2|STARTED|Overall Study||30
379906|NCT01946425|932660|P1|STARTED|Overall Study||30
379907|NCT01946412|932674|P1|NOT COMPLETED|Overall Study||5
379908|NCT01946412|932674|P1|COMPLETED|Overall Study||28
379909|NCT01946412|932674|P1|STARTED|Overall Study||33
379910|NCT01946243|932696|P1|NOT COMPLETED|Overall Study||0
379911|NCT01946243|932696|P1|COMPLETED|Overall Study||96
379912|NCT01946243|932696|P1|STARTED|Overall Study||96
379913|NCT01946204|932719|P2|NOT COMPLETED|Overall Study||806
379914|NCT01946204|932720|P1|NOT COMPLETED|Overall Study||401
379915|NCT01946204|932719|P2|COMPLETED|Overall Study||0
379916|NCT01946204|932720|P1|COMPLETED|Overall Study||0
379917|NCT01946204|932719|P2|Treated|Overall Study||803
379918|NCT01946204|932720|P1|Treated|Overall Study||398
379919|NCT01946204|932719|P2|STARTED|Overall Study||806
379920|NCT01946204|932720|P1|STARTED|Overall Study||401
379921|NCT01946178|932736|P1|NOT COMPLETED|Overall Study||2
379922|NCT01946178|932736|P1|COMPLETED|Overall Study||71
379923|NCT01946178|932736|P1|STARTED|Overall Study||73
379924|NCT01946126|932746|P2|NOT COMPLETED|Overall Study||0
379925|NCT01946126|932747|P1|NOT COMPLETED|Overall Study||0
379926|NCT01946126|932746|P2|COMPLETED|Overall Study||275
379927|NCT01946126|932747|P1|COMPLETED|Overall Study||184
379928|NCT01946126|932746|P2|STARTED|Overall Study||275
379929|NCT01946126|932747|P1|STARTED|Overall Study||184
379930|NCT01945970|932761|P6|NOT COMPLETED|Overall Study||0
379931|NCT01945970|932762|P5|NOT COMPLETED|Overall Study||0
379932|NCT01945970|932763|P4|NOT COMPLETED|Overall Study||0
379933|NCT01945970|932764|P3|NOT COMPLETED|Overall Study||0
379934|NCT01945970|932765|P2|NOT COMPLETED|Overall Study||0
379935|NCT01945970|932766|P1|NOT COMPLETED|Overall Study||0
379936|NCT01945970|932761|P6|COMPLETED|Overall Study||5
379937|NCT01945970|932762|P5|COMPLETED|Overall Study||5
379938|NCT01945970|932763|P4|COMPLETED|Overall Study||5
379939|NCT01945970|932764|P3|COMPLETED|Overall Study||5
379940|NCT01945970|932765|P2|COMPLETED|Overall Study||5
379941|NCT01945970|932766|P1|COMPLETED|Overall Study||5
379942|NCT01945970|932761|P6|STARTED|Overall Study||5
379943|NCT01945970|932762|P5|STARTED|Overall Study||5
379944|NCT01945970|932763|P4|STARTED|Overall Study||5
379945|NCT01945970|932764|P3|STARTED|Overall Study||5
379946|NCT01945970|932765|P2|STARTED|Overall Study||5
379947|NCT01945970|932766|P1|STARTED|Overall Study||5
379948|NCT01945944|932805|P2|NOT COMPLETED|Overall Study||3
379949|NCT01945944|932806|P1|NOT COMPLETED|Overall Study||1
379950|NCT01945944|932805|P2|COMPLETED|Overall Study||6
379951|NCT01945944|932806|P1|COMPLETED|Overall Study||8
379952|NCT01945944|932805|P2|STARTED|Overall Study||9
379953|NCT01945944|932806|P1|STARTED|Overall Study||9
379954|NCT01945489|932830|P2|NOT COMPLETED|Cycle 2||1
379955|NCT01945489|932831|P1|NOT COMPLETED|Cycle 2||1
379956|NCT01945489|932830|P2|COMPLETED|Cycle 2||106
379957|NCT01945489|932831|P1|COMPLETED|Cycle 2||87
379958|NCT01945489|932830|P2|STARTED|Cycle 2||107
379959|NCT01945489|932831|P1|STARTED|Cycle 2|Not all participants participated in Cycle 2.|88
379960|NCT01945489|932830|P2|NOT COMPLETED|Cycle 1||4
379961|NCT01945489|932831|P1|NOT COMPLETED|Cycle 1||13
379962|NCT01945489|932830|P2|COMPLETED|Cycle 1||121
379963|NCT01945489|932831|P1|COMPLETED|Cycle 1||116
379964|NCT01945489|932830|P2|STARTED|Cycle 1||125
379965|NCT01945489|932831|P1|STARTED|Cycle 1||129
379966|NCT01945294|932851|P4|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||6
379967|NCT01945294|932852|P3|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||8
379968|NCT01945294|932853|P2|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||5
379969|NCT01945294|932854|P1|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0
379970|NCT01945294|932851|P4|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||23
379971|NCT01945294|932852|P3|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97
379972|NCT01945294|932853|P2|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97
379973|NCT01945294|932854|P1|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0
379974|NCT01945294|932851|P4|STARTED|Period 2: BOC+ PR Treatment & Follow-up||29
379975|NCT01945294|932852|P3|STARTED|Period 2: BOC+ PR Treatment & Follow-up||105
379976|NCT01945294|932853|P2|STARTED|Period 2: BOC+ PR Treatment & Follow-up||102
379977|NCT01945294|932854|P1|STARTED|Period 2: BOC+ PR Treatment & Follow-up|Participants were assigned to 1 of the 3 arms after upon the 12-week BOC + PR lead-in.|0
379978|NCT01945294|932851|P4|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
379979|NCT01945294|932852|P3|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
379980|NCT01945294|932853|P2|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
379981|NCT01945294|932854|P1|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||21
379982|NCT01945294|932851|P4|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
379983|NCT01945294|932852|P3|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
379984|NCT01945294|932853|P2|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
379985|NCT01945294|932854|P1|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||236
379986|NCT01945294|932851|P4|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
379987|NCT01945294|932852|P3|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
379988|NCT01945294|932853|P2|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
379989|NCT01945294|932854|P1|STARTED|Period 1: 12-Week PR + BOC Lead-In||257
379990|NCT01945242|932885|P2|NOT COMPLETED|Overall Study||3
379991|NCT01945242|932886|P1|NOT COMPLETED|Overall Study||3
379992|NCT01945242|932885|P2|COMPLETED|Overall Study||120
379993|NCT01945242|932886|P1|COMPLETED|Overall Study||1248
379994|NCT01945242|932885|P2|STARTED|Overall Study||123
379995|NCT01945242|932886|P1|STARTED|Overall Study||1251
379996|NCT01945138|932900|P2|NOT COMPLETED|Overall Study||0
379997|NCT01945138|932901|P1|NOT COMPLETED|Overall Study||0
379998|NCT01945138|932900|P2|COMPLETED|Overall Study||7
379999|NCT01945138|932901|P1|COMPLETED|Overall Study||7
380000|NCT01945138|932900|P2|STARTED|Overall Study||7
380001|NCT01945138|932901|P1|STARTED|Overall Study||7
380002|NCT01945112|932935|P2|NOT COMPLETED|Overall Study||0
380003|NCT01945112|932936|P1|NOT COMPLETED|Overall Study||0
380004|NCT01945112|932935|P2|COMPLETED|Overall Study||51
380005|NCT01945112|932936|P1|COMPLETED|Overall Study||77
380006|NCT01945112|932935|P2|STARTED|Overall Study|total number of sites where tape was applied|51
380007|NCT01945112|932936|P1|STARTED|Overall Study|total number of sites where tape was applied|77
380008|NCT01945086|932944|P3|NOT COMPLETED|Overall Study||2
380009|NCT01945086|932945|P2|NOT COMPLETED|Overall Study||0
380010|NCT01945086|932946|P1|NOT COMPLETED|Overall Study||1
380011|NCT01945086|932944|P3|COMPLETED|Overall Study||26
380012|NCT01945086|932945|P2|COMPLETED|Overall Study||24
380013|NCT01945086|932946|P1|COMPLETED|Overall Study||26
380014|NCT01945086|932944|P3|STARTED|Overall Study||28
380015|NCT01945086|932945|P2|STARTED|Overall Study||24
380016|NCT01945086|932946|P1|STARTED|Overall Study||27
380017|NCT01945034|932990|P3|NOT COMPLETED|Overall Study||7
380018|NCT01945034|932991|P2|NOT COMPLETED|Overall Study||5
380019|NCT01945034|932992|P1|NOT COMPLETED|Overall Study||1
380020|NCT01945034|932990|P3|COMPLETED|Overall Study||145
380021|NCT01945034|932991|P2|COMPLETED|Overall Study||80
380022|NCT01945034|932992|P1|COMPLETED|Overall Study||66
380023|NCT01945034|932990|P3|STARTED|Overall Study||152
380024|NCT01945034|932991|P2|STARTED|Overall Study||85
380025|NCT01945034|932992|P1|STARTED|Overall Study||67
380026|NCT01945021|933042|P1|NOT COMPLETED|Overall Study||47
380027|NCT01945021|933042|P1|COMPLETED|Overall Study|Completed is defined as patients who continued crizotinib at the time of final analysis (ongoing)|80
380028|NCT01945021|933042|P1|Patient Reported Outcome -Evaluable|Overall Study|All patients from the safety population who completed a baseline and >/= 1 post-baseline assessment.|123
380029|NCT01945021|933042|P1|Response Evaluable Population|Overall Study|All patients in the safety population who had an adequate baseline tumor assessment|127
380030|NCT01945021|933042|P1|Safety Population|Overall Study|All enrolled patients who received at least 1 dose of study medication.|127
380123|NCT01943435|933355|P2|NOT COMPLETED|6 Month Follow up||7
380031|NCT01945021|933042|P1|STARTED|Overall Study|127 pts with ROS1+ & ALK negative tumors were consented and started study (2 more were screen fails)|127
380032|NCT01944969|933056|P1|NOT COMPLETED|Overall Study||26
380033|NCT01944969|933056|P1|COMPLETED|Overall Study||0
380034|NCT01944969|933056|P1|STARTED|Overall Study||26
380035|NCT01944878|933069|P2|NOT COMPLETED|Overall Study||0
380036|NCT01944878|933070|P1|NOT COMPLETED|Overall Study||0
380037|NCT01944878|933069|P2|COMPLETED|Overall Study||328
380038|NCT01944878|933070|P1|COMPLETED|Overall Study||127
380039|NCT01944878|933069|P2|STARTED|Overall Study||328
380040|NCT01944878|933070|P1|STARTED|Overall Study||127
380041|NCT01944774|933081|P3|NOT COMPLETED|Overall Study||8
380042|NCT01944774|933082|P2|NOT COMPLETED|Overall Study||8
380043|NCT01944774|933083|P1|NOT COMPLETED|Overall Study||6
380044|NCT01944774|933081|P3|COMPLETED|Overall Study||62
380045|NCT01944774|933082|P2|COMPLETED|Overall Study||60
380046|NCT01944774|933083|P1|COMPLETED|Overall Study||63
380047|NCT01944774|933081|P3|Received Treatment|Overall Study||70
380048|NCT01944774|933082|P2|Received Treatment|Overall Study||67
380049|NCT01944774|933083|P1|Received Treatment|Overall Study||68
380050|NCT01944774|933081|P3|STARTED|Overall Study||70
380051|NCT01944774|933082|P2|STARTED|Overall Study||68
380052|NCT01944774|933083|P1|STARTED|Overall Study||69
380053|NCT01944722|933126|P1|NOT COMPLETED|Overall Study||9515
380054|NCT01944722|933126|P1|COMPLETED|Overall Study||24343
380055|NCT01944722|933126|P1|STARTED|Overall Study||33858
380056|NCT01944670|933160|P1|NOT COMPLETED|Overall Study||2
380057|NCT01944670|933160|P1|COMPLETED|Overall Study||24
380058|NCT01944670|933160|P1|STARTED|Overall Study||26
380059|NCT01944631|933167|P2|NOT COMPLETED|Overall Study||2
380060|NCT01944631|933168|P1|NOT COMPLETED|Overall Study||4
380061|NCT01944631|933167|P2|COMPLETED|Overall Study||98
380062|NCT01944631|933168|P1|COMPLETED|Overall Study||96
380063|NCT01944631|933167|P2|STARTED|Overall Study||100
380064|NCT01944631|933168|P1|STARTED|Overall Study||100
380065|NCT01944462|933184|P1|NOT COMPLETED|Optional Vaccination||0
380066|NCT01944462|933184|P1|COMPLETED|Optional Vaccination||20
380067|NCT01944462|933184|P1|STARTED|Optional Vaccination||20
380068|NCT01944462|933184|P1|NOT COMPLETED|PPPP Educational Program||60
380069|NCT01944462|933184|P1|COMPLETED|PPPP Educational Program||143
380070|NCT01944462|933184|P1|3 Month Follow-Up|PPPP Educational Program||143
380071|NCT01944462|933184|P1|Post-Test|PPPP Educational Program||187
380072|NCT01944462|933184|P1|Baseline|PPPP Educational Program||203
380073|NCT01944462|933184|P1|STARTED|PPPP Educational Program||203
380074|NCT01944345|933193|P1|NOT COMPLETED|Overall Study||0
380075|NCT01944345|933193|P1|COMPLETED|Overall Study||69
380076|NCT01944345|933193|P1|STARTED|Overall Study||69
380077|NCT01944319|933201|P2|NOT COMPLETED|Overall Study||0
380078|NCT01944319|933202|P1|NOT COMPLETED|Overall Study||0
380079|NCT01944319|933201|P2|COMPLETED|Overall Study||39
380080|NCT01944319|933202|P1|COMPLETED|Overall Study||40
380081|NCT01944319|933201|P2|STARTED|Overall Study||39
380082|NCT01944319|933202|P1|STARTED|Overall Study||40
380083|NCT01944098|933214|P2|NOT COMPLETED|Overall Study||0
380084|NCT01944098|933215|P1|NOT COMPLETED|Overall Study||1
380085|NCT01944098|933214|P2|COMPLETED|Overall Study||10
380086|NCT01944098|933215|P1|COMPLETED|Overall Study||9
380087|NCT01944098|933214|P2|STARTED|Overall Study||10
380088|NCT01944098|933215|P1|STARTED|Overall Study||10
380089|NCT01944059|933227|P1|NOT COMPLETED|Overall Study||7
380090|NCT01944059|933227|P1|COMPLETED|Overall Study||24
380091|NCT01944059|933227|P1|STARTED|Overall Study||31
380092|NCT01943864|933236|P1|NOT COMPLETED|Overall Study||0
380093|NCT01943864|933236|P1|COMPLETED|Overall Study|Death or 1 year from randomization after progression was considered completion; 20 participants died|20
380094|NCT01943864|933236|P1|STARTED|Overall Study||20
380095|NCT01943565|933267|P3|NOT COMPLETED|Overall Study||0
380096|NCT01943565|933268|P2|NOT COMPLETED|Overall Study||0
380097|NCT01943565|933269|P1|NOT COMPLETED|Overall Study||0
380098|NCT01943565|933267|P3|COMPLETED|Overall Study||9
380099|NCT01943565|933268|P2|COMPLETED|Overall Study||9
380100|NCT01943565|933269|P1|COMPLETED|Overall Study||11
380101|NCT01943565|933267|P3|STARTED|Overall Study||9
380102|NCT01943565|933268|P2|STARTED|Overall Study||9
380103|NCT01943565|933269|P1|STARTED|Overall Study||11
380104|NCT01943552|933300|P2|NOT COMPLETED|Overall Study||25
380105|NCT01943552|933301|P1|NOT COMPLETED|Overall Study||25
380106|NCT01943552|933300|P2|COMPLETED|Overall Study||69
380107|NCT01943552|933301|P1|COMPLETED|Overall Study||71
380108|NCT01943552|933300|P2|STARTED|Overall Study||94
380109|NCT01943552|933301|P1|STARTED|Overall Study|One patient was randomised to the placebo group, but received nebulized ipratropium bromide.|96
380110|NCT01943539|933317|P2|NOT COMPLETED|Overall Study||0
380111|NCT01943539|933318|P1|NOT COMPLETED|Overall Study||4
380112|NCT01943539|933317|P2|COMPLETED|Overall Study||40
380113|NCT01943539|933318|P1|COMPLETED|Overall Study||40
380114|NCT01943539|933317|P2|STARTED|Overall Study||40
380115|NCT01943539|933318|P1|STARTED|Overall Study||44
380116|NCT01943474|933329|P2|NOT COMPLETED|Overall Study||0
380117|NCT01943474|933330|P1|NOT COMPLETED|Overall Study||0
380118|NCT01943474|933329|P2|COMPLETED|Overall Study||125
380119|NCT01943474|933330|P1|COMPLETED|Overall Study||123
380120|NCT01943474|933329|P2|STARTED|Overall Study||125
380121|NCT01943474|933330|P1|STARTED|Overall Study||123
380122|NCT01943435|933354|P3|NOT COMPLETED|6 Month Follow up||15
380124|NCT01943435|933356|P1|NOT COMPLETED|6 Month Follow up||12
380125|NCT01943435|933354|P3|COMPLETED|6 Month Follow up||65
380126|NCT01943435|933355|P2|COMPLETED|6 Month Follow up||59
380127|NCT01943435|933356|P1|COMPLETED|6 Month Follow up||67
380128|NCT01943435|933354|P3|STARTED|6 Month Follow up||80
380129|NCT01943435|933355|P2|STARTED|6 Month Follow up||66
380130|NCT01943435|933356|P1|STARTED|6 Month Follow up||79
380131|NCT01943435|933354|P3|NOT COMPLETED|2 Month Follow up||0
380132|NCT01943435|933355|P2|NOT COMPLETED|2 Month Follow up||3
380133|NCT01943435|933356|P1|NOT COMPLETED|2 Month Follow up||2
380134|NCT01943435|933354|P3|COMPLETED|2 Month Follow up||80
380135|NCT01943435|933355|P2|COMPLETED|2 Month Follow up||66
380136|NCT01943435|933356|P1|COMPLETED|2 Month Follow up||79
380137|NCT01943435|933354|P3|STARTED|2 Month Follow up||80
380138|NCT01943435|933355|P2|STARTED|2 Month Follow up||69
380139|NCT01943435|933356|P1|STARTED|2 Month Follow up||81
380140|NCT01943435|933354|P3|NOT COMPLETED|Intervention Period||4
380141|NCT01943435|933355|P2|NOT COMPLETED|Intervention Period||3
380142|NCT01943435|933356|P1|NOT COMPLETED|Intervention Period||3
380143|NCT01943435|933354|P3|COMPLETED|Intervention Period||80
380144|NCT01943435|933355|P2|COMPLETED|Intervention Period||69
380145|NCT01943435|933356|P1|COMPLETED|Intervention Period||81
380146|NCT01943435|933354|P3|STARTED|Intervention Period||84
380147|NCT01943435|933355|P2|STARTED|Intervention Period||72
380148|NCT01943435|933356|P1|STARTED|Intervention Period||84
380149|NCT01943435|933354|P3|NOT COMPLETED|Baseline Eligibility and Randomization||3
380150|NCT01943435|933355|P2|NOT COMPLETED|Baseline Eligibility and Randomization||12
380151|NCT01943435|933356|P1|NOT COMPLETED|Baseline Eligibility and Randomization||4
380152|NCT01943435|933354|P3|COMPLETED|Baseline Eligibility and Randomization||84
380153|NCT01943435|933355|P2|COMPLETED|Baseline Eligibility and Randomization||72
380154|NCT01943435|933356|P1|COMPLETED|Baseline Eligibility and Randomization||84
380155|NCT01943435|933354|P3|STARTED|Baseline Eligibility and Randomization||87
380156|NCT01943435|933355|P2|STARTED|Baseline Eligibility and Randomization||84
380157|NCT01943435|933356|P1|STARTED|Baseline Eligibility and Randomization||88
380158|NCT01943344|933370|P1|NOT COMPLETED|Overall Study||3
380159|NCT01943344|933370|P1|COMPLETED|Overall Study||9
380160|NCT01943344|933370|P1|STARTED|Overall Study||12
380161|NCT01943292|933377|P3|NOT COMPLETED|Overall Study||0
380162|NCT01943292|933378|P2|NOT COMPLETED|Overall Study||0
380163|NCT01943292|933379|P1|NOT COMPLETED|Overall Study||1
380164|NCT01943292|933377|P3|COMPLETED|Overall Study||3
380165|NCT01943292|933378|P2|COMPLETED|Overall Study||3
380166|NCT01943292|933379|P1|COMPLETED|Overall Study||2
380167|NCT01943292|933377|P3|Completed Follow-Up|Overall Study||3
380168|NCT01943292|933378|P2|Completed Follow-Up|Overall Study||3
380169|NCT01943292|933379|P1|Completed Follow-Up|Overall Study||2
380170|NCT01943292|933377|P3|Completed Treatment|Overall Study||3
380171|NCT01943292|933378|P2|Completed Treatment|Overall Study||3
380172|NCT01943292|933379|P1|Completed Treatment|Overall Study||3
380173|NCT01943292|933377|P3|Completed Cycle 1|Overall Study||3
380174|NCT01943292|933378|P2|Completed Cycle 1|Overall Study||3
380175|NCT01943292|933379|P1|Completed Cycle 1|Overall Study||3
380176|NCT01943292|933377|P3|STARTED|Overall Study||3
380177|NCT01943292|933378|P2|STARTED|Overall Study||3
380178|NCT01943292|933379|P1|STARTED|Overall Study||3
380179|NCT01943110|933390|P1|NOT COMPLETED|Overall Study||0
380180|NCT01943110|933390|P1|COMPLETED|Overall Study||30
380181|NCT01943110|933390|P1|STARTED|Overall Study||30
380182|NCT01942785|933406|P1|NOT COMPLETED|Overall Study||4
380183|NCT01942785|933406|P1|COMPLETED|Overall Study||50
380184|NCT01942785|933406|P1|STARTED|Overall Study||54
380185|NCT01942733|933435|P1|NOT COMPLETED|Overall Study||3
380186|NCT01942733|933435|P1|COMPLETED|Overall Study||41
380187|NCT01942733|933435|P1|STARTED|Overall Study||44
380188|NCT01942720|933464|P1|NOT COMPLETED|Overall Study||21
380189|NCT01942720|933464|P1|COMPLETED|Overall Study||53
380190|NCT01942720|933464|P1|STARTED|Overall Study||74
380191|NCT01942707|933474|P2|NOT COMPLETED|Overall Study||0
380192|NCT01942707|933475|P1|NOT COMPLETED|Overall Study||0
380193|NCT01942707|933474|P2|COMPLETED|Overall Study||23
380194|NCT01942707|933475|P1|COMPLETED|Overall Study||23
380195|NCT01942707|933474|P2|STARTED|Overall Study||23
380196|NCT01942707|933475|P1|STARTED|Overall Study||23
380197|NCT01942590|933487|P2|NOT COMPLETED|Overall Study||1
380198|NCT01942590|933488|P1|NOT COMPLETED|Overall Study||1
380199|NCT01942590|933487|P2|COMPLETED|Overall Study||4
380200|NCT01942590|933488|P1|COMPLETED|Overall Study||7
380201|NCT01942590|933487|P2|STARTED|Overall Study||5
380202|NCT01942590|933488|P1|STARTED|Overall Study||8
380203|NCT01942161|933521|P3|NOT COMPLETED|Overall Study||6
380204|NCT01942161|933522|P2|NOT COMPLETED|Overall Study||6
380205|NCT01942161|933523|P1|NOT COMPLETED|Overall Study||8
380206|NCT01942161|933521|P3|COMPLETED|Overall Study||35
380207|NCT01942161|933522|P2|COMPLETED|Overall Study||24
380208|NCT01942161|933523|P1|COMPLETED|Overall Study||27
380209|NCT01942161|933521|P3|STARTED|Overall Study||41
380210|NCT01942161|933522|P2|STARTED|Overall Study||30
380211|NCT01942161|933523|P1|STARTED|Overall Study||35
380212|NCT01942148|933543|P1|NOT COMPLETED|Overall Study||27
380213|NCT01942148|933543|P1|COMPLETED|Overall Study||41
380214|NCT01942148|933543|P1|STARTED|Overall Study||68
380215|NCT01942135|933551|P2|NOT COMPLETED|Overall Study||174
380216|NCT01942135|933552|P1|NOT COMPLETED|Overall Study||347
380217|NCT01942135|933551|P2|COMPLETED|Overall Study||0
380218|NCT01942135|933552|P1|COMPLETED|Overall Study||0
380219|NCT01942135|933551|P2|STARTED|Overall Study||174
380220|NCT01942135|933552|P1|STARTED|Overall Study||347
380221|NCT01941940|933589|P1|NOT COMPLETED|Overall Study||33
380222|NCT01941940|933589|P1|COMPLETED|Overall Study||194
380223|NCT01941940|933589|P1|STARTED|Overall Study||227
380224|NCT01941615|933629|P1|NOT COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0
380225|NCT01941615|933629|P1|COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0
380226|NCT01941615|933629|P1|STARTED|Microgynon® Plus Deleobuvir+Faldaprevir||0
380227|NCT01941615|933629|P1|NOT COMPLETED|Reference Treatment: Microgynon®||0
380228|NCT01941615|933629|P1|COMPLETED|Reference Treatment: Microgynon®||0
380229|NCT01941615|933629|P1|STARTED|Reference Treatment: Microgynon®||0
380230|NCT01941615|933629|P1|NOT COMPLETED|Run in Treatment: Microgynon®||0
380231|NCT01941615|933629|P1|COMPLETED|Run in Treatment: Microgynon®||16
380232|NCT01941615|933629|P1|STARTED|Run in Treatment: Microgynon®||16
380233|NCT01941498|933638|P1|NOT COMPLETED|Overall Study||1
380234|NCT01941498|933638|P1|COMPLETED|Overall Study||96
380235|NCT01941498|933638|P1|STARTED|Overall Study||97
380236|NCT01941485|933684|P1|NOT COMPLETED|Overall Study||0
380237|NCT01941485|933684|P1|COMPLETED|Overall Study||59
380238|NCT01941485|933684|P1|STARTED|Overall Study||59
380239|NCT01941472|933750|P1|NOT COMPLETED|Overall Study||0
380240|NCT01941472|933750|P1|COMPLETED|Overall Study||40
380241|NCT01941472|933750|P1|STARTED|Overall Study||40
380242|NCT01941186|933756|P2|NOT COMPLETED|Follow-up||0
380243|NCT01941186|933757|P1|NOT COMPLETED|Follow-up||1
380244|NCT01941186|933756|P2|COMPLETED|Follow-up||33
380245|NCT01941186|933757|P1|COMPLETED|Follow-up||30
380246|NCT01941186|933756|P2|STARTED|Follow-up||33
380247|NCT01941186|933757|P1|STARTED|Follow-up||31
380248|NCT01941186|933756|P2|NOT COMPLETED|Randomization/Allocation to Study Group||0
380249|NCT01941186|933757|P1|NOT COMPLETED|Randomization/Allocation to Study Group||0
380250|NCT01941186|933756|P2|COMPLETED|Randomization/Allocation to Study Group||33
380251|NCT01941186|933757|P1|COMPLETED|Randomization/Allocation to Study Group||31
380252|NCT01941186|933756|P2|STARTED|Randomization/Allocation to Study Group||33
380253|NCT01941186|933757|P1|STARTED|Randomization/Allocation to Study Group||31
380254|NCT01940523|933785|P2|NOT COMPLETED|Overall Study||0
380255|NCT01940523|933786|P1|NOT COMPLETED|Overall Study||0
380256|NCT01940523|933785|P2|COMPLETED|Overall Study||320
380257|NCT01940523|933786|P1|COMPLETED|Overall Study||320
380258|NCT01940523|933785|P2|STARTED|Overall Study||320
380259|NCT01940523|933786|P1|STARTED|Overall Study||320
380260|NCT01940510|933794|P1|NOT COMPLETED|Overall Study||0
380261|NCT01940510|933794|P1|COMPLETED|Overall Study||24
380262|NCT01940510|933794|P1|STARTED|Overall Study||24
380263|NCT01940497|933827|P2|NOT COMPLETED|Overall Study||118
380264|NCT01940497|933828|P1|NOT COMPLETED|Overall Study||120
380265|NCT01940497|933827|P2|COMPLETED|Overall Study||1
380266|NCT01940497|933828|P1|COMPLETED|Overall Study||1
380267|NCT01940497|933827|P2|Treated: Neoadjuvant|Overall Study||21
380268|NCT01940497|933828|P1|Treated: Neoadjuvant|Overall Study||20
380269|NCT01940497|933827|P2|Treated: Adjuvant|Overall Study||92
380270|NCT01940497|933828|P1|Treated: Adjuvant|Overall Study||95
380271|NCT01940497|933827|P2|Treated|Overall Study||113
380272|NCT01940497|933828|P1|Treated|Overall Study||115
380273|NCT01940497|933827|P2|STARTED|Overall Study||119
380274|NCT01940497|933828|P1|STARTED|Overall Study||121
380275|NCT01940484|933867|P1|NOT COMPLETED|Overall Study||10
380276|NCT01940484|933867|P1|COMPLETED|Overall Study||88
380277|NCT01940484|933867|P1|STARTED|Overall Study||98
380278|NCT01940471|933887|P2|NOT COMPLETED|Open-Label Extension||8
380279|NCT01940471|933888|P1|NOT COMPLETED|Open-Label Extension||14
380280|NCT01940471|933887|P2|COMPLETED|Open-Label Extension||0
380281|NCT01940471|933888|P1|COMPLETED|Open-Label Extension||0
380282|NCT01940471|933887|P2|STARTED|Open-Label Extension||8
380283|NCT01940471|933888|P1|STARTED|Open-Label Extension||14
380284|NCT01940471|933887|P2|NOT COMPLETED|Double-Blind Phase||285
380285|NCT01940471|933888|P1|NOT COMPLETED|Double-Blind Phase||568
380286|NCT01940471|933887|P2|COMPLETED|Double-Blind Phase||8
380287|NCT01940471|933888|P1|COMPLETED|Double-Blind Phase||14
380288|NCT01940471|933887|P2|STARTED|Double-Blind Phase||293
380289|NCT01940471|933888|P1|STARTED|Double-Blind Phase||582
380290|NCT01940354|933906|P2|NOT COMPLETED|Overall Study||2
380291|NCT01940354|933907|P1|NOT COMPLETED|Overall Study||4
380292|NCT01940354|933906|P2|COMPLETED|Overall Study||108
380293|NCT01940354|933907|P1|COMPLETED|Overall Study||106
380294|NCT01940354|933906|P2|STARTED|Overall Study||110
380295|NCT01940354|933907|P1|STARTED|Overall Study||110
380296|NCT01940341|933919|P2|NOT COMPLETED|Open-label Extension Phase||1
380297|NCT01940341|933920|P1|NOT COMPLETED|Open-label Extension Phase||4
380298|NCT01940341|933919|P2|COMPLETED|Open-label Extension Phase||0
380299|NCT01940341|933920|P1|COMPLETED|Open-label Extension Phase||0
380300|NCT01940341|933919|P2|STARTED|Open-label Extension Phase||1
380301|NCT01940341|933920|P1|STARTED|Open-label Extension Phase||4
380302|NCT01940341|933919|P2|NOT COMPLETED|Double-Blind Phase||140
380303|NCT01940341|933920|P1|NOT COMPLETED|Double-Blind Phase||281
380304|NCT01940341|933919|P2|COMPLETED|Double-Blind Phase||1
380305|NCT01940341|933920|P1|COMPLETED|Double-Blind Phase||4
380306|NCT01940341|933919|P2|STARTED|Double-Blind Phase||141
380307|NCT01940341|933920|P1|STARTED|Double-Blind Phase||285
380308|NCT01940146|933938|P4|NOT COMPLETED|Overall Study||2
380309|NCT01940146|933939|P3|NOT COMPLETED|Overall Study||1
380310|NCT01940146|933940|P2|NOT COMPLETED|Overall Study||0
380311|NCT01940146|933941|P1|NOT COMPLETED|Overall Study||1
380312|NCT01940146|933938|P4|COMPLETED|Overall Study||53
380313|NCT01940146|933939|P3|COMPLETED|Overall Study||55
380314|NCT01940146|933940|P2|COMPLETED|Overall Study||55
380315|NCT01940146|933941|P1|COMPLETED|Overall Study||55
380316|NCT01940146|933938|P4|STARTED|Overall Study||55
380317|NCT01940146|933939|P3|STARTED|Overall Study||56
380318|NCT01940146|933940|P2|STARTED|Overall Study||55
380319|NCT01940146|933941|P1|STARTED|Overall Study||56
380320|NCT01940120|933951|P1|NOT COMPLETED|Overall Study||48
380321|NCT01940120|933951|P1|COMPLETED|Overall Study||30
380322|NCT01940120|933951|P1|STARTED|Overall Study||78
380323|NCT01939938|934105|P1|NOT COMPLETED|Overall Study||0
380324|NCT01939938|934105|P1|COMPLETED|Overall Study||10
380325|NCT01939938|934105|P1|STARTED|Overall Study||10
380326|NCT01939548|934113|P3|NOT COMPLETED|Overall Study||30
380327|NCT01939548|934114|P2|NOT COMPLETED|Overall Study||49
380328|NCT01939548|934115|P1|NOT COMPLETED|Overall Study||37
380329|NCT01939548|934113|P3|COMPLETED|Overall Study||50
380330|NCT01939548|934114|P2|COMPLETED|Overall Study||33
380331|NCT01939548|934115|P1|COMPLETED|Overall Study||41
380332|NCT01939548|934113|P3|STARTED|Overall Study||80
380333|NCT01939548|934114|P2|STARTED|Overall Study||82
380334|NCT01939548|934115|P1|STARTED|Overall Study||78
380335|NCT01939496|934189|P3|NOT COMPLETED|Overall Study||2
380336|NCT01939496|934190|P2|NOT COMPLETED|Overall Study||3
380337|NCT01939496|934191|P1|NOT COMPLETED|Overall Study||9
380338|NCT01939496|934189|P3|COMPLETED|Overall Study||54
380339|NCT01939496|934190|P2|COMPLETED|Overall Study||54
380340|NCT01939496|934191|P1|COMPLETED|Overall Study||47
380341|NCT01939496|934189|P3|STARTED|Overall Study||56
380342|NCT01939496|934190|P2|STARTED|Overall Study||57
380343|NCT01939496|934191|P1|STARTED|Overall Study||56
380344|NCT01939405|934243|P2|NOT COMPLETED|Overall Study||2
380345|NCT01939405|934244|P1|NOT COMPLETED|Overall Study||3
380346|NCT01939405|934243|P2|COMPLETED|Overall Study||28
380347|NCT01939405|934244|P1|COMPLETED|Overall Study||27
380348|NCT01939405|934243|P2|STARTED|Overall Study||30
380349|NCT01939405|934244|P1|STARTED|Overall Study||30
380350|NCT01939314|934258|P2|NOT COMPLETED|Overall Study||8
380351|NCT01939314|934259|P1|NOT COMPLETED|Overall Study||9
380352|NCT01939314|934258|P2|COMPLETED|Overall Study||40
380353|NCT01939314|934259|P1|COMPLETED|Overall Study||36
380354|NCT01939314|934258|P2|24 Hour Endpoint|Overall Study||40
380355|NCT01939314|934259|P1|24 Hour Endpoint|Overall Study||36
380356|NCT01939314|934258|P2|15 Minute Endpoint|Overall Study||46
380357|NCT01939314|934259|P1|15 Minute Endpoint|Overall Study||41
380358|NCT01939314|934258|P2|STARTED|Overall Study||48
380359|NCT01939314|934259|P1|STARTED|Overall Study||45
380360|NCT01939301|934271|P2|NOT COMPLETED|Overall Study||1
380361|NCT01939301|934272|P1|NOT COMPLETED|Overall Study||1
380362|NCT01939301|934271|P2|COMPLETED|Overall Study||38
380363|NCT01939301|934272|P1|COMPLETED|Overall Study||38
380364|NCT01939301|934271|P2|STARTED|Overall Study||39
380365|NCT01939301|934272|P1|STARTED|Overall Study||39
380366|NCT01939223|934280|P2|NOT COMPLETED|Overall Study||11
380367|NCT01939223|934281|P1|NOT COMPLETED|Overall Study||13
380368|NCT01939223|934280|P2|COMPLETED|Overall Study||0
380369|NCT01939223|934281|P1|COMPLETED|Overall Study||1
380370|NCT01939223|934280|P2|Participants Received Treatment|Overall Study||11
380371|NCT01939223|934281|P1|Participants Received Treatment|Overall Study||14
380372|NCT01939223|934280|P2|STARTED|Overall Study||11
380373|NCT01939223|934281|P1|STARTED|Overall Study||14
380374|NCT01939197|934296|P7|NOT COMPLETED|Overall Study||2
380375|NCT01939197|934297|P6|NOT COMPLETED|Overall Study||1
380376|NCT01939197|934298|P5|NOT COMPLETED|Overall Study||4
380377|NCT01939197|934299|P4|NOT COMPLETED|Overall Study||1
380378|NCT01939197|934300|P3|NOT COMPLETED|Overall Study||0
380379|NCT01939197|934301|P2|NOT COMPLETED|Overall Study||1
380380|NCT01939197|934302|P1|NOT COMPLETED|Overall Study||1
380381|NCT01939197|934296|P7|COMPLETED|Overall Study||26
380382|NCT01939197|934297|P6|COMPLETED|Overall Study||4
380383|NCT01939197|934298|P5|COMPLETED|Overall Study||196
380384|NCT01939197|934299|P4|COMPLETED|Overall Study||11
380385|NCT01939197|934300|P3|COMPLETED|Overall Study||10
380386|NCT01939197|934301|P2|COMPLETED|Overall Study||31
380387|NCT01939197|934302|P1|COMPLETED|Overall Study||30
380388|NCT01939197|934296|P7|STARTED|Overall Study||28
380389|NCT01939197|934297|P6|STARTED|Overall Study||5
380390|NCT01939197|934298|P5|STARTED|Overall Study||200
380391|NCT01939197|934299|P4|STARTED|Overall Study||12
380392|NCT01939197|934300|P3|STARTED|Overall Study||10
380393|NCT01939197|934301|P2|STARTED|Overall Study||32
380394|NCT01939197|934302|P1|STARTED|Overall Study||31
380395|NCT01939145|934362|P2|NOT COMPLETED|Overall Study||7
380396|NCT01939145|934363|P1|NOT COMPLETED|Overall Study||2
380397|NCT01939145|934362|P2|COMPLETED|Overall Study||44
380398|NCT01939145|934363|P1|COMPLETED|Overall Study||47
380399|NCT01939145|934362|P2|STARTED|Overall Study||51
380400|NCT01939145|934363|P1|STARTED|Overall Study||49
380401|NCT01939002|934373|P2|NOT COMPLETED|Overall Study||18
380402|NCT01939002|934374|P1|NOT COMPLETED|Overall Study||19
380403|NCT01939002|934373|P2|COMPLETED|Overall Study||80
380404|NCT01939002|934374|P1|COMPLETED|Overall Study||84
380405|NCT01939002|934373|P2|STARTED|Overall Study||98
380406|NCT01939002|934374|P1|STARTED|Overall Study||103
380407|NCT01938989|934440|P2|NOT COMPLETED|Overall Study||0
380408|NCT01938989|934441|P1|NOT COMPLETED|Overall Study||0
380409|NCT01938989|934440|P2|COMPLETED|Overall Study||77
380410|NCT01938989|934441|P1|COMPLETED|Overall Study||77
380411|NCT01938989|934440|P2|STARTED|Overall Study||77
380412|NCT01938989|934441|P1|STARTED|Overall Study||77
380413|NCT01938833|934447|P1|NOT COMPLETED|Overall Study||0
380414|NCT01938833|934447|P1|COMPLETED|Overall Study||9
380415|NCT01938833|934447|P1|STARTED|Overall Study||9
380416|NCT01938573|934455|P2|NOT COMPLETED|Overall Study||0
380417|NCT01938573|934456|P1|NOT COMPLETED|Overall Study||2
380418|NCT01938573|934455|P2|COMPLETED|Overall Study||6
380419|NCT01938573|934456|P1|COMPLETED|Overall Study||13
380420|NCT01938573|934455|P2|STARTED|Overall Study||6
380421|NCT01938573|934456|P1|STARTED|Overall Study||15
380422|NCT01938430|934476|P14|NOT COMPLETED|Overall Study||1
380423|NCT01938430|934477|P13|NOT COMPLETED|Overall Study||0
380424|NCT01938430|934478|P12|NOT COMPLETED|Overall Study||1
380425|NCT01938430|934479|P11|NOT COMPLETED|Overall Study||3
380426|NCT01938430|934480|P10|NOT COMPLETED|Overall Study||3
380427|NCT01938430|934481|P9|NOT COMPLETED|Overall Study||4
380428|NCT01938430|934482|P8|NOT COMPLETED|Overall Study||1
380429|NCT01938430|934483|P7|NOT COMPLETED|Overall Study||2
380430|NCT01938430|934484|P6|NOT COMPLETED|Overall Study||1
380431|NCT01938430|934485|P5|NOT COMPLETED|Overall Study||0
380432|NCT01938430|934486|P4|NOT COMPLETED|Overall Study||2
380433|NCT01938430|934487|P3|NOT COMPLETED|Overall Study||5
380434|NCT01938430|934488|P2|NOT COMPLETED|Overall Study||3
380435|NCT01938430|934489|P1|NOT COMPLETED|Overall Study||4
380436|NCT01938430|934476|P14|COMPLETED|Overall Study||2
380437|NCT01938430|934477|P13|COMPLETED|Overall Study||4
380438|NCT01938430|934478|P12|COMPLETED|Overall Study||3
380439|NCT01938430|934479|P11|COMPLETED|Overall Study||3
380440|NCT01938430|934480|P10|COMPLETED|Overall Study||23
380441|NCT01938430|934481|P9|COMPLETED|Overall Study||22
380442|NCT01938430|934482|P8|COMPLETED|Overall Study||24
380443|NCT01938430|934483|P7|COMPLETED|Overall Study||24
380444|NCT01938430|934484|P6|COMPLETED|Overall Study||55
380445|NCT01938430|934485|P5|COMPLETED|Overall Study||55
380446|NCT01938430|934486|P4|COMPLETED|Overall Study||24
380447|NCT01938430|934487|P3|COMPLETED|Overall Study||18
380448|NCT01938430|934488|P2|COMPLETED|Overall Study||26
380449|NCT01938430|934489|P1|COMPLETED|Overall Study||26
380450|NCT01938430|934476|P14|STARTED|Overall Study||3
380451|NCT01938430|934477|P13|STARTED|Overall Study||4
380452|NCT01938430|934478|P12|STARTED|Overall Study||4
380453|NCT01938430|934479|P11|STARTED|Overall Study||6
380454|NCT01938430|934480|P10|STARTED|Overall Study||26
380455|NCT01938430|934481|P9|STARTED|Overall Study||26
380456|NCT01938430|934482|P8|STARTED|Overall Study||25
380457|NCT01938430|934483|P7|STARTED|Overall Study||26
380458|NCT01938430|934484|P6|STARTED|Overall Study||56
380459|NCT01938430|934485|P5|STARTED|Overall Study||55
380460|NCT01938430|934486|P4|STARTED|Overall Study||26
380461|NCT01938430|934487|P3|STARTED|Overall Study||23
380462|NCT01938430|934488|P2|STARTED|Overall Study||29
380463|NCT01938430|934489|P1|STARTED|Overall Study||30
380464|NCT01938391|934814|P1|NOT COMPLETED|12 Month Follow up||2
380465|NCT01938391|934814|P1|COMPLETED|12 Month Follow up||22
380466|NCT01938391|934814|P1|STARTED|12 Month Follow up||24
380467|NCT01938391|934814|P1|NOT COMPLETED|6 Month Follow up||1
380468|NCT01938391|934814|P1|COMPLETED|6 Month Follow up||24
380469|NCT01938391|934814|P1|STARTED|6 Month Follow up||25
380470|NCT01938391|934814|P1|NOT COMPLETED|2 Week Follow up||0
380471|NCT01938391|934814|P1|COMPLETED|2 Week Follow up||25
380472|NCT01938391|934814|P1|STARTED|2 Week Follow up||25
380473|NCT01938391|934814|P1|NOT COMPLETED|Baseline||0
380474|NCT01938391|934814|P1|COMPLETED|Baseline||25
380475|NCT01938391|934814|P1|STARTED|Baseline||25
380476|NCT01938170|934824|P1|NOT COMPLETED|Overall Study||0
380477|NCT01938170|934824|P1|COMPLETED|Overall Study||41
380478|NCT01938170|934824|P1|STARTED|Overall Study||41
380479|NCT01938079|934831|P2|NOT COMPLETED|Overall Study||0
380480|NCT01938079|934832|P1|NOT COMPLETED|Overall Study||0
380481|NCT01938079|934831|P2|COMPLETED|Overall Study||10
380482|NCT01938079|934832|P1|COMPLETED|Overall Study||10
380483|NCT01938079|934831|P2|STARTED|Overall Study||10
380484|NCT01938079|934832|P1|STARTED|Overall Study||10
380485|NCT01938066|934840|P2|NOT COMPLETED|Overall Study||2
380486|NCT01938066|934841|P1|NOT COMPLETED|Overall Study||1
380487|NCT01938066|934840|P2|COMPLETED|Overall Study||13
380488|NCT01938066|934841|P1|COMPLETED|Overall Study||14
380489|NCT01938066|934840|P2|STARTED|Overall Study||15
380490|NCT01938066|934841|P1|STARTED|Overall Study||15
380491|NCT01938040|934851|P2|NOT COMPLETED|Overall Study||0
380492|NCT01938040|934852|P1|NOT COMPLETED|Overall Study||0
380493|NCT01938040|934851|P2|COMPLETED|Overall Study||27
380494|NCT01938040|934852|P1|COMPLETED|Overall Study||28
380495|NCT01938040|934851|P2|Behavior Metrics|Overall Study||27
380496|NCT01938040|934852|P1|Behavior Metrics|Overall Study||28
380591|NCT01937195|935268|P1|COMPLETED|Overall Study||95
380497|NCT01938040|934851|P2|Plasma Analysis|Overall Study|complete set of blood samples could not be obtained|25
380498|NCT01938040|934852|P1|Plasma Analysis|Overall Study|complete set of blood samples could not be obtained|24
380499|NCT01938040|934851|P2|STARTED|Overall Study||27
380500|NCT01938040|934852|P1|STARTED|Overall Study||28
380501|NCT01937975|934881|P3|NOT COMPLETED|Overall Study||0
380502|NCT01937975|934882|P2|NOT COMPLETED|Overall Study||0
380503|NCT01937975|934883|P1|NOT COMPLETED|Overall Study||0
380504|NCT01937975|934881|P3|COMPLETED|Overall Study||8
380505|NCT01937975|934882|P2|COMPLETED|Overall Study||8
380506|NCT01937975|934883|P1|COMPLETED|Overall Study||8
380507|NCT01937975|934881|P3|STARTED|Overall Study||8
380508|NCT01937975|934882|P2|STARTED|Overall Study||8
380509|NCT01937975|934883|P1|STARTED|Overall Study||8
380510|NCT01937871|934933|P3|NOT COMPLETED|Overall Study||11
380511|NCT01937871|934934|P2|NOT COMPLETED|Overall Study||17
380512|NCT01937871|934935|P1|NOT COMPLETED|Overall Study||24
380513|NCT01937871|934933|P3|COMPLETED|Overall Study||174
380514|NCT01937871|934934|P2|COMPLETED|Overall Study||346
380515|NCT01937871|934935|P1|COMPLETED|Overall Study||337
380516|NCT01937871|934933|P3|Received at Least One Dose of Study Drug|Overall Study||185
380517|NCT01937871|934934|P2|Received at Least One Dose of Study Drug|Overall Study||362
380518|NCT01937871|934935|P1|Received at Least One Dose of Study Drug|Overall Study||361
380519|NCT01937871|934933|P3|STARTED|Overall Study||185
380520|NCT01937871|934934|P2|STARTED|Overall Study||363
380521|NCT01937871|934935|P1|STARTED|Overall Study||361
380522|NCT01937715|935011|P5|NOT COMPLETED|Overall Study||2
380523|NCT01937715|935012|P4|NOT COMPLETED|Overall Study||4
380524|NCT01937715|935013|P3|NOT COMPLETED|Overall Study||0
380525|NCT01937715|935014|P2|NOT COMPLETED|Overall Study||1
380526|NCT01937715|935015|P1|NOT COMPLETED|Overall Study||0
380527|NCT01937715|935011|P5|COMPLETED|Overall Study||1
380528|NCT01937715|935012|P4|COMPLETED|Overall Study||1
380529|NCT01937715|935013|P3|COMPLETED|Overall Study||3
380530|NCT01937715|935014|P2|COMPLETED|Overall Study||3
380531|NCT01937715|935015|P1|COMPLETED|Overall Study||3
380532|NCT01937715|935011|P5|STARTED|Overall Study||3
380533|NCT01937715|935012|P4|STARTED|Overall Study||5
380534|NCT01937715|935013|P3|STARTED|Overall Study||3
380535|NCT01937715|935014|P2|STARTED|Overall Study||4
380536|NCT01937715|935015|P1|STARTED|Overall Study||3
380537|NCT01937598|935137|P2|NOT COMPLETED|Overall Study||0
380538|NCT01937598|935138|P1|NOT COMPLETED|Overall Study||0
380539|NCT01937598|935137|P2|COMPLETED|Overall Study||8
380540|NCT01937598|935138|P1|COMPLETED|Overall Study||8
380541|NCT01937598|935137|P2|STARTED|Overall Study||8
380542|NCT01937598|935138|P1|STARTED|Overall Study||8
380543|NCT01937520|935162|P2|NOT COMPLETED|Overall Study||0
380544|NCT01937520|935163|P1|NOT COMPLETED|Overall Study||0
380545|NCT01937520|935162|P2|COMPLETED|Overall Study||9
380546|NCT01937520|935163|P1|COMPLETED|Overall Study||11
380547|NCT01937520|935162|P2|STARTED|Overall Study||9
380548|NCT01937520|935163|P1|STARTED|Overall Study||11
380549|NCT01937507|935199|P1|NOT COMPLETED|Overall Study||2
380550|NCT01937507|935199|P1|COMPLETED|Overall Study||0
380551|NCT01937507|935199|P1|STARTED|Overall Study||2
380552|NCT01937364|935208|P2|NOT COMPLETED|Overall Study||1
380553|NCT01937364|935209|P1|NOT COMPLETED|Overall Study||2
380554|NCT01937364|935208|P2|COMPLETED|Overall Study||7
380555|NCT01937364|935209|P1|COMPLETED|Overall Study||7
380556|NCT01937364|935208|P2|STARTED|Overall Study||8
380557|NCT01937364|935209|P1|STARTED|Overall Study||9
380558|NCT01937351|935221|P2|NOT COMPLETED|Overall Study||2
380559|NCT01937351|935222|P1|NOT COMPLETED|Overall Study||9
380560|NCT01937351|935221|P2|COMPLETED|Overall Study||26
380561|NCT01937351|935222|P1|COMPLETED|Overall Study||125
380562|NCT01937351|935221|P2|6-Month Follow-up|Overall Study||26
380563|NCT01937351|935222|P1|6-Month Follow-up|Overall Study||125
380564|NCT01937351|935221|P2|30-Day Follow-up|Overall Study||27
380565|NCT01937351|935222|P1|30-Day Follow-up|Overall Study||128
380566|NCT01937351|935221|P2|Treated w Study Device|Overall Study||28
380567|NCT01937351|935222|P1|Treated w Study Device|Overall Study||130
380568|NCT01937351|935221|P2|STARTED|Overall Study||28
380569|NCT01937351|935222|P1|STARTED|Overall Study||134
380570|NCT01937312|935230|P2|NOT COMPLETED|Overall Study||3
380571|NCT01937312|935231|P1|NOT COMPLETED|Overall Study||11
380572|NCT01937312|935230|P2|COMPLETED|Overall Study||92
380573|NCT01937312|935231|P1|COMPLETED|Overall Study||83
380574|NCT01937312|935230|P2|Treated|Overall Study||95
380575|NCT01937312|935231|P1|Treated|Overall Study||93
380576|NCT01937312|935230|P2|STARTED|Overall Study||95
380577|NCT01937312|935231|P1|STARTED|Overall Study||94
380578|NCT01937299|935246|P2|NOT COMPLETED|Overall Study||4
380579|NCT01937299|935247|P1|NOT COMPLETED|Overall Study||14
380580|NCT01937299|935246|P2|COMPLETED|Overall Study||112
380581|NCT01937299|935247|P1|COMPLETED|Overall Study||103
380582|NCT01937299|935246|P2|STARTED|Overall Study||116
380583|NCT01937299|935247|P1|STARTED|Overall Study||117
380584|NCT01937260|935260|P2|NOT COMPLETED|Overall Study||0
380585|NCT01937260|935261|P1|NOT COMPLETED|Overall Study||1
380586|NCT01937260|935260|P2|COMPLETED|Overall Study||10
380587|NCT01937260|935261|P1|COMPLETED|Overall Study||20
380588|NCT01937260|935260|P2|STARTED|Overall Study||10
380589|NCT01937260|935261|P1|STARTED|Overall Study||21
380590|NCT01937195|935268|P1|NOT COMPLETED|Overall Study||0
380592|NCT01937195|935268|P1|STARTED|Overall Study||95
380593|NCT01937130|935282|P4|NOT COMPLETED|Overall Study||2
380594|NCT01937130|935283|P3|NOT COMPLETED|Overall Study||3
380595|NCT01937130|935284|P2|NOT COMPLETED|Overall Study||4
380596|NCT01937130|935285|P1|NOT COMPLETED|Overall Study||5
380597|NCT01937130|935282|P4|COMPLETED|Overall Study||2
380598|NCT01937130|935283|P3|COMPLETED|Overall Study||2
380599|NCT01937130|935284|P2|COMPLETED|Overall Study||3
380600|NCT01937130|935285|P1|COMPLETED|Overall Study||0
380601|NCT01937130|935282|P4|STARTED|Overall Study||4
380602|NCT01937130|935283|P3|STARTED|Overall Study||5
380603|NCT01937130|935284|P2|STARTED|Overall Study||7
380604|NCT01937130|935285|P1|STARTED|Overall Study||5
380605|NCT01937026|935312|P1|NOT COMPLETED|Period 2 (At Dosing Day 3 Through Day 8)||0
380606|NCT01937026|935312|P1|COMPLETED|Period 2 (At Dosing Day 3 Through Day 8)||18
380607|NCT01937026|935312|P1|Received Probenecid on Days 3 Through 7|Period 2 (At Dosing Day 3 Through Day 8)||18
380608|NCT01937026|935312|P1|Received Baricitinib|Period 2 (At Dosing Day 3 Through Day 8)||18
380609|NCT01937026|935312|P1|STARTED|Period 2 (At Dosing Day 3 Through Day 8)||18
380610|NCT01937026|935312|P1|NOT COMPLETED|Period 1 (Day 1 Through Predose Day 3)||0
380611|NCT01937026|935312|P1|COMPLETED|Period 1 (Day 1 Through Predose Day 3)||18
380612|NCT01937026|935312|P1|Received Baricitinib|Period 1 (Day 1 Through Predose Day 3)||18
380613|NCT01937026|935312|P1|STARTED|Period 1 (Day 1 Through Predose Day 3)||18
380614|NCT01936974|935323|P2|NOT COMPLETED|Overall Study||5
380615|NCT01936974|935324|P1|NOT COMPLETED|Overall Study||2
380616|NCT01936974|935323|P2|COMPLETED|Overall Study||0
380617|NCT01936974|935324|P1|COMPLETED|Overall Study||0
380618|NCT01936974|935323|P2|STARTED|Overall Study||5
380619|NCT01936974|935324|P1|STARTED|Overall Study||2
380620|NCT01936909|935333|P3|NOT COMPLETED|Overall Study||6
380621|NCT01936909|935334|P2|NOT COMPLETED|Overall Study||8
380622|NCT01936909|935335|P1|NOT COMPLETED|Overall Study||10
380623|NCT01936909|935333|P3|COMPLETED|Overall Study||14
380624|NCT01936909|935334|P2|COMPLETED|Overall Study||12
380625|NCT01936909|935335|P1|COMPLETED|Overall Study||10
380626|NCT01936909|935333|P3|STARTED|Overall Study||20
380627|NCT01936909|935334|P2|STARTED|Overall Study||20
380628|NCT01936909|935335|P1|STARTED|Overall Study||20
380629|NCT01936896|935349|P1|NOT COMPLETED|Overall Study||0
380630|NCT01936896|935349|P1|COMPLETED|Overall Study||10
380631|NCT01936896|935349|P1|STARTED|Overall Study||10
380632|NCT01936870|935354|P1|NOT COMPLETED|Overall Study||189
380633|NCT01936870|935354|P1|COMPLETED|Overall Study||2303
380634|NCT01936870|935354|P1|STARTED|Overall Study||2492
380635|NCT01936844|935369|P2|NOT COMPLETED|Overall Study||7
380636|NCT01936844|935370|P1|NOT COMPLETED|Overall Study||6
380637|NCT01936844|935369|P2|COMPLETED|Overall Study||8
380638|NCT01936844|935370|P1|COMPLETED|Overall Study||9
380639|NCT01936844|935369|P2|STARTED|Overall Study||15
380640|NCT01936844|935370|P1|STARTED|Overall Study||15
380641|NCT01936662|935382|P2|NOT COMPLETED|Overall Study||0
380642|NCT01936662|935383|P1|NOT COMPLETED|Overall Study||0
380643|NCT01936662|935382|P2|COMPLETED|Overall Study||42
380644|NCT01936662|935383|P1|COMPLETED|Overall Study||42
380645|NCT01936662|935382|P2|STARTED|Overall Study||42
380646|NCT01936662|935383|P1|STARTED|Overall Study||42
380647|NCT01936649|935391|P1|NOT COMPLETED|Overall Study||13
380648|NCT01936649|935391|P1|COMPLETED|Overall Study||50
380649|NCT01936649|935391|P1|Treated|Overall Study||51
380650|NCT01936649|935391|P1|STARTED|Overall Study||63
380651|NCT01936623|935398|P2|NOT COMPLETED|Overall Study||5
380652|NCT01936623|935399|P1|NOT COMPLETED|Overall Study||0
380653|NCT01936623|935398|P2|COMPLETED|Overall Study||35
380654|NCT01936623|935399|P1|COMPLETED|Overall Study||40
380655|NCT01936623|935398|P2|STARTED|Overall Study||40
380656|NCT01936623|935399|P1|STARTED|Overall Study||40
380657|NCT01936467|935413|P2|NOT COMPLETED|Overall Study||0
380658|NCT01936467|935414|P1|NOT COMPLETED|Overall Study||0
380659|NCT01936467|935413|P2|COMPLETED|Overall Study||61
380660|NCT01936467|935414|P1|COMPLETED|Overall Study||60
380661|NCT01936467|935413|P2|STARTED|Overall Study||61
380662|NCT01936467|935414|P1|STARTED|Overall Study||60
380663|NCT01936389|935434|P2|NOT COMPLETED|Overall Study||0
380664|NCT01936389|935435|P1|NOT COMPLETED|Overall Study||1
380665|NCT01936389|935434|P2|COMPLETED|Overall Study||5
380666|NCT01936389|935435|P1|COMPLETED|Overall Study||4
380667|NCT01936389|935434|P2|STARTED|Overall Study||5
380668|NCT01936389|935435|P1|STARTED|Overall Study||5
380669|NCT01936363|935443|P2|NOT COMPLETED|Overall Study||5
380670|NCT01936363|935444|P1|NOT COMPLETED|Overall Study||7
380671|NCT01936363|935443|P2|COMPLETED|Overall Study||28
380672|NCT01936363|935444|P1|COMPLETED|Overall Study||25
380673|NCT01936363|935443|P2|STARTED|Overall Study||33
380674|NCT01936363|935444|P1|STARTED|Overall Study||32
380675|NCT01936181|935470|P4|NOT COMPLETED|Transition-extension||5
380676|NCT01936181|935471|P3|NOT COMPLETED|Transition-extension||6
380677|NCT01936181|935472|P2|NOT COMPLETED|Transition-extension||0
380678|NCT01936181|935473|P1|NOT COMPLETED|Transition-extension||15
380679|NCT01936181|935470|P4|COMPLETED|Transition-extension||96
380680|NCT01936181|935471|P3|COMPLETED|Transition-extension||88
380681|NCT01936181|935472|P2|COMPLETED|Transition-extension||0
380682|NCT01936181|935473|P1|COMPLETED|Transition-extension||186
380683|NCT01936181|935470|P4|STARTED|Transition-extension||101
380684|NCT01936181|935471|P3|STARTED|Transition-extension||94
380685|NCT01936181|935472|P2|STARTED|Transition-extension||0
380686|NCT01936181|935473|P1|STARTED|Transition-extension||201
380687|NCT01936181|935470|P4|NOT COMPLETED|Randomised, Double-blind||0
380688|NCT01936181|935471|P3|NOT COMPLETED|Randomised, Double-blind||0
380689|NCT01936181|935472|P2|NOT COMPLETED|Randomised, Double-blind||68
380690|NCT01936181|935473|P1|NOT COMPLETED|Randomised, Double-blind||64
380691|NCT01936181|935470|P4|COMPLETED|Randomised, Double-blind||0
380692|NCT01936181|935471|P3|COMPLETED|Randomised, Double-blind||0
380693|NCT01936181|935472|P2|COMPLETED|Randomised, Double-blind||225
380694|NCT01936181|935473|P1|COMPLETED|Randomised, Double-blind||227
380695|NCT01936181|935470|P4|STARTED|Randomised, Double-blind||0
380696|NCT01936181|935471|P3|STARTED|Randomised, Double-blind||0
380697|NCT01936181|935472|P2|STARTED|Randomised, Double-blind||293
380698|NCT01936181|935473|P1|STARTED|Randomised, Double-blind||291
380699|NCT01935622|935487|P3|NOT COMPLETED|Overall Study||0
380700|NCT01935622|935488|P2|NOT COMPLETED|Overall Study||2
380701|NCT01935622|935489|P1|NOT COMPLETED|Overall Study||2
380702|NCT01935622|935487|P3|COMPLETED|Overall Study||4
380703|NCT01935622|935488|P2|COMPLETED|Overall Study||1
380704|NCT01935622|935489|P1|COMPLETED|Overall Study||1
380705|NCT01935622|935487|P3|STARTED|Overall Study||4
380706|NCT01935622|935488|P2|STARTED|Overall Study||3
380707|NCT01935622|935489|P1|STARTED|Overall Study||3
380708|NCT01935180|935499|P2|NOT COMPLETED|Overall Study||14
380709|NCT01935180|935500|P1|NOT COMPLETED|Overall Study||21
380710|NCT01935180|935499|P2|COMPLETED|Overall Study||561
380711|NCT01935180|935500|P1|COMPLETED|Overall Study||552
380712|NCT01935180|935499|P2|STARTED|Overall Study||575
380713|NCT01935180|935500|P1|STARTED|Overall Study||573
380714|NCT01934894|935520|P2|NOT COMPLETED|Overall Study||5
380715|NCT01934894|935521|P1|NOT COMPLETED|Overall Study||6
380716|NCT01934894|935520|P2|COMPLETED|Overall Study||0
380717|NCT01934894|935521|P1|COMPLETED|Overall Study||0
380718|NCT01934894|935520|P2|STARTED|Overall Study||5
380719|NCT01934894|935521|P1|STARTED|Overall Study||6
380720|NCT01934790|935536|P1|NOT COMPLETED|Long Term Follow up||0
380721|NCT01934790|935536|P1|COMPLETED|Long Term Follow up||12
380722|NCT01934790|935536|P1|STARTED|Long Term Follow up||12
380723|NCT01934790|935536|P1|NOT COMPLETED|Active Follow up||24
380724|NCT01934790|935536|P1|COMPLETED|Active Follow up||10
380725|NCT01934790|935536|P1|STARTED|Active Follow up||34
380726|NCT01934790|935536|P1|NOT COMPLETED|Treatment||16
380727|NCT01934790|935536|P1|COMPLETED|Treatment||29
380728|NCT01934790|935536|P1|Participants Received Study Treatment|Treatment||44
380729|NCT01934790|935536|P1|STARTED|Treatment|Eligible for treatment|45
380730|NCT01934582|935564|P1|NOT COMPLETED|Overall Study||0
380731|NCT01934582|935564|P1|COMPLETED|Overall Study||13
380732|NCT01934582|935564|P1|STARTED|Overall Study||13
380733|NCT01934517|935578|P1|NOT COMPLETED|Overall Study||0
380734|NCT01934517|935578|P1|COMPLETED|Overall Study||25
380735|NCT01934517|935578|P1|STARTED|Overall Study||25
380736|NCT01934504|935590|P4|NOT COMPLETED|Overall Study||7
380737|NCT01934504|935591|P3|NOT COMPLETED|Overall Study||5
380738|NCT01934504|935592|P2|NOT COMPLETED|Overall Study||0
380739|NCT01934504|935593|P1|NOT COMPLETED|Overall Study||1
380740|NCT01934504|935590|P4|COMPLETED|Overall Study||1
380741|NCT01934504|935591|P3|COMPLETED|Overall Study||11
380742|NCT01934504|935592|P2|COMPLETED|Overall Study||3
380743|NCT01934504|935593|P1|COMPLETED|Overall Study||5
380744|NCT01934504|935590|P4|STARTED|Overall Study||8
380745|NCT01934504|935591|P3|STARTED|Overall Study||16
380746|NCT01934504|935592|P2|STARTED|Overall Study||3
380747|NCT01934504|935593|P1|STARTED|Overall Study||6
380748|NCT01934231|935615|P1|NOT COMPLETED|Overall Study||0
380749|NCT01934231|935615|P1|COMPLETED|Overall Study||27
380750|NCT01934231|935615|P1|STARTED|Overall Study||27
380751|NCT01934218|935626|P2|NOT COMPLETED|Open-Label Phase||24
380752|NCT01934218|935627|P1|NOT COMPLETED|Open-Label Phase||26
380753|NCT01934218|935626|P2|COMPLETED|Open-Label Phase||304
380754|NCT01934218|935627|P1|COMPLETED|Open-Label Phase||290
380755|NCT01934218|935626|P2|STARTED|Open-Label Phase||328
380756|NCT01934218|935627|P1|STARTED|Open-Label Phase||316
380757|NCT01934218|935626|P2|NOT COMPLETED|Double-blind Phase||54
380758|NCT01934218|935627|P1|NOT COMPLETED|Double-blind Phase||48
380759|NCT01934218|935626|P2|COMPLETED|Double-blind Phase||356
380760|NCT01934218|935627|P1|COMPLETED|Double-blind Phase||356
380761|NCT01934218|935626|P2|Analyzed Participants|Double-blind Phase||407
380762|NCT01934218|935627|P1|Analyzed Participants|Double-blind Phase||402
380763|NCT01934218|935626|P2|STARTED|Double-blind Phase||410
380764|NCT01934218|935627|P1|STARTED|Double-blind Phase||404
380765|NCT01934192|935638|P4|NOT COMPLETED|Overall Study||1
380766|NCT01934192|935639|P3|NOT COMPLETED|Overall Study||1
380767|NCT01934192|935640|P2|NOT COMPLETED|Overall Study||7
380768|NCT01934192|935641|P1|NOT COMPLETED|Overall Study||9
380769|NCT01934192|935638|P4|COMPLETED|Overall Study||3
380770|NCT01934192|935639|P3|COMPLETED|Overall Study||3
380771|NCT01934192|935640|P2|COMPLETED|Overall Study||37
380772|NCT01934192|935641|P1|COMPLETED|Overall Study||31
380773|NCT01934192|935638|P4|STARTED|Overall Study||4
380774|NCT01934192|935639|P3|STARTED|Overall Study||4
380775|NCT01934192|935640|P2|STARTED|Overall Study||44
380776|NCT01934192|935641|P1|STARTED|Overall Study||40
380777|NCT01934010|935778|P3|NOT COMPLETED|Overall Study||2
380778|NCT01934010|935779|P2|NOT COMPLETED|Overall Study||11
380779|NCT01934010|935780|P1|NOT COMPLETED|Overall Study||23
380780|NCT01934010|935778|P3|COMPLETED|Overall Study||74
380781|NCT01934010|935779|P2|COMPLETED|Overall Study||56
380782|NCT01934010|935780|P1|COMPLETED|Overall Study||91
380783|NCT01934010|935778|P3|STARTED|Overall Study||76
380784|NCT01934010|935779|P2|STARTED|Overall Study||67
380785|NCT01934010|935780|P1|STARTED|Overall Study||114
380786|NCT01933932|935799|P2|NOT COMPLETED|Overall Study||178
380787|NCT01933932|935800|P1|NOT COMPLETED|Overall Study||184
380788|NCT01933932|935799|P2|COMPLETED|Overall Study|These were the number of patients who were still ongoing at data cut-off|78
380789|NCT01933932|935800|P1|COMPLETED|Overall Study|These were the number of patients who were still ongoing at data cut-off|70
380790|NCT01933932|935799|P2|STARTED|Overall Study||256
380791|NCT01933932|935800|P1|STARTED|Overall Study||254
380792|NCT01933919|935818|P2|NOT COMPLETED|Open-label Long-term Phase||6
380793|NCT01933919|935819|P1|NOT COMPLETED|Open-label Long-term Phase||7
380794|NCT01933919|935818|P2|COMPLETED|Open-label Long-term Phase||9
380795|NCT01933919|935819|P1|COMPLETED|Open-label Long-term Phase||12
380796|NCT01933919|935818|P2|STARTED|Open-label Long-term Phase||15
380797|NCT01933919|935819|P1|STARTED|Open-label Long-term Phase||19
380798|NCT01933919|935818|P2|NOT COMPLETED|Double-blind Placebo-controlled Phase||4
380799|NCT01933919|935819|P1|NOT COMPLETED|Double-blind Placebo-controlled Phase||0
380800|NCT01933919|935818|P2|COMPLETED|Double-blind Placebo-controlled Phase||15
380801|NCT01933919|935819|P1|COMPLETED|Double-blind Placebo-controlled Phase||19
380802|NCT01933919|935818|P2|Received Study Drug|Double-blind Placebo-controlled Phase||19
380803|NCT01933919|935819|P1|Received Study Drug|Double-blind Placebo-controlled Phase||19
380804|NCT01933919|935818|P2|STARTED|Double-blind Placebo-controlled Phase||19
380805|NCT01933919|935819|P1|STARTED|Double-blind Placebo-controlled Phase||19
380806|NCT01933880|935855|P2|NOT COMPLETED|Overall Study||1
380807|NCT01933880|935856|P1|NOT COMPLETED|Overall Study||30
380808|NCT01933880|935855|P2|COMPLETED|Overall Study||40
380809|NCT01933880|935856|P1|COMPLETED|Overall Study||123
380810|NCT01933880|935855|P2|STARTED|Overall Study||41
380811|NCT01933880|935856|P1|STARTED|Overall Study||153
380812|NCT01933776|935923|P2|NOT COMPLETED|Overall Study||0
380813|NCT01933776|935924|P1|NOT COMPLETED|Overall Study||0
380814|NCT01933776|935923|P2|COMPLETED|Overall Study||20
380815|NCT01933776|935924|P1|COMPLETED|Overall Study||20
380816|NCT01933776|935923|P2|STARTED|Overall Study||20
380817|NCT01933776|935924|P1|STARTED|Overall Study||20
380818|NCT01933672|935932|P7|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
380819|NCT01933672|935933|P6|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
380820|NCT01933672|935934|P5|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
380821|NCT01933672|935935|P4|NOT COMPLETED|Third Intervention Period (12-16 Days)||1
380822|NCT01933672|935936|P3|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
380823|NCT01933672|935937|P2|NOT COMPLETED|Third Intervention Period (12-16 Days)||1
380824|NCT01933672|935938|P1|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
380825|NCT01933672|935932|P7|COMPLETED|Third Intervention Period (12-16 Days)||6
380826|NCT01933672|935933|P6|COMPLETED|Third Intervention Period (12-16 Days)||4
380827|NCT01933672|935934|P5|COMPLETED|Third Intervention Period (12-16 Days)||6
380828|NCT01933672|935935|P4|COMPLETED|Third Intervention Period (12-16 Days)||4
380829|NCT01933672|935936|P3|COMPLETED|Third Intervention Period (12-16 Days)||1
380830|NCT01933672|935937|P2|COMPLETED|Third Intervention Period (12-16 Days)||5
380831|NCT01933672|935938|P1|COMPLETED|Third Intervention Period (12-16 Days)||0
380832|NCT01933672|935932|P7|STARTED|Third Intervention Period (12-16 Days)||6
380833|NCT01933672|935933|P6|STARTED|Third Intervention Period (12-16 Days)||4
380834|NCT01933672|935934|P5|STARTED|Third Intervention Period (12-16 Days)||6
380835|NCT01933672|935935|P4|STARTED|Third Intervention Period (12-16 Days)||5
380836|NCT01933672|935936|P3|STARTED|Third Intervention Period (12-16 Days)||1
380837|NCT01933672|935937|P2|STARTED|Third Intervention Period (12-16 Days)||6
380838|NCT01933672|935938|P1|STARTED|Third Intervention Period (12-16 Days)||0
380839|NCT01933672|935932|P7|NOT COMPLETED|Second Washout Period (7-14 Days)||0
380840|NCT01933672|935933|P6|NOT COMPLETED|Second Washout Period (7-14 Days)||0
380841|NCT01933672|935934|P5|NOT COMPLETED|Second Washout Period (7-14 Days)||0
380842|NCT01933672|935935|P4|NOT COMPLETED|Second Washout Period (7-14 Days)||0
380843|NCT01933672|935936|P3|NOT COMPLETED|Second Washout Period (7-14 Days)||0
380844|NCT01933672|935937|P2|NOT COMPLETED|Second Washout Period (7-14 Days)||0
380845|NCT01933672|935938|P1|NOT COMPLETED|Second Washout Period (7-14 Days)||0
380846|NCT01933672|935932|P7|COMPLETED|Second Washout Period (7-14 Days)||6
380847|NCT01933672|935933|P6|COMPLETED|Second Washout Period (7-14 Days)||4
380848|NCT01933672|935934|P5|COMPLETED|Second Washout Period (7-14 Days)||6
380849|NCT01933672|935935|P4|COMPLETED|Second Washout Period (7-14 Days)||5
380850|NCT01933672|935936|P3|COMPLETED|Second Washout Period (7-14 Days)||1
380851|NCT01933672|935937|P2|COMPLETED|Second Washout Period (7-14 Days)||6
380852|NCT01933672|935938|P1|COMPLETED|Second Washout Period (7-14 Days)||0
380853|NCT01933672|935932|P7|STARTED|Second Washout Period (7-14 Days)||6
380854|NCT01933672|935933|P6|STARTED|Second Washout Period (7-14 Days)||4
380855|NCT01933672|935934|P5|STARTED|Second Washout Period (7-14 Days)||6
380856|NCT01933672|935935|P4|STARTED|Second Washout Period (7-14 Days)||5
380857|NCT01933672|935936|P3|STARTED|Second Washout Period (7-14 Days)||1
380858|NCT01933672|935937|P2|STARTED|Second Washout Period (7-14 Days)||6
380859|NCT01933672|935938|P1|STARTED|Second Washout Period (7-14 Days)||0
380860|NCT01933672|935932|P7|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
380861|NCT01933672|935933|P6|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
380862|NCT01933672|935934|P5|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
380863|NCT01933672|935935|P4|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
380864|NCT01933672|935936|P3|NOT COMPLETED|Second Intervention Period (12-16 Days)||1
380865|NCT01933672|935937|P2|NOT COMPLETED|Second Intervention Period (12-16 Days)||1
380866|NCT01933672|935938|P1|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
380867|NCT01933672|935932|P7|COMPLETED|Second Intervention Period (12-16 Days)||6
380868|NCT01933672|935933|P6|COMPLETED|Second Intervention Period (12-16 Days)||4
380869|NCT01933672|935934|P5|COMPLETED|Second Intervention Period (12-16 Days)||6
380870|NCT01933672|935935|P4|COMPLETED|Second Intervention Period (12-16 Days)||5
380871|NCT01933672|935936|P3|COMPLETED|Second Intervention Period (12-16 Days)||1
380872|NCT01933672|935937|P2|COMPLETED|Second Intervention Period (12-16 Days)||6
380873|NCT01933672|935938|P1|COMPLETED|Second Intervention Period (12-16 Days)||0
380874|NCT01933672|935932|P7|STARTED|Second Intervention Period (12-16 Days)||6
380875|NCT01933672|935933|P6|STARTED|Second Intervention Period (12-16 Days)||4
380876|NCT01933672|935934|P5|STARTED|Second Intervention Period (12-16 Days)||6
380877|NCT01933672|935935|P4|STARTED|Second Intervention Period (12-16 Days)||5
380878|NCT01933672|935936|P3|STARTED|Second Intervention Period (12-16 Days)||2
380879|NCT01933672|935937|P2|STARTED|Second Intervention Period (12-16 Days)||7
380880|NCT01933672|935938|P1|STARTED|Second Intervention Period (12-16 Days)||0
380881|NCT01933672|935932|P7|NOT COMPLETED|First Washout Period (7-14 Days)||0
380882|NCT01933672|935933|P6|NOT COMPLETED|First Washout Period (7-14 Days)||0
380883|NCT01933672|935934|P5|NOT COMPLETED|First Washout Period (7-14 Days)||0
380884|NCT01933672|935935|P4|NOT COMPLETED|First Washout Period (7-14 Days)||0
380885|NCT01933672|935936|P3|NOT COMPLETED|First Washout Period (7-14 Days)||0
380886|NCT01933672|935937|P2|NOT COMPLETED|First Washout Period (7-14 Days)||0
380887|NCT01933672|935938|P1|NOT COMPLETED|First Washout Period (7-14 Days)||0
380888|NCT01933672|935932|P7|COMPLETED|First Washout Period (7-14 Days)||6
380889|NCT01933672|935933|P6|COMPLETED|First Washout Period (7-14 Days)||4
380890|NCT01933672|935934|P5|COMPLETED|First Washout Period (7-14 Days)||6
380891|NCT01933672|935935|P4|COMPLETED|First Washout Period (7-14 Days)||5
380892|NCT01933672|935936|P3|COMPLETED|First Washout Period (7-14 Days)||2
380893|NCT01933672|935937|P2|COMPLETED|First Washout Period (7-14 Days)||7
380894|NCT01933672|935938|P1|COMPLETED|First Washout Period (7-14 Days)||0
380895|NCT01933672|935932|P7|STARTED|First Washout Period (7-14 Days)||6
380896|NCT01933672|935933|P6|STARTED|First Washout Period (7-14 Days)||4
380897|NCT01933672|935934|P5|STARTED|First Washout Period (7-14 Days)||6
380898|NCT01933672|935935|P4|STARTED|First Washout Period (7-14 Days)||5
380899|NCT01933672|935936|P3|STARTED|First Washout Period (7-14 Days)||2
380900|NCT01933672|935937|P2|STARTED|First Washout Period (7-14 Days)||7
380901|NCT01933672|935938|P1|STARTED|First Washout Period (7-14 Days)||0
380902|NCT01933672|935932|P7|NOT COMPLETED|First Intervention Period (12-16 Days)||0
380903|NCT01933672|935933|P6|NOT COMPLETED|First Intervention Period (12-16 Days)||1
380904|NCT01933672|935934|P5|NOT COMPLETED|First Intervention Period (12-16 Days)||1
380905|NCT01933672|935935|P4|NOT COMPLETED|First Intervention Period (12-16 Days)||0
380906|NCT01933672|935936|P3|NOT COMPLETED|First Intervention Period (12-16 Days)||1
380907|NCT01933672|935937|P2|NOT COMPLETED|First Intervention Period (12-16 Days)||0
380908|NCT01933672|935938|P1|NOT COMPLETED|First Intervention Period (12-16 Days)||0
380909|NCT01933672|935932|P7|COMPLETED|First Intervention Period (12-16 Days)||6
380910|NCT01933672|935933|P6|COMPLETED|First Intervention Period (12-16 Days)||4
380911|NCT01933672|935934|P5|COMPLETED|First Intervention Period (12-16 Days)||6
380912|NCT01933672|935935|P4|COMPLETED|First Intervention Period (12-16 Days)||5
380913|NCT01933672|935936|P3|COMPLETED|First Intervention Period (12-16 Days)||2
380914|NCT01933672|935937|P2|COMPLETED|First Intervention Period (12-16 Days)||7
380915|NCT01933672|935938|P1|COMPLETED|First Intervention Period (12-16 Days)||0
380916|NCT01933672|935932|P7|STARTED|First Intervention Period (12-16 Days)||6
380917|NCT01933672|935933|P6|STARTED|First Intervention Period (12-16 Days)||5
380918|NCT01933672|935934|P5|STARTED|First Intervention Period (12-16 Days)||7
380919|NCT01933672|935935|P4|STARTED|First Intervention Period (12-16 Days)||5
380920|NCT01933672|935936|P3|STARTED|First Intervention Period (12-16 Days)||3
380921|NCT01933672|935937|P2|STARTED|First Intervention Period (12-16 Days)||7
380922|NCT01933672|935938|P1|STARTED|First Intervention Period (12-16 Days)||0
380923|NCT01933672|935932|P7|NOT COMPLETED|Metformin Run-in Period||0
380924|NCT01933672|935933|P6|NOT COMPLETED|Metformin Run-in Period||0
380925|NCT01933672|935934|P5|NOT COMPLETED|Metformin Run-in Period||0
380926|NCT01933672|935935|P4|NOT COMPLETED|Metformin Run-in Period||0
380927|NCT01933672|935936|P3|NOT COMPLETED|Metformin Run-in Period||0
380928|NCT01933672|935937|P2|NOT COMPLETED|Metformin Run-in Period||0
380929|NCT01933672|935938|P1|NOT COMPLETED|Metformin Run-in Period||10
380930|NCT01933672|935932|P7|COMPLETED|Metformin Run-in Period||0
380931|NCT01933672|935933|P6|COMPLETED|Metformin Run-in Period||0
380932|NCT01933672|935934|P5|COMPLETED|Metformin Run-in Period||0
380933|NCT01933672|935935|P4|COMPLETED|Metformin Run-in Period||0
380934|NCT01933672|935936|P3|COMPLETED|Metformin Run-in Period||0
380935|NCT01933672|935937|P2|COMPLETED|Metformin Run-in Period||0
380936|NCT01933672|935938|P1|COMPLETED|Metformin Run-in Period||33
380937|NCT01933672|935932|P7|Received Treatment|Metformin Run-in Period||0
380938|NCT01933672|935933|P6|Received Treatment|Metformin Run-in Period||0
380939|NCT01933672|935934|P5|Received Treatment|Metformin Run-in Period||0
380940|NCT01933672|935935|P4|Received Treatment|Metformin Run-in Period||0
380941|NCT01933672|935936|P3|Received Treatment|Metformin Run-in Period||0
380942|NCT01933672|935937|P2|Received Treatment|Metformin Run-in Period||0
380943|NCT01933672|935938|P1|Received Treatment|Metformin Run-in Period||43
380944|NCT01933672|935932|P7|STARTED|Metformin Run-in Period||0
380945|NCT01933672|935933|P6|STARTED|Metformin Run-in Period||0
380946|NCT01933672|935934|P5|STARTED|Metformin Run-in Period||0
380947|NCT01933672|935935|P4|STARTED|Metformin Run-in Period||0
380948|NCT01933672|935936|P3|STARTED|Metformin Run-in Period||0
380949|NCT01933672|935937|P2|STARTED|Metformin Run-in Period||0
380950|NCT01933672|935938|P1|STARTED|Metformin Run-in Period||43
380951|NCT01933425|935984|P2|NOT COMPLETED|Overall Study||0
380952|NCT01933425|935985|P1|NOT COMPLETED|Overall Study||0
380953|NCT01933425|935984|P2|COMPLETED|Overall Study||7
380954|NCT01933425|935985|P1|COMPLETED|Overall Study||7
380955|NCT01933425|935984|P2|STARTED|Overall Study||7
380956|NCT01933425|935985|P1|STARTED|Overall Study||7
380957|NCT01933399|935998|P3|NOT COMPLETED|Overall Study||0
380958|NCT01933399|935999|P2|NOT COMPLETED|Overall Study||0
380959|NCT01933399|936000|P1|NOT COMPLETED|Overall Study||0
380960|NCT01933399|935998|P3|COMPLETED|Overall Study||37
380961|NCT01933399|935999|P2|COMPLETED|Overall Study||32
380962|NCT01933399|936000|P1|COMPLETED|Overall Study||29
380963|NCT01933399|935998|P3|STARTED|Overall Study||37
380964|NCT01933399|935999|P2|STARTED|Overall Study||32
380965|NCT01933399|936000|P1|STARTED|Overall Study||29
380966|NCT01933334|936013|P2|NOT COMPLETED|Overall Study||2
380967|NCT01933334|936014|P1|NOT COMPLETED|Overall Study||5
380968|NCT01933334|936013|P2|COMPLETED|Overall Study||29
380969|NCT01933334|936014|P1|COMPLETED|Overall Study||27
380970|NCT01933334|936013|P2|STARTED|Overall Study||31
380971|NCT01933334|936014|P1|STARTED|Overall Study||32
380972|NCT01933243|936026|P2|NOT COMPLETED|Overall Study||4
380973|NCT01933243|936027|P1|NOT COMPLETED|Overall Study||2
380974|NCT01933243|936026|P2|COMPLETED|Overall Study||8
380975|NCT01933243|936027|P1|COMPLETED|Overall Study||10
380976|NCT01933243|936026|P2|STARTED|Overall Study||12
380977|NCT01933243|936027|P1|STARTED|Overall Study||12
380978|NCT01933230|936037|P1|NOT COMPLETED|Overall Study||0
380979|NCT01933230|936037|P1|COMPLETED|Overall Study||2
380980|NCT01933230|936037|P1|STARTED|Overall Study||2
380981|NCT01933048|936043|P2|NOT COMPLETED|Overall Study||28
380982|NCT01933048|936044|P1|NOT COMPLETED|Overall Study||25
380983|NCT01933048|936043|P2|COMPLETED|Overall Study||501
380984|NCT01933048|936044|P1|COMPLETED|Overall Study||523
380985|NCT01933048|936043|P2|STARTED|Overall Study||529
380986|NCT01933048|936044|P1|STARTED|Overall Study||548
380987|NCT01932970|936057|P1|NOT COMPLETED|Overall Study||18
380988|NCT01932970|936057|P1|COMPLETED|Overall Study||140
380989|NCT01932970|936057|P1|Received Treatment|Overall Study|Includes participants who completed the washout period and received etelcalcetide|148
380990|NCT01932970|936057|P1|STARTED|Overall Study|Includes all participants who enrolled into the washout period.|158
380991|NCT01932762|936069|P4|NOT COMPLETED|Overall Study||1
380992|NCT01932762|936070|P3|NOT COMPLETED|Overall Study||0
380993|NCT01932762|936071|P2|NOT COMPLETED|Overall Study||2
380994|NCT01932762|936072|P1|NOT COMPLETED|Overall Study||6
380995|NCT01932762|936069|P4|COMPLETED|Overall Study||18
380996|NCT01932762|936070|P3|COMPLETED|Overall Study||19
380997|NCT01932762|936071|P2|COMPLETED|Overall Study||28
380998|NCT01932762|936072|P1|COMPLETED|Overall Study||24
380999|NCT01932762|936069|P4|STARTED|Overall Study||19
381000|NCT01932762|936070|P3|STARTED|Overall Study||19
381001|NCT01932762|936071|P2|STARTED|Overall Study||30
381002|NCT01932762|936072|P1|STARTED|Overall Study||30
381003|NCT01932606|936108|P2|NOT COMPLETED|Overall Study||0
381004|NCT01932606|936109|P1|NOT COMPLETED|Overall Study||0
381005|NCT01932606|936108|P2|COMPLETED|Overall Study||14
381006|NCT01932606|936109|P1|COMPLETED|Overall Study||14
381007|NCT01932606|936108|P2|STARTED|Overall Study||14
381008|NCT01932606|936109|P1|STARTED|Overall Study||14
381009|NCT01932164|936159|P1|NOT COMPLETED|Overall Study||0
381010|NCT01932164|936159|P1|COMPLETED|Overall Study|In all 5 patients we observed bone formation closing the alveolar cleft after 6 months|5
381011|NCT01932164|936159|P1|Cleft Lip and Palate|Overall Study|The surgeries were performed between december 2013 and june 2014.|5
381012|NCT01932164|936159|P1|Cleft Lip and Palate|Overall Study|Alveolar bone graft surgeries were did using their dental pulp stem cells with biomaterial|5
381013|NCT01932164|936159|P1|Cleft Lip and Palate|Overall Study|Mesenchymal stem cell obtained from dental pulp of 5patients was obtained, caractherized and frozen|5
381014|NCT01932164|936159|P1|Cleft Lip and Palate|Overall Study|Dental pulp was obtained from teeth of 5 different patients (09/2013)|5
381015|NCT01932164|936159|P1|Cleft Lip and Palate|Overall Study|It was performed de extraction of deciduous teeth of 5 cleft lip/palate patients (09/2013)|5
381016|NCT01932164|936159|P1|STARTED|Overall Study|It was performed the selection of 5 patients to participate of these study (08/2013)|5
381017|NCT01932112|936164|P1|NOT COMPLETED|Overall Study||0
381018|NCT01932112|936164|P1|COMPLETED|Overall Study||378
381019|NCT01932112|936164|P1|STARTED|Overall Study||378
381020|NCT01932060|936170|P2|NOT COMPLETED|Overall Study||0
381021|NCT01932060|936171|P1|NOT COMPLETED|Overall Study||0
381022|NCT01932060|936170|P2|COMPLETED|Overall Study||24
381023|NCT01932060|936171|P1|COMPLETED|Overall Study||27
381024|NCT01932060|936170|P2|STARTED|Overall Study||24
381025|NCT01932060|936171|P1|STARTED|Overall Study||27
381026|NCT01931956|936181|P2|NOT COMPLETED|4 Years Follow-up Period||0
381027|NCT01931956|936182|P1|NOT COMPLETED|4 Years Follow-up Period||14
381028|NCT01931956|936181|P2|COMPLETED|4 Years Follow-up Period||0
381029|NCT01931956|936182|P1|COMPLETED|4 Years Follow-up Period||1
381030|NCT01931956|936181|P2|STARTED|4 Years Follow-up Period||0
381031|NCT01931956|936182|P1|STARTED|4 Years Follow-up Period||15
381032|NCT01931956|936181|P2|NOT COMPLETED|3 Years Follow-up Period||0
381033|NCT01931956|936182|P1|NOT COMPLETED|3 Years Follow-up Period||6
381034|NCT01931956|936181|P2|COMPLETED|3 Years Follow-up Period||0
381035|NCT01931956|936182|P1|COMPLETED|3 Years Follow-up Period||15
381036|NCT01931956|936181|P2|STARTED|3 Years Follow-up Period||0
381037|NCT01931956|936182|P1|STARTED|3 Years Follow-up Period||21
381038|NCT01931956|936181|P2|NOT COMPLETED|2 Years Follow-up Period||1
381039|NCT01931956|936182|P1|NOT COMPLETED|2 Years Follow-up Period||12
381040|NCT01931956|936181|P2|COMPLETED|2 Years Follow-up Period||0
381041|NCT01931956|936182|P1|COMPLETED|2 Years Follow-up Period||21
381042|NCT01931956|936181|P2|STARTED|2 Years Follow-up Period||1
381043|NCT01931956|936182|P1|STARTED|2 Years Follow-up Period||33
381044|NCT01931956|936181|P2|NOT COMPLETED|12 Months Follow-up Period||1
381045|NCT01931956|936182|P1|NOT COMPLETED|12 Months Follow-up Period||10
381046|NCT01931956|936181|P2|COMPLETED|12 Months Follow-up Period||1
381047|NCT01931956|936182|P1|COMPLETED|12 Months Follow-up Period||33
381048|NCT01931956|936181|P2|STARTED|12 Months Follow-up Period||2
381049|NCT01931956|936182|P1|STARTED|12 Months Follow-up Period||43
381050|NCT01931956|936181|P2|NOT COMPLETED|6 Months Follow-up Period||2
381051|NCT01931956|936182|P1|NOT COMPLETED|6 Months Follow-up Period||10
381052|NCT01931956|936181|P2|COMPLETED|6 Months Follow-up Period||2
381053|NCT01931956|936182|P1|COMPLETED|6 Months Follow-up Period||43
381054|NCT01931956|936181|P2|STARTED|6 Months Follow-up Period||4
381055|NCT01931956|936182|P1|STARTED|6 Months Follow-up Period||53
381056|NCT01931956|936181|P2|NOT COMPLETED|30 Days Follow-up Period||3
381057|NCT01931956|936182|P1|NOT COMPLETED|30 Days Follow-up Period||6
381058|NCT01931956|936181|P2|COMPLETED|30 Days Follow-up Period||4
381059|NCT01931956|936182|P1|COMPLETED|30 Days Follow-up Period||53
381060|NCT01931956|936181|P2|STARTED|30 Days Follow-up Period||7
381061|NCT01931956|936182|P1|STARTED|30 Days Follow-up Period||59
381062|NCT01931878|936308|P2|NOT COMPLETED|Second Intervention (After 3 Months)||2
381063|NCT01931878|936309|P1|NOT COMPLETED|Second Intervention (After 3 Months)||0
381064|NCT01931878|936308|P2|COMPLETED|Second Intervention (After 3 Months)||12
381065|NCT01931878|936309|P1|COMPLETED|Second Intervention (After 3 Months)||9
381066|NCT01931878|936308|P2|STARTED|Second Intervention (After 3 Months)||14
381067|NCT01931878|936309|P1|STARTED|Second Intervention (After 3 Months)||9
381068|NCT01931878|936308|P2|NOT COMPLETED|First Intervention||0
381069|NCT01931878|936309|P1|NOT COMPLETED|First Intervention||1
381070|NCT01931878|936308|P2|COMPLETED|First Intervention||14
381071|NCT01931878|936309|P1|COMPLETED|First Intervention||9
381072|NCT01931878|936308|P2|STARTED|First Intervention||14
381073|NCT01931878|936309|P1|STARTED|First Intervention||10
381074|NCT01931865|936319|P1|NOT COMPLETED|Overall Study||4
381075|NCT01931865|936319|P1|COMPLETED|Overall Study||8
381076|NCT01931865|936319|P1|STARTED|Overall Study||12
381077|NCT01931839|936332|P7|NOT COMPLETED|Overall Study||4
381078|NCT01931839|936333|P6|NOT COMPLETED|Overall Study||5
381079|NCT01931839|936334|P5|NOT COMPLETED|Overall Study||1
381080|NCT01931839|936335|P4|NOT COMPLETED|Overall Study||14
381081|NCT01931839|936336|P3|NOT COMPLETED|Overall Study||39
381082|NCT01931839|936337|P2|NOT COMPLETED|Overall Study||26
381083|NCT01931839|936338|P1|NOT COMPLETED|Overall Study||41
381084|NCT01931839|936332|P7|COMPLETED|Overall Study||56
381085|NCT01931839|936333|P6|COMPLETED|Overall Study||50
381086|NCT01931839|936334|P5|COMPLETED|Overall Study||18
381087|NCT01931839|936335|P4|COMPLETED|Overall Study||162
381088|NCT01931839|936336|P3|COMPLETED|Overall Study||301
381089|NCT01931839|936337|P2|COMPLETED|Overall Study||152
381090|NCT01931839|936338|P1|COMPLETED|Overall Study||294
381091|NCT01931839|936332|P7|Safety Analysis Set (As Dosed)|Overall Study||60
381092|NCT01931839|936333|P6|Safety Analysis Set (As Dosed)|Overall Study||55
381093|NCT01931839|936334|P5|Safety Analysis Set (As Dosed)|Overall Study||19
381094|NCT01931839|936335|P4|Safety Analysis Set (As Dosed)|Overall Study||176
381095|NCT01931839|936336|P3|Safety Analysis Set (As Dosed)|Overall Study||340
381096|NCT01931839|936337|P2|Safety Analysis Set (As Dosed)|Overall Study||178
381097|NCT01931839|936338|P1|Safety Analysis Set (As Dosed)|Overall Study||335
381098|NCT01931839|936332|P7|Full Analysis Set (As Randomized)|Overall Study||60
381099|NCT01931839|936333|P6|Full Analysis Set (As Randomized)|Overall Study||55
381100|NCT01931839|936334|P5|Full Analysis Set (As Randomized)|Overall Study||19
381101|NCT01931839|936335|P4|Full Analysis Set (As Randomized)|Overall Study||176
381102|NCT01931839|936336|P3|Full Analysis Set (As Randomized)|Overall Study||340
381103|NCT01931839|936337|P2|Full Analysis Set (As Randomized)|Overall Study||179
381104|NCT01931839|936338|P1|Full Analysis Set (As Randomized)|Overall Study||334
381105|NCT01931839|936332|P7|STARTED|Overall Study||60
381106|NCT01931839|936333|P6|STARTED|Overall Study||55
381107|NCT01931839|936334|P5|STARTED|Overall Study||19
381108|NCT01931839|936335|P4|STARTED|Overall Study||176
381109|NCT01931839|936336|P3|STARTED|Overall Study||340
381110|NCT01931839|936337|P2|STARTED|Overall Study||178
381111|NCT01931839|936338|P1|STARTED|Overall Study||335
381112|NCT01931709|936406|P1|NOT COMPLETED|Overall Study||0
381113|NCT01931709|936406|P1|COMPLETED|Overall Study||35
381114|NCT01931709|936406|P1|STARTED|Overall Study||35
381115|NCT01931527|936418|P2|NOT COMPLETED|Overall Study||0
381116|NCT01931527|936419|P1|NOT COMPLETED|Overall Study||0
381117|NCT01931527|936418|P2|COMPLETED|Overall Study||15
381118|NCT01931527|936419|P1|COMPLETED|Overall Study||16
381119|NCT01931527|936418|P2|STARTED|Overall Study||15
381120|NCT01931527|936419|P1|STARTED|Overall Study||16
381121|NCT01931475|936429|P2|NOT COMPLETED|Period 2: Extension Treatment Phase||19
381122|NCT01931475|936430|P1|NOT COMPLETED|Period 2: Extension Treatment Phase||4
381123|NCT01931475|936429|P2|COMPLETED|Period 2: Extension Treatment Phase||157
381124|NCT01931475|936430|P1|COMPLETED|Period 2: Extension Treatment Phase||162
381125|NCT01931475|936429|P2|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||175
381126|NCT01931475|936430|P1|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||166
381127|NCT01931475|936429|P2|STARTED|Period 2: Extension Treatment Phase||176
381128|NCT01931475|936430|P1|STARTED|Period 2: Extension Treatment Phase||166
381129|NCT01931475|936429|P2|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||26
381130|NCT01931475|936430|P1|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||39
381131|NCT01931475|936429|P2|COMPLETED|Period 1: Double-Blind Treatment Phase||176
381132|NCT01931475|936430|P1|COMPLETED|Period 1: Double-Blind Treatment Phase||166
381133|NCT01931475|936429|P2|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||198
381134|NCT01931475|936430|P1|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||199
381135|NCT01931475|936429|P2|STARTED|Period 1: Double-Blind Treatment Phase||202
381136|NCT01931475|936430|P1|STARTED|Period 1: Double-Blind Treatment Phase||205
381137|NCT01931462|936457|P1|NOT COMPLETED|Overall Study||1
381138|NCT01931462|936457|P1|COMPLETED|Overall Study||1
381139|NCT01931462|936457|P1|STARTED|Overall Study||2
381140|NCT01931397|936468|P1|NOT COMPLETED|Overall Study||11
381141|NCT01931397|936468|P1|COMPLETED|Overall Study||19
381142|NCT01931397|936468|P1|STARTED|Overall Study||30
381143|NCT01931150|936479|P2|NOT COMPLETED|Overall Study||2
381144|NCT01931150|936480|P1|NOT COMPLETED|Overall Study||1
381145|NCT01931150|936479|P2|COMPLETED|Overall Study||4
381146|NCT01931150|936480|P1|COMPLETED|Overall Study||4
381147|NCT01931150|936479|P2|STARTED|Overall Study||6
381148|NCT01931150|936480|P1|STARTED|Overall Study||5
381149|NCT01931059|936488|P2|NOT COMPLETED|Day3||0
381150|NCT01931059|936489|P1|NOT COMPLETED|Day3||1
381151|NCT01931059|936488|P2|COMPLETED|Day3||4
381152|NCT01931059|936489|P1|COMPLETED|Day3||5
381153|NCT01931059|936488|P2|STARTED|Day3||4
381154|NCT01931059|936489|P1|STARTED|Day3||6
381155|NCT01931059|936488|P2|NOT COMPLETED|Day2||0
381156|NCT01931059|936489|P1|NOT COMPLETED|Day2||0
381157|NCT01931059|936488|P2|COMPLETED|Day2||4
381158|NCT01931059|936489|P1|COMPLETED|Day2||6
381159|NCT01931059|936488|P2|STARTED|Day2||4
381160|NCT01931059|936489|P1|STARTED|Day2||6
381161|NCT01931059|936488|P2|NOT COMPLETED|Day 1||1
381162|NCT01931059|936489|P1|NOT COMPLETED|Day 1||0
381163|NCT01931059|936488|P2|COMPLETED|Day 1||4
381164|NCT01931059|936489|P1|COMPLETED|Day 1||6
381165|NCT01931059|936488|P2|STARTED|Day 1||5
381166|NCT01931059|936489|P1|STARTED|Day 1||6
381167|NCT01930890|936505|P4|NOT COMPLETED|Overall Study||27
381168|NCT01930890|936506|P3|NOT COMPLETED|Overall Study||13
381169|NCT01930890|936507|P2|NOT COMPLETED|Overall Study||33
381170|NCT01930890|936508|P1|NOT COMPLETED|Overall Study||14
381171|NCT01930890|936505|P4|COMPLETED|Overall Study||0
381172|NCT01930890|936506|P3|COMPLETED|Overall Study||0
381173|NCT01930890|936507|P2|COMPLETED|Overall Study||0
381174|NCT01930890|936508|P1|COMPLETED|Overall Study||0
381175|NCT01930890|936505|P4|STARTED|Overall Study||27
381176|NCT01930890|936506|P3|STARTED|Overall Study||13
381177|NCT01930890|936507|P2|STARTED|Overall Study||33
381178|NCT01930890|936508|P1|STARTED|Overall Study||14
381179|NCT01930799|936522|P1|NOT COMPLETED|Overall Study||8
381180|NCT01930799|936522|P1|COMPLETED|Overall Study||112
381181|NCT01930799|936522|P1|STARTED|Overall Study||120
381182|NCT01930487|936527|P2|NOT COMPLETED|Second Intervention (30 Days)||0
381183|NCT01930487|936528|P1|NOT COMPLETED|Second Intervention (30 Days)||0
381184|NCT01930487|936527|P2|COMPLETED|Second Intervention (30 Days)||23
381185|NCT01930487|936528|P1|COMPLETED|Second Intervention (30 Days)||19
381186|NCT01930487|936527|P2|STARTED|Second Intervention (30 Days)||23
381187|NCT01930487|936528|P1|STARTED|Second Intervention (30 Days)||19
381188|NCT01930487|936527|P2|NOT COMPLETED|Washout Period (3 Weeks)||0
381189|NCT01930487|936528|P1|NOT COMPLETED|Washout Period (3 Weeks)||0
381190|NCT01930487|936527|P2|COMPLETED|Washout Period (3 Weeks)||23
381191|NCT01930487|936528|P1|COMPLETED|Washout Period (3 Weeks)||19
381192|NCT01930487|936527|P2|STARTED|Washout Period (3 Weeks)||23
381193|NCT01930487|936528|P1|STARTED|Washout Period (3 Weeks)||19
381194|NCT01930487|936527|P2|NOT COMPLETED|First Intervention (30 Days)||2
381195|NCT01930487|936528|P1|NOT COMPLETED|First Intervention (30 Days)||2
381196|NCT01930487|936527|P2|COMPLETED|First Intervention (30 Days)||23
381197|NCT01930487|936528|P1|COMPLETED|First Intervention (30 Days)||19
381198|NCT01930487|936527|P2|STARTED|First Intervention (30 Days)||25
381199|NCT01930487|936528|P1|STARTED|First Intervention (30 Days)||21
381200|NCT01930435|936622|P1|NOT COMPLETED|Overall Study||0
381201|NCT01930435|936622|P1|COMPLETED|Overall Study||20
381202|NCT01930435|936622|P1|STARTED|Overall Study||20
381203|NCT01930162|936630|P1|NOT COMPLETED|Overall Study||5
381204|NCT01930162|936630|P1|COMPLETED|Overall Study||4
381205|NCT01930162|936630|P1|STARTED|Overall Study||9
381206|NCT01930058|936642|P3|NOT COMPLETED|Overall Study||0
381207|NCT01930058|936643|P2|NOT COMPLETED|Overall Study||0
381208|NCT01930058|936644|P1|NOT COMPLETED|Overall Study||0
381209|NCT01930058|936642|P3|COMPLETED|Overall Study||3
381210|NCT01930058|936643|P2|COMPLETED|Overall Study||3
381211|NCT01930058|936644|P1|COMPLETED|Overall Study||3
381212|NCT01930058|936642|P3|STARTED|Overall Study||3
381213|NCT01930058|936643|P2|STARTED|Overall Study||3
381214|NCT01930058|936644|P1|STARTED|Overall Study||3
381215|NCT01930045|936666|P6|NOT COMPLETED|Part 2 - Period 5||0
381216|NCT01930045|936667|P5|NOT COMPLETED|Part 2 - Period 5||0
381217|NCT01930045|936668|P4|NOT COMPLETED|Part 2 - Period 5||0
381218|NCT01930045|936669|P3|NOT COMPLETED|Part 2 - Period 5||0
381219|NCT01930045|936670|P2|NOT COMPLETED|Part 2 - Period 5||0
381220|NCT01930045|936671|P1|NOT COMPLETED|Part 2 - Period 5||0
381221|NCT01930045|936666|P6|COMPLETED|Part 2 - Period 5||1
381222|NCT01930045|936667|P5|COMPLETED|Part 2 - Period 5||3
381223|NCT01930045|936668|P4|COMPLETED|Part 2 - Period 5||3
381224|NCT01930045|936669|P3|COMPLETED|Part 2 - Period 5||3
381225|NCT01930045|936670|P2|COMPLETED|Part 2 - Period 5||3
381226|NCT01930045|936671|P1|COMPLETED|Part 2 - Period 5||3
381227|NCT01930045|936666|P6|STARTED|Part 2 - Period 5||1
381228|NCT01930045|936667|P5|STARTED|Part 2 - Period 5||3
381229|NCT01930045|936668|P4|STARTED|Part 2 - Period 5||3
381230|NCT01930045|936669|P3|STARTED|Part 2 - Period 5||3
381231|NCT01930045|936670|P2|STARTED|Part 2 - Period 5||3
381232|NCT01930045|936671|P1|STARTED|Part 2 - Period 5||3
381233|NCT01930045|936666|P6|NOT COMPLETED|Part 2 - Period 4||0
381234|NCT01930045|936667|P5|NOT COMPLETED|Part 2 - Period 4||0
381235|NCT01930045|936668|P4|NOT COMPLETED|Part 2 - Period 4||0
381236|NCT01930045|936669|P3|NOT COMPLETED|Part 2 - Period 4||0
381237|NCT01930045|936670|P2|NOT COMPLETED|Part 2 - Period 4||0
381238|NCT01930045|936671|P1|NOT COMPLETED|Part 2 - Period 4||0
381239|NCT01930045|936666|P6|COMPLETED|Part 2 - Period 4||1
381240|NCT01930045|936667|P5|COMPLETED|Part 2 - Period 4||3
381241|NCT01930045|936668|P4|COMPLETED|Part 2 - Period 4||3
381242|NCT01930045|936669|P3|COMPLETED|Part 2 - Period 4||3
381243|NCT01930045|936670|P2|COMPLETED|Part 2 - Period 4||3
381244|NCT01930045|936671|P1|COMPLETED|Part 2 - Period 4||3
381245|NCT01930045|936666|P6|STARTED|Part 2 - Period 4||1
381246|NCT01930045|936667|P5|STARTED|Part 2 - Period 4||3
381247|NCT01930045|936668|P4|STARTED|Part 2 - Period 4||3
381248|NCT01930045|936669|P3|STARTED|Part 2 - Period 4||3
381249|NCT01930045|936670|P2|STARTED|Part 2 - Period 4||3
381250|NCT01930045|936671|P1|STARTED|Part 2 - Period 4||3
381251|NCT01930045|936666|P6|NOT COMPLETED|Pause (up to 37 Days)||2
381252|NCT01930045|936667|P5|NOT COMPLETED|Pause (up to 37 Days)||0
381253|NCT01930045|936668|P4|NOT COMPLETED|Pause (up to 37 Days)||0
381254|NCT01930045|936669|P3|NOT COMPLETED|Pause (up to 37 Days)||0
381255|NCT01930045|936670|P2|NOT COMPLETED|Pause (up to 37 Days)||0
381256|NCT01930045|936671|P1|NOT COMPLETED|Pause (up to 37 Days)||0
381257|NCT01930045|936666|P6|COMPLETED|Pause (up to 37 Days)||1
381258|NCT01930045|936667|P5|COMPLETED|Pause (up to 37 Days)||3
381259|NCT01930045|936668|P4|COMPLETED|Pause (up to 37 Days)||3
381260|NCT01930045|936669|P3|COMPLETED|Pause (up to 37 Days)||3
381261|NCT01930045|936670|P2|COMPLETED|Pause (up to 37 Days)||3
381262|NCT01930045|936671|P1|COMPLETED|Pause (up to 37 Days)||3
381263|NCT01930045|936666|P6|STARTED|Pause (up to 37 Days)||3
381264|NCT01930045|936667|P5|STARTED|Pause (up to 37 Days)||3
381265|NCT01930045|936668|P4|STARTED|Pause (up to 37 Days)||3
381266|NCT01930045|936669|P3|STARTED|Pause (up to 37 Days)|The participant who missed treatment in Period 3, resumed the study|3
381267|NCT01930045|936670|P2|STARTED|Pause (up to 37 Days)||3
381268|NCT01930045|936671|P1|STARTED|Pause (up to 37 Days)||3
381269|NCT01930045|936666|P6|NOT COMPLETED|Part 1 - Period 3||0
381270|NCT01930045|936667|P5|NOT COMPLETED|Part 1 - Period 3||0
381271|NCT01930045|936668|P4|NOT COMPLETED|Part 1 - Period 3||0
381272|NCT01930045|936669|P3|NOT COMPLETED|Part 1 - Period 3||0
381273|NCT01930045|936670|P2|NOT COMPLETED|Part 1 - Period 3||0
381274|NCT01930045|936671|P1|NOT COMPLETED|Part 1 - Period 3||0
381275|NCT01930045|936666|P6|COMPLETED|Part 1 - Period 3||3
381276|NCT01930045|936667|P5|COMPLETED|Part 1 - Period 3||3
381277|NCT01930045|936668|P4|COMPLETED|Part 1 - Period 3||3
381278|NCT01930045|936669|P3|COMPLETED|Part 1 - Period 3||2
381279|NCT01930045|936670|P2|COMPLETED|Part 1 - Period 3||3
381280|NCT01930045|936671|P1|COMPLETED|Part 1 - Period 3||3
381281|NCT01930045|936666|P6|STARTED|Part 1 - Period 3||3
381282|NCT01930045|936667|P5|STARTED|Part 1 - Period 3||3
381283|NCT01930045|936668|P4|STARTED|Part 1 - Period 3||3
381284|NCT01930045|936669|P3|STARTED|Part 1 - Period 3|One participant missed treatment during Period 3 only.|2
381285|NCT01930045|936670|P2|STARTED|Part 1 - Period 3||3
381286|NCT01930045|936671|P1|STARTED|Part 1 - Period 3||3
381287|NCT01930045|936666|P6|NOT COMPLETED|Part 1 - Period 2||0
381288|NCT01930045|936667|P5|NOT COMPLETED|Part 1 - Period 2||0
381289|NCT01930045|936668|P4|NOT COMPLETED|Part 1 - Period 2||0
381290|NCT01930045|936669|P3|NOT COMPLETED|Part 1 - Period 2||0
381291|NCT01930045|936670|P2|NOT COMPLETED|Part 1 - Period 2||0
381292|NCT01930045|936671|P1|NOT COMPLETED|Part 1 - Period 2||0
381293|NCT01930045|936666|P6|COMPLETED|Part 1 - Period 2||3
381294|NCT01930045|936667|P5|COMPLETED|Part 1 - Period 2||3
381295|NCT01930045|936668|P4|COMPLETED|Part 1 - Period 2||3
381296|NCT01930045|936669|P3|COMPLETED|Part 1 - Period 2||3
381297|NCT01930045|936670|P2|COMPLETED|Part 1 - Period 2||3
381298|NCT01930045|936671|P1|COMPLETED|Part 1 - Period 2||3
381299|NCT01930045|936666|P6|STARTED|Part 1 - Period 2||3
381300|NCT01930045|936667|P5|STARTED|Part 1 - Period 2||3
381301|NCT01930045|936668|P4|STARTED|Part 1 - Period 2||3
381302|NCT01930045|936669|P3|STARTED|Part 1 - Period 2||3
381303|NCT01930045|936670|P2|STARTED|Part 1 - Period 2||3
381304|NCT01930045|936671|P1|STARTED|Part 1 - Period 2||3
381305|NCT01930045|936666|P6|NOT COMPLETED|Part 1 - Period 1||0
381306|NCT01930045|936667|P5|NOT COMPLETED|Part 1 - Period 1||0
381307|NCT01930045|936668|P4|NOT COMPLETED|Part 1 - Period 1||0
381308|NCT01930045|936669|P3|NOT COMPLETED|Part 1 - Period 1||0
381309|NCT01930045|936670|P2|NOT COMPLETED|Part 1 - Period 1||0
381310|NCT01930045|936671|P1|NOT COMPLETED|Part 1 - Period 1||0
381311|NCT01930045|936666|P6|COMPLETED|Part 1 - Period 1||3
381312|NCT01930045|936667|P5|COMPLETED|Part 1 - Period 1||3
381313|NCT01930045|936668|P4|COMPLETED|Part 1 - Period 1||3
381314|NCT01930045|936669|P3|COMPLETED|Part 1 - Period 1||3
381315|NCT01930045|936670|P2|COMPLETED|Part 1 - Period 1||3
381316|NCT01930045|936671|P1|COMPLETED|Part 1 - Period 1||3
381317|NCT01930045|936666|P6|STARTED|Part 1 - Period 1||3
381318|NCT01930045|936667|P5|STARTED|Part 1 - Period 1||3
381319|NCT01930045|936668|P4|STARTED|Part 1 - Period 1||3
381320|NCT01930045|936669|P3|STARTED|Part 1 - Period 1||3
381321|NCT01930045|936670|P2|STARTED|Part 1 - Period 1||3
381322|NCT01930045|936671|P1|STARTED|Part 1 - Period 1||3
381323|NCT01929993|936698|P2|NOT COMPLETED|Overall Study||28
381324|NCT01929993|936699|P1|NOT COMPLETED|Overall Study||30
381325|NCT01929993|936698|P2|COMPLETED|Overall Study||54
381326|NCT01929993|936699|P1|COMPLETED|Overall Study||52
381327|NCT01929993|936698|P2|STARTED|Overall Study||82
381328|NCT01929993|936699|P1|STARTED|Overall Study||82
381329|NCT01929980|936705|P1|NOT COMPLETED|Overall Study||1
381330|NCT01929980|936705|P1|COMPLETED|Overall Study||3
381331|NCT01929980|936705|P1|STARTED|Overall Study||4
381332|NCT01929889|936709|P1|NOT COMPLETED|Overall Study||5
381333|NCT01929889|936709|P1|COMPLETED|Overall Study|3 subjects completed the study.|3
381334|NCT01929889|936709|P1|STARTED|Overall Study|Target enrollment goal was 20 completed subjects.|8
381335|NCT01929876|936713|P1|NOT COMPLETED|Period 2||1
381336|NCT01929876|936713|P1|COMPLETED|Period 2||15
381337|NCT01929876|936713|P1|STARTED|Period 2||16
381338|NCT01929876|936713|P1|NOT COMPLETED|Period 1||0
381339|NCT01929876|936713|P1|COMPLETED|Period 1||16
381340|NCT01929876|936713|P1|STARTED|Period 1||16
381341|NCT01929863|936726|P2|NOT COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||6
381342|NCT01929863|936727|P1|NOT COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||6
381343|NCT01929863|936726|P2|COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||0
381344|NCT01929863|936727|P1|COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||0
381345|NCT01929863|936726|P2|STARTED|Period 4:Follow-up-Metformin (7-10 Days)||6
381346|NCT01929863|936727|P1|STARTED|Period 4:Follow-up-Metformin (7-10 Days)||6
381347|NCT01929863|936726|P2|NOT COMPLETED|Period 3:Intervention Period 2 (7 Days)||1
381348|NCT01929863|936727|P1|NOT COMPLETED|Period 3:Intervention Period 2 (7 Days)||0
381349|NCT01929863|936726|P2|COMPLETED|Period 3:Intervention Period 2 (7 Days)||6
381350|NCT01929863|936727|P1|COMPLETED|Period 3:Intervention Period 2 (7 Days)||6
381351|NCT01929863|936726|P2|STARTED|Period 3:Intervention Period 2 (7 Days)||7
381352|NCT01929863|936727|P1|STARTED|Period 3:Intervention Period 2 (7 Days)||6
381353|NCT01929863|936726|P2|NOT COMPLETED|Period 2:Washout Period (13-15 Days)||0
381354|NCT01929863|936727|P1|NOT COMPLETED|Period 2:Washout Period (13-15 Days)||0
381355|NCT01929863|936726|P2|COMPLETED|Period 2:Washout Period (13-15 Days)||7
381356|NCT01929863|936727|P1|COMPLETED|Period 2:Washout Period (13-15 Days)||6
381357|NCT01929863|936726|P2|STARTED|Period 2:Washout Period (13-15 Days)||7
381358|NCT01929863|936727|P1|STARTED|Period 2:Washout Period (13-15 Days)||6
381359|NCT01929863|936726|P2|NOT COMPLETED|Period 1:Intervention Period 1 (7 Days)||1
381360|NCT01929863|936727|P1|NOT COMPLETED|Period 1:Intervention Period 1 (7 Days)||1
381361|NCT01929863|936726|P2|COMPLETED|Period 1:Intervention Period 1 (7 Days)||7
381362|NCT01929863|936727|P1|COMPLETED|Period 1:Intervention Period 1 (7 Days)||6
381363|NCT01929863|936726|P2|STARTED|Period 1:Intervention Period 1 (7 Days)||8
381364|NCT01929863|936727|P1|STARTED|Period 1:Intervention Period 1 (7 Days)||7
381365|NCT01929759|936770|P1|NOT COMPLETED|Overall Study||0
381366|NCT01929759|936770|P1|COMPLETED|Overall Study||10
381367|NCT01929759|936770|P1|STARTED|Overall Study||10
381368|NCT01929681|936784|P2|NOT COMPLETED|Overall Study||1
381369|NCT01929681|936785|P1|NOT COMPLETED|Overall Study||2
381370|NCT01929681|936784|P2|COMPLETED|Overall Study||24
381371|NCT01929681|936785|P1|COMPLETED|Overall Study||26
381372|NCT01929681|936784|P2|STARTED|Overall Study||25
381373|NCT01929681|936785|P1|STARTED|Overall Study||28
381374|NCT01929473|936799|P1|NOT COMPLETED|Overall Study||587
381375|NCT01929473|936799|P1|COMPLETED|Overall Study||3243
381376|NCT01929473|936799|P1|365 Day|Overall Study||3589
381377|NCT01929473|936799|P1|STARTED|Overall Study|0 day|3830
381378|NCT01929460|936805|P2|NOT COMPLETED|Overall Study||0
381379|NCT01929460|936806|P1|NOT COMPLETED|Overall Study||0
381380|NCT01929460|936805|P2|COMPLETED|Overall Study||13
381381|NCT01929460|936806|P1|COMPLETED|Overall Study||13
381382|NCT01929460|936805|P2|STARTED|Overall Study||13
381383|NCT01929460|936806|P1|STARTED|Overall Study||13
381384|NCT01929317|936830|P2|NOT COMPLETED|Long-term Phase||4
381385|NCT01929317|936831|P1|NOT COMPLETED|Long-term Phase||19
381386|NCT01929317|936830|P2|COMPLETED|Long-term Phase||14
381387|NCT01929317|936831|P1|COMPLETED|Long-term Phase||25
381388|NCT01929317|936830|P2|STARTED|Long-term Phase||18
381389|NCT01929317|936831|P1|STARTED|Long-term Phase||44
381390|NCT01929317|936830|P2|NOT COMPLETED|Dose Increase Effect Verification Phase||1
381391|NCT01929317|936831|P1|NOT COMPLETED|Dose Increase Effect Verification Phase||9
381392|NCT01929317|936830|P2|COMPLETED|Dose Increase Effect Verification Phase||19
381393|NCT01929317|936831|P1|COMPLETED|Dose Increase Effect Verification Phase||52
381394|NCT01929317|936830|P2|STARTED|Dose Increase Effect Verification Phase||20
381395|NCT01929317|936831|P1|STARTED|Dose Increase Effect Verification Phase||61
381396|NCT01929135|936900|P2|NOT COMPLETED|Overall Study||1
381397|NCT01929135|936901|P1|NOT COMPLETED|Overall Study||1
381398|NCT01929135|936900|P2|COMPLETED|Overall Study||18
381399|NCT01929135|936901|P1|COMPLETED|Overall Study||18
381400|NCT01929135|936900|P2|STARTED|Overall Study||19
381401|NCT01929135|936901|P1|STARTED|Overall Study||19
381402|NCT01929083|936915|P2|NOT COMPLETED|Intervention 2||1
381403|NCT01929083|936916|P1|NOT COMPLETED|Intervention 2||0
381404|NCT01929083|936915|P2|COMPLETED|Intervention 2||8
381405|NCT01929083|936916|P1|COMPLETED|Intervention 2||7
381406|NCT01929083|936915|P2|Returned for 2nd Ibutilide Administratio|Intervention 2||8
381407|NCT01929083|936916|P1|Returned for 2nd Ibutilide Administratio|Intervention 2||7
381408|NCT01929083|936915|P2|STARTED|Intervention 2||9
381409|NCT01929083|936916|P1|STARTED|Intervention 2||7
381410|NCT01929083|936915|P2|NOT COMPLETED|Intervention 1||0
381411|NCT01929083|936916|P1|NOT COMPLETED|Intervention 1||3
381412|NCT01929083|936915|P2|COMPLETED|Intervention 1||9
381413|NCT01929083|936916|P1|COMPLETED|Intervention 1||7
381414|NCT01929083|936915|P2|Returned for 1st Ibutilide Administratio|Intervention 1||9
381415|NCT01929083|936916|P1|Returned for 1st Ibutilide Administratio|Intervention 1||7
381416|NCT01929083|936915|P2|STARTED|Intervention 1||9
381417|NCT01929083|936916|P1|STARTED|Intervention 1|Number of patients randomized to receive progesterone first|10
381418|NCT01929044|936942|P2|NOT COMPLETED|Overall Study||17
381419|NCT01929044|936943|P1|NOT COMPLETED|Overall Study||11
381420|NCT01929044|936942|P2|COMPLETED|Overall Study||129
381421|NCT01929044|936943|P1|COMPLETED|Overall Study||142
381422|NCT01929044|936942|P2|STARTED|Overall Study||146
381423|NCT01929044|936943|P1|STARTED|Overall Study||153
381424|NCT01929031|936965|P6|NOT COMPLETED|Overall Study||1
381425|NCT01929031|936966|P5|NOT COMPLETED|Overall Study||1
381426|NCT01929031|936967|P4|NOT COMPLETED|Overall Study||0
381427|NCT01929031|936968|P3|NOT COMPLETED|Overall Study||1
381428|NCT01929031|936969|P2|NOT COMPLETED|Overall Study||2
381429|NCT01929031|936970|P1|NOT COMPLETED|Overall Study||4
381430|NCT01929031|936965|P6|COMPLETED|Overall Study||35
381431|NCT01929031|936966|P5|COMPLETED|Overall Study||33
381432|NCT01929031|936967|P4|COMPLETED|Overall Study||35
381433|NCT01929031|936968|P3|COMPLETED|Overall Study||34
381434|NCT01929031|936969|P2|COMPLETED|Overall Study||207
381435|NCT01929031|936970|P1|COMPLETED|Overall Study||209
381436|NCT01929031|936965|P6|STARTED|Overall Study||36
381437|NCT01929031|936966|P5|STARTED|Overall Study||34
381438|NCT01929031|936967|P4|STARTED|Overall Study||35
381439|NCT01929031|936968|P3|STARTED|Overall Study||35
381440|NCT01929031|936969|P2|STARTED|Overall Study||209
381441|NCT01929031|936970|P1|STARTED|Overall Study||213
381442|NCT01928940|936994|P2|NOT COMPLETED|Overall Study||1
381443|NCT01928940|936995|P1|NOT COMPLETED|Overall Study||0
381444|NCT01928940|936994|P2|COMPLETED|Overall Study||5
381445|NCT01928940|936995|P1|COMPLETED|Overall Study||6
381446|NCT01928940|936994|P2|STARTED|Overall Study||6
381447|NCT01928940|936995|P1|STARTED|Overall Study||6
381448|NCT01928927|937038|P2|NOT COMPLETED|Overall Study||1
381449|NCT01928927|937039|P1|NOT COMPLETED|Overall Study||2
381450|NCT01928927|937038|P2|COMPLETED|Overall Study||14
381451|NCT01928927|937039|P1|COMPLETED|Overall Study||27
381452|NCT01928927|937038|P2|STARTED|Overall Study||15
381453|NCT01928927|937039|P1|STARTED|Overall Study||29
381454|NCT01928862|937166|P5|NOT COMPLETED|Overall Study||1
381455|NCT01928862|937167|P4|NOT COMPLETED|Overall Study||0
381456|NCT01928862|937168|P3|NOT COMPLETED|Overall Study||0
381457|NCT01928862|937169|P2|NOT COMPLETED|Overall Study||0
381458|NCT01928862|937170|P1|NOT COMPLETED|Overall Study||1
381459|NCT01928862|937166|P5|COMPLETED|Overall Study||13
381460|NCT01928862|937167|P4|COMPLETED|Overall Study||16
381461|NCT01928862|937168|P3|COMPLETED|Overall Study||16
381462|NCT01928862|937169|P2|COMPLETED|Overall Study||16
381463|NCT01928862|937170|P1|COMPLETED|Overall Study||15
381464|NCT01928862|937166|P5|STARTED|Overall Study||14
381465|NCT01928862|937167|P4|STARTED|Overall Study||16
381466|NCT01928862|937168|P3|STARTED|Overall Study||16
381467|NCT01928862|937169|P2|STARTED|Overall Study||16
381468|NCT01928862|937170|P1|STARTED|Overall Study||16
381469|NCT01928797|937209|P2|NOT COMPLETED|Overall Study||0
381470|NCT01928797|937210|P1|NOT COMPLETED|Overall Study||0
381471|NCT01928797|937209|P2|COMPLETED|Overall Study||30
381472|NCT01928797|937210|P1|COMPLETED|Overall Study||30
381473|NCT01928797|937209|P2|STARTED|Overall Study||30
381474|NCT01928797|937210|P1|STARTED|Overall Study||30
381475|NCT01928771|937223|P3|NOT COMPLETED|Overall Study||40
381476|NCT01928771|937224|P2|NOT COMPLETED|Overall Study||40
381477|NCT01928771|937225|P1|NOT COMPLETED|Overall Study||46
381478|NCT01928771|937223|P3|COMPLETED|Overall Study||367
381479|NCT01928771|937224|P2|COMPLETED|Overall Study||358
381480|NCT01928771|937225|P1|COMPLETED|Overall Study||354
381481|NCT01928771|937223|P3|Received Treatment|Overall Study||407
381482|NCT01928771|937224|P2|Received Treatment|Overall Study||398
381483|NCT01928771|937225|P1|Received Treatment|Overall Study||399
381484|NCT01928771|937223|P3|STARTED|Overall Study||407
381485|NCT01928771|937224|P2|STARTED|Overall Study||398
381486|NCT01928771|937225|P1|STARTED|Overall Study||400
381487|NCT01928693|937305|P3|NOT COMPLETED|Overall Study||0
381488|NCT01928693|937306|P2|NOT COMPLETED|Overall Study||0
381489|NCT01928693|937307|P1|NOT COMPLETED|Overall Study||0
381490|NCT01928693|937305|P3|COMPLETED|Overall Study||1
381491|NCT01928693|937306|P2|COMPLETED|Overall Study||1
381492|NCT01928693|937307|P1|COMPLETED|Overall Study||0
381493|NCT01928693|937305|P3|STARTED|Overall Study||1
381494|NCT01928693|937306|P2|STARTED|Overall Study||1
381495|NCT01928693|937307|P1|STARTED|Overall Study||0
381496|NCT01928680|937333|P1|NOT COMPLETED|Overall Study||0
381497|NCT01928680|937333|P1|COMPLETED|Overall Study||33
381498|NCT01928680|937333|P1|STARTED|Overall Study||33
381499|NCT01928615|937337|P1|NOT COMPLETED|Overall Study||2
381500|NCT01928615|937337|P1|COMPLETED|Overall Study||0
381501|NCT01928615|937337|P1|STARTED|Overall Study||2
381502|NCT01928472|937356|P4|NOT COMPLETED|Overall Study||2
381503|NCT01928472|937357|P3|NOT COMPLETED|Overall Study||7
381504|NCT01928472|937358|P2|NOT COMPLETED|Overall Study||8
381505|NCT01928472|937359|P1|NOT COMPLETED|Overall Study||8
381506|NCT01928472|937356|P4|COMPLETED|Overall Study||100
381507|NCT01928472|937357|P3|COMPLETED|Overall Study||91
381508|NCT01928472|937358|P2|COMPLETED|Overall Study||96
381509|NCT01928472|937359|P1|COMPLETED|Overall Study||90
381510|NCT01928472|937356|P4|STARTED|Overall Study||102
381511|NCT01928472|937357|P3|STARTED|Overall Study||98
381512|NCT01928472|937358|P2|STARTED|Overall Study||104
381513|NCT01928472|937359|P1|STARTED|Overall Study||98
381514|NCT01928433|937429|P3|NOT COMPLETED|Overall Study||28
381515|NCT01928433|937430|P2|NOT COMPLETED|Overall Study||21
381516|NCT01928433|937431|P1|NOT COMPLETED|Overall Study||20
381517|NCT01928433|937429|P3|COMPLETED|Overall Study||46
381518|NCT01928433|937430|P2|COMPLETED|Overall Study||54
381519|NCT01928433|937431|P1|COMPLETED|Overall Study||56
381520|NCT01928433|937429|P3|STARTED|Overall Study||74
381521|NCT01928433|937430|P2|STARTED|Overall Study||75
381522|NCT01928433|937431|P1|STARTED|Overall Study||76
381523|NCT01928381|937454|P7|NOT COMPLETED|Part 2 - Post Third Intervention||0
381524|NCT01928381|937455|P6|NOT COMPLETED|Part 2 - Post Third Intervention||0
381525|NCT01928381|937456|P5|NOT COMPLETED|Part 2 - Post Third Intervention||0
381526|NCT01928381|937457|P4|NOT COMPLETED|Part 2 - Post Third Intervention||0
381527|NCT01928381|937458|P3|NOT COMPLETED|Part 2 - Post Third Intervention||1
381528|NCT01928381|937459|P2|NOT COMPLETED|Part 2 - Post Third Intervention||0
381529|NCT01928381|937460|P1|NOT COMPLETED|Part 2 - Post Third Intervention||0
381530|NCT01928381|937454|P7|COMPLETED|Part 2 - Post Third Intervention||5
381531|NCT01928381|937455|P6|COMPLETED|Part 2 - Post Third Intervention||5
381532|NCT01928381|937456|P5|COMPLETED|Part 2 - Post Third Intervention||3
381533|NCT01928381|937457|P4|COMPLETED|Part 2 - Post Third Intervention||4
381534|NCT01928381|937458|P3|COMPLETED|Part 2 - Post Third Intervention||3
381535|NCT01928381|937459|P2|COMPLETED|Part 2 - Post Third Intervention||5
381536|NCT01928381|937460|P1|COMPLETED|Part 2 - Post Third Intervention||0
381537|NCT01928381|937454|P7|STARTED|Part 2 - Post Third Intervention||5
381538|NCT01928381|937455|P6|STARTED|Part 2 - Post Third Intervention||5
381539|NCT01928381|937456|P5|STARTED|Part 2 - Post Third Intervention||3
381540|NCT01928381|937457|P4|STARTED|Part 2 - Post Third Intervention||4
381541|NCT01928381|937458|P3|STARTED|Part 2 - Post Third Intervention||4
381542|NCT01928381|937459|P2|STARTED|Part 2 - Post Third Intervention||5
381543|NCT01928381|937460|P1|STARTED|Part 2 - Post Third Intervention||0
381544|NCT01928381|937454|P7|NOT COMPLETED|Part 2 - Third Intervention||0
381545|NCT01928381|937455|P6|NOT COMPLETED|Part 2 - Third Intervention||0
381546|NCT01928381|937456|P5|NOT COMPLETED|Part 2 - Third Intervention||0
381547|NCT01928381|937457|P4|NOT COMPLETED|Part 2 - Third Intervention||0
381548|NCT01928381|937458|P3|NOT COMPLETED|Part 2 - Third Intervention||0
381549|NCT01928381|937459|P2|NOT COMPLETED|Part 2 - Third Intervention||0
381550|NCT01928381|937460|P1|NOT COMPLETED|Part 2 - Third Intervention||0
381551|NCT01928381|937454|P7|COMPLETED|Part 2 - Third Intervention||5
381552|NCT01928381|937455|P6|COMPLETED|Part 2 - Third Intervention||5
381553|NCT01928381|937456|P5|COMPLETED|Part 2 - Third Intervention||3
381554|NCT01928381|937457|P4|COMPLETED|Part 2 - Third Intervention||4
381555|NCT01928381|937458|P3|COMPLETED|Part 2 - Third Intervention||4
381556|NCT01928381|937459|P2|COMPLETED|Part 2 - Third Intervention||5
381557|NCT01928381|937460|P1|COMPLETED|Part 2 - Third Intervention||0
381558|NCT01928381|937454|P7|STARTED|Part 2 - Third Intervention||5
381559|NCT01928381|937455|P6|STARTED|Part 2 - Third Intervention||5
381560|NCT01928381|937456|P5|STARTED|Part 2 - Third Intervention||3
381561|NCT01928381|937457|P4|STARTED|Part 2 - Third Intervention||4
381562|NCT01928381|937458|P3|STARTED|Part 2 - Third Intervention||4
381563|NCT01928381|937459|P2|STARTED|Part 2 - Third Intervention||5
381564|NCT01928381|937460|P1|STARTED|Part 2 - Third Intervention||0
381565|NCT01928381|937454|P7|NOT COMPLETED|Washout Second Intervention||0
381566|NCT01928381|937455|P6|NOT COMPLETED|Washout Second Intervention||0
381567|NCT01928381|937456|P5|NOT COMPLETED|Washout Second Intervention||0
381568|NCT01928381|937457|P4|NOT COMPLETED|Washout Second Intervention||0
381569|NCT01928381|937458|P3|NOT COMPLETED|Washout Second Intervention||0
381570|NCT01928381|937459|P2|NOT COMPLETED|Washout Second Intervention||0
381571|NCT01928381|937460|P1|NOT COMPLETED|Washout Second Intervention||0
381572|NCT01928381|937454|P7|COMPLETED|Washout Second Intervention||5
381573|NCT01928381|937455|P6|COMPLETED|Washout Second Intervention||5
381574|NCT01928381|937456|P5|COMPLETED|Washout Second Intervention||3
381575|NCT01928381|937457|P4|COMPLETED|Washout Second Intervention||4
381576|NCT01928381|937458|P3|COMPLETED|Washout Second Intervention||4
381577|NCT01928381|937459|P2|COMPLETED|Washout Second Intervention||5
381578|NCT01928381|937460|P1|COMPLETED|Washout Second Intervention||0
381579|NCT01928381|937454|P7|STARTED|Washout Second Intervention||5
381580|NCT01928381|937455|P6|STARTED|Washout Second Intervention||5
381581|NCT01928381|937456|P5|STARTED|Washout Second Intervention||3
381582|NCT01928381|937457|P4|STARTED|Washout Second Intervention||4
381583|NCT01928381|937458|P3|STARTED|Washout Second Intervention||4
381584|NCT01928381|937459|P2|STARTED|Washout Second Intervention||5
381585|NCT01928381|937460|P1|STARTED|Washout Second Intervention||0
381586|NCT01928381|937454|P7|NOT COMPLETED|Part 2 - Second Intervention||0
381587|NCT01928381|937455|P6|NOT COMPLETED|Part 2 - Second Intervention||0
381588|NCT01928381|937456|P5|NOT COMPLETED|Part 2 - Second Intervention||0
381589|NCT01928381|937457|P4|NOT COMPLETED|Part 2 - Second Intervention||1
381590|NCT01928381|937458|P3|NOT COMPLETED|Part 2 - Second Intervention||0
381591|NCT01928381|937459|P2|NOT COMPLETED|Part 2 - Second Intervention||1
381592|NCT01928381|937460|P1|NOT COMPLETED|Part 2 - Second Intervention||0
381593|NCT01928381|937454|P7|COMPLETED|Part 2 - Second Intervention||5
381594|NCT01928381|937455|P6|COMPLETED|Part 2 - Second Intervention||5
381595|NCT01928381|937456|P5|COMPLETED|Part 2 - Second Intervention||3
381596|NCT01928381|937457|P4|COMPLETED|Part 2 - Second Intervention||4
381597|NCT01928381|937458|P3|COMPLETED|Part 2 - Second Intervention||4
381598|NCT01928381|937459|P2|COMPLETED|Part 2 - Second Intervention||5
381599|NCT01928381|937460|P1|COMPLETED|Part 2 - Second Intervention||0
381600|NCT01928381|937454|P7|STARTED|Part 2 - Second Intervention||5
381601|NCT01928381|937455|P6|STARTED|Part 2 - Second Intervention||5
381602|NCT01928381|937456|P5|STARTED|Part 2 - Second Intervention||3
381603|NCT01928381|937457|P4|STARTED|Part 2 - Second Intervention||5
381604|NCT01928381|937458|P3|STARTED|Part 2 - Second Intervention||4
381605|NCT01928381|937459|P2|STARTED|Part 2 - Second Intervention||6
381606|NCT01928381|937460|P1|STARTED|Part 2 - Second Intervention||0
381607|NCT01928381|937454|P7|NOT COMPLETED|Washout First Intervention||0
381608|NCT01928381|937455|P6|NOT COMPLETED|Washout First Intervention||0
381609|NCT01928381|937456|P5|NOT COMPLETED|Washout First Intervention||1
381610|NCT01928381|937457|P4|NOT COMPLETED|Washout First Intervention||0
381611|NCT01928381|937458|P3|NOT COMPLETED|Washout First Intervention||0
381612|NCT01928381|937459|P2|NOT COMPLETED|Washout First Intervention||0
381613|NCT01928381|937460|P1|NOT COMPLETED|Washout First Intervention||0
381614|NCT01928381|937454|P7|COMPLETED|Washout First Intervention||5
381615|NCT01928381|937455|P6|COMPLETED|Washout First Intervention||5
381616|NCT01928381|937456|P5|COMPLETED|Washout First Intervention||3
381617|NCT01928381|937457|P4|COMPLETED|Washout First Intervention||5
381618|NCT01928381|937458|P3|COMPLETED|Washout First Intervention||4
381619|NCT01928381|937459|P2|COMPLETED|Washout First Intervention||6
381620|NCT01928381|937460|P1|COMPLETED|Washout First Intervention||0
381621|NCT01928381|937454|P7|STARTED|Washout First Intervention||5
381622|NCT01928381|937455|P6|STARTED|Washout First Intervention||5
381623|NCT01928381|937456|P5|STARTED|Washout First Intervention||4
381624|NCT01928381|937457|P4|STARTED|Washout First Intervention||5
381625|NCT01928381|937458|P3|STARTED|Washout First Intervention||4
381626|NCT01928381|937459|P2|STARTED|Washout First Intervention||6
381627|NCT01928381|937460|P1|STARTED|Washout First Intervention||0
381628|NCT01928381|937454|P7|NOT COMPLETED|Part 2 - First Intervention||1
381629|NCT01928381|937455|P6|NOT COMPLETED|Part 2 - First Intervention||1
381630|NCT01928381|937456|P5|NOT COMPLETED|Part 2 - First Intervention||0
381631|NCT01928381|937457|P4|NOT COMPLETED|Part 2 - First Intervention||1
381632|NCT01928381|937458|P3|NOT COMPLETED|Part 2 - First Intervention||2
381633|NCT01928381|937459|P2|NOT COMPLETED|Part 2 - First Intervention||0
381634|NCT01928381|937460|P1|NOT COMPLETED|Part 2 - First Intervention||0
381635|NCT01928381|937454|P7|COMPLETED|Part 2 - First Intervention||5
381636|NCT01928381|937455|P6|COMPLETED|Part 2 - First Intervention||5
381637|NCT01928381|937456|P5|COMPLETED|Part 2 - First Intervention||4
381638|NCT01928381|937457|P4|COMPLETED|Part 2 - First Intervention||5
381639|NCT01928381|937458|P3|COMPLETED|Part 2 - First Intervention||4
381640|NCT01928381|937459|P2|COMPLETED|Part 2 - First Intervention||6
381641|NCT01928381|937460|P1|COMPLETED|Part 2 - First Intervention||0
381642|NCT01928381|937454|P7|STARTED|Part 2 - First Intervention||6
381643|NCT01928381|937455|P6|STARTED|Part 2 - First Intervention||6
381644|NCT01928381|937456|P5|STARTED|Part 2 - First Intervention||4
381645|NCT01928381|937457|P4|STARTED|Part 2 - First Intervention||6
381646|NCT01928381|937458|P3|STARTED|Part 2 - First Intervention||6
381647|NCT01928381|937459|P2|STARTED|Part 2 - First Intervention||6
381648|NCT01928381|937460|P1|STARTED|Part 2 - First Intervention||0
381649|NCT01928381|937454|P7|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
381650|NCT01928381|937455|P6|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
381651|NCT01928381|937456|P5|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
381652|NCT01928381|937457|P4|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
381653|NCT01928381|937458|P3|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
381654|NCT01928381|937459|P2|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
381655|NCT01928381|937460|P1|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||14
381656|NCT01928381|937454|P7|COMPLETED|Placebo run-in & Part 2 Eligibility||0
381657|NCT01928381|937455|P6|COMPLETED|Placebo run-in & Part 2 Eligibility||0
381658|NCT01928381|937456|P5|COMPLETED|Placebo run-in & Part 2 Eligibility||0
381659|NCT01928381|937457|P4|COMPLETED|Placebo run-in & Part 2 Eligibility||0
381660|NCT01928381|937458|P3|COMPLETED|Placebo run-in & Part 2 Eligibility||0
381661|NCT01928381|937459|P2|COMPLETED|Placebo run-in & Part 2 Eligibility||0
381662|NCT01928381|937460|P1|COMPLETED|Placebo run-in & Part 2 Eligibility||34
381663|NCT01928381|937454|P7|STARTED|Placebo run-in & Part 2 Eligibility||0
381664|NCT01928381|937455|P6|STARTED|Placebo run-in & Part 2 Eligibility||0
381665|NCT01928381|937456|P5|STARTED|Placebo run-in & Part 2 Eligibility||0
381666|NCT01928381|937457|P4|STARTED|Placebo run-in & Part 2 Eligibility||0
381667|NCT01928381|937458|P3|STARTED|Placebo run-in & Part 2 Eligibility||0
381668|NCT01928381|937459|P2|STARTED|Placebo run-in & Part 2 Eligibility||0
381669|NCT01928381|937460|P1|STARTED|Placebo run-in & Part 2 Eligibility||48
381670|NCT01928381|937454|P7|NOT COMPLETED|Part 1 - Pain Training||0
381671|NCT01928381|937455|P6|NOT COMPLETED|Part 1 - Pain Training||0
381672|NCT01928381|937456|P5|NOT COMPLETED|Part 1 - Pain Training||0
381673|NCT01928381|937457|P4|NOT COMPLETED|Part 1 - Pain Training||0
381674|NCT01928381|937458|P3|NOT COMPLETED|Part 1 - Pain Training||0
381675|NCT01928381|937459|P2|NOT COMPLETED|Part 1 - Pain Training||0
381676|NCT01928381|937460|P1|NOT COMPLETED|Part 1 - Pain Training||35
381677|NCT01928381|937454|P7|COMPLETED|Part 1 - Pain Training||0
381678|NCT01928381|937455|P6|COMPLETED|Part 1 - Pain Training||0
381679|NCT01928381|937456|P5|COMPLETED|Part 1 - Pain Training||0
381680|NCT01928381|937457|P4|COMPLETED|Part 1 - Pain Training||0
381681|NCT01928381|937458|P3|COMPLETED|Part 1 - Pain Training||0
381682|NCT01928381|937459|P2|COMPLETED|Part 1 - Pain Training||0
381683|NCT01928381|937460|P1|COMPLETED|Part 1 - Pain Training||48
381684|NCT01928381|937454|P7|STARTED|Part 1 - Pain Training||0
381685|NCT01928381|937455|P6|STARTED|Part 1 - Pain Training||0
381686|NCT01928381|937456|P5|STARTED|Part 1 - Pain Training||0
381687|NCT01928381|937457|P4|STARTED|Part 1 - Pain Training||0
381688|NCT01928381|937458|P3|STARTED|Part 1 - Pain Training||0
381689|NCT01928381|937459|P2|STARTED|Part 1 - Pain Training||0
381690|NCT01928381|937460|P1|STARTED|Part 1 - Pain Training||83
381691|NCT01928381|937454|P7|NOT COMPLETED|Screening for Pain Training||0
381692|NCT01928381|937455|P6|NOT COMPLETED|Screening for Pain Training||0
381693|NCT01928381|937456|P5|NOT COMPLETED|Screening for Pain Training||0
381694|NCT01928381|937457|P4|NOT COMPLETED|Screening for Pain Training||0
381695|NCT01928381|937458|P3|NOT COMPLETED|Screening for Pain Training||0
381696|NCT01928381|937459|P2|NOT COMPLETED|Screening for Pain Training||0
381697|NCT01928381|937460|P1|NOT COMPLETED|Screening for Pain Training||60
381698|NCT01928381|937454|P7|COMPLETED|Screening for Pain Training||0
381699|NCT01928381|937455|P6|COMPLETED|Screening for Pain Training||0
381700|NCT01928381|937456|P5|COMPLETED|Screening for Pain Training||0
381701|NCT01928381|937457|P4|COMPLETED|Screening for Pain Training||0
381702|NCT01928381|937458|P3|COMPLETED|Screening for Pain Training||0
381703|NCT01928381|937459|P2|COMPLETED|Screening for Pain Training||0
381704|NCT01928381|937460|P1|COMPLETED|Screening for Pain Training||83
381705|NCT01928381|937454|P7|STARTED|Screening for Pain Training||0
381706|NCT01928381|937455|P6|STARTED|Screening for Pain Training||0
381707|NCT01928381|937456|P5|STARTED|Screening for Pain Training||0
381708|NCT01928381|937457|P4|STARTED|Screening for Pain Training||0
381709|NCT01928381|937458|P3|STARTED|Screening for Pain Training||0
381710|NCT01928381|937459|P2|STARTED|Screening for Pain Training||0
381711|NCT01928381|937460|P1|STARTED|Screening for Pain Training||143
381712|NCT01928186|937473|P1|NOT COMPLETED|Overall Study||0
381713|NCT01928186|937473|P1|COMPLETED|Overall Study||28
381714|NCT01928186|937473|P1|STARTED|Overall Study||28
381715|NCT01928082|937487|P1|NOT COMPLETED|Overall Study||1
381716|NCT01928082|937487|P1|COMPLETED|Overall Study||0
381717|NCT01928082|937487|P1|STARTED|Overall Study||1
381718|NCT01928030|937491|P3|NOT COMPLETED|Overall Study||0
381719|NCT01928030|937492|P2|NOT COMPLETED|Overall Study||0
381720|NCT01928030|937493|P1|NOT COMPLETED|Overall Study||0
381721|NCT01928030|937491|P3|COMPLETED|Overall Study||0
381722|NCT01928030|937492|P2|COMPLETED|Overall Study||0
381723|NCT01928030|937493|P1|COMPLETED|Overall Study||3
381724|NCT01928030|937491|P3|STARTED|Overall Study||0
381725|NCT01928030|937492|P2|STARTED|Overall Study||0
381726|NCT01928030|937493|P1|STARTED|Overall Study||3
381727|NCT01927887|937500|P1|NOT COMPLETED|Overall Study||0
381728|NCT01927887|937500|P1|COMPLETED|Overall Study||12
381729|NCT01927887|937500|P1|STARTED|Overall Study||12
381730|NCT01927757|937505|P1|NOT COMPLETED|Overall Study||23
381731|NCT01927757|937505|P1|COMPLETED|Overall Study||67
381732|NCT01927757|937505|P1|Received Etanercept|Overall Study||88
381733|NCT01927757|937505|P1|STARTED|Overall Study||90
381734|NCT01927575|937523|P1|NOT COMPLETED|Overall Study||0
381735|NCT01927575|937523|P1|COMPLETED|Overall Study||1
381736|NCT01927575|937523|P1|STARTED|Overall Study||1
381737|NCT01927419|937533|P2|NOT COMPLETED|Overall Study||28
381738|NCT01927419|937534|P1|NOT COMPLETED|Overall Study||70
381739|NCT01927419|937533|P2|COMPLETED|Overall Study|All participants who did not discontinue study drug during treatment period (Parts 1 and 2)|19
381740|NCT01927419|937534|P1|COMPLETED|Overall Study|All participants who did not discontinue study drug during treatment period (Parts 1 and 2)|25
381741|NCT01927419|937533|P2|Received Treatment|Overall Study||46
381742|NCT01927419|937534|P1|Received Treatment|Overall Study||94
381743|NCT01927419|937533|P2|STARTED|Overall Study||47
381744|NCT01927419|937534|P1|STARTED|Overall Study||95
381745|NCT01927120|937550|P1|NOT COMPLETED|Overall Study||10
381746|NCT01927120|937550|P1|COMPLETED|Overall Study||10
381747|NCT01927120|937550|P1|STARTED|Overall Study||20
381748|NCT01927055|937568|P3|NOT COMPLETED|Double-Blind||13
381749|NCT01927055|937569|P2|NOT COMPLETED|Double-Blind||11
381750|NCT01927055|937570|P1|NOT COMPLETED|Double-Blind||0
381751|NCT01927055|937568|P3|COMPLETED|Double-Blind||10
381752|NCT01927055|937569|P2|COMPLETED|Double-Blind||11
381753|NCT01927055|937570|P1|COMPLETED|Double-Blind||0
381754|NCT01927055|937568|P3|STARTED|Double-Blind||23
381755|NCT01927055|937569|P2|STARTED|Double-Blind||22
381756|NCT01927055|937570|P1|STARTED|Double-Blind||0
381757|NCT01927055|937568|P3|NOT COMPLETED|Open-label||0
381758|NCT01927055|937569|P2|NOT COMPLETED|Open-label||0
381759|NCT01927055|937570|P1|NOT COMPLETED|Open-label||16
381760|NCT01927055|937568|P3|COMPLETED|Open-label||0
381761|NCT01927055|937569|P2|COMPLETED|Open-label||0
381762|NCT01927055|937570|P1|COMPLETED|Open-label||45
381763|NCT01927055|937568|P3|STARTED|Open-label||0
381764|NCT01927055|937569|P2|STARTED|Open-label||0
381765|NCT01927055|937570|P1|STARTED|Open-label||61
381766|NCT01926977|937579|P2|NOT COMPLETED|Overall Study||0
381767|NCT01926977|937580|P1|NOT COMPLETED|Overall Study||0
381768|NCT01926977|937579|P2|COMPLETED|Overall Study||53
381769|NCT01926977|937580|P1|COMPLETED|Overall Study||47
381770|NCT01926977|937579|P2|STARTED|Overall Study||53
381771|NCT01926977|937580|P1|STARTED|Overall Study||47
381772|NCT01926782|937594|P6|NOT COMPLETED|Overall Study||41
381773|NCT01926782|937595|P5|NOT COMPLETED|Overall Study||8
381774|NCT01926782|937596|P4|NOT COMPLETED|Overall Study||20
381775|NCT01926782|937597|P3|NOT COMPLETED|Overall Study||40
381776|NCT01926782|937598|P2|NOT COMPLETED|Overall Study||13
381777|NCT01926782|937599|P1|NOT COMPLETED|Overall Study||28
381778|NCT01926782|937594|P6|COMPLETED|Overall Study||105
381779|NCT01926782|937595|P5|COMPLETED|Overall Study||29
381780|NCT01926782|937596|P4|COMPLETED|Overall Study||53
381781|NCT01926782|937597|P3|COMPLETED|Overall Study||272
381782|NCT01926782|937598|P2|COMPLETED|Overall Study||65
381783|NCT01926782|937599|P1|COMPLETED|Overall Study||129
381784|NCT01926782|937594|P6|Completed 24 Weeks Treatment Period|Overall Study||120
381785|NCT01926782|937595|P5|Completed 24 Weeks Treatment Period|Overall Study||31
381786|NCT01926782|937596|P4|Completed 24 Weeks Treatment Period|Overall Study||58
381787|NCT01926782|937597|P3|Completed 24 Weeks Treatment Period|Overall Study||285
381788|NCT01926782|937598|P2|Completed 24 Weeks Treatment Period|Overall Study||68
381789|NCT01926782|937599|P1|Completed 24 Weeks Treatment Period|Overall Study||137
381790|NCT01926782|937594|P6|Treated|Overall Study||146
381791|NCT01926782|937595|P5|Treated|Overall Study||37
381792|NCT01926782|937596|P4|Treated|Overall Study||72
381793|NCT01926782|937597|P3|Treated|Overall Study||312
381794|NCT01926782|937598|P2|Treated|Overall Study||78
381795|NCT01926782|937599|P1|Treated|Overall Study||157
381796|NCT01926782|937594|P6|STARTED|Overall Study||146
381797|NCT01926782|937595|P5|STARTED|Overall Study||37
381798|NCT01926782|937596|P4|STARTED|Overall Study||73
381799|NCT01926782|937597|P3|STARTED|Overall Study||312
381800|NCT01926782|937598|P2|STARTED|Overall Study||78
381801|NCT01926782|937599|P1|STARTED|Overall Study||157
381802|NCT01926626|937748|P1|NOT COMPLETED|Overall Study||22
381803|NCT01926626|937748|P1|COMPLETED|Overall Study||16
381804|NCT01926626|937748|P1|Received Moclobemide|Overall Study||37
381805|NCT01926626|937748|P1|STARTED|Overall Study||38
381806|NCT01926119|937758|P1|NOT COMPLETED|Overall Study||1
381807|NCT01926119|937758|P1|COMPLETED|Overall Study||3
381808|NCT01926119|937758|P1|STARTED|Overall Study||4
381809|NCT01926028|937771|P3|NOT COMPLETED|Overall Study||2
381810|NCT01926028|937772|P2|NOT COMPLETED|Overall Study||22
381811|NCT01926028|937773|P1|NOT COMPLETED|Overall Study||21
381812|NCT01926028|937771|P3|COMPLETED|Overall Study||12
381813|NCT01926028|937772|P2|COMPLETED|Overall Study||67
381814|NCT01926028|937773|P1|COMPLETED|Overall Study||64
381815|NCT01926028|937771|P3|STARTED|Overall Study||14
381816|NCT01926028|937772|P2|STARTED|Overall Study||89
381817|NCT01926028|937773|P1|STARTED|Overall Study||85
381818|NCT01926015|937809|P2|NOT COMPLETED|Overall Study||1
381819|NCT01926015|937810|P1|NOT COMPLETED|Overall Study||2
381820|NCT01926015|937809|P2|COMPLETED|Overall Study||95
381821|NCT01926015|937810|P1|COMPLETED|Overall Study||94
381822|NCT01926015|937809|P2|Received >=1 Vaccination|Overall Study||96
381823|NCT01926015|937810|P1|Received >=1 Vaccination|Overall Study||94
381824|NCT01926015|937809|P2|STARTED|Overall Study|Participants who passed all entry criteria and who were randomized into the study|96
381825|NCT01926015|937810|P1|STARTED|Overall Study|Participants who passed all entry criteria and who were randomized into the study|96
381826|NCT01925781|937842|P2|NOT COMPLETED|Overall Study||4
381827|NCT01925781|937843|P1|NOT COMPLETED|Overall Study||2
381828|NCT01925781|937842|P2|COMPLETED|Overall Study||1
381829|NCT01925781|937843|P1|COMPLETED|Overall Study||3
381830|NCT01925781|937842|P2|STARTED|Overall Study||5
381831|NCT01925781|937843|P1|STARTED|Overall Study||5
381832|NCT01925768|937853|P2|NOT COMPLETED|Overall Study||23
381833|NCT01925768|937854|P1|NOT COMPLETED|Overall Study||11
381834|NCT01925768|937853|P2|COMPLETED|Overall Study|Completed = participants who completed week 24|87
381835|NCT01925768|937854|P1|COMPLETED|Overall Study|Completed = participants who completed week 24|98
381836|NCT01925768|937853|P2|Escaped Early (EE)|Overall Study|EE= investigator’s discretion plus <10% improvement in both swollen & tender joint counts at Week16|13
381837|NCT01925768|937854|P1|Escaped Early (EE)|Overall Study|EE= investigator’s discretion plus <10% improvement in both swollen & tender joint counts at Week16|35
381838|NCT01925768|937853|P2|Completed Week 16|Overall Study||91
381839|NCT01925768|937854|P1|Completed Week 16|Overall Study||101
381840|NCT01925768|937853|P2|Safety Population|Overall Study|Safety population = participants who were randomized and received at least one dose of study drug.|109
381841|NCT01925768|937854|P1|Safety Population|Overall Study|Safety population = participants who were randomized and received at least one dose of study drug.|109
381842|NCT01925768|937853|P2|Received Treatment|Overall Study||109
381843|NCT01925768|937854|P1|Received Treatment|Overall Study||109
381844|NCT01925768|937853|P2|STARTED|Overall Study||110
381845|NCT01925768|937854|P1|STARTED|Overall Study||109
381846|NCT01925703|937862|P1|NOT COMPLETED|Overall Study||4
381847|NCT01925703|937862|P1|COMPLETED|Overall Study||9
381848|NCT01925703|937862|P1|Follow-up Completed|Overall Study||9
381849|NCT01925703|937862|P1|Full Iron Repletion Achieved|Overall Study||11
381850|NCT01925703|937862|P1|Dosing Regimen Completed|Overall Study||12
381851|NCT01925703|937862|P1|STARTED|Overall Study||13
381852|NCT01925612|937873|P5|NOT COMPLETED|Overall Study||2
381853|NCT01925612|937874|P4|NOT COMPLETED|Overall Study||1
381854|NCT01925612|937875|P3|NOT COMPLETED|Overall Study||1
381855|NCT01925612|937876|P2|NOT COMPLETED|Overall Study||4
381856|NCT01925612|937877|P1|NOT COMPLETED|Overall Study||4
381857|NCT01925612|937873|P5|COMPLETED|Overall Study||10
381858|NCT01925612|937874|P4|COMPLETED|Overall Study||10
381859|NCT01925612|937875|P3|COMPLETED|Overall Study||10
381860|NCT01925612|937876|P2|COMPLETED|Overall Study||18
381861|NCT01925612|937877|P1|COMPLETED|Overall Study||25
381862|NCT01925612|937873|P5|STARTED|Overall Study||12
381863|NCT01925612|937874|P4|STARTED|Overall Study||11
381864|NCT01925612|937875|P3|STARTED|Overall Study||11
381865|NCT01925612|937876|P2|STARTED|Overall Study||22
381866|NCT01925612|937877|P1|STARTED|Overall Study||29
381867|NCT01925469|937916|P2|NOT COMPLETED|Overall Study||0
381868|NCT01925469|937917|P1|NOT COMPLETED|Overall Study||1
381869|NCT01925469|937916|P2|COMPLETED|Overall Study||15
381870|NCT01925469|937917|P1|COMPLETED|Overall Study||14
381871|NCT01925469|937916|P2|STARTED|Overall Study||15
381872|NCT01925469|937917|P1|STARTED|Overall Study||15
381873|NCT01925417|937927|P1|NOT COMPLETED|Overall Study||3
381874|NCT01925417|937927|P1|COMPLETED|Overall Study||31
381875|NCT01925417|937927|P1|STARTED|Overall Study||34
381876|NCT01925404|937938|P4|NOT COMPLETED|Overall Study||0
381877|NCT01925404|937939|P3|NOT COMPLETED|Overall Study||0
381878|NCT01925404|937940|P2|NOT COMPLETED|Overall Study||0
381879|NCT01925404|937941|P1|NOT COMPLETED|Overall Study||0
381880|NCT01925404|937938|P4|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|0
381881|NCT01925404|937939|P3|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|0
381882|NCT01925404|937940|P2|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|0
381883|NCT01925404|937941|P1|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|0
381884|NCT01925404|937938|P4|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|0
381885|NCT01925404|937939|P3|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|0
381886|NCT01925404|937940|P2|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|0
381887|NCT01925404|937941|P1|STARTED|Overall Study|"The primary outcome of this study is at the level of a park.~The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users"|0
381888|NCT01925274|937958|P3|NOT COMPLETED|Overall Study||6
381889|NCT01925274|937959|P2|NOT COMPLETED|Overall Study||6
381890|NCT01925274|937960|P1|NOT COMPLETED|Overall Study||7
381891|NCT01925274|937958|P3|COMPLETED|Overall Study||0
381892|NCT01925274|937959|P2|COMPLETED|Overall Study||0
381893|NCT01925274|937960|P1|COMPLETED|Overall Study||0
381894|NCT01925274|937958|P3|STARTED|Overall Study||6
381895|NCT01925274|937959|P2|STARTED|Overall Study||6
381896|NCT01925274|937960|P1|STARTED|Overall Study||7
381897|NCT01925209|938041|P4|NOT COMPLETED|Follow-up||4
381898|NCT01925209|938042|P3|NOT COMPLETED|Follow-up||1
381899|NCT01925209|938043|P2|NOT COMPLETED|Follow-up||6
381900|NCT01925209|938044|P1|NOT COMPLETED|Follow-up||1
381901|NCT01925209|938041|P4|COMPLETED|Follow-up||54
381902|NCT01925209|938042|P3|COMPLETED|Follow-up||55
381903|NCT01925209|938043|P2|COMPLETED|Follow-up||55
381904|NCT01925209|938044|P1|COMPLETED|Follow-up||56
381905|NCT01925209|938041|P4|STARTED|Follow-up||58
381906|NCT01925209|938042|P3|STARTED|Follow-up||56
381907|NCT01925209|938043|P2|STARTED|Follow-up||61
381908|NCT01925209|938044|P1|STARTED|Follow-up||57
381909|NCT01925209|938041|P4|NOT COMPLETED|Maintenance Treatment Epoch||2
381910|NCT01925209|938042|P3|NOT COMPLETED|Maintenance Treatment Epoch||2
381911|NCT01925209|938043|P2|NOT COMPLETED|Maintenance Treatment Epoch||1
381912|NCT01925209|938044|P1|NOT COMPLETED|Maintenance Treatment Epoch||0
381913|NCT01925209|938041|P4|COMPLETED|Maintenance Treatment Epoch||48
381914|NCT01925209|938042|P3|COMPLETED|Maintenance Treatment Epoch||50
381915|NCT01925209|938043|P2|COMPLETED|Maintenance Treatment Epoch||45
381916|NCT01925209|938044|P1|COMPLETED|Maintenance Treatment Epoch||49
381917|NCT01925209|938041|P4|STARTED|Maintenance Treatment Epoch||50
381918|NCT01925209|938042|P3|STARTED|Maintenance Treatment Epoch||52
381919|NCT01925209|938043|P2|STARTED|Maintenance Treatment Epoch||46
381920|NCT01925209|938044|P1|STARTED|Maintenance Treatment Epoch||49
381921|NCT01925209|938041|P4|NOT COMPLETED|Treatment Epoch||5
381922|NCT01925209|938042|P3|NOT COMPLETED|Treatment Epoch||7
381923|NCT01925209|938043|P2|NOT COMPLETED|Treatment Epoch||8
381924|NCT01925209|938044|P1|NOT COMPLETED|Treatment Epoch||9
381925|NCT01925209|938041|P4|COMPLETED|Treatment Epoch||57
381926|NCT01925209|938042|P3|COMPLETED|Treatment Epoch||56
381927|NCT01925209|938043|P2|COMPLETED|Treatment Epoch||55
381928|NCT01925209|938044|P1|COMPLETED|Treatment Epoch||54
381929|NCT01925209|938041|P4|Full Analysis Set|Treatment Epoch||62
381930|NCT01925209|938042|P3|Full Analysis Set|Treatment Epoch||63
381931|NCT01925209|938043|P2|Full Analysis Set|Treatment Epoch||63
381932|NCT01925209|938044|P1|Full Analysis Set|Treatment Epoch||63
381933|NCT01925209|938041|P4|STARTED|Treatment Epoch||62
381934|NCT01925209|938042|P3|STARTED|Treatment Epoch||63
381935|NCT01925209|938043|P2|STARTED|Treatment Epoch||63
381936|NCT01925209|938044|P1|STARTED|Treatment Epoch||63
381937|NCT01925183|938076|P2|NOT COMPLETED|Overall Study||0
381938|NCT01925183|938077|P1|NOT COMPLETED|Overall Study||1
381939|NCT01925183|938076|P2|COMPLETED|Overall Study||3
381940|NCT01925183|938077|P1|COMPLETED|Overall Study||2
381941|NCT01925183|938076|P2|STARTED|Overall Study||3
381942|NCT01925183|938077|P1|STARTED|Overall Study||3
381943|NCT01925170|938085|P1|NOT COMPLETED|Overall Study||53
381944|NCT01925170|938085|P1|COMPLETED|Overall Study||1585
381945|NCT01925170|938085|P1|STARTED|Overall Study||1638
381946|NCT01925144|938103|P1|NOT COMPLETED|Period 2 (At Dosing Day 3 Through Day12)||0
381947|NCT01925144|938103|P1|COMPLETED|Period 2 (At Dosing Day 3 Through Day12)||30
381948|NCT01925144|938103|P1|Received 8 Doses of Omeprazole|Period 2 (At Dosing Day 3 Through Day12)||30
381949|NCT01925144|938103|P1|Received Baricitinib|Period 2 (At Dosing Day 3 Through Day12)||30
381950|NCT01925144|938103|P1|STARTED|Period 2 (At Dosing Day 3 Through Day12)||30
381951|NCT01925144|938103|P1|NOT COMPLETED|Period 1 (Day 1 Through Predose Day 3)||0
381952|NCT01925144|938103|P1|COMPLETED|Period 1 (Day 1 Through Predose Day 3)||30
381953|NCT01925144|938103|P1|Received Baricitinib|Period 1 (Day 1 Through Predose Day 3)||30
381954|NCT01925144|938103|P1|STARTED|Period 1 (Day 1 Through Predose Day 3)||30
381955|NCT01924975|938116|P2|NOT COMPLETED|Overall Study||0
381956|NCT01924975|938117|P1|NOT COMPLETED|Overall Study||0
381957|NCT01924975|938116|P2|COMPLETED|Overall Study||51
381958|NCT01924975|938117|P1|COMPLETED|Overall Study||51
381959|NCT01924975|938116|P2|STARTED|Overall Study||51
381960|NCT01924975|938117|P1|STARTED|Overall Study||51
381961|NCT01924949|938127|P1|NOT COMPLETED|Overall Study||0
381962|NCT01924949|938127|P1|COMPLETED|Overall Study||5
381963|NCT01924949|938127|P1|STARTED|Overall Study||5
381964|NCT01924871|938138|P2|NOT COMPLETED|Overall Study||2
381965|NCT01924871|938139|P1|NOT COMPLETED|Overall Study||6
381966|NCT01924871|938138|P2|COMPLETED|Overall Study||29
381967|NCT01924871|938139|P1|COMPLETED|Overall Study||25
381968|NCT01924871|938138|P2|STARTED|Overall Study||31
381969|NCT01924871|938139|P1|STARTED|Overall Study||31
381970|NCT01924845|938145|P1|NOT COMPLETED|Overall Study||6
381971|NCT01924845|938145|P1|COMPLETED|Overall Study||18
381972|NCT01924845|938145|P1|STARTED|Overall Study||24
381973|NCT01924767|938158|P5|NOT COMPLETED|Overall Study||0
381974|NCT01924767|938159|P4|NOT COMPLETED|Overall Study||0
381975|NCT01924767|938160|P3|NOT COMPLETED|Overall Study||1
381976|NCT01924767|938161|P2|NOT COMPLETED|Overall Study||0
381977|NCT01924767|938162|P1|NOT COMPLETED|Overall Study||1
381978|NCT01924767|938158|P5|COMPLETED|Overall Study||9
381979|NCT01924767|938159|P4|COMPLETED|Overall Study||9
381980|NCT01924767|938160|P3|COMPLETED|Overall Study||8
381981|NCT01924767|938161|P2|COMPLETED|Overall Study||9
381982|NCT01924767|938162|P1|COMPLETED|Overall Study||11
381983|NCT01924767|938158|P5|STARTED|Overall Study||9
381984|NCT01924767|938159|P4|STARTED|Overall Study||9
381985|NCT01924767|938160|P3|STARTED|Overall Study||9
381986|NCT01924767|938161|P2|STARTED|Overall Study||9
381987|NCT01924767|938162|P1|STARTED|Overall Study||12
381988|NCT01924559|938262|P1|NOT COMPLETED|Overall Study||0
381989|NCT01924559|938262|P1|COMPLETED|Overall Study|The order in which subjects started scenarios (in biohazard gear vs street clothing) was randomized|37
381990|NCT01924559|938262|P1|STARTED|Overall Study|All 37 participants were scored under the same six scenarios, resulting in 222 observations.|37
381991|NCT01924429|938278|P2|NOT COMPLETED|Period 2 - Second Intervention (4 Weeks)||0
381992|NCT01924429|938279|P1|NOT COMPLETED|Period 2 - Second Intervention (4 Weeks)||0
381993|NCT01924429|938278|P2|COMPLETED|Period 2 - Second Intervention (4 Weeks)||11
381994|NCT01924429|938279|P1|COMPLETED|Period 2 - Second Intervention (4 Weeks)||14
381995|NCT01924429|938278|P2|STARTED|Period 2 - Second Intervention (4 Weeks)||11
381996|NCT01924429|938279|P1|STARTED|Period 2 - Second Intervention (4 Weeks)||14
381997|NCT01924429|938278|P2|NOT COMPLETED|Washout Period (2 Weeks)||2
381998|NCT01924429|938279|P1|NOT COMPLETED|Washout Period (2 Weeks)||3
381999|NCT01924429|938278|P2|COMPLETED|Washout Period (2 Weeks)||11
382000|NCT01924429|938279|P1|COMPLETED|Washout Period (2 Weeks)||14
382001|NCT01924429|938278|P2|STARTED|Washout Period (2 Weeks)||13
382002|NCT01924429|938279|P1|STARTED|Washout Period (2 Weeks)||17
382003|NCT01924429|938278|P2|NOT COMPLETED|Period 1 - First Intervention (4 Weeks)||0
382004|NCT01924429|938279|P1|NOT COMPLETED|Period 1 - First Intervention (4 Weeks)||0
382005|NCT01924429|938278|P2|COMPLETED|Period 1 - First Intervention (4 Weeks)||13
382006|NCT01924429|938279|P1|COMPLETED|Period 1 - First Intervention (4 Weeks)||17
382007|NCT01924429|938278|P2|STARTED|Period 1 - First Intervention (4 Weeks)||13
382008|NCT01924429|938279|P1|STARTED|Period 1 - First Intervention (4 Weeks)||17
382009|NCT01924390|938311|P2|NOT COMPLETED|Overall Study||1
382010|NCT01924390|938312|P1|NOT COMPLETED|Overall Study||1
382011|NCT01924390|938311|P2|COMPLETED|Overall Study||21
382012|NCT01924390|938312|P1|COMPLETED|Overall Study||21
382013|NCT01924390|938311|P2|STARTED|Overall Study||22
382014|NCT01924390|938312|P1|STARTED|Overall Study||22
382015|NCT01924364|938322|P1|NOT COMPLETED|Overall Study||3
382016|NCT01924364|938322|P1|COMPLETED|Overall Study||4
382017|NCT01924364|938322|P1|STARTED|Overall Study||7
382018|NCT01924299|938339|P2|NOT COMPLETED|Period 2||1
382019|NCT01924299|938340|P1|NOT COMPLETED|Period 2||1
382020|NCT01924299|938339|P2|COMPLETED|Period 2||17
382021|NCT01924299|938340|P1|COMPLETED|Period 2||17
382022|NCT01924299|938339|P2|Received Baricitinib|Period 2||17
382023|NCT01924299|938340|P1|Received Baricitinib|Period 2||17
382024|NCT01924299|938339|P2|Received at Least 1 Dose of Study Drug|Period 2||18
382025|NCT01924299|938340|P1|Received at Least 1 Dose of Study Drug|Period 2||18
382026|NCT01924299|938339|P2|STARTED|Period 2||18
382027|NCT01924299|938340|P1|STARTED|Period 2||18
382028|NCT01924299|938339|P2|NOT COMPLETED|Period 1||0
382029|NCT01924299|938340|P1|NOT COMPLETED|Period 1||0
382030|NCT01924299|938339|P2|COMPLETED|Period 1||18
382031|NCT01924299|938340|P1|COMPLETED|Period 1||18
382032|NCT01924299|938339|P2|Received Baricitinib|Period 1||18
382033|NCT01924299|938340|P1|Received Baricitinib|Period 1||18
382034|NCT01924299|938339|P2|STARTED|Period 1||18
382035|NCT01924299|938340|P1|STARTED|Period 1||18
382036|NCT01924182|938362|P2|NOT COMPLETED|Overall Study||0
382037|NCT01924182|938363|P1|NOT COMPLETED|Overall Study||1
382038|NCT01924182|938362|P2|COMPLETED|Overall Study||0
382039|NCT01924182|938363|P1|COMPLETED|Overall Study||2
382040|NCT01924182|938362|P2|STARTED|Overall Study||0
382041|NCT01924182|938363|P1|STARTED|Overall Study||3
382042|NCT01924169|938375|P1|NOT COMPLETED|Overall Study||0
382043|NCT01924169|938375|P1|COMPLETED|Overall Study||3
382044|NCT01924169|938375|P1|STARTED|Overall Study||3
382045|NCT01923896|938382|P2|NOT COMPLETED|Overall Study||0
382046|NCT01923896|938383|P1|NOT COMPLETED|Overall Study||1
382047|NCT01923896|938382|P2|COMPLETED|Overall Study||8
382048|NCT01923896|938383|P1|COMPLETED|Overall Study||7
382049|NCT01923896|938382|P2|STARTED|Overall Study||8
382050|NCT01923896|938383|P1|STARTED|Overall Study||8
382051|NCT01923805|938397|P2|NOT COMPLETED|Overall Study||5
382052|NCT01923805|938398|P1|NOT COMPLETED|Overall Study||3
382053|NCT01923805|938397|P2|COMPLETED|Overall Study||0
382054|NCT01923805|938398|P1|COMPLETED|Overall Study||0
382055|NCT01923805|938397|P2|STARTED|Overall Study|early termination|5
382056|NCT01923805|938398|P1|STARTED|Overall Study|early termination|3
382057|NCT01923740|938406|P2|NOT COMPLETED|3 Year Clinical Follow-up||0
382058|NCT01923740|938407|P1|NOT COMPLETED|3 Year Clinical Follow-up||1
382059|NCT01923740|938406|P2|COMPLETED|3 Year Clinical Follow-up||225
382060|NCT01923740|938407|P1|COMPLETED|3 Year Clinical Follow-up||223
382061|NCT01923740|938406|P2|STARTED|3 Year Clinical Follow-up||225
382062|NCT01923740|938407|P1|STARTED|3 Year Clinical Follow-up||224
382063|NCT01923740|938406|P2|NOT COMPLETED|2 Year Clinical Follow-up||3
382064|NCT01923740|938407|P1|NOT COMPLETED|2 Year Clinical Follow-up||2
382065|NCT01923740|938406|P2|COMPLETED|2 Year Clinical Follow-up||225
382066|NCT01923740|938407|P1|COMPLETED|2 Year Clinical Follow-up||224
382067|NCT01923740|938406|P2|STARTED|2 Year Clinical Follow-up||228
382068|NCT01923740|938407|P1|STARTED|2 Year Clinical Follow-up||226
382069|NCT01923740|938406|P2|NOT COMPLETED|1 Year Clinical Follow-up||0
382070|NCT01923740|938407|P1|NOT COMPLETED|1 Year Clinical Follow-up||1
382071|NCT01923740|938406|P2|COMPLETED|1 Year Clinical Follow-up||228
382072|NCT01923740|938407|P1|COMPLETED|1 Year Clinical Follow-up||226
382073|NCT01923740|938406|P2|STARTED|1 Year Clinical Follow-up||228
382074|NCT01923740|938407|P1|STARTED|1 Year Clinical Follow-up||227
382075|NCT01923740|938406|P2|NOT COMPLETED|270-day Clinical Follow-up||4
382076|NCT01923740|938407|P1|NOT COMPLETED|270-day Clinical Follow-up||0
382077|NCT01923740|938406|P2|COMPLETED|270-day Clinical Follow-up||228
382078|NCT01923740|938407|P1|COMPLETED|270-day Clinical Follow-up||227
382079|NCT01923740|938406|P2|STARTED|270-day Clinical Follow-up||232
382080|NCT01923740|938407|P1|STARTED|270-day Clinical Follow-up||227
382081|NCT01923740|938406|P2|NOT COMPLETED|180-day Clinical Follow-up||0
382082|NCT01923740|938407|P1|NOT COMPLETED|180-day Clinical Follow-up||0
382083|NCT01923740|938406|P2|COMPLETED|180-day Clinical Follow-up||232
382084|NCT01923740|938407|P1|COMPLETED|180-day Clinical Follow-up||227
382085|NCT01923740|938406|P2|STARTED|180-day Clinical Follow-up||232
382086|NCT01923740|938407|P1|STARTED|180-day Clinical Follow-up||227
382087|NCT01923740|938406|P2|NOT COMPLETED|30-day Clinical Follow-up||0
382088|NCT01923740|938407|P1|NOT COMPLETED|30-day Clinical Follow-up||0
382089|NCT01923740|938406|P2|COMPLETED|30-day Clinical Follow-up||232
382090|NCT01923740|938407|P1|COMPLETED|30-day Clinical Follow-up||227
382091|NCT01923740|938406|P2|STARTED|30-day Clinical Follow-up|Per-treatment-evaluable (PTE) population|232
382092|NCT01923740|938407|P1|STARTED|30-day Clinical Follow-up|Per-treatment-evaluable (PTE) population|227
382093|NCT01923480|938668|P6|NOT COMPLETED|Period 2 (Hours 1-7)||0
382094|NCT01923480|938669|P5|NOT COMPLETED|Period 2 (Hours 1-7)||0
382095|NCT01923480|938670|P4|NOT COMPLETED|Period 2 (Hours 1-7)||0
382096|NCT01923480|938671|P3|NOT COMPLETED|Period 2 (Hours 1-7)||0
382097|NCT01923480|938672|P2|NOT COMPLETED|Period 2 (Hours 1-7)||0
382098|NCT01923480|938673|P1|NOT COMPLETED|Period 2 (Hours 1-7)||0
382099|NCT01923480|938668|P6|COMPLETED|Period 2 (Hours 1-7)||2
382100|NCT01923480|938669|P5|COMPLETED|Period 2 (Hours 1-7)||2
382101|NCT01923480|938670|P4|COMPLETED|Period 2 (Hours 1-7)||2
382102|NCT01923480|938671|P3|COMPLETED|Period 2 (Hours 1-7)||2
382103|NCT01923480|938672|P2|COMPLETED|Period 2 (Hours 1-7)||1
382104|NCT01923480|938673|P1|COMPLETED|Period 2 (Hours 1-7)||1
382105|NCT01923480|938668|P6|STARTED|Period 2 (Hours 1-7)||2
382106|NCT01923480|938669|P5|STARTED|Period 2 (Hours 1-7)||2
382107|NCT01923480|938670|P4|STARTED|Period 2 (Hours 1-7)||2
382108|NCT01923480|938671|P3|STARTED|Period 2 (Hours 1-7)||2
382109|NCT01923480|938672|P2|STARTED|Period 2 (Hours 1-7)|One subject completed Period 1, but withdrew from the study prior to the start of Period 2.|1
382110|NCT01923480|938673|P1|STARTED|Period 2 (Hours 1-7)||1
382111|NCT01923480|938668|P6|NOT COMPLETED|Period 1 (Hours 1-7)||0
382112|NCT01923480|938669|P5|NOT COMPLETED|Period 1 (Hours 1-7)||0
382113|NCT01923480|938670|P4|NOT COMPLETED|Period 1 (Hours 1-7)||0
382114|NCT01923480|938671|P3|NOT COMPLETED|Period 1 (Hours 1-7)||0
382115|NCT01923480|938672|P2|NOT COMPLETED|Period 1 (Hours 1-7)||0
382116|NCT01923480|938673|P1|NOT COMPLETED|Period 1 (Hours 1-7)||0
382117|NCT01923480|938668|P6|COMPLETED|Period 1 (Hours 1-7)||2
382118|NCT01923480|938669|P5|COMPLETED|Period 1 (Hours 1-7)||2
382119|NCT01923480|938670|P4|COMPLETED|Period 1 (Hours 1-7)||2
382120|NCT01923480|938671|P3|COMPLETED|Period 1 (Hours 1-7)||2
382121|NCT01923480|938672|P2|COMPLETED|Period 1 (Hours 1-7)|One subject completed Period 1, but withdrew from the study prior to the start of Period 2.|2
382122|NCT01923480|938673|P1|COMPLETED|Period 1 (Hours 1-7)||1
382123|NCT01923480|938668|P6|STARTED|Period 1 (Hours 1-7)||2
382124|NCT01923480|938669|P5|STARTED|Period 1 (Hours 1-7)||2
382125|NCT01923480|938670|P4|STARTED|Period 1 (Hours 1-7)||2
382126|NCT01923480|938671|P3|STARTED|Period 1 (Hours 1-7)||2
382127|NCT01923480|938672|P2|STARTED|Period 1 (Hours 1-7)||2
382128|NCT01923480|938673|P1|STARTED|Period 1 (Hours 1-7)||1
382129|NCT01923467|938828|P1|NOT COMPLETED|Overall Study||541
382130|NCT01923467|938828|P1|COMPLETED|Overall Study|Completed 3-month follow up survey|226
382131|NCT01923467|938828|P1|Baseline Completed, Enrolled|Overall Study||288
382132|NCT01923467|938828|P1|STARTED|Overall Study|Offered stop smoking program|767
382133|NCT01923389|938834|P2|NOT COMPLETED|Overall Study||0
382134|NCT01923389|938835|P1|NOT COMPLETED|Overall Study||1
382135|NCT01923389|938834|P2|COMPLETED|Overall Study||2
382136|NCT01923389|938835|P1|COMPLETED|Overall Study||1
382137|NCT01923389|938834|P2|STARTED|Overall Study||2
382138|NCT01923389|938835|P1|STARTED|Overall Study||2
382139|NCT01922986|938859|P2|NOT COMPLETED|Overall Study||0
382140|NCT01922986|938860|P1|NOT COMPLETED|Overall Study||0
382141|NCT01922986|938859|P2|COMPLETED|Overall Study||2
382142|NCT01922986|938860|P1|COMPLETED|Overall Study||2
382143|NCT01922986|938859|P2|STARTED|Overall Study||2
382144|NCT01922986|938860|P1|STARTED|Overall Study||2
382145|NCT01922934|938872|P2|NOT COMPLETED|Visit 12 / Final Visits||290
382146|NCT01922934|938873|P1|NOT COMPLETED|Visit 12 / Final Visits||6
382147|NCT01922934|938872|P2|COMPLETED|Visit 12 / Final Visits|290 patients did not have a second weight recorded at one year (+/- 6months) of first weight|2640
382148|NCT01922934|938873|P1|COMPLETED|Visit 12 / Final Visits|6 patients did not return for final visit and weight measure|113
382149|NCT01922934|938872|P2|STARTED|Visit 12 / Final Visits||2930
382150|NCT01922934|938873|P1|STARTED|Visit 12 / Final Visits||119
382151|NCT01922934|938872|P2|NOT COMPLETED|Visit 1- Weight Measured||1284
382152|NCT01922934|938873|P1|NOT COMPLETED|Visit 1- Weight Measured||21
382153|NCT01922934|938872|P2|COMPLETED|Visit 1- Weight Measured|1284 patients did not have any weights recorded in EMR during study timeframe|2930
382154|NCT01922934|938873|P1|COMPLETED|Visit 1- Weight Measured|Patients first received tool and were weighed at Visit 1|119
382155|NCT01922934|938872|P2|STARTED|Visit 1- Weight Measured||4214
382156|NCT01922934|938873|P1|STARTED|Visit 1- Weight Measured|21 patients did not return for Visit 1 to receive tool or have weight measured.|140
382157|NCT01922934|938872|P2|NOT COMPLETED|Visit 0 - Patient Contacted & Consented||0
382158|NCT01922934|938873|P1|NOT COMPLETED|Visit 0 - Patient Contacted & Consented||235
382159|NCT01922934|938872|P2|COMPLETED|Visit 0 - Patient Contacted & Consented||4214
382160|NCT01922934|938873|P1|COMPLETED|Visit 0 - Patient Contacted & Consented|reflects number of patients that were contacted and agreed to attend Visit 0|140
382161|NCT01922934|938872|P2|STARTED|Visit 0 - Patient Contacted & Consented|Control group patients were not contacted or offered intervention|4214
382162|NCT01922934|938873|P1|STARTED|Visit 0 - Patient Contacted & Consented||375
382163|NCT01922934|938872|P2|NOT COMPLETED|Eligible Patients||88
382164|NCT01922934|938873|P1|NOT COMPLETED|Eligible Patients||53
382165|NCT01922934|938872|P2|COMPLETED|Eligible Patients|81 patients did not meet inclusion criteria as they were 80 years or older. 7 patients had died.|4214
382166|NCT01922934|938873|P1|COMPLETED|Eligible Patients|375 patients determined eligible after original random selection from DHHA data warehouse.|375
382167|NCT01922934|938872|P2|STARTED|Eligible Patients||4302
382168|NCT01922934|938873|P1|STARTED|Eligible Patients||428
382169|NCT01922739|938885|P1|NOT COMPLETED|Open-label Treatment Period||34
382170|NCT01922739|938885|P1|COMPLETED|Open-label Treatment Period||136
382171|NCT01922739|938885|P1|Treatment SAS and FAS|Open-label Treatment Period|SAS = safety analysis set FAS = full analysis set|170
382172|NCT01922739|938885|P1|STARTED|Open-label Treatment Period||170
382173|NCT01922739|938885|P1|NOT COMPLETED|Titration/Adjustment Period||12
382174|NCT01922739|938885|P1|COMPLETED|Titration/Adjustment Period||170
382175|NCT01922739|938885|P1|Safety Analysis Set|Titration/Adjustment Period||182
382176|NCT01922739|938885|P1|STARTED|Titration/Adjustment Period||182
382177|NCT01922349|938914|P4|NOT COMPLETED|Multiple Rising Dose (MRD) Period||1
382178|NCT01922349|938915|P3|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
382179|NCT01922349|938916|P2|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
382180|NCT01922349|938917|P1|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
382181|NCT01922349|938914|P4|COMPLETED|Multiple Rising Dose (MRD) Period||26
382182|NCT01922349|938915|P3|COMPLETED|Multiple Rising Dose (MRD) Period||18
382183|NCT01922349|938916|P2|COMPLETED|Multiple Rising Dose (MRD) Period||27
382184|NCT01922349|938917|P1|COMPLETED|Multiple Rising Dose (MRD) Period||24
382185|NCT01922349|938914|P4|STARTED|Multiple Rising Dose (MRD) Period||27
382186|NCT01922349|938915|P3|STARTED|Multiple Rising Dose (MRD) Period||18
382187|NCT01922349|938916|P2|STARTED|Multiple Rising Dose (MRD) Period||27
382188|NCT01922349|938917|P1|STARTED|Multiple Rising Dose (MRD) Period|One subject discontinued the trial after the SRD period due to non-compliance with the protocol.|24
382189|NCT01922349|938914|P4|NOT COMPLETED|Single Rising Dose (SRD) Period||0
382190|NCT01922349|938915|P3|NOT COMPLETED|Single Rising Dose (SRD) Period||0
382191|NCT01922349|938916|P2|NOT COMPLETED|Single Rising Dose (SRD) Period||0
382192|NCT01922349|938917|P1|NOT COMPLETED|Single Rising Dose (SRD) Period||0
382193|NCT01922349|938914|P4|COMPLETED|Single Rising Dose (SRD) Period||27
382194|NCT01922349|938915|P3|COMPLETED|Single Rising Dose (SRD) Period||18
382195|NCT01922349|938916|P2|COMPLETED|Single Rising Dose (SRD) Period||27
382196|NCT01922349|938917|P1|COMPLETED|Single Rising Dose (SRD) Period||25
382197|NCT01922349|938914|P4|STARTED|Single Rising Dose (SRD) Period||27
382198|NCT01922349|938915|P3|STARTED|Single Rising Dose (SRD) Period||18
382199|NCT01922349|938916|P2|STARTED|Single Rising Dose (SRD) Period||27
382200|NCT01922349|938917|P1|STARTED|Single Rising Dose (SRD) Period||25
382201|NCT01922271|939024|P2|NOT COMPLETED|PERIOD 2||0
382202|NCT01922271|939025|P1|NOT COMPLETED|PERIOD 2||0
382203|NCT01922271|939024|P2|COMPLETED|PERIOD 2||76
382204|NCT01922271|939025|P1|COMPLETED|PERIOD 2||75
382205|NCT01922271|939024|P2|STARTED|PERIOD 2||76
382206|NCT01922271|939025|P1|STARTED|PERIOD 2||75
382207|NCT01922271|939024|P2|NOT COMPLETED|WASHOUT Period||0
382208|NCT01922271|939025|P1|NOT COMPLETED|WASHOUT Period||1
382209|NCT01922271|939024|P2|COMPLETED|WASHOUT Period||76
382210|NCT01922271|939025|P1|COMPLETED|WASHOUT Period||75
382211|NCT01922271|939024|P2|STARTED|WASHOUT Period||76
382212|NCT01922271|939025|P1|STARTED|WASHOUT Period||76
382213|NCT01922271|939024|P2|NOT COMPLETED|PERIOD 1||0
382214|NCT01922271|939025|P1|NOT COMPLETED|PERIOD 1||0
382215|NCT01922271|939024|P2|COMPLETED|PERIOD 1||76
382216|NCT01922271|939025|P1|COMPLETED|PERIOD 1||76
382217|NCT01922271|939024|P2|STARTED|PERIOD 1||76
382218|NCT01922271|939025|P1|STARTED|PERIOD 1||76
382219|NCT01922219|939043|P1|NOT COMPLETED|Overall Study||9
382220|NCT01922219|939043|P1|COMPLETED|Overall Study||28
382221|NCT01922219|939043|P1|STARTED|Overall Study||37
382222|NCT01922115|939051|P2|NOT COMPLETED|Overall Study||7
382223|NCT01922115|939052|P1|NOT COMPLETED|Overall Study||7
382224|NCT01922115|939051|P2|COMPLETED|Overall Study||24
382225|NCT01922115|939052|P1|COMPLETED|Overall Study||21
382226|NCT01922115|939051|P2|STARTED|Overall Study||31
382227|NCT01922115|939052|P1|STARTED|Overall Study||28
382228|NCT01922089|939066|P2|NOT COMPLETED|Overall Study||30
382229|NCT01922089|939067|P1|NOT COMPLETED|Overall Study||39
382230|NCT01922089|939066|P2|COMPLETED|Overall Study||221
382231|NCT01922089|939067|P1|COMPLETED|Overall Study||208
382232|NCT01922089|939066|P2|Safety Set|Overall Study||251
382233|NCT01922089|939067|P1|Safety Set|Overall Study||246
382234|NCT01922089|939066|P2|STARTED|Overall Study||251
382235|NCT01922089|939067|P1|STARTED|Overall Study||247
382236|NCT01922037|939079|P2|NOT COMPLETED|Overall Study||174
382237|NCT01922037|939080|P1|NOT COMPLETED|Overall Study||10
382238|NCT01922037|939079|P2|COMPLETED|Overall Study||563
382239|NCT01922037|939080|P1|COMPLETED|Overall Study||59
382240|NCT01922037|939079|P2|Treated|Overall Study||732
382241|NCT01922037|939080|P1|Treated|Overall Study||69
382242|NCT01922037|939079|P2|STARTED|Overall Study||737
382243|NCT01922037|939080|P1|STARTED|Overall Study||69
382244|NCT01922011|939174|P2|NOT COMPLETED|Overall Study||5
382245|NCT01922011|939175|P1|NOT COMPLETED|Overall Study||6
382246|NCT01922011|939174|P2|COMPLETED|Overall Study||69
382247|NCT01922011|939175|P1|COMPLETED|Overall Study||69
382248|NCT01922011|939174|P2|Treatment Actually Received|Overall Study|One participant intended for treatment with Vancomycin or Nafcillin was treated with Daptomycin|72
382249|NCT01922011|939175|P1|Treatment Actually Received|Overall Study|One participant intended for treatment with Vancomycin or Nafcillin was treated with Daptomycin|74
382250|NCT01922011|939174|P2|Treated|Overall Study|Treated Participants|73
382251|NCT01922011|939175|P1|Treated|Overall Study|Treated Participants|73
382252|NCT01922011|939174|P2|STARTED|Overall Study|Randomized participants|74
382253|NCT01922011|939175|P1|STARTED|Overall Study|Randomized participants|75
382254|NCT01921894|939218|P3|NOT COMPLETED|Overall Study||0
382255|NCT01921894|939219|P2|NOT COMPLETED|Overall Study||0
382256|NCT01921894|939220|P1|NOT COMPLETED|Overall Study||0
382257|NCT01921894|939218|P3|COMPLETED|Overall Study||8
382258|NCT01921894|939219|P2|COMPLETED|Overall Study||8
382259|NCT01921894|939220|P1|COMPLETED|Overall Study||8
382260|NCT01921894|939218|P3|STARTED|Overall Study||8
382261|NCT01921894|939219|P2|STARTED|Overall Study||8
382262|NCT01921894|939220|P1|STARTED|Overall Study||8
382263|NCT01921829|939242|P2|NOT COMPLETED|Overall Study||1
382264|NCT01921829|939243|P1|NOT COMPLETED|Overall Study||0
382265|NCT01921829|939242|P2|COMPLETED|Overall Study||8
382266|NCT01921829|939243|P1|COMPLETED|Overall Study||10
382267|NCT01921829|939242|P2|STARTED|Overall Study||9
382268|NCT01921829|939243|P1|STARTED|Overall Study||10
382269|NCT01921751|939292|P3|NOT COMPLETED|Overall Study||0
382270|NCT01921751|939293|P2|NOT COMPLETED|Overall Study||0
382271|NCT01921751|939294|P1|NOT COMPLETED|Overall Study||0
382272|NCT01921751|939292|P3|COMPLETED|Overall Study|All randomized patients are reported here.|5
382273|NCT01921751|939293|P2|COMPLETED|Overall Study|All randomized patients are reported here.|4
382274|NCT01921751|939294|P1|COMPLETED|Overall Study|All randomized patients are reported here.|4
382275|NCT01921751|939292|P3|STARTED|Overall Study||5
382276|NCT01921751|939293|P2|STARTED|Overall Study||4
382277|NCT01921751|939294|P1|STARTED|Overall Study||4
382278|NCT01921452|939312|P1|NOT COMPLETED|Overall Study||0
382279|NCT01921452|939312|P1|COMPLETED|Overall Study||283
382280|NCT01921452|939312|P1|STARTED|Overall Study||283
382281|NCT01921348|939319|P2|NOT COMPLETED|Overall Study||2
382282|NCT01921348|939320|P1|NOT COMPLETED|Overall Study||1
382283|NCT01921348|939319|P2|COMPLETED|Overall Study||7
382284|NCT01921348|939320|P1|COMPLETED|Overall Study||8
382285|NCT01921348|939319|P2|STARTED|Overall Study||9
382286|NCT01921348|939320|P1|STARTED|Overall Study||9
382287|NCT01921322|939332|P2|NOT COMPLETED|Overall Study||17
382288|NCT01921322|939333|P1|NOT COMPLETED|Overall Study||15
382289|NCT01921322|939332|P2|COMPLETED|Overall Study||44
382290|NCT01921322|939333|P1|COMPLETED|Overall Study||42
382291|NCT01921322|939332|P2|STARTED|Overall Study||61
382292|NCT01921322|939333|P1|STARTED|Overall Study||57
382293|NCT01921296|939341|P1|NOT COMPLETED|Overall Study||0
382294|NCT01921296|939341|P1|COMPLETED|Overall Study||2
382295|NCT01921296|939341|P1|STARTED|Overall Study||2
382296|NCT01921270|939349|P1|NOT COMPLETED|Overall Study||1
382297|NCT01921270|939349|P1|COMPLETED|Overall Study||17
382298|NCT01921270|939349|P1|STARTED|Overall Study||18
382299|NCT01921257|939365|P1|NOT COMPLETED|Overall Study||3
382300|NCT01921257|939365|P1|COMPLETED|Overall Study||13
382301|NCT01921257|939365|P1|Active Treatment|Overall Study||13
382302|NCT01921257|939365|P1|Placebo run-in|Overall Study||16
382303|NCT01921257|939365|P1|STARTED|Overall Study||16
382304|NCT01921205|939372|P2|NOT COMPLETED|Overall Study||20
382305|NCT01921205|939373|P1|NOT COMPLETED|Overall Study||21
382306|NCT01921205|939372|P2|COMPLETED|Overall Study||151
382307|NCT01921205|939373|P1|COMPLETED|Overall Study||151
382308|NCT01921205|939372|P2|STARTED|Overall Study||171
382309|NCT01921205|939373|P1|STARTED|Overall Study||172
382310|NCT01921166|939403|P2|NOT COMPLETED|Overall Study||0
382311|NCT01921166|939404|P1|NOT COMPLETED|Overall Study||0
382312|NCT01921166|939403|P2|COMPLETED|Overall Study||15
382313|NCT01921166|939404|P1|COMPLETED|Overall Study||8
382314|NCT01921166|939403|P2|STARTED|Overall Study||15
382315|NCT01921166|939404|P1|STARTED|Overall Study||8
382316|NCT01921101|939414|P2|NOT COMPLETED|Overall Study||6
382317|NCT01921101|939415|P1|NOT COMPLETED|Overall Study||16
382318|NCT01921101|939414|P2|COMPLETED|Overall Study||32
382319|NCT01921101|939415|P1|COMPLETED|Overall Study||24
382320|NCT01921101|939414|P2|STARTED|Overall Study||38
382321|NCT01921101|939415|P1|STARTED|Overall Study||40
382322|NCT01920958|939423|P1|NOT COMPLETED|Overall Study||5
382323|NCT01920958|939423|P1|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|228
382324|NCT01920958|939423|P1|STARTED|Overall Study||233
382325|NCT01920893|939441|P2|NOT COMPLETED|Overall Study||2
382326|NCT01920893|939442|P1|NOT COMPLETED|Overall Study||7
382327|NCT01920893|939441|P2|COMPLETED|Overall Study||28
382328|NCT01920893|939442|P1|COMPLETED|Overall Study||23
382329|NCT01920893|939441|P2|Treated (Safety Population)|Overall Study||30
382330|NCT01920893|939442|P1|Treated (Safety Population)|Overall Study||30
382331|NCT01920893|939441|P2|STARTED|Overall Study||30
382332|NCT01920893|939442|P1|STARTED|Overall Study||30
382333|NCT01920854|939475|P7|NOT COMPLETED|Overall Study||1
382334|NCT01920854|939476|P6|NOT COMPLETED|Overall Study||0
382335|NCT01920854|939477|P5|NOT COMPLETED|Overall Study||1
382336|NCT01920854|939478|P4|NOT COMPLETED|Overall Study||0
382337|NCT01920854|939479|P3|NOT COMPLETED|Overall Study||0
382338|NCT01920854|939480|P2|NOT COMPLETED|Overall Study||0
382339|NCT01920854|939481|P1|NOT COMPLETED|Overall Study||1
382340|NCT01920854|939475|P7|COMPLETED|Overall Study||5
382341|NCT01920854|939476|P6|COMPLETED|Overall Study||6
382342|NCT01920854|939477|P5|COMPLETED|Overall Study||5
382343|NCT01920854|939478|P4|COMPLETED|Overall Study||6
382344|NCT01920854|939479|P3|COMPLETED|Overall Study||6
382345|NCT01920854|939480|P2|COMPLETED|Overall Study||6
382346|NCT01920854|939481|P1|COMPLETED|Overall Study||11
382347|NCT01920854|939475|P7|STARTED|Overall Study||6
382348|NCT01920854|939476|P6|STARTED|Overall Study||6
382349|NCT01920854|939477|P5|STARTED|Overall Study||6
382350|NCT01920854|939478|P4|STARTED|Overall Study||6
382351|NCT01920854|939479|P3|STARTED|Overall Study||6
382352|NCT01920854|939480|P2|STARTED|Overall Study||6
382353|NCT01920854|939481|P1|STARTED|Overall Study||12
382354|NCT01920802|939608|P3|NOT COMPLETED|Overall Study||1
382355|NCT01920802|939609|P2|NOT COMPLETED|Overall Study||2
382356|NCT01920802|939610|P1|NOT COMPLETED|Overall Study||4
382357|NCT01920802|939608|P3|COMPLETED|Overall Study||10
382358|NCT01920802|939609|P2|COMPLETED|Overall Study||7
382359|NCT01920802|939610|P1|COMPLETED|Overall Study||7
382360|NCT01920802|939608|P3|STARTED|Overall Study||11
382361|NCT01920802|939609|P2|STARTED|Overall Study||9
382362|NCT01920802|939610|P1|STARTED|Overall Study||11
382363|NCT01920594|939641|P2|NOT COMPLETED|Overall Study||3
382364|NCT01920594|939642|P1|NOT COMPLETED|Overall Study||7
382365|NCT01920594|939641|P2|COMPLETED|Overall Study||25
382366|NCT01920594|939642|P1|COMPLETED|Overall Study||20
382367|NCT01920594|939641|P2|STARTED|Overall Study||28
382368|NCT01920594|939642|P1|STARTED|Overall Study||27
382369|NCT01920568|939692|P2|NOT COMPLETED|Overall Study||84
382370|NCT01920568|939693|P1|NOT COMPLETED|Overall Study||151
382371|NCT01920568|939692|P2|COMPLETED|Overall Study||75
382372|NCT01920568|939693|P1|COMPLETED|Overall Study||175
382373|NCT01920568|939692|P2|STARTED|Overall Study||159
382374|NCT01920568|939693|P1|STARTED|Overall Study||326
382375|NCT01920555|939719|P5|NOT COMPLETED|Overall Study||1
382376|NCT01920555|939720|P4|NOT COMPLETED|Overall Study||3
382377|NCT01920555|939721|P3|NOT COMPLETED|Overall Study||1
382378|NCT01920555|939722|P2|NOT COMPLETED|Overall Study||4
382379|NCT01920555|939723|P1|NOT COMPLETED|Overall Study||4
382380|NCT01920555|939719|P5|COMPLETED|Overall Study||18
382381|NCT01920555|939720|P4|COMPLETED|Overall Study||17
382382|NCT01920555|939721|P3|COMPLETED|Overall Study||21
382383|NCT01920555|939722|P2|COMPLETED|Overall Study||16
382384|NCT01920555|939723|P1|COMPLETED|Overall Study||14
382385|NCT01920555|939719|P5|STARTED|Overall Study||19
382386|NCT01920555|939720|P4|STARTED|Overall Study||20
382387|NCT01920555|939721|P3|STARTED|Overall Study||22
382388|NCT01920555|939722|P2|STARTED|Overall Study||20
382389|NCT01920555|939723|P1|STARTED|Overall Study||18
382390|NCT01920282|939783|P3|NOT COMPLETED|Overall Study||0
382391|NCT01920282|939784|P2|NOT COMPLETED|Overall Study||0
382392|NCT01920282|939785|P1|NOT COMPLETED|Overall Study||0
382393|NCT01920282|939783|P3|COMPLETED|Overall Study||15
382394|NCT01920282|939784|P2|COMPLETED|Overall Study||15
382395|NCT01920282|939785|P1|COMPLETED|Overall Study||15
382396|NCT01920282|939783|P3|STARTED|Overall Study||15
382397|NCT01920282|939784|P2|STARTED|Overall Study||15
382398|NCT01920282|939785|P1|STARTED|Overall Study||15
382399|NCT01920178|939798|P2|NOT COMPLETED|Overall Study||1
382400|NCT01920178|939799|P1|NOT COMPLETED|Overall Study||2
382401|NCT01920178|939798|P2|COMPLETED|Overall Study||1
382402|NCT01920178|939799|P1|COMPLETED|Overall Study||3
382403|NCT01920178|939798|P2|STARTED|Overall Study||2
382404|NCT01920178|939799|P1|STARTED|Overall Study||5
382405|NCT01919996|939809|P1|NOT COMPLETED|Overall Study||0
382406|NCT01919996|939809|P1|COMPLETED|Overall Study||8
382407|NCT01919996|939809|P1|STARTED|Overall Study||8
382408|NCT01919801|939817|P2|NOT COMPLETED|Overall Study||3
382409|NCT01919801|939818|P1|NOT COMPLETED|Overall Study||1
382410|NCT01919801|939817|P2|COMPLETED|Overall Study||57
382411|NCT01919801|939818|P1|COMPLETED|Overall Study||60
382412|NCT01919801|939817|P2|STARTED|Overall Study||60
382413|NCT01919801|939818|P1|STARTED|Overall Study||61
382414|NCT01919723|939843|P2|NOT COMPLETED|Overall Study||2
382415|NCT01919723|939844|P1|NOT COMPLETED|Overall Study||2
382416|NCT01919723|939843|P2|COMPLETED|Overall Study||33
382417|NCT01919723|939844|P1|COMPLETED|Overall Study||33
382418|NCT01919723|939843|P2|STARTED|Overall Study||35
382419|NCT01919723|939844|P1|STARTED|Overall Study||35
382420|NCT01919606|939858|P2|NOT COMPLETED|Overall Study||0
382421|NCT01919606|939859|P1|NOT COMPLETED|Overall Study||0
382422|NCT01919606|939858|P2|COMPLETED|Overall Study||0
382423|NCT01919606|939859|P1|COMPLETED|Overall Study||1
382424|NCT01919606|939858|P2|STARTED|Overall Study||0
382425|NCT01919606|939859|P1|STARTED|Overall Study||1
382426|NCT01919450|939871|P4|NOT COMPLETED|Overall Study||1
382427|NCT01919450|939872|P3|NOT COMPLETED|Overall Study||0
382428|NCT01919450|939873|P2|NOT COMPLETED|Overall Study||0
382429|NCT01919450|939874|P1|NOT COMPLETED|Overall Study||0
382430|NCT01919450|939871|P4|COMPLETED|Overall Study||19
382431|NCT01919450|939872|P3|COMPLETED|Overall Study||20
382432|NCT01919450|939873|P2|COMPLETED|Overall Study||20
382433|NCT01919450|939874|P1|COMPLETED|Overall Study||20
382434|NCT01919450|939871|P4|STARTED|Overall Study||20
382435|NCT01919450|939872|P3|STARTED|Overall Study||20
382436|NCT01919450|939873|P2|STARTED|Overall Study||20
382437|NCT01919450|939874|P1|STARTED|Overall Study||20
382438|NCT01919307|939884|P1|NOT COMPLETED|Overall Study||9
382439|NCT01919307|939884|P1|COMPLETED|Overall Study||20
382440|NCT01919307|939884|P1|STARTED|Overall Study||29
382441|NCT01919229|939894|P3|NOT COMPLETED|Overall Study||1
382442|NCT01919229|939895|P2|NOT COMPLETED|Overall Study||0
382443|NCT01919229|939896|P1|NOT COMPLETED|Overall Study||0
382444|NCT01919229|939894|P3|COMPLETED|Overall Study||3
382445|NCT01919229|939895|P2|COMPLETED|Overall Study||6
382446|NCT01919229|939896|P1|COMPLETED|Overall Study||4
382447|NCT01919229|939894|P3|STARTED|Overall Study||4
382448|NCT01919229|939895|P2|STARTED|Overall Study||6
382449|NCT01919229|939896|P1|STARTED|Overall Study||4
382450|NCT01919216|939928|P3|NOT COMPLETED|Overall Study||1
382451|NCT01919216|939929|P2|NOT COMPLETED|Overall Study||1
382452|NCT01919216|939930|P1|NOT COMPLETED|Overall Study||2
382453|NCT01919216|939928|P3|COMPLETED|Overall Study||4
382454|NCT01919216|939929|P2|COMPLETED|Overall Study||20
382455|NCT01919216|939930|P1|COMPLETED|Overall Study||26
382456|NCT01919216|939928|P3|STARTED|Overall Study||5
382457|NCT01919216|939929|P2|STARTED|Overall Study||21
382458|NCT01919216|939930|P1|STARTED|Overall Study||28
382459|NCT01918800|939940|P2|NOT COMPLETED|Overall Study||5
382460|NCT01918800|939941|P1|NOT COMPLETED|Overall Study||9
382461|NCT01918800|939940|P2|COMPLETED|Overall Study||104
382462|NCT01918800|939941|P1|COMPLETED|Overall Study||100
382463|NCT01918800|939940|P2|STARTED|Overall Study||109
382464|NCT01918800|939941|P1|STARTED|Overall Study||109
382465|NCT01918371|939961|P2|NOT COMPLETED|Overall Study||1
382466|NCT01918371|939962|P1|NOT COMPLETED|Overall Study||1
382467|NCT01918371|939961|P2|COMPLETED|Overall Study||156
382468|NCT01918371|939962|P1|COMPLETED|Overall Study||165
382469|NCT01918371|939961|P2|Participants With Complete Data|Overall Study||156
382470|NCT01918371|939962|P1|Participants With Complete Data|Overall Study||165
382471|NCT01918371|939961|P2|STARTED|Overall Study||157
382472|NCT01918371|939962|P1|STARTED|Overall Study||166
382473|NCT01918332|940040|P4|NOT COMPLETED|Overall Study||7
382474|NCT01918332|940041|P3|NOT COMPLETED|Overall Study||9
382475|NCT01918332|940042|P2|NOT COMPLETED|Overall Study||5
382476|NCT01918332|940043|P1|NOT COMPLETED|Overall Study||8
382477|NCT01918332|940040|P4|COMPLETED|Overall Study||38
382478|NCT01918332|940041|P3|COMPLETED|Overall Study||30
382479|NCT01918332|940042|P2|COMPLETED|Overall Study||36
382480|NCT01918332|940043|P1|COMPLETED|Overall Study||35
382481|NCT01918332|940040|P4|STARTED|Overall Study||45
382482|NCT01918332|940041|P3|STARTED|Overall Study||39
382483|NCT01918332|940042|P2|STARTED|Overall Study||41
382484|NCT01918332|940043|P1|STARTED|Overall Study||43
382485|NCT01918306|940055|P4|NOT COMPLETED|Overall Study||3
382486|NCT01918306|940056|P3|NOT COMPLETED|Overall Study||2
382487|NCT01918306|940057|P2|NOT COMPLETED|Overall Study||0
382488|NCT01918306|940058|P1|NOT COMPLETED|Overall Study||6
382489|NCT01918306|940055|P4|COMPLETED|Overall Study||0
382490|NCT01918306|940056|P3|COMPLETED|Overall Study||0
382491|NCT01918306|940057|P2|COMPLETED|Overall Study||0
382492|NCT01918306|940058|P1|COMPLETED|Overall Study||0
382493|NCT01918306|940055|P4|STARTED|Overall Study||3
382494|NCT01918306|940056|P3|STARTED|Overall Study|1 participant Crossed-over to ARM 2|2
382495|NCT01918306|940057|P2|STARTED|Overall Study|No patients enrolled|0
382496|NCT01918306|940058|P1|STARTED|Overall Study||6
382497|NCT01918085|940080|P2|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0
382498|NCT01918085|940081|P1|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0
382499|NCT01918085|940080|P2|COMPLETED|Test Period 2: Hydrocolloid Strip||11
382500|NCT01918085|940081|P1|COMPLETED|Test Period 2: Hydrocolloid Strip||10
382501|NCT01918085|940080|P2|STARTED|Test Period 2: Hydrocolloid Strip||11
382502|NCT01918085|940081|P1|STARTED|Test Period 2: Hydrocolloid Strip||10
382503|NCT01918085|940080|P2|NOT COMPLETED|Test Period 2: Strata Strip||0
382504|NCT01918085|940081|P1|NOT COMPLETED|Test Period 2: Strata Strip||0
382505|NCT01918085|940080|P2|COMPLETED|Test Period 2: Strata Strip||11
382506|NCT01918085|940081|P1|COMPLETED|Test Period 2: Strata Strip||10
382507|NCT01918085|940080|P2|STARTED|Test Period 2: Strata Strip||11
382508|NCT01918085|940081|P1|STARTED|Test Period 2: Strata Strip||10
382509|NCT01918085|940080|P2|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0
382510|NCT01918085|940081|P1|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0
382511|NCT01918085|940080|P2|COMPLETED|Test Period 1: Hydrocolloid Strip||11
382512|NCT01918085|940081|P1|COMPLETED|Test Period 1: Hydrocolloid Strip||10
382513|NCT01918085|940080|P2|STARTED|Test Period 1: Hydrocolloid Strip||11
382514|NCT01918085|940081|P1|STARTED|Test Period 1: Hydrocolloid Strip||10
382515|NCT01918085|940080|P2|NOT COMPLETED|Test Period 1: Strata Strip||1
382516|NCT01918085|940081|P1|NOT COMPLETED|Test Period 1: Strata Strip||0
382517|NCT01918085|940080|P2|COMPLETED|Test Period 1: Strata Strip||11
382518|NCT01918085|940081|P1|COMPLETED|Test Period 1: Strata Strip||10
382519|NCT01918085|940080|P2|STARTED|Test Period 1: Strata Strip||12
382520|NCT01918085|940081|P1|STARTED|Test Period 1: Strata Strip||10
382521|NCT01918033|940092|P3|NOT COMPLETED|Overall Study||3
382522|NCT01918033|940093|P2|NOT COMPLETED|Overall Study||2
382523|NCT01918033|940094|P1|NOT COMPLETED|Overall Study||5
382524|NCT01918033|940092|P3|COMPLETED|Overall Study||199
382525|NCT01918033|940093|P2|COMPLETED|Overall Study||201
382526|NCT01918033|940094|P1|COMPLETED|Overall Study||198
382527|NCT01918033|940092|P3|Treated|Overall Study|One randomized participant did not receive study drug.|201
382528|NCT01918033|940093|P2|Treated|Overall Study||203
382529|NCT01918033|940094|P1|Treated|Overall Study|One randomized participant did not receive study drug.|202
382530|NCT01918033|940092|P3|STARTED|Overall Study||202
382531|NCT01918033|940093|P2|STARTED|Overall Study||203
382532|NCT01918033|940094|P1|STARTED|Overall Study||203
382533|NCT01917812|940135|P3|NOT COMPLETED|Overall Study||0
382534|NCT01917812|940136|P2|NOT COMPLETED|Overall Study||0
382535|NCT01917812|940137|P1|NOT COMPLETED|Overall Study||1
382536|NCT01917812|940135|P3|COMPLETED|Overall Study||16
382537|NCT01917812|940136|P2|COMPLETED|Overall Study||16
382538|NCT01917812|940137|P1|COMPLETED|Overall Study||15
382539|NCT01917812|940135|P3|STARTED|Overall Study||16
382540|NCT01917812|940136|P2|STARTED|Overall Study||16
382541|NCT01917812|940137|P1|STARTED|Overall Study||16
382542|NCT01917773|940157|P1|NOT COMPLETED|Overall Study||0
382543|NCT01917773|940157|P1|COMPLETED|Overall Study||13
382544|NCT01917773|940157|P1|STARTED|Overall Study||13
382545|NCT01917656|940165|P2|NOT COMPLETED|Overall Study||24
382546|NCT01917656|940166|P1|NOT COMPLETED|Overall Study||26
382547|NCT01917656|940165|P2|COMPLETED|Overall Study||147
382548|NCT01917656|940166|P1|COMPLETED|Overall Study||146
382549|NCT01917656|940165|P2|Exposed During Ramadan (Fasting)|Overall Study||163
382550|NCT01917656|940166|P1|Exposed During Ramadan (Fasting)|Overall Study||152
382551|NCT01917656|940165|P2|Exposed|Overall Study|1 subject was withdrawn prior to exposure to first SU dose after randomisation|170
382552|NCT01917656|940166|P1|Exposed|Overall Study|1 subject was withdrawn prior to exposure to trial products|171
382553|NCT01917656|940165|P2|STARTED|Overall Study||171
382554|NCT01917656|940166|P1|STARTED|Overall Study||172
382555|NCT01917526|940192|P2|NOT COMPLETED|Overall Study||1
382556|NCT01917526|940193|P1|NOT COMPLETED|Overall Study||1
382557|NCT01917526|940192|P2|COMPLETED|Overall Study|1 patient in oxygen cannula group receive oxygen mask|249
382558|NCT01917526|940193|P1|COMPLETED|Overall Study|One patient in oxygen mask received oxygen cannula|249
382559|NCT01917526|940192|P2|STARTED|Overall Study||250
382560|NCT01917526|940193|P1|STARTED|Overall Study||250
382561|NCT01917513|940203|P2|NOT COMPLETED|Overall Study||102
382562|NCT01917513|940204|P1|NOT COMPLETED|Overall Study||95
382563|NCT01917513|940203|P2|COMPLETED|Overall Study||396
382564|NCT01917513|940204|P1|COMPLETED|Overall Study||407
382565|NCT01917513|940203|P2|STARTED|Overall Study||498
382566|NCT01917513|940204|P1|STARTED|Overall Study||502
382567|NCT01917344|940210|P1|NOT COMPLETED|Overall Study||1
382568|NCT01917344|940210|P1|COMPLETED|Overall Study||9
382569|NCT01917344|940210|P1|STARTED|Overall Study||10
382570|NCT01917214|940214|P1|NOT COMPLETED|Overall Study||0
382571|NCT01917214|940214|P1|COMPLETED|Overall Study||212
382572|NCT01917214|940214|P1|STARTED|Overall Study||212
382573|NCT01916980|940225|P2|NOT COMPLETED|Overall Study||4
382574|NCT01916980|940226|P1|NOT COMPLETED|Overall Study||7
382575|NCT01916980|940225|P2|COMPLETED|Overall Study||25
382576|NCT01916980|940226|P1|COMPLETED|Overall Study||58
382577|NCT01916980|940225|P2|STARTED|Overall Study||29
382578|NCT01916980|940226|P1|STARTED|Overall Study||65
382579|NCT01916967|940245|P3|NOT COMPLETED|Overall Study||9
382580|NCT01916967|940246|P2|NOT COMPLETED|Overall Study||1
382581|NCT01916967|940247|P1|NOT COMPLETED|Overall Study||0
382582|NCT01916967|940245|P3|COMPLETED|Overall Study||71
382583|NCT01916967|940246|P2|COMPLETED|Overall Study||78
382584|NCT01916967|940247|P1|COMPLETED|Overall Study||80
382585|NCT01916967|940245|P3|STARTED|Overall Study||80
382586|NCT01916967|940246|P2|STARTED|Overall Study||79
382587|NCT01916967|940247|P1|STARTED|Overall Study||80
382588|NCT01916941|940290|P2|NOT COMPLETED|Overall Study||4
382589|NCT01916941|940291|P1|NOT COMPLETED|Overall Study||5
382590|NCT01916941|940290|P2|COMPLETED|Overall Study||14
382591|NCT01916941|940291|P1|COMPLETED|Overall Study||13
382592|NCT01916941|940290|P2|STARTED|Overall Study||18
382593|NCT01916941|940291|P1|STARTED|Overall Study||18
382594|NCT01916928|940297|P1|NOT COMPLETED|Overall Study||0
382595|NCT01916928|940297|P1|COMPLETED|Overall Study||50
382596|NCT01916928|940297|P1|STARTED|Overall Study||50
382597|NCT01916824|940303|P2|NOT COMPLETED|Overall Study||9
382598|NCT01916824|940304|P1|NOT COMPLETED|Overall Study||7
382599|NCT01916824|940303|P2|COMPLETED|Overall Study||20
382600|NCT01916824|940304|P1|COMPLETED|Overall Study||17
382601|NCT01916824|940303|P2|STARTED|Overall Study||29
382602|NCT01916824|940304|P1|STARTED|Overall Study||24
382603|NCT01916681|940314|P4|NOT COMPLETED|Overall Study||0
382604|NCT01916681|940315|P3|NOT COMPLETED|Overall Study||0
382605|NCT01916681|940316|P2|NOT COMPLETED|Overall Study||0
382606|NCT01916681|940317|P1|NOT COMPLETED|Overall Study||0
382607|NCT01916681|940314|P4|COMPLETED|Overall Study||125
382608|NCT01916681|940315|P3|COMPLETED|Overall Study||123
382609|NCT01916681|940316|P2|COMPLETED|Overall Study||120
382610|NCT01916681|940317|P1|COMPLETED|Overall Study||123
382611|NCT01916681|940314|P4|STARTED|Overall Study||125
382612|NCT01916681|940315|P3|STARTED|Overall Study||123
382613|NCT01916681|940316|P2|STARTED|Overall Study||120
382614|NCT01916681|940317|P1|STARTED|Overall Study||123
382615|NCT01916629|940357|P2|NOT COMPLETED|Overall Study||0
382616|NCT01916629|940358|P1|NOT COMPLETED|Overall Study||0
382617|NCT01916629|940357|P2|COMPLETED|Overall Study||5
382618|NCT01916629|940358|P1|COMPLETED|Overall Study||7
382619|NCT01916629|940357|P2|STARTED|Overall Study||5
382620|NCT01916629|940358|P1|STARTED|Overall Study||7
382621|NCT01916590|940366|P2|NOT COMPLETED|Overall Study||0
382622|NCT01916590|940367|P1|NOT COMPLETED|Overall Study||0
382623|NCT01916590|940366|P2|COMPLETED|Overall Study||3
382624|NCT01916590|940367|P1|COMPLETED|Overall Study||4
382625|NCT01916590|940366|P2|STARTED|Overall Study||3
382626|NCT01916590|940367|P1|STARTED|Overall Study||4
382627|NCT01916304|940373|P1|NOT COMPLETED|Overall Study||17
382628|NCT01916304|940373|P1|COMPLETED|Overall Study||84
382629|NCT01916304|940373|P1|Intent-to-Treat Set|Overall Study||84
382630|NCT01916304|940373|P1|Safety Set|Overall Study||101
382631|NCT01916304|940373|P1|STARTED|Overall Study||101
382632|NCT01916226|940385|P4|NOT COMPLETED|Overall Study||4
382633|NCT01916226|940386|P3|NOT COMPLETED|Overall Study||3
382634|NCT01916226|940387|P2|NOT COMPLETED|Overall Study||1
382635|NCT01916226|940388|P1|NOT COMPLETED|Overall Study||1
382636|NCT01916226|940385|P4|COMPLETED|Overall Study||167
382637|NCT01916226|940386|P3|COMPLETED|Overall Study||168
382638|NCT01916226|940387|P2|COMPLETED|Overall Study||169
382639|NCT01916226|940388|P1|COMPLETED|Overall Study||169
382640|NCT01916226|940385|P4|STARTED|Overall Study||171
382641|NCT01916226|940386|P3|STARTED|Overall Study||171
382642|NCT01916226|940387|P2|STARTED|Overall Study||170
382643|NCT01916226|940388|P1|STARTED|Overall Study||170
382644|NCT01916109|940422|P1|NOT COMPLETED|Overall Study||1
382645|NCT01916109|940422|P1|COMPLETED|Overall Study||3
382646|NCT01916109|940422|P1|STARTED|Overall Study||4
382647|NCT01915940|940428|P3|NOT COMPLETED|Treatment Period||4
382648|NCT01915940|940429|P2|NOT COMPLETED|Treatment Period||11
382649|NCT01915940|940430|P1|NOT COMPLETED|Treatment Period||0
382650|NCT01915940|940428|P3|COMPLETED|Treatment Period||62
382651|NCT01915940|940429|P2|COMPLETED|Treatment Period||53
382652|NCT01915940|940430|P1|COMPLETED|Treatment Period||0
382653|NCT01915940|940428|P3|STARTED|Treatment Period||66
382654|NCT01915940|940429|P2|STARTED|Treatment Period||64
382655|NCT01915940|940430|P1|STARTED|Treatment Period||0
382656|NCT01915940|940428|P3|NOT COMPLETED|Pre-randomization Washout Period||0
382657|NCT01915940|940429|P2|NOT COMPLETED|Pre-randomization Washout Period||0
382658|NCT01915940|940430|P1|NOT COMPLETED|Pre-randomization Washout Period||39
382659|NCT01915940|940428|P3|COMPLETED|Pre-randomization Washout Period||0
382660|NCT01915940|940429|P2|COMPLETED|Pre-randomization Washout Period||0
382661|NCT01915940|940430|P1|COMPLETED|Pre-randomization Washout Period||130
382662|NCT01915940|940428|P3|STARTED|Pre-randomization Washout Period||0
382663|NCT01915940|940429|P2|STARTED|Pre-randomization Washout Period||0
382664|NCT01915940|940430|P1|STARTED|Pre-randomization Washout Period||169
382665|NCT01915914|940446|P4|NOT COMPLETED|Follow-up Phase||2
382666|NCT01915914|940447|P3|NOT COMPLETED|Follow-up Phase||0
382667|NCT01915914|940448|P2|NOT COMPLETED|Follow-up Phase||0
382668|NCT01915914|940449|P1|NOT COMPLETED|Follow-up Phase||0
382669|NCT01915914|940446|P4|COMPLETED|Follow-up Phase||64
382670|NCT01915914|940447|P3|COMPLETED|Follow-up Phase||0
382671|NCT01915914|940448|P2|COMPLETED|Follow-up Phase||0
382672|NCT01915914|940449|P1|COMPLETED|Follow-up Phase||0
382673|NCT01915914|940446|P4|STARTED|Follow-up Phase||66
382674|NCT01915914|940447|P3|STARTED|Follow-up Phase||0
382675|NCT01915914|940448|P2|STARTED|Follow-up Phase||0
382676|NCT01915914|940449|P1|STARTED|Follow-up Phase||0
382677|NCT01915914|940446|P4|NOT COMPLETED|Maintenance Phase||0
382678|NCT01915914|940447|P3|NOT COMPLETED|Maintenance Phase||2
382679|NCT01915914|940448|P2|NOT COMPLETED|Maintenance Phase||6
382680|NCT01915914|940449|P1|NOT COMPLETED|Maintenance Phase||0
382681|NCT01915914|940446|P4|COMPLETED|Maintenance Phase||0
382682|NCT01915914|940447|P3|COMPLETED|Maintenance Phase||51
382683|NCT01915914|940448|P2|COMPLETED|Maintenance Phase||48
382684|NCT01915914|940449|P1|COMPLETED|Maintenance Phase||0
382685|NCT01915914|940446|P4|STARTED|Maintenance Phase||0
382686|NCT01915914|940447|P3|STARTED|Maintenance Phase||53
382687|NCT01915914|940448|P2|STARTED|Maintenance Phase||54
382688|NCT01915914|940449|P1|STARTED|Maintenance Phase||0
382689|NCT01915914|940446|P4|NOT COMPLETED|Acute Phase||0
382690|NCT01915914|940447|P3|NOT COMPLETED|Acute Phase||0
382691|NCT01915914|940448|P2|NOT COMPLETED|Acute Phase||0
382692|NCT01915914|940449|P1|NOT COMPLETED|Acute Phase||12
382693|NCT01915914|940446|P4|COMPLETED|Acute Phase||0
382694|NCT01915914|940447|P3|COMPLETED|Acute Phase||0
382695|NCT01915914|940448|P2|COMPLETED|Acute Phase||0
382696|NCT01915914|940449|P1|COMPLETED|Acute Phase||111
382697|NCT01915914|940446|P4|Completed–Not Entered Maintenance Phase|Acute Phase||0
382698|NCT01915914|940447|P3|Completed–Not Entered Maintenance Phase|Acute Phase||0
382699|NCT01915914|940448|P2|Completed–Not Entered Maintenance Phase|Acute Phase||0
382700|NCT01915914|940449|P1|Completed–Not Entered Maintenance Phase|Acute Phase||4
382701|NCT01915914|940446|P4|STARTED|Acute Phase||0
382702|NCT01915914|940447|P3|STARTED|Acute Phase||0
382703|NCT01915914|940448|P2|STARTED|Acute Phase||0
382704|NCT01915914|940449|P1|STARTED|Acute Phase||123
382705|NCT01915849|940481|P4|NOT COMPLETED|Treatment Period 4 (4 Days)||0
382706|NCT01915849|940482|P3|NOT COMPLETED|Treatment Period 4 (4 Days)||0
382707|NCT01915849|940483|P2|NOT COMPLETED|Treatment Period 4 (4 Days)||0
382708|NCT01915849|940484|P1|NOT COMPLETED|Treatment Period 4 (4 Days)||0
382709|NCT01915849|940481|P4|COMPLETED|Treatment Period 4 (4 Days)||3
382710|NCT01915849|940482|P3|COMPLETED|Treatment Period 4 (4 Days)||3
382711|NCT01915849|940483|P2|COMPLETED|Treatment Period 4 (4 Days)||3
382712|NCT01915849|940484|P1|COMPLETED|Treatment Period 4 (4 Days)||3
382713|NCT01915849|940481|P4|STARTED|Treatment Period 4 (4 Days)||3
382714|NCT01915849|940482|P3|STARTED|Treatment Period 4 (4 Days)||3
382715|NCT01915849|940483|P2|STARTED|Treatment Period 4 (4 Days)||3
382716|NCT01915849|940484|P1|STARTED|Treatment Period 4 (4 Days)||3
382717|NCT01915849|940481|P4|NOT COMPLETED|Treatment Period 3 (4 Days)||0
382718|NCT01915849|940482|P3|NOT COMPLETED|Treatment Period 3 (4 Days)||0
382719|NCT01915849|940483|P2|NOT COMPLETED|Treatment Period 3 (4 Days)||0
382720|NCT01915849|940484|P1|NOT COMPLETED|Treatment Period 3 (4 Days)||0
382721|NCT01915849|940481|P4|COMPLETED|Treatment Period 3 (4 Days)||3
382722|NCT01915849|940482|P3|COMPLETED|Treatment Period 3 (4 Days)||3
382723|NCT01915849|940483|P2|COMPLETED|Treatment Period 3 (4 Days)||3
382724|NCT01915849|940484|P1|COMPLETED|Treatment Period 3 (4 Days)||3
382725|NCT01915849|940481|P4|STARTED|Treatment Period 3 (4 Days)||3
382726|NCT01915849|940482|P3|STARTED|Treatment Period 3 (4 Days)||3
382727|NCT01915849|940483|P2|STARTED|Treatment Period 3 (4 Days)||3
382728|NCT01915849|940484|P1|STARTED|Treatment Period 3 (4 Days)||3
382729|NCT01915849|940481|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
382730|NCT01915849|940482|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
382731|NCT01915849|940483|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
382732|NCT01915849|940484|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
382733|NCT01915849|940481|P4|COMPLETED|Treatment Period 2 (4 Days)||3
382734|NCT01915849|940482|P3|COMPLETED|Treatment Period 2 (4 Days)||3
382735|NCT01915849|940483|P2|COMPLETED|Treatment Period 2 (4 Days)||3
382736|NCT01915849|940484|P1|COMPLETED|Treatment Period 2 (4 Days)||3
382737|NCT01915849|940481|P4|STARTED|Treatment Period 2 (4 Days)||3
382738|NCT01915849|940482|P3|STARTED|Treatment Period 2 (4 Days)||3
382739|NCT01915849|940483|P2|STARTED|Treatment Period 2 (4 Days)||3
382740|NCT01915849|940484|P1|STARTED|Treatment Period 2 (4 Days)||3
382741|NCT01915849|940481|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
382742|NCT01915849|940482|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
382743|NCT01915849|940483|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
382744|NCT01915849|940484|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||2
382745|NCT01915849|940481|P4|COMPLETED|Treatment Period 1 (4 Days)||3
382746|NCT01915849|940482|P3|COMPLETED|Treatment Period 1 (4 Days)||3
382747|NCT01915849|940483|P2|COMPLETED|Treatment Period 1 (4 Days)||3
382748|NCT01915849|940484|P1|COMPLETED|Treatment Period 1 (4 Days)||3
382749|NCT01915849|940481|P4|STARTED|Treatment Period 1 (4 Days)||3
382750|NCT01915849|940482|P3|STARTED|Treatment Period 1 (4 Days)||3
382751|NCT01915849|940483|P2|STARTED|Treatment Period 1 (4 Days)||3
382752|NCT01915849|940484|P1|STARTED|Treatment Period 1 (4 Days)||5
382753|NCT01915823|940496|P2|NOT COMPLETED|Overall Study||2
382754|NCT01915823|940497|P1|NOT COMPLETED|Overall Study||2
382755|NCT01915823|940496|P2|COMPLETED|Overall Study||173
382756|NCT01915823|940497|P1|COMPLETED|Overall Study||171
382757|NCT01915823|940496|P2|STARTED|Overall Study||175
382758|NCT01915823|940497|P1|STARTED|Overall Study||173
382759|NCT01915732|940509|P2|NOT COMPLETED|Overall Study||71
382760|NCT01915732|940510|P1|NOT COMPLETED|Overall Study||70
382761|NCT01915732|940509|P2|COMPLETED|Overall Study||445
382762|NCT01915732|940510|P1|COMPLETED|Overall Study||430
382763|NCT01915732|940509|P2|STARTED|Overall Study||516
382764|NCT01915732|940510|P1|STARTED|Overall Study||500
382765|NCT01915173|940538|P4|NOT COMPLETED|Overall Study||0
382766|NCT01915173|940539|P3|NOT COMPLETED|Overall Study||0
382767|NCT01915173|940540|P2|NOT COMPLETED|Overall Study||0
382768|NCT01915173|940541|P1|NOT COMPLETED|Overall Study||0
382769|NCT01915173|940538|P4|COMPLETED|Overall Study||6
382770|NCT01915173|940539|P3|COMPLETED|Overall Study||6
382771|NCT01915173|940540|P2|COMPLETED|Overall Study||6
382772|NCT01915173|940541|P1|COMPLETED|Overall Study||6
382773|NCT01915173|940538|P4|STARTED|Overall Study||6
382774|NCT01915173|940539|P3|STARTED|Overall Study||6
382775|NCT01915173|940540|P2|STARTED|Overall Study||6
382776|NCT01915173|940541|P1|STARTED|Overall Study||6
382777|NCT01915108|940563|P4|NOT COMPLETED|Overall Study||2
382778|NCT01915108|940564|P3|NOT COMPLETED|Overall Study||1
382779|NCT01915108|940565|P2|NOT COMPLETED|Overall Study||3
382780|NCT01915108|940566|P1|NOT COMPLETED|Overall Study||2
382781|NCT01915108|940563|P4|COMPLETED|Overall Study|two patients were excluded from the study|30
382782|NCT01915108|940564|P3|COMPLETED|Overall Study|one patients were excluded from the study|31
382783|NCT01915108|940565|P2|COMPLETED|Overall Study|three patients were excluded from the study|29
382784|NCT01915108|940566|P1|COMPLETED|Overall Study|two patients were excluded from the study|30
382785|NCT01915108|940563|P4|STARTED|Overall Study||32
382786|NCT01915108|940564|P3|STARTED|Overall Study||32
382787|NCT01915108|940565|P2|STARTED|Overall Study||32
382788|NCT01915108|940566|P1|STARTED|Overall Study||32
382789|NCT01914926|940578|P2|NOT COMPLETED|Overall Study||1
382790|NCT01914926|940579|P1|NOT COMPLETED|Overall Study||1
382791|NCT01914926|940578|P2|COMPLETED|Overall Study||24
382792|NCT01914926|940579|P1|COMPLETED|Overall Study||28
382793|NCT01914926|940578|P2|STARTED|Overall Study||25
382794|NCT01914926|940579|P1|STARTED|Overall Study||29
382795|NCT01914757|940588|P3|NOT COMPLETED|Overall Study||38
382796|NCT01914757|940589|P2|NOT COMPLETED|Overall Study||51
382797|NCT01914757|940590|P1|NOT COMPLETED|Overall Study||36
382798|NCT01914757|940588|P3|COMPLETED|Overall Study||402
382799|NCT01914757|940589|P2|COMPLETED|Overall Study||390
382800|NCT01914757|940590|P1|COMPLETED|Overall Study||389
382801|NCT01914757|940588|P3|STARTED|Overall Study||440
382802|NCT01914757|940589|P2|STARTED|Overall Study||441
382803|NCT01914757|940590|P1|STARTED|Overall Study||425
382804|NCT01914679|940664|P1|NOT COMPLETED|Overall Study||5
382805|NCT01914679|940664|P1|COMPLETED|Overall Study||12
382806|NCT01914679|940664|P1|Began 12 Week Actual RINCE Treatment|Overall Study||17
382807|NCT01914679|940664|P1|STARTED|Overall Study||17
382808|NCT01914666|940671|P3|NOT COMPLETED|Tapering Period||0
382809|NCT01914666|940672|P2|NOT COMPLETED|Tapering Period||0
382810|NCT01914666|940673|P1|NOT COMPLETED|Tapering Period||0
382811|NCT01914666|940671|P3|COMPLETED|Tapering Period||40
382812|NCT01914666|940672|P2|COMPLETED|Tapering Period||39
382813|NCT01914666|940673|P1|COMPLETED|Tapering Period||59
382814|NCT01914666|940671|P3|STARTED|Tapering Period|7 Pts who discontinued, and 33 Pts who completed Treatment Period entered Tapering Period.|40
382815|NCT01914666|940672|P2|STARTED|Tapering Period|3 Pts who discontinued, and 36 Pts who completed Treatment Period entered Tapering Period.|39
382816|NCT01914666|940673|P1|STARTED|Tapering Period|4 Pts who discontinued, and 55 Pts who completed Treatment Period entered Tapering Period.|59
382817|NCT01914666|940671|P3|NOT COMPLETED|Treatment Period||8
382818|NCT01914666|940672|P2|NOT COMPLETED|Treatment Period||6
382819|NCT01914666|940673|P1|NOT COMPLETED|Treatment Period||13
382820|NCT01914666|940671|P3|COMPLETED|Treatment Period||33
382821|NCT01914666|940672|P2|COMPLETED|Treatment Period||36
382822|NCT01914666|940673|P1|COMPLETED|Treatment Period||55
382823|NCT01914666|940671|P3|Received at Least 1 Dose of Study Drug|Treatment Period||41
382824|NCT01914666|940672|P2|Received at Least 1 Dose of Study Drug|Treatment Period||42
382825|NCT01914666|940673|P1|Received at Least 1 Dose of Study Drug|Treatment Period||68
382826|NCT01914666|940671|P3|STARTED|Treatment Period||41
382827|NCT01914666|940672|P2|STARTED|Treatment Period||42
382828|NCT01914666|940673|P1|STARTED|Treatment Period||68
382829|NCT01914003|940708|P2|NOT COMPLETED|Overall Study||12
382830|NCT01914003|940709|P1|NOT COMPLETED|Overall Study||8
382831|NCT01914003|940708|P2|COMPLETED|Overall Study|Number of subjects who completed through study and qualify as evaluable|14
382832|NCT01914003|940709|P1|COMPLETED|Overall Study|Number of subjects who completed through study and qualify as evaluable|19
382833|NCT01914003|940708|P2|STARTED|Overall Study||26
382834|NCT01914003|940709|P1|STARTED|Overall Study||27
382835|NCT01913795|940719|P4|NOT COMPLETED|Overall Study||1
382836|NCT01913795|940720|P3|NOT COMPLETED|Overall Study||0
382837|NCT01913795|940721|P2|NOT COMPLETED|Overall Study||3
382838|NCT01913795|940722|P1|NOT COMPLETED|Overall Study||0
382839|NCT01913795|940719|P4|COMPLETED|Overall Study||5
382840|NCT01913795|940720|P3|COMPLETED|Overall Study||9
382841|NCT01913795|940721|P2|COMPLETED|Overall Study||7
382842|NCT01913795|940722|P1|COMPLETED|Overall Study||4
382843|NCT01913795|940719|P4|STARTED|Overall Study||6
382844|NCT01913795|940720|P3|STARTED|Overall Study||9
382845|NCT01913795|940721|P2|STARTED|Overall Study||10
382846|NCT01913795|940722|P1|STARTED|Overall Study||4
382847|NCT01913600|940740|P1|NOT COMPLETED|Overall Study||1
382848|NCT01913600|940740|P1|COMPLETED|Overall Study||55
382849|NCT01913600|940740|P1|STARTED|Overall Study||56
382850|NCT01913535|940762|P5|NOT COMPLETED|Phase 2 (Days 3-5)||0
382851|NCT01913535|940763|P4|NOT COMPLETED|Phase 2 (Days 3-5)||0
382852|NCT01913535|940764|P3|NOT COMPLETED|Phase 2 (Days 3-5)||0
382853|NCT01913535|940765|P2|NOT COMPLETED|Phase 2 (Days 3-5)||0
382854|NCT01913535|940766|P1|NOT COMPLETED|Phase 2 (Days 3-5)||0
382855|NCT01913535|940762|P5|COMPLETED|Phase 2 (Days 3-5)||1
382856|NCT01913535|940763|P4|COMPLETED|Phase 2 (Days 3-5)||2
382857|NCT01913535|940764|P3|COMPLETED|Phase 2 (Days 3-5)||1
382858|NCT01913535|940765|P2|COMPLETED|Phase 2 (Days 3-5)||2
382859|NCT01913535|940766|P1|COMPLETED|Phase 2 (Days 3-5)||2
382860|NCT01913535|940762|P5|STARTED|Phase 2 (Days 3-5)||1
382861|NCT01913535|940763|P4|STARTED|Phase 2 (Days 3-5)||2
382862|NCT01913535|940764|P3|STARTED|Phase 2 (Days 3-5)||1
382863|NCT01913535|940765|P2|STARTED|Phase 2 (Days 3-5)||2
382864|NCT01913535|940766|P1|STARTED|Phase 2 (Days 3-5)||2
382865|NCT01913535|940762|P5|NOT COMPLETED|Phase 1 (Days 0-2)||0
382866|NCT01913535|940763|P4|NOT COMPLETED|Phase 1 (Days 0-2)||0
382867|NCT01913535|940764|P3|NOT COMPLETED|Phase 1 (Days 0-2)||0
382868|NCT01913535|940765|P2|NOT COMPLETED|Phase 1 (Days 0-2)||0
382869|NCT01913535|940766|P1|NOT COMPLETED|Phase 1 (Days 0-2)||0
382870|NCT01913535|940762|P5|COMPLETED|Phase 1 (Days 0-2)||1
382871|NCT01913535|940763|P4|COMPLETED|Phase 1 (Days 0-2)||2
382872|NCT01913535|940764|P3|COMPLETED|Phase 1 (Days 0-2)||1
382873|NCT01913535|940765|P2|COMPLETED|Phase 1 (Days 0-2)||2
382874|NCT01913535|940766|P1|COMPLETED|Phase 1 (Days 0-2)||2
382875|NCT01913535|940762|P5|STARTED|Phase 1 (Days 0-2)||1
382876|NCT01913535|940763|P4|STARTED|Phase 1 (Days 0-2)||2
382877|NCT01913535|940764|P3|STARTED|Phase 1 (Days 0-2)||1
382878|NCT01913535|940765|P2|STARTED|Phase 1 (Days 0-2)||2
382879|NCT01913535|940766|P1|STARTED|Phase 1 (Days 0-2)||2
382880|NCT01913483|940799|P2|NOT COMPLETED|Overall Study||22
382881|NCT01913483|940800|P1|NOT COMPLETED|Overall Study||21
382882|NCT01913483|940799|P2|COMPLETED|Overall Study||343
382883|NCT01913483|940800|P1|COMPLETED|Overall Study||346
382884|NCT01913483|940799|P2|Received at Least 1 Dose of Study Drug|Overall Study||321
382885|NCT01913483|940800|P1|Received at Least 1 Dose of Study Drug|Overall Study||335
382886|NCT01913483|940799|P2|STARTED|Overall Study||365
382887|NCT01913483|940800|P1|STARTED|Overall Study||367
382888|NCT01913470|940812|P2|NOT COMPLETED|Overall Study||3
382889|NCT01913470|940813|P1|NOT COMPLETED|Overall Study||0
382890|NCT01913470|940812|P2|COMPLETED|Overall Study||4
382891|NCT01913470|940813|P1|COMPLETED|Overall Study||5
382892|NCT01913470|940812|P2|STARTED|Overall Study||7
382893|NCT01913470|940813|P1|STARTED|Overall Study||5
382894|NCT01913405|940831|P1|NOT COMPLETED|Overall Study||2
382895|NCT01913405|940831|P1|COMPLETED|Overall Study||20
382896|NCT01913405|940831|P1|STARTED|Overall Study||22
382897|NCT01913041|940885|P1|NOT COMPLETED|Overall Study||39
382898|NCT01913041|940885|P1|COMPLETED|Overall Study||830
382899|NCT01913041|940885|P1|STARTED|Overall Study||869
382900|NCT01912781|940891|P2|NOT COMPLETED|Overall Study||0
382901|NCT01912781|940892|P1|NOT COMPLETED|Overall Study||2
382902|NCT01912781|940891|P2|COMPLETED|Overall Study||35
382903|NCT01912781|940892|P1|COMPLETED|Overall Study||69
382904|NCT01912781|940891|P2|STARTED|Overall Study||35
382905|NCT01912781|940892|P1|STARTED|Overall Study||71
382906|NCT01912768|940923|P2|NOT COMPLETED|Overall Study||4
382907|NCT01912768|940924|P1|NOT COMPLETED|Overall Study||10
382908|NCT01912768|940923|P2|COMPLETED|Overall Study||109
382909|NCT01912768|940924|P1|COMPLETED|Overall Study||229
382910|NCT01912768|940923|P2|STARTED|Overall Study||113
382911|NCT01912768|940924|P1|STARTED|Overall Study||239
382912|NCT01912599|940955|P2|NOT COMPLETED|Overall Study||1
382913|NCT01912599|940956|P1|NOT COMPLETED|Overall Study||0
382914|NCT01912599|940955|P2|COMPLETED|Overall Study||15
382915|NCT01912599|940956|P1|COMPLETED|Overall Study||20
382916|NCT01912599|940955|P2|STARTED|Overall Study||16
382917|NCT01912599|940956|P1|STARTED|Overall Study||20
382918|NCT01912495|940970|P1|NOT COMPLETED|Overall Study||0
382919|NCT01912495|940970|P1|COMPLETED|Overall Study||57
382920|NCT01912495|940970|P1|STARTED|Overall Study|8 patients had only screening visit, total enrollment: 65|57
382921|NCT01912404|940981|P2|NOT COMPLETED|Overall Study||0
382922|NCT01912404|940982|P1|NOT COMPLETED|Overall Study||1
382923|NCT01912404|940981|P2|COMPLETED|Overall Study||2
382924|NCT01912404|940982|P1|COMPLETED|Overall Study||2
382925|NCT01912404|940981|P2|STARTED|Overall Study||2
382926|NCT01912404|940982|P1|STARTED|Overall Study||3
382927|NCT01912352|940988|P1|NOT COMPLETED|Overall Study||5
382928|NCT01912352|940988|P1|COMPLETED|Overall Study||78
382929|NCT01912352|940988|P1|STARTED|Overall Study||83
382930|NCT01912339|940995|P3|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||53
382931|NCT01912339|940996|P2|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
382932|NCT01912339|940997|P1|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||133
382933|NCT01912339|940995|P3|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
382934|NCT01912339|940996|P2|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
382935|NCT01912339|940997|P1|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
382936|NCT01912339|940995|P3|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)|Control subjects that have crossed over.|53
382937|NCT01912339|940996|P2|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)|All subjects for the control group either completed study or crossed over.|0
382938|NCT01912339|940997|P1|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)||133
382939|NCT01912339|940995|P3|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||0
382940|NCT01912339|940996|P2|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||0
382941|NCT01912339|940997|P1|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||1
382942|NCT01912339|940995|P3|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Still in study|0
382943|NCT01912339|940996|P2|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Of the 61 subjects, there were 53 crossover subjects and 8 that completed their study participation.|61
382944|NCT01912339|940997|P1|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Still in study|133
382945|NCT01912339|940995|P3|STARTED|Unblinded (3 to 6 Months/Crossover)||0
382946|NCT01912339|940996|P2|STARTED|Unblinded (3 to 6 Months/Crossover)||61
382947|NCT01912339|940997|P1|STARTED|Unblinded (3 to 6 Months/Crossover)||134
382948|NCT01912339|940995|P3|NOT COMPLETED|Blinded (0 to 3 Months)||0
382949|NCT01912339|940996|P2|NOT COMPLETED|Blinded (0 to 3 Months)||0
382950|NCT01912339|940997|P1|NOT COMPLETED|Blinded (0 to 3 Months)||2
382951|NCT01912339|940995|P3|COMPLETED|Blinded (0 to 3 Months)||0
382952|NCT01912339|940996|P2|COMPLETED|Blinded (0 to 3 Months)||61
382953|NCT01912339|940997|P1|COMPLETED|Blinded (0 to 3 Months)||134
382954|NCT01912339|940995|P3|STARTED|Blinded (0 to 3 Months)||0
382955|NCT01912339|940996|P2|STARTED|Blinded (0 to 3 Months)||61
382956|NCT01912339|940997|P1|STARTED|Blinded (0 to 3 Months)||136
382957|NCT01912222|941014|P3|NOT COMPLETED|Part B: Treatment Period||20
382958|NCT01912222|941015|P2|NOT COMPLETED|Part B: Treatment Period||15
382959|NCT01912222|941016|P1|NOT COMPLETED|Part B: Treatment Period||13
382960|NCT01912222|941014|P3|COMPLETED|Part B: Treatment Period||0
382961|NCT01912222|941015|P2|COMPLETED|Part B: Treatment Period||0
382962|NCT01912222|941016|P1|COMPLETED|Part B: Treatment Period||0
382963|NCT01912222|941014|P3|STARTED|Part B: Treatment Period||20
382964|NCT01912222|941015|P2|STARTED|Part B: Treatment Period||15
382965|NCT01912222|941016|P1|STARTED|Part B: Treatment Period||13
382966|NCT01912222|941014|P3|NOT COMPLETED|Part A: Pharmacokinetic Period||2
382967|NCT01912222|941015|P2|NOT COMPLETED|Part A: Pharmacokinetic Period||2
382968|NCT01912222|941016|P1|NOT COMPLETED|Part A: Pharmacokinetic Period||1
382969|NCT01912222|941014|P3|COMPLETED|Part A: Pharmacokinetic Period||18
382970|NCT01912222|941015|P2|COMPLETED|Part A: Pharmacokinetic Period||13
382971|NCT01912222|941016|P1|COMPLETED|Part A: Pharmacokinetic Period||12
382972|NCT01912222|941014|P3|STARTED|Part A: Pharmacokinetic Period||20
382973|NCT01912222|941015|P2|STARTED|Part A: Pharmacokinetic Period||15
382974|NCT01912222|941016|P1|STARTED|Part A: Pharmacokinetic Period||13
382975|NCT01911845|941039|P1|NOT COMPLETED|Overall Study||6
382976|NCT01911845|941039|P1|COMPLETED|Overall Study||32
382977|NCT01911845|941039|P1|Completed Study Drug|Overall Study||37
382978|NCT01911845|941039|P1|STARTED|Overall Study||38
382979|NCT01911819|941056|P3|NOT COMPLETED|Overall Study||0
382980|NCT01911819|941057|P2|NOT COMPLETED|Overall Study||2
382981|NCT01911819|941058|P1|NOT COMPLETED|Overall Study||1
382982|NCT01911819|941056|P3|COMPLETED|Overall Study||10
382983|NCT01911819|941057|P2|COMPLETED|Overall Study||9
382984|NCT01911819|941058|P1|COMPLETED|Overall Study||9
382985|NCT01911819|941056|P3|STARTED|Overall Study||10
382986|NCT01911819|941057|P2|STARTED|Overall Study|One of 10 sinuses was replaced to another sinus due to infection.|11
382987|NCT01911819|941058|P1|STARTED|Overall Study||10
382988|NCT01911793|941071|P2|NOT COMPLETED|Overall Study||5
382989|NCT01911793|941072|P1|NOT COMPLETED|Overall Study||1
382990|NCT01911793|941071|P2|COMPLETED|Overall Study||0
382991|NCT01911793|941072|P1|COMPLETED|Overall Study||0
382992|NCT01911793|941071|P2|STARTED|Overall Study||5
382993|NCT01911793|941072|P1|STARTED|Overall Study||1
382994|NCT01911780|941096|P2|NOT COMPLETED|Extension Period (52 Weeks)||3
382995|NCT01911780|941097|P1|NOT COMPLETED|Extension Period (52 Weeks)||4
382996|NCT01911780|941096|P2|COMPLETED|Extension Period (52 Weeks)||58
382997|NCT01911780|941097|P1|COMPLETED|Extension Period (52 Weeks)||61
382998|NCT01911780|941096|P2|STARTED|Extension Period (52 Weeks)||61
382999|NCT01911780|941097|P1|STARTED|Extension Period (52 Weeks)||65
383000|NCT01911780|941096|P2|NOT COMPLETED|Double-blind Period (8 Weeks)||3
383001|NCT01911780|941097|P1|NOT COMPLETED|Double-blind Period (8 Weeks)||3
383002|NCT01911780|941096|P2|COMPLETED|Double-blind Period (8 Weeks)||61
383003|NCT01911780|941097|P1|COMPLETED|Double-blind Period (8 Weeks)||65
383004|NCT01911780|941096|P2|STARTED|Double-blind Period (8 Weeks)||64
383005|NCT01911780|941097|P1|STARTED|Double-blind Period (8 Weeks)||68
383006|NCT01911689|941117|P2|NOT COMPLETED|Overall Study||0
383007|NCT01911689|941118|P1|NOT COMPLETED|Overall Study||0
383008|NCT01911689|941117|P2|COMPLETED|Overall Study||51
383009|NCT01911689|941118|P1|COMPLETED|Overall Study||117
383010|NCT01911689|941117|P2|STARTED|Overall Study||51
383011|NCT01911689|941118|P1|STARTED|Overall Study||117
383012|NCT01911546|941131|P1|NOT COMPLETED|Overall Study||6
383013|NCT01911546|941131|P1|COMPLETED|Overall Study||14
383014|NCT01911546|941131|P1|STARTED|Overall Study||20
383015|NCT01911442|941141|P3|NOT COMPLETED|Overall Study||12
383016|NCT01911442|941142|P2|NOT COMPLETED|Overall Study||4
383017|NCT01911442|941143|P1|NOT COMPLETED|Overall Study||6
383018|NCT01911442|941141|P3|COMPLETED|Overall Study||38
383019|NCT01911442|941142|P2|COMPLETED|Overall Study||47
383020|NCT01911442|941143|P1|COMPLETED|Overall Study||43
383021|NCT01911442|941141|P3|STARTED|Overall Study||50
383022|NCT01911442|941142|P2|STARTED|Overall Study||51
383023|NCT01911442|941143|P1|STARTED|Overall Study||49
383024|NCT01911429|941172|P3|NOT COMPLETED|Overall Study||20
383025|NCT01911429|941173|P2|NOT COMPLETED|Overall Study||10
383026|NCT01911429|941174|P1|NOT COMPLETED|Overall Study||12
383027|NCT01911429|941172|P3|COMPLETED|Overall Study||93
383028|NCT01911429|941173|P2|COMPLETED|Overall Study||96
383029|NCT01911429|941174|P1|COMPLETED|Overall Study||96
383030|NCT01911429|941172|P3|STARTED|Overall Study|one subject randomized to Placebo group was never dosed for study medication, making the total 112|113
383031|NCT01911429|941173|P2|STARTED|Overall Study|Subjects received lurasidone 40/mg day from Days 1-3, and 80mg/day from days 4 to Week 6 visit|106
383032|NCT01911429|941174|P1|STARTED|Overall Study||108
383033|NCT01911403|941208|P2|NOT COMPLETED|Overall Study||3
383034|NCT01911403|941209|P1|NOT COMPLETED|Overall Study||9
383035|NCT01911403|941208|P2|COMPLETED|Overall Study||59
383036|NCT01911403|941209|P1|COMPLETED|Overall Study||52
383037|NCT01911403|941208|P2|STARTED|Overall Study||62
383038|NCT01911403|941209|P1|STARTED|Overall Study||61
383039|NCT01911390|941230|P4|NOT COMPLETED|Overall Study||1
383040|NCT01911390|941231|P3|NOT COMPLETED|Overall Study||1
383041|NCT01911390|941232|P2|NOT COMPLETED|Overall Study||0
383042|NCT01911390|941233|P1|NOT COMPLETED|Overall Study||1
383043|NCT01911390|941230|P4|COMPLETED|Overall Study||10
383044|NCT01911390|941231|P3|COMPLETED|Overall Study||9
383045|NCT01911390|941232|P2|COMPLETED|Overall Study||10
383046|NCT01911390|941233|P1|COMPLETED|Overall Study||9
383047|NCT01911390|941230|P4|STARTED|Overall Study||11
383048|NCT01911390|941231|P3|STARTED|Overall Study||10
383049|NCT01911390|941232|P2|STARTED|Overall Study||10
383050|NCT01911390|941233|P1|STARTED|Overall Study||10
383051|NCT01911351|941249|P2|NOT COMPLETED|Overall Study||0
383052|NCT01911351|941250|P1|NOT COMPLETED|Overall Study||0
383053|NCT01911351|941249|P2|COMPLETED|Overall Study||43
383054|NCT01911351|941250|P1|COMPLETED|Overall Study||39
383055|NCT01911351|941249|P2|STARTED|Overall Study||43
383056|NCT01911351|941250|P1|STARTED|Overall Study||39
383057|NCT01911273|941266|P2|NOT COMPLETED|Overall Study||2
383058|NCT01911273|941267|P1|NOT COMPLETED|Overall Study||1
383059|NCT01911273|941266|P2|COMPLETED|Overall Study||0
383060|NCT01911273|941267|P1|COMPLETED|Overall Study||0
383061|NCT01911273|941266|P2|STARTED|Overall Study||2
383062|NCT01911273|941267|P1|STARTED|Overall Study||1
383063|NCT01911260|941301|P4|NOT COMPLETED|Follow-up Period||12
383064|NCT01911260|941302|P3|NOT COMPLETED|Follow-up Period||15
383065|NCT01911260|941303|P2|NOT COMPLETED|Follow-up Period||20
383066|NCT01911260|941304|P1|NOT COMPLETED|Follow-up Period||13
383067|NCT01911260|941301|P4|COMPLETED|Follow-up Period||30
383068|NCT01911260|941302|P3|COMPLETED|Follow-up Period||24
383069|NCT01911260|941303|P2|COMPLETED|Follow-up Period||18
383070|NCT01911260|941304|P1|COMPLETED|Follow-up Period||27
383071|NCT01911260|941301|P4|STARTED|Follow-up Period||42
383072|NCT01911260|941302|P3|STARTED|Follow-up Period||39
383073|NCT01911260|941303|P2|STARTED|Follow-up Period||38
383074|NCT01911260|941304|P1|STARTED|Follow-up Period||40
383075|NCT01911260|941301|P4|NOT COMPLETED|Supplementation Period||8
383076|NCT01911260|941302|P3|NOT COMPLETED|Supplementation Period||10
383077|NCT01911260|941303|P2|NOT COMPLETED|Supplementation Period||12
383078|NCT01911260|941304|P1|NOT COMPLETED|Supplementation Period||10
383079|NCT01911260|941301|P4|COMPLETED|Supplementation Period||42
383080|NCT01911260|941302|P3|COMPLETED|Supplementation Period||39
383081|NCT01911260|941303|P2|COMPLETED|Supplementation Period||38
383082|NCT01911260|941304|P1|COMPLETED|Supplementation Period||40
383083|NCT01911260|941301|P4|STARTED|Supplementation Period||50
383084|NCT01911260|941302|P3|STARTED|Supplementation Period||49
383085|NCT01911260|941303|P2|STARTED|Supplementation Period||50
383086|NCT01911260|941304|P1|STARTED|Supplementation Period||50
383087|NCT01911221|941314|P1|NOT COMPLETED|Overall Study||0
383088|NCT01911221|941314|P1|COMPLETED|Overall Study||13
383089|NCT01911221|941314|P1|STARTED|Overall Study||13
383090|NCT01911169|941330|P2|NOT COMPLETED|Overall Study||0
383091|NCT01911169|941331|P1|NOT COMPLETED|Overall Study||0
383092|NCT01911169|941330|P2|COMPLETED|Overall Study||3
383093|NCT01911169|941331|P1|COMPLETED|Overall Study||6
383094|NCT01911169|941330|P2|STARTED|Overall Study||3
383095|NCT01911169|941331|P1|STARTED|Overall Study||6
383096|NCT01911065|941341|P2|NOT COMPLETED|Overall Study||0
383097|NCT01911065|941342|P1|NOT COMPLETED|Overall Study||0
383098|NCT01911065|941341|P2|COMPLETED|Overall Study||9
383099|NCT01911065|941342|P1|COMPLETED|Overall Study||45
383100|NCT01911065|941341|P2|STARTED|Overall Study||9
383101|NCT01911065|941342|P1|STARTED|Overall Study||45
383102|NCT01910831|941350|P1|NOT COMPLETED|Overall Study||1
383103|NCT01910831|941350|P1|COMPLETED|Overall Study||19
383104|NCT01910831|941350|P1|STARTED|Overall Study||20
383105|NCT01910792|941359|P2|NOT COMPLETED|Overall Study||0
383106|NCT01910792|941360|P1|NOT COMPLETED|Overall Study||0
383107|NCT01910792|941359|P2|COMPLETED|Overall Study||10
383108|NCT01910792|941360|P1|COMPLETED|Overall Study||9
383109|NCT01910792|941359|P2|STARTED|Overall Study||10
383110|NCT01910792|941360|P1|STARTED|Overall Study||9
383111|NCT01910688|941366|P1|NOT COMPLETED|Overall Study||5
383112|NCT01910688|941366|P1|COMPLETED|Overall Study||20
383113|NCT01910688|941366|P1|12months|Overall Study||22
383114|NCT01910688|941366|P1|3rd RFA Treatment|Overall Study||18
383115|NCT01910688|941366|P1|7.5months|Overall Study||24
383116|NCT01910688|941366|P1|2nd RFA Treatment|Overall Study||22
383117|NCT01910688|941366|P1|3.5month|Overall Study||25
383118|NCT01910688|941366|P1|STARTED|Overall Study||25
383119|NCT01910636|941375|P2|NOT COMPLETED|Overall Study||0
383120|NCT01910636|941376|P1|NOT COMPLETED|Overall Study||0
383121|NCT01910636|941375|P2|COMPLETED|Overall Study||63
383122|NCT01910636|941376|P1|COMPLETED|Overall Study||90
383123|NCT01910636|941375|P2|STARTED|Overall Study||63
383124|NCT01910636|941376|P1|STARTED|Overall Study||90
383125|NCT01910441|941390|P2|NOT COMPLETED|Overall Study||10
383126|NCT01910441|941391|P1|NOT COMPLETED|Overall Study||7
383127|NCT01910441|941390|P2|COMPLETED|Overall Study||37
383128|NCT01910441|941391|P1|COMPLETED|Overall Study||41
383129|NCT01910441|941390|P2|STARTED|Overall Study||47
383130|NCT01910441|941391|P1|STARTED|Overall Study||48
383131|NCT01910402|941399|P2|NOT COMPLETED|Continuation Phase||0
383132|NCT01910402|941400|P1|NOT COMPLETED|Continuation Phase||90
383133|NCT01910402|941399|P2|COMPLETED|Continuation Phase||0
383134|NCT01910402|941400|P1|COMPLETED|Continuation Phase||30
383135|NCT01910402|941399|P2|STARTED|Continuation Phase||0
383136|NCT01910402|941400|P1|STARTED|Continuation Phase||120
383137|NCT01910402|941399|P2|NOT COMPLETED|Randomized Phase||55
383138|NCT01910402|941400|P1|NOT COMPLETED|Randomized Phase||42
383139|NCT01910402|941399|P2|COMPLETED|Randomized Phase||192
383140|NCT01910402|941400|P1|COMPLETED|Randomized Phase||206
383141|NCT01910402|941399|P2|STARTED|Randomized Phase||247
383142|NCT01910402|941400|P1|STARTED|Randomized Phase||248
383143|NCT01910389|941470|P2|NOT COMPLETED|Overall Study||8
383144|NCT01910389|941471|P1|NOT COMPLETED|Overall Study||15
383145|NCT01910389|941470|P2|COMPLETED|Overall Study||0
383146|NCT01910389|941471|P1|COMPLETED|Overall Study||0
383147|NCT01910389|941470|P2|STARTED|Overall Study||8
383148|NCT01910389|941471|P1|STARTED|Overall Study||15
383149|NCT01910311|941501|P1|NOT COMPLETED|Period 2 (Days 3-32)||0
383150|NCT01910311|941501|P1|COMPLETED|Period 2 (Days 3-32)||18
383151|NCT01910311|941501|P1|Received At Least 1 Dose of Rifampicin|Period 2 (Days 3-32)||18
383152|NCT01910311|941501|P1|Received Baricitinib|Period 2 (Days 3-32)||18
383153|NCT01910311|941501|P1|STARTED|Period 2 (Days 3-32)||18
383154|NCT01910311|941501|P1|NOT COMPLETED|Period 1 (Days 1-2)||0
383155|NCT01910311|941501|P1|COMPLETED|Period 1 (Days 1-2)||18
383156|NCT01910311|941501|P1|Received Baricitinib|Period 1 (Days 1-2)||18
383157|NCT01910311|941501|P1|STARTED|Period 1 (Days 1-2)||18
383163|NCT01910116|941539|P2|NOT COMPLETED|Overall Study||16
383164|NCT01910116|941540|P1|NOT COMPLETED|Overall Study||14
383165|NCT01910116|941539|P2|COMPLETED|Overall Study||94
383166|NCT01910116|941540|P1|COMPLETED|Overall Study||96
383167|NCT01910116|941539|P2|Week 16|Overall Study||94
383168|NCT01910116|941540|P1|Week 16|Overall Study||96
383169|NCT01910116|941539|P2|Week 12|Overall Study||96
383170|NCT01910116|941540|P1|Week 12|Overall Study||97
383171|NCT01910116|941539|P2|Week 8|Overall Study||99
383172|NCT01910116|941540|P1|Week 8|Overall Study||98
383173|NCT01910116|941539|P2|Week 4|Overall Study||102
383174|NCT01910116|941540|P1|Week 4|Overall Study||106
383175|NCT01910116|941539|P2|STARTED|Overall Study||110
383176|NCT01910116|941540|P1|STARTED|Overall Study||110
383177|NCT01910064|941616|P1|NOT COMPLETED|Overall Study||45
383178|NCT01910064|941616|P1|COMPLETED|Overall Study||391
383179|NCT01910064|941616|P1|STARTED|Overall Study||436
383180|NCT01909804|941637|P12|NOT COMPLETED|Overall Study||3
383181|NCT01909804|941638|P11|NOT COMPLETED|Overall Study||1
383182|NCT01909804|941639|P10|NOT COMPLETED|Overall Study||1
383183|NCT01909804|941640|P9|NOT COMPLETED|Overall Study||0
383184|NCT01909804|941641|P8|NOT COMPLETED|Overall Study||1
383185|NCT01909804|941642|P7|NOT COMPLETED|Overall Study||2
383186|NCT01909804|941643|P6|NOT COMPLETED|Overall Study||4
383187|NCT01909804|941644|P5|NOT COMPLETED|Overall Study||8
383188|NCT01909804|941645|P4|NOT COMPLETED|Overall Study||0
383189|NCT01909804|941646|P3|NOT COMPLETED|Overall Study||0
383190|NCT01909804|941647|P2|NOT COMPLETED|Overall Study||1
383191|NCT01909804|941648|P1|NOT COMPLETED|Overall Study||4
383192|NCT01909804|941637|P12|COMPLETED|Overall Study||26
383193|NCT01909804|941638|P11|COMPLETED|Overall Study||26
383194|NCT01909804|941639|P10|COMPLETED|Overall Study||28
383195|NCT01909804|941640|P9|COMPLETED|Overall Study||27
383196|NCT01909804|941641|P8|COMPLETED|Overall Study||25
383197|NCT01909804|941642|P7|COMPLETED|Overall Study||25
383198|NCT01909804|941643|P6|COMPLETED|Overall Study||21
383199|NCT01909804|941644|P5|COMPLETED|Overall Study||18
383200|NCT01909804|941645|P4|COMPLETED|Overall Study||26
383201|NCT01909804|941646|P3|COMPLETED|Overall Study||27
383202|NCT01909804|941647|P2|COMPLETED|Overall Study||27
383203|NCT01909804|941648|P1|COMPLETED|Overall Study||22
383204|NCT01909804|941637|P12|STARTED|Overall Study||29
383205|NCT01909804|941638|P11|STARTED|Overall Study||27
383206|NCT01909804|941639|P10|STARTED|Overall Study||29
383207|NCT01909804|941640|P9|STARTED|Overall Study||27
383208|NCT01909804|941641|P8|STARTED|Overall Study||26
383209|NCT01909804|941642|P7|STARTED|Overall Study||27
383210|NCT01909804|941643|P6|STARTED|Overall Study||25
383211|NCT01909804|941644|P5|STARTED|Overall Study||26
383212|NCT01909804|941645|P4|STARTED|Overall Study||26
383213|NCT01909804|941646|P3|STARTED|Overall Study||27
383214|NCT01909804|941647|P2|STARTED|Overall Study||28
383215|NCT01909804|941648|P1|STARTED|Overall Study||26
383216|NCT01909778|941694|P1|NOT COMPLETED|Overall Study||1
383217|NCT01909778|941694|P1|COMPLETED|Overall Study||1
383218|NCT01909778|941694|P1|STARTED|Overall Study||2
383219|NCT01909713|941718|P1|NOT COMPLETED|Overall Study||0
383220|NCT01909713|941718|P1|COMPLETED|Overall Study||35
383221|NCT01909713|941718|P1|STARTED|Overall Study||35
383222|NCT01909674|941773|P2|NOT COMPLETED|Overall Study||2
383223|NCT01909674|941774|P1|NOT COMPLETED|Overall Study||5
383224|NCT01909674|941773|P2|COMPLETED|Overall Study||7
383225|NCT01909674|941774|P1|COMPLETED|Overall Study||7
383226|NCT01909674|941773|P2|STARTED|Overall Study||9
383227|NCT01909674|941774|P1|STARTED|Overall Study||12
383228|NCT01909570|941782|P2|NOT COMPLETED|Overall Study||27
383229|NCT01909570|941783|P1|NOT COMPLETED|Overall Study||27
383230|NCT01909570|941782|P2|COMPLETED|Overall Study||64
383231|NCT01909570|941783|P1|COMPLETED|Overall Study||57
383232|NCT01909570|941782|P2|STARTED|Overall Study||91
383233|NCT01909570|941783|P1|STARTED|Overall Study||84
383234|NCT01909466|941793|P2|NOT COMPLETED|Overall Study||23
383235|NCT01909466|941794|P1|NOT COMPLETED|Overall Study||22
383236|NCT01909466|941793|P2|COMPLETED|Overall Study||50
383237|NCT01909466|941794|P1|COMPLETED|Overall Study||46
383238|NCT01909466|941793|P2|STARTED|Overall Study||73
383239|NCT01909466|941794|P1|STARTED|Overall Study||68
383240|NCT01909336|941817|P3|NOT COMPLETED|Overall Study||3
383241|NCT01909336|941818|P2|NOT COMPLETED|Overall Study||3
383242|NCT01909336|941819|P1|NOT COMPLETED|Overall Study||4
383243|NCT01909336|941817|P3|COMPLETED|Overall Study||52
383244|NCT01909336|941818|P2|COMPLETED|Overall Study||50
383245|NCT01909336|941819|P1|COMPLETED|Overall Study||49
383246|NCT01909336|941817|P3|STARTED|Overall Study||55
383247|NCT01909336|941818|P2|STARTED|Overall Study||53
383248|NCT01909336|941819|P1|STARTED|Overall Study||53
383249|NCT01909180|941833|P1|NOT COMPLETED|Overall Study||0
383250|NCT01909180|941833|P1|COMPLETED|Overall Study||49
383251|NCT01909180|941833|P1|STARTED|Overall Study||49
383252|NCT01909141|941841|P2|NOT COMPLETED|Overall Study||0
383253|NCT01909141|941842|P1|NOT COMPLETED|Overall Study||0
383254|NCT01909141|941841|P2|COMPLETED|Overall Study||50
383255|NCT01909141|941842|P1|COMPLETED|Overall Study||50
383256|NCT01909141|941841|P2|STARTED|Overall Study||50
383257|NCT01909141|941842|P1|STARTED|Overall Study||50
383258|NCT01909011|941858|P2|NOT COMPLETED|Overall Study||0
383259|NCT01909011|941859|P1|NOT COMPLETED|Overall Study||0
383260|NCT01909011|941858|P2|COMPLETED|Overall Study||9
383261|NCT01909011|941859|P1|COMPLETED|Overall Study||7
383262|NCT01909011|941858|P2|STARTED|Overall Study||9
383263|NCT01909011|941859|P1|STARTED|Overall Study||7
383264|NCT01908907|941871|P2|NOT COMPLETED|Overall Study||0
383265|NCT01908907|941872|P1|NOT COMPLETED|Overall Study||2
383266|NCT01908907|941871|P2|COMPLETED|Overall Study||29
383267|NCT01908907|941872|P1|COMPLETED|Overall Study||29
383268|NCT01908907|941871|P2|STARTED|Overall Study||29
383269|NCT01908907|941872|P1|STARTED|Overall Study||31
383270|NCT01908842|941894|P2|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||17
383271|NCT01908842|941895|P1|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||25
383272|NCT01908842|941894|P2|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262
383273|NCT01908842|941895|P1|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262
383274|NCT01908842|941894|P2|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||279
383275|NCT01908842|941895|P1|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||287
383276|NCT01908842|941894|P2|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||65
383277|NCT01908842|941895|P1|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||70
383278|NCT01908842|941894|P2|COMPLETED|Switch to Other BNX Formulation (Day 15)||279
383279|NCT01908842|941895|P1|COMPLETED|Switch to Other BNX Formulation (Day 15)||287
383280|NCT01908842|941894|P2|STARTED|Switch to Other BNX Formulation (Day 15)||344
383281|NCT01908842|941895|P1|STARTED|Switch to Other BNX Formulation (Day 15)||357
383282|NCT01908842|941894|P2|NOT COMPLETED|Induction||31
383283|NCT01908842|941895|P1|NOT COMPLETED|Induction||26
383284|NCT01908842|941894|P2|COMPLETED|Induction||344
383285|NCT01908842|941895|P1|COMPLETED|Induction||357
383286|NCT01908842|941894|P2|STARTED|Induction||375
383287|NCT01908842|941895|P1|STARTED|Induction||383
383288|NCT01908829|941916|P3|NOT COMPLETED|Overall Study||39
383289|NCT01908829|941917|P2|NOT COMPLETED|Overall Study||49
383290|NCT01908829|941918|P1|NOT COMPLETED|Overall Study||49
383291|NCT01908829|941916|P3|COMPLETED|Overall Study||680
383292|NCT01908829|941917|P2|COMPLETED|Overall Study||679
383293|NCT01908829|941918|P1|COMPLETED|Overall Study||678
383294|NCT01908829|941916|P3|Treated With Double-blind Drug|Overall Study||719
383295|NCT01908829|941917|P2|Treated With Double-blind Drug|Overall Study||728
383296|NCT01908829|941918|P1|Treated With Double-blind Drug|Overall Study||725
383297|NCT01908829|941916|P3|STARTED|Overall Study||719
383298|NCT01908829|941917|P2|STARTED|Overall Study||728
383299|NCT01908829|941918|P1|STARTED|Overall Study||727
383300|NCT01908803|942033|P2|NOT COMPLETED|Overall Study||1
383301|NCT01908803|942034|P1|NOT COMPLETED|Overall Study||4
383302|NCT01908803|942033|P2|COMPLETED|Overall Study||23
383303|NCT01908803|942034|P1|COMPLETED|Overall Study||42
383304|NCT01908803|942033|P2|Treated|Overall Study||24
383305|NCT01908803|942034|P1|Treated|Overall Study|Two randomized subjects discontinued prior to receiving investigational product.|44
383306|NCT01908803|942033|P2|STARTED|Overall Study||24
383307|NCT01908803|942034|P1|STARTED|Overall Study||46
383308|NCT01908140|942047|P2|NOT COMPLETED|Overall Study||79
383309|NCT01908140|942048|P1|NOT COMPLETED|Overall Study||66
383310|NCT01908140|942047|P2|COMPLETED|Overall Study||386
383311|NCT01908140|942048|P1|COMPLETED|Overall Study||402
383312|NCT01908140|942047|P2|STARTED|Overall Study||465
383313|NCT01908140|942048|P1|STARTED|Overall Study||468
383314|NCT01908127|942058|P2|NOT COMPLETED|Overall Study||0
383315|NCT01908127|942059|P1|NOT COMPLETED|Overall Study||1
383316|NCT01908127|942058|P2|COMPLETED|Overall Study||23
383317|NCT01908127|942059|P1|COMPLETED|Overall Study||22
383318|NCT01908127|942058|P2|STARTED|Overall Study||23
383319|NCT01908127|942059|P1|STARTED|Overall Study||23
383320|NCT01907906|942069|P2|NOT COMPLETED|Overall Study||1
383321|NCT01907906|942070|P1|NOT COMPLETED|Overall Study||4
383322|NCT01907906|942069|P2|COMPLETED|Overall Study||12
383323|NCT01907906|942070|P1|COMPLETED|Overall Study||12
383324|NCT01907906|942069|P2|STARTED|Overall Study||13
383325|NCT01907906|942070|P1|STARTED|Overall Study||16
383326|NCT01907854|942150|P2|NOT COMPLETED|Overall Study||13
383327|NCT01907854|942151|P1|NOT COMPLETED|Overall Study||16
383328|NCT01907854|942150|P2|COMPLETED|Overall Study||191
383329|NCT01907854|942151|P1|COMPLETED|Overall Study||187
383330|NCT01907854|942150|P2|Exposed|Overall Study||204
383331|NCT01907854|942151|P1|Exposed|Overall Study|One subject in lira arm was not exposed (Reason: withdrawal by subject)|202
383332|NCT01907854|942150|P2|STARTED|Overall Study||204
383333|NCT01907854|942151|P1|STARTED|Overall Study||203
383334|NCT01907815|942171|P2|NOT COMPLETED|Overall Study||0
383335|NCT01907815|942172|P1|NOT COMPLETED|Overall Study||1
383336|NCT01907815|942171|P2|COMPLETED|Overall Study||7
383337|NCT01907815|942172|P1|COMPLETED|Overall Study||16
383338|NCT01907815|942171|P2|STARTED|Overall Study||7
383339|NCT01907815|942172|P1|STARTED|Overall Study||17
383340|NCT01907516|942188|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
383341|NCT01907516|942189|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
383342|NCT01907516|942188|P2|COMPLETED|Second Intervention (3 Weeks)||34
383343|NCT01907516|942189|P1|COMPLETED|Second Intervention (3 Weeks)||40
383344|NCT01907516|942188|P2|STARTED|Second Intervention (3 Weeks)||34
383345|NCT01907516|942189|P1|STARTED|Second Intervention (3 Weeks)||40
383346|NCT01907516|942188|P2|NOT COMPLETED|First Intervention (3 Weeks)||16
383347|NCT01907516|942189|P1|NOT COMPLETED|First Intervention (3 Weeks)||10
383348|NCT01907516|942188|P2|COMPLETED|First Intervention (3 Weeks)||34
383349|NCT01907516|942189|P1|COMPLETED|First Intervention (3 Weeks)||40
383350|NCT01907516|942188|P2|STARTED|First Intervention (3 Weeks)||50
383351|NCT01907516|942189|P1|STARTED|First Intervention (3 Weeks)||50
383352|NCT01907490|942196|P1|NOT COMPLETED|Overall Study||0
383353|NCT01907490|942196|P1|COMPLETED|Overall Study||38
383354|NCT01907490|942196|P1|STARTED|Overall Study||38
383355|NCT01907334|942200|P2|NOT COMPLETED|Overall Study||0
383356|NCT01907334|942201|P1|NOT COMPLETED|Overall Study||0
383357|NCT01907334|942200|P2|COMPLETED|Overall Study||4
383358|NCT01907334|942201|P1|COMPLETED|Overall Study||6
383359|NCT01907334|942200|P2|STARTED|Overall Study||4
383360|NCT01907334|942201|P1|STARTED|Overall Study||6
383361|NCT01907321|942206|P1|NOT COMPLETED|Overall Study||2
383362|NCT01907321|942206|P1|COMPLETED|Overall Study||12
383363|NCT01907321|942206|P1|STARTED|Overall Study||14
383364|NCT01907269|942213|P2|NOT COMPLETED|18 Month Outcome Measures Post-intervent||280
383365|NCT01907269|942214|P1|NOT COMPLETED|18 Month Outcome Measures Post-intervent||319
383366|NCT01907269|942213|P2|COMPLETED|18 Month Outcome Measures Post-intervent||970
383367|NCT01907269|942214|P1|COMPLETED|18 Month Outcome Measures Post-intervent||859
383368|NCT01907269|942213|P2|STARTED|18 Month Outcome Measures Post-intervent||1250
383369|NCT01907269|942214|P1|STARTED|18 Month Outcome Measures Post-intervent||1178
383370|NCT01907269|942213|P2|NOT COMPLETED|6 Month Outcome Measures Post-interventi||289
383371|NCT01907269|942214|P1|NOT COMPLETED|6 Month Outcome Measures Post-interventi||389
383372|NCT01907269|942213|P2|COMPLETED|6 Month Outcome Measures Post-interventi||1053
383373|NCT01907269|942214|P1|COMPLETED|6 Month Outcome Measures Post-interventi||953
383374|NCT01907269|942213|P2|STARTED|6 Month Outcome Measures Post-interventi||1342
383375|NCT01907269|942214|P1|STARTED|6 Month Outcome Measures Post-interventi||1342
383376|NCT01907113|942233|P5|NOT COMPLETED|Overall Study||0
383377|NCT01907113|942234|P4|NOT COMPLETED|Overall Study||0
383378|NCT01907113|942235|P3|NOT COMPLETED|Overall Study||0
383379|NCT01907113|942236|P2|NOT COMPLETED|Overall Study||0
383380|NCT01907113|942237|P1|NOT COMPLETED|Overall Study||0
383381|NCT01907113|942233|P5|COMPLETED|Overall Study||8
383382|NCT01907113|942234|P4|COMPLETED|Overall Study||8
383383|NCT01907113|942235|P3|COMPLETED|Overall Study||7
383384|NCT01907113|942236|P2|COMPLETED|Overall Study||9
383385|NCT01907113|942237|P1|COMPLETED|Overall Study||8
383386|NCT01907113|942233|P5|STARTED|Overall Study||8
383387|NCT01907113|942234|P4|STARTED|Overall Study||8
383388|NCT01907113|942235|P3|STARTED|Overall Study||7
383389|NCT01907113|942236|P2|STARTED|Overall Study||9
383390|NCT01907113|942237|P1|STARTED|Overall Study||8
383391|NCT01907087|942324|P1|NOT COMPLETED|Overall Study||1
383392|NCT01907087|942324|P1|COMPLETED|Overall Study||23
383393|NCT01907087|942324|P1|STARTED|Overall Study||24
383394|NCT01906658|942337|P4|NOT COMPLETED|Overall Study||0
383395|NCT01906658|942338|P3|NOT COMPLETED|Overall Study||3
383396|NCT01906658|942339|P2|NOT COMPLETED|Overall Study||1
383397|NCT01906658|942340|P1|NOT COMPLETED|Overall Study||2
383398|NCT01906658|942337|P4|COMPLETED|Overall Study||11
383399|NCT01906658|942338|P3|COMPLETED|Overall Study||7
383400|NCT01906658|942339|P2|COMPLETED|Overall Study||10
383401|NCT01906658|942340|P1|COMPLETED|Overall Study||9
383402|NCT01906658|942337|P4|STARTED|Overall Study||11
383403|NCT01906658|942338|P3|STARTED|Overall Study||10
383404|NCT01906658|942339|P2|STARTED|Overall Study||11
383405|NCT01906658|942340|P1|STARTED|Overall Study||11
383406|NCT01906515|942364|P2|NOT COMPLETED|Overall Study||0
383407|NCT01906515|942365|P1|NOT COMPLETED|Overall Study||0
383408|NCT01906515|942364|P2|COMPLETED|Overall Study||61
383409|NCT01906515|942365|P1|COMPLETED|Overall Study||45
383410|NCT01906515|942364|P2|STARTED|Overall Study||61
383411|NCT01906515|942365|P1|STARTED|Overall Study||45
383412|NCT01906372|942373|P1|NOT COMPLETED|Overall Study||2
383413|NCT01906372|942373|P1|COMPLETED|Overall Study||10
383414|NCT01906372|942373|P1|Visit 10: Follow up Phase Completed|Overall Study||8
383415|NCT01906372|942373|P1|Visit 7: Treatment Phase Completed|Overall Study||10
383416|NCT01906372|942373|P1|STARTED|Overall Study||12
383417|NCT01905956|942380|P2|NOT COMPLETED|Overall Study||11
383418|NCT01905956|942381|P1|NOT COMPLETED|Overall Study||6
383419|NCT01905956|942380|P2|COMPLETED|Overall Study|Per-protocol population|48
383420|NCT01905956|942381|P1|COMPLETED|Overall Study|Per-protocol population|54
383421|NCT01905956|942380|P2|Intention-to-treat Population|Overall Study|Intention-to-treat population|54
383422|NCT01905956|942381|P1|Intention-to-treat Population|Overall Study|Intention-to-treat population|57
383423|NCT01905956|942380|P2|STARTED|Overall Study|Randomized|59
383424|NCT01905956|942381|P1|STARTED|Overall Study|Randomized|60
383425|NCT01905683|942403|P1|NOT COMPLETED|Overall Study||51
383426|NCT01905683|942403|P1|COMPLETED|Overall Study||319
383427|NCT01905683|942403|P1|STARTED|Overall Study||370
383428|NCT01905657|942419|P3|NOT COMPLETED|Overall Study||328
383429|NCT01905657|942420|P2|NOT COMPLETED|Overall Study||346
383430|NCT01905657|942421|P1|NOT COMPLETED|Overall Study||345
383431|NCT01905657|942419|P3|COMPLETED|Overall Study||15
383432|NCT01905657|942420|P2|COMPLETED|Overall Study||0
383433|NCT01905657|942421|P1|COMPLETED|Overall Study||0
383434|NCT01905657|942419|P3|Treated|Overall Study||309
383435|NCT01905657|942420|P2|Treated|Overall Study||343
383436|NCT01905657|942421|P1|Treated|Overall Study||339
383437|NCT01905657|942419|P3|STARTED|Overall Study||343
383438|NCT01905657|942420|P2|STARTED|Overall Study||346
383439|NCT01905657|942421|P1|STARTED|Overall Study||345
383440|NCT01905553|942446|P2|NOT COMPLETED|Period 2||0
383441|NCT01905553|942447|P1|NOT COMPLETED|Period 2||1
383442|NCT01905553|942446|P2|COMPLETED|Period 2||4
383443|NCT01905553|942447|P1|COMPLETED|Period 2||4
383444|NCT01905553|942446|P2|STARTED|Period 2||4
383445|NCT01905553|942447|P1|STARTED|Period 2||5
383446|NCT01905553|942446|P2|NOT COMPLETED|Period 1||0
383447|NCT01905553|942447|P1|NOT COMPLETED|Period 1||0
383448|NCT01905553|942446|P2|COMPLETED|Period 1||4
383449|NCT01905553|942447|P1|COMPLETED|Period 1||5
383450|NCT01905553|942446|P2|STARTED|Period 1||4
383451|NCT01905553|942447|P1|STARTED|Period 1||5
383452|NCT01905540|942461|P4|NOT COMPLETED|Period 3||1
383453|NCT01905540|942462|P3|NOT COMPLETED|Period 3||1
383454|NCT01905540|942463|P2|NOT COMPLETED|Period 3||0
383455|NCT01905540|942464|P1|NOT COMPLETED|Period 3||1
383456|NCT01905540|942461|P4|COMPLETED|Period 3||6
383457|NCT01905540|942462|P3|COMPLETED|Period 3||6
383458|NCT01905540|942463|P2|COMPLETED|Period 3||7
383459|NCT01905540|942464|P1|COMPLETED|Period 3||6
383460|NCT01905540|942461|P4|STARTED|Period 3||7
383461|NCT01905540|942462|P3|STARTED|Period 3||7
383462|NCT01905540|942463|P2|STARTED|Period 3||7
383463|NCT01905540|942464|P1|STARTED|Period 3||7
383464|NCT01905540|942461|P4|NOT COMPLETED|Period 2||0
383465|NCT01905540|942462|P3|NOT COMPLETED|Period 2||0
383466|NCT01905540|942463|P2|NOT COMPLETED|Period 2||0
383467|NCT01905540|942464|P1|NOT COMPLETED|Period 2||0
383468|NCT01905540|942461|P4|COMPLETED|Period 2||7
383469|NCT01905540|942462|P3|COMPLETED|Period 2||7
383470|NCT01905540|942463|P2|COMPLETED|Period 2||7
383471|NCT01905540|942464|P1|COMPLETED|Period 2||7
383472|NCT01905540|942461|P4|STARTED|Period 2||7
383473|NCT01905540|942462|P3|STARTED|Period 2||7
383474|NCT01905540|942463|P2|STARTED|Period 2||7
383475|NCT01905540|942464|P1|STARTED|Period 2||7
383476|NCT01905540|942461|P4|NOT COMPLETED|Period 1||0
383477|NCT01905540|942462|P3|NOT COMPLETED|Period 1||0
383478|NCT01905540|942463|P2|NOT COMPLETED|Period 1||0
383479|NCT01905540|942464|P1|NOT COMPLETED|Period 1||0
383480|NCT01905540|942461|P4|COMPLETED|Period 1||7
383481|NCT01905540|942462|P3|COMPLETED|Period 1||7
383482|NCT01905540|942463|P2|COMPLETED|Period 1||7
383483|NCT01905540|942464|P1|COMPLETED|Period 1||7
383484|NCT01905540|942461|P4|STARTED|Period 1||7
383485|NCT01905540|942462|P3|STARTED|Period 1||7
383486|NCT01905540|942463|P2|STARTED|Period 1||7
383487|NCT01905540|942464|P1|STARTED|Period 1||7
383488|NCT01905423|942486|P4|NOT COMPLETED|Overall Study||0
383489|NCT01905423|942487|P3|NOT COMPLETED|Overall Study||0
383490|NCT01905423|942488|P2|NOT COMPLETED|Overall Study||0
383491|NCT01905423|942489|P1|NOT COMPLETED|Overall Study||0
383492|NCT01905423|942486|P4|COMPLETED|Overall Study||3324
383493|NCT01905423|942487|P3|COMPLETED|Overall Study||4119
383494|NCT01905423|942488|P2|COMPLETED|Overall Study||4111
383495|NCT01905423|942489|P1|COMPLETED|Overall Study||7753
383496|NCT01905423|942486|P4|Year 3 Follow-up|Overall Study||0
383497|NCT01905423|942487|P3|Year 3 Follow-up|Overall Study||0
383498|NCT01905423|942488|P2|Year 3 Follow-up|Overall Study||1028
383499|NCT01905423|942489|P1|Year 3 Follow-up|Overall Study||1776
383500|NCT01905423|942486|P4|Year 2 Follow-up|Overall Study||0
383501|NCT01905423|942487|P3|Year 2 Follow-up|Overall Study||0
383502|NCT01905423|942488|P2|Year 2 Follow-up|Overall Study||1043
383503|NCT01905423|942489|P1|Year 2 Follow-up|Overall Study||1972
383504|NCT01905423|942486|P4|Year 1 Follow-up|Overall Study||1690
383505|NCT01905423|942487|P3|Year 1 Follow-up|Overall Study||2037
383506|NCT01905423|942488|P2|Year 1 Follow-up|Overall Study||1007
383507|NCT01905423|942489|P1|Year 1 Follow-up|Overall Study||1840
383508|NCT01905423|942486|P4|Baseline|Overall Study||1634
383509|NCT01905423|942487|P3|Baseline|Overall Study||2082
383510|NCT01905423|942488|P2|Baseline|Overall Study||1033
383511|NCT01905423|942489|P1|Baseline|Overall Study||2165
383512|NCT01905423|942486|P4|STARTED|Overall Study||3324
383513|NCT01905423|942487|P3|STARTED|Overall Study||4119
383514|NCT01905423|942488|P2|STARTED|Overall Study||4111
383515|NCT01905423|942489|P1|STARTED|Overall Study||7753
383516|NCT01905254|942497|P1|NOT COMPLETED|Overall Study||0
383517|NCT01905254|942497|P1|COMPLETED|Overall Study||34
383518|NCT01905254|942497|P1|STARTED|Overall Study||34
383519|NCT01904864|942503|P2|NOT COMPLETED|Overall Study||12
383520|NCT01904864|942504|P1|NOT COMPLETED|Overall Study||9
383521|NCT01904864|942503|P2|COMPLETED|Overall Study||28
383522|NCT01904864|942504|P1|COMPLETED|Overall Study||31
383523|NCT01904864|942503|P2|STARTED|Overall Study||40
383524|NCT01904864|942504|P1|STARTED|Overall Study||40
383525|NCT01904773|942510|P9|NOT COMPLETED|Sixth Intervention||0
383526|NCT01904773|942511|P8|NOT COMPLETED|Sixth Intervention||0
383527|NCT01904773|942512|P7|NOT COMPLETED|Sixth Intervention||0
383528|NCT01904773|942513|P6|NOT COMPLETED|Sixth Intervention||0
383529|NCT01904773|942514|P5|NOT COMPLETED|Sixth Intervention||0
383530|NCT01904773|942515|P4|NOT COMPLETED|Sixth Intervention||0
383531|NCT01904773|942516|P3|NOT COMPLETED|Sixth Intervention||0
383532|NCT01904773|942517|P2|NOT COMPLETED|Sixth Intervention||0
383533|NCT01904773|942518|P1|NOT COMPLETED|Sixth Intervention||0
383534|NCT01904773|942510|P9|COMPLETED|Sixth Intervention||4
383535|NCT01904773|942511|P8|COMPLETED|Sixth Intervention||2
383536|NCT01904773|942512|P7|COMPLETED|Sixth Intervention||3
383537|NCT01904773|942513|P6|COMPLETED|Sixth Intervention||4
383538|NCT01904773|942514|P5|COMPLETED|Sixth Intervention||3
383539|NCT01904773|942515|P4|COMPLETED|Sixth Intervention||2
383540|NCT01904773|942516|P3|COMPLETED|Sixth Intervention||1
383541|NCT01904773|942517|P2|COMPLETED|Sixth Intervention||0
383542|NCT01904773|942518|P1|COMPLETED|Sixth Intervention||0
383543|NCT01904773|942510|P9|STARTED|Sixth Intervention||4
383544|NCT01904773|942511|P8|STARTED|Sixth Intervention||2
383545|NCT01904773|942512|P7|STARTED|Sixth Intervention||3
383546|NCT01904773|942513|P6|STARTED|Sixth Intervention||4
383547|NCT01904773|942514|P5|STARTED|Sixth Intervention||3
383548|NCT01904773|942515|P4|STARTED|Sixth Intervention||2
383549|NCT01904773|942516|P3|STARTED|Sixth Intervention||1
383550|NCT01904773|942517|P2|STARTED|Sixth Intervention||0
383551|NCT01904773|942518|P1|STARTED|Sixth Intervention||0
383552|NCT01904773|942510|P9|NOT COMPLETED|Placebo Washout Fifth Intervention||0
383553|NCT01904773|942511|P8|NOT COMPLETED|Placebo Washout Fifth Intervention||0
383554|NCT01904773|942512|P7|NOT COMPLETED|Placebo Washout Fifth Intervention||0
383555|NCT01904773|942513|P6|NOT COMPLETED|Placebo Washout Fifth Intervention||0
383556|NCT01904773|942514|P5|NOT COMPLETED|Placebo Washout Fifth Intervention||0
383557|NCT01904773|942515|P4|NOT COMPLETED|Placebo Washout Fifth Intervention||0
383558|NCT01904773|942516|P3|NOT COMPLETED|Placebo Washout Fifth Intervention||0
383559|NCT01904773|942517|P2|NOT COMPLETED|Placebo Washout Fifth Intervention||1
383560|NCT01904773|942518|P1|NOT COMPLETED|Placebo Washout Fifth Intervention||0
383561|NCT01904773|942510|P9|COMPLETED|Placebo Washout Fifth Intervention||4
383562|NCT01904773|942511|P8|COMPLETED|Placebo Washout Fifth Intervention||2
383563|NCT01904773|942512|P7|COMPLETED|Placebo Washout Fifth Intervention||3
383564|NCT01904773|942513|P6|COMPLETED|Placebo Washout Fifth Intervention||4
383565|NCT01904773|942514|P5|COMPLETED|Placebo Washout Fifth Intervention||3
383566|NCT01904773|942515|P4|COMPLETED|Placebo Washout Fifth Intervention||2
383567|NCT01904773|942516|P3|COMPLETED|Placebo Washout Fifth Intervention||1
383568|NCT01904773|942517|P2|COMPLETED|Placebo Washout Fifth Intervention||0
383569|NCT01904773|942518|P1|COMPLETED|Placebo Washout Fifth Intervention||0
383570|NCT01904773|942510|P9|STARTED|Placebo Washout Fifth Intervention||4
383571|NCT01904773|942511|P8|STARTED|Placebo Washout Fifth Intervention||2
383572|NCT01904773|942512|P7|STARTED|Placebo Washout Fifth Intervention||3
383573|NCT01904773|942513|P6|STARTED|Placebo Washout Fifth Intervention||4
383574|NCT01904773|942514|P5|STARTED|Placebo Washout Fifth Intervention||3
383575|NCT01904773|942515|P4|STARTED|Placebo Washout Fifth Intervention||2
383576|NCT01904773|942516|P3|STARTED|Placebo Washout Fifth Intervention||1
383577|NCT01904773|942517|P2|STARTED|Placebo Washout Fifth Intervention||1
383578|NCT01904773|942518|P1|STARTED|Placebo Washout Fifth Intervention||0
383579|NCT01904773|942510|P9|NOT COMPLETED|Fifth Intervention||0
383580|NCT01904773|942511|P8|NOT COMPLETED|Fifth Intervention||1
383581|NCT01904773|942512|P7|NOT COMPLETED|Fifth Intervention||0
383582|NCT01904773|942513|P6|NOT COMPLETED|Fifth Intervention||0
383583|NCT01904773|942514|P5|NOT COMPLETED|Fifth Intervention||0
383584|NCT01904773|942515|P4|NOT COMPLETED|Fifth Intervention||0
383585|NCT01904773|942516|P3|NOT COMPLETED|Fifth Intervention||0
383586|NCT01904773|942517|P2|NOT COMPLETED|Fifth Intervention||0
383587|NCT01904773|942518|P1|NOT COMPLETED|Fifth Intervention||0
383588|NCT01904773|942510|P9|COMPLETED|Fifth Intervention||4
383589|NCT01904773|942511|P8|COMPLETED|Fifth Intervention||2
383590|NCT01904773|942512|P7|COMPLETED|Fifth Intervention||3
383591|NCT01904773|942513|P6|COMPLETED|Fifth Intervention||4
383592|NCT01904773|942514|P5|COMPLETED|Fifth Intervention||3
383593|NCT01904773|942515|P4|COMPLETED|Fifth Intervention||2
383594|NCT01904773|942516|P3|COMPLETED|Fifth Intervention||1
383595|NCT01904773|942517|P2|COMPLETED|Fifth Intervention||1
383596|NCT01904773|942518|P1|COMPLETED|Fifth Intervention||0
383597|NCT01904773|942510|P9|STARTED|Fifth Intervention||4
383598|NCT01904773|942511|P8|STARTED|Fifth Intervention||3
383599|NCT01904773|942512|P7|STARTED|Fifth Intervention||3
383600|NCT01904773|942513|P6|STARTED|Fifth Intervention||4
383601|NCT01904773|942514|P5|STARTED|Fifth Intervention||3
383602|NCT01904773|942515|P4|STARTED|Fifth Intervention||2
383603|NCT01904773|942516|P3|STARTED|Fifth Intervention||1
383604|NCT01904773|942517|P2|STARTED|Fifth Intervention||1
383605|NCT01904773|942518|P1|STARTED|Fifth Intervention||0
383606|NCT01904773|942510|P9|NOT COMPLETED|Placebo Washout Fourth Intervention||0
383607|NCT01904773|942511|P8|NOT COMPLETED|Placebo Washout Fourth Intervention||0
383608|NCT01904773|942512|P7|NOT COMPLETED|Placebo Washout Fourth Intervention||0
383609|NCT01904773|942513|P6|NOT COMPLETED|Placebo Washout Fourth Intervention||0
383610|NCT01904773|942514|P5|NOT COMPLETED|Placebo Washout Fourth Intervention||0
383611|NCT01904773|942515|P4|NOT COMPLETED|Placebo Washout Fourth Intervention||0
383612|NCT01904773|942516|P3|NOT COMPLETED|Placebo Washout Fourth Intervention||0
383613|NCT01904773|942517|P2|NOT COMPLETED|Placebo Washout Fourth Intervention||0
383614|NCT01904773|942518|P1|NOT COMPLETED|Placebo Washout Fourth Intervention||0
383615|NCT01904773|942510|P9|COMPLETED|Placebo Washout Fourth Intervention||4
383616|NCT01904773|942511|P8|COMPLETED|Placebo Washout Fourth Intervention||3
383617|NCT01904773|942512|P7|COMPLETED|Placebo Washout Fourth Intervention||3
383618|NCT01904773|942513|P6|COMPLETED|Placebo Washout Fourth Intervention||4
383619|NCT01904773|942514|P5|COMPLETED|Placebo Washout Fourth Intervention||3
383620|NCT01904773|942515|P4|COMPLETED|Placebo Washout Fourth Intervention||2
383621|NCT01904773|942516|P3|COMPLETED|Placebo Washout Fourth Intervention||1
383622|NCT01904773|942517|P2|COMPLETED|Placebo Washout Fourth Intervention||1
383623|NCT01904773|942518|P1|COMPLETED|Placebo Washout Fourth Intervention||0
383624|NCT01904773|942510|P9|STARTED|Placebo Washout Fourth Intervention||4
383625|NCT01904773|942511|P8|STARTED|Placebo Washout Fourth Intervention||3
383626|NCT01904773|942512|P7|STARTED|Placebo Washout Fourth Intervention||3
383627|NCT01904773|942513|P6|STARTED|Placebo Washout Fourth Intervention||4
383628|NCT01904773|942514|P5|STARTED|Placebo Washout Fourth Intervention||3
383629|NCT01904773|942515|P4|STARTED|Placebo Washout Fourth Intervention||2
383630|NCT01904773|942516|P3|STARTED|Placebo Washout Fourth Intervention||1
383631|NCT01904773|942517|P2|STARTED|Placebo Washout Fourth Intervention||1
383632|NCT01904773|942518|P1|STARTED|Placebo Washout Fourth Intervention||0
383633|NCT01904773|942510|P9|NOT COMPLETED|Fourth Intervention||0
383634|NCT01904773|942511|P8|NOT COMPLETED|Fourth Intervention||0
383635|NCT01904773|942512|P7|NOT COMPLETED|Fourth Intervention||0
383636|NCT01904773|942513|P6|NOT COMPLETED|Fourth Intervention||0
383637|NCT01904773|942514|P5|NOT COMPLETED|Fourth Intervention||0
383638|NCT01904773|942515|P4|NOT COMPLETED|Fourth Intervention||0
383639|NCT01904773|942516|P3|NOT COMPLETED|Fourth Intervention||0
383640|NCT01904773|942517|P2|NOT COMPLETED|Fourth Intervention||0
383641|NCT01904773|942518|P1|NOT COMPLETED|Fourth Intervention||0
383642|NCT01904773|942510|P9|COMPLETED|Fourth Intervention||4
383643|NCT01904773|942511|P8|COMPLETED|Fourth Intervention||3
383644|NCT01904773|942512|P7|COMPLETED|Fourth Intervention||3
383645|NCT01904773|942513|P6|COMPLETED|Fourth Intervention||4
383646|NCT01904773|942514|P5|COMPLETED|Fourth Intervention||3
383647|NCT01904773|942515|P4|COMPLETED|Fourth Intervention||2
383648|NCT01904773|942516|P3|COMPLETED|Fourth Intervention||1
383649|NCT01904773|942517|P2|COMPLETED|Fourth Intervention||1
383650|NCT01904773|942518|P1|COMPLETED|Fourth Intervention||0
383651|NCT01904773|942510|P9|STARTED|Fourth Intervention||4
383652|NCT01904773|942511|P8|STARTED|Fourth Intervention||3
383653|NCT01904773|942512|P7|STARTED|Fourth Intervention||3
383654|NCT01904773|942513|P6|STARTED|Fourth Intervention||4
383655|NCT01904773|942514|P5|STARTED|Fourth Intervention||3
383656|NCT01904773|942515|P4|STARTED|Fourth Intervention||2
383657|NCT01904773|942516|P3|STARTED|Fourth Intervention||1
383658|NCT01904773|942517|P2|STARTED|Fourth Intervention||1
383659|NCT01904773|942518|P1|STARTED|Fourth Intervention||0
383660|NCT01904773|942510|P9|NOT COMPLETED|Placebo Washout Third Intervention||0
383661|NCT01904773|942511|P8|NOT COMPLETED|Placebo Washout Third Intervention||0
383662|NCT01904773|942512|P7|NOT COMPLETED|Placebo Washout Third Intervention||0
383663|NCT01904773|942513|P6|NOT COMPLETED|Placebo Washout Third Intervention||0
383664|NCT01904773|942514|P5|NOT COMPLETED|Placebo Washout Third Intervention||0
383665|NCT01904773|942515|P4|NOT COMPLETED|Placebo Washout Third Intervention||0
383666|NCT01904773|942516|P3|NOT COMPLETED|Placebo Washout Third Intervention||0
383667|NCT01904773|942517|P2|NOT COMPLETED|Placebo Washout Third Intervention||0
383668|NCT01904773|942518|P1|NOT COMPLETED|Placebo Washout Third Intervention||0
383669|NCT01904773|942510|P9|COMPLETED|Placebo Washout Third Intervention||4
383670|NCT01904773|942511|P8|COMPLETED|Placebo Washout Third Intervention||3
383671|NCT01904773|942512|P7|COMPLETED|Placebo Washout Third Intervention||3
383672|NCT01904773|942513|P6|COMPLETED|Placebo Washout Third Intervention||4
383673|NCT01904773|942514|P5|COMPLETED|Placebo Washout Third Intervention||3
383674|NCT01904773|942515|P4|COMPLETED|Placebo Washout Third Intervention||2
383675|NCT01904773|942516|P3|COMPLETED|Placebo Washout Third Intervention||1
383676|NCT01904773|942517|P2|COMPLETED|Placebo Washout Third Intervention||1
383677|NCT01904773|942518|P1|COMPLETED|Placebo Washout Third Intervention||0
383678|NCT01904773|942510|P9|STARTED|Placebo Washout Third Intervention||4
383679|NCT01904773|942511|P8|STARTED|Placebo Washout Third Intervention||3
383680|NCT01904773|942512|P7|STARTED|Placebo Washout Third Intervention||3
383681|NCT01904773|942513|P6|STARTED|Placebo Washout Third Intervention||4
383682|NCT01904773|942514|P5|STARTED|Placebo Washout Third Intervention||3
383683|NCT01904773|942515|P4|STARTED|Placebo Washout Third Intervention||2
383684|NCT01904773|942516|P3|STARTED|Placebo Washout Third Intervention||1
383685|NCT01904773|942517|P2|STARTED|Placebo Washout Third Intervention||1
383686|NCT01904773|942518|P1|STARTED|Placebo Washout Third Intervention||0
383687|NCT01904773|942510|P9|NOT COMPLETED|Third Intervention||0
383688|NCT01904773|942511|P8|NOT COMPLETED|Third Intervention||0
383689|NCT01904773|942512|P7|NOT COMPLETED|Third Intervention||0
383690|NCT01904773|942513|P6|NOT COMPLETED|Third Intervention||0
383691|NCT01904773|942514|P5|NOT COMPLETED|Third Intervention||0
383692|NCT01904773|942515|P4|NOT COMPLETED|Third Intervention||0
383693|NCT01904773|942516|P3|NOT COMPLETED|Third Intervention||0
383694|NCT01904773|942517|P2|NOT COMPLETED|Third Intervention||0
383695|NCT01904773|942518|P1|NOT COMPLETED|Third Intervention||0
383696|NCT01904773|942510|P9|COMPLETED|Third Intervention||4
383697|NCT01904773|942511|P8|COMPLETED|Third Intervention||3
383698|NCT01904773|942512|P7|COMPLETED|Third Intervention||3
383699|NCT01904773|942513|P6|COMPLETED|Third Intervention||4
383700|NCT01904773|942514|P5|COMPLETED|Third Intervention||3
383701|NCT01904773|942515|P4|COMPLETED|Third Intervention||2
383702|NCT01904773|942516|P3|COMPLETED|Third Intervention||1
383703|NCT01904773|942517|P2|COMPLETED|Third Intervention||1
383704|NCT01904773|942518|P1|COMPLETED|Third Intervention||0
383705|NCT01904773|942510|P9|STARTED|Third Intervention||4
383706|NCT01904773|942511|P8|STARTED|Third Intervention||3
383707|NCT01904773|942512|P7|STARTED|Third Intervention||3
383708|NCT01904773|942513|P6|STARTED|Third Intervention||4
383709|NCT01904773|942514|P5|STARTED|Third Intervention||3
383710|NCT01904773|942515|P4|STARTED|Third Intervention||2
383711|NCT01904773|942516|P3|STARTED|Third Intervention||1
383712|NCT01904773|942517|P2|STARTED|Third Intervention||1
383713|NCT01904773|942518|P1|STARTED|Third Intervention||0
383714|NCT01904773|942510|P9|NOT COMPLETED|Placebo Washout Second Intervention||0
383715|NCT01904773|942511|P8|NOT COMPLETED|Placebo Washout Second Intervention||0
383716|NCT01904773|942512|P7|NOT COMPLETED|Placebo Washout Second Intervention||0
383717|NCT01904773|942513|P6|NOT COMPLETED|Placebo Washout Second Intervention||0
383718|NCT01904773|942514|P5|NOT COMPLETED|Placebo Washout Second Intervention||0
383719|NCT01904773|942515|P4|NOT COMPLETED|Placebo Washout Second Intervention||0
383720|NCT01904773|942516|P3|NOT COMPLETED|Placebo Washout Second Intervention||0
383721|NCT01904773|942517|P2|NOT COMPLETED|Placebo Washout Second Intervention||0
383722|NCT01904773|942518|P1|NOT COMPLETED|Placebo Washout Second Intervention||0
383723|NCT01904773|942510|P9|COMPLETED|Placebo Washout Second Intervention||4
383724|NCT01904773|942511|P8|COMPLETED|Placebo Washout Second Intervention||3
383725|NCT01904773|942512|P7|COMPLETED|Placebo Washout Second Intervention||3
383726|NCT01904773|942513|P6|COMPLETED|Placebo Washout Second Intervention||4
383727|NCT01904773|942514|P5|COMPLETED|Placebo Washout Second Intervention||3
383728|NCT01904773|942515|P4|COMPLETED|Placebo Washout Second Intervention||2
383729|NCT01904773|942516|P3|COMPLETED|Placebo Washout Second Intervention||1
383730|NCT01904773|942517|P2|COMPLETED|Placebo Washout Second Intervention||1
383731|NCT01904773|942518|P1|COMPLETED|Placebo Washout Second Intervention||0
383732|NCT01904773|942510|P9|STARTED|Placebo Washout Second Intervention||4
383733|NCT01904773|942511|P8|STARTED|Placebo Washout Second Intervention||3
383734|NCT01904773|942512|P7|STARTED|Placebo Washout Second Intervention||3
383735|NCT01904773|942513|P6|STARTED|Placebo Washout Second Intervention||4
383736|NCT01904773|942514|P5|STARTED|Placebo Washout Second Intervention||3
383737|NCT01904773|942515|P4|STARTED|Placebo Washout Second Intervention||2
383738|NCT01904773|942516|P3|STARTED|Placebo Washout Second Intervention||1
383739|NCT01904773|942517|P2|STARTED|Placebo Washout Second Intervention||1
383740|NCT01904773|942518|P1|STARTED|Placebo Washout Second Intervention||0
383741|NCT01904773|942510|P9|NOT COMPLETED|Second Intervention||0
383742|NCT01904773|942511|P8|NOT COMPLETED|Second Intervention||0
383743|NCT01904773|942512|P7|NOT COMPLETED|Second Intervention||0
383744|NCT01904773|942513|P6|NOT COMPLETED|Second Intervention||0
383745|NCT01904773|942514|P5|NOT COMPLETED|Second Intervention||0
383746|NCT01904773|942515|P4|NOT COMPLETED|Second Intervention||0
383747|NCT01904773|942516|P3|NOT COMPLETED|Second Intervention||0
383748|NCT01904773|942517|P2|NOT COMPLETED|Second Intervention||0
383749|NCT01904773|942518|P1|NOT COMPLETED|Second Intervention||0
383750|NCT01904773|942510|P9|COMPLETED|Second Intervention||4
383751|NCT01904773|942511|P8|COMPLETED|Second Intervention||3
383752|NCT01904773|942512|P7|COMPLETED|Second Intervention||3
383753|NCT01904773|942513|P6|COMPLETED|Second Intervention||4
383754|NCT01904773|942514|P5|COMPLETED|Second Intervention||3
383755|NCT01904773|942515|P4|COMPLETED|Second Intervention||2
383756|NCT01904773|942516|P3|COMPLETED|Second Intervention||1
383757|NCT01904773|942517|P2|COMPLETED|Second Intervention||1
383758|NCT01904773|942518|P1|COMPLETED|Second Intervention||0
383759|NCT01904773|942510|P9|STARTED|Second Intervention||4
383760|NCT01904773|942511|P8|STARTED|Second Intervention||3
383761|NCT01904773|942512|P7|STARTED|Second Intervention||3
383762|NCT01904773|942513|P6|STARTED|Second Intervention||4
383763|NCT01904773|942514|P5|STARTED|Second Intervention||3
383764|NCT01904773|942515|P4|STARTED|Second Intervention||2
383765|NCT01904773|942516|P3|STARTED|Second Intervention||1
383766|NCT01904773|942517|P2|STARTED|Second Intervention||1
383767|NCT01904773|942518|P1|STARTED|Second Intervention||0
383768|NCT01904773|942510|P9|NOT COMPLETED|Placebo Washout First Intervention||0
383769|NCT01904773|942511|P8|NOT COMPLETED|Placebo Washout First Intervention||0
383770|NCT01904773|942512|P7|NOT COMPLETED|Placebo Washout First Intervention||0
383771|NCT01904773|942513|P6|NOT COMPLETED|Placebo Washout First Intervention||0
383772|NCT01904773|942514|P5|NOT COMPLETED|Placebo Washout First Intervention||0
383773|NCT01904773|942515|P4|NOT COMPLETED|Placebo Washout First Intervention||0
383774|NCT01904773|942516|P3|NOT COMPLETED|Placebo Washout First Intervention||0
383775|NCT01904773|942517|P2|NOT COMPLETED|Placebo Washout First Intervention||1
383776|NCT01904773|942518|P1|NOT COMPLETED|Placebo Washout First Intervention||0
383777|NCT01904773|942510|P9|COMPLETED|Placebo Washout First Intervention||4
383778|NCT01904773|942511|P8|COMPLETED|Placebo Washout First Intervention||3
383779|NCT01904773|942512|P7|COMPLETED|Placebo Washout First Intervention||3
383780|NCT01904773|942513|P6|COMPLETED|Placebo Washout First Intervention||4
383781|NCT01904773|942514|P5|COMPLETED|Placebo Washout First Intervention||3
383782|NCT01904773|942515|P4|COMPLETED|Placebo Washout First Intervention||2
383783|NCT01904773|942516|P3|COMPLETED|Placebo Washout First Intervention||1
383784|NCT01904773|942517|P2|COMPLETED|Placebo Washout First Intervention||1
383785|NCT01904773|942518|P1|COMPLETED|Placebo Washout First Intervention||0
383786|NCT01904773|942510|P9|STARTED|Placebo Washout First Intervention||4
383787|NCT01904773|942511|P8|STARTED|Placebo Washout First Intervention||3
383788|NCT01904773|942512|P7|STARTED|Placebo Washout First Intervention||3
383789|NCT01904773|942513|P6|STARTED|Placebo Washout First Intervention||4
383790|NCT01904773|942514|P5|STARTED|Placebo Washout First Intervention||3
383791|NCT01904773|942515|P4|STARTED|Placebo Washout First Intervention||2
383792|NCT01904773|942516|P3|STARTED|Placebo Washout First Intervention||1
383793|NCT01904773|942517|P2|STARTED|Placebo Washout First Intervention||2
383794|NCT01904773|942518|P1|STARTED|Placebo Washout First Intervention||0
383795|NCT01904773|942510|P9|NOT COMPLETED|First Intervention||0
383796|NCT01904773|942511|P8|NOT COMPLETED|First Intervention||0
383797|NCT01904773|942512|P7|NOT COMPLETED|First Intervention||1
383798|NCT01904773|942513|P6|NOT COMPLETED|First Intervention||0
383799|NCT01904773|942514|P5|NOT COMPLETED|First Intervention||0
383800|NCT01904773|942515|P4|NOT COMPLETED|First Intervention||0
383801|NCT01904773|942516|P3|NOT COMPLETED|First Intervention||0
383802|NCT01904773|942517|P2|NOT COMPLETED|First Intervention||0
383803|NCT01904773|942518|P1|NOT COMPLETED|First Intervention||0
383804|NCT01904773|942510|P9|COMPLETED|First Intervention||4
383805|NCT01904773|942511|P8|COMPLETED|First Intervention||3
383806|NCT01904773|942512|P7|COMPLETED|First Intervention||3
383807|NCT01904773|942513|P6|COMPLETED|First Intervention||4
383808|NCT01904773|942514|P5|COMPLETED|First Intervention||3
383809|NCT01904773|942515|P4|COMPLETED|First Intervention||2
383810|NCT01904773|942516|P3|COMPLETED|First Intervention||1
383811|NCT01904773|942517|P2|COMPLETED|First Intervention||2
383812|NCT01904773|942518|P1|COMPLETED|First Intervention||0
383813|NCT01904773|942510|P9|STARTED|First Intervention||4
383814|NCT01904773|942511|P8|STARTED|First Intervention||3
383815|NCT01904773|942512|P7|STARTED|First Intervention||4
383816|NCT01904773|942513|P6|STARTED|First Intervention||4
383817|NCT01904773|942514|P5|STARTED|First Intervention||3
383818|NCT01904773|942515|P4|STARTED|First Intervention||2
383819|NCT01904773|942516|P3|STARTED|First Intervention||1
383820|NCT01904773|942517|P2|STARTED|First Intervention||2
383821|NCT01904773|942518|P1|STARTED|First Intervention||0
383822|NCT01904773|942510|P9|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
383823|NCT01904773|942511|P8|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
383824|NCT01904773|942512|P7|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
383825|NCT01904773|942513|P6|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
383826|NCT01904773|942514|P5|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
383827|NCT01904773|942515|P4|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
383828|NCT01904773|942516|P3|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
383829|NCT01904773|942517|P2|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
383830|NCT01904773|942518|P1|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||1
383831|NCT01904773|942510|P9|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
383832|NCT01904773|942511|P8|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
383833|NCT01904773|942512|P7|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
383834|NCT01904773|942513|P6|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
383835|NCT01904773|942514|P5|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
383836|NCT01904773|942515|P4|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
383837|NCT01904773|942516|P3|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
383838|NCT01904773|942517|P2|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
383839|NCT01904773|942518|P1|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||23
383840|NCT01904773|942510|P9|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
383841|NCT01904773|942511|P8|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
383842|NCT01904773|942512|P7|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
383843|NCT01904773|942513|P6|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
383844|NCT01904773|942514|P5|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
383845|NCT01904773|942515|P4|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
383846|NCT01904773|942516|P3|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
383847|NCT01904773|942517|P2|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
383848|NCT01904773|942518|P1|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||4
383849|NCT01904773|942510|P9|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
383850|NCT01904773|942511|P8|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
383851|NCT01904773|942512|P7|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
383852|NCT01904773|942513|P6|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
383853|NCT01904773|942514|P5|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
383854|NCT01904773|942515|P4|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
383855|NCT01904773|942516|P3|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
383856|NCT01904773|942517|P2|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
383857|NCT01904773|942518|P1|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||20
383858|NCT01904773|942510|P9|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
383859|NCT01904773|942511|P8|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
383860|NCT01904773|942512|P7|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
383861|NCT01904773|942513|P6|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
383862|NCT01904773|942514|P5|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
383863|NCT01904773|942515|P4|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
383864|NCT01904773|942516|P3|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
383865|NCT01904773|942517|P2|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
383866|NCT01904773|942518|P1|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||24
383867|NCT01904773|942510|P9|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
383868|NCT01904773|942511|P8|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
383869|NCT01904773|942512|P7|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
383870|NCT01904773|942513|P6|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
383871|NCT01904773|942514|P5|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
383872|NCT01904773|942515|P4|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
383873|NCT01904773|942516|P3|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
383874|NCT01904773|942517|P2|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
383875|NCT01904773|942518|P1|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
383876|NCT01904773|942510|P9|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
383877|NCT01904773|942511|P8|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
383878|NCT01904773|942512|P7|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
383879|NCT01904773|942513|P6|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
383880|NCT01904773|942514|P5|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
383881|NCT01904773|942515|P4|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
383882|NCT01904773|942516|P3|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
383883|NCT01904773|942517|P2|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
383884|NCT01904773|942518|P1|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||24
383885|NCT01904773|942510|P9|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
383886|NCT01904773|942511|P8|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
383887|NCT01904773|942512|P7|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
383888|NCT01904773|942513|P6|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
383889|NCT01904773|942514|P5|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
383890|NCT01904773|942515|P4|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
383891|NCT01904773|942516|P3|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
383892|NCT01904773|942517|P2|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
383893|NCT01904773|942518|P1|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||24
383894|NCT01904773|942510|P9|NOT COMPLETED|Screen||0
383895|NCT01904773|942511|P8|NOT COMPLETED|Screen||0
383896|NCT01904773|942512|P7|NOT COMPLETED|Screen||0
383897|NCT01904773|942513|P6|NOT COMPLETED|Screen||0
383898|NCT01904773|942514|P5|NOT COMPLETED|Screen||0
383899|NCT01904773|942515|P4|NOT COMPLETED|Screen||0
383900|NCT01904773|942516|P3|NOT COMPLETED|Screen||0
383901|NCT01904773|942517|P2|NOT COMPLETED|Screen||0
383902|NCT01904773|942518|P1|NOT COMPLETED|Screen||4
383903|NCT01904773|942510|P9|COMPLETED|Screen||0
383904|NCT01904773|942511|P8|COMPLETED|Screen||0
383905|NCT01904773|942512|P7|COMPLETED|Screen||0
383906|NCT01904773|942513|P6|COMPLETED|Screen||0
383907|NCT01904773|942514|P5|COMPLETED|Screen||0
383908|NCT01904773|942515|P4|COMPLETED|Screen||0
383909|NCT01904773|942516|P3|COMPLETED|Screen||0
383910|NCT01904773|942517|P2|COMPLETED|Screen||0
383911|NCT01904773|942518|P1|COMPLETED|Screen||24
383912|NCT01904773|942510|P9|STARTED|Screen||0
383913|NCT01904773|942511|P8|STARTED|Screen||0
383914|NCT01904773|942512|P7|STARTED|Screen||0
383915|NCT01904773|942513|P6|STARTED|Screen||0
383916|NCT01904773|942514|P5|STARTED|Screen||0
383917|NCT01904773|942515|P4|STARTED|Screen||0
383918|NCT01904773|942516|P3|STARTED|Screen||0
383919|NCT01904773|942517|P2|STARTED|Screen||0
383920|NCT01904773|942518|P1|STARTED|Screen||28
383921|NCT01904760|942535|P2|NOT COMPLETED|Overall Study||0
383922|NCT01904760|942536|P1|NOT COMPLETED|Overall Study||1
383923|NCT01904760|942535|P2|COMPLETED|Overall Study||40
383924|NCT01904760|942536|P1|COMPLETED|Overall Study||39
383925|NCT01904760|942535|P2|STARTED|Overall Study||40
383926|NCT01904760|942536|P1|STARTED|Overall Study||40
383927|NCT01904721|942551|P7|NOT COMPLETED|Overall Study||7
383928|NCT01904721|942552|P6|NOT COMPLETED|Overall Study||9
383929|NCT01904721|942553|P5|NOT COMPLETED|Overall Study||8
383930|NCT01904721|942554|P4|NOT COMPLETED|Overall Study||1
383931|NCT01904721|942555|P3|NOT COMPLETED|Overall Study||1
383932|NCT01904721|942556|P2|NOT COMPLETED|Overall Study||0
383933|NCT01904721|942557|P1|NOT COMPLETED|Overall Study||0
383934|NCT01904721|942551|P7|COMPLETED|Overall Study||57
383935|NCT01904721|942552|P6|COMPLETED|Overall Study||56
383936|NCT01904721|942553|P5|COMPLETED|Overall Study||57
383937|NCT01904721|942554|P4|COMPLETED|Overall Study||11
383938|NCT01904721|942555|P3|COMPLETED|Overall Study||11
383939|NCT01904721|942556|P2|COMPLETED|Overall Study||13
383940|NCT01904721|942557|P1|COMPLETED|Overall Study||13
383941|NCT01904721|942551|P7|STARTED|Overall Study||64
383942|NCT01904721|942552|P6|STARTED|Overall Study||65
383943|NCT01904721|942553|P5|STARTED|Overall Study||65
383944|NCT01904721|942554|P4|STARTED|Overall Study||12
383945|NCT01904721|942555|P3|STARTED|Overall Study||12
383946|NCT01904721|942556|P2|STARTED|Overall Study||13
383947|NCT01904721|942557|P1|STARTED|Overall Study||13
383948|NCT01904604|942587|P3|NOT COMPLETED|Overall Study||0
383949|NCT01904604|942588|P2|NOT COMPLETED|Overall Study||4
383950|NCT01904604|942589|P1|NOT COMPLETED|Overall Study||3
383951|NCT01904604|942587|P3|COMPLETED|Overall Study|COMPLETED: Completed the Week 52 Oral Food Challenge (OFC).|25
383952|NCT01904604|942588|P2|COMPLETED|Overall Study|COMPLETED: Completed the Week 52 Oral Food Challenge (OFC).|21
383953|NCT01904604|942589|P1|COMPLETED|Overall Study|COMPLETED: Completed the Week 52 Oral Food Challenge (OFC).|22
383954|NCT01904604|942587|P3|STARTED|Overall Study||25
383955|NCT01904604|942588|P2|STARTED|Overall Study||25
383956|NCT01904604|942589|P1|STARTED|Overall Study||25
383957|NCT01904526|942605|P1|NOT COMPLETED|Overall Study||0
383958|NCT01904526|942605|P1|COMPLETED|Overall Study||5
383959|NCT01904526|942605|P1|STARTED|Overall Study||5
383960|NCT01904448|942619|P1|NOT COMPLETED|Overall Study||0
383961|NCT01904448|942619|P1|COMPLETED|Overall Study||5
383962|NCT01904448|942619|P1|STARTED|Overall Study||5
383963|NCT01904279|942643|P2|NOT COMPLETED|Overall Study||3
383964|NCT01904279|942644|P1|NOT COMPLETED|Overall Study||3
383965|NCT01904279|942643|P2|COMPLETED|Overall Study||22
383966|NCT01904279|942644|P1|COMPLETED|Overall Study||24
383967|NCT01904279|942643|P2|STARTED|Overall Study||25
383968|NCT01904279|942644|P1|STARTED|Overall Study||27
383969|NCT01904149|942670|P6|NOT COMPLETED|Overall Study||3
383970|NCT01904149|942671|P5|NOT COMPLETED|Overall Study||5
383971|NCT01904149|942672|P4|NOT COMPLETED|Overall Study||4
383972|NCT01904149|942673|P3|NOT COMPLETED|Overall Study||2
383973|NCT01904149|942674|P2|NOT COMPLETED|Overall Study||11
383974|NCT01904149|942675|P1|NOT COMPLETED|Overall Study||5
383975|NCT01904149|942670|P6|COMPLETED|Overall Study||48
383976|NCT01904149|942671|P5|COMPLETED|Overall Study||46
383977|NCT01904149|942672|P4|COMPLETED|Overall Study||47
383978|NCT01904149|942673|P3|COMPLETED|Overall Study||148
383979|NCT01904149|942674|P2|COMPLETED|Overall Study||140
383980|NCT01904149|942675|P1|COMPLETED|Overall Study||147
383981|NCT01904149|942670|P6|Multiple-dose Phase|Overall Study||49
383982|NCT01904149|942671|P5|Multiple-dose Phase|Overall Study||48
383983|NCT01904149|942672|P4|Multiple-dose Phase|Overall Study||48
383984|NCT01904149|942673|P3|Multiple-dose Phase|Overall Study||149
383985|NCT01904149|942674|P2|Multiple-dose Phase|Overall Study||146
383986|NCT01904149|942675|P1|Multiple-dose Phase|Overall Study||150
383987|NCT01904149|942670|P6|Single-dose Phase|Overall Study||51
383988|NCT01904149|942671|P5|Single-dose Phase|Overall Study||51
383989|NCT01904149|942672|P4|Single-dose Phase|Overall Study||51
383990|NCT01904149|942673|P3|Single-dose Phase|Overall Study||150
383991|NCT01904149|942674|P2|Single-dose Phase|Overall Study||151
383992|NCT01904149|942675|P1|Single-dose Phase|Overall Study||152
383993|NCT01904149|942670|P6|STARTED|Overall Study||51
383994|NCT01904149|942671|P5|STARTED|Overall Study||51
383995|NCT01904149|942672|P4|STARTED|Overall Study||51
383996|NCT01904149|942673|P3|STARTED|Overall Study||150
383997|NCT01904149|942674|P2|STARTED|Overall Study||151
383998|NCT01904149|942675|P1|STARTED|Overall Study||152
383999|NCT01904071|942700|P3|NOT COMPLETED|Overall Study||0
384000|NCT01904071|942701|P2|NOT COMPLETED|Overall Study||0
384001|NCT01904071|942702|P1|NOT COMPLETED|Overall Study||0
384002|NCT01904071|942700|P3|COMPLETED|Overall Study||20
384003|NCT01904071|942701|P2|COMPLETED|Overall Study||20
384004|NCT01904071|942702|P1|COMPLETED|Overall Study||24
384005|NCT01904071|942700|P3|STARTED|Overall Study||20
384006|NCT01904071|942701|P2|STARTED|Overall Study||20
384007|NCT01904071|942702|P1|STARTED|Overall Study||24
384008|NCT01904058|942726|P4|NOT COMPLETED|Overall Study||1
384009|NCT01904058|942727|P3|NOT COMPLETED|Overall Study||1
384010|NCT01904058|942728|P2|NOT COMPLETED|Overall Study||0
384011|NCT01904058|942729|P1|NOT COMPLETED|Overall Study||3
384012|NCT01904058|942726|P4|COMPLETED|Overall Study||12
384013|NCT01904058|942727|P3|COMPLETED|Overall Study||10
384014|NCT01904058|942728|P2|COMPLETED|Overall Study||21
384015|NCT01904058|942729|P1|COMPLETED|Overall Study||18
384016|NCT01904058|942726|P4|STARTED|Overall Study||13
384017|NCT01904058|942727|P3|STARTED|Overall Study||11
384018|NCT01904058|942728|P2|STARTED|Overall Study||21
384019|NCT01904058|942729|P1|STARTED|Overall Study||21
384020|NCT01903993|942769|P2|NOT COMPLETED|Overall Study||95
384021|NCT01903993|942770|P1|NOT COMPLETED|Overall Study||123
384022|NCT01903993|942769|P2|COMPLETED|Overall Study||49
384023|NCT01903993|942770|P1|COMPLETED|Overall Study||20
384024|NCT01903993|942769|P2|Received Treatment|Overall Study||142
384025|NCT01903993|942770|P1|Received Treatment|Overall Study||135
384026|NCT01903993|942769|P2|STARTED|Overall Study||144
384027|NCT01903993|942770|P1|STARTED|Overall Study||143
384028|NCT01903876|942787|P2|NOT COMPLETED|Six-Month Follow-up Period||145
384029|NCT01903876|942788|P1|NOT COMPLETED|Six-Month Follow-up Period||91
384030|NCT01903876|942787|P2|COMPLETED|Six-Month Follow-up Period||123
384031|NCT01903876|942788|P1|COMPLETED|Six-Month Follow-up Period||92
384032|NCT01903876|942787|P2|STARTED|Six-Month Follow-up Period||268
384033|NCT01903876|942788|P1|STARTED|Six-Month Follow-up Period||183
384034|NCT01903876|942787|P2|NOT COMPLETED|Baseline to Post-Intervention Period||108
384035|NCT01903876|942788|P1|NOT COMPLETED|Baseline to Post-Intervention Period||184
384036|NCT01903876|942787|P2|COMPLETED|Baseline to Post-Intervention Period||268
384037|NCT01903876|942788|P1|COMPLETED|Baseline to Post-Intervention Period||183
384038|NCT01903876|942787|P2|STARTED|Baseline to Post-Intervention Period||376
384039|NCT01903876|942788|P1|STARTED|Baseline to Post-Intervention Period||367
384040|NCT01903863|942798|P2|NOT COMPLETED|Overall Study||0
384041|NCT01903863|942799|P1|NOT COMPLETED|Overall Study||2
384042|NCT01903863|942798|P2|COMPLETED|Overall Study||16
384043|NCT01903863|942799|P1|COMPLETED|Overall Study||13
384044|NCT01903863|942798|P2|STARTED|Overall Study||16
384045|NCT01903863|942799|P1|STARTED|Overall Study||15
384046|NCT01903720|942819|P1|NOT COMPLETED|Overall Study||12
384047|NCT01903720|942819|P1|COMPLETED|Overall Study||59
384048|NCT01903720|942819|P1|STARTED|Overall Study||71
384049|NCT01903564|942836|P2|NOT COMPLETED|Overall Study||0
384050|NCT01903564|942837|P1|NOT COMPLETED|Overall Study||0
384051|NCT01903564|942836|P2|COMPLETED|Overall Study||29
384052|NCT01903564|942837|P1|COMPLETED|Overall Study||10
384053|NCT01903564|942836|P2|STARTED|Overall Study||29
384054|NCT01903564|942837|P1|STARTED|Overall Study||10
384055|NCT01903460|942857|P4|NOT COMPLETED|Overall Study||1
384056|NCT01903460|942858|P3|NOT COMPLETED|Overall Study||0
384057|NCT01903460|942859|P2|NOT COMPLETED|Overall Study||0
384058|NCT01903460|942860|P1|NOT COMPLETED|Overall Study||0
384059|NCT01903460|942857|P4|COMPLETED|Overall Study||2
384060|NCT01903460|942858|P3|COMPLETED|Overall Study||3
384061|NCT01903460|942859|P2|COMPLETED|Overall Study||8
384062|NCT01903460|942860|P1|COMPLETED|Overall Study||6
384063|NCT01903460|942857|P4|STARTED|Overall Study||3
384064|NCT01903460|942858|P3|STARTED|Overall Study||3
384065|NCT01903460|942859|P2|STARTED|Overall Study||8
384066|NCT01903460|942860|P1|STARTED|Overall Study||6
384067|NCT01903265|942879|P2|NOT COMPLETED|Overall Study||17
384068|NCT01903265|942880|P1|NOT COMPLETED|Overall Study||14
384069|NCT01903265|942879|P2|COMPLETED|Overall Study||85
384070|NCT01903265|942880|P1|COMPLETED|Overall Study||89
384071|NCT01903265|942879|P2|STARTED|Overall Study||102
384072|NCT01903265|942880|P1|STARTED|Overall Study||103
384073|NCT01903187|942896|P2|NOT COMPLETED|12 Month||0
384074|NCT01903187|942897|P1|NOT COMPLETED|12 Month||0
384075|NCT01903187|942896|P2|COMPLETED|12 Month||0
384076|NCT01903187|942897|P1|COMPLETED|12 Month||2
384077|NCT01903187|942896|P2|STARTED|12 Month||0
384078|NCT01903187|942897|P1|STARTED|12 Month||2
384079|NCT01903187|942896|P2|NOT COMPLETED|6 Month||0
384080|NCT01903187|942897|P1|NOT COMPLETED|6 Month||0
384081|NCT01903187|942896|P2|COMPLETED|6 Month||0
384082|NCT01903187|942897|P1|COMPLETED|6 Month||2
384083|NCT01903187|942896|P2|STARTED|6 Month||0
384084|NCT01903187|942897|P1|STARTED|6 Month||2
384085|NCT01903187|942896|P2|NOT COMPLETED|3 Month||0
384086|NCT01903187|942897|P1|NOT COMPLETED|3 Month||0
384087|NCT01903187|942896|P2|COMPLETED|3 Month||0
384088|NCT01903187|942897|P1|COMPLETED|3 Month||2
384089|NCT01903187|942896|P2|STARTED|3 Month||0
384090|NCT01903187|942897|P1|STARTED|3 Month||2
384091|NCT01903187|942896|P2|NOT COMPLETED|1 Month||0
384092|NCT01903187|942897|P1|NOT COMPLETED|1 Month||0
384093|NCT01903187|942896|P2|COMPLETED|1 Month||2
384094|NCT01903187|942897|P1|COMPLETED|1 Month||2
384095|NCT01903187|942896|P2|STARTED|1 Month||2
384096|NCT01903187|942897|P1|STARTED|1 Month||2
384097|NCT01903187|942896|P2|NOT COMPLETED|Procedure||0
384098|NCT01903187|942897|P1|NOT COMPLETED|Procedure||0
384099|NCT01903187|942896|P2|COMPLETED|Procedure||2
384100|NCT01903187|942897|P1|COMPLETED|Procedure||2
384101|NCT01903187|942896|P2|STARTED|Procedure||2
384102|NCT01903187|942897|P1|STARTED|Procedure||2
384103|NCT01903148|942911|P1|NOT COMPLETED|Overall Study||0
384104|NCT01903148|942911|P1|COMPLETED|Overall Study||441
384105|NCT01903148|942911|P1|STARTED|Overall Study||441
384106|NCT01903031|942930|P3|NOT COMPLETED|Overall Study||5
384107|NCT01903031|942931|P2|NOT COMPLETED|Overall Study||3
384108|NCT01903031|942932|P1|NOT COMPLETED|Overall Study||2
384109|NCT01903031|942930|P3|COMPLETED|Overall Study||24
384110|NCT01903031|942931|P2|COMPLETED|Overall Study||25
384111|NCT01903031|942932|P1|COMPLETED|Overall Study||25
384112|NCT01903031|942930|P3|STARTED|Overall Study||29
384113|NCT01903031|942931|P2|STARTED|Overall Study||28
384114|NCT01903031|942932|P1|STARTED|Overall Study||27
384115|NCT01903005|942974|P1|NOT COMPLETED|Overall Study||373
384204|NCT01901341|943131|P2|STARTED|Overall Study||22
384116|NCT01903005|942974|P1|COMPLETED|Overall Study|Primary study OX219-006 (n=194); Primary study OX219-007 (n=98)|292
384117|NCT01903005|942974|P1|STARTED|Overall Study|Primary study OX219-006 (n=475); Primary study OX219-007 (n=190)|665
384118|NCT01902888|942988|P1|NOT COMPLETED|Overall Study||3
384119|NCT01902888|942988|P1|COMPLETED|Overall Study||0
384120|NCT01902888|942988|P1|STARTED|Overall Study||3
384121|NCT01902758|942995|P2|NOT COMPLETED|Overall Study||0
384122|NCT01902758|942996|P1|NOT COMPLETED|Overall Study||0
384123|NCT01902758|942995|P2|COMPLETED|Overall Study||14
384124|NCT01902758|942996|P1|COMPLETED|Overall Study||14
384125|NCT01902758|942995|P2|STARTED|Overall Study||14
384126|NCT01902758|942996|P1|STARTED|Overall Study||14
384127|NCT01902459|943004|P2|NOT COMPLETED|Overall Study||0
384128|NCT01902459|943005|P1|NOT COMPLETED|Overall Study||0
384129|NCT01902459|943004|P2|COMPLETED|Overall Study||75
384130|NCT01902459|943005|P1|COMPLETED|Overall Study||75
384131|NCT01902459|943004|P2|STARTED|Overall Study||75
384132|NCT01902459|943005|P1|STARTED|Overall Study||75
384133|NCT01902303|943023|P2|NOT COMPLETED|Overall Study||24
384134|NCT01902303|943024|P1|NOT COMPLETED|Overall Study||23
384135|NCT01902303|943023|P2|COMPLETED|Overall Study|19 not treated /did not use medication as they did not develop a cold sore|57
384136|NCT01902303|943024|P1|COMPLETED|Overall Study|21 not treated - did not use placebo medication as they did not develop cold sore|54
384137|NCT01902303|943023|P2|Number of Participants|Overall Study|Number of randomized participants who developed a cold sore and used the assigned treatment.|62
384138|NCT01902303|943024|P1|Number of Participants|Overall Study|Number of randomized participants who developed a cold sore and used the assigned treatment.|56
384139|NCT01902303|943023|P2|STARTED|Overall Study|Allocated to active treatment|81
384140|NCT01902303|943024|P1|STARTED|Overall Study|Allocated to placebo|77
384141|NCT01902134|943038|P6|NOT COMPLETED|Overall Study||9
384142|NCT01902134|943039|P5|NOT COMPLETED|Overall Study||7
384143|NCT01902134|943040|P4|NOT COMPLETED|Overall Study||2
384144|NCT01902134|943041|P3|NOT COMPLETED|Overall Study||15
384145|NCT01902134|943042|P2|NOT COMPLETED|Overall Study||11
384146|NCT01902134|943043|P1|NOT COMPLETED|Overall Study||8
384147|NCT01902134|943038|P6|COMPLETED|Overall Study||45
384148|NCT01902134|943039|P5|COMPLETED|Overall Study||46
384149|NCT01902134|943040|P4|COMPLETED|Overall Study||52
384150|NCT01902134|943041|P3|COMPLETED|Overall Study||145
384151|NCT01902134|943042|P2|COMPLETED|Overall Study||150
384152|NCT01902134|943043|P1|COMPLETED|Overall Study||151
384153|NCT01902134|943038|P6|Multiple-dose Phase|Overall Study||52
384154|NCT01902134|943039|P5|Multiple-dose Phase|Overall Study||53
384155|NCT01902134|943040|P4|Multiple-dose Phase|Overall Study||54
384156|NCT01902134|943041|P3|Multiple-dose Phase|Overall Study||160
384157|NCT01902134|943042|P2|Multiple-dose Phase|Overall Study||160
384158|NCT01902134|943043|P1|Multiple-dose Phase|Overall Study||159
384159|NCT01902134|943038|P6|Single-dose Phase|Overall Study||54
384160|NCT01902134|943039|P5|Single-dose Phase|Overall Study||53
384161|NCT01902134|943040|P4|Single-dose Phase|Overall Study||54
384162|NCT01902134|943041|P3|Single-dose Phase|Overall Study||160
384163|NCT01902134|943042|P2|Single-dose Phase|Overall Study||161
384164|NCT01902134|943043|P1|Single-dose Phase|Overall Study||159
384165|NCT01902134|943038|P6|STARTED|Overall Study||54
384166|NCT01902134|943039|P5|STARTED|Overall Study||53
384167|NCT01902134|943040|P4|STARTED|Overall Study||54
384168|NCT01902134|943041|P3|STARTED|Overall Study||160
384169|NCT01902134|943042|P2|STARTED|Overall Study||161
384170|NCT01902134|943043|P1|STARTED|Overall Study||159
384171|NCT01901809|943069|P4|NOT COMPLETED|Overall Study||2
384172|NCT01901809|943070|P3|NOT COMPLETED|Overall Study||3
384173|NCT01901809|943071|P2|NOT COMPLETED|Overall Study||0
384174|NCT01901809|943072|P1|NOT COMPLETED|Overall Study||0
384175|NCT01901809|943069|P4|COMPLETED|Overall Study||22
384176|NCT01901809|943070|P3|COMPLETED|Overall Study||21
384177|NCT01901809|943071|P2|COMPLETED|Overall Study||23
384178|NCT01901809|943072|P1|COMPLETED|Overall Study||19
384179|NCT01901809|943069|P4|STARTED|Overall Study||24
384180|NCT01901809|943070|P3|STARTED|Overall Study||24
384181|NCT01901809|943071|P2|STARTED|Overall Study||23
384182|NCT01901809|943072|P1|STARTED|Overall Study||19
384183|NCT01901588|943088|P2|NOT COMPLETED|Overall Study||0
384184|NCT01901588|943089|P1|NOT COMPLETED|Overall Study||0
384185|NCT01901588|943088|P2|COMPLETED|Overall Study||31
384186|NCT01901588|943089|P1|COMPLETED|Overall Study||32
384187|NCT01901588|943088|P2|STARTED|Overall Study||31
384188|NCT01901588|943089|P1|STARTED|Overall Study||32
384189|NCT01901575|943105|P1|NOT COMPLETED|Overall Study||0
384190|NCT01901575|943105|P1|COMPLETED|Overall Study||16
384191|NCT01901575|943105|P1|STARTED|Overall Study|enrolled patients with PVC's present prior to sedation with remifentanil IVPCA|16
384192|NCT01901393|943112|P2|NOT COMPLETED|Overall Study||0
384193|NCT01901393|943113|P1|NOT COMPLETED|Overall Study||1
384194|NCT01901393|943112|P2|COMPLETED|Overall Study||49
384195|NCT01901393|943113|P1|COMPLETED|Overall Study||50
384196|NCT01901393|943112|P2|STARTED|Overall Study||49
384197|NCT01901393|943113|P1|STARTED|Overall Study||51
384198|NCT01901341|943131|P2|NOT COMPLETED|Overall Study||21
384199|NCT01901341|943132|P1|NOT COMPLETED|Overall Study||20
384200|NCT01901341|943131|P2|COMPLETED|Overall Study||1
384201|NCT01901341|943132|P1|COMPLETED|Overall Study||2
384202|NCT01901341|943131|P2|Received at Least 1 Dose of Study Drug|Overall Study||22
384203|NCT01901341|943132|P1|Received at Least 1 Dose of Study Drug|Overall Study||22
384205|NCT01901341|943132|P1|STARTED|Overall Study||22
384206|NCT01901328|943146|P2|NOT COMPLETED|Overall Study||21
384207|NCT01901328|943147|P1|NOT COMPLETED|Overall Study||22
384208|NCT01901328|943146|P2|COMPLETED|Overall Study||2
384209|NCT01901328|943147|P1|COMPLETED|Overall Study||4
384210|NCT01901328|943146|P2|Received at Least 1 Dose of Study Drug|Overall Study||23
384211|NCT01901328|943147|P1|Received at Least 1 Dose of Study Drug|Overall Study||26
384212|NCT01901328|943146|P2|STARTED|Overall Study||23
384213|NCT01901328|943147|P1|STARTED|Overall Study||26
384214|NCT01901302|943161|P2|NOT COMPLETED|Overall Study||23
384215|NCT01901302|943162|P1|NOT COMPLETED|Overall Study||27
384216|NCT01901302|943161|P2|COMPLETED|Overall Study||7
384217|NCT01901302|943162|P1|COMPLETED|Overall Study||4
384218|NCT01901302|943161|P2|Received at Least 1 Dose of Study Drug|Overall Study||30
384219|NCT01901302|943162|P1|Received at Least 1 Dose of Study Drug|Overall Study||31
384220|NCT01901302|943161|P2|STARTED|Overall Study||30
384221|NCT01901302|943162|P1|STARTED|Overall Study||31
384222|NCT01901250|943176|P2|NOT COMPLETED|Overall Study||126
384223|NCT01901250|943177|P1|NOT COMPLETED|Overall Study||138
384224|NCT01901250|943176|P2|COMPLETED|Overall Study||139
384225|NCT01901250|943177|P1|COMPLETED|Overall Study||122
384226|NCT01901250|943176|P2|End of 1st Grade|Overall Study||151
384227|NCT01901250|943177|P1|End of 1st Grade|Overall Study||143
384228|NCT01901250|943176|P2|Start of 1st Grade|Overall Study||176
384229|NCT01901250|943177|P1|Start of 1st Grade|Overall Study||173
384230|NCT01901250|943176|P2|End of Kidergarten|Overall Study||212
384231|NCT01901250|943177|P1|End of Kidergarten|Overall Study||215
384232|NCT01901250|943176|P2|STARTED|Overall Study||265
384233|NCT01901250|943177|P1|STARTED|Overall Study||260
384234|NCT01901211|943185|P2|NOT COMPLETED|Second Ten-week Period||0
384235|NCT01901211|943186|P1|NOT COMPLETED|Second Ten-week Period||0
384236|NCT01901211|943185|P2|COMPLETED|Second Ten-week Period||5
384237|NCT01901211|943186|P1|COMPLETED|Second Ten-week Period||6
384238|NCT01901211|943185|P2|STARTED|Second Ten-week Period||5
384239|NCT01901211|943186|P1|STARTED|Second Ten-week Period||6
384240|NCT01901211|943185|P2|NOT COMPLETED|Washout (6 Weeks)||0
384241|NCT01901211|943186|P1|NOT COMPLETED|Washout (6 Weeks)||0
384242|NCT01901211|943185|P2|COMPLETED|Washout (6 Weeks)||5
384243|NCT01901211|943186|P1|COMPLETED|Washout (6 Weeks)||6
384244|NCT01901211|943185|P2|STARTED|Washout (6 Weeks)||5
384245|NCT01901211|943186|P1|STARTED|Washout (6 Weeks)||6
384246|NCT01901211|943185|P2|NOT COMPLETED|First Ten-week Period||0
384247|NCT01901211|943186|P1|NOT COMPLETED|First Ten-week Period||0
384248|NCT01901211|943185|P2|COMPLETED|First Ten-week Period||5
384249|NCT01901211|943186|P1|COMPLETED|First Ten-week Period||6
384250|NCT01901211|943185|P2|STARTED|First Ten-week Period||5
384251|NCT01901211|943186|P1|STARTED|First Ten-week Period||6
384252|NCT01901185|943209|P1|NOT COMPLETED|Overall Study||2
384253|NCT01901185|943209|P1|COMPLETED|Overall Study||75
384254|NCT01901185|943209|P1|Received Etanercept With Autoinjector A|Overall Study||75
384255|NCT01901185|943209|P1|STARTED|Overall Study||77
384256|NCT01900665|943218|P2|NOT COMPLETED|Open Label Period||859
384257|NCT01900665|943219|P1|NOT COMPLETED|Open Label Period||881
384258|NCT01900665|943218|P2|COMPLETED|Open Label Period||0
384259|NCT01900665|943219|P1|COMPLETED|Open Label Period||0
384260|NCT01900665|943218|P2|STARTED|Open Label Period|Patients from Placebo Controlled Period were not required to enter into Open Label Period.|859
384261|NCT01900665|943219|P1|STARTED|Open Label Period|Patients from Placebo Controlled Period were not required to enter into Open Label Period.|881
384262|NCT01900665|943218|P2|NOT COMPLETED|Placebo Controlled Period||164
384263|NCT01900665|943219|P1|NOT COMPLETED|Placebo Controlled Period||143
384264|NCT01900665|943218|P2|COMPLETED|Placebo Controlled Period||908
384265|NCT01900665|943219|P1|COMPLETED|Placebo Controlled Period||914
384266|NCT01900665|943218|P2|Received at Least 1 Dose of Study Drug|Placebo Controlled Period||1067
384267|NCT01900665|943219|P1|Received at Least 1 Dose of Study Drug|Placebo Controlled Period||1054
384268|NCT01900665|943218|P2|STARTED|Placebo Controlled Period||1072
384269|NCT01900665|943219|P1|STARTED|Placebo Controlled Period||1057
384270|NCT01900652|943262|P2|NOT COMPLETED|Overall Study||3
384271|NCT01900652|943263|P1|NOT COMPLETED|Overall Study||8
384272|NCT01900652|943262|P2|COMPLETED|Overall Study||25
384273|NCT01900652|943263|P1|COMPLETED|Overall Study||75
384274|NCT01900652|943262|P2|Post-Erlotinib Progression Tumor Sample|Overall Study||23
384275|NCT01900652|943263|P1|Post-Erlotinib Progression Tumor Sample|Overall Study||66
384276|NCT01900652|943262|P2|STARTED|Overall Study||28
384277|NCT01900652|943263|P1|STARTED|Overall Study||83
384278|NCT01900444|943297|P1|NOT COMPLETED|Overall Study||3
384279|NCT01900444|943297|P1|COMPLETED|Overall Study||116
384280|NCT01900444|943297|P1|STARTED|Overall Study||119
384281|NCT01900431|943310|P3|NOT COMPLETED|Open-Label Treatment Period (Part C)||8
384282|NCT01900431|943311|P2|NOT COMPLETED|Open-Label Treatment Period (Part C)||0
384283|NCT01900431|943312|P1|NOT COMPLETED|Open-Label Treatment Period (Part C)||0
384284|NCT01900431|943310|P3|COMPLETED|Open-Label Treatment Period (Part C)||13
384285|NCT01900431|943311|P2|COMPLETED|Open-Label Treatment Period (Part C)||0
384286|NCT01900431|943312|P1|COMPLETED|Open-Label Treatment Period (Part C)||0
384287|NCT01900431|943310|P3|STARTED|Open-Label Treatment Period (Part C)|10 non-responders (5 Placebo, 5 Sarilumab) & 11 non-completers (6 Placebo, 5 Sarilumab) from Part A.|21
384288|NCT01900431|943311|P2|STARTED|Open-Label Treatment Period (Part C)||0
384289|NCT01900431|943312|P1|STARTED|Open-Label Treatment Period (Part C)||0
384290|NCT01900431|943310|P3|NOT COMPLETED|Extended Treatment Period (Part B)||0
384291|NCT01900431|943311|P2|NOT COMPLETED|Extended Treatment Period (Part B)||10
384292|NCT01900431|943312|P1|NOT COMPLETED|Extended Treatment Period (Part B)||1
384293|NCT01900431|943310|P3|COMPLETED|Extended Treatment Period (Part B)||0
384294|NCT01900431|943311|P2|COMPLETED|Extended Treatment Period (Part B)||12
384295|NCT01900431|943312|P1|COMPLETED|Extended Treatment Period (Part B)||7
384296|NCT01900431|943310|P3|STARTED|Extended Treatment Period (Part B)||0
384297|NCT01900431|943311|P2|STARTED|Extended Treatment Period (Part B)||22
384298|NCT01900431|943312|P1|STARTED|Extended Treatment Period (Part B)||8
384299|NCT01900431|943310|P3|NOT COMPLETED|Principal Treatment Period (Part A)||0
384300|NCT01900431|943311|P2|NOT COMPLETED|Principal Treatment Period (Part A)||10
384301|NCT01900431|943312|P1|NOT COMPLETED|Principal Treatment Period (Part A)||7
384302|NCT01900431|943310|P3|COMPLETED|Principal Treatment Period (Part A)||0
384303|NCT01900431|943311|P2|COMPLETED|Principal Treatment Period (Part A)|22 responders entered Part B, 5 non-responders entered Part C, 1 discontinued the study.|28
384304|NCT01900431|943312|P1|COMPLETED|Principal Treatment Period (Part A)|8 responders entered Part B and 5 non-responders entered Part C.|13
384305|NCT01900431|943310|P3|STARTED|Principal Treatment Period (Part A)||0
384306|NCT01900431|943311|P2|STARTED|Principal Treatment Period (Part A)||38
384307|NCT01900431|943312|P1|STARTED|Principal Treatment Period (Part A)||20
384308|NCT01900314|943338|P2|NOT COMPLETED|Overall Study||4
384309|NCT01900314|943339|P1|NOT COMPLETED|Overall Study||4
384310|NCT01900314|943338|P2|COMPLETED|Overall Study|1 patient had 4 TMS Tx, but missed too many for protocol requirements,|16
384311|NCT01900314|943339|P1|COMPLETED|Overall Study|1 patient had MRI, then moved away after 5 TMS treatments|16
384312|NCT01900314|943338|P2|Completed MRI#1|Overall Study|2 withdrew consent, 1 patient was unable to tolerate MRI|17
384313|NCT01900314|943339|P1|Completed MRI#1|Overall Study|2 withdrew consent prior to MRI, 1 had MRI technical failure|17
384314|NCT01900314|943338|P2|STARTED|Overall Study||20
384315|NCT01900314|943339|P1|STARTED|Overall Study||20
384316|NCT01900249|943350|P3|NOT COMPLETED|Overall Study||4
384317|NCT01900249|943351|P2|NOT COMPLETED|Overall Study||5
384318|NCT01900249|943352|P1|NOT COMPLETED|Overall Study||3
384319|NCT01900249|943350|P3|COMPLETED|Overall Study||65
384320|NCT01900249|943351|P2|COMPLETED|Overall Study||63
384321|NCT01900249|943352|P1|COMPLETED|Overall Study||64
384322|NCT01900249|943350|P3|STARTED|Overall Study||69
384323|NCT01900249|943351|P2|STARTED|Overall Study||68
384324|NCT01900249|943352|P1|STARTED|Overall Study||67
384325|NCT01900067|943362|P2|NOT COMPLETED|Overall Study||13
384326|NCT01900067|943363|P1|NOT COMPLETED|Overall Study||12
384327|NCT01900067|943362|P2|COMPLETED|Overall Study||124
384328|NCT01900067|943363|P1|COMPLETED|Overall Study||122
384329|NCT01900067|943362|P2|STARTED|Overall Study||137
384330|NCT01900067|943363|P1|STARTED|Overall Study||134
384331|NCT01900054|943369|P1|NOT COMPLETED|Overall Study||2
384332|NCT01900054|943369|P1|COMPLETED|Overall Study||56
384333|NCT01900054|943369|P1|STARTED|Overall Study||58
384334|NCT01899911|943374|P1|NOT COMPLETED|Overall Study||0
384335|NCT01899911|943374|P1|COMPLETED|Overall Study||12
384336|NCT01899911|943374|P1|STARTED|Overall Study||12
384337|NCT01899768|943378|P1|NOT COMPLETED|Part C||0
384338|NCT01899768|943378|P1|COMPLETED|Part C||11
384339|NCT01899768|943378|P1|STARTED|Part C||11
384340|NCT01899768|943378|P1|NOT COMPLETED|Part B||2
384341|NCT01899768|943378|P1|COMPLETED|Part B||11
384342|NCT01899768|943378|P1|STARTED|Part B||13
384343|NCT01899768|943378|P1|NOT COMPLETED|Part A||3
384344|NCT01899768|943378|P1|COMPLETED|Part A||13
384345|NCT01899768|943378|P1|STARTED|Part A||16
384346|NCT01899742|943452|P2|NOT COMPLETED|Overall Study||16
384347|NCT01899742|943453|P1|NOT COMPLETED|Overall Study||17
384348|NCT01899742|943452|P2|COMPLETED|Overall Study||231
384349|NCT01899742|943453|P1|COMPLETED|Overall Study||230
384350|NCT01899742|943452|P2|STARTED|Overall Study||247
384351|NCT01899742|943453|P1|STARTED|Overall Study||247
384352|NCT01899677|943463|P2|NOT COMPLETED|Overall Study||7
384353|NCT01899677|943464|P1|NOT COMPLETED|Overall Study||10
384354|NCT01899677|943463|P2|COMPLETED|Overall Study||28
384355|NCT01899677|943464|P1|COMPLETED|Overall Study||25
384356|NCT01899677|943463|P2|STARTED|Overall Study||35
384357|NCT01899677|943464|P1|STARTED|Overall Study||35
384358|NCT01899144|943492|P1|NOT COMPLETED|Treatment Period 5||1
384359|NCT01899144|943492|P1|COMPLETED|Treatment Period 5|Last treatment taken by the patient who discontinued was ABS Spiromax 180 mcg.|57
384360|NCT01899144|943492|P1|STARTED|Treatment Period 5||58
384361|NCT01899144|943492|P1|NOT COMPLETED|Treatment Period 4||0
384362|NCT01899144|943492|P1|COMPLETED|Treatment Period 4||58
384363|NCT01899144|943492|P1|STARTED|Treatment Period 4||58
384364|NCT01899144|943492|P1|NOT COMPLETED|Treatment Period 3||2
384365|NCT01899144|943492|P1|COMPLETED|Treatment Period 3|Last treatment taken by patients who discontinued were ABS Spiromax 180 mcg and ABS Spiromax 90 mcg.|58
384366|NCT01899144|943492|P1|STARTED|Treatment Period 3||60
384367|NCT01899144|943492|P1|NOT COMPLETED|Treatment Period 2||1
384368|NCT01899144|943492|P1|COMPLETED|Treatment Period 2|Last treatment taken by the patient who discontinued was placebo.|60
384369|NCT01899144|943492|P1|STARTED|Treatment Period 2||61
384370|NCT01899144|943492|P1|NOT COMPLETED|Treatment Period 1||0
384371|NCT01899144|943492|P1|COMPLETED|Treatment Period 1||61
384372|NCT01899144|943492|P1|STARTED|Treatment Period 1||61
384373|NCT01898884|943519|P9|NOT COMPLETED|Multiple Dose Period||1
384374|NCT01898884|943520|P8|NOT COMPLETED|Multiple Dose Period||0
384375|NCT01898884|943521|P7|NOT COMPLETED|Multiple Dose Period||1
384376|NCT01898884|943522|P6|NOT COMPLETED|Multiple Dose Period||0
384377|NCT01898884|943523|P5|NOT COMPLETED|Multiple Dose Period||0
384378|NCT01898884|943524|P4|NOT COMPLETED|Multiple Dose Period||0
384379|NCT01898884|943525|P3|NOT COMPLETED|Multiple Dose Period||0
384380|NCT01898884|943526|P2|NOT COMPLETED|Multiple Dose Period||0
384381|NCT01898884|943527|P1|NOT COMPLETED|Multiple Dose Period||0
384382|NCT01898884|943519|P9|COMPLETED|Multiple Dose Period||5
384383|NCT01898884|943520|P8|COMPLETED|Multiple Dose Period||6
384384|NCT01898884|943521|P7|COMPLETED|Multiple Dose Period||5
384385|NCT01898884|943522|P6|COMPLETED|Multiple Dose Period||6
384386|NCT01898884|943523|P5|COMPLETED|Multiple Dose Period||0
384387|NCT01898884|943524|P4|COMPLETED|Multiple Dose Period||0
384388|NCT01898884|943525|P3|COMPLETED|Multiple Dose Period||0
384389|NCT01898884|943526|P2|COMPLETED|Multiple Dose Period||0
384390|NCT01898884|943527|P1|COMPLETED|Multiple Dose Period||0
384391|NCT01898884|943519|P9|Treated|Multiple Dose Period||5
384392|NCT01898884|943520|P8|Treated|Multiple Dose Period||6
384393|NCT01898884|943521|P7|Treated|Multiple Dose Period||6
384394|NCT01898884|943522|P6|Treated|Multiple Dose Period||6
384395|NCT01898884|943523|P5|Treated|Multiple Dose Period||0
384396|NCT01898884|943524|P4|Treated|Multiple Dose Period||0
384397|NCT01898884|943525|P3|Treated|Multiple Dose Period||0
384398|NCT01898884|943526|P2|Treated|Multiple Dose Period||0
384399|NCT01898884|943527|P1|Treated|Multiple Dose Period||0
384400|NCT01898884|943519|P9|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
384401|NCT01898884|943520|P8|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
384402|NCT01898884|943521|P7|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
384403|NCT01898884|943522|P6|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
384404|NCT01898884|943523|P5|STARTED|Multiple Dose Period||0
384405|NCT01898884|943524|P4|STARTED|Multiple Dose Period||0
384406|NCT01898884|943525|P3|STARTED|Multiple Dose Period||0
384407|NCT01898884|943526|P2|STARTED|Multiple Dose Period||0
384408|NCT01898884|943527|P1|STARTED|Multiple Dose Period||0
384409|NCT01898884|943519|P9|NOT COMPLETED|Single Dose Period||0
384410|NCT01898884|943520|P8|NOT COMPLETED|Single Dose Period||0
384411|NCT01898884|943521|P7|NOT COMPLETED|Single Dose Period||0
384412|NCT01898884|943522|P6|NOT COMPLETED|Single Dose Period||0
384413|NCT01898884|943523|P5|NOT COMPLETED|Single Dose Period||0
384414|NCT01898884|943524|P4|NOT COMPLETED|Single Dose Period||0
384415|NCT01898884|943525|P3|NOT COMPLETED|Single Dose Period||0
384416|NCT01898884|943526|P2|NOT COMPLETED|Single Dose Period||0
384417|NCT01898884|943527|P1|NOT COMPLETED|Single Dose Period||0
384418|NCT01898884|943519|P9|COMPLETED|Single Dose Period||0
384419|NCT01898884|943520|P8|COMPLETED|Single Dose Period||0
384420|NCT01898884|943521|P7|COMPLETED|Single Dose Period||0
384421|NCT01898884|943522|P6|COMPLETED|Single Dose Period||0
384422|NCT01898884|943523|P5|COMPLETED|Single Dose Period||6
384423|NCT01898884|943524|P4|COMPLETED|Single Dose Period||6
384424|NCT01898884|943525|P3|COMPLETED|Single Dose Period||6
384425|NCT01898884|943526|P2|COMPLETED|Single Dose Period||6
384426|NCT01898884|943527|P1|COMPLETED|Single Dose Period||8
384427|NCT01898884|943519|P9|STARTED|Single Dose Period||0
384428|NCT01898884|943520|P8|STARTED|Single Dose Period||0
384429|NCT01898884|943521|P7|STARTED|Single Dose Period||0
384430|NCT01898884|943522|P6|STARTED|Single Dose Period||0
384431|NCT01898884|943523|P5|STARTED|Single Dose Period||6
384432|NCT01898884|943524|P4|STARTED|Single Dose Period||6
384433|NCT01898884|943525|P3|STARTED|Single Dose Period||6
384434|NCT01898884|943526|P2|STARTED|Single Dose Period||6
384435|NCT01898884|943527|P1|STARTED|Single Dose Period||8
384436|NCT01898598|943679|P2|NOT COMPLETED|Overall Study||2
384437|NCT01898598|943680|P1|NOT COMPLETED|Overall Study||4
384438|NCT01898598|943679|P2|COMPLETED|Overall Study||4
384439|NCT01898598|943680|P1|COMPLETED|Overall Study||8
384440|NCT01898598|943679|P2|Treated|Overall Study||5
384441|NCT01898598|943680|P1|Treated|Overall Study||11
384442|NCT01898598|943679|P2|STARTED|Overall Study||6
384443|NCT01898598|943680|P1|STARTED|Overall Study||12
384444|NCT01898442|943699|P3|NOT COMPLETED|Overall Study||3
384445|NCT01898442|943700|P2|NOT COMPLETED|Overall Study||2
384446|NCT01898442|943701|P1|NOT COMPLETED|Overall Study||1
384447|NCT01898442|943699|P3|COMPLETED|Overall Study||15
384448|NCT01898442|943700|P2|COMPLETED|Overall Study||15
384449|NCT01898442|943701|P1|COMPLETED|Overall Study||16
384450|NCT01898442|943699|P3|STARTED|Overall Study||18
384451|NCT01898442|943700|P2|STARTED|Overall Study||17
384452|NCT01898442|943701|P1|STARTED|Overall Study||17
384453|NCT01898403|943724|P1|NOT COMPLETED|Overall Study||0
384454|NCT01898403|943724|P1|COMPLETED|Overall Study||50
384455|NCT01898403|943724|P1|STARTED|Overall Study||50
384456|NCT01898286|943730|P1|NOT COMPLETED|Overall Study||3
384457|NCT01898286|943730|P1|COMPLETED|Overall Study|"For this study completed is defined as completing the Early Termination visit"|35
384458|NCT01898286|943730|P1|STARTED|Overall Study||38
384459|NCT01898208|943740|P3|NOT COMPLETED|Overall Study||37
384460|NCT01898208|943741|P2|NOT COMPLETED|Overall Study||49
384461|NCT01898208|943742|P1|NOT COMPLETED|Overall Study||40
384462|NCT01898208|943740|P3|COMPLETED|Overall Study||212
384463|NCT01898208|943741|P2|COMPLETED|Overall Study||198
384464|NCT01898208|943742|P1|COMPLETED|Overall Study||207
384465|NCT01898208|943740|P3|STARTED|Overall Study||249
384466|NCT01898208|943741|P2|STARTED|Overall Study||247
384467|NCT01898208|943742|P1|STARTED|Overall Study||247
384468|NCT01898195|943789|P3|NOT COMPLETED|Smoking Abstinence||36
384469|NCT01898195|943790|P2|NOT COMPLETED|Smoking Abstinence||38
384470|NCT01898195|943791|P1|NOT COMPLETED|Smoking Abstinence||35
384471|NCT01898195|943789|P3|COMPLETED|Smoking Abstinence||15
384472|NCT01898195|943790|P2|COMPLETED|Smoking Abstinence||16
384473|NCT01898195|943791|P1|COMPLETED|Smoking Abstinence||18
384474|NCT01898195|943789|P3|STARTED|Smoking Abstinence||51
384475|NCT01898195|943790|P2|STARTED|Smoking Abstinence||54
384476|NCT01898195|943791|P1|STARTED|Smoking Abstinence||53
384477|NCT01898195|943789|P3|NOT COMPLETED|Varenicline Adherence||36
384478|NCT01898195|943790|P2|NOT COMPLETED|Varenicline Adherence||38
384479|NCT01898195|943791|P1|NOT COMPLETED|Varenicline Adherence||35
384480|NCT01898195|943789|P3|COMPLETED|Varenicline Adherence||15
384481|NCT01898195|943790|P2|COMPLETED|Varenicline Adherence||16
384482|NCT01898195|943791|P1|COMPLETED|Varenicline Adherence||18
384483|NCT01898195|943789|P3|STARTED|Varenicline Adherence||51
384484|NCT01898195|943790|P2|STARTED|Varenicline Adherence||54
384485|NCT01898195|943791|P1|STARTED|Varenicline Adherence||53
384486|NCT01898091|943804|P2|NOT COMPLETED|Overall Study||6
384487|NCT01898091|943805|P1|NOT COMPLETED|Overall Study||2
384488|NCT01898091|943804|P2|COMPLETED|Overall Study||19
384489|NCT01898091|943805|P1|COMPLETED|Overall Study||23
384490|NCT01898091|943804|P2|STARTED|Overall Study|Allocated to intervention. All allocated received intervention.|25
384491|NCT01898091|943805|P1|STARTED|Overall Study|Allocated to intervention. All allocated received intervention.|25
384492|NCT01897792|943813|P2|NOT COMPLETED|Overall Study||0
384493|NCT01897792|943814|P1|NOT COMPLETED|Overall Study||0
384494|NCT01897792|943813|P2|COMPLETED|Overall Study||5
384495|NCT01897792|943814|P1|COMPLETED|Overall Study||6
384496|NCT01897792|943813|P2|STARTED|Overall Study||5
384497|NCT01897792|943814|P1|STARTED|Overall Study||6
384498|NCT01897727|943840|P2|NOT COMPLETED|Overall Study||1
384499|NCT01897727|943841|P1|NOT COMPLETED|Overall Study||0
384500|NCT01897727|943840|P2|COMPLETED|Overall Study||8
384501|NCT01897727|943841|P1|COMPLETED|Overall Study||8
384502|NCT01897727|943840|P2|STARTED|Overall Study||9
384503|NCT01897727|943841|P1|STARTED|Overall Study||8
384504|NCT01897402|943849|P2|NOT COMPLETED|Overall Study||16
384505|NCT01897402|943850|P1|NOT COMPLETED|Overall Study||19
384506|NCT01897402|943849|P2|COMPLETED|Overall Study||244
384507|NCT01897402|943850|P1|COMPLETED|Overall Study||246
384508|NCT01897402|943849|P2|STARTED|Overall Study||260
384509|NCT01897402|943850|P1|STARTED|Overall Study||265
384510|NCT01897285|943862|P1|NOT COMPLETED|Overall Study||0
384511|NCT01897285|943862|P1|COMPLETED|Overall Study||20
384512|NCT01897285|943862|P1|STARTED|Overall Study|All 20 participants received original AND test adhesive dressings on upper arms and lower back.|20
384513|NCT01897233|943870|P1|NOT COMPLETED|Part B (24 Weeks)||4
384514|NCT01897233|943870|P1|COMPLETED|Part B (24 Weeks)||54
384515|NCT01897233|943870|P1|STARTED|Part B (24 Weeks)|6 participants from Part A also participated in Part B of the study.|58
384516|NCT01897233|943870|P1|NOT COMPLETED|Part A (14 Days)||0
384517|NCT01897233|943870|P1|COMPLETED|Part A (14 Days)||10
384518|NCT01897233|943870|P1|Part A Cohort 2 (9 to 11 Years)|Part A (14 Days)||5
384519|NCT01897233|943870|P1|Part A Cohort 1 (6 to 8 Years)|Part A (14 Days)||5
384520|NCT01897233|943870|P1|STARTED|Part A (14 Days)||10
384521|NCT01897025|943894|P2|NOT COMPLETED|Overall Study||0
384522|NCT01897025|943895|P1|NOT COMPLETED|Overall Study||0
384523|NCT01897025|943894|P2|COMPLETED|Overall Study||9
384524|NCT01897025|943895|P1|COMPLETED|Overall Study||10
384525|NCT01897025|943894|P2|STARTED|Overall Study||9
384526|NCT01897025|943895|P1|STARTED|Overall Study||10
384527|NCT01896986|943903|P2|NOT COMPLETED|Overall Study||23
384528|NCT01896986|943904|P1|NOT COMPLETED|Overall Study||14
384529|NCT01896986|943903|P2|COMPLETED|Overall Study||0
384530|NCT01896986|943904|P1|COMPLETED|Overall Study||0
384531|NCT01896986|943903|P2|STARTED|Overall Study||23
384532|NCT01896986|943904|P1|STARTED|Overall Study||14
384533|NCT01896934|943910|P1|NOT COMPLETED|Overall Study||2
384534|NCT01896934|943910|P1|COMPLETED|Overall Study||19
384535|NCT01896934|943910|P1|STARTED|Overall Study||21
384536|NCT01896895|943919|P4|NOT COMPLETED|OLEX Period||0
384537|NCT01896895|943920|P3|NOT COMPLETED|OLEX Period||0
384538|NCT01896895|943921|P2|NOT COMPLETED|OLEX Period||0
384539|NCT01896895|943922|P1|NOT COMPLETED|OLEX Period||0
384540|NCT01896895|943919|P4|COMPLETED|OLEX Period||39
384541|NCT01896895|943920|P3|COMPLETED|OLEX Period||0
384542|NCT01896895|943921|P2|COMPLETED|OLEX Period||0
384543|NCT01896895|943922|P1|COMPLETED|OLEX Period||0
384544|NCT01896895|943919|P4|STARTED|OLEX Period|Not all participants who completed double-blind MP fulfilled the inclusion criteria for OLEX period.|39
384545|NCT01896895|943920|P3|STARTED|OLEX Period||0
384546|NCT01896895|943921|P2|STARTED|OLEX Period||0
384547|NCT01896895|943922|P1|STARTED|OLEX Period||0
384548|NCT01896895|943919|P4|NOT COMPLETED|Double-blind MP||0
384549|NCT01896895|943920|P3|NOT COMPLETED|Double-blind MP||3
384550|NCT01896895|943921|P2|NOT COMPLETED|Double-blind MP||2
384551|NCT01896895|943922|P1|NOT COMPLETED|Double-blind MP||1
384552|NCT01896895|943919|P4|COMPLETED|Double-blind MP||0
384553|NCT01896895|943920|P3|COMPLETED|Double-blind MP||16
384554|NCT01896895|943921|P2|COMPLETED|Double-blind MP||20
384555|NCT01896895|943922|P1|COMPLETED|Double-blind MP||19
384556|NCT01896895|943919|P4|STARTED|Double-blind MP||0
384557|NCT01896895|943920|P3|STARTED|Double-blind MP||19
384558|NCT01896895|943921|P2|STARTED|Double-blind MP||22
384559|NCT01896895|943922|P1|STARTED|Double-blind MP||20
384560|NCT01896726|943937|P1|NOT COMPLETED|Treatment Period 2 (Days 23-31)||2
384561|NCT01896726|943937|P1|COMPLETED|Treatment Period 2 (Days 23-31)||18
384562|NCT01896726|943937|P1|Received Microgynon|Treatment Period 2 (Days 23-31)||18
384563|NCT01896726|943937|P1|Received at Least 1 Dose of Baricitinib|Treatment Period 2 (Days 23-31)||20
384564|NCT01896726|943937|P1|STARTED|Treatment Period 2 (Days 23-31)||20
384565|NCT01896726|943937|P1|NOT COMPLETED|Treatment Period 1 (Days 1-22)||0
384566|NCT01896726|943937|P1|COMPLETED|Treatment Period 1 (Days 1-22)||20
384567|NCT01896726|943937|P1|Received Microgynon|Treatment Period 1 (Days 1-22)||20
384568|NCT01896726|943937|P1|STARTED|Treatment Period 1 (Days 1-22)||20
384569|NCT01896700|943952|P2|NOT COMPLETED|Overall Study||6
384570|NCT01896700|943953|P1|NOT COMPLETED|Overall Study||4
384571|NCT01896700|943952|P2|COMPLETED|Overall Study||6
384572|NCT01896700|943953|P1|COMPLETED|Overall Study||8
384573|NCT01896700|943952|P2|STARTED|Overall Study||12
384574|NCT01896700|943953|P1|STARTED|Overall Study||12
384575|NCT01896687|943975|P2|NOT COMPLETED|Overall Study||0
384576|NCT01896687|943976|P1|NOT COMPLETED|Overall Study||0
384577|NCT01896687|943975|P2|COMPLETED|Overall Study||15
384578|NCT01896687|943976|P1|COMPLETED|Overall Study||15
384579|NCT01896687|943975|P2|STARTED|Overall Study||15
384580|NCT01896687|943976|P1|STARTED|Overall Study||15
384581|NCT01896557|943984|P2|NOT COMPLETED|Clopidogrel + GI Protector||4
384582|NCT01896557|943985|P1|NOT COMPLETED|Clopidogrel + GI Protector||2
384583|NCT01896557|943984|P2|COMPLETED|Clopidogrel + GI Protector||44
384584|NCT01896557|943985|P1|COMPLETED|Clopidogrel + GI Protector||41
384585|NCT01896557|943984|P2|STARTED|Clopidogrel + GI Protector||48
384586|NCT01896557|943985|P1|STARTED|Clopidogrel + GI Protector||43
384587|NCT01896557|943984|P2|NOT COMPLETED|Clopidogrel Alone||0
384588|NCT01896557|943985|P1|NOT COMPLETED|Clopidogrel Alone||1
384589|NCT01896557|943984|P2|COMPLETED|Clopidogrel Alone||48
384590|NCT01896557|943985|P1|COMPLETED|Clopidogrel Alone||43
384591|NCT01896557|943984|P2|STARTED|Clopidogrel Alone||48
384592|NCT01896557|943985|P1|STARTED|Clopidogrel Alone||44
384593|NCT01896544|943996|P3|NOT COMPLETED|Overall Study||0
384594|NCT01896544|943997|P2|NOT COMPLETED|Overall Study||0
384595|NCT01896544|943998|P1|NOT COMPLETED|Overall Study||0
384596|NCT01896544|943996|P3|COMPLETED|Overall Study||10
384597|NCT01896544|943997|P2|COMPLETED|Overall Study||10
384598|NCT01896544|943998|P1|COMPLETED|Overall Study||10
384599|NCT01896544|943996|P3|STARTED|Overall Study||10
384600|NCT01896544|943997|P2|STARTED|Overall Study||10
384601|NCT01896544|943998|P1|STARTED|Overall Study||10
384602|NCT01896297|944018|P1|NOT COMPLETED|Overall Study||1
384603|NCT01896297|944018|P1|COMPLETED|Overall Study||59
384604|NCT01896297|944018|P1|STARTED|Overall Study||60
384605|NCT01896232|944025|P2|NOT COMPLETED|Overall Study||53
384606|NCT01896232|944026|P1|NOT COMPLETED|Overall Study||49
384607|NCT01896232|944025|P2|COMPLETED|Overall Study||287
384608|NCT01896232|944026|P1|COMPLETED|Overall Study||294
384609|NCT01896232|944025|P2|Received Treatment|Overall Study||338
384610|NCT01896232|944026|P1|Received Treatment|Overall Study||341
384611|NCT01896232|944025|P2|STARTED|Overall Study||340
384612|NCT01896232|944026|P1|STARTED|Overall Study||343
384613|NCT01896206|944046|P1|NOT COMPLETED|Overall Study||0
384614|NCT01896206|944046|P1|COMPLETED|Overall Study||21
384615|NCT01896206|944046|P1|STARTED|Overall Study||21
384616|NCT01896193|944054|P2|NOT COMPLETED|Overall Study||12
384617|NCT01896193|944055|P1|NOT COMPLETED|Overall Study||21
384618|NCT01896193|944054|P2|COMPLETED|Overall Study||53
384619|NCT01896193|944055|P1|COMPLETED|Overall Study||41
384620|NCT01896193|944054|P2|STARTED|Overall Study||65
384621|NCT01896193|944055|P1|STARTED|Overall Study||62
384622|NCT01896115|944081|P2|NOT COMPLETED|Overall Study||0
384623|NCT01896115|944082|P1|NOT COMPLETED|Overall Study||1
384624|NCT01896115|944081|P2|COMPLETED|Overall Study||24
384625|NCT01896115|944082|P1|COMPLETED|Overall Study||15
384626|NCT01896115|944081|P2|Phase 2 Steering|Overall Study||24
384627|NCT01896115|944082|P1|Phase 2 Steering|Overall Study||0
384628|NCT01896115|944081|P2|Phase 2 Single Contact|Overall Study||24
384629|NCT01896115|944082|P1|Phase 2 Single Contact|Overall Study||0
384630|NCT01896115|944081|P2|Phase 1 Ventral Steering|Overall Study||0
384631|NCT01896115|944082|P1|Phase 1 Ventral Steering|Overall Study||15
384632|NCT01896115|944081|P2|Phase 1 Dorsal Steering|Overall Study||0
384633|NCT01896115|944082|P1|Phase 1 Dorsal Steering|Overall Study||15
384634|NCT01896115|944081|P2|Phase 1 Conventional PW|Overall Study||0
384635|NCT01896115|944082|P1|Phase 1 Conventional PW|Overall Study||15
384636|NCT01896115|944081|P2|Phase 1 Short PW|Overall Study||0
384637|NCT01896115|944082|P1|Phase 1 Short PW|Overall Study||15
384638|NCT01896115|944081|P2|STARTED|Overall Study||24
384639|NCT01896115|944082|P1|STARTED|Overall Study||16
384640|NCT01896050|944107|P2|NOT COMPLETED|Overall Study||2
384641|NCT01896050|944108|P1|NOT COMPLETED|Overall Study||38
384642|NCT01896050|944107|P2|COMPLETED|Overall Study||20
384643|NCT01896050|944108|P1|COMPLETED|Overall Study|This includes only patients who remained on the same aromatase inhibitor medication for 12 months|55
384644|NCT01896050|944107|P2|STARTED|Overall Study||22
384645|NCT01896050|944108|P1|STARTED|Overall Study||93
384646|NCT01895972|944118|P1|NOT COMPLETED|Overall Study||9
384647|NCT01895972|944118|P1|COMPLETED|Overall Study||121
384648|NCT01895972|944118|P1|STARTED|Overall Study||130
384649|NCT01895946|944125|P2|NOT COMPLETED|Overall Study||0
384650|NCT01895946|944126|P1|NOT COMPLETED|Overall Study||0
384651|NCT01895946|944125|P2|COMPLETED|Overall Study||12
384652|NCT01895946|944126|P1|COMPLETED|Overall Study||18
384653|NCT01895946|944125|P2|STARTED|Overall Study||12
384654|NCT01895946|944126|P1|STARTED|Overall Study||18
384655|NCT01895634|944144|P1|NOT COMPLETED|Overall Study||3
384656|NCT01895634|944144|P1|COMPLETED|Overall Study||46
384657|NCT01895634|944144|P1|STARTED|Overall Study||49
384658|NCT01895608|944156|P4|NOT COMPLETED|Overall Study||0
384659|NCT01895608|944157|P3|NOT COMPLETED|Overall Study||3
384660|NCT01895608|944158|P2|NOT COMPLETED|Overall Study||1
384661|NCT01895608|944159|P1|NOT COMPLETED|Overall Study||0
384662|NCT01895608|944156|P4|COMPLETED|Overall Study||6
384663|NCT01895608|944157|P3|COMPLETED|Overall Study||8
384664|NCT01895608|944158|P2|COMPLETED|Overall Study||6
384665|NCT01895608|944159|P1|COMPLETED|Overall Study||10
384666|NCT01895608|944156|P4|STARTED|Overall Study||6
384667|NCT01895608|944157|P3|STARTED|Overall Study||11
384668|NCT01895608|944158|P2|STARTED|Overall Study||7
384669|NCT01895608|944159|P1|STARTED|Overall Study||10
384670|NCT01895543|944189|P1|NOT COMPLETED|Overall Study||129
384671|NCT01895543|944189|P1|COMPLETED|Overall Study||282
384672|NCT01895543|944189|P1|Per Protocol Analysis Set|Overall Study|Set included all enrolled patients who had no major protocol deviations.|380
384673|NCT01895543|944189|P1|Safety Analysis Set|Overall Study|Set included all enrolled patients who took at least one dose of Investigational Medicinal Product.|409
384674|NCT01895543|944189|P1|STARTED|Overall Study||411
384675|NCT01895452|944205|P2|NOT COMPLETED|Overall Study||28
384676|NCT01895452|944206|P1|NOT COMPLETED|Overall Study||4
384677|NCT01895452|944205|P2|COMPLETED|Overall Study||198
384678|NCT01895452|944206|P1|COMPLETED|Overall Study||61
384679|NCT01895452|944205|P2|STARTED|Overall Study||226
384680|NCT01895452|944206|P1|STARTED|Overall Study||65
384681|NCT01895335|944216|P1|NOT COMPLETED|Overall Study||215
384682|NCT01895335|944216|P1|COMPLETED|Overall Study||786
384683|NCT01895335|944216|P1|Treated|Overall Study||1000
384684|NCT01895335|944216|P1|STARTED|Overall Study||1001
384685|NCT01895322|944233|P1|NOT COMPLETED|Overall Study||13
384686|NCT01895322|944233|P1|COMPLETED|Overall Study||7
384687|NCT01895322|944233|P1|STARTED|Overall Study||20
384688|NCT01895309|944242|P2|NOT COMPLETED|Overall Study||51
384689|NCT01895309|944243|P1|NOT COMPLETED|Overall Study||40
384690|NCT01895309|944242|P2|COMPLETED|Overall Study||246
384691|NCT01895309|944243|P1|COMPLETED|Overall Study||259
384692|NCT01895309|944242|P2|STARTED|Overall Study||297
384693|NCT01895309|944243|P1|STARTED|Overall Study||299
384694|NCT01895270|944257|P2|NOT COMPLETED|Isradipine Taper (W7-8)||2
384695|NCT01895270|944258|P1|NOT COMPLETED|Isradipine Taper (W7-8)||0
384696|NCT01895270|944257|P2|COMPLETED|Isradipine Taper (W7-8)||0
384697|NCT01895270|944258|P1|COMPLETED|Isradipine Taper (W7-8)||2
384698|NCT01895270|944257|P2|STARTED|Isradipine Taper (W7-8)||2
384699|NCT01895270|944258|P1|STARTED|Isradipine Taper (W7-8)||2
384700|NCT01895270|944257|P2|NOT COMPLETED|Buprenorphine Taper (W5 to W6D3)||5
384701|NCT01895270|944258|P1|NOT COMPLETED|Buprenorphine Taper (W5 to W6D3)||3
384702|NCT01895270|944257|P2|COMPLETED|Buprenorphine Taper (W5 to W6D3)||2
384703|NCT01895270|944258|P1|COMPLETED|Buprenorphine Taper (W5 to W6D3)||2
384704|NCT01895270|944257|P2|STARTED|Buprenorphine Taper (W5 to W6D3)|1 subject missed meds prior to bup taper so did not start this phase|7
384705|NCT01895270|944258|P1|STARTED|Buprenorphine Taper (W5 to W6D3)||5
384706|NCT01895270|944257|P2|NOT COMPLETED|Study Medications Induction (W1-4)||6
384707|NCT01895270|944258|P1|NOT COMPLETED|Study Medications Induction (W1-4)||6
384708|NCT01895270|944257|P2|COMPLETED|Study Medications Induction (W1-4)||8
384709|NCT01895270|944258|P1|COMPLETED|Study Medications Induction (W1-4)||5
384710|NCT01895270|944257|P2|STARTED|Study Medications Induction (W1-4)||14
384711|NCT01895270|944258|P1|STARTED|Study Medications Induction (W1-4)||11
384712|NCT01895127|944266|P2|NOT COMPLETED|Long Term Follow-up (Month 3-12)||3
384713|NCT01895127|944267|P1|NOT COMPLETED|Long Term Follow-up (Month 3-12)||2
384714|NCT01895127|944266|P2|COMPLETED|Long Term Follow-up (Month 3-12)||4
384715|NCT01895127|944267|P1|COMPLETED|Long Term Follow-up (Month 3-12)||1
384716|NCT01895127|944266|P2|STARTED|Long Term Follow-up (Month 3-12)||7
384717|NCT01895127|944267|P1|STARTED|Long Term Follow-up (Month 3-12)||3
384718|NCT01895127|944266|P2|NOT COMPLETED|Month 3 Follow-up & Biopsy||0
384719|NCT01895127|944267|P1|NOT COMPLETED|Month 3 Follow-up & Biopsy||0
384720|NCT01895127|944266|P2|COMPLETED|Month 3 Follow-up & Biopsy||7
384721|NCT01895127|944267|P1|COMPLETED|Month 3 Follow-up & Biopsy||3
384722|NCT01895127|944266|P2|STARTED|Month 3 Follow-up & Biopsy||7
384723|NCT01895127|944267|P1|STARTED|Month 3 Follow-up & Biopsy||3
384724|NCT01895127|944266|P2|NOT COMPLETED|Treatment Period (Week 0-Month 3)||0
384725|NCT01895127|944267|P1|NOT COMPLETED|Treatment Period (Week 0-Month 3)||0
384726|NCT01895127|944266|P2|COMPLETED|Treatment Period (Week 0-Month 3)||7
384727|NCT01895127|944267|P1|COMPLETED|Treatment Period (Week 0-Month 3)||3
384728|NCT01895127|944266|P2|STARTED|Treatment Period (Week 0-Month 3)||7
384729|NCT01895127|944267|P1|STARTED|Treatment Period (Week 0-Month 3)||3
384730|NCT01895127|944266|P2|NOT COMPLETED|Screening||0
384731|NCT01895127|944267|P1|NOT COMPLETED|Screening||0
384732|NCT01895127|944266|P2|COMPLETED|Screening||7
384733|NCT01895127|944267|P1|COMPLETED|Screening|One subject was found to be pregnant at screening so was withdrawn from the study prior to treatment|4
384734|NCT01895127|944266|P2|STARTED|Screening||7
384735|NCT01895127|944267|P1|STARTED|Screening||4
384736|NCT01895101|944277|P3|NOT COMPLETED|Overall Study||5
384737|NCT01895101|944278|P2|NOT COMPLETED|Overall Study||5
384738|NCT01895101|944279|P1|NOT COMPLETED|Overall Study||1
384739|NCT01895101|944277|P3|COMPLETED|Overall Study||245
384740|NCT01895101|944278|P2|COMPLETED|Overall Study||245
384741|NCT01895101|944279|P1|COMPLETED|Overall Study||249
384742|NCT01895101|944277|P3|STARTED|Overall Study||250
384743|NCT01895101|944278|P2|STARTED|Overall Study||250
384744|NCT01895101|944279|P1|STARTED|Overall Study||250
384745|NCT01895088|944293|P1|NOT COMPLETED|Overall Study||18
384746|NCT01895088|944293|P1|COMPLETED|Overall Study||253
384747|NCT01895088|944293|P1|STARTED|Overall Study|1 subject consented for monitoring after device removal (not included in cohort), per FDA request.|271
384748|NCT01895062|944299|P2|NOT COMPLETED|Overall Study||0
384749|NCT01895062|944300|P1|NOT COMPLETED|Overall Study||0
384750|NCT01895062|944299|P2|COMPLETED|Overall Study||24
384751|NCT01895062|944300|P1|COMPLETED|Overall Study||30
384752|NCT01895062|944299|P2|STARTED|Overall Study||24
384753|NCT01895062|944300|P1|STARTED|Overall Study||30
384754|NCT01895036|944308|P1|NOT COMPLETED|Overall Study||0
384755|NCT01895036|944308|P1|COMPLETED|Overall Study||6
384756|NCT01895036|944308|P1|STARTED|Overall Study||6
384757|NCT01894984|944314|P2|NOT COMPLETED|Overall Study||175
384758|NCT01894984|944315|P1|NOT COMPLETED|Overall Study||314
384759|NCT01894984|944314|P2|COMPLETED|Overall Study||69
384760|NCT01894984|944315|P1|COMPLETED|Overall Study||82
384761|NCT01894984|944314|P2|STARTED|Overall Study||244
384762|NCT01894984|944315|P1|STARTED|Overall Study||396
384763|NCT01894906|944333|P2|NOT COMPLETED|Overall Study||0
384764|NCT01894906|944334|P1|NOT COMPLETED|Overall Study||0
384765|NCT01894906|944333|P2|COMPLETED|Overall Study||6
384766|NCT01894906|944334|P1|COMPLETED|Overall Study||6
384767|NCT01894906|944333|P2|Treatment F|Overall Study||6
384768|NCT01894906|944334|P1|Treatment F|Overall Study||6
384769|NCT01894906|944333|P2|Treatment E|Overall Study||6
384770|NCT01894906|944334|P1|Treatment E|Overall Study||6
384771|NCT01894906|944333|P2|Treatment D|Overall Study||6
384772|NCT01894906|944334|P1|Treatment D|Overall Study||6
384773|NCT01894906|944333|P2|Treatment C|Overall Study||6
384774|NCT01894906|944334|P1|Treatment C|Overall Study||6
384775|NCT01894906|944333|P2|Treatment B|Overall Study||6
384776|NCT01894906|944334|P1|Treatment B|Overall Study||6
384777|NCT01894906|944333|P2|Treatment A|Overall Study||6
384778|NCT01894906|944334|P1|Treatment A|Overall Study||6
384779|NCT01894906|944333|P2|STARTED|Overall Study||6
384780|NCT01894906|944334|P1|STARTED|Overall Study||6
384781|NCT01894672|944364|P1|NOT COMPLETED|Overall Study||0
384782|NCT01894672|944364|P1|COMPLETED|Overall Study||7
384783|NCT01894672|944364|P1|STARTED|Overall Study||7
384784|NCT01894620|944372|P2|NOT COMPLETED|Overall Study||1
384785|NCT01894620|944373|P1|NOT COMPLETED|Overall Study||0
384786|NCT01894620|944372|P2|COMPLETED|Overall Study||4
384787|NCT01894620|944373|P1|COMPLETED|Overall Study||6
384788|NCT01894620|944372|P2|STARTED|Overall Study||5
384789|NCT01894620|944373|P1|STARTED|Overall Study||6
384790|NCT01894607|944381|P1|NOT COMPLETED|Overall Study||1
384791|NCT01894607|944381|P1|COMPLETED|Overall Study||10
384792|NCT01894607|944381|P1|STARTED|Overall Study||11
384793|NCT01894581|944388|P2|NOT COMPLETED|Overall Study||7
384794|NCT01894581|944389|P1|NOT COMPLETED|Overall Study||5
384795|NCT01894581|944388|P2|COMPLETED|Overall Study||12
384796|NCT01894581|944389|P1|COMPLETED|Overall Study||15
384797|NCT01894581|944388|P2|STARTED|Overall Study||19
384798|NCT01894581|944389|P1|STARTED|Overall Study||20
384799|NCT01894555|944395|P1|NOT COMPLETED|Overall Study||0
384800|NCT01894555|944395|P1|COMPLETED|Overall Study||33
384801|NCT01894555|944395|P1|STARTED|Overall Study||33
384802|NCT01894503|944399|P1|NOT COMPLETED|Overall Study||0
384803|NCT01894503|944399|P1|COMPLETED|Overall Study||5
384804|NCT01894503|944399|P1|STARTED|Overall Study||5
384805|NCT01894477|944406|P2|NOT COMPLETED|Overall Study||2
384806|NCT01894477|944407|P1|NOT COMPLETED|Overall Study||0
384807|NCT01894477|944406|P2|COMPLETED|Overall Study||65
384808|NCT01894477|944407|P1|COMPLETED|Overall Study||35
384809|NCT01894477|944406|P2|STARTED|Overall Study||67
384810|NCT01894477|944407|P1|STARTED|Overall Study||35
384811|NCT01894256|944418|P3|NOT COMPLETED|Part B||14
384812|NCT01894256|944419|P2|NOT COMPLETED|Part B||14
384813|NCT01894256|944420|P1|NOT COMPLETED|Part B||15
384814|NCT01894256|944418|P3|COMPLETED|Part B||0
384815|NCT01894256|944419|P2|COMPLETED|Part B||0
384816|NCT01894256|944420|P1|COMPLETED|Part B||0
384817|NCT01894256|944418|P3|STARTED|Part B||14
384818|NCT01894256|944419|P2|STARTED|Part B||14
384819|NCT01894256|944420|P1|STARTED|Part B||15
384820|NCT01894256|944418|P3|NOT COMPLETED|Part A||0
384821|NCT01894256|944419|P2|NOT COMPLETED|Part A||1
384822|NCT01894256|944420|P1|NOT COMPLETED|Part A||0
384823|NCT01894256|944418|P3|COMPLETED|Part A||14
384824|NCT01894256|944419|P2|COMPLETED|Part A||14
384825|NCT01894256|944420|P1|COMPLETED|Part A||15
384826|NCT01894256|944418|P3|STARTED|Part A||14
384827|NCT01894256|944419|P2|STARTED|Part A||15
384828|NCT01894256|944420|P1|STARTED|Part A||15
384829|NCT01894230|944466|P2|NOT COMPLETED|Overall Study||7
384830|NCT01894230|944467|P1|NOT COMPLETED|Overall Study||7
384831|NCT01894230|944466|P2|COMPLETED|Overall Study||69
384832|NCT01894230|944467|P1|COMPLETED|Overall Study||76
384833|NCT01894230|944466|P2|STARTED|Overall Study||76
384834|NCT01894230|944467|P1|STARTED|Overall Study||83
384835|NCT01894100|944493|P2|NOT COMPLETED|Overall Study||1
384836|NCT01894100|944494|P1|NOT COMPLETED|Overall Study||3
384837|NCT01894100|944493|P2|COMPLETED|Overall Study||14
384838|NCT01894100|944494|P1|COMPLETED|Overall Study||12
384839|NCT01894100|944493|P2|STARTED|Overall Study||15
384840|NCT01894100|944494|P1|STARTED|Overall Study||15
384841|NCT01894087|944504|P2|NOT COMPLETED|Overall Study||0
384842|NCT01894087|944505|P1|NOT COMPLETED|Overall Study||6
384843|NCT01894087|944504|P2|COMPLETED|Overall Study||102
384844|NCT01894087|944505|P1|COMPLETED|Overall Study||96
384845|NCT01894087|944504|P2|STARTED|Overall Study||102
384846|NCT01894087|944505|P1|STARTED|Overall Study||102
384847|NCT01894022|944519|P2|NOT COMPLETED|Overall Study||10
384848|NCT01894022|944520|P1|NOT COMPLETED|Overall Study||9
384849|NCT01894022|944519|P2|COMPLETED|Overall Study||0
384850|NCT01894022|944520|P1|COMPLETED|Overall Study||0
384851|NCT01894022|944519|P2|STARTED|Overall Study||10
384852|NCT01894022|944520|P1|STARTED|Overall Study||9
384853|NCT01893905|944574|P2|NOT COMPLETED|Overall Study||14
384854|NCT01893905|944575|P1|NOT COMPLETED|Overall Study||25
384855|NCT01893905|944574|P2|COMPLETED|Overall Study||64
384856|NCT01893905|944575|P1|COMPLETED|Overall Study||55
384857|NCT01893905|944574|P2|STARTED|Overall Study||78
384858|NCT01893905|944575|P1|STARTED|Overall Study||80
384859|NCT01893879|944583|P2|NOT COMPLETED|Overall Study||3
384860|NCT01893879|944584|P1|NOT COMPLETED|Overall Study||2
384861|NCT01893879|944583|P2|COMPLETED|Overall Study||4
384862|NCT01893879|944584|P1|COMPLETED|Overall Study||5
384863|NCT01893879|944583|P2|STARTED|Overall Study||7
384864|NCT01893879|944584|P1|STARTED|Overall Study||7
384865|NCT01893567|944590|P1|NOT COMPLETED|Overall Study||0
384866|NCT01893567|944590|P1|COMPLETED|Overall Study||28
384867|NCT01893567|944590|P1|STARTED|Overall Study||28
384868|NCT01893411|944597|P3|NOT COMPLETED|Overall Study||9
384869|NCT01893411|944598|P2|NOT COMPLETED|Overall Study||7
384870|NCT01893411|944599|P1|NOT COMPLETED|Overall Study||17
384871|NCT01893411|944597|P3|COMPLETED|Overall Study||69
384872|NCT01893411|944598|P2|COMPLETED|Overall Study||70
384873|NCT01893411|944599|P1|COMPLETED|Overall Study||139
384874|NCT01893411|944597|P3|STARTED|Overall Study||78
384875|NCT01893411|944598|P2|STARTED|Overall Study||77
384876|NCT01893411|944599|P1|STARTED|Overall Study||156
384877|NCT01893359|944664|P3|NOT COMPLETED|Overall Study||0
384878|NCT01893359|944665|P2|NOT COMPLETED|Overall Study||0
384879|NCT01893359|944666|P1|NOT COMPLETED|Overall Study||0
384880|NCT01893359|944664|P3|COMPLETED|Overall Study||0
384881|NCT01893359|944665|P2|COMPLETED|Overall Study||2
384882|NCT01893359|944666|P1|COMPLETED|Overall Study||0
384883|NCT01893359|944664|P3|STARTED|Overall Study||0
384884|NCT01893359|944665|P2|STARTED|Overall Study||2
384885|NCT01893359|944666|P1|STARTED|Overall Study||0
384886|NCT01893346|944681|P4|NOT COMPLETED|Overall Study||0
384887|NCT01893346|944682|P3|NOT COMPLETED|Overall Study||0
384888|NCT01893346|944683|P2|NOT COMPLETED|Overall Study||1
384889|NCT01893346|944684|P1|NOT COMPLETED|Overall Study||3
384890|NCT01893346|944681|P4|COMPLETED|Overall Study||8
384891|NCT01893346|944682|P3|COMPLETED|Overall Study||8
384892|NCT01893346|944683|P2|COMPLETED|Overall Study||7
384893|NCT01893346|944684|P1|COMPLETED|Overall Study||8
384894|NCT01893346|944681|P4|Patients Who Received Full Infusion|Overall Study||8
384895|NCT01893346|944682|P3|Patients Who Received Full Infusion|Overall Study||8
384896|NCT01893346|944683|P2|Patients Who Received Full Infusion|Overall Study||8
384897|NCT01893346|944684|P1|Patients Who Received Full Infusion|Overall Study||8
384898|NCT01893346|944681|P4|STARTED|Overall Study||8
384899|NCT01893346|944682|P3|STARTED|Overall Study||8
384900|NCT01893346|944683|P2|STARTED|Overall Study||8
384901|NCT01893346|944684|P1|STARTED|Overall Study||11
384902|NCT01893281|944698|P1|NOT COMPLETED|Overall Study||3
384903|NCT01893281|944698|P1|COMPLETED|Overall Study||75
384904|NCT01893281|944698|P1|Received at Least 1 Dose of Study Drug|Overall Study||78
384905|NCT01893281|944698|P1|STARTED|Overall Study||78
384906|NCT01893203|944705|P1|NOT COMPLETED|Overall Study||1
384907|NCT01893203|944705|P1|COMPLETED|Overall Study||13
384908|NCT01893203|944705|P1|STARTED|Overall Study||14
384909|NCT01892865|944714|P2|NOT COMPLETED|Overall Study||0
384910|NCT01892865|944715|P1|NOT COMPLETED|Overall Study||0
384911|NCT01892865|944714|P2|COMPLETED|Overall Study||379
384912|NCT01892865|944715|P1|COMPLETED|Overall Study||356
384913|NCT01892865|944714|P2|STARTED|Overall Study|100 operative days scheduled with the Predictive Modeling System method were included|379
384914|NCT01892865|944715|P1|STARTED|Overall Study|107 operative days scheduled with the Historical Means method were included|356
384915|NCT01892709|944727|P1|NOT COMPLETED|Overall Study||0
384916|NCT01892709|944727|P1|COMPLETED|Overall Study||215
384917|NCT01892709|944727|P1|STARTED|Overall Study||215
384918|NCT01892657|944737|P1|NOT COMPLETED|Overall Study||18
384919|NCT01892657|944737|P1|COMPLETED|Overall Study||110
384920|NCT01892657|944737|P1|STARTED|Overall Study||128
384921|NCT01892306|944755|P2|NOT COMPLETED|Overall Study||6
384922|NCT01892306|944756|P1|NOT COMPLETED|Overall Study||5
384923|NCT01892306|944755|P2|COMPLETED|Overall Study||10
384924|NCT01892306|944756|P1|COMPLETED|Overall Study||8
384925|NCT01892306|944755|P2|STARTED|Overall Study||16
384926|NCT01892306|944756|P1|STARTED|Overall Study||13
384927|NCT01892267|944778|P2|NOT COMPLETED|Overall Study||0
384928|NCT01892267|944779|P1|NOT COMPLETED|Overall Study||0
384929|NCT01892267|944778|P2|COMPLETED|Overall Study||10
384930|NCT01892267|944779|P1|COMPLETED|Overall Study||9
384931|NCT01892267|944778|P2|STARTED|Overall Study||10
384932|NCT01892267|944779|P1|STARTED|Overall Study||9
384933|NCT01892189|944814|P9|NOT COMPLETED|Third Intervention Period (1 Day)||0
384934|NCT01892189|944815|P8|NOT COMPLETED|Third Intervention Period (1 Day)||0
384935|NCT01892189|944816|P7|NOT COMPLETED|Third Intervention Period (1 Day)||0
384936|NCT01892189|944817|P6|NOT COMPLETED|Third Intervention Period (1 Day)||0
384937|NCT01892189|944818|P5|NOT COMPLETED|Third Intervention Period (1 Day)||0
384938|NCT01892189|944819|P4|NOT COMPLETED|Third Intervention Period (1 Day)||0
384939|NCT01892189|944820|P3|NOT COMPLETED|Third Intervention Period (1 Day)||0
384940|NCT01892189|944821|P2|NOT COMPLETED|Third Intervention Period (1 Day)||0
384941|NCT01892189|944822|P1|NOT COMPLETED|Third Intervention Period (1 Day)||0
384942|NCT01892189|944814|P9|COMPLETED|Third Intervention Period (1 Day)||1
384943|NCT01892189|944815|P8|COMPLETED|Third Intervention Period (1 Day)||3
384944|NCT01892189|944816|P7|COMPLETED|Third Intervention Period (1 Day)||2
384945|NCT01892189|944817|P6|COMPLETED|Third Intervention Period (1 Day)||2
384946|NCT01892189|944818|P5|COMPLETED|Third Intervention Period (1 Day)||3
384947|NCT01892189|944819|P4|COMPLETED|Third Intervention Period (1 Day)||2
384948|NCT01892189|944820|P3|COMPLETED|Third Intervention Period (1 Day)||1
384949|NCT01892189|944821|P2|COMPLETED|Third Intervention Period (1 Day)||3
384950|NCT01892189|944822|P1|COMPLETED|Third Intervention Period (1 Day)||3
384951|NCT01892189|944814|P9|STARTED|Third Intervention Period (1 Day)||1
384952|NCT01892189|944815|P8|STARTED|Third Intervention Period (1 Day)||3
384953|NCT01892189|944816|P7|STARTED|Third Intervention Period (1 Day)||2
384954|NCT01892189|944817|P6|STARTED|Third Intervention Period (1 Day)||2
384955|NCT01892189|944818|P5|STARTED|Third Intervention Period (1 Day)||3
384956|NCT01892189|944819|P4|STARTED|Third Intervention Period (1 Day)||2
384957|NCT01892189|944820|P3|STARTED|Third Intervention Period (1 Day)||1
384958|NCT01892189|944821|P2|STARTED|Third Intervention Period (1 Day)||3
384959|NCT01892189|944822|P1|STARTED|Third Intervention Period (1 Day)||3
384960|NCT01892189|944814|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
384961|NCT01892189|944815|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
384962|NCT01892189|944816|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
384963|NCT01892189|944817|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
384964|NCT01892189|944818|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
384965|NCT01892189|944819|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
384966|NCT01892189|944820|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
384967|NCT01892189|944821|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
384968|NCT01892189|944822|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
384969|NCT01892189|944814|P9|COMPLETED|Washout Period 2 (7 Days)||1
384970|NCT01892189|944815|P8|COMPLETED|Washout Period 2 (7 Days)||3
384971|NCT01892189|944816|P7|COMPLETED|Washout Period 2 (7 Days)||2
384972|NCT01892189|944817|P6|COMPLETED|Washout Period 2 (7 Days)||2
384973|NCT01892189|944818|P5|COMPLETED|Washout Period 2 (7 Days)||3
384974|NCT01892189|944819|P4|COMPLETED|Washout Period 2 (7 Days)||2
384975|NCT01892189|944820|P3|COMPLETED|Washout Period 2 (7 Days)||1
384976|NCT01892189|944821|P2|COMPLETED|Washout Period 2 (7 Days)||3
384977|NCT01892189|944822|P1|COMPLETED|Washout Period 2 (7 Days)||3
384978|NCT01892189|944814|P9|STARTED|Washout Period 2 (7 Days)||1
384979|NCT01892189|944815|P8|STARTED|Washout Period 2 (7 Days)||3
384980|NCT01892189|944816|P7|STARTED|Washout Period 2 (7 Days)||2
384981|NCT01892189|944817|P6|STARTED|Washout Period 2 (7 Days)||2
384982|NCT01892189|944818|P5|STARTED|Washout Period 2 (7 Days)||3
384983|NCT01892189|944819|P4|STARTED|Washout Period 2 (7 Days)||2
384984|NCT01892189|944820|P3|STARTED|Washout Period 2 (7 Days)||1
384985|NCT01892189|944821|P2|STARTED|Washout Period 2 (7 Days)||3
384986|NCT01892189|944822|P1|STARTED|Washout Period 2 (7 Days)||3
384987|NCT01892189|944814|P9|NOT COMPLETED|Second Intervention Period (1 Day)||0
384988|NCT01892189|944815|P8|NOT COMPLETED|Second Intervention Period (1 Day)||0
384989|NCT01892189|944816|P7|NOT COMPLETED|Second Intervention Period (1 Day)||0
384990|NCT01892189|944817|P6|NOT COMPLETED|Second Intervention Period (1 Day)||0
384991|NCT01892189|944818|P5|NOT COMPLETED|Second Intervention Period (1 Day)||0
384992|NCT01892189|944819|P4|NOT COMPLETED|Second Intervention Period (1 Day)||0
384993|NCT01892189|944820|P3|NOT COMPLETED|Second Intervention Period (1 Day)||0
384994|NCT01892189|944821|P2|NOT COMPLETED|Second Intervention Period (1 Day)||0
384995|NCT01892189|944822|P1|NOT COMPLETED|Second Intervention Period (1 Day)||0
384996|NCT01892189|944814|P9|COMPLETED|Second Intervention Period (1 Day)||1
384997|NCT01892189|944815|P8|COMPLETED|Second Intervention Period (1 Day)||3
384998|NCT01892189|944816|P7|COMPLETED|Second Intervention Period (1 Day)||2
384999|NCT01892189|944817|P6|COMPLETED|Second Intervention Period (1 Day)||2
385000|NCT01892189|944818|P5|COMPLETED|Second Intervention Period (1 Day)||3
385001|NCT01892189|944819|P4|COMPLETED|Second Intervention Period (1 Day)||2
385002|NCT01892189|944820|P3|COMPLETED|Second Intervention Period (1 Day)||1
385003|NCT01892189|944821|P2|COMPLETED|Second Intervention Period (1 Day)||3
385004|NCT01892189|944822|P1|COMPLETED|Second Intervention Period (1 Day)||3
385005|NCT01892189|944814|P9|STARTED|Second Intervention Period (1 Day)||1
385006|NCT01892189|944815|P8|STARTED|Second Intervention Period (1 Day)||3
385007|NCT01892189|944816|P7|STARTED|Second Intervention Period (1 Day)||2
385008|NCT01892189|944817|P6|STARTED|Second Intervention Period (1 Day)||2
385009|NCT01892189|944818|P5|STARTED|Second Intervention Period (1 Day)||3
385010|NCT01892189|944819|P4|STARTED|Second Intervention Period (1 Day)||2
385011|NCT01892189|944820|P3|STARTED|Second Intervention Period (1 Day)||1
385012|NCT01892189|944821|P2|STARTED|Second Intervention Period (1 Day)||3
385013|NCT01892189|944822|P1|STARTED|Second Intervention Period (1 Day)||3
385014|NCT01892189|944814|P9|NOT COMPLETED|Washout Period 1 (7 Days)||2
385015|NCT01892189|944815|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
385016|NCT01892189|944816|P7|NOT COMPLETED|Washout Period 1 (7 Days)||1
385017|NCT01892189|944817|P6|NOT COMPLETED|Washout Period 1 (7 Days)||1
385018|NCT01892189|944818|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
385019|NCT01892189|944819|P4|NOT COMPLETED|Washout Period 1 (7 Days)||1
385020|NCT01892189|944820|P3|NOT COMPLETED|Washout Period 1 (7 Days)||2
385021|NCT01892189|944821|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
385022|NCT01892189|944822|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
385023|NCT01892189|944814|P9|COMPLETED|Washout Period 1 (7 Days)||1
385024|NCT01892189|944815|P8|COMPLETED|Washout Period 1 (7 Days)||3
385025|NCT01892189|944816|P7|COMPLETED|Washout Period 1 (7 Days)||2
385026|NCT01892189|944817|P6|COMPLETED|Washout Period 1 (7 Days)||2
385027|NCT01892189|944818|P5|COMPLETED|Washout Period 1 (7 Days)||3
385028|NCT01892189|944819|P4|COMPLETED|Washout Period 1 (7 Days)||2
385029|NCT01892189|944820|P3|COMPLETED|Washout Period 1 (7 Days)||1
385030|NCT01892189|944821|P2|COMPLETED|Washout Period 1 (7 Days)||3
385031|NCT01892189|944822|P1|COMPLETED|Washout Period 1 (7 Days)||3
385032|NCT01892189|944814|P9|STARTED|Washout Period 1 (7 Days)||3
385033|NCT01892189|944815|P8|STARTED|Washout Period 1 (7 Days)||3
385034|NCT01892189|944816|P7|STARTED|Washout Period 1 (7 Days)||3
385035|NCT01892189|944817|P6|STARTED|Washout Period 1 (7 Days)||3
385036|NCT01892189|944818|P5|STARTED|Washout Period 1 (7 Days)||3
385037|NCT01892189|944819|P4|STARTED|Washout Period 1 (7 Days)||3
385038|NCT01892189|944820|P3|STARTED|Washout Period 1 (7 Days)||3
385039|NCT01892189|944821|P2|STARTED|Washout Period 1 (7 Days)||3
385040|NCT01892189|944822|P1|STARTED|Washout Period 1 (7 Days)||3
385041|NCT01892189|944814|P9|NOT COMPLETED|First Intervention Period (1 Day)||0
385042|NCT01892189|944815|P8|NOT COMPLETED|First Intervention Period (1 Day)||0
385043|NCT01892189|944816|P7|NOT COMPLETED|First Intervention Period (1 Day)||0
385044|NCT01892189|944817|P6|NOT COMPLETED|First Intervention Period (1 Day)||0
385045|NCT01892189|944818|P5|NOT COMPLETED|First Intervention Period (1 Day)||0
385046|NCT01892189|944819|P4|NOT COMPLETED|First Intervention Period (1 Day)||0
385047|NCT01892189|944820|P3|NOT COMPLETED|First Intervention Period (1 Day)||0
385048|NCT01892189|944821|P2|NOT COMPLETED|First Intervention Period (1 Day)||0
385049|NCT01892189|944822|P1|NOT COMPLETED|First Intervention Period (1 Day)||0
385050|NCT01892189|944814|P9|COMPLETED|First Intervention Period (1 Day)||3
385051|NCT01892189|944815|P8|COMPLETED|First Intervention Period (1 Day)||3
385052|NCT01892189|944816|P7|COMPLETED|First Intervention Period (1 Day)||3
385053|NCT01892189|944817|P6|COMPLETED|First Intervention Period (1 Day)||3
385054|NCT01892189|944818|P5|COMPLETED|First Intervention Period (1 Day)||3
385055|NCT01892189|944819|P4|COMPLETED|First Intervention Period (1 Day)||3
385056|NCT01892189|944820|P3|COMPLETED|First Intervention Period (1 Day)||3
385057|NCT01892189|944821|P2|COMPLETED|First Intervention Period (1 Day)||3
385058|NCT01892189|944822|P1|COMPLETED|First Intervention Period (1 Day)||3
385059|NCT01892189|944814|P9|STARTED|First Intervention Period (1 Day)||3
385060|NCT01892189|944815|P8|STARTED|First Intervention Period (1 Day)||3
385061|NCT01892189|944816|P7|STARTED|First Intervention Period (1 Day)||3
385062|NCT01892189|944817|P6|STARTED|First Intervention Period (1 Day)||3
385063|NCT01892189|944818|P5|STARTED|First Intervention Period (1 Day)||3
385064|NCT01892189|944819|P4|STARTED|First Intervention Period (1 Day)||3
385065|NCT01892189|944820|P3|STARTED|First Intervention Period (1 Day)||3
385066|NCT01892189|944821|P2|STARTED|First Intervention Period (1 Day)||3
385067|NCT01892189|944822|P1|STARTED|First Intervention Period (1 Day)||3
385068|NCT01892163|944864|P2|NOT COMPLETED|Overall Study||1
385069|NCT01892163|944865|P1|NOT COMPLETED|Overall Study||2
385070|NCT01892163|944864|P2|COMPLETED|Overall Study||49
385071|NCT01892163|944865|P1|COMPLETED|Overall Study||48
385072|NCT01892163|944864|P2|STARTED|Overall Study||50
385073|NCT01892163|944865|P1|STARTED|Overall Study||50
385074|NCT01892020|944877|P2|NOT COMPLETED|Period 2||0
385075|NCT01892020|944878|P1|NOT COMPLETED|Period 2||1
385076|NCT01892020|944877|P2|COMPLETED|Period 2||74
385077|NCT01892020|944878|P1|COMPLETED|Period 2||77
385078|NCT01892020|944877|P2|STARTED|Period 2||74
385079|NCT01892020|944878|P1|STARTED|Period 2||78
385080|NCT01892020|944877|P2|NOT COMPLETED|Period 1||6
385081|NCT01892020|944878|P1|NOT COMPLETED|Period 1||3
385082|NCT01892020|944877|P2|COMPLETED|Period 1||74
385083|NCT01892020|944878|P1|COMPLETED|Period 1||78
385084|NCT01892020|944877|P2|STARTED|Period 1||80
385085|NCT01892020|944878|P1|STARTED|Period 1||81
385086|NCT01891968|944896|P1|NOT COMPLETED|Overall Study||0
385087|NCT01891968|944896|P1|COMPLETED|Overall Study||15
385088|NCT01891968|944896|P1|STARTED|Overall Study||15
385089|NCT01891890|944903|P3|NOT COMPLETED|Overall Study||7
385090|NCT01891890|944904|P2|NOT COMPLETED|Overall Study||3
385091|NCT01891890|944905|P1|NOT COMPLETED|Overall Study||7
385092|NCT01891890|944903|P3|COMPLETED|Overall Study||14
385093|NCT01891890|944904|P2|COMPLETED|Overall Study||24
385094|NCT01891890|944905|P1|COMPLETED|Overall Study||17
385095|NCT01891890|944903|P3|STARTED|Overall Study||21
385096|NCT01891890|944904|P2|STARTED|Overall Study||27
385097|NCT01891890|944905|P1|STARTED|Overall Study||24
385098|NCT01891864|944948|P6|NOT COMPLETED|Extension Period||0
385099|NCT01891864|944949|P5|NOT COMPLETED|Extension Period||7
385100|NCT01891864|944950|P4|NOT COMPLETED|Extension Period||5
385101|NCT01891864|944951|P3|NOT COMPLETED|Extension Period||8
385102|NCT01891864|944952|P2|NOT COMPLETED|Extension Period||0
385103|NCT01891864|944953|P1|NOT COMPLETED|Extension Period||0
385104|NCT01891864|944948|P6|COMPLETED|Extension Period||90
385105|NCT01891864|944949|P5|COMPLETED|Extension Period||88
385106|NCT01891864|944950|P4|COMPLETED|Extension Period||137
385107|NCT01891864|944951|P3|COMPLETED|Extension Period||132
385108|NCT01891864|944952|P2|COMPLETED|Extension Period||0
385109|NCT01891864|944953|P1|COMPLETED|Extension Period||0
385110|NCT01891864|944948|P6|STARTED|Extension Period|1 patient discontinued between Treatment Period 2 and Extension Period due to an adverse event|90
385111|NCT01891864|944949|P5|STARTED|Extension Period|1 patient discontinued between Treatment Period 2 and Extension Period due to lack of efficacy|95
385112|NCT01891864|944950|P4|STARTED|Extension Period||142
385113|NCT01891864|944951|P3|STARTED|Extension Period|2 patients withdrew consent 1 patient lost to FU between Treatment Period 2 and the Extension period|140
385114|NCT01891864|944952|P2|STARTED|Extension Period||0
385115|NCT01891864|944953|P1|STARTED|Extension Period||0
385116|NCT01891864|944948|P6|NOT COMPLETED|Treatment Period 2||5
385117|NCT01891864|944949|P5|NOT COMPLETED|Treatment Period 2||4
385118|NCT01891864|944950|P4|NOT COMPLETED|Treatment Period 2||9
385119|NCT01891864|944951|P3|NOT COMPLETED|Treatment Period 2||7
385120|NCT01891864|944952|P2|NOT COMPLETED|Treatment Period 2||0
385121|NCT01891864|944953|P1|NOT COMPLETED|Treatment Period 2||0
385122|NCT01891864|944948|P6|COMPLETED|Treatment Period 2||91
385123|NCT01891864|944949|P5|COMPLETED|Treatment Period 2||96
385124|NCT01891864|944950|P4|COMPLETED|Treatment Period 2||142
385125|NCT01891864|944951|P3|COMPLETED|Treatment Period 2||143
385126|NCT01891864|944952|P2|COMPLETED|Treatment Period 2||0
385127|NCT01891864|944953|P1|COMPLETED|Treatment Period 2||0
385128|NCT01891864|944948|P6|STARTED|Treatment Period 2|"Part of the patients re-randomized from Enbrel ® Etanercept treatment arm in Treatment Period 1"|96
385129|NCT01891864|944949|P5|STARTED|Treatment Period 2|"Part of the patients re-randomized from GP2015 Etanercept treatment arm in Treatment Period 1"|100
385130|NCT01891864|944950|P4|STARTED|Treatment Period 2|"Part of the patients re-randomized from Enbrel ® Etanercept treatment arm in Treatment Period 1"|151
385131|NCT01891864|944951|P3|STARTED|Treatment Period 2|"Part of the patients re-randomized from GP2015 Etanercept treatment arm in Treatment Period 1"|150
385132|NCT01891864|944952|P2|STARTED|Treatment Period 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
385133|NCT01891864|944953|P1|STARTED|Treatment Period 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
385134|NCT01891864|944948|P6|NOT COMPLETED|Treatment Period 1||0
385135|NCT01891864|944949|P5|NOT COMPLETED|Treatment Period 1||0
385136|NCT01891864|944950|P4|NOT COMPLETED|Treatment Period 1||0
385137|NCT01891864|944951|P3|NOT COMPLETED|Treatment Period 1||0
385138|NCT01891864|944952|P2|NOT COMPLETED|Treatment Period 1||12
385139|NCT01891864|944953|P1|NOT COMPLETED|Treatment Period 1||8
385140|NCT01891864|944948|P6|COMPLETED|Treatment Period 1||0
385141|NCT01891864|944949|P5|COMPLETED|Treatment Period 1||0
385142|NCT01891864|944950|P4|COMPLETED|Treatment Period 1||0
385143|NCT01891864|944951|P3|COMPLETED|Treatment Period 1||0
385144|NCT01891864|944952|P2|COMPLETED|Treatment Period 1|8 patients discontinued after completion of Treatment Period 1 and did NOT start Treatment Period 2|255
385145|NCT01891864|944953|P1|COMPLETED|Treatment Period 1|6 patients discontinued after completion of Treatment Period 1 and did NOT start Treatment Period 2|256
385146|NCT01891864|944948|P6|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
385147|NCT01891864|944949|P5|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
385148|NCT01891864|944950|P4|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
385149|NCT01891864|944951|P3|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
385150|NCT01891864|944952|P2|STARTED|Treatment Period 1||267
385151|NCT01891864|944953|P1|STARTED|Treatment Period 1||264
385152|NCT01891734|944975|P2|NOT COMPLETED|Overall Study||3
385153|NCT01891734|944976|P1|NOT COMPLETED|Overall Study||3
385154|NCT01891734|944975|P2|COMPLETED|Overall Study||13
385155|NCT01891734|944976|P1|COMPLETED|Overall Study||14
385156|NCT01891734|944975|P2|STARTED|Overall Study||16
385157|NCT01891734|944976|P1|STARTED|Overall Study||17
385158|NCT01891669|944996|P10|NOT COMPLETED|Overall Study||2
385159|NCT01891669|944997|P9|NOT COMPLETED|Overall Study||1
385160|NCT01891669|944998|P8|NOT COMPLETED|Overall Study||4
385161|NCT01891669|944999|P7|NOT COMPLETED|Overall Study||1
385162|NCT01891669|945000|P6|NOT COMPLETED|Overall Study||0
385163|NCT01891669|945001|P5|NOT COMPLETED|Overall Study||0
385164|NCT01891669|945002|P4|NOT COMPLETED|Overall Study||0
385165|NCT01891669|945003|P3|NOT COMPLETED|Overall Study||0
385166|NCT01891669|945004|P2|NOT COMPLETED|Overall Study||1
385167|NCT01891669|945005|P1|NOT COMPLETED|Overall Study||2
385168|NCT01891669|944996|P10|COMPLETED|Overall Study||1
385169|NCT01891669|944997|P9|COMPLETED|Overall Study||2
385170|NCT01891669|944998|P8|COMPLETED|Overall Study||2
385171|NCT01891669|944999|P7|COMPLETED|Overall Study||1
385172|NCT01891669|945000|P6|COMPLETED|Overall Study||2
385173|NCT01891669|945001|P5|COMPLETED|Overall Study||2
385174|NCT01891669|945002|P4|COMPLETED|Overall Study||2
385175|NCT01891669|945003|P3|COMPLETED|Overall Study||2
385176|NCT01891669|945004|P2|COMPLETED|Overall Study||1
385177|NCT01891669|945005|P1|COMPLETED|Overall Study||0
385178|NCT01891669|944996|P10|STARTED|Overall Study||3
385179|NCT01891669|944997|P9|STARTED|Overall Study||3
385180|NCT01891669|944998|P8|STARTED|Overall Study||6
385181|NCT01891669|944999|P7|STARTED|Overall Study||2
385182|NCT01891669|945000|P6|STARTED|Overall Study||2
385183|NCT01891669|945001|P5|STARTED|Overall Study||2
385184|NCT01891669|945002|P4|STARTED|Overall Study||2
385185|NCT01891669|945003|P3|STARTED|Overall Study||2
385186|NCT01891669|945004|P2|STARTED|Overall Study||2
385187|NCT01891669|945005|P1|STARTED|Overall Study||2
385188|NCT01890967|945162|P6|NOT COMPLETED|Overall Study||13
385189|NCT01890967|945163|P5|NOT COMPLETED|Overall Study||10
385190|NCT01890967|945164|P4|NOT COMPLETED|Overall Study||11
385191|NCT01890967|945165|P3|NOT COMPLETED|Overall Study||10
385192|NCT01890967|945166|P2|NOT COMPLETED|Overall Study||11
385193|NCT01890967|945167|P1|NOT COMPLETED|Overall Study||10
385194|NCT01890967|945162|P6|COMPLETED|Overall Study||75
385195|NCT01890967|945163|P5|COMPLETED|Overall Study||77
385196|NCT01890967|945164|P4|COMPLETED|Overall Study||77
385197|NCT01890967|945165|P3|COMPLETED|Overall Study||78
385198|NCT01890967|945166|P2|COMPLETED|Overall Study||77
385199|NCT01890967|945167|P1|COMPLETED|Overall Study||78
385200|NCT01890967|945162|P6|Received at Least One Dose of Study Drug|Overall Study||87
385201|NCT01890967|945163|P5|Received at Least One Dose of Study Drug|Overall Study||86
385202|NCT01890967|945164|P4|Received at Least One Dose of Study Drug|Overall Study||86
385203|NCT01890967|945165|P3|Received at Least One Dose of Study Drug|Overall Study||86
385204|NCT01890967|945166|P2|Received at Least One Dose of Study Drug|Overall Study||87
385205|NCT01890967|945167|P1|Received at Least One Dose of Study Drug|Overall Study||87
385206|NCT01890967|945162|P6|STARTED|Overall Study||88
385207|NCT01890967|945163|P5|STARTED|Overall Study||87
385208|NCT01890967|945164|P4|STARTED|Overall Study||88
385209|NCT01890967|945165|P3|STARTED|Overall Study||88
385210|NCT01890967|945166|P2|STARTED|Overall Study||88
385211|NCT01890967|945167|P1|STARTED|Overall Study||88
385212|NCT01890954|945236|P2|NOT COMPLETED|Overall Study||0
385213|NCT01890954|945237|P1|NOT COMPLETED|Overall Study||1
385214|NCT01890954|945236|P2|COMPLETED|Overall Study||8
385215|NCT01890954|945237|P1|COMPLETED|Overall Study||8
385216|NCT01890954|945236|P2|STARTED|Overall Study||8
385217|NCT01890954|945237|P1|STARTED|Overall Study||9
385218|NCT01890915|945245|P2|NOT COMPLETED|Overall Study||1
385219|NCT01890915|945246|P1|NOT COMPLETED|Overall Study||3
385220|NCT01890915|945245|P2|COMPLETED|Overall Study||9
385221|NCT01890915|945246|P1|COMPLETED|Overall Study||8
385222|NCT01890915|945245|P2|STARTED|Overall Study||10
385223|NCT01890915|945246|P1|STARTED|Overall Study||11
385224|NCT01890785|945262|P6|NOT COMPLETED|Third Intervention||0
385225|NCT01890785|945263|P5|NOT COMPLETED|Third Intervention||0
385226|NCT01890785|945264|P4|NOT COMPLETED|Third Intervention||0
385227|NCT01890785|945265|P3|NOT COMPLETED|Third Intervention||0
385228|NCT01890785|945266|P2|NOT COMPLETED|Third Intervention||1
385229|NCT01890785|945267|P1|NOT COMPLETED|Third Intervention||0
385230|NCT01890785|945262|P6|COMPLETED|Third Intervention||5
385231|NCT01890785|945263|P5|COMPLETED|Third Intervention||5
385232|NCT01890785|945264|P4|COMPLETED|Third Intervention||5
385233|NCT01890785|945265|P3|COMPLETED|Third Intervention||5
385234|NCT01890785|945266|P2|COMPLETED|Third Intervention||4
385235|NCT01890785|945267|P1|COMPLETED|Third Intervention||5
385236|NCT01890785|945262|P6|STARTED|Third Intervention||5
385237|NCT01890785|945263|P5|STARTED|Third Intervention||5
385238|NCT01890785|945264|P4|STARTED|Third Intervention||5
385239|NCT01890785|945265|P3|STARTED|Third Intervention||5
385240|NCT01890785|945266|P2|STARTED|Third Intervention||5
385241|NCT01890785|945267|P1|STARTED|Third Intervention||5
385242|NCT01890785|945262|P6|NOT COMPLETED|Second Intervention||0
385243|NCT01890785|945263|P5|NOT COMPLETED|Second Intervention||0
385244|NCT01890785|945264|P4|NOT COMPLETED|Second Intervention||0
385245|NCT01890785|945265|P3|NOT COMPLETED|Second Intervention||0
385246|NCT01890785|945266|P2|NOT COMPLETED|Second Intervention||0
385247|NCT01890785|945267|P1|NOT COMPLETED|Second Intervention||0
385248|NCT01890785|945262|P6|COMPLETED|Second Intervention||5
385249|NCT01890785|945263|P5|COMPLETED|Second Intervention||5
385250|NCT01890785|945264|P4|COMPLETED|Second Intervention||5
385251|NCT01890785|945265|P3|COMPLETED|Second Intervention||5
385252|NCT01890785|945266|P2|COMPLETED|Second Intervention||5
385253|NCT01890785|945267|P1|COMPLETED|Second Intervention||5
385254|NCT01890785|945262|P6|STARTED|Second Intervention||5
385255|NCT01890785|945263|P5|STARTED|Second Intervention||5
385256|NCT01890785|945264|P4|STARTED|Second Intervention||5
385257|NCT01890785|945265|P3|STARTED|Second Intervention||5
385258|NCT01890785|945266|P2|STARTED|Second Intervention||5
385259|NCT01890785|945267|P1|STARTED|Second Intervention||5
385260|NCT01890785|945262|P6|NOT COMPLETED|First Intervention||0
385261|NCT01890785|945263|P5|NOT COMPLETED|First Intervention||0
385262|NCT01890785|945264|P4|NOT COMPLETED|First Intervention||0
385263|NCT01890785|945265|P3|NOT COMPLETED|First Intervention||0
385264|NCT01890785|945266|P2|NOT COMPLETED|First Intervention||0
385265|NCT01890785|945267|P1|NOT COMPLETED|First Intervention||0
385266|NCT01890785|945262|P6|COMPLETED|First Intervention||5
385267|NCT01890785|945263|P5|COMPLETED|First Intervention||5
385268|NCT01890785|945264|P4|COMPLETED|First Intervention||5
385269|NCT01890785|945265|P3|COMPLETED|First Intervention||5
385270|NCT01890785|945266|P2|COMPLETED|First Intervention||5
385271|NCT01890785|945267|P1|COMPLETED|First Intervention||5
385272|NCT01890785|945262|P6|STARTED|First Intervention||5
385273|NCT01890785|945263|P5|STARTED|First Intervention||5
385274|NCT01890785|945264|P4|STARTED|First Intervention||5
385275|NCT01890785|945265|P3|STARTED|First Intervention||5
385276|NCT01890785|945266|P2|STARTED|First Intervention||5
385277|NCT01890785|945267|P1|STARTED|First Intervention||5
385278|NCT01890759|945286|P2|NOT COMPLETED|Overall Study||12
385279|NCT01890759|945287|P1|NOT COMPLETED|Overall Study||2
385280|NCT01890759|945286|P2|COMPLETED|Overall Study||188
385281|NCT01890759|945287|P1|COMPLETED|Overall Study||98
385282|NCT01890759|945286|P2|STARTED|Overall Study||200
385283|NCT01890759|945287|P1|STARTED|Overall Study||100
385284|NCT01890746|945321|P2|NOT COMPLETED|Overall Study||74
385285|NCT01890746|945322|P1|NOT COMPLETED|Overall Study||74
385286|NCT01890746|945321|P2|COMPLETED|Overall Study||0
385287|NCT01890746|945322|P1|COMPLETED|Overall Study||0
385288|NCT01890746|945321|P2|STARTED|Overall Study||74
385289|NCT01890746|945322|P1|STARTED|Overall Study||74
385290|NCT01890694|945348|P2|NOT COMPLETED|Overall Study||1
385291|NCT01890694|945349|P1|NOT COMPLETED|Overall Study||1
385292|NCT01890694|945348|P2|COMPLETED|Overall Study||0
385293|NCT01890694|945349|P1|COMPLETED|Overall Study||0
385294|NCT01890694|945348|P2|STARTED|Overall Study||1
385295|NCT01890694|945349|P1|STARTED|Overall Study||1
385296|NCT01890642|945384|P3|NOT COMPLETED|Overall Study||0
385297|NCT01890642|945385|P2|NOT COMPLETED|Overall Study||0
385298|NCT01890642|945386|P1|NOT COMPLETED|Overall Study||0
385299|NCT01890642|945384|P3|COMPLETED|Overall Study||96
385300|NCT01890642|945385|P2|COMPLETED|Overall Study||53
385301|NCT01890642|945386|P1|COMPLETED|Overall Study||56
385302|NCT01890642|945384|P3|STARTED|Overall Study||96
385303|NCT01890642|945385|P2|STARTED|Overall Study||53
385304|NCT01890642|945386|P1|STARTED|Overall Study||56
385305|NCT01890577|945406|P1|NOT COMPLETED|Overall Study||28
385306|NCT01890577|945406|P1|COMPLETED|Overall Study||0
385307|NCT01890577|945406|P1|STARTED|Overall Study||28
385308|NCT01890512|945419|P1|NOT COMPLETED|Overall Study||3
385309|NCT01890512|945419|P1|COMPLETED|Overall Study||17
385310|NCT01890512|945419|P1|STARTED|Overall Study||20
385311|NCT01890473|945425|P2|NOT COMPLETED|Overall Study||0
385312|NCT01890473|945426|P1|NOT COMPLETED|Overall Study||2
385313|NCT01890473|945425|P2|COMPLETED|Overall Study||113
385314|NCT01890473|945426|P1|COMPLETED|Overall Study||109
385315|NCT01890473|945425|P2|STARTED|Overall Study||113
385316|NCT01890473|945426|P1|STARTED|Overall Study||111
385317|NCT01890434|945452|P1|NOT COMPLETED|Overall Study||20
385318|NCT01890434|945452|P1|COMPLETED|Overall Study||458
385319|NCT01890434|945452|P1|Evaluated for Efficacy|Overall Study||389
385320|NCT01890434|945452|P1|STARTED|Overall Study||478
385321|NCT01890421|945482|P1|NOT COMPLETED|Overall Study||11
385322|NCT01890421|945482|P1|COMPLETED|Overall Study||415
385323|NCT01890421|945482|P1|STARTED|Overall Study||426
385324|NCT01890343|945508|P3|NOT COMPLETED|Overall Study||0
385325|NCT01890343|945509|P2|NOT COMPLETED|Overall Study||0
385326|NCT01890343|945510|P1|NOT COMPLETED|Overall Study||0
385327|NCT01890343|945508|P3|COMPLETED|Overall Study||10
385328|NCT01890343|945509|P2|COMPLETED|Overall Study||10
385329|NCT01890343|945510|P1|COMPLETED|Overall Study||8
385330|NCT01890343|945508|P3|STARTED|Overall Study||10
385331|NCT01890343|945509|P2|STARTED|Overall Study||10
385332|NCT01890343|945510|P1|STARTED|Overall Study||8
385333|NCT01890148|945521|P1|NOT COMPLETED|Overall Study||1
385334|NCT01890148|945521|P1|COMPLETED|Overall Study||4
385335|NCT01890148|945521|P1|STARTED|Overall Study||5
385336|NCT01890122|945541|P4|NOT COMPLETED|Overall Study||59
385337|NCT01890122|945542|P3|NOT COMPLETED|Overall Study||13
385338|NCT01890122|945543|P2|NOT COMPLETED|Overall Study||37
385339|NCT01890122|945544|P1|NOT COMPLETED|Overall Study||27
385340|NCT01890122|945541|P4|COMPLETED|Overall Study||104
385341|NCT01890122|945542|P3|COMPLETED|Overall Study||146
385342|NCT01890122|945543|P2|COMPLETED|Overall Study||126
385343|NCT01890122|945544|P1|COMPLETED|Overall Study||135
385344|NCT01890122|945541|P4|Treated|Overall Study||163
385345|NCT01890122|945542|P3|Treated|Overall Study||159
385346|NCT01890122|945543|P2|Treated|Overall Study||162
385442|NCT01887678|945799|P1|COMPLETED|Overall Study||102
385347|NCT01890122|945544|P1|Treated|Overall Study|Treated = Randomized participants who received at least one dose of study drug.|161
385348|NCT01890122|945541|P4|STARTED|Overall Study||163
385349|NCT01890122|945542|P3|STARTED|Overall Study||159
385350|NCT01890122|945543|P2|STARTED|Overall Study||163
385351|NCT01890122|945544|P1|STARTED|Overall Study|Started = Enrolled set which included all participants who signed informed consent.|162
385352|NCT01890031|945611|P5|NOT COMPLETED|Overall Study||0
385353|NCT01890031|945612|P4|NOT COMPLETED|Overall Study||0
385354|NCT01890031|945613|P3|NOT COMPLETED|Overall Study||0
385355|NCT01890031|945614|P2|NOT COMPLETED|Overall Study||0
385356|NCT01890031|945615|P1|NOT COMPLETED|Overall Study||0
385357|NCT01890031|945611|P5|COMPLETED|Overall Study||8
385358|NCT01890031|945612|P4|COMPLETED|Overall Study||11
385359|NCT01890031|945613|P3|COMPLETED|Overall Study||12
385360|NCT01890031|945614|P2|COMPLETED|Overall Study||50
385361|NCT01890031|945615|P1|COMPLETED|Overall Study||50
385362|NCT01890031|945611|P5|STARTED|Overall Study||8
385363|NCT01890031|945612|P4|STARTED|Overall Study||11
385364|NCT01890031|945613|P3|STARTED|Overall Study||12
385365|NCT01890031|945614|P2|STARTED|Overall Study||50
385366|NCT01890031|945615|P1|STARTED|Overall Study||50
385367|NCT01889797|945634|P2|NOT COMPLETED|Overall Study||0
385368|NCT01889797|945635|P1|NOT COMPLETED|Overall Study||0
385369|NCT01889797|945634|P2|COMPLETED|Overall Study||16
385370|NCT01889797|945635|P1|COMPLETED|Overall Study||16
385371|NCT01889797|945634|P2|STARTED|Overall Study||16
385372|NCT01889797|945635|P1|STARTED|Overall Study||16
385373|NCT01889667|945650|P3|NOT COMPLETED|Overall Study||0
385374|NCT01889667|945651|P2|NOT COMPLETED|Overall Study||0
385375|NCT01889667|945652|P1|NOT COMPLETED|Overall Study||0
385376|NCT01889667|945650|P3|COMPLETED|Overall Study||10
385377|NCT01889667|945651|P2|COMPLETED|Overall Study||10
385378|NCT01889667|945652|P1|COMPLETED|Overall Study||10
385379|NCT01889667|945650|P3|STARTED|Overall Study||10
385380|NCT01889667|945651|P2|STARTED|Overall Study||10
385381|NCT01889667|945652|P1|STARTED|Overall Study||10
385382|NCT01889563|945674|P2|NOT COMPLETED|Overall Study||5
385383|NCT01889563|945675|P1|NOT COMPLETED|Overall Study||7
385384|NCT01889563|945674|P2|COMPLETED|Overall Study||10
385385|NCT01889563|945675|P1|COMPLETED|Overall Study||10
385386|NCT01889563|945674|P2|STARTED|Overall Study||15
385387|NCT01889563|945675|P1|STARTED|Overall Study||17
385388|NCT01889420|945683|P1|NOT COMPLETED|Overall Study||0
385389|NCT01889420|945683|P1|COMPLETED|Overall Study||1
385390|NCT01889420|945683|P1|STARTED|Overall Study||1
385391|NCT01889251|945691|P2|NOT COMPLETED|Overall Study||0
385392|NCT01889251|945692|P1|NOT COMPLETED|Overall Study||1
385393|NCT01889251|945691|P2|COMPLETED|Overall Study||57
385394|NCT01889251|945692|P1|COMPLETED|Overall Study||114
385395|NCT01889251|945691|P2|STARTED|Overall Study||57
385396|NCT01889251|945692|P1|STARTED|Overall Study||115
385397|NCT01888965|945698|P1|NOT COMPLETED|Overall Study||9
385398|NCT01888965|945698|P1|COMPLETED|Overall Study||0
385399|NCT01888965|945698|P1|STARTED|Overall Study||9
385400|NCT01888952|945704|P1|NOT COMPLETED|Overall Study||0
385401|NCT01888952|945704|P1|COMPLETED|Overall Study||10
385402|NCT01888952|945704|P1|STARTED|Overall Study||10
385403|NCT01888900|945710|P2|NOT COMPLETED|Overall Study||2
385404|NCT01888900|945711|P1|NOT COMPLETED|Overall Study||0
385405|NCT01888900|945710|P2|COMPLETED|Overall Study||11
385406|NCT01888900|945711|P1|COMPLETED|Overall Study||22
385407|NCT01888900|945710|P2|STARTED|Overall Study||13
385408|NCT01888900|945711|P1|STARTED|Overall Study||22
385409|NCT01888367|945734|P3|NOT COMPLETED|Overall Study||5
385410|NCT01888367|945735|P2|NOT COMPLETED|Overall Study||5
385411|NCT01888367|945736|P1|NOT COMPLETED|Overall Study||8
385412|NCT01888367|945734|P3|COMPLETED|Overall Study||73
385413|NCT01888367|945735|P2|COMPLETED|Overall Study||66
385414|NCT01888367|945736|P1|COMPLETED|Overall Study||288
385415|NCT01888367|945734|P3|STARTED|Overall Study||78
385416|NCT01888367|945735|P2|STARTED|Overall Study||71
385417|NCT01888367|945736|P1|STARTED|Overall Study||296
385418|NCT01888003|945756|P3|NOT COMPLETED|Overall Study||40
385419|NCT01888003|945757|P2|NOT COMPLETED|Overall Study||6
385420|NCT01888003|945758|P1|NOT COMPLETED|Overall Study||5
385421|NCT01888003|945756|P3|COMPLETED|Overall Study||0
385422|NCT01888003|945757|P2|COMPLETED|Overall Study||0
385423|NCT01888003|945758|P1|COMPLETED|Overall Study||0
385424|NCT01888003|945756|P3|STARTED|Overall Study||40
385425|NCT01888003|945757|P2|STARTED|Overall Study||6
385426|NCT01888003|945758|P1|STARTED|Overall Study||5
385427|NCT01887990|945779|P4|NOT COMPLETED|Overall Study||0
385428|NCT01887990|945780|P3|NOT COMPLETED|Overall Study||0
385429|NCT01887990|945781|P2|NOT COMPLETED|Overall Study||0
385430|NCT01887990|945782|P1|NOT COMPLETED|Overall Study||0
385431|NCT01887990|945779|P4|COMPLETED|Overall Study||2
385432|NCT01887990|945780|P3|COMPLETED|Overall Study||2
385433|NCT01887990|945781|P2|COMPLETED|Overall Study||7
385434|NCT01887990|945782|P1|COMPLETED|Overall Study||7
385435|NCT01887990|945779|P4|STARTED|Overall Study||2
385436|NCT01887990|945780|P3|STARTED|Overall Study||2
385437|NCT01887990|945781|P2|STARTED|Overall Study||7
385438|NCT01887990|945782|P1|STARTED|Overall Study||7
385439|NCT01887678|945798|P2|NOT COMPLETED|Overall Study||28
385440|NCT01887678|945799|P1|NOT COMPLETED|Overall Study||17
385441|NCT01887678|945798|P2|COMPLETED|Overall Study||85
385443|NCT01887678|945798|P2|STARTED|Overall Study||113
385444|NCT01887678|945799|P1|STARTED|Overall Study||119
385445|NCT01887470|945845|P4|NOT COMPLETED|Overall Study||0
385446|NCT01887470|945846|P3|NOT COMPLETED|Overall Study||0
385447|NCT01887470|945847|P2|NOT COMPLETED|Overall Study||0
385448|NCT01887470|945848|P1|NOT COMPLETED|Overall Study||0
385449|NCT01887470|945845|P4|COMPLETED|Overall Study||10
385450|NCT01887470|945846|P3|COMPLETED|Overall Study||10
385451|NCT01887470|945847|P2|COMPLETED|Overall Study||10
385452|NCT01887470|945848|P1|COMPLETED|Overall Study||10
385453|NCT01887470|945845|P4|STARTED|Overall Study||10
385454|NCT01887470|945846|P3|STARTED|Overall Study||10
385455|NCT01887470|945847|P2|STARTED|Overall Study||10
385456|NCT01887470|945848|P1|STARTED|Overall Study||10
385457|NCT01887418|945867|P3|NOT COMPLETED|Overall Study||1
385458|NCT01887418|945868|P2|NOT COMPLETED|Overall Study||0
385459|NCT01887418|945869|P1|NOT COMPLETED|Overall Study||0
385460|NCT01887418|945867|P3|COMPLETED|Overall Study||9
385461|NCT01887418|945868|P2|COMPLETED|Overall Study||14
385462|NCT01887418|945869|P1|COMPLETED|Overall Study||15
385463|NCT01887418|945867|P3|STARTED|Overall Study||10
385464|NCT01887418|945868|P2|STARTED|Overall Study||14
385465|NCT01887418|945869|P1|STARTED|Overall Study||15
385466|NCT01887353|945888|P2|NOT COMPLETED|Overall Study||3
385467|NCT01887353|945889|P1|NOT COMPLETED|Overall Study||4
385468|NCT01887353|945888|P2|COMPLETED|Overall Study|Study was stopped early because of difficulty recruiting.|1
385469|NCT01887353|945889|P1|COMPLETED|Overall Study|Study was stopped early because of difficulty recruiting.|0
385470|NCT01887353|945888|P2|STARTED|Overall Study||4
385471|NCT01887353|945889|P1|STARTED|Overall Study||4
385472|NCT01887288|945895|P1|NOT COMPLETED|Overall Study||16
385473|NCT01887288|945895|P1|COMPLETED|Overall Study||0
385474|NCT01887288|945895|P1|STARTED|Overall Study||16
385475|NCT01887171|945902|P2|NOT COMPLETED|Overall Study||0
385476|NCT01887171|945903|P1|NOT COMPLETED|Overall Study||0
385477|NCT01887171|945902|P2|COMPLETED|Overall Study||43
385478|NCT01887171|945903|P1|COMPLETED|Overall Study||43
385479|NCT01887171|945902|P2|STARTED|Overall Study||43
385480|NCT01887171|945903|P1|STARTED|Overall Study||43
385481|NCT01887132|945909|P1|NOT COMPLETED|Overall Study||0
385482|NCT01887132|945909|P1|COMPLETED|Overall Study||4
385483|NCT01887132|945909|P1|STARTED|Overall Study||4
385484|NCT01886963|945916|P2|NOT COMPLETED|Overall Study||4
385485|NCT01886963|945917|P1|NOT COMPLETED|Overall Study||5
385486|NCT01886963|945916|P2|COMPLETED|Overall Study||49
385487|NCT01886963|945917|P1|COMPLETED|Overall Study||46
385488|NCT01886963|945916|P2|12 Week Follow Up|Overall Study||22
385489|NCT01886963|945917|P1|12 Week Follow Up|Overall Study||24
385490|NCT01886963|945916|P2|4 Week Follow Up|Overall Study||26
385491|NCT01886963|945917|P1|4 Week Follow Up|Overall Study||24
385492|NCT01886963|945916|P2|2 Week Follow Up|Overall Study||35
385493|NCT01886963|945917|P1|2 Week Follow Up|Overall Study||38
385494|NCT01886963|945916|P2|STARTED|Overall Study||53
385495|NCT01886963|945917|P1|STARTED|Overall Study||51
385496|NCT01886937|945925|P2|NOT COMPLETED|Overall Study||0
385497|NCT01886937|945926|P1|NOT COMPLETED|Overall Study||0
385498|NCT01886937|945925|P2|COMPLETED|Overall Study||6
385499|NCT01886937|945926|P1|COMPLETED|Overall Study||7
385500|NCT01886937|945925|P2|STARTED|Overall Study||6
385501|NCT01886937|945926|P1|STARTED|Overall Study||7
385502|NCT01886807|945935|P3|NOT COMPLETED|Overall Study||10
385503|NCT01886807|945936|P2|NOT COMPLETED|Overall Study||10
385504|NCT01886807|945937|P1|NOT COMPLETED|Overall Study||5
385505|NCT01886807|945935|P3|COMPLETED|Overall Study||153
385506|NCT01886807|945936|P2|COMPLETED|Overall Study||145
385507|NCT01886807|945937|P1|COMPLETED|Overall Study||159
385508|NCT01886807|945935|P3|STARTED|Overall Study||163
385509|NCT01886807|945936|P2|STARTED|Overall Study||155
385510|NCT01886807|945937|P1|STARTED|Overall Study||164
385511|NCT01886781|945947|P2|NOT COMPLETED|Overall Study||2
385512|NCT01886781|945948|P1|NOT COMPLETED|Overall Study||14
385513|NCT01886781|945947|P2|COMPLETED|Overall Study||25
385514|NCT01886781|945948|P1|COMPLETED|Overall Study||40
385515|NCT01886781|945947|P2|STARTED|Overall Study||27
385516|NCT01886781|945948|P1|STARTED|Overall Study||54
385517|NCT01886716|945958|P4|NOT COMPLETED|1-Month Post Follow-Up||0
385518|NCT01886716|945959|P3|NOT COMPLETED|1-Month Post Follow-Up||0
385519|NCT01886716|945960|P2|NOT COMPLETED|1-Month Post Follow-Up||0
385520|NCT01886716|945961|P1|NOT COMPLETED|1-Month Post Follow-Up||0
385521|NCT01886716|945958|P4|COMPLETED|1-Month Post Follow-Up||14
385522|NCT01886716|945959|P3|COMPLETED|1-Month Post Follow-Up||19
385523|NCT01886716|945960|P2|COMPLETED|1-Month Post Follow-Up||17
385524|NCT01886716|945961|P1|COMPLETED|1-Month Post Follow-Up||20
385525|NCT01886716|945958|P4|STARTED|1-Month Post Follow-Up||14
385526|NCT01886716|945959|P3|STARTED|1-Month Post Follow-Up||19
385527|NCT01886716|945960|P2|STARTED|1-Month Post Follow-Up||17
385528|NCT01886716|945961|P1|STARTED|1-Month Post Follow-Up||20
385529|NCT01886716|945958|P4|NOT COMPLETED|1-Week Post Follow-Up||0
385530|NCT01886716|945959|P3|NOT COMPLETED|1-Week Post Follow-Up||0
385531|NCT01886716|945960|P2|NOT COMPLETED|1-Week Post Follow-Up||0
385532|NCT01886716|945961|P1|NOT COMPLETED|1-Week Post Follow-Up||0
385533|NCT01886716|945958|P4|COMPLETED|1-Week Post Follow-Up||14
385534|NCT01886716|945959|P3|COMPLETED|1-Week Post Follow-Up||19
385535|NCT01886716|945960|P2|COMPLETED|1-Week Post Follow-Up||17
385536|NCT01886716|945961|P1|COMPLETED|1-Week Post Follow-Up||20
385537|NCT01886716|945958|P4|STARTED|1-Week Post Follow-Up||14
385538|NCT01886716|945959|P3|STARTED|1-Week Post Follow-Up||19
385539|NCT01886716|945960|P2|STARTED|1-Week Post Follow-Up||17
385540|NCT01886716|945961|P1|STARTED|1-Week Post Follow-Up||20
385541|NCT01886716|945958|P4|NOT COMPLETED|Week 4||0
385542|NCT01886716|945959|P3|NOT COMPLETED|Week 4||0
385543|NCT01886716|945960|P2|NOT COMPLETED|Week 4||0
385544|NCT01886716|945961|P1|NOT COMPLETED|Week 4||0
385545|NCT01886716|945958|P4|COMPLETED|Week 4||14
385546|NCT01886716|945959|P3|COMPLETED|Week 4||19
385547|NCT01886716|945960|P2|COMPLETED|Week 4||17
385548|NCT01886716|945961|P1|COMPLETED|Week 4||20
385549|NCT01886716|945958|P4|STARTED|Week 4||14
385550|NCT01886716|945959|P3|STARTED|Week 4||19
385551|NCT01886716|945960|P2|STARTED|Week 4||17
385552|NCT01886716|945961|P1|STARTED|Week 4||20
385553|NCT01886716|945958|P4|NOT COMPLETED|Week 3||1
385554|NCT01886716|945959|P3|NOT COMPLETED|Week 3||0
385555|NCT01886716|945960|P2|NOT COMPLETED|Week 3||1
385556|NCT01886716|945961|P1|NOT COMPLETED|Week 3||1
385557|NCT01886716|945958|P4|COMPLETED|Week 3||14
385558|NCT01886716|945959|P3|COMPLETED|Week 3||19
385559|NCT01886716|945960|P2|COMPLETED|Week 3||17
385560|NCT01886716|945961|P1|COMPLETED|Week 3||20
385561|NCT01886716|945958|P4|STARTED|Week 3||15
385562|NCT01886716|945959|P3|STARTED|Week 3||19
385563|NCT01886716|945960|P2|STARTED|Week 3||18
385564|NCT01886716|945961|P1|STARTED|Week 3||21
385565|NCT01886716|945958|P4|NOT COMPLETED|Week 2||3
385566|NCT01886716|945959|P3|NOT COMPLETED|Week 2||1
385567|NCT01886716|945960|P2|NOT COMPLETED|Week 2||2
385568|NCT01886716|945961|P1|NOT COMPLETED|Week 2||3
385569|NCT01886716|945958|P4|COMPLETED|Week 2||15
385570|NCT01886716|945959|P3|COMPLETED|Week 2||19
385571|NCT01886716|945960|P2|COMPLETED|Week 2||18
385572|NCT01886716|945961|P1|COMPLETED|Week 2||21
385573|NCT01886716|945958|P4|STARTED|Week 2||18
385574|NCT01886716|945959|P3|STARTED|Week 2||20
385575|NCT01886716|945960|P2|STARTED|Week 2||20
385576|NCT01886716|945961|P1|STARTED|Week 2||24
385577|NCT01886716|945958|P4|NOT COMPLETED|Week 1||2
385578|NCT01886716|945959|P3|NOT COMPLETED|Week 1||2
385579|NCT01886716|945960|P2|NOT COMPLETED|Week 1||0
385580|NCT01886716|945961|P1|NOT COMPLETED|Week 1||0
385581|NCT01886716|945958|P4|COMPLETED|Week 1||18
385582|NCT01886716|945959|P3|COMPLETED|Week 1||20
385583|NCT01886716|945960|P2|COMPLETED|Week 1||20
385584|NCT01886716|945961|P1|COMPLETED|Week 1||24
385585|NCT01886716|945958|P4|STARTED|Week 1||20
385586|NCT01886716|945959|P3|STARTED|Week 1||22
385587|NCT01886716|945960|P2|STARTED|Week 1||20
385588|NCT01886716|945961|P1|STARTED|Week 1||24
385589|NCT01886690|945977|P2|NOT COMPLETED|Overall Study||2
385590|NCT01886690|945978|P1|NOT COMPLETED|Overall Study||0
385591|NCT01886690|945977|P2|COMPLETED|Overall Study||71
385592|NCT01886690|945978|P1|COMPLETED|Overall Study||75
385593|NCT01886690|945977|P2|STARTED|Overall Study||73
385594|NCT01886690|945978|P1|STARTED|Overall Study||75
385595|NCT01886313|945994|P2|NOT COMPLETED|Overall Study||1
385596|NCT01886313|945995|P1|NOT COMPLETED|Overall Study||1
385597|NCT01886313|945994|P2|COMPLETED|Overall Study||4
385598|NCT01886313|945995|P1|COMPLETED|Overall Study||5
385599|NCT01886313|945994|P2|STARTED|Overall Study||5
385600|NCT01886313|945995|P1|STARTED|Overall Study||6
385601|NCT01886300|946001|P1|NOT COMPLETED|Overall Study||16
385602|NCT01886300|946001|P1|COMPLETED|Overall Study||0
385603|NCT01886300|946001|P1|STARTED|Overall Study||16
385604|NCT01886287|946012|P1|NOT COMPLETED|Overall Study||2
385605|NCT01886287|946012|P1|COMPLETED|Overall Study||0
385606|NCT01886287|946012|P1|STARTED|Overall Study||2
385607|NCT01886235|946017|P1|NOT COMPLETED|Overall Study||0
385608|NCT01886235|946017|P1|COMPLETED|Overall Study||10
385609|NCT01886235|946017|P1|STARTED|Overall Study||10
385610|NCT01885936|946030|P2|NOT COMPLETED|Overall Study||0
385611|NCT01885936|946031|P1|NOT COMPLETED|Overall Study||1
385612|NCT01885936|946030|P2|COMPLETED|Overall Study||5
385613|NCT01885936|946031|P1|COMPLETED|Overall Study||7
385614|NCT01885936|946030|P2|STARTED|Overall Study||5
385615|NCT01885936|946031|P1|STARTED|Overall Study||8
385616|NCT01885910|946041|P1|NOT COMPLETED|Overall Study||8
385617|NCT01885910|946041|P1|COMPLETED|Overall Study||24
385618|NCT01885910|946041|P1|STARTED|Overall Study||32
385619|NCT01885871|946055|P1|NOT COMPLETED|Overall Study||0
385620|NCT01885871|946055|P1|COMPLETED|Overall Study||20
385621|NCT01885871|946055|P1|STARTED|Overall Study||20
385622|NCT01885559|946065|P2|NOT COMPLETED|Overall Study||36
385623|NCT01885559|946066|P1|NOT COMPLETED|Overall Study||24
385624|NCT01885559|946065|P2|COMPLETED|Overall Study||208
385625|NCT01885559|946066|P1|COMPLETED|Overall Study||218
385626|NCT01885559|946065|P2|STARTED|Overall Study||244
385627|NCT01885559|946066|P1|STARTED|Overall Study||242
385628|NCT01885208|946088|P2|NOT COMPLETED|Overall Study||38
385629|NCT01885208|946089|P1|NOT COMPLETED|Overall Study||32
385630|NCT01885208|946088|P2|COMPLETED|Overall Study||369
385631|NCT01885208|946089|P1|COMPLETED|Overall Study||374
385632|NCT01885208|946088|P2|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|85
385727|NCT01883804|946459|P1|NOT COMPLETED|Overall Study||5
385633|NCT01885208|946089|P1|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|82
385634|NCT01885208|946088|P2|Exposed|Overall Study||405
385635|NCT01885208|946089|P1|Exposed|Overall Study||404
385636|NCT01885208|946088|P2|STARTED|Overall Study||407
385637|NCT01885208|946089|P1|STARTED|Overall Study||406
385638|NCT01885117|946107|P2|NOT COMPLETED|Overall Study||0
385639|NCT01885117|946108|P1|NOT COMPLETED|Overall Study||0
385640|NCT01885117|946107|P2|COMPLETED|Overall Study||64
385641|NCT01885117|946108|P1|COMPLETED|Overall Study||61
385642|NCT01885117|946107|P2|STARTED|Overall Study||64
385643|NCT01885117|946108|P1|STARTED|Overall Study||61
385644|NCT01885104|946130|P2|NOT COMPLETED|Overall Study||1
385645|NCT01885104|946131|P1|NOT COMPLETED|Overall Study||2
385646|NCT01885104|946130|P2|COMPLETED|Overall Study||33
385647|NCT01885104|946131|P1|COMPLETED|Overall Study||29
385648|NCT01885104|946130|P2|STARTED|Overall Study||34
385649|NCT01885104|946131|P1|STARTED|Overall Study||31
385650|NCT01885000|946141|P2|NOT COMPLETED|Overall Study||2
385651|NCT01885000|946142|P1|NOT COMPLETED|Overall Study||2
385652|NCT01885000|946141|P2|COMPLETED|Overall Study||42
385653|NCT01885000|946142|P1|COMPLETED|Overall Study||46
385654|NCT01885000|946141|P2|STARTED|Overall Study||44
385655|NCT01885000|946142|P1|STARTED|Overall Study||48
385656|NCT01884844|946156|P2|NOT COMPLETED|Overall Study||5
385657|NCT01884844|946157|P1|NOT COMPLETED|Overall Study||3
385658|NCT01884844|946156|P2|COMPLETED|Overall Study||12
385659|NCT01884844|946157|P1|COMPLETED|Overall Study||13
385660|NCT01884844|946156|P2|STARTED|Overall Study||17
385661|NCT01884844|946157|P1|STARTED|Overall Study||16
385662|NCT01884688|946163|P1|NOT COMPLETED|Overall Study||2
385663|NCT01884688|946163|P1|COMPLETED|Overall Study||1
385664|NCT01884688|946163|P1|STARTED|Overall Study||3
385665|NCT01884675|946169|P2|NOT COMPLETED|Overall Study||2
385666|NCT01884675|946170|P1|NOT COMPLETED|Overall Study||3
385667|NCT01884675|946169|P2|COMPLETED|Overall Study||15
385668|NCT01884675|946170|P1|COMPLETED|Overall Study||13
385669|NCT01884675|946169|P2|STARTED|Overall Study||17
385670|NCT01884675|946170|P1|STARTED|Overall Study||16
385671|NCT01884597|946213|P3|NOT COMPLETED|Overall Study||1
385672|NCT01884597|946214|P2|NOT COMPLETED|Overall Study||1
385673|NCT01884597|946215|P1|NOT COMPLETED|Overall Study||1
385674|NCT01884597|946213|P3|COMPLETED|Overall Study||15
385675|NCT01884597|946214|P2|COMPLETED|Overall Study||2
385676|NCT01884597|946215|P1|COMPLETED|Overall Study||4
385677|NCT01884597|946213|P3|STARTED|Overall Study||16
385678|NCT01884597|946214|P2|STARTED|Overall Study||3
385679|NCT01884597|946215|P1|STARTED|Overall Study||5
385680|NCT01884571|946244|P1|NOT COMPLETED|Overall Study||8
385681|NCT01884571|946244|P1|COMPLETED|Overall Study||23
385682|NCT01884571|946244|P1|STARTED|Overall Study||31
385683|NCT01884545|946259|P4|NOT COMPLETED|Overall Study||9
385684|NCT01884545|946260|P3|NOT COMPLETED|Overall Study||14
385685|NCT01884545|946261|P2|NOT COMPLETED|Overall Study||18
385686|NCT01884545|946262|P1|NOT COMPLETED|Overall Study||13
385687|NCT01884545|946259|P4|COMPLETED|Overall Study||43
385688|NCT01884545|946260|P3|COMPLETED|Overall Study||35
385689|NCT01884545|946261|P2|COMPLETED|Overall Study||31
385690|NCT01884545|946262|P1|COMPLETED|Overall Study||37
385691|NCT01884545|946259|P4|STARTED|Overall Study||52
385692|NCT01884545|946260|P3|STARTED|Overall Study||49
385693|NCT01884545|946261|P2|STARTED|Overall Study||49
385694|NCT01884545|946262|P1|STARTED|Overall Study||50
385695|NCT01884519|946370|P2|NOT COMPLETED|Overall Study||0
385696|NCT01884519|946371|P1|NOT COMPLETED|Overall Study||0
385697|NCT01884519|946370|P2|COMPLETED|Overall Study||60
385698|NCT01884519|946371|P1|COMPLETED|Overall Study||60
385699|NCT01884519|946370|P2|STARTED|Overall Study||60
385700|NCT01884519|946371|P1|STARTED|Overall Study||60
385701|NCT01884064|946415|P2|NOT COMPLETED|Overall Study||0
385702|NCT01884064|946416|P1|NOT COMPLETED|Overall Study||0
385703|NCT01884064|946415|P2|COMPLETED|Overall Study||5
385704|NCT01884064|946416|P1|COMPLETED|Overall Study||12
385705|NCT01884064|946415|P2|STARTED|Overall Study||5
385706|NCT01884064|946416|P1|STARTED|Overall Study||12
385707|NCT01883999|946422|P1|NOT COMPLETED|Overall Study||3
385708|NCT01883999|946422|P1|COMPLETED|Overall Study||61
385709|NCT01883999|946422|P1|STARTED|Overall Study||64
385710|NCT01883986|946430|P2|NOT COMPLETED|Overall Study||1
385711|NCT01883986|946431|P1|NOT COMPLETED|Overall Study||3
385712|NCT01883986|946430|P2|COMPLETED|Overall Study|Completed study|19
385713|NCT01883986|946431|P1|COMPLETED|Overall Study|Received allocated intervention|17
385714|NCT01883986|946430|P2|Did Not Complete Study|Overall Study|Did not completed study|1
385715|NCT01883986|946431|P1|Did Not Complete Study|Overall Study||3
385716|NCT01883986|946430|P2|STARTED|Overall Study|Allocated to usual care arm|20
385717|NCT01883986|946431|P1|STARTED|Overall Study|Allocated to intervention arm|20
385718|NCT01883908|946445|P2|NOT COMPLETED|Overall Study||0
385719|NCT01883908|946446|P1|NOT COMPLETED|Overall Study||0
385720|NCT01883908|946445|P2|COMPLETED|Overall Study||1
385721|NCT01883908|946446|P1|COMPLETED|Overall Study||3
385722|NCT01883908|946445|P2|STARTED|Overall Study||1
385723|NCT01883908|946446|P1|STARTED|Overall Study||3
385724|NCT01883895|946454|P1|NOT COMPLETED|Overall Study||2
385725|NCT01883895|946454|P1|COMPLETED|Overall Study||32
385726|NCT01883895|946454|P1|STARTED|Overall Study||34
385728|NCT01883804|946459|P1|COMPLETED|Overall Study||20
385729|NCT01883804|946459|P1|STARTED|Overall Study||25
385730|NCT01883635|946468|P2|NOT COMPLETED|Overall Study||0
385731|NCT01883635|946469|P1|NOT COMPLETED|Overall Study||4
385732|NCT01883635|946468|P2|COMPLETED|Overall Study||20
385733|NCT01883635|946469|P1|COMPLETED|Overall Study||20
385734|NCT01883635|946468|P2|STARTED|Overall Study||20
385735|NCT01883635|946469|P1|STARTED|Overall Study||24
385736|NCT01883453|946483|P2|NOT COMPLETED|Overall Study||23
385737|NCT01883453|946484|P1|NOT COMPLETED|Overall Study||25
385738|NCT01883453|946483|P2|COMPLETED|Overall Study||50
385739|NCT01883453|946484|P1|COMPLETED|Overall Study||48
385740|NCT01883453|946483|P2|STARTED|Overall Study||73
385741|NCT01883453|946484|P1|STARTED|Overall Study||73
385742|NCT01883440|946492|P2|NOT COMPLETED|Overall Study||0
385743|NCT01883440|946493|P1|NOT COMPLETED|Overall Study||3
385744|NCT01883440|946492|P2|COMPLETED|Overall Study||45
385745|NCT01883440|946493|P1|COMPLETED|Overall Study||42
385746|NCT01883440|946492|P2|STARTED|Overall Study||45
385747|NCT01883440|946493|P1|STARTED|Overall Study||45
385748|NCT01883427|946503|P2|NOT COMPLETED|Overall Study||0
385749|NCT01883427|946504|P1|NOT COMPLETED|Overall Study||0
385750|NCT01883427|946503|P2|COMPLETED|Overall Study||20
385751|NCT01883427|946504|P1|COMPLETED|Overall Study||20
385752|NCT01883427|946503|P2|STARTED|Overall Study||20
385753|NCT01883427|946504|P1|STARTED|Overall Study||20
385754|NCT01882985|946510|P1|NOT COMPLETED|Overall Study||2
385755|NCT01882985|946510|P1|COMPLETED|Overall Study||12
385756|NCT01882985|946510|P1|STARTED|Overall Study||14
385757|NCT01882907|946519|P2|NOT COMPLETED|Overall Study||28
385758|NCT01882907|946520|P1|NOT COMPLETED|Overall Study||14
385759|NCT01882907|946519|P2|COMPLETED|Overall Study||83
385760|NCT01882907|946520|P1|COMPLETED|Overall Study||103
385761|NCT01882907|946519|P2|STARTED|Overall Study||111
385762|NCT01882907|946520|P1|STARTED|Overall Study||117
385763|NCT01882868|946526|P1|NOT COMPLETED|Overall Study||0
385764|NCT01882868|946526|P1|COMPLETED|Overall Study||62
385765|NCT01882868|946526|P1|STARTED|Overall Study||62
385766|NCT01882829|946556|P1|NOT COMPLETED|Overall Study||6
385767|NCT01882829|946556|P1|COMPLETED|Overall Study||14
385768|NCT01882829|946556|P1|STARTED|Overall Study||20
385769|NCT01882725|946570|P1|NOT COMPLETED|Overall Study||0
385770|NCT01882725|946570|P1|COMPLETED|Overall Study||14
385771|NCT01882725|946570|P1|STARTED|Overall Study||14
385772|NCT01882647|946577|P2|NOT COMPLETED|Overall Study||6
385773|NCT01882647|946578|P1|NOT COMPLETED|Overall Study||2
385774|NCT01882647|946577|P2|COMPLETED|Overall Study||106
385775|NCT01882647|946578|P1|COMPLETED|Overall Study||108
385776|NCT01882647|946577|P2|STARTED|Overall Study||112
385777|NCT01882647|946578|P1|STARTED|Overall Study||110
385778|NCT01882543|946596|P2|NOT COMPLETED|Overall Study||3
385779|NCT01882543|946597|P1|NOT COMPLETED|Overall Study||4
385780|NCT01882543|946596|P2|COMPLETED|Overall Study||29
385781|NCT01882543|946597|P1|COMPLETED|Overall Study||33
385782|NCT01882543|946596|P2|STARTED|Overall Study||32
385783|NCT01882543|946597|P1|STARTED|Overall Study||37
385784|NCT01882465|946618|P7|NOT COMPLETED|Period 3||0
385785|NCT01882465|946619|P6|NOT COMPLETED|Period 3||0
385786|NCT01882465|946620|P5|NOT COMPLETED|Period 3||0
385787|NCT01882465|946621|P4|NOT COMPLETED|Period 3||0
385788|NCT01882465|946622|P3|NOT COMPLETED|Period 3||0
385789|NCT01882465|946623|P2|NOT COMPLETED|Period 3||0
385790|NCT01882465|946624|P1|NOT COMPLETED|Period 3||0
385791|NCT01882465|946618|P7|COMPLETED|Period 3||0
385792|NCT01882465|946619|P6|COMPLETED|Period 3||5
385793|NCT01882465|946620|P5|COMPLETED|Period 3||4
385794|NCT01882465|946621|P4|COMPLETED|Period 3||5
385795|NCT01882465|946622|P3|COMPLETED|Period 3||5
385796|NCT01882465|946623|P2|COMPLETED|Period 3||6
385797|NCT01882465|946624|P1|COMPLETED|Period 3||6
385798|NCT01882465|946618|P7|STARTED|Period 3||0
385799|NCT01882465|946619|P6|STARTED|Period 3||5
385800|NCT01882465|946620|P5|STARTED|Period 3||4
385801|NCT01882465|946621|P4|STARTED|Period 3||5
385802|NCT01882465|946622|P3|STARTED|Period 3||5
385803|NCT01882465|946623|P2|STARTED|Period 3||6
385804|NCT01882465|946624|P1|STARTED|Period 3||6
385805|NCT01882465|946618|P7|NOT COMPLETED|Period 2||0
385806|NCT01882465|946619|P6|NOT COMPLETED|Period 2||0
385807|NCT01882465|946620|P5|NOT COMPLETED|Period 2||1
385808|NCT01882465|946621|P4|NOT COMPLETED|Period 2||0
385809|NCT01882465|946622|P3|NOT COMPLETED|Period 2||0
385810|NCT01882465|946623|P2|NOT COMPLETED|Period 2||0
385811|NCT01882465|946624|P1|NOT COMPLETED|Period 2||0
385812|NCT01882465|946618|P7|COMPLETED|Period 2||0
385813|NCT01882465|946619|P6|COMPLETED|Period 2||5
385814|NCT01882465|946620|P5|COMPLETED|Period 2||4
385815|NCT01882465|946621|P4|COMPLETED|Period 2||5
385816|NCT01882465|946622|P3|COMPLETED|Period 2||5
385817|NCT01882465|946623|P2|COMPLETED|Period 2||6
385818|NCT01882465|946624|P1|COMPLETED|Period 2||6
385819|NCT01882465|946618|P7|STARTED|Period 2||0
385820|NCT01882465|946619|P6|STARTED|Period 2||5
385821|NCT01882465|946620|P5|STARTED|Period 2||5
385822|NCT01882465|946621|P4|STARTED|Period 2||5
385823|NCT01882465|946622|P3|STARTED|Period 2||5
385824|NCT01882465|946623|P2|STARTED|Period 2||6
385825|NCT01882465|946624|P1|STARTED|Period 2||6
385826|NCT01882465|946618|P7|NOT COMPLETED|Period 1||1
385827|NCT01882465|946619|P6|NOT COMPLETED|Period 1||0
385828|NCT01882465|946620|P5|NOT COMPLETED|Period 1||0
385829|NCT01882465|946621|P4|NOT COMPLETED|Period 1||1
385830|NCT01882465|946622|P3|NOT COMPLETED|Period 1||0
385831|NCT01882465|946623|P2|NOT COMPLETED|Period 1||0
385832|NCT01882465|946624|P1|NOT COMPLETED|Period 1||0
385833|NCT01882465|946618|P7|COMPLETED|Period 1||0
385834|NCT01882465|946619|P6|COMPLETED|Period 1||5
385835|NCT01882465|946620|P5|COMPLETED|Period 1||5
385836|NCT01882465|946621|P4|COMPLETED|Period 1||5
385837|NCT01882465|946622|P3|COMPLETED|Period 1||5
385838|NCT01882465|946623|P2|COMPLETED|Period 1||6
385839|NCT01882465|946624|P1|COMPLETED|Period 1||6
385840|NCT01882465|946618|P7|STARTED|Period 1||1
385841|NCT01882465|946619|P6|STARTED|Period 1||5
385842|NCT01882465|946620|P5|STARTED|Period 1||5
385843|NCT01882465|946621|P4|STARTED|Period 1||6
385844|NCT01882465|946622|P3|STARTED|Period 1||5
385845|NCT01882465|946623|P2|STARTED|Period 1||6
385846|NCT01882465|946624|P1|STARTED|Period 1||6
385847|NCT01882439|946636|P4|NOT COMPLETED|Overall Study||9
385848|NCT01882439|946637|P3|NOT COMPLETED|Overall Study||10
385849|NCT01882439|946638|P2|NOT COMPLETED|Overall Study||21
385850|NCT01882439|946639|P1|NOT COMPLETED|Overall Study||9
385851|NCT01882439|946636|P4|COMPLETED|Overall Study||56
385852|NCT01882439|946637|P3|COMPLETED|Overall Study||56
385853|NCT01882439|946638|P2|COMPLETED|Overall Study||111
385854|NCT01882439|946639|P1|COMPLETED|Overall Study||122
385855|NCT01882439|946636|P4|STARTED|Overall Study|Received treatment|65
385856|NCT01882439|946637|P3|STARTED|Overall Study|Received treatment|66
385857|NCT01882439|946638|P2|STARTED|Overall Study|Received treatment|132
385858|NCT01882439|946639|P1|STARTED|Overall Study|Received treatment|131
385859|NCT01882413|946819|P1|NOT COMPLETED|Overall Study||0
385860|NCT01882413|946819|P1|COMPLETED|Overall Study||204
385861|NCT01882413|946819|P1|STARTED|Overall Study||204
385862|NCT01882257|946836|P3|NOT COMPLETED|Therapy Portion of Study (12 Months)||4
385863|NCT01882257|946837|P2|NOT COMPLETED|Therapy Portion of Study (12 Months)||11
385864|NCT01882257|946838|P1|NOT COMPLETED|Therapy Portion of Study (12 Months)||0
385865|NCT01882257|946836|P3|COMPLETED|Therapy Portion of Study (12 Months)||18
385866|NCT01882257|946837|P2|COMPLETED|Therapy Portion of Study (12 Months)||27
385867|NCT01882257|946838|P1|COMPLETED|Therapy Portion of Study (12 Months)||11
385868|NCT01882257|946836|P3|STARTED|Therapy Portion of Study (12 Months)||22
385869|NCT01882257|946837|P2|STARTED|Therapy Portion of Study (12 Months)||38
385870|NCT01882257|946838|P1|STARTED|Therapy Portion of Study (12 Months)||11
385871|NCT01882257|946836|P3|NOT COMPLETED|Study Origination to Beginning Therapy||1
385872|NCT01882257|946837|P2|NOT COMPLETED|Study Origination to Beginning Therapy||2
385873|NCT01882257|946838|P1|NOT COMPLETED|Study Origination to Beginning Therapy||0
385874|NCT01882257|946836|P3|COMPLETED|Study Origination to Beginning Therapy||22
385875|NCT01882257|946837|P2|COMPLETED|Study Origination to Beginning Therapy||38
385876|NCT01882257|946838|P1|COMPLETED|Study Origination to Beginning Therapy||11
385877|NCT01882257|946836|P3|Started Therapy Using Device|Study Origination to Beginning Therapy|Of the 23 who were given the device, 1 chose not to begin the actual therapy|22
385878|NCT01882257|946837|P2|Started Therapy Using Device|Study Origination to Beginning Therapy|Of the 40 who were given the device, 2 chose not to begin the actual therapy|38
385879|NCT01882257|946838|P1|Started Therapy Using Device|Study Origination to Beginning Therapy||11
385880|NCT01882257|946836|P3|STARTED|Study Origination to Beginning Therapy||23
385881|NCT01882257|946837|P2|STARTED|Study Origination to Beginning Therapy||40
385882|NCT01882257|946838|P1|STARTED|Study Origination to Beginning Therapy||11
385883|NCT01882062|946845|P1|NOT COMPLETED|Overall Study||0
385884|NCT01882062|946845|P1|COMPLETED|Overall Study|18th of july 2013|10
385885|NCT01882062|946845|P1|STARTED|Overall Study|16th of may 2013|10
385886|NCT01881984|946849|P1|NOT COMPLETED|Overall Study||0
385887|NCT01881984|946849|P1|COMPLETED|Overall Study||4
385888|NCT01881984|946849|P1|STARTED|Overall Study||4
385889|NCT01881932|946857|P3|NOT COMPLETED|Overall Study||0
385890|NCT01881932|946858|P2|NOT COMPLETED|Overall Study||0
385891|NCT01881932|946859|P1|NOT COMPLETED|Overall Study||0
385892|NCT01881932|946857|P3|COMPLETED|Overall Study||13
385893|NCT01881932|946858|P2|COMPLETED|Overall Study||4
385894|NCT01881932|946859|P1|COMPLETED|Overall Study||2
385895|NCT01881932|946857|P3|STARTED|Overall Study||13
385896|NCT01881932|946858|P2|STARTED|Overall Study||4
385897|NCT01881932|946859|P1|STARTED|Overall Study||2
385898|NCT01881776|946870|P3|NOT COMPLETED|Overall Study||2
385899|NCT01881776|946871|P2|NOT COMPLETED|Overall Study||4
385900|NCT01881776|946872|P1|NOT COMPLETED|Overall Study||1
385901|NCT01881776|946870|P3|COMPLETED|Overall Study||20
385902|NCT01881776|946871|P2|COMPLETED|Overall Study||20
385903|NCT01881776|946872|P1|COMPLETED|Overall Study||23
385904|NCT01881776|946870|P3|STARTED|Overall Study||22
385905|NCT01881776|946871|P2|STARTED|Overall Study||24
385906|NCT01881776|946872|P1|STARTED|Overall Study||24
385907|NCT01881737|946898|P1|NOT COMPLETED|Overall Study||5
385908|NCT01881737|946898|P1|COMPLETED|Overall Study||10
385909|NCT01881737|946898|P1|Number Screened|Overall Study||15
385910|NCT01881737|946898|P1|STARTED|Overall Study|This is a pilot study|15
385911|NCT01881230|946910|P3|NOT COMPLETED|Overall Study||66
385912|NCT01881230|946911|P2|NOT COMPLETED|Overall Study||64
385913|NCT01881230|946912|P1|NOT COMPLETED|Overall Study||61
386002|NCT01880320|947187|P2|COMPLETED|Overall Study||192
385914|NCT01881230|946910|P3|COMPLETED|Overall Study|Not applicable according to the study design|0
385915|NCT01881230|946911|P2|COMPLETED|Overall Study|Not applicable according to the study design|0
385916|NCT01881230|946912|P1|COMPLETED|Overall Study|Not applicable according to the study design|0
385917|NCT01881230|946910|P3|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|64
385918|NCT01881230|946911|P2|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|64
385919|NCT01881230|946912|P1|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|60
385920|NCT01881230|946910|P3|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of IP|64
385921|NCT01881230|946911|P2|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of IP|64
385922|NCT01881230|946912|P1|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of Investigational Product (IP)|60
385923|NCT01881230|946910|P3|STARTED|Overall Study||66
385924|NCT01881230|946911|P2|STARTED|Overall Study||64
385925|NCT01881230|946912|P1|STARTED|Overall Study||61
385926|NCT01881126|946940|P2|NOT COMPLETED|Overall Study||2
385927|NCT01881126|946941|P1|NOT COMPLETED|Overall Study||1
385928|NCT01881126|946940|P2|COMPLETED|Overall Study||44
385929|NCT01881126|946941|P1|COMPLETED|Overall Study||46
385930|NCT01881126|946940|P2|STARTED|Overall Study||46
385931|NCT01881126|946941|P1|STARTED|Overall Study||47
385932|NCT01881113|946949|P2|NOT COMPLETED|Overall Study||6
385933|NCT01881113|946950|P1|NOT COMPLETED|Overall Study||8
385934|NCT01881113|946949|P2|COMPLETED|Overall Study||44
385935|NCT01881113|946950|P1|COMPLETED|Overall Study||43
385936|NCT01881113|946949|P2|STARTED|Overall Study||50
385937|NCT01881113|946950|P1|STARTED|Overall Study||51
385938|NCT01881087|947007|P3|NOT COMPLETED|Overall Study||2
385939|NCT01881087|947008|P2|NOT COMPLETED|Overall Study||0
385940|NCT01881087|947009|P1|NOT COMPLETED|Overall Study||1
385941|NCT01881087|947007|P3|COMPLETED|Overall Study||60
385942|NCT01881087|947008|P2|COMPLETED|Overall Study||61
385943|NCT01881087|947009|P1|COMPLETED|Overall Study||59
385944|NCT01881087|947007|P3|STARTED|Overall Study||62
385945|NCT01881087|947008|P2|STARTED|Overall Study||61
385946|NCT01881087|947009|P1|STARTED|Overall Study||60
385947|NCT01880840|947022|P2|NOT COMPLETED|Overall Study||5
385948|NCT01880840|947023|P1|NOT COMPLETED|Overall Study||8
385949|NCT01880840|947022|P2|COMPLETED|Overall Study||91
385950|NCT01880840|947023|P1|COMPLETED|Overall Study||87
385951|NCT01880840|947022|P2|STARTED|Overall Study||96
385952|NCT01880840|947023|P1|STARTED|Overall Study||95
385953|NCT01880736|947033|P4|NOT COMPLETED|Overall Study||6
385954|NCT01880736|947034|P3|NOT COMPLETED|Overall Study||1
385955|NCT01880736|947035|P2|NOT COMPLETED|Overall Study||2
385956|NCT01880736|947036|P1|NOT COMPLETED|Overall Study||1
385957|NCT01880736|947033|P4|COMPLETED|Overall Study||108
385958|NCT01880736|947034|P3|COMPLETED|Overall Study||114
385959|NCT01880736|947035|P2|COMPLETED|Overall Study||113
385960|NCT01880736|947036|P1|COMPLETED|Overall Study||113
385961|NCT01880736|947033|P4|STARTED|Overall Study||114
385962|NCT01880736|947034|P3|STARTED|Overall Study||115
385963|NCT01880736|947035|P2|STARTED|Overall Study||115
385964|NCT01880736|947036|P1|STARTED|Overall Study||114
385965|NCT01880723|947080|P2|NOT COMPLETED|Overall Study||0
385966|NCT01880723|947081|P1|NOT COMPLETED|Overall Study||0
385967|NCT01880723|947080|P2|COMPLETED|Overall Study||16
385968|NCT01880723|947081|P1|COMPLETED|Overall Study||16
385969|NCT01880723|947080|P2|STARTED|Overall Study||16
385970|NCT01880723|947081|P1|STARTED|Overall Study||16
385971|NCT01880697|947097|P2|NOT COMPLETED|Overall Study||1
385972|NCT01880697|947098|P1|NOT COMPLETED|Overall Study||0
385973|NCT01880697|947097|P2|COMPLETED|Overall Study||62
385974|NCT01880697|947098|P1|COMPLETED|Overall Study||63
385975|NCT01880697|947097|P2|STARTED|Overall Study||63
385976|NCT01880697|947098|P1|STARTED|Overall Study||63
385977|NCT01880515|947120|P2|NOT COMPLETED|Overall Study||9
385978|NCT01880515|947121|P1|NOT COMPLETED|Overall Study||8
385979|NCT01880515|947120|P2|COMPLETED|Overall Study||45
385980|NCT01880515|947121|P1|COMPLETED|Overall Study||45
385981|NCT01880515|947120|P2|STARTED|Overall Study||54
385982|NCT01880515|947121|P1|STARTED|Overall Study||53
385983|NCT01880437|947132|P3|NOT COMPLETED|Overall Study||19
385984|NCT01880437|947133|P2|NOT COMPLETED|Overall Study||4
385985|NCT01880437|947134|P1|NOT COMPLETED|Overall Study||15
385986|NCT01880437|947132|P3|COMPLETED|Overall Study||0
385987|NCT01880437|947133|P2|COMPLETED|Overall Study||0
385988|NCT01880437|947134|P1|COMPLETED|Overall Study||0
385989|NCT01880437|947132|P3|STARTED|Overall Study||19
385990|NCT01880437|947133|P2|STARTED|Overall Study||4
385991|NCT01880437|947134|P1|STARTED|Overall Study||15
385992|NCT01880424|947160|P2|NOT COMPLETED|Overall Study||55
385993|NCT01880424|947161|P1|NOT COMPLETED|Overall Study||33
385994|NCT01880424|947160|P2|COMPLETED|Overall Study||367
385995|NCT01880424|947161|P1|COMPLETED|Overall Study||384
385996|NCT01880424|947160|P2|STARTED|Overall Study||422
385997|NCT01880424|947161|P1|STARTED|Overall Study||417
385998|NCT01880320|947186|P3|NOT COMPLETED|Overall Study||8
385999|NCT01880320|947187|P2|NOT COMPLETED|Overall Study||25
386000|NCT01880320|947188|P1|NOT COMPLETED|Overall Study||20
386001|NCT01880320|947186|P3|COMPLETED|Overall Study||61
386003|NCT01880320|947188|P1|COMPLETED|Overall Study||197
386004|NCT01880320|947186|P3|STARTED|Overall Study||69
386005|NCT01880320|947187|P2|STARTED|Overall Study||217
386006|NCT01880320|947188|P1|STARTED|Overall Study||217
386007|NCT01880099|947205|P3|NOT COMPLETED|Overall Study||7
386008|NCT01880099|947206|P2|NOT COMPLETED|Overall Study||10
386009|NCT01880099|947207|P1|NOT COMPLETED|Overall Study||8
386010|NCT01880099|947205|P3|COMPLETED|Overall Study||15
386011|NCT01880099|947206|P2|COMPLETED|Overall Study||11
386012|NCT01880099|947207|P1|COMPLETED|Overall Study||9
386013|NCT01880099|947205|P3|STARTED|Overall Study||22
386014|NCT01880099|947206|P2|STARTED|Overall Study||21
386015|NCT01880099|947207|P1|STARTED|Overall Study||17
386016|NCT01880086|947217|P2|NOT COMPLETED|Overall Study||1
386017|NCT01880086|947218|P1|NOT COMPLETED|Overall Study||1
386018|NCT01880086|947217|P2|COMPLETED|Overall Study||6
386019|NCT01880086|947218|P1|COMPLETED|Overall Study||5
386020|NCT01880086|947217|P2|STARTED|Overall Study||7
386021|NCT01880086|947218|P1|STARTED|Overall Study||6
386022|NCT01879852|947238|P2|NOT COMPLETED|Overall Study||0
386023|NCT01879852|947239|P1|NOT COMPLETED|Overall Study||2
386024|NCT01879852|947238|P2|COMPLETED|Overall Study||13
386025|NCT01879852|947239|P1|COMPLETED|Overall Study||12
386026|NCT01879852|947238|P2|STARTED|Overall Study||13
386027|NCT01879852|947239|P1|STARTED|Overall Study||14
386028|NCT01879800|947253|P2|NOT COMPLETED|Overall Study||4
386029|NCT01879800|947254|P1|NOT COMPLETED|Overall Study||0
386030|NCT01879800|947253|P2|COMPLETED|Overall Study||26
386031|NCT01879800|947254|P1|COMPLETED|Overall Study||14
386032|NCT01879800|947253|P2|STARTED|Overall Study||30
386033|NCT01879800|947254|P1|STARTED|Overall Study||14
386034|NCT01879735|947266|P2|NOT COMPLETED|Overall Study||0
386035|NCT01879735|947267|P1|NOT COMPLETED|Overall Study||0
386036|NCT01879735|947266|P2|COMPLETED|Overall Study||16
386037|NCT01879735|947267|P1|COMPLETED|Overall Study||6
386038|NCT01879735|947266|P2|STARTED|Overall Study||16
386039|NCT01879735|947267|P1|STARTED|Overall Study||6
386040|NCT01879722|947283|P10|NOT COMPLETED|Overall Study||0
386041|NCT01879722|947284|P9|NOT COMPLETED|Overall Study||2
386042|NCT01879722|947285|P8|NOT COMPLETED|Overall Study||1
386043|NCT01879722|947286|P7|NOT COMPLETED|Overall Study||0
386044|NCT01879722|947287|P6|NOT COMPLETED|Overall Study||0
386045|NCT01879722|947288|P5|NOT COMPLETED|Overall Study||1
386046|NCT01879722|947289|P4|NOT COMPLETED|Overall Study||1
386047|NCT01879722|947290|P3|NOT COMPLETED|Overall Study||0
386048|NCT01879722|947291|P2|NOT COMPLETED|Overall Study||1
386049|NCT01879722|947292|P1|NOT COMPLETED|Overall Study||0
386050|NCT01879722|947283|P10|COMPLETED|Overall Study||6
386051|NCT01879722|947284|P9|COMPLETED|Overall Study||6
386052|NCT01879722|947285|P8|COMPLETED|Overall Study||7
386053|NCT01879722|947286|P7|COMPLETED|Overall Study||8
386054|NCT01879722|947287|P6|COMPLETED|Overall Study||9
386055|NCT01879722|947288|P5|COMPLETED|Overall Study||7
386056|NCT01879722|947289|P4|COMPLETED|Overall Study||7
386057|NCT01879722|947290|P3|COMPLETED|Overall Study||7
386058|NCT01879722|947291|P2|COMPLETED|Overall Study||7
386059|NCT01879722|947292|P1|COMPLETED|Overall Study||7
386060|NCT01879722|947283|P10|STARTED|Overall Study||6
386061|NCT01879722|947284|P9|STARTED|Overall Study||8
386062|NCT01879722|947285|P8|STARTED|Overall Study||8
386063|NCT01879722|947286|P7|STARTED|Overall Study||8
386064|NCT01879722|947287|P6|STARTED|Overall Study||9
386065|NCT01879722|947288|P5|STARTED|Overall Study||8
386066|NCT01879722|947289|P4|STARTED|Overall Study||8
386067|NCT01879722|947290|P3|STARTED|Overall Study||7
386068|NCT01879722|947291|P2|STARTED|Overall Study||8
386069|NCT01879722|947292|P1|STARTED|Overall Study||7
386070|NCT01879683|947440|P1|NOT COMPLETED|Overall Study||1
386071|NCT01879683|947440|P1|COMPLETED|Overall Study||9
386072|NCT01879683|947440|P1|STARTED|Overall Study||10
386073|NCT01879618|947447|P1|NOT COMPLETED|Overall Study||21
386074|NCT01879618|947447|P1|COMPLETED|Overall Study||131
386075|NCT01879618|947447|P1|STARTED|Overall Study||152
386076|NCT01879579|947454|P2|NOT COMPLETED|Overall Study||2
386077|NCT01879579|947455|P1|NOT COMPLETED|Overall Study||5
386078|NCT01879579|947454|P2|COMPLETED|Overall Study||26
386079|NCT01879579|947455|P1|COMPLETED|Overall Study||28
386080|NCT01879579|947454|P2|STARTED|Overall Study||28
386081|NCT01879579|947455|P1|STARTED|Overall Study||33
386082|NCT01879553|947485|P2|NOT COMPLETED|Overall Study||0
386083|NCT01879553|947486|P1|NOT COMPLETED|Overall Study||1
386084|NCT01879553|947485|P2|COMPLETED|Overall Study||63
386085|NCT01879553|947486|P1|COMPLETED|Overall Study||62
386086|NCT01879553|947485|P2|STARTED|Overall Study||63
386087|NCT01879553|947486|P1|STARTED|Overall Study||63
386088|NCT01879540|947507|P1|NOT COMPLETED|Overall Study||0
386089|NCT01879540|947507|P1|COMPLETED|Overall Study||63
386090|NCT01879540|947507|P1|STARTED|Overall Study||63
386091|NCT01879410|947520|P2|NOT COMPLETED|Overall Study||38
386092|NCT01879410|947521|P1|NOT COMPLETED|Overall Study||24
386093|NCT01879410|947520|P2|COMPLETED|Overall Study||312
386094|NCT01879410|947521|P1|COMPLETED|Overall Study||326
386095|NCT01879410|947520|P2|Intent-to-Treat Population|Overall Study||348
386096|NCT01879410|947521|P1|Intent-to-Treat Population|Overall Study||349
386097|NCT01879410|947520|P2|STARTED|Overall Study||350
386098|NCT01879410|947521|P1|STARTED|Overall Study||350
386099|NCT01879371|947535|P6|NOT COMPLETED|Overall Study||0
386100|NCT01879371|947536|P5|NOT COMPLETED|Overall Study||0
386101|NCT01879371|947537|P4|NOT COMPLETED|Overall Study||0
386102|NCT01879371|947538|P3|NOT COMPLETED|Overall Study||0
386103|NCT01879371|947539|P2|NOT COMPLETED|Overall Study||0
386104|NCT01879371|947540|P1|NOT COMPLETED|Overall Study||0
386105|NCT01879371|947535|P6|COMPLETED|Overall Study||6
386106|NCT01879371|947536|P5|COMPLETED|Overall Study||6
386107|NCT01879371|947537|P4|COMPLETED|Overall Study||6
386108|NCT01879371|947538|P3|COMPLETED|Overall Study||6
386109|NCT01879371|947539|P2|COMPLETED|Overall Study||6
386110|NCT01879371|947540|P1|COMPLETED|Overall Study||6
386111|NCT01879371|947535|P6|STARTED|Overall Study||6
386112|NCT01879371|947536|P5|STARTED|Overall Study||6
386113|NCT01879371|947537|P4|STARTED|Overall Study||6
386114|NCT01879371|947538|P3|STARTED|Overall Study||6
386115|NCT01879371|947539|P2|STARTED|Overall Study||6
386116|NCT01879371|947540|P1|STARTED|Overall Study||6
386117|NCT01879345|947557|P3|NOT COMPLETED|7-day Multiple-dose Period||0
386118|NCT01879345|947558|P2|NOT COMPLETED|7-day Multiple-dose Period||0
386119|NCT01879345|947559|P1|NOT COMPLETED|7-day Multiple-dose Period||0
386120|NCT01879345|947557|P3|COMPLETED|7-day Multiple-dose Period||6
386121|NCT01879345|947558|P2|COMPLETED|7-day Multiple-dose Period||6
386122|NCT01879345|947559|P1|COMPLETED|7-day Multiple-dose Period||6
386123|NCT01879345|947557|P3|STARTED|7-day Multiple-dose Period||6
386124|NCT01879345|947558|P2|STARTED|7-day Multiple-dose Period||6
386125|NCT01879345|947559|P1|STARTED|7-day Multiple-dose Period||6
386126|NCT01879345|947557|P3|NOT COMPLETED|Single-dose Period||0
386127|NCT01879345|947558|P2|NOT COMPLETED|Single-dose Period||0
386128|NCT01879345|947559|P1|NOT COMPLETED|Single-dose Period||0
386129|NCT01879345|947557|P3|COMPLETED|Single-dose Period||6
386130|NCT01879345|947558|P2|COMPLETED|Single-dose Period||6
386131|NCT01879345|947559|P1|COMPLETED|Single-dose Period||6
386132|NCT01879345|947557|P3|STARTED|Single-dose Period||6
386133|NCT01879345|947558|P2|STARTED|Single-dose Period||6
386134|NCT01879345|947559|P1|STARTED|Single-dose Period||6
386135|NCT01879332|947576|P3|NOT COMPLETED|Overall Study||4
386136|NCT01879332|947577|P2|NOT COMPLETED|Overall Study||6
386137|NCT01879332|947578|P1|NOT COMPLETED|Overall Study||6
386138|NCT01879332|947576|P3|COMPLETED|Overall Study||0
386139|NCT01879332|947577|P2|COMPLETED|Overall Study||0
386140|NCT01879332|947578|P1|COMPLETED|Overall Study||0
386141|NCT01879332|947576|P3|STARTED|Overall Study||4
386142|NCT01879332|947577|P2|STARTED|Overall Study||6
386143|NCT01879332|947578|P1|STARTED|Overall Study||6
386144|NCT01879319|947588|P2|NOT COMPLETED|Overall Study||5
386145|NCT01879319|947589|P1|NOT COMPLETED|Overall Study||2
386146|NCT01879319|947588|P2|COMPLETED|Overall Study||77
386147|NCT01879319|947589|P1|COMPLETED|Overall Study||80
386148|NCT01879319|947588|P2|Received Treatment|Overall Study||82
386149|NCT01879319|947589|P1|Received Treatment|Overall Study||82
386150|NCT01879319|947588|P2|STARTED|Overall Study||82
386151|NCT01879319|947589|P1|STARTED|Overall Study||82
386152|NCT01879176|947599|P2|NOT COMPLETED|Overall Study||6
386153|NCT01879176|947600|P1|NOT COMPLETED|Overall Study||8
386154|NCT01879176|947599|P2|COMPLETED|Overall Study||16
386155|NCT01879176|947600|P1|COMPLETED|Overall Study||16
386156|NCT01879176|947599|P2|STARTED|Overall Study||22
386157|NCT01879176|947600|P1|STARTED|Overall Study||24
386158|NCT01879072|947606|P1|NOT COMPLETED|Overall Study||48
386159|NCT01879072|947606|P1|COMPLETED|Overall Study||1709
386160|NCT01879072|947606|P1|STARTED|Overall Study||1757
386161|NCT01879059|947610|P1|NOT COMPLETED|Overall Study||0
386162|NCT01879059|947610|P1|COMPLETED|Overall Study||13
386163|NCT01879059|947610|P1|STARTED|Overall Study||13
386164|NCT01878825|947616|P2|NOT COMPLETED|Overall Study||0
386165|NCT01878825|947617|P1|NOT COMPLETED|Overall Study||0
386166|NCT01878825|947616|P2|COMPLETED|Overall Study||60
386167|NCT01878825|947617|P1|COMPLETED|Overall Study||60
386168|NCT01878825|947616|P2|STARTED|Overall Study||60
386169|NCT01878825|947617|P1|STARTED|Overall Study||60
386170|NCT01878812|947655|P2|NOT COMPLETED|Overall Study||0
386171|NCT01878812|947656|P1|NOT COMPLETED|Overall Study||0
386172|NCT01878812|947655|P2|COMPLETED|Overall Study||57
386173|NCT01878812|947656|P1|COMPLETED|Overall Study||60
386174|NCT01878812|947655|P2|STARTED|Overall Study||57
386175|NCT01878812|947656|P1|STARTED|Overall Study||60
386176|NCT01878799|947692|P2|NOT COMPLETED|Overall Study||0
386177|NCT01878799|947693|P1|NOT COMPLETED|Overall Study||1
386178|NCT01878799|947692|P2|COMPLETED|Overall Study||13
386179|NCT01878799|947693|P1|COMPLETED|Overall Study||36
386180|NCT01878799|947692|P2|STARTED|Overall Study||13
386181|NCT01878799|947693|P1|STARTED|Overall Study||37
386182|NCT01878656|947701|P2|NOT COMPLETED|Overall Study||0
386183|NCT01878656|947702|P1|NOT COMPLETED|Overall Study||0
386184|NCT01878656|947701|P2|COMPLETED|Overall Study||72
386185|NCT01878656|947702|P1|COMPLETED|Overall Study||72
386186|NCT01878656|947701|P2|STARTED|Overall Study||72
386187|NCT01878656|947702|P1|STARTED|Overall Study||72
386188|NCT01878604|947708|P1|NOT COMPLETED|Overall Study||0
386189|NCT01878604|947708|P1|COMPLETED|Overall Study||5
386190|NCT01878604|947708|P1|STARTED|Overall Study||5
386191|NCT01878526|947715|P2|NOT COMPLETED|Overall Study||2
386192|NCT01878526|947716|P1|NOT COMPLETED|Overall Study||3
386193|NCT01878526|947715|P2|COMPLETED|Overall Study||38
386194|NCT01878526|947716|P1|COMPLETED|Overall Study||37
386195|NCT01878526|947715|P2|STARTED|Overall Study||40
386196|NCT01878526|947716|P1|STARTED|Overall Study||40
386197|NCT01878214|947731|P2|NOT COMPLETED|Overall Study||44
386198|NCT01878214|947732|P1|NOT COMPLETED|Overall Study||53
386199|NCT01878214|947731|P2|COMPLETED|Overall Study||175
386200|NCT01878214|947732|P1|COMPLETED|Overall Study||170
386201|NCT01878214|947731|P2|STARTED|Overall Study||219
386202|NCT01878214|947732|P1|STARTED|Overall Study||223
386203|NCT01878175|947746|P1|NOT COMPLETED|Overall Study||2
386204|NCT01878175|947746|P1|COMPLETED|Overall Study||13
386205|NCT01878175|947746|P1|STARTED|Overall Study||15
386206|NCT01878149|947765|P2|NOT COMPLETED|Overall Study||2
386207|NCT01878149|947766|P1|NOT COMPLETED|Overall Study||2
386208|NCT01878149|947765|P2|COMPLETED|Overall Study||15
386209|NCT01878149|947766|P1|COMPLETED|Overall Study||19
386210|NCT01878149|947765|P2|STARTED|Overall Study||17
386211|NCT01878149|947766|P1|STARTED|Overall Study||21
386212|NCT01878097|947774|P2|NOT COMPLETED|Implementation Year 4||3007
386213|NCT01878097|947775|P1|NOT COMPLETED|Implementation Year 4||3604
386214|NCT01878097|947774|P2|COMPLETED|Implementation Year 4||6607
386215|NCT01878097|947775|P1|COMPLETED|Implementation Year 4||6981
386216|NCT01878097|947774|P2|STARTED|Implementation Year 4||9614
386217|NCT01878097|947775|P1|STARTED|Implementation Year 4||10585
386218|NCT01878097|947774|P2|NOT COMPLETED|Implementation Year 3||2980
386219|NCT01878097|947775|P1|NOT COMPLETED|Implementation Year 3||3494
386220|NCT01878097|947774|P2|COMPLETED|Implementation Year 3||6770
386221|NCT01878097|947775|P1|COMPLETED|Implementation Year 3||7046
386222|NCT01878097|947774|P2|STARTED|Implementation Year 3||9750
386223|NCT01878097|947775|P1|STARTED|Implementation Year 3||10540
386224|NCT01878097|947774|P2|NOT COMPLETED|Implementation Year 2||2841
386225|NCT01878097|947775|P1|NOT COMPLETED|Implementation Year 2||3281
386226|NCT01878097|947774|P2|COMPLETED|Implementation Year 2||6770
386227|NCT01878097|947775|P1|COMPLETED|Implementation Year 2||8286
386228|NCT01878097|947774|P2|STARTED|Implementation Year 2||9611
386229|NCT01878097|947775|P1|STARTED|Implementation Year 2||11567
386230|NCT01878097|947774|P2|NOT COMPLETED|Implementation Year 1||2549
386231|NCT01878097|947775|P1|NOT COMPLETED|Implementation Year 1||3202
386232|NCT01878097|947774|P2|COMPLETED|Implementation Year 1||7317
386233|NCT01878097|947775|P1|COMPLETED|Implementation Year 1||8540
386234|NCT01878097|947774|P2|STARTED|Implementation Year 1||9866
386235|NCT01878097|947775|P1|STARTED|Implementation Year 1||11742
386236|NCT01878097|947774|P2|NOT COMPLETED|Baseline||1800
386237|NCT01878097|947775|P1|NOT COMPLETED|Baseline||2497
386238|NCT01878097|947774|P2|COMPLETED|Baseline|Anonymous surveys; sum of all completed surveys.|8281
386239|NCT01878097|947775|P1|COMPLETED|Baseline|Anonymous surveys so only last year data provided as annual completed.|8228
386240|NCT01878097|947774|P2|STARTED|Baseline|number of students in 13 control schools completing anonymous surveys with non missing data|10081
386241|NCT01878097|947775|P1|STARTED|Baseline|number of students in 13 intervention schools completing anonymous surveys with non missing data|10725
386242|NCT01877941|947785|P1|NOT COMPLETED|Overall Study||0
386243|NCT01877941|947785|P1|COMPLETED|Overall Study||39
386244|NCT01877941|947785|P1|STARTED|Overall Study||39
386245|NCT01877720|947791|P2|NOT COMPLETED|Overall Study||0
386246|NCT01877720|947792|P1|NOT COMPLETED|Overall Study||1
386247|NCT01877720|947791|P2|COMPLETED|Overall Study||8
386248|NCT01877720|947792|P1|COMPLETED|Overall Study||7
386249|NCT01877720|947791|P2|2nd Intervention|Overall Study||8
386250|NCT01877720|947792|P1|2nd Intervention|Overall Study||7
386251|NCT01877720|947791|P2|1st Intervention|Overall Study||8
386252|NCT01877720|947792|P1|1st Intervention|Overall Study||7
386253|NCT01877720|947791|P2|STARTED|Overall Study||8
386254|NCT01877720|947792|P1|STARTED|Overall Study||8
386255|NCT01877668|947821|P5|NOT COMPLETED|Overall Study||10
386256|NCT01877668|947822|P4|NOT COMPLETED|Overall Study||8
386257|NCT01877668|947823|P3|NOT COMPLETED|Overall Study||12
386258|NCT01877668|947824|P2|NOT COMPLETED|Overall Study||8
386259|NCT01877668|947825|P1|NOT COMPLETED|Overall Study||11
386260|NCT01877668|947821|P5|COMPLETED|Overall Study||43
386261|NCT01877668|947822|P4|COMPLETED|Overall Study||44
386262|NCT01877668|947823|P3|COMPLETED|Overall Study||94
386263|NCT01877668|947824|P2|COMPLETED|Overall Study||96
386264|NCT01877668|947825|P1|COMPLETED|Overall Study||96
386265|NCT01877668|947821|P5|STARTED|Overall Study|Received treatment|53
386266|NCT01877668|947822|P4|STARTED|Overall Study|Received treatment|52
386267|NCT01877668|947823|P3|STARTED|Overall Study|Received treatment|106
386268|NCT01877668|947824|P2|STARTED|Overall Study|Received treatment|104
386269|NCT01877668|947825|P1|STARTED|Overall Study|Received treatment|107
386270|NCT01877642|948056|P7|NOT COMPLETED|Overall Study||0
386271|NCT01877642|948057|P6|NOT COMPLETED|Overall Study||0
386272|NCT01877642|948058|P5|NOT COMPLETED|Overall Study||0
386273|NCT01877642|948059|P4|NOT COMPLETED|Overall Study||0
386274|NCT01877642|948060|P3|NOT COMPLETED|Overall Study||0
386275|NCT01877642|948061|P2|NOT COMPLETED|Overall Study||0
386276|NCT01877642|948062|P1|NOT COMPLETED|Overall Study||0
386277|NCT01877642|948056|P7|COMPLETED|Overall Study||3
386278|NCT01877642|948057|P6|COMPLETED|Overall Study||3
386279|NCT01877642|948058|P5|COMPLETED|Overall Study||3
386280|NCT01877642|948059|P4|COMPLETED|Overall Study||3
386281|NCT01877642|948060|P3|COMPLETED|Overall Study||3
386282|NCT01877642|948061|P2|COMPLETED|Overall Study||3
386283|NCT01877642|948062|P1|COMPLETED|Overall Study||4
386284|NCT01877642|948056|P7|STARTED|Overall Study||3
386285|NCT01877642|948057|P6|STARTED|Overall Study||3
386286|NCT01877642|948058|P5|STARTED|Overall Study||3
386287|NCT01877642|948059|P4|STARTED|Overall Study||3
386288|NCT01877642|948060|P3|STARTED|Overall Study||3
386289|NCT01877642|948061|P2|STARTED|Overall Study||3
386290|NCT01877642|948062|P1|STARTED|Overall Study||4
386291|NCT01877564|948085|P2|NOT COMPLETED|Overall Study||0
386292|NCT01877564|948086|P1|NOT COMPLETED|Overall Study||0
386293|NCT01877564|948085|P2|COMPLETED|Overall Study||4
386294|NCT01877564|948086|P1|COMPLETED|Overall Study||6
386295|NCT01877564|948085|P2|STARTED|Overall Study||4
386296|NCT01877564|948086|P1|STARTED|Overall Study||6
386297|NCT01877538|948092|P1|NOT COMPLETED|Overall Study||0
386298|NCT01877538|948092|P1|COMPLETED|Overall Study||7
386299|NCT01877538|948092|P1|STARTED|Overall Study||7
386300|NCT01877421|948129|P18|NOT COMPLETED|Phase 2||0
386301|NCT01877421|948130|P17|NOT COMPLETED|Phase 2||0
386302|NCT01877421|948131|P16|NOT COMPLETED|Phase 2||1
386303|NCT01877421|948132|P15|NOT COMPLETED|Phase 2||0
386304|NCT01877421|948133|P14|NOT COMPLETED|Phase 2||0
386305|NCT01877421|948134|P13|NOT COMPLETED|Phase 2||1
386306|NCT01877421|948135|P12|NOT COMPLETED|Phase 2||0
386307|NCT01877421|948136|P11|NOT COMPLETED|Phase 2||2
386308|NCT01877421|948137|P10|NOT COMPLETED|Phase 2||0
386309|NCT01877421|948138|P9|NOT COMPLETED|Phase 2||1
386310|NCT01877421|948139|P8|NOT COMPLETED|Phase 2||0
386311|NCT01877421|948140|P7|NOT COMPLETED|Phase 2||1
386312|NCT01877421|948141|P6|NOT COMPLETED|Phase 2||0
386313|NCT01877421|948142|P5|NOT COMPLETED|Phase 2||0
386314|NCT01877421|948143|P4|NOT COMPLETED|Phase 2||0
386315|NCT01877421|948144|P3|NOT COMPLETED|Phase 2||0
386316|NCT01877421|948145|P2|NOT COMPLETED|Phase 2||0
386317|NCT01877421|948146|P1|NOT COMPLETED|Phase 2||0
386318|NCT01877421|948129|P18|COMPLETED|Phase 2||0
386319|NCT01877421|948130|P17|COMPLETED|Phase 2||0
386320|NCT01877421|948131|P16|COMPLETED|Phase 2||2
386321|NCT01877421|948132|P15|COMPLETED|Phase 2||7
386322|NCT01877421|948133|P14|COMPLETED|Phase 2||3
386323|NCT01877421|948134|P13|COMPLETED|Phase 2||6
386324|NCT01877421|948135|P12|COMPLETED|Phase 2||3
386325|NCT01877421|948136|P11|COMPLETED|Phase 2||5
386326|NCT01877421|948137|P10|COMPLETED|Phase 2||3
386327|NCT01877421|948138|P9|COMPLETED|Phase 2||5
386328|NCT01877421|948139|P8|COMPLETED|Phase 2||2
386329|NCT01877421|948140|P7|COMPLETED|Phase 2||6
386330|NCT01877421|948141|P6|COMPLETED|Phase 2||3
386331|NCT01877421|948142|P5|COMPLETED|Phase 2||7
386332|NCT01877421|948143|P4|COMPLETED|Phase 2||2
386333|NCT01877421|948144|P3|COMPLETED|Phase 2||4
386334|NCT01877421|948145|P2|COMPLETED|Phase 2||0
386335|NCT01877421|948146|P1|COMPLETED|Phase 2||0
386336|NCT01877421|948129|P18|STARTED|Phase 2||0
386337|NCT01877421|948130|P17|STARTED|Phase 2||0
386338|NCT01877421|948131|P16|STARTED|Phase 2||3
386339|NCT01877421|948132|P15|STARTED|Phase 2||7
386340|NCT01877421|948133|P14|STARTED|Phase 2||3
386341|NCT01877421|948134|P13|STARTED|Phase 2||7
386342|NCT01877421|948135|P12|STARTED|Phase 2||3
386343|NCT01877421|948136|P11|STARTED|Phase 2||7
386344|NCT01877421|948137|P10|STARTED|Phase 2||3
386345|NCT01877421|948138|P9|STARTED|Phase 2||6
386346|NCT01877421|948139|P8|STARTED|Phase 2||2
386347|NCT01877421|948140|P7|STARTED|Phase 2||7
386348|NCT01877421|948141|P6|STARTED|Phase 2||3
386349|NCT01877421|948142|P5|STARTED|Phase 2||7
386350|NCT01877421|948143|P4|STARTED|Phase 2||2
386351|NCT01877421|948144|P3|STARTED|Phase 2||4
386352|NCT01877421|948145|P2|STARTED|Phase 2||0
386353|NCT01877421|948146|P1|STARTED|Phase 2||0
386354|NCT01877421|948129|P18|NOT COMPLETED|Phase 1||0
386355|NCT01877421|948130|P17|NOT COMPLETED|Phase 1||0
386356|NCT01877421|948131|P16|NOT COMPLETED|Phase 1||0
386357|NCT01877421|948132|P15|NOT COMPLETED|Phase 1||0
386358|NCT01877421|948133|P14|NOT COMPLETED|Phase 1||0
386359|NCT01877421|948134|P13|NOT COMPLETED|Phase 1||0
386360|NCT01877421|948135|P12|NOT COMPLETED|Phase 1||0
386361|NCT01877421|948136|P11|NOT COMPLETED|Phase 1||0
386362|NCT01877421|948137|P10|NOT COMPLETED|Phase 1||0
386363|NCT01877421|948138|P9|NOT COMPLETED|Phase 1||0
386364|NCT01877421|948139|P8|NOT COMPLETED|Phase 1||0
386365|NCT01877421|948140|P7|NOT COMPLETED|Phase 1||0
386366|NCT01877421|948141|P6|NOT COMPLETED|Phase 1||0
386367|NCT01877421|948142|P5|NOT COMPLETED|Phase 1||0
386368|NCT01877421|948143|P4|NOT COMPLETED|Phase 1||0
386369|NCT01877421|948144|P3|NOT COMPLETED|Phase 1||0
386370|NCT01877421|948145|P2|NOT COMPLETED|Phase 1||0
386371|NCT01877421|948146|P1|NOT COMPLETED|Phase 1||0
386372|NCT01877421|948129|P18|COMPLETED|Phase 1||3
386373|NCT01877421|948130|P17|COMPLETED|Phase 1||7
386374|NCT01877421|948131|P16|COMPLETED|Phase 1||3
386375|NCT01877421|948132|P15|COMPLETED|Phase 1||7
386376|NCT01877421|948133|P14|COMPLETED|Phase 1||3
386377|NCT01877421|948134|P13|COMPLETED|Phase 1||7
386378|NCT01877421|948135|P12|COMPLETED|Phase 1||3
386379|NCT01877421|948136|P11|COMPLETED|Phase 1||7
386380|NCT01877421|948137|P10|COMPLETED|Phase 1||3
386381|NCT01877421|948138|P9|COMPLETED|Phase 1||7
386382|NCT01877421|948139|P8|COMPLETED|Phase 1||2
386383|NCT01877421|948140|P7|COMPLETED|Phase 1||4
386384|NCT01877421|948141|P6|COMPLETED|Phase 1||2
386385|NCT01877421|948142|P5|COMPLETED|Phase 1||4
386386|NCT01877421|948143|P4|COMPLETED|Phase 1||2
386387|NCT01877421|948144|P3|COMPLETED|Phase 1||4
386388|NCT01877421|948145|P2|COMPLETED|Phase 1||1
386389|NCT01877421|948146|P1|COMPLETED|Phase 1||2
386390|NCT01877421|948129|P18|STARTED|Phase 1||3
386391|NCT01877421|948130|P17|STARTED|Phase 1||7
386392|NCT01877421|948131|P16|STARTED|Phase 1||3
386393|NCT01877421|948132|P15|STARTED|Phase 1||7
386394|NCT01877421|948133|P14|STARTED|Phase 1||3
386395|NCT01877421|948134|P13|STARTED|Phase 1||7
386396|NCT01877421|948135|P12|STARTED|Phase 1||3
386397|NCT01877421|948136|P11|STARTED|Phase 1||7
386398|NCT01877421|948137|P10|STARTED|Phase 1||3
386399|NCT01877421|948138|P9|STARTED|Phase 1||7
386400|NCT01877421|948139|P8|STARTED|Phase 1||2
386401|NCT01877421|948140|P7|STARTED|Phase 1||4
386402|NCT01877421|948141|P6|STARTED|Phase 1||2
386403|NCT01877421|948142|P5|STARTED|Phase 1||4
386404|NCT01877421|948143|P4|STARTED|Phase 1||2
386405|NCT01877421|948144|P3|STARTED|Phase 1||4
386406|NCT01877421|948145|P2|STARTED|Phase 1||1
386407|NCT01877421|948146|P1|STARTED|Phase 1||2
386408|NCT01877408|948256|P2|NOT COMPLETED|Overall Study||2
386409|NCT01877408|948257|P1|NOT COMPLETED|Overall Study||0
386410|NCT01877408|948256|P2|COMPLETED|Overall Study|Completed follow up visit 28 days after procedure|98
386411|NCT01877408|948257|P1|COMPLETED|Overall Study|Completed follow up visit 28 days after procedure|50
386412|NCT01877408|948256|P2|STARTED|Overall Study||100
386413|NCT01877408|948257|P1|STARTED|Overall Study||50
386414|NCT01877343|948277|P7|NOT COMPLETED|Overall Study||0
386415|NCT01877343|948278|P6|NOT COMPLETED|Overall Study||0
386416|NCT01877343|948279|P5|NOT COMPLETED|Overall Study||0
386417|NCT01877343|948280|P4|NOT COMPLETED|Overall Study||0
386418|NCT01877343|948281|P3|NOT COMPLETED|Overall Study||0
386419|NCT01877343|948282|P2|NOT COMPLETED|Overall Study||0
386420|NCT01877343|948283|P1|NOT COMPLETED|Overall Study||0
386421|NCT01877343|948277|P7|COMPLETED|Overall Study||0
386422|NCT01877343|948278|P6|COMPLETED|Overall Study||5
386423|NCT01877343|948279|P5|COMPLETED|Overall Study||0
386424|NCT01877343|948280|P4|COMPLETED|Overall Study||0
386425|NCT01877343|948281|P3|COMPLETED|Overall Study||0
386426|NCT01877343|948282|P2|COMPLETED|Overall Study||3
386427|NCT01877343|948283|P1|COMPLETED|Overall Study||2
386428|NCT01877343|948277|P7|STARTED|Overall Study||0
386429|NCT01877343|948278|P6|STARTED|Overall Study||5
386430|NCT01877343|948279|P5|STARTED|Overall Study||0
386431|NCT01877343|948280|P4|STARTED|Overall Study||0
386432|NCT01877343|948281|P3|STARTED|Overall Study||0
386433|NCT01877343|948282|P2|STARTED|Overall Study||3
386434|NCT01877343|948283|P1|STARTED|Overall Study||2
386435|NCT01877278|948290|P2|NOT COMPLETED|Overall Study||3
386436|NCT01877278|948291|P1|NOT COMPLETED|Overall Study||3
386437|NCT01877278|948290|P2|COMPLETED|Overall Study||30
386438|NCT01877278|948291|P1|COMPLETED|Overall Study||30
386439|NCT01877278|948290|P2|STARTED|Overall Study||33
386440|NCT01877278|948291|P1|STARTED|Overall Study||33
386441|NCT01877161|948299|P1|NOT COMPLETED|Third Session of Stimulation||0
386442|NCT01877161|948299|P1|COMPLETED|Third Session of Stimulation||12
386443|NCT01877161|948299|P1|STARTED|Third Session of Stimulation||12
386444|NCT01877161|948299|P1|NOT COMPLETED|Washout (at Least 3 Days)||0
386445|NCT01877161|948299|P1|COMPLETED|Washout (at Least 3 Days)||12
386446|NCT01877161|948299|P1|STARTED|Washout (at Least 3 Days)||12
386447|NCT01877161|948299|P1|NOT COMPLETED|Second Session of Stimulation||0
386448|NCT01877161|948299|P1|COMPLETED|Second Session of Stimulation||12
386449|NCT01877161|948299|P1|STARTED|Second Session of Stimulation||12
386450|NCT01877161|948299|P1|NOT COMPLETED|Washout (at Least 3 Days)||0
386451|NCT01877161|948299|P1|COMPLETED|Washout (at Least 3 Days)||12
386452|NCT01877161|948299|P1|STARTED|Washout (at Least 3 Days)||12
386453|NCT01877161|948299|P1|NOT COMPLETED|First Session of Stimulation||0
386454|NCT01877161|948299|P1|COMPLETED|First Session of Stimulation||12
386455|NCT01877161|948299|P1|STARTED|First Session of Stimulation||12
386456|NCT01877148|948309|P2|NOT COMPLETED|Overall Study||1
386457|NCT01877148|948310|P1|NOT COMPLETED|Overall Study||1
386458|NCT01877148|948309|P2|COMPLETED|Overall Study||5
386459|NCT01877148|948310|P1|COMPLETED|Overall Study||5
386460|NCT01877148|948309|P2|STARTED|Overall Study||6
386461|NCT01877148|948310|P1|STARTED|Overall Study||6
386462|NCT01876992|948324|P2|NOT COMPLETED|Overall Study||0
386463|NCT01876992|948325|P1|NOT COMPLETED|Overall Study||0
386464|NCT01876992|948324|P2|COMPLETED|Overall Study||5
386465|NCT01876992|948325|P1|COMPLETED|Overall Study||5
386466|NCT01876992|948324|P2|STARTED|Overall Study||5
386467|NCT01876992|948325|P1|STARTED|Overall Study||5
386468|NCT01876979|948339|P2|NOT COMPLETED|Overall Study||3
386469|NCT01876979|948340|P1|NOT COMPLETED|Overall Study||2
386470|NCT01876979|948339|P2|COMPLETED|Overall Study||0
386471|NCT01876979|948340|P1|COMPLETED|Overall Study||0
386472|NCT01876979|948339|P2|STARTED|Overall Study||3
386473|NCT01876979|948340|P1|STARTED|Overall Study||2
386474|NCT01876823|948346|P1|NOT COMPLETED|Overall Study||9
386475|NCT01876823|948346|P1|COMPLETED|Overall Study||26
386476|NCT01876823|948346|P1|STARTED|Overall Study||35
386477|NCT01876810|948359|P2|NOT COMPLETED|Overall Study||1
386478|NCT01876810|948360|P1|NOT COMPLETED|Overall Study||0
386479|NCT01876810|948359|P2|COMPLETED|Overall Study||13
386480|NCT01876810|948360|P1|COMPLETED|Overall Study||14
386481|NCT01876810|948359|P2|STARTED|Overall Study||14
386482|NCT01876810|948360|P1|STARTED|Overall Study||14
386483|NCT01876784|948372|P2|NOT COMPLETED|Overall Study||119
386484|NCT01876784|948373|P1|NOT COMPLETED|Overall Study||119
386485|NCT01876784|948372|P2|COMPLETED|Overall Study||0
386486|NCT01876784|948373|P1|COMPLETED|Overall Study||0
386487|NCT01876784|948372|P2|Treated|Overall Study||118
386488|NCT01876784|948373|P1|Treated|Overall Study||117
386489|NCT01876784|948372|P2|STARTED|Overall Study||119
386490|NCT01876784|948373|P1|STARTED|Overall Study||119
386491|NCT01876732|948379|P1|NOT COMPLETED|Overall Study||75
386492|NCT01876732|948379|P1|COMPLETED|Overall Study||57
386493|NCT01876732|948379|P1|STARTED|Overall Study||132
386494|NCT01876706|948384|P1|NOT COMPLETED|Overall Study||4
386495|NCT01876706|948384|P1|COMPLETED|Overall Study||47
386496|NCT01876706|948384|P1|12 Months|Overall Study||41
386497|NCT01876706|948384|P1|1 Month|Overall Study||51
386498|NCT01876706|948384|P1|STARTED|Overall Study||51
386499|NCT01876368|948403|P2|NOT COMPLETED|Overall Study||13
386500|NCT01876368|948404|P1|NOT COMPLETED|Overall Study||9
386501|NCT01876368|948403|P2|COMPLETED|Overall Study||175
386502|NCT01876368|948404|P1|COMPLETED|Overall Study||179
386503|NCT01876368|948403|P2|Safety Set (SAF)|Overall Study||187
386504|NCT01876368|948404|P1|Safety Set (SAF)|Overall Study||188
386505|NCT01876368|948403|P2|Full Analysis Set (FAS)|Overall Study|One patient was not included in the SAF and FAS due to mis-randomization.|187
386506|NCT01876368|948404|P1|Full Analysis Set (FAS)|Overall Study||188
386507|NCT01876368|948403|P2|STARTED|Overall Study||188
386508|NCT01876368|948404|P1|STARTED|Overall Study||188
386509|NCT01876329|948433|P3|NOT COMPLETED|Overall Study||0
386510|NCT01876329|948434|P2|NOT COMPLETED|Overall Study||0
386511|NCT01876329|948435|P1|NOT COMPLETED|Overall Study||0
386512|NCT01876329|948433|P3|COMPLETED|Overall Study||44
386513|NCT01876329|948434|P2|COMPLETED|Overall Study||36
386514|NCT01876329|948435|P1|COMPLETED|Overall Study||45
386515|NCT01876329|948433|P3|STARTED|Overall Study||44
386516|NCT01876329|948434|P2|STARTED|Overall Study||36
386517|NCT01876329|948435|P1|STARTED|Overall Study||45
386518|NCT01875991|948448|P2|NOT COMPLETED|Overall Study||6
386519|NCT01875991|948449|P1|NOT COMPLETED|Overall Study||7
386520|NCT01875991|948448|P2|COMPLETED|Overall Study||103
386521|NCT01875991|948449|P1|COMPLETED|Overall Study||101
386522|NCT01875991|948448|P2|Received Etanercept in Period 2|Overall Study||103
386523|NCT01875991|948449|P1|Received Etanercept in Period 2|Overall Study||102
386524|NCT01875991|948448|P2|Received Etanercept in Period 1|Overall Study||108
386525|NCT01875991|948449|P1|Received Etanercept in Period 1|Overall Study||108
386526|NCT01875991|948448|P2|STARTED|Overall Study||109
386527|NCT01875991|948449|P1|STARTED|Overall Study||108
386528|NCT01875978|948472|P2|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0
386529|NCT01875978|948473|P1|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0
386530|NCT01875978|948472|P2|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
386531|NCT01875978|948473|P1|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
386532|NCT01875978|948472|P2|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
386533|NCT01875978|948473|P1|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
386534|NCT01875978|948472|P2|NOT COMPLETED|Study 4weeks||0
386535|NCT01875978|948473|P1|NOT COMPLETED|Study 4weeks||0
386536|NCT01875978|948472|P2|COMPLETED|Study 4weeks||20
386537|NCT01875978|948473|P1|COMPLETED|Study 4weeks||20
386538|NCT01875978|948472|P2|STARTED|Study 4weeks||20
386539|NCT01875978|948473|P1|STARTED|Study 4weeks||20
386540|NCT01875848|948487|P2|NOT COMPLETED|Overall Study||0
386541|NCT01875848|948488|P1|NOT COMPLETED|Overall Study||2
386542|NCT01875848|948487|P2|COMPLETED|Overall Study|4 patients completed the opioid dose escalation arm of the study|4
386543|NCT01875848|948488|P1|COMPLETED|Overall Study|1 patient completed the Buprenorphine arm of the study. 2 patients withdrew|1
386544|NCT01875848|948487|P2|STARTED|Overall Study|4 patients were enrolled in the opioid dose escalation arm of the study|4
386545|NCT01875848|948488|P1|STARTED|Overall Study|3 patients were enrolled in the Buprenorphine arm of the study|3
386546|NCT01875783|948496|P1|NOT COMPLETED|Overall Study||0
386547|NCT01875783|948496|P1|COMPLETED|Overall Study||385
386548|NCT01875783|948496|P1|STARTED|Overall Study||385
386549|NCT01875731|948505|P2|NOT COMPLETED|Overall Study||0
386550|NCT01875731|948506|P1|NOT COMPLETED|Overall Study||1
386551|NCT01875731|948505|P2|COMPLETED|Overall Study||32
386552|NCT01875731|948506|P1|COMPLETED|Overall Study||33
386553|NCT01875731|948505|P2|STARTED|Overall Study||32
386554|NCT01875731|948506|P1|STARTED|Overall Study||34
386555|NCT01875510|948516|P2|NOT COMPLETED|Overall Study||0
386556|NCT01875510|948517|P1|NOT COMPLETED|Overall Study||0
386557|NCT01875510|948516|P2|COMPLETED|Overall Study||40
386558|NCT01875510|948517|P1|COMPLETED|Overall Study||40
386559|NCT01875510|948516|P2|STARTED|Overall Study||40
386560|NCT01875510|948517|P1|STARTED|Overall Study||40
386561|NCT01875471|948525|P2|NOT COMPLETED|Overall Study||1
386562|NCT01875471|948526|P1|NOT COMPLETED|Overall Study||1
386563|NCT01875471|948525|P2|COMPLETED|Overall Study||137
386564|NCT01875471|948526|P1|COMPLETED|Overall Study||136
386565|NCT01875471|948525|P2|Completed Per Protocol|Overall Study||123
386566|NCT01875471|948526|P1|Completed Per Protocol|Overall Study||127
386567|NCT01875471|948525|P2|STARTED|Overall Study||138
386568|NCT01875471|948526|P1|STARTED|Overall Study||137
386569|NCT01875445|948534|P2|NOT COMPLETED|Overall Study||0
386570|NCT01875445|948535|P1|NOT COMPLETED|Overall Study||7
386571|NCT01875445|948534|P2|COMPLETED|Overall Study||19
386572|NCT01875445|948535|P1|COMPLETED|Overall Study||12
386573|NCT01875445|948534|P2|STARTED|Overall Study||19
386574|NCT01875445|948535|P1|STARTED|Overall Study||19
386575|NCT01875185|948545|P2|NOT COMPLETED|Overall Study||48
386576|NCT01875185|948546|P1|NOT COMPLETED|Overall Study||52
386577|NCT01875185|948545|P2|COMPLETED|Overall Study||0
386578|NCT01875185|948546|P1|COMPLETED|Overall Study||0
386579|NCT01875185|948545|P2|STARTED|Overall Study||48
386580|NCT01875185|948546|P1|STARTED|Overall Study||52
386581|NCT01875159|948560|P2|NOT COMPLETED|Overall Study||0
386582|NCT01875159|948561|P1|NOT COMPLETED|Overall Study||3
386583|NCT01875159|948560|P2|COMPLETED|Overall Study||53
386584|NCT01875159|948561|P1|COMPLETED|Overall Study||42
386585|NCT01875159|948560|P2|STARTED|Overall Study||53
386586|NCT01875159|948561|P1|STARTED|Overall Study||45
386587|NCT01874951|948571|P2|NOT COMPLETED|Overall Study||0
386588|NCT01874951|948572|P1|NOT COMPLETED|Overall Study||0
386589|NCT01874951|948571|P2|COMPLETED|Overall Study||6
386590|NCT01874951|948572|P1|COMPLETED|Overall Study||6
386591|NCT01874951|948571|P2|STARTED|Overall Study||6
386592|NCT01874951|948572|P1|STARTED|Overall Study||6
386593|NCT01874665|948594|P2|NOT COMPLETED|Overall Study||15
386594|NCT01874665|948595|P1|NOT COMPLETED|Overall Study||30
386595|NCT01874665|948594|P2|COMPLETED|Overall Study||0
386596|NCT01874665|948595|P1|COMPLETED|Overall Study||0
386597|NCT01874665|948594|P2|STARTED|Overall Study||15
386598|NCT01874665|948595|P1|STARTED|Overall Study||30
386599|NCT01874353|948623|P2|NOT COMPLETED|Overall Study||37
386600|NCT01874353|948624|P1|NOT COMPLETED|Overall Study||55
386601|NCT01874353|948623|P2|COMPLETED|Overall Study||62
386602|NCT01874353|948624|P1|COMPLETED|Overall Study||141
386603|NCT01874353|948623|P2|STARTED|Overall Study||99
386604|NCT01874353|948624|P1|STARTED|Overall Study||196
386605|NCT01874340|948651|P4|NOT COMPLETED|Overall Study||5
386606|NCT01874340|948652|P3|NOT COMPLETED|Overall Study||8
386607|NCT01874340|948653|P2|NOT COMPLETED|Overall Study||8
386608|NCT01874340|948654|P1|NOT COMPLETED|Overall Study||6
386609|NCT01874340|948651|P4|COMPLETED|Overall Study||1
386610|NCT01874340|948652|P3|COMPLETED|Overall Study||0
386611|NCT01874340|948653|P2|COMPLETED|Overall Study||0
386612|NCT01874340|948654|P1|COMPLETED|Overall Study||0
386613|NCT01874340|948651|P4|STARTED|Overall Study||6
386614|NCT01874340|948652|P3|STARTED|Overall Study||8
386615|NCT01874340|948653|P2|STARTED|Overall Study||8
386616|NCT01874340|948654|P1|STARTED|Overall Study||6
386617|NCT01874275|948682|P2|NOT COMPLETED|Overall Study||0
386618|NCT01874275|948683|P1|NOT COMPLETED|Overall Study||1
386619|NCT01874275|948682|P2|COMPLETED|Overall Study||2
386620|NCT01874275|948683|P1|COMPLETED|Overall Study||3
386621|NCT01874275|948682|P2|STARTED|Overall Study||2
386622|NCT01874275|948683|P1|STARTED|Overall Study||4
386623|NCT01874262|948697|P2|NOT COMPLETED|Overall Study||3
386624|NCT01874262|948698|P1|NOT COMPLETED|Overall Study||5
386625|NCT01874262|948697|P2|COMPLETED|Overall Study||80
386626|NCT01874262|948698|P1|COMPLETED|Overall Study||86
386627|NCT01874262|948697|P2|Not Included Due to Tehnical Issues|Overall Study||3
386628|NCT01874262|948698|P1|Not Included Due to Tehnical Issues|Overall Study||3
386629|NCT01874262|948697|P2|Not Correctly Randomised|Overall Study||0
386630|NCT01874262|948698|P1|Not Correctly Randomised|Overall Study||2
386631|NCT01874262|948697|P2|STARTED|Overall Study||83
386632|NCT01874262|948698|P1|STARTED|Overall Study||91
386633|NCT01874145|948706|P2|NOT COMPLETED|Extension Period||4
386634|NCT01874145|948707|P1|NOT COMPLETED|Extension Period||6
386635|NCT01874145|948706|P2|COMPLETED|Extension Period||97
386636|NCT01874145|948707|P1|COMPLETED|Extension Period||91
386637|NCT01874145|948706|P2|Full Analysis Set|Extension Period||101
386638|NCT01874145|948707|P1|Full Analysis Set|Extension Period||95
386639|NCT01874145|948706|P2|STARTED|Extension Period|Non-Switchers|101
386640|NCT01874145|948707|P1|STARTED|Extension Period|Switchers|97
386641|NCT01874145|948706|P2|NOT COMPLETED|Core Period||7
386642|NCT01874145|948707|P1|NOT COMPLETED|Core Period||3
386643|NCT01874145|948706|P2|COMPLETED|Core Period||101
386644|NCT01874145|948707|P1|COMPLETED|Core Period||98
386645|NCT01874145|948706|P2|Full Analysis Set|Core Period||108
386646|NCT01874145|948707|P1|Full Analysis Set|Core Period||100
386647|NCT01874145|948706|P2|STARTED|Core Period||108
386648|NCT01874145|948707|P1|STARTED|Core Period||101
386649|NCT01874132|948746|P3|NOT COMPLETED|Overall Study||3
386650|NCT01874132|948747|P2|NOT COMPLETED|Overall Study||4
386651|NCT01874132|948748|P1|NOT COMPLETED|Overall Study||4
386652|NCT01874132|948746|P3|COMPLETED|Overall Study||19
386653|NCT01874132|948747|P2|COMPLETED|Overall Study||18
386654|NCT01874132|948748|P1|COMPLETED|Overall Study||18
386655|NCT01874132|948746|P3|STARTED|Overall Study||22
386656|NCT01874132|948747|P2|STARTED|Overall Study||22
386657|NCT01874132|948748|P1|STARTED|Overall Study||22
386658|NCT01874119|948759|P2|NOT COMPLETED|Second Intervention (6 Days)||0
386659|NCT01874119|948760|P1|NOT COMPLETED|Second Intervention (6 Days)||0
386660|NCT01874119|948759|P2|COMPLETED|Second Intervention (6 Days)||3
386661|NCT01874119|948760|P1|COMPLETED|Second Intervention (6 Days)||4
386662|NCT01874119|948759|P2|STARTED|Second Intervention (6 Days)||3
386663|NCT01874119|948760|P1|STARTED|Second Intervention (6 Days)||4
386664|NCT01874119|948759|P2|NOT COMPLETED|Washout (7 Days)||2
386665|NCT01874119|948760|P1|NOT COMPLETED|Washout (7 Days)||3
386666|NCT01874119|948759|P2|COMPLETED|Washout (7 Days)||3
386667|NCT01874119|948760|P1|COMPLETED|Washout (7 Days)||4
386668|NCT01874119|948759|P2|STARTED|Washout (7 Days)||5
386669|NCT01874119|948760|P1|STARTED|Washout (7 Days)||7
386670|NCT01874119|948759|P2|NOT COMPLETED|First Intervention (6 Days)||0
386671|NCT01874119|948760|P1|NOT COMPLETED|First Intervention (6 Days)||1
386672|NCT01874119|948759|P2|COMPLETED|First Intervention (6 Days)||5
386673|NCT01874119|948760|P1|COMPLETED|First Intervention (6 Days)||7
386674|NCT01874119|948759|P2|STARTED|First Intervention (6 Days)||5
386675|NCT01874119|948760|P1|STARTED|First Intervention (6 Days)||8
386676|NCT01874054|948766|P1|NOT COMPLETED|Follow-up Period||49
386677|NCT01874054|948766|P1|COMPLETED|Follow-up Period||2
386678|NCT01874054|948766|P1|STARTED|Follow-up Period|4 patients withdrew consent and did not enter the follow-up period.|51
386679|NCT01874054|948766|P1|NOT COMPLETED|Treatment Period||38
386680|NCT01874054|948766|P1|COMPLETED|Treatment Period||17
386681|NCT01874054|948766|P1|STARTED|Treatment Period||55
386682|NCT01873989|948777|P2|NOT COMPLETED|Overall Study||1
386683|NCT01873989|948778|P1|NOT COMPLETED|Overall Study||1
386684|NCT01873989|948777|P2|COMPLETED|Overall Study||6
386685|NCT01873989|948778|P1|COMPLETED|Overall Study||7
386686|NCT01873989|948777|P2|STARTED|Overall Study||7
386687|NCT01873989|948778|P1|STARTED|Overall Study||8
386688|NCT01873950|948788|P5|NOT COMPLETED|Period 5||0
386689|NCT01873950|948789|P4|NOT COMPLETED|Period 5||1
386690|NCT01873950|948790|P3|NOT COMPLETED|Period 5||0
386691|NCT01873950|948791|P2|NOT COMPLETED|Period 5||0
386692|NCT01873950|948792|P1|NOT COMPLETED|Period 5||0
386693|NCT01873950|948788|P5|COMPLETED|Period 5||4
386694|NCT01873950|948789|P4|COMPLETED|Period 5||3
386695|NCT01873950|948790|P3|COMPLETED|Period 5||4
386696|NCT01873950|948791|P2|COMPLETED|Period 5||5
386697|NCT01873950|948792|P1|COMPLETED|Period 5||4
386698|NCT01873950|948788|P5|STARTED|Period 5||4
386699|NCT01873950|948789|P4|STARTED|Period 5||4
386700|NCT01873950|948790|P3|STARTED|Period 5||4
386701|NCT01873950|948791|P2|STARTED|Period 5||5
386702|NCT01873950|948792|P1|STARTED|Period 5||4
386703|NCT01873950|948788|P5|NOT COMPLETED|Period 4||0
386704|NCT01873950|948789|P4|NOT COMPLETED|Period 4||0
386705|NCT01873950|948790|P3|NOT COMPLETED|Period 4||0
386706|NCT01873950|948791|P2|NOT COMPLETED|Period 4||0
386707|NCT01873950|948792|P1|NOT COMPLETED|Period 4||0
386708|NCT01873950|948788|P5|COMPLETED|Period 4||5
386709|NCT01873950|948789|P4|COMPLETED|Period 4||4
386710|NCT01873950|948790|P3|COMPLETED|Period 4||4
386711|NCT01873950|948791|P2|COMPLETED|Period 4||5
386712|NCT01873950|948792|P1|COMPLETED|Period 4||4
386713|NCT01873950|948788|P5|STARTED|Period 4||5
386714|NCT01873950|948789|P4|STARTED|Period 4||4
386715|NCT01873950|948790|P3|STARTED|Period 4||4
386716|NCT01873950|948791|P2|STARTED|Period 4||5
386717|NCT01873950|948792|P1|STARTED|Period 4||4
386718|NCT01873950|948788|P5|NOT COMPLETED|Period 3||0
386719|NCT01873950|948789|P4|NOT COMPLETED|Period 3||0
386720|NCT01873950|948790|P3|NOT COMPLETED|Period 3||0
386721|NCT01873950|948791|P2|NOT COMPLETED|Period 3||0
386722|NCT01873950|948792|P1|NOT COMPLETED|Period 3||0
386723|NCT01873950|948788|P5|COMPLETED|Period 3||4
386724|NCT01873950|948789|P4|COMPLETED|Period 3||5
386725|NCT01873950|948790|P3|COMPLETED|Period 3||5
386726|NCT01873950|948791|P2|COMPLETED|Period 3||4
386727|NCT01873950|948792|P1|COMPLETED|Period 3||4
386728|NCT01873950|948788|P5|STARTED|Period 3||4
386729|NCT01873950|948789|P4|STARTED|Period 3||5
386730|NCT01873950|948790|P3|STARTED|Period 3||5
386731|NCT01873950|948791|P2|STARTED|Period 3||4
386732|NCT01873950|948792|P1|STARTED|Period 3||4
386733|NCT01873950|948788|P5|NOT COMPLETED|Period 2||0
386734|NCT01873950|948789|P4|NOT COMPLETED|Period 2||0
386735|NCT01873950|948790|P3|NOT COMPLETED|Period 2||0
386736|NCT01873950|948791|P2|NOT COMPLETED|Period 2||0
386737|NCT01873950|948792|P1|NOT COMPLETED|Period 2||0
386738|NCT01873950|948788|P5|COMPLETED|Period 2||5
386739|NCT01873950|948789|P4|COMPLETED|Period 2||4
386740|NCT01873950|948790|P3|COMPLETED|Period 2||4
386741|NCT01873950|948791|P2|COMPLETED|Period 2||4
386742|NCT01873950|948792|P1|COMPLETED|Period 2||5
386743|NCT01873950|948788|P5|STARTED|Period 2||5
386744|NCT01873950|948789|P4|STARTED|Period 2||4
386745|NCT01873950|948790|P3|STARTED|Period 2||4
386746|NCT01873950|948791|P2|STARTED|Period 2||4
386747|NCT01873950|948792|P1|STARTED|Period 2||5
386748|NCT01873950|948788|P5|NOT COMPLETED|Period 1||0
386749|NCT01873950|948789|P4|NOT COMPLETED|Period 1||0
386750|NCT01873950|948790|P3|NOT COMPLETED|Period 1||0
386751|NCT01873950|948791|P2|NOT COMPLETED|Period 1||0
386752|NCT01873950|948792|P1|NOT COMPLETED|Period 1||0
386753|NCT01873950|948788|P5|COMPLETED|Period 1||4
386754|NCT01873950|948789|P4|COMPLETED|Period 1||4
386755|NCT01873950|948790|P3|COMPLETED|Period 1||5
386756|NCT01873950|948791|P2|COMPLETED|Period 1||4
386757|NCT01873950|948792|P1|COMPLETED|Period 1||5
386758|NCT01873950|948788|P5|STARTED|Period 1||4
386759|NCT01873950|948789|P4|STARTED|Period 1||4
386760|NCT01873950|948790|P3|STARTED|Period 1||5
386761|NCT01873950|948791|P2|STARTED|Period 1||4
386762|NCT01873950|948792|P1|STARTED|Period 1||5
386763|NCT01873859|948829|P2|NOT COMPLETED|Overall Study||4
386764|NCT01873859|948830|P1|NOT COMPLETED|Overall Study||0
386765|NCT01873859|948829|P2|COMPLETED|Overall Study||79
386766|NCT01873859|948830|P1|COMPLETED|Overall Study||83
386767|NCT01873859|948829|P2|STARTED|Overall Study||83
386768|NCT01873859|948830|P1|STARTED|Overall Study||83
386769|NCT01873729|948838|P1|NOT COMPLETED|Overall Study||1
386770|NCT01873729|948838|P1|COMPLETED|Overall Study||2
386771|NCT01873729|948838|P1|STARTED|Overall Study||3
386772|NCT01873417|948843|P1|NOT COMPLETED|Overall Study||35
386773|NCT01873417|948843|P1|COMPLETED|Overall Study||202
386774|NCT01873417|948843|P1|Safety Population|Overall Study|Participants who received at least 1 dose of dimethyl fumarate (DMF), recorded in diary data.|233
386775|NCT01873417|948843|P1|STARTED|Overall Study||237
386776|NCT01872910|948860|P6|NOT COMPLETED|Overall Study||0
386777|NCT01872910|948861|P5|NOT COMPLETED|Overall Study||0
386778|NCT01872910|948862|P4|NOT COMPLETED|Overall Study||0
386779|NCT01872910|948863|P3|NOT COMPLETED|Overall Study||2
386780|NCT01872910|948864|P2|NOT COMPLETED|Overall Study||0
386781|NCT01872910|948865|P1|NOT COMPLETED|Overall Study||2
386782|NCT01872910|948860|P6|COMPLETED|Overall Study||3
386783|NCT01872910|948861|P5|COMPLETED|Overall Study||15
386784|NCT01872910|948862|P4|COMPLETED|Overall Study||15
386785|NCT01872910|948863|P3|COMPLETED|Overall Study||28
386786|NCT01872910|948864|P2|COMPLETED|Overall Study||31
386787|NCT01872910|948865|P1|COMPLETED|Overall Study||28
386788|NCT01872910|948860|P6|Received Any Study Drug|Overall Study||3
386789|NCT01872910|948861|P5|Received Any Study Drug|Overall Study||15
386790|NCT01872910|948862|P4|Received Any Study Drug|Overall Study||15
386791|NCT01872910|948863|P3|Received Any Study Drug|Overall Study||30
386792|NCT01872910|948864|P2|Received Any Study Drug|Overall Study||31
386793|NCT01872910|948865|P1|Received Any Study Drug|Overall Study||30
386794|NCT01872910|948860|P6|STARTED|Overall Study||3
386795|NCT01872910|948861|P5|STARTED|Overall Study||15
386796|NCT01872910|948862|P4|STARTED|Overall Study||15
386797|NCT01872910|948863|P3|STARTED|Overall Study||30
386798|NCT01872910|948864|P2|STARTED|Overall Study||31
386799|NCT01872910|948865|P1|STARTED|Overall Study||30
386800|NCT01872819|948905|P1|NOT COMPLETED|Overall Study||0
386801|NCT01872819|948905|P1|COMPLETED|Overall Study||14
386802|NCT01872819|948905|P1|STARTED|Overall Study||14
386803|NCT01872715|948910|P1|NOT COMPLETED|Overall Study||4
386804|NCT01872715|948910|P1|COMPLETED|Overall Study||20
386805|NCT01872715|948910|P1|STARTED|Overall Study||24
386806|NCT01872611|948927|P2|NOT COMPLETED|Overall Study||12
386807|NCT01872611|948928|P1|NOT COMPLETED|Overall Study||24
386808|NCT01872611|948927|P2|COMPLETED|Overall Study||292
386809|NCT01872611|948928|P1|COMPLETED|Overall Study||277
386810|NCT01872611|948927|P2|Full Analysis Set|Overall Study||293
386811|NCT01872611|948928|P1|Full Analysis Set|Overall Study||289
386812|NCT01872611|948927|P2|Treated (Safety Analysis Set)|Overall Study||295
386813|NCT01872611|948928|P1|Treated (Safety Analysis Set)|Overall Study||293
386814|NCT01872611|948927|P2|Randomized|Overall Study||304
386815|NCT01872611|948928|P1|Randomized|Overall Study||301
386816|NCT01872611|948927|P2|STARTED|Overall Study||304
386817|NCT01872611|948928|P1|STARTED|Overall Study||301
386818|NCT01872078|948950|P4|NOT COMPLETED|Overall Study||2
386819|NCT01872078|948951|P3|NOT COMPLETED|Overall Study||3
386820|NCT01872078|948952|P2|NOT COMPLETED|Overall Study||0
386821|NCT01872078|948953|P1|NOT COMPLETED|Overall Study||0
386822|NCT01872078|948950|P4|COMPLETED|Overall Study||15
386823|NCT01872078|948951|P3|COMPLETED|Overall Study||14
386824|NCT01872078|948952|P2|COMPLETED|Overall Study||15
386825|NCT01872078|948953|P1|COMPLETED|Overall Study||16
386826|NCT01872078|948950|P4|STARTED|Overall Study||17
386827|NCT01872078|948951|P3|STARTED|Overall Study||17
386828|NCT01872078|948952|P2|STARTED|Overall Study||15
386829|NCT01872078|948953|P1|STARTED|Overall Study||16
386830|NCT01871870|948963|P1|NOT COMPLETED|Overall Study||9
386831|NCT01871870|948963|P1|COMPLETED|Overall Study||11
386832|NCT01871870|948963|P1|STARTED|Overall Study||20
386833|NCT01871805|948974|P6|NOT COMPLETED|Phase II||87
386834|NCT01871805|948975|P5|NOT COMPLETED|Phase II||0
386835|NCT01871805|948976|P4|NOT COMPLETED|Phase II||0
386836|NCT01871805|948977|P3|NOT COMPLETED|Phase II||0
386837|NCT01871805|948978|P2|NOT COMPLETED|Phase II||0
386838|NCT01871805|948979|P1|NOT COMPLETED|Phase II||0
386839|NCT01871805|948974|P6|COMPLETED|Phase II||0
386840|NCT01871805|948975|P5|COMPLETED|Phase II||0
386841|NCT01871805|948976|P4|COMPLETED|Phase II||0
386842|NCT01871805|948977|P3|COMPLETED|Phase II||0
386843|NCT01871805|948978|P2|COMPLETED|Phase II||0
386844|NCT01871805|948979|P1|COMPLETED|Phase II||0
386845|NCT01871805|948974|P6|STARTED|Phase II||87
386846|NCT01871805|948975|P5|STARTED|Phase II||0
386847|NCT01871805|948976|P4|STARTED|Phase II||0
386848|NCT01871805|948977|P3|STARTED|Phase II||0
386849|NCT01871805|948978|P2|STARTED|Phase II||0
386850|NCT01871805|948979|P1|STARTED|Phase II||0
386851|NCT01871805|948974|P6|NOT COMPLETED|Phase I||0
386852|NCT01871805|948975|P5|NOT COMPLETED|Phase I||13
386853|NCT01871805|948976|P4|NOT COMPLETED|Phase I||7
386854|NCT01871805|948977|P3|NOT COMPLETED|Phase I||13
386855|NCT01871805|948978|P2|NOT COMPLETED|Phase I||7
386856|NCT01871805|948979|P1|NOT COMPLETED|Phase I||7
386857|NCT01871805|948974|P6|COMPLETED|Phase I||0
386858|NCT01871805|948975|P5|COMPLETED|Phase I||0
386859|NCT01871805|948976|P4|COMPLETED|Phase I||0
386860|NCT01871805|948977|P3|COMPLETED|Phase I||0
386861|NCT01871805|948978|P2|COMPLETED|Phase I||0
386862|NCT01871805|948979|P1|COMPLETED|Phase I||0
386863|NCT01871805|948974|P6|STARTED|Phase I||0
386864|NCT01871805|948975|P5|STARTED|Phase I||13
386865|NCT01871805|948976|P4|STARTED|Phase I||7
386866|NCT01871805|948977|P3|STARTED|Phase I||13
386867|NCT01871805|948978|P2|STARTED|Phase I||7
386868|NCT01871805|948979|P1|STARTED|Phase I||7
386869|NCT01871558|949047|P2|NOT COMPLETED|Overall Study||2
386870|NCT01871558|949048|P1|NOT COMPLETED|Overall Study||3
386871|NCT01871558|949047|P2|COMPLETED|Overall Study||19
386872|NCT01871558|949048|P1|COMPLETED|Overall Study||18
386873|NCT01871558|949047|P2|STARTED|Overall Study||21
386874|NCT01871558|949048|P1|STARTED|Overall Study||21
386875|NCT01871532|949068|P2|NOT COMPLETED|Overall Study||2
386876|NCT01871532|949069|P1|NOT COMPLETED|Overall Study||1
386877|NCT01871532|949068|P2|COMPLETED|Overall Study||10
386878|NCT01871532|949069|P1|COMPLETED|Overall Study||11
386879|NCT01871532|949068|P2|Subjects Received hCG Treatment|Overall Study||9
386880|NCT01871532|949069|P1|Subjects Received hCG Treatment|Overall Study||11
386881|NCT01871532|949068|P2|STARTED|Overall Study||12
386882|NCT01871532|949069|P1|STARTED|Overall Study||12
386883|NCT01871519|949103|P1|NOT COMPLETED|Overall Study||90
386884|NCT01871519|949103|P1|COMPLETED|Overall Study||260
386885|NCT01871519|949103|P1|STARTED|Overall Study||350
386886|NCT01871441|949124|P1|NOT COMPLETED|Overall Study||0
386887|NCT01871441|949124|P1|COMPLETED|Overall Study||4
386888|NCT01871441|949124|P1|STARTED|Overall Study||4
386889|NCT01871402|949133|P2|NOT COMPLETED|Overall Study||3
386890|NCT01871402|949134|P1|NOT COMPLETED|Overall Study||1
386891|NCT01871402|949133|P2|COMPLETED|Overall Study||108
386892|NCT01871402|949134|P1|COMPLETED|Overall Study||109
386893|NCT01871402|949133|P2|STARTED|Overall Study||111
386894|NCT01871402|949134|P1|STARTED|Overall Study||110
386895|NCT01871285|949152|P4|NOT COMPLETED|Second Intervention (1 Day)||0
386896|NCT01871285|949153|P3|NOT COMPLETED|Second Intervention (1 Day)||0
386897|NCT01871285|949154|P2|NOT COMPLETED|Second Intervention (1 Day)||0
386898|NCT01871285|949155|P1|NOT COMPLETED|Second Intervention (1 Day)||0
386899|NCT01871285|949152|P4|COMPLETED|Second Intervention (1 Day)||2
386900|NCT01871285|949153|P3|COMPLETED|Second Intervention (1 Day)||3
386901|NCT01871285|949154|P2|COMPLETED|Second Intervention (1 Day)||14
386902|NCT01871285|949155|P1|COMPLETED|Second Intervention (1 Day)||17
386903|NCT01871285|949152|P4|STARTED|Second Intervention (1 Day)||2
386904|NCT01871285|949153|P3|STARTED|Second Intervention (1 Day)||3
386905|NCT01871285|949154|P2|STARTED|Second Intervention (1 Day)||14
386906|NCT01871285|949155|P1|STARTED|Second Intervention (1 Day)||17
386907|NCT01871285|949152|P4|NOT COMPLETED|First Intervention (1 Day)||0
386908|NCT01871285|949153|P3|NOT COMPLETED|First Intervention (1 Day)||1
386909|NCT01871285|949154|P2|NOT COMPLETED|First Intervention (1 Day)||1
386910|NCT01871285|949155|P1|NOT COMPLETED|First Intervention (1 Day)||1
386911|NCT01871285|949152|P4|COMPLETED|First Intervention (1 Day)||2
386912|NCT01871285|949153|P3|COMPLETED|First Intervention (1 Day)||3
386913|NCT01871285|949154|P2|COMPLETED|First Intervention (1 Day)||14
386914|NCT01871285|949155|P1|COMPLETED|First Intervention (1 Day)||17
386915|NCT01871285|949152|P4|STARTED|First Intervention (1 Day)||2
386916|NCT01871285|949153|P3|STARTED|First Intervention (1 Day)||4
386917|NCT01871285|949154|P2|STARTED|First Intervention (1 Day)||15
386918|NCT01871285|949155|P1|STARTED|First Intervention (1 Day)||18
386919|NCT01871142|949181|P1|NOT COMPLETED|Overall Study||1
386920|NCT01871142|949181|P1|COMPLETED|Overall Study||11
386921|NCT01871142|949181|P1|Received 3000mg Aes-103 + Hypoxia|Overall Study||12
386922|NCT01871142|949181|P1|Received 1000mg Aes 103+ Hypoxia|Overall Study||11
386923|NCT01871142|949181|P1|Received Placebo + Hypoxia|Overall Study||12
386924|NCT01871142|949181|P1|Received Placebo + Normoixa|Overall Study||11
386925|NCT01871142|949181|P1|STARTED|Overall Study||12
386926|NCT01871090|949197|P2|NOT COMPLETED|Overall Study||23
386927|NCT01871090|949198|P1|NOT COMPLETED|Overall Study||2
386928|NCT01871090|949197|P2|COMPLETED|Overall Study||25
386929|NCT01871090|949198|P1|COMPLETED|Overall Study||33
386930|NCT01871090|949197|P2|STARTED|Overall Study||48
386931|NCT01871090|949198|P1|STARTED|Overall Study||35
386932|NCT01870999|949211|P3|NOT COMPLETED|Overall Study||7
386933|NCT01870999|949212|P2|NOT COMPLETED|Overall Study||8
386934|NCT01870999|949213|P1|NOT COMPLETED|Overall Study||4
386935|NCT01870999|949211|P3|COMPLETED|Overall Study||4
386936|NCT01870999|949212|P2|COMPLETED|Overall Study||8
386937|NCT01870999|949213|P1|COMPLETED|Overall Study||10
386938|NCT01870999|949211|P3|Safety Population; Received Study Drug|Overall Study||10
386939|NCT01870999|949212|P2|Safety Population; Received Study Drug|Overall Study||15
386940|NCT01870999|949213|P1|Safety Population; Received Study Drug|Overall Study||14
386941|NCT01870999|949211|P3|STARTED|Overall Study||11
386942|NCT01870999|949212|P2|STARTED|Overall Study||16
386943|NCT01870999|949213|P1|STARTED|Overall Study||14
386944|NCT01870973|949271|P2|NOT COMPLETED|Overall Study||3
386945|NCT01870973|949272|P1|NOT COMPLETED|Overall Study||10
386946|NCT01870973|949271|P2|COMPLETED|Overall Study||49
386947|NCT01870973|949272|P1|COMPLETED|Overall Study||46
386948|NCT01870973|949271|P2|STARTED|Overall Study||52
386949|NCT01870973|949272|P1|STARTED|Overall Study||56
386950|NCT01870921|949278|P1|NOT COMPLETED|Overall Study||90
386951|NCT01870921|949278|P1|COMPLETED|Overall Study||1914
386952|NCT01870921|949278|P1|STARTED|Overall Study||2004
386953|NCT01870856|949286|P2|NOT COMPLETED|Overall Study||0
386954|NCT01870856|949287|P1|NOT COMPLETED|Overall Study||0
386955|NCT01870856|949286|P2|COMPLETED|Overall Study||27
386956|NCT01870856|949287|P1|COMPLETED|Overall Study||25
386957|NCT01870856|949286|P2|STARTED|Overall Study||27
386958|NCT01870856|949287|P1|STARTED|Overall Study||25
386959|NCT01870843|949297|P1|NOT COMPLETED|Overall Study||53
386960|NCT01870843|949297|P1|COMPLETED|Overall Study||208
386961|NCT01870843|949297|P1|STARTED|Overall Study||261
386962|NCT01870778|949312|P2|NOT COMPLETED|Overall Study||9
386963|NCT01870778|949313|P1|NOT COMPLETED|Overall Study||8
386964|NCT01870778|949312|P2|COMPLETED|Overall Study||3262
386965|NCT01870778|949313|P1|COMPLETED|Overall Study||3266
386966|NCT01870778|949312|P2|Biomarker Analysis Set|Overall Study||510
386967|NCT01870778|949313|P1|Biomarker Analysis Set|Overall Study||521
386968|NCT01870778|949312|P2|Full Analysis Set|Overall Study||3271
386969|NCT01870778|949313|P1|Full Analysis Set|Overall Study||3274
386970|NCT01870778|949312|P2|Safety Set|Overall Study||3248
386971|NCT01870778|949313|P1|Safety Set|Overall Study||3257
386972|NCT01870778|949312|P2|STARTED|Overall Study||3271
386973|NCT01870778|949313|P1|STARTED|Overall Study||3274
386974|NCT01870739|949339|P2|NOT COMPLETED|Add-on Period (40 Weeks)||2
386975|NCT01870739|949340|P1|NOT COMPLETED|Add-on Period (40 Weeks)||3
386976|NCT01870739|949339|P2|COMPLETED|Add-on Period (40 Weeks)||51
386977|NCT01870739|949340|P1|COMPLETED|Add-on Period (40 Weeks)||51
386978|NCT01870739|949339|P2|STARTED|Add-on Period (40 Weeks)||53
386979|NCT01870739|949340|P1|STARTED|Add-on Period (40 Weeks)||54
386980|NCT01870739|949339|P2|NOT COMPLETED|Single Drug Treatment (12 Weeks)||4
386981|NCT01870739|949340|P1|NOT COMPLETED|Single Drug Treatment (12 Weeks)||3
386982|NCT01870739|949339|P2|COMPLETED|Single Drug Treatment (12 Weeks)||53
386983|NCT01870739|949340|P1|COMPLETED|Single Drug Treatment (12 Weeks)|"Completed indicates maintenance dose complete"|54
386984|NCT01870739|949339|P2|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||56
386985|NCT01870739|949340|P1|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||57
386986|NCT01870739|949339|P2|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||56
386987|NCT01870739|949340|P1|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||57
386988|NCT01870739|949339|P2|STARTED|Single Drug Treatment (12 Weeks)||57
386989|NCT01870739|949340|P1|STARTED|Single Drug Treatment (12 Weeks)|"Start = Safety/Pharmacokinetic/Pharmacodynamic analysis set"|57
386990|NCT01870726|949379|P7|NOT COMPLETED|Overall Study||10
386991|NCT01870726|949380|P6|NOT COMPLETED|Overall Study||5
386992|NCT01870726|949381|P5|NOT COMPLETED|Overall Study||7
386993|NCT01870726|949382|P4|NOT COMPLETED|Overall Study||6
386994|NCT01870726|949383|P3|NOT COMPLETED|Overall Study||4
386995|NCT01870726|949384|P2|NOT COMPLETED|Overall Study||6
386996|NCT01870726|949385|P1|NOT COMPLETED|Overall Study||5
386997|NCT01870726|949379|P7|COMPLETED|Overall Study||0
386998|NCT01870726|949380|P6|COMPLETED|Overall Study||0
386999|NCT01870726|949381|P5|COMPLETED|Overall Study||0
387000|NCT01870726|949382|P4|COMPLETED|Overall Study||0
387001|NCT01870726|949383|P3|COMPLETED|Overall Study||0
387002|NCT01870726|949384|P2|COMPLETED|Overall Study||0
387003|NCT01870726|949385|P1|COMPLETED|Overall Study||0
387004|NCT01870726|949379|P7|STARTED|Overall Study||10
387005|NCT01870726|949380|P6|STARTED|Overall Study||5
387006|NCT01870726|949381|P5|STARTED|Overall Study||7
387007|NCT01870726|949382|P4|STARTED|Overall Study||6
387008|NCT01870726|949383|P3|STARTED|Overall Study||4
387009|NCT01870726|949384|P2|STARTED|Overall Study||6
387010|NCT01870726|949385|P1|STARTED|Overall Study||5
387011|NCT01870596|949470|P2|NOT COMPLETED|Overall Study||0
387012|NCT01870596|949471|P1|NOT COMPLETED|Overall Study||0
387013|NCT01870596|949470|P2|COMPLETED|Overall Study||18
387014|NCT01870596|949471|P1|COMPLETED|Overall Study||14
387015|NCT01870596|949470|P2|STARTED|Overall Study||18
387016|NCT01870596|949471|P1|STARTED|Overall Study||14
387017|NCT01870583|949480|P3|NOT COMPLETED|Overall Study||8
387018|NCT01870583|949481|P2|NOT COMPLETED|Overall Study||18
387019|NCT01870583|949482|P1|NOT COMPLETED|Overall Study||11
387020|NCT01870583|949480|P3|COMPLETED|Overall Study||455
387021|NCT01870583|949481|P2|COMPLETED|Overall Study||456
387022|NCT01870583|949482|P1|COMPLETED|Overall Study||456
387023|NCT01870583|949480|P3|STARTED|Overall Study||463
387024|NCT01870583|949481|P2|STARTED|Overall Study||474
387025|NCT01870583|949482|P1|STARTED|Overall Study||467
387026|NCT01870388|949492|P2|NOT COMPLETED|Overall Study||0
387027|NCT01870388|949493|P1|NOT COMPLETED|Overall Study||0
387028|NCT01870388|949492|P2|COMPLETED|Overall Study||8
387029|NCT01870388|949493|P1|COMPLETED|Overall Study||8
387030|NCT01870388|949492|P2|Received 1 Dose of Study Drug|Overall Study||8
387031|NCT01870388|949493|P1|Received 1 Dose of Study Drug|Overall Study||8
387032|NCT01870388|949492|P2|STARTED|Overall Study||8
387033|NCT01870388|949493|P1|STARTED|Overall Study||8
387034|NCT01870076|949505|P4|NOT COMPLETED|Overall Study||0
387035|NCT01870076|949506|P3|NOT COMPLETED|Overall Study||1
387036|NCT01870076|949507|P2|NOT COMPLETED|Overall Study||0
387037|NCT01870076|949508|P1|NOT COMPLETED|Overall Study||1
387038|NCT01870076|949505|P4|COMPLETED|Overall Study||11
387039|NCT01870076|949506|P3|COMPLETED|Overall Study||7
387040|NCT01870076|949507|P2|COMPLETED|Overall Study||12
387041|NCT01870076|949508|P1|COMPLETED|Overall Study||9
387042|NCT01870076|949505|P4|STARTED|Overall Study||11
387043|NCT01870076|949506|P3|STARTED|Overall Study||8
387044|NCT01870076|949507|P2|STARTED|Overall Study||12
387045|NCT01870076|949508|P1|STARTED|Overall Study||10
387046|NCT01869959|949526|P5|NOT COMPLETED|Treatment Period||0
387047|NCT01869959|949527|P4|NOT COMPLETED|Treatment Period||2
387048|NCT01869959|949528|P3|NOT COMPLETED|Treatment Period||3
387049|NCT01869959|949529|P2|NOT COMPLETED|Treatment Period||2
387050|NCT01869959|949530|P1|NOT COMPLETED|Treatment Period||1
387051|NCT01869959|949526|P5|COMPLETED|Treatment Period||0
387052|NCT01869959|949527|P4|COMPLETED|Treatment Period||8
387053|NCT01869959|949528|P3|COMPLETED|Treatment Period||12
387054|NCT01869959|949529|P2|COMPLETED|Treatment Period||8
387055|NCT01869959|949530|P1|COMPLETED|Treatment Period||10
387056|NCT01869959|949526|P5|Received at Least 1 Dose of Study Drug|Treatment Period||0
387057|NCT01869959|949527|P4|Received at Least 1 Dose of Study Drug|Treatment Period||10
387058|NCT01869959|949528|P3|Received at Least 1 Dose of Study Drug|Treatment Period||15
387059|NCT01869959|949529|P2|Received at Least 1 Dose of Study Drug|Treatment Period||10
387060|NCT01869959|949530|P1|Received at Least 1 Dose of Study Drug|Treatment Period||11
387061|NCT01869959|949526|P5|STARTED|Treatment Period|Participants were randomized to treatment groups for the Treatment Period.|0
387062|NCT01869959|949527|P4|STARTED|Treatment Period||10
387063|NCT01869959|949528|P3|STARTED|Treatment Period||15
387064|NCT01869959|949529|P2|STARTED|Treatment Period||10
387065|NCT01869959|949530|P1|STARTED|Treatment Period||11
387066|NCT01869959|949526|P5|NOT COMPLETED|Randomization Period||1
387067|NCT01869959|949527|P4|NOT COMPLETED|Randomization Period||0
387068|NCT01869959|949528|P3|NOT COMPLETED|Randomization Period||0
387069|NCT01869959|949529|P2|NOT COMPLETED|Randomization Period||0
387070|NCT01869959|949530|P1|NOT COMPLETED|Randomization Period||0
387071|NCT01869959|949526|P5|COMPLETED|Randomization Period|One participant discontinued after randomization but did not receive study drug.|46
387072|NCT01869959|949527|P4|COMPLETED|Randomization Period||0
387073|NCT01869959|949528|P3|COMPLETED|Randomization Period||0
387074|NCT01869959|949529|P2|COMPLETED|Randomization Period||0
387075|NCT01869959|949530|P1|COMPLETED|Randomization Period||0
387076|NCT01869959|949526|P5|STARTED|Randomization Period||47
387077|NCT01869959|949527|P4|STARTED|Randomization Period||0
387078|NCT01869959|949528|P3|STARTED|Randomization Period||0
387079|NCT01869959|949529|P2|STARTED|Randomization Period||0
387080|NCT01869959|949530|P1|STARTED|Randomization Period||0
387081|NCT01869699|949600|P2|NOT COMPLETED|Overall Study||0
387082|NCT01869699|949601|P1|NOT COMPLETED|Overall Study||1
387083|NCT01869699|949600|P2|COMPLETED|Overall Study||20
387084|NCT01869699|949601|P1|COMPLETED|Overall Study||20
387085|NCT01869699|949600|P2|STARTED|Overall Study||20
387086|NCT01869699|949601|P1|STARTED|Overall Study||21
387087|NCT01869686|949619|P1|NOT COMPLETED|Overall Study||0
387088|NCT01869686|949619|P1|COMPLETED|Overall Study||12
387089|NCT01869686|949619|P1|STARTED|Overall Study||12
387090|NCT01869647|949634|P3|NOT COMPLETED|Overall Study||0
387091|NCT01869647|949635|P2|NOT COMPLETED|Overall Study||6
387092|NCT01869647|949636|P1|NOT COMPLETED|Overall Study||1
387093|NCT01869647|949634|P3|COMPLETED|Overall Study||62
387094|NCT01869647|949635|P2|COMPLETED|Overall Study||130
387095|NCT01869647|949636|P1|COMPLETED|Overall Study||65
387096|NCT01869647|949634|P3|STARTED|Overall Study||62
387097|NCT01869647|949635|P2|STARTED|Overall Study||136
387098|NCT01869647|949636|P1|STARTED|Overall Study||66
387099|NCT01869478|949649|P2|NOT COMPLETED|Overall Study||0
387100|NCT01869478|949650|P1|NOT COMPLETED|Overall Study||0
387101|NCT01869478|949649|P2|COMPLETED|Overall Study||1
387102|NCT01869478|949650|P1|COMPLETED|Overall Study||0
387103|NCT01869478|949649|P2|STARTED|Overall Study||1
387104|NCT01869478|949650|P1|STARTED|Overall Study||0
387105|NCT01869439|949658|P1|NOT COMPLETED|Overall Study||0
387106|NCT01869439|949658|P1|COMPLETED|Overall Study||40
387107|NCT01869439|949658|P1|STARTED|Overall Study||40
387108|NCT01869348|949664|P2|NOT COMPLETED|Overall Study||1
387109|NCT01869348|949665|P1|NOT COMPLETED|Overall Study||1
387110|NCT01869348|949664|P2|COMPLETED|Overall Study||19
387111|NCT01869348|949665|P1|COMPLETED|Overall Study||19
387112|NCT01869348|949664|P2|STARTED|Overall Study||20
387113|NCT01869348|949665|P1|STARTED|Overall Study||20
387114|NCT01869075|949677|P6|NOT COMPLETED|Phase 2||0
387115|NCT01869075|949678|P5|NOT COMPLETED|Phase 2||0
387116|NCT01869075|949679|P4|NOT COMPLETED|Phase 2||0
387117|NCT01869075|949680|P3|NOT COMPLETED|Phase 2||0
387118|NCT01869075|949681|P2|NOT COMPLETED|Phase 2||0
387119|NCT01869075|949682|P1|NOT COMPLETED|Phase 2||0
387120|NCT01869075|949677|P6|COMPLETED|Phase 2||45
387121|NCT01869075|949678|P5|COMPLETED|Phase 2||75
387122|NCT01869075|949679|P4|COMPLETED|Phase 2||45
387123|NCT01869075|949680|P3|COMPLETED|Phase 2||75
387124|NCT01869075|949681|P2|COMPLETED|Phase 2||30
387125|NCT01869075|949682|P1|COMPLETED|Phase 2||90
387126|NCT01869075|949677|P6|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|45
387127|NCT01869075|949678|P5|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|75
387128|NCT01869075|949679|P4|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|45
387129|NCT01869075|949680|P3|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|75
387130|NCT01869075|949681|P2|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|30
387131|NCT01869075|949682|P1|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|90
387132|NCT01869075|949677|P6|NOT COMPLETED|Phase 1||0
387133|NCT01869075|949678|P5|NOT COMPLETED|Phase 1||0
387134|NCT01869075|949679|P4|NOT COMPLETED|Phase 1||0
387135|NCT01869075|949680|P3|NOT COMPLETED|Phase 1||0
387136|NCT01869075|949681|P2|NOT COMPLETED|Phase 1||0
387137|NCT01869075|949682|P1|NOT COMPLETED|Phase 1||0
387138|NCT01869075|949677|P6|COMPLETED|Phase 1||90
387139|NCT01869075|949678|P5|COMPLETED|Phase 1||30
387140|NCT01869075|949679|P4|COMPLETED|Phase 1||75
387141|NCT01869075|949680|P3|COMPLETED|Phase 1||45
387142|NCT01869075|949681|P2|COMPLETED|Phase 1||75
387143|NCT01869075|949682|P1|COMPLETED|Phase 1||45
387144|NCT01869075|949677|P6|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|90
387145|NCT01869075|949678|P5|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|30
387146|NCT01869075|949679|P4|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|75
387147|NCT01869075|949680|P3|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|45
387148|NCT01869075|949681|P2|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|75
387149|NCT01869075|949682|P1|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|45
387150|NCT01869075|949677|P6|NOT COMPLETED|Phase 0 (Baseline)||0
387151|NCT01869075|949678|P5|NOT COMPLETED|Phase 0 (Baseline)||0
387152|NCT01869075|949679|P4|NOT COMPLETED|Phase 0 (Baseline)||0
387153|NCT01869075|949680|P3|NOT COMPLETED|Phase 0 (Baseline)||0
387154|NCT01869075|949681|P2|NOT COMPLETED|Phase 0 (Baseline)||0
387155|NCT01869075|949682|P1|NOT COMPLETED|Phase 0 (Baseline)||0
387156|NCT01869075|949677|P6|COMPLETED|Phase 0 (Baseline)||341
387157|NCT01869075|949678|P5|COMPLETED|Phase 0 (Baseline)||0
387158|NCT01869075|949679|P4|COMPLETED|Phase 0 (Baseline)||416
387159|NCT01869075|949680|P3|COMPLETED|Phase 0 (Baseline)||0
387160|NCT01869075|949681|P2|COMPLETED|Phase 0 (Baseline)||418
387161|NCT01869075|949682|P1|COMPLETED|Phase 0 (Baseline)||0
387162|NCT01869075|949677|P6|STARTED|Phase 0 (Baseline)||341
387163|NCT01869075|949678|P5|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
387164|NCT01869075|949679|P4|STARTED|Phase 0 (Baseline)||416
387165|NCT01869075|949680|P3|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
387166|NCT01869075|949681|P2|STARTED|Phase 0 (Baseline)||418
387167|NCT01869075|949682|P1|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
387168|NCT01868997|949698|P2|NOT COMPLETED|Overall Study||6
387169|NCT01868997|949699|P1|NOT COMPLETED|Overall Study||7
387170|NCT01868997|949698|P2|COMPLETED|Overall Study||36
387171|NCT01868997|949699|P1|COMPLETED|Overall Study||38
387172|NCT01868997|949698|P2|STARTED|Overall Study|randomized and treated|42
387173|NCT01868997|949699|P1|STARTED|Overall Study|randomized and treated|45
387174|NCT01868893|949715|P1|NOT COMPLETED|Overall Study||20
387175|NCT01868893|949715|P1|COMPLETED|Overall Study||0
387176|NCT01868893|949715|P1|STARTED|Overall Study||20
387177|NCT01868789|949724|P2|NOT COMPLETED|Overall Study||2
387178|NCT01868789|949725|P1|NOT COMPLETED|Overall Study||2
387179|NCT01868789|949724|P2|COMPLETED|Overall Study||12
387180|NCT01868789|949725|P1|COMPLETED|Overall Study||7
387181|NCT01868789|949724|P2|STARTED|Overall Study||14
387182|NCT01868789|949725|P1|STARTED|Overall Study||9
387183|NCT01868776|949735|P2|NOT COMPLETED|Overall Study||0
387184|NCT01868776|949736|P1|NOT COMPLETED|Overall Study||0
387185|NCT01868776|949735|P2|COMPLETED|Overall Study||50
387186|NCT01868776|949736|P1|COMPLETED|Overall Study||50
387187|NCT01868776|949735|P2|STARTED|Overall Study||50
387188|NCT01868776|949736|P1|STARTED|Overall Study||50
387189|NCT01868633|949744|P2|NOT COMPLETED|Overall Study||0
387190|NCT01868633|949745|P1|NOT COMPLETED|Overall Study||0
387191|NCT01868633|949744|P2|COMPLETED|Overall Study||26
387192|NCT01868633|949745|P1|COMPLETED|Overall Study||26
387193|NCT01868633|949744|P2|STARTED|Overall Study||26
387194|NCT01868633|949745|P1|STARTED|Overall Study||26
387195|NCT01868542|949761|P2|NOT COMPLETED|Overall Study||2
387196|NCT01868542|949762|P1|NOT COMPLETED|Overall Study||0
387197|NCT01868542|949761|P2|COMPLETED|Overall Study||21
387198|NCT01868542|949762|P1|COMPLETED|Overall Study||23
387199|NCT01868542|949761|P2|STARTED|Overall Study||23
387200|NCT01868542|949762|P1|STARTED|Overall Study||23
387201|NCT01868503|949780|P1|NOT COMPLETED|Overall Study||2
387202|NCT01868503|949780|P1|COMPLETED|Overall Study||5
387203|NCT01868503|949780|P1|STARTED|Overall Study||7
387204|NCT01868334|949792|P4|NOT COMPLETED|Year 2 Pre-post Study||0
387205|NCT01868334|949793|P3|NOT COMPLETED|Year 2 Pre-post Study||0
387206|NCT01868334|949794|P2|NOT COMPLETED|Year 2 Pre-post Study||0
387207|NCT01868334|949795|P1|NOT COMPLETED|Year 2 Pre-post Study||0
387208|NCT01868334|949792|P4|COMPLETED|Year 2 Pre-post Study||19274
387209|NCT01868334|949793|P3|COMPLETED|Year 2 Pre-post Study||20904
387210|NCT01868334|949794|P2|COMPLETED|Year 2 Pre-post Study||8047
387211|NCT01868334|949795|P1|COMPLETED|Year 2 Pre-post Study||22324
387212|NCT01868334|949792|P4|STARTED|Year 2 Pre-post Study|Reflects: Year 1 Intervention sites who chose not to actively engage Year 2|19274
387213|NCT01868334|949793|P3|STARTED|Year 2 Pre-post Study|Reflects: Year 1 Control sites who became active in the intervention during Year 2|20904
387214|NCT01868334|949794|P2|STARTED|Year 2 Pre-post Study|Reflects: the six Year 1 Intervention sites who chose not to actively engage Year 2|8047
387215|NCT01868334|949795|P1|STARTED|Year 2 Pre-post Study|Reflects: control sites from Year 1 (N=8) and Year 1 Intervention sites who continued in Y2 (N=4)|22324
387216|NCT01868334|949792|P4|NOT COMPLETED|Year 1 RCCT Study||0
387217|NCT01868334|949793|P3|NOT COMPLETED|Year 1 RCCT Study||0
387218|NCT01868334|949794|P2|NOT COMPLETED|Year 1 RCCT Study||0
387219|NCT01868334|949795|P1|NOT COMPLETED|Year 1 RCCT Study||0
387220|NCT01868334|949792|P4|COMPLETED|Year 1 RCCT Study||20904
387221|NCT01868334|949793|P3|COMPLETED|Year 1 RCCT Study||19274
387222|NCT01868334|949794|P2|COMPLETED|Year 1 RCCT Study||17185
387223|NCT01868334|949795|P1|COMPLETED|Year 1 RCCT Study||13186
387224|NCT01868334|949792|P4|STARTED|Year 1 RCCT Study||20904
387225|NCT01868334|949793|P3|STARTED|Year 1 RCCT Study||19274
387226|NCT01868334|949794|P2|STARTED|Year 1 RCCT Study||17185
387227|NCT01868334|949795|P1|STARTED|Year 1 RCCT Study||13186
387228|NCT01868243|949835|P2|NOT COMPLETED|Overall Study||1
387229|NCT01868243|949836|P1|NOT COMPLETED|Overall Study||0
387230|NCT01868243|949835|P2|COMPLETED|Overall Study||11
387231|NCT01868243|949836|P1|COMPLETED|Overall Study||15
387232|NCT01868243|949835|P2|STARTED|Overall Study||12
387233|NCT01868243|949836|P1|STARTED|Overall Study||15
387234|NCT01868074|949846|P2|NOT COMPLETED|Overall Study||4
387235|NCT01868074|949847|P1|NOT COMPLETED|Overall Study||7
387236|NCT01868074|949846|P2|COMPLETED|Overall Study||32
387237|NCT01868074|949847|P1|COMPLETED|Overall Study||29
387238|NCT01868074|949846|P2|STARTED|Overall Study||36
387239|NCT01868074|949847|P1|STARTED|Overall Study||36
387240|NCT01868035|949857|P1|NOT COMPLETED|Overall Study||7
387241|NCT01868035|949857|P1|COMPLETED|Overall Study|These participants completed 10 years of follow-up.|8
387242|NCT01868035|949857|P1|STARTED|Overall Study||15
387243|NCT01868009|949873|P2|NOT COMPLETED|Period 2 (5-9 Days)||0
387244|NCT01868009|949874|P1|NOT COMPLETED|Period 2 (5-9 Days)||2
387245|NCT01868009|949873|P2|COMPLETED|Period 2 (5-9 Days)||142
387246|NCT01868009|949874|P1|COMPLETED|Period 2 (5-9 Days)||141
387247|NCT01868009|949873|P2|STARTED|Period 2 (5-9 Days)||142
387248|NCT01868009|949874|P1|STARTED|Period 2 (5-9 Days)||143
387249|NCT01868009|949873|P2|NOT COMPLETED|Period 1 (5-9 Days)||2
387250|NCT01868009|949874|P1|NOT COMPLETED|Period 1 (5-9 Days)||0
387251|NCT01868009|949873|P2|COMPLETED|Period 1 (5-9 Days)||142
387252|NCT01868009|949874|P1|COMPLETED|Period 1 (5-9 Days)||143
387253|NCT01868009|949873|P2|STARTED|Period 1 (5-9 Days)||144
387254|NCT01868009|949874|P1|STARTED|Period 1 (5-9 Days)||143
387255|NCT01867710|949888|P4|NOT COMPLETED|Overall Study||7
387256|NCT01867710|949889|P3|NOT COMPLETED|Overall Study||9
387257|NCT01867710|949890|P2|NOT COMPLETED|Overall Study||7
387258|NCT01867710|949891|P1|NOT COMPLETED|Overall Study||8
387259|NCT01867710|949888|P4|COMPLETED|Overall Study||35
387260|NCT01867710|949889|P3|COMPLETED|Overall Study||31
387261|NCT01867710|949890|P2|COMPLETED|Overall Study||34
387262|NCT01867710|949891|P1|COMPLETED|Overall Study||33
387263|NCT01867710|949888|P4|Treated|Overall Study||42
387264|NCT01867710|949889|P3|Treated|Overall Study||39
387265|NCT01867710|949890|P2|Treated|Overall Study||41
387266|NCT01867710|949891|P1|Treated|Overall Study||41
387267|NCT01867710|949888|P4|STARTED|Overall Study||42
387268|NCT01867710|949889|P3|STARTED|Overall Study||40
387269|NCT01867710|949890|P2|STARTED|Overall Study||41
387270|NCT01867710|949891|P1|STARTED|Overall Study||41
387271|NCT01867658|949905|P1|NOT COMPLETED|Overall Study||9
387272|NCT01867658|949905|P1|COMPLETED|Overall Study||103
387273|NCT01867658|949905|P1|STARTED|Overall Study||112
387274|NCT01867632|949918|P2|NOT COMPLETED|Overall Study||0
387275|NCT01867632|949919|P1|NOT COMPLETED|Overall Study||0
387276|NCT01867632|949918|P2|COMPLETED|Overall Study||66
387277|NCT01867632|949919|P1|COMPLETED|Overall Study||65
387278|NCT01867632|949918|P2|STARTED|Overall Study||66
387279|NCT01867632|949919|P1|STARTED|Overall Study||65
387280|NCT01867580|949929|P2|NOT COMPLETED|Overall Study||24
387281|NCT01867580|949930|P1|NOT COMPLETED|Overall Study||28
387282|NCT01867580|949929|P2|COMPLETED|Overall Study||64
387283|NCT01867580|949930|P1|COMPLETED|Overall Study||65
387284|NCT01867580|949929|P2|STARTED|Overall Study||88
387285|NCT01867580|949930|P1|STARTED|Overall Study||93
387286|NCT01867515|949943|P3|NOT COMPLETED|Overall Study||11
387287|NCT01867515|949944|P2|NOT COMPLETED|Overall Study||1
387288|NCT01867515|949945|P1|NOT COMPLETED|Overall Study||0
387289|NCT01867515|949943|P3|COMPLETED|Overall Study||14
387290|NCT01867515|949944|P2|COMPLETED|Overall Study||11
387291|NCT01867515|949945|P1|COMPLETED|Overall Study||13
387292|NCT01867515|949943|P3|STARTED|Overall Study||25
387293|NCT01867515|949944|P2|STARTED|Overall Study||12
387294|NCT01867515|949945|P1|STARTED|Overall Study||13
387295|NCT01867424|949955|P2|NOT COMPLETED|Overall Study||1
387296|NCT01867424|949956|P1|NOT COMPLETED|Overall Study||2
387297|NCT01867424|949955|P2|COMPLETED|Overall Study||11
387298|NCT01867424|949956|P1|COMPLETED|Overall Study||10
387299|NCT01867424|949955|P2|STARTED|Overall Study||12
387300|NCT01867424|949956|P1|STARTED|Overall Study||12
387301|NCT01867307|949970|P2|NOT COMPLETED|Overall Study||3
387302|NCT01867307|949971|P1|NOT COMPLETED|Overall Study||3
387303|NCT01867307|949970|P2|COMPLETED|Overall Study||16
387304|NCT01867307|949971|P1|COMPLETED|Overall Study||15
387305|NCT01867307|949970|P2|STARTED|Overall Study|Started are the treated patients|19
387306|NCT01867307|949971|P1|STARTED|Overall Study|Started are the treated patients|18
387307|NCT01867164|949979|P2|NOT COMPLETED|Overall Study||0
387308|NCT01867164|949980|P1|NOT COMPLETED|Overall Study||0
387309|NCT01867164|949979|P2|COMPLETED|Overall Study||79
387310|NCT01867164|949980|P1|COMPLETED|Overall Study||81
387311|NCT01867164|949979|P2|STARTED|Overall Study||79
387312|NCT01867164|949980|P1|STARTED|Overall Study||81
387313|NCT01867086|949994|P1|NOT COMPLETED|Overall Study||1
387314|NCT01867086|949994|P1|COMPLETED|Overall Study|"Completed means subject had been given all manufactured doses."|0
387315|NCT01867086|949994|P1|STARTED|Overall Study||1
387316|NCT01867047|950003|P2|NOT COMPLETED|Overall Study||5
387317|NCT01867047|950004|P1|NOT COMPLETED|Overall Study||8
387318|NCT01867047|950003|P2|COMPLETED|Overall Study||23
387319|NCT01867047|950004|P1|COMPLETED|Overall Study||23
387320|NCT01867047|950003|P2|STARTED|Overall Study||28
387321|NCT01867047|950004|P1|STARTED|Overall Study||31
387322|NCT01867021|950024|P2|NOT COMPLETED|Overall Study||10
387323|NCT01867021|950025|P1|NOT COMPLETED|Overall Study||2
387324|NCT01867021|950024|P2|COMPLETED|Overall Study||1440
387325|NCT01867021|950025|P1|COMPLETED|Overall Study||1450
387326|NCT01867021|950024|P2|STARTED|Overall Study||1450
387327|NCT01867021|950025|P1|STARTED|Overall Study||1452
387328|NCT01866943|950044|P2|NOT COMPLETED|Overall Study||22
387329|NCT01866943|950045|P1|NOT COMPLETED|Overall Study||19
387330|NCT01866943|950044|P2|COMPLETED|Overall Study|Unknown - the only spreadsheet available is de-identified and blinded.|0
387331|NCT01866943|950045|P1|COMPLETED|Overall Study|Unknown - the only spreadsheet available is de-identified and blinded.|0
387332|NCT01866943|950044|P2|STARTED|Overall Study||22
387333|NCT01866943|950045|P1|STARTED|Overall Study||19
387334|NCT01866709|950056|P2|NOT COMPLETED|Overall Study||0
387335|NCT01866709|950057|P1|NOT COMPLETED|Overall Study||1
387336|NCT01866709|950056|P2|COMPLETED|Overall Study||17
387337|NCT01866709|950057|P1|COMPLETED|Overall Study||14
387338|NCT01866709|950056|P2|STARTED|Overall Study||17
387339|NCT01866709|950057|P1|STARTED|Overall Study||15
387340|NCT01866592|950065|P1|NOT COMPLETED|Overall Study||23
387341|NCT01866592|950065|P1|COMPLETED|Overall Study||58
387342|NCT01866592|950065|P1|STARTED|Overall Study||81
387343|NCT01866423|950098|P1|NOT COMPLETED|Overall Study||4
387344|NCT01866423|950098|P1|COMPLETED|Overall Study||0
387345|NCT01866423|950098|P1|STARTED|Overall Study||4
387346|NCT01866319|950111|P3|NOT COMPLETED|Overall Study||277
387347|NCT01866319|950112|P2|NOT COMPLETED|Overall Study||279
387348|NCT01866319|950113|P1|NOT COMPLETED|Overall Study||277
387349|NCT01866319|950111|P3|COMPLETED|Overall Study||0
387350|NCT01866319|950112|P2|COMPLETED|Overall Study||0
387351|NCT01866319|950113|P1|COMPLETED|Overall Study||1
387352|NCT01866319|950111|P3|Treated|Overall Study||277
387353|NCT01866319|950112|P2|Treated|Overall Study||278
387354|NCT01866319|950113|P1|Treated|Overall Study||256
387355|NCT01866319|950111|P3|STARTED|Overall Study||277
387356|NCT01866319|950112|P2|STARTED|Overall Study||279
387357|NCT01866319|950113|P1|STARTED|Overall Study||278
387358|NCT01866306|950134|P7|NOT COMPLETED|Overall Study||0
387359|NCT01866306|950135|P6|NOT COMPLETED|Overall Study||0
387360|NCT01866306|950136|P5|NOT COMPLETED|Overall Study||0
387361|NCT01866306|950137|P4|NOT COMPLETED|Overall Study||0
387362|NCT01866306|950138|P3|NOT COMPLETED|Overall Study||0
387363|NCT01866306|950139|P2|NOT COMPLETED|Overall Study||0
387364|NCT01866306|950140|P1|NOT COMPLETED|Overall Study||0
387365|NCT01866306|950134|P7|COMPLETED|Overall Study||23
387366|NCT01866306|950135|P6|COMPLETED|Overall Study||6
387367|NCT01866306|950136|P5|COMPLETED|Overall Study||6
387368|NCT01866306|950137|P4|COMPLETED|Overall Study||6
387369|NCT01866306|950138|P3|COMPLETED|Overall Study||6
387370|NCT01866306|950139|P2|COMPLETED|Overall Study||6
387371|NCT01866306|950140|P1|COMPLETED|Overall Study||6
387372|NCT01866306|950134|P7|STARTED|Overall Study||23
387373|NCT01866306|950135|P6|STARTED|Overall Study||6
387374|NCT01866306|950136|P5|STARTED|Overall Study||6
387375|NCT01866306|950137|P4|STARTED|Overall Study||6
387376|NCT01866306|950138|P3|STARTED|Overall Study||6
387377|NCT01866306|950139|P2|STARTED|Overall Study||6
387378|NCT01866306|950140|P1|STARTED|Overall Study||6
387379|NCT01866293|950212|P1|NOT COMPLETED|Overall Study||2
387380|NCT01866293|950212|P1|COMPLETED|Overall Study||9
387381|NCT01866293|950212|P1|STARTED|Overall Study||11
387382|NCT01866163|950222|P2|NOT COMPLETED|Overall Study||4
387383|NCT01866163|950223|P1|NOT COMPLETED|Overall Study||10
387384|NCT01866163|950222|P2|COMPLETED|Overall Study||99
387385|NCT01866163|950223|P1|COMPLETED|Overall Study||313
387386|NCT01866163|950222|P2|STARTED|Overall Study||103
387387|NCT01866163|950223|P1|STARTED|Overall Study||323
387388|NCT01866150|950233|P1|NOT COMPLETED|Overall Study||0
387389|NCT01866150|950233|P1|COMPLETED|Overall Study||450
387390|NCT01866150|950233|P1|STARTED|Overall Study||450
387391|NCT01865812|950254|P1|NOT COMPLETED|Overall Study||2
387392|NCT01865812|950254|P1|COMPLETED|Overall Study||24
387393|NCT01865812|950254|P1|STARTED|Overall Study||26
387394|NCT01865747|950262|P2|NOT COMPLETED|Primary Intent to Treat (PITT)||152
387395|NCT01865747|950263|P1|NOT COMPLETED|Primary Intent to Treat (PITT)||131
387396|NCT01865747|950262|P2|COMPLETED|Primary Intent to Treat (PITT)||36
387397|NCT01865747|950263|P1|COMPLETED|Primary Intent to Treat (PITT)||56
387398|NCT01865747|950262|P2|STARTED|Primary Intent to Treat (PITT)|Three subjects in the everolimus arm were randomized but not treated.|188
387399|NCT01865747|950263|P1|STARTED|Primary Intent to Treat (PITT)||187
387400|NCT01865747|950262|P2|NOT COMPLETED|Overall Study (ITT)||255
387401|NCT01865747|950263|P1|NOT COMPLETED|Overall Study (ITT)||198
387402|NCT01865747|950262|P2|COMPLETED|Overall Study (ITT)|Five subjects were randomized but not treated|73
387403|NCT01865747|950263|P1|COMPLETED|Overall Study (ITT)|One subject randomized to everolimus arm received cabozantinib discontd due to clin. deterioration|132
387404|NCT01865747|950262|P2|STARTED|Overall Study (ITT)||328
387405|NCT01865747|950263|P1|STARTED|Overall Study (ITT)||330
387406|NCT01865708|950273|P1|NOT COMPLETED|Overall Study||0
387407|NCT01865708|950273|P1|COMPLETED|Overall Study||10
387408|NCT01865708|950273|P1|STARTED|Overall Study||10
387409|NCT01865084|950281|P3|NOT COMPLETED|Open Label Extension (OLE) Period||7
387410|NCT01865084|950282|P2|NOT COMPLETED|Open Label Extension (OLE) Period||11
387411|NCT01865084|950283|P1|NOT COMPLETED|Open Label Extension (OLE) Period||0
387412|NCT01865084|950281|P3|COMPLETED|Open Label Extension (OLE) Period||158
387413|NCT01865084|950282|P2|COMPLETED|Open Label Extension (OLE) Period||139
387414|NCT01865084|950283|P1|COMPLETED|Open Label Extension (OLE) Period||0
387415|NCT01865084|950281|P3|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|165
387416|NCT01865084|950282|P2|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|150
387417|NCT01865084|950283|P1|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|0
387418|NCT01865084|950281|P3|NOT COMPLETED|Double Blind Period (DB)||6
387419|NCT01865084|950282|P2|NOT COMPLETED|Double Blind Period (DB)||4
387420|NCT01865084|950283|P1|NOT COMPLETED|Double Blind Period (DB)||5
387421|NCT01865084|950281|P3|COMPLETED|Double Blind Period (DB)||107
387422|NCT01865084|950282|P2|COMPLETED|Double Blind Period (DB)|One participant stopped therapy during the DB period but remained in the study for follow-up.|98
387423|NCT01865084|950283|P1|COMPLETED|Double Blind Period (DB)||111
387424|NCT01865084|950281|P3|Received at Least One Dose of Study Drug|Double Blind Period (DB)||112
387425|NCT01865084|950282|P2|Received at Least One Dose of Study Drug|Double Blind Period (DB)||102
387426|NCT01865084|950283|P1|Received at Least One Dose of Study Drug|Double Blind Period (DB)||116
387427|NCT01865084|950281|P3|STARTED|Double Blind Period (DB)||113
387428|NCT01865084|950282|P2|STARTED|Double Blind Period (DB)||102
387429|NCT01865084|950283|P1|STARTED|Double Blind Period (DB)||116
387430|NCT01864538|950309|P1|NOT COMPLETED|Overall Study||11
387431|NCT01864538|950309|P1|COMPLETED|Overall Study||0
387432|NCT01864538|950309|P1|STARTED|Overall Study||11
387433|NCT01864434|950315|P2|NOT COMPLETED|Overall Study||0
387434|NCT01864434|950316|P1|NOT COMPLETED|Overall Study||0
387435|NCT01864434|950315|P2|COMPLETED|Overall Study||25
387436|NCT01864434|950316|P1|COMPLETED|Overall Study||25
387437|NCT01864434|950315|P2|STARTED|Overall Study||25
387438|NCT01864434|950316|P1|STARTED|Overall Study||25
387439|NCT01864200|950328|P2|NOT COMPLETED|Overall Study||3
387440|NCT01864200|950329|P1|NOT COMPLETED|Overall Study||2
387441|NCT01864200|950328|P2|COMPLETED|Overall Study||26
387442|NCT01864200|950329|P1|COMPLETED|Overall Study||43
387443|NCT01864200|950328|P2|STARTED|Overall Study||29
387444|NCT01864200|950329|P1|STARTED|Overall Study||45
387445|NCT01864174|950337|P2|NOT COMPLETED|Off Treatment Follow-Up||0
387446|NCT01864174|950338|P1|NOT COMPLETED|Off Treatment Follow-Up||3
387447|NCT01864174|950337|P2|COMPLETED|Off Treatment Follow-Up||1
387448|NCT01864174|950338|P1|COMPLETED|Off Treatment Follow-Up||6
387449|NCT01864174|950337|P2|STARTED|Off Treatment Follow-Up||1
387450|NCT01864174|950338|P1|STARTED|Off Treatment Follow-Up||9
387451|NCT01864174|950337|P2|NOT COMPLETED|Double Blind - Compliant Randomized||26
387452|NCT01864174|950338|P1|NOT COMPLETED|Double Blind - Compliant Randomized||23
387453|NCT01864174|950337|P2|COMPLETED|Double Blind - Compliant Randomized||245
387454|NCT01864174|950338|P1|COMPLETED|Double Blind - Compliant Randomized||245
387455|NCT01864174|950337|P2|STARTED|Double Blind - Compliant Randomized||271
387456|NCT01864174|950338|P1|STARTED|Double Blind - Compliant Randomized||268
387457|NCT01864174|950337|P2|NOT COMPLETED|Double Blind Treatment - All Treated||14
387458|NCT01864174|950338|P1|NOT COMPLETED|Double Blind Treatment - All Treated||15
387459|NCT01864174|950337|P2|COMPLETED|Double Blind Treatment - All Treated||271
387460|NCT01864174|950338|P1|COMPLETED|Double Blind Treatment - All Treated||268
387461|NCT01864174|950337|P2|STARTED|Double Blind Treatment - All Treated||285
387462|NCT01864174|950338|P1|STARTED|Double Blind Treatment - All Treated||283
387463|NCT01864148|950357|P5|NOT COMPLETED|Overall Study||23
387464|NCT01864148|950358|P4|NOT COMPLETED|Overall Study||26
387465|NCT01864148|950359|P3|NOT COMPLETED|Overall Study||11
387466|NCT01864148|950360|P2|NOT COMPLETED|Overall Study||5
387467|NCT01864148|950361|P1|NOT COMPLETED|Overall Study||20
387468|NCT01864148|950357|P5|COMPLETED|Overall Study||69
387469|NCT01864148|950358|P4|COMPLETED|Overall Study||68
387470|NCT01864148|950359|P3|COMPLETED|Overall Study||84
387471|NCT01864148|950360|P2|COMPLETED|Overall Study||40
387472|NCT01864148|950361|P1|COMPLETED|Overall Study||73
387473|NCT01864148|950357|P5|Randomized and Dosed|Overall Study||92
387474|NCT01864148|950358|P4|Randomized and Dosed|Overall Study||93
387475|NCT01864148|950359|P3|Randomized and Dosed|Overall Study||95
387476|NCT01864148|950360|P2|Randomized and Dosed|Overall Study||45
387477|NCT01864148|950361|P1|Randomized and Dosed|Overall Study||93
387478|NCT01864148|950357|P5|STARTED|Overall Study||92
387479|NCT01864148|950358|P4|STARTED|Overall Study||94
387480|NCT01864148|950359|P3|STARTED|Overall Study||95
387481|NCT01864148|950360|P2|STARTED|Overall Study||45
387482|NCT01864148|950361|P1|STARTED|Overall Study||93
387483|NCT01864005|950390|P2|NOT COMPLETED|Overall Study||6
387484|NCT01864005|950391|P1|NOT COMPLETED|Overall Study||3
387485|NCT01864005|950390|P2|COMPLETED|Overall Study||25
387486|NCT01864005|950391|P1|COMPLETED|Overall Study||26
387487|NCT01864005|950390|P2|STARTED|Overall Study||31
387488|NCT01864005|950391|P1|STARTED|Overall Study||29
387489|NCT01863953|950408|P3|NOT COMPLETED|Overall Study||1
387490|NCT01863953|950409|P2|NOT COMPLETED|Overall Study||0
387491|NCT01863953|950410|P1|NOT COMPLETED|Overall Study||0
387492|NCT01863953|950408|P3|COMPLETED|Overall Study||37
387493|NCT01863953|950409|P2|COMPLETED|Overall Study||36
387494|NCT01863953|950410|P1|COMPLETED|Overall Study||38
387495|NCT01863953|950408|P3|STARTED|Overall Study||38
387496|NCT01863953|950409|P2|STARTED|Overall Study||36
387497|NCT01863953|950410|P1|STARTED|Overall Study||38
387498|NCT01863771|950424|P4|NOT COMPLETED|Maintenance Phase||43
387499|NCT01863771|950425|P3|NOT COMPLETED|Maintenance Phase||12
387500|NCT01863771|950426|P2|NOT COMPLETED|Maintenance Phase||5
387501|NCT01863771|950427|P1|NOT COMPLETED|Maintenance Phase||0
387502|NCT01863771|950424|P4|COMPLETED|Maintenance Phase||17
387503|NCT01863771|950425|P3|COMPLETED|Maintenance Phase||19
387504|NCT01863771|950426|P2|COMPLETED|Maintenance Phase||27
387505|NCT01863771|950427|P1|COMPLETED|Maintenance Phase||0
387506|NCT01863771|950424|P4|STARTED|Maintenance Phase||60
387507|NCT01863771|950425|P3|STARTED|Maintenance Phase||31
387508|NCT01863771|950426|P2|STARTED|Maintenance Phase||32
387509|NCT01863771|950427|P1|STARTED|Maintenance Phase||0
387510|NCT01863771|950424|P4|NOT COMPLETED|Induction Phase||0
387511|NCT01863771|950425|P3|NOT COMPLETED|Induction Phase||0
387512|NCT01863771|950426|P2|NOT COMPLETED|Induction Phase||0
387513|NCT01863771|950427|P1|NOT COMPLETED|Induction Phase||21
387514|NCT01863771|950424|P4|COMPLETED|Induction Phase||0
387515|NCT01863771|950425|P3|COMPLETED|Induction Phase||0
387516|NCT01863771|950426|P2|COMPLETED|Induction Phase||0
387517|NCT01863771|950427|P1|COMPLETED|Induction Phase|Same participants who completed the induction phase participated in the maintenance phase.|123
387518|NCT01863771|950424|P4|STARTED|Induction Phase||0
387519|NCT01863771|950425|P3|STARTED|Induction Phase||0
387520|NCT01863771|950426|P2|STARTED|Induction Phase||0
387521|NCT01863771|950427|P1|STARTED|Induction Phase||144
387522|NCT01863758|950439|P1|NOT COMPLETED|Prophylactic Treatment-Phase II||2
387523|NCT01863758|950439|P1|COMPLETED|Prophylactic Treatment-Phase II||64
387524|NCT01863758|950439|P1|STARTED|Prophylactic Treatment-Phase II||66
387525|NCT01863758|950439|P1|NOT COMPLETED|Prophylactic Treatment-Phase I||0
387526|NCT01863758|950439|P1|COMPLETED|Prophylactic Treatment-Phase I||66
387527|NCT01863758|950439|P1|STARTED|Prophylactic Treatment-Phase I||66
387528|NCT01863758|950439|P1|NOT COMPLETED|Pharmacokinetic Assessment||0
387529|NCT01863758|950439|P1|COMPLETED|Pharmacokinetic Assessment||66
387530|NCT01863758|950439|P1|STARTED|Pharmacokinetic Assessment||66
387531|NCT01863680|950447|P1|NOT COMPLETED|Overall Study||57
387532|NCT01863680|950447|P1|COMPLETED|Overall Study||121
387533|NCT01863680|950447|P1|Subjects Who Have Undergone IVF/ET|Overall Study||123
387534|NCT01863680|950447|P1|Subjects Received Study Drug|Overall Study||149
387535|NCT01863680|950447|P1|Subjects Received hCG Injection|Overall Study||162
387536|NCT01863680|950447|P1|Subjects Started COS Treatment|Overall Study||169
387537|NCT01863680|950447|P1|STARTED|Overall Study||178
387538|NCT01863667|950455|P2|NOT COMPLETED|Overall Study||32
387539|NCT01863667|950456|P1|NOT COMPLETED|Overall Study||33
387540|NCT01863667|950455|P2|COMPLETED|Overall Study||0
387541|NCT01863667|950456|P1|COMPLETED|Overall Study||0
387542|NCT01863667|950455|P2|STARTED|Overall Study||32
387543|NCT01863667|950456|P1|STARTED|Overall Study||33
387544|NCT01863563|950476|P1|NOT COMPLETED|Overall Study||0
387545|NCT01863563|950476|P1|COMPLETED|Overall Study||100
387546|NCT01863563|950476|P1|STARTED|Overall Study||100
387547|NCT01863433|950480|P1|NOT COMPLETED|Overall Study||1
387548|NCT01863433|950480|P1|COMPLETED|Overall Study|1 subject was withdrawn from the study due to evidence of substance abuse.|119
387549|NCT01863433|950480|P1|STARTED|Overall Study||120
387550|NCT01863368|950490|P2|NOT COMPLETED|Phase II, Day 35 to Day 90||0
387551|NCT01863368|950491|P1|NOT COMPLETED|Phase II, Day 35 to Day 90||2
387552|NCT01863368|950490|P2|COMPLETED|Phase II, Day 35 to Day 90||41
387553|NCT01863368|950491|P1|COMPLETED|Phase II, Day 35 to Day 90||41
387554|NCT01863368|950490|P2|STARTED|Phase II, Day 35 to Day 90||41
387555|NCT01863368|950491|P1|STARTED|Phase II, Day 35 to Day 90||43
387556|NCT01863368|950490|P2|NOT COMPLETED|Phase I, Day 0 to Day 35||7
387557|NCT01863368|950491|P1|NOT COMPLETED|Phase I, Day 0 to Day 35||3
387558|NCT01863368|950490|P2|COMPLETED|Phase I, Day 0 to Day 35||41
387559|NCT01863368|950491|P1|COMPLETED|Phase I, Day 0 to Day 35||43
387560|NCT01863368|950490|P2|Treated|Phase I, Day 0 to Day 35||47
387561|NCT01863368|950491|P1|Treated|Phase I, Day 0 to Day 35||46
387562|NCT01863368|950490|P2|STARTED|Phase I, Day 0 to Day 35||48
387563|NCT01863368|950491|P1|STARTED|Phase I, Day 0 to Day 35||46
387564|NCT01863134|950506|P2|NOT COMPLETED|Overall Study||0
387565|NCT01863134|950507|P1|NOT COMPLETED|Overall Study||0
387566|NCT01863134|950506|P2|COMPLETED|Overall Study||68
387567|NCT01863134|950507|P1|COMPLETED|Overall Study||72
387568|NCT01863134|950506|P2|STARTED|Overall Study||68
387569|NCT01863134|950507|P1|STARTED|Overall Study||72
387570|NCT01862991|950516|P3|NOT COMPLETED|Overall Study||1
387571|NCT01862991|950517|P2|NOT COMPLETED|Overall Study||1
387572|NCT01862991|950518|P1|NOT COMPLETED|Overall Study||3
387573|NCT01862991|950516|P3|COMPLETED|Overall Study||27
387574|NCT01862991|950517|P2|COMPLETED|Overall Study||27
387575|NCT01862991|950518|P1|COMPLETED|Overall Study||21
387576|NCT01862991|950516|P3|STARTED|Overall Study||28
387577|NCT01862991|950517|P2|STARTED|Overall Study||28
387578|NCT01862991|950518|P1|STARTED|Overall Study||24
387579|NCT01862484|950531|P2|NOT COMPLETED|Overall Study||8
387580|NCT01862484|950532|P1|NOT COMPLETED|Overall Study||2
387581|NCT01862484|950531|P2|COMPLETED|Overall Study||6
387582|NCT01862484|950532|P1|COMPLETED|Overall Study||13
387583|NCT01862484|950531|P2|STARTED|Overall Study||14
387584|NCT01862484|950532|P1|STARTED|Overall Study||15
387585|NCT01862419|950540|P2|NOT COMPLETED|Overall Study||0
387586|NCT01862419|950541|P1|NOT COMPLETED|Overall Study||0
387587|NCT01862419|950540|P2|COMPLETED|Overall Study||1192
387588|NCT01862419|950541|P1|COMPLETED|Overall Study||1201
387589|NCT01862419|950540|P2|STARTED|Overall Study||1192
387590|NCT01862419|950541|P1|STARTED|Overall Study||1201
387591|NCT01862250|950551|P1|NOT COMPLETED|Overall Study||4
387592|NCT01862250|950551|P1|COMPLETED|Overall Study||8
387593|NCT01862250|950551|P1|STARTED|Overall Study||12
387594|NCT01862159|950558|P1|NOT COMPLETED|Overall Study||0
387595|NCT01862159|950558|P1|COMPLETED|Overall Study||25038
387596|NCT01862159|950558|P1|STARTED|Overall Study||25038
387597|NCT01862133|950565|P2|NOT COMPLETED|Overall Study||0
387598|NCT01862133|950566|P1|NOT COMPLETED|Overall Study||0
387599|NCT01862133|950565|P2|COMPLETED|Overall Study||31
387600|NCT01862133|950566|P1|COMPLETED|Overall Study|All 105 patients recorded preferences; 92 (88%) returned to the study clinic during the 6 mo. study|105
387601|NCT01862133|950565|P2|Returned During 6 mo Study|Overall Study||31
387602|NCT01862133|950566|P1|Returned During 6 mo Study|Overall Study||92
387603|NCT01862133|950565|P2|STARTED|Overall Study||31
387604|NCT01862133|950566|P1|STARTED|Overall Study||105
387605|NCT01861925|950575|P3|NOT COMPLETED|Overall Study||0
387606|NCT01861925|950576|P2|NOT COMPLETED|Overall Study||0
387607|NCT01861925|950577|P1|NOT COMPLETED|Overall Study||0
387608|NCT01861925|950575|P3|COMPLETED|Overall Study||8
387609|NCT01861925|950576|P2|COMPLETED|Overall Study||8
387610|NCT01861925|950577|P1|COMPLETED|Overall Study||34
387611|NCT01861925|950575|P3|STARTED|Overall Study||8
387612|NCT01861925|950576|P2|STARTED|Overall Study||8
387613|NCT01861925|950577|P1|STARTED|Overall Study||34
387614|NCT01861756|950600|P2|NOT COMPLETED|Overall Study||18
387615|NCT01861756|950601|P1|NOT COMPLETED|Overall Study||13
387616|NCT01861756|950600|P2|COMPLETED|Overall Study||85
387617|NCT01861756|950601|P1|COMPLETED|Overall Study||88
387618|NCT01861756|950600|P2|STARTED|Overall Study||103
387619|NCT01861756|950601|P1|STARTED|Overall Study||101
387620|NCT01861704|950609|P2|NOT COMPLETED|Overall Study||3
387621|NCT01861704|950610|P1|NOT COMPLETED|Overall Study||3
387622|NCT01861704|950609|P2|COMPLETED|Overall Study||104
387623|NCT01861704|950610|P1|COMPLETED|Overall Study||67
387624|NCT01861704|950609|P2|STARTED|Overall Study||107
387625|NCT01861704|950610|P1|STARTED|Overall Study||70
387626|NCT01861665|950618|P2|NOT COMPLETED|Overall Study||0
387627|NCT01861665|950619|P1|NOT COMPLETED|Overall Study||0
387628|NCT01861665|950618|P2|COMPLETED|Overall Study||17
387629|NCT01861665|950619|P1|COMPLETED|Overall Study||10
387630|NCT01861665|950618|P2|STARTED|Overall Study||17
387631|NCT01861665|950619|P1|STARTED|Overall Study||10
387632|NCT01861522|950627|P2|NOT COMPLETED|Overall Study||0
387633|NCT01861522|950628|P1|NOT COMPLETED|Overall Study||3
387634|NCT01861522|950627|P2|COMPLETED|Overall Study||232
387635|NCT01861522|950628|P1|COMPLETED|Overall Study||237
387636|NCT01861522|950627|P2|STARTED|Overall Study|One subject who did not receive any study drug was excluded from the FAS and the Safety Analysis Set|232
387637|NCT01861522|950628|P1|STARTED|Overall Study||240
387638|NCT01861457|950636|P2|NOT COMPLETED|Overall Study||0
387639|NCT01861457|950637|P1|NOT COMPLETED|Overall Study||0
387640|NCT01861457|950636|P2|COMPLETED|Overall Study||19
387641|NCT01861457|950637|P1|COMPLETED|Overall Study||20
387642|NCT01861457|950636|P2|STARTED|Overall Study||19
387643|NCT01861457|950637|P1|STARTED|Overall Study||20
387644|NCT01861301|950645|P1|NOT COMPLETED|Overall Study||0
387645|NCT01861301|950645|P1|COMPLETED|Overall Study||18
387646|NCT01861301|950645|P1|STARTED|Overall Study||18
387647|NCT01860989|950652|P1|NOT COMPLETED|Overall Study||5
387648|NCT01860989|950652|P1|COMPLETED|Overall Study||6
387649|NCT01860989|950652|P1|STARTED|Overall Study||11
387650|NCT01860976|950658|P2|NOT COMPLETED|Long Term Extension||107
387651|NCT01860976|950659|P1|NOT COMPLETED|Long Term Extension||113
387652|NCT01860976|950658|P2|COMPLETED|Long Term Extension||8
387653|NCT01860976|950659|P1|COMPLETED|Long Term Extension||0
387654|NCT01860976|950658|P2|STARTED|Long Term Extension||115
387655|NCT01860976|950659|P1|STARTED|Long Term Extension||113
387656|NCT01860976|950658|P2|NOT COMPLETED|Open-Label||64
387657|NCT01860976|950659|P1|NOT COMPLETED|Open-Label||74
387658|NCT01860976|950658|P2|COMPLETED|Open-Label||121
387659|NCT01860976|950659|P1|COMPLETED|Open-Label||123
387660|NCT01860976|950658|P2|STARTED|Open-Label||185
387661|NCT01860976|950659|P1|STARTED|Open-Label||197
387662|NCT01860976|950658|P2|NOT COMPLETED|Blinded Treatment||113
387663|NCT01860976|950659|P1|NOT COMPLETED|Blinded Treatment||88
387664|NCT01860976|950658|P2|COMPLETED|Blinded Treatment||98
387665|NCT01860976|950659|P1|COMPLETED|Blinded Treatment||125
387666|NCT01860976|950658|P2|STARTED|Blinded Treatment||211
387667|NCT01860976|950659|P1|STARTED|Blinded Treatment||213
387668|NCT01860846|950681|P1|NOT COMPLETED|Overall Study||33
387669|NCT01860846|950681|P1|COMPLETED|Overall Study||73
387670|NCT01860846|950681|P1|Month 12|Overall Study||73
387671|NCT01860846|950681|P1|Month 6|Overall Study||85
387672|NCT01860846|950681|P1|Month 4|Overall Study||82
387673|NCT01860846|950681|P1|Month 2|Overall Study||83
387674|NCT01860846|950681|P1|Month 1|Overall Study||97
387675|NCT01860846|950681|P1|STARTED|Overall Study||106
387676|NCT01860703|950692|P4|NOT COMPLETED|Overall Study||2
387677|NCT01860703|950693|P3|NOT COMPLETED|Overall Study||1
387678|NCT01860703|950694|P2|NOT COMPLETED|Overall Study||5
387679|NCT01860703|950695|P1|NOT COMPLETED|Overall Study||2
387680|NCT01860703|950692|P4|COMPLETED|Overall Study||10
387681|NCT01860703|950693|P3|COMPLETED|Overall Study||11
387682|NCT01860703|950694|P2|COMPLETED|Overall Study||8
387683|NCT01860703|950695|P1|COMPLETED|Overall Study||11
387684|NCT01860703|950692|P4|STARTED|Overall Study||12
387685|NCT01860703|950693|P3|STARTED|Overall Study||12
387686|NCT01860703|950694|P2|STARTED|Overall Study||13
387687|NCT01860703|950695|P1|STARTED|Overall Study||13
387688|NCT01860677|950727|P2|NOT COMPLETED|Second Intervention (1 Day)||0
387689|NCT01860677|950728|P1|NOT COMPLETED|Second Intervention (1 Day)||7
387690|NCT01860677|950727|P2|COMPLETED|Second Intervention (1 Day)||0
387691|NCT01860677|950728|P1|COMPLETED|Second Intervention (1 Day)||1
387692|NCT01860677|950727|P2|STARTED|Second Intervention (1 Day)||0
387693|NCT01860677|950728|P1|STARTED|Second Intervention (1 Day)||8
387694|NCT01860677|950727|P2|NOT COMPLETED|First Intervention (1 Day)||0
387695|NCT01860677|950728|P1|NOT COMPLETED|First Intervention (1 Day)||0
387696|NCT01860677|950727|P2|COMPLETED|First Intervention (1 Day)||0
387697|NCT01860677|950728|P1|COMPLETED|First Intervention (1 Day)||8
387698|NCT01860677|950727|P2|STARTED|First Intervention (1 Day)||0
387699|NCT01860677|950728|P1|STARTED|First Intervention (1 Day)||8
387700|NCT01860586|950737|P1|NOT COMPLETED|Overall Study||0
387701|NCT01860586|950737|P1|COMPLETED|Overall Study||20
387702|NCT01860586|950737|P1|STARTED|Overall Study||20
387703|NCT01860573|950745|P2|NOT COMPLETED|Overall Study||0
387704|NCT01860573|950746|P1|NOT COMPLETED|Overall Study||0
387705|NCT01860573|950745|P2|COMPLETED|Overall Study||85
387706|NCT01860573|950746|P1|COMPLETED|Overall Study||83
387707|NCT01860573|950745|P2|STARTED|Overall Study||85
387708|NCT01860573|950746|P1|STARTED|Overall Study||83
387709|NCT01860534|950766|P2|NOT COMPLETED|ROP #2||0
387710|NCT01860534|950767|P1|NOT COMPLETED|ROP #2||1
387711|NCT01860534|950766|P2|COMPLETED|ROP #2||13
387712|NCT01860534|950767|P1|COMPLETED|ROP #2||13
387713|NCT01860534|950766|P2|STARTED|ROP #2||13
387714|NCT01860534|950767|P1|STARTED|ROP #2||14
387715|NCT01860534|950766|P2|NOT COMPLETED|ROP #1||1
387716|NCT01860534|950767|P1|NOT COMPLETED|ROP #1||0
387717|NCT01860534|950766|P2|COMPLETED|ROP #1||13
387718|NCT01860534|950767|P1|COMPLETED|ROP #1||14
387719|NCT01860534|950766|P2|STARTED|ROP #1||14
387720|NCT01860534|950767|P1|STARTED|ROP #1||14
387721|NCT01860521|950781|P2|NOT COMPLETED|Overall Study||0
387722|NCT01860521|950782|P1|NOT COMPLETED|Overall Study||0
387723|NCT01860521|950781|P2|COMPLETED|Overall Study|June 2013|52
387724|NCT01860521|950782|P1|COMPLETED|Overall Study|June 2013|52
387725|NCT01860521|950781|P2|STARTED|Overall Study|September 2011|52
387726|NCT01860521|950782|P1|STARTED|Overall Study|September 2011|52
387727|NCT01860170|950797|P3|NOT COMPLETED|Overall Study||0
387728|NCT01860170|950798|P2|NOT COMPLETED|Overall Study||0
387729|NCT01860170|950799|P1|NOT COMPLETED|Overall Study||0
387730|NCT01860170|950797|P3|COMPLETED|Overall Study||22
387731|NCT01860170|950798|P2|COMPLETED|Overall Study||3
387732|NCT01860170|950799|P1|COMPLETED|Overall Study||3
387733|NCT01860170|950797|P3|STARTED|Overall Study||22
387734|NCT01860170|950798|P2|STARTED|Overall Study||3
387735|NCT01860170|950799|P1|STARTED|Overall Study||3
387736|NCT01860079|950815|P2|NOT COMPLETED|Overall Study||22
387737|NCT01860079|950816|P1|NOT COMPLETED|Overall Study||14
387738|NCT01860079|950815|P2|COMPLETED|Overall Study||363
387739|NCT01860079|950816|P1|COMPLETED|Overall Study||370
387740|NCT01860079|950815|P2|STARTED|Overall Study||385
387741|NCT01860079|950816|P1|STARTED|Overall Study||384
387742|NCT01860040|950824|P2|NOT COMPLETED|Overall Study||0
387743|NCT01860040|950825|P1|NOT COMPLETED|Overall Study||1
387744|NCT01860040|950824|P2|COMPLETED|Overall Study|did not meet recruitment goal|0
387745|NCT01860040|950825|P1|COMPLETED|Overall Study|did not meet recruitment goal|0
387746|NCT01860040|950824|P2|STARTED|Overall Study|did not meet recruitment goal|0
387747|NCT01860040|950825|P1|STARTED|Overall Study|did not meet recruitment goal|1
387748|NCT01859988|950836|P6|NOT COMPLETED|Overall Study||19
387749|NCT01859988|950837|P5|NOT COMPLETED|Overall Study||23
387750|NCT01859988|950838|P4|NOT COMPLETED|Overall Study||10
387751|NCT01859988|950839|P3|NOT COMPLETED|Overall Study||28
387752|NCT01859988|950840|P2|NOT COMPLETED|Overall Study||12
387753|NCT01859988|950841|P1|NOT COMPLETED|Overall Study||11
387754|NCT01859988|950836|P6|COMPLETED|Overall Study||42
387755|NCT01859988|950837|P5|COMPLETED|Overall Study||42
387756|NCT01859988|950838|P4|COMPLETED|Overall Study||55
387757|NCT01859988|950839|P3|COMPLETED|Overall Study||34
387758|NCT01859988|950840|P2|COMPLETED|Overall Study||52
387759|NCT01859988|950841|P1|COMPLETED|Overall Study||52
387760|NCT01859988|950836|P6|Treated|Overall Study||61
387761|NCT01859988|950837|P5|Treated|Overall Study||65
387762|NCT01859988|950838|P4|Treated|Overall Study||65
387763|NCT01859988|950839|P3|Treated|Overall Study||61
387764|NCT01859988|950840|P2|Treated|Overall Study||64
387765|NCT01859988|950841|P1|Treated|Overall Study||63
387766|NCT01859988|950836|P6|STARTED|Overall Study||61
387767|NCT01859988|950837|P5|STARTED|Overall Study||65
387768|NCT01859988|950838|P4|STARTED|Overall Study||65
387769|NCT01859988|950839|P3|STARTED|Overall Study||62
387770|NCT01859988|950840|P2|STARTED|Overall Study||64
387771|NCT01859988|950841|P1|STARTED|Overall Study||63
387772|NCT01859949|950935|P2|NOT COMPLETED|Overall Study||17
387773|NCT01859949|950936|P1|NOT COMPLETED|Overall Study||14
387774|NCT01859949|950935|P2|COMPLETED|Overall Study||15
387775|NCT01859949|950936|P1|COMPLETED|Overall Study||15
387776|NCT01859949|950935|P2|STARTED|Overall Study|Treated participants|32
387777|NCT01859949|950936|P1|STARTED|Overall Study|Treated participants|29
387778|NCT01859793|950954|P2|NOT COMPLETED|2nd Intervention Period||0
387779|NCT01859793|950955|P1|NOT COMPLETED|2nd Intervention Period||0
387780|NCT01859793|950954|P2|COMPLETED|2nd Intervention Period||16
387781|NCT01859793|950955|P1|COMPLETED|2nd Intervention Period||14
387782|NCT01859793|950954|P2|STARTED|2nd Intervention Period||16
387783|NCT01859793|950955|P1|STARTED|2nd Intervention Period||14
387784|NCT01859793|950954|P2|NOT COMPLETED|Washout Period (4 Weeks)||1
387785|NCT01859793|950955|P1|NOT COMPLETED|Washout Period (4 Weeks)||1
387786|NCT01859793|950954|P2|COMPLETED|Washout Period (4 Weeks)||16
387787|NCT01859793|950955|P1|COMPLETED|Washout Period (4 Weeks)||14
387788|NCT01859793|950954|P2|STARTED|Washout Period (4 Weeks)||17
387789|NCT01859793|950955|P1|STARTED|Washout Period (4 Weeks)||15
387790|NCT01859793|950954|P2|NOT COMPLETED|First Intervention (8 Weeks)||1
387791|NCT01859793|950955|P1|NOT COMPLETED|First Intervention (8 Weeks)||5
387792|NCT01859793|950954|P2|COMPLETED|First Intervention (8 Weeks)||17
387793|NCT01859793|950955|P1|COMPLETED|First Intervention (8 Weeks)||15
387794|NCT01859793|950954|P2|STARTED|First Intervention (8 Weeks)||18
387795|NCT01859793|950955|P1|STARTED|First Intervention (8 Weeks)||20
387796|NCT01859715|950968|P3|NOT COMPLETED|Overall Study||23
387797|NCT01859715|950969|P2|NOT COMPLETED|Overall Study||8
387798|NCT01859715|950970|P1|NOT COMPLETED|Overall Study||16
387799|NCT01859715|950968|P3|COMPLETED|Overall Study||93
387800|NCT01859715|950969|P2|COMPLETED|Overall Study||83
387801|NCT01859715|950970|P1|COMPLETED|Overall Study||125
387802|NCT01859715|950968|P3|STARTED|Overall Study||116
387803|NCT01859715|950969|P2|STARTED|Overall Study||91
387804|NCT01859715|950970|P1|STARTED|Overall Study||141
387805|NCT01859702|950981|P1|NOT COMPLETED|Overall Study||5
387806|NCT01859702|950981|P1|COMPLETED|Overall Study||31
387807|NCT01859702|950981|P1|STARTED|Overall Study||36
387808|NCT01859637|950985|P1|NOT COMPLETED|Overall Study||0
387809|NCT01859637|950985|P1|COMPLETED|Overall Study||6
387810|NCT01859637|950985|P1|STARTED|Overall Study||6
387811|NCT01859611|950991|P1|NOT COMPLETED|Overall Study||8
387812|NCT01859611|950991|P1|COMPLETED|Overall Study||43
387813|NCT01859611|950991|P1|STARTED|Overall Study||51
387814|NCT01859598|950995|P1|NOT COMPLETED|Visit 3 at 6 Months||912
387815|NCT01859598|950995|P1|COMPLETED|Visit 3 at 6 Months|Loss to follow-up, N=1517; Come back at visit 3, N=605;|16341
387816|NCT01859598|950995|P1|STARTED|Visit 3 at 6 Months||17253
387817|NCT01859598|950995|P1|NOT COMPLETED|Visit 2 at 3 Months||1742
387818|NCT01859598|950995|P1|COMPLETED|Visit 2 at 3 Months||17253
387819|NCT01859598|950995|P1|STARTED|Visit 2 at 3 Months|At visit 1, patients remained at baseline, N=18995|18995
387820|NCT01859507|951003|P1|NOT COMPLETED|Overall Study||4
387821|NCT01859507|951003|P1|COMPLETED|Overall Study||28
387822|NCT01859507|951003|P1|STARTED|Overall Study||32
387823|NCT01859494|951008|P1|NOT COMPLETED|Overall Study||1
387824|NCT01859494|951008|P1|COMPLETED|Overall Study||218
387825|NCT01859494|951008|P1|STARTED|Overall Study||219
387826|NCT01859390|951019|P2|NOT COMPLETED|Overall Study||7
387827|NCT01859390|951020|P1|NOT COMPLETED|Overall Study||1
387828|NCT01859390|951019|P2|COMPLETED|Overall Study||30
387829|NCT01859390|951020|P1|COMPLETED|Overall Study||35
387830|NCT01859390|951019|P2|Withdrawals|Overall Study||2
387831|NCT01859390|951020|P1|Withdrawals|Overall Study||2
387832|NCT01859390|951019|P2|STARTED|Overall Study||37
387833|NCT01859390|951020|P1|STARTED|Overall Study||36
387834|NCT01859325|951044|P3|NOT COMPLETED|Overall Study||0
387835|NCT01859325|951045|P2|NOT COMPLETED|Overall Study||4
387836|NCT01859325|951046|P1|NOT COMPLETED|Overall Study||3
387837|NCT01859325|951044|P3|COMPLETED|Overall Study||2
387838|NCT01859325|951045|P2|COMPLETED|Overall Study||12
387839|NCT01859325|951046|P1|COMPLETED|Overall Study||12
387840|NCT01859325|951044|P3|STARTED|Overall Study||2
387841|NCT01859325|951045|P2|STARTED|Overall Study||16
387842|NCT01859325|951046|P1|STARTED|Overall Study||15
387843|NCT01859312|951054|P1|NOT COMPLETED|Overall Study||0
387844|NCT01859312|951054|P1|COMPLETED|Overall Study|Based on medication & supply accountability, one participant was found to be partially non-compliant|8
387845|NCT01859312|951054|P1|STARTED|Overall Study||8
387846|NCT01859247|951109|P8|NOT COMPLETED|Overall Study||0
387847|NCT01859247|951110|P7|NOT COMPLETED|Overall Study||0
387848|NCT01859247|951111|P6|NOT COMPLETED|Overall Study||0
387849|NCT01859247|951112|P5|NOT COMPLETED|Overall Study||0
387850|NCT01859247|951113|P4|NOT COMPLETED|Overall Study||0
387851|NCT01859247|951114|P3|NOT COMPLETED|Overall Study||0
387852|NCT01859247|951115|P2|NOT COMPLETED|Overall Study||0
387853|NCT01859247|951116|P1|NOT COMPLETED|Overall Study||0
387854|NCT01859247|951109|P8|COMPLETED|Overall Study||1
387855|NCT01859247|951110|P7|COMPLETED|Overall Study||1
387856|NCT01859247|951111|P6|COMPLETED|Overall Study||1
387857|NCT01859247|951112|P5|COMPLETED|Overall Study||1
387858|NCT01859247|951113|P4|COMPLETED|Overall Study||1
387859|NCT01859247|951114|P3|COMPLETED|Overall Study||1
387860|NCT01859247|951115|P2|COMPLETED|Overall Study||1
387861|NCT01859247|951116|P1|COMPLETED|Overall Study||1
387862|NCT01859247|951109|P8|STARTED|Overall Study||1
387863|NCT01859247|951110|P7|STARTED|Overall Study||1
387864|NCT01859247|951111|P6|STARTED|Overall Study||1
387865|NCT01859247|951112|P5|STARTED|Overall Study||1
387866|NCT01859247|951113|P4|STARTED|Overall Study||1
387867|NCT01859247|951114|P3|STARTED|Overall Study||1
387868|NCT01859247|951115|P2|STARTED|Overall Study||1
387869|NCT01859247|951116|P1|STARTED|Overall Study||1
387870|NCT01859195|951143|P2|NOT COMPLETED|Overall Study||0
387871|NCT01859195|951144|P1|NOT COMPLETED|Overall Study||0
387872|NCT01859195|951143|P2|COMPLETED|Overall Study||12
387873|NCT01859195|951144|P1|COMPLETED|Overall Study||24
387874|NCT01859195|951143|P2|STARTED|Overall Study||12
387875|NCT01859195|951144|P1|STARTED|Overall Study||24
387876|NCT01859143|951154|P2|NOT COMPLETED|Overall Study||0
387877|NCT01859143|951155|P1|NOT COMPLETED|Overall Study||2
387878|NCT01859143|951154|P2|COMPLETED|Overall Study||60
387879|NCT01859143|951155|P1|COMPLETED|Overall Study||238
387880|NCT01859143|951154|P2|STARTED|Overall Study|One participant in this group received trivalent influenza vaccine on Day 1.|60
387881|NCT01859143|951155|P1|STARTED|Overall Study||240
387882|NCT01859078|951169|P1|NOT COMPLETED|Overall Study||0
387883|NCT01859078|951169|P1|COMPLETED|Overall Study||28
387884|NCT01859078|951169|P1|STARTED|Overall Study||28
387885|NCT01859013|951185|P2|NOT COMPLETED|Overall Study||5
387886|NCT01859013|951186|P1|NOT COMPLETED|Overall Study||4
387887|NCT01859013|951185|P2|COMPLETED|Overall Study||9
387888|NCT01859013|951186|P1|COMPLETED|Overall Study||12
387889|NCT01859013|951185|P2|STARTED|Overall Study||14
387890|NCT01859013|951186|P1|STARTED|Overall Study||16
387891|NCT01858766|951211|P19|NOT COMPLETED|Overall Study||4
387892|NCT01858766|951212|P18|NOT COMPLETED|Overall Study||4
387893|NCT01858766|951213|P17|NOT COMPLETED|Overall Study||3
387894|NCT01858766|951214|P16|NOT COMPLETED|Overall Study||6
387895|NCT01858766|951215|P15|NOT COMPLETED|Overall Study||8
387896|NCT01858766|951216|P14|NOT COMPLETED|Overall Study||3
387897|NCT01858766|951217|P13|NOT COMPLETED|Overall Study||5
387898|NCT01858766|951218|P12|NOT COMPLETED|Overall Study||5
387899|NCT01858766|951219|P11|NOT COMPLETED|Overall Study||0
387900|NCT01858766|951220|P10|NOT COMPLETED|Overall Study||0
387901|NCT01858766|951221|P9|NOT COMPLETED|Overall Study||0
387902|NCT01858766|951222|P8|NOT COMPLETED|Overall Study||2
387903|NCT01858766|951223|P7|NOT COMPLETED|Overall Study||0
387904|NCT01858766|951224|P6|NOT COMPLETED|Overall Study||4
387905|NCT01858766|951225|P5|NOT COMPLETED|Overall Study||1
387906|NCT01858766|951226|P4|NOT COMPLETED|Overall Study||0
387907|NCT01858766|951227|P3|NOT COMPLETED|Overall Study||1
387908|NCT01858766|951228|P2|NOT COMPLETED|Overall Study||0
387909|NCT01858766|951229|P1|NOT COMPLETED|Overall Study||1
387910|NCT01858766|951211|P19|COMPLETED|Overall Study||22
387911|NCT01858766|951212|P18|COMPLETED|Overall Study||23
387912|NCT01858766|951213|P17|COMPLETED|Overall Study||22
387913|NCT01858766|951214|P16|COMPLETED|Overall Study||20
387914|NCT01858766|951215|P15|COMPLETED|Overall Study||23
387915|NCT01858766|951216|P14|COMPLETED|Overall Study||26
387916|NCT01858766|951217|P13|COMPLETED|Overall Study||25
387917|NCT01858766|951218|P12|COMPLETED|Overall Study||25
387918|NCT01858766|951219|P11|COMPLETED|Overall Study||5
387919|NCT01858766|951220|P10|COMPLETED|Overall Study||4
387920|NCT01858766|951221|P9|COMPLETED|Overall Study||1
387921|NCT01858766|951222|P8|COMPLETED|Overall Study||5
387922|NCT01858766|951223|P7|COMPLETED|Overall Study||7
387923|NCT01858766|951224|P6|COMPLETED|Overall Study||24
387924|NCT01858766|951225|P5|COMPLETED|Overall Study||26
387925|NCT01858766|951226|P4|COMPLETED|Overall Study||10
387926|NCT01858766|951227|P3|COMPLETED|Overall Study||10
387927|NCT01858766|951228|P2|COMPLETED|Overall Study||28
387928|NCT01858766|951229|P1|COMPLETED|Overall Study||26
387929|NCT01858766|951211|P19|STARTED|Overall Study||26
387930|NCT01858766|951212|P18|STARTED|Overall Study||27
387931|NCT01858766|951213|P17|STARTED|Overall Study||25
387932|NCT01858766|951214|P16|STARTED|Overall Study||26
387933|NCT01858766|951215|P15|STARTED|Overall Study||31
387934|NCT01858766|951216|P14|STARTED|Overall Study||29
387935|NCT01858766|951217|P13|STARTED|Overall Study||30
387936|NCT01858766|951218|P12|STARTED|Overall Study||30
387937|NCT01858766|951219|P11|STARTED|Overall Study||5
387938|NCT01858766|951220|P10|STARTED|Overall Study||4
387939|NCT01858766|951221|P9|STARTED|Overall Study||1
387940|NCT01858766|951222|P8|STARTED|Overall Study||7
387941|NCT01858766|951223|P7|STARTED|Overall Study||7
387942|NCT01858766|951224|P6|STARTED|Overall Study||28
387943|NCT01858766|951225|P5|STARTED|Overall Study||27
387944|NCT01858766|951226|P4|STARTED|Overall Study||10
387945|NCT01858766|951227|P3|STARTED|Overall Study||11
387946|NCT01858766|951228|P2|STARTED|Overall Study||28
387947|NCT01858766|951229|P1|STARTED|Overall Study||27
387948|NCT01858701|951300|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
387949|NCT01858701|951301|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
387950|NCT01858701|951300|P2|COMPLETED|Period 2, Second 30 Days of Wear||16
387951|NCT01858701|951301|P1|COMPLETED|Period 2, Second 30 Days of Wear||18
387952|NCT01858701|951300|P2|STARTED|Period 2, Second 30 Days of Wear||17
387953|NCT01858701|951301|P1|STARTED|Period 2, Second 30 Days of Wear||18
387954|NCT01858701|951300|P2|NOT COMPLETED|Washout Period, 1-13 Days||2
387955|NCT01858701|951301|P1|NOT COMPLETED|Washout Period, 1-13 Days||2
387956|NCT01858701|951300|P2|COMPLETED|Washout Period, 1-13 Days||17
387957|NCT01858701|951301|P1|COMPLETED|Washout Period, 1-13 Days||18
387958|NCT01858701|951300|P2|STARTED|Washout Period, 1-13 Days||19
387959|NCT01858701|951301|P1|STARTED|Washout Period, 1-13 Days||20
387960|NCT01858701|951300|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||1
387961|NCT01858701|951301|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||0
387962|NCT01858701|951300|P2|COMPLETED|Period 1, First 30 Days of Wear||19
387963|NCT01858701|951301|P1|COMPLETED|Period 1, First 30 Days of Wear||20
387964|NCT01858701|951300|P2|STARTED|Period 1, First 30 Days of Wear||20
387965|NCT01858701|951301|P1|STARTED|Period 1, First 30 Days of Wear||20
387966|NCT01858636|951307|P1|NOT COMPLETED|Overall Study||28
387967|NCT01858636|951307|P1|COMPLETED|Overall Study||207
387968|NCT01858636|951307|P1|Device Deployment|Overall Study||211
387969|NCT01858636|951307|P1|STARTED|Overall Study|Subjects consented|235
387970|NCT01858545|951314|P2|NOT COMPLETED|Overall Study||6
387971|NCT01858545|951315|P1|NOT COMPLETED|Overall Study||4
387972|NCT01858545|951314|P2|COMPLETED|Overall Study||23
387973|NCT01858545|951315|P1|COMPLETED|Overall Study||23
387974|NCT01858545|951314|P2|STARTED|Overall Study||29
387975|NCT01858545|951315|P1|STARTED|Overall Study||27
387976|NCT01858428|951323|P2|NOT COMPLETED|Overall Study||10
387977|NCT01858428|951324|P1|NOT COMPLETED|Overall Study||1
387978|NCT01858428|951323|P2|COMPLETED|Overall Study||190
387979|NCT01858428|951324|P1|COMPLETED|Overall Study||99
387980|NCT01858428|951323|P2|STARTED|Overall Study||200
387981|NCT01858428|951324|P1|STARTED|Overall Study|EverCross™ Balloon Catheter now a product of Medtronic|100
387982|NCT01858389|951360|P2|NOT COMPLETED|Overall Study||25
387983|NCT01858389|951361|P1|NOT COMPLETED|Overall Study||16
387984|NCT01858389|951360|P2|COMPLETED|Overall Study||0
387985|NCT01858389|951361|P1|COMPLETED|Overall Study||0
387986|NCT01858389|951360|P2|Received Treatment|Overall Study||22
387987|NCT01858389|951361|P1|Received Treatment|Overall Study||16
387988|NCT01858389|951360|P2|STARTED|Overall Study|Enrolled|25
387989|NCT01858389|951361|P1|STARTED|Overall Study|Enrolled|16
387990|NCT01858376|951376|P1|NOT COMPLETED|Overall Study||4
387991|NCT01858376|951376|P1|COMPLETED|Overall Study||20
387992|NCT01858376|951376|P1|STARTED|Overall Study||24
387993|NCT01857986|951384|P2|NOT COMPLETED|Overall Study||7
387994|NCT01857986|951385|P1|NOT COMPLETED|Overall Study||5
387995|NCT01857986|951384|P2|COMPLETED|Overall Study||30
387996|NCT01857986|951385|P1|COMPLETED|Overall Study||34
387997|NCT01857986|951384|P2|STARTED|Overall Study||37
387998|NCT01857986|951385|P1|STARTED|Overall Study||39
387999|NCT01857882|951397|P2|NOT COMPLETED|Overall Study||0
388000|NCT01857882|951398|P1|NOT COMPLETED|Overall Study||0
388001|NCT01857882|951397|P2|COMPLETED|Overall Study||20
388002|NCT01857882|951398|P1|COMPLETED|Overall Study||21
388003|NCT01857882|951397|P2|STARTED|Overall Study||20
388004|NCT01857882|951398|P1|STARTED|Overall Study||21
388005|NCT01857713|951404|P1|NOT COMPLETED|Overall Study||6
388006|NCT01857713|951404|P1|COMPLETED|Overall Study||89
388007|NCT01857713|951404|P1|STARTED|Overall Study||95
388008|NCT01857622|951414|P3|NOT COMPLETED|Overall Study||2
388009|NCT01857622|951415|P2|NOT COMPLETED|Overall Study||1
388010|NCT01857622|951416|P1|NOT COMPLETED|Overall Study||11
388011|NCT01857622|951414|P3|COMPLETED|Overall Study||19
388012|NCT01857622|951415|P2|COMPLETED|Overall Study||21
388013|NCT01857622|951416|P1|COMPLETED|Overall Study||39
388014|NCT01857622|951414|P3|STARTED|Overall Study||21
388015|NCT01857622|951415|P2|STARTED|Overall Study||22
388016|NCT01857622|951416|P1|STARTED|Overall Study||50
388017|NCT01857583|951428|P4|NOT COMPLETED|Overall Study||4
388018|NCT01857583|951429|P3|NOT COMPLETED|Overall Study||3
388019|NCT01857583|951430|P2|NOT COMPLETED|Overall Study||1
388020|NCT01857583|951431|P1|NOT COMPLETED|Overall Study||1
388021|NCT01857583|951428|P4|COMPLETED|Overall Study||17
388022|NCT01857583|951429|P3|COMPLETED|Overall Study||19
388023|NCT01857583|951430|P2|COMPLETED|Overall Study||6
388024|NCT01857583|951431|P1|COMPLETED|Overall Study||29
388025|NCT01857583|951428|P4|Safety Analysis Population|Overall Study||20
388026|NCT01857583|951429|P3|Safety Analysis Population|Overall Study||22
388027|NCT01857583|951430|P2|Safety Analysis Population|Overall Study||7
388028|NCT01857583|951431|P1|Safety Analysis Population|Overall Study||30
388029|NCT01857583|951428|P4|STARTED|Overall Study||21
388030|NCT01857583|951429|P3|STARTED|Overall Study||22
388031|NCT01857583|951430|P2|STARTED|Overall Study||7
388032|NCT01857583|951431|P1|STARTED|Overall Study||30
388033|NCT01857531|951441|P1|NOT COMPLETED|Overall Study||4
388034|NCT01857531|951441|P1|COMPLETED|Overall Study||12
388035|NCT01857531|951441|P1|STARTED|Overall Study||16
388036|NCT01857362|951450|P2|NOT COMPLETED|Overall Study||0
388037|NCT01857362|951451|P1|NOT COMPLETED|Overall Study||0
388038|NCT01857362|951450|P2|COMPLETED|Overall Study||6
388039|NCT01857362|951451|P1|COMPLETED|Overall Study||6
388040|NCT01857362|951450|P2|STARTED|Overall Study||6
388041|NCT01857362|951451|P1|STARTED|Overall Study||6
388042|NCT01857323|951459|P1|NOT COMPLETED|Overall Study||64
388043|NCT01857323|951459|P1|COMPLETED|Overall Study||253
388044|NCT01857323|951459|P1|Safety Population|Overall Study|One enrolled participant was lost to follow-up.|316
388045|NCT01857323|951459|P1|STARTED|Overall Study|36 day treatment cohort: 45 participants 50 day treatment cohort: 272 participants|317
388046|NCT01857297|951470|P2|NOT COMPLETED|Overall Study||0
388047|NCT01857297|951471|P1|NOT COMPLETED|Overall Study||0
388048|NCT01857297|951470|P2|COMPLETED|Overall Study||60
388049|NCT01857297|951471|P1|COMPLETED|Overall Study||60
388050|NCT01857297|951470|P2|STARTED|Overall Study||60
388051|NCT01857297|951471|P1|STARTED|Overall Study||60
388052|NCT01857258|951485|P2|NOT COMPLETED|Second Intervention (3 h Postprandially)||0
388053|NCT01857258|951486|P1|NOT COMPLETED|Second Intervention (3 h Postprandially)||0
388054|NCT01857258|951485|P2|COMPLETED|Second Intervention (3 h Postprandially)||7
388055|NCT01857258|951486|P1|COMPLETED|Second Intervention (3 h Postprandially)||8
388056|NCT01857258|951485|P2|STARTED|Second Intervention (3 h Postprandially)||7
388057|NCT01857258|951486|P1|STARTED|Second Intervention (3 h Postprandially)||8
388058|NCT01857258|951485|P2|NOT COMPLETED|Wash-out Period (7 Days)||0
388059|NCT01857258|951486|P1|NOT COMPLETED|Wash-out Period (7 Days)||0
388060|NCT01857258|951485|P2|COMPLETED|Wash-out Period (7 Days)||7
388061|NCT01857258|951486|P1|COMPLETED|Wash-out Period (7 Days)||8
388062|NCT01857258|951485|P2|STARTED|Wash-out Period (7 Days)||7
388063|NCT01857258|951486|P1|STARTED|Wash-out Period (7 Days)||8
388064|NCT01857258|951485|P2|NOT COMPLETED|First Intervention (3 h Postprandially)||0
388065|NCT01857258|951486|P1|NOT COMPLETED|First Intervention (3 h Postprandially)||0
388066|NCT01857258|951485|P2|COMPLETED|First Intervention (3 h Postprandially)||7
388067|NCT01857258|951486|P1|COMPLETED|First Intervention (3 h Postprandially)||8
388068|NCT01857258|951485|P2|STARTED|First Intervention (3 h Postprandially)||7
388069|NCT01857258|951486|P1|STARTED|First Intervention (3 h Postprandially)||8
388070|NCT01857206|951508|P2|NOT COMPLETED|Overall Study||10
388071|NCT01857206|951509|P1|NOT COMPLETED|Overall Study||13
388072|NCT01857206|951508|P2|COMPLETED|Overall Study||673
388073|NCT01857206|951509|P1|COMPLETED|Overall Study||1359
388074|NCT01857206|951508|P2|STARTED|Overall Study||683
388075|NCT01857206|951509|P1|STARTED|Overall Study||1372
388076|NCT01857102|951527|P2|NOT COMPLETED|Period 2||0
388077|NCT01857102|951528|P1|NOT COMPLETED|Period 2||2
388078|NCT01857102|951527|P2|COMPLETED|Period 2||51
388079|NCT01857102|951528|P1|COMPLETED|Period 2||53
388080|NCT01857102|951527|P2|Neophytes|Period 2||4
388081|NCT01857102|951528|P1|Neophytes|Period 2||7
388082|NCT01857102|951527|P2|Habitual Users|Period 2||47
388083|NCT01857102|951528|P1|Habitual Users|Period 2||48
388084|NCT01857102|951527|P2|STARTED|Period 2||51
388085|NCT01857102|951528|P1|STARTED|Period 2||55
388086|NCT01857102|951527|P2|NOT COMPLETED|Period 1||5
388087|NCT01857102|951528|P1|NOT COMPLETED|Period 1||3
388088|NCT01857102|951527|P2|COMPLETED|Period 1||51
388089|NCT01857102|951528|P1|COMPLETED|Period 1||55
388090|NCT01857102|951527|P2|Neophtyes|Period 1||4
388091|NCT01857102|951528|P1|Neophtyes|Period 1||7
388092|NCT01857102|951527|P2|Habitual Users|Period 1||52
388093|NCT01857102|951528|P1|Habitual Users|Period 1||51
388094|NCT01857102|951527|P2|STARTED|Period 1||56
388095|NCT01857102|951528|P1|STARTED|Period 1||58
388096|NCT01857063|951538|P2|NOT COMPLETED|Period 2 (7 Days)||2
388097|NCT01857063|951539|P1|NOT COMPLETED|Period 2 (7 Days)||4
388098|NCT01857063|951538|P2|COMPLETED|Period 2 (7 Days)||104
388099|NCT01857063|951539|P1|COMPLETED|Period 2 (7 Days)||104
388100|NCT01857063|951538|P2|STARTED|Period 2 (7 Days)||106
388101|NCT01857063|951539|P1|STARTED|Period 2 (7 Days)||108
388102|NCT01857063|951538|P2|NOT COMPLETED|Period 1 (7 Days)||4
388103|NCT01857063|951539|P1|NOT COMPLETED|Period 1 (7 Days)||2
388104|NCT01857063|951538|P2|COMPLETED|Period 1 (7 Days)||106
388105|NCT01857063|951539|P1|COMPLETED|Period 1 (7 Days)||108
388106|NCT01857063|951538|P2|STARTED|Period 1 (7 Days)||110
388107|NCT01857063|951539|P1|STARTED|Period 1 (7 Days)||110
388108|NCT01856933|951565|P1|NOT COMPLETED|Overall Study||0
388109|NCT01856933|951565|P1|COMPLETED|Overall Study||6
388110|NCT01856933|951565|P1|STARTED|Overall Study||6
388111|NCT01856907|951572|P3|NOT COMPLETED|Overall Study||0
388112|NCT01856907|951573|P2|NOT COMPLETED|Overall Study||3
388113|NCT01856907|951574|P1|NOT COMPLETED|Overall Study||0
388114|NCT01856907|951572|P3|COMPLETED|Overall Study||12
388115|NCT01856907|951573|P2|COMPLETED|Overall Study||9
388116|NCT01856907|951574|P1|COMPLETED|Overall Study||12
388117|NCT01856907|951572|P3|STARTED|Overall Study||12
388118|NCT01856907|951573|P2|STARTED|Overall Study||12
388119|NCT01856907|951574|P1|STARTED|Overall Study||12
388120|NCT01856764|951614|P2|NOT COMPLETED|Overall Study||0
388121|NCT01856764|951615|P1|NOT COMPLETED|Overall Study||0
388122|NCT01856764|951614|P2|COMPLETED|Overall Study||20
388123|NCT01856764|951615|P1|COMPLETED|Overall Study||20
388124|NCT01856764|951614|P2|STARTED|Overall Study||20
388125|NCT01856764|951615|P1|STARTED|Overall Study||20
388126|NCT01856686|951627|P2|NOT COMPLETED|Overall Study||11
388127|NCT01856686|951628|P1|NOT COMPLETED|Overall Study||5
388128|NCT01856686|951627|P2|COMPLETED|Overall Study||22
388129|NCT01856686|951628|P1|COMPLETED|Overall Study||26
388130|NCT01856686|951627|P2|STARTED|Overall Study||33
388131|NCT01856686|951628|P1|STARTED|Overall Study||31
388132|NCT01856673|951671|P3|NOT COMPLETED|Overall Study||34
388133|NCT01856673|951672|P2|NOT COMPLETED|Overall Study||85
388134|NCT01856673|951673|P1|NOT COMPLETED|Overall Study||98
388135|NCT01856673|951671|P3|COMPLETED|Overall Study||137
388136|NCT01856673|951672|P2|COMPLETED|Overall Study|A percentage of 80.9% completed the follow-up (exit survey)|90
388137|NCT01856673|951673|P1|COMPLETED|Overall Study|A percentage of 75.1% completed the follow-up (exit survey)|77
388138|NCT01856673|951671|P3|Quibdó Participants|Overall Study||83
388139|NCT01856673|951672|P2|Quibdó Participants|Overall Study||86
388140|NCT01856673|951673|P1|Quibdó Participants|Overall Study||83
388141|NCT01856673|951671|P3|Buenaventura Participants|Overall Study||88
388142|NCT01856673|951672|P2|Buenaventura Participants|Overall Study||89
388143|NCT01856673|951673|P1|Buenaventura Participants|Overall Study||92
388144|NCT01856673|951671|P3|STARTED|Overall Study||171
388145|NCT01856673|951672|P2|STARTED|Overall Study||175
388146|NCT01856673|951673|P1|STARTED|Overall Study||175
388147|NCT01856569|951684|P1|NOT COMPLETED|Overall Study||13
388148|NCT01856569|951684|P1|COMPLETED|Overall Study||139
388149|NCT01856569|951684|P1|Full Analysis Set|Overall Study||144
388150|NCT01856569|951684|P1|STARTED|Overall Study||152
388151|NCT01856530|951695|P2|NOT COMPLETED|Overall Study||0
388152|NCT01856530|951696|P1|NOT COMPLETED|Overall Study||0
388153|NCT01856530|951695|P2|COMPLETED|Overall Study||27
388154|NCT01856530|951696|P1|COMPLETED|Overall Study||27
388155|NCT01856530|951695|P2|STARTED|Overall Study||27
388156|NCT01856530|951696|P1|STARTED|Overall Study||27
388157|NCT01856491|951712|P1|NOT COMPLETED|Overall Study||15
388158|NCT01856491|951712|P1|COMPLETED|Overall Study||152
388159|NCT01856491|951712|P1|STARTED|Overall Study||167
388160|NCT01856361|951721|P2|NOT COMPLETED|Overall Study||0
388161|NCT01856361|951722|P1|NOT COMPLETED|Overall Study||0
388162|NCT01856361|951721|P2|COMPLETED|Overall Study||1
388163|NCT01856361|951722|P1|COMPLETED|Overall Study||1
388164|NCT01856361|951721|P2|STARTED|Overall Study||1
388165|NCT01856361|951722|P1|STARTED|Overall Study||1
388166|NCT01856322|951739|P3|NOT COMPLETED|Overall Study||3
388167|NCT01856322|951740|P2|NOT COMPLETED|Overall Study||0
388168|NCT01856322|951741|P1|NOT COMPLETED|Overall Study||0
388169|NCT01856322|951739|P3|COMPLETED|Overall Study||0
388170|NCT01856322|951740|P2|COMPLETED|Overall Study||0
388171|NCT01856322|951741|P1|COMPLETED|Overall Study||0
388172|NCT01856322|951739|P3|STARTED|Overall Study||3
388173|NCT01856322|951740|P2|STARTED|Overall Study||0
388174|NCT01856322|951741|P1|STARTED|Overall Study||0
388175|NCT01856270|951750|P2|NOT COMPLETED|Overall Study||12
388176|NCT01856270|951751|P1|NOT COMPLETED|Overall Study||11
388177|NCT01856270|951750|P2|COMPLETED|Overall Study||14
388178|NCT01856270|951751|P1|COMPLETED|Overall Study||13
388179|NCT01856270|951750|P2|STARTED|Overall Study||26
388180|NCT01856270|951751|P1|STARTED|Overall Study||24
388181|NCT01856257|951774|P4|NOT COMPLETED|Overall Study||2
388182|NCT01856257|951775|P3|NOT COMPLETED|Overall Study||0
388183|NCT01856257|951776|P2|NOT COMPLETED|Overall Study||1
388184|NCT01856257|951777|P1|NOT COMPLETED|Overall Study||3
388185|NCT01856257|951774|P4|COMPLETED|Overall Study||0
388186|NCT01856257|951775|P3|COMPLETED|Overall Study||11
388187|NCT01856257|951776|P2|COMPLETED|Overall Study||28
388188|NCT01856257|951777|P1|COMPLETED|Overall Study||26
388189|NCT01856257|951774|P4|STARTED|Overall Study||2
388190|NCT01856257|951775|P3|STARTED|Overall Study||11
388191|NCT01856257|951776|P2|STARTED|Overall Study||29
388192|NCT01856257|951777|P1|STARTED|Overall Study||29
388193|NCT01856218|951876|P1|NOT COMPLETED|Long-Term Extension Phase||0
388194|NCT01856218|951876|P1|COMPLETED|Long-Term Extension Phase||3
388195|NCT01856218|951876|P1|STARTED|Long-Term Extension Phase||3
388196|NCT01856218|951876|P1|NOT COMPLETED|First Phase||0
388197|NCT01856218|951876|P1|COMPLETED|First Phase||3
388198|NCT01856218|951876|P1|STARTED|First Phase||3
388199|NCT01855997|951890|P1|NOT COMPLETED|Overall Study||0
388200|NCT01855997|951890|P1|COMPLETED|Overall Study||1669
388201|NCT01855997|951890|P1|STARTED|Overall Study||1669
388202|NCT01855958|951945|P2|NOT COMPLETED|Overall Study||0
388203|NCT01855958|951946|P1|NOT COMPLETED|Overall Study||1
388204|NCT01855958|951945|P2|COMPLETED|Overall Study||13
388205|NCT01855958|951946|P1|COMPLETED|Overall Study||12
388206|NCT01855958|951945|P2|STARTED|Overall Study||13
388207|NCT01855958|951946|P1|STARTED|Overall Study||13
388208|NCT01855945|951976|P12|NOT COMPLETED|Overall Study||3
388209|NCT01855945|951977|P11|NOT COMPLETED|Overall Study||5
388210|NCT01855945|951978|P10|NOT COMPLETED|Overall Study||2
388211|NCT01855945|951979|P9|NOT COMPLETED|Overall Study||2
388212|NCT01855945|951980|P8|NOT COMPLETED|Overall Study||8
388213|NCT01855945|951981|P7|NOT COMPLETED|Overall Study||10
388214|NCT01855945|951982|P6|NOT COMPLETED|Overall Study||3
388215|NCT01855945|951983|P5|NOT COMPLETED|Overall Study||1
388216|NCT01855945|951984|P4|NOT COMPLETED|Overall Study||4
388217|NCT01855945|951985|P3|NOT COMPLETED|Overall Study||12
388218|NCT01855945|951986|P2|NOT COMPLETED|Overall Study||11
388219|NCT01855945|951987|P1|NOT COMPLETED|Overall Study||16
388220|NCT01855945|951976|P12|COMPLETED|Overall Study||49
388221|NCT01855945|951977|P11|COMPLETED|Overall Study||46
388222|NCT01855945|951978|P10|COMPLETED|Overall Study||49
388223|NCT01855945|951979|P9|COMPLETED|Overall Study||46
388224|NCT01855945|951980|P8|COMPLETED|Overall Study||47
388225|NCT01855945|951981|P7|COMPLETED|Overall Study||43
388226|NCT01855945|951982|P6|COMPLETED|Overall Study||50
388227|NCT01855945|951983|P5|COMPLETED|Overall Study||50
388228|NCT01855945|951984|P4|COMPLETED|Overall Study||49
388229|NCT01855945|951985|P3|COMPLETED|Overall Study||39
388230|NCT01855945|951986|P2|COMPLETED|Overall Study||44
388231|NCT01855945|951987|P1|COMPLETED|Overall Study||38
388232|NCT01855945|951976|P12|STARTED|Overall Study||52
388233|NCT01855945|951977|P11|STARTED|Overall Study||51
388234|NCT01855945|951978|P10|STARTED|Overall Study||51
388235|NCT01855945|951979|P9|STARTED|Overall Study||48
388236|NCT01855945|951980|P8|STARTED|Overall Study||55
388237|NCT01855945|951981|P7|STARTED|Overall Study||53
388238|NCT01855945|951982|P6|STARTED|Overall Study||53
388239|NCT01855945|951983|P5|STARTED|Overall Study||51
388240|NCT01855945|951984|P4|STARTED|Overall Study||53
388241|NCT01855945|951985|P3|STARTED|Overall Study||51
388242|NCT01855945|951986|P2|STARTED|Overall Study||55
388243|NCT01855945|951987|P1|STARTED|Overall Study||54
388244|NCT01855919|952123|P2|NOT COMPLETED|Overall Study||26
388245|NCT01855919|952124|P1|NOT COMPLETED|Overall Study||23
388246|NCT01855919|952123|P2|COMPLETED|Overall Study||200
388247|NCT01855919|952124|P1|COMPLETED|Overall Study||209
388248|NCT01855919|952123|P2|Received at Least 1 Dose of Study Drug|Overall Study||226
388249|NCT01855919|952124|P1|Received at Least 1 Dose of Study Drug|Overall Study||232
388250|NCT01855919|952123|P2|STARTED|Overall Study||226
388251|NCT01855919|952124|P1|STARTED|Overall Study||232
388252|NCT01855789|952156|P4|NOT COMPLETED|2) Week 24 up to End of Study||58
388253|NCT01855789|952157|P3|NOT COMPLETED|2) Week 24 up to End of Study||18
388254|NCT01855789|952158|P2|NOT COMPLETED|2) Week 24 up to End of Study||15
388255|NCT01855789|952159|P1|NOT COMPLETED|2) Week 24 up to End of Study||0
388256|NCT01855789|952156|P4|COMPLETED|2) Week 24 up to End of Study||250
388257|NCT01855789|952157|P3|COMPLETED|2) Week 24 up to End of Study||129
388258|NCT01855789|952158|P2|COMPLETED|2) Week 24 up to End of Study||132
388259|NCT01855789|952159|P1|COMPLETED|2) Week 24 up to End of Study||0
388260|NCT01855789|952156|P4|STARTED|2) Week 24 up to End of Study||308
388261|NCT01855789|952157|P3|STARTED|2) Week 24 up to End of Study||147
388262|NCT01855789|952158|P2|STARTED|2) Week 24 up to End of Study||147
388263|NCT01855789|952159|P1|STARTED|2) Week 24 up to End of Study||0
388264|NCT01855789|952156|P4|NOT COMPLETED|1) Baseline up to Week 24||0
388265|NCT01855789|952157|P3|NOT COMPLETED|1) Baseline up to Week 24||0
388266|NCT01855789|952158|P2|NOT COMPLETED|1) Baseline up to Week 24||0
388267|NCT01855789|952159|P1|NOT COMPLETED|1) Baseline up to Week 24||116
388268|NCT01855789|952156|P4|COMPLETED|1) Baseline up to Week 24||0
388269|NCT01855789|952157|P3|COMPLETED|1) Baseline up to Week 24||0
388270|NCT01855789|952158|P2|COMPLETED|1) Baseline up to Week 24||0
388271|NCT01855789|952159|P1|COMPLETED|1) Baseline up to Week 24||602
388272|NCT01855789|952156|P4|STARTED|1) Baseline up to Week 24||0
388273|NCT01855789|952157|P3|STARTED|1) Baseline up to Week 24||0
388274|NCT01855789|952158|P2|STARTED|1) Baseline up to Week 24||0
388275|NCT01855789|952159|P1|STARTED|1) Baseline up to Week 24||718
388276|NCT01855074|952181|P1|NOT COMPLETED|Overall Study||14
388277|NCT01855074|952181|P1|COMPLETED|Overall Study||66
388278|NCT01855074|952181|P1|Treated|Overall Study||79
388279|NCT01855074|952181|P1|STARTED|Overall Study||80
388280|NCT01854944|952193|P3|NOT COMPLETED|Overall Study||1
388281|NCT01854944|952194|P2|NOT COMPLETED|Overall Study||0
388282|NCT01854944|952195|P1|NOT COMPLETED|Overall Study||0
388283|NCT01854944|952193|P3|COMPLETED|Overall Study||3
388284|NCT01854944|952194|P2|COMPLETED|Overall Study||4
388285|NCT01854944|952195|P1|COMPLETED|Overall Study||4
388286|NCT01854944|952193|P3|STARTED|Overall Study||4
388287|NCT01854944|952194|P2|STARTED|Overall Study||4
388288|NCT01854944|952195|P1|STARTED|Overall Study||4
388289|NCT01854905|952245|P1|NOT COMPLETED|Overall Study||0
388290|NCT01854905|952245|P1|COMPLETED|Overall Study||400
388291|NCT01854905|952245|P1|STARTED|Overall Study||400
388292|NCT01854827|952249|P1|NOT COMPLETED|Overall Study||1
388293|NCT01854827|952249|P1|COMPLETED|Overall Study||29
388294|NCT01854827|952249|P1|STARTED|Overall Study||30
388295|NCT01854710|952261|P6|NOT COMPLETED|Overall Study||2
388296|NCT01854710|952262|P5|NOT COMPLETED|Overall Study||2
388297|NCT01854710|952263|P4|NOT COMPLETED|Overall Study||2
388298|NCT01854710|952264|P3|NOT COMPLETED|Overall Study||2
388299|NCT01854710|952265|P2|NOT COMPLETED|Overall Study||3
388300|NCT01854710|952266|P1|NOT COMPLETED|Overall Study||4
388301|NCT01854710|952261|P6|COMPLETED|Overall Study||8
388302|NCT01854710|952262|P5|COMPLETED|Overall Study||8
388303|NCT01854710|952263|P4|COMPLETED|Overall Study||8
388304|NCT01854710|952264|P3|COMPLETED|Overall Study||8
388305|NCT01854710|952265|P2|COMPLETED|Overall Study||7
388306|NCT01854710|952266|P1|COMPLETED|Overall Study||6
388307|NCT01854710|952261|P6|STARTED|Overall Study||10
388308|NCT01854710|952262|P5|STARTED|Overall Study||10
388309|NCT01854710|952263|P4|STARTED|Overall Study||10
388310|NCT01854710|952264|P3|STARTED|Overall Study||10
388311|NCT01854710|952265|P2|STARTED|Overall Study||10
388312|NCT01854710|952266|P1|STARTED|Overall Study||10
388313|NCT01854697|952287|P5|NOT COMPLETED|Overall Study||2
388314|NCT01854697|952288|P4|NOT COMPLETED|Overall Study||3
388315|NCT01854697|952289|P3|NOT COMPLETED|Overall Study||2
388316|NCT01854697|952290|P2|NOT COMPLETED|Overall Study||3
388317|NCT01854697|952291|P1|NOT COMPLETED|Overall Study||6
388318|NCT01854697|952287|P5|COMPLETED|Overall Study||39
388319|NCT01854697|952288|P4|COMPLETED|Overall Study||80
388320|NCT01854697|952289|P3|COMPLETED|Overall Study||82
388321|NCT01854697|952290|P2|COMPLETED|Overall Study||31
388322|NCT01854697|952291|P1|COMPLETED|Overall Study||63
388323|NCT01854697|952287|P5|STARTED|Overall Study||41
388324|NCT01854697|952288|P4|STARTED|Overall Study||83
388325|NCT01854697|952289|P3|STARTED|Overall Study||84
388326|NCT01854697|952290|P2|STARTED|Overall Study||34
388327|NCT01854697|952291|P1|STARTED|Overall Study||69
388328|NCT01854658|952335|P4|NOT COMPLETED|Overall Study||59
388329|NCT01854658|952336|P3|NOT COMPLETED|Overall Study||80
388330|NCT01854658|952337|P2|NOT COMPLETED|Overall Study||75
388331|NCT01854658|952338|P1|NOT COMPLETED|Overall Study||93
388332|NCT01854658|952335|P4|COMPLETED|Overall Study||165
388333|NCT01854658|952336|P3|COMPLETED|Overall Study||432
388334|NCT01854658|952337|P2|COMPLETED|Overall Study||365
388335|NCT01854658|952338|P1|COMPLETED|Overall Study||346
388336|NCT01854658|952335|P4|STARTED|Overall Study||224
388337|NCT01854658|952336|P3|STARTED|Overall Study||512
388338|NCT01854658|952337|P2|STARTED|Overall Study||440
388339|NCT01854658|952338|P1|STARTED|Overall Study||439
388340|NCT01854645|952373|P5|NOT COMPLETED|Overall Study||60
388341|NCT01854645|952374|P4|NOT COMPLETED|Overall Study||62
388342|NCT01854645|952375|P3|NOT COMPLETED|Overall Study||82
388343|NCT01854645|952376|P2|NOT COMPLETED|Overall Study||106
388344|NCT01854645|952377|P1|NOT COMPLETED|Overall Study||98
388345|NCT01854645|952373|P5|COMPLETED|Overall Study||160
388346|NCT01854645|952374|P4|COMPLETED|Overall Study||391
388347|NCT01854645|952375|P3|COMPLETED|Overall Study||370
388348|NCT01854645|952376|P2|COMPLETED|Overall Study||345
388349|NCT01854645|952377|P1|COMPLETED|Overall Study||429
388350|NCT01854645|952373|P5|STARTED|Overall Study||220
388351|NCT01854645|952374|P4|STARTED|Overall Study||453
388352|NCT01854645|952375|P3|STARTED|Overall Study||452
388353|NCT01854645|952376|P2|STARTED|Overall Study||451
388354|NCT01854645|952377|P1|STARTED|Overall Study||527
388355|NCT01854632|952416|P2|NOT COMPLETED|Overall Study||13
388356|NCT01854632|952417|P1|NOT COMPLETED|Overall Study||26
388357|NCT01854632|952416|P2|COMPLETED|Overall Study||574
388358|NCT01854632|952417|P1|COMPLETED|Overall Study||1148
388359|NCT01854632|952416|P2|STARTED|Overall Study||587
388360|NCT01854632|952417|P1|STARTED|Overall Study||1174
388361|NCT01854593|952425|P2|NOT COMPLETED|Overall Study||1
388362|NCT01854593|952426|P1|NOT COMPLETED|Overall Study||2
388363|NCT01854593|952425|P2|COMPLETED|Overall Study||34
388364|NCT01854593|952426|P1|COMPLETED|Overall Study||32
388365|NCT01854593|952425|P2|STARTED|Overall Study||35
388366|NCT01854593|952426|P1|STARTED|Overall Study||34
388367|NCT01854528|952458|P2|NOT COMPLETED|Overall Study||15
388368|NCT01854528|952459|P1|NOT COMPLETED|Overall Study||0
388369|NCT01854528|952458|P2|COMPLETED|Overall Study||32
388370|NCT01854528|952459|P1|COMPLETED|Overall Study||101
388371|NCT01854528|952458|P2|STARTED|Overall Study||47
388372|NCT01854528|952459|P1|STARTED|Overall Study||101
388373|NCT01854281|952479|P4|NOT COMPLETED|Overall Study||0
388374|NCT01854281|952480|P3|NOT COMPLETED|Overall Study||0
388375|NCT01854281|952481|P2|NOT COMPLETED|Overall Study||0
388376|NCT01854281|952482|P1|NOT COMPLETED|Overall Study||0
388377|NCT01854281|952479|P4|COMPLETED|Overall Study||8
388378|NCT01854281|952480|P3|COMPLETED|Overall Study||5
388379|NCT01854281|952481|P2|COMPLETED|Overall Study||19
388380|NCT01854281|952482|P1|COMPLETED|Overall Study||15
388381|NCT01854281|952479|P4|STARTED|Overall Study||8
388382|NCT01854281|952480|P3|STARTED|Overall Study||5
388383|NCT01854281|952481|P2|STARTED|Overall Study||19
388384|NCT01854281|952482|P1|STARTED|Overall Study||15
388385|NCT01854268|952492|P1|NOT COMPLETED|Overall Study||0
388386|NCT01854268|952492|P1|COMPLETED|Overall Study||25
388387|NCT01854268|952492|P1|STARTED|Overall Study||25
388388|NCT01854242|952498|P1|NOT COMPLETED|Overall Study||0
388389|NCT01854242|952498|P1|COMPLETED|Overall Study||50
388390|NCT01854242|952498|P1|STARTED|Overall Study||50
388391|NCT01854047|952507|P5|NOT COMPLETED|Overall Study||19
388392|NCT01854047|952508|P4|NOT COMPLETED|Overall Study||15
388393|NCT01854047|952509|P3|NOT COMPLETED|Overall Study||13
388394|NCT01854047|952510|P2|NOT COMPLETED|Overall Study||8
388395|NCT01854047|952511|P1|NOT COMPLETED|Overall Study||12
388396|NCT01854047|952507|P5|COMPLETED|Overall Study||135
388397|NCT01854047|952508|P4|COMPLETED|Overall Study||142
388398|NCT01854047|952509|P3|COMPLETED|Overall Study||137
388399|NCT01854047|952510|P2|COMPLETED|Overall Study||149
388400|NCT01854047|952511|P1|COMPLETED|Overall Study||146
388401|NCT01854047|952507|P5|Completed 12-week Study Treatment|Overall Study||143
388402|NCT01854047|952508|P4|Completed 12-week Study Treatment|Overall Study||146
388403|NCT01854047|952509|P3|Completed 12-week Study Treatment|Overall Study||141
388404|NCT01854047|952510|P2|Completed 12-week Study Treatment|Overall Study||149
388405|NCT01854047|952511|P1|Completed 12-week Study Treatment|Overall Study||153
388406|NCT01854047|952507|P5|Treated|Overall Study||150
388407|NCT01854047|952508|P4|Treated|Overall Study||157
388408|NCT01854047|952509|P3|Treated|Overall Study||148
388409|NCT01854047|952510|P2|Treated|Overall Study||156
388410|NCT01854047|952511|P1|Treated|Overall Study||158
388411|NCT01854047|952507|P5|STARTED|Overall Study||154
388412|NCT01854047|952508|P4|STARTED|Overall Study||157
388413|NCT01854047|952509|P3|STARTED|Overall Study||150
388414|NCT01854047|952510|P2|STARTED|Overall Study||157
388415|NCT01854047|952511|P1|STARTED|Overall Study||158
388416|NCT01854034|952633|P1|NOT COMPLETED|Overall Study||0
388417|NCT01854034|952633|P1|COMPLETED|Overall Study||29
388418|NCT01854034|952633|P1|STARTED|Overall Study||29
388419|NCT01853982|952642|P2|NOT COMPLETED|Overall Study||1
388420|NCT01853982|952643|P1|NOT COMPLETED|Overall Study||2
388421|NCT01853982|952642|P2|COMPLETED|Overall Study||1
388422|NCT01853982|952643|P1|COMPLETED|Overall Study||0
388423|NCT01853982|952642|P2|Received at Least 1 Dose of Study Drug|Overall Study||2
388424|NCT01853982|952643|P1|Received at Least 1 Dose of Study Drug|Overall Study||2
388425|NCT01853982|952642|P2|STARTED|Overall Study||2
388426|NCT01853982|952643|P1|STARTED|Overall Study||2
388427|NCT01853839|952649|P1|NOT COMPLETED|Overall Study||429
388428|NCT01853839|952649|P1|COMPLETED|Overall Study||1663
388429|NCT01853839|952649|P1|STARTED|Overall Study||2092
388430|NCT01853696|952671|P2|NOT COMPLETED|Overall Study||5
388431|NCT01853696|952672|P1|NOT COMPLETED|Overall Study||6
388432|NCT01853696|952671|P2|COMPLETED|Overall Study||78
388433|NCT01853696|952672|P1|COMPLETED|Overall Study||78
388434|NCT01853696|952671|P2|STARTED|Overall Study||83
388435|NCT01853696|952672|P1|STARTED|Overall Study||84
388436|NCT01853605|952684|P4|NOT COMPLETED|Overall Study||0
388437|NCT01853605|952685|P3|NOT COMPLETED|Overall Study||0
388438|NCT01853605|952686|P2|NOT COMPLETED|Overall Study||0
388439|NCT01853605|952687|P1|NOT COMPLETED|Overall Study||0
388440|NCT01853605|952684|P4|COMPLETED|Overall Study||428
388441|NCT01853605|952685|P3|COMPLETED|Overall Study||751
388442|NCT01853605|952686|P2|COMPLETED|Overall Study||693
388443|NCT01853605|952687|P1|COMPLETED|Overall Study||1939
388444|NCT01853605|952684|P4|STARTED|Overall Study||428
388445|NCT01853605|952685|P3|STARTED|Overall Study||751
388446|NCT01853605|952686|P2|STARTED|Overall Study||693
388447|NCT01853605|952687|P1|STARTED|Overall Study||1939
388448|NCT01853475|952708|P3|NOT COMPLETED|Overall Study||0
388449|NCT01853475|952709|P2|NOT COMPLETED|Overall Study||1
388450|NCT01853475|952710|P1|NOT COMPLETED|Overall Study||0
388451|NCT01853475|952708|P3|COMPLETED|Overall Study||8
388452|NCT01853475|952709|P2|COMPLETED|Overall Study||7
388453|NCT01853475|952710|P1|COMPLETED|Overall Study||8
388454|NCT01853475|952708|P3|STARTED|Overall Study||8
388455|NCT01853475|952709|P2|STARTED|Overall Study||8
388456|NCT01853475|952710|P1|STARTED|Overall Study||8
388457|NCT01853397|952731|P4|NOT COMPLETED|Overall Study||2
388458|NCT01853397|952732|P3|NOT COMPLETED|Overall Study||0
388459|NCT01853397|952733|P2|NOT COMPLETED|Overall Study||0
388460|NCT01853397|952734|P1|NOT COMPLETED|Overall Study||0
388461|NCT01853397|952731|P4|COMPLETED|Overall Study||15
388462|NCT01853397|952732|P3|COMPLETED|Overall Study||17
388463|NCT01853397|952733|P2|COMPLETED|Overall Study||20
388464|NCT01853397|952734|P1|COMPLETED|Overall Study||18
388465|NCT01853397|952731|P4|STARTED|Overall Study||17
388466|NCT01853397|952732|P3|STARTED|Overall Study||17
388467|NCT01853397|952733|P2|STARTED|Overall Study||20
388468|NCT01853397|952734|P1|STARTED|Overall Study||18
388469|NCT01853384|952762|P2|NOT COMPLETED|Completed Follow up Visit 2||3
388470|NCT01853384|952763|P1|NOT COMPLETED|Completed Follow up Visit 2||3
388471|NCT01853384|952762|P2|COMPLETED|Completed Follow up Visit 2||91
388472|NCT01853384|952763|P1|COMPLETED|Completed Follow up Visit 2||93
388473|NCT01853384|952762|P2|STARTED|Completed Follow up Visit 2||94
388474|NCT01853384|952763|P1|STARTED|Completed Follow up Visit 2||96
388475|NCT01853384|952762|P2|NOT COMPLETED|Completed Follow up Visit 1||9
388476|NCT01853384|952763|P1|NOT COMPLETED|Completed Follow up Visit 1||14
388477|NCT01853384|952762|P2|COMPLETED|Completed Follow up Visit 1||85
388478|NCT01853384|952763|P1|COMPLETED|Completed Follow up Visit 1||82
388479|NCT01853384|952762|P2|STARTED|Completed Follow up Visit 1||94
388480|NCT01853384|952763|P1|STARTED|Completed Follow up Visit 1||96
388481|NCT01853384|952762|P2|NOT COMPLETED|Enrolled in Follow up Period||0
388482|NCT01853384|952763|P1|NOT COMPLETED|Enrolled in Follow up Period||0
388483|NCT01853384|952762|P2|COMPLETED|Enrolled in Follow up Period||94
388484|NCT01853384|952763|P1|COMPLETED|Enrolled in Follow up Period||96
388485|NCT01853384|952762|P2|Not Enrolled in Follow-up|Enrolled in Follow up Period||27
388486|NCT01853384|952763|P1|Not Enrolled in Follow-up|Enrolled in Follow up Period||35
388487|NCT01853384|952762|P2|STARTED|Enrolled in Follow up Period||94
388488|NCT01853384|952763|P1|STARTED|Enrolled in Follow up Period||96
388489|NCT01853384|952762|P2|NOT COMPLETED|Randomized||46
388490|NCT01853384|952763|P1|NOT COMPLETED|Randomized||62
388491|NCT01853384|952762|P2|COMPLETED|Randomized||75
388492|NCT01853384|952763|P1|COMPLETED|Randomized||69
388493|NCT01853384|952762|P2|STARTED|Randomized||121
388494|NCT01853384|952763|P1|STARTED|Randomized||131
388495|NCT01853371|952783|P2|NOT COMPLETED|Overall Study||2
388496|NCT01853371|952784|P1|NOT COMPLETED|Overall Study||0
388497|NCT01853371|952783|P2|COMPLETED|Overall Study||8
388498|NCT01853371|952784|P1|COMPLETED|Overall Study||10
388499|NCT01853371|952783|P2|STARTED|Overall Study||10
388500|NCT01853371|952784|P1|STARTED|Overall Study||10
388501|NCT01853332|952792|P1|NOT COMPLETED|Overall Study||59
388502|NCT01853332|952792|P1|COMPLETED|Overall Study||151
388503|NCT01853332|952792|P1|STARTED|Overall Study||210
388504|NCT01853280|952803|P2|NOT COMPLETED|Overall Study||6
388505|NCT01853280|952804|P1|NOT COMPLETED|Overall Study||2
388506|NCT01853280|952803|P2|COMPLETED|Overall Study||16
388507|NCT01853280|952804|P1|COMPLETED|Overall Study||20
388508|NCT01853280|952803|P2|STARTED|Overall Study||22
388509|NCT01853280|952804|P1|STARTED|Overall Study||22
388510|NCT01853254|952810|P1|NOT COMPLETED|Overall Study||104
388511|NCT01853254|952810|P1|COMPLETED|Overall Study||168
388512|NCT01853254|952810|P1|STARTED|Overall Study||272
388513|NCT01853215|952814|P1|NOT COMPLETED|Overall Study||0
388514|NCT01853215|952814|P1|COMPLETED|Overall Study||24
388515|NCT01853215|952814|P1|STARTED|Overall Study||24
388516|NCT01853176|952827|P2|NOT COMPLETED|Overall Study||0
388517|NCT01853176|952828|P1|NOT COMPLETED|Overall Study||4
388518|NCT01853176|952827|P2|COMPLETED|Overall Study||0
388519|NCT01853176|952828|P1|COMPLETED|Overall Study||0
388520|NCT01853176|952827|P2|STARTED|Overall Study||0
388521|NCT01853176|952828|P1|STARTED|Overall Study||4
388522|NCT01853085|952834|P1|NOT COMPLETED|Overall Study||235
388523|NCT01853085|952834|P1|COMPLETED|Overall Study||1595
388524|NCT01853085|952834|P1|STARTED|Overall Study||1830
388525|NCT01853072|952847|P2|NOT COMPLETED|Overall Study||21
388526|NCT01853072|952848|P1|NOT COMPLETED|Overall Study||12
388527|NCT01853072|952847|P2|COMPLETED|Overall Study||286
388528|NCT01853072|952848|P1|COMPLETED|Overall Study||296
388529|NCT01853072|952847|P2|Full Analysis Set|Overall Study||300
388530|NCT01853072|952848|P1|Full Analysis Set|Overall Study||298
388531|NCT01853072|952847|P2|Treated (Safety Analysis Set)|Overall Study||302
388532|NCT01853072|952848|P1|Treated (Safety Analysis Set)|Overall Study||301
388533|NCT01853072|952847|P2|Randomized|Overall Study||307
388534|NCT01853072|952848|P1|Randomized|Overall Study||308
388535|NCT01853072|952847|P2|STARTED|Overall Study||307
388536|NCT01853072|952848|P1|STARTED|Overall Study||308
388537|NCT01853046|952868|P2|NOT COMPLETED|Overall Study||6
388538|NCT01853046|952869|P1|NOT COMPLETED|Overall Study||18
388539|NCT01853046|952868|P2|COMPLETED|Overall Study||0
388540|NCT01853046|952869|P1|COMPLETED|Overall Study||0
388541|NCT01853046|952868|P2|Received Treatment|Overall Study||6
388542|NCT01853046|952869|P1|Received Treatment|Overall Study||18
388543|NCT01853046|952868|P2|STARTED|Overall Study||6
388544|NCT01853046|952869|P1|STARTED|Overall Study||18
388545|NCT01852955|952923|P2|NOT COMPLETED|Overall Study||3
388546|NCT01852955|952924|P1|NOT COMPLETED|Overall Study||2
388547|NCT01852955|952923|P2|COMPLETED|Overall Study||32
388548|NCT01852955|952924|P1|COMPLETED|Overall Study||33
388549|NCT01852955|952923|P2|STARTED|Overall Study||35
388550|NCT01852955|952924|P1|STARTED|Overall Study||35
388551|NCT01852825|952937|P3|NOT COMPLETED|Overall Study||0
388552|NCT01852825|952938|P2|NOT COMPLETED|Overall Study||0
388553|NCT01852825|952939|P1|NOT COMPLETED|Overall Study||2
388554|NCT01852825|952937|P3|COMPLETED|Overall Study||3
388555|NCT01852825|952938|P2|COMPLETED|Overall Study||7
388556|NCT01852825|952939|P1|COMPLETED|Overall Study||14
388557|NCT01852825|952937|P3|STARTED|Overall Study||3
388558|NCT01852825|952938|P2|STARTED|Overall Study||7
388559|NCT01852825|952939|P1|STARTED|Overall Study||16
388560|NCT01852812|952965|P3|NOT COMPLETED|Overall Study||1
388561|NCT01852812|952966|P2|NOT COMPLETED|Overall Study||1
388562|NCT01852812|952967|P1|NOT COMPLETED|Overall Study||0
388563|NCT01852812|952965|P3|COMPLETED|Overall Study||17
388564|NCT01852812|952966|P2|COMPLETED|Overall Study||17
388565|NCT01852812|952967|P1|COMPLETED|Overall Study||51
388566|NCT01852812|952965|P3|STARTED|Overall Study||18
388567|NCT01852812|952966|P2|STARTED|Overall Study||18
388568|NCT01852812|952967|P1|STARTED|Overall Study||51
388569|NCT01852669|952989|P2|NOT COMPLETED|Overall Study||1
388570|NCT01852669|952990|P1|NOT COMPLETED|Overall Study||0
388571|NCT01852669|952989|P2|COMPLETED|Overall Study|Randomisation error. Patient has protocol violation which necessitated exclusion from analysis|68
388572|NCT01852669|952990|P1|COMPLETED|Overall Study||71
388573|NCT01852669|952989|P2|STARTED|Overall Study||69
388574|NCT01852669|952990|P1|STARTED|Overall Study||71
388575|NCT01852591|952996|P1|NOT COMPLETED|Overall Study||3
388576|NCT01852591|952996|P1|COMPLETED|Overall Study||5
388577|NCT01852591|952996|P1|STARTED|Overall Study||8
388578|NCT01852383|953003|P1|NOT COMPLETED|Overall Study||11
388579|NCT01852383|953003|P1|COMPLETED|Overall Study||19
388580|NCT01852383|953003|P1|STARTED|Overall Study||30
388581|NCT01852344|953014|P4|NOT COMPLETED|Overall Study||0
388582|NCT01852344|953015|P3|NOT COMPLETED|Overall Study||0
388583|NCT01852344|953016|P2|NOT COMPLETED|Overall Study||0
388584|NCT01852344|953017|P1|NOT COMPLETED|Overall Study||0
388585|NCT01852344|953014|P4|COMPLETED|Overall Study||27
388586|NCT01852344|953015|P3|COMPLETED|Overall Study||27
388587|NCT01852344|953016|P2|COMPLETED|Overall Study||27
388588|NCT01852344|953017|P1|COMPLETED|Overall Study||27
388589|NCT01852344|953014|P4|Actual Participation in First Assignment|Overall Study||27
388590|NCT01852344|953015|P3|Actual Participation in First Assignment|Overall Study||27
388591|NCT01852344|953016|P2|Actual Participation in First Assignment|Overall Study||27
388592|NCT01852344|953017|P1|Actual Participation in First Assignment|Overall Study||27
388593|NCT01852344|953014|P4|STARTED|Overall Study||27
388594|NCT01852344|953015|P3|STARTED|Overall Study||27
388595|NCT01852344|953016|P2|STARTED|Overall Study||27
388596|NCT01852344|953017|P1|STARTED|Overall Study||27
388597|NCT01852292|953037|P2|NOT COMPLETED|Overall Study||79
388598|NCT01852292|953038|P1|NOT COMPLETED|Overall Study||79
388599|NCT01852292|953037|P2|COMPLETED|Overall Study|Completed = participants who were ongoing and did not discontinue study treatment per protocol|0
388600|NCT01852292|953038|P1|COMPLETED|Overall Study|Completed = participants who were ongoing and did not discontinue study treatment per protocol|0
388601|NCT01852292|953037|P2|STARTED|Overall Study||79
388602|NCT01852292|953038|P1|STARTED|Overall Study||79
388603|NCT01852214|953062|P2|NOT COMPLETED|Period 2||0
388604|NCT01852214|953063|P1|NOT COMPLETED|Period 2||0
388605|NCT01852214|953062|P2|COMPLETED|Period 2||20
388606|NCT01852214|953063|P1|COMPLETED|Period 2||25
388607|NCT01852214|953062|P2|STARTED|Period 2||20
388608|NCT01852214|953063|P1|STARTED|Period 2||25
388609|NCT01852214|953062|P2|NOT COMPLETED|Washout Period||1
388610|NCT01852214|953063|P1|NOT COMPLETED|Washout Period||0
388611|NCT01852214|953062|P2|COMPLETED|Washout Period||20
388612|NCT01852214|953063|P1|COMPLETED|Washout Period||25
388613|NCT01852214|953062|P2|STARTED|Washout Period||21
388614|NCT01852214|953063|P1|STARTED|Washout Period||25
388615|NCT01852214|953062|P2|NOT COMPLETED|Period 1||3
388616|NCT01852214|953063|P1|NOT COMPLETED|Period 1||1
388617|NCT01852214|953062|P2|COMPLETED|Period 1||21
388618|NCT01852214|953063|P1|COMPLETED|Period 1||25
388619|NCT01852214|953062|P2|STARTED|Period 1||24
388620|NCT01852214|953063|P1|STARTED|Period 1||26
388621|NCT01852175|953077|P2|NOT COMPLETED|Overall Study||0
388622|NCT01852175|953078|P1|NOT COMPLETED|Overall Study||0
388623|NCT01852175|953077|P2|COMPLETED|Overall Study||55
388624|NCT01852175|953078|P1|COMPLETED|Overall Study||55
388625|NCT01852175|953077|P2|STARTED|Overall Study||55
388626|NCT01852175|953078|P1|STARTED|Overall Study||55
388627|NCT01852162|953090|P2|NOT COMPLETED|Overall Study||1
388628|NCT01852162|953091|P1|NOT COMPLETED|Overall Study||4
388629|NCT01852162|953090|P2|COMPLETED|Overall Study||16
388630|NCT01852162|953091|P1|COMPLETED|Overall Study||14
388631|NCT01852162|953090|P2|STARTED|Overall Study||17
388632|NCT01852162|953091|P1|STARTED|Overall Study||18
388633|NCT01852110|953107|P6|NOT COMPLETED|Overall Study||0
388634|NCT01852110|953108|P5|NOT COMPLETED|Overall Study||0
388635|NCT01852110|953109|P4|NOT COMPLETED|Overall Study||0
388636|NCT01852110|953110|P3|NOT COMPLETED|Overall Study||0
388637|NCT01852110|953111|P2|NOT COMPLETED|Overall Study||46
388638|NCT01852110|953112|P1|NOT COMPLETED|Overall Study||50
388639|NCT01852110|953107|P6|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
388640|NCT01852110|953108|P5|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
388641|NCT01852110|953109|P4|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
388642|NCT01852110|953110|P3|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
388643|NCT01852110|953111|P2|COMPLETED|Overall Study||74
388644|NCT01852110|953112|P1|COMPLETED|Overall Study||70
388645|NCT01852110|953107|P6|Treated|Overall Study||0
388646|NCT01852110|953108|P5|Treated|Overall Study||0
388647|NCT01852110|953109|P4|Treated|Overall Study||0
388648|NCT01852110|953110|P3|Treated|Overall Study||0
388649|NCT01852110|953111|P2|Treated|Overall Study||120
388650|NCT01852110|953112|P1|Treated|Overall Study||119
388651|NCT01852110|953107|P6|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
388652|NCT01852110|953108|P5|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
388653|NCT01852110|953109|P4|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
388654|NCT01852110|953110|P3|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
388655|NCT01852110|953111|P2|STARTED|Overall Study||120
388656|NCT01852110|953112|P1|STARTED|Overall Study||120
388657|NCT01852032|953140|P1|NOT COMPLETED|Overall Study||0
388658|NCT01852032|953140|P1|COMPLETED|Overall Study||23
388659|NCT01852032|953140|P1|STARTED|Overall Study||23
388660|NCT01852019|953150|P5|NOT COMPLETED|Day 8||0
388661|NCT01852019|953151|P4|NOT COMPLETED|Day 8||0
388662|NCT01852019|953152|P3|NOT COMPLETED|Day 8||0
388663|NCT01852019|953153|P2|NOT COMPLETED|Day 8||0
388664|NCT01852019|953154|P1|NOT COMPLETED|Day 8||0
388665|NCT01852019|953150|P5|COMPLETED|Day 8||6
388666|NCT01852019|953151|P4|COMPLETED|Day 8||6
388667|NCT01852019|953152|P3|COMPLETED|Day 8||0
388668|NCT01852019|953153|P2|COMPLETED|Day 8||0
388669|NCT01852019|953154|P1|COMPLETED|Day 8||0
388670|NCT01852019|953150|P5|STARTED|Day 8||6
388671|NCT01852019|953151|P4|STARTED|Day 8||6
388672|NCT01852019|953152|P3|STARTED|Day 8||0
388673|NCT01852019|953153|P2|STARTED|Day 8||0
388674|NCT01852019|953154|P1|STARTED|Day 8||0
388675|NCT01852019|953150|P5|NOT COMPLETED|Day 1||0
388676|NCT01852019|953151|P4|NOT COMPLETED|Day 1||0
388677|NCT01852019|953152|P3|NOT COMPLETED|Day 1||0
388678|NCT01852019|953153|P2|NOT COMPLETED|Day 1||0
388679|NCT01852019|953154|P1|NOT COMPLETED|Day 1||0
388680|NCT01852019|953150|P5|COMPLETED|Day 1||0
388681|NCT01852019|953151|P4|COMPLETED|Day 1||0
388682|NCT01852019|953152|P3|COMPLETED|Day 1||6
388683|NCT01852019|953153|P2|COMPLETED|Day 1||3
388684|NCT01852019|953154|P1|COMPLETED|Day 1||3
388685|NCT01852019|953150|P5|STARTED|Day 1||0
388686|NCT01852019|953151|P4|STARTED|Day 1||0
388687|NCT01852019|953152|P3|STARTED|Day 1||6
388688|NCT01852019|953153|P2|STARTED|Day 1||3
388689|NCT01852019|953154|P1|STARTED|Day 1||3
388690|NCT01851876|953175|P2|NOT COMPLETED|Overall Study||0
388691|NCT01851876|953176|P1|NOT COMPLETED|Overall Study||0
388692|NCT01851876|953175|P2|COMPLETED|Overall Study||62
388693|NCT01851876|953176|P1|COMPLETED|Overall Study||56
388694|NCT01851876|953175|P2|STARTED|Overall Study||62
388695|NCT01851876|953176|P1|STARTED|Overall Study||56
388696|NCT01851863|953186|P4|NOT COMPLETED|Overall Study||3
388697|NCT01851863|953187|P3|NOT COMPLETED|Overall Study||5
388698|NCT01851863|953188|P2|NOT COMPLETED|Overall Study||9
388699|NCT01851863|953189|P1|NOT COMPLETED|Overall Study||5
388700|NCT01851863|953186|P4|COMPLETED|Overall Study||63
388701|NCT01851863|953187|P3|COMPLETED|Overall Study||60
388702|NCT01851863|953188|P2|COMPLETED|Overall Study||57
388703|NCT01851863|953189|P1|COMPLETED|Overall Study||60
388704|NCT01851863|953186|P4|STARTED|Overall Study||66
388705|NCT01851863|953187|P3|STARTED|Overall Study||65
388706|NCT01851863|953188|P2|STARTED|Overall Study||66
388707|NCT01851863|953189|P1|STARTED|Overall Study||65
388708|NCT01851772|953210|P1|NOT COMPLETED|Overall Study||0
388709|NCT01851772|953210|P1|COMPLETED|Overall Study||3
388710|NCT01851772|953210|P1|STARTED|Overall Study||3
388711|NCT01851720|953218|P2|NOT COMPLETED|Overall Study||1
388712|NCT01851720|953219|P1|NOT COMPLETED|Overall Study||0
388713|NCT01851720|953218|P2|COMPLETED|Overall Study||0
388714|NCT01851720|953219|P1|COMPLETED|Overall Study||0
388715|NCT01851720|953218|P2|STARTED|Overall Study||1
388716|NCT01851720|953219|P1|STARTED|Overall Study||0
388717|NCT01851655|953227|P2|NOT COMPLETED|Overall Study||0
388718|NCT01851655|953228|P1|NOT COMPLETED|Overall Study||0
388719|NCT01851655|953227|P2|COMPLETED|Overall Study||12
388720|NCT01851655|953228|P1|COMPLETED|Overall Study||12
388721|NCT01851655|953227|P2|STARTED|Overall Study||12
388722|NCT01851655|953228|P1|STARTED|Overall Study||12
388723|NCT01851590|953249|P3|NOT COMPLETED|Overall Study||3
388724|NCT01851590|953250|P2|NOT COMPLETED|Overall Study||1
388725|NCT01851590|953251|P1|NOT COMPLETED|Overall Study||0
388726|NCT01851590|953249|P3|COMPLETED|Overall Study|All patients (25) were included in the ITT population and final outcome analyses.|22
388727|NCT01851590|953250|P2|COMPLETED|Overall Study|All patients (25) were included in the ITT population and final outcome analyses.|24
388728|NCT01851590|953251|P1|COMPLETED|Overall Study|All patients (23) were included in the ITT population and final outcome analyses.|23
388729|NCT01851590|953249|P3|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|22
388730|NCT01851590|953250|P2|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|24
388731|NCT01851590|953251|P1|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|23
388732|NCT01851590|953249|P3|At 9 Month: End of Topical Treatments|Overall Study|Washout period of the Terbinafine treatment arm continues.|22
388733|NCT01851590|953250|P2|At 9 Month: End of Topical Treatments|Overall Study|End of topical Amorolfine Lacquer treatment. Washout period of the Amorolfine treatment arm begins.|24
388734|NCT01851590|953251|P1|At 9 Month: End of Topical Treatments|Overall Study|End of topical Resin Lacquer treatment. Washout period of the Resin Lacquer treatment arm begins.|23
388735|NCT01851590|953249|P3|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|22
388736|NCT01851590|953250|P2|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|24
388737|NCT01851590|953251|P1|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|23
388738|NCT01851590|953249|P3|At 3 Month: End of Terbinafine Treatment|Overall Study|End of oral Terbinafine treatment. Washout period of the Terbinafine treatment arm begins.|22
388739|NCT01851590|953250|P2|At 3 Month: End of Terbinafine Treatment|Overall Study|Topical Amorolfine Lacquer Treatment continues ->|24
388740|NCT01851590|953251|P1|At 3 Month: End of Terbinafine Treatment|Overall Study|Topical Resin Lacquer treatment continues ->|23
388741|NCT01851590|953249|P3|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|25
388742|NCT01851590|953250|P2|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|25
388743|NCT01851590|953251|P1|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|23
388744|NCT01851330|953274|P3|NOT COMPLETED|Overall Study||12
388745|NCT01851330|953275|P2|NOT COMPLETED|Overall Study||16
388746|NCT01851330|953276|P1|NOT COMPLETED|Overall Study||13
388747|NCT01851330|953274|P3|COMPLETED|Overall Study||204
388748|NCT01851330|953275|P2|COMPLETED|Overall Study||200
388749|NCT01851330|953276|P1|COMPLETED|Overall Study||202
388750|NCT01851330|953274|P3|STARTED|Overall Study||216
388751|NCT01851330|953275|P2|STARTED|Overall Study||216
388752|NCT01851330|953276|P1|STARTED|Overall Study||215
388753|NCT01851174|953311|P1|NOT COMPLETED|Overall Study||0
388754|NCT01851174|953311|P1|COMPLETED|Overall Study||15
388755|NCT01851174|953311|P1|STARTED|Overall Study||15
388756|NCT01850615|953318|P2|NOT COMPLETED|Overall Study||5
388757|NCT01850615|953319|P1|NOT COMPLETED|Overall Study||9
388758|NCT01850615|953318|P2|COMPLETED|Overall Study||115
388759|NCT01850615|953319|P1|COMPLETED|Overall Study||107
388760|NCT01850615|953318|P2|Exposed|Overall Study||120
388761|NCT01850615|953319|P1|Exposed|Overall Study||115
388762|NCT01850615|953318|P2|STARTED|Overall Study||120
388763|NCT01850615|953319|P1|STARTED|Overall Study||116
388764|NCT01850589|953337|P2|NOT COMPLETED|Overall Study||0
388765|NCT01850589|953338|P1|NOT COMPLETED|Overall Study||8
388766|NCT01850589|953337|P2|COMPLETED|Overall Study||22
388767|NCT01850589|953338|P1|COMPLETED|Overall Study||14
388768|NCT01850589|953337|P2|STARTED|Overall Study||22
388769|NCT01850589|953338|P1|STARTED|Overall Study||22
388770|NCT01850550|953346|P2|NOT COMPLETED|Overall Study||3
388771|NCT01850550|953347|P1|NOT COMPLETED|Overall Study||0
388772|NCT01850550|953346|P2|COMPLETED|Overall Study||37
388773|NCT01850550|953347|P1|COMPLETED|Overall Study||40
388774|NCT01850550|953346|P2|STARTED|Overall Study||40
388775|NCT01850550|953347|P1|STARTED|Overall Study||40
388776|NCT01850485|953357|P2|NOT COMPLETED|Overall Study||0
388777|NCT01850485|953358|P1|NOT COMPLETED|Overall Study||0
388778|NCT01850485|953357|P2|COMPLETED|Overall Study||13
388779|NCT01850485|953358|P1|COMPLETED|Overall Study||9
388780|NCT01850485|953357|P2|STARTED|Overall Study||13
388781|NCT01850485|953358|P1|STARTED|Overall Study||9
388782|NCT01850394|953379|P3|NOT COMPLETED|Overall Study||0
388783|NCT01850394|953380|P2|NOT COMPLETED|Overall Study||0
388784|NCT01850394|953381|P1|NOT COMPLETED|Overall Study||0
388785|NCT01850394|953379|P3|COMPLETED|Overall Study||45
388786|NCT01850394|953380|P2|COMPLETED|Overall Study||45
388787|NCT01850394|953381|P1|COMPLETED|Overall Study||45
388788|NCT01850394|953379|P3|STARTED|Overall Study||45
388789|NCT01850394|953380|P2|STARTED|Overall Study||45
388790|NCT01850394|953381|P1|STARTED|Overall Study||45
388791|NCT01850030|953403|P2|NOT COMPLETED|Overall Study||369
388792|NCT01850030|953404|P1|NOT COMPLETED|Overall Study||347
388793|NCT01850030|953403|P2|COMPLETED|Overall Study||142
388794|NCT01850030|953404|P1|COMPLETED|Overall Study||173
388795|NCT01850030|953403|P2|STARTED|Overall Study||511
388796|NCT01850030|953404|P1|STARTED|Overall Study||520
388797|NCT01849848|953416|P1|NOT COMPLETED|Overall Study||4
388798|NCT01849848|953416|P1|COMPLETED|Overall Study||13
388799|NCT01849848|953416|P1|STARTED|Overall Study||17
388800|NCT01849770|953433|P3|NOT COMPLETED|Overall Study||1
388801|NCT01849770|953434|P2|NOT COMPLETED|Overall Study||4
388802|NCT01849770|953435|P1|NOT COMPLETED|Overall Study||0
388803|NCT01849770|953433|P3|COMPLETED|Overall Study||19
388804|NCT01849770|953434|P2|COMPLETED|Overall Study||15
388805|NCT01849770|953435|P1|COMPLETED|Overall Study||20
388806|NCT01849770|953433|P3|STARTED|Overall Study||20
388807|NCT01849770|953434|P2|STARTED|Overall Study||19
388808|NCT01849770|953435|P1|STARTED|Overall Study||20
388809|NCT01849692|953478|P8|NOT COMPLETED|Overall Study||0
388810|NCT01849692|953479|P7|NOT COMPLETED|Overall Study||0
388811|NCT01849692|953480|P6|NOT COMPLETED|Overall Study||0
388812|NCT01849692|953481|P5|NOT COMPLETED|Overall Study||0
388813|NCT01849692|953482|P4|NOT COMPLETED|Overall Study||0
388814|NCT01849692|953483|P3|NOT COMPLETED|Overall Study||0
388815|NCT01849692|953484|P2|NOT COMPLETED|Overall Study||0
388816|NCT01849692|953485|P1|NOT COMPLETED|Overall Study||0
388817|NCT01849692|953478|P8|COMPLETED|Overall Study||3
388818|NCT01849692|953479|P7|COMPLETED|Overall Study||10
388819|NCT01849692|953480|P6|COMPLETED|Overall Study||3
388820|NCT01849692|953481|P5|COMPLETED|Overall Study||10
388821|NCT01849692|953482|P4|COMPLETED|Overall Study||3
388822|NCT01849692|953483|P3|COMPLETED|Overall Study||10
388823|NCT01849692|953484|P2|COMPLETED|Overall Study||3
388824|NCT01849692|953485|P1|COMPLETED|Overall Study||10
388825|NCT01849692|953478|P8|STARTED|Overall Study||3
388826|NCT01849692|953479|P7|STARTED|Overall Study||10
388827|NCT01849692|953480|P6|STARTED|Overall Study||3
388828|NCT01849692|953481|P5|STARTED|Overall Study||10
388829|NCT01849692|953482|P4|STARTED|Overall Study||3
388830|NCT01849692|953483|P3|STARTED|Overall Study||10
388831|NCT01849692|953484|P2|STARTED|Overall Study||3
388832|NCT01849692|953485|P1|STARTED|Overall Study||10
388833|NCT01849588|953514|P1|NOT COMPLETED|Overall Study||3
388834|NCT01849588|953514|P1|COMPLETED|Overall Study||0
388835|NCT01849588|953514|P1|STARTED|Overall Study||3
388836|NCT01849562|953524|P3|NOT COMPLETED|Overall Study||0
388837|NCT01849562|953525|P2|NOT COMPLETED|Overall Study||0
388838|NCT01849562|953526|P1|NOT COMPLETED|Overall Study||2
388839|NCT01849562|953524|P3|COMPLETED|Overall Study||10
388840|NCT01849562|953525|P2|COMPLETED|Overall Study||10
388841|NCT01849562|953526|P1|COMPLETED|Overall Study||8
388842|NCT01849562|953524|P3|STARTED|Overall Study||10
388843|NCT01849562|953525|P2|STARTED|Overall Study||10
388844|NCT01849562|953526|P1|STARTED|Overall Study||10
388845|NCT01849497|953539|P2|NOT COMPLETED|Overall Study||4
388846|NCT01849497|953540|P1|NOT COMPLETED|Overall Study||1
388847|NCT01849497|953539|P2|COMPLETED|Overall Study||70
388848|NCT01849497|953540|P1|COMPLETED|Overall Study||74
388849|NCT01849497|953539|P2|Received Treatment|Overall Study||74
388850|NCT01849497|953540|P1|Received Treatment|Overall Study||75
388851|NCT01849497|953539|P2|STARTED|Overall Study||74
388852|NCT01849497|953540|P1|STARTED|Overall Study||75
388853|NCT01849458|953548|P1|NOT COMPLETED|Overall Study||4
388854|NCT01849458|953548|P1|COMPLETED|Overall Study||46
388855|NCT01849458|953548|P1|6 Months Follow-up|Overall Study||50
388856|NCT01849458|953548|P1|STARTED|Overall Study||50
388857|NCT01849419|953558|P1|NOT COMPLETED|Overall Study||0
388858|NCT01849419|953558|P1|COMPLETED|Overall Study||65
388859|NCT01849419|953558|P1|STARTED|Overall Study||65
388860|NCT01849289|953587|P2|NOT COMPLETED|Overall Study||24
388861|NCT01849289|953588|P1|NOT COMPLETED|Overall Study||32
388862|NCT01849289|953587|P2|COMPLETED|Overall Study||254
388863|NCT01849289|953588|P1|COMPLETED|Overall Study||523
388864|NCT01849289|953587|P2|Exposed|Overall Study||278
388865|NCT01849289|953588|P1|Exposed|Overall Study|2 subjects withdrew prior to exposure of trial products|553
388866|NCT01849289|953587|P2|STARTED|Overall Study||278
388867|NCT01849289|953588|P1|STARTED|Overall Study||555
388868|NCT01849263|953604|P1|NOT COMPLETED|Overall Study||0
388869|NCT01849263|953604|P1|COMPLETED|Overall Study||40
388870|NCT01849263|953604|P1|STARTED|Overall Study||40
388871|NCT01849068|953616|P2|NOT COMPLETED|Overall Study||0
388872|NCT01849068|953617|P1|NOT COMPLETED|Overall Study||0
388873|NCT01849068|953616|P2|COMPLETED|Overall Study||10
388874|NCT01849068|953617|P1|COMPLETED|Overall Study||10
388875|NCT01849068|953616|P2|STARTED|Overall Study||10
388876|NCT01849068|953617|P1|STARTED|Overall Study||10
388877|NCT01848990|953632|P3|NOT COMPLETED|Overall Study||11
388878|NCT01848990|953633|P2|NOT COMPLETED|Overall Study||9
388879|NCT01848990|953634|P1|NOT COMPLETED|Overall Study||33
388880|NCT01848990|953632|P3|COMPLETED|Overall Study||103
388881|NCT01848990|953633|P2|COMPLETED|Overall Study||106
388882|NCT01848990|953634|P1|COMPLETED|Overall Study||194
388883|NCT01848990|953632|P3|Received at Least 1 Dose of Study Drug|Overall Study||113
388884|NCT01848990|953633|P2|Received at Least 1 Dose of Study Drug|Overall Study||115
388885|NCT01848990|953634|P1|Received at Least 1 Dose of Study Drug|Overall Study||227
388886|NCT01848990|953632|P3|STARTED|Overall Study|One participant was randomized and withdrew consent before start of study treatment.|114
388887|NCT01848990|953633|P2|STARTED|Overall Study||115
388888|NCT01848990|953634|P1|STARTED|Overall Study||227
388889|NCT01848977|953649|P1|NOT COMPLETED|Overall Study||0
388890|NCT01848977|953649|P1|COMPLETED|Overall Study||20
388891|NCT01848977|953649|P1|STARTED|Overall Study||20
388892|NCT01848938|953660|P2|NOT COMPLETED|Overall Study||1
388893|NCT01848938|953661|P1|NOT COMPLETED|Overall Study||1
388894|NCT01848938|953660|P2|COMPLETED|Overall Study||60
388895|NCT01848938|953661|P1|COMPLETED|Overall Study||61
388896|NCT01848938|953660|P2|STARTED|Overall Study||61
388897|NCT01848938|953661|P1|STARTED|Overall Study||62
388898|NCT01848899|953679|P2|NOT COMPLETED|Overall Study||0
388899|NCT01848899|953680|P1|NOT COMPLETED|Overall Study||0
388900|NCT01848899|953679|P2|COMPLETED|Overall Study||50
388901|NCT01848899|953680|P1|COMPLETED|Overall Study||50
388902|NCT01848899|953679|P2|STARTED|Overall Study||50
388903|NCT01848899|953680|P1|STARTED|Overall Study||50
388904|NCT01848847|953696|P2|NOT COMPLETED|Overall Study||3
388905|NCT01848847|953697|P1|NOT COMPLETED|Overall Study||2
388906|NCT01848847|953696|P2|COMPLETED|Overall Study||48
388907|NCT01848847|953697|P1|COMPLETED|Overall Study||49
388908|NCT01848847|953696|P2|STARTED|Overall Study||51
388909|NCT01848847|953697|P1|STARTED|Overall Study||51
388910|NCT01848834|953710|P5|NOT COMPLETED|Overall Study||132
388911|NCT01848834|953711|P4|NOT COMPLETED|Overall Study||37
388912|NCT01848834|953712|P3|NOT COMPLETED|Overall Study||32
388913|NCT01848834|953713|P2|NOT COMPLETED|Overall Study||60
388914|NCT01848834|953714|P1|NOT COMPLETED|Overall Study||30
388915|NCT01848834|953710|P5|COMPLETED|Overall Study|Completed means two-year treatment completed|0
388916|NCT01848834|953711|P4|COMPLETED|Overall Study|Completed means two-year treatment completed|2
388917|NCT01848834|953712|P3|COMPLETED|Overall Study|Completed means two-year treatment completed|1
388918|NCT01848834|953713|P2|COMPLETED|Overall Study|Completed means two-year treatment completed|1
388919|NCT01848834|953714|P1|COMPLETED|Overall Study|Completed means two-year treatment completed|2
388920|NCT01848834|953710|P5|Treated|Overall Study||132
388921|NCT01848834|953711|P4|Treated|Overall Study||39
388922|NCT01848834|953712|P3|Treated|Overall Study||33
388923|NCT01848834|953713|P2|Treated|Overall Study||60
388924|NCT01848834|953714|P1|Treated|Overall Study||32
388925|NCT01848834|953710|P5|STARTED|Overall Study||132
388926|NCT01848834|953711|P4|STARTED|Overall Study||39
388927|NCT01848834|953712|P3|STARTED|Overall Study||33
388928|NCT01848834|953713|P2|STARTED|Overall Study||61
388929|NCT01848834|953714|P1|STARTED|Overall Study||32
388930|NCT01848756|953749|P1|NOT COMPLETED|Overall Study||3
388931|NCT01848756|953749|P1|COMPLETED|Overall Study|Cycle 1|12
388932|NCT01848756|953749|P1|STARTED|Overall Study||15
388933|NCT01848366|953759|P1|NOT COMPLETED|Overall Study||0
388934|NCT01848366|953759|P1|COMPLETED|Overall Study||8
388935|NCT01848366|953759|P1|STARTED|Overall Study||8
388936|NCT01848288|953763|P1|NOT COMPLETED|Overall Study||3
388937|NCT01848288|953763|P1|COMPLETED|Overall Study|Two subjects were discontinued prior to undergoing surgery.|97
388938|NCT01848288|953763|P1|STARTED|Overall Study||100
388939|NCT01848210|953774|P2|NOT COMPLETED|Overall Study||78
388940|NCT01848210|953775|P1|NOT COMPLETED|Overall Study||88
388941|NCT01848210|953774|P2|COMPLETED|Overall Study||340
388942|NCT01848210|953775|P1|COMPLETED|Overall Study||323
388943|NCT01848210|953774|P2|Per Protocol Population|Overall Study||245
388944|NCT01848210|953775|P1|Per Protocol Population|Overall Study||222
388945|NCT01848210|953774|P2|Intent-to-Treat (ITT) Population|Overall Study||388
388946|NCT01848210|953775|P1|Intent-to-Treat (ITT) Population|Overall Study||383
388947|NCT01848210|953774|P2|Safety Population-Received Study Drug|Overall Study||398
388948|NCT01848210|953775|P1|Safety Population-Received Study Drug|Overall Study||394
388949|NCT01848210|953774|P2|STARTED|Overall Study||418
388950|NCT01848210|953775|P1|STARTED|Overall Study||411
388951|NCT01848145|953787|P1|NOT COMPLETED|Subsequent Infusions: Weeks 3-8||10
388952|NCT01848145|953787|P1|COMPLETED|Subsequent Infusions: Weeks 3-8||20
388953|NCT01848145|953787|P1|STARTED|Subsequent Infusions: Weeks 3-8||30
388954|NCT01848145|953787|P1|NOT COMPLETED|Infusion 3: Week 2, Day 1 - 120 Minutes||1
388955|NCT01848145|953787|P1|COMPLETED|Infusion 3: Week 2, Day 1 - 120 Minutes||30
388956|NCT01848145|953787|P1|Completed Within 15min of Infusion Time|Infusion 3: Week 2, Day 1 - 120 Minutes||26
388957|NCT01848145|953787|P1|STARTED|Infusion 3: Week 2, Day 1 - 120 Minutes||31
388958|NCT01848145|953787|P1|NOT COMPLETED|Infusion 2: Week 1, Day 3 - 167 Minutes||2
388959|NCT01848145|953787|P1|COMPLETED|Infusion 2: Week 1, Day 3 - 167 Minutes|Includes participants that completed Infusion 2 and proceeded to the next infusion, Infusion 3.|31
388960|NCT01848145|953787|P1|Completed Within 15min of Infusion Time|Infusion 2: Week 1, Day 3 - 167 Minutes||24
388961|NCT01848145|953787|P1|STARTED|Infusion 2: Week 1, Day 3 - 167 Minutes||33
388962|NCT01848145|953787|P1|NOT COMPLETED|Infusion 1: Week 1, Day 1 - 226 Minutes||1
388963|NCT01848145|953787|P1|COMPLETED|Infusion 1: Week 1, Day 1 - 226 Minutes|Includes participants that completed Infusion 1 and proceeded to the next infusion, Infusion 2.|33
388964|NCT01848145|953787|P1|Completed Within 15min of Infusion Time|Infusion 1: Week 1, Day 1 - 226 Minutes|Number of patients who completed within 15 minutes (min) of infusion time.|1
388965|NCT01848145|953787|P1|STARTED|Infusion 1: Week 1, Day 1 - 226 Minutes||34
388966|NCT01848067|953796|P1|NOT COMPLETED|Overall Study||0
388967|NCT01848067|953796|P1|COMPLETED|Overall Study||9
388968|NCT01848067|953796|P1|STARTED|Overall Study||9
388969|NCT01848054|953804|P2|NOT COMPLETED|Stabilization/Maintenance||40
388970|NCT01848054|953805|P1|NOT COMPLETED|Stabilization/Maintenance||40
388971|NCT01848054|953804|P2|COMPLETED|Stabilization/Maintenance||107
388972|NCT01848054|953805|P1|COMPLETED|Stabilization/Maintenance||92
388973|NCT01848054|953804|P2|STARTED|Stabilization/Maintenance||147
388974|NCT01848054|953805|P1|STARTED|Stabilization/Maintenance||132
388975|NCT01848054|953804|P2|NOT COMPLETED|Induction Phase||8
388976|NCT01848054|953805|P1|NOT COMPLETED|Induction Phase||23
388977|NCT01848054|953804|P2|COMPLETED|Induction Phase||147
388978|NCT01848054|953805|P1|COMPLETED|Induction Phase||132
388979|NCT01848054|953804|P2|STARTED|Induction Phase||155
388980|NCT01848054|953805|P1|STARTED|Induction Phase||155
388981|NCT01847885|953827|P3|NOT COMPLETED|Randomization||2
388982|NCT01847885|953828|P2|NOT COMPLETED|Randomization||4
388983|NCT01847885|953829|P1|NOT COMPLETED|Randomization||0
388984|NCT01847885|953827|P3|COMPLETED|Randomization||13
388985|NCT01847885|953828|P2|COMPLETED|Randomization||27
388986|NCT01847885|953829|P1|COMPLETED|Randomization||0
388987|NCT01847885|953827|P3|Per Protocol Set|Randomization||13
388988|NCT01847885|953828|P2|Per Protocol Set|Randomization||27
388989|NCT01847885|953829|P1|Per Protocol Set|Randomization||0
388990|NCT01847885|953827|P3|Safety Set|Randomization||13
388991|NCT01847885|953828|P2|Safety Set|Randomization||28
388992|NCT01847885|953829|P1|Safety Set|Randomization||0
388993|NCT01847885|953827|P3|Full Analysis Set|Randomization||15
388994|NCT01847885|953828|P2|Full Analysis Set|Randomization||28
388995|NCT01847885|953829|P1|Full Analysis Set|Randomization||0
388996|NCT01847885|953827|P3|STARTED|Randomization||15
388997|NCT01847885|953828|P2|STARTED|Randomization||31
388998|NCT01847885|953829|P1|STARTED|Randomization||0
388999|NCT01847885|953827|P3|NOT COMPLETED|Initial Enrollment (Consented)||0
389000|NCT01847885|953828|P2|NOT COMPLETED|Initial Enrollment (Consented)||0
389001|NCT01847885|953829|P1|NOT COMPLETED|Initial Enrollment (Consented)||48
389002|NCT01847885|953827|P3|COMPLETED|Initial Enrollment (Consented)||0
389003|NCT01847885|953828|P2|COMPLETED|Initial Enrollment (Consented)||0
389004|NCT01847885|953829|P1|COMPLETED|Initial Enrollment (Consented)||40
389005|NCT01847885|953827|P3|Per Protocol Set|Initial Enrollment (Consented)||0
389006|NCT01847885|953828|P2|Per Protocol Set|Initial Enrollment (Consented)||0
389007|NCT01847885|953829|P1|Per Protocol Set|Initial Enrollment (Consented)||40
389008|NCT01847885|953827|P3|Safety Set|Initial Enrollment (Consented)||0
389009|NCT01847885|953828|P2|Safety Set|Initial Enrollment (Consented)||0
389010|NCT01847885|953829|P1|Safety Set|Initial Enrollment (Consented)||41
389011|NCT01847885|953827|P3|Full Analysis Set|Initial Enrollment (Consented)||0
389012|NCT01847885|953828|P2|Full Analysis Set|Initial Enrollment (Consented)||0
389013|NCT01847885|953829|P1|Full Analysis Set|Initial Enrollment (Consented)||43
389014|NCT01847885|953827|P3|Randomized|Initial Enrollment (Consented)||0
389015|NCT01847885|953828|P2|Randomized|Initial Enrollment (Consented)||0
389016|NCT01847885|953829|P1|Randomized|Initial Enrollment (Consented)||46
389017|NCT01847885|953827|P3|STARTED|Initial Enrollment (Consented)||0
389018|NCT01847885|953828|P2|STARTED|Initial Enrollment (Consented)||0
389019|NCT01847885|953829|P1|STARTED|Initial Enrollment (Consented)||88
389020|NCT01847547|953863|P2|NOT COMPLETED|Overall Study||0
389021|NCT01847547|953864|P1|NOT COMPLETED|Overall Study||0
389022|NCT01847547|953863|P2|COMPLETED|Overall Study||2991
389023|NCT01847547|953864|P1|COMPLETED|Overall Study||2991
389024|NCT01847547|953863|P2|STARTED|Overall Study||2991
389025|NCT01847547|953864|P1|STARTED|Overall Study||2991
389026|NCT01847443|953906|P4|NOT COMPLETED|Study Period 4||0
389027|NCT01847443|953907|P3|NOT COMPLETED|Study Period 4||0
389028|NCT01847443|953908|P2|NOT COMPLETED|Study Period 4||0
389029|NCT01847443|953909|P1|NOT COMPLETED|Study Period 4||0
389030|NCT01847443|953906|P4|COMPLETED|Study Period 4||21
389031|NCT01847443|953907|P3|COMPLETED|Study Period 4||21
389032|NCT01847443|953908|P2|COMPLETED|Study Period 4||19
389033|NCT01847443|953909|P1|COMPLETED|Study Period 4||16
389034|NCT01847443|953906|P4|STARTED|Study Period 4||21
389035|NCT01847443|953907|P3|STARTED|Study Period 4||21
389036|NCT01847443|953908|P2|STARTED|Study Period 4||19
389037|NCT01847443|953909|P1|STARTED|Study Period 4||16
389038|NCT01847443|953906|P4|NOT COMPLETED|Washout Period Before Study Period 4||0
389039|NCT01847443|953907|P3|NOT COMPLETED|Washout Period Before Study Period 4||0
389040|NCT01847443|953908|P2|NOT COMPLETED|Washout Period Before Study Period 4||0
389041|NCT01847443|953909|P1|NOT COMPLETED|Washout Period Before Study Period 4||2
389042|NCT01847443|953906|P4|COMPLETED|Washout Period Before Study Period 4||21
389043|NCT01847443|953907|P3|COMPLETED|Washout Period Before Study Period 4||21
389044|NCT01847443|953908|P2|COMPLETED|Washout Period Before Study Period 4||19
389045|NCT01847443|953909|P1|COMPLETED|Washout Period Before Study Period 4||16
389046|NCT01847443|953906|P4|STARTED|Washout Period Before Study Period 4||21
389047|NCT01847443|953907|P3|STARTED|Washout Period Before Study Period 4||21
389048|NCT01847443|953908|P2|STARTED|Washout Period Before Study Period 4||19
389049|NCT01847443|953909|P1|STARTED|Washout Period Before Study Period 4||18
389050|NCT01847443|953906|P4|NOT COMPLETED|Study Period 3||0
389051|NCT01847443|953907|P3|NOT COMPLETED|Study Period 3||0
389052|NCT01847443|953908|P2|NOT COMPLETED|Study Period 3||0
389053|NCT01847443|953909|P1|NOT COMPLETED|Study Period 3||0
389054|NCT01847443|953906|P4|COMPLETED|Study Period 3||21
389055|NCT01847443|953907|P3|COMPLETED|Study Period 3||21
389056|NCT01847443|953908|P2|COMPLETED|Study Period 3||19
389057|NCT01847443|953909|P1|COMPLETED|Study Period 3||18
389058|NCT01847443|953906|P4|STARTED|Study Period 3||21
389059|NCT01847443|953907|P3|STARTED|Study Period 3||21
389060|NCT01847443|953908|P2|STARTED|Study Period 3||19
389061|NCT01847443|953909|P1|STARTED|Study Period 3||18
389062|NCT01847443|953906|P4|NOT COMPLETED|Washout Period Before Study Period 3||0
389063|NCT01847443|953907|P3|NOT COMPLETED|Washout Period Before Study Period 3||0
389064|NCT01847443|953908|P2|NOT COMPLETED|Washout Period Before Study Period 3||0
389065|NCT01847443|953909|P1|NOT COMPLETED|Washout Period Before Study Period 3||1
389066|NCT01847443|953906|P4|COMPLETED|Washout Period Before Study Period 3||21
389067|NCT01847443|953907|P3|COMPLETED|Washout Period Before Study Period 3||21
389068|NCT01847443|953908|P2|COMPLETED|Washout Period Before Study Period 3||19
389069|NCT01847443|953909|P1|COMPLETED|Washout Period Before Study Period 3||18
389070|NCT01847443|953906|P4|STARTED|Washout Period Before Study Period 3||21
389071|NCT01847443|953907|P3|STARTED|Washout Period Before Study Period 3||21
389072|NCT01847443|953908|P2|STARTED|Washout Period Before Study Period 3||19
389073|NCT01847443|953909|P1|STARTED|Washout Period Before Study Period 3||19
389074|NCT01847443|953906|P4|NOT COMPLETED|Study Period 2||0
389075|NCT01847443|953907|P3|NOT COMPLETED|Study Period 2||0
389076|NCT01847443|953908|P2|NOT COMPLETED|Study Period 2||0
389077|NCT01847443|953909|P1|NOT COMPLETED|Study Period 2||0
389078|NCT01847443|953906|P4|COMPLETED|Study Period 2||21
389079|NCT01847443|953907|P3|COMPLETED|Study Period 2||21
389080|NCT01847443|953908|P2|COMPLETED|Study Period 2||19
389081|NCT01847443|953909|P1|COMPLETED|Study Period 2||19
389082|NCT01847443|953906|P4|STARTED|Study Period 2||21
389083|NCT01847443|953907|P3|STARTED|Study Period 2||21
389084|NCT01847443|953908|P2|STARTED|Study Period 2||19
389085|NCT01847443|953909|P1|STARTED|Study Period 2||19
389086|NCT01847443|953906|P4|NOT COMPLETED|Washout Period Before Study Period 2||0
389087|NCT01847443|953907|P3|NOT COMPLETED|Washout Period Before Study Period 2||0
389088|NCT01847443|953908|P2|NOT COMPLETED|Washout Period Before Study Period 2||1
389089|NCT01847443|953909|P1|NOT COMPLETED|Washout Period Before Study Period 2||2
389090|NCT01847443|953906|P4|COMPLETED|Washout Period Before Study Period 2||21
389091|NCT01847443|953907|P3|COMPLETED|Washout Period Before Study Period 2||21
389092|NCT01847443|953908|P2|COMPLETED|Washout Period Before Study Period 2||19
389093|NCT01847443|953909|P1|COMPLETED|Washout Period Before Study Period 2||19
389094|NCT01847443|953906|P4|STARTED|Washout Period Before Study Period 2||21
389095|NCT01847443|953907|P3|STARTED|Washout Period Before Study Period 2||21
389096|NCT01847443|953908|P2|STARTED|Washout Period Before Study Period 2||20
389097|NCT01847443|953909|P1|STARTED|Washout Period Before Study Period 2||21
389098|NCT01847443|953906|P4|NOT COMPLETED|Study Period 1||0
389099|NCT01847443|953907|P3|NOT COMPLETED|Study Period 1||0
389100|NCT01847443|953908|P2|NOT COMPLETED|Study Period 1||1
389101|NCT01847443|953909|P1|NOT COMPLETED|Study Period 1||0
389102|NCT01847443|953906|P4|COMPLETED|Study Period 1||21
389103|NCT01847443|953907|P3|COMPLETED|Study Period 1||21
389104|NCT01847443|953908|P2|COMPLETED|Study Period 1||20
389105|NCT01847443|953909|P1|COMPLETED|Study Period 1||21
389106|NCT01847443|953906|P4|STARTED|Study Period 1||21
389107|NCT01847443|953907|P3|STARTED|Study Period 1||21
389108|NCT01847443|953908|P2|STARTED|Study Period 1||21
389109|NCT01847443|953909|P1|STARTED|Study Period 1||21
389110|NCT01847430|953939|P1|NOT COMPLETED|Overall Study||0
389111|NCT01847430|953939|P1|COMPLETED|Overall Study||302
389112|NCT01847430|953939|P1|STARTED|Overall Study||302
389113|NCT01847196|953950|P1|NOT COMPLETED|Overall Study||0
389114|NCT01847196|953950|P1|COMPLETED|Overall Study||5
389115|NCT01847196|953950|P1|STARTED|Overall Study|Includes all subjects in which Angel Catheter placement was attempted.|5
389116|NCT01847131|953957|P2|NOT COMPLETED|Overall Study||0
389117|NCT01847131|953958|P1|NOT COMPLETED|Overall Study||0
389118|NCT01847131|953957|P2|COMPLETED|Overall Study||25
389119|NCT01847131|953958|P1|COMPLETED|Overall Study||25
389120|NCT01847131|953957|P2|STARTED|Overall Study||25
389121|NCT01847131|953958|P1|STARTED|Overall Study||25
389122|NCT01846741|953966|P1|NOT COMPLETED|Implantation to 18-Month/End of Study||0
389123|NCT01846741|953966|P1|COMPLETED|Implantation to 18-Month/End of Study||20
389124|NCT01846741|953966|P1|STARTED|Implantation to 18-Month/End of Study||20
389125|NCT01846741|953966|P1|NOT COMPLETED|Baseline Visit||2
389126|NCT01846741|953966|P1|COMPLETED|Baseline Visit||20
389127|NCT01846741|953966|P1|STARTED|Baseline Visit||22
389128|NCT01846455|954027|P5|NOT COMPLETED|Overall Study||0
389129|NCT01846455|954028|P4|NOT COMPLETED|Overall Study||0
389130|NCT01846455|954029|P3|NOT COMPLETED|Overall Study||0
389131|NCT01846455|954030|P2|NOT COMPLETED|Overall Study||0
389132|NCT01846455|954031|P1|NOT COMPLETED|Overall Study||0
389133|NCT01846455|954027|P5|COMPLETED|Overall Study||8
389134|NCT01846455|954028|P4|COMPLETED|Overall Study||10
389135|NCT01846455|954029|P3|COMPLETED|Overall Study||8
389136|NCT01846455|954030|P2|COMPLETED|Overall Study||8
389137|NCT01846455|954031|P1|COMPLETED|Overall Study||9
389138|NCT01846455|954027|P5|PK Population|Overall Study||8
389139|NCT01846455|954028|P4|PK Population|Overall Study||6
389140|NCT01846455|954029|P3|PK Population|Overall Study||6
389141|NCT01846455|954030|P2|PK Population|Overall Study||7
389142|NCT01846455|954031|P1|PK Population|Overall Study||6
389143|NCT01846455|954027|P5|STARTED|Overall Study||8
389144|NCT01846455|954028|P4|STARTED|Overall Study||10
389145|NCT01846455|954029|P3|STARTED|Overall Study||8
389146|NCT01846455|954030|P2|STARTED|Overall Study||8
389147|NCT01846455|954031|P1|STARTED|Overall Study||9
389148|NCT01846442|954092|P4|NOT COMPLETED|Overall Study||3
389149|NCT01846442|954093|P3|NOT COMPLETED|Overall Study||4
389150|NCT01846442|954094|P2|NOT COMPLETED|Overall Study||6
389151|NCT01846442|954095|P1|NOT COMPLETED|Overall Study||6
389152|NCT01846442|954092|P4|COMPLETED|Overall Study||51
389153|NCT01846442|954093|P3|COMPLETED|Overall Study||52
389154|NCT01846442|954094|P2|COMPLETED|Overall Study||48
389155|NCT01846442|954095|P1|COMPLETED|Overall Study||48
389156|NCT01846442|954092|P4|ITT Population|Overall Study||54
389157|NCT01846442|954093|P3|ITT Population|Overall Study||56
389158|NCT01846442|954094|P2|ITT Population|Overall Study||53
389159|NCT01846442|954095|P1|ITT Population|Overall Study||53
389160|NCT01846442|954092|P4|Safety Population|Overall Study||54
389161|NCT01846442|954093|P3|Safety Population|Overall Study||56
389162|NCT01846442|954094|P2|Safety Population|Overall Study||53
389163|NCT01846442|954095|P1|Safety Population|Overall Study||54
389164|NCT01846442|954092|P4|STARTED|Overall Study||54
389165|NCT01846442|954093|P3|STARTED|Overall Study||56
389166|NCT01846442|954094|P2|STARTED|Overall Study||54
389167|NCT01846442|954095|P1|STARTED|Overall Study||54
389168|NCT01846416|954136|P3|NOT COMPLETED|Overall Study||13
389169|NCT01846416|954137|P2|NOT COMPLETED|Overall Study||93
389170|NCT01846416|954138|P1|NOT COMPLETED|Overall Study||31
389171|NCT01846416|954136|P3|COMPLETED|Overall Study||0
389172|NCT01846416|954137|P2|COMPLETED|Overall Study||0
389173|NCT01846416|954138|P1|COMPLETED|Overall Study||0
389174|NCT01846416|954136|P3|STARTED|Overall Study||13
389175|NCT01846416|954137|P2|STARTED|Overall Study||93
389176|NCT01846416|954138|P1|STARTED|Overall Study||31
389177|NCT01846299|954183|P2|NOT COMPLETED|Overall Study||10
389178|NCT01846299|954184|P1|NOT COMPLETED|Overall Study||12
389179|NCT01846299|954183|P2|COMPLETED|Overall Study||50
389180|NCT01846299|954184|P1|COMPLETED|Overall Study||106
389181|NCT01846299|954183|P2|Safety Set|Overall Study||58
389182|NCT01846299|954184|P1|Safety Set|Overall Study|Two participants randomized to sham received ranibizumab at Month 1.|119
389183|NCT01846299|954183|P2|Full Analysis Set|Overall Study||60
389184|NCT01846299|954184|P1|Full Analysis Set|Overall Study|One participant did not receive study treatment prior to discontinuation.|117
389185|NCT01846299|954183|P2|STARTED|Overall Study||60
389186|NCT01846299|954184|P1|STARTED|Overall Study||118
389187|NCT01846221|954222|P2|NOT COMPLETED|Overall Study||0
389188|NCT01846221|954223|P1|NOT COMPLETED|Overall Study||3
389189|NCT01846221|954222|P2|COMPLETED|Overall Study||51
389190|NCT01846221|954223|P1|COMPLETED|Overall Study||47
389191|NCT01846221|954222|P2|STARTED|Overall Study||51
389192|NCT01846221|954223|P1|STARTED|Overall Study||50
389193|NCT01846104|954237|P1|NOT COMPLETED|Overall Study||1
389194|NCT01846104|954237|P1|COMPLETED|Overall Study||3
389195|NCT01846104|954237|P1|STARTED|Overall Study||4
389196|NCT01846039|954243|P1|NOT COMPLETED|Overall Study||2
389197|NCT01846039|954243|P1|COMPLETED|Overall Study||27
389198|NCT01846039|954243|P1|STARTED|Overall Study||29
389199|NCT01845974|954255|P2|NOT COMPLETED|Overall Study||0
389200|NCT01845974|954256|P1|NOT COMPLETED|Overall Study||1
389201|NCT01845974|954255|P2|COMPLETED|Overall Study||9
389202|NCT01845974|954256|P1|COMPLETED|Overall Study||3
389203|NCT01845974|954255|P2|STARTED|Overall Study||9
389204|NCT01845974|954256|P1|STARTED|Overall Study||4
389205|NCT01845831|954264|P5|NOT COMPLETED|Outpatient Phase||0
389206|NCT01845831|954265|P4|NOT COMPLETED|Outpatient Phase||0
389207|NCT01845831|954266|P3|NOT COMPLETED|Outpatient Phase||0
389208|NCT01845831|954267|P2|NOT COMPLETED|Outpatient Phase||0
389209|NCT01845831|954268|P1|NOT COMPLETED|Outpatient Phase||0
389210|NCT01845831|954264|P5|COMPLETED|Outpatient Phase||87
389211|NCT01845831|954265|P4|COMPLETED|Outpatient Phase||98
389212|NCT01845831|954266|P3|COMPLETED|Outpatient Phase||68
389213|NCT01845831|954267|P2|COMPLETED|Outpatient Phase||0
389214|NCT01845831|954268|P1|COMPLETED|Outpatient Phase||0
389215|NCT01845831|954264|P5|STARTED|Outpatient Phase||87
389216|NCT01845831|954265|P4|STARTED|Outpatient Phase||98
389217|NCT01845831|954266|P3|STARTED|Outpatient Phase||68
389218|NCT01845831|954267|P2|STARTED|Outpatient Phase||0
389219|NCT01845831|954268|P1|STARTED|Outpatient Phase||0
389220|NCT01845831|954264|P5|NOT COMPLETED|Inpatient Phase||0
389221|NCT01845831|954265|P4|NOT COMPLETED|Inpatient Phase||0
389222|NCT01845831|954266|P3|NOT COMPLETED|Inpatient Phase||0
389223|NCT01845831|954267|P2|NOT COMPLETED|Inpatient Phase||1
389224|NCT01845831|954268|P1|NOT COMPLETED|Inpatient Phase||1
389225|NCT01845831|954264|P5|COMPLETED|Inpatient Phase||0
389226|NCT01845831|954265|P4|COMPLETED|Inpatient Phase||0
389227|NCT01845831|954266|P3|COMPLETED|Inpatient Phase||0
389228|NCT01845831|954267|P2|COMPLETED|Inpatient Phase||138
389229|NCT01845831|954268|P1|COMPLETED|Inpatient Phase||139
389230|NCT01845831|954264|P5|STARTED|Inpatient Phase||0
389231|NCT01845831|954265|P4|STARTED|Inpatient Phase||0
389232|NCT01845831|954266|P3|STARTED|Inpatient Phase||0
389233|NCT01845831|954267|P2|STARTED|Inpatient Phase||139
389234|NCT01845831|954268|P1|STARTED|Inpatient Phase||140
389235|NCT01845792|954297|P2|NOT COMPLETED|Overall Study||0
389236|NCT01845792|954298|P1|NOT COMPLETED|Overall Study||0
389237|NCT01845792|954297|P2|COMPLETED|Overall Study||2
389238|NCT01845792|954298|P1|COMPLETED|Overall Study||5
389239|NCT01845792|954297|P2|STARTED|Overall Study||2
389240|NCT01845792|954298|P1|STARTED|Overall Study||5
389241|NCT01845636|954306|P1|NOT COMPLETED|Overall Study||4
389242|NCT01845636|954306|P1|COMPLETED|Overall Study||37
389243|NCT01845636|954306|P1|STARTED|Overall Study||41
389244|NCT01845220|954314|P2|NOT COMPLETED|Overall Study||0
389245|NCT01845220|954315|P1|NOT COMPLETED|Overall Study||0
389246|NCT01845220|954314|P2|COMPLETED|Overall Study||30
389247|NCT01845220|954315|P1|COMPLETED|Overall Study||30
389248|NCT01845220|954314|P2|STARTED|Overall Study||30
389249|NCT01845220|954315|P1|STARTED|Overall Study||30
389250|NCT01845155|954323|P2|NOT COMPLETED|Overall Study||0
389251|NCT01845155|954324|P1|NOT COMPLETED|Overall Study||1
389252|NCT01845155|954323|P2|COMPLETED|Overall Study||144
389253|NCT01845155|954324|P1|COMPLETED|Overall Study||145
389254|NCT01845155|954323|P2|STARTED|Overall Study||144
389255|NCT01845155|954324|P1|STARTED|Overall Study||146
389256|NCT01845103|954332|P1|NOT COMPLETED|Overall Study||0
389257|NCT01845103|954332|P1|COMPLETED|Overall Study||1
389258|NCT01845103|954332|P1|STARTED|Overall Study||1
389259|NCT01845077|954340|P6|NOT COMPLETED|Treatment Period 2||0
389260|NCT01845077|954341|P5|NOT COMPLETED|Treatment Period 2||0
389261|NCT01845077|954342|P4|NOT COMPLETED|Treatment Period 2||0
389262|NCT01845077|954343|P3|NOT COMPLETED|Treatment Period 2||0
389263|NCT01845077|954344|P2|NOT COMPLETED|Treatment Period 2||0
389264|NCT01845077|954345|P1|NOT COMPLETED|Treatment Period 2||0
389265|NCT01845077|954340|P6|COMPLETED|Treatment Period 2||11
389266|NCT01845077|954341|P5|COMPLETED|Treatment Period 2||11
389267|NCT01845077|954342|P4|COMPLETED|Treatment Period 2||10
389268|NCT01845077|954343|P3|COMPLETED|Treatment Period 2||11
389269|NCT01845077|954344|P2|COMPLETED|Treatment Period 2||11
389270|NCT01845077|954345|P1|COMPLETED|Treatment Period 2||11
389271|NCT01845077|954340|P6|STARTED|Treatment Period 2||11
389272|NCT01845077|954341|P5|STARTED|Treatment Period 2||11
389273|NCT01845077|954342|P4|STARTED|Treatment Period 2||10
389274|NCT01845077|954343|P3|STARTED|Treatment Period 2||11
389275|NCT01845077|954344|P2|STARTED|Treatment Period 2||11
389276|NCT01845077|954345|P1|STARTED|Treatment Period 2||11
389277|NCT01845077|954340|P6|NOT COMPLETED|Washout Period||1
389278|NCT01845077|954341|P5|NOT COMPLETED|Washout Period||1
389279|NCT01845077|954342|P4|NOT COMPLETED|Washout Period||2
389280|NCT01845077|954343|P3|NOT COMPLETED|Washout Period||1
389281|NCT01845077|954344|P2|NOT COMPLETED|Washout Period||1
389282|NCT01845077|954345|P1|NOT COMPLETED|Washout Period||1
389283|NCT01845077|954340|P6|COMPLETED|Washout Period||11
389284|NCT01845077|954341|P5|COMPLETED|Washout Period||11
389285|NCT01845077|954342|P4|COMPLETED|Washout Period||10
389286|NCT01845077|954343|P3|COMPLETED|Washout Period||11
389287|NCT01845077|954344|P2|COMPLETED|Washout Period||11
389288|NCT01845077|954345|P1|COMPLETED|Washout Period||11
389289|NCT01845077|954340|P6|STARTED|Washout Period||12
389290|NCT01845077|954341|P5|STARTED|Washout Period||12
389291|NCT01845077|954342|P4|STARTED|Washout Period||12
389292|NCT01845077|954343|P3|STARTED|Washout Period||12
389293|NCT01845077|954344|P2|STARTED|Washout Period||12
389294|NCT01845077|954345|P1|STARTED|Washout Period||12
389295|NCT01845077|954340|P6|NOT COMPLETED|Treatment Period 1||0
389296|NCT01845077|954341|P5|NOT COMPLETED|Treatment Period 1||0
389297|NCT01845077|954342|P4|NOT COMPLETED|Treatment Period 1||0
389298|NCT01845077|954343|P3|NOT COMPLETED|Treatment Period 1||0
389299|NCT01845077|954344|P2|NOT COMPLETED|Treatment Period 1||0
389300|NCT01845077|954345|P1|NOT COMPLETED|Treatment Period 1||0
389301|NCT01845077|954340|P6|COMPLETED|Treatment Period 1||12
389302|NCT01845077|954341|P5|COMPLETED|Treatment Period 1||12
389303|NCT01845077|954342|P4|COMPLETED|Treatment Period 1||12
389304|NCT01845077|954343|P3|COMPLETED|Treatment Period 1||12
389305|NCT01845077|954344|P2|COMPLETED|Treatment Period 1||12
389306|NCT01845077|954345|P1|COMPLETED|Treatment Period 1||12
389307|NCT01845077|954340|P6|STARTED|Treatment Period 1||12
389308|NCT01845077|954341|P5|STARTED|Treatment Period 1||12
389309|NCT01845077|954342|P4|STARTED|Treatment Period 1||12
389310|NCT01845077|954343|P3|STARTED|Treatment Period 1||12
389311|NCT01845077|954344|P2|STARTED|Treatment Period 1||12
389312|NCT01845077|954345|P1|STARTED|Treatment Period 1||12
389313|NCT01845025|954391|P2|NOT COMPLETED|Overall Study||77
389314|NCT01845025|954392|P1|NOT COMPLETED|Overall Study||85
389315|NCT01845025|954391|P2|COMPLETED|Overall Study||332
389316|NCT01845025|954392|P1|COMPLETED|Overall Study||326
389317|NCT01845025|954391|P2|STARTED|Overall Study||409
389318|NCT01845025|954392|P1|STARTED|Overall Study||411
389319|NCT01844895|954414|P1|NOT COMPLETED|Day 29 - Day113 - Autoinjector||6
389320|NCT01844895|954414|P1|COMPLETED|Day 29 - Day113 - Autoinjector||111
389321|NCT01844895|954414|P1|STARTED|Day 29 - Day113 - Autoinjector||117
389322|NCT01844895|954414|P1|NOT COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||3
389323|NCT01844895|954414|P1|COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||117
389324|NCT01844895|954414|P1|STARTED|Day 1 to Day 28 - Pre-filled Syringe||120
389325|NCT01844856|954432|P2|NOT COMPLETED|Overall Study||16
389326|NCT01844856|954433|P1|NOT COMPLETED|Overall Study||24
389327|NCT01844856|954432|P2|COMPLETED|Overall Study||255
389328|NCT01844856|954433|P1|COMPLETED|Overall Study||246
389329|NCT01844856|954432|P2|Received at Least 1 Dose of Study Drug|Overall Study||268
389330|NCT01844856|954433|P1|Received at Least 1 Dose of Study Drug|Overall Study||270
389331|NCT01844856|954432|P2|STARTED|Overall Study||271
389332|NCT01844856|954433|P1|STARTED|Overall Study||270
389333|NCT01844830|954445|P2|NOT COMPLETED|Overall Study||0
389334|NCT01844830|954446|P1|NOT COMPLETED|Overall Study||1
389335|NCT01844830|954445|P2|COMPLETED|Overall Study||30
389336|NCT01844830|954446|P1|COMPLETED|Overall Study||59
389337|NCT01844830|954445|P2|400 µL Dose|Overall Study||10
389338|NCT01844830|954446|P1|400 µL Dose|Overall Study||20
389339|NCT01844830|954445|P2|200 µL Dose|Overall Study||12
389340|NCT01844830|954446|P1|200 µL Dose|Overall Study||24
389341|NCT01844830|954445|P2|100 µL Dose|Overall Study||8
389342|NCT01844830|954446|P1|100 µL Dose|Overall Study||16
389343|NCT01844830|954445|P2|STARTED|Overall Study||30
389344|NCT01844830|954446|P1|STARTED|Overall Study||60
389345|NCT01844817|954476|P2|NOT COMPLETED|Treatment||63
389346|NCT01844817|954477|P1|NOT COMPLETED|Treatment||64
389347|NCT01844817|954476|P2|COMPLETED|Treatment||0
389348|NCT01844817|954477|P1|COMPLETED|Treatment||0
389349|NCT01844817|954476|P2|STARTED|Treatment||63
389350|NCT01844817|954477|P1|STARTED|Treatment||64
389351|NCT01844817|954476|P2|NOT COMPLETED|Enrolled and Randomized||3
389352|NCT01844817|954477|P1|NOT COMPLETED|Enrolled and Randomized||2
389353|NCT01844817|954476|P2|COMPLETED|Enrolled and Randomized||63
389354|NCT01844817|954477|P1|COMPLETED|Enrolled and Randomized||64
389355|NCT01844817|954476|P2|STARTED|Enrolled and Randomized||66
389356|NCT01844817|954477|P1|STARTED|Enrolled and Randomized||66
389357|NCT01844778|954490|P3|NOT COMPLETED|Overall Study||4
389358|NCT01844778|954491|P2|NOT COMPLETED|Overall Study||3
389359|NCT01844778|954492|P1|NOT COMPLETED|Overall Study||2
389360|NCT01844778|954490|P3|COMPLETED|Overall Study||14
389361|NCT01844778|954491|P2|COMPLETED|Overall Study||25
389362|NCT01844778|954492|P1|COMPLETED|Overall Study||12
389363|NCT01844778|954490|P3|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||15
389364|NCT01844778|954491|P2|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||25
389365|NCT01844778|954492|P1|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||12
389366|NCT01844778|954490|P3|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||18
389367|NCT01844778|954491|P2|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||28
389368|NCT01844778|954492|P1|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||14
389369|NCT01844778|954490|P3|STARTED|Overall Study||18
389370|NCT01844778|954491|P2|STARTED|Overall Study||28
389371|NCT01844778|954492|P1|STARTED|Overall Study||14
389372|NCT01844765|954518|P2|NOT COMPLETED|Overall Study||6
389373|NCT01844765|954519|P1|NOT COMPLETED|Overall Study||9
389374|NCT01844765|954518|P2|COMPLETED|Overall Study|Completed = patients ongoing treatment at time of data cut-off|19
389375|NCT01844765|954519|P1|COMPLETED|Overall Study|Completed = patients ongoing treatment at time of data cut-off|25
389376|NCT01844765|954518|P2|Untreated|Overall Study||0
389377|NCT01844765|954519|P1|Untreated|Overall Study|Did not receive study drug due to adverse event (AE).|1
389378|NCT01844765|954518|P2|Treated|Overall Study||25
389379|NCT01844765|954519|P1|Treated|Overall Study||33
389380|NCT01844765|954518|P2|STARTED|Overall Study||25
389381|NCT01844765|954519|P1|STARTED|Overall Study||34
389382|NCT01844700|954539|P2|NOT COMPLETED|Overall Study||1
389383|NCT01844700|954540|P1|NOT COMPLETED|Overall Study||3
389384|NCT01844700|954539|P2|COMPLETED|Overall Study||2
389385|NCT01844700|954540|P1|COMPLETED|Overall Study||1
389386|NCT01844700|954539|P2|STARTED|Overall Study||3
389387|NCT01844700|954540|P1|STARTED|Overall Study||4
389388|NCT01844687|954552|P1|NOT COMPLETED|Visit 8||0
389389|NCT01844687|954552|P1|COMPLETED|Visit 8||31
389390|NCT01844687|954552|P1|STARTED|Visit 8||31
389391|NCT01844687|954552|P1|NOT COMPLETED|Visit 7||0
389392|NCT01844687|954552|P1|COMPLETED|Visit 7||31
389393|NCT01844687|954552|P1|STARTED|Visit 7||31
389394|NCT01844687|954552|P1|NOT COMPLETED|Visit 6||0
389395|NCT01844687|954552|P1|COMPLETED|Visit 6||31
389396|NCT01844687|954552|P1|STARTED|Visit 6||31
389397|NCT01844687|954552|P1|NOT COMPLETED|Visit 5||0
389398|NCT01844687|954552|P1|COMPLETED|Visit 5||31
389399|NCT01844687|954552|P1|STARTED|Visit 5||31
389400|NCT01844687|954552|P1|NOT COMPLETED|Visit 4||4
389401|NCT01844687|954552|P1|COMPLETED|Visit 4||31
389402|NCT01844687|954552|P1|STARTED|Visit 4||35
389403|NCT01844687|954552|P1|NOT COMPLETED|Visit 3||5
389404|NCT01844687|954552|P1|COMPLETED|Visit 3||35
389405|NCT01844687|954552|P1|STARTED|Visit 3||40
389406|NCT01844687|954552|P1|NOT COMPLETED|Visit 2||2
389407|NCT01844687|954552|P1|COMPLETED|Visit 2||40
389408|NCT01844687|954552|P1|STARTED|Visit 2||42
389409|NCT01844687|954552|P1|NOT COMPLETED|Visit 1||8
389410|NCT01844687|954552|P1|COMPLETED|Visit 1||42
389411|NCT01844687|954552|P1|STARTED|Visit 1||50
389412|NCT01844531|954615|P4|NOT COMPLETED|Overall Study||0
389413|NCT01844531|954616|P3|NOT COMPLETED|Overall Study||0
389414|NCT01844531|954617|P2|NOT COMPLETED|Overall Study||1
389415|NCT01844531|954618|P1|NOT COMPLETED|Overall Study||0
389416|NCT01844531|954615|P4|COMPLETED|Overall Study||6
389417|NCT01844531|954616|P3|COMPLETED|Overall Study||6
389418|NCT01844531|954617|P2|COMPLETED|Overall Study||5
389419|NCT01844531|954618|P1|COMPLETED|Overall Study||6
389420|NCT01844531|954615|P4|STARTED|Overall Study||6
389421|NCT01844531|954616|P3|STARTED|Overall Study||6
389422|NCT01844531|954617|P2|STARTED|Overall Study||6
389423|NCT01844531|954618|P1|STARTED|Overall Study||6
389424|NCT01844518|954648|P1|NOT COMPLETED|Long-Term Extension||157
389425|NCT01844518|954648|P1|COMPLETED|Long-Term Extension|Study is on-going|0
389426|NCT01844518|954648|P1|STARTED|Long-Term Extension|7 participants completed ST but did not continue in study.|157
389427|NCT01844518|954648|P1|NOT COMPLETED|Short-Term (ST) Period||9
389428|NCT01844518|954648|P1|COMPLETED|Short-Term (ST) Period||164
389429|NCT01844518|954648|P1|STARTED|Short-Term (ST) Period||173
389430|NCT01844505|954665|P3|NOT COMPLETED|Overall Study||295
389431|NCT01844505|954666|P2|NOT COMPLETED|Overall Study||269
389432|NCT01844505|954667|P1|NOT COMPLETED|Overall Study||249
389433|NCT01844505|954665|P3|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|16
389434|NCT01844505|954666|P2|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|44
389435|NCT01844505|954667|P1|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|64
389436|NCT01844505|954665|P3|STARTED|Overall Study||311
389437|NCT01844505|954666|P2|STARTED|Overall Study||313
389438|NCT01844505|954667|P1|STARTED|Overall Study||313
389439|NCT01844479|954717|P2|NOT COMPLETED|Second Intervention up to 30 Minutes||0
389440|NCT01844479|954718|P1|NOT COMPLETED|Second Intervention up to 30 Minutes||0
389441|NCT01844479|954717|P2|COMPLETED|Second Intervention up to 30 Minutes||13
389442|NCT01844479|954718|P1|COMPLETED|Second Intervention up to 30 Minutes||14
389443|NCT01844479|954717|P2|STARTED|Second Intervention up to 30 Minutes||13
389444|NCT01844479|954718|P1|STARTED|Second Intervention up to 30 Minutes||14
389445|NCT01844479|954717|P2|NOT COMPLETED|First Intervention up to 30 Minutes||0
389446|NCT01844479|954718|P1|NOT COMPLETED|First Intervention up to 30 Minutes||0
389447|NCT01844479|954717|P2|COMPLETED|First Intervention up to 30 Minutes||13
389448|NCT01844479|954718|P1|COMPLETED|First Intervention up to 30 Minutes||14
389449|NCT01844479|954717|P2|STARTED|First Intervention up to 30 Minutes||13
389450|NCT01844479|954718|P1|STARTED|First Intervention up to 30 Minutes||14
389451|NCT01844388|954748|P2|NOT COMPLETED|Overall Study||7
389452|NCT01844388|954749|P1|NOT COMPLETED|Overall Study||8
389453|NCT01844388|954748|P2|COMPLETED|Overall Study||114
389454|NCT01844388|954749|P1|COMPLETED|Overall Study||236
389455|NCT01844388|954748|P2|STARTED|Overall Study||121
389456|NCT01844388|954749|P1|STARTED|Overall Study||244
389457|NCT01844206|954761|P2|NOT COMPLETED|Overall Study||1
389458|NCT01844206|954762|P1|NOT COMPLETED|Overall Study||0
389459|NCT01844206|954761|P2|COMPLETED|Overall Study|One patient requested that epidural catheter be removed during the first post-operative day.|2
389460|NCT01844206|954762|P1|COMPLETED|Overall Study||2
389461|NCT01844206|954761|P2|STARTED|Overall Study||3
389462|NCT01844206|954762|P1|STARTED|Overall Study||2
389463|NCT01843972|954778|P10|NOT COMPLETED|Overall Study||0
389464|NCT01843972|954779|P9|NOT COMPLETED|Overall Study||0
389465|NCT01843972|954780|P8|NOT COMPLETED|Overall Study||0
389466|NCT01843972|954781|P7|NOT COMPLETED|Overall Study||0
389467|NCT01843972|954782|P6|NOT COMPLETED|Overall Study||0
389468|NCT01843972|954783|P5|NOT COMPLETED|Overall Study||1
389469|NCT01843972|954784|P4|NOT COMPLETED|Overall Study||0
389470|NCT01843972|954785|P3|NOT COMPLETED|Overall Study||0
389471|NCT01843972|954786|P2|NOT COMPLETED|Overall Study||0
389472|NCT01843972|954787|P1|NOT COMPLETED|Overall Study||0
389473|NCT01843972|954778|P10|COMPLETED|Overall Study||12
389474|NCT01843972|954779|P9|COMPLETED|Overall Study||17
389475|NCT01843972|954780|P8|COMPLETED|Overall Study||5
389476|NCT01843972|954781|P7|COMPLETED|Overall Study||5
389477|NCT01843972|954782|P6|COMPLETED|Overall Study||6
389478|NCT01843972|954783|P5|COMPLETED|Overall Study||5
389479|NCT01843972|954784|P4|COMPLETED|Overall Study||6
389480|NCT01843972|954785|P3|COMPLETED|Overall Study||5
389481|NCT01843972|954786|P2|COMPLETED|Overall Study||6
389482|NCT01843972|954787|P1|COMPLETED|Overall Study||13
389483|NCT01843972|954778|P10|STARTED|Overall Study||12
389484|NCT01843972|954779|P9|STARTED|Overall Study||17
389485|NCT01843972|954780|P8|STARTED|Overall Study||5
389486|NCT01843972|954781|P7|STARTED|Overall Study||5
389487|NCT01843972|954782|P6|STARTED|Overall Study||6
389488|NCT01843972|954783|P5|STARTED|Overall Study||6
389489|NCT01843972|954784|P4|STARTED|Overall Study||6
389490|NCT01843972|954785|P3|STARTED|Overall Study||5
389491|NCT01843972|954786|P2|STARTED|Overall Study||6
389492|NCT01843972|954787|P1|STARTED|Overall Study||13
389493|NCT01843933|954857|P2|NOT COMPLETED|Overall Study||4
389494|NCT01843933|954858|P1|NOT COMPLETED|Overall Study||6
389495|NCT01843933|954857|P2|COMPLETED|Overall Study||103
389496|NCT01843933|954858|P1|COMPLETED|Overall Study||98
389497|NCT01843933|954857|P2|STARTED|Overall Study||107
389498|NCT01843933|954858|P1|STARTED|Overall Study||104
389499|NCT01843920|954866|P2|NOT COMPLETED|Overall Study||0
389500|NCT01843920|954867|P1|NOT COMPLETED|Overall Study||0
389501|NCT01843920|954866|P2|COMPLETED|Overall Study||9
389502|NCT01843920|954867|P1|COMPLETED|Overall Study||12
389503|NCT01843920|954866|P2|STARTED|Overall Study||9
389504|NCT01843920|954867|P1|STARTED|Overall Study||12
389505|NCT01843777|954877|P2|NOT COMPLETED|Overall Study||0
389506|NCT01843777|954878|P1|NOT COMPLETED|Overall Study||1
389507|NCT01843777|954877|P2|COMPLETED|Overall Study|Number of subjects who received the treatment that completed collection of outcome measures|10
389508|NCT01843777|954878|P1|COMPLETED|Overall Study|Final number of standard-of-care participants.|10
389509|NCT01843777|954877|P2|Per Protocol Population|Overall Study|A subject was randomized to treatment but received standard of care and is not in the analyses.|9
389510|NCT01843777|954878|P1|Per Protocol Population|Overall Study||11
389511|NCT01843777|954877|P2|STARTED|Overall Study|Number of participants randomized to treatment.|10
389512|NCT01843777|954878|P1|STARTED|Overall Study|Number of participants randomized to standard-of-care.|11
389513|NCT01843673|954886|P1|NOT COMPLETED|Overall Study||6
389514|NCT01843673|954886|P1|COMPLETED|Overall Study||10
389515|NCT01843673|954886|P1|STARTED|Overall Study||16
389516|NCT01843660|954898|P1|NOT COMPLETED|Overall Study||30
389517|NCT01843660|954898|P1|COMPLETED|Overall Study||1029
389518|NCT01843660|954898|P1|STARTED|Overall Study||1059
389519|NCT01843465|954916|P1|NOT COMPLETED|Overall Study||0
389520|NCT01843465|954916|P1|COMPLETED|Overall Study||34
389521|NCT01843465|954916|P1|STARTED|Overall Study|This study had no follow-up. It focused in the acute setting of cryoballoon ablation.|34
389522|NCT01843374|954922|P2|NOT COMPLETED|Overall Study||321
389523|NCT01843374|954923|P1|NOT COMPLETED|Overall Study||164
389524|NCT01843374|954922|P2|COMPLETED|Overall Study||61
389525|NCT01843374|954923|P1|COMPLETED|Overall Study||25
389526|NCT01843374|954922|P2|RANDOMIZED|Overall Study||382
389527|NCT01843374|954923|P1|RANDOMIZED|Overall Study||189
389528|NCT01843374|954922|P2|STARTED|Overall Study||382
389529|NCT01843374|954923|P1|STARTED|Overall Study||189
389530|NCT01843348|954950|P3|NOT COMPLETED|Overall Study||41
389531|NCT01843348|954951|P2|NOT COMPLETED|Overall Study||40
389532|NCT01843348|954952|P1|NOT COMPLETED|Overall Study||23
389533|NCT01843348|954950|P3|COMPLETED|Overall Study||158
389534|NCT01843348|954951|P2|COMPLETED|Overall Study||168
389535|NCT01843348|954952|P1|COMPLETED|Overall Study||182
389536|NCT01843348|954950|P3|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|80
389537|NCT01843348|954951|P2|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|111
389538|NCT01843348|954952|P1|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|147
389539|NCT01843348|954950|P3|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|199
389540|NCT01843348|954951|P2|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|208
389541|NCT01843348|954952|P1|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|205
389542|NCT01843348|954950|P3|Safety Analysis Set (SAS)|Overall Study|One participant received TAC + Certican in error - analyzed with TAC + Certican arm|198
389543|NCT01843348|954951|P2|Safety Analysis Set (SAS)|Overall Study|Two participants received TAC + Certican in other arms in errorr - analyzed with TAC + Certican arm|210
389544|NCT01843348|954952|P1|Safety Analysis Set (SAS)|Overall Study|One participant received TAC + Certican in error - analyzed with TAC + Certican arm|204
389545|NCT01843348|954950|P3|STARTED|Overall Study||199
389546|NCT01843348|954951|P2|STARTED|Overall Study||208
389547|NCT01843348|954952|P1|STARTED|Overall Study||205
389548|NCT01843205|954992|P2|NOT COMPLETED|Second Treatment (11 Days)||0
389549|NCT01843205|954993|P1|NOT COMPLETED|Second Treatment (11 Days)||0
389550|NCT01843205|954992|P2|COMPLETED|Second Treatment (11 Days)||4
389551|NCT01843205|954993|P1|COMPLETED|Second Treatment (11 Days)||4
389552|NCT01843205|954992|P2|STARTED|Second Treatment (11 Days)||4
389553|NCT01843205|954993|P1|STARTED|Second Treatment (11 Days)||4
389554|NCT01843205|954992|P2|NOT COMPLETED|First Treatment (11 Days)||0
389555|NCT01843205|954993|P1|NOT COMPLETED|First Treatment (11 Days)||1
389556|NCT01843205|954992|P2|COMPLETED|First Treatment (11 Days)|4 completing subjects switched to placebo for Condition 2.|4
389557|NCT01843205|954993|P1|COMPLETED|First Treatment (11 Days)|4 completing subjects switched to buspirone for Condition 2.|4
389558|NCT01843205|954992|P2|STARTED|First Treatment (11 Days)||4
389559|NCT01843205|954993|P1|STARTED|First Treatment (11 Days)||5
389560|NCT01843192|955054|P3|NOT COMPLETED|Overall Study||2
389561|NCT01843192|955055|P2|NOT COMPLETED|Overall Study||6
389562|NCT01843192|955056|P1|NOT COMPLETED|Overall Study||2
389563|NCT01843192|955054|P3|COMPLETED|Overall Study||9
389564|NCT01843192|955055|P2|COMPLETED|Overall Study||28
389565|NCT01843192|955056|P1|COMPLETED|Overall Study||24
389566|NCT01843192|955054|P3|STARTED|Overall Study||11
389567|NCT01843192|955055|P2|STARTED|Overall Study||34
389568|NCT01843192|955056|P1|STARTED|Overall Study||26
389569|NCT01842958|955087|P2|NOT COMPLETED|Overall Study||1
389570|NCT01842958|955088|P1|NOT COMPLETED|Overall Study||1
389571|NCT01842958|955087|P2|COMPLETED|Overall Study||24
389572|NCT01842958|955088|P1|COMPLETED|Overall Study||24
389573|NCT01842958|955087|P2|Randomized|Overall Study||25
389574|NCT01842958|955088|P1|Randomized|Overall Study|One subject was randomized to 3.3 mm implant, but received the 4.1 mm implant.|25
389575|NCT01842958|955087|P2|STARTED|Overall Study||25
389576|NCT01842958|955088|P1|STARTED|Overall Study||25
389577|NCT01842906|955108|P2|NOT COMPLETED|Overall Study||0
389578|NCT01842906|955109|P1|NOT COMPLETED|Overall Study||0
389579|NCT01842906|955108|P2|COMPLETED|Overall Study||104
389580|NCT01842906|955109|P1|COMPLETED|Overall Study||115
389581|NCT01842906|955108|P2|STARTED|Overall Study||104
389582|NCT01842906|955109|P1|STARTED|Overall Study||115
389583|NCT01842841|955121|P1|NOT COMPLETED|Overall Study||0
389584|NCT01842841|955121|P1|COMPLETED|Overall Study||5
389585|NCT01842841|955121|P1|STARTED|Overall Study||5
389586|NCT01842789|955142|P2|NOT COMPLETED|Overall Study||0
389587|NCT01842789|955143|P1|NOT COMPLETED|Overall Study||0
389588|NCT01842789|955142|P2|COMPLETED|Overall Study||8
389589|NCT01842789|955143|P1|COMPLETED|Overall Study||10
389590|NCT01842789|955142|P2|STARTED|Overall Study||8
389591|NCT01842789|955143|P1|STARTED|Overall Study||10
389592|NCT01842646|955152|P1|NOT COMPLETED|Overall Study||0
389593|NCT01842646|955152|P1|COMPLETED|Overall Study||35
389594|NCT01842646|955152|P1|STARTED|Overall Study||35
389595|NCT01842633|955161|P3|NOT COMPLETED|Overall Study||0
389596|NCT01842633|955162|P2|NOT COMPLETED|Overall Study||2
389597|NCT01842633|955163|P1|NOT COMPLETED|Overall Study||3
389598|NCT01842633|955161|P3|COMPLETED|Overall Study||34
389599|NCT01842633|955162|P2|COMPLETED|Overall Study||64
389600|NCT01842633|955163|P1|COMPLETED|Overall Study||62
389601|NCT01842633|955161|P3|STARTED|Overall Study||34
389602|NCT01842633|955162|P2|STARTED|Overall Study||66
389603|NCT01842633|955163|P1|STARTED|Overall Study||65
389604|NCT01842620|955210|P2|NOT COMPLETED|Period 2||0
389605|NCT01842620|955211|P1|NOT COMPLETED|Period 2||0
389606|NCT01842620|955210|P2|COMPLETED|Period 2||12
389607|NCT01842620|955211|P1|COMPLETED|Period 2||12
389608|NCT01842620|955210|P2|STARTED|Period 2||12
389609|NCT01842620|955211|P1|STARTED|Period 2||12
389610|NCT01842620|955210|P2|NOT COMPLETED|Washout Period||0
389611|NCT01842620|955211|P1|NOT COMPLETED|Washout Period||0
389612|NCT01842620|955210|P2|COMPLETED|Washout Period||12
389613|NCT01842620|955211|P1|COMPLETED|Washout Period||12
389614|NCT01842620|955210|P2|STARTED|Washout Period||12
389615|NCT01842620|955211|P1|STARTED|Washout Period||12
389616|NCT01842620|955210|P2|NOT COMPLETED|Period 1||0
389617|NCT01842620|955211|P1|NOT COMPLETED|Period 1||1
389618|NCT01842620|955210|P2|COMPLETED|Period 1||12
389619|NCT01842620|955211|P1|COMPLETED|Period 1||12
389620|NCT01842620|955210|P2|STARTED|Period 1||12
389621|NCT01842620|955211|P1|STARTED|Period 1||13
389622|NCT01842607|955227|P1|NOT COMPLETED|Overall Study||66
389623|NCT01842607|955227|P1|COMPLETED|Overall Study||585
389624|NCT01842607|955227|P1|STARTED|Overall Study||651
389625|NCT01842594|955246|P1|NOT COMPLETED|Overall Study||3
389626|NCT01842594|955246|P1|COMPLETED|Overall Study||10
389627|NCT01842594|955246|P1|STARTED|Overall Study||13
389628|NCT01842464|955251|P1|NOT COMPLETED|Overall Study||0
389629|NCT01842464|955251|P1|COMPLETED|Overall Study||44
389630|NCT01842464|955251|P1|STARTED|Overall Study||44
389631|NCT01842438|955259|P2|NOT COMPLETED|T2: 6month Follow-up||4
389632|NCT01842438|955260|P1|NOT COMPLETED|T2: 6month Follow-up||4
389633|NCT01842438|955259|P2|COMPLETED|T2: 6month Follow-up||32
389634|NCT01842438|955260|P1|COMPLETED|T2: 6month Follow-up||32
389635|NCT01842438|955259|P2|STARTED|T2: 6month Follow-up||36
389636|NCT01842438|955260|P1|STARTED|T2: 6month Follow-up||36
389637|NCT01842438|955259|P2|NOT COMPLETED|T1: Immediately After the Intervention||8
389638|NCT01842438|955260|P1|NOT COMPLETED|T1: Immediately After the Intervention||6
389639|NCT01842438|955259|P2|COMPLETED|T1: Immediately After the Intervention||36
389640|NCT01842438|955260|P1|COMPLETED|T1: Immediately After the Intervention||36
389641|NCT01842438|955259|P2|STARTED|T1: Immediately After the Intervention||44
389642|NCT01842438|955260|P1|STARTED|T1: Immediately After the Intervention||42
389643|NCT01841970|955272|P1|NOT COMPLETED|Overall Study||11
389644|NCT01841970|955272|P1|COMPLETED|Overall Study||9
389645|NCT01841970|955272|P1|STARTED|Overall Study||20
389646|NCT01841931|955288|P1|NOT COMPLETED|Overall Study||4
389647|NCT01841931|955288|P1|COMPLETED|Overall Study|As the PI left the institution the study was terminated|0
389648|NCT01841931|955288|P1|STARTED|Overall Study||4
389649|NCT01841697|955298|P2|NOT COMPLETED|Overall Study||18
389650|NCT01841697|955299|P1|NOT COMPLETED|Overall Study||20
389651|NCT01841697|955298|P2|COMPLETED|Overall Study||302
389652|NCT01841697|955299|P1|COMPLETED|Overall Study||302
389653|NCT01841697|955298|P2|STARTED|Overall Study||320
389654|NCT01841697|955299|P1|STARTED|Overall Study||322
389655|NCT01841619|955315|P1|NOT COMPLETED|Overall Study||0
389656|NCT01841619|955315|P1|COMPLETED|Overall Study||16
389657|NCT01841619|955315|P1|STARTED|Overall Study||16
389658|NCT01841606|955325|P2|NOT COMPLETED|Overall Study||0
389659|NCT01841606|955326|P1|NOT COMPLETED|Overall Study||0
389660|NCT01841606|955325|P2|COMPLETED|Overall Study||27
389661|NCT01841606|955326|P1|COMPLETED|Overall Study||25
389662|NCT01841606|955325|P2|STARTED|Overall Study||27
389663|NCT01841606|955326|P1|STARTED|Overall Study||25
389664|NCT01841593|955334|P2|NOT COMPLETED|Third Intervention (Days 15 to 21)||0
389665|NCT01841593|955335|P1|NOT COMPLETED|Third Intervention (Days 15 to 21)||0
389666|NCT01841593|955334|P2|COMPLETED|Third Intervention (Days 15 to 21)||6
389667|NCT01841593|955335|P1|COMPLETED|Third Intervention (Days 15 to 21)||11
389668|NCT01841593|955334|P2|STARTED|Third Intervention (Days 15 to 21)||6
389669|NCT01841593|955335|P1|STARTED|Third Intervention (Days 15 to 21)||11
389670|NCT01841593|955334|P2|NOT COMPLETED|Second Intervention (Days 8 to 14)||0
389671|NCT01841593|955335|P1|NOT COMPLETED|Second Intervention (Days 8 to 14)||1
389672|NCT01841593|955334|P2|COMPLETED|Second Intervention (Days 8 to 14)||6
389673|NCT01841593|955335|P1|COMPLETED|Second Intervention (Days 8 to 14)||11
389674|NCT01841593|955334|P2|STARTED|Second Intervention (Days 8 to 14)||6
389675|NCT01841593|955335|P1|STARTED|Second Intervention (Days 8 to 14)||12
389676|NCT01841593|955334|P2|NOT COMPLETED|First Intervention (Days 1 to 7)||1
389677|NCT01841593|955335|P1|NOT COMPLETED|First Intervention (Days 1 to 7)||0
389678|NCT01841593|955334|P2|COMPLETED|First Intervention (Days 1 to 7)||6
389679|NCT01841593|955335|P1|COMPLETED|First Intervention (Days 1 to 7)||12
389680|NCT01841593|955334|P2|STARTED|First Intervention (Days 1 to 7)||7
389681|NCT01841593|955335|P1|STARTED|First Intervention (Days 1 to 7)||12
389682|NCT01841567|955351|P1|NOT COMPLETED|Overall Study||3
389683|NCT01841567|955351|P1|COMPLETED|Overall Study||57
389684|NCT01841567|955351|P1|STARTED|Overall Study||60
389685|NCT01841216|955358|P2|NOT COMPLETED|Overall Study||0
389686|NCT01841216|955359|P1|NOT COMPLETED|Overall Study||0
389687|NCT01841216|955358|P2|COMPLETED|Overall Study||15
389688|NCT01841216|955359|P1|COMPLETED|Overall Study||15
389689|NCT01841216|955358|P2|STARTED|Overall Study||15
389690|NCT01841216|955359|P1|STARTED|Overall Study||15
389691|NCT01841021|955367|P1|NOT COMPLETED|Overall Study||0
389692|NCT01841021|955367|P1|COMPLETED|Overall Study||1
389693|NCT01841021|955367|P1|STARTED|Overall Study||1
389694|NCT01840943|955379|P2|NOT COMPLETED|Overall Study||12
389695|NCT01840943|955380|P1|NOT COMPLETED|Overall Study||13
389696|NCT01840943|955379|P2|COMPLETED|Overall Study||0
389697|NCT01840943|955380|P1|COMPLETED|Overall Study||1
389698|NCT01840943|955379|P2|STARTED|Overall Study||12
389699|NCT01840943|955380|P1|STARTED|Overall Study||14
389700|NCT01840605|955416|P2|NOT COMPLETED|Overall Study||2
389701|NCT01840605|955417|P1|NOT COMPLETED|Overall Study||2
389702|NCT01840605|955416|P2|COMPLETED|Overall Study||150
389703|NCT01840605|955417|P1|COMPLETED|Overall Study||149
389704|NCT01840605|955416|P2|STARTED|Overall Study||152
389705|NCT01840605|955417|P1|STARTED|Overall Study||151
389706|NCT01840410|955431|P2|NOT COMPLETED|Overall Study||4
389707|NCT01840410|955432|P1|NOT COMPLETED|Overall Study||7
389708|NCT01840410|955431|P2|COMPLETED|Overall Study||55
389709|NCT01840410|955432|P1|COMPLETED|Overall Study||112
389710|NCT01840410|955431|P2|Full Analysis Set|Overall Study||59
389711|NCT01840410|955432|P1|Full Analysis Set|Overall Study||119
389712|NCT01840410|955431|P2|Safety Set|Overall Study|52 received ranibizumab at or after Month 2;7 did not receive ranibizumab any time during the study|59
389713|NCT01840410|955432|P1|Safety Set|Overall Study||119
389714|NCT01840410|955431|P2|STARTED|Overall Study||59
389715|NCT01840410|955432|P1|STARTED|Overall Study||119
389716|NCT01840345|955468|P1|NOT COMPLETED|Overall Study||1
389717|NCT01840345|955468|P1|COMPLETED|Overall Study||10
389718|NCT01840345|955468|P1|STARTED|Overall Study||11
389719|NCT01840319|955475|P1|NOT COMPLETED|Overall Study||0
389720|NCT01840319|955475|P1|COMPLETED|Overall Study||156
389721|NCT01840319|955475|P1|STARTED|Overall Study||156
389722|NCT01840072|955481|P2|NOT COMPLETED|Overall Study||47
389723|NCT01840072|955482|P1|NOT COMPLETED|Overall Study||7
389724|NCT01840072|955481|P2|COMPLETED|Overall Study||1986
389725|NCT01840072|955482|P1|COMPLETED|Overall Study||2031
389726|NCT01840072|955481|P2|STARTED|Overall Study||2033
389727|NCT01840072|955482|P1|STARTED|Overall Study||2038
389728|NCT01839708|955506|P2|NOT COMPLETED|Overall Study||67
389729|NCT01839708|955507|P1|NOT COMPLETED|Overall Study||76
389730|NCT01839708|955506|P2|COMPLETED|Overall Study||115
389731|NCT01839708|955507|P1|COMPLETED|Overall Study||311
389732|NCT01839708|955506|P2|STARTED|Overall Study||182
389733|NCT01839708|955507|P1|STARTED|Overall Study||387
389734|NCT01839695|955539|P1|NOT COMPLETED|Overall Study||0
389735|NCT01839695|955539|P1|COMPLETED|Overall Study||9
389736|NCT01839695|955539|P1|STARTED|Overall Study||9
389737|NCT01839604|955549|P5|NOT COMPLETED|Overall Study||0
389738|NCT01839604|955550|P4|NOT COMPLETED|Overall Study||0
389739|NCT01839604|955551|P3|NOT COMPLETED|Overall Study||0
389740|NCT01839604|955552|P2|NOT COMPLETED|Overall Study||0
389741|NCT01839604|955553|P1|NOT COMPLETED|Overall Study||0
389742|NCT01839604|955549|P5|COMPLETED|Overall Study||15
389743|NCT01839604|955550|P4|COMPLETED|Overall Study||5
389744|NCT01839604|955551|P3|COMPLETED|Overall Study||7
389745|NCT01839604|955552|P2|COMPLETED|Overall Study||6
389746|NCT01839604|955553|P1|COMPLETED|Overall Study||6
389747|NCT01839604|955549|P5|STARTED|Overall Study||15
389748|NCT01839604|955550|P4|STARTED|Overall Study||5
389749|NCT01839604|955551|P3|STARTED|Overall Study||7
389750|NCT01839604|955552|P2|STARTED|Overall Study||6
389751|NCT01839604|955553|P1|STARTED|Overall Study||6
389752|NCT01839318|955580|P6|NOT COMPLETED|Period 3, Third Day of Wear||0
389753|NCT01839318|955581|P5|NOT COMPLETED|Period 3, Third Day of Wear||0
389754|NCT01839318|955582|P4|NOT COMPLETED|Period 3, Third Day of Wear||0
389755|NCT01839318|955583|P3|NOT COMPLETED|Period 3, Third Day of Wear||0
389756|NCT01839318|955584|P2|NOT COMPLETED|Period 3, Third Day of Wear||0
389757|NCT01839318|955585|P1|NOT COMPLETED|Period 3, Third Day of Wear||0
389758|NCT01839318|955580|P6|COMPLETED|Period 3, Third Day of Wear||2
389759|NCT01839318|955581|P5|COMPLETED|Period 3, Third Day of Wear||7
389760|NCT01839318|955582|P4|COMPLETED|Period 3, Third Day of Wear||6
389761|NCT01839318|955583|P3|COMPLETED|Period 3, Third Day of Wear||5
389762|NCT01839318|955584|P2|COMPLETED|Period 3, Third Day of Wear||4
389763|NCT01839318|955585|P1|COMPLETED|Period 3, Third Day of Wear||4
389764|NCT01839318|955580|P6|STARTED|Period 3, Third Day of Wear||2
389765|NCT01839318|955581|P5|STARTED|Period 3, Third Day of Wear||7
389766|NCT01839318|955582|P4|STARTED|Period 3, Third Day of Wear||6
389767|NCT01839318|955583|P3|STARTED|Period 3, Third Day of Wear||5
389768|NCT01839318|955584|P2|STARTED|Period 3, Third Day of Wear||4
389769|NCT01839318|955585|P1|STARTED|Period 3, Third Day of Wear||4
389770|NCT01839318|955580|P6|NOT COMPLETED|Period 2, Second Day of Wear||0
389771|NCT01839318|955581|P5|NOT COMPLETED|Period 2, Second Day of Wear||0
389772|NCT01839318|955582|P4|NOT COMPLETED|Period 2, Second Day of Wear||0
389773|NCT01839318|955583|P3|NOT COMPLETED|Period 2, Second Day of Wear||0
389774|NCT01839318|955584|P2|NOT COMPLETED|Period 2, Second Day of Wear||0
389775|NCT01839318|955585|P1|NOT COMPLETED|Period 2, Second Day of Wear||0
389776|NCT01839318|955580|P6|COMPLETED|Period 2, Second Day of Wear||2
389777|NCT01839318|955581|P5|COMPLETED|Period 2, Second Day of Wear||7
389778|NCT01839318|955582|P4|COMPLETED|Period 2, Second Day of Wear||6
389779|NCT01839318|955583|P3|COMPLETED|Period 2, Second Day of Wear||5
389780|NCT01839318|955584|P2|COMPLETED|Period 2, Second Day of Wear||4
389781|NCT01839318|955585|P1|COMPLETED|Period 2, Second Day of Wear||4
389782|NCT01839318|955580|P6|STARTED|Period 2, Second Day of Wear||2
389783|NCT01839318|955581|P5|STARTED|Period 2, Second Day of Wear||7
389784|NCT01839318|955582|P4|STARTED|Period 2, Second Day of Wear||6
389785|NCT01839318|955583|P3|STARTED|Period 2, Second Day of Wear||5
389786|NCT01839318|955584|P2|STARTED|Period 2, Second Day of Wear||4
389787|NCT01839318|955585|P1|STARTED|Period 2, Second Day of Wear||4
389788|NCT01839318|955580|P6|NOT COMPLETED|Period 1, First Day of Wear||0
389789|NCT01839318|955581|P5|NOT COMPLETED|Period 1, First Day of Wear||0
389790|NCT01839318|955582|P4|NOT COMPLETED|Period 1, First Day of Wear||0
389791|NCT01839318|955583|P3|NOT COMPLETED|Period 1, First Day of Wear||0
389792|NCT01839318|955584|P2|NOT COMPLETED|Period 1, First Day of Wear||0
389793|NCT01839318|955585|P1|NOT COMPLETED|Period 1, First Day of Wear||0
389794|NCT01839318|955580|P6|COMPLETED|Period 1, First Day of Wear||2
389795|NCT01839318|955581|P5|COMPLETED|Period 1, First Day of Wear||7
389796|NCT01839318|955582|P4|COMPLETED|Period 1, First Day of Wear||6
389797|NCT01839318|955583|P3|COMPLETED|Period 1, First Day of Wear||5
389798|NCT01839318|955584|P2|COMPLETED|Period 1, First Day of Wear||4
389799|NCT01839318|955585|P1|COMPLETED|Period 1, First Day of Wear||4
389800|NCT01839318|955580|P6|STARTED|Period 1, First Day of Wear||2
389801|NCT01839318|955581|P5|STARTED|Period 1, First Day of Wear||7
389802|NCT01839318|955582|P4|STARTED|Period 1, First Day of Wear||6
389803|NCT01839318|955583|P3|STARTED|Period 1, First Day of Wear||5
389804|NCT01839318|955584|P2|STARTED|Period 1, First Day of Wear||4
389805|NCT01839318|955585|P1|STARTED|Period 1, First Day of Wear||4
389806|NCT01839279|955599|P3|NOT COMPLETED|Overall Study||2
389807|NCT01839279|955600|P2|NOT COMPLETED|Overall Study||2
389808|NCT01839279|955601|P1|NOT COMPLETED|Overall Study||13
389809|NCT01839279|955599|P3|COMPLETED|Overall Study||30
389810|NCT01839279|955600|P2|COMPLETED|Overall Study||30
389811|NCT01839279|955601|P1|COMPLETED|Overall Study||59
389812|NCT01839279|955599|P3|PK/QTc Analysis Set|Overall Study||0
389813|NCT01839279|955600|P2|PK/QTc Analysis Set|Overall Study||0
389814|NCT01839279|955601|P1|PK/QTc Analysis Set|Overall Study||70
389815|NCT01839279|955599|P3|Moxifloxacin/Placebo Analysis Set|Overall Study||30
389816|NCT01839279|955600|P2|Moxifloxacin/Placebo Analysis Set|Overall Study||31
389817|NCT01839279|955601|P1|Moxifloxacin/Placebo Analysis Set|Overall Study||0
389818|NCT01839279|955599|P3|PK Analysis Set|Overall Study||0
389819|NCT01839279|955600|P2|PK Analysis Set|Overall Study||0
389820|NCT01839279|955601|P1|PK Analysis Set|Overall Study||70
389821|NCT01839279|955599|P3|QT/QTc Analysis Set|Overall Study||32
389822|NCT01839279|955600|P2|QT/QTc Analysis Set|Overall Study||32
389823|NCT01839279|955601|P1|QT/QTc Analysis Set|Overall Study||72
389824|NCT01839279|955599|P3|STARTED|Overall Study||32
389825|NCT01839279|955600|P2|STARTED|Overall Study||32
389826|NCT01839279|955601|P1|STARTED|Overall Study||72
389827|NCT01839058|955622|P2|NOT COMPLETED|Overall Study||3
389828|NCT01839058|955623|P1|NOT COMPLETED|Overall Study||4
389829|NCT01839058|955622|P2|COMPLETED|Overall Study||16
389830|NCT01839058|955623|P1|COMPLETED|Overall Study||17
389831|NCT01839058|955622|P2|STARTED|Overall Study||19
389832|NCT01839058|955623|P1|STARTED|Overall Study||21
389833|NCT01838980|955629|P1|NOT COMPLETED|Overall Study||0
389834|NCT01838980|955629|P1|COMPLETED|Overall Study||15
389835|NCT01838980|955629|P1|STARTED|Overall Study||15
389836|NCT01838941|955633|P1|NOT COMPLETED|Overall Study||2
389837|NCT01838941|955633|P1|COMPLETED|Overall Study||10
389838|NCT01838941|955633|P1|STARTED|Overall Study||12
389839|NCT01838785|955638|P1|NOT COMPLETED|Overall Study||0
389840|NCT01838785|955638|P1|COMPLETED|Overall Study||25
389841|NCT01838785|955638|P1|STARTED|Overall Study||25
389842|NCT01838694|955645|P2|NOT COMPLETED|Overall Study||1
389843|NCT01838694|955646|P1|NOT COMPLETED|Overall Study||0
389844|NCT01838694|955645|P2|COMPLETED|Overall Study||21
389845|NCT01838694|955646|P1|COMPLETED|Overall Study||8
389846|NCT01838694|955645|P2|STARTED|Overall Study||22
389847|NCT01838694|955646|P1|STARTED|Overall Study||8
389848|NCT01838681|955655|P4|NOT COMPLETED|Period B/A+||117
389849|NCT01838681|955656|P3|NOT COMPLETED|Period B/A+||95
389850|NCT01838681|955657|P2|NOT COMPLETED|Period B/A+||62
389851|NCT01838681|955658|P1|NOT COMPLETED|Period B/A+||0
389852|NCT01838681|955655|P4|COMPLETED|Period B/A+||653
389853|NCT01838681|955656|P3|COMPLETED|Period B/A+||349
389854|NCT01838681|955657|P2|COMPLETED|Period B/A+||380
389855|NCT01838681|955658|P1|COMPLETED|Period B/A+||0
389856|NCT01838681|955655|P4|STARTED|Period B/A+||770
389857|NCT01838681|955656|P3|STARTED|Period B/A+||444
389858|NCT01838681|955657|P2|STARTED|Period B/A+||442
389859|NCT01838681|955658|P1|STARTED|Period B/A+||0
389860|NCT01838681|955655|P4|NOT COMPLETED|Period A||0
389861|NCT01838681|955656|P3|NOT COMPLETED|Period A||0
389862|NCT01838681|955657|P2|NOT COMPLETED|Period A||0
389863|NCT01838681|955658|P1|NOT COMPLETED|Period A||325
389864|NCT01838681|955655|P4|COMPLETED|Period A||0
389865|NCT01838681|955656|P3|COMPLETED|Period A||0
389866|NCT01838681|955657|P2|COMPLETED|Period A||0
389867|NCT01838681|955658|P1|COMPLETED|Period A||1661
389868|NCT01838681|955655|P4|STARTED|Period A||0
389869|NCT01838681|955656|P3|STARTED|Period A||0
389870|NCT01838681|955657|P2|STARTED|Period A||0
389871|NCT01838681|955658|P1|STARTED|Period A||1986
389872|NCT01838655|955698|P1|NOT COMPLETED|Overall Study||0
389873|NCT01838655|955698|P1|COMPLETED|Overall Study||5
389874|NCT01838655|955698|P1|STARTED|Overall Study||5
389875|NCT01838642|955766|P1|NOT COMPLETED|Overall Study||1
389876|NCT01838642|955766|P1|COMPLETED|Overall Study||2
389877|NCT01838642|955766|P1|STARTED|Overall Study||3
389878|NCT01838616|955779|P2|NOT COMPLETED|Pick-up Arm||0
389879|NCT01838616|955780|P1|NOT COMPLETED|Pick-up Arm||15
389880|NCT01838616|955779|P2|COMPLETED|Pick-up Arm||0
389881|NCT01838616|955780|P1|COMPLETED|Pick-up Arm|Participants completed the tapentadol pick-up arm after initially on oxycodone/naloxone PR treatment|35
389882|NCT01838616|955779|P2|Full Analysis Set|Pick-up Arm||0
389883|NCT01838616|955780|P1|Full Analysis Set|Pick-up Arm||49
389884|NCT01838616|955779|P2|STARTED|Pick-up Arm||0
389885|NCT01838616|955780|P1|STARTED|Pick-up Arm|Switch to Tapentadol (PR) after Oxycodone/Naloxone (PR) treatment discontinuation.|50
389886|NCT01838616|955779|P2|NOT COMPLETED|Continuation Period||14
389887|NCT01838616|955780|P1|NOT COMPLETED|Continuation Period||14
389888|NCT01838616|955779|P2|COMPLETED|Continuation Period||48
389889|NCT01838616|955780|P1|COMPLETED|Continuation Period||86
389890|NCT01838616|955779|P2|Switched to Pick-up Arm|Continuation Period||7
389891|NCT01838616|955780|P1|Switched to Pick-up Arm|Continuation Period||0
389892|NCT01838616|955779|P2|STARTED|Continuation Period||62
389893|NCT01838616|955780|P1|STARTED|Continuation Period||100
389894|NCT01838616|955779|P2|NOT COMPLETED|Titration Period||66
389895|NCT01838616|955780|P1|NOT COMPLETED|Titration Period||30
389896|NCT01838616|955779|P2|COMPLETED|Titration Period||62
389897|NCT01838616|955780|P1|COMPLETED|Titration Period||100
389898|NCT01838616|955779|P2|Per Protocol Set|Titration Period||112
389899|NCT01838616|955780|P1|Per Protocol Set|Titration Period||117
389900|NCT01838616|955779|P2|Full Analysis Set|Titration Period||128
389901|NCT01838616|955780|P1|Full Analysis Set|Titration Period||130
389902|NCT01838616|955779|P2|Switched to Pick-up Arm|Titration Period||43
389903|NCT01838616|955780|P1|Switched to Pick-up Arm|Titration Period||0
389904|NCT01838616|955779|P2|Major Protocol Deviations|Titration Period||16
389905|NCT01838616|955780|P1|Major Protocol Deviations|Titration Period||13
389906|NCT01838616|955779|P2|No Post Baseline Pain Intensity Values|Titration Period||2
389907|NCT01838616|955780|P1|No Post Baseline Pain Intensity Values|Titration Period||0
389908|NCT01838616|955779|P2|STARTED|Titration Period||128
389909|NCT01838616|955780|P1|STARTED|Titration Period||130
389910|NCT01838590|955851|P2|NOT COMPLETED|Overall Study||5
389911|NCT01838590|955852|P1|NOT COMPLETED|Overall Study||12
389912|NCT01838590|955851|P2|COMPLETED|Overall Study||46
389913|NCT01838590|955852|P1|COMPLETED|Overall Study||40
389914|NCT01838590|955851|P2|STARTED|Overall Study||51
389915|NCT01838590|955852|P1|STARTED|Overall Study||52
389916|NCT01838499|955876|P2|NOT COMPLETED|Overall Study||17
389917|NCT01838499|955877|P1|NOT COMPLETED|Overall Study||24
389918|NCT01838499|955876|P2|COMPLETED|Overall Study||37
389919|NCT01838499|955877|P1|COMPLETED|Overall Study||31
389920|NCT01838499|955876|P2|STARTED|Overall Study||54
389921|NCT01838499|955877|P1|STARTED|Overall Study||55
389922|NCT01838304|955889|P2|NOT COMPLETED|Overall Study||0
389923|NCT01838304|955890|P1|NOT COMPLETED|Overall Study||1
389924|NCT01838304|955889|P2|COMPLETED|Overall Study||20
389925|NCT01838304|955890|P1|COMPLETED|Overall Study||19
389926|NCT01838304|955889|P2|STARTED|Overall Study||20
389927|NCT01838304|955890|P1|STARTED|Overall Study||20
389928|NCT01838213|955904|P2|NOT COMPLETED|Overall Study||191
389929|NCT01838213|955905|P1|NOT COMPLETED|Overall Study||166
389930|NCT01838213|955904|P2|COMPLETED|Overall Study||262
389931|NCT01838213|955905|P1|COMPLETED|Overall Study||81
389932|NCT01838213|955904|P2|STARTED|Overall Study||453
389933|NCT01838213|955905|P1|STARTED|Overall Study||247
389934|NCT01838044|955913|P2|NOT COMPLETED|Overall Study||16
389935|NCT01838044|955914|P1|NOT COMPLETED|Overall Study||8
389936|NCT01838044|955913|P2|COMPLETED|Overall Study||75
389937|NCT01838044|955914|P1|COMPLETED|Overall Study||81
389938|NCT01838044|955913|P2|STARTED|Overall Study||91
389939|NCT01838044|955914|P1|STARTED|Overall Study||89
389940|NCT01837966|955947|P2|NOT COMPLETED|Overall Study||1
389941|NCT01837966|955948|P1|NOT COMPLETED|Overall Study||2
389942|NCT01837966|955947|P2|COMPLETED|Overall Study||45
389943|NCT01837966|955948|P1|COMPLETED|Overall Study||45
389944|NCT01837966|955947|P2|STARTED|Overall Study||46
389945|NCT01837966|955948|P1|STARTED|Overall Study||47
389946|NCT01837823|955954|P1|NOT COMPLETED|Overall Study||6
389947|NCT01837823|955954|P1|COMPLETED|Overall Study||85
389948|NCT01837823|955954|P1|STARTED|Overall Study||91
389949|NCT01837797|955985|P5|NOT COMPLETED|Period 3||23
389950|NCT01837797|955986|P4|NOT COMPLETED|Period 3||0
389951|NCT01837797|955987|P3|NOT COMPLETED|Period 3||0
389952|NCT01837797|955988|P2|NOT COMPLETED|Period 3||0
389953|NCT01837797|955989|P1|NOT COMPLETED|Period 3||0
389954|NCT01837797|955985|P5|COMPLETED|Period 3||24
389955|NCT01837797|955986|P4|COMPLETED|Period 3||0
389956|NCT01837797|955987|P3|COMPLETED|Period 3||0
389957|NCT01837797|955988|P2|COMPLETED|Period 3||0
389958|NCT01837797|955989|P1|COMPLETED|Period 3||0
389959|NCT01837797|955985|P5|STARTED|Period 3||47
389960|NCT01837797|955986|P4|STARTED|Period 3||0
389961|NCT01837797|955987|P3|STARTED|Period 3||0
389962|NCT01837797|955988|P2|STARTED|Period 3||0
389963|NCT01837797|955989|P1|STARTED|Period 3||0
389964|NCT01837797|955985|P5|NOT COMPLETED|Period 2||0
389965|NCT01837797|955986|P4|NOT COMPLETED|Period 2||5
389966|NCT01837797|955987|P3|NOT COMPLETED|Period 2||2
389967|NCT01837797|955988|P2|NOT COMPLETED|Period 2||5
389968|NCT01837797|955989|P1|NOT COMPLETED|Period 2||0
389969|NCT01837797|955985|P5|COMPLETED|Period 2||0
389970|NCT01837797|955986|P4|COMPLETED|Period 2||1
389971|NCT01837797|955987|P3|COMPLETED|Period 2||1
389972|NCT01837797|955988|P2|COMPLETED|Period 2||1
389973|NCT01837797|955989|P1|COMPLETED|Period 2||0
389974|NCT01837797|955985|P5|STARTED|Period 2||0
389975|NCT01837797|955986|P4|STARTED|Period 2||6
389976|NCT01837797|955987|P3|STARTED|Period 2||3
389977|NCT01837797|955988|P2|STARTED|Period 2||6
389978|NCT01837797|955989|P1|STARTED|Period 2||0
389979|NCT01837797|955985|P5|NOT COMPLETED|Period 1||0
389980|NCT01837797|955986|P4|NOT COMPLETED|Period 1||0
389981|NCT01837797|955987|P3|NOT COMPLETED|Period 1||0
389982|NCT01837797|955988|P2|NOT COMPLETED|Period 1||0
389983|NCT01837797|955989|P1|NOT COMPLETED|Period 1||102
389984|NCT01837797|955985|P5|COMPLETED|Period 1||0
389985|NCT01837797|955986|P4|COMPLETED|Period 1||0
389986|NCT01837797|955987|P3|COMPLETED|Period 1||0
389987|NCT01837797|955988|P2|COMPLETED|Period 1||0
389988|NCT01837797|955989|P1|COMPLETED|Period 1||27
389989|NCT01837797|955985|P5|STARTED|Period 1||0
389990|NCT01837797|955986|P4|STARTED|Period 1||0
389991|NCT01837797|955987|P3|STARTED|Period 1||0
389992|NCT01837797|955988|P2|STARTED|Period 1||0
389993|NCT01837797|955989|P1|STARTED|Period 1||129
389994|NCT01837719|956024|P1|NOT COMPLETED|Period 5: Days 29-31 (Treatment E)||1
389995|NCT01837719|956024|P1|COMPLETED|Period 5: Days 29-31 (Treatment E)||30
389996|NCT01837719|956024|P1|STARTED|Period 5: Days 29-31 (Treatment E)|Reflects the 31 patients remaining after 32 were discharged at the end of Period 4, as per protocol|31
389997|NCT01837719|956024|P1|NOT COMPLETED|Period 4: Days 22-28 (Treatment D or C)||0
389998|NCT01837719|956024|P1|COMPLETED|Period 4: Days 22-28 (Treatment D or C)|Number finishing period; 32 patients were discharged following Period 4, as per protocol|63
389999|NCT01837719|956024|P1|STARTED|Period 4: Days 22-28 (Treatment D or C)||63
390000|NCT01837719|956024|P1|NOT COMPLETED|Period 3: Days 15-21 (Treatment C or D)||0
390001|NCT01837719|956024|P1|COMPLETED|Period 3: Days 15-21 (Treatment C or D)||63
390002|NCT01837719|956024|P1|STARTED|Period 3: Days 15-21 (Treatment C or D)||63
390003|NCT01837719|956024|P1|NOT COMPLETED|Period 2: Days 8-14 (Treatment B or A)||1
390004|NCT01837719|956024|P1|COMPLETED|Period 2: Days 8-14 (Treatment B or A)||63
390005|NCT01837719|956024|P1|STARTED|Period 2: Days 8-14 (Treatment B or A)||64
390006|NCT01837719|956024|P1|NOT COMPLETED|Period 1: Days 1-7 (Treatment A or B)||0
390007|NCT01837719|956024|P1|COMPLETED|Period 1: Days 1-7 (Treatment A or B)||64
390008|NCT01837719|956024|P1|STARTED|Period 1: Days 1-7 (Treatment A or B)|Received treatment|64
390009|NCT01837680|956093|P2|NOT COMPLETED|Overall Study||8
390010|NCT01837680|956094|P1|NOT COMPLETED|Overall Study||10
390011|NCT01837680|956093|P2|COMPLETED|Overall Study||45
390012|NCT01837680|956094|P1|COMPLETED|Overall Study||42
390013|NCT01837680|956093|P2|STARTED|Overall Study||53
390014|NCT01837680|956094|P1|STARTED|Overall Study||52
390015|NCT01837550|956132|P2|NOT COMPLETED|T0-T2, 6 Months Follow-up||0
390016|NCT01837550|956133|P1|NOT COMPLETED|T0-T2, 6 Months Follow-up||0
390017|NCT01837550|956132|P2|COMPLETED|T0-T2, 6 Months Follow-up||37
390018|NCT01837550|956133|P1|COMPLETED|T0-T2, 6 Months Follow-up||37
390019|NCT01837550|956132|P2|STARTED|T0-T2, 6 Months Follow-up||37
390020|NCT01837550|956133|P1|STARTED|T0-T2, 6 Months Follow-up||37
390021|NCT01837550|956132|P2|NOT COMPLETED|T0-T1, 5 Weeks||0
390022|NCT01837550|956133|P1|NOT COMPLETED|T0-T1, 5 Weeks||0
390023|NCT01837550|956132|P2|COMPLETED|T0-T1, 5 Weeks||37
390024|NCT01837550|956133|P1|COMPLETED|T0-T1, 5 Weeks||37
390025|NCT01837550|956132|P2|STARTED|T0-T1, 5 Weeks||37
390026|NCT01837550|956133|P1|STARTED|T0-T1, 5 Weeks||37
390027|NCT01837537|956145|P1|NOT COMPLETED|Overall Study||0
390028|NCT01837537|956145|P1|COMPLETED|Overall Study||90
390029|NCT01837537|956145|P1|STARTED|Overall Study||90
390030|NCT01837524|956152|P2|NOT COMPLETED|Overall Study||2
390031|NCT01837524|956153|P1|NOT COMPLETED|Overall Study||3
390032|NCT01837524|956152|P2|COMPLETED|Overall Study||25
390033|NCT01837524|956153|P1|COMPLETED|Overall Study||25
390034|NCT01837524|956152|P2|STARTED|Overall Study||27
390035|NCT01837524|956153|P1|STARTED|Overall Study||28
390036|NCT01836809|956163|P4|NOT COMPLETED|Overall Study||2
390037|NCT01836809|956164|P3|NOT COMPLETED|Overall Study||0
390038|NCT01836809|956165|P2|NOT COMPLETED|Overall Study||0
390039|NCT01836809|956166|P1|NOT COMPLETED|Overall Study||0
390040|NCT01836809|956163|P4|COMPLETED|Overall Study||0
390041|NCT01836809|956164|P3|COMPLETED|Overall Study||0
390042|NCT01836809|956165|P2|COMPLETED|Overall Study||0
390043|NCT01836809|956166|P1|COMPLETED|Overall Study||0
390044|NCT01836809|956163|P4|STARTED|Overall Study||2
390045|NCT01836809|956164|P3|STARTED|Overall Study||0
390046|NCT01836809|956165|P2|STARTED|Overall Study||0
390047|NCT01836809|956166|P1|STARTED|Overall Study||0
390048|NCT01836523|956200|P4|NOT COMPLETED|Overall Study||74
390049|NCT01836523|956201|P3|NOT COMPLETED|Overall Study||91
390050|NCT01836523|956202|P2|NOT COMPLETED|Overall Study||85
390051|NCT01836523|956203|P1|NOT COMPLETED|Overall Study||51
390052|NCT01836523|956200|P4|COMPLETED|Overall Study||274
390053|NCT01836523|956201|P3|COMPLETED|Overall Study||258
390054|NCT01836523|956202|P2|COMPLETED|Overall Study||265
390055|NCT01836523|956203|P1|COMPLETED|Overall Study||300
390056|NCT01836523|956200|P4|Exposed|Overall Study||348
390057|NCT01836523|956201|P3|Exposed|Overall Study||347
390058|NCT01836523|956202|P2|Exposed|Overall Study||348
390059|NCT01836523|956203|P1|Exposed|Overall Study||350
390060|NCT01836523|956200|P4|STARTED|Overall Study||348
390061|NCT01836523|956201|P3|STARTED|Overall Study||349
390062|NCT01836523|956202|P2|STARTED|Overall Study||350
390063|NCT01836523|956203|P1|STARTED|Overall Study||351
390064|NCT01836471|956230|P5|NOT COMPLETED|Overall Study||5
390065|NCT01836471|956231|P4|NOT COMPLETED|Overall Study||2
390066|NCT01836471|956232|P3|NOT COMPLETED|Overall Study||2
390067|NCT01836471|956233|P2|NOT COMPLETED|Overall Study||9
390068|NCT01836471|956234|P1|NOT COMPLETED|Overall Study||11
390069|NCT01836471|956230|P5|COMPLETED|Overall Study||49
390070|NCT01836471|956231|P4|COMPLETED|Overall Study||40
390071|NCT01836471|956232|P3|COMPLETED|Overall Study||49
390072|NCT01836471|956233|P2|COMPLETED|Overall Study||85
390073|NCT01836471|956234|P1|COMPLETED|Overall Study||82
390074|NCT01836471|956230|P5|STARTED|Overall Study||54
390075|NCT01836471|956231|P4|STARTED|Overall Study||42
390076|NCT01836471|956232|P3|STARTED|Overall Study||51
390077|NCT01836471|956233|P2|STARTED|Overall Study||94
390078|NCT01836471|956234|P1|STARTED|Overall Study||93
390079|NCT01836458|956263|P4|NOT COMPLETED|Overall Study||6
390080|NCT01836458|956264|P3|NOT COMPLETED|Overall Study||5
390081|NCT01836458|956265|P2|NOT COMPLETED|Overall Study||2
390082|NCT01836458|956266|P1|NOT COMPLETED|Overall Study||3
390083|NCT01836458|956263|P4|COMPLETED|Overall Study||1
390084|NCT01836458|956264|P3|COMPLETED|Overall Study||2
390085|NCT01836458|956265|P2|COMPLETED|Overall Study||2
390086|NCT01836458|956266|P1|COMPLETED|Overall Study||4
390087|NCT01836458|956263|P4|STARTED|Overall Study||7
390088|NCT01836458|956264|P3|STARTED|Overall Study||7
390089|NCT01836458|956265|P2|STARTED|Overall Study||4
390090|NCT01836458|956266|P1|STARTED|Overall Study||7
390091|NCT01836133|956288|P1|NOT COMPLETED|Overall Study||0
390092|NCT01836133|956288|P1|COMPLETED|Overall Study||70
390093|NCT01836133|956288|P1|STARTED|Overall Study||70
390094|NCT01836042|956297|P3|NOT COMPLETED|Overall Study||0
390095|NCT01836042|956298|P2|NOT COMPLETED|Overall Study||0
390096|NCT01836042|956299|P1|NOT COMPLETED|Overall Study||0
390097|NCT01836042|956297|P3|COMPLETED|Overall Study||22
390098|NCT01836042|956298|P2|COMPLETED|Overall Study||35
390099|NCT01836042|956299|P1|COMPLETED|Overall Study||51
390100|NCT01836042|956297|P3|STARTED|Overall Study||22
390101|NCT01836042|956298|P2|STARTED|Overall Study||35
390102|NCT01836042|956299|P1|STARTED|Overall Study||51
390103|NCT01835912|956307|P1|NOT COMPLETED|Overall Study||0
390104|NCT01835912|956307|P1|COMPLETED|Overall Study||10
390105|NCT01835912|956307|P1|Chronic Placebo|Overall Study||10
390106|NCT01835912|956307|P1|Chronic|Overall Study||10
390107|NCT01835912|956307|P1|Acute Placebo|Overall Study||10
390108|NCT01835912|956307|P1|Acute|Overall Study||10
390109|NCT01835912|956307|P1|STARTED|Overall Study||10
390110|NCT01835899|956328|P3|NOT COMPLETED|Overall Study||1
390111|NCT01835899|956329|P2|NOT COMPLETED|Overall Study||1
390112|NCT01835899|956330|P1|NOT COMPLETED|Overall Study||0
390113|NCT01835899|956328|P3|COMPLETED|Overall Study||8
390114|NCT01835899|956329|P2|COMPLETED|Overall Study||8
390115|NCT01835899|956330|P1|COMPLETED|Overall Study||6
390116|NCT01835899|956328|P3|STARTED|Overall Study||9
390117|NCT01835899|956329|P2|STARTED|Overall Study||9
390118|NCT01835899|956330|P1|STARTED|Overall Study||6
390119|NCT01835756|956350|P2|NOT COMPLETED|Overall Study||0
390120|NCT01835756|956351|P1|NOT COMPLETED|Overall Study||0
390121|NCT01835756|956350|P2|COMPLETED|Overall Study||31
390122|NCT01835756|956351|P1|COMPLETED|Overall Study||31
390123|NCT01835756|956350|P2|STARTED|Overall Study||31
390124|NCT01835756|956351|P1|STARTED|Overall Study||31
390125|NCT01835743|956363|P2|NOT COMPLETED|Overall Study||0
390126|NCT01835743|956364|P1|NOT COMPLETED|Overall Study||0
390127|NCT01835743|956363|P2|COMPLETED|Overall Study||32
390128|NCT01835743|956364|P1|COMPLETED|Overall Study||37
390129|NCT01835743|956363|P2|STARTED|Overall Study||32
390130|NCT01835743|956364|P1|STARTED|Overall Study||37
390131|NCT01835548|956374|P3|NOT COMPLETED|Double-Blind Treatment Period||0
390132|NCT01835548|956375|P2|NOT COMPLETED|Double-Blind Treatment Period||2
390133|NCT01835548|956376|P1|NOT COMPLETED|Double-Blind Treatment Period||0
390134|NCT01835548|956374|P3|COMPLETED|Double-Blind Treatment Period||0
390135|NCT01835548|956375|P2|COMPLETED|Double-Blind Treatment Period||39
390136|NCT01835548|956376|P1|COMPLETED|Double-Blind Treatment Period||44
390137|NCT01835548|956374|P3|STARTED|Double-Blind Treatment Period||0
390138|NCT01835548|956375|P2|STARTED|Double-Blind Treatment Period||41
390139|NCT01835548|956376|P1|STARTED|Double-Blind Treatment Period||44
390140|NCT01835548|956374|P3|NOT COMPLETED|Dose Stabilization Period||0
390141|NCT01835548|956375|P2|NOT COMPLETED|Dose Stabilization Period||0
390142|NCT01835548|956376|P1|NOT COMPLETED|Dose Stabilization Period||0
390143|NCT01835548|956374|P3|COMPLETED|Dose Stabilization Period||85
390144|NCT01835548|956375|P2|COMPLETED|Dose Stabilization Period||0
390145|NCT01835548|956376|P1|COMPLETED|Dose Stabilization Period||0
390146|NCT01835548|956374|P3|STARTED|Dose Stabilization Period||85
390147|NCT01835548|956375|P2|STARTED|Dose Stabilization Period||0
390148|NCT01835548|956376|P1|STARTED|Dose Stabilization Period||0
390149|NCT01835548|956374|P3|NOT COMPLETED|Dose Optimization Period||2
390150|NCT01835548|956375|P2|NOT COMPLETED|Dose Optimization Period||0
390151|NCT01835548|956376|P1|NOT COMPLETED|Dose Optimization Period||0
390152|NCT01835548|956374|P3|COMPLETED|Dose Optimization Period||85
390153|NCT01835548|956375|P2|COMPLETED|Dose Optimization Period||0
390154|NCT01835548|956376|P1|COMPLETED|Dose Optimization Period||0
390155|NCT01835548|956374|P3|STARTED|Dose Optimization Period||87
390156|NCT01835548|956375|P2|STARTED|Dose Optimization Period||0
390157|NCT01835548|956376|P1|STARTED|Dose Optimization Period||0
390158|NCT01835548|956374|P3|NOT COMPLETED|Screening/Washout Period||0
390159|NCT01835548|956375|P2|NOT COMPLETED|Screening/Washout Period||0
390160|NCT01835548|956376|P1|NOT COMPLETED|Screening/Washout Period||0
390161|NCT01835548|956374|P3|COMPLETED|Screening/Washout Period||87
390162|NCT01835548|956375|P2|COMPLETED|Screening/Washout Period||0
390163|NCT01835548|956376|P1|COMPLETED|Screening/Washout Period||0
390164|NCT01835548|956374|P3|STARTED|Screening/Washout Period||87
390165|NCT01835548|956375|P2|STARTED|Screening/Washout Period||0
390166|NCT01835548|956376|P1|STARTED|Screening/Washout Period||0
390167|NCT01835496|956396|P1|NOT COMPLETED|Overall Study||0
390168|NCT01835496|956396|P1|COMPLETED|Overall Study||8
390169|NCT01835496|956396|P1|STARTED|Overall Study||8
390170|NCT01835470|956405|P1|NOT COMPLETED|Long Term Treatment Period||2
390171|NCT01835470|956405|P1|COMPLETED|Long Term Treatment Period|Completed=Still on Treatment|18
390172|NCT01835470|956405|P1|STARTED|Long Term Treatment Period||20
390173|NCT01835470|956405|P1|NOT COMPLETED|Short Term Treatment Period (to Week 16)||0
390174|NCT01835470|956405|P1|COMPLETED|Short Term Treatment Period (to Week 16)||20
390175|NCT01835470|956405|P1|STARTED|Short Term Treatment Period (to Week 16)||20
390176|NCT01835431|956417|P2|NOT COMPLETED|Overall Study||12
390177|NCT01835431|956418|P1|NOT COMPLETED|Overall Study||8
390178|NCT01835431|956417|P2|COMPLETED|Overall Study||168
390179|NCT01835431|956418|P1|COMPLETED|Overall Study||174
390180|NCT01835431|956417|P2|Exposed|Overall Study|One subject was withdrawn before exposure|179
390181|NCT01835431|956418|P1|Exposed|Overall Study|One subject was withdrawn before exposure.|181
390182|NCT01835431|956417|P2|STARTED|Overall Study||180
390183|NCT01835431|956418|P1|STARTED|Overall Study||182
390184|NCT01835379|956438|P2|NOT COMPLETED|Overall Study||0
390185|NCT01835379|956439|P1|NOT COMPLETED|Overall Study||0
390186|NCT01835379|956438|P2|COMPLETED|Overall Study||41
390187|NCT01835379|956439|P1|COMPLETED|Overall Study||41
390188|NCT01835379|956438|P2|STARTED|Overall Study||41
390189|NCT01835379|956439|P1|STARTED|Overall Study||41
390190|NCT01835262|956449|P2|NOT COMPLETED|Overall Study||0
390191|NCT01835262|956450|P1|NOT COMPLETED|Overall Study||0
390192|NCT01835262|956449|P2|COMPLETED|Overall Study||45
390193|NCT01835262|956450|P1|COMPLETED|Overall Study||45
390194|NCT01835262|956449|P2|STARTED|Overall Study||45
390195|NCT01835262|956450|P1|STARTED|Overall Study||45
390196|NCT01835132|956456|P1|NOT COMPLETED|2nd Extension Phase - As Needed (PRN)||0
390197|NCT01835132|956456|P1|COMPLETED|2nd Extension Phase - As Needed (PRN)||3
390198|NCT01835132|956456|P1|STARTED|2nd Extension Phase - As Needed (PRN)|PRN extension - Participants starting this phase may not equal those who completed the 1st extension|3
390199|NCT01835132|956456|P1|NOT COMPLETED|1st Extension Phase||0
390200|NCT01835132|956456|P1|COMPLETED|1st Extension Phase|Completed 52 Weeks|6
390201|NCT01835132|956456|P1|STARTED|1st Extension Phase||6
390202|NCT01835132|956456|P1|NOT COMPLETED|Initial Phase||2
390203|NCT01835132|956456|P1|COMPLETED|Initial Phase||6
390204|NCT01835132|956456|P1|STARTED|Initial Phase||8
390205|NCT01835015|956501|P5|NOT COMPLETED|Overall Study||0
390206|NCT01835015|956502|P4|NOT COMPLETED|Overall Study||0
390207|NCT01835015|956503|P3|NOT COMPLETED|Overall Study||1
390208|NCT01835015|956504|P2|NOT COMPLETED|Overall Study||0
390209|NCT01835015|956505|P1|NOT COMPLETED|Overall Study||0
390210|NCT01835015|956501|P5|COMPLETED|Overall Study||6
390211|NCT01835015|956502|P4|COMPLETED|Overall Study||6
390212|NCT01835015|956503|P3|COMPLETED|Overall Study||6
390213|NCT01835015|956504|P2|COMPLETED|Overall Study||6
390214|NCT01835015|956505|P1|COMPLETED|Overall Study||6
390215|NCT01835015|956501|P5|STARTED|Overall Study||6
390216|NCT01835015|956502|P4|STARTED|Overall Study||6
390217|NCT01835015|956503|P3|STARTED|Overall Study||7
390218|NCT01835015|956504|P2|STARTED|Overall Study||6
390219|NCT01835015|956505|P1|STARTED|Overall Study||6
390220|NCT01834651|956578|P1|NOT COMPLETED|Overall Study||1
390221|NCT01834651|956578|P1|COMPLETED|Overall Study|Evaluable for primary outcome assessment at 12 weeks|16
390222|NCT01834651|956578|P1|STARTED|Overall Study||17
390223|NCT01834586|956588|P1|NOT COMPLETED|Overall Study||1
390224|NCT01834586|956588|P1|COMPLETED|Overall Study||29
390225|NCT01834586|956588|P1|STARTED|Overall Study||30
390226|NCT01834404|956595|P2|NOT COMPLETED|Overall Study||0
390227|NCT01834404|956596|P1|NOT COMPLETED|Overall Study||0
390228|NCT01834404|956595|P2|COMPLETED|Overall Study||12
390229|NCT01834404|956596|P1|COMPLETED|Overall Study||12
390230|NCT01834404|956595|P2|STARTED|Overall Study||12
390231|NCT01834404|956596|P1|STARTED|Overall Study||12
390232|NCT01834274|956628|P2|NOT COMPLETED|Overall Study||41
390233|NCT01834274|956629|P1|NOT COMPLETED|Overall Study||47
390234|NCT01834274|956628|P2|COMPLETED|Overall Study||5
390235|NCT01834274|956629|P1|COMPLETED|Overall Study||3
390236|NCT01834274|956628|P2|STARTED|Overall Study||46
390237|NCT01834274|956629|P1|STARTED|Overall Study||50
390238|NCT01834261|956641|P2|NOT COMPLETED|MGH Rest + Nueroeconomic Task fMRI||0
390239|NCT01834261|956642|P1|NOT COMPLETED|MGH Rest + Nueroeconomic Task fMRI||0
390240|NCT01834261|956641|P2|COMPLETED|MGH Rest + Nueroeconomic Task fMRI||10
390241|NCT01834261|956642|P1|COMPLETED|MGH Rest + Nueroeconomic Task fMRI|Enrollment completed in May 2015.|10
390242|NCT01834261|956641|P2|STARTED|MGH Rest + Nueroeconomic Task fMRI||10
390243|NCT01834261|956642|P1|STARTED|MGH Rest + Nueroeconomic Task fMRI|Subjects who dropped out/were excluded (10), did so before they received either Oxytocin or Placebo.|10
390244|NCT01834261|956641|P2|NOT COMPLETED|MIT fMRI and MEG Resting State Study||1
390245|NCT01834261|956642|P1|NOT COMPLETED|MIT fMRI and MEG Resting State Study||1
390246|NCT01834261|956641|P2|COMPLETED|MIT fMRI and MEG Resting State Study||9
390247|NCT01834261|956642|P1|COMPLETED|MIT fMRI and MEG Resting State Study|Enrollment completed in March 2014.|10
390248|NCT01834261|956641|P2|STARTED|MIT fMRI and MEG Resting State Study||10
390249|NCT01834261|956642|P1|STARTED|MIT fMRI and MEG Resting State Study||11
390250|NCT01834222|956652|P1|NOT COMPLETED|Overall Study||1
390251|NCT01834222|956652|P1|COMPLETED|Overall Study||658
390252|NCT01834222|956652|P1|Treated|Overall Study||658
390253|NCT01834222|956652|P1|STARTED|Overall Study||659
390254|NCT01834027|956663|P2|NOT COMPLETED|Overall Study||0
390255|NCT01834027|956664|P1|NOT COMPLETED|Overall Study||0
390256|NCT01834027|956663|P2|COMPLETED|Overall Study||28
390257|NCT01834027|956664|P1|COMPLETED|Overall Study||28
390258|NCT01834027|956663|P2|STARTED|Overall Study||28
390259|NCT01834027|956664|P1|STARTED|Overall Study||28
390260|NCT01833988|956674|P2|NOT COMPLETED|Overall Study||0
390261|NCT01833988|956675|P1|NOT COMPLETED|Overall Study||0
390262|NCT01833988|956674|P2|COMPLETED|Overall Study||16
390263|NCT01833988|956675|P1|COMPLETED|Overall Study||16
390264|NCT01833988|956674|P2|STARTED|Overall Study||16
390265|NCT01833988|956675|P1|STARTED|Overall Study||16
390266|NCT01833936|956731|P2|NOT COMPLETED|Overall Study||2
390267|NCT01833936|956732|P1|NOT COMPLETED|Overall Study||4
390268|NCT01833936|956731|P2|COMPLETED|Overall Study||18
390269|NCT01833936|956732|P1|COMPLETED|Overall Study||16
390270|NCT01833936|956731|P2|STARTED|Overall Study||20
390271|NCT01833936|956732|P1|STARTED|Overall Study||20
390272|NCT01833897|956738|P1|NOT COMPLETED|Overall Study||1
390273|NCT01833897|956738|P1|COMPLETED|Overall Study||7
390274|NCT01833897|956738|P1|STARTED|Overall Study||8
390275|NCT01833845|956746|P1|NOT COMPLETED|Overall Study||0
390276|NCT01833845|956746|P1|COMPLETED|Overall Study||4
390277|NCT01833845|956746|P1|STARTED|Overall Study||4
390278|NCT01833741|956750|P1|NOT COMPLETED|Overall Study||140
390279|NCT01833741|956750|P1|COMPLETED|Overall Study||997
390280|NCT01833741|956750|P1|STARTED|Overall Study||1137
390281|NCT01833533|956765|P2|NOT COMPLETED|Overall Study||21
390282|NCT01833533|956766|P1|NOT COMPLETED|Overall Study||6
390283|NCT01833533|956765|P2|COMPLETED|Overall Study||184
390284|NCT01833533|956766|P1|COMPLETED|Overall Study||94
390285|NCT01833533|956765|P2|STARTED|Overall Study||205
390286|NCT01833533|956766|P1|STARTED|Overall Study||100
390287|NCT01833481|956783|P3|NOT COMPLETED|Overall Study||0
390288|NCT01833481|956784|P2|NOT COMPLETED|Overall Study||0
390289|NCT01833481|956785|P1|NOT COMPLETED|Overall Study||0
390290|NCT01833481|956783|P3|COMPLETED|Overall Study||10
390291|NCT01833481|956784|P2|COMPLETED|Overall Study||10
390292|NCT01833481|956785|P1|COMPLETED|Overall Study||10
390293|NCT01833481|956783|P3|STARTED|Overall Study||10
390294|NCT01833481|956784|P2|STARTED|Overall Study||10
390295|NCT01833481|956785|P1|STARTED|Overall Study||10
390296|NCT01833403|956799|P1|NOT COMPLETED|Overall Study||0
390297|NCT01833403|956799|P1|COMPLETED|Overall Study||4
390298|NCT01833403|956799|P1|STARTED|Overall Study||4
390299|NCT01833247|956804|P1|NOT COMPLETED|Overall Study||0
390300|NCT01833247|956804|P1|COMPLETED|Overall Study||12
390301|NCT01833247|956804|P1|STARTED|Overall Study||12
390302|NCT01833169|956810|P1|NOT COMPLETED|Overall Study||146
390303|NCT01833169|956810|P1|COMPLETED|Overall Study||0
390304|NCT01833169|956810|P1|Consented to be Followed for Survival|Overall Study||128
390305|NCT01833169|956810|P1|STARTED|Overall Study||146
390306|NCT01833130|956823|P2|NOT COMPLETED|Overall Study||19
390307|NCT01833130|956824|P1|NOT COMPLETED|Overall Study||10
390308|NCT01833130|956823|P2|COMPLETED|Overall Study||8
390309|NCT01833130|956824|P1|COMPLETED|Overall Study||15
390310|NCT01833130|956823|P2|STARTED|Overall Study||27
390311|NCT01833130|956824|P1|STARTED|Overall Study||25
390318|NCT01833078|956871|P1|NOT COMPLETED|Overall Study||0
390319|NCT01833078|956871|P1|COMPLETED|Overall Study||5
390320|NCT01833078|956871|P1|STARTED|Overall Study||5
390321|NCT01833065|956879|P5|NOT COMPLETED|Overall Study||36
390322|NCT01833065|956880|P4|NOT COMPLETED|Overall Study||9
390323|NCT01833065|956881|P3|NOT COMPLETED|Overall Study||12
390324|NCT01833065|956882|P2|NOT COMPLETED|Overall Study||13
390325|NCT01833065|956883|P1|NOT COMPLETED|Overall Study||24
390326|NCT01833065|956879|P5|COMPLETED|Overall Study||74
390327|NCT01833065|956880|P4|COMPLETED|Overall Study||41
390328|NCT01833065|956881|P3|COMPLETED|Overall Study||23
390329|NCT01833065|956882|P2|COMPLETED|Overall Study||40
390330|NCT01833065|956883|P1|COMPLETED|Overall Study||41
390331|NCT01833065|956879|P5|Intention-to-treat Analysis Set|Overall Study|Randomized patients|111
390332|NCT01833065|956880|P4|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
390333|NCT01833065|956881|P3|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
390334|NCT01833065|956882|P2|Intention-to-treat Analysis Set|Overall Study|Randomized patients|53
390335|NCT01833065|956883|P1|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
390336|NCT01833065|956879|P5|STARTED|Overall Study|Randomized patients - As treated|110
390337|NCT01833065|956880|P4|STARTED|Overall Study|Randomized patients - As treated|50
390338|NCT01833065|956881|P3|STARTED|Overall Study|Randomized patients - As treated|35
390339|NCT01833065|956882|P2|STARTED|Overall Study|Randomized patients - As treated|53
390340|NCT01833065|956883|P1|STARTED|Overall Study|Randomized patients - As treated|65
390341|NCT01832766|956914|P2|NOT COMPLETED|Second Intervention||0
390342|NCT01832766|956915|P1|NOT COMPLETED|Second Intervention||0
390343|NCT01832766|956914|P2|COMPLETED|Second Intervention||5
390344|NCT01832766|956915|P1|COMPLETED|Second Intervention||7
390345|NCT01832766|956914|P2|STARTED|Second Intervention||5
390346|NCT01832766|956915|P1|STARTED|Second Intervention||7
390347|NCT01832766|956914|P2|NOT COMPLETED|Washout||1
390348|NCT01832766|956915|P1|NOT COMPLETED|Washout||0
390349|NCT01832766|956914|P2|COMPLETED|Washout||5
390350|NCT01832766|956915|P1|COMPLETED|Washout||7
390351|NCT01832766|956914|P2|STARTED|Washout||6
390352|NCT01832766|956915|P1|STARTED|Washout||7
390353|NCT01832766|956914|P2|NOT COMPLETED|First Intervention||0
390354|NCT01832766|956915|P1|NOT COMPLETED|First Intervention||0
390355|NCT01832766|956914|P2|COMPLETED|First Intervention|one participant did not return for cross over visit|6
390356|NCT01832766|956915|P1|COMPLETED|First Intervention||7
390357|NCT01832766|956914|P2|STARTED|First Intervention||6
390358|NCT01832766|956915|P1|STARTED|First Intervention||7
390359|NCT01832506|956928|P3|NOT COMPLETED|Overall Study||0
390360|NCT01832506|956929|P2|NOT COMPLETED|Overall Study||0
390361|NCT01832506|956930|P1|NOT COMPLETED|Overall Study||0
390362|NCT01832506|956928|P3|COMPLETED|Overall Study||6
390363|NCT01832506|956929|P2|COMPLETED|Overall Study||3
390364|NCT01832506|956930|P1|COMPLETED|Overall Study||3
390365|NCT01832506|956928|P3|STARTED|Overall Study||6
390366|NCT01832506|956929|P2|STARTED|Overall Study||3
390367|NCT01832506|956930|P1|STARTED|Overall Study||3
390368|NCT01832493|956981|P1|NOT COMPLETED|Overall Study||8
390369|NCT01832493|956981|P1|COMPLETED|Overall Study||42
390370|NCT01832493|956981|P1|STARTED|Overall Study||50
390371|NCT01832259|956990|P2|NOT COMPLETED|Overall Study||0
390372|NCT01832259|956991|P1|NOT COMPLETED|Overall Study||0
390373|NCT01832259|956990|P2|COMPLETED|Overall Study||15
390374|NCT01832259|956991|P1|COMPLETED|Overall Study||15
390375|NCT01832259|956990|P2|STARTED|Overall Study||15
390376|NCT01832259|956991|P1|STARTED|Overall Study||15
390377|NCT01832155|956999|P2|NOT COMPLETED|End of Study: 4 - 8 Weeks||0
390378|NCT01832155|957000|P1|NOT COMPLETED|End of Study: 4 - 8 Weeks||0
390379|NCT01832155|956999|P2|COMPLETED|End of Study: 4 - 8 Weeks||18
390380|NCT01832155|957000|P1|COMPLETED|End of Study: 4 - 8 Weeks||16
390381|NCT01832155|956999|P2|STARTED|End of Study: 4 - 8 Weeks||18
390382|NCT01832155|957000|P1|STARTED|End of Study: 4 - 8 Weeks||16
390383|NCT01832155|956999|P2|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||0
390384|NCT01832155|957000|P1|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||1
390385|NCT01832155|956999|P2|COMPLETED|Mid-point of Study: 0 - 4 Weeks||18
390386|NCT01832155|957000|P1|COMPLETED|Mid-point of Study: 0 - 4 Weeks||16
390387|NCT01832155|956999|P2|STARTED|Mid-point of Study: 0 - 4 Weeks||18
390388|NCT01832155|957000|P1|STARTED|Mid-point of Study: 0 - 4 Weeks||17
390389|NCT01832155|956999|P2|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||0
390390|NCT01832155|957000|P1|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||1
390391|NCT01832155|956999|P2|COMPLETED|Beginning of Study: Baseline at 0 Week||18
390392|NCT01832155|957000|P1|COMPLETED|Beginning of Study: Baseline at 0 Week||17
390393|NCT01832155|956999|P2|STARTED|Beginning of Study: Baseline at 0 Week||18
390394|NCT01832155|957000|P1|STARTED|Beginning of Study: Baseline at 0 Week||18
390395|NCT01832090|957023|P2|NOT COMPLETED|Overall Study||1
390396|NCT01832090|957024|P1|NOT COMPLETED|Overall Study||6
390397|NCT01832090|957023|P2|COMPLETED|Overall Study||28
390398|NCT01832090|957024|P1|COMPLETED|Overall Study||83
390399|NCT01832090|957023|P2|STARTED|Overall Study||29
390400|NCT01832090|957024|P1|STARTED|Overall Study||89
390401|NCT01831934|957069|P2|NOT COMPLETED|Overall Study||0
390402|NCT01831934|957070|P1|NOT COMPLETED|Overall Study||1
390403|NCT01831934|957069|P2|COMPLETED|Overall Study||10
390404|NCT01831934|957070|P1|COMPLETED|Overall Study|Volunteer consented but not enrolled after reporting a prior bad reaction to influenza vaccine.|11
390405|NCT01831934|957069|P2|STARTED|Overall Study||10
390406|NCT01831934|957070|P1|STARTED|Overall Study||12
390407|NCT01831817|957080|P4|NOT COMPLETED|Overall Study||0
390408|NCT01831817|957081|P3|NOT COMPLETED|Overall Study||0
390409|NCT01831817|957082|P2|NOT COMPLETED|Overall Study||0
390410|NCT01831817|957083|P1|NOT COMPLETED|Overall Study||4
390411|NCT01831817|957080|P4|COMPLETED|Overall Study||36
390412|NCT01831817|957081|P3|COMPLETED|Overall Study||35
390413|NCT01831817|957082|P2|COMPLETED|Overall Study||34
390414|NCT01831817|957083|P1|COMPLETED|Overall Study||31
390415|NCT01831817|957080|P4|STARTED|Overall Study||36
390416|NCT01831817|957081|P3|STARTED|Overall Study||35
390417|NCT01831817|957082|P2|STARTED|Overall Study||34
390418|NCT01831817|957083|P1|STARTED|Overall Study||35
390419|NCT01831791|957121|P1|NOT COMPLETED|Overall Study||10
390420|NCT01831791|957121|P1|COMPLETED|Overall Study||110
390421|NCT01831791|957121|P1|STARTED|Overall Study||120
390422|NCT01831765|957150|P3|NOT COMPLETED|Overall Study||42
390423|NCT01831765|957151|P2|NOT COMPLETED|Overall Study||27
390424|NCT01831765|957152|P1|NOT COMPLETED|Overall Study||44
390425|NCT01831765|957150|P3|COMPLETED|Overall Study||338
390426|NCT01831765|957151|P2|COMPLETED|Overall Study||355
390427|NCT01831765|957152|P1|COMPLETED|Overall Study||337
390428|NCT01831765|957150|P3|Completed 52 Weeks|Overall Study||338
390429|NCT01831765|957151|P2|Completed 52 Weeks|Overall Study|This arm did not continue in the trial after 26 weeks ( 26 to 52 weeks).|0
390430|NCT01831765|957152|P1|Completed 52 Weeks|Overall Study||337
390431|NCT01831765|957150|P3|Completed 26 Weeks|Overall Study||356
390432|NCT01831765|957151|P2|Completed 26 Weeks|Overall Study||355
390433|NCT01831765|957152|P1|Completed 26 Weeks|Overall Study||351
390434|NCT01831765|957150|P3|STARTED|Overall Study||380
390435|NCT01831765|957151|P2|STARTED|Overall Study||382
390436|NCT01831765|957152|P1|STARTED|Overall Study||381
390437|NCT01831726|957178|P1|NOT COMPLETED|Overall Study||80
390438|NCT01831726|957178|P1|COMPLETED|Overall Study||0
390439|NCT01831726|957178|P1|STARTED|Overall Study||80
390440|NCT01831466|957197|P12|NOT COMPLETED|Overall Study||4
390441|NCT01831466|957198|P11|NOT COMPLETED|Overall Study||2
390442|NCT01831466|957199|P10|NOT COMPLETED|Overall Study||5
390443|NCT01831466|957200|P9|NOT COMPLETED|Overall Study||3
390444|NCT01831466|957201|P8|NOT COMPLETED|Overall Study||2
390445|NCT01831466|957202|P7|NOT COMPLETED|Overall Study||1
390446|NCT01831466|957203|P6|NOT COMPLETED|Overall Study||26
390447|NCT01831466|957204|P5|NOT COMPLETED|Overall Study||17
390448|NCT01831466|957205|P4|NOT COMPLETED|Overall Study||19
390449|NCT01831466|957206|P3|NOT COMPLETED|Overall Study||23
390450|NCT01831466|957207|P2|NOT COMPLETED|Overall Study||18
390451|NCT01831466|957208|P1|NOT COMPLETED|Overall Study||16
390452|NCT01831466|957197|P12|COMPLETED|Overall Study||3
390453|NCT01831466|957198|P11|COMPLETED|Overall Study||4
390454|NCT01831466|957199|P10|COMPLETED|Overall Study||2
390455|NCT01831466|957200|P9|COMPLETED|Overall Study||4
390456|NCT01831466|957201|P8|COMPLETED|Overall Study||5
390457|NCT01831466|957202|P7|COMPLETED|Overall Study||6
390458|NCT01831466|957203|P6|COMPLETED|Overall Study||48
390459|NCT01831466|957204|P5|COMPLETED|Overall Study||57
390460|NCT01831466|957205|P4|COMPLETED|Overall Study||51
390461|NCT01831466|957206|P3|COMPLETED|Overall Study||48
390462|NCT01831466|957207|P2|COMPLETED|Overall Study||52
390463|NCT01831466|957208|P1|COMPLETED|Overall Study||55
390464|NCT01831466|957197|P12|STARTED|Overall Study|Treated|7
390465|NCT01831466|957198|P11|STARTED|Overall Study|Treated|6
390466|NCT01831466|957199|P10|STARTED|Overall Study|Treated|7
390467|NCT01831466|957200|P9|STARTED|Overall Study|Treated|7
390468|NCT01831466|957201|P8|STARTED|Overall Study|Treated|7
390469|NCT01831466|957202|P7|STARTED|Overall Study|Treated|7
390470|NCT01831466|957203|P6|STARTED|Overall Study|Treated|74
390471|NCT01831466|957204|P5|STARTED|Overall Study|Treated|74
390472|NCT01831466|957205|P4|STARTED|Overall Study|Treated|70
390473|NCT01831466|957206|P3|STARTED|Overall Study|Treated|71
390474|NCT01831466|957207|P2|STARTED|Overall Study|Treated|70
390475|NCT01831466|957208|P1|STARTED|Overall Study|Treated|71
390476|NCT01831258|957330|P2|NOT COMPLETED|Overall Study||3
390477|NCT01831258|957331|P1|NOT COMPLETED|Overall Study||5
390478|NCT01831258|957330|P2|COMPLETED|Overall Study||32
390479|NCT01831258|957331|P1|COMPLETED|Overall Study||30
390480|NCT01831258|957330|P2|STARTED|Overall Study||35
390481|NCT01831258|957331|P1|STARTED|Overall Study||35
390482|NCT01831232|957357|P1|NOT COMPLETED|Overall Study||0
390483|NCT01831232|957357|P1|COMPLETED|Overall Study||24
390484|NCT01831232|957357|P1|STARTED|Overall Study||24
390485|NCT01831219|957368|P2|NOT COMPLETED|Overall Study||24
390486|NCT01831219|957369|P1|NOT COMPLETED|Overall Study||33
390487|NCT01831219|957368|P2|COMPLETED|Overall Study||21
390488|NCT01831219|957369|P1|COMPLETED|Overall Study||40
390489|NCT01831219|957368|P2|STARTED|Overall Study||45
390490|NCT01831219|957369|P1|STARTED|Overall Study||73
390491|NCT01831154|957390|P3|NOT COMPLETED|Overall Study||0
390492|NCT01831154|957391|P2|NOT COMPLETED|Overall Study||0
390493|NCT01831154|957392|P1|NOT COMPLETED|Overall Study||0
390494|NCT01831154|957390|P3|COMPLETED|Overall Study||11
390495|NCT01831154|957391|P2|COMPLETED|Overall Study||11
390496|NCT01831154|957392|P1|COMPLETED|Overall Study||15
390497|NCT01831154|957390|P3|STARTED|Overall Study|Study IRB approval 11-11-2009, first subjects enrolled 6-7-2010|11
390498|NCT01831154|957391|P2|STARTED|Overall Study|Study IRB approval 11-11-2009, first subjects enrolled 6-7-2010|11
390499|NCT01831154|957392|P1|STARTED|Overall Study|Study Institutional Review Board (IRB) approval 11-11-2009, first subjects enrolled 6-7-2010|15
390500|NCT01830972|957417|P2|NOT COMPLETED|Part IV||1
390501|NCT01830972|957418|P1|NOT COMPLETED|Part IV||3
390502|NCT01830972|957417|P2|COMPLETED|Part IV||10
390503|NCT01830972|957418|P1|COMPLETED|Part IV||39
390504|NCT01830972|957417|P2|STARTED|Part IV||11
390505|NCT01830972|957418|P1|STARTED|Part IV||42
390506|NCT01830972|957417|P2|NOT COMPLETED|Part III||0
390507|NCT01830972|957418|P1|NOT COMPLETED|Part III||2
390508|NCT01830972|957417|P2|COMPLETED|Part III||11
390509|NCT01830972|957418|P1|COMPLETED|Part III||42
390510|NCT01830972|957417|P2|STARTED|Part III||11
390511|NCT01830972|957418|P1|STARTED|Part III|2 participants withdrew consent and did not enter Part 3|44
390512|NCT01830972|957417|P2|NOT COMPLETED|Part II||2
390513|NCT01830972|957418|P1|NOT COMPLETED|Part II||2
390514|NCT01830972|957417|P2|COMPLETED|Part II||11
390515|NCT01830972|957418|P1|COMPLETED|Part II||44
390516|NCT01830972|957417|P2|STARTED|Part II|Entered study at Part 2|13
390517|NCT01830972|957418|P1|STARTED|Part II||46
390518|NCT01830972|957417|P2|NOT COMPLETED|Part I||0
390519|NCT01830972|957418|P1|NOT COMPLETED|Part I||0
390520|NCT01830972|957417|P2|COMPLETED|Part I|Not applicable; participants in this arm entered during Part 2.|0
390521|NCT01830972|957418|P1|COMPLETED|Part I||46
390522|NCT01830972|957417|P2|STARTED|Part I|Not applicable; participants in this arm entered during Part 2.|0
390523|NCT01830972|957418|P1|STARTED|Part I||46
390524|NCT01830933|957444|P2|NOT COMPLETED|Overall Study||232
390525|NCT01830933|957445|P1|NOT COMPLETED|Overall Study||168
390526|NCT01830933|957444|P2|COMPLETED|Overall Study||580
390527|NCT01830933|957445|P1|COMPLETED|Overall Study||655
390528|NCT01830933|957444|P2|Completed Meet-up|Overall Study||603
390529|NCT01830933|957445|P1|Completed Meet-up|Overall Study||675
390530|NCT01830933|957444|P2|STARTED|Overall Study||812
390531|NCT01830933|957445|P1|STARTED|Overall Study||823
390532|NCT01830920|957462|P5|NOT COMPLETED|Overall Study||8
390533|NCT01830920|957463|P4|NOT COMPLETED|Overall Study||16
390534|NCT01830920|957464|P3|NOT COMPLETED|Overall Study||8
390535|NCT01830920|957465|P2|NOT COMPLETED|Overall Study||6
390536|NCT01830920|957466|P1|NOT COMPLETED|Overall Study||21
390537|NCT01830920|957462|P5|COMPLETED|Overall Study||99
390538|NCT01830920|957463|P4|COMPLETED|Overall Study||109
390539|NCT01830920|957464|P3|COMPLETED|Overall Study||40
390540|NCT01830920|957465|P2|COMPLETED|Overall Study||40
390541|NCT01830920|957466|P1|COMPLETED|Overall Study||105
390542|NCT01830920|957462|P5|Received Allocated Drug|Overall Study||105
390543|NCT01830920|957463|P4|Received Allocated Drug|Overall Study||119
390544|NCT01830920|957464|P3|Received Allocated Drug|Overall Study||47
390545|NCT01830920|957465|P2|Received Allocated Drug|Overall Study||45
390546|NCT01830920|957466|P1|Received Allocated Drug|Overall Study||115
390547|NCT01830920|957462|P5|STARTED|Overall Study||107
390548|NCT01830920|957463|P4|STARTED|Overall Study||125
390549|NCT01830920|957464|P3|STARTED|Overall Study||48
390550|NCT01830920|957465|P2|STARTED|Overall Study||46
390551|NCT01830920|957466|P1|STARTED|Overall Study||126
390552|NCT01830881|957505|P2|NOT COMPLETED|Overall Study||1
390553|NCT01830881|957506|P1|NOT COMPLETED|Overall Study||0
390554|NCT01830881|957505|P2|COMPLETED|Overall Study||61
390555|NCT01830881|957506|P1|COMPLETED|Overall Study||62
390556|NCT01830881|957505|P2|STARTED|Overall Study||62
390557|NCT01830881|957506|P1|STARTED|Overall Study||62
390558|NCT01830855|957554|P4|NOT COMPLETED|Overall Study||82
390559|NCT01830855|957555|P3|NOT COMPLETED|Overall Study||66
390560|NCT01830855|957556|P2|NOT COMPLETED|Overall Study||61
390561|NCT01830855|957557|P1|NOT COMPLETED|Overall Study||155
390562|NCT01830855|957554|P4|COMPLETED|Overall Study||815
390563|NCT01830855|957555|P3|COMPLETED|Overall Study||521
390564|NCT01830855|957556|P2|COMPLETED|Overall Study||537
390565|NCT01830855|957557|P1|COMPLETED|Overall Study||1353
390566|NCT01830855|957554|P4|STARTED|Overall Study||897
390567|NCT01830855|957555|P3|STARTED|Overall Study||587
390568|NCT01830855|957556|P2|STARTED|Overall Study||598
390569|NCT01830855|957557|P1|STARTED|Overall Study||1508
390570|NCT01830842|957663|P2|NOT COMPLETED|Overall Study||2
390571|NCT01830842|957664|P1|NOT COMPLETED|Overall Study||5
390572|NCT01830842|957663|P2|COMPLETED|Overall Study||22
390573|NCT01830842|957664|P1|COMPLETED|Overall Study||25
390574|NCT01830842|957663|P2|STARTED|Overall Study||24
390575|NCT01830842|957664|P1|STARTED|Overall Study||30
390576|NCT01830790|957672|P2|NOT COMPLETED|Overall Study||0
390577|NCT01830790|957673|P1|NOT COMPLETED|Overall Study||0
390578|NCT01830790|957672|P2|COMPLETED|Overall Study||10
390579|NCT01830790|957673|P1|COMPLETED|Overall Study||0
390580|NCT01830790|957672|P2|STARTED|Overall Study||10
390581|NCT01830790|957673|P1|STARTED|Overall Study||0
390582|NCT01830699|957683|P2|NOT COMPLETED|Overall Study||0
390583|NCT01830699|957684|P1|NOT COMPLETED|Overall Study||0
390584|NCT01830699|957683|P2|COMPLETED|Overall Study||20
390585|NCT01830699|957684|P1|COMPLETED|Overall Study||13
390586|NCT01830699|957683|P2|STARTED|Overall Study||20
390587|NCT01830699|957684|P1|STARTED|Overall Study||13
390588|NCT01830543|957697|P3|NOT COMPLETED|Overall Study||214
390589|NCT01830543|957698|P2|NOT COMPLETED|Overall Study||152
390590|NCT01830543|957699|P1|NOT COMPLETED|Overall Study||159
390591|NCT01830543|957697|P3|COMPLETED|Overall Study||492
390592|NCT01830543|957698|P2|COMPLETED|Overall Study||557
390593|NCT01830543|957699|P1|COMPLETED|Overall Study||550
390594|NCT01830543|957697|P3|Treated|Overall Study||697
390595|NCT01830543|957698|P2|Treated|Overall Study||706
390596|NCT01830543|957699|P1|Treated|Overall Study||696
390597|NCT01830543|957697|P3|STARTED|Overall Study||706
390598|NCT01830543|957698|P2|STARTED|Overall Study||709
390599|NCT01830543|957699|P1|STARTED|Overall Study||709
390600|NCT01830205|957735|P4|NOT COMPLETED|Overall Study||0
390601|NCT01830205|957736|P3|NOT COMPLETED|Overall Study||0
390602|NCT01830205|957737|P2|NOT COMPLETED|Overall Study||0
390603|NCT01830205|957738|P1|NOT COMPLETED|Overall Study||0
390604|NCT01830205|957735|P4|COMPLETED|Overall Study||12
390605|NCT01830205|957736|P3|COMPLETED|Overall Study||6
390606|NCT01830205|957737|P2|COMPLETED|Overall Study||6
390607|NCT01830205|957738|P1|COMPLETED|Overall Study||12
390608|NCT01830205|957735|P4|STARTED|Overall Study||12
390609|NCT01830205|957736|P3|STARTED|Overall Study||6
390610|NCT01830205|957737|P2|STARTED|Overall Study||6
390611|NCT01830205|957738|P1|STARTED|Overall Study||12
390612|NCT01830140|957822|P2|NOT COMPLETED|Overall Study||4
390613|NCT01830140|957823|P1|NOT COMPLETED|Overall Study||7
390614|NCT01830140|957822|P2|COMPLETED|Overall Study||229
390615|NCT01830140|957823|P1|COMPLETED|Overall Study||226
390616|NCT01830140|957822|P2|STARTED|Overall Study||233
390617|NCT01830140|957823|P1|STARTED|Overall Study||233
390618|NCT01830127|957831|P2|NOT COMPLETED|Overall Study||9
390619|NCT01830127|957832|P1|NOT COMPLETED|Overall Study||5
390620|NCT01830127|957831|P2|COMPLETED|Overall Study||8
390621|NCT01830127|957832|P1|COMPLETED|Overall Study||13
390622|NCT01830127|957831|P2|STARTED|Overall Study||17
390623|NCT01830127|957832|P1|STARTED|Overall Study||18
390624|NCT01829919|957840|P1|NOT COMPLETED|Overall Study||0
390625|NCT01829919|957840|P1|COMPLETED|Overall Study||24
390626|NCT01829919|957840|P1|STARTED|Overall Study||24
390627|NCT01829516|957856|P2|NOT COMPLETED|2nd Intervention||0
390628|NCT01829516|957857|P1|NOT COMPLETED|2nd Intervention||0
390629|NCT01829516|957856|P2|COMPLETED|2nd Intervention||14
390630|NCT01829516|957857|P1|COMPLETED|2nd Intervention||18
390631|NCT01829516|957856|P2|STARTED|2nd Intervention||14
390632|NCT01829516|957857|P1|STARTED|2nd Intervention||18
390633|NCT01829516|957856|P2|NOT COMPLETED|Washout Period - 1 Week||0
390634|NCT01829516|957857|P1|NOT COMPLETED|Washout Period - 1 Week||0
390635|NCT01829516|957856|P2|COMPLETED|Washout Period - 1 Week||14
390636|NCT01829516|957857|P1|COMPLETED|Washout Period - 1 Week||18
390637|NCT01829516|957856|P2|STARTED|Washout Period - 1 Week||14
390638|NCT01829516|957857|P1|STARTED|Washout Period - 1 Week||18
390639|NCT01829516|957856|P2|NOT COMPLETED|First Intervention||0
390640|NCT01829516|957857|P1|NOT COMPLETED|First Intervention||0
390641|NCT01829516|957856|P2|COMPLETED|First Intervention||14
390642|NCT01829516|957857|P1|COMPLETED|First Intervention||18
390643|NCT01829516|957856|P2|STARTED|First Intervention||14
390644|NCT01829516|957857|P1|STARTED|First Intervention||18
390645|NCT01829503|957865|P1|NOT COMPLETED|Overall Study||0
390646|NCT01829503|957865|P1|COMPLETED|Overall Study||44
390647|NCT01829503|957865|P1|STARTED|Overall Study||44
390648|NCT01829477|957881|P2|NOT COMPLETED|Overall Study||15
390649|NCT01829477|957882|P1|NOT COMPLETED|Overall Study||16
390650|NCT01829477|957881|P2|COMPLETED|Overall Study||1
390651|NCT01829477|957882|P1|COMPLETED|Overall Study||1
390652|NCT01829477|957881|P2|STARTED|Overall Study||16
390653|NCT01829477|957882|P1|STARTED|Overall Study||17
390654|NCT01829464|957895|P3|NOT COMPLETED|Overall Study||26
390655|NCT01829464|957896|P2|NOT COMPLETED|Overall Study||29
390656|NCT01829464|957897|P1|NOT COMPLETED|Overall Study||28
390657|NCT01829464|957895|P3|COMPLETED|Overall Study||3
390658|NCT01829464|957896|P2|COMPLETED|Overall Study||2
390659|NCT01829464|957897|P1|COMPLETED|Overall Study||2
390660|NCT01829464|957895|P3|STARTED|Overall Study||29
390661|NCT01829464|957896|P2|STARTED|Overall Study||31
390662|NCT01829464|957897|P1|STARTED|Overall Study||30
390663|NCT01829399|957913|P2|NOT COMPLETED|Visit 2 (One Month Later)||0
390664|NCT01829399|957914|P1|NOT COMPLETED|Visit 2 (One Month Later)||0
390665|NCT01829399|957913|P2|COMPLETED|Visit 2 (One Month Later)||12
390666|NCT01829399|957914|P1|COMPLETED|Visit 2 (One Month Later)||12
390667|NCT01829399|957913|P2|STARTED|Visit 2 (One Month Later)||12
390668|NCT01829399|957914|P1|STARTED|Visit 2 (One Month Later)||12
390669|NCT01829399|957913|P2|NOT COMPLETED|Visit 1||0
390670|NCT01829399|957914|P1|NOT COMPLETED|Visit 1||0
390671|NCT01829399|957913|P2|COMPLETED|Visit 1||12
390672|NCT01829399|957914|P1|COMPLETED|Visit 1||12
390673|NCT01829399|957913|P2|STARTED|Visit 1||12
390674|NCT01829399|957914|P1|STARTED|Visit 1||12
390675|NCT01829243|957922|P2|NOT COMPLETED|Second Intervention||0
390676|NCT01829243|957923|P1|NOT COMPLETED|Second Intervention||0
390677|NCT01829243|957922|P2|COMPLETED|Second Intervention||13
390678|NCT01829243|957923|P1|COMPLETED|Second Intervention||7
390679|NCT01829243|957922|P2|STARTED|Second Intervention||13
390680|NCT01829243|957923|P1|STARTED|Second Intervention||7
390681|NCT01829243|957922|P2|NOT COMPLETED|Washout Period of 1 Week||0
390682|NCT01829243|957923|P1|NOT COMPLETED|Washout Period of 1 Week||0
390683|NCT01829243|957922|P2|COMPLETED|Washout Period of 1 Week||13
390684|NCT01829243|957923|P1|COMPLETED|Washout Period of 1 Week||7
390685|NCT01829243|957922|P2|STARTED|Washout Period of 1 Week||13
390686|NCT01829243|957923|P1|STARTED|Washout Period of 1 Week||7
390687|NCT01829243|957922|P2|NOT COMPLETED|First Intervention||2
390688|NCT01829243|957923|P1|NOT COMPLETED|First Intervention||4
390689|NCT01829243|957922|P2|COMPLETED|First Intervention||13
390690|NCT01829243|957923|P1|COMPLETED|First Intervention||7
390691|NCT01829243|957922|P2|STARTED|First Intervention||15
390692|NCT01829243|957923|P1|STARTED|First Intervention||11
390693|NCT01829230|957937|P2|NOT COMPLETED|Overall Study||4
390694|NCT01829230|957938|P1|NOT COMPLETED|Overall Study||1
390695|NCT01829230|957937|P2|COMPLETED|Overall Study||38
390696|NCT01829230|957938|P1|COMPLETED|Overall Study||39
390697|NCT01829230|957937|P2|STARTED|Overall Study||42
390698|NCT01829230|957938|P1|STARTED|Overall Study||40
390699|NCT01829191|957948|P2|NOT COMPLETED|Overall Study||14
390700|NCT01829191|957949|P1|NOT COMPLETED|Overall Study||7
390701|NCT01829191|957948|P2|COMPLETED|Overall Study||50
390702|NCT01829191|957949|P1|COMPLETED|Overall Study||56
390703|NCT01829191|957948|P2|STARTED|Overall Study||64
390704|NCT01829191|957949|P1|STARTED|Overall Study||63
390705|NCT01829165|957958|P2|NOT COMPLETED|Overall Study||0
390706|NCT01829165|957959|P1|NOT COMPLETED|Overall Study||2
390707|NCT01829165|957958|P2|COMPLETED|Overall Study||13
390708|NCT01829165|957959|P1|COMPLETED|Overall Study||18
390709|NCT01829165|957958|P2|STARTED|Overall Study||13
390710|NCT01829165|957959|P1|STARTED|Overall Study||20
390711|NCT01829113|957967|P2|NOT COMPLETED|Overall Study||78
390712|NCT01829113|957968|P1|NOT COMPLETED|Overall Study||77
390713|NCT01829113|957967|P2|COMPLETED|Overall Study||0
390714|NCT01829113|957968|P1|COMPLETED|Overall Study||0
390715|NCT01829113|957967|P2|STARTED|Overall Study|Two patients were enrolled and randomized but never received treatment.|78
390716|NCT01829113|957968|P1|STARTED|Overall Study|Three patients were enrolled and randomized but never received treatment.|77
390717|NCT01828983|957982|P2|NOT COMPLETED|Overall Study||0
390718|NCT01828983|957983|P1|NOT COMPLETED|Overall Study||0
390719|NCT01828983|957982|P2|COMPLETED|Overall Study||81
390720|NCT01828983|957983|P1|COMPLETED|Overall Study||80
390721|NCT01828983|957982|P2|STARTED|Overall Study||81
390722|NCT01828983|957983|P1|STARTED|Overall Study||80
390723|NCT01828593|957996|P3|NOT COMPLETED|Placebo-Free Phase||6
390724|NCT01828593|957997|P2|NOT COMPLETED|Placebo-Free Phase||6
390725|NCT01828593|957998|P1|NOT COMPLETED|Placebo-Free Phase||0
390726|NCT01828593|957996|P3|COMPLETED|Placebo-Free Phase|SBI 5.0 g includes SBI 5.0 plus placebo who started taking SBI at Wk 4|41
390727|NCT01828593|957997|P2|COMPLETED|Placebo-Free Phase|SBI 2.5 g includes SBI 2.5 plus placebo who started taking SBI at Wk 4|49
390728|NCT01828593|957998|P1|COMPLETED|Placebo-Free Phase|Placebo subjects took either SBI 2.5 or 5.0 g in the placebo-free phase|0
390729|NCT01828593|957996|P3|STARTED|Placebo-Free Phase|SBI 5.0 g includes SBI 5.0 plus placebo who started taking SBI at Wk 4|47
390730|NCT01828593|957997|P2|STARTED|Placebo-Free Phase|SBI 2.5 g includes SBI 2.5 plus placebo who started taking SBI at Wk 4|55
390731|NCT01828593|957998|P1|STARTED|Placebo-Free Phase|Placebo subjects took either SBI 2.5 or 5.0 g in the placebo-free phase|0
390732|NCT01828593|957996|P3|NOT COMPLETED|Placebo-Controlled Phase||1
390733|NCT01828593|957997|P2|NOT COMPLETED|Placebo-Controlled Phase||0
390734|NCT01828593|957998|P1|NOT COMPLETED|Placebo-Controlled Phase||0
390735|NCT01828593|957996|P3|COMPLETED|Placebo-Controlled Phase||32
390736|NCT01828593|957997|P2|COMPLETED|Placebo-Controlled Phase||34
390737|NCT01828593|957998|P1|COMPLETED|Placebo-Controlled Phase||36
390738|NCT01828593|957996|P3|STARTED|Placebo-Controlled Phase||33
390739|NCT01828593|957997|P2|STARTED|Placebo-Controlled Phase||34
390740|NCT01828593|957998|P1|STARTED|Placebo-Controlled Phase||36
390741|NCT01828476|958021|P2|NOT COMPLETED|Overall Study||0
390742|NCT01828476|958022|P1|NOT COMPLETED|Overall Study||0
390743|NCT01828476|958021|P2|COMPLETED|Overall Study||0
390744|NCT01828476|958022|P1|COMPLETED|Overall Study||13
390745|NCT01828476|958021|P2|STARTED|Overall Study||0
390746|NCT01828476|958022|P1|STARTED|Overall Study||13
390747|NCT01828281|958044|P2|NOT COMPLETED|Overall Study||0
390748|NCT01828281|958045|P1|NOT COMPLETED|Overall Study||1
390749|NCT01828281|958044|P2|COMPLETED|Overall Study||45
390750|NCT01828281|958045|P1|COMPLETED|Overall Study||44
390751|NCT01828281|958044|P2|STARTED|Overall Study||45
390752|NCT01828281|958045|P1|STARTED|Overall Study||45
390753|NCT01828216|958057|P2|NOT COMPLETED|Overall Study||0
390754|NCT01828216|958058|P1|NOT COMPLETED|Overall Study||0
390755|NCT01828216|958057|P2|COMPLETED|Overall Study||157
390756|NCT01828216|958058|P1|COMPLETED|Overall Study||159
390757|NCT01828216|958057|P2|STARTED|Overall Study||157
390758|NCT01828216|958058|P1|STARTED|Overall Study||159
390759|NCT01828164|958066|P1|NOT COMPLETED|Overall Study||17
390760|NCT01828164|958066|P1|COMPLETED|Overall Study||32
390761|NCT01828164|958066|P1|STARTED|Overall Study|11 out of 60 subjects did not meet inclusion criteria after enrollment.|49
390762|NCT01828112|958078|P2|NOT COMPLETED|Overall Study||108
390763|NCT01828112|958079|P1|NOT COMPLETED|Overall Study||82
390764|NCT01828112|958078|P2|COMPLETED|Overall Study|Completed = Ongoing at time of data cut-off of 26-Jan-2016|8
390765|NCT01828112|958079|P1|COMPLETED|Overall Study|Completed = Ongoing at time of data cut-off of 26-Jan-2016|33
390766|NCT01828112|958078|P2|Treated|Overall Study||113
390767|NCT01828112|958079|P1|Treated|Overall Study||115
390768|NCT01828112|958078|P2|Untreated|Overall Study||3
390769|NCT01828112|958079|P1|Untreated|Overall Study||0
390770|NCT01828112|958078|P2|Untreated Patients|Overall Study|untreated = did not receive study drug|3
390771|NCT01828112|958079|P1|Untreated Patients|Overall Study||0
390772|NCT01828112|958078|P2|Discontinued From Study|Overall Study||10
390773|NCT01828112|958079|P1|Discontinued From Study|Overall Study||14
390774|NCT01828112|958078|P2|Entered Survival Follow-up Phase|Overall Study||19
390775|NCT01828112|958079|P1|Entered Survival Follow-up Phase|Overall Study||61
390776|NCT01828112|958078|P2|Entered Post-treatment Follow-up Phase|Overall Study||5
390777|NCT01828112|958079|P1|Entered Post-treatment Follow-up Phase|Overall Study||7
390778|NCT01828112|958078|P2|Entered Extension Treatment Phase|Overall Study||74
390779|NCT01828112|958079|P1|Entered Extension Treatment Phase|Overall Study||0
390780|NCT01828112|958078|P2|STARTED|Overall Study||116
390781|NCT01828112|958079|P1|STARTED|Overall Study||115
390782|NCT01828099|958087|P2|NOT COMPLETED|Overall Study||157
390783|NCT01828099|958088|P1|NOT COMPLETED|Overall Study||94
390784|NCT01828099|958087|P2|COMPLETED|Overall Study|Completed = Patients ongoing at the time of data cut-off of 24-Jun-2016|30
390785|NCT01828099|958088|P1|COMPLETED|Overall Study|Completed = Patients ongoing at the time of data cut-off of 24-Jun-2016|95
390786|NCT01828099|958087|P2|Discontinued From Study|Overall Study||29
390787|NCT01828099|958088|P1|Discontinued From Study|Overall Study||20
390788|NCT01828099|958087|P2|Entered Survival Follow-up Phase|Overall Study||31
390789|NCT01828099|958088|P1|Entered Survival Follow-up Phase|Overall Study||64
390790|NCT01828099|958087|P2|Entered Post-treatment Follow-up Phase|Overall Study||16
390791|NCT01828099|958088|P1|Entered Post-treatment Follow-up Phase|Overall Study||10
390792|NCT01828099|958087|P2|Entered Extension-treatment Phase|Overall Study||81
390793|NCT01828099|958088|P1|Entered Extension-treatment Phase|Overall Study||0
390794|NCT01828099|958087|P2|Discontinued From Treatment Phase|Overall Study||157
390795|NCT01828099|958088|P1|Discontinued From Treatment Phase|Overall Study||94
390796|NCT01828099|958087|P2|Treated|Overall Study||175
390797|NCT01828099|958088|P1|Treated|Overall Study|discontinued from treatment phase = Not completed|189
390798|NCT01828099|958087|P2|Untreated Patients|Overall Study||12
390799|NCT01828099|958088|P1|Untreated Patients|Overall Study||0
390800|NCT01828099|958087|P2|STARTED|Overall Study||187
390801|NCT01828099|958088|P1|STARTED|Overall Study||189
390802|NCT01827839|958094|P1|NOT COMPLETED|Overall Study||3
390803|NCT01827839|958094|P1|COMPLETED|Overall Study||93
390804|NCT01827839|958094|P1|STARTED|Overall Study||96
390805|NCT01827670|958118|P2|NOT COMPLETED|Overall Study||3
390806|NCT01827670|958119|P1|NOT COMPLETED|Overall Study||3
390807|NCT01827670|958118|P2|COMPLETED|Overall Study||56
390808|NCT01827670|958119|P1|COMPLETED|Overall Study||57
390809|NCT01827670|958118|P2|STARTED|Overall Study||59
390810|NCT01827670|958119|P1|STARTED|Overall Study||60
390811|NCT01827592|958138|P3|NOT COMPLETED|Overall Study||76
390812|NCT01827592|958139|P2|NOT COMPLETED|Overall Study||80
390813|NCT01827592|958140|P1|NOT COMPLETED|Overall Study||74
390814|NCT01827592|958138|P3|COMPLETED|Overall Study||48
390815|NCT01827592|958139|P2|COMPLETED|Overall Study||46
390816|NCT01827592|958140|P1|COMPLETED|Overall Study||52
390817|NCT01827592|958138|P3|Safety Analysis Set|Overall Study||124
390818|NCT01827592|958139|P2|Safety Analysis Set|Overall Study||126
390819|NCT01827592|958140|P1|Safety Analysis Set|Overall Study|1 patient withdrew consent before getting the treatment.|125
390820|NCT01827592|958138|P3|STARTED|Overall Study|Randomized patients.|124
390821|NCT01827592|958139|P2|STARTED|Overall Study|Randomized patients.|126
390822|NCT01827592|958140|P1|STARTED|Overall Study|Randomized patients.|126
390823|NCT01827475|958172|P3|NOT COMPLETED|Overall Study||0
390824|NCT01827475|958173|P2|NOT COMPLETED|Overall Study||0
390825|NCT01827475|958174|P1|NOT COMPLETED|Overall Study||0
390826|NCT01827475|958172|P3|COMPLETED|Overall Study||30
390827|NCT01827475|958173|P2|COMPLETED|Overall Study||30
390828|NCT01827475|958174|P1|COMPLETED|Overall Study||30
390829|NCT01827475|958172|P3|STARTED|Overall Study||30
390830|NCT01827475|958173|P2|STARTED|Overall Study||30
390831|NCT01827475|958174|P1|STARTED|Overall Study||30
390832|NCT01827462|958188|P3|NOT COMPLETED|Overall Study||28
390833|NCT01827462|958189|P2|NOT COMPLETED|Overall Study||18
390834|NCT01827462|958190|P1|NOT COMPLETED|Overall Study||41
390835|NCT01827462|958188|P3|COMPLETED|Overall Study||12
390836|NCT01827462|958189|P2|COMPLETED|Overall Study||19
390837|NCT01827462|958190|P1|COMPLETED|Overall Study||18
390838|NCT01827462|958188|P3|STARTED|Overall Study||40
390839|NCT01827462|958189|P2|STARTED|Overall Study||37
390840|NCT01827462|958190|P1|STARTED|Overall Study||59
390841|NCT01827371|958205|P4|NOT COMPLETED|Overall Study||23
390842|NCT01827371|958206|P3|NOT COMPLETED|Overall Study||11
390843|NCT01827371|958207|P2|NOT COMPLETED|Overall Study||7
390844|NCT01827371|958208|P1|NOT COMPLETED|Overall Study||13
390845|NCT01827371|958205|P4|COMPLETED|Overall Study||97
390846|NCT01827371|958206|P3|COMPLETED|Overall Study||93
390847|NCT01827371|958207|P2|COMPLETED|Overall Study||89
390848|NCT01827371|958208|P1|COMPLETED|Overall Study||102
390849|NCT01827371|958205|P4|STARTED|Overall Study||120
390850|NCT01827371|958206|P3|STARTED|Overall Study||104
390851|NCT01827371|958207|P2|STARTED|Overall Study||96
390852|NCT01827371|958208|P1|STARTED|Overall Study||115
390853|NCT01827358|958232|P2|NOT COMPLETED|Overall Study||31
390854|NCT01827358|958233|P1|NOT COMPLETED|Overall Study||35
390855|NCT01827358|958232|P2|COMPLETED|Overall Study||44
390856|NCT01827358|958233|P1|COMPLETED|Overall Study||45
390857|NCT01827358|958232|P2|STARTED|Overall Study||75
390858|NCT01827358|958233|P1|STARTED|Overall Study||80
390859|NCT01827332|958267|P2|NOT COMPLETED|Overall Study||1
390860|NCT01827332|958268|P1|NOT COMPLETED|Overall Study||2
390861|NCT01827332|958267|P2|COMPLETED|Overall Study||7
390862|NCT01827332|958268|P1|COMPLETED|Overall Study||6
390863|NCT01827332|958267|P2|STARTED|Overall Study||8
390864|NCT01827332|958268|P1|STARTED|Overall Study||8
390865|NCT01827319|958276|P1|NOT COMPLETED|Overall Study||3
390866|NCT01827319|958276|P1|COMPLETED|Overall Study||200
390867|NCT01827319|958276|P1|STARTED|Overall Study||203
390868|NCT01827306|958284|P2|NOT COMPLETED|Overall Study||5
390869|NCT01827306|958285|P1|NOT COMPLETED|Overall Study||11
390870|NCT01827306|958284|P2|COMPLETED|Overall Study||8
390871|NCT01827306|958285|P1|COMPLETED|Overall Study||10
390872|NCT01827306|958284|P2|STARTED|Overall Study||13
390873|NCT01827306|958285|P1|STARTED|Overall Study||21
390874|NCT01827267|958299|P2|NOT COMPLETED|Overall Study||12
390875|NCT01827267|958300|P1|NOT COMPLETED|Overall Study||5
390876|NCT01827267|958299|P2|COMPLETED|Overall Study||32
390877|NCT01827267|958300|P1|COMPLETED|Overall Study||13
390878|NCT01827267|958299|P2|Recieved Study Drug|Overall Study||43
390879|NCT01827267|958300|P1|Recieved Study Drug|Overall Study||17
390880|NCT01827267|958299|P2|STARTED|Overall Study|44 subjects were randomized; 43 subjects were treated.|44
390881|NCT01827267|958300|P1|STARTED|Overall Study|18 subjects were randomized but 17 received treatment.|18
390882|NCT01827254|958315|P1|NOT COMPLETED|Overall Study||59
390883|NCT01827254|958315|P1|COMPLETED|Overall Study||2
390884|NCT01827254|958315|P1|Evaluable Population|Overall Study||52
390885|NCT01827254|958315|P1|STARTED|Overall Study||61
390886|NCT01826981|958340|P15|NOT COMPLETED|Overall Study||0
390887|NCT01826981|958341|P14|NOT COMPLETED|Overall Study||5
390888|NCT01826981|958342|P13|NOT COMPLETED|Overall Study||1
390889|NCT01826981|958343|P12|NOT COMPLETED|Overall Study||2
390890|NCT01826981|958344|P11|NOT COMPLETED|Overall Study||2
390891|NCT01826981|958345|P10|NOT COMPLETED|Overall Study||1
390892|NCT01826981|958346|P9|NOT COMPLETED|Overall Study||7
390893|NCT01826981|958347|P8|NOT COMPLETED|Overall Study||11
390894|NCT01826981|958348|P7|NOT COMPLETED|Overall Study||1
390895|NCT01826981|958349|P6|NOT COMPLETED|Overall Study||1
390896|NCT01826981|958350|P5|NOT COMPLETED|Overall Study||7
390897|NCT01826981|958351|P4|NOT COMPLETED|Overall Study||0
390898|NCT01826981|958352|P3|NOT COMPLETED|Overall Study||0
390899|NCT01826981|958353|P2|NOT COMPLETED|Overall Study||1
390900|NCT01826981|958354|P1|NOT COMPLETED|Overall Study||0
390901|NCT01826981|958340|P15|COMPLETED|Overall Study||8
390902|NCT01826981|958341|P14|COMPLETED|Overall Study||15
390903|NCT01826981|958342|P13|COMPLETED|Overall Study||25
390904|NCT01826981|958343|P12|COMPLETED|Overall Study||25
390905|NCT01826981|958344|P11|COMPLETED|Overall Study||22
390906|NCT01826981|958345|P10|COMPLETED|Overall Study||26
390907|NCT01826981|958346|P9|COMPLETED|Overall Study||13
390908|NCT01826981|958347|P8|COMPLETED|Overall Study||40
390909|NCT01826981|958348|P7|COMPLETED|Overall Study||24
390910|NCT01826981|958349|P6|COMPLETED|Overall Study||25
390911|NCT01826981|958350|P5|COMPLETED|Overall Study||18
390912|NCT01826981|958351|P4|COMPLETED|Overall Study||26
390913|NCT01826981|958352|P3|COMPLETED|Overall Study||25
390914|NCT01826981|958353|P2|COMPLETED|Overall Study||9
390915|NCT01826981|958354|P1|COMPLETED|Overall Study||19
390916|NCT01826981|958340|P15|STARTED|Overall Study||8
390917|NCT01826981|958341|P14|STARTED|Overall Study||20
390918|NCT01826981|958342|P13|STARTED|Overall Study||26
390919|NCT01826981|958343|P12|STARTED|Overall Study||27
390920|NCT01826981|958344|P11|STARTED|Overall Study||24
390921|NCT01826981|958345|P10|STARTED|Overall Study||27
390922|NCT01826981|958346|P9|STARTED|Overall Study||20
390923|NCT01826981|958347|P8|STARTED|Overall Study||51
390924|NCT01826981|958348|P7|STARTED|Overall Study||25
390925|NCT01826981|958349|P6|STARTED|Overall Study||26
390926|NCT01826981|958350|P5|STARTED|Overall Study||25
390927|NCT01826981|958351|P4|STARTED|Overall Study||26
390928|NCT01826981|958352|P3|STARTED|Overall Study||25
390929|NCT01826981|958353|P2|STARTED|Overall Study||10
390930|NCT01826981|958354|P1|STARTED|Overall Study||19
390931|NCT01826812|958502|P2|NOT COMPLETED|Overall Study||1
390932|NCT01826812|958503|P1|NOT COMPLETED|Overall Study||0
390933|NCT01826812|958502|P2|COMPLETED|Overall Study||32
390934|NCT01826812|958503|P1|COMPLETED|Overall Study||167
390935|NCT01826812|958502|P2|STARTED|Overall Study||33
390936|NCT01826812|958503|P1|STARTED|Overall Study||167
390937|NCT01826604|958519|P2|NOT COMPLETED|Overall Study||9
390938|NCT01826604|958520|P1|NOT COMPLETED|Overall Study||8
390939|NCT01826604|958519|P2|COMPLETED|Overall Study||148
390940|NCT01826604|958520|P1|COMPLETED|Overall Study||136
390941|NCT01826604|958519|P2|STARTED|Overall Study||157
390942|NCT01826604|958520|P1|STARTED|Overall Study||144
390943|NCT01826513|958531|P3|NOT COMPLETED|Overall Study||0
390944|NCT01826513|958532|P2|NOT COMPLETED|Overall Study||0
390945|NCT01826513|958533|P1|NOT COMPLETED|Overall Study||0
390946|NCT01826513|958531|P3|COMPLETED|Overall Study||10
390947|NCT01826513|958532|P2|COMPLETED|Overall Study||10
390948|NCT01826513|958533|P1|COMPLETED|Overall Study||5
390949|NCT01826513|958531|P3|STARTED|Overall Study||10
390950|NCT01826513|958532|P2|STARTED|Overall Study||10
390951|NCT01826513|958533|P1|STARTED|Overall Study||5
390952|NCT01826422|958564|P2|NOT COMPLETED|Overall Study||3
390953|NCT01826422|958565|P1|NOT COMPLETED|Overall Study||1
390954|NCT01826422|958564|P2|COMPLETED|Overall Study||19
390955|NCT01826422|958565|P1|COMPLETED|Overall Study||17
390956|NCT01826422|958564|P2|STARTED|Overall Study||22
390957|NCT01826422|958565|P1|STARTED|Overall Study||18
390958|NCT01826370|958609|P1|NOT COMPLETED|Overall Study||20
390959|NCT01826370|958609|P1|COMPLETED|Overall Study||658
390960|NCT01826370|958609|P1|STARTED|Overall Study||678
390961|NCT01826227|958615|P1|NOT COMPLETED|Overall Study||0
390962|NCT01826227|958615|P1|COMPLETED|Overall Study||5
390963|NCT01826227|958615|P1|STARTED|Overall Study||5
390964|NCT01826214|958621|P2|NOT COMPLETED|Overall Study||34
390965|NCT01826214|958622|P1|NOT COMPLETED|Overall Study||35
390966|NCT01826214|958621|P2|COMPLETED|Overall Study||0
390967|NCT01826214|958622|P1|COMPLETED|Overall Study||0
390968|NCT01826214|958621|P2|Treated|Overall Study|Treated = received at least one dose of study drug|34
390969|NCT01826214|958622|P1|Treated|Overall Study|Treated = received at least one dose of study drug|35
390970|NCT01826214|958621|P2|Untreated|Overall Study|Untreated = did not receive study drug|1
390971|NCT01826214|958622|P1|Untreated|Overall Study|Untreated = did not receive study drug|0
390972|NCT01826214|958621|P2|STARTED|Overall Study|35 patients were randomized but only 34 patients received at least one dose of study drug|34
390973|NCT01826214|958622|P1|STARTED|Overall Study||35
390974|NCT01826201|958640|P1|NOT COMPLETED|Overall Study||4
390975|NCT01826201|958640|P1|COMPLETED|Overall Study||17
390976|NCT01826201|958640|P1|STARTED|Overall Study|Subjects in each arm are same|21
390977|NCT01825941|958648|P2|NOT COMPLETED|Overall Study||1
390978|NCT01825941|958649|P1|NOT COMPLETED|Overall Study||4
390979|NCT01825941|958648|P2|COMPLETED|Overall Study||103
390980|NCT01825941|958649|P1|COMPLETED|Overall Study||100
390981|NCT01825941|958648|P2|STARTED|Overall Study||104
390982|NCT01825941|958649|P1|STARTED|Overall Study||104
390983|NCT01825837|958659|P4|NOT COMPLETED|PART II||0
390984|NCT01825837|958660|P3|NOT COMPLETED|PART II||19
390985|NCT01825837|958661|P2|NOT COMPLETED|PART II||14
390986|NCT01825837|958662|P1|NOT COMPLETED|PART II||19
390987|NCT01825837|958659|P4|COMPLETED|PART II||0
390988|NCT01825837|958660|P3|COMPLETED|PART II||7
390989|NCT01825837|958661|P2|COMPLETED|PART II||12
390990|NCT01825837|958662|P1|COMPLETED|PART II||16
390991|NCT01825837|958659|P4|Per-Protocol Population|PART II||0
390992|NCT01825837|958660|P3|Per-Protocol Population|PART II||24
390993|NCT01825837|958661|P2|Per-Protocol Population|PART II||23
390994|NCT01825837|958662|P1|Per-Protocol Population|PART II||32
390995|NCT01825837|958659|P4|Intent-to-Treat Population|PART II||0
390996|NCT01825837|958660|P3|Intent-to-Treat Population|PART II||26
390997|NCT01825837|958661|P2|Intent-to-Treat Population|PART II||25
390998|NCT01825837|958662|P1|Intent-to-Treat Population|PART II||34
390999|NCT01825837|958659|P4|Safety Population (Double-Blind)|PART II||0
391000|NCT01825837|958660|P3|Safety Population (Double-Blind)|PART II||26
391001|NCT01825837|958661|P2|Safety Population (Double-Blind)|PART II||26
391002|NCT01825837|958662|P1|Safety Population (Double-Blind)|PART II||35
391003|NCT01825837|958659|P4|Randomized Patients|PART II||0
391004|NCT01825837|958660|P3|Randomized Patients|PART II||26
391005|NCT01825837|958661|P2|Randomized Patients|PART II||26
391006|NCT01825837|958662|P1|Randomized Patients|PART II||35
391007|NCT01825837|958659|P4|STARTED|PART II||0
391008|NCT01825837|958660|P3|STARTED|PART II||26
391009|NCT01825837|958661|P2|STARTED|PART II||26
391010|NCT01825837|958662|P1|STARTED|PART II||35
391011|NCT01825837|958659|P4|NOT COMPLETED|PART I||17
391012|NCT01825837|958660|P3|NOT COMPLETED|PART I||0
391013|NCT01825837|958661|P2|NOT COMPLETED|PART I||0
391014|NCT01825837|958662|P1|NOT COMPLETED|PART I||0
391015|NCT01825837|958659|P4|COMPLETED|PART I||87
391016|NCT01825837|958660|P3|COMPLETED|PART I||0
391017|NCT01825837|958661|P2|COMPLETED|PART I||0
391018|NCT01825837|958662|P1|COMPLETED|PART I||0
391019|NCT01825837|958659|P4|Safety Population (Open-Label)|PART I||104
391020|NCT01825837|958660|P3|Safety Population (Open-Label)|PART I||0
391021|NCT01825837|958661|P2|Safety Population (Open-Label)|PART I||0
391022|NCT01825837|958662|P1|Safety Population (Open-Label)|PART I||0
391023|NCT01825837|958659|P4|Enrolled|PART I||104
391024|NCT01825837|958660|P3|Enrolled|PART I||0
391025|NCT01825837|958661|P2|Enrolled|PART I||0
391026|NCT01825837|958662|P1|Enrolled|PART I||0
391027|NCT01825837|958659|P4|STARTED|PART I||104
391028|NCT01825837|958660|P3|STARTED|PART I||0
391029|NCT01825837|958661|P2|STARTED|PART I||0
391030|NCT01825837|958662|P1|STARTED|PART I||0
391031|NCT01825798|958672|P2|NOT COMPLETED|Overall Study||5
391032|NCT01825798|958673|P1|NOT COMPLETED|Overall Study||2
391033|NCT01825798|958672|P2|COMPLETED|Overall Study||23
391034|NCT01825798|958673|P1|COMPLETED|Overall Study||30
391035|NCT01825798|958672|P2|STARTED|Overall Study||28
391036|NCT01825798|958673|P1|STARTED|Overall Study||32
391037|NCT01825577|958701|P1|NOT COMPLETED|Overall Study||8
391038|NCT01825577|958701|P1|COMPLETED|Overall Study||6
391039|NCT01825577|958701|P1|STARTED|Overall Study||14
391040|NCT01825408|958710|P4|NOT COMPLETED|Overall Study||0
391041|NCT01825408|958711|P3|NOT COMPLETED|Overall Study||0
391042|NCT01825408|958712|P2|NOT COMPLETED|Overall Study||0
391043|NCT01825408|958713|P1|NOT COMPLETED|Overall Study||0
391044|NCT01825408|958710|P4|COMPLETED|Overall Study||12
391045|NCT01825408|958711|P3|COMPLETED|Overall Study||14
391046|NCT01825408|958712|P2|COMPLETED|Overall Study||7
391047|NCT01825408|958713|P1|COMPLETED|Overall Study||7
391048|NCT01825408|958710|P4|STARTED|Overall Study||12
391049|NCT01825408|958711|P3|STARTED|Overall Study||14
391050|NCT01825408|958712|P2|STARTED|Overall Study||7
391051|NCT01825408|958713|P1|STARTED|Overall Study||7
391052|NCT01825200|958725|P2|NOT COMPLETED|Overall Study||7
391053|NCT01825200|958726|P1|NOT COMPLETED|Overall Study||5
391054|NCT01825200|958725|P2|COMPLETED|Overall Study||1314
391055|NCT01825200|958726|P1|COMPLETED|Overall Study||1314
391056|NCT01825200|958725|P2|STARTED|Overall Study||1321
391057|NCT01825200|958726|P1|STARTED|Overall Study||1319
391058|NCT01825122|958740|P2|NOT COMPLETED|Overall Study||19
391059|NCT01825122|958741|P1|NOT COMPLETED|Overall Study||10
391060|NCT01825122|958740|P2|COMPLETED|Overall Study||59
391061|NCT01825122|958741|P1|COMPLETED|Overall Study||67
391062|NCT01825122|958740|P2|STARTED|Overall Study||78
391063|NCT01825122|958741|P1|STARTED|Overall Study||77
391064|NCT01824979|958749|P2|NOT COMPLETED|Overall Study||13
391065|NCT01824979|958750|P1|NOT COMPLETED|Overall Study||13
391066|NCT01824979|958749|P2|COMPLETED|Overall Study||37
391067|NCT01824979|958750|P1|COMPLETED|Overall Study||37
391068|NCT01824979|958749|P2|STARTED|Overall Study||50
391069|NCT01824979|958750|P1|STARTED|Overall Study||50
391070|NCT01824901|958758|P4|NOT COMPLETED|Overall Study||0
391071|NCT01824901|958759|P3|NOT COMPLETED|Overall Study||0
391072|NCT01824901|958760|P2|NOT COMPLETED|Overall Study||0
391073|NCT01824901|958761|P1|NOT COMPLETED|Overall Study||0
391074|NCT01824901|958758|P4|COMPLETED|Overall Study||0
391075|NCT01824901|958759|P3|COMPLETED|Overall Study||0
391076|NCT01824901|958760|P2|COMPLETED|Overall Study||0
391077|NCT01824901|958761|P1|COMPLETED|Overall Study||2
391078|NCT01824901|958758|P4|STARTED|Overall Study||0
391079|NCT01824901|958759|P3|STARTED|Overall Study||0
391080|NCT01824901|958760|P2|STARTED|Overall Study||0
391081|NCT01824901|958761|P1|STARTED|Overall Study||2
391082|NCT01824823|958767|P2|NOT COMPLETED|Overall Study||1
391083|NCT01824823|958768|P1|NOT COMPLETED|Overall Study||2
391084|NCT01824823|958767|P2|COMPLETED|Overall Study||0
391085|NCT01824823|958768|P1|COMPLETED|Overall Study||0
391086|NCT01824823|958767|P2|STARTED|Overall Study||1
391087|NCT01824823|958768|P1|STARTED|Overall Study||2
391088|NCT01824602|958778|P4|NOT COMPLETED|Overall Study||5
391089|NCT01824602|958779|P3|NOT COMPLETED|Overall Study||4
391090|NCT01824602|958780|P2|NOT COMPLETED|Overall Study||0
391091|NCT01824602|958781|P1|NOT COMPLETED|Overall Study||1
391092|NCT01824602|958778|P4|COMPLETED|Overall Study||5
391093|NCT01824602|958779|P3|COMPLETED|Overall Study||5
391094|NCT01824602|958780|P2|COMPLETED|Overall Study||8
391095|NCT01824602|958781|P1|COMPLETED|Overall Study||10
391096|NCT01824602|958778|P4|Intent-to-treat Population|Overall Study||9
391097|NCT01824602|958779|P3|Intent-to-treat Population|Overall Study||9
391098|NCT01824602|958780|P2|Intent-to-treat Population|Overall Study||8
391099|NCT01824602|958781|P1|Intent-to-treat Population|Overall Study||11
391100|NCT01824602|958778|P4|Safety Population|Overall Study||10
391101|NCT01824602|958779|P3|Safety Population|Overall Study||9
391102|NCT01824602|958780|P2|Safety Population|Overall Study||8
391103|NCT01824602|958781|P1|Safety Population|Overall Study||11
391104|NCT01824602|958778|P4|STARTED|Overall Study||10
391105|NCT01824602|958779|P3|STARTED|Overall Study||9
391106|NCT01824602|958780|P2|STARTED|Overall Study||8
391107|NCT01824602|958781|P1|STARTED|Overall Study||11
391108|NCT01824589|958795|P4|NOT COMPLETED|Overall Study||0
391109|NCT01824589|958796|P3|NOT COMPLETED|Overall Study||0
391110|NCT01824589|958797|P2|NOT COMPLETED|Overall Study||0
391111|NCT01824589|958798|P1|NOT COMPLETED|Overall Study||0
391112|NCT01824589|958795|P4|COMPLETED|Overall Study||0
391113|NCT01824589|958796|P3|COMPLETED|Overall Study||0
391114|NCT01824589|958797|P2|COMPLETED|Overall Study||0
391115|NCT01824589|958798|P1|COMPLETED|Overall Study||1
391116|NCT01824589|958795|P4|STARTED|Overall Study||0
391117|NCT01824589|958796|P3|STARTED|Overall Study||0
391118|NCT01824589|958797|P2|STARTED|Overall Study||0
391119|NCT01824589|958798|P1|STARTED|Overall Study||1
391120|NCT01824576|958820|P1|NOT COMPLETED|Overall Study||2
391121|NCT01824576|958820|P1|COMPLETED|Overall Study||7
391122|NCT01824576|958820|P1|STARTED|Overall Study||9
391123|NCT01824498|958838|P6|NOT COMPLETED|3rd Intervention (8 Weeks)||0
391124|NCT01824498|958839|P5|NOT COMPLETED|3rd Intervention (8 Weeks)||0
391125|NCT01824498|958840|P4|NOT COMPLETED|3rd Intervention (8 Weeks)||0
391126|NCT01824498|958841|P3|NOT COMPLETED|3rd Intervention (8 Weeks)||0
391127|NCT01824498|958842|P2|NOT COMPLETED|3rd Intervention (8 Weeks)||0
391128|NCT01824498|958843|P1|NOT COMPLETED|3rd Intervention (8 Weeks)||0
391129|NCT01824498|958838|P6|COMPLETED|3rd Intervention (8 Weeks)||4
391130|NCT01824498|958839|P5|COMPLETED|3rd Intervention (8 Weeks)||3
391131|NCT01824498|958840|P4|COMPLETED|3rd Intervention (8 Weeks)||2
391132|NCT01824498|958841|P3|COMPLETED|3rd Intervention (8 Weeks)||4
391133|NCT01824498|958842|P2|COMPLETED|3rd Intervention (8 Weeks)||2
391134|NCT01824498|958843|P1|COMPLETED|3rd Intervention (8 Weeks)||3
391135|NCT01824498|958838|P6|STARTED|3rd Intervention (8 Weeks)||4
391136|NCT01824498|958839|P5|STARTED|3rd Intervention (8 Weeks)||3
391137|NCT01824498|958840|P4|STARTED|3rd Intervention (8 Weeks)||2
391138|NCT01824498|958841|P3|STARTED|3rd Intervention (8 Weeks)||4
391139|NCT01824498|958842|P2|STARTED|3rd Intervention (8 Weeks)||2
391140|NCT01824498|958843|P1|STARTED|3rd Intervention (8 Weeks)||3
391141|NCT01824498|958838|P6|NOT COMPLETED|Washout (8 Weeks)||0
391142|NCT01824498|958839|P5|NOT COMPLETED|Washout (8 Weeks)||0
391143|NCT01824498|958840|P4|NOT COMPLETED|Washout (8 Weeks)||0
391144|NCT01824498|958841|P3|NOT COMPLETED|Washout (8 Weeks)||0
391145|NCT01824498|958842|P2|NOT COMPLETED|Washout (8 Weeks)||0
391146|NCT01824498|958843|P1|NOT COMPLETED|Washout (8 Weeks)||0
391147|NCT01824498|958838|P6|COMPLETED|Washout (8 Weeks)||4
391148|NCT01824498|958839|P5|COMPLETED|Washout (8 Weeks)||3
391149|NCT01824498|958840|P4|COMPLETED|Washout (8 Weeks)||2
391150|NCT01824498|958841|P3|COMPLETED|Washout (8 Weeks)||4
391151|NCT01824498|958842|P2|COMPLETED|Washout (8 Weeks)||2
391152|NCT01824498|958843|P1|COMPLETED|Washout (8 Weeks)||3
391153|NCT01824498|958838|P6|STARTED|Washout (8 Weeks)||4
391154|NCT01824498|958839|P5|STARTED|Washout (8 Weeks)||3
391155|NCT01824498|958840|P4|STARTED|Washout (8 Weeks)||2
391156|NCT01824498|958841|P3|STARTED|Washout (8 Weeks)||4
391157|NCT01824498|958842|P2|STARTED|Washout (8 Weeks)||2
391158|NCT01824498|958843|P1|STARTED|Washout (8 Weeks)||3
391159|NCT01824498|958838|P6|NOT COMPLETED|2nd Intervention (8 Weeks)||0
391160|NCT01824498|958839|P5|NOT COMPLETED|2nd Intervention (8 Weeks)||0
391161|NCT01824498|958840|P4|NOT COMPLETED|2nd Intervention (8 Weeks)||0
391162|NCT01824498|958841|P3|NOT COMPLETED|2nd Intervention (8 Weeks)||0
391163|NCT01824498|958842|P2|NOT COMPLETED|2nd Intervention (8 Weeks)||0
391164|NCT01824498|958843|P1|NOT COMPLETED|2nd Intervention (8 Weeks)||0
391165|NCT01824498|958838|P6|COMPLETED|2nd Intervention (8 Weeks)||4
391166|NCT01824498|958839|P5|COMPLETED|2nd Intervention (8 Weeks)||3
391167|NCT01824498|958840|P4|COMPLETED|2nd Intervention (8 Weeks)||2
391168|NCT01824498|958841|P3|COMPLETED|2nd Intervention (8 Weeks)||4
391169|NCT01824498|958842|P2|COMPLETED|2nd Intervention (8 Weeks)||2
391170|NCT01824498|958843|P1|COMPLETED|2nd Intervention (8 Weeks)||3
391171|NCT01824498|958838|P6|STARTED|2nd Intervention (8 Weeks)||4
391172|NCT01824498|958839|P5|STARTED|2nd Intervention (8 Weeks)||3
391173|NCT01824498|958840|P4|STARTED|2nd Intervention (8 Weeks)||2
391174|NCT01824498|958841|P3|STARTED|2nd Intervention (8 Weeks)||4
391175|NCT01824498|958842|P2|STARTED|2nd Intervention (8 Weeks)||2
391176|NCT01824498|958843|P1|STARTED|2nd Intervention (8 Weeks)||3
391177|NCT01824498|958838|P6|NOT COMPLETED|Washout (8 Weeks)||0
391178|NCT01824498|958839|P5|NOT COMPLETED|Washout (8 Weeks)||1
391179|NCT01824498|958840|P4|NOT COMPLETED|Washout (8 Weeks)||1
391180|NCT01824498|958841|P3|NOT COMPLETED|Washout (8 Weeks)||2
391181|NCT01824498|958842|P2|NOT COMPLETED|Washout (8 Weeks)||0
391182|NCT01824498|958843|P1|NOT COMPLETED|Washout (8 Weeks)||2
391183|NCT01824498|958838|P6|COMPLETED|Washout (8 Weeks)||4
391184|NCT01824498|958839|P5|COMPLETED|Washout (8 Weeks)||3
391185|NCT01824498|958840|P4|COMPLETED|Washout (8 Weeks)||2
391186|NCT01824498|958841|P3|COMPLETED|Washout (8 Weeks)||4
391187|NCT01824498|958842|P2|COMPLETED|Washout (8 Weeks)||2
391188|NCT01824498|958843|P1|COMPLETED|Washout (8 Weeks)||3
391189|NCT01824498|958838|P6|STARTED|Washout (8 Weeks)||4
391190|NCT01824498|958839|P5|STARTED|Washout (8 Weeks)|1 dropped out|4
391191|NCT01824498|958840|P4|STARTED|Washout (8 Weeks)|1 dropped out|3
391192|NCT01824498|958841|P3|STARTED|Washout (8 Weeks)|2 dropped out|6
391193|NCT01824498|958842|P2|STARTED|Washout (8 Weeks)||2
391194|NCT01824498|958843|P1|STARTED|Washout (8 Weeks)|2 dropped out|5
391195|NCT01824498|958838|P6|NOT COMPLETED|1st Intervention (8 Weeks)||0
391196|NCT01824498|958839|P5|NOT COMPLETED|1st Intervention (8 Weeks)||0
391197|NCT01824498|958840|P4|NOT COMPLETED|1st Intervention (8 Weeks)||0
391198|NCT01824498|958841|P3|NOT COMPLETED|1st Intervention (8 Weeks)||0
391199|NCT01824498|958842|P2|NOT COMPLETED|1st Intervention (8 Weeks)||0
391200|NCT01824498|958843|P1|NOT COMPLETED|1st Intervention (8 Weeks)||0
391201|NCT01824498|958838|P6|COMPLETED|1st Intervention (8 Weeks)||4
391202|NCT01824498|958839|P5|COMPLETED|1st Intervention (8 Weeks)||4
391203|NCT01824498|958840|P4|COMPLETED|1st Intervention (8 Weeks)||3
391204|NCT01824498|958841|P3|COMPLETED|1st Intervention (8 Weeks)||6
391205|NCT01824498|958842|P2|COMPLETED|1st Intervention (8 Weeks)||2
391206|NCT01824498|958843|P1|COMPLETED|1st Intervention (8 Weeks)||5
391207|NCT01824498|958838|P6|STARTED|1st Intervention (8 Weeks)||4
391208|NCT01824498|958839|P5|STARTED|1st Intervention (8 Weeks)||4
391209|NCT01824498|958840|P4|STARTED|1st Intervention (8 Weeks)||3
391210|NCT01824498|958841|P3|STARTED|1st Intervention (8 Weeks)||6
391211|NCT01824498|958842|P2|STARTED|1st Intervention (8 Weeks)||2
391212|NCT01824498|958843|P1|STARTED|1st Intervention (8 Weeks)||5
391213|NCT01824446|958851|P1|NOT COMPLETED|Overall Study||0
391214|NCT01824446|958851|P1|COMPLETED|Overall Study||6
391215|NCT01824446|958851|P1|STARTED|Overall Study||6
391216|NCT01824355|958874|P1|NOT COMPLETED|Overall Study||3
391217|NCT01824355|958874|P1|COMPLETED|Overall Study||110
391218|NCT01824355|958874|P1|STARTED|Overall Study||113
391219|NCT01824342|958885|P2|NOT COMPLETED|Overall Study||5
391220|NCT01824342|958886|P1|NOT COMPLETED|Overall Study||9
391221|NCT01824342|958885|P2|COMPLETED|Overall Study||2
391222|NCT01824342|958886|P1|COMPLETED|Overall Study||2
391223|NCT01824342|958885|P2|STARTED|Overall Study||7
391224|NCT01824342|958886|P1|STARTED|Overall Study||11
391225|NCT01824303|958900|P2|NOT COMPLETED|Open Label Extension||0
391226|NCT01824303|958901|P1|NOT COMPLETED|Open Label Extension||0
391227|NCT01824303|958900|P2|COMPLETED|Open Label Extension||11
391228|NCT01824303|958901|P1|COMPLETED|Open Label Extension||12
391229|NCT01824303|958900|P2|STARTED|Open Label Extension|2 participants completed the Randomized Study but did not enter the Open Label Extension.|11
391230|NCT01824303|958901|P1|STARTED|Open Label Extension|2 participants completed the Randomized Study but did not enter the Open Label Extension.|12
391231|NCT01824303|958900|P2|NOT COMPLETED|Randomized Study||1
391232|NCT01824303|958901|P1|NOT COMPLETED|Randomized Study||2
391233|NCT01824303|958900|P2|COMPLETED|Randomized Study||13
391234|NCT01824303|958901|P1|COMPLETED|Randomized Study||14
391235|NCT01824303|958900|P2|STARTED|Randomized Study||14
391236|NCT01824303|958901|P1|STARTED|Randomized Study||16
391237|NCT01824160|958925|P1|NOT COMPLETED|Overall Study||0
391238|NCT01824160|958925|P1|COMPLETED|Overall Study||50
391239|NCT01824160|958925|P1|STARTED|Overall Study||50
391240|NCT01823679|958929|P1|NOT COMPLETED|Overall Study||1
391241|NCT01823679|958929|P1|COMPLETED|Overall Study||1
391242|NCT01823679|958929|P1|STARTED|Overall Study||2
391243|NCT01823653|958937|P1|NOT COMPLETED|Overall Study||0
391244|NCT01823653|958937|P1|COMPLETED|Overall Study||60
391245|NCT01823653|958937|P1|STARTED|Overall Study||60
391246|NCT01823614|958951|P6|NOT COMPLETED|Overall Study||0
391247|NCT01823614|958952|P5|NOT COMPLETED|Overall Study||0
391248|NCT01823614|958953|P4|NOT COMPLETED|Overall Study||0
391249|NCT01823614|958954|P3|NOT COMPLETED|Overall Study||0
391250|NCT01823614|958955|P2|NOT COMPLETED|Overall Study||0
391251|NCT01823614|958956|P1|NOT COMPLETED|Overall Study||0
391252|NCT01823614|958951|P6|COMPLETED|Overall Study||154
391253|NCT01823614|958952|P5|COMPLETED|Overall Study||172
391254|NCT01823614|958953|P4|COMPLETED|Overall Study||122
391255|NCT01823614|958954|P3|COMPLETED|Overall Study||176
391256|NCT01823614|958955|P2|COMPLETED|Overall Study||140
391257|NCT01823614|958956|P1|COMPLETED|Overall Study||179
391258|NCT01823614|958951|P6|STARTED|Overall Study||154
391259|NCT01823614|958952|P5|STARTED|Overall Study||172
391260|NCT01823614|958953|P4|STARTED|Overall Study||122
391261|NCT01823614|958954|P3|STARTED|Overall Study||176
391262|NCT01823614|958955|P2|STARTED|Overall Study||140
391263|NCT01823614|958956|P1|STARTED|Overall Study||179
391264|NCT01823536|958982|P6|NOT COMPLETED|Overall Study||0
391265|NCT01823536|958983|P5|NOT COMPLETED|Overall Study||2
391266|NCT01823536|958984|P4|NOT COMPLETED|Overall Study||2
391267|NCT01823536|958985|P3|NOT COMPLETED|Overall Study||1
391268|NCT01823536|958986|P2|NOT COMPLETED|Overall Study||2
391269|NCT01823536|958987|P1|NOT COMPLETED|Overall Study||2
391270|NCT01823536|958982|P6|COMPLETED|Overall Study||2
391271|NCT01823536|958983|P5|COMPLETED|Overall Study||99
391272|NCT01823536|958984|P4|COMPLETED|Overall Study||64
391273|NCT01823536|958985|P3|COMPLETED|Overall Study||119
391274|NCT01823536|958986|P2|COMPLETED|Overall Study||101
391275|NCT01823536|958987|P1|COMPLETED|Overall Study||71
391276|NCT01823536|958982|P6|STARTED|Overall Study||2
391277|NCT01823536|958983|P5|STARTED|Overall Study||101
391278|NCT01823536|958984|P4|STARTED|Overall Study||66
391279|NCT01823536|958985|P3|STARTED|Overall Study||120
391280|NCT01823536|958986|P2|STARTED|Overall Study||103
391281|NCT01823536|958987|P1|STARTED|Overall Study||73
391282|NCT01823510|959025|P2|NOT COMPLETED|Days 22-28||0
391283|NCT01823510|959026|P1|NOT COMPLETED|Days 22-28||0
391284|NCT01823510|959025|P2|COMPLETED|Days 22-28||10
391285|NCT01823510|959026|P1|COMPLETED|Days 22-28||10
391286|NCT01823510|959025|P2|STARTED|Days 22-28||10
391287|NCT01823510|959026|P1|STARTED|Days 22-28||10
391288|NCT01823510|959025|P2|NOT COMPLETED|Days 8-21||0
391289|NCT01823510|959026|P1|NOT COMPLETED|Days 8-21||0
391290|NCT01823510|959025|P2|COMPLETED|Days 8-21||10
391291|NCT01823510|959026|P1|COMPLETED|Days 8-21||10
391292|NCT01823510|959025|P2|STARTED|Days 8-21||10
391293|NCT01823510|959026|P1|STARTED|Days 8-21||10
391294|NCT01823510|959025|P2|NOT COMPLETED|Days 1-7||0
391295|NCT01823510|959026|P1|NOT COMPLETED|Days 1-7||0
391296|NCT01823510|959025|P2|COMPLETED|Days 1-7||10
391297|NCT01823510|959026|P1|COMPLETED|Days 1-7||10
391298|NCT01823510|959025|P2|STARTED|Days 1-7||10
391299|NCT01823510|959026|P1|STARTED|Days 1-7||10
391300|NCT01823341|959038|P1|NOT COMPLETED|Overall Study||15
391301|NCT01823341|959038|P1|COMPLETED|Overall Study||82
391302|NCT01823341|959038|P1|STARTED|Overall Study||97
391303|NCT01823289|959081|P1|NOT COMPLETED|Overall Study||24
391304|NCT01823289|959081|P1|COMPLETED|Overall Study||47
391305|NCT01823289|959081|P1|STARTED|Overall Study||71
391306|NCT01823224|959089|P2|NOT COMPLETED|Overall Study||11
391307|NCT01823224|959090|P1|NOT COMPLETED|Overall Study||6
391308|NCT01823224|959089|P2|COMPLETED|Overall Study||22
391309|NCT01823224|959090|P1|COMPLETED|Overall Study||28
391310|NCT01823224|959089|P2|STARTED|Overall Study||33
391311|NCT01823224|959090|P1|STARTED|Overall Study||34
391312|NCT01823146|959100|P2|NOT COMPLETED|Overall Study||2
391313|NCT01823146|959101|P1|NOT COMPLETED|Overall Study||2
391314|NCT01823146|959100|P2|COMPLETED|Overall Study||49
391315|NCT01823146|959101|P1|COMPLETED|Overall Study||53
391316|NCT01823146|959100|P2|STARTED|Overall Study||51
391317|NCT01823146|959101|P1|STARTED|Overall Study||55
391318|NCT01822899|959113|P2|NOT COMPLETED|Overall Study||18
391319|NCT01822899|959114|P1|NOT COMPLETED|Overall Study||24
391320|NCT01822899|959113|P2|COMPLETED|Overall Study||340
391321|NCT01822899|959114|P1|COMPLETED|Overall Study||334
391322|NCT01822899|959113|P2|STARTED|Overall Study||358
391323|NCT01822899|959114|P1|STARTED|Overall Study||358
391324|NCT01822821|959124|P2|NOT COMPLETED|Overall Study||1
391325|NCT01822821|959125|P1|NOT COMPLETED|Overall Study||2
391326|NCT01822821|959124|P2|COMPLETED|Overall Study||74
391327|NCT01822821|959125|P1|COMPLETED|Overall Study||73
391328|NCT01822821|959124|P2|STARTED|Overall Study||75
391329|NCT01822821|959125|P1|STARTED|Overall Study||75
391330|NCT01822756|959154|P5|NOT COMPLETED|Overall Study||7
391331|NCT01822756|959155|P4|NOT COMPLETED|Overall Study||4
391332|NCT01822756|959156|P3|NOT COMPLETED|Overall Study||10
391333|NCT01822756|959157|P2|NOT COMPLETED|Overall Study||4
391334|NCT01822756|959158|P1|NOT COMPLETED|Overall Study||16
391335|NCT01822756|959154|P5|COMPLETED|Overall Study||1
391336|NCT01822756|959155|P4|COMPLETED|Overall Study||0
391337|NCT01822756|959156|P3|COMPLETED|Overall Study||0
391338|NCT01822756|959157|P2|COMPLETED|Overall Study||0
391339|NCT01822756|959158|P1|COMPLETED|Overall Study||0
391340|NCT01822756|959154|P5|Discontinued From the Study|Overall Study||7
391341|NCT01822756|959155|P4|Discontinued From the Study|Overall Study||4
391342|NCT01822756|959156|P3|Discontinued From the Study|Overall Study||10
391343|NCT01822756|959157|P2|Discontinued From the Study|Overall Study||4
391344|NCT01822756|959158|P1|Discontinued From the Study|Overall Study||16
391345|NCT01822756|959154|P5|STARTED|Overall Study||8
391346|NCT01822756|959155|P4|STARTED|Overall Study||4
391347|NCT01822756|959156|P3|STARTED|Overall Study||10
391348|NCT01822756|959157|P2|STARTED|Overall Study||4
391349|NCT01822756|959158|P1|STARTED|Overall Study||16
391350|NCT01822691|959200|P1|NOT COMPLETED|Overall Study||2
391351|NCT01822691|959200|P1|COMPLETED|Overall Study||13
391352|NCT01822691|959200|P1|STARTED|Overall Study||15
391353|NCT01822678|959211|P3|NOT COMPLETED|Overall Study||11
391354|NCT01822678|959212|P2|NOT COMPLETED|Overall Study||15
391355|NCT01822678|959213|P1|NOT COMPLETED|Overall Study||12
391356|NCT01822678|959211|P3|COMPLETED|Overall Study||29
391357|NCT01822678|959212|P2|COMPLETED|Overall Study||49
391358|NCT01822678|959213|P1|COMPLETED|Overall Study||45
391359|NCT01822678|959211|P3|Per Protocol Population|Overall Study||34
391360|NCT01822678|959212|P2|Per Protocol Population|Overall Study||52
391361|NCT01822678|959213|P1|Per Protocol Population|Overall Study||45
391362|NCT01822678|959211|P3|Intention-to-Treat Population (ITT)|Overall Study||40
391363|NCT01822678|959212|P2|Intention-to-Treat Population (ITT)|Overall Study|1 patient was excluded from the ITT population because he did not have post baseline efficacy data|63
391364|NCT01822678|959213|P1|Intention-to-Treat Population (ITT)|Overall Study||57
391365|NCT01822678|959211|P3|Safety Population|Overall Study||40
391366|NCT01822678|959212|P2|Safety Population|Overall Study||64
391367|NCT01822678|959213|P1|Safety Population|Overall Study||57
391368|NCT01822678|959211|P3|Treated|Overall Study||40
391369|NCT01822678|959212|P2|Treated|Overall Study||64
391370|NCT01822678|959213|P1|Treated|Overall Study||57
391371|NCT01822678|959211|P3|STARTED|Overall Study||40
391372|NCT01822678|959212|P2|STARTED|Overall Study||64
391373|NCT01822678|959213|P1|STARTED|Overall Study||57
391374|NCT01822665|959221|P1|NOT COMPLETED|Overall Study||8
391375|NCT01822665|959221|P1|COMPLETED|Overall Study||20
391376|NCT01822665|959221|P1|Received Paracetamol Tablet (1000 mg)|Overall Study||28
391377|NCT01822665|959221|P1|Received Ibuprofen Capsule (400 mg)|Overall Study|Two participants, each in period 3 and period 4 did not complete treatment for 'other reason'.|24
391378|NCT01822665|959221|P1|Received Placebo Tablet|Overall Study|5 participants did not complete; Period 2(1:other reason); Period 4(3:adverse event; 1:other reason)|23
391379|NCT01822665|959221|P1|Received Ibuprofen Tablet (400 mg)|Overall Study|5 participants did not complete; Period 3(2:adverse events;1:other reason); Period 4(2:other reason)|23
391380|NCT01822665|959221|P1|STARTED|Overall Study||28
391381|NCT01822574|959248|P3|NOT COMPLETED|Overall Study||0
391382|NCT01822574|959249|P2|NOT COMPLETED|Overall Study||0
391383|NCT01822574|959250|P1|NOT COMPLETED|Overall Study||0
391384|NCT01822574|959248|P3|COMPLETED|Overall Study||30
391385|NCT01822574|959249|P2|COMPLETED|Overall Study||30
391386|NCT01822574|959250|P1|COMPLETED|Overall Study||30
391387|NCT01822574|959248|P3|STARTED|Overall Study||30
391388|NCT01822574|959249|P2|STARTED|Overall Study||30
391389|NCT01822574|959250|P1|STARTED|Overall Study||30
391390|NCT01822561|959264|P1|NOT COMPLETED|Overall Study||2
391391|NCT01822561|959264|P1|COMPLETED|Overall Study||13
391392|NCT01822561|959264|P1|STARTED|Overall Study||15
391393|NCT01822548|959274|P2|NOT COMPLETED|Overall Study||0
391394|NCT01822548|959275|P1|NOT COMPLETED|Overall Study||0
391395|NCT01822548|959274|P2|COMPLETED|Overall Study||24
391396|NCT01822548|959275|P1|COMPLETED|Overall Study||40
391397|NCT01822548|959274|P2|Discontinued Intervention|Overall Study||5
391398|NCT01822548|959275|P1|Discontinued Intervention|Overall Study||0
391399|NCT01822548|959274|P2|STARTED|Overall Study||24
391400|NCT01822548|959275|P1|STARTED|Overall Study|Received allocated intervention n=38 Did not receive allocated intervention (only metformin) n=2|40
391401|NCT01822535|959285|P2|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||0
391402|NCT01822535|959286|P1|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||1
391403|NCT01822535|959285|P2|COMPLETED|Visit 2 - Tetraplegia Only - Drug||0
391404|NCT01822535|959286|P1|COMPLETED|Visit 2 - Tetraplegia Only - Drug||10
391405|NCT01822535|959285|P2|STARTED|Visit 2 - Tetraplegia Only - Drug|Able-bodied subjects were not enrolled for a second visit.|0
391406|NCT01822535|959286|P1|STARTED|Visit 2 - Tetraplegia Only - Drug|These subjects were individuals who completed Visit 1 of testing.|11
391407|NCT01822535|959285|P2|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||2
391408|NCT01822535|959286|P1|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||6
391409|NCT01822535|959285|P2|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11
391410|NCT01822535|959286|P1|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11
391411|NCT01822535|959285|P2|STARTED|Visit 1 - Tetraplegia and Able-Bodied||13
391412|NCT01822535|959286|P1|STARTED|Visit 1 - Tetraplegia and Able-Bodied||17
391413|NCT01822301|959298|P1|NOT COMPLETED|Overall Study||0
391414|NCT01822301|959298|P1|COMPLETED|Overall Study||5
391415|NCT01822301|959298|P1|STARTED|Overall Study||5
391416|NCT01822223|959310|P2|NOT COMPLETED|Overall Study||1
391417|NCT01822223|959311|P1|NOT COMPLETED|Overall Study||0
391418|NCT01822223|959310|P2|COMPLETED|Overall Study||9
391419|NCT01822223|959311|P1|COMPLETED|Overall Study||10
391420|NCT01822223|959310|P2|STARTED|Overall Study||10
391421|NCT01822223|959311|P1|STARTED|Overall Study||10
391422|NCT01822197|959327|P1|NOT COMPLETED|Overall Study||0
391423|NCT01822197|959327|P1|COMPLETED|Overall Study||30
391424|NCT01822197|959327|P1|STARTED|Overall Study||30
391425|NCT01822119|959333|P1|NOT COMPLETED|Overall Study||0
391426|NCT01822119|959333|P1|COMPLETED|Overall Study||27
391427|NCT01822119|959333|P1|STARTED|Overall Study||27
391428|NCT01821963|959356|P1|NOT COMPLETED|Overall Study||1
391429|NCT01821963|959356|P1|COMPLETED|Overall Study||0
391430|NCT01821963|959356|P1|STARTED|Overall Study||1
391431|NCT01821937|959362|P2|NOT COMPLETED|Overall Study||3
391432|NCT01821937|959363|P1|NOT COMPLETED|Overall Study||0
391433|NCT01821937|959362|P2|COMPLETED|Overall Study|2 patients discontinued during Single dose period,1 Patient discontinued during Multiple dose period|12
391434|NCT01821937|959363|P1|COMPLETED|Overall Study||10
391435|NCT01821937|959362|P2|STARTED|Overall Study||15
391436|NCT01821937|959363|P1|STARTED|Overall Study||10
391437|NCT01821859|959381|P1|NOT COMPLETED|Overall Study||5
391438|NCT01821859|959381|P1|COMPLETED|Overall Study||0
391439|NCT01821859|959381|P1|STARTED|Overall Study||5
391440|NCT01821807|959387|P2|NOT COMPLETED|Overall Study||1
391441|NCT01821807|959388|P1|NOT COMPLETED|Overall Study||3
391442|NCT01821807|959387|P2|COMPLETED|Overall Study||109
391443|NCT01821807|959388|P1|COMPLETED|Overall Study||147
391444|NCT01821807|959387|P2|STARTED|Overall Study||110
391445|NCT01821807|959388|P1|STARTED|Overall Study||150
391446|NCT01821534|959396|P1|NOT COMPLETED|Overall Study||0
391447|NCT01821534|959396|P1|COMPLETED|Overall Study||201
391448|NCT01821534|959396|P1|STARTED|Overall Study||201
391449|NCT01821417|959405|P2|NOT COMPLETED|Overall Study||0
391450|NCT01821417|959406|P1|NOT COMPLETED|Overall Study||0
391451|NCT01821417|959405|P2|COMPLETED|Overall Study||31
391452|NCT01821417|959406|P1|COMPLETED|Overall Study||37
391453|NCT01821417|959405|P2|STARTED|Overall Study||31
391454|NCT01821417|959406|P1|STARTED|Overall Study||37
391455|NCT01821378|959419|P3|NOT COMPLETED|Overall Study||42
391456|NCT01821378|959420|P2|NOT COMPLETED|Overall Study||54
391457|NCT01821378|959421|P1|NOT COMPLETED|Overall Study||27
391458|NCT01821378|959419|P3|COMPLETED|Overall Study||70
391459|NCT01821378|959420|P2|COMPLETED|Overall Study||145
391460|NCT01821378|959421|P1|COMPLETED|Overall Study||74
391461|NCT01821378|959419|P3|STARTED|Overall Study||112
391462|NCT01821378|959420|P2|STARTED|Overall Study||199
391463|NCT01821378|959421|P1|STARTED|Overall Study||101
391464|NCT01821352|959459|P2|NOT COMPLETED|Overall Study||0
391465|NCT01821352|959460|P1|NOT COMPLETED|Overall Study||0
391466|NCT01821352|959459|P2|COMPLETED|Overall Study||25
391467|NCT01821352|959460|P1|COMPLETED|Overall Study||28
391468|NCT01821352|959459|P2|STARTED|Overall Study||25
391469|NCT01821352|959460|P1|STARTED|Overall Study||28
391470|NCT01821326|959470|P1|NOT COMPLETED|Overall Study||0
391471|NCT01821326|959470|P1|COMPLETED|Overall Study||339
391472|NCT01821326|959470|P1|STARTED|Overall Study||339
391473|NCT01821118|959476|P2|NOT COMPLETED|Overall Study||1
391474|NCT01821118|959477|P1|NOT COMPLETED|Overall Study||0
391475|NCT01821118|959476|P2|COMPLETED|Overall Study||11
391476|NCT01821118|959477|P1|COMPLETED|Overall Study||24
391477|NCT01821118|959476|P2|STARTED|Overall Study||12
391478|NCT01821118|959477|P1|STARTED|Overall Study||24
391479|NCT01821105|959510|P1|NOT COMPLETED|Overall Study||0
391480|NCT01821105|959510|P1|COMPLETED|Overall Study||21
391481|NCT01821105|959510|P1|STARTED|Overall Study||21
391482|NCT01820754|959516|P1|NOT COMPLETED|Overall Study||0
391483|NCT01820754|959516|P1|COMPLETED|Overall Study||24
391484|NCT01820754|959516|P1|STARTED|Overall Study||24
391485|NCT01820585|959528|P4|NOT COMPLETED|Overall Study||49
391486|NCT01820585|959529|P3|NOT COMPLETED|Overall Study||34
391487|NCT01820585|959530|P2|NOT COMPLETED|Overall Study||32
391488|NCT01820585|959531|P1|NOT COMPLETED|Overall Study||27
391489|NCT01820585|959528|P4|COMPLETED|Overall Study||83
391490|NCT01820585|959529|P3|COMPLETED|Overall Study||101
391491|NCT01820585|959530|P2|COMPLETED|Overall Study||98
391492|NCT01820585|959531|P1|COMPLETED|Overall Study||104
391493|NCT01820585|959528|P4|Completed Maintenance Period|Overall Study||84
391494|NCT01820585|959529|P3|Completed Maintenance Period|Overall Study||101
391495|NCT01820585|959530|P2|Completed Maintenance Period|Overall Study||98
391496|NCT01820585|959531|P1|Completed Maintenance Period|Overall Study||105
391497|NCT01820585|959528|P4|Entered Maintenance Period|Overall Study||123
391498|NCT01820585|959529|P3|Entered Maintenance Period|Overall Study||131
391499|NCT01820585|959530|P2|Entered Maintenance Period|Overall Study||124
391500|NCT01820585|959531|P1|Entered Maintenance Period|Overall Study||128
391501|NCT01820585|959528|P4|Completed Titration Period|Overall Study||126
391502|NCT01820585|959529|P3|Completed Titration Period|Overall Study||131
391503|NCT01820585|959530|P2|Completed Titration Period|Overall Study||125
391504|NCT01820585|959531|P1|Completed Titration Period|Overall Study||128
391505|NCT01820585|959528|P4|Full Analysis Set|Overall Study||129
391506|NCT01820585|959529|P3|Full Analysis Set|Overall Study||135
391507|NCT01820585|959530|P2|Full Analysis Set|Overall Study||130
391508|NCT01820585|959531|P1|Full Analysis Set|Overall Study||131
391509|NCT01820585|959528|P4|Randomized and Treated|Overall Study||132
391510|NCT01820585|959529|P3|Randomized and Treated|Overall Study||135
391511|NCT01820585|959530|P2|Randomized and Treated|Overall Study||130
391512|NCT01820585|959531|P1|Randomized and Treated|Overall Study||131
391513|NCT01820585|959528|P4|STARTED|Overall Study||132
391514|NCT01820585|959529|P3|STARTED|Overall Study||135
391515|NCT01820585|959530|P2|STARTED|Overall Study||130
391516|NCT01820585|959531|P1|STARTED|Overall Study||131
391517|NCT01820559|959544|P3|NOT COMPLETED|Overall Study||29
391518|NCT01820559|959545|P2|NOT COMPLETED|Overall Study||13
391519|NCT01820559|959546|P1|NOT COMPLETED|Overall Study||14
391520|NCT01820559|959544|P3|COMPLETED|Overall Study||110
391521|NCT01820559|959545|P2|COMPLETED|Overall Study||122
391522|NCT01820559|959546|P1|COMPLETED|Overall Study||122
391523|NCT01820559|959544|P3|Completed Maintenance Period|Overall Study||110
391524|NCT01820559|959545|P2|Completed Maintenance Period|Overall Study||123
391525|NCT01820559|959546|P1|Completed Maintenance Period|Overall Study||122
391526|NCT01820559|959544|P3|Entered Maintenance Period|Overall Study||129
391527|NCT01820559|959545|P2|Entered Maintenance Period|Overall Study||133
391528|NCT01820559|959546|P1|Entered Maintenance Period|Overall Study||129
391529|NCT01820559|959544|P3|Completed Tutration Period|Overall Study||131
391530|NCT01820559|959545|P2|Completed Tutration Period|Overall Study||134
391531|NCT01820559|959546|P1|Completed Tutration Period|Overall Study||130
391532|NCT01820559|959544|P3|Randomized and Treated|Overall Study||139
391533|NCT01820559|959545|P2|Randomized and Treated|Overall Study||135
391534|NCT01820559|959546|P1|Randomized and Treated|Overall Study||136
391535|NCT01820559|959544|P3|STARTED|Overall Study||139
391536|NCT01820559|959545|P2|STARTED|Overall Study||135
391537|NCT01820559|959546|P1|STARTED|Overall Study||136
391538|NCT01820416|959557|P3|NOT COMPLETED|Overall Study||0
391539|NCT01820416|959558|P2|NOT COMPLETED|Overall Study||2
391540|NCT01820416|959559|P1|NOT COMPLETED|Overall Study||3
391541|NCT01820416|959557|P3|COMPLETED|Overall Study||11
391542|NCT01820416|959558|P2|COMPLETED|Overall Study||10
391543|NCT01820416|959559|P1|COMPLETED|Overall Study||9
391544|NCT01820416|959557|P3|STARTED|Overall Study||11
391545|NCT01820416|959558|P2|STARTED|Overall Study||12
391546|NCT01820416|959559|P1|STARTED|Overall Study||12
391547|NCT01820364|959567|P2|NOT COMPLETED|Part II: LGX818 + MEK162||1
391548|NCT01820364|959568|P1|NOT COMPLETED|Part II: LGX818 + MEK162||0
391549|NCT01820364|959567|P2|COMPLETED|Part II: LGX818 + MEK162||0
391550|NCT01820364|959568|P1|COMPLETED|Part II: LGX818 + MEK162||0
391551|NCT01820364|959567|P2|STARTED|Part II: LGX818 + MEK162||1
391552|NCT01820364|959568|P1|STARTED|Part II: LGX818 + MEK162||0
391553|NCT01820364|959567|P2|NOT COMPLETED|Part I: LGX818||0
391554|NCT01820364|959568|P1|NOT COMPLETED|Part I: LGX818||14
391555|NCT01820364|959567|P2|COMPLETED|Part I: LGX818||0
391556|NCT01820364|959568|P1|COMPLETED|Part I: LGX818||1
391557|NCT01820364|959567|P2|STARTED|Part I: LGX818||0
391558|NCT01820364|959568|P1|STARTED|Part I: LGX818||15
391559|NCT01819935|959582|P2|NOT COMPLETED|Overall Study||0
391560|NCT01819935|959583|P1|NOT COMPLETED|Overall Study||0
391561|NCT01819935|959582|P2|COMPLETED|Overall Study||4943
391562|NCT01819935|959583|P1|COMPLETED|Overall Study||328
391563|NCT01819935|959582|P2|STARTED|Overall Study||4943
391564|NCT01819935|959583|P1|STARTED|Overall Study||328
391565|NCT01819922|959603|P2|NOT COMPLETED|Second Intervention Period (1 Day)||0
391566|NCT01819922|959604|P1|NOT COMPLETED|Second Intervention Period (1 Day)||0
391567|NCT01819922|959603|P2|COMPLETED|Second Intervention Period (1 Day)||6
391568|NCT01819922|959604|P1|COMPLETED|Second Intervention Period (1 Day)||6
391569|NCT01819922|959603|P2|STARTED|Second Intervention Period (1 Day)||6
391570|NCT01819922|959604|P1|STARTED|Second Intervention Period (1 Day)||6
391571|NCT01819922|959603|P2|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0
391572|NCT01819922|959604|P1|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0
391573|NCT01819922|959603|P2|COMPLETED|Washout Period (at Least 7-10 Days)||6
391574|NCT01819922|959604|P1|COMPLETED|Washout Period (at Least 7-10 Days)||6
391575|NCT01819922|959603|P2|STARTED|Washout Period (at Least 7-10 Days)||6
391576|NCT01819922|959604|P1|STARTED|Washout Period (at Least 7-10 Days)||6
391577|NCT01819922|959603|P2|NOT COMPLETED|First Intervention Period (1 Day)||0
391578|NCT01819922|959604|P1|NOT COMPLETED|First Intervention Period (1 Day)||0
391579|NCT01819922|959603|P2|COMPLETED|First Intervention Period (1 Day)||6
391580|NCT01819922|959604|P1|COMPLETED|First Intervention Period (1 Day)||6
391581|NCT01819922|959603|P2|STARTED|First Intervention Period (1 Day)||6
391582|NCT01819922|959604|P1|STARTED|First Intervention Period (1 Day)||6
391583|NCT01819883|959690|P2|NOT COMPLETED|Overall Study||0
391584|NCT01819883|959691|P1|NOT COMPLETED|Overall Study||4
391585|NCT01819883|959690|P2|COMPLETED|Overall Study||20
391586|NCT01819883|959691|P1|COMPLETED|Overall Study||16
391587|NCT01819883|959690|P2|STARTED|Overall Study||20
391588|NCT01819883|959691|P1|STARTED|Overall Study||20
391589|NCT01819844|959697|P1|NOT COMPLETED|Overall Study||0
391590|NCT01819844|959697|P1|COMPLETED|Overall Study||12
391591|NCT01819844|959697|P1|STARTED|Overall Study||12
391592|NCT01819415|959714|P4|NOT COMPLETED|Overall Study||2
391593|NCT01819415|959715|P3|NOT COMPLETED|Overall Study||1
391594|NCT01819415|959716|P2|NOT COMPLETED|Overall Study||4
391595|NCT01819415|959717|P1|NOT COMPLETED|Overall Study||3
391596|NCT01819415|959714|P4|COMPLETED|Overall Study||8
391597|NCT01819415|959715|P3|COMPLETED|Overall Study||9
391598|NCT01819415|959716|P2|COMPLETED|Overall Study||6
391599|NCT01819415|959717|P1|COMPLETED|Overall Study||7
391600|NCT01819415|959714|P4|STARTED|Overall Study||10
391601|NCT01819415|959715|P3|STARTED|Overall Study||10
391602|NCT01819415|959716|P2|STARTED|Overall Study||10
391603|NCT01819415|959717|P1|STARTED|Overall Study||10
391604|NCT01819311|959729|P2|NOT COMPLETED|Follow-up Phase (8 Weeks)||7
391605|NCT01819311|959730|P1|NOT COMPLETED|Follow-up Phase (8 Weeks)||7
391606|NCT01819311|959729|P2|COMPLETED|Follow-up Phase (8 Weeks)||23
391607|NCT01819311|959730|P1|COMPLETED|Follow-up Phase (8 Weeks)||24
391608|NCT01819311|959729|P2|STARTED|Follow-up Phase (8 Weeks)||30
391609|NCT01819311|959730|P1|STARTED|Follow-up Phase (8 Weeks)||31
391610|NCT01819311|959729|P2|NOT COMPLETED|Treatment Phase (4 Weeks)||1
391611|NCT01819311|959730|P1|NOT COMPLETED|Treatment Phase (4 Weeks)||2
391612|NCT01819311|959729|P2|COMPLETED|Treatment Phase (4 Weeks)||30
391613|NCT01819311|959730|P1|COMPLETED|Treatment Phase (4 Weeks)||31
391614|NCT01819311|959729|P2|STARTED|Treatment Phase (4 Weeks)||31
391615|NCT01819311|959730|P1|STARTED|Treatment Phase (4 Weeks)||33
391616|NCT01819272|959752|P6|NOT COMPLETED|Overall Study||7
391617|NCT01819272|959753|P5|NOT COMPLETED|Overall Study||4
391618|NCT01819272|959754|P4|NOT COMPLETED|Overall Study||5
391619|NCT01819272|959755|P3|NOT COMPLETED|Overall Study||3
391620|NCT01819272|959756|P2|NOT COMPLETED|Overall Study||3
391621|NCT01819272|959757|P1|NOT COMPLETED|Overall Study||6
391622|NCT01819272|959752|P6|COMPLETED|Overall Study||33
391623|NCT01819272|959753|P5|COMPLETED|Overall Study||36
391624|NCT01819272|959754|P4|COMPLETED|Overall Study||35
391625|NCT01819272|959755|P3|COMPLETED|Overall Study||37
391626|NCT01819272|959756|P2|COMPLETED|Overall Study||36
391627|NCT01819272|959757|P1|COMPLETED|Overall Study||35
391628|NCT01819272|959752|P6|STARTED|Overall Study||40
391629|NCT01819272|959753|P5|STARTED|Overall Study||40
391630|NCT01819272|959754|P4|STARTED|Overall Study||40
391631|NCT01819272|959755|P3|STARTED|Overall Study||40
391632|NCT01819272|959756|P2|STARTED|Overall Study||39
391633|NCT01819272|959757|P1|STARTED|Overall Study||41
391634|NCT01819194|959783|P1|NOT COMPLETED|Overall Study||2
391635|NCT01819194|959783|P1|COMPLETED|Overall Study||60
391636|NCT01819194|959783|P1|STARTED|Overall Study||62
391637|NCT01819129|959790|P2|NOT COMPLETED|Overall Study||39
391638|NCT01819129|959791|P1|NOT COMPLETED|Overall Study||44
391639|NCT01819129|959790|P2|COMPLETED|Overall Study||305
391640|NCT01819129|959791|P1|COMPLETED|Overall Study||301
391641|NCT01819129|959790|P2|Exposed|Overall Study||341
391642|NCT01819129|959791|P1|Exposed|Overall Study||341
391643|NCT01819129|959790|P2|STARTED|Overall Study||344
391644|NCT01819129|959791|P1|STARTED|Overall Study||345
391645|NCT01818752|959805|P2|NOT COMPLETED|Overall Study||198
391646|NCT01818752|959806|P1|NOT COMPLETED|Overall Study||187
391647|NCT01818752|959805|P2|COMPLETED|Overall Study|Completed treatment|280
391648|NCT01818752|959806|P1|COMPLETED|Overall Study|Completed treatment|290
391649|NCT01818752|959805|P2|Received Treatment|Overall Study||474
391650|NCT01818752|959806|P1|Received Treatment|Overall Study||470
391651|NCT01818752|959805|P2|STARTED|Overall Study||478
391652|NCT01818752|959806|P1|STARTED|Overall Study||477
391653|NCT01818700|959824|P1|NOT COMPLETED|Overall Study||104
391654|NCT01818700|959824|P1|COMPLETED|Overall Study|104 subjects dropped out this study prior to study completion.|141
391655|NCT01818700|959824|P1|PP Set|Overall Study|105 subjects excluded from PP set due to various reasons.|105
391656|NCT01818700|959824|P1|FAS Set|Overall Study|31 subjects excluded from FAS due to no assessment of primary efficacy(26) and IC/EC violation(5).|210
391657|NCT01818700|959824|P1|Safety Set|Overall Study|4 subjects were not study drug administered.|241
391658|NCT01818700|959824|P1|STARTED|Overall Study|The No. of enrolled patients|245
391659|NCT01818596|959835|P2|NOT COMPLETED|Overall Study||6
391660|NCT01818596|959836|P1|NOT COMPLETED|Overall Study||246
391661|NCT01818596|959835|P2|COMPLETED|Overall Study||0
391662|NCT01818596|959836|P1|COMPLETED|Overall Study||0
391663|NCT01818596|959835|P2|STARTED|Overall Study||6
391664|NCT01818596|959836|P1|STARTED|Overall Study||246
391665|NCT01818414|959869|P2|NOT COMPLETED|Overall Study||0
391666|NCT01818414|959870|P1|NOT COMPLETED|Overall Study||0
391667|NCT01818414|959869|P2|COMPLETED|Overall Study||15
391668|NCT01818414|959870|P1|COMPLETED|Overall Study||14
391669|NCT01818414|959869|P2|STARTED|Overall Study||15
391670|NCT01818414|959870|P1|STARTED|Overall Study||14
391671|NCT01818336|959884|P2|NOT COMPLETED|Overall Study||12
391672|NCT01818336|959885|P1|NOT COMPLETED|Overall Study||0
391673|NCT01818336|959884|P2|COMPLETED|Overall Study||47
391674|NCT01818336|959885|P1|COMPLETED|Overall Study||391
391675|NCT01818336|959884|P2|STARTED|Overall Study||59
391676|NCT01818336|959885|P1|STARTED|Overall Study||391
391677|NCT01818297|959893|P2|NOT COMPLETED|Open Label Phase (3-12 Months)||10
391678|NCT01818297|959894|P1|NOT COMPLETED|Open Label Phase (3-12 Months)||18
391679|NCT01818297|959893|P2|COMPLETED|Open Label Phase (3-12 Months)||19
391680|NCT01818297|959894|P1|COMPLETED|Open Label Phase (3-12 Months)||14
391681|NCT01818297|959893|P2|STARTED|Open Label Phase (3-12 Months)||29
391682|NCT01818297|959894|P1|STARTED|Open Label Phase (3-12 Months)||32
391683|NCT01818297|959893|P2|NOT COMPLETED|Blinded Phase (Randomization - 3 Months)||1
391684|NCT01818297|959894|P1|NOT COMPLETED|Blinded Phase (Randomization - 3 Months)||0
391685|NCT01818297|959893|P2|COMPLETED|Blinded Phase (Randomization - 3 Months)||29
391686|NCT01818297|959894|P1|COMPLETED|Blinded Phase (Randomization - 3 Months)||32
391687|NCT01818297|959893|P2|Week 6|Blinded Phase (Randomization - 3 Months)||29
391688|NCT01818297|959894|P1|Week 6|Blinded Phase (Randomization - 3 Months)||32
391689|NCT01818297|959893|P2|Week 1|Blinded Phase (Randomization - 3 Months)||30
391690|NCT01818297|959894|P1|Week 1|Blinded Phase (Randomization - 3 Months)||32
391691|NCT01818297|959893|P2|STARTED|Blinded Phase (Randomization - 3 Months)||30
391692|NCT01818297|959894|P1|STARTED|Blinded Phase (Randomization - 3 Months)||32
391693|NCT01818141|959912|P2|NOT COMPLETED|Overall Study||3
391694|NCT01818141|959913|P1|NOT COMPLETED|Overall Study||3
391695|NCT01818141|959912|P2|COMPLETED|Overall Study||13
391696|NCT01818141|959913|P1|COMPLETED|Overall Study||15
391697|NCT01818141|959912|P2|STARTED|Overall Study||16
391698|NCT01818141|959913|P1|STARTED|Overall Study||18
391699|NCT01818063|959923|P2|NOT COMPLETED|Overall Study||0
391700|NCT01818063|959924|P1|NOT COMPLETED|Overall Study||0
391701|NCT01818063|959923|P2|COMPLETED|Overall Study||4
391702|NCT01818063|959924|P1|COMPLETED|Overall Study||5
391703|NCT01818063|959923|P2|STARTED|Overall Study||4
391704|NCT01818063|959924|P1|STARTED|Overall Study||5
391705|NCT01817907|959932|P2|NOT COMPLETED|Second Intervention||0
391706|NCT01817907|959933|P1|NOT COMPLETED|Second Intervention||0
391707|NCT01817907|959932|P2|COMPLETED|Second Intervention||7
391708|NCT01817907|959933|P1|COMPLETED|Second Intervention||8
391709|NCT01817907|959932|P2|STARTED|Second Intervention||7
391710|NCT01817907|959933|P1|STARTED|Second Intervention||8
391711|NCT01817907|959932|P2|NOT COMPLETED|Washout Period||0
391712|NCT01817907|959933|P1|NOT COMPLETED|Washout Period||0
391713|NCT01817907|959932|P2|COMPLETED|Washout Period||7
391714|NCT01817907|959933|P1|COMPLETED|Washout Period||8
391715|NCT01817907|959932|P2|STARTED|Washout Period||7
391716|NCT01817907|959933|P1|STARTED|Washout Period||8
391717|NCT01817907|959932|P2|NOT COMPLETED|First Intervention||0
391718|NCT01817907|959933|P1|NOT COMPLETED|First Intervention||0
391719|NCT01817907|959932|P2|COMPLETED|First Intervention||7
391720|NCT01817907|959933|P1|COMPLETED|First Intervention||8
391721|NCT01817907|959932|P2|STARTED|First Intervention||7
391722|NCT01817907|959933|P1|STARTED|First Intervention||8
391723|NCT01817855|959945|P4|NOT COMPLETED|Overall Study||0
391724|NCT01817855|959946|P3|NOT COMPLETED|Overall Study||2
391725|NCT01817855|959947|P2|NOT COMPLETED|Overall Study||2
391726|NCT01817855|959948|P1|NOT COMPLETED|Overall Study||0
391727|NCT01817855|959945|P4|COMPLETED|Overall Study||5
391728|NCT01817855|959946|P3|COMPLETED|Overall Study||9
391729|NCT01817855|959947|P2|COMPLETED|Overall Study||6
391730|NCT01817855|959948|P1|COMPLETED|Overall Study||23
391731|NCT01817855|959945|P4|STARTED|Overall Study||5
391732|NCT01817855|959946|P3|STARTED|Overall Study||11
391733|NCT01817855|959947|P2|STARTED|Overall Study||8
391734|NCT01817855|959948|P1|STARTED|Overall Study||23
391735|NCT01817790|959978|P2|NOT COMPLETED|Overall Study||8
391736|NCT01817790|959979|P1|NOT COMPLETED|Overall Study||4
391737|NCT01817790|959978|P2|COMPLETED|Overall Study||304
391738|NCT01817790|959979|P1|COMPLETED|Overall Study||310
391739|NCT01817790|959978|P2|STARTED|Overall Study||312
391740|NCT01817790|959979|P1|STARTED|Overall Study||314
391741|NCT01817777|960023|P3|NOT COMPLETED|Interventional Phase (20 Weeks)||5
391742|NCT01817777|960024|P2|NOT COMPLETED|Interventional Phase (20 Weeks)||5
391743|NCT01817777|960025|P1|NOT COMPLETED|Interventional Phase (20 Weeks)||0
391744|NCT01817777|960023|P3|COMPLETED|Interventional Phase (20 Weeks)||10
391745|NCT01817777|960024|P2|COMPLETED|Interventional Phase (20 Weeks)||11
391746|NCT01817777|960025|P1|COMPLETED|Interventional Phase (20 Weeks)||0
391747|NCT01817777|960023|P3|STARTED|Interventional Phase (20 Weeks)||15
391748|NCT01817777|960024|P2|STARTED|Interventional Phase (20 Weeks)||16
391749|NCT01817777|960025|P1|STARTED|Interventional Phase (20 Weeks)||0
391750|NCT01817777|960023|P3|NOT COMPLETED|Observational Phase (8 Weeks)||0
391751|NCT01817777|960024|P2|NOT COMPLETED|Observational Phase (8 Weeks)||0
391752|NCT01817777|960025|P1|NOT COMPLETED|Observational Phase (8 Weeks)||5
391753|NCT01817777|960023|P3|COMPLETED|Observational Phase (8 Weeks)||0
391754|NCT01817777|960024|P2|COMPLETED|Observational Phase (8 Weeks)||0
391755|NCT01817777|960025|P1|COMPLETED|Observational Phase (8 Weeks)||31
391756|NCT01817777|960023|P3|STARTED|Observational Phase (8 Weeks)||0
391757|NCT01817777|960024|P2|STARTED|Observational Phase (8 Weeks)||0
391758|NCT01817777|960025|P1|STARTED|Observational Phase (8 Weeks)||36
391759|NCT01817764|960049|P2|NOT COMPLETED|Overall Study||38
391760|NCT01817764|960050|P1|NOT COMPLETED|Overall Study||34
391761|NCT01817764|960049|P2|COMPLETED|Overall Study||315
391762|NCT01817764|960050|P1|COMPLETED|Overall Study||319
391763|NCT01817764|960049|P2|STARTED|Overall Study||353
391764|NCT01817764|960050|P1|STARTED|Overall Study||353
391765|NCT01817725|960058|P1|NOT COMPLETED|Overall Study||1
391766|NCT01817725|960058|P1|COMPLETED|Overall Study||19
391767|NCT01817725|960058|P1|STARTED|Overall Study||20
391768|NCT01817491|960065|P2|NOT COMPLETED|Overall Study||0
391769|NCT01817491|960066|P1|NOT COMPLETED|Overall Study||4
391770|NCT01817491|960065|P2|COMPLETED|Overall Study||28
391771|NCT01817491|960066|P1|COMPLETED|Overall Study||28
391772|NCT01817491|960065|P2|STARTED|Overall Study||28
391773|NCT01817491|960066|P1|STARTED|Overall Study||32
391774|NCT01817374|960112|P1|NOT COMPLETED|Overall Study||0
391775|NCT01817374|960112|P1|COMPLETED|Overall Study||6
391776|NCT01817374|960112|P1|STARTED|Overall Study||6
391777|NCT01816893|960126|P2|NOT COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||0
391778|NCT01816893|960127|P1|NOT COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||0
391779|NCT01816893|960126|P2|COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||11
391780|NCT01816893|960127|P1|COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||9
391781|NCT01816893|960126|P2|STARTED|Hypoglycemic Clamp/ Euglycemic Clamp||11
391782|NCT01816893|960127|P1|STARTED|Hypoglycemic Clamp/ Euglycemic Clamp||9
391783|NCT01816893|960126|P2|NOT COMPLETED|Washout Period||0
391784|NCT01816893|960127|P1|NOT COMPLETED|Washout Period||2
391785|NCT01816893|960126|P2|COMPLETED|Washout Period||11
391786|NCT01816893|960127|P1|COMPLETED|Washout Period||9
391787|NCT01816893|960126|P2|STARTED|Washout Period||11
391788|NCT01816893|960127|P1|STARTED|Washout Period||11
391789|NCT01816893|960126|P2|NOT COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||0
391790|NCT01816893|960127|P1|NOT COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||0
391791|NCT01816893|960126|P2|COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||11
391792|NCT01816893|960127|P1|COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||11
391793|NCT01816893|960126|P2|STARTED|Euglycemic Clamp/ Hypoglycemic Clamp||11
391794|NCT01816893|960127|P1|STARTED|Euglycemic Clamp/ Hypoglycemic Clamp||11
391803|NCT01816685|960162|P2|NOT COMPLETED|Overall Study||11
391804|NCT01816685|960163|P1|NOT COMPLETED|Overall Study||10
391805|NCT01816685|960162|P2|COMPLETED|Overall Study||56
391806|NCT01816685|960163|P1|COMPLETED|Overall Study||58
391807|NCT01816685|960162|P2|STARTED|Overall Study||67
391808|NCT01816685|960163|P1|STARTED|Overall Study||68
391809|NCT01816477|960173|P2|NOT COMPLETED|Overall Study||1
391810|NCT01816477|960174|P1|NOT COMPLETED|Overall Study||16
391811|NCT01816477|960173|P2|COMPLETED|Overall Study||41
391812|NCT01816477|960174|P1|COMPLETED|Overall Study||27
391813|NCT01816477|960173|P2|STARTED|Overall Study||42
391814|NCT01816477|960174|P1|STARTED|Overall Study||43
391815|NCT01816451|960187|P3|NOT COMPLETED|Overall Study||0
391816|NCT01816451|960188|P2|NOT COMPLETED|Overall Study||0
391817|NCT01816451|960189|P1|NOT COMPLETED|Overall Study||0
391818|NCT01816451|960187|P3|COMPLETED|Overall Study||8
391819|NCT01816451|960188|P2|COMPLETED|Overall Study||11
391820|NCT01816451|960189|P1|COMPLETED|Overall Study||13
391821|NCT01816451|960187|P3|STARTED|Overall Study||8
391822|NCT01816451|960188|P2|STARTED|Overall Study||11
391823|NCT01816451|960189|P1|STARTED|Overall Study||13
391824|NCT01816295|960228|P2|NOT COMPLETED|OLE Phase||56
391825|NCT01816295|960229|P1|NOT COMPLETED|OLE Phase||53
391826|NCT01816295|960228|P2|COMPLETED|OLE Phase||227
391827|NCT01816295|960229|P1|COMPLETED|OLE Phase||222
391828|NCT01816295|960228|P2|STARTED|OLE Phase|Participants who completed the DBP and still met eligibility criteria had option to enroll in OLE.|283
391829|NCT01816295|960229|P1|STARTED|OLE Phase|Participants who completed the DBP and still met eligibility criteria had option to enroll in OLE.|275
391830|NCT01816295|960228|P2|NOT COMPLETED|Double Blind Phase||56
391831|NCT01816295|960229|P1|NOT COMPLETED|Double Blind Phase||63
391832|NCT01816295|960228|P2|COMPLETED|Double Blind Phase||302
391833|NCT01816295|960229|P1|COMPLETED|Double Blind Phase||294
391834|NCT01816295|960228|P2|Received Study Drug|Double Blind Phase||354
391835|NCT01816295|960229|P1|Received Study Drug|Double Blind Phase||356
391836|NCT01816295|960228|P2|STARTED|Double Blind Phase||358
391837|NCT01816295|960229|P1|STARTED|Double Blind Phase||357
391838|NCT01816243|960244|P1|NOT COMPLETED|Overall Study||12
391839|NCT01816243|960244|P1|COMPLETED|Overall Study||27
391840|NCT01816243|960244|P1|STARTED|Overall Study||39
391841|NCT01816074|960255|P4|NOT COMPLETED|Phase 2||1
391842|NCT01816074|960256|P3|NOT COMPLETED|Phase 2||0
391843|NCT01816074|960257|P2|NOT COMPLETED|Phase 2||2
391844|NCT01816074|960258|P1|NOT COMPLETED|Phase 2||2
391845|NCT01816074|960255|P4|COMPLETED|Phase 2||9
391846|NCT01816074|960256|P3|COMPLETED|Phase 2||10
391847|NCT01816074|960257|P2|COMPLETED|Phase 2||7
391848|NCT01816074|960258|P1|COMPLETED|Phase 2||9
391849|NCT01816074|960255|P4|STARTED|Phase 2||10
391850|NCT01816074|960256|P3|STARTED|Phase 2||10
391851|NCT01816074|960257|P2|STARTED|Phase 2||9
391852|NCT01816074|960258|P1|STARTED|Phase 2||11
391853|NCT01816074|960255|P4|NOT COMPLETED|Phase 1||0
391854|NCT01816074|960256|P3|NOT COMPLETED|Phase 1||1
391855|NCT01816074|960257|P2|NOT COMPLETED|Phase 1||0
391856|NCT01816074|960258|P1|NOT COMPLETED|Phase 1||0
391857|NCT01816074|960255|P4|COMPLETED|Phase 1||10
391858|NCT01816074|960256|P3|COMPLETED|Phase 1||10
391859|NCT01816074|960257|P2|COMPLETED|Phase 1||9
391860|NCT01816074|960258|P1|COMPLETED|Phase 1||11
391861|NCT01816074|960255|P4|STARTED|Phase 1||10
391862|NCT01816074|960256|P3|STARTED|Phase 1||11
391863|NCT01816074|960257|P2|STARTED|Phase 1||9
391864|NCT01816074|960258|P1|STARTED|Phase 1||11
391865|NCT01816048|960286|P1|NOT COMPLETED|Overall Study||6
391866|NCT01816048|960286|P1|COMPLETED|Overall Study||2
391867|NCT01816048|960286|P1|STARTED|Overall Study||8
391868|NCT01815918|960301|P2|NOT COMPLETED|Overall Study||19
391869|NCT01815918|960302|P1|NOT COMPLETED|Overall Study||18
391870|NCT01815918|960301|P2|COMPLETED|Overall Study||11
391871|NCT01815918|960302|P1|COMPLETED|Overall Study||12
391872|NCT01815918|960301|P2|STARTED|Overall Study||30
391873|NCT01815918|960302|P1|STARTED|Overall Study||30
391874|NCT01815840|960318|P2|NOT COMPLETED|Overall Study||63
391875|NCT01815840|960319|P1|NOT COMPLETED|Overall Study||59
391876|NCT01815840|960318|P2|COMPLETED|Overall Study||50
391877|NCT01815840|960319|P1|COMPLETED|Overall Study||57
391878|NCT01815840|960318|P2|STARTED|Overall Study||113
391879|NCT01815840|960319|P1|STARTED|Overall Study||116
391880|NCT01815736|960349|P2|NOT COMPLETED|Overall Study||478
391881|NCT01815736|960350|P1|NOT COMPLETED|Overall Study||961
391882|NCT01815736|960349|P2|COMPLETED|Overall Study||2
391883|NCT01815736|960350|P1|COMPLETED|Overall Study||2
391884|NCT01815736|960349|P2|STARTED|Overall Study||480
391885|NCT01815736|960350|P1|STARTED|Overall Study||963
391886|NCT01815671|960366|P2|NOT COMPLETED|Overall Study||0
391887|NCT01815671|960367|P1|NOT COMPLETED|Overall Study||0
391888|NCT01815671|960366|P2|COMPLETED|Overall Study||85
391889|NCT01815671|960367|P1|COMPLETED|Overall Study||88
391890|NCT01815671|960366|P2|STARTED|Overall Study||85
391891|NCT01815671|960367|P1|STARTED|Overall Study||88
391892|NCT01815645|960379|P2|NOT COMPLETED|Overall Study||0
391893|NCT01815645|960380|P1|NOT COMPLETED|Overall Study||0
391894|NCT01815645|960379|P2|COMPLETED|Overall Study||33
391895|NCT01815645|960380|P1|COMPLETED|Overall Study||32
391896|NCT01815645|960379|P2|STARTED|Overall Study||33
391897|NCT01815645|960380|P1|STARTED|Overall Study||32
391898|NCT01815138|960398|P2|NOT COMPLETED|Overall Study||6
391899|NCT01815138|960399|P1|NOT COMPLETED|Overall Study||8
391900|NCT01815138|960398|P2|COMPLETED|Overall Study||31
391901|NCT01815138|960399|P1|COMPLETED|Overall Study||26
391902|NCT01815138|960398|P2|STARTED|Overall Study||37
391903|NCT01815138|960399|P1|STARTED|Overall Study||34
391904|NCT01815099|960411|P1|NOT COMPLETED|Overall Study||2
391905|NCT01815099|960411|P1|COMPLETED|Overall Study||2
391906|NCT01815099|960411|P1|Began rTMS Treatment|Overall Study||3
391907|NCT01815099|960411|P1|STARTED|Overall Study||4
391908|NCT01815008|960416|P1|NOT COMPLETED|Overall Study||4
391909|NCT01815008|960416|P1|COMPLETED|Overall Study|transcriptomic data was available on 9 participants only|15
392006|NCT01813890|960676|P2|COMPLETED|Overall Study||17
391910|NCT01815008|960416|P1|STARTED|Overall Study|Had difficulty in completing enrollment|19
391911|NCT01814878|960425|P2|NOT COMPLETED|Overall Study||30
391912|NCT01814878|960426|P1|NOT COMPLETED|Overall Study||46
391913|NCT01814878|960425|P2|COMPLETED|Overall Study||128
391914|NCT01814878|960426|P1|COMPLETED|Overall Study||116
391915|NCT01814878|960425|P2|STARTED|Overall Study||158
391916|NCT01814878|960426|P1|STARTED|Overall Study||162
391917|NCT01814800|960446|P1|NOT COMPLETED|Overall Study||5
391918|NCT01814800|960446|P1|COMPLETED|Overall Study||54
391919|NCT01814800|960446|P1|STARTED|Overall Study||59
391920|NCT01814787|960485|P2|NOT COMPLETED|Overall Study||0
391921|NCT01814787|960486|P1|NOT COMPLETED|Overall Study||0
391922|NCT01814787|960485|P2|COMPLETED|Overall Study||684
391923|NCT01814787|960486|P1|COMPLETED|Overall Study||685
391924|NCT01814787|960485|P2|STARTED|Overall Study||684
391925|NCT01814787|960486|P1|STARTED|Overall Study||685
391926|NCT01814774|960492|P1|NOT COMPLETED|Overall Study||0
391927|NCT01814774|960492|P1|COMPLETED|Overall Study||48
391928|NCT01814774|960492|P1|STARTED|Overall Study||48
391929|NCT01814761|960506|P2|NOT COMPLETED|Overall Study||30
391930|NCT01814761|960507|P1|NOT COMPLETED|Overall Study||8
391931|NCT01814761|960506|P2|COMPLETED|Overall Study||240
391932|NCT01814761|960507|P1|COMPLETED|Overall Study||34
391933|NCT01814761|960506|P2|STARTED|Overall Study||270
391934|NCT01814761|960507|P1|STARTED|Overall Study||42
391935|NCT01814748|960521|P2|NOT COMPLETED|Overall Study||7
391936|NCT01814748|960522|P1|NOT COMPLETED|Overall Study||8
391937|NCT01814748|960521|P2|COMPLETED|Overall Study||94
391938|NCT01814748|960522|P1|COMPLETED|Overall Study||94
391939|NCT01814748|960521|P2|STARTED|Overall Study||101
391940|NCT01814748|960522|P1|STARTED|Overall Study||102
391941|NCT01814722|960545|P3|NOT COMPLETED|Overall Study||0
391942|NCT01814722|960546|P2|NOT COMPLETED|Overall Study||0
391943|NCT01814722|960547|P1|NOT COMPLETED|Overall Study||0
391944|NCT01814722|960545|P3|COMPLETED|Overall Study||6
391945|NCT01814722|960546|P2|COMPLETED|Overall Study||21
391946|NCT01814722|960547|P1|COMPLETED|Overall Study||36
391947|NCT01814722|960545|P3|STARTED|Overall Study||6
391948|NCT01814722|960546|P2|STARTED|Overall Study||21
391949|NCT01814722|960547|P1|STARTED|Overall Study||36
391950|NCT01814696|960566|P2|NOT COMPLETED|Overall Study||0
391951|NCT01814696|960567|P1|NOT COMPLETED|Overall Study||2
391952|NCT01814696|960566|P2|COMPLETED|Overall Study||11
391953|NCT01814696|960567|P1|COMPLETED|Overall Study||13
391954|NCT01814696|960566|P2|STARTED|Overall Study||11
391955|NCT01814696|960567|P1|STARTED|Overall Study||15
391956|NCT01814670|960585|P1|NOT COMPLETED|Overall Study||12
391957|NCT01814670|960585|P1|COMPLETED|Overall Study||173
391958|NCT01814670|960585|P1|STARTED|Overall Study||185
391959|NCT01814553|960595|P2|NOT COMPLETED|Overall Study||22
391960|NCT01814553|960596|P1|NOT COMPLETED|Overall Study||18
391961|NCT01814553|960595|P2|COMPLETED|Overall Study||0
391962|NCT01814553|960596|P1|COMPLETED|Overall Study||0
391963|NCT01814553|960595|P2|STARTED|Overall Study||22
391964|NCT01814553|960596|P1|STARTED|Overall Study||18
391965|NCT01814397|960610|P1|NOT COMPLETED|Overall Study||14
391966|NCT01814397|960610|P1|COMPLETED|Overall Study||36
391967|NCT01814397|960610|P1|3 Month Evaluation|Overall Study||43
391968|NCT01814397|960610|P1|STARTED|Overall Study||50
391969|NCT01814332|960619|P2|NOT COMPLETED|Overall Study||16
391970|NCT01814332|960620|P1|NOT COMPLETED|Overall Study||16
391971|NCT01814332|960619|P2|COMPLETED|Overall Study||49
391972|NCT01814332|960620|P1|COMPLETED|Overall Study||47
391973|NCT01814332|960619|P2|STARTED|Overall Study||65
391974|NCT01814332|960620|P1|STARTED|Overall Study||63
391975|NCT01814241|960632|P1|NOT COMPLETED|Overall Study||4
391976|NCT01814241|960632|P1|COMPLETED|Overall Study||16
391977|NCT01814241|960632|P1|STARTED|Overall Study||20
391978|NCT01814137|960642|P2|NOT COMPLETED|Overall Study||5
391979|NCT01814137|960643|P1|NOT COMPLETED|Overall Study||5
391980|NCT01814137|960642|P2|COMPLETED|Overall Study||15
391981|NCT01814137|960643|P1|COMPLETED|Overall Study||15
391982|NCT01814137|960642|P2|STARTED|Overall Study||20
391983|NCT01814137|960643|P1|STARTED|Overall Study||20
391984|NCT01814046|960659|P3|NOT COMPLETED|Retreatment||0
391985|NCT01814046|960660|P2|NOT COMPLETED|Retreatment||0
391986|NCT01814046|960661|P1|NOT COMPLETED|Retreatment||0
391987|NCT01814046|960659|P3|COMPLETED|Retreatment||3
391988|NCT01814046|960660|P2|COMPLETED|Retreatment||0
391989|NCT01814046|960661|P1|COMPLETED|Retreatment||0
391990|NCT01814046|960659|P3|STARTED|Retreatment||3
391991|NCT01814046|960660|P2|STARTED|Retreatment||0
391992|NCT01814046|960661|P1|STARTED|Retreatment||0
391993|NCT01814046|960659|P3|NOT COMPLETED|Drug Administration||0
391994|NCT01814046|960660|P2|NOT COMPLETED|Drug Administration||0
391995|NCT01814046|960661|P1|NOT COMPLETED|Drug Administration||1
391996|NCT01814046|960659|P3|COMPLETED|Drug Administration||0
391997|NCT01814046|960660|P2|COMPLETED|Drug Administration||2
391998|NCT01814046|960661|P1|COMPLETED|Drug Administration||21
391999|NCT01814046|960659|P3|STARTED|Drug Administration||0
392000|NCT01814046|960660|P2|STARTED|Drug Administration||2
392001|NCT01814046|960661|P1|STARTED|Drug Administration||22
392002|NCT01813890|960675|P3|NOT COMPLETED|Overall Study||6
392003|NCT01813890|960676|P2|NOT COMPLETED|Overall Study||4
392004|NCT01813890|960677|P1|NOT COMPLETED|Overall Study||9
392005|NCT01813890|960675|P3|COMPLETED|Overall Study||13
392007|NCT01813890|960677|P1|COMPLETED|Overall Study||11
392008|NCT01813890|960675|P3|STARTED|Overall Study||19
392009|NCT01813890|960676|P2|STARTED|Overall Study||21
392010|NCT01813890|960677|P1|STARTED|Overall Study||20
392011|NCT01813721|960706|P1|NOT COMPLETED|Overall Study||64
392012|NCT01813721|960706|P1|COMPLETED|Overall Study||943
392013|NCT01813721|960706|P1|STARTED|Overall Study|Indicates number of participants enrolled|1007
392014|NCT01813474|960761|P3|NOT COMPLETED|Overall Study||11
392015|NCT01813474|960762|P2|NOT COMPLETED|Overall Study||7
392016|NCT01813474|960763|P1|NOT COMPLETED|Overall Study||3
392017|NCT01813474|960761|P3|COMPLETED|Overall Study|ongoing study at final data cut off|1
392018|NCT01813474|960762|P2|COMPLETED|Overall Study||0
392019|NCT01813474|960763|P1|COMPLETED|Overall Study|ongoing study at final data cut off|1
392020|NCT01813474|960761|P3|STARTED|Overall Study||12
392021|NCT01813474|960762|P2|STARTED|Overall Study||7
392022|NCT01813474|960763|P1|STARTED|Overall Study||4
392023|NCT01813422|960787|P2|NOT COMPLETED|Overall Study||16
392024|NCT01813422|960788|P1|NOT COMPLETED|Overall Study||20
392025|NCT01813422|960787|P2|COMPLETED|Overall Study||468
392026|NCT01813422|960788|P1|COMPLETED|Overall Study||466
392027|NCT01813422|960787|P2|Received Treatment|Overall Study||484
392028|NCT01813422|960788|P1|Received Treatment|Overall Study||484
392029|NCT01813422|960787|P2|STARTED|Overall Study||484
392030|NCT01813422|960788|P1|STARTED|Overall Study||486
392031|NCT01813110|960800|P2|NOT COMPLETED|Overall Study||1
392032|NCT01813110|960801|P1|NOT COMPLETED|Overall Study||0
392033|NCT01813110|960800|P2|COMPLETED|Overall Study||10
392034|NCT01813110|960801|P1|COMPLETED|Overall Study||10
392035|NCT01813110|960800|P2|STARTED|Overall Study||11
392036|NCT01813110|960801|P1|STARTED|Overall Study||10
392037|NCT01813019|960813|P2|NOT COMPLETED|Overall Study||6
392038|NCT01813019|960814|P1|NOT COMPLETED|Overall Study||7
392039|NCT01813019|960813|P2|COMPLETED|Overall Study||20
392040|NCT01813019|960814|P1|COMPLETED|Overall Study||17
392041|NCT01813019|960813|P2|STARTED|Overall Study||26
392042|NCT01813019|960814|P1|STARTED|Overall Study||24
392043|NCT01812837|960825|P3|NOT COMPLETED|Overall Study||0
392044|NCT01812837|960826|P2|NOT COMPLETED|Overall Study||1
392045|NCT01812837|960827|P1|NOT COMPLETED|Overall Study||2
392046|NCT01812837|960825|P3|COMPLETED|Overall Study||17
392047|NCT01812837|960826|P2|COMPLETED|Overall Study||16
392048|NCT01812837|960827|P1|COMPLETED|Overall Study||15
392049|NCT01812837|960825|P3|STARTED|Overall Study||17
392050|NCT01812837|960826|P2|STARTED|Overall Study||17
392051|NCT01812837|960827|P1|STARTED|Overall Study||17
392052|NCT01812707|960839|P4|NOT COMPLETED|Overall Study||2
392053|NCT01812707|960840|P3|NOT COMPLETED|Overall Study||0
392054|NCT01812707|960841|P2|NOT COMPLETED|Overall Study||0
392055|NCT01812707|960842|P1|NOT COMPLETED|Overall Study||2
392056|NCT01812707|960839|P4|COMPLETED|Overall Study||23
392057|NCT01812707|960840|P3|COMPLETED|Overall Study||25
392058|NCT01812707|960841|P2|COMPLETED|Overall Study||25
392059|NCT01812707|960842|P1|COMPLETED|Overall Study||23
392060|NCT01812707|960839|P4|Treated|Overall Study||25
392061|NCT01812707|960840|P3|Treated|Overall Study||25
392062|NCT01812707|960841|P2|Treated|Overall Study||25
392063|NCT01812707|960842|P1|Treated|Overall Study||25
392064|NCT01812707|960839|P4|STARTED|Overall Study||25
392065|NCT01812707|960840|P3|STARTED|Overall Study||25
392066|NCT01812707|960841|P2|STARTED|Overall Study||25
392067|NCT01812707|960842|P1|STARTED|Overall Study||25
392068|NCT01812681|960878|P2|NOT COMPLETED|Overall Study||0
392069|NCT01812681|960879|P1|NOT COMPLETED|Overall Study||3
392070|NCT01812681|960878|P2|COMPLETED|Overall Study||24
392071|NCT01812681|960879|P1|COMPLETED|Overall Study||57
392072|NCT01812681|960878|P2|STARTED|Overall Study||24
392073|NCT01812681|960879|P1|STARTED|Overall Study||60
392074|NCT01812655|960890|P3|NOT COMPLETED|Overall Study||0
392075|NCT01812655|960891|P2|NOT COMPLETED|Overall Study||1
392076|NCT01812655|960892|P1|NOT COMPLETED|Overall Study||1
392077|NCT01812655|960890|P3|COMPLETED|Overall Study||10
392078|NCT01812655|960891|P2|COMPLETED|Overall Study||10
392079|NCT01812655|960892|P1|COMPLETED|Overall Study||8
392080|NCT01812655|960890|P3|STARTED|Overall Study|Nurses provided their usual, standard care throughout the entire burn wound care.|10
392081|NCT01812655|960891|P2|STARTED|Overall Study|Passive Distraction-Patients watched a movie during their burn wound care.|11
392082|NCT01812655|960892|P1|STARTED|Overall Study|Virtual Reality-Patients used an interactive VR program during their burn wound care procedure.|9
392083|NCT01812473|960908|P2|NOT COMPLETED|Overall Study||0
392084|NCT01812473|960909|P1|NOT COMPLETED|Overall Study||0
392085|NCT01812473|960908|P2|COMPLETED|Overall Study||13
392086|NCT01812473|960909|P1|COMPLETED|Overall Study||22
392087|NCT01812473|960908|P2|STARTED|Overall Study||13
392088|NCT01812473|960909|P1|STARTED|Overall Study||22
392089|NCT01812057|960917|P2|NOT COMPLETED|Overall Study||0
392090|NCT01812057|960918|P1|NOT COMPLETED|Overall Study||2
392091|NCT01812057|960917|P2|COMPLETED|Overall Study||24
392092|NCT01812057|960918|P1|COMPLETED|Overall Study||23
392093|NCT01812057|960917|P2|STARTED|Overall Study||24
392094|NCT01812057|960918|P1|STARTED|Overall Study||25
392095|NCT01812044|960959|P3|NOT COMPLETED|Overall Study||0
392096|NCT01812044|960960|P2|NOT COMPLETED|Overall Study||0
392097|NCT01812044|960961|P1|NOT COMPLETED|Overall Study||0
392098|NCT01812044|960959|P3|COMPLETED|Overall Study||16
392099|NCT01812044|960960|P2|COMPLETED|Overall Study||17
392100|NCT01812044|960961|P1|COMPLETED|Overall Study||17
392101|NCT01812044|960959|P3|STARTED|Overall Study||16
392102|NCT01812044|960960|P2|STARTED|Overall Study||17
392103|NCT01812044|960961|P1|STARTED|Overall Study||17
392104|NCT01812005|960992|P2|NOT COMPLETED|Overall Study||0
392105|NCT01812005|960993|P1|NOT COMPLETED|Overall Study||0
392106|NCT01812005|960992|P2|COMPLETED|Overall Study||13
392107|NCT01812005|960993|P1|COMPLETED|Overall Study||1
392108|NCT01812005|960992|P2|STARTED|Overall Study||13
392109|NCT01812005|960993|P1|STARTED|Overall Study||1
392110|NCT01811953|961021|P6|NOT COMPLETED|Overall Study||1
392111|NCT01811953|961022|P5|NOT COMPLETED|Overall Study||1
392112|NCT01811953|961023|P4|NOT COMPLETED|Overall Study||1
392113|NCT01811953|961024|P3|NOT COMPLETED|Overall Study||0
392114|NCT01811953|961025|P2|NOT COMPLETED|Overall Study||0
392115|NCT01811953|961026|P1|NOT COMPLETED|Overall Study||0
392116|NCT01811953|961021|P6|COMPLETED|Overall Study||11
392117|NCT01811953|961022|P5|COMPLETED|Overall Study||11
392118|NCT01811953|961023|P4|COMPLETED|Overall Study||5
392119|NCT01811953|961024|P3|COMPLETED|Overall Study||6
392120|NCT01811953|961025|P2|COMPLETED|Overall Study||6
392121|NCT01811953|961026|P1|COMPLETED|Overall Study||6
392122|NCT01811953|961021|P6|STARTED|Overall Study||12
392123|NCT01811953|961022|P5|STARTED|Overall Study||12
392124|NCT01811953|961023|P4|STARTED|Overall Study||6
392125|NCT01811953|961024|P3|STARTED|Overall Study||6
392126|NCT01811953|961025|P2|STARTED|Overall Study||6
392127|NCT01811953|961026|P1|STARTED|Overall Study||6
392128|NCT01811732|961072|P2|NOT COMPLETED|Overall Study||58
392129|NCT01811732|961073|P1|NOT COMPLETED|Overall Study||55
392130|NCT01811732|961072|P2|COMPLETED|Overall Study||271
392131|NCT01811732|961073|P1|COMPLETED|Overall Study||276
392132|NCT01811732|961072|P2|STARTED|Overall Study||329
392133|NCT01811732|961073|P1|STARTED|Overall Study||331
392134|NCT01811706|961083|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
392135|NCT01811706|961084|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
392136|NCT01811706|961083|P2|COMPLETED|Second Intervention (4 Weeks)||10
392137|NCT01811706|961084|P1|COMPLETED|Second Intervention (4 Weeks)||9
392138|NCT01811706|961083|P2|STARTED|Second Intervention (4 Weeks)||10
392139|NCT01811706|961084|P1|STARTED|Second Intervention (4 Weeks)||9
392140|NCT01811706|961083|P2|NOT COMPLETED|Washout ( 2 Weeks)||0
392141|NCT01811706|961084|P1|NOT COMPLETED|Washout ( 2 Weeks)||0
392142|NCT01811706|961083|P2|COMPLETED|Washout ( 2 Weeks)||10
392143|NCT01811706|961084|P1|COMPLETED|Washout ( 2 Weeks)||9
392144|NCT01811706|961083|P2|STARTED|Washout ( 2 Weeks)||10
392145|NCT01811706|961084|P1|STARTED|Washout ( 2 Weeks)||9
392146|NCT01811706|961083|P2|NOT COMPLETED|First Intervention ( 4 Weeks)||0
392147|NCT01811706|961084|P1|NOT COMPLETED|First Intervention ( 4 Weeks)||1
392148|NCT01811706|961083|P2|COMPLETED|First Intervention ( 4 Weeks)||10
392149|NCT01811706|961084|P1|COMPLETED|First Intervention ( 4 Weeks)||9
392150|NCT01811706|961083|P2|STARTED|First Intervention ( 4 Weeks)||10
392151|NCT01811706|961084|P1|STARTED|First Intervention ( 4 Weeks)||10
392152|NCT01811680|961094|P1|NOT COMPLETED|Overall Study||0
392153|NCT01811680|961094|P1|COMPLETED|Overall Study||10
392154|NCT01811680|961094|P1|STARTED|Overall Study||10
392155|NCT01811563|961101|P2|NOT COMPLETED|Overall Study||3
392156|NCT01811563|961102|P1|NOT COMPLETED|Overall Study||5
392157|NCT01811563|961101|P2|COMPLETED|Overall Study||20
392158|NCT01811563|961102|P1|COMPLETED|Overall Study||20
392159|NCT01811563|961101|P2|STARTED|Overall Study||23
392160|NCT01811563|961102|P1|STARTED|Overall Study||25
392161|NCT01811485|961131|P3|NOT COMPLETED|Overall Study||5
392162|NCT01811485|961132|P2|NOT COMPLETED|Overall Study||4
392163|NCT01811485|961133|P1|NOT COMPLETED|Overall Study||2
392164|NCT01811485|961131|P3|COMPLETED|Overall Study||51
392165|NCT01811485|961132|P2|COMPLETED|Overall Study||55
392166|NCT01811485|961133|P1|COMPLETED|Overall Study||54
392167|NCT01811485|961131|P3|STARTED|Overall Study||56
392168|NCT01811485|961132|P2|STARTED|Overall Study||59
392169|NCT01811485|961133|P1|STARTED|Overall Study|"Started indicates randomized patients"|56
392170|NCT01811472|961153|P3|NOT COMPLETED|Overall Study||5
392171|NCT01811472|961154|P2|NOT COMPLETED|Overall Study||0
392172|NCT01811472|961155|P1|NOT COMPLETED|Overall Study||2
392173|NCT01811472|961153|P3|COMPLETED|Overall Study||16
392174|NCT01811472|961154|P2|COMPLETED|Overall Study||11
392175|NCT01811472|961155|P1|COMPLETED|Overall Study||18
392176|NCT01811472|961153|P3|STARTED|Overall Study||21
392177|NCT01811472|961154|P2|STARTED|Overall Study||11
392178|NCT01811472|961155|P1|STARTED|Overall Study||20
392179|NCT01811355|961200|P2|NOT COMPLETED|Second Dose||0
392180|NCT01811355|961201|P1|NOT COMPLETED|Second Dose||0
392181|NCT01811355|961200|P2|COMPLETED|Second Dose||12
392182|NCT01811355|961201|P1|COMPLETED|Second Dose||9
392183|NCT01811355|961200|P2|STARTED|Second Dose||12
392184|NCT01811355|961201|P1|STARTED|Second Dose||9
392185|NCT01811355|961200|P2|NOT COMPLETED|Washout||0
392186|NCT01811355|961201|P1|NOT COMPLETED|Washout||0
392187|NCT01811355|961200|P2|COMPLETED|Washout||12
392188|NCT01811355|961201|P1|COMPLETED|Washout||9
392189|NCT01811355|961200|P2|STARTED|Washout||12
392190|NCT01811355|961201|P1|STARTED|Washout||9
392191|NCT01811355|961200|P2|NOT COMPLETED|First Dose||0
392192|NCT01811355|961201|P1|NOT COMPLETED|First Dose||2
392193|NCT01811355|961200|P2|COMPLETED|First Dose||12
392194|NCT01811355|961201|P1|COMPLETED|First Dose||9
392195|NCT01811355|961200|P2|STARTED|First Dose||12
392196|NCT01811355|961201|P1|STARTED|First Dose||11
392197|NCT01811316|961212|P3|NOT COMPLETED|Overall Study||0
392198|NCT01811316|961213|P2|NOT COMPLETED|Overall Study||0
392199|NCT01811316|961214|P1|NOT COMPLETED|Overall Study||3
392200|NCT01811316|961212|P3|COMPLETED|Overall Study||19
392201|NCT01811316|961213|P2|COMPLETED|Overall Study||22
392202|NCT01811316|961214|P1|COMPLETED|Overall Study||18
392203|NCT01811316|961212|P3|Visit 12 Weeks|Overall Study||19
392204|NCT01811316|961213|P2|Visit 12 Weeks|Overall Study||22
392205|NCT01811316|961214|P1|Visit 12 Weeks|Overall Study||18
392206|NCT01811316|961212|P3|Visit 4 Weeks|Overall Study||19
392207|NCT01811316|961213|P2|Visit 4 Weeks|Overall Study||22
392208|NCT01811316|961214|P1|Visit 4 Weeks|Overall Study||19
392209|NCT01811316|961212|P3|STARTED|Overall Study||19
392210|NCT01811316|961213|P2|STARTED|Overall Study||22
392211|NCT01811316|961214|P1|STARTED|Overall Study||21
392212|NCT01811303|961231|P4|NOT COMPLETED|Fourth Intervention (1 Day)||0
392213|NCT01811303|961232|P3|NOT COMPLETED|Fourth Intervention (1 Day)||0
392214|NCT01811303|961233|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
392215|NCT01811303|961234|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
392216|NCT01811303|961231|P4|COMPLETED|Fourth Intervention (1 Day)||2
392217|NCT01811303|961232|P3|COMPLETED|Fourth Intervention (1 Day)||4
392218|NCT01811303|961233|P2|COMPLETED|Fourth Intervention (1 Day)||4
392219|NCT01811303|961234|P1|COMPLETED|Fourth Intervention (1 Day)||4
392220|NCT01811303|961231|P4|STARTED|Fourth Intervention (1 Day)||2
392221|NCT01811303|961232|P3|STARTED|Fourth Intervention (1 Day)||4
392222|NCT01811303|961233|P2|STARTED|Fourth Intervention (1 Day)||4
392223|NCT01811303|961234|P1|STARTED|Fourth Intervention (1 Day)||4
392224|NCT01811303|961231|P4|NOT COMPLETED|Washout (2 Days or More)||0
392225|NCT01811303|961232|P3|NOT COMPLETED|Washout (2 Days or More)||0
392226|NCT01811303|961233|P2|NOT COMPLETED|Washout (2 Days or More)||0
392227|NCT01811303|961234|P1|NOT COMPLETED|Washout (2 Days or More)||0
392228|NCT01811303|961231|P4|COMPLETED|Washout (2 Days or More)||2
392229|NCT01811303|961232|P3|COMPLETED|Washout (2 Days or More)||4
392230|NCT01811303|961233|P2|COMPLETED|Washout (2 Days or More)||4
392231|NCT01811303|961234|P1|COMPLETED|Washout (2 Days or More)||4
392232|NCT01811303|961231|P4|STARTED|Washout (2 Days or More)||2
392233|NCT01811303|961232|P3|STARTED|Washout (2 Days or More)||4
392234|NCT01811303|961233|P2|STARTED|Washout (2 Days or More)||4
392235|NCT01811303|961234|P1|STARTED|Washout (2 Days or More)||4
392236|NCT01811303|961231|P4|NOT COMPLETED|Third Intervention (1 Day)||0
392237|NCT01811303|961232|P3|NOT COMPLETED|Third Intervention (1 Day)||0
392238|NCT01811303|961233|P2|NOT COMPLETED|Third Intervention (1 Day)||0
392239|NCT01811303|961234|P1|NOT COMPLETED|Third Intervention (1 Day)||0
392240|NCT01811303|961231|P4|COMPLETED|Third Intervention (1 Day)||2
392241|NCT01811303|961232|P3|COMPLETED|Third Intervention (1 Day)||4
392242|NCT01811303|961233|P2|COMPLETED|Third Intervention (1 Day)||4
392243|NCT01811303|961234|P1|COMPLETED|Third Intervention (1 Day)||4
392244|NCT01811303|961231|P4|STARTED|Third Intervention (1 Day)||2
392245|NCT01811303|961232|P3|STARTED|Third Intervention (1 Day)||4
392246|NCT01811303|961233|P2|STARTED|Third Intervention (1 Day)||4
392247|NCT01811303|961234|P1|STARTED|Third Intervention (1 Day)||4
392248|NCT01811303|961231|P4|NOT COMPLETED|Washout (2 Days or More)||0
392249|NCT01811303|961232|P3|NOT COMPLETED|Washout (2 Days or More)||0
392250|NCT01811303|961233|P2|NOT COMPLETED|Washout (2 Days or More)||0
392251|NCT01811303|961234|P1|NOT COMPLETED|Washout (2 Days or More)||0
392252|NCT01811303|961231|P4|COMPLETED|Washout (2 Days or More)||2
392253|NCT01811303|961232|P3|COMPLETED|Washout (2 Days or More)||4
392254|NCT01811303|961233|P2|COMPLETED|Washout (2 Days or More)||4
392255|NCT01811303|961234|P1|COMPLETED|Washout (2 Days or More)||4
392256|NCT01811303|961231|P4|STARTED|Washout (2 Days or More)||2
392257|NCT01811303|961232|P3|STARTED|Washout (2 Days or More)||4
392258|NCT01811303|961233|P2|STARTED|Washout (2 Days or More)||4
392259|NCT01811303|961234|P1|STARTED|Washout (2 Days or More)||4
392260|NCT01811303|961231|P4|NOT COMPLETED|Second Intervention (1 Day)||0
392261|NCT01811303|961232|P3|NOT COMPLETED|Second Intervention (1 Day)||0
392262|NCT01811303|961233|P2|NOT COMPLETED|Second Intervention (1 Day)||0
392263|NCT01811303|961234|P1|NOT COMPLETED|Second Intervention (1 Day)||0
392264|NCT01811303|961231|P4|COMPLETED|Second Intervention (1 Day)||2
392265|NCT01811303|961232|P3|COMPLETED|Second Intervention (1 Day)||4
392266|NCT01811303|961233|P2|COMPLETED|Second Intervention (1 Day)||4
392267|NCT01811303|961234|P1|COMPLETED|Second Intervention (1 Day)||4
392268|NCT01811303|961231|P4|STARTED|Second Intervention (1 Day)||2
392269|NCT01811303|961232|P3|STARTED|Second Intervention (1 Day)||4
392270|NCT01811303|961233|P2|STARTED|Second Intervention (1 Day)||4
392271|NCT01811303|961234|P1|STARTED|Second Intervention (1 Day)||4
392272|NCT01811303|961231|P4|NOT COMPLETED|Washout (2 Days or More)||0
392273|NCT01811303|961232|P3|NOT COMPLETED|Washout (2 Days or More)||0
392274|NCT01811303|961233|P2|NOT COMPLETED|Washout (2 Days or More)||0
392275|NCT01811303|961234|P1|NOT COMPLETED|Washout (2 Days or More)||0
392276|NCT01811303|961231|P4|COMPLETED|Washout (2 Days or More)||2
392277|NCT01811303|961232|P3|COMPLETED|Washout (2 Days or More)||4
392278|NCT01811303|961233|P2|COMPLETED|Washout (2 Days or More)||4
392279|NCT01811303|961234|P1|COMPLETED|Washout (2 Days or More)||4
392280|NCT01811303|961231|P4|STARTED|Washout (2 Days or More)||2
392281|NCT01811303|961232|P3|STARTED|Washout (2 Days or More)||4
392282|NCT01811303|961233|P2|STARTED|Washout (2 Days or More)||4
392283|NCT01811303|961234|P1|STARTED|Washout (2 Days or More)||4
392284|NCT01811303|961231|P4|NOT COMPLETED|First Intervention (1 Day)||0
392285|NCT01811303|961232|P3|NOT COMPLETED|First Intervention (1 Day)||0
392286|NCT01811303|961233|P2|NOT COMPLETED|First Intervention (1 Day)||0
392287|NCT01811303|961234|P1|NOT COMPLETED|First Intervention (1 Day)||0
392288|NCT01811303|961231|P4|COMPLETED|First Intervention (1 Day)||2
392289|NCT01811303|961232|P3|COMPLETED|First Intervention (1 Day)||4
392290|NCT01811303|961233|P2|COMPLETED|First Intervention (1 Day)||4
392291|NCT01811303|961234|P1|COMPLETED|First Intervention (1 Day)||4
392292|NCT01811303|961231|P4|STARTED|First Intervention (1 Day)||2
392293|NCT01811303|961232|P3|STARTED|First Intervention (1 Day)||4
392294|NCT01811303|961233|P2|STARTED|First Intervention (1 Day)||4
392295|NCT01811303|961234|P1|STARTED|First Intervention (1 Day)||4
392296|NCT01811238|961242|P1|NOT COMPLETED|Overall Study||81
392297|NCT01811238|961242|P1|COMPLETED|Overall Study|159 subjects regardless PP set completed study visit.|159
392298|NCT01811238|961242|P1|PP Set|Overall Study|89 subjects excluded from PP set due to various reasons.|120
392299|NCT01811238|961242|P1|ITT Set|Overall Study|11 subjects excluded from ITT set due to no primary efficacy assessment(5) and IC/EC violation(6).|209
392300|NCT01811238|961242|P1|Safety Set|Overall Study|20 subjects excluded from the safety set due to study drug not administered.|220
392301|NCT01811238|961242|P1|STARTED|Overall Study|First patient was recruited on 26 Sep. 2012.|240
392302|NCT01811212|961251|P1|NOT COMPLETED|Overall Study||0
392303|NCT01811212|961251|P1|COMPLETED|Overall Study||25
392304|NCT01811212|961251|P1|STARTED|Overall Study||25
392305|NCT01811186|961266|P2|NOT COMPLETED|Overall Study||62
392306|NCT01811186|961267|P1|NOT COMPLETED|Overall Study||71
392307|NCT01811186|961266|P2|COMPLETED|Overall Study||64
392308|NCT01811186|961267|P1|COMPLETED|Overall Study||61
392309|NCT01811186|961266|P2|STARTED|Overall Study||126
392310|NCT01811186|961267|P1|STARTED|Overall Study||132
392311|NCT01810952|961285|P2|NOT COMPLETED|Overall Study||0
392312|NCT01810952|961286|P1|NOT COMPLETED|Overall Study||0
392313|NCT01810952|961285|P2|COMPLETED|Overall Study||17
392314|NCT01810952|961286|P1|COMPLETED|Overall Study||20
392315|NCT01810952|961285|P2|STARTED|Overall Study||17
392316|NCT01810952|961286|P1|STARTED|Overall Study||20
392317|NCT01810939|961300|P3|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||22
392318|NCT01810939|961301|P2|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||10
392319|NCT01810939|961302|P1|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||0
392320|NCT01810939|961300|P3|COMPLETED|Part B Placebo-Controlled Withdrawal||30
392321|NCT01810939|961301|P2|COMPLETED|Part B Placebo-Controlled Withdrawal||45
392322|NCT01810939|961302|P1|COMPLETED|Part B Placebo-Controlled Withdrawal||0
392323|NCT01810939|961300|P3|STARTED|Part B Placebo-Controlled Withdrawal|Part A participants with Part A baseline serum potassium ≥ 5.5 mEq/L who responded to treatment|52
392324|NCT01810939|961301|P2|STARTED|Part B Placebo-Controlled Withdrawal|Part A participants with Part A baseline serum potassium ≥ 5.5 mEq/L who responded to treatment|55
392325|NCT01810939|961302|P1|STARTED|Part B Placebo-Controlled Withdrawal||0
392326|NCT01810939|961300|P3|NOT COMPLETED|Part A Treatment Period||0
392327|NCT01810939|961301|P2|NOT COMPLETED|Part A Treatment Period||0
392328|NCT01810939|961302|P1|NOT COMPLETED|Part A Treatment Period||24
392329|NCT01810939|961300|P3|COMPLETED|Part A Treatment Period||0
392330|NCT01810939|961301|P2|COMPLETED|Part A Treatment Period||0
392331|NCT01810939|961302|P1|COMPLETED|Part A Treatment Period||219
392332|NCT01810939|961300|P3|STARTED|Part A Treatment Period||0
392333|NCT01810939|961301|P2|STARTED|Part A Treatment Period||0
392334|NCT01810939|961302|P1|STARTED|Part A Treatment Period||243
392335|NCT01810783|961315|P1|NOT COMPLETED|Overall Study||109
392336|NCT01810783|961315|P1|COMPLETED|Overall Study||101
392337|NCT01810783|961315|P1|STARTED|Overall Study||210
392338|NCT01810692|961321|P2|NOT COMPLETED|Overall Study||0
392339|NCT01810692|961322|P1|NOT COMPLETED|Overall Study||0
392340|NCT01810692|961321|P2|COMPLETED|Overall Study||77
392341|NCT01810692|961322|P1|COMPLETED|Overall Study||77
392342|NCT01810692|961321|P2|STARTED|Overall Study||77
392343|NCT01810692|961322|P1|STARTED|Overall Study||77
392344|NCT01810666|961334|P1|NOT COMPLETED|Overall Study||0
392345|NCT01810666|961334|P1|COMPLETED|Overall Study||30
392346|NCT01810666|961334|P1|STARTED|Overall Study||30
392347|NCT01810380|961343|P3|NOT COMPLETED|Overall Study||32
392348|NCT01810380|961344|P2|NOT COMPLETED|Overall Study||38
392349|NCT01810380|961345|P1|NOT COMPLETED|Overall Study||55
392350|NCT01810380|961343|P3|COMPLETED|Overall Study||122
392351|NCT01810380|961344|P2|COMPLETED|Overall Study||113
392352|NCT01810380|961345|P1|COMPLETED|Overall Study||108
392353|NCT01810380|961343|P3|Treated|Overall Study||153
392354|NCT01810380|961344|P2|Treated|Overall Study||150
392355|NCT01810380|961345|P1|Treated|Overall Study||161
392356|NCT01810380|961343|P3|STARTED|Overall Study||154
392357|NCT01810380|961344|P2|STARTED|Overall Study||151
392358|NCT01810380|961345|P1|STARTED|Overall Study||163
392359|NCT01810302|961406|P2|NOT COMPLETED|Overall Study||1
392360|NCT01810302|961407|P1|NOT COMPLETED|Overall Study||1
392361|NCT01810302|961406|P2|COMPLETED|Overall Study||0
392362|NCT01810302|961407|P1|COMPLETED|Overall Study||0
392363|NCT01810302|961406|P2|STARTED|Overall Study||1
392364|NCT01810302|961407|P1|STARTED|Overall Study||1
392365|NCT01810289|961417|P2|NOT COMPLETED|Overall Study||0
392366|NCT01810289|961418|P1|NOT COMPLETED|Overall Study||0
392367|NCT01810289|961417|P2|COMPLETED|Overall Study||4747
392368|NCT01810289|961418|P1|COMPLETED|Overall Study||7277
392369|NCT01810289|961417|P2|STARTED|Overall Study||4747
392370|NCT01810289|961418|P1|STARTED|Overall Study||7277
392371|NCT01810263|961426|P2|NOT COMPLETED|Overall Study||7
392372|NCT01810263|961427|P1|NOT COMPLETED|Overall Study||8
392373|NCT01810263|961426|P2|COMPLETED|Overall Study||11
392374|NCT01810263|961427|P1|COMPLETED|Overall Study|2014 July|8
392375|NCT01810263|961426|P2|STARTED|Overall Study||18
392376|NCT01810263|961427|P1|STARTED|Overall Study||16
392377|NCT01810042|961433|P1|NOT COMPLETED|Overall Study||10
392378|NCT01810042|961433|P1|COMPLETED|Overall Study||39
392379|NCT01810042|961433|P1|STARTED|Overall Study||49
392380|NCT01809938|961440|P2|NOT COMPLETED|Second Intervention (170 Minutes)||0
392381|NCT01809938|961441|P1|NOT COMPLETED|Second Intervention (170 Minutes)||0
392382|NCT01809938|961440|P2|COMPLETED|Second Intervention (170 Minutes)||5
392383|NCT01809938|961441|P1|COMPLETED|Second Intervention (170 Minutes)||5
392384|NCT01809938|961440|P2|STARTED|Second Intervention (170 Minutes)||5
392385|NCT01809938|961441|P1|STARTED|Second Intervention (170 Minutes)||5
392386|NCT01809938|961440|P2|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0
392387|NCT01809938|961441|P1|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0
392388|NCT01809938|961440|P2|COMPLETED|Washout (Not Less Than 24 Hours)||5
392389|NCT01809938|961441|P1|COMPLETED|Washout (Not Less Than 24 Hours)||5
392390|NCT01809938|961440|P2|STARTED|Washout (Not Less Than 24 Hours)||5
392391|NCT01809938|961441|P1|STARTED|Washout (Not Less Than 24 Hours)||5
392392|NCT01809938|961440|P2|NOT COMPLETED|First Intervention (170 Minutes)||0
392393|NCT01809938|961441|P1|NOT COMPLETED|First Intervention (170 Minutes)||0
392394|NCT01809938|961440|P2|COMPLETED|First Intervention (170 Minutes)||5
392395|NCT01809938|961441|P1|COMPLETED|First Intervention (170 Minutes)||5
392396|NCT01809938|961440|P2|STARTED|First Intervention (170 Minutes)||5
392397|NCT01809938|961441|P1|STARTED|First Intervention (170 Minutes)||5
392398|NCT01809899|961450|P2|NOT COMPLETED|Overall Study||0
392399|NCT01809899|961451|P1|NOT COMPLETED|Overall Study||0
392400|NCT01809899|961450|P2|COMPLETED|Overall Study||4
392401|NCT01809899|961451|P1|COMPLETED|Overall Study||8
392402|NCT01809899|961450|P2|STARTED|Overall Study||4
392403|NCT01809899|961451|P1|STARTED|Overall Study||8
392404|NCT01809834|961459|P1|NOT COMPLETED|Overall Study||0
392405|NCT01809834|961459|P1|COMPLETED|Overall Study||44
392406|NCT01809834|961459|P1|STARTED|Overall Study||44
392407|NCT01809639|961487|P2|NOT COMPLETED|Overall Study||0
392408|NCT01809639|961488|P1|NOT COMPLETED|Overall Study||0
392409|NCT01809639|961487|P2|COMPLETED|Overall Study||7
392410|NCT01809639|961488|P1|COMPLETED|Overall Study||18
392411|NCT01809639|961487|P2|STARTED|Overall Study||7
392412|NCT01809639|961488|P1|STARTED|Overall Study||18
392413|NCT01809327|961499|P5|NOT COMPLETED|Overall Study||25
392414|NCT01809327|961500|P4|NOT COMPLETED|Overall Study||12
392415|NCT01809327|961501|P3|NOT COMPLETED|Overall Study||22
392416|NCT01809327|961502|P2|NOT COMPLETED|Overall Study||26
392417|NCT01809327|961503|P1|NOT COMPLETED|Overall Study||32
392418|NCT01809327|961499|P5|COMPLETED|Overall Study||212
392419|NCT01809327|961500|P4|COMPLETED|Overall Study||225
392420|NCT01809327|961501|P3|COMPLETED|Overall Study||216
392421|NCT01809327|961502|P2|COMPLETED|Overall Study||211
392422|NCT01809327|961503|P1|COMPLETED|Overall Study||205
392423|NCT01809327|961499|P5|STARTED|Overall Study||237
392424|NCT01809327|961500|P4|STARTED|Overall Study||237
392425|NCT01809327|961501|P3|STARTED|Overall Study||238
392426|NCT01809327|961502|P2|STARTED|Overall Study||237
392427|NCT01809327|961503|P1|STARTED|Overall Study||237
392428|NCT01809314|961545|P1|NOT COMPLETED|Overall Study||745
392429|NCT01809314|961545|P1|COMPLETED|Overall Study||422
392430|NCT01809314|961545|P1|STARTED|Overall Study||1167
392431|NCT01809262|961551|P10|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
392432|NCT01809262|961552|P9|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
392433|NCT01809262|961553|P8|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
392434|NCT01809262|961554|P7|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
392435|NCT01809262|961555|P6|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
392436|NCT01809262|961556|P5|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
392437|NCT01809262|961557|P4|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
392438|NCT01809262|961558|P3|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
392439|NCT01809262|961559|P2|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
392440|NCT01809262|961560|P1|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
392441|NCT01809262|961551|P10|COMPLETED|Period 5 (Fifth Dose + Washout)||4
392442|NCT01809262|961552|P9|COMPLETED|Period 5 (Fifth Dose + Washout)||3
392443|NCT01809262|961553|P8|COMPLETED|Period 5 (Fifth Dose + Washout)||4
392444|NCT01809262|961554|P7|COMPLETED|Period 5 (Fifth Dose + Washout)||3
392445|NCT01809262|961555|P6|COMPLETED|Period 5 (Fifth Dose + Washout)||3
392446|NCT01809262|961556|P5|COMPLETED|Period 5 (Fifth Dose + Washout)||3
392447|NCT01809262|961557|P4|COMPLETED|Period 5 (Fifth Dose + Washout)||3
392448|NCT01809262|961558|P3|COMPLETED|Period 5 (Fifth Dose + Washout)||4
392449|NCT01809262|961559|P2|COMPLETED|Period 5 (Fifth Dose + Washout)||3
392450|NCT01809262|961560|P1|COMPLETED|Period 5 (Fifth Dose + Washout)||4
392451|NCT01809262|961551|P10|STARTED|Period 5 (Fifth Dose + Washout)||4
392452|NCT01809262|961552|P9|STARTED|Period 5 (Fifth Dose + Washout)||3
392453|NCT01809262|961553|P8|STARTED|Period 5 (Fifth Dose + Washout)||4
392454|NCT01809262|961554|P7|STARTED|Period 5 (Fifth Dose + Washout)||3
392455|NCT01809262|961555|P6|STARTED|Period 5 (Fifth Dose + Washout)||3
392456|NCT01809262|961556|P5|STARTED|Period 5 (Fifth Dose + Washout)||3
392457|NCT01809262|961557|P4|STARTED|Period 5 (Fifth Dose + Washout)||3
392458|NCT01809262|961558|P3|STARTED|Period 5 (Fifth Dose + Washout)||4
392459|NCT01809262|961559|P2|STARTED|Period 5 (Fifth Dose + Washout)||3
392460|NCT01809262|961560|P1|STARTED|Period 5 (Fifth Dose + Washout)||4
392461|NCT01809262|961551|P10|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
392462|NCT01809262|961552|P9|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
392463|NCT01809262|961553|P8|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
392464|NCT01809262|961554|P7|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
392465|NCT01809262|961555|P6|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
392466|NCT01809262|961556|P5|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
392467|NCT01809262|961557|P4|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
392468|NCT01809262|961558|P3|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
392469|NCT01809262|961559|P2|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
392470|NCT01809262|961560|P1|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
392471|NCT01809262|961551|P10|COMPLETED|Period 4 (Fourth Dose + Washout)||4
392472|NCT01809262|961552|P9|COMPLETED|Period 4 (Fourth Dose + Washout)||3
392473|NCT01809262|961553|P8|COMPLETED|Period 4 (Fourth Dose + Washout)||4
392474|NCT01809262|961554|P7|COMPLETED|Period 4 (Fourth Dose + Washout)||3
392475|NCT01809262|961555|P6|COMPLETED|Period 4 (Fourth Dose + Washout)||3
392476|NCT01809262|961556|P5|COMPLETED|Period 4 (Fourth Dose + Washout)||3
392477|NCT01809262|961557|P4|COMPLETED|Period 4 (Fourth Dose + Washout)||3
392478|NCT01809262|961558|P3|COMPLETED|Period 4 (Fourth Dose + Washout)||4
392479|NCT01809262|961559|P2|COMPLETED|Period 4 (Fourth Dose + Washout)||3
392480|NCT01809262|961560|P1|COMPLETED|Period 4 (Fourth Dose + Washout)||4
392481|NCT01809262|961551|P10|STARTED|Period 4 (Fourth Dose + Washout)||4
392482|NCT01809262|961552|P9|STARTED|Period 4 (Fourth Dose + Washout)||3
392483|NCT01809262|961553|P8|STARTED|Period 4 (Fourth Dose + Washout)||4
392484|NCT01809262|961554|P7|STARTED|Period 4 (Fourth Dose + Washout)||3
392485|NCT01809262|961555|P6|STARTED|Period 4 (Fourth Dose + Washout)||3
392486|NCT01809262|961556|P5|STARTED|Period 4 (Fourth Dose + Washout)||3
392487|NCT01809262|961557|P4|STARTED|Period 4 (Fourth Dose + Washout)||3
392488|NCT01809262|961558|P3|STARTED|Period 4 (Fourth Dose + Washout)||4
392489|NCT01809262|961559|P2|STARTED|Period 4 (Fourth Dose + Washout)||3
392490|NCT01809262|961560|P1|STARTED|Period 4 (Fourth Dose + Washout)||4
392491|NCT01809262|961551|P10|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
392492|NCT01809262|961552|P9|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
392493|NCT01809262|961553|P8|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
392494|NCT01809262|961554|P7|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
392495|NCT01809262|961555|P6|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
392496|NCT01809262|961556|P5|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
392497|NCT01809262|961557|P4|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
392498|NCT01809262|961558|P3|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
392499|NCT01809262|961559|P2|NOT COMPLETED|Period 3 (Third Dose + Washout)||1
392500|NCT01809262|961560|P1|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
392501|NCT01809262|961551|P10|COMPLETED|Period 3 (Third Dose + Washout)||4
392502|NCT01809262|961552|P9|COMPLETED|Period 3 (Third Dose + Washout)||3
392503|NCT01809262|961553|P8|COMPLETED|Period 3 (Third Dose + Washout)||4
392504|NCT01809262|961554|P7|COMPLETED|Period 3 (Third Dose + Washout)||3
392505|NCT01809262|961555|P6|COMPLETED|Period 3 (Third Dose + Washout)||3
392506|NCT01809262|961556|P5|COMPLETED|Period 3 (Third Dose + Washout)||3
392507|NCT01809262|961557|P4|COMPLETED|Period 3 (Third Dose + Washout)||3
392508|NCT01809262|961558|P3|COMPLETED|Period 3 (Third Dose + Washout)||4
392509|NCT01809262|961559|P2|COMPLETED|Period 3 (Third Dose + Washout)||3
392510|NCT01809262|961560|P1|COMPLETED|Period 3 (Third Dose + Washout)||4
392511|NCT01809262|961551|P10|STARTED|Period 3 (Third Dose + Washout)||4
392512|NCT01809262|961552|P9|STARTED|Period 3 (Third Dose + Washout)||3
392513|NCT01809262|961553|P8|STARTED|Period 3 (Third Dose + Washout)||4
392514|NCT01809262|961554|P7|STARTED|Period 3 (Third Dose + Washout)||3
392515|NCT01809262|961555|P6|STARTED|Period 3 (Third Dose + Washout)||3
392516|NCT01809262|961556|P5|STARTED|Period 3 (Third Dose + Washout)||3
392517|NCT01809262|961557|P4|STARTED|Period 3 (Third Dose + Washout)||3
392518|NCT01809262|961558|P3|STARTED|Period 3 (Third Dose + Washout)||4
392519|NCT01809262|961559|P2|STARTED|Period 3 (Third Dose + Washout)||4
392520|NCT01809262|961560|P1|STARTED|Period 3 (Third Dose + Washout)||4
392521|NCT01809262|961551|P10|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
392522|NCT01809262|961552|P9|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
392523|NCT01809262|961553|P8|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
392524|NCT01809262|961554|P7|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
392525|NCT01809262|961555|P6|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
392526|NCT01809262|961556|P5|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
392527|NCT01809262|961557|P4|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
392528|NCT01809262|961558|P3|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
392529|NCT01809262|961559|P2|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
392530|NCT01809262|961560|P1|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
392531|NCT01809262|961551|P10|COMPLETED|Period 2 (Second Dose + Washout)||4
392532|NCT01809262|961552|P9|COMPLETED|Period 2 (Second Dose + Washout)||3
392533|NCT01809262|961553|P8|COMPLETED|Period 2 (Second Dose + Washout)||4
392534|NCT01809262|961554|P7|COMPLETED|Period 2 (Second Dose + Washout)||3
392535|NCT01809262|961555|P6|COMPLETED|Period 2 (Second Dose + Washout)||3
392536|NCT01809262|961556|P5|COMPLETED|Period 2 (Second Dose + Washout)||3
392537|NCT01809262|961557|P4|COMPLETED|Period 2 (Second Dose + Washout)||3
392538|NCT01809262|961558|P3|COMPLETED|Period 2 (Second Dose + Washout)||4
392539|NCT01809262|961559|P2|COMPLETED|Period 2 (Second Dose + Washout)||4
392540|NCT01809262|961560|P1|COMPLETED|Period 2 (Second Dose + Washout)||4
392541|NCT01809262|961551|P10|STARTED|Period 2 (Second Dose + Washout)||4
392542|NCT01809262|961552|P9|STARTED|Period 2 (Second Dose + Washout)||3
392543|NCT01809262|961553|P8|STARTED|Period 2 (Second Dose + Washout)||4
392544|NCT01809262|961554|P7|STARTED|Period 2 (Second Dose + Washout)||3
392545|NCT01809262|961555|P6|STARTED|Period 2 (Second Dose + Washout)||3
392546|NCT01809262|961556|P5|STARTED|Period 2 (Second Dose + Washout)||3
392547|NCT01809262|961557|P4|STARTED|Period 2 (Second Dose + Washout)||3
392548|NCT01809262|961558|P3|STARTED|Period 2 (Second Dose + Washout)||4
392549|NCT01809262|961559|P2|STARTED|Period 2 (Second Dose + Washout)||4
392550|NCT01809262|961560|P1|STARTED|Period 2 (Second Dose + Washout)||4
392551|NCT01809262|961551|P10|NOT COMPLETED|Period 1 (First Dose + Washout)||0
392552|NCT01809262|961552|P9|NOT COMPLETED|Period 1 (First Dose + Washout)||0
392553|NCT01809262|961553|P8|NOT COMPLETED|Period 1 (First Dose + Washout)||0
392554|NCT01809262|961554|P7|NOT COMPLETED|Period 1 (First Dose + Washout)||0
392555|NCT01809262|961555|P6|NOT COMPLETED|Period 1 (First Dose + Washout)||0
392556|NCT01809262|961556|P5|NOT COMPLETED|Period 1 (First Dose + Washout)||1
392557|NCT01809262|961557|P4|NOT COMPLETED|Period 1 (First Dose + Washout)||0
392558|NCT01809262|961558|P3|NOT COMPLETED|Period 1 (First Dose + Washout)||0
392559|NCT01809262|961559|P2|NOT COMPLETED|Period 1 (First Dose + Washout)||0
392560|NCT01809262|961560|P1|NOT COMPLETED|Period 1 (First Dose + Washout)||0
392561|NCT01809262|961551|P10|COMPLETED|Period 1 (First Dose + Washout)||4
392562|NCT01809262|961552|P9|COMPLETED|Period 1 (First Dose + Washout)||3
392563|NCT01809262|961553|P8|COMPLETED|Period 1 (First Dose + Washout)||4
392564|NCT01809262|961554|P7|COMPLETED|Period 1 (First Dose + Washout)||3
392565|NCT01809262|961555|P6|COMPLETED|Period 1 (First Dose + Washout)||3
392566|NCT01809262|961556|P5|COMPLETED|Period 1 (First Dose + Washout)||3
392567|NCT01809262|961557|P4|COMPLETED|Period 1 (First Dose + Washout)||3
392568|NCT01809262|961558|P3|COMPLETED|Period 1 (First Dose + Washout)||4
392569|NCT01809262|961559|P2|COMPLETED|Period 1 (First Dose + Washout)||4
392570|NCT01809262|961560|P1|COMPLETED|Period 1 (First Dose + Washout)||4
392571|NCT01809262|961551|P10|STARTED|Period 1 (First Dose + Washout)||4
392572|NCT01809262|961552|P9|STARTED|Period 1 (First Dose + Washout)||3
392573|NCT01809262|961553|P8|STARTED|Period 1 (First Dose + Washout)||4
392574|NCT01809262|961554|P7|STARTED|Period 1 (First Dose + Washout)||3
392575|NCT01809262|961555|P6|STARTED|Period 1 (First Dose + Washout)||3
392576|NCT01809262|961556|P5|STARTED|Period 1 (First Dose + Washout)||4
392577|NCT01809262|961557|P4|STARTED|Period 1 (First Dose + Washout)||3
392578|NCT01809262|961558|P3|STARTED|Period 1 (First Dose + Washout)||4
392579|NCT01809262|961559|P2|STARTED|Period 1 (First Dose + Washout)||4
392580|NCT01809262|961560|P1|STARTED|Period 1 (First Dose + Washout)||4
392581|NCT01809210|961634|P7|NOT COMPLETED|Overall Study||5
392582|NCT01809210|961635|P6|NOT COMPLETED|Overall Study||3
392583|NCT01809210|961636|P5|NOT COMPLETED|Overall Study||2
392584|NCT01809210|961637|P4|NOT COMPLETED|Overall Study||1
392585|NCT01809210|961638|P3|NOT COMPLETED|Overall Study||3
392586|NCT01809210|961639|P2|NOT COMPLETED|Overall Study||1
392587|NCT01809210|961640|P1|NOT COMPLETED|Overall Study||1
392588|NCT01809210|961634|P7|COMPLETED|Overall Study||7
392589|NCT01809210|961635|P6|COMPLETED|Overall Study||12
392590|NCT01809210|961636|P5|COMPLETED|Overall Study||4
392591|NCT01809210|961637|P4|COMPLETED|Overall Study||2
392592|NCT01809210|961638|P3|COMPLETED|Overall Study||4
392593|NCT01809210|961639|P2|COMPLETED|Overall Study||8
392594|NCT01809210|961640|P1|COMPLETED|Overall Study||2
392595|NCT01809210|961634|P7|STARTED|Overall Study||12
392596|NCT01809210|961635|P6|STARTED|Overall Study||15
392597|NCT01809210|961636|P5|STARTED|Overall Study||6
392598|NCT01809210|961637|P4|STARTED|Overall Study||3
392599|NCT01809210|961638|P3|STARTED|Overall Study||7
392600|NCT01809210|961639|P2|STARTED|Overall Study||9
392601|NCT01809210|961640|P1|STARTED|Overall Study||3
392602|NCT01809197|961714|P2|NOT COMPLETED|Overall Study||8
392603|NCT01809197|961715|P1|NOT COMPLETED|Overall Study||10
392604|NCT01809197|961714|P2|COMPLETED|Overall Study||177
392605|NCT01809197|961715|P1|COMPLETED|Overall Study||177
392606|NCT01809197|961714|P2|STARTED|Overall Study||185
392607|NCT01809197|961715|P1|STARTED|Overall Study||187
392608|NCT01809106|961725|P4|NOT COMPLETED|Overall Study||4
392609|NCT01809106|961726|P3|NOT COMPLETED|Overall Study||3
392610|NCT01809106|961727|P2|NOT COMPLETED|Overall Study||5
392611|NCT01809106|961728|P1|NOT COMPLETED|Overall Study||8
392612|NCT01809106|961725|P4|COMPLETED|Overall Study||124
392613|NCT01809106|961726|P3|COMPLETED|Overall Study||127
392614|NCT01809106|961727|P2|COMPLETED|Overall Study||125
392615|NCT01809106|961728|P1|COMPLETED|Overall Study||122
392616|NCT01809106|961725|P4|STARTED|Overall Study||128
392617|NCT01809106|961726|P3|STARTED|Overall Study||130
392618|NCT01809106|961727|P2|STARTED|Overall Study||130
392619|NCT01809106|961728|P1|STARTED|Overall Study||130
392620|NCT01809054|961748|P2|NOT COMPLETED|Overall Study||0
392621|NCT01809054|961749|P1|NOT COMPLETED|Overall Study||0
392622|NCT01809054|961748|P2|COMPLETED|Overall Study||22
392623|NCT01809054|961749|P1|COMPLETED|Overall Study||27
392624|NCT01809054|961748|P2|STARTED|Overall Study||22
392625|NCT01809054|961749|P1|STARTED|Overall Study||27
392626|NCT01808963|961757|P1|NOT COMPLETED|Overall Study||0
392627|NCT01808963|961757|P1|COMPLETED|Overall Study||13
392628|NCT01808963|961757|P1|STARTED|Overall Study||13
392629|NCT01808950|961764|P3|NOT COMPLETED|Overall Study||0
392630|NCT01808950|961765|P2|NOT COMPLETED|Overall Study||0
392631|NCT01808950|961766|P1|NOT COMPLETED|Overall Study||0
392632|NCT01808950|961764|P3|COMPLETED|Overall Study||0
392633|NCT01808950|961765|P2|COMPLETED|Overall Study||3
392634|NCT01808950|961766|P1|COMPLETED|Overall Study||1
392635|NCT01808950|961764|P3|STARTED|Overall Study||0
392636|NCT01808950|961765|P2|STARTED|Overall Study||3
392637|NCT01808950|961766|P1|STARTED|Overall Study||1
392638|NCT01808755|961777|P2|NOT COMPLETED|Overall Study||0
392639|NCT01808755|961778|P1|NOT COMPLETED|Overall Study||0
392640|NCT01808755|961777|P2|COMPLETED|Overall Study||30
392641|NCT01808755|961778|P1|COMPLETED|Overall Study||30
392642|NCT01808755|961777|P2|STARTED|Overall Study||30
392643|NCT01808755|961778|P1|STARTED|Overall Study||30
392644|NCT01808651|961786|P3|NOT COMPLETED|Study Period 2||0
392645|NCT01808651|961787|P2|NOT COMPLETED|Study Period 2||0
392646|NCT01808651|961788|P1|NOT COMPLETED|Study Period 2||0
392647|NCT01808651|961786|P3|COMPLETED|Study Period 2|3 Pts who DC'd from Study Period 1 and 30 pts who completed Study Period 1 entered Study Period 2.|33
392648|NCT01808651|961787|P2|COMPLETED|Study Period 2|5 Pts who DC'd from Study Period 1 and 47 Pts who completed Study Period 1 entered Study Period 2.|52
392649|NCT01808651|961788|P1|COMPLETED|Study Period 2|9 Pts who DC'd from Study Period 1 and 68 Pts who completed Study Period 1 entered Study Period 2.|77
392650|NCT01808651|961786|P3|STARTED|Study Period 2||33
392651|NCT01808651|961787|P2|STARTED|Study Period 2||52
392652|NCT01808651|961788|P1|STARTED|Study Period 2||77
392653|NCT01808651|961786|P3|NOT COMPLETED|Study Period 1||5
392654|NCT01808651|961787|P2|NOT COMPLETED|Study Period 1||17
392655|NCT01808651|961788|P1|NOT COMPLETED|Study Period 1||26
392656|NCT01808651|961786|P3|COMPLETED|Study Period 1||31
392657|NCT01808651|961787|P2|COMPLETED|Study Period 1||48
392658|NCT01808651|961788|P1|COMPLETED|Study Period 1||73
392659|NCT01808651|961786|P3|Received at Least One Dose of Study Drug|Study Period 1||36
392660|NCT01808651|961787|P2|Received at Least One Dose of Study Drug|Study Period 1||65
392661|NCT01808651|961788|P1|Received at Least One Dose of Study Drug|Study Period 1||98
392662|NCT01808651|961786|P3|STARTED|Study Period 1||36
392663|NCT01808651|961787|P2|STARTED|Study Period 1||65
392664|NCT01808651|961788|P1|STARTED|Study Period 1||99
392665|NCT01808612|961823|P3|NOT COMPLETED|Discontinuation Period||0
392666|NCT01808612|961824|P2|NOT COMPLETED|Discontinuation Period||1
392667|NCT01808612|961825|P1|NOT COMPLETED|Discontinuation Period||2
392668|NCT01808612|961823|P3|COMPLETED|Discontinuation Period||145
392669|NCT01808612|961824|P2|COMPLETED|Discontinuation Period||37
392670|NCT01808612|961825|P1|COMPLETED|Discontinuation Period||85
392671|NCT01808612|961823|P3|STARTED|Discontinuation Period||145
392672|NCT01808612|961824|P2|STARTED|Discontinuation Period||38
392673|NCT01808612|961825|P1|STARTED|Discontinuation Period||87
392674|NCT01808612|961823|P3|NOT COMPLETED|Treatment Period||14
392675|NCT01808612|961824|P2|NOT COMPLETED|Treatment Period||7
392676|NCT01808612|961825|P1|NOT COMPLETED|Treatment Period||15
392677|NCT01808612|961823|P3|COMPLETED|Treatment Period|101 participants who completed the Treatment Period did not enter the Discontinuation Period.|246
392678|NCT01808612|961824|P2|COMPLETED|Treatment Period|39 participants who completed the Treatment Period did not enter the Discontinuation Period.|77
392679|NCT01808612|961825|P1|COMPLETED|Treatment Period|67 participants who completed the Treatment Period did not enter the Discontinuation Period.|154
392680|NCT01808612|961823|P3|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|259
392681|NCT01808612|961824|P2|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|83
392682|NCT01808612|961825|P1|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|168
392683|NCT01808612|961823|P3|STARTED|Treatment Period||260
392684|NCT01808612|961824|P2|STARTED|Treatment Period||84
392685|NCT01808612|961825|P1|STARTED|Treatment Period||169
392686|NCT01808560|961857|P3|NOT COMPLETED|4-Month After Cataract Surgery||0
392687|NCT01808560|961858|P2|NOT COMPLETED|4-Month After Cataract Surgery||0
392688|NCT01808560|961859|P1|NOT COMPLETED|4-Month After Cataract Surgery||0
392689|NCT01808560|961857|P3|COMPLETED|4-Month After Cataract Surgery||13
392690|NCT01808560|961858|P2|COMPLETED|4-Month After Cataract Surgery||0
392691|NCT01808560|961859|P1|COMPLETED|4-Month After Cataract Surgery||0
392692|NCT01808560|961857|P3|STARTED|4-Month After Cataract Surgery||13
392693|NCT01808560|961858|P2|STARTED|4-Month After Cataract Surgery||0
392694|NCT01808560|961859|P1|STARTED|4-Month After Cataract Surgery||0
392695|NCT01808560|961857|P3|NOT COMPLETED|Crossover Treatment||0
392696|NCT01808560|961858|P2|NOT COMPLETED|Crossover Treatment||0
392697|NCT01808560|961859|P1|NOT COMPLETED|Crossover Treatment||0
392698|NCT01808560|961857|P3|COMPLETED|Crossover Treatment||13
392699|NCT01808560|961858|P2|COMPLETED|Crossover Treatment||0
392700|NCT01808560|961859|P1|COMPLETED|Crossover Treatment||0
392701|NCT01808560|961857|P3|STARTED|Crossover Treatment|Post-Treatment Group Received Crossover LipiFlow treatment 3 Months after cataract surgery|13
392702|NCT01808560|961858|P2|STARTED|Crossover Treatment||0
392703|NCT01808560|961859|P1|STARTED|Crossover Treatment||0
392704|NCT01808560|961857|P3|NOT COMPLETED|3-Month After Cataract Surgery||0
392705|NCT01808560|961858|P2|NOT COMPLETED|3-Month After Cataract Surgery||0
392706|NCT01808560|961859|P1|NOT COMPLETED|3-Month After Cataract Surgery||0
392707|NCT01808560|961857|P3|COMPLETED|3-Month After Cataract Surgery||0
392708|NCT01808560|961858|P2|COMPLETED|3-Month After Cataract Surgery||13
392709|NCT01808560|961859|P1|COMPLETED|3-Month After Cataract Surgery||17
392710|NCT01808560|961857|P3|STARTED|3-Month After Cataract Surgery||0
392711|NCT01808560|961858|P2|STARTED|3-Month After Cataract Surgery||13
392712|NCT01808560|961859|P1|STARTED|3-Month After Cataract Surgery||17
392713|NCT01808560|961857|P3|NOT COMPLETED|1-Month After Cataract Surgery||0
392714|NCT01808560|961858|P2|NOT COMPLETED|1-Month After Cataract Surgery||0
392715|NCT01808560|961859|P1|NOT COMPLETED|1-Month After Cataract Surgery||0
392716|NCT01808560|961857|P3|COMPLETED|1-Month After Cataract Surgery||0
392717|NCT01808560|961858|P2|COMPLETED|1-Month After Cataract Surgery||13
392718|NCT01808560|961859|P1|COMPLETED|1-Month After Cataract Surgery||16
392719|NCT01808560|961857|P3|STARTED|1-Month After Cataract Surgery||0
392720|NCT01808560|961858|P2|STARTED|1-Month After Cataract Surgery|ITT: 3 subjects withdrew b/c they were unable to complete cataract surgery scheduled for both eyes|13
392721|NCT01808560|961859|P1|STARTED|1-Month After Cataract Surgery|ITT: 2 subjects withdrew b/c they were unable to complete cataract surgery scheduled for both eyes|16
392722|NCT01808560|961857|P3|NOT COMPLETED|Randomization and Treatment Allocation||0
392723|NCT01808560|961858|P2|NOT COMPLETED|Randomization and Treatment Allocation||0
392724|NCT01808560|961859|P1|NOT COMPLETED|Randomization and Treatment Allocation||0
392725|NCT01808560|961857|P3|COMPLETED|Randomization and Treatment Allocation||0
392726|NCT01808560|961858|P2|COMPLETED|Randomization and Treatment Allocation||16
392727|NCT01808560|961859|P1|COMPLETED|Randomization and Treatment Allocation||18
392728|NCT01808560|961857|P3|STARTED|Randomization and Treatment Allocation||0
392729|NCT01808560|961858|P2|STARTED|Randomization and Treatment Allocation||16
392730|NCT01808560|961859|P1|STARTED|Randomization and Treatment Allocation||18
392731|NCT01808547|961884|P2|NOT COMPLETED|Overall Study||46
392732|NCT01808547|961885|P1|NOT COMPLETED|Overall Study||37
392733|NCT01808547|961884|P2|COMPLETED|Overall Study||48
392734|NCT01808547|961885|P1|COMPLETED|Overall Study||137
392735|NCT01808547|961884|P2|mITT Population|Overall Study||85
392736|NCT01808547|961885|P1|mITT Population|Overall Study||168
392737|NCT01808547|961884|P2|Safety Population|Overall Study||85
392738|NCT01808547|961885|P1|Safety Population|Overall Study||170
392739|NCT01808547|961884|P2|STARTED|Overall Study||94
392740|NCT01808547|961885|P1|STARTED|Overall Study||174
392741|NCT01808534|961891|P1|NOT COMPLETED|Overall Study||4
392742|NCT01808534|961891|P1|COMPLETED|Overall Study||1
392743|NCT01808534|961891|P1|STARTED|Overall Study||5
392744|NCT01808508|961902|P3|NOT COMPLETED|Overall Study||0
392745|NCT01808508|961903|P2|NOT COMPLETED|Overall Study||0
392746|NCT01808508|961904|P1|NOT COMPLETED|Overall Study||1
392747|NCT01808508|961902|P3|COMPLETED|Overall Study||3
392748|NCT01808508|961903|P2|COMPLETED|Overall Study||9
392749|NCT01808508|961904|P1|COMPLETED|Overall Study||10
392750|NCT01808508|961902|P3|STARTED|Overall Study||3
392751|NCT01808508|961903|P2|STARTED|Overall Study||9
392752|NCT01808508|961904|P1|STARTED|Overall Study||11
392753|NCT01808339|961921|P6|NOT COMPLETED|Treatment Period 3 (14 Days)||0
392754|NCT01808339|961922|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||0
392755|NCT01808339|961923|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
392756|NCT01808339|961924|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||1
392757|NCT01808339|961925|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||0
392758|NCT01808339|961926|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
392759|NCT01808339|961921|P6|COMPLETED|Treatment Period 3 (14 Days)||5
392760|NCT01808339|961922|P5|COMPLETED|Treatment Period 3 (14 Days)||4
392761|NCT01808339|961923|P4|COMPLETED|Treatment Period 3 (14 Days)||2
392762|NCT01808339|961924|P3|COMPLETED|Treatment Period 3 (14 Days)||3
392763|NCT01808339|961925|P2|COMPLETED|Treatment Period 3 (14 Days)||3
392764|NCT01808339|961926|P1|COMPLETED|Treatment Period 3 (14 Days)||4
392765|NCT01808339|961921|P6|STARTED|Treatment Period 3 (14 Days)||5
392766|NCT01808339|961922|P5|STARTED|Treatment Period 3 (14 Days)||4
392767|NCT01808339|961923|P4|STARTED|Treatment Period 3 (14 Days)||2
392768|NCT01808339|961924|P3|STARTED|Treatment Period 3 (14 Days)||4
392769|NCT01808339|961925|P2|STARTED|Treatment Period 3 (14 Days)||3
392770|NCT01808339|961926|P1|STARTED|Treatment Period 3 (14 Days)||4
392771|NCT01808339|961921|P6|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
392772|NCT01808339|961922|P5|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
392773|NCT01808339|961923|P4|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
392774|NCT01808339|961924|P3|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
392775|NCT01808339|961925|P2|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
392776|NCT01808339|961926|P1|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
392777|NCT01808339|961921|P6|COMPLETED|Washout Period 2 (14-21 Days)||5
392778|NCT01808339|961922|P5|COMPLETED|Washout Period 2 (14-21 Days)||4
392779|NCT01808339|961923|P4|COMPLETED|Washout Period 2 (14-21 Days)||2
392780|NCT01808339|961924|P3|COMPLETED|Washout Period 2 (14-21 Days)||4
392781|NCT01808339|961925|P2|COMPLETED|Washout Period 2 (14-21 Days)||3
392782|NCT01808339|961926|P1|COMPLETED|Washout Period 2 (14-21 Days)||4
392783|NCT01808339|961921|P6|STARTED|Washout Period 2 (14-21 Days)||5
392784|NCT01808339|961922|P5|STARTED|Washout Period 2 (14-21 Days)||4
392785|NCT01808339|961923|P4|STARTED|Washout Period 2 (14-21 Days)||2
392786|NCT01808339|961924|P3|STARTED|Washout Period 2 (14-21 Days)||4
392787|NCT01808339|961925|P2|STARTED|Washout Period 2 (14-21 Days)||3
392788|NCT01808339|961926|P1|STARTED|Washout Period 2 (14-21 Days)||4
392789|NCT01808339|961921|P6|NOT COMPLETED|Treatment Period 2 (14 Days)||0
392790|NCT01808339|961922|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||0
392791|NCT01808339|961923|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||0
392792|NCT01808339|961924|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||0
392793|NCT01808339|961925|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||0
392794|NCT01808339|961926|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||0
392795|NCT01808339|961921|P6|COMPLETED|Treatment Period 2 (14 Days)||5
392796|NCT01808339|961922|P5|COMPLETED|Treatment Period 2 (14 Days)||4
392797|NCT01808339|961923|P4|COMPLETED|Treatment Period 2 (14 Days)||2
392798|NCT01808339|961924|P3|COMPLETED|Treatment Period 2 (14 Days)||4
392799|NCT01808339|961925|P2|COMPLETED|Treatment Period 2 (14 Days)||3
392800|NCT01808339|961926|P1|COMPLETED|Treatment Period 2 (14 Days)||4
392801|NCT01808339|961921|P6|STARTED|Treatment Period 2 (14 Days)||5
392802|NCT01808339|961922|P5|STARTED|Treatment Period 2 (14 Days)||4
392803|NCT01808339|961923|P4|STARTED|Treatment Period 2 (14 Days)||2
392804|NCT01808339|961924|P3|STARTED|Treatment Period 2 (14 Days)||4
392805|NCT01808339|961925|P2|STARTED|Treatment Period 2 (14 Days)||3
392806|NCT01808339|961926|P1|STARTED|Treatment Period 2 (14 Days)||4
392807|NCT01808339|961921|P6|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
392808|NCT01808339|961922|P5|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
392809|NCT01808339|961923|P4|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
392810|NCT01808339|961924|P3|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
392811|NCT01808339|961925|P2|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
392812|NCT01808339|961926|P1|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
392813|NCT01808339|961921|P6|COMPLETED|Washout Period 1 (14-21 Days)||5
392814|NCT01808339|961922|P5|COMPLETED|Washout Period 1 (14-21 Days)||4
392815|NCT01808339|961923|P4|COMPLETED|Washout Period 1 (14-21 Days)||2
392816|NCT01808339|961924|P3|COMPLETED|Washout Period 1 (14-21 Days)||4
392817|NCT01808339|961925|P2|COMPLETED|Washout Period 1 (14-21 Days)||3
392818|NCT01808339|961926|P1|COMPLETED|Washout Period 1 (14-21 Days)||4
392819|NCT01808339|961921|P6|STARTED|Washout Period 1 (14-21 Days)||5
392820|NCT01808339|961922|P5|STARTED|Washout Period 1 (14-21 Days)||4
392821|NCT01808339|961923|P4|STARTED|Washout Period 1 (14-21 Days)||2
392822|NCT01808339|961924|P3|STARTED|Washout Period 1 (14-21 Days)||4
392823|NCT01808339|961925|P2|STARTED|Washout Period 1 (14-21 Days)||3
392824|NCT01808339|961926|P1|STARTED|Washout Period 1 (14-21 Days)||4
392825|NCT01808339|961921|P6|NOT COMPLETED|Treatment Period 1 (14 Days)||1
392826|NCT01808339|961922|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||2
392827|NCT01808339|961923|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||2
392828|NCT01808339|961924|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||0
392829|NCT01808339|961925|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
392830|NCT01808339|961926|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||0
392831|NCT01808339|961921|P6|COMPLETED|Treatment Period 1 (14 Days)||5
392832|NCT01808339|961922|P5|COMPLETED|Treatment Period 1 (14 Days)||4
392833|NCT01808339|961923|P4|COMPLETED|Treatment Period 1 (14 Days)||2
392834|NCT01808339|961924|P3|COMPLETED|Treatment Period 1 (14 Days)||4
392835|NCT01808339|961925|P2|COMPLETED|Treatment Period 1 (14 Days)||3
392836|NCT01808339|961926|P1|COMPLETED|Treatment Period 1 (14 Days)||4
392837|NCT01808339|961921|P6|STARTED|Treatment Period 1 (14 Days)||6
392838|NCT01808339|961922|P5|STARTED|Treatment Period 1 (14 Days)||6
392839|NCT01808339|961923|P4|STARTED|Treatment Period 1 (14 Days)||4
392840|NCT01808339|961924|P3|STARTED|Treatment Period 1 (14 Days)||4
392841|NCT01808339|961925|P2|STARTED|Treatment Period 1 (14 Days)||4
392842|NCT01808339|961926|P1|STARTED|Treatment Period 1 (14 Days)||4
392843|NCT01808326|961943|P1|NOT COMPLETED|Overall Study||0
392844|NCT01808326|961943|P1|COMPLETED|Overall Study||5
392845|NCT01808326|961943|P1|STARTED|Overall Study||5
392846|NCT01808313|961970|P1|NOT COMPLETED|Overall Study||10
392847|NCT01808313|961970|P1|COMPLETED|Overall Study||123
392848|NCT01808313|961970|P1|STARTED|Overall Study||133
392849|NCT01808261|962000|P2|NOT COMPLETED|Overall Study||33
392850|NCT01808261|962001|P1|NOT COMPLETED|Overall Study||36
392851|NCT01808261|962000|P2|COMPLETED|Overall Study||32
392852|NCT01808261|962001|P1|COMPLETED|Overall Study||32
392853|NCT01808261|962000|P2|STARTED|Overall Study||65
392854|NCT01808261|962001|P1|STARTED|Overall Study||68
392855|NCT01808248|962057|P1|NOT COMPLETED|Overall Study||5
392856|NCT01808248|962057|P1|COMPLETED|Overall Study||42
392857|NCT01808248|962057|P1|Completed Posttreatment Week 12 Visit|Overall Study||45
392858|NCT01808248|962057|P1|STARTED|Overall Study||47
392859|NCT01808209|962071|P2|NOT COMPLETED|Overall Study||1
392860|NCT01808209|962072|P1|NOT COMPLETED|Overall Study||0
392861|NCT01808209|962071|P2|COMPLETED|Overall Study||26
392862|NCT01808209|962072|P1|COMPLETED|Overall Study||33
392863|NCT01808209|962071|P2|STARTED|Overall Study||27
392864|NCT01808209|962072|P1|STARTED|Overall Study||33
392865|NCT01808144|962116|P2|NOT COMPLETED|Overall Study||48
392866|NCT01808144|962117|P1|NOT COMPLETED|Overall Study||40
392867|NCT01808144|962116|P2|COMPLETED|Overall Study||51
392868|NCT01808144|962117|P1|COMPLETED|Overall Study||57
392869|NCT01808144|962116|P2|STARTED|Overall Study||99
392870|NCT01808144|962117|P1|STARTED|Overall Study||97
392871|NCT01808118|962125|P3|NOT COMPLETED|Period 2||8
392872|NCT01808118|962126|P2|NOT COMPLETED|Period 2||13
392873|NCT01808118|962127|P1|NOT COMPLETED|Period 2||0
392874|NCT01808118|962125|P3|COMPLETED|Period 2||144
392875|NCT01808118|962126|P2|COMPLETED|Period 2||140
392876|NCT01808118|962127|P1|COMPLETED|Period 2||0
392877|NCT01808118|962125|P3|STARTED|Period 2||152
392878|NCT01808118|962126|P2|STARTED|Period 2||153
392879|NCT01808118|962127|P1|STARTED|Period 2||0
392880|NCT01808118|962125|P3|NOT COMPLETED|Period 1||0
392881|NCT01808118|962126|P2|NOT COMPLETED|Period 1||0
392882|NCT01808118|962127|P1|NOT COMPLETED|Period 1||368
392883|NCT01808118|962125|P3|COMPLETED|Period 1||0
392884|NCT01808118|962126|P2|COMPLETED|Period 1||0
392885|NCT01808118|962127|P1|COMPLETED|Period 1||305
392886|NCT01808118|962125|P3|STARTED|Period 1||0
392887|NCT01808118|962126|P2|STARTED|Period 1||0
392888|NCT01808118|962127|P1|STARTED|Period 1||673
392889|NCT01808092|962190|P2|NOT COMPLETED|Overall Study||45
392890|NCT01808092|962191|P1|NOT COMPLETED|Overall Study||54
392891|NCT01808092|962190|P2|COMPLETED|Overall Study||363
392892|NCT01808092|962191|P1|COMPLETED|Overall Study||355
392893|NCT01808092|962190|P2|STARTED|Overall Study||408
392894|NCT01808092|962191|P1|STARTED|Overall Study||409
392895|NCT01808066|962293|P1|NOT COMPLETED|Overall Study||15
392896|NCT01808066|962293|P1|COMPLETED|Overall Study||6
392897|NCT01808066|962293|P1|STARTED|Overall Study||21
392898|NCT01807949|962300|P3|NOT COMPLETED|Overall Study||9
392899|NCT01807949|962301|P2|NOT COMPLETED|Overall Study||7
392900|NCT01807949|962302|P1|NOT COMPLETED|Overall Study||2
392901|NCT01807949|962300|P3|COMPLETED|Overall Study||180
392902|NCT01807949|962301|P2|COMPLETED|Overall Study||180
392903|NCT01807949|962302|P1|COMPLETED|Overall Study||185
392904|NCT01807949|962300|P3|STARTED|Overall Study||189
392905|NCT01807949|962301|P2|STARTED|Overall Study||187
392906|NCT01807949|962302|P1|STARTED|Overall Study||187
392907|NCT01807923|962354|P3|NOT COMPLETED|Overall Study||11
392908|NCT01807923|962355|P2|NOT COMPLETED|Overall Study||6
392909|NCT01807923|962356|P1|NOT COMPLETED|Overall Study||5
392910|NCT01807923|962354|P3|COMPLETED|Overall Study||176
392911|NCT01807923|962355|P2|COMPLETED|Overall Study||179
392912|NCT01807923|962356|P1|COMPLETED|Overall Study||182
392913|NCT01807923|962354|P3|STARTED|Overall Study||187
392914|NCT01807923|962355|P2|STARTED|Overall Study||185
392915|NCT01807923|962356|P1|STARTED|Overall Study||187
392916|NCT01807871|962407|P2|NOT COMPLETED|Overall Study||218
392917|NCT01807871|962408|P1|NOT COMPLETED|Overall Study||178
392918|NCT01807871|962407|P2|COMPLETED|Overall Study||127
392919|NCT01807871|962408|P1|COMPLETED|Overall Study||178
392920|NCT01807871|962407|P2|STARTED|Overall Study||345
392921|NCT01807871|962408|P1|STARTED|Overall Study||356
392922|NCT01807624|962418|P1|NOT COMPLETED|Overall Study||0
392923|NCT01807624|962418|P1|COMPLETED|Overall Study||24
392924|NCT01807624|962418|P1|STARTED|Overall Study||24
392925|NCT01807585|962437|P3|NOT COMPLETED|Overall Study||6
392926|NCT01807585|962438|P2|NOT COMPLETED|Overall Study||4
392927|NCT01807585|962439|P1|NOT COMPLETED|Overall Study||1
392928|NCT01807585|962437|P3|COMPLETED|Overall Study||108
392929|NCT01807585|962438|P2|COMPLETED|Overall Study||104
392930|NCT01807585|962439|P1|COMPLETED|Overall Study||19
392931|NCT01807585|962437|P3|3 Mos|Overall Study||113
392932|NCT01807585|962438|P2|3 Mos|Overall Study||108
392933|NCT01807585|962439|P1|3 Mos|Overall Study||20
392934|NCT01807585|962437|P3|STARTED|Overall Study||114
392935|NCT01807585|962438|P2|STARTED|Overall Study||108
392936|NCT01807585|962439|P1|STARTED|Overall Study||20
392937|NCT01807520|962455|P7|NOT COMPLETED|Follow-up Period (132-140 Weeks)||1
392938|NCT01807520|962456|P6|NOT COMPLETED|Follow-up Period (132-140 Weeks)||4
392939|NCT01807520|962457|P5|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
392940|NCT01807520|962458|P4|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
392941|NCT01807520|962459|P3|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
392942|NCT01807520|962460|P2|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
392943|NCT01807520|962461|P1|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
392944|NCT01807520|962455|P7|COMPLETED|Follow-up Period (132-140 Weeks)||75
392945|NCT01807520|962456|P6|COMPLETED|Follow-up Period (132-140 Weeks)||77
392946|NCT01807520|962457|P5|COMPLETED|Follow-up Period (132-140 Weeks)||0
392947|NCT01807520|962458|P4|COMPLETED|Follow-up Period (132-140 Weeks)||0
392948|NCT01807520|962459|P3|COMPLETED|Follow-up Period (132-140 Weeks)||2
392949|NCT01807520|962460|P2|COMPLETED|Follow-up Period (132-140 Weeks)||0
392950|NCT01807520|962461|P1|COMPLETED|Follow-up Period (132-140 Weeks)||0
392951|NCT01807520|962455|P7|STARTED|Follow-up Period (132-140 Weeks)|These participants received AIN457 300mg during treatment period 1 and/or treatment period 2.|76
392952|NCT01807520|962456|P6|STARTED|Follow-up Period (132-140 Weeks)|These participants received AIN457150mg during treatment period 1 and/or treatment period 2.|81
392953|NCT01807520|962457|P5|STARTED|Follow-up Period (132-140 Weeks)||0
392954|NCT01807520|962458|P4|STARTED|Follow-up Period (132-140 Weeks)||0
392955|NCT01807520|962459|P3|STARTED|Follow-up Period (132-140 Weeks)|These participants discontinued from Treatment Period 1.|2
392956|NCT01807520|962460|P2|STARTED|Follow-up Period (132-140 Weeks)||0
392957|NCT01807520|962461|P1|STARTED|Follow-up Period (132-140 Weeks)||0
392958|NCT01807520|962455|P7|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
392959|NCT01807520|962456|P6|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
392960|NCT01807520|962457|P5|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||5
392961|NCT01807520|962458|P4|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||7
392962|NCT01807520|962459|P3|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
392963|NCT01807520|962460|P2|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||18
392964|NCT01807520|962461|P1|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||25
392965|NCT01807520|962455|P7|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
392966|NCT01807520|962456|P6|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
392967|NCT01807520|962457|P5|COMPLETED|Treatment Period 2 (16-132 Weeks)||24
392968|NCT01807520|962458|P4|COMPLETED|Treatment Period 2 (16-132 Weeks)||22
392969|NCT01807520|962459|P3|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
392970|NCT01807520|962460|P2|COMPLETED|Treatment Period 2 (16-132 Weeks)||47
392971|NCT01807520|962461|P1|COMPLETED|Treatment Period 2 (16-132 Weeks)||38
392972|NCT01807520|962455|P7|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
392973|NCT01807520|962456|P6|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
392974|NCT01807520|962457|P5|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||29
392975|NCT01807520|962458|P4|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||29
392976|NCT01807520|962459|P3|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
392977|NCT01807520|962460|P2|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||66
392978|NCT01807520|962461|P1|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||67
392979|NCT01807520|962455|P7|Safety Set|Treatment Period 2 (16-132 Weeks)||0
392980|NCT01807520|962456|P6|Safety Set|Treatment Period 2 (16-132 Weeks)||0
392981|NCT01807520|962457|P5|Safety Set|Treatment Period 2 (16-132 Weeks)||29
392982|NCT01807520|962458|P4|Safety Set|Treatment Period 2 (16-132 Weeks)||29
392983|NCT01807520|962459|P3|Safety Set|Treatment Period 2 (16-132 Weeks)||0
392984|NCT01807520|962460|P2|Safety Set|Treatment Period 2 (16-132 Weeks)||65
392985|NCT01807520|962461|P1|Safety Set|Treatment Period 2 (16-132 Weeks)||63
392986|NCT01807520|962455|P7|STARTED|Treatment Period 2 (16-132 Weeks)||0
392987|NCT01807520|962456|P6|STARTED|Treatment Period 2 (16-132 Weeks)||0
392988|NCT01807520|962457|P5|STARTED|Treatment Period 2 (16-132 Weeks)||29
392989|NCT01807520|962458|P4|STARTED|Treatment Period 2 (16-132 Weeks)||29
392990|NCT01807520|962459|P3|STARTED|Treatment Period 2 (16-132 Weeks)||0
392991|NCT01807520|962460|P2|STARTED|Treatment Period 2 (16-132 Weeks)||65
392992|NCT01807520|962461|P1|STARTED|Treatment Period 2 (16-132 Weeks)||63
392993|NCT01807520|962455|P7|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
392994|NCT01807520|962456|P6|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
392995|NCT01807520|962457|P5|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
392996|NCT01807520|962458|P4|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
392997|NCT01807520|962459|P3|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||7
392998|NCT01807520|962460|P2|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||1
392999|NCT01807520|962461|P1|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||4
393000|NCT01807520|962455|P7|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
393001|NCT01807520|962456|P6|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
393002|NCT01807520|962457|P5|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
393003|NCT01807520|962458|P4|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
393004|NCT01807520|962459|P3|COMPLETED|Treatment Period 1 (0-16 Weeks)||58
393005|NCT01807520|962460|P2|COMPLETED|Treatment Period 1 (0-16 Weeks)||65
393006|NCT01807520|962461|P1|COMPLETED|Treatment Period 1 (0-16 Weeks)||63
393007|NCT01807520|962455|P7|Safety Set|Treatment Period 1 (0-16 Weeks)||0
393008|NCT01807520|962456|P6|Safety Set|Treatment Period 1 (0-16 Weeks)||0
393009|NCT01807520|962457|P5|Safety Set|Treatment Period 1 (0-16 Weeks)||0
393010|NCT01807520|962458|P4|Safety Set|Treatment Period 1 (0-16 Weeks)||0
393011|NCT01807520|962459|P3|Safety Set|Treatment Period 1 (0-16 Weeks)||65
393012|NCT01807520|962460|P2|Safety Set|Treatment Period 1 (0-16 Weeks)||65
393013|NCT01807520|962461|P1|Safety Set|Treatment Period 1 (0-16 Weeks)||67
393014|NCT01807520|962455|P7|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
393015|NCT01807520|962456|P6|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
393016|NCT01807520|962457|P5|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
393017|NCT01807520|962458|P4|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
393018|NCT01807520|962459|P3|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||65
393019|NCT01807520|962460|P2|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||66
393020|NCT01807520|962461|P1|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||67
393021|NCT01807520|962455|P7|STARTED|Treatment Period 1 (0-16 Weeks)||0
393022|NCT01807520|962456|P6|STARTED|Treatment Period 1 (0-16 Weeks)||0
393023|NCT01807520|962457|P5|STARTED|Treatment Period 1 (0-16 Weeks)||0
393024|NCT01807520|962458|P4|STARTED|Treatment Period 1 (0-16 Weeks)||0
393025|NCT01807520|962459|P3|STARTED|Treatment Period 1 (0-16 Weeks)||65
393026|NCT01807520|962460|P2|STARTED|Treatment Period 1 (0-16 Weeks)||66
393027|NCT01807520|962461|P1|STARTED|Treatment Period 1 (0-16 Weeks)||67
393028|NCT01807455|962480|P1|NOT COMPLETED|Overall Study||0
393029|NCT01807455|962480|P1|COMPLETED|Overall Study||12
393030|NCT01807455|962480|P1|STARTED|Overall Study||12
393031|NCT01807234|962494|P6|NOT COMPLETED|Overall Study||4
393032|NCT01807234|962495|P5|NOT COMPLETED|Overall Study||4
393033|NCT01807234|962496|P4|NOT COMPLETED|Overall Study||2
393034|NCT01807234|962497|P3|NOT COMPLETED|Overall Study||2
393035|NCT01807234|962498|P2|NOT COMPLETED|Overall Study||6
393036|NCT01807234|962499|P1|NOT COMPLETED|Overall Study||5
393037|NCT01807234|962494|P6|COMPLETED|Overall Study||8
393038|NCT01807234|962495|P5|COMPLETED|Overall Study||8
393039|NCT01807234|962496|P4|COMPLETED|Overall Study||10
393040|NCT01807234|962497|P3|COMPLETED|Overall Study||10
393041|NCT01807234|962498|P2|COMPLETED|Overall Study||6
393042|NCT01807234|962499|P1|COMPLETED|Overall Study||7
393043|NCT01807234|962494|P6|Completed Only 1 Attack|Overall Study||1
393044|NCT01807234|962495|P5|Completed Only 1 Attack|Overall Study||0
393045|NCT01807234|962496|P4|Completed Only 1 Attack|Overall Study||1
393046|NCT01807234|962497|P3|Completed Only 1 Attack|Overall Study||0
393047|NCT01807234|962498|P2|Completed Only 1 Attack|Overall Study||1
393048|NCT01807234|962499|P1|Completed Only 1 Attack|Overall Study||2
393049|NCT01807234|962494|P6|Randomized, But Did Not Take Drug|Overall Study||3
393050|NCT01807234|962495|P5|Randomized, But Did Not Take Drug|Overall Study||4
393051|NCT01807234|962496|P4|Randomized, But Did Not Take Drug|Overall Study||1
393052|NCT01807234|962497|P3|Randomized, But Did Not Take Drug|Overall Study||2
393053|NCT01807234|962498|P2|Randomized, But Did Not Take Drug|Overall Study||5
393054|NCT01807234|962499|P1|Randomized, But Did Not Take Drug|Overall Study||3
393055|NCT01807234|962494|P6|STARTED|Overall Study||12
393056|NCT01807234|962495|P5|STARTED|Overall Study||12
393057|NCT01807234|962496|P4|STARTED|Overall Study||12
393058|NCT01807234|962497|P3|STARTED|Overall Study||12
393059|NCT01807234|962498|P2|STARTED|Overall Study||12
393060|NCT01807234|962499|P1|STARTED|Overall Study||12
393061|NCT01807156|962534|P1|NOT COMPLETED|Overall Study||1
393062|NCT01807156|962534|P1|COMPLETED|Overall Study||6
393063|NCT01807156|962534|P1|STARTED|Overall Study||7
393064|NCT01807000|962539|P1|NOT COMPLETED|Overall Study||0
393065|NCT01807000|962539|P1|COMPLETED|Overall Study||6
393066|NCT01807000|962539|P1|STARTED|Overall Study||6
393067|NCT01806961|962558|P1|NOT COMPLETED|Overall Study||16
393068|NCT01806961|962558|P1|COMPLETED|Overall Study||0
393069|NCT01806961|962558|P1|STARTED|Overall Study||16
393070|NCT01806896|962564|P2|NOT COMPLETED|Overall Study||0
393071|NCT01806896|962565|P1|NOT COMPLETED|Overall Study||3
393072|NCT01806896|962564|P2|COMPLETED|Overall Study||17
393073|NCT01806896|962565|P1|COMPLETED|Overall Study||17
393074|NCT01806896|962564|P2|Received Treatment|Overall Study||17
393075|NCT01806896|962565|P1|Received Treatment|Overall Study||19
393076|NCT01806896|962564|P2|STARTED|Overall Study||17
393077|NCT01806896|962565|P1|STARTED|Overall Study||20
393078|NCT01806857|962593|P2|NOT COMPLETED|Overall Study||0
393079|NCT01806857|962594|P1|NOT COMPLETED|Overall Study||1
393080|NCT01806857|962593|P2|COMPLETED|Overall Study||29
393081|NCT01806857|962594|P1|COMPLETED|Overall Study||30
393082|NCT01806857|962593|P2|STARTED|Overall Study||29
393083|NCT01806857|962594|P1|STARTED|Overall Study||31
393084|NCT01806779|962632|P3|NOT COMPLETED|Overall Study||23
393085|NCT01806779|962633|P2|NOT COMPLETED|Overall Study||44
393086|NCT01806779|962634|P1|NOT COMPLETED|Overall Study||42
393087|NCT01806779|962632|P3|COMPLETED|Overall Study||0
393088|NCT01806779|962633|P2|COMPLETED|Overall Study||40
393089|NCT01806779|962634|P1|COMPLETED|Overall Study||48
393090|NCT01806779|962632|P3|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|0
393091|NCT01806779|962633|P2|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|83
393092|NCT01806779|962634|P1|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|87
393093|NCT01806779|962632|P3|Randomized at Visit 2|Overall Study||0
393094|NCT01806779|962633|P2|Randomized at Visit 2|Overall Study||84
393095|NCT01806779|962634|P1|Randomized at Visit 2|Overall Study||90
393096|NCT01806779|962632|P3|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|2
393097|NCT01806779|962633|P2|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|84
393098|NCT01806779|962634|P1|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|90
393099|NCT01806779|962632|P3|STARTED|Overall Study|All 197 subjects received nicotine patches but 23 dropped before receiving other study drugs.|23
393100|NCT01806779|962633|P2|STARTED|Overall Study||84
393101|NCT01806779|962634|P1|STARTED|Overall Study||90
393102|NCT01806714|962649|P2|NOT COMPLETED|Overall Study||170
393103|NCT01806714|962650|P1|NOT COMPLETED|Overall Study||200
393104|NCT01806714|962649|P2|COMPLETED|Overall Study||1919
393105|NCT01806714|962650|P1|COMPLETED|Overall Study||1893
393106|NCT01806714|962649|P2|STARTED|Overall Study||2089
393107|NCT01806714|962650|P1|STARTED|Overall Study||2093
393108|NCT01806662|962660|P2|NOT COMPLETED|Second Intervention (Weeks 16-32)||4
393109|NCT01806662|962661|P1|NOT COMPLETED|Second Intervention (Weeks 16-32)||2
393110|NCT01806662|962660|P2|COMPLETED|Second Intervention (Weeks 16-32)||11
393111|NCT01806662|962661|P1|COMPLETED|Second Intervention (Weeks 16-32)||10
393112|NCT01806662|962660|P2|STARTED|Second Intervention (Weeks 16-32)||15
393113|NCT01806662|962661|P1|STARTED|Second Intervention (Weeks 16-32)||12
393114|NCT01806662|962660|P2|NOT COMPLETED|First Intervention (Weeks 0-16)||1
393115|NCT01806662|962661|P1|NOT COMPLETED|First Intervention (Weeks 0-16)||4
393116|NCT01806662|962660|P2|COMPLETED|First Intervention (Weeks 0-16)||15
393117|NCT01806662|962661|P1|COMPLETED|First Intervention (Weeks 0-16)||12
393118|NCT01806662|962660|P2|Received Intervention|First Intervention (Weeks 0-16)||15
393119|NCT01806662|962661|P1|Received Intervention|First Intervention (Weeks 0-16)||12
393120|NCT01806662|962660|P2|STARTED|First Intervention (Weeks 0-16)||16
393121|NCT01806662|962661|P1|STARTED|First Intervention (Weeks 0-16)||16
393122|NCT01806623|962667|P1|NOT COMPLETED|Overall Study||58
393123|NCT01806623|962667|P1|COMPLETED|Overall Study||99
393124|NCT01806623|962667|P1|STARTED|Overall Study||157
393125|NCT01806597|962687|P6|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||12
393126|NCT01806597|962688|P5|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
393127|NCT01806597|962689|P4|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
393128|NCT01806597|962690|P3|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
393129|NCT01806597|962691|P2|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
393130|NCT01806597|962692|P1|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
393131|NCT01806597|962687|P6|COMPLETED|Follow-up Period (Week 132 to Week 140)||149
393132|NCT01806597|962688|P5|COMPLETED|Follow-up Period (Week 132 to Week 140)||3
393133|NCT01806597|962689|P4|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
393134|NCT01806597|962690|P3|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
393135|NCT01806597|962691|P2|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
393136|NCT01806597|962692|P1|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
393137|NCT01806597|962687|P6|STARTED|Follow-up Period (Week 132 to Week 140)||161
393138|NCT01806597|962688|P5|STARTED|Follow-up Period (Week 132 to Week 140)||3
393139|NCT01806597|962689|P4|STARTED|Follow-up Period (Week 132 to Week 140)||0
393140|NCT01806597|962690|P3|STARTED|Follow-up Period (Week 132 to Week 140)||0
393141|NCT01806597|962691|P2|STARTED|Follow-up Period (Week 132 to Week 140)||0
393142|NCT01806597|962692|P1|STARTED|Follow-up Period (Week 132 to Week 140)||0
393143|NCT01806597|962687|P6|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
393144|NCT01806597|962688|P5|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||1
393145|NCT01806597|962689|P4|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||11
393146|NCT01806597|962690|P3|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||14
393147|NCT01806597|962691|P2|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||20
393148|NCT01806597|962692|P1|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||39
393149|NCT01806597|962687|P6|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
393150|NCT01806597|962688|P5|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
393151|NCT01806597|962689|P4|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||20
393152|NCT01806597|962690|P3|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||17
393153|NCT01806597|962691|P2|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||44
393154|NCT01806597|962692|P1|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||24
393155|NCT01806597|962687|P6|STARTED|Treatment Period 2 (Week 16 to Week 132)||0
393156|NCT01806597|962688|P5|STARTED|Treatment Period 2 (Week 16 to Week 132)||1
393157|NCT01806597|962689|P4|STARTED|Treatment Period 2 (Week 16 to Week 132)||31
393158|NCT01806597|962690|P3|STARTED|Treatment Period 2 (Week 16 to Week 132)||31
393159|NCT01806597|962691|P2|STARTED|Treatment Period 2 (Week 16 to Week 132)||64
393160|NCT01806597|962692|P1|STARTED|Treatment Period 2 (Week 16 to Week 132)||63
393161|NCT01806597|962687|P6|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
393162|NCT01806597|962688|P5|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
393163|NCT01806597|962689|P4|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
393164|NCT01806597|962690|P3|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
393165|NCT01806597|962691|P2|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
393166|NCT01806597|962692|P1|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
393167|NCT01806597|962687|P6|COMPLETED|Period 1 (Baseline to Week 16)||0
393168|NCT01806597|962688|P5|COMPLETED|Period 1 (Baseline to Week 16)||63
393169|NCT01806597|962689|P4|COMPLETED|Period 1 (Baseline to Week 16)||0
393170|NCT01806597|962690|P3|COMPLETED|Period 1 (Baseline to Week 16)||0
393171|NCT01806597|962691|P2|COMPLETED|Period 1 (Baseline to Week 16)||64
393172|NCT01806597|962692|P1|COMPLETED|Period 1 (Baseline to Week 16)||63
393173|NCT01806597|962687|P6|STARTED|Period 1 (Baseline to Week 16)||0
393174|NCT01806597|962688|P5|STARTED|Period 1 (Baseline to Week 16)||68
393175|NCT01806597|962689|P4|STARTED|Period 1 (Baseline to Week 16)||0
393176|NCT01806597|962690|P3|STARTED|Period 1 (Baseline to Week 16)||0
393177|NCT01806597|962691|P2|STARTED|Period 1 (Baseline to Week 16)||69
393178|NCT01806597|962692|P1|STARTED|Period 1 (Baseline to Week 16)||68
393179|NCT01806584|962728|P2|NOT COMPLETED|Overall Study||18
393180|NCT01806584|962729|P1|NOT COMPLETED|Overall Study||14
393181|NCT01806584|962728|P2|COMPLETED|Overall Study||0
393182|NCT01806584|962729|P1|COMPLETED|Overall Study||0
393183|NCT01806584|962728|P2|STARTED|Overall Study||18
393184|NCT01806584|962729|P1|STARTED|Overall Study||14
393185|NCT01806545|962743|P2|NOT COMPLETED|Overall Study||5
393186|NCT01806545|962744|P1|NOT COMPLETED|Overall Study||6
393187|NCT01806545|962743|P2|COMPLETED|Overall Study||30
393188|NCT01806545|962744|P1|COMPLETED|Overall Study||23
393189|NCT01806545|962743|P2|STARTED|Overall Study||35
393190|NCT01806545|962744|P1|STARTED|Overall Study||29
393191|NCT01806389|962766|P1|NOT COMPLETED|Overall Study||4
393192|NCT01806389|962766|P1|COMPLETED|Overall Study||10
393193|NCT01806389|962766|P1|STARTED|Overall Study||14
393194|NCT01806298|962780|P1|NOT COMPLETED|Overall Study||10
393195|NCT01806298|962780|P1|COMPLETED|Overall Study||68
393196|NCT01806298|962780|P1|STARTED|Overall Study||78
393197|NCT01806051|962790|P1|NOT COMPLETED|Overall Study||6
393198|NCT01806051|962790|P1|COMPLETED|Overall Study||0
393199|NCT01806051|962790|P1|STARTED|Overall Study||6
393200|NCT01805895|962798|P2|NOT COMPLETED|Overall Study||0
393201|NCT01805895|962799|P1|NOT COMPLETED|Overall Study||0
393202|NCT01805895|962798|P2|COMPLETED|Overall Study||8
393203|NCT01805895|962799|P1|COMPLETED|Overall Study||8
393204|NCT01805895|962798|P2|STARTED|Overall Study||8
393205|NCT01805895|962799|P1|STARTED|Overall Study||8
393206|NCT01805882|962816|P9|NOT COMPLETED|Overall Study||1
393207|NCT01805882|962817|P8|NOT COMPLETED|Overall Study||0
393208|NCT01805882|962818|P7|NOT COMPLETED|Overall Study||2
393209|NCT01805882|962819|P6|NOT COMPLETED|Overall Study||1
393210|NCT01805882|962820|P5|NOT COMPLETED|Overall Study||0
393211|NCT01805882|962821|P4|NOT COMPLETED|Overall Study||2
393212|NCT01805882|962822|P3|NOT COMPLETED|Overall Study||1
393213|NCT01805882|962823|P2|NOT COMPLETED|Overall Study||0
393214|NCT01805882|962824|P1|NOT COMPLETED|Overall Study||0
393215|NCT01805882|962816|P9|COMPLETED|Overall Study||24
393216|NCT01805882|962817|P8|COMPLETED|Overall Study||25
393217|NCT01805882|962818|P7|COMPLETED|Overall Study||48
393218|NCT01805882|962819|P6|COMPLETED|Overall Study||20
393219|NCT01805882|962820|P5|COMPLETED|Overall Study||14
393220|NCT01805882|962821|P4|COMPLETED|Overall Study||32
393221|NCT01805882|962822|P3|COMPLETED|Overall Study||19
393222|NCT01805882|962823|P2|COMPLETED|Overall Study||20
393223|NCT01805882|962824|P1|COMPLETED|Overall Study||20
393224|NCT01805882|962816|P9|STARTED|Overall Study||25
393225|NCT01805882|962817|P8|STARTED|Overall Study||25
393226|NCT01805882|962818|P7|STARTED|Overall Study||50
393227|NCT01805882|962819|P6|STARTED|Overall Study||21
393228|NCT01805882|962820|P5|STARTED|Overall Study||14
393229|NCT01805882|962821|P4|STARTED|Overall Study||34
393230|NCT01805882|962822|P3|STARTED|Overall Study||20
393231|NCT01805882|962823|P2|STARTED|Overall Study||20
393232|NCT01805882|962824|P1|STARTED|Overall Study||20
393233|NCT01805687|962844|P1|NOT COMPLETED|Overall Study||0
393234|NCT01805687|962844|P1|COMPLETED|Overall Study||25
393235|NCT01805687|962844|P1|STARTED|Overall Study||25
393236|NCT01805440|962851|P3|NOT COMPLETED|Overall Study||0
393237|NCT01805440|962852|P2|NOT COMPLETED|Overall Study||0
393238|NCT01805440|962853|P1|NOT COMPLETED|Overall Study||1
393239|NCT01805440|962851|P3|COMPLETED|Overall Study||26
393240|NCT01805440|962852|P2|COMPLETED|Overall Study||17
393241|NCT01805440|962853|P1|COMPLETED|Overall Study||18
393242|NCT01805440|962851|P3|STARTED|Overall Study||26
393243|NCT01805440|962852|P2|STARTED|Overall Study||17
393244|NCT01805440|962853|P1|STARTED|Overall Study||19
393245|NCT01805323|962866|P1|NOT COMPLETED|Overall Study||0
393246|NCT01805323|962866|P1|COMPLETED|Overall Study||101
393247|NCT01805323|962866|P1|STARTED|Overall Study||101
393248|NCT01805297|962873|P2|NOT COMPLETED|Overall Study||3
393249|NCT01805297|962874|P1|NOT COMPLETED|Overall Study||2
393250|NCT01805297|962873|P2|COMPLETED|Overall Study||3
393251|NCT01805297|962874|P1|COMPLETED|Overall Study||4
393252|NCT01805297|962873|P2|STARTED|Overall Study||6
393253|NCT01805297|962874|P1|STARTED|Overall Study||6
393254|NCT01805180|962888|P3|NOT COMPLETED|Pivotal Randomization Through Study Exit||5
393255|NCT01805180|962889|P2|NOT COMPLETED|Pivotal Randomization Through Study Exit||5
393256|NCT01805180|962890|P1|NOT COMPLETED|Pivotal Randomization Through Study Exit||0
393257|NCT01805180|962888|P3|COMPLETED|Pivotal Randomization Through Study Exit||15
393258|NCT01805180|962889|P2|COMPLETED|Pivotal Randomization Through Study Exit||17
393259|NCT01805180|962890|P1|COMPLETED|Pivotal Randomization Through Study Exit||0
393260|NCT01805180|962888|P3|STARTED|Pivotal Randomization Through Study Exit||20
393261|NCT01805180|962889|P2|STARTED|Pivotal Randomization Through Study Exit||22
393262|NCT01805180|962890|P1|STARTED|Pivotal Randomization Through Study Exit|lead-in donors were not randomized and did not participate in this period.|0
393263|NCT01805180|962888|P3|NOT COMPLETED|Lead-in Donor Phase||0
393264|NCT01805180|962889|P2|NOT COMPLETED|Lead-in Donor Phase||0
393265|NCT01805180|962890|P1|NOT COMPLETED|Lead-in Donor Phase||1
393266|NCT01805180|962888|P3|COMPLETED|Lead-in Donor Phase||0
393267|NCT01805180|962889|P2|COMPLETED|Lead-in Donor Phase||0
393268|NCT01805180|962890|P1|COMPLETED|Lead-in Donor Phase||6
393269|NCT01805180|962888|P3|STARTED|Lead-in Donor Phase|pivotal trial subjects were not screened or enrolled in this period.|0
393270|NCT01805180|962889|P2|STARTED|Lead-in Donor Phase|pivotal trial subjects were not screened or enrolled in this period.|0
393271|NCT01805180|962890|P1|STARTED|Lead-in Donor Phase||7
393272|NCT01805089|962915|P2|NOT COMPLETED|Overall Study||4
393273|NCT01805089|962916|P1|NOT COMPLETED|Overall Study||5
393274|NCT01805089|962915|P2|COMPLETED|Overall Study||43
393275|NCT01805089|962916|P1|COMPLETED|Overall Study||43
393276|NCT01805089|962915|P2|STARTED|Overall Study||47
393277|NCT01805089|962916|P1|STARTED|Overall Study||48
393278|NCT01804946|962928|P2|NOT COMPLETED|Overall Study||4
393279|NCT01804946|962929|P1|NOT COMPLETED|Overall Study||2
393280|NCT01804946|962928|P2|COMPLETED|Overall Study||76
393281|NCT01804946|962929|P1|COMPLETED|Overall Study||79
393282|NCT01804946|962928|P2|STARTED|Overall Study||80
393283|NCT01804946|962929|P1|STARTED|Overall Study||81
393284|NCT01804881|962953|P2|NOT COMPLETED|Overall Study||4
393285|NCT01804881|962954|P1|NOT COMPLETED|Overall Study||5
393286|NCT01804881|962953|P2|COMPLETED|Overall Study||10
393287|NCT01804881|962954|P1|COMPLETED|Overall Study||11
393288|NCT01804881|962953|P2|STARTED|Overall Study||14
393289|NCT01804881|962954|P1|STARTED|Overall Study||16
393290|NCT01804842|962967|P3|NOT COMPLETED|Overall Study||1
393291|NCT01804842|962968|P2|NOT COMPLETED|Overall Study||2
393292|NCT01804842|962969|P1|NOT COMPLETED|Overall Study||3
393293|NCT01804842|962967|P3|COMPLETED|Overall Study||8
393294|NCT01804842|962968|P2|COMPLETED|Overall Study||6
393295|NCT01804842|962969|P1|COMPLETED|Overall Study||6
393296|NCT01804842|962967|P3|Completed Treatment C|Overall Study||9
393297|NCT01804842|962968|P2|Completed Treatment C|Overall Study||7
393298|NCT01804842|962969|P1|Completed Treatment C|Overall Study||7
393299|NCT01804842|962967|P3|Completed Treatment B|Overall Study||8
393300|NCT01804842|962968|P2|Completed Treatment B|Overall Study||8
393301|NCT01804842|962969|P1|Completed Treatment B|Overall Study||8
393302|NCT01804842|962967|P3|Completed Treatment A|Overall Study||8
393303|NCT01804842|962968|P2|Completed Treatment A|Overall Study||6
393304|NCT01804842|962969|P1|Completed Treatment A|Overall Study||9
393305|NCT01804842|962967|P3|STARTED|Overall Study||9
393306|NCT01804842|962968|P2|STARTED|Overall Study||8
393307|NCT01804842|962969|P1|STARTED|Overall Study||9
393308|NCT01804673|962986|P1|NOT COMPLETED|Overall Study||140
393309|NCT01804673|962986|P1|COMPLETED|Overall Study||34
393310|NCT01804673|962986|P1|Completed Hour 72|Overall Study||36
393311|NCT01804673|962986|P1|Completed Hour 48|Overall Study||79
393312|NCT01804673|962986|P1|Completed Hour 24|Overall Study||170
393313|NCT01804673|962986|P1|STARTED|Overall Study||174
393314|NCT01804257|963002|P1|NOT COMPLETED|Overall Study||1
393315|NCT01804257|963002|P1|COMPLETED|Overall Study||27
393316|NCT01804257|963002|P1|STARTED|Overall Study||28
393317|NCT01804140|963006|P1|NOT COMPLETED|Overall Study||114
393318|NCT01804140|963006|P1|COMPLETED|Overall Study|This includes all the participants with mutation results from the sampling or biopsy procedures.|548
393319|NCT01804140|963006|P1|STARTED|Overall Study|This includes all the participants who were enrolled for this study.|662
393320|NCT01804101|963013|P2|NOT COMPLETED|Overall Study||0
393321|NCT01804101|963014|P1|NOT COMPLETED|Overall Study||0
393322|NCT01804101|963013|P2|COMPLETED|Overall Study||10
393323|NCT01804101|963014|P1|COMPLETED|Overall Study||38
393324|NCT01804101|963013|P2|STARTED|Overall Study||10
393325|NCT01804101|963014|P1|STARTED|Overall Study||38
393326|NCT01804075|963024|P2|NOT COMPLETED|Overall Study||0
393327|NCT01804075|963025|P1|NOT COMPLETED|Overall Study||0
393328|NCT01804075|963024|P2|COMPLETED|Overall Study||16
393329|NCT01804075|963025|P1|COMPLETED|Overall Study||15
393330|NCT01804075|963024|P2|STARTED|Overall Study||16
393331|NCT01804075|963025|P1|STARTED|Overall Study||15
393332|NCT01804062|963033|P1|NOT COMPLETED|Overall Study||0
393333|NCT01804062|963033|P1|COMPLETED|Overall Study||30
393334|NCT01804062|963033|P1|STARTED|Overall Study||30
393335|NCT01804036|963040|P2|NOT COMPLETED|Overall Study||20
393336|NCT01804036|963041|P1|NOT COMPLETED|Overall Study||13
393337|NCT01804036|963040|P2|COMPLETED|Overall Study||21
393338|NCT01804036|963041|P1|COMPLETED|Overall Study||18
393339|NCT01804036|963040|P2|STARTED|Overall Study||41
393340|NCT01804036|963041|P1|STARTED|Overall Study||31
393341|NCT01803737|963075|P2|NOT COMPLETED|Overall Study||3
393342|NCT01803737|963076|P1|NOT COMPLETED|Overall Study||1
393343|NCT01803737|963075|P2|COMPLETED|Overall Study||10
393344|NCT01803737|963076|P1|COMPLETED|Overall Study||12
393345|NCT01803737|963075|P2|STARTED|Overall Study||13
393346|NCT01803737|963076|P1|STARTED|Overall Study||13
393347|NCT01803711|963100|P2|NOT COMPLETED|Overall Study||1
393348|NCT01803711|963101|P1|NOT COMPLETED|Overall Study||1
393349|NCT01803711|963100|P2|COMPLETED|Overall Study||2
393350|NCT01803711|963101|P1|COMPLETED|Overall Study||1
393351|NCT01803711|963100|P2|STARTED|Overall Study||3
393352|NCT01803711|963101|P1|STARTED|Overall Study||2
393353|NCT01803646|963119|P2|NOT COMPLETED|Overall Study||10
393354|NCT01803646|963120|P1|NOT COMPLETED|Overall Study||17
393355|NCT01803646|963119|P2|COMPLETED|Overall Study||129
393356|NCT01803646|963120|P1|COMPLETED|Overall Study||187
393357|NCT01803646|963119|P2|STARTED|Overall Study||139
393358|NCT01803646|963120|P1|STARTED|Overall Study||204
393359|NCT01803607|963132|P2|NOT COMPLETED|Overall Study||67
393360|NCT01803607|963133|P1|NOT COMPLETED|Overall Study||68
393361|NCT01803607|963132|P2|COMPLETED|Overall Study||0
393362|NCT01803607|963133|P1|COMPLETED|Overall Study||0
393363|NCT01803607|963132|P2|STARTED|Overall Study||67
393364|NCT01803607|963133|P1|STARTED|Overall Study||68
393365|NCT01803464|963157|P4|NOT COMPLETED|Overall Study||0
393366|NCT01803464|963158|P3|NOT COMPLETED|Overall Study||4
393367|NCT01803464|963159|P2|NOT COMPLETED|Overall Study||0
393368|NCT01803464|963160|P1|NOT COMPLETED|Overall Study||1
393369|NCT01803464|963157|P4|COMPLETED|Overall Study||10
393370|NCT01803464|963158|P3|COMPLETED|Overall Study||6
393371|NCT01803464|963159|P2|COMPLETED|Overall Study||4
393372|NCT01803464|963160|P1|COMPLETED|Overall Study||4
393373|NCT01803464|963157|P4|STARTED|Overall Study||10
393374|NCT01803464|963158|P3|STARTED|Overall Study||10
393375|NCT01803464|963159|P2|STARTED|Overall Study||4
393376|NCT01803464|963160|P1|STARTED|Overall Study||5
393377|NCT01802775|963180|P2|NOT COMPLETED|Overall Study||12
393378|NCT01802775|963181|P1|NOT COMPLETED|Overall Study||6
393379|NCT01802775|963180|P2|COMPLETED|Overall Study||89
393380|NCT01802775|963181|P1|COMPLETED|Overall Study||96
393381|NCT01802775|963180|P2|Received Drug (Safety Analysis Set)|Overall Study||100
393382|NCT01802775|963181|P1|Received Drug (Safety Analysis Set)|Overall Study||101
393383|NCT01802775|963180|P2|STARTED|Overall Study||101
393384|NCT01802775|963181|P1|STARTED|Overall Study||102
393385|NCT01802632|963203|P6|NOT COMPLETED|Overall Study||28
393386|NCT01802632|963204|P5|NOT COMPLETED|Overall Study||12
393387|NCT01802632|963205|P4|NOT COMPLETED|Overall Study||60
393388|NCT01802632|963206|P3|NOT COMPLETED|Overall Study||271
393389|NCT01802632|963207|P2|NOT COMPLETED|Overall Study||31
393390|NCT01802632|963208|P1|NOT COMPLETED|Overall Study||201
393391|NCT01802632|963203|P6|COMPLETED|Overall Study||0
393392|NCT01802632|963204|P5|COMPLETED|Overall Study||0
393393|NCT01802632|963205|P4|COMPLETED|Overall Study||0
393394|NCT01802632|963206|P3|COMPLETED|Overall Study||0
393395|NCT01802632|963207|P2|COMPLETED|Overall Study||0
393396|NCT01802632|963208|P1|COMPLETED|Overall Study||0
393397|NCT01802632|963203|P6|STARTED|Overall Study||28
393398|NCT01802632|963204|P5|STARTED|Overall Study||12
393399|NCT01802632|963205|P4|STARTED|Overall Study||60
393400|NCT01802632|963206|P3|STARTED|Overall Study||271
393401|NCT01802632|963207|P2|STARTED|Overall Study||31
393402|NCT01802632|963208|P1|STARTED|Overall Study||201
393403|NCT01802554|963224|P2|NOT COMPLETED|Overall Study||6
393404|NCT01802554|963225|P1|NOT COMPLETED|Overall Study||8
393405|NCT01802554|963224|P2|COMPLETED|Overall Study||43
393406|NCT01802554|963225|P1|COMPLETED|Overall Study||43
393407|NCT01802554|963224|P2|STARTED|Overall Study||49
393408|NCT01802554|963225|P1|STARTED|Overall Study||51
393409|NCT01802515|963242|P3|NOT COMPLETED|Overall Study||0
393410|NCT01802515|963243|P2|NOT COMPLETED|Overall Study||0
393411|NCT01802515|963244|P1|NOT COMPLETED|Overall Study||3
393412|NCT01802515|963242|P3|COMPLETED|Overall Study||4
393413|NCT01802515|963243|P2|COMPLETED|Overall Study||5
393414|NCT01802515|963244|P1|COMPLETED|Overall Study||2
393415|NCT01802515|963242|P3|STARTED|Overall Study||4
393416|NCT01802515|963243|P2|STARTED|Overall Study||5
393417|NCT01802515|963244|P1|STARTED|Overall Study||5
393418|NCT01802320|963255|P1|NOT COMPLETED|Overall Study||2
393419|NCT01802320|963255|P1|COMPLETED|Overall Study||16
393420|NCT01802320|963255|P1|STARTED|Overall Study||18
393421|NCT01802151|963264|P4|NOT COMPLETED|Overall Study||0
393422|NCT01802151|963265|P3|NOT COMPLETED|Overall Study||2
393423|NCT01802151|963266|P2|NOT COMPLETED|Overall Study||0
393424|NCT01802151|963267|P1|NOT COMPLETED|Overall Study||0
393425|NCT01802151|963264|P4|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
393426|NCT01802151|963265|P3|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
393427|NCT01802151|963266|P2|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|21
393428|NCT01802151|963267|P1|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
393429|NCT01802151|963264|P4|STARTED|Overall Study||20
393430|NCT01802151|963265|P3|STARTED|Overall Study||22
393431|NCT01802151|963266|P2|STARTED|Overall Study||21
393432|NCT01802151|963267|P1|STARTED|Overall Study||20
393433|NCT01801982|963329|P1|NOT COMPLETED|Overall Study||1
393434|NCT01801982|963329|P1|COMPLETED|Overall Study||0
393435|NCT01801982|963329|P1|STARTED|Overall Study||1
393436|NCT01801917|963343|P4|NOT COMPLETED|Extension - All Active||0
393437|NCT01801917|963344|P3|NOT COMPLETED|Extension - All Active||0
393438|NCT01801917|963345|P2|NOT COMPLETED|Extension - All Active||0
393439|NCT01801917|963346|P1|NOT COMPLETED|Extension - All Active||0
393440|NCT01801917|963343|P4|COMPLETED|Extension - All Active||0
393441|NCT01801917|963344|P3|COMPLETED|Extension - All Active||3
393442|NCT01801917|963345|P2|COMPLETED|Extension - All Active||0
393443|NCT01801917|963346|P1|COMPLETED|Extension - All Active||6
393444|NCT01801917|963343|P4|STARTED|Extension - All Active||0
393445|NCT01801917|963344|P3|STARTED|Extension - All Active||3
393446|NCT01801917|963345|P2|STARTED|Extension - All Active||0
393447|NCT01801917|963346|P1|STARTED|Extension - All Active||6
393448|NCT01801917|963343|P4|NOT COMPLETED|Period 1 - Randomized||0
393449|NCT01801917|963344|P3|NOT COMPLETED|Period 1 - Randomized||1
393450|NCT01801917|963345|P2|NOT COMPLETED|Period 1 - Randomized||0
393451|NCT01801917|963346|P1|NOT COMPLETED|Period 1 - Randomized||1
393452|NCT01801917|963343|P4|COMPLETED|Period 1 - Randomized||1
393453|NCT01801917|963344|P3|COMPLETED|Period 1 - Randomized||3
393454|NCT01801917|963345|P2|COMPLETED|Period 1 - Randomized||2
393455|NCT01801917|963346|P1|COMPLETED|Period 1 - Randomized||6
393456|NCT01801917|963343|P4|STARTED|Period 1 - Randomized||1
393457|NCT01801917|963344|P3|STARTED|Period 1 - Randomized||4
393458|NCT01801917|963345|P2|STARTED|Period 1 - Randomized||2
393459|NCT01801917|963346|P1|STARTED|Period 1 - Randomized||7
393460|NCT01801735|963366|P1|NOT COMPLETED|Overall Study||210
393461|NCT01801735|963366|P1|COMPLETED|Overall Study||390
393462|NCT01801735|963366|P1|STARTED|Overall Study||600
393463|NCT01801475|963373|P5|NOT COMPLETED|Overall Study||1
393464|NCT01801475|963374|P4|NOT COMPLETED|Overall Study||0
393465|NCT01801475|963375|P3|NOT COMPLETED|Overall Study||0
393466|NCT01801475|963376|P2|NOT COMPLETED|Overall Study||0
393467|NCT01801475|963377|P1|NOT COMPLETED|Overall Study||0
393468|NCT01801475|963373|P5|COMPLETED|Overall Study||39
393469|NCT01801475|963374|P4|COMPLETED|Overall Study||10
393470|NCT01801475|963375|P3|COMPLETED|Overall Study||10
393471|NCT01801475|963376|P2|COMPLETED|Overall Study||30
393472|NCT01801475|963377|P1|COMPLETED|Overall Study||10
393473|NCT01801475|963373|P5|STARTED|Overall Study||40
393474|NCT01801475|963374|P4|STARTED|Overall Study||10
393475|NCT01801475|963375|P3|STARTED|Overall Study||10
393476|NCT01801475|963376|P2|STARTED|Overall Study||30
393477|NCT01801475|963377|P1|STARTED|Overall Study||10
393478|NCT01801449|963388|P1|NOT COMPLETED|Overall Study||0
393479|NCT01801449|963388|P1|COMPLETED|Overall Study||6
393480|NCT01801449|963388|P1|STARTED|Overall Study||6
393481|NCT01801436|963402|P1|NOT COMPLETED|Overall Study||9
393482|NCT01801436|963402|P1|COMPLETED|Overall Study||5
393483|NCT01801436|963402|P1|STARTED|Overall Study||14
393484|NCT01801358|963440|P6|NOT COMPLETED|Overall Study||8
393485|NCT01801358|963441|P5|NOT COMPLETED|Overall Study||6
393486|NCT01801358|963442|P4|NOT COMPLETED|Overall Study||6
393487|NCT01801358|963443|P3|NOT COMPLETED|Overall Study||6
393488|NCT01801358|963444|P2|NOT COMPLETED|Overall Study||6
393489|NCT01801358|963445|P1|NOT COMPLETED|Overall Study||6
393490|NCT01801358|963440|P6|COMPLETED|Overall Study||0
393491|NCT01801358|963441|P5|COMPLETED|Overall Study||0
393492|NCT01801358|963442|P4|COMPLETED|Overall Study||0
393493|NCT01801358|963443|P3|COMPLETED|Overall Study||0
393494|NCT01801358|963444|P2|COMPLETED|Overall Study||0
393495|NCT01801358|963445|P1|COMPLETED|Overall Study||0
393496|NCT01801358|963440|P6|STARTED|Overall Study||8
393497|NCT01801358|963441|P5|STARTED|Overall Study||6
393498|NCT01801358|963442|P4|STARTED|Overall Study||6
393499|NCT01801358|963443|P3|STARTED|Overall Study||6
393500|NCT01801358|963444|P2|STARTED|Overall Study||6
393501|NCT01801358|963445|P1|STARTED|Overall Study||6
393502|NCT01801280|963567|P4|NOT COMPLETED|Period 4||0
393503|NCT01801280|963568|P3|NOT COMPLETED|Period 4||1
393504|NCT01801280|963569|P2|NOT COMPLETED|Period 4||0
393505|NCT01801280|963570|P1|NOT COMPLETED|Period 4||0
393506|NCT01801280|963567|P4|COMPLETED|Period 4||5
393507|NCT01801280|963568|P3|COMPLETED|Period 4||4
393508|NCT01801280|963569|P2|COMPLETED|Period 4||4
393509|NCT01801280|963570|P1|COMPLETED|Period 4||4
393510|NCT01801280|963567|P4|STARTED|Period 4||5
393511|NCT01801280|963568|P3|STARTED|Period 4||5
393512|NCT01801280|963569|P2|STARTED|Period 4||4
393513|NCT01801280|963570|P1|STARTED|Period 4||4
393514|NCT01801280|963567|P4|NOT COMPLETED|Period 3||0
393515|NCT01801280|963568|P3|NOT COMPLETED|Period 3||0
393516|NCT01801280|963569|P2|NOT COMPLETED|Period 3||0
393517|NCT01801280|963570|P1|NOT COMPLETED|Period 3||0
393518|NCT01801280|963567|P4|COMPLETED|Period 3||5
393519|NCT01801280|963568|P3|COMPLETED|Period 3||5
393520|NCT01801280|963569|P2|COMPLETED|Period 3||4
393521|NCT01801280|963570|P1|COMPLETED|Period 3||4
393522|NCT01801280|963567|P4|STARTED|Period 3||5
393523|NCT01801280|963568|P3|STARTED|Period 3||5
393524|NCT01801280|963569|P2|STARTED|Period 3||4
393525|NCT01801280|963570|P1|STARTED|Period 3||4
393526|NCT01801280|963567|P4|NOT COMPLETED|Period 2||0
393527|NCT01801280|963568|P3|NOT COMPLETED|Period 2||0
393528|NCT01801280|963569|P2|NOT COMPLETED|Period 2||0
393529|NCT01801280|963570|P1|NOT COMPLETED|Period 2||1
393530|NCT01801280|963567|P4|COMPLETED|Period 2||5
393531|NCT01801280|963568|P3|COMPLETED|Period 2||5
393532|NCT01801280|963569|P2|COMPLETED|Period 2||4
393533|NCT01801280|963570|P1|COMPLETED|Period 2||4
393534|NCT01801280|963567|P4|STARTED|Period 2||5
393535|NCT01801280|963568|P3|STARTED|Period 2||5
393536|NCT01801280|963569|P2|STARTED|Period 2||4
393537|NCT01801280|963570|P1|STARTED|Period 2||5
393538|NCT01801280|963567|P4|NOT COMPLETED|Period 1||0
393539|NCT01801280|963568|P3|NOT COMPLETED|Period 1||0
393540|NCT01801280|963569|P2|NOT COMPLETED|Period 1||1
393541|NCT01801280|963570|P1|NOT COMPLETED|Period 1||0
393542|NCT01801280|963567|P4|COMPLETED|Period 1||5
393543|NCT01801280|963568|P3|COMPLETED|Period 1||5
393544|NCT01801280|963569|P2|COMPLETED|Period 1||4
393545|NCT01801280|963570|P1|COMPLETED|Period 1||5
393546|NCT01801280|963567|P4|STARTED|Period 1||5
393547|NCT01801280|963568|P3|STARTED|Period 1||5
393548|NCT01801280|963569|P2|STARTED|Period 1||5
393549|NCT01801280|963570|P1|STARTED|Period 1|Each period lasted 10-14 weeks|5
393550|NCT01801124|963580|P1|NOT COMPLETED|Overall Study||0
393551|NCT01801124|963580|P1|COMPLETED|Overall Study||13
393552|NCT01801124|963580|P1|STARTED|Overall Study||13
393553|NCT01801111|963585|P1|NOT COMPLETED|Overall Study||138
393554|NCT01801111|963585|P1|COMPLETED|Overall Study||0
393555|NCT01801111|963585|P1|STARTED|Overall Study||138
393556|NCT01800968|963610|P2|NOT COMPLETED|Overall Study||32
393557|NCT01800968|963611|P1|NOT COMPLETED|Overall Study||36
393558|NCT01800968|963610|P2|COMPLETED|Overall Study||114
393559|NCT01800968|963611|P1|COMPLETED|Overall Study||118
393560|NCT01800968|963610|P2|STARTED|Overall Study||146
393561|NCT01800968|963611|P1|STARTED|Overall Study||154
393562|NCT01800916|963653|P9|NOT COMPLETED|Test Period 3 (1 Week)||0
393563|NCT01800916|963654|P8|NOT COMPLETED|Test Period 3 (1 Week)||0
393564|NCT01800916|963655|P7|NOT COMPLETED|Test Period 3 (1 Week)||0
393565|NCT01800916|963656|P6|NOT COMPLETED|Test Period 3 (1 Week)||0
393566|NCT01800916|963657|P5|NOT COMPLETED|Test Period 3 (1 Week)||0
393567|NCT01800916|963658|P4|NOT COMPLETED|Test Period 3 (1 Week)||0
393568|NCT01800916|963659|P3|NOT COMPLETED|Test Period 3 (1 Week)||0
393569|NCT01800916|963660|P2|NOT COMPLETED|Test Period 3 (1 Week)||0
393570|NCT01800916|963661|P1|NOT COMPLETED|Test Period 3 (1 Week)||0
393571|NCT01800916|963653|P9|COMPLETED|Test Period 3 (1 Week)||7
393572|NCT01800916|963654|P8|COMPLETED|Test Period 3 (1 Week)||7
393573|NCT01800916|963655|P7|COMPLETED|Test Period 3 (1 Week)||7
393574|NCT01800916|963656|P6|COMPLETED|Test Period 3 (1 Week)||7
393575|NCT01800916|963657|P5|COMPLETED|Test Period 3 (1 Week)||7
393576|NCT01800916|963658|P4|COMPLETED|Test Period 3 (1 Week)||6
393577|NCT01800916|963659|P3|COMPLETED|Test Period 3 (1 Week)||7
393578|NCT01800916|963660|P2|COMPLETED|Test Period 3 (1 Week)||7
393579|NCT01800916|963661|P1|COMPLETED|Test Period 3 (1 Week)||7
393580|NCT01800916|963653|P9|STARTED|Test Period 3 (1 Week)||7
393581|NCT01800916|963654|P8|STARTED|Test Period 3 (1 Week)||7
393582|NCT01800916|963655|P7|STARTED|Test Period 3 (1 Week)||7
393583|NCT01800916|963656|P6|STARTED|Test Period 3 (1 Week)||7
393584|NCT01800916|963657|P5|STARTED|Test Period 3 (1 Week)||7
393585|NCT01800916|963658|P4|STARTED|Test Period 3 (1 Week)||6
393586|NCT01800916|963659|P3|STARTED|Test Period 3 (1 Week)||7
393587|NCT01800916|963660|P2|STARTED|Test Period 3 (1 Week)||7
393588|NCT01800916|963661|P1|STARTED|Test Period 3 (1 Week)||7
393589|NCT01800916|963653|P9|NOT COMPLETED|Test Period 2 (1 Week)||0
393590|NCT01800916|963654|P8|NOT COMPLETED|Test Period 2 (1 Week)||0
393591|NCT01800916|963655|P7|NOT COMPLETED|Test Period 2 (1 Week)||0
393592|NCT01800916|963656|P6|NOT COMPLETED|Test Period 2 (1 Week)||0
393593|NCT01800916|963657|P5|NOT COMPLETED|Test Period 2 (1 Week)||0
393594|NCT01800916|963658|P4|NOT COMPLETED|Test Period 2 (1 Week)||0
393595|NCT01800916|963659|P3|NOT COMPLETED|Test Period 2 (1 Week)||0
393596|NCT01800916|963660|P2|NOT COMPLETED|Test Period 2 (1 Week)||0
393597|NCT01800916|963661|P1|NOT COMPLETED|Test Period 2 (1 Week)||0
393598|NCT01800916|963653|P9|COMPLETED|Test Period 2 (1 Week)||7
393599|NCT01800916|963654|P8|COMPLETED|Test Period 2 (1 Week)||7
393600|NCT01800916|963655|P7|COMPLETED|Test Period 2 (1 Week)||7
393601|NCT01800916|963656|P6|COMPLETED|Test Period 2 (1 Week)||7
393602|NCT01800916|963657|P5|COMPLETED|Test Period 2 (1 Week)||7
393603|NCT01800916|963658|P4|COMPLETED|Test Period 2 (1 Week)||6
393604|NCT01800916|963659|P3|COMPLETED|Test Period 2 (1 Week)||7
393605|NCT01800916|963660|P2|COMPLETED|Test Period 2 (1 Week)||7
393606|NCT01800916|963661|P1|COMPLETED|Test Period 2 (1 Week)||7
393607|NCT01800916|963653|P9|STARTED|Test Period 2 (1 Week)||7
393608|NCT01800916|963654|P8|STARTED|Test Period 2 (1 Week)||7
393609|NCT01800916|963655|P7|STARTED|Test Period 2 (1 Week)||7
393610|NCT01800916|963656|P6|STARTED|Test Period 2 (1 Week)||7
393611|NCT01800916|963657|P5|STARTED|Test Period 2 (1 Week)||7
393612|NCT01800916|963658|P4|STARTED|Test Period 2 (1 Week)||6
393613|NCT01800916|963659|P3|STARTED|Test Period 2 (1 Week)||7
393614|NCT01800916|963660|P2|STARTED|Test Period 2 (1 Week)||7
393615|NCT01800916|963661|P1|STARTED|Test Period 2 (1 Week)||7
393616|NCT01800916|963653|P9|NOT COMPLETED|Test Period 1 (1 Week)||0
393617|NCT01800916|963654|P8|NOT COMPLETED|Test Period 1 (1 Week)||0
393618|NCT01800916|963655|P7|NOT COMPLETED|Test Period 1 (1 Week)||0
393619|NCT01800916|963656|P6|NOT COMPLETED|Test Period 1 (1 Week)||0
393620|NCT01800916|963657|P5|NOT COMPLETED|Test Period 1 (1 Week)||1
393621|NCT01800916|963658|P4|NOT COMPLETED|Test Period 1 (1 Week)||1
393622|NCT01800916|963659|P3|NOT COMPLETED|Test Period 1 (1 Week)||0
393623|NCT01800916|963660|P2|NOT COMPLETED|Test Period 1 (1 Week)||0
393624|NCT01800916|963661|P1|NOT COMPLETED|Test Period 1 (1 Week)||0
393625|NCT01800916|963653|P9|COMPLETED|Test Period 1 (1 Week)||7
393626|NCT01800916|963654|P8|COMPLETED|Test Period 1 (1 Week)||7
393627|NCT01800916|963655|P7|COMPLETED|Test Period 1 (1 Week)||7
393628|NCT01800916|963656|P6|COMPLETED|Test Period 1 (1 Week)||7
393629|NCT01800916|963657|P5|COMPLETED|Test Period 1 (1 Week)||7
393630|NCT01800916|963658|P4|COMPLETED|Test Period 1 (1 Week)||6
393631|NCT01800916|963659|P3|COMPLETED|Test Period 1 (1 Week)||7
393632|NCT01800916|963660|P2|COMPLETED|Test Period 1 (1 Week)||7
393633|NCT01800916|963661|P1|COMPLETED|Test Period 1 (1 Week)||7
393634|NCT01800916|963653|P9|STARTED|Test Period 1 (1 Week)||7
393635|NCT01800916|963654|P8|STARTED|Test Period 1 (1 Week)||7
393636|NCT01800916|963655|P7|STARTED|Test Period 1 (1 Week)||7
393637|NCT01800916|963656|P6|STARTED|Test Period 1 (1 Week)||7
393638|NCT01800916|963657|P5|STARTED|Test Period 1 (1 Week)||8
393639|NCT01800916|963658|P4|STARTED|Test Period 1 (1 Week)||7
393640|NCT01800916|963659|P3|STARTED|Test Period 1 (1 Week)||7
393641|NCT01800916|963660|P2|STARTED|Test Period 1 (1 Week)||7
393642|NCT01800916|963661|P1|STARTED|Test Period 1 (1 Week)||7
393643|NCT01800903|963671|P6|NOT COMPLETED|Third Test Period||0
393644|NCT01800903|963672|P5|NOT COMPLETED|Third Test Period||0
393645|NCT01800903|963673|P4|NOT COMPLETED|Third Test Period||0
393646|NCT01800903|963674|P3|NOT COMPLETED|Third Test Period||0
393647|NCT01800903|963675|P2|NOT COMPLETED|Third Test Period||0
393648|NCT01800903|963676|P1|NOT COMPLETED|Third Test Period||0
393649|NCT01800903|963671|P6|COMPLETED|Third Test Period||6
393650|NCT01800903|963672|P5|COMPLETED|Third Test Period||6
393651|NCT01800903|963673|P4|COMPLETED|Third Test Period||7
393652|NCT01800903|963674|P3|COMPLETED|Third Test Period||4
393653|NCT01800903|963675|P2|COMPLETED|Third Test Period||6
393654|NCT01800903|963676|P1|COMPLETED|Third Test Period||6
393655|NCT01800903|963671|P6|STARTED|Third Test Period||6
393656|NCT01800903|963672|P5|STARTED|Third Test Period||6
393657|NCT01800903|963673|P4|STARTED|Third Test Period||7
393658|NCT01800903|963674|P3|STARTED|Third Test Period||4
393659|NCT01800903|963675|P2|STARTED|Third Test Period||6
393660|NCT01800903|963676|P1|STARTED|Third Test Period||6
393661|NCT01800903|963671|P6|NOT COMPLETED|Second Test Period||0
393662|NCT01800903|963672|P5|NOT COMPLETED|Second Test Period||0
393663|NCT01800903|963673|P4|NOT COMPLETED|Second Test Period||0
393664|NCT01800903|963674|P3|NOT COMPLETED|Second Test Period||0
393665|NCT01800903|963675|P2|NOT COMPLETED|Second Test Period||0
393666|NCT01800903|963676|P1|NOT COMPLETED|Second Test Period||1
393667|NCT01800903|963671|P6|COMPLETED|Second Test Period||6
393668|NCT01800903|963672|P5|COMPLETED|Second Test Period||6
393669|NCT01800903|963673|P4|COMPLETED|Second Test Period||7
393670|NCT01800903|963674|P3|COMPLETED|Second Test Period||4
393671|NCT01800903|963675|P2|COMPLETED|Second Test Period||6
393672|NCT01800903|963676|P1|COMPLETED|Second Test Period||6
393673|NCT01800903|963671|P6|STARTED|Second Test Period||6
393674|NCT01800903|963672|P5|STARTED|Second Test Period||6
393675|NCT01800903|963673|P4|STARTED|Second Test Period||7
393676|NCT01800903|963674|P3|STARTED|Second Test Period||4
393677|NCT01800903|963675|P2|STARTED|Second Test Period||6
393678|NCT01800903|963676|P1|STARTED|Second Test Period||7
393679|NCT01800903|963671|P6|NOT COMPLETED|First Test Period||0
393680|NCT01800903|963672|P5|NOT COMPLETED|First Test Period||0
393681|NCT01800903|963673|P4|NOT COMPLETED|First Test Period||0
393682|NCT01800903|963674|P3|NOT COMPLETED|First Test Period||0
393683|NCT01800903|963675|P2|NOT COMPLETED|First Test Period||0
393684|NCT01800903|963676|P1|NOT COMPLETED|First Test Period||0
393685|NCT01800903|963671|P6|COMPLETED|First Test Period||6
393686|NCT01800903|963672|P5|COMPLETED|First Test Period||6
393687|NCT01800903|963673|P4|COMPLETED|First Test Period||7
393688|NCT01800903|963674|P3|COMPLETED|First Test Period||4
393689|NCT01800903|963675|P2|COMPLETED|First Test Period||6
393690|NCT01800903|963676|P1|COMPLETED|First Test Period||7
393691|NCT01800903|963671|P6|STARTED|First Test Period||6
393692|NCT01800903|963672|P5|STARTED|First Test Period||6
393693|NCT01800903|963673|P4|STARTED|First Test Period||7
393694|NCT01800903|963674|P3|STARTED|First Test Period||4
393695|NCT01800903|963675|P2|STARTED|First Test Period||6
393696|NCT01800903|963676|P1|STARTED|First Test Period||7
393697|NCT01800890|963682|P9|NOT COMPLETED|Test Period 3||0
393698|NCT01800890|963683|P8|NOT COMPLETED|Test Period 3||0
393699|NCT01800890|963684|P7|NOT COMPLETED|Test Period 3||0
393700|NCT01800890|963685|P6|NOT COMPLETED|Test Period 3||0
393701|NCT01800890|963686|P5|NOT COMPLETED|Test Period 3||0
393702|NCT01800890|963687|P4|NOT COMPLETED|Test Period 3||0
393703|NCT01800890|963688|P3|NOT COMPLETED|Test Period 3||0
393704|NCT01800890|963689|P2|NOT COMPLETED|Test Period 3||0
393705|NCT01800890|963690|P1|NOT COMPLETED|Test Period 3||0
393706|NCT01800890|963682|P9|COMPLETED|Test Period 3||3
393707|NCT01800890|963683|P8|COMPLETED|Test Period 3||3
393708|NCT01800890|963684|P7|COMPLETED|Test Period 3||3
393709|NCT01800890|963685|P6|COMPLETED|Test Period 3||4
393710|NCT01800890|963686|P5|COMPLETED|Test Period 3||4
393711|NCT01800890|963687|P4|COMPLETED|Test Period 3||2
393712|NCT01800890|963688|P3|COMPLETED|Test Period 3||3
393713|NCT01800890|963689|P2|COMPLETED|Test Period 3||3
393714|NCT01800890|963690|P1|COMPLETED|Test Period 3||3
393715|NCT01800890|963682|P9|STARTED|Test Period 3||3
393716|NCT01800890|963683|P8|STARTED|Test Period 3||3
393717|NCT01800890|963684|P7|STARTED|Test Period 3||3
393718|NCT01800890|963685|P6|STARTED|Test Period 3||4
393719|NCT01800890|963686|P5|STARTED|Test Period 3||4
393720|NCT01800890|963687|P4|STARTED|Test Period 3||2
393721|NCT01800890|963688|P3|STARTED|Test Period 3||3
393722|NCT01800890|963689|P2|STARTED|Test Period 3||3
393723|NCT01800890|963690|P1|STARTED|Test Period 3||3
393724|NCT01800890|963682|P9|NOT COMPLETED|Test Period 2||0
393725|NCT01800890|963683|P8|NOT COMPLETED|Test Period 2||0
393726|NCT01800890|963684|P7|NOT COMPLETED|Test Period 2||0
393727|NCT01800890|963685|P6|NOT COMPLETED|Test Period 2||0
393728|NCT01800890|963686|P5|NOT COMPLETED|Test Period 2||0
393729|NCT01800890|963687|P4|NOT COMPLETED|Test Period 2||0
393730|NCT01800890|963688|P3|NOT COMPLETED|Test Period 2||0
393731|NCT01800890|963689|P2|NOT COMPLETED|Test Period 2||0
393732|NCT01800890|963690|P1|NOT COMPLETED|Test Period 2||0
393733|NCT01800890|963682|P9|COMPLETED|Test Period 2||3
393734|NCT01800890|963683|P8|COMPLETED|Test Period 2||3
393735|NCT01800890|963684|P7|COMPLETED|Test Period 2||3
393736|NCT01800890|963685|P6|COMPLETED|Test Period 2||4
393737|NCT01800890|963686|P5|COMPLETED|Test Period 2||4
393738|NCT01800890|963687|P4|COMPLETED|Test Period 2||2
393739|NCT01800890|963688|P3|COMPLETED|Test Period 2||3
393740|NCT01800890|963689|P2|COMPLETED|Test Period 2||3
393741|NCT01800890|963690|P1|COMPLETED|Test Period 2||3
393742|NCT01800890|963682|P9|STARTED|Test Period 2||3
393743|NCT01800890|963683|P8|STARTED|Test Period 2||3
393744|NCT01800890|963684|P7|STARTED|Test Period 2||3
393745|NCT01800890|963685|P6|STARTED|Test Period 2||4
393746|NCT01800890|963686|P5|STARTED|Test Period 2||4
393747|NCT01800890|963687|P4|STARTED|Test Period 2||2
393748|NCT01800890|963688|P3|STARTED|Test Period 2||3
393749|NCT01800890|963689|P2|STARTED|Test Period 2||3
393750|NCT01800890|963690|P1|STARTED|Test Period 2||3
393751|NCT01800890|963682|P9|NOT COMPLETED|Test Period 1||0
393752|NCT01800890|963683|P8|NOT COMPLETED|Test Period 1||0
393753|NCT01800890|963684|P7|NOT COMPLETED|Test Period 1||0
393754|NCT01800890|963685|P6|NOT COMPLETED|Test Period 1||0
393755|NCT01800890|963686|P5|NOT COMPLETED|Test Period 1||0
393756|NCT01800890|963687|P4|NOT COMPLETED|Test Period 1||1
393757|NCT01800890|963688|P3|NOT COMPLETED|Test Period 1||0
393758|NCT01800890|963689|P2|NOT COMPLETED|Test Period 1||0
393759|NCT01800890|963690|P1|NOT COMPLETED|Test Period 1||0
393760|NCT01800890|963682|P9|COMPLETED|Test Period 1||3
393761|NCT01800890|963683|P8|COMPLETED|Test Period 1||3
393762|NCT01800890|963684|P7|COMPLETED|Test Period 1||3
393763|NCT01800890|963685|P6|COMPLETED|Test Period 1||4
393764|NCT01800890|963686|P5|COMPLETED|Test Period 1||4
393765|NCT01800890|963687|P4|COMPLETED|Test Period 1||2
393766|NCT01800890|963688|P3|COMPLETED|Test Period 1||3
393767|NCT01800890|963689|P2|COMPLETED|Test Period 1||3
393768|NCT01800890|963690|P1|COMPLETED|Test Period 1||3
393769|NCT01800890|963682|P9|STARTED|Test Period 1||3
393770|NCT01800890|963683|P8|STARTED|Test Period 1||3
393771|NCT01800890|963684|P7|STARTED|Test Period 1||3
393772|NCT01800890|963685|P6|STARTED|Test Period 1||4
393773|NCT01800890|963686|P5|STARTED|Test Period 1||4
393774|NCT01800890|963687|P4|STARTED|Test Period 1||3
393775|NCT01800890|963688|P3|STARTED|Test Period 1||3
393776|NCT01800890|963689|P2|STARTED|Test Period 1||3
393777|NCT01800890|963690|P1|STARTED|Test Period 1||3
393778|NCT01800786|963702|P2|NOT COMPLETED|Overall Study||1
393779|NCT01800786|963703|P1|NOT COMPLETED|Overall Study||2
393780|NCT01800786|963702|P2|COMPLETED|Overall Study||15
393781|NCT01800786|963703|P1|COMPLETED|Overall Study||15
393782|NCT01800786|963702|P2|STARTED|Overall Study||16
393783|NCT01800786|963703|P1|STARTED|Overall Study||17
393784|NCT01800318|963713|P4|NOT COMPLETED|Overall Study||1
393785|NCT01800318|963714|P3|NOT COMPLETED|Overall Study||1
393786|NCT01800318|963715|P2|NOT COMPLETED|Overall Study||5
393787|NCT01800318|963716|P1|NOT COMPLETED|Overall Study||2
393788|NCT01800318|963713|P4|COMPLETED|Overall Study||39
393789|NCT01800318|963714|P3|COMPLETED|Overall Study||40
393790|NCT01800318|963715|P2|COMPLETED|Overall Study||37
393791|NCT01800318|963716|P1|COMPLETED|Overall Study||37
393792|NCT01800318|963713|P4|STARTED|Overall Study||40
393793|NCT01800318|963714|P3|STARTED|Overall Study||41
393794|NCT01800318|963715|P2|STARTED|Overall Study||42
393795|NCT01800318|963716|P1|STARTED|Overall Study||39
393796|NCT01800162|963745|P3|NOT COMPLETED|Overall Study||0
393797|NCT01800162|963746|P2|NOT COMPLETED|Overall Study||0
393798|NCT01800162|963747|P1|NOT COMPLETED|Overall Study||0
393799|NCT01800162|963745|P3|COMPLETED|Overall Study||1
393800|NCT01800162|963746|P2|COMPLETED|Overall Study||0
393801|NCT01800162|963747|P1|COMPLETED|Overall Study||1
393802|NCT01800162|963745|P3|STARTED|Overall Study|1 subject randomized to expectant management on 11/1/2013.|1
393803|NCT01800162|963746|P2|STARTED|Overall Study||0
393804|NCT01800162|963747|P1|STARTED|Overall Study|1 subject was randomized to uterine evacuation on 6/26/2013.|1
393805|NCT01799993|963773|P2|NOT COMPLETED|Overall Study||128
393806|NCT01799993|963774|P1|NOT COMPLETED|Overall Study||133
393807|NCT01799993|963773|P2|COMPLETED|Overall Study||235
393808|NCT01799993|963774|P1|COMPLETED|Overall Study||229
393809|NCT01799993|963773|P2|mITT Population|Overall Study||253
393810|NCT01799993|963774|P1|mITT Population|Overall Study||255
393811|NCT01799993|963773|P2|ITT Population|Overall Study||358
393812|NCT01799993|963774|P1|ITT Population|Overall Study||354
393813|NCT01799993|963773|P2|STARTED|Overall Study||363
393814|NCT01799993|963774|P1|STARTED|Overall Study||362
393815|NCT01799941|963806|P1|NOT COMPLETED|Overall Study||96
393816|NCT01799941|963806|P1|COMPLETED|Overall Study||271
393817|NCT01799941|963806|P1|STARTED|Overall Study||367
393818|NCT01799720|963863|P3|NOT COMPLETED|Overall Study||1
393819|NCT01799720|963864|P2|NOT COMPLETED|Overall Study||1
393820|NCT01799720|963865|P1|NOT COMPLETED|Overall Study||3
393821|NCT01799720|963863|P3|COMPLETED|Overall Study||18
393822|NCT01799720|963864|P2|COMPLETED|Overall Study||17
393823|NCT01799720|963865|P1|COMPLETED|Overall Study||17
393824|NCT01799720|963863|P3|Began the Treatment and Finished it|Overall Study||18
393825|NCT01799720|963864|P2|Began the Treatment and Finished it|Overall Study||17
393826|NCT01799720|963865|P1|Began the Treatment and Finished it|Overall Study||17
393827|NCT01799720|963863|P3|Began the Treatment|Overall Study||19
393828|NCT01799720|963864|P2|Began the Treatment|Overall Study||18
393829|NCT01799720|963865|P1|Began the Treatment|Overall Study||20
393830|NCT01799720|963863|P3|STARTED|Overall Study||19
393831|NCT01799720|963864|P2|STARTED|Overall Study||18
393832|NCT01799720|963865|P1|STARTED|Overall Study||20
393833|NCT01799590|963903|P3|NOT COMPLETED|Overall Study||14
393834|NCT01799590|963904|P2|NOT COMPLETED|Overall Study||16
393835|NCT01799590|963905|P1|NOT COMPLETED|Overall Study||26
393836|NCT01799590|963903|P3|COMPLETED|Overall Study||77
393837|NCT01799590|963904|P2|COMPLETED|Overall Study||78
393838|NCT01799590|963905|P1|COMPLETED|Overall Study||85
393839|NCT01799590|963903|P3|STARTED|Overall Study||91
393840|NCT01799590|963904|P2|STARTED|Overall Study||94
393841|NCT01799590|963905|P1|STARTED|Overall Study||111
393842|NCT01799278|963940|P1|NOT COMPLETED|Overall Study||0
393843|NCT01799278|963940|P1|COMPLETED|Overall Study||60
393844|NCT01799278|963940|P1|STARTED|Overall Study||60
393845|NCT01799239|963948|P2|NOT COMPLETED|Period 2 (7 Days)||1
393846|NCT01799239|963949|P1|NOT COMPLETED|Period 2 (7 Days)||2
393847|NCT01799239|963948|P2|COMPLETED|Period 2 (7 Days)||14
393848|NCT01799239|963949|P1|COMPLETED|Period 2 (7 Days)||11
393849|NCT01799239|963948|P2|STARTED|Period 2 (7 Days)||15
393850|NCT01799239|963949|P1|STARTED|Period 2 (7 Days)||13
393851|NCT01799239|963948|P2|NOT COMPLETED|Period 1 (7 Days)||1
393852|NCT01799239|963949|P1|NOT COMPLETED|Period 1 (7 Days)||3
393853|NCT01799239|963948|P2|COMPLETED|Period 1 (7 Days)||15
393854|NCT01799239|963949|P1|COMPLETED|Period 1 (7 Days)||12
393855|NCT01799239|963948|P2|STARTED|Period 1 (7 Days)|It was uncertain in which order the product were tested for 1 subject. Subject is excl from analysis|16
393856|NCT01799239|963949|P1|STARTED|Period 1 (7 Days)|It was uncertain in which order the product were tested for 1 subject. Subject is excl from analysis|15
393857|NCT01799226|963957|P2|NOT COMPLETED|Overall Study||0
393858|NCT01799226|963958|P1|NOT COMPLETED|Overall Study||2
393859|NCT01799226|963957|P2|COMPLETED|Overall Study||16
393860|NCT01799226|963958|P1|COMPLETED|Overall Study||14
393861|NCT01799226|963957|P2|Left Stent Side|Overall Study||8
393862|NCT01799226|963958|P1|Left Stent Side|Overall Study||8
393863|NCT01799226|963957|P2|Right Stent Side|Overall Study||8
393864|NCT01799226|963958|P1|Right Stent Side|Overall Study||8
393865|NCT01799226|963957|P2|STARTED|Overall Study||16
393866|NCT01799226|963958|P1|STARTED|Overall Study||16
393867|NCT01798992|963970|P4|NOT COMPLETED|Overall Study||1
393868|NCT01798992|963971|P3|NOT COMPLETED|Overall Study||2
393869|NCT01798992|963972|P2|NOT COMPLETED|Overall Study||2
393870|NCT01798992|963973|P1|NOT COMPLETED|Overall Study||0
393871|NCT01798992|963970|P4|COMPLETED|Overall Study||16
393872|NCT01798992|963971|P3|COMPLETED|Overall Study||14
393873|NCT01798992|963972|P2|COMPLETED|Overall Study||17
393874|NCT01798992|963973|P1|COMPLETED|Overall Study||4
393875|NCT01798992|963970|P4|STARTED|Overall Study||17
393876|NCT01798992|963971|P3|STARTED|Overall Study||16
393877|NCT01798992|963972|P2|STARTED|Overall Study||19
393878|NCT01798992|963973|P1|STARTED|Overall Study||4
393879|NCT01798966|963987|P1|NOT COMPLETED|Overall Study||0
393880|NCT01798966|963987|P1|COMPLETED|Overall Study||10
393881|NCT01798966|963987|P1|STARTED|Overall Study||10
393882|NCT01798927|963993|P1|NOT COMPLETED|Overall Study||1
393883|NCT01798927|963993|P1|COMPLETED|Overall Study||3
393884|NCT01798927|963993|P1|STARTED|Overall Study||4
393885|NCT01798706|964001|P2|NOT COMPLETED|Overall Study||21
393886|NCT01798706|964002|P1|NOT COMPLETED|Overall Study||21
393887|NCT01798706|964001|P2|COMPLETED|Overall Study||153
393888|NCT01798706|964002|P1|COMPLETED|Overall Study||155
393889|NCT01798706|964001|P2|STARTED|Overall Study||174
393890|NCT01798706|964002|P1|STARTED|Overall Study||176
393891|NCT01798550|964030|P2|NOT COMPLETED|Overall Study||6
393892|NCT01798550|964031|P1|NOT COMPLETED|Overall Study||2
393893|NCT01798550|964030|P2|COMPLETED|Overall Study||26
393894|NCT01798550|964031|P1|COMPLETED|Overall Study||28
393895|NCT01798550|964030|P2|STARTED|Overall Study||32
393896|NCT01798550|964031|P1|STARTED|Overall Study||30
393897|NCT01798485|964047|P2|NOT COMPLETED|Overall Study||290
393898|NCT01798485|964048|P1|NOT COMPLETED|Overall Study||346
393899|NCT01798485|964047|P2|COMPLETED|Overall Study||59
393900|NCT01798485|964048|P1|COMPLETED|Overall Study||1
393901|NCT01798485|964047|P2|Randomized as of 19 October 2015|Overall Study||337
393902|NCT01798485|964048|P1|Randomized as of 19 October 2015|Overall Study||335
393903|NCT01798485|964047|P2|Safety Population as of 23 Dec 2015|Overall Study||342
393904|NCT01798485|964048|P1|Safety Population as of 23 Dec 2015|Overall Study||338
393905|NCT01798485|964047|P2|STARTED|Overall Study||349
393906|NCT01798485|964048|P1|STARTED|Overall Study||347
393907|NCT01798394|964084|P2|NOT COMPLETED|Overall Study||3
393908|NCT01798394|964085|P1|NOT COMPLETED|Overall Study||3
393909|NCT01798394|964084|P2|COMPLETED|Overall Study||19
393910|NCT01798394|964085|P1|COMPLETED|Overall Study||21
393911|NCT01798394|964084|P2|STARTED|Overall Study||22
393912|NCT01798394|964085|P1|STARTED|Overall Study||24
393913|NCT01798316|964105|P2|NOT COMPLETED|Overall Study||0
393914|NCT01798316|964106|P1|NOT COMPLETED|Overall Study||0
393915|NCT01798316|964105|P2|COMPLETED|Overall Study||53
393916|NCT01798316|964106|P1|COMPLETED|Overall Study||52
393917|NCT01798316|964105|P2|STARTED|Overall Study||53
393918|NCT01798316|964106|P1|STARTED|Overall Study||52
393919|NCT01798264|964128|P4|NOT COMPLETED|Overall Study||4
393920|NCT01798264|964129|P3|NOT COMPLETED|Overall Study||0
393921|NCT01798264|964130|P2|NOT COMPLETED|Overall Study||0
393922|NCT01798264|964131|P1|NOT COMPLETED|Overall Study||1
393923|NCT01798264|964128|P4|COMPLETED|Overall Study||7
393924|NCT01798264|964129|P3|COMPLETED|Overall Study||10
393925|NCT01798264|964130|P2|COMPLETED|Overall Study||11
393926|NCT01798264|964131|P1|COMPLETED|Overall Study||11
393927|NCT01798264|964128|P4|STARTED|Overall Study||11
393928|NCT01798264|964129|P3|STARTED|Overall Study||10
393929|NCT01798264|964130|P2|STARTED|Overall Study||11
393930|NCT01798264|964131|P1|STARTED|Overall Study||12
393931|NCT01798186|964157|P4|NOT COMPLETED|Overall Study||0
393932|NCT01798186|964158|P3|NOT COMPLETED|Overall Study||0
393933|NCT01798186|964159|P2|NOT COMPLETED|Overall Study||0
393934|NCT01798186|964160|P1|NOT COMPLETED|Overall Study||0
393935|NCT01798186|964157|P4|COMPLETED|Overall Study||8
393936|NCT01798186|964158|P3|COMPLETED|Overall Study||6
393937|NCT01798186|964159|P2|COMPLETED|Overall Study||6
393938|NCT01798186|964160|P1|COMPLETED|Overall Study||6
393939|NCT01798186|964157|P4|STARTED|Overall Study||8
393940|NCT01798186|964158|P3|STARTED|Overall Study||6
393941|NCT01798186|964159|P2|STARTED|Overall Study||6
393942|NCT01798186|964160|P1|STARTED|Overall Study||6
393943|NCT01798134|964174|P1|NOT COMPLETED|Overall Study||16
393944|NCT01798134|964174|P1|COMPLETED|Overall Study||9
393945|NCT01798134|964174|P1|STARTED|Overall Study||25
393946|NCT01798004|964181|P1|NOT COMPLETED|Overall Study||87
393947|NCT01798004|964181|P1|COMPLETED|Overall Study||63
393948|NCT01798004|964181|P1|STARTED|Overall Study||150
393949|NCT01797783|964187|P2|NOT COMPLETED|Overall Study||1
393950|NCT01797783|964188|P1|NOT COMPLETED|Overall Study||2
393951|NCT01797783|964187|P2|COMPLETED|Overall Study||26
393952|NCT01797783|964188|P1|COMPLETED|Overall Study||50
393953|NCT01797783|964187|P2|STARTED|Overall Study||27
393954|NCT01797783|964188|P1|STARTED|Overall Study||52
393955|NCT01797731|964212|P2|NOT COMPLETED|Overall Study||3
393956|NCT01797731|964213|P1|NOT COMPLETED|Overall Study||3
393957|NCT01797731|964212|P2|COMPLETED|Overall Study|3 excluded due to not having proper radiographs for adequate follow up|47
393958|NCT01797731|964213|P1|COMPLETED|Overall Study|3 were excluded due to not having proper radiographs for adequate follow up|47
393959|NCT01797731|964212|P2|STARTED|Overall Study||50
393960|NCT01797731|964213|P1|STARTED|Overall Study||50
393961|NCT01797705|964221|P1|NOT COMPLETED|Overall Study||5
393962|NCT01797705|964221|P1|COMPLETED|Overall Study||28
393963|NCT01797705|964221|P1|STARTED|Overall Study||33
393964|NCT01797575|964229|P4|NOT COMPLETED|Week 8 Re-Randomization||3
393965|NCT01797575|964230|P3|NOT COMPLETED|Week 8 Re-Randomization||1
393966|NCT01797575|964231|P2|NOT COMPLETED|Week 8 Re-Randomization||0
393967|NCT01797575|964232|P1|NOT COMPLETED|Week 8 Re-Randomization||0
393968|NCT01797575|964229|P4|COMPLETED|Week 8 Re-Randomization||7
393969|NCT01797575|964230|P3|COMPLETED|Week 8 Re-Randomization||4
393970|NCT01797575|964231|P2|COMPLETED|Week 8 Re-Randomization||5
393971|NCT01797575|964232|P1|COMPLETED|Week 8 Re-Randomization||4
393972|NCT01797575|964229|P4|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|10
393973|NCT01797575|964230|P3|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|5
393974|NCT01797575|964231|P2|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|5
393975|NCT01797575|964232|P1|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|4
393976|NCT01797575|964229|P4|NOT COMPLETED|Baseline Allocation||7
393977|NCT01797575|964230|P3|NOT COMPLETED|Baseline Allocation||5
393978|NCT01797575|964231|P2|NOT COMPLETED|Baseline Allocation||1
393979|NCT01797575|964232|P1|NOT COMPLETED|Baseline Allocation||1
393980|NCT01797575|964229|P4|COMPLETED|Baseline Allocation||8
393981|NCT01797575|964230|P3|COMPLETED|Baseline Allocation||4
393982|NCT01797575|964231|P2|COMPLETED|Baseline Allocation||8
393983|NCT01797575|964232|P1|COMPLETED|Baseline Allocation||4
393984|NCT01797575|964229|P4|STARTED|Baseline Allocation||15
393985|NCT01797575|964230|P3|STARTED|Baseline Allocation||9
393986|NCT01797575|964231|P2|STARTED|Baseline Allocation||9
393987|NCT01797575|964232|P1|STARTED|Baseline Allocation||5
393988|NCT01797536|964286|P4|NOT COMPLETED|Overall Study||0
393989|NCT01797536|964287|P3|NOT COMPLETED|Overall Study||0
393990|NCT01797536|964288|P2|NOT COMPLETED|Overall Study||1
393991|NCT01797536|964289|P1|NOT COMPLETED|Overall Study||0
393992|NCT01797536|964286|P4|COMPLETED|Overall Study||8
393993|NCT01797536|964287|P3|COMPLETED|Overall Study||7
393994|NCT01797536|964288|P2|COMPLETED|Overall Study||10
393995|NCT01797536|964289|P1|COMPLETED|Overall Study||8
393996|NCT01797536|964286|P4|STARTED|Overall Study||8
393997|NCT01797536|964287|P3|STARTED|Overall Study||7
393998|NCT01797536|964288|P2|STARTED|Overall Study|Includes 3 participants from mild arm who were mistakenly re-enrolled and also dosed in moderate arm|11
393999|NCT01797536|964289|P1|STARTED|Overall Study||8
394000|NCT01797484|964321|P2|NOT COMPLETED|Overall Study||0
394001|NCT01797484|964322|P1|NOT COMPLETED|Overall Study||0
394002|NCT01797484|964321|P2|COMPLETED|Overall Study||10
394003|NCT01797484|964322|P1|COMPLETED|Overall Study||10
394004|NCT01797484|964321|P2|STARTED|Overall Study||10
394005|NCT01797484|964322|P1|STARTED|Overall Study||10
394006|NCT01797471|964328|P1|NOT COMPLETED|Overall Study||0
394007|NCT01797471|964328|P1|COMPLETED|Overall Study||1
394008|NCT01797471|964328|P1|STARTED|Overall Study||1
394009|NCT01797458|964340|P3|NOT COMPLETED|Overall Study||7
394010|NCT01797458|964341|P2|NOT COMPLETED|Overall Study||9
394011|NCT01797458|964342|P1|NOT COMPLETED|Overall Study||12
394012|NCT01797458|964340|P3|COMPLETED|Overall Study||58
394013|NCT01797458|964341|P2|COMPLETED|Overall Study||43
394014|NCT01797458|964342|P1|COMPLETED|Overall Study||40
394015|NCT01797458|964340|P3|STARTED|Overall Study||65
394016|NCT01797458|964341|P2|STARTED|Overall Study||52
394017|NCT01797458|964342|P1|STARTED|Overall Study||52
394018|NCT01797445|964361|P2|NOT COMPLETED|Overall Study||437
394019|NCT01797445|964362|P1|NOT COMPLETED|Overall Study||435
394020|NCT01797445|964361|P2|COMPLETED|Overall Study||0
394021|NCT01797445|964362|P1|COMPLETED|Overall Study||0
394022|NCT01797445|964361|P2|STARTED|Overall Study||437
394023|NCT01797445|964362|P1|STARTED|Overall Study||435
394024|NCT01797380|964402|P2|NOT COMPLETED|Overall Study||2
394025|NCT01797380|964403|P1|NOT COMPLETED|Overall Study||3
394026|NCT01797380|964402|P2|COMPLETED|Overall Study||0
394027|NCT01797380|964403|P1|COMPLETED|Overall Study|Terminated due to lack of enrollment|0
394028|NCT01797380|964402|P2|STARTED|Overall Study||2
394029|NCT01797380|964403|P1|STARTED|Overall Study|Terminated due to lack of enrollment|3
394030|NCT01797328|964411|P2|NOT COMPLETED|Overall Study||0
394031|NCT01797328|964412|P1|NOT COMPLETED|Overall Study||2
394032|NCT01797328|964411|P2|COMPLETED|Overall Study||12
394033|NCT01797328|964412|P1|COMPLETED|Overall Study||14
394034|NCT01797328|964411|P2|STARTED|Overall Study||12
394035|NCT01797328|964412|P1|STARTED|Overall Study||16
394036|NCT01797120|964420|P2|NOT COMPLETED|Overall Study||65
394037|NCT01797120|964421|P1|NOT COMPLETED|Overall Study||66
394038|NCT01797120|964420|P2|COMPLETED|Overall Study||0
394039|NCT01797120|964421|P1|COMPLETED|Overall Study||0
394040|NCT01797120|964420|P2|STARTED|Overall Study||65
394041|NCT01797120|964421|P1|STARTED|Overall Study||66
394042|NCT01797094|964435|P2|NOT COMPLETED|Overall Study||2
394043|NCT01797094|964436|P1|NOT COMPLETED|Overall Study||6
394044|NCT01797094|964435|P2|COMPLETED|Overall Study||51
394045|NCT01797094|964436|P1|COMPLETED|Overall Study||42
394046|NCT01797094|964435|P2|STARTED|Overall Study||53
394047|NCT01797094|964436|P1|STARTED|Overall Study||48
394048|NCT01797081|964458|P4|NOT COMPLETED|Overall Study||9
394049|NCT01797081|964459|P3|NOT COMPLETED|Overall Study||5
394050|NCT01797081|964460|P2|NOT COMPLETED|Overall Study||4
394051|NCT01797081|964461|P1|NOT COMPLETED|Overall Study||14
394052|NCT01797081|964458|P4|COMPLETED|Overall Study||40
394053|NCT01797081|964459|P3|COMPLETED|Overall Study||43
394054|NCT01797081|964460|P2|COMPLETED|Overall Study||95
394055|NCT01797081|964461|P1|COMPLETED|Overall Study||90
394056|NCT01797081|964458|P4|STARTED|Overall Study||49
394057|NCT01797081|964459|P3|STARTED|Overall Study||48
394058|NCT01797081|964460|P2|STARTED|Overall Study||99
394059|NCT01797081|964461|P1|STARTED|Overall Study||104
394060|NCT01797029|964480|P2|NOT COMPLETED|Overall Study||61
394061|NCT01797029|964481|P1|NOT COMPLETED|Overall Study||159
394062|NCT01797029|964480|P2|COMPLETED|Overall Study||526
394063|NCT01797029|964481|P1|COMPLETED|Overall Study||1015
394064|NCT01797029|964480|P2|STARTED|Overall Study||587
394065|NCT01797029|964481|P1|STARTED|Overall Study||1174
394066|NCT01796977|964489|P1|NOT COMPLETED|Overall Study||0
394067|NCT01796977|964489|P1|COMPLETED|Overall Study||27
394068|NCT01796977|964489|P1|STARTED|Overall Study||27
394069|NCT01796964|964502|P2|NOT COMPLETED|Overall Study||3
394070|NCT01796964|964503|P1|NOT COMPLETED|Overall Study||3
394071|NCT01796964|964502|P2|COMPLETED|Overall Study||42
394072|NCT01796964|964503|P1|COMPLETED|Overall Study||41
394073|NCT01796964|964502|P2|STARTED|Overall Study||45
394074|NCT01796964|964503|P1|STARTED|Overall Study||44
394075|NCT01796860|964525|P1|NOT COMPLETED|Overall Study||3
394076|NCT01796860|964525|P1|COMPLETED|Overall Study||7
394077|NCT01796860|964525|P1|STARTED|Overall Study||10
394078|NCT01796548|964531|P1|NOT COMPLETED|Overall Study||3
394079|NCT01796548|964531|P1|COMPLETED|Overall Study||14
394080|NCT01796548|964531|P1|Treated|Overall Study||15
394081|NCT01796548|964531|P1|STARTED|Overall Study||17
394082|NCT01796236|964545|P2|NOT COMPLETED|Overall Study||2
394083|NCT01796236|964546|P1|NOT COMPLETED|Overall Study||2
394084|NCT01796236|964545|P2|COMPLETED|Overall Study||50
394085|NCT01796236|964546|P1|COMPLETED|Overall Study||49
394086|NCT01796236|964545|P2|STARTED|Overall Study||52
394087|NCT01796236|964546|P1|STARTED|Overall Study||51
394088|NCT01795937|964565|P3|NOT COMPLETED|Overall Study||0
394089|NCT01795937|964566|P2|NOT COMPLETED|Overall Study||1
394090|NCT01795937|964567|P1|NOT COMPLETED|Overall Study||1
394091|NCT01795937|964565|P3|COMPLETED|Overall Study||17
394092|NCT01795937|964566|P2|COMPLETED|Overall Study||15
394093|NCT01795937|964567|P1|COMPLETED|Overall Study||17
394094|NCT01795937|964565|P3|STARTED|Overall Study||17
394095|NCT01795937|964566|P2|STARTED|Overall Study||16
394096|NCT01795937|964567|P1|STARTED|Overall Study||18
394097|NCT01795898|964596|P1|NOT COMPLETED|Overall Study||60
394098|NCT01795898|964596|P1|COMPLETED|Overall Study||177
394099|NCT01795898|964596|P1|STARTED|Overall Study||237
394100|NCT01795859|964606|P2|NOT COMPLETED|Overall Study||2
394101|NCT01795859|964607|P1|NOT COMPLETED|Overall Study||1
394102|NCT01795859|964606|P2|COMPLETED|Overall Study||43
394103|NCT01795859|964607|P1|COMPLETED|Overall Study||44
394104|NCT01795859|964606|P2|STARTED|Overall Study||45
394105|NCT01795859|964607|P1|STARTED|Overall Study||45
394106|NCT01795716|964623|P2|NOT COMPLETED|Second Intervention (13 Days)||0
394107|NCT01795716|964624|P1|NOT COMPLETED|Second Intervention (13 Days)||0
394108|NCT01795716|964623|P2|COMPLETED|Second Intervention (13 Days)||11
394109|NCT01795716|964624|P1|COMPLETED|Second Intervention (13 Days)||10
394110|NCT01795716|964623|P2|STARTED|Second Intervention (13 Days)||11
394111|NCT01795716|964624|P1|STARTED|Second Intervention (13 Days)||10
394112|NCT01795716|964623|P2|NOT COMPLETED|Washout (10 Days)||0
394113|NCT01795716|964624|P1|NOT COMPLETED|Washout (10 Days)||0
394114|NCT01795716|964623|P2|COMPLETED|Washout (10 Days)||11
394115|NCT01795716|964624|P1|COMPLETED|Washout (10 Days)||10
394116|NCT01795716|964623|P2|STARTED|Washout (10 Days)||11
394117|NCT01795716|964624|P1|STARTED|Washout (10 Days)||10
394118|NCT01795716|964623|P2|NOT COMPLETED|First Intervention (13 Days)||0
394119|NCT01795716|964624|P1|NOT COMPLETED|First Intervention (13 Days)||0
394120|NCT01795716|964623|P2|COMPLETED|First Intervention (13 Days)||11
394121|NCT01795716|964624|P1|COMPLETED|First Intervention (13 Days)||10
394122|NCT01795716|964623|P2|STARTED|First Intervention (13 Days)||11
394123|NCT01795716|964624|P1|STARTED|First Intervention (13 Days)||10
394124|NCT01795547|964632|P2|NOT COMPLETED|Overall Study||64
394125|NCT01795547|964633|P1|NOT COMPLETED|Overall Study||48
394126|NCT01795547|964632|P2|COMPLETED|Overall Study||83
394127|NCT01795547|964633|P1|COMPLETED|Overall Study||100
394128|NCT01795547|964632|P2|STARTED|Overall Study||147
394129|NCT01795547|964633|P1|STARTED|Overall Study||148
394130|NCT01795534|964655|P2|NOT COMPLETED|Second Intervention (Second Shot)||0
394131|NCT01795534|964656|P1|NOT COMPLETED|Second Intervention (Second Shot)||0
394132|NCT01795534|964655|P2|COMPLETED|Second Intervention (Second Shot)||5
394133|NCT01795534|964656|P1|COMPLETED|Second Intervention (Second Shot)||5
394134|NCT01795534|964655|P2|STARTED|Second Intervention (Second Shot)||5
394135|NCT01795534|964656|P1|STARTED|Second Intervention (Second Shot)||5
394136|NCT01795534|964655|P2|NOT COMPLETED|Wash Out Period (4 Days)||0
394137|NCT01795534|964656|P1|NOT COMPLETED|Wash Out Period (4 Days)||0
394138|NCT01795534|964655|P2|COMPLETED|Wash Out Period (4 Days)||5
394139|NCT01795534|964656|P1|COMPLETED|Wash Out Period (4 Days)||5
394140|NCT01795534|964655|P2|STARTED|Wash Out Period (4 Days)||5
394141|NCT01795534|964656|P1|STARTED|Wash Out Period (4 Days)||5
394142|NCT01795534|964655|P2|NOT COMPLETED|First Intervention (First Shot)||0
394143|NCT01795534|964656|P1|NOT COMPLETED|First Intervention (First Shot)||0
394144|NCT01795534|964655|P2|COMPLETED|First Intervention (First Shot)||5
394145|NCT01795534|964656|P1|COMPLETED|First Intervention (First Shot)||5
394146|NCT01795534|964655|P2|STARTED|First Intervention (First Shot)||5
394147|NCT01795534|964656|P1|STARTED|First Intervention (First Shot)||5
394148|NCT01795495|964665|P3|NOT COMPLETED|Overall Study||2
394149|NCT01795495|964666|P2|NOT COMPLETED|Overall Study||0
394150|NCT01795495|964667|P1|NOT COMPLETED|Overall Study||1
394151|NCT01795495|964665|P3|COMPLETED|Overall Study||19
394152|NCT01795495|964666|P2|COMPLETED|Overall Study||22
394153|NCT01795495|964667|P1|COMPLETED|Overall Study||19
394154|NCT01795495|964665|P3|STARTED|Overall Study||21
394155|NCT01795495|964666|P2|STARTED|Overall Study||22
394156|NCT01795495|964667|P1|STARTED|Overall Study||20
394157|NCT01794949|964680|P2|NOT COMPLETED|Overall Study||0
394158|NCT01794949|964681|P1|NOT COMPLETED|Overall Study||1
394159|NCT01794949|964680|P2|COMPLETED|Overall Study||1
394160|NCT01794949|964681|P1|COMPLETED|Overall Study||6
394161|NCT01794949|964680|P2|6 Month Follow-up|Overall Study||1
394162|NCT01794949|964681|P1|6 Month Follow-up|Overall Study||6
394163|NCT01794949|964680|P2|STARTED|Overall Study||1
394164|NCT01794949|964681|P1|STARTED|Overall Study||7
394165|NCT01794936|964687|P1|NOT COMPLETED|Overall Study||0
394166|NCT01794936|964687|P1|COMPLETED|Overall Study||9
394167|NCT01794936|964687|P1|STARTED|Overall Study||9
394168|NCT01794845|964692|P1|NOT COMPLETED|Overall Study||1
394169|NCT01794845|964692|P1|COMPLETED|Overall Study||4
394170|NCT01794845|964692|P1|STARTED|Overall Study||5
394171|NCT01794806|964701|P2|NOT COMPLETED|Overall Study||1
394172|NCT01794806|964702|P1|NOT COMPLETED|Overall Study||5
394173|NCT01794806|964701|P2|COMPLETED|Overall Study||27
394174|NCT01794806|964702|P1|COMPLETED|Overall Study||26
394175|NCT01794806|964701|P2|4 Weeks|Overall Study||27
394176|NCT01794806|964702|P1|4 Weeks|Overall Study||26
394177|NCT01794806|964701|P2|1 Week|Overall Study||28
394178|NCT01794806|964702|P1|1 Week|Overall Study||28
394179|NCT01794806|964701|P2|STARTED|Overall Study||28
394180|NCT01794806|964702|P1|STARTED|Overall Study||31
394181|NCT01794741|964714|P2|NOT COMPLETED|Overall Study||9
394182|NCT01794741|964715|P1|NOT COMPLETED|Overall Study||19
394183|NCT01794741|964714|P2|COMPLETED|Overall Study||92
394184|NCT01794741|964715|P1|COMPLETED|Overall Study||285
394185|NCT01794741|964714|P2|STARTED|Overall Study||101
394186|NCT01794741|964715|P1|STARTED|Overall Study||304
394187|NCT01794455|964723|P2|NOT COMPLETED|Overall Study||0
394188|NCT01794455|964724|P1|NOT COMPLETED|Overall Study||0
394189|NCT01794455|964723|P2|COMPLETED|Overall Study||1
394190|NCT01794455|964724|P1|COMPLETED|Overall Study||0
394191|NCT01794455|964723|P2|STARTED|Overall Study||1
394192|NCT01794455|964724|P1|STARTED|Overall Study||0
394193|NCT01794000|964742|P2|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
394194|NCT01794000|964743|P1|NOT COMPLETED|Open-Label Extension Phase (OLE)||3
394195|NCT01794000|964742|P2|COMPLETED|Open-Label Extension Phase (OLE)||0
394196|NCT01794000|964743|P1|COMPLETED|Open-Label Extension Phase (OLE)||0
394197|NCT01794000|964742|P2|STARTED|Open-Label Extension Phase (OLE)|Placebo arm was not applicable to Open-Label Extension Phase|0
394198|NCT01794000|964743|P1|STARTED|Open-Label Extension Phase (OLE)|Pts. who had not permanently discontinued study drug and concluded DBP were eligible to enter OLE|3
394199|NCT01794000|964742|P2|NOT COMPLETED|Double-Blind Phase (DBP)||166
394200|NCT01794000|964743|P1|NOT COMPLETED|Double-Blind Phase (DBP)||169
394201|NCT01794000|964742|P2|COMPLETED|Double-Blind Phase (DBP)||4
394202|NCT01794000|964743|P1|COMPLETED|Double-Blind Phase (DBP)||2
394203|NCT01794000|964742|P2|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||166
394204|NCT01794000|964743|P1|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||169
394205|NCT01794000|964742|P2|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170
394206|NCT01794000|964743|P1|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170
394207|NCT01794000|964742|P2|STARTED|Double-Blind Phase (DBP)||170
394208|NCT01794000|964743|P1|STARTED|Double-Blind Phase (DBP)||171
394209|NCT01793935|964776|P2|NOT COMPLETED|Overall Study||3
394210|NCT01793935|964777|P1|NOT COMPLETED|Overall Study||6
394211|NCT01793935|964776|P2|COMPLETED|Overall Study||31
394212|NCT01793935|964777|P1|COMPLETED|Overall Study||28
394213|NCT01793935|964776|P2|STARTED|Overall Study||34
394214|NCT01793935|964777|P1|STARTED|Overall Study||34
394215|NCT01793883|964814|P3|NOT COMPLETED|Overall Study||8
394216|NCT01793883|964815|P2|NOT COMPLETED|Overall Study||10
394217|NCT01793883|964816|P1|NOT COMPLETED|Overall Study||12
394218|NCT01793883|964814|P3|COMPLETED|Overall Study||204
394219|NCT01793883|964815|P2|COMPLETED|Overall Study||204
394220|NCT01793883|964816|P1|COMPLETED|Overall Study||201
394221|NCT01793883|964814|P3|STARTED|Overall Study||212
394222|NCT01793883|964815|P2|STARTED|Overall Study||214
394223|NCT01793883|964816|P1|STARTED|Overall Study||213
394224|NCT01793688|964824|P1|NOT COMPLETED|Overall Study||2
394225|NCT01793688|964824|P1|COMPLETED|Overall Study||980
394226|NCT01793688|964824|P1|STARTED|Overall Study||982
394227|NCT01793285|964831|P1|NOT COMPLETED|Overall Study||0
394228|NCT01793285|964831|P1|COMPLETED|Overall Study||85
394229|NCT01793285|964831|P1|STARTED|Overall Study||85
394230|NCT01792986|964851|P1|NOT COMPLETED|Overall Study||0
394231|NCT01792986|964851|P1|COMPLETED|Overall Study||12
394232|NCT01792986|964851|P1|STARTED|Overall Study||12
394233|NCT01792830|964866|P7|NOT COMPLETED|Overall Study||3
394234|NCT01792830|964867|P6|NOT COMPLETED|Overall Study||0
394235|NCT01792830|964868|P5|NOT COMPLETED|Overall Study||12
394236|NCT01792830|964869|P4|NOT COMPLETED|Overall Study||5
394237|NCT01792830|964870|P3|NOT COMPLETED|Overall Study||0
394238|NCT01792830|964871|P2|NOT COMPLETED|Overall Study||0
394239|NCT01792830|964872|P1|NOT COMPLETED|Overall Study||25
394240|NCT01792830|964866|P7|COMPLETED|Overall Study||9
394241|NCT01792830|964867|P6|COMPLETED|Overall Study||4
394242|NCT01792830|964868|P5|COMPLETED|Overall Study||29
394243|NCT01792830|964869|P4|COMPLETED|Overall Study||22
394244|NCT01792830|964870|P3|COMPLETED|Overall Study||4
394245|NCT01792830|964871|P2|COMPLETED|Overall Study||3
394246|NCT01792830|964872|P1|COMPLETED|Overall Study||59
394247|NCT01792830|964866|P7|STARTED|Overall Study||12
394248|NCT01792830|964867|P6|STARTED|Overall Study||4
394249|NCT01792830|964868|P5|STARTED|Overall Study||41
394250|NCT01792830|964869|P4|STARTED|Overall Study||27
394251|NCT01792830|964870|P3|STARTED|Overall Study||4
394252|NCT01792830|964871|P2|STARTED|Overall Study||3
394253|NCT01792830|964872|P1|STARTED|Overall Study||84
394254|NCT01792817|964902|P3|NOT COMPLETED|Phase 2 Open Label||26
394255|NCT01792817|964903|P2|NOT COMPLETED|Phase 2 Open Label||0
394256|NCT01792817|964904|P1|NOT COMPLETED|Phase 2 Open Label||0
394257|NCT01792817|964902|P3|COMPLETED|Phase 2 Open Label||74
394258|NCT01792817|964903|P2|COMPLETED|Phase 2 Open Label||0
394259|NCT01792817|964904|P1|COMPLETED|Phase 2 Open Label||0
394260|NCT01792817|964902|P3|STARTED|Phase 2 Open Label||100
394261|NCT01792817|964903|P2|STARTED|Phase 2 Open Label||0
394262|NCT01792817|964904|P1|STARTED|Phase 2 Open Label||0
394263|NCT01792817|964902|P3|NOT COMPLETED|Phase 1 Double Blind Period||0
394264|NCT01792817|964903|P2|NOT COMPLETED|Phase 1 Double Blind Period||31
394265|NCT01792817|964904|P1|NOT COMPLETED|Phase 1 Double Blind Period||19
394266|NCT01792817|964902|P3|COMPLETED|Phase 1 Double Blind Period||0
394267|NCT01792817|964903|P2|COMPLETED|Phase 1 Double Blind Period||42
394268|NCT01792817|964904|P1|COMPLETED|Phase 1 Double Blind Period||58
394269|NCT01792817|964902|P3|STARTED|Phase 1 Double Blind Period||0
394270|NCT01792817|964903|P2|STARTED|Phase 1 Double Blind Period||73
394271|NCT01792817|964904|P1|STARTED|Phase 1 Double Blind Period||77
394272|NCT01792635|964920|P3|NOT COMPLETED|Part B||4
394273|NCT01792635|964921|P2|NOT COMPLETED|Part B||4
394274|NCT01792635|964922|P1|NOT COMPLETED|Part B||0
394275|NCT01792635|964920|P3|COMPLETED|Part B||3
394276|NCT01792635|964921|P2|COMPLETED|Part B||2
394277|NCT01792635|964922|P1|COMPLETED|Part B||0
394278|NCT01792635|964920|P3|STARTED|Part B||7
394279|NCT01792635|964921|P2|STARTED|Part B||6
394280|NCT01792635|964922|P1|STARTED|Part B||0
394281|NCT01792635|964920|P3|NOT COMPLETED|Part A||0
394282|NCT01792635|964921|P2|NOT COMPLETED|Part A||0
394283|NCT01792635|964922|P1|NOT COMPLETED|Part A||0
394284|NCT01792635|964920|P3|COMPLETED|Part A||0
394285|NCT01792635|964921|P2|COMPLETED|Part A||0
394286|NCT01792635|964922|P1|COMPLETED|Part A||6
394287|NCT01792635|964920|P3|STARTED|Part A||0
394288|NCT01792635|964921|P2|STARTED|Part A||0
394289|NCT01792635|964922|P1|STARTED|Part A||6
394290|NCT01792518|964950|P2|NOT COMPLETED|Overall Study||7
394291|NCT01792518|964951|P1|NOT COMPLETED|Overall Study||8
394292|NCT01792518|964950|P2|COMPLETED|Overall Study||175
394293|NCT01792518|964951|P1|COMPLETED|Overall Study||170
394294|NCT01792518|964950|P2|STARTED|Overall Study||182
394295|NCT01792518|964951|P1|STARTED|Overall Study||178
394296|NCT01792284|964961|P3|NOT COMPLETED|Randomization Period 2||0
394297|NCT01792284|964962|P2|NOT COMPLETED|Randomization Period 2||3
394298|NCT01792284|964963|P1|NOT COMPLETED|Randomization Period 2||0
394299|NCT01792284|964961|P3|COMPLETED|Randomization Period 2||85
394300|NCT01792284|964962|P2|COMPLETED|Randomization Period 2||87
394301|NCT01792284|964963|P1|COMPLETED|Randomization Period 2||0
394302|NCT01792284|964961|P3|Received at Least 1 Dose of Study Drug|Randomization Period 2||85
394303|NCT01792284|964962|P2|Received at Least 1 Dose of Study Drug|Randomization Period 2||90
394304|NCT01792284|964963|P1|Received at Least 1 Dose of Study Drug|Randomization Period 2||0
394305|NCT01792284|964961|P3|STARTED|Randomization Period 2||85
394306|NCT01792284|964962|P2|STARTED|Randomization Period 2||90
394307|NCT01792284|964963|P1|STARTED|Randomization Period 2||0
394308|NCT01792284|964961|P3|NOT COMPLETED|Randomization Period 1||5
394309|NCT01792284|964962|P2|NOT COMPLETED|Randomization Period 1||2
394310|NCT01792284|964963|P1|NOT COMPLETED|Randomization Period 1||0
394311|NCT01792284|964961|P3|COMPLETED|Randomization Period 1||85
394312|NCT01792284|964962|P2|COMPLETED|Randomization Period 1||90
394313|NCT01792284|964963|P1|COMPLETED|Randomization Period 1||0
394314|NCT01792284|964961|P3|Received at Least 1 Dose of Study Drug|Randomization Period 1||90
394315|NCT01792284|964962|P2|Received at Least 1 Dose of Study Drug|Randomization Period 1||92
394316|NCT01792284|964963|P1|Received at Least 1 Dose of Study Drug|Randomization Period 1||0
394317|NCT01792284|964961|P3|STARTED|Randomization Period 1||90
394318|NCT01792284|964962|P2|STARTED|Randomization Period 1||92
394319|NCT01792284|964963|P1|STARTED|Randomization Period 1||0
394320|NCT01792284|964961|P3|NOT COMPLETED|Lead-in Period||0
394321|NCT01792284|964962|P2|NOT COMPLETED|Lead-in Period||0
394322|NCT01792284|964963|P1|NOT COMPLETED|Lead-in Period||30
394323|NCT01792284|964961|P3|COMPLETED|Lead-in Period||0
394324|NCT01792284|964962|P2|COMPLETED|Lead-in Period||0
394325|NCT01792284|964963|P1|COMPLETED|Lead-in Period|Participants that completed the Lead-in Period were randomized and entered Randomization Period 1.|182
394326|NCT01792284|964961|P3|STARTED|Lead-in Period||0
394327|NCT01792284|964962|P2|STARTED|Lead-in Period||0
394328|NCT01792284|964963|P1|STARTED|Lead-in Period||212
394329|NCT01792024|965001|P1|NOT COMPLETED|Overall Study||0
394330|NCT01792024|965001|P1|COMPLETED|Overall Study||27
394331|NCT01792024|965001|P1|STARTED|Overall Study||27
394332|NCT01791972|965011|P2|NOT COMPLETED|Overall Study||0
394333|NCT01791972|965012|P1|NOT COMPLETED|Overall Study||0
394334|NCT01791972|965011|P2|COMPLETED|Overall Study||19
394335|NCT01791972|965012|P1|COMPLETED|Overall Study||19
394336|NCT01791972|965011|P2|STARTED|Overall Study||19
394337|NCT01791972|965012|P1|STARTED|Overall Study||19
394338|NCT01791894|965022|P1|NOT COMPLETED|Overall Study||1
394339|NCT01791894|965022|P1|COMPLETED|Overall Study||4
394340|NCT01791894|965022|P1|STARTED|Overall Study||5
394341|NCT01791803|965033|P4|NOT COMPLETED|Overall Study||5
394342|NCT01791803|965034|P3|NOT COMPLETED|Overall Study||2
394343|NCT01791803|965035|P2|NOT COMPLETED|Overall Study||2
394344|NCT01791803|965036|P1|NOT COMPLETED|Overall Study||0
394345|NCT01791803|965033|P4|COMPLETED|Overall Study||37
394346|NCT01791803|965034|P3|COMPLETED|Overall Study||38
394347|NCT01791803|965035|P2|COMPLETED|Overall Study||39
394348|NCT01791803|965036|P1|COMPLETED|Overall Study||41
394349|NCT01791803|965033|P4|STARTED|Overall Study||42
394350|NCT01791803|965034|P3|STARTED|Overall Study||40
394351|NCT01791803|965035|P2|STARTED|Overall Study||41
394352|NCT01791803|965036|P1|STARTED|Overall Study||41
394353|NCT01791725|965054|P3|NOT COMPLETED|Overall Study||0
394354|NCT01791725|965055|P2|NOT COMPLETED|Overall Study||1
394355|NCT01791725|965056|P1|NOT COMPLETED|Overall Study||0
394356|NCT01791725|965054|P3|COMPLETED|Overall Study||6
394357|NCT01791725|965055|P2|COMPLETED|Overall Study||4
394358|NCT01791725|965056|P1|COMPLETED|Overall Study||12
394359|NCT01791725|965054|P3|STARTED|Overall Study||6
394360|NCT01791725|965055|P2|STARTED|Overall Study||5
394361|NCT01791725|965056|P1|STARTED|Overall Study||12
394362|NCT01791517|965079|P12|NOT COMPLETED|Phase II||1
394363|NCT01791517|965080|P11|NOT COMPLETED|Phase II||1
394364|NCT01791517|965081|P10|NOT COMPLETED|Phase II||3
394365|NCT01791517|965082|P9|NOT COMPLETED|Phase II||2
394366|NCT01791517|965083|P8|NOT COMPLETED|Phase II||3
394367|NCT01791517|965084|P7|NOT COMPLETED|Phase II||2
394368|NCT01791517|965085|P6|NOT COMPLETED|Phase II||4
394369|NCT01791517|965086|P5|NOT COMPLETED|Phase II||2
394370|NCT01791517|965087|P4|NOT COMPLETED|Phase II||0
394371|NCT01791517|965088|P3|NOT COMPLETED|Phase II||1
394372|NCT01791517|965089|P2|NOT COMPLETED|Phase II||0
394373|NCT01791517|965090|P1|NOT COMPLETED|Phase II||2
394374|NCT01791517|965079|P12|COMPLETED|Phase II||17
394375|NCT01791517|965080|P11|COMPLETED|Phase II||15
394376|NCT01791517|965081|P10|COMPLETED|Phase II||15
394377|NCT01791517|965082|P9|COMPLETED|Phase II||17
394378|NCT01791517|965083|P8|COMPLETED|Phase II||17
394379|NCT01791517|965084|P7|COMPLETED|Phase II||17
394380|NCT01791517|965085|P6|COMPLETED|Phase II||14
394381|NCT01791517|965086|P5|COMPLETED|Phase II||16
394382|NCT01791517|965087|P4|COMPLETED|Phase II||15
394383|NCT01791517|965088|P3|COMPLETED|Phase II||15
394384|NCT01791517|965089|P2|COMPLETED|Phase II||14
394385|NCT01791517|965090|P1|COMPLETED|Phase II||15
394386|NCT01791517|965079|P12|STARTED|Phase II||18
394387|NCT01791517|965080|P11|STARTED|Phase II||16
394388|NCT01791517|965081|P10|STARTED|Phase II||18
394389|NCT01791517|965082|P9|STARTED|Phase II||19
394390|NCT01791517|965083|P8|STARTED|Phase II||20
394391|NCT01791517|965084|P7|STARTED|Phase II||19
394392|NCT01791517|965085|P6|STARTED|Phase II||18
394393|NCT01791517|965086|P5|STARTED|Phase II||18
394394|NCT01791517|965087|P4|STARTED|Phase II||15
394395|NCT01791517|965088|P3|STARTED|Phase II||16
394396|NCT01791517|965089|P2|STARTED|Phase II||14
394397|NCT01791517|965090|P1|STARTED|Phase II||17
394398|NCT01791517|965079|P12|NOT COMPLETED|Phase I: Period 4||0
394399|NCT01791517|965080|P11|NOT COMPLETED|Phase I: Period 4||0
394400|NCT01791517|965081|P10|NOT COMPLETED|Phase I: Period 4||0
394401|NCT01791517|965082|P9|NOT COMPLETED|Phase I: Period 4||0
394402|NCT01791517|965083|P8|NOT COMPLETED|Phase I: Period 4||0
394403|NCT01791517|965084|P7|NOT COMPLETED|Phase I: Period 4||0
394404|NCT01791517|965085|P6|NOT COMPLETED|Phase I: Period 4||0
394405|NCT01791517|965086|P5|NOT COMPLETED|Phase I: Period 4||0
394406|NCT01791517|965087|P4|NOT COMPLETED|Phase I: Period 4||0
394407|NCT01791517|965088|P3|NOT COMPLETED|Phase I: Period 4||0
394408|NCT01791517|965089|P2|NOT COMPLETED|Phase I: Period 4||0
394409|NCT01791517|965090|P1|NOT COMPLETED|Phase I: Period 4||0
394410|NCT01791517|965079|P12|COMPLETED|Phase I: Period 4||18
394411|NCT01791517|965080|P11|COMPLETED|Phase I: Period 4||16
394412|NCT01791517|965081|P10|COMPLETED|Phase I: Period 4||18
394413|NCT01791517|965082|P9|COMPLETED|Phase I: Period 4||19
394414|NCT01791517|965083|P8|COMPLETED|Phase I: Period 4||20
394415|NCT01791517|965084|P7|COMPLETED|Phase I: Period 4||19
394416|NCT01791517|965085|P6|COMPLETED|Phase I: Period 4||18
394417|NCT01791517|965086|P5|COMPLETED|Phase I: Period 4||18
394418|NCT01791517|965087|P4|COMPLETED|Phase I: Period 4||15
394419|NCT01791517|965088|P3|COMPLETED|Phase I: Period 4||16
394420|NCT01791517|965089|P2|COMPLETED|Phase I: Period 4||14
394421|NCT01791517|965090|P1|COMPLETED|Phase I: Period 4||17
394422|NCT01791517|965079|P12|STARTED|Phase I: Period 4||18
394423|NCT01791517|965080|P11|STARTED|Phase I: Period 4||16
394424|NCT01791517|965081|P10|STARTED|Phase I: Period 4||18
394425|NCT01791517|965082|P9|STARTED|Phase I: Period 4||19
394426|NCT01791517|965083|P8|STARTED|Phase I: Period 4||20
394427|NCT01791517|965084|P7|STARTED|Phase I: Period 4||19
394428|NCT01791517|965085|P6|STARTED|Phase I: Period 4||18
394429|NCT01791517|965086|P5|STARTED|Phase I: Period 4||18
394430|NCT01791517|965087|P4|STARTED|Phase I: Period 4||15
394431|NCT01791517|965088|P3|STARTED|Phase I: Period 4||16
394432|NCT01791517|965089|P2|STARTED|Phase I: Period 4||14
394433|NCT01791517|965090|P1|STARTED|Phase I: Period 4||17
394434|NCT01791517|965079|P12|NOT COMPLETED|Phase I: Period 3||1
394435|NCT01791517|965080|P11|NOT COMPLETED|Phase I: Period 3||0
394436|NCT01791517|965081|P10|NOT COMPLETED|Phase I: Period 3||0
394437|NCT01791517|965082|P9|NOT COMPLETED|Phase I: Period 3||0
394438|NCT01791517|965083|P8|NOT COMPLETED|Phase I: Period 3||0
394439|NCT01791517|965084|P7|NOT COMPLETED|Phase I: Period 3||0
394440|NCT01791517|965085|P6|NOT COMPLETED|Phase I: Period 3||0
394441|NCT01791517|965086|P5|NOT COMPLETED|Phase I: Period 3||1
394442|NCT01791517|965087|P4|NOT COMPLETED|Phase I: Period 3||1
394443|NCT01791517|965088|P3|NOT COMPLETED|Phase I: Period 3||0
394444|NCT01791517|965089|P2|NOT COMPLETED|Phase I: Period 3||1
394445|NCT01791517|965090|P1|NOT COMPLETED|Phase I: Period 3||0
394446|NCT01791517|965079|P12|COMPLETED|Phase I: Period 3||18
394447|NCT01791517|965080|P11|COMPLETED|Phase I: Period 3||16
394448|NCT01791517|965081|P10|COMPLETED|Phase I: Period 3||18
394449|NCT01791517|965082|P9|COMPLETED|Phase I: Period 3||19
394450|NCT01791517|965083|P8|COMPLETED|Phase I: Period 3||20
394451|NCT01791517|965084|P7|COMPLETED|Phase I: Period 3||19
394452|NCT01791517|965085|P6|COMPLETED|Phase I: Period 3||18
394453|NCT01791517|965086|P5|COMPLETED|Phase I: Period 3||18
394454|NCT01791517|965087|P4|COMPLETED|Phase I: Period 3||15
394455|NCT01791517|965088|P3|COMPLETED|Phase I: Period 3||16
394456|NCT01791517|965089|P2|COMPLETED|Phase I: Period 3||14
394457|NCT01791517|965090|P1|COMPLETED|Phase I: Period 3||17
394458|NCT01791517|965079|P12|STARTED|Phase I: Period 3||19
394459|NCT01791517|965080|P11|STARTED|Phase I: Period 3||16
394460|NCT01791517|965081|P10|STARTED|Phase I: Period 3||18
394461|NCT01791517|965082|P9|STARTED|Phase I: Period 3||19
394462|NCT01791517|965083|P8|STARTED|Phase I: Period 3||20
394463|NCT01791517|965084|P7|STARTED|Phase I: Period 3||19
394464|NCT01791517|965085|P6|STARTED|Phase I: Period 3||18
394465|NCT01791517|965086|P5|STARTED|Phase I: Period 3||19
394466|NCT01791517|965087|P4|STARTED|Phase I: Period 3||16
394467|NCT01791517|965088|P3|STARTED|Phase I: Period 3||16
394468|NCT01791517|965089|P2|STARTED|Phase I: Period 3||15
394469|NCT01791517|965090|P1|STARTED|Phase I: Period 3||17
394470|NCT01791517|965079|P12|NOT COMPLETED|Phase I: Period 2||0
394471|NCT01791517|965080|P11|NOT COMPLETED|Phase I: Period 2||2
394472|NCT01791517|965081|P10|NOT COMPLETED|Phase I: Period 2||1
394473|NCT01791517|965082|P9|NOT COMPLETED|Phase I: Period 2||0
394474|NCT01791517|965083|P8|NOT COMPLETED|Phase I: Period 2||0
394475|NCT01791517|965084|P7|NOT COMPLETED|Phase I: Period 2||0
394476|NCT01791517|965085|P6|NOT COMPLETED|Phase I: Period 2||1
394477|NCT01791517|965086|P5|NOT COMPLETED|Phase I: Period 2||0
394478|NCT01791517|965087|P4|NOT COMPLETED|Phase I: Period 2||1
394479|NCT01791517|965088|P3|NOT COMPLETED|Phase I: Period 2||2
394480|NCT01791517|965089|P2|NOT COMPLETED|Phase I: Period 2||3
394481|NCT01791517|965090|P1|NOT COMPLETED|Phase I: Period 2||1
394482|NCT01791517|965079|P12|COMPLETED|Phase I: Period 2||19
394483|NCT01791517|965080|P11|COMPLETED|Phase I: Period 2||16
394484|NCT01791517|965081|P10|COMPLETED|Phase I: Period 2||18
394485|NCT01791517|965082|P9|COMPLETED|Phase I: Period 2||19
394486|NCT01791517|965083|P8|COMPLETED|Phase I: Period 2||20
394487|NCT01791517|965084|P7|COMPLETED|Phase I: Period 2||19
394488|NCT01791517|965085|P6|COMPLETED|Phase I: Period 2||18
394489|NCT01791517|965086|P5|COMPLETED|Phase I: Period 2||19
394490|NCT01791517|965087|P4|COMPLETED|Phase I: Period 2||16
394491|NCT01791517|965088|P3|COMPLETED|Phase I: Period 2||16
394492|NCT01791517|965089|P2|COMPLETED|Phase I: Period 2||15
394493|NCT01791517|965090|P1|COMPLETED|Phase I: Period 2||17
394494|NCT01791517|965079|P12|STARTED|Phase I: Period 2||19
394495|NCT01791517|965080|P11|STARTED|Phase I: Period 2||18
394496|NCT01791517|965081|P10|STARTED|Phase I: Period 2||19
394497|NCT01791517|965082|P9|STARTED|Phase I: Period 2||19
394498|NCT01791517|965083|P8|STARTED|Phase I: Period 2||20
394499|NCT01791517|965084|P7|STARTED|Phase I: Period 2||19
394500|NCT01791517|965085|P6|STARTED|Phase I: Period 2||19
394501|NCT01791517|965086|P5|STARTED|Phase I: Period 2||19
394502|NCT01791517|965087|P4|STARTED|Phase I: Period 2||17
394503|NCT01791517|965088|P3|STARTED|Phase I: Period 2||18
394504|NCT01791517|965089|P2|STARTED|Phase I: Period 2||18
394505|NCT01791517|965090|P1|STARTED|Phase I: Period 2||18
394506|NCT01791517|965079|P12|NOT COMPLETED|Phase I: Period 1||1
394507|NCT01791517|965080|P11|NOT COMPLETED|Phase I: Period 1||0
394508|NCT01791517|965081|P10|NOT COMPLETED|Phase I: Period 1||1
394509|NCT01791517|965082|P9|NOT COMPLETED|Phase I: Period 1||1
394510|NCT01791517|965083|P8|NOT COMPLETED|Phase I: Period 1||0
394511|NCT01791517|965084|P7|NOT COMPLETED|Phase I: Period 1||1
394512|NCT01791517|965085|P6|NOT COMPLETED|Phase I: Period 1||1
394513|NCT01791517|965086|P5|NOT COMPLETED|Phase I: Period 1||1
394514|NCT01791517|965087|P4|NOT COMPLETED|Phase I: Period 1||2
394515|NCT01791517|965088|P3|NOT COMPLETED|Phase I: Period 1||2
394516|NCT01791517|965089|P2|NOT COMPLETED|Phase I: Period 1||2
394517|NCT01791517|965090|P1|NOT COMPLETED|Phase I: Period 1||1
394518|NCT01791517|965079|P12|COMPLETED|Phase I: Period 1||19
394519|NCT01791517|965080|P11|COMPLETED|Phase I: Period 1||18
394520|NCT01791517|965081|P10|COMPLETED|Phase I: Period 1||19
394521|NCT01791517|965082|P9|COMPLETED|Phase I: Period 1||19
394522|NCT01791517|965083|P8|COMPLETED|Phase I: Period 1||20
394523|NCT01791517|965084|P7|COMPLETED|Phase I: Period 1||19
394524|NCT01791517|965085|P6|COMPLETED|Phase I: Period 1||19
394525|NCT01791517|965086|P5|COMPLETED|Phase I: Period 1||19
394526|NCT01791517|965087|P4|COMPLETED|Phase I: Period 1||17
394527|NCT01791517|965088|P3|COMPLETED|Phase I: Period 1||18
394528|NCT01791517|965089|P2|COMPLETED|Phase I: Period 1||18
394529|NCT01791517|965090|P1|COMPLETED|Phase I: Period 1||18
394530|NCT01791517|965079|P12|STARTED|Phase I: Period 1||20
394531|NCT01791517|965080|P11|STARTED|Phase I: Period 1||18
394532|NCT01791517|965081|P10|STARTED|Phase I: Period 1||20
394533|NCT01791517|965082|P9|STARTED|Phase I: Period 1||20
394534|NCT01791517|965083|P8|STARTED|Phase I: Period 1||20
394535|NCT01791517|965084|P7|STARTED|Phase I: Period 1||20
394536|NCT01791517|965085|P6|STARTED|Phase I: Period 1||20
394537|NCT01791517|965086|P5|STARTED|Phase I: Period 1||20
394538|NCT01791517|965087|P4|STARTED|Phase I: Period 1||19
394539|NCT01791517|965088|P3|STARTED|Phase I: Period 1||20
394540|NCT01791517|965089|P2|STARTED|Phase I: Period 1||20
394541|NCT01791517|965090|P1|STARTED|Phase I: Period 1||19
394542|NCT01791491|965116|P1|NOT COMPLETED|Overall Study||0
394543|NCT01791491|965116|P1|COMPLETED|Overall Study||9
394544|NCT01791491|965116|P1|STARTED|Overall Study|Reasons for enrollment and non-treatment: 1 withdrew consent and 6 no longer met study criteria.|9
394545|NCT01791465|965128|P1|NOT COMPLETED|Overall Study||0
394546|NCT01791465|965128|P1|COMPLETED|Overall Study||6
394547|NCT01791465|965128|P1|STARTED|Overall Study||6
394548|NCT01791413|965154|P2|NOT COMPLETED|Overall Study||1
394549|NCT01791413|965155|P1|NOT COMPLETED|Overall Study||5
394550|NCT01791413|965154|P2|COMPLETED|Overall Study||19
394551|NCT01791413|965155|P1|COMPLETED|Overall Study||15
394552|NCT01791413|965154|P2|STARTED|Overall Study||20
394553|NCT01791413|965155|P1|STARTED|Overall Study||20
394554|NCT01791244|965164|P2|NOT COMPLETED|Overall Study||18
394555|NCT01791244|965165|P1|NOT COMPLETED|Overall Study||15
394556|NCT01791244|965164|P2|COMPLETED|Overall Study||29
394557|NCT01791244|965165|P1|COMPLETED|Overall Study||31
394558|NCT01791244|965164|P2|Intent to Treat (ITT)|Overall Study||39
394559|NCT01791244|965165|P1|Intent to Treat (ITT)|Overall Study||38
394560|NCT01791244|965164|P2|STARTED|Overall Study||47
394561|NCT01791244|965165|P1|STARTED|Overall Study||46
394562|NCT01791205|965201|P2|NOT COMPLETED|Phase II||0
394563|NCT01791205|965202|P1|NOT COMPLETED|Phase II||12
394564|NCT01791205|965201|P2|COMPLETED|Phase II||0
394565|NCT01791205|965202|P1|COMPLETED|Phase II||92
394566|NCT01791205|965201|P2|STARTED|Phase II||0
394567|NCT01791205|965202|P1|STARTED|Phase II|Participants who received tocilizumab monotherapy in Phase I was observed in Phase II.|104
394568|NCT01791205|965201|P2|NOT COMPLETED|Phase I||0
394569|NCT01791205|965202|P1|NOT COMPLETED|Phase I||0
394570|NCT01791205|965201|P2|COMPLETED|Phase I||152
394571|NCT01791205|965202|P1|COMPLETED|Phase I||152
394572|NCT01791205|965201|P2|STARTED|Phase I||152
394573|NCT01791205|965202|P1|STARTED|Phase I||152
394574|NCT01791153|965286|P4|NOT COMPLETED|Overall Study||5
394575|NCT01791153|965287|P3|NOT COMPLETED|Overall Study||6
394576|NCT01791153|965288|P2|NOT COMPLETED|Overall Study||8
394577|NCT01791153|965289|P1|NOT COMPLETED|Overall Study||15
394578|NCT01791153|965286|P4|COMPLETED|Overall Study|Completed Study to Week 52|46
394579|NCT01791153|965287|P3|COMPLETED|Overall Study|Completed Study to Week 52|44
394580|NCT01791153|965288|P2|COMPLETED|Overall Study|Completed Study to Week 52|41
394581|NCT01791153|965289|P1|COMPLETED|Overall Study|Completed Study to Week 52|85
394582|NCT01791153|965286|P4|STARTED|Overall Study||51
394583|NCT01791153|965287|P3|STARTED|Overall Study||50
394584|NCT01791153|965288|P2|STARTED|Overall Study||49
394585|NCT01791153|965289|P1|STARTED|Overall Study||100
394586|NCT01790828|965345|P1|NOT COMPLETED|Overall Study||34
394587|NCT01790828|965345|P1|COMPLETED|Overall Study||8
394588|NCT01790828|965345|P1|STARTED|Overall Study||42
394589|NCT01790750|965368|P1|NOT COMPLETED|Overall Study||0
394590|NCT01790750|965368|P1|COMPLETED|Overall Study||50
394591|NCT01790750|965368|P1|STARTED|Overall Study||50
394592|NCT01790685|965375|P2|NOT COMPLETED|Overall Study||0
394593|NCT01790685|965376|P1|NOT COMPLETED|Overall Study||0
394594|NCT01790685|965375|P2|COMPLETED|Overall Study||17
394595|NCT01790685|965376|P1|COMPLETED|Overall Study||23
394596|NCT01790685|965375|P2|STARTED|Overall Study||17
394597|NCT01790685|965376|P1|STARTED|Overall Study||23
394598|NCT01790659|965384|P2|NOT COMPLETED|Overall Study||6
394599|NCT01790659|965385|P1|NOT COMPLETED|Overall Study||6
394600|NCT01790659|965384|P2|COMPLETED|Overall Study||192
394601|NCT01790659|965385|P1|COMPLETED|Overall Study||195
394602|NCT01790659|965384|P2|STARTED|Overall Study||198
394603|NCT01790659|965385|P1|STARTED|Overall Study||201
394604|NCT01790633|965403|P2|NOT COMPLETED|Overall Study||5
394605|NCT01790633|965404|P1|NOT COMPLETED|Overall Study||48
394606|NCT01790633|965403|P2|COMPLETED|Overall Study||159
394607|NCT01790633|965404|P1|COMPLETED|Overall Study||115
394608|NCT01790633|965403|P2|STARTED|Overall Study||164
394609|NCT01790633|965404|P1|STARTED|Overall Study||163
394610|NCT01790594|965417|P3|NOT COMPLETED|Overall Study||3
394611|NCT01790594|965418|P2|NOT COMPLETED|Overall Study||3
394612|NCT01790594|965419|P1|NOT COMPLETED|Overall Study||5
394613|NCT01790594|965417|P3|COMPLETED|Overall Study||0
394614|NCT01790594|965418|P2|COMPLETED|Overall Study||18
394615|NCT01790594|965419|P1|COMPLETED|Overall Study||17
394616|NCT01790594|965417|P3|STARTED|Overall Study||3
394617|NCT01790594|965418|P2|STARTED|Overall Study||21
394618|NCT01790594|965419|P1|STARTED|Overall Study||22
394619|NCT01790581|965487|P2|NOT COMPLETED|Overall Study||0
394620|NCT01790581|965488|P1|NOT COMPLETED|Overall Study||0
394621|NCT01790581|965487|P2|COMPLETED|Overall Study||12
394622|NCT01790581|965488|P1|COMPLETED|Overall Study||12
394623|NCT01790581|965487|P2|STARTED|Overall Study||12
394624|NCT01790581|965488|P1|STARTED|Overall Study||12
394625|NCT01790568|965496|P2|NOT COMPLETED|Overall Study||1
394626|NCT01790568|965497|P1|NOT COMPLETED|Overall Study||0
394627|NCT01790568|965496|P2|COMPLETED|Overall Study||25
394628|NCT01790568|965497|P1|COMPLETED|Overall Study||12
394629|NCT01790568|965496|P2|STARTED|Overall Study||26
394630|NCT01790568|965497|P1|STARTED|Overall Study||12
394631|NCT01790516|965505|P2|NOT COMPLETED|Overall Study||0
394632|NCT01790516|965506|P1|NOT COMPLETED|Overall Study||1
394633|NCT01790516|965505|P2|COMPLETED|Overall Study||1
394634|NCT01790516|965506|P1|COMPLETED|Overall Study||0
394635|NCT01790516|965505|P2|STARTED|Overall Study||1
394636|NCT01790516|965506|P1|STARTED|Overall Study||1
394637|NCT01790490|965515|P3|NOT COMPLETED|Overall Study||0
394638|NCT01790490|965516|P2|NOT COMPLETED|Overall Study||0
394639|NCT01790490|965517|P1|NOT COMPLETED|Overall Study||0
394640|NCT01790490|965515|P3|COMPLETED|Overall Study||2
394641|NCT01790490|965516|P2|COMPLETED|Overall Study||3
394642|NCT01790490|965517|P1|COMPLETED|Overall Study||3
394643|NCT01790490|965515|P3|STARTED|Overall Study||2
394644|NCT01790490|965516|P2|STARTED|Overall Study||3
394645|NCT01790490|965517|P1|STARTED|Overall Study||3
394646|NCT01790438|965530|P2|NOT COMPLETED|Overall Study||11
394647|NCT01790438|965531|P1|NOT COMPLETED|Overall Study||35
394648|NCT01790438|965530|P2|COMPLETED|Overall Study||202
394649|NCT01790438|965531|P1|COMPLETED|Overall Study||393
394650|NCT01790438|965530|P2|Received at Least One Dose of Study Drug|Overall Study||212
394651|NCT01790438|965531|P1|Received at Least One Dose of Study Drug|Overall Study||427
394652|NCT01790438|965530|P2|STARTED|Overall Study||213
394653|NCT01790438|965531|P1|STARTED|Overall Study||428
394654|NCT01790178|965583|P2|NOT COMPLETED|Overall Study||0
394655|NCT01790178|965584|P1|NOT COMPLETED|Overall Study||0
394656|NCT01790178|965583|P2|COMPLETED|Overall Study||24
394657|NCT01790178|965584|P1|COMPLETED|Overall Study||16
394658|NCT01790178|965583|P2|STARTED|Overall Study||24
394659|NCT01790178|965584|P1|STARTED|Overall Study||16
394660|NCT01789970|965600|P3|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||44
394661|NCT01789970|965601|P2|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||50
394662|NCT01789970|965602|P1|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||0
394663|NCT01789970|965600|P3|COMPLETED|Double-blind Treatment Period (12 Weeks)||147
394664|NCT01789970|965601|P2|COMPLETED|Double-blind Treatment Period (12 Weeks)||130
394665|NCT01789970|965602|P1|COMPLETED|Double-blind Treatment Period (12 Weeks)||0
394666|NCT01789970|965600|P3|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||191
394667|NCT01789970|965601|P2|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)|One participant was randomized but not treated.|179
394668|NCT01789970|965602|P1|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||0
394669|NCT01789970|965600|P3|STARTED|Double-blind Treatment Period (12 Weeks)||191
394670|NCT01789970|965601|P2|STARTED|Double-blind Treatment Period (12 Weeks)||180
394671|NCT01789970|965602|P1|STARTED|Double-blind Treatment Period (12 Weeks)||0
394672|NCT01789970|965600|P3|NOT COMPLETED|Open-label Titration Period||0
394673|NCT01789970|965601|P2|NOT COMPLETED|Open-label Titration Period||0
394674|NCT01789970|965602|P1|NOT COMPLETED|Open-label Titration Period||254
394675|NCT01789970|965600|P3|COMPLETED|Open-label Titration Period||0
394676|NCT01789970|965601|P2|COMPLETED|Open-label Titration Period||0
394677|NCT01789970|965602|P1|COMPLETED|Open-label Titration Period||371
394678|NCT01789970|965600|P3|Safety Analysis Set|Open-label Titration Period||0
394679|NCT01789970|965601|P2|Safety Analysis Set|Open-label Titration Period||0
394680|NCT01789970|965602|P1|Safety Analysis Set|Open-label Titration Period|Two enrolled patients were not treated|623
394681|NCT01789970|965600|P3|STARTED|Open-label Titration Period||0
394682|NCT01789970|965601|P2|STARTED|Open-label Titration Period||0
394683|NCT01789970|965602|P1|STARTED|Open-label Titration Period||625
394684|NCT01789814|965636|P2|NOT COMPLETED|Overall Study||0
394685|NCT01789814|965637|P1|NOT COMPLETED|Overall Study||0
394686|NCT01789814|965636|P2|COMPLETED|Overall Study||12
394687|NCT01789814|965637|P1|COMPLETED|Overall Study||12
394688|NCT01789814|965636|P2|STARTED|Overall Study||12
394689|NCT01789814|965637|P1|STARTED|Overall Study||12
394690|NCT01789775|965645|P2|NOT COMPLETED|Overall Study||7
394691|NCT01789775|965646|P1|NOT COMPLETED|Overall Study||2
394692|NCT01789775|965645|P2|COMPLETED|Overall Study||50
394693|NCT01789775|965646|P1|COMPLETED|Overall Study||53
394694|NCT01789775|965645|P2|STARTED|Overall Study||57
394695|NCT01789775|965646|P1|STARTED|Overall Study||55
394696|NCT01789606|965654|P2|NOT COMPLETED|Overall Study||450
394697|NCT01789606|965655|P1|NOT COMPLETED|Overall Study||23
394698|NCT01789606|965654|P2|COMPLETED|Overall Study||382
394699|NCT01789606|965655|P1|COMPLETED|Overall Study||228
394700|NCT01789606|965654|P2|STARTED|Overall Study||832
394701|NCT01789606|965655|P1|STARTED|Overall Study||251
394702|NCT01789476|965675|P2|NOT COMPLETED|Overall Study||2
394703|NCT01789476|965676|P1|NOT COMPLETED|Overall Study||8
394704|NCT01789476|965675|P2|COMPLETED|Overall Study||15
394705|NCT01789476|965676|P1|COMPLETED|Overall Study||26
394706|NCT01789476|965675|P2|STARTED|Overall Study||17
394707|NCT01789476|965676|P1|STARTED|Overall Study||34
394708|NCT01789255|965686|P1|NOT COMPLETED|Overall Study||0
394709|NCT01789255|965686|P1|COMPLETED|Overall Study||12
394710|NCT01789255|965686|P1|STARTED|Overall Study||12
394711|NCT01789138|965693|P2|NOT COMPLETED|Overall Study||52
394712|NCT01789138|965694|P1|NOT COMPLETED|Overall Study||41
394713|NCT01789138|965693|P2|COMPLETED|Overall Study||206
394714|NCT01789138|965694|P1|COMPLETED|Overall Study||213
394715|NCT01789138|965693|P2|STARTED|Overall Study||258
394716|NCT01789138|965694|P1|STARTED|Overall Study||254
394717|NCT01788943|965704|P2|NOT COMPLETED|Overall Study||0
394718|NCT01788943|965705|P1|NOT COMPLETED|Overall Study||1
394719|NCT01788943|965704|P2|COMPLETED|Overall Study||12
394720|NCT01788943|965705|P1|COMPLETED|Overall Study|2FA-PET Brain Image Analysis Completion Date|12
394721|NCT01788943|965704|P2|STARTED|Overall Study||12
394722|NCT01788943|965705|P1|STARTED|Overall Study|Recruitment for study began.|13
394723|NCT01788631|965715|P2|NOT COMPLETED|Overall Study||1
394724|NCT01788631|965716|P1|NOT COMPLETED|Overall Study||3
394725|NCT01788631|965715|P2|COMPLETED|Overall Study||43
394726|NCT01788631|965716|P1|COMPLETED|Overall Study||49
394727|NCT01788631|965715|P2|Randomized|Overall Study||47
394728|NCT01788631|965716|P1|Randomized|Overall Study||53
394729|NCT01788631|965715|P2|STARTED|Overall Study||44
394730|NCT01788631|965716|P1|STARTED|Overall Study||52
394731|NCT01788566|965734|P1|NOT COMPLETED|Overall Study||8
394732|NCT01788566|965734|P1|COMPLETED|Overall Study||53
394733|NCT01788566|965734|P1|STARTED|Overall Study||61
394734|NCT01788358|965744|P1|NOT COMPLETED|Overall Study||98
394735|NCT01788358|965744|P1|COMPLETED|Overall Study|217 subjects completed the study at Week 28 while the remaining 193 subjects completed at Week 52|410
394736|NCT01788358|965744|P1|Completed Week 52|Overall Study||193
394737|NCT01788358|965744|P1|Entered Extension to Week 52|Overall Study|Only the first 200 subjects who completed Week 28 visit, continued treatment up to 52 weeks.|200
394738|NCT01788358|965744|P1|Completed Week 28|Overall Study||417
394739|NCT01788358|965744|P1|Treated|Overall Study||508
394740|NCT01788358|965744|P1|STARTED|Overall Study||508
394741|NCT01788228|965758|P2|NOT COMPLETED|Overall Study||0
394742|NCT01788228|965759|P1|NOT COMPLETED|Overall Study||1
394743|NCT01788228|965758|P2|COMPLETED|Overall Study||1
394744|NCT01788228|965759|P1|COMPLETED|Overall Study||48
394745|NCT01788228|965758|P2|STARTED|Overall Study||1
394746|NCT01788228|965759|P1|STARTED|Overall Study||49
394747|NCT01788215|965778|P2|NOT COMPLETED|Overall Study||1
394748|NCT01788215|965779|P1|NOT COMPLETED|Overall Study||2
394749|NCT01788215|965778|P2|COMPLETED|Overall Study||4
394750|NCT01788215|965779|P1|COMPLETED|Overall Study||3
394751|NCT01788215|965778|P2|12 Weeks of Doxycycline or Placebo|Overall Study||5
394752|NCT01788215|965779|P1|12 Weeks of Doxycycline or Placebo|Overall Study||5
394753|NCT01788215|965778|P2|STARTED|Overall Study||5
394754|NCT01788215|965779|P1|STARTED|Overall Study||5
394755|NCT01788163|965808|P9|NOT COMPLETED|Overall Study||16
394756|NCT01788163|965809|P8|NOT COMPLETED|Overall Study||48
394757|NCT01788163|965810|P7|NOT COMPLETED|Overall Study||1
394758|NCT01788163|965811|P6|NOT COMPLETED|Overall Study||7
394759|NCT01788163|965812|P5|NOT COMPLETED|Overall Study||0
394760|NCT01788163|965813|P4|NOT COMPLETED|Overall Study||0
394761|NCT01788163|965814|P3|NOT COMPLETED|Overall Study||0
394762|NCT01788163|965815|P2|NOT COMPLETED|Overall Study||0
394763|NCT01788163|965816|P1|NOT COMPLETED|Overall Study||55
394764|NCT01788163|965808|P9|COMPLETED|Overall Study||956
394765|NCT01788163|965809|P8|COMPLETED|Overall Study||254
394766|NCT01788163|965810|P7|COMPLETED|Overall Study||49
394767|NCT01788163|965811|P6|COMPLETED|Overall Study||95
394768|NCT01788163|965812|P5|COMPLETED|Overall Study||94
394769|NCT01788163|965813|P4|COMPLETED|Overall Study||71
394770|NCT01788163|965814|P3|COMPLETED|Overall Study||62
394771|NCT01788163|965815|P2|COMPLETED|Overall Study||271
394772|NCT01788163|965816|P1|COMPLETED|Overall Study||1403
394773|NCT01788163|965808|P9|STARTED|Overall Study||972
394774|NCT01788163|965809|P8|STARTED|Overall Study||302
394775|NCT01788163|965810|P7|STARTED|Overall Study||50
394776|NCT01788163|965811|P6|STARTED|Overall Study||102
394777|NCT01788163|965812|P5|STARTED|Overall Study||94
394778|NCT01788163|965813|P4|STARTED|Overall Study||71
394779|NCT01788163|965814|P3|STARTED|Overall Study||62
394780|NCT01788163|965815|P2|STARTED|Overall Study||271
394781|NCT01788163|965816|P1|STARTED|Overall Study||1458
394782|NCT01788046|965979|P2|NOT COMPLETED|Overall Study||37
394783|NCT01788046|965980|P1|NOT COMPLETED|Overall Study||56
394784|NCT01788046|965979|P2|COMPLETED|Overall Study||218
394785|NCT01788046|965980|P1|COMPLETED|Overall Study||204
394786|NCT01788046|965979|P2|Received Treatment|Overall Study||252
394787|NCT01788046|965980|P1|Received Treatment|Overall Study||259
394788|NCT01788046|965979|P2|STARTED|Overall Study||255
394789|NCT01788046|965980|P1|STARTED|Overall Study||260
394790|NCT01787916|965996|P2|NOT COMPLETED|Second Intervention (24 Weeks)||0
394791|NCT01787916|965997|P1|NOT COMPLETED|Second Intervention (24 Weeks)||0
394792|NCT01787916|965996|P2|COMPLETED|Second Intervention (24 Weeks)||7
394793|NCT01787916|965997|P1|COMPLETED|Second Intervention (24 Weeks)||8
394794|NCT01787916|965996|P2|STARTED|Second Intervention (24 Weeks)||7
394795|NCT01787916|965997|P1|STARTED|Second Intervention (24 Weeks)||8
394796|NCT01787916|965996|P2|NOT COMPLETED|Washout (4 Weeks)||0
394797|NCT01787916|965997|P1|NOT COMPLETED|Washout (4 Weeks)||0
394798|NCT01787916|965996|P2|COMPLETED|Washout (4 Weeks)||7
394799|NCT01787916|965997|P1|COMPLETED|Washout (4 Weeks)||8
394800|NCT01787916|965996|P2|STARTED|Washout (4 Weeks)||7
394801|NCT01787916|965997|P1|STARTED|Washout (4 Weeks)||8
394802|NCT01787916|965996|P2|NOT COMPLETED|First Intervention (24 Weeks)||0
394803|NCT01787916|965997|P1|NOT COMPLETED|First Intervention (24 Weeks)||0
394804|NCT01787916|965996|P2|COMPLETED|First Intervention (24 Weeks)||7
394805|NCT01787916|965997|P1|COMPLETED|First Intervention (24 Weeks)||8
394806|NCT01787916|965996|P2|STARTED|First Intervention (24 Weeks)||7
394807|NCT01787916|965997|P1|STARTED|First Intervention (24 Weeks)||8
394808|NCT01787838|966003|P1|NOT COMPLETED|Overall Study||1413
394809|NCT01787838|966003|P1|COMPLETED|Overall Study|This is the number of patients successfully immunized in a one year period.|1096
394810|NCT01787838|966003|P1|STARTED|Overall Study|This is the number who met Centers for Disease Control and Prevention guidelines for vaccine.|2509
394811|NCT01787825|966007|P2|NOT COMPLETED|Overall Study||1
394812|NCT01787825|966008|P1|NOT COMPLETED|Overall Study||6
394813|NCT01787825|966007|P2|COMPLETED|Overall Study||60
394814|NCT01787825|966008|P1|COMPLETED|Overall Study||54
394815|NCT01787825|966007|P2|STARTED|Overall Study||61
394816|NCT01787825|966008|P1|STARTED|Overall Study||60
394817|NCT01787799|966019|P1|NOT COMPLETED|Overall Study||0
394818|NCT01787799|966019|P1|COMPLETED|Overall Study||100
394819|NCT01787799|966019|P1|STARTED|Overall Study||100
394820|NCT01787760|966026|P3|NOT COMPLETED|Overall Study||5
394821|NCT01787760|966027|P2|NOT COMPLETED|Overall Study||16
394822|NCT01787760|966028|P1|NOT COMPLETED|Overall Study||26
394823|NCT01787760|966026|P3|COMPLETED|Overall Study||46
394824|NCT01787760|966027|P2|COMPLETED|Overall Study||34
394825|NCT01787760|966028|P1|COMPLETED|Overall Study||25
394826|NCT01787760|966026|P3|STARTED|Overall Study||51
394827|NCT01787760|966027|P2|STARTED|Overall Study||50
394828|NCT01787760|966028|P1|STARTED|Overall Study||51
394829|NCT01787591|966042|P4|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
394830|NCT01787591|966043|P3|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
394831|NCT01787591|966044|P2|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
394832|NCT01787591|966045|P1|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
394833|NCT01787591|966042|P4|COMPLETED|Period 4 (Cross-over Arm 4)||5
394834|NCT01787591|966043|P3|COMPLETED|Period 4 (Cross-over Arm 4)||5
394835|NCT01787591|966044|P2|COMPLETED|Period 4 (Cross-over Arm 4)||5
394836|NCT01787591|966045|P1|COMPLETED|Period 4 (Cross-over Arm 4)||5
394837|NCT01787591|966042|P4|STARTED|Period 4 (Cross-over Arm 4)||5
394838|NCT01787591|966043|P3|STARTED|Period 4 (Cross-over Arm 4)||5
394839|NCT01787591|966044|P2|STARTED|Period 4 (Cross-over Arm 4)||5
394840|NCT01787591|966045|P1|STARTED|Period 4 (Cross-over Arm 4)||5
394841|NCT01787591|966042|P4|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
394842|NCT01787591|966043|P3|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
394843|NCT01787591|966044|P2|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
394844|NCT01787591|966045|P1|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
394845|NCT01787591|966042|P4|COMPLETED|Period 3 (Cross-over Arm 3)||5
394846|NCT01787591|966043|P3|COMPLETED|Period 3 (Cross-over Arm 3)||5
394847|NCT01787591|966044|P2|COMPLETED|Period 3 (Cross-over Arm 3)||5
394848|NCT01787591|966045|P1|COMPLETED|Period 3 (Cross-over Arm 3)||5
394849|NCT01787591|966042|P4|STARTED|Period 3 (Cross-over Arm 3)||5
394850|NCT01787591|966043|P3|STARTED|Period 3 (Cross-over Arm 3)||5
394851|NCT01787591|966044|P2|STARTED|Period 3 (Cross-over Arm 3)||5
394852|NCT01787591|966045|P1|STARTED|Period 3 (Cross-over Arm 3)||5
394853|NCT01787591|966042|P4|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
394854|NCT01787591|966043|P3|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
394855|NCT01787591|966044|P2|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
394856|NCT01787591|966045|P1|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
394857|NCT01787591|966042|P4|COMPLETED|Period 2 (Cross-over Arm 2)||5
394858|NCT01787591|966043|P3|COMPLETED|Period 2 (Cross-over Arm 2)||5
394859|NCT01787591|966044|P2|COMPLETED|Period 2 (Cross-over Arm 2)||5
394860|NCT01787591|966045|P1|COMPLETED|Period 2 (Cross-over Arm 2)||5
394861|NCT01787591|966042|P4|STARTED|Period 2 (Cross-over Arm 2)||5
394862|NCT01787591|966043|P3|STARTED|Period 2 (Cross-over Arm 2)||5
394863|NCT01787591|966044|P2|STARTED|Period 2 (Cross-over Arm 2)||5
394864|NCT01787591|966045|P1|STARTED|Period 2 (Cross-over Arm 2)||5
394865|NCT01787591|966042|P4|NOT COMPLETED|Period 1 (Cross-over Arm 1)||1
394866|NCT01787591|966043|P3|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
394867|NCT01787591|966044|P2|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
394868|NCT01787591|966045|P1|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
394869|NCT01787591|966042|P4|COMPLETED|Period 1 (Cross-over Arm 1)||5
394870|NCT01787591|966043|P3|COMPLETED|Period 1 (Cross-over Arm 1)||5
394871|NCT01787591|966044|P2|COMPLETED|Period 1 (Cross-over Arm 1)||5
394872|NCT01787591|966045|P1|COMPLETED|Period 1 (Cross-over Arm 1)||5
394873|NCT01787591|966042|P4|STARTED|Period 1 (Cross-over Arm 1)||6
394874|NCT01787591|966043|P3|STARTED|Period 1 (Cross-over Arm 1)||5
394875|NCT01787591|966044|P2|STARTED|Period 1 (Cross-over Arm 1)||5
394876|NCT01787591|966045|P1|STARTED|Period 1 (Cross-over Arm 1)||5
394877|NCT01787461|966073|P2|NOT COMPLETED|Overall Study||9
394878|NCT01787461|966074|P1|NOT COMPLETED|Overall Study||14
394879|NCT01787461|966073|P2|COMPLETED|Overall Study||89
394880|NCT01787461|966074|P1|COMPLETED|Overall Study||82
394881|NCT01787461|966073|P2|STARTED|Overall Study||98
394882|NCT01787461|966074|P1|STARTED|Overall Study||96
394883|NCT01787383|966102|P2|NOT COMPLETED|Overall Study||22
394884|NCT01787383|966103|P1|NOT COMPLETED|Overall Study||9
394885|NCT01787383|966102|P2|COMPLETED|Overall Study||76
394886|NCT01787383|966103|P1|COMPLETED|Overall Study||92
394887|NCT01787383|966102|P2|STARTED|Overall Study||98
394888|NCT01787383|966103|P1|STARTED|Overall Study||101
394889|NCT01787279|966123|P1|NOT COMPLETED|Overall Study||3
394890|NCT01787279|966123|P1|COMPLETED|Overall Study||56
394891|NCT01787279|966123|P1|STARTED|Overall Study||59
394892|NCT01787240|966134|P2|NOT COMPLETED|Overall Study||1
394893|NCT01787240|966135|P1|NOT COMPLETED|Overall Study||5
394894|NCT01787240|966134|P2|COMPLETED|Overall Study||4
394895|NCT01787240|966135|P1|COMPLETED|Overall Study||10
394896|NCT01787240|966134|P2|STARTED|Overall Study||5
394897|NCT01787240|966135|P1|STARTED|Overall Study||15
394898|NCT01787188|966149|P3|NOT COMPLETED|Overall Study||18
394899|NCT01787188|966150|P2|NOT COMPLETED|Overall Study||18
394900|NCT01787188|966151|P1|NOT COMPLETED|Overall Study||17
394901|NCT01787188|966149|P3|COMPLETED|Overall Study||116
394902|NCT01787188|966150|P2|COMPLETED|Overall Study||112
394903|NCT01787188|966151|P1|COMPLETED|Overall Study||122
394904|NCT01787188|966149|P3|STARTED|Overall Study||134
394905|NCT01787188|966150|P2|STARTED|Overall Study||130
394906|NCT01787188|966151|P1|STARTED|Overall Study||139
394907|NCT01787175|966206|P2|NOT COMPLETED|Overall Study||0
394908|NCT01787175|966207|P1|NOT COMPLETED|Overall Study||0
394909|NCT01787175|966206|P2|COMPLETED|Overall Study||28
394910|NCT01787175|966207|P1|COMPLETED|Overall Study||30
394911|NCT01787175|966206|P2|STARTED|Overall Study||28
394912|NCT01787175|966207|P1|STARTED|Overall Study||30
394913|NCT01787032|966223|P6|NOT COMPLETED|Overall Study||1
394914|NCT01787032|966224|P5|NOT COMPLETED|Overall Study||1
394915|NCT01787032|966225|P4|NOT COMPLETED|Overall Study||0
394916|NCT01787032|966226|P3|NOT COMPLETED|Overall Study||0
394917|NCT01787032|966227|P2|NOT COMPLETED|Overall Study||0
394918|NCT01787032|966228|P1|NOT COMPLETED|Overall Study||0
394919|NCT01787032|966223|P6|COMPLETED|Overall Study||3
394920|NCT01787032|966224|P5|COMPLETED|Overall Study||3
394921|NCT01787032|966225|P4|COMPLETED|Overall Study||3
394922|NCT01787032|966226|P3|COMPLETED|Overall Study||3
394923|NCT01787032|966227|P2|COMPLETED|Overall Study||3
394924|NCT01787032|966228|P1|COMPLETED|Overall Study||3
394925|NCT01787032|966223|P6|Received T2|Overall Study||4
394926|NCT01787032|966224|P5|Received T2|Overall Study||4
394927|NCT01787032|966225|P4|Received T2|Overall Study||3
394928|NCT01787032|966226|P3|Received T2|Overall Study||3
394929|NCT01787032|966227|P2|Received T2|Overall Study||3
394930|NCT01787032|966228|P1|Received T2|Overall Study||3
394931|NCT01787032|966223|P6|Received T1|Overall Study||4
394932|NCT01787032|966224|P5|Received T1|Overall Study||3
394933|NCT01787032|966225|P4|Received T1|Overall Study||3
394934|NCT01787032|966226|P3|Received T1|Overall Study||3
394935|NCT01787032|966227|P2|Received T1|Overall Study||3
394936|NCT01787032|966228|P1|Received T1|Overall Study||3
394937|NCT01787032|966223|P6|Received R|Overall Study||3
394938|NCT01787032|966224|P5|Received R|Overall Study||4
394939|NCT01787032|966225|P4|Received R|Overall Study||3
394940|NCT01787032|966226|P3|Received R|Overall Study||3
394941|NCT01787032|966227|P2|Received R|Overall Study||3
394942|NCT01787032|966228|P1|Received R|Overall Study||3
394943|NCT01787032|966223|P6|STARTED|Overall Study||4
394944|NCT01787032|966224|P5|STARTED|Overall Study||4
394945|NCT01787032|966225|P4|STARTED|Overall Study||3
394946|NCT01787032|966226|P3|STARTED|Overall Study||3
394947|NCT01787032|966227|P2|STARTED|Overall Study||3
394948|NCT01787032|966228|P1|STARTED|Overall Study||3
394949|NCT01786993|966252|P2|NOT COMPLETED|Overall Study||10
394950|NCT01786993|966253|P1|NOT COMPLETED|Overall Study||12
394951|NCT01786993|966252|P2|COMPLETED|Overall Study||170
394952|NCT01786993|966253|P1|COMPLETED|Overall Study||189
394953|NCT01786993|966252|P2|Per Protocol Population at 9 Months|Overall Study||170
394954|NCT01786993|966253|P1|Per Protocol Population at 9 Months|Overall Study||189
394955|NCT01786993|966252|P2|STARTED|Overall Study||180
394956|NCT01786993|966253|P1|STARTED|Overall Study||201
394957|NCT01786954|966260|P2|NOT COMPLETED|Overall Study||0
394958|NCT01786954|966261|P1|NOT COMPLETED|Overall Study||0
394959|NCT01786954|966260|P2|COMPLETED|Overall Study||34
394960|NCT01786954|966261|P1|COMPLETED|Overall Study||34
394961|NCT01786954|966260|P2|STARTED|Overall Study||34
394962|NCT01786954|966261|P1|STARTED|Overall Study||34
394963|NCT01786902|966273|P2|NOT COMPLETED|Overall Study||3
394964|NCT01786902|966274|P1|NOT COMPLETED|Overall Study||4
394965|NCT01786902|966273|P2|COMPLETED|Overall Study||31
394966|NCT01786902|966274|P1|COMPLETED|Overall Study||32
394967|NCT01786902|966273|P2|STARTED|Overall Study||34
394968|NCT01786902|966274|P1|STARTED|Overall Study||36
394969|NCT01786876|966284|P1|NOT COMPLETED|Overall Study||0
394970|NCT01786876|966284|P1|COMPLETED|Overall Study||6
394971|NCT01786876|966284|P1|STARTED|Overall Study||6
394972|NCT01786707|966303|P2|NOT COMPLETED|Overall Study||1
394973|NCT01786707|966304|P1|NOT COMPLETED|Overall Study||1
394974|NCT01786707|966303|P2|COMPLETED|Overall Study||0
394975|NCT01786707|966304|P1|COMPLETED|Overall Study||0
394976|NCT01786707|966303|P2|STARTED|Overall Study||1
394977|NCT01786707|966304|P1|STARTED|Overall Study||1
394978|NCT01786668|966316|P4|NOT COMPLETED|Overall Study||4
394979|NCT01786668|966317|P3|NOT COMPLETED|Overall Study||5
394980|NCT01786668|966318|P2|NOT COMPLETED|Overall Study||1
394981|NCT01786668|966319|P1|NOT COMPLETED|Overall Study||1
394982|NCT01786668|966316|P4|COMPLETED|Overall Study||47
394983|NCT01786668|966317|P3|COMPLETED|Overall Study||47
394984|NCT01786668|966318|P2|COMPLETED|Overall Study||51
394985|NCT01786668|966319|P1|COMPLETED|Overall Study||51
394986|NCT01786668|966316|P4|STARTED|Overall Study||51
394987|NCT01786668|966317|P3|STARTED|Overall Study||52
394988|NCT01786668|966318|P2|STARTED|Overall Study||52
394989|NCT01786668|966319|P1|STARTED|Overall Study||52
394990|NCT01786629|966419|P2|NOT COMPLETED|Overall Study||5
394991|NCT01786629|966420|P1|NOT COMPLETED|Overall Study||0
394992|NCT01786629|966419|P2|COMPLETED|Overall Study||164
394993|NCT01786629|966420|P1|COMPLETED|Overall Study||169
394994|NCT01786629|966419|P2|STARTED|Overall Study||169
394995|NCT01786629|966420|P1|STARTED|Overall Study||169
394996|NCT01786551|966426|P1|NOT COMPLETED|Overall Study||2
394997|NCT01786551|966426|P1|COMPLETED|Overall Study||14
394998|NCT01786551|966426|P1|STARTED|Overall Study||16
394999|NCT01786330|966434|P2|NOT COMPLETED|Overall Study||3
395000|NCT01786330|966435|P1|NOT COMPLETED|Overall Study||1
395001|NCT01786330|966434|P2|COMPLETED|Overall Study||27
395002|NCT01786330|966435|P1|COMPLETED|Overall Study||29
395003|NCT01786330|966434|P2|STARTED|Overall Study||30
395004|NCT01786330|966435|P1|STARTED|Overall Study||30
395005|NCT01786252|966449|P2|NOT COMPLETED|Overall Study||0
395006|NCT01786252|966450|P1|NOT COMPLETED|Overall Study||0
395007|NCT01786252|966449|P2|COMPLETED|Overall Study||8
395008|NCT01786252|966450|P1|COMPLETED|Overall Study||7
395009|NCT01786252|966449|P2|STARTED|Overall Study||8
395010|NCT01786252|966450|P1|STARTED|Overall Study||7
395011|NCT01786239|966464|P2|NOT COMPLETED|Overall Study||11
395012|NCT01786239|966465|P1|NOT COMPLETED|Overall Study||11
395013|NCT01786239|966464|P2|COMPLETED|Overall Study||14
395014|NCT01786239|966465|P1|COMPLETED|Overall Study||14
395015|NCT01786239|966464|P2|STARTED|Overall Study||25
395016|NCT01786239|966465|P1|STARTED|Overall Study||25
395017|NCT01786174|966473|P2|NOT COMPLETED|Overall Study||0
395018|NCT01786174|966474|P1|NOT COMPLETED|Overall Study||2
395019|NCT01786174|966473|P2|COMPLETED|Overall Study||10
395020|NCT01786174|966474|P1|COMPLETED|Overall Study||16
395021|NCT01786174|966473|P2|Randomized|Overall Study||11
395022|NCT01786174|966474|P1|Randomized|Overall Study||19
395023|NCT01786174|966473|P2|STARTED|Overall Study||10
395024|NCT01786174|966474|P1|STARTED|Overall Study||18
395025|NCT01786161|966490|P2|NOT COMPLETED|Overall Study||0
395026|NCT01786161|966491|P1|NOT COMPLETED|Overall Study||0
395027|NCT01786161|966490|P2|COMPLETED|Overall Study||22
395028|NCT01786161|966491|P1|COMPLETED|Overall Study||22
395029|NCT01786161|966490|P2|STARTED|Overall Study||22
395030|NCT01786161|966491|P1|STARTED|Overall Study||22
395031|NCT01786109|966504|P3|NOT COMPLETED|Overall Study||2
395032|NCT01786109|966505|P2|NOT COMPLETED|Overall Study||0
395033|NCT01786109|966506|P1|NOT COMPLETED|Overall Study||1
395034|NCT01786109|966504|P3|COMPLETED|Overall Study||25
395035|NCT01786109|966505|P2|COMPLETED|Overall Study||24
395036|NCT01786109|966506|P1|COMPLETED|Overall Study||23
395037|NCT01786109|966504|P3|STARTED|Overall Study||27
395038|NCT01786109|966505|P2|STARTED|Overall Study||24
395039|NCT01786109|966506|P1|STARTED|Overall Study||24
395040|NCT01785875|966535|P3|NOT COMPLETED|Overall Study||107
395041|NCT01785875|966536|P2|NOT COMPLETED|Overall Study||289
395042|NCT01785875|966537|P1|NOT COMPLETED|Overall Study||294
395043|NCT01785875|966535|P3|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|16
395044|NCT01785875|966536|P2|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|95
395045|NCT01785875|966537|P1|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|90
395046|NCT01785875|966535|P3|Received Etelcalcetide|Overall Study||123
395047|NCT01785875|966536|P2|Received Etelcalcetide|Overall Study||384
395048|NCT01785875|966537|P1|Received Etelcalcetide|Overall Study||383
395049|NCT01785875|966535|P3|STARTED|Overall Study||123
395050|NCT01785875|966536|P2|STARTED|Overall Study||384
395051|NCT01785875|966537|P1|STARTED|Overall Study||384
395052|NCT01785849|966606|P2|NOT COMPLETED|Overall Study||34
395053|NCT01785849|966607|P1|NOT COMPLETED|Overall Study||61
395054|NCT01785849|966606|P2|COMPLETED|Overall Study||220
395055|NCT01785849|966607|P1|COMPLETED|Overall Study||193
395056|NCT01785849|966606|P2|Received Treatment|Overall Study||251
395057|NCT01785849|966607|P1|Received Treatment|Overall Study||254
395058|NCT01785849|966606|P2|STARTED|Overall Study||254
395059|NCT01785849|966607|P1|STARTED|Overall Study||254
395060|NCT01785628|966625|P2|NOT COMPLETED|Overall Study||3
395061|NCT01785628|966626|P1|NOT COMPLETED|Overall Study||2
395062|NCT01785628|966625|P2|COMPLETED|Overall Study||12
395063|NCT01785628|966626|P1|COMPLETED|Overall Study||13
395064|NCT01785628|966625|P2|STARTED|Overall Study||15
395065|NCT01785628|966626|P1|STARTED|Overall Study||15
395066|NCT01785615|966649|P4|NOT COMPLETED|Atorvastatin Phase||0
395067|NCT01785615|966650|P3|NOT COMPLETED|Atorvastatin Phase||0
395068|NCT01785615|966651|P2|NOT COMPLETED|Atorvastatin Phase||0
395069|NCT01785615|966652|P1|NOT COMPLETED|Atorvastatin Phase||0
395070|NCT01785615|966649|P4|COMPLETED|Atorvastatin Phase||0
395071|NCT01785615|966650|P3|COMPLETED|Atorvastatin Phase||0
395072|NCT01785615|966651|P2|COMPLETED|Atorvastatin Phase||44
395073|NCT01785615|966652|P1|COMPLETED|Atorvastatin Phase||44
395074|NCT01785615|966649|P4|STARTED|Atorvastatin Phase||0
395075|NCT01785615|966650|P3|STARTED|Atorvastatin Phase||0
395076|NCT01785615|966651|P2|STARTED|Atorvastatin Phase||44
395077|NCT01785615|966652|P1|STARTED|Atorvastatin Phase||44
395078|NCT01785615|966649|P4|NOT COMPLETED|Dietary Phase||24
395079|NCT01785615|966650|P3|NOT COMPLETED|Dietary Phase||0
395080|NCT01785615|966651|P2|NOT COMPLETED|Dietary Phase||0
395081|NCT01785615|966652|P1|NOT COMPLETED|Dietary Phase||0
395082|NCT01785615|966649|P4|COMPLETED|Dietary Phase||116
395083|NCT01785615|966650|P3|COMPLETED|Dietary Phase||35
395084|NCT01785615|966651|P2|COMPLETED|Dietary Phase||0
395085|NCT01785615|966652|P1|COMPLETED|Dietary Phase||0
395086|NCT01785615|966649|P4|STARTED|Dietary Phase||140
395087|NCT01785615|966650|P3|STARTED|Dietary Phase||35
395088|NCT01785615|966651|P2|STARTED|Dietary Phase||0
395089|NCT01785615|966652|P1|STARTED|Dietary Phase||0
395090|NCT01785602|966724|P2|NOT COMPLETED|Overall Study||9
395091|NCT01785602|966725|P1|NOT COMPLETED|Overall Study||13
395092|NCT01785602|966724|P2|COMPLETED|Overall Study||18
395093|NCT01785602|966725|P1|COMPLETED|Overall Study||63
395094|NCT01785602|966724|P2|STARTED|Overall Study||27
395095|NCT01785602|966725|P1|STARTED|Overall Study||76
395096|NCT01785524|966735|P2|NOT COMPLETED|Overall Study||2
395097|NCT01785524|966736|P1|NOT COMPLETED|Overall Study||2
395098|NCT01785524|966735|P2|COMPLETED|Overall Study||2
395099|NCT01785524|966736|P1|COMPLETED|Overall Study||5
395100|NCT01785524|966735|P2|STARTED|Overall Study||4
395101|NCT01785524|966736|P1|STARTED|Overall Study||7
395102|NCT01785472|966755|P3|NOT COMPLETED|Overall Study||22
395103|NCT01785472|966756|P2|NOT COMPLETED|Overall Study||19
395104|NCT01785472|966757|P1|NOT COMPLETED|Overall Study||24
395105|NCT01785472|966755|P3|COMPLETED|Overall Study||464
395106|NCT01785472|966756|P2|COMPLETED|Overall Study||454
395107|NCT01785472|966757|P1|COMPLETED|Overall Study||455
395108|NCT01785472|966755|P3|Safety Set (SAF)|Overall Study||484
395109|NCT01785472|966756|P2|Safety Set (SAF)|Overall Study||472
395110|NCT01785472|966757|P1|Safety Set (SAF)|Overall Study||478
395111|NCT01785472|966755|P3|Full Analysis Set (FAS)|Overall Study||484
395112|NCT01785472|966756|P2|Full Analysis Set (FAS)|Overall Study||472
395113|NCT01785472|966757|P1|Full Analysis Set (FAS)|Overall Study||479
395114|NCT01785472|966755|P3|STARTED|Overall Study||486
395115|NCT01785472|966756|P2|STARTED|Overall Study||473
395116|NCT01785472|966757|P1|STARTED|Overall Study||479
395117|NCT01785186|966804|P5|NOT COMPLETED|Overall Study||6
395118|NCT01785186|966805|P4|NOT COMPLETED|Overall Study||5
395119|NCT01785186|966806|P3|NOT COMPLETED|Overall Study||5
395120|NCT01785186|966807|P2|NOT COMPLETED|Overall Study||6
395121|NCT01785186|966808|P1|NOT COMPLETED|Overall Study||6
395122|NCT01785186|966804|P5|COMPLETED|Overall Study||117
395123|NCT01785186|966805|P4|COMPLETED|Overall Study||58
395124|NCT01785186|966806|P3|COMPLETED|Overall Study||52
395125|NCT01785186|966807|P2|COMPLETED|Overall Study||57
395126|NCT01785186|966808|P1|COMPLETED|Overall Study||53
395127|NCT01785186|966804|P5|STARTED|Overall Study||123
395128|NCT01785186|966805|P4|STARTED|Overall Study||63
395129|NCT01785186|966806|P3|STARTED|Overall Study||57
395130|NCT01785186|966807|P2|STARTED|Overall Study||63
395131|NCT01785186|966808|P1|STARTED|Overall Study||59
395132|NCT01785160|966830|P1|NOT COMPLETED|Treatment Period 2: Raltegravir + Faldap||0
395133|NCT01785160|966830|P1|COMPLETED|Treatment Period 2: Raltegravir + Faldap||23
395134|NCT01785160|966830|P1|STARTED|Treatment Period 2: Raltegravir + Faldap||23
395135|NCT01785160|966830|P1|NOT COMPLETED|Washout Period of at Least 7 Days||1
395136|NCT01785160|966830|P1|COMPLETED|Washout Period of at Least 7 Days||23
395137|NCT01785160|966830|P1|STARTED|Washout Period of at Least 7 Days||24
395138|NCT01785160|966830|P1|NOT COMPLETED|Treatment Period 1: Raltegravir||1
395139|NCT01785160|966830|P1|COMPLETED|Treatment Period 1: Raltegravir||24
395140|NCT01785160|966830|P1|STARTED|Treatment Period 1: Raltegravir||25
395141|NCT01785134|966840|P2|NOT COMPLETED|Overall Study||7
395142|NCT01785134|966841|P1|NOT COMPLETED|Overall Study||12
395143|NCT01785134|966840|P2|COMPLETED|Overall Study||33
395144|NCT01785134|966841|P1|COMPLETED|Overall Study||29
395145|NCT01785134|966840|P2|STARTED|Overall Study||40
395146|NCT01785134|966841|P1|STARTED|Overall Study||41
395147|NCT01785095|966855|P1|NOT COMPLETED|Overall Study||3
395148|NCT01785095|966855|P1|COMPLETED|Overall Study||24
395149|NCT01785095|966855|P1|STARTED|Overall Study||27
395150|NCT01784965|966865|P2|NOT COMPLETED|Overall Study||11
395151|NCT01784965|966866|P1|NOT COMPLETED|Overall Study||6
395152|NCT01784965|966865|P2|COMPLETED|Overall Study||24
395153|NCT01784965|966866|P1|COMPLETED|Overall Study||27
395154|NCT01784965|966865|P2|STARTED|Overall Study||35
395155|NCT01784965|966866|P1|STARTED|Overall Study||33
395156|NCT01784770|966876|P1|NOT COMPLETED|Overall Study||0
395157|NCT01784770|966876|P1|COMPLETED|Overall Study||21
395158|NCT01784770|966876|P1|STARTED|Overall Study||21
395159|NCT01784666|966884|P3|NOT COMPLETED|Overall Study||0
395160|NCT01784666|966885|P2|NOT COMPLETED|Overall Study||0
395161|NCT01784666|966886|P1|NOT COMPLETED|Overall Study||0
395162|NCT01784666|966884|P3|COMPLETED|Overall Study||1
395163|NCT01784666|966885|P2|COMPLETED|Overall Study||0
395164|NCT01784666|966886|P1|COMPLETED|Overall Study||1
395165|NCT01784666|966884|P3|STARTED|Overall Study||1
395166|NCT01784666|966885|P2|STARTED|Overall Study||0
395167|NCT01784666|966886|P1|STARTED|Overall Study||1
395168|NCT01784614|966894|P8|NOT COMPLETED|Period 4||0
395169|NCT01784614|966895|P7|NOT COMPLETED|Period 4||0
395170|NCT01784614|966896|P6|NOT COMPLETED|Period 4||0
395171|NCT01784614|966897|P5|NOT COMPLETED|Period 4||0
395172|NCT01784614|966898|P4|NOT COMPLETED|Period 4||0
395173|NCT01784614|966899|P3|NOT COMPLETED|Period 4||0
395174|NCT01784614|966900|P2|NOT COMPLETED|Period 4||0
395175|NCT01784614|966901|P1|NOT COMPLETED|Period 4||0
395176|NCT01784614|966894|P8|COMPLETED|Period 4||2
395177|NCT01784614|966895|P7|COMPLETED|Period 4||3
395178|NCT01784614|966896|P6|COMPLETED|Period 4||3
395179|NCT01784614|966897|P5|COMPLETED|Period 4||3
395180|NCT01784614|966898|P4|COMPLETED|Period 4||3
395181|NCT01784614|966899|P3|COMPLETED|Period 4||3
395182|NCT01784614|966900|P2|COMPLETED|Period 4||2
395183|NCT01784614|966901|P1|COMPLETED|Period 4||3
395184|NCT01784614|966894|P8|STARTED|Period 4||2
395185|NCT01784614|966895|P7|STARTED|Period 4||3
395186|NCT01784614|966896|P6|STARTED|Period 4||3
395187|NCT01784614|966897|P5|STARTED|Period 4||3
395188|NCT01784614|966898|P4|STARTED|Period 4||3
395189|NCT01784614|966899|P3|STARTED|Period 4||3
395190|NCT01784614|966900|P2|STARTED|Period 4||2
395191|NCT01784614|966901|P1|STARTED|Period 4||3
395192|NCT01784614|966894|P8|NOT COMPLETED|Period 3||0
395193|NCT01784614|966895|P7|NOT COMPLETED|Period 3||0
395194|NCT01784614|966896|P6|NOT COMPLETED|Period 3||0
395195|NCT01784614|966897|P5|NOT COMPLETED|Period 3||0
395196|NCT01784614|966898|P4|NOT COMPLETED|Period 3||0
395197|NCT01784614|966899|P3|NOT COMPLETED|Period 3||0
395198|NCT01784614|966900|P2|NOT COMPLETED|Period 3||0
395199|NCT01784614|966901|P1|NOT COMPLETED|Period 3||0
395200|NCT01784614|966894|P8|COMPLETED|Period 3||2
395201|NCT01784614|966895|P7|COMPLETED|Period 3||3
395202|NCT01784614|966896|P6|COMPLETED|Period 3||3
395203|NCT01784614|966897|P5|COMPLETED|Period 3||3
395204|NCT01784614|966898|P4|COMPLETED|Period 3||3
395205|NCT01784614|966899|P3|COMPLETED|Period 3||3
395206|NCT01784614|966900|P2|COMPLETED|Period 3||2
395207|NCT01784614|966901|P1|COMPLETED|Period 3||3
395208|NCT01784614|966894|P8|STARTED|Period 3||2
395209|NCT01784614|966895|P7|STARTED|Period 3||3
395210|NCT01784614|966896|P6|STARTED|Period 3||3
395211|NCT01784614|966897|P5|STARTED|Period 3||3
395212|NCT01784614|966898|P4|STARTED|Period 3||3
395213|NCT01784614|966899|P3|STARTED|Period 3||3
395214|NCT01784614|966900|P2|STARTED|Period 3||2
395215|NCT01784614|966901|P1|STARTED|Period 3||3
395216|NCT01784614|966894|P8|NOT COMPLETED|Period 2||0
395217|NCT01784614|966895|P7|NOT COMPLETED|Period 2||0
395218|NCT01784614|966896|P6|NOT COMPLETED|Period 2||0
395219|NCT01784614|966897|P5|NOT COMPLETED|Period 2||0
395220|NCT01784614|966898|P4|NOT COMPLETED|Period 2||0
395221|NCT01784614|966899|P3|NOT COMPLETED|Period 2||0
395222|NCT01784614|966900|P2|NOT COMPLETED|Period 2||0
395223|NCT01784614|966901|P1|NOT COMPLETED|Period 2||0
395224|NCT01784614|966894|P8|COMPLETED|Period 2||2
395225|NCT01784614|966895|P7|COMPLETED|Period 2||3
395226|NCT01784614|966896|P6|COMPLETED|Period 2||3
395227|NCT01784614|966897|P5|COMPLETED|Period 2||3
395228|NCT01784614|966898|P4|COMPLETED|Period 2||3
395229|NCT01784614|966899|P3|COMPLETED|Period 2||3
395230|NCT01784614|966900|P2|COMPLETED|Period 2|One participant withdrew consent after completed Period 2 and did not enter Period 3.|3
395231|NCT01784614|966901|P1|COMPLETED|Period 2||3
395232|NCT01784614|966894|P8|STARTED|Period 2||2
395233|NCT01784614|966895|P7|STARTED|Period 2||3
395234|NCT01784614|966896|P6|STARTED|Period 2||3
395235|NCT01784614|966897|P5|STARTED|Period 2||3
395236|NCT01784614|966898|P4|STARTED|Period 2||3
395237|NCT01784614|966899|P3|STARTED|Period 2||3
395238|NCT01784614|966900|P2|STARTED|Period 2||3
395239|NCT01784614|966901|P1|STARTED|Period 2||3
395240|NCT01784614|966894|P8|NOT COMPLETED|Period 1||0
395241|NCT01784614|966895|P7|NOT COMPLETED|Period 1||0
395242|NCT01784614|966896|P6|NOT COMPLETED|Period 1||0
395243|NCT01784614|966897|P5|NOT COMPLETED|Period 1||0
395244|NCT01784614|966898|P4|NOT COMPLETED|Period 1||0
395245|NCT01784614|966899|P3|NOT COMPLETED|Period 1||0
395246|NCT01784614|966900|P2|NOT COMPLETED|Period 1||0
395247|NCT01784614|966901|P1|NOT COMPLETED|Period 1||0
395248|NCT01784614|966894|P8|COMPLETED|Period 1|One participant withdrew consent after completed Period 1 and did not enter Period 2.|3
395249|NCT01784614|966895|P7|COMPLETED|Period 1||3
395250|NCT01784614|966896|P6|COMPLETED|Period 1||3
395251|NCT01784614|966897|P5|COMPLETED|Period 1||3
395252|NCT01784614|966898|P4|COMPLETED|Period 1||3
395253|NCT01784614|966899|P3|COMPLETED|Period 1||3
395254|NCT01784614|966900|P2|COMPLETED|Period 1||3
395255|NCT01784614|966901|P1|COMPLETED|Period 1||3
395256|NCT01784614|966894|P8|Received at Least 1 Dose of Study Drug|Period 1||3
395257|NCT01784614|966895|P7|Received at Least 1 Dose of Study Drug|Period 1||3
395258|NCT01784614|966896|P6|Received at Least 1 Dose of Study Drug|Period 1||3
395259|NCT01784614|966897|P5|Received at Least 1 Dose of Study Drug|Period 1||3
395260|NCT01784614|966898|P4|Received at Least 1 Dose of Study Drug|Period 1||3
395261|NCT01784614|966899|P3|Received at Least 1 Dose of Study Drug|Period 1||3
395262|NCT01784614|966900|P2|Received at Least 1 Dose of Study Drug|Period 1||3
395263|NCT01784614|966901|P1|Received at Least 1 Dose of Study Drug|Period 1||3
395264|NCT01784614|966894|P8|STARTED|Period 1||3
395265|NCT01784614|966895|P7|STARTED|Period 1||3
395266|NCT01784614|966896|P6|STARTED|Period 1||3
395267|NCT01784614|966897|P5|STARTED|Period 1||3
395268|NCT01784614|966898|P4|STARTED|Period 1||3
395269|NCT01784614|966899|P3|STARTED|Period 1||3
395270|NCT01784614|966900|P2|STARTED|Period 1||3
395271|NCT01784614|966901|P1|STARTED|Period 1||3
395272|NCT01784055|966935|P1|NOT COMPLETED|Overall Study||26
395273|NCT01784055|966935|P1|COMPLETED|Overall Study||100
395274|NCT01784055|966935|P1|STARTED|Overall Study||126
395275|NCT01783938|966941|P2|NOT COMPLETED|Overall Study||53
395276|NCT01783938|966942|P1|NOT COMPLETED|Overall Study||47
395277|NCT01783938|966941|P2|COMPLETED|Overall Study|Completed=continuing treatment; did not permanently discontinue both study drugs in treatment period|17
395278|NCT01783938|966942|P1|COMPLETED|Overall Study|Completed=continuing treatment; did not permanently discontinue both study drugs in treatment period|21
395279|NCT01783938|966941|P2|STARTED|Overall Study||70
395280|NCT01783938|966942|P1|STARTED|Overall Study||68
395281|NCT01783912|966957|P3|NOT COMPLETED|Overall Study||23
395282|NCT01783912|966958|P2|NOT COMPLETED|Overall Study||46
395283|NCT01783912|966959|P1|NOT COMPLETED|Overall Study||30
395284|NCT01783912|966957|P3|COMPLETED|Overall Study||25
395285|NCT01783912|966958|P2|COMPLETED|Overall Study||58
395286|NCT01783912|966959|P1|COMPLETED|Overall Study||88
395287|NCT01783912|966957|P3|STARTED|Overall Study||48
395288|NCT01783912|966958|P2|STARTED|Overall Study||104
395289|NCT01783912|966959|P1|STARTED|Overall Study||118
395290|NCT01783886|966970|P3|NOT COMPLETED|Overall Study||10
395291|NCT01783886|966971|P2|NOT COMPLETED|Overall Study||11
395292|NCT01783886|966972|P1|NOT COMPLETED|Overall Study||5
395293|NCT01783886|966970|P3|COMPLETED|Overall Study||117
395294|NCT01783886|966971|P2|COMPLETED|Overall Study||116
395295|NCT01783886|966972|P1|COMPLETED|Overall Study||122
395296|NCT01783886|966970|P3|Participants Received Treatment|Overall Study||124
395297|NCT01783886|966971|P2|Participants Received Treatment|Overall Study||127
395298|NCT01783886|966972|P1|Participants Received Treatment|Overall Study||127
395299|NCT01783886|966970|P3|STARTED|Overall Study||127
395300|NCT01783886|966971|P2|STARTED|Overall Study||127
395301|NCT01783886|966972|P1|STARTED|Overall Study||127
395302|NCT01783860|967000|P2|NOT COMPLETED|Overall Study||0
395303|NCT01783860|967001|P1|NOT COMPLETED|Overall Study||0
395304|NCT01783860|967000|P2|COMPLETED|Overall Study||50
395305|NCT01783860|967001|P1|COMPLETED|Overall Study||50
395306|NCT01783860|967000|P2|STARTED|Overall Study||50
395307|NCT01783860|967001|P1|STARTED|Overall Study||50
395308|NCT01783821|967019|P2|NOT COMPLETED|Overall Study||1
395309|NCT01783821|967020|P1|NOT COMPLETED|Overall Study||1
395310|NCT01783821|967019|P2|COMPLETED|Overall Study||30
395311|NCT01783821|967020|P1|COMPLETED|Overall Study||29
395312|NCT01783821|967019|P2|STARTED|Overall Study||31
395313|NCT01783821|967020|P1|STARTED|Overall Study||30
395314|NCT01783743|967038|P2|NOT COMPLETED|Rescreening of Subjects by Senior Grader||10920
395315|NCT01783743|967039|P1|NOT COMPLETED|Rescreening of Subjects by Senior Grader||10896
395316|NCT01783743|967038|P2|COMPLETED|Rescreening of Subjects by Senior Grader||3044
395317|NCT01783743|967039|P1|COMPLETED|Rescreening of Subjects by Senior Grader||2613
395318|NCT01783743|967038|P2|Random Sample From Subject Absent at MDA|Rescreening of Subjects by Senior Grader||849
395409|NCT01783418|967277|P1|COMPLETED|Overall Study||7
395319|NCT01783743|967039|P1|Random Sample From Subject Absent at MDA|Rescreening of Subjects by Senior Grader||846
395320|NCT01783743|967038|P2|Random Sample From Non TT Cases by CTA|Rescreening of Subjects by Senior Grader||1786
395321|NCT01783743|967039|P1|Random Sample From Non TT Cases by CTA|Rescreening of Subjects by Senior Grader||1721
395322|NCT01783743|967038|P2|TT Positive Cases Screened by CTA|Rescreening of Subjects by Senior Grader||409
395323|NCT01783743|967039|P1|TT Positive Cases Screened by CTA|Rescreening of Subjects by Senior Grader||46
395324|NCT01783743|967038|P2|STARTED|Rescreening of Subjects by Senior Grader||13964
395325|NCT01783743|967039|P1|STARTED|Rescreening of Subjects by Senior Grader||13509
395326|NCT01783743|967038|P2|NOT COMPLETED|Screening of Subjects by CTA During MDA||4439
395327|NCT01783743|967039|P1|NOT COMPLETED|Screening of Subjects by CTA During MDA||3427
395328|NCT01783743|967038|P2|COMPLETED|Screening of Subjects by CTA During MDA||9525
395329|NCT01783743|967039|P1|COMPLETED|Screening of Subjects by CTA During MDA||10082
395330|NCT01783743|967038|P2|STARTED|Screening of Subjects by CTA During MDA||13964
395331|NCT01783743|967039|P1|STARTED|Screening of Subjects by CTA During MDA||13509
395332|NCT01783730|967053|P1|NOT COMPLETED|Overall Study||6
395333|NCT01783730|967053|P1|COMPLETED|Overall Study||157
395334|NCT01783730|967053|P1|STARTED|Overall Study||163
395335|NCT01783678|967078|P6|NOT COMPLETED|Overall Study||5
395336|NCT01783678|967079|P5|NOT COMPLETED|Overall Study||7
395337|NCT01783678|967080|P4|NOT COMPLETED|Overall Study||8
395338|NCT01783678|967081|P3|NOT COMPLETED|Overall Study||1
395339|NCT01783678|967082|P2|NOT COMPLETED|Overall Study||18
395340|NCT01783678|967083|P1|NOT COMPLETED|Overall Study||2
395341|NCT01783678|967078|P6|COMPLETED|Overall Study||26
395342|NCT01783678|967079|P5|COMPLETED|Overall Study||42
395343|NCT01783678|967080|P4|COMPLETED|Overall Study||50
395344|NCT01783678|967081|P3|COMPLETED|Overall Study||5
395345|NCT01783678|967082|P2|COMPLETED|Overall Study||94
395346|NCT01783678|967083|P1|COMPLETED|Overall Study||17
395347|NCT01783678|967078|P6|STARTED|Overall Study||31
395348|NCT01783678|967079|P5|STARTED|Overall Study||49
395349|NCT01783678|967080|P4|STARTED|Overall Study||58
395350|NCT01783678|967081|P3|STARTED|Overall Study||6
395351|NCT01783678|967082|P2|STARTED|Overall Study||112
395352|NCT01783678|967083|P1|STARTED|Overall Study||19
395353|NCT01783639|967155|P1|NOT COMPLETED|Overall Study||0
395354|NCT01783639|967155|P1|COMPLETED|Overall Study||120
395355|NCT01783639|967155|P1|STARTED|Overall Study||120
395356|NCT01783574|967161|P2|NOT COMPLETED|Overall Study||9
395357|NCT01783574|967162|P1|NOT COMPLETED|Overall Study||5
395358|NCT01783574|967161|P2|COMPLETED|Overall Study||41
395359|NCT01783574|967162|P1|COMPLETED|Overall Study||46
395360|NCT01783574|967161|P2|STARTED|Overall Study||50
395361|NCT01783574|967162|P1|STARTED|Overall Study||51
395362|NCT01783561|967174|P2|NOT COMPLETED|Overall Study||0
395363|NCT01783561|967175|P1|NOT COMPLETED|Overall Study||0
395364|NCT01783561|967174|P2|COMPLETED|Overall Study||10
395365|NCT01783561|967175|P1|COMPLETED|Overall Study||11
395366|NCT01783561|967174|P2|STARTED|Overall Study||10
395367|NCT01783561|967175|P1|STARTED|Overall Study||11
395368|NCT01783548|967185|P2|NOT COMPLETED|Overall Study||18
395369|NCT01783548|967186|P1|NOT COMPLETED|Overall Study||34
395370|NCT01783548|967185|P2|COMPLETED|Overall Study||167
395371|NCT01783548|967186|P1|COMPLETED|Overall Study||328
395372|NCT01783548|967185|P2|Full Analysis Set (FAS)|Overall Study||184
395373|NCT01783548|967186|P1|Full Analysis Set (FAS)|Overall Study||358
395374|NCT01783548|967185|P2|STARTED|Overall Study|Randomized|185
395375|NCT01783548|967186|P1|STARTED|Overall Study|Randomized|362
395376|NCT01783496|967204|P6|NOT COMPLETED|Overall Study||1
395377|NCT01783496|967205|P5|NOT COMPLETED|Overall Study||0
395378|NCT01783496|967206|P4|NOT COMPLETED|Overall Study||2
395379|NCT01783496|967207|P3|NOT COMPLETED|Overall Study||0
395380|NCT01783496|967208|P2|NOT COMPLETED|Overall Study||0
395381|NCT01783496|967209|P1|NOT COMPLETED|Overall Study||1
395382|NCT01783496|967204|P6|COMPLETED|Overall Study||4
395383|NCT01783496|967205|P5|COMPLETED|Overall Study||5
395384|NCT01783496|967206|P4|COMPLETED|Overall Study||8
395385|NCT01783496|967207|P3|COMPLETED|Overall Study||10
395386|NCT01783496|967208|P2|COMPLETED|Overall Study||10
395387|NCT01783496|967209|P1|COMPLETED|Overall Study||9
395388|NCT01783496|967204|P6|STARTED|Overall Study||5
395389|NCT01783496|967205|P5|STARTED|Overall Study||5
395390|NCT01783496|967206|P4|STARTED|Overall Study||10
395391|NCT01783496|967207|P3|STARTED|Overall Study||10
395392|NCT01783496|967208|P2|STARTED|Overall Study||10
395393|NCT01783496|967209|P1|STARTED|Overall Study||10
395394|NCT01783483|967237|P2|NOT COMPLETED|Overall Study||15
395395|NCT01783483|967238|P1|NOT COMPLETED|Overall Study||20
395396|NCT01783483|967237|P2|COMPLETED|Overall Study||101
395397|NCT01783483|967238|P1|COMPLETED|Overall Study||100
395398|NCT01783483|967237|P2|STARTED|Overall Study||116
395399|NCT01783483|967238|P1|STARTED|Overall Study||120
395400|NCT01783470|967266|P2|NOT COMPLETED|Overall Study||0
395401|NCT01783470|967267|P1|NOT COMPLETED|Overall Study||0
395402|NCT01783470|967266|P2|COMPLETED|Overall Study||6
395403|NCT01783470|967267|P1|COMPLETED|Overall Study||6
395404|NCT01783470|967266|P2|STARTED|Overall Study|Single-dose|6
395405|NCT01783470|967267|P1|STARTED|Overall Study||6
395406|NCT01783418|967276|P2|NOT COMPLETED|Overall Study||0
395407|NCT01783418|967277|P1|NOT COMPLETED|Overall Study||1
395408|NCT01783418|967276|P2|COMPLETED|Overall Study||6
395410|NCT01783418|967276|P2|STARTED|Overall Study||6
395411|NCT01783418|967277|P1|STARTED|Overall Study||8
395412|NCT01783236|967297|P2|NOT COMPLETED|Overall Study||0
395413|NCT01783236|967298|P1|NOT COMPLETED|Overall Study||2
395414|NCT01783236|967297|P2|COMPLETED|Overall Study||8
395415|NCT01783236|967298|P1|COMPLETED|Overall Study||6
395416|NCT01783236|967297|P2|STARTED|Overall Study||8
395417|NCT01783236|967298|P1|STARTED|Overall Study||8
395418|NCT01783080|967312|P1|NOT COMPLETED|Overall Study||0
395419|NCT01783080|967312|P1|COMPLETED|Overall Study||16
395420|NCT01783080|967312|P1|STARTED|Overall Study||16
395421|NCT01783054|967319|P1|NOT COMPLETED|Overall Study||0
395422|NCT01783054|967319|P1|COMPLETED|Overall Study||2
395423|NCT01783054|967319|P1|STARTED|Overall Study||2
395424|NCT01783015|967330|P3|NOT COMPLETED|Open Label Treatment||6
395425|NCT01783015|967331|P2|NOT COMPLETED|Open Label Treatment||0
395426|NCT01783015|967332|P1|NOT COMPLETED|Open Label Treatment||0
395427|NCT01783015|967330|P3|COMPLETED|Open Label Treatment||5
395428|NCT01783015|967331|P2|COMPLETED|Open Label Treatment||0
395429|NCT01783015|967332|P1|COMPLETED|Open Label Treatment||0
395430|NCT01783015|967330|P3|STARTED|Open Label Treatment||11
395431|NCT01783015|967331|P2|STARTED|Open Label Treatment||0
395432|NCT01783015|967332|P1|STARTED|Open Label Treatment||0
395433|NCT01783015|967330|P3|NOT COMPLETED|Blinded Treatment||0
395434|NCT01783015|967331|P2|NOT COMPLETED|Blinded Treatment||3
395435|NCT01783015|967332|P1|NOT COMPLETED|Blinded Treatment||2
395436|NCT01783015|967330|P3|COMPLETED|Blinded Treatment||0
395437|NCT01783015|967331|P2|COMPLETED|Blinded Treatment||2
395438|NCT01783015|967332|P1|COMPLETED|Blinded Treatment||9
395439|NCT01783015|967330|P3|Treated|Blinded Treatment||0
395440|NCT01783015|967331|P2|Treated|Blinded Treatment||5
395441|NCT01783015|967332|P1|Treated|Blinded Treatment||11
395442|NCT01783015|967330|P3|STARTED|Blinded Treatment||0
395443|NCT01783015|967331|P2|STARTED|Blinded Treatment||5
395444|NCT01783015|967332|P1|STARTED|Blinded Treatment||11
395445|NCT01782963|967417|P1|NOT COMPLETED|Overall Study||0
395446|NCT01782963|967417|P1|COMPLETED|Overall Study||50
395447|NCT01782963|967417|P1|STARTED|Overall Study||50
395448|NCT01782898|967428|P2|NOT COMPLETED|Overall Study||6
395449|NCT01782898|967429|P1|NOT COMPLETED|Overall Study||6
395450|NCT01782898|967428|P2|COMPLETED|Overall Study||29
395451|NCT01782898|967429|P1|COMPLETED|Overall Study||29
395452|NCT01782898|967428|P2|STARTED|Overall Study||35
395453|NCT01782898|967429|P1|STARTED|Overall Study||35
395454|NCT01782885|967441|P2|NOT COMPLETED|Overall Study||6
395455|NCT01782885|967442|P1|NOT COMPLETED|Overall Study||4
395456|NCT01782885|967441|P2|COMPLETED|Overall Study||33
395457|NCT01782885|967442|P1|COMPLETED|Overall Study||32
395458|NCT01782885|967441|P2|STARTED|Overall Study||39
395459|NCT01782885|967442|P1|STARTED|Overall Study||36
395460|NCT01782872|967468|P4|NOT COMPLETED|Overall Study||1
395461|NCT01782872|967469|P3|NOT COMPLETED|Overall Study||0
395462|NCT01782872|967470|P2|NOT COMPLETED|Overall Study||1
395463|NCT01782872|967471|P1|NOT COMPLETED|Overall Study||0
395464|NCT01782872|967468|P4|COMPLETED|Overall Study||19
395465|NCT01782872|967469|P3|COMPLETED|Overall Study||20
395466|NCT01782872|967470|P2|COMPLETED|Overall Study||19
395467|NCT01782872|967471|P1|COMPLETED|Overall Study||20
395468|NCT01782872|967468|P4|STARTED|Overall Study||20
395469|NCT01782872|967469|P3|STARTED|Overall Study||20
395470|NCT01782872|967470|P2|STARTED|Overall Study||20
395471|NCT01782872|967471|P1|STARTED|Overall Study||20
395472|NCT01782859|967495|P2|NOT COMPLETED|Overall Study||7
395473|NCT01782859|967496|P1|NOT COMPLETED|Overall Study||6
395474|NCT01782859|967495|P2|COMPLETED|Overall Study||13
395475|NCT01782859|967496|P1|COMPLETED|Overall Study||14
395476|NCT01782859|967495|P2|STARTED|Overall Study||20
395477|NCT01782859|967496|P1|STARTED|Overall Study||20
395478|NCT01782742|967512|P2|NOT COMPLETED|Open Label Phase||0
395479|NCT01782742|967513|P1|NOT COMPLETED|Open Label Phase||0
395480|NCT01782742|967512|P2|COMPLETED|Open Label Phase||0
395481|NCT01782742|967513|P1|COMPLETED|Open Label Phase||19
395482|NCT01782742|967512|P2|STARTED|Open Label Phase||0
395483|NCT01782742|967513|P1|STARTED|Open Label Phase||19
395484|NCT01782742|967512|P2|NOT COMPLETED|Double-blind Treatment Phase||0
395485|NCT01782742|967513|P1|NOT COMPLETED|Double-blind Treatment Phase||1
395486|NCT01782742|967512|P2|COMPLETED|Double-blind Treatment Phase||4
395487|NCT01782742|967513|P1|COMPLETED|Double-blind Treatment Phase||15
395488|NCT01782742|967512|P2|STARTED|Double-blind Treatment Phase||4
395489|NCT01782742|967513|P1|STARTED|Double-blind Treatment Phase||16
395490|NCT01782664|967552|P6|NOT COMPLETED|Overall Study||0
395491|NCT01782664|967553|P5|NOT COMPLETED|Overall Study||0
395492|NCT01782664|967554|P4|NOT COMPLETED|Overall Study||5
395493|NCT01782664|967555|P3|NOT COMPLETED|Overall Study||4
395494|NCT01782664|967556|P2|NOT COMPLETED|Overall Study||5
395495|NCT01782664|967557|P1|NOT COMPLETED|Overall Study||6
395496|NCT01782664|967552|P6|COMPLETED|Overall Study||2
395497|NCT01782664|967553|P5|COMPLETED|Overall Study||6
395498|NCT01782664|967554|P4|COMPLETED|Overall Study||9
395499|NCT01782664|967555|P3|COMPLETED|Overall Study||12
395500|NCT01782664|967556|P2|COMPLETED|Overall Study||10
395501|NCT01782664|967557|P1|COMPLETED|Overall Study||8
395502|NCT01782664|967552|P6|STARTED|Overall Study||2
395503|NCT01782664|967553|P5|STARTED|Overall Study||6
395504|NCT01782664|967554|P4|STARTED|Overall Study||14
395505|NCT01782664|967555|P3|STARTED|Overall Study||16
395506|NCT01782664|967556|P2|STARTED|Overall Study||15
395507|NCT01782664|967557|P1|STARTED|Overall Study||14
395508|NCT01782495|967714|P11|NOT COMPLETED|Overall Study||0
395509|NCT01782495|967715|P10|NOT COMPLETED|Overall Study||0
395510|NCT01782495|967716|P9|NOT COMPLETED|Overall Study||0
395511|NCT01782495|967717|P8|NOT COMPLETED|Overall Study||3
395512|NCT01782495|967718|P7|NOT COMPLETED|Overall Study||0
395513|NCT01782495|967719|P6|NOT COMPLETED|Overall Study||0
395514|NCT01782495|967720|P5|NOT COMPLETED|Overall Study||0
395515|NCT01782495|967721|P4|NOT COMPLETED|Overall Study||0
395516|NCT01782495|967722|P3|NOT COMPLETED|Overall Study||0
395517|NCT01782495|967723|P2|NOT COMPLETED|Overall Study||1
395518|NCT01782495|967724|P1|NOT COMPLETED|Overall Study||0
395519|NCT01782495|967714|P11|COMPLETED|Overall Study||1
395520|NCT01782495|967715|P10|COMPLETED|Overall Study||2
395521|NCT01782495|967716|P9|COMPLETED|Overall Study||3
395522|NCT01782495|967717|P8|COMPLETED|Overall Study||6
395523|NCT01782495|967718|P7|COMPLETED|Overall Study||12
395524|NCT01782495|967719|P6|COMPLETED|Overall Study||22
395525|NCT01782495|967720|P5|COMPLETED|Overall Study||2
395526|NCT01782495|967721|P4|COMPLETED|Overall Study||4
395527|NCT01782495|967722|P3|COMPLETED|Overall Study||13
395528|NCT01782495|967723|P2|COMPLETED|Overall Study||26
395529|NCT01782495|967724|P1|COMPLETED|Overall Study||34
395530|NCT01782495|967714|P11|STARTED|Overall Study||1
395531|NCT01782495|967715|P10|STARTED|Overall Study||2
395532|NCT01782495|967716|P9|STARTED|Overall Study||3
395533|NCT01782495|967717|P8|STARTED|Overall Study||9
395534|NCT01782495|967718|P7|STARTED|Overall Study||12
395535|NCT01782495|967719|P6|STARTED|Overall Study||22
395536|NCT01782495|967720|P5|STARTED|Overall Study||2
395537|NCT01782495|967721|P4|STARTED|Overall Study||4
395538|NCT01782495|967722|P3|STARTED|Overall Study||13
395539|NCT01782495|967723|P2|STARTED|Overall Study||27
395540|NCT01782495|967724|P1|STARTED|Overall Study||34
395541|NCT01782482|967783|P2|NOT COMPLETED|Overall Study||10
395542|NCT01782482|967784|P1|NOT COMPLETED|Overall Study||10
395543|NCT01782482|967783|P2|COMPLETED|Overall Study||270
395544|NCT01782482|967784|P1|COMPLETED|Overall Study||271
395545|NCT01782482|967783|P2|STARTED|Overall Study||280
395546|NCT01782482|967784|P1|STARTED|Overall Study||281
395547|NCT01782469|967792|P1|NOT COMPLETED|Overall Study||1
395548|NCT01782469|967792|P1|COMPLETED|Overall Study||15
395549|NCT01782469|967792|P1|STARTED|Overall Study||16
395550|NCT01782326|967802|P2|NOT COMPLETED|Double-blind Treatment||320
395551|NCT01782326|967803|P1|NOT COMPLETED|Double-blind Treatment||278
395552|NCT01782326|967802|P2|COMPLETED|Double-blind Treatment||1360
395553|NCT01782326|967803|P1|COMPLETED|Double-blind Treatment||1400
395554|NCT01782326|967802|P2|STARTED|Double-blind Treatment||1680
395555|NCT01782326|967803|P1|STARTED|Double-blind Treatment||1678
395556|NCT01782326|967802|P2|NOT COMPLETED|Planned Treatment Epoch||208
395557|NCT01782326|967803|P1|NOT COMPLETED|Planned Treatment Epoch||202
395558|NCT01782326|967802|P2|COMPLETED|Planned Treatment Epoch||1474
395559|NCT01782326|967803|P1|COMPLETED|Planned Treatment Epoch||1478
395560|NCT01782326|967802|P2|Urine Cortisol Set|Planned Treatment Epoch||269
395561|NCT01782326|967803|P1|Urine Cortisol Set|Planned Treatment Epoch||266
395562|NCT01782326|967802|P2|Safety Set (SAF)|Planned Treatment Epoch||1680
395563|NCT01782326|967803|P1|Safety Set (SAF)|Planned Treatment Epoch||1678
395564|NCT01782326|967802|P2|Serial Spirometry Set|Planned Treatment Epoch||279
395565|NCT01782326|967803|P1|Serial Spirometry Set|Planned Treatment Epoch||280
395566|NCT01782326|967802|P2|Per-protocol Set (PPS)|Planned Treatment Epoch||1556
395567|NCT01782326|967803|P1|Per-protocol Set (PPS)|Planned Treatment Epoch||1528
395568|NCT01782326|967802|P2|Full Analysis Set (FAS)|Planned Treatment Epoch||1679
395569|NCT01782326|967803|P1|Full Analysis Set (FAS)|Planned Treatment Epoch||1675
395570|NCT01782326|967802|P2|STARTED|Planned Treatment Epoch||1682
395571|NCT01782326|967803|P1|STARTED|Planned Treatment Epoch||1680
395572|NCT01782222|967866|P3|NOT COMPLETED|Overall Study||4
395573|NCT01782222|967867|P2|NOT COMPLETED|Overall Study||11
395574|NCT01782222|967868|P1|NOT COMPLETED|Overall Study||8
395575|NCT01782222|967866|P3|COMPLETED|Overall Study||37
395576|NCT01782222|967867|P2|COMPLETED|Overall Study||30
395577|NCT01782222|967868|P1|COMPLETED|Overall Study||32
395578|NCT01782222|967866|P3|STARTED|Overall Study||41
395579|NCT01782222|967867|P2|STARTED|Overall Study||41
395580|NCT01782222|967868|P1|STARTED|Overall Study||40
395581|NCT01781962|967900|P1|NOT COMPLETED|Overall Study||5
395582|NCT01781962|967900|P1|COMPLETED|Overall Study||201
395583|NCT01781962|967900|P1|STARTED|Overall Study||206
395584|NCT01781832|967906|P1|NOT COMPLETED|Overall Study||1
395585|NCT01781832|967906|P1|COMPLETED|Overall Study||25
395586|NCT01781832|967906|P1|STARTED|Overall Study||26
395587|NCT01781806|967913|P2|NOT COMPLETED|Overall Study||3
395588|NCT01781806|967914|P1|NOT COMPLETED|Overall Study||79
395589|NCT01781806|967913|P2|COMPLETED|Overall Study||1
395590|NCT01781806|967914|P1|COMPLETED|Overall Study||218
395591|NCT01781806|967913|P2|Week 48|Overall Study||1
395592|NCT01781806|967914|P1|Week 48|Overall Study||222
395593|NCT01781806|967913|P2|Week 36|Overall Study||1
395594|NCT01781806|967914|P1|Week 36|Overall Study||247
395595|NCT01781806|967913|P2|Week 24|Overall Study||1
395596|NCT01781806|967914|P1|Week 24|Overall Study||260
395597|NCT01781806|967913|P2|Week 12|Overall Study||2
395598|NCT01781806|967914|P1|Week 12|Overall Study||272
395599|NCT01781806|967913|P2|Week 8|Overall Study||4
395600|NCT01781806|967914|P1|Week 8|Overall Study||278
395601|NCT01781806|967913|P2|Week 4|Overall Study||4
395602|NCT01781806|967914|P1|Week 4|Overall Study||284
395603|NCT01781806|967913|P2|Week 0|Overall Study||4
395604|NCT01781806|967914|P1|Week 0|Overall Study||297
395605|NCT01781806|967913|P2|STARTED|Overall Study||4
395606|NCT01781806|967914|P1|STARTED|Overall Study||297
395607|NCT01781637|967926|P2|NOT COMPLETED|Overall Study||6
395608|NCT01781637|967927|P1|NOT COMPLETED|Overall Study||4
395609|NCT01781637|967926|P2|COMPLETED|Overall Study||2
395610|NCT01781637|967927|P1|COMPLETED|Overall Study||24
395611|NCT01781637|967926|P2|STARTED|Overall Study||8
395612|NCT01781637|967927|P1|STARTED|Overall Study||28
395613|NCT01781481|967935|P1|NOT COMPLETED|Overall Study||0
395614|NCT01781481|967935|P1|COMPLETED|Overall Study||148
395615|NCT01781481|967935|P1|STARTED|Overall Study||148
395616|NCT01781403|967994|P3|NOT COMPLETED|Overall Study||0
395617|NCT01781403|967995|P2|NOT COMPLETED|Overall Study||0
395618|NCT01781403|967996|P1|NOT COMPLETED|Overall Study||0
395619|NCT01781403|967994|P3|COMPLETED|Overall Study||18
395620|NCT01781403|967995|P2|COMPLETED|Overall Study||2
395621|NCT01781403|967996|P1|COMPLETED|Overall Study||2
395622|NCT01781403|967994|P3|STARTED|Overall Study||18
395623|NCT01781403|967995|P2|STARTED|Overall Study||2
395624|NCT01781403|967996|P1|STARTED|Overall Study||2
395625|NCT01781299|968014|P2|NOT COMPLETED|Overall Study||1
395626|NCT01781299|968015|P1|NOT COMPLETED|Overall Study||0
395627|NCT01781299|968014|P2|COMPLETED|Overall Study||4
395628|NCT01781299|968015|P1|COMPLETED|Overall Study||4
395629|NCT01781299|968014|P2|STARTED|Overall Study||5
395630|NCT01781299|968015|P1|STARTED|Overall Study||4
395631|NCT01781208|968023|P1|NOT COMPLETED|Overall Study||0
395632|NCT01781208|968023|P1|COMPLETED|Overall Study||62
395633|NCT01781208|968023|P1|Overall Study|Overall Study||62
395634|NCT01781208|968023|P1|STARTED|Overall Study||62
395635|NCT01781169|968030|P2|NOT COMPLETED|Overall Study||0
395636|NCT01781169|968031|P1|NOT COMPLETED|Overall Study||1
395637|NCT01781169|968030|P2|COMPLETED|Overall Study||21
395638|NCT01781169|968031|P1|COMPLETED|Overall Study||21
395639|NCT01781169|968030|P2|STARTED|Overall Study||21
395640|NCT01781169|968031|P1|STARTED|Overall Study||22
395641|NCT01781078|968039|P3|NOT COMPLETED|Overall Study||16
395642|NCT01781078|968040|P2|NOT COMPLETED|Overall Study||5
395643|NCT01781078|968041|P1|NOT COMPLETED|Overall Study||12
395644|NCT01781078|968039|P3|COMPLETED|Overall Study||0
395645|NCT01781078|968040|P2|COMPLETED|Overall Study|Patients having completed the MRI + 1 month (Primary endpoint assessment)|113
395646|NCT01781078|968041|P1|COMPLETED|Overall Study|Patients having completed the MRI + 1 month (Primary endpoint assessment)|217
395647|NCT01781078|968039|P3|STARTED|Overall Study||16
395648|NCT01781078|968040|P2|STARTED|Overall Study|Randomized post implantation|118
395649|NCT01781078|968041|P1|STARTED|Overall Study|Randomized post implantation|229
395650|NCT01781026|968051|P1|NOT COMPLETED|Overall Study||2
395651|NCT01781026|968051|P1|COMPLETED|Overall Study||0
395652|NCT01781026|968051|P1|STARTED|Overall Study||2
395653|NCT01780987|968057|P2|NOT COMPLETED|Overall Study||6
395654|NCT01780987|968058|P1|NOT COMPLETED|Overall Study||3
395655|NCT01780987|968057|P2|COMPLETED|Overall Study||34
395656|NCT01780987|968058|P1|COMPLETED|Overall Study||37
395657|NCT01780987|968057|P2|STARTED|Overall Study|Including one participant who withdrew from the study prior to receiving any study medication.|40
395658|NCT01780987|968058|P1|STARTED|Overall Study||40
395659|NCT01780974|968076|P2|NOT COMPLETED|Overall Study||3
395660|NCT01780974|968077|P1|NOT COMPLETED|Overall Study||2
395661|NCT01780974|968076|P2|COMPLETED|Overall Study||18
395662|NCT01780974|968077|P1|COMPLETED|Overall Study||19
395663|NCT01780974|968076|P2|STARTED|Overall Study||21
395664|NCT01780974|968077|P1|STARTED|Overall Study||21
395665|NCT01780935|968087|P2|NOT COMPLETED|Overall Study||336
395666|NCT01780935|968088|P1|NOT COMPLETED|Overall Study||335
395667|NCT01780935|968087|P2|COMPLETED|Overall Study||0
395668|NCT01780935|968088|P1|COMPLETED|Overall Study||0
395669|NCT01780935|968087|P2|Safety Set|Overall Study||336
395670|NCT01780935|968088|P1|Safety Set|Overall Study||334
395671|NCT01780935|968087|P2|STARTED|Overall Study||336
395672|NCT01780935|968088|P1|STARTED|Overall Study||335
395673|NCT01780922|968118|P6|NOT COMPLETED|Third Intervention (1 Day)||0
395674|NCT01780922|968119|P5|NOT COMPLETED|Third Intervention (1 Day)||0
395675|NCT01780922|968120|P4|NOT COMPLETED|Third Intervention (1 Day)||0
395676|NCT01780922|968121|P3|NOT COMPLETED|Third Intervention (1 Day)||0
395677|NCT01780922|968122|P2|NOT COMPLETED|Third Intervention (1 Day)||0
395678|NCT01780922|968123|P1|NOT COMPLETED|Third Intervention (1 Day)||0
395679|NCT01780922|968118|P6|COMPLETED|Third Intervention (1 Day)||2
395680|NCT01780922|968119|P5|COMPLETED|Third Intervention (1 Day)||2
395681|NCT01780922|968120|P4|COMPLETED|Third Intervention (1 Day)||2
395682|NCT01780922|968121|P3|COMPLETED|Third Intervention (1 Day)||2
395683|NCT01780922|968122|P2|COMPLETED|Third Intervention (1 Day)||2
395684|NCT01780922|968123|P1|COMPLETED|Third Intervention (1 Day)||2
395685|NCT01780922|968118|P6|STARTED|Third Intervention (1 Day)||2
395686|NCT01780922|968119|P5|STARTED|Third Intervention (1 Day)||2
395687|NCT01780922|968120|P4|STARTED|Third Intervention (1 Day)||2
395688|NCT01780922|968121|P3|STARTED|Third Intervention (1 Day)||2
395689|NCT01780922|968122|P2|STARTED|Third Intervention (1 Day)||2
395690|NCT01780922|968123|P1|STARTED|Third Intervention (1 Day)||2
395691|NCT01780922|968118|P6|NOT COMPLETED|Washout (7 Days)||0
395692|NCT01780922|968119|P5|NOT COMPLETED|Washout (7 Days)||0
395693|NCT01780922|968120|P4|NOT COMPLETED|Washout (7 Days)||0
395694|NCT01780922|968121|P3|NOT COMPLETED|Washout (7 Days)||0
395695|NCT01780922|968122|P2|NOT COMPLETED|Washout (7 Days)||0
395696|NCT01780922|968123|P1|NOT COMPLETED|Washout (7 Days)||0
395697|NCT01780922|968118|P6|COMPLETED|Washout (7 Days)||2
395698|NCT01780922|968119|P5|COMPLETED|Washout (7 Days)||2
395699|NCT01780922|968120|P4|COMPLETED|Washout (7 Days)||2
395700|NCT01780922|968121|P3|COMPLETED|Washout (7 Days)||2
395701|NCT01780922|968122|P2|COMPLETED|Washout (7 Days)||2
395702|NCT01780922|968123|P1|COMPLETED|Washout (7 Days)||2
395703|NCT01780922|968118|P6|STARTED|Washout (7 Days)||2
395704|NCT01780922|968119|P5|STARTED|Washout (7 Days)||2
395705|NCT01780922|968120|P4|STARTED|Washout (7 Days)||2
395706|NCT01780922|968121|P3|STARTED|Washout (7 Days)||2
395707|NCT01780922|968122|P2|STARTED|Washout (7 Days)||2
395708|NCT01780922|968123|P1|STARTED|Washout (7 Days)||2
395709|NCT01780922|968118|P6|NOT COMPLETED|Second Intervention (1 Day)||0
395710|NCT01780922|968119|P5|NOT COMPLETED|Second Intervention (1 Day)||0
395711|NCT01780922|968120|P4|NOT COMPLETED|Second Intervention (1 Day)||0
395712|NCT01780922|968121|P3|NOT COMPLETED|Second Intervention (1 Day)||0
395713|NCT01780922|968122|P2|NOT COMPLETED|Second Intervention (1 Day)||0
395714|NCT01780922|968123|P1|NOT COMPLETED|Second Intervention (1 Day)||0
395715|NCT01780922|968118|P6|COMPLETED|Second Intervention (1 Day)||2
395716|NCT01780922|968119|P5|COMPLETED|Second Intervention (1 Day)||2
395717|NCT01780922|968120|P4|COMPLETED|Second Intervention (1 Day)||2
395718|NCT01780922|968121|P3|COMPLETED|Second Intervention (1 Day)||2
395719|NCT01780922|968122|P2|COMPLETED|Second Intervention (1 Day)||2
395720|NCT01780922|968123|P1|COMPLETED|Second Intervention (1 Day)||2
395721|NCT01780922|968118|P6|STARTED|Second Intervention (1 Day)||2
395722|NCT01780922|968119|P5|STARTED|Second Intervention (1 Day)||2
395723|NCT01780922|968120|P4|STARTED|Second Intervention (1 Day)||2
395724|NCT01780922|968121|P3|STARTED|Second Intervention (1 Day)||2
395725|NCT01780922|968122|P2|STARTED|Second Intervention (1 Day)||2
395726|NCT01780922|968123|P1|STARTED|Second Intervention (1 Day)||2
395727|NCT01780922|968118|P6|NOT COMPLETED|Washout (7 Days)||0
395728|NCT01780922|968119|P5|NOT COMPLETED|Washout (7 Days)||0
395729|NCT01780922|968120|P4|NOT COMPLETED|Washout (7 Days)||0
395730|NCT01780922|968121|P3|NOT COMPLETED|Washout (7 Days)||0
395731|NCT01780922|968122|P2|NOT COMPLETED|Washout (7 Days)||0
395732|NCT01780922|968123|P1|NOT COMPLETED|Washout (7 Days)||0
395733|NCT01780922|968118|P6|COMPLETED|Washout (7 Days)||2
395734|NCT01780922|968119|P5|COMPLETED|Washout (7 Days)||2
395735|NCT01780922|968120|P4|COMPLETED|Washout (7 Days)||2
395736|NCT01780922|968121|P3|COMPLETED|Washout (7 Days)||2
395737|NCT01780922|968122|P2|COMPLETED|Washout (7 Days)||2
395738|NCT01780922|968123|P1|COMPLETED|Washout (7 Days)||2
395739|NCT01780922|968118|P6|STARTED|Washout (7 Days)||2
395740|NCT01780922|968119|P5|STARTED|Washout (7 Days)||2
395741|NCT01780922|968120|P4|STARTED|Washout (7 Days)||2
395742|NCT01780922|968121|P3|STARTED|Washout (7 Days)||2
395743|NCT01780922|968122|P2|STARTED|Washout (7 Days)||2
395744|NCT01780922|968123|P1|STARTED|Washout (7 Days)||2
395745|NCT01780922|968118|P6|NOT COMPLETED|First Intervention (1 Day)||0
395746|NCT01780922|968119|P5|NOT COMPLETED|First Intervention (1 Day)||0
395747|NCT01780922|968120|P4|NOT COMPLETED|First Intervention (1 Day)||0
395748|NCT01780922|968121|P3|NOT COMPLETED|First Intervention (1 Day)||0
395749|NCT01780922|968122|P2|NOT COMPLETED|First Intervention (1 Day)||0
395750|NCT01780922|968123|P1|NOT COMPLETED|First Intervention (1 Day)||0
395751|NCT01780922|968118|P6|COMPLETED|First Intervention (1 Day)||2
395752|NCT01780922|968119|P5|COMPLETED|First Intervention (1 Day)||2
395753|NCT01780922|968120|P4|COMPLETED|First Intervention (1 Day)||2
395754|NCT01780922|968121|P3|COMPLETED|First Intervention (1 Day)||2
395755|NCT01780922|968122|P2|COMPLETED|First Intervention (1 Day)||2
395756|NCT01780922|968123|P1|COMPLETED|First Intervention (1 Day)||2
395757|NCT01780922|968118|P6|STARTED|First Intervention (1 Day)||2
395758|NCT01780922|968119|P5|STARTED|First Intervention (1 Day)||2
395759|NCT01780922|968120|P4|STARTED|First Intervention (1 Day)||2
395760|NCT01780922|968121|P3|STARTED|First Intervention (1 Day)||2
395761|NCT01780922|968122|P2|STARTED|First Intervention (1 Day)||2
395762|NCT01780922|968123|P1|STARTED|First Intervention (1 Day)||2
395763|NCT01780870|968178|P2|NOT COMPLETED|Overall Study||0
395764|NCT01780870|968179|P1|NOT COMPLETED|Overall Study||0
395765|NCT01780870|968178|P2|COMPLETED|Overall Study||5
395766|NCT01780870|968179|P1|COMPLETED|Overall Study||0
395767|NCT01780870|968178|P2|STARTED|Overall Study||5
395768|NCT01780870|968179|P1|STARTED|Overall Study||0
395769|NCT01780584|968192|P3|NOT COMPLETED|Overall Study||2
395770|NCT01780584|968193|P2|NOT COMPLETED|Overall Study||1
395771|NCT01780584|968194|P1|NOT COMPLETED|Overall Study||1
395772|NCT01780584|968192|P3|COMPLETED|Overall Study||13
395773|NCT01780584|968193|P2|COMPLETED|Overall Study||14
395774|NCT01780584|968194|P1|COMPLETED|Overall Study||14
395775|NCT01780584|968192|P3|STARTED|Overall Study||15
395776|NCT01780584|968193|P2|STARTED|Overall Study||15
395777|NCT01780584|968194|P1|STARTED|Overall Study||15
395778|NCT01780545|968216|P2|NOT COMPLETED|Overall Study||2
395779|NCT01780545|968217|P1|NOT COMPLETED|Overall Study||4
395780|NCT01780545|968216|P2|COMPLETED|Overall Study||99
395781|NCT01780545|968217|P1|COMPLETED|Overall Study||95
395782|NCT01780545|968216|P2|STARTED|Overall Study||101
395783|NCT01780545|968217|P1|STARTED|Overall Study||99
395784|NCT01780506|968235|P2|NOT COMPLETED|Overall Study||434
395785|NCT01780506|968236|P1|NOT COMPLETED|Overall Study||438
395786|NCT01780506|968235|P2|COMPLETED|Overall Study||0
395787|NCT01780506|968236|P1|COMPLETED|Overall Study||0
395788|NCT01780506|968235|P2|STARTED|Overall Study||434
395789|NCT01780506|968236|P1|STARTED|Overall Study||438
395790|NCT01780389|968274|P1|NOT COMPLETED|Overall Study||1
395791|NCT01780389|968274|P1|COMPLETED|Overall Study|One patient discontinued due to adverse event.|4
395792|NCT01780389|968274|P1|STARTED|Overall Study||5
395793|NCT01780350|968285|P1|NOT COMPLETED|Overall Study||0
395794|NCT01780350|968285|P1|COMPLETED|Overall Study||200
395795|NCT01780350|968285|P1|STARTED|Overall Study||200
395796|NCT01780337|968292|P2|NOT COMPLETED|Overall Study||0
395797|NCT01780337|968293|P1|NOT COMPLETED|Overall Study||0
395798|NCT01780337|968292|P2|COMPLETED|Overall Study||6
395799|NCT01780337|968293|P1|COMPLETED|Overall Study||6
395800|NCT01780337|968292|P2|STARTED|Overall Study||6
395801|NCT01780337|968293|P1|STARTED|Overall Study||6
395802|NCT01780324|968305|P2|NOT COMPLETED|Overall Study||6
395803|NCT01780324|968306|P1|NOT COMPLETED|Overall Study||1
395804|NCT01780324|968305|P2|COMPLETED|Overall Study||33
395805|NCT01780324|968306|P1|COMPLETED|Overall Study||40
395806|NCT01780324|968305|P2|STARTED|Overall Study||39
395807|NCT01780324|968306|P1|STARTED|Overall Study||41
395808|NCT01779869|968312|P1|NOT COMPLETED|Overall Study||2
395809|NCT01779869|968312|P1|COMPLETED|Overall Study||14
395810|NCT01779869|968312|P1|STARTED|Overall Study||16
395811|NCT01779648|968318|P2|NOT COMPLETED|Overall Study||0
395812|NCT01779648|968319|P1|NOT COMPLETED|Overall Study||1
395813|NCT01779648|968318|P2|COMPLETED|Overall Study||27
395814|NCT01779648|968319|P1|COMPLETED|Overall Study||27
395815|NCT01779648|968318|P2|STARTED|Overall Study||27
395816|NCT01779648|968319|P1|STARTED|Overall Study||28
395817|NCT01779440|968349|P2|NOT COMPLETED|Overall Study||5
395818|NCT01779440|968350|P1|NOT COMPLETED|Overall Study||3
395819|NCT01779440|968349|P2|COMPLETED|Overall Study||23
395820|NCT01779440|968350|P1|COMPLETED|Overall Study||27
395821|NCT01779440|968349|P2|STARTED|Overall Study||28
395822|NCT01779440|968350|P1|STARTED|Overall Study||30
395823|NCT01779219|968360|P2|NOT COMPLETED|Overall Study||0
395824|NCT01779219|968361|P1|NOT COMPLETED|Overall Study||0
395825|NCT01779219|968360|P2|COMPLETED|Overall Study|First interim analysis|21
395826|NCT01779219|968361|P1|COMPLETED|Overall Study|First interim analysis|21
395827|NCT01779219|968360|P2|STARTED|Overall Study|First interim analysis|21
395828|NCT01779219|968361|P1|STARTED|Overall Study|First interim analysis|21
395829|NCT01779167|968373|P1|NOT COMPLETED|Overall Study||1
395830|NCT01779167|968373|P1|COMPLETED|Overall Study||3
395831|NCT01779167|968373|P1|STARTED|Overall Study||4
395832|NCT01778985|968380|P2|NOT COMPLETED|Overall Study||3
395833|NCT01778985|968381|P1|NOT COMPLETED|Overall Study||7
395834|NCT01778985|968380|P2|COMPLETED|Overall Study||12
395835|NCT01778985|968381|P1|COMPLETED|Overall Study||8
395836|NCT01778985|968380|P2|STARTED|Overall Study||15
395837|NCT01778985|968381|P1|STARTED|Overall Study||15
395838|NCT01778855|968427|P2|NOT COMPLETED|Overall Study||1
395839|NCT01778855|968428|P1|NOT COMPLETED|Overall Study||0
395840|NCT01778855|968427|P2|COMPLETED|Overall Study||3
395841|NCT01778855|968428|P1|COMPLETED|Overall Study||2
395842|NCT01778855|968427|P2|STARTED|Overall Study||4
395843|NCT01778855|968428|P1|STARTED|Overall Study||2
395844|NCT01778751|968436|P2|NOT COMPLETED|Overall Study||2
395845|NCT01778751|968437|P1|NOT COMPLETED|Overall Study||2
395846|NCT01778751|968436|P2|COMPLETED|Overall Study||23
395847|NCT01778751|968437|P1|COMPLETED|Overall Study||23
395848|NCT01778751|968436|P2|STARTED|Overall Study||25
395849|NCT01778751|968437|P1|STARTED|Overall Study||25
395850|NCT01778634|968451|P2|NOT COMPLETED|Overall Study||0
395851|NCT01778634|968452|P1|NOT COMPLETED|Overall Study||0
395852|NCT01778634|968451|P2|COMPLETED|Overall Study||60
395853|NCT01778634|968452|P1|COMPLETED|Overall Study||61
395854|NCT01778634|968451|P2|STARTED|Overall Study||60
395855|NCT01778634|968452|P1|STARTED|Overall Study||61
395856|NCT01778530|968488|P1|NOT COMPLETED|Overall Study||2
395857|NCT01778530|968488|P1|COMPLETED|Overall Study||0
395858|NCT01778530|968488|P1|STARTED|Overall Study||2
395859|NCT01778296|968493|P1|NOT COMPLETED|Overall Study||0
395860|NCT01778296|968493|P1|COMPLETED|Overall Study|No patient was lost to follow-up.|12
395861|NCT01778296|968493|P1|STARTED|Overall Study|There were 12 patients included in the study in the initial stage.|12
395862|NCT01778127|968500|P3|NOT COMPLETED|Overall Study||6
395863|NCT01778127|968501|P2|NOT COMPLETED|Overall Study||2
395864|NCT01778127|968502|P1|NOT COMPLETED|Overall Study||8
395865|NCT01778127|968500|P3|COMPLETED|Overall Study||26
395866|NCT01778127|968501|P2|COMPLETED|Overall Study||31
395867|NCT01778127|968502|P1|COMPLETED|Overall Study||25
395868|NCT01778127|968500|P3|STARTED|Overall Study||32
395869|NCT01778127|968501|P2|STARTED|Overall Study||33
395870|NCT01778127|968502|P1|STARTED|Overall Study||33
395871|NCT01778062|968545|P2|NOT COMPLETED|Overall Study||11
395872|NCT01778062|968546|P1|NOT COMPLETED|Overall Study||6
395873|NCT01778062|968545|P2|COMPLETED|Overall Study||57
395874|NCT01778062|968546|P1|COMPLETED|Overall Study||62
395875|NCT01778062|968545|P2|Intent to Treat (ITT)|Overall Study|One failed to perform primary efficacy evaluation and was excluded, 135 were included in the ITT set|67
395876|NCT01778062|968546|P1|Intent to Treat (ITT)|Overall Study||68
395877|NCT01778062|968545|P2|Safety Set|Overall Study||68
395878|NCT01778062|968546|P1|Safety Set|Overall Study||68
395879|NCT01778062|968545|P2|STARTED|Overall Study||68
395880|NCT01778062|968546|P1|STARTED|Overall Study||68
395881|NCT01778049|968560|P6|NOT COMPLETED|Double Blind Treatment Period||7
395882|NCT01778049|968561|P5|NOT COMPLETED|Double Blind Treatment Period||12
395883|NCT01778049|968562|P4|NOT COMPLETED|Double Blind Treatment Period||12
395884|NCT01778049|968563|P3|NOT COMPLETED|Double Blind Treatment Period||15
395885|NCT01778049|968564|P2|NOT COMPLETED|Double Blind Treatment Period||0
395886|NCT01778049|968565|P1|NOT COMPLETED|Double Blind Treatment Period||0
395887|NCT01778049|968560|P6|COMPLETED|Double Blind Treatment Period||105
395888|NCT01778049|968561|P5|COMPLETED|Double Blind Treatment Period||102
395889|NCT01778049|968562|P4|COMPLETED|Double Blind Treatment Period||118
395890|NCT01778049|968563|P3|COMPLETED|Double Blind Treatment Period||111
395891|NCT01778049|968564|P2|COMPLETED|Double Blind Treatment Period||0
395892|NCT01778049|968565|P1|COMPLETED|Double Blind Treatment Period||0
395893|NCT01778049|968560|P6|STARTED|Double Blind Treatment Period||112
395894|NCT01778049|968561|P5|STARTED|Double Blind Treatment Period||114
395895|NCT01778049|968562|P4|STARTED|Double Blind Treatment Period||130
395896|NCT01778049|968563|P3|STARTED|Double Blind Treatment Period||126
395897|NCT01778049|968564|P2|STARTED|Double Blind Treatment Period||0
395898|NCT01778049|968565|P1|STARTED|Double Blind Treatment Period||0
395899|NCT01778049|968560|P6|NOT COMPLETED|Open Label Treatment Period||0
395900|NCT01778049|968561|P5|NOT COMPLETED|Open Label Treatment Period||0
395901|NCT01778049|968562|P4|NOT COMPLETED|Open Label Treatment Period||0
395902|NCT01778049|968563|P3|NOT COMPLETED|Open Label Treatment Period||0
395903|NCT01778049|968564|P2|NOT COMPLETED|Open Label Treatment Period||129
395904|NCT01778049|968565|P1|NOT COMPLETED|Open Label Treatment Period||98
395905|NCT01778049|968560|P6|COMPLETED|Open Label Treatment Period||0
395906|NCT01778049|968561|P5|COMPLETED|Open Label Treatment Period||0
395907|NCT01778049|968562|P4|COMPLETED|Open Label Treatment Period||0
395908|NCT01778049|968563|P3|COMPLETED|Open Label Treatment Period||0
395909|NCT01778049|968564|P2|COMPLETED|Open Label Treatment Period||226
395910|NCT01778049|968565|P1|COMPLETED|Open Label Treatment Period||256
395911|NCT01778049|968560|P6|STARTED|Open Label Treatment Period||0
395912|NCT01778049|968561|P5|STARTED|Open Label Treatment Period||0
395913|NCT01778049|968562|P4|STARTED|Open Label Treatment Period||0
395914|NCT01778049|968563|P3|STARTED|Open Label Treatment Period||0
395915|NCT01778049|968564|P2|STARTED|Open Label Treatment Period||355
395916|NCT01778049|968565|P1|STARTED|Open Label Treatment Period||354
395917|NCT01778023|968583|P2|NOT COMPLETED|Overall Study||3
395918|NCT01778023|968584|P1|NOT COMPLETED|Overall Study||0
395919|NCT01778023|968583|P2|COMPLETED|Overall Study||15
395920|NCT01778023|968584|P1|COMPLETED|Overall Study||36
395921|NCT01778023|968583|P2|Exposed|Overall Study||15
395922|NCT01778023|968584|P1|Exposed|Overall Study||36
395923|NCT01778023|968583|P2|STARTED|Overall Study||18
395924|NCT01778023|968584|P1|STARTED|Overall Study||36
395925|NCT01778010|968601|P1|NOT COMPLETED|Overall Study||5
395926|NCT01778010|968601|P1|COMPLETED|Overall Study||8
395927|NCT01778010|968601|P1|STARTED|Overall Study||13
395928|NCT01777997|968642|P1|NOT COMPLETED|Weeks 48 to 72/96 on ART||2
395929|NCT01777997|968642|P1|COMPLETED|Weeks 48 to 72/96 on ART||26
395930|NCT01777997|968642|P1|STARTED|Weeks 48 to 72/96 on ART||28
395931|NCT01777997|968642|P1|NOT COMPLETED|Weeks 0 to 24/48 on ART||1
395932|NCT01777997|968642|P1|COMPLETED|Weeks 0 to 24/48 on ART|7 of these participants opted not to continue ART into next period|35
395933|NCT01777997|968642|P1|STARTED|Weeks 0 to 24/48 on ART||36
395934|NCT01777997|968642|P1|NOT COMPLETED|12 Week lead-in of no ART||2
395935|NCT01777997|968642|P1|COMPLETED|12 Week lead-in of no ART||36
395936|NCT01777997|968642|P1|STARTED|12 Week lead-in of no ART||38
395937|NCT01777945|968654|P1|NOT COMPLETED|Overall Study||0
395938|NCT01777945|968654|P1|COMPLETED|Overall Study||46
395939|NCT01777945|968654|P1|Evaluable Participants|Overall Study||45
395940|NCT01777945|968654|P1|STARTED|Overall Study||46
395941|NCT01777932|968664|P1|NOT COMPLETED|Overall Study||205
395942|NCT01777932|968664|P1|COMPLETED|Overall Study||15
395943|NCT01777932|968664|P1|STARTED|Overall Study||220
395944|NCT01777776|968682|P4|NOT COMPLETED|Overall Study||4
395945|NCT01777776|968683|P3|NOT COMPLETED|Overall Study||6
395946|NCT01777776|968684|P2|NOT COMPLETED|Overall Study||12
395947|NCT01777776|968685|P1|NOT COMPLETED|Overall Study||6
395948|NCT01777776|968682|P4|COMPLETED|Overall Study||0
395949|NCT01777776|968683|P3|COMPLETED|Overall Study||0
395950|NCT01777776|968684|P2|COMPLETED|Overall Study||0
395951|NCT01777776|968685|P1|COMPLETED|Overall Study||0
395952|NCT01777776|968682|P4|STARTED|Overall Study||4
395953|NCT01777776|968683|P3|STARTED|Overall Study||6
395954|NCT01777776|968684|P2|STARTED|Overall Study||12
395955|NCT01777776|968685|P1|STARTED|Overall Study||6
395956|NCT01777763|968744|P2|NOT COMPLETED|Overall Study||47
395957|NCT01777763|968745|P1|NOT COMPLETED|Overall Study||4
395958|NCT01777763|968744|P2|COMPLETED|Overall Study||163
395959|NCT01777763|968745|P1|COMPLETED|Overall Study||16
395960|NCT01777763|968744|P2|STARTED|Overall Study||210
395961|NCT01777763|968745|P1|STARTED|Overall Study||20
395962|NCT01777620|968769|P2|NOT COMPLETED|Overall Study||0
395963|NCT01777620|968770|P1|NOT COMPLETED|Overall Study||1
395964|NCT01777620|968769|P2|COMPLETED|Overall Study||62
395965|NCT01777620|968770|P1|COMPLETED|Overall Study||62
395966|NCT01777620|968769|P2|STARTED|Overall Study||62
395967|NCT01777620|968770|P1|STARTED|Overall Study||63
395968|NCT01777581|968796|P2|NOT COMPLETED|Overall Study||2
395969|NCT01777581|968797|P1|NOT COMPLETED|Overall Study||3
395970|NCT01777581|968796|P2|COMPLETED|Overall Study||3
395971|NCT01777581|968797|P1|COMPLETED|Overall Study||5
395972|NCT01777581|968796|P2|STARTED|Overall Study|Includes one subject screened/consented but not assigned to either arm.|5
395973|NCT01777581|968797|P1|STARTED|Overall Study|Includes one subject screened/consented but not assigned to either arm.|8
395974|NCT01777542|968815|P2|NOT COMPLETED|Second Intervention (20 Weeks)||1
395975|NCT01777542|968816|P1|NOT COMPLETED|Second Intervention (20 Weeks)||0
395976|NCT01777542|968815|P2|COMPLETED|Second Intervention (20 Weeks)||14
395977|NCT01777542|968816|P1|COMPLETED|Second Intervention (20 Weeks)||15
395978|NCT01777542|968815|P2|STARTED|Second Intervention (20 Weeks)||15
395979|NCT01777542|968816|P1|STARTED|Second Intervention (20 Weeks)||15
395980|NCT01777542|968815|P2|NOT COMPLETED|Washout Period (28 +/- 2 Weeks)||0
395981|NCT01777542|968816|P1|NOT COMPLETED|Washout Period (28 +/- 2 Weeks)||0
395982|NCT01777542|968815|P2|COMPLETED|Washout Period (28 +/- 2 Weeks)||15
395983|NCT01777542|968816|P1|COMPLETED|Washout Period (28 +/- 2 Weeks)||15
395984|NCT01777542|968815|P2|STARTED|Washout Period (28 +/- 2 Weeks)||15
395985|NCT01777542|968816|P1|STARTED|Washout Period (28 +/- 2 Weeks)||15
395986|NCT01777542|968815|P2|NOT COMPLETED|First Intervention (20 Weeks)||0
395987|NCT01777542|968816|P1|NOT COMPLETED|First Intervention (20 Weeks)||0
395988|NCT01777542|968815|P2|COMPLETED|First Intervention (20 Weeks)||15
395989|NCT01777542|968816|P1|COMPLETED|First Intervention (20 Weeks)||15
395990|NCT01777542|968815|P2|STARTED|First Intervention (20 Weeks)||15
395991|NCT01777542|968816|P1|STARTED|First Intervention (20 Weeks)||15
395992|NCT01777438|968857|P2|NOT COMPLETED|Overall Study||0
395993|NCT01777438|968858|P1|NOT COMPLETED|Overall Study||0
395994|NCT01777438|968857|P2|COMPLETED|Overall Study||82
395995|NCT01777438|968858|P1|COMPLETED|Overall Study||352
395996|NCT01777438|968857|P2|STARTED|Overall Study||82
395997|NCT01777438|968858|P1|STARTED|Overall Study||352
395998|NCT01777425|968870|P1|NOT COMPLETED|Overall Study||0
395999|NCT01777425|968870|P1|COMPLETED|Overall Study||389
396000|NCT01777425|968870|P1|STARTED|Overall Study||389
396001|NCT01777412|968876|P1|NOT COMPLETED|Overall Study||0
396002|NCT01777412|968876|P1|COMPLETED|Overall Study||10
396003|NCT01777412|968876|P1|STARTED|Overall Study||10
396004|NCT01777334|968884|P2|NOT COMPLETED|Overall Study||63
396005|NCT01777334|968885|P1|NOT COMPLETED|Overall Study||53
396006|NCT01777334|968884|P2|COMPLETED|Overall Study||388
396007|NCT01777334|968885|P1|COMPLETED|Overall Study||401
396008|NCT01777334|968884|P2|STARTED|Overall Study||451
396009|NCT01777334|968885|P1|STARTED|Overall Study||454
396010|NCT01777321|968895|P2|NOT COMPLETED|Overall Study||1
396011|NCT01777321|968896|P1|NOT COMPLETED|Overall Study||0
396012|NCT01777321|968895|P2|COMPLETED|Overall Study||29
396013|NCT01777321|968896|P1|COMPLETED|Overall Study||30
396014|NCT01777321|968895|P2|STARTED|Overall Study||30
396015|NCT01777321|968896|P1|STARTED|Overall Study||30
396016|NCT01777282|968937|P5|NOT COMPLETED|Overall Study||7
396017|NCT01777282|968938|P4|NOT COMPLETED|Overall Study||2
396018|NCT01777282|968939|P3|NOT COMPLETED|Overall Study||6
396019|NCT01777282|968940|P2|NOT COMPLETED|Overall Study||4
396020|NCT01777282|968941|P1|NOT COMPLETED|Overall Study||11
396021|NCT01777282|968937|P5|COMPLETED|Overall Study||54
396022|NCT01777282|968938|P4|COMPLETED|Overall Study||59
396023|NCT01777282|968939|P3|COMPLETED|Overall Study||59
396024|NCT01777282|968940|P2|COMPLETED|Overall Study||63
396025|NCT01777282|968941|P1|COMPLETED|Overall Study||109
396026|NCT01777282|968937|P5|Completing Follow-up Period|Overall Study||54
396027|NCT01777282|968938|P4|Completing Follow-up Period|Overall Study||59
396028|NCT01777282|968939|P3|Completing Follow-up Period|Overall Study||59
396029|NCT01777282|968940|P2|Completing Follow-up Period|Overall Study||63
396030|NCT01777282|968941|P1|Completing Follow-up Period|Overall Study||109
396031|NCT01777282|968937|P5|Completing Treatment Period|Overall Study||54
396032|NCT01777282|968938|P4|Completing Treatment Period|Overall Study||59
396033|NCT01777282|968939|P3|Completing Treatment Period|Overall Study||59
396034|NCT01777282|968940|P2|Completing Treatment Period|Overall Study||63
396035|NCT01777282|968941|P1|Completing Treatment Period|Overall Study||109
396036|NCT01777282|968937|P5|STARTED|Overall Study||61
396037|NCT01777282|968938|P4|STARTED|Overall Study||61
396038|NCT01777282|968939|P3|STARTED|Overall Study||65
396039|NCT01777282|968940|P2|STARTED|Overall Study||67
396040|NCT01777282|968941|P1|STARTED|Overall Study||120
396041|NCT01777269|968985|P2|NOT COMPLETED|Overall Study||59
396042|NCT01777269|968986|P1|NOT COMPLETED|Overall Study||55
396043|NCT01777269|968985|P2|COMPLETED|Overall Study||184
396044|NCT01777269|968986|P1|COMPLETED|Overall Study||191
396045|NCT01777269|968985|P2|STARTED|Overall Study||243
396046|NCT01777269|968986|P1|STARTED|Overall Study||246
396047|NCT01777217|969014|P2|NOT COMPLETED|Overall Study||0
396048|NCT01777217|969015|P1|NOT COMPLETED|Overall Study||0
396049|NCT01777217|969014|P2|COMPLETED|Overall Study||4
396050|NCT01777217|969015|P1|COMPLETED|Overall Study||4
396051|NCT01777217|969014|P2|STARTED|Overall Study||4
396052|NCT01777217|969015|P1|STARTED|Overall Study||4
396053|NCT01777191|969023|P2|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||13
396054|NCT01777191|969024|P1|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||9
396055|NCT01777191|969023|P2|COMPLETED|Safety Extension Per (Week 12-Week 48)||78
396056|NCT01777191|969024|P1|COMPLETED|Safety Extension Per (Week 12-Week 48)||85
396057|NCT01777191|969023|P2|STARTED|Safety Extension Per (Week 12-Week 48)|Participation in the safety extension period was optional.|91
396058|NCT01777191|969024|P1|STARTED|Safety Extension Per (Week 12-Week 48)|Participation in the safety extension period was optional.|94
396059|NCT01777191|969023|P2|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||8
396060|NCT01777191|969024|P1|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||6
396061|NCT01777191|969023|P2|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||94
396062|NCT01777191|969024|P1|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||96
396063|NCT01777191|969023|P2|STARTED|Treatment Period (Per) (Week 0-Week 12)||102
396064|NCT01777191|969024|P1|STARTED|Treatment Period (Per) (Week 0-Week 12)||102
396065|NCT01777126|969054|P2|NOT COMPLETED|Overall Study||0
396066|NCT01777126|969055|P1|NOT COMPLETED|Overall Study||0
396067|NCT01777126|969054|P2|COMPLETED|Overall Study||46
396068|NCT01777126|969055|P1|COMPLETED|Overall Study||48
396069|NCT01777126|969054|P2|STARTED|Overall Study||46
396070|NCT01777126|969055|P1|STARTED|Overall Study||48
396071|NCT01776645|969078|P2|NOT COMPLETED|Overall Study||14
396072|NCT01776645|969079|P1|NOT COMPLETED|Overall Study||14
396073|NCT01776645|969078|P2|COMPLETED|Overall Study||14
396074|NCT01776645|969079|P1|COMPLETED|Overall Study||14
396075|NCT01776645|969078|P2|STARTED|Overall Study||28
396076|NCT01776645|969079|P1|STARTED|Overall Study||28
396077|NCT01776554|969087|P2|NOT COMPLETED|Overall Study||23
396078|NCT01776554|969088|P1|NOT COMPLETED|Overall Study||17
396079|NCT01776554|969087|P2|COMPLETED|Overall Study||307
396080|NCT01776554|969088|P1|COMPLETED|Overall Study||315
396081|NCT01776554|969087|P2|STARTED|Overall Study||330
396082|NCT01776554|969088|P1|STARTED|Overall Study||332
396083|NCT01776541|969131|P2|NOT COMPLETED|Overall Study||75
396084|NCT01776541|969132|P1|NOT COMPLETED|Overall Study||56
396085|NCT01776541|969131|P2|COMPLETED|Overall Study||416
396086|NCT01776541|969132|P1|COMPLETED|Overall Study||432
396087|NCT01776541|969131|P2|STARTED|Overall Study||491
396088|NCT01776541|969132|P1|STARTED|Overall Study||488
396089|NCT01776268|969153|P2|NOT COMPLETED|Overall Study||0
396090|NCT01776268|969154|P1|NOT COMPLETED|Overall Study||0
396091|NCT01776268|969153|P2|COMPLETED|Overall Study||51
396092|NCT01776268|969154|P1|COMPLETED|Overall Study||48
396093|NCT01776268|969153|P2|STARTED|Overall Study||51
396094|NCT01776268|969154|P1|STARTED|Overall Study||48
396095|NCT01776008|969162|P1|NOT COMPLETED|Overall Study||2
396096|NCT01776008|969162|P1|COMPLETED|Overall Study||14
396097|NCT01776008|969162|P1|STARTED|Overall Study||16
396098|NCT01775995|969176|P2|NOT COMPLETED|Overall Study||1
396099|NCT01775995|969177|P1|NOT COMPLETED|Overall Study||1
396100|NCT01775995|969176|P2|COMPLETED|Overall Study|One control participant was unable to reach at 26 week follow up|13
396101|NCT01775995|969177|P1|COMPLETED|Overall Study|One experimental participant was unable to reach at 26 week follow up|20
396102|NCT01775995|969176|P2|STARTED|Overall Study||14
396103|NCT01775995|969177|P1|STARTED|Overall Study||21
396104|NCT01775865|969240|P3|NOT COMPLETED|Overall Study||0
396105|NCT01775865|969241|P2|NOT COMPLETED|Overall Study||1
396106|NCT01775865|969242|P1|NOT COMPLETED|Overall Study||3
396107|NCT01775865|969240|P3|COMPLETED|Overall Study||17
396108|NCT01775865|969241|P2|COMPLETED|Overall Study||13
396109|NCT01775865|969242|P1|COMPLETED|Overall Study||11
396110|NCT01775865|969240|P3|STARTED|Overall Study||17
396111|NCT01775865|969241|P2|STARTED|Overall Study||14
396112|NCT01775865|969242|P1|STARTED|Overall Study||14
396113|NCT01775852|969258|P2|NOT COMPLETED|Overall Study||1
396114|NCT01775852|969259|P1|NOT COMPLETED|Overall Study||0
396115|NCT01775852|969258|P2|COMPLETED|Overall Study||13
396116|NCT01775852|969259|P1|COMPLETED|Overall Study||31
396117|NCT01775852|969258|P2|STARTED|Overall Study||14
396118|NCT01775852|969259|P1|STARTED|Overall Study||31
396119|NCT01775787|969271|P2|NOT COMPLETED|Second 7-10 Days||2
396120|NCT01775787|969272|P1|NOT COMPLETED|Second 7-10 Days||0
396121|NCT01775787|969271|P2|COMPLETED|Second 7-10 Days||6
396122|NCT01775787|969272|P1|COMPLETED|Second 7-10 Days||12
396123|NCT01775787|969271|P2|STARTED|Second 7-10 Days||8
396124|NCT01775787|969272|P1|STARTED|Second 7-10 Days||12
396125|NCT01775787|969271|P2|NOT COMPLETED|First 7-10 Days||6
396126|NCT01775787|969272|P1|NOT COMPLETED|First 7-10 Days||1
396127|NCT01775787|969271|P2|COMPLETED|First 7-10 Days||8
396128|NCT01775787|969272|P1|COMPLETED|First 7-10 Days||12
396129|NCT01775787|969271|P2|STARTED|First 7-10 Days||14
396130|NCT01775787|969272|P1|STARTED|First 7-10 Days||13
396131|NCT01775774|969283|P3|NOT COMPLETED|Overall Study||0
396132|NCT01775774|969284|P2|NOT COMPLETED|Overall Study||0
396133|NCT01775774|969285|P1|NOT COMPLETED|Overall Study||0
396134|NCT01775774|969283|P3|COMPLETED|Overall Study||3
396135|NCT01775774|969284|P2|COMPLETED|Overall Study||3
396136|NCT01775774|969285|P1|COMPLETED|Overall Study||3
396137|NCT01775774|969283|P3|STARTED|Overall Study||3
396138|NCT01775774|969284|P2|STARTED|Overall Study||3
396139|NCT01775774|969285|P1|STARTED|Overall Study||3
396140|NCT01775722|969311|P1|NOT COMPLETED|Overall Study||2
396141|NCT01775722|969311|P1|COMPLETED|Overall Study||20
396142|NCT01775722|969311|P1|STARTED|Overall Study||22
396143|NCT01775670|969319|P2|NOT COMPLETED|Overall Study||1
396144|NCT01775670|969320|P1|NOT COMPLETED|Overall Study||1
396145|NCT01775670|969319|P2|COMPLETED|Overall Study||2
396146|NCT01775670|969320|P1|COMPLETED|Overall Study||0
396147|NCT01775670|969319|P2|STARTED|Overall Study||3
396148|NCT01775670|969320|P1|STARTED|Overall Study||1
396149|NCT01775553|969346|P1|NOT COMPLETED|Overall Study||13
396150|NCT01775553|969346|P1|COMPLETED|Overall Study||0
396151|NCT01775553|969346|P1|STARTED|Overall Study||13
396152|NCT01775189|969354|P7|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
396153|NCT01775189|969355|P6|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
396154|NCT01775189|969356|P5|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
396155|NCT01775189|969357|P4|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
396156|NCT01775189|969358|P3|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
396157|NCT01775189|969359|P2|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
396158|NCT01775189|969360|P1|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
396159|NCT01775189|969354|P7|COMPLETED|Treatment Phase: Fourth Intervention||7
396160|NCT01775189|969355|P6|COMPLETED|Treatment Phase: Fourth Intervention||7
396161|NCT01775189|969356|P5|COMPLETED|Treatment Phase: Fourth Intervention||8
396162|NCT01775189|969357|P4|COMPLETED|Treatment Phase: Fourth Intervention||6
396163|NCT01775189|969358|P3|COMPLETED|Treatment Phase: Fourth Intervention||0
396164|NCT01775189|969359|P2|COMPLETED|Treatment Phase: Fourth Intervention||0
396165|NCT01775189|969360|P1|COMPLETED|Treatment Phase: Fourth Intervention||0
396166|NCT01775189|969354|P7|STARTED|Treatment Phase: Fourth Intervention||7
396167|NCT01775189|969355|P6|STARTED|Treatment Phase: Fourth Intervention||7
396168|NCT01775189|969356|P5|STARTED|Treatment Phase: Fourth Intervention||8
396169|NCT01775189|969357|P4|STARTED|Treatment Phase: Fourth Intervention||6
396170|NCT01775189|969358|P3|STARTED|Treatment Phase: Fourth Intervention||0
396171|NCT01775189|969359|P2|STARTED|Treatment Phase: Fourth Intervention||0
396172|NCT01775189|969360|P1|STARTED|Treatment Phase: Fourth Intervention||0
396173|NCT01775189|969354|P7|NOT COMPLETED|Treatment Phase: Washout Period 3||1
396174|NCT01775189|969355|P6|NOT COMPLETED|Treatment Phase: Washout Period 3||0
396175|NCT01775189|969356|P5|NOT COMPLETED|Treatment Phase: Washout Period 3||0
396176|NCT01775189|969357|P4|NOT COMPLETED|Treatment Phase: Washout Period 3||1
396177|NCT01775189|969358|P3|NOT COMPLETED|Treatment Phase: Washout Period 3||0
396178|NCT01775189|969359|P2|NOT COMPLETED|Treatment Phase: Washout Period 3||0
396179|NCT01775189|969360|P1|NOT COMPLETED|Treatment Phase: Washout Period 3||0
396180|NCT01775189|969354|P7|COMPLETED|Treatment Phase: Washout Period 3||7
396181|NCT01775189|969355|P6|COMPLETED|Treatment Phase: Washout Period 3||7
396182|NCT01775189|969356|P5|COMPLETED|Treatment Phase: Washout Period 3||8
396183|NCT01775189|969357|P4|COMPLETED|Treatment Phase: Washout Period 3||6
396184|NCT01775189|969358|P3|COMPLETED|Treatment Phase: Washout Period 3||0
396185|NCT01775189|969359|P2|COMPLETED|Treatment Phase: Washout Period 3||0
396186|NCT01775189|969360|P1|COMPLETED|Treatment Phase: Washout Period 3||0
396187|NCT01775189|969354|P7|STARTED|Treatment Phase: Washout Period 3||8
396188|NCT01775189|969355|P6|STARTED|Treatment Phase: Washout Period 3||7
396189|NCT01775189|969356|P5|STARTED|Treatment Phase: Washout Period 3||8
396190|NCT01775189|969357|P4|STARTED|Treatment Phase: Washout Period 3||7
396191|NCT01775189|969358|P3|STARTED|Treatment Phase: Washout Period 3||0
396192|NCT01775189|969359|P2|STARTED|Treatment Phase: Washout Period 3||0
396193|NCT01775189|969360|P1|STARTED|Treatment Phase: Washout Period 3||0
396194|NCT01775189|969354|P7|NOT COMPLETED|Treatment Phase: Third Intervention||0
396195|NCT01775189|969355|P6|NOT COMPLETED|Treatment Phase: Third Intervention||0
396196|NCT01775189|969356|P5|NOT COMPLETED|Treatment Phase: Third Intervention||0
396197|NCT01775189|969357|P4|NOT COMPLETED|Treatment Phase: Third Intervention||0
396198|NCT01775189|969358|P3|NOT COMPLETED|Treatment Phase: Third Intervention||0
396199|NCT01775189|969359|P2|NOT COMPLETED|Treatment Phase: Third Intervention||0
396200|NCT01775189|969360|P1|NOT COMPLETED|Treatment Phase: Third Intervention||0
396201|NCT01775189|969354|P7|COMPLETED|Treatment Phase: Third Intervention||8
396202|NCT01775189|969355|P6|COMPLETED|Treatment Phase: Third Intervention||7
396203|NCT01775189|969356|P5|COMPLETED|Treatment Phase: Third Intervention||8
396204|NCT01775189|969357|P4|COMPLETED|Treatment Phase: Third Intervention||7
396205|NCT01775189|969358|P3|COMPLETED|Treatment Phase: Third Intervention||0
396206|NCT01775189|969359|P2|COMPLETED|Treatment Phase: Third Intervention||0
396207|NCT01775189|969360|P1|COMPLETED|Treatment Phase: Third Intervention||0
396208|NCT01775189|969354|P7|STARTED|Treatment Phase: Third Intervention||8
396209|NCT01775189|969355|P6|STARTED|Treatment Phase: Third Intervention||7
396210|NCT01775189|969356|P5|STARTED|Treatment Phase: Third Intervention||8
396211|NCT01775189|969357|P4|STARTED|Treatment Phase: Third Intervention||7
396212|NCT01775189|969358|P3|STARTED|Treatment Phase: Third Intervention||0
396213|NCT01775189|969359|P2|STARTED|Treatment Phase: Third Intervention||0
396214|NCT01775189|969360|P1|STARTED|Treatment Phase: Third Intervention||0
396215|NCT01775189|969354|P7|NOT COMPLETED|Treatment Phase: Washout Period 2||0
396216|NCT01775189|969355|P6|NOT COMPLETED|Treatment Phase: Washout Period 2||0
396217|NCT01775189|969356|P5|NOT COMPLETED|Treatment Phase: Washout Period 2||0
396218|NCT01775189|969357|P4|NOT COMPLETED|Treatment Phase: Washout Period 2||1
396219|NCT01775189|969358|P3|NOT COMPLETED|Treatment Phase: Washout Period 2||0
396220|NCT01775189|969359|P2|NOT COMPLETED|Treatment Phase: Washout Period 2||0
396221|NCT01775189|969360|P1|NOT COMPLETED|Treatment Phase: Washout Period 2||0
396222|NCT01775189|969354|P7|COMPLETED|Treatment Phase: Washout Period 2||8
396223|NCT01775189|969355|P6|COMPLETED|Treatment Phase: Washout Period 2||7
396224|NCT01775189|969356|P5|COMPLETED|Treatment Phase: Washout Period 2||8
396225|NCT01775189|969357|P4|COMPLETED|Treatment Phase: Washout Period 2||7
396226|NCT01775189|969358|P3|COMPLETED|Treatment Phase: Washout Period 2||0
396227|NCT01775189|969359|P2|COMPLETED|Treatment Phase: Washout Period 2||0
396228|NCT01775189|969360|P1|COMPLETED|Treatment Phase: Washout Period 2||0
396229|NCT01775189|969354|P7|STARTED|Treatment Phase: Washout Period 2||8
396230|NCT01775189|969355|P6|STARTED|Treatment Phase: Washout Period 2||7
396231|NCT01775189|969356|P5|STARTED|Treatment Phase: Washout Period 2||8
396232|NCT01775189|969357|P4|STARTED|Treatment Phase: Washout Period 2||8
396233|NCT01775189|969358|P3|STARTED|Treatment Phase: Washout Period 2||0
396234|NCT01775189|969359|P2|STARTED|Treatment Phase: Washout Period 2||0
396235|NCT01775189|969360|P1|STARTED|Treatment Phase: Washout Period 2||0
396236|NCT01775189|969354|P7|NOT COMPLETED|Treatment Phase: Second Intervention||0
396237|NCT01775189|969355|P6|NOT COMPLETED|Treatment Phase: Second Intervention||0
396238|NCT01775189|969356|P5|NOT COMPLETED|Treatment Phase: Second Intervention||0
396239|NCT01775189|969357|P4|NOT COMPLETED|Treatment Phase: Second Intervention||0
396240|NCT01775189|969358|P3|NOT COMPLETED|Treatment Phase: Second Intervention||0
396241|NCT01775189|969359|P2|NOT COMPLETED|Treatment Phase: Second Intervention||0
396242|NCT01775189|969360|P1|NOT COMPLETED|Treatment Phase: Second Intervention||0
396243|NCT01775189|969354|P7|COMPLETED|Treatment Phase: Second Intervention||8
396244|NCT01775189|969355|P6|COMPLETED|Treatment Phase: Second Intervention||7
396245|NCT01775189|969356|P5|COMPLETED|Treatment Phase: Second Intervention||8
396246|NCT01775189|969357|P4|COMPLETED|Treatment Phase: Second Intervention||8
396247|NCT01775189|969358|P3|COMPLETED|Treatment Phase: Second Intervention||0
396248|NCT01775189|969359|P2|COMPLETED|Treatment Phase: Second Intervention||0
396249|NCT01775189|969360|P1|COMPLETED|Treatment Phase: Second Intervention||0
396250|NCT01775189|969354|P7|STARTED|Treatment Phase: Second Intervention||8
396251|NCT01775189|969355|P6|STARTED|Treatment Phase: Second Intervention||7
396252|NCT01775189|969356|P5|STARTED|Treatment Phase: Second Intervention||8
396253|NCT01775189|969357|P4|STARTED|Treatment Phase: Second Intervention||8
396254|NCT01775189|969358|P3|STARTED|Treatment Phase: Second Intervention||0
396255|NCT01775189|969359|P2|STARTED|Treatment Phase: Second Intervention||0
396256|NCT01775189|969360|P1|STARTED|Treatment Phase: Second Intervention||0
396257|NCT01775189|969354|P7|NOT COMPLETED|Treatment Phase: Washout Period 1||0
396258|NCT01775189|969355|P6|NOT COMPLETED|Treatment Phase: Washout Period 1||1
396259|NCT01775189|969356|P5|NOT COMPLETED|Treatment Phase: Washout Period 1||0
396260|NCT01775189|969357|P4|NOT COMPLETED|Treatment Phase: Washout Period 1||0
396261|NCT01775189|969358|P3|NOT COMPLETED|Treatment Phase: Washout Period 1||0
396262|NCT01775189|969359|P2|NOT COMPLETED|Treatment Phase: Washout Period 1||0
396263|NCT01775189|969360|P1|NOT COMPLETED|Treatment Phase: Washout Period 1||0
396264|NCT01775189|969354|P7|COMPLETED|Treatment Phase: Washout Period 1||8
396265|NCT01775189|969355|P6|COMPLETED|Treatment Phase: Washout Period 1||7
396266|NCT01775189|969356|P5|COMPLETED|Treatment Phase: Washout Period 1||8
396267|NCT01775189|969357|P4|COMPLETED|Treatment Phase: Washout Period 1||8
396268|NCT01775189|969358|P3|COMPLETED|Treatment Phase: Washout Period 1||0
396269|NCT01775189|969359|P2|COMPLETED|Treatment Phase: Washout Period 1||0
396270|NCT01775189|969360|P1|COMPLETED|Treatment Phase: Washout Period 1||0
396271|NCT01775189|969354|P7|STARTED|Treatment Phase: Washout Period 1||8
396272|NCT01775189|969355|P6|STARTED|Treatment Phase: Washout Period 1||8
396273|NCT01775189|969356|P5|STARTED|Treatment Phase: Washout Period 1||8
396274|NCT01775189|969357|P4|STARTED|Treatment Phase: Washout Period 1||8
396275|NCT01775189|969358|P3|STARTED|Treatment Phase: Washout Period 1||0
396276|NCT01775189|969359|P2|STARTED|Treatment Phase: Washout Period 1||0
396277|NCT01775189|969360|P1|STARTED|Treatment Phase: Washout Period 1||0
396278|NCT01775189|969354|P7|NOT COMPLETED|Treatment Phase: First Intervention||0
396279|NCT01775189|969355|P6|NOT COMPLETED|Treatment Phase: First Intervention||0
396280|NCT01775189|969356|P5|NOT COMPLETED|Treatment Phase: First Intervention||0
396281|NCT01775189|969357|P4|NOT COMPLETED|Treatment Phase: First Intervention||0
396282|NCT01775189|969358|P3|NOT COMPLETED|Treatment Phase: First Intervention||0
396283|NCT01775189|969359|P2|NOT COMPLETED|Treatment Phase: First Intervention||0
396284|NCT01775189|969360|P1|NOT COMPLETED|Treatment Phase: First Intervention||0
396285|NCT01775189|969354|P7|COMPLETED|Treatment Phase: First Intervention||8
396286|NCT01775189|969355|P6|COMPLETED|Treatment Phase: First Intervention||8
396287|NCT01775189|969356|P5|COMPLETED|Treatment Phase: First Intervention||8
396288|NCT01775189|969357|P4|COMPLETED|Treatment Phase: First Intervention||8
396289|NCT01775189|969358|P3|COMPLETED|Treatment Phase: First Intervention||0
396290|NCT01775189|969359|P2|COMPLETED|Treatment Phase: First Intervention||0
396291|NCT01775189|969360|P1|COMPLETED|Treatment Phase: First Intervention||0
396292|NCT01775189|969354|P7|STARTED|Treatment Phase: First Intervention||8
396293|NCT01775189|969355|P6|STARTED|Treatment Phase: First Intervention||8
396294|NCT01775189|969356|P5|STARTED|Treatment Phase: First Intervention||8
396295|NCT01775189|969357|P4|STARTED|Treatment Phase: First Intervention||8
396296|NCT01775189|969358|P3|STARTED|Treatment Phase: First Intervention||0
396297|NCT01775189|969359|P2|STARTED|Treatment Phase: First Intervention||0
396298|NCT01775189|969360|P1|STARTED|Treatment Phase: First Intervention||0
396299|NCT01775189|969354|P7|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
396300|NCT01775189|969355|P6|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
396301|NCT01775189|969356|P5|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
396302|NCT01775189|969357|P4|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
396303|NCT01775189|969358|P3|NOT COMPLETED|Drug Discrimination Phase: Day 2||7
396304|NCT01775189|969359|P2|NOT COMPLETED|Drug Discrimination Phase: Day 2||3
396305|NCT01775189|969360|P1|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
396306|NCT01775189|969354|P7|COMPLETED|Drug Discrimination Phase: Day 2||0
396307|NCT01775189|969355|P6|COMPLETED|Drug Discrimination Phase: Day 2||0
396308|NCT01775189|969356|P5|COMPLETED|Drug Discrimination Phase: Day 2||0
396309|NCT01775189|969357|P4|COMPLETED|Drug Discrimination Phase: Day 2||0
396310|NCT01775189|969358|P3|COMPLETED|Drug Discrimination Phase: Day 2||16
396311|NCT01775189|969359|P2|COMPLETED|Drug Discrimination Phase: Day 2||16
396312|NCT01775189|969360|P1|COMPLETED|Drug Discrimination Phase: Day 2||0
396313|NCT01775189|969354|P7|STARTED|Drug Discrimination Phase: Day 2||0
396314|NCT01775189|969355|P6|STARTED|Drug Discrimination Phase: Day 2||0
396315|NCT01775189|969356|P5|STARTED|Drug Discrimination Phase: Day 2||0
396316|NCT01775189|969357|P4|STARTED|Drug Discrimination Phase: Day 2||0
396317|NCT01775189|969358|P3|STARTED|Drug Discrimination Phase: Day 2||23
396318|NCT01775189|969359|P2|STARTED|Drug Discrimination Phase: Day 2||19
396319|NCT01775189|969360|P1|STARTED|Drug Discrimination Phase: Day 2||0
396320|NCT01775189|969354|P7|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
396321|NCT01775189|969355|P6|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
396322|NCT01775189|969356|P5|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
396323|NCT01775189|969357|P4|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
396324|NCT01775189|969358|P3|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
396325|NCT01775189|969359|P2|NOT COMPLETED|Drug Discrimination Phase: Day 1||3
396326|NCT01775189|969360|P1|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
396327|NCT01775189|969354|P7|COMPLETED|Drug Discrimination Phase: Day 1||0
396328|NCT01775189|969355|P6|COMPLETED|Drug Discrimination Phase: Day 1||0
396329|NCT01775189|969356|P5|COMPLETED|Drug Discrimination Phase: Day 1||0
396330|NCT01775189|969357|P4|COMPLETED|Drug Discrimination Phase: Day 1||0
396331|NCT01775189|969358|P3|COMPLETED|Drug Discrimination Phase: Day 1||23
396332|NCT01775189|969359|P2|COMPLETED|Drug Discrimination Phase: Day 1||19
396333|NCT01775189|969360|P1|COMPLETED|Drug Discrimination Phase: Day 1||0
396334|NCT01775189|969354|P7|STARTED|Drug Discrimination Phase: Day 1||0
396335|NCT01775189|969355|P6|STARTED|Drug Discrimination Phase: Day 1||0
396336|NCT01775189|969356|P5|STARTED|Drug Discrimination Phase: Day 1||0
396337|NCT01775189|969357|P4|STARTED|Drug Discrimination Phase: Day 1||0
396338|NCT01775189|969358|P3|STARTED|Drug Discrimination Phase: Day 1||23
396339|NCT01775189|969359|P2|STARTED|Drug Discrimination Phase: Day 1||22
396340|NCT01775189|969360|P1|STARTED|Drug Discrimination Phase: Day 1||0
396341|NCT01775189|969354|P7|NOT COMPLETED|Naloxone Challenge Phase||0
396342|NCT01775189|969355|P6|NOT COMPLETED|Naloxone Challenge Phase||0
396343|NCT01775189|969356|P5|NOT COMPLETED|Naloxone Challenge Phase||0
396344|NCT01775189|969357|P4|NOT COMPLETED|Naloxone Challenge Phase||0
396345|NCT01775189|969358|P3|NOT COMPLETED|Naloxone Challenge Phase||0
396346|NCT01775189|969359|P2|NOT COMPLETED|Naloxone Challenge Phase||0
396347|NCT01775189|969360|P1|NOT COMPLETED|Naloxone Challenge Phase||0
396348|NCT01775189|969354|P7|COMPLETED|Naloxone Challenge Phase||0
396349|NCT01775189|969355|P6|COMPLETED|Naloxone Challenge Phase||0
396350|NCT01775189|969356|P5|COMPLETED|Naloxone Challenge Phase||0
396351|NCT01775189|969357|P4|COMPLETED|Naloxone Challenge Phase||0
396352|NCT01775189|969358|P3|COMPLETED|Naloxone Challenge Phase||0
396353|NCT01775189|969359|P2|COMPLETED|Naloxone Challenge Phase||0
396354|NCT01775189|969360|P1|COMPLETED|Naloxone Challenge Phase||45
396355|NCT01775189|969354|P7|STARTED|Naloxone Challenge Phase||0
396356|NCT01775189|969355|P6|STARTED|Naloxone Challenge Phase||0
396357|NCT01775189|969356|P5|STARTED|Naloxone Challenge Phase||0
396358|NCT01775189|969357|P4|STARTED|Naloxone Challenge Phase||0
396359|NCT01775189|969358|P3|STARTED|Naloxone Challenge Phase||0
396360|NCT01775189|969359|P2|STARTED|Naloxone Challenge Phase||0
396361|NCT01775189|969360|P1|STARTED|Naloxone Challenge Phase||45
396362|NCT01775137|969579|P1|NOT COMPLETED|Overall Study||11
396363|NCT01775137|969579|P1|COMPLETED|Overall Study||34
396364|NCT01775137|969579|P1|STARTED|Overall Study||45
396365|NCT01775124|969606|P2|NOT COMPLETED|Extension Period||18
396366|NCT01775124|969607|P1|NOT COMPLETED|Extension Period||12
396367|NCT01775124|969606|P2|COMPLETED|Extension Period||138
396368|NCT01775124|969607|P1|COMPLETED|Extension Period||145
396369|NCT01775124|969606|P2|STARTED|Extension Period||156
396370|NCT01775124|969607|P1|STARTED|Extension Period||157
396371|NCT01775124|969606|P2|NOT COMPLETED|Core Period||10
396372|NCT01775124|969607|P1|NOT COMPLETED|Core Period||11
396373|NCT01775124|969606|P2|COMPLETED|Core Period||156
396374|NCT01775124|969607|P1|COMPLETED|Core Period||157
396375|NCT01775124|969606|P2|Safety Set|Core Period||166
396376|NCT01775124|969607|P1|Safety Set|Core Period|1 patient was mis-randomized & 1 patient discontinued due to AE. No treatment given|166
396377|NCT01775124|969606|P2|Per Protocol Set|Core Period||155
396378|NCT01775124|969607|P1|Per Protocol Set|Core Period||157
396379|NCT01775124|969606|P2|Full Analysis Set|Core Period||166
396380|NCT01775124|969607|P1|Full Analysis Set|Core Period||167
396381|NCT01775124|969606|P2|STARTED|Core Period||166
396382|NCT01775124|969607|P1|STARTED|Core Period||168
396383|NCT01774981|969642|P8|NOT COMPLETED|Overall Study||1
396384|NCT01774981|969643|P7|NOT COMPLETED|Overall Study||0
396385|NCT01774981|969644|P6|NOT COMPLETED|Overall Study||1
396386|NCT01774981|969645|P5|NOT COMPLETED|Overall Study||1
396387|NCT01774981|969646|P4|NOT COMPLETED|Overall Study||0
396388|NCT01774981|969647|P3|NOT COMPLETED|Overall Study||0
396389|NCT01774981|969648|P2|NOT COMPLETED|Overall Study||0
396390|NCT01774981|969649|P1|NOT COMPLETED|Overall Study||0
396391|NCT01774981|969642|P8|COMPLETED|Overall Study||11
396392|NCT01774981|969643|P7|COMPLETED|Overall Study||13
396393|NCT01774981|969644|P6|COMPLETED|Overall Study||13
396394|NCT01774981|969645|P5|COMPLETED|Overall Study||5
396395|NCT01774981|969646|P4|COMPLETED|Overall Study||4
396396|NCT01774981|969647|P3|COMPLETED|Overall Study||4
396397|NCT01774981|969648|P2|COMPLETED|Overall Study||4
396398|NCT01774981|969649|P1|COMPLETED|Overall Study||3
396399|NCT01774981|969642|P8|Received at Least 1 Dose of Study Drug|Overall Study||12
396400|NCT01774981|969643|P7|Received at Least 1 Dose of Study Drug|Overall Study||13
396401|NCT01774981|969644|P6|Received at Least 1 Dose of Study Drug|Overall Study||14
396402|NCT01774981|969645|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
396403|NCT01774981|969646|P4|Received at Least 1 Dose of Study Drug|Overall Study||4
396404|NCT01774981|969647|P3|Received at Least 1 Dose of Study Drug|Overall Study||4
396405|NCT01774981|969648|P2|Received at Least 1 Dose of Study Drug|Overall Study||4
396406|NCT01774981|969649|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
396407|NCT01774981|969642|P8|STARTED|Overall Study||12
396408|NCT01774981|969643|P7|STARTED|Overall Study||13
396409|NCT01774981|969644|P6|STARTED|Overall Study||14
396410|NCT01774981|969645|P5|STARTED|Overall Study||6
396411|NCT01774981|969646|P4|STARTED|Overall Study||4
396412|NCT01774981|969647|P3|STARTED|Overall Study||4
396413|NCT01774981|969648|P2|STARTED|Overall Study||4
396414|NCT01774981|969649|P1|STARTED|Overall Study||3
396415|NCT01774968|969681|P2|NOT COMPLETED|Overall Study||35
396416|NCT01774968|969682|P1|NOT COMPLETED|Overall Study||30
396417|NCT01774968|969681|P2|COMPLETED|Overall Study||128
396418|NCT01774968|969682|P1|COMPLETED|Overall Study||132
396419|NCT01774968|969681|P2|Received at Least 1 Dose of Study Drug|Overall Study||161
396420|NCT01774968|969682|P1|Received at Least 1 Dose of Study Drug|Overall Study||162
396421|NCT01774968|969681|P2|STARTED|Overall Study||163
396422|NCT01774968|969682|P1|STARTED|Overall Study||162
396423|NCT01774929|969716|P1|NOT COMPLETED|Overall Study||3
396424|NCT01774929|969716|P1|COMPLETED|Overall Study||32
396425|NCT01774929|969716|P1|STARTED|Overall Study||35
396426|NCT01774903|969722|P1|NOT COMPLETED|Overall Study||11
396427|NCT01774903|969722|P1|COMPLETED|Overall Study||34
396428|NCT01774903|969722|P1|STARTED|Overall Study||45
396429|NCT01774851|969731|P2|NOT COMPLETED|Overall Study||0
396430|NCT01774851|969732|P1|NOT COMPLETED|Overall Study||0
396431|NCT01774851|969731|P2|COMPLETED|Overall Study||42
396432|NCT01774851|969732|P1|COMPLETED|Overall Study||42
396433|NCT01774851|969731|P2|STARTED|Overall Study||42
396434|NCT01774851|969732|P1|STARTED|Overall Study||42
396435|NCT01774786|969740|P2|NOT COMPLETED|Overall Study||392
396436|NCT01774786|969741|P1|NOT COMPLETED|Overall Study||388
396437|NCT01774786|969740|P2|COMPLETED|Overall Study||0
396438|NCT01774786|969741|P1|COMPLETED|Overall Study||0
396439|NCT01774786|969740|P2|Received at Least One Dose of Placebo|Overall Study||388
396440|NCT01774786|969741|P1|Received at Least One Dose of Placebo|Overall Study||0
396441|NCT01774786|969740|P2|Received at Least One Dose of Pertuzumab|Overall Study|One participant randomized to placebo arm received 1 dose of pertuzumab by error.|1
396442|NCT01774786|969741|P1|Received at Least One Dose of Pertuzumab|Overall Study||384
396443|NCT01774786|969740|P2|Did Not Receive Study Drug|Overall Study||3
396444|NCT01774786|969741|P1|Did Not Receive Study Drug|Overall Study||4
396445|NCT01774786|969740|P2|STARTED|Overall Study||392
396446|NCT01774786|969741|P1|STARTED|Overall Study||388
396447|NCT01774604|969771|P2|NOT COMPLETED|Overall Study||0
396448|NCT01774604|969772|P1|NOT COMPLETED|Overall Study||0
396449|NCT01774604|969771|P2|COMPLETED|Overall Study||226
396450|NCT01774604|969772|P1|COMPLETED|Overall Study||223
396451|NCT01774604|969771|P2|STARTED|Overall Study||226
396452|NCT01774604|969772|P1|STARTED|Overall Study||223
396453|NCT01774591|969792|P2|NOT COMPLETED|Overall Study||4
396454|NCT01774591|969793|P1|NOT COMPLETED|Overall Study||1
396455|NCT01774591|969792|P2|COMPLETED|Overall Study||7
396456|NCT01774591|969793|P1|COMPLETED|Overall Study||9
396457|NCT01774591|969792|P2|STARTED|Overall Study||11
396458|NCT01774591|969793|P1|STARTED|Overall Study||10
396459|NCT01774344|969805|P2|NOT COMPLETED|Overall Study||148
396460|NCT01774344|969806|P1|NOT COMPLETED|Overall Study||32
396461|NCT01774344|969805|P2|COMPLETED|Overall Study||231
396462|NCT01774344|969806|P1|COMPLETED|Overall Study||162
396463|NCT01774344|969805|P2|Treated|Overall Study||374
396464|NCT01774344|969806|P1|Treated|Overall Study||193
396465|NCT01774344|969805|P2|STARTED|Overall Study||379
396466|NCT01774344|969806|P1|STARTED|Overall Study||194
396467|NCT01774305|969822|P2|NOT COMPLETED|Overall Study||0
396468|NCT01774305|969823|P1|NOT COMPLETED|Overall Study||1
396469|NCT01774305|969822|P2|COMPLETED|Overall Study||71
396470|NCT01774305|969823|P1|COMPLETED|Overall Study||70
396471|NCT01774305|969822|P2|STARTED|Overall Study||71
396472|NCT01774305|969823|P1|STARTED|Overall Study||71
396473|NCT01774253|969831|P1|NOT COMPLETED|Overall Study||9
396474|NCT01774253|969831|P1|COMPLETED|Overall Study||0
396475|NCT01774253|969831|P1|STARTED|Overall Study||9
396476|NCT01774149|969841|P2|NOT COMPLETED|Overall Study||3
396477|NCT01774149|969842|P1|NOT COMPLETED|Overall Study||1
396478|NCT01774149|969841|P2|COMPLETED|Overall Study||12
396479|NCT01774149|969842|P1|COMPLETED|Overall Study||14
396480|NCT01774149|969841|P2|STARTED|Overall Study||15
396481|NCT01774149|969842|P1|STARTED|Overall Study||15
396482|NCT01774110|969850|P1|NOT COMPLETED|Overall Study||7
396483|NCT01774110|969850|P1|COMPLETED|Overall Study||5
396484|NCT01774110|969850|P1|STARTED|Overall Study||12
396485|NCT01774097|969858|P2|NOT COMPLETED|Overall Study||2
396486|NCT01774097|969859|P1|NOT COMPLETED|Overall Study||2
396487|NCT01774097|969858|P2|COMPLETED|Overall Study||40
396488|NCT01774097|969859|P1|COMPLETED|Overall Study||38
396489|NCT01774097|969858|P2|STARTED|Overall Study||42
396490|NCT01774097|969859|P1|STARTED|Overall Study||40
396491|NCT01774084|969889|P2|NOT COMPLETED|Overall Study||0
396492|NCT01774084|969890|P1|NOT COMPLETED|Overall Study||1
396493|NCT01774084|969889|P2|COMPLETED|Overall Study||12
396494|NCT01774084|969890|P1|COMPLETED|Overall Study||10
396495|NCT01774084|969889|P2|STARTED|Overall Study||12
396496|NCT01774084|969890|P1|STARTED|Overall Study||11
396497|NCT01774045|969900|P2|NOT COMPLETED|Overall Study||0
396498|NCT01774045|969901|P1|NOT COMPLETED|Overall Study||0
396499|NCT01774045|969900|P2|COMPLETED|Overall Study||7
396500|NCT01774045|969901|P1|COMPLETED|Overall Study||23
396501|NCT01774045|969900|P2|STARTED|Overall Study||7
396502|NCT01774045|969901|P1|STARTED|Overall Study||23
396503|NCT01773954|969915|P1|NOT COMPLETED|Overall Study||9
396504|NCT01773954|969915|P1|COMPLETED|Overall Study||31
396505|NCT01773954|969915|P1|STARTED|Overall Study||40
396506|NCT01773889|969920|P1|NOT COMPLETED|Overall Study||2
396507|NCT01773889|969920|P1|COMPLETED|Overall Study||0
396508|NCT01773889|969920|P1|STARTED|Overall Study||2
396509|NCT01773473|969926|P2|NOT COMPLETED|Overall Study||19
396510|NCT01773473|969927|P1|NOT COMPLETED|Overall Study||16
396511|NCT01773473|969926|P2|COMPLETED|Overall Study||177
396512|NCT01773473|969927|P1|COMPLETED|Overall Study||191
396513|NCT01773473|969926|P2|Received at Least 1 Dose of Study Drug|Overall Study||196
396514|NCT01773473|969927|P1|Received at Least 1 Dose of Study Drug|Overall Study||207
396515|NCT01773473|969926|P2|STARTED|Overall Study||196
396516|NCT01773473|969927|P1|STARTED|Overall Study||207
396517|NCT01773291|969948|P3|NOT COMPLETED|Overall Study||1
396518|NCT01773291|969949|P2|NOT COMPLETED|Overall Study||0
396519|NCT01773291|969950|P1|NOT COMPLETED|Overall Study||1
396520|NCT01773291|969948|P3|COMPLETED|Overall Study||6
396521|NCT01773291|969949|P2|COMPLETED|Overall Study||9
396522|NCT01773291|969950|P1|COMPLETED|Overall Study||7
396523|NCT01773291|969948|P3|STARTED|Overall Study||7
396524|NCT01773291|969949|P2|STARTED|Overall Study||9
396525|NCT01773291|969950|P1|STARTED|Overall Study||8
396526|NCT01773226|969961|P1|NOT COMPLETED|Overall Study||1
396527|NCT01773226|969961|P1|COMPLETED|Overall Study|Withdrawal of one subject after one-month assessment due to persistent OA symptoms|10
396528|NCT01773226|969961|P1|STARTED|Overall Study||11
396529|NCT01773135|969971|P1|NOT COMPLETED|Overall Study||0
396530|NCT01773135|969971|P1|COMPLETED|Overall Study||262
396531|NCT01773135|969971|P1|STARTED|Overall Study||262
396532|NCT01773122|969980|P4|NOT COMPLETED|Overall Study||1
396533|NCT01773122|969981|P3|NOT COMPLETED|Overall Study||0
396534|NCT01773122|969982|P2|NOT COMPLETED|Overall Study||1
396535|NCT01773122|969983|P1|NOT COMPLETED|Overall Study||3
396536|NCT01773122|969980|P4|COMPLETED|Overall Study||18
396537|NCT01773122|969981|P3|COMPLETED|Overall Study||19
396538|NCT01773122|969982|P2|COMPLETED|Overall Study||18
396539|NCT01773122|969983|P1|COMPLETED|Overall Study||17
396540|NCT01773122|969980|P4|STARTED|Overall Study||19
396541|NCT01773122|969981|P3|STARTED|Overall Study||19
396542|NCT01773122|969982|P2|STARTED|Overall Study||19
396543|NCT01773122|969983|P1|STARTED|Overall Study||20
396544|NCT01773070|969997|P1|NOT COMPLETED|Overall Study||81
396545|NCT01773070|969997|P1|COMPLETED|Overall Study||397
396546|NCT01773070|969997|P1|STARTED|Overall Study||478
396547|NCT01772823|970007|P2|NOT COMPLETED|Extension Phase (Visits 24,48wks Post tx||9
396548|NCT01772823|970008|P1|NOT COMPLETED|Extension Phase (Visits 24,48wks Post tx||10
396549|NCT01772823|970007|P2|COMPLETED|Extension Phase (Visits 24,48wks Post tx||33
396550|NCT01772823|970008|P1|COMPLETED|Extension Phase (Visits 24,48wks Post tx||53
396551|NCT01772823|970007|P2|STARTED|Extension Phase (Visits 24,48wks Post tx|10 of the 52 subjects that completed the Treatment Phase were not eligible for the Extension Phase|42
396552|NCT01772823|970008|P1|STARTED|Extension Phase (Visits 24,48wks Post tx|25 of the 88 subjects that completed the Treatment Phase were not eligible for the Extension Phase|63
396553|NCT01772823|970007|P2|NOT COMPLETED|Treatment Phase (Week 0- Week 48)||18
396554|NCT01772823|970008|P1|NOT COMPLETED|Treatment Phase (Week 0- Week 48)||28
396555|NCT01772823|970007|P2|COMPLETED|Treatment Phase (Week 0- Week 48)||52
396556|NCT01772823|970008|P1|COMPLETED|Treatment Phase (Week 0- Week 48)||88
396557|NCT01772823|970007|P2|STARTED|Treatment Phase (Week 0- Week 48)||70
396558|NCT01772823|970008|P1|STARTED|Treatment Phase (Week 0- Week 48)||116
396559|NCT01772823|970007|P2|NOT COMPLETED|Behavioral Intervention (BL -3MV or PCC)||2
396560|NCT01772823|970008|P1|NOT COMPLETED|Behavioral Intervention (BL -3MV or PCC)||12
396561|NCT01772823|970007|P2|COMPLETED|Behavioral Intervention (BL -3MV or PCC)||70
396562|NCT01772823|970008|P1|COMPLETED|Behavioral Intervention (BL -3MV or PCC)||116
396563|NCT01772823|970007|P2|STARTED|Behavioral Intervention (BL -3MV or PCC)||72
396564|NCT01772823|970008|P1|STARTED|Behavioral Intervention (BL -3MV or PCC)||128
396565|NCT01772758|970108|P4|NOT COMPLETED|Overall Study||0
396566|NCT01772758|970109|P3|NOT COMPLETED|Overall Study||0
396567|NCT01772758|970110|P2|NOT COMPLETED|Overall Study||0
396568|NCT01772758|970111|P1|NOT COMPLETED|Overall Study||0
396569|NCT01772758|970108|P4|COMPLETED|Overall Study||17
396570|NCT01772758|970109|P3|COMPLETED|Overall Study||12
396571|NCT01772758|970110|P2|COMPLETED|Overall Study||17
396572|NCT01772758|970111|P1|COMPLETED|Overall Study||18
396573|NCT01772758|970108|P4|STARTED|Overall Study||17
396574|NCT01772758|970109|P3|STARTED|Overall Study||12
396575|NCT01772758|970110|P2|STARTED|Overall Study||17
396576|NCT01772758|970111|P1|STARTED|Overall Study||18
396577|NCT01772654|970123|P2|NOT COMPLETED|Overall Study||0
396578|NCT01772654|970124|P1|NOT COMPLETED|Overall Study||0
396579|NCT01772654|970123|P2|COMPLETED|Overall Study||15
396580|NCT01772654|970124|P1|COMPLETED|Overall Study||2
396581|NCT01772654|970123|P2|STARTED|Overall Study||15
396582|NCT01772654|970124|P1|STARTED|Overall Study||2
396583|NCT01772576|970130|P1|NOT COMPLETED|Overall Study||34
396584|NCT01772576|970130|P1|COMPLETED|Overall Study||133
396585|NCT01772576|970130|P1|STARTED|Overall Study||167
396586|NCT01772550|970142|P3|NOT COMPLETED|Overall Study||6
396587|NCT01772550|970143|P2|NOT COMPLETED|Overall Study||1
396588|NCT01772550|970144|P1|NOT COMPLETED|Overall Study||1
396589|NCT01772550|970142|P3|COMPLETED|Overall Study||27
396590|NCT01772550|970143|P2|COMPLETED|Overall Study||102
396591|NCT01772550|970144|P1|COMPLETED|Overall Study||101
396592|NCT01772550|970142|P3|CT Cardiac|Overall Study||1
396593|NCT01772550|970143|P2|CT Cardiac|Overall Study||7
396594|NCT01772550|970144|P1|CT Cardiac|Overall Study||7
396595|NCT01772550|970142|P3|CT Kidney|Overall Study||6
396596|NCT01772550|970143|P2|CT Kidney|Overall Study||19
396597|NCT01772550|970144|P1|CT Kidney|Overall Study||12
396598|NCT01772550|970142|P3|CT Liver|Overall Study||8
396599|NCT01772550|970143|P2|CT Liver|Overall Study||14
396600|NCT01772550|970144|P1|CT Liver|Overall Study||18
396601|NCT01772550|970142|P3|CT Angiogram|Overall Study||4
396602|NCT01772550|970143|P2|CT Angiogram|Overall Study||25
396603|NCT01772550|970144|P1|CT Angiogram|Overall Study||24
396604|NCT01772550|970142|P3|CT Pancreas|Overall Study||8
396605|NCT01772550|970143|P2|CT Pancreas|Overall Study||36
396606|NCT01772550|970144|P1|CT Pancreas|Overall Study||40
396607|NCT01772550|970142|P3|STARTED|Overall Study||33
396608|NCT01772550|970143|P2|STARTED|Overall Study||103
396609|NCT01772550|970144|P1|STARTED|Overall Study||102
396610|NCT01772537|970185|P3|NOT COMPLETED|Overall Study||0
396611|NCT01772537|970186|P2|NOT COMPLETED|Overall Study||0
396612|NCT01772537|970187|P1|NOT COMPLETED|Overall Study||1
396613|NCT01772537|970185|P3|COMPLETED|Overall Study||6
396614|NCT01772537|970186|P2|COMPLETED|Overall Study||3
396615|NCT01772537|970187|P1|COMPLETED|Overall Study||4
396616|NCT01772537|970185|P3|STARTED|Overall Study||6
396617|NCT01772537|970186|P2|STARTED|Overall Study||3
396618|NCT01772537|970187|P1|STARTED|Overall Study||5
396619|NCT01772368|970201|P1|NOT COMPLETED|Overall Study||7
396620|NCT01772368|970201|P1|COMPLETED|Overall Study||65
396621|NCT01772368|970201|P1|Received Advair Diskus 100/50 mcg|Overall Study||66
396622|NCT01772368|970201|P1|Received FS MDPI 100/50 mcg|Overall Study||68
396623|NCT01772368|970201|P1|Received FS MDPI 100/25 mcg|Overall Study||67
396624|NCT01772368|970201|P1|Received FS MDPI 100/12.5mcg|Overall Study||69
396625|NCT01772368|970201|P1|Received FS MDPI 100/6.25 mcg|Overall Study||68
396626|NCT01772368|970201|P1|Received Fp MDPI 100 mcg|Overall Study||67
396627|NCT01772368|970201|P1|STARTED|Overall Study||72
396628|NCT01772316|970247|P1|NOT COMPLETED|Overall Study||7
396629|NCT01772316|970247|P1|COMPLETED|Overall Study||40
396630|NCT01772316|970247|P1|STARTED|Overall Study||47
396631|NCT01772147|970268|P3|NOT COMPLETED|Overall Study||18
396632|NCT01772147|970269|P2|NOT COMPLETED|Overall Study||25
396633|NCT01772147|970270|P1|NOT COMPLETED|Overall Study||31
396634|NCT01772147|970268|P3|COMPLETED|Overall Study||184
396635|NCT01772147|970269|P2|COMPLETED|Overall Study||178
396636|NCT01772147|970270|P1|COMPLETED|Overall Study||170
396637|NCT01772147|970268|P3|STARTED|Overall Study||202
396638|NCT01772147|970269|P2|STARTED|Overall Study||203
396639|NCT01772147|970270|P1|STARTED|Overall Study||201
396640|NCT01772134|970290|P3|NOT COMPLETED|Overall Study||22
396641|NCT01772134|970291|P2|NOT COMPLETED|Overall Study||14
396642|NCT01772134|970292|P1|NOT COMPLETED|Overall Study||29
396643|NCT01772134|970290|P3|COMPLETED|Overall Study||184
396644|NCT01772134|970291|P2|COMPLETED|Overall Study||190
396645|NCT01772134|970292|P1|COMPLETED|Overall Study||178
396646|NCT01772134|970290|P3|Received Randomized Study Medication|Overall Study||205
396647|NCT01772134|970291|P2|Received Randomized Study Medication|Overall Study||204
396648|NCT01772134|970292|P1|Received Randomized Study Medication|Overall Study||205
396649|NCT01772134|970290|P3|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|206
396742|NCT01770392|970540|P1|COMPLETED|Nintedanib||26
396650|NCT01772134|970291|P2|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|204
396651|NCT01772134|970292|P1|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|207
396652|NCT01771991|970311|P2|NOT COMPLETED|Overall Study||6
396653|NCT01771991|970312|P1|NOT COMPLETED|Overall Study||8
396654|NCT01771991|970311|P2|COMPLETED|Overall Study||30
396655|NCT01771991|970312|P1|COMPLETED|Overall Study||30
396656|NCT01771991|970311|P2|Started Treatment|Overall Study||34
396657|NCT01771991|970312|P1|Started Treatment|Overall Study||37
396658|NCT01771991|970311|P2|STARTED|Overall Study||36
396659|NCT01771991|970312|P1|STARTED|Overall Study||38
396660|NCT01771965|970320|P2|NOT COMPLETED|Overall Study||5
396661|NCT01771965|970321|P1|NOT COMPLETED|Overall Study||3
396662|NCT01771965|970320|P2|COMPLETED|Overall Study||4
396663|NCT01771965|970321|P1|COMPLETED|Overall Study||7
396664|NCT01771965|970320|P2|STARTED|Overall Study||9
396665|NCT01771965|970321|P1|STARTED|Overall Study||10
396666|NCT01771913|970329|P2|NOT COMPLETED|Overall Study||0
396667|NCT01771913|970330|P1|NOT COMPLETED|Overall Study||1
396668|NCT01771913|970329|P2|COMPLETED|Overall Study||11
396669|NCT01771913|970330|P1|COMPLETED|Overall Study||8
396670|NCT01771913|970329|P2|STARTED|Overall Study||11
396671|NCT01771913|970330|P1|STARTED|Overall Study||9
396672|NCT01771666|970340|P1|NOT COMPLETED|Overall Study||0
396673|NCT01771666|970340|P1|COMPLETED|Overall Study||23
396674|NCT01771666|970340|P1|STARTED|Overall Study||23
396675|NCT01771172|970345|P1|NOT COMPLETED|Overall Study||2
396676|NCT01771172|970345|P1|COMPLETED|Overall Study||46
396677|NCT01771172|970345|P1|STARTED|Overall Study||48
396678|NCT01770860|970349|P1|NOT COMPLETED|Overall Study||6
396679|NCT01770860|970349|P1|COMPLETED|Overall Study||40
396680|NCT01770860|970349|P1|Randomization|Overall Study|One participant withdrew before randomization|45
396681|NCT01770860|970349|P1|STARTED|Overall Study|Forty-six subjects were enrolled but one subject withdrew before randomization.|46
396682|NCT01770743|970397|P5|NOT COMPLETED|Overall Study||2
396683|NCT01770743|970398|P4|NOT COMPLETED|Overall Study||2
396684|NCT01770743|970399|P3|NOT COMPLETED|Overall Study||1
396685|NCT01770743|970400|P2|NOT COMPLETED|Overall Study||3
396686|NCT01770743|970401|P1|NOT COMPLETED|Overall Study||2
396687|NCT01770743|970397|P5|COMPLETED|Overall Study||21
396688|NCT01770743|970398|P4|COMPLETED|Overall Study||42
396689|NCT01770743|970399|P3|COMPLETED|Overall Study||22
396690|NCT01770743|970400|P2|COMPLETED|Overall Study||31
396691|NCT01770743|970401|P1|COMPLETED|Overall Study||42
396692|NCT01770743|970397|P5|Treated|Overall Study||23
396693|NCT01770743|970398|P4|Treated|Overall Study||44
396694|NCT01770743|970399|P3|Treated|Overall Study||23
396695|NCT01770743|970400|P2|Treated|Overall Study||34
396696|NCT01770743|970401|P1|Treated|Overall Study||44
396697|NCT01770743|970397|P5|STARTED|Overall Study||23
396698|NCT01770743|970398|P4|STARTED|Overall Study||44
396699|NCT01770743|970399|P3|STARTED|Overall Study||23
396700|NCT01770743|970400|P2|STARTED|Overall Study||34
396701|NCT01770743|970401|P1|STARTED|Overall Study||44
396702|NCT01770691|970453|P1|NOT COMPLETED|Overall Study||0
396703|NCT01770691|970453|P1|COMPLETED|Overall Study||7
396704|NCT01770691|970453|P1|STARTED|Overall Study||7
396705|NCT01770652|970464|P4|NOT COMPLETED|Overall Study||0
396706|NCT01770652|970465|P3|NOT COMPLETED|Overall Study||0
396707|NCT01770652|970466|P2|NOT COMPLETED|Overall Study||0
396708|NCT01770652|970467|P1|NOT COMPLETED|Overall Study||0
396709|NCT01770652|970464|P4|COMPLETED|Overall Study||8
396710|NCT01770652|970465|P3|COMPLETED|Overall Study||8
396711|NCT01770652|970466|P2|COMPLETED|Overall Study||8
396712|NCT01770652|970467|P1|COMPLETED|Overall Study||8
396713|NCT01770652|970464|P4|STARTED|Overall Study||8
396714|NCT01770652|970465|P3|STARTED|Overall Study||8
396715|NCT01770652|970466|P2|STARTED|Overall Study||8
396716|NCT01770652|970467|P1|STARTED|Overall Study||8
396717|NCT01770509|970503|P2|NOT COMPLETED|Overall Study||3
396718|NCT01770509|970504|P1|NOT COMPLETED|Overall Study||1
396719|NCT01770509|970503|P2|COMPLETED|Overall Study||14
396720|NCT01770509|970504|P1|COMPLETED|Overall Study||11
396721|NCT01770509|970503|P2|STARTED|Overall Study||17
396722|NCT01770509|970504|P1|STARTED|Overall Study||12
396723|NCT01770483|970520|P2|NOT COMPLETED|Overall Study||0
396724|NCT01770483|970521|P1|NOT COMPLETED|Overall Study||0
396725|NCT01770483|970520|P2|COMPLETED|Overall Study||33
396726|NCT01770483|970521|P1|COMPLETED|Overall Study||33
396727|NCT01770483|970520|P2|STARTED|Overall Study||33
396728|NCT01770483|970521|P1|STARTED|Overall Study||33
396729|NCT01770431|970531|P2|NOT COMPLETED|Overall Study||32
396730|NCT01770431|970532|P1|NOT COMPLETED|Overall Study||10
396731|NCT01770431|970531|P2|COMPLETED|Overall Study||316
396732|NCT01770431|970532|P1|COMPLETED|Overall Study||686
396733|NCT01770431|970531|P2|STARTED|Overall Study||348
396734|NCT01770431|970532|P1|STARTED|Overall Study||696
396735|NCT01770392|970540|P1|NOT COMPLETED|Nintedanib+ Rifampicin||0
396736|NCT01770392|970540|P1|COMPLETED|Nintedanib+ Rifampicin||25
396737|NCT01770392|970540|P1|STARTED|Nintedanib+ Rifampicin||25
396738|NCT01770392|970540|P1|NOT COMPLETED|Washout Period of at Least 14 Days||1
396739|NCT01770392|970540|P1|COMPLETED|Washout Period of at Least 14 Days||25
396740|NCT01770392|970540|P1|STARTED|Washout Period of at Least 14 Days||26
396741|NCT01770392|970540|P1|NOT COMPLETED|Nintedanib||0
396743|NCT01770392|970540|P1|STARTED|Nintedanib||26
396744|NCT01770379|970555|P3|NOT COMPLETED|Overall Study||42
396745|NCT01770379|970556|P2|NOT COMPLETED|Overall Study||44
396746|NCT01770379|970557|P1|NOT COMPLETED|Overall Study||39
396747|NCT01770379|970555|P3|COMPLETED|Overall Study||39
396748|NCT01770379|970556|P2|COMPLETED|Overall Study||37
396749|NCT01770379|970557|P1|COMPLETED|Overall Study||41
396750|NCT01770379|970555|P3|STARTED|Overall Study||81
396751|NCT01770379|970556|P2|STARTED|Overall Study||81
396752|NCT01770379|970557|P1|STARTED|Overall Study||80
396753|NCT01770366|970576|P2|NOT COMPLETED|Overall Study||2
396754|NCT01770366|970577|P1|NOT COMPLETED|Overall Study||2
396755|NCT01770366|970576|P2|COMPLETED|Overall Study||4
396756|NCT01770366|970577|P1|COMPLETED|Overall Study||2
396757|NCT01770366|970576|P2|STARTED|Overall Study||6
396758|NCT01770366|970577|P1|STARTED|Overall Study||4
396759|NCT01770314|970585|P2|NOT COMPLETED|Overall Study||0
396760|NCT01770314|970586|P1|NOT COMPLETED|Overall Study||0
396761|NCT01770314|970585|P2|COMPLETED|Overall Study||90
396762|NCT01770314|970586|P1|COMPLETED|Overall Study||86
396763|NCT01770314|970585|P2|Contributed Data to One-month Follow-up|Overall Study||66
396764|NCT01770314|970586|P1|Contributed Data to One-month Follow-up|Overall Study||61
396765|NCT01770314|970585|P2|Contributed Data to Post-test|Overall Study||67
396766|NCT01770314|970586|P1|Contributed Data to Post-test|Overall Study||65
396767|NCT01770314|970585|P2|Contributed Data to Baseline|Overall Study||72
396768|NCT01770314|970586|P1|Contributed Data to Baseline|Overall Study||68
396769|NCT01770314|970585|P2|STARTED|Overall Study||90
396770|NCT01770314|970586|P1|STARTED|Overall Study||86
396771|NCT01770145|970594|P1|NOT COMPLETED|Treatment||4
396772|NCT01770145|970594|P1|COMPLETED|Treatment||97
396773|NCT01770145|970594|P1|STARTED|Treatment||101
396774|NCT01770145|970594|P1|NOT COMPLETED|Baseline||26
396775|NCT01770145|970594|P1|COMPLETED|Baseline||101
396776|NCT01770145|970594|P1|STARTED|Baseline||127
396777|NCT01769612|970599|P1|NOT COMPLETED|Overall Study||0
396778|NCT01769612|970599|P1|COMPLETED|Overall Study||168
396779|NCT01769612|970599|P1|STARTED|Overall Study||168
396780|NCT01769586|970607|P2|NOT COMPLETED|Overall Study||0
396781|NCT01769586|970608|P1|NOT COMPLETED|Overall Study||0
396782|NCT01769586|970607|P2|COMPLETED|Overall Study||100
396783|NCT01769586|970608|P1|COMPLETED|Overall Study||100
396784|NCT01769586|970607|P2|STARTED|Overall Study||100
396785|NCT01769586|970608|P1|STARTED|Overall Study||100
396786|NCT01769508|970614|P1|NOT COMPLETED|Overall Study||6
396787|NCT01769508|970614|P1|COMPLETED|Overall Study||6
396788|NCT01769508|970614|P1|STARTED|Overall Study||12
396789|NCT01769456|970623|P1|NOT COMPLETED|Overall Study||37
396790|NCT01769456|970623|P1|COMPLETED|Overall Study||41
396791|NCT01769456|970623|P1|STARTED|Overall Study|1 subject inadvertently enrolled, discontin'd after baseline, re-enrolled later and completed study|78
396792|NCT01769443|970644|P2|NOT COMPLETED|Overall Study||0
396793|NCT01769443|970645|P1|NOT COMPLETED|Overall Study||1
396794|NCT01769443|970644|P2|COMPLETED|Overall Study||1
396795|NCT01769443|970645|P1|COMPLETED|Overall Study||0
396796|NCT01769443|970644|P2|STARTED|Overall Study||1
396797|NCT01769443|970645|P1|STARTED|Overall Study||1
396798|NCT01769391|970689|P2|NOT COMPLETED|Overall Study||9
396799|NCT01769391|970690|P1|NOT COMPLETED|Overall Study||20
396800|NCT01769391|970689|P2|COMPLETED|Overall Study||48
396801|NCT01769391|970690|P1|COMPLETED|Overall Study||90
396802|NCT01769391|970689|P2|Received at Least One Dose of Study Drug|Overall Study||55
396803|NCT01769391|970690|P1|Received at Least One Dose of Study Drug|Overall Study||106
396804|NCT01769391|970689|P2|STARTED|Overall Study||57
396805|NCT01769391|970690|P1|STARTED|Overall Study||110
396806|NCT01769378|970709|P2|NOT COMPLETED|Overall Study||4
396807|NCT01769378|970710|P1|NOT COMPLETED|Overall Study||25
396808|NCT01769378|970709|P2|COMPLETED|Overall Study|Completed the study on study treatment|56
396809|NCT01769378|970710|P1|COMPLETED|Overall Study|Completed the study on study treatment|215
396810|NCT01769378|970709|P2|Received at Least 1 Dose of Study Drug|Overall Study||60
396811|NCT01769378|970710|P1|Received at Least 1 Dose of Study Drug|Overall Study||239
396812|NCT01769378|970709|P2|STARTED|Overall Study||60
396813|NCT01769378|970710|P1|STARTED|Overall Study||240
396814|NCT01769365|970748|P3|NOT COMPLETED|Overall Study||2
396815|NCT01769365|970749|P2|NOT COMPLETED|Overall Study||2
396816|NCT01769365|970750|P1|NOT COMPLETED|Overall Study||0
396817|NCT01769365|970748|P3|COMPLETED|Overall Study||101
396818|NCT01769365|970749|P2|COMPLETED|Overall Study||100
396819|NCT01769365|970750|P1|COMPLETED|Overall Study||102
396820|NCT01769365|970748|P3|STARTED|Overall Study||103
396821|NCT01769365|970749|P2|STARTED|Overall Study||102
396822|NCT01769365|970750|P1|STARTED|Overall Study||102
396823|NCT01769352|970762|P4|NOT COMPLETED|Overall Study||0
396824|NCT01769352|970763|P3|NOT COMPLETED|Overall Study||0
396825|NCT01769352|970764|P2|NOT COMPLETED|Overall Study||0
396826|NCT01769352|970765|P1|NOT COMPLETED|Overall Study||0
396827|NCT01769352|970762|P4|COMPLETED|Overall Study||8
396828|NCT01769352|970763|P3|COMPLETED|Overall Study||9
396829|NCT01769352|970764|P2|COMPLETED|Overall Study||12
396830|NCT01769352|970765|P1|COMPLETED|Overall Study||13
396831|NCT01769352|970762|P4|STARTED|Overall Study||8
396832|NCT01769352|970763|P3|STARTED|Overall Study||9
396833|NCT01769352|970764|P2|STARTED|Overall Study||12
396834|NCT01769352|970765|P1|STARTED|Overall Study||13
396835|NCT01769339|970790|P1|NOT COMPLETED|Overall Study||43
396836|NCT01769339|970790|P1|COMPLETED|Overall Study||72
396837|NCT01769339|970790|P1|STARTED|Overall Study||115
396838|NCT01769326|970801|P4|NOT COMPLETED|Overall Study||0
396839|NCT01769326|970802|P3|NOT COMPLETED|Overall Study||1
396840|NCT01769326|970803|P2|NOT COMPLETED|Overall Study||4
396841|NCT01769326|970804|P1|NOT COMPLETED|Overall Study||2
396842|NCT01769326|970801|P4|COMPLETED|Overall Study||8
396843|NCT01769326|970802|P3|COMPLETED|Overall Study||8
396844|NCT01769326|970803|P2|COMPLETED|Overall Study||8
396845|NCT01769326|970804|P1|COMPLETED|Overall Study||9
396846|NCT01769326|970801|P4|STARTED|Overall Study||8
396847|NCT01769326|970802|P3|STARTED|Overall Study||9
396848|NCT01769326|970803|P2|STARTED|Overall Study||12
396849|NCT01769326|970804|P1|STARTED|Overall Study||11
396850|NCT01769248|970816|P2|NOT COMPLETED|Overall Study||12
396851|NCT01769248|970817|P1|NOT COMPLETED|Overall Study||28
396852|NCT01769248|970816|P2|COMPLETED|Overall Study||58
396853|NCT01769248|970817|P1|COMPLETED|Overall Study||42
396854|NCT01769248|970816|P2|Participants Who Crossed-over|Overall Study||12
396855|NCT01769248|970817|P1|Participants Who Crossed-over|Overall Study||28
396856|NCT01769248|970816|P2|STARTED|Overall Study||70
396857|NCT01769248|970817|P1|STARTED|Overall Study||70
396858|NCT01769222|970829|P2|NOT COMPLETED|Overall Study||0
396859|NCT01769222|970830|P1|NOT COMPLETED|Overall Study||0
396860|NCT01769222|970829|P2|COMPLETED|Overall Study||0
396861|NCT01769222|970830|P1|COMPLETED|Overall Study||3
396862|NCT01769222|970829|P2|STARTED|Overall Study||0
396863|NCT01769222|970830|P1|STARTED|Overall Study||3
396864|NCT01769196|970846|P2|NOT COMPLETED|Overall Study||272
396865|NCT01769196|970847|P1|NOT COMPLETED|Overall Study||272
396866|NCT01769196|970846|P2|COMPLETED|Overall Study||0
396867|NCT01769196|970847|P1|COMPLETED|Overall Study||0
396868|NCT01769196|970846|P2|STARTED|Overall Study||272
396869|NCT01769196|970847|P1|STARTED|Overall Study||272
396870|NCT01769105|970877|P2|NOT COMPLETED|Cross-over||0
396871|NCT01769105|970878|P1|NOT COMPLETED|Cross-over||5
396872|NCT01769105|970877|P2|COMPLETED|Cross-over|Was not intended by the study protocol|0
396873|NCT01769105|970878|P1|COMPLETED|Cross-over||9
396874|NCT01769105|970877|P2|STARTED|Cross-over|Cross-over was only intended for the Lid margin hygiene group|0
396875|NCT01769105|970878|P1|STARTED|Cross-over||14
396876|NCT01769105|970877|P2|NOT COMPLETED|First Intervention||2
396877|NCT01769105|970878|P1|NOT COMPLETED|First Intervention||2
396878|NCT01769105|970877|P2|COMPLETED|First Intervention||17
396879|NCT01769105|970878|P1|COMPLETED|First Intervention||14
396880|NCT01769105|970877|P2|STARTED|First Intervention||19
396881|NCT01769105|970878|P1|STARTED|First Intervention||16
396882|NCT01768676|970899|P2|NOT COMPLETED|Overall Study||31
396883|NCT01768676|970900|P1|NOT COMPLETED|Overall Study||24
396884|NCT01768676|970899|P2|COMPLETED|Overall Study||60
396885|NCT01768676|970900|P1|COMPLETED|Overall Study||66
396886|NCT01768676|970899|P2|STARTED|Overall Study||91
396887|NCT01768676|970900|P1|STARTED|Overall Study||90
396888|NCT01768572|970917|P3|NOT COMPLETED|Overall Study||6
396889|NCT01768572|970918|P2|NOT COMPLETED|Overall Study||12
396890|NCT01768572|970919|P1|NOT COMPLETED|Overall Study||9
396891|NCT01768572|970917|P3|COMPLETED|Overall Study||96
396892|NCT01768572|970918|P2|COMPLETED|Overall Study||39
396893|NCT01768572|970919|P1|COMPLETED|Overall Study||40
396894|NCT01768572|970917|P3|STARTED|Overall Study||102
396895|NCT01768572|970918|P2|STARTED|Overall Study||51
396896|NCT01768572|970919|P1|STARTED|Overall Study||49
396897|NCT01768559|970930|P3|NOT COMPLETED|Overall Study||13
396898|NCT01768559|970931|P2|NOT COMPLETED|Overall Study||17
396899|NCT01768559|970932|P1|NOT COMPLETED|Overall Study||30
396900|NCT01768559|970930|P3|COMPLETED|Overall Study||285
396901|NCT01768559|970931|P2|COMPLETED|Overall Study||281
396902|NCT01768559|970932|P1|COMPLETED|Overall Study||268
396903|NCT01768559|970930|P3|Treated|Overall Study|4 participants received Insulin Glulisine QD (for more than 50%)|297
396904|NCT01768559|970931|P2|Treated|Overall Study|1 participant received Insulin Glulisine TID (for more than 50%)|298
396905|NCT01768559|970932|P1|Treated|Overall Study||298
396906|NCT01768559|970930|P3|STARTED|Overall Study||298
396907|NCT01768559|970931|P2|STARTED|Overall Study||298
396908|NCT01768559|970932|P1|STARTED|Overall Study||298
396909|NCT01768325|970982|P2|NOT COMPLETED|Overall Study||0
396910|NCT01768325|970983|P1|NOT COMPLETED|Overall Study||0
396911|NCT01768325|970982|P2|COMPLETED|Overall Study||41
396912|NCT01768325|970983|P1|COMPLETED|Overall Study||37
396913|NCT01768325|970982|P2|STARTED|Overall Study||41
396914|NCT01768325|970983|P1|STARTED|Overall Study||37
396915|NCT01768286|970997|P4|NOT COMPLETED|Overall Study||1
396916|NCT01768286|970998|P3|NOT COMPLETED|Overall Study||2
396917|NCT01768286|970999|P2|NOT COMPLETED|Overall Study||4
396918|NCT01768286|971000|P1|NOT COMPLETED|Overall Study||7
396919|NCT01768286|970997|P4|COMPLETED|Overall Study||110
396920|NCT01768286|970998|P3|COMPLETED|Overall Study||108
396921|NCT01768286|970999|P2|COMPLETED|Overall Study||107
396922|NCT01768286|971000|P1|COMPLETED|Overall Study||102
396923|NCT01768286|970997|P4|STARTED|Overall Study||111
396924|NCT01768286|970998|P3|STARTED|Overall Study||110
396925|NCT01768286|970999|P2|STARTED|Overall Study||111
396926|NCT01768286|971000|P1|STARTED|Overall Study||109
396927|NCT01768117|971062|P1|NOT COMPLETED|Overall Study||6
396928|NCT01768117|971062|P1|COMPLETED|Overall Study||7
396929|NCT01768117|971062|P1|STARTED|Overall Study||13
396930|NCT01768013|971070|P1|NOT COMPLETED|Overall Study||0
396931|NCT01768013|971070|P1|COMPLETED|Overall Study||13
396932|NCT01768013|971070|P1|STARTED|Overall Study||13
396933|NCT01768000|971103|P4|NOT COMPLETED|Overall Study||2
396934|NCT01768000|971104|P3|NOT COMPLETED|Overall Study||1
396935|NCT01768000|971105|P2|NOT COMPLETED|Overall Study||2
396936|NCT01768000|971106|P1|NOT COMPLETED|Overall Study||1
396937|NCT01768000|971103|P4|COMPLETED|Overall Study||8
396938|NCT01768000|971104|P3|COMPLETED|Overall Study||9
396939|NCT01768000|971105|P2|COMPLETED|Overall Study||8
396940|NCT01768000|971106|P1|COMPLETED|Overall Study||9
396941|NCT01768000|971103|P4|STARTED|Overall Study||10
396942|NCT01768000|971104|P3|STARTED|Overall Study||10
396943|NCT01768000|971105|P2|STARTED|Overall Study||10
396944|NCT01768000|971106|P1|STARTED|Overall Study||10
396945|NCT01767987|971126|P2|NOT COMPLETED|Overall Study||1
396946|NCT01767987|971127|P1|NOT COMPLETED|Overall Study||4
396947|NCT01767987|971126|P2|COMPLETED|Overall Study||1
396948|NCT01767987|971127|P1|COMPLETED|Overall Study||0
396949|NCT01767987|971126|P2|STARTED|Overall Study||2
396950|NCT01767987|971127|P1|STARTED|Overall Study||4
396951|NCT01767935|971149|P1|NOT COMPLETED|Overall Study||0
396952|NCT01767935|971149|P1|COMPLETED|Overall Study||1
396953|NCT01767935|971149|P1|STARTED|Overall Study||1
396954|NCT01767701|971157|P1|NOT COMPLETED|Overall Study||0
396955|NCT01767701|971157|P1|COMPLETED|Overall Study||20
396956|NCT01767701|971157|P1|STARTED|Overall Study|All 20 patients who entered the treatment phase completed the six months trial period.|20
396957|NCT01767688|971170|P2|NOT COMPLETED|Overall Study||0
396958|NCT01767688|971171|P1|NOT COMPLETED|Overall Study||0
396959|NCT01767688|971170|P2|COMPLETED|Overall Study||8
396960|NCT01767688|971171|P1|COMPLETED|Overall Study||8
396961|NCT01767688|971170|P2|STARTED|Overall Study||8
396962|NCT01767688|971171|P1|STARTED|Overall Study||8
396963|NCT01767597|971193|P2|NOT COMPLETED|Overall Study||1
396964|NCT01767597|971194|P1|NOT COMPLETED|Overall Study||4
396965|NCT01767597|971193|P2|COMPLETED|Overall Study||499
396966|NCT01767597|971194|P1|COMPLETED|Overall Study||496
396967|NCT01767597|971193|P2|STARTED|Overall Study||500
396968|NCT01767597|971194|P1|STARTED|Overall Study||500
396969|NCT01767519|971203|P3|NOT COMPLETED|Overall Study||5
396970|NCT01767519|971204|P2|NOT COMPLETED|Overall Study||13
396971|NCT01767519|971205|P1|NOT COMPLETED|Overall Study||14
396972|NCT01767519|971203|P3|COMPLETED|Overall Study||55
396973|NCT01767519|971204|P2|COMPLETED|Overall Study||138
396974|NCT01767519|971205|P1|COMPLETED|Overall Study||131
396975|NCT01767519|971203|P3|STARTED|Overall Study||60
396976|NCT01767519|971204|P2|STARTED|Overall Study||151
396977|NCT01767519|971205|P1|STARTED|Overall Study||145
396978|NCT01767506|971233|P2|NOT COMPLETED|Overall Study||0
396979|NCT01767506|971234|P1|NOT COMPLETED|Overall Study||0
396980|NCT01767506|971233|P2|COMPLETED|Overall Study|The study was conducted at the community level.|0
396981|NCT01767506|971234|P1|COMPLETED|Overall Study|The study was conducted at the community level.|0
396982|NCT01767506|971233|P2|STARTED|Overall Study|"26 communities were randomized to control group~The study was conducted at the community level."|0
396983|NCT01767506|971234|P1|STARTED|Overall Study|"26 communities were randomized to intervention group~The study was conducted at the community level."|0
396984|NCT01767467|971246|P2|NOT COMPLETED|End of Study Phase (up to Month 13)||63
396985|NCT01767467|971247|P1|NOT COMPLETED|End of Study Phase (up to Month 13)||47
396986|NCT01767467|971246|P2|COMPLETED|End of Study Phase (up to Month 13)||216
396987|NCT01767467|971247|P1|COMPLETED|End of Study Phase (up to Month 13)||236
396988|NCT01767467|971246|P2|STARTED|End of Study Phase (up to Month 13)||279
396989|NCT01767467|971247|P1|STARTED|End of Study Phase (up to Month 13)||283
396990|NCT01767467|971246|P2|NOT COMPLETED|Vaccination Phase (up to Month 2)||20
396991|NCT01767467|971247|P1|NOT COMPLETED|Vaccination Phase (up to Month 2)||17
396992|NCT01767467|971246|P2|COMPLETED|Vaccination Phase (up to Month 2)||259
396993|NCT01767467|971247|P1|COMPLETED|Vaccination Phase (up to Month 2)||266
396994|NCT01767467|971246|P2|STARTED|Vaccination Phase (up to Month 2)||279
396995|NCT01767467|971247|P1|STARTED|Vaccination Phase (up to Month 2)||283
396996|NCT01767376|971298|P3|NOT COMPLETED|Overall Study||0
396997|NCT01767376|971299|P2|NOT COMPLETED|Overall Study||3
396998|NCT01767376|971300|P1|NOT COMPLETED|Overall Study||4
396999|NCT01767376|971298|P3|COMPLETED|Overall Study||232
397000|NCT01767376|971299|P2|COMPLETED|Overall Study||225
397001|NCT01767376|971300|P1|COMPLETED|Overall Study||227
397002|NCT01767376|971298|P3|STARTED|Overall Study||232
397003|NCT01767376|971299|P2|STARTED|Overall Study||228
397004|NCT01767376|971300|P1|STARTED|Overall Study||231
397005|NCT01767285|971347|P2|NOT COMPLETED|Overall Study||6
397006|NCT01767285|971348|P1|NOT COMPLETED|Overall Study||7
397007|NCT01767285|971347|P2|COMPLETED|Overall Study||24
397008|NCT01767285|971348|P1|COMPLETED|Overall Study||22
397009|NCT01767285|971347|P2|STARTED|Overall Study||30
397010|NCT01767285|971348|P1|STARTED|Overall Study||29
397011|NCT01767116|971366|P2|NOT COMPLETED|Overall Study||2
397012|NCT01767116|971367|P1|NOT COMPLETED|Overall Study||2
397013|NCT01767116|971366|P2|COMPLETED|Overall Study||207
397014|NCT01767116|971367|P1|COMPLETED|Overall Study||208
397015|NCT01767116|971366|P2|STARTED|Overall Study||209
397016|NCT01767116|971367|P1|STARTED|Overall Study||210
397017|NCT01767103|971386|P3|NOT COMPLETED|Overall Study||0
397018|NCT01767103|971387|P2|NOT COMPLETED|Overall Study||0
397019|NCT01767103|971388|P1|NOT COMPLETED|Overall Study||0
397020|NCT01767103|971386|P3|COMPLETED|Overall Study||7
397021|NCT01767103|971387|P2|COMPLETED|Overall Study||7
397022|NCT01767103|971388|P1|COMPLETED|Overall Study||7
397023|NCT01767103|971386|P3|STARTED|Overall Study||7
397024|NCT01767103|971387|P2|STARTED|Overall Study||7
397025|NCT01767103|971388|P1|STARTED|Overall Study||7
397026|NCT01767064|971416|P2|NOT COMPLETED|Overall Study||0
397027|NCT01767064|971417|P1|NOT COMPLETED|Overall Study||0
397028|NCT01767064|971416|P2|COMPLETED|Overall Study||7
397029|NCT01767064|971417|P1|COMPLETED|Overall Study||7
397030|NCT01767064|971416|P2|STARTED|Overall Study||7
397031|NCT01767064|971417|P1|STARTED|Overall Study||7
397032|NCT01766921|971425|P2|NOT COMPLETED|Overall Study||17
397033|NCT01766921|971426|P1|NOT COMPLETED|Overall Study||24
397034|NCT01766921|971425|P2|COMPLETED|Overall Study||676
397035|NCT01766921|971426|P1|COMPLETED|Overall Study||676
397036|NCT01766921|971425|P2|STARTED|Overall Study||693
397037|NCT01766921|971426|P1|STARTED|Overall Study||700
397038|NCT01766778|971447|P2|NOT COMPLETED|Overall Study||4
397039|NCT01766778|971448|P1|NOT COMPLETED|Overall Study||5
397040|NCT01766778|971447|P2|COMPLETED|Overall Study||57
397041|NCT01766778|971448|P1|COMPLETED|Overall Study||51
397042|NCT01766778|971447|P2|STARTED|Overall Study||61
397043|NCT01766778|971448|P1|STARTED|Overall Study|Intent to treat population|56
397044|NCT01766713|971466|P2|NOT COMPLETED|Overall Study||2
397045|NCT01766713|971467|P1|NOT COMPLETED|Overall Study||2
397046|NCT01766713|971466|P2|COMPLETED|Overall Study||23
397047|NCT01766713|971467|P1|COMPLETED|Overall Study||23
397048|NCT01766713|971466|P2|STARTED|Overall Study||25
397049|NCT01766713|971467|P1|STARTED|Overall Study||25
397050|NCT01766466|971475|P4|NOT COMPLETED|Day 5||0
397051|NCT01766466|971476|P3|NOT COMPLETED|Day 5||0
397052|NCT01766466|971477|P2|NOT COMPLETED|Day 5||0
397053|NCT01766466|971478|P1|NOT COMPLETED|Day 5||0
397054|NCT01766466|971475|P4|COMPLETED|Day 5||6
397055|NCT01766466|971476|P3|COMPLETED|Day 5||0
397056|NCT01766466|971477|P2|COMPLETED|Day 5||6
397057|NCT01766466|971478|P1|COMPLETED|Day 5||0
397058|NCT01766466|971475|P4|STARTED|Day 5||6
397059|NCT01766466|971476|P3|STARTED|Day 5||0
397060|NCT01766466|971477|P2|STARTED|Day 5||6
397061|NCT01766466|971478|P1|STARTED|Day 5||0
397062|NCT01766466|971475|P4|NOT COMPLETED|Day 1||0
397063|NCT01766466|971476|P3|NOT COMPLETED|Day 1||0
397064|NCT01766466|971477|P2|NOT COMPLETED|Day 1||0
397065|NCT01766466|971478|P1|NOT COMPLETED|Day 1||0
397066|NCT01766466|971475|P4|COMPLETED|Day 1||0
397067|NCT01766466|971476|P3|COMPLETED|Day 1||6
397068|NCT01766466|971477|P2|COMPLETED|Day 1||0
397069|NCT01766466|971478|P1|COMPLETED|Day 1||6
397070|NCT01766466|971475|P4|STARTED|Day 1||0
397071|NCT01766466|971476|P3|STARTED|Day 1||6
397072|NCT01766466|971477|P2|STARTED|Day 1||0
397073|NCT01766466|971478|P1|STARTED|Day 1||6
397074|NCT01766440|971491|P1|NOT COMPLETED|Overall Study||1
397075|NCT01766440|971491|P1|COMPLETED|Overall Study||17
397076|NCT01766440|971491|P1|STARTED|Overall Study||18
397077|NCT01766336|971502|P2|NOT COMPLETED|Overall Study||75
397078|NCT01766336|971503|P1|NOT COMPLETED|Overall Study||90
397079|NCT01766336|971502|P2|COMPLETED|Overall Study||71
397080|NCT01766336|971503|P1|COMPLETED|Overall Study||60
397081|NCT01766336|971502|P2|STARTED|Overall Study||146
397082|NCT01766336|971503|P1|STARTED|Overall Study||150
397083|NCT01766310|971511|P2|NOT COMPLETED|Overall Study||3
397084|NCT01766310|971512|P1|NOT COMPLETED|Overall Study||1
397085|NCT01766310|971511|P2|COMPLETED|Overall Study||23
397086|NCT01766310|971512|P1|COMPLETED|Overall Study||23
397087|NCT01766310|971511|P2|STARTED|Overall Study||26
397088|NCT01766310|971512|P1|STARTED|Overall Study||24
397089|NCT01766102|971522|P2|NOT COMPLETED|Overall Study||0
397090|NCT01766102|971523|P1|NOT COMPLETED|Overall Study||0
397091|NCT01766102|971522|P2|COMPLETED|Overall Study||36
397092|NCT01766102|971523|P1|COMPLETED|Overall Study||36
397093|NCT01766102|971522|P2|STARTED|Overall Study||36
397094|NCT01766102|971523|P1|STARTED|Overall Study||36
397095|NCT01766076|971533|P2|NOT COMPLETED|Overall Study||0
397096|NCT01766076|971534|P1|NOT COMPLETED|Overall Study||0
397097|NCT01766076|971533|P2|COMPLETED|Overall Study||15
397098|NCT01766076|971534|P1|COMPLETED|Overall Study||15
397099|NCT01766076|971533|P2|STARTED|Overall Study||15
397100|NCT01766076|971534|P1|STARTED|Overall Study||15
397101|NCT01766050|971540|P1|NOT COMPLETED|Overall Study||4
397102|NCT01766050|971540|P1|COMPLETED|Overall Study||18
397103|NCT01766050|971540|P1|STARTED|Overall Study||22
397104|NCT01766037|971675|P2|NOT COMPLETED|Overall Study||29
397105|NCT01766037|971676|P1|NOT COMPLETED|Overall Study||29
397106|NCT01766037|971675|P2|COMPLETED|Overall Study||31
397107|NCT01766037|971676|P1|COMPLETED|Overall Study||82
397108|NCT01766037|971675|P2|STARTED|Overall Study||60
397109|NCT01766037|971676|P1|STARTED|Overall Study||111
397110|NCT01766024|971713|P2|NOT COMPLETED|Overall Study||0
397111|NCT01766024|971714|P1|NOT COMPLETED|Overall Study||0
397112|NCT01766024|971713|P2|COMPLETED|Overall Study||16
397113|NCT01766024|971714|P1|COMPLETED|Overall Study||16
397114|NCT01766024|971713|P2|STARTED|Overall Study||16
397115|NCT01766024|971714|P1|STARTED|Overall Study||16
397116|NCT01765972|971724|P4|NOT COMPLETED|Overall Study||0
397117|NCT01765972|971725|P3|NOT COMPLETED|Overall Study||0
397118|NCT01765972|971726|P2|NOT COMPLETED|Overall Study||0
397119|NCT01765972|971727|P1|NOT COMPLETED|Overall Study||0
397120|NCT01765972|971724|P4|COMPLETED|Overall Study||6
397121|NCT01765972|971725|P3|COMPLETED|Overall Study||6
397122|NCT01765972|971726|P2|COMPLETED|Overall Study||6
397123|NCT01765972|971727|P1|COMPLETED|Overall Study||6
397124|NCT01765972|971724|P4|STARTED|Overall Study||6
397125|NCT01765972|971725|P3|STARTED|Overall Study||6
397126|NCT01765972|971726|P2|STARTED|Overall Study||6
397127|NCT01765972|971727|P1|STARTED|Overall Study||6
397128|NCT01765803|971737|P1|NOT COMPLETED|Overall Study||0
397129|NCT01765803|971737|P1|COMPLETED|Overall Study||6
397130|NCT01765803|971737|P1|STARTED|Overall Study||6
397131|NCT01765764|971745|P3|NOT COMPLETED|Post-treatment Period||0
397132|NCT01765764|971746|P2|NOT COMPLETED|Post-treatment Period||0
397133|NCT01765764|971747|P1|NOT COMPLETED|Post-treatment Period||0
397134|NCT01765764|971745|P3|COMPLETED|Post-treatment Period||112
397135|NCT01765764|971746|P2|COMPLETED|Post-treatment Period||107
397136|NCT01765764|971747|P1|COMPLETED|Post-treatment Period||114
397137|NCT01765764|971745|P3|STARTED|Post-treatment Period|3 participants did not enter the Post-treatment Period [1 Personal Reasons,2 LFU].|112
397138|NCT01765764|971746|P2|STARTED|Post-treatment Period|2 participants did not enter the Post-treatment Period [2 Lost-to-Follow-up (LFU)]|107
397139|NCT01765764|971747|P1|STARTED|Post-treatment Period|1 participant did not enter the Post-treatment Period. [Personal Reasons]|114
397140|NCT01765764|971745|P3|NOT COMPLETED|Treatment Period||6
397141|NCT01765764|971746|P2|NOT COMPLETED|Treatment Period||9
397142|NCT01765764|971747|P1|NOT COMPLETED|Treatment Period||3
397143|NCT01765764|971745|P3|COMPLETED|Treatment Period||115
397144|NCT01765764|971746|P2|COMPLETED|Treatment Period||109
397145|NCT01765764|971747|P1|COMPLETED|Treatment Period||115
397146|NCT01765764|971745|P3|STARTED|Treatment Period||121
397147|NCT01765764|971746|P2|STARTED|Treatment Period||118
397148|NCT01765764|971747|P1|STARTED|Treatment Period||118
397149|NCT01765751|971767|P3|NOT COMPLETED|Overall Study||1
397150|NCT01765751|971768|P2|NOT COMPLETED|Overall Study||2
397151|NCT01765751|971769|P1|NOT COMPLETED|Overall Study||0
397152|NCT01765751|971767|P3|COMPLETED|Overall Study||15
397153|NCT01765751|971768|P2|COMPLETED|Overall Study||14
397154|NCT01765751|971769|P1|COMPLETED|Overall Study||16
397155|NCT01765751|971767|P3|STARTED|Overall Study||16
397156|NCT01765751|971768|P2|STARTED|Overall Study||16
397157|NCT01765751|971769|P1|STARTED|Overall Study||16
397158|NCT01765673|971801|P1|NOT COMPLETED|Overall Study||1
397159|NCT01765673|971801|P1|COMPLETED|Overall Study||11
397160|NCT01765673|971801|P1|STARTED|Overall Study||12
397161|NCT01765582|971827|P3|NOT COMPLETED|Overall Study||95
397162|NCT01765582|971828|P2|NOT COMPLETED|Overall Study||92
397163|NCT01765582|971829|P1|NOT COMPLETED|Overall Study||93
397164|NCT01765582|971827|P3|COMPLETED|Overall Study||0
397165|NCT01765582|971828|P2|COMPLETED|Overall Study||0
397166|NCT01765582|971829|P1|COMPLETED|Overall Study||0
397167|NCT01765582|971827|P3|STARTED|Overall Study||95
397168|NCT01765582|971828|P2|STARTED|Overall Study||92
397169|NCT01765582|971829|P1|STARTED|Overall Study||93
397170|NCT01765569|971862|P1|NOT COMPLETED|Period C||1
397171|NCT01765569|971862|P1|COMPLETED|Period C||27
397172|NCT01765569|971862|P1|STARTED|Period C||28
397173|NCT01765569|971862|P1|NOT COMPLETED|Period B||1
397174|NCT01765569|971862|P1|COMPLETED|Period B||28
397175|NCT01765569|971862|P1|STARTED|Period B||29
397176|NCT01765569|971862|P1|NOT COMPLETED|Period A||0
397177|NCT01765569|971862|P1|COMPLETED|Period A||29
397178|NCT01765569|971862|P1|STARTED|Period A||29
397179|NCT01765543|971883|P1|NOT COMPLETED|Overall Study||3
397180|NCT01765543|971883|P1|COMPLETED|Overall Study||24
397181|NCT01765543|971883|P1|STARTED|Overall Study||27
397182|NCT01765530|971907|P2|NOT COMPLETED|Overall Study||1
397183|NCT01765530|971908|P1|NOT COMPLETED|Overall Study||1
397184|NCT01765530|971907|P2|COMPLETED|Overall Study||36
397185|NCT01765530|971908|P1|COMPLETED|Overall Study||36
397186|NCT01765530|971907|P2|STARTED|Overall Study||37
397187|NCT01765530|971908|P1|STARTED|Overall Study||37
397188|NCT01765465|971918|P2|NOT COMPLETED|Overall Study||4
397189|NCT01765465|971919|P1|NOT COMPLETED|Overall Study||7
397190|NCT01765465|971918|P2|COMPLETED|Overall Study||63
397191|NCT01765465|971919|P1|COMPLETED|Overall Study||64
397192|NCT01765465|971918|P2|STARTED|Overall Study||67
397193|NCT01765465|971919|P1|STARTED|Overall Study||71
397194|NCT01765426|971935|P4|NOT COMPLETED|Overall Study||0
397195|NCT01765426|971936|P3|NOT COMPLETED|Overall Study||0
397196|NCT01765426|971937|P2|NOT COMPLETED|Overall Study||1
397197|NCT01765426|971938|P1|NOT COMPLETED|Overall Study||0
397198|NCT01765426|971935|P4|COMPLETED|Overall Study||15
397199|NCT01765426|971936|P3|COMPLETED|Overall Study||17
397200|NCT01765426|971937|P2|COMPLETED|Overall Study||16
397201|NCT01765426|971938|P1|COMPLETED|Overall Study||18
397202|NCT01765426|971935|P4|Completed All Vaccinations|Overall Study||15
397203|NCT01765426|971936|P3|Completed All Vaccinations|Overall Study||17
397204|NCT01765426|971937|P2|Completed All Vaccinations|Overall Study||16
397205|NCT01765426|971938|P1|Completed All Vaccinations|Overall Study||17
397206|NCT01765426|971935|P4|STARTED|Overall Study||15
397207|NCT01765426|971936|P3|STARTED|Overall Study||17
397208|NCT01765426|971937|P2|STARTED|Overall Study||17
397209|NCT01765426|971938|P1|STARTED|Overall Study||18
397210|NCT01765270|971994|P2|NOT COMPLETED|Overall Study||1
397211|NCT01765270|971995|P1|NOT COMPLETED|Overall Study||1
397212|NCT01765270|971994|P2|COMPLETED|Overall Study||6
397213|NCT01765270|971995|P1|COMPLETED|Overall Study||4
397214|NCT01765270|971994|P2|STARTED|Overall Study||7
397215|NCT01765270|971995|P1|STARTED|Overall Study||5
397216|NCT01765192|972017|P2|NOT COMPLETED|End of Treatment Period 2 to Final Visit||1
397217|NCT01765192|972018|P1|NOT COMPLETED|End of Treatment Period 2 to Final Visit||0
397218|NCT01765192|972017|P2|COMPLETED|End of Treatment Period 2 to Final Visit||27
397219|NCT01765192|972018|P1|COMPLETED|End of Treatment Period 2 to Final Visit||30
397220|NCT01765192|972017|P2|STARTED|End of Treatment Period 2 to Final Visit||28
397221|NCT01765192|972018|P1|STARTED|End of Treatment Period 2 to Final Visit||30
397222|NCT01765192|972017|P2|NOT COMPLETED|Treatment Period 2||2
397223|NCT01765192|972018|P1|NOT COMPLETED|Treatment Period 2||0
397224|NCT01765192|972017|P2|COMPLETED|Treatment Period 2||28
397225|NCT01765192|972018|P1|COMPLETED|Treatment Period 2||30
397226|NCT01765192|972017|P2|STARTED|Treatment Period 2||30
397227|NCT01765192|972018|P1|STARTED|Treatment Period 2||30
397228|NCT01765192|972017|P2|NOT COMPLETED|Washout Period||1
397229|NCT01765192|972018|P1|NOT COMPLETED|Washout Period||2
397230|NCT01765192|972017|P2|COMPLETED|Washout Period||30
397231|NCT01765192|972018|P1|COMPLETED|Washout Period||30
397232|NCT01765192|972017|P2|STARTED|Washout Period||31
397233|NCT01765192|972018|P1|STARTED|Washout Period||32
397234|NCT01765192|972017|P2|NOT COMPLETED|Treatment Period 1||1
397235|NCT01765192|972018|P1|NOT COMPLETED|Treatment Period 1||0
397236|NCT01765192|972017|P2|COMPLETED|Treatment Period 1||31
397237|NCT01765192|972018|P1|COMPLETED|Treatment Period 1||32
397238|NCT01765192|972017|P2|STARTED|Treatment Period 1||32
397239|NCT01765192|972018|P1|STARTED|Treatment Period 1||32
397240|NCT01765179|972036|P1|NOT COMPLETED|Overall Study||27
397241|NCT01765179|972036|P1|COMPLETED|Overall Study||117
397242|NCT01765179|972036|P1|STARTED|Overall Study||144
397243|NCT01765153|972043|P2|NOT COMPLETED|Rest Phase 2||1
397244|NCT01765153|972044|P1|NOT COMPLETED|Rest Phase 2||2
397245|NCT01765153|972043|P2|COMPLETED|Rest Phase 2||7
397246|NCT01765153|972044|P1|COMPLETED|Rest Phase 2||8
397247|NCT01765153|972043|P2|STARTED|Rest Phase 2||8
397248|NCT01765153|972044|P1|STARTED|Rest Phase 2||10
397249|NCT01765153|972043|P2|NOT COMPLETED|Training Phase 2||1
397250|NCT01765153|972044|P1|NOT COMPLETED|Training Phase 2||0
397251|NCT01765153|972043|P2|COMPLETED|Training Phase 2||8
397252|NCT01765153|972044|P1|COMPLETED|Training Phase 2||10
397253|NCT01765153|972043|P2|STARTED|Training Phase 2||9
397254|NCT01765153|972044|P1|STARTED|Training Phase 2|1st subject didn't use same training(phase 1) as subsequent participants Phase 1 and 2 data removed.|10
397255|NCT01765153|972043|P2|NOT COMPLETED|Rest Phase 1||1
397256|NCT01765153|972044|P1|NOT COMPLETED|Rest Phase 1||0
397257|NCT01765153|972043|P2|COMPLETED|Rest Phase 1||9
397258|NCT01765153|972044|P1|COMPLETED|Rest Phase 1||9
397259|NCT01765153|972043|P2|STARTED|Rest Phase 1||10
397260|NCT01765153|972044|P1|STARTED|Rest Phase 1||9
397261|NCT01765153|972043|P2|NOT COMPLETED|Training Phase 1||1
397262|NCT01765153|972044|P1|NOT COMPLETED|Training Phase 1||1
397263|NCT01765153|972043|P2|COMPLETED|Training Phase 1||10
397264|NCT01765153|972044|P1|COMPLETED|Training Phase 1||9
397265|NCT01765153|972043|P2|STARTED|Training Phase 1||11
397266|NCT01765153|972044|P1|STARTED|Training Phase 1||10
397267|NCT01764997|972151|P5|NOT COMPLETED|Study Drug Treatment Period||36
397268|NCT01764997|972152|P4|NOT COMPLETED|Study Drug Treatment Period||0
397269|NCT01764997|972153|P3|NOT COMPLETED|Study Drug Treatment Period||0
397270|NCT01764997|972154|P2|NOT COMPLETED|Study Drug Treatment Period||1
397271|NCT01764997|972155|P1|NOT COMPLETED|Study Drug Treatment Period||0
397272|NCT01764997|972151|P5|COMPLETED|Study Drug Treatment Period||286
397273|NCT01764997|972152|P4|COMPLETED|Study Drug Treatment Period||13
397274|NCT01764997|972153|P3|COMPLETED|Study Drug Treatment Period||13
397275|NCT01764997|972154|P2|COMPLETED|Study Drug Treatment Period||16
397276|NCT01764997|972155|P1|COMPLETED|Study Drug Treatment Period||0
397277|NCT01764997|972151|P5|STARTED|Study Drug Treatment Period||322
397278|NCT01764997|972152|P4|STARTED|Study Drug Treatment Period||13
397279|NCT01764997|972153|P3|STARTED|Study Drug Treatment Period||13
397280|NCT01764997|972154|P2|STARTED|Study Drug Treatment Period||17
397281|NCT01764997|972155|P1|STARTED|Study Drug Treatment Period||0
397282|NCT01764997|972151|P5|NOT COMPLETED|Run-in Period||0
397283|NCT01764997|972152|P4|NOT COMPLETED|Run-in Period||0
397284|NCT01764997|972153|P3|NOT COMPLETED|Run-in Period||0
397285|NCT01764997|972154|P2|NOT COMPLETED|Run-in Period||0
397286|NCT01764997|972155|P1|NOT COMPLETED|Run-in Period||38
397287|NCT01764997|972151|P5|COMPLETED|Run-in Period||0
397288|NCT01764997|972152|P4|COMPLETED|Run-in Period||0
397289|NCT01764997|972153|P3|COMPLETED|Run-in Period||0
397290|NCT01764997|972154|P2|COMPLETED|Run-in Period||0
397291|NCT01764997|972155|P1|COMPLETED|Run-in Period|43 participants proceeded to randomized treatment and 322 proceeded to open-label sub-study.|738
397292|NCT01764997|972151|P5|STARTED|Run-in Period||0
397293|NCT01764997|972152|P4|STARTED|Run-in Period||0
397294|NCT01764997|972153|P3|STARTED|Run-in Period||0
397295|NCT01764997|972154|P2|STARTED|Run-in Period||0
397296|NCT01764997|972155|P1|STARTED|Run-in Period||776
397297|NCT01764945|972182|P8|NOT COMPLETED|Overall Study||0
397298|NCT01764945|972183|P7|NOT COMPLETED|Overall Study||1
397299|NCT01764945|972184|P6|NOT COMPLETED|Overall Study||0
397300|NCT01764945|972185|P5|NOT COMPLETED|Overall Study||0
397301|NCT01764945|972186|P4|NOT COMPLETED|Overall Study||0
397302|NCT01764945|972187|P3|NOT COMPLETED|Overall Study||0
397303|NCT01764945|972188|P2|NOT COMPLETED|Overall Study||1
397304|NCT01764945|972189|P1|NOT COMPLETED|Overall Study||0
397305|NCT01764945|972182|P8|COMPLETED|Overall Study||9
397306|NCT01764945|972183|P7|COMPLETED|Overall Study||8
397307|NCT01764945|972184|P6|COMPLETED|Overall Study||8
397308|NCT01764945|972185|P5|COMPLETED|Overall Study||10
397309|NCT01764945|972186|P4|COMPLETED|Overall Study||5
397310|NCT01764945|972187|P3|COMPLETED|Overall Study||5
397311|NCT01764945|972188|P2|COMPLETED|Overall Study||4
397312|NCT01764945|972189|P1|COMPLETED|Overall Study||5
397313|NCT01764945|972182|P8|STARTED|Overall Study||9
397314|NCT01764945|972183|P7|STARTED|Overall Study||9
397315|NCT01764945|972184|P6|STARTED|Overall Study||8
397316|NCT01764945|972185|P5|STARTED|Overall Study||10
397317|NCT01764945|972186|P4|STARTED|Overall Study||5
397318|NCT01764945|972187|P3|STARTED|Overall Study||5
397319|NCT01764945|972188|P2|STARTED|Overall Study||5
397320|NCT01764945|972189|P1|STARTED|Overall Study||5
397321|NCT01764919|972223|P1|NOT COMPLETED|Overall Study||0
397322|NCT01764919|972223|P1|COMPLETED|Overall Study||4
397323|NCT01764919|972223|P1|STARTED|Overall Study||4
397324|NCT01764841|972235|P4|NOT COMPLETED|Overall Study||19
397325|NCT01764841|972236|P3|NOT COMPLETED|Overall Study||14
397326|NCT01764841|972237|P2|NOT COMPLETED|Overall Study||26
397327|NCT01764841|972238|P1|NOT COMPLETED|Overall Study||23
397328|NCT01764841|972235|P4|COMPLETED|Overall Study||49
397329|NCT01764841|972236|P3|COMPLETED|Overall Study||56
397330|NCT01764841|972237|P2|COMPLETED|Overall Study||111
397331|NCT01764841|972238|P1|COMPLETED|Overall Study||118
397332|NCT01764841|972235|P4|Participants Received Treatment|Overall Study|safety population|68
397333|NCT01764841|972236|P3|Participants Received Treatment|Overall Study|safety population|69
397334|NCT01764841|972237|P2|Participants Received Treatment|Overall Study|safety population|136
397335|NCT01764841|972238|P1|Participants Received Treatment|Overall Study|safety population|141
397336|NCT01764841|972235|P4|STARTED|Overall Study||68
397337|NCT01764841|972236|P3|STARTED|Overall Study||70
397338|NCT01764841|972237|P2|STARTED|Overall Study||137
397339|NCT01764841|972238|P1|STARTED|Overall Study||141
397340|NCT01764685|972272|P2|NOT COMPLETED|Overall Study||1
397341|NCT01764685|972273|P1|NOT COMPLETED|Overall Study||0
397342|NCT01764685|972272|P2|COMPLETED|Overall Study||3
397343|NCT01764685|972273|P1|COMPLETED|Overall Study||0
397344|NCT01764685|972272|P2|STARTED|Overall Study||4
397345|NCT01764685|972273|P1|STARTED|Overall Study||0
397346|NCT01764633|972281|P2|NOT COMPLETED|Overall Study||93
397347|NCT01764633|972282|P1|NOT COMPLETED|Overall Study||118
397348|NCT01764633|972281|P2|COMPLETED|Overall Study||13691
397349|NCT01764633|972282|P1|COMPLETED|Overall Study||13662
397350|NCT01764633|972281|P2|Received Treatment|Overall Study||13769
397351|NCT01764633|972282|P1|Received Treatment|Overall Study||13756
397352|NCT01764633|972281|P2|STARTED|Overall Study||13784
397353|NCT01764633|972282|P1|STARTED|Overall Study||13780
397354|NCT01764607|972304|P1|NOT COMPLETED|Overall Study||0
397355|NCT01764607|972304|P1|COMPLETED|Overall Study||1
397356|NCT01764607|972304|P1|STARTED|Overall Study||1
397357|NCT01764386|972311|P2|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||53
397358|NCT01764386|972312|P1|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||16
397359|NCT01764386|972311|P2|COMPLETED|Uncontrolled Treatment Period (UTP)|Completed the 78-week study.|28
397360|NCT01764386|972312|P1|COMPLETED|Uncontrolled Treatment Period (UTP)|Completed the 78-week study.|55
397361|NCT01764386|972311|P2|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||35
397362|NCT01764386|972312|P1|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||61
397363|NCT01764386|972311|P2|STARTED|Uncontrolled Treatment Period (UTP)|One subject completed the 26-week CTP, but did not continue in the UTP.|81
397364|NCT01764386|972312|P1|STARTED|Uncontrolled Treatment Period (UTP)||71
397365|NCT01764386|972311|P2|NOT COMPLETED|Controlled Treatment Period (CTP)||7
397366|NCT01764386|972312|P1|NOT COMPLETED|Controlled Treatment Period (CTP)||82
397367|NCT01764386|972311|P2|COMPLETED|Controlled Treatment Period (CTP)|Completed the 26-week Controlled Treatment Period.|82
397368|NCT01764386|972312|P1|COMPLETED|Controlled Treatment Period (CTP)|Completed the 26-week Controlled Treatment Period.|71
397369|NCT01764386|972311|P2|STARTED|Controlled Treatment Period (CTP)||89
397370|NCT01764386|972312|P1|STARTED|Controlled Treatment Period (CTP)||153
397371|NCT01764022|972355|P2|NOT COMPLETED|Overall Study||12
397372|NCT01764022|972356|P1|NOT COMPLETED|Overall Study||21
397373|NCT01764022|972355|P2|COMPLETED|Overall Study||49
397374|NCT01764022|972356|P1|COMPLETED|Overall Study||44
397375|NCT01764022|972355|P2|Received at Least 1 Dose of Study Drug|Overall Study||61
397376|NCT01764022|972356|P1|Received at Least 1 Dose of Study Drug|Overall Study||63
397377|NCT01764022|972355|P2|STARTED|Overall Study||61
397378|NCT01764022|972356|P1|STARTED|Overall Study||65
397379|NCT01763996|972384|P2|NOT COMPLETED|Treatment Period 2||1
397380|NCT01763996|972385|P1|NOT COMPLETED|Treatment Period 2||0
397381|NCT01763996|972384|P2|COMPLETED|Treatment Period 2||14
397382|NCT01763996|972385|P1|COMPLETED|Treatment Period 2||15
397383|NCT01763996|972384|P2|STARTED|Treatment Period 2||15
397384|NCT01763996|972385|P1|STARTED|Treatment Period 2||15
397385|NCT01763996|972384|P2|NOT COMPLETED|Treatment Period 1||0
397386|NCT01763996|972385|P1|NOT COMPLETED|Treatment Period 1||0
397387|NCT01763996|972384|P2|COMPLETED|Treatment Period 1||15
397388|NCT01763996|972385|P1|COMPLETED|Treatment Period 1||15
397389|NCT01763996|972384|P2|STARTED|Treatment Period 1||15
397390|NCT01763996|972385|P1|STARTED|Treatment Period 1||15
397391|NCT01763918|972415|P4|NOT COMPLETED|Overall Study||2
397392|NCT01763918|972416|P3|NOT COMPLETED|Overall Study||10
397393|NCT01763918|972417|P2|NOT COMPLETED|Overall Study||1
397394|NCT01763918|972418|P1|NOT COMPLETED|Overall Study||6
397395|NCT01763918|972415|P4|COMPLETED|Overall Study||108
397396|NCT01763918|972416|P3|COMPLETED|Overall Study||101
397397|NCT01763918|972417|P2|COMPLETED|Overall Study||54
397398|NCT01763918|972418|P1|COMPLETED|Overall Study||49
397399|NCT01763918|972415|P4|Received Treatment|Overall Study||110
397400|NCT01763918|972416|P3|Received Treatment|Overall Study||110
397401|NCT01763918|972417|P2|Received Treatment|Overall Study||55
397402|NCT01763918|972418|P1|Received Treatment|Overall Study||54
397403|NCT01763918|972415|P4|STARTED|Overall Study||110
397404|NCT01763918|972416|P3|STARTED|Overall Study||111
397405|NCT01763918|972417|P2|STARTED|Overall Study||55
397406|NCT01763918|972418|P1|STARTED|Overall Study||55
397407|NCT01763905|972516|P4|NOT COMPLETED|Overall Study||1
397408|NCT01763905|972517|P3|NOT COMPLETED|Overall Study||9
397409|NCT01763905|972518|P2|NOT COMPLETED|Overall Study||1
397410|NCT01763905|972519|P1|NOT COMPLETED|Overall Study||6
397411|NCT01763905|972516|P4|COMPLETED|Overall Study||101
397412|NCT01763905|972517|P3|COMPLETED|Overall Study||94
397413|NCT01763905|972518|P2|COMPLETED|Overall Study||50
397414|NCT01763905|972519|P1|COMPLETED|Overall Study||45
397415|NCT01763905|972516|P4|STARTED|Overall Study||102
397416|NCT01763905|972517|P3|STARTED|Overall Study||103
397417|NCT01763905|972518|P2|STARTED|Overall Study||51
397418|NCT01763905|972519|P1|STARTED|Overall Study||51
397419|NCT01763866|972637|P24|NOT COMPLETED|Overall Study||2
397420|NCT01763866|972638|P23|NOT COMPLETED|Overall Study||3
397421|NCT01763866|972639|P22|NOT COMPLETED|Overall Study||1
397422|NCT01763866|972640|P21|NOT COMPLETED|Overall Study||4
397423|NCT01763866|972641|P20|NOT COMPLETED|Overall Study||2
397424|NCT01763866|972642|P19|NOT COMPLETED|Overall Study||6
397425|NCT01763866|972643|P18|NOT COMPLETED|Overall Study||1
397426|NCT01763866|972644|P17|NOT COMPLETED|Overall Study||1
397427|NCT01763866|972645|P16|NOT COMPLETED|Overall Study||3
397428|NCT01763866|972646|P15|NOT COMPLETED|Overall Study||12
397429|NCT01763866|972647|P14|NOT COMPLETED|Overall Study||0
397430|NCT01763866|972648|P13|NOT COMPLETED|Overall Study||4
397431|NCT01763866|972649|P12|NOT COMPLETED|Overall Study||2
397432|NCT01763866|972650|P11|NOT COMPLETED|Overall Study||8
397433|NCT01763866|972651|P10|NOT COMPLETED|Overall Study||1
397434|NCT01763866|972652|P9|NOT COMPLETED|Overall Study||3
397435|NCT01763866|972653|P8|NOT COMPLETED|Overall Study||0
397436|NCT01763866|972654|P7|NOT COMPLETED|Overall Study||7
397437|NCT01763866|972655|P6|NOT COMPLETED|Overall Study||3
397438|NCT01763866|972656|P5|NOT COMPLETED|Overall Study||2
397439|NCT01763866|972657|P4|NOT COMPLETED|Overall Study||0
397440|NCT01763866|972658|P3|NOT COMPLETED|Overall Study||5
397441|NCT01763866|972659|P2|NOT COMPLETED|Overall Study||1
397442|NCT01763866|972660|P1|NOT COMPLETED|Overall Study||2
397443|NCT01763866|972637|P24|COMPLETED|Overall Study||113
397444|NCT01763866|972638|P23|COMPLETED|Overall Study||109
397445|NCT01763866|972639|P22|COMPLETED|Overall Study||54
397446|NCT01763866|972640|P21|COMPLETED|Overall Study||52
397447|NCT01763866|972641|P20|COMPLETED|Overall Study||110
397448|NCT01763866|972642|P19|COMPLETED|Overall Study||105
397449|NCT01763866|972643|P18|COMPLETED|Overall Study||55
397450|NCT01763866|972644|P17|COMPLETED|Overall Study||55
397451|NCT01763866|972645|P16|COMPLETED|Overall Study||112
397452|NCT01763866|972646|P15|COMPLETED|Overall Study||102
397453|NCT01763866|972647|P14|COMPLETED|Overall Study||57
397454|NCT01763866|972648|P13|COMPLETED|Overall Study||54
397455|NCT01763866|972649|P12|COMPLETED|Overall Study||108
397456|NCT01763866|972650|P11|COMPLETED|Overall Study||102
397457|NCT01763866|972651|P10|COMPLETED|Overall Study||53
397458|NCT01763866|972652|P9|COMPLETED|Overall Study||53
397459|NCT01763866|972653|P8|COMPLETED|Overall Study||55
397460|NCT01763866|972654|P7|COMPLETED|Overall Study||48
397461|NCT01763866|972655|P6|COMPLETED|Overall Study||107
397462|NCT01763866|972656|P5|COMPLETED|Overall Study||108
397463|NCT01763866|972657|P4|COMPLETED|Overall Study||55
397464|NCT01763866|972658|P3|COMPLETED|Overall Study||51
397465|NCT01763866|972659|P2|COMPLETED|Overall Study||54
397466|NCT01763866|972660|P1|COMPLETED|Overall Study||54
397467|NCT01763866|972637|P24|Received Treatment|Overall Study||115
397468|NCT01763866|972638|P23|Received Treatment|Overall Study||112
397469|NCT01763866|972639|P22|Received Treatment|Overall Study||55
397470|NCT01763866|972640|P21|Received Treatment|Overall Study||56
397471|NCT01763866|972641|P20|Received Treatment|Overall Study||112
397472|NCT01763866|972642|P19|Received Treatment|Overall Study||111
397473|NCT01763866|972643|P18|Received Treatment|Overall Study||55
397474|NCT01763866|972644|P17|Received Treatment|Overall Study||56
397475|NCT01763866|972645|P16|Received Treatment|Overall Study||115
397476|NCT01763866|972646|P15|Received Treatment|Overall Study||113
397477|NCT01763866|972647|P14|Received Treatment|Overall Study||57
397478|NCT01763866|972648|P13|Received Treatment|Overall Study||58
397479|NCT01763866|972649|P12|Received Treatment|Overall Study||110
397480|NCT01763866|972650|P11|Received Treatment|Overall Study||109
397481|NCT01763866|972651|P10|Received Treatment|Overall Study||54
397482|NCT01763866|972652|P9|Received Treatment|Overall Study||56
397483|NCT01763866|972653|P8|Received Treatment|Overall Study||55
397484|NCT01763866|972654|P7|Received Treatment|Overall Study||55
397485|NCT01763866|972655|P6|Received Treatment|Overall Study||110
397486|NCT01763866|972656|P5|Received Treatment|Overall Study||110
397487|NCT01763866|972657|P4|Received Treatment|Overall Study||55
397488|NCT01763866|972658|P3|Received Treatment|Overall Study||56
397489|NCT01763866|972659|P2|Received Treatment|Overall Study||55
397490|NCT01763866|972660|P1|Received Treatment|Overall Study||56
397491|NCT01763866|972637|P24|STARTED|Overall Study||115
397492|NCT01763866|972638|P23|STARTED|Overall Study||112
397493|NCT01763866|972639|P22|STARTED|Overall Study||55
397494|NCT01763866|972640|P21|STARTED|Overall Study||56
397495|NCT01763866|972641|P20|STARTED|Overall Study||112
397496|NCT01763866|972642|P19|STARTED|Overall Study||111
397497|NCT01763866|972643|P18|STARTED|Overall Study||56
397498|NCT01763866|972644|P17|STARTED|Overall Study||56
397499|NCT01763866|972645|P16|STARTED|Overall Study||115
397500|NCT01763866|972646|P15|STARTED|Overall Study||114
397501|NCT01763866|972647|P14|STARTED|Overall Study||57
397502|NCT01763866|972648|P13|STARTED|Overall Study||58
397503|NCT01763866|972649|P12|STARTED|Overall Study||110
397504|NCT01763866|972650|P11|STARTED|Overall Study||110
397505|NCT01763866|972651|P10|STARTED|Overall Study||54
397506|NCT01763866|972652|P9|STARTED|Overall Study||56
397507|NCT01763866|972653|P8|STARTED|Overall Study||55
397508|NCT01763866|972654|P7|STARTED|Overall Study||55
397509|NCT01763866|972655|P6|STARTED|Overall Study||110
397510|NCT01763866|972656|P5|STARTED|Overall Study||110
397511|NCT01763866|972657|P4|STARTED|Overall Study||55
397512|NCT01763866|972658|P3|STARTED|Overall Study||56
397513|NCT01763866|972659|P2|STARTED|Overall Study||55
397514|NCT01763866|972660|P1|STARTED|Overall Study||56
397515|NCT01763827|973220|P6|NOT COMPLETED|Overall Study||2
397516|NCT01763827|973221|P5|NOT COMPLETED|Overall Study||6
397517|NCT01763827|973222|P4|NOT COMPLETED|Overall Study||1
397518|NCT01763827|973223|P3|NOT COMPLETED|Overall Study||4
397519|NCT01763827|973224|P2|NOT COMPLETED|Overall Study||1
397520|NCT01763827|973225|P1|NOT COMPLETED|Overall Study||3
397521|NCT01763827|973220|P6|COMPLETED|Overall Study||151
397522|NCT01763827|973221|P5|COMPLETED|Overall Study||147
397523|NCT01763827|973222|P4|COMPLETED|Overall Study||76
397524|NCT01763827|973223|P3|COMPLETED|Overall Study||73
397525|NCT01763827|973224|P2|COMPLETED|Overall Study||77
397526|NCT01763827|973225|P1|COMPLETED|Overall Study||74
397527|NCT01763827|973220|P6|Received at Least 1 Dose of Study Drug|Overall Study||153
397528|NCT01763827|973221|P5|Received at Least 1 Dose of Study Drug|Overall Study||153
397529|NCT01763827|973222|P4|Received at Least 1 Dose of Study Drug|Overall Study||77
397530|NCT01763827|973223|P3|Received at Least 1 Dose of Study Drug|Overall Study||77
397531|NCT01763827|973224|P2|Received at Least 1 Dose of Study Drug|Overall Study||78
397532|NCT01763827|973225|P1|Received at Least 1 Dose of Study Drug|Overall Study||76
397533|NCT01763827|973220|P6|STARTED|Overall Study||153
397534|NCT01763827|973221|P5|STARTED|Overall Study||153
397535|NCT01763827|973222|P4|STARTED|Overall Study||77
397536|NCT01763827|973223|P3|STARTED|Overall Study||77
397537|NCT01763827|973224|P2|STARTED|Overall Study||78
397538|NCT01763827|973225|P1|STARTED|Overall Study||77
397539|NCT01763645|973367|P2|NOT COMPLETED|Overall Study||24
397540|NCT01763645|973368|P1|NOT COMPLETED|Overall Study||26
397541|NCT01763645|973367|P2|COMPLETED|Overall Study|Completed the study according the protocol.|45
397542|NCT01763645|973368|P1|COMPLETED|Overall Study|Completed the study according the protocol.|43
397543|NCT01763645|973367|P2|Received at Least 1 Dose of Study Drug|Overall Study||66
397544|NCT01763645|973368|P1|Received at Least 1 Dose of Study Drug|Overall Study||68
397545|NCT01763645|973367|P2|STARTED|Overall Study||69
397546|NCT01763645|973368|P1|STARTED|Overall Study||69
397547|NCT01763567|973386|P1|NOT COMPLETED|Overall Study||0
397548|NCT01763567|973386|P1|COMPLETED|Overall Study||19
397549|NCT01763567|973386|P1|STARTED|Overall Study||19
397550|NCT01763047|973396|P2|NOT COMPLETED|Period 2||5
397551|NCT01763047|973397|P1|NOT COMPLETED|Period 2||4
397552|NCT01763047|973396|P2|COMPLETED|Period 2||121
397553|NCT01763047|973397|P1|COMPLETED|Period 2||126
397554|NCT01763047|973396|P2|Hyperopes|Period 2||54
397555|NCT01763047|973397|P1|Hyperopes|Period 2||56
397556|NCT01763047|973396|P2|Myopes|Period 2||72
397557|NCT01763047|973397|P1|Myopes|Period 2||74
397558|NCT01763047|973396|P2|STARTED|Period 2||126
397559|NCT01763047|973397|P1|STARTED|Period 2||130
397560|NCT01763047|973396|P2|NOT COMPLETED|Period 1||11
397561|NCT01763047|973397|P1|NOT COMPLETED|Period 1||9
397562|NCT01763047|973396|P2|COMPLETED|Period 1||126
397563|NCT01763047|973397|P1|COMPLETED|Period 1||130
397564|NCT01763047|973396|P2|Hyperopes|Period 1||61
397565|NCT01763047|973397|P1|Hyperopes|Period 1||62
397566|NCT01763047|973396|P2|Myopes|Period 1||76
397567|NCT01763047|973397|P1|Myopes|Period 1||77
397568|NCT01763047|973396|P2|STARTED|Period 1||137
397569|NCT01763047|973397|P1|STARTED|Period 1||139
397570|NCT01762982|973413|P1|NOT COMPLETED|Overall Study||0
397571|NCT01762982|973413|P1|COMPLETED|Overall Study||36
397572|NCT01762982|973413|P1|Received Empty Finn Chamber|Overall Study||36
397573|NCT01762982|973413|P1|Received SLS|Overall Study||36
397574|NCT01762982|973413|P1|Received Benzalkonium Chloride|Overall Study||36
397575|NCT01762982|973413|P1|Received Saline Water|Overall Study||36
397576|NCT01762982|973413|P1|STARTED|Overall Study||36
397577|NCT01762943|973436|P2|NOT COMPLETED|Overall Study||2
397578|NCT01762943|973437|P1|NOT COMPLETED|Overall Study||4
397579|NCT01762943|973436|P2|COMPLETED|Overall Study||15
397580|NCT01762943|973437|P1|COMPLETED|Overall Study||15
397581|NCT01762943|973436|P2|Withdrawal|Overall Study||15
397582|NCT01762943|973437|P1|Withdrawal|Overall Study||15
397583|NCT01762943|973436|P2|Addback|Overall Study||15
397584|NCT01762943|973437|P1|Addback|Overall Study||16
397585|NCT01762943|973436|P2|Hypogonadism|Overall Study||15
397586|NCT01762943|973437|P1|Hypogonadism|Overall Study||18
397587|NCT01762943|973436|P2|STARTED|Overall Study||17
397588|NCT01762943|973437|P1|STARTED|Overall Study||19
397589|NCT01762904|973445|P1|NOT COMPLETED|Overall Study||0
397590|NCT01762904|973445|P1|COMPLETED|Overall Study|October, 2013|135
397591|NCT01762904|973445|P1|STARTED|Overall Study|January, 2013|135
397592|NCT01762800|973454|P2|NOT COMPLETED|Overall Study||21
397593|NCT01762800|973455|P1|NOT COMPLETED|Overall Study||19
397594|NCT01762800|973454|P2|COMPLETED|Overall Study||183
397595|NCT01762800|973455|P1|COMPLETED|Overall Study||183
397596|NCT01762800|973454|P2|STARTED|Overall Study||204
397597|NCT01762800|973455|P1|STARTED|Overall Study||202
397598|NCT01762761|973529|P2|NOT COMPLETED|Overall Study||4
397599|NCT01762761|973530|P1|NOT COMPLETED|Overall Study||2
397600|NCT01762761|973529|P2|COMPLETED|Overall Study||100
397601|NCT01762761|973530|P1|COMPLETED|Overall Study||49
397602|NCT01762761|973529|P2|STARTED|Overall Study||104
397603|NCT01762761|973530|P1|STARTED|Overall Study||51
397604|NCT01762722|973584|P2|NOT COMPLETED|Overall Study||0
397605|NCT01762722|973585|P1|NOT COMPLETED|Overall Study||0
397606|NCT01762722|973584|P2|COMPLETED|Overall Study||11
397607|NCT01762722|973585|P1|COMPLETED|Overall Study||12
397608|NCT01762722|973584|P2|STARTED|Overall Study||11
397609|NCT01762722|973585|P1|STARTED|Overall Study||12
397610|NCT01762501|973593|P2|NOT COMPLETED|Overall Study||23
397611|NCT01762501|973594|P1|NOT COMPLETED|Overall Study||27
397612|NCT01762501|973593|P2|COMPLETED|Overall Study||336
397613|NCT01762501|973594|P1|COMPLETED|Overall Study||332
397614|NCT01762501|973593|P2|STARTED|Overall Study||359
397615|NCT01762501|973594|P1|STARTED|Overall Study||359
397616|NCT01762345|973608|P1|NOT COMPLETED|Overall Study||7
397617|NCT01762345|973608|P1|COMPLETED|Overall Study||76
397618|NCT01762345|973608|P1|STARTED|Overall Study||83
397619|NCT01762059|973618|P1|NOT COMPLETED|Overall Study||0
397620|NCT01762059|973618|P1|COMPLETED|Overall Study||20
397621|NCT01762059|973618|P1|STARTED|Overall Study||20
397622|NCT01761747|973645|P1|NOT COMPLETED|Overall Study||1
397623|NCT01761747|973645|P1|COMPLETED|Overall Study||2
397624|NCT01761747|973645|P1|STARTED|Overall Study||3
397625|NCT01761565|973656|P1|NOT COMPLETED|40 Consecutive Doses of SUF 15 mcg||1
397626|NCT01761565|973656|P1|COMPLETED|40 Consecutive Doses of SUF 15 mcg||38
397627|NCT01761565|973656|P1|STARTED|40 Consecutive Doses of SUF 15 mcg|Subject was withdrawn from the study prior to the second arm/period due to non-compliance|39
397628|NCT01761565|973656|P1|NOT COMPLETED|Single Dose of SUF NT 15 mcg||0
397629|NCT01761565|973656|P1|COMPLETED|Single Dose of SUF NT 15 mcg||40
397630|NCT01761565|973656|P1|STARTED|Single Dose of SUF NT 15 mcg||40
397631|NCT01761279|973665|P1|NOT COMPLETED|Overall Study||0
397632|NCT01761279|973665|P1|COMPLETED|Overall Study||84
397633|NCT01761279|973665|P1|STARTED|Overall Study||84
397634|NCT01761175|973680|P2|NOT COMPLETED|Overall Study||0
397635|NCT01761175|973681|P1|NOT COMPLETED|Overall Study||0
397636|NCT01761175|973680|P2|COMPLETED|Overall Study||112
397637|NCT01761175|973681|P1|COMPLETED|Overall Study||112
397638|NCT01761175|973680|P2|STARTED|Overall Study||112
397639|NCT01761175|973681|P1|STARTED|Overall Study||112
397640|NCT01761162|973709|P1|NOT COMPLETED|Overall Study||3
397641|NCT01761162|973709|P1|COMPLETED|Overall Study||226
397642|NCT01761162|973709|P1|STARTED|Overall Study||229
397643|NCT01761019|973717|P1|NOT COMPLETED|Overall Study||0
397644|NCT01761019|973717|P1|COMPLETED|Overall Study||8
397645|NCT01761019|973717|P1|STARTED|Overall Study||8
397646|NCT01760993|973725|P1|NOT COMPLETED|Overall Study||0
397647|NCT01760993|973725|P1|COMPLETED|Overall Study||0
397648|NCT01760993|973725|P1|STARTED|Overall Study||0
397649|NCT01760941|973742|P1|NOT COMPLETED|Overall Study||0
397650|NCT01760941|973742|P1|COMPLETED|Overall Study||1
397651|NCT01760941|973742|P1|STARTED|Overall Study||1
397652|NCT01760889|973752|P3|NOT COMPLETED|Overall Study||0
397653|NCT01760889|973753|P2|NOT COMPLETED|Overall Study||0
397654|NCT01760889|973754|P1|NOT COMPLETED|Overall Study||0
397655|NCT01760889|973752|P3|COMPLETED|Overall Study||0
397656|NCT01760889|973753|P2|COMPLETED|Overall Study||0
397657|NCT01760889|973754|P1|COMPLETED|Overall Study||0
397658|NCT01760889|973752|P3|STARTED|Overall Study||0
397659|NCT01760889|973753|P2|STARTED|Overall Study||0
397660|NCT01760889|973754|P1|STARTED|Overall Study||0
397661|NCT01760876|973801|P1|NOT COMPLETED|Overall Study||6
397662|NCT01760876|973801|P1|COMPLETED|Overall Study|12 months clinical FU of last patient in July 2015.|100
397663|NCT01760876|973801|P1|STARTED|Overall Study||106
397664|NCT01760785|973807|P2|NOT COMPLETED|Overall Study||0
397665|NCT01760785|973808|P1|NOT COMPLETED|Overall Study||0
397666|NCT01760785|973807|P2|COMPLETED|Overall Study||27
397667|NCT01760785|973808|P1|COMPLETED|Overall Study||23
397668|NCT01760785|973807|P2|STARTED|Overall Study||27
397669|NCT01760785|973808|P1|STARTED|Overall Study||23
397670|NCT01760473|973814|P1|NOT COMPLETED|Overall Study||15
397671|NCT01760473|973814|P1|COMPLETED|Overall Study||12
397672|NCT01760473|973814|P1|STARTED|Overall Study||27
397673|NCT01760304|973837|P2|NOT COMPLETED|Overall Study||0
397674|NCT01760304|973838|P1|NOT COMPLETED|Overall Study||0
397675|NCT01760304|973837|P2|COMPLETED|Overall Study||3
397676|NCT01760304|973838|P1|COMPLETED|Overall Study||2
397677|NCT01760304|973837|P2|STARTED|Overall Study||3
397678|NCT01760304|973838|P1|STARTED|Overall Study||2
397679|NCT01759602|973848|P1|NOT COMPLETED|Overall Study||0
397680|NCT01759602|973848|P1|COMPLETED|Overall Study||10
397681|NCT01759602|973848|P1|STARTED|Overall Study||10
397682|NCT01759511|973856|P1|NOT COMPLETED|Overall Study||34
397683|NCT01759511|973856|P1|COMPLETED|Overall Study||0
397684|NCT01759511|973856|P1|STARTED|Overall Study||34
397685|NCT01759420|973864|P1|NOT COMPLETED|Overall Study||6
397686|NCT01759420|973864|P1|COMPLETED|Overall Study||22
397687|NCT01759420|973864|P1|STARTED|Overall Study||28
397688|NCT01759407|973871|P2|NOT COMPLETED|Overall Study||2
397689|NCT01759407|973872|P1|NOT COMPLETED|Overall Study||0
397690|NCT01759407|973871|P2|COMPLETED|Overall Study||7
397691|NCT01759407|973872|P1|COMPLETED|Overall Study||10
397692|NCT01759407|973871|P2|STARTED|Overall Study||9
397693|NCT01759407|973872|P1|STARTED|Overall Study||10
397694|NCT01759381|973884|P2|NOT COMPLETED|Overall Study||0
397695|NCT01759381|973885|P1|NOT COMPLETED|Overall Study||1
397696|NCT01759381|973884|P2|COMPLETED|Overall Study||11
397697|NCT01759381|973885|P1|COMPLETED|Overall Study||7
397698|NCT01759381|973884|P2|STARTED|Overall Study||11
397699|NCT01759381|973885|P1|STARTED|Overall Study||8
397700|NCT01759368|973893|P2|NOT COMPLETED|Overall Study||0
397701|NCT01759368|973894|P1|NOT COMPLETED|Overall Study||1
397702|NCT01759368|973893|P2|COMPLETED|Overall Study||47
397703|NCT01759368|973894|P1|COMPLETED|Overall Study||46
397704|NCT01759368|973893|P2|STARTED|Overall Study||47
397705|NCT01759368|973894|P1|STARTED|Overall Study||47
397706|NCT01759290|973912|P1|NOT COMPLETED|Overall Study||81
397707|NCT01759290|973912|P1|COMPLETED|Overall Study||1719
397708|NCT01759290|973912|P1|STARTED|Overall Study||1800
397709|NCT01759264|973972|P1|NOT COMPLETED|Overall Study||10
397710|NCT01759264|973972|P1|COMPLETED|Overall Study||91
397711|NCT01759264|973972|P1|STARTED|Overall Study||101
397712|NCT01759251|973985|P1|NOT COMPLETED|Follow-up Period||0
397713|NCT01759251|973985|P1|COMPLETED|Follow-up Period||305
397714|NCT01759251|973985|P1|STARTED|Follow-up Period||305
397715|NCT01759251|973985|P1|NOT COMPLETED|60 Days Treatment Period||0
397716|NCT01759251|973985|P1|COMPLETED|60 Days Treatment Period||305
397717|NCT01759251|973985|P1|STARTED|60 Days Treatment Period||305
397718|NCT01759251|973985|P1|NOT COMPLETED|30 Days Treatment Period||4
397719|NCT01759251|973985|P1|COMPLETED|30 Days Treatment Period||305
397720|NCT01759251|973985|P1|STARTED|30 Days Treatment Period||309
397721|NCT01759160|973991|P2|NOT COMPLETED|Overall Study||0
397722|NCT01759160|973992|P1|NOT COMPLETED|Overall Study||0
397723|NCT01759160|973991|P2|COMPLETED|Overall Study||30
397724|NCT01759160|973992|P1|COMPLETED|Overall Study||30
397725|NCT01759160|973991|P2|STARTED|Overall Study||30
397726|NCT01759160|973992|P1|STARTED|Overall Study||30
397727|NCT01758900|974000|P2|NOT COMPLETED|Overall Study||8
397728|NCT01758900|974001|P1|NOT COMPLETED|Overall Study||7
397729|NCT01758900|974000|P2|COMPLETED|Overall Study||100
397730|NCT01758900|974001|P1|COMPLETED|Overall Study||99
397731|NCT01758900|974000|P2|STARTED|Overall Study||108
397732|NCT01758900|974001|P1|STARTED|Overall Study||106
397733|NCT01758289|974019|P1|NOT COMPLETED|Overall Study||53
397734|NCT01758289|974019|P1|COMPLETED|Overall Study||52
397735|NCT01758289|974019|P1|STARTED|Overall Study||105
397736|NCT01757964|974038|P2|NOT COMPLETED|Overall Study||0
397737|NCT01757964|974039|P1|NOT COMPLETED|Overall Study||0
397738|NCT01757964|974038|P2|COMPLETED|Overall Study||4
397739|NCT01757964|974039|P1|COMPLETED|Overall Study||9
397740|NCT01757964|974038|P2|STARTED|Overall Study||4
397741|NCT01757964|974039|P1|STARTED|Overall Study||9
397742|NCT01757847|974045|P2|NOT COMPLETED|Overall Study||4
397743|NCT01757847|974046|P1|NOT COMPLETED|Overall Study||3
397744|NCT01757847|974045|P2|COMPLETED|Overall Study||42
397745|NCT01757847|974046|P1|COMPLETED|Overall Study||41
397746|NCT01757847|974045|P2|STARTED|Overall Study||46
397747|NCT01757847|974046|P1|STARTED|Overall Study||44
397748|NCT01757821|974054|P1|NOT COMPLETED|Overall Study||1
397749|NCT01757821|974054|P1|COMPLETED|Overall Study|10 subjects|10
397750|NCT01757821|974054|P1|STARTED|Overall Study|11 subjects|11
397751|NCT01757717|974062|P1|NOT COMPLETED|Overall Study||0
397752|NCT01757717|974062|P1|COMPLETED|Overall Study||3
397753|NCT01757717|974062|P1|STARTED|Overall Study||3
397754|NCT01757704|974069|P2|NOT COMPLETED|Overall Study||3
397755|NCT01757704|974070|P1|NOT COMPLETED|Overall Study||1
397756|NCT01757704|974069|P2|COMPLETED|Overall Study||10
397757|NCT01757704|974070|P1|COMPLETED|Overall Study||10
397758|NCT01757704|974069|P2|STARTED|Overall Study|Two patients excluded intraoperatively due to failure to obtain TCD signals and one due to adhesion.|13
397759|NCT01757704|974070|P1|STARTED|Overall Study|One patient was excluded at start of surgery due to opening of the pleurae during sternotomy.|11
397760|NCT01757691|974088|P2|NOT COMPLETED|Overall Study||0
397761|NCT01757691|974089|P1|NOT COMPLETED|Overall Study||2
397762|NCT01757691|974088|P2|COMPLETED|Overall Study||0
397763|NCT01757691|974089|P1|COMPLETED|Overall Study||0
397764|NCT01757691|974088|P2|STARTED|Overall Study||0
397765|NCT01757691|974089|P1|STARTED|Overall Study||2
397766|NCT01757678|974102|P1|NOT COMPLETED|Overall Study||0
397767|NCT01757678|974102|P1|COMPLETED|Overall Study||276
397768|NCT01757678|974102|P1|STARTED|Overall Study||276
397769|NCT01757561|974118|P4|NOT COMPLETED|Overall Study||9
397770|NCT01757561|974119|P3|NOT COMPLETED|Overall Study||7
397771|NCT01757561|974120|P2|NOT COMPLETED|Overall Study||6
397772|NCT01757561|974121|P1|NOT COMPLETED|Overall Study||6
397773|NCT01757561|974118|P4|COMPLETED|Overall Study||25
397774|NCT01757561|974119|P3|COMPLETED|Overall Study||31
397775|NCT01757561|974120|P2|COMPLETED|Overall Study||28
397776|NCT01757561|974121|P1|COMPLETED|Overall Study||32
397777|NCT01757561|974118|P4|STARTED|Overall Study||34
397778|NCT01757561|974119|P3|STARTED|Overall Study||38
397779|NCT01757561|974120|P2|STARTED|Overall Study||34
397780|NCT01757561|974121|P1|STARTED|Overall Study||38
397781|NCT01757405|974137|P2|NOT COMPLETED|Overall Study||2
397782|NCT01757405|974138|P1|NOT COMPLETED|Overall Study||1
397783|NCT01757405|974137|P2|COMPLETED|Overall Study||18
397784|NCT01757405|974138|P1|COMPLETED|Overall Study||17
397785|NCT01757405|974137|P2|STARTED|Overall Study||20
397786|NCT01757405|974138|P1|STARTED|Overall Study||18
397787|NCT01757275|974156|P2|NOT COMPLETED|Overall Study||13
397788|NCT01757275|974157|P1|NOT COMPLETED|Overall Study||9
397789|NCT01757275|974156|P2|COMPLETED|Overall Study||98
397790|NCT01757275|974157|P1|COMPLETED|Overall Study||102
397791|NCT01757275|974156|P2|STARTED|Overall Study||111
397792|NCT01757275|974157|P1|STARTED|Overall Study||111
397793|NCT01757197|974179|P1|NOT COMPLETED|Overall Study||2
397794|NCT01757197|974179|P1|COMPLETED|Overall Study||0
397795|NCT01757197|974179|P1|STARTED|Overall Study||2
397796|NCT01757184|974188|P2|NOT COMPLETED|Open-Label Period||0
397797|NCT01757184|974189|P1|NOT COMPLETED|Open-Label Period||0
397798|NCT01757184|974188|P2|COMPLETED|Open-Label Period|This period is currently ongoing.|30
397799|NCT01757184|974189|P1|COMPLETED|Open-Label Period|This period is currently ongoing.|35
397800|NCT01757184|974188|P2|STARTED|Open-Label Period||30
397801|NCT01757184|974189|P1|STARTED|Open-Label Period||35
397802|NCT01757184|974188|P2|NOT COMPLETED|Double-Blind Period||0
397803|NCT01757184|974189|P1|NOT COMPLETED|Double-Blind Period||1
397804|NCT01757184|974188|P2|COMPLETED|Double-Blind Period||30
397805|NCT01757184|974189|P1|COMPLETED|Double-Blind Period||35
397806|NCT01757184|974188|P2|STARTED|Double-Blind Period||30
397807|NCT01757184|974189|P1|STARTED|Double-Blind Period||36
397808|NCT01757171|974213|P2|NOT COMPLETED|Overall Study||1
397809|NCT01757171|974214|P1|NOT COMPLETED|Overall Study||8
397810|NCT01757171|974213|P2|COMPLETED|Overall Study||23
397811|NCT01757171|974214|P1|COMPLETED|Overall Study||53
397812|NCT01757171|974213|P2|STARTED|Overall Study||24
397813|NCT01757171|974214|P1|STARTED|Overall Study||61
397814|NCT01756976|974228|P2|NOT COMPLETED|Overall Study||0
397815|NCT01756976|974229|P1|NOT COMPLETED|Overall Study||3
397816|NCT01756976|974228|P2|COMPLETED|Overall Study||8
397817|NCT01756976|974229|P1|COMPLETED|Overall Study||73
397818|NCT01756976|974228|P2|STARTED|Overall Study||8
397819|NCT01756976|974229|P1|STARTED|Overall Study||76
397820|NCT01756586|974237|P2|NOT COMPLETED|Overall Study||2
397821|NCT01756586|974238|P1|NOT COMPLETED|Overall Study||2
397822|NCT01756586|974237|P2|COMPLETED|Overall Study||0
397823|NCT01756586|974238|P1|COMPLETED|Overall Study||0
397824|NCT01756586|974237|P2|STARTED|Overall Study||2
397825|NCT01756586|974238|P1|STARTED|Overall Study||2
397826|NCT01756391|974244|P1|NOT COMPLETED|Overall Study||32
397827|NCT01756391|974244|P1|COMPLETED|Overall Study||319
397828|NCT01756391|974244|P1|STARTED|Overall Study||351
397829|NCT01756300|974248|P1|NOT COMPLETED|Overall Study||2
397830|NCT01756300|974248|P1|COMPLETED|Overall Study|Subjects with follow up available at 12 months|33
397831|NCT01756300|974248|P1|STARTED|Overall Study|Subjects underwent renal denervation treatment with the study catheter.|35
397832|NCT01756274|974270|P1|NOT COMPLETED|Overall Study||3
397833|NCT01756274|974270|P1|COMPLETED|Overall Study||159
397834|NCT01756274|974270|P1|STARTED|Overall Study||162
397835|NCT01756235|974277|P1|NOT COMPLETED|Overall Study||2
397836|NCT01756235|974277|P1|COMPLETED|Overall Study||460
397837|NCT01756235|974277|P1|STARTED|Overall Study||462
397838|NCT01756157|974298|P2|NOT COMPLETED|Second Intervention Period||0
397839|NCT01756157|974299|P1|NOT COMPLETED|Second Intervention Period||0
397840|NCT01756157|974298|P2|COMPLETED|Second Intervention Period||22
397841|NCT01756157|974299|P1|COMPLETED|Second Intervention Period||22
397842|NCT01756157|974298|P2|STARTED|Second Intervention Period||22
397843|NCT01756157|974299|P1|STARTED|Second Intervention Period||22
397844|NCT01756157|974298|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
397845|NCT01756157|974299|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
397846|NCT01756157|974298|P2|COMPLETED|Washout Period (at Least 7 Days)||22
397847|NCT01756157|974299|P1|COMPLETED|Washout Period (at Least 7 Days)||22
397848|NCT01756157|974298|P2|STARTED|Washout Period (at Least 7 Days)||22
397849|NCT01756157|974299|P1|STARTED|Washout Period (at Least 7 Days)||22
397850|NCT01756157|974298|P2|NOT COMPLETED|First Intervention Period||2
397851|NCT01756157|974299|P1|NOT COMPLETED|First Intervention Period||1
397852|NCT01756157|974298|P2|COMPLETED|First Intervention Period||22
397853|NCT01756157|974299|P1|COMPLETED|First Intervention Period||22
397854|NCT01756157|974298|P2|STARTED|First Intervention Period||24
397855|NCT01756157|974299|P1|STARTED|First Intervention Period||23
397856|NCT01756079|974313|P1|NOT COMPLETED|Treatment / Follow-up: Week 4 to Week 72||35
397857|NCT01756079|974313|P1|COMPLETED|Treatment / Follow-up: Week 4 to Week 72||23
397858|NCT01756079|974313|P1|Treated in Treatment Period|Treatment / Follow-up: Week 4 to Week 72||54
397859|NCT01756079|974313|P1|STARTED|Treatment / Follow-up: Week 4 to Week 72||58
397860|NCT01756079|974313|P1|NOT COMPLETED|Lead-in: Day 0 to Week 4||0
397861|NCT01756079|974313|P1|COMPLETED|Lead-in: Day 0 to Week 4||58
397862|NCT01756079|974313|P1|STARTED|Lead-in: Day 0 to Week 4||58
397863|NCT01756053|974319|P2|NOT COMPLETED|Period 2 (10 Days)||2
397864|NCT01756053|974320|P1|NOT COMPLETED|Period 2 (10 Days)||0
397865|NCT01756053|974319|P2|COMPLETED|Period 2 (10 Days)||6
397866|NCT01756053|974320|P1|COMPLETED|Period 2 (10 Days)||7
397867|NCT01756053|974319|P2|STARTED|Period 2 (10 Days)||8
397868|NCT01756053|974320|P1|STARTED|Period 2 (10 Days)||7
397869|NCT01756053|974319|P2|NOT COMPLETED|Washout Period (~21 Days)||0
397870|NCT01756053|974320|P1|NOT COMPLETED|Washout Period (~21 Days)||0
397871|NCT01756053|974319|P2|COMPLETED|Washout Period (~21 Days)||8
397872|NCT01756053|974320|P1|COMPLETED|Washout Period (~21 Days)||7
397873|NCT01756053|974319|P2|STARTED|Washout Period (~21 Days)||8
397874|NCT01756053|974320|P1|STARTED|Washout Period (~21 Days)||7
397875|NCT01756053|974319|P2|NOT COMPLETED|Period 1 (10 Days)||1
397876|NCT01756053|974320|P1|NOT COMPLETED|Period 1 (10 Days)||1
397877|NCT01756053|974319|P2|COMPLETED|Period 1 (10 Days)||8
397878|NCT01756053|974320|P1|COMPLETED|Period 1 (10 Days)||7
397879|NCT01756053|974319|P2|STARTED|Period 1 (10 Days)||9
397880|NCT01756053|974320|P1|STARTED|Period 1 (10 Days)||8
397881|NCT01755702|974340|P1|NOT COMPLETED|Period III||0
397882|NCT01755702|974340|P1|COMPLETED|Period III||58
397883|NCT01755702|974340|P1|Received Ibuprofen|Period III||18
397884|NCT01755702|974340|P1|Received Paracetamol/Caffeine|Period III||10
397885|NCT01755702|974340|P1|Received Placebo|Period III||13
397886|NCT01755702|974340|P1|Received Paracetamol|Period III||17
397887|NCT01755702|974340|P1|STARTED|Period III||58
397888|NCT01755702|974340|P1|NOT COMPLETED|Washout Period II||5
397889|NCT01755702|974340|P1|COMPLETED|Washout Period II||58
397890|NCT01755702|974340|P1|STARTED|Washout Period II||63
397891|NCT01755702|974340|P1|NOT COMPLETED|Period II||0
397892|NCT01755702|974340|P1|COMPLETED|Period II||63
397893|NCT01755702|974340|P1|Received Paracetamol|Period II||17
397894|NCT01755702|974340|P1|Received Paracetamol/Caffeine|Period II||20
397895|NCT01755702|974340|P1|Received Placebo|Period II||15
397896|NCT01755702|974340|P1|Received Ibuprofen|Period II||11
397897|NCT01755702|974340|P1|STARTED|Period II||63
397898|NCT01755702|974340|P1|NOT COMPLETED|Wash Out Period I||3
397899|NCT01755702|974340|P1|COMPLETED|Wash Out Period I||63
397900|NCT01755702|974340|P1|STARTED|Wash Out Period I||66
397901|NCT01755702|974340|P1|NOT COMPLETED|Period I||0
397902|NCT01755702|974340|P1|COMPLETED|Period I||66
397903|NCT01755702|974340|P1|Received Paracetamol/Caffeine|Period I||17
397904|NCT01755702|974340|P1|Received Ibuprofen|Period I||16
397905|NCT01755702|974340|P1|Received Placebo|Period I||17
397906|NCT01755702|974340|P1|Received Paracetamol|Period I||16
397907|NCT01755702|974340|P1|STARTED|Period I||66
397908|NCT01755637|974382|P2|NOT COMPLETED|Period 2||0
397909|NCT01755637|974383|P1|NOT COMPLETED|Period 2||0
397910|NCT01755637|974382|P2|COMPLETED|Period 2||27
397911|NCT01755637|974383|P1|COMPLETED|Period 2||28
397912|NCT01755637|974382|P2|STARTED|Period 2||27
397913|NCT01755637|974383|P1|STARTED|Period 2||28
397914|NCT01755637|974382|P2|NOT COMPLETED|Period 1||1
397915|NCT01755637|974383|P1|NOT COMPLETED|Period 1||0
397916|NCT01755637|974382|P2|COMPLETED|Period 1||27
397917|NCT01755637|974383|P1|COMPLETED|Period 1||28
397918|NCT01755637|974382|P2|STARTED|Period 1||28
397919|NCT01755637|974383|P1|STARTED|Period 1||28
397920|NCT01755455|974401|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
397921|NCT01755455|974402|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
397922|NCT01755455|974401|P2|COMPLETED|Second Intervention (6 Weeks)||11
397923|NCT01755455|974402|P1|COMPLETED|Second Intervention (6 Weeks)||11
397924|NCT01755455|974401|P2|STARTED|Second Intervention (6 Weeks)||11
397925|NCT01755455|974402|P1|STARTED|Second Intervention (6 Weeks)||11
397926|NCT01755455|974401|P2|NOT COMPLETED|Washout (4 Weeks)||0
397927|NCT01755455|974402|P1|NOT COMPLETED|Washout (4 Weeks)||0
397928|NCT01755455|974401|P2|COMPLETED|Washout (4 Weeks)||11
397929|NCT01755455|974402|P1|COMPLETED|Washout (4 Weeks)||11
397930|NCT01755455|974401|P2|STARTED|Washout (4 Weeks)||11
397931|NCT01755455|974402|P1|STARTED|Washout (4 Weeks)||11
397932|NCT01755455|974401|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
397933|NCT01755455|974402|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
397934|NCT01755455|974401|P2|COMPLETED|First Intervention (6 Weeks)||11
397935|NCT01755455|974402|P1|COMPLETED|First Intervention (6 Weeks)||11
397936|NCT01755455|974401|P2|STARTED|First Intervention (6 Weeks)||11
397937|NCT01755455|974402|P1|STARTED|First Intervention (6 Weeks)||11
397938|NCT01755234|974416|P2|NOT COMPLETED|Overall Study||8
397939|NCT01755234|974417|P1|NOT COMPLETED|Overall Study||15
397940|NCT01755234|974416|P2|COMPLETED|Overall Study||37
397941|NCT01755234|974417|P1|COMPLETED|Overall Study||30
397942|NCT01755234|974416|P2|STARTED|Overall Study||45
397943|NCT01755234|974417|P1|STARTED|Overall Study||45
397944|NCT01755169|974433|P4|NOT COMPLETED|Overall Study||0
397945|NCT01755169|974434|P3|NOT COMPLETED|Overall Study||0
397946|NCT01755169|974435|P2|NOT COMPLETED|Overall Study||0
397947|NCT01755169|974436|P1|NOT COMPLETED|Overall Study||0
397948|NCT01755169|974433|P4|COMPLETED|Overall Study||1
397949|NCT01755169|974434|P3|COMPLETED|Overall Study||0
397950|NCT01755169|974435|P2|COMPLETED|Overall Study||1
397951|NCT01755169|974436|P1|COMPLETED|Overall Study||2
397952|NCT01755169|974433|P4|STARTED|Overall Study||1
397953|NCT01755169|974434|P3|STARTED|Overall Study||0
397954|NCT01755169|974435|P2|STARTED|Overall Study||1
397955|NCT01755169|974436|P1|STARTED|Overall Study||2
397956|NCT01755156|974448|P2|NOT COMPLETED|Phase B (Weeks 24-104)||36
397957|NCT01755156|974449|P1|NOT COMPLETED|Phase B (Weeks 24-104)||39
397958|NCT01755156|974448|P2|COMPLETED|Phase B (Weeks 24-104)||141
397959|NCT01755156|974449|P1|COMPLETED|Phase B (Weeks 24-104)||144
397960|NCT01755156|974448|P2|STARTED|Phase B (Weeks 24-104)||177
397961|NCT01755156|974449|P1|STARTED|Phase B (Weeks 24-104)|1 participant who completed Phase A did not continue to Phase B.|183
397962|NCT01755156|974448|P2|NOT COMPLETED|Phase A (Weeks 0-24)||24
397963|NCT01755156|974449|P1|NOT COMPLETED|Phase A (Weeks 0-24)||17
397964|NCT01755156|974448|P2|COMPLETED|Phase A (Weeks 0-24)||177
397965|NCT01755156|974449|P1|COMPLETED|Phase A (Weeks 0-24)||184
397966|NCT01755156|974448|P2|STARTED|Phase A (Weeks 0-24)||201
397967|NCT01755156|974449|P1|STARTED|Phase A (Weeks 0-24)||201
397968|NCT01755143|974495|P2|NOT COMPLETED|Overall Study||3
397969|NCT01755143|974496|P1|NOT COMPLETED|Overall Study||11
397970|NCT01755143|974495|P2|COMPLETED|Overall Study||86
397971|NCT01755143|974496|P1|COMPLETED|Overall Study||166
397972|NCT01755143|974495|P2|STARTED|Overall Study||89
397973|NCT01755143|974496|P1|STARTED|Overall Study||177
397974|NCT01755091|974513|P3|NOT COMPLETED|Overall Study||7
397975|NCT01755091|974514|P2|NOT COMPLETED|Overall Study||3
397976|NCT01755091|974515|P1|NOT COMPLETED|Overall Study||9
397977|NCT01755091|974513|P3|COMPLETED|Overall Study||20
397978|NCT01755091|974514|P2|COMPLETED|Overall Study||19
397979|NCT01755091|974515|P1|COMPLETED|Overall Study||17
397980|NCT01755091|974513|P3|STARTED|Overall Study||27
397981|NCT01755091|974514|P2|STARTED|Overall Study||22
397982|NCT01755091|974515|P1|STARTED|Overall Study||26
397983|NCT01755026|974540|P2|NOT COMPLETED|Overall Study||1
397984|NCT01755026|974541|P1|NOT COMPLETED|Overall Study||2
397985|NCT01755026|974540|P2|COMPLETED|Overall Study||11
397986|NCT01755026|974541|P1|COMPLETED|Overall Study||9
397987|NCT01755026|974540|P2|STARTED|Overall Study||12
397988|NCT01755026|974541|P1|STARTED|Overall Study||11
397989|NCT01754922|974549|P2|NOT COMPLETED|Overall Study||1
397990|NCT01754922|974550|P1|NOT COMPLETED|Overall Study||0
397991|NCT01754922|974549|P2|COMPLETED|Overall Study||17
397992|NCT01754922|974550|P1|COMPLETED|Overall Study||32
397993|NCT01754922|974549|P2|STARTED|Overall Study||18
397994|NCT01754922|974550|P1|STARTED|Overall Study||32
397995|NCT01754766|974563|P3|NOT COMPLETED|Overall Study||0
397996|NCT01754766|974564|P2|NOT COMPLETED|Overall Study||1
397997|NCT01754766|974565|P1|NOT COMPLETED|Overall Study||1
397998|NCT01754766|974563|P3|COMPLETED|Overall Study||30
397999|NCT01754766|974564|P2|COMPLETED|Overall Study||28
398000|NCT01754766|974565|P1|COMPLETED|Overall Study||30
398001|NCT01754766|974563|P3|STARTED|Overall Study||30
398002|NCT01754766|974564|P2|STARTED|Overall Study||29
398003|NCT01754766|974565|P1|STARTED|Overall Study||31
398004|NCT01754727|974579|P1|NOT COMPLETED|Overall Study||2
398005|NCT01754727|974579|P1|COMPLETED|Overall Study||450
398006|NCT01754727|974579|P1|STARTED|Overall Study||452
398007|NCT01754714|974597|P4|NOT COMPLETED|Overall Study||1
398008|NCT01754714|974598|P3|NOT COMPLETED|Overall Study||2
398009|NCT01754714|974599|P2|NOT COMPLETED|Overall Study||1
398010|NCT01754714|974600|P1|NOT COMPLETED|Overall Study||0
398011|NCT01754714|974597|P4|COMPLETED|Overall Study||27
398012|NCT01754714|974598|P3|COMPLETED|Overall Study||24
398013|NCT01754714|974599|P2|COMPLETED|Overall Study||26
398014|NCT01754714|974600|P1|COMPLETED|Overall Study||27
398015|NCT01754714|974597|P4|STARTED|Overall Study||28
398016|NCT01754714|974598|P3|STARTED|Overall Study||26
398017|NCT01754714|974599|P2|STARTED|Overall Study||27
398018|NCT01754714|974600|P1|STARTED|Overall Study||27
398019|NCT01754623|974690|P1|NOT COMPLETED|Overall Study||0
398020|NCT01754623|974690|P1|COMPLETED|Overall Study||9
398021|NCT01754623|974690|P1|STARTED|Overall Study||9
398022|NCT01754519|974697|P1|NOT COMPLETED|Overall Study||0
398023|NCT01754519|974697|P1|COMPLETED|Overall Study||1
398024|NCT01754519|974697|P1|STARTED|Overall Study||1
398025|NCT01754493|974706|P1|NOT COMPLETED|Overall Study||7
398026|NCT01754493|974706|P1|COMPLETED|Overall Study||10
398027|NCT01754493|974706|P1|STARTED|Overall Study||17
398028|NCT01754480|974716|P2|NOT COMPLETED|Primary Part II||11
398029|NCT01754480|974717|P1|NOT COMPLETED|Primary Part II||15
398030|NCT01754480|974716|P2|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6 (not required for pediatric subjects)|102
398031|NCT01754480|974717|P1|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6 (not required for pediatric subjects)|96
398032|NCT01754480|974716|P2|Completed Study up to Week 6|Primary Part II||108
398033|NCT01754480|974717|P1|Completed Study up to Week 6|Primary Part II||100
398034|NCT01754480|974716|P2|STARTED|Primary Part II||113
398035|NCT01754480|974717|P1|STARTED|Primary Part II||111
398036|NCT01754480|974716|P2|NOT COMPLETED|Part I + Part II (Overall Study)||23
398037|NCT01754480|974717|P1|NOT COMPLETED|Part I + Part II (Overall Study)||25
398038|NCT01754480|974716|P2|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6 (not required for 3 pediatric subjects)|139
398039|NCT01754480|974717|P1|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6 (not required for 2 pediatric subjects)|138
398040|NCT01754480|974716|P2|Completed Study up to Week 6|Part I + Part II (Overall Study)||153
398041|NCT01754480|974717|P1|Completed Study up to Week 6|Part I + Part II (Overall Study)||147
398042|NCT01754480|974716|P2|STARTED|Part I + Part II (Overall Study)||162
398043|NCT01754480|974717|P1|STARTED|Part I + Part II (Overall Study)||163
398044|NCT01754467|974731|P1|NOT COMPLETED|Overall Study||1
398045|NCT01754467|974731|P1|COMPLETED|Overall Study||8
398046|NCT01754467|974731|P1|STARTED|Overall Study||9
398047|NCT01754402|974741|P3|NOT COMPLETED|Overall Study||4
398048|NCT01754402|974742|P2|NOT COMPLETED|Overall Study||2
398049|NCT01754402|974743|P1|NOT COMPLETED|Overall Study||2
398050|NCT01754402|974741|P3|COMPLETED|Overall Study||26
398051|NCT01754402|974742|P2|COMPLETED|Overall Study||0
398052|NCT01754402|974743|P1|COMPLETED|Overall Study||4
398053|NCT01754402|974741|P3|STARTED|Overall Study||30
398054|NCT01754402|974742|P2|STARTED|Overall Study||2
398055|NCT01754402|974743|P1|STARTED|Overall Study||6
398056|NCT01754389|974755|P3|NOT COMPLETED|Overall Study||0
398057|NCT01754389|974756|P2|NOT COMPLETED|Overall Study||0
398058|NCT01754389|974757|P1|NOT COMPLETED|Overall Study||0
398059|NCT01754389|974755|P3|COMPLETED|Overall Study||47
398060|NCT01754389|974756|P2|COMPLETED|Overall Study||45
398061|NCT01754389|974757|P1|COMPLETED|Overall Study||46
398062|NCT01754389|974755|P3|STARTED|Overall Study||47
398063|NCT01754389|974756|P2|STARTED|Overall Study||45
398064|NCT01754389|974757|P1|STARTED|Overall Study||46
398065|NCT01754376|974777|P1|NOT COMPLETED|Overall Study||3
398066|NCT01754376|974777|P1|COMPLETED|Overall Study||3
398067|NCT01754376|974777|P1|Completed 2-week Lead in of Vemurafenib|Overall Study||6
398068|NCT01754376|974777|P1|STARTED|Overall Study||6
398069|NCT01754259|974788|P2|NOT COMPLETED|Overall Study||6
398070|NCT01754259|974789|P1|NOT COMPLETED|Overall Study||5
398071|NCT01754259|974788|P2|COMPLETED|Overall Study||18
398072|NCT01754259|974789|P1|COMPLETED|Overall Study||18
398073|NCT01754259|974788|P2|STARTED|Overall Study||24
398074|NCT01754259|974789|P1|STARTED|Overall Study||23
398075|NCT01754194|974799|P2|NOT COMPLETED|Overall Study||27
398076|NCT01754194|974800|P1|NOT COMPLETED|Overall Study||52
398077|NCT01754194|974799|P2|COMPLETED|Overall Study||97
398078|NCT01754194|974800|P1|COMPLETED|Overall Study||117
398079|NCT01754194|974799|P2|STARTED|Overall Study||124
398080|NCT01754194|974800|P1|STARTED|Overall Study||169
398081|NCT01753856|974822|P2|NOT COMPLETED|Overall Study||2
398082|NCT01753856|974823|P1|NOT COMPLETED|Overall Study||3
398083|NCT01753856|974822|P2|COMPLETED|Overall Study||34
398084|NCT01753856|974823|P1|COMPLETED|Overall Study||30
398085|NCT01753856|974822|P2|Completed 3-Month Bone Biopsy|Overall Study||35
398086|NCT01753856|974823|P1|Completed 3-Month Bone Biopsy|Overall Study||31
398087|NCT01753856|974822|P2|Received at Least 1 Dose of Study Drug|Overall Study||36
398088|NCT01753856|974823|P1|Received at Least 1 Dose of Study Drug|Overall Study||33
398089|NCT01753856|974822|P2|STARTED|Overall Study||36
398090|NCT01753856|974823|P1|STARTED|Overall Study||33
398091|NCT01753713|974875|P2|NOT COMPLETED|Overall Study||0
398092|NCT01753713|974876|P1|NOT COMPLETED|Overall Study||0
398093|NCT01753713|974875|P2|COMPLETED|Overall Study||19
398094|NCT01753713|974876|P1|COMPLETED|Overall Study||14
398095|NCT01753713|974875|P2|STARTED|Overall Study||19
398096|NCT01753713|974876|P1|STARTED|Overall Study||14
398097|NCT01753557|974894|P2|NOT COMPLETED|Overall Study||0
398098|NCT01753557|974895|P1|NOT COMPLETED|Overall Study||0
398099|NCT01753557|974894|P2|COMPLETED|Overall Study||19
398100|NCT01753557|974895|P1|COMPLETED|Overall Study||35
398101|NCT01753557|974894|P2|STARTED|Overall Study||19
398102|NCT01753557|974895|P1|STARTED|Overall Study||35
398103|NCT01753518|974913|P2|NOT COMPLETED|Postpartum Follow-up||15
398104|NCT01753518|974914|P1|NOT COMPLETED|Postpartum Follow-up||22
398105|NCT01753518|974913|P2|COMPLETED|Postpartum Follow-up||88
398106|NCT01753518|974914|P1|COMPLETED|Postpartum Follow-up||81
398107|NCT01753518|974913|P2|STARTED|Postpartum Follow-up||103
398108|NCT01753518|974914|P1|STARTED|Postpartum Follow-up||103
398109|NCT01753518|974913|P2|NOT COMPLETED|Intention-to-Treat Analysis||7
398110|NCT01753518|974914|P1|NOT COMPLETED|Intention-to-Treat Analysis||7
398111|NCT01753518|974913|P2|COMPLETED|Intention-to-Treat Analysis||103
398112|NCT01753518|974914|P1|COMPLETED|Intention-to-Treat Analysis||103
398113|NCT01753518|974913|P2|STARTED|Intention-to-Treat Analysis||110
398114|NCT01753518|974914|P1|STARTED|Intention-to-Treat Analysis||110
398115|NCT01753336|974936|P1|NOT COMPLETED|Overall Study||20
398116|NCT01753336|974936|P1|COMPLETED|Overall Study||92
398117|NCT01753336|974936|P1|Cycle 3|Overall Study||93
398118|NCT01753336|974936|P1|Cycle 2|Overall Study||98
398119|NCT01753336|974936|P1|Cycle 1|Overall Study||112
398120|NCT01753336|974936|P1|STARTED|Overall Study||112
398121|NCT01753323|974948|P3|NOT COMPLETED|Overall Study||9
398122|NCT01753323|974949|P2|NOT COMPLETED|Overall Study||0
398123|NCT01753323|974950|P1|NOT COMPLETED|Overall Study||1
398124|NCT01753323|974948|P3|COMPLETED|Overall Study||13
398125|NCT01753323|974949|P2|COMPLETED|Overall Study||10
398126|NCT01753323|974950|P1|COMPLETED|Overall Study||10
398127|NCT01753323|974948|P3|Intent-to-treat Analysis Set|Overall Study||22
398128|NCT01753323|974949|P2|Intent-to-treat Analysis Set|Overall Study||10
398129|NCT01753323|974950|P1|Intent-to-treat Analysis Set|Overall Study||11
398130|NCT01753323|974948|P3|Safety Set|Overall Study||22
398131|NCT01753323|974949|P2|Safety Set|Overall Study||10
398132|NCT01753323|974950|P1|Safety Set|Overall Study||11
398133|NCT01753323|974948|P3|Pharmacokinetic(PK) Set|Overall Study||21
398134|NCT01753323|974949|P2|Pharmacokinetic(PK) Set|Overall Study||10
398135|NCT01753323|974950|P1|Pharmacokinetic(PK) Set|Overall Study||10
398136|NCT01753323|974948|P3|Pharmacodynamic (PD) Set|Overall Study||21
398137|NCT01753323|974949|P2|Pharmacodynamic (PD) Set|Overall Study||10
398138|NCT01753323|974950|P1|Pharmacodynamic (PD) Set|Overall Study||10
398139|NCT01753323|974948|P3|STARTED|Overall Study||22
398140|NCT01753323|974949|P2|STARTED|Overall Study||10
398141|NCT01753323|974950|P1|STARTED|Overall Study||11
398142|NCT01753310|974988|P2|NOT COMPLETED|Overall Study||24
398143|NCT01753310|974989|P1|NOT COMPLETED|Overall Study||32
398144|NCT01753310|974988|P2|COMPLETED|Overall Study||21
398145|NCT01753310|974989|P1|COMPLETED|Overall Study||57
398146|NCT01753310|974988|P2|STARTED|Overall Study||45
398147|NCT01753310|974989|P1|STARTED|Overall Study||89
398148|NCT01753115|975012|P3|NOT COMPLETED|Overall Study||14
398149|NCT01753115|975013|P2|NOT COMPLETED|Overall Study||15
398150|NCT01753115|975014|P1|NOT COMPLETED|Overall Study||12
398151|NCT01753115|975012|P3|COMPLETED|Overall Study||56
398152|NCT01753115|975013|P2|COMPLETED|Overall Study||25
398153|NCT01753115|975014|P1|COMPLETED|Overall Study||32
398154|NCT01753115|975012|P3|Treated|Overall Study||67
398155|NCT01753115|975013|P2|Treated|Overall Study||39
398156|NCT01753115|975014|P1|Treated|Overall Study||38
398157|NCT01753115|975012|P3|STARTED|Overall Study||70
398158|NCT01753115|975013|P2|STARTED|Overall Study||40
398159|NCT01753115|975014|P1|STARTED|Overall Study||44
398160|NCT01753076|975024|P2|NOT COMPLETED|Overall Study||46
398161|NCT01753076|975025|P1|NOT COMPLETED|Overall Study||41
398162|NCT01753076|975024|P2|COMPLETED|Overall Study||106
398163|NCT01753076|975025|P1|COMPLETED|Overall Study||110
398164|NCT01753076|975024|P2|STARTED|Overall Study||152
398165|NCT01753076|975025|P1|STARTED|Overall Study||151
398166|NCT01752907|975051|P2|NOT COMPLETED|Overall Study||20
398167|NCT01752907|975052|P1|NOT COMPLETED|Overall Study||12
398168|NCT01752907|975051|P2|COMPLETED|Overall Study||133
398169|NCT01752907|975052|P1|COMPLETED|Overall Study||139
398170|NCT01752907|975051|P2|Received Pegfilgrastim|Overall Study||151
398171|NCT01752907|975052|P1|Received Pegfilgrastim|Overall Study||149
398172|NCT01752907|975051|P2|STARTED|Overall Study||153
398173|NCT01752907|975052|P1|STARTED|Overall Study||151
398174|NCT01752855|975072|P2|NOT COMPLETED|Overall Study||4
398175|NCT01752855|975073|P1|NOT COMPLETED|Overall Study||1
398176|NCT01752855|975072|P2|COMPLETED|Overall Study||40
398177|NCT01752855|975073|P1|COMPLETED|Overall Study||43
398178|NCT01752855|975072|P2|STARTED|Overall Study||44
398179|NCT01752855|975073|P1|STARTED|Overall Study||44
398180|NCT01752712|975089|P2|NOT COMPLETED|Overall Study||10
398181|NCT01752712|975090|P1|NOT COMPLETED|Overall Study||9
398182|NCT01752712|975089|P2|COMPLETED|Overall Study||21
398183|NCT01752712|975090|P1|COMPLETED|Overall Study||22
398184|NCT01752712|975089|P2|STARTED|Overall Study||31
398185|NCT01752712|975090|P1|STARTED|Overall Study||31
398186|NCT01752400|975106|P1|NOT COMPLETED|Overall Study||0
398187|NCT01752400|975106|P1|COMPLETED|Overall Study||6
398188|NCT01752400|975106|P1|STARTED|Overall Study||6
398189|NCT01752023|975119|P2|NOT COMPLETED|Overall Study||1
398190|NCT01752023|975120|P1|NOT COMPLETED|Overall Study||2
398191|NCT01752023|975119|P2|COMPLETED|Overall Study||0
398192|NCT01752023|975120|P1|COMPLETED|Overall Study||0
398193|NCT01752023|975119|P2|STARTED|Overall Study||1
398194|NCT01752023|975120|P1|STARTED|Overall Study||2
398195|NCT01751971|975138|P2|NOT COMPLETED|Overall Study||1
398196|NCT01751971|975139|P1|NOT COMPLETED|Overall Study||2
398197|NCT01751971|975138|P2|COMPLETED|Overall Study||24
398198|NCT01751971|975139|P1|COMPLETED|Overall Study||20
398199|NCT01751971|975138|P2|STARTED|Overall Study||25
398200|NCT01751971|975139|P1|STARTED|Overall Study||22
398201|NCT01751906|975156|P2|NOT COMPLETED|Overall Study||9
398202|NCT01751906|975157|P1|NOT COMPLETED|Overall Study||9
398203|NCT01751906|975156|P2|COMPLETED|Overall Study||677
398204|NCT01751906|975157|P1|COMPLETED|Overall Study||1313
398205|NCT01751906|975156|P2|STARTED|Overall Study||686
398206|NCT01751906|975157|P1|STARTED|Overall Study||1322
398207|NCT01751867|975307|P2|NOT COMPLETED|Overall Study||99
398208|NCT01751867|975308|P1|NOT COMPLETED|Overall Study||36
398209|NCT01751867|975307|P2|COMPLETED|Overall Study||0
398210|NCT01751867|975308|P1|COMPLETED|Overall Study||0
398211|NCT01751867|975307|P2|Treated|Overall Study||98
398212|NCT01751867|975308|P1|Treated|Overall Study||34
398213|NCT01751867|975307|P2|STARTED|Overall Study||99
398214|NCT01751867|975308|P1|STARTED|Overall Study||36
398215|NCT01751802|975328|P2|NOT COMPLETED|Overall Study||2
398216|NCT01751802|975329|P1|NOT COMPLETED|Overall Study||4
398217|NCT01751802|975328|P2|COMPLETED|Overall Study||2
398218|NCT01751802|975329|P1|COMPLETED|Overall Study||1
398219|NCT01751802|975328|P2|Completed Period 3|Overall Study||1
398220|NCT01751802|975329|P1|Completed Period 3|Overall Study||2
398221|NCT01751802|975328|P2|Completed Period 2|Overall Study||1
398222|NCT01751802|975329|P1|Completed Period 2|Overall Study||2
398223|NCT01751802|975328|P2|Completed Period 1|Overall Study||4
398224|NCT01751802|975329|P1|Completed Period 1|Overall Study||2
398225|NCT01751802|975328|P2|STARTED|Overall Study||4
398226|NCT01751802|975329|P1|STARTED|Overall Study||5
398227|NCT01751724|975343|P2|NOT COMPLETED|Overall Study||2
398228|NCT01751724|975344|P1|NOT COMPLETED|Overall Study||1
398229|NCT01751724|975343|P2|COMPLETED|Overall Study||42
398230|NCT01751724|975344|P1|COMPLETED|Overall Study||41
398231|NCT01751724|975343|P2|STARTED|Overall Study||44
398232|NCT01751724|975344|P1|STARTED|Overall Study||42
398233|NCT01751412|975370|P1|NOT COMPLETED|Overall Study||1
398234|NCT01751412|975370|P1|COMPLETED|Overall Study||11
398235|NCT01751412|975370|P1|STARTED|Overall Study||12
398236|NCT01751386|975382|P2|NOT COMPLETED|Overall Study||3
398237|NCT01751386|975383|P1|NOT COMPLETED|Overall Study||2
398238|NCT01751386|975382|P2|COMPLETED|Overall Study||16
398239|NCT01751386|975383|P1|COMPLETED|Overall Study||18
398240|NCT01751386|975382|P2|STARTED|Overall Study||19
398241|NCT01751386|975383|P1|STARTED|Overall Study||20
398242|NCT01751308|975394|P5|NOT COMPLETED|Phase 2||0
398243|NCT01751308|975395|P4|NOT COMPLETED|Phase 2||0
398244|NCT01751308|975396|P3|NOT COMPLETED|Phase 2||0
398245|NCT01751308|975397|P2|NOT COMPLETED|Phase 2||0
398246|NCT01751308|975398|P1|NOT COMPLETED|Phase 2||0
398247|NCT01751308|975394|P5|COMPLETED|Phase 2|DP, AE and death were considered as completed (defined in protocol)|16
398248|NCT01751308|975395|P4|COMPLETED|Phase 2||0
398249|NCT01751308|975396|P3|COMPLETED|Phase 2||0
398250|NCT01751308|975397|P2|COMPLETED|Phase 2||0
398251|NCT01751308|975398|P1|COMPLETED|Phase 2||0
398252|NCT01751308|975394|P5|STARTED|Phase 2|Phase 1 and Phase 2 were separate populations.|16
398253|NCT01751308|975395|P4|STARTED|Phase 2||0
398254|NCT01751308|975396|P3|STARTED|Phase 2||0
398255|NCT01751308|975397|P2|STARTED|Phase 2||0
398256|NCT01751308|975398|P1|STARTED|Phase 2||0
398257|NCT01751308|975394|P5|NOT COMPLETED|Phase 1||0
398258|NCT01751308|975395|P4|NOT COMPLETED|Phase 1||0
398259|NCT01751308|975396|P3|NOT COMPLETED|Phase 1||0
398260|NCT01751308|975397|P2|NOT COMPLETED|Phase 1||0
398261|NCT01751308|975398|P1|NOT COMPLETED|Phase 1||0
398262|NCT01751308|975394|P5|COMPLETED|Phase 1||0
398263|NCT01751308|975395|P4|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|7
398264|NCT01751308|975396|P3|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|7
398265|NCT01751308|975397|P2|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|3
398266|NCT01751308|975398|P1|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|6
398267|NCT01751308|975394|P5|STARTED|Phase 1|Phase 1 and Phase 2 were separate populations.|0
398268|NCT01751308|975395|P4|STARTED|Phase 1||7
398269|NCT01751308|975396|P3|STARTED|Phase 1||7
398270|NCT01751308|975397|P2|STARTED|Phase 1||3
398271|NCT01751308|975398|P1|STARTED|Phase 1||6
398272|NCT01751178|975438|P3|NOT COMPLETED|Overall Study||2
398273|NCT01751178|975439|P2|NOT COMPLETED|Overall Study||0
398274|NCT01751178|975440|P1|NOT COMPLETED|Overall Study||3
398275|NCT01751178|975438|P3|COMPLETED|Overall Study||105
398276|NCT01751178|975439|P2|COMPLETED|Overall Study||109
398277|NCT01751178|975440|P1|COMPLETED|Overall Study||105
398278|NCT01751178|975438|P3|STARTED|Overall Study||107
398279|NCT01751178|975439|P2|STARTED|Overall Study||109
398280|NCT01751178|975440|P1|STARTED|Overall Study||108
398281|NCT01751165|975460|P3|NOT COMPLETED|Overall Study||3
398282|NCT01751165|975461|P2|NOT COMPLETED|Overall Study||3
398283|NCT01751165|975462|P1|NOT COMPLETED|Overall Study||2
398284|NCT01751165|975460|P3|COMPLETED|Overall Study||113
398285|NCT01751165|975461|P2|COMPLETED|Overall Study||116
398286|NCT01751165|975462|P1|COMPLETED|Overall Study||117
398287|NCT01751165|975460|P3|STARTED|Overall Study||116
398288|NCT01751165|975461|P2|STARTED|Overall Study||119
398289|NCT01751165|975462|P1|STARTED|Overall Study||119
398290|NCT01751113|975502|P6|NOT COMPLETED|Treatment Period 3 (4 Weeks)||1
398291|NCT01751113|975503|P5|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
398292|NCT01751113|975504|P4|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
398293|NCT01751113|975505|P3|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
398294|NCT01751113|975506|P2|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
398295|NCT01751113|975507|P1|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
398296|NCT01751113|975502|P6|COMPLETED|Treatment Period 3 (4 Weeks)||9
398297|NCT01751113|975503|P5|COMPLETED|Treatment Period 3 (4 Weeks)||8
398298|NCT01751113|975504|P4|COMPLETED|Treatment Period 3 (4 Weeks)||8
398299|NCT01751113|975505|P3|COMPLETED|Treatment Period 3 (4 Weeks)||9
398300|NCT01751113|975506|P2|COMPLETED|Treatment Period 3 (4 Weeks)||8
398301|NCT01751113|975507|P1|COMPLETED|Treatment Period 3 (4 Weeks)||8
398302|NCT01751113|975502|P6|STARTED|Treatment Period 3 (4 Weeks)||10
398303|NCT01751113|975503|P5|STARTED|Treatment Period 3 (4 Weeks)||8
398304|NCT01751113|975504|P4|STARTED|Treatment Period 3 (4 Weeks)||8
398305|NCT01751113|975505|P3|STARTED|Treatment Period 3 (4 Weeks)||9
398306|NCT01751113|975506|P2|STARTED|Treatment Period 3 (4 Weeks)||8
398307|NCT01751113|975507|P1|STARTED|Treatment Period 3 (4 Weeks)||8
398308|NCT01751113|975502|P6|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
398309|NCT01751113|975503|P5|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
398310|NCT01751113|975504|P4|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
398311|NCT01751113|975505|P3|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
398312|NCT01751113|975506|P2|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
398313|NCT01751113|975507|P1|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
398314|NCT01751113|975502|P6|COMPLETED|Washout Period 2 (2 Weeks)||10
398315|NCT01751113|975503|P5|COMPLETED|Washout Period 2 (2 Weeks)||8
398316|NCT01751113|975504|P4|COMPLETED|Washout Period 2 (2 Weeks)||8
398317|NCT01751113|975505|P3|COMPLETED|Washout Period 2 (2 Weeks)||9
398318|NCT01751113|975506|P2|COMPLETED|Washout Period 2 (2 Weeks)||8
398319|NCT01751113|975507|P1|COMPLETED|Washout Period 2 (2 Weeks)||8
398320|NCT01751113|975502|P6|STARTED|Washout Period 2 (2 Weeks)||10
398321|NCT01751113|975503|P5|STARTED|Washout Period 2 (2 Weeks)||8
398322|NCT01751113|975504|P4|STARTED|Washout Period 2 (2 Weeks)||8
398323|NCT01751113|975505|P3|STARTED|Washout Period 2 (2 Weeks)||9
398324|NCT01751113|975506|P2|STARTED|Washout Period 2 (2 Weeks)||8
398325|NCT01751113|975507|P1|STARTED|Washout Period 2 (2 Weeks)||8
398326|NCT01751113|975502|P6|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
398327|NCT01751113|975503|P5|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
398328|NCT01751113|975504|P4|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
398329|NCT01751113|975505|P3|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
398330|NCT01751113|975506|P2|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
398331|NCT01751113|975507|P1|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
398332|NCT01751113|975502|P6|COMPLETED|Treatment Period 2 (4 Weeks)||10
398333|NCT01751113|975503|P5|COMPLETED|Treatment Period 2 (4 Weeks)||8
398334|NCT01751113|975504|P4|COMPLETED|Treatment Period 2 (4 Weeks)||8
398335|NCT01751113|975505|P3|COMPLETED|Treatment Period 2 (4 Weeks)||9
398336|NCT01751113|975506|P2|COMPLETED|Treatment Period 2 (4 Weeks)||8
398337|NCT01751113|975507|P1|COMPLETED|Treatment Period 2 (4 Weeks)||8
398338|NCT01751113|975502|P6|STARTED|Treatment Period 2 (4 Weeks)||10
398339|NCT01751113|975503|P5|STARTED|Treatment Period 2 (4 Weeks)||8
398340|NCT01751113|975504|P4|STARTED|Treatment Period 2 (4 Weeks)||8
398341|NCT01751113|975505|P3|STARTED|Treatment Period 2 (4 Weeks)||9
398342|NCT01751113|975506|P2|STARTED|Treatment Period 2 (4 Weeks)||8
398343|NCT01751113|975507|P1|STARTED|Treatment Period 2 (4 Weeks)||8
398344|NCT01751113|975502|P6|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
398345|NCT01751113|975503|P5|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
398346|NCT01751113|975504|P4|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
398347|NCT01751113|975505|P3|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
398348|NCT01751113|975506|P2|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
398349|NCT01751113|975507|P1|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
398350|NCT01751113|975502|P6|COMPLETED|Washout Period 1 (2 Weeks)||10
398351|NCT01751113|975503|P5|COMPLETED|Washout Period 1 (2 Weeks)||8
398352|NCT01751113|975504|P4|COMPLETED|Washout Period 1 (2 Weeks)||8
398353|NCT01751113|975505|P3|COMPLETED|Washout Period 1 (2 Weeks)||9
398354|NCT01751113|975506|P2|COMPLETED|Washout Period 1 (2 Weeks)||8
398355|NCT01751113|975507|P1|COMPLETED|Washout Period 1 (2 Weeks)||8
398356|NCT01751113|975502|P6|STARTED|Washout Period 1 (2 Weeks)||10
398357|NCT01751113|975503|P5|STARTED|Washout Period 1 (2 Weeks)||8
398358|NCT01751113|975504|P4|STARTED|Washout Period 1 (2 Weeks)||8
398359|NCT01751113|975505|P3|STARTED|Washout Period 1 (2 Weeks)||9
398360|NCT01751113|975506|P2|STARTED|Washout Period 1 (2 Weeks)||8
398361|NCT01751113|975507|P1|STARTED|Washout Period 1 (2 Weeks)||8
398362|NCT01751113|975502|P6|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
398363|NCT01751113|975503|P5|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
398364|NCT01751113|975504|P4|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
398365|NCT01751113|975505|P3|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
398366|NCT01751113|975506|P2|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
398367|NCT01751113|975507|P1|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
398368|NCT01751113|975502|P6|COMPLETED|Treatment Period 1 (4 Weeks)||10
398369|NCT01751113|975503|P5|COMPLETED|Treatment Period 1 (4 Weeks)||8
398370|NCT01751113|975504|P4|COMPLETED|Treatment Period 1 (4 Weeks)||8
398371|NCT01751113|975505|P3|COMPLETED|Treatment Period 1 (4 Weeks)||9
398372|NCT01751113|975506|P2|COMPLETED|Treatment Period 1 (4 Weeks)||8
398373|NCT01751113|975507|P1|COMPLETED|Treatment Period 1 (4 Weeks)||8
398374|NCT01751113|975502|P6|STARTED|Treatment Period 1 (4 Weeks)||10
398375|NCT01751113|975503|P5|STARTED|Treatment Period 1 (4 Weeks)||9
398376|NCT01751113|975504|P4|STARTED|Treatment Period 1 (4 Weeks)||9
398377|NCT01751113|975505|P3|STARTED|Treatment Period 1 (4 Weeks)||9
398378|NCT01751113|975506|P2|STARTED|Treatment Period 1 (4 Weeks)||8
398379|NCT01751113|975507|P1|STARTED|Treatment Period 1 (4 Weeks)||8
398380|NCT01751087|975548|P3|NOT COMPLETED|Overall Study||1
398381|NCT01751087|975549|P2|NOT COMPLETED|Overall Study||0
398382|NCT01751087|975550|P1|NOT COMPLETED|Overall Study||1
398383|NCT01751087|975548|P3|COMPLETED|Overall Study||99
398384|NCT01751087|975549|P2|COMPLETED|Overall Study||100
398385|NCT01751087|975550|P1|COMPLETED|Overall Study||99
398386|NCT01751087|975548|P3|STARTED|Overall Study||100
398387|NCT01751087|975549|P2|STARTED|Overall Study||100
398388|NCT01751087|975550|P1|STARTED|Overall Study||100
398389|NCT01751022|975585|P3|NOT COMPLETED|Overall Study||27
398390|NCT01751022|975586|P2|NOT COMPLETED|Overall Study||44
398391|NCT01751022|975587|P1|NOT COMPLETED|Overall Study||56
398392|NCT01751022|975585|P3|COMPLETED|Overall Study|6 month visit|273
398393|NCT01751022|975586|P2|COMPLETED|Overall Study|6 month visit|282
398394|NCT01751022|975587|P1|COMPLETED|Overall Study|6 month visit|443
398395|NCT01751022|975585|P3|STARTED|Overall Study||300
398396|NCT01751022|975586|P2|STARTED|Overall Study||326
398397|NCT01751022|975587|P1|STARTED|Overall Study||499
398398|NCT01750931|975619|P2|NOT COMPLETED|Period 2||0
398399|NCT01750931|975620|P1|NOT COMPLETED|Period 2||0
398400|NCT01750931|975619|P2|COMPLETED|Period 2||14
398401|NCT01750931|975620|P1|COMPLETED|Period 2||14
398402|NCT01750931|975619|P2|STARTED|Period 2||14
398403|NCT01750931|975620|P1|STARTED|Period 2||14
398404|NCT01750931|975619|P2|NOT COMPLETED|Wash Out||0
398405|NCT01750931|975620|P1|NOT COMPLETED|Wash Out||0
398406|NCT01750931|975619|P2|COMPLETED|Wash Out||14
398407|NCT01750931|975620|P1|COMPLETED|Wash Out||14
398408|NCT01750931|975619|P2|STARTED|Wash Out||14
398409|NCT01750931|975620|P1|STARTED|Wash Out||14
398410|NCT01750931|975619|P2|NOT COMPLETED|Period 1||0
398411|NCT01750931|975620|P1|NOT COMPLETED|Period 1||0
398412|NCT01750931|975619|P2|COMPLETED|Period 1||14
398413|NCT01750931|975620|P1|COMPLETED|Period 1||14
398414|NCT01750931|975619|P2|STARTED|Period 1||14
398415|NCT01750931|975620|P1|STARTED|Period 1||14
398416|NCT01750840|975638|P1|NOT COMPLETED|Overall Study||4
398417|NCT01750840|975638|P1|COMPLETED|Overall Study||4
398418|NCT01750840|975638|P1|STARTED|Overall Study||8
398419|NCT01750684|975645|P2|NOT COMPLETED|Overall Study||2
398420|NCT01750684|975646|P1|NOT COMPLETED|Overall Study||2
398421|NCT01750684|975645|P2|COMPLETED|Overall Study||5
398422|NCT01750684|975646|P1|COMPLETED|Overall Study||4
398423|NCT01750684|975645|P2|STARTED|Overall Study||7
398424|NCT01750684|975646|P1|STARTED|Overall Study||6
398425|NCT01750502|975654|P2|NOT COMPLETED|Overall Study||0
398426|NCT01750502|975655|P1|NOT COMPLETED|Overall Study||0
398427|NCT01750502|975654|P2|COMPLETED|Overall Study||186
398428|NCT01750502|975655|P1|COMPLETED|Overall Study||70
398429|NCT01750502|975654|P2|STARTED|Overall Study||186
398430|NCT01750502|975655|P1|STARTED|Overall Study||70
398431|NCT01750398|975668|P1|NOT COMPLETED|Bipolar Androgen Thearpy Phase||3
398432|NCT01750398|975668|P1|COMPLETED|Bipolar Androgen Thearpy Phase||26
398433|NCT01750398|975668|P1|STARTED|Bipolar Androgen Thearpy Phase||29
398434|NCT01750398|975668|P1|NOT COMPLETED|ADT Lead In Phase||4
398435|NCT01750398|975668|P1|COMPLETED|ADT Lead In Phase||29
398436|NCT01750398|975668|P1|STARTED|ADT Lead In Phase||33
398437|NCT01750346|975681|P3|NOT COMPLETED|Overall Study||0
398438|NCT01750346|975682|P2|NOT COMPLETED|Overall Study||0
398439|NCT01750346|975683|P1|NOT COMPLETED|Overall Study||1
398440|NCT01750346|975681|P3|COMPLETED|Overall Study||3
398441|NCT01750346|975682|P2|COMPLETED|Overall Study||2
398442|NCT01750346|975683|P1|COMPLETED|Overall Study||2
398443|NCT01750346|975681|P3|STARTED|Overall Study||3
398444|NCT01750346|975682|P2|STARTED|Overall Study||2
398445|NCT01750346|975683|P1|STARTED|Overall Study||3
398446|NCT01750294|975709|P1|NOT COMPLETED|Overall Study||2
398447|NCT01750294|975709|P1|COMPLETED|Overall Study||12
398448|NCT01750294|975709|P1|STARTED|Overall Study||14
398449|NCT01750281|975716|P3|NOT COMPLETED|Overall Study||84
398450|NCT01750281|975717|P2|NOT COMPLETED|Overall Study||85
398451|NCT01750281|975718|P1|NOT COMPLETED|Overall Study||43
398452|NCT01750281|975716|P3|COMPLETED|Overall Study||0
398453|NCT01750281|975717|P2|COMPLETED|Overall Study||0
398454|NCT01750281|975718|P1|COMPLETED|Overall Study||0
398455|NCT01750281|975716|P3|Did Not Receive Treatment|Overall Study||0
398456|NCT01750281|975717|P2|Did Not Receive Treatment|Overall Study||1
398457|NCT01750281|975718|P1|Did Not Receive Treatment|Overall Study||0
398458|NCT01750281|975716|P3|Received Treatment|Overall Study||84
398459|NCT01750281|975717|P2|Received Treatment|Overall Study||84
398460|NCT01750281|975718|P1|Received Treatment|Overall Study||43
398461|NCT01750281|975716|P3|STARTED|Overall Study||84
398462|NCT01750281|975717|P2|STARTED|Overall Study||85
398463|NCT01750281|975718|P1|STARTED|Overall Study||43
398464|NCT01750255|975731|P2|NOT COMPLETED|Overall Study||5
398465|NCT01750255|975732|P1|NOT COMPLETED|Overall Study||6
398466|NCT01750255|975731|P2|COMPLETED|Overall Study||38
398467|NCT01750255|975732|P1|COMPLETED|Overall Study||43
398468|NCT01750255|975731|P2|STARTED|Overall Study||43
398469|NCT01750255|975732|P1|STARTED|Overall Study||49
398470|NCT01750242|975748|P1|NOT COMPLETED|Overall Study||3
398471|NCT01750242|975748|P1|COMPLETED|Overall Study||20
398472|NCT01750242|975748|P1|Readable Images|Overall Study|Subjects with readable images were analyzed and there were 3 subjects with unreadable images.|20
398473|NCT01750242|975748|P1|STARTED|Overall Study||23
398474|NCT01750229|975753|P1|NOT COMPLETED|Long-term Follow-up Phase||3
398475|NCT01750229|975753|P1|COMPLETED|Long-term Follow-up Phase||25
398476|NCT01750229|975753|P1|STARTED|Long-term Follow-up Phase|Four subjects who had protocol violations continued to be followed in long-term follow-up phase.|28
398477|NCT01750229|975753|P1|NOT COMPLETED|Randomized Crossover Phase||2
398478|NCT01750229|975753|P1|COMPLETED|Randomized Crossover Phase||28
398479|NCT01750229|975753|P1|Protocol Violation|Randomized Crossover Phase||4
398480|NCT01750229|975753|P1|Subjects Received 5882 Hz|Randomized Crossover Phase||24
398481|NCT01750229|975753|P1|Subjects Received 3030 Hz|Randomized Crossover Phase||24
398482|NCT01750229|975753|P1|Subjects Received 1200 Hz|Randomized Crossover Phase||24
398483|NCT01750229|975753|P1|Subject Received Sham|Randomized Crossover Phase||24
398484|NCT01750229|975753|P1|STARTED|Randomized Crossover Phase||30
398485|NCT01750086|975765|P2|NOT COMPLETED|Overall Study||1
398486|NCT01750086|975766|P1|NOT COMPLETED|Overall Study||1
398487|NCT01750086|975765|P2|COMPLETED|Overall Study||13
398488|NCT01750086|975766|P1|COMPLETED|Overall Study||12
398489|NCT01750086|975765|P2|STARTED|Overall Study||14
398490|NCT01750086|975766|P1|STARTED|Overall Study||13
398491|NCT01749982|975776|P4|NOT COMPLETED|Overall Study||3
398492|NCT01749982|975777|P3|NOT COMPLETED|Overall Study||0
398493|NCT01749982|975778|P2|NOT COMPLETED|Overall Study||0
398494|NCT01749982|975779|P1|NOT COMPLETED|Overall Study||0
398495|NCT01749982|975776|P4|COMPLETED|Overall Study||12
398496|NCT01749982|975777|P3|COMPLETED|Overall Study||15
398497|NCT01749982|975778|P2|COMPLETED|Overall Study||15
398498|NCT01749982|975779|P1|COMPLETED|Overall Study||15
398499|NCT01749982|975776|P4|STARTED|Overall Study||15
398500|NCT01749982|975777|P3|STARTED|Overall Study||15
398501|NCT01749982|975778|P2|STARTED|Overall Study||15
398502|NCT01749982|975779|P1|STARTED|Overall Study||15
398503|NCT01749956|975797|P1|NOT COMPLETED|Overall Study||15
398504|NCT01749956|975797|P1|COMPLETED|Overall Study||24
398505|NCT01749956|975797|P1|STARTED|Overall Study||39
398506|NCT01749800|975810|P3|NOT COMPLETED|Overall Study||0
398507|NCT01749800|975811|P2|NOT COMPLETED|Overall Study||1
398508|NCT01749800|975812|P1|NOT COMPLETED|Overall Study||3
398509|NCT01749800|975810|P3|COMPLETED|Overall Study||0
398510|NCT01749800|975811|P2|COMPLETED|Overall Study||0
398511|NCT01749800|975812|P1|COMPLETED|Overall Study||3
398512|NCT01749800|975810|P3|STARTED|Overall Study||0
398513|NCT01749800|975811|P2|STARTED|Overall Study|1 subject showed significant motor impairments but decided to undergo therapy (exclusion criterion)|1
398514|NCT01749800|975812|P1|STARTED|Overall Study|3 subjects did not show significant attention span deficit (required inclusion criterion)|6
398515|NCT01749735|975822|P2|NOT COMPLETED|Overall Study||0
398516|NCT01749735|975823|P1|NOT COMPLETED|Overall Study||1
398517|NCT01749735|975822|P2|COMPLETED|Overall Study||0
398518|NCT01749735|975823|P1|COMPLETED|Overall Study||1
398519|NCT01749735|975822|P2|STARTED|Overall Study||0
398520|NCT01749735|975823|P1|STARTED|Overall Study||2
398521|NCT01749631|975831|P1|NOT COMPLETED|Overall Study||0
398522|NCT01749631|975831|P1|COMPLETED|Overall Study||97
398523|NCT01749631|975831|P1|STARTED|Overall Study||97
398524|NCT01749605|975843|P2|NOT COMPLETED|Overall Study||3
398525|NCT01749605|975844|P1|NOT COMPLETED|Overall Study||4
398526|NCT01749605|975843|P2|COMPLETED|Overall Study||14
398527|NCT01749605|975844|P1|COMPLETED|Overall Study||14
398528|NCT01749605|975843|P2|STARTED|Overall Study||17
398529|NCT01749605|975844|P1|STARTED|Overall Study||18
398530|NCT01749501|975852|P2|NOT COMPLETED|Overall Study||0
398531|NCT01749501|975853|P1|NOT COMPLETED|Overall Study||0
398532|NCT01749501|975852|P2|COMPLETED|Overall Study||23
398533|NCT01749501|975853|P1|COMPLETED|Overall Study||22
398534|NCT01749501|975852|P2|STARTED|Overall Study||23
398535|NCT01749501|975853|P1|STARTED|Overall Study||22
398536|NCT01749410|975861|P1|NOT COMPLETED|Overall Study||0
398537|NCT01749410|975861|P1|COMPLETED|Overall Study||33
398538|NCT01749410|975861|P1|STARTED|Overall Study||33
398539|NCT01748955|975867|P2|NOT COMPLETED|Overall Study||5
398540|NCT01748955|975868|P1|NOT COMPLETED|Overall Study||3
398541|NCT01748955|975867|P2|COMPLETED|Overall Study||4
398542|NCT01748955|975868|P1|COMPLETED|Overall Study||3
398543|NCT01748955|975867|P2|STARTED|Overall Study||9
398544|NCT01748955|975868|P1|STARTED|Overall Study||6
398545|NCT01748942|975878|P2|NOT COMPLETED|Overall Study||4
398546|NCT01748942|975879|P1|NOT COMPLETED|Overall Study||4
398547|NCT01748942|975878|P2|COMPLETED|Overall Study||33
398548|NCT01748942|975879|P1|COMPLETED|Overall Study||35
398549|NCT01748942|975878|P2|STARTED|Overall Study||37
398550|NCT01748942|975879|P1|STARTED|Overall Study||39
398551|NCT01748916|975899|P6|NOT COMPLETED|Overall Study||0
398552|NCT01748916|975900|P5|NOT COMPLETED|Overall Study||0
398553|NCT01748916|975901|P4|NOT COMPLETED|Overall Study||0
398554|NCT01748916|975902|P3|NOT COMPLETED|Overall Study||0
398555|NCT01748916|975903|P2|NOT COMPLETED|Overall Study||0
398556|NCT01748916|975904|P1|NOT COMPLETED|Overall Study||0
398557|NCT01748916|975899|P6|COMPLETED|Overall Study||3
398558|NCT01748916|975900|P5|COMPLETED|Overall Study||3
398559|NCT01748916|975901|P4|COMPLETED|Overall Study||3
398560|NCT01748916|975902|P3|COMPLETED|Overall Study||2
398561|NCT01748916|975903|P2|COMPLETED|Overall Study||3
398562|NCT01748916|975904|P1|COMPLETED|Overall Study||2
398563|NCT01748916|975899|P6|STARTED|Overall Study||3
398564|NCT01748916|975900|P5|STARTED|Overall Study||3
398565|NCT01748916|975901|P4|STARTED|Overall Study||3
398566|NCT01748916|975902|P3|STARTED|Overall Study||2
398567|NCT01748916|975903|P2|STARTED|Overall Study||3
398568|NCT01748916|975904|P1|STARTED|Overall Study||2
398569|NCT01748890|975912|P1|NOT COMPLETED|Overall Study||4
398570|NCT01748890|975912|P1|COMPLETED|Overall Study|Insufficient recruitment for analysis|0
398571|NCT01748890|975912|P1|STARTED|Overall Study||4
398572|NCT01748799|975924|P8|NOT COMPLETED|Overall Study||0
398573|NCT01748799|975925|P7|NOT COMPLETED|Overall Study||1
398574|NCT01748799|975926|P6|NOT COMPLETED|Overall Study||1
398575|NCT01748799|975927|P5|NOT COMPLETED|Overall Study||0
398576|NCT01748799|975928|P4|NOT COMPLETED|Overall Study||0
398577|NCT01748799|975929|P3|NOT COMPLETED|Overall Study||0
398578|NCT01748799|975930|P2|NOT COMPLETED|Overall Study||0
398579|NCT01748799|975931|P1|NOT COMPLETED|Overall Study||5
398580|NCT01748799|975924|P8|COMPLETED|Overall Study||1
398581|NCT01748799|975925|P7|COMPLETED|Overall Study||1
398582|NCT01748799|975926|P6|COMPLETED|Overall Study||1
398583|NCT01748799|975927|P5|COMPLETED|Overall Study||1
398584|NCT01748799|975928|P4|COMPLETED|Overall Study||2
398585|NCT01748799|975929|P3|COMPLETED|Overall Study||1
398586|NCT01748799|975930|P2|COMPLETED|Overall Study||1
398587|NCT01748799|975931|P1|COMPLETED|Overall Study||1
398588|NCT01748799|975924|P8|Completed Self-titrated Sativex|Overall Study||1
398589|NCT01748799|975925|P7|Completed Self-titrated Sativex|Overall Study||1
398590|NCT01748799|975926|P6|Completed Self-titrated Sativex|Overall Study||1
398591|NCT01748799|975927|P5|Completed Self-titrated Sativex|Overall Study||1
398592|NCT01748799|975928|P4|Completed Self-titrated Sativex|Overall Study||2
398593|NCT01748799|975929|P3|Completed Self-titrated Sativex|Overall Study||1
398594|NCT01748799|975930|P2|Completed Self-titrated Sativex|Overall Study||1
398595|NCT01748799|975931|P1|Completed Self-titrated Sativex|Overall Study||1
398596|NCT01748799|975924|P8|Completed SAU of Self-titrated Sativex|Overall Study||1
398597|NCT01748799|975925|P7|Completed SAU of Self-titrated Sativex|Overall Study||1
398598|NCT01748799|975926|P6|Completed SAU of Self-titrated Sativex|Overall Study||2
398599|NCT01748799|975927|P5|Completed SAU of Self-titrated Sativex|Overall Study||1
398600|NCT01748799|975928|P4|Completed SAU of Self-titrated Sativex|Overall Study||2
398601|NCT01748799|975929|P3|Completed SAU of Self-titrated Sativex|Overall Study||1
398602|NCT01748799|975930|P2|Completed SAU of Self-titrated Sativex|Overall Study||1
398603|NCT01748799|975931|P1|Completed SAU of Self-titrated Sativex|Overall Study||2
398604|NCT01748799|975924|P8|Completed Self-titrated Placebo|Overall Study||1
398605|NCT01748799|975925|P7|Completed Self-titrated Placebo|Overall Study||1
398606|NCT01748799|975926|P6|Completed Self-titrated Placebo|Overall Study||2
398607|NCT01748799|975927|P5|Completed Self-titrated Placebo|Overall Study||1
398608|NCT01748799|975928|P4|Completed Self-titrated Placebo|Overall Study||2
398609|NCT01748799|975929|P3|Completed Self-titrated Placebo|Overall Study||1
398610|NCT01748799|975930|P2|Completed Self-titrated Placebo|Overall Study||1
398611|NCT01748799|975931|P1|Completed Self-titrated Placebo|Overall Study||4
398612|NCT01748799|975924|P8|Completed SAU of Self-titrated Placebo|Overall Study||1
398613|NCT01748799|975925|P7|Completed SAU of Self-titrated Placebo|Overall Study||1
398614|NCT01748799|975926|P6|Completed SAU of Self-titrated Placebo|Overall Study||2
398615|NCT01748799|975927|P5|Completed SAU of Self-titrated Placebo|Overall Study||1
398616|NCT01748799|975928|P4|Completed SAU of Self-titrated Placebo|Overall Study||2
398617|NCT01748799|975929|P3|Completed SAU of Self-titrated Placebo|Overall Study||1
398618|NCT01748799|975930|P2|Completed SAU of Self-titrated Placebo|Overall Study||1
398619|NCT01748799|975931|P1|Completed SAU of Self-titrated Placebo|Overall Study||5
398620|NCT01748799|975924|P8|Completed Fixed Dose Sativex|Overall Study||1
398621|NCT01748799|975925|P7|Completed Fixed Dose Sativex|Overall Study||1
398622|NCT01748799|975926|P6|Completed Fixed Dose Sativex|Overall Study||1
398623|NCT01748799|975927|P5|Completed Fixed Dose Sativex|Overall Study||1
398624|NCT01748799|975928|P4|Completed Fixed Dose Sativex|Overall Study||2
398625|NCT01748799|975929|P3|Completed Fixed Dose Sativex|Overall Study||1
398626|NCT01748799|975930|P2|Completed Fixed Dose Sativex|Overall Study||1
398627|NCT01748799|975931|P1|Completed Fixed Dose Sativex|Overall Study||1
398628|NCT01748799|975924|P8|Completed SAU of Fixed Dose Sativex|Overall Study||1
398629|NCT01748799|975925|P7|Completed SAU of Fixed Dose Sativex|Overall Study||1
398630|NCT01748799|975926|P6|Completed SAU of Fixed Dose Sativex|Overall Study||1
398631|NCT01748799|975927|P5|Completed SAU of Fixed Dose Sativex|Overall Study||1
398632|NCT01748799|975928|P4|Completed SAU of Fixed Dose Sativex|Overall Study||2
398633|NCT01748799|975929|P3|Completed SAU of Fixed Dose Sativex|Overall Study||1
398634|NCT01748799|975930|P2|Completed SAU of Fixed Dose Sativex|Overall Study||1
398635|NCT01748799|975931|P1|Completed SAU of Fixed Dose Sativex|Overall Study||1
398636|NCT01748799|975924|P8|Completed Fixed Dose Placebo|Overall Study||1
398637|NCT01748799|975925|P7|Completed Fixed Dose Placebo|Overall Study||1
398638|NCT01748799|975926|P6|Completed Fixed Dose Placebo|Overall Study||1
398639|NCT01748799|975927|P5|Completed Fixed Dose Placebo|Overall Study||1
398640|NCT01748799|975928|P4|Completed Fixed Dose Placebo|Overall Study||2
398641|NCT01748799|975929|P3|Completed Fixed Dose Placebo|Overall Study||1
398642|NCT01748799|975930|P2|Completed Fixed Dose Placebo|Overall Study||1
398643|NCT01748799|975931|P1|Completed Fixed Dose Placebo|Overall Study||2
398644|NCT01748799|975924|P8|Completed SAU of Fixed Dose Placebo|Overall Study||1
398645|NCT01748799|975925|P7|Completed SAU of Fixed Dose Placebo|Overall Study||1
398646|NCT01748799|975926|P6|Completed SAU of Fixed Dose Placebo|Overall Study||1
398647|NCT01748799|975927|P5|Completed SAU of Fixed Dose Placebo|Overall Study||1
398648|NCT01748799|975928|P4|Completed SAU of Fixed Dose Placebo|Overall Study||2
398649|NCT01748799|975929|P3|Completed SAU of Fixed Dose Placebo|Overall Study||1
398650|NCT01748799|975930|P2|Completed SAU of Fixed Dose Placebo|Overall Study||1
398651|NCT01748799|975931|P1|Completed SAU of Fixed Dose Placebo|Overall Study||2
398652|NCT01748799|975924|P8|STARTED|Overall Study||1
398653|NCT01748799|975925|P7|STARTED|Overall Study||2
398654|NCT01748799|975926|P6|STARTED|Overall Study||2
398655|NCT01748799|975927|P5|STARTED|Overall Study||1
398656|NCT01748799|975928|P4|STARTED|Overall Study||2
398657|NCT01748799|975929|P3|STARTED|Overall Study||1
398658|NCT01748799|975930|P2|STARTED|Overall Study||1
398659|NCT01748799|975931|P1|STARTED|Overall Study||6
398660|NCT01748760|975967|P2|NOT COMPLETED|Overall Study||2
398661|NCT01748760|975968|P1|NOT COMPLETED|Overall Study||6
398662|NCT01748760|975967|P2|COMPLETED|Overall Study||23
398663|NCT01748760|975968|P1|COMPLETED|Overall Study||19
398664|NCT01748760|975967|P2|STARTED|Overall Study||25
398665|NCT01748760|975968|P1|STARTED|Overall Study||25
398666|NCT01748695|975974|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
398667|NCT01748695|975975|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
398668|NCT01748695|975974|P2|COMPLETED|Second Intervention (4 Weeks)||11
398669|NCT01748695|975975|P1|COMPLETED|Second Intervention (4 Weeks)||14
398670|NCT01748695|975974|P2|STARTED|Second Intervention (4 Weeks)||11
398671|NCT01748695|975975|P1|STARTED|Second Intervention (4 Weeks)||14
398672|NCT01748695|975974|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
398673|NCT01748695|975975|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
398674|NCT01748695|975974|P2|COMPLETED|First Intervention (4 Weeks)||11
398675|NCT01748695|975975|P1|COMPLETED|First Intervention (4 Weeks)||14
398676|NCT01748695|975974|P2|STARTED|First Intervention (4 Weeks)||11
398677|NCT01748695|975975|P1|STARTED|First Intervention (4 Weeks)||14
398678|NCT01748643|975985|P2|NOT COMPLETED|Overall Study||0
398679|NCT01748643|975986|P1|NOT COMPLETED|Overall Study||0
398680|NCT01748643|975985|P2|COMPLETED|Overall Study||30
398681|NCT01748643|975986|P1|COMPLETED|Overall Study||30
398682|NCT01748643|975985|P2|STARTED|Overall Study||30
398683|NCT01748643|975986|P1|STARTED|Overall Study||30
398684|NCT01748292|976004|P2|NOT COMPLETED|Overall Study||12
398685|NCT01748292|976005|P1|NOT COMPLETED|Overall Study||2
398686|NCT01748292|976004|P2|COMPLETED|Overall Study||28
398687|NCT01748292|976005|P1|COMPLETED|Overall Study||18
398688|NCT01748292|976004|P2|STARTED|Overall Study||40
398689|NCT01748292|976005|P1|STARTED|Overall Study||20
398690|NCT01748227|976021|P1|NOT COMPLETED|Overall Study||3
398691|NCT01748227|976021|P1|COMPLETED|Overall Study||17
398692|NCT01748227|976021|P1|STARTED|Overall Study||20
398693|NCT01748162|976031|P2|NOT COMPLETED|Overall Study||5
398694|NCT01748162|976032|P1|NOT COMPLETED|Overall Study||5
398695|NCT01748162|976031|P2|COMPLETED|Overall Study||0
398696|NCT01748162|976032|P1|COMPLETED|Overall Study||0
398697|NCT01748162|976031|P2|Started 6 Month Followup|Overall Study|No participants in either arm had additional croup episodes in the first 6 months; study terminated.|0
398698|NCT01748162|976032|P1|Started 6 Month Followup|Overall Study|No participants in either arm had additional croup episodes in the first 6 months; study terminated.|0
398699|NCT01748162|976031|P2|Completed 6 Month Initial Treatment|Overall Study||0
398700|NCT01748162|976032|P1|Completed 6 Month Initial Treatment|Overall Study||0
398701|NCT01748162|976031|P2|Started 6 Month Initial Treatment Plan|Overall Study||2
398702|NCT01748162|976032|P1|Started 6 Month Initial Treatment Plan|Overall Study||2
398703|NCT01748162|976031|P2|STARTED|Overall Study||5
398704|NCT01748162|976032|P1|STARTED|Overall Study||5
398705|NCT01748071|976043|P3|NOT COMPLETED|Overall Study||0
398706|NCT01748071|976044|P2|NOT COMPLETED|Overall Study||2
398707|NCT01748071|976045|P1|NOT COMPLETED|Overall Study||2
398708|NCT01748071|976043|P3|COMPLETED|Overall Study||40
398709|NCT01748071|976044|P2|COMPLETED|Overall Study||38
398710|NCT01748071|976045|P1|COMPLETED|Overall Study||38
398711|NCT01748071|976043|P3|STARTED|Overall Study||40
398712|NCT01748071|976044|P2|STARTED|Overall Study||40
398713|NCT01748071|976045|P1|STARTED|Overall Study||40
398714|NCT01748045|976067|P2|NOT COMPLETED|Overall Study||0
398715|NCT01748045|976068|P1|NOT COMPLETED|Overall Study||0
398716|NCT01748045|976067|P2|COMPLETED|Overall Study||1
398717|NCT01748045|976068|P1|COMPLETED|Overall Study||2
398718|NCT01748045|976067|P2|STARTED|Overall Study||1
398719|NCT01748045|976068|P1|STARTED|Overall Study||2
398720|NCT01747928|976094|P8|NOT COMPLETED|Overall Study||0
398721|NCT01747928|976095|P7|NOT COMPLETED|Overall Study||0
398722|NCT01747928|976096|P6|NOT COMPLETED|Overall Study||0
398723|NCT01747928|976097|P5|NOT COMPLETED|Overall Study||0
398724|NCT01747928|976098|P4|NOT COMPLETED|Overall Study||0
398725|NCT01747928|976099|P3|NOT COMPLETED|Overall Study||0
398726|NCT01747928|976100|P2|NOT COMPLETED|Overall Study||0
398727|NCT01747928|976101|P1|NOT COMPLETED|Overall Study||0
398728|NCT01747928|976094|P8|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
398729|NCT01747928|976095|P7|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
398730|NCT01747928|976096|P6|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
398731|NCT01747928|976097|P5|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
398732|NCT01747928|976098|P4|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
398733|NCT01747928|976099|P3|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
398734|NCT01747928|976100|P2|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
398735|NCT01747928|976101|P1|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
398736|NCT01747928|976094|P8|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
398737|NCT01747928|976095|P7|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
398738|NCT01747928|976096|P6|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
398739|NCT01747928|976097|P5|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
398740|NCT01747928|976098|P4|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
398741|NCT01747928|976099|P3|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
398742|NCT01747928|976100|P2|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
398743|NCT01747928|976101|P1|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
398744|NCT01747850|976308|P3|NOT COMPLETED|Overall Study||6
398745|NCT01747850|976309|P2|NOT COMPLETED|Overall Study||7
398746|NCT01747850|976310|P1|NOT COMPLETED|Overall Study||1
398747|NCT01747850|976308|P3|COMPLETED|Overall Study||14
398748|NCT01747850|976309|P2|COMPLETED|Overall Study||13
398749|NCT01747850|976310|P1|COMPLETED|Overall Study||4
398750|NCT01747850|976308|P3|STARTED|Overall Study||20
398751|NCT01747850|976309|P2|STARTED|Overall Study||20
398752|NCT01747850|976310|P1|STARTED|Overall Study||5
398753|NCT01747811|976332|P2|NOT COMPLETED|Overall Study||4
398754|NCT01747811|976333|P1|NOT COMPLETED|Overall Study||2
398755|NCT01747811|976332|P2|COMPLETED|Overall Study||12
398756|NCT01747811|976333|P1|COMPLETED|Overall Study||14
398757|NCT01747811|976332|P2|STARTED|Overall Study||16
398758|NCT01747811|976333|P1|STARTED|Overall Study||16
398759|NCT01747772|976349|P1|NOT COMPLETED|Overall Study||9
398760|NCT01747772|976349|P1|COMPLETED|Overall Study||171
398761|NCT01747772|976349|P1|Analysis Population|Overall Study|All participants who completed the study and had adequate SWE and liver biopsy data.|164
398762|NCT01747772|976349|P1|STARTED|Overall Study||180
398763|NCT01747655|976357|P2|NOT COMPLETED|PEG-J Period (Continued Treatment)||0
398764|NCT01747655|976358|P1|NOT COMPLETED|PEG-J Period (Continued Treatment)||0
398765|NCT01747655|976357|P2|COMPLETED|PEG-J Period (Continued Treatment)||15
398766|NCT01747655|976358|P1|COMPLETED|PEG-J Period (Continued Treatment)||41
398767|NCT01747655|976357|P2|STARTED|PEG-J Period (Continued Treatment)|SoC MAS: 6 SoC participants plus 9 participants who received Duodopa via PEG-J then returned to SoC|15
398768|NCT01747655|976358|P1|STARTED|PEG-J Period (Continued Treatment)||41
398769|NCT01747655|976357|P2|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||0
398770|NCT01747655|976358|P1|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||14
398771|NCT01747655|976357|P2|COMPLETED|PEG-J Period (Duodopa Treatment)||6
398772|NCT01747655|976358|P1|COMPLETED|PEG-J Period (Duodopa Treatment)||44
398773|NCT01747655|976357|P2|STARTED|PEG-J Period (Duodopa Treatment)|Participants in the MAS that returned to SoC (no PEG-J introduced; did not meet selection criteria)|6
398774|NCT01747655|976358|P1|STARTED|PEG-J Period (Duodopa Treatment)|Dudopa MAS: Participants in the MAS that received Duodopa via PEG-J.|58
398775|NCT01747655|976357|P2|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0
398776|NCT01747655|976358|P1|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0
398777|NCT01747655|976357|P2|COMPLETED|Temporary Naso-jejunal Tube Period||0
398778|NCT01747655|976358|P1|COMPLETED|Temporary Naso-jejunal Tube Period||64
398779|NCT01747655|976357|P2|STARTED|Temporary Naso-jejunal Tube Period||0
398780|NCT01747655|976358|P1|STARTED|Temporary Naso-jejunal Tube Period|Main Analysis Set (MAS): participants with baseline and 1 further visit and ≥ 1 Duodopa treatment|64
398781|NCT01747629|976388|P2|NOT COMPLETED|Overall Study||6
398782|NCT01747629|976389|P1|NOT COMPLETED|Overall Study||8
398783|NCT01747629|976388|P2|COMPLETED|Overall Study||69
398784|NCT01747629|976389|P1|COMPLETED|Overall Study||77
398785|NCT01747629|976388|P2|Treated|Overall Study|Safety set and full analysis set|75
398786|NCT01747629|976389|P1|Treated|Overall Study|Safety set and full analysis set|84
398787|NCT01747629|976388|P2|STARTED|Overall Study||75
398788|NCT01747629|976389|P1|STARTED|Overall Study||85
398789|NCT01747551|976423|P2|NOT COMPLETED|Overall Study||21
398790|NCT01747551|976424|P1|NOT COMPLETED|Overall Study||43
398791|NCT01747551|976423|P2|COMPLETED|Overall Study||0
398792|NCT01747551|976424|P1|COMPLETED|Overall Study||0
398793|NCT01747551|976423|P2|STARTED|Overall Study||21
398794|NCT01747551|976424|P1|STARTED|Overall Study||43
398795|NCT01747343|976436|P1|NOT COMPLETED|Underwear/Differential Reinforcement||0
398796|NCT01747343|976436|P1|COMPLETED|Underwear/Differential Reinforcement||4
398797|NCT01747343|976436|P1|STARTED|Underwear/Differential Reinforcement||4
398798|NCT01747343|976436|P1|NOT COMPLETED|Underwear||0
398799|NCT01747343|976436|P1|COMPLETED|Underwear||4
398800|NCT01747343|976436|P1|STARTED|Underwear||4
398801|NCT01747343|976436|P1|NOT COMPLETED|Baseline||0
398802|NCT01747343|976436|P1|COMPLETED|Baseline||4
398803|NCT01747343|976436|P1|STARTED|Baseline||4
398804|NCT01747330|976442|P1|NOT COMPLETED|Overall Study||0
398805|NCT01747330|976442|P1|COMPLETED|Overall Study||40
398806|NCT01747330|976442|P1|STARTED|Overall Study||40
398807|NCT01746979|976456|P2|NOT COMPLETED|Overall Study||347
398808|NCT01746979|976457|P1|NOT COMPLETED|Overall Study||346
398809|NCT01746979|976456|P2|COMPLETED|Overall Study||0
398810|NCT01746979|976457|P1|COMPLETED|Overall Study||0
398811|NCT01746979|976456|P2|STARTED|Overall Study||347
398812|NCT01746979|976457|P1|STARTED|Overall Study||346
398813|NCT01746940|976469|P4|NOT COMPLETED|Safety Second Phase||0
398814|NCT01746940|976470|P3|NOT COMPLETED|Safety Second Phase||0
398815|NCT01746940|976471|P2|NOT COMPLETED|Safety Second Phase||0
398816|NCT01746940|976472|P1|NOT COMPLETED|Safety Second Phase||0
398817|NCT01746940|976469|P4|COMPLETED|Safety Second Phase||0
398818|NCT01746940|976470|P3|COMPLETED|Safety Second Phase||0
398819|NCT01746940|976471|P2|COMPLETED|Safety Second Phase||18
398820|NCT01746940|976472|P1|COMPLETED|Safety Second Phase||18
398821|NCT01746940|976469|P4|STARTED|Safety Second Phase||0
398822|NCT01746940|976470|P3|STARTED|Safety Second Phase||0
398823|NCT01746940|976471|P2|STARTED|Safety Second Phase||18
398824|NCT01746940|976472|P1|STARTED|Safety Second Phase||18
398825|NCT01746940|976469|P4|NOT COMPLETED|Safety and Efficacy First Phase||3
398826|NCT01746940|976470|P3|NOT COMPLETED|Safety and Efficacy First Phase||0
398827|NCT01746940|976471|P2|NOT COMPLETED|Safety and Efficacy First Phase||0
398828|NCT01746940|976472|P1|NOT COMPLETED|Safety and Efficacy First Phase||0
398829|NCT01746940|976469|P4|COMPLETED|Safety and Efficacy First Phase||0
398830|NCT01746940|976470|P3|COMPLETED|Safety and Efficacy First Phase||40
398831|NCT01746940|976471|P2|COMPLETED|Safety and Efficacy First Phase||41
398832|NCT01746940|976472|P1|COMPLETED|Safety and Efficacy First Phase||39
398833|NCT01746940|976469|P4|STARTED|Safety and Efficacy First Phase||3
398834|NCT01746940|976470|P3|STARTED|Safety and Efficacy First Phase||40
398835|NCT01746940|976471|P2|STARTED|Safety and Efficacy First Phase||41
398836|NCT01746940|976472|P1|STARTED|Safety and Efficacy First Phase||39
398837|NCT01746862|976482|P2|NOT COMPLETED|Overall Study||3
398838|NCT01746862|976483|P1|NOT COMPLETED|Overall Study||8
398839|NCT01746862|976482|P2|COMPLETED|Overall Study||27
398840|NCT01746862|976483|P1|COMPLETED|Overall Study||52
398841|NCT01746862|976482|P2|Treated|Overall Study||30
398842|NCT01746862|976483|P1|Treated|Overall Study||59
398843|NCT01746862|976482|P2|STARTED|Overall Study||30
398844|NCT01746862|976483|P1|STARTED|Overall Study||60
398845|NCT01746784|976508|P5|NOT COMPLETED|Overall Study||0
398846|NCT01746784|976509|P4|NOT COMPLETED|Overall Study||0
398847|NCT01746784|976510|P3|NOT COMPLETED|Overall Study||0
398848|NCT01746784|976511|P2|NOT COMPLETED|Overall Study||0
398849|NCT01746784|976512|P1|NOT COMPLETED|Overall Study||0
398850|NCT01746784|976508|P5|COMPLETED|Overall Study||19
398851|NCT01746784|976509|P4|COMPLETED|Overall Study||9
398852|NCT01746784|976510|P3|COMPLETED|Overall Study||9
398853|NCT01746784|976511|P2|COMPLETED|Overall Study||10
398854|NCT01746784|976512|P1|COMPLETED|Overall Study||19
398855|NCT01746784|976508|P5|Enrolled|Overall Study||19
398856|NCT01746784|976509|P4|Enrolled|Overall Study||9
398857|NCT01746784|976510|P3|Enrolled|Overall Study||9
398858|NCT01746784|976511|P2|Enrolled|Overall Study||10
398859|NCT01746784|976512|P1|Enrolled|Overall Study||19
398860|NCT01746784|976508|P5|STARTED|Overall Study||19
398861|NCT01746784|976509|P4|STARTED|Overall Study||9
398862|NCT01746784|976510|P3|STARTED|Overall Study||9
398863|NCT01746784|976511|P2|STARTED|Overall Study||10
398864|NCT01746784|976512|P1|STARTED|Overall Study||19
398865|NCT01746511|976536|P2|NOT COMPLETED|Overall Study||0
398866|NCT01746511|976537|P1|NOT COMPLETED|Overall Study||0
398867|NCT01746511|976536|P2|COMPLETED|Overall Study||39
398868|NCT01746511|976537|P1|COMPLETED|Overall Study||40
398869|NCT01746511|976536|P2|STARTED|Overall Study||39
398870|NCT01746511|976537|P1|STARTED|Overall Study||40
398871|NCT01746368|976553|P2|NOT COMPLETED|Overall Study||1
398872|NCT01746368|976554|P1|NOT COMPLETED|Overall Study||2
398873|NCT01746368|976553|P2|COMPLETED|Overall Study||16
398874|NCT01746368|976554|P1|COMPLETED|Overall Study||31
398875|NCT01746368|976553|P2|Analyzed for Satisfaction|Overall Study||16
398876|NCT01746368|976554|P1|Analyzed for Satisfaction|Overall Study||30
398877|NCT01746368|976553|P2|Analyzed for AD Completion Rate|Overall Study||17
398878|NCT01746368|976554|P1|Analyzed for AD Completion Rate|Overall Study||32
398879|NCT01746368|976553|P2|Assessment Completed|Overall Study||16
398880|NCT01746368|976554|P1|Assessment Completed|Overall Study||31
398881|NCT01746368|976553|P2|Recieved Allocated Intervention|Overall Study||8
398882|NCT01746368|976554|P1|Recieved Allocated Intervention|Overall Study||31
398883|NCT01746368|976553|P2|STARTED|Overall Study||17
398884|NCT01746368|976554|P1|STARTED|Overall Study||33
398885|NCT01746264|976562|P1|NOT COMPLETED|Overall Study||0
398886|NCT01746264|976562|P1|COMPLETED|Overall Study||19
398887|NCT01746264|976562|P1|STARTED|Overall Study||19
398888|NCT01746173|976581|P1|NOT COMPLETED|Overall Study||2
398889|NCT01746173|976581|P1|COMPLETED|Overall Study||3
398890|NCT01746173|976581|P1|STARTED|Overall Study||5
398891|NCT01746108|976589|P3|NOT COMPLETED|Overall Study||0
398892|NCT01746108|976590|P2|NOT COMPLETED|Overall Study||4
398893|NCT01746108|976591|P1|NOT COMPLETED|Overall Study||0
398894|NCT01746108|976589|P3|COMPLETED|Overall Study||6
398895|NCT01746108|976590|P2|COMPLETED|Overall Study||24
398896|NCT01746108|976591|P1|COMPLETED|Overall Study||18
398897|NCT01746108|976589|P3|STARTED|Overall Study||6
398898|NCT01746108|976590|P2|STARTED|Overall Study||28
398899|NCT01746108|976591|P1|STARTED|Overall Study||18
398900|NCT01746043|976631|P4|NOT COMPLETED|Overall Study||0
398901|NCT01746043|976632|P3|NOT COMPLETED|Overall Study||0
398902|NCT01746043|976633|P2|NOT COMPLETED|Overall Study||0
398903|NCT01746043|976634|P1|NOT COMPLETED|Overall Study||0
398904|NCT01746043|976631|P4|COMPLETED|Overall Study||5
398905|NCT01746043|976632|P3|COMPLETED|Overall Study||5
398906|NCT01746043|976633|P2|COMPLETED|Overall Study||4
398907|NCT01746043|976634|P1|COMPLETED|Overall Study||5
398908|NCT01746043|976631|P4|STARTED|Overall Study||5
398909|NCT01746043|976632|P3|STARTED|Overall Study||5
398910|NCT01746043|976633|P2|STARTED|Overall Study||4
398911|NCT01746043|976634|P1|STARTED|Overall Study||5
398912|NCT01745952|976644|P3|NOT COMPLETED|Overall Study||0
398913|NCT01745952|976645|P2|NOT COMPLETED|Overall Study||1
398914|NCT01745952|976646|P1|NOT COMPLETED|Overall Study||1
398915|NCT01745952|976644|P3|COMPLETED|Overall Study||3
398916|NCT01745952|976645|P2|COMPLETED|Overall Study|data of one patient not used due to no seizure diary entries on multiple occasions|3
398917|NCT01745952|976646|P1|COMPLETED|Overall Study||3
398918|NCT01745952|976644|P3|STARTED|Overall Study||3
398919|NCT01745952|976645|P2|STARTED|Overall Study||4
398920|NCT01745952|976646|P1|STARTED|Overall Study||4
398921|NCT01745913|976672|P2|NOT COMPLETED|Overall Study||1
398922|NCT01745913|976673|P1|NOT COMPLETED|Overall Study||1
398923|NCT01745913|976672|P2|COMPLETED|Overall Study||0
398924|NCT01745913|976673|P1|COMPLETED|Overall Study||0
398925|NCT01745913|976672|P2|STARTED|Overall Study||1
398926|NCT01745913|976673|P1|STARTED|Overall Study||1
398927|NCT01745848|976689|P1|NOT COMPLETED|Overall Study||6
398928|NCT01745848|976689|P1|COMPLETED|Overall Study||20
398929|NCT01745848|976689|P1|STARTED|Overall Study||26
398930|NCT01745380|976696|P2|NOT COMPLETED|Overall Study||1
398931|NCT01745380|976697|P1|NOT COMPLETED|Overall Study||1
398932|NCT01745380|976696|P2|COMPLETED|Overall Study||49
398933|NCT01745380|976697|P1|COMPLETED|Overall Study||99
398934|NCT01745380|976696|P2|STARTED|Overall Study||50
398935|NCT01745380|976697|P1|STARTED|Overall Study||100
398936|NCT01745133|976736|P3|NOT COMPLETED|Overall Study||4
398937|NCT01745133|976737|P2|NOT COMPLETED|Overall Study||4
398938|NCT01745133|976738|P1|NOT COMPLETED|Overall Study||6
398939|NCT01745133|976736|P3|COMPLETED|Overall Study||15
398940|NCT01745133|976737|P2|COMPLETED|Overall Study||16
398941|NCT01745133|976738|P1|COMPLETED|Overall Study||13
398942|NCT01745133|976736|P3|STARTED|Overall Study||19
398943|NCT01745133|976737|P2|STARTED|Overall Study||20
398944|NCT01745133|976738|P1|STARTED|Overall Study||19
398945|NCT01745094|976750|P4|NOT COMPLETED|Overall Study||3
398946|NCT01745094|976751|P3|NOT COMPLETED|Overall Study||12
398947|NCT01745094|976752|P2|NOT COMPLETED|Overall Study||0
398948|NCT01745094|976753|P1|NOT COMPLETED|Overall Study||5
398949|NCT01745094|976750|P4|COMPLETED|Overall Study||90
398950|NCT01745094|976751|P3|COMPLETED|Overall Study||46
398951|NCT01745094|976752|P2|COMPLETED|Overall Study||37
398952|NCT01745094|976753|P1|COMPLETED|Overall Study||30
398953|NCT01745094|976750|P4|STARTED|Overall Study||93
398954|NCT01745094|976751|P3|STARTED|Overall Study||58
398955|NCT01745094|976752|P2|STARTED|Overall Study||37
398956|NCT01745094|976753|P1|STARTED|Overall Study||35
398957|NCT01745055|976819|P1|NOT COMPLETED|Overall Study||0
398958|NCT01745055|976819|P1|COMPLETED|Overall Study||12
398959|NCT01745055|976819|P1|STARTED|Overall Study||12
398960|NCT01744977|976854|P2|NOT COMPLETED|Overall Study||5
398961|NCT01744977|976855|P1|NOT COMPLETED|Overall Study||11
398962|NCT01744977|976854|P2|COMPLETED|Overall Study||115
398963|NCT01744977|976855|P1|COMPLETED|Overall Study||109
398964|NCT01744977|976854|P2|6 Month Completed|Overall Study||115
398965|NCT01744977|976855|P1|6 Month Completed|Overall Study||113
398966|NCT01744977|976854|P2|STARTED|Overall Study||120
398967|NCT01744977|976855|P1|STARTED|Overall Study||120
398968|NCT01744860|976863|P1|NOT COMPLETED|Overall Study||0
398969|NCT01744860|976863|P1|COMPLETED|Overall Study||420
398970|NCT01744860|976863|P1|STARTED|Overall Study||420
398971|NCT01744821|976901|P4|NOT COMPLETED|Overall Study||0
398972|NCT01744821|976902|P3|NOT COMPLETED|Overall Study||0
398973|NCT01744821|976903|P2|NOT COMPLETED|Overall Study||0
398974|NCT01744821|976904|P1|NOT COMPLETED|Overall Study||0
398975|NCT01744821|976901|P4|COMPLETED|Overall Study||1
398976|NCT01744821|976902|P3|COMPLETED|Overall Study||2
398977|NCT01744821|976903|P2|COMPLETED|Overall Study||3
398978|NCT01744821|976904|P1|COMPLETED|Overall Study||1
398979|NCT01744821|976901|P4|STARTED|Overall Study||1
398980|NCT01744821|976902|P3|STARTED|Overall Study||2
398981|NCT01744821|976903|P2|STARTED|Overall Study||3
398982|NCT01744821|976904|P1|STARTED|Overall Study||1
398983|NCT01744782|976926|P1|NOT COMPLETED|Overall Study||1
398984|NCT01744782|976926|P1|COMPLETED|Overall Study||16
398985|NCT01744782|976926|P1|STARTED|Overall Study||17
398986|NCT01744730|976939|P5|NOT COMPLETED|Overall Study||0
398987|NCT01744730|976940|P4|NOT COMPLETED|Overall Study||0
398988|NCT01744730|976941|P3|NOT COMPLETED|Overall Study||0
398989|NCT01744730|976942|P2|NOT COMPLETED|Overall Study||0
398990|NCT01744730|976943|P1|NOT COMPLETED|Overall Study||0
398991|NCT01744730|976939|P5|COMPLETED|Overall Study|Please note this study (NCT01431326) is ongoing and data only represents a subset of this study.|178
398992|NCT01744730|976940|P4|COMPLETED|Overall Study||11
398993|NCT01744730|976941|P3|COMPLETED|Overall Study||4
398994|NCT01744730|976942|P2|COMPLETED|Overall Study||3
398995|NCT01744730|976943|P1|COMPLETED|Overall Study||4
398996|NCT01744730|976939|P5|STARTED|Overall Study|Please note this study (NCT01431326) is ongoing and data only represents a subset of this study.|178
398997|NCT01744730|976940|P4|STARTED|Overall Study||11
398998|NCT01744730|976941|P3|STARTED|Overall Study||4
398999|NCT01744730|976942|P2|STARTED|Overall Study||3
399000|NCT01744730|976943|P1|STARTED|Overall Study||4
399001|NCT01744691|976986|P1|NOT COMPLETED|Overall Study||43
399002|NCT01744691|976986|P1|COMPLETED|Overall Study|Participants who were on study treatment at the time of the primary analysis|101
399003|NCT01744691|976986|P1|STARTED|Overall Study|Participants who received study treatment|144
399004|NCT01744496|976993|P2|NOT COMPLETED|Maintenance Period||4
399005|NCT01744496|976994|P1|NOT COMPLETED|Maintenance Period||4
399006|NCT01744496|976993|P2|COMPLETED|Maintenance Period||29
399007|NCT01744496|976994|P1|COMPLETED|Maintenance Period||27
399008|NCT01744496|976993|P2|STARTED|Maintenance Period||33
399009|NCT01744496|976994|P1|STARTED|Maintenance Period||31
399010|NCT01744496|976993|P2|NOT COMPLETED|Titration Period||2
399011|NCT01744496|976994|P1|NOT COMPLETED|Titration Period||2
399012|NCT01744496|976993|P2|COMPLETED|Titration Period||33
399013|NCT01744496|976994|P1|COMPLETED|Titration Period||31
399014|NCT01744496|976993|P2|STARTED|Titration Period||35
399015|NCT01744496|976994|P1|STARTED|Titration Period||33
399016|NCT01744483|977015|P3|NOT COMPLETED|Overall Study||28
399017|NCT01744483|977016|P2|NOT COMPLETED|Overall Study||22
399018|NCT01744483|977017|P1|NOT COMPLETED|Overall Study||29
399019|NCT01744483|977015|P3|COMPLETED|Overall Study||10
399020|NCT01744483|977016|P2|COMPLETED|Overall Study||13
399021|NCT01744483|977017|P1|COMPLETED|Overall Study||15
399022|NCT01744483|977015|P3|STARTED|Overall Study||38
399023|NCT01744483|977016|P2|STARTED|Overall Study||35
399024|NCT01744483|977017|P1|STARTED|Overall Study||44
399025|NCT01744392|977025|P1|NOT COMPLETED|Overall Study||1
399026|NCT01744392|977025|P1|COMPLETED|Overall Study||22
399027|NCT01744392|977025|P1|STARTED|Overall Study||23
399028|NCT01744353|977041|P3|NOT COMPLETED|Overall Study||0
399029|NCT01744353|977042|P2|NOT COMPLETED|Overall Study||0
399030|NCT01744353|977043|P1|NOT COMPLETED|Overall Study||0
399031|NCT01744353|977041|P3|COMPLETED|Overall Study||3
399032|NCT01744353|977042|P2|COMPLETED|Overall Study||26
399033|NCT01744353|977043|P1|COMPLETED|Overall Study||6
399034|NCT01744353|977041|P3|STARTED|Overall Study||3
399035|NCT01744353|977042|P2|STARTED|Overall Study||26
399036|NCT01744353|977043|P1|STARTED|Overall Study||6
399037|NCT01744340|977054|P2|NOT COMPLETED|Overall Study||0
399038|NCT01744340|977055|P1|NOT COMPLETED|Overall Study||0
399039|NCT01744340|977054|P2|COMPLETED|Overall Study||15
399040|NCT01744340|977055|P1|COMPLETED|Overall Study||8
399041|NCT01744340|977054|P2|STARTED|Overall Study||15
399042|NCT01744340|977055|P1|STARTED|Overall Study||8
399043|NCT01744197|977065|P2|NOT COMPLETED|Overall Study||3
399044|NCT01744197|977066|P1|NOT COMPLETED|Overall Study||4
399045|NCT01744197|977065|P2|COMPLETED|Overall Study||26
399046|NCT01744197|977066|P1|COMPLETED|Overall Study||28
399047|NCT01744197|977065|P2|STARTED|Overall Study||29
399048|NCT01744197|977066|P1|STARTED|Overall Study||32
399049|NCT01743963|977078|P2|NOT COMPLETED|Overall Study||0
399050|NCT01743963|977079|P1|NOT COMPLETED|Overall Study||0
399051|NCT01743963|977078|P2|COMPLETED|Overall Study||17
399052|NCT01743963|977079|P1|COMPLETED|Overall Study||21
399053|NCT01743963|977078|P2|STARTED|Overall Study||17
399054|NCT01743963|977079|P1|STARTED|Overall Study||21
399055|NCT01743729|977087|P2|NOT COMPLETED|Overall Study||12
399056|NCT01743729|977088|P1|NOT COMPLETED|Overall Study||37
399057|NCT01743729|977087|P2|COMPLETED|Overall Study||348
399058|NCT01743729|977088|P1|COMPLETED|Overall Study||321
399059|NCT01743729|977087|P2|STARTED|Overall Study|One placebo participant was considered for Lifitegrast arm; Placebo safety analysis set (N= 359).|360
399060|NCT01743729|977088|P1|STARTED|Overall Study|One participant from placebo arm included in Lifitegrast arm for safety analysis set (N=359).|358
399061|NCT01743521|977100|P4|NOT COMPLETED|Overall Study||0
399062|NCT01743521|977101|P3|NOT COMPLETED|Overall Study||0
399063|NCT01743521|977102|P2|NOT COMPLETED|Overall Study||0
399064|NCT01743521|977103|P1|NOT COMPLETED|Overall Study||0
399065|NCT01743521|977100|P4|COMPLETED|Overall Study||2
399066|NCT01743521|977101|P3|COMPLETED|Overall Study||2
399067|NCT01743521|977102|P2|COMPLETED|Overall Study||3
399068|NCT01743521|977103|P1|COMPLETED|Overall Study||7
399069|NCT01743521|977100|P4|STARTED|Overall Study||2
399070|NCT01743521|977101|P3|STARTED|Overall Study||2
399071|NCT01743521|977102|P2|STARTED|Overall Study||3
399072|NCT01743521|977103|P1|STARTED|Overall Study||7
399073|NCT01743469|977157|P4|NOT COMPLETED|Follow-up Period - Post-Treatment||16
399074|NCT01743469|977158|P3|NOT COMPLETED|Follow-up Period - Post-Treatment||23
399075|NCT01743469|977159|P2|NOT COMPLETED|Follow-up Period - Post-Treatment||48
399076|NCT01743469|977160|P1|NOT COMPLETED|Follow-up Period - Post-Treatment||45
399077|NCT01743469|977157|P4|COMPLETED|Follow-up Period - Post-Treatment||5
399078|NCT01743469|977158|P3|COMPLETED|Follow-up Period - Post-Treatment||14
399079|NCT01743469|977159|P2|COMPLETED|Follow-up Period - Post-Treatment||5
399080|NCT01743469|977160|P1|COMPLETED|Follow-up Period - Post-Treatment||6
399081|NCT01743469|977157|P4|STARTED|Follow-up Period - Post-Treatment||21
399082|NCT01743469|977158|P3|STARTED|Follow-up Period - Post-Treatment||37
399083|NCT01743469|977159|P2|STARTED|Follow-up Period - Post-Treatment||53
399084|NCT01743469|977160|P1|STARTED|Follow-up Period - Post-Treatment||51
399085|NCT01743469|977157|P4|NOT COMPLETED|Active Treatment Phase||21
399086|NCT01743469|977158|P3|NOT COMPLETED|Active Treatment Phase||38
399087|NCT01743469|977159|P2|NOT COMPLETED|Active Treatment Phase||55
399088|NCT01743469|977160|P1|NOT COMPLETED|Active Treatment Phase||53
399089|NCT01743469|977157|P4|COMPLETED|Active Treatment Phase||0
399090|NCT01743469|977158|P3|COMPLETED|Active Treatment Phase||0
399091|NCT01743469|977159|P2|COMPLETED|Active Treatment Phase||0
399092|NCT01743469|977160|P1|COMPLETED|Active Treatment Phase||0
399093|NCT01743469|977157|P4|STARTED|Active Treatment Phase||21
399094|NCT01743469|977158|P3|STARTED|Active Treatment Phase||38
399095|NCT01743469|977159|P2|STARTED|Active Treatment Phase||55
399096|NCT01743469|977160|P1|STARTED|Active Treatment Phase||53
399097|NCT01743092|977200|P2|NOT COMPLETED|Overall Study||15
399098|NCT01743092|977201|P1|NOT COMPLETED|Overall Study||14
399099|NCT01743092|977200|P2|COMPLETED|Overall Study||11
399100|NCT01743092|977201|P1|COMPLETED|Overall Study||19
399101|NCT01743092|977200|P2|STARTED|Overall Study||26
399102|NCT01743092|977201|P1|STARTED|Overall Study||33
399103|NCT01743027|977213|P4|NOT COMPLETED|Overall Study||1
399104|NCT01743027|977214|P3|NOT COMPLETED|Overall Study||9
399105|NCT01743027|977215|P2|NOT COMPLETED|Overall Study||5
399106|NCT01743027|977216|P1|NOT COMPLETED|Overall Study||5
399107|NCT01743027|977213|P4|COMPLETED|Overall Study||48
399108|NCT01743027|977214|P3|COMPLETED|Overall Study||90
399109|NCT01743027|977215|P2|COMPLETED|Overall Study||94
399110|NCT01743027|977216|P1|COMPLETED|Overall Study||93
399111|NCT01743027|977213|P4|STARTED|Overall Study||49
399112|NCT01743027|977214|P3|STARTED|Overall Study||99
399113|NCT01743027|977215|P2|STARTED|Overall Study||99
399114|NCT01743027|977216|P1|STARTED|Overall Study||98
399115|NCT01743001|977256|P2|NOT COMPLETED|Overall Study||0
399116|NCT01743001|977257|P1|NOT COMPLETED|Overall Study||3
399117|NCT01743001|977256|P2|COMPLETED|Overall Study||112
399118|NCT01743001|977257|P1|COMPLETED|Overall Study||111
399119|NCT01743001|977256|P2|STARTED|Overall Study||112
399120|NCT01743001|977257|P1|STARTED|Overall Study||114
399121|NCT01742936|977271|P2|NOT COMPLETED|Overall Study||0
399122|NCT01742936|977272|P1|NOT COMPLETED|Overall Study||0
399123|NCT01742936|977271|P2|COMPLETED|Overall Study||50
399124|NCT01742936|977272|P1|COMPLETED|Overall Study||50
399125|NCT01742936|977271|P2|STARTED|Overall Study||50
399126|NCT01742936|977272|P1|STARTED|Overall Study||50
399127|NCT01742897|977280|P1|NOT COMPLETED|Overall Study||5
399128|NCT01742897|977280|P1|COMPLETED|Overall Study||30
399129|NCT01742897|977280|P1|Treated|Overall Study||33
399130|NCT01742897|977280|P1|STARTED|Overall Study||35
399131|NCT01742832|977286|P2|NOT COMPLETED|Overall Study||5
399132|NCT01742832|977287|P1|NOT COMPLETED|Overall Study||1
399133|NCT01742832|977286|P2|COMPLETED|Overall Study||23
399134|NCT01742832|977287|P1|COMPLETED|Overall Study||19
399135|NCT01742832|977286|P2|STARTED|Overall Study||28
399136|NCT01742832|977287|P1|STARTED|Overall Study||20
399137|NCT01742364|977297|P4|NOT COMPLETED|Overall Study||0
399138|NCT01742364|977298|P3|NOT COMPLETED|Overall Study||0
399139|NCT01742364|977299|P2|NOT COMPLETED|Overall Study||0
399140|NCT01742364|977300|P1|NOT COMPLETED|Overall Study||0
399141|NCT01742364|977297|P4|COMPLETED|Overall Study||15
399142|NCT01742364|977298|P3|COMPLETED|Overall Study||15
399143|NCT01742364|977299|P2|COMPLETED|Overall Study||33
399144|NCT01742364|977300|P1|COMPLETED|Overall Study||33
399145|NCT01742364|977297|P4|STARTED|Overall Study||15
399146|NCT01742364|977298|P3|STARTED|Overall Study||15
399147|NCT01742364|977299|P2|STARTED|Overall Study||33
399148|NCT01742364|977300|P1|STARTED|Overall Study||33
399149|NCT01741792|977329|P3|NOT COMPLETED|Overall Study||12
399150|NCT01741792|977330|P2|NOT COMPLETED|Overall Study||1
399151|NCT01741792|977331|P1|NOT COMPLETED|Overall Study||6
399152|NCT01741792|977329|P3|COMPLETED|Overall Study||2
399153|NCT01741792|977330|P2|COMPLETED|Overall Study||1
399154|NCT01741792|977331|P1|COMPLETED|Overall Study||3
399155|NCT01741792|977329|P3|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|13
399156|NCT01741792|977330|P2|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|1
399157|NCT01741792|977331|P1|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|7
399158|NCT01741792|977329|P3|STARTED|Overall Study||14
399159|NCT01741792|977330|P2|STARTED|Overall Study|Cohort 2 was closed to enrollment on recommendation of the data monitoring committee|2
399160|NCT01741792|977331|P1|STARTED|Overall Study|3 participants were not considered evaluable and were replaced as specified in the protocol.|9
399161|NCT01741701|977398|P2|NOT COMPLETED|Overall Study||2
399162|NCT01741701|977399|P1|NOT COMPLETED|Overall Study||5
399163|NCT01741701|977398|P2|COMPLETED|Overall Study||13
399164|NCT01741701|977399|P1|COMPLETED|Overall Study||13
399165|NCT01741701|977398|P2|STARTED|Overall Study||15
399166|NCT01741701|977399|P1|STARTED|Overall Study||18
399167|NCT01741688|977415|P1|NOT COMPLETED|Overall Study||3
399168|NCT01741688|977415|P1|COMPLETED|Overall Study||13
399169|NCT01741688|977415|P1|STARTED|Overall Study||16
399170|NCT01741350|977434|P2|NOT COMPLETED|12-Month Follow-up Assessment||2
399171|NCT01741350|977435|P1|NOT COMPLETED|12-Month Follow-up Assessment||3
399172|NCT01741350|977434|P2|COMPLETED|12-Month Follow-up Assessment||109
399173|NCT01741350|977435|P1|COMPLETED|12-Month Follow-up Assessment||111
399174|NCT01741350|977434|P2|STARTED|12-Month Follow-up Assessment||111
399175|NCT01741350|977435|P1|STARTED|12-Month Follow-up Assessment||114
399176|NCT01741350|977434|P2|NOT COMPLETED|6-Month Follow-up Assessment||8
399177|NCT01741350|977435|P1|NOT COMPLETED|6-Month Follow-up Assessment||15
399178|NCT01741350|977434|P2|COMPLETED|6-Month Follow-up Assessment||111
399179|NCT01741350|977435|P1|COMPLETED|6-Month Follow-up Assessment||114
399180|NCT01741350|977434|P2|STARTED|6-Month Follow-up Assessment||119
399181|NCT01741350|977435|P1|STARTED|6-Month Follow-up Assessment||129
399182|NCT01741350|977434|P2|NOT COMPLETED|3-Month Follow-up Assessment||22
399183|NCT01741350|977435|P1|NOT COMPLETED|3-Month Follow-up Assessment||6
399184|NCT01741350|977434|P2|COMPLETED|3-Month Follow-up Assessment||119
399185|NCT01741350|977435|P1|COMPLETED|3-Month Follow-up Assessment||129
399186|NCT01741350|977434|P2|STARTED|3-Month Follow-up Assessment||141
399187|NCT01741350|977435|P1|STARTED|3-Month Follow-up Assessment||135
399188|NCT01741350|977434|P2|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14
399189|NCT01741350|977435|P1|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14
399190|NCT01741350|977434|P2|COMPLETED|Post Intervention Assessment (at Week 4)||141
399191|NCT01741350|977435|P1|COMPLETED|Post Intervention Assessment (at Week 4)||135
399192|NCT01741350|977434|P2|STARTED|Post Intervention Assessment (at Week 4)||155
399193|NCT01741350|977435|P1|STARTED|Post Intervention Assessment (at Week 4)||149
399194|NCT01741350|977434|P2|NOT COMPLETED|Study Intervention||0
399195|NCT01741350|977435|P1|NOT COMPLETED|Study Intervention||0
399196|NCT01741350|977434|P2|COMPLETED|Study Intervention||155
399197|NCT01741350|977435|P1|COMPLETED|Study Intervention||149
399198|NCT01741350|977434|P2|STARTED|Study Intervention||155
399199|NCT01741350|977435|P1|STARTED|Study Intervention||149
399200|NCT01741272|977571|P2|NOT COMPLETED|Overall Study||0
399201|NCT01741272|977572|P1|NOT COMPLETED|Overall Study||0
399202|NCT01741272|977571|P2|COMPLETED|Overall Study||97
399203|NCT01741272|977572|P1|COMPLETED|Overall Study||92
399204|NCT01741272|977571|P2|STARTED|Overall Study||97
399205|NCT01741272|977572|P1|STARTED|Overall Study||92
399206|NCT01741259|977588|P2|NOT COMPLETED|Overall Study||6
399207|NCT01741259|977589|P1|NOT COMPLETED|Overall Study||6
399208|NCT01741259|977588|P2|COMPLETED|Overall Study||129
399209|NCT01741259|977589|P1|COMPLETED|Overall Study||127
399210|NCT01741259|977588|P2|STARTED|Overall Study||135
399211|NCT01741259|977589|P1|STARTED|Overall Study||133
399212|NCT01740817|977643|P2|NOT COMPLETED|Second Intervention (48 h)||0
399213|NCT01740817|977644|P1|NOT COMPLETED|Second Intervention (48 h)||0
399214|NCT01740817|977643|P2|COMPLETED|Second Intervention (48 h)||4
399215|NCT01740817|977644|P1|COMPLETED|Second Intervention (48 h)||8
399216|NCT01740817|977643|P2|STARTED|Second Intervention (48 h)||4
399217|NCT01740817|977644|P1|STARTED|Second Intervention (48 h)||8
399218|NCT01740817|977643|P2|NOT COMPLETED|Washout (4-6 Weeks)||0
399219|NCT01740817|977644|P1|NOT COMPLETED|Washout (4-6 Weeks)||0
399220|NCT01740817|977643|P2|COMPLETED|Washout (4-6 Weeks)||4
399221|NCT01740817|977644|P1|COMPLETED|Washout (4-6 Weeks)||8
399222|NCT01740817|977643|P2|STARTED|Washout (4-6 Weeks)||4
399223|NCT01740817|977644|P1|STARTED|Washout (4-6 Weeks)||8
399224|NCT01740817|977643|P2|NOT COMPLETED|First Intervention (48 h)||0
399225|NCT01740817|977644|P1|NOT COMPLETED|First Intervention (48 h)||0
399226|NCT01740817|977643|P2|COMPLETED|First Intervention (48 h)||4
399227|NCT01740817|977644|P1|COMPLETED|First Intervention (48 h)||8
399228|NCT01740817|977643|P2|STARTED|First Intervention (48 h)||4
399229|NCT01740817|977644|P1|STARTED|First Intervention (48 h)||8
399230|NCT01740726|977656|P2|NOT COMPLETED|Overall Study||0
399231|NCT01740726|977657|P1|NOT COMPLETED|Overall Study||0
399232|NCT01740726|977656|P2|COMPLETED|Overall Study||1
399233|NCT01740726|977657|P1|COMPLETED|Overall Study||0
399234|NCT01740726|977656|P2|STARTED|Overall Study||1
399235|NCT01740726|977657|P1|STARTED|Overall Study||0
399236|NCT01740713|977682|P3|NOT COMPLETED|Overall Study||1
399237|NCT01740713|977683|P2|NOT COMPLETED|Overall Study||2
399238|NCT01740713|977684|P1|NOT COMPLETED|Overall Study||0
399239|NCT01740713|977682|P3|COMPLETED|Overall Study||6
399240|NCT01740713|977683|P2|COMPLETED|Overall Study||6
399241|NCT01740713|977684|P1|COMPLETED|Overall Study||6
399242|NCT01740713|977682|P3|STARTED|Overall Study||7
399243|NCT01740713|977683|P2|STARTED|Overall Study||8
399244|NCT01740713|977684|P1|STARTED|Overall Study||6
399245|NCT01740440|977708|P1|NOT COMPLETED|Overall Study||3
399246|NCT01740440|977708|P1|COMPLETED|Overall Study||27
399247|NCT01740440|977708|P1|STARTED|Overall Study||30
399248|NCT01740427|977716|P2|NOT COMPLETED|Overall Study||222
399249|NCT01740427|977717|P1|NOT COMPLETED|Overall Study||444
399250|NCT01740427|977716|P2|COMPLETED|Overall Study||0
399251|NCT01740427|977717|P1|COMPLETED|Overall Study||0
399252|NCT01740427|977716|P2|STARTED|Overall Study||222
399253|NCT01740427|977717|P1|STARTED|Overall Study||444
399254|NCT01740414|977746|P2|NOT COMPLETED|Overall Study||8
399255|NCT01740414|977747|P1|NOT COMPLETED|Overall Study||9
399256|NCT01740414|977746|P2|COMPLETED|Overall Study||8
399257|NCT01740414|977747|P1|COMPLETED|Overall Study||3
399258|NCT01740414|977746|P2|STARTED|Overall Study||16
399259|NCT01740414|977747|P1|STARTED|Overall Study||12
399260|NCT01740401|977769|P1|NOT COMPLETED|Overall Study||10
399261|NCT01740401|977769|P1|COMPLETED|Overall Study||0
399262|NCT01740401|977769|P1|STARTED|Overall Study||10
399263|NCT01740388|977778|P2|NOT COMPLETED|Overall Study||44
399264|NCT01740388|977779|P1|NOT COMPLETED|Overall Study||46
399265|NCT01740388|977778|P2|COMPLETED|Overall Study||28
399266|NCT01740388|977779|P1|COMPLETED|Overall Study||18
399267|NCT01740388|977778|P2|STARTED|Overall Study||72
399268|NCT01740388|977779|P1|STARTED|Overall Study||64
399269|NCT01740362|977799|P4|NOT COMPLETED|Overall Study||0
399270|NCT01740362|977800|P3|NOT COMPLETED|Overall Study||0
399271|NCT01740362|977801|P2|NOT COMPLETED|Overall Study||0
399272|NCT01740362|977802|P1|NOT COMPLETED|Overall Study||0
399273|NCT01740362|977799|P4|COMPLETED|Overall Study||6
399274|NCT01740362|977800|P3|COMPLETED|Overall Study||6
399275|NCT01740362|977801|P2|COMPLETED|Overall Study||6
399276|NCT01740362|977802|P1|COMPLETED|Overall Study||6
399277|NCT01740362|977799|P4|STARTED|Overall Study||6
399278|NCT01740362|977800|P3|STARTED|Overall Study||6
399279|NCT01740362|977801|P2|STARTED|Overall Study||6
399280|NCT01740362|977802|P1|STARTED|Overall Study||6
399281|NCT01740297|977831|P3|NOT COMPLETED|Overall Study||98
399282|NCT01740297|977832|P2|NOT COMPLETED|Overall Study||100
399283|NCT01740297|977833|P1|NOT COMPLETED|Overall Study||19
399284|NCT01740297|977831|P3|COMPLETED|Overall Study||0
399285|NCT01740297|977832|P2|COMPLETED|Overall Study||0
399286|NCT01740297|977833|P1|COMPLETED|Overall Study||0
399287|NCT01740297|977831|P3|Received Ipilimumab|Overall Study||92
399288|NCT01740297|977832|P2|Received Ipilimumab|Overall Study||95
399289|NCT01740297|977833|P1|Received Ipilimumab|Overall Study||18
399290|NCT01740297|977831|P3|Received Talimogene Laherparepvec|Overall Study||95
399291|NCT01740297|977832|P2|Received Talimogene Laherparepvec|Overall Study||0
399292|NCT01740297|977833|P1|Received Talimogene Laherparepvec|Overall Study||19
399293|NCT01740297|977831|P3|STARTED|Overall Study||98
399294|NCT01740297|977832|P2|STARTED|Overall Study||100
399295|NCT01740297|977833|P1|STARTED|Overall Study||19
399296|NCT01740206|977865|P2|NOT COMPLETED|Overall Study||0
399297|NCT01740206|977866|P1|NOT COMPLETED|Overall Study||0
399298|NCT01740206|977865|P2|COMPLETED|Overall Study||34
399299|NCT01740206|977866|P1|COMPLETED|Overall Study||14
399300|NCT01740206|977865|P2|STARTED|Overall Study||34
399301|NCT01740206|977866|P1|STARTED|Overall Study||14
399302|NCT01740128|977884|P2|NOT COMPLETED|Overall Study||7
399303|NCT01740128|977885|P1|NOT COMPLETED|Overall Study||6
399304|NCT01740128|977884|P2|COMPLETED|Overall Study||4
399305|NCT01740128|977885|P1|COMPLETED|Overall Study||4
399306|NCT01740128|977884|P2|STARTED|Overall Study||11
399307|NCT01740128|977885|P1|STARTED|Overall Study||10
399308|NCT01740089|977914|P3|NOT COMPLETED|After 12 Weeks||11
399309|NCT01740089|977915|P2|NOT COMPLETED|After 12 Weeks||3
399310|NCT01740089|977916|P1|NOT COMPLETED|After 12 Weeks||7
399311|NCT01740089|977914|P3|COMPLETED|After 12 Weeks|"Withdrawn due to:~No EVR (n=4) AE (n=5) Non-attendance of visit (n=1) Withdrawn consent (n=1)"|37
399312|NCT01740089|977915|P2|COMPLETED|After 12 Weeks|"Withdrawn due to:~Withdrawn consent (n=1) No EVR (n=1) Non-compliance (n=1)"|45
399313|NCT01740089|977916|P1|COMPLETED|After 12 Weeks|"Withdrawn due to:~No EVR (n=3) AE (n=2) No EOT (n=1) Non-compliance (n=1)"|43
399314|NCT01740089|977914|P3|STARTED|After 12 Weeks||48
399315|NCT01740089|977915|P2|STARTED|After 12 Weeks||48
399316|NCT01740089|977916|P1|STARTED|After 12 Weeks||50
399317|NCT01740089|977914|P3|NOT COMPLETED|First 12 Weeks of Treatment||2
399318|NCT01740089|977915|P2|NOT COMPLETED|First 12 Weeks of Treatment||2
399319|NCT01740089|977916|P1|NOT COMPLETED|First 12 Weeks of Treatment||0
399320|NCT01740089|977914|P3|COMPLETED|First 12 Weeks of Treatment|"Withdrawn due to:~AE before W12 (n=2)"|48
399321|NCT01740089|977915|P2|COMPLETED|First 12 Weeks of Treatment|"Withdrawn due to:~AE before W12 (n=1) Withdrew consent before W12 (n=1)"|48
399322|NCT01740089|977916|P1|COMPLETED|First 12 Weeks of Treatment||50
399323|NCT01740089|977914|P3|STARTED|First 12 Weeks of Treatment||50
399324|NCT01740089|977915|P2|STARTED|First 12 Weeks of Treatment||50
399325|NCT01740089|977916|P1|STARTED|First 12 Weeks of Treatment||50
399326|NCT01739803|977934|P2|NOT COMPLETED|Overall Study||6
399327|NCT01739803|977935|P1|NOT COMPLETED|Overall Study||9
399328|NCT01739803|977934|P2|COMPLETED|Overall Study||68
399329|NCT01739803|977935|P1|COMPLETED|Overall Study||67
399330|NCT01739803|977934|P2|STARTED|Overall Study||74
399331|NCT01739803|977935|P1|STARTED|Overall Study||76
399332|NCT01739790|977947|P2|NOT COMPLETED|Overall Study||4
399333|NCT01739790|977948|P1|NOT COMPLETED|Overall Study||2
399334|NCT01739790|977947|P2|COMPLETED|Overall Study||23
399335|NCT01739790|977948|P1|COMPLETED|Overall Study||22
399336|NCT01739790|977947|P2|STARTED|Overall Study||27
399337|NCT01739790|977948|P1|STARTED|Overall Study||24
399338|NCT01739595|977957|P3|NOT COMPLETED|Overall Study||2
399339|NCT01739595|977958|P2|NOT COMPLETED|Overall Study||1
399340|NCT01739595|977959|P1|NOT COMPLETED|Overall Study||13
399341|NCT01739595|977957|P3|COMPLETED|Overall Study||45
399342|NCT01739595|977958|P2|COMPLETED|Overall Study||21
399343|NCT01739595|977959|P1|COMPLETED|Overall Study||99
399344|NCT01739595|977957|P3|STARTED|Overall Study||47
399345|NCT01739595|977958|P2|STARTED|Overall Study||22
399346|NCT01739595|977959|P1|STARTED|Overall Study||112
399347|NCT01739361|977969|P2|NOT COMPLETED|Overall Study||1
399348|NCT01739361|977970|P1|NOT COMPLETED|Overall Study||3
399349|NCT01739361|977969|P2|COMPLETED|Overall Study||22
399350|NCT01739361|977970|P1|COMPLETED|Overall Study||18
399351|NCT01739361|977969|P2|STARTED|Overall Study||23
399352|NCT01739361|977970|P1|STARTED|Overall Study||21
399353|NCT01739348|977984|P4|NOT COMPLETED|Part II (Extension Study)||396
399354|NCT01739348|977985|P3|NOT COMPLETED|Part II (Extension Study)||61
399355|NCT01739348|977986|P2|NOT COMPLETED|Part II (Extension Study)||366
399356|NCT01739348|977987|P1|NOT COMPLETED|Part II (Extension Study)||379
399357|NCT01739348|977984|P4|COMPLETED|Part II (Extension Study)||0
399358|NCT01739348|977985|P3|COMPLETED|Part II (Extension Study)||0
399359|NCT01739348|977986|P2|COMPLETED|Part II (Extension Study)||0
399360|NCT01739348|977987|P1|COMPLETED|Part II (Extension Study)||0
399361|NCT01739348|977984|P4|Treated|Part II (Extension Study)||394
399362|NCT01739348|977985|P3|Treated|Part II (Extension Study)||61
399363|NCT01739348|977986|P2|Treated|Part II (Extension Study)||365
399364|NCT01739348|977987|P1|Treated|Part II (Extension Study)||379
399365|NCT01739348|977984|P4|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|396
399366|NCT01739348|977985|P3|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|61
399367|NCT01739348|977986|P2|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|366
399368|NCT01739348|977987|P1|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|379
399369|NCT01739348|977984|P4|NOT COMPLETED|Part I (Base Study)||189
399370|NCT01739348|977985|P3|NOT COMPLETED|Part I (Base Study)||26
399371|NCT01739348|977986|P2|NOT COMPLETED|Part I (Base Study)||203
399372|NCT01739348|977987|P1|NOT COMPLETED|Part I (Base Study)||202
399373|NCT01739348|977984|P4|COMPLETED|Part I (Base Study)||516
399374|NCT01739348|977985|P3|COMPLETED|Part I (Base Study)||77
399375|NCT01739348|977986|P2|COMPLETED|Part I (Base Study)||497
399376|NCT01739348|977987|P1|COMPLETED|Part I (Base Study)||501
399377|NCT01739348|977984|P4|Treated|Part I (Base Study)||705
399378|NCT01739348|977985|P3|Treated|Part I (Base Study)||103
399379|NCT01739348|977986|P2|Treated|Part I (Base Study)||700
399380|NCT01739348|977987|P1|Treated|Part I (Base Study)||702
399381|NCT01739348|977984|P4|STARTED|Part I (Base Study)||705
399382|NCT01739348|977985|P3|STARTED|Part I (Base Study)||103
399383|NCT01739348|977986|P2|STARTED|Part I (Base Study)||700
399384|NCT01739348|977987|P1|STARTED|Part I (Base Study)||703
399385|NCT01739335|978059|P2|NOT COMPLETED|Overall Study||5
399386|NCT01739335|978060|P1|NOT COMPLETED|Overall Study||7
399387|NCT01739335|978059|P2|COMPLETED|Overall Study||35
399388|NCT01739335|978060|P1|COMPLETED|Overall Study||34
399389|NCT01739335|978059|P2|STARTED|Overall Study||40
399390|NCT01739335|978060|P1|STARTED|Overall Study||41
399391|NCT01738984|978094|P2|NOT COMPLETED|Overall Study||39
399392|NCT01738984|978095|P1|NOT COMPLETED|Overall Study||64
399393|NCT01738984|978094|P2|COMPLETED|Overall Study||210
399394|NCT01738984|978095|P1|COMPLETED|Overall Study||186
399395|NCT01738984|978094|P2|STARTED|Overall Study||249
399396|NCT01738984|978095|P1|STARTED|Overall Study||250
399397|NCT01738971|978108|P3|NOT COMPLETED|Overall Study||17
399398|NCT01738971|978109|P2|NOT COMPLETED|Overall Study||30
399399|NCT01738971|978110|P1|NOT COMPLETED|Overall Study||19
399400|NCT01738971|978108|P3|COMPLETED|Overall Study|39 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|39
399401|NCT01738971|978109|P2|COMPLETED|Overall Study|28 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|28
399402|NCT01738971|978110|P1|COMPLETED|Overall Study|35 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|35
399403|NCT01738971|978108|P3|STARTED|Overall Study|56 participants recruited to this arm|56
399404|NCT01738971|978109|P2|STARTED|Overall Study|58 participants recruited to this arm|58
399405|NCT01738971|978110|P1|STARTED|Overall Study|54 participants recruited to this arm|54
399406|NCT01738919|978126|P2|NOT COMPLETED|Overall Study||3
399407|NCT01738919|978127|P1|NOT COMPLETED|Overall Study||1
399408|NCT01738919|978126|P2|COMPLETED|Overall Study||14
399409|NCT01738919|978127|P1|COMPLETED|Overall Study||14
399410|NCT01738919|978126|P2|STARTED|Overall Study||17
399411|NCT01738919|978127|P1|STARTED|Overall Study||15
399412|NCT01738750|978145|P2|NOT COMPLETED|Overall Study||0
399413|NCT01738750|978146|P1|NOT COMPLETED|Overall Study||0
399414|NCT01738750|978145|P2|COMPLETED|Overall Study||51
399415|NCT01738750|978146|P1|COMPLETED|Overall Study||49
399416|NCT01738750|978145|P2|STARTED|Overall Study||51
399417|NCT01738750|978146|P1|STARTED|Overall Study||49
399418|NCT01738737|978159|P5|NOT COMPLETED|Overall Study||4
399419|NCT01738737|978160|P4|NOT COMPLETED|Overall Study||4
399420|NCT01738737|978161|P3|NOT COMPLETED|Overall Study||4
399421|NCT01738737|978162|P2|NOT COMPLETED|Overall Study||4
399422|NCT01738737|978163|P1|NOT COMPLETED|Overall Study||4
399423|NCT01738737|978159|P5|COMPLETED|Overall Study||25
399424|NCT01738737|978160|P4|COMPLETED|Overall Study||25
399425|NCT01738737|978161|P3|COMPLETED|Overall Study||25
399426|NCT01738737|978162|P2|COMPLETED|Overall Study||25
399427|NCT01738737|978163|P1|COMPLETED|Overall Study||25
399428|NCT01738737|978159|P5|STARTED|Overall Study||29
399429|NCT01738737|978160|P4|STARTED|Overall Study||29
399430|NCT01738737|978161|P3|STARTED|Overall Study||29
399431|NCT01738737|978162|P2|STARTED|Overall Study||29
399432|NCT01738737|978163|P1|STARTED|Overall Study||29
399433|NCT01738698|978199|P4|NOT COMPLETED|Overall Study||0
399434|NCT01738698|978200|P3|NOT COMPLETED|Overall Study||0
399435|NCT01738698|978201|P2|NOT COMPLETED|Overall Study||0
399436|NCT01738698|978202|P1|NOT COMPLETED|Overall Study||0
399437|NCT01738698|978199|P4|COMPLETED|Overall Study||0
399438|NCT01738698|978200|P3|COMPLETED|Overall Study||0
399439|NCT01738698|978201|P2|COMPLETED|Overall Study||0
399440|NCT01738698|978202|P1|COMPLETED|Overall Study||0
399441|NCT01738698|978199|P4|STARTED|Overall Study||0
399442|NCT01738698|978200|P3|STARTED|Overall Study||0
399443|NCT01738698|978201|P2|STARTED|Overall Study||0
399444|NCT01738698|978202|P1|STARTED|Overall Study||0
399445|NCT01738672|978268|P1|NOT COMPLETED|Overall Study||5
399446|NCT01738672|978268|P1|COMPLETED|Overall Study||11
399447|NCT01738672|978268|P1|STARTED|Overall Study||16
399448|NCT01738646|978277|P1|NOT COMPLETED|Overall Study||2
399449|NCT01738646|978277|P1|COMPLETED|Overall Study|Participants who discontinued study drug for any reason.|38
399450|NCT01738646|978277|P1|STARTED|Overall Study||40
399451|NCT01738581|978287|P2|NOT COMPLETED|Overall Study||0
399452|NCT01738581|978288|P1|NOT COMPLETED|Overall Study||1
399453|NCT01738581|978287|P2|COMPLETED|Overall Study||4
399454|NCT01738581|978288|P1|COMPLETED|Overall Study||4
399455|NCT01738581|978287|P2|STARTED|Overall Study||4
399456|NCT01738581|978288|P1|STARTED|Overall Study||5
399457|NCT01738503|978312|P7|NOT COMPLETED|PET Imaging Sub-study||1
399458|NCT01738503|978313|P6|NOT COMPLETED|PET Imaging Sub-study||2
399459|NCT01738503|978314|P5|NOT COMPLETED|PET Imaging Sub-study||0
399460|NCT01738503|978315|P4|NOT COMPLETED|PET Imaging Sub-study||0
399461|NCT01738503|978316|P3|NOT COMPLETED|PET Imaging Sub-study||0
399462|NCT01738503|978317|P2|NOT COMPLETED|PET Imaging Sub-study||0
399463|NCT01738503|978318|P1|NOT COMPLETED|PET Imaging Sub-study||0
399464|NCT01738503|978312|P7|COMPLETED|PET Imaging Sub-study|Completion defined as a total of 6 injections plus all PET images|1
399465|NCT01738503|978313|P6|COMPLETED|PET Imaging Sub-study|Completion defined as a total of 12 injections plus all PET images|1
399466|NCT01738503|978314|P5|COMPLETED|PET Imaging Sub-study||0
399467|NCT01738503|978315|P4|COMPLETED|PET Imaging Sub-study||0
399468|NCT01738503|978316|P3|COMPLETED|PET Imaging Sub-study||0
399469|NCT01738503|978317|P2|COMPLETED|PET Imaging Sub-study||0
399470|NCT01738503|978318|P1|COMPLETED|PET Imaging Sub-study||0
399471|NCT01738503|978312|P7|STARTED|PET Imaging Sub-study||2
399472|NCT01738503|978313|P6|STARTED|PET Imaging Sub-study||3
399473|NCT01738503|978314|P5|STARTED|PET Imaging Sub-study||0
399474|NCT01738503|978315|P4|STARTED|PET Imaging Sub-study||0
399475|NCT01738503|978316|P3|STARTED|PET Imaging Sub-study||0
399476|NCT01738503|978317|P2|STARTED|PET Imaging Sub-study||0
399477|NCT01738503|978318|P1|STARTED|PET Imaging Sub-study||0
399478|NCT01738503|978312|P7|NOT COMPLETED|Treatment Period||8
399479|NCT01738503|978313|P6|NOT COMPLETED|Treatment Period||6
399480|NCT01738503|978314|P5|NOT COMPLETED|Treatment Period||8
399481|NCT01738503|978315|P4|NOT COMPLETED|Treatment Period||6
399482|NCT01738503|978316|P3|NOT COMPLETED|Treatment Period||5
399483|NCT01738503|978317|P2|NOT COMPLETED|Treatment Period||5
399484|NCT01738503|978318|P1|NOT COMPLETED|Treatment Period||0
399485|NCT01738503|978312|P7|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|6
399486|NCT01738503|978313|P6|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|9
399487|NCT01738503|978314|P5|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|7
399488|NCT01738503|978315|P4|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|9
399489|NCT01738503|978316|P3|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|10
399490|NCT01738503|978317|P2|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|10
399491|NCT01738503|978318|P1|COMPLETED|Treatment Period||0
399492|NCT01738503|978312|P7|STARTED|Treatment Period||14
399493|NCT01738503|978313|P6|STARTED|Treatment Period||15
399494|NCT01738503|978314|P5|STARTED|Treatment Period||15
399495|NCT01738503|978315|P4|STARTED|Treatment Period||15
399496|NCT01738503|978316|P3|STARTED|Treatment Period||15
399497|NCT01738503|978317|P2|STARTED|Treatment Period||15
399498|NCT01738503|978318|P1|STARTED|Treatment Period||0
399499|NCT01738503|978312|P7|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
399500|NCT01738503|978313|P6|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
399501|NCT01738503|978314|P5|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
399502|NCT01738503|978315|P4|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
399503|NCT01738503|978316|P3|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
399504|NCT01738503|978317|P2|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
399505|NCT01738503|978318|P1|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||35
399506|NCT01738503|978312|P7|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
399507|NCT01738503|978313|P6|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
399508|NCT01738503|978314|P5|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
399509|NCT01738503|978315|P4|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
399510|NCT01738503|978316|P3|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
399511|NCT01738503|978317|P2|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
399512|NCT01738503|978318|P1|COMPLETED|Induction/Stabilization (Days -14 to -1)||89
399513|NCT01738503|978312|P7|STARTED|Induction/Stabilization (Days -14 to -1)||0
399514|NCT01738503|978313|P6|STARTED|Induction/Stabilization (Days -14 to -1)||0
399515|NCT01738503|978314|P5|STARTED|Induction/Stabilization (Days -14 to -1)||0
399516|NCT01738503|978315|P4|STARTED|Induction/Stabilization (Days -14 to -1)||0
399517|NCT01738503|978316|P3|STARTED|Induction/Stabilization (Days -14 to -1)||0
399518|NCT01738503|978317|P2|STARTED|Induction/Stabilization (Days -14 to -1)||0
399519|NCT01738503|978318|P1|STARTED|Induction/Stabilization (Days -14 to -1)||124
399520|NCT01738477|978516|P2|NOT COMPLETED|Overall Study||4
399521|NCT01738477|978517|P1|NOT COMPLETED|Overall Study||1
399522|NCT01738477|978516|P2|COMPLETED|Overall Study||124
399523|NCT01738477|978517|P1|COMPLETED|Overall Study||36
399524|NCT01738477|978516|P2|STARTED|Overall Study||128
399525|NCT01738477|978517|P1|STARTED|Overall Study||37
399526|NCT01738438|978545|P1|NOT COMPLETED|Overall Study||35
399527|NCT01738438|978545|P1|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
399528|NCT01738438|978545|P1|STARTED|Overall Study||35
399529|NCT01738321|978553|P2|NOT COMPLETED|Overall Study||0
399530|NCT01738321|978554|P1|NOT COMPLETED|Overall Study||0
399531|NCT01738321|978553|P2|COMPLETED|Overall Study||30
399532|NCT01738321|978554|P1|COMPLETED|Overall Study||33
399533|NCT01738321|978553|P2|STARTED|Overall Study||30
399534|NCT01738321|978554|P1|STARTED|Overall Study||33
399535|NCT01737996|978563|P3|NOT COMPLETED|Overall Study||2
399536|NCT01737996|978564|P2|NOT COMPLETED|Overall Study||1
399537|NCT01737996|978565|P1|NOT COMPLETED|Overall Study||0
399538|NCT01737996|978563|P3|COMPLETED|Overall Study|One patient withdrew consent after the first dose due to private reasons.|14
399539|NCT01737996|978564|P2|COMPLETED|Overall Study||7
399540|NCT01737996|978565|P1|COMPLETED|Overall Study||8
399541|NCT01737996|978563|P3|STARTED|Overall Study||16
399542|NCT01737996|978564|P2|STARTED|Overall Study||8
399543|NCT01737996|978565|P1|STARTED|Overall Study||8
399544|NCT01737944|978606|P4|NOT COMPLETED|Overall Study||0
399545|NCT01737944|978607|P3|NOT COMPLETED|Overall Study||0
399546|NCT01737944|978608|P2|NOT COMPLETED|Overall Study||0
399547|NCT01737944|978609|P1|NOT COMPLETED|Overall Study||0
399548|NCT01737944|978606|P4|COMPLETED|Overall Study||9
399549|NCT01737944|978607|P3|COMPLETED|Overall Study||9
399550|NCT01737944|978608|P2|COMPLETED|Overall Study||9
399551|NCT01737944|978609|P1|COMPLETED|Overall Study||9
399552|NCT01737944|978606|P4|STARTED|Overall Study|10 patients randomized, one patient discontinued before first study drug dose|9
399553|NCT01737944|978607|P3|STARTED|Overall Study|10 patients randomized, one patient discontinued before first study drug dose|9
399554|NCT01737944|978608|P2|STARTED|Overall Study||9
399555|NCT01737944|978609|P1|STARTED|Overall Study||9
399556|NCT01737931|978627|P3|NOT COMPLETED|Overall Study||1
399557|NCT01737931|978628|P2|NOT COMPLETED|Overall Study||2
399558|NCT01737931|978629|P1|NOT COMPLETED|Overall Study||0
399559|NCT01737931|978627|P3|COMPLETED|Overall Study||38
399560|NCT01737931|978628|P2|COMPLETED|Overall Study||38
399561|NCT01737931|978629|P1|COMPLETED|Overall Study||38
399562|NCT01737931|978627|P3|STARTED|Overall Study||39
399563|NCT01737931|978628|P2|STARTED|Overall Study||40
399564|NCT01737931|978629|P1|STARTED|Overall Study||38
399565|NCT01737879|978644|P1|NOT COMPLETED|Overall Study||41
399566|NCT01737879|978644|P1|COMPLETED|Overall Study||0
399567|NCT01737879|978644|P1|Transitioned to Epoetin Alfa|Overall Study||0
399568|NCT01737879|978644|P1|Received Peginesatide|Overall Study||34
399569|NCT01737879|978644|P1|STARTED|Overall Study||41
399570|NCT01737840|978653|P2|NOT COMPLETED|Overall Study||2
399571|NCT01737840|978654|P1|NOT COMPLETED|Overall Study||2
399572|NCT01737840|978653|P2|COMPLETED|Overall Study||33
399573|NCT01737840|978654|P1|COMPLETED|Overall Study||33
399574|NCT01737840|978653|P2|STARTED|Overall Study||35
399575|NCT01737840|978654|P1|STARTED|Overall Study||35
399576|NCT01737762|978664|P2|NOT COMPLETED|Overall Study||17
399577|NCT01737762|978665|P1|NOT COMPLETED|Overall Study||20
399578|NCT01737762|978664|P2|COMPLETED|Overall Study||61
399579|NCT01737762|978665|P1|COMPLETED|Overall Study||57
399580|NCT01737762|978664|P2|STARTED|Overall Study||78
399581|NCT01737762|978665|P1|STARTED|Overall Study||77
399582|NCT01737710|978678|P5|NOT COMPLETED|Overall Study||0
399583|NCT01737710|978679|P4|NOT COMPLETED|Overall Study||0
399584|NCT01737710|978680|P3|NOT COMPLETED|Overall Study||3
399585|NCT01737710|978681|P2|NOT COMPLETED|Overall Study||4
399586|NCT01737710|978682|P1|NOT COMPLETED|Overall Study||2
399587|NCT01737710|978678|P5|COMPLETED|Overall Study||21
399588|NCT01737710|978679|P4|COMPLETED|Overall Study||23
399589|NCT01737710|978680|P3|COMPLETED|Overall Study||102
399590|NCT01737710|978681|P2|COMPLETED|Overall Study||101
399591|NCT01737710|978682|P1|COMPLETED|Overall Study||112
399592|NCT01737710|978678|P5|STARTED|Overall Study||21
399593|NCT01737710|978679|P4|STARTED|Overall Study||23
399594|NCT01737710|978680|P3|STARTED|Overall Study||105
399595|NCT01737710|978681|P2|STARTED|Overall Study||105
399596|NCT01737710|978682|P1|STARTED|Overall Study||114
399597|NCT01737684|978721|P3|NOT COMPLETED|Overall Study||0
399598|NCT01737684|978722|P2|NOT COMPLETED|Overall Study||0
399599|NCT01737684|978723|P1|NOT COMPLETED|Overall Study||0
399600|NCT01737684|978721|P3|COMPLETED|Overall Study|Participants with mild hepatic insufficiency were not enrolled in study.|0
399601|NCT01737684|978722|P2|COMPLETED|Overall Study||8
399602|NCT01737684|978723|P1|COMPLETED|Overall Study||8
399603|NCT01737684|978721|P3|STARTED|Overall Study|Participants with mild hepatic insufficiency were not enrolled in study.|0
399604|NCT01737684|978722|P2|STARTED|Overall Study||8
399605|NCT01737684|978723|P1|STARTED|Overall Study||8
399606|NCT01737593|978742|P3|NOT COMPLETED|Overall Study||0
399607|NCT01737593|978743|P2|NOT COMPLETED|Overall Study||0
399608|NCT01737593|978744|P1|NOT COMPLETED|Overall Study||0
399609|NCT01737593|978742|P3|COMPLETED|Overall Study||39
399610|NCT01737593|978743|P2|COMPLETED|Overall Study||32
399611|NCT01737593|978744|P1|COMPLETED|Overall Study||37
399612|NCT01737593|978742|P3|STARTED|Overall Study||39
399613|NCT01737593|978743|P2|STARTED|Overall Study||32
399614|NCT01737593|978744|P1|STARTED|Overall Study||37
399615|NCT01737268|978773|P1|NOT COMPLETED|Overall Study||9
399616|NCT01737268|978773|P1|COMPLETED|Overall Study||11
399617|NCT01737268|978773|P1|Treated|Overall Study||20
399618|NCT01737268|978773|P1|STARTED|Overall Study||20
399619|NCT01737021|978787|P2|NOT COMPLETED|Overall Study||3
399620|NCT01737021|978788|P1|NOT COMPLETED|Overall Study||5
399621|NCT01737021|978787|P2|COMPLETED|Overall Study||6
399622|NCT01737021|978788|P1|COMPLETED|Overall Study||17
399623|NCT01737021|978787|P2|STARTED|Overall Study||9
399624|NCT01737021|978788|P1|STARTED|Overall Study||22
399625|NCT01736930|978794|P1|NOT COMPLETED|Overall Study||1
399626|NCT01736930|978794|P1|COMPLETED|Overall Study|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|19
399627|NCT01736930|978794|P1|STARTED|Overall Study|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|20
399628|NCT01736917|978834|P1|NOT COMPLETED|Overall Study||11
399629|NCT01736917|978834|P1|COMPLETED|Overall Study||54
399630|NCT01736917|978834|P1|STARTED|Overall Study||65
399631|NCT01736696|978848|P7|NOT COMPLETED|Overall Study||0
399632|NCT01736696|978849|P6|NOT COMPLETED|Overall Study||0
399633|NCT01736696|978850|P5|NOT COMPLETED|Overall Study||0
399634|NCT01736696|978851|P4|NOT COMPLETED|Overall Study||0
399635|NCT01736696|978852|P3|NOT COMPLETED|Overall Study||1
399636|NCT01736696|978853|P2|NOT COMPLETED|Overall Study||0
399637|NCT01736696|978854|P1|NOT COMPLETED|Overall Study||0
399638|NCT01736696|978848|P7|COMPLETED|Overall Study||13
399639|NCT01736696|978849|P6|COMPLETED|Overall Study||8
399640|NCT01736696|978850|P5|COMPLETED|Overall Study||9
399641|NCT01736696|978851|P4|COMPLETED|Overall Study||9
399642|NCT01736696|978852|P3|COMPLETED|Overall Study||9
399643|NCT01736696|978853|P2|COMPLETED|Overall Study||5
399644|NCT01736696|978854|P1|COMPLETED|Overall Study||5
399645|NCT01736696|978848|P7|STARTED|Overall Study||13
399646|NCT01736696|978849|P6|STARTED|Overall Study||8
399647|NCT01736696|978850|P5|STARTED|Overall Study||9
399648|NCT01736696|978851|P4|STARTED|Overall Study||9
399649|NCT01736696|978852|P3|STARTED|Overall Study||10
399650|NCT01736696|978853|P2|STARTED|Overall Study||5
399651|NCT01736696|978854|P1|STARTED|Overall Study||5
399652|NCT01736657|979171|P1|NOT COMPLETED|Overall Study||1
399653|NCT01736657|979171|P1|COMPLETED|Overall Study||72
399654|NCT01736657|979171|P1|STARTED|Overall Study||73
399655|NCT01736579|979180|P2|NOT COMPLETED|Overall Study||2
399656|NCT01736579|979181|P1|NOT COMPLETED|Overall Study||2
399657|NCT01736579|979180|P2|COMPLETED|Overall Study||0
399658|NCT01736579|979181|P1|COMPLETED|Overall Study||0
399659|NCT01736579|979180|P2|STARTED|Overall Study||2
399660|NCT01736579|979181|P1|STARTED|Overall Study||2
399661|NCT01736553|979217|P2|NOT COMPLETED|Overall Study||4
399662|NCT01736553|979218|P1|NOT COMPLETED|Overall Study||19
399663|NCT01736553|979217|P2|COMPLETED|Overall Study||23
399664|NCT01736553|979218|P1|COMPLETED|Overall Study||7
399665|NCT01736553|979217|P2|STARTED|Overall Study||27
399666|NCT01736553|979218|P1|STARTED|Overall Study||26
399667|NCT01736540|979269|P1|NOT COMPLETED|Overall Study||15
399668|NCT01736540|979269|P1|COMPLETED|Overall Study||228
399669|NCT01736540|979269|P1|STARTED|Overall Study||243
399670|NCT01736527|979326|P1|NOT COMPLETED|Overall Study||0
399671|NCT01736527|979326|P1|COMPLETED|Overall Study||12
399672|NCT01736527|979326|P1|STARTED|Overall Study||12
399673|NCT01736475|979335|P2|NOT COMPLETED|Overall Study||0
399674|NCT01736475|979336|P1|NOT COMPLETED|Overall Study||12
399675|NCT01736475|979335|P2|COMPLETED|Overall Study||17
399676|NCT01736475|979336|P1|COMPLETED|Overall Study||109
399677|NCT01736475|979335|P2|STARTED|Overall Study||17
399678|NCT01736475|979336|P1|STARTED|Overall Study||121
399679|NCT01736397|979391|P2|NOT COMPLETED|Overall Study||24
399680|NCT01736397|979392|P1|NOT COMPLETED|Overall Study||14
399681|NCT01736397|979391|P2|COMPLETED|Overall Study||50
399682|NCT01736397|979392|P1|COMPLETED|Overall Study||61
399683|NCT01736397|979391|P2|STARTED|Overall Study||74
399684|NCT01736397|979392|P1|STARTED|Overall Study||75
399685|NCT01736215|979404|P1|NOT COMPLETED|Overall Study||14
399686|NCT01736215|979404|P1|COMPLETED|Overall Study||19
399687|NCT01736215|979404|P1|Treated|Overall Study||25
399688|NCT01736215|979404|P1|STARTED|Overall Study||33
399689|NCT01736176|979416|P1|NOT COMPLETED|Overall Study||11
399690|NCT01736176|979416|P1|COMPLETED|Overall Study||28
399691|NCT01736176|979416|P1|Received LCIG|Overall Study||38
399692|NCT01736176|979416|P1|STARTED|Overall Study|Enrolled participants who underwent the PEG-J placement procedure|39
399693|NCT01735916|979463|P3|NOT COMPLETED|Overall Study||7
399694|NCT01735916|979464|P2|NOT COMPLETED|Overall Study||19
399695|NCT01735916|979465|P1|NOT COMPLETED|Overall Study||18
399696|NCT01735916|979463|P3|COMPLETED|Overall Study|Study was cancelled before any subjects completed 24 months of follow-up or met any study endpoints.|0
399697|NCT01735916|979464|P2|COMPLETED|Overall Study|Study was cancelled before any subjects completed 24 months of follow-up or met any study endpoints.|0
399698|NCT01735916|979465|P1|COMPLETED|Overall Study||0
399699|NCT01735916|979463|P3|STARTED|Overall Study||7
399700|NCT01735916|979464|P2|STARTED|Overall Study||19
399701|NCT01735916|979465|P1|STARTED|Overall Study||18
399702|NCT01735877|979486|P2|NOT COMPLETED|Overall Study||0
399703|NCT01735877|979487|P1|NOT COMPLETED|Overall Study||1
399704|NCT01735877|979486|P2|COMPLETED|Overall Study||21
399705|NCT01735877|979487|P1|COMPLETED|Overall Study||26
399706|NCT01735877|979486|P2|STARTED|Overall Study||21
399707|NCT01735877|979487|P1|STARTED|Overall Study||27
399708|NCT01735630|979503|P2|NOT COMPLETED|Overall Study||18
399709|NCT01735630|979504|P1|NOT COMPLETED|Overall Study||18
399710|NCT01735630|979503|P2|COMPLETED|Overall Study||157
399711|NCT01735630|979504|P1|COMPLETED|Overall Study||157
399712|NCT01735630|979503|P2|STARTED|Overall Study||175
399713|NCT01735630|979504|P1|STARTED|Overall Study||175
399714|NCT01735617|979518|P1|NOT COMPLETED|Overall Study||0
399715|NCT01735617|979518|P1|COMPLETED|Overall Study||16
399716|NCT01735617|979518|P1|STARTED|Overall Study||16
399717|NCT01735396|979531|P1|NOT COMPLETED|Overall Study||1
399718|NCT01735396|979531|P1|COMPLETED|Overall Study||10
399719|NCT01735396|979531|P1|STARTED|Overall Study||11
399720|NCT01735214|979540|P1|NOT COMPLETED|Overall Study||0
399721|NCT01735214|979540|P1|COMPLETED|Overall Study||358
399722|NCT01735214|979540|P1|STARTED|Overall Study||358
399723|NCT01735201|979560|P8|NOT COMPLETED|Overall Study||2
399724|NCT01735201|979561|P7|NOT COMPLETED|Overall Study||3
399725|NCT01735201|979562|P6|NOT COMPLETED|Overall Study||5
399726|NCT01735201|979563|P5|NOT COMPLETED|Overall Study||1
399727|NCT01735201|979564|P4|NOT COMPLETED|Overall Study||2
399728|NCT01735201|979565|P3|NOT COMPLETED|Overall Study||0
399729|NCT01735201|979566|P2|NOT COMPLETED|Overall Study||1
399730|NCT01735201|979567|P1|NOT COMPLETED|Overall Study||3
399731|NCT01735201|979560|P8|COMPLETED|Overall Study||42
399732|NCT01735201|979561|P7|COMPLETED|Overall Study||42
399733|NCT01735201|979562|P6|COMPLETED|Overall Study||40
399734|NCT01735201|979563|P5|COMPLETED|Overall Study||44
399735|NCT01735201|979564|P4|COMPLETED|Overall Study||42
399736|NCT01735201|979565|P3|COMPLETED|Overall Study||44
399737|NCT01735201|979566|P2|COMPLETED|Overall Study||43
399738|NCT01735201|979567|P1|COMPLETED|Overall Study||42
399739|NCT01735201|979560|P8|STARTED|Overall Study||44
399740|NCT01735201|979561|P7|STARTED|Overall Study||45
399741|NCT01735201|979562|P6|STARTED|Overall Study||45
399742|NCT01735201|979563|P5|STARTED|Overall Study||45
399743|NCT01735201|979564|P4|STARTED|Overall Study||44
399744|NCT01735201|979565|P3|STARTED|Overall Study||44
399745|NCT01735201|979566|P2|STARTED|Overall Study||44
399746|NCT01735201|979567|P1|STARTED|Overall Study||45
399747|NCT01735175|979603|P2|NOT COMPLETED|Overall Study||13
399748|NCT01735175|979604|P1|NOT COMPLETED|Overall Study||29
399749|NCT01735175|979603|P2|COMPLETED|Overall Study||144
399750|NCT01735175|979604|P1|COMPLETED|Overall Study||130
399751|NCT01735175|979603|P2|Completed the 6-month SFU Visit|Overall Study||138
399752|NCT01735175|979604|P1|Completed the 6-month SFU Visit|Overall Study||120
399753|NCT01735175|979603|P2|Completed All Treatments as Planned|Overall Study||150
399754|NCT01735175|979604|P1|Completed All Treatments as Planned|Overall Study||140
399755|NCT01735175|979603|P2|Completed All Cycles|Overall Study||150
399756|NCT01735175|979604|P1|Completed All Cycles|Overall Study||141
399757|NCT01735175|979603|P2|STARTED|Overall Study||157
399758|NCT01735175|979604|P1|STARTED|Overall Study||159
399759|NCT01734993|979624|P1|NOT COMPLETED|Overall Study||2
399760|NCT01734993|979624|P1|COMPLETED|Overall Study||9
399761|NCT01734993|979624|P1|STARTED|Overall Study||11
399762|NCT01734889|979650|P1|NOT COMPLETED|Overall Study||0
399763|NCT01734889|979650|P1|COMPLETED|Overall Study||18
399764|NCT01734889|979650|P1|STARTED|Overall Study||18
399765|NCT01734785|979661|P4|NOT COMPLETED|Double−Blind Period||0
399766|NCT01734785|979662|P3|NOT COMPLETED|Double−Blind Period||5
399767|NCT01734785|979663|P2|NOT COMPLETED|Double−Blind Period||9
399768|NCT01734785|979664|P1|NOT COMPLETED|Double−Blind Period||5
399769|NCT01734785|979661|P4|COMPLETED|Double−Blind Period||0
399770|NCT01734785|979662|P3|COMPLETED|Double−Blind Period||105
399771|NCT01734785|979663|P2|COMPLETED|Double−Blind Period||103
399772|NCT01734785|979664|P1|COMPLETED|Double−Blind Period||106
399773|NCT01734785|979661|P4|STARTED|Double−Blind Period||0
399774|NCT01734785|979662|P3|STARTED|Double−Blind Period||110
399775|NCT01734785|979663|P2|STARTED|Double−Blind Period||112
399776|NCT01734785|979664|P1|STARTED|Double−Blind Period||111
399777|NCT01734785|979661|P4|NOT COMPLETED|Open−Label Period||273
399778|NCT01734785|979662|P3|NOT COMPLETED|Open−Label Period||0
399779|NCT01734785|979663|P2|NOT COMPLETED|Open−Label Period||0
399780|NCT01734785|979664|P1|NOT COMPLETED|Open−Label Period||0
399781|NCT01734785|979661|P4|COMPLETED|Open−Label Period||333
399782|NCT01734785|979662|P3|COMPLETED|Open−Label Period||0
399783|NCT01734785|979663|P2|COMPLETED|Open−Label Period||0
399784|NCT01734785|979664|P1|COMPLETED|Open−Label Period||0
399785|NCT01734785|979661|P4|STARTED|Open−Label Period||606
399786|NCT01734785|979662|P3|STARTED|Open−Label Period||0
399787|NCT01734785|979663|P2|STARTED|Open−Label Period||0
399788|NCT01734785|979664|P1|STARTED|Open−Label Period||0
399789|NCT01734772|979681|P2|NOT COMPLETED|Overall Study||3
399790|NCT01734772|979682|P1|NOT COMPLETED|Overall Study||1
399791|NCT01734772|979681|P2|COMPLETED|Overall Study||21
399792|NCT01734772|979682|P1|COMPLETED|Overall Study||23
399793|NCT01734772|979681|P2|STARTED|Overall Study||24
399794|NCT01734772|979682|P1|STARTED|Overall Study||24
399795|NCT01734655|979699|P1|NOT COMPLETED|Overall Study||0
399796|NCT01734655|979699|P1|COMPLETED|Overall Study||40
399797|NCT01734655|979699|P1|STARTED|Overall Study||40
399798|NCT01734551|979710|P2|NOT COMPLETED|Overall Study||0
399799|NCT01734551|979711|P1|NOT COMPLETED|Overall Study||0
399800|NCT01734551|979710|P2|COMPLETED|Overall Study||16
399801|NCT01734551|979711|P1|COMPLETED|Overall Study||15
399802|NCT01734551|979710|P2|STARTED|Overall Study||16
399803|NCT01734551|979711|P1|STARTED|Overall Study||15
399804|NCT01734395|979723|P1|NOT COMPLETED|Overall Study||410
399805|NCT01734395|979723|P1|COMPLETED|Overall Study||1472
399806|NCT01734395|979723|P1|STARTED|Overall Study||1882
399807|NCT01734317|979729|P1|NOT COMPLETED|Overall Study||0
399808|NCT01734317|979729|P1|COMPLETED|Overall Study||10
399809|NCT01734317|979729|P1|STARTED|Overall Study||10
399810|NCT01734239|979735|P2|NOT COMPLETED|Overall Study||0
399811|NCT01734239|979736|P1|NOT COMPLETED|Overall Study||0
399812|NCT01734239|979735|P2|COMPLETED|Overall Study||50
399813|NCT01734239|979736|P1|COMPLETED|Overall Study||52
399814|NCT01734239|979735|P2|STARTED|Overall Study||50
399815|NCT01734239|979736|P1|STARTED|Overall Study||52
399816|NCT01734161|979751|P2|NOT COMPLETED|Overall Study||8
399817|NCT01734161|979752|P1|NOT COMPLETED|Overall Study||6
399818|NCT01734161|979751|P2|COMPLETED|Overall Study||53
399819|NCT01734161|979752|P1|COMPLETED|Overall Study||55
399820|NCT01734161|979751|P2|STARTED|Overall Study||61
399821|NCT01734161|979752|P1|STARTED|Overall Study||61
399822|NCT01733953|979760|P2|NOT COMPLETED|Overall Study||7
399823|NCT01733953|979761|P1|NOT COMPLETED|Overall Study||5
399824|NCT01733953|979760|P2|COMPLETED|Overall Study||6
399825|NCT01733953|979761|P1|COMPLETED|Overall Study||9
399826|NCT01733953|979760|P2|STARTED|Overall Study||13
399827|NCT01733953|979761|P1|STARTED|Overall Study||14
399828|NCT01733758|979781|P4|NOT COMPLETED|Overall Study||8
399829|NCT01733758|979782|P3|NOT COMPLETED|Overall Study||15
399830|NCT01733758|979783|P2|NOT COMPLETED|Overall Study||12
399831|NCT01733758|979784|P1|NOT COMPLETED|Overall Study||15
399832|NCT01733758|979781|P4|COMPLETED|Overall Study||95
399833|NCT01733758|979782|P3|COMPLETED|Overall Study||135
399834|NCT01733758|979783|P2|COMPLETED|Overall Study||148
399835|NCT01733758|979784|P1|COMPLETED|Overall Study||62
399836|NCT01733758|979781|P4|STARTED|Overall Study||103
399837|NCT01733758|979782|P3|STARTED|Overall Study||150
399838|NCT01733758|979783|P2|STARTED|Overall Study||160
399839|NCT01733758|979784|P1|STARTED|Overall Study||77
399852|NCT01733368|979885|P1|NOT COMPLETED|Overall Study||31
399853|NCT01733368|979885|P1|COMPLETED|Overall Study||167
399854|NCT01733368|979885|P1|STARTED|Overall Study||198
399855|NCT01733329|979895|P2|NOT COMPLETED|Overall Study||1
399856|NCT01733329|979896|P1|NOT COMPLETED|Overall Study||2
399857|NCT01733329|979895|P2|COMPLETED|Overall Study||60
399858|NCT01733329|979896|P1|COMPLETED|Overall Study||60
399859|NCT01733329|979895|P2|STARTED|Overall Study||61
399860|NCT01733329|979896|P1|STARTED|Overall Study||62
399861|NCT01733316|979908|P1|NOT COMPLETED|Overall Study||2
399862|NCT01733316|979908|P1|COMPLETED|Overall Study||39
399863|NCT01733316|979908|P1|STARTED|Overall Study||41
399864|NCT01733277|979932|P2|NOT COMPLETED|Overall Study||0
399865|NCT01733277|979933|P1|NOT COMPLETED|Overall Study||0
399866|NCT01733277|979932|P2|COMPLETED|Overall Study||25
399867|NCT01733277|979933|P1|COMPLETED|Overall Study||25
399868|NCT01733277|979932|P2|STARTED|Overall Study||25
399869|NCT01733277|979933|P1|STARTED|Overall Study||25
399870|NCT01733212|979945|P2|NOT COMPLETED|Overall Study||0
399871|NCT01733212|979946|P1|NOT COMPLETED|Overall Study||0
399872|NCT01733212|979945|P2|COMPLETED|Overall Study||123
399873|NCT01733212|979946|P1|COMPLETED|Overall Study||116
399874|NCT01733212|979945|P2|STARTED|Overall Study||123
399875|NCT01733212|979946|P1|STARTED|Overall Study||116
399876|NCT01733121|979954|P2|NOT COMPLETED|Follow-Up Period (Week 6 to 8)||0
399877|NCT01733121|979955|P1|NOT COMPLETED|Follow-Up Period (Week 6 to 8)||0
399878|NCT01733121|979954|P2|COMPLETED|Follow-Up Period (Week 6 to 8)||46
399879|NCT01733121|979955|P1|COMPLETED|Follow-Up Period (Week 6 to 8)||44
399880|NCT01733121|979954|P2|STARTED|Follow-Up Period (Week 6 to 8)||46
399881|NCT01733121|979955|P1|STARTED|Follow-Up Period (Week 6 to 8)||44
399882|NCT01733121|979954|P2|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||5
399883|NCT01733121|979955|P1|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||7
399884|NCT01733121|979954|P2|COMPLETED|Double-Blind Period (Week 0 to 6)||46
399885|NCT01733121|979955|P1|COMPLETED|Double-Blind Period (Week 0 to 6)||44
399886|NCT01733121|979954|P2|STARTED|Double-Blind Period (Week 0 to 6)||51
399887|NCT01733121|979955|P1|STARTED|Double-Blind Period (Week 0 to 6)||51
399888|NCT01733069|979969|P2|NOT COMPLETED|Overall Study||0
399889|NCT01733069|979970|P1|NOT COMPLETED|Overall Study||0
399890|NCT01733069|979969|P2|COMPLETED|Overall Study||1598
399891|NCT01733069|979970|P1|COMPLETED|Overall Study||264
399892|NCT01733069|979969|P2|STARTED|Overall Study||1598
399893|NCT01733069|979970|P1|STARTED|Overall Study||264
399894|NCT01733056|979979|P3|NOT COMPLETED|Overall Study||0
399895|NCT01733056|979980|P2|NOT COMPLETED|Overall Study||0
399896|NCT01733056|979981|P1|NOT COMPLETED|Overall Study||0
399897|NCT01733056|979979|P3|COMPLETED|Overall Study||12
399898|NCT01733056|979980|P2|COMPLETED|Overall Study||10
399899|NCT01733056|979981|P1|COMPLETED|Overall Study||21
399900|NCT01733056|979979|P3|STARTED|Overall Study||12
399901|NCT01733056|979980|P2|STARTED|Overall Study||10
399902|NCT01733056|979981|P1|STARTED|Overall Study||21
399903|NCT01732926|979997|P2|NOT COMPLETED|Overall Study||110
399904|NCT01732926|979998|P1|NOT COMPLETED|Overall Study||267
399905|NCT01732926|979997|P2|COMPLETED|Overall Study||45
399906|NCT01732926|979998|P1|COMPLETED|Overall Study||53
399907|NCT01732926|979997|P2|STARTED|Overall Study||155
399908|NCT01732926|979998|P1|STARTED|Overall Study||320
399909|NCT01732913|980014|P2|NOT COMPLETED|Overall Study||69
399910|NCT01732913|980015|P1|NOT COMPLETED|Overall Study||156
399911|NCT01732913|980014|P2|COMPLETED|Overall Study||28
399912|NCT01732913|980015|P1|COMPLETED|Overall Study||42
399913|NCT01732913|980014|P2|STARTED|Overall Study||97
399914|NCT01732913|980015|P1|STARTED|Overall Study||198
399915|NCT01732835|980029|P1|NOT COMPLETED|2-year Extended Follow-up||5
399916|NCT01732835|980029|P1|COMPLETED|2-year Extended Follow-up||39
399917|NCT01732835|980029|P1|STARTED|2-year Extended Follow-up||44
399918|NCT01732835|980029|P1|NOT COMPLETED|6-month Primary Endpoint||24
399919|NCT01732835|980029|P1|COMPLETED|6-month Primary Endpoint||44
399920|NCT01732835|980029|P1|STARTED|6-month Primary Endpoint||68
399921|NCT01732822|980062|P2|NOT COMPLETED|Overall Study||113
399922|NCT01732822|980063|P1|NOT COMPLETED|Overall Study||123
399923|NCT01732822|980062|P2|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the PACD|6842
399924|NCT01732822|980063|P1|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the PACD|6807
399925|NCT01732822|980062|P2|STARTED|Overall Study||6955
399926|NCT01732822|980063|P1|STARTED|Overall Study||6930
399927|NCT01732796|980136|P3|NOT COMPLETED|Overall Study||13
399928|NCT01732796|980137|P2|NOT COMPLETED|Overall Study||42
399929|NCT01732796|980138|P1|NOT COMPLETED|Overall Study||46
399930|NCT01732796|980136|P3|COMPLETED|Overall Study||38
399931|NCT01732796|980137|P2|COMPLETED|Overall Study||169
399932|NCT01732796|980138|P1|COMPLETED|Overall Study||162
399933|NCT01732796|980136|P3|STARTED|Overall Study||51
399934|NCT01732796|980137|P2|STARTED|Overall Study||211
399935|NCT01732796|980138|P1|STARTED|Overall Study||208
399936|NCT01732770|980156|P2|NOT COMPLETED|Overall Study||8
399937|NCT01732770|980157|P1|NOT COMPLETED|Overall Study||10
399938|NCT01732770|980156|P2|COMPLETED|Overall Study||313
399939|NCT01732770|980157|P1|COMPLETED|Overall Study||312
399940|NCT01732770|980156|P2|Received Study Treatment|Overall Study||320
399941|NCT01732770|980157|P1|Received Study Treatment|Overall Study||320
399942|NCT01732770|980156|P2|STARTED|Overall Study||321
399943|NCT01732770|980157|P1|STARTED|Overall Study||322
399944|NCT01732757|980172|P3|NOT COMPLETED|Overall Study||0
399945|NCT01732757|980173|P2|NOT COMPLETED|Overall Study||0
399946|NCT01732757|980174|P1|NOT COMPLETED|Overall Study||1
399947|NCT01732757|980172|P3|COMPLETED|Overall Study||52
399948|NCT01732757|980173|P2|COMPLETED|Overall Study||52
399949|NCT01732757|980174|P1|COMPLETED|Overall Study||52
399950|NCT01732757|980172|P3|STARTED|Overall Study||52
399951|NCT01732757|980173|P2|STARTED|Overall Study||52
399952|NCT01732757|980174|P1|STARTED|Overall Study||53
399953|NCT01732692|980214|P2|NOT COMPLETED|Overall Study||1
399954|NCT01732692|980215|P1|NOT COMPLETED|Overall Study||0
399955|NCT01732692|980214|P2|COMPLETED|Overall Study||69
399956|NCT01732692|980215|P1|COMPLETED|Overall Study||70
399957|NCT01732692|980214|P2|STARTED|Overall Study||70
399958|NCT01732692|980215|P1|STARTED|Overall Study||70
399959|NCT01732588|980232|P3|NOT COMPLETED|Third Intervention (7 Days)||0
399960|NCT01732588|980233|P2|NOT COMPLETED|Third Intervention (7 Days)||0
399961|NCT01732588|980234|P1|NOT COMPLETED|Third Intervention (7 Days)||0
399962|NCT01732588|980232|P3|COMPLETED|Third Intervention (7 Days)||4
399963|NCT01732588|980233|P2|COMPLETED|Third Intervention (7 Days)||2
399964|NCT01732588|980234|P1|COMPLETED|Third Intervention (7 Days)||4
399965|NCT01732588|980232|P3|STARTED|Third Intervention (7 Days)||4
399966|NCT01732588|980233|P2|STARTED|Third Intervention (7 Days)||2
399967|NCT01732588|980234|P1|STARTED|Third Intervention (7 Days)||4
399968|NCT01732588|980232|P3|NOT COMPLETED|Second Intervention (7 Days)||0
399969|NCT01732588|980233|P2|NOT COMPLETED|Second Intervention (7 Days)||0
399970|NCT01732588|980234|P1|NOT COMPLETED|Second Intervention (7 Days)||0
399971|NCT01732588|980232|P3|COMPLETED|Second Intervention (7 Days)||4
399972|NCT01732588|980233|P2|COMPLETED|Second Intervention (7 Days)||2
399973|NCT01732588|980234|P1|COMPLETED|Second Intervention (7 Days)||4
399974|NCT01732588|980232|P3|STARTED|Second Intervention (7 Days)||4
399975|NCT01732588|980233|P2|STARTED|Second Intervention (7 Days)||2
399976|NCT01732588|980234|P1|STARTED|Second Intervention (7 Days)||4
399977|NCT01732588|980232|P3|NOT COMPLETED|First Intervention (7 Days)||0
399978|NCT01732588|980233|P2|NOT COMPLETED|First Intervention (7 Days)||1
399979|NCT01732588|980234|P1|NOT COMPLETED|First Intervention (7 Days)||0
399980|NCT01732588|980232|P3|COMPLETED|First Intervention (7 Days)||4
399981|NCT01732588|980233|P2|COMPLETED|First Intervention (7 Days)||2
399982|NCT01732588|980234|P1|COMPLETED|First Intervention (7 Days)||4
399983|NCT01732588|980232|P3|STARTED|First Intervention (7 Days)||4
399984|NCT01732588|980233|P2|STARTED|First Intervention (7 Days)||3
399985|NCT01732588|980234|P1|STARTED|First Intervention (7 Days)||4
399986|NCT01732549|980250|P2|NOT COMPLETED|Overall Study||73
399987|NCT01732549|980251|P1|NOT COMPLETED|Overall Study||71
399988|NCT01732549|980250|P2|COMPLETED|Overall Study||0
399989|NCT01732549|980251|P1|COMPLETED|Overall Study||0
399990|NCT01732549|980250|P2|Withdrawn During Treatment:Final Analysi|Overall Study||73
399991|NCT01732549|980251|P1|Withdrawn During Treatment:Final Analysi|Overall Study||71
399992|NCT01732549|980250|P2|Ongoing Treatment Period:Final Analysis|Overall Study||0
399993|NCT01732549|980251|P1|Ongoing Treatment Period:Final Analysis|Overall Study||0
399994|NCT01732549|980250|P2|Withdrawn During Treatment:Data Cut-off|Overall Study|Withdrawn during treatment period 61 (AE 3, Consent withdrawn 6, Disease progression 46, Other 6)|61
399995|NCT01732549|980251|P1|Withdrawn During Treatment:Data Cut-off|Overall Study|Withdrawn during treatment period 59 (AE 13, Consent withdrawn 13, Disease progression 31, Other 2)|59
399996|NCT01732549|980250|P2|Ongoing in Treatment Period:Data Cut-off|Overall Study||12
399997|NCT01732549|980251|P1|Ongoing in Treatment Period:Data Cut-off|Overall Study||12
399998|NCT01732549|980250|P2|STARTED|Overall Study||73
399999|NCT01732549|980251|P1|STARTED|Overall Study||71
400000|NCT01732510|980278|P7|NOT COMPLETED|Overall Study||8
400001|NCT01732510|980279|P6|NOT COMPLETED|Overall Study||13
400002|NCT01732510|980280|P5|NOT COMPLETED|Overall Study||5
400003|NCT01732510|980281|P4|NOT COMPLETED|Overall Study||5
400004|NCT01732510|980282|P3|NOT COMPLETED|Overall Study||4
400005|NCT01732510|980283|P2|NOT COMPLETED|Overall Study||5
400006|NCT01732510|980284|P1|NOT COMPLETED|Overall Study||1
400007|NCT01732510|980278|P7|COMPLETED|Overall Study||0
400008|NCT01732510|980279|P6|COMPLETED|Overall Study||0
400009|NCT01732510|980280|P5|COMPLETED|Overall Study||3
400010|NCT01732510|980281|P4|COMPLETED|Overall Study||5
400011|NCT01732510|980282|P3|COMPLETED|Overall Study||4
400012|NCT01732510|980283|P2|COMPLETED|Overall Study||4
400013|NCT01732510|980284|P1|COMPLETED|Overall Study||8
400014|NCT01732510|980278|P7|STARTED|Overall Study||8
400015|NCT01732510|980279|P6|STARTED|Overall Study||13
400016|NCT01732510|980280|P5|STARTED|Overall Study||8
400017|NCT01732510|980281|P4|STARTED|Overall Study||10
400018|NCT01732510|980282|P3|STARTED|Overall Study||8
400019|NCT01732510|980283|P2|STARTED|Overall Study||9
400020|NCT01732510|980284|P1|STARTED|Overall Study||9
400021|NCT01732484|980363|P1|NOT COMPLETED|Overall Study||26
400022|NCT01732484|980363|P1|COMPLETED|Overall Study||74
400023|NCT01732484|980363|P1|Allocation|Overall Study||100
400024|NCT01732484|980363|P1|Randomized|Overall Study|Randomized implantation SN60WF IOL in on eye and iMics NY-60 in the other eye.|100
400025|NCT01732484|980363|P1|STARTED|Overall Study||100
400026|NCT01732471|980371|P1|NOT COMPLETED|Overall Study||1
400027|NCT01732471|980371|P1|COMPLETED|Overall Study||89
400028|NCT01732471|980371|P1|STARTED|Overall Study||90
400029|NCT01732458|980382|P4|NOT COMPLETED|Overall Study||2
400030|NCT01732458|980383|P3|NOT COMPLETED|Overall Study||3
400031|NCT01732458|980384|P2|NOT COMPLETED|Overall Study||5
400032|NCT01732458|980385|P1|NOT COMPLETED|Overall Study||3
400033|NCT01732458|980382|P4|COMPLETED|Overall Study||50
400034|NCT01732458|980383|P3|COMPLETED|Overall Study||55
400035|NCT01732458|980384|P2|COMPLETED|Overall Study||53
400036|NCT01732458|980385|P1|COMPLETED|Overall Study||57
400037|NCT01732458|980382|P4|Treated|Overall Study||52
400038|NCT01732458|980383|P3|Treated|Overall Study||56
400039|NCT01732458|980384|P2|Treated|Overall Study||55
400040|NCT01732458|980385|P1|Treated|Overall Study||57
400041|NCT01732458|980382|P4|STARTED|Overall Study||52
400042|NCT01732458|980383|P3|STARTED|Overall Study||58
400043|NCT01732458|980384|P2|STARTED|Overall Study||58
400044|NCT01732458|980385|P1|STARTED|Overall Study||60
400045|NCT01732445|980447|P1|NOT COMPLETED|Overall Study||0
400046|NCT01732445|980447|P1|COMPLETED|Overall Study||14
400047|NCT01732445|980447|P1|STARTED|Overall Study||14
400048|NCT01732263|980456|P2|NOT COMPLETED|Overall Study||0
400049|NCT01732263|980457|P1|NOT COMPLETED|Overall Study||0
400050|NCT01732263|980456|P2|COMPLETED|Overall Study||20
400051|NCT01732263|980457|P1|COMPLETED|Overall Study||23
400052|NCT01732263|980456|P2|STARTED|Overall Study||20
400053|NCT01732263|980457|P1|STARTED|Overall Study||23
400054|NCT01731990|980499|P2|NOT COMPLETED|Overall Study||8
400055|NCT01731990|980500|P1|NOT COMPLETED|Overall Study||4
400056|NCT01731990|980499|P2|COMPLETED|Overall Study||12
400057|NCT01731990|980500|P1|COMPLETED|Overall Study||14
400058|NCT01731990|980499|P2|STARTED|Overall Study||20
400059|NCT01731990|980500|P1|STARTED|Overall Study|"Started indicates Safety and Pharmacodynamics set ."|18
400060|NCT01731938|980516|P2|NOT COMPLETED|Primary Part II||13
400061|NCT01731938|980517|P1|NOT COMPLETED|Primary Part II||13
400062|NCT01731938|980516|P2|COMPLETED|Primary Part II||95
400063|NCT01731938|980517|P1|COMPLETED|Primary Part II||103
400064|NCT01731938|980516|P2|STARTED|Primary Part II|Subjects from Preliminary Part I were not carried over to Primary Part II to assess safety/efficacy.|108
400065|NCT01731938|980517|P1|STARTED|Primary Part II|Preliminary Part I was for study team familiarization with FS Grifols application.|116
400066|NCT01731938|980516|P2|NOT COMPLETED|Preliminary Part I||8
400067|NCT01731938|980517|P1|NOT COMPLETED|Preliminary Part I||3
400068|NCT01731938|980516|P2|COMPLETED|Preliminary Part I||44
400069|NCT01731938|980517|P1|COMPLETED|Preliminary Part I||48
400070|NCT01731938|980516|P2|STARTED|Preliminary Part I||52
400071|NCT01731938|980517|P1|STARTED|Preliminary Part I||51
400072|NCT01731470|980529|P1|NOT COMPLETED|Overall Study||2
400073|NCT01731470|980529|P1|COMPLETED|Overall Study|Number of patients enrolled in the study|14
400074|NCT01731470|980529|P1|STARTED|Overall Study|Number of patients consented to participate in the study|16
400075|NCT01731119|980534|P1|NOT COMPLETED|Overall Study||2
400076|NCT01731119|980534|P1|COMPLETED|Overall Study||7
400077|NCT01731119|980534|P1|STARTED|Overall Study||9
400078|NCT01731041|980544|P2|NOT COMPLETED|Overall Study||0
400079|NCT01731041|980545|P1|NOT COMPLETED|Overall Study||0
400080|NCT01731041|980544|P2|COMPLETED|Overall Study||30
400081|NCT01731041|980545|P1|COMPLETED|Overall Study||30
400082|NCT01731041|980544|P2|STARTED|Overall Study||30
400083|NCT01731041|980545|P1|STARTED|Overall Study||30
400084|NCT01731002|980556|P3|NOT COMPLETED|Overall Study||3
400085|NCT01731002|980557|P2|NOT COMPLETED|Overall Study||4
400086|NCT01731002|980558|P1|NOT COMPLETED|Overall Study||4
400087|NCT01731002|980556|P3|COMPLETED|Overall Study||74
400088|NCT01731002|980557|P2|COMPLETED|Overall Study||68
400089|NCT01731002|980558|P1|COMPLETED|Overall Study||71
400090|NCT01731002|980556|P3|STARTED|Overall Study||77
400091|NCT01731002|980557|P2|STARTED|Overall Study||72
400092|NCT01731002|980558|P1|STARTED|Overall Study||75
400093|NCT01730846|980572|P3|NOT COMPLETED|Overall Study||0
400094|NCT01730846|980573|P2|NOT COMPLETED|Overall Study||0
400095|NCT01730846|980574|P1|NOT COMPLETED|Overall Study||0
400096|NCT01730846|980572|P3|COMPLETED|Overall Study||13
400097|NCT01730846|980573|P2|COMPLETED|Overall Study||11
400098|NCT01730846|980574|P1|COMPLETED|Overall Study||11
400099|NCT01730846|980572|P3|STARTED|Overall Study||13
400100|NCT01730846|980573|P2|STARTED|Overall Study||11
400101|NCT01730846|980574|P1|STARTED|Overall Study||11
400102|NCT01730378|980587|P2|NOT COMPLETED|Overall Study||0
400103|NCT01730378|980588|P1|NOT COMPLETED|Overall Study||1
400104|NCT01730378|980587|P2|COMPLETED|Overall Study||47
400105|NCT01730378|980588|P1|COMPLETED|Overall Study||83
400106|NCT01730378|980587|P2|STARTED|Overall Study||47
400107|NCT01730378|980588|P1|STARTED|Overall Study||84
400108|NCT01730339|980619|P2|NOT COMPLETED|Overall Study||3
400109|NCT01730339|980620|P1|NOT COMPLETED|Overall Study||5
400110|NCT01730339|980619|P2|COMPLETED|Overall Study||52
400111|NCT01730339|980620|P1|COMPLETED|Overall Study||40
400112|NCT01730339|980619|P2|STARTED|Overall Study||55
400113|NCT01730339|980620|P1|STARTED|Overall Study||45
400114|NCT01730053|980660|P6|NOT COMPLETED|Overall Study||13
400115|NCT01730053|980661|P5|NOT COMPLETED|Overall Study||9
400116|NCT01730053|980662|P4|NOT COMPLETED|Overall Study||8
400117|NCT01730053|980663|P3|NOT COMPLETED|Overall Study||11
400118|NCT01730053|980664|P2|NOT COMPLETED|Overall Study||14
400119|NCT01730053|980665|P1|NOT COMPLETED|Overall Study||5
400120|NCT01730053|980660|P6|COMPLETED|Overall Study||41
400121|NCT01730053|980661|P5|COMPLETED|Overall Study||44
400122|NCT01730053|980662|P4|COMPLETED|Overall Study||45
400123|NCT01730053|980663|P3|COMPLETED|Overall Study||38
400124|NCT01730053|980664|P2|COMPLETED|Overall Study||34
400125|NCT01730053|980665|P1|COMPLETED|Overall Study||43
400126|NCT01730053|980660|P6|Treated|Overall Study||54
400127|NCT01730053|980661|P5|Treated|Overall Study||53
400128|NCT01730053|980662|P4|Treated|Overall Study||53
400129|NCT01730053|980663|P3|Treated|Overall Study||49
400130|NCT01730053|980664|P2|Treated|Overall Study||48
400131|NCT01730053|980665|P1|Treated|Overall Study||48
400132|NCT01730053|980660|P6|STARTED|Overall Study||54
400133|NCT01730053|980661|P5|STARTED|Overall Study||53
400134|NCT01730053|980662|P4|STARTED|Overall Study||53
400135|NCT01730053|980663|P3|STARTED|Overall Study||49
400136|NCT01730053|980664|P2|STARTED|Overall Study||48
400137|NCT01730053|980665|P1|STARTED|Overall Study||48
400138|NCT01730040|980824|P7|NOT COMPLETED|Overall Study||9
400139|NCT01730040|980825|P6|NOT COMPLETED|Overall Study||7
400140|NCT01730040|980826|P5|NOT COMPLETED|Overall Study||6
400141|NCT01730040|980827|P4|NOT COMPLETED|Overall Study||8
400142|NCT01730040|980828|P3|NOT COMPLETED|Overall Study||11
400143|NCT01730040|980829|P2|NOT COMPLETED|Overall Study||15
400144|NCT01730040|980830|P1|NOT COMPLETED|Overall Study||13
400145|NCT01730040|980824|P7|COMPLETED|Overall Study||38
400146|NCT01730040|980825|P6|COMPLETED|Overall Study||40
400147|NCT01730040|980826|P5|COMPLETED|Overall Study||39
400148|NCT01730040|980827|P4|COMPLETED|Overall Study||39
400149|NCT01730040|980828|P3|COMPLETED|Overall Study||46
400150|NCT01730040|980829|P2|COMPLETED|Overall Study||40
400151|NCT01730040|980830|P1|COMPLETED|Overall Study||44
400152|NCT01730040|980824|P7|Treated|Overall Study||47
400153|NCT01730040|980825|P6|Treated|Overall Study||46
400154|NCT01730040|980826|P5|Treated|Overall Study||45
400155|NCT01730040|980827|P4|Treated|Overall Study||47
400156|NCT01730040|980828|P3|Treated|Overall Study||57
400157|NCT01730040|980829|P2|Treated|Overall Study||55
400158|NCT01730040|980830|P1|Treated|Overall Study||57
400159|NCT01730040|980824|P7|STARTED|Overall Study||47
400160|NCT01730040|980825|P6|STARTED|Overall Study||47
400161|NCT01730040|980826|P5|STARTED|Overall Study||45
400162|NCT01730040|980827|P4|STARTED|Overall Study||47
400163|NCT01730040|980828|P3|STARTED|Overall Study||57
400164|NCT01730040|980829|P2|STARTED|Overall Study||55
400165|NCT01730040|980830|P1|STARTED|Overall Study||57
400166|NCT01729923|981007|P1|NOT COMPLETED|Overall Study||27
400167|NCT01729923|981007|P1|COMPLETED|Overall Study||0
400168|NCT01729923|981007|P1|STARTED|Overall Study||27
400169|NCT01729871|981019|P2|NOT COMPLETED|Overall Study||23
400170|NCT01729871|981020|P1|NOT COMPLETED|Overall Study||12
400171|NCT01729871|981019|P2|COMPLETED|Overall Study||101
400172|NCT01729871|981020|P1|COMPLETED|Overall Study||112
400173|NCT01729871|981019|P2|STARTED|Overall Study||124
400174|NCT01729871|981020|P1|STARTED|Overall Study||124
400175|NCT01729845|981039|P3|NOT COMPLETED|Efficacy of Dec/MEC||0
400176|NCT01729845|981040|P2|NOT COMPLETED|Efficacy of Dec/MEC||0
400177|NCT01729845|981041|P1|NOT COMPLETED|Efficacy of Dec/MEC||0
400178|NCT01729845|981039|P3|COMPLETED|Efficacy of Dec/MEC||0
400179|NCT01729845|981040|P2|COMPLETED|Efficacy of Dec/MEC||22
400180|NCT01729845|981041|P1|COMPLETED|Efficacy of Dec/MEC||0
400181|NCT01729845|981039|P3|STARTED|Efficacy of Dec/MEC||0
400182|NCT01729845|981040|P2|STARTED|Efficacy of Dec/MEC||22
400183|NCT01729845|981041|P1|STARTED|Efficacy of Dec/MEC||0
400184|NCT01729845|981039|P3|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
400185|NCT01729845|981040|P2|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
400186|NCT01729845|981041|P1|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
400187|NCT01729845|981039|P3|COMPLETED|Safety/Tolerability of Dec/MEC||12
400188|NCT01729845|981040|P2|COMPLETED|Safety/Tolerability of Dec/MEC||34
400189|NCT01729845|981041|P1|COMPLETED|Safety/Tolerability of Dec/MEC||6
400190|NCT01729845|981039|P3|STARTED|Safety/Tolerability of Dec/MEC||12
400191|NCT01729845|981040|P2|STARTED|Safety/Tolerability of Dec/MEC||34
400192|NCT01729845|981041|P1|STARTED|Safety/Tolerability of Dec/MEC||6
400193|NCT01729754|981056|P10|NOT COMPLETED|Part 3||7
400194|NCT01729754|981057|P9|NOT COMPLETED|Part 3||1
400195|NCT01729754|981058|P8|NOT COMPLETED|Part 3||3
400196|NCT01729754|981059|P7|NOT COMPLETED|Part 3||0
400197|NCT01729754|981060|P6|NOT COMPLETED|Part 3||13
400198|NCT01729754|981061|P5|NOT COMPLETED|Part 3||4
400199|NCT01729754|981062|P4|NOT COMPLETED|Part 3||0
400200|NCT01729754|981063|P3|NOT COMPLETED|Part 3||5
400201|NCT01729754|981064|P2|NOT COMPLETED|Part 3||5
400202|NCT01729754|981065|P1|NOT COMPLETED|Part 3||0
400203|NCT01729754|981056|P10|COMPLETED|Part 3||114
400204|NCT01729754|981057|P9|COMPLETED|Part 3||65
400205|NCT01729754|981058|P8|COMPLETED|Part 3||66
400206|NCT01729754|981059|P7|COMPLETED|Part 3||0
400207|NCT01729754|981060|P6|COMPLETED|Part 3||224
400208|NCT01729754|981061|P5|COMPLETED|Part 3||17
400209|NCT01729754|981062|P4|COMPLETED|Part 3||0
400210|NCT01729754|981063|P3|COMPLETED|Part 3||105
400211|NCT01729754|981064|P2|COMPLETED|Part 3||165
400212|NCT01729754|981065|P1|COMPLETED|Part 3||0
400213|NCT01729754|981056|P10|STARTED|Part 3|156 participants completed Part 2 but did not enter Part 3|121
400214|NCT01729754|981057|P9|STARTED|Part 3||66
400215|NCT01729754|981058|P8|STARTED|Part 3||69
400216|NCT01729754|981059|P7|STARTED|Part 3||0
400217|NCT01729754|981060|P6|STARTED|Part 3|31 participants completed Part 2 but did not enter Part 3|237
400218|NCT01729754|981061|P5|STARTED|Part 3||21
400219|NCT01729754|981062|P4|STARTED|Part 3||0
400220|NCT01729754|981063|P3|STARTED|Part 3||110
400221|NCT01729754|981064|P2|STARTED|Part 3|14 participants completed Part 2 but did not enter Part 3|170
400222|NCT01729754|981065|P1|STARTED|Part 3||0
400223|NCT01729754|981056|P10|NOT COMPLETED|Part 2||12
400224|NCT01729754|981057|P9|NOT COMPLETED|Part 2||4
400225|NCT01729754|981058|P8|NOT COMPLETED|Part 2||3
400226|NCT01729754|981059|P7|NOT COMPLETED|Part 2||0
400227|NCT01729754|981060|P6|NOT COMPLETED|Part 2||0
400228|NCT01729754|981061|P5|NOT COMPLETED|Part 2||0
400229|NCT01729754|981062|P4|NOT COMPLETED|Part 2||5
400230|NCT01729754|981063|P3|NOT COMPLETED|Part 2||0
400231|NCT01729754|981064|P2|NOT COMPLETED|Part 2||0
400232|NCT01729754|981065|P1|NOT COMPLETED|Part 2||6
400233|NCT01729754|981056|P10|COMPLETED|Part 2||277
400234|NCT01729754|981057|P9|COMPLETED|Part 2||66
400235|NCT01729754|981058|P8|COMPLETED|Part 2||69
400236|NCT01729754|981059|P7|COMPLETED|Part 2||0
400237|NCT01729754|981060|P6|COMPLETED|Part 2||268
400238|NCT01729754|981061|P5|COMPLETED|Part 2||21
400239|NCT01729754|981062|P4|COMPLETED|Part 2||0
400240|NCT01729754|981063|P3|COMPLETED|Part 2||110
400241|NCT01729754|981064|P2|COMPLETED|Part 2||184
400242|NCT01729754|981065|P1|COMPLETED|Part 2||0
400243|NCT01729754|981056|P10|STARTED|Part 2||289
400244|NCT01729754|981057|P9|STARTED|Part 2||70
400245|NCT01729754|981058|P8|STARTED|Part 2||72
400246|NCT01729754|981059|P7|STARTED|Part 2||0
400247|NCT01729754|981060|P6|STARTED|Part 2||268
400248|NCT01729754|981061|P5|STARTED|Part 2||21
400249|NCT01729754|981062|P4|STARTED|Part 2|1 participant completed Part 1 but did not enter Part 2|5
400250|NCT01729754|981063|P3|STARTED|Part 2||110
400251|NCT01729754|981064|P2|STARTED|Part 2||184
400252|NCT01729754|981065|P1|STARTED|Part 2||6
400253|NCT01729754|981056|P10|NOT COMPLETED|Part 1||24
400254|NCT01729754|981057|P9|NOT COMPLETED|Part 1||0
400255|NCT01729754|981058|P8|NOT COMPLETED|Part 1||0
400256|NCT01729754|981059|P7|NOT COMPLETED|Part 1||14
400257|NCT01729754|981060|P6|NOT COMPLETED|Part 1||0
400258|NCT01729754|981061|P5|NOT COMPLETED|Part 1||0
400259|NCT01729754|981062|P4|NOT COMPLETED|Part 1||12
400260|NCT01729754|981063|P3|NOT COMPLETED|Part 1||0
400261|NCT01729754|981064|P2|NOT COMPLETED|Part 1||0
400262|NCT01729754|981065|P1|NOT COMPLETED|Part 1||14
400263|NCT01729754|981056|P10|COMPLETED|Part 1||289
400264|NCT01729754|981057|P9|COMPLETED|Part 1||70
400265|NCT01729754|981058|P8|COMPLETED|Part 1||72
400266|NCT01729754|981059|P7|COMPLETED|Part 1||0
400267|NCT01729754|981060|P6|COMPLETED|Part 1||268
400268|NCT01729754|981061|P5|COMPLETED|Part 1||21
400269|NCT01729754|981062|P4|COMPLETED|Part 1||6
400270|NCT01729754|981063|P3|COMPLETED|Part 1||110
400271|NCT01729754|981064|P2|COMPLETED|Part 1||184
400272|NCT01729754|981065|P1|COMPLETED|Part 1||6
400273|NCT01729754|981056|P10|STARTED|Part 1||313
400274|NCT01729754|981057|P9|STARTED|Part 1||70
400275|NCT01729754|981058|P8|STARTED|Part 1||72
400276|NCT01729754|981059|P7|STARTED|Part 1||14
400277|NCT01729754|981060|P6|STARTED|Part 1||268
400278|NCT01729754|981061|P5|STARTED|Part 1||21
400279|NCT01729754|981062|P4|STARTED|Part 1||18
400280|NCT01729754|981063|P3|STARTED|Part 1||110
400281|NCT01729754|981064|P2|STARTED|Part 1||184
400282|NCT01729754|981065|P1|STARTED|Part 1||20
400283|NCT01729728|981272|P3|NOT COMPLETED|Overall Study||1
400284|NCT01729728|981273|P2|NOT COMPLETED|Overall Study||6
400285|NCT01729728|981274|P1|NOT COMPLETED|Overall Study||1
400286|NCT01729728|981272|P3|COMPLETED|Overall Study||16
400287|NCT01729728|981273|P2|COMPLETED|Overall Study||22
400288|NCT01729728|981274|P1|COMPLETED|Overall Study||20
400289|NCT01729728|981272|P3|STARTED|Overall Study||17
400290|NCT01729728|981273|P2|STARTED|Overall Study||28
400291|NCT01729728|981274|P1|STARTED|Overall Study||21
400292|NCT01729559|981407|P2|NOT COMPLETED|Overall Study||28
400293|NCT01729559|981408|P1|NOT COMPLETED|Overall Study||31
400294|NCT01729559|981407|P2|COMPLETED|Overall Study||216
400295|NCT01729559|981408|P1|COMPLETED|Overall Study||220
400296|NCT01729559|981407|P2|STARTED|Overall Study||244
400297|NCT01729559|981408|P1|STARTED|Overall Study||251
400298|NCT01729338|981420|P1|NOT COMPLETED|Overall Study||2
400299|NCT01729338|981420|P1|COMPLETED|Overall Study||14
400300|NCT01729338|981420|P1|STARTED|Overall Study||16
400301|NCT01729247|981435|P1|NOT COMPLETED|Overall Study||0
400302|NCT01729247|981435|P1|COMPLETED|Overall Study||50
400303|NCT01729247|981435|P1|STARTED|Overall Study||50
400304|NCT01729026|981451|P2|NOT COMPLETED|3-month to 6-month (Final) Follow-up||2
400305|NCT01729026|981452|P1|NOT COMPLETED|3-month to 6-month (Final) Follow-up||1
400306|NCT01729026|981451|P2|COMPLETED|3-month to 6-month (Final) Follow-up||6
400307|NCT01729026|981452|P1|COMPLETED|3-month to 6-month (Final) Follow-up||6
400308|NCT01729026|981451|P2|STARTED|3-month to 6-month (Final) Follow-up||8
400309|NCT01729026|981452|P1|STARTED|3-month to 6-month (Final) Follow-up||7
400310|NCT01729026|981451|P2|NOT COMPLETED|Randomization to 3-month Follow-up||2
400311|NCT01729026|981452|P1|NOT COMPLETED|Randomization to 3-month Follow-up||2
400312|NCT01729026|981451|P2|COMPLETED|Randomization to 3-month Follow-up||8
400313|NCT01729026|981452|P1|COMPLETED|Randomization to 3-month Follow-up||7
400314|NCT01729026|981451|P2|STARTED|Randomization to 3-month Follow-up||10
400315|NCT01729026|981452|P1|STARTED|Randomization to 3-month Follow-up||9
400316|NCT01728792|981463|P5|NOT COMPLETED|Overall Study||0
400317|NCT01728792|981464|P4|NOT COMPLETED|Overall Study||3
400318|NCT01728792|981465|P3|NOT COMPLETED|Overall Study||4
400319|NCT01728792|981466|P2|NOT COMPLETED|Overall Study||2
400320|NCT01728792|981467|P1|NOT COMPLETED|Overall Study||3
400321|NCT01728792|981463|P5|COMPLETED|Overall Study||16
400322|NCT01728792|981464|P4|COMPLETED|Overall Study||14
400323|NCT01728792|981465|P3|COMPLETED|Overall Study||13
400324|NCT01728792|981466|P2|COMPLETED|Overall Study||14
400325|NCT01728792|981467|P1|COMPLETED|Overall Study||11
400326|NCT01728792|981463|P5|STARTED|Overall Study||16
400327|NCT01728792|981464|P4|STARTED|Overall Study||17
400328|NCT01728792|981465|P3|STARTED|Overall Study||17
400329|NCT01728792|981466|P2|STARTED|Overall Study||16
400330|NCT01728792|981467|P1|STARTED|Overall Study||14
400331|NCT01728584|981518|P4|NOT COMPLETED|Overall Study||1
400332|NCT01728584|981519|P3|NOT COMPLETED|Overall Study||1
400333|NCT01728584|981520|P2|NOT COMPLETED|Overall Study||0
400334|NCT01728584|981521|P1|NOT COMPLETED|Overall Study||8
400335|NCT01728584|981518|P4|COMPLETED|Overall Study||29
400336|NCT01728584|981519|P3|COMPLETED|Overall Study||30
400337|NCT01728584|981520|P2|COMPLETED|Overall Study||30
400338|NCT01728584|981521|P1|COMPLETED|Overall Study||28
400339|NCT01728584|981518|P4|STARTED|Overall Study|Randomized - NMB/pressure conditions were changed in 5 (all to Deep/Std)|30
400340|NCT01728584|981519|P3|STARTED|Overall Study|Randomized|31
400341|NCT01728584|981520|P2|STARTED|Overall Study|Randomized - NMB/pressure conditions were changed in 7 (2 to Std/Std, 4 to Deep/Std, 1 to Deep/Low)|30
400342|NCT01728584|981521|P1|STARTED|Overall Study|Randomized|36
400343|NCT01728376|981579|P6|NOT COMPLETED|Overall Study||2
400344|NCT01728376|981580|P5|NOT COMPLETED|Overall Study||2
400345|NCT01728376|981581|P4|NOT COMPLETED|Overall Study||2
400346|NCT01728376|981582|P3|NOT COMPLETED|Overall Study||2
400347|NCT01728376|981583|P2|NOT COMPLETED|Overall Study||2
400348|NCT01728376|981584|P1|NOT COMPLETED|Overall Study||4
400349|NCT01728376|981579|P6|COMPLETED|Overall Study||5
400350|NCT01728376|981580|P5|COMPLETED|Overall Study||12
400351|NCT01728376|981581|P4|COMPLETED|Overall Study||7
400352|NCT01728376|981582|P3|COMPLETED|Overall Study||17
400353|NCT01728376|981583|P2|COMPLETED|Overall Study||9
400354|NCT01728376|981584|P1|COMPLETED|Overall Study||18
400355|NCT01728376|981579|P6|Treated|Overall Study||7
400356|NCT01728376|981580|P5|Treated|Overall Study||14
400357|NCT01728376|981581|P4|Treated|Overall Study||9
400358|NCT01728376|981582|P3|Treated|Overall Study||19
400359|NCT01728376|981583|P2|Treated|Overall Study||10
400360|NCT01728376|981584|P1|Treated|Overall Study||22
400361|NCT01728376|981579|P6|STARTED|Overall Study||7
400362|NCT01728376|981580|P5|STARTED|Overall Study||14
400363|NCT01728376|981581|P4|STARTED|Overall Study||9
400364|NCT01728376|981582|P3|STARTED|Overall Study||19
400365|NCT01728376|981583|P2|STARTED|Overall Study||11
400366|NCT01728376|981584|P1|STARTED|Overall Study||22
400367|NCT01728337|981646|P1|NOT COMPLETED|Overall Study||0
400368|NCT01728337|981646|P1|COMPLETED|Overall Study||80
400369|NCT01728337|981646|P1|STARTED|Overall Study||80
400370|NCT01728324|981657|P3|NOT COMPLETED|Termination of RBV||15
400371|NCT01728324|981658|P2|NOT COMPLETED|Termination of RBV||37
400372|NCT01728324|981659|P1|NOT COMPLETED|Termination of RBV||39
400373|NCT01728324|981657|P3|COMPLETED|Termination of RBV||57
400374|NCT01728324|981658|P2|COMPLETED|Termination of RBV||176
400375|NCT01728324|981659|P1|COMPLETED|Termination of RBV||172
400376|NCT01728324|981657|P3|STARTED|Termination of RBV||72
400377|NCT01728324|981658|P2|STARTED|Termination of RBV||213
400378|NCT01728324|981659|P1|STARTED|Termination of RBV||211
400379|NCT01728324|981657|P3|NOT COMPLETED|Termination of FDV||14
400380|NCT01728324|981658|P2|NOT COMPLETED|Termination of FDV||36
400381|NCT01728324|981659|P1|NOT COMPLETED|Termination of FDV||38
400382|NCT01728324|981657|P3|COMPLETED|Termination of FDV||58
400383|NCT01728324|981658|P2|COMPLETED|Termination of FDV||177
400384|NCT01728324|981659|P1|COMPLETED|Termination of FDV||173
400385|NCT01728324|981657|P3|STARTED|Termination of FDV||72
400386|NCT01728324|981658|P2|STARTED|Termination of FDV||213
400387|NCT01728324|981659|P1|STARTED|Termination of FDV||211
400388|NCT01728324|981657|P3|NOT COMPLETED|Termination of DBV||14
400389|NCT01728324|981658|P2|NOT COMPLETED|Termination of DBV||36
400390|NCT01728324|981659|P1|NOT COMPLETED|Termination of DBV||38
400391|NCT01728324|981657|P3|COMPLETED|Termination of DBV||58
400392|NCT01728324|981658|P2|COMPLETED|Termination of DBV||177
400393|NCT01728324|981659|P1|COMPLETED|Termination of DBV||173
400394|NCT01728324|981657|P3|STARTED|Termination of DBV||72
400395|NCT01728324|981658|P2|STARTED|Termination of DBV||213
400396|NCT01728324|981659|P1|STARTED|Termination of DBV||211
400397|NCT01728246|981680|P2|NOT COMPLETED|Overall Study||36
400398|NCT01728246|981681|P1|NOT COMPLETED|Overall Study||36
400399|NCT01728246|981680|P2|COMPLETED|Overall Study||195
400400|NCT01728246|981681|P1|COMPLETED|Overall Study||206
400401|NCT01728246|981680|P2|STARTED|Overall Study||231
400402|NCT01728246|981681|P1|STARTED|Overall Study||242
400403|NCT01728116|981699|P2|NOT COMPLETED|Overall Study||47
400404|NCT01728116|981700|P1|NOT COMPLETED|Overall Study||161
400405|NCT01728116|981699|P2|COMPLETED|Overall Study|Completed to Week 52|60
400406|NCT01728116|981700|P1|COMPLETED|Overall Study|Completed to Week 78|52
400407|NCT01728116|981699|P2|STARTED|Overall Study|Sham mITT subjects|107
400408|NCT01728116|981700|P1|STARTED|Overall Study|EndoBarrier mITT Subjects|213
400409|NCT01728077|981725|P2|NOT COMPLETED|Overall Study||5
400410|NCT01728077|981726|P1|NOT COMPLETED|Overall Study||8
400411|NCT01728077|981725|P2|COMPLETED|Overall Study||2
400412|NCT01728077|981726|P1|COMPLETED|Overall Study||11
400413|NCT01728077|981725|P2|STARTED|Overall Study||7
400414|NCT01728077|981726|P1|STARTED|Overall Study||19
400415|NCT01727895|981741|P2|NOT COMPLETED|Overall Study||0
400416|NCT01727895|981742|P1|NOT COMPLETED|Overall Study||0
400417|NCT01727895|981741|P2|COMPLETED|Overall Study||5
400418|NCT01727895|981742|P1|COMPLETED|Overall Study||10
400419|NCT01727895|981741|P2|STARTED|Overall Study||5
400420|NCT01727895|981742|P1|STARTED|Overall Study||10
400421|NCT01727791|981748|P1|NOT COMPLETED|Overall Study||0
400422|NCT01727791|981748|P1|COMPLETED|Overall Study||10
400423|NCT01727791|981748|P1|STARTED|Overall Study||10
400424|NCT01727726|981781|P3|NOT COMPLETED|Overall Study||20
400425|NCT01727726|981782|P2|NOT COMPLETED|Overall Study||14
400426|NCT01727726|981783|P1|NOT COMPLETED|Overall Study||26
400427|NCT01727726|981781|P3|COMPLETED|Overall Study||186
400428|NCT01727726|981782|P2|COMPLETED|Overall Study||86
400429|NCT01727726|981783|P1|COMPLETED|Overall Study||171
400430|NCT01727726|981781|P3|STARTED|Overall Study||206
400431|NCT01727726|981782|P2|STARTED|Overall Study||100
400432|NCT01727726|981783|P1|STARTED|Overall Study||197
400433|NCT01727713|981815|P1|NOT COMPLETED|Overall Study||35
400434|NCT01727713|981815|P1|COMPLETED|Overall Study||75
400435|NCT01727713|981815|P1|STARTED|Overall Study||110
400436|NCT01727700|981842|P3|NOT COMPLETED|Overall Study||2
400437|NCT01727700|981843|P2|NOT COMPLETED|Overall Study||10
400438|NCT01727700|981844|P1|NOT COMPLETED|Overall Study||2
400439|NCT01727700|981842|P3|COMPLETED|Overall Study||42
400440|NCT01727700|981843|P2|COMPLETED|Overall Study||35
400441|NCT01727700|981844|P1|COMPLETED|Overall Study||42
400442|NCT01727700|981842|P3|STARTED|Overall Study||44
400443|NCT01727700|981843|P2|STARTED|Overall Study||45
400444|NCT01727700|981844|P1|STARTED|Overall Study||44
400445|NCT01727505|981867|P2|NOT COMPLETED|Second 24 Hours||1
400446|NCT01727505|981868|P1|NOT COMPLETED|Second 24 Hours||0
400447|NCT01727505|981867|P2|COMPLETED|Second 24 Hours||10
400448|NCT01727505|981868|P1|COMPLETED|Second 24 Hours||14
400449|NCT01727505|981867|P2|STARTED|Second 24 Hours||11
400450|NCT01727505|981868|P1|STARTED|Second 24 Hours||14
400451|NCT01727505|981867|P2|NOT COMPLETED|First 24 Hours||1
400452|NCT01727505|981868|P1|NOT COMPLETED|First 24 Hours||0
400453|NCT01727505|981867|P2|COMPLETED|First 24 Hours||11
400454|NCT01727505|981868|P1|COMPLETED|First 24 Hours||14
400455|NCT01727505|981867|P2|STARTED|First 24 Hours||12
400456|NCT01727505|981868|P1|STARTED|First 24 Hours||14
400457|NCT01727414|981886|P2|NOT COMPLETED|Overall Study||0
400458|NCT01727414|981887|P1|NOT COMPLETED|Overall Study||3
400459|NCT01727414|981886|P2|COMPLETED|Overall Study||45
400460|NCT01727414|981887|P1|COMPLETED|Overall Study||123
400461|NCT01727414|981886|P2|STARTED|Overall Study||45
400462|NCT01727414|981887|P1|STARTED|Overall Study||126
400463|NCT01727297|981893|P2|NOT COMPLETED|Overall Study||51
400464|NCT01727297|981894|P1|NOT COMPLETED|Overall Study||102
400465|NCT01727297|981893|P2|COMPLETED|Overall Study||0
400466|NCT01727297|981894|P1|COMPLETED|Overall Study||293
400467|NCT01727297|981893|P2|STARTED|Overall Study||51
400468|NCT01727297|981894|P1|STARTED|Overall Study||395
400469|NCT01727258|981910|P3|NOT COMPLETED|Overall Study||1
400470|NCT01727258|981911|P2|NOT COMPLETED|Overall Study||3
400471|NCT01727258|981912|P1|NOT COMPLETED|Overall Study||2
400472|NCT01727258|981910|P3|COMPLETED|Overall Study||50
400473|NCT01727258|981911|P2|COMPLETED|Overall Study||48
400474|NCT01727258|981912|P1|COMPLETED|Overall Study||49
400475|NCT01727258|981910|P3|STARTED|Overall Study||51
400476|NCT01727258|981911|P2|STARTED|Overall Study||51
400477|NCT01727258|981912|P1|STARTED|Overall Study||51
400478|NCT01727180|981935|P1|NOT COMPLETED|Overall Study||0
400479|NCT01727180|981935|P1|COMPLETED|Overall Study||108
400480|NCT01727180|981935|P1|STARTED|Overall Study||108
400481|NCT01727167|981941|P2|NOT COMPLETED|Overall Study||0
400482|NCT01727167|981942|P1|NOT COMPLETED|Overall Study||0
400483|NCT01727167|981941|P2|COMPLETED|Overall Study||0
400484|NCT01727167|981942|P1|COMPLETED|Overall Study||1
400485|NCT01727167|981941|P2|STARTED|Overall Study||0
400486|NCT01727167|981942|P1|STARTED|Overall Study||1
400487|NCT01727141|981954|P4|NOT COMPLETED|Overall Study||15
400488|NCT01727141|981955|P3|NOT COMPLETED|Overall Study||3
400489|NCT01727141|981956|P2|NOT COMPLETED|Overall Study||9
400490|NCT01727141|981957|P1|NOT COMPLETED|Overall Study||5
400491|NCT01727141|981954|P4|COMPLETED|Overall Study||246
400492|NCT01727141|981955|P3|COMPLETED|Overall Study||258
400493|NCT01727141|981956|P2|COMPLETED|Overall Study||251
400494|NCT01727141|981957|P1|COMPLETED|Overall Study||255
400495|NCT01727141|981954|P4|Full Analysis Set|Overall Study||261
400496|NCT01727141|981955|P3|Full Analysis Set|Overall Study||261
400497|NCT01727141|981956|P2|Full Analysis Set|Overall Study||260
400498|NCT01727141|981957|P1|Full Analysis Set|Overall Study||258
400499|NCT01727141|981954|P4|Safety Set|Overall Study||260
400500|NCT01727141|981955|P3|Safety Set|Overall Study||262
400501|NCT01727141|981956|P2|Safety Set|Overall Study||260
400502|NCT01727141|981957|P1|Safety Set|Overall Study||258
400503|NCT01727141|981954|P4|STARTED|Overall Study||261
400504|NCT01727141|981955|P3|STARTED|Overall Study||261
400505|NCT01727141|981956|P2|STARTED|Overall Study||260
400506|NCT01727141|981957|P1|STARTED|Overall Study||260
400507|NCT01727089|982009|P2|NOT COMPLETED|Overall Study||0
400508|NCT01727089|982010|P1|NOT COMPLETED|Overall Study||0
400509|NCT01727089|982009|P2|COMPLETED|Overall Study||30
400510|NCT01727089|982010|P1|COMPLETED|Overall Study||29
400511|NCT01727089|982009|P2|STARTED|Overall Study||30
400512|NCT01727089|982010|P1|STARTED|Overall Study||29
400513|NCT01727024|982022|P2|NOT COMPLETED|Period 2||0
400514|NCT01727024|982023|P1|NOT COMPLETED|Period 2||0
400515|NCT01727024|982022|P2|COMPLETED|Period 2||64
400516|NCT01727024|982023|P1|COMPLETED|Period 2||68
400517|NCT01727024|982022|P2|STARTED|Period 2||64
400518|NCT01727024|982023|P1|STARTED|Period 2||68
400519|NCT01727024|982022|P2|NOT COMPLETED|Period 1||4
400520|NCT01727024|982023|P1|NOT COMPLETED|Period 1||3
400521|NCT01727024|982022|P2|COMPLETED|Period 1||64
400522|NCT01727024|982023|P1|COMPLETED|Period 1||68
400523|NCT01727024|982022|P2|STARTED|Period 1||68
400524|NCT01727024|982023|P1|STARTED|Period 1||71
400525|NCT01726621|982036|P1|NOT COMPLETED|Overall Study||4
400526|NCT01726621|982036|P1|COMPLETED|Overall Study||51
400527|NCT01726621|982036|P1|STARTED|Overall Study||55
400528|NCT01726517|982045|P5|NOT COMPLETED|Overall Study||0
400529|NCT01726517|982046|P4|NOT COMPLETED|Overall Study||0
400530|NCT01726517|982047|P3|NOT COMPLETED|Overall Study||1
400531|NCT01726517|982048|P2|NOT COMPLETED|Overall Study||0
400532|NCT01726517|982049|P1|NOT COMPLETED|Overall Study||0
400533|NCT01726517|982045|P5|COMPLETED|Overall Study||21
400534|NCT01726517|982046|P4|COMPLETED|Overall Study||19
400535|NCT01726517|982047|P3|COMPLETED|Overall Study||18
400536|NCT01726517|982048|P2|COMPLETED|Overall Study||21
400537|NCT01726517|982049|P1|COMPLETED|Overall Study||20
400538|NCT01726517|982045|P5|STARTED|Overall Study||21
400539|NCT01726517|982046|P4|STARTED|Overall Study||19
400540|NCT01726517|982047|P3|STARTED|Overall Study||19
400541|NCT01726517|982048|P2|STARTED|Overall Study||21
400542|NCT01726517|982049|P1|STARTED|Overall Study||20
400543|NCT01726504|982078|P2|NOT COMPLETED|Overall Study||28
400544|NCT01726504|982079|P1|NOT COMPLETED|Overall Study||12
400545|NCT01726504|982078|P2|COMPLETED|Overall Study||511
400546|NCT01726504|982079|P1|COMPLETED|Overall Study||524
400547|NCT01726504|982078|P2|STARTED|Overall Study||539
400548|NCT01726504|982079|P1|STARTED|Overall Study||536
400549|NCT01726335|982105|P1|NOT COMPLETED|Overall Study||24
400550|NCT01726335|982105|P1|COMPLETED|Overall Study||29
400551|NCT01726335|982105|P1|STARTED|Overall Study||53
400552|NCT01726049|982123|P2|NOT COMPLETED|Overall Study||4
400553|NCT01726049|982124|P1|NOT COMPLETED|Overall Study||5
400554|NCT01726049|982123|P2|COMPLETED|Overall Study||22
400555|NCT01726049|982124|P1|COMPLETED|Overall Study||21
400556|NCT01726049|982123|P2|STARTED|Overall Study||26
400557|NCT01726049|982124|P1|STARTED|Overall Study||26
400558|NCT01726023|982138|P2|NOT COMPLETED|Overall Study||26
400559|NCT01726023|982139|P1|NOT COMPLETED|Overall Study||29
400560|NCT01726023|982138|P2|COMPLETED|Overall Study||196
400561|NCT01726023|982139|P1|COMPLETED|Overall Study||190
400562|NCT01726023|982138|P2|STARTED|Overall Study||222
400563|NCT01726023|982139|P1|STARTED|Overall Study||219
400564|NCT01725984|982231|P2|NOT COMPLETED|Overall Study||0
400565|NCT01725984|982232|P1|NOT COMPLETED|Overall Study||0
400566|NCT01725984|982231|P2|COMPLETED|Overall Study||41
400567|NCT01725984|982232|P1|COMPLETED|Overall Study||39
400568|NCT01725984|982231|P2|STARTED|Overall Study||41
400569|NCT01725984|982232|P1|STARTED|Overall Study||39
400570|NCT01725529|982259|P3|NOT COMPLETED|Overall Study||10
400571|NCT01725529|982260|P2|NOT COMPLETED|Overall Study||16
400572|NCT01725529|982261|P1|NOT COMPLETED|Overall Study||15
400573|NCT01725529|982259|P3|COMPLETED|Overall Study||142
400574|NCT01725529|982260|P2|COMPLETED|Overall Study||137
400575|NCT01725529|982261|P1|COMPLETED|Overall Study||137
400576|NCT01725529|982259|P3|STARTED|Overall Study||152
400577|NCT01725529|982260|P2|STARTED|Overall Study||153
400578|NCT01725529|982261|P1|STARTED|Overall Study||152
400579|NCT01725451|982287|P4|NOT COMPLETED|Period 6||0
400580|NCT01725451|982288|P3|NOT COMPLETED|Period 6||0
400581|NCT01725451|982289|P2|NOT COMPLETED|Period 6||0
400582|NCT01725451|982290|P1|NOT COMPLETED|Period 6||0
400583|NCT01725451|982287|P4|COMPLETED|Period 6||7
400584|NCT01725451|982288|P3|COMPLETED|Period 6||6
400585|NCT01725451|982289|P2|COMPLETED|Period 6||6
400586|NCT01725451|982290|P1|COMPLETED|Period 6||7
400587|NCT01725451|982287|P4|STARTED|Period 6||7
400588|NCT01725451|982288|P3|STARTED|Period 6||6
400589|NCT01725451|982289|P2|STARTED|Period 6||6
400590|NCT01725451|982290|P1|STARTED|Period 6||7
400591|NCT01725451|982287|P4|NOT COMPLETED|Washout From Period 5||0
400592|NCT01725451|982288|P3|NOT COMPLETED|Washout From Period 5||0
400593|NCT01725451|982289|P2|NOT COMPLETED|Washout From Period 5||0
400594|NCT01725451|982290|P1|NOT COMPLETED|Washout From Period 5||0
400595|NCT01725451|982287|P4|COMPLETED|Washout From Period 5||7
400596|NCT01725451|982288|P3|COMPLETED|Washout From Period 5||6
400597|NCT01725451|982289|P2|COMPLETED|Washout From Period 5||6
400598|NCT01725451|982290|P1|COMPLETED|Washout From Period 5||7
400599|NCT01725451|982287|P4|STARTED|Washout From Period 5||7
400600|NCT01725451|982288|P3|STARTED|Washout From Period 5||6
400601|NCT01725451|982289|P2|STARTED|Washout From Period 5||6
400602|NCT01725451|982290|P1|STARTED|Washout From Period 5||7
400603|NCT01725451|982287|P4|NOT COMPLETED|Period 5||0
400604|NCT01725451|982288|P3|NOT COMPLETED|Period 5||0
400605|NCT01725451|982289|P2|NOT COMPLETED|Period 5||0
400606|NCT01725451|982290|P1|NOT COMPLETED|Period 5||0
400607|NCT01725451|982287|P4|COMPLETED|Period 5||7
400608|NCT01725451|982288|P3|COMPLETED|Period 5||6
400609|NCT01725451|982289|P2|COMPLETED|Period 5||6
400610|NCT01725451|982290|P1|COMPLETED|Period 5||7
400611|NCT01725451|982287|P4|STARTED|Period 5||7
400612|NCT01725451|982288|P3|STARTED|Period 5||6
400613|NCT01725451|982289|P2|STARTED|Period 5||6
400614|NCT01725451|982290|P1|STARTED|Period 5||7
400615|NCT01725451|982287|P4|NOT COMPLETED|Washout From Period 4||0
400616|NCT01725451|982288|P3|NOT COMPLETED|Washout From Period 4||0
400617|NCT01725451|982289|P2|NOT COMPLETED|Washout From Period 4||0
400618|NCT01725451|982290|P1|NOT COMPLETED|Washout From Period 4||0
400619|NCT01725451|982287|P4|COMPLETED|Washout From Period 4||7
400620|NCT01725451|982288|P3|COMPLETED|Washout From Period 4||6
400621|NCT01725451|982289|P2|COMPLETED|Washout From Period 4||6
400622|NCT01725451|982290|P1|COMPLETED|Washout From Period 4||7
400623|NCT01725451|982287|P4|STARTED|Washout From Period 4||7
400624|NCT01725451|982288|P3|STARTED|Washout From Period 4||6
400625|NCT01725451|982289|P2|STARTED|Washout From Period 4||6
400626|NCT01725451|982290|P1|STARTED|Washout From Period 4||7
400627|NCT01725451|982287|P4|NOT COMPLETED|Period 4||0
400628|NCT01725451|982288|P3|NOT COMPLETED|Period 4||1
400629|NCT01725451|982289|P2|NOT COMPLETED|Period 4||0
400630|NCT01725451|982290|P1|NOT COMPLETED|Period 4||0
400631|NCT01725451|982287|P4|COMPLETED|Period 4||7
400632|NCT01725451|982288|P3|COMPLETED|Period 4||6
400633|NCT01725451|982289|P2|COMPLETED|Period 4||6
400634|NCT01725451|982290|P1|COMPLETED|Period 4||7
400635|NCT01725451|982287|P4|STARTED|Period 4||7
400636|NCT01725451|982288|P3|STARTED|Period 4||7
400637|NCT01725451|982289|P2|STARTED|Period 4||6
400638|NCT01725451|982290|P1|STARTED|Period 4||7
400639|NCT01725451|982287|P4|NOT COMPLETED|Washout From Period 3||0
400640|NCT01725451|982288|P3|NOT COMPLETED|Washout From Period 3||1
400641|NCT01725451|982289|P2|NOT COMPLETED|Washout From Period 3||1
400642|NCT01725451|982290|P1|NOT COMPLETED|Washout From Period 3||0
400643|NCT01725451|982287|P4|COMPLETED|Washout From Period 3||7
400644|NCT01725451|982288|P3|COMPLETED|Washout From Period 3||7
400645|NCT01725451|982289|P2|COMPLETED|Washout From Period 3||6
400646|NCT01725451|982290|P1|COMPLETED|Washout From Period 3||7
400647|NCT01725451|982287|P4|STARTED|Washout From Period 3||7
400648|NCT01725451|982288|P3|STARTED|Washout From Period 3||8
400649|NCT01725451|982289|P2|STARTED|Washout From Period 3||7
400650|NCT01725451|982290|P1|STARTED|Washout From Period 3||7
400651|NCT01725451|982287|P4|NOT COMPLETED|Period 3||0
400652|NCT01725451|982288|P3|NOT COMPLETED|Period 3||0
400653|NCT01725451|982289|P2|NOT COMPLETED|Period 3||0
400654|NCT01725451|982290|P1|NOT COMPLETED|Period 3||0
400655|NCT01725451|982287|P4|COMPLETED|Period 3||7
400656|NCT01725451|982288|P3|COMPLETED|Period 3||8
400657|NCT01725451|982289|P2|COMPLETED|Period 3||7
400658|NCT01725451|982290|P1|COMPLETED|Period 3||7
400659|NCT01725451|982287|P4|STARTED|Period 3||7
400660|NCT01725451|982288|P3|STARTED|Period 3||8
400661|NCT01725451|982289|P2|STARTED|Period 3||7
400662|NCT01725451|982290|P1|STARTED|Period 3||7
400663|NCT01725451|982287|P4|NOT COMPLETED|Washout From Period 2||0
400664|NCT01725451|982288|P3|NOT COMPLETED|Washout From Period 2||0
400665|NCT01725451|982289|P2|NOT COMPLETED|Washout From Period 2||0
400666|NCT01725451|982290|P1|NOT COMPLETED|Washout From Period 2||0
400667|NCT01725451|982287|P4|COMPLETED|Washout From Period 2||7
400668|NCT01725451|982288|P3|COMPLETED|Washout From Period 2||8
400669|NCT01725451|982289|P2|COMPLETED|Washout From Period 2||7
400670|NCT01725451|982290|P1|COMPLETED|Washout From Period 2||7
400671|NCT01725451|982287|P4|STARTED|Washout From Period 2||7
400672|NCT01725451|982288|P3|STARTED|Washout From Period 2||8
400673|NCT01725451|982289|P2|STARTED|Washout From Period 2||7
400674|NCT01725451|982290|P1|STARTED|Washout From Period 2||7
400675|NCT01725451|982287|P4|NOT COMPLETED|Period 2||0
400676|NCT01725451|982288|P3|NOT COMPLETED|Period 2||0
400677|NCT01725451|982289|P2|NOT COMPLETED|Period 2||0
400678|NCT01725451|982290|P1|NOT COMPLETED|Period 2||0
400679|NCT01725451|982287|P4|COMPLETED|Period 2||7
400680|NCT01725451|982288|P3|COMPLETED|Period 2||8
400681|NCT01725451|982289|P2|COMPLETED|Period 2||7
400682|NCT01725451|982290|P1|COMPLETED|Period 2||7
400683|NCT01725451|982287|P4|STARTED|Period 2||7
400684|NCT01725451|982288|P3|STARTED|Period 2||8
400685|NCT01725451|982289|P2|STARTED|Period 2||7
400686|NCT01725451|982290|P1|STARTED|Period 2||7
400687|NCT01725451|982287|P4|NOT COMPLETED|Washout From Period 1||0
400688|NCT01725451|982288|P3|NOT COMPLETED|Washout From Period 1||0
400689|NCT01725451|982289|P2|NOT COMPLETED|Washout From Period 1||0
400690|NCT01725451|982290|P1|NOT COMPLETED|Washout From Period 1||0
400691|NCT01725451|982287|P4|COMPLETED|Washout From Period 1||7
400692|NCT01725451|982288|P3|COMPLETED|Washout From Period 1||8
400693|NCT01725451|982289|P2|COMPLETED|Washout From Period 1||7
400694|NCT01725451|982290|P1|COMPLETED|Washout From Period 1||7
400695|NCT01725451|982287|P4|STARTED|Washout From Period 1||7
400696|NCT01725451|982288|P3|STARTED|Washout From Period 1||8
400697|NCT01725451|982289|P2|STARTED|Washout From Period 1||7
400698|NCT01725451|982290|P1|STARTED|Washout From Period 1||7
400699|NCT01725451|982287|P4|NOT COMPLETED|Period 1||0
400700|NCT01725451|982288|P3|NOT COMPLETED|Period 1||0
400701|NCT01725451|982289|P2|NOT COMPLETED|Period 1||0
400702|NCT01725451|982290|P1|NOT COMPLETED|Period 1||1
400703|NCT01725451|982287|P4|COMPLETED|Period 1||7
400704|NCT01725451|982288|P3|COMPLETED|Period 1||8
400705|NCT01725451|982289|P2|COMPLETED|Period 1||7
400706|NCT01725451|982290|P1|COMPLETED|Period 1||7
400707|NCT01725451|982287|P4|STARTED|Period 1||7
400708|NCT01725451|982288|P3|STARTED|Period 1||8
400709|NCT01725451|982289|P2|STARTED|Period 1||7
400710|NCT01725451|982290|P1|STARTED|Period 1||8
400711|NCT01725386|982312|P2|NOT COMPLETED|Overall Study||46
400712|NCT01725386|982313|P1|NOT COMPLETED|Overall Study||175
400713|NCT01725386|982312|P2|COMPLETED|Overall Study||17
400714|NCT01725386|982313|P1|COMPLETED|Overall Study||13
400715|NCT01725386|982312|P2|STARTED|Overall Study||63
400716|NCT01725386|982313|P1|STARTED|Overall Study||188
400717|NCT01725308|982332|P3|NOT COMPLETED|Treatment Period II||64
400718|NCT01725308|982333|P2|NOT COMPLETED|Treatment Period II||29
400719|NCT01725308|982334|P1|NOT COMPLETED|Treatment Period II||55
400720|NCT01725308|982332|P3|COMPLETED|Treatment Period II||74
400721|NCT01725308|982333|P2|COMPLETED|Treatment Period II||31
400722|NCT01725308|982334|P1|COMPLETED|Treatment Period II||79
400723|NCT01725308|982332|P3|Treated|Treatment Period II||130
400724|NCT01725308|982333|P2|Treated|Treatment Period II||53
400725|NCT01725308|982334|P1|Treated|Treatment Period II||120
400726|NCT01725308|982332|P3|STARTED|Treatment Period II||138
400727|NCT01725308|982333|P2|STARTED|Treatment Period II||60
400728|NCT01725308|982334|P1|STARTED|Treatment Period II||134
400729|NCT01725308|982332|P3|NOT COMPLETED|Treatment Period I||41
400730|NCT01725308|982333|P2|NOT COMPLETED|Treatment Period I||14
400731|NCT01725308|982334|P1|NOT COMPLETED|Treatment Period I||44
400732|NCT01725308|982332|P3|COMPLETED|Treatment Period I||138
400733|NCT01725308|982333|P2|COMPLETED|Treatment Period I||60
400734|NCT01725308|982334|P1|COMPLETED|Treatment Period I||134
400735|NCT01725308|982332|P3|Treated|Treatment Period I||179
400736|NCT01725308|982333|P2|Treated|Treatment Period I||74
400737|NCT01725308|982334|P1|Treated|Treatment Period I||177
400738|NCT01725308|982332|P3|STARTED|Treatment Period I||179
400739|NCT01725308|982333|P2|STARTED|Treatment Period I||74
400740|NCT01725308|982334|P1|STARTED|Treatment Period I||178
400741|NCT01725282|982481|P4|NOT COMPLETED|Overall Study||7
400742|NCT01725282|982482|P3|NOT COMPLETED|Overall Study||8
400743|NCT01725282|982483|P2|NOT COMPLETED|Overall Study||5
400744|NCT01725282|982484|P1|NOT COMPLETED|Overall Study||2
400745|NCT01725282|982481|P4|COMPLETED|Overall Study||36
400746|NCT01725282|982482|P3|COMPLETED|Overall Study||33
400747|NCT01725282|982483|P2|COMPLETED|Overall Study||39
400748|NCT01725282|982484|P1|COMPLETED|Overall Study||42
400749|NCT01725282|982481|P4|STARTED|Overall Study||43
400750|NCT01725282|982482|P3|STARTED|Overall Study||41
400751|NCT01725282|982483|P2|STARTED|Overall Study||44
400752|NCT01725282|982484|P1|STARTED|Overall Study||44
400753|NCT01725217|982517|P3|NOT COMPLETED|Overall Study||0
400754|NCT01725217|982518|P2|NOT COMPLETED|Overall Study||0
400755|NCT01725217|982519|P1|NOT COMPLETED|Overall Study||1
400756|NCT01725217|982517|P3|COMPLETED|Overall Study||66
400757|NCT01725217|982518|P2|COMPLETED|Overall Study||66
400758|NCT01725217|982519|P1|COMPLETED|Overall Study||65
400759|NCT01725217|982517|P3|STARTED|Overall Study||66
400760|NCT01725217|982518|P2|STARTED|Overall Study||66
400761|NCT01725217|982519|P1|STARTED|Overall Study||66
400762|NCT01725126|982553|P6|NOT COMPLETED|Overall Study||0
400763|NCT01725126|982554|P5|NOT COMPLETED|Overall Study||0
400764|NCT01725126|982555|P4|NOT COMPLETED|Overall Study||1
400765|NCT01725126|982556|P3|NOT COMPLETED|Overall Study||0
400766|NCT01725126|982557|P2|NOT COMPLETED|Overall Study||1
400767|NCT01725126|982558|P1|NOT COMPLETED|Overall Study||0
400768|NCT01725126|982553|P6|COMPLETED|Overall Study||12
400769|NCT01725126|982554|P5|COMPLETED|Overall Study||6
400770|NCT01725126|982555|P4|COMPLETED|Overall Study||13
400771|NCT01725126|982556|P3|COMPLETED|Overall Study||6
400772|NCT01725126|982557|P2|COMPLETED|Overall Study||10
400773|NCT01725126|982558|P1|COMPLETED|Overall Study||4
400774|NCT01725126|982553|P6|STARTED|Overall Study||12
400775|NCT01725126|982554|P5|STARTED|Overall Study||6
400776|NCT01725126|982555|P4|STARTED|Overall Study||14
400777|NCT01725126|982556|P3|STARTED|Overall Study||6
400778|NCT01725126|982557|P2|STARTED|Overall Study||11
400779|NCT01725126|982558|P1|STARTED|Overall Study||4
400780|NCT01724528|982756|P2|NOT COMPLETED|Overall Study||3
400781|NCT01724528|982757|P1|NOT COMPLETED|Overall Study||4
400782|NCT01724528|982756|P2|COMPLETED|Overall Study||170
400783|NCT01724528|982757|P1|COMPLETED|Overall Study||169
400784|NCT01724528|982756|P2|STARTED|Overall Study||173
400785|NCT01724528|982757|P1|STARTED|Overall Study||173
400786|NCT01724359|982771|P1|NOT COMPLETED|Overall Study||31
400787|NCT01724359|982771|P1|COMPLETED|Overall Study||64
400788|NCT01724359|982771|P1|STARTED|Overall Study||95
400789|NCT01724216|982784|P1|NOT COMPLETED|Overall Study||1
400790|NCT01724216|982784|P1|COMPLETED|Overall Study||10
400791|NCT01724216|982784|P1|STARTED|Overall Study||11
400792|NCT01724177|982788|P1|NOT COMPLETED|Overall Study||26
400793|NCT01724177|982788|P1|COMPLETED|Overall Study||0
400794|NCT01724177|982788|P1|Safety Population|Overall Study|Safety Population includes participants who received at least one dose of lenalidomide|26
400795|NCT01724177|982788|P1|STARTED|Overall Study||26
400796|NCT01724021|982801|P2|NOT COMPLETED|Overall Study||133
400797|NCT01724021|982802|P1|NOT COMPLETED|Overall Study||127
400798|NCT01724021|982801|P2|COMPLETED|Overall Study||236
400799|NCT01724021|982802|P1|COMPLETED|Overall Study||244
400800|NCT01724021|982801|P2|STARTED|Overall Study||369
400801|NCT01724021|982802|P1|STARTED|Overall Study||371
400802|NCT01723904|982834|P1|NOT COMPLETED|Overall Study||11
400803|NCT01723904|982834|P1|COMPLETED|Overall Study||79
400804|NCT01723904|982834|P1|STARTED|Overall Study||90
400805|NCT01723722|982846|P2|NOT COMPLETED|Overall Study||0
400806|NCT01723722|982847|P1|NOT COMPLETED|Overall Study||0
400807|NCT01723722|982846|P2|COMPLETED|Overall Study||20
400808|NCT01723722|982847|P1|COMPLETED|Overall Study||20
400809|NCT01723722|982846|P2|STARTED|Overall Study||20
400810|NCT01723722|982847|P1|STARTED|Overall Study||20
400811|NCT01723397|982855|P2|NOT COMPLETED|Study Period 2||1
400812|NCT01723397|982856|P1|NOT COMPLETED|Study Period 2||0
400813|NCT01723397|982855|P2|COMPLETED|Study Period 2||5
400814|NCT01723397|982856|P1|COMPLETED|Study Period 2||7
400815|NCT01723397|982855|P2|STARTED|Study Period 2||6
400816|NCT01723397|982856|P1|STARTED|Study Period 2||7
400817|NCT01723397|982855|P2|NOT COMPLETED|Washout||0
400818|NCT01723397|982856|P1|NOT COMPLETED|Washout||0
400819|NCT01723397|982855|P2|COMPLETED|Washout||6
400820|NCT01723397|982856|P1|COMPLETED|Washout||7
400821|NCT01723397|982855|P2|STARTED|Washout||6
400822|NCT01723397|982856|P1|STARTED|Washout||7
400823|NCT01723397|982855|P2|NOT COMPLETED|Study Period 1||1
400824|NCT01723397|982856|P1|NOT COMPLETED|Study Period 1||0
400825|NCT01723397|982855|P2|COMPLETED|Study Period 1||6
400826|NCT01723397|982856|P1|COMPLETED|Study Period 1||7
400827|NCT01723397|982855|P2|STARTED|Study Period 1||7
400828|NCT01723397|982856|P1|STARTED|Study Period 1||7
400829|NCT01723254|982870|P8|NOT COMPLETED|Overall Study||3
400830|NCT01723254|982871|P7|NOT COMPLETED|Overall Study||1
400831|NCT01723254|982872|P6|NOT COMPLETED|Overall Study||2
400832|NCT01723254|982873|P5|NOT COMPLETED|Overall Study||2
400833|NCT01723254|982874|P4|NOT COMPLETED|Overall Study||2
400834|NCT01723254|982875|P3|NOT COMPLETED|Overall Study||3
400835|NCT01723254|982876|P2|NOT COMPLETED|Overall Study||3
400836|NCT01723254|982877|P1|NOT COMPLETED|Overall Study||1
400837|NCT01723254|982870|P8|COMPLETED|Overall Study||60
400838|NCT01723254|982871|P7|COMPLETED|Overall Study||19
400839|NCT01723254|982872|P6|COMPLETED|Overall Study||18
400840|NCT01723254|982873|P5|COMPLETED|Overall Study||18
400841|NCT01723254|982874|P4|COMPLETED|Overall Study||18
400842|NCT01723254|982875|P3|COMPLETED|Overall Study||17
400843|NCT01723254|982876|P2|COMPLETED|Overall Study||18
400844|NCT01723254|982877|P1|COMPLETED|Overall Study||5
400845|NCT01723254|982870|P8|STARTED|Overall Study||63
400846|NCT01723254|982871|P7|STARTED|Overall Study||20
400847|NCT01723254|982872|P6|STARTED|Overall Study||20
400848|NCT01723254|982873|P5|STARTED|Overall Study||20
400849|NCT01723254|982874|P4|STARTED|Overall Study||20
400850|NCT01723254|982875|P3|STARTED|Overall Study||20
400851|NCT01723254|982876|P2|STARTED|Overall Study||21
400852|NCT01723254|982877|P1|STARTED|Overall Study||6
400853|NCT01723228|982929|P2|NOT COMPLETED|Overall Study||11
400854|NCT01723228|982930|P1|NOT COMPLETED|Overall Study||8
400855|NCT01723228|982929|P2|COMPLETED|Overall Study||73
400856|NCT01723228|982930|P1|COMPLETED|Overall Study||78
400857|NCT01723228|982929|P2|STARTED|Overall Study||84
400858|NCT01723228|982930|P1|STARTED|Overall Study||86
400859|NCT01722994|982948|P2|NOT COMPLETED|Overall Study||17
400860|NCT01722994|982949|P1|NOT COMPLETED|Overall Study||25
400861|NCT01722994|982948|P2|COMPLETED|Overall Study||31
400862|NCT01722994|982949|P1|COMPLETED|Overall Study||24
400863|NCT01722994|982948|P2|STARTED|Overall Study||48
400864|NCT01722994|982949|P1|STARTED|Overall Study||49
400865|NCT01722929|982963|P1|NOT COMPLETED|Overall Study||0
400866|NCT01722929|982963|P1|COMPLETED|Overall Study||4
400867|NCT01722929|982963|P1|STARTED|Overall Study||4
400868|NCT01722877|982968|P1|NOT COMPLETED|Overall Study||2
400869|NCT01722877|982968|P1|COMPLETED|Overall Study||27
400870|NCT01722877|982968|P1|STARTED|Overall Study||29
400871|NCT01722734|982978|P3|NOT COMPLETED|Overall Study||2
400872|NCT01722734|982979|P2|NOT COMPLETED|Overall Study||1
400873|NCT01722734|982980|P1|NOT COMPLETED|Overall Study||2
400874|NCT01722734|982978|P3|COMPLETED|Overall Study||307
400875|NCT01722734|982979|P2|COMPLETED|Overall Study||276
400876|NCT01722734|982980|P1|COMPLETED|Overall Study||552
400877|NCT01722734|982978|P3|STARTED|Overall Study||309
400878|NCT01722734|982979|P2|STARTED|Overall Study||277
400879|NCT01722734|982980|P1|STARTED|Overall Study||554
400880|NCT01722643|982990|P2|NOT COMPLETED|Overall Study||1
400881|NCT01722643|982991|P1|NOT COMPLETED|Overall Study||0
400882|NCT01722643|982990|P2|COMPLETED|Overall Study||30
400883|NCT01722643|982991|P1|COMPLETED|Overall Study||30
400884|NCT01722643|982990|P2|STARTED|Overall Study||31
400885|NCT01722643|982991|P1|STARTED|Overall Study||30
400886|NCT01722552|982999|P1|NOT COMPLETED|Overall Study||4
400887|NCT01722552|982999|P1|COMPLETED|Overall Study|Number of subjects who completed the intervention|116
400888|NCT01722552|982999|P1|STARTED|Overall Study|Number of subjects enrolled|120
400889|NCT01722487|983009|P2|NOT COMPLETED|Overall Study||7
400890|NCT01722487|983010|P1|NOT COMPLETED|Overall Study||2
400891|NCT01722487|983009|P2|COMPLETED|Overall Study|Participants who were still on study or died at study closure|126
400892|NCT01722487|983010|P1|COMPLETED|Overall Study|Participants who were still on study or died at study closure|134
400893|NCT01722487|983009|P2|STARTED|Overall Study||133
400894|NCT01722487|983010|P1|STARTED|Overall Study||136
400895|NCT01722435|983028|P1|NOT COMPLETED|Overall Study||0
400896|NCT01722435|983028|P1|COMPLETED|Overall Study||78
400897|NCT01722435|983028|P1|STARTED|Overall Study||78
400898|NCT01722331|983039|P7|NOT COMPLETED|Part 3||2
400899|NCT01722331|983040|P6|NOT COMPLETED|Part 3||3
400900|NCT01722331|983041|P5|NOT COMPLETED|Part 3||0
400901|NCT01722331|983042|P4|NOT COMPLETED|Part 3||1
400902|NCT01722331|983043|P3|NOT COMPLETED|Part 3||0
400903|NCT01722331|983044|P2|NOT COMPLETED|Part 3||17
400904|NCT01722331|983045|P1|NOT COMPLETED|Part 3||15
400905|NCT01722331|983039|P7|COMPLETED|Part 3||65
400906|NCT01722331|983040|P6|COMPLETED|Part 3||59
400907|NCT01722331|983041|P5|COMPLETED|Part 3||0
400908|NCT01722331|983042|P4|COMPLETED|Part 3||18
400909|NCT01722331|983043|P3|COMPLETED|Part 3||0
400910|NCT01722331|983044|P2|COMPLETED|Part 3||232
400911|NCT01722331|983045|P1|COMPLETED|Part 3||264
400912|NCT01722331|983039|P7|STARTED|Part 3||67
400913|NCT01722331|983040|P6|STARTED|Part 3||62
400914|NCT01722331|983041|P5|STARTED|Part 3||0
400915|NCT01722331|983042|P4|STARTED|Part 3||19
400916|NCT01722331|983043|P3|STARTED|Part 3||0
400917|NCT01722331|983044|P2|STARTED|Part 3||249
400918|NCT01722331|983045|P1|STARTED|Part 3||279
400919|NCT01722331|983039|P7|NOT COMPLETED|Part 2||7
400920|NCT01722331|983040|P6|NOT COMPLETED|Part 2||10
400921|NCT01722331|983041|P5|NOT COMPLETED|Part 2||0
400922|NCT01722331|983042|P4|NOT COMPLETED|Part 2||0
400923|NCT01722331|983043|P3|NOT COMPLETED|Part 2||31
400924|NCT01722331|983044|P2|NOT COMPLETED|Part 2||0
400925|NCT01722331|983045|P1|NOT COMPLETED|Part 2||19
400926|NCT01722331|983039|P7|COMPLETED|Part 2||67
400927|NCT01722331|983040|P6|COMPLETED|Part 2||62
400928|NCT01722331|983041|P5|COMPLETED|Part 2||0
400929|NCT01722331|983042|P4|COMPLETED|Part 2||19
400930|NCT01722331|983043|P3|COMPLETED|Part 2||0
400931|NCT01722331|983044|P2|COMPLETED|Part 2||249
400932|NCT01722331|983045|P1|COMPLETED|Part 2||279
400933|NCT01722331|983039|P7|STARTED|Part 2||74
400934|NCT01722331|983040|P6|STARTED|Part 2||72
400935|NCT01722331|983041|P5|STARTED|Part 2||0
400936|NCT01722331|983042|P4|STARTED|Part 2||19
400937|NCT01722331|983043|P3|STARTED|Part 2|1 participant who completed Part 1 did not enter Part 2|31
400938|NCT01722331|983044|P2|STARTED|Part 2||249
400939|NCT01722331|983045|P1|STARTED|Part 2||298
400940|NCT01722331|983039|P7|NOT COMPLETED|Part 1||0
400941|NCT01722331|983040|P6|NOT COMPLETED|Part 1||0
400942|NCT01722331|983041|P5|NOT COMPLETED|Part 1||9
400943|NCT01722331|983042|P4|NOT COMPLETED|Part 1||0
400944|NCT01722331|983043|P3|NOT COMPLETED|Part 1||9
400945|NCT01722331|983044|P2|NOT COMPLETED|Part 1||0
400946|NCT01722331|983045|P1|NOT COMPLETED|Part 1||10
400947|NCT01722331|983039|P7|COMPLETED|Part 1||74
400948|NCT01722331|983040|P6|COMPLETED|Part 1||72
400949|NCT01722331|983041|P5|COMPLETED|Part 1||0
400950|NCT01722331|983042|P4|COMPLETED|Part 1||19
400951|NCT01722331|983043|P3|COMPLETED|Part 1||32
400952|NCT01722331|983044|P2|COMPLETED|Part 1||249
400953|NCT01722331|983045|P1|COMPLETED|Part 1||298
400954|NCT01722331|983039|P7|STARTED|Part 1||74
400955|NCT01722331|983040|P6|STARTED|Part 1||72
400956|NCT01722331|983041|P5|STARTED|Part 1||9
400957|NCT01722331|983042|P4|STARTED|Part 1||19
400958|NCT01722331|983043|P3|STARTED|Part 1||41
400959|NCT01722331|983044|P2|STARTED|Part 1||249
400960|NCT01722331|983045|P1|STARTED|Part 1||308
400961|NCT01722266|983088|P4|NOT COMPLETED|Overall Study||0
400962|NCT01722266|983089|P3|NOT COMPLETED|Overall Study||5
400963|NCT01722266|983090|P2|NOT COMPLETED|Overall Study||3
400964|NCT01722266|983091|P1|NOT COMPLETED|Overall Study||1
400965|NCT01722266|983088|P4|COMPLETED|Overall Study|3 subjects randomized to 1.2 mg group and 1 to 1.8 mg group tolerated only 0.6 mg|18
400966|NCT01722266|983089|P3|COMPLETED|Overall Study||13
400967|NCT01722266|983090|P2|COMPLETED|Overall Study||15
400968|NCT01722266|983091|P1|COMPLETED|Overall Study||17
400969|NCT01722266|983088|P4|STARTED|Overall Study|3 withdrew consent; 1 dropped out due to nausea|18
400970|NCT01722266|983089|P3|STARTED|Overall Study||18
400971|NCT01722266|983090|P2|STARTED|Overall Study||18
400972|NCT01722266|983091|P1|STARTED|Overall Study||18
400973|NCT01722162|983119|P2|NOT COMPLETED|Overall Study||6
400974|NCT01722162|983120|P1|NOT COMPLETED|Overall Study||5
400975|NCT01722162|983119|P2|COMPLETED|Overall Study||18
400976|NCT01722162|983120|P1|COMPLETED|Overall Study||18
400977|NCT01722162|983119|P2|STARTED|Overall Study||24
400978|NCT01722162|983120|P1|STARTED|Overall Study||23
400979|NCT01722097|983130|P2|NOT COMPLETED|Overall Study||5
400980|NCT01722097|983131|P1|NOT COMPLETED|Overall Study||6
400981|NCT01722097|983130|P2|COMPLETED|Overall Study||50
400982|NCT01722097|983131|P1|COMPLETED|Overall Study||49
400983|NCT01722097|983130|P2|STARTED|Overall Study||55
400984|NCT01722097|983131|P1|STARTED|Overall Study||55
400985|NCT01722071|983139|P2|NOT COMPLETED|Overall Study||0
400986|NCT01722071|983140|P1|NOT COMPLETED|Overall Study||1
400987|NCT01722071|983139|P2|COMPLETED|Overall Study||10
400988|NCT01722071|983140|P1|COMPLETED|Overall Study||9
400989|NCT01722071|983139|P2|STARTED|Overall Study||10
400990|NCT01722071|983140|P1|STARTED|Overall Study||10
400991|NCT01722045|983146|P1|NOT COMPLETED|Overall Study||28
400992|NCT01722045|983146|P1|COMPLETED|Overall Study||126
400993|NCT01722045|983146|P1|STARTED|Overall Study||154
400994|NCT01721967|983156|P1|NOT COMPLETED|Overall Study||3
400995|NCT01721967|983156|P1|COMPLETED|Overall Study||11
400996|NCT01721967|983156|P1|STARTED|Overall Study||14
400997|NCT01721837|983165|P1|NOT COMPLETED|Overall Study||0
400998|NCT01721837|983165|P1|COMPLETED|Overall Study||2120
400999|NCT01721837|983165|P1|STARTED|Overall Study||2120
401000|NCT01721772|983171|P2|NOT COMPLETED|Overall Study||192
401001|NCT01721772|983172|P1|NOT COMPLETED|Overall Study||111
401002|NCT01721772|983171|P2|COMPLETED|Overall Study|Continuing in treatment period|13
401003|NCT01721772|983172|P1|COMPLETED|Overall Study|Continuing in treatment period|95
401004|NCT01721772|983171|P2|STARTED|Overall Study||205
401005|NCT01721772|983172|P1|STARTED|Overall Study||206
401006|NCT01721759|983192|P1|NOT COMPLETED|Overall Study||102
401007|NCT01721759|983192|P1|COMPLETED|Overall Study|Completed=continuing to receive treatment|15
401008|NCT01721759|983192|P1|STARTED|Overall Study||117
401009|NCT01721746|983200|P3|NOT COMPLETED|Follow-Up Period||0
401010|NCT01721746|983201|P2|NOT COMPLETED|Follow-Up Period||0
401011|NCT01721746|983202|P1|NOT COMPLETED|Follow-Up Period||0
401012|NCT01721746|983200|P3|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|19
401013|NCT01721746|983201|P2|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|11
401014|NCT01721746|983202|P1|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|92
401015|NCT01721746|983200|P3|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|19
401016|NCT01721746|983201|P2|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|11
401017|NCT01721746|983202|P1|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|92
401018|NCT01721746|983200|P3|NOT COMPLETED|Treatment Period||57
401019|NCT01721746|983201|P2|NOT COMPLETED|Treatment Period||45
401020|NCT01721746|983202|P1|NOT COMPLETED|Treatment Period||233
401021|NCT01721746|983200|P3|COMPLETED|Treatment Period||0
401022|NCT01721746|983201|P2|COMPLETED|Treatment Period||0
401023|NCT01721746|983202|P1|COMPLETED|Treatment Period|Completed=Continuing in Treatment Period|35
401024|NCT01721746|983200|P3|STARTED|Treatment Period||57
401025|NCT01721746|983201|P2|STARTED|Treatment Period||45
401026|NCT01721746|983202|P1|STARTED|Treatment Period||268
401027|NCT01721681|983218|P1|NOT COMPLETED|Overall Study||0
401028|NCT01721681|983218|P1|COMPLETED|Overall Study||9
401029|NCT01721681|983218|P1|STARTED|Overall Study||9
401030|NCT01721603|983224|P1|NOT COMPLETED|Overall Study||0
401031|NCT01721603|983224|P1|COMPLETED|Overall Study||2
401032|NCT01721603|983224|P1|STARTED|Overall Study||2
401033|NCT01721564|983235|P1|NOT COMPLETED|Overall Study||0
401034|NCT01721564|983235|P1|COMPLETED|Overall Study||8
401035|NCT01721564|983235|P1|STARTED|Overall Study||8
401036|NCT01721486|983242|P2|NOT COMPLETED|Overall Study||1
401037|NCT01721486|983243|P1|NOT COMPLETED|Overall Study||1
401038|NCT01721486|983242|P2|COMPLETED|Overall Study||19
401039|NCT01721486|983243|P1|COMPLETED|Overall Study||20
401040|NCT01721486|983242|P2|STARTED|Overall Study||20
401041|NCT01721486|983243|P1|STARTED|Overall Study||21
401042|NCT01721460|983255|P1|NOT COMPLETED|Overall Study||1
401043|NCT01721460|983255|P1|COMPLETED|Overall Study||5
401044|NCT01721460|983255|P1|STARTED|Overall Study||6
401045|NCT01721408|983264|P2|NOT COMPLETED|Overall Study||24
401046|NCT01721408|983265|P1|NOT COMPLETED|Overall Study||36
401047|NCT01721408|983264|P2|COMPLETED|Overall Study||207
401048|NCT01721408|983265|P1|COMPLETED|Overall Study||196
401049|NCT01721408|983264|P2|STARTED|Overall Study|Number of participants treated.|231
401050|NCT01721408|983265|P1|STARTED|Overall Study|Number of participants treated.|232
401051|NCT01721330|983281|P2|NOT COMPLETED|Overall Study||1
401052|NCT01721330|983282|P1|NOT COMPLETED|Overall Study||0
401053|NCT01721330|983281|P2|COMPLETED|Overall Study||1
401054|NCT01721330|983282|P1|COMPLETED|Overall Study||1
401055|NCT01721330|983281|P2|STARTED|Overall Study||2
401056|NCT01721330|983282|P1|STARTED|Overall Study||1
401057|NCT01721317|983290|P2|NOT COMPLETED|Overall Study||4
401058|NCT01721317|983291|P1|NOT COMPLETED|Overall Study||2
401059|NCT01721317|983290|P2|COMPLETED|Overall Study||0
401060|NCT01721317|983291|P1|COMPLETED|Overall Study||0
401061|NCT01721317|983290|P2|STARTED|Overall Study||4
401062|NCT01721317|983291|P1|STARTED|Overall Study||2
401063|NCT01721226|983359|P2|NOT COMPLETED|Overall Study||7
401064|NCT01721226|983360|P1|NOT COMPLETED|Overall Study||5
401065|NCT01721226|983359|P2|COMPLETED|Overall Study||50
401066|NCT01721226|983360|P1|COMPLETED|Overall Study||50
401067|NCT01721226|983359|P2|Week 24|Overall Study||50
401068|NCT01721226|983360|P1|Week 24|Overall Study||50
401069|NCT01721226|983359|P2|Week 12|Overall Study||53
401070|NCT01721226|983360|P1|Week 12|Overall Study||48
401071|NCT01721226|983359|P2|Baseline|Overall Study||57
401072|NCT01721226|983360|P1|Baseline|Overall Study||53
401073|NCT01721226|983359|P2|STARTED|Overall Study||57
401074|NCT01721226|983360|P1|STARTED|Overall Study||55
401075|NCT01721200|983370|P2|NOT COMPLETED|Overall Study||5
401076|NCT01721200|983371|P1|NOT COMPLETED|Overall Study||3
401077|NCT01721200|983370|P2|COMPLETED|Overall Study||58
401078|NCT01721200|983371|P1|COMPLETED|Overall Study||59
401079|NCT01721200|983370|P2|Completed 2 Week Follow-up|Overall Study||61
401080|NCT01721200|983371|P1|Completed 2 Week Follow-up|Overall Study||60
401081|NCT01721200|983370|P2|STARTED|Overall Study||63
401082|NCT01721200|983371|P1|STARTED|Overall Study||62
401083|NCT01721161|983396|P2|NOT COMPLETED|Overall Study||7
401084|NCT01721161|983397|P1|NOT COMPLETED|Overall Study||4
401085|NCT01721161|983396|P2|COMPLETED|Overall Study||34
401086|NCT01721161|983397|P1|COMPLETED|Overall Study||37
401087|NCT01721161|983396|P2|STARTED|Overall Study||41
401088|NCT01721161|983397|P1|STARTED|Overall Study||41
401089|NCT01721109|983420|P1|NOT COMPLETED|Extension Phase||37
401090|NCT01721109|983420|P1|COMPLETED|Extension Phase|Participants turned 18 years old or the study drug became commercially available in their country.|3
401091|NCT01721109|983420|P1|STARTED|Extension Phase|Only 40 participants entered the optional extension phase.|40
401092|NCT01721109|983420|P1|NOT COMPLETED|Main Phase||1
401093|NCT01721109|983420|P1|COMPLETED|Main Phase||49
401094|NCT01721109|983420|P1|STARTED|Main Phase||50
401095|NCT01721096|983435|P2|NOT COMPLETED|Overall Study||10
401096|NCT01721096|983436|P1|NOT COMPLETED|Overall Study||27
401097|NCT01721096|983435|P2|COMPLETED|Overall Study||203
401098|NCT01721096|983436|P1|COMPLETED|Overall Study||296
401099|NCT01721096|983435|P2|STARTED|Overall Study||213
401100|NCT01721096|983436|P1|STARTED|Overall Study||323
401101|NCT01721070|983585|P1|NOT COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||1
401102|NCT01721070|983585|P1|COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||18
401103|NCT01721070|983585|P1|STARTED|Ketoconazole 400 mg and SUF NT 15 mcg||19
401104|NCT01721070|983585|P1|NOT COMPLETED|SUF NT 15 mcg||0
401105|NCT01721070|983585|P1|COMPLETED|SUF NT 15 mcg||19
401106|NCT01721070|983585|P1|STARTED|SUF NT 15 mcg||19
401107|NCT01721057|983596|P7|NOT COMPLETED|Follow Up||0
401108|NCT01721057|983597|P6|NOT COMPLETED|Follow Up||0
401109|NCT01721057|983598|P5|NOT COMPLETED|Follow Up||0
401110|NCT01721057|983599|P4|NOT COMPLETED|Follow Up||0
401111|NCT01721057|983600|P3|NOT COMPLETED|Follow Up||0
401112|NCT01721057|983601|P2|NOT COMPLETED|Follow Up||0
401113|NCT01721057|983602|P1|NOT COMPLETED|Follow Up||0
401114|NCT01721057|983596|P7|COMPLETED|Follow Up||22
401115|NCT01721057|983597|P6|COMPLETED|Follow Up||19
401116|NCT01721057|983598|P5|COMPLETED|Follow Up||17
401117|NCT01721057|983599|P4|COMPLETED|Follow Up||0
401118|NCT01721057|983600|P3|COMPLETED|Follow Up||0
401119|NCT01721057|983601|P2|COMPLETED|Follow Up||0
401120|NCT01721057|983602|P1|COMPLETED|Follow Up||0
401121|NCT01721057|983596|P7|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|22
401122|NCT01721057|983597|P6|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|19
401123|NCT01721057|983598|P5|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|17
401124|NCT01721057|983599|P4|STARTED|Follow Up|Rescued participants who entered post-treatment follow-up are included in Baricitinib 4 mg FollowUp|0
401125|NCT01721057|983600|P3|STARTED|Follow Up||0
401126|NCT01721057|983601|P2|STARTED|Follow Up||0
401127|NCT01721057|983602|P1|STARTED|Follow Up||0
401128|NCT01721057|983596|P7|NOT COMPLETED|Rescue Period||0
401129|NCT01721057|983597|P6|NOT COMPLETED|Rescue Period||0
401130|NCT01721057|983598|P5|NOT COMPLETED|Rescue Period||0
401131|NCT01721057|983599|P4|NOT COMPLETED|Rescue Period||3
401132|NCT01721057|983600|P3|NOT COMPLETED|Rescue Period||0
401133|NCT01721057|983601|P2|NOT COMPLETED|Rescue Period||0
401134|NCT01721057|983602|P1|NOT COMPLETED|Rescue Period||0
401135|NCT01721057|983596|P7|COMPLETED|Rescue Period||0
401136|NCT01721057|983597|P6|COMPLETED|Rescue Period||0
401137|NCT01721057|983598|P5|COMPLETED|Rescue Period||0
401138|NCT01721057|983599|P4|COMPLETED|Rescue Period||88
401139|NCT01721057|983600|P3|COMPLETED|Rescue Period||0
401140|NCT01721057|983601|P2|COMPLETED|Rescue Period||0
401141|NCT01721057|983602|P1|COMPLETED|Rescue Period||0
401142|NCT01721057|983596|P7|STARTED|Rescue Period||0
401143|NCT01721057|983597|P6|STARTED|Rescue Period||0
401144|NCT01721057|983598|P5|STARTED|Rescue Period||0
401145|NCT01721057|983599|P4|STARTED|Rescue Period|Participants who were determined to be nonresponders based on tender/swollen joint count.|91
401146|NCT01721057|983600|P3|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
401147|NCT01721057|983601|P2|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
401148|NCT01721057|983602|P1|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
401149|NCT01721057|983596|P7|NOT COMPLETED|Treatment Period||0
401150|NCT01721057|983597|P6|NOT COMPLETED|Treatment Period||0
401151|NCT01721057|983598|P5|NOT COMPLETED|Treatment Period||0
401152|NCT01721057|983599|P4|NOT COMPLETED|Treatment Period||0
401153|NCT01721057|983600|P3|NOT COMPLETED|Treatment Period||23
401154|NCT01721057|983601|P2|NOT COMPLETED|Treatment Period||19
401155|NCT01721057|983602|P1|NOT COMPLETED|Treatment Period||28
401156|NCT01721057|983596|P7|COMPLETED|Treatment Period||0
401157|NCT01721057|983597|P6|COMPLETED|Treatment Period||0
401158|NCT01721057|983598|P5|COMPLETED|Treatment Period||0
401159|NCT01721057|983599|P4|COMPLETED|Treatment Period||0
401160|NCT01721057|983600|P3|COMPLETED|Treatment Period|"Completers include rescued participants."|204
401161|NCT01721057|983601|P2|COMPLETED|Treatment Period|"Completers include rescued participants."|210
401162|NCT01721057|983602|P1|COMPLETED|Treatment Period|"Completers include rescued participants."|200
401163|NCT01721057|983596|P7|Rescued|Treatment Period||0
401164|NCT01721057|983597|P6|Rescued|Treatment Period||0
401165|NCT01721057|983598|P5|Rescued|Treatment Period||0
401166|NCT01721057|983599|P4|Rescued|Treatment Period||0
401167|NCT01721057|983600|P3|Rescued|Treatment Period||15
401168|NCT01721057|983601|P2|Rescued|Treatment Period||21
401169|NCT01721057|983602|P1|Rescued|Treatment Period||55
401170|NCT01721057|983596|P7|Received at Least 1 Dose of Study Drug|Treatment Period||0
401171|NCT01721057|983597|P6|Received at Least 1 Dose of Study Drug|Treatment Period||0
401172|NCT01721057|983598|P5|Received at Least 1 Dose of Study Drug|Treatment Period||0
401173|NCT01721057|983599|P4|Received at Least 1 Dose of Study Drug|Treatment Period||0
401174|NCT01721057|983600|P3|Received at Least 1 Dose of Study Drug|Treatment Period||227
401175|NCT01721057|983601|P2|Received at Least 1 Dose of Study Drug|Treatment Period||229
401176|NCT01721057|983602|P1|Received at Least 1 Dose of Study Drug|Treatment Period||228
401177|NCT01721057|983596|P7|STARTED|Treatment Period||0
401178|NCT01721057|983597|P6|STARTED|Treatment Period||0
401179|NCT01721057|983598|P5|STARTED|Treatment Period||0
401180|NCT01721057|983599|P4|STARTED|Treatment Period||0
401181|NCT01721057|983600|P3|STARTED|Treatment Period||227
401182|NCT01721057|983601|P2|STARTED|Treatment Period||229
401183|NCT01721057|983602|P1|STARTED|Treatment Period||228
401184|NCT01721044|983675|P3|NOT COMPLETED|Follow Up||0
401185|NCT01721044|983676|P2|NOT COMPLETED|Follow Up||0
401186|NCT01721044|983677|P1|NOT COMPLETED|Follow Up||0
401187|NCT01721044|983675|P3|COMPLETED|Follow Up||20
401188|NCT01721044|983676|P2|COMPLETED|Follow Up||9
401189|NCT01721044|983677|P1|COMPLETED|Follow Up||19
401190|NCT01721044|983675|P3|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|20
401191|NCT01721044|983676|P2|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|9
401192|NCT01721044|983677|P1|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|19
401193|NCT01721044|983675|P3|NOT COMPLETED|Treatment Period||19
401194|NCT01721044|983676|P2|NOT COMPLETED|Treatment Period||17
401195|NCT01721044|983677|P1|NOT COMPLETED|Treatment Period||32
401196|NCT01721044|983675|P3|COMPLETED|Treatment Period||158
401197|NCT01721044|983676|P2|COMPLETED|Treatment Period||157
401198|NCT01721044|983677|P1|COMPLETED|Treatment Period||144
401199|NCT01721044|983675|P3|Rescue Week 16-24|Treatment Period||33
401200|NCT01721044|983676|P2|Rescue Week 16-24|Treatment Period||38
401201|NCT01721044|983677|P1|Rescue Week 16-24|Treatment Period||56
401202|NCT01721044|983675|P3|STARTED|Treatment Period||177
401203|NCT01721044|983676|P2|STARTED|Treatment Period|Randomized to 4mg (N=11) but received 2mg due to moderate renal impairment were included in 4mg arm|174
401204|NCT01721044|983677|P1|STARTED|Treatment Period||176
401205|NCT01720797|983750|P2|NOT COMPLETED|Overall Study||0
401206|NCT01720797|983751|P1|NOT COMPLETED|Overall Study||3
401207|NCT01720797|983750|P2|COMPLETED|Overall Study||9
401208|NCT01720797|983751|P1|COMPLETED|Overall Study||9
401209|NCT01720797|983750|P2|STARTED|Overall Study||9
401210|NCT01720797|983751|P1|STARTED|Overall Study||12
401211|NCT01720602|983757|P1|NOT COMPLETED|Overall Study||5
401212|NCT01720602|983757|P1|COMPLETED|Overall Study||10
401213|NCT01720602|983757|P1|STARTED|Overall Study||15
401214|NCT01720446|983767|P4|NOT COMPLETED|Overall Study||20
401215|NCT01720446|983768|P3|NOT COMPLETED|Overall Study||20
401216|NCT01720446|983769|P2|NOT COMPLETED|Overall Study||11
401217|NCT01720446|983770|P1|NOT COMPLETED|Overall Study||14
401218|NCT01720446|983767|P4|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|805
401219|NCT01720446|983768|P3|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|804
401220|NCT01720446|983769|P2|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|811
401221|NCT01720446|983770|P1|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|812
401222|NCT01720446|983767|P4|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|159
401223|NCT01720446|983768|P3|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|151
401224|NCT01720446|983769|P2|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|186
401225|NCT01720446|983770|P1|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|164
401226|NCT01720446|983767|P4|STARTED|Overall Study||825
401227|NCT01720446|983768|P3|STARTED|Overall Study||824
401228|NCT01720446|983769|P2|STARTED|Overall Study||822
401229|NCT01720446|983770|P1|STARTED|Overall Study||826
401230|NCT01720316|983831|P2|NOT COMPLETED|Open-label Glycine||0
401231|NCT01720316|983832|P1|NOT COMPLETED|Open-label Glycine||0
401232|NCT01720316|983831|P2|COMPLETED|Open-label Glycine||1
401233|NCT01720316|983832|P1|COMPLETED|Open-label Glycine||1
401234|NCT01720316|983831|P2|STARTED|Open-label Glycine||1
401235|NCT01720316|983832|P1|STARTED|Open-label Glycine||1
401236|NCT01720316|983831|P2|NOT COMPLETED|Double-Blind Glycine Placebo Crossover||0
401237|NCT01720316|983832|P1|NOT COMPLETED|Double-Blind Glycine Placebo Crossover||0
401238|NCT01720316|983831|P2|COMPLETED|Double-Blind Glycine Placebo Crossover||1
401239|NCT01720316|983832|P1|COMPLETED|Double-Blind Glycine Placebo Crossover||1
401240|NCT01720316|983831|P2|STARTED|Double-Blind Glycine Placebo Crossover||1
401241|NCT01720316|983832|P1|STARTED|Double-Blind Glycine Placebo Crossover||1
401242|NCT01720277|983880|P2|NOT COMPLETED|Overall Study||558
401243|NCT01720277|983881|P1|NOT COMPLETED|Overall Study||503
401244|NCT01720277|983880|P2|COMPLETED|Overall Study|intent-to-treat approach|938
401245|NCT01720277|983881|P1|COMPLETED|Overall Study|intent-to-treat approach|958
401246|NCT01720277|983880|P2|STARTED|Overall Study||1496
401247|NCT01720277|983881|P1|STARTED|Overall Study||1461
401248|NCT01720251|983894|P3|NOT COMPLETED|Overall Study||0
401249|NCT01720251|983895|P2|NOT COMPLETED|Overall Study||2
401250|NCT01720251|983896|P1|NOT COMPLETED|Overall Study||1
401251|NCT01720251|983894|P3|COMPLETED|Overall Study||82
401252|NCT01720251|983895|P2|COMPLETED|Overall Study||77
401253|NCT01720251|983896|P1|COMPLETED|Overall Study||78
401254|NCT01720251|983894|P3|STARTED|Overall Study||82
401255|NCT01720251|983895|P2|STARTED|Overall Study||79
401256|NCT01720251|983896|P1|STARTED|Overall Study||79
401257|NCT01720173|983904|P1|NOT COMPLETED|Overall Study||0
401258|NCT01720173|983904|P1|COMPLETED|Overall Study||30
401259|NCT01720173|983904|P1|STARTED|Overall Study||30
401260|NCT01720043|983912|P1|NOT COMPLETED|Overall Study||1
401261|NCT01720043|983912|P1|COMPLETED|Overall Study||7
401262|NCT01720043|983912|P1|STARTED|Overall Study||8
401263|NCT01719861|983916|P1|NOT COMPLETED|Cycle 2||1
401264|NCT01719861|983916|P1|COMPLETED|Cycle 2||1
401265|NCT01719861|983916|P1|STARTED|Cycle 2||2
401266|NCT01719861|983916|P1|NOT COMPLETED|Cycle 1||4
401267|NCT01719861|983916|P1|COMPLETED|Cycle 1||2
401268|NCT01719861|983916|P1|STARTED|Cycle 1||6
401269|NCT01719757|983924|P1|NOT COMPLETED|Overall Study||101
401270|NCT01719757|983924|P1|COMPLETED|Overall Study||258
401271|NCT01719757|983924|P1|STARTED|Overall Study||359
401272|NCT01719744|983932|P1|NOT COMPLETED|Overall Study||0
401273|NCT01719744|983932|P1|COMPLETED|Overall Study||25
401274|NCT01719744|983932|P1|STARTED|Overall Study||25
401275|NCT01719653|983943|P5|NOT COMPLETED|Overall Study||21
401276|NCT01719653|983944|P4|NOT COMPLETED|Overall Study||18
401277|NCT01719653|983945|P3|NOT COMPLETED|Overall Study||18
401278|NCT01719653|983946|P2|NOT COMPLETED|Overall Study||13
401279|NCT01719653|983947|P1|NOT COMPLETED|Overall Study||9
401280|NCT01719653|983943|P5|COMPLETED|Overall Study||200
401281|NCT01719653|983944|P4|COMPLETED|Overall Study||200
401282|NCT01719653|983945|P3|COMPLETED|Overall Study||200
401283|NCT01719653|983946|P2|COMPLETED|Overall Study||200
401284|NCT01719653|983947|P1|COMPLETED|Overall Study||200
401285|NCT01719653|983943|P5|STARTED|Overall Study||221
401286|NCT01719653|983944|P4|STARTED|Overall Study||218
401287|NCT01719653|983945|P3|STARTED|Overall Study||218
401288|NCT01719653|983946|P2|STARTED|Overall Study||213
401289|NCT01719653|983947|P1|STARTED|Overall Study||209
401290|NCT01719224|983969|P2|NOT COMPLETED|Intervention 2: Position Change(At 3.5h)||0
401291|NCT01719224|983970|P1|NOT COMPLETED|Intervention 2: Position Change(At 3.5h)||0
401292|NCT01719224|983969|P2|COMPLETED|Intervention 2: Position Change(At 3.5h)||16
401293|NCT01719224|983970|P1|COMPLETED|Intervention 2: Position Change(At 3.5h)||14
401294|NCT01719224|983969|P2|STARTED|Intervention 2: Position Change(At 3.5h)||16
401295|NCT01719224|983970|P1|STARTED|Intervention 2: Position Change(At 3.5h)||14
401296|NCT01719224|983969|P2|NOT COMPLETED|Intervention 1: Sleeping Position 1||2
401297|NCT01719224|983970|P1|NOT COMPLETED|Intervention 1: Sleeping Position 1||4
401298|NCT01719224|983969|P2|COMPLETED|Intervention 1: Sleeping Position 1||16
401299|NCT01719224|983970|P1|COMPLETED|Intervention 1: Sleeping Position 1||14
401300|NCT01719224|983969|P2|STARTED|Intervention 1: Sleeping Position 1||18
401301|NCT01719224|983970|P1|STARTED|Intervention 1: Sleeping Position 1||18
401302|NCT01719172|983979|P1|NOT COMPLETED|Overall Study||2
401303|NCT01719172|983979|P1|COMPLETED|Overall Study||28
401304|NCT01719172|983979|P1|STARTED|Overall Study||30
401305|NCT01719003|983993|P9|NOT COMPLETED|Overall Study||4
401306|NCT01719003|983994|P8|NOT COMPLETED|Overall Study||20
401307|NCT01719003|983995|P7|NOT COMPLETED|Overall Study||20
401308|NCT01719003|983996|P6|NOT COMPLETED|Overall Study||12
401309|NCT01719003|983997|P5|NOT COMPLETED|Overall Study||17
401310|NCT01719003|983998|P4|NOT COMPLETED|Overall Study||13
401311|NCT01719003|983999|P3|NOT COMPLETED|Overall Study||17
401312|NCT01719003|984000|P2|NOT COMPLETED|Overall Study||17
401313|NCT01719003|984001|P1|NOT COMPLETED|Overall Study||9
401314|NCT01719003|983993|P9|COMPLETED|Overall Study||49
401315|NCT01719003|983994|P8|COMPLETED|Overall Study||151
401316|NCT01719003|983995|P7|COMPLETED|Overall Study||150
401317|NCT01719003|983996|P6|COMPLETED|Overall Study||160
401318|NCT01719003|983997|P5|COMPLETED|Overall Study||150
401319|NCT01719003|983998|P4|COMPLETED|Overall Study||156
401320|NCT01719003|983999|P3|COMPLETED|Overall Study||154
401321|NCT01719003|984000|P2|COMPLETED|Overall Study||153
401322|NCT01719003|984001|P1|COMPLETED|Overall Study||161
401323|NCT01719003|983993|P9|STARTED|Overall Study||53
401324|NCT01719003|983994|P8|STARTED|Overall Study||171
401325|NCT01719003|983995|P7|STARTED|Overall Study||170
401326|NCT01719003|983996|P6|STARTED|Overall Study||172
401327|NCT01719003|983997|P5|STARTED|Overall Study||167
401328|NCT01719003|983998|P4|STARTED|Overall Study||169
401329|NCT01719003|983999|P3|STARTED|Overall Study||171
401330|NCT01719003|984000|P2|STARTED|Overall Study||170
401331|NCT01719003|984001|P1|STARTED|Overall Study||170
401332|NCT01718691|984038|P2|NOT COMPLETED|Overall Study||1
401333|NCT01718691|984039|P1|NOT COMPLETED|Overall Study||18
401334|NCT01718691|984038|P2|COMPLETED|Overall Study||9
401335|NCT01718691|984039|P1|COMPLETED|Overall Study||42
401336|NCT01718691|984038|P2|STARTED|Overall Study||10
401337|NCT01718691|984039|P1|STARTED|Overall Study||60
401338|NCT01718535|984082|P10|NOT COMPLETED|Overall Study||0
401339|NCT01718535|984083|P9|NOT COMPLETED|Overall Study||0
401340|NCT01718535|984084|P8|NOT COMPLETED|Overall Study||0
401341|NCT01718535|984085|P7|NOT COMPLETED|Overall Study||0
401342|NCT01718535|984086|P6|NOT COMPLETED|Overall Study||0
401343|NCT01718535|984087|P5|NOT COMPLETED|Overall Study||0
401344|NCT01718535|984088|P4|NOT COMPLETED|Overall Study||1
401345|NCT01718535|984089|P3|NOT COMPLETED|Overall Study||0
401346|NCT01718535|984090|P2|NOT COMPLETED|Overall Study||0
401347|NCT01718535|984091|P1|NOT COMPLETED|Overall Study||1
401348|NCT01718535|984082|P10|COMPLETED|Overall Study||1
401349|NCT01718535|984083|P9|COMPLETED|Overall Study||15
401350|NCT01718535|984084|P8|COMPLETED|Overall Study||6
401351|NCT01718535|984085|P7|COMPLETED|Overall Study||11
401352|NCT01718535|984086|P6|COMPLETED|Overall Study||40
401353|NCT01718535|984087|P5|COMPLETED|Overall Study||1
401354|NCT01718535|984088|P4|COMPLETED|Overall Study||7
401355|NCT01718535|984089|P3|COMPLETED|Overall Study||19
401356|NCT01718535|984090|P2|COMPLETED|Overall Study||95
401357|NCT01718535|984091|P1|COMPLETED|Overall Study||130
401358|NCT01718535|984082|P10|First Pass|Overall Study||1
401359|NCT01718535|984083|P9|First Pass|Overall Study||15
401360|NCT01718535|984084|P8|First Pass|Overall Study||6
401361|NCT01718535|984085|P7|First Pass|Overall Study||11
401362|NCT01718535|984086|P6|First Pass|Overall Study||39
401363|NCT01718535|984087|P5|First Pass|Overall Study||1
401364|NCT01718535|984088|P4|First Pass|Overall Study||7
401365|NCT01718535|984089|P3|First Pass|Overall Study||19
401366|NCT01718535|984090|P2|First Pass|Overall Study||94
401367|NCT01718535|984091|P1|First Pass|Overall Study||128
401368|NCT01718535|984082|P10|STARTED|Overall Study||1
401369|NCT01718535|984083|P9|STARTED|Overall Study||15
401370|NCT01718535|984084|P8|STARTED|Overall Study||6
401371|NCT01718535|984085|P7|STARTED|Overall Study||11
401372|NCT01718535|984086|P6|STARTED|Overall Study||40
401373|NCT01718535|984087|P5|STARTED|Overall Study||1
401374|NCT01718535|984088|P4|STARTED|Overall Study||8
401375|NCT01718535|984089|P3|STARTED|Overall Study||19
401376|NCT01718535|984090|P2|STARTED|Overall Study||95
401377|NCT01718535|984091|P1|STARTED|Overall Study||131
401378|NCT01718509|984115|P2|NOT COMPLETED|Overall Study||48
401379|NCT01718509|984116|P1|NOT COMPLETED|Overall Study||48
401380|NCT01718509|984115|P2|COMPLETED|Overall Study||147
401381|NCT01718509|984116|P1|COMPLETED|Overall Study||147
401382|NCT01718509|984115|P2|STARTED|Overall Study||195
401383|NCT01718509|984116|P1|STARTED|Overall Study||195
401384|NCT01718483|984162|P2|NOT COMPLETED|Overall Study||34
401385|NCT01718483|984163|P1|NOT COMPLETED|Overall Study||34
401386|NCT01718483|984162|P2|COMPLETED|Overall Study||158
401387|NCT01718483|984163|P1|COMPLETED|Overall Study||157
401388|NCT01718483|984162|P2|Treated|Overall Study||192
401389|NCT01718483|984163|P1|Treated|Overall Study||187
401390|NCT01718483|984162|P2|STARTED|Overall Study||192
401391|NCT01718483|984163|P1|STARTED|Overall Study||191
401392|NCT01718353|984209|P2|NOT COMPLETED|Overall Study||5
401393|NCT01718353|984210|P1|NOT COMPLETED|Overall Study||12
401394|NCT01718353|984209|P2|COMPLETED|Overall Study|Participants at study cut-off, AE, DP and consent withdrawn were considered completed.|17
401395|NCT01718353|984210|P1|COMPLETED|Overall Study|Participants at study cut-off, Adverse Event (AE), DP & consent withdrawn were considered completed.|29
401396|NCT01718353|984209|P2|Treated From Cycle 5|Overall Study|3 participants switched from Treatment B to A & 12 participants switched from Treatment A to B.|25
401397|NCT01718353|984210|P1|Treated From Cycle 5|Overall Study|12 participants switched from Treatment A to B & 3 participants switched from Treatment B to A.|23
401398|NCT01718353|984209|P2|Treated up to End of Cycle 4|Overall Study|6 participants discontinued before Cycle 5|16
401399|NCT01718353|984210|P1|Treated up to End of Cycle 4|Overall Study|7 participants discontinued before Cycle 5|32
401400|NCT01718353|984209|P2|Treated|Overall Study||22
401401|NCT01718353|984210|P1|Treated|Overall Study||39
401402|NCT01718353|984209|P2|STARTED|Overall Study||22
401403|NCT01718353|984210|P1|STARTED|Overall Study||41
401404|NCT01718028|984228|P2|NOT COMPLETED|Overall Study||0
401405|NCT01718028|984229|P1|NOT COMPLETED|Overall Study||0
401406|NCT01718028|984228|P2|COMPLETED|Overall Study||24
401407|NCT01718028|984229|P1|COMPLETED|Overall Study||25
401408|NCT01718028|984228|P2|STARTED|Overall Study||24
401409|NCT01718028|984229|P1|STARTED|Overall Study||25
401410|NCT01717989|984241|P1|NOT COMPLETED|Overall Study||1066
401411|NCT01717989|984241|P1|COMPLETED|Overall Study||1182
401412|NCT01717989|984241|P1|STARTED|Overall Study||2248
401413|NCT01717976|984309|P2|NOT COMPLETED|Overall Study||1
401414|NCT01717976|984310|P1|NOT COMPLETED|Overall Study||0
401415|NCT01717976|984309|P2|COMPLETED|Overall Study||256
401416|NCT01717976|984310|P1|COMPLETED|Overall Study||257
401417|NCT01717976|984309|P2|STARTED|Overall Study||257
401418|NCT01717976|984310|P1|STARTED|Overall Study||257
401419|NCT01717898|984324|P4|NOT COMPLETED|Overall Study||0
401420|NCT01717898|984325|P3|NOT COMPLETED|Overall Study||0
401421|NCT01717898|984326|P2|NOT COMPLETED|Overall Study||0
401422|NCT01717898|984327|P1|NOT COMPLETED|Overall Study||6
401423|NCT01717898|984324|P4|COMPLETED|Overall Study||0
401424|NCT01717898|984325|P3|COMPLETED|Overall Study||0
401425|NCT01717898|984326|P2|COMPLETED|Overall Study||0
401426|NCT01717898|984327|P1|COMPLETED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
401427|NCT01717898|984324|P4|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
401428|NCT01717898|984325|P3|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
401429|NCT01717898|984326|P2|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
401430|NCT01717898|984327|P1|STARTED|Overall Study||6
401431|NCT01717872|984354|P2|NOT COMPLETED|Overall Study||0
401432|NCT01717872|984355|P1|NOT COMPLETED|Overall Study||0
401433|NCT01717872|984354|P2|COMPLETED|Overall Study||25
401434|NCT01717872|984355|P1|COMPLETED|Overall Study||25
401435|NCT01717872|984354|P2|STARTED|Overall Study||25
401436|NCT01717872|984355|P1|STARTED|Overall Study||25
401437|NCT01717768|984375|P12|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
401438|NCT01717768|984376|P11|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
401439|NCT01717768|984377|P10|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||1
401440|NCT01717768|984378|P9|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
401441|NCT01717768|984379|P8|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||2
401442|NCT01717768|984380|P7|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
401443|NCT01717768|984381|P6|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
401444|NCT01717768|984382|P5|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
401445|NCT01717768|984383|P4|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
401446|NCT01717768|984384|P3|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
401447|NCT01717768|984385|P2|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
401448|NCT01717768|984386|P1|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
401449|NCT01717768|984375|P12|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
401450|NCT01717768|984376|P11|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
401451|NCT01717768|984377|P10|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15
401452|NCT01717768|984378|P9|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
401453|NCT01717768|984379|P8|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15
401454|NCT01717768|984380|P7|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
401455|NCT01717768|984381|P6|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
401456|NCT01717768|984382|P5|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
401457|NCT01717768|984383|P4|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
401458|NCT01717768|984384|P3|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
401459|NCT01717768|984385|P2|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
401460|NCT01717768|984386|P1|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
401461|NCT01717768|984375|P12|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
401462|NCT01717768|984376|P11|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
401463|NCT01717768|984377|P10|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||16
401464|NCT01717768|984378|P9|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
401465|NCT01717768|984379|P8|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||17
401466|NCT01717768|984380|P7|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
401467|NCT01717768|984381|P6|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
401468|NCT01717768|984382|P5|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
401469|NCT01717768|984383|P4|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
401470|NCT01717768|984384|P3|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
401471|NCT01717768|984385|P2|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
401472|NCT01717768|984386|P1|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
401473|NCT01717768|984375|P12|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||1
401474|NCT01717768|984376|P11|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
401475|NCT01717768|984377|P10|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
401476|NCT01717768|984378|P9|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
401477|NCT01717768|984379|P8|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
401478|NCT01717768|984380|P7|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
401479|NCT01717768|984381|P6|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
401480|NCT01717768|984382|P5|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
401481|NCT01717768|984383|P4|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
401482|NCT01717768|984384|P3|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
401483|NCT01717768|984385|P2|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
401484|NCT01717768|984386|P1|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
401485|NCT01717768|984375|P12|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||15
401486|NCT01717768|984376|P11|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16
401487|NCT01717768|984377|P10|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
401488|NCT01717768|984378|P9|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16
401489|NCT01717768|984379|P8|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
401490|NCT01717768|984380|P7|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||17
401491|NCT01717768|984381|P6|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
401492|NCT01717768|984382|P5|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
401493|NCT01717768|984383|P4|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
401494|NCT01717768|984384|P3|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
401495|NCT01717768|984385|P2|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
401496|NCT01717768|984386|P1|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
401497|NCT01717768|984375|P12|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
401498|NCT01717768|984376|P11|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
401499|NCT01717768|984377|P10|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
401500|NCT01717768|984378|P9|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
401501|NCT01717768|984379|P8|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
401502|NCT01717768|984380|P7|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||17
401503|NCT01717768|984381|P6|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
401504|NCT01717768|984382|P5|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
401505|NCT01717768|984383|P4|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
401506|NCT01717768|984384|P3|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
401507|NCT01717768|984385|P2|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
401508|NCT01717768|984386|P1|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
401509|NCT01717768|984375|P12|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
401510|NCT01717768|984376|P11|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
401511|NCT01717768|984377|P10|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
401512|NCT01717768|984378|P9|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
401513|NCT01717768|984379|P8|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
401514|NCT01717768|984380|P7|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
401515|NCT01717768|984381|P6|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
401516|NCT01717768|984382|P5|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
401517|NCT01717768|984383|P4|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
401518|NCT01717768|984384|P3|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
401519|NCT01717768|984385|P2|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
401520|NCT01717768|984386|P1|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
401521|NCT01717768|984375|P12|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
401522|NCT01717768|984376|P11|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
401523|NCT01717768|984377|P10|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
401524|NCT01717768|984378|P9|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
401525|NCT01717768|984379|P8|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
401526|NCT01717768|984380|P7|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
401527|NCT01717768|984381|P6|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5
401528|NCT01717768|984382|P5|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5
401529|NCT01717768|984383|P4|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||4
401530|NCT01717768|984384|P3|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
401531|NCT01717768|984385|P2|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
401532|NCT01717768|984386|P1|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
401533|NCT01717768|984375|P12|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
401534|NCT01717768|984376|P11|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
401535|NCT01717768|984377|P10|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
401536|NCT01717768|984378|P9|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
401537|NCT01717768|984379|P8|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
401538|NCT01717768|984380|P7|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
401539|NCT01717768|984381|P6|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5
401540|NCT01717768|984382|P5|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5
401541|NCT01717768|984383|P4|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||4
401542|NCT01717768|984384|P3|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
401543|NCT01717768|984385|P2|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
401544|NCT01717768|984386|P1|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
401545|NCT01717768|984375|P12|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
401546|NCT01717768|984376|P11|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
401547|NCT01717768|984377|P10|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
401548|NCT01717768|984378|P9|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
401549|NCT01717768|984379|P8|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
401550|NCT01717768|984380|P7|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
401551|NCT01717768|984381|P6|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
401552|NCT01717768|984382|P5|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
401553|NCT01717768|984383|P4|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
401554|NCT01717768|984384|P3|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
401555|NCT01717768|984385|P2|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
401556|NCT01717768|984386|P1|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
401557|NCT01717768|984375|P12|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
401558|NCT01717768|984376|P11|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
401559|NCT01717768|984377|P10|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
401560|NCT01717768|984378|P9|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
401561|NCT01717768|984379|P8|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
401562|NCT01717768|984380|P7|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
401563|NCT01717768|984381|P6|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5
401564|NCT01717768|984382|P5|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5
401565|NCT01717768|984383|P4|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||4
401566|NCT01717768|984384|P3|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
401567|NCT01717768|984385|P2|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
401568|NCT01717768|984386|P1|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
401569|NCT01717768|984375|P12|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
401570|NCT01717768|984376|P11|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
401571|NCT01717768|984377|P10|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
401572|NCT01717768|984378|P9|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
401573|NCT01717768|984379|P8|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
401574|NCT01717768|984380|P7|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
401575|NCT01717768|984381|P6|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5
401576|NCT01717768|984382|P5|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5
401577|NCT01717768|984383|P4|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||4
401578|NCT01717768|984384|P3|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
401579|NCT01717768|984385|P2|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
401580|NCT01717768|984386|P1|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
401581|NCT01717768|984375|P12|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
401582|NCT01717768|984376|P11|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
401583|NCT01717768|984377|P10|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
401584|NCT01717768|984378|P9|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
401585|NCT01717768|984379|P8|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
401586|NCT01717768|984380|P7|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
401587|NCT01717768|984381|P6|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
401588|NCT01717768|984382|P5|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
401589|NCT01717768|984383|P4|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
401590|NCT01717768|984384|P3|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
401591|NCT01717768|984385|P2|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
401592|NCT01717768|984386|P1|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
401593|NCT01717768|984375|P12|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
401594|NCT01717768|984376|P11|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
401595|NCT01717768|984377|P10|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
401596|NCT01717768|984378|P9|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
401597|NCT01717768|984379|P8|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
401598|NCT01717768|984380|P7|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
401599|NCT01717768|984381|P6|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5
401600|NCT01717768|984382|P5|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5
401601|NCT01717768|984383|P4|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||4
401602|NCT01717768|984384|P3|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
401603|NCT01717768|984385|P2|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
401604|NCT01717768|984386|P1|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
401605|NCT01717768|984375|P12|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
401606|NCT01717768|984376|P11|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
401607|NCT01717768|984377|P10|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
401608|NCT01717768|984378|P9|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
401609|NCT01717768|984379|P8|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
401610|NCT01717768|984380|P7|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
401611|NCT01717768|984381|P6|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5
401612|NCT01717768|984382|P5|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5
401613|NCT01717768|984383|P4|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||4
401614|NCT01717768|984384|P3|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
401615|NCT01717768|984385|P2|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
401616|NCT01717768|984386|P1|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
401617|NCT01717768|984375|P12|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
401618|NCT01717768|984376|P11|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
401619|NCT01717768|984377|P10|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
401620|NCT01717768|984378|P9|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
401621|NCT01717768|984379|P8|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
401622|NCT01717768|984380|P7|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
401623|NCT01717768|984381|P6|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
401624|NCT01717768|984382|P5|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
401625|NCT01717768|984383|P4|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
401626|NCT01717768|984384|P3|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
401627|NCT01717768|984385|P2|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
401628|NCT01717768|984386|P1|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
401629|NCT01717768|984375|P12|COMPLETED|Part 2 (Duration of 15 Days)||0
401630|NCT01717768|984376|P11|COMPLETED|Part 2 (Duration of 15 Days)||0
401631|NCT01717768|984377|P10|COMPLETED|Part 2 (Duration of 15 Days)||0
401632|NCT01717768|984378|P9|COMPLETED|Part 2 (Duration of 15 Days)||0
401633|NCT01717768|984379|P8|COMPLETED|Part 2 (Duration of 15 Days)||0
401634|NCT01717768|984380|P7|COMPLETED|Part 2 (Duration of 15 Days)||0
401635|NCT01717768|984381|P6|COMPLETED|Part 2 (Duration of 15 Days)||0
401636|NCT01717768|984382|P5|COMPLETED|Part 2 (Duration of 15 Days)||0
401637|NCT01717768|984383|P4|COMPLETED|Part 2 (Duration of 15 Days)||0
401638|NCT01717768|984384|P3|COMPLETED|Part 2 (Duration of 15 Days)||17
401639|NCT01717768|984385|P2|COMPLETED|Part 2 (Duration of 15 Days)||0
401640|NCT01717768|984386|P1|COMPLETED|Part 2 (Duration of 15 Days)||0
401641|NCT01717768|984375|P12|STARTED|Part 2 (Duration of 15 Days)||0
401642|NCT01717768|984376|P11|STARTED|Part 2 (Duration of 15 Days)||0
401643|NCT01717768|984377|P10|STARTED|Part 2 (Duration of 15 Days)||0
401644|NCT01717768|984378|P9|STARTED|Part 2 (Duration of 15 Days)||0
401645|NCT01717768|984379|P8|STARTED|Part 2 (Duration of 15 Days)||0
401646|NCT01717768|984380|P7|STARTED|Part 2 (Duration of 15 Days)||0
401647|NCT01717768|984381|P6|STARTED|Part 2 (Duration of 15 Days)||0
401648|NCT01717768|984382|P5|STARTED|Part 2 (Duration of 15 Days)||0
401649|NCT01717768|984383|P4|STARTED|Part 2 (Duration of 15 Days)||0
401650|NCT01717768|984384|P3|STARTED|Part 2 (Duration of 15 Days)||17
401651|NCT01717768|984385|P2|STARTED|Part 2 (Duration of 15 Days)||0
401652|NCT01717768|984386|P1|STARTED|Part 2 (Duration of 15 Days)||0
401653|NCT01717768|984375|P12|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
401654|NCT01717768|984376|P11|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
401655|NCT01717768|984377|P10|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
401656|NCT01717768|984378|P9|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
401657|NCT01717768|984379|P8|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
401658|NCT01717768|984380|P7|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
401659|NCT01717768|984381|P6|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
401660|NCT01717768|984382|P5|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
401661|NCT01717768|984383|P4|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
401662|NCT01717768|984384|P3|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
401663|NCT01717768|984385|P2|NOT COMPLETED|Part 1 (Duration of 15 Days)||1
401664|NCT01717768|984386|P1|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
401665|NCT01717768|984375|P12|COMPLETED|Part 1 (Duration of 15 Days)||0
401666|NCT01717768|984376|P11|COMPLETED|Part 1 (Duration of 15 Days)||0
401667|NCT01717768|984377|P10|COMPLETED|Part 1 (Duration of 15 Days)||0
401668|NCT01717768|984378|P9|COMPLETED|Part 1 (Duration of 15 Days)||0
401669|NCT01717768|984379|P8|COMPLETED|Part 1 (Duration of 15 Days)||0
401670|NCT01717768|984380|P7|COMPLETED|Part 1 (Duration of 15 Days)||0
401671|NCT01717768|984381|P6|COMPLETED|Part 1 (Duration of 15 Days)||0
401672|NCT01717768|984382|P5|COMPLETED|Part 1 (Duration of 15 Days)||0
401673|NCT01717768|984383|P4|COMPLETED|Part 1 (Duration of 15 Days)||0
401674|NCT01717768|984384|P3|COMPLETED|Part 1 (Duration of 15 Days)||0
401675|NCT01717768|984385|P2|COMPLETED|Part 1 (Duration of 15 Days)||16
401676|NCT01717768|984386|P1|COMPLETED|Part 1 (Duration of 15 Days)||17
401677|NCT01717768|984375|P12|STARTED|Part 1 (Duration of 15 Days)||0
401678|NCT01717768|984376|P11|STARTED|Part 1 (Duration of 15 Days)||0
401679|NCT01717768|984377|P10|STARTED|Part 1 (Duration of 15 Days)||0
401680|NCT01717768|984378|P9|STARTED|Part 1 (Duration of 15 Days)||0
401681|NCT01717768|984379|P8|STARTED|Part 1 (Duration of 15 Days)||0
401682|NCT01717768|984380|P7|STARTED|Part 1 (Duration of 15 Days)||0
401683|NCT01717768|984381|P6|STARTED|Part 1 (Duration of 15 Days)||0
401684|NCT01717768|984382|P5|STARTED|Part 1 (Duration of 15 Days)||0
401685|NCT01717768|984383|P4|STARTED|Part 1 (Duration of 15 Days)||0
401686|NCT01717768|984384|P3|STARTED|Part 1 (Duration of 15 Days)||0
401687|NCT01717768|984385|P2|STARTED|Part 1 (Duration of 15 Days)||17
401688|NCT01717768|984386|P1|STARTED|Part 1 (Duration of 15 Days)||17
401689|NCT01717638|984437|P13|NOT COMPLETED|Overall Study||19
401690|NCT01717638|984438|P12|NOT COMPLETED|Overall Study||0
401691|NCT01717638|984439|P11|NOT COMPLETED|Overall Study||0
401692|NCT01717638|984440|P10|NOT COMPLETED|Overall Study||1
401693|NCT01717638|984441|P9|NOT COMPLETED|Overall Study||2
401694|NCT01717638|984442|P8|NOT COMPLETED|Overall Study||1
401695|NCT01717638|984443|P7|NOT COMPLETED|Overall Study||2
401696|NCT01717638|984444|P6|NOT COMPLETED|Overall Study||1
401697|NCT01717638|984445|P5|NOT COMPLETED|Overall Study||1
401698|NCT01717638|984446|P4|NOT COMPLETED|Overall Study||0
401699|NCT01717638|984447|P3|NOT COMPLETED|Overall Study||1
401700|NCT01717638|984448|P2|NOT COMPLETED|Overall Study||1
401701|NCT01717638|984449|P1|NOT COMPLETED|Overall Study||0
401702|NCT01717638|984437|P13|COMPLETED|Overall Study||190
401703|NCT01717638|984438|P12|COMPLETED|Overall Study||12
401704|NCT01717638|984439|P11|COMPLETED|Overall Study||11
401705|NCT01717638|984440|P10|COMPLETED|Overall Study||99
401706|NCT01717638|984441|P9|COMPLETED|Overall Study||26
401707|NCT01717638|984442|P8|COMPLETED|Overall Study||28
401708|NCT01717638|984443|P7|COMPLETED|Overall Study||41
401709|NCT01717638|984444|P6|COMPLETED|Overall Study||54
401710|NCT01717638|984445|P5|COMPLETED|Overall Study||63
401711|NCT01717638|984446|P4|COMPLETED|Overall Study||66
401712|NCT01717638|984447|P3|COMPLETED|Overall Study||59
401713|NCT01717638|984448|P2|COMPLETED|Overall Study||60
401714|NCT01717638|984449|P1|COMPLETED|Overall Study||67
401715|NCT01717638|984437|P13|STARTED|Overall Study||209
401716|NCT01717638|984438|P12|STARTED|Overall Study||12
401717|NCT01717638|984439|P11|STARTED|Overall Study||11
401718|NCT01717638|984440|P10|STARTED|Overall Study||100
401719|NCT01717638|984441|P9|STARTED|Overall Study||28
401720|NCT01717638|984442|P8|STARTED|Overall Study||29
401721|NCT01717638|984443|P7|STARTED|Overall Study||43
401722|NCT01717638|984444|P6|STARTED|Overall Study||55
401723|NCT01717638|984445|P5|STARTED|Overall Study||64
401724|NCT01717638|984446|P4|STARTED|Overall Study||66
401725|NCT01717638|984447|P3|STARTED|Overall Study||60
401726|NCT01717638|984448|P2|STARTED|Overall Study||61
401727|NCT01717638|984449|P1|STARTED|Overall Study||67
401728|NCT01717456|984593|P2|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4
401729|NCT01717456|984594|P1|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4
401730|NCT01717456|984593|P2|COMPLETED|Follow-Up 6 Months After End of Tx||2
401731|NCT01717456|984594|P1|COMPLETED|Follow-Up 6 Months After End of Tx||7
401732|NCT01717456|984593|P2|STARTED|Follow-Up 6 Months After End of Tx||6
401733|NCT01717456|984594|P1|STARTED|Follow-Up 6 Months After End of Tx||11
401734|NCT01717456|984593|P2|NOT COMPLETED|End of Treatment||2
401735|NCT01717456|984594|P1|NOT COMPLETED|End of Treatment||0
401736|NCT01717456|984593|P2|COMPLETED|End of Treatment||6
401737|NCT01717456|984594|P1|COMPLETED|End of Treatment||11
401738|NCT01717456|984593|P2|STARTED|End of Treatment||8
401739|NCT01717456|984594|P1|STARTED|End of Treatment||11
401740|NCT01717391|984662|P1|NOT COMPLETED|Overall Study||9
401741|NCT01717391|984662|P1|COMPLETED|Overall Study||27
401742|NCT01717391|984662|P1|STARTED|Overall Study||36
401743|NCT01717326|984691|P20|NOT COMPLETED|Overall Study||6
401744|NCT01717326|984692|P19|NOT COMPLETED|Overall Study||4
401745|NCT01717326|984693|P18|NOT COMPLETED|Overall Study||0
401746|NCT01717326|984694|P17|NOT COMPLETED|Overall Study||1
401747|NCT01717326|984695|P16|NOT COMPLETED|Overall Study||3
401748|NCT01717326|984696|P15|NOT COMPLETED|Overall Study||0
401749|NCT01717326|984697|P14|NOT COMPLETED|Overall Study||0
401750|NCT01717326|984698|P13|NOT COMPLETED|Overall Study||1
401751|NCT01717326|984699|P12|NOT COMPLETED|Overall Study||0
401752|NCT01717326|984700|P11|NOT COMPLETED|Overall Study||2
401753|NCT01717326|984701|P10|NOT COMPLETED|Overall Study||2
401754|NCT01717326|984702|P9|NOT COMPLETED|Overall Study||0
401755|NCT01717326|984703|P8|NOT COMPLETED|Overall Study||0
401756|NCT01717326|984704|P7|NOT COMPLETED|Overall Study||1
401757|NCT01717326|984705|P6|NOT COMPLETED|Overall Study||0
401758|NCT01717326|984706|P5|NOT COMPLETED|Overall Study||2
401759|NCT01717326|984707|P4|NOT COMPLETED|Overall Study||2
401760|NCT01717326|984708|P3|NOT COMPLETED|Overall Study||0
401761|NCT01717326|984709|P2|NOT COMPLETED|Overall Study||1
401762|NCT01717326|984710|P1|NOT COMPLETED|Overall Study||3
401763|NCT01717326|984691|P20|COMPLETED|Overall Study||15
401764|NCT01717326|984692|P19|COMPLETED|Overall Study||16
401765|NCT01717326|984693|P18|COMPLETED|Overall Study||31
401766|NCT01717326|984694|P17|COMPLETED|Overall Study||29
401767|NCT01717326|984695|P16|COMPLETED|Overall Study||27
401768|NCT01717326|984696|P15|COMPLETED|Overall Study||29
401769|NCT01717326|984697|P14|COMPLETED|Overall Study||32
401770|NCT01717326|984698|P13|COMPLETED|Overall Study||32
401771|NCT01717326|984699|P12|COMPLETED|Overall Study||33
401772|NCT01717326|984700|P11|COMPLETED|Overall Study||30
401773|NCT01717326|984701|P10|COMPLETED|Overall Study||29
401774|NCT01717326|984702|P9|COMPLETED|Overall Study||32
401775|NCT01717326|984703|P8|COMPLETED|Overall Study||29
401776|NCT01717326|984704|P7|COMPLETED|Overall Study||30
401777|NCT01717326|984705|P6|COMPLETED|Overall Study||31
401778|NCT01717326|984706|P5|COMPLETED|Overall Study||31
401779|NCT01717326|984707|P4|COMPLETED|Overall Study||28
401780|NCT01717326|984708|P3|COMPLETED|Overall Study||13
401781|NCT01717326|984709|P2|COMPLETED|Overall Study||26
401782|NCT01717326|984710|P1|COMPLETED|Overall Study||22
401783|NCT01717326|984691|P20|Treated|Overall Study||21
401784|NCT01717326|984692|P19|Treated|Overall Study||20
401785|NCT01717326|984693|P18|Treated|Overall Study||31
401786|NCT01717326|984694|P17|Treated|Overall Study||30
401787|NCT01717326|984695|P16|Treated|Overall Study||30
401788|NCT01717326|984696|P15|Treated|Overall Study||29
401789|NCT01717326|984697|P14|Treated|Overall Study||32
401790|NCT01717326|984698|P13|Treated|Overall Study||33
401791|NCT01717326|984699|P12|Treated|Overall Study||33
401792|NCT01717326|984700|P11|Treated|Overall Study||32
401793|NCT01717326|984701|P10|Treated|Overall Study||31
401794|NCT01717326|984702|P9|Treated|Overall Study||32
401795|NCT01717326|984703|P8|Treated|Overall Study||29
401796|NCT01717326|984704|P7|Treated|Overall Study||31
401797|NCT01717326|984705|P6|Treated|Overall Study||31
401798|NCT01717326|984706|P5|Treated|Overall Study||33
401799|NCT01717326|984707|P4|Treated|Overall Study||30
401800|NCT01717326|984708|P3|Treated|Overall Study|Number excludes 1 participant randomized to A3 but treated on Arm A2|12
401801|NCT01717326|984709|P2|Treated|Overall Study|Number includes 1 additional participant randomized to A3 but treated on A2|28
401802|NCT01717326|984710|P1|Treated|Overall Study||25
401803|NCT01717326|984691|P20|STARTED|Overall Study||21
401804|NCT01717326|984692|P19|STARTED|Overall Study||20
401805|NCT01717326|984693|P18|STARTED|Overall Study||31
401806|NCT01717326|984694|P17|STARTED|Overall Study||30
401807|NCT01717326|984695|P16|STARTED|Overall Study||30
401808|NCT01717326|984696|P15|STARTED|Overall Study||29
401809|NCT01717326|984697|P14|STARTED|Overall Study||32
401810|NCT01717326|984698|P13|STARTED|Overall Study||33
401811|NCT01717326|984699|P12|STARTED|Overall Study||33
401812|NCT01717326|984700|P11|STARTED|Overall Study||32
401813|NCT01717326|984701|P10|STARTED|Overall Study||31
401814|NCT01717326|984702|P9|STARTED|Overall Study||32
401815|NCT01717326|984703|P8|STARTED|Overall Study||29
401816|NCT01717326|984704|P7|STARTED|Overall Study||31
401817|NCT01717326|984705|P6|STARTED|Overall Study||31
401818|NCT01717326|984706|P5|STARTED|Overall Study||33
401819|NCT01717326|984707|P4|STARTED|Overall Study||30
401820|NCT01717326|984708|P3|STARTED|Overall Study||13
401821|NCT01717326|984709|P2|STARTED|Overall Study||27
401822|NCT01717326|984710|P1|STARTED|Overall Study||25
401823|NCT01717313|984974|P2|NOT COMPLETED|Phase B (Weeks 24 to 54)||16
401824|NCT01717313|984975|P1|NOT COMPLETED|Phase B (Weeks 24 to 54)||12
401825|NCT01717313|984974|P2|COMPLETED|Phase B (Weeks 24 to 54)||135
401826|NCT01717313|984975|P1|COMPLETED|Phase B (Weeks 24 to 54)||134
401827|NCT01717313|984974|P2|STARTED|Phase B (Weeks 24 to 54)||151
401828|NCT01717313|984975|P1|STARTED|Phase B (Weeks 24 to 54)||146
401829|NCT01717313|984974|P2|NOT COMPLETED|Interphase||0
401830|NCT01717313|984975|P1|NOT COMPLETED|Interphase||1
401831|NCT01717313|984974|P2|COMPLETED|Interphase||151
401832|NCT01717313|984975|P1|COMPLETED|Interphase||146
401833|NCT01717313|984974|P2|STARTED|Interphase||151
401834|NCT01717313|984975|P1|STARTED|Interphase||147
401835|NCT01717313|984974|P2|NOT COMPLETED|Phase A (Weeks 0 to 24)||13
401836|NCT01717313|984975|P1|NOT COMPLETED|Phase A (Weeks 0 to 24)||18
401837|NCT01717313|984974|P2|COMPLETED|Phase A (Weeks 0 to 24)||151
401838|NCT01717313|984975|P1|COMPLETED|Phase A (Weeks 0 to 24)||147
401839|NCT01717313|984974|P2|STARTED|Phase A (Weeks 0 to 24)||164
401840|NCT01717313|984975|P1|STARTED|Phase A (Weeks 0 to 24)||165
401841|NCT01717287|985013|P2|NOT COMPLETED|Overall Study||3
401842|NCT01717287|985014|P1|NOT COMPLETED|Overall Study||0
401843|NCT01717287|985013|P2|COMPLETED|Overall Study||25
401844|NCT01717287|985014|P1|COMPLETED|Overall Study||4
401845|NCT01717287|985013|P2|STARTED|Overall Study||28
401846|NCT01717287|985014|P1|STARTED|Overall Study||4
401847|NCT01717209|985036|P1|NOT COMPLETED|Overall Study||0
401848|NCT01717209|985036|P1|COMPLETED|Overall Study||14
401849|NCT01717209|985036|P1|STARTED|Overall Study||14
401850|NCT01717040|985047|P2|NOT COMPLETED|Overall Study||5
401851|NCT01717040|985048|P1|NOT COMPLETED|Overall Study||5
401852|NCT01717040|985047|P2|COMPLETED|Overall Study||15
401853|NCT01717040|985048|P1|COMPLETED|Overall Study||12
401854|NCT01717040|985047|P2|STARTED|Overall Study||20
401855|NCT01717040|985048|P1|STARTED|Overall Study||17
401856|NCT01717014|985054|P1|NOT COMPLETED|Overall Study||0
401857|NCT01717014|985054|P1|COMPLETED|Overall Study||8
401858|NCT01717014|985054|P1|STARTED|Overall Study||8
401859|NCT01716754|985066|P4|NOT COMPLETED|Overall Study||8
401860|NCT01716754|985067|P3|NOT COMPLETED|Overall Study||14
401861|NCT01716754|985068|P2|NOT COMPLETED|Overall Study||4
401862|NCT01716754|985069|P1|NOT COMPLETED|Overall Study||11
401863|NCT01716754|985066|P4|COMPLETED|Overall Study||89
401864|NCT01716754|985067|P3|COMPLETED|Overall Study||121
401865|NCT01716754|985068|P2|COMPLETED|Overall Study||36
401866|NCT01716754|985069|P1|COMPLETED|Overall Study||188
401867|NCT01716754|985066|P4|Safety Set|Overall Study||96
401868|NCT01716754|985067|P3|Safety Set|Overall Study||131
401869|NCT01716754|985068|P2|Safety Set|Overall Study||40
401870|NCT01716754|985069|P1|Safety Set|Overall Study||199
401871|NCT01716754|985066|P4|FAS|Overall Study||96
401872|NCT01716754|985067|P3|FAS|Overall Study||131
401873|NCT01716754|985068|P2|FAS|Overall Study||40
401874|NCT01716754|985069|P1|FAS|Overall Study||199
401875|NCT01716754|985066|P4|STARTED|Overall Study||97
401876|NCT01716754|985067|P3|STARTED|Overall Study||135
401877|NCT01716754|985068|P2|STARTED|Overall Study||40
401878|NCT01716754|985069|P1|STARTED|Overall Study||199
401879|NCT01716663|985090|P1|NOT COMPLETED|Overall Study||6
401880|NCT01716663|985090|P1|COMPLETED|Overall Study|Effectiveness population = enrolled and treated (study device inserted and RF energy applied)|228
401881|NCT01716663|985090|P1|Safety|Overall Study|Enrolled patients who had a study device inserted.|230
401882|NCT01716663|985090|P1|STARTED|Overall Study|Enrolled = signed informed consent and met eligibility requirements|234
401883|NCT01716585|985100|P2|NOT COMPLETED|Open-label Treatment||7
401884|NCT01716585|985101|P1|NOT COMPLETED|Open-label Treatment||0
401885|NCT01716585|985100|P2|COMPLETED|Open-label Treatment|The number of participants who completed open-label study drug.|150
401886|NCT01716585|985101|P1|COMPLETED|Open-label Treatment|not applicable to this arm|0
401887|NCT01716585|985100|P2|STARTED|Open-label Treatment||157
401888|NCT01716585|985101|P1|STARTED|Open-label Treatment|not applicable to this arm|0
401889|NCT01716585|985100|P2|NOT COMPLETED|Double-blind Treatment||2
401890|NCT01716585|985101|P1|NOT COMPLETED|Double-blind Treatment||13
401891|NCT01716585|985100|P2|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|157
401892|NCT01716585|985101|P1|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|464
401893|NCT01716585|985100|P2|Randomized But Not Treated|Double-blind Treatment||1
401894|NCT01716585|985101|P1|Randomized But Not Treated|Double-blind Treatment||4
401895|NCT01716585|985100|P2|STARTED|Double-blind Treatment||159
401896|NCT01716585|985101|P1|STARTED|Double-blind Treatment||477
401897|NCT01716559|985113|P1|NOT COMPLETED|Overall Study||111
401898|NCT01716559|985113|P1|COMPLETED|Overall Study||49
401899|NCT01716559|985113|P1|STARTED|Overall Study||160
401900|NCT01716520|985121|P6|NOT COMPLETED|Treatment Period 3 (14 Days)||2
401901|NCT01716520|985122|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||0
401902|NCT01716520|985123|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
401903|NCT01716520|985124|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||1
401904|NCT01716520|985125|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||0
401905|NCT01716520|985126|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
401906|NCT01716520|985121|P6|COMPLETED|Treatment Period 3 (14 Days)||23
401907|NCT01716520|985122|P5|COMPLETED|Treatment Period 3 (14 Days)||29
401908|NCT01716520|985123|P4|COMPLETED|Treatment Period 3 (14 Days)||28
401909|NCT01716520|985124|P3|COMPLETED|Treatment Period 3 (14 Days)||25
401910|NCT01716520|985125|P2|COMPLETED|Treatment Period 3 (14 Days)||27
401911|NCT01716520|985126|P1|COMPLETED|Treatment Period 3 (14 Days)||27
401912|NCT01716520|985121|P6|STARTED|Treatment Period 3 (14 Days)||25
401913|NCT01716520|985122|P5|STARTED|Treatment Period 3 (14 Days)||29
401914|NCT01716520|985123|P4|STARTED|Treatment Period 3 (14 Days)||28
401915|NCT01716520|985124|P3|STARTED|Treatment Period 3 (14 Days)||26
401916|NCT01716520|985125|P2|STARTED|Treatment Period 3 (14 Days)||27
401917|NCT01716520|985126|P1|STARTED|Treatment Period 3 (14 Days)||27
401918|NCT01716520|985121|P6|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2
401919|NCT01716520|985122|P5|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
401920|NCT01716520|985123|P4|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
401921|NCT01716520|985124|P3|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1
401922|NCT01716520|985125|P2|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1
401923|NCT01716520|985126|P1|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2
401924|NCT01716520|985121|P6|COMPLETED|Washout Period 2 (10 to 14 Days)||25
401925|NCT01716520|985122|P5|COMPLETED|Washout Period 2 (10 to 14 Days)||29
401926|NCT01716520|985123|P4|COMPLETED|Washout Period 2 (10 to 14 Days)||28
401927|NCT01716520|985124|P3|COMPLETED|Washout Period 2 (10 to 14 Days)||26
401928|NCT01716520|985125|P2|COMPLETED|Washout Period 2 (10 to 14 Days)||27
401929|NCT01716520|985126|P1|COMPLETED|Washout Period 2 (10 to 14 Days)||27
401930|NCT01716520|985121|P6|STARTED|Washout Period 2 (10 to 14 Days)||27
401931|NCT01716520|985122|P5|STARTED|Washout Period 2 (10 to 14 Days)||29
401932|NCT01716520|985123|P4|STARTED|Washout Period 2 (10 to 14 Days)||28
401933|NCT01716520|985124|P3|STARTED|Washout Period 2 (10 to 14 Days)||27
401934|NCT01716520|985125|P2|STARTED|Washout Period 2 (10 to 14 Days)||28
401935|NCT01716520|985126|P1|STARTED|Washout Period 2 (10 to 14 Days)||29
401936|NCT01716520|985121|P6|NOT COMPLETED|Treatment Period 2 (14 Days)||0
401937|NCT01716520|985122|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||2
401938|NCT01716520|985123|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||1
401939|NCT01716520|985124|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||0
401940|NCT01716520|985125|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||0
401941|NCT01716520|985126|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||0
401942|NCT01716520|985121|P6|COMPLETED|Treatment Period 2 (14 Days)||27
401943|NCT01716520|985122|P5|COMPLETED|Treatment Period 2 (14 Days)||29
401944|NCT01716520|985123|P4|COMPLETED|Treatment Period 2 (14 Days)||28
401945|NCT01716520|985124|P3|COMPLETED|Treatment Period 2 (14 Days)||27
401946|NCT01716520|985125|P2|COMPLETED|Treatment Period 2 (14 Days)||28
401947|NCT01716520|985126|P1|COMPLETED|Treatment Period 2 (14 Days)||29
401948|NCT01716520|985121|P6|STARTED|Treatment Period 2 (14 Days)||27
401949|NCT01716520|985122|P5|STARTED|Treatment Period 2 (14 Days)||31
401950|NCT01716520|985123|P4|STARTED|Treatment Period 2 (14 Days)||29
401951|NCT01716520|985124|P3|STARTED|Treatment Period 2 (14 Days)||27
401952|NCT01716520|985125|P2|STARTED|Treatment Period 2 (14 Days)||28
401953|NCT01716520|985126|P1|STARTED|Treatment Period 2 (14 Days)||29
401954|NCT01716520|985121|P6|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||2
401955|NCT01716520|985122|P5|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
401956|NCT01716520|985123|P4|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
401957|NCT01716520|985124|P3|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
401958|NCT01716520|985125|P2|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
401959|NCT01716520|985126|P1|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
401960|NCT01716520|985121|P6|COMPLETED|Washout Period 1 (10 to 14 Days)||27
401961|NCT01716520|985122|P5|COMPLETED|Washout Period 1 (10 to 14 Days)||31
401962|NCT01716520|985123|P4|COMPLETED|Washout Period 1 (10 to 14 Days)||29
401963|NCT01716520|985124|P3|COMPLETED|Washout Period 1 (10 to 14 Days)||27
401964|NCT01716520|985125|P2|COMPLETED|Washout Period 1 (10 to 14 Days)||28
401965|NCT01716520|985126|P1|COMPLETED|Washout Period 1 (10 to 14 Days)||29
401966|NCT01716520|985121|P6|STARTED|Washout Period 1 (10 to 14 Days)||29
401967|NCT01716520|985122|P5|STARTED|Washout Period 1 (10 to 14 Days)||31
401968|NCT01716520|985123|P4|STARTED|Washout Period 1 (10 to 14 Days)||29
401969|NCT01716520|985124|P3|STARTED|Washout Period 1 (10 to 14 Days)||28
401970|NCT01716520|985125|P2|STARTED|Washout Period 1 (10 to 14 Days)||29
401971|NCT01716520|985126|P1|STARTED|Washout Period 1 (10 to 14 Days)||29
401972|NCT01716520|985121|P6|NOT COMPLETED|Treatment Period 1 (14 Days)||1
401973|NCT01716520|985122|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||0
401974|NCT01716520|985123|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||1
401975|NCT01716520|985124|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||2
401976|NCT01716520|985125|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
401977|NCT01716520|985126|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||2
401978|NCT01716520|985121|P6|COMPLETED|Treatment Period 1 (14 Days)||29
401979|NCT01716520|985122|P5|COMPLETED|Treatment Period 1 (14 Days)||31
401980|NCT01716520|985123|P4|COMPLETED|Treatment Period 1 (14 Days)||29
401981|NCT01716520|985124|P3|COMPLETED|Treatment Period 1 (14 Days)||28
401982|NCT01716520|985125|P2|COMPLETED|Treatment Period 1 (14 Days)||29
401983|NCT01716520|985126|P1|COMPLETED|Treatment Period 1 (14 Days)||29
401984|NCT01716520|985121|P6|STARTED|Treatment Period 1 (14 Days)||30
401985|NCT01716520|985122|P5|STARTED|Treatment Period 1 (14 Days)||31
401986|NCT01716520|985123|P4|STARTED|Treatment Period 1 (14 Days)||30
401987|NCT01716520|985124|P3|STARTED|Treatment Period 1 (14 Days)||30
401988|NCT01716520|985125|P2|STARTED|Treatment Period 1 (14 Days)||30
401989|NCT01716520|985126|P1|STARTED|Treatment Period 1 (14 Days)||31
401990|NCT01716468|985142|P1|NOT COMPLETED|Overall Study||6
401991|NCT01716468|985142|P1|COMPLETED|Overall Study||11
401992|NCT01716468|985142|P1|STARTED|Overall Study||17
401993|NCT01716455|985152|P6|NOT COMPLETED|Overall Study||0
401994|NCT01716455|985153|P5|NOT COMPLETED|Overall Study||0
401995|NCT01716455|985154|P4|NOT COMPLETED|Overall Study||0
401996|NCT01716455|985155|P3|NOT COMPLETED|Overall Study||0
401997|NCT01716455|985156|P2|NOT COMPLETED|Overall Study||0
401998|NCT01716455|985157|P1|NOT COMPLETED|Overall Study||0
401999|NCT01716455|985152|P6|COMPLETED|Overall Study||8
402000|NCT01716455|985153|P5|COMPLETED|Overall Study||26
402001|NCT01716455|985154|P4|COMPLETED|Overall Study||8
402002|NCT01716455|985155|P3|COMPLETED|Overall Study||8
402003|NCT01716455|985156|P2|COMPLETED|Overall Study||8
402004|NCT01716455|985157|P1|COMPLETED|Overall Study||8
402005|NCT01716455|985152|P6|STARTED|Overall Study||8
402006|NCT01716455|985153|P5|STARTED|Overall Study||26
402007|NCT01716455|985154|P4|STARTED|Overall Study||8
402008|NCT01716455|985155|P3|STARTED|Overall Study||8
402009|NCT01716455|985156|P2|STARTED|Overall Study||8
402010|NCT01716455|985157|P1|STARTED|Overall Study||8
402011|NCT01716234|985181|P7|NOT COMPLETED|Overall Study||0
402012|NCT01716234|985182|P6|NOT COMPLETED|Overall Study||14
402013|NCT01716234|985183|P5|NOT COMPLETED|Overall Study||5
402014|NCT01716234|985184|P4|NOT COMPLETED|Overall Study||12
402015|NCT01716234|985185|P3|NOT COMPLETED|Overall Study||5
402016|NCT01716234|985186|P2|NOT COMPLETED|Overall Study||10
402017|NCT01716234|985187|P1|NOT COMPLETED|Overall Study||10
402018|NCT01716234|985181|P7|COMPLETED|Overall Study||1
402019|NCT01716234|985182|P6|COMPLETED|Overall Study||18
402020|NCT01716234|985183|P5|COMPLETED|Overall Study||10
402021|NCT01716234|985184|P4|COMPLETED|Overall Study||16
402022|NCT01716234|985185|P3|COMPLETED|Overall Study||15
402023|NCT01716234|985186|P2|COMPLETED|Overall Study||12
402024|NCT01716234|985187|P1|COMPLETED|Overall Study||14
402025|NCT01716234|985181|P7|Treated|Overall Study||1
402026|NCT01716234|985182|P6|Treated|Overall Study||30
402027|NCT01716234|985183|P5|Treated|Overall Study||15
402028|NCT01716234|985184|P4|Treated|Overall Study||28
402029|NCT01716234|985185|P3|Treated|Overall Study||19
402030|NCT01716234|985186|P2|Treated|Overall Study||21
402031|NCT01716234|985187|P1|Treated|Overall Study||22
402032|NCT01716234|985181|P7|STARTED|Overall Study||1
402033|NCT01716234|985182|P6|STARTED|Overall Study||32
402034|NCT01716234|985183|P5|STARTED|Overall Study||15
402035|NCT01716234|985184|P4|STARTED|Overall Study||28
402036|NCT01716234|985185|P3|STARTED|Overall Study||20
402037|NCT01716234|985186|P2|STARTED|Overall Study||22
402038|NCT01716234|985187|P1|STARTED|Overall Study||24
402039|NCT01716221|985224|P1|NOT COMPLETED|Overall Study||0
402040|NCT01716221|985224|P1|COMPLETED|Overall Study||1
402041|NCT01716221|985224|P1|STARTED|Overall Study||1
402042|NCT01716169|985250|P1|NOT COMPLETED|Overall Study||4
402043|NCT01716169|985250|P1|COMPLETED|Overall Study||6
402044|NCT01716169|985250|P1|Standard of Care Dressings Used|Overall Study||7
402045|NCT01716169|985250|P1|STARTED|Overall Study||10
402046|NCT01716156|985259|P3|NOT COMPLETED|Overall Study||2
402047|NCT01716156|985260|P2|NOT COMPLETED|Overall Study||1
402048|NCT01716156|985261|P1|NOT COMPLETED|Overall Study||2
402049|NCT01716156|985259|P3|COMPLETED|Overall Study||11
402050|NCT01716156|985260|P2|COMPLETED|Overall Study||3
402051|NCT01716156|985261|P1|COMPLETED|Overall Study||7
402052|NCT01716156|985259|P3|STARTED|Overall Study||13
402053|NCT01716156|985260|P2|STARTED|Overall Study||4
402054|NCT01716156|985261|P1|STARTED|Overall Study||9
402055|NCT01716052|985287|P2|NOT COMPLETED|Overall Study||1
402056|NCT01716052|985288|P1|NOT COMPLETED|Overall Study||1
402057|NCT01716052|985287|P2|COMPLETED|Overall Study||0
402058|NCT01716052|985288|P1|COMPLETED|Overall Study||0
402059|NCT01716052|985287|P2|STARTED|Overall Study||1
402060|NCT01716052|985288|P1|STARTED|Overall Study||1
402061|NCT01716013|985296|P2|NOT COMPLETED|Overall Study||0
402062|NCT01716013|985297|P1|NOT COMPLETED|Overall Study||3
402063|NCT01716013|985296|P2|COMPLETED|Overall Study||54
402064|NCT01716013|985297|P1|COMPLETED|Overall Study||105
402065|NCT01716013|985296|P2|STARTED|Overall Study||54
402066|NCT01716013|985297|P1|STARTED|Overall Study||108
402067|NCT01715948|985309|P1|NOT COMPLETED|Overall Study||1
402068|NCT01715948|985309|P1|COMPLETED|Overall Study||8
402069|NCT01715948|985309|P1|STARTED|Overall Study||9
402070|NCT01715896|985330|P2|NOT COMPLETED|Overall Study||11
402071|NCT01715896|985331|P1|NOT COMPLETED|Overall Study||3
402072|NCT01715896|985330|P2|COMPLETED|Overall Study||59
402073|NCT01715896|985331|P1|COMPLETED|Overall Study||65
402074|NCT01715896|985330|P2|STARTED|Overall Study||70
402075|NCT01715896|985331|P1|STARTED|Overall Study||68
402076|NCT01715857|985394|P1|NOT COMPLETED|Overall Study||96
402077|NCT01715857|985394|P1|COMPLETED|Overall Study||4004
402078|NCT01715857|985394|P1|STARTED|Overall Study||4100
402079|NCT01715831|985404|P1|NOT COMPLETED|Overall Study||1
402080|NCT01715831|985404|P1|COMPLETED|Overall Study||25
402081|NCT01715831|985404|P1|STARTED|Overall Study||26
402082|NCT01715415|985422|P2|NOT COMPLETED|Open-label Treatment||2
402083|NCT01715415|985423|P1|NOT COMPLETED|Open-label Treatment||0
402084|NCT01715415|985422|P2|COMPLETED|Open-label Treatment|The number of participants who completed open-label study drug.|94
402085|NCT01715415|985423|P1|COMPLETED|Open-label Treatment|not applicable to this arm|0
402086|NCT01715415|985422|P2|STARTED|Open-label Treatment||96
402087|NCT01715415|985423|P1|STARTED|Open-label Treatment|not applicable to this arm|0
402088|NCT01715415|985422|P2|NOT COMPLETED|Double-blind Treatment||2
402089|NCT01715415|985423|P1|NOT COMPLETED|Double-blind Treatment||5
402090|NCT01715415|985422|P2|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|96
402091|NCT01715415|985423|P1|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|292
402092|NCT01715415|985422|P2|Randomized But Not Treated|Double-blind Treatment||1
402093|NCT01715415|985423|P1|Randomized But Not Treated|Double-blind Treatment||0
402094|NCT01715415|985422|P2|STARTED|Double-blind Treatment||98
402095|NCT01715415|985423|P1|STARTED|Double-blind Treatment||297
402096|NCT01715298|985437|P2|NOT COMPLETED|Overall Study||11
402097|NCT01715298|985438|P1|NOT COMPLETED|Overall Study||7
402098|NCT01715298|985437|P2|COMPLETED|Overall Study||205
402099|NCT01715298|985438|P1|COMPLETED|Overall Study||209
402100|NCT01715298|985437|P2|Full Analysis Set (FAS)|Overall Study||214
402101|NCT01715298|985438|P1|Full Analysis Set (FAS)|Overall Study|patients were analyzed according to the treatment to which they were randomized|215
402102|NCT01715298|985437|P2|STARTED|Overall Study||216
402103|NCT01715298|985438|P1|STARTED|Overall Study||216
402104|NCT01715207|985476|P2|NOT COMPLETED|Overall Study||1
402105|NCT01715207|985477|P1|NOT COMPLETED|Overall Study||1
402106|NCT01715207|985476|P2|COMPLETED|Overall Study||14
402107|NCT01715207|985477|P1|COMPLETED|Overall Study||14
402108|NCT01715207|985476|P2|STARTED|Overall Study||15
402109|NCT01715207|985477|P1|STARTED|Overall Study||15
402110|NCT01715129|985485|P1|NOT COMPLETED|Overall Study||9
402111|NCT01715129|985485|P1|COMPLETED|Overall Study||117
402112|NCT01715129|985485|P1|STARTED|Overall Study||126
402113|NCT01715064|985504|P2|NOT COMPLETED|Overall Study||0
402114|NCT01715064|985505|P1|NOT COMPLETED|Overall Study||0
402115|NCT01715064|985504|P2|COMPLETED|Overall Study||18
402116|NCT01715064|985505|P1|COMPLETED|Overall Study||18
402117|NCT01715064|985504|P2|STARTED|Overall Study||18
402118|NCT01715064|985505|P1|STARTED|Overall Study||18
402119|NCT01714817|985513|P2|NOT COMPLETED|Overall Study||42
402120|NCT01714817|985514|P1|NOT COMPLETED|Overall Study||48
402121|NCT01714817|985513|P2|COMPLETED|Overall Study|Completed = continued study through Year 1|161
402210|NCT01713998|985725|P1|NOT COMPLETED|Overall Study||3
402122|NCT01714817|985514|P1|COMPLETED|Overall Study|Completed = continued study through Year 1|155
402123|NCT01714817|985513|P2|Treated|Overall Study||203
402124|NCT01714817|985514|P1|Treated|Overall Study||202
402125|NCT01714817|985513|P2|STARTED|Overall Study||203
402126|NCT01714817|985514|P1|STARTED|Overall Study||203
402127|NCT01714804|985535|P2|NOT COMPLETED|Overall Study||0
402128|NCT01714804|985536|P1|NOT COMPLETED|Overall Study||1
402129|NCT01714804|985535|P2|COMPLETED|Overall Study||30
402130|NCT01714804|985536|P1|COMPLETED|Overall Study||29
402131|NCT01714804|985535|P2|STARTED|Overall Study||30
402132|NCT01714804|985536|P1|STARTED|Overall Study||30
402133|NCT01714635|985547|P3|NOT COMPLETED|Overall Study||2
402134|NCT01714635|985548|P2|NOT COMPLETED|Overall Study||0
402135|NCT01714635|985549|P1|NOT COMPLETED|Overall Study||2
402136|NCT01714635|985547|P3|COMPLETED|Overall Study||146
402137|NCT01714635|985548|P2|COMPLETED|Overall Study||150
402138|NCT01714635|985549|P1|COMPLETED|Overall Study||145
402139|NCT01714635|985547|P3|STARTED|Overall Study||148
402140|NCT01714635|985548|P2|STARTED|Overall Study||150
402141|NCT01714635|985549|P1|STARTED|Overall Study||147
402142|NCT01714609|985565|P2|NOT COMPLETED|Overall Study||0
402143|NCT01714609|985566|P1|NOT COMPLETED|Overall Study||1
402144|NCT01714609|985565|P2|COMPLETED|Overall Study||5
402145|NCT01714609|985566|P1|COMPLETED|Overall Study||4
402146|NCT01714609|985565|P2|STARTED|Overall Study||5
402147|NCT01714609|985566|P1|STARTED|Overall Study||5
402148|NCT01714544|985572|P1|NOT COMPLETED|Overall Study||3
402149|NCT01714544|985572|P1|COMPLETED|Overall Study||57
402150|NCT01714544|985572|P1|STARTED|Overall Study||60
402151|NCT01714505|985576|P2|NOT COMPLETED|Admission 2 (40 Hours)||0
402152|NCT01714505|985577|P1|NOT COMPLETED|Admission 2 (40 Hours)||0
402153|NCT01714505|985576|P2|COMPLETED|Admission 2 (40 Hours)||9
402154|NCT01714505|985577|P1|COMPLETED|Admission 2 (40 Hours)||9
402155|NCT01714505|985576|P2|STARTED|Admission 2 (40 Hours)||9
402156|NCT01714505|985577|P1|STARTED|Admission 2 (40 Hours)||9
402157|NCT01714505|985576|P2|NOT COMPLETED|Admission 1 (40 Hours)||1
402158|NCT01714505|985577|P1|NOT COMPLETED|Admission 1 (40 Hours)||1
402159|NCT01714505|985576|P2|COMPLETED|Admission 1 (40 Hours)||9
402160|NCT01714505|985577|P1|COMPLETED|Admission 1 (40 Hours)||9
402161|NCT01714505|985576|P2|STARTED|Admission 1 (40 Hours)||10
402162|NCT01714505|985577|P1|STARTED|Admission 1 (40 Hours)||10
402163|NCT01714492|985587|P1|NOT COMPLETED|Overall Study||0
402164|NCT01714492|985587|P1|COMPLETED|Overall Study||8
402165|NCT01714492|985587|P1|STARTED|Overall Study||8
402166|NCT01714336|985598|P2|NOT COMPLETED|Overall Study||0
402167|NCT01714336|985599|P1|NOT COMPLETED|Overall Study||0
402168|NCT01714336|985598|P2|COMPLETED|Overall Study||69
402169|NCT01714336|985599|P1|COMPLETED|Overall Study||69
402170|NCT01714336|985598|P2|STARTED|Overall Study||69
402171|NCT01714336|985599|P1|STARTED|Overall Study||69
402172|NCT01714323|985621|P2|NOT COMPLETED|Overall Study||172
402173|NCT01714323|985622|P1|NOT COMPLETED|Overall Study||164
402174|NCT01714323|985621|P2|COMPLETED|Overall Study||508
402175|NCT01714323|985622|P1|COMPLETED|Overall Study||513
402176|NCT01714323|985621|P2|STARTED|Overall Study||680
402177|NCT01714323|985622|P1|STARTED|Overall Study||677
402178|NCT01714310|985643|P3|NOT COMPLETED|Double Blind Adjunctive Treatment||0
402179|NCT01714310|985644|P2|NOT COMPLETED|Double Blind Adjunctive Treatment||3
402180|NCT01714310|985645|P1|NOT COMPLETED|Double Blind Adjunctive Treatment||2
402181|NCT01714310|985643|P3|COMPLETED|Double Blind Adjunctive Treatment||0
402182|NCT01714310|985644|P2|COMPLETED|Double Blind Adjunctive Treatment||11
402183|NCT01714310|985645|P1|COMPLETED|Double Blind Adjunctive Treatment||10
402184|NCT01714310|985643|P3|STARTED|Double Blind Adjunctive Treatment|No one remained on lisdexamfetamine alone in Period 2.|0
402185|NCT01714310|985644|P2|STARTED|Double Blind Adjunctive Treatment|Adjunctive placebo was initiated at beginning of Period 2, at study week 4.|14
402186|NCT01714310|985645|P1|STARTED|Double Blind Adjunctive Treatment|Adjunctive fluoxetine treatment was initiated at beginning of Period 2, at study week 4.|12
402187|NCT01714310|985643|P3|NOT COMPLETED|Open Lisdexamfetamine Titration||4
402188|NCT01714310|985644|P2|NOT COMPLETED|Open Lisdexamfetamine Titration||0
402189|NCT01714310|985645|P1|NOT COMPLETED|Open Lisdexamfetamine Titration||0
402190|NCT01714310|985643|P3|COMPLETED|Open Lisdexamfetamine Titration||30
402191|NCT01714310|985644|P2|COMPLETED|Open Lisdexamfetamine Titration||0
402192|NCT01714310|985645|P1|COMPLETED|Open Lisdexamfetamine Titration||0
402193|NCT01714310|985643|P3|STARTED|Open Lisdexamfetamine Titration||34
402194|NCT01714310|985644|P2|STARTED|Open Lisdexamfetamine Titration||0
402195|NCT01714310|985645|P1|STARTED|Open Lisdexamfetamine Titration||0
402196|NCT01714232|985692|P1|NOT COMPLETED|Overall Study||0
402197|NCT01714232|985692|P1|COMPLETED|Overall Study||106
402198|NCT01714232|985692|P1|STARTED|Overall Study||106
402199|NCT01714024|985701|P3|NOT COMPLETED|Overall Study||3
402200|NCT01714024|985702|P2|NOT COMPLETED|Overall Study||6
402201|NCT01714024|985703|P1|NOT COMPLETED|Overall Study||1
402202|NCT01714024|985701|P3|COMPLETED|Overall Study||8
402203|NCT01714024|985702|P2|COMPLETED|Overall Study||12
402204|NCT01714024|985703|P1|COMPLETED|Overall Study||12
402205|NCT01714024|985701|P3|STARTED|Overall Study||11
402206|NCT01714024|985702|P2|STARTED|Overall Study||18
402207|NCT01714024|985703|P1|STARTED|Overall Study||13
402208|NCT01713998|985723|P3|NOT COMPLETED|Overall Study||2
402209|NCT01713998|985724|P2|NOT COMPLETED|Overall Study||0
402211|NCT01713998|985723|P3|COMPLETED|Overall Study||14
402212|NCT01713998|985724|P2|COMPLETED|Overall Study||15
402213|NCT01713998|985725|P1|COMPLETED|Overall Study||13
402214|NCT01713998|985723|P3|STARTED|Overall Study||16
402215|NCT01713998|985724|P2|STARTED|Overall Study||15
402216|NCT01713998|985725|P1|STARTED|Overall Study||16
402217|NCT01713933|985743|P1|NOT COMPLETED|Overall Study||6
402218|NCT01713933|985743|P1|COMPLETED|Overall Study||31
402219|NCT01713933|985743|P1|STARTED|Overall Study||37
402220|NCT01713686|985755|P1|NOT COMPLETED|Overall Study||15
402221|NCT01713686|985755|P1|COMPLETED|Overall Study||110
402222|NCT01713686|985755|P1|STARTED|Overall Study|129 enrolled, 125 treated. 2 withdrew consent prior to treatment; 2 excluded after enrollment.|125
402223|NCT01713660|985764|P1|NOT COMPLETED|Overall Study||0
402224|NCT01713660|985764|P1|COMPLETED|Overall Study||37
402225|NCT01713660|985764|P1|STARTED|Overall Study||37
402226|NCT01713621|985772|P2|NOT COMPLETED|Overall Study||16
402227|NCT01713621|985773|P1|NOT COMPLETED|Overall Study||7
402228|NCT01713621|985772|P2|COMPLETED|Overall Study||1
402229|NCT01713621|985773|P1|COMPLETED|Overall Study||1
402230|NCT01713621|985772|P2|STARTED|Overall Study||17
402231|NCT01713621|985773|P1|STARTED|Overall Study||8
402232|NCT01713608|985783|P4|NOT COMPLETED|Overall Study||0
402233|NCT01713608|985784|P3|NOT COMPLETED|Overall Study||0
402234|NCT01713608|985785|P2|NOT COMPLETED|Overall Study||0
402235|NCT01713608|985786|P1|NOT COMPLETED|Overall Study||0
402236|NCT01713608|985783|P4|COMPLETED|Overall Study||12
402237|NCT01713608|985784|P3|COMPLETED|Overall Study||8
402238|NCT01713608|985785|P2|COMPLETED|Overall Study||6
402239|NCT01713608|985786|P1|COMPLETED|Overall Study||8
402240|NCT01713608|985783|P4|STARTED|Overall Study||12
402241|NCT01713608|985784|P3|STARTED|Overall Study||8
402242|NCT01713608|985785|P2|STARTED|Overall Study||6
402243|NCT01713608|985786|P1|STARTED|Overall Study||8
402244|NCT01713530|985806|P2|NOT COMPLETED|Overall Study||19
402245|NCT01713530|985807|P1|NOT COMPLETED|Overall Study||25
402246|NCT01713530|985806|P2|COMPLETED|Overall Study||117
402247|NCT01713530|985807|P1|COMPLETED|Overall Study||113
402248|NCT01713530|985806|P2|Exposed|Overall Study|One (1) subject was withdrawn by the investigator|135
402249|NCT01713530|985807|P1|Exposed|Overall Study|One (1) subject was randomised in error and 1 subject withdrew consent|136
402250|NCT01713530|985806|P2|STARTED|Overall Study||136
402251|NCT01713530|985807|P1|STARTED|Overall Study||138
402252|NCT01713400|985825|P2|NOT COMPLETED|Overall Study||0
402253|NCT01713400|985826|P1|NOT COMPLETED|Overall Study||0
402254|NCT01713400|985825|P2|COMPLETED|Overall Study||15
402255|NCT01713400|985826|P1|COMPLETED|Overall Study||15
402256|NCT01713400|985825|P2|STARTED|Overall Study||15
402257|NCT01713400|985826|P1|STARTED|Overall Study||15
402258|NCT01713348|985838|P4|NOT COMPLETED|Overall Study||0
402259|NCT01713348|985839|P3|NOT COMPLETED|Overall Study||2
402260|NCT01713348|985840|P2|NOT COMPLETED|Overall Study||2
402261|NCT01713348|985841|P1|NOT COMPLETED|Overall Study||4
402262|NCT01713348|985838|P4|COMPLETED|Overall Study||15
402263|NCT01713348|985839|P3|COMPLETED|Overall Study||28
402264|NCT01713348|985840|P2|COMPLETED|Overall Study||11
402265|NCT01713348|985841|P1|COMPLETED|Overall Study||25
402266|NCT01713348|985838|P4|STARTED|Overall Study||15
402267|NCT01713348|985839|P3|STARTED|Overall Study||30
402268|NCT01713348|985840|P2|STARTED|Overall Study||13
402269|NCT01713348|985841|P1|STARTED|Overall Study||29
402270|NCT01713283|985871|P2|NOT COMPLETED|Overall Study||3
402271|NCT01713283|985872|P1|NOT COMPLETED|Overall Study||11
402272|NCT01713283|985871|P2|COMPLETED|Overall Study||26
402273|NCT01713283|985872|P1|COMPLETED|Overall Study||20
402274|NCT01713283|985871|P2|STARTED|Overall Study||29
402275|NCT01713283|985872|P1|STARTED|Overall Study||31
402276|NCT01713036|985894|P1|NOT COMPLETED|Overall Study||1
402277|NCT01713036|985894|P1|COMPLETED|Overall Study||5
402278|NCT01713036|985894|P1|STARTED|Overall Study||6
402279|NCT01712984|985934|P3|NOT COMPLETED|Overall Study||10
402280|NCT01712984|985935|P2|NOT COMPLETED|Overall Study||16
402281|NCT01712984|985936|P1|NOT COMPLETED|Overall Study||16
402282|NCT01712984|985934|P3|COMPLETED|Overall Study||836
402283|NCT01712984|985935|P2|COMPLETED|Overall Study||821
402284|NCT01712984|985936|P1|COMPLETED|Overall Study||1656
402285|NCT01712984|985934|P3|STARTED|Overall Study||846
402286|NCT01712984|985935|P2|STARTED|Overall Study||837
402287|NCT01712984|985936|P1|STARTED|Overall Study||1672
402288|NCT01712854|985956|P1|NOT COMPLETED|Overall Study||1
402289|NCT01712854|985956|P1|COMPLETED|Overall Study||8
402290|NCT01712854|985956|P1|STARTED|Overall Study||9
402291|NCT01712776|985963|P2|NOT COMPLETED|Overall Study||0
402292|NCT01712776|985964|P1|NOT COMPLETED|Overall Study||0
402293|NCT01712776|985963|P2|COMPLETED|Overall Study||50
402294|NCT01712776|985964|P1|COMPLETED|Overall Study|trial to enroll 50 in each group for total of 100|50
402295|NCT01712776|985963|P2|STARTED|Overall Study||50
402296|NCT01712776|985964|P1|STARTED|Overall Study||50
402297|NCT01712711|985972|P2|NOT COMPLETED|Overall Study||0
402298|NCT01712711|985973|P1|NOT COMPLETED|Overall Study||0
402299|NCT01712711|985972|P2|COMPLETED|Overall Study||20
402300|NCT01712711|985973|P1|COMPLETED|Overall Study||20
402301|NCT01712711|985972|P2|STARTED|Overall Study||20
402302|NCT01712711|985973|P1|STARTED|Overall Study||20
402303|NCT01712685|985979|P1|NOT COMPLETED|Overall Study||1
402304|NCT01712685|985979|P1|COMPLETED|Overall Study||11
402305|NCT01712685|985979|P1|STARTED|Overall Study||12
402306|NCT01712516|985995|P4|NOT COMPLETED|Overall Study||13
402307|NCT01712516|985996|P3|NOT COMPLETED|Overall Study||6
402308|NCT01712516|985997|P2|NOT COMPLETED|Overall Study||10
402309|NCT01712516|985998|P1|NOT COMPLETED|Overall Study||6
402310|NCT01712516|985995|P4|COMPLETED|Overall Study||236
402311|NCT01712516|985996|P3|COMPLETED|Overall Study||245
402312|NCT01712516|985997|P2|COMPLETED|Overall Study||241
402313|NCT01712516|985998|P1|COMPLETED|Overall Study||244
402314|NCT01712516|985995|P4|Full Analysis Set|Overall Study||247
402315|NCT01712516|985996|P3|Full Analysis Set|Overall Study||250
402316|NCT01712516|985997|P2|Full Analysis Set|Overall Study||251
402317|NCT01712516|985998|P1|Full Analysis Set|Overall Study||250
402318|NCT01712516|985995|P4|Safety Set|Overall Study||248
402319|NCT01712516|985996|P3|Safety Set|Overall Study||251
402320|NCT01712516|985997|P2|Safety Set|Overall Study||251
402321|NCT01712516|985998|P1|Safety Set|Overall Study||250
402322|NCT01712516|985995|P4|STARTED|Overall Study||249
402323|NCT01712516|985996|P3|STARTED|Overall Study||251
402324|NCT01712516|985997|P2|STARTED|Overall Study||251
402325|NCT01712516|985998|P1|STARTED|Overall Study||250
402326|NCT01712399|986048|P1|NOT COMPLETED|Overall Study||397
402327|NCT01712399|986048|P1|COMPLETED|Overall Study||0
402328|NCT01712399|986048|P1|STARTED|Overall Study||397
402329|NCT01712360|986065|P4|NOT COMPLETED|Overall Study||2
402330|NCT01712360|986066|P3|NOT COMPLETED|Overall Study||0
402331|NCT01712360|986067|P2|NOT COMPLETED|Overall Study||1
402332|NCT01712360|986068|P1|NOT COMPLETED|Overall Study||0
402333|NCT01712360|986065|P4|COMPLETED|Overall Study||4
402334|NCT01712360|986066|P3|COMPLETED|Overall Study||6
402335|NCT01712360|986067|P2|COMPLETED|Overall Study||21
402336|NCT01712360|986068|P1|COMPLETED|Overall Study||22
402337|NCT01712360|986065|P4|STARTED|Overall Study||6
402338|NCT01712360|986066|P3|STARTED|Overall Study||6
402339|NCT01712360|986067|P2|STARTED|Overall Study||22
402340|NCT01712360|986068|P1|STARTED|Overall Study||22
402341|NCT01712334|986094|P2|NOT COMPLETED|Treatment Period 2||0
402342|NCT01712334|986095|P1|NOT COMPLETED|Treatment Period 2||0
402343|NCT01712334|986094|P2|COMPLETED|Treatment Period 2||41
402344|NCT01712334|986095|P1|COMPLETED|Treatment Period 2||44
402345|NCT01712334|986094|P2|STARTED|Treatment Period 2||41
402346|NCT01712334|986095|P1|STARTED|Treatment Period 2||44
402347|NCT01712334|986094|P2|NOT COMPLETED|Treatment Period 1||2
402348|NCT01712334|986095|P1|NOT COMPLETED|Treatment Period 1||0
402349|NCT01712334|986094|P2|COMPLETED|Treatment Period 1||41
402350|NCT01712334|986095|P1|COMPLETED|Treatment Period 1||44
402351|NCT01712334|986094|P2|Received Treatment|Treatment Period 1||41
402352|NCT01712334|986095|P1|Received Treatment|Treatment Period 1||44
402353|NCT01712334|986094|P2|STARTED|Treatment Period 1||43
402354|NCT01712334|986095|P1|STARTED|Treatment Period 1||44
402355|NCT01712256|986103|P1|NOT COMPLETED|Overall Study||1
402356|NCT01712256|986103|P1|COMPLETED|Overall Study||32
402357|NCT01712256|986103|P1|STARTED|Overall Study||33
402358|NCT01712204|986114|P2|NOT COMPLETED|Overall Study||5
402359|NCT01712204|986115|P1|NOT COMPLETED|Overall Study||8
402360|NCT01712204|986114|P2|COMPLETED|Overall Study||36
402361|NCT01712204|986115|P1|COMPLETED|Overall Study||33
402362|NCT01712204|986114|P2|STARTED|Overall Study||41
402363|NCT01712204|986115|P1|STARTED|Overall Study||41
402364|NCT01712178|986123|P2|NOT COMPLETED|Overall Study||3
402365|NCT01712178|986124|P1|NOT COMPLETED|Overall Study||1
402366|NCT01712178|986123|P2|COMPLETED|Overall Study||47
402367|NCT01712178|986124|P1|COMPLETED|Overall Study||49
402368|NCT01712178|986123|P2|STARTED|Overall Study||50
402369|NCT01712178|986124|P1|STARTED|Overall Study||50
402370|NCT01712074|986149|P3|NOT COMPLETED|Double Blind Period||8
402371|NCT01712074|986150|P2|NOT COMPLETED|Double Blind Period||14
402372|NCT01712074|986151|P1|NOT COMPLETED|Double Blind Period||0
402373|NCT01712074|986149|P3|COMPLETED|Double Blind Period||86
402374|NCT01712074|986150|P2|COMPLETED|Double Blind Period||77
402375|NCT01712074|986151|P1|COMPLETED|Double Blind Period||0
402376|NCT01712074|986149|P3|STARTED|Double Blind Period||94
402377|NCT01712074|986150|P2|STARTED|Double Blind Period||91
402378|NCT01712074|986151|P1|STARTED|Double Blind Period||0
402379|NCT01712074|986149|P3|NOT COMPLETED|Placebo Run-in Period||0
402380|NCT01712074|986150|P2|NOT COMPLETED|Placebo Run-in Period||0
402381|NCT01712074|986151|P1|NOT COMPLETED|Placebo Run-in Period||10
402382|NCT01712074|986149|P3|COMPLETED|Placebo Run-in Period||0
402383|NCT01712074|986150|P2|COMPLETED|Placebo Run-in Period||0
402384|NCT01712074|986151|P1|COMPLETED|Placebo Run-in Period||185
402385|NCT01712074|986149|P3|STARTED|Placebo Run-in Period||0
402386|NCT01712074|986150|P2|STARTED|Placebo Run-in Period||0
402387|NCT01712074|986151|P1|STARTED|Placebo Run-in Period||195
402388|NCT01712061|986207|P3|NOT COMPLETED|Overall Study||11
402389|NCT01712061|986208|P2|NOT COMPLETED|Overall Study||26
402390|NCT01712061|986209|P1|NOT COMPLETED|Overall Study||10
402391|NCT01712061|986207|P3|COMPLETED|Overall Study||45
402392|NCT01712061|986208|P2|COMPLETED|Overall Study||114
402393|NCT01712061|986209|P1|COMPLETED|Overall Study||20
402394|NCT01712061|986207|P3|STARTED|Overall Study||56
402395|NCT01712061|986208|P2|STARTED|Overall Study||140
402396|NCT01712061|986209|P1|STARTED|Overall Study||30
402397|NCT01712009|986249|P3|NOT COMPLETED|Overall Study||21
402398|NCT01712009|986250|P2|NOT COMPLETED|Overall Study||29
402399|NCT01712009|986251|P1|NOT COMPLETED|Overall Study||38
402400|NCT01712009|986249|P3|COMPLETED|Overall Study||181
402401|NCT01712009|986250|P2|COMPLETED|Overall Study||171
402402|NCT01712009|986251|P1|COMPLETED|Overall Study||160
402403|NCT01712009|986249|P3|Received Naproxen / Loratadine|Overall Study||198
402404|NCT01712009|986250|P2|Received Naproxen / Loratadine|Overall Study||193
402405|NCT01712009|986251|P1|Received Naproxen / Loratadine|Overall Study||0
402406|NCT01712009|986249|P3|Received Pegfilgrastim|Overall Study||200
402407|NCT01712009|986250|P2|Received Pegfilgrastim|Overall Study||196
402408|NCT01712009|986251|P1|Received Pegfilgrastim|Overall Study||191
402409|NCT01712009|986249|P3|STARTED|Overall Study||202
402410|NCT01712009|986250|P2|STARTED|Overall Study||200
402411|NCT01712009|986251|P1|STARTED|Overall Study||198
402412|NCT01711918|986277|P1|NOT COMPLETED|Overall Study||2
402413|NCT01711918|986277|P1|COMPLETED|Overall Study||7
402414|NCT01711918|986277|P1|STARTED|Overall Study||9
402415|NCT01711866|986285|P1|NOT COMPLETED|Overall Study||8
402416|NCT01711866|986285|P1|COMPLETED|Overall Study||79
402417|NCT01711866|986285|P1|STARTED|Overall Study||87
402418|NCT01711853|986290|P1|NOT COMPLETED|Overall Study||3
402419|NCT01711853|986290|P1|COMPLETED|Overall Study||16
402420|NCT01711853|986290|P1|STARTED|Overall Study||19
402421|NCT01711736|986297|P2|NOT COMPLETED|Overall Study||8
402422|NCT01711736|986298|P1|NOT COMPLETED|Overall Study||12
402423|NCT01711736|986297|P2|COMPLETED|Overall Study|Up to Day 180|294
402424|NCT01711736|986298|P1|COMPLETED|Overall Study|Up to Day 180|287
402425|NCT01711736|986297|P2|STARTED|Overall Study||302
402426|NCT01711736|986298|P1|STARTED|Overall Study||299
402427|NCT01711645|986326|P1|NOT COMPLETED|Overall Study||19
402428|NCT01711645|986326|P1|COMPLETED|Overall Study||36
402429|NCT01711645|986326|P1|STARTED|Overall Study||55
402430|NCT01711424|986361|P1|NOT COMPLETED|Overall Study||0
402431|NCT01711424|986361|P1|COMPLETED|Overall Study||1209
402432|NCT01711424|986361|P1|STARTED|Overall Study||1209
402433|NCT01711359|986371|P3|NOT COMPLETED|Follow Up||28
402434|NCT01711359|986372|P2|NOT COMPLETED|Follow Up||15
402435|NCT01711359|986373|P1|NOT COMPLETED|Follow Up||25
402436|NCT01711359|986371|P3|COMPLETED|Follow Up||0
402437|NCT01711359|986372|P2|COMPLETED|Follow Up||0
402438|NCT01711359|986373|P1|COMPLETED|Follow Up||0
402439|NCT01711359|986371|P3|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|28
402440|NCT01711359|986372|P2|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|15
402441|NCT01711359|986373|P1|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|25
402442|NCT01711359|986371|P3|NOT COMPLETED|Treatment Period||42
402443|NCT01711359|986372|P2|NOT COMPLETED|Treatment Period||24
402444|NCT01711359|986373|P1|NOT COMPLETED|Treatment Period||52
402445|NCT01711359|986371|P3|COMPLETED|Treatment Period||173
402446|NCT01711359|986372|P2|COMPLETED|Treatment Period||136
402447|NCT01711359|986373|P1|COMPLETED|Treatment Period||161
402448|NCT01711359|986371|P3|Rescued|Treatment Period||6
402449|NCT01711359|986372|P2|Rescued|Treatment Period||7
402450|NCT01711359|986373|P1|Rescued|Treatment Period||26
402451|NCT01711359|986371|P3|Received at Least One Dose of Study Drug|Treatment Period||215
402452|NCT01711359|986372|P2|Received at Least One Dose of Study Drug|Treatment Period||159
402453|NCT01711359|986373|P1|Received at Least One Dose of Study Drug|Treatment Period||210
402454|NCT01711359|986371|P3|STARTED|Treatment Period||215
402455|NCT01711359|986372|P2|STARTED|Treatment Period||160
402456|NCT01711359|986373|P1|STARTED|Treatment Period||213
402457|NCT01711216|986444|P1|NOT COMPLETED|Overall Study||217
402458|NCT01711216|986444|P1|COMPLETED|Overall Study||782
402459|NCT01711216|986444|P1|STARTED|Overall Study||999
402460|NCT01711177|986468|P3|NOT COMPLETED|Overall Study||0
402461|NCT01711177|986469|P2|NOT COMPLETED|Overall Study||0
402462|NCT01711177|986470|P1|NOT COMPLETED|Overall Study||0
402463|NCT01711177|986468|P3|COMPLETED|Overall Study||3
402464|NCT01711177|986469|P2|COMPLETED|Overall Study||3
402465|NCT01711177|986470|P1|COMPLETED|Overall Study||10
402466|NCT01711177|986468|P3|STARTED|Overall Study||3
402467|NCT01711177|986469|P2|STARTED|Overall Study||3
402468|NCT01711177|986470|P1|STARTED|Overall Study||10
402469|NCT01710839|986480|P2|NOT COMPLETED|Overall Study||6
402470|NCT01710839|986481|P1|NOT COMPLETED|Overall Study||1
402471|NCT01710839|986480|P2|COMPLETED|Overall Study||0
402472|NCT01710839|986481|P1|COMPLETED|Overall Study||23
402473|NCT01710839|986480|P2|STARTED|Overall Study||6
402474|NCT01710839|986481|P1|STARTED|Overall Study||24
402475|NCT01710800|986503|P1|NOT COMPLETED|Overall Study||22
402476|NCT01710800|986503|P1|COMPLETED|Overall Study|22 drop outs(consented but did not participate, refused 2nd intervention)|41
402477|NCT01710800|986503|P1|Received Placebo Intervention|Overall Study||45
402478|NCT01710800|986503|P1|Received PPI Intervention|Overall Study||44
402479|NCT01710800|986503|P1|STARTED|Overall Study|63 patients consented to be part of the study|63
402480|NCT01710787|986512|P3|NOT COMPLETED|Overall Study||0
402481|NCT01710787|986513|P2|NOT COMPLETED|Overall Study||0
402482|NCT01710787|986514|P1|NOT COMPLETED|Overall Study||0
402483|NCT01710787|986512|P3|COMPLETED|Overall Study||22
402484|NCT01710787|986513|P2|COMPLETED|Overall Study||44
402485|NCT01710787|986514|P1|COMPLETED|Overall Study||44
402486|NCT01710787|986512|P3|STARTED|Overall Study||22
402487|NCT01710787|986513|P2|STARTED|Overall Study||44
402488|NCT01710787|986514|P1|STARTED|Overall Study||44
402489|NCT01710657|986570|P3|NOT COMPLETED|Overall Study||32
402490|NCT01710657|986571|P2|NOT COMPLETED|Overall Study||12
402491|NCT01710657|986572|P1|NOT COMPLETED|Overall Study||18
402492|NCT01710657|986570|P3|COMPLETED|Overall Study||148
402493|NCT01710657|986571|P2|COMPLETED|Overall Study||171
402494|NCT01710657|986572|P1|COMPLETED|Overall Study||166
402495|NCT01710657|986570|P3|Maintenance Period (12 Weeks)|Overall Study||168
402496|NCT01710657|986571|P2|Maintenance Period (12 Weeks)|Overall Study||175
402497|NCT01710657|986572|P1|Maintenance Period (12 Weeks)|Overall Study||176
402498|NCT01710657|986570|P3|Titration Period (4 Weeks)|Overall Study||180
402499|NCT01710657|986571|P2|Titration Period (4 Weeks)|Overall Study||183
402500|NCT01710657|986572|P1|Titration Period (4 Weeks)|Overall Study||184
402501|NCT01710657|986570|P3|STARTED|Overall Study||180
402502|NCT01710657|986571|P2|STARTED|Overall Study||183
402503|NCT01710657|986572|P1|STARTED|Overall Study||184
402504|NCT01710527|986589|P2|NOT COMPLETED|Period 3: Intervention Period 2||0
402505|NCT01710527|986590|P1|NOT COMPLETED|Period 3: Intervention Period 2||0
402506|NCT01710527|986589|P2|COMPLETED|Period 3: Intervention Period 2||15
402507|NCT01710527|986590|P1|COMPLETED|Period 3: Intervention Period 2||16
402508|NCT01710527|986589|P2|STARTED|Period 3: Intervention Period 2||15
402509|NCT01710527|986590|P1|STARTED|Period 3: Intervention Period 2||16
402510|NCT01710527|986589|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||1
402511|NCT01710527|986590|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
402512|NCT01710527|986589|P2|COMPLETED|Period 2: Washout Period (7 Days)||15
402513|NCT01710527|986590|P1|COMPLETED|Period 2: Washout Period (7 Days)||16
402514|NCT01710527|986589|P2|STARTED|Period 2: Washout Period (7 Days)||16
402515|NCT01710527|986590|P1|STARTED|Period 2: Washout Period (7 Days)||16
402516|NCT01710527|986589|P2|NOT COMPLETED|Period 1: Intervention Period 1||0
402517|NCT01710527|986590|P1|NOT COMPLETED|Period 1: Intervention Period 1||0
402518|NCT01710527|986589|P2|COMPLETED|Period 1: Intervention Period 1||16
402519|NCT01710527|986590|P1|COMPLETED|Period 1: Intervention Period 1||16
402520|NCT01710527|986589|P2|STARTED|Period 1: Intervention Period 1||16
402521|NCT01710527|986590|P1|STARTED|Period 1: Intervention Period 1||16
402522|NCT01710514|986616|P2|NOT COMPLETED|Overall Study||7
402523|NCT01710514|986617|P1|NOT COMPLETED|Overall Study||7
402524|NCT01710514|986616|P2|COMPLETED|Overall Study||47
402525|NCT01710514|986617|P1|COMPLETED|Overall Study||47
402526|NCT01710514|986616|P2|Safety Analysis Set|Overall Study|All subjects received at least one dose of IMP.|54
402527|NCT01710514|986617|P1|Safety Analysis Set|Overall Study|All subjects received at least one dose of Investigational Medicinal Product (IMP).|54
402528|NCT01710514|986616|P2|FAS With Embryo Transfer (ET)|Overall Study|Data on pregnancy was reported for the subjects with embryo transfer.|47
402529|NCT01710514|986617|P1|FAS With Embryo Transfer (ET)|Overall Study|Data on pregnancy was reported for the subjects with embryo transfer.|43
402530|NCT01710514|986616|P2|Full Analysis Set (FAS)|Overall Study|All randomised and exposed subjects with at least one completed primary efficacy assessment.|48
402531|NCT01710514|986617|P1|Full Analysis Set (FAS)|Overall Study|All randomised and exposed subjects with at least one completed primary efficacy assessment.|46
402532|NCT01710514|986616|P2|Intent-To-Treat (ITT) Analysis Set|Overall Study|All randomised subjects were included in the ITT analysis set.|54
402533|NCT01710514|986617|P1|Intent-To-Treat (ITT) Analysis Set|Overall Study|All randomised subjects were included in the Intent-To-Treat (ITT) analysis set.|54
402534|NCT01710514|986616|P2|STARTED|Overall Study||54
402535|NCT01710514|986617|P1|STARTED|Overall Study||54
402536|NCT01710501|986638|P3|NOT COMPLETED|Overall Study||0
402537|NCT01710501|986639|P2|NOT COMPLETED|Overall Study||0
402538|NCT01710501|986640|P1|NOT COMPLETED|Overall Study||2
402539|NCT01710501|986638|P3|COMPLETED|Overall Study||30
402540|NCT01710501|986639|P2|COMPLETED|Overall Study||28
402541|NCT01710501|986640|P1|COMPLETED|Overall Study||27
402542|NCT01710501|986638|P3|STARTED|Overall Study||30
402543|NCT01710501|986639|P2|STARTED|Overall Study||28
402544|NCT01710501|986640|P1|STARTED|Overall Study||29
402545|NCT01710358|986672|P3|NOT COMPLETED|Follow-up Period||0
402546|NCT01710358|986673|P2|NOT COMPLETED|Follow-up Period||0
402547|NCT01710358|986674|P1|NOT COMPLETED|Follow-up Period||0
402548|NCT01710358|986672|P3|COMPLETED|Follow-up Period||20
402549|NCT01710358|986673|P2|COMPLETED|Follow-up Period||76
402550|NCT01710358|986674|P1|COMPLETED|Follow-up Period||33
402551|NCT01710358|986672|P3|STARTED|Follow-up Period|Participants from treatment who entered the post-treatment follow-up period.|20
402552|NCT01710358|986673|P2|STARTED|Follow-up Period|Rescued participants who entered post-treatment follow-up are included in Baricitinib 4mg follow up.|76
402553|NCT01710358|986674|P1|STARTED|Follow-up Period|Participants from treatment who entered the post-treatment follow-up period.|33
402554|NCT01710358|986672|P3|NOT COMPLETED|Rescue Period||0
402555|NCT01710358|986673|P2|NOT COMPLETED|Rescue Period||31
402556|NCT01710358|986674|P1|NOT COMPLETED|Rescue Period||0
402557|NCT01710358|986672|P3|COMPLETED|Rescue Period||0
402558|NCT01710358|986673|P2|COMPLETED|Rescue Period||196
402559|NCT01710358|986674|P1|COMPLETED|Rescue Period||0
402560|NCT01710358|986672|P3|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
402561|NCT01710358|986673|P2|STARTED|Rescue Period|Baricitinib 4 mg administered PO QD through Week 52. Participants continued background MTX therapy.|227
402562|NCT01710358|986674|P1|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
402563|NCT01710358|986672|P3|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||15
402564|NCT01710358|986673|P2|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||22
402565|NCT01710358|986674|P1|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||16
402566|NCT01710358|986672|P3|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|252
402567|NCT01710358|986673|P2|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|402
402568|NCT01710358|986674|P1|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|294
402569|NCT01710358|986672|P3|Rescued|Treatment Period Part B (Weeks 24 to 52)||11
402570|NCT01710358|986673|P2|Rescued|Treatment Period Part B (Weeks 24 to 52)||8
402571|NCT01710358|986674|P1|Rescued|Treatment Period Part B (Weeks 24 to 52)||5
402572|NCT01710358|986672|P3|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)||267
402573|NCT01710358|986673|P2|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)||424
402574|NCT01710358|986674|P1|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)|Participants originally randomized to placebo received baricitinib during Part B.|306
402575|NCT01710358|986672|P3|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|267
402576|NCT01710358|986673|P2|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|424
402577|NCT01710358|986674|P1|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|310
402578|NCT01710358|986672|P3|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||23
402579|NCT01710358|986673|P2|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||29
402580|NCT01710358|986674|P1|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||51
402581|NCT01710358|986672|P3|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|307
402582|NCT01710358|986673|P2|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|459
402583|NCT01710358|986674|P1|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|438
402584|NCT01710358|986672|P3|Rescued|Treatment Period Part A (Weeks 0 to 24)||40
402585|NCT01710358|986673|P2|Rescued|Treatment Period Part A (Weeks 0 to 24)||35
402586|NCT01710358|986674|P1|Rescued|Treatment Period Part A (Weeks 0 to 24)||128
402587|NCT01710358|986672|P3|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||330
402588|NCT01710358|986673|P2|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||487
402589|NCT01710358|986674|P1|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||488
402590|NCT01710358|986672|P3|STARTED|Treatment Period Part A (Weeks 0 to 24)||330
402591|NCT01710358|986673|P2|STARTED|Treatment Period Part A (Weeks 0 to 24)||488
402592|NCT01710358|986674|P1|STARTED|Treatment Period Part A (Weeks 0 to 24)||489
402593|NCT01710345|986745|P3|NOT COMPLETED|Overall Study||1
402594|NCT01710345|986746|P2|NOT COMPLETED|Overall Study||5
402595|NCT01710345|986747|P1|NOT COMPLETED|Overall Study||3
402596|NCT01710345|986745|P3|COMPLETED|Overall Study||19
402597|NCT01710345|986746|P2|COMPLETED|Overall Study||35
402598|NCT01710345|986747|P1|COMPLETED|Overall Study||37
402599|NCT01710345|986745|P3|STARTED|Overall Study||20
402600|NCT01710345|986746|P2|STARTED|Overall Study||40
402601|NCT01710345|986747|P1|STARTED|Overall Study|41 patients were randomized to sufentanil 20 mcg, one patient not dosed due to damaged medication.|40
402602|NCT01710332|986757|P2|NOT COMPLETED|Overall Study||0
402603|NCT01710332|986758|P1|NOT COMPLETED|Overall Study||0
402604|NCT01710332|986757|P2|COMPLETED|Overall Study||6
402605|NCT01710332|986758|P1|COMPLETED|Overall Study||6
402606|NCT01710332|986757|P2|STARTED|Overall Study||6
402607|NCT01710332|986758|P1|STARTED|Overall Study||6
402608|NCT01710254|986766|P1|NOT COMPLETED|Overall Study||0
402609|NCT01710254|986766|P1|COMPLETED|Overall Study||30
402610|NCT01710254|986766|P1|STARTED|Overall Study||30
402611|NCT01710046|986774|P2|NOT COMPLETED|Overall Study||0
402612|NCT01710046|986775|P1|NOT COMPLETED|Overall Study||1
402613|NCT01710046|986774|P2|COMPLETED|Overall Study||3
402614|NCT01710046|986775|P1|COMPLETED|Overall Study||8
402615|NCT01710046|986774|P2|STARTED|Overall Study||3
402616|NCT01710046|986775|P1|STARTED|Overall Study||9
402617|NCT01710033|986815|P5|NOT COMPLETED|Stage 2||1
402618|NCT01710033|986816|P4|NOT COMPLETED|Stage 2||0
402619|NCT01710033|986817|P3|NOT COMPLETED|Stage 2||0
402620|NCT01710033|986818|P2|NOT COMPLETED|Stage 2||0
402621|NCT01710033|986819|P1|NOT COMPLETED|Stage 2||0
402622|NCT01710033|986815|P5|COMPLETED|Stage 2||3
402623|NCT01710033|986816|P4|COMPLETED|Stage 2||0
402624|NCT01710033|986817|P3|COMPLETED|Stage 2||0
402625|NCT01710033|986818|P2|COMPLETED|Stage 2||0
402626|NCT01710033|986819|P1|COMPLETED|Stage 2||0
402627|NCT01710033|986815|P5|STARTED|Stage 2||4
402628|NCT01710033|986816|P4|STARTED|Stage 2||0
402629|NCT01710033|986817|P3|STARTED|Stage 2||0
402630|NCT01710033|986818|P2|STARTED|Stage 2||0
402631|NCT01710033|986819|P1|STARTED|Stage 2||0
402632|NCT01710033|986815|P5|NOT COMPLETED|Stage 1||0
402633|NCT01710033|986816|P4|NOT COMPLETED|Stage 1||0
402634|NCT01710033|986817|P3|NOT COMPLETED|Stage 1||0
402635|NCT01710033|986818|P2|NOT COMPLETED|Stage 1||0
402636|NCT01710033|986819|P1|NOT COMPLETED|Stage 1||0
402637|NCT01710033|986815|P5|COMPLETED|Stage 1||0
402638|NCT01710033|986816|P4|COMPLETED|Stage 1||6
402639|NCT01710033|986817|P3|COMPLETED|Stage 1||6
402640|NCT01710033|986818|P2|COMPLETED|Stage 1||6
402641|NCT01710033|986819|P1|COMPLETED|Stage 1||6
402642|NCT01710033|986815|P5|STARTED|Stage 1||0
402643|NCT01710033|986816|P4|STARTED|Stage 1||6
402644|NCT01710033|986817|P3|STARTED|Stage 1||6
402645|NCT01710033|986818|P2|STARTED|Stage 1||6
402646|NCT01710033|986819|P1|STARTED|Stage 1||6
402647|NCT01710020|986900|P1|NOT COMPLETED|Period 2||0
402648|NCT01710020|986900|P1|COMPLETED|Period 2||11
402649|NCT01710020|986900|P1|STARTED|Period 2||11
402650|NCT01710020|986900|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
402651|NCT01710020|986900|P1|COMPLETED|Washout Period (at Least 14 Days)||11
402652|NCT01710020|986900|P1|STARTED|Washout Period (at Least 14 Days)||11
402653|NCT01710020|986900|P1|NOT COMPLETED|Period 1||1
402654|NCT01710020|986900|P1|COMPLETED|Period 1||11
402655|NCT01710020|986900|P1|STARTED|Period 1||12
402656|NCT01709903|986919|P2|NOT COMPLETED|Overall Study||39
402657|NCT01709903|986920|P1|NOT COMPLETED|Overall Study||29
402658|NCT01709903|986919|P2|COMPLETED|Overall Study||333
402659|NCT01709903|986920|P1|COMPLETED|Overall Study||343
402660|NCT01709903|986919|P2|STARTED|Overall Study|Randomized set|372
402661|NCT01709903|986920|P1|STARTED|Overall Study|Randomized set|372
402662|NCT01709864|986944|P2|NOT COMPLETED|Overall Study||11
402663|NCT01709864|986945|P1|NOT COMPLETED|Overall Study||7
402664|NCT01709864|986944|P2|COMPLETED|Overall Study||208
402665|NCT01709864|986945|P1|COMPLETED|Overall Study||215
402666|NCT01709864|986944|P2|Per Protocol Set (PPS)|Overall Study|PPS included all patients in the FAS who did not have any major protocol deviations.|201
402667|NCT01709864|986945|P1|Per Protocol Set (PPS)|Overall Study|PPS included all patients in the FAS who did not have any major protocol deviations.|204
402668|NCT01709864|986944|P2|Full Analysis Set (FAS)|Overall Study|FAS included all randomized patients who received at least one dose of trial drug.|216
402669|NCT01709864|986945|P1|Full Analysis Set (FAS)|Overall Study|FAS included all randomized patients who received at least one dose of trial drug.|222
402670|NCT01709864|986944|P2|STARTED|Overall Study||219
402671|NCT01709864|986945|P1|STARTED|Overall Study||222
402672|NCT01709799|986982|P3|NOT COMPLETED|Overall Study||3
402673|NCT01709799|986983|P2|NOT COMPLETED|Overall Study||3
402674|NCT01709799|986984|P1|NOT COMPLETED|Overall Study||3
402675|NCT01709799|986982|P3|COMPLETED|Overall Study||15
402676|NCT01709799|986983|P2|COMPLETED|Overall Study||18
402677|NCT01709799|986984|P1|COMPLETED|Overall Study||22
402678|NCT01709799|986982|P3|STARTED|Overall Study||18
402679|NCT01709799|986983|P2|STARTED|Overall Study||21
402680|NCT01709799|986984|P1|STARTED|Overall Study||25
402681|NCT01709786|987007|P1|NOT COMPLETED|Overall Study||0
402682|NCT01709786|987007|P1|COMPLETED|Overall Study||88
402683|NCT01709786|987007|P1|STARTED|Overall Study||88
402684|NCT01709708|987016|P2|NOT COMPLETED|Overall Study||2
402685|NCT01709708|987017|P1|NOT COMPLETED|Overall Study||1
402686|NCT01709708|987016|P2|COMPLETED|Overall Study||12
402687|NCT01709708|987017|P1|COMPLETED|Overall Study||26
402688|NCT01709708|987016|P2|STARTED|Overall Study||14
402689|NCT01709708|987017|P1|STARTED|Overall Study||27
402690|NCT01709695|987041|P2|NOT COMPLETED|Overall Study||1
402691|NCT01709695|987042|P1|NOT COMPLETED|Overall Study||1
402692|NCT01709695|987041|P2|COMPLETED|Overall Study||13
402693|NCT01709695|987042|P1|COMPLETED|Overall Study||12
402694|NCT01709695|987041|P2|STARTED|Overall Study||14
402695|NCT01709695|987042|P1|STARTED|Overall Study||13
402696|NCT01709578|987067|P3|NOT COMPLETED|Overall Study||51
402697|NCT01709578|987068|P2|NOT COMPLETED|Overall Study||56
402698|NCT01709578|987069|P1|NOT COMPLETED|Overall Study||80
402699|NCT01709578|987067|P3|COMPLETED|Overall Study||133
402700|NCT01709578|987068|P2|COMPLETED|Overall Study||125
402701|NCT01709578|987069|P1|COMPLETED|Overall Study||101
402702|NCT01709578|987067|P3|STARTED|Overall Study||184
402703|NCT01709578|987068|P2|STARTED|Overall Study||181
402704|NCT01709578|987069|P1|STARTED|Overall Study||181
402705|NCT01709513|987200|P3|NOT COMPLETED|Overall Study||30
402706|NCT01709513|987201|P2|NOT COMPLETED|Overall Study||43
402707|NCT01709513|987202|P1|NOT COMPLETED|Overall Study||21
402708|NCT01709513|987200|P3|COMPLETED|Overall Study||96
402709|NCT01709513|987201|P2|COMPLETED|Overall Study||82
402710|NCT01709513|987202|P1|COMPLETED|Overall Study||42
402711|NCT01709513|987200|P3|Treated|Overall Study||126
402712|NCT01709513|987201|P2|Treated|Overall Study||124
402713|NCT01709513|987202|P1|Treated|Overall Study||63
402714|NCT01709513|987200|P3|STARTED|Overall Study||126
402715|NCT01709513|987201|P2|STARTED|Overall Study||125
402716|NCT01709513|987202|P1|STARTED|Overall Study||63
402717|NCT01709500|987263|P2|NOT COMPLETED|Overall Study||82
402718|NCT01709500|987264|P1|NOT COMPLETED|Overall Study||167
402719|NCT01709500|987263|P2|COMPLETED|Overall Study||0
402720|NCT01709500|987264|P1|COMPLETED|Overall Study||0
402721|NCT01709500|987263|P2|Treated|Overall Study||81
402722|NCT01709500|987264|P1|Treated|Overall Study||167
402723|NCT01709500|987263|P2|STARTED|Overall Study||82
402724|NCT01709500|987264|P1|STARTED|Overall Study||167
402725|NCT01709474|987320|P2|NOT COMPLETED|Overall Study||0
402726|NCT01709474|987321|P1|NOT COMPLETED|Overall Study||0
402727|NCT01709474|987320|P2|COMPLETED|Overall Study||4
402728|NCT01709474|987321|P1|COMPLETED|Overall Study||3
402729|NCT01709474|987320|P2|STARTED|Overall Study||4
402730|NCT01709474|987321|P1|STARTED|Overall Study||3
402731|NCT01709422|987331|P2|NOT COMPLETED|Overall Study||0
402732|NCT01709422|987332|P1|NOT COMPLETED|Overall Study||0
402733|NCT01709422|987331|P2|COMPLETED|Overall Study||70
402734|NCT01709422|987332|P1|COMPLETED|Overall Study||70
402735|NCT01709422|987331|P2|STARTED|Overall Study||70
402736|NCT01709422|987332|P1|STARTED|Overall Study||70
402737|NCT01709409|987342|P2|NOT COMPLETED|Overall Study||0
402738|NCT01709409|987343|P1|NOT COMPLETED|Overall Study||1
402739|NCT01709409|987342|P2|COMPLETED|Overall Study||45
402740|NCT01709409|987343|P1|COMPLETED|Overall Study||42
402741|NCT01709409|987342|P2|STARTED|Overall Study||45
402742|NCT01709409|987343|P1|STARTED|Overall Study||43
402743|NCT01709383|987351|P2|NOT COMPLETED|Overall Study||0
402744|NCT01709383|987352|P1|NOT COMPLETED|Overall Study||1
402745|NCT01709383|987351|P2|COMPLETED|Overall Study||14
402746|NCT01709383|987352|P1|COMPLETED|Overall Study||23
402747|NCT01709383|987351|P2|Included in Analysis|Overall Study||13
402748|NCT01709383|987352|P1|Included in Analysis|Overall Study||22
402749|NCT01709383|987351|P2|Completed Follow-ups|Overall Study||14
402750|NCT01709383|987352|P1|Completed Follow-ups|Overall Study||23
402751|NCT01709383|987351|P2|Completed Treatment|Overall Study||14
402752|NCT01709383|987352|P1|Completed Treatment|Overall Study||24
402753|NCT01709383|987351|P2|STARTED|Overall Study||14
402754|NCT01709383|987352|P1|STARTED|Overall Study||24
402755|NCT01709331|987370|P1|NOT COMPLETED|Overall Study||1
402756|NCT01709331|987370|P1|COMPLETED|Overall Study||17
402757|NCT01709331|987370|P1|STARTED|Overall Study||18
402758|NCT01709305|987376|P5|NOT COMPLETED|Phase 2||47
402759|NCT01709305|987377|P4|NOT COMPLETED|Phase 2||48
402760|NCT01709305|987378|P3|NOT COMPLETED|Phase 2||45
402761|NCT01709305|987379|P2|NOT COMPLETED|Phase 2||52
402762|NCT01709305|987380|P1|NOT COMPLETED|Phase 2||0
402763|NCT01709305|987376|P5|COMPLETED|Phase 2||507
402764|NCT01709305|987377|P4|COMPLETED|Phase 2||508
402765|NCT01709305|987378|P3|COMPLETED|Phase 2||505
402766|NCT01709305|987379|P2|COMPLETED|Phase 2||500
402767|NCT01709305|987380|P1|COMPLETED|Phase 2||0
402768|NCT01709305|987376|P5|STARTED|Phase 2||554
402769|NCT01709305|987377|P4|STARTED|Phase 2||556
402770|NCT01709305|987378|P3|STARTED|Phase 2||550
402771|NCT01709305|987379|P2|STARTED|Phase 2||552
402772|NCT01709305|987380|P1|STARTED|Phase 2||0
402773|NCT01709305|987376|P5|NOT COMPLETED|Phase 1||0
402774|NCT01709305|987377|P4|NOT COMPLETED|Phase 1||0
402775|NCT01709305|987378|P3|NOT COMPLETED|Phase 1||0
402776|NCT01709305|987379|P2|NOT COMPLETED|Phase 1||0
402777|NCT01709305|987380|P1|NOT COMPLETED|Phase 1||637
402778|NCT01709305|987376|P5|COMPLETED|Phase 1||0
402779|NCT01709305|987377|P4|COMPLETED|Phase 1||0
402780|NCT01709305|987378|P3|COMPLETED|Phase 1||0
402781|NCT01709305|987379|P2|COMPLETED|Phase 1||0
402782|NCT01709305|987380|P1|COMPLETED|Phase 1||4933
402783|NCT01709305|987376|P5|STARTED|Phase 1||0
402784|NCT01709305|987377|P4|STARTED|Phase 1||0
402785|NCT01709305|987378|P3|STARTED|Phase 1||0
402786|NCT01709305|987379|P2|STARTED|Phase 1||0
402787|NCT01709305|987380|P1|STARTED|Phase 1||5570
402788|NCT01709227|987417|P2|NOT COMPLETED|Overall Study||9
402789|NCT01709227|987418|P1|NOT COMPLETED|Overall Study||1
402790|NCT01709227|987417|P2|COMPLETED|Overall Study||32
402791|NCT01709227|987418|P1|COMPLETED|Overall Study||31
402792|NCT01709227|987417|P2|STARTED|Overall Study||41
402793|NCT01709227|987418|P1|STARTED|Overall Study||32
402794|NCT01709162|987444|P2|NOT COMPLETED|Overall Study||5
402795|NCT01709162|987445|P1|NOT COMPLETED|Overall Study||6
402796|NCT01709162|987444|P2|COMPLETED|Overall Study|Completed treatment as per protocol|0
402797|NCT01709162|987445|P1|COMPLETED|Overall Study|Completed treatment as per protocol|12
402798|NCT01709162|987444|P2|Still Receiving Treatment|Overall Study||0
402799|NCT01709162|987445|P1|Still Receiving Treatment|Overall Study||0
402800|NCT01709162|987444|P2|Received Treatment|Overall Study||4
402801|NCT01709162|987445|P1|Received Treatment|Overall Study||18
402802|NCT01709162|987444|P2|STARTED|Overall Study|Randomized|5
402803|NCT01709162|987445|P1|STARTED|Overall Study|Randomized|18
402804|NCT01709136|987457|P1|NOT COMPLETED|Overall Study||0
402805|NCT01709136|987457|P1|COMPLETED|Overall Study||3
402806|NCT01709136|987457|P1|STARTED|Overall Study||3
402807|NCT01709110|987466|P2|NOT COMPLETED|Overall Study||168
402808|NCT01709110|987467|P1|NOT COMPLETED|Overall Study||185
402809|NCT01709110|987466|P2|COMPLETED|Overall Study||515
402810|NCT01709110|987467|P1|COMPLETED|Overall Study||498
402811|NCT01709110|987466|P2|Received at Least One Dose of Study Drug|Overall Study||680
402812|NCT01709110|987467|P1|Received at Least One Dose of Study Drug|Overall Study||680
402813|NCT01709110|987466|P2|STARTED|Overall Study||683
402814|NCT01709110|987467|P1|STARTED|Overall Study||683
402815|NCT01709084|987497|P2|NOT COMPLETED|Overall Study||15
402816|NCT01709084|987498|P1|NOT COMPLETED|Overall Study||16
402817|NCT01709084|987497|P2|COMPLETED|Overall Study||198
402818|NCT01709084|987498|P1|COMPLETED|Overall Study||197
402819|NCT01709084|987497|P2|Treated|Overall Study||211
402820|NCT01709084|987498|P1|Treated|Overall Study||213
402821|NCT01709084|987497|P2|STARTED|Overall Study||213
402822|NCT01709084|987498|P1|STARTED|Overall Study||213
402823|NCT01708967|987516|P2|NOT COMPLETED|Overall Study||7
402824|NCT01708967|987517|P1|NOT COMPLETED|Overall Study||0
402825|NCT01708967|987516|P2|COMPLETED|Overall Study||43
402826|NCT01708967|987517|P1|COMPLETED|Overall Study||50
402827|NCT01708967|987516|P2|STARTED|Overall Study||50
402828|NCT01708967|987517|P1|STARTED|Overall Study||50
402829|NCT01708954|987526|P3|NOT COMPLETED|Step 2||0
402830|NCT01708954|987527|P2|NOT COMPLETED|Step 2||7
402831|NCT01708954|987528|P1|NOT COMPLETED|Step 2||13
402832|NCT01708954|987526|P3|COMPLETED|Step 2||0
402833|NCT01708954|987527|P2|COMPLETED|Step 2|Treatment continued until progressive disease or unacceptable toxicity.|0
402834|NCT01708954|987528|P1|COMPLETED|Step 2|Treatment continued until progressive disease or unacceptable toxicity.|0
402835|NCT01708954|987526|P3|STARTED|Step 2|Only patients with disease progression on Arms A and B were allowed to register to Step 2.|0
402836|NCT01708954|987527|P2|STARTED|Step 2|Only patients with disease progression in Step 1 are eligible to register to Step 2.|7
402837|NCT01708954|987528|P1|STARTED|Step 2|Only patients with disease progression in Step 1 are eligible to register to Step 2.|13
402838|NCT01708954|987526|P3|NOT COMPLETED|Step 1||43
402839|NCT01708954|987527|P2|NOT COMPLETED|Step 1||40
402840|NCT01708954|987528|P1|NOT COMPLETED|Step 1||42
402841|NCT01708954|987526|P3|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
402842|NCT01708954|987527|P2|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
402843|NCT01708954|987528|P1|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
402844|NCT01708954|987526|P3|Patients With MET Status Data Available|Step 1||24
402845|NCT01708954|987527|P2|Patients With MET Status Data Available|Step 1||32
402846|NCT01708954|987528|P1|Patients With MET Status Data Available|Step 1||30
402847|NCT01708954|987526|P3|Eligible and Treated|Step 1||35
402848|NCT01708954|987527|P2|Eligible and Treated|Step 1||38
402849|NCT01708954|987528|P1|Eligible and Treated|Step 1||38
402850|NCT01708954|987526|P3|Started Protocol Therapy|Step 1||39
402851|NCT01708954|987527|P2|Started Protocol Therapy|Step 1||40
402852|NCT01708954|987528|P1|Started Protocol Therapy|Step 1||40
402853|NCT01708954|987526|P3|STARTED|Step 1||43
402854|NCT01708954|987527|P2|STARTED|Step 1||40
402855|NCT01708954|987528|P1|STARTED|Step 1||42
402856|NCT01708915|987553|P4|NOT COMPLETED|Overall Study||33
402857|NCT01708915|987554|P3|NOT COMPLETED|Overall Study||46
402858|NCT01708915|987555|P2|NOT COMPLETED|Overall Study||62
402859|NCT01708915|987556|P1|NOT COMPLETED|Overall Study||86
402860|NCT01708915|987553|P4|COMPLETED|Overall Study||169
402861|NCT01708915|987554|P3|COMPLETED|Overall Study||152
402862|NCT01708915|987555|P2|COMPLETED|Overall Study||139
402863|NCT01708915|987556|P1|COMPLETED|Overall Study||118
402864|NCT01708915|987553|P4|STARTED|Overall Study||202
402865|NCT01708915|987554|P3|STARTED|Overall Study||198
402866|NCT01708915|987555|P2|STARTED|Overall Study||201
402867|NCT01708915|987556|P1|STARTED|Overall Study||204
402868|NCT01708902|987585|P7|NOT COMPLETED|Overall Study||7
402869|NCT01708902|987586|P6|NOT COMPLETED|Overall Study||7
402870|NCT01708902|987587|P5|NOT COMPLETED|Overall Study||16
402871|NCT01708902|987588|P4|NOT COMPLETED|Overall Study||10
402872|NCT01708902|987589|P3|NOT COMPLETED|Overall Study||17
402873|NCT01708902|987590|P2|NOT COMPLETED|Overall Study||8
402874|NCT01708902|987591|P1|NOT COMPLETED|Overall Study||17
402875|NCT01708902|987585|P7|COMPLETED|Overall Study||65
402876|NCT01708902|987586|P6|COMPLETED|Overall Study||64
402877|NCT01708902|987587|P5|COMPLETED|Overall Study||131
402878|NCT01708902|987588|P4|COMPLETED|Overall Study||137
402879|NCT01708902|987589|P3|COMPLETED|Overall Study||127
402880|NCT01708902|987590|P2|COMPLETED|Overall Study||137
402881|NCT01708902|987591|P1|COMPLETED|Overall Study||130
402882|NCT01708902|987585|P7|STARTED|Overall Study||72
402883|NCT01708902|987586|P6|STARTED|Overall Study||71
402884|NCT01708902|987587|P5|STARTED|Overall Study||147
402885|NCT01708902|987588|P4|STARTED|Overall Study||147
402886|NCT01708902|987589|P3|STARTED|Overall Study||144
402887|NCT01708902|987590|P2|STARTED|Overall Study||145
402888|NCT01708902|987591|P1|STARTED|Overall Study||147
402889|NCT01708525|987650|P1|NOT COMPLETED|Overall Study||0
402890|NCT01708525|987650|P1|COMPLETED|Overall Study||2
402891|NCT01708525|987650|P1|STARTED|Overall Study||2
402892|NCT01708317|987655|P1|NOT COMPLETED|Final Education Period||0
402893|NCT01708317|987655|P1|COMPLETED|Final Education Period||909
402894|NCT01708317|987655|P1|STARTED|Final Education Period|# of ED patients eligible for ACASI, had it been available, in final education period|909
402895|NCT01708317|987655|P1|NOT COMPLETED|ACASI + Education Period||0
402896|NCT01708317|987655|P1|COMPLETED|ACASI + Education Period||2601
402897|NCT01708317|987655|P1|STARTED|ACASI + Education Period|# of ED patients eligible for ACASI in the period the ACASI was actually available.|2601
402898|NCT01708317|987655|P1|NOT COMPLETED|Initial Education Period||0
402899|NCT01708317|987655|P1|COMPLETED|Initial Education Period||982
402900|NCT01708317|987655|P1|STARTED|Initial Education Period|# of ED patients eligible for ACASI, had it been available, in initial education period|982
402901|NCT01708317|987655|P1|NOT COMPLETED|2010 Control Period||0
402902|NCT01708317|987655|P1|COMPLETED|2010 Control Period||3929
402903|NCT01708317|987655|P1|STARTED|2010 Control Period|# of ED patients eligible for ACASI, had it been available, in control period|3929
402904|NCT01708291|987664|P2|NOT COMPLETED|Overall Study||1
402905|NCT01708291|987665|P1|NOT COMPLETED|Overall Study||2
402906|NCT01708291|987664|P2|COMPLETED|Overall Study||20
402907|NCT01708291|987665|P1|COMPLETED|Overall Study||19
402908|NCT01708291|987664|P2|STARTED|Overall Study||21
402909|NCT01708291|987665|P1|STARTED|Overall Study||21
402910|NCT01708278|987677|P6|NOT COMPLETED|Overall Study||0
402911|NCT01708278|987678|P5|NOT COMPLETED|Overall Study||0
402912|NCT01708278|987679|P4|NOT COMPLETED|Overall Study||0
402913|NCT01708278|987680|P3|NOT COMPLETED|Overall Study||0
402914|NCT01708278|987681|P2|NOT COMPLETED|Overall Study||0
402915|NCT01708278|987682|P1|NOT COMPLETED|Overall Study||0
402916|NCT01708278|987677|P6|COMPLETED|Overall Study||1
402917|NCT01708278|987678|P5|COMPLETED|Overall Study||1
402918|NCT01708278|987679|P4|COMPLETED|Overall Study||2
402919|NCT01708278|987680|P3|COMPLETED|Overall Study||2
402920|NCT01708278|987681|P2|COMPLETED|Overall Study||2
402921|NCT01708278|987682|P1|COMPLETED|Overall Study||1
402922|NCT01708278|987677|P6|STARTED|Overall Study||1
402923|NCT01708278|987678|P5|STARTED|Overall Study||1
402924|NCT01708278|987679|P4|STARTED|Overall Study||2
402925|NCT01708278|987680|P3|STARTED|Overall Study||2
402926|NCT01708278|987681|P2|STARTED|Overall Study||2
402927|NCT01708278|987682|P1|STARTED|Overall Study||1
402928|NCT01708213|987696|P1|NOT COMPLETED|Overall Study||1
402929|NCT01708213|987696|P1|COMPLETED|Overall Study||71
402930|NCT01708213|987696|P1|STARTED|Overall Study||72
402931|NCT01708187|987704|P2|NOT COMPLETED|Overall Study||1
402932|NCT01708187|987705|P1|NOT COMPLETED|Overall Study||0
402933|NCT01708187|987704|P2|COMPLETED|Overall Study||0
402934|NCT01708187|987705|P1|COMPLETED|Overall Study||1
402935|NCT01708187|987704|P2|STARTED|Overall Study||1
402936|NCT01708187|987705|P1|STARTED|Overall Study||1
402937|NCT01708174|987714|P3|NOT COMPLETED|Survival Follow-up||0
402938|NCT01708174|987715|P2|NOT COMPLETED|Survival Follow-up||0
402939|NCT01708174|987716|P1|NOT COMPLETED|Survival Follow-up||0
402940|NCT01708174|987714|P3|COMPLETED|Survival Follow-up||0
402941|NCT01708174|987715|P2|COMPLETED|Survival Follow-up||10
402942|NCT01708174|987716|P1|COMPLETED|Survival Follow-up||1
402943|NCT01708174|987714|P3|STARTED|Survival Follow-up||0
402944|NCT01708174|987715|P2|STARTED|Survival Follow-up||10
402945|NCT01708174|987716|P1|STARTED|Survival Follow-up||1
402946|NCT01708174|987714|P3|NOT COMPLETED|Treatment Period||1
402947|NCT01708174|987715|P2|NOT COMPLETED|Treatment Period||2
402948|NCT01708174|987716|P1|NOT COMPLETED|Treatment Period||1
402949|NCT01708174|987714|P3|COMPLETED|Treatment Period||3
402950|NCT01708174|987715|P2|COMPLETED|Treatment Period||14
402951|NCT01708174|987716|P1|COMPLETED|Treatment Period||1
402952|NCT01708174|987714|P3|Pharmacokinetic Analysis Set|Treatment Period||0
402953|NCT01708174|987715|P2|Pharmacokinetic Analysis Set|Treatment Period||13
402954|NCT01708174|987716|P1|Pharmacokinetic Analysis Set|Treatment Period||2
402955|NCT01708174|987714|P3|STARTED|Treatment Period||4
402956|NCT01708174|987715|P2|STARTED|Treatment Period||16
402957|NCT01708174|987716|P1|STARTED|Treatment Period||2
402958|NCT01708161|987748|P6|NOT COMPLETED|Overall Study||1
402959|NCT01708161|987749|P5|NOT COMPLETED|Overall Study||6
402960|NCT01708161|987750|P4|NOT COMPLETED|Overall Study||16
402961|NCT01708161|987751|P3|NOT COMPLETED|Overall Study||10
402962|NCT01708161|987752|P2|NOT COMPLETED|Overall Study||10
402963|NCT01708161|987753|P1|NOT COMPLETED|Overall Study||4
402964|NCT01708161|987748|P6|COMPLETED|Overall Study||0
402965|NCT01708161|987749|P5|COMPLETED|Overall Study||0
402966|NCT01708161|987750|P4|COMPLETED|Overall Study||0
402967|NCT01708161|987751|P3|COMPLETED|Overall Study||0
402968|NCT01708161|987752|P2|COMPLETED|Overall Study||0
402969|NCT01708161|987753|P1|COMPLETED|Overall Study||0
402970|NCT01708161|987748|P6|STARTED|Overall Study||1
402971|NCT01708161|987749|P5|STARTED|Overall Study||6
402972|NCT01708161|987750|P4|STARTED|Overall Study||16
402973|NCT01708161|987751|P3|STARTED|Overall Study||10
402974|NCT01708161|987752|P2|STARTED|Overall Study||10
402975|NCT01708161|987753|P1|STARTED|Overall Study||4
402976|NCT01708122|987795|P2|NOT COMPLETED|Overall Study||0
402977|NCT01708122|987796|P1|NOT COMPLETED|Overall Study||0
402978|NCT01708122|987795|P2|COMPLETED|Overall Study||26
402979|NCT01708122|987796|P1|COMPLETED|Overall Study||27
402980|NCT01708122|987795|P2|STARTED|Overall Study||26
402981|NCT01708122|987796|P1|STARTED|Overall Study||27
402982|NCT01708057|987804|P3|NOT COMPLETED|Overall Study||1
402983|NCT01708057|987805|P2|NOT COMPLETED|Overall Study||1
402984|NCT01708057|987806|P1|NOT COMPLETED|Overall Study||1
402985|NCT01708057|987804|P3|COMPLETED|Overall Study||0
402986|NCT01708057|987805|P2|COMPLETED|Overall Study||0
402987|NCT01708057|987806|P1|COMPLETED|Overall Study||0
402988|NCT01708057|987804|P3|STARTED|Overall Study||1
402989|NCT01708057|987805|P2|STARTED|Overall Study||1
402990|NCT01708057|987806|P1|STARTED|Overall Study||1
402991|NCT01707667|987864|P2|NOT COMPLETED|Period 2||0
402992|NCT01707667|987865|P1|NOT COMPLETED|Period 2||0
402993|NCT01707667|987864|P2|COMPLETED|Period 2||6
402994|NCT01707667|987865|P1|COMPLETED|Period 2||6
402995|NCT01707667|987864|P2|STARTED|Period 2||6
402996|NCT01707667|987865|P1|STARTED|Period 2||6
402997|NCT01707667|987864|P2|NOT COMPLETED|Period 1||0
402998|NCT01707667|987865|P1|NOT COMPLETED|Period 1||1
402999|NCT01707667|987864|P2|COMPLETED|Period 1||6
403000|NCT01707667|987865|P1|COMPLETED|Period 1||6
403001|NCT01707667|987864|P2|STARTED|Period 1||6
403002|NCT01707667|987865|P1|STARTED|Period 1||7
403003|NCT01707654|987883|P1|NOT COMPLETED|Overall Study||0
403004|NCT01707654|987883|P1|COMPLETED|Overall Study||9
403005|NCT01707654|987883|P1|STARTED|Overall Study||9
403006|NCT01707290|987889|P2|NOT COMPLETED|Overall Study||1
403007|NCT01707290|987890|P1|NOT COMPLETED|Overall Study||86
403008|NCT01707290|987889|P2|COMPLETED|Overall Study||3
403009|NCT01707290|987890|P1|COMPLETED|Overall Study||35
403010|NCT01707290|987889|P2|STARTED|Overall Study||4
403011|NCT01707290|987890|P1|STARTED|Overall Study||121
403012|NCT01707238|987913|P2|NOT COMPLETED|Overall Study||0
403013|NCT01707238|987914|P1|NOT COMPLETED|Overall Study||0
403014|NCT01707238|987913|P2|COMPLETED|Overall Study||52
403015|NCT01707238|987914|P1|COMPLETED|Overall Study||48
403016|NCT01707238|987913|P2|STARTED|Overall Study||52
403017|NCT01707238|987914|P1|STARTED|Overall Study||48
403018|NCT01707225|987930|P1|NOT COMPLETED|Overall Study||0
403019|NCT01707225|987930|P1|COMPLETED|Overall Study||10
403020|NCT01707225|987930|P1|STARTED|Overall Study||10
403021|NCT01707095|987937|P2|NOT COMPLETED|Overall Study||0
403022|NCT01707095|987938|P1|NOT COMPLETED|Overall Study||0
403023|NCT01707095|987937|P2|COMPLETED|Overall Study||42
403024|NCT01707095|987938|P1|COMPLETED|Overall Study||42
403025|NCT01707095|987937|P2|STARTED|Overall Study||42
403026|NCT01707095|987938|P1|STARTED|Overall Study||42
403027|NCT01707043|987948|P2|NOT COMPLETED|Overall Study||0
403028|NCT01707043|987949|P1|NOT COMPLETED|Overall Study||0
403029|NCT01707043|987948|P2|COMPLETED|Overall Study||10
403030|NCT01707043|987949|P1|COMPLETED|Overall Study||10
403031|NCT01707043|987948|P2|STARTED|Overall Study||10
403032|NCT01707043|987949|P1|STARTED|Overall Study||10
403033|NCT01706965|987959|P2|NOT COMPLETED|Overall Study||1
403034|NCT01706965|987960|P1|NOT COMPLETED|Overall Study||1
403035|NCT01706965|987959|P2|COMPLETED|Overall Study||12
403036|NCT01706965|987960|P1|COMPLETED|Overall Study||13
403037|NCT01706965|987959|P2|STARTED|Overall Study||13
403038|NCT01706965|987960|P1|STARTED|Overall Study||14
403039|NCT01706952|987968|P1|NOT COMPLETED|Overall Study||8
403040|NCT01706952|987968|P1|COMPLETED|Overall Study||37
403041|NCT01706952|987968|P1|STARTED|Overall Study||45
403042|NCT01706926|987984|P4|NOT COMPLETED|Overall Study||5
403043|NCT01706926|987985|P3|NOT COMPLETED|Overall Study||6
403044|NCT01706926|987986|P2|NOT COMPLETED|Overall Study||4
403045|NCT01706926|987987|P1|NOT COMPLETED|Overall Study||6
403046|NCT01706926|987984|P4|COMPLETED|Overall Study||74
403047|NCT01706926|987985|P3|COMPLETED|Overall Study||79
403048|NCT01706926|987986|P2|COMPLETED|Overall Study||77
403049|NCT01706926|987987|P1|COMPLETED|Overall Study||75
403050|NCT01706926|987984|P4|STARTED|Overall Study||79
403051|NCT01706926|987985|P3|STARTED|Overall Study||85
403052|NCT01706926|987986|P2|STARTED|Overall Study||81
403053|NCT01706926|987987|P1|STARTED|Overall Study||81
403054|NCT01706822|988096|P1|NOT COMPLETED|Overall Study||0
403055|NCT01706822|988096|P1|COMPLETED|Overall Study||8
403056|NCT01706822|988096|P1|STARTED|Overall Study||8
403057|NCT01706770|988106|P2|NOT COMPLETED|Overall Study||0
403058|NCT01706770|988107|P1|NOT COMPLETED|Overall Study||2
403059|NCT01706770|988106|P2|COMPLETED|Overall Study||17
403060|NCT01706770|988107|P1|COMPLETED|Overall Study||31
403061|NCT01706770|988106|P2|STARTED|Overall Study||17
403062|NCT01706770|988107|P1|STARTED|Overall Study||33
403063|NCT01706666|988118|P3|NOT COMPLETED|Overall Study||0
403064|NCT01706666|988119|P2|NOT COMPLETED|Overall Study||0
403065|NCT01706666|988120|P1|NOT COMPLETED|Overall Study||0
403066|NCT01706666|988118|P3|COMPLETED|Overall Study||1
403067|NCT01706666|988119|P2|COMPLETED|Overall Study||1
403068|NCT01706666|988120|P1|COMPLETED|Overall Study||1
403069|NCT01706666|988118|P3|STARTED|Overall Study||1
403070|NCT01706666|988119|P2|STARTED|Overall Study||1
403071|NCT01706666|988120|P1|STARTED|Overall Study||1
403072|NCT01706588|988139|P5|NOT COMPLETED|Overall Study||0
403073|NCT01706588|988140|P4|NOT COMPLETED|Overall Study||0
403074|NCT01706588|988141|P3|NOT COMPLETED|Overall Study||0
403075|NCT01706588|988142|P2|NOT COMPLETED|Overall Study||0
403076|NCT01706588|988143|P1|NOT COMPLETED|Overall Study||0
403077|NCT01706588|988139|P5|COMPLETED|Overall Study||16
403078|NCT01706588|988140|P4|COMPLETED|Overall Study||14
403079|NCT01706588|988141|P3|COMPLETED|Overall Study||15
403080|NCT01706588|988142|P2|COMPLETED|Overall Study||15
403081|NCT01706588|988143|P1|COMPLETED|Overall Study||15
403082|NCT01706588|988139|P5|STARTED|Overall Study||16
403083|NCT01706588|988140|P4|STARTED|Overall Study||14
403084|NCT01706588|988141|P3|STARTED|Overall Study||15
403085|NCT01706588|988142|P2|STARTED|Overall Study||15
403086|NCT01706588|988143|P1|STARTED|Overall Study||15
403087|NCT01706575|988155|P1|NOT COMPLETED|Overall Study||12
403088|NCT01706575|988155|P1|COMPLETED|Overall Study||64
403089|NCT01706575|988155|P1|Treated|Overall Study||70
403090|NCT01706575|988155|P1|STARTED|Overall Study||76
403091|NCT01706549|988166|P1|NOT COMPLETED|Overall Study||0
403092|NCT01706549|988166|P1|COMPLETED|Overall Study||16
403093|NCT01706549|988166|P1|STARTED|Overall Study||16
403094|NCT01706536|988176|P5|NOT COMPLETED|Overall Study||2
403095|NCT01706536|988177|P4|NOT COMPLETED|Overall Study||4
403096|NCT01706536|988178|P3|NOT COMPLETED|Overall Study||5
403097|NCT01706536|988179|P2|NOT COMPLETED|Overall Study||4
403098|NCT01706536|988180|P1|NOT COMPLETED|Overall Study||4
403099|NCT01706536|988176|P5|COMPLETED|Overall Study||57
403100|NCT01706536|988177|P4|COMPLETED|Overall Study||53
403101|NCT01706536|988178|P3|COMPLETED|Overall Study||49
403102|NCT01706536|988179|P2|COMPLETED|Overall Study||51
403103|NCT01706536|988180|P1|COMPLETED|Overall Study||53
403104|NCT01706536|988176|P5|STARTED|Overall Study||59
403105|NCT01706536|988177|P4|STARTED|Overall Study||57
403106|NCT01706536|988178|P3|STARTED|Overall Study||54
403107|NCT01706536|988179|P2|STARTED|Overall Study||55
403108|NCT01706536|988180|P1|STARTED|Overall Study||57
403109|NCT01706328|988239|P3|NOT COMPLETED|12-week Double-blind Treatment Period||45
403110|NCT01706328|988240|P2|NOT COMPLETED|12-week Double-blind Treatment Period||46
403111|NCT01706328|988241|P1|NOT COMPLETED|12-week Double-blind Treatment Period||0
403112|NCT01706328|988239|P3|COMPLETED|12-week Double-blind Treatment Period||371
403113|NCT01706328|988240|P2|COMPLETED|12-week Double-blind Treatment Period||366
403114|NCT01706328|988241|P1|COMPLETED|12-week Double-blind Treatment Period||0
403115|NCT01706328|988239|P3|STARTED|12-week Double-blind Treatment Period||416
403116|NCT01706328|988240|P2|STARTED|12-week Double-blind Treatment Period||412
403117|NCT01706328|988241|P1|STARTED|12-week Double-blind Treatment Period||0
403118|NCT01706328|988239|P3|NOT COMPLETED|2-week Run-in Period||0
403119|NCT01706328|988240|P2|NOT COMPLETED|2-week Run-in Period||0
403120|NCT01706328|988241|P1|NOT COMPLETED|2-week Run-in Period||165
403121|NCT01706328|988239|P3|COMPLETED|2-week Run-in Period||0
403122|NCT01706328|988240|P2|COMPLETED|2-week Run-in Period||0
403123|NCT01706328|988241|P1|COMPLETED|2-week Run-in Period||828
403124|NCT01706328|988239|P3|STARTED|2-week Run-in Period||0
403125|NCT01706328|988240|P2|STARTED|2-week Run-in Period||0
403126|NCT01706328|988241|P1|STARTED|2-week Run-in Period||993
403127|NCT01706263|988251|P1|NOT COMPLETED|Overall Study||0
403128|NCT01706263|988251|P1|COMPLETED|Overall Study||28
403129|NCT01706263|988251|P1|STARTED|Overall Study||28
403130|NCT01706250|988260|P1|NOT COMPLETED|Overall Study||2
403131|NCT01706250|988260|P1|COMPLETED|Overall Study||18
403132|NCT01706250|988260|P1|STARTED|Overall Study||20
403133|NCT01706159|988291|P2|NOT COMPLETED|Overall Study||2
403134|NCT01706159|988292|P1|NOT COMPLETED|Overall Study||8
403135|NCT01706159|988291|P2|COMPLETED|Overall Study||4
403136|NCT01706159|988292|P1|COMPLETED|Overall Study||6
403137|NCT01706159|988291|P2|Completers (With Baron Score at Week 8)|Overall Study||3
403138|NCT01706159|988292|P1|Completers (With Baron Score at Week 8)|Overall Study||6
403139|NCT01706159|988291|P2|Exposed|Overall Study|One subject was not exposed to placebo.|5
403140|NCT01706159|988292|P1|Exposed|Overall Study|One subject was not exposed to rFXIII.|13
403141|NCT01706159|988291|P2|STARTED|Overall Study||6
403142|NCT01706159|988292|P1|STARTED|Overall Study||14
403143|NCT01706146|988306|P1|NOT COMPLETED|Overall Study||6
403144|NCT01706146|988306|P1|COMPLETED|Overall Study|1 pt developed permanent AF; 1 pt needed dual antiplatelet therapy; 3 possible TIA; 1 withdraw|53
403145|NCT01706146|988306|P1|STARTED|Overall Study||59
403146|NCT01705717|988313|P2|NOT COMPLETED|Overall Study||5
403147|NCT01705717|988314|P1|NOT COMPLETED|Overall Study||2
403148|NCT01705717|988313|P2|COMPLETED|Overall Study||7
403149|NCT01705717|988314|P1|COMPLETED|Overall Study||35
403150|NCT01705717|988313|P2|STARTED|Overall Study||12
403151|NCT01705717|988314|P1|STARTED|Overall Study||37
403152|NCT01705652|988331|P2|NOT COMPLETED|Overall Study||3
403153|NCT01705652|988332|P1|NOT COMPLETED|Overall Study||3
403154|NCT01705652|988331|P2|COMPLETED|Overall Study||9
403155|NCT01705652|988332|P1|COMPLETED|Overall Study||6
403156|NCT01705652|988331|P2|STARTED|Overall Study||12
403157|NCT01705652|988332|P1|STARTED|Overall Study||9
403158|NCT01705587|988340|P2|NOT COMPLETED|Overall Study||1
403159|NCT01705587|988341|P1|NOT COMPLETED|Overall Study||0
403160|NCT01705587|988340|P2|COMPLETED|Overall Study||5
403161|NCT01705587|988341|P1|COMPLETED|Overall Study||7
403162|NCT01705587|988340|P2|STARTED|Overall Study||6
403163|NCT01705587|988341|P1|STARTED|Overall Study||7
403164|NCT01705574|988359|P2|NOT COMPLETED|Overall Study||163
403165|NCT01705574|988360|P1|NOT COMPLETED|Overall Study||167
403166|NCT01705574|988359|P2|COMPLETED|Overall Study||127
403167|NCT01705574|988360|P1|COMPLETED|Overall Study||126
403168|NCT01705574|988359|P2|STARTED|Overall Study||290
403169|NCT01705574|988360|P1|STARTED|Overall Study||293
403170|NCT01705496|988368|P1|NOT COMPLETED|Overall Study||4
403171|NCT01705496|988368|P1|COMPLETED|Overall Study||19
403172|NCT01705496|988368|P1|STARTED|Overall Study||23
403173|NCT01705145|988378|P1|NOT COMPLETED|Part B||1
403174|NCT01705145|988378|P1|COMPLETED|Part B||33
403175|NCT01705145|988378|P1|STARTED|Part B|Eight participants from Part A continued in Part B of the study.|34
403176|NCT01705145|988378|P1|NOT COMPLETED|Part A||0
403177|NCT01705145|988378|P1|COMPLETED|Part A||9
403178|NCT01705145|988378|P1|STARTED|Part A||9
403179|NCT01705106|988406|P1|NOT COMPLETED|Overall Study||0
403180|NCT01705106|988406|P1|COMPLETED|Overall Study||21
403181|NCT01705106|988406|P1|STARTED|Overall Study||21
403182|NCT01704976|988416|P2|NOT COMPLETED|Overall Study||2
403183|NCT01704976|988417|P1|NOT COMPLETED|Overall Study||1
403184|NCT01704976|988416|P2|COMPLETED|Overall Study|2 participants completed < 11 SR-WBV sessions, they were excluded from statistical analysis|11
403185|NCT01704976|988417|P1|COMPLETED|Overall Study|One participant completed < 11 SR-WBV sessions and was excluded from the statistical analysis|13
403186|NCT01704976|988416|P2|STARTED|Overall Study||13
403187|NCT01704976|988417|P1|STARTED|Overall Study||14
403188|NCT01704846|988433|P2|NOT COMPLETED|Treatment Period 4||0
403189|NCT01704846|988434|P1|NOT COMPLETED|Treatment Period 4||0
403190|NCT01704846|988433|P2|COMPLETED|Treatment Period 4||29
403191|NCT01704846|988434|P1|COMPLETED|Treatment Period 4||30
403192|NCT01704846|988433|P2|STARTED|Treatment Period 4||29
403193|NCT01704846|988434|P1|STARTED|Treatment Period 4||30
403194|NCT01704846|988433|P2|NOT COMPLETED|Treatment Period 3||0
403195|NCT01704846|988434|P1|NOT COMPLETED|Treatment Period 3||0
403196|NCT01704846|988433|P2|COMPLETED|Treatment Period 3||29
403197|NCT01704846|988434|P1|COMPLETED|Treatment Period 3||30
403198|NCT01704846|988433|P2|STARTED|Treatment Period 3||29
403199|NCT01704846|988434|P1|STARTED|Treatment Period 3||30
403200|NCT01704846|988433|P2|NOT COMPLETED|Treatment Period 2||1
403201|NCT01704846|988434|P1|NOT COMPLETED|Treatment Period 2||0
403202|NCT01704846|988433|P2|COMPLETED|Treatment Period 2||29
403203|NCT01704846|988434|P1|COMPLETED|Treatment Period 2||30
403204|NCT01704846|988433|P2|STARTED|Treatment Period 2||30
403205|NCT01704846|988434|P1|STARTED|Treatment Period 2||30
403206|NCT01704846|988433|P2|NOT COMPLETED|Treatment Period 1||0
403207|NCT01704846|988434|P1|NOT COMPLETED|Treatment Period 1||0
403208|NCT01704846|988433|P2|COMPLETED|Treatment Period 1||30
403209|NCT01704846|988434|P1|COMPLETED|Treatment Period 1||30
403210|NCT01704846|988433|P2|STARTED|Treatment Period 1||30
403211|NCT01704846|988434|P1|STARTED|Treatment Period 1||30
403212|NCT01704781|988457|P5|NOT COMPLETED|Overall Study||0
403213|NCT01704781|988458|P4|NOT COMPLETED|Overall Study||0
403214|NCT01704781|988459|P3|NOT COMPLETED|Overall Study||0
403215|NCT01704781|988460|P2|NOT COMPLETED|Overall Study||0
403216|NCT01704781|988461|P1|NOT COMPLETED|Overall Study||0
403217|NCT01704781|988457|P5|COMPLETED|Overall Study||12
403218|NCT01704781|988458|P4|COMPLETED|Overall Study||12
403219|NCT01704781|988459|P3|COMPLETED|Overall Study||6
403220|NCT01704781|988460|P2|COMPLETED|Overall Study||3
403221|NCT01704781|988461|P1|COMPLETED|Overall Study||3
403222|NCT01704781|988457|P5|STARTED|Overall Study||12
403223|NCT01704781|988458|P4|STARTED|Overall Study||12
403224|NCT01704781|988459|P3|STARTED|Overall Study||6
403225|NCT01704781|988460|P2|STARTED|Overall Study||3
403226|NCT01704781|988461|P1|STARTED|Overall Study||3
403227|NCT01704755|988489|P2|NOT COMPLETED|Overall Study||7
403228|NCT01704755|988490|P1|NOT COMPLETED|Overall Study||12
403229|NCT01704755|988489|P2|COMPLETED|Overall Study||165
403230|NCT01704755|988490|P1|COMPLETED|Overall Study||196
403231|NCT01704755|988489|P2|Completed Study Drug|Overall Study||163
403232|NCT01704755|988490|P1|Completed Study Drug|Overall Study||204
403233|NCT01704755|988489|P2|STARTED|Overall Study||172
403234|NCT01704755|988490|P1|STARTED|Overall Study||208
403235|NCT01704651|988504|P2|NOT COMPLETED|Overall Study||7
403236|NCT01704651|988505|P1|NOT COMPLETED|Overall Study||5
403237|NCT01704651|988504|P2|COMPLETED|Overall Study||68
403238|NCT01704651|988505|P1|COMPLETED|Overall Study||66
403239|NCT01704651|988504|P2|STARTED|Overall Study||75
403240|NCT01704651|988505|P1|STARTED|Overall Study||71
403241|NCT01704599|988513|P1|NOT COMPLETED|Overall Study||1
403242|NCT01704599|988513|P1|COMPLETED|Overall Study|11 screened 8 entered study 1 terminated.|7
403243|NCT01704599|988513|P1|STARTED|Overall Study|Study was started January 22, 2010|8
403244|NCT01704521|988542|P2|NOT COMPLETED|Overall Study||0
403245|NCT01704521|988543|P1|NOT COMPLETED|Overall Study||0
403246|NCT01704521|988542|P2|COMPLETED|Overall Study||2
403247|NCT01704521|988543|P1|COMPLETED|Overall Study||3
403248|NCT01704521|988542|P2|STARTED|Overall Study||2
403249|NCT01704521|988543|P1|STARTED|Overall Study||3
403250|NCT01704495|988553|P4|NOT COMPLETED|Optional Safety Extension||31
403251|NCT01704495|988554|P3|NOT COMPLETED|Optional Safety Extension||31
403252|NCT01704495|988555|P2|NOT COMPLETED|Optional Safety Extension||33
403253|NCT01704495|988556|P1|NOT COMPLETED|Optional Safety Extension||29
403254|NCT01704495|988553|P4|COMPLETED|Optional Safety Extension||85
403255|NCT01704495|988554|P3|COMPLETED|Optional Safety Extension||83
403256|NCT01704495|988555|P2|COMPLETED|Optional Safety Extension||88
403257|NCT01704495|988556|P1|COMPLETED|Optional Safety Extension||87
403258|NCT01704495|988553|P4|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|116
403259|NCT01704495|988554|P3|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|114
403260|NCT01704495|988555|P2|STARTED|Optional Safety Extension|35 subjects did not enter safety extension|121
403261|NCT01704495|988556|P1|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|116
403262|NCT01704495|988553|P4|NOT COMPLETED|Subjects Randomized||17
403263|NCT01704495|988554|P3|NOT COMPLETED|Subjects Randomized||16
403264|NCT01704495|988555|P2|NOT COMPLETED|Subjects Randomized||15
403265|NCT01704495|988556|P1|NOT COMPLETED|Subjects Randomized||22
403266|NCT01704495|988553|P4|COMPLETED|Subjects Randomized||145
403267|NCT01704495|988554|P3|COMPLETED|Subjects Randomized||144
403268|NCT01704495|988555|P2|COMPLETED|Subjects Randomized||141
403269|NCT01704495|988556|P1|COMPLETED|Subjects Randomized||140
403270|NCT01704495|988553|P4|STARTED|Subjects Randomized||162
403271|NCT01704495|988554|P3|STARTED|Subjects Randomized||160
403272|NCT01704495|988555|P2|STARTED|Subjects Randomized||156
403273|NCT01704495|988556|P1|STARTED|Subjects Randomized||162
403274|NCT01704404|988730|P6|NOT COMPLETED|Overall Study||0
403275|NCT01704404|988731|P5|NOT COMPLETED|Overall Study||1
403276|NCT01704404|988732|P4|NOT COMPLETED|Overall Study||3
403277|NCT01704404|988733|P3|NOT COMPLETED|Overall Study||1
403278|NCT01704404|988734|P2|NOT COMPLETED|Overall Study||1
403279|NCT01704404|988735|P1|NOT COMPLETED|Overall Study||1
403280|NCT01704404|988730|P6|COMPLETED|Overall Study||9
403281|NCT01704404|988731|P5|COMPLETED|Overall Study||10
403282|NCT01704404|988732|P4|COMPLETED|Overall Study||8
403283|NCT01704404|988733|P3|COMPLETED|Overall Study||9
403284|NCT01704404|988734|P2|COMPLETED|Overall Study||9
403285|NCT01704404|988735|P1|COMPLETED|Overall Study||10
403286|NCT01704404|988730|P6|STARTED|Overall Study||9
403287|NCT01704404|988731|P5|STARTED|Overall Study||11
403288|NCT01704404|988732|P4|STARTED|Overall Study||11
403289|NCT01704404|988733|P3|STARTED|Overall Study||10
403290|NCT01704404|988734|P2|STARTED|Overall Study||10
403291|NCT01704404|988735|P1|STARTED|Overall Study||11
403292|NCT01704287|988772|P5|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||45
403293|NCT01704287|988773|P4|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||53
403294|NCT01704287|988774|P3|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
403295|NCT01704287|988775|P2|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
403296|NCT01704287|988776|P1|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
403297|NCT01704287|988772|P5|COMPLETED|Switch to Pembrolizumab Treatment Period||0
403298|NCT01704287|988773|P4|COMPLETED|Switch to Pembrolizumab Treatment Period||0
403299|NCT01704287|988774|P3|COMPLETED|Switch to Pembrolizumab Treatment Period||0
403300|NCT01704287|988775|P2|COMPLETED|Switch to Pembrolizumab Treatment Period||0
403301|NCT01704287|988776|P1|COMPLETED|Switch to Pembrolizumab Treatment Period||0
403302|NCT01704287|988772|P5|STARTED|Switch to Pembrolizumab Treatment Period||45
403303|NCT01704287|988773|P4|STARTED|Switch to Pembrolizumab Treatment Period||53
403304|NCT01704287|988774|P3|STARTED|Switch to Pembrolizumab Treatment Period||0
403305|NCT01704287|988775|P2|STARTED|Switch to Pembrolizumab Treatment Period||0
403306|NCT01704287|988776|P1|STARTED|Switch to Pembrolizumab Treatment Period||0
403307|NCT01704287|988772|P5|NOT COMPLETED|Initial Treatment Period||0
403308|NCT01704287|988773|P4|NOT COMPLETED|Initial Treatment Period||0
403309|NCT01704287|988774|P3|NOT COMPLETED|Initial Treatment Period||179
403310|NCT01704287|988775|P2|NOT COMPLETED|Initial Treatment Period||181
403311|NCT01704287|988776|P1|NOT COMPLETED|Initial Treatment Period||180
403312|NCT01704287|988772|P5|COMPLETED|Initial Treatment Period||0
403313|NCT01704287|988773|P4|COMPLETED|Initial Treatment Period||0
403314|NCT01704287|988774|P3|COMPLETED|Initial Treatment Period||0
403315|NCT01704287|988775|P2|COMPLETED|Initial Treatment Period||0
403316|NCT01704287|988776|P1|COMPLETED|Initial Treatment Period||0
403317|NCT01704287|988772|P5|Treated|Initial Treatment Period||0
403318|NCT01704287|988773|P4|Treated|Initial Treatment Period||0
403319|NCT01704287|988774|P3|Treated|Initial Treatment Period||171
403320|NCT01704287|988775|P2|Treated|Initial Treatment Period||179
403321|NCT01704287|988776|P1|Treated|Initial Treatment Period||178
403322|NCT01704287|988772|P5|STARTED|Initial Treatment Period||0
403323|NCT01704287|988773|P4|STARTED|Initial Treatment Period||0
403324|NCT01704287|988774|P3|STARTED|Initial Treatment Period||179
403325|NCT01704287|988775|P2|STARTED|Initial Treatment Period||181
403326|NCT01704287|988776|P1|STARTED|Initial Treatment Period||180
403327|NCT01704261|988811|P2|NOT COMPLETED|Overall Study||15
403328|NCT01704261|988812|P1|NOT COMPLETED|Overall Study||13
403329|NCT01704261|988811|P2|COMPLETED|Overall Study||138
403330|NCT01704261|988812|P1|COMPLETED|Overall Study||141
403331|NCT01704261|988811|P2|STARTED|Overall Study||153
403332|NCT01704261|988812|P1|STARTED|Overall Study||154
403333|NCT01704196|988828|P2|NOT COMPLETED|Overall Study||24
403334|NCT01704196|988829|P1|NOT COMPLETED|Overall Study||19
403335|NCT01704196|988828|P2|COMPLETED|Overall Study||65
403336|NCT01704196|988829|P1|COMPLETED|Overall Study||71
403337|NCT01704196|988828|P2|STARTED|Overall Study||89
403338|NCT01704196|988829|P1|STARTED|Overall Study||90
403339|NCT01704079|988839|P2|NOT COMPLETED|Overall Study||23
403340|NCT01704079|988840|P1|NOT COMPLETED|Overall Study||14
403341|NCT01704079|988839|P2|COMPLETED|Overall Study||121
403342|NCT01704079|988840|P1|COMPLETED|Overall Study||58
403343|NCT01704079|988839|P2|Entered Extension Study|Overall Study||102
403344|NCT01704079|988840|P1|Entered Extension Study|Overall Study||53
403345|NCT01704079|988839|P2|STARTED|Overall Study||144
403346|NCT01704079|988840|P1|STARTED|Overall Study||72
403347|NCT01703988|988856|P4|NOT COMPLETED|Overall Study||1
403348|NCT01703988|988857|P3|NOT COMPLETED|Overall Study||0
403349|NCT01703988|988858|P2|NOT COMPLETED|Overall Study||0
403350|NCT01703988|988859|P1|NOT COMPLETED|Overall Study||0
403351|NCT01703988|988856|P4|COMPLETED|Overall Study||8
403352|NCT01703988|988857|P3|COMPLETED|Overall Study||9
403353|NCT01703988|988858|P2|COMPLETED|Overall Study||8
403354|NCT01703988|988859|P1|COMPLETED|Overall Study||8
403355|NCT01703988|988856|P4|STARTED|Overall Study||9
403356|NCT01703988|988857|P3|STARTED|Overall Study||9
403357|NCT01703988|988858|P2|STARTED|Overall Study||8
403358|NCT01703988|988859|P1|STARTED|Overall Study||8
403359|NCT01703858|988889|P3|NOT COMPLETED|Overall Study||0
403360|NCT01703858|988890|P2|NOT COMPLETED|Overall Study||1
403361|NCT01703858|988891|P1|NOT COMPLETED|Overall Study||0
403362|NCT01703858|988889|P3|COMPLETED|Overall Study||5
403363|NCT01703858|988890|P2|COMPLETED|Overall Study||4
403364|NCT01703858|988891|P1|COMPLETED|Overall Study||5
403365|NCT01703858|988889|P3|STARTED|Overall Study||5
403366|NCT01703858|988890|P2|STARTED|Overall Study||5
403367|NCT01703858|988891|P1|STARTED|Overall Study||5
403368|NCT01703845|988916|P2|NOT COMPLETED|Overall Study||0
403369|NCT01703845|988917|P1|NOT COMPLETED|Overall Study||3
403370|NCT01703845|988916|P2|COMPLETED|Overall Study||16
403371|NCT01703845|988917|P1|COMPLETED|Overall Study||13
403372|NCT01703845|988916|P2|STARTED|Overall Study|started are actually the randomized|16
403373|NCT01703845|988917|P1|STARTED|Overall Study|started are actually the randomized|16
403374|NCT01703832|988954|P2|NOT COMPLETED|Overall Study||0
403375|NCT01703832|988955|P1|NOT COMPLETED|Overall Study||1
403376|NCT01703832|988954|P2|COMPLETED|Overall Study||32
403377|NCT01703832|988955|P1|COMPLETED|Overall Study||32
403378|NCT01703832|988954|P2|STARTED|Overall Study||32
403379|NCT01703832|988955|P1|STARTED|Overall Study||33
403380|NCT01703819|988987|P2|NOT COMPLETED|Overall Study||2
403381|NCT01703819|988988|P1|NOT COMPLETED|Overall Study||0
403382|NCT01703819|988987|P2|COMPLETED|Overall Study||30
403383|NCT01703819|988988|P1|COMPLETED|Overall Study||34
403384|NCT01703819|988987|P2|STARTED|Overall Study||32
403385|NCT01703819|988988|P1|STARTED|Overall Study||34
403386|NCT01703741|989018|P1|NOT COMPLETED|Overall Study||18
403387|NCT01703741|989018|P1|COMPLETED|Overall Study||127
403388|NCT01703741|989018|P1|Per Protocol (PP) Population|Overall Study|Subjects having 24 hr pharmacokinetic (PK) data for testosterone, with no major protocol violations.|106
403389|NCT01703741|989018|P1|STARTED|Overall Study||145
403390|NCT01703702|989036|P2|NOT COMPLETED|Overall Study||22
403391|NCT01703702|989037|P1|NOT COMPLETED|Overall Study||36
403392|NCT01703702|989036|P2|COMPLETED|Overall Study||288
403393|NCT01703702|989037|P1|COMPLETED|Overall Study||272
403394|NCT01703702|989036|P2|STARTED|Overall Study||310
403395|NCT01703702|989037|P1|STARTED|Overall Study||308
403396|NCT01703663|989054|P2|NOT COMPLETED|Second Treatment Period||0
403397|NCT01703663|989055|P1|NOT COMPLETED|Second Treatment Period||0
403398|NCT01703663|989054|P2|COMPLETED|Second Treatment Period||8
403399|NCT01703663|989055|P1|COMPLETED|Second Treatment Period||11
403400|NCT01703663|989054|P2|STARTED|Second Treatment Period||8
403401|NCT01703663|989055|P1|STARTED|Second Treatment Period||11
403402|NCT01703663|989054|P2|NOT COMPLETED|First Treatment Period||0
403403|NCT01703663|989055|P1|NOT COMPLETED|First Treatment Period||0
403404|NCT01703663|989054|P2|COMPLETED|First Treatment Period||20
403405|NCT01703663|989055|P1|COMPLETED|First Treatment Period||20
403406|NCT01703663|989054|P2|STARTED|First Treatment Period||20
403407|NCT01703663|989055|P1|STARTED|First Treatment Period||20
403408|NCT01703286|989061|P6|NOT COMPLETED|Period 3 Including Washout||0
403409|NCT01703286|989062|P5|NOT COMPLETED|Period 3 Including Washout||0
403410|NCT01703286|989063|P4|NOT COMPLETED|Period 3 Including Washout||0
403411|NCT01703286|989064|P3|NOT COMPLETED|Period 3 Including Washout||0
403412|NCT01703286|989065|P2|NOT COMPLETED|Period 3 Including Washout||0
403413|NCT01703286|989066|P1|NOT COMPLETED|Period 3 Including Washout||0
403414|NCT01703286|989061|P6|COMPLETED|Period 3 Including Washout||6
403415|NCT01703286|989062|P5|COMPLETED|Period 3 Including Washout||7
403416|NCT01703286|989063|P4|COMPLETED|Period 3 Including Washout||5
403417|NCT01703286|989064|P3|COMPLETED|Period 3 Including Washout||7
403418|NCT01703286|989065|P2|COMPLETED|Period 3 Including Washout||7
403419|NCT01703286|989066|P1|COMPLETED|Period 3 Including Washout||7
403420|NCT01703286|989061|P6|STARTED|Period 3 Including Washout||6
403421|NCT01703286|989062|P5|STARTED|Period 3 Including Washout||7
403422|NCT01703286|989063|P4|STARTED|Period 3 Including Washout||5
403423|NCT01703286|989064|P3|STARTED|Period 3 Including Washout||7
403424|NCT01703286|989065|P2|STARTED|Period 3 Including Washout||7
403425|NCT01703286|989066|P1|STARTED|Period 3 Including Washout||7
403426|NCT01703286|989061|P6|NOT COMPLETED|Period 2 Including Washout||0
403427|NCT01703286|989062|P5|NOT COMPLETED|Period 2 Including Washout||0
403428|NCT01703286|989063|P4|NOT COMPLETED|Period 2 Including Washout||1
403429|NCT01703286|989064|P3|NOT COMPLETED|Period 2 Including Washout||0
403430|NCT01703286|989065|P2|NOT COMPLETED|Period 2 Including Washout||0
403431|NCT01703286|989066|P1|NOT COMPLETED|Period 2 Including Washout||0
403432|NCT01703286|989061|P6|COMPLETED|Period 2 Including Washout||6
403433|NCT01703286|989062|P5|COMPLETED|Period 2 Including Washout||7
403434|NCT01703286|989063|P4|COMPLETED|Period 2 Including Washout||5
403435|NCT01703286|989064|P3|COMPLETED|Period 2 Including Washout||7
403436|NCT01703286|989065|P2|COMPLETED|Period 2 Including Washout||7
403437|NCT01703286|989066|P1|COMPLETED|Period 2 Including Washout||7
403438|NCT01703286|989061|P6|STARTED|Period 2 Including Washout||6
403439|NCT01703286|989062|P5|STARTED|Period 2 Including Washout||7
403440|NCT01703286|989063|P4|STARTED|Period 2 Including Washout||6
403441|NCT01703286|989064|P3|STARTED|Period 2 Including Washout||7
403442|NCT01703286|989065|P2|STARTED|Period 2 Including Washout||7
403443|NCT01703286|989066|P1|STARTED|Period 2 Including Washout||7
403444|NCT01703286|989061|P6|NOT COMPLETED|Period 1 Including Washout||1
403445|NCT01703286|989062|P5|NOT COMPLETED|Period 1 Including Washout||0
403446|NCT01703286|989063|P4|NOT COMPLETED|Period 1 Including Washout||1
403447|NCT01703286|989064|P3|NOT COMPLETED|Period 1 Including Washout||0
403448|NCT01703286|989065|P2|NOT COMPLETED|Period 1 Including Washout||0
403449|NCT01703286|989066|P1|NOT COMPLETED|Period 1 Including Washout||0
403450|NCT01703286|989061|P6|COMPLETED|Period 1 Including Washout||6
403451|NCT01703286|989062|P5|COMPLETED|Period 1 Including Washout||7
403452|NCT01703286|989063|P4|COMPLETED|Period 1 Including Washout||6
403453|NCT01703286|989064|P3|COMPLETED|Period 1 Including Washout||7
403454|NCT01703286|989065|P2|COMPLETED|Period 1 Including Washout||7
403455|NCT01703286|989066|P1|COMPLETED|Period 1 Including Washout||7
403456|NCT01703286|989061|P6|STARTED|Period 1 Including Washout||7
403457|NCT01703286|989062|P5|STARTED|Period 1 Including Washout||7
403458|NCT01703286|989063|P4|STARTED|Period 1 Including Washout||7
403459|NCT01703286|989064|P3|STARTED|Period 1 Including Washout||7
403460|NCT01703286|989065|P2|STARTED|Period 1 Including Washout||7
403461|NCT01703286|989066|P1|STARTED|Period 1 Including Washout||7
403462|NCT01703260|989089|P3|NOT COMPLETED|Overall Study||3
403463|NCT01703260|989090|P2|NOT COMPLETED|Overall Study||4
403464|NCT01703260|989091|P1|NOT COMPLETED|Overall Study||3
403465|NCT01703260|989089|P3|COMPLETED|Overall Study||3
403466|NCT01703260|989090|P2|COMPLETED|Overall Study||3
403467|NCT01703260|989091|P1|COMPLETED|Overall Study||4
403468|NCT01703260|989089|P3|STARTED|Overall Study||6
403469|NCT01703260|989090|P2|STARTED|Overall Study||7
403470|NCT01703260|989091|P1|STARTED|Overall Study||7
403471|NCT01703221|989117|P3|NOT COMPLETED|Phase B - (Week 25 to 52)||5
403472|NCT01703221|989118|P2|NOT COMPLETED|Phase B - (Week 25 to 52)||14
403473|NCT01703221|989119|P1|NOT COMPLETED|Phase B - (Week 25 to 52)||16
403474|NCT01703221|989117|P3|COMPLETED|Phase B - (Week 25 to 52)||75
403475|NCT01703221|989118|P2|COMPLETED|Phase B - (Week 25 to 52)||147
403476|NCT01703221|989119|P1|COMPLETED|Phase B - (Week 25 to 52)||143
403477|NCT01703221|989117|P3|STARTED|Phase B - (Week 25 to 52)||80
403478|NCT01703221|989118|P2|STARTED|Phase B - (Week 25 to 52)||161
403479|NCT01703221|989119|P1|STARTED|Phase B - (Week 25 to 52)||159
403480|NCT01703221|989117|P3|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
403481|NCT01703221|989118|P2|NOT COMPLETED|Phase A (Up to 24 Weeks)||4
403482|NCT01703221|989119|P1|NOT COMPLETED|Phase A (Up to 24 Weeks)||7
403483|NCT01703221|989117|P3|COMPLETED|Phase A (Up to 24 Weeks)||80
403484|NCT01703221|989118|P2|COMPLETED|Phase A (Up to 24 Weeks)||161
403485|NCT01703221|989119|P1|COMPLETED|Phase A (Up to 24 Weeks)||159
403486|NCT01703221|989117|P3|STARTED|Phase A (Up to 24 Weeks)||83
403487|NCT01703221|989118|P2|STARTED|Phase A (Up to 24 Weeks)||165
403488|NCT01703221|989119|P1|STARTED|Phase A (Up to 24 Weeks)||166
403489|NCT01703208|989150|P2|NOT COMPLETED|Overall Study||2102
403490|NCT01703208|989151|P1|NOT COMPLETED|Overall Study||2100
403491|NCT01703208|989150|P2|COMPLETED|Overall Study||0
403492|NCT01703208|989151|P1|COMPLETED|Overall Study||0
403493|NCT01703208|989150|P2|Treated|Overall Study||2100
403494|NCT01703208|989151|P1|Treated|Overall Study||2092
403495|NCT01703208|989150|P2|STARTED|Overall Study||2102
403496|NCT01703208|989151|P1|STARTED|Overall Study||2100
403497|NCT01703169|989205|P1|NOT COMPLETED|Overall Study||0
403498|NCT01703169|989205|P1|COMPLETED|Overall Study||13
403499|NCT01703169|989205|P1|STARTED|Overall Study||13
403500|NCT01703091|989215|P2|NOT COMPLETED|Overall Study||4
403501|NCT01703091|989216|P1|NOT COMPLETED|Overall Study||9
403502|NCT01703091|989215|P2|COMPLETED|Overall Study||95
403503|NCT01703091|989216|P1|COMPLETED|Overall Study||89
403504|NCT01703091|989215|P2|Received at Least One Dose of Study Drug|Overall Study||98
403505|NCT01703091|989216|P1|Received at Least One Dose of Study Drug|Overall Study||94
403506|NCT01703091|989215|P2|STARTED|Overall Study||99
403507|NCT01703091|989216|P1|STARTED|Overall Study||98
403508|NCT01703000|989232|P1|NOT COMPLETED|Overall Study||1
403509|NCT01703000|989232|P1|COMPLETED|Overall Study||99
403510|NCT01703000|989232|P1|STARTED|Overall Study||100
403511|NCT01702987|989265|P2|NOT COMPLETED|Overall Study||0
403512|NCT01702987|989266|P1|NOT COMPLETED|Overall Study||1
403513|NCT01702987|989265|P2|COMPLETED|Overall Study||12
403514|NCT01702987|989266|P1|COMPLETED|Overall Study||9
403515|NCT01702987|989265|P2|STARTED|Overall Study||12
403516|NCT01702987|989266|P1|STARTED|Overall Study||10
403520|NCT01702909|989278|P1|NOT COMPLETED|Overall Study||0
403521|NCT01702909|989278|P1|COMPLETED|Overall Study||7
403522|NCT01702909|989278|P1|STARTED|Overall Study||7
403523|NCT01702896|989284|P1|NOT COMPLETED|Overall Study||8
403524|NCT01702896|989284|P1|COMPLETED|Overall Study||0
403525|NCT01702896|989284|P1|STARTED|Overall Study||8
403526|NCT01702532|989292|P2|NOT COMPLETED|Overall Study||1
403527|NCT01702532|989293|P1|NOT COMPLETED|Overall Study||0
403528|NCT01702532|989292|P2|COMPLETED|Overall Study||160
403529|NCT01702532|989293|P1|COMPLETED|Overall Study||161
403530|NCT01702532|989292|P2|Safety Population|Overall Study|One subject randomized but did not receive the study treatment.|160
403531|NCT01702532|989293|P1|Safety Population|Overall Study||161
403532|NCT01702532|989292|P2|STARTED|Overall Study||161
403533|NCT01702532|989293|P1|STARTED|Overall Study||161
403534|NCT01702519|989303|P2|NOT COMPLETED|Period 2||0
403535|NCT01702519|989304|P1|NOT COMPLETED|Period 2||0
403536|NCT01702519|989303|P2|COMPLETED|Period 2||18
403537|NCT01702519|989304|P1|COMPLETED|Period 2||19
403538|NCT01702519|989303|P2|STARTED|Period 2||18
403539|NCT01702519|989304|P1|STARTED|Period 2||19
403540|NCT01702519|989303|P2|NOT COMPLETED|Washout Period||2
403541|NCT01702519|989304|P1|NOT COMPLETED|Washout Period||1
403542|NCT01702519|989303|P2|COMPLETED|Washout Period||18
403543|NCT01702519|989304|P1|COMPLETED|Washout Period||19
403544|NCT01702519|989303|P2|STARTED|Washout Period||20
403545|NCT01702519|989304|P1|STARTED|Washout Period||20
403546|NCT01702519|989303|P2|NOT COMPLETED|Period 1||0
403547|NCT01702519|989304|P1|NOT COMPLETED|Period 1||0
403548|NCT01702519|989303|P2|COMPLETED|Period 1||20
403549|NCT01702519|989304|P1|COMPLETED|Period 1||20
403550|NCT01702519|989303|P2|STARTED|Period 1||20
403551|NCT01702519|989304|P1|STARTED|Period 1||20
403552|NCT01702454|989322|P2|NOT COMPLETED|Overall Study||8
403553|NCT01702454|989323|P1|NOT COMPLETED|Overall Study||3
403554|NCT01702454|989322|P2|COMPLETED|Overall Study||221
403555|NCT01702454|989323|P1|COMPLETED|Overall Study||238
403556|NCT01702454|989322|P2|STARTED|Overall Study||229
403557|NCT01702454|989323|P1|STARTED|Overall Study||241
403558|NCT01702428|989405|P4|NOT COMPLETED|Overall Study||57
403559|NCT01702428|989406|P3|NOT COMPLETED|Overall Study||53
403560|NCT01702428|989407|P2|NOT COMPLETED|Overall Study||70
403561|NCT01702428|989408|P1|NOT COMPLETED|Overall Study||64
403562|NCT01702428|989405|P4|COMPLETED|Overall Study||1232
403563|NCT01702428|989406|P3|COMPLETED|Overall Study||1190
403564|NCT01702428|989407|P2|COMPLETED|Overall Study||1162
403565|NCT01702428|989408|P1|COMPLETED|Overall Study||1175
403566|NCT01702428|989405|P4|STARTED|Overall Study||1289
403567|NCT01702428|989406|P3|STARTED|Overall Study||1243
403568|NCT01702428|989407|P2|STARTED|Overall Study||1232
403569|NCT01702428|989408|P1|STARTED|Overall Study||1239
403570|NCT01702363|989495|P1|NOT COMPLETED|Overall Study||20
403571|NCT01702363|989495|P1|COMPLETED|Overall Study||111
403572|NCT01702363|989495|P1|STARTED|Overall Study||131
403573|NCT01702311|989512|P2|NOT COMPLETED|Overall Study||13
403574|NCT01702311|989513|P1|NOT COMPLETED|Overall Study||16
403575|NCT01702311|989512|P2|COMPLETED|Overall Study||100
403576|NCT01702311|989513|P1|COMPLETED|Overall Study||106
403577|NCT01702311|989512|P2|STARTED|Overall Study||113
403578|NCT01702311|989513|P1|STARTED|Overall Study||122
403579|NCT01702298|989543|P1|NOT COMPLETED|Overall Study||1
403580|NCT01702298|989543|P1|COMPLETED|Overall Study||41
403581|NCT01702298|989543|P1|STARTED|Overall Study||42
403582|NCT01702259|989556|P2|NOT COMPLETED|Overall Study||0
403583|NCT01702259|989557|P1|NOT COMPLETED|Overall Study||0
403584|NCT01702259|989556|P2|COMPLETED|Overall Study||34
403585|NCT01702259|989557|P1|COMPLETED|Overall Study||34
403586|NCT01702259|989556|P2|STARTED|Overall Study||34
403587|NCT01702259|989557|P1|STARTED|Overall Study||34
403588|NCT01702246|989571|P1|NOT COMPLETED|Overall Study||5
403589|NCT01702246|989571|P1|COMPLETED|Overall Study||19
403590|NCT01702246|989571|P1|STARTED|Overall Study||24
403591|NCT01702233|989583|P3|NOT COMPLETED|Overall Study||5
403592|NCT01702233|989584|P2|NOT COMPLETED|Overall Study||3
403593|NCT01702233|989585|P1|NOT COMPLETED|Overall Study||6
403594|NCT01702233|989583|P3|COMPLETED|Overall Study||31
403595|NCT01702233|989584|P2|COMPLETED|Overall Study|One of these Patient completed the Trial but had no valid outcome measure after enrolment|64
403596|NCT01702233|989585|P1|COMPLETED|Overall Study||66
403597|NCT01702233|989583|P3|Per Protocol Set|Overall Study||27
403598|NCT01702233|989584|P2|Per Protocol Set|Overall Study||58
403599|NCT01702233|989585|P1|Per Protocol Set|Overall Study||58
403600|NCT01702233|989583|P3|Full Analysis Set (ITT)|Overall Study||31
403601|NCT01702233|989584|P2|Full Analysis Set (ITT)|Overall Study||63
403602|NCT01702233|989585|P1|Full Analysis Set (ITT)|Overall Study||66
403603|NCT01702233|989583|P3|STARTED|Overall Study||36
403604|NCT01702233|989584|P2|STARTED|Overall Study||67
403605|NCT01702233|989585|P1|STARTED|Overall Study||72
403606|NCT01702025|989625|P4|NOT COMPLETED|Overall Study||0
403607|NCT01702025|989626|P3|NOT COMPLETED|Overall Study||1
403608|NCT01702025|989627|P2|NOT COMPLETED|Overall Study||1
403609|NCT01702025|989628|P1|NOT COMPLETED|Overall Study||2
403610|NCT01702025|989625|P4|COMPLETED|Overall Study||10
403611|NCT01702025|989626|P3|COMPLETED|Overall Study||9
403612|NCT01702025|989627|P2|COMPLETED|Overall Study||9
403613|NCT01702025|989628|P1|COMPLETED|Overall Study||9
403614|NCT01702025|989625|P4|STARTED|Overall Study||10
403615|NCT01702025|989626|P3|STARTED|Overall Study||10
403616|NCT01702025|989627|P2|STARTED|Overall Study||10
403617|NCT01702025|989628|P1|STARTED|Overall Study||11
403618|NCT01701999|989644|P2|NOT COMPLETED|Overall Study||0
403619|NCT01701999|989645|P1|NOT COMPLETED|Overall Study||0
403620|NCT01701999|989644|P2|COMPLETED|Overall Study||37
403621|NCT01701999|989645|P1|COMPLETED|Overall Study||8
403622|NCT01701999|989644|P2|STARTED|Overall Study||37
403623|NCT01701999|989645|P1|STARTED|Overall Study||8
403624|NCT01701973|989657|P8|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
403625|NCT01701973|989658|P7|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
403626|NCT01701973|989659|P6|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
403627|NCT01701973|989660|P5|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
403628|NCT01701973|989661|P4|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
403629|NCT01701973|989662|P3|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
403630|NCT01701973|989663|P2|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
403631|NCT01701973|989664|P1|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
403632|NCT01701973|989657|P8|COMPLETED|Aim 2: Second Intervention (1 Day)||3
403633|NCT01701973|989658|P7|COMPLETED|Aim 2: Second Intervention (1 Day)||5
403634|NCT01701973|989659|P6|COMPLETED|Aim 2: Second Intervention (1 Day)||3
403635|NCT01701973|989660|P5|COMPLETED|Aim 2: Second Intervention (1 Day)||2
403636|NCT01701973|989661|P4|COMPLETED|Aim 2: Second Intervention (1 Day)||4
403637|NCT01701973|989662|P3|COMPLETED|Aim 2: Second Intervention (1 Day)||5
403638|NCT01701973|989663|P2|COMPLETED|Aim 2: Second Intervention (1 Day)||0
403639|NCT01701973|989664|P1|COMPLETED|Aim 2: Second Intervention (1 Day)||0
403640|NCT01701973|989657|P8|STARTED|Aim 2: Second Intervention (1 Day)|1 subject was lost to follow-up in between Periods 3 and 4.|3
403641|NCT01701973|989658|P7|STARTED|Aim 2: Second Intervention (1 Day)||5
403642|NCT01701973|989659|P6|STARTED|Aim 2: Second Intervention (1 Day)||3
403643|NCT01701973|989660|P5|STARTED|Aim 2: Second Intervention (1 Day)||2
403644|NCT01701973|989661|P4|STARTED|Aim 2: Second Intervention (1 Day)||4
403645|NCT01701973|989662|P3|STARTED|Aim 2: Second Intervention (1 Day)||5
403646|NCT01701973|989663|P2|STARTED|Aim 2: Second Intervention (1 Day)||0
403647|NCT01701973|989664|P1|STARTED|Aim 2: Second Intervention (1 Day)||0
403648|NCT01701973|989657|P8|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
403649|NCT01701973|989658|P7|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
403650|NCT01701973|989659|P6|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
403651|NCT01701973|989660|P5|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
403652|NCT01701973|989661|P4|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
403653|NCT01701973|989662|P3|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
403654|NCT01701973|989663|P2|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
403655|NCT01701973|989664|P1|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
403656|NCT01701973|989657|P8|COMPLETED|Aim 2: First Intervention (1 Day)||4
403657|NCT01701973|989658|P7|COMPLETED|Aim 2: First Intervention (1 Day)||5
403658|NCT01701973|989659|P6|COMPLETED|Aim 2: First Intervention (1 Day)||3
403659|NCT01701973|989660|P5|COMPLETED|Aim 2: First Intervention (1 Day)||2
403660|NCT01701973|989661|P4|COMPLETED|Aim 2: First Intervention (1 Day)||4
403661|NCT01701973|989662|P3|COMPLETED|Aim 2: First Intervention (1 Day)||5
403662|NCT01701973|989663|P2|COMPLETED|Aim 2: First Intervention (1 Day)||0
403663|NCT01701973|989664|P1|COMPLETED|Aim 2: First Intervention (1 Day)||0
403664|NCT01701973|989657|P8|STARTED|Aim 2: First Intervention (1 Day)||4
403665|NCT01701973|989658|P7|STARTED|Aim 2: First Intervention (1 Day)||5
403666|NCT01701973|989659|P6|STARTED|Aim 2: First Intervention (1 Day)||3
403667|NCT01701973|989660|P5|STARTED|Aim 2: First Intervention (1 Day)||2
403668|NCT01701973|989661|P4|STARTED|Aim 2: First Intervention (1 Day)||4
403669|NCT01701973|989662|P3|STARTED|Aim 2: First Intervention (1 Day)||5
403670|NCT01701973|989663|P2|STARTED|Aim 2: First Intervention (1 Day)||0
403671|NCT01701973|989664|P1|STARTED|Aim 2: First Intervention (1 Day)||0
403672|NCT01701973|989657|P8|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
403673|NCT01701973|989658|P7|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
403674|NCT01701973|989659|P6|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
403675|NCT01701973|989660|P5|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
403676|NCT01701973|989661|P4|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
403677|NCT01701973|989662|P3|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
403678|NCT01701973|989663|P2|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
403679|NCT01701973|989664|P1|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
403680|NCT01701973|989657|P8|COMPLETED|Aim 1: Second Intervention (1 Day)||0
403681|NCT01701973|989658|P7|COMPLETED|Aim 1: Second Intervention (1 Day)||0
403682|NCT01701973|989659|P6|COMPLETED|Aim 1: Second Intervention (1 Day)||0
403683|NCT01701973|989660|P5|COMPLETED|Aim 1: Second Intervention (1 Day)||0
403684|NCT01701973|989661|P4|COMPLETED|Aim 1: Second Intervention (1 Day)||0
403685|NCT01701973|989662|P3|COMPLETED|Aim 1: Second Intervention (1 Day)||0
403686|NCT01701973|989663|P2|COMPLETED|Aim 1: Second Intervention (1 Day)||17
403687|NCT01701973|989664|P1|COMPLETED|Aim 1: Second Intervention (1 Day)||22
403688|NCT01701973|989657|P8|STARTED|Aim 1: Second Intervention (1 Day)||0
403689|NCT01701973|989658|P7|STARTED|Aim 1: Second Intervention (1 Day)||0
403690|NCT01701973|989659|P6|STARTED|Aim 1: Second Intervention (1 Day)||0
403691|NCT01701973|989660|P5|STARTED|Aim 1: Second Intervention (1 Day)||0
403692|NCT01701973|989661|P4|STARTED|Aim 1: Second Intervention (1 Day)||0
403693|NCT01701973|989662|P3|STARTED|Aim 1: Second Intervention (1 Day)||0
403694|NCT01701973|989663|P2|STARTED|Aim 1: Second Intervention (1 Day)|3 subjects were lost to follow-up in between Periods 1 and 2.|17
403695|NCT01701973|989664|P1|STARTED|Aim 1: Second Intervention (1 Day)|1 subject was lost to follow-up in between Periods 1 and 2.|22
403696|NCT01701973|989657|P8|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
403697|NCT01701973|989658|P7|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
403698|NCT01701973|989659|P6|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
403699|NCT01701973|989660|P5|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
403700|NCT01701973|989661|P4|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
403701|NCT01701973|989662|P3|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
403702|NCT01701973|989663|P2|NOT COMPLETED|Aim 1: First Intervention (1 Day)||1
403703|NCT01701973|989664|P1|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
403704|NCT01701973|989657|P8|COMPLETED|Aim 1: First Intervention (1 Day)||0
403705|NCT01701973|989658|P7|COMPLETED|Aim 1: First Intervention (1 Day)||0
403706|NCT01701973|989659|P6|COMPLETED|Aim 1: First Intervention (1 Day)||0
403707|NCT01701973|989660|P5|COMPLETED|Aim 1: First Intervention (1 Day)||0
403708|NCT01701973|989661|P4|COMPLETED|Aim 1: First Intervention (1 Day)||0
403709|NCT01701973|989662|P3|COMPLETED|Aim 1: First Intervention (1 Day)||0
403710|NCT01701973|989663|P2|COMPLETED|Aim 1: First Intervention (1 Day)||20
403711|NCT01701973|989664|P1|COMPLETED|Aim 1: First Intervention (1 Day)||23
403712|NCT01701973|989657|P8|STARTED|Aim 1: First Intervention (1 Day)||0
403713|NCT01701973|989658|P7|STARTED|Aim 1: First Intervention (1 Day)||0
403714|NCT01701973|989659|P6|STARTED|Aim 1: First Intervention (1 Day)||0
403715|NCT01701973|989660|P5|STARTED|Aim 1: First Intervention (1 Day)||0
403716|NCT01701973|989661|P4|STARTED|Aim 1: First Intervention (1 Day)||0
403717|NCT01701973|989662|P3|STARTED|Aim 1: First Intervention (1 Day)||0
403718|NCT01701973|989663|P2|STARTED|Aim 1: First Intervention (1 Day)||21
403719|NCT01701973|989664|P1|STARTED|Aim 1: First Intervention (1 Day)||23
403720|NCT01701674|989711|P1|NOT COMPLETED|Overall Study||1
403721|NCT01701674|989711|P1|COMPLETED|Overall Study||12
403722|NCT01701674|989711|P1|STARTED|Overall Study||13
403723|NCT01701622|989718|P1|NOT COMPLETED|Overall Study||0
403724|NCT01701622|989718|P1|COMPLETED|Overall Study||1
403725|NCT01701622|989718|P1|STARTED|Overall Study||1
403726|NCT01701505|989729|P6|NOT COMPLETED|Overall Study||0
403727|NCT01701505|989730|P5|NOT COMPLETED|Overall Study||0
403728|NCT01701505|989731|P4|NOT COMPLETED|Overall Study||0
403729|NCT01701505|989732|P3|NOT COMPLETED|Overall Study||0
403730|NCT01701505|989733|P2|NOT COMPLETED|Overall Study||0
403731|NCT01701505|989734|P1|NOT COMPLETED|Overall Study||0
403732|NCT01701505|989729|P6|COMPLETED|Overall Study||8
403733|NCT01701505|989730|P5|COMPLETED|Overall Study||8
403734|NCT01701505|989731|P4|COMPLETED|Overall Study||8
403735|NCT01701505|989732|P3|COMPLETED|Overall Study||8
403736|NCT01701505|989733|P2|COMPLETED|Overall Study||8
403737|NCT01701505|989734|P1|COMPLETED|Overall Study||8
403738|NCT01701505|989729|P6|STARTED|Overall Study||8
403739|NCT01701505|989730|P5|STARTED|Overall Study||8
403740|NCT01701505|989731|P4|STARTED|Overall Study||8
403741|NCT01701505|989732|P3|STARTED|Overall Study||8
403742|NCT01701505|989733|P2|STARTED|Overall Study||8
403743|NCT01701505|989734|P1|STARTED|Overall Study||8
403744|NCT01701414|989786|P2|NOT COMPLETED|Overall Study||1
403745|NCT01701414|989787|P1|NOT COMPLETED|Overall Study||1
403746|NCT01701414|989786|P2|COMPLETED|Overall Study||18
403747|NCT01701414|989787|P1|COMPLETED|Overall Study||18
403748|NCT01701414|989786|P2|STARTED|Overall Study||19
403749|NCT01701414|989787|P1|STARTED|Overall Study||19
403750|NCT01701401|989797|P4|NOT COMPLETED|Overall Study||6
403751|NCT01701401|989798|P3|NOT COMPLETED|Overall Study||5
403752|NCT01701401|989799|P2|NOT COMPLETED|Overall Study||9
403753|NCT01701401|989800|P1|NOT COMPLETED|Overall Study||10
403754|NCT01701401|989797|P4|COMPLETED|Overall Study||212
403755|NCT01701401|989798|P3|COMPLETED|Overall Study||212
403756|NCT01701401|989799|P2|COMPLETED|Overall Study||209
403757|NCT01701401|989800|P1|COMPLETED|Overall Study||207
403758|NCT01701401|989797|P4|STARTED|Overall Study||218
403759|NCT01701401|989798|P3|STARTED|Overall Study||217
403760|NCT01701401|989799|P2|STARTED|Overall Study||218
403761|NCT01701401|989800|P1|STARTED|Overall Study||217
403762|NCT01701375|989846|P1|NOT COMPLETED|Overall Study||0
403763|NCT01701375|989846|P1|COMPLETED|Overall Study||2
403764|NCT01701375|989846|P1|STARTED|Overall Study||2
403765|NCT01701362|989852|P2|NOT COMPLETED|Overall Study||56
403766|NCT01701362|989853|P1|NOT COMPLETED|Overall Study||42
403767|NCT01701362|989852|P2|COMPLETED|Overall Study||211
403768|NCT01701362|989853|P1|COMPLETED|Overall Study||233
403769|NCT01701362|989852|P2|TREATED|Overall Study||265
403770|NCT01701362|989853|P1|TREATED|Overall Study||274
403771|NCT01701362|989852|P2|STARTED|Overall Study||267
403772|NCT01701362|989853|P1|STARTED|Overall Study||275
403773|NCT01701271|989881|P1|NOT COMPLETED|Overall Study||0
403774|NCT01701271|989881|P1|COMPLETED|Overall Study||20
403775|NCT01701271|989881|P1|STARTED|Overall Study||20
403776|NCT01701258|989891|P13|NOT COMPLETED|EEG (Session 4)||0
403777|NCT01701258|989892|P12|NOT COMPLETED|EEG (Session 4)||0
403778|NCT01701258|989893|P11|NOT COMPLETED|EEG (Session 4)||0
403779|NCT01701258|989894|P10|NOT COMPLETED|EEG (Session 4)||0
403780|NCT01701258|989895|P9|NOT COMPLETED|EEG (Session 4)||0
403781|NCT01701258|989896|P8|NOT COMPLETED|EEG (Session 4)||0
403782|NCT01701258|989897|P7|NOT COMPLETED|EEG (Session 4)||0
403783|NCT01701258|989898|P6|NOT COMPLETED|EEG (Session 4)||0
403784|NCT01701258|989899|P5|NOT COMPLETED|EEG (Session 4)||0
403785|NCT01701258|989900|P4|NOT COMPLETED|EEG (Session 4)||0
403786|NCT01701258|989901|P3|NOT COMPLETED|EEG (Session 4)||0
403787|NCT01701258|989902|P2|NOT COMPLETED|EEG (Session 4)||0
403788|NCT01701258|989903|P1|NOT COMPLETED|EEG (Session 4)||0
403789|NCT01701258|989891|P13|COMPLETED|EEG (Session 4)||0
403790|NCT01701258|989892|P12|COMPLETED|EEG (Session 4)||0
403791|NCT01701258|989893|P11|COMPLETED|EEG (Session 4)||17
403792|NCT01701258|989894|P10|COMPLETED|EEG (Session 4)||0
403793|NCT01701258|989895|P9|COMPLETED|EEG (Session 4)||0
403794|NCT01701258|989896|P8|COMPLETED|EEG (Session 4)||16
403795|NCT01701258|989897|P7|COMPLETED|EEG (Session 4)||0
403796|NCT01701258|989898|P6|COMPLETED|EEG (Session 4)||0
403797|NCT01701258|989899|P5|COMPLETED|EEG (Session 4)||14
403798|NCT01701258|989900|P4|COMPLETED|EEG (Session 4)||0
403799|NCT01701258|989901|P3|COMPLETED|EEG (Session 4)||0
403800|NCT01701258|989902|P2|COMPLETED|EEG (Session 4)||19
403801|NCT01701258|989903|P1|COMPLETED|EEG (Session 4)||0
403802|NCT01701258|989891|P13|STARTED|EEG (Session 4)||0
403803|NCT01701258|989892|P12|STARTED|EEG (Session 4)||0
403804|NCT01701258|989893|P11|STARTED|EEG (Session 4)||17
403805|NCT01701258|989894|P10|STARTED|EEG (Session 4)||0
403806|NCT01701258|989895|P9|STARTED|EEG (Session 4)||0
403807|NCT01701258|989896|P8|STARTED|EEG (Session 4)||16
403808|NCT01701258|989897|P7|STARTED|EEG (Session 4)||0
403809|NCT01701258|989898|P6|STARTED|EEG (Session 4)||0
403810|NCT01701258|989899|P5|STARTED|EEG (Session 4)||14
403811|NCT01701258|989900|P4|STARTED|EEG (Session 4)||0
403812|NCT01701258|989901|P3|STARTED|EEG (Session 4)||0
403813|NCT01701258|989902|P2|STARTED|EEG (Session 4)||19
403814|NCT01701258|989903|P1|STARTED|EEG (Session 4)||0
403815|NCT01701258|989891|P13|NOT COMPLETED|PET (Session 3)||0
403816|NCT01701258|989892|P12|NOT COMPLETED|PET (Session 3)||0
403817|NCT01701258|989893|P11|NOT COMPLETED|PET (Session 3)||0
403818|NCT01701258|989894|P10|NOT COMPLETED|PET (Session 3)||0
403819|NCT01701258|989895|P9|NOT COMPLETED|PET (Session 3)||0
403820|NCT01701258|989896|P8|NOT COMPLETED|PET (Session 3)||0
403821|NCT01701258|989897|P7|NOT COMPLETED|PET (Session 3)||0
403822|NCT01701258|989898|P6|NOT COMPLETED|PET (Session 3)||0
403823|NCT01701258|989899|P5|NOT COMPLETED|PET (Session 3)||0
403824|NCT01701258|989900|P4|NOT COMPLETED|PET (Session 3)||0
403825|NCT01701258|989901|P3|NOT COMPLETED|PET (Session 3)||0
403826|NCT01701258|989902|P2|NOT COMPLETED|PET (Session 3)||0
403827|NCT01701258|989903|P1|NOT COMPLETED|PET (Session 3)||0
403828|NCT01701258|989891|P13|COMPLETED|PET (Session 3)||0
403829|NCT01701258|989892|P12|COMPLETED|PET (Session 3)||0
403830|NCT01701258|989893|P11|COMPLETED|PET (Session 3)||18
403831|NCT01701258|989894|P10|COMPLETED|PET (Session 3)||0
403832|NCT01701258|989895|P9|COMPLETED|PET (Session 3)||0
403833|NCT01701258|989896|P8|COMPLETED|PET (Session 3)||19
403834|NCT01701258|989897|P7|COMPLETED|PET (Session 3)||0
403835|NCT01701258|989898|P6|COMPLETED|PET (Session 3)||0
403836|NCT01701258|989899|P5|COMPLETED|PET (Session 3)||16
403837|NCT01701258|989900|P4|COMPLETED|PET (Session 3)||0
403838|NCT01701258|989901|P3|COMPLETED|PET (Session 3)||0
403839|NCT01701258|989902|P2|COMPLETED|PET (Session 3)||20
403840|NCT01701258|989903|P1|COMPLETED|PET (Session 3)||0
403841|NCT01701258|989891|P13|STARTED|PET (Session 3)||0
403842|NCT01701258|989892|P12|STARTED|PET (Session 3)||0
403843|NCT01701258|989893|P11|STARTED|PET (Session 3)||18
403844|NCT01701258|989894|P10|STARTED|PET (Session 3)||0
403845|NCT01701258|989895|P9|STARTED|PET (Session 3)||0
403846|NCT01701258|989896|P8|STARTED|PET (Session 3)||19
403847|NCT01701258|989897|P7|STARTED|PET (Session 3)||0
403848|NCT01701258|989898|P6|STARTED|PET (Session 3)||0
403849|NCT01701258|989899|P5|STARTED|PET (Session 3)||16
403850|NCT01701258|989900|P4|STARTED|PET (Session 3)||0
403851|NCT01701258|989901|P3|STARTED|PET (Session 3)||0
403852|NCT01701258|989902|P2|STARTED|PET (Session 3)||20
403853|NCT01701258|989903|P1|STARTED|PET (Session 3)||0
403854|NCT01701258|989891|P13|NOT COMPLETED|Drug+fMRI (Session 2)||0
403855|NCT01701258|989892|P12|NOT COMPLETED|Drug+fMRI (Session 2)||0
403856|NCT01701258|989893|P11|NOT COMPLETED|Drug+fMRI (Session 2)||0
403857|NCT01701258|989894|P10|NOT COMPLETED|Drug+fMRI (Session 2)||0
403858|NCT01701258|989895|P9|NOT COMPLETED|Drug+fMRI (Session 2)||0
403859|NCT01701258|989896|P8|NOT COMPLETED|Drug+fMRI (Session 2)||0
403860|NCT01701258|989897|P7|NOT COMPLETED|Drug+fMRI (Session 2)||0
403861|NCT01701258|989898|P6|NOT COMPLETED|Drug+fMRI (Session 2)||0
403862|NCT01701258|989899|P5|NOT COMPLETED|Drug+fMRI (Session 2)||0
403863|NCT01701258|989900|P4|NOT COMPLETED|Drug+fMRI (Session 2)||0
403864|NCT01701258|989901|P3|NOT COMPLETED|Drug+fMRI (Session 2)||0
403865|NCT01701258|989902|P2|NOT COMPLETED|Drug+fMRI (Session 2)||0
403866|NCT01701258|989903|P1|NOT COMPLETED|Drug+fMRI (Session 2)||0
403867|NCT01701258|989891|P13|COMPLETED|Drug+fMRI (Session 2)||7
403868|NCT01701258|989892|P12|COMPLETED|Drug+fMRI (Session 2)||10
403869|NCT01701258|989893|P11|COMPLETED|Drug+fMRI (Session 2)||0
403870|NCT01701258|989894|P10|COMPLETED|Drug+fMRI (Session 2)||6
403871|NCT01701258|989895|P9|COMPLETED|Drug+fMRI (Session 2)||6
403872|NCT01701258|989896|P8|COMPLETED|Drug+fMRI (Session 2)||0
403873|NCT01701258|989897|P7|COMPLETED|Drug+fMRI (Session 2)||8
403874|NCT01701258|989898|P6|COMPLETED|Drug+fMRI (Session 2)||9
403875|NCT01701258|989899|P5|COMPLETED|Drug+fMRI (Session 2)||0
403876|NCT01701258|989900|P4|COMPLETED|Drug+fMRI (Session 2)||11
403877|NCT01701258|989901|P3|COMPLETED|Drug+fMRI (Session 2)||11
403878|NCT01701258|989902|P2|COMPLETED|Drug+fMRI (Session 2)||0
403879|NCT01701258|989903|P1|COMPLETED|Drug+fMRI (Session 2)||0
403880|NCT01701258|989891|P13|Received Drug Challenge|Drug+fMRI (Session 2)||7
403881|NCT01701258|989892|P12|Received Drug Challenge|Drug+fMRI (Session 2)||10
403882|NCT01701258|989893|P11|Received Drug Challenge|Drug+fMRI (Session 2)||0
403883|NCT01701258|989894|P10|Received Drug Challenge|Drug+fMRI (Session 2)||6
403884|NCT01701258|989895|P9|Received Drug Challenge|Drug+fMRI (Session 2)||6
403885|NCT01701258|989896|P8|Received Drug Challenge|Drug+fMRI (Session 2)||0
403886|NCT01701258|989897|P7|Received Drug Challenge|Drug+fMRI (Session 2)||8
403887|NCT01701258|989898|P6|Received Drug Challenge|Drug+fMRI (Session 2)||9
403888|NCT01701258|989899|P5|Received Drug Challenge|Drug+fMRI (Session 2)||0
403889|NCT01701258|989900|P4|Received Drug Challenge|Drug+fMRI (Session 2)||11
403890|NCT01701258|989901|P3|Received Drug Challenge|Drug+fMRI (Session 2)||11
403891|NCT01701258|989902|P2|Received Drug Challenge|Drug+fMRI (Session 2)||0
403892|NCT01701258|989903|P1|Received Drug Challenge|Drug+fMRI (Session 2)||0
403893|NCT01701258|989891|P13|STARTED|Drug+fMRI (Session 2)||7
403894|NCT01701258|989892|P12|STARTED|Drug+fMRI (Session 2)||10
403895|NCT01701258|989893|P11|STARTED|Drug+fMRI (Session 2)||0
403896|NCT01701258|989894|P10|STARTED|Drug+fMRI (Session 2)||6
403897|NCT01701258|989895|P9|STARTED|Drug+fMRI (Session 2)||6
403898|NCT01701258|989896|P8|STARTED|Drug+fMRI (Session 2)||0
403899|NCT01701258|989897|P7|STARTED|Drug+fMRI (Session 2)||8
403900|NCT01701258|989898|P6|STARTED|Drug+fMRI (Session 2)||9
403901|NCT01701258|989899|P5|STARTED|Drug+fMRI (Session 2)||0
403902|NCT01701258|989900|P4|STARTED|Drug+fMRI (Session 2)||11
403903|NCT01701258|989901|P3|STARTED|Drug+fMRI (Session 2)||11
403904|NCT01701258|989902|P2|STARTED|Drug+fMRI (Session 2)||0
403905|NCT01701258|989903|P1|STARTED|Drug+fMRI (Session 2)||0
403906|NCT01701258|989891|P13|NOT COMPLETED|Assessment and Scheduling||0
403907|NCT01701258|989892|P12|NOT COMPLETED|Assessment and Scheduling||0
403908|NCT01701258|989893|P11|NOT COMPLETED|Assessment and Scheduling||0
403909|NCT01701258|989894|P10|NOT COMPLETED|Assessment and Scheduling||0
403910|NCT01701258|989895|P9|NOT COMPLETED|Assessment and Scheduling||0
403911|NCT01701258|989896|P8|NOT COMPLETED|Assessment and Scheduling||0
403912|NCT01701258|989897|P7|NOT COMPLETED|Assessment and Scheduling||0
403913|NCT01701258|989898|P6|NOT COMPLETED|Assessment and Scheduling||0
403914|NCT01701258|989899|P5|NOT COMPLETED|Assessment and Scheduling||0
403915|NCT01701258|989900|P4|NOT COMPLETED|Assessment and Scheduling||0
403916|NCT01701258|989901|P3|NOT COMPLETED|Assessment and Scheduling||0
403917|NCT01701258|989902|P2|NOT COMPLETED|Assessment and Scheduling||0
403918|NCT01701258|989903|P1|NOT COMPLETED|Assessment and Scheduling||83
403919|NCT01701258|989891|P13|COMPLETED|Assessment and Scheduling||0
403920|NCT01701258|989892|P12|COMPLETED|Assessment and Scheduling||0
403921|NCT01701258|989893|P11|COMPLETED|Assessment and Scheduling||0
403922|NCT01701258|989894|P10|COMPLETED|Assessment and Scheduling||0
403923|NCT01701258|989895|P9|COMPLETED|Assessment and Scheduling||0
403924|NCT01701258|989896|P8|COMPLETED|Assessment and Scheduling||0
403925|NCT01701258|989897|P7|COMPLETED|Assessment and Scheduling||0
403926|NCT01701258|989898|P6|COMPLETED|Assessment and Scheduling||0
403927|NCT01701258|989899|P5|COMPLETED|Assessment and Scheduling||0
403928|NCT01701258|989900|P4|COMPLETED|Assessment and Scheduling||0
403929|NCT01701258|989901|P3|COMPLETED|Assessment and Scheduling||0
403930|NCT01701258|989902|P2|COMPLETED|Assessment and Scheduling||0
403931|NCT01701258|989903|P1|COMPLETED|Assessment and Scheduling||70
403932|NCT01701258|989891|P13|Returned for EEG (Session 4)|Assessment and Scheduling||0
403933|NCT01701258|989892|P12|Returned for EEG (Session 4)|Assessment and Scheduling||0
403934|NCT01701258|989893|P11|Returned for EEG (Session 4)|Assessment and Scheduling||0
403935|NCT01701258|989894|P10|Returned for EEG (Session 4)|Assessment and Scheduling||0
403936|NCT01701258|989895|P9|Returned for EEG (Session 4)|Assessment and Scheduling||0
403937|NCT01701258|989896|P8|Returned for EEG (Session 4)|Assessment and Scheduling||0
403938|NCT01701258|989897|P7|Returned for EEG (Session 4)|Assessment and Scheduling||0
403939|NCT01701258|989898|P6|Returned for EEG (Session 4)|Assessment and Scheduling||0
403940|NCT01701258|989899|P5|Returned for EEG (Session 4)|Assessment and Scheduling||0
403941|NCT01701258|989900|P4|Returned for EEG (Session 4)|Assessment and Scheduling||0
403942|NCT01701258|989901|P3|Returned for EEG (Session 4)|Assessment and Scheduling||0
403943|NCT01701258|989902|P2|Returned for EEG (Session 4)|Assessment and Scheduling||0
403944|NCT01701258|989903|P1|Returned for EEG (Session 4)|Assessment and Scheduling||66
403945|NCT01701258|989891|P13|Returned for PET (Session 3)|Assessment and Scheduling||0
403946|NCT01701258|989892|P12|Returned for PET (Session 3)|Assessment and Scheduling||0
403947|NCT01701258|989893|P11|Returned for PET (Session 3)|Assessment and Scheduling||0
403948|NCT01701258|989894|P10|Returned for PET (Session 3)|Assessment and Scheduling||0
403949|NCT01701258|989895|P9|Returned for PET (Session 3)|Assessment and Scheduling||0
403950|NCT01701258|989896|P8|Returned for PET (Session 3)|Assessment and Scheduling||0
403951|NCT01701258|989897|P7|Returned for PET (Session 3)|Assessment and Scheduling||0
403952|NCT01701258|989898|P6|Returned for PET (Session 3)|Assessment and Scheduling||0
403953|NCT01701258|989899|P5|Returned for PET (Session 3)|Assessment and Scheduling||0
403954|NCT01701258|989900|P4|Returned for PET (Session 3)|Assessment and Scheduling||0
403955|NCT01701258|989901|P3|Returned for PET (Session 3)|Assessment and Scheduling||0
403956|NCT01701258|989902|P2|Returned for PET (Session 3)|Assessment and Scheduling||0
403957|NCT01701258|989903|P1|Returned for PET (Session 3)|Assessment and Scheduling||73
403958|NCT01701258|989891|P13|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
403959|NCT01701258|989892|P12|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
403960|NCT01701258|989893|P11|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
403961|NCT01701258|989894|P10|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
403962|NCT01701258|989895|P9|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
403963|NCT01701258|989896|P8|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
403964|NCT01701258|989897|P7|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
403965|NCT01701258|989898|P6|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
403966|NCT01701258|989899|P5|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
403967|NCT01701258|989900|P4|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
403968|NCT01701258|989901|P3|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
403969|NCT01701258|989902|P2|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
403970|NCT01701258|989903|P1|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||68
403971|NCT01701258|989891|P13|Eligible After Screening Visit|Assessment and Scheduling||0
403972|NCT01701258|989892|P12|Eligible After Screening Visit|Assessment and Scheduling||0
403973|NCT01701258|989893|P11|Eligible After Screening Visit|Assessment and Scheduling||0
403974|NCT01701258|989894|P10|Eligible After Screening Visit|Assessment and Scheduling||0
403975|NCT01701258|989895|P9|Eligible After Screening Visit|Assessment and Scheduling||0
403976|NCT01701258|989896|P8|Eligible After Screening Visit|Assessment and Scheduling||0
403977|NCT01701258|989897|P7|Eligible After Screening Visit|Assessment and Scheduling||0
403978|NCT01701258|989898|P6|Eligible After Screening Visit|Assessment and Scheduling||0
403979|NCT01701258|989899|P5|Eligible After Screening Visit|Assessment and Scheduling||0
403980|NCT01701258|989900|P4|Eligible After Screening Visit|Assessment and Scheduling||0
403981|NCT01701258|989901|P3|Eligible After Screening Visit|Assessment and Scheduling||0
403982|NCT01701258|989902|P2|Eligible After Screening Visit|Assessment and Scheduling||0
403983|NCT01701258|989903|P1|Eligible After Screening Visit|Assessment and Scheduling||96
403984|NCT01701258|989891|P13|STARTED|Assessment and Scheduling||0
403985|NCT01701258|989892|P12|STARTED|Assessment and Scheduling||0
403986|NCT01701258|989893|P11|STARTED|Assessment and Scheduling||0
403987|NCT01701258|989894|P10|STARTED|Assessment and Scheduling||0
403988|NCT01701258|989895|P9|STARTED|Assessment and Scheduling||0
403989|NCT01701258|989896|P8|STARTED|Assessment and Scheduling||0
403990|NCT01701258|989897|P7|STARTED|Assessment and Scheduling||0
403991|NCT01701258|989898|P6|STARTED|Assessment and Scheduling||0
403992|NCT01701258|989899|P5|STARTED|Assessment and Scheduling||0
403993|NCT01701258|989900|P4|STARTED|Assessment and Scheduling||0
403994|NCT01701258|989901|P3|STARTED|Assessment and Scheduling||0
403995|NCT01701258|989902|P2|STARTED|Assessment and Scheduling||0
403996|NCT01701258|989903|P1|STARTED|Assessment and Scheduling||153
403997|NCT01701245|989957|P2|NOT COMPLETED|Overall Study||15
403998|NCT01701245|989958|P1|NOT COMPLETED|Overall Study||12
403999|NCT01701245|989957|P2|COMPLETED|Overall Study||33
404000|NCT01701245|989958|P1|COMPLETED|Overall Study||37
404001|NCT01701245|989957|P2|FAS Matched Data|Overall Study||32
404002|NCT01701245|989958|P1|FAS Matched Data|Overall Study||42
404003|NCT01701245|989957|P2|FAS Unmatched Data|Overall Study|3 patients protocol violation|45
404004|NCT01701245|989958|P1|FAS Unmatched Data|Overall Study|1 patient protocol violation|48
404005|NCT01701245|989957|P2|STARTED|Overall Study||48
404006|NCT01701245|989958|P1|STARTED|Overall Study||49
404007|NCT01701115|989972|P2|NOT COMPLETED|Overall Study||0
404008|NCT01701115|989973|P1|NOT COMPLETED|Overall Study||2
404009|NCT01701115|989972|P2|COMPLETED|Overall Study||77
404010|NCT01701115|989973|P1|COMPLETED|Overall Study||75
404011|NCT01701115|989972|P2|STARTED|Overall Study||77
404012|NCT01701115|989973|P1|STARTED|Overall Study||77
404013|NCT01701102|989989|P4|NOT COMPLETED|Overall Study||0
404014|NCT01701102|989990|P3|NOT COMPLETED|Overall Study||0
404015|NCT01701102|989991|P2|NOT COMPLETED|Overall Study||0
404016|NCT01701102|989992|P1|NOT COMPLETED|Overall Study||0
404017|NCT01701102|989989|P4|COMPLETED|Overall Study||18
404018|NCT01701102|989990|P3|COMPLETED|Overall Study||10
404019|NCT01701102|989991|P2|COMPLETED|Overall Study||6
404020|NCT01701102|989992|P1|COMPLETED|Overall Study||22
404021|NCT01701102|989989|P4|STARTED|Overall Study||18
404022|NCT01701102|989990|P3|STARTED|Overall Study||10
404023|NCT01701102|989991|P2|STARTED|Overall Study||6
404024|NCT01701102|989992|P1|STARTED|Overall Study||22
404025|NCT01701063|990005|P3|NOT COMPLETED|Overall Study||2
404026|NCT01701063|990006|P2|NOT COMPLETED|Overall Study||1
404027|NCT01701063|990007|P1|NOT COMPLETED|Overall Study||0
404028|NCT01701063|990005|P3|COMPLETED|Overall Study||8
404029|NCT01701063|990006|P2|COMPLETED|Overall Study||18
404030|NCT01701063|990007|P1|COMPLETED|Overall Study||13
404031|NCT01701063|990005|P3|STARTED|Overall Study||10
404032|NCT01701063|990006|P2|STARTED|Overall Study||19
404033|NCT01701063|990007|P1|STARTED|Overall Study||13
404034|NCT01701037|990049|P1|NOT COMPLETED|Overall Study||0
404035|NCT01701037|990049|P1|COMPLETED|Overall Study||13
404036|NCT01701037|990049|P1|STARTED|Overall Study||13
404037|NCT01701024|990060|P2|NOT COMPLETED|Overall Study||9
404038|NCT01701024|990061|P1|NOT COMPLETED|Overall Study||10
404039|NCT01701024|990060|P2|COMPLETED|Overall Study||236
404040|NCT01701024|990061|P1|COMPLETED|Overall Study||243
404041|NCT01701024|990060|P2|STARTED|Overall Study||245
404042|NCT01701024|990061|P1|STARTED|Overall Study||253
404043|NCT01701011|990076|P3|NOT COMPLETED|Overall Study||34
404044|NCT01701011|990077|P2|NOT COMPLETED|Overall Study||24
404045|NCT01701011|990078|P1|NOT COMPLETED|Overall Study||35
404046|NCT01701011|990076|P3|COMPLETED|Overall Study||90
404047|NCT01701011|990077|P2|COMPLETED|Overall Study||102
404048|NCT01701011|990078|P1|COMPLETED|Overall Study||92
404049|NCT01701011|990076|P3|STARTED|Overall Study||124
404050|NCT01701011|990077|P2|STARTED|Overall Study||126
404051|NCT01701011|990078|P1|STARTED|Overall Study||127
404052|NCT01700959|990095|P6|NOT COMPLETED|Overall Study||25
404053|NCT01700959|990096|P5|NOT COMPLETED|Overall Study||27
404054|NCT01700959|990097|P4|NOT COMPLETED|Overall Study||35
404055|NCT01700959|990098|P3|NOT COMPLETED|Overall Study||40
404056|NCT01700959|990099|P2|NOT COMPLETED|Overall Study||24
404057|NCT01700959|990100|P1|NOT COMPLETED|Overall Study||27
404058|NCT01700959|990095|P6|COMPLETED|Overall Study||72
404059|NCT01700959|990096|P5|COMPLETED|Overall Study||69
404060|NCT01700959|990097|P4|COMPLETED|Overall Study||70
404061|NCT01700959|990098|P3|COMPLETED|Overall Study||65
404062|NCT01700959|990099|P2|COMPLETED|Overall Study||64
404063|NCT01700959|990100|P1|COMPLETED|Overall Study||62
404064|NCT01700959|990095|P6|STARTED|Overall Study||97
404065|NCT01700959|990096|P5|STARTED|Overall Study||96
404066|NCT01700959|990097|P4|STARTED|Overall Study||105
404067|NCT01700959|990098|P3|STARTED|Overall Study||105
404068|NCT01700959|990099|P2|STARTED|Overall Study||88
404069|NCT01700959|990100|P1|STARTED|Overall Study||89
404070|NCT01700907|990124|P2|NOT COMPLETED|Overall Study||0
404071|NCT01700907|990125|P1|NOT COMPLETED|Overall Study||0
404072|NCT01700907|990124|P2|COMPLETED|Overall Study||10
404073|NCT01700907|990125|P1|COMPLETED|Overall Study||10
404074|NCT01700907|990124|P2|STARTED|Overall Study||10
404075|NCT01700907|990125|P1|STARTED|Overall Study||10
404076|NCT01700816|990141|P2|NOT COMPLETED|Overall Study||0
404077|NCT01700816|990142|P1|NOT COMPLETED|Overall Study||0
404078|NCT01700816|990141|P2|COMPLETED|Overall Study||19
404079|NCT01700816|990142|P1|COMPLETED|Overall Study||21
404080|NCT01700816|990141|P2|STARTED|Overall Study||19
404081|NCT01700816|990142|P1|STARTED|Overall Study||21
404082|NCT01700530|990171|P3|NOT COMPLETED|Overall Study||1
404083|NCT01700530|990172|P2|NOT COMPLETED|Overall Study||3
404084|NCT01700530|990173|P1|NOT COMPLETED|Overall Study||0
404085|NCT01700530|990171|P3|COMPLETED|Overall Study||19
404086|NCT01700530|990172|P2|COMPLETED|Overall Study||18
404087|NCT01700530|990173|P1|COMPLETED|Overall Study||9
404088|NCT01700530|990171|P3|STARTED|Overall Study||20
404089|NCT01700530|990172|P2|STARTED|Overall Study||21
404090|NCT01700530|990173|P1|STARTED|Overall Study||9
404091|NCT01700517|990187|P3|NOT COMPLETED|Overall Study||0
404092|NCT01700517|990188|P2|NOT COMPLETED|Overall Study||0
404093|NCT01700517|990189|P1|NOT COMPLETED|Overall Study||0
404094|NCT01700517|990187|P3|COMPLETED|Overall Study||40
404095|NCT01700517|990188|P2|COMPLETED|Overall Study||40
404096|NCT01700517|990189|P1|COMPLETED|Overall Study||40
404097|NCT01700517|990187|P3|STARTED|Overall Study||40
404098|NCT01700517|990188|P2|STARTED|Overall Study||40
404099|NCT01700517|990189|P1|STARTED|Overall Study||40
404100|NCT01700439|990197|P1|NOT COMPLETED|Overall Study||889
404101|NCT01700439|990197|P1|COMPLETED|Overall Study||0
404102|NCT01700439|990197|P1|2 Year|Overall Study||215
404103|NCT01700439|990197|P1|1 Year|Overall Study||573
404104|NCT01700439|990197|P1|3 Month|Overall Study||778
404105|NCT01700439|990197|P1|Discharge|Overall Study||831
404106|NCT01700439|990197|P1|Study Valve Group|Overall Study|Received the Edwards INTUITY surgical aortic heart valve.|839
404107|NCT01700439|990197|P1|STARTED|Overall Study||889
404108|NCT01700387|990222|P2|NOT COMPLETED|Overall Study||4
404109|NCT01700387|990223|P1|NOT COMPLETED|Overall Study||4
404110|NCT01700387|990222|P2|COMPLETED|Overall Study||6
404111|NCT01700387|990223|P1|COMPLETED|Overall Study||6
404112|NCT01700387|990222|P2|STARTED|Overall Study||10
404113|NCT01700387|990223|P1|STARTED|Overall Study||10
404114|NCT01700348|990233|P1|NOT COMPLETED|Overall Study||23
404115|NCT01700348|990233|P1|COMPLETED|Overall Study||93
404116|NCT01700348|990233|P1|STARTED|Overall Study||116
404117|NCT01700335|990237|P2|NOT COMPLETED|Overall Study||4
404118|NCT01700335|990238|P1|NOT COMPLETED|Overall Study||1
404119|NCT01700335|990237|P2|COMPLETED|Overall Study||2
404120|NCT01700335|990238|P1|COMPLETED|Overall Study||2
404121|NCT01700335|990237|P2|STARTED|Overall Study||6
404122|NCT01700335|990238|P1|STARTED|Overall Study||3
404123|NCT01700192|990251|P2|NOT COMPLETED|Overall Study||128
404124|NCT01700192|990252|P1|NOT COMPLETED|Overall Study||180
404125|NCT01700192|990251|P2|COMPLETED|Overall Study||613
404126|NCT01700192|990252|P1|COMPLETED|Overall Study||561
404127|NCT01700192|990251|P2|All Participants as Treated (APaT)|Overall Study|Three participants randomized to receive placebo were given MK-8237 12 DU.|738
404128|NCT01700192|990252|P1|All Participants as Treated (APaT)|Overall Study|Three participants randomized to receive placebo were given MK-8237 12 DU.|743
404129|NCT01700192|990251|P2|Treated|Overall Study||741
404130|NCT01700192|990252|P1|Treated|Overall Study||740
404131|NCT01700192|990251|P2|STARTED|Overall Study||741
404132|NCT01700192|990252|P1|STARTED|Overall Study||741
404133|NCT01700179|990270|P1|NOT COMPLETED|Overall Study||2
404134|NCT01700179|990270|P1|COMPLETED|Overall Study||6
404135|NCT01700179|990270|P1|STARTED|Overall Study||8
404136|NCT01700140|990277|P3|NOT COMPLETED|Overall Study||1
404137|NCT01700140|990278|P2|NOT COMPLETED|Overall Study||9
404138|NCT01700140|990279|P1|NOT COMPLETED|Overall Study||6
404139|NCT01700140|990277|P3|COMPLETED|Overall Study||61
404140|NCT01700140|990278|P2|COMPLETED|Overall Study||57
404141|NCT01700140|990279|P1|COMPLETED|Overall Study||55
404142|NCT01700140|990277|P3|STARTED|Overall Study||62
404143|NCT01700140|990278|P2|STARTED|Overall Study||66
404144|NCT01700140|990279|P1|STARTED|Overall Study||61
404145|NCT01700036|990311|P1|NOT COMPLETED|Overall Study||0
404146|NCT01700036|990311|P1|COMPLETED|Overall Study||40
404147|NCT01700036|990311|P1|STARTED|Overall Study||40
404148|NCT01699867|990320|P1|NOT COMPLETED|Overall Study||3
404149|NCT01699867|990320|P1|COMPLETED|Overall Study||47
404150|NCT01699867|990320|P1|STARTED|Overall Study||50
404151|NCT01699815|990327|P2|NOT COMPLETED|Overall Study||8
404152|NCT01699815|990328|P1|NOT COMPLETED|Overall Study||5
404153|NCT01699815|990327|P2|COMPLETED|Overall Study||56
404154|NCT01699815|990328|P1|COMPLETED|Overall Study||57
404155|NCT01699815|990327|P2|STARTED|Overall Study||64
404156|NCT01699815|990328|P1|STARTED|Overall Study||62
404157|NCT01699789|990340|P2|NOT COMPLETED|Overall Study||126
404158|NCT01699789|990341|P1|NOT COMPLETED|Overall Study||102
404159|NCT01699789|990340|P2|COMPLETED|Overall Study|Clients in 46 programs with complete or partially complete data at baseline, 6 and 12 mo FU analyzed|514
404160|NCT01699789|990341|P1|COMPLETED|Overall Study|Clients in 44 programs with complete or partially complete data at baseline, 6 and 12 mo FU analyzed|504
404161|NCT01699789|990340|P2|12-Month Follow-Up|Overall Study||369
404162|NCT01699789|990341|P1|12-Month Follow-Up|Overall Study||364
404163|NCT01699789|990340|P2|6-Month Follow-Up|Overall Study||379
404164|NCT01699789|990341|P1|6-Month Follow-Up|Overall Study||380
404165|NCT01699789|990340|P2|Baseline|Overall Study||488
404166|NCT01699789|990341|P1|Baseline|Overall Study||492
404167|NCT01699789|990340|P2|STARTED|Overall Study|640 eligible clients enrolled and contacted by telephone for baseline or follow-up survey in CEP arm|640
404168|NCT01699789|990341|P1|STARTED|Overall Study|606 eligible clients enrolled and contacted by telephone for baseline or follow-up survey in RS arm|606
404169|NCT01699763|990403|P1|NOT COMPLETED|Overall Study||0
404170|NCT01699763|990403|P1|COMPLETED|Overall Study||112
404171|NCT01699763|990403|P1|STARTED|Overall Study||112
404172|NCT01699750|990411|P2|NOT COMPLETED|Overall Study||3
404173|NCT01699750|990412|P1|NOT COMPLETED|Overall Study||0
404174|NCT01699750|990411|P2|COMPLETED|Overall Study||33
404175|NCT01699750|990412|P1|COMPLETED|Overall Study||34
404176|NCT01699750|990411|P2|STARTED|Overall Study||36
404177|NCT01699750|990412|P1|STARTED|Overall Study||34
404178|NCT01699698|990436|P2|NOT COMPLETED|Overall Study||5
404179|NCT01699698|990437|P1|NOT COMPLETED|Overall Study||2
404180|NCT01699698|990436|P2|COMPLETED|Overall Study||56
404181|NCT01699698|990437|P1|COMPLETED|Overall Study||42
404182|NCT01699698|990436|P2|STARTED|Overall Study||61
404183|NCT01699698|990437|P1|STARTED|Overall Study||44
404184|NCT01699685|990447|P2|NOT COMPLETED|Period 2||0
404185|NCT01699685|990448|P1|NOT COMPLETED|Period 2||1
404186|NCT01699685|990447|P2|COMPLETED|Period 2||36
404187|NCT01699685|990448|P1|COMPLETED|Period 2||35
404188|NCT01699685|990447|P2|STARTED|Period 2||36
404189|NCT01699685|990448|P1|STARTED|Period 2||36
404190|NCT01699685|990447|P2|NOT COMPLETED|Period 1||3
404191|NCT01699685|990448|P1|NOT COMPLETED|Period 1||3
404192|NCT01699685|990447|P2|COMPLETED|Period 1||36
404193|NCT01699685|990448|P1|COMPLETED|Period 1||36
404194|NCT01699685|990447|P2|Full Analysis Population (FAS)|Period 1||38
404195|NCT01699685|990448|P1|Full Analysis Population (FAS)|Period 1||38
404196|NCT01699685|990447|P2|Safety Population|Period 1||38
404197|NCT01699685|990448|P1|Safety Population|Period 1||39
404198|NCT01699685|990447|P2|STARTED|Period 1||39
404199|NCT01699685|990448|P1|STARTED|Period 1||39
404200|NCT01699607|990466|P2|NOT COMPLETED|Overall Study||0
404201|NCT01699607|990467|P1|NOT COMPLETED|Overall Study||0
404202|NCT01699607|990466|P2|COMPLETED|Overall Study||4
404203|NCT01699607|990467|P1|COMPLETED|Overall Study||6
404204|NCT01699607|990466|P2|STARTED|Overall Study||4
404205|NCT01699607|990467|P1|STARTED|Overall Study||6
404206|NCT01699373|990474|P2|NOT COMPLETED|Overall Study||0
404207|NCT01699373|990475|P1|NOT COMPLETED|Overall Study||0
404208|NCT01699373|990474|P2|COMPLETED|Overall Study||85
404209|NCT01699373|990475|P1|COMPLETED|Overall Study||85
404210|NCT01699373|990474|P2|STARTED|Overall Study||85
404211|NCT01699373|990475|P1|STARTED|Overall Study||85
404216|NCT01699022|990495|P1|NOT COMPLETED|Overall Study||3
404217|NCT01699022|990495|P1|COMPLETED|Overall Study||14
404218|NCT01699022|990495|P1|STARTED|Overall Study||17
404219|NCT01698814|990510|P2|NOT COMPLETED|Overall Study||3
404220|NCT01698814|990511|P1|NOT COMPLETED|Overall Study||2
404221|NCT01698814|990510|P2|COMPLETED|Overall Study||166
404222|NCT01698814|990511|P1|COMPLETED|Overall Study||329
404223|NCT01698814|990510|P2|STARTED|Overall Study||169
404224|NCT01698814|990511|P1|STARTED|Overall Study||331
404225|NCT01698801|990517|P1|NOT COMPLETED|Follow Up Phase||5
404226|NCT01698801|990517|P1|COMPLETED|Follow Up Phase|Completed includes participants who remain in follow-up for up to 5 years from start of treatment|6
404227|NCT01698801|990517|P1|STARTED|Follow Up Phase|11 participants did not complete the study and moved into the follow up phase lasting up to 5 years.|11
404228|NCT01698801|990517|P1|NOT COMPLETED|Treatment Phase||11
404229|NCT01698801|990517|P1|COMPLETED|Treatment Phase|Completed includes participants who continued to receive study medication and treatment is ongoing.|15
404230|NCT01698801|990517|P1|STARTED|Treatment Phase||26
404231|NCT01698775|990528|P2|NOT COMPLETED|Phase B||11
404232|NCT01698775|990529|P1|NOT COMPLETED|Phase B||14
404233|NCT01698775|990528|P2|COMPLETED|Phase B||86
404234|NCT01698775|990529|P1|COMPLETED|Phase B||84
404235|NCT01698775|990528|P2|STARTED|Phase B||97
404236|NCT01698775|990529|P1|STARTED|Phase B||98
404237|NCT01698775|990528|P2|NOT COMPLETED|Phase A||9
404238|NCT01698775|990529|P1|NOT COMPLETED|Phase A||9
404239|NCT01698775|990528|P2|COMPLETED|Phase A||97
404240|NCT01698775|990529|P1|COMPLETED|Phase A||98
404241|NCT01698775|990528|P2|STARTED|Phase A||106
404242|NCT01698775|990529|P1|STARTED|Phase A||107
404243|NCT01698710|990555|P1|NOT COMPLETED|Overall Study||0
404244|NCT01698710|990555|P1|COMPLETED|Overall Study||5
404245|NCT01698710|990555|P1|STARTED|Overall Study||5
404246|NCT01698684|990564|P3|NOT COMPLETED|Overall Study||21
404247|NCT01698684|990565|P2|NOT COMPLETED|Overall Study||23
404248|NCT01698684|990566|P1|NOT COMPLETED|Overall Study||29
404249|NCT01698684|990564|P3|COMPLETED|Overall Study||127
404250|NCT01698684|990565|P2|COMPLETED|Overall Study||124
404251|NCT01698684|990566|P1|COMPLETED|Overall Study||116
404252|NCT01698684|990564|P3|Safety Population|Overall Study||146
404253|NCT01698684|990565|P2|Safety Population|Overall Study||146
404254|NCT01698684|990566|P1|Safety Population|Overall Study||143
404255|NCT01698684|990564|P3|ITT Population|Overall Study||139
404256|NCT01698684|990565|P2|ITT Population|Overall Study||139
404257|NCT01698684|990566|P1|ITT Population|Overall Study||136
404258|NCT01698684|990564|P3|STARTED|Overall Study||148
404259|NCT01698684|990565|P2|STARTED|Overall Study||147
404260|NCT01698684|990566|P1|STARTED|Overall Study||145
404261|NCT01698554|990578|P4|NOT COMPLETED|Overall Study||2
404262|NCT01698554|990579|P3|NOT COMPLETED|Overall Study||2
404263|NCT01698554|990580|P2|NOT COMPLETED|Overall Study||10
404264|NCT01698554|990581|P1|NOT COMPLETED|Overall Study||6
404265|NCT01698554|990578|P4|COMPLETED|Overall Study||77
404266|NCT01698554|990579|P3|COMPLETED|Overall Study||73
404267|NCT01698554|990580|P2|COMPLETED|Overall Study||147
404268|NCT01698554|990581|P1|COMPLETED|Overall Study||147
404269|NCT01698554|990578|P4|STARTED|Overall Study||79
404270|NCT01698554|990579|P3|STARTED|Overall Study||75
404271|NCT01698554|990580|P2|STARTED|Overall Study||157
404272|NCT01698554|990581|P1|STARTED|Overall Study||153
404273|NCT01698528|990609|P2|NOT COMPLETED|Overall Study||4
404274|NCT01698528|990610|P1|NOT COMPLETED|Overall Study||1
404275|NCT01698528|990609|P2|COMPLETED|Overall Study||16
404276|NCT01698528|990610|P1|COMPLETED|Overall Study||19
404277|NCT01698528|990609|P2|STARTED|Overall Study||20
404278|NCT01698528|990610|P1|STARTED|Overall Study||20
404279|NCT01698502|990626|P2|NOT COMPLETED|Overall Study||0
404280|NCT01698502|990627|P1|NOT COMPLETED|Overall Study||0
404281|NCT01698502|990626|P2|COMPLETED|Overall Study||10
404282|NCT01698502|990627|P1|COMPLETED|Overall Study||11
404283|NCT01698502|990626|P2|STARTED|Overall Study||10
404284|NCT01698502|990627|P1|STARTED|Overall Study||11
404285|NCT01698320|990637|P3|NOT COMPLETED|40-Week Open-Label Period||10
404286|NCT01698320|990638|P2|NOT COMPLETED|40-Week Open-Label Period||19
404287|NCT01698320|990639|P1|NOT COMPLETED|40-Week Open-Label Period||0
404288|NCT01698320|990637|P3|COMPLETED|40-Week Open-Label Period||146
404289|NCT01698320|990638|P2|COMPLETED|40-Week Open-Label Period||146
404290|NCT01698320|990639|P1|COMPLETED|40-Week Open-Label Period||0
404291|NCT01698320|990637|P3|STARTED|40-Week Open-Label Period||156
404292|NCT01698320|990638|P2|STARTED|40-Week Open-Label Period||165
404293|NCT01698320|990639|P1|STARTED|40-Week Open-Label Period||0
404294|NCT01698320|990637|P3|NOT COMPLETED|12-Week Double-Blind Period||12
404295|NCT01698320|990638|P2|NOT COMPLETED|12-Week Double-Blind Period||4
404296|NCT01698320|990639|P1|NOT COMPLETED|12-Week Double-Blind Period||0
404297|NCT01698320|990637|P3|COMPLETED|12-Week Double-Blind Period||156
404298|NCT01698320|990638|P2|COMPLETED|12-Week Double-Blind Period||165
404299|NCT01698320|990639|P1|COMPLETED|12-Week Double-Blind Period||0
404300|NCT01698320|990637|P3|Safety Population|12-Week Double-Blind Period||168
404301|NCT01698320|990638|P2|Safety Population|12-Week Double-Blind Period|One participant took both placebo and albuterol so is counted in both treatment groups for safety.|170
404302|NCT01698320|990639|P1|Safety Population|12-Week Double-Blind Period||0
404303|NCT01698320|990637|P3|STARTED|12-Week Double-Blind Period||168
404304|NCT01698320|990638|P2|STARTED|12-Week Double-Blind Period||169
404305|NCT01698320|990639|P1|STARTED|12-Week Double-Blind Period||0
404306|NCT01698320|990637|P3|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0
404307|NCT01698320|990638|P2|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0
404308|NCT01698320|990639|P1|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||27
404309|NCT01698320|990637|P3|COMPLETED|Run-In Period (Week -1 to Day 0)||0
404310|NCT01698320|990638|P2|COMPLETED|Run-In Period (Week -1 to Day 0)||0
404311|NCT01698320|990639|P1|COMPLETED|Run-In Period (Week -1 to Day 0)||337
404312|NCT01698320|990637|P3|STARTED|Run-In Period (Week -1 to Day 0)||0
404313|NCT01698320|990638|P2|STARTED|Run-In Period (Week -1 to Day 0)||0
404314|NCT01698320|990639|P1|STARTED|Run-In Period (Week -1 to Day 0)||364
404315|NCT01698268|990659|P2|NOT COMPLETED|Overall Study||1
404316|NCT01698268|990660|P1|NOT COMPLETED|Overall Study||2
404317|NCT01698268|990659|P2|COMPLETED|Overall Study||24
404318|NCT01698268|990660|P1|COMPLETED|Overall Study||23
404319|NCT01698268|990659|P2|STARTED|Overall Study||25
404320|NCT01698268|990660|P1|STARTED|Overall Study||25
404321|NCT01697969|990666|P1|NOT COMPLETED|Overall Study||3
404322|NCT01697969|990666|P1|COMPLETED|Overall Study||10
404323|NCT01697969|990666|P1|STARTED|Overall Study||13
404324|NCT01697956|990673|P2|NOT COMPLETED|Overall Study||1
404325|NCT01697956|990674|P1|NOT COMPLETED|Overall Study||1
404326|NCT01697956|990673|P2|COMPLETED|Overall Study||31
404327|NCT01697956|990674|P1|COMPLETED|Overall Study||66
404328|NCT01697956|990673|P2|Per Protocol Population|Overall Study||31
404329|NCT01697956|990674|P1|Per Protocol Population|Overall Study||66
404330|NCT01697956|990673|P2|STARTED|Overall Study|enrolled and randomized|32
404331|NCT01697956|990674|P1|STARTED|Overall Study|enrolled and randomized|67
404332|NCT01697696|990704|P2|NOT COMPLETED|Overall Study||47
404333|NCT01697696|990705|P1|NOT COMPLETED|Overall Study||47
404334|NCT01697696|990704|P2|COMPLETED|Overall Study||210
404335|NCT01697696|990705|P1|COMPLETED|Overall Study||207
404336|NCT01697696|990704|P2|Full Analysis Set (FAS)|Overall Study||255
404337|NCT01697696|990705|P1|Full Analysis Set (FAS)|Overall Study||251
404338|NCT01697696|990704|P2|Safety Set|Overall Study|Safety set included a patient that was treated, but not randomized|256
404339|NCT01697696|990705|P1|Safety Set|Overall Study||251
404340|NCT01697696|990704|P2|STARTED|Overall Study||257
404341|NCT01697696|990705|P1|STARTED|Overall Study||254
404342|NCT01697592|990737|P10|NOT COMPLETED|Phase B (Week 25 to Week 52)||0
404343|NCT01697592|990738|P9|NOT COMPLETED|Phase B (Week 25 to Week 52)||2
404344|NCT01697592|990739|P8|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
404345|NCT01697592|990740|P7|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
404346|NCT01697592|990741|P6|NOT COMPLETED|Phase B (Week 25 to Week 52)||2
404347|NCT01697592|990742|P5|NOT COMPLETED|Phase B (Week 25 to Week 52)||0
404348|NCT01697592|990743|P4|NOT COMPLETED|Phase B (Week 25 to Week 52)||3
404349|NCT01697592|990744|P3|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
404350|NCT01697592|990745|P2|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
404351|NCT01697592|990746|P1|NOT COMPLETED|Phase B (Week 25 to Week 52)||5
404352|NCT01697592|990737|P10|COMPLETED|Phase B (Week 25 to Week 52)||30
404353|NCT01697592|990738|P9|COMPLETED|Phase B (Week 25 to Week 52)||32
404354|NCT01697592|990739|P8|COMPLETED|Phase B (Week 25 to Week 52)||32
404355|NCT01697592|990740|P7|COMPLETED|Phase B (Week 25 to Week 52)||31
404356|NCT01697592|990741|P6|COMPLETED|Phase B (Week 25 to Week 52)||60
404357|NCT01697592|990742|P5|COMPLETED|Phase B (Week 25 to Week 52)||67
404358|NCT01697592|990743|P4|COMPLETED|Phase B (Week 25 to Week 52)||60
404359|NCT01697592|990744|P3|COMPLETED|Phase B (Week 25 to Week 52)||64
404360|NCT01697592|990745|P2|COMPLETED|Phase B (Week 25 to Week 52)||61
404361|NCT01697592|990746|P1|COMPLETED|Phase B (Week 25 to Week 52)||118
404362|NCT01697592|990737|P10|STARTED|Phase B (Week 25 to Week 52)||30
404363|NCT01697592|990738|P9|STARTED|Phase B (Week 25 to Week 52)||34
404364|NCT01697592|990739|P8|STARTED|Phase B (Week 25 to Week 52)||33
404365|NCT01697592|990740|P7|STARTED|Phase B (Week 25 to Week 52)||32
404366|NCT01697592|990741|P6|STARTED|Phase B (Week 25 to Week 52)||62
404367|NCT01697592|990742|P5|STARTED|Phase B (Week 25 to Week 52)||67
404368|NCT01697592|990743|P4|STARTED|Phase B (Week 25 to Week 52)||63
404369|NCT01697592|990744|P3|STARTED|Phase B (Week 25 to Week 52)||65
404370|NCT01697592|990745|P2|STARTED|Phase B (Week 25 to Week 52)||62
404371|NCT01697592|990746|P1|STARTED|Phase B (Week 25 to Week 52)||123
404372|NCT01697592|990737|P10|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
404373|NCT01697592|990738|P9|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
404374|NCT01697592|990739|P8|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
404375|NCT01697592|990740|P7|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
404376|NCT01697592|990741|P6|NOT COMPLETED|Phase A (Up to 24 Weeks)||1
404377|NCT01697592|990742|P5|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
404378|NCT01697592|990743|P4|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
404379|NCT01697592|990744|P3|NOT COMPLETED|Phase A (Up to 24 Weeks)||1
404380|NCT01697592|990745|P2|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
404381|NCT01697592|990746|P1|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
404382|NCT01697592|990737|P10|COMPLETED|Phase A (Up to 24 Weeks)||30
404383|NCT01697592|990738|P9|COMPLETED|Phase A (Up to 24 Weeks)||34
404384|NCT01697592|990739|P8|COMPLETED|Phase A (Up to 24 Weeks)||33
404385|NCT01697592|990740|P7|COMPLETED|Phase A (Up to 24 Weeks)||32
404386|NCT01697592|990741|P6|COMPLETED|Phase A (Up to 24 Weeks)||62
404387|NCT01697592|990742|P5|COMPLETED|Phase A (Up to 24 Weeks)||67
404388|NCT01697592|990743|P4|COMPLETED|Phase A (Up to 24 Weeks)||63
404389|NCT01697592|990744|P3|COMPLETED|Phase A (Up to 24 Weeks)||65
404390|NCT01697592|990745|P2|COMPLETED|Phase A (Up to 24 Weeks)||62
404391|NCT01697592|990746|P1|COMPLETED|Phase A (Up to 24 Weeks)||123
404392|NCT01697592|990737|P10|STARTED|Phase A (Up to 24 Weeks)||32
404393|NCT01697592|990738|P9|STARTED|Phase A (Up to 24 Weeks)||34
404394|NCT01697592|990739|P8|STARTED|Phase A (Up to 24 Weeks)||33
404395|NCT01697592|990740|P7|STARTED|Phase A (Up to 24 Weeks)||34
404396|NCT01697592|990741|P6|STARTED|Phase A (Up to 24 Weeks)||63
404397|NCT01697592|990742|P5|STARTED|Phase A (Up to 24 Weeks)||67
404398|NCT01697592|990743|P4|STARTED|Phase A (Up to 24 Weeks)||65
404399|NCT01697592|990744|P3|STARTED|Phase A (Up to 24 Weeks)||66
404400|NCT01697592|990745|P2|STARTED|Phase A (Up to 24 Weeks)||65
404401|NCT01697592|990746|P1|STARTED|Phase A (Up to 24 Weeks)||126
404402|NCT01697579|990815|P7|NOT COMPLETED|Optional Extension-Cycles 2-6||69
404403|NCT01697579|990816|P6|NOT COMPLETED|Optional Extension-Cycles 2-6||35
404404|NCT01697579|990817|P5|NOT COMPLETED|Optional Extension-Cycles 2-6||0
404405|NCT01697579|990818|P4|NOT COMPLETED|Optional Extension-Cycles 2-6||0
404406|NCT01697579|990819|P3|NOT COMPLETED|Optional Extension-Cycles 2-6||0
404407|NCT01697579|990820|P2|NOT COMPLETED|Optional Extension-Cycles 2-6||0
404408|NCT01697579|990821|P1|NOT COMPLETED|Optional Extension-Cycles 2-6||0
404409|NCT01697579|990815|P7|COMPLETED|Optional Extension-Cycles 2-6||37
404410|NCT01697579|990816|P6|COMPLETED|Optional Extension-Cycles 2-6||12
404411|NCT01697579|990817|P5|COMPLETED|Optional Extension-Cycles 2-6||0
404412|NCT01697579|990818|P4|COMPLETED|Optional Extension-Cycles 2-6||0
404413|NCT01697579|990819|P3|COMPLETED|Optional Extension-Cycles 2-6||0
404414|NCT01697579|990820|P2|COMPLETED|Optional Extension-Cycles 2-6||0
404415|NCT01697579|990821|P1|COMPLETED|Optional Extension-Cycles 2-6||0
404416|NCT01697579|990815|P7|STARTED|Optional Extension-Cycles 2-6|Enrollment in Cycles 2-6 was optional.|106
404417|NCT01697579|990816|P6|STARTED|Optional Extension-Cycles 2-6|Enrollment in Cycles 2-6 was optional.|47
404418|NCT01697579|990817|P5|STARTED|Optional Extension-Cycles 2-6|21 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
404419|NCT01697579|990818|P4|STARTED|Optional Extension-Cycles 2-6|27 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
404420|NCT01697579|990819|P3|STARTED|Optional Extension-Cycles 2-6|25 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
404421|NCT01697579|990820|P2|STARTED|Optional Extension-Cycles 2-6|33 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
404422|NCT01697579|990821|P1|STARTED|Optional Extension-Cycles 2-6|47 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 5 mg/kg|0
404423|NCT01697579|990815|P7|NOT COMPLETED|Base Study-Cycle 1||0
404424|NCT01697579|990816|P6|NOT COMPLETED|Base Study-Cycle 1||0
404425|NCT01697579|990817|P5|NOT COMPLETED|Base Study-Cycle 1||3
404426|NCT01697579|990818|P4|NOT COMPLETED|Base Study-Cycle 1||1
404427|NCT01697579|990819|P3|NOT COMPLETED|Base Study-Cycle 1||1
404428|NCT01697579|990820|P2|NOT COMPLETED|Base Study-Cycle 1||1
404429|NCT01697579|990821|P1|NOT COMPLETED|Base Study-Cycle 1||2
404430|NCT01697579|990815|P7|COMPLETED|Base Study-Cycle 1||0
404431|NCT01697579|990816|P6|COMPLETED|Base Study-Cycle 1||0
404432|NCT01697579|990817|P5|COMPLETED|Base Study-Cycle 1||35
404433|NCT01697579|990818|P4|COMPLETED|Base Study-Cycle 1||40
404434|NCT01697579|990819|P3|COMPLETED|Base Study-Cycle 1||43
404435|NCT01697579|990820|P2|COMPLETED|Base Study-Cycle 1||42
404436|NCT01697579|990821|P1|COMPLETED|Base Study-Cycle 1||72
404437|NCT01697579|990815|P7|STARTED|Base Study-Cycle 1|Enrollment in Cycles 2-6 was optional.|0
404438|NCT01697579|990816|P6|STARTED|Base Study-Cycle 1|Enrollment in Cycles 2-6 was optional.|0
404439|NCT01697579|990817|P5|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|38
404440|NCT01697579|990818|P4|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|41
404441|NCT01697579|990819|P3|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|44
404442|NCT01697579|990820|P2|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|43
404443|NCT01697579|990821|P1|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|74
404444|NCT01697501|990933|P1|NOT COMPLETED|Overall Study||2
404445|NCT01697501|990933|P1|COMPLETED|Overall Study||86
404446|NCT01697501|990933|P1|STARTED|Overall Study||88
404447|NCT01697462|990976|P1|NOT COMPLETED|Overall Study||77
404448|NCT01697462|990976|P1|COMPLETED|Overall Study||181
404449|NCT01697462|990976|P1|STARTED|Overall Study||258
404450|NCT01697449|990983|P1|NOT COMPLETED|Overall Study||90
404451|NCT01697449|990983|P1|COMPLETED|Overall Study||101
404452|NCT01697449|990983|P1|STARTED|Overall Study||191
404453|NCT01697358|990994|P2|NOT COMPLETED|Period II: 6-24M Long-term Follow-up||55
404454|NCT01697358|990995|P1|NOT COMPLETED|Period II: 6-24M Long-term Follow-up||49
404455|NCT01697358|990994|P2|COMPLETED|Period II: 6-24M Long-term Follow-up||52
404456|NCT01697358|990995|P1|COMPLETED|Period II: 6-24M Long-term Follow-up||48
404457|NCT01697358|990994|P2|STARTED|Period II: 6-24M Long-term Follow-up||107
404458|NCT01697358|990995|P1|STARTED|Period II: 6-24M Long-term Follow-up||97
404459|NCT01697358|990994|P2|NOT COMPLETED|Period I: Randomization to 6 Months||1
404460|NCT01697358|990995|P1|NOT COMPLETED|Period I: Randomization to 6 Months||13
404461|NCT01697358|990994|P2|COMPLETED|Period I: Randomization to 6 Months||107
404462|NCT01697358|990995|P1|COMPLETED|Period I: Randomization to 6 Months||97
404463|NCT01697358|990994|P2|STARTED|Period I: Randomization to 6 Months||108
404464|NCT01697358|990995|P1|STARTED|Period I: Randomization to 6 Months||110
404465|NCT01697345|991011|P1|NOT COMPLETED|Overall Study||1
404466|NCT01697345|991011|P1|COMPLETED|Overall Study|One patient withdrew due to symptoms of recurrent Gardnerella vaginalis.|12
404467|NCT01697345|991011|P1|STARTED|Overall Study||13
404468|NCT01697332|991030|P1|NOT COMPLETED|Overall Study||0
404469|NCT01697332|991030|P1|COMPLETED|Overall Study||1
404470|NCT01697332|991030|P1|STARTED|Overall Study||1
404471|NCT01697319|991036|P1|NOT COMPLETED|Extension Phase||15
404472|NCT01697319|991036|P1|COMPLETED|Extension Phase||0
404473|NCT01697319|991036|P1|STARTED|Extension Phase||15
404474|NCT01697319|991036|P1|NOT COMPLETED|Primary Phase||1
404475|NCT01697319|991036|P1|COMPLETED|Primary Phase||15
404476|NCT01697319|991036|P1|STARTED|Primary Phase|One subject enrolled but did not receive a single dose of study drug|16
404477|NCT01696994|991045|P2|NOT COMPLETED|Overall Study||8437
404478|NCT01696994|991046|P1|NOT COMPLETED|Overall Study||5192
404479|NCT01696994|991045|P2|COMPLETED|Overall Study||30668
404480|NCT01696994|991046|P1|COMPLETED|Overall Study||33919
404481|NCT01696994|991045|P2|STARTED|Overall Study||39105
404482|NCT01696994|991046|P1|STARTED|Overall Study||39111
404483|NCT01696981|991074|P2|NOT COMPLETED|Overall Study||10374
404484|NCT01696981|991075|P1|NOT COMPLETED|Overall Study||1201
404485|NCT01696981|991074|P2|COMPLETED|Overall Study||67071
404486|NCT01696981|991075|P1|COMPLETED|Overall Study||76254
404487|NCT01696981|991074|P2|STARTED|Overall Study||77445
404488|NCT01696981|991075|P1|STARTED|Overall Study||77455
404489|NCT01696968|991095|P2|NOT COMPLETED|Overall Study||6812
404490|NCT01696968|991096|P1|NOT COMPLETED|Overall Study||1201
404491|NCT01696968|991095|P2|COMPLETED|Overall Study||70633
404492|NCT01696968|991096|P1|COMPLETED|Overall Study||76255
404493|NCT01696968|991095|P2|STARTED|Overall Study||77445
404494|NCT01696968|991096|P1|STARTED|Overall Study||77456
404495|NCT01696942|991118|P2|NOT COMPLETED|Overall Study||3
404496|NCT01696942|991119|P1|NOT COMPLETED|Overall Study||2
404497|NCT01696942|991118|P2|COMPLETED|Overall Study||2
404498|NCT01696942|991119|P1|COMPLETED|Overall Study||3
404499|NCT01696942|991118|P2|STARTED|Overall Study||5
404500|NCT01696942|991119|P1|STARTED|Overall Study||5
404501|NCT01696929|991127|P1|NOT COMPLETED|Overall Study||1
404502|NCT01696929|991127|P1|COMPLETED|Overall Study||5
404503|NCT01696929|991127|P1|STARTED|Overall Study||6
404504|NCT01696773|991134|P2|NOT COMPLETED|Day 28, Second Intervention||0
404505|NCT01696773|991135|P1|NOT COMPLETED|Day 28, Second Intervention||0
404506|NCT01696773|991134|P2|COMPLETED|Day 28, Second Intervention||6
404507|NCT01696773|991135|P1|COMPLETED|Day 28, Second Intervention||5
404508|NCT01696773|991134|P2|STARTED|Day 28, Second Intervention||6
404509|NCT01696773|991135|P1|STARTED|Day 28, Second Intervention||5
404510|NCT01696773|991134|P2|NOT COMPLETED|Days 15-27, Washout||0
404511|NCT01696773|991135|P1|NOT COMPLETED|Days 15-27, Washout||1
404512|NCT01696773|991134|P2|COMPLETED|Days 15-27, Washout||6
404513|NCT01696773|991135|P1|COMPLETED|Days 15-27, Washout||5
404514|NCT01696773|991134|P2|STARTED|Days 15-27, Washout||6
404515|NCT01696773|991135|P1|STARTED|Days 15-27, Washout||6
404516|NCT01696773|991134|P2|NOT COMPLETED|Day 14, First Intervention||0
404517|NCT01696773|991135|P1|NOT COMPLETED|Day 14, First Intervention||0
404518|NCT01696773|991134|P2|COMPLETED|Day 14, First Intervention||6
404519|NCT01696773|991135|P1|COMPLETED|Day 14, First Intervention||6
404520|NCT01696773|991134|P2|STARTED|Day 14, First Intervention||6
404521|NCT01696773|991135|P1|STARTED|Day 14, First Intervention||6
404522|NCT01696773|991134|P2|NOT COMPLETED|Days 1-13, Washout||0
404523|NCT01696773|991135|P1|NOT COMPLETED|Days 1-13, Washout||0
404524|NCT01696773|991134|P2|COMPLETED|Days 1-13, Washout||6
404525|NCT01696773|991135|P1|COMPLETED|Days 1-13, Washout||6
404526|NCT01696773|991134|P2|STARTED|Days 1-13, Washout||6
404527|NCT01696773|991135|P1|STARTED|Days 1-13, Washout||6
404528|NCT01696760|991143|P2|NOT COMPLETED|Overall Study||0
404529|NCT01696760|991144|P1|NOT COMPLETED|Overall Study||0
404530|NCT01696760|991143|P2|COMPLETED|Overall Study||3
404531|NCT01696760|991144|P1|COMPLETED|Overall Study||9
404532|NCT01696760|991143|P2|STARTED|Overall Study||3
404533|NCT01696760|991144|P1|STARTED|Overall Study||9
404534|NCT01696695|991162|P1|NOT COMPLETED|Overall Study||882
404535|NCT01696695|991162|P1|COMPLETED|Overall Study||0
404536|NCT01696695|991162|P1|STARTED|Overall Study||882
404537|NCT01696643|991174|P2|NOT COMPLETED|Overall Study||535
404538|NCT01696643|991175|P1|NOT COMPLETED|Overall Study||529
404539|NCT01696643|991174|P2|COMPLETED|Overall Study||169
404540|NCT01696643|991175|P1|COMPLETED|Overall Study||174
404541|NCT01696643|991174|P2|Received at Least 1 Dose of Study Drug|Overall Study|2 participants randomized to placebo took CB-5945. Their results are included in the CB-5945 group.|702
404542|NCT01696643|991175|P1|Received at Least 1 Dose of Study Drug|Overall Study||701
404543|NCT01696643|991174|P2|STARTED|Overall Study||704
404544|NCT01696643|991175|P1|STARTED|Overall Study||703
404545|NCT01696357|991192|P2|NOT COMPLETED|Overall Study||1
404546|NCT01696357|991193|P1|NOT COMPLETED|Overall Study||2
404547|NCT01696357|991192|P2|COMPLETED|Overall Study||41
404548|NCT01696357|991193|P1|COMPLETED|Overall Study||40
404549|NCT01696357|991192|P2|STARTED|Overall Study||42
404550|NCT01696357|991193|P1|STARTED|Overall Study||42
404551|NCT01696214|991203|P4|NOT COMPLETED|Overall Study||0
404552|NCT01696214|991204|P3|NOT COMPLETED|Overall Study||0
404553|NCT01696214|991205|P2|NOT COMPLETED|Overall Study||1
404554|NCT01696214|991206|P1|NOT COMPLETED|Overall Study||0
404555|NCT01696214|991203|P4|COMPLETED|Overall Study||5
404556|NCT01696214|991204|P3|COMPLETED|Overall Study||5
404557|NCT01696214|991205|P2|COMPLETED|Overall Study||4
404558|NCT01696214|991206|P1|COMPLETED|Overall Study||5
404559|NCT01696214|991203|P4|STARTED|Overall Study||5
404560|NCT01696214|991204|P3|STARTED|Overall Study||5
404561|NCT01696214|991205|P2|STARTED|Overall Study||5
404562|NCT01696214|991206|P1|STARTED|Overall Study||5
404563|NCT01696188|991218|P2|NOT COMPLETED|Overall Study||1
404564|NCT01696188|991219|P1|NOT COMPLETED|Overall Study||1
404565|NCT01696188|991218|P2|COMPLETED|Overall Study||42
404566|NCT01696188|991219|P1|COMPLETED|Overall Study||40
404567|NCT01696188|991218|P2|STARTED|Overall Study||43
404568|NCT01696188|991219|P1|STARTED|Overall Study||41
404569|NCT01696084|991233|P2|NOT COMPLETED|Overall Study||146
404570|NCT01696084|991234|P1|NOT COMPLETED|Overall Study||131
404571|NCT01696084|991233|P2|COMPLETED|Overall Study||10
404572|NCT01696084|991234|P1|COMPLETED|Overall Study||22
404573|NCT01696084|991233|P2|STARTED|Overall Study||156
404574|NCT01696084|991234|P1|STARTED|Overall Study||153
404575|NCT01696071|991250|P2|NOT COMPLETED|Treatment Period 2: 4 Weeks||0
404576|NCT01696071|991251|P1|NOT COMPLETED|Treatment Period 2: 4 Weeks||1
404577|NCT01696071|991250|P2|COMPLETED|Treatment Period 2: 4 Weeks||47
404578|NCT01696071|991251|P1|COMPLETED|Treatment Period 2: 4 Weeks||50
404579|NCT01696071|991250|P2|STARTED|Treatment Period 2: 4 Weeks||47
404580|NCT01696071|991251|P1|STARTED|Treatment Period 2: 4 Weeks||51
404581|NCT01696071|991250|P2|NOT COMPLETED|Treatment Period 1: 4 Weeks||0
404582|NCT01696071|991251|P1|NOT COMPLETED|Treatment Period 1: 4 Weeks||0
404583|NCT01696071|991250|P2|COMPLETED|Treatment Period 1: 4 Weeks||47
404584|NCT01696071|991251|P1|COMPLETED|Treatment Period 1: 4 Weeks||51
404585|NCT01696071|991250|P2|STARTED|Treatment Period 1: 4 Weeks||47
404586|NCT01696071|991251|P1|STARTED|Treatment Period 1: 4 Weeks||51
404587|NCT01696058|991279|P2|NOT COMPLETED|Overall Study||31
404588|NCT01696058|991280|P1|NOT COMPLETED|Overall Study||43
404589|NCT01696058|991279|P2|COMPLETED|Overall Study||538
404590|NCT01696058|991280|P1|COMPLETED|Overall Study||523
404591|NCT01696058|991279|P2|STARTED|Overall Study||569
404592|NCT01696058|991280|P1|STARTED|Overall Study||566
404593|NCT01696045|991308|P2|NOT COMPLETED|Overall Study||7
404594|NCT01696045|991309|P1|NOT COMPLETED|Overall Study||3
404595|NCT01696045|991308|P2|COMPLETED|Overall Study||1
404596|NCT01696045|991309|P1|COMPLETED|Overall Study||1
404597|NCT01696045|991308|P2|STARTED|Overall Study||8
404598|NCT01696045|991309|P1|STARTED|Overall Study||4
404599|NCT01695993|991328|P3|NOT COMPLETED|Overall Study||6
404600|NCT01695993|991329|P2|NOT COMPLETED|Overall Study||5
404601|NCT01695993|991330|P1|NOT COMPLETED|Overall Study||5
404602|NCT01695993|991328|P3|COMPLETED|Overall Study||75
404603|NCT01695993|991329|P2|COMPLETED|Overall Study||75
404604|NCT01695993|991330|P1|COMPLETED|Overall Study||76
404605|NCT01695993|991328|P3|STARTED|Overall Study||81
404606|NCT01695993|991329|P2|STARTED|Overall Study||80
404607|NCT01695993|991330|P1|STARTED|Overall Study||81
404608|NCT01695772|991338|P1|NOT COMPLETED|Overall Study||38
404609|NCT01695772|991338|P1|COMPLETED|Overall Study||12
404610|NCT01695772|991338|P1|STARTED|Overall Study||50
404611|NCT01695746|991350|P1|NOT COMPLETED|Overall Study||12
404612|NCT01695746|991350|P1|COMPLETED|Overall Study||96
404613|NCT01695746|991350|P1|STARTED|Overall Study||108
404614|NCT01695668|991366|P2|NOT COMPLETED|Overall Study||17
404615|NCT01695668|991367|P1|NOT COMPLETED|Overall Study||15
404616|NCT01695668|991366|P2|COMPLETED|Overall Study||20
404617|NCT01695668|991367|P1|COMPLETED|Overall Study||23
404618|NCT01695668|991366|P2|STARTED|Overall Study||37
404619|NCT01695668|991367|P1|STARTED|Overall Study||38
404620|NCT01695369|991373|P1|NOT COMPLETED|Overall Study||0
404621|NCT01695369|991373|P1|COMPLETED|Overall Study||61
404622|NCT01695369|991373|P1|STARTED|Overall Study||61
404623|NCT01695330|991379|P2|NOT COMPLETED|Overall Study||0
404624|NCT01695330|991380|P1|NOT COMPLETED|Overall Study||47
404625|NCT01695330|991379|P2|COMPLETED|Overall Study||0
404626|NCT01695330|991380|P1|COMPLETED|Overall Study||5
404627|NCT01695330|991379|P2|STARTED|Overall Study||0
404628|NCT01695330|991380|P1|STARTED|Overall Study||52
404629|NCT01695304|991386|P2|NOT COMPLETED|Overall Study||0
404630|NCT01695304|991387|P1|NOT COMPLETED|Overall Study||0
404631|NCT01695304|991386|P2|COMPLETED|Overall Study|3 deaths & 2 drop out in the intervention group, contributed some information over the 26 weeks|120
404632|NCT01695304|991387|P1|COMPLETED|Overall Study|2 deaths & 1 drop out in the intervention group, contributed some information over the 26 weeks|120
404633|NCT01695304|991386|P2|STARTED|Overall Study||120
404634|NCT01695304|991387|P1|STARTED|Overall Study||120
404635|NCT01695239|991399|P4|NOT COMPLETED|Overall Study||6
404636|NCT01695239|991400|P3|NOT COMPLETED|Overall Study||10
404637|NCT01695239|991401|P2|NOT COMPLETED|Overall Study||4
404638|NCT01695239|991402|P1|NOT COMPLETED|Overall Study||15
404639|NCT01695239|991399|P4|COMPLETED|Overall Study||97
404640|NCT01695239|991400|P3|COMPLETED|Overall Study||97
404641|NCT01695239|991401|P2|COMPLETED|Overall Study||97
404642|NCT01695239|991402|P1|COMPLETED|Overall Study||91
404643|NCT01695239|991399|P4|Classified as Inadequate Responder (IR)|Overall Study||10
404644|NCT01695239|991400|P3|Classified as Inadequate Responder (IR)|Overall Study||11
404645|NCT01695239|991401|P2|Classified as Inadequate Responder (IR)|Overall Study||9
404646|NCT01695239|991402|P1|Classified as Inadequate Responder (IR)|Overall Study||27
404647|NCT01695239|991399|P4|Received at Least 1 Dose of Study Drug|Overall Study||102
404648|NCT01695239|991400|P3|Received at Least 1 Dose of Study Drug|Overall Study||107
404649|NCT01695239|991401|P2|Received at Least 1 Dose of Study Drug|Overall Study||101
404650|NCT01695239|991402|P1|Received at Least 1 Dose of Study Drug|Overall Study||106
404651|NCT01695239|991399|P4|STARTED|Overall Study||103
404652|NCT01695239|991400|P3|STARTED|Overall Study||107
404653|NCT01695239|991401|P2|STARTED|Overall Study||101
404654|NCT01695239|991402|P1|STARTED|Overall Study||106
404655|NCT01695044|991493|P1|NOT COMPLETED|Overall Study||102
404656|NCT01695044|991493|P1|COMPLETED|Overall Study||17
404657|NCT01695044|991493|P1|STARTED|Overall Study||119
404658|NCT01694966|991506|P3|NOT COMPLETED|Overall Study||34
404659|NCT01694966|991507|P2|NOT COMPLETED|Overall Study||15
404660|NCT01694966|991508|P1|NOT COMPLETED|Overall Study||34
404661|NCT01694966|991506|P3|COMPLETED|Overall Study||464
404662|NCT01694966|991507|P2|COMPLETED|Overall Study||232
404663|NCT01694966|991508|P1|COMPLETED|Overall Study||470
404664|NCT01694966|991506|P3|STARTED|Overall Study||498
404665|NCT01694966|991507|P2|STARTED|Overall Study||247
404666|NCT01694966|991508|P1|STARTED|Overall Study||504
404667|NCT01694771|991518|P2|NOT COMPLETED|Overall Study||40
404668|NCT01694771|991519|P1|NOT COMPLETED|Overall Study||40
404669|NCT01694771|991518|P2|COMPLETED|Overall Study||525
404670|NCT01694771|991519|P1|COMPLETED|Overall Study||527
404671|NCT01694771|991518|P2|STARTED|Overall Study||565
404672|NCT01694771|991519|P1|STARTED|Overall Study||567
404673|NCT01694706|991543|P3|NOT COMPLETED|Overall Study||0
404674|NCT01694706|991544|P2|NOT COMPLETED|Overall Study||1
404675|NCT01694706|991545|P1|NOT COMPLETED|Overall Study||1
404676|NCT01694706|991543|P3|COMPLETED|Overall Study||5
404677|NCT01694706|991544|P2|COMPLETED|Overall Study||4
404678|NCT01694706|991545|P1|COMPLETED|Overall Study||4
404679|NCT01694706|991543|P3|Received Faldaprevir Fed|Overall Study||5
404680|NCT01694706|991544|P2|Received Faldaprevir Fed|Overall Study||5
404681|NCT01694706|991545|P1|Received Faldaprevir Fed|Overall Study||4
404682|NCT01694706|991543|P3|Received Faldaprevir +OMP|Overall Study||5
404683|NCT01694706|991544|P2|Received Faldaprevir +OMP|Overall Study||5
404684|NCT01694706|991545|P1|Received Faldaprevir +OMP|Overall Study||5
404685|NCT01694706|991543|P3|Received Faldaprevir|Overall Study||5
404686|NCT01694706|991544|P2|Received Faldaprevir|Overall Study||5
404687|NCT01694706|991545|P1|Received Faldaprevir|Overall Study||5
404688|NCT01694706|991543|P3|STARTED|Overall Study||5
404689|NCT01694706|991544|P2|STARTED|Overall Study||5
404690|NCT01694706|991545|P1|STARTED|Overall Study||5
404691|NCT01694667|991562|P2|NOT COMPLETED|Overall Study||0
404692|NCT01694667|991563|P1|NOT COMPLETED|Overall Study||0
404693|NCT01694667|991562|P2|COMPLETED|Overall Study||28
404694|NCT01694667|991563|P1|COMPLETED|Overall Study||29
404695|NCT01694667|991562|P2|STARTED|Overall Study||28
404696|NCT01694667|991563|P1|STARTED|Overall Study||29
404697|NCT01694641|991581|P2|NOT COMPLETED|Overall Study||10
404698|NCT01694641|991582|P1|NOT COMPLETED|Overall Study||12
404699|NCT01694641|991581|P2|COMPLETED|Overall Study||71
404700|NCT01694641|991582|P1|COMPLETED|Overall Study||68
404701|NCT01694641|991581|P2|STARTED|Overall Study||81
404702|NCT01694641|991582|P1|STARTED|Overall Study||80
404703|NCT01694420|991590|P1|NOT COMPLETED|Overall Study||3
404704|NCT01694420|991590|P1|COMPLETED|Overall Study||30
404705|NCT01694420|991590|P1|STARTED|Overall Study||33
404706|NCT01694199|991601|P2|NOT COMPLETED|Overall Study||0
404707|NCT01694199|991602|P1|NOT COMPLETED|Overall Study||0
404708|NCT01694199|991601|P2|COMPLETED|Overall Study||68
404709|NCT01694199|991602|P1|COMPLETED|Overall Study||71
404710|NCT01694199|991601|P2|STARTED|Overall Study||68
404711|NCT01694199|991602|P1|STARTED|Overall Study||71
404712|NCT01694108|991618|P2|NOT COMPLETED|Overall Study||0
404713|NCT01694108|991619|P1|NOT COMPLETED|Overall Study||0
404714|NCT01694108|991618|P2|COMPLETED|Overall Study|100% follow-up|2133
404715|NCT01694108|991619|P1|COMPLETED|Overall Study|100% follow-up|2129
404716|NCT01694108|991618|P2|STARTED|Overall Study||2133
404717|NCT01694108|991619|P1|STARTED|Overall Study||2129
404718|NCT01693900|991675|P2|NOT COMPLETED|Overall Study||0
404719|NCT01693900|991676|P1|NOT COMPLETED|Overall Study||0
404720|NCT01693900|991675|P2|COMPLETED|Overall Study||25
404721|NCT01693900|991676|P1|COMPLETED|Overall Study||25
404722|NCT01693900|991675|P2|STARTED|Overall Study||25
404723|NCT01693900|991676|P1|STARTED|Overall Study||25
404724|NCT01693653|991690|P2|NOT COMPLETED|Overall Study||0
404725|NCT01693653|991691|P1|NOT COMPLETED|Overall Study||0
404726|NCT01693653|991690|P2|COMPLETED|Overall Study||0
404727|NCT01693653|991691|P1|COMPLETED|Overall Study||1
404728|NCT01693653|991690|P2|STARTED|Overall Study||0
404729|NCT01693653|991691|P1|STARTED|Overall Study||1
404730|NCT01693484|991715|P1|NOT COMPLETED|Overall Study||13
404731|NCT01693484|991715|P1|COMPLETED|Overall Study|Study closed by PI|0
404732|NCT01693484|991715|P1|STARTED|Overall Study||13
404733|NCT01693367|991721|P2|NOT COMPLETED|Overall Study||2
404734|NCT01693367|991722|P1|NOT COMPLETED|Overall Study||1
404735|NCT01693367|991721|P2|COMPLETED|Overall Study||1
404736|NCT01693367|991722|P1|COMPLETED|Overall Study||1
404737|NCT01693367|991721|P2|STARTED|Overall Study||3
404738|NCT01693367|991722|P1|STARTED|Overall Study||2
404739|NCT01693185|991740|P2|NOT COMPLETED|Overall Study||6
404740|NCT01693185|991741|P1|NOT COMPLETED|Overall Study||0
404741|NCT01693185|991740|P2|COMPLETED|Overall Study||27
404742|NCT01693185|991741|P1|COMPLETED|Overall Study||27
404743|NCT01693185|991740|P2|STARTED|Overall Study||33
404744|NCT01693185|991741|P1|STARTED|Overall Study||27
404745|NCT01693120|991757|P1|NOT COMPLETED|Phased RF Study Procedure and Follow-up||17
404746|NCT01693120|991757|P1|COMPLETED|Phased RF Study Procedure and Follow-up|112 of the 129 subjects with a Phased RF procedure completed the 6-month follow-up visit|112
404747|NCT01693120|991757|P1|STARTED|Phased RF Study Procedure and Follow-up||129
404748|NCT01693120|991757|P1|NOT COMPLETED|Enrollment||70
404749|NCT01693120|991757|P1|COMPLETED|Enrollment|129 of the 199 enrolled subjects underwent a Phased RF study procedure|129
404750|NCT01693120|991757|P1|STARTED|Enrollment|70 subjects exited the study after consent, but prior to undergoing a study ablation procedure.|199
404751|NCT01693068|991766|P3|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||1
404752|NCT01693068|991767|P2|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
404753|NCT01693068|991768|P1|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
404754|NCT01693068|991766|P3|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||40
404755|NCT01693068|991767|P2|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
404756|NCT01693068|991768|P1|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
404757|NCT01693068|991766|P3|Treated|Cross-over (Dacarbazine To Pimasertib)||41
404758|NCT01693068|991767|P2|Treated|Cross-over (Dacarbazine To Pimasertib)||0
404759|NCT01693068|991768|P1|Treated|Cross-over (Dacarbazine To Pimasertib)||0
404760|NCT01693068|991766|P3|STARTED|Cross-over (Dacarbazine To Pimasertib)||41
404761|NCT01693068|991767|P2|STARTED|Cross-over (Dacarbazine To Pimasertib)||0
404762|NCT01693068|991768|P1|STARTED|Cross-over (Dacarbazine To Pimasertib)||0
404763|NCT01693068|991766|P3|NOT COMPLETED|Randomization Period||0
404764|NCT01693068|991767|P2|NOT COMPLETED|Randomization Period||5
404765|NCT01693068|991768|P1|NOT COMPLETED|Randomization Period||2
404766|NCT01693068|991766|P3|COMPLETED|Randomization Period||0
404767|NCT01693068|991767|P2|COMPLETED|Randomization Period||125
404768|NCT01693068|991768|P1|COMPLETED|Randomization Period||62
404769|NCT01693068|991766|P3|Treated|Randomization Period||0
404770|NCT01693068|991767|P2|Treated|Randomization Period||130
404771|NCT01693068|991768|P1|Treated|Randomization Period||61
404772|NCT01693068|991766|P3|STARTED|Randomization Period||0
404773|NCT01693068|991767|P2|STARTED|Randomization Period||130
404774|NCT01693068|991768|P1|STARTED|Randomization Period||64
404775|NCT01693029|991800|P2|NOT COMPLETED|Overall Study||57
404776|NCT01693029|991801|P1|NOT COMPLETED|Overall Study||44
404777|NCT01693029|991800|P2|COMPLETED|Overall Study||161
404778|NCT01693029|991801|P1|COMPLETED|Overall Study||173
404779|NCT01693029|991800|P2|STARTED|Overall Study||218
404780|NCT01693029|991801|P1|STARTED|Overall Study||217
404781|NCT01692951|991817|P4|NOT COMPLETED|Overall Study||0
404782|NCT01692951|991818|P3|NOT COMPLETED|Overall Study||0
404783|NCT01692951|991819|P2|NOT COMPLETED|Overall Study||0
404784|NCT01692951|991820|P1|NOT COMPLETED|Overall Study||0
404785|NCT01692951|991817|P4|COMPLETED|Overall Study||54
404786|NCT01692951|991818|P3|COMPLETED|Overall Study||18
404787|NCT01692951|991819|P2|COMPLETED|Overall Study||111
404788|NCT01692951|991820|P1|COMPLETED|Overall Study||37
404789|NCT01692951|991817|P4|STARTED|Overall Study||54
404790|NCT01692951|991818|P3|STARTED|Overall Study||18
404791|NCT01692951|991819|P2|STARTED|Overall Study||111
404792|NCT01692951|991820|P1|STARTED|Overall Study||37
404793|NCT01692938|991832|P2|NOT COMPLETED|Overall Study||4
404794|NCT01692938|991833|P1|NOT COMPLETED|Overall Study||4
404795|NCT01692938|991832|P2|COMPLETED|Overall Study||12
404796|NCT01692938|991833|P1|COMPLETED|Overall Study||12
404797|NCT01692938|991832|P2|STARTED|Overall Study||16
404798|NCT01692938|991833|P1|STARTED|Overall Study||16
404799|NCT01692782|991844|P3|NOT COMPLETED|Overall Study||10
404800|NCT01692782|991845|P2|NOT COMPLETED|Overall Study||56
404801|NCT01692782|991846|P1|NOT COMPLETED|Overall Study||20
404802|NCT01692782|991844|P3|COMPLETED|Overall Study||100
404803|NCT01692782|991845|P2|COMPLETED|Overall Study||59
404804|NCT01692782|991846|P1|COMPLETED|Overall Study||96
404805|NCT01692782|991844|P3|STARTED|Overall Study||110
404806|NCT01692782|991845|P2|STARTED|Overall Study||115
404807|NCT01692782|991846|P1|STARTED|Overall Study||116
404808|NCT01692730|991871|P2|NOT COMPLETED|Overall Study||227
404809|NCT01692730|991872|P1|NOT COMPLETED|Overall Study||225
404810|NCT01692730|991871|P2|COMPLETED|Overall Study||502
404811|NCT01692730|991872|P1|COMPLETED|Overall Study||498
404812|NCT01692730|991871|P2|STARTED|Overall Study||729
404813|NCT01692730|991872|P1|STARTED|Overall Study||723
404814|NCT01692691|991880|P1|NOT COMPLETED|Overall Study||0
404815|NCT01692691|991880|P1|COMPLETED|Overall Study||1
404816|NCT01692691|991880|P1|STARTED|Overall Study||1
404817|NCT01692626|991886|P2|NOT COMPLETED|Overall Study||6
404818|NCT01692626|991887|P1|NOT COMPLETED|Overall Study||4
404819|NCT01692626|991886|P2|COMPLETED|Overall Study||1
404820|NCT01692626|991887|P1|COMPLETED|Overall Study||2
404821|NCT01692626|991886|P2|STARTED|Overall Study||7
404822|NCT01692626|991887|P1|STARTED|Overall Study||6
404823|NCT01692340|991895|P3|NOT COMPLETED|Overall Study||0
404824|NCT01692340|991896|P2|NOT COMPLETED|Overall Study||0
404825|NCT01692340|991897|P1|NOT COMPLETED|Overall Study||0
404826|NCT01692340|991895|P3|COMPLETED|Overall Study||0
404827|NCT01692340|991896|P2|COMPLETED|Overall Study||4
404828|NCT01692340|991897|P1|COMPLETED|Overall Study||8
404829|NCT01692340|991895|P3|STARTED|Overall Study||0
404830|NCT01692340|991896|P2|STARTED|Overall Study||4
404831|NCT01692340|991897|P1|STARTED|Overall Study||8
404832|NCT01692301|991914|P2|NOT COMPLETED|Overall Study||42
404833|NCT01692301|991915|P1|NOT COMPLETED|Overall Study||45
404834|NCT01692301|991914|P2|COMPLETED|Overall Study||183
404835|NCT01692301|991915|P1|COMPLETED|Overall Study||184
404836|NCT01692301|991914|P2|STARTED|Overall Study||225
404837|NCT01692301|991915|P1|STARTED|Overall Study|"Started indicates patients in randomized, full analysis and safety set"|229
404838|NCT01691898|991947|P6|NOT COMPLETED|Overall Study||40
404839|NCT01691898|991948|P5|NOT COMPLETED|Overall Study||39
404840|NCT01691898|991949|P4|NOT COMPLETED|Overall Study||9
404841|NCT01691898|991950|P3|NOT COMPLETED|Overall Study||18
404842|NCT01691898|991951|P2|NOT COMPLETED|Overall Study||58
404843|NCT01691898|991952|P1|NOT COMPLETED|Overall Study||60
404844|NCT01691898|991947|P6|COMPLETED|Overall Study||0
404845|NCT01691898|991948|P5|COMPLETED|Overall Study||0
404846|NCT01691898|991949|P4|COMPLETED|Overall Study||0
404847|NCT01691898|991950|P3|COMPLETED|Overall Study||2
404848|NCT01691898|991951|P2|COMPLETED|Overall Study||1
404849|NCT01691898|991952|P1|COMPLETED|Overall Study||3
404850|NCT01691898|991947|P6|STARTED|Overall Study||40
404851|NCT01691898|991948|P5|STARTED|Overall Study||39
404852|NCT01691898|991949|P4|STARTED|Overall Study||9
404853|NCT01691898|991950|P3|STARTED|Overall Study||20
404854|NCT01691898|991951|P2|STARTED|Overall Study||59
404855|NCT01691898|991952|P1|STARTED|Overall Study||63
404856|NCT01691885|992098|P2|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0
404857|NCT01691885|992099|P1|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0
404858|NCT01691885|992098|P2|COMPLETED|Treatment Period 2 (7-14 Days)||21
404859|NCT01691885|992099|P1|COMPLETED|Treatment Period 2 (7-14 Days)||21
404860|NCT01691885|992098|P2|STARTED|Treatment Period 2 (7-14 Days)||21
404861|NCT01691885|992099|P1|STARTED|Treatment Period 2 (7-14 Days)||21
404862|NCT01691885|992098|P2|NOT COMPLETED|Washout Period (7-9 Days)||1
404863|NCT01691885|992099|P1|NOT COMPLETED|Washout Period (7-9 Days)||0
404864|NCT01691885|992098|P2|COMPLETED|Washout Period (7-9 Days)||21
404865|NCT01691885|992099|P1|COMPLETED|Washout Period (7-9 Days)||21
404866|NCT01691885|992098|P2|STARTED|Washout Period (7-9 Days)||22
404867|NCT01691885|992099|P1|STARTED|Washout Period (7-9 Days)||21
404868|NCT01691885|992098|P2|NOT COMPLETED|Treatment Period 1(7-14 Days)||1
404869|NCT01691885|992099|P1|NOT COMPLETED|Treatment Period 1(7-14 Days)||1
404870|NCT01691885|992098|P2|COMPLETED|Treatment Period 1(7-14 Days)||22
404871|NCT01691885|992099|P1|COMPLETED|Treatment Period 1(7-14 Days)||21
404872|NCT01691885|992098|P2|STARTED|Treatment Period 1(7-14 Days)||23
404873|NCT01691885|992099|P1|STARTED|Treatment Period 1(7-14 Days)||22
404874|NCT01691859|992105|P1|NOT COMPLETED|Overall Study||347
404875|NCT01691859|992105|P1|COMPLETED|Overall Study||0
404876|NCT01691859|992105|P1|STARTED|Overall Study||347
404877|NCT01691794|992127|P3|NOT COMPLETED|Overall Study||10
404878|NCT01691794|992128|P2|NOT COMPLETED|Overall Study||18
404879|NCT01691794|992129|P1|NOT COMPLETED|Overall Study||1
404880|NCT01691794|992127|P3|COMPLETED|Overall Study|Completed baseline to End of Study|13
404881|NCT01691794|992128|P2|COMPLETED|Overall Study|Completed baseline to End of Study|15
404882|NCT01691794|992129|P1|COMPLETED|Overall Study|Completed baseline to End of Study|2
404883|NCT01691794|992127|P3|STARTED|Overall Study||23
404884|NCT01691794|992128|P2|STARTED|Overall Study||33
404885|NCT01691794|992129|P1|STARTED|Overall Study||3
404886|NCT01691781|992145|P2|NOT COMPLETED|Overall Study||7
404887|NCT01691781|992146|P1|NOT COMPLETED|Overall Study||7
404888|NCT01691781|992145|P2|COMPLETED|Overall Study||15
404889|NCT01691781|992146|P1|COMPLETED|Overall Study||12
404890|NCT01691781|992145|P2|STARTED|Overall Study||22
404891|NCT01691781|992146|P1|STARTED|Overall Study||19
404892|NCT01691690|992158|P2|NOT COMPLETED|Overall Study||4
404893|NCT01691690|992159|P1|NOT COMPLETED|Overall Study||7
404894|NCT01691690|992158|P2|COMPLETED|Overall Study||121
404895|NCT01691690|992159|P1|COMPLETED|Overall Study||118
404896|NCT01691690|992158|P2|STARTED|Overall Study||125
404897|NCT01691690|992159|P1|STARTED|Overall Study||125
404898|NCT01691612|992169|P1|NOT COMPLETED|Overall Study||7
404899|NCT01691612|992169|P1|COMPLETED|Overall Study||7
404900|NCT01691612|992169|P1|Second Visit (Bronchoscopy)|Overall Study||7
404901|NCT01691612|992169|P1|First Visit (Allergen Challenge)|Overall Study||8
404902|NCT01691612|992169|P1|STARTED|Overall Study||14
404903|NCT01691560|992180|P4|NOT COMPLETED|Overall Study||0
404904|NCT01691560|992181|P3|NOT COMPLETED|Overall Study||0
404905|NCT01691560|992182|P2|NOT COMPLETED|Overall Study||0
404906|NCT01691560|992183|P1|NOT COMPLETED|Overall Study||0
404907|NCT01691560|992180|P4|COMPLETED|Overall Study||33
404908|NCT01691560|992181|P3|COMPLETED|Overall Study||34
404909|NCT01691560|992182|P2|COMPLETED|Overall Study||33
404910|NCT01691560|992183|P1|COMPLETED|Overall Study||34
404911|NCT01691560|992180|P4|STARTED|Overall Study||33
404912|NCT01691560|992181|P3|STARTED|Overall Study||34
404913|NCT01691560|992182|P2|STARTED|Overall Study||33
404914|NCT01691560|992183|P1|STARTED|Overall Study||34
404915|NCT01691534|992220|P7|NOT COMPLETED|Overall Study||1
404916|NCT01691534|992221|P6|NOT COMPLETED|Overall Study||1
404917|NCT01691534|992222|P5|NOT COMPLETED|Overall Study||0
404918|NCT01691534|992223|P4|NOT COMPLETED|Overall Study||1
404919|NCT01691534|992224|P3|NOT COMPLETED|Overall Study||1
404920|NCT01691534|992225|P2|NOT COMPLETED|Overall Study||1
404921|NCT01691534|992226|P1|NOT COMPLETED|Overall Study||0
404922|NCT01691534|992220|P7|COMPLETED|Overall Study||14
404923|NCT01691534|992221|P6|COMPLETED|Overall Study||14
404924|NCT01691534|992222|P5|COMPLETED|Overall Study||15
404925|NCT01691534|992223|P4|COMPLETED|Overall Study||14
404926|NCT01691534|992224|P3|COMPLETED|Overall Study||14
404927|NCT01691534|992225|P2|COMPLETED|Overall Study||14
404928|NCT01691534|992226|P1|COMPLETED|Overall Study||15
404929|NCT01691534|992220|P7|STARTED|Overall Study||15
404930|NCT01691534|992221|P6|STARTED|Overall Study||15
404931|NCT01691534|992222|P5|STARTED|Overall Study||15
404932|NCT01691534|992223|P4|STARTED|Overall Study||15
404933|NCT01691534|992224|P3|STARTED|Overall Study||15
404934|NCT01691534|992225|P2|STARTED|Overall Study||15
404935|NCT01691534|992226|P1|STARTED|Overall Study||15
404936|NCT01691521|992280|P3|NOT COMPLETED|Overall Study||9
404937|NCT01691521|992281|P2|NOT COMPLETED|Overall Study||16
404938|NCT01691521|992282|P1|NOT COMPLETED|Overall Study||12
404939|NCT01691521|992280|P3|COMPLETED|Overall Study||185
404940|NCT01691521|992281|P2|COMPLETED|Overall Study||175
404941|NCT01691521|992282|P1|COMPLETED|Overall Study||179
404942|NCT01691521|992280|P3|STARTED|Overall Study||194
404943|NCT01691521|992281|P2|STARTED|Overall Study||191
404944|NCT01691521|992282|P1|STARTED|Overall Study||191
404945|NCT01691508|992304|P2|NOT COMPLETED|Overall Study||3
404946|NCT01691508|992305|P1|NOT COMPLETED|Overall Study||4
404947|NCT01691508|992304|P2|COMPLETED|Overall Study||66
404948|NCT01691508|992305|P1|COMPLETED|Overall Study||62
404949|NCT01691508|992304|P2|STARTED|Overall Study||69
404950|NCT01691508|992305|P1|STARTED|Overall Study||66
404951|NCT01691482|992319|P2|NOT COMPLETED|Treatment Period 2||2
404952|NCT01691482|992320|P1|NOT COMPLETED|Treatment Period 2||1
404953|NCT01691482|992319|P2|COMPLETED|Treatment Period 2||26
404954|NCT01691482|992320|P1|COMPLETED|Treatment Period 2||27
404955|NCT01691482|992319|P2|STARTED|Treatment Period 2||28
404956|NCT01691482|992320|P1|STARTED|Treatment Period 2||28
404957|NCT01691482|992319|P2|NOT COMPLETED|Treatment Period 1||0
404958|NCT01691482|992320|P1|NOT COMPLETED|Treatment Period 1||0
404959|NCT01691482|992319|P2|COMPLETED|Treatment Period 1||28
404960|NCT01691482|992320|P1|COMPLETED|Treatment Period 1||28
404961|NCT01691482|992319|P2|STARTED|Treatment Period 1||28
404962|NCT01691482|992320|P1|STARTED|Treatment Period 1||28
404963|NCT01691430|992338|P2|NOT COMPLETED|Overall Study||20
404964|NCT01691430|992339|P1|NOT COMPLETED|Overall Study||22
404965|NCT01691430|992338|P2|COMPLETED|Overall Study||73
404966|NCT01691430|992339|P1|COMPLETED|Overall Study||70
404967|NCT01691430|992338|P2|Received Medication|Overall Study||93
404968|NCT01691430|992339|P1|Received Medication|Overall Study||92
404969|NCT01691430|992338|P2|STARTED|Overall Study||93
404970|NCT01691430|992339|P1|STARTED|Overall Study||92
404971|NCT01691339|992367|P4|NOT COMPLETED|Overall Study||0
404972|NCT01691339|992368|P3|NOT COMPLETED|Overall Study||0
404973|NCT01691339|992369|P2|NOT COMPLETED|Overall Study||0
404974|NCT01691339|992370|P1|NOT COMPLETED|Overall Study||0
404975|NCT01691339|992367|P4|COMPLETED|Overall Study||49
404976|NCT01691339|992368|P3|COMPLETED|Overall Study||51
404977|NCT01691339|992369|P2|COMPLETED|Overall Study||50
404978|NCT01691339|992370|P1|COMPLETED|Overall Study||50
404979|NCT01691339|992367|P4|STARTED|Overall Study||49
404980|NCT01691339|992368|P3|STARTED|Overall Study||51
404981|NCT01691339|992369|P2|STARTED|Overall Study||50
404982|NCT01691339|992370|P1|STARTED|Overall Study||50
404983|NCT01691326|992398|P2|NOT COMPLETED|Overall Study||0
404984|NCT01691326|992399|P1|NOT COMPLETED|Overall Study||0
404985|NCT01691326|992398|P2|COMPLETED|Overall Study||30
404986|NCT01691326|992399|P1|COMPLETED|Overall Study||30
404987|NCT01691326|992398|P2|STARTED|Overall Study||30
404988|NCT01691326|992399|P1|STARTED|Overall Study||30
404989|NCT01691313|992417|P4|NOT COMPLETED|Overall Study||0
404990|NCT01691313|992418|P3|NOT COMPLETED|Overall Study||0
404991|NCT01691313|992419|P2|NOT COMPLETED|Overall Study||0
404992|NCT01691313|992420|P1|NOT COMPLETED|Overall Study||0
404993|NCT01691313|992417|P4|COMPLETED|Overall Study||25
404994|NCT01691313|992418|P3|COMPLETED|Overall Study||25
404995|NCT01691313|992419|P2|COMPLETED|Overall Study||32
404996|NCT01691313|992420|P1|COMPLETED|Overall Study||22
404997|NCT01691313|992417|P4|STARTED|Overall Study||25
404998|NCT01691313|992418|P3|STARTED|Overall Study||25
404999|NCT01691313|992419|P2|STARTED|Overall Study||32
405000|NCT01691313|992420|P1|STARTED|Overall Study||22
405001|NCT01691248|992436|P2|NOT COMPLETED|Overall Study||114
405002|NCT01691248|992437|P1|NOT COMPLETED|Overall Study||111
405003|NCT01691248|992436|P2|COMPLETED|Overall Study||192
405004|NCT01691248|992437|P1|COMPLETED|Overall Study||194
405005|NCT01691248|992436|P2|Safety Analysis Set|Overall Study|A participant randomized to Fidaxomicin, received placebo instead.|300
405006|NCT01691248|992437|P1|Safety Analysis Set|Overall Study|A participant randomized to Fidaxomicin, received placebo instead.|300
405007|NCT01691248|992436|P2|Treated|Overall Study|Received at least 1 dose of study drug|299
405008|NCT01691248|992437|P1|Treated|Overall Study|Received at least 1 dose of study drug|301
405009|NCT01691248|992436|P2|STARTED|Overall Study|Randomized|306
405010|NCT01691248|992437|P1|STARTED|Overall Study|Randomized|305
405011|NCT01691092|992447|P1|NOT COMPLETED|Overall Study||41
405012|NCT01691092|992447|P1|COMPLETED|Overall Study||38
405013|NCT01691092|992447|P1|STARTED|Overall Study||79
405014|NCT01691027|992451|P1|NOT COMPLETED|Video Games Training||0
405015|NCT01691027|992451|P1|COMPLETED|Video Games Training|Four subjects were able to complete video games training module|4
405016|NCT01691027|992451|P1|STARTED|Video Games Training|Four subjects started video game training module|4
405017|NCT01691027|992451|P1|NOT COMPLETED|Line and Circle Tracing Training||0
405018|NCT01691027|992451|P1|COMPLETED|Line and Circle Tracing Training|Four subjects were able to complete line and circle tracing training module.|4
405019|NCT01691027|992451|P1|STARTED|Line and Circle Tracing Training|Four subjects started line and circle tracing training module|4
405020|NCT01691027|992451|P1|NOT COMPLETED|Scotoma Awareness||0
405021|NCT01691027|992451|P1|COMPLETED|Scotoma Awareness|Four subjects were able to complete scotoma awareness training module|4
405022|NCT01691027|992451|P1|STARTED|Scotoma Awareness|Four subjects started scotoma awareness training module|4
405023|NCT01691014|992460|P4|NOT COMPLETED|Overall Study||5
405024|NCT01691014|992461|P3|NOT COMPLETED|Overall Study||11
405025|NCT01691014|992462|P2|NOT COMPLETED|Overall Study||15
405026|NCT01691014|992463|P1|NOT COMPLETED|Overall Study||3
405027|NCT01691014|992460|P4|COMPLETED|Overall Study||4
405028|NCT01691014|992461|P3|COMPLETED|Overall Study||25
405029|NCT01691014|992462|P2|COMPLETED|Overall Study||11
405030|NCT01691014|992463|P1|COMPLETED|Overall Study||5
405031|NCT01691014|992460|P4|STARTED|Overall Study||9
405032|NCT01691014|992461|P3|STARTED|Overall Study||36
405033|NCT01691014|992462|P2|STARTED|Overall Study||26
405034|NCT01691014|992463|P1|STARTED|Overall Study||8
405035|NCT01690988|992508|P3|NOT COMPLETED|Overall Study||7
405036|NCT01690988|992509|P2|NOT COMPLETED|Overall Study||5
405037|NCT01690988|992510|P1|NOT COMPLETED|Overall Study||6
405038|NCT01690988|992508|P3|COMPLETED|Overall Study||216
405039|NCT01690988|992509|P2|COMPLETED|Overall Study||217
405040|NCT01690988|992510|P1|COMPLETED|Overall Study||221
405041|NCT01690988|992508|P3|STARTED|Overall Study||223
405042|NCT01690988|992509|P2|STARTED|Overall Study||222
405043|NCT01690988|992510|P1|STARTED|Overall Study||227
405044|NCT01690923|992535|P2|NOT COMPLETED|Overall Study||1
405045|NCT01690923|992536|P1|NOT COMPLETED|Overall Study||0
405046|NCT01690923|992535|P2|COMPLETED|Overall Study||10
405047|NCT01690923|992536|P1|COMPLETED|Overall Study||10
405048|NCT01690923|992535|P2|STARTED|Overall Study|1 participant was withdrawn and excluded due to poor fit with the pillows mask|11
405049|NCT01690923|992536|P1|STARTED|Overall Study||10
405050|NCT01690663|992545|P4|NOT COMPLETED|Overall Study||4
405051|NCT01690663|992546|P3|NOT COMPLETED|Overall Study||3
405052|NCT01690663|992547|P2|NOT COMPLETED|Overall Study||3
405053|NCT01690663|992548|P1|NOT COMPLETED|Overall Study||3
405054|NCT01690663|992545|P4|COMPLETED|Overall Study||20
405055|NCT01690663|992546|P3|COMPLETED|Overall Study||19
405056|NCT01690663|992547|P2|COMPLETED|Overall Study||17
405057|NCT01690663|992548|P1|COMPLETED|Overall Study||20
405058|NCT01690663|992545|P4|STARTED|Overall Study||24
405059|NCT01690663|992546|P3|STARTED|Overall Study||22
405060|NCT01690663|992547|P2|STARTED|Overall Study||20
405061|NCT01690663|992548|P1|STARTED|Overall Study||23
405062|NCT01690546|992562|P1|NOT COMPLETED|Overall Study||9
405063|NCT01690546|992562|P1|COMPLETED|Overall Study||26
405064|NCT01690546|992562|P1|Extended Release Injectable NTX|Overall Study||27
405065|NCT01690546|992562|P1|STARTED|Overall Study||35
405066|NCT01690299|992578|P6|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||30
405067|NCT01690299|992579|P5|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||33
405068|NCT01690299|992580|P4|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||26
405069|NCT01690299|992581|P3|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
405070|NCT01690299|992582|P2|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
405071|NCT01690299|992583|P1|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
405072|NCT01690299|992578|P6|COMPLETED|Apremilast Extension Phase (Weeks16-104)||50
405073|NCT01690299|992579|P5|COMPLETED|Apremilast Extension Phase (Weeks16-104)||41
405074|NCT01690299|992580|P4|COMPLETED|Apremilast Extension Phase (Weeks16-104)||47
405075|NCT01690299|992581|P3|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
405076|NCT01690299|992582|P2|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
405077|NCT01690299|992583|P1|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
405078|NCT01690299|992578|P6|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|79
405079|NCT01690299|992579|P5|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|74
405080|NCT01690299|992580|P4|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|73
405081|NCT01690299|992581|P3|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
405082|NCT01690299|992582|P2|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
405083|NCT01690299|992583|P1|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
405084|NCT01690299|992578|P6|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|80
405085|NCT01690299|992579|P5|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|74
405086|NCT01690299|992580|P4|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|73
405087|NCT01690299|992581|P3|STARTED|Apremilast Extension Phase (Weeks16-104)||0
405088|NCT01690299|992582|P2|STARTED|Apremilast Extension Phase (Weeks16-104)||0
405089|NCT01690299|992583|P1|STARTED|Apremilast Extension Phase (Weeks16-104)||0
405090|NCT01690299|992578|P6|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
405091|NCT01690299|992579|P5|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
405092|NCT01690299|992580|P4|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
405093|NCT01690299|992581|P3|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||2
405094|NCT01690299|992582|P2|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||6
405095|NCT01690299|992583|P1|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||9
405096|NCT01690299|992578|P6|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
405097|NCT01690299|992579|P5|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
405098|NCT01690299|992580|P4|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
405099|NCT01690299|992581|P3|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||81
405100|NCT01690299|992582|P2|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||77
405101|NCT01690299|992583|P1|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||75
405102|NCT01690299|992578|P6|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
405103|NCT01690299|992579|P5|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
405104|NCT01690299|992580|P4|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
405105|NCT01690299|992581|P3|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|83
405106|NCT01690299|992582|P2|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|83
405107|NCT01690299|992583|P1|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|84
405108|NCT01690299|992578|P6|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
405109|NCT01690299|992579|P5|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
405110|NCT01690299|992580|P4|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
405111|NCT01690299|992581|P3|STARTED|Placebo-controlled Phase (Weeks 0-16)||83
405112|NCT01690299|992582|P2|STARTED|Placebo-controlled Phase (Weeks 0-16)||83
405113|NCT01690299|992583|P1|STARTED|Placebo-controlled Phase (Weeks 0-16)||84
405114|NCT01690273|992628|P3|NOT COMPLETED|Overall Study||0
405115|NCT01690273|992629|P2|NOT COMPLETED|Overall Study||0
405116|NCT01690273|992630|P1|NOT COMPLETED|Overall Study||0
405117|NCT01690273|992628|P3|COMPLETED|Overall Study||20
405118|NCT01690273|992629|P2|COMPLETED|Overall Study||17
405119|NCT01690273|992630|P1|COMPLETED|Overall Study||18
405120|NCT01690273|992628|P3|STARTED|Overall Study||20
405121|NCT01690273|992629|P2|STARTED|Overall Study||17
405122|NCT01690273|992630|P1|STARTED|Overall Study||18
405123|NCT01690117|992682|P2|NOT COMPLETED|Overall Study||14
405124|NCT01690117|992683|P1|NOT COMPLETED|Overall Study||16
405125|NCT01690117|992682|P2|COMPLETED|Overall Study||31
405126|NCT01690117|992683|P1|COMPLETED|Overall Study||31
405127|NCT01690117|992682|P2|Post-Measurement|Overall Study||40
405128|NCT01690117|992683|P1|Post-Measurement|Overall Study||41
405129|NCT01690117|992682|P2|STARTED|Overall Study||45
405130|NCT01690117|992683|P1|STARTED|Overall Study||47
405131|NCT01690052|992719|P2|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0
405132|NCT01690052|992720|P1|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0
405133|NCT01690052|992719|P2|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6
405134|NCT01690052|992720|P1|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6
405135|NCT01690052|992719|P2|STARTED|SECOND INTERVENTION: 4 WEEKS||6
405136|NCT01690052|992720|P1|STARTED|SECOND INTERVENTION: 4 WEEKS||6
405137|NCT01690052|992719|P2|NOT COMPLETED|Washout Period of 1 Week||0
405138|NCT01690052|992720|P1|NOT COMPLETED|Washout Period of 1 Week||0
405139|NCT01690052|992719|P2|COMPLETED|Washout Period of 1 Week||6
405140|NCT01690052|992720|P1|COMPLETED|Washout Period of 1 Week||6
405141|NCT01690052|992719|P2|STARTED|Washout Period of 1 Week||6
405142|NCT01690052|992720|P1|STARTED|Washout Period of 1 Week||6
405143|NCT01690052|992719|P2|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||2
405144|NCT01690052|992720|P1|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||1
405145|NCT01690052|992719|P2|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6
405146|NCT01690052|992720|P1|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6
405147|NCT01690052|992719|P2|STARTED|FIRST INTERVENTION: 4 WEEKS||8
405148|NCT01690052|992720|P1|STARTED|FIRST INTERVENTION: 4 WEEKS||7
405149|NCT01690000|992728|P2|NOT COMPLETED|Overall Study||6
405150|NCT01690000|992729|P1|NOT COMPLETED|Overall Study||3
405151|NCT01690000|992728|P2|COMPLETED|Overall Study||35
405152|NCT01690000|992729|P1|COMPLETED|Overall Study||37
405153|NCT01690000|992728|P2|STARTED|Overall Study||41
405154|NCT01690000|992729|P1|STARTED|Overall Study||40
405155|NCT01689974|992737|P2|NOT COMPLETED|Overall Study||5
405156|NCT01689974|992738|P1|NOT COMPLETED|Overall Study||5
405157|NCT01689974|992737|P2|COMPLETED|Overall Study||0
405158|NCT01689974|992738|P1|COMPLETED|Overall Study||0
405159|NCT01689974|992737|P2|STARTED|Overall Study||5
405160|NCT01689974|992738|P1|STARTED|Overall Study||5
405161|NCT01689909|992746|P2|NOT COMPLETED|Overall Study||0
405162|NCT01689909|992747|P1|NOT COMPLETED|Overall Study||0
405163|NCT01689909|992746|P2|COMPLETED|Overall Study||52
405164|NCT01689909|992747|P1|COMPLETED|Overall Study||51
405165|NCT01689909|992746|P2|STARTED|Overall Study||52
405166|NCT01689909|992747|P1|STARTED|Overall Study||51
405167|NCT01689857|992767|P2|NOT COMPLETED|Overall Study||2
405168|NCT01689857|992768|P1|NOT COMPLETED|Overall Study||5
405169|NCT01689857|992767|P2|COMPLETED|Overall Study||18
405170|NCT01689857|992768|P1|COMPLETED|Overall Study||15
405171|NCT01689857|992767|P2|STARTED|Overall Study||20
405172|NCT01689857|992768|P1|STARTED|Overall Study||20
405173|NCT01689779|992776|P2|NOT COMPLETED|Overall Study||0
405174|NCT01689779|992777|P1|NOT COMPLETED|Overall Study||0
405175|NCT01689779|992776|P2|COMPLETED|Overall Study||32
405176|NCT01689779|992777|P1|COMPLETED|Overall Study||28
405177|NCT01689779|992776|P2|STARTED|Overall Study||32
405178|NCT01689779|992777|P1|STARTED|Overall Study||28
405179|NCT01689649|992793|P1|NOT COMPLETED|Overall Study||22
405180|NCT01689649|992793|P1|COMPLETED|Overall Study||117
405181|NCT01689649|992793|P1|STARTED|Overall Study||139
405182|NCT01689532|992805|P2|NOT COMPLETED|Overall Study||9
405183|NCT01689532|992806|P1|NOT COMPLETED|Overall Study||14
405184|NCT01689532|992805|P2|COMPLETED|Overall Study||52
405185|NCT01689532|992806|P1|COMPLETED|Overall Study||47
405186|NCT01689532|992805|P2|STARTED|Overall Study||61
405187|NCT01689532|992806|P1|STARTED|Overall Study||61
405188|NCT01689519|992870|P2|NOT COMPLETED|Overall Study||138
405189|NCT01689519|992871|P1|NOT COMPLETED|Overall Study||166
405190|NCT01689519|992870|P2|COMPLETED|Overall Study||109
405191|NCT01689519|992871|P1|COMPLETED|Overall Study||82
405192|NCT01689519|992870|P2|Received Treatment|Overall Study||246
405193|NCT01689519|992871|P1|Received Treatment|Overall Study||247
405194|NCT01689519|992870|P2|STARTED|Overall Study||247
405195|NCT01689519|992871|P1|STARTED|Overall Study||248
405196|NCT01689441|992887|P2|NOT COMPLETED|Overall Study||0
405197|NCT01689441|992888|P1|NOT COMPLETED|Overall Study||0
405198|NCT01689441|992887|P2|COMPLETED|Overall Study||31
405199|NCT01689441|992888|P1|COMPLETED|Overall Study||36
405200|NCT01689441|992887|P2|STARTED|Overall Study||31
405201|NCT01689441|992888|P1|STARTED|Overall Study||36
405202|NCT01689363|992898|P8|NOT COMPLETED|Overall Study||0
405203|NCT01689363|992899|P7|NOT COMPLETED|Overall Study||0
405204|NCT01689363|992900|P6|NOT COMPLETED|Overall Study||0
405205|NCT01689363|992901|P5|NOT COMPLETED|Overall Study||0
405206|NCT01689363|992902|P4|NOT COMPLETED|Overall Study||0
405207|NCT01689363|992903|P3|NOT COMPLETED|Overall Study||0
405208|NCT01689363|992904|P2|NOT COMPLETED|Overall Study||1
405209|NCT01689363|992905|P1|NOT COMPLETED|Overall Study||0
405210|NCT01689363|992898|P8|COMPLETED|Overall Study||32
405211|NCT01689363|992899|P7|COMPLETED|Overall Study||32
405212|NCT01689363|992900|P6|COMPLETED|Overall Study||31
405213|NCT01689363|992901|P5|COMPLETED|Overall Study||31
405214|NCT01689363|992902|P4|COMPLETED|Overall Study||31
405215|NCT01689363|992903|P3|COMPLETED|Overall Study||32
405216|NCT01689363|992904|P2|COMPLETED|Overall Study||31
405217|NCT01689363|992905|P1|COMPLETED|Overall Study||32
405218|NCT01689363|992898|P8|STARTED|Overall Study||32
405219|NCT01689363|992899|P7|STARTED|Overall Study||32
405220|NCT01689363|992900|P6|STARTED|Overall Study||31
405221|NCT01689363|992901|P5|STARTED|Overall Study||31
405222|NCT01689363|992902|P4|STARTED|Overall Study||31
405223|NCT01689363|992903|P3|STARTED|Overall Study||32
405224|NCT01689363|992904|P2|STARTED|Overall Study||32
405225|NCT01689363|992905|P1|STARTED|Overall Study||32
405226|NCT01689350|992951|P2|NOT COMPLETED|Overall Study||0
405227|NCT01689350|992952|P1|NOT COMPLETED|Overall Study||0
405228|NCT01689350|992951|P2|COMPLETED|Overall Study||45
405229|NCT01689350|992952|P1|COMPLETED|Overall Study||47
405230|NCT01689350|992951|P2|STARTED|Overall Study||45
405231|NCT01689350|992952|P1|STARTED|Overall Study||47
405232|NCT01689337|992960|P1|NOT COMPLETED|Overall Study||1
405233|NCT01689337|992960|P1|COMPLETED|Overall Study||0
405234|NCT01689337|992960|P1|STARTED|Overall Study||1
405235|NCT01689324|992975|P1|NOT COMPLETED|Overall Study||0
405236|NCT01689324|992975|P1|COMPLETED|Overall Study||43
405237|NCT01689324|992975|P1|STARTED|Overall Study||43
405238|NCT01689207|992999|P11|NOT COMPLETED|Overall Study||0
405239|NCT01689207|993000|P10|NOT COMPLETED|Overall Study||0
405240|NCT01689207|993001|P9|NOT COMPLETED|Overall Study||1
405241|NCT01689207|993002|P8|NOT COMPLETED|Overall Study||0
405242|NCT01689207|993003|P7|NOT COMPLETED|Overall Study||0
405243|NCT01689207|993004|P6|NOT COMPLETED|Overall Study||1
405244|NCT01689207|993005|P5|NOT COMPLETED|Overall Study||2
405245|NCT01689207|993006|P4|NOT COMPLETED|Overall Study||0
405246|NCT01689207|993007|P3|NOT COMPLETED|Overall Study||0
405247|NCT01689207|993008|P2|NOT COMPLETED|Overall Study||1
405248|NCT01689207|993009|P1|NOT COMPLETED|Overall Study||0
405249|NCT01689207|992999|P11|COMPLETED|Overall Study|Subjects completed study|8
405250|NCT01689207|993000|P10|COMPLETED|Overall Study|Subjects completed study|10
405251|NCT01689207|993001|P9|COMPLETED|Overall Study|Subjects completed study|5
405252|NCT01689207|993002|P8|COMPLETED|Overall Study|Subjects completed study|10
405253|NCT01689207|993003|P7|COMPLETED|Overall Study|Subjects completed study|10
405254|NCT01689207|993004|P6|COMPLETED|Overall Study|Subjects completed study|7
405255|NCT01689207|993005|P5|COMPLETED|Overall Study|Subjects completed study|2
405256|NCT01689207|993006|P4|COMPLETED|Overall Study|Subjects completed study|8
405257|NCT01689207|993007|P3|COMPLETED|Overall Study|Subjects completed study|16
405258|NCT01689207|993008|P2|COMPLETED|Overall Study|Subjects completed study|7
405259|NCT01689207|993009|P1|COMPLETED|Overall Study|Subjects completed study|4
405260|NCT01689207|992999|P11|STARTED|Overall Study|Subjects randomised|8
405261|NCT01689207|993000|P10|STARTED|Overall Study|Subjects randomised|10
405262|NCT01689207|993001|P9|STARTED|Overall Study|Subjects randomised|6
405263|NCT01689207|993002|P8|STARTED|Overall Study|Subjects randomised|10
405264|NCT01689207|993003|P7|STARTED|Overall Study|Subjects randomised|10
405265|NCT01689207|993004|P6|STARTED|Overall Study|Subjects randomised|8
405266|NCT01689207|993005|P5|STARTED|Overall Study|Subjects randomised|4
405267|NCT01689207|993006|P4|STARTED|Overall Study|Subjects randomised|8
405268|NCT01689207|993007|P3|STARTED|Overall Study|Subjects randomised|16
405269|NCT01689207|993008|P2|STARTED|Overall Study|Subjects randomised|8
405270|NCT01689207|993009|P1|STARTED|Overall Study|Subjects randomised|4
405271|NCT01689155|993105|P1|NOT COMPLETED|Overall Study||0
405272|NCT01689155|993105|P1|COMPLETED|Overall Study||116
405273|NCT01689155|993105|P1|STARTED|Overall Study||116
405274|NCT01688921|993116|P2|NOT COMPLETED|Overall Study||15
405275|NCT01688921|993117|P1|NOT COMPLETED|Overall Study||16
405276|NCT01688921|993116|P2|COMPLETED|Overall Study||608
405277|NCT01688921|993117|P1|COMPLETED|Overall Study||611
405278|NCT01688921|993116|P2|STARTED|Overall Study||623
405279|NCT01688921|993117|P1|STARTED|Overall Study||627
405280|NCT01688882|993142|P2|NOT COMPLETED|Overall Study||1
405281|NCT01688882|993143|P1|NOT COMPLETED|Overall Study||3
405282|NCT01688882|993142|P2|COMPLETED|Overall Study|The one patient that discontinued was already switched to open-label QGE031 treatment.|6
405283|NCT01688882|993143|P1|COMPLETED|Overall Study||10
405284|NCT01688882|993142|P2|Safety Follow-up|Overall Study||5
405285|NCT01688882|993143|P1|Safety Follow-up|Overall Study||11
405286|NCT01688882|993142|P2|STARTED|Overall Study|4 patients who completed 12 weeks of placebo changed to open-label QGE031 treatment.|7
405287|NCT01688882|993143|P1|STARTED|Overall Study||13
405288|NCT01688843|993157|P1|NOT COMPLETED|Overall Study||0
405289|NCT01688843|993157|P1|COMPLETED|Overall Study||1060
405290|NCT01688843|993157|P1|STARTED|Overall Study||1060
405291|NCT01688830|993188|P21|NOT COMPLETED|Overall Study||0
405292|NCT01688830|993189|P20|NOT COMPLETED|Overall Study||0
405293|NCT01688830|993190|P19|NOT COMPLETED|Overall Study||0
405294|NCT01688830|993191|P18|NOT COMPLETED|Overall Study||0
405295|NCT01688830|993192|P17|NOT COMPLETED|Overall Study||0
405296|NCT01688830|993193|P16|NOT COMPLETED|Overall Study||0
405297|NCT01688830|993194|P15|NOT COMPLETED|Overall Study||0
405298|NCT01688830|993195|P14|NOT COMPLETED|Overall Study||0
405299|NCT01688830|993196|P13|NOT COMPLETED|Overall Study||0
405300|NCT01688830|993197|P12|NOT COMPLETED|Overall Study||0
405301|NCT01688830|993198|P11|NOT COMPLETED|Overall Study||1
405302|NCT01688830|993199|P10|NOT COMPLETED|Overall Study||0
405303|NCT01688830|993200|P9|NOT COMPLETED|Overall Study||0
405304|NCT01688830|993201|P8|NOT COMPLETED|Overall Study||0
405305|NCT01688830|993202|P7|NOT COMPLETED|Overall Study||0
405306|NCT01688830|993203|P6|NOT COMPLETED|Overall Study||0
405307|NCT01688830|993204|P5|NOT COMPLETED|Overall Study||0
405308|NCT01688830|993205|P4|NOT COMPLETED|Overall Study||0
405309|NCT01688830|993206|P3|NOT COMPLETED|Overall Study||0
405310|NCT01688830|993207|P2|NOT COMPLETED|Overall Study||0
405311|NCT01688830|993208|P1|NOT COMPLETED|Overall Study||0
405312|NCT01688830|993188|P21|COMPLETED|Overall Study||9
405313|NCT01688830|993189|P20|COMPLETED|Overall Study||3
405314|NCT01688830|993190|P19|COMPLETED|Overall Study||8
405315|NCT01688830|993191|P18|COMPLETED|Overall Study||9
405316|NCT01688830|993192|P17|COMPLETED|Overall Study||9
405317|NCT01688830|993193|P16|COMPLETED|Overall Study||9
405318|NCT01688830|993194|P15|COMPLETED|Overall Study||6
405319|NCT01688830|993195|P14|COMPLETED|Overall Study||6
405320|NCT01688830|993196|P13|COMPLETED|Overall Study||6
405321|NCT01688830|993197|P12|COMPLETED|Overall Study||6
405322|NCT01688830|993198|P11|COMPLETED|Overall Study||5
405323|NCT01688830|993199|P10|COMPLETED|Overall Study||6
405324|NCT01688830|993200|P9|COMPLETED|Overall Study||6
405325|NCT01688830|993201|P8|COMPLETED|Overall Study||6
405326|NCT01688830|993202|P7|COMPLETED|Overall Study||12
405327|NCT01688830|993203|P6|COMPLETED|Overall Study||6
405328|NCT01688830|993204|P5|COMPLETED|Overall Study||5
405329|NCT01688830|993205|P4|COMPLETED|Overall Study||6
405330|NCT01688830|993206|P3|COMPLETED|Overall Study||6
405331|NCT01688830|993207|P2|COMPLETED|Overall Study||6
405332|NCT01688830|993208|P1|COMPLETED|Overall Study||21
405333|NCT01688830|993188|P21|STARTED|Overall Study||9
405334|NCT01688830|993189|P20|STARTED|Overall Study||3
405335|NCT01688830|993190|P19|STARTED|Overall Study||8
405336|NCT01688830|993191|P18|STARTED|Overall Study||9
405337|NCT01688830|993192|P17|STARTED|Overall Study||9
405338|NCT01688830|993193|P16|STARTED|Overall Study||9
405339|NCT01688830|993194|P15|STARTED|Overall Study||6
405340|NCT01688830|993195|P14|STARTED|Overall Study||6
405341|NCT01688830|993196|P13|STARTED|Overall Study||6
405342|NCT01688830|993197|P12|STARTED|Overall Study||6
405343|NCT01688830|993198|P11|STARTED|Overall Study||6
405344|NCT01688830|993199|P10|STARTED|Overall Study||6
405345|NCT01688830|993200|P9|STARTED|Overall Study||6
405346|NCT01688830|993201|P8|STARTED|Overall Study||6
405347|NCT01688830|993202|P7|STARTED|Overall Study||12
405348|NCT01688830|993203|P6|STARTED|Overall Study||6
405349|NCT01688830|993204|P5|STARTED|Overall Study||5
405350|NCT01688830|993205|P4|STARTED|Overall Study||6
405351|NCT01688830|993206|P3|STARTED|Overall Study||6
405352|NCT01688830|993207|P2|STARTED|Overall Study||6
405353|NCT01688830|993208|P1|STARTED|Overall Study||21
405360|NCT01688635|993367|P2|NOT COMPLETED|Period 4||0
405361|NCT01688635|993368|P1|NOT COMPLETED|Period 4||0
405362|NCT01688635|993367|P2|COMPLETED|Period 4||42
405363|NCT01688635|993368|P1|COMPLETED|Period 4||40
405364|NCT01688635|993367|P2|STARTED|Period 4||42
405365|NCT01688635|993368|P1|STARTED|Period 4||40
405366|NCT01688635|993367|P2|NOT COMPLETED|Washout 3||0
405367|NCT01688635|993368|P1|NOT COMPLETED|Washout 3||1
405368|NCT01688635|993367|P2|COMPLETED|Washout 3||42
405369|NCT01688635|993368|P1|COMPLETED|Washout 3||40
405370|NCT01688635|993367|P2|STARTED|Washout 3||42
405371|NCT01688635|993368|P1|STARTED|Washout 3||41
405372|NCT01688635|993367|P2|NOT COMPLETED|Period 3||0
405373|NCT01688635|993368|P1|NOT COMPLETED|Period 3||0
405374|NCT01688635|993367|P2|COMPLETED|Period 3||42
405375|NCT01688635|993368|P1|COMPLETED|Period 3||41
405376|NCT01688635|993367|P2|STARTED|Period 3||42
405377|NCT01688635|993368|P1|STARTED|Period 3||41
405378|NCT01688635|993367|P2|NOT COMPLETED|Washout 2||2
405379|NCT01688635|993368|P1|NOT COMPLETED|Washout 2||3
405380|NCT01688635|993367|P2|COMPLETED|Washout 2||42
405381|NCT01688635|993368|P1|COMPLETED|Washout 2||41
405382|NCT01688635|993367|P2|STARTED|Washout 2||44
405383|NCT01688635|993368|P1|STARTED|Washout 2||44
405384|NCT01688635|993367|P2|NOT COMPLETED|Period 2||0
405385|NCT01688635|993368|P1|NOT COMPLETED|Period 2||0
405386|NCT01688635|993367|P2|COMPLETED|Period 2||44
405387|NCT01688635|993368|P1|COMPLETED|Period 2||44
405388|NCT01688635|993367|P2|STARTED|Period 2||44
405389|NCT01688635|993368|P1|STARTED|Period 2||44
405390|NCT01688635|993367|P2|NOT COMPLETED|Washout 1||2
405391|NCT01688635|993368|P1|NOT COMPLETED|Washout 1||1
405392|NCT01688635|993367|P2|COMPLETED|Washout 1||44
405393|NCT01688635|993368|P1|COMPLETED|Washout 1||44
405394|NCT01688635|993367|P2|STARTED|Washout 1||46
405395|NCT01688635|993368|P1|STARTED|Washout 1||45
405396|NCT01688635|993367|P2|NOT COMPLETED|Period 1||0
405397|NCT01688635|993368|P1|NOT COMPLETED|Period 1||0
405398|NCT01688635|993367|P2|COMPLETED|Period 1||46
405399|NCT01688635|993368|P1|COMPLETED|Period 1||45
405400|NCT01688635|993367|P2|Received at Least 1 Dose of Study Drug|Period 1||46
405401|NCT01688635|993368|P1|Received at Least 1 Dose of Study Drug|Period 1||45
405402|NCT01688635|993367|P2|STARTED|Period 1||46
405403|NCT01688635|993368|P1|STARTED|Period 1||45
405404|NCT01688609|993380|P1|NOT COMPLETED|Overall Study||0
405405|NCT01688609|993380|P1|COMPLETED|Overall Study||18
405406|NCT01688609|993380|P1|STARTED|Overall Study||18
405407|NCT01688466|993390|P2|NOT COMPLETED|Overall Study||7
405408|NCT01688466|993391|P1|NOT COMPLETED|Overall Study||2
405409|NCT01688466|993390|P2|COMPLETED|Overall Study||10
405410|NCT01688466|993391|P1|COMPLETED|Overall Study||15
405411|NCT01688466|993390|P2|STARTED|Overall Study||17
405412|NCT01688466|993391|P1|STARTED|Overall Study||17
405413|NCT01688336|993399|P1|NOT COMPLETED|Overall Study||0
405414|NCT01688336|993399|P1|COMPLETED|Overall Study||9
405415|NCT01688336|993399|P1|STARTED|Overall Study||9
405416|NCT01688310|993411|P2|NOT COMPLETED|Overall Study||0
405417|NCT01688310|993412|P1|NOT COMPLETED|Overall Study||0
405418|NCT01688310|993411|P2|COMPLETED|Overall Study||100
405419|NCT01688310|993412|P1|COMPLETED|Overall Study||100
405420|NCT01688310|993411|P2|STARTED|Overall Study||100
405421|NCT01688310|993412|P1|STARTED|Overall Study||100
405422|NCT01688102|993432|P2|NOT COMPLETED|Overall Study||18
405423|NCT01688102|993433|P1|NOT COMPLETED|Overall Study||16
405424|NCT01688102|993432|P2|COMPLETED|Overall Study||40
405425|NCT01688102|993433|P1|COMPLETED|Overall Study||44
405426|NCT01688102|993432|P2|STARTED|Overall Study||58
405427|NCT01688102|993433|P1|STARTED|Overall Study||60
405428|NCT01688050|993461|P1|NOT COMPLETED|Overall Study||50
405429|NCT01688050|993461|P1|COMPLETED|Overall Study||0
405430|NCT01688050|993461|P1|30 Days|Overall Study||50
405431|NCT01688050|993461|P1|STARTED|Overall Study||50
405432|NCT01688037|993470|P3|NOT COMPLETED|Follow-up Period (Week 12 to 16)||0
405433|NCT01688037|993471|P2|NOT COMPLETED|Follow-up Period (Week 12 to 16)||1
405434|NCT01688037|993472|P1|NOT COMPLETED|Follow-up Period (Week 12 to 16)||0
405435|NCT01688037|993470|P3|COMPLETED|Follow-up Period (Week 12 to 16)||17
405436|NCT01688037|993471|P2|COMPLETED|Follow-up Period (Week 12 to 16)||21
405437|NCT01688037|993472|P1|COMPLETED|Follow-up Period (Week 12 to 16)||42
405438|NCT01688037|993470|P3|STARTED|Follow-up Period (Week 12 to 16)||17
405439|NCT01688037|993471|P2|STARTED|Follow-up Period (Week 12 to 16)||22
405440|NCT01688037|993472|P1|STARTED|Follow-up Period (Week 12 to 16)||42
405441|NCT01688037|993470|P3|NOT COMPLETED|Open-Label Period (Week 6 to 12)||4
405442|NCT01688037|993471|P2|NOT COMPLETED|Open-Label Period (Week 6 to 12)||3
405443|NCT01688037|993472|P1|NOT COMPLETED|Open-Label Period (Week 6 to 12)||5
405444|NCT01688037|993470|P3|COMPLETED|Open-Label Period (Week 6 to 12)||17
405445|NCT01688037|993471|P2|COMPLETED|Open-Label Period (Week 6 to 12)||22
405446|NCT01688037|993472|P1|COMPLETED|Open-Label Period (Week 6 to 12)||42
405447|NCT01688037|993470|P3|STARTED|Open-Label Period (Week 6 to 12)||21
405448|NCT01688037|993471|P2|STARTED|Open-Label Period (Week 6 to 12)||25
405449|NCT01688037|993472|P1|STARTED|Open-Label Period (Week 6 to 12)||47
405450|NCT01688037|993470|P3|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||6
405451|NCT01688037|993471|P2|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||3
405452|NCT01688037|993472|P1|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||7
405453|NCT01688037|993470|P3|COMPLETED|Double-Blind Period (Week 0 to 6)||21
405454|NCT01688037|993471|P2|COMPLETED|Double-Blind Period (Week 0 to 6)||25
405455|NCT01688037|993472|P1|COMPLETED|Double-Blind Period (Week 0 to 6)||47
405456|NCT01688037|993470|P3|STARTED|Double-Blind Period (Week 0 to 6)||27
405457|NCT01688037|993471|P2|STARTED|Double-Blind Period (Week 0 to 6)||28
405458|NCT01688037|993472|P1|STARTED|Double-Blind Period (Week 0 to 6)||54
405459|NCT01687998|993488|P2|NOT COMPLETED|Overall Study||120
405460|NCT01687998|993489|P1|NOT COMPLETED|Overall Study||112
405461|NCT01687998|993488|P2|COMPLETED|Overall Study||5934
405462|NCT01687998|993489|P1|COMPLETED|Overall Study||5926
405463|NCT01687998|993488|P2|Received at Least One Dose of Study Drug|Overall Study||6052
405464|NCT01687998|993489|P1|Received at Least One Dose of Study Drug|Overall Study||6036
405465|NCT01687998|993488|P2|STARTED|Overall Study||6054
405466|NCT01687998|993489|P1|STARTED|Overall Study||6038
405467|NCT01687972|993507|P2|NOT COMPLETED|Overall Study||0
405468|NCT01687972|993508|P1|NOT COMPLETED|Overall Study||0
405469|NCT01687972|993507|P2|COMPLETED|Overall Study||44
405470|NCT01687972|993508|P1|COMPLETED|Overall Study||44
405471|NCT01687972|993507|P2|STARTED|Overall Study||44
405472|NCT01687972|993508|P1|STARTED|Overall Study||44
405473|NCT01687790|993518|P1|NOT COMPLETED|Overall Study||0
405474|NCT01687790|993518|P1|COMPLETED|Overall Study||60
405475|NCT01687790|993518|P1|STARTED|Overall Study||60
405476|NCT01687712|993525|P2|NOT COMPLETED|Cycle 3||24
405477|NCT01687712|993526|P1|NOT COMPLETED|Cycle 3||24
405478|NCT01687712|993525|P2|COMPLETED|Cycle 3||0
405479|NCT01687712|993526|P1|COMPLETED|Cycle 3||4
405480|NCT01687712|993525|P2|Clinical Pregnancy|Cycle 3||0
405481|NCT01687712|993526|P1|Clinical Pregnancy|Cycle 3||5
405482|NCT01687712|993525|P2|Biochemically Pregnant|Cycle 3||2
405483|NCT01687712|993526|P1|Biochemically Pregnant|Cycle 3||7
405484|NCT01687712|993525|P2|Embryo Transfer|Cycle 3||24
405485|NCT01687712|993526|P1|Embryo Transfer|Cycle 3||26
405486|NCT01687712|993525|P2|Fertilization Performed|Cycle 3||24
405487|NCT01687712|993526|P1|Fertilization Performed|Cycle 3||27
405488|NCT01687712|993525|P2|Ooctye/Ovum Pick-Up|Cycle 3||24
405489|NCT01687712|993526|P1|Ooctye/Ovum Pick-Up|Cycle 3||27
405490|NCT01687712|993525|P2|Received hCG|Cycle 3||24
405491|NCT01687712|993526|P1|Received hCG|Cycle 3||27
405492|NCT01687712|993525|P2|STARTED|Cycle 3||24
405493|NCT01687712|993526|P1|STARTED|Cycle 3||28
405494|NCT01687712|993525|P2|NOT COMPLETED|Cycle 2||95
405495|NCT01687712|993526|P1|NOT COMPLETED|Cycle 2||93
405496|NCT01687712|993525|P2|COMPLETED|Cycle 2||25
405497|NCT01687712|993526|P1|COMPLETED|Cycle 2||16
405498|NCT01687712|993525|P2|Clinical Pregnancy|Cycle 2||26
405499|NCT01687712|993526|P1|Clinical Pregnancy|Cycle 2||17
405500|NCT01687712|993525|P2|Biochemical Pregnancy|Cycle 2||43
405501|NCT01687712|993526|P1|Biochemical Pregnancy|Cycle 2||35
405502|NCT01687712|993525|P2|Embryo Transfer|Cycle 2||117
405503|NCT01687712|993526|P1|Embryo Transfer|Cycle 2||101
405504|NCT01687712|993525|P2|Fertilization Performed|Cycle 2||119
405505|NCT01687712|993526|P1|Fertilization Performed|Cycle 2||106
405506|NCT01687712|993525|P2|Oocyte/Ovum Pick Up|Cycle 2||119
405507|NCT01687712|993526|P1|Oocyte/Ovum Pick Up|Cycle 2||107
405508|NCT01687712|993525|P2|Received hCG|Cycle 2||119
405509|NCT01687712|993526|P1|Received hCG|Cycle 2||107
405510|NCT01687712|993525|P2|STARTED|Cycle 2||120
405511|NCT01687712|993526|P1|STARTED|Cycle 2||109
405512|NCT01687712|993525|P2|NOT COMPLETED|Cycle 1||429
405513|NCT01687712|993526|P1|NOT COMPLETED|Cycle 1||448
405514|NCT01687712|993525|P2|COMPLETED|Cycle 1||122
405515|NCT01687712|993526|P1|COMPLETED|Cycle 1||101
405516|NCT01687712|993525|P2|Clinical Pregnancy|Cycle 1||138
405517|NCT01687712|993526|P1|Clinical Pregnancy|Cycle 1||114
405518|NCT01687712|993525|P2|Biochemical Pregnancy|Cycle 1||203
405519|NCT01687712|993526|P1|Biochemical Pregnancy|Cycle 1||163
405520|NCT01687712|993525|P2|Embryo Transfer|Cycle 1||483
405521|NCT01687712|993526|P1|Embryo Transfer|Cycle 1||466
405522|NCT01687712|993525|P2|Fertilization Performed|Cycle 1||512
405523|NCT01687712|993526|P1|Fertilization Performed|Cycle 1||508
405524|NCT01687712|993525|P2|Oocyte/Ovum Pick Up|Cycle 1||517
405525|NCT01687712|993526|P1|Oocyte/Ovum Pick Up|Cycle 1||513
405526|NCT01687712|993525|P2|Received hCG|Cycle 1||520
405527|NCT01687712|993526|P1|Received hCG|Cycle 1||516
405528|NCT01687712|993525|P2|STARTED|Cycle 1||551
405529|NCT01687712|993526|P1|STARTED|Cycle 1||549
405530|NCT01687478|993566|P2|NOT COMPLETED|Overall Study||39
405531|NCT01687478|993567|P1|NOT COMPLETED|Overall Study||32
405532|NCT01687478|993566|P2|COMPLETED|Overall Study||49
405533|NCT01687478|993567|P1|COMPLETED|Overall Study||56
405534|NCT01687478|993566|P2|Safety Analysis Set|Overall Study||87
405535|NCT01687478|993567|P1|Safety Analysis Set|Overall Study||88
405536|NCT01687478|993566|P2|STARTED|Overall Study||88
405537|NCT01687478|993567|P1|STARTED|Overall Study||88
405538|NCT01687296|993591|P2|NOT COMPLETED|Overall Study||5
405539|NCT01687296|993592|P1|NOT COMPLETED|Overall Study||7
405540|NCT01687296|993591|P2|COMPLETED|Overall Study||123
405541|NCT01687296|993592|P1|COMPLETED|Overall Study||116
405542|NCT01687296|993591|P2|STARTED|Overall Study||128
405543|NCT01687296|993592|P1|STARTED|Overall Study||123
405544|NCT01687283|993614|P2|NOT COMPLETED|Overall Study||27
405545|NCT01687283|993615|P1|NOT COMPLETED|Overall Study||35
405546|NCT01687283|993614|P2|COMPLETED|Overall Study||130
405547|NCT01687283|993615|P1|COMPLETED|Overall Study||123
405548|NCT01687283|993614|P2|STARTED|Overall Study||157
405549|NCT01687283|993615|P1|STARTED|Overall Study||158
405550|NCT01687270|993638|P1|NOT COMPLETED|Overall Study||12
405551|NCT01687270|993638|P1|COMPLETED|Overall Study||28
405552|NCT01687270|993638|P1|STARTED|Overall Study||40
405553|NCT01687257|993649|P3|NOT COMPLETED|Overall Study||6
405554|NCT01687257|993650|P2|NOT COMPLETED|Overall Study||4
405555|NCT01687257|993651|P1|NOT COMPLETED|Overall Study||8
405556|NCT01687257|993649|P3|COMPLETED|Overall Study||15
405557|NCT01687257|993650|P2|COMPLETED|Overall Study||0
405558|NCT01687257|993651|P1|COMPLETED|Overall Study||17
405559|NCT01687257|993649|P3|STARTED|Overall Study||21
405560|NCT01687257|993650|P2|STARTED|Overall Study||4
405561|NCT01687257|993651|P1|STARTED|Overall Study||25
405562|NCT01687244|993679|P2|NOT COMPLETED|Overall Study||0
405563|NCT01687244|993680|P1|NOT COMPLETED|Overall Study||0
405564|NCT01687244|993679|P2|COMPLETED|Overall Study||19
405565|NCT01687244|993680|P1|COMPLETED|Overall Study||21
405566|NCT01687244|993679|P2|STARTED|Overall Study||19
405567|NCT01687244|993680|P1|STARTED|Overall Study||21
405568|NCT01687218|993716|P6|NOT COMPLETED|Overall Study||0
405569|NCT01687218|993717|P5|NOT COMPLETED|Overall Study||1
405570|NCT01687218|993718|P4|NOT COMPLETED|Overall Study||2
405571|NCT01687218|993719|P3|NOT COMPLETED|Overall Study||1
405572|NCT01687218|993720|P2|NOT COMPLETED|Overall Study||3
405573|NCT01687218|993721|P1|NOT COMPLETED|Overall Study||3
405574|NCT01687218|993716|P6|COMPLETED|Overall Study||32
405575|NCT01687218|993717|P5|COMPLETED|Overall Study||32
405576|NCT01687218|993718|P4|COMPLETED|Overall Study||32
405577|NCT01687218|993719|P3|COMPLETED|Overall Study||30
405578|NCT01687218|993720|P2|COMPLETED|Overall Study||29
405579|NCT01687218|993721|P1|COMPLETED|Overall Study||30
405580|NCT01687218|993716|P6|STARTED|Overall Study||32
405581|NCT01687218|993717|P5|STARTED|Overall Study||33
405582|NCT01687218|993718|P4|STARTED|Overall Study||34
405583|NCT01687218|993719|P3|STARTED|Overall Study||31
405584|NCT01687218|993720|P2|STARTED|Overall Study||32
405585|NCT01687218|993721|P1|STARTED|Overall Study||33
405586|NCT01687166|993745|P4|NOT COMPLETED|Overall Study||2
405587|NCT01687166|993746|P3|NOT COMPLETED|Overall Study||14
405588|NCT01687166|993747|P2|NOT COMPLETED|Overall Study||27
405589|NCT01687166|993748|P1|NOT COMPLETED|Overall Study||28
405590|NCT01687166|993745|P4|COMPLETED|Overall Study||1
405591|NCT01687166|993746|P3|COMPLETED|Overall Study||42
405592|NCT01687166|993747|P2|COMPLETED|Overall Study||145
405593|NCT01687166|993748|P1|COMPLETED|Overall Study||139
405594|NCT01687166|993745|P4|STARTED|Overall Study||3
405595|NCT01687166|993746|P3|STARTED|Overall Study||56
405596|NCT01687166|993747|P2|STARTED|Overall Study||172
405597|NCT01687166|993748|P1|STARTED|Overall Study||167
405598|NCT01687114|993760|P1|NOT COMPLETED|Overall Study||0
405599|NCT01687114|993760|P1|COMPLETED|Overall Study||5
405600|NCT01687114|993760|P1|STARTED|Overall Study||5
405601|NCT01687101|993764|P1|NOT COMPLETED|Overall Study||7
405602|NCT01687101|993764|P1|COMPLETED|Overall Study||25
405603|NCT01687101|993764|P1|STARTED|Overall Study||32
405604|NCT01687088|993770|P2|NOT COMPLETED|Overall Study||0
405605|NCT01687088|993771|P1|NOT COMPLETED|Overall Study||0
405606|NCT01687088|993770|P2|COMPLETED|Overall Study||50
405607|NCT01687088|993771|P1|COMPLETED|Overall Study||50
405608|NCT01687088|993770|P2|STARTED|Overall Study||50
405609|NCT01687088|993771|P1|STARTED|Overall Study||50
405610|NCT01687036|993777|P1|NOT COMPLETED|Overall Study||0
405611|NCT01687036|993777|P1|COMPLETED|Overall Study||10
405612|NCT01687036|993777|P1|STARTED|Overall Study||10
405613|NCT01686932|993791|P2|NOT COMPLETED|Period 2||0
405614|NCT01686932|993792|P1|NOT COMPLETED|Period 2||0
405615|NCT01686932|993791|P2|COMPLETED|Period 2||25
405616|NCT01686932|993792|P1|COMPLETED|Period 2||24
405617|NCT01686932|993791|P2|STARTED|Period 2||25
405618|NCT01686932|993792|P1|STARTED|Period 2||24
405619|NCT01686932|993791|P2|NOT COMPLETED|Period 1||1
405620|NCT01686932|993792|P1|NOT COMPLETED|Period 1||1
405621|NCT01686932|993791|P2|COMPLETED|Period 1||25
405622|NCT01686932|993792|P1|COMPLETED|Period 1||24
405623|NCT01686932|993791|P2|STARTED|Period 1||26
405624|NCT01686932|993792|P1|STARTED|Period 1||25
405625|NCT01686828|993822|P4|NOT COMPLETED|Overall Study||0
405626|NCT01686828|993823|P3|NOT COMPLETED|Overall Study||1
405627|NCT01686828|993824|P2|NOT COMPLETED|Overall Study||1
405628|NCT01686828|993825|P1|NOT COMPLETED|Overall Study||1
405629|NCT01686828|993822|P4|COMPLETED|Overall Study||13
405630|NCT01686828|993823|P3|COMPLETED|Overall Study||12
405631|NCT01686828|993824|P2|COMPLETED|Overall Study||13
405632|NCT01686828|993825|P1|COMPLETED|Overall Study||12
405633|NCT01686828|993822|P4|STARTED|Overall Study||13
405634|NCT01686828|993823|P3|STARTED|Overall Study||13
405635|NCT01686828|993824|P2|STARTED|Overall Study||14
405636|NCT01686828|993825|P1|STARTED|Overall Study||13
405637|NCT01686646|993847|P4|NOT COMPLETED|Overall Study||0
405638|NCT01686646|993848|P3|NOT COMPLETED|Overall Study||0
405639|NCT01686646|993849|P2|NOT COMPLETED|Overall Study||0
405640|NCT01686646|993850|P1|NOT COMPLETED|Overall Study||0
405641|NCT01686646|993847|P4|COMPLETED|Overall Study||75
405642|NCT01686646|993848|P3|COMPLETED|Overall Study||75
405643|NCT01686646|993849|P2|COMPLETED|Overall Study||45
405644|NCT01686646|993850|P1|COMPLETED|Overall Study||45
405645|NCT01686646|993847|P4|Safety Population|Overall Study||75
405646|NCT01686646|993848|P3|Safety Population|Overall Study||74
405647|NCT01686646|993849|P2|Safety Population|Overall Study||45
405648|NCT01686646|993850|P1|Safety Population|Overall Study|One subject randomized to Paracetamol+Caffeine (500/65) group but received 1000/130 combination.|46
405649|NCT01686646|993847|P4|Intent to Treat Population|Overall Study||75
405650|NCT01686646|993848|P3|Intent to Treat Population|Overall Study||75
405651|NCT01686646|993849|P2|Intent to Treat Population|Overall Study||45
405652|NCT01686646|993850|P1|Intent to Treat Population|Overall Study||45
405653|NCT01686646|993847|P4|STARTED|Overall Study||75
405654|NCT01686646|993848|P3|STARTED|Overall Study||75
405655|NCT01686646|993849|P2|STARTED|Overall Study||45
405656|NCT01686646|993850|P1|STARTED|Overall Study||45
405657|NCT01686633|993899|P3|NOT COMPLETED|Overall Study||25
405658|NCT01686633|993900|P2|NOT COMPLETED|Overall Study||32
405659|NCT01686633|993901|P1|NOT COMPLETED|Overall Study||51
405660|NCT01686633|993899|P3|COMPLETED|Overall Study||321
405661|NCT01686633|993900|P2|COMPLETED|Overall Study||314
405662|NCT01686633|993901|P1|COMPLETED|Overall Study||296
405663|NCT01686633|993899|P3|STARTED|Overall Study||346
405664|NCT01686633|993900|P2|STARTED|Overall Study||346
405665|NCT01686633|993901|P1|STARTED|Overall Study||347
405666|NCT01686568|993926|P2|NOT COMPLETED|Sub-Study||2
405667|NCT01686568|993927|P1|NOT COMPLETED|Sub-Study||2
405668|NCT01686568|993926|P2|COMPLETED|Sub-Study||9
405669|NCT01686568|993927|P1|COMPLETED|Sub-Study||12
405670|NCT01686568|993926|P2|STARTED|Sub-Study||11
405671|NCT01686568|993927|P1|STARTED|Sub-Study||14
405672|NCT01686568|993926|P2|NOT COMPLETED|Main Study||4
405673|NCT01686568|993927|P1|NOT COMPLETED|Main Study||2
405674|NCT01686568|993926|P2|COMPLETED|Main Study||11
405675|NCT01686568|993927|P1|COMPLETED|Main Study||14
405676|NCT01686568|993926|P2|STARTED|Main Study||15
405677|NCT01686568|993927|P1|STARTED|Main Study||16
405678|NCT01686503|993953|P4|NOT COMPLETED|Overall Study||1
405679|NCT01686503|993954|P3|NOT COMPLETED|Overall Study||2
405680|NCT01686503|993955|P2|NOT COMPLETED|Overall Study||3
405681|NCT01686503|993956|P1|NOT COMPLETED|Overall Study||1
405682|NCT01686503|993953|P4|COMPLETED|Overall Study||32
405683|NCT01686503|993954|P3|COMPLETED|Overall Study||64
405684|NCT01686503|993955|P2|COMPLETED|Overall Study||63
405685|NCT01686503|993956|P1|COMPLETED|Overall Study||65
405686|NCT01686503|993953|P4|STARTED|Overall Study||33
405687|NCT01686503|993954|P3|STARTED|Overall Study||66
405688|NCT01686503|993955|P2|STARTED|Overall Study||66
405689|NCT01686503|993956|P1|STARTED|Overall Study||66
405690|NCT01686451|993972|P2|NOT COMPLETED|Overall Study||0
405691|NCT01686451|993973|P1|NOT COMPLETED|Overall Study||0
405692|NCT01686451|993972|P2|COMPLETED|Overall Study||27
405693|NCT01686451|993973|P1|COMPLETED|Overall Study||33
405694|NCT01686451|993972|P2|STARTED|Overall Study||27
405695|NCT01686451|993973|P1|STARTED|Overall Study||33
405696|NCT01685996|994003|P2|NOT COMPLETED|Overall Study||13
405697|NCT01685996|994004|P1|NOT COMPLETED|Overall Study||16
405698|NCT01685996|994003|P2|COMPLETED|Overall Study||27
405699|NCT01685996|994004|P1|COMPLETED|Overall Study||18
405700|NCT01685996|994003|P2|STARTED|Overall Study||40
405701|NCT01685996|994004|P1|STARTED|Overall Study||34
405702|NCT01685983|994012|P1|NOT COMPLETED|Overall Study||82
405703|NCT01685983|994012|P1|COMPLETED|Overall Study||0
405704|NCT01685983|994012|P1|STARTED|Overall Study||82
405705|NCT01685840|994024|P2|NOT COMPLETED|Overall Study||332
405706|NCT01685840|994025|P1|NOT COMPLETED|Overall Study||329
405707|NCT01685840|994024|P2|COMPLETED|Overall Study||114
405708|NCT01685840|994025|P1|COMPLETED|Overall Study||119
405709|NCT01685840|994024|P2|STARTED|Overall Study||446
405710|NCT01685840|994025|P1|STARTED|Overall Study||448
405711|NCT01685801|994069|P4|NOT COMPLETED|Open-label Period (8 Weeks)||0
405712|NCT01685801|994070|P3|NOT COMPLETED|Open-label Period (8 Weeks)||0
405713|NCT01685801|994071|P2|NOT COMPLETED|Open-label Period (8 Weeks)||0
405714|NCT01685801|994072|P1|NOT COMPLETED|Open-label Period (8 Weeks)||0
405715|NCT01685801|994069|P4|COMPLETED|Open-label Period (8 Weeks)||4
405716|NCT01685801|994070|P3|COMPLETED|Open-label Period (8 Weeks)||7
405717|NCT01685801|994071|P2|COMPLETED|Open-label Period (8 Weeks)||5
405718|NCT01685801|994072|P1|COMPLETED|Open-label Period (8 Weeks)||5
405719|NCT01685801|994069|P4|STARTED|Open-label Period (8 Weeks)||4
405720|NCT01685801|994070|P3|STARTED|Open-label Period (8 Weeks)||7
405721|NCT01685801|994071|P2|STARTED|Open-label Period (8 Weeks)||5
405722|NCT01685801|994072|P1|STARTED|Open-label Period (8 Weeks)||5
405723|NCT01685801|994069|P4|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
405724|NCT01685801|994070|P3|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
405725|NCT01685801|994071|P2|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
405726|NCT01685801|994072|P1|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
405727|NCT01685801|994069|P4|COMPLETED|Washout Period 2 (4 Weeks)||4
405728|NCT01685801|994070|P3|COMPLETED|Washout Period 2 (4 Weeks)||7
405729|NCT01685801|994071|P2|COMPLETED|Washout Period 2 (4 Weeks)||5
405730|NCT01685801|994072|P1|COMPLETED|Washout Period 2 (4 Weeks)||5
405731|NCT01685801|994069|P4|STARTED|Washout Period 2 (4 Weeks)||4
405732|NCT01685801|994070|P3|STARTED|Washout Period 2 (4 Weeks)||7
405733|NCT01685801|994071|P2|STARTED|Washout Period 2 (4 Weeks)||5
405734|NCT01685801|994072|P1|STARTED|Washout Period 2 (4 Weeks)||5
405735|NCT01685801|994069|P4|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1
405736|NCT01685801|994070|P3|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0
405737|NCT01685801|994071|P2|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1
405738|NCT01685801|994072|P1|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0
405739|NCT01685801|994069|P4|COMPLETED|Cycle 2 Period 2 (2 Weeks)||4
405740|NCT01685801|994070|P3|COMPLETED|Cycle 2 Period 2 (2 Weeks)||7
405741|NCT01685801|994071|P2|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5
405742|NCT01685801|994072|P1|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5
405743|NCT01685801|994069|P4|STARTED|Cycle 2 Period 2 (2 Weeks)||5
405744|NCT01685801|994070|P3|STARTED|Cycle 2 Period 2 (2 Weeks)||7
405745|NCT01685801|994071|P2|STARTED|Cycle 2 Period 2 (2 Weeks)||6
405746|NCT01685801|994072|P1|STARTED|Cycle 2 Period 2 (2 Weeks)||5
405747|NCT01685801|994069|P4|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
405748|NCT01685801|994070|P3|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
405749|NCT01685801|994071|P2|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
405750|NCT01685801|994072|P1|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
405751|NCT01685801|994069|P4|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5
405752|NCT01685801|994070|P3|COMPLETED|Cycle 2 Period 1 (2 Weeks)||7
405753|NCT01685801|994071|P2|COMPLETED|Cycle 2 Period 1 (2 Weeks)||6
405754|NCT01685801|994072|P1|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5
405755|NCT01685801|994069|P4|STARTED|Cycle 2 Period 1 (2 Weeks)||5
405756|NCT01685801|994070|P3|STARTED|Cycle 2 Period 1 (2 Weeks)||7
405757|NCT01685801|994071|P2|STARTED|Cycle 2 Period 1 (2 Weeks)||6
405758|NCT01685801|994072|P1|STARTED|Cycle 2 Period 1 (2 Weeks)||5
405759|NCT01685801|994069|P4|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
405760|NCT01685801|994070|P3|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
405761|NCT01685801|994071|P2|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
405762|NCT01685801|994072|P1|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
405763|NCT01685801|994069|P4|COMPLETED|Washout Period 1 (4 Weeks)||5
405764|NCT01685801|994070|P3|COMPLETED|Washout Period 1 (4 Weeks)||7
405765|NCT01685801|994071|P2|COMPLETED|Washout Period 1 (4 Weeks)||6
405766|NCT01685801|994072|P1|COMPLETED|Washout Period 1 (4 Weeks)||5
405767|NCT01685801|994069|P4|STARTED|Washout Period 1 (4 Weeks)||5
405768|NCT01685801|994070|P3|STARTED|Washout Period 1 (4 Weeks)||7
405769|NCT01685801|994071|P2|STARTED|Washout Period 1 (4 Weeks)||6
405770|NCT01685801|994072|P1|STARTED|Washout Period 1 (4 Weeks)||5
405771|NCT01685801|994069|P4|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||1
405772|NCT01685801|994070|P3|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
405773|NCT01685801|994071|P2|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
405774|NCT01685801|994072|P1|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
405775|NCT01685801|994069|P4|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5
405776|NCT01685801|994070|P3|COMPLETED|Cycle 1 Period 2 (2 Weeks)||7
405777|NCT01685801|994071|P2|COMPLETED|Cycle 1 Period 2 (2 Weeks)||6
405778|NCT01685801|994072|P1|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5
405779|NCT01685801|994069|P4|STARTED|Cycle 1 Period 2 (2 Weeks)||6
405780|NCT01685801|994070|P3|STARTED|Cycle 1 Period 2 (2 Weeks)||7
405781|NCT01685801|994071|P2|STARTED|Cycle 1 Period 2 (2 Weeks)||6
405782|NCT01685801|994072|P1|STARTED|Cycle 1 Period 2 (2 Weeks)||5
405783|NCT01685801|994069|P4|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
405784|NCT01685801|994070|P3|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
405785|NCT01685801|994071|P2|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
405786|NCT01685801|994072|P1|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
405787|NCT01685801|994069|P4|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6
405788|NCT01685801|994070|P3|COMPLETED|Cycle 1 Period 1 (2 Weeks)||7
405789|NCT01685801|994071|P2|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6
405790|NCT01685801|994072|P1|COMPLETED|Cycle 1 Period 1 (2 Weeks)||5
405791|NCT01685801|994069|P4|STARTED|Cycle 1 Period 1 (2 Weeks)||6
405792|NCT01685801|994070|P3|STARTED|Cycle 1 Period 1 (2 Weeks)||7
405793|NCT01685801|994071|P2|STARTED|Cycle 1 Period 1 (2 Weeks)||6
405794|NCT01685801|994072|P1|STARTED|Cycle 1 Period 1 (2 Weeks)||5
405795|NCT01685684|994094|P3|NOT COMPLETED|Double-blind Maintenance Phase||96
405796|NCT01685684|994095|P2|NOT COMPLETED|Double-blind Maintenance Phase||71
405797|NCT01685684|994096|P1|NOT COMPLETED|Double-blind Maintenance Phase||0
405798|NCT01685684|994094|P3|COMPLETED|Double-blind Maintenance Phase||100
405799|NCT01685684|994095|P2|COMPLETED|Double-blind Maintenance Phase||122
405800|NCT01685684|994096|P1|COMPLETED|Double-blind Maintenance Phase||0
405801|NCT01685684|994094|P3|STARTED|Double-blind Maintenance Phase||196
405802|NCT01685684|994095|P2|STARTED|Double-blind Maintenance Phase||193
405803|NCT01685684|994096|P1|STARTED|Double-blind Maintenance Phase||0
405804|NCT01685684|994094|P3|NOT COMPLETED|Titration Phase||0
405805|NCT01685684|994095|P2|NOT COMPLETED|Titration Phase||0
405806|NCT01685684|994096|P1|NOT COMPLETED|Titration Phase||351
405807|NCT01685684|994094|P3|COMPLETED|Titration Phase||0
405808|NCT01685684|994095|P2|COMPLETED|Titration Phase||0
405809|NCT01685684|994096|P1|COMPLETED|Titration Phase||389
405810|NCT01685684|994094|P3|STARTED|Titration Phase||0
405811|NCT01685684|994095|P2|STARTED|Titration Phase||0
405812|NCT01685684|994096|P1|STARTED|Titration Phase||740
405813|NCT01685606|994120|P1|NOT COMPLETED|Overall Study||1
405814|NCT01685606|994120|P1|COMPLETED|Overall Study||5
405815|NCT01685606|994120|P1|STARTED|Overall Study||6
405816|NCT01685567|994125|P1|NOT COMPLETED|Overall Study||0
405817|NCT01685567|994125|P1|COMPLETED|Overall Study||219
405818|NCT01685567|994125|P1|STARTED|Overall Study||219
405819|NCT01685437|994133|P1|NOT COMPLETED|Overall Study||31
405820|NCT01685437|994133|P1|COMPLETED|Overall Study||158
405821|NCT01685437|994133|P1|STARTED|Overall Study||189
405822|NCT01685372|994147|P2|NOT COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||4
405823|NCT01685372|994148|P1|NOT COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||3
405824|NCT01685372|994147|P2|COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||5
405825|NCT01685372|994148|P1|COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||4
405826|NCT01685372|994147|P2|STARTED|Timepoint 3 (T3): 3rd Blood Draw||9
405827|NCT01685372|994148|P1|STARTED|Timepoint 3 (T3): 3rd Blood Draw||7
405828|NCT01685372|994147|P2|NOT COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||0
405829|NCT01685372|994148|P1|NOT COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||0
405830|NCT01685372|994147|P2|COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||9
405831|NCT01685372|994148|P1|COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||7
405832|NCT01685372|994147|P2|STARTED|Timepoint 2 (T2): 2nd Blood Draw||9
405833|NCT01685372|994148|P1|STARTED|Timepoint 2 (T2): 2nd Blood Draw||7
405834|NCT01685372|994147|P2|NOT COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||0
405835|NCT01685372|994148|P1|NOT COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||0
405836|NCT01685372|994147|P2|COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||9
405837|NCT01685372|994148|P1|COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||7
405838|NCT01685372|994147|P2|STARTED|Timepoint 1 (T1): Vaccine,1st Blood Draw||9
405839|NCT01685372|994148|P1|STARTED|Timepoint 1 (T1): Vaccine,1st Blood Draw||7
405840|NCT01685320|994170|P2|NOT COMPLETED|Overall Study||0
405841|NCT01685320|994171|P1|NOT COMPLETED|Overall Study||0
405842|NCT01685320|994170|P2|COMPLETED|Overall Study||15
405843|NCT01685320|994171|P1|COMPLETED|Overall Study||15
405844|NCT01685320|994170|P2|STARTED|Overall Study||15
405845|NCT01685320|994171|P1|STARTED|Overall Study||15
405846|NCT01685242|994181|P2|NOT COMPLETED|Overall Study||3
405847|NCT01685242|994182|P1|NOT COMPLETED|Overall Study||1
405848|NCT01685242|994181|P2|COMPLETED|Overall Study||47
405849|NCT01685242|994182|P1|COMPLETED|Overall Study||49
405850|NCT01685242|994181|P2|STARTED|Overall Study||50
405851|NCT01685242|994182|P1|STARTED|Overall Study||50
405852|NCT01685216|994236|P1|NOT COMPLETED|Overall Study||1
405853|NCT01685216|994236|P1|COMPLETED|Overall Study||6
405854|NCT01685216|994236|P1|STARTED|Overall Study||7
405855|NCT01685203|994253|P7|NOT COMPLETED|Overall Study||0
405856|NCT01685203|994254|P6|NOT COMPLETED|Overall Study||3
405857|NCT01685203|994255|P5|NOT COMPLETED|Overall Study||0
405858|NCT01685203|994256|P4|NOT COMPLETED|Overall Study||1
405859|NCT01685203|994257|P3|NOT COMPLETED|Overall Study||0
405860|NCT01685203|994258|P2|NOT COMPLETED|Overall Study||3
405861|NCT01685203|994259|P1|NOT COMPLETED|Overall Study||4
405862|NCT01685203|994253|P7|COMPLETED|Overall Study||52
405863|NCT01685203|994254|P6|COMPLETED|Overall Study||44
405864|NCT01685203|994255|P5|COMPLETED|Overall Study||49
405865|NCT01685203|994256|P4|COMPLETED|Overall Study||41
405866|NCT01685203|994257|P3|COMPLETED|Overall Study||40
405867|NCT01685203|994258|P2|COMPLETED|Overall Study||39
405868|NCT01685203|994259|P1|COMPLETED|Overall Study||40
405869|NCT01685203|994253|P7|Completed Study Drug|Overall Study||52
405870|NCT01685203|994254|P6|Completed Study Drug|Overall Study||43
405871|NCT01685203|994255|P5|Completed Study Drug|Overall Study||49
405872|NCT01685203|994256|P4|Completed Study Drug|Overall Study||42
405873|NCT01685203|994257|P3|Completed Study Drug|Overall Study||39
405874|NCT01685203|994258|P2|Completed Study Drug|Overall Study||40
405875|NCT01685203|994259|P1|Completed Study Drug|Overall Study||42
405876|NCT01685203|994253|P7|STARTED|Overall Study||52
405877|NCT01685203|994254|P6|STARTED|Overall Study||47
405878|NCT01685203|994255|P5|STARTED|Overall Study||49
405879|NCT01685203|994256|P4|STARTED|Overall Study||42
405880|NCT01685203|994257|P3|STARTED|Overall Study||40
405881|NCT01685203|994258|P2|STARTED|Overall Study||42
405882|NCT01685203|994259|P1|STARTED|Overall Study||44
405883|NCT01685060|994303|P1|NOT COMPLETED|Overall Study||140
405884|NCT01685060|994303|P1|COMPLETED|Overall Study||0
405885|NCT01685060|994303|P1|Discontinued From Study|Overall Study||35
405886|NCT01685060|994303|P1|Entered Survival Follow up|Overall Study||98
405887|NCT01685060|994303|P1|Entered Post-treatment Efficacy f/u|Overall Study||7
405888|NCT01685060|994303|P1|STARTED|Overall Study||140
405889|NCT01685021|994318|P1|NOT COMPLETED|Overall Study||16
405890|NCT01685021|994318|P1|COMPLETED|Overall Study|Last patient last visit date. Study was Terminated prematurely.|6
405891|NCT01685021|994318|P1|STARTED|Overall Study||22
405892|NCT01684930|994329|P2|NOT COMPLETED|Overall Study||1
405893|NCT01684930|994330|P1|NOT COMPLETED|Overall Study||3
405894|NCT01684930|994329|P2|COMPLETED|Overall Study||13
405895|NCT01684930|994330|P1|COMPLETED|Overall Study||9
405896|NCT01684930|994329|P2|STARTED|Overall Study||14
405897|NCT01684930|994330|P1|STARTED|Overall Study||12
405898|NCT01684878|994350|P4|NOT COMPLETED|Part 2: Randomized Phase||78
405899|NCT01684878|994351|P3|NOT COMPLETED|Part 2: Randomized Phase||78
405900|NCT01684878|994352|P2|NOT COMPLETED|Part 2: Randomized Phase||0
405901|NCT01684878|994353|P1|NOT COMPLETED|Part 2: Randomized Phase||0
405902|NCT01684878|994350|P4|COMPLETED|Part 2: Randomized Phase||0
405903|NCT01684878|994351|P3|COMPLETED|Part 2: Randomized Phase||0
405904|NCT01684878|994352|P2|COMPLETED|Part 2: Randomized Phase||0
405905|NCT01684878|994353|P1|COMPLETED|Part 2: Randomized Phase||0
405906|NCT01684878|994350|P4|Participants Mis-randomized|Part 2: Randomized Phase||0
405907|NCT01684878|994351|P3|Participants Mis-randomized|Part 2: Randomized Phase||2
405908|NCT01684878|994352|P2|Participants Mis-randomized|Part 2: Randomized Phase||0
405909|NCT01684878|994353|P1|Participants Mis-randomized|Part 2: Randomized Phase||0
405910|NCT01684878|994350|P4|Participants Randomized But Not Treated|Part 2: Randomized Phase||2
405911|NCT01684878|994351|P3|Participants Randomized But Not Treated|Part 2: Randomized Phase||1
405912|NCT01684878|994352|P2|Participants Randomized But Not Treated|Part 2: Randomized Phase||0
405913|NCT01684878|994353|P1|Participants Randomized But Not Treated|Part 2: Randomized Phase||0
405914|NCT01684878|994350|P4|STARTED|Part 2: Randomized Phase||78
405915|NCT01684878|994351|P3|STARTED|Part 2: Randomized Phase||78
405916|NCT01684878|994352|P2|STARTED|Part 2: Randomized Phase||0
405917|NCT01684878|994353|P1|STARTED|Part 2: Randomized Phase||0
405918|NCT01684878|994350|P4|NOT COMPLETED|Part 1: Safety Run in Phase||0
405919|NCT01684878|994351|P3|NOT COMPLETED|Part 1: Safety Run in Phase||0
405920|NCT01684878|994352|P2|NOT COMPLETED|Part 1: Safety Run in Phase||23
405921|NCT01684878|994353|P1|NOT COMPLETED|Part 1: Safety Run in Phase||16
405922|NCT01684878|994350|P4|COMPLETED|Part 1: Safety Run in Phase||0
405923|NCT01684878|994351|P3|COMPLETED|Part 1: Safety Run in Phase||0
405924|NCT01684878|994352|P2|COMPLETED|Part 1: Safety Run in Phase||5
405925|NCT01684878|994353|P1|COMPLETED|Part 1: Safety Run in Phase||6
405926|NCT01684878|994350|P4|STARTED|Part 1: Safety Run in Phase||0
405927|NCT01684878|994351|P3|STARTED|Part 1: Safety Run in Phase||0
405928|NCT01684878|994352|P2|STARTED|Part 1: Safety Run in Phase||28
405929|NCT01684878|994353|P1|STARTED|Part 1: Safety Run in Phase||22
405930|NCT01684839|994377|P1|NOT COMPLETED|Overall Study||0
405931|NCT01684839|994377|P1|COMPLETED|Overall Study||9
405932|NCT01684839|994377|P1|STARTED|Overall Study||9
405933|NCT01684826|994381|P1|NOT COMPLETED|Overall Study||10
405934|NCT01684826|994381|P1|COMPLETED|Overall Study||39
405935|NCT01684826|994381|P1|Collected Dose and Image Information|Overall Study||39
405936|NCT01684826|994381|P1|STARTED|Overall Study||49
405937|NCT01684748|994389|P2|NOT COMPLETED|Second Intervention - 8 Weeks||0
405938|NCT01684748|994390|P1|NOT COMPLETED|Second Intervention - 8 Weeks||0
405939|NCT01684748|994389|P2|COMPLETED|Second Intervention - 8 Weeks||8
405940|NCT01684748|994390|P1|COMPLETED|Second Intervention - 8 Weeks||8
405941|NCT01684748|994389|P2|STARTED|Second Intervention - 8 Weeks||8
405942|NCT01684748|994390|P1|STARTED|Second Intervention - 8 Weeks||8
405943|NCT01684748|994389|P2|NOT COMPLETED|First Intervention - 8 Weeks||2
405944|NCT01684748|994390|P1|NOT COMPLETED|First Intervention - 8 Weeks||2
405945|NCT01684748|994389|P2|COMPLETED|First Intervention - 8 Weeks||8
405946|NCT01684748|994390|P1|COMPLETED|First Intervention - 8 Weeks||8
405947|NCT01684748|994389|P2|STARTED|First Intervention - 8 Weeks||10
405948|NCT01684748|994390|P1|STARTED|First Intervention - 8 Weeks||10
405949|NCT01684592|994399|P2|NOT COMPLETED|Overall Study||24
405950|NCT01684592|994400|P1|NOT COMPLETED|Overall Study||26
405951|NCT01684592|994399|P2|COMPLETED|Overall Study||40
405952|NCT01684592|994400|P1|COMPLETED|Overall Study||38
405953|NCT01684592|994399|P2|STARTED|Overall Study||64
405954|NCT01684592|994400|P1|STARTED|Overall Study||64
405955|NCT01684566|994420|P2|NOT COMPLETED|Overall Study||7
405956|NCT01684566|994421|P1|NOT COMPLETED|Overall Study||16
405957|NCT01684566|994420|P2|COMPLETED|Overall Study||49
405958|NCT01684566|994421|P1|COMPLETED|Overall Study||44
405959|NCT01684566|994420|P2|Treated (ITT)|Overall Study||52
405960|NCT01684566|994421|P1|Treated (ITT)|Overall Study||57
405961|NCT01684566|994420|P2|STARTED|Overall Study||56
405962|NCT01684566|994421|P1|STARTED|Overall Study||60
405963|NCT01684436|994443|P1|NOT COMPLETED|Overall Study||1
405964|NCT01684436|994443|P1|COMPLETED|Overall Study||29
405965|NCT01684436|994443|P1|STARTED|Overall Study||30
405966|NCT01684423|994457|P5|NOT COMPLETED|Overall Study||0
405967|NCT01684423|994458|P4|NOT COMPLETED|Overall Study||0
405968|NCT01684423|994459|P3|NOT COMPLETED|Overall Study||1
405969|NCT01684423|994460|P2|NOT COMPLETED|Overall Study||0
405970|NCT01684423|994461|P1|NOT COMPLETED|Overall Study||0
405971|NCT01684423|994457|P5|COMPLETED|Overall Study||7
405972|NCT01684423|994458|P4|COMPLETED|Overall Study||19
405973|NCT01684423|994459|P3|COMPLETED|Overall Study||12
405974|NCT01684423|994460|P2|COMPLETED|Overall Study||13
405975|NCT01684423|994461|P1|COMPLETED|Overall Study||11
405976|NCT01684423|994457|P5|STARTED|Overall Study||7
405977|NCT01684423|994458|P4|STARTED|Overall Study||19
405978|NCT01684423|994459|P3|STARTED|Overall Study||13
405979|NCT01684423|994460|P2|STARTED|Overall Study||13
405980|NCT01684423|994461|P1|STARTED|Overall Study||11
405981|NCT01684410|994498|P3|NOT COMPLETED|Overall Study||0
405982|NCT01684410|994499|P2|NOT COMPLETED|Overall Study||0
405983|NCT01684410|994500|P1|NOT COMPLETED|Overall Study||0
405984|NCT01684410|994498|P3|COMPLETED|Overall Study||10
405985|NCT01684410|994499|P2|COMPLETED|Overall Study||10
405986|NCT01684410|994500|P1|COMPLETED|Overall Study||10
405987|NCT01684410|994498|P3|STARTED|Overall Study||10
405988|NCT01684410|994499|P2|STARTED|Overall Study||10
405989|NCT01684410|994500|P1|STARTED|Overall Study||10
405990|NCT01684215|994518|P4|NOT COMPLETED|Overall Study||43
405991|NCT01684215|994519|P3|NOT COMPLETED|Overall Study||6
405992|NCT01684215|994520|P2|NOT COMPLETED|Overall Study||6
405993|NCT01684215|994521|P1|NOT COMPLETED|Overall Study||6
405994|NCT01684215|994518|P4|COMPLETED|Overall Study||0
405995|NCT01684215|994519|P3|COMPLETED|Overall Study||0
405996|NCT01684215|994520|P2|COMPLETED|Overall Study||0
405997|NCT01684215|994521|P1|COMPLETED|Overall Study||0
405998|NCT01684215|994518|P4|Treated|Overall Study||42
405999|NCT01684215|994519|P3|Treated|Overall Study||6
406000|NCT01684215|994520|P2|Treated|Overall Study||6
406001|NCT01684215|994521|P1|Treated|Overall Study||6
406002|NCT01684215|994518|P4|STARTED|Overall Study||43
406003|NCT01684215|994519|P3|STARTED|Overall Study||6
406004|NCT01684215|994520|P2|STARTED|Overall Study||6
406005|NCT01684215|994521|P1|STARTED|Overall Study||6
406006|NCT01684046|994595|P2|NOT COMPLETED|Period 2, Second 30 Days||0
406007|NCT01684046|994596|P1|NOT COMPLETED|Period 2, Second 30 Days||0
406008|NCT01684046|994595|P2|COMPLETED|Period 2, Second 30 Days||93
406009|NCT01684046|994596|P1|COMPLETED|Period 2, Second 30 Days||97
406010|NCT01684046|994595|P2|STARTED|Period 2, Second 30 Days||93
406011|NCT01684046|994596|P1|STARTED|Period 2, Second 30 Days||97
406012|NCT01684046|994595|P2|NOT COMPLETED|Period 1, First 30 Days||2
406013|NCT01684046|994596|P1|NOT COMPLETED|Period 1, First 30 Days||0
406014|NCT01684046|994595|P2|COMPLETED|Period 1, First 30 Days||93
406015|NCT01684046|994596|P1|COMPLETED|Period 1, First 30 Days||97
406016|NCT01684046|994595|P2|STARTED|Period 1, First 30 Days||95
406017|NCT01684046|994596|P1|STARTED|Period 1, First 30 Days||97
406018|NCT01684033|994602|P2|NOT COMPLETED|Period 2, Second 30 Days||0
406019|NCT01684033|994603|P1|NOT COMPLETED|Period 2, Second 30 Days||1
406020|NCT01684033|994602|P2|COMPLETED|Period 2, Second 30 Days||98
406021|NCT01684033|994603|P1|COMPLETED|Period 2, Second 30 Days||94
406022|NCT01684033|994602|P2|STARTED|Period 2, Second 30 Days||98
406023|NCT01684033|994603|P1|STARTED|Period 2, Second 30 Days||95
406024|NCT01684033|994602|P2|NOT COMPLETED|Period 1, First 30 Days||1
406025|NCT01684033|994603|P1|NOT COMPLETED|Period 1, First 30 Days||4
406026|NCT01684033|994602|P2|COMPLETED|Period 1, First 30 Days||98
406027|NCT01684033|994603|P1|COMPLETED|Period 1, First 30 Days||95
406028|NCT01684033|994602|P2|STARTED|Period 1, First 30 Days||99
406029|NCT01684033|994603|P1|STARTED|Period 1, First 30 Days||99
406030|NCT01684007|994613|P2|NOT COMPLETED|Overall Study||0
406031|NCT01684007|994614|P1|NOT COMPLETED|Overall Study||0
406032|NCT01684007|994613|P2|COMPLETED|Overall Study||50
406033|NCT01684007|994614|P1|COMPLETED|Overall Study||53
406034|NCT01684007|994613|P2|STARTED|Overall Study||50
406035|NCT01684007|994614|P1|STARTED|Overall Study||53
406036|NCT01683864|994625|P3|NOT COMPLETED|Overall Study||0
406037|NCT01683864|994626|P2|NOT COMPLETED|Overall Study||0
406038|NCT01683864|994627|P1|NOT COMPLETED|Overall Study||0
406039|NCT01683864|994625|P3|COMPLETED|Overall Study||0
406040|NCT01683864|994626|P2|COMPLETED|Overall Study||0
406041|NCT01683864|994627|P1|COMPLETED|Overall Study||0
406042|NCT01683864|994625|P3|STARTED|Overall Study||0
406043|NCT01683864|994626|P2|STARTED|Overall Study||0
406044|NCT01683864|994627|P1|STARTED|Overall Study||0
406045|NCT01683838|994637|P2|NOT COMPLETED|Overall Study||12
406046|NCT01683838|994638|P1|NOT COMPLETED|Overall Study||26
406047|NCT01683838|994637|P2|COMPLETED|Overall Study||88
406048|NCT01683838|994638|P1|COMPLETED|Overall Study||78
406049|NCT01683838|994637|P2|Efficacy Population|Overall Study||93
406050|NCT01683838|994638|P1|Efficacy Population|Overall Study||89
406051|NCT01683838|994637|P2|Safety Population|Overall Study||100
406052|NCT01683838|994638|P1|Safety Population|Overall Study||103
406053|NCT01683838|994637|P2|Intent to Treat (ITT) Population|Overall Study||100
406054|NCT01683838|994638|P1|Intent to Treat (ITT) Population|Overall Study||103
406055|NCT01683838|994637|P2|STARTED|Overall Study||100
406056|NCT01683838|994638|P1|STARTED|Overall Study||104
406057|NCT01683812|994660|P1|NOT COMPLETED|Overall Study||0
406058|NCT01683812|994660|P1|COMPLETED|Overall Study||23
406059|NCT01683812|994660|P1|STARTED|Overall Study||23
406060|NCT01683630|994667|P2|NOT COMPLETED|Overall Study||0
406061|NCT01683630|994668|P1|NOT COMPLETED|Overall Study||0
406062|NCT01683630|994667|P2|COMPLETED|Overall Study||445
406063|NCT01683630|994668|P1|COMPLETED|Overall Study||1404
406064|NCT01683630|994667|P2|STARTED|Overall Study||445
406065|NCT01683630|994668|P1|STARTED|Overall Study||1404
406066|NCT01683604|994678|P1|NOT COMPLETED|Overall Study||5
406067|NCT01683604|994678|P1|COMPLETED|Overall Study||32
406068|NCT01683604|994678|P1|STARTED|Overall Study||37
406069|NCT01683526|994843|P2|NOT COMPLETED|Overall Study||0
406070|NCT01683526|994844|P1|NOT COMPLETED|Overall Study||0
406071|NCT01683526|994843|P2|COMPLETED|Overall Study||57
406072|NCT01683526|994844|P1|COMPLETED|Overall Study||60
406073|NCT01683526|994843|P2|STARTED|Overall Study||57
406074|NCT01683526|994844|P1|STARTED|Overall Study||60
406075|NCT01683409|994863|P5|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||3
406076|NCT01683409|994864|P4|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
406077|NCT01683409|994865|P3|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||1
406078|NCT01683409|994866|P2|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
406079|NCT01683409|994867|P1|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
406080|NCT01683409|994863|P5|COMPLETED|Washout Period 2 (Weeks 29-32)||9
406081|NCT01683409|994864|P4|COMPLETED|Washout Period 2 (Weeks 29-32)||6
406082|NCT01683409|994865|P3|COMPLETED|Washout Period 2 (Weeks 29-32)||7
406083|NCT01683409|994866|P2|COMPLETED|Washout Period 2 (Weeks 29-32)||6
406084|NCT01683409|994867|P1|COMPLETED|Washout Period 2 (Weeks 29-32)||6
406085|NCT01683409|994863|P5|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 8 participants.|12
406086|NCT01683409|994864|P4|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 16 participants.|6
406087|NCT01683409|994865|P3|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 17 participants.|8
406088|NCT01683409|994866|P2|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 11 participants.|6
406089|NCT01683409|994867|P1|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 18 participants.|6
406090|NCT01683409|994863|P5|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||3
406091|NCT01683409|994864|P4|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||2
406092|NCT01683409|994865|P3|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||1
406093|NCT01683409|994866|P2|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||4
406094|NCT01683409|994867|P1|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||3
406095|NCT01683409|994863|P5|COMPLETED|Washout Period 1 (Weeks 25-28)||20
406096|NCT01683409|994864|P4|COMPLETED|Washout Period 1 (Weeks 25-28)||22
406097|NCT01683409|994865|P3|COMPLETED|Washout Period 1 (Weeks 25-28)||25
406098|NCT01683409|994866|P2|COMPLETED|Washout Period 1 (Weeks 25-28)||17
406099|NCT01683409|994867|P1|COMPLETED|Washout Period 1 (Weeks 25-28)||24
406100|NCT01683409|994863|P5|STARTED|Washout Period 1 (Weeks 25-28)||23
406101|NCT01683409|994864|P4|STARTED|Washout Period 1 (Weeks 25-28)||24
406102|NCT01683409|994865|P3|STARTED|Washout Period 1 (Weeks 25-28)||26
406103|NCT01683409|994866|P2|STARTED|Washout Period 1 (Weeks 25-28)||21
406104|NCT01683409|994867|P1|STARTED|Washout Period 1 (Weeks 25-28)||27
406105|NCT01683409|994863|P5|NOT COMPLETED|Treatment Period (Weeks 1-24)||2
406106|NCT01683409|994864|P4|NOT COMPLETED|Treatment Period (Weeks 1-24)||2
406107|NCT01683409|994865|P3|NOT COMPLETED|Treatment Period (Weeks 1-24)||1
406108|NCT01683409|994866|P2|NOT COMPLETED|Treatment Period (Weeks 1-24)||4
406109|NCT01683409|994867|P1|NOT COMPLETED|Treatment Period (Weeks 1-24)||0
406110|NCT01683409|994863|P5|COMPLETED|Treatment Period (Weeks 1-24)||23
406111|NCT01683409|994864|P4|COMPLETED|Treatment Period (Weeks 1-24)||24
406112|NCT01683409|994865|P3|COMPLETED|Treatment Period (Weeks 1-24)||26
406113|NCT01683409|994866|P2|COMPLETED|Treatment Period (Weeks 1-24)||21
406114|NCT01683409|994867|P1|COMPLETED|Treatment Period (Weeks 1-24)||27
406115|NCT01683409|994863|P5|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||25
406116|NCT01683409|994864|P4|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||26
406117|NCT01683409|994865|P3|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||26
406118|NCT01683409|994866|P2|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||25
406119|NCT01683409|994867|P1|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||27
406120|NCT01683409|994863|P5|STARTED|Treatment Period (Weeks 1-24)||25
406121|NCT01683409|994864|P4|STARTED|Treatment Period (Weeks 1-24)||26
406122|NCT01683409|994865|P3|STARTED|Treatment Period (Weeks 1-24)||27
406123|NCT01683409|994866|P2|STARTED|Treatment Period (Weeks 1-24)||25
406124|NCT01683409|994867|P1|STARTED|Treatment Period (Weeks 1-24)||27
406125|NCT01683383|994910|P2|NOT COMPLETED|Overall Study||0
406126|NCT01683383|994911|P1|NOT COMPLETED|Overall Study||1
406127|NCT01683383|994910|P2|COMPLETED|Overall Study||51
406128|NCT01683383|994911|P1|COMPLETED|Overall Study||49
406129|NCT01683383|994910|P2|Transported and Treated|Overall Study||51
406130|NCT01683383|994911|P1|Transported and Treated|Overall Study||49
406131|NCT01683383|994910|P2|STARTED|Overall Study||51
406132|NCT01683383|994911|P1|STARTED|Overall Study||50
406133|NCT01683266|994927|P2|NOT COMPLETED|Overall Study||50
406134|NCT01683266|994928|P1|NOT COMPLETED|Overall Study||55
406135|NCT01683266|994927|P2|COMPLETED|Overall Study||225
406136|NCT01683266|994928|P1|COMPLETED|Overall Study||219
406137|NCT01683266|994927|P2|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|273
406138|NCT01683266|994928|P1|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|273
406139|NCT01683266|994927|P2|STARTED|Overall Study||275
406140|NCT01683266|994928|P1|STARTED|Overall Study||274
406141|NCT01683058|994956|P1|NOT COMPLETED|Overall Study||29
406142|NCT01683058|994956|P1|COMPLETED|Overall Study||45
406143|NCT01683058|994956|P1|STARTED|Overall Study||74
406144|NCT01683019|994987|P3|NOT COMPLETED|Overall Study||4
406145|NCT01683019|994988|P2|NOT COMPLETED|Overall Study||1
406146|NCT01683019|994989|P1|NOT COMPLETED|Overall Study||2
406147|NCT01683019|994987|P3|COMPLETED|Overall Study||15
406148|NCT01683019|994988|P2|COMPLETED|Overall Study||14
406149|NCT01683019|994989|P1|COMPLETED|Overall Study||16
406150|NCT01683019|994987|P3|STARTED|Overall Study||19
406151|NCT01683019|994988|P2|STARTED|Overall Study||15
406152|NCT01683019|994989|P1|STARTED|Overall Study||18
406153|NCT01682954|994999|P2|NOT COMPLETED|Overall Study||5
406154|NCT01682954|995000|P1|NOT COMPLETED|Overall Study||5
406155|NCT01682954|994999|P2|COMPLETED|Overall Study||33
406156|NCT01682954|995000|P1|COMPLETED|Overall Study||35
406157|NCT01682954|994999|P2|STARTED|Overall Study||38
406158|NCT01682954|995000|P1|STARTED|Overall Study||40
406159|NCT01682876|995012|P4|NOT COMPLETED|Overall Study||19
406160|NCT01682876|995013|P3|NOT COMPLETED|Overall Study||11
406161|NCT01682876|995014|P2|NOT COMPLETED|Overall Study||20
406162|NCT01682876|995015|P1|NOT COMPLETED|Overall Study||21
406163|NCT01682876|995012|P4|COMPLETED|Overall Study||157
406164|NCT01682876|995013|P3|COMPLETED|Overall Study||169
406165|NCT01682876|995014|P2|COMPLETED|Overall Study||163
406166|NCT01682876|995015|P1|COMPLETED|Overall Study||155
406167|NCT01682876|995012|P4|STARTED|Overall Study||176
406168|NCT01682876|995013|P3|STARTED|Overall Study||180
406169|NCT01682876|995014|P2|STARTED|Overall Study||183
406170|NCT01682876|995015|P1|STARTED|Overall Study||176
406171|NCT01682863|995061|P3|NOT COMPLETED|Overall Study||24
406172|NCT01682863|995062|P2|NOT COMPLETED|Overall Study||17
406173|NCT01682863|995063|P1|NOT COMPLETED|Overall Study||27
406174|NCT01682863|995061|P3|COMPLETED|Overall Study||183
406175|NCT01682863|995062|P2|COMPLETED|Overall Study||187
406176|NCT01682863|995063|P1|COMPLETED|Overall Study||177
406177|NCT01682863|995061|P3|Randomized Set|Overall Study|1 randomized patient was not treated; experienced an AE prior to receiving any study drug|207
406178|NCT01682863|995062|P2|Randomized Set|Overall Study||204
406179|NCT01682863|995063|P1|Randomized Set|Overall Study||204
406180|NCT01682863|995061|P3|Full Analysis Set (FAS)|Overall Study||206
406181|NCT01682863|995062|P2|Full Analysis Set (FAS)|Overall Study||204
406182|NCT01682863|995063|P1|Full Analysis Set (FAS)|Overall Study|included all randomized patients who received at least one dose of study medication|204
406183|NCT01682863|995061|P3|Safety Set|Overall Study||206
406184|NCT01682863|995062|P2|Safety Set|Overall Study||204
406185|NCT01682863|995063|P1|Safety Set|Overall Study||204
406186|NCT01682863|995061|P3|STARTED|Overall Study||207
406187|NCT01682863|995062|P2|STARTED|Overall Study||204
406188|NCT01682863|995063|P1|STARTED|Overall Study||204
406189|NCT01682837|995092|P1|NOT COMPLETED|Fourth Intervention (4 Weeks)||0
406190|NCT01682837|995092|P1|COMPLETED|Fourth Intervention (4 Weeks)||30
406191|NCT01682837|995092|P1|Received Placebo|Fourth Intervention (4 Weeks)||7
406192|NCT01682837|995092|P1|Received KCl|Fourth Intervention (4 Weeks)||8
406193|NCT01682837|995092|P1|Received KCit|Fourth Intervention (4 Weeks)||9
406194|NCT01682837|995092|P1|Received KMgCit|Fourth Intervention (4 Weeks)||6
406195|NCT01682837|995092|P1|STARTED|Fourth Intervention (4 Weeks)||30
406196|NCT01682837|995092|P1|NOT COMPLETED|Third Intervention (4 Weeks)||0
406197|NCT01682837|995092|P1|COMPLETED|Third Intervention (4 Weeks)||30
406198|NCT01682837|995092|P1|Received Placebo|Third Intervention (4 Weeks)||7
406199|NCT01682837|995092|P1|Received KCl|Third Intervention (4 Weeks)||7
406200|NCT01682837|995092|P1|Received KCit|Third Intervention (4 Weeks)||7
406201|NCT01682837|995092|P1|Received KMgCit|Third Intervention (4 Weeks)||9
406202|NCT01682837|995092|P1|STARTED|Third Intervention (4 Weeks)||30
406203|NCT01682837|995092|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
406204|NCT01682837|995092|P1|COMPLETED|Second Intervention (4 Weeks)||30
406205|NCT01682837|995092|P1|Received Placebo|Second Intervention (4 Weeks)||9
406206|NCT01682837|995092|P1|Received KCl|Second Intervention (4 Weeks)||8
406207|NCT01682837|995092|P1|Received KCit|Second Intervention (4 Weeks)||6
406208|NCT01682837|995092|P1|Received KMgCit|Second Intervention (4 Weeks)||7
406209|NCT01682837|995092|P1|STARTED|Second Intervention (4 Weeks)||30
406210|NCT01682837|995092|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
406211|NCT01682837|995092|P1|COMPLETED|First Intervention (4 Weeks)||30
406212|NCT01682837|995092|P1|Received Placebo|First Intervention (4 Weeks)||7
406213|NCT01682837|995092|P1|Received KCl|First Intervention (4 Weeks)||7
406214|NCT01682837|995092|P1|Received KCit|First Intervention (4 Weeks)||8
406215|NCT01682837|995092|P1|Received KMgCit|First Intervention (4 Weeks)||8
406216|NCT01682837|995092|P1|STARTED|First Intervention (4 Weeks)||30
406217|NCT01682837|995092|P1|NOT COMPLETED|Baseline||5
406218|NCT01682837|995092|P1|COMPLETED|Baseline||30
406219|NCT01682837|995092|P1|STARTED|Baseline||35
406220|NCT01682759|995136|P2|NOT COMPLETED|Overall Study||70
406221|NCT01682759|995137|P1|NOT COMPLETED|Overall Study||69
406222|NCT01682759|995136|P2|COMPLETED|Overall Study||305
406223|NCT01682759|995137|P1|COMPLETED|Overall Study||307
406224|NCT01682759|995136|P2|Treated|Overall Study||375
406225|NCT01682759|995137|P1|Treated|Overall Study||375
406226|NCT01682759|995136|P2|STARTED|Overall Study||375
406227|NCT01682759|995137|P1|STARTED|Overall Study||376
406228|NCT01682720|995161|P4|NOT COMPLETED|Overall Study||39
406229|NCT01682720|995162|P3|NOT COMPLETED|Overall Study||7
406230|NCT01682720|995163|P2|NOT COMPLETED|Overall Study||5
406231|NCT01682720|995164|P1|NOT COMPLETED|Overall Study||85
406232|NCT01682720|995161|P4|COMPLETED|Overall Study||211
406233|NCT01682720|995162|P3|COMPLETED|Overall Study||5
406234|NCT01682720|995163|P2|COMPLETED|Overall Study||69
406235|NCT01682720|995164|P1|COMPLETED|Overall Study||0
406236|NCT01682720|995161|P4|Included in Full Analysis Set|Overall Study||250
406237|NCT01682720|995162|P3|Included in Full Analysis Set|Overall Study||11
406238|NCT01682720|995163|P2|Included in Full Analysis Set|Overall Study||73
406239|NCT01682720|995164|P1|Included in Full Analysis Set|Overall Study||0
406240|NCT01682720|995161|P4|STARTED|Overall Study||250
406241|NCT01682720|995162|P3|STARTED|Overall Study||12
406242|NCT01682720|995163|P2|STARTED|Overall Study||74
406243|NCT01682720|995164|P1|STARTED|Overall Study||85
406244|NCT01682681|995181|P1|NOT COMPLETED|Overall Study||332
406245|NCT01682681|995181|P1|COMPLETED|Overall Study||902
406246|NCT01682681|995181|P1|Treated|Overall Study|2 Participants were not compliant with eligibility criteria|1232
406247|NCT01682681|995181|P1|STARTED|Overall Study||1234
406248|NCT01682642|995191|P2|NOT COMPLETED|Overall Study||1
406249|NCT01682642|995192|P1|NOT COMPLETED|Overall Study||0
406250|NCT01682642|995191|P2|COMPLETED|Overall Study||58
406251|NCT01682642|995192|P1|COMPLETED|Overall Study||61
406252|NCT01682642|995191|P2|STARTED|Overall Study||59
406253|NCT01682642|995192|P1|STARTED|Overall Study||61
406254|NCT01682603|995210|P1|NOT COMPLETED|Overall Study||3
406255|NCT01682603|995210|P1|COMPLETED|Overall Study||34
406256|NCT01682603|995210|P1|STARTED|Overall Study||37
406257|NCT01682538|995224|P1|NOT COMPLETED|Overall Study||0
406258|NCT01682538|995224|P1|COMPLETED|Overall Study||12
406259|NCT01682538|995224|P1|STARTED|Overall Study||12
406260|NCT01682512|995255|P3|NOT COMPLETED|Overall Study||18
406261|NCT01682512|995256|P2|NOT COMPLETED|Overall Study||71
406262|NCT01682512|995257|P1|NOT COMPLETED|Overall Study||72
406263|NCT01682512|995255|P3|COMPLETED|Overall Study||48
406264|NCT01682512|995256|P2|COMPLETED|Overall Study||40
406265|NCT01682512|995257|P1|COMPLETED|Overall Study||44
406266|NCT01682512|995255|P3|Randomized in Part-II|Overall Study||0
406267|NCT01682512|995256|P2|Randomized in Part-II|Overall Study||46
406268|NCT01682512|995257|P1|Randomized in Part-II|Overall Study||50
406269|NCT01682512|995255|P3|Randomized in Part-I|Overall Study||66
406270|NCT01682512|995256|P2|Randomized in Part-I|Overall Study||65
406271|NCT01682512|995257|P1|Randomized in Part-I|Overall Study||66
406272|NCT01682512|995255|P3|STARTED|Overall Study||66
406273|NCT01682512|995256|P2|STARTED|Overall Study||111
406274|NCT01682512|995257|P1|STARTED|Overall Study||116
406275|NCT01682460|995282|P1|NOT COMPLETED|Overall Study||4
406276|NCT01682460|995282|P1|COMPLETED|Overall Study||11
406277|NCT01682460|995282|P1|STARTED|Overall Study||15
406278|NCT01682135|995300|P3|NOT COMPLETED|Overall Study||0
406279|NCT01682135|995301|P2|NOT COMPLETED|Overall Study||0
406280|NCT01682135|995302|P1|NOT COMPLETED|Overall Study||0
406281|NCT01682135|995300|P3|COMPLETED|Overall Study||12
406282|NCT01682135|995301|P2|COMPLETED|Overall Study||10
406283|NCT01682135|995302|P1|COMPLETED|Overall Study||6
406284|NCT01682135|995300|P3|Received at Least 1 Dose of Study Drug|Overall Study||12
406285|NCT01682135|995301|P2|Received at Least 1 Dose of Study Drug|Overall Study||10
406372|NCT01681277|995467|P1|COMPLETED|Overall Study||11
406286|NCT01682135|995302|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
406287|NCT01682135|995300|P3|STARTED|Overall Study||12
406288|NCT01682135|995301|P2|STARTED|Overall Study||10
406289|NCT01682135|995302|P1|STARTED|Overall Study||6
406290|NCT01682044|995334|P1|NOT COMPLETED|Overall Study||4
406291|NCT01682044|995334|P1|COMPLETED|Overall Study||16
406292|NCT01682044|995334|P1|STARTED|Overall Study||20
406293|NCT01682031|995346|P2|NOT COMPLETED|Overall Study||5
406294|NCT01682031|995347|P1|NOT COMPLETED|Overall Study||1
406295|NCT01682031|995346|P2|COMPLETED|Overall Study||5
406296|NCT01682031|995347|P1|COMPLETED|Overall Study||7
406297|NCT01682031|995346|P2|STARTED|Overall Study||10
406298|NCT01682031|995347|P1|STARTED|Overall Study||8
406299|NCT01681849|995370|P3|NOT COMPLETED|Overall Study||39
406300|NCT01681849|995371|P2|NOT COMPLETED|Overall Study||7
406301|NCT01681849|995372|P1|NOT COMPLETED|Overall Study||8
406302|NCT01681849|995370|P3|COMPLETED|Overall Study||17
406303|NCT01681849|995371|P2|COMPLETED|Overall Study||6
406304|NCT01681849|995372|P1|COMPLETED|Overall Study||7
406305|NCT01681849|995370|P3|STARTED|Overall Study||56
406306|NCT01681849|995371|P2|STARTED|Overall Study||13
406307|NCT01681849|995372|P1|STARTED|Overall Study||15
406308|NCT01681628|995383|P2|NOT COMPLETED|19 Months Follow-up||43
406309|NCT01681628|995384|P1|NOT COMPLETED|19 Months Follow-up||62
406310|NCT01681628|995383|P2|COMPLETED|19 Months Follow-up||64
406311|NCT01681628|995384|P1|COMPLETED|19 Months Follow-up||52
406312|NCT01681628|995383|P2|STARTED|19 Months Follow-up||107
406313|NCT01681628|995384|P1|STARTED|19 Months Follow-up||114
406314|NCT01681628|995383|P2|NOT COMPLETED|Time 2 to Time 3 (One Week Later).||15
406315|NCT01681628|995384|P1|NOT COMPLETED|Time 2 to Time 3 (One Week Later).||0
406316|NCT01681628|995383|P2|COMPLETED|Time 2 to Time 3 (One Week Later).||107
406317|NCT01681628|995384|P1|COMPLETED|Time 2 to Time 3 (One Week Later).|Only wait list group studied in this period.|0
406318|NCT01681628|995383|P2|STARTED|Time 2 to Time 3 (One Week Later).||122
406319|NCT01681628|995384|P1|STARTED|Time 2 to Time 3 (One Week Later).|Only wait list group studied in this period.|0
406320|NCT01681628|995383|P2|NOT COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||6
406321|NCT01681628|995384|P1|NOT COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||14
406322|NCT01681628|995383|P2|COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||122
406323|NCT01681628|995384|P1|COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||114
406324|NCT01681628|995383|P2|STARTED|Time 1 (Entry) to Time 2 One Week Later.||128
406325|NCT01681628|995384|P1|STARTED|Time 1 (Entry) to Time 2 One Week Later.||128
406326|NCT01681576|995397|P2|NOT COMPLETED|Period 2||1
406327|NCT01681576|995398|P1|NOT COMPLETED|Period 2||4
406328|NCT01681576|995397|P2|COMPLETED|Period 2||35
406329|NCT01681576|995398|P1|COMPLETED|Period 2||30
406330|NCT01681576|995397|P2|STARTED|Period 2|Period 2: LCZ696 400mg|36
406331|NCT01681576|995398|P1|STARTED|Period 2|Period 2: Valsartan 320mg|34
406332|NCT01681576|995397|P2|NOT COMPLETED|Period 1||0
406333|NCT01681576|995398|P1|NOT COMPLETED|Period 1||2
406334|NCT01681576|995397|P2|COMPLETED|Period 1||36
406335|NCT01681576|995398|P1|COMPLETED|Period 1||34
406336|NCT01681576|995397|P2|STARTED|Period 1||36
406337|NCT01681576|995398|P1|STARTED|Period 1||36
406338|NCT01681511|995414|P2|NOT COMPLETED|Overall Study||14
406339|NCT01681511|995415|P1|NOT COMPLETED|Overall Study||18
406340|NCT01681511|995414|P2|COMPLETED|Overall Study||35
406341|NCT01681511|995415|P1|COMPLETED|Overall Study||28
406342|NCT01681511|995414|P2|Evaluable Population|Overall Study|Subjects w/ positive urine culture results also removed from the TIC arm of this population.|14
406343|NCT01681511|995415|P1|Evaluable Population|Overall Study|Subjects w/ positive urine culture results also removed from the Lubri-Sil arm of this population.|16
406344|NCT01681511|995414|P2|Intent to Treat (ITT) Population|Overall Study|Any subject receiving the TIC treatment after randomization.|46
406345|NCT01681511|995415|P1|Intent to Treat (ITT) Population|Overall Study|Any subject receiving the Lubri-Sil treatment after randomization.|45
406346|NCT01681511|995414|P2|STARTED|Overall Study|All randomized subjects in the TIC arm.|49
406347|NCT01681511|995415|P1|STARTED|Overall Study|All randomized subjects in the Lubri-Sil arm.|46
406348|NCT01681472|995433|P4|NOT COMPLETED|Overall Study||0
406349|NCT01681472|995434|P3|NOT COMPLETED|Overall Study||0
406350|NCT01681472|995435|P2|NOT COMPLETED|Overall Study||1
406351|NCT01681472|995436|P1|NOT COMPLETED|Overall Study||0
406352|NCT01681472|995433|P4|COMPLETED|Overall Study||8
406353|NCT01681472|995434|P3|COMPLETED|Overall Study||8
406354|NCT01681472|995435|P2|COMPLETED|Overall Study||7
406355|NCT01681472|995436|P1|COMPLETED|Overall Study||8
406356|NCT01681472|995433|P4|STARTED|Overall Study||8
406357|NCT01681472|995434|P3|STARTED|Overall Study||8
406358|NCT01681472|995435|P2|STARTED|Overall Study||8
406359|NCT01681472|995436|P1|STARTED|Overall Study||8
406360|NCT01681368|995446|P1|NOT COMPLETED|Overall Study||2
406361|NCT01681368|995446|P1|COMPLETED|Overall Study||9
406362|NCT01681368|995446|P1|STARTED|Overall Study||11
406363|NCT01681277|995463|P5|NOT COMPLETED|Overall Study||0
406364|NCT01681277|995464|P4|NOT COMPLETED|Overall Study||0
406365|NCT01681277|995465|P3|NOT COMPLETED|Overall Study||0
406366|NCT01681277|995466|P2|NOT COMPLETED|Overall Study||0
406367|NCT01681277|995467|P1|NOT COMPLETED|Overall Study||1
406368|NCT01681277|995463|P5|COMPLETED|Overall Study||9
406369|NCT01681277|995464|P4|COMPLETED|Overall Study||9
406370|NCT01681277|995465|P3|COMPLETED|Overall Study||9
406371|NCT01681277|995466|P2|COMPLETED|Overall Study||9
406373|NCT01681277|995463|P5|STARTED|Overall Study||9
406374|NCT01681277|995464|P4|STARTED|Overall Study||9
406375|NCT01681277|995465|P3|STARTED|Overall Study||9
406376|NCT01681277|995466|P2|STARTED|Overall Study||9
406377|NCT01681277|995467|P1|STARTED|Overall Study||12
406378|NCT01681212|995508|P1|NOT COMPLETED|Overall Study||6
406379|NCT01681212|995508|P1|COMPLETED|Overall Study|Completed=patients who received treatment; not completed=patients who did not receive treatment|15
406380|NCT01681212|995508|P1|Received Treatment|Overall Study||15
406381|NCT01681212|995508|P1|STARTED|Overall Study|Enrolled|21
406382|NCT01681121|995516|P2|NOT COMPLETED|Overall Study||11
406383|NCT01681121|995517|P1|NOT COMPLETED|Overall Study||8
406384|NCT01681121|995516|P2|COMPLETED|Overall Study||38
406385|NCT01681121|995517|P1|COMPLETED|Overall Study||36
406386|NCT01681121|995516|P2|STARTED|Overall Study||49
406387|NCT01681121|995517|P1|STARTED|Overall Study||44
406388|NCT01681095|995525|P2|NOT COMPLETED|Overall Study||0
406389|NCT01681095|995526|P1|NOT COMPLETED|Overall Study||0
406390|NCT01681095|995525|P2|COMPLETED|Overall Study||55
406391|NCT01681095|995526|P1|COMPLETED|Overall Study||55
406392|NCT01681095|995525|P2|STARTED|Overall Study||55
406393|NCT01681095|995526|P1|STARTED|Overall Study||55
406394|NCT01681069|995566|P2|NOT COMPLETED|Overall Study||7
406395|NCT01681069|995567|P1|NOT COMPLETED|Overall Study||5
406396|NCT01681069|995566|P2|COMPLETED|Overall Study|Valid Case Analysis Set (VAS)|53
406397|NCT01681069|995567|P1|COMPLETED|Overall Study|Valid Case Analysis Set (VAS)|55
406398|NCT01681069|995566|P2|Full Analysis Set (FAS)|Overall Study||60
406399|NCT01681069|995567|P1|Full Analysis Set (FAS)|Overall Study||57
406400|NCT01681069|995566|P2|STARTED|Overall Study||60
406401|NCT01681069|995567|P1|STARTED|Overall Study||60
406402|NCT01681030|995580|P3|NOT COMPLETED|Overall Study||0
406403|NCT01681030|995581|P2|NOT COMPLETED|Overall Study||0
406404|NCT01681030|995582|P1|NOT COMPLETED|Overall Study||0
406405|NCT01681030|995580|P3|COMPLETED|Overall Study||11
406406|NCT01681030|995581|P2|COMPLETED|Overall Study||18
406407|NCT01681030|995582|P1|COMPLETED|Overall Study||13
406408|NCT01681030|995580|P3|STARTED|Overall Study||11
406409|NCT01681030|995581|P2|STARTED|Overall Study||18
406410|NCT01681030|995582|P1|STARTED|Overall Study||13
406411|NCT01681004|995604|P2|NOT COMPLETED|Study Completion||8
406412|NCT01681004|995605|P1|NOT COMPLETED|Study Completion||12
406413|NCT01681004|995604|P2|COMPLETED|Study Completion||36
406414|NCT01681004|995605|P1|COMPLETED|Study Completion||89
406415|NCT01681004|995604|P2|STARTED|Study Completion||44
406416|NCT01681004|995605|P1|STARTED|Study Completion||101
406417|NCT01681004|995604|P2|NOT COMPLETED|Primary Endpoint: 6 Months||2
406418|NCT01681004|995605|P1|NOT COMPLETED|Primary Endpoint: 6 Months||1
406419|NCT01681004|995604|P2|COMPLETED|Primary Endpoint: 6 Months||44
406420|NCT01681004|995605|P1|COMPLETED|Primary Endpoint: 6 Months||101
406421|NCT01681004|995604|P2|Crossover to Surgical Treatment|Primary Endpoint: 6 Months|Crossover to surgical treatment allowed per study protocol after the 6-month visit was complete.|39
406422|NCT01681004|995605|P1|Crossover to Surgical Treatment|Primary Endpoint: 6 Months||0
406423|NCT01681004|995604|P2|STARTED|Primary Endpoint: 6 Months||46
406424|NCT01681004|995605|P1|STARTED|Primary Endpoint: 6 Months||102
406425|NCT01680991|995662|P3|NOT COMPLETED|Overall Study||4
406426|NCT01680991|995663|P2|NOT COMPLETED|Overall Study||19
406427|NCT01680991|995664|P1|NOT COMPLETED|Overall Study||8
406428|NCT01680991|995662|P3|COMPLETED|Overall Study||9
406429|NCT01680991|995663|P2|COMPLETED|Overall Study||4
406430|NCT01680991|995664|P1|COMPLETED|Overall Study||4
406431|NCT01680991|995662|P3|STARTED|Overall Study||13
406432|NCT01680991|995663|P2|STARTED|Overall Study||23
406433|NCT01680991|995664|P1|STARTED|Overall Study||12
406434|NCT01680900|995725|P2|NOT COMPLETED|Overall Study||1
406435|NCT01680900|995726|P1|NOT COMPLETED|Overall Study||4
406436|NCT01680900|995725|P2|COMPLETED|Overall Study||11
406437|NCT01680900|995726|P1|COMPLETED|Overall Study||20
406438|NCT01680900|995725|P2|STARTED|Overall Study||12
406439|NCT01680900|995726|P1|STARTED|Overall Study||24
406440|NCT01680861|995744|P2|NOT COMPLETED|First 12 Months Post-transplant||0
406441|NCT01680861|995745|P1|NOT COMPLETED|First 12 Months Post-transplant||0
406442|NCT01680861|995744|P2|COMPLETED|First 12 Months Post-transplant||15
406443|NCT01680861|995745|P1|COMPLETED|First 12 Months Post-transplant||15
406444|NCT01680861|995744|P2|STARTED|First 12 Months Post-transplant||15
406445|NCT01680861|995745|P1|STARTED|First 12 Months Post-transplant||15
406446|NCT01680861|995744|P2|NOT COMPLETED|Early Post-transplant Period||1
406447|NCT01680861|995745|P1|NOT COMPLETED|Early Post-transplant Period||1
406448|NCT01680861|995744|P2|COMPLETED|Early Post-transplant Period||15
406449|NCT01680861|995745|P1|COMPLETED|Early Post-transplant Period||15
406450|NCT01680861|995744|P2|STARTED|Early Post-transplant Period|One patient developed immediate DGF (delayed graft function) and was therefore ineligible.|16
406451|NCT01680861|995745|P1|STARTED|Early Post-transplant Period|One patient didn't produce sufficient urine during first 24hr post-transplant (ineligible).|16
406452|NCT01680848|995763|P1|NOT COMPLETED|Overall Study||93
406453|NCT01680848|995763|P1|COMPLETED|Overall Study||189
406454|NCT01680848|995763|P1|STARTED|Overall Study||282
406461|NCT01680666|995778|P2|NOT COMPLETED|Overall Study||0
406462|NCT01680666|995779|P1|NOT COMPLETED|Overall Study||0
406463|NCT01680666|995778|P2|COMPLETED|Overall Study||66
406464|NCT01680666|995779|P1|COMPLETED|Overall Study||84
406465|NCT01680666|995778|P2|STARTED|Overall Study||66
406466|NCT01680666|995779|P1|STARTED|Overall Study||84
406467|NCT01680653|995793|P1|NOT COMPLETED|Overall Study||0
406468|NCT01680653|995793|P1|COMPLETED|Overall Study||57
406469|NCT01680653|995793|P1|STARTED|Overall Study||57
406470|NCT01680549|995805|P2|NOT COMPLETED|Overall Study||8
406471|NCT01680549|995806|P1|NOT COMPLETED|Overall Study||5
406472|NCT01680549|995805|P2|COMPLETED|Overall Study||17
406473|NCT01680549|995806|P1|COMPLETED|Overall Study||20
406474|NCT01680549|995805|P2|STARTED|Overall Study||25
406475|NCT01680549|995806|P1|STARTED|Overall Study||25
406476|NCT01680497|995818|P1|NOT COMPLETED|Overall Study||2
406477|NCT01680497|995818|P1|COMPLETED|Overall Study||68
406478|NCT01680497|995818|P1|STARTED|Overall Study||70
406479|NCT01680458|995828|P1|NOT COMPLETED|Overall Study||3
406480|NCT01680458|995828|P1|COMPLETED|Overall Study||27
406481|NCT01680458|995828|P1|STARTED|Overall Study||30
406482|NCT01680341|995839|P2|NOT COMPLETED|Overall Study||17
406483|NCT01680341|995840|P1|NOT COMPLETED|Overall Study||21
406484|NCT01680341|995839|P2|COMPLETED|Overall Study||119
406485|NCT01680341|995840|P1|COMPLETED|Overall Study||115
406486|NCT01680341|995839|P2|Exposed|Overall Study|Two (2) subjects withdrew consent prior to exposure to trial product.|134
406487|NCT01680341|995840|P1|Exposed|Overall Study|One (1) subject withdrew consent prior to exposure to trial product.|135
406488|NCT01680341|995839|P2|STARTED|Overall Study||136
406489|NCT01680341|995840|P1|STARTED|Overall Study||136
406490|NCT01680328|995860|P1|NOT COMPLETED|Overall Study||2
406491|NCT01680328|995860|P1|COMPLETED|Overall Study||80
406492|NCT01680328|995860|P1|Subjects Missing Injections|Overall Study|One missed the [1600 μL, 450 μL/s; thighs]; one missed the [400 μL, 300 μL/s; abdomen]|2
406493|NCT01680328|995860|P1|STARTED|Overall Study||82
406494|NCT01680172|995898|P2|NOT COMPLETED|Overall Study||0
406495|NCT01680172|995899|P1|NOT COMPLETED|Overall Study||0
406496|NCT01680172|995898|P2|COMPLETED|Overall Study||2
406497|NCT01680172|995899|P1|COMPLETED|Overall Study||3
406498|NCT01680172|995898|P2|STARTED|Overall Study||2
406499|NCT01680172|995899|P1|STARTED|Overall Study||3
406500|NCT01680159|995911|P1|NOT COMPLETED|Increased Dose Period||8
406501|NCT01680159|995911|P1|COMPLETED|Increased Dose Period||43
406502|NCT01680159|995911|P1|STARTED|Increased Dose Period||51
406503|NCT01680159|995911|P1|NOT COMPLETED|Screening Period||7
406504|NCT01680159|995911|P1|COMPLETED|Screening Period||39
406505|NCT01680159|995911|P1|STARTED|Screening Period||46
406506|NCT01680016|995938|P4|NOT COMPLETED|Overall Study||5
406507|NCT01680016|995939|P3|NOT COMPLETED|Overall Study||5
406508|NCT01680016|995940|P2|NOT COMPLETED|Overall Study||8
406509|NCT01680016|995941|P1|NOT COMPLETED|Overall Study||6
406510|NCT01680016|995938|P4|COMPLETED|Overall Study||195
406511|NCT01680016|995939|P3|COMPLETED|Overall Study||196
406512|NCT01680016|995940|P2|COMPLETED|Overall Study||114
406513|NCT01680016|995941|P1|COMPLETED|Overall Study||115
406514|NCT01680016|995938|P4|STARTED|Overall Study||200
406515|NCT01680016|995939|P3|STARTED|Overall Study||201
406516|NCT01680016|995940|P2|STARTED|Overall Study||122
406517|NCT01680016|995941|P1|STARTED|Overall Study||121
406518|NCT01679613|996003|P4|NOT COMPLETED|Overall Study||2
406519|NCT01679613|996004|P3|NOT COMPLETED|Overall Study||2
406520|NCT01679613|996005|P2|NOT COMPLETED|Overall Study||1
406521|NCT01679613|996006|P1|NOT COMPLETED|Overall Study||0
406522|NCT01679613|996003|P4|COMPLETED|Overall Study||11
406523|NCT01679613|996004|P3|COMPLETED|Overall Study||11
406524|NCT01679613|996005|P2|COMPLETED|Overall Study||3
406525|NCT01679613|996006|P1|COMPLETED|Overall Study||4
406526|NCT01679613|996003|P4|Received Nintedanib+Ketoconazole (Main)|Overall Study|Two subjects received only ketoconazole not nintedanib|13
406527|NCT01679613|996004|P3|Received Nintedanib+Ketoconazole (Main)|Overall Study|Two subjects received only ketoconazole not nintedanib|13
406528|NCT01679613|996005|P2|Received Nintedanib+Ketoconazole (Main)|Overall Study||0
406529|NCT01679613|996006|P1|Received Nintedanib+Ketoconazole (Main)|Overall Study||0
406530|NCT01679613|996003|P4|Received Nintedanib (Main)|Overall Study||11
406531|NCT01679613|996004|P3|Received Nintedanib (Main)|Overall Study||13
406532|NCT01679613|996005|P2|Received Nintedanib (Main)|Overall Study||0
406533|NCT01679613|996006|P1|Received Nintedanib (Main)|Overall Study||0
406534|NCT01679613|996003|P4|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0
406535|NCT01679613|996004|P3|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0
406536|NCT01679613|996005|P2|Received Nintedanib+Ketoconazole (Pilot)|Overall Study|One subject received only ketoconazole not nintedanib|4
406537|NCT01679613|996006|P1|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||4
406538|NCT01679613|996003|P4|Received Nintedanib (Pilot)|Overall Study||0
406539|NCT01679613|996004|P3|Received Nintedanib (Pilot)|Overall Study||0
406540|NCT01679613|996005|P2|Received Nintedanib (Pilot)|Overall Study||3
406541|NCT01679613|996006|P1|Received Nintedanib (Pilot)|Overall Study||4
406542|NCT01679613|996003|P4|STARTED|Overall Study||13
406543|NCT01679613|996004|P3|STARTED|Overall Study||13
406544|NCT01679613|996005|P2|STARTED|Overall Study||4
406545|NCT01679613|996006|P1|STARTED|Overall Study||4
406546|NCT01679600|996019|P2|NOT COMPLETED|Overall Study||0
406547|NCT01679600|996020|P1|NOT COMPLETED|Overall Study||0
406548|NCT01679600|996019|P2|COMPLETED|Overall Study||7
406549|NCT01679600|996020|P1|COMPLETED|Overall Study||7
406550|NCT01679600|996019|P2|STARTED|Overall Study||7
406551|NCT01679600|996020|P1|STARTED|Overall Study||7
406552|NCT01679314|996028|P2|NOT COMPLETED|Overall Study||0
406553|NCT01679314|996029|P1|NOT COMPLETED|Overall Study||2
406554|NCT01679314|996028|P2|COMPLETED|Overall Study||28
406555|NCT01679314|996029|P1|COMPLETED|Overall Study||24
406556|NCT01679314|996028|P2|STARTED|Overall Study||28
406557|NCT01679314|996029|P1|STARTED|Overall Study||26
406558|NCT01679236|996049|P2|NOT COMPLETED|Overall Study||15
406559|NCT01679236|996050|P1|NOT COMPLETED|Overall Study||15
406560|NCT01679236|996049|P2|COMPLETED|Overall Study||10
406561|NCT01679236|996050|P1|COMPLETED|Overall Study||15
406562|NCT01679236|996049|P2|STARTED|Overall Study||25
406563|NCT01679236|996050|P1|STARTED|Overall Study||30
406564|NCT01679197|996056|P1|NOT COMPLETED|Overall Study||4
406565|NCT01679197|996056|P1|COMPLETED|Overall Study||19
406566|NCT01679197|996056|P1|STARTED|Overall Study||23
406567|NCT01679028|996075|P6|NOT COMPLETED|Overall Study||0
406568|NCT01679028|996076|P5|NOT COMPLETED|Overall Study||0
406569|NCT01679028|996077|P4|NOT COMPLETED|Overall Study||0
406570|NCT01679028|996078|P3|NOT COMPLETED|Overall Study||0
406571|NCT01679028|996079|P2|NOT COMPLETED|Overall Study||0
406572|NCT01679028|996080|P1|NOT COMPLETED|Overall Study||0
406573|NCT01679028|996075|P6|COMPLETED|Overall Study||6
406574|NCT01679028|996076|P5|COMPLETED|Overall Study||2
406575|NCT01679028|996077|P4|COMPLETED|Overall Study||4
406576|NCT01679028|996078|P3|COMPLETED|Overall Study||2
406577|NCT01679028|996079|P2|COMPLETED|Overall Study||4
406578|NCT01679028|996080|P1|COMPLETED|Overall Study||2
406579|NCT01679028|996075|P6|STARTED|Overall Study||6
406580|NCT01679028|996076|P5|STARTED|Overall Study||2
406581|NCT01679028|996077|P4|STARTED|Overall Study||4
406582|NCT01679028|996078|P3|STARTED|Overall Study||2
406583|NCT01679028|996079|P2|STARTED|Overall Study||4
406584|NCT01679028|996080|P1|STARTED|Overall Study||2
406585|NCT01679002|996097|P3|NOT COMPLETED|Overall Study||0
406586|NCT01679002|996098|P2|NOT COMPLETED|Overall Study||1
406587|NCT01679002|996099|P1|NOT COMPLETED|Overall Study||1
406588|NCT01679002|996097|P3|COMPLETED|Overall Study||4
406589|NCT01679002|996098|P2|COMPLETED|Overall Study||3
406590|NCT01679002|996099|P1|COMPLETED|Overall Study||3
406591|NCT01679002|996097|P3|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4
406592|NCT01679002|996098|P2|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4
406593|NCT01679002|996099|P1|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||3
406594|NCT01679002|996097|P3|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
406595|NCT01679002|996098|P2|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
406596|NCT01679002|996099|P1|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
406597|NCT01679002|996097|P3|BIA 2-093 900 mg Once-daily Period|Overall Study||4
406598|NCT01679002|996098|P2|BIA 2-093 900 mg Once-daily Period|Overall Study||3
406599|NCT01679002|996099|P1|BIA 2-093 900 mg Once-daily Period|Overall Study||4
406600|NCT01679002|996097|P3|STARTED|Overall Study||4
406601|NCT01679002|996098|P2|STARTED|Overall Study||4
406602|NCT01679002|996099|P1|STARTED|Overall Study||4
406603|NCT01678976|996115|P2|NOT COMPLETED|Second Period||0
406604|NCT01678976|996116|P1|NOT COMPLETED|Second Period||0
406605|NCT01678976|996115|P2|COMPLETED|Second Period||6
406606|NCT01678976|996116|P1|COMPLETED|Second Period||6
406607|NCT01678976|996115|P2|STARTED|Second Period||6
406608|NCT01678976|996116|P1|STARTED|Second Period||6
406609|NCT01678976|996115|P2|NOT COMPLETED|First Period||1
406610|NCT01678976|996116|P1|NOT COMPLETED|First Period||0
406611|NCT01678976|996115|P2|COMPLETED|First Period||6
406612|NCT01678976|996116|P1|COMPLETED|First Period||6
406613|NCT01678976|996115|P2|STARTED|First Period||7
406614|NCT01678976|996116|P1|STARTED|First Period||6
406615|NCT01678911|996126|P2|NOT COMPLETED|Second Intervention||0
406616|NCT01678911|996127|P1|NOT COMPLETED|Second Intervention||2
406617|NCT01678911|996126|P2|COMPLETED|Second Intervention||1
406618|NCT01678911|996127|P1|COMPLETED|Second Intervention||2
406619|NCT01678911|996126|P2|STARTED|Second Intervention||1
406620|NCT01678911|996127|P1|STARTED|Second Intervention||4
406621|NCT01678911|996126|P2|NOT COMPLETED|First Intervention||0
406622|NCT01678911|996127|P1|NOT COMPLETED|First Intervention||0
406623|NCT01678911|996126|P2|COMPLETED|First Intervention||1
406624|NCT01678911|996127|P1|COMPLETED|First Intervention||4
406625|NCT01678911|996126|P2|Cross Over|First Intervention||1
406626|NCT01678911|996127|P1|Cross Over|First Intervention||4
406627|NCT01678911|996126|P2|STARTED|First Intervention||1
406628|NCT01678911|996127|P1|STARTED|First Intervention||4
406629|NCT01678885|996143|P5|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||17
406630|NCT01678885|996144|P4|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
406631|NCT01678885|996145|P3|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
406632|NCT01678885|996146|P2|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
406633|NCT01678885|996147|P1|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
406634|NCT01678885|996143|P5|COMPLETED|Phase II; 8 Week Low Calorie Diet||70
406635|NCT01678885|996144|P4|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
406636|NCT01678885|996145|P3|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
406637|NCT01678885|996146|P2|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
406638|NCT01678885|996147|P1|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
406639|NCT01678885|996143|P5|STARTED|Phase II; 8 Week Low Calorie Diet||87
406640|NCT01678885|996144|P4|STARTED|Phase II; 8 Week Low Calorie Diet||0
406641|NCT01678885|996145|P3|STARTED|Phase II; 8 Week Low Calorie Diet||0
406642|NCT01678885|996146|P2|STARTED|Phase II; 8 Week Low Calorie Diet||0
406643|NCT01678885|996147|P1|STARTED|Phase II; 8 Week Low Calorie Diet||0
406644|NCT01678885|996143|P5|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
406645|NCT01678885|996144|P4|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||3
406646|NCT01678885|996145|P3|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||1
406647|NCT01678885|996146|P2|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||3
406648|NCT01678885|996147|P1|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
406649|NCT01678885|996143|P5|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
406650|NCT01678885|996144|P4|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||21
406651|NCT01678885|996145|P3|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||22
406652|NCT01678885|996146|P2|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||15
406653|NCT01678885|996147|P1|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||22
406654|NCT01678885|996143|P5|STARTED|Phase I; 2 Wks Duration, Both Sub-study||0
406655|NCT01678885|996144|P4|STARTED|Phase I; 2 Wks Duration, Both Sub-study||24
406656|NCT01678885|996145|P3|STARTED|Phase I; 2 Wks Duration, Both Sub-study||23
406657|NCT01678885|996146|P2|STARTED|Phase I; 2 Wks Duration, Both Sub-study||18
406658|NCT01678885|996147|P1|STARTED|Phase I; 2 Wks Duration, Both Sub-study||22
406659|NCT01678846|996157|P2|NOT COMPLETED|Overall Study||0
406660|NCT01678846|996158|P1|NOT COMPLETED|Overall Study||0
406661|NCT01678846|996157|P2|COMPLETED|Overall Study||1899
406662|NCT01678846|996158|P1|COMPLETED|Overall Study||1921
406663|NCT01678846|996157|P2|STARTED|Overall Study||1899
406664|NCT01678846|996158|P1|STARTED|Overall Study|Whole school implementation. Started and completed shows number of students in the end-line survey.|1921
406665|NCT01678820|996173|P3|NOT COMPLETED|Overall Study||57
406666|NCT01678820|996174|P2|NOT COMPLETED|Overall Study||63
406667|NCT01678820|996175|P1|NOT COMPLETED|Overall Study||62
406668|NCT01678820|996173|P3|COMPLETED|Overall Study||43
406669|NCT01678820|996174|P2|COMPLETED|Overall Study||36
406670|NCT01678820|996175|P1|COMPLETED|Overall Study||38
406671|NCT01678820|996173|P3|Treated With Double-blind Study Drug|Overall Study||98
406672|NCT01678820|996174|P2|Treated With Double-blind Study Drug|Overall Study||97
406673|NCT01678820|996175|P1|Treated With Double-blind Study Drug|Overall Study||100
406674|NCT01678820|996173|P3|STARTED|Overall Study||100
406675|NCT01678820|996174|P2|STARTED|Overall Study||99
406676|NCT01678820|996175|P1|STARTED|Overall Study||100
406677|NCT01678807|996220|P3|NOT COMPLETED|Overall Study||0
406678|NCT01678807|996221|P2|NOT COMPLETED|Overall Study||5
406679|NCT01678807|996222|P1|NOT COMPLETED|Overall Study||4
406680|NCT01678807|996220|P3|COMPLETED|Overall Study||65
406681|NCT01678807|996221|P2|COMPLETED|Overall Study||60
406682|NCT01678807|996222|P1|COMPLETED|Overall Study||61
406683|NCT01678807|996220|P3|STARTED|Overall Study||65
406684|NCT01678807|996221|P2|STARTED|Overall Study||65
406685|NCT01678807|996222|P1|STARTED|Overall Study||65
406686|NCT01678443|996233|P1|NOT COMPLETED|Overall Study||0
406687|NCT01678443|996233|P1|COMPLETED|Overall Study||2
406688|NCT01678443|996233|P1|STARTED|Overall Study||2
406689|NCT01678313|996240|P2|NOT COMPLETED|Prostate Biopsy at 3 Months||12
406690|NCT01678313|996241|P1|NOT COMPLETED|Prostate Biopsy at 3 Months||11
406691|NCT01678313|996240|P2|COMPLETED|Prostate Biopsy at 3 Months||37
406692|NCT01678313|996241|P1|COMPLETED|Prostate Biopsy at 3 Months||45
406693|NCT01678313|996240|P2|STARTED|Prostate Biopsy at 3 Months||49
406694|NCT01678313|996241|P1|STARTED|Prostate Biopsy at 3 Months||56
406695|NCT01678313|996240|P2|NOT COMPLETED|PSA >4 ng/dL at 3 Months||9
406696|NCT01678313|996241|P1|NOT COMPLETED|PSA >4 ng/dL at 3 Months||8
406697|NCT01678313|996240|P2|COMPLETED|PSA >4 ng/dL at 3 Months||49
406698|NCT01678313|996241|P1|COMPLETED|PSA >4 ng/dL at 3 Months||56
406699|NCT01678313|996240|P2|STARTED|PSA >4 ng/dL at 3 Months||58
406700|NCT01678313|996241|P1|STARTED|PSA >4 ng/dL at 3 Months||64
406701|NCT01678313|996240|P2|NOT COMPLETED|Completed the 3-month Therapy||12
406702|NCT01678313|996241|P1|NOT COMPLETED|Completed the 3-month Therapy||6
406703|NCT01678313|996240|P2|COMPLETED|Completed the 3-month Therapy||58
406704|NCT01678313|996241|P1|COMPLETED|Completed the 3-month Therapy||64
406705|NCT01678313|996240|P2|STARTED|Completed the 3-month Therapy||70
406706|NCT01678313|996241|P1|STARTED|Completed the 3-month Therapy||70
406707|NCT01678196|996259|P2|NOT COMPLETED|Overall Study||0
406708|NCT01678196|996260|P1|NOT COMPLETED|Overall Study||0
406709|NCT01678196|996259|P2|COMPLETED|Overall Study|Primary outcome data was from the electronic medical record and was available for all participants.|32
406710|NCT01678196|996260|P1|COMPLETED|Overall Study|Primary outcome data was from the electronic medical record and was available for all participants.|34
406711|NCT01678196|996259|P2|STARTED|Overall Study||32
406712|NCT01678196|996260|P1|STARTED|Overall Study||34
406713|NCT01678131|996275|P3|NOT COMPLETED|Overall Study||2
406714|NCT01678131|996276|P2|NOT COMPLETED|Overall Study||1
406715|NCT01678131|996277|P1|NOT COMPLETED|Overall Study||0
406716|NCT01678131|996275|P3|COMPLETED|Overall Study||9
406717|NCT01678131|996276|P2|COMPLETED|Overall Study||9
406718|NCT01678131|996277|P1|COMPLETED|Overall Study||10
406719|NCT01678131|996275|P3|STARTED|Overall Study||11
406720|NCT01678131|996276|P2|STARTED|Overall Study||10
406721|NCT01678131|996277|P1|STARTED|Overall Study||10
406722|NCT01677988|996285|P1|NOT COMPLETED|Overall Study||2
406723|NCT01677988|996285|P1|COMPLETED|Overall Study||1
406724|NCT01677988|996285|P1|STARTED|Overall Study||3
406725|NCT01677936|996298|P2|NOT COMPLETED|Overall Study||5
406726|NCT01677936|996299|P1|NOT COMPLETED|Overall Study||9
406727|NCT01677936|996298|P2|COMPLETED|Overall Study|Full analysis dataset completers|15
406728|NCT01677936|996299|P1|COMPLETED|Overall Study|Full analysis dataset completers|22
406729|NCT01677936|996298|P2|STARTED|Overall Study|20 randomized to snacks; 1 excluded due to lack of post-baseline evaluation; 19 = full dataset|20
406730|NCT01677936|996299|P1|STARTED|Overall Study|31 randomized to raisins; 4 excluded due to lack of post-baseline evaluation; 27 = full dataset|31
406731|NCT01677910|996310|P4|NOT COMPLETED|Open-Label Extension Period (OLE)||36
406732|NCT01677910|996311|P3|NOT COMPLETED|Open-Label Extension Period (OLE)||0
406733|NCT01677910|996312|P2|NOT COMPLETED|Open-Label Extension Period (OLE)||0
406734|NCT01677910|996313|P1|NOT COMPLETED|Open-Label Extension Period (OLE)||0
406735|NCT01677910|996310|P4|COMPLETED|Open-Label Extension Period (OLE)||79
406736|NCT01677910|996311|P3|COMPLETED|Open-Label Extension Period (OLE)||0
406737|NCT01677910|996312|P2|COMPLETED|Open-Label Extension Period (OLE)||0
406738|NCT01677910|996313|P1|COMPLETED|Open-Label Extension Period (OLE)||0
406739|NCT01677910|996310|P4|STARTED|Open-Label Extension Period (OLE)||115
406740|NCT01677910|996311|P3|STARTED|Open-Label Extension Period (OLE)||0
406741|NCT01677910|996312|P2|STARTED|Open-Label Extension Period (OLE)||0
406742|NCT01677910|996313|P1|STARTED|Open-Label Extension Period (OLE)||0
406743|NCT01677910|996310|P4|NOT COMPLETED|Double-Blind Treatment Period||0
406744|NCT01677910|996311|P3|NOT COMPLETED|Double-Blind Treatment Period||7
406745|NCT01677910|996312|P2|NOT COMPLETED|Double-Blind Treatment Period||3
406746|NCT01677910|996313|P1|NOT COMPLETED|Double-Blind Treatment Period||7
406747|NCT01677910|996310|P4|COMPLETED|Double-Blind Treatment Period||0
406748|NCT01677910|996311|P3|COMPLETED|Double-Blind Treatment Period||38
406749|NCT01677910|996312|P2|COMPLETED|Double-Blind Treatment Period||42
406750|NCT01677910|996313|P1|COMPLETED|Double-Blind Treatment Period||38
406751|NCT01677910|996310|P4|STARTED|Double-Blind Treatment Period||0
406752|NCT01677910|996311|P3|STARTED|Double-Blind Treatment Period||45
406753|NCT01677910|996312|P2|STARTED|Double-Blind Treatment Period||45
406754|NCT01677910|996313|P1|STARTED|Double-Blind Treatment Period||45
406755|NCT01677858|996340|P5|NOT COMPLETED|Overall Study||85
406756|NCT01677858|996341|P4|NOT COMPLETED|Overall Study||6
406757|NCT01677858|996342|P3|NOT COMPLETED|Overall Study||14
406758|NCT01677858|996343|P2|NOT COMPLETED|Overall Study||2
406759|NCT01677858|996344|P1|NOT COMPLETED|Overall Study||3
406760|NCT01677858|996340|P5|COMPLETED|Overall Study|Completed indicates participants ongoing in study|4
406761|NCT01677858|996341|P4|COMPLETED|Overall Study|Completed indicates participants ongoing in study|0
406762|NCT01677858|996342|P3|COMPLETED|Overall Study|Completed indicates participants ongoing in study|1
406763|NCT01677858|996343|P2|COMPLETED|Overall Study|Completed indicates participants ongoing in study|1
406764|NCT01677858|996344|P1|COMPLETED|Overall Study|Completed indicates participants ongoing in study|0
406765|NCT01677858|996340|P5|STARTED|Overall Study||89
406766|NCT01677858|996341|P4|STARTED|Overall Study||6
406767|NCT01677858|996342|P3|STARTED|Overall Study||15
406768|NCT01677858|996343|P2|STARTED|Overall Study||3
406769|NCT01677858|996344|P1|STARTED|Overall Study||3
406770|NCT01677767|996417|P1|NOT COMPLETED|Overall Study||22
406771|NCT01677767|996417|P1|COMPLETED|Overall Study||102
406772|NCT01677767|996417|P1|STARTED|Overall Study||124
406773|NCT01677624|996431|P1|NOT COMPLETED|Overall Study||1
406774|NCT01677624|996431|P1|COMPLETED|Overall Study||27
406775|NCT01677624|996431|P1|STARTED|Overall Study||28
406776|NCT01677507|996436|P2|NOT COMPLETED|Second Assigment||5
406777|NCT01677507|996437|P1|NOT COMPLETED|Second Assigment||3
406778|NCT01677507|996436|P2|COMPLETED|Second Assigment||51
406779|NCT01677507|996437|P1|COMPLETED|Second Assigment||60
406780|NCT01677507|996436|P2|STARTED|Second Assigment||56
406781|NCT01677507|996437|P1|STARTED|Second Assigment||63
406782|NCT01677507|996436|P2|NOT COMPLETED|Initial Assignment||2
406783|NCT01677507|996437|P1|NOT COMPLETED|Initial Assignment||0
406784|NCT01677507|996436|P2|COMPLETED|Initial Assignment||56
406785|NCT01677507|996437|P1|COMPLETED|Initial Assignment||63
406786|NCT01677507|996436|P2|STARTED|Initial Assignment||58
406787|NCT01677507|996437|P1|STARTED|Initial Assignment||63
406788|NCT01677299|996451|P4|NOT COMPLETED|Overall Study||1
406789|NCT01677299|996452|P3|NOT COMPLETED|Overall Study||1
406790|NCT01677299|996453|P2|NOT COMPLETED|Overall Study||3
406791|NCT01677299|996454|P1|NOT COMPLETED|Overall Study||0
406792|NCT01677299|996451|P4|COMPLETED|Overall Study||5
406793|NCT01677299|996452|P3|COMPLETED|Overall Study||5
406794|NCT01677299|996453|P2|COMPLETED|Overall Study||3
406795|NCT01677299|996454|P1|COMPLETED|Overall Study||6
406796|NCT01677299|996451|P4|STARTED|Overall Study||6
406797|NCT01677299|996452|P3|STARTED|Overall Study||6
406798|NCT01677299|996453|P2|STARTED|Overall Study||6
406799|NCT01677299|996454|P1|STARTED|Overall Study||6
406800|NCT01677286|996476|P1|NOT COMPLETED|Overall Study||11
406801|NCT01677286|996476|P1|COMPLETED|Overall Study||14
406802|NCT01677286|996476|P1|STARTED|Overall Study||25
406803|NCT01677195|996486|P3|NOT COMPLETED|Overall Study||30
406804|NCT01677195|996487|P2|NOT COMPLETED|Overall Study||32
406805|NCT01677195|996488|P1|NOT COMPLETED|Overall Study||29
406806|NCT01677195|996486|P3|COMPLETED|Overall Study||50
406807|NCT01677195|996487|P2|COMPLETED|Overall Study||51
406808|NCT01677195|996488|P1|COMPLETED|Overall Study||42
406809|NCT01677195|996486|P3|STARTED|Overall Study||80
406810|NCT01677195|996487|P2|STARTED|Overall Study||83
406811|NCT01677195|996488|P1|STARTED|Overall Study||71
406812|NCT01677182|996499|P3|NOT COMPLETED|Overall Study||39
406813|NCT01677182|996500|P2|NOT COMPLETED|Overall Study||28
406814|NCT01677182|996501|P1|NOT COMPLETED|Overall Study||34
406815|NCT01677182|996499|P3|COMPLETED|Overall Study||143
406816|NCT01677182|996500|P2|COMPLETED|Overall Study||141
406817|NCT01677182|996501|P1|COMPLETED|Overall Study||150
406818|NCT01677182|996499|P3|STARTED|Overall Study||182
406819|NCT01677182|996500|P2|STARTED|Overall Study||169
406820|NCT01677182|996501|P1|STARTED|Overall Study||184
406821|NCT01676961|996533|P1|NOT COMPLETED|Overall Study||5
406822|NCT01676961|996533|P1|COMPLETED|Overall Study||0
406823|NCT01676961|996533|P1|STARTED|Overall Study||5
406824|NCT01676896|996541|P3|NOT COMPLETED|Overall Study||19
406825|NCT01676896|996542|P2|NOT COMPLETED|Overall Study||7
406826|NCT01676896|996543|P1|NOT COMPLETED|Overall Study||12
406827|NCT01676896|996541|P3|COMPLETED|Overall Study||81
406828|NCT01676896|996542|P2|COMPLETED|Overall Study||89
406829|NCT01676896|996543|P1|COMPLETED|Overall Study||84
406830|NCT01676896|996541|P3|STARTED|Overall Study||100
406831|NCT01676896|996542|P2|STARTED|Overall Study||96
406832|NCT01676896|996543|P1|STARTED|Overall Study||96
406833|NCT01676714|996638|P1|NOT COMPLETED|Overall Study||0
406834|NCT01676714|996638|P1|COMPLETED|Overall Study||10
406835|NCT01676714|996638|P1|STARTED|Overall Study||10
406836|NCT01676701|996647|P2|NOT COMPLETED|Overall Study||4
406837|NCT01676701|996648|P1|NOT COMPLETED|Overall Study||4
406838|NCT01676701|996647|P2|COMPLETED|Overall Study||0
406839|NCT01676701|996648|P1|COMPLETED|Overall Study||0
406840|NCT01676701|996647|P2|Completed Post-Treatment Follow-Up|Overall Study||4
406841|NCT01676701|996648|P1|Completed Post-Treatment Follow-Up|Overall Study||4
406842|NCT01676701|996647|P2|Received at Least 1 Dose of Study Drug|Overall Study||4
406843|NCT01676701|996648|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
406844|NCT01676701|996647|P2|STARTED|Overall Study||4
406845|NCT01676701|996648|P1|STARTED|Overall Study||4
406846|NCT01676532|996674|P1|NOT COMPLETED|Overall Study||0
406847|NCT01676532|996674|P1|COMPLETED|Overall Study||127
406848|NCT01676532|996674|P1|STARTED|Overall Study||127
406849|NCT01676415|996685|P2|NOT COMPLETED|Overall Study||0
406850|NCT01676415|996686|P1|NOT COMPLETED|Overall Study||0
406851|NCT01676415|996685|P2|COMPLETED|Overall Study||5
406852|NCT01676415|996686|P1|COMPLETED|Overall Study||4
406853|NCT01676415|996685|P2|STARTED|Overall Study||5
406854|NCT01676415|996686|P1|STARTED|Overall Study||4
406855|NCT01676298|996706|P8|NOT COMPLETED|Overall Study||0
406856|NCT01676298|996707|P7|NOT COMPLETED|Overall Study||0
406857|NCT01676298|996708|P6|NOT COMPLETED|Overall Study||0
406858|NCT01676298|996709|P5|NOT COMPLETED|Overall Study||0
406859|NCT01676298|996710|P4|NOT COMPLETED|Overall Study||0
406860|NCT01676298|996711|P3|NOT COMPLETED|Overall Study||0
406861|NCT01676298|996712|P2|NOT COMPLETED|Overall Study||0
406862|NCT01676298|996713|P1|NOT COMPLETED|Overall Study||0
406863|NCT01676298|996706|P8|COMPLETED|Overall Study||1
406864|NCT01676298|996707|P7|COMPLETED|Overall Study||1
406865|NCT01676298|996708|P6|COMPLETED|Overall Study||1
406866|NCT01676298|996709|P5|COMPLETED|Overall Study||1
406867|NCT01676298|996710|P4|COMPLETED|Overall Study||1
406868|NCT01676298|996711|P3|COMPLETED|Overall Study||1
406869|NCT01676298|996712|P2|COMPLETED|Overall Study||1
406870|NCT01676298|996713|P1|COMPLETED|Overall Study||1
406871|NCT01676298|996706|P8|Participated in All Tests|Overall Study||1
406872|NCT01676298|996707|P7|Participated in All Tests|Overall Study||1
406873|NCT01676298|996708|P6|Participated in All Tests|Overall Study||1
406874|NCT01676298|996709|P5|Participated in All Tests|Overall Study||1
406875|NCT01676298|996710|P4|Participated in All Tests|Overall Study||1
406876|NCT01676298|996711|P3|Participated in All Tests|Overall Study||1
406877|NCT01676298|996712|P2|Participated in All Tests|Overall Study||1
406878|NCT01676298|996713|P1|Participated in All Tests|Overall Study||1
406879|NCT01676298|996706|P8|All Genotypes Confirmed With Reference|Overall Study||1
406880|NCT01676298|996707|P7|All Genotypes Confirmed With Reference|Overall Study||1
406881|NCT01676298|996708|P6|All Genotypes Confirmed With Reference|Overall Study||1
406882|NCT01676298|996709|P5|All Genotypes Confirmed With Reference|Overall Study||1
406883|NCT01676298|996710|P4|All Genotypes Confirmed With Reference|Overall Study||1
406884|NCT01676298|996711|P3|All Genotypes Confirmed With Reference|Overall Study||1
406885|NCT01676298|996712|P2|All Genotypes Confirmed With Reference|Overall Study||1
406886|NCT01676298|996713|P1|All Genotypes Confirmed With Reference|Overall Study||1
406887|NCT01676298|996706|P8|STARTED|Overall Study||1
406888|NCT01676298|996707|P7|STARTED|Overall Study||1
406889|NCT01676298|996708|P6|STARTED|Overall Study||1
406890|NCT01676298|996709|P5|STARTED|Overall Study||1
406891|NCT01676298|996710|P4|STARTED|Overall Study||1
406892|NCT01676298|996711|P3|STARTED|Overall Study||1
406893|NCT01676298|996712|P2|STARTED|Overall Study||1
406894|NCT01676298|996713|P1|STARTED|Overall Study||1
406895|NCT01676220|996733|P2|NOT COMPLETED|Overall Study||125
406896|NCT01676220|996734|P1|NOT COMPLETED|Overall Study||102
406897|NCT01676220|996733|P2|COMPLETED|Overall Study||314
406898|NCT01676220|996734|P1|COMPLETED|Overall Study||337
406899|NCT01676220|996733|P2|Modified Intent-To-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post­baseline data|430
406900|NCT01676220|996734|P1|Modified Intent-To-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post­baseline data|432
406901|NCT01676220|996733|P2|Treated|Overall Study||438
406902|NCT01676220|996734|P1|Treated|Overall Study||435
406903|NCT01676220|996733|P2|STARTED|Overall Study||439
406904|NCT01676220|996734|P1|STARTED|Overall Study||439
406905|NCT01676012|996764|P1|NOT COMPLETED|Overall Study||3
406906|NCT01676012|996764|P1|COMPLETED|Overall Study||29
406907|NCT01676012|996764|P1|STARTED|Overall Study||32
406908|NCT01675830|996768|P1|NOT COMPLETED|Overall Study||0
406909|NCT01675830|996768|P1|COMPLETED|Overall Study||10
406910|NCT01675830|996768|P1|STARTED|Overall Study||10
406911|NCT01675661|996775|P2|NOT COMPLETED|Overall Study||46
406912|NCT01675661|996776|P1|NOT COMPLETED|Overall Study||40
406913|NCT01675661|996775|P2|COMPLETED|Overall Study||103
406914|NCT01675661|996776|P1|COMPLETED|Overall Study||113
406915|NCT01675661|996775|P2|STARTED|Overall Study||149
406916|NCT01675661|996776|P1|STARTED|Overall Study||153
406917|NCT01675635|996784|P2|NOT COMPLETED|Overall Study||0
406918|NCT01675635|996785|P1|NOT COMPLETED|Overall Study||0
406919|NCT01675635|996784|P2|COMPLETED|Overall Study||117
406920|NCT01675635|996785|P1|COMPLETED|Overall Study||117
406921|NCT01675635|996784|P2|STARTED|Overall Study||117
406922|NCT01675635|996785|P1|STARTED|Overall Study||117
406923|NCT01675622|996805|P2|NOT COMPLETED|Overall Study||24
406924|NCT01675622|996806|P1|NOT COMPLETED|Overall Study||26
406925|NCT01675622|996805|P2|COMPLETED|Overall Study||96
406926|NCT01675622|996806|P1|COMPLETED|Overall Study||96
406927|NCT01675622|996805|P2|STARTED|Overall Study||120
406928|NCT01675622|996806|P1|STARTED|Overall Study||122
406929|NCT01675544|996830|P1|NOT COMPLETED|Overall Study||2
406930|NCT01675544|996830|P1|COMPLETED|Overall Study||44
406931|NCT01675544|996830|P1|STARTED|Overall Study||46
406932|NCT01675531|996835|P1|NOT COMPLETED|Overall Study||25
406933|NCT01675531|996835|P1|COMPLETED|Overall Study||41
406934|NCT01675531|996835|P1|STARTED|Overall Study||66
406935|NCT01675492|996842|P1|NOT COMPLETED|Overall Study||42
406936|NCT01675492|996842|P1|COMPLETED|Overall Study||42
406937|NCT01675492|996842|P1|STARTED|Overall Study||84
406938|NCT01675479|996847|P1|NOT COMPLETED|Overall Study||11
406939|NCT01675479|996847|P1|COMPLETED|Overall Study||58
406940|NCT01675479|996847|P1|STARTED|Overall Study||69
406941|NCT01675453|996854|P2|NOT COMPLETED|Overall Study||0
406942|NCT01675453|996855|P1|NOT COMPLETED|Overall Study||0
406943|NCT01675453|996854|P2|COMPLETED|Overall Study||20
406944|NCT01675453|996855|P1|COMPLETED|Overall Study||20
406945|NCT01675453|996854|P2|STARTED|Overall Study||20
406946|NCT01675453|996855|P1|STARTED|Overall Study||20
406947|NCT01675427|996861|P1|NOT COMPLETED|Overall Study||34
406948|NCT01675427|996861|P1|COMPLETED|Overall Study||4732
406949|NCT01675427|996861|P1|STARTED|Overall Study||4766
406950|NCT01675167|997148|P3|NOT COMPLETED|Double-blind Treatment Phase||110
406951|NCT01675167|997149|P2|NOT COMPLETED|Double-blind Treatment Phase||48
406952|NCT01675167|997150|P1|NOT COMPLETED|Double-blind Treatment Phase||0
406953|NCT01675167|997148|P3|COMPLETED|Double-blind Treatment Phase||147
406954|NCT01675167|997149|P2|COMPLETED|Double-blind Treatment Phase||206
406955|NCT01675167|997150|P1|COMPLETED|Double-blind Treatment Phase||0
406956|NCT01675167|997148|P3|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|257
406957|NCT01675167|997149|P2|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|254
406958|NCT01675167|997150|P1|STARTED|Double-blind Treatment Phase|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
406959|NCT01675167|997148|P3|NOT COMPLETED|Open-label Titration Phase||0
406960|NCT01675167|997149|P2|NOT COMPLETED|Open-label Titration Phase||0
406961|NCT01675167|997150|P1|NOT COMPLETED|Open-label Titration Phase||304
406962|NCT01675167|997148|P3|COMPLETED|Open-label Titration Phase||0
406963|NCT01675167|997149|P2|COMPLETED|Open-label Titration Phase||0
406964|NCT01675167|997150|P1|COMPLETED|Open-label Titration Phase||511
406965|NCT01675167|997148|P3|STARTED|Open-label Titration Phase||0
406966|NCT01675167|997149|P2|STARTED|Open-label Titration Phase||0
406967|NCT01675167|997150|P1|STARTED|Open-label Titration Phase||815
406968|NCT01675141|997172|P1|NOT COMPLETED|Overall Study||11
406969|NCT01675141|997172|P1|COMPLETED|Overall Study||0
406970|NCT01675141|997172|P1|STARTED|Overall Study||11
406971|NCT01675128|997185|P3|NOT COMPLETED|Overall Study||1
406972|NCT01675128|997186|P2|NOT COMPLETED|Overall Study||2
406973|NCT01675128|997187|P1|NOT COMPLETED|Overall Study||2
406974|NCT01675128|997185|P3|COMPLETED|Overall Study||9
406975|NCT01675128|997186|P2|COMPLETED|Overall Study||8
406976|NCT01675128|997187|P1|COMPLETED|Overall Study||2
406977|NCT01675128|997185|P3|STARTED|Overall Study||10
406978|NCT01675128|997186|P2|STARTED|Overall Study||10
406979|NCT01675128|997187|P1|STARTED|Overall Study||4
406980|NCT01675063|997209|P1|NOT COMPLETED|Overall Study||0
406981|NCT01675063|997209|P1|COMPLETED|Overall Study||77
406982|NCT01675063|997209|P1|STARTED|Overall Study||77
406983|NCT01675050|997215|P2|NOT COMPLETED|Second Period Treatment||0
406984|NCT01675050|997216|P1|NOT COMPLETED|Second Period Treatment||0
406985|NCT01675050|997215|P2|COMPLETED|Second Period Treatment||2
406986|NCT01675050|997216|P1|COMPLETED|Second Period Treatment||1
406987|NCT01675050|997215|P2|STARTED|Second Period Treatment||2
406988|NCT01675050|997216|P1|STARTED|Second Period Treatment||1
406989|NCT01675050|997215|P2|NOT COMPLETED|Wash Out Period||0
406990|NCT01675050|997216|P1|NOT COMPLETED|Wash Out Period||0
406991|NCT01675050|997215|P2|COMPLETED|Wash Out Period||2
406992|NCT01675050|997216|P1|COMPLETED|Wash Out Period||1
406993|NCT01675050|997215|P2|STARTED|Wash Out Period||2
406994|NCT01675050|997216|P1|STARTED|Wash Out Period||1
406995|NCT01675050|997215|P2|NOT COMPLETED|Period One Treatment||0
406996|NCT01675050|997216|P1|NOT COMPLETED|Period One Treatment||1
406997|NCT01675050|997215|P2|COMPLETED|Period One Treatment||2
406998|NCT01675050|997216|P1|COMPLETED|Period One Treatment||1
406999|NCT01675050|997215|P2|STARTED|Period One Treatment||2
407000|NCT01675050|997216|P1|STARTED|Period One Treatment||2
407001|NCT01675011|997226|P2|NOT COMPLETED|Overall Study||1
407002|NCT01675011|997227|P1|NOT COMPLETED|Overall Study||3
407003|NCT01675011|997226|P2|COMPLETED|Overall Study||0
407004|NCT01675011|997227|P1|COMPLETED|Overall Study||0
407005|NCT01675011|997226|P2|STARTED|Overall Study||1
407006|NCT01675011|997227|P1|STARTED|Overall Study||3
407007|NCT01674725|997235|P2|NOT COMPLETED|Overall Study||1
407008|NCT01674725|997236|P1|NOT COMPLETED|Overall Study||3
407009|NCT01674725|997235|P2|COMPLETED|Overall Study||94
407010|NCT01674725|997236|P1|COMPLETED|Overall Study||89
407011|NCT01674725|997235|P2|STARTED|Overall Study||95
407012|NCT01674725|997236|P1|STARTED|Overall Study||92
407013|NCT01674712|997255|P5|NOT COMPLETED|Overall Study||11
407014|NCT01674712|997256|P4|NOT COMPLETED|Overall Study||8
407015|NCT01674712|997257|P3|NOT COMPLETED|Overall Study||9
407016|NCT01674712|997258|P2|NOT COMPLETED|Overall Study||9
407017|NCT01674712|997259|P1|NOT COMPLETED|Overall Study||10
407018|NCT01674712|997255|P5|COMPLETED|Overall Study||102
407019|NCT01674712|997256|P4|COMPLETED|Overall Study||108
407020|NCT01674712|997257|P3|COMPLETED|Overall Study||106
407021|NCT01674712|997258|P2|COMPLETED|Overall Study||108
407022|NCT01674712|997259|P1|COMPLETED|Overall Study||104
407023|NCT01674712|997255|P5|Safety Subject Sample|Overall Study||112
407024|NCT01674712|997256|P4|Safety Subject Sample|Overall Study||115
407025|NCT01674712|997257|P3|Safety Subject Sample|Overall Study||113
407026|NCT01674712|997258|P2|Safety Subject Sample|Overall Study||117
407027|NCT01674712|997259|P1|Safety Subject Sample|Overall Study||111
407028|NCT01674712|997255|P5|Full Analysis Subject Sample|Overall Study||111
407029|NCT01674712|997256|P4|Full Analysis Subject Sample|Overall Study||112
407030|NCT01674712|997257|P3|Full Analysis Subject Sample|Overall Study||110
407031|NCT01674712|997258|P2|Full Analysis Subject Sample|Overall Study||114
407032|NCT01674712|997259|P1|Full Analysis Subject Sample|Overall Study||109
407033|NCT01674712|997255|P5|STARTED|Overall Study||113
407034|NCT01674712|997256|P4|STARTED|Overall Study||116
407035|NCT01674712|997257|P3|STARTED|Overall Study||115
407036|NCT01674712|997258|P2|STARTED|Overall Study||117
407037|NCT01674712|997259|P1|STARTED|Overall Study||114
407038|NCT01674647|997283|P2|NOT COMPLETED|30-day Safety Follow-up Period||41
407039|NCT01674647|997284|P1|NOT COMPLETED|30-day Safety Follow-up Period||58
407040|NCT01674647|997283|P2|COMPLETED|30-day Safety Follow-up Period||446
407041|NCT01674647|997284|P1|COMPLETED|30-day Safety Follow-up Period||924
407042|NCT01674647|997283|P2|STARTED|30-day Safety Follow-up Period||487
407043|NCT01674647|997284|P1|STARTED|30-day Safety Follow-up Period||982
407044|NCT01674647|997283|P2|NOT COMPLETED|Treatment Period||102
407045|NCT01674647|997284|P1|NOT COMPLETED|Treatment Period||156
407046|NCT01674647|997283|P2|COMPLETED|Treatment Period||400
407047|NCT01674647|997284|P1|COMPLETED|Treatment Period||846
407048|NCT01674647|997283|P2|Subjects Received Treatment|Treatment Period||499
407049|NCT01674647|997284|P1|Subjects Received Treatment|Treatment Period||988
407050|NCT01674647|997283|P2|STARTED|Treatment Period||502
407051|NCT01674647|997284|P1|STARTED|Treatment Period||1002
407052|NCT01674634|997310|P1|NOT COMPLETED|Overall Study||6
407053|NCT01674634|997310|P1|COMPLETED|Overall Study||709
407054|NCT01674634|997310|P1|STARTED|Overall Study||715
407055|NCT01674621|997330|P5|NOT COMPLETED|Overall Study||6
407056|NCT01674621|997331|P4|NOT COMPLETED|Overall Study||7
407057|NCT01674621|997332|P3|NOT COMPLETED|Overall Study||8
407058|NCT01674621|997333|P2|NOT COMPLETED|Overall Study||5
407059|NCT01674621|997334|P1|NOT COMPLETED|Overall Study||6
407060|NCT01674621|997330|P5|COMPLETED|Overall Study||45
407061|NCT01674621|997331|P4|COMPLETED|Overall Study||41
407062|NCT01674621|997332|P3|COMPLETED|Overall Study||43
407063|NCT01674621|997333|P2|COMPLETED|Overall Study||45
407064|NCT01674621|997334|P1|COMPLETED|Overall Study||44
407065|NCT01674621|997330|P5|STARTED|Overall Study||51
407066|NCT01674621|997331|P4|STARTED|Overall Study||48
407067|NCT01674621|997332|P3|STARTED|Overall Study||51
407068|NCT01674621|997333|P2|STARTED|Overall Study||50
407069|NCT01674621|997334|P1|STARTED|Overall Study||50
407070|NCT01674569|997356|P1|NOT COMPLETED|Overall Study||10
407071|NCT01674569|997356|P1|COMPLETED|Overall Study||25
407072|NCT01674569|997356|P1|STARTED|Overall Study||35
407073|NCT01674062|997362|P2|NOT COMPLETED|Overall Study||29
407074|NCT01674062|997363|P1|NOT COMPLETED|Overall Study||66
407075|NCT01674062|997362|P2|COMPLETED|Overall Study||0
407076|NCT01674062|997363|P1|COMPLETED|Overall Study||0
407077|NCT01674062|997362|P2|STARTED|Overall Study||29
407078|NCT01674062|997363|P1|STARTED|Overall Study||66
407079|NCT01674010|997378|P3|NOT COMPLETED|Randomization Phase 2||61
407080|NCT01674010|997379|P2|NOT COMPLETED|Randomization Phase 2||62
407081|NCT01674010|997380|P1|NOT COMPLETED|Randomization Phase 2||0
407082|NCT01674010|997378|P3|COMPLETED|Randomization Phase 2||3
407083|NCT01674010|997379|P2|COMPLETED|Randomization Phase 2||3
407084|NCT01674010|997380|P1|COMPLETED|Randomization Phase 2||0
407085|NCT01674010|997378|P3|STARTED|Randomization Phase 2||64
407086|NCT01674010|997379|P2|STARTED|Randomization Phase 2||65
407087|NCT01674010|997380|P1|STARTED|Randomization Phase 2||0
407088|NCT01674010|997378|P3|NOT COMPLETED|Open Treatment Phase 1||0
407089|NCT01674010|997379|P2|NOT COMPLETED|Open Treatment Phase 1||0
407090|NCT01674010|997380|P1|NOT COMPLETED|Open Treatment Phase 1||180
407091|NCT01674010|997378|P3|COMPLETED|Open Treatment Phase 1||0
407092|NCT01674010|997379|P2|COMPLETED|Open Treatment Phase 1||0
407093|NCT01674010|997380|P1|COMPLETED|Open Treatment Phase 1||129
407094|NCT01674010|997378|P3|STARTED|Open Treatment Phase 1||0
407095|NCT01674010|997379|P2|STARTED|Open Treatment Phase 1||0
407096|NCT01674010|997380|P1|STARTED|Open Treatment Phase 1||309
407097|NCT01673984|997399|P2|NOT COMPLETED|Overall Study||6
407098|NCT01673984|997400|P1|NOT COMPLETED|Overall Study||10
407099|NCT01673984|997399|P2|COMPLETED|Overall Study||1
407100|NCT01673984|997400|P1|COMPLETED|Overall Study||4
407101|NCT01673984|997399|P2|STARTED|Overall Study||7
407102|NCT01673984|997400|P1|STARTED|Overall Study||14
407103|NCT01673919|997418|P1|NOT COMPLETED|Overall Study||0
407104|NCT01673919|997418|P1|COMPLETED|Overall Study||7
407105|NCT01673919|997418|P1|STARTED|Overall Study||7
407106|NCT01673867|997442|P2|NOT COMPLETED|Treatment||268
407107|NCT01673867|997443|P1|NOT COMPLETED|Treatment||244
407108|NCT01673867|997442|P2|COMPLETED|Treatment||0
407109|NCT01673867|997443|P1|COMPLETED|Treatment||43
407110|NCT01673867|997442|P2|STARTED|Treatment||268
407111|NCT01673867|997443|P1|STARTED|Treatment||287
407112|NCT01673867|997442|P2|NOT COMPLETED|Randomization||22
407113|NCT01673867|997443|P1|NOT COMPLETED|Randomization||5
407114|NCT01673867|997442|P2|COMPLETED|Randomization||268
407115|NCT01673867|997443|P1|COMPLETED|Randomization||287
407116|NCT01673867|997442|P2|STARTED|Randomization||290
407117|NCT01673867|997443|P1|STARTED|Randomization||292
407118|NCT01673854|997469|P1|NOT COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||19
407119|NCT01673854|997469|P1|COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||0
407120|NCT01673854|997469|P1|STARTED|Vem 2 Phase (Vemurafenib Retreatment)||19
407121|NCT01673854|997469|P1|NOT COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||27
407122|NCT01673854|997469|P1|COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||19
407123|NCT01673854|997469|P1|STARTED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||46
407124|NCT01673854|997469|P1|NOT COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||0
407125|NCT01673854|997469|P1|COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||46
407126|NCT01673854|997469|P1|STARTED|Vem 1 Phase (Vemurafenib, 960 mg)||46
407127|NCT01673828|997479|P2|NOT COMPLETED|Overall Study||0
407128|NCT01673828|997480|P1|NOT COMPLETED|Overall Study||0
407129|NCT01673828|997479|P2|COMPLETED|Overall Study||6
407130|NCT01673828|997480|P1|COMPLETED|Overall Study||7
407131|NCT01673828|997479|P2|STARTED|Overall Study||6
407132|NCT01673828|997480|P1|STARTED|Overall Study||7
407133|NCT01673802|997486|P1|NOT COMPLETED|Gadoxetate Double Dose 0.050 mmol/kg||0
407134|NCT01673802|997486|P1|COMPLETED|Gadoxetate Double Dose 0.050 mmol/kg||10
407135|NCT01673802|997486|P1|STARTED|Gadoxetate Double Dose 0.050 mmol/kg||10
407136|NCT01673802|997486|P1|NOT COMPLETED|Gadoxetate Standard Dose 0.025 mmol/kg||0
407137|NCT01673802|997486|P1|COMPLETED|Gadoxetate Standard Dose 0.025 mmol/kg||8
407138|NCT01673802|997486|P1|STARTED|Gadoxetate Standard Dose 0.025 mmol/kg||8
407139|NCT01673698|997492|P2|NOT COMPLETED|Overall Study||13
407140|NCT01673698|997493|P1|NOT COMPLETED|Overall Study||51
407141|NCT01673698|997492|P2|COMPLETED|Overall Study||126
407142|NCT01673698|997493|P1|COMPLETED|Overall Study||136
407143|NCT01673698|997492|P2|STARTED|Overall Study||139
407144|NCT01673698|997493|P1|STARTED|Overall Study||187
407145|NCT01673620|997503|P2|NOT COMPLETED|Overall Study||0
407146|NCT01673620|997504|P1|NOT COMPLETED|Overall Study||1
407147|NCT01673620|997503|P2|COMPLETED|Overall Study||22
407148|NCT01673620|997504|P1|COMPLETED|Overall Study||46
407149|NCT01673620|997503|P2|STARTED|Overall Study||22
407150|NCT01673620|997504|P1|STARTED|Overall Study||47
407151|NCT01673594|997514|P2|NOT COMPLETED|Overall Study||6
407152|NCT01673594|997515|P1|NOT COMPLETED|Overall Study||6
407153|NCT01673594|997514|P2|COMPLETED|Overall Study||13
407154|NCT01673594|997515|P1|COMPLETED|Overall Study||12
407155|NCT01673594|997514|P2|STARTED|Overall Study||19
407156|NCT01673594|997515|P1|STARTED|Overall Study||18
407157|NCT01673568|997525|P2|NOT COMPLETED|Overall Study||0
407158|NCT01673568|997526|P1|NOT COMPLETED|Overall Study||0
407159|NCT01673568|997525|P2|COMPLETED|Overall Study||28
407160|NCT01673568|997526|P1|COMPLETED|Overall Study||28
407161|NCT01673568|997525|P2|STARTED|Overall Study||28
407162|NCT01673568|997526|P1|STARTED|Overall Study||28
407163|NCT01673490|997534|P1|NOT COMPLETED|Overall Study||7
407164|NCT01673490|997534|P1|COMPLETED|Overall Study||52
407165|NCT01673490|997534|P1|STARTED|Overall Study||59
407166|NCT01673425|997547|P1|NOT COMPLETED|Overall Study||1
407167|NCT01673425|997547|P1|COMPLETED|Overall Study||4
407168|NCT01673425|997547|P1|STARTED|Overall Study||5
407169|NCT01673347|997551|P1|NOT COMPLETED|Overall Study||7
407170|NCT01673347|997551|P1|COMPLETED|Overall Study||17
407171|NCT01673347|997551|P1|STARTED|Overall Study||24
407172|NCT01673282|997560|P2|NOT COMPLETED|Overall Study||26
407173|NCT01673282|997561|P1|NOT COMPLETED|Overall Study||33
407174|NCT01673282|997560|P2|COMPLETED|Overall Study||132
407175|NCT01673282|997561|P1|COMPLETED|Overall Study||120
407176|NCT01673282|997560|P2|STARTED|Overall Study||158
407177|NCT01673282|997561|P1|STARTED|Overall Study||153
407178|NCT01673256|997567|P1|NOT COMPLETED|Overall Study||0
407179|NCT01673256|997567|P1|COMPLETED|Overall Study||90
407180|NCT01673256|997567|P1|STARTED|Overall Study||90
407181|NCT01673191|997573|P2|NOT COMPLETED|Overall Study||0
407182|NCT01673191|997574|P1|NOT COMPLETED|Overall Study||0
407183|NCT01673191|997573|P2|COMPLETED|Overall Study||11
407184|NCT01673191|997574|P1|COMPLETED|Overall Study||26
407185|NCT01673191|997573|P2|STARTED|Overall Study||11
407186|NCT01673191|997574|P1|STARTED|Overall Study||26
407187|NCT01673178|997597|P5|NOT COMPLETED|Overall Study||2
407188|NCT01673178|997598|P4|NOT COMPLETED|Overall Study||8
407189|NCT01673178|997599|P3|NOT COMPLETED|Overall Study||3
407190|NCT01673178|997600|P2|NOT COMPLETED|Overall Study||2
407191|NCT01673178|997601|P1|NOT COMPLETED|Overall Study||3
407192|NCT01673178|997597|P5|COMPLETED|Overall Study||19
407193|NCT01673178|997598|P4|COMPLETED|Overall Study||14
407194|NCT01673178|997599|P3|COMPLETED|Overall Study||18
407195|NCT01673178|997600|P2|COMPLETED|Overall Study||19
407196|NCT01673178|997601|P1|COMPLETED|Overall Study||19
407197|NCT01673178|997597|P5|STARTED|Overall Study||21
407198|NCT01673178|997598|P4|STARTED|Overall Study||22
407199|NCT01673178|997599|P3|STARTED|Overall Study||21
407200|NCT01673178|997600|P2|STARTED|Overall Study||21
407201|NCT01673178|997601|P1|STARTED|Overall Study||22
407202|NCT01673126|997840|P2|NOT COMPLETED|Overall Study||3
407203|NCT01673126|997841|P1|NOT COMPLETED|Overall Study||4
407204|NCT01673126|997840|P2|COMPLETED|Overall Study||23
407205|NCT01673126|997841|P1|COMPLETED|Overall Study||32
407206|NCT01673126|997840|P2|STARTED|Overall Study|First stimulation (20 minutes) Washout (2days) Second stimulation (20 minutes)|26
407207|NCT01673126|997841|P1|STARTED|Overall Study|First stimulation (20 minutes) Washout (2 days) Second stimulation (20 minutes)|36
407208|NCT01673113|997849|P2|NOT COMPLETED|Overall Study||0
407209|NCT01673113|997850|P1|NOT COMPLETED|Overall Study||0
407210|NCT01673113|997849|P2|COMPLETED|Overall Study||11
407211|NCT01673113|997850|P1|COMPLETED|Overall Study||11
407212|NCT01673113|997849|P2|STARTED|Overall Study||11
407213|NCT01673113|997850|P1|STARTED|Overall Study||11
407214|NCT01673009|997857|P1|NOT COMPLETED|Overall Study||13
407215|NCT01673009|997857|P1|COMPLETED|Overall Study||23
407216|NCT01673009|997857|P1|STARTED|Overall Study||36
407217|NCT01672996|997869|P3|NOT COMPLETED|Overall Study||0
407218|NCT01672996|997870|P2|NOT COMPLETED|Overall Study||0
407219|NCT01672996|997871|P1|NOT COMPLETED|Overall Study||0
407220|NCT01672996|997869|P3|COMPLETED|Overall Study||6
407221|NCT01672996|997870|P2|COMPLETED|Overall Study||30
407222|NCT01672996|997871|P1|COMPLETED|Overall Study||30
407223|NCT01672996|997869|P3|STARTED|Overall Study||6
407224|NCT01672996|997870|P2|STARTED|Overall Study||30
407225|NCT01672996|997871|P1|STARTED|Overall Study||30
407226|NCT01672983|997907|P6|NOT COMPLETED|Overall Study||0
407227|NCT01672983|997908|P5|NOT COMPLETED|Overall Study||0
407228|NCT01672983|997909|P4|NOT COMPLETED|Overall Study||0
407229|NCT01672983|997910|P3|NOT COMPLETED|Overall Study||0
407230|NCT01672983|997911|P2|NOT COMPLETED|Overall Study||0
407231|NCT01672983|997912|P1|NOT COMPLETED|Overall Study||0
407232|NCT01672983|997907|P6|COMPLETED|Overall Study||18
407233|NCT01672983|997908|P5|COMPLETED|Overall Study||19
407234|NCT01672983|997909|P4|COMPLETED|Overall Study||18
407235|NCT01672983|997910|P3|COMPLETED|Overall Study||19
407236|NCT01672983|997911|P2|COMPLETED|Overall Study||18
407237|NCT01672983|997912|P1|COMPLETED|Overall Study||18
407238|NCT01672983|997907|P6|Completed Study Drug|Overall Study||17
407239|NCT01672983|997908|P5|Completed Study Drug|Overall Study||12
407240|NCT01672983|997909|P4|Completed Study Drug|Overall Study||18
407241|NCT01672983|997910|P3|Completed Study Drug|Overall Study||18
407242|NCT01672983|997911|P2|Completed Study Drug|Overall Study||17
407243|NCT01672983|997912|P1|Completed Study Drug|Overall Study||18
407244|NCT01672983|997907|P6|STARTED|Overall Study||18
407245|NCT01672983|997908|P5|STARTED|Overall Study||19
407246|NCT01672983|997909|P4|STARTED|Overall Study||18
407247|NCT01672983|997910|P3|STARTED|Overall Study||19
407248|NCT01672983|997911|P2|STARTED|Overall Study||18
407249|NCT01672983|997912|P1|STARTED|Overall Study||18
407250|NCT01672970|997942|P1|NOT COMPLETED|Overall Study||47
407251|NCT01672970|997942|P1|COMPLETED|Overall Study||244
407252|NCT01672970|997942|P1|Treated|Overall Study||290
407253|NCT01672970|997942|P1|STARTED|Overall Study||291
407254|NCT01672957|997978|P1|NOT COMPLETED|Overall Study||55
407255|NCT01672957|997978|P1|COMPLETED|Overall Study||73
407256|NCT01672957|997978|P1|Intent-to-treat (ITT) Population|Overall Study|All enrolled participants who had no major protocol violation.|123
407257|NCT01672957|997978|P1|STARTED|Overall Study||128
407258|NCT01672892|997993|P2|NOT COMPLETED|Overall Study||3
407259|NCT01672892|997994|P1|NOT COMPLETED|Overall Study||8
407260|NCT01672892|997993|P2|COMPLETED|Overall Study|Eligible subjects available for analysis|149
407261|NCT01672892|997994|P1|COMPLETED|Overall Study|Eligible subjects available for analysis|129
407262|NCT01672892|997993|P2|STARTED|Overall Study||152
407263|NCT01672892|997994|P1|STARTED|Overall Study||137
407264|NCT01672827|998008|P1|NOT COMPLETED|Overall Study||0
407265|NCT01672827|998008|P1|COMPLETED|Overall Study||276
407266|NCT01672827|998008|P1|STARTED|Overall Study||276
407267|NCT01672788|998014|P4|NOT COMPLETED|Treatment Period 4 (3 Days)||0
407268|NCT01672788|998015|P3|NOT COMPLETED|Treatment Period 4 (3 Days)||0
407269|NCT01672788|998016|P2|NOT COMPLETED|Treatment Period 4 (3 Days)||0
407270|NCT01672788|998017|P1|NOT COMPLETED|Treatment Period 4 (3 Days)||0
407271|NCT01672788|998014|P4|COMPLETED|Treatment Period 4 (3 Days)||8
407272|NCT01672788|998015|P3|COMPLETED|Treatment Period 4 (3 Days)||9
407273|NCT01672788|998016|P2|COMPLETED|Treatment Period 4 (3 Days)||9
407274|NCT01672788|998017|P1|COMPLETED|Treatment Period 4 (3 Days)||9
407275|NCT01672788|998014|P4|STARTED|Treatment Period 4 (3 Days)||8
407276|NCT01672788|998015|P3|STARTED|Treatment Period 4 (3 Days)||9
407277|NCT01672788|998016|P2|STARTED|Treatment Period 4 (3 Days)||9
407278|NCT01672788|998017|P1|STARTED|Treatment Period 4 (3 Days)||9
407279|NCT01672788|998014|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
407280|NCT01672788|998015|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
407281|NCT01672788|998016|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
407282|NCT01672788|998017|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
407283|NCT01672788|998014|P4|COMPLETED|Washout Period 3 (7 Days)||8
407284|NCT01672788|998015|P3|COMPLETED|Washout Period 3 (7 Days)||9
407285|NCT01672788|998016|P2|COMPLETED|Washout Period 3 (7 Days)||9
407286|NCT01672788|998017|P1|COMPLETED|Washout Period 3 (7 Days)||9
407287|NCT01672788|998014|P4|STARTED|Washout Period 3 (7 Days)||8
407288|NCT01672788|998015|P3|STARTED|Washout Period 3 (7 Days)||9
407289|NCT01672788|998016|P2|STARTED|Washout Period 3 (7 Days)||9
407290|NCT01672788|998017|P1|STARTED|Washout Period 3 (7 Days)||9
407291|NCT01672788|998014|P4|NOT COMPLETED|Treatment Period 3 (3 Days)||0
407292|NCT01672788|998015|P3|NOT COMPLETED|Treatment Period 3 (3 Days)||0
407293|NCT01672788|998016|P2|NOT COMPLETED|Treatment Period 3 (3 Days)||0
407294|NCT01672788|998017|P1|NOT COMPLETED|Treatment Period 3 (3 Days)||0
407295|NCT01672788|998014|P4|COMPLETED|Treatment Period 3 (3 Days)||8
407296|NCT01672788|998015|P3|COMPLETED|Treatment Period 3 (3 Days)||9
407297|NCT01672788|998016|P2|COMPLETED|Treatment Period 3 (3 Days)||9
407298|NCT01672788|998017|P1|COMPLETED|Treatment Period 3 (3 Days)||9
407299|NCT01672788|998014|P4|STARTED|Treatment Period 3 (3 Days)||8
407300|NCT01672788|998015|P3|STARTED|Treatment Period 3 (3 Days)||9
407301|NCT01672788|998016|P2|STARTED|Treatment Period 3 (3 Days)||9
407302|NCT01672788|998017|P1|STARTED|Treatment Period 3 (3 Days)||9
407303|NCT01672788|998014|P4|NOT COMPLETED|Washout Period 2 (7 Days)||1
407304|NCT01672788|998015|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
407305|NCT01672788|998016|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
407306|NCT01672788|998017|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
407307|NCT01672788|998014|P4|COMPLETED|Washout Period 2 (7 Days)||8
407308|NCT01672788|998015|P3|COMPLETED|Washout Period 2 (7 Days)||9
407309|NCT01672788|998016|P2|COMPLETED|Washout Period 2 (7 Days)||9
407310|NCT01672788|998017|P1|COMPLETED|Washout Period 2 (7 Days)||9
407311|NCT01672788|998014|P4|STARTED|Washout Period 2 (7 Days)||9
407312|NCT01672788|998015|P3|STARTED|Washout Period 2 (7 Days)||9
407313|NCT01672788|998016|P2|STARTED|Washout Period 2 (7 Days)||9
407314|NCT01672788|998017|P1|STARTED|Washout Period 2 (7 Days)||9
407315|NCT01672788|998014|P4|NOT COMPLETED|Treatment Period 2 (3 Days)||0
407316|NCT01672788|998015|P3|NOT COMPLETED|Treatment Period 2 (3 Days)||0
407317|NCT01672788|998016|P2|NOT COMPLETED|Treatment Period 2 (3 Days)||0
407318|NCT01672788|998017|P1|NOT COMPLETED|Treatment Period 2 (3 Days)||0
407319|NCT01672788|998014|P4|COMPLETED|Treatment Period 2 (3 Days)||9
407320|NCT01672788|998015|P3|COMPLETED|Treatment Period 2 (3 Days)||9
407321|NCT01672788|998016|P2|COMPLETED|Treatment Period 2 (3 Days)||9
407322|NCT01672788|998017|P1|COMPLETED|Treatment Period 2 (3 Days)||9
407323|NCT01672788|998014|P4|STARTED|Treatment Period 2 (3 Days)||9
407324|NCT01672788|998015|P3|STARTED|Treatment Period 2 (3 Days)||9
407325|NCT01672788|998016|P2|STARTED|Treatment Period 2 (3 Days)||9
407326|NCT01672788|998017|P1|STARTED|Treatment Period 2 (3 Days)||9
407327|NCT01672788|998014|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
407328|NCT01672788|998015|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
407329|NCT01672788|998016|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
407330|NCT01672788|998017|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
407331|NCT01672788|998014|P4|COMPLETED|Washout Period 1 (7 Days)||9
407332|NCT01672788|998015|P3|COMPLETED|Washout Period 1 (7 Days)||9
407333|NCT01672788|998016|P2|COMPLETED|Washout Period 1 (7 Days)||9
407334|NCT01672788|998017|P1|COMPLETED|Washout Period 1 (7 Days)||9
407335|NCT01672788|998014|P4|STARTED|Washout Period 1 (7 Days)||9
407336|NCT01672788|998015|P3|STARTED|Washout Period 1 (7 Days)||9
407337|NCT01672788|998016|P2|STARTED|Washout Period 1 (7 Days)||9
407338|NCT01672788|998017|P1|STARTED|Washout Period 1 (7 Days)||9
407339|NCT01672788|998014|P4|NOT COMPLETED|Treatment Period 1 (3 Days)||0
407340|NCT01672788|998015|P3|NOT COMPLETED|Treatment Period 1 (3 Days)||0
407341|NCT01672788|998016|P2|NOT COMPLETED|Treatment Period 1 (3 Days)||0
407342|NCT01672788|998017|P1|NOT COMPLETED|Treatment Period 1 (3 Days)||0
407343|NCT01672788|998014|P4|COMPLETED|Treatment Period 1 (3 Days)||9
407344|NCT01672788|998015|P3|COMPLETED|Treatment Period 1 (3 Days)||9
407345|NCT01672788|998016|P2|COMPLETED|Treatment Period 1 (3 Days)||9
407346|NCT01672788|998017|P1|COMPLETED|Treatment Period 1 (3 Days)||9
407347|NCT01672788|998014|P4|STARTED|Treatment Period 1 (3 Days)||9
407348|NCT01672788|998015|P3|STARTED|Treatment Period 1 (3 Days)||9
407349|NCT01672788|998016|P2|STARTED|Treatment Period 1 (3 Days)||9
407350|NCT01672788|998017|P1|STARTED|Treatment Period 1 (3 Days)||9
407351|NCT01672723|998047|P2|NOT COMPLETED|Second Intervention||0
407352|NCT01672723|998048|P1|NOT COMPLETED|Second Intervention||0
407353|NCT01672723|998047|P2|COMPLETED|Second Intervention||15
407354|NCT01672723|998048|P1|COMPLETED|Second Intervention||16
407355|NCT01672723|998047|P2|STARTED|Second Intervention||15
407356|NCT01672723|998048|P1|STARTED|Second Intervention||16
407357|NCT01672723|998047|P2|NOT COMPLETED|Washout Period of 10 Days||0
407358|NCT01672723|998048|P1|NOT COMPLETED|Washout Period of 10 Days||0
407359|NCT01672723|998047|P2|COMPLETED|Washout Period of 10 Days||15
407360|NCT01672723|998048|P1|COMPLETED|Washout Period of 10 Days||16
407361|NCT01672723|998047|P2|STARTED|Washout Period of 10 Days||15
407362|NCT01672723|998048|P1|STARTED|Washout Period of 10 Days||16
407363|NCT01672723|998047|P2|NOT COMPLETED|First Intervention||0
407364|NCT01672723|998048|P1|NOT COMPLETED|First Intervention||3
407365|NCT01672723|998047|P2|COMPLETED|First Intervention||15
407366|NCT01672723|998048|P1|COMPLETED|First Intervention||16
407367|NCT01672723|998047|P2|STARTED|First Intervention||15
407368|NCT01672723|998048|P1|STARTED|First Intervention||19
407369|NCT01672658|998060|P2|NOT COMPLETED|Overall Study||1
407370|NCT01672658|998061|P1|NOT COMPLETED|Overall Study||0
407371|NCT01672658|998060|P2|COMPLETED|Overall Study||14
407372|NCT01672658|998061|P1|COMPLETED|Overall Study||16
407373|NCT01672658|998060|P2|STARTED|Overall Study||15
407374|NCT01672658|998061|P1|STARTED|Overall Study||16
407375|NCT01672294|998085|P4|NOT COMPLETED|Overall Study||13
407376|NCT01672294|998086|P3|NOT COMPLETED|Overall Study||11
407377|NCT01672294|998087|P2|NOT COMPLETED|Overall Study||21
407378|NCT01672294|998088|P1|NOT COMPLETED|Overall Study||6
407379|NCT01672294|998085|P4|COMPLETED|Overall Study||59
407380|NCT01672294|998086|P3|COMPLETED|Overall Study||61
407381|NCT01672294|998087|P2|COMPLETED|Overall Study||50
407382|NCT01672294|998088|P1|COMPLETED|Overall Study||65
407383|NCT01672294|998085|P4|STARTED|Overall Study||72
407384|NCT01672294|998086|P3|STARTED|Overall Study||72
407385|NCT01672294|998087|P2|STARTED|Overall Study||71
407386|NCT01672294|998088|P1|STARTED|Overall Study||71
407387|NCT01672242|998110|P2|NOT COMPLETED|Period 2||0
407388|NCT01672242|998111|P1|NOT COMPLETED|Period 2||0
407389|NCT01672242|998110|P2|COMPLETED|Period 2||2
407390|NCT01672242|998111|P1|COMPLETED|Period 2||4
407391|NCT01672242|998110|P2|STARTED|Period 2||2
407392|NCT01672242|998111|P1|STARTED|Period 2||4
407393|NCT01672242|998110|P2|NOT COMPLETED|Period 1||0
407394|NCT01672242|998111|P1|NOT COMPLETED|Period 1||0
407395|NCT01672242|998110|P2|COMPLETED|Period 1||2
407396|NCT01672242|998111|P1|COMPLETED|Period 1||4
407397|NCT01672242|998110|P2|STARTED|Period 1||2
407398|NCT01672242|998111|P1|STARTED|Period 1||4
407399|NCT01671839|998117|P1|NOT COMPLETED|Overall Study||5
407400|NCT01671839|998117|P1|COMPLETED|Overall Study||50
407401|NCT01671839|998117|P1|STARTED|Overall Study||55
407402|NCT01671748|998128|P2|NOT COMPLETED|12 Week Treatment Phase||0
407403|NCT01671748|998129|P1|NOT COMPLETED|12 Week Treatment Phase||0
407404|NCT01671748|998128|P2|COMPLETED|12 Week Treatment Phase||17
407405|NCT01671748|998129|P1|COMPLETED|12 Week Treatment Phase||19
407406|NCT01671748|998128|P2|STARTED|12 Week Treatment Phase||17
407407|NCT01671748|998129|P1|STARTED|12 Week Treatment Phase||19
407408|NCT01671748|998128|P2|NOT COMPLETED|4 Week run-in Phase||0
407409|NCT01671748|998129|P1|NOT COMPLETED|4 Week run-in Phase||11
407410|NCT01671748|998128|P2|COMPLETED|4 Week run-in Phase||0
407411|NCT01671748|998129|P1|COMPLETED|4 Week run-in Phase||36
407412|NCT01671748|998128|P2|STARTED|4 Week run-in Phase||0
407413|NCT01671748|998129|P1|STARTED|4 Week run-in Phase||47
407414|NCT01671605|998149|P2|NOT COMPLETED|Overall Study||0
407415|NCT01671605|998150|P1|NOT COMPLETED|Overall Study||0
407416|NCT01671605|998149|P2|COMPLETED|Overall Study||31
407417|NCT01671605|998150|P1|COMPLETED|Overall Study||72
407418|NCT01671605|998149|P2|STARTED|Overall Study||31
407419|NCT01671605|998150|P1|STARTED|Overall Study||72
407420|NCT01671488|998156|P1|NOT COMPLETED|Overall Study||1
407421|NCT01671488|998156|P1|COMPLETED|Overall Study||10
407422|NCT01671488|998156|P1|STARTED|Overall Study||11
407423|NCT01671319|998162|P1|NOT COMPLETED|Overall Study||1
407424|NCT01671319|998162|P1|COMPLETED|Overall Study||41
407425|NCT01671319|998162|P1|STARTED|Overall Study||42
407426|NCT01671293|998170|P2|NOT COMPLETED|Overall Study||2
407427|NCT01671293|998171|P1|NOT COMPLETED|Overall Study||3
407428|NCT01671293|998170|P2|COMPLETED|Overall Study||32
407429|NCT01671293|998171|P1|COMPLETED|Overall Study||33
407430|NCT01671293|998170|P2|STARTED|Overall Study||34
407431|NCT01671293|998171|P1|STARTED|Overall Study||36
407432|NCT01671280|998177|P1|NOT COMPLETED|Overall Study||2
407433|NCT01671280|998177|P1|COMPLETED|Overall Study||401
407434|NCT01671280|998177|P1|STARTED|Overall Study|The number is enrollment.|403
407435|NCT01671176|998183|P1|NOT COMPLETED|Overall Study||0
407436|NCT01671176|998183|P1|COMPLETED|Overall Study||30
407437|NCT01671176|998183|P1|STARTED|Overall Study||30
407438|NCT01671111|998188|P1|NOT COMPLETED|Overall Study||30
407439|NCT01671111|998188|P1|COMPLETED|Overall Study||0
407440|NCT01671111|998188|P1|STARTED|Overall Study||30
407441|NCT01671059|998198|P1|NOT COMPLETED|Overall Study||5
407442|NCT01671059|998198|P1|COMPLETED|Overall Study||75
407443|NCT01671059|998198|P1|STARTED|Overall Study||80
407444|NCT01670825|998223|P2|NOT COMPLETED|Overall Study||0
407445|NCT01670825|998224|P1|NOT COMPLETED|Overall Study||0
407446|NCT01670825|998223|P2|COMPLETED|Overall Study||39
407447|NCT01670825|998224|P1|COMPLETED|Overall Study||42
407448|NCT01670825|998223|P2|STARTED|Overall Study||39
407449|NCT01670825|998224|P1|STARTED|Overall Study||42
407450|NCT01670721|998290|P1|NOT COMPLETED|Overall Study||53
407451|NCT01670721|998290|P1|COMPLETED|Overall Study|81 participants with DP and 41 with adverse events were considered as completed.|122
407452|NCT01670721|998290|P1|STARTED|Overall Study||175
407453|NCT01670656|998302|P5|NOT COMPLETED|Overall Study||11
407454|NCT01670656|998303|P4|NOT COMPLETED|Overall Study||6
407455|NCT01670656|998304|P3|NOT COMPLETED|Overall Study||8
407456|NCT01670656|998305|P2|NOT COMPLETED|Overall Study||7
407457|NCT01670656|998306|P1|NOT COMPLETED|Overall Study||3
407458|NCT01670656|998302|P5|COMPLETED|Overall Study||79
407459|NCT01670656|998303|P4|COMPLETED|Overall Study||79
407460|NCT01670656|998304|P3|COMPLETED|Overall Study||79
407461|NCT01670656|998305|P2|COMPLETED|Overall Study||84
407462|NCT01670656|998306|P1|COMPLETED|Overall Study||83
407463|NCT01670656|998302|P5|Treated|Overall Study||90
407464|NCT01670656|998303|P4|Treated|Overall Study||85
407465|NCT01670656|998304|P3|Treated|Overall Study||86
407466|NCT01670656|998305|P2|Treated|Overall Study||91
407467|NCT01670656|998306|P1|Treated|Overall Study||86
407468|NCT01670656|998302|P5|STARTED|Overall Study||90
407469|NCT01670656|998303|P4|STARTED|Overall Study||85
407470|NCT01670656|998304|P3|STARTED|Overall Study||87
407471|NCT01670656|998305|P2|STARTED|Overall Study||91
407472|NCT01670656|998306|P1|STARTED|Overall Study||86
407473|NCT01670526|998335|P2|NOT COMPLETED|Overall Study||6
407474|NCT01670526|998336|P1|NOT COMPLETED|Overall Study||12
407475|NCT01670526|998335|P2|COMPLETED|Overall Study||39
407476|NCT01670526|998336|P1|COMPLETED|Overall Study||37
407477|NCT01670526|998335|P2|STARTED|Overall Study||45
407478|NCT01670526|998336|P1|STARTED|Overall Study||49
407479|NCT01670487|998350|P2|NOT COMPLETED|Overall Study||0
407480|NCT01670487|998351|P1|NOT COMPLETED|Overall Study||0
407481|NCT01670487|998350|P2|COMPLETED|Overall Study||150
407482|NCT01670487|998351|P1|COMPLETED|Overall Study||150
407483|NCT01670487|998350|P2|STARTED|Overall Study||150
407484|NCT01670487|998351|P1|STARTED|Overall Study||150
407485|NCT01670292|998357|P1|NOT COMPLETED|Overall Study||14
407486|NCT01670292|998357|P1|COMPLETED|Overall Study||68
407487|NCT01670292|998357|P1|STARTED|Overall Study||82
407488|NCT01670279|998398|P4|NOT COMPLETED|Overall Study||1
407489|NCT01670279|998399|P3|NOT COMPLETED|Overall Study||0
407490|NCT01670279|998400|P2|NOT COMPLETED|Overall Study||2
407491|NCT01670279|998401|P1|NOT COMPLETED|Overall Study||0
407492|NCT01670279|998398|P4|COMPLETED|Overall Study||4
407493|NCT01670279|998399|P3|COMPLETED|Overall Study||0
407494|NCT01670279|998400|P2|COMPLETED|Overall Study||5
407495|NCT01670279|998401|P1|COMPLETED|Overall Study||6
407496|NCT01670279|998398|P4|STARTED|Overall Study||5
407497|NCT01670279|998399|P3|STARTED|Overall Study||0
407498|NCT01670279|998400|P2|STARTED|Overall Study||7
407499|NCT01670279|998401|P1|STARTED|Overall Study||6
407500|NCT01670201|998436|P1|NOT COMPLETED|Overall Study||0
407501|NCT01670201|998436|P1|COMPLETED|Overall Study||8
407502|NCT01670201|998436|P1|STARTED|Overall Study||8
407503|NCT01670188|998443|P2|NOT COMPLETED|Overall Study||1
407504|NCT01670188|998444|P1|NOT COMPLETED|Overall Study||0
407505|NCT01670188|998443|P2|COMPLETED|Overall Study||39
407506|NCT01670188|998444|P1|COMPLETED|Overall Study||38
407507|NCT01670188|998443|P2|STARTED|Overall Study||40
407508|NCT01670188|998444|P1|STARTED|Overall Study||38
407509|NCT01670045|998450|P1|NOT COMPLETED|Overall Study||16
407510|NCT01670045|998450|P1|COMPLETED|Overall Study||27
407511|NCT01670045|998450|P1|STARTED|Overall Study||43
407512|NCT01670019|998468|P2|NOT COMPLETED|Overall Study||0
407513|NCT01670019|998469|P1|NOT COMPLETED|Overall Study||9
407514|NCT01670019|998468|P2|COMPLETED|Overall Study||23
407515|NCT01670019|998469|P1|COMPLETED|Overall Study||14
407516|NCT01670019|998468|P2|STARTED|Overall Study||23
407517|NCT01670019|998469|P1|STARTED|Overall Study||23
407518|NCT01669902|998483|P1|NOT COMPLETED|Overall Study||29
407519|NCT01669902|998483|P1|COMPLETED|Overall Study||78
407520|NCT01669902|998483|P1|STARTED|Overall Study||107
407521|NCT01669863|998510|P1|NOT COMPLETED|Overall Study||0
407522|NCT01669863|998510|P1|COMPLETED|Overall Study||6
407523|NCT01669863|998510|P1|STARTED|Overall Study||6
407524|NCT01669811|998518|P2|NOT COMPLETED|Overall Study||11
407525|NCT01669811|998519|P1|NOT COMPLETED|Overall Study||3
407526|NCT01669811|998518|P2|COMPLETED|Overall Study||131
407527|NCT01669811|998519|P1|COMPLETED|Overall Study||142
407528|NCT01669811|998518|P2|STARTED|Overall Study||142
407529|NCT01669811|998519|P1|STARTED|Overall Study||145
407530|NCT01669785|998540|P3|NOT COMPLETED|Overall Study||0
407531|NCT01669785|998541|P2|NOT COMPLETED|Overall Study||0
407532|NCT01669785|998542|P1|NOT COMPLETED|Overall Study||0
407533|NCT01669785|998540|P3|COMPLETED|Overall Study||46
407534|NCT01669785|998541|P2|COMPLETED|Overall Study||48
407535|NCT01669785|998542|P1|COMPLETED|Overall Study||45
407536|NCT01669785|998540|P3|STARTED|Overall Study||46
407537|NCT01669785|998541|P2|STARTED|Overall Study||48
407538|NCT01669785|998542|P1|STARTED|Overall Study||45
407539|NCT01669720|998579|P2|NOT COMPLETED|Overall Study||0
407540|NCT01669720|998580|P1|NOT COMPLETED|Overall Study||0
407541|NCT01669720|998579|P2|COMPLETED|Overall Study||3
407542|NCT01669720|998580|P1|COMPLETED|Overall Study||7
407543|NCT01669720|998579|P2|STARTED|Overall Study||3
407544|NCT01669720|998580|P1|STARTED|Overall Study||7
407545|NCT01669642|998593|P6|NOT COMPLETED|Overall Study||10
407546|NCT01669642|998594|P5|NOT COMPLETED|Overall Study||0
407547|NCT01669642|998595|P4|NOT COMPLETED|Overall Study||1
407548|NCT01669642|998596|P3|NOT COMPLETED|Overall Study||0
407549|NCT01669642|998597|P2|NOT COMPLETED|Overall Study||0
407550|NCT01669642|998598|P1|NOT COMPLETED|Overall Study||0
407551|NCT01669642|998593|P6|COMPLETED|Overall Study||0
407552|NCT01669642|998594|P5|COMPLETED|Overall Study||20
407553|NCT01669642|998595|P4|COMPLETED|Overall Study||20
407554|NCT01669642|998596|P3|COMPLETED|Overall Study||20
407555|NCT01669642|998597|P2|COMPLETED|Overall Study||20
407556|NCT01669642|998598|P1|COMPLETED|Overall Study||20
407557|NCT01669642|998593|P6|STARTED|Overall Study||10
407558|NCT01669642|998594|P5|STARTED|Overall Study||20
407559|NCT01669642|998595|P4|STARTED|Overall Study||21
407560|NCT01669642|998596|P3|STARTED|Overall Study||20
407561|NCT01669642|998597|P2|STARTED|Overall Study||20
407562|NCT01669642|998598|P1|STARTED|Overall Study||20
407563|NCT01669629|998630|P2|NOT COMPLETED|Period 2||0
407564|NCT01669629|998631|P1|NOT COMPLETED|Period 2||0
407565|NCT01669629|998630|P2|COMPLETED|Period 2||89
407566|NCT01669629|998631|P1|COMPLETED|Period 2||91
407567|NCT01669629|998630|P2|STARTED|Period 2||89
407568|NCT01669629|998631|P1|STARTED|Period 2||91
407569|NCT01669629|998630|P2|NOT COMPLETED|Period 1||2
407570|NCT01669629|998631|P1|NOT COMPLETED|Period 1||1
407571|NCT01669629|998630|P2|COMPLETED|Period 1||89
407572|NCT01669629|998631|P1|COMPLETED|Period 1||91
407573|NCT01669629|998630|P2|STARTED|Period 1||91
407574|NCT01669629|998631|P1|STARTED|Period 1||92
407575|NCT01669603|998647|P2|NOT COMPLETED|Overall Study||38
407576|NCT01669603|998648|P1|NOT COMPLETED|Overall Study||37
407577|NCT01669603|998647|P2|COMPLETED|Overall Study||57
407578|NCT01669603|998648|P1|COMPLETED|Overall Study||58
407579|NCT01669603|998647|P2|STARTED|Overall Study||95
407580|NCT01669603|998648|P1|STARTED|Overall Study||95
407581|NCT01669577|998654|P1|NOT COMPLETED|Overall Study||134
407582|NCT01669577|998654|P1|COMPLETED|Overall Study|complete case analysis (data missing completely at random)|200
407583|NCT01669577|998654|P1|STARTED|Overall Study|calculated ISS<16, no informed consent, not enough data(complete case analysis), were excluded|334
407584|NCT01669434|998660|P2|NOT COMPLETED|Overall Study||7
407585|NCT01669434|998661|P1|NOT COMPLETED|Overall Study||9
407586|NCT01669434|998660|P2|COMPLETED|Overall Study||138
407587|NCT01669434|998661|P1|COMPLETED|Overall Study||137
407588|NCT01669434|998660|P2|STARTED|Overall Study||145
407589|NCT01669434|998661|P1|STARTED|Overall Study||146
407590|NCT01669174|998679|P2|NOT COMPLETED|Overall Study||6
407591|NCT01669174|998680|P1|NOT COMPLETED|Overall Study||6
407592|NCT01669174|998679|P2|COMPLETED|Overall Study||28
407593|NCT01669174|998680|P1|COMPLETED|Overall Study||27
407594|NCT01669174|998679|P2|STARTED|Overall Study||34
407595|NCT01669174|998680|P1|STARTED|Overall Study||33
407596|NCT01669148|998691|P1|NOT COMPLETED|Overall Study||70
407597|NCT01669148|998691|P1|COMPLETED|Overall Study||426
407598|NCT01669148|998691|P1|STARTED|Overall Study||496
407599|NCT01669122|998696|P1|NOT COMPLETED|Period IV||0
407600|NCT01669122|998696|P1|COMPLETED|Period IV||37
407601|NCT01669122|998696|P1|STARTED|Period IV|Participants who received Lozenge A=9, Lozenge B=10, Lozenge C=9, Reference Lozenge=9|37
407602|NCT01669122|998696|P1|NOT COMPLETED|Period III||0
407603|NCT01669122|998696|P1|COMPLETED|Period III||37
407604|NCT01669122|998696|P1|STARTED|Period III|Participants who received Lozenge A=10, Lozenge B=8, Lozenge C=10, Reference Lozenge=9|37
407605|NCT01669122|998696|P1|NOT COMPLETED|Washout Period III||0
407606|NCT01669122|998696|P1|COMPLETED|Washout Period III||37
407607|NCT01669122|998696|P1|STARTED|Washout Period III||37
407608|NCT01669122|998696|P1|NOT COMPLETED|Washout Period II||2
407609|NCT01669122|998696|P1|COMPLETED|Washout Period II||37
407610|NCT01669122|998696|P1|STARTED|Washout Period II||39
407611|NCT01669122|998696|P1|NOT COMPLETED|Period II||0
407612|NCT01669122|998696|P1|COMPLETED|Period II||39
407613|NCT01669122|998696|P1|STARTED|Period II|Participants who received Lozenge A=9, Lozenge B=10, Lozenge C=10, Reference Lozenge=10|39
407614|NCT01669122|998696|P1|NOT COMPLETED|Washout Period I||0
407615|NCT01669122|998696|P1|COMPLETED|Washout Period I||39
407616|NCT01669122|998696|P1|STARTED|Washout Period I||39
407617|NCT01669122|998696|P1|NOT COMPLETED|Period I||1
407618|NCT01669122|998696|P1|COMPLETED|Period I||39
407619|NCT01669122|998696|P1|Safety Population|Period I||39
407620|NCT01669122|998696|P1|STARTED|Period I|Participants who received Lozenge A=10, Lozenge B=10, Lozenge C=10, Reference Lozenge=10|40
407621|NCT01668836|998730|P4|NOT COMPLETED|Overall Study||0
407622|NCT01668836|998731|P3|NOT COMPLETED|Overall Study||0
407623|NCT01668836|998732|P2|NOT COMPLETED|Overall Study||0
407624|NCT01668836|998733|P1|NOT COMPLETED|Overall Study||0
407625|NCT01668836|998730|P4|COMPLETED|Overall Study||12
407626|NCT01668836|998731|P3|COMPLETED|Overall Study||12
407627|NCT01668836|998732|P2|COMPLETED|Overall Study||12
407628|NCT01668836|998733|P1|COMPLETED|Overall Study||12
407629|NCT01668836|998730|P4|STARTED|Overall Study||12
407630|NCT01668836|998731|P3|STARTED|Overall Study||12
407631|NCT01668836|998732|P2|STARTED|Overall Study||12
407632|NCT01668836|998733|P1|STARTED|Overall Study||12
407633|NCT01668797|998789|P4|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||96
407634|NCT01668797|998790|P3|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||83
407635|NCT01668797|998791|P2|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
407636|NCT01668797|998792|P1|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
407637|NCT01668797|998789|P4|COMPLETED|Phase C (Double-Blind Maintenance Phase)||9
407638|NCT01668797|998790|P3|COMPLETED|Phase C (Double-Blind Maintenance Phase)||14
407639|NCT01668797|998791|P2|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
407640|NCT01668797|998792|P1|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
407641|NCT01668797|998789|P4|STARTED|Phase C (Double-Blind Maintenance Phase)||105
407642|NCT01668797|998790|P3|STARTED|Phase C (Double-Blind Maintenance Phase)|N= 202 rolled over from Phase B|97
407643|NCT01668797|998791|P2|STARTED|Phase C (Double-Blind Maintenance Phase)||0
407644|NCT01668797|998792|P1|STARTED|Phase C (Double-Blind Maintenance Phase)||0
407645|NCT01668797|998789|P4|NOT COMPLETED|Phase B (Stabilization Phase)||0
407646|NCT01668797|998790|P3|NOT COMPLETED|Phase B (Stabilization Phase)||0
407647|NCT01668797|998791|P2|NOT COMPLETED|Phase B (Stabilization Phase)||262
407648|NCT01668797|998792|P1|NOT COMPLETED|Phase B (Stabilization Phase)||0
407649|NCT01668797|998789|P4|COMPLETED|Phase B (Stabilization Phase)||0
407650|NCT01668797|998790|P3|COMPLETED|Phase B (Stabilization Phase)||0
407651|NCT01668797|998791|P2|COMPLETED|Phase B (Stabilization Phase)||202
407652|NCT01668797|998792|P1|COMPLETED|Phase B (Stabilization Phase)||0
407653|NCT01668797|998789|P4|STARTED|Phase B (Stabilization Phase)||0
407654|NCT01668797|998790|P3|STARTED|Phase B (Stabilization Phase)||0
407655|NCT01668797|998791|P2|STARTED|Phase B (Stabilization Phase)|N= 464; 346 rolled over from Phase A and 118 entered directly into Phase B|464
407656|NCT01668797|998792|P1|STARTED|Phase B (Stabilization Phase)||0
407657|NCT01668797|998789|P4|NOT COMPLETED|Phase A (Conversion Phase)||0
407658|NCT01668797|998790|P3|NOT COMPLETED|Phase A (Conversion Phase)||0
407659|NCT01668797|998791|P2|NOT COMPLETED|Phase A (Conversion Phase)||0
407660|NCT01668797|998792|P1|NOT COMPLETED|Phase A (Conversion Phase)||60
407661|NCT01668797|998789|P4|COMPLETED|Phase A (Conversion Phase)||0
407662|NCT01668797|998790|P3|COMPLETED|Phase A (Conversion Phase)||0
407663|NCT01668797|998791|P2|COMPLETED|Phase A (Conversion Phase)||0
407664|NCT01668797|998792|P1|COMPLETED|Phase A (Conversion Phase)||346
407665|NCT01668797|998789|P4|STARTED|Phase A (Conversion Phase)||0
407666|NCT01668797|998790|P3|STARTED|Phase A (Conversion Phase)||0
407667|NCT01668797|998791|P2|STARTED|Phase A (Conversion Phase)||0
407668|NCT01668797|998792|P1|STARTED|Phase A (Conversion Phase)||406
407669|NCT01668784|998857|P2|NOT COMPLETED|Treated (Overall)||369
407670|NCT01668784|998858|P1|NOT COMPLETED|Treated (Overall)||339
407671|NCT01668784|998857|P2|COMPLETED|Treated (Overall)||28
407672|NCT01668784|998858|P1|COMPLETED|Treated (Overall)||67
407673|NCT01668784|998857|P2|STARTED|Treated (Overall)||397
407674|NCT01668784|998858|P1|STARTED|Treated (Overall)||406
407675|NCT01668784|998857|P2|NOT COMPLETED|Randomized (Pre-treatment)||14
407676|NCT01668784|998858|P1|NOT COMPLETED|Randomized (Pre-treatment)||4
407677|NCT01668784|998857|P2|COMPLETED|Randomized (Pre-treatment)||397
407678|NCT01668784|998858|P1|COMPLETED|Randomized (Pre-treatment)||406
407679|NCT01668784|998857|P2|STARTED|Randomized (Pre-treatment)||411
407680|NCT01668784|998858|P1|STARTED|Randomized (Pre-treatment)||410
407681|NCT01668667|998886|P4|NOT COMPLETED|Overall Study||23
407682|NCT01668667|998887|P3|NOT COMPLETED|Overall Study||31
407683|NCT01668667|998888|P2|NOT COMPLETED|Overall Study||26
407684|NCT01668667|998889|P1|NOT COMPLETED|Overall Study||31
407685|NCT01668667|998886|P4|COMPLETED|Overall Study||102
407686|NCT01668667|998887|P3|COMPLETED|Overall Study||94
407687|NCT01668667|998888|P2|COMPLETED|Overall Study||99
407688|NCT01668667|998889|P1|COMPLETED|Overall Study||95
407689|NCT01668667|998886|P4|STARTED|Overall Study||125
407690|NCT01668667|998887|P3|STARTED|Overall Study||125
407691|NCT01668667|998888|P2|STARTED|Overall Study||125
407692|NCT01668667|998889|P1|STARTED|Overall Study||126
407693|NCT01668654|998911|P1|NOT COMPLETED|Overall Study||4
407694|NCT01668654|998911|P1|COMPLETED|Overall Study||0
407695|NCT01668654|998911|P1|STARTED|Overall Study||4
407696|NCT01668628|998954|P3|NOT COMPLETED|Overall Study||0
407697|NCT01668628|998955|P2|NOT COMPLETED|Overall Study||0
407698|NCT01668628|998956|P1|NOT COMPLETED|Overall Study||2
407699|NCT01668628|998954|P3|COMPLETED|Overall Study||367
407700|NCT01668628|998955|P2|COMPLETED|Overall Study||359
407701|NCT01668628|998956|P1|COMPLETED|Overall Study||347
407702|NCT01668628|998954|P3|STARTED|Overall Study|2 subjects had been excluded due to protocol violation and then data of the rest were anlayzed.|367
407703|NCT01668628|998955|P2|STARTED|Overall Study||359
407704|NCT01668628|998956|P1|STARTED|Overall Study|5 subjects had been excluded due to protocol violation and then data of the rest were anlayzed.|349
407705|NCT01668589|998972|P4|NOT COMPLETED|Overall Study||35
407706|NCT01668589|998973|P3|NOT COMPLETED|Overall Study||35
407707|NCT01668589|998974|P2|NOT COMPLETED|Overall Study||58
407708|NCT01668589|998975|P1|NOT COMPLETED|Overall Study||139
407709|NCT01668589|998972|P4|COMPLETED|Overall Study||266
407710|NCT01668589|998973|P3|COMPLETED|Overall Study||265
407711|NCT01668589|998974|P2|COMPLETED|Overall Study||242
407712|NCT01668589|998975|P1|COMPLETED|Overall Study||461
407713|NCT01668589|998972|P4|Received Denosumab|Overall Study||301
407714|NCT01668589|998973|P3|Received Denosumab|Overall Study||300
407715|NCT01668589|998974|P2|Received Denosumab|Overall Study||300
407716|NCT01668589|998975|P1|Received Denosumab|Overall Study||599
407717|NCT01668589|998972|P4|STARTED|Overall Study||301
407718|NCT01668589|998973|P3|STARTED|Overall Study||300
407719|NCT01668589|998974|P2|STARTED|Overall Study||300
407720|NCT01668589|998975|P1|STARTED|Overall Study||600
407721|NCT01668173|999013|P1|NOT COMPLETED|Overall Study||7
407722|NCT01668173|999013|P1|COMPLETED|Overall Study||0
407723|NCT01668173|999013|P1|STARTED|Overall Study||7
407724|NCT01668030|999017|P2|NOT COMPLETED|Overall Study||0
407725|NCT01668030|999018|P1|NOT COMPLETED|Overall Study||0
407726|NCT01668030|999017|P2|COMPLETED|Overall Study||10
407727|NCT01668030|999018|P1|COMPLETED|Overall Study||10
407728|NCT01668030|999017|P2|STARTED|Overall Study||10
407729|NCT01668030|999018|P1|STARTED|Overall Study||10
407730|NCT01668017|999028|P5|NOT COMPLETED|Overall Study||0
407731|NCT01668017|999029|P4|NOT COMPLETED|Overall Study||0
407732|NCT01668017|999030|P3|NOT COMPLETED|Overall Study||0
407733|NCT01668017|999031|P2|NOT COMPLETED|Overall Study||0
407734|NCT01668017|999032|P1|NOT COMPLETED|Overall Study||0
407735|NCT01668017|999028|P5|COMPLETED|Overall Study||2
407736|NCT01668017|999029|P4|COMPLETED|Overall Study||5
407737|NCT01668017|999030|P3|COMPLETED|Overall Study||6
407738|NCT01668017|999031|P2|COMPLETED|Overall Study||9
407739|NCT01668017|999032|P1|COMPLETED|Overall Study||4
407740|NCT01668017|999028|P5|STARTED|Overall Study||2
407741|NCT01668017|999029|P4|STARTED|Overall Study||5
407742|NCT01668017|999030|P3|STARTED|Overall Study||6
407743|NCT01668017|999031|P2|STARTED|Overall Study||9
407744|NCT01668017|999032|P1|STARTED|Overall Study||4
407745|NCT01668004|999139|P1|NOT COMPLETED|Overall Study||25
407746|NCT01668004|999139|P1|COMPLETED|Overall Study||76
407747|NCT01668004|999139|P1|Treated|Overall Study||101
407748|NCT01668004|999139|P1|STARTED|Overall Study||101
407749|NCT01667978|999152|P2|NOT COMPLETED|Overall Study||0
407750|NCT01667978|999153|P1|NOT COMPLETED|Overall Study||2
407751|NCT01667978|999152|P2|COMPLETED|Overall Study||17
407752|NCT01667978|999153|P1|COMPLETED|Overall Study||16
407753|NCT01667978|999152|P2|STARTED|Overall Study||17
407754|NCT01667978|999153|P1|STARTED|Overall Study||18
407755|NCT01667926|999161|P3|NOT COMPLETED|Overall Study||11
407756|NCT01667926|999162|P2|NOT COMPLETED|Overall Study||4
407757|NCT01667926|999163|P1|NOT COMPLETED|Overall Study||5
407758|NCT01667926|999161|P3|COMPLETED|Overall Study|Participants in the screen fail group were not randomized in the study.|0
407759|NCT01667926|999162|P2|COMPLETED|Overall Study||9
407760|NCT01667926|999163|P1|COMPLETED|Overall Study||8
407761|NCT01667926|999161|P3|STARTED|Overall Study||11
407762|NCT01667926|999162|P2|STARTED|Overall Study||13
407763|NCT01667926|999163|P1|STARTED|Overall Study||13
407764|NCT01667900|999176|P20|NOT COMPLETED|Part B||0
407765|NCT01667900|999177|P19|NOT COMPLETED|Part B||0
407766|NCT01667900|999178|P18|NOT COMPLETED|Part B||0
407767|NCT01667900|999179|P17|NOT COMPLETED|Part B||1
407768|NCT01667900|999180|P16|NOT COMPLETED|Part B||0
407769|NCT01667900|999181|P15|NOT COMPLETED|Part B||0
407770|NCT01667900|999182|P14|NOT COMPLETED|Part B||0
407771|NCT01667900|999183|P13|NOT COMPLETED|Part B||0
407772|NCT01667900|999184|P12|NOT COMPLETED|Part B||0
407773|NCT01667900|999185|P11|NOT COMPLETED|Part B||0
407774|NCT01667900|999186|P10|NOT COMPLETED|Part B||0
407775|NCT01667900|999187|P9|NOT COMPLETED|Part B||0
407776|NCT01667900|999188|P8|NOT COMPLETED|Part B||0
407777|NCT01667900|999189|P7|NOT COMPLETED|Part B||0
407778|NCT01667900|999190|P6|NOT COMPLETED|Part B||0
407779|NCT01667900|999191|P5|NOT COMPLETED|Part B||0
407780|NCT01667900|999192|P4|NOT COMPLETED|Part B||0
407781|NCT01667900|999193|P3|NOT COMPLETED|Part B||0
407782|NCT01667900|999194|P2|NOT COMPLETED|Part B||0
407783|NCT01667900|999195|P1|NOT COMPLETED|Part B||0
407784|NCT01667900|999176|P20|COMPLETED|Part B||10
407785|NCT01667900|999177|P19|COMPLETED|Part B||10
407786|NCT01667900|999178|P18|COMPLETED|Part B||11
407787|NCT01667900|999179|P17|COMPLETED|Part B||10
407788|NCT01667900|999180|P16|COMPLETED|Part B||0
407789|NCT01667900|999181|P15|COMPLETED|Part B||0
407790|NCT01667900|999182|P14|COMPLETED|Part B||0
407791|NCT01667900|999183|P13|COMPLETED|Part B||0
407792|NCT01667900|999184|P12|COMPLETED|Part B||0
407793|NCT01667900|999185|P11|COMPLETED|Part B||0
407794|NCT01667900|999186|P10|COMPLETED|Part B||0
407795|NCT01667900|999187|P9|COMPLETED|Part B||0
407796|NCT01667900|999188|P8|COMPLETED|Part B||0
407797|NCT01667900|999189|P7|COMPLETED|Part B||0
407798|NCT01667900|999190|P6|COMPLETED|Part B||0
407799|NCT01667900|999191|P5|COMPLETED|Part B||0
407800|NCT01667900|999192|P4|COMPLETED|Part B||0
407801|NCT01667900|999193|P3|COMPLETED|Part B||0
407802|NCT01667900|999194|P2|COMPLETED|Part B||0
407803|NCT01667900|999195|P1|COMPLETED|Part B||0
407804|NCT01667900|999176|P20|STARTED|Part B||10
407805|NCT01667900|999177|P19|STARTED|Part B||10
407806|NCT01667900|999178|P18|STARTED|Part B||11
407807|NCT01667900|999179|P17|STARTED|Part B||11
407808|NCT01667900|999180|P16|STARTED|Part B|Part A participants did not participate in Part B.|0
407809|NCT01667900|999181|P15|STARTED|Part B|Part A participants did not participate in Part B.|0
407810|NCT01667900|999182|P14|STARTED|Part B|Part A participants did not participate in Part B.|0
407811|NCT01667900|999183|P13|STARTED|Part B|Part A participants did not participate in Part B.|0
407812|NCT01667900|999184|P12|STARTED|Part B|Part A participants did not participate in Part B.|0
407813|NCT01667900|999185|P11|STARTED|Part B|Part A participants did not participate in Part B.|0
407814|NCT01667900|999186|P10|STARTED|Part B|Part A participants did not participate in Part B.|0
407815|NCT01667900|999187|P9|STARTED|Part B|Part A participants did not participate in Part B.|0
407816|NCT01667900|999188|P8|STARTED|Part B|Part A participants did not participate in Part B.|0
407817|NCT01667900|999189|P7|STARTED|Part B|Part A participants did not participate in Part B.|0
407818|NCT01667900|999190|P6|STARTED|Part B|Part A participants did not participate in Part B.|0
407819|NCT01667900|999191|P5|STARTED|Part B|Part A participants did not participate in Part B.|0
407820|NCT01667900|999192|P4|STARTED|Part B|Part A participants did not participate in Part B.|0
407821|NCT01667900|999193|P3|STARTED|Part B|Part A participants did not participate in Part B.|0
407822|NCT01667900|999194|P2|STARTED|Part B|Part A participants did not participate in Part B.|0
407823|NCT01667900|999195|P1|STARTED|Part B|Part A participants did not participate in Part B.|0
407824|NCT01667900|999176|P20|NOT COMPLETED|Part A, Period 3||0
407825|NCT01667900|999177|P19|NOT COMPLETED|Part A, Period 3||0
407826|NCT01667900|999178|P18|NOT COMPLETED|Part A, Period 3||0
407827|NCT01667900|999179|P17|NOT COMPLETED|Part A, Period 3||0
407828|NCT01667900|999180|P16|NOT COMPLETED|Part A, Period 3||0
407829|NCT01667900|999181|P15|NOT COMPLETED|Part A, Period 3||0
407830|NCT01667900|999182|P14|NOT COMPLETED|Part A, Period 3||0
407831|NCT01667900|999183|P13|NOT COMPLETED|Part A, Period 3||0
407832|NCT01667900|999184|P12|NOT COMPLETED|Part A, Period 3||0
407833|NCT01667900|999185|P11|NOT COMPLETED|Part A, Period 3||0
407834|NCT01667900|999186|P10|NOT COMPLETED|Part A, Period 3||0
407835|NCT01667900|999187|P9|NOT COMPLETED|Part A, Period 3||0
407836|NCT01667900|999188|P8|NOT COMPLETED|Part A, Period 3||0
407837|NCT01667900|999189|P7|NOT COMPLETED|Part A, Period 3||0
407838|NCT01667900|999190|P6|NOT COMPLETED|Part A, Period 3||0
407839|NCT01667900|999191|P5|NOT COMPLETED|Part A, Period 3||0
407840|NCT01667900|999192|P4|NOT COMPLETED|Part A, Period 3||0
407841|NCT01667900|999193|P3|NOT COMPLETED|Part A, Period 3||0
407842|NCT01667900|999194|P2|NOT COMPLETED|Part A, Period 3||0
407843|NCT01667900|999195|P1|NOT COMPLETED|Part A, Period 3||0
407844|NCT01667900|999176|P20|COMPLETED|Part A, Period 3||0
407845|NCT01667900|999177|P19|COMPLETED|Part A, Period 3||0
407846|NCT01667900|999178|P18|COMPLETED|Part A, Period 3||0
407847|NCT01667900|999179|P17|COMPLETED|Part A, Period 3||0
407848|NCT01667900|999180|P16|COMPLETED|Part A, Period 3||1
407849|NCT01667900|999181|P15|COMPLETED|Part A, Period 3||1
407850|NCT01667900|999182|P14|COMPLETED|Part A, Period 3||1
407851|NCT01667900|999183|P13|COMPLETED|Part A, Period 3||1
407852|NCT01667900|999184|P12|COMPLETED|Part A, Period 3||1
407853|NCT01667900|999185|P11|COMPLETED|Part A, Period 3||1
407854|NCT01667900|999186|P10|COMPLETED|Part A, Period 3||1
407855|NCT01667900|999187|P9|COMPLETED|Part A, Period 3||1
407856|NCT01667900|999188|P8|COMPLETED|Part A, Period 3||1
407857|NCT01667900|999189|P7|COMPLETED|Part A, Period 3||1
407858|NCT01667900|999190|P6|COMPLETED|Part A, Period 3||1
407859|NCT01667900|999191|P5|COMPLETED|Part A, Period 3||1
407860|NCT01667900|999192|P4|COMPLETED|Part A, Period 3||1
407861|NCT01667900|999193|P3|COMPLETED|Part A, Period 3||1
407862|NCT01667900|999194|P2|COMPLETED|Part A, Period 3||1
407863|NCT01667900|999195|P1|COMPLETED|Part A, Period 3||1
407864|NCT01667900|999176|P20|STARTED|Part A, Period 3||0
407865|NCT01667900|999177|P19|STARTED|Part A, Period 3||0
407866|NCT01667900|999178|P18|STARTED|Part A, Period 3||0
407867|NCT01667900|999179|P17|STARTED|Part A, Period 3||0
407868|NCT01667900|999180|P16|STARTED|Part A, Period 3||1
407869|NCT01667900|999181|P15|STARTED|Part A, Period 3||1
407870|NCT01667900|999182|P14|STARTED|Part A, Period 3||1
407871|NCT01667900|999183|P13|STARTED|Part A, Period 3||1
407872|NCT01667900|999184|P12|STARTED|Part A, Period 3||1
407873|NCT01667900|999185|P11|STARTED|Part A, Period 3||1
407874|NCT01667900|999186|P10|STARTED|Part A, Period 3||1
407875|NCT01667900|999187|P9|STARTED|Part A, Period 3||1
407876|NCT01667900|999188|P8|STARTED|Part A, Period 3||1
407877|NCT01667900|999189|P7|STARTED|Part A, Period 3||1
407878|NCT01667900|999190|P6|STARTED|Part A, Period 3||1
407879|NCT01667900|999191|P5|STARTED|Part A, Period 3||1
407880|NCT01667900|999192|P4|STARTED|Part A, Period 3||1
407881|NCT01667900|999193|P3|STARTED|Part A, Period 3||1
407882|NCT01667900|999194|P2|STARTED|Part A, Period 3||1
407883|NCT01667900|999195|P1|STARTED|Part A, Period 3||1
407884|NCT01667900|999176|P20|NOT COMPLETED|Part A, Washout 2||0
407885|NCT01667900|999177|P19|NOT COMPLETED|Part A, Washout 2||0
407886|NCT01667900|999178|P18|NOT COMPLETED|Part A, Washout 2||0
407887|NCT01667900|999179|P17|NOT COMPLETED|Part A, Washout 2||0
407888|NCT01667900|999180|P16|NOT COMPLETED|Part A, Washout 2||0
407889|NCT01667900|999181|P15|NOT COMPLETED|Part A, Washout 2||0
407890|NCT01667900|999182|P14|NOT COMPLETED|Part A, Washout 2||0
407891|NCT01667900|999183|P13|NOT COMPLETED|Part A, Washout 2||0
407892|NCT01667900|999184|P12|NOT COMPLETED|Part A, Washout 2||0
407893|NCT01667900|999185|P11|NOT COMPLETED|Part A, Washout 2||0
407894|NCT01667900|999186|P10|NOT COMPLETED|Part A, Washout 2||0
407895|NCT01667900|999187|P9|NOT COMPLETED|Part A, Washout 2||0
407896|NCT01667900|999188|P8|NOT COMPLETED|Part A, Washout 2||0
407897|NCT01667900|999189|P7|NOT COMPLETED|Part A, Washout 2||0
407898|NCT01667900|999190|P6|NOT COMPLETED|Part A, Washout 2||0
407899|NCT01667900|999191|P5|NOT COMPLETED|Part A, Washout 2||0
407900|NCT01667900|999192|P4|NOT COMPLETED|Part A, Washout 2||0
407901|NCT01667900|999193|P3|NOT COMPLETED|Part A, Washout 2||0
407902|NCT01667900|999194|P2|NOT COMPLETED|Part A, Washout 2||0
407903|NCT01667900|999195|P1|NOT COMPLETED|Part A, Washout 2||0
407904|NCT01667900|999176|P20|COMPLETED|Part A, Washout 2||0
407905|NCT01667900|999177|P19|COMPLETED|Part A, Washout 2||0
407906|NCT01667900|999178|P18|COMPLETED|Part A, Washout 2||0
407907|NCT01667900|999179|P17|COMPLETED|Part A, Washout 2||0
407908|NCT01667900|999180|P16|COMPLETED|Part A, Washout 2||1
407909|NCT01667900|999181|P15|COMPLETED|Part A, Washout 2||1
407910|NCT01667900|999182|P14|COMPLETED|Part A, Washout 2||1
407911|NCT01667900|999183|P13|COMPLETED|Part A, Washout 2||1
407912|NCT01667900|999184|P12|COMPLETED|Part A, Washout 2||1
407913|NCT01667900|999185|P11|COMPLETED|Part A, Washout 2||1
407914|NCT01667900|999186|P10|COMPLETED|Part A, Washout 2||1
407915|NCT01667900|999187|P9|COMPLETED|Part A, Washout 2||1
407916|NCT01667900|999188|P8|COMPLETED|Part A, Washout 2||1
407917|NCT01667900|999189|P7|COMPLETED|Part A, Washout 2||1
407918|NCT01667900|999190|P6|COMPLETED|Part A, Washout 2||1
407919|NCT01667900|999191|P5|COMPLETED|Part A, Washout 2||1
407920|NCT01667900|999192|P4|COMPLETED|Part A, Washout 2||1
407921|NCT01667900|999193|P3|COMPLETED|Part A, Washout 2||1
407922|NCT01667900|999194|P2|COMPLETED|Part A, Washout 2||1
407923|NCT01667900|999195|P1|COMPLETED|Part A, Washout 2||1
407924|NCT01667900|999176|P20|STARTED|Part A, Washout 2||0
407925|NCT01667900|999177|P19|STARTED|Part A, Washout 2||0
407926|NCT01667900|999178|P18|STARTED|Part A, Washout 2||0
407927|NCT01667900|999179|P17|STARTED|Part A, Washout 2||0
407928|NCT01667900|999180|P16|STARTED|Part A, Washout 2||1
407929|NCT01667900|999181|P15|STARTED|Part A, Washout 2||1
407930|NCT01667900|999182|P14|STARTED|Part A, Washout 2||1
407931|NCT01667900|999183|P13|STARTED|Part A, Washout 2||1
407932|NCT01667900|999184|P12|STARTED|Part A, Washout 2||1
407933|NCT01667900|999185|P11|STARTED|Part A, Washout 2||1
407934|NCT01667900|999186|P10|STARTED|Part A, Washout 2||1
407935|NCT01667900|999187|P9|STARTED|Part A, Washout 2||1
407936|NCT01667900|999188|P8|STARTED|Part A, Washout 2||1
407937|NCT01667900|999189|P7|STARTED|Part A, Washout 2||1
407938|NCT01667900|999190|P6|STARTED|Part A, Washout 2||1
407939|NCT01667900|999191|P5|STARTED|Part A, Washout 2||1
407940|NCT01667900|999192|P4|STARTED|Part A, Washout 2||1
407941|NCT01667900|999193|P3|STARTED|Part A, Washout 2||1
407942|NCT01667900|999194|P2|STARTED|Part A, Washout 2||1
407943|NCT01667900|999195|P1|STARTED|Part A, Washout 2||1
407944|NCT01667900|999176|P20|NOT COMPLETED|Part A, Period 2||0
407945|NCT01667900|999177|P19|NOT COMPLETED|Part A, Period 2||0
407946|NCT01667900|999178|P18|NOT COMPLETED|Part A, Period 2||0
407947|NCT01667900|999179|P17|NOT COMPLETED|Part A, Period 2||0
407948|NCT01667900|999180|P16|NOT COMPLETED|Part A, Period 2||0
407949|NCT01667900|999181|P15|NOT COMPLETED|Part A, Period 2||0
407950|NCT01667900|999182|P14|NOT COMPLETED|Part A, Period 2||0
407951|NCT01667900|999183|P13|NOT COMPLETED|Part A, Period 2||0
407952|NCT01667900|999184|P12|NOT COMPLETED|Part A, Period 2||0
407953|NCT01667900|999185|P11|NOT COMPLETED|Part A, Period 2||0
407954|NCT01667900|999186|P10|NOT COMPLETED|Part A, Period 2||0
407955|NCT01667900|999187|P9|NOT COMPLETED|Part A, Period 2||0
407956|NCT01667900|999188|P8|NOT COMPLETED|Part A, Period 2||0
407957|NCT01667900|999189|P7|NOT COMPLETED|Part A, Period 2||0
407958|NCT01667900|999190|P6|NOT COMPLETED|Part A, Period 2||0
407959|NCT01667900|999191|P5|NOT COMPLETED|Part A, Period 2||0
407960|NCT01667900|999192|P4|NOT COMPLETED|Part A, Period 2||0
407961|NCT01667900|999193|P3|NOT COMPLETED|Part A, Period 2||0
407962|NCT01667900|999194|P2|NOT COMPLETED|Part A, Period 2||0
407963|NCT01667900|999195|P1|NOT COMPLETED|Part A, Period 2||0
407964|NCT01667900|999176|P20|COMPLETED|Part A, Period 2||0
407965|NCT01667900|999177|P19|COMPLETED|Part A, Period 2||0
407966|NCT01667900|999178|P18|COMPLETED|Part A, Period 2||0
407967|NCT01667900|999179|P17|COMPLETED|Part A, Period 2||0
407968|NCT01667900|999180|P16|COMPLETED|Part A, Period 2||1
407969|NCT01667900|999181|P15|COMPLETED|Part A, Period 2||1
407970|NCT01667900|999182|P14|COMPLETED|Part A, Period 2||1
407971|NCT01667900|999183|P13|COMPLETED|Part A, Period 2||1
407972|NCT01667900|999184|P12|COMPLETED|Part A, Period 2||1
407973|NCT01667900|999185|P11|COMPLETED|Part A, Period 2||1
407974|NCT01667900|999186|P10|COMPLETED|Part A, Period 2||1
407975|NCT01667900|999187|P9|COMPLETED|Part A, Period 2||1
407976|NCT01667900|999188|P8|COMPLETED|Part A, Period 2||1
407977|NCT01667900|999189|P7|COMPLETED|Part A, Period 2||1
407978|NCT01667900|999190|P6|COMPLETED|Part A, Period 2||1
407979|NCT01667900|999191|P5|COMPLETED|Part A, Period 2||1
407980|NCT01667900|999192|P4|COMPLETED|Part A, Period 2||1
407981|NCT01667900|999193|P3|COMPLETED|Part A, Period 2||1
407982|NCT01667900|999194|P2|COMPLETED|Part A, Period 2||1
407983|NCT01667900|999195|P1|COMPLETED|Part A, Period 2||1
407984|NCT01667900|999176|P20|STARTED|Part A, Period 2||0
407985|NCT01667900|999177|P19|STARTED|Part A, Period 2||0
407986|NCT01667900|999178|P18|STARTED|Part A, Period 2||0
407987|NCT01667900|999179|P17|STARTED|Part A, Period 2||0
407988|NCT01667900|999180|P16|STARTED|Part A, Period 2||1
407989|NCT01667900|999181|P15|STARTED|Part A, Period 2||1
407990|NCT01667900|999182|P14|STARTED|Part A, Period 2||1
407991|NCT01667900|999183|P13|STARTED|Part A, Period 2||1
407992|NCT01667900|999184|P12|STARTED|Part A, Period 2||1
407993|NCT01667900|999185|P11|STARTED|Part A, Period 2||1
407994|NCT01667900|999186|P10|STARTED|Part A, Period 2||1
407995|NCT01667900|999187|P9|STARTED|Part A, Period 2||1
407996|NCT01667900|999188|P8|STARTED|Part A, Period 2||1
407997|NCT01667900|999189|P7|STARTED|Part A, Period 2||1
407998|NCT01667900|999190|P6|STARTED|Part A, Period 2||1
407999|NCT01667900|999191|P5|STARTED|Part A, Period 2||1
408000|NCT01667900|999192|P4|STARTED|Part A, Period 2||1
408001|NCT01667900|999193|P3|STARTED|Part A, Period 2||1
408002|NCT01667900|999194|P2|STARTED|Part A, Period 2||1
408003|NCT01667900|999195|P1|STARTED|Part A, Period 2||1
408004|NCT01667900|999176|P20|NOT COMPLETED|Part A, Washout 1||0
408005|NCT01667900|999177|P19|NOT COMPLETED|Part A, Washout 1||0
408006|NCT01667900|999178|P18|NOT COMPLETED|Part A, Washout 1||0
408007|NCT01667900|999179|P17|NOT COMPLETED|Part A, Washout 1||0
408008|NCT01667900|999180|P16|NOT COMPLETED|Part A, Washout 1||0
408009|NCT01667900|999181|P15|NOT COMPLETED|Part A, Washout 1||0
408010|NCT01667900|999182|P14|NOT COMPLETED|Part A, Washout 1||0
408011|NCT01667900|999183|P13|NOT COMPLETED|Part A, Washout 1||0
408012|NCT01667900|999184|P12|NOT COMPLETED|Part A, Washout 1||0
408013|NCT01667900|999185|P11|NOT COMPLETED|Part A, Washout 1||0
408014|NCT01667900|999186|P10|NOT COMPLETED|Part A, Washout 1||0
408015|NCT01667900|999187|P9|NOT COMPLETED|Part A, Washout 1||0
408016|NCT01667900|999188|P8|NOT COMPLETED|Part A, Washout 1||0
408017|NCT01667900|999189|P7|NOT COMPLETED|Part A, Washout 1||0
408018|NCT01667900|999190|P6|NOT COMPLETED|Part A, Washout 1||0
408019|NCT01667900|999191|P5|NOT COMPLETED|Part A, Washout 1||0
408020|NCT01667900|999192|P4|NOT COMPLETED|Part A, Washout 1||0
408021|NCT01667900|999193|P3|NOT COMPLETED|Part A, Washout 1||0
408022|NCT01667900|999194|P2|NOT COMPLETED|Part A, Washout 1||0
408023|NCT01667900|999195|P1|NOT COMPLETED|Part A, Washout 1||0
408024|NCT01667900|999176|P20|COMPLETED|Part A, Washout 1||0
408025|NCT01667900|999177|P19|COMPLETED|Part A, Washout 1||0
408026|NCT01667900|999178|P18|COMPLETED|Part A, Washout 1||0
408027|NCT01667900|999179|P17|COMPLETED|Part A, Washout 1||0
408028|NCT01667900|999180|P16|COMPLETED|Part A, Washout 1||1
408029|NCT01667900|999181|P15|COMPLETED|Part A, Washout 1||1
408030|NCT01667900|999182|P14|COMPLETED|Part A, Washout 1||1
408031|NCT01667900|999183|P13|COMPLETED|Part A, Washout 1||1
408032|NCT01667900|999184|P12|COMPLETED|Part A, Washout 1||1
408033|NCT01667900|999185|P11|COMPLETED|Part A, Washout 1||1
408034|NCT01667900|999186|P10|COMPLETED|Part A, Washout 1||1
408035|NCT01667900|999187|P9|COMPLETED|Part A, Washout 1||1
408036|NCT01667900|999188|P8|COMPLETED|Part A, Washout 1||1
408037|NCT01667900|999189|P7|COMPLETED|Part A, Washout 1||1
408038|NCT01667900|999190|P6|COMPLETED|Part A, Washout 1||1
408039|NCT01667900|999191|P5|COMPLETED|Part A, Washout 1||1
408040|NCT01667900|999192|P4|COMPLETED|Part A, Washout 1||1
408041|NCT01667900|999193|P3|COMPLETED|Part A, Washout 1||1
408042|NCT01667900|999194|P2|COMPLETED|Part A, Washout 1||1
408043|NCT01667900|999195|P1|COMPLETED|Part A, Washout 1||1
408044|NCT01667900|999176|P20|STARTED|Part A, Washout 1||0
408045|NCT01667900|999177|P19|STARTED|Part A, Washout 1||0
408046|NCT01667900|999178|P18|STARTED|Part A, Washout 1||0
408047|NCT01667900|999179|P17|STARTED|Part A, Washout 1||0
408048|NCT01667900|999180|P16|STARTED|Part A, Washout 1||1
408049|NCT01667900|999181|P15|STARTED|Part A, Washout 1||1
408050|NCT01667900|999182|P14|STARTED|Part A, Washout 1||1
408051|NCT01667900|999183|P13|STARTED|Part A, Washout 1||1
408052|NCT01667900|999184|P12|STARTED|Part A, Washout 1||1
408053|NCT01667900|999185|P11|STARTED|Part A, Washout 1||1
408054|NCT01667900|999186|P10|STARTED|Part A, Washout 1||1
408055|NCT01667900|999187|P9|STARTED|Part A, Washout 1||1
408056|NCT01667900|999188|P8|STARTED|Part A, Washout 1||1
408057|NCT01667900|999189|P7|STARTED|Part A, Washout 1||1
408058|NCT01667900|999190|P6|STARTED|Part A, Washout 1||1
408059|NCT01667900|999191|P5|STARTED|Part A, Washout 1||1
408060|NCT01667900|999192|P4|STARTED|Part A, Washout 1||1
408061|NCT01667900|999193|P3|STARTED|Part A, Washout 1||1
408062|NCT01667900|999194|P2|STARTED|Part A, Washout 1||1
408063|NCT01667900|999195|P1|STARTED|Part A, Washout 1||1
408064|NCT01667900|999176|P20|NOT COMPLETED|Part A, Period 1||0
408065|NCT01667900|999177|P19|NOT COMPLETED|Part A, Period 1||0
408066|NCT01667900|999178|P18|NOT COMPLETED|Part A, Period 1||0
408067|NCT01667900|999179|P17|NOT COMPLETED|Part A, Period 1||0
408068|NCT01667900|999180|P16|NOT COMPLETED|Part A, Period 1||0
408069|NCT01667900|999181|P15|NOT COMPLETED|Part A, Period 1||0
408070|NCT01667900|999182|P14|NOT COMPLETED|Part A, Period 1||0
408071|NCT01667900|999183|P13|NOT COMPLETED|Part A, Period 1||0
408072|NCT01667900|999184|P12|NOT COMPLETED|Part A, Period 1||0
408073|NCT01667900|999185|P11|NOT COMPLETED|Part A, Period 1||0
408074|NCT01667900|999186|P10|NOT COMPLETED|Part A, Period 1||0
408075|NCT01667900|999187|P9|NOT COMPLETED|Part A, Period 1||0
408076|NCT01667900|999188|P8|NOT COMPLETED|Part A, Period 1||0
408077|NCT01667900|999189|P7|NOT COMPLETED|Part A, Period 1||0
408078|NCT01667900|999190|P6|NOT COMPLETED|Part A, Period 1||0
408079|NCT01667900|999191|P5|NOT COMPLETED|Part A, Period 1||0
408080|NCT01667900|999192|P4|NOT COMPLETED|Part A, Period 1||0
408081|NCT01667900|999193|P3|NOT COMPLETED|Part A, Period 1||0
408082|NCT01667900|999194|P2|NOT COMPLETED|Part A, Period 1||0
408083|NCT01667900|999195|P1|NOT COMPLETED|Part A, Period 1||0
408084|NCT01667900|999176|P20|COMPLETED|Part A, Period 1||0
408085|NCT01667900|999177|P19|COMPLETED|Part A, Period 1||0
408086|NCT01667900|999178|P18|COMPLETED|Part A, Period 1||0
408087|NCT01667900|999179|P17|COMPLETED|Part A, Period 1||0
408088|NCT01667900|999180|P16|COMPLETED|Part A, Period 1||1
408089|NCT01667900|999181|P15|COMPLETED|Part A, Period 1||1
408090|NCT01667900|999182|P14|COMPLETED|Part A, Period 1||1
408091|NCT01667900|999183|P13|COMPLETED|Part A, Period 1||1
408092|NCT01667900|999184|P12|COMPLETED|Part A, Period 1||1
408093|NCT01667900|999185|P11|COMPLETED|Part A, Period 1||1
408094|NCT01667900|999186|P10|COMPLETED|Part A, Period 1||1
408095|NCT01667900|999187|P9|COMPLETED|Part A, Period 1||1
408096|NCT01667900|999188|P8|COMPLETED|Part A, Period 1||1
408097|NCT01667900|999189|P7|COMPLETED|Part A, Period 1||1
408098|NCT01667900|999190|P6|COMPLETED|Part A, Period 1||1
408099|NCT01667900|999191|P5|COMPLETED|Part A, Period 1||1
408100|NCT01667900|999192|P4|COMPLETED|Part A, Period 1||1
408101|NCT01667900|999193|P3|COMPLETED|Part A, Period 1||1
408102|NCT01667900|999194|P2|COMPLETED|Part A, Period 1||1
408103|NCT01667900|999195|P1|COMPLETED|Part A, Period 1||1
408104|NCT01667900|999176|P20|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
408105|NCT01667900|999177|P19|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
408106|NCT01667900|999178|P18|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
408107|NCT01667900|999179|P17|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
408108|NCT01667900|999180|P16|STARTED|Part A, Period 1||1
408109|NCT01667900|999181|P15|STARTED|Part A, Period 1||1
408110|NCT01667900|999182|P14|STARTED|Part A, Period 1||1
408111|NCT01667900|999183|P13|STARTED|Part A, Period 1||1
408112|NCT01667900|999184|P12|STARTED|Part A, Period 1||1
408113|NCT01667900|999185|P11|STARTED|Part A, Period 1||1
408114|NCT01667900|999186|P10|STARTED|Part A, Period 1||1
408115|NCT01667900|999187|P9|STARTED|Part A, Period 1||1
408116|NCT01667900|999188|P8|STARTED|Part A, Period 1||1
408117|NCT01667900|999189|P7|STARTED|Part A, Period 1||1
408118|NCT01667900|999190|P6|STARTED|Part A, Period 1||1
408119|NCT01667900|999191|P5|STARTED|Part A, Period 1||1
408120|NCT01667900|999192|P4|STARTED|Part A, Period 1||1
408121|NCT01667900|999193|P3|STARTED|Part A, Period 1||1
408122|NCT01667900|999194|P2|STARTED|Part A, Period 1||1
408123|NCT01667900|999195|P1|STARTED|Part A, Period 1||1
408124|NCT01667848|999235|P2|NOT COMPLETED|Overall Study||0
408125|NCT01667848|999236|P1|NOT COMPLETED|Overall Study||0
408126|NCT01667848|999235|P2|COMPLETED|Overall Study||81
408127|NCT01667848|999236|P1|COMPLETED|Overall Study||67
408128|NCT01667848|999235|P2|STARTED|Overall Study||81
408129|NCT01667848|999236|P1|STARTED|Overall Study||67
408130|NCT01667796|999246|P2|NOT COMPLETED|Overall Study||1
408131|NCT01667796|999247|P1|NOT COMPLETED|Overall Study||3
408132|NCT01667796|999246|P2|COMPLETED|Overall Study||29
408133|NCT01667796|999247|P1|COMPLETED|Overall Study||24
408134|NCT01667796|999246|P2|STARTED|Overall Study||30
408135|NCT01667796|999247|P1|STARTED|Overall Study||27
408136|NCT01667731|999258|P5|NOT COMPLETED|Overall Study||28
408137|NCT01667731|999259|P4|NOT COMPLETED|Overall Study||2
408138|NCT01667731|999260|P3|NOT COMPLETED|Overall Study||2
408139|NCT01667731|999261|P2|NOT COMPLETED|Overall Study||16
408140|NCT01667731|999262|P1|NOT COMPLETED|Overall Study||5
408141|NCT01667731|999258|P5|COMPLETED|Overall Study||87
408142|NCT01667731|999259|P4|COMPLETED|Overall Study||15
408143|NCT01667731|999260|P3|COMPLETED|Overall Study||22
408144|NCT01667731|999261|P2|COMPLETED|Overall Study||26
408145|NCT01667731|999262|P1|COMPLETED|Overall Study||21
408146|NCT01667731|999258|P5|STARTED|Overall Study||115
408147|NCT01667731|999259|P4|STARTED|Overall Study||17
408148|NCT01667731|999260|P3|STARTED|Overall Study||24
408149|NCT01667731|999261|P2|STARTED|Overall Study||42
408150|NCT01667731|999262|P1|STARTED|Overall Study||26
408151|NCT01667679|999317|P2|NOT COMPLETED|Treatment Period 2 (<=12 Weeks)||22
408152|NCT01667679|999318|P1|NOT COMPLETED|Treatment Period 2 (<=12 Weeks)||22
408153|NCT01667679|999317|P2|COMPLETED|Treatment Period 2 (<=12 Weeks)||85
408154|NCT01667679|999318|P1|COMPLETED|Treatment Period 2 (<=12 Weeks)||100
408155|NCT01667679|999317|P2|STARTED|Treatment Period 2 (<=12 Weeks)||107
408156|NCT01667679|999318|P1|STARTED|Treatment Period 2 (<=12 Weeks)||122
408157|NCT01667679|999317|P2|NOT COMPLETED|Treatment Period 1 (<=12 Weeks)||30
408158|NCT01667679|999318|P1|NOT COMPLETED|Treatment Period 1 (<=12 Weeks)||16
408159|NCT01667679|999317|P2|COMPLETED|Treatment Period 1 (<=12 Weeks)||107
408160|NCT01667679|999318|P1|COMPLETED|Treatment Period 1 (<=12 Weeks)||122
408161|NCT01667679|999317|P2|STARTED|Treatment Period 1 (<=12 Weeks)||137
408162|NCT01667679|999318|P1|STARTED|Treatment Period 1 (<=12 Weeks)||138
408163|NCT01667536|999376|P1|NOT COMPLETED|Overall Study||0
408164|NCT01667536|999376|P1|COMPLETED|Overall Study|105 subjects comprised the safety popn, defined as all subjects who received an MIP-1404 injection.|105
408165|NCT01667536|999376|P1|STARTED|Overall Study||105
408166|NCT01667471|999387|P1|NOT COMPLETED|Overall Study||0
408167|NCT01667471|999387|P1|COMPLETED|Overall Study||7
408168|NCT01667471|999387|P1|STARTED|Overall Study||7
408169|NCT01667432|999403|P1|NOT COMPLETED|Overall Study||57
408170|NCT01667432|999403|P1|COMPLETED|Overall Study||84
408171|NCT01667432|999403|P1|STARTED|Overall Study||141
408172|NCT01667250|999410|P3|NOT COMPLETED|Randomised Period||0
408173|NCT01667250|999411|P2|NOT COMPLETED|Randomised Period||1
408174|NCT01667250|999412|P1|NOT COMPLETED|Randomised Period||1
408175|NCT01667250|999410|P3|COMPLETED|Randomised Period||0
408176|NCT01667250|999411|P2|COMPLETED|Randomised Period||28
408177|NCT01667250|999412|P1|COMPLETED|Randomised Period||29
408178|NCT01667250|999410|P3|STARTED|Randomised Period||0
408179|NCT01667250|999411|P2|STARTED|Randomised Period||29
408180|NCT01667250|999412|P1|STARTED|Randomised Period||30
408181|NCT01667250|999410|P3|NOT COMPLETED|Run-in (no Treatment)||14
408182|NCT01667250|999411|P2|NOT COMPLETED|Run-in (no Treatment)||0
408183|NCT01667250|999412|P1|NOT COMPLETED|Run-in (no Treatment)||0
408184|NCT01667250|999410|P3|COMPLETED|Run-in (no Treatment)||59
408185|NCT01667250|999411|P2|COMPLETED|Run-in (no Treatment)||0
408186|NCT01667250|999412|P1|COMPLETED|Run-in (no Treatment)||0
408187|NCT01667250|999410|P3|STARTED|Run-in (no Treatment)||73
408188|NCT01667250|999411|P2|STARTED|Run-in (no Treatment)||0
408189|NCT01667250|999412|P1|STARTED|Run-in (no Treatment)||0
408190|NCT01667224|999428|P2|NOT COMPLETED|Overall Study||2
408191|NCT01667224|999429|P1|NOT COMPLETED|Overall Study||4
408192|NCT01667224|999428|P2|COMPLETED|Overall Study||38
408193|NCT01667224|999429|P1|COMPLETED|Overall Study||36
408194|NCT01667224|999428|P2|STARTED|Overall Study||40
408195|NCT01667224|999429|P1|STARTED|Overall Study||40
408196|NCT01667107|999443|P2|NOT COMPLETED|Overall Study||7
408197|NCT01667107|999444|P1|NOT COMPLETED|Overall Study||4
408198|NCT01667107|999443|P2|COMPLETED|Overall Study||11
408199|NCT01667107|999444|P1|COMPLETED|Overall Study||4
408200|NCT01667107|999443|P2|STARTED|Overall Study||18
408201|NCT01667107|999444|P1|STARTED|Overall Study||8
408202|NCT01666951|999462|P2|NOT COMPLETED|Overall Study||1
408203|NCT01666951|999463|P1|NOT COMPLETED|Overall Study||1
408204|NCT01666951|999462|P2|COMPLETED|Overall Study||17
408205|NCT01666951|999463|P1|COMPLETED|Overall Study||17
408206|NCT01666951|999462|P2|STARTED|Overall Study||18
408207|NCT01666951|999463|P1|STARTED|Overall Study||18
408208|NCT01666912|999501|P2|NOT COMPLETED|Overall Study||11
408209|NCT01666912|999502|P1|NOT COMPLETED|Overall Study||21
408210|NCT01666912|999501|P2|COMPLETED|Overall Study||37
408211|NCT01666912|999502|P1|COMPLETED|Overall Study||27
408212|NCT01666912|999501|P2|STARTED|Overall Study||48
408213|NCT01666912|999502|P1|STARTED|Overall Study||48
408214|NCT01666782|999514|P2|NOT COMPLETED|Overall Study||1
408215|NCT01666782|999515|P1|NOT COMPLETED|Overall Study||4
408216|NCT01666782|999514|P2|COMPLETED|Overall Study||50
408217|NCT01666782|999515|P1|COMPLETED|Overall Study||50
408218|NCT01666782|999514|P2|STARTED|Overall Study||51
408219|NCT01666782|999515|P1|STARTED|Overall Study||54
408220|NCT01666314|999539|P4|NOT COMPLETED|Overall Study||36
408221|NCT01666314|999540|P3|NOT COMPLETED|Overall Study||36
408222|NCT01666314|999541|P2|NOT COMPLETED|Overall Study||32
408223|NCT01666314|999542|P1|NOT COMPLETED|Overall Study||33
408224|NCT01666314|999539|P4|COMPLETED|Overall Study||0
408225|NCT01666314|999540|P3|COMPLETED|Overall Study||0
408226|NCT01666314|999541|P2|COMPLETED|Overall Study||0
408227|NCT01666314|999542|P1|COMPLETED|Overall Study||0
408228|NCT01666314|999539|P4|STARTED|Overall Study||36
408229|NCT01666314|999540|P3|STARTED|Overall Study||36
408230|NCT01666314|999541|P2|STARTED|Overall Study||32
408231|NCT01666314|999542|P1|STARTED|Overall Study||33
408232|NCT01666210|999653|P2|NOT COMPLETED|Overall Study||1
408233|NCT01666210|999654|P1|NOT COMPLETED|Overall Study||2
408234|NCT01666210|999653|P2|COMPLETED|Overall Study||29
408235|NCT01666210|999654|P1|COMPLETED|Overall Study||28
408236|NCT01666210|999653|P2|STARTED|Overall Study||30
408237|NCT01666210|999654|P1|STARTED|Overall Study||30
408238|NCT01666197|999666|P2|NOT COMPLETED|Overall Study||0
408239|NCT01666197|999667|P1|NOT COMPLETED|Overall Study||0
408240|NCT01666197|999666|P2|COMPLETED|Overall Study||50
408241|NCT01666197|999667|P1|COMPLETED|Overall Study||50
408242|NCT01666197|999666|P2|STARTED|Overall Study||50
408243|NCT01666197|999667|P1|STARTED|Overall Study||50
408244|NCT01666119|999673|P1|NOT COMPLETED|Overall Study||52
408245|NCT01666119|999673|P1|COMPLETED|Overall Study||197
408246|NCT01666119|999673|P1|STARTED|Overall Study||249
408247|NCT01666002|999680|P2|NOT COMPLETED|Overall Study||0
408248|NCT01666002|999681|P1|NOT COMPLETED|Overall Study||5
408249|NCT01666002|999680|P2|COMPLETED|Overall Study||10
408250|NCT01666002|999681|P1|COMPLETED|Overall Study||12
408251|NCT01666002|999680|P2|STARTED|Overall Study||10
408252|NCT01666002|999681|P1|STARTED|Overall Study||17
408253|NCT01665950|999692|P3|NOT COMPLETED|Overall Study||1
408254|NCT01665950|999693|P2|NOT COMPLETED|Overall Study||0
408255|NCT01665950|999694|P1|NOT COMPLETED|Overall Study||1
408256|NCT01665950|999692|P3|COMPLETED|Overall Study||1
408257|NCT01665950|999693|P2|COMPLETED|Overall Study||0
408258|NCT01665950|999694|P1|COMPLETED|Overall Study||1
408259|NCT01665950|999692|P3|STARTED|Overall Study||2
408260|NCT01665950|999693|P2|STARTED|Overall Study||0
408261|NCT01665950|999694|P1|STARTED|Overall Study||2
408262|NCT01665911|999702|P1|NOT COMPLETED|Overall Study||6
408263|NCT01665911|999702|P1|COMPLETED|Overall Study||22
408264|NCT01665911|999702|P1|3.0 mg Sodium Fluoride in 200 ml Milk|Overall Study||22
408265|NCT01665911|999702|P1|3.0 mg Sodium Fluoride in 100 ml Milk|Overall Study||22
408266|NCT01665911|999702|P1|1.5 mg Sodium Fluoride in 200 ml Milk|Overall Study||25
408267|NCT01665911|999702|P1|1.5 mg Sodium Fluoride in 100 ml Milk|Overall Study||23
408268|NCT01665911|999702|P1|0 mg Fluoride in 200 ml Milk|Overall Study||22
408269|NCT01665911|999702|P1|STARTED|Overall Study||28
408270|NCT01665807|999711|P3|NOT COMPLETED|Overall Study||1
408271|NCT01665807|999712|P2|NOT COMPLETED|Overall Study||0
408272|NCT01665807|999713|P1|NOT COMPLETED|Overall Study||2
408273|NCT01665807|999711|P3|COMPLETED|Overall Study||401
408274|NCT01665807|999712|P2|COMPLETED|Overall Study||58
408275|NCT01665807|999713|P1|COMPLETED|Overall Study||409
408276|NCT01665807|999711|P3|STARTED|Overall Study||402
408277|NCT01665807|999712|P2|STARTED|Overall Study||58
408278|NCT01665807|999713|P1|STARTED|Overall Study||411
408279|NCT01665599|999724|P1|NOT COMPLETED|Overall Study||8
408280|NCT01665599|999724|P1|COMPLETED|Overall Study||172
408281|NCT01665599|999724|P1|STARTED|Overall Study||180
408282|NCT01665508|999744|P1|NOT COMPLETED|Overall Study||5
408283|NCT01665508|999744|P1|COMPLETED|Overall Study||7
408284|NCT01665508|999744|P1|STARTED|Overall Study||12
408285|NCT01665430|999760|P1|NOT COMPLETED|Overall Study||9
408286|NCT01665430|999760|P1|COMPLETED|Overall Study||29
408287|NCT01665430|999760|P1|STARTED|Overall Study||38
408288|NCT01665170|999776|P2|NOT COMPLETED|Overall Study||0
408289|NCT01665170|999777|P1|NOT COMPLETED|Overall Study||0
408290|NCT01665170|999776|P2|COMPLETED|Overall Study||30
408291|NCT01665170|999777|P1|COMPLETED|Overall Study|Last TSST/ last patient out|30
408292|NCT01665170|999776|P2|After TSST|Overall Study||30
408293|NCT01665170|999777|P1|After TSST|Overall Study||30
408294|NCT01665170|999776|P2|During TSST|Overall Study||30
408295|NCT01665170|999777|P1|During TSST|Overall Study||30
408296|NCT01665170|999776|P2|Bevore TSST|Overall Study||30
408297|NCT01665170|999777|P1|Bevore TSST|Overall Study||30
408298|NCT01665170|999776|P2|STARTED|Overall Study||30
408299|NCT01665170|999777|P1|STARTED|Overall Study|First patient in|30
408300|NCT01665157|999828|P3|NOT COMPLETED|Overall Study||0
408301|NCT01665157|999829|P2|NOT COMPLETED|Overall Study||0
408302|NCT01665157|999830|P1|NOT COMPLETED|Overall Study||0
408303|NCT01665157|999828|P3|COMPLETED|Overall Study||60
408304|NCT01665157|999829|P2|COMPLETED|Overall Study||60
408305|NCT01665157|999830|P1|COMPLETED|Overall Study||60
408306|NCT01665157|999828|P3|STARTED|Overall Study||60
408307|NCT01665157|999829|P2|STARTED|Overall Study||60
408308|NCT01665157|999830|P1|STARTED|Overall Study||60
408309|NCT01665053|999858|P2|NOT COMPLETED|Overall Study||15
408310|NCT01665053|999859|P1|NOT COMPLETED|Overall Study||32
408311|NCT01665053|999858|P2|COMPLETED|Overall Study||831
408312|NCT01665053|999859|P1|COMPLETED|Overall Study||806
408313|NCT01665053|999858|P2|Death With No 12-month Clinical FU|Overall Study||9
408314|NCT01665053|999859|P1|Death With No 12-month Clinical FU|Overall Study||9
408315|NCT01665053|999858|P2|No 12-Month F/U|Overall Study||15
408316|NCT01665053|999859|P1|No 12-Month F/U|Overall Study||32
408317|NCT01665053|999858|P2|Completed 12-Month Clinical F/U|Overall Study||822
408318|NCT01665053|999859|P1|Completed 12-Month Clinical F/U|Overall Study||797
408319|NCT01665053|999858|P2|STARTED|Overall Study||846
408320|NCT01665053|999859|P1|STARTED|Overall Study||838
408321|NCT01664975|999899|P2|NOT COMPLETED|Overall Study||3
408322|NCT01664975|999900|P1|NOT COMPLETED|Overall Study||5
408323|NCT01664975|999899|P2|COMPLETED|Overall Study||51
408324|NCT01664975|999900|P1|COMPLETED|Overall Study||52
408325|NCT01664975|999899|P2|STARTED|Overall Study||54
408326|NCT01664975|999900|P1|STARTED|Overall Study||57
408327|NCT01664949|999908|P2|NOT COMPLETED|Overall Study||25
408328|NCT01664949|999909|P1|NOT COMPLETED|Overall Study||24
408329|NCT01664949|999908|P2|COMPLETED|Overall Study||211
408330|NCT01664949|999909|P1|COMPLETED|Overall Study||200
408331|NCT01664949|999908|P2|STARTED|Overall Study||236
408332|NCT01664949|999909|P1|STARTED|Overall Study||224
408341|NCT01664806|999946|P2|NOT COMPLETED|Overall Study||0
408342|NCT01664806|999947|P1|NOT COMPLETED|Overall Study||0
408343|NCT01664806|999946|P2|COMPLETED|Overall Study||20
408344|NCT01664806|999947|P1|COMPLETED|Overall Study||20
408345|NCT01664806|999946|P2|STARTED|Overall Study||20
408346|NCT01664806|999947|P1|STARTED|Overall Study||20
408347|NCT01664793|999957|P2|NOT COMPLETED|Overall Study||0
408348|NCT01664793|999958|P1|NOT COMPLETED|Overall Study||0
408349|NCT01664793|999957|P2|COMPLETED|Overall Study||38626
408350|NCT01664793|999958|P1|COMPLETED|Overall Study||49039
408351|NCT01664793|999957|P2|STARTED|Overall Study||38626
408352|NCT01664793|999958|P1|STARTED|Overall Study||49039
408353|NCT01664624|999970|P4|NOT COMPLETED|Overall Study||0
408354|NCT01664624|999971|P3|NOT COMPLETED|Overall Study||0
408355|NCT01664624|999972|P2|NOT COMPLETED|Overall Study||1
408356|NCT01664624|999973|P1|NOT COMPLETED|Overall Study||0
408357|NCT01664624|999970|P4|COMPLETED|Overall Study||9
408358|NCT01664624|999971|P3|COMPLETED|Overall Study||10
408359|NCT01664624|999972|P2|COMPLETED|Overall Study||10
408360|NCT01664624|999973|P1|COMPLETED|Overall Study||10
408361|NCT01664624|999970|P4|STARTED|Overall Study||9
408362|NCT01664624|999971|P3|STARTED|Overall Study||10
408363|NCT01664624|999972|P2|STARTED|Overall Study||11
408364|NCT01664624|999973|P1|STARTED|Overall Study||10
408365|NCT01664559|1000005|P2|NOT COMPLETED|Overall Study||0
408366|NCT01664559|1000006|P1|NOT COMPLETED|Overall Study||0
408367|NCT01664559|1000005|P2|COMPLETED|Overall Study||33
408368|NCT01664559|1000006|P1|COMPLETED|Overall Study||34
408369|NCT01664559|1000005|P2|STARTED|Overall Study||33
408370|NCT01664559|1000006|P1|STARTED|Overall Study||34
408371|NCT01664533|1000020|P1|NOT COMPLETED|Overall Study||57
408372|NCT01664533|1000020|P1|COMPLETED|Overall Study||0
408373|NCT01664533|1000020|P1|STARTED|Overall Study||57
408374|NCT01664494|1000028|P1|NOT COMPLETED|Overall Study||193
408375|NCT01664494|1000028|P1|COMPLETED|Overall Study||370
408376|NCT01664494|1000028|P1|STARTED|Overall Study||563
408377|NCT01664247|1000035|P2|NOT COMPLETED|Overall Study||41
408378|NCT01664247|1000036|P1|NOT COMPLETED|Overall Study||14
408379|NCT01664247|1000035|P2|COMPLETED|Overall Study||131
408380|NCT01664247|1000036|P1|COMPLETED|Overall Study||160
408381|NCT01664247|1000035|P2|Exposed|Overall Study|Two subjects were randomised in error and withdrew prior to exposure to drug|170
408382|NCT01664247|1000036|P1|Exposed|Overall Study|1 subject was randomised in error and withdrew before exposure to the drug|173
408383|NCT01664247|1000035|P2|STARTED|Overall Study||172
408384|NCT01664247|1000036|P1|STARTED|Overall Study||174
408385|NCT01664117|1000058|P1|NOT COMPLETED|Overall Study||0
408386|NCT01664117|1000058|P1|COMPLETED|Overall Study||209
408387|NCT01664117|1000058|P1|STARTED|Overall Study||209
408388|NCT01664104|1000113|P1|NOT COMPLETED|Overall Study||16
408389|NCT01664104|1000113|P1|COMPLETED|Overall Study||120
408390|NCT01664104|1000113|P1|STARTED|Overall Study||136
408391|NCT01664052|1000182|P2|NOT COMPLETED|Phase 2||4
408392|NCT01664052|1000183|P1|NOT COMPLETED|Phase 2||0
408393|NCT01664052|1000182|P2|COMPLETED|Phase 2||31
408394|NCT01664052|1000183|P1|COMPLETED|Phase 2||0
408395|NCT01664052|1000182|P2|Repeat HSG and Hysterectomy at 90 Days|Phase 2||10
408396|NCT01664052|1000183|P1|Repeat HSG and Hysterectomy at 90 Days|Phase 2||0
408397|NCT01664052|1000182|P2|Repeat HSG and Hysterectomy at 60 Days|Phase 2||10
408398|NCT01664052|1000183|P1|Repeat HSG and Hysterectomy at 60 Days|Phase 2||0
408399|NCT01664052|1000182|P2|Repeat HSG and Hysterectomy at 30 Days|Phase 2||10
408400|NCT01664052|1000183|P1|Repeat HSG and Hysterectomy at 30 Days|Phase 2||0
408401|NCT01664052|1000182|P2|HSG 1 Hour Post Placement|Phase 2||31
408402|NCT01664052|1000183|P1|HSG 1 Hour Post Placement|Phase 2||0
408403|NCT01664052|1000182|P2|Insert Placed|Phase 2||31
408404|NCT01664052|1000183|P1|Insert Placed|Phase 2||0
408405|NCT01664052|1000182|P2|STARTED|Phase 2||35
408406|NCT01664052|1000183|P1|STARTED|Phase 2|Screened and enrolled|0
408407|NCT01664052|1000182|P2|NOT COMPLETED|Phase 1||0
408408|NCT01664052|1000183|P1|NOT COMPLETED|Phase 1||7
408409|NCT01664052|1000182|P2|COMPLETED|Phase 1||0
408410|NCT01664052|1000183|P1|COMPLETED|Phase 1||24
408411|NCT01664052|1000182|P2|Repeat HSG and Hysterectomy at 90 Days|Phase 1||0
408412|NCT01664052|1000183|P1|Repeat HSG and Hysterectomy at 90 Days|Phase 1||7
408413|NCT01664052|1000182|P2|Repeat HSG and Hysterectomy at 60 Days|Phase 1||0
408414|NCT01664052|1000183|P1|Repeat HSG and Hysterectomy at 60 Days|Phase 1||8
408415|NCT01664052|1000182|P2|Repeat HSG and Hysterectomy at 30 Days|Phase 1||0
408416|NCT01664052|1000183|P1|Repeat HSG and Hysterectomy at 30 Days|Phase 1||9
408417|NCT01664052|1000182|P2|HSG 1 Hour Post Placement|Phase 1||0
408418|NCT01664052|1000183|P1|HSG 1 Hour Post Placement|Phase 1||24
408419|NCT01664052|1000182|P2|Insert Placed in at Least One Tube|Phase 1||0
408420|NCT01664052|1000183|P1|Insert Placed in at Least One Tube|Phase 1||25
408421|NCT01664052|1000182|P2|STARTED|Phase 1||0
408422|NCT01664052|1000183|P1|STARTED|Phase 1|Screening and enrollment|31
408423|NCT01664039|1000201|P2|NOT COMPLETED|Overall Study||9
408424|NCT01664039|1000202|P1|NOT COMPLETED|Overall Study||6
408425|NCT01664039|1000201|P2|COMPLETED|Overall Study||43
408426|NCT01664039|1000202|P1|COMPLETED|Overall Study||46
408427|NCT01664039|1000201|P2|STARTED|Overall Study||52
408428|NCT01664039|1000202|P1|STARTED|Overall Study||52
408429|NCT01663987|1000224|P2|NOT COMPLETED|Overall Study||6
408430|NCT01663987|1000225|P1|NOT COMPLETED|Overall Study||13
408431|NCT01663987|1000224|P2|COMPLETED|Overall Study||34
408432|NCT01663987|1000225|P1|COMPLETED|Overall Study||26
408433|NCT01663987|1000224|P2|STARTED|Overall Study||40
408434|NCT01663987|1000225|P1|STARTED|Overall Study||39
408435|NCT01663922|1000251|P2|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0
408436|NCT01663922|1000252|P1|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0
408437|NCT01663922|1000251|P2|COMPLETED|Third Intervention (14 Days or 5 Days)||9
408438|NCT01663922|1000252|P1|COMPLETED|Third Intervention (14 Days or 5 Days)||8
408439|NCT01663922|1000251|P2|STARTED|Third Intervention (14 Days or 5 Days)||9
408440|NCT01663922|1000252|P1|STARTED|Third Intervention (14 Days or 5 Days)||8
408441|NCT01663922|1000251|P2|NOT COMPLETED|Washout (7 Days)||0
408442|NCT01663922|1000252|P1|NOT COMPLETED|Washout (7 Days)||0
408443|NCT01663922|1000251|P2|COMPLETED|Washout (7 Days)||9
408444|NCT01663922|1000252|P1|COMPLETED|Washout (7 Days)||8
408445|NCT01663922|1000251|P2|STARTED|Washout (7 Days)||9
408446|NCT01663922|1000252|P1|STARTED|Washout (7 Days)||8
408447|NCT01663922|1000251|P2|NOT COMPLETED|Second Intervention (14 Days)||0
408448|NCT01663922|1000252|P1|NOT COMPLETED|Second Intervention (14 Days)||0
408449|NCT01663922|1000251|P2|COMPLETED|Second Intervention (14 Days)||9
408450|NCT01663922|1000252|P1|COMPLETED|Second Intervention (14 Days)||8
408451|NCT01663922|1000251|P2|STARTED|Second Intervention (14 Days)||9
408452|NCT01663922|1000252|P1|STARTED|Second Intervention (14 Days)||8
408453|NCT01663922|1000251|P2|NOT COMPLETED|Washout (7 Days)||0
408454|NCT01663922|1000252|P1|NOT COMPLETED|Washout (7 Days)||0
408455|NCT01663922|1000251|P2|COMPLETED|Washout (7 Days)||9
408456|NCT01663922|1000252|P1|COMPLETED|Washout (7 Days)||8
408457|NCT01663922|1000251|P2|STARTED|Washout (7 Days)||9
408458|NCT01663922|1000252|P1|STARTED|Washout (7 Days)||8
408459|NCT01663922|1000251|P2|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0
408460|NCT01663922|1000252|P1|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0
408461|NCT01663922|1000251|P2|COMPLETED|First Intervention (14 Days or 5 Days)||9
408462|NCT01663922|1000252|P1|COMPLETED|First Intervention (14 Days or 5 Days)||8
408463|NCT01663922|1000251|P2|STARTED|First Intervention (14 Days or 5 Days)||9
408464|NCT01663922|1000252|P1|STARTED|First Intervention (14 Days or 5 Days)||8
408465|NCT01663779|1000259|P2|NOT COMPLETED|Overall Study||0
408466|NCT01663779|1000260|P1|NOT COMPLETED|Overall Study||0
408467|NCT01663779|1000259|P2|COMPLETED|Overall Study||23
408468|NCT01663779|1000260|P1|COMPLETED|Overall Study||27
408469|NCT01663779|1000259|P2|STARTED|Overall Study||23
408470|NCT01663779|1000260|P1|STARTED|Overall Study||27
408471|NCT01663727|1000268|P2|NOT COMPLETED|Overall Study||239
408472|NCT01663727|1000269|P1|NOT COMPLETED|Overall Study||242
408473|NCT01663727|1000268|P2|COMPLETED|Overall Study||0
408474|NCT01663727|1000269|P1|COMPLETED|Overall Study||0
408475|NCT01663727|1000268|P2|STARTED|Overall Study||239
408476|NCT01663727|1000269|P1|STARTED|Overall Study||242
408477|NCT01663714|1000297|P1|NOT COMPLETED|Long-Term Follow-Up||6
408478|NCT01663714|1000297|P1|COMPLETED|Long-Term Follow-Up||16
408479|NCT01663714|1000297|P1|STARTED|Long-Term Follow-Up|22 of the30 participants withdrawing from Study BEX104514 enrolled in the LTFU study.|22
408480|NCT01663714|1000297|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||30
408481|NCT01663714|1000297|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
408482|NCT01663714|1000297|P1|STARTED|Dosimetric and Therapeutic Treatment||30
408483|NCT01663623|1000326|P2|NOT COMPLETED|Overall Study||20
408484|NCT01663623|1000327|P1|NOT COMPLETED|Overall Study||12
408485|NCT01663623|1000326|P2|COMPLETED|Overall Study||33
408486|NCT01663623|1000327|P1|COMPLETED|Overall Study||40
408487|NCT01663623|1000326|P2|STARTED|Overall Study||53
408488|NCT01663623|1000327|P1|STARTED|Overall Study||52
408489|NCT01663532|1000337|P2|NOT COMPLETED|Overall Study||107
408490|NCT01663532|1000338|P1|NOT COMPLETED|Overall Study||74
408491|NCT01663532|1000337|P2|COMPLETED|Overall Study||65
408492|NCT01663532|1000338|P1|COMPLETED|Overall Study||94
408493|NCT01663532|1000337|P2|STARTED|Overall Study||172
408494|NCT01663532|1000338|P1|STARTED|Overall Study||168
408495|NCT01663506|1000356|P1|NOT COMPLETED|Overall Study||8
408496|NCT01663506|1000356|P1|COMPLETED|Overall Study||15
408497|NCT01663506|1000356|P1|STARTED|Overall Study||23
408498|NCT01663363|1000385|P1|NOT COMPLETED|Overall Study||0
408499|NCT01663363|1000385|P1|COMPLETED|Overall Study|334 Eyes were treated among 170 participants|170
408500|NCT01663363|1000385|P1|STARTED|Overall Study|334 Eyes were treated among 170 participants|170
408501|NCT01663285|1000390|P1|NOT COMPLETED|Overall Study||0
408502|NCT01663285|1000390|P1|COMPLETED|Overall Study||1
408503|NCT01663285|1000390|P1|STARTED|Overall Study||1
408504|NCT01663233|1000398|P2|NOT COMPLETED|Overall Study||7
408505|NCT01663233|1000399|P1|NOT COMPLETED|Overall Study||4
408506|NCT01663233|1000398|P2|COMPLETED|Overall Study||129
408507|NCT01663233|1000399|P1|COMPLETED|Overall Study||126
408508|NCT01663233|1000398|P2|STARTED|Overall Study||136
408509|NCT01663233|1000399|P1|STARTED|Overall Study||130
408510|NCT01663103|1000423|P2|NOT COMPLETED|Overall Study||2
408511|NCT01663103|1000424|P1|NOT COMPLETED|Overall Study||3
408512|NCT01663103|1000423|P2|COMPLETED|Overall Study||19
408513|NCT01663103|1000424|P1|COMPLETED|Overall Study||18
408514|NCT01663103|1000423|P2|STARTED|Overall Study||21
408515|NCT01663103|1000424|P1|STARTED|Overall Study||21
408516|NCT01663012|1000440|P1|NOT COMPLETED|Overall Study||0
408517|NCT01663012|1000440|P1|COMPLETED|Overall Study||20
408518|NCT01663012|1000440|P1|STARTED|Overall Study||20
408519|NCT01662999|1000452|P6|NOT COMPLETED|Period 3||0
408520|NCT01662999|1000453|P5|NOT COMPLETED|Period 3||0
408521|NCT01662999|1000454|P4|NOT COMPLETED|Period 3||0
408522|NCT01662999|1000455|P3|NOT COMPLETED|Period 3||0
408523|NCT01662999|1000456|P2|NOT COMPLETED|Period 3||1
408524|NCT01662999|1000457|P1|NOT COMPLETED|Period 3||0
408525|NCT01662999|1000452|P6|COMPLETED|Period 3||7
408526|NCT01662999|1000453|P5|COMPLETED|Period 3||7
408527|NCT01662999|1000454|P4|COMPLETED|Period 3||7
408528|NCT01662999|1000455|P3|COMPLETED|Period 3||7
408529|NCT01662999|1000456|P2|COMPLETED|Period 3|Participant did not provide 36, 48, or 60 hour samples in this period for Treatment B.|6
408530|NCT01662999|1000457|P1|COMPLETED|Period 3||7
408531|NCT01662999|1000452|P6|STARTED|Period 3||7
408532|NCT01662999|1000453|P5|STARTED|Period 3||7
408533|NCT01662999|1000454|P4|STARTED|Period 3||7
408534|NCT01662999|1000455|P3|STARTED|Period 3||7
408535|NCT01662999|1000456|P2|STARTED|Period 3||7
408536|NCT01662999|1000457|P1|STARTED|Period 3||7
408537|NCT01662999|1000452|P6|NOT COMPLETED|Period 2||0
408538|NCT01662999|1000453|P5|NOT COMPLETED|Period 2||0
408539|NCT01662999|1000454|P4|NOT COMPLETED|Period 2||0
408540|NCT01662999|1000455|P3|NOT COMPLETED|Period 2||0
408541|NCT01662999|1000456|P2|NOT COMPLETED|Period 2||0
408542|NCT01662999|1000457|P1|NOT COMPLETED|Period 2||0
408543|NCT01662999|1000452|P6|COMPLETED|Period 2||7
408544|NCT01662999|1000453|P5|COMPLETED|Period 2||7
408545|NCT01662999|1000454|P4|COMPLETED|Period 2||7
408546|NCT01662999|1000455|P3|COMPLETED|Period 2||7
408547|NCT01662999|1000456|P2|COMPLETED|Period 2||7
408548|NCT01662999|1000457|P1|COMPLETED|Period 2||7
408549|NCT01662999|1000452|P6|STARTED|Period 2||7
408550|NCT01662999|1000453|P5|STARTED|Period 2||7
408551|NCT01662999|1000454|P4|STARTED|Period 2||7
408552|NCT01662999|1000455|P3|STARTED|Period 2||7
408553|NCT01662999|1000456|P2|STARTED|Period 2||7
408554|NCT01662999|1000457|P1|STARTED|Period 2||7
408555|NCT01662999|1000452|P6|NOT COMPLETED|Period 1||0
408556|NCT01662999|1000453|P5|NOT COMPLETED|Period 1||0
408557|NCT01662999|1000454|P4|NOT COMPLETED|Period 1||0
408558|NCT01662999|1000455|P3|NOT COMPLETED|Period 1||0
408559|NCT01662999|1000456|P2|NOT COMPLETED|Period 1||0
408560|NCT01662999|1000457|P1|NOT COMPLETED|Period 1||0
408561|NCT01662999|1000452|P6|COMPLETED|Period 1||7
408562|NCT01662999|1000453|P5|COMPLETED|Period 1||7
408563|NCT01662999|1000454|P4|COMPLETED|Period 1||7
408564|NCT01662999|1000455|P3|COMPLETED|Period 1||7
408565|NCT01662999|1000456|P2|COMPLETED|Period 1||7
408566|NCT01662999|1000457|P1|COMPLETED|Period 1||7
408567|NCT01662999|1000452|P6|STARTED|Period 1||7
408568|NCT01662999|1000453|P5|STARTED|Period 1||7
408569|NCT01662999|1000454|P4|STARTED|Period 1||7
408570|NCT01662999|1000455|P3|STARTED|Period 1||7
408571|NCT01662999|1000456|P2|STARTED|Period 1||7
408572|NCT01662999|1000457|P1|STARTED|Period 1||7
408573|NCT01662986|1000528|P2|NOT COMPLETED|Overall Study||13
408574|NCT01662986|1000529|P1|NOT COMPLETED|Overall Study||18
408575|NCT01662986|1000528|P2|COMPLETED|Overall Study||26
408576|NCT01662986|1000529|P1|COMPLETED|Overall Study||22
408577|NCT01662986|1000528|P2|STARTED|Overall Study||39
408578|NCT01662986|1000529|P1|STARTED|Overall Study||40
408579|NCT01662908|1000561|P2|NOT COMPLETED|Overall Study||5
408580|NCT01662908|1000562|P1|NOT COMPLETED|Overall Study||6
408581|NCT01662908|1000561|P2|COMPLETED|Overall Study||23
408582|NCT01662908|1000562|P1|COMPLETED|Overall Study||50
408583|NCT01662908|1000561|P2|STARTED|Overall Study||28
408584|NCT01662908|1000562|P1|STARTED|Overall Study||56
408585|NCT01662882|1000579|P3|NOT COMPLETED|Overall Study||0
408586|NCT01662882|1000580|P2|NOT COMPLETED|Overall Study||0
408587|NCT01662882|1000581|P1|NOT COMPLETED|Overall Study||0
408588|NCT01662882|1000579|P3|COMPLETED|Overall Study||15
408589|NCT01662882|1000580|P2|COMPLETED|Overall Study||18
408590|NCT01662882|1000581|P1|COMPLETED|Overall Study||15
408591|NCT01662882|1000579|P3|STARTED|Overall Study||15
408592|NCT01662882|1000580|P2|STARTED|Overall Study||18
408593|NCT01662882|1000581|P1|STARTED|Overall Study||15
408594|NCT01662856|1000594|P2|NOT COMPLETED|Primary Part II||2
408595|NCT01662856|1000595|P1|NOT COMPLETED|Primary Part II||10
408596|NCT01662856|1000594|P2|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6|55
408597|NCT01662856|1000595|P1|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6|99
408598|NCT01662856|1000594|P2|Completed Study up to Week 6|Primary Part II||56
408599|NCT01662856|1000595|P1|Completed Study up to Week 6|Primary Part II||106
408600|NCT01662856|1000594|P2|STARTED|Primary Part II||57
408601|NCT01662856|1000595|P1|STARTED|Primary Part II||109
408602|NCT01662856|1000594|P2|NOT COMPLETED|Part I + Part II (Overall Study)||2
408603|NCT01662856|1000595|P1|NOT COMPLETED|Part I + Part II (Overall Study)||16
408604|NCT01662856|1000594|P2|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6|55
408605|NCT01662856|1000595|P1|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6|152
408606|NCT01662856|1000594|P2|Completed Study up to Week 6|Part I + Part II (Overall Study)||56
408607|NCT01662856|1000595|P1|Completed Study up to Week 6|Part I + Part II (Overall Study)||164
408608|NCT01662856|1000594|P2|STARTED|Part I + Part II (Overall Study)||57
408609|NCT01662856|1000595|P1|STARTED|Part I + Part II (Overall Study)||168
408610|NCT01662791|1000609|P2|NOT COMPLETED|Part 2 - Interventional||0
408611|NCT01662791|1000610|P1|NOT COMPLETED|Part 2 - Interventional||0
408612|NCT01662791|1000609|P2|COMPLETED|Part 2 - Interventional||0
408613|NCT01662791|1000610|P1|COMPLETED|Part 2 - Interventional||8
408614|NCT01662791|1000609|P2|STARTED|Part 2 - Interventional|The Control Group did not take part in the second part of the study.|0
408615|NCT01662791|1000610|P1|STARTED|Part 2 - Interventional||8
408616|NCT01662791|1000609|P2|NOT COMPLETED|Part 1 - Observational||0
408617|NCT01662791|1000610|P1|NOT COMPLETED|Part 1 - Observational||0
408618|NCT01662791|1000609|P2|COMPLETED|Part 1 - Observational||41
408619|NCT01662791|1000610|P1|COMPLETED|Part 1 - Observational||8
408620|NCT01662791|1000609|P2|STARTED|Part 1 - Observational||41
408621|NCT01662791|1000610|P1|STARTED|Part 1 - Observational||8
408622|NCT01662765|1000634|P2|NOT COMPLETED|Overall Study||2
408623|NCT01662765|1000635|P1|NOT COMPLETED|Overall Study||1
408624|NCT01662765|1000634|P2|COMPLETED|Overall Study||40
408625|NCT01662765|1000635|P1|COMPLETED|Overall Study||41
408626|NCT01662765|1000634|P2|STARTED|Overall Study||42
408627|NCT01662765|1000635|P1|STARTED|Overall Study||42
408628|NCT01662648|1000649|P2|NOT COMPLETED|Overall Study||178
408629|NCT01662648|1000650|P1|NOT COMPLETED|Overall Study||147
408630|NCT01662648|1000649|P2|COMPLETED|Overall Study||419
408631|NCT01662648|1000650|P1|COMPLETED|Overall Study||373
408632|NCT01662648|1000649|P2|STARTED|Overall Study||597
408633|NCT01662648|1000650|P1|STARTED|Overall Study||520
408634|NCT01662635|1000672|P1|NOT COMPLETED|Overall Study||30
408635|NCT01662635|1000672|P1|COMPLETED|Overall Study||200
408636|NCT01662635|1000672|P1|STARTED|Overall Study||230
408637|NCT01662583|1000681|P3|NOT COMPLETED|Overall Study||0
408638|NCT01662583|1000682|P2|NOT COMPLETED|Overall Study||0
408639|NCT01662583|1000683|P1|NOT COMPLETED|Overall Study||0
408640|NCT01662583|1000681|P3|COMPLETED|Overall Study||219
408641|NCT01662583|1000682|P2|COMPLETED|Overall Study||225
408642|NCT01662583|1000683|P1|COMPLETED|Overall Study||216
408643|NCT01662583|1000681|P3|STARTED|Overall Study||219
408644|NCT01662583|1000682|P2|STARTED|Overall Study||225
408645|NCT01662583|1000683|P1|STARTED|Overall Study||216
408646|NCT01662531|1000696|P1|NOT COMPLETED|Overall Study||0
408647|NCT01662531|1000696|P1|COMPLETED|Overall Study||27
408648|NCT01662531|1000696|P1|STARTED|Overall Study||27
408649|NCT01662492|1000723|P3|NOT COMPLETED|Overall Study||6
408650|NCT01662492|1000724|P2|NOT COMPLETED|Overall Study||1
408651|NCT01662492|1000725|P1|NOT COMPLETED|Overall Study||3
408652|NCT01662492|1000723|P3|COMPLETED|Overall Study||31
408653|NCT01662492|1000724|P2|COMPLETED|Overall Study||42
408654|NCT01662492|1000725|P1|COMPLETED|Overall Study||42
408655|NCT01662492|1000723|P3|STARTED|Overall Study||37
408656|NCT01662492|1000724|P2|STARTED|Overall Study||43
408657|NCT01662492|1000725|P1|STARTED|Overall Study||45
408658|NCT01662440|1000749|P4|NOT COMPLETED|Overall Study||4
408659|NCT01662440|1000750|P3|NOT COMPLETED|Overall Study||6
408660|NCT01662440|1000751|P2|NOT COMPLETED|Overall Study||6
408661|NCT01662440|1000752|P1|NOT COMPLETED|Overall Study||9
408662|NCT01662440|1000749|P4|COMPLETED|Overall Study||52
408663|NCT01662440|1000750|P3|COMPLETED|Overall Study||215
408664|NCT01662440|1000751|P2|COMPLETED|Overall Study||211
408665|NCT01662440|1000752|P1|COMPLETED|Overall Study||158
408666|NCT01662440|1000749|P4|STARTED|Overall Study||56
408667|NCT01662440|1000750|P3|STARTED|Overall Study||221
408668|NCT01662440|1000751|P2|STARTED|Overall Study||217
408669|NCT01662440|1000752|P1|STARTED|Overall Study||167
408670|NCT01662362|1000800|P1|NOT COMPLETED|Overall Study||38
408671|NCT01662362|1000800|P1|COMPLETED|Overall Study||25
408672|NCT01662362|1000800|P1|STARTED|Overall Study||63
408673|NCT01662336|1000805|P1|NOT COMPLETED|Overall Study||66
408674|NCT01662336|1000805|P1|COMPLETED|Overall Study||107
408675|NCT01662336|1000805|P1|Completed Month 12 Visit|Overall Study||109
408676|NCT01662336|1000805|P1|Completed Month 6 Visit|Overall Study||142
408677|NCT01662336|1000805|P1|STARTED|Overall Study||173
408678|NCT01662310|1000831|P5|NOT COMPLETED|Open-Label Extension Phase||10
408679|NCT01662310|1000832|P4|NOT COMPLETED|Open-Label Extension Phase||11
408680|NCT01662310|1000833|P3|NOT COMPLETED|Open-Label Extension Phase||0
408681|NCT01662310|1000834|P2|NOT COMPLETED|Open-Label Extension Phase||0
408682|NCT01662310|1000835|P1|NOT COMPLETED|Open-Label Extension Phase||0
408683|NCT01662310|1000831|P5|COMPLETED|Open-Label Extension Phase||49
408684|NCT01662310|1000832|P4|COMPLETED|Open-Label Extension Phase||36
408685|NCT01662310|1000833|P3|COMPLETED|Open-Label Extension Phase||0
408686|NCT01662310|1000834|P2|COMPLETED|Open-Label Extension Phase||0
408687|NCT01662310|1000835|P1|COMPLETED|Open-Label Extension Phase||0
408688|NCT01662310|1000831|P5|STARTED|Open-Label Extension Phase||59
408689|NCT01662310|1000832|P4|STARTED|Open-Label Extension Phase||47
408690|NCT01662310|1000833|P3|STARTED|Open-Label Extension Phase||0
408691|NCT01662310|1000834|P2|STARTED|Open-Label Extension Phase||0
408692|NCT01662310|1000835|P1|STARTED|Open-Label Extension Phase||0
408693|NCT01662310|1000831|P5|NOT COMPLETED|Double-Blind Phase||0
408694|NCT01662310|1000832|P4|NOT COMPLETED|Double-Blind Phase||0
408695|NCT01662310|1000833|P3|NOT COMPLETED|Double-Blind Phase||5
408696|NCT01662310|1000834|P2|NOT COMPLETED|Double-Blind Phase||15
408697|NCT01662310|1000835|P1|NOT COMPLETED|Double-Blind Phase||0
408698|NCT01662310|1000831|P5|COMPLETED|Double-Blind Phase||0
408699|NCT01662310|1000832|P4|COMPLETED|Double-Blind Phase||0
408700|NCT01662310|1000833|P3|COMPLETED|Double-Blind Phase||66
408701|NCT01662310|1000834|P2|COMPLETED|Double-Blind Phase||50
408702|NCT01662310|1000835|P1|COMPLETED|Double-Blind Phase||0
408703|NCT01662310|1000831|P5|Treated|Double-Blind Phase||0
408704|NCT01662310|1000832|P4|Treated|Double-Blind Phase||0
408705|NCT01662310|1000833|P3|Treated|Double-Blind Phase||71
408706|NCT01662310|1000834|P2|Treated|Double-Blind Phase||64
408707|NCT01662310|1000835|P1|Treated|Double-Blind Phase||0
408708|NCT01662310|1000831|P5|STARTED|Double-Blind Phase||0
408709|NCT01662310|1000832|P4|STARTED|Double-Blind Phase||0
408710|NCT01662310|1000833|P3|STARTED|Double-Blind Phase||71
408711|NCT01662310|1000834|P2|STARTED|Double-Blind Phase||65
408712|NCT01662310|1000835|P1|STARTED|Double-Blind Phase||0
408713|NCT01662310|1000831|P5|NOT COMPLETED|Run-In or Stabilization Phase||0
408714|NCT01662310|1000832|P4|NOT COMPLETED|Run-In or Stabilization Phase||0
408715|NCT01662310|1000833|P3|NOT COMPLETED|Run-In or Stabilization Phase||0
408716|NCT01662310|1000834|P2|NOT COMPLETED|Run-In or Stabilization Phase||0
408717|NCT01662310|1000835|P1|NOT COMPLETED|Run-In or Stabilization Phase||65
408718|NCT01662310|1000831|P5|COMPLETED|Run-In or Stabilization Phase||0
408719|NCT01662310|1000832|P4|COMPLETED|Run-In or Stabilization Phase||0
408720|NCT01662310|1000833|P3|COMPLETED|Run-In or Stabilization Phase||0
408721|NCT01662310|1000834|P2|COMPLETED|Run-In or Stabilization Phase||0
408722|NCT01662310|1000835|P1|COMPLETED|Run-In or Stabilization Phase||136
408723|NCT01662310|1000831|P5|STARTED|Run-In or Stabilization Phase||0
408724|NCT01662310|1000832|P4|STARTED|Run-In or Stabilization Phase||0
408725|NCT01662310|1000833|P3|STARTED|Run-In or Stabilization Phase||0
408726|NCT01662310|1000834|P2|STARTED|Run-In or Stabilization Phase||0
408727|NCT01662310|1000835|P1|STARTED|Run-In or Stabilization Phase||201
408728|NCT01662115|1000870|P3|NOT COMPLETED|Overall Study||0
408729|NCT01662115|1000871|P2|NOT COMPLETED|Overall Study||0
408730|NCT01662115|1000872|P1|NOT COMPLETED|Overall Study||0
408731|NCT01662115|1000870|P3|COMPLETED|Overall Study||0
408732|NCT01662115|1000871|P2|COMPLETED|Overall Study||2
408733|NCT01662115|1000872|P1|COMPLETED|Overall Study||2
408734|NCT01662115|1000870|P3|STARTED|Overall Study||0
408735|NCT01662115|1000871|P2|STARTED|Overall Study||2
408736|NCT01662115|1000872|P1|STARTED|Overall Study||2
408737|NCT01662102|1000891|P2|NOT COMPLETED|Overall Study||0
408738|NCT01662102|1000892|P1|NOT COMPLETED|Overall Study||1
408739|NCT01662102|1000891|P2|COMPLETED|Overall Study||0
408740|NCT01662102|1000892|P1|COMPLETED|Overall Study||0
408741|NCT01662102|1000891|P2|STARTED|Overall Study||0
408742|NCT01662102|1000892|P1|STARTED|Overall Study||1
408743|NCT01662063|1000900|P3|NOT COMPLETED|Overall Study||1
408744|NCT01662063|1000901|P2|NOT COMPLETED|Overall Study||29
408745|NCT01662063|1000902|P1|NOT COMPLETED|Overall Study||5
408746|NCT01662063|1000900|P3|COMPLETED|Overall Study||0
408747|NCT01662063|1000901|P2|COMPLETED|Overall Study||144
408748|NCT01662063|1000902|P1|COMPLETED|Overall Study||39
408749|NCT01662063|1000900|P3|STARTED|Overall Study||1
408750|NCT01662063|1000901|P2|STARTED|Overall Study||173
408751|NCT01662063|1000902|P1|STARTED|Overall Study||44
408752|NCT01662024|1000981|P1|NOT COMPLETED|Overall Study||5
408753|NCT01662024|1000981|P1|COMPLETED|Overall Study||15
408754|NCT01662024|1000981|P1|STARTED|Overall Study||20
408755|NCT01661972|1000993|P2|NOT COMPLETED|Overall Study||4
408756|NCT01661972|1000994|P1|NOT COMPLETED|Overall Study||2
408757|NCT01661972|1000993|P2|COMPLETED|Overall Study||46
408758|NCT01661972|1000994|P1|COMPLETED|Overall Study||11
408759|NCT01661972|1000993|P2|STARTED|Overall Study||50
408760|NCT01661972|1000994|P1|STARTED|Overall Study||13
408761|NCT01661933|1001004|P1|NOT COMPLETED|High-dose Gluten Challenge||2
408762|NCT01661933|1001004|P1|COMPLETED|High-dose Gluten Challenge||8
408763|NCT01661933|1001004|P1|STARTED|High-dose Gluten Challenge|2 of 10 available after post-GC-1g did not enroll for reasons unrelated to gluten.|10
408764|NCT01661933|1001004|P1|NOT COMPLETED|Low-dose Gluten Challenge||2
408765|NCT01661933|1001004|P1|COMPLETED|Low-dose Gluten Challenge|Two had challenge interrupted for 1-2 weeks. All completed challenge.|10
408766|NCT01661933|1001004|P1|STARTED|Low-dose Gluten Challenge|One was symptomatically intolerant to gluten >25 mg. One had active CeD pre- & post-micro-challenge|12
408767|NCT01661933|1001004|P1|NOT COMPLETED|Gluten Micro-challenge||0
408768|NCT01661933|1001004|P1|COMPLETED|Gluten Micro-challenge|Two gluten intolerant participants did not proceed to the low-dose challenge.|12
408769|NCT01661933|1001004|P1|STARTED|Gluten Micro-challenge|All 12 enrolled completed hookworm inoculation and gluten micro-challenge.|12
408770|NCT01661881|1001011|P1|NOT COMPLETED|Overall Study||0
408771|NCT01661881|1001011|P1|COMPLETED|Overall Study||23
408772|NCT01661881|1001011|P1|STARTED|Overall Study||23
408773|NCT01661790|1001019|P2|NOT COMPLETED|Overall Study||2
408774|NCT01661790|1001020|P1|NOT COMPLETED|Overall Study||0
408775|NCT01661790|1001019|P2|COMPLETED|Overall Study||34
408776|NCT01661790|1001020|P1|COMPLETED|Overall Study||36
408777|NCT01661790|1001019|P2|STARTED|Overall Study||36
408778|NCT01661790|1001020|P1|STARTED|Overall Study||36
408779|NCT01661764|1001032|P6|NOT COMPLETED|Overall Study||2
408780|NCT01661764|1001033|P5|NOT COMPLETED|Overall Study||3
408781|NCT01661764|1001034|P4|NOT COMPLETED|Overall Study||2
408782|NCT01661764|1001035|P3|NOT COMPLETED|Overall Study||3
408783|NCT01661764|1001036|P2|NOT COMPLETED|Overall Study||5
408784|NCT01661764|1001037|P1|NOT COMPLETED|Overall Study||2
408785|NCT01661764|1001032|P6|COMPLETED|Overall Study||18
408786|NCT01661764|1001033|P5|COMPLETED|Overall Study||16
408787|NCT01661764|1001034|P4|COMPLETED|Overall Study||24
408788|NCT01661764|1001035|P3|COMPLETED|Overall Study||22
408789|NCT01661764|1001036|P2|COMPLETED|Overall Study||20
408790|NCT01661764|1001037|P1|COMPLETED|Overall Study||24
408791|NCT01661764|1001032|P6|STARTED|Overall Study||20
408792|NCT01661764|1001033|P5|STARTED|Overall Study||19
408793|NCT01661764|1001034|P4|STARTED|Overall Study||26
408794|NCT01661764|1001035|P3|STARTED|Overall Study||25
408795|NCT01661764|1001036|P2|STARTED|Overall Study||25
408796|NCT01661764|1001037|P1|STARTED|Overall Study||26
408797|NCT01661621|1001101|P2|NOT COMPLETED|Overall Study||0
408798|NCT01661621|1001102|P1|NOT COMPLETED|Overall Study||0
408799|NCT01661621|1001101|P2|COMPLETED|Overall Study||279
408800|NCT01661621|1001102|P1|COMPLETED|Overall Study||116
408801|NCT01661621|1001101|P2|STARTED|Overall Study||279
408802|NCT01661621|1001102|P1|STARTED|Overall Study||116
408803|NCT01661270|1001124|P2|NOT COMPLETED|Overall Study||0
408804|NCT01661270|1001125|P1|NOT COMPLETED|Overall Study||0
408805|NCT01661270|1001124|P2|COMPLETED|Overall Study|Treatment until disease progression/death, toxicity, consent withdrawal or Investigator's decision.|223
408806|NCT01661270|1001125|P1|COMPLETED|Overall Study|Treatment until disease progression/death, toxicity, consent withdrawal or Investigator's decision.|109
408807|NCT01661270|1001124|P2|Other Reasons|Overall Study||2
408808|NCT01661270|1001125|P1|Other Reasons|Overall Study||0
408809|NCT01661270|1001124|P2|Participant’s Request|Overall Study|Met EOT criteria|48
408810|NCT01661270|1001125|P1|Participant’s Request|Overall Study|Met EOT criteria|15
408811|NCT01661270|1001124|P2|Physician Decision|Overall Study|Met EOT criteria|8
408812|NCT01661270|1001125|P1|Physician Decision|Overall Study|Met EOT criteria|1
408813|NCT01661270|1001124|P2|Disease Progression|Overall Study|Met EOT criteria|118
408814|NCT01661270|1001125|P1|Disease Progression|Overall Study|Met EOT criteria|67
408815|NCT01661270|1001124|P2|Adverse Event|Overall Study|Met EOT criteria|47
408816|NCT01661270|1001125|P1|Adverse Event|Overall Study|Met end of treatment (EOT) criteria.|26
408817|NCT01661270|1001124|P2|STARTED|Overall Study||223
408818|NCT01661270|1001125|P1|STARTED|Overall Study||109
408819|NCT01661205|1001136|P1|NOT COMPLETED|Overall Study||2
408820|NCT01661205|1001136|P1|COMPLETED|Overall Study||24
408821|NCT01661205|1001136|P1|STARTED|Overall Study||26
408822|NCT01661179|1001147|P1|NOT COMPLETED|Overall Study||6
408823|NCT01661179|1001147|P1|COMPLETED|Overall Study||8
408824|NCT01661179|1001147|P1|STARTED|Overall Study||14
408825|NCT01661140|1001151|P3|NOT COMPLETED|Double-Blind Period||50
408826|NCT01661140|1001152|P2|NOT COMPLETED|Double-Blind Period||41
408827|NCT01661140|1001153|P1|NOT COMPLETED|Double-Blind Period||0
408828|NCT01661140|1001151|P3|COMPLETED|Double-Blind Period||86
408829|NCT01661140|1001152|P2|COMPLETED|Double-Blind Period||95
408830|NCT01661140|1001153|P1|COMPLETED|Double-Blind Period||0
408831|NCT01661140|1001151|P3|STARTED|Double-Blind Period|Only those with a good/moderate disease response in the initial phase were randomized.|136
408832|NCT01661140|1001152|P2|STARTED|Double-Blind Period|Only those with a good/moderate disease response in the initial phase were randomized.|136
408833|NCT01661140|1001153|P1|STARTED|Double-Blind Period|Those with a good/moderate disease response in the initial phase were randomized to the MTX arms.|0
408834|NCT01661140|1001151|P3|NOT COMPLETED|Open-Label Period||0
408835|NCT01661140|1001152|P2|NOT COMPLETED|Open-Label Period||0
408836|NCT01661140|1001153|P1|NOT COMPLETED|Open-Label Period||76
408837|NCT01661140|1001151|P3|COMPLETED|Open-Label Period||0
408838|NCT01661140|1001152|P2|COMPLETED|Open-Label Period||0
408839|NCT01661140|1001153|P1|COMPLETED|Open-Label Period||351
408840|NCT01661140|1001151|P3|STARTED|Open-Label Period||0
408841|NCT01661140|1001152|P2|STARTED|Open-Label Period||0
408842|NCT01661140|1001153|P1|STARTED|Open-Label Period|All participants entered the study in the initial phase for 24 weeks of open label treatment.|427
408843|NCT01661114|1001194|P1|NOT COMPLETED|Overall Study||0
408844|NCT01661114|1001194|P1|COMPLETED|Overall Study||39
408845|NCT01661114|1001194|P1|STARTED|Overall Study||39
408846|NCT01661062|1001199|P1|NOT COMPLETED|Overall Study||5
408847|NCT01661062|1001199|P1|COMPLETED|Overall Study||18
408848|NCT01661062|1001199|P1|STARTED|Overall Study||23
408849|NCT01660906|1001204|P1|NOT COMPLETED|Overall Study||3
408850|NCT01660906|1001204|P1|COMPLETED|Overall Study||36
408851|NCT01660906|1001204|P1|STARTED|Overall Study||39
408852|NCT01660893|1001216|P3|NOT COMPLETED|Overall Study||0
408853|NCT01660893|1001217|P2|NOT COMPLETED|Overall Study||0
408854|NCT01660893|1001218|P1|NOT COMPLETED|Overall Study||0
408855|NCT01660893|1001216|P3|COMPLETED|Overall Study||6
408856|NCT01660893|1001217|P2|COMPLETED|Overall Study||10
408857|NCT01660893|1001218|P1|COMPLETED|Overall Study||10
408858|NCT01660893|1001216|P3|STARTED|Overall Study||6
408859|NCT01660893|1001217|P2|STARTED|Overall Study||10
408860|NCT01660893|1001218|P1|STARTED|Overall Study||10
408861|NCT01660815|1001265|P1|NOT COMPLETED|Overall Study||0
408862|NCT01660815|1001265|P1|COMPLETED|Overall Study||7
408863|NCT01660815|1001265|P1|STARTED|Overall Study||7
408864|NCT01660802|1001272|P2|NOT COMPLETED|Overall Study||11
408865|NCT01660802|1001273|P1|NOT COMPLETED|Overall Study||4
408866|NCT01660802|1001272|P2|COMPLETED|Overall Study||121
408867|NCT01660802|1001273|P1|COMPLETED|Overall Study||126
408868|NCT01660802|1001272|P2|STARTED|Overall Study||132
408869|NCT01660802|1001273|P1|STARTED|Overall Study||130
408870|NCT01660763|1001287|P2|NOT COMPLETED|Overall Study||61
408871|NCT01660763|1001288|P1|NOT COMPLETED|Overall Study||100
408872|NCT01660763|1001287|P2|COMPLETED|Overall Study||43
408873|NCT01660763|1001288|P1|COMPLETED|Overall Study||215
408874|NCT01660763|1001287|P2|STARTED|Overall Study||104
408875|NCT01660763|1001288|P1|STARTED|Overall Study||315
408876|NCT01660737|1001294|P1|NOT COMPLETED|Overall Study||0
408877|NCT01660737|1001294|P1|COMPLETED|Overall Study||123
408878|NCT01660737|1001294|P1|STARTED|Overall Study||123
408879|NCT01660698|1001311|P2|NOT COMPLETED|Overall Study||0
408880|NCT01660698|1001312|P1|NOT COMPLETED|Overall Study||0
408881|NCT01660698|1001311|P2|COMPLETED|Overall Study||10
408882|NCT01660698|1001312|P1|COMPLETED|Overall Study||10
408883|NCT01660698|1001311|P2|STARTED|Overall Study||10
408884|NCT01660698|1001312|P1|STARTED|Overall Study||10
408885|NCT01660672|1001322|P1|NOT COMPLETED|Overall Study||0
408886|NCT01660672|1001322|P1|COMPLETED|Overall Study||7
408887|NCT01660672|1001322|P1|STARTED|Overall Study||7
408888|NCT01660451|1001336|P3|NOT COMPLETED|Overall Study||105
408889|NCT01660451|1001337|P2|NOT COMPLETED|Overall Study||17
408890|NCT01660451|1001338|P1|NOT COMPLETED|Overall Study||17
408891|NCT01660451|1001336|P3|COMPLETED|Overall Study||37
408892|NCT01660451|1001337|P2|COMPLETED|Overall Study||34
408893|NCT01660451|1001338|P1|COMPLETED|Overall Study||16
408894|NCT01660451|1001336|P3|STARTED|Overall Study||142
408895|NCT01660451|1001337|P2|STARTED|Overall Study||51
408896|NCT01660451|1001338|P1|STARTED|Overall Study||33
408897|NCT01660412|1001366|P2|NOT COMPLETED|Overall Study||3
408898|NCT01660412|1001367|P1|NOT COMPLETED|Overall Study||0
408899|NCT01660412|1001366|P2|COMPLETED|Overall Study||28
408900|NCT01660412|1001367|P1|COMPLETED|Overall Study||29
408901|NCT01660412|1001366|P2|Injection 4|Overall Study||31
408902|NCT01660412|1001367|P1|Injection 4|Overall Study||29
408903|NCT01660412|1001366|P2|Injection 3|Overall Study||31
408904|NCT01660412|1001367|P1|Injection 3|Overall Study||29
408905|NCT01660412|1001366|P2|Injection 2|Overall Study||31
408906|NCT01660412|1001367|P1|Injection 2|Overall Study||29
408907|NCT01660412|1001366|P2|Injection 1|Overall Study||31
408908|NCT01660412|1001367|P1|Injection 1|Overall Study||29
408909|NCT01660412|1001366|P2|Other|Overall Study||4
408910|NCT01660412|1001367|P1|Other|Overall Study||2
408911|NCT01660412|1001366|P2|Appendicular Structures|Overall Study||11
408912|NCT01660412|1001367|P1|Appendicular Structures|Overall Study||17
408913|NCT01660412|1001366|P2|Thorax|Overall Study||9
408914|NCT01660412|1001367|P1|Thorax|Overall Study||9
408915|NCT01660412|1001366|P2|Head|Overall Study||4
408916|NCT01660412|1001367|P1|Head|Overall Study||1
408917|NCT01660412|1001366|P2|STARTED|Overall Study||31
408918|NCT01660412|1001367|P1|STARTED|Overall Study||29
408919|NCT01660334|1001373|P1|NOT COMPLETED|Overall Study||1
408920|NCT01660334|1001373|P1|COMPLETED|Overall Study||12
408921|NCT01660334|1001373|P1|STARTED|Overall Study||13
408922|NCT01660321|1001378|P1|NOT COMPLETED|Overall Study||0
408923|NCT01660321|1001378|P1|COMPLETED|Overall Study||26
408924|NCT01660321|1001378|P1|STARTED|Overall Study||26
408925|NCT01660230|1001402|P12|NOT COMPLETED|Overall Study||0
408926|NCT01660230|1001403|P11|NOT COMPLETED|Overall Study||0
408927|NCT01660230|1001404|P10|NOT COMPLETED|Overall Study||0
408928|NCT01660230|1001405|P9|NOT COMPLETED|Overall Study||0
408929|NCT01660230|1001406|P8|NOT COMPLETED|Overall Study||0
408930|NCT01660230|1001407|P7|NOT COMPLETED|Overall Study||0
408931|NCT01660230|1001408|P6|NOT COMPLETED|Overall Study||0
408932|NCT01660230|1001409|P5|NOT COMPLETED|Overall Study||0
408933|NCT01660230|1001410|P4|NOT COMPLETED|Overall Study||0
408934|NCT01660230|1001411|P3|NOT COMPLETED|Overall Study||0
408935|NCT01660230|1001412|P2|NOT COMPLETED|Overall Study||0
408936|NCT01660230|1001413|P1|NOT COMPLETED|Overall Study||0
408937|NCT01660230|1001402|P12|COMPLETED|Overall Study||14
408938|NCT01660230|1001403|P11|COMPLETED|Overall Study||6
408939|NCT01660230|1001404|P10|COMPLETED|Overall Study||6
408940|NCT01660230|1001405|P9|COMPLETED|Overall Study||6
408941|NCT01660230|1001406|P8|COMPLETED|Overall Study||6
408942|NCT01660230|1001407|P7|COMPLETED|Overall Study||4
408943|NCT01660230|1001408|P6|COMPLETED|Overall Study||2
408944|NCT01660230|1001409|P5|COMPLETED|Overall Study||4
408945|NCT01660230|1001410|P4|COMPLETED|Overall Study||4
408946|NCT01660230|1001411|P3|COMPLETED|Overall Study||4
408947|NCT01660230|1001412|P2|COMPLETED|Overall Study||4
408948|NCT01660230|1001413|P1|COMPLETED|Overall Study||4
408949|NCT01660230|1001402|P12|STARTED|Overall Study||14
408950|NCT01660230|1001403|P11|STARTED|Overall Study||6
408951|NCT01660230|1001404|P10|STARTED|Overall Study||6
408952|NCT01660230|1001405|P9|STARTED|Overall Study||6
408953|NCT01660230|1001406|P8|STARTED|Overall Study||6
408954|NCT01660230|1001407|P7|STARTED|Overall Study||4
408955|NCT01660230|1001408|P6|STARTED|Overall Study||2
408956|NCT01660230|1001409|P5|STARTED|Overall Study||4
408957|NCT01660230|1001410|P4|STARTED|Overall Study||4
408958|NCT01660230|1001411|P3|STARTED|Overall Study||4
408959|NCT01660230|1001412|P2|STARTED|Overall Study||4
408960|NCT01660230|1001413|P1|STARTED|Overall Study||4
408961|NCT01660191|1001585|P3|NOT COMPLETED|End of Treatment||1
408962|NCT01660191|1001586|P2|NOT COMPLETED|End of Treatment||6
408963|NCT01660191|1001587|P1|NOT COMPLETED|End of Treatment||1
408964|NCT01660191|1001585|P3|COMPLETED|End of Treatment||43
408965|NCT01660191|1001586|P2|COMPLETED|End of Treatment||39
408966|NCT01660191|1001587|P1|COMPLETED|End of Treatment||44
408967|NCT01660191|1001585|P3|STARTED|End of Treatment||44
408968|NCT01660191|1001586|P2|STARTED|End of Treatment||45
408969|NCT01660191|1001587|P1|STARTED|End of Treatment||45
408970|NCT01660191|1001585|P3|NOT COMPLETED|Randomization||0
408971|NCT01660191|1001586|P2|NOT COMPLETED|Randomization||0
408972|NCT01660191|1001587|P1|NOT COMPLETED|Randomization||0
408973|NCT01660191|1001585|P3|COMPLETED|Randomization||44
408974|NCT01660191|1001586|P2|COMPLETED|Randomization||45
408975|NCT01660191|1001587|P1|COMPLETED|Randomization||45
408976|NCT01660191|1001585|P3|STARTED|Randomization||44
408977|NCT01660191|1001586|P2|STARTED|Randomization||45
408978|NCT01660191|1001587|P1|STARTED|Randomization||45
408979|NCT01660191|1001585|P3|NOT COMPLETED|Enrollment and Washout||0
408980|NCT01660191|1001586|P2|NOT COMPLETED|Enrollment and Washout||0
408981|NCT01660191|1001587|P1|NOT COMPLETED|Enrollment and Washout||0
408982|NCT01660191|1001585|P3|COMPLETED|Enrollment and Washout||44
408983|NCT01660191|1001586|P2|COMPLETED|Enrollment and Washout||45
408984|NCT01660191|1001587|P1|COMPLETED|Enrollment and Washout||45
408985|NCT01660191|1001585|P3|STARTED|Enrollment and Washout||44
408986|NCT01660191|1001586|P2|STARTED|Enrollment and Washout||45
408987|NCT01660191|1001587|P1|STARTED|Enrollment and Washout||45
408988|NCT01660022|1001616|P6|NOT COMPLETED|Second Sequence (42 Days)||0
408989|NCT01660022|1001617|P5|NOT COMPLETED|Second Sequence (42 Days)||0
408990|NCT01660022|1001618|P4|NOT COMPLETED|Second Sequence (42 Days)||0
408991|NCT01660022|1001619|P3|NOT COMPLETED|Second Sequence (42 Days)||0
408992|NCT01660022|1001620|P2|NOT COMPLETED|Second Sequence (42 Days)||0
408993|NCT01660022|1001621|P1|NOT COMPLETED|Second Sequence (42 Days)||0
408994|NCT01660022|1001616|P6|COMPLETED|Second Sequence (42 Days)||16
408995|NCT01660022|1001617|P5|COMPLETED|Second Sequence (42 Days)||6
408996|NCT01660022|1001618|P4|COMPLETED|Second Sequence (42 Days)||7
408997|NCT01660022|1001619|P3|COMPLETED|Second Sequence (42 Days)||8
408998|NCT01660022|1001620|P2|COMPLETED|Second Sequence (42 Days)||7
408999|NCT01660022|1001621|P1|COMPLETED|Second Sequence (42 Days)||8
409000|NCT01660022|1001616|P6|STARTED|Second Sequence (42 Days)||16
409001|NCT01660022|1001617|P5|STARTED|Second Sequence (42 Days)||6
409002|NCT01660022|1001618|P4|STARTED|Second Sequence (42 Days)||7
409003|NCT01660022|1001619|P3|STARTED|Second Sequence (42 Days)||8
409004|NCT01660022|1001620|P2|STARTED|Second Sequence (42 Days)||7
409005|NCT01660022|1001621|P1|STARTED|Second Sequence (42 Days)||8
409006|NCT01660022|1001616|P6|NOT COMPLETED|First Sequence (7 Days)||4
409007|NCT01660022|1001617|P5|NOT COMPLETED|First Sequence (7 Days)||1
409008|NCT01660022|1001618|P4|NOT COMPLETED|First Sequence (7 Days)||1
409009|NCT01660022|1001619|P3|NOT COMPLETED|First Sequence (7 Days)||0
409010|NCT01660022|1001620|P2|NOT COMPLETED|First Sequence (7 Days)||1
409011|NCT01660022|1001621|P1|NOT COMPLETED|First Sequence (7 Days)||0
409012|NCT01660022|1001616|P6|COMPLETED|First Sequence (7 Days)||16
409013|NCT01660022|1001617|P5|COMPLETED|First Sequence (7 Days)||6
409014|NCT01660022|1001618|P4|COMPLETED|First Sequence (7 Days)||7
409015|NCT01660022|1001619|P3|COMPLETED|First Sequence (7 Days)||8
409016|NCT01660022|1001620|P2|COMPLETED|First Sequence (7 Days)||7
409017|NCT01660022|1001621|P1|COMPLETED|First Sequence (7 Days)||8
409018|NCT01660022|1001616|P6|STARTED|First Sequence (7 Days)||20
409019|NCT01660022|1001617|P5|STARTED|First Sequence (7 Days)||7
409020|NCT01660022|1001618|P4|STARTED|First Sequence (7 Days)||8
409021|NCT01660022|1001619|P3|STARTED|First Sequence (7 Days)||8
409022|NCT01660022|1001620|P2|STARTED|First Sequence (7 Days)||8
409023|NCT01660022|1001621|P1|STARTED|First Sequence (7 Days)||8
409024|NCT01659996|1001680|P3|NOT COMPLETED|Overall Study||11
409025|NCT01659996|1001681|P2|NOT COMPLETED|Overall Study||7
409026|NCT01659996|1001682|P1|NOT COMPLETED|Overall Study||8
409027|NCT01659996|1001680|P3|COMPLETED|Overall Study||461
409028|NCT01659996|1001681|P2|COMPLETED|Overall Study||388
409029|NCT01659996|1001682|P1|COMPLETED|Overall Study||413
409030|NCT01659996|1001680|P3|STARTED|Overall Study||472
409031|NCT01659996|1001681|P2|STARTED|Overall Study||395
409032|NCT01659996|1001682|P1|STARTED|Overall Study||421
409033|NCT01659853|1001714|P2|NOT COMPLETED|Treatment Period 2||0
409034|NCT01659853|1001715|P1|NOT COMPLETED|Treatment Period 2||0
409035|NCT01659853|1001714|P2|COMPLETED|Treatment Period 2||35
409036|NCT01659853|1001715|P1|COMPLETED|Treatment Period 2||33
409037|NCT01659853|1001714|P2|STARTED|Treatment Period 2||35
409038|NCT01659853|1001715|P1|STARTED|Treatment Period 2||33
409039|NCT01659853|1001714|P2|NOT COMPLETED|Washout , 3 to 7 Days||0
409040|NCT01659853|1001715|P1|NOT COMPLETED|Washout , 3 to 7 Days||2
409041|NCT01659853|1001714|P2|COMPLETED|Washout , 3 to 7 Days||35
409042|NCT01659853|1001715|P1|COMPLETED|Washout , 3 to 7 Days||33
409043|NCT01659853|1001714|P2|STARTED|Washout , 3 to 7 Days||35
409044|NCT01659853|1001715|P1|STARTED|Washout , 3 to 7 Days||35
409045|NCT01659853|1001714|P2|NOT COMPLETED|Treatment Period 1||0
409046|NCT01659853|1001715|P1|NOT COMPLETED|Treatment Period 1||0
409047|NCT01659853|1001714|P2|COMPLETED|Treatment Period 1||35
409048|NCT01659853|1001715|P1|COMPLETED|Treatment Period 1||35
409049|NCT01659853|1001714|P2|STARTED|Treatment Period 1||35
409050|NCT01659853|1001715|P1|STARTED|Treatment Period 1||35
409051|NCT01659736|1001725|P2|NOT COMPLETED|3-month Follow-up||1
409052|NCT01659736|1001726|P1|NOT COMPLETED|3-month Follow-up||0
409053|NCT01659736|1001725|P2|COMPLETED|3-month Follow-up||9
409054|NCT01659736|1001726|P1|COMPLETED|3-month Follow-up||9
409055|NCT01659736|1001725|P2|STARTED|3-month Follow-up||10
409056|NCT01659736|1001726|P1|STARTED|3-month Follow-up||9
409057|NCT01659736|1001725|P2|NOT COMPLETED|Treatment Period||2
409058|NCT01659736|1001726|P1|NOT COMPLETED|Treatment Period||5
409059|NCT01659736|1001725|P2|COMPLETED|Treatment Period||10
409060|NCT01659736|1001726|P1|COMPLETED|Treatment Period|n = 10, but data from one completer was excluded from all analyses due to protocol violation.|9
409061|NCT01659736|1001725|P2|STARTED|Treatment Period||12
409062|NCT01659736|1001726|P1|STARTED|Treatment Period||14
409063|NCT01659567|1001740|P1|NOT COMPLETED|Overall Study||123
409064|NCT01659567|1001740|P1|COMPLETED|Overall Study||393
409065|NCT01659567|1001740|P1|STARTED|Overall Study||516
409066|NCT01659554|1001757|P1|NOT COMPLETED|Overall Study||4
409067|NCT01659554|1001757|P1|COMPLETED|Overall Study||0
409068|NCT01659554|1001757|P1|STARTED|Overall Study|4 subjects enrolled; 4 subjects treated and 4 did not complete protocol schema|4
409069|NCT01659320|1001764|P1|NOT COMPLETED|Overall Study||3
409070|NCT01659320|1001764|P1|COMPLETED|Overall Study||13
409071|NCT01659320|1001764|P1|STARTED|Overall Study||16
409072|NCT01659268|1001770|P2|NOT COMPLETED|Overall Study||0
409073|NCT01659268|1001771|P1|NOT COMPLETED|Overall Study||0
409074|NCT01659268|1001770|P2|COMPLETED|Overall Study||8
409075|NCT01659268|1001771|P1|COMPLETED|Overall Study||9
409076|NCT01659268|1001770|P2|STARTED|Overall Study||8
409077|NCT01659268|1001771|P1|STARTED|Overall Study||9
409078|NCT01659125|1001783|P1|NOT COMPLETED|Overall Study||14
409079|NCT01659125|1001783|P1|COMPLETED|Overall Study||12
409080|NCT01659125|1001783|P1|Completed 6-month Follow-up|Overall Study||12
409081|NCT01659125|1001783|P1|Completed 3-month Follow-up|Overall Study||16
409082|NCT01659125|1001783|P1|Completed the Posttreatment Assessment|Overall Study||17
409083|NCT01659125|1001783|P1|Initiated Treatment|Overall Study||24
409084|NCT01659125|1001783|P1|STARTED|Overall Study||26
409085|NCT01659021|1001790|P2|NOT COMPLETED|Overall Study||37
409086|NCT01659021|1001791|P1|NOT COMPLETED|Overall Study||88
409087|NCT01659021|1001790|P2|COMPLETED|Overall Study||50
409088|NCT01659021|1001791|P1|COMPLETED|Overall Study||86
409089|NCT01659021|1001790|P2|Randomized and Treated|Overall Study||86
409090|NCT01659021|1001791|P1|Randomized and Treated|Overall Study||173
409091|NCT01659021|1001790|P2|STARTED|Overall Study||87
409092|NCT01659021|1001791|P1|STARTED|Overall Study||174
409093|NCT01658943|1001809|P2|NOT COMPLETED|Overall Study||67
409094|NCT01658943|1001810|P1|NOT COMPLETED|Overall Study||70
409095|NCT01658943|1001809|P2|COMPLETED|Overall Study||0
409096|NCT01658943|1001810|P1|COMPLETED|Overall Study||0
409097|NCT01658943|1001809|P2|Eligible and Began Protocol Therapy|Overall Study||58
409098|NCT01658943|1001810|P1|Eligible and Began Protocol Therapy|Overall Study||62
409099|NCT01658943|1001809|P2|Eligible|Overall Study||58
409100|NCT01658943|1001810|P1|Eligible|Overall Study||63
409101|NCT01658943|1001809|P2|STARTED|Overall Study||67
409102|NCT01658943|1001810|P1|STARTED|Overall Study||70
409103|NCT01658904|1001825|P3|NOT COMPLETED|Overall Study||0
409104|NCT01658904|1001826|P2|NOT COMPLETED|Overall Study||0
409105|NCT01658904|1001827|P1|NOT COMPLETED|Overall Study||2
409106|NCT01658904|1001825|P3|COMPLETED|Overall Study||0
409107|NCT01658904|1001826|P2|COMPLETED|Overall Study||0
409108|NCT01658904|1001827|P1|COMPLETED|Overall Study||1
409109|NCT01658904|1001825|P3|STARTED|Overall Study||0
409110|NCT01658904|1001826|P2|STARTED|Overall Study||0
409111|NCT01658904|1001827|P1|STARTED|Overall Study||3
409112|NCT01658839|1001844|P1|NOT COMPLETED|Overall Study||0
409113|NCT01658839|1001844|P1|COMPLETED|Overall Study||25
409114|NCT01658839|1001844|P1|STARTED|Overall Study||25
409115|NCT01658813|1001853|P1|NOT COMPLETED|Overall Study||3
409116|NCT01658813|1001853|P1|COMPLETED|Overall Study||15
409117|NCT01658813|1001853|P1|Treated|Overall Study||18
409118|NCT01658813|1001853|P1|Eligible|Overall Study||18
409119|NCT01658813|1001853|P1|STARTED|Overall Study||18
409120|NCT01658735|1001864|P3|NOT COMPLETED|Overall Study||4
409121|NCT01658735|1001865|P2|NOT COMPLETED|Overall Study||7
409122|NCT01658735|1001866|P1|NOT COMPLETED|Overall Study||5
409123|NCT01658735|1001864|P3|COMPLETED|Overall Study||34
409124|NCT01658735|1001865|P2|COMPLETED|Overall Study||29
409125|NCT01658735|1001866|P1|COMPLETED|Overall Study||34
409126|NCT01658735|1001864|P3|STARTED|Overall Study||38
409127|NCT01658735|1001865|P2|STARTED|Overall Study||36
409128|NCT01658735|1001866|P1|STARTED|Overall Study||39
409129|NCT01658657|1001897|P2|NOT COMPLETED|Overall Study||3
409130|NCT01658657|1001898|P1|NOT COMPLETED|Overall Study||3
409131|NCT01658657|1001897|P2|COMPLETED|Overall Study||7
409132|NCT01658657|1001898|P1|COMPLETED|Overall Study||4
409133|NCT01658657|1001897|P2|STARTED|Overall Study||10
409134|NCT01658657|1001898|P1|STARTED|Overall Study||7
409135|NCT01658579|1001908|P4|NOT COMPLETED|Treatment Period B||1
409136|NCT01658579|1001909|P3|NOT COMPLETED|Treatment Period B||0
409137|NCT01658579|1001910|P2|NOT COMPLETED|Treatment Period B||0
409138|NCT01658579|1001911|P1|NOT COMPLETED|Treatment Period B||0
409139|NCT01658579|1001908|P4|COMPLETED|Treatment Period B||12
409140|NCT01658579|1001909|P3|COMPLETED|Treatment Period B||14
409141|NCT01658579|1001910|P2|COMPLETED|Treatment Period B||15
409142|NCT01658579|1001911|P1|COMPLETED|Treatment Period B||14
409143|NCT01658579|1001908|P4|STARTED|Treatment Period B||13
409144|NCT01658579|1001909|P3|STARTED|Treatment Period B||14
409145|NCT01658579|1001910|P2|STARTED|Treatment Period B||15
409146|NCT01658579|1001911|P1|STARTED|Treatment Period B||14
409147|NCT01658579|1001908|P4|NOT COMPLETED|Treatment Period A||1
409148|NCT01658579|1001909|P3|NOT COMPLETED|Treatment Period A||1
409149|NCT01658579|1001910|P2|NOT COMPLETED|Treatment Period A||0
409150|NCT01658579|1001911|P1|NOT COMPLETED|Treatment Period A||1
409151|NCT01658579|1001908|P4|COMPLETED|Treatment Period A||13
409152|NCT01658579|1001909|P3|COMPLETED|Treatment Period A||14
409153|NCT01658579|1001910|P2|COMPLETED|Treatment Period A||15
409154|NCT01658579|1001911|P1|COMPLETED|Treatment Period A||14
409155|NCT01658579|1001908|P4|STARTED|Treatment Period A||14
409156|NCT01658579|1001909|P3|STARTED|Treatment Period A||15
409157|NCT01658579|1001910|P2|STARTED|Treatment Period A||15
409158|NCT01658579|1001911|P1|STARTED|Treatment Period A||15
409159|NCT01658514|1001939|P3|NOT COMPLETED|Overall Study||2
409160|NCT01658514|1001940|P2|NOT COMPLETED|Overall Study||0
409161|NCT01658514|1001941|P1|NOT COMPLETED|Overall Study||1
409162|NCT01658514|1001939|P3|COMPLETED|Overall Study||12
409163|NCT01658514|1001940|P2|COMPLETED|Overall Study||11
409164|NCT01658514|1001941|P1|COMPLETED|Overall Study||13
409165|NCT01658514|1001939|P3|Completed - Severe RI Cohort Only|Overall Study||3
409166|NCT01658514|1001940|P2|Completed - Severe RI Cohort Only|Overall Study||2
409167|NCT01658514|1001941|P1|Completed - Severe RI Cohort Only|Overall Study||3
409168|NCT01658514|1001939|P3|Started - Severe RI Cohort Only|Overall Study||3
409169|NCT01658514|1001940|P2|Started - Severe RI Cohort Only|Overall Study||2
409170|NCT01658514|1001941|P1|Started - Severe RI Cohort Only|Overall Study||3
409253|NCT01657461|1002065|P1|NOT COMPLETED|Overall Study||10
409171|NCT01658514|1001939|P3|Completed - Moderate RI Cohort Only|Overall Study||2
409172|NCT01658514|1001940|P2|Completed - Moderate RI Cohort Only|Overall Study||4
409173|NCT01658514|1001941|P1|Completed - Moderate RI Cohort Only|Overall Study||3
409174|NCT01658514|1001939|P3|Started - Moderate RI Cohort Only|Overall Study||4
409175|NCT01658514|1001940|P2|Started - Moderate RI Cohort Only|Overall Study||4
409176|NCT01658514|1001941|P1|Started - Moderate RI Cohort Only|Overall Study||4
409177|NCT01658514|1001939|P3|Completed - Mild RI Cohort Only|Overall Study||4
409178|NCT01658514|1001940|P2|Completed - Mild RI Cohort Only|Overall Study||3
409179|NCT01658514|1001941|P1|Completed - Mild RI Cohort Only|Overall Study||4
409180|NCT01658514|1001939|P3|Started - Mild RI Cohort Only|Overall Study||4
409181|NCT01658514|1001940|P2|Started - Mild RI Cohort Only|Overall Study||3
409182|NCT01658514|1001941|P1|Started - Mild RI Cohort Only|Overall Study||4
409183|NCT01658514|1001939|P3|Completed - Normal RF Cohort Only|Overall Study||3
409184|NCT01658514|1001940|P2|Completed - Normal RF Cohort Only|Overall Study||2
409185|NCT01658514|1001941|P1|Completed - Normal RF Cohort Only|Overall Study||3
409186|NCT01658514|1001939|P3|Started - Normal RF Cohort Only|Overall Study||3
409187|NCT01658514|1001940|P2|Started - Normal RF Cohort Only|Overall Study||2
409188|NCT01658514|1001941|P1|Started - Normal RF Cohort Only|Overall Study||3
409189|NCT01658514|1001939|P3|Completed Treatment C|Overall Study||12
409190|NCT01658514|1001940|P2|Completed Treatment C|Overall Study||11
409191|NCT01658514|1001941|P1|Completed Treatment C|Overall Study||13
409192|NCT01658514|1001939|P3|Completed Treatment B|Overall Study||14
409193|NCT01658514|1001940|P2|Completed Treatment B|Overall Study||11
409194|NCT01658514|1001941|P1|Completed Treatment B|Overall Study||13
409195|NCT01658514|1001939|P3|Completed Treatment A|Overall Study||12
409196|NCT01658514|1001940|P2|Completed Treatment A|Overall Study||11
409197|NCT01658514|1001941|P1|Completed Treatment A|Overall Study||14
409198|NCT01658514|1001939|P3|STARTED|Overall Study||14
409199|NCT01658514|1001940|P2|STARTED|Overall Study||11
409200|NCT01658514|1001941|P1|STARTED|Overall Study||14
409201|NCT01658436|1001952|P2|NOT COMPLETED|Overall Study||11
409202|NCT01658436|1001953|P1|NOT COMPLETED|Overall Study||20
409203|NCT01658436|1001952|P2|COMPLETED|Overall Study||0
409204|NCT01658436|1001953|P1|COMPLETED|Overall Study||0
409205|NCT01658436|1001952|P2|STARTED|Overall Study||11
409206|NCT01658436|1001953|P1|STARTED|Overall Study||20
409207|NCT01658228|1001962|P2|NOT COMPLETED|Overall Study||8
409208|NCT01658228|1001963|P1|NOT COMPLETED|Overall Study||7
409209|NCT01658228|1001962|P2|COMPLETED|Overall Study||23
409210|NCT01658228|1001963|P1|COMPLETED|Overall Study||23
409211|NCT01658228|1001962|P2|STARTED|Overall Study||31
409212|NCT01658228|1001963|P1|STARTED|Overall Study||30
409213|NCT01658072|1001975|P2|NOT COMPLETED|Overall Study||2
409214|NCT01658072|1001976|P1|NOT COMPLETED|Overall Study||4
409215|NCT01658072|1001975|P2|COMPLETED|Overall Study||43
409216|NCT01658072|1001976|P1|COMPLETED|Overall Study||41
409217|NCT01658072|1001975|P2|STARTED|Overall Study||45
409218|NCT01658072|1001976|P1|STARTED|Overall Study||45
409219|NCT01658020|1001984|P2|NOT COMPLETED|Overall Study||9
409220|NCT01658020|1001985|P1|NOT COMPLETED|Overall Study||8
409221|NCT01658020|1001984|P2|COMPLETED|Overall Study||158
409222|NCT01658020|1001985|P1|COMPLETED|Overall Study||167
409223|NCT01658020|1001984|P2|STARTED|Overall Study||167
409224|NCT01658020|1001985|P1|STARTED|Overall Study||175
409225|NCT01657903|1002001|P1|NOT COMPLETED|Overall Study||2
409226|NCT01657903|1002001|P1|COMPLETED|Overall Study||54
409227|NCT01657903|1002001|P1|Received NaF/KNO3 Toothpaste 2|Overall Study||55
409228|NCT01657903|1002001|P1|Received NaF/KNO3 Toothpaste 3|Overall Study||54
409229|NCT01657903|1002001|P1|Received NaF/KNO3 Toothpaste 1|Overall Study|One participant withdrew consent in study period 3|55
409230|NCT01657903|1002001|P1|Received Placebo (No NaF/KNO3)Toothpaste|Overall Study|One participant was lost to follow up in study period 1|56
409231|NCT01657903|1002001|P1|STARTED|Overall Study||56
409232|NCT01657877|1002023|P1|NOT COMPLETED|Overall Study||14
409233|NCT01657877|1002023|P1|COMPLETED|Overall Study||65
409234|NCT01657877|1002023|P1|Received 1500ppm Fluoride as SMFP+0% CSP|Overall Study|Discontinuations: 1 protocol violation in P1 and 1 withdrawal of consent and AE in P3|71
409235|NCT01657877|1002023|P1|Received 0ppm Fluoride+ 0% CSP|Overall Study|Discontinuation: 1 in P4 due to other reasons|69
409236|NCT01657877|1002023|P1|Received 0ppm Fluoride+ 5% CSP|Overall Study|Discontinuations: 1 protocol violation in P1 and P2 each and 1 withdrawal of consent in P1.|71
409237|NCT01657877|1002023|P1|Received 1500ppm Fluoride as SMFP+5% CSP|Overall Study|Discontinuations:2 withdrawal of consent in period (P) 1; 1 AE in P2;1 protocol violation in P3 & P4|75
409238|NCT01657877|1002023|P1|Received 500ppm Fluoride as SMFP+ 0% CSP|Overall Study|Discontinuations: 1 due to other reason in P2 and 1 protocol violation in P4|70
409239|NCT01657877|1002023|P1|STARTED|Overall Study||79
409240|NCT01657799|1002043|P3|NOT COMPLETED|Overall Study||102
409241|NCT01657799|1002044|P2|NOT COMPLETED|Overall Study||103
409242|NCT01657799|1002045|P1|NOT COMPLETED|Overall Study||102
409243|NCT01657799|1002043|P3|COMPLETED|Overall Study||0
409244|NCT01657799|1002044|P2|COMPLETED|Overall Study||0
409245|NCT01657799|1002045|P1|COMPLETED|Overall Study||0
409246|NCT01657799|1002043|P3|Received Treatment|Overall Study||102
409247|NCT01657799|1002044|P2|Received Treatment|Overall Study||103
409248|NCT01657799|1002045|P1|Received Treatment|Overall Study||101
409249|NCT01657799|1002043|P3|STARTED|Overall Study||102
409250|NCT01657799|1002044|P2|STARTED|Overall Study||103
409251|NCT01657799|1002045|P1|STARTED|Overall Study||102
409252|NCT01657461|1002064|P2|NOT COMPLETED|Overall Study||20
409254|NCT01657461|1002064|P2|COMPLETED|Overall Study||78
409255|NCT01657461|1002065|P1|COMPLETED|Overall Study||88
409256|NCT01657461|1002064|P2|STARTED|Overall Study||98
409257|NCT01657461|1002065|P1|STARTED|Overall Study||98
409258|NCT01657370|1002095|P6|NOT COMPLETED|Overall Study||4
409259|NCT01657370|1002096|P5|NOT COMPLETED|Overall Study||7
409260|NCT01657370|1002097|P4|NOT COMPLETED|Overall Study||5
409261|NCT01657370|1002098|P3|NOT COMPLETED|Overall Study||7
409262|NCT01657370|1002099|P2|NOT COMPLETED|Overall Study||4
409263|NCT01657370|1002100|P1|NOT COMPLETED|Overall Study||6
409264|NCT01657370|1002095|P6|COMPLETED|Overall Study||27
409265|NCT01657370|1002096|P5|COMPLETED|Overall Study||27
409266|NCT01657370|1002097|P4|COMPLETED|Overall Study||28
409267|NCT01657370|1002098|P3|COMPLETED|Overall Study||25
409268|NCT01657370|1002099|P2|COMPLETED|Overall Study||28
409269|NCT01657370|1002100|P1|COMPLETED|Overall Study||27
409270|NCT01657370|1002095|P6|STARTED|Overall Study||31
409271|NCT01657370|1002096|P5|STARTED|Overall Study||34
409272|NCT01657370|1002097|P4|STARTED|Overall Study||33
409273|NCT01657370|1002098|P3|STARTED|Overall Study||32
409274|NCT01657370|1002099|P2|STARTED|Overall Study||32
409275|NCT01657370|1002100|P1|STARTED|Overall Study||33
409276|NCT01657305|1002182|P1|NOT COMPLETED|Overall Study||25
409277|NCT01657305|1002182|P1|COMPLETED|Overall Study||82
409278|NCT01657305|1002182|P1|STARTED|Overall Study||107
409279|NCT01657292|1002232|P1|NOT COMPLETED|Overall Study||10
409280|NCT01657292|1002232|P1|COMPLETED|Overall Study||51
409281|NCT01657292|1002232|P1|STARTED|Overall Study||61
409282|NCT01657253|1002241|P2|NOT COMPLETED|Overall Study||18
409283|NCT01657253|1002242|P1|NOT COMPLETED|Overall Study||17
409284|NCT01657253|1002241|P2|COMPLETED|Overall Study||72
409285|NCT01657253|1002242|P1|COMPLETED|Overall Study||76
409286|NCT01657253|1002241|P2|STARTED|Overall Study||90
409287|NCT01657253|1002242|P1|STARTED|Overall Study||93
409288|NCT01657032|1002254|P2|NOT COMPLETED|Overall Study||7
409289|NCT01657032|1002255|P1|NOT COMPLETED|Overall Study||0
409290|NCT01657032|1002254|P2|COMPLETED|Overall Study||37
409291|NCT01657032|1002255|P1|COMPLETED|Overall Study||44
409292|NCT01657032|1002254|P2|STARTED|Overall Study||44
409293|NCT01657032|1002255|P1|STARTED|Overall Study||44
409294|NCT01657019|1002281|P1|NOT COMPLETED|Overall Study||235
409295|NCT01657019|1002281|P1|COMPLETED|Overall Study||369
409296|NCT01657019|1002281|P1|STARTED|Overall Study||604
409297|NCT01656967|1002295|P2|NOT COMPLETED|Overall Study||2
409298|NCT01656967|1002296|P1|NOT COMPLETED|Overall Study||4
409299|NCT01656967|1002295|P2|COMPLETED|Overall Study||31
409300|NCT01656967|1002296|P1|COMPLETED|Overall Study||29
409301|NCT01656967|1002295|P2|ETT Insertion|Overall Study||31
409302|NCT01656967|1002296|P1|ETT Insertion|Overall Study||29
409303|NCT01656967|1002295|P2|SGA Placement|Overall Study||33
409304|NCT01656967|1002296|P1|SGA Placement|Overall Study||32
409305|NCT01656967|1002295|P2|STARTED|Overall Study||33
409306|NCT01656967|1002296|P1|STARTED|Overall Study||33
409307|NCT01656889|1002318|P2|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||9
409308|NCT01656889|1002319|P1|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||4
409309|NCT01656889|1002318|P2|COMPLETED|Post Treatment Follow-Up, 3 Months||204
409310|NCT01656889|1002319|P1|COMPLETED|Post Treatment Follow-Up, 3 Months||206
409311|NCT01656889|1002318|P2|STARTED|Post Treatment Follow-Up, 3 Months||213
409312|NCT01656889|1002319|P1|STARTED|Post Treatment Follow-Up, 3 Months||210
409313|NCT01656889|1002318|P2|NOT COMPLETED|Treatment Period, 12 Weeks||11
409314|NCT01656889|1002319|P1|NOT COMPLETED|Treatment Period, 12 Weeks||12
409315|NCT01656889|1002318|P2|COMPLETED|Treatment Period, 12 Weeks|Completed treatment|214
409316|NCT01656889|1002319|P1|COMPLETED|Treatment Period, 12 Weeks|Completed treatment|210
409317|NCT01656889|1002318|P2|STARTED|Treatment Period, 12 Weeks|Randomized (Met all I/E criteria at completion of run-in)|225
409318|NCT01656889|1002319|P1|STARTED|Treatment Period, 12 Weeks|Randomized (Met all I/E criteria at completion of run-in)|222
409319|NCT01656850|1002339|P2|NOT COMPLETED|Second Intervention (3 Months)||0
409320|NCT01656850|1002340|P1|NOT COMPLETED|Second Intervention (3 Months)||0
409321|NCT01656850|1002339|P2|COMPLETED|Second Intervention (3 Months)||16
409322|NCT01656850|1002340|P1|COMPLETED|Second Intervention (3 Months)||17
409323|NCT01656850|1002339|P2|STARTED|Second Intervention (3 Months)||16
409324|NCT01656850|1002340|P1|STARTED|Second Intervention (3 Months)||17
409325|NCT01656850|1002339|P2|NOT COMPLETED|Washout (2 Weeks)||0
409326|NCT01656850|1002340|P1|NOT COMPLETED|Washout (2 Weeks)||0
409327|NCT01656850|1002339|P2|COMPLETED|Washout (2 Weeks)||16
409328|NCT01656850|1002340|P1|COMPLETED|Washout (2 Weeks)||17
409329|NCT01656850|1002339|P2|STARTED|Washout (2 Weeks)||16
409330|NCT01656850|1002340|P1|STARTED|Washout (2 Weeks)||17
409331|NCT01656850|1002339|P2|NOT COMPLETED|First Intervention (3 Months)||4
409332|NCT01656850|1002340|P1|NOT COMPLETED|First Intervention (3 Months)||3
409333|NCT01656850|1002339|P2|COMPLETED|First Intervention (3 Months)||16
409334|NCT01656850|1002340|P1|COMPLETED|First Intervention (3 Months)||17
409335|NCT01656850|1002339|P2|STARTED|First Intervention (3 Months)||20
409336|NCT01656850|1002340|P1|STARTED|First Intervention (3 Months)||20
409337|NCT01656772|1002420|P2|NOT COMPLETED|Overall Study||0
409338|NCT01656772|1002421|P1|NOT COMPLETED|Overall Study||0
409339|NCT01656772|1002420|P2|COMPLETED|Overall Study||77
409340|NCT01656772|1002421|P1|COMPLETED|Overall Study||43
409341|NCT01656772|1002420|P2|STARTED|Overall Study||77
409342|NCT01656772|1002421|P1|STARTED|Overall Study||43
409343|NCT01656759|1002431|P2|NOT COMPLETED|Overall Study||3
409344|NCT01656759|1002432|P1|NOT COMPLETED|Overall Study||2
409345|NCT01656759|1002431|P2|COMPLETED|Overall Study||22
409346|NCT01656759|1002432|P1|COMPLETED|Overall Study||25
409347|NCT01656759|1002431|P2|STARTED|Overall Study||25
409348|NCT01656759|1002432|P1|STARTED|Overall Study||27
409349|NCT01656486|1002444|P1|NOT COMPLETED|Overall Study||0
409350|NCT01656486|1002444|P1|COMPLETED|Overall Study||1
409351|NCT01656486|1002444|P1|STARTED|Overall Study||1
409352|NCT01656460|1002448|P4|NOT COMPLETED|Overall Study||0
409353|NCT01656460|1002449|P3|NOT COMPLETED|Overall Study||0
409354|NCT01656460|1002450|P2|NOT COMPLETED|Overall Study||0
409355|NCT01656460|1002451|P1|NOT COMPLETED|Overall Study||0
409356|NCT01656460|1002448|P4|COMPLETED|Overall Study||3
409357|NCT01656460|1002449|P3|COMPLETED|Overall Study||3
409358|NCT01656460|1002450|P2|COMPLETED|Overall Study||3
409359|NCT01656460|1002451|P1|COMPLETED|Overall Study||3
409360|NCT01656460|1002448|P4|STARTED|Overall Study||3
409361|NCT01656460|1002449|P3|STARTED|Overall Study||3
409362|NCT01656460|1002450|P2|STARTED|Overall Study||3
409363|NCT01656460|1002451|P1|STARTED|Overall Study||3
409364|NCT01656434|1002463|P2|NOT COMPLETED|Overall Study||580
409365|NCT01656434|1002464|P1|NOT COMPLETED|Overall Study||2401
409366|NCT01656434|1002463|P2|COMPLETED|Overall Study||40
409367|NCT01656434|1002464|P1|COMPLETED|Overall Study||152
409368|NCT01656434|1002463|P2|Treated|Overall Study||604
409369|NCT01656434|1002464|P1|Treated|Overall Study|One treated participant had incomplete data and was not included in the Safety Analyses.|2466
409370|NCT01656434|1002463|P2|STARTED|Overall Study||620
409371|NCT01656434|1002464|P1|STARTED|Overall Study||2553
409372|NCT01656408|1002490|P10|NOT COMPLETED|Overall Study||3
409373|NCT01656408|1002491|P9|NOT COMPLETED|Overall Study||2
409374|NCT01656408|1002492|P8|NOT COMPLETED|Overall Study||1
409375|NCT01656408|1002493|P7|NOT COMPLETED|Overall Study||1
409376|NCT01656408|1002494|P6|NOT COMPLETED|Overall Study||2
409377|NCT01656408|1002495|P5|NOT COMPLETED|Overall Study||1
409378|NCT01656408|1002496|P4|NOT COMPLETED|Overall Study||0
409379|NCT01656408|1002497|P3|NOT COMPLETED|Overall Study||2
409380|NCT01656408|1002498|P2|NOT COMPLETED|Overall Study||0
409381|NCT01656408|1002499|P1|NOT COMPLETED|Overall Study||1
409382|NCT01656408|1002490|P10|COMPLETED|Overall Study||15
409383|NCT01656408|1002491|P9|COMPLETED|Overall Study||16
409384|NCT01656408|1002492|P8|COMPLETED|Overall Study||7
409385|NCT01656408|1002493|P7|COMPLETED|Overall Study||9
409386|NCT01656408|1002494|P6|COMPLETED|Overall Study||7
409387|NCT01656408|1002495|P5|COMPLETED|Overall Study||8
409388|NCT01656408|1002496|P4|COMPLETED|Overall Study||7
409389|NCT01656408|1002497|P3|COMPLETED|Overall Study||6
409390|NCT01656408|1002498|P2|COMPLETED|Overall Study||8
409391|NCT01656408|1002499|P1|COMPLETED|Overall Study||7
409392|NCT01656408|1002490|P10|STARTED|Overall Study||18
409393|NCT01656408|1002491|P9|STARTED|Overall Study||18
409394|NCT01656408|1002492|P8|STARTED|Overall Study||8
409395|NCT01656408|1002493|P7|STARTED|Overall Study||10
409396|NCT01656408|1002494|P6|STARTED|Overall Study||9
409397|NCT01656408|1002495|P5|STARTED|Overall Study||9
409398|NCT01656408|1002496|P4|STARTED|Overall Study||7
409399|NCT01656408|1002497|P3|STARTED|Overall Study||8
409400|NCT01656408|1002498|P2|STARTED|Overall Study||8
409401|NCT01656408|1002499|P1|STARTED|Overall Study||8
409402|NCT01656304|1002688|P1|NOT COMPLETED|Overall Study||1
409403|NCT01656304|1002688|P1|COMPLETED|Overall Study||15
409404|NCT01656304|1002688|P1|STARTED|Overall Study||16
409405|NCT01656252|1002697|P1|NOT COMPLETED|Phase II||0
409406|NCT01656252|1002697|P1|COMPLETED|Phase II||0
409407|NCT01656252|1002697|P1|STARTED|Phase II||0
409408|NCT01656252|1002697|P1|NOT COMPLETED|Phase I||0
409409|NCT01656252|1002697|P1|COMPLETED|Phase I||14
409410|NCT01656252|1002697|P1|STARTED|Phase I||14
409411|NCT01656161|1002729|P1|NOT COMPLETED|Overall Study||7
409412|NCT01656161|1002729|P1|COMPLETED|Overall Study|Per protocol analysis set|113
409413|NCT01656161|1002729|P1|Received Triptorelin at Day 169|Overall Study||115
409414|NCT01656161|1002729|P1|Received Triptorelin at Day 1|Overall Study|Safety analysis set|120
409415|NCT01656161|1002729|P1|STARTED|Overall Study|Intention to treat analysis set|120
409416|NCT01656031|1002743|P1|NOT COMPLETED|Overall Study||0
409417|NCT01656031|1002743|P1|COMPLETED|Overall Study||39
409418|NCT01656031|1002743|P1|STARTED|Overall Study||39
409419|NCT01655719|1002747|P1|NOT COMPLETED|Overall Study||0
409420|NCT01655719|1002747|P1|COMPLETED|Overall Study||1
409421|NCT01655719|1002747|P1|STARTED|Overall Study||1
409422|NCT01655498|1002753|P1|NOT COMPLETED|Overall Study||5
409423|NCT01655498|1002753|P1|COMPLETED|Overall Study||56
409424|NCT01655498|1002753|P1|STARTED|Overall Study||61
409425|NCT01655381|1002760|P1|NOT COMPLETED|Overall Study||3
409426|NCT01655381|1002760|P1|COMPLETED|Overall Study||12
409427|NCT01655381|1002760|P1|STARTED|Overall Study||15
409428|NCT01655329|1002780|P1|NOT COMPLETED|Overall Study||0
409429|NCT01655329|1002780|P1|COMPLETED|Overall Study||10
409430|NCT01655329|1002780|P1|STARTED|Overall Study|The same 10 radiologists are interpreting images in both arms.|10
409431|NCT01655069|1002800|P4|NOT COMPLETED|Overall Study||4
409432|NCT01655069|1002801|P3|NOT COMPLETED|Overall Study||2
409433|NCT01655069|1002802|P2|NOT COMPLETED|Overall Study||12
409434|NCT01655069|1002803|P1|NOT COMPLETED|Overall Study||8
409435|NCT01655069|1002800|P4|COMPLETED|Overall Study||11
409436|NCT01655069|1002801|P3|COMPLETED|Overall Study||12
409437|NCT01655069|1002802|P2|COMPLETED|Overall Study||46
409438|NCT01655069|1002803|P1|COMPLETED|Overall Study||53
409439|NCT01655069|1002800|P4|Full Analysis Set (FAS)|Overall Study||15
409440|NCT01655069|1002801|P3|Full Analysis Set (FAS)|Overall Study||14
409441|NCT01655069|1002802|P2|Full Analysis Set (FAS)|Overall Study||57
409442|NCT01655069|1002803|P1|Full Analysis Set (FAS)|Overall Study||60
409443|NCT01655069|1002800|P4|Safety Analysis Set (SAF)|Overall Study||15
409444|NCT01655069|1002801|P3|Safety Analysis Set (SAF)|Overall Study||14
409445|NCT01655069|1002802|P2|Safety Analysis Set (SAF)|Overall Study||57
409446|NCT01655069|1002803|P1|Safety Analysis Set (SAF)|Overall Study||61
409447|NCT01655069|1002800|P4|STARTED|Overall Study||15
409448|NCT01655069|1002801|P3|STARTED|Overall Study||14
409449|NCT01655069|1002802|P2|STARTED|Overall Study||58
409450|NCT01655069|1002803|P1|STARTED|Overall Study||61
409451|NCT01655043|1002818|P1|NOT COMPLETED|Overall Study||0
409452|NCT01655043|1002818|P1|COMPLETED|Overall Study||20
409453|NCT01655043|1002818|P1|STARTED|Overall Study||20
409454|NCT01654887|1002824|P2|NOT COMPLETED|Overall Study||0
409455|NCT01654887|1002825|P1|NOT COMPLETED|Overall Study||0
409456|NCT01654887|1002824|P2|COMPLETED|Overall Study||88
409457|NCT01654887|1002825|P1|COMPLETED|Overall Study||103
409458|NCT01654887|1002824|P2|STARTED|Overall Study||88
409459|NCT01654887|1002825|P1|STARTED|Overall Study||103
409460|NCT01654861|1002841|P1|NOT COMPLETED|Overall Study||0
409461|NCT01654861|1002841|P1|COMPLETED|Overall Study||3
409462|NCT01654861|1002841|P1|STARTED|Overall Study||3
409463|NCT01654796|1002849|P3|NOT COMPLETED|Overall Study||1
409464|NCT01654796|1002850|P2|NOT COMPLETED|Overall Study||3
409465|NCT01654796|1002851|P1|NOT COMPLETED|Overall Study||1
409466|NCT01654796|1002849|P3|COMPLETED|Overall Study||28
409467|NCT01654796|1002850|P2|COMPLETED|Overall Study||26
409468|NCT01654796|1002851|P1|COMPLETED|Overall Study||25
409469|NCT01654796|1002849|P3|STARTED|Overall Study||29
409470|NCT01654796|1002850|P2|STARTED|Overall Study||29
409471|NCT01654796|1002851|P1|STARTED|Overall Study||26
409472|NCT01654666|1002863|P3|NOT COMPLETED|Overall Study||14
409473|NCT01654666|1002864|P2|NOT COMPLETED|Overall Study||13
409474|NCT01654666|1002865|P1|NOT COMPLETED|Overall Study||15
409475|NCT01654666|1002863|P3|COMPLETED|Overall Study||49
409476|NCT01654666|1002864|P2|COMPLETED|Overall Study||50
409477|NCT01654666|1002865|P1|COMPLETED|Overall Study||48
409478|NCT01654666|1002863|P3|Primary Analysis|Overall Study||54
409479|NCT01654666|1002864|P2|Primary Analysis|Overall Study||56
409480|NCT01654666|1002865|P1|Primary Analysis|Overall Study||52
409481|NCT01654666|1002863|P3|STARTED|Overall Study||63
409482|NCT01654666|1002864|P2|STARTED|Overall Study||63
409483|NCT01654666|1002865|P1|STARTED|Overall Study||63
409484|NCT01654601|1002890|P2|NOT COMPLETED|2nd Administration||1
409485|NCT01654601|1002891|P1|NOT COMPLETED|2nd Administration||1
409486|NCT01654601|1002890|P2|COMPLETED|2nd Administration||11
409487|NCT01654601|1002891|P1|COMPLETED|2nd Administration||11
409488|NCT01654601|1002890|P2|STARTED|2nd Administration||12
409489|NCT01654601|1002891|P1|STARTED|2nd Administration||12
409490|NCT01654601|1002890|P2|NOT COMPLETED|1st Administration||2
409491|NCT01654601|1002891|P1|NOT COMPLETED|1st Administration||2
409492|NCT01654601|1002890|P2|COMPLETED|1st Administration||12
409493|NCT01654601|1002891|P1|COMPLETED|1st Administration||12
409494|NCT01654601|1002890|P2|STARTED|1st Administration||14
409495|NCT01654601|1002891|P1|STARTED|1st Administration||14
409496|NCT01654549|1002905|P2|NOT COMPLETED|Overall Study||1
409497|NCT01654549|1002906|P1|NOT COMPLETED|Overall Study||0
409498|NCT01654549|1002905|P2|COMPLETED|Overall Study||19
409499|NCT01654549|1002906|P1|COMPLETED|Overall Study||20
409500|NCT01654549|1002905|P2|STARTED|Overall Study||20
409501|NCT01654549|1002906|P1|STARTED|Overall Study||20
409502|NCT01654536|1002918|P2|NOT COMPLETED|Overall Study||38
409503|NCT01654536|1002919|P1|NOT COMPLETED|Overall Study||44
409504|NCT01654536|1002918|P2|COMPLETED|Overall Study||331
409505|NCT01654536|1002919|P1|COMPLETED|Overall Study||324
409506|NCT01654536|1002918|P2|STARTED|Overall Study||369
409507|NCT01654536|1002919|P1|STARTED|Overall Study||368
409508|NCT01654523|1002955|P1|NOT COMPLETED|Overall Study||1
409509|NCT01654523|1002955|P1|COMPLETED|Overall Study||19
409510|NCT01654523|1002955|P1|STARTED|Overall Study||20
409511|NCT01654302|1002961|P2|NOT COMPLETED|Second Intervention (Day 7)||1
409512|NCT01654302|1002962|P1|NOT COMPLETED|Second Intervention (Day 7)||1
409513|NCT01654302|1002961|P2|COMPLETED|Second Intervention (Day 7)||19
409514|NCT01654302|1002962|P1|COMPLETED|Second Intervention (Day 7)||19
409515|NCT01654302|1002961|P2|STARTED|Second Intervention (Day 7)||20
409516|NCT01654302|1002962|P1|STARTED|Second Intervention (Day 7)||20
409517|NCT01654302|1002961|P2|NOT COMPLETED|First Intervention (Day 1)||0
409518|NCT01654302|1002962|P1|NOT COMPLETED|First Intervention (Day 1)||0
409519|NCT01654302|1002961|P2|COMPLETED|First Intervention (Day 1)||20
409520|NCT01654302|1002962|P1|COMPLETED|First Intervention (Day 1)||20
409521|NCT01654302|1002961|P2|STARTED|First Intervention (Day 1)||20
409522|NCT01654302|1002962|P1|STARTED|First Intervention (Day 1)||20
409523|NCT01654276|1002968|P1|NOT COMPLETED|Overall Study||6
409524|NCT01654276|1002968|P1|COMPLETED|Overall Study||18
409525|NCT01654276|1002968|P1|Visit 4 (6months)|Overall Study||18
409526|NCT01654276|1002968|P1|Visit 3 (4 Months)|Overall Study||18
409527|NCT01654276|1002968|P1|Visit 2 (2 Months)|Overall Study||19
409528|NCT01654276|1002968|P1|STARTED|Overall Study||24
409529|NCT01654263|1002992|P6|NOT COMPLETED|Overall Study||1
409530|NCT01654263|1002993|P5|NOT COMPLETED|Overall Study||1
409531|NCT01654263|1002994|P4|NOT COMPLETED|Overall Study||1
409532|NCT01654263|1002995|P3|NOT COMPLETED|Overall Study||2
409533|NCT01654263|1002996|P2|NOT COMPLETED|Overall Study||0
409534|NCT01654263|1002997|P1|NOT COMPLETED|Overall Study||0
409535|NCT01654263|1002992|P6|COMPLETED|Overall Study||148
409536|NCT01654263|1002993|P5|COMPLETED|Overall Study||139
409537|NCT01654263|1002994|P4|COMPLETED|Overall Study||144
409538|NCT01654263|1002995|P3|COMPLETED|Overall Study||137
409539|NCT01654263|1002996|P2|COMPLETED|Overall Study||147
409540|NCT01654263|1002997|P1|COMPLETED|Overall Study||164
409541|NCT01654263|1002992|P6|STARTED|Overall Study||149
409542|NCT01654263|1002993|P5|STARTED|Overall Study||140
409543|NCT01654263|1002994|P4|STARTED|Overall Study||145
409544|NCT01654263|1002995|P3|STARTED|Overall Study||139
409545|NCT01654263|1002996|P2|STARTED|Overall Study||147
409546|NCT01654263|1002997|P1|STARTED|Overall Study||164
409547|NCT01654250|1003022|P2|NOT COMPLETED|Overall Study||0
409548|NCT01654250|1003023|P1|NOT COMPLETED|Overall Study||1
409549|NCT01654250|1003022|P2|COMPLETED|Overall Study||42
409550|NCT01654250|1003023|P1|COMPLETED|Overall Study||43
409551|NCT01654250|1003022|P2|STARTED|Overall Study||42
409552|NCT01654250|1003023|P1|STARTED|Overall Study||44
409553|NCT01654224|1003040|P2|NOT COMPLETED|Overall Study||12
409554|NCT01654224|1003041|P1|NOT COMPLETED|Overall Study||6
409555|NCT01654224|1003040|P2|COMPLETED|Overall Study||98
409556|NCT01654224|1003041|P1|COMPLETED|Overall Study||89
409557|NCT01654224|1003040|P2|STARTED|Overall Study||110
409558|NCT01654224|1003041|P1|STARTED|Overall Study||95
409559|NCT01654107|1003053|P2|NOT COMPLETED|Overall Study||8
409560|NCT01654107|1003054|P1|NOT COMPLETED|Overall Study||3
409561|NCT01654107|1003053|P2|COMPLETED|Overall Study||22
409562|NCT01654107|1003054|P1|COMPLETED|Overall Study||25
409563|NCT01654107|1003053|P2|STARTED|Overall Study||30
409564|NCT01654107|1003054|P1|STARTED|Overall Study||28
409565|NCT01653964|1003060|P1|NOT COMPLETED|Overall Study||0
409566|NCT01653964|1003060|P1|COMPLETED|Overall Study||82
409567|NCT01653964|1003060|P1|STARTED|Overall Study||82
409568|NCT01653912|1003066|P6|NOT COMPLETED|Phase 2: GSK2110183 125 mg||8
409569|NCT01653912|1003067|P5|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
409570|NCT01653912|1003068|P4|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
409571|NCT01653912|1003069|P3|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
409572|NCT01653912|1003070|P2|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
409573|NCT01653912|1003071|P1|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
409574|NCT01653912|1003066|P6|COMPLETED|Phase 2: GSK2110183 125 mg||22
409575|NCT01653912|1003067|P5|COMPLETED|Phase 2: GSK2110183 125 mg||0
409576|NCT01653912|1003068|P4|COMPLETED|Phase 2: GSK2110183 125 mg||0
409577|NCT01653912|1003069|P3|COMPLETED|Phase 2: GSK2110183 125 mg||0
409578|NCT01653912|1003070|P2|COMPLETED|Phase 2: GSK2110183 125 mg||0
409579|NCT01653912|1003071|P1|COMPLETED|Phase 2: GSK2110183 125 mg||0
409580|NCT01653912|1003066|P6|STARTED|Phase 2: GSK2110183 125 mg|Per SAP, Cohort B (n=2) data was summarized in phase 2 total column as cohort B had <10 subjects.|30
409581|NCT01653912|1003067|P5|STARTED|Phase 2: GSK2110183 125 mg||0
409582|NCT01653912|1003068|P4|STARTED|Phase 2: GSK2110183 125 mg||0
409583|NCT01653912|1003069|P3|STARTED|Phase 2: GSK2110183 125 mg||0
409584|NCT01653912|1003070|P2|STARTED|Phase 2: GSK2110183 125 mg||0
409585|NCT01653912|1003071|P1|STARTED|Phase 2: GSK2110183 125 mg||0
409586|NCT01653912|1003066|P6|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
409587|NCT01653912|1003067|P5|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
409588|NCT01653912|1003068|P4|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
409589|NCT01653912|1003069|P3|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
409590|NCT01653912|1003070|P2|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
409591|NCT01653912|1003071|P1|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
409592|NCT01653912|1003066|P6|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
409593|NCT01653912|1003067|P5|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||3
409594|NCT01653912|1003068|P4|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
409595|NCT01653912|1003069|P3|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
409596|NCT01653912|1003070|P2|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
409597|NCT01653912|1003071|P1|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
409598|NCT01653912|1003066|P6|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
409599|NCT01653912|1003067|P5|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||3
409600|NCT01653912|1003068|P4|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
409601|NCT01653912|1003069|P3|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
409602|NCT01653912|1003070|P2|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
409603|NCT01653912|1003071|P1|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
409604|NCT01653912|1003066|P6|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
409605|NCT01653912|1003067|P5|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
409606|NCT01653912|1003068|P4|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||2
409607|NCT01653912|1003069|P3|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
409608|NCT01653912|1003070|P2|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
409609|NCT01653912|1003071|P1|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
409610|NCT01653912|1003066|P6|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
409611|NCT01653912|1003067|P5|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
409612|NCT01653912|1003068|P4|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||10
409613|NCT01653912|1003069|P3|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
409614|NCT01653912|1003070|P2|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
409615|NCT01653912|1003071|P1|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
409616|NCT01653912|1003066|P6|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
409617|NCT01653912|1003067|P5|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
409618|NCT01653912|1003068|P4|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||12
409619|NCT01653912|1003069|P3|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
409620|NCT01653912|1003070|P2|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
409621|NCT01653912|1003071|P1|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
409622|NCT01653912|1003066|P6|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
409623|NCT01653912|1003067|P5|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
409624|NCT01653912|1003068|P4|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
409625|NCT01653912|1003069|P3|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||2
409626|NCT01653912|1003070|P2|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
409627|NCT01653912|1003071|P1|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
409628|NCT01653912|1003066|P6|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
409629|NCT01653912|1003067|P5|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
409630|NCT01653912|1003068|P4|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
409631|NCT01653912|1003069|P3|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||4
409632|NCT01653912|1003070|P2|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
409633|NCT01653912|1003071|P1|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
409634|NCT01653912|1003066|P6|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
409635|NCT01653912|1003067|P5|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
409636|NCT01653912|1003068|P4|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
409637|NCT01653912|1003069|P3|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||6
409638|NCT01653912|1003070|P2|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
409639|NCT01653912|1003071|P1|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
409640|NCT01653912|1003066|P6|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
409641|NCT01653912|1003067|P5|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
409642|NCT01653912|1003068|P4|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
409643|NCT01653912|1003069|P3|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
409644|NCT01653912|1003070|P2|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||1
409645|NCT01653912|1003071|P1|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
409646|NCT01653912|1003066|P6|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
409647|NCT01653912|1003067|P5|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
409648|NCT01653912|1003068|P4|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
409649|NCT01653912|1003069|P3|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
409650|NCT01653912|1003070|P2|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||3
409651|NCT01653912|1003071|P1|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
409652|NCT01653912|1003066|P6|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
409653|NCT01653912|1003067|P5|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
409654|NCT01653912|1003068|P4|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
409655|NCT01653912|1003069|P3|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
409656|NCT01653912|1003070|P2|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||4
409657|NCT01653912|1003071|P1|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
409658|NCT01653912|1003066|P6|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
409659|NCT01653912|1003067|P5|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
409660|NCT01653912|1003068|P4|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
409661|NCT01653912|1003069|P3|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
409662|NCT01653912|1003070|P2|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
409663|NCT01653912|1003071|P1|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
409664|NCT01653912|1003066|P6|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
409665|NCT01653912|1003067|P5|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
409666|NCT01653912|1003068|P4|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
409667|NCT01653912|1003069|P3|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
409668|NCT01653912|1003070|P2|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
409669|NCT01653912|1003071|P1|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||4
409670|NCT01653912|1003066|P6|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
409671|NCT01653912|1003067|P5|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
409672|NCT01653912|1003068|P4|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
409673|NCT01653912|1003069|P3|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
409674|NCT01653912|1003070|P2|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
409675|NCT01653912|1003071|P1|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||4
409676|NCT01653782|1003089|P3|NOT COMPLETED|Overall Study||6
409677|NCT01653782|1003090|P2|NOT COMPLETED|Overall Study||18
409678|NCT01653782|1003091|P1|NOT COMPLETED|Overall Study||16
409679|NCT01653782|1003089|P3|COMPLETED|Overall Study||46
409680|NCT01653782|1003090|P2|COMPLETED|Overall Study||37
409681|NCT01653782|1003091|P1|COMPLETED|Overall Study||36
409682|NCT01653782|1003089|P3|STARTED|Overall Study||52
409683|NCT01653782|1003090|P2|STARTED|Overall Study||55
409684|NCT01653782|1003091|P1|STARTED|Overall Study||52
409685|NCT01653743|1003101|P2|NOT COMPLETED|Overall Study||0
409686|NCT01653743|1003102|P1|NOT COMPLETED|Overall Study||4
409687|NCT01653743|1003101|P2|COMPLETED|Overall Study||27
409688|NCT01653743|1003102|P1|COMPLETED|Overall Study||50
409689|NCT01653743|1003101|P2|STARTED|Overall Study||27
409690|NCT01653743|1003102|P1|STARTED|Overall Study||54
409691|NCT01653509|1003118|P2|NOT COMPLETED|Overall Study||0
409692|NCT01653509|1003119|P1|NOT COMPLETED|Overall Study||0
409693|NCT01653509|1003118|P2|COMPLETED|Overall Study||13
409694|NCT01653509|1003119|P1|COMPLETED|Overall Study||12
409695|NCT01653509|1003118|P2|STARTED|Overall Study||13
409696|NCT01653509|1003119|P1|STARTED|Overall Study||12
409697|NCT01653418|1003137|P1|NOT COMPLETED|Overall Study||0
409698|NCT01653418|1003137|P1|COMPLETED|Overall Study||10
409699|NCT01653418|1003137|P1|STARTED|Overall Study||10
409700|NCT01653262|1003149|P1|NOT COMPLETED|Overall Study||3
409701|NCT01653262|1003149|P1|COMPLETED|Overall Study||26
409702|NCT01653262|1003149|P1|STARTED|Overall Study||29
409703|NCT01653158|1003162|P8|NOT COMPLETED|Overall Study||15
409704|NCT01653158|1003163|P7|NOT COMPLETED|Overall Study||2
409705|NCT01653158|1003164|P6|NOT COMPLETED|Overall Study||1
409706|NCT01653158|1003165|P5|NOT COMPLETED|Overall Study||1
409707|NCT01653158|1003166|P4|NOT COMPLETED|Overall Study||2
409708|NCT01653158|1003167|P3|NOT COMPLETED|Overall Study||0
409709|NCT01653158|1003168|P2|NOT COMPLETED|Overall Study||0
409710|NCT01653158|1003169|P1|NOT COMPLETED|Overall Study||1
409711|NCT01653158|1003162|P8|COMPLETED|Overall Study||4
409712|NCT01653158|1003163|P7|COMPLETED|Overall Study||7
409713|NCT01653158|1003164|P6|COMPLETED|Overall Study||2
409714|NCT01653158|1003165|P5|COMPLETED|Overall Study||2
409715|NCT01653158|1003166|P4|COMPLETED|Overall Study||1
409716|NCT01653158|1003167|P3|COMPLETED|Overall Study||3
409717|NCT01653158|1003168|P2|COMPLETED|Overall Study||3
409718|NCT01653158|1003169|P1|COMPLETED|Overall Study||2
409719|NCT01653158|1003162|P8|STARTED|Overall Study|Six (6) and 13 participants were enrolled in dose escalation and expansion cohorts, respectively.|19
409720|NCT01653158|1003163|P7|STARTED|Overall Study||9
409721|NCT01653158|1003164|P6|STARTED|Overall Study||3
409722|NCT01653158|1003165|P5|STARTED|Overall Study||3
409723|NCT01653158|1003166|P4|STARTED|Overall Study||3
409724|NCT01653158|1003167|P3|STARTED|Overall Study||3
409725|NCT01653158|1003168|P2|STARTED|Overall Study||3
409726|NCT01653158|1003169|P1|STARTED|Overall Study||3
409727|NCT01653132|1003441|P2|NOT COMPLETED|Second Intervention||0
409728|NCT01653132|1003442|P1|NOT COMPLETED|Second Intervention||0
409729|NCT01653132|1003441|P2|COMPLETED|Second Intervention||5
409730|NCT01653132|1003442|P1|COMPLETED|Second Intervention||4
409731|NCT01653132|1003441|P2|STARTED|Second Intervention||5
409732|NCT01653132|1003442|P1|STARTED|Second Intervention||4
409733|NCT01653132|1003441|P2|NOT COMPLETED|Washout 1-2 Months||0
409734|NCT01653132|1003442|P1|NOT COMPLETED|Washout 1-2 Months||0
409735|NCT01653132|1003441|P2|COMPLETED|Washout 1-2 Months||5
409736|NCT01653132|1003442|P1|COMPLETED|Washout 1-2 Months||4
409737|NCT01653132|1003441|P2|STARTED|Washout 1-2 Months||5
409738|NCT01653132|1003442|P1|STARTED|Washout 1-2 Months||4
409739|NCT01653132|1003441|P2|NOT COMPLETED|First Intervention||0
409740|NCT01653132|1003442|P1|NOT COMPLETED|First Intervention||1
409741|NCT01653132|1003441|P2|COMPLETED|First Intervention||5
409742|NCT01653132|1003442|P1|COMPLETED|First Intervention|one dropped out: wanted to start anticholinergic drug for tremor that could affect saliva volume|4
409743|NCT01653132|1003441|P2|STARTED|First Intervention||5
409744|NCT01653132|1003442|P1|STARTED|First Intervention||5
409745|NCT01653028|1003461|P5|NOT COMPLETED|Overall Study||0
409746|NCT01653028|1003462|P4|NOT COMPLETED|Overall Study||0
409747|NCT01653028|1003463|P3|NOT COMPLETED|Overall Study||0
409748|NCT01653028|1003464|P2|NOT COMPLETED|Overall Study||0
409749|NCT01653028|1003465|P1|NOT COMPLETED|Overall Study||0
409750|NCT01653028|1003461|P5|COMPLETED|Overall Study||29
409751|NCT01653028|1003462|P4|COMPLETED|Overall Study||10
409752|NCT01653028|1003463|P3|COMPLETED|Overall Study||11
409753|NCT01653028|1003464|P2|COMPLETED|Overall Study||10
409754|NCT01653028|1003465|P1|COMPLETED|Overall Study||12
409755|NCT01653028|1003461|P5|STARTED|Overall Study||29
409756|NCT01653028|1003462|P4|STARTED|Overall Study||10
409757|NCT01653028|1003463|P3|STARTED|Overall Study||11
409758|NCT01653028|1003464|P2|STARTED|Overall Study||10
409759|NCT01653028|1003465|P1|STARTED|Overall Study||12
409760|NCT01652885|1003492|P1|NOT COMPLETED|Overall Study||1
409761|NCT01652885|1003492|P1|COMPLETED|Overall Study||22
409762|NCT01652885|1003492|P1|STARTED|Overall Study||23
409763|NCT01652729|1003520|P3|NOT COMPLETED|Overall Study||14
409764|NCT01652729|1003521|P2|NOT COMPLETED|Overall Study||13
409765|NCT01652729|1003522|P1|NOT COMPLETED|Overall Study||27
409766|NCT01652729|1003520|P3|COMPLETED|Overall Study||47
409767|NCT01652729|1003521|P2|COMPLETED|Overall Study||109
409768|NCT01652729|1003522|P1|COMPLETED|Overall Study|The double-enrolled subject’s reasons for withdrawal were LTFU and PV. Only PV is shown below.|155
409769|NCT01652729|1003520|P3|Meal Test Evaluable|Overall Study||15
409770|NCT01652729|1003521|P2|Meal Test Evaluable|Overall Study||31
409771|NCT01652729|1003522|P1|Meal Test Evaluable|Overall Study|ITT subjects who ate >=75% of meal and did not miss 2-hour postprandial glucose measures at V3 and 8|44
409772|NCT01652729|1003520|P3|Meal Test Subjects|Overall Study||20
409773|NCT01652729|1003521|P2|Meal Test Subjects|Overall Study||41
409774|NCT01652729|1003522|P1|Meal Test Subjects|Overall Study||60
409775|NCT01652729|1003520|P3|Evaluable|Overall Study||43
409776|NCT01652729|1003521|P2|Evaluable|Overall Study||91
409777|NCT01652729|1003522|P1|Evaluable|Overall Study|Subjects who completed study procedures to Week 24 or beyond and had adequate study drug exposure|143
409778|NCT01652729|1003520|P3|Treated|Overall Study||61
409779|NCT01652729|1003521|P2|Treated|Overall Study||122
409780|NCT01652729|1003522|P1|Treated|Overall Study|All subjects who received at least one dose of study medication even if not randomized.|181
409781|NCT01652729|1003520|P3|Modified Intent-to-Treat|Overall Study||61
409782|NCT01652729|1003521|P2|Modified Intent-to-Treat|Overall Study||122
409875|NCT01651949|1003763|P1|Vaccination 1|Overall Study||1103
409783|NCT01652729|1003522|P1|Modified Intent-to-Treat|Overall Study|All randomized subjects who received at least one dose of study drug.|181
409784|NCT01652729|1003520|P3|STARTED|Overall Study||61
409785|NCT01652729|1003521|P2|STARTED|Overall Study||122
409786|NCT01652729|1003522|P1|STARTED|Overall Study|One subject was enrolled twice at different sites. He was randomized to exenatide at both sites.|182
409787|NCT01652716|1003544|P2|NOT COMPLETED|Overall Study||46
409788|NCT01652716|1003545|P1|NOT COMPLETED|Overall Study||56
409789|NCT01652716|1003544|P2|COMPLETED|Overall Study|* completed study|102
409790|NCT01652716|1003545|P1|COMPLETED|Overall Study|* completed study|173
409791|NCT01652716|1003544|P2|Completed 28-week|Overall Study||118
409792|NCT01652716|1003545|P1|Completed 28-week|Overall Study||197
409793|NCT01652716|1003544|P2|STARTED|Overall Study|Two subjects in the exenatide BID group withdrew from the study before receiving study drug.|148
409794|NCT01652716|1003545|P1|STARTED|Overall Study||229
409795|NCT01652703|1003565|P6|NOT COMPLETED|Overall Study||2
409796|NCT01652703|1003566|P5|NOT COMPLETED|Overall Study||1
409797|NCT01652703|1003567|P4|NOT COMPLETED|Overall Study||2
409798|NCT01652703|1003568|P3|NOT COMPLETED|Overall Study||3
409799|NCT01652703|1003569|P2|NOT COMPLETED|Overall Study||1
409800|NCT01652703|1003570|P1|NOT COMPLETED|Overall Study||0
409801|NCT01652703|1003565|P6|COMPLETED|Overall Study||51
409802|NCT01652703|1003566|P5|COMPLETED|Overall Study||51
409803|NCT01652703|1003567|P4|COMPLETED|Overall Study||50
409804|NCT01652703|1003568|P3|COMPLETED|Overall Study||47
409805|NCT01652703|1003569|P2|COMPLETED|Overall Study||50
409806|NCT01652703|1003570|P1|COMPLETED|Overall Study||52
409807|NCT01652703|1003565|P6|Received Treatment|Overall Study||53
409808|NCT01652703|1003566|P5|Received Treatment|Overall Study||51
409809|NCT01652703|1003567|P4|Received Treatment|Overall Study||52
409810|NCT01652703|1003568|P3|Received Treatment|Overall Study||49
409811|NCT01652703|1003569|P2|Received Treatment|Overall Study||50
409812|NCT01652703|1003570|P1|Received Treatment|Overall Study||52
409813|NCT01652703|1003565|P6|STARTED|Overall Study||53
409814|NCT01652703|1003566|P5|STARTED|Overall Study||52
409815|NCT01652703|1003567|P4|STARTED|Overall Study||52
409816|NCT01652703|1003568|P3|STARTED|Overall Study||50
409817|NCT01652703|1003569|P2|STARTED|Overall Study||51
409818|NCT01652703|1003570|P1|STARTED|Overall Study||52
409819|NCT01652690|1003628|P2|NOT COMPLETED|Overall Study||21
409820|NCT01652690|1003629|P1|NOT COMPLETED|Overall Study||35
409821|NCT01652690|1003628|P2|COMPLETED|Overall Study||279
409822|NCT01652690|1003629|P1|COMPLETED|Overall Study||265
409823|NCT01652690|1003628|P2|STARTED|Overall Study||300
409824|NCT01652690|1003629|P1|STARTED|Overall Study||300
409825|NCT01652664|1003663|P2|NOT COMPLETED|Overall Study||1
409826|NCT01652664|1003664|P1|NOT COMPLETED|Overall Study||6
409827|NCT01652664|1003663|P2|COMPLETED|Overall Study||74
409828|NCT01652664|1003664|P1|COMPLETED|Overall Study||71
409829|NCT01652664|1003663|P2|STARTED|Overall Study||75
409830|NCT01652664|1003664|P1|STARTED|Overall Study||77
409831|NCT01652573|1003673|P2|NOT COMPLETED|Overall Study||1
409832|NCT01652573|1003674|P1|NOT COMPLETED|Overall Study||0
409833|NCT01652573|1003673|P2|COMPLETED|Overall Study||10
409834|NCT01652573|1003674|P1|COMPLETED|Overall Study||10
409835|NCT01652573|1003673|P2|STARTED|Overall Study||11
409836|NCT01652573|1003674|P1|STARTED|Overall Study||10
409837|NCT01652495|1003716|P2|NOT COMPLETED|Overall Study||2
409838|NCT01652495|1003717|P1|NOT COMPLETED|Overall Study||2
409839|NCT01652495|1003716|P2|COMPLETED|Overall Study||20
409840|NCT01652495|1003717|P1|COMPLETED|Overall Study||20
409841|NCT01652495|1003716|P2|STARTED|Overall Study||22
409842|NCT01652495|1003717|P1|STARTED|Overall Study||22
409843|NCT01652287|1003729|P2|NOT COMPLETED|Overall Study||0
409844|NCT01652287|1003730|P1|NOT COMPLETED|Overall Study||2
409845|NCT01652287|1003729|P2|COMPLETED|Overall Study||31
409846|NCT01652287|1003730|P1|COMPLETED|Overall Study|• Did not receive allocated intervention (withdrew consent) (n=2)|29
409847|NCT01652287|1003729|P2|STARTED|Overall Study||31
409848|NCT01652287|1003730|P1|STARTED|Overall Study||31
409849|NCT01652040|1003738|P2|NOT COMPLETED|Overall Study||2
409850|NCT01652040|1003739|P1|NOT COMPLETED|Overall Study||2
409851|NCT01652040|1003738|P2|COMPLETED|Overall Study||11
409852|NCT01652040|1003739|P1|COMPLETED|Overall Study||11
409853|NCT01652040|1003738|P2|STARTED|Overall Study||13
409854|NCT01652040|1003739|P1|STARTED|Overall Study||13
409855|NCT01652001|1003749|P2|NOT COMPLETED|Overall Study||6
409856|NCT01652001|1003750|P1|NOT COMPLETED|Overall Study||9
409857|NCT01652001|1003749|P2|COMPLETED|Overall Study||79
409858|NCT01652001|1003750|P1|COMPLETED|Overall Study||91
409859|NCT01652001|1003749|P2|STARTED|Overall Study||85
409860|NCT01652001|1003750|P1|STARTED|Overall Study||100
409861|NCT01651949|1003761|P3|NOT COMPLETED|Overall Study||31
409862|NCT01651949|1003762|P2|NOT COMPLETED|Overall Study||86
409863|NCT01651949|1003763|P1|NOT COMPLETED|Overall Study||53
409864|NCT01651949|1003761|P3|COMPLETED|Overall Study||282
409865|NCT01651949|1003762|P2|COMPLETED|Overall Study||1015
409866|NCT01651949|1003763|P1|COMPLETED|Overall Study||1053
409867|NCT01651949|1003761|P3|Vaccination 3|Overall Study||291
409868|NCT01651949|1003762|P2|Vaccination 3|Overall Study||1037
409869|NCT01651949|1003763|P1|Vaccination 3|Overall Study||1067
409870|NCT01651949|1003761|P3|Vaccination 2|Overall Study||298
409871|NCT01651949|1003762|P2|Vaccination 2|Overall Study||1069
409872|NCT01651949|1003763|P1|Vaccination 2|Overall Study||1089
409873|NCT01651949|1003761|P3|Vaccination 1|Overall Study||313
409874|NCT01651949|1003762|P2|Vaccination 1|Overall Study||1099
409876|NCT01651949|1003761|P3|STARTED|Overall Study||313
409877|NCT01651949|1003762|P2|STARTED|Overall Study||1101
409878|NCT01651949|1003763|P1|STARTED|Overall Study||1106
409879|NCT01651936|1003783|P3|NOT COMPLETED|Extension Study||14
409880|NCT01651936|1003784|P2|NOT COMPLETED|Extension Study||0
409881|NCT01651936|1003785|P1|NOT COMPLETED|Extension Study||0
409882|NCT01651936|1003783|P3|COMPLETED|Extension Study||0
409883|NCT01651936|1003784|P2|COMPLETED|Extension Study||0
409884|NCT01651936|1003785|P1|COMPLETED|Extension Study||0
409885|NCT01651936|1003783|P3|STARTED|Extension Study|Includes completers and early escapees from the Base Study|14
409886|NCT01651936|1003784|P2|STARTED|Extension Study||0
409887|NCT01651936|1003785|P1|STARTED|Extension Study||0
409888|NCT01651936|1003783|P3|NOT COMPLETED|Base Study||0
409889|NCT01651936|1003784|P2|NOT COMPLETED|Base Study||25
409890|NCT01651936|1003785|P1|NOT COMPLETED|Base Study||27
409891|NCT01651936|1003783|P3|COMPLETED|Base Study||0
409892|NCT01651936|1003784|P2|COMPLETED|Base Study||1
409893|NCT01651936|1003785|P1|COMPLETED|Base Study||3
409894|NCT01651936|1003783|P3|STARTED|Base Study||0
409895|NCT01651936|1003784|P2|STARTED|Base Study||26
409896|NCT01651936|1003785|P1|STARTED|Base Study||30
409897|NCT01651806|1003811|P5|NOT COMPLETED|Overall Study||0
409898|NCT01651806|1003812|P4|NOT COMPLETED|Overall Study||0
409899|NCT01651806|1003813|P3|NOT COMPLETED|Overall Study||0
409900|NCT01651806|1003814|P2|NOT COMPLETED|Overall Study||0
409901|NCT01651806|1003815|P1|NOT COMPLETED|Overall Study||0
409902|NCT01651806|1003811|P5|COMPLETED|Overall Study||8
409903|NCT01651806|1003812|P4|COMPLETED|Overall Study||7
409904|NCT01651806|1003813|P3|COMPLETED|Overall Study||25
409905|NCT01651806|1003814|P2|COMPLETED|Overall Study||12
409906|NCT01651806|1003815|P1|COMPLETED|Overall Study||13
409907|NCT01651806|1003811|P5|STARTED|Overall Study||8
409908|NCT01651806|1003812|P4|STARTED|Overall Study||7
409909|NCT01651806|1003813|P3|STARTED|Overall Study||25
409910|NCT01651806|1003814|P2|STARTED|Overall Study||12
409911|NCT01651806|1003815|P1|STARTED|Overall Study||13
409912|NCT01651793|1003832|P4|NOT COMPLETED|Overall Study||1
409913|NCT01651793|1003833|P3|NOT COMPLETED|Overall Study||0
409914|NCT01651793|1003834|P2|NOT COMPLETED|Overall Study||0
409915|NCT01651793|1003835|P1|NOT COMPLETED|Overall Study||0
409916|NCT01651793|1003832|P4|COMPLETED|Overall Study||5
409917|NCT01651793|1003833|P3|COMPLETED|Overall Study||6
409918|NCT01651793|1003834|P2|COMPLETED|Overall Study||6
409919|NCT01651793|1003835|P1|COMPLETED|Overall Study||6
409920|NCT01651793|1003832|P4|STARTED|Overall Study||6
409921|NCT01651793|1003833|P3|STARTED|Overall Study||6
409922|NCT01651793|1003834|P2|STARTED|Overall Study||6
409923|NCT01651793|1003835|P1|STARTED|Overall Study||6
409924|NCT01651780|1003855|P2|NOT COMPLETED|Overall Study||10
409925|NCT01651780|1003856|P1|NOT COMPLETED|Overall Study||11
409926|NCT01651780|1003855|P2|COMPLETED|Overall Study||388
409927|NCT01651780|1003856|P1|COMPLETED|Overall Study||394
409928|NCT01651780|1003855|P2|BRAVO 2 Feasibility Cohort|Overall Study|1st 2 participants/site made up the bivalirudin feasibility cohort (BRAVO2) and analyzed separately.|0
409929|NCT01651780|1003856|P1|BRAVO 2 Feasibility Cohort|Overall Study|1st 2 participants/site made up the bivalirudin feasibility cohort (BRAVO2) and analyzed separately.|65
409930|NCT01651780|1003855|P2|Received at Least 1 Dose of Study Drug|Overall Study||394
409931|NCT01651780|1003856|P1|Received at Least 1 Dose of Study Drug|Overall Study|All but 1 participant in the bivalirudin group (withdrew consent) comprised the ITT population.|393
409932|NCT01651780|1003855|P2|Intent-To-Treat (ITT) Population|Overall Study||398
409933|NCT01651780|1003856|P1|Intent-To-Treat (ITT) Population|Overall Study||404
409934|NCT01651780|1003855|P2|STARTED|Overall Study||398
409935|NCT01651780|1003856|P1|STARTED|Overall Study||405
409936|NCT01651351|1003888|P2|NOT COMPLETED|Overall Study||0
409937|NCT01651351|1003889|P1|NOT COMPLETED|Overall Study||0
409938|NCT01651351|1003888|P2|COMPLETED|Overall Study||15
409939|NCT01651351|1003889|P1|COMPLETED|Overall Study||15
409940|NCT01651351|1003888|P2|STARTED|Overall Study||15
409941|NCT01651351|1003889|P1|STARTED|Overall Study||15
409942|NCT01651260|1003906|P1|NOT COMPLETED|Overall Study||3
409943|NCT01651260|1003906|P1|COMPLETED|Overall Study||62
409944|NCT01651260|1003906|P1|STARTED|Overall Study||65
409945|NCT01651208|1003913|P2|NOT COMPLETED|Overall Study||16
409946|NCT01651208|1003914|P1|NOT COMPLETED|Overall Study||14
409947|NCT01651208|1003913|P2|COMPLETED|Overall Study|16 subjects had no pharmacy claims data to analyze primary outcome|209
409948|NCT01651208|1003914|P1|COMPLETED|Overall Study|14 patients had no pharmacy claims data to analyze primary outcome|213
409949|NCT01651208|1003913|P2|STARTED|Overall Study||225
409950|NCT01651208|1003914|P1|STARTED|Overall Study||227
409951|NCT01651104|1003922|P1|NOT COMPLETED|Overall Study||0
409952|NCT01651104|1003922|P1|COMPLETED|Overall Study||63
409953|NCT01651104|1003922|P1|STARTED|Overall Study||63
409954|NCT01651039|1003929|P1|NOT COMPLETED|Overall Study||30
409955|NCT01651039|1003929|P1|COMPLETED|Overall Study||2
409956|NCT01651039|1003929|P1|STARTED|Overall Study||32
409957|NCT01651000|1003942|P2|NOT COMPLETED|Overall Study||28
409958|NCT01651000|1003943|P1|NOT COMPLETED|Overall Study||10
409959|NCT01651000|1003942|P2|COMPLETED|Overall Study||113
409960|NCT01651000|1003943|P1|COMPLETED|Overall Study||62
409961|NCT01651000|1003942|P2|Entered Extension Study|Overall Study||93
409962|NCT01651000|1003943|P1|Entered Extension Study|Overall Study||50
409963|NCT01651000|1003942|P2|STARTED|Overall Study||141
409964|NCT01651000|1003943|P1|STARTED|Overall Study||72
409965|NCT01650844|1003957|P2|NOT COMPLETED|Overall Study||4
409966|NCT01650844|1003958|P1|NOT COMPLETED|Overall Study||1
409967|NCT01650844|1003957|P2|COMPLETED|Overall Study||196
409968|NCT01650844|1003958|P1|COMPLETED|Overall Study||199
409969|NCT01650844|1003957|P2|STARTED|Overall Study||200
409970|NCT01650844|1003958|P1|STARTED|Overall Study||200
409971|NCT01650831|1003964|P1|NOT COMPLETED|Overall Study||1
409972|NCT01650831|1003964|P1|COMPLETED|Overall Study||112
409973|NCT01650831|1003964|P1|STARTED|Overall Study||113
409974|NCT01650805|1003974|P2|NOT COMPLETED|Overall Study||0
409975|NCT01650805|1003975|P1|NOT COMPLETED|Overall Study||1
409976|NCT01650805|1003974|P2|COMPLETED|Overall Study||152
409977|NCT01650805|1003975|P1|COMPLETED|Overall Study|Completed means patient initiated and discontinued study treatment.|154
409978|NCT01650805|1003974|P2|STARTED|Overall Study||152
409979|NCT01650805|1003975|P1|STARTED|Overall Study|Started means patient has been randomized.|155
409980|NCT01650779|1003985|P1|NOT COMPLETED|Overall Study||1
409981|NCT01650779|1003985|P1|COMPLETED|Overall Study||14
409982|NCT01650779|1003985|P1|STARTED|Overall Study||15
409983|NCT01650545|1003994|P2|NOT COMPLETED|Overall Study||0
409984|NCT01650545|1003995|P1|NOT COMPLETED|Overall Study||0
409985|NCT01650545|1003994|P2|COMPLETED|Overall Study||10
409986|NCT01650545|1003995|P1|COMPLETED|Overall Study||11
409987|NCT01650545|1003994|P2|STARTED|Overall Study||10
409988|NCT01650545|1003995|P1|STARTED|Overall Study||11
409989|NCT01650519|1004007|P2|NOT COMPLETED|Overall Study||0
409990|NCT01650519|1004008|P1|NOT COMPLETED|Overall Study||1
409991|NCT01650519|1004007|P2|COMPLETED|Overall Study||31
409992|NCT01650519|1004008|P1|COMPLETED|Overall Study||19
409993|NCT01650519|1004007|P2|STARTED|Overall Study||31
409994|NCT01650519|1004008|P1|STARTED|Overall Study||20
409995|NCT01650350|1004026|P1|NOT COMPLETED|Overall Study||0
409996|NCT01650350|1004026|P1|COMPLETED|Overall Study||7
409997|NCT01650350|1004026|P1|STARTED|Overall Study||7
409998|NCT01650324|1004036|P5|NOT COMPLETED|Overall Study||0
409999|NCT01650324|1004037|P4|NOT COMPLETED|Overall Study||0
410000|NCT01650324|1004038|P3|NOT COMPLETED|Overall Study||0
410001|NCT01650324|1004039|P2|NOT COMPLETED|Overall Study||0
410002|NCT01650324|1004040|P1|NOT COMPLETED|Overall Study||0
410003|NCT01650324|1004036|P5|COMPLETED|Overall Study||6
410004|NCT01650324|1004037|P4|COMPLETED|Overall Study||6
410005|NCT01650324|1004038|P3|COMPLETED|Overall Study||6
410006|NCT01650324|1004039|P2|COMPLETED|Overall Study||6
410007|NCT01650324|1004040|P1|COMPLETED|Overall Study||8
410008|NCT01650324|1004036|P5|STARTED|Overall Study||6
410009|NCT01650324|1004037|P4|STARTED|Overall Study||6
410010|NCT01650324|1004038|P3|STARTED|Overall Study||6
410011|NCT01650324|1004039|P2|STARTED|Overall Study||6
410012|NCT01650324|1004040|P1|STARTED|Overall Study||8
410013|NCT01650285|1004069|P1|NOT COMPLETED|Overall Study||1
410014|NCT01650285|1004069|P1|COMPLETED|Overall Study||4
410015|NCT01650285|1004069|P1|STARTED|Overall Study||5
410016|NCT01650246|1004074|P1|NOT COMPLETED|Overall Study||143
410017|NCT01650246|1004074|P1|COMPLETED|Overall Study||0
410018|NCT01650246|1004074|P1|STARTED|Overall Study||143
410019|NCT01649856|1004081|P2|NOT COMPLETED|Overall Study||78
410020|NCT01649856|1004082|P1|NOT COMPLETED|Overall Study||139
410021|NCT01649856|1004081|P2|COMPLETED|Overall Study||125
410022|NCT01649856|1004082|P1|COMPLETED|Overall Study||230
410023|NCT01649856|1004081|P2|STARTED|Overall Study||203
410024|NCT01649856|1004082|P1|STARTED|Overall Study||369
410025|NCT01649804|1004114|P1|NOT COMPLETED|Overall Study||8
410026|NCT01649804|1004114|P1|COMPLETED|Overall Study||4
410027|NCT01649804|1004114|P1|STARTED|Overall Study||12
410028|NCT01649791|1004126|P1|NOT COMPLETED|Overall Study||3
410029|NCT01649791|1004126|P1|COMPLETED|Overall Study||5
410030|NCT01649791|1004126|P1|STARTED|Overall Study||8
410031|NCT01649609|1004135|P2|NOT COMPLETED|Overall Study||0
410032|NCT01649609|1004136|P1|NOT COMPLETED|Overall Study||0
410033|NCT01649609|1004135|P2|COMPLETED|Overall Study||20
410034|NCT01649609|1004136|P1|COMPLETED|Overall Study||20
410035|NCT01649609|1004135|P2|STARTED|Overall Study||20
410036|NCT01649609|1004136|P1|STARTED|Overall Study||20
410037|NCT01649596|1004146|P2|NOT COMPLETED|Overall Study||0
410038|NCT01649596|1004147|P1|NOT COMPLETED|Overall Study||0
410039|NCT01649596|1004146|P2|COMPLETED|Overall Study||48
410040|NCT01649596|1004147|P1|COMPLETED|Overall Study||46
410041|NCT01649596|1004146|P2|STARTED|Overall Study||48
410042|NCT01649596|1004147|P1|STARTED|Overall Study||46
410043|NCT01649557|1004158|P3|NOT COMPLETED|Overall Study||9
410044|NCT01649557|1004159|P2|NOT COMPLETED|Overall Study||14
410045|NCT01649557|1004160|P1|NOT COMPLETED|Overall Study||44
410046|NCT01649557|1004158|P3|COMPLETED|Overall Study||15
410047|NCT01649557|1004159|P2|COMPLETED|Overall Study||27
410048|NCT01649557|1004160|P1|COMPLETED|Overall Study||135
410049|NCT01649557|1004158|P3|52-week Enrollers|Overall Study||2
410050|NCT01649557|1004159|P2|52-week Enrollers|Overall Study||6
410051|NCT01649557|1004160|P1|52-week Enrollers|Overall Study||20
410052|NCT01649557|1004158|P3|6-week Enrollers|Overall Study||22
410053|NCT01649557|1004159|P2|6-week Enrollers|Overall Study||35
410054|NCT01649557|1004160|P1|6-week Enrollers|Overall Study||159
410055|NCT01649557|1004158|P3|STARTED|Overall Study||24
410056|NCT01649557|1004159|P2|STARTED|Overall Study||41
410057|NCT01649557|1004160|P1|STARTED|Overall Study||179
410058|NCT01649505|1004197|P2|NOT COMPLETED|Overall Study||1
410059|NCT01649505|1004198|P1|NOT COMPLETED|Overall Study||1
410060|NCT01649505|1004197|P2|COMPLETED|Overall Study||0
410061|NCT01649505|1004198|P1|COMPLETED|Overall Study||0
410062|NCT01649505|1004197|P2|STARTED|Overall Study||1
410063|NCT01649505|1004198|P1|STARTED|Overall Study||1
410064|NCT01649362|1004206|P2|NOT COMPLETED|Overall Study||14
410065|NCT01649362|1004207|P1|NOT COMPLETED|Overall Study||1
410066|NCT01649362|1004206|P2|COMPLETED|Overall Study||40
410067|NCT01649362|1004207|P1|COMPLETED|Overall Study||46
410068|NCT01649362|1004206|P2|STARTED|Overall Study||54
410069|NCT01649362|1004207|P1|STARTED|Overall Study||47
410070|NCT01649297|1004222|P5|NOT COMPLETED|Overall Study||4
410071|NCT01649297|1004223|P4|NOT COMPLETED|Overall Study||19
410072|NCT01649297|1004224|P3|NOT COMPLETED|Overall Study||17
410073|NCT01649297|1004225|P2|NOT COMPLETED|Overall Study||13
410074|NCT01649297|1004226|P1|NOT COMPLETED|Overall Study||14
410075|NCT01649297|1004222|P5|COMPLETED|Overall Study||103
410076|NCT01649297|1004223|P4|COMPLETED|Overall Study||201
410077|NCT01649297|1004224|P3|COMPLETED|Overall Study||202
410078|NCT01649297|1004225|P2|COMPLETED|Overall Study||205
410079|NCT01649297|1004226|P1|COMPLETED|Overall Study||205
410080|NCT01649297|1004222|P5|STARTED|Overall Study|randomised|107
410081|NCT01649297|1004223|P4|STARTED|Overall Study|randomised|220
410082|NCT01649297|1004224|P3|STARTED|Overall Study|randomised|219
410083|NCT01649297|1004225|P2|STARTED|Overall Study|randomised|218
410084|NCT01649297|1004226|P1|STARTED|Overall Study|randomised|219
410085|NCT01649271|1004245|P2|NOT COMPLETED|Overall Study||7
410086|NCT01649271|1004246|P1|NOT COMPLETED|Overall Study||6
410087|NCT01649271|1004245|P2|COMPLETED|Overall Study||0
410088|NCT01649271|1004246|P1|COMPLETED|Overall Study||0
410089|NCT01649271|1004245|P2|STARTED|Overall Study||7
410090|NCT01649271|1004246|P1|STARTED|Overall Study||6
410091|NCT01649232|1004261|P2|NOT COMPLETED|Overall Study||0
410092|NCT01649232|1004262|P1|NOT COMPLETED|Overall Study||2
410093|NCT01649232|1004261|P2|COMPLETED|Overall Study||30
410094|NCT01649232|1004262|P1|COMPLETED|Overall Study|technical problems or excessive artifacts, two data sets were excluded from further analysis.|28
410095|NCT01649232|1004261|P2|STARTED|Overall Study||30
410096|NCT01649232|1004262|P1|STARTED|Overall Study||30
410097|NCT01649180|1004282|P1|NOT COMPLETED|Overall Study||0
410098|NCT01649180|1004282|P1|COMPLETED|Overall Study||3
410099|NCT01649180|1004282|P1|STARTED|Overall Study||3
410100|NCT01648920|1004290|P1|NOT COMPLETED|Overall Study||0
410101|NCT01648920|1004290|P1|COMPLETED|Overall Study||50
410102|NCT01648920|1004290|P1|STARTED|Overall Study||50
410103|NCT01648790|1004314|P5|NOT COMPLETED|Treatment 5||0
410104|NCT01648790|1004315|P4|NOT COMPLETED|Treatment 5||0
410105|NCT01648790|1004316|P3|NOT COMPLETED|Treatment 5||0
410106|NCT01648790|1004317|P2|NOT COMPLETED|Treatment 5||0
410107|NCT01648790|1004318|P1|NOT COMPLETED|Treatment 5||0
410108|NCT01648790|1004314|P5|COMPLETED|Treatment 5||4
410109|NCT01648790|1004315|P4|COMPLETED|Treatment 5||3
410110|NCT01648790|1004316|P3|COMPLETED|Treatment 5||4
410111|NCT01648790|1004317|P2|COMPLETED|Treatment 5||4
410112|NCT01648790|1004318|P1|COMPLETED|Treatment 5||4
410113|NCT01648790|1004314|P5|STARTED|Treatment 5||4
410114|NCT01648790|1004315|P4|STARTED|Treatment 5||3
410115|NCT01648790|1004316|P3|STARTED|Treatment 5||4
410116|NCT01648790|1004317|P2|STARTED|Treatment 5||4
410117|NCT01648790|1004318|P1|STARTED|Treatment 5||4
410118|NCT01648790|1004314|P5|NOT COMPLETED|Treatment 4||0
410119|NCT01648790|1004315|P4|NOT COMPLETED|Treatment 4||0
410120|NCT01648790|1004316|P3|NOT COMPLETED|Treatment 4||0
410121|NCT01648790|1004317|P2|NOT COMPLETED|Treatment 4||0
410122|NCT01648790|1004318|P1|NOT COMPLETED|Treatment 4||0
410123|NCT01648790|1004314|P5|COMPLETED|Treatment 4||4
410124|NCT01648790|1004315|P4|COMPLETED|Treatment 4||3
410125|NCT01648790|1004316|P3|COMPLETED|Treatment 4||4
410126|NCT01648790|1004317|P2|COMPLETED|Treatment 4||4
410127|NCT01648790|1004318|P1|COMPLETED|Treatment 4||4
410128|NCT01648790|1004314|P5|STARTED|Treatment 4||4
410129|NCT01648790|1004315|P4|STARTED|Treatment 4||3
410130|NCT01648790|1004316|P3|STARTED|Treatment 4||4
410131|NCT01648790|1004317|P2|STARTED|Treatment 4||4
410132|NCT01648790|1004318|P1|STARTED|Treatment 4||4
410133|NCT01648790|1004314|P5|NOT COMPLETED|Treatment 3||0
410134|NCT01648790|1004315|P4|NOT COMPLETED|Treatment 3||1
410135|NCT01648790|1004316|P3|NOT COMPLETED|Treatment 3||0
410136|NCT01648790|1004317|P2|NOT COMPLETED|Treatment 3||0
410137|NCT01648790|1004318|P1|NOT COMPLETED|Treatment 3||0
410138|NCT01648790|1004314|P5|COMPLETED|Treatment 3||4
410139|NCT01648790|1004315|P4|COMPLETED|Treatment 3||3
410140|NCT01648790|1004316|P3|COMPLETED|Treatment 3||4
410141|NCT01648790|1004317|P2|COMPLETED|Treatment 3||4
410142|NCT01648790|1004318|P1|COMPLETED|Treatment 3||4
410143|NCT01648790|1004314|P5|STARTED|Treatment 3||4
410144|NCT01648790|1004315|P4|STARTED|Treatment 3|Withdrew consent prior to dosing on this treatment day.|4
410145|NCT01648790|1004316|P3|STARTED|Treatment 3||4
410146|NCT01648790|1004317|P2|STARTED|Treatment 3||4
410147|NCT01648790|1004318|P1|STARTED|Treatment 3||4
410148|NCT01648790|1004314|P5|NOT COMPLETED|Treatment 2||0
410149|NCT01648790|1004315|P4|NOT COMPLETED|Treatment 2||0
410150|NCT01648790|1004316|P3|NOT COMPLETED|Treatment 2||0
410151|NCT01648790|1004317|P2|NOT COMPLETED|Treatment 2||0
410152|NCT01648790|1004318|P1|NOT COMPLETED|Treatment 2||0
410153|NCT01648790|1004314|P5|COMPLETED|Treatment 2||4
410154|NCT01648790|1004315|P4|COMPLETED|Treatment 2||4
410155|NCT01648790|1004316|P3|COMPLETED|Treatment 2||4
410156|NCT01648790|1004317|P2|COMPLETED|Treatment 2||4
410157|NCT01648790|1004318|P1|COMPLETED|Treatment 2||4
410158|NCT01648790|1004314|P5|STARTED|Treatment 2||4
410159|NCT01648790|1004315|P4|STARTED|Treatment 2||4
410160|NCT01648790|1004316|P3|STARTED|Treatment 2||4
410161|NCT01648790|1004317|P2|STARTED|Treatment 2||4
410162|NCT01648790|1004318|P1|STARTED|Treatment 2||4
410163|NCT01648790|1004314|P5|NOT COMPLETED|Treatment 1||0
410164|NCT01648790|1004315|P4|NOT COMPLETED|Treatment 1||0
410165|NCT01648790|1004316|P3|NOT COMPLETED|Treatment 1||0
410166|NCT01648790|1004317|P2|NOT COMPLETED|Treatment 1||0
410167|NCT01648790|1004318|P1|NOT COMPLETED|Treatment 1||0
410168|NCT01648790|1004314|P5|COMPLETED|Treatment 1||4
410169|NCT01648790|1004315|P4|COMPLETED|Treatment 1||4
410170|NCT01648790|1004316|P3|COMPLETED|Treatment 1||4
410171|NCT01648790|1004317|P2|COMPLETED|Treatment 1||4
410172|NCT01648790|1004318|P1|COMPLETED|Treatment 1||4
410173|NCT01648790|1004314|P5|Received at Least 1 Dose of Study Drug|Treatment 1||4
410174|NCT01648790|1004315|P4|Received at Least 1 Dose of Study Drug|Treatment 1||4
410175|NCT01648790|1004316|P3|Received at Least 1 Dose of Study Drug|Treatment 1||4
410176|NCT01648790|1004317|P2|Received at Least 1 Dose of Study Drug|Treatment 1||4
410177|NCT01648790|1004318|P1|Received at Least 1 Dose of Study Drug|Treatment 1||4
410178|NCT01648790|1004314|P5|STARTED|Treatment 1||4
410179|NCT01648790|1004315|P4|STARTED|Treatment 1||4
410180|NCT01648790|1004316|P3|STARTED|Treatment 1||4
410181|NCT01648790|1004317|P2|STARTED|Treatment 1||4
410182|NCT01648790|1004318|P1|STARTED|Treatment 1||4
410183|NCT01648699|1004339|P1|NOT COMPLETED|Overall Study||5
410184|NCT01648699|1004339|P1|COMPLETED|Overall Study||15
410185|NCT01648699|1004339|P1|STARTED|Overall Study||20
410186|NCT01648582|1004368|P3|NOT COMPLETED|Overall Study||32
410187|NCT01648582|1004369|P2|NOT COMPLETED|Overall Study||38
410188|NCT01648582|1004370|P1|NOT COMPLETED|Overall Study||32
410189|NCT01648582|1004368|P3|COMPLETED|Overall Study||227
410190|NCT01648582|1004369|P2|COMPLETED|Overall Study||219
410191|NCT01648582|1004370|P1|COMPLETED|Overall Study||226
410192|NCT01648582|1004368|P3|Modified Intent-to-Treat Population|Overall Study||250
410193|NCT01648582|1004369|P2|Modified Intent-to-Treat Population|Overall Study||252
410194|NCT01648582|1004370|P1|Modified Intent-to-Treat Population|Overall Study||253
410195|NCT01648582|1004368|P3|Received at Least One Dose of Study Drug|Overall Study||259
410196|NCT01648582|1004369|P2|Received at Least One Dose of Study Drug|Overall Study||257
410197|NCT01648582|1004370|P1|Received at Least One Dose of Study Drug|Overall Study||258
410198|NCT01648582|1004368|P3|STARTED|Overall Study||259
410199|NCT01648582|1004369|P2|STARTED|Overall Study||257
410200|NCT01648582|1004370|P1|STARTED|Overall Study||258
410201|NCT01648530|1004439|P1|NOT COMPLETED|Overall Study||10874
410202|NCT01648530|1004439|P1|COMPLETED|Overall Study||5915
410203|NCT01648530|1004439|P1|STARTED|Overall Study||16789
410204|NCT01648491|1004445|P1|NOT COMPLETED|Overall Study||0
410205|NCT01648491|1004445|P1|COMPLETED|Overall Study||1
410206|NCT01648491|1004445|P1|STARTED|Overall Study||1
410207|NCT01648452|1004452|P1|NOT COMPLETED|Overall Study||0
410208|NCT01648452|1004452|P1|COMPLETED|Overall Study|One participant was explanted due to an adverse event. Remainder kept implant at study completion.|5
410209|NCT01648452|1004452|P1|STARTED|Overall Study||5
410210|NCT01648348|1004473|P6|NOT COMPLETED|Overall Study||6
410211|NCT01648348|1004474|P5|NOT COMPLETED|Overall Study||3
410212|NCT01648348|1004475|P4|NOT COMPLETED|Overall Study||0
410213|NCT01648348|1004476|P3|NOT COMPLETED|Overall Study||1
410214|NCT01648348|1004477|P2|NOT COMPLETED|Overall Study||0
410215|NCT01648348|1004478|P1|NOT COMPLETED|Overall Study||2
410216|NCT01648348|1004473|P6|COMPLETED|Overall Study||43
410217|NCT01648348|1004474|P5|COMPLETED|Overall Study||49
410218|NCT01648348|1004475|P4|COMPLETED|Overall Study||3
410219|NCT01648348|1004476|P3|COMPLETED|Overall Study||3
410220|NCT01648348|1004477|P2|COMPLETED|Overall Study||3
410221|NCT01648348|1004478|P1|COMPLETED|Overall Study||3
410222|NCT01648348|1004473|P6|STARTED|Overall Study||49
410223|NCT01648348|1004474|P5|STARTED|Overall Study||52
410224|NCT01648348|1004475|P4|STARTED|Overall Study||3
410225|NCT01648348|1004476|P3|STARTED|Overall Study||4
410226|NCT01648348|1004477|P2|STARTED|Overall Study||3
410227|NCT01648348|1004478|P1|STARTED|Overall Study||5
410228|NCT01648322|1004507|P4|NOT COMPLETED|Overall Study||4
410229|NCT01648322|1004508|P3|NOT COMPLETED|Overall Study||5
410230|NCT01648322|1004509|P2|NOT COMPLETED|Overall Study||5
410231|NCT01648322|1004510|P1|NOT COMPLETED|Overall Study||2
410232|NCT01648322|1004507|P4|COMPLETED|Overall Study||61
410233|NCT01648322|1004508|P3|COMPLETED|Overall Study||60
410234|NCT01648322|1004509|P2|COMPLETED|Overall Study||62
410235|NCT01648322|1004510|P1|COMPLETED|Overall Study||33
410236|NCT01648322|1004507|P4|STARTED|Overall Study||65
410237|NCT01648322|1004508|P3|STARTED|Overall Study||65
410238|NCT01648322|1004509|P2|STARTED|Overall Study||67
410239|NCT01648322|1004510|P1|STARTED|Overall Study||35
410240|NCT01648283|1004523|P1|NOT COMPLETED|Overall Study||14
410241|NCT01648283|1004523|P1|COMPLETED|Overall Study||64
410242|NCT01648283|1004523|P1|STARTED|Overall Study||78
410243|NCT01648140|1004533|P4|NOT COMPLETED|Overall Study||2
410244|NCT01648140|1004534|P3|NOT COMPLETED|Overall Study||8
410245|NCT01648140|1004535|P2|NOT COMPLETED|Overall Study||12
410246|NCT01648140|1004536|P1|NOT COMPLETED|Overall Study||12
410247|NCT01648140|1004533|P4|COMPLETED|Overall Study||11
410248|NCT01648140|1004534|P3|COMPLETED|Overall Study||9
410249|NCT01648140|1004535|P2|COMPLETED|Overall Study||28
410250|NCT01648140|1004536|P1|COMPLETED|Overall Study||29
410251|NCT01648140|1004533|P4|STARTED|Overall Study||13
410252|NCT01648140|1004534|P3|STARTED|Overall Study||17
410253|NCT01648140|1004535|P2|STARTED|Overall Study||40
410254|NCT01648140|1004536|P1|STARTED|Overall Study||41
410255|NCT01648101|1004701|P3|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0
410256|NCT01648101|1004702|P2|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
410257|NCT01648101|1004703|P1|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0
410258|NCT01648101|1004701|P3|COMPLETED|Taper/Follow-up Phase (4 Weeks)||3
410259|NCT01648101|1004702|P2|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
410260|NCT01648101|1004703|P1|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
410261|NCT01648101|1004701|P3|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|3
410262|NCT01648101|1004702|P2|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|2
410263|NCT01648101|1004703|P1|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|1
410264|NCT01648101|1004701|P3|NOT COMPLETED|Transition Phase (4 Weeks)||4
410265|NCT01648101|1004702|P2|NOT COMPLETED|Transition Phase (4 Weeks)||5
410266|NCT01648101|1004703|P1|NOT COMPLETED|Transition Phase (4 Weeks)||5
410267|NCT01648101|1004701|P3|COMPLETED|Transition Phase (4 Weeks)||5
410268|NCT01648101|1004702|P2|COMPLETED|Transition Phase (4 Weeks)||13
410269|NCT01648101|1004703|P1|COMPLETED|Transition Phase (4 Weeks)||12
410270|NCT01648101|1004701|P3|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|9
410271|NCT01648101|1004702|P2|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|18
410272|NCT01648101|1004703|P1|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|17
410273|NCT01648101|1004701|P3|NOT COMPLETED|Maintenance Phase (12 Weeks)||6
410274|NCT01648101|1004702|P2|NOT COMPLETED|Maintenance Phase (12 Weeks)||3
410275|NCT01648101|1004703|P1|NOT COMPLETED|Maintenance Phase (12 Weeks)||3
410276|NCT01648101|1004701|P3|COMPLETED|Maintenance Phase (12 Weeks)||12
410277|NCT01648101|1004702|P2|COMPLETED|Maintenance Phase (12 Weeks)||20
410278|NCT01648101|1004703|P1|COMPLETED|Maintenance Phase (12 Weeks)||20
410279|NCT01648101|1004701|P3|STARTED|Maintenance Phase (12 Weeks)||18
410280|NCT01648101|1004702|P2|STARTED|Maintenance Phase (12 Weeks)||23
410281|NCT01648101|1004703|P1|STARTED|Maintenance Phase (12 Weeks)||23
410282|NCT01648101|1004701|P3|NOT COMPLETED|Titration Phase (4 Weeks)||6
410283|NCT01648101|1004702|P2|NOT COMPLETED|Titration Phase (4 Weeks)||3
410284|NCT01648101|1004703|P1|NOT COMPLETED|Titration Phase (4 Weeks)||2
410285|NCT01648101|1004701|P3|COMPLETED|Titration Phase (4 Weeks)||18
410286|NCT01648101|1004702|P2|COMPLETED|Titration Phase (4 Weeks)||23
410287|NCT01648101|1004703|P1|COMPLETED|Titration Phase (4 Weeks)||23
410288|NCT01648101|1004701|P3|STARTED|Titration Phase (4 Weeks)||24
410289|NCT01648101|1004702|P2|STARTED|Titration Phase (4 Weeks)||26
410290|NCT01648101|1004703|P1|STARTED|Titration Phase (4 Weeks)||25
410291|NCT01647945|1004755|P4|NOT COMPLETED|Overall Study||1
410292|NCT01647945|1004756|P3|NOT COMPLETED|Overall Study||2
410293|NCT01647945|1004757|P2|NOT COMPLETED|Overall Study||0
410294|NCT01647945|1004758|P1|NOT COMPLETED|Overall Study||0
410295|NCT01647945|1004755|P4|COMPLETED|Overall Study||5
410296|NCT01647945|1004756|P3|COMPLETED|Overall Study||3
410297|NCT01647945|1004757|P2|COMPLETED|Overall Study||6
410298|NCT01647945|1004758|P1|COMPLETED|Overall Study||6
410299|NCT01647945|1004755|P4|STARTED|Overall Study||6
410300|NCT01647945|1004756|P3|STARTED|Overall Study||5
410301|NCT01647945|1004757|P2|STARTED|Overall Study||6
410302|NCT01647945|1004758|P1|STARTED|Overall Study||6
410303|NCT01647737|1004778|P2|NOT COMPLETED|Overall Study||5
410304|NCT01647737|1004779|P1|NOT COMPLETED|Overall Study||4
410305|NCT01647737|1004778|P2|COMPLETED|Overall Study||25
410306|NCT01647737|1004779|P1|COMPLETED|Overall Study||26
410307|NCT01647737|1004778|P2|STARTED|Overall Study||30
410308|NCT01647737|1004779|P1|STARTED|Overall Study||30
410309|NCT01647711|1004790|P5|NOT COMPLETED|Overall Study||6
410310|NCT01647711|1004791|P4|NOT COMPLETED|Overall Study||11
410311|NCT01647711|1004792|P3|NOT COMPLETED|Overall Study||9
410312|NCT01647711|1004793|P2|NOT COMPLETED|Overall Study||3
410313|NCT01647711|1004794|P1|NOT COMPLETED|Overall Study||6
410314|NCT01647711|1004790|P5|COMPLETED|Overall Study||0
410315|NCT01647711|1004791|P4|COMPLETED|Overall Study||0
410316|NCT01647711|1004792|P3|COMPLETED|Overall Study||0
410317|NCT01647711|1004793|P2|COMPLETED|Overall Study||0
410318|NCT01647711|1004794|P1|COMPLETED|Overall Study||0
410319|NCT01647711|1004790|P5|STARTED|Overall Study||6
410320|NCT01647711|1004791|P4|STARTED|Overall Study||11
410321|NCT01647711|1004792|P3|STARTED|Overall Study||9
410322|NCT01647711|1004793|P2|STARTED|Overall Study||3
410323|NCT01647711|1004794|P1|STARTED|Overall Study||6
410324|NCT01647542|1004822|P3|NOT COMPLETED|Overall Study||72
410325|NCT01647542|1004823|P2|NOT COMPLETED|Overall Study||73
410326|NCT01647542|1004824|P1|NOT COMPLETED|Overall Study||76
410327|NCT01647542|1004822|P3|COMPLETED|Overall Study||59
410328|NCT01647542|1004823|P2|COMPLETED|Overall Study||58
410329|NCT01647542|1004824|P1|COMPLETED|Overall Study||55
410330|NCT01647542|1004822|P3|STARTED|Overall Study||131
410331|NCT01647542|1004823|P2|STARTED|Overall Study||131
410332|NCT01647542|1004824|P1|STARTED|Overall Study||131
410333|NCT01647464|1004841|P1|NOT COMPLETED|Overall Study||0
410334|NCT01647464|1004841|P1|COMPLETED|Overall Study||10
410335|NCT01647464|1004841|P1|STARTED|Overall Study||10
410336|NCT01647438|1004847|P2|NOT COMPLETED|Overall Study||0
410337|NCT01647438|1004848|P1|NOT COMPLETED|Overall Study||0
410338|NCT01647438|1004847|P2|COMPLETED|Overall Study||31
410339|NCT01647438|1004848|P1|COMPLETED|Overall Study||32
410340|NCT01647438|1004847|P2|STARTED|Overall Study||31
410341|NCT01647438|1004848|P1|STARTED|Overall Study||32
410342|NCT01647282|1004858|P2|NOT COMPLETED|Overall Study||5
410343|NCT01647282|1004859|P1|NOT COMPLETED|Overall Study||7
410344|NCT01647282|1004858|P2|COMPLETED|Overall Study||25
410345|NCT01647282|1004859|P1|COMPLETED|Overall Study||23
410346|NCT01647282|1004858|P2|STARTED|Overall Study||30
410347|NCT01647282|1004859|P1|STARTED|Overall Study||30
410348|NCT01647217|1004869|P2|NOT COMPLETED|Overall Study||1
410349|NCT01647217|1004870|P1|NOT COMPLETED|Overall Study||1
410350|NCT01647217|1004869|P2|COMPLETED|Overall Study||8
410351|NCT01647217|1004870|P1|COMPLETED|Overall Study||7
410352|NCT01647217|1004869|P2|STARTED|Overall Study||9
410353|NCT01647217|1004870|P1|STARTED|Overall Study||8
410354|NCT01646827|1004880|P2|NOT COMPLETED|Overall Study||5
410355|NCT01646827|1004881|P1|NOT COMPLETED|Overall Study||2
410356|NCT01646827|1004880|P2|COMPLETED|Overall Study||14
410357|NCT01646827|1004881|P1|COMPLETED|Overall Study||16
410358|NCT01646827|1004880|P2|STARTED|Overall Study||19
410359|NCT01646827|1004881|P1|STARTED|Overall Study||18
410360|NCT01646814|1004911|P2|NOT COMPLETED|Overall Study||6
410361|NCT01646814|1004912|P1|NOT COMPLETED|Overall Study||11
410362|NCT01646814|1004911|P2|COMPLETED|Overall Study||120
410363|NCT01646814|1004912|P1|COMPLETED|Overall Study||110
410364|NCT01646814|1004911|P2|STARTED|Overall Study||126
410365|NCT01646814|1004912|P1|STARTED|Overall Study||121
410366|NCT01646762|1004918|P1|NOT COMPLETED|Overall Study||0
410367|NCT01646762|1004918|P1|COMPLETED|Overall Study||13
410368|NCT01646762|1004918|P1|STARTED|Overall Study||13
410369|NCT01646671|1004930|P3|NOT COMPLETED|Overall Study||0
410370|NCT01646671|1004931|P2|NOT COMPLETED|Overall Study||0
410371|NCT01646671|1004932|P1|NOT COMPLETED|Overall Study||0
410372|NCT01646671|1004930|P3|COMPLETED|Overall Study||21
410373|NCT01646671|1004931|P2|COMPLETED|Overall Study||11
410374|NCT01646671|1004932|P1|COMPLETED|Overall Study||3
410375|NCT01646671|1004930|P3|STARTED|Overall Study||21
410376|NCT01646671|1004931|P2|STARTED|Overall Study||11
410377|NCT01646671|1004932|P1|STARTED|Overall Study||3
410378|NCT01646398|1004968|P2|NOT COMPLETED|Overall Study||0
410379|NCT01646398|1004969|P1|NOT COMPLETED|Overall Study||1
410380|NCT01646398|1004968|P2|COMPLETED|Overall Study||382
410381|NCT01646398|1004969|P1|COMPLETED|Overall Study||381
410382|NCT01646398|1004968|P2|STARTED|Overall Study||382
410383|NCT01646398|1004969|P1|STARTED|Overall Study||382
410384|NCT01646385|1004985|P2|NOT COMPLETED|Overall Study||871
410385|NCT01646385|1004986|P1|NOT COMPLETED|Overall Study||838
410386|NCT01646385|1004985|P2|COMPLETED|Overall Study|Completed refers to participants who continued up to last follow-up.|1993
410387|NCT01646385|1004986|P1|COMPLETED|Overall Study|Completed refers to participants who continued up to last follow-up.|2691
410388|NCT01646385|1004985|P2|STARTED|Overall Study||2864
410389|NCT01646385|1004986|P1|STARTED|Overall Study||3529
410390|NCT01646320|1005019|P2|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||7
410391|NCT01646320|1005020|P1|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||6
410392|NCT01646320|1005019|P2|COMPLETED|Long-term Period (Weeks 24 to 52)||140
410393|NCT01646320|1005020|P1|COMPLETED|Long-term Period (Weeks 24 to 52)||141
410394|NCT01646320|1005019|P2|STARTED|Long-term Period (Weeks 24 to 52)||147
410395|NCT01646320|1005020|P1|STARTED|Long-term Period (Weeks 24 to 52)||147
410396|NCT01646320|1005019|P2|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||7
410397|NCT01646320|1005020|P1|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||12
410398|NCT01646320|1005019|P2|COMPLETED|Short-term Period (Day 1 to Week 24)||153
410399|NCT01646320|1005020|P1|COMPLETED|Short-term Period (Day 1 to Week 24)||148
410400|NCT01646320|1005019|P2|STARTED|Short-term Period (Day 1 to Week 24)||160
410401|NCT01646320|1005020|P1|STARTED|Short-term Period (Day 1 to Week 24)||160
410402|NCT01646268|1005036|P2|NOT COMPLETED|Overall Study||16
410403|NCT01646268|1005037|P1|NOT COMPLETED|Overall Study||11
410404|NCT01646268|1005036|P2|COMPLETED|Overall Study||107
410405|NCT01646268|1005037|P1|COMPLETED|Overall Study||113
410406|NCT01646268|1005036|P2|STARTED|Overall Study||123
410407|NCT01646268|1005037|P1|STARTED|Overall Study||124
410408|NCT01646255|1005051|P2|NOT COMPLETED|Overall Study||14
410409|NCT01646255|1005052|P1|NOT COMPLETED|Overall Study||21
410410|NCT01646255|1005051|P2|COMPLETED|Overall Study||160
410411|NCT01646255|1005052|P1|COMPLETED|Overall Study||151
410412|NCT01646255|1005051|P2|STARTED|Overall Study||174
410413|NCT01646255|1005052|P1|STARTED|Overall Study||172
410414|NCT01646216|1005084|P2|NOT COMPLETED|Overall Study||13
410415|NCT01646216|1005085|P1|NOT COMPLETED|Overall Study||11
410416|NCT01646216|1005084|P2|COMPLETED|Overall Study||4
410417|NCT01646216|1005085|P1|COMPLETED|Overall Study||6
410418|NCT01646216|1005084|P2|STARTED|Overall Study||17
410419|NCT01646216|1005085|P1|STARTED|Overall Study||17
410420|NCT01646177|1005108|P4|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
410421|NCT01646177|1005109|P3|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
410422|NCT01646177|1005110|P2|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
410423|NCT01646177|1005111|P1|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
410424|NCT01646177|1005108|P4|COMPLETED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
410425|NCT01646177|1005109|P3|COMPLETED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
410426|NCT01646177|1005110|P2|COMPLETED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
410427|NCT01646177|1005111|P1|COMPLETED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
410428|NCT01646177|1005108|P4|STARTED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
410429|NCT01646177|1005109|P3|STARTED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
410430|NCT01646177|1005110|P2|STARTED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
410431|NCT01646177|1005111|P1|STARTED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
410432|NCT01646177|1005108|P4|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||22
410433|NCT01646177|1005109|P3|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||26
410434|NCT01646177|1005110|P2|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||13
410435|NCT01646177|1005111|P1|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||10
410436|NCT01646177|1005108|P4|COMPLETED|Blinded Induction Dosing (Week 0-12)||363
410437|NCT01646177|1005109|P3|COMPLETED|Blinded Induction Dosing (Week 0-12)||360
410438|NCT01646177|1005110|P2|COMPLETED|Blinded Induction Dosing (Week 0-12)||369
410439|NCT01646177|1005111|P1|COMPLETED|Blinded Induction Dosing (Week 0-12)||183
410440|NCT01646177|1005108|P4|STARTED|Blinded Induction Dosing (Week 0-12)||385
410441|NCT01646177|1005109|P3|STARTED|Blinded Induction Dosing (Week 0-12)||386
410442|NCT01646177|1005110|P2|STARTED|Blinded Induction Dosing (Week 0-12)||382
410443|NCT01646177|1005111|P1|STARTED|Blinded Induction Dosing (Week 0-12)||193
410444|NCT01646151|1005189|P1|NOT COMPLETED|Overall Study||170
410445|NCT01646151|1005189|P1|COMPLETED|Overall Study||2410
410446|NCT01646151|1005189|P1|STARTED|Overall Study||2580
410447|NCT01646138|1005205|P5|NOT COMPLETED|Overall Study||2
410448|NCT01646138|1005206|P4|NOT COMPLETED|Overall Study||0
410449|NCT01646138|1005207|P3|NOT COMPLETED|Overall Study||0
410450|NCT01646138|1005208|P2|NOT COMPLETED|Overall Study||0
410451|NCT01646138|1005209|P1|NOT COMPLETED|Overall Study||0
410452|NCT01646138|1005205|P5|COMPLETED|Overall Study||13
410453|NCT01646138|1005206|P4|COMPLETED|Overall Study||19
410454|NCT01646138|1005207|P3|COMPLETED|Overall Study||5
410455|NCT01646138|1005208|P2|COMPLETED|Overall Study||4
410456|NCT01646138|1005209|P1|COMPLETED|Overall Study||5
410457|NCT01646138|1005205|P5|STARTED|Overall Study||15
410458|NCT01646138|1005206|P4|STARTED|Overall Study||19
410459|NCT01646138|1005207|P3|STARTED|Overall Study||5
410460|NCT01646138|1005208|P2|STARTED|Overall Study||4
410461|NCT01646138|1005209|P1|STARTED|Overall Study||5
410462|NCT01646125|1005223|P2|NOT COMPLETED|Overall Study||28
410463|NCT01646125|1005224|P1|NOT COMPLETED|Overall Study||31
410464|NCT01646125|1005223|P2|COMPLETED|Overall Study||0
410465|NCT01646125|1005224|P1|COMPLETED|Overall Study||0
410466|NCT01646125|1005223|P2|STARTED|Overall Study||28
410467|NCT01646125|1005224|P1|STARTED|Overall Study||31
410468|NCT01646073|1005249|P2|NOT COMPLETED|Period B (12 Weeks)||13
410469|NCT01646073|1005250|P1|NOT COMPLETED|Period B (12 Weeks)||1
410470|NCT01646073|1005249|P2|COMPLETED|Period B (12 Weeks)||320
410471|NCT01646073|1005250|P1|COMPLETED|Period B (12 Weeks)||84
410472|NCT01646073|1005249|P2|STARTED|Period B (12 Weeks)||333
410473|NCT01646073|1005250|P1|STARTED|Period B (12 Weeks)||85
410474|NCT01646073|1005249|P2|NOT COMPLETED|Period A (12 Weeks)||5
410475|NCT01646073|1005250|P1|NOT COMPLETED|Period A (12 Weeks)||2
410476|NCT01646073|1005249|P2|COMPLETED|Period A (12 Weeks)||333
410477|NCT01646073|1005250|P1|COMPLETED|Period A (12 Weeks)||85
410478|NCT01646073|1005249|P2|STARTED|Period A (12 Weeks)||338
410479|NCT01646073|1005250|P1|STARTED|Period A (12 Weeks)||87
410480|NCT01646021|1005291|P2|NOT COMPLETED|Overall Study||141
410481|NCT01646021|1005292|P1|NOT COMPLETED|Overall Study||139
410482|NCT01646021|1005291|P2|COMPLETED|Overall Study||0
410483|NCT01646021|1005292|P1|COMPLETED|Overall Study||0
410484|NCT01646021|1005291|P2|Treated|Overall Study||139
410485|NCT01646021|1005292|P1|Treated|Overall Study||139
410486|NCT01646021|1005291|P2|STARTED|Overall Study||141
410487|NCT01646021|1005292|P1|STARTED|Overall Study||139
410488|NCT01645735|1005331|P2|NOT COMPLETED|Overall Study||1
410489|NCT01645735|1005332|P1|NOT COMPLETED|Overall Study||4
410490|NCT01645735|1005331|P2|COMPLETED|Overall Study||16
410491|NCT01645735|1005332|P1|COMPLETED|Overall Study||28
410492|NCT01645735|1005331|P2|STARTED|Overall Study||17
410493|NCT01645735|1005332|P1|STARTED|Overall Study||32
410494|NCT01645709|1005346|P2|NOT COMPLETED|Overall Study||0
410495|NCT01645709|1005347|P1|NOT COMPLETED|Overall Study||0
410496|NCT01645709|1005346|P2|COMPLETED|Overall Study|Study was terminated; not made unblind|0
410497|NCT01645709|1005347|P1|COMPLETED|Overall Study|Study was terminated; not made unblind|0
410498|NCT01645709|1005346|P2|STARTED|Overall Study|Study was terminated; not made unblind|0
410499|NCT01645709|1005347|P1|STARTED|Overall Study|Study was terminated; not made unblind|0
410500|NCT01645280|1005374|P5|NOT COMPLETED|Overall Study||8
410501|NCT01645280|1005375|P4|NOT COMPLETED|Overall Study||6
410502|NCT01645280|1005376|P3|NOT COMPLETED|Overall Study||6
410503|NCT01645280|1005377|P2|NOT COMPLETED|Overall Study||3
410504|NCT01645280|1005378|P1|NOT COMPLETED|Overall Study||6
410505|NCT01645280|1005374|P5|COMPLETED|Overall Study||47
410506|NCT01645280|1005375|P4|COMPLETED|Overall Study||48
410507|NCT01645280|1005376|P3|COMPLETED|Overall Study||49
410508|NCT01645280|1005377|P2|COMPLETED|Overall Study||51
410509|NCT01645280|1005378|P1|COMPLETED|Overall Study||49
410510|NCT01645280|1005374|P5|STARTED|Overall Study||55
410511|NCT01645280|1005375|P4|STARTED|Overall Study||54
410512|NCT01645280|1005376|P3|STARTED|Overall Study||55
410513|NCT01645280|1005377|P2|STARTED|Overall Study||54
410514|NCT01645280|1005378|P1|STARTED|Overall Study|16 participants in placebo group early escaped to receive Ustekinmab; included in safety population.|55
410515|NCT01645176|1005406|P1|NOT COMPLETED|Overall Study||5
410516|NCT01645176|1005406|P1|COMPLETED|Overall Study||16
410517|NCT01645176|1005406|P1|STARTED|Overall Study||21
410518|NCT01645111|1005410|P1|NOT COMPLETED|Overall Study||15
410519|NCT01645111|1005410|P1|COMPLETED|Overall Study||35
410520|NCT01645111|1005410|P1|STARTED|Overall Study||50
410521|NCT01645098|1005416|P2|NOT COMPLETED|Overall Study||0
410522|NCT01645098|1005417|P1|NOT COMPLETED|Overall Study||0
410523|NCT01645098|1005416|P2|COMPLETED|Overall Study||29
410524|NCT01645098|1005417|P1|COMPLETED|Overall Study||24
410525|NCT01645098|1005416|P2|STARTED|Overall Study||29
410526|NCT01645098|1005417|P1|STARTED|Overall Study||24
410527|NCT01645059|1005431|P1|NOT COMPLETED|Overall Study||0
410528|NCT01645059|1005431|P1|COMPLETED|Overall Study||129
410529|NCT01645059|1005431|P1|STARTED|Overall Study||129
410530|NCT01644734|1005449|P1|NOT COMPLETED|Overall Study||266
410531|NCT01644734|1005449|P1|COMPLETED|Overall Study||1016
410532|NCT01644734|1005449|P1|STARTED|Overall Study|Patients with documentation of treatment.|1282
410533|NCT01644695|1005454|P1|NOT COMPLETED|Overall Study||0
410534|NCT01644695|1005454|P1|COMPLETED|Overall Study||85
410535|NCT01644695|1005454|P1|STARTED|Overall Study||85
410536|NCT01644643|1005463|P4|NOT COMPLETED|Overall Study||10
410537|NCT01644643|1005464|P3|NOT COMPLETED|Overall Study||5
410538|NCT01644643|1005465|P2|NOT COMPLETED|Overall Study||0
410539|NCT01644643|1005466|P1|NOT COMPLETED|Overall Study||2
410540|NCT01644643|1005463|P4|COMPLETED|Overall Study||143
410541|NCT01644643|1005464|P3|COMPLETED|Overall Study||148
410542|NCT01644643|1005465|P2|COMPLETED|Overall Study||12
410543|NCT01644643|1005466|P1|COMPLETED|Overall Study||13
410544|NCT01644643|1005463|P4|STARTED|Overall Study||153
410545|NCT01644643|1005464|P3|STARTED|Overall Study||153
410546|NCT01644643|1005465|P2|STARTED|Overall Study||12
410547|NCT01644643|1005466|P1|STARTED|Overall Study||15
410548|NCT01644617|1005631|P3|NOT COMPLETED|Overall Study||7
410549|NCT01644617|1005632|P2|NOT COMPLETED|Overall Study||5
410550|NCT01644617|1005633|P1|NOT COMPLETED|Overall Study||6
410551|NCT01644617|1005631|P3|COMPLETED|Overall Study||34
410552|NCT01644617|1005632|P2|COMPLETED|Overall Study||36
410553|NCT01644617|1005633|P1|COMPLETED|Overall Study||36
410554|NCT01644617|1005631|P3|STARTED|Overall Study||41
410555|NCT01644617|1005632|P2|STARTED|Overall Study||41
410556|NCT01644617|1005633|P1|STARTED|Overall Study||42
410557|NCT01644500|1005686|P3|NOT COMPLETED|Overall Study||15
410558|NCT01644500|1005687|P2|NOT COMPLETED|Overall Study||24
410559|NCT01644500|1005688|P1|NOT COMPLETED|Overall Study||22
410560|NCT01644500|1005686|P3|COMPLETED|Overall Study||230
410561|NCT01644500|1005687|P2|COMPLETED|Overall Study||224
410562|NCT01644500|1005688|P1|COMPLETED|Overall Study||222
410563|NCT01644500|1005686|P3|Modified Intent-to-treat Population|Overall Study||242
410564|NCT01644500|1005687|P2|Modified Intent-to-treat Population|Overall Study||239
410565|NCT01644500|1005688|P1|Modified Intent-to-treat Population|Overall Study||239
410566|NCT01644500|1005686|P3|Received at Least One Dose of Study Drug|Overall Study||243
410567|NCT01644500|1005687|P2|Received at Least One Dose of Study Drug|Overall Study||248
410568|NCT01644500|1005688|P1|Received at Least One Dose of Study Drug|Overall Study||244
410569|NCT01644500|1005686|P3|STARTED|Overall Study||245
410570|NCT01644500|1005687|P2|STARTED|Overall Study||248
410571|NCT01644500|1005688|P1|STARTED|Overall Study||244
410572|NCT01644474|1005758|P2|NOT COMPLETED|Overall Study||8
410573|NCT01644474|1005759|P1|NOT COMPLETED|Overall Study||7
410574|NCT01644474|1005758|P2|COMPLETED|Overall Study||44
410575|NCT01644474|1005759|P1|COMPLETED|Overall Study||44
410576|NCT01644474|1005758|P2|Treated|Overall Study||52
410577|NCT01644474|1005759|P1|Treated|Overall Study||51
410578|NCT01644474|1005758|P2|STARTED|Overall Study|Randomized|52
410579|NCT01644474|1005759|P1|STARTED|Overall Study|Randomized|51
410580|NCT01644396|1005799|P1|NOT COMPLETED|Overall Study||0
410581|NCT01644396|1005799|P1|COMPLETED|Overall Study||50
410582|NCT01644396|1005799|P1|STARTED|Overall Study||50
410583|NCT01644331|1005843|P2|NOT COMPLETED|Overall Study||10
410584|NCT01644331|1005844|P1|NOT COMPLETED|Overall Study||11
410585|NCT01644331|1005843|P2|COMPLETED|Overall Study||118
410586|NCT01644331|1005844|P1|COMPLETED|Overall Study||118
410587|NCT01644331|1005843|P2|STARTED|Overall Study||128
410588|NCT01644331|1005844|P1|STARTED|Overall Study||129
410589|NCT01644292|1005876|P1|NOT COMPLETED|Overall Study||0
410590|NCT01644292|1005876|P1|COMPLETED|Overall Study||2
410591|NCT01644292|1005876|P1|STARTED|Overall Study||2
410592|NCT01644240|1005883|P3|NOT COMPLETED|Overall Study||0
410593|NCT01644240|1005884|P2|NOT COMPLETED|Overall Study||0
410594|NCT01644240|1005885|P1|NOT COMPLETED|Overall Study||0
410595|NCT01644240|1005883|P3|COMPLETED|Overall Study||6
410596|NCT01644240|1005884|P2|COMPLETED|Overall Study||4
410597|NCT01644240|1005885|P1|COMPLETED|Overall Study||6
410598|NCT01644240|1005883|P3|STARTED|Overall Study||6
410599|NCT01644240|1005884|P2|STARTED|Overall Study||4
410600|NCT01644240|1005885|P1|STARTED|Overall Study||6
410601|NCT01644188|1005943|P2|NOT COMPLETED|Overall Study||75
410602|NCT01644188|1005944|P1|NOT COMPLETED|Overall Study||122
410603|NCT01644188|1005943|P2|COMPLETED|Overall Study||166
410604|NCT01644188|1005944|P1|COMPLETED|Overall Study||357
410605|NCT01644188|1005943|P2|Treated|Overall Study||241
410606|NCT01644188|1005944|P1|Treated|Overall Study||479
410607|NCT01644188|1005943|P2|STARTED|Overall Study|Randomized|241
410608|NCT01644188|1005944|P1|STARTED|Overall Study|Randomized|479
410609|NCT01644175|1006002|P2|NOT COMPLETED|Overall Study||53
410610|NCT01644175|1006003|P1|NOT COMPLETED|Overall Study||32
410611|NCT01644175|1006002|P2|COMPLETED|Overall Study||156
410612|NCT01644175|1006003|P1|COMPLETED|Overall Study||75
410613|NCT01644175|1006002|P2|Treated|Overall Study||207
410614|NCT01644175|1006003|P1|Treated|Overall Study||107
410615|NCT01644175|1006002|P2|STARTED|Overall Study|Randomized|209
410616|NCT01644175|1006003|P1|STARTED|Overall Study|Randomized|107
410617|NCT01644058|1006053|P1|NOT COMPLETED|Overall Study||0
410618|NCT01644058|1006053|P1|COMPLETED|Overall Study||18
410619|NCT01644058|1006053|P1|STARTED|Overall Study||18
410620|NCT01643928|1006063|P5|NOT COMPLETED|Overall Study||2
410621|NCT01643928|1006064|P4|NOT COMPLETED|Overall Study||3
410622|NCT01643928|1006065|P3|NOT COMPLETED|Overall Study||3
410623|NCT01643928|1006066|P2|NOT COMPLETED|Overall Study||2
410624|NCT01643928|1006067|P1|NOT COMPLETED|Overall Study||10
410625|NCT01643928|1006063|P5|COMPLETED|Overall Study||28
410626|NCT01643928|1006064|P4|COMPLETED|Overall Study||27
410627|NCT01643928|1006065|P3|COMPLETED|Overall Study||30
410628|NCT01643928|1006066|P2|COMPLETED|Overall Study||30
410629|NCT01643928|1006067|P1|COMPLETED|Overall Study||48
410630|NCT01643928|1006063|P5|STARTED|Overall Study||30
410631|NCT01643928|1006064|P4|STARTED|Overall Study||30
410632|NCT01643928|1006065|P3|STARTED|Overall Study||33
410633|NCT01643928|1006066|P2|STARTED|Overall Study||32
410634|NCT01643928|1006067|P1|STARTED|Overall Study||58
410635|NCT01643902|1006352|P1|NOT COMPLETED|Overall Study||0
410636|NCT01643902|1006352|P1|COMPLETED|Overall Study||20
410637|NCT01643902|1006352|P1|STARTED|Overall Study||20
410638|NCT01643876|1006357|P1|NOT COMPLETED|Overall Study||0
410639|NCT01643876|1006357|P1|COMPLETED|Overall Study||48
410640|NCT01643876|1006357|P1|STARTED|Overall Study||48
410641|NCT01643798|1006362|P2|NOT COMPLETED|Pretreatment 2 and Stimulation||0
410642|NCT01643798|1006363|P1|NOT COMPLETED|Pretreatment 2 and Stimulation||0
410643|NCT01643798|1006362|P2|COMPLETED|Pretreatment 2 and Stimulation||8
410644|NCT01643798|1006363|P1|COMPLETED|Pretreatment 2 and Stimulation||6
410645|NCT01643798|1006362|P2|STARTED|Pretreatment 2 and Stimulation||8
410646|NCT01643798|1006363|P1|STARTED|Pretreatment 2 and Stimulation||6
410647|NCT01643798|1006362|P2|NOT COMPLETED|Pretreatment 1 and Stimulation||0
410648|NCT01643798|1006363|P1|NOT COMPLETED|Pretreatment 1 and Stimulation||1
410649|NCT01643798|1006362|P2|COMPLETED|Pretreatment 1 and Stimulation||8
410650|NCT01643798|1006363|P1|COMPLETED|Pretreatment 1 and Stimulation||6
410651|NCT01643798|1006362|P2|STARTED|Pretreatment 1 and Stimulation||8
410652|NCT01643798|1006363|P1|STARTED|Pretreatment 1 and Stimulation||7
410653|NCT01643668|1006374|P1|NOT COMPLETED|Overall Study||1
410654|NCT01643668|1006374|P1|COMPLETED|Overall Study||33
410655|NCT01643668|1006374|P1|STARTED|Overall Study||34
410656|NCT01643616|1006388|P2|NOT COMPLETED|Overall Study||0
410657|NCT01643616|1006389|P1|NOT COMPLETED|Overall Study||0
410658|NCT01643616|1006388|P2|COMPLETED|Overall Study||125
410659|NCT01643616|1006389|P1|COMPLETED|Overall Study||125
410660|NCT01643616|1006388|P2|STARTED|Overall Study||125
410661|NCT01643616|1006389|P1|STARTED|Overall Study||125
410662|NCT01643525|1006399|P1|NOT COMPLETED|Overall Study||0
410663|NCT01643525|1006399|P1|COMPLETED|Overall Study||29
410664|NCT01643525|1006399|P1|STARTED|Overall Study||29
410665|NCT01643213|1006405|P2|NOT COMPLETED|Overall Study||0
410666|NCT01643213|1006406|P1|NOT COMPLETED|Overall Study||1
410667|NCT01643213|1006405|P2|COMPLETED|Overall Study||14
410668|NCT01643213|1006406|P1|COMPLETED|Overall Study||12
410669|NCT01643213|1006405|P2|STARTED|Overall Study||14
410670|NCT01643213|1006406|P1|STARTED|Overall Study||13
410671|NCT01643044|1006414|P2|NOT COMPLETED|Overall Study||5
410672|NCT01643044|1006415|P1|NOT COMPLETED|Overall Study||4
410673|NCT01643044|1006414|P2|COMPLETED|Overall Study||19
410674|NCT01643044|1006415|P1|COMPLETED|Overall Study||20
410675|NCT01643044|1006414|P2|STARTED|Overall Study||24
410676|NCT01643044|1006415|P1|STARTED|Overall Study||24
410677|NCT01642914|1006424|P3|NOT COMPLETED|Overall Study||40
410678|NCT01642914|1006425|P2|NOT COMPLETED|Overall Study||32
410679|NCT01642914|1006426|P1|NOT COMPLETED|Overall Study||46
410680|NCT01642914|1006424|P3|COMPLETED|Overall Study||120
410681|NCT01642914|1006425|P2|COMPLETED|Overall Study||122
410682|NCT01642914|1006426|P1|COMPLETED|Overall Study||127
410683|NCT01642914|1006424|P3|STARTED|Overall Study||160
410684|NCT01642914|1006425|P2|STARTED|Overall Study||154
410685|NCT01642914|1006426|P1|STARTED|Overall Study||173
410686|NCT01642732|1006501|P1|NOT COMPLETED|Overall Study||1
410687|NCT01642732|1006501|P1|COMPLETED|Overall Study||0
410688|NCT01642732|1006501|P1|STARTED|Overall Study||1
410689|NCT01642615|1006506|P3|NOT COMPLETED|Double Blind Maintenance Phase||6
410690|NCT01642615|1006507|P2|NOT COMPLETED|Double Blind Maintenance Phase||7
410691|NCT01642615|1006508|P1|NOT COMPLETED|Double Blind Maintenance Phase||0
410692|NCT01642615|1006506|P3|COMPLETED|Double Blind Maintenance Phase||20
410693|NCT01642615|1006507|P2|COMPLETED|Double Blind Maintenance Phase||18
410694|NCT01642615|1006508|P1|COMPLETED|Double Blind Maintenance Phase||0
410695|NCT01642615|1006506|P3|STARTED|Double Blind Maintenance Phase||26
410696|NCT01642615|1006507|P2|STARTED|Double Blind Maintenance Phase||25
410697|NCT01642615|1006508|P1|STARTED|Double Blind Maintenance Phase||0
410698|NCT01642615|1006506|P3|NOT COMPLETED|Open Label Maintenance Phase||0
410699|NCT01642615|1006507|P2|NOT COMPLETED|Open Label Maintenance Phase||0
410700|NCT01642615|1006508|P1|NOT COMPLETED|Open Label Maintenance Phase||5
410701|NCT01642615|1006506|P3|COMPLETED|Open Label Maintenance Phase||0
410702|NCT01642615|1006507|P2|COMPLETED|Open Label Maintenance Phase||0
410703|NCT01642615|1006508|P1|COMPLETED|Open Label Maintenance Phase||58
410704|NCT01642615|1006506|P3|Safety Analysis Set|Open Label Maintenance Phase||0
410705|NCT01642615|1006507|P2|Safety Analysis Set|Open Label Maintenance Phase||0
410706|NCT01642615|1006508|P1|Safety Analysis Set|Open Label Maintenance Phase||62
410707|NCT01642615|1006506|P3|STARTED|Open Label Maintenance Phase||0
410708|NCT01642615|1006507|P2|STARTED|Open Label Maintenance Phase||0
410709|NCT01642615|1006508|P1|STARTED|Open Label Maintenance Phase||63
410710|NCT01642602|1006522|P1|NOT COMPLETED|Overall Study||2
410711|NCT01642602|1006522|P1|COMPLETED|Overall Study||102
410712|NCT01642602|1006522|P1|STARTED|Overall Study||104
410713|NCT01642589|1006529|P2|NOT COMPLETED|Overall Study||1
410714|NCT01642589|1006530|P1|NOT COMPLETED|Overall Study||1
410715|NCT01642589|1006529|P2|COMPLETED|Overall Study||99
410716|NCT01642589|1006530|P1|COMPLETED|Overall Study||199
410717|NCT01642589|1006529|P2|STARTED|Overall Study||100
410718|NCT01642589|1006530|P1|STARTED|Overall Study||200
410719|NCT01642485|1006544|P8|NOT COMPLETED|Period 2, Day 3||0
410720|NCT01642485|1006545|P7|NOT COMPLETED|Period 2, Day 3||0
410721|NCT01642485|1006546|P6|NOT COMPLETED|Period 2, Day 3||0
410722|NCT01642485|1006547|P5|NOT COMPLETED|Period 2, Day 3||0
410723|NCT01642485|1006548|P4|NOT COMPLETED|Period 2, Day 3||0
410724|NCT01642485|1006549|P3|NOT COMPLETED|Period 2, Day 3||0
410725|NCT01642485|1006550|P2|NOT COMPLETED|Period 2, Day 3||0
410726|NCT01642485|1006551|P1|NOT COMPLETED|Period 2, Day 3||0
410727|NCT01642485|1006544|P8|COMPLETED|Period 2, Day 3||4
410728|NCT01642485|1006545|P7|COMPLETED|Period 2, Day 3||4
410729|NCT01642485|1006546|P6|COMPLETED|Period 2, Day 3||4
410730|NCT01642485|1006547|P5|COMPLETED|Period 2, Day 3||4
410731|NCT01642485|1006548|P4|COMPLETED|Period 2, Day 3||4
410732|NCT01642485|1006549|P3|COMPLETED|Period 2, Day 3||4
410733|NCT01642485|1006550|P2|COMPLETED|Period 2, Day 3||4
410734|NCT01642485|1006551|P1|COMPLETED|Period 2, Day 3||4
410735|NCT01642485|1006544|P8|STARTED|Period 2, Day 3||4
410736|NCT01642485|1006545|P7|STARTED|Period 2, Day 3||4
410737|NCT01642485|1006546|P6|STARTED|Period 2, Day 3||4
410738|NCT01642485|1006547|P5|STARTED|Period 2, Day 3||4
410739|NCT01642485|1006548|P4|STARTED|Period 2, Day 3||4
410740|NCT01642485|1006549|P3|STARTED|Period 2, Day 3||4
410741|NCT01642485|1006550|P2|STARTED|Period 2, Day 3||4
410742|NCT01642485|1006551|P1|STARTED|Period 2, Day 3||4
410743|NCT01642485|1006544|P8|NOT COMPLETED|Period 2, Day 2||0
410744|NCT01642485|1006545|P7|NOT COMPLETED|Period 2, Day 2||0
410745|NCT01642485|1006546|P6|NOT COMPLETED|Period 2, Day 2||0
410746|NCT01642485|1006547|P5|NOT COMPLETED|Period 2, Day 2||0
410747|NCT01642485|1006548|P4|NOT COMPLETED|Period 2, Day 2||0
410748|NCT01642485|1006549|P3|NOT COMPLETED|Period 2, Day 2||0
410749|NCT01642485|1006550|P2|NOT COMPLETED|Period 2, Day 2||0
410750|NCT01642485|1006551|P1|NOT COMPLETED|Period 2, Day 2||0
410751|NCT01642485|1006544|P8|COMPLETED|Period 2, Day 2||4
410752|NCT01642485|1006545|P7|COMPLETED|Period 2, Day 2||4
410753|NCT01642485|1006546|P6|COMPLETED|Period 2, Day 2||4
410754|NCT01642485|1006547|P5|COMPLETED|Period 2, Day 2||4
410755|NCT01642485|1006548|P4|COMPLETED|Period 2, Day 2||4
410756|NCT01642485|1006549|P3|COMPLETED|Period 2, Day 2||4
410757|NCT01642485|1006550|P2|COMPLETED|Period 2, Day 2||4
410758|NCT01642485|1006551|P1|COMPLETED|Period 2, Day 2||4
410759|NCT01642485|1006544|P8|STARTED|Period 2, Day 2||4
410760|NCT01642485|1006545|P7|STARTED|Period 2, Day 2||4
410761|NCT01642485|1006546|P6|STARTED|Period 2, Day 2||4
410762|NCT01642485|1006547|P5|STARTED|Period 2, Day 2||4
410763|NCT01642485|1006548|P4|STARTED|Period 2, Day 2||4
410764|NCT01642485|1006549|P3|STARTED|Period 2, Day 2||4
410765|NCT01642485|1006550|P2|STARTED|Period 2, Day 2||4
410766|NCT01642485|1006551|P1|STARTED|Period 2, Day 2||4
410767|NCT01642485|1006544|P8|NOT COMPLETED|Period 2, Day 1||0
410768|NCT01642485|1006545|P7|NOT COMPLETED|Period 2, Day 1||0
410769|NCT01642485|1006546|P6|NOT COMPLETED|Period 2, Day 1||0
410770|NCT01642485|1006547|P5|NOT COMPLETED|Period 2, Day 1||0
410771|NCT01642485|1006548|P4|NOT COMPLETED|Period 2, Day 1||0
410772|NCT01642485|1006549|P3|NOT COMPLETED|Period 2, Day 1||0
410773|NCT01642485|1006550|P2|NOT COMPLETED|Period 2, Day 1||0
410774|NCT01642485|1006551|P1|NOT COMPLETED|Period 2, Day 1||0
410775|NCT01642485|1006544|P8|COMPLETED|Period 2, Day 1||4
410776|NCT01642485|1006545|P7|COMPLETED|Period 2, Day 1||4
410777|NCT01642485|1006546|P6|COMPLETED|Period 2, Day 1||4
410778|NCT01642485|1006547|P5|COMPLETED|Period 2, Day 1||4
410779|NCT01642485|1006548|P4|COMPLETED|Period 2, Day 1||4
410780|NCT01642485|1006549|P3|COMPLETED|Period 2, Day 1||4
410781|NCT01642485|1006550|P2|COMPLETED|Period 2, Day 1||4
410782|NCT01642485|1006551|P1|COMPLETED|Period 2, Day 1||4
410783|NCT01642485|1006544|P8|STARTED|Period 2, Day 1||4
410784|NCT01642485|1006545|P7|STARTED|Period 2, Day 1||4
410785|NCT01642485|1006546|P6|STARTED|Period 2, Day 1||4
410786|NCT01642485|1006547|P5|STARTED|Period 2, Day 1||4
410787|NCT01642485|1006548|P4|STARTED|Period 2, Day 1||4
410788|NCT01642485|1006549|P3|STARTED|Period 2, Day 1||4
410789|NCT01642485|1006550|P2|STARTED|Period 2, Day 1||4
410790|NCT01642485|1006551|P1|STARTED|Period 2, Day 1||4
410791|NCT01642485|1006544|P8|NOT COMPLETED|Period 1, Day 3||0
410792|NCT01642485|1006545|P7|NOT COMPLETED|Period 1, Day 3||0
410793|NCT01642485|1006546|P6|NOT COMPLETED|Period 1, Day 3||0
410794|NCT01642485|1006547|P5|NOT COMPLETED|Period 1, Day 3||0
410795|NCT01642485|1006548|P4|NOT COMPLETED|Period 1, Day 3||0
410796|NCT01642485|1006549|P3|NOT COMPLETED|Period 1, Day 3||0
410797|NCT01642485|1006550|P2|NOT COMPLETED|Period 1, Day 3||0
410798|NCT01642485|1006551|P1|NOT COMPLETED|Period 1, Day 3||0
410799|NCT01642485|1006544|P8|COMPLETED|Period 1, Day 3||4
410800|NCT01642485|1006545|P7|COMPLETED|Period 1, Day 3||4
410801|NCT01642485|1006546|P6|COMPLETED|Period 1, Day 3||4
410802|NCT01642485|1006547|P5|COMPLETED|Period 1, Day 3||4
410803|NCT01642485|1006548|P4|COMPLETED|Period 1, Day 3||4
410804|NCT01642485|1006549|P3|COMPLETED|Period 1, Day 3||4
410805|NCT01642485|1006550|P2|COMPLETED|Period 1, Day 3||4
410806|NCT01642485|1006551|P1|COMPLETED|Period 1, Day 3||4
410807|NCT01642485|1006544|P8|STARTED|Period 1, Day 3||4
410808|NCT01642485|1006545|P7|STARTED|Period 1, Day 3||4
410809|NCT01642485|1006546|P6|STARTED|Period 1, Day 3||4
410810|NCT01642485|1006547|P5|STARTED|Period 1, Day 3||4
410811|NCT01642485|1006548|P4|STARTED|Period 1, Day 3||4
410812|NCT01642485|1006549|P3|STARTED|Period 1, Day 3||4
410813|NCT01642485|1006550|P2|STARTED|Period 1, Day 3||4
410814|NCT01642485|1006551|P1|STARTED|Period 1, Day 3||4
410815|NCT01642485|1006544|P8|NOT COMPLETED|Period 1, Day 2||0
410816|NCT01642485|1006545|P7|NOT COMPLETED|Period 1, Day 2||0
410817|NCT01642485|1006546|P6|NOT COMPLETED|Period 1, Day 2||0
410818|NCT01642485|1006547|P5|NOT COMPLETED|Period 1, Day 2||0
410819|NCT01642485|1006548|P4|NOT COMPLETED|Period 1, Day 2||0
410820|NCT01642485|1006549|P3|NOT COMPLETED|Period 1, Day 2||0
410821|NCT01642485|1006550|P2|NOT COMPLETED|Period 1, Day 2||0
410822|NCT01642485|1006551|P1|NOT COMPLETED|Period 1, Day 2||0
410823|NCT01642485|1006544|P8|COMPLETED|Period 1, Day 2||4
410824|NCT01642485|1006545|P7|COMPLETED|Period 1, Day 2||4
410825|NCT01642485|1006546|P6|COMPLETED|Period 1, Day 2||4
410826|NCT01642485|1006547|P5|COMPLETED|Period 1, Day 2||4
410827|NCT01642485|1006548|P4|COMPLETED|Period 1, Day 2||4
410828|NCT01642485|1006549|P3|COMPLETED|Period 1, Day 2||4
410829|NCT01642485|1006550|P2|COMPLETED|Period 1, Day 2||4
410830|NCT01642485|1006551|P1|COMPLETED|Period 1, Day 2||4
410831|NCT01642485|1006544|P8|STARTED|Period 1, Day 2||4
410832|NCT01642485|1006545|P7|STARTED|Period 1, Day 2||4
410833|NCT01642485|1006546|P6|STARTED|Period 1, Day 2||4
410834|NCT01642485|1006547|P5|STARTED|Period 1, Day 2||4
410835|NCT01642485|1006548|P4|STARTED|Period 1, Day 2||4
410836|NCT01642485|1006549|P3|STARTED|Period 1, Day 2||4
410837|NCT01642485|1006550|P2|STARTED|Period 1, Day 2||4
410838|NCT01642485|1006551|P1|STARTED|Period 1, Day 2||4
410839|NCT01642485|1006544|P8|NOT COMPLETED|Period 1, Day 1||0
410840|NCT01642485|1006545|P7|NOT COMPLETED|Period 1, Day 1||0
410841|NCT01642485|1006546|P6|NOT COMPLETED|Period 1, Day 1||0
410842|NCT01642485|1006547|P5|NOT COMPLETED|Period 1, Day 1||0
410843|NCT01642485|1006548|P4|NOT COMPLETED|Period 1, Day 1||0
410844|NCT01642485|1006549|P3|NOT COMPLETED|Period 1, Day 1||0
410845|NCT01642485|1006550|P2|NOT COMPLETED|Period 1, Day 1||0
410846|NCT01642485|1006551|P1|NOT COMPLETED|Period 1, Day 1||0
410847|NCT01642485|1006544|P8|COMPLETED|Period 1, Day 1||4
410848|NCT01642485|1006545|P7|COMPLETED|Period 1, Day 1||4
410849|NCT01642485|1006546|P6|COMPLETED|Period 1, Day 1||4
410850|NCT01642485|1006547|P5|COMPLETED|Period 1, Day 1||4
410851|NCT01642485|1006548|P4|COMPLETED|Period 1, Day 1||4
410852|NCT01642485|1006549|P3|COMPLETED|Period 1, Day 1||4
410853|NCT01642485|1006550|P2|COMPLETED|Period 1, Day 1||4
410854|NCT01642485|1006551|P1|COMPLETED|Period 1, Day 1||4
410855|NCT01642485|1006544|P8|STARTED|Period 1, Day 1||4
410856|NCT01642485|1006545|P7|STARTED|Period 1, Day 1||4
410857|NCT01642485|1006546|P6|STARTED|Period 1, Day 1||4
410858|NCT01642485|1006547|P5|STARTED|Period 1, Day 1||4
410859|NCT01642485|1006548|P4|STARTED|Period 1, Day 1||4
410860|NCT01642485|1006549|P3|STARTED|Period 1, Day 1||4
410861|NCT01642485|1006550|P2|STARTED|Period 1, Day 1||4
410862|NCT01642485|1006551|P1|STARTED|Period 1, Day 1|crossover so all subjects had this treatment|4
410866|NCT01642277|1006613|P2|NOT COMPLETED|Overall Study||0
410867|NCT01642277|1006614|P1|NOT COMPLETED|Overall Study||24
410868|NCT01642277|1006613|P2|COMPLETED|Overall Study||60
410869|NCT01642277|1006614|P1|COMPLETED|Overall Study||50
410870|NCT01642277|1006613|P2|STARTED|Overall Study||60
410871|NCT01642277|1006614|P1|STARTED|Overall Study||74
410872|NCT01642238|1006623|P2|NOT COMPLETED|Second Intervention (1 Day)||0
410873|NCT01642238|1006624|P1|NOT COMPLETED|Second Intervention (1 Day)||0
410874|NCT01642238|1006623|P2|COMPLETED|Second Intervention (1 Day)||8
410875|NCT01642238|1006624|P1|COMPLETED|Second Intervention (1 Day)||7
410876|NCT01642238|1006623|P2|STARTED|Second Intervention (1 Day)||8
410877|NCT01642238|1006624|P1|STARTED|Second Intervention (1 Day)||7
410878|NCT01642238|1006623|P2|NOT COMPLETED|Washout (1-2 Weeks)||0
410879|NCT01642238|1006624|P1|NOT COMPLETED|Washout (1-2 Weeks)||0
410880|NCT01642238|1006623|P2|COMPLETED|Washout (1-2 Weeks)||8
410881|NCT01642238|1006624|P1|COMPLETED|Washout (1-2 Weeks)||7
410882|NCT01642238|1006623|P2|STARTED|Washout (1-2 Weeks)||8
410883|NCT01642238|1006624|P1|STARTED|Washout (1-2 Weeks)||7
410884|NCT01642238|1006623|P2|NOT COMPLETED|First Intervention (1 Day)||0
410885|NCT01642238|1006624|P1|NOT COMPLETED|First Intervention (1 Day)||0
410886|NCT01642238|1006623|P2|COMPLETED|First Intervention (1 Day)||8
410887|NCT01642238|1006624|P1|COMPLETED|First Intervention (1 Day)||7
410888|NCT01642238|1006623|P2|STARTED|First Intervention (1 Day)||8
410889|NCT01642238|1006624|P1|STARTED|First Intervention (1 Day)||7
410890|NCT01642212|1006646|P5|NOT COMPLETED|Open-label Extension||8
410891|NCT01642212|1006647|P4|NOT COMPLETED|Open-label Extension||10
410892|NCT01642212|1006648|P3|NOT COMPLETED|Open-label Extension||0
410893|NCT01642212|1006649|P2|NOT COMPLETED|Open-label Extension||0
410894|NCT01642212|1006650|P1|NOT COMPLETED|Open-label Extension||0
410895|NCT01642212|1006646|P5|COMPLETED|Open-label Extension||37
410896|NCT01642212|1006647|P4|COMPLETED|Open-label Extension||27
410897|NCT01642212|1006648|P3|COMPLETED|Open-label Extension||0
410898|NCT01642212|1006649|P2|COMPLETED|Open-label Extension||0
410899|NCT01642212|1006650|P1|COMPLETED|Open-label Extension||0
410900|NCT01642212|1006646|P5|STARTED|Open-label Extension|Four participants completed double-blind treatment but did not enter the open-label extension.|45
410901|NCT01642212|1006647|P4|STARTED|Open-label Extension|Two participants completed double-blind treatment but did not enter the open-label extension.|37
410902|NCT01642212|1006648|P3|STARTED|Open-label Extension||0
410903|NCT01642212|1006649|P2|STARTED|Open-label Extension||0
410904|NCT01642212|1006650|P1|STARTED|Open-label Extension||0
410905|NCT01642212|1006646|P5|NOT COMPLETED|Double-blind Treatment||0
410906|NCT01642212|1006647|P4|NOT COMPLETED|Double-blind Treatment||0
410907|NCT01642212|1006648|P3|NOT COMPLETED|Double-blind Treatment||2
410908|NCT01642212|1006649|P2|NOT COMPLETED|Double-blind Treatment||3
410909|NCT01642212|1006650|P1|NOT COMPLETED|Double-blind Treatment||0
410910|NCT01642212|1006646|P5|COMPLETED|Double-blind Treatment||0
410911|NCT01642212|1006647|P4|COMPLETED|Double-blind Treatment||0
410912|NCT01642212|1006648|P3|COMPLETED|Double-blind Treatment||49
410913|NCT01642212|1006649|P2|COMPLETED|Double-blind Treatment||39
410914|NCT01642212|1006650|P1|COMPLETED|Double-blind Treatment||0
410915|NCT01642212|1006646|P5|STARTED|Double-blind Treatment||0
410916|NCT01642212|1006647|P4|STARTED|Double-blind Treatment||0
410917|NCT01642212|1006648|P3|STARTED|Double-blind Treatment||51
410918|NCT01642212|1006649|P2|STARTED|Double-blind Treatment||42
410919|NCT01642212|1006650|P1|STARTED|Double-blind Treatment||0
410920|NCT01642212|1006646|P5|NOT COMPLETED|Single-blind Baseline||0
410921|NCT01642212|1006647|P4|NOT COMPLETED|Single-blind Baseline||0
410922|NCT01642212|1006648|P3|NOT COMPLETED|Single-blind Baseline||0
410923|NCT01642212|1006649|P2|NOT COMPLETED|Single-blind Baseline||0
410924|NCT01642212|1006650|P1|NOT COMPLETED|Single-blind Baseline||26
410925|NCT01642212|1006646|P5|COMPLETED|Single-blind Baseline||0
410926|NCT01642212|1006647|P4|COMPLETED|Single-blind Baseline||0
410927|NCT01642212|1006648|P3|COMPLETED|Single-blind Baseline||0
410928|NCT01642212|1006649|P2|COMPLETED|Single-blind Baseline||0
410929|NCT01642212|1006650|P1|COMPLETED|Single-blind Baseline||93
410930|NCT01642212|1006646|P5|STARTED|Single-blind Baseline||0
410931|NCT01642212|1006647|P4|STARTED|Single-blind Baseline||0
410932|NCT01642212|1006648|P3|STARTED|Single-blind Baseline||0
410933|NCT01642212|1006649|P2|STARTED|Single-blind Baseline||0
410934|NCT01642212|1006650|P1|STARTED|Single-blind Baseline||119
410935|NCT01642147|1006700|P2|NOT COMPLETED|Overall Study||0
410936|NCT01642147|1006701|P1|NOT COMPLETED|Overall Study||0
410937|NCT01642147|1006700|P2|COMPLETED|Overall Study||30
410938|NCT01642147|1006701|P1|COMPLETED|Overall Study||30
410939|NCT01642147|1006700|P2|STARTED|Overall Study||30
410940|NCT01642147|1006701|P1|STARTED|Overall Study||30
410941|NCT01642082|1006729|P1|NOT COMPLETED|Overall Study||0
410942|NCT01642082|1006729|P1|COMPLETED|Overall Study||28
410943|NCT01642082|1006729|P1|STARTED|Overall Study||28
410944|NCT01642004|1006745|P2|NOT COMPLETED|Treatment||127
410945|NCT01642004|1006746|P1|NOT COMPLETED|Treatment||110
410946|NCT01642004|1006745|P2|COMPLETED|Treatment||2
410947|NCT01642004|1006746|P1|COMPLETED|Treatment||21
410948|NCT01642004|1006745|P2|STARTED|Treatment||129
410949|NCT01642004|1006746|P1|STARTED|Treatment||131
410950|NCT01642004|1006745|P2|NOT COMPLETED|Randomization||8
410951|NCT01642004|1006746|P1|NOT COMPLETED|Randomization||4
410952|NCT01642004|1006745|P2|COMPLETED|Randomization||129
410953|NCT01642004|1006746|P1|COMPLETED|Randomization||131
410954|NCT01642004|1006745|P2|STARTED|Randomization||137
410955|NCT01642004|1006746|P1|STARTED|Randomization||135
410956|NCT01641991|1006780|P4|NOT COMPLETED|Overall Study||16
410957|NCT01641991|1006781|P3|NOT COMPLETED|Overall Study||17
410958|NCT01641991|1006782|P2|NOT COMPLETED|Overall Study||8
410959|NCT01641991|1006783|P1|NOT COMPLETED|Overall Study||9
410960|NCT01641991|1006780|P4|COMPLETED|Overall Study||66
410961|NCT01641991|1006781|P3|COMPLETED|Overall Study||65
410962|NCT01641991|1006782|P2|COMPLETED|Overall Study||74
410963|NCT01641991|1006783|P1|COMPLETED|Overall Study||73
410964|NCT01641991|1006780|P4|STARTED|Overall Study||82
410965|NCT01641991|1006781|P3|STARTED|Overall Study||82
410966|NCT01641991|1006782|P2|STARTED|Overall Study||82
410967|NCT01641991|1006783|P1|STARTED|Overall Study||82
410968|NCT01641978|1006859|P1|NOT COMPLETED|Overall Study||0
410969|NCT01641978|1006859|P1|COMPLETED|Overall Study||125
410970|NCT01641978|1006859|P1|STARTED|Overall Study||125
410971|NCT01641952|1006867|P1|NOT COMPLETED|Overall Study||34
410972|NCT01641952|1006867|P1|COMPLETED|Overall Study||471
410973|NCT01641952|1006867|P1|Treated|Overall Study||504
410974|NCT01641952|1006867|P1|STARTED|Overall Study||505
410975|NCT01641939|1006883|P3|NOT COMPLETED|Overall Study||70
410976|NCT01641939|1006884|P2|NOT COMPLETED|Overall Study||228
410977|NCT01641939|1006885|P1|NOT COMPLETED|Overall Study||117
410978|NCT01641939|1006883|P3|COMPLETED|Overall Study||0
410979|NCT01641939|1006884|P2|COMPLETED|Overall Study||0
410980|NCT01641939|1006885|P1|COMPLETED|Overall Study||0
410981|NCT01641939|1006883|P3|Stage 2|Overall Study||0
410982|NCT01641939|1006884|P2|Stage 2|Overall Study||153
410983|NCT01641939|1006885|P1|Stage 2|Overall Study||80
410984|NCT01641939|1006883|P3|Stage 1|Overall Study||70
410985|NCT01641939|1006884|P2|Stage 1|Overall Study||75
410986|NCT01641939|1006885|P1|Stage 1|Overall Study||37
410987|NCT01641939|1006883|P3|STARTED|Overall Study||70
410988|NCT01641939|1006884|P2|STARTED|Overall Study||228
410989|NCT01641939|1006885|P1|STARTED|Overall Study||117
410990|NCT01641926|1006928|P4|NOT COMPLETED|Overall Study||4
410991|NCT01641926|1006929|P3|NOT COMPLETED|Overall Study||11
410992|NCT01641926|1006930|P2|NOT COMPLETED|Overall Study||15
410993|NCT01641926|1006931|P1|NOT COMPLETED|Overall Study||28
410994|NCT01641926|1006928|P4|COMPLETED|Overall Study||53
410995|NCT01641926|1006929|P3|COMPLETED|Overall Study||46
410996|NCT01641926|1006930|P2|COMPLETED|Overall Study||130
410997|NCT01641926|1006931|P1|COMPLETED|Overall Study||115
410998|NCT01641926|1006928|P4|Treated (All Participants as Treated)|Overall Study||57
410999|NCT01641926|1006929|P3|Treated (All Participants as Treated)|Overall Study||56
411000|NCT01641926|1006930|P2|Treated (All Participants as Treated)|Overall Study||144
411001|NCT01641926|1006931|P1|Treated (All Participants as Treated)|Overall Study||142
411002|NCT01641926|1006928|P4|STARTED|Overall Study||57
411003|NCT01641926|1006929|P3|STARTED|Overall Study||57
411004|NCT01641926|1006930|P2|STARTED|Overall Study||145
411005|NCT01641926|1006931|P1|STARTED|Overall Study||143
411006|NCT01641900|1006959|P2|NOT COMPLETED|Overall Study||2
411007|NCT01641900|1006960|P1|NOT COMPLETED|Overall Study||2
411008|NCT01641900|1006959|P2|COMPLETED|Overall Study||29
411009|NCT01641900|1006960|P1|COMPLETED|Overall Study||26
411010|NCT01641900|1006959|P2|Completed Drug Intervention|Overall Study||29
411011|NCT01641900|1006960|P1|Completed Drug Intervention|Overall Study|n=1,assigned to drug intervention first, completed the session and dropped out of the study.|26
411012|NCT01641900|1006959|P2|Completed Placebo Intervention|Overall Study|n=2,both assigned to placebo intervention first, completed the session and dropped out of the study.|29
411013|NCT01641900|1006960|P1|Completed Placebo Intervention|Overall Study|n=1,assigned to placebo intervention first, completed the session and dropped out of the study.|27
411014|NCT01641900|1006959|P2|STARTED|Overall Study||31
411015|NCT01641900|1006960|P1|STARTED|Overall Study||28
411016|NCT01641861|1006972|P2|NOT COMPLETED|Overall Study||25
411017|NCT01641861|1006973|P1|NOT COMPLETED|Overall Study||35
411018|NCT01641861|1006972|P2|COMPLETED|Overall Study||217
411019|NCT01641861|1006973|P1|COMPLETED|Overall Study||211
411020|NCT01641861|1006972|P2|STARTED|Overall Study||242
411021|NCT01641861|1006973|P1|STARTED|Overall Study||246
411022|NCT01641835|1006987|P1|NOT COMPLETED|Overall Study||0
411023|NCT01641835|1006987|P1|COMPLETED|Overall Study||303
411024|NCT01641835|1006987|P1|STARTED|Overall Study||303
411025|NCT01641822|1006994|P3|NOT COMPLETED|Comparative Phase||10
411026|NCT01641822|1006995|P2|NOT COMPLETED|Comparative Phase||6
411027|NCT01641822|1006996|P1|NOT COMPLETED|Comparative Phase||0
411028|NCT01641822|1006994|P3|COMPLETED|Comparative Phase||37
411029|NCT01641822|1006995|P2|COMPLETED|Comparative Phase||37
411030|NCT01641822|1006996|P1|COMPLETED|Comparative Phase||0
411031|NCT01641822|1006994|P3|Received Randomized Study Drug Treatment|Comparative Phase||46
411032|NCT01641822|1006995|P2|Received Randomized Study Drug Treatment|Comparative Phase||42
411033|NCT01641822|1006996|P1|Received Randomized Study Drug Treatment|Comparative Phase||0
411034|NCT01641822|1006994|P3|STARTED|Comparative Phase||47
411035|NCT01641822|1006995|P2|STARTED|Comparative Phase||43
411036|NCT01641822|1006996|P1|STARTED|Comparative Phase|Participants continuing into the Comparative Phase were randomized to the AZLI or Placebo group.|0
411037|NCT01641822|1006994|P3|NOT COMPLETED|Run-in Phase||0
411038|NCT01641822|1006995|P2|NOT COMPLETED|Run-in Phase||0
411039|NCT01641822|1006996|P1|NOT COMPLETED|Run-in Phase||14
411040|NCT01641822|1006994|P3|COMPLETED|Run-in Phase||0
411041|NCT01641822|1006995|P2|COMPLETED|Run-in Phase||0
411042|NCT01641822|1006996|P1|COMPLETED|Run-in Phase|3 participants who completed the TIS Run-In Phase did not continue to the Comparative Phase.|93
411043|NCT01641822|1006994|P3|STARTED|Run-in Phase||0
411044|NCT01641822|1006995|P2|STARTED|Run-in Phase||0
411045|NCT01641822|1006996|P1|STARTED|Run-in Phase||107
411046|NCT01641692|1007013|P8|NOT COMPLETED|Washout Period 3 or Follow-up||0
411047|NCT01641692|1007014|P7|NOT COMPLETED|Washout Period 3 or Follow-up||1
411048|NCT01641692|1007015|P6|NOT COMPLETED|Washout Period 3 or Follow-up||2
411049|NCT01641692|1007016|P5|NOT COMPLETED|Washout Period 3 or Follow-up||0
411050|NCT01641692|1007017|P4|NOT COMPLETED|Washout Period 3 or Follow-up||1
411051|NCT01641692|1007018|P3|NOT COMPLETED|Washout Period 3 or Follow-up||1
411052|NCT01641692|1007019|P2|NOT COMPLETED|Washout Period 3 or Follow-up||0
411053|NCT01641692|1007020|P1|NOT COMPLETED|Washout Period 3 or Follow-up||1
411054|NCT01641692|1007013|P8|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|38
411055|NCT01641692|1007014|P7|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|32
411056|NCT01641692|1007015|P6|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|37
411057|NCT01641692|1007016|P5|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|40
411058|NCT01641692|1007017|P4|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|41
411059|NCT01641692|1007018|P3|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|36
411060|NCT01641692|1007019|P2|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|32
411061|NCT01641692|1007020|P1|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|42
411062|NCT01641692|1007013|P8|STARTED|Washout Period 3 or Follow-up||38
411063|NCT01641692|1007014|P7|STARTED|Washout Period 3 or Follow-up||33
411064|NCT01641692|1007015|P6|STARTED|Washout Period 3 or Follow-up||39
411065|NCT01641692|1007016|P5|STARTED|Washout Period 3 or Follow-up||40
411066|NCT01641692|1007017|P4|STARTED|Washout Period 3 or Follow-up||42
411067|NCT01641692|1007018|P3|STARTED|Washout Period 3 or Follow-up||37
411068|NCT01641692|1007019|P2|STARTED|Washout Period 3 or Follow-up||32
411069|NCT01641692|1007020|P1|STARTED|Washout Period 3 or Follow-up||43
411070|NCT01641692|1007013|P8|NOT COMPLETED|Treatment Period 3||0
411071|NCT01641692|1007014|P7|NOT COMPLETED|Treatment Period 3||2
411072|NCT01641692|1007015|P6|NOT COMPLETED|Treatment Period 3||0
411073|NCT01641692|1007016|P5|NOT COMPLETED|Treatment Period 3||0
411074|NCT01641692|1007017|P4|NOT COMPLETED|Treatment Period 3||0
411075|NCT01641692|1007018|P3|NOT COMPLETED|Treatment Period 3||1
411076|NCT01641692|1007019|P2|NOT COMPLETED|Treatment Period 3||1
411077|NCT01641692|1007020|P1|NOT COMPLETED|Treatment Period 3||0
411078|NCT01641692|1007013|P8|COMPLETED|Treatment Period 3||38
411079|NCT01641692|1007014|P7|COMPLETED|Treatment Period 3||33
411080|NCT01641692|1007015|P6|COMPLETED|Treatment Period 3||39
411081|NCT01641692|1007016|P5|COMPLETED|Treatment Period 3||40
411082|NCT01641692|1007017|P4|COMPLETED|Treatment Period 3||42
411083|NCT01641692|1007018|P3|COMPLETED|Treatment Period 3||37
411084|NCT01641692|1007019|P2|COMPLETED|Treatment Period 3||32
411085|NCT01641692|1007020|P1|COMPLETED|Treatment Period 3||43
411086|NCT01641692|1007013|P8|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|38
411087|NCT01641692|1007014|P7|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|35
411088|NCT01641692|1007015|P6|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|39
411089|NCT01641692|1007016|P5|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|40
411090|NCT01641692|1007017|P4|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|42
411091|NCT01641692|1007018|P3|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|38
411092|NCT01641692|1007019|P2|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|33
411093|NCT01641692|1007020|P1|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|43
411094|NCT01641692|1007013|P8|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
411095|NCT01641692|1007014|P7|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
411096|NCT01641692|1007015|P6|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
411097|NCT01641692|1007016|P5|NOT COMPLETED|Washout Period 2 (12-14 Days)||3
411098|NCT01641692|1007017|P4|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
411099|NCT01641692|1007018|P3|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
411100|NCT01641692|1007019|P2|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
411101|NCT01641692|1007020|P1|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
411102|NCT01641692|1007013|P8|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|34
411103|NCT01641692|1007014|P7|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|42
411104|NCT01641692|1007015|P6|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|42
411105|NCT01641692|1007016|P5|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|34
411106|NCT01641692|1007017|P4|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|41
411107|NCT01641692|1007018|P3|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|39
411108|NCT01641692|1007019|P2|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|46
411109|NCT01641692|1007020|P1|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|30
411110|NCT01641692|1007013|P8|STARTED|Washout Period 2 (12-14 Days)||35
411111|NCT01641692|1007014|P7|STARTED|Washout Period 2 (12-14 Days)||43
411112|NCT01641692|1007015|P6|STARTED|Washout Period 2 (12-14 Days)||43
411113|NCT01641692|1007016|P5|STARTED|Washout Period 2 (12-14 Days)||37
411114|NCT01641692|1007017|P4|STARTED|Washout Period 2 (12-14 Days)||41
411115|NCT01641692|1007018|P3|STARTED|Washout Period 2 (12-14 Days)||40
411116|NCT01641692|1007019|P2|STARTED|Washout Period 2 (12-14 Days)||46
411117|NCT01641692|1007020|P1|STARTED|Washout Period 2 (12-14 Days)||30
411118|NCT01641692|1007013|P8|NOT COMPLETED|Treatment Period 2||1
411119|NCT01641692|1007014|P7|NOT COMPLETED|Treatment Period 2||0
411120|NCT01641692|1007015|P6|NOT COMPLETED|Treatment Period 2||2
411121|NCT01641692|1007016|P5|NOT COMPLETED|Treatment Period 2||0
411122|NCT01641692|1007017|P4|NOT COMPLETED|Treatment Period 2||0
411123|NCT01641692|1007018|P3|NOT COMPLETED|Treatment Period 2||0
411124|NCT01641692|1007019|P2|NOT COMPLETED|Treatment Period 2||0
411125|NCT01641692|1007020|P1|NOT COMPLETED|Treatment Period 2||3
411126|NCT01641692|1007013|P8|COMPLETED|Treatment Period 2||35
411127|NCT01641692|1007014|P7|COMPLETED|Treatment Period 2||43
411128|NCT01641692|1007015|P6|COMPLETED|Treatment Period 2||43
411129|NCT01641692|1007016|P5|COMPLETED|Treatment Period 2||37
411130|NCT01641692|1007017|P4|COMPLETED|Treatment Period 2||41
411131|NCT01641692|1007018|P3|COMPLETED|Treatment Period 2||40
411132|NCT01641692|1007019|P2|COMPLETED|Treatment Period 2||46
411133|NCT01641692|1007020|P1|COMPLETED|Treatment Period 2||30
411134|NCT01641692|1007013|P8|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|36
411135|NCT01641692|1007014|P7|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|43
411136|NCT01641692|1007015|P6|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|45
411137|NCT01641692|1007016|P5|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|37
411138|NCT01641692|1007017|P4|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|41
411139|NCT01641692|1007018|P3|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|40
411140|NCT01641692|1007019|P2|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|46
411141|NCT01641692|1007020|P1|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|33
411142|NCT01641692|1007013|P8|NOT COMPLETED|Washout Period 1 (12-14 Days)||1
411143|NCT01641692|1007014|P7|NOT COMPLETED|Washout Period 1 (12-14 Days)||2
411144|NCT01641692|1007015|P6|NOT COMPLETED|Washout Period 1 (12-14 Days)||0
411145|NCT01641692|1007016|P5|NOT COMPLETED|Washout Period 1 (12-14 Days)||4
411146|NCT01641692|1007017|P4|NOT COMPLETED|Washout Period 1 (12-14 Days)||2
411147|NCT01641692|1007018|P3|NOT COMPLETED|Washout Period 1 (12-14 Days)||3
411148|NCT01641692|1007019|P2|NOT COMPLETED|Washout Period 1 (12-14 Days)||1
411149|NCT01641692|1007020|P1|NOT COMPLETED|Washout Period 1 (12-14 Days)||4
411150|NCT01641692|1007013|P8|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|47
411151|NCT01641692|1007014|P7|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|36
411152|NCT01641692|1007015|P6|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|37
411153|NCT01641692|1007016|P5|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|35
411154|NCT01641692|1007017|P4|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|39
411155|NCT01641692|1007018|P3|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|47
411156|NCT01641692|1007019|P2|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|44
411157|NCT01641692|1007020|P1|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|36
411158|NCT01641692|1007013|P8|STARTED|Washout Period 1 (12-14 Days)||48
411159|NCT01641692|1007014|P7|STARTED|Washout Period 1 (12-14 Days)||38
411160|NCT01641692|1007015|P6|STARTED|Washout Period 1 (12-14 Days)||37
411161|NCT01641692|1007016|P5|STARTED|Washout Period 1 (12-14 Days)||39
411162|NCT01641692|1007017|P4|STARTED|Washout Period 1 (12-14 Days)||41
411163|NCT01641692|1007018|P3|STARTED|Washout Period 1 (12-14 Days)||50
411164|NCT01641692|1007019|P2|STARTED|Washout Period 1 (12-14 Days)||45
411165|NCT01641692|1007020|P1|STARTED|Washout Period 1 (12-14 Days)||40
411166|NCT01641692|1007013|P8|NOT COMPLETED|Treatment Period 1||3
411167|NCT01641692|1007014|P7|NOT COMPLETED|Treatment Period 1||0
411168|NCT01641692|1007015|P6|NOT COMPLETED|Treatment Period 1||2
411169|NCT01641692|1007016|P5|NOT COMPLETED|Treatment Period 1||4
411170|NCT01641692|1007017|P4|NOT COMPLETED|Treatment Period 1||0
411171|NCT01641692|1007018|P3|NOT COMPLETED|Treatment Period 1||1
411172|NCT01641692|1007019|P2|NOT COMPLETED|Treatment Period 1||0
411173|NCT01641692|1007020|P1|NOT COMPLETED|Treatment Period 1||2
411174|NCT01641692|1007013|P8|COMPLETED|Treatment Period 1||48
411175|NCT01641692|1007014|P7|COMPLETED|Treatment Period 1||38
411176|NCT01641692|1007015|P6|COMPLETED|Treatment Period 1||37
411177|NCT01641692|1007016|P5|COMPLETED|Treatment Period 1||39
411178|NCT01641692|1007017|P4|COMPLETED|Treatment Period 1||41
411179|NCT01641692|1007018|P3|COMPLETED|Treatment Period 1||50
411180|NCT01641692|1007019|P2|COMPLETED|Treatment Period 1||45
411181|NCT01641692|1007020|P1|COMPLETED|Treatment Period 1||40
411182|NCT01641692|1007013|P8|STARTED|Treatment Period 1||51
411183|NCT01641692|1007014|P7|STARTED|Treatment Period 1||38
411184|NCT01641692|1007015|P6|STARTED|Treatment Period 1||39
411185|NCT01641692|1007016|P5|STARTED|Treatment Period 1||43
411186|NCT01641692|1007017|P4|STARTED|Treatment Period 1||41
411187|NCT01641692|1007018|P3|STARTED|Treatment Period 1||51
411188|NCT01641692|1007019|P2|STARTED|Treatment Period 1||45
411189|NCT01641692|1007020|P1|STARTED|Treatment Period 1||42
411190|NCT01641653|1007209|P2|NOT COMPLETED|Overall Study||0
411191|NCT01641653|1007210|P1|NOT COMPLETED|Overall Study||0
411192|NCT01641653|1007209|P2|COMPLETED|Overall Study||30
411193|NCT01641653|1007210|P1|COMPLETED|Overall Study||30
411194|NCT01641653|1007209|P2|STARTED|Overall Study||30
411195|NCT01641653|1007210|P1|STARTED|Overall Study||30
411196|NCT01641640|1007220|P1|NOT COMPLETED|Overall Study||36
411197|NCT01641640|1007220|P1|COMPLETED|Overall Study||292
411198|NCT01641640|1007220|P1|Enrolled and Treated|Overall Study||327
411199|NCT01641640|1007220|P1|STARTED|Overall Study||328
411200|NCT01641471|1007231|P2|NOT COMPLETED|Overall Study||27
411201|NCT01641471|1007232|P1|NOT COMPLETED|Overall Study||23
411202|NCT01641471|1007231|P2|COMPLETED|Overall Study||31
411203|NCT01641471|1007232|P1|COMPLETED|Overall Study||35
411204|NCT01641471|1007231|P2|STARTED|Overall Study||58
411205|NCT01641471|1007232|P1|STARTED|Overall Study||58
411206|NCT01641367|1007250|P6|NOT COMPLETED|Overall Study||1
411207|NCT01641367|1007251|P5|NOT COMPLETED|Overall Study||3
411208|NCT01641367|1007252|P4|NOT COMPLETED|Overall Study||0
411209|NCT01641367|1007253|P3|NOT COMPLETED|Overall Study||4
411210|NCT01641367|1007254|P2|NOT COMPLETED|Overall Study||1
411211|NCT01641367|1007255|P1|NOT COMPLETED|Overall Study||34
411212|NCT01641367|1007250|P6|COMPLETED|Overall Study||33
411213|NCT01641367|1007251|P5|COMPLETED|Overall Study||67
411214|NCT01641367|1007252|P4|COMPLETED|Overall Study||8
411215|NCT01641367|1007253|P3|COMPLETED|Overall Study||68
411216|NCT01641367|1007254|P2|COMPLETED|Overall Study||73
411217|NCT01641367|1007255|P1|COMPLETED|Overall Study||253
411218|NCT01641367|1007250|P6|STARTED|Overall Study||34
411219|NCT01641367|1007251|P5|STARTED|Overall Study||70
411220|NCT01641367|1007252|P4|STARTED|Overall Study||8
411221|NCT01641367|1007253|P3|STARTED|Overall Study||72
411222|NCT01641367|1007254|P2|STARTED|Overall Study||74
411223|NCT01641367|1007255|P1|STARTED|Overall Study||287
411224|NCT01641237|1007270|P4|NOT COMPLETED|Period IV||0
411225|NCT01641237|1007271|P3|NOT COMPLETED|Period IV||0
411226|NCT01641237|1007272|P2|NOT COMPLETED|Period IV||0
411227|NCT01641237|1007273|P1|NOT COMPLETED|Period IV||0
411228|NCT01641237|1007270|P4|COMPLETED|Period IV||15
411229|NCT01641237|1007271|P3|COMPLETED|Period IV||15
411230|NCT01641237|1007272|P2|COMPLETED|Period IV||15
411231|NCT01641237|1007273|P1|COMPLETED|Period IV||15
411232|NCT01641237|1007270|P4|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
411233|NCT01641237|1007271|P3|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
411234|NCT01641237|1007272|P2|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
411235|NCT01641237|1007273|P1|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
411236|NCT01641237|1007270|P4|NOT COMPLETED|Period III||0
411237|NCT01641237|1007271|P3|NOT COMPLETED|Period III||0
411238|NCT01641237|1007272|P2|NOT COMPLETED|Period III||0
411239|NCT01641237|1007273|P1|NOT COMPLETED|Period III||1
411240|NCT01641237|1007270|P4|COMPLETED|Period III||16
411241|NCT01641237|1007271|P3|COMPLETED|Period III||15
411242|NCT01641237|1007272|P2|COMPLETED|Period III||14
411243|NCT01641237|1007273|P1|COMPLETED|Period III||15
411244|NCT01641237|1007270|P4|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|16
411245|NCT01641237|1007271|P3|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|15
411246|NCT01641237|1007272|P2|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
411247|NCT01641237|1007273|P1|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|16
411248|NCT01641237|1007270|P4|NOT COMPLETED|Period II||0
411249|NCT01641237|1007271|P3|NOT COMPLETED|Period II||0
411250|NCT01641237|1007272|P2|NOT COMPLETED|Period II||0
411251|NCT01641237|1007273|P1|NOT COMPLETED|Period II||1
411252|NCT01641237|1007270|P4|COMPLETED|Period II||15
411253|NCT01641237|1007271|P3|COMPLETED|Period II||16
411254|NCT01641237|1007272|P2|COMPLETED|Period II||16
411255|NCT01641237|1007273|P1|COMPLETED|Period II||14
411256|NCT01641237|1007270|P4|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|15
411257|NCT01641237|1007271|P3|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|16
411258|NCT01641237|1007272|P2|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|16
411259|NCT01641237|1007273|P1|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|15
411260|NCT01641237|1007270|P4|NOT COMPLETED|Period I||0
411261|NCT01641237|1007271|P3|NOT COMPLETED|Period I||0
411262|NCT01641237|1007272|P2|NOT COMPLETED|Period I||0
411263|NCT01641237|1007273|P1|NOT COMPLETED|Period I||0
411264|NCT01641237|1007270|P4|COMPLETED|Period I||15
411265|NCT01641237|1007271|P3|COMPLETED|Period I||15
411266|NCT01641237|1007272|P2|COMPLETED|Period I||16
411267|NCT01641237|1007273|P1|COMPLETED|Period I||16
411268|NCT01641237|1007270|P4|STARTED|Period I||15
411269|NCT01641237|1007271|P3|STARTED|Period I||15
411270|NCT01641237|1007272|P2|STARTED|Period I||16
411271|NCT01641237|1007273|P1|STARTED|Period I||16
411272|NCT01641159|1007297|P2|NOT COMPLETED|Overall Study||2
411273|NCT01641159|1007298|P1|NOT COMPLETED|Overall Study||2
411274|NCT01641159|1007297|P2|COMPLETED|Overall Study||25
411275|NCT01641159|1007298|P1|COMPLETED|Overall Study||33
411276|NCT01641159|1007297|P2|STARTED|Overall Study||27
411277|NCT01641159|1007298|P1|STARTED|Overall Study||35
411278|NCT01641133|1007309|P3|NOT COMPLETED|Overall Study||8
411279|NCT01641133|1007310|P2|NOT COMPLETED|Overall Study||9
411280|NCT01641133|1007311|P1|NOT COMPLETED|Overall Study||10
411281|NCT01641133|1007309|P3|COMPLETED|Overall Study||90
411282|NCT01641133|1007310|P2|COMPLETED|Overall Study||90
411283|NCT01641133|1007311|P1|COMPLETED|Overall Study||87
411284|NCT01641133|1007309|P3|STARTED|Overall Study||98
411285|NCT01641133|1007310|P2|STARTED|Overall Study||99
411286|NCT01641133|1007311|P1|STARTED|Overall Study||97
411287|NCT01641120|1007349|P1|NOT COMPLETED|30 Gauge Needle Weeks 2 and 3||0
411288|NCT01641120|1007349|P1|COMPLETED|30 Gauge Needle Weeks 2 and 3||20
411289|NCT01641120|1007349|P1|STARTED|30 Gauge Needle Weeks 2 and 3||20
411290|NCT01641120|1007349|P1|NOT COMPLETED|25 Gauge Needle Weeks 1, 4, 5||0
411291|NCT01641120|1007349|P1|COMPLETED|25 Gauge Needle Weeks 1, 4, 5||20
411292|NCT01641120|1007349|P1|STARTED|25 Gauge Needle Weeks 1, 4, 5||20
411293|NCT01641081|1007361|P10|NOT COMPLETED|Period 5||0
411294|NCT01641081|1007362|P9|NOT COMPLETED|Period 5||0
411295|NCT01641081|1007363|P8|NOT COMPLETED|Period 5||0
411296|NCT01641081|1007364|P7|NOT COMPLETED|Period 5||0
411297|NCT01641081|1007365|P6|NOT COMPLETED|Period 5||0
411298|NCT01641081|1007366|P5|NOT COMPLETED|Period 5||0
411299|NCT01641081|1007367|P4|NOT COMPLETED|Period 5||0
411300|NCT01641081|1007368|P3|NOT COMPLETED|Period 5||2
411301|NCT01641081|1007369|P2|NOT COMPLETED|Period 5||0
411302|NCT01641081|1007370|P1|NOT COMPLETED|Period 5||0
411303|NCT01641081|1007361|P10|COMPLETED|Period 5||14
411304|NCT01641081|1007362|P9|COMPLETED|Period 5||14
411305|NCT01641081|1007363|P8|COMPLETED|Period 5||14
411306|NCT01641081|1007364|P7|COMPLETED|Period 5||16
411307|NCT01641081|1007365|P6|COMPLETED|Period 5||18
411308|NCT01641081|1007366|P5|COMPLETED|Period 5||16
411309|NCT01641081|1007367|P4|COMPLETED|Period 5||20
411310|NCT01641081|1007368|P3|COMPLETED|Period 5||12
411311|NCT01641081|1007369|P2|COMPLETED|Period 5||17
411312|NCT01641081|1007370|P1|COMPLETED|Period 5||16
411313|NCT01641081|1007361|P10|STARTED|Period 5||14
411314|NCT01641081|1007362|P9|STARTED|Period 5||14
411315|NCT01641081|1007363|P8|STARTED|Period 5||14
411316|NCT01641081|1007364|P7|STARTED|Period 5||16
411317|NCT01641081|1007365|P6|STARTED|Period 5||18
411318|NCT01641081|1007366|P5|STARTED|Period 5||16
411319|NCT01641081|1007367|P4|STARTED|Period 5||20
411320|NCT01641081|1007368|P3|STARTED|Period 5||14
411321|NCT01641081|1007369|P2|STARTED|Period 5||17
411322|NCT01641081|1007370|P1|STARTED|Period 5||16
411323|NCT01641081|1007361|P10|NOT COMPLETED|Period 4||0
411324|NCT01641081|1007362|P9|NOT COMPLETED|Period 4||0
411325|NCT01641081|1007363|P8|NOT COMPLETED|Period 4||0
411326|NCT01641081|1007364|P7|NOT COMPLETED|Period 4||0
411327|NCT01641081|1007365|P6|NOT COMPLETED|Period 4||0
411328|NCT01641081|1007366|P5|NOT COMPLETED|Period 4||0
411329|NCT01641081|1007367|P4|NOT COMPLETED|Period 4||1
411330|NCT01641081|1007368|P3|NOT COMPLETED|Period 4||0
411331|NCT01641081|1007369|P2|NOT COMPLETED|Period 4||1
411332|NCT01641081|1007370|P1|NOT COMPLETED|Period 4||0
411333|NCT01641081|1007361|P10|COMPLETED|Period 4||14
411334|NCT01641081|1007362|P9|COMPLETED|Period 4||14
411335|NCT01641081|1007363|P8|COMPLETED|Period 4||14
411336|NCT01641081|1007364|P7|COMPLETED|Period 4||16
411337|NCT01641081|1007365|P6|COMPLETED|Period 4||18
411338|NCT01641081|1007366|P5|COMPLETED|Period 4||16
411339|NCT01641081|1007367|P4|COMPLETED|Period 4||20
411340|NCT01641081|1007368|P3|COMPLETED|Period 4||14
411341|NCT01641081|1007369|P2|COMPLETED|Period 4||17
411342|NCT01641081|1007370|P1|COMPLETED|Period 4||16
411343|NCT01641081|1007361|P10|STARTED|Period 4||14
411344|NCT01641081|1007362|P9|STARTED|Period 4||14
411345|NCT01641081|1007363|P8|STARTED|Period 4||14
411346|NCT01641081|1007364|P7|STARTED|Period 4||16
411347|NCT01641081|1007365|P6|STARTED|Period 4||18
411348|NCT01641081|1007366|P5|STARTED|Period 4||16
411349|NCT01641081|1007367|P4|STARTED|Period 4||21
411350|NCT01641081|1007368|P3|STARTED|Period 4||14
411351|NCT01641081|1007369|P2|STARTED|Period 4||18
411352|NCT01641081|1007370|P1|STARTED|Period 4||16
411353|NCT01641081|1007361|P10|NOT COMPLETED|Period 3||0
411354|NCT01641081|1007362|P9|NOT COMPLETED|Period 3||1
411355|NCT01641081|1007363|P8|NOT COMPLETED|Period 3||0
411356|NCT01641081|1007364|P7|NOT COMPLETED|Period 3||0
411357|NCT01641081|1007365|P6|NOT COMPLETED|Period 3||0
411358|NCT01641081|1007366|P5|NOT COMPLETED|Period 3||0
411359|NCT01641081|1007367|P4|NOT COMPLETED|Period 3||0
411360|NCT01641081|1007368|P3|NOT COMPLETED|Period 3||1
411361|NCT01641081|1007369|P2|NOT COMPLETED|Period 3||0
411362|NCT01641081|1007370|P1|NOT COMPLETED|Period 3||0
411363|NCT01641081|1007361|P10|COMPLETED|Period 3||14
411364|NCT01641081|1007362|P9|COMPLETED|Period 3||14
411365|NCT01641081|1007363|P8|COMPLETED|Period 3||14
411366|NCT01641081|1007364|P7|COMPLETED|Period 3||16
411367|NCT01641081|1007365|P6|COMPLETED|Period 3||18
411368|NCT01641081|1007366|P5|COMPLETED|Period 3||16
411369|NCT01641081|1007367|P4|COMPLETED|Period 3||21
411370|NCT01641081|1007368|P3|COMPLETED|Period 3||14
411371|NCT01641081|1007369|P2|COMPLETED|Period 3||18
411372|NCT01641081|1007370|P1|COMPLETED|Period 3||16
411373|NCT01641081|1007361|P10|STARTED|Period 3||14
411374|NCT01641081|1007362|P9|STARTED|Period 3||15
411375|NCT01641081|1007363|P8|STARTED|Period 3||14
411376|NCT01641081|1007364|P7|STARTED|Period 3||16
411377|NCT01641081|1007365|P6|STARTED|Period 3||18
411378|NCT01641081|1007366|P5|STARTED|Period 3||16
411379|NCT01641081|1007367|P4|STARTED|Period 3||21
411380|NCT01641081|1007368|P3|STARTED|Period 3||15
411381|NCT01641081|1007369|P2|STARTED|Period 3||18
411382|NCT01641081|1007370|P1|STARTED|Period 3||16
411383|NCT01641081|1007361|P10|NOT COMPLETED|Period 2||0
411384|NCT01641081|1007362|P9|NOT COMPLETED|Period 2||0
411385|NCT01641081|1007363|P8|NOT COMPLETED|Period 2||0
411386|NCT01641081|1007364|P7|NOT COMPLETED|Period 2||2
411387|NCT01641081|1007365|P6|NOT COMPLETED|Period 2||1
411388|NCT01641081|1007366|P5|NOT COMPLETED|Period 2||0
411389|NCT01641081|1007367|P4|NOT COMPLETED|Period 2||1
411390|NCT01641081|1007368|P3|NOT COMPLETED|Period 2||0
411391|NCT01641081|1007369|P2|NOT COMPLETED|Period 2||0
411392|NCT01641081|1007370|P1|NOT COMPLETED|Period 2||1
411393|NCT01641081|1007361|P10|COMPLETED|Period 2||14
411394|NCT01641081|1007362|P9|COMPLETED|Period 2||15
411395|NCT01641081|1007363|P8|COMPLETED|Period 2||14
411396|NCT01641081|1007364|P7|COMPLETED|Period 2||16
411397|NCT01641081|1007365|P6|COMPLETED|Period 2||18
411398|NCT01641081|1007366|P5|COMPLETED|Period 2||16
411399|NCT01641081|1007367|P4|COMPLETED|Period 2||21
411400|NCT01641081|1007368|P3|COMPLETED|Period 2||15
411401|NCT01641081|1007369|P2|COMPLETED|Period 2||18
411402|NCT01641081|1007370|P1|COMPLETED|Period 2||16
411403|NCT01641081|1007361|P10|STARTED|Period 2||14
411404|NCT01641081|1007362|P9|STARTED|Period 2||15
411405|NCT01641081|1007363|P8|STARTED|Period 2||14
411406|NCT01641081|1007364|P7|STARTED|Period 2||18
411407|NCT01641081|1007365|P6|STARTED|Period 2||19
411408|NCT01641081|1007366|P5|STARTED|Period 2||16
411409|NCT01641081|1007367|P4|STARTED|Period 2||22
411410|NCT01641081|1007368|P3|STARTED|Period 2||15
411411|NCT01641081|1007369|P2|STARTED|Period 2||18
411412|NCT01641081|1007370|P1|STARTED|Period 2||17
411413|NCT01641081|1007361|P10|NOT COMPLETED|Period 1||0
411414|NCT01641081|1007362|P9|NOT COMPLETED|Period 1||0
411415|NCT01641081|1007363|P8|NOT COMPLETED|Period 1||3
411416|NCT01641081|1007364|P7|NOT COMPLETED|Period 1||1
411417|NCT01641081|1007365|P6|NOT COMPLETED|Period 1||0
411418|NCT01641081|1007366|P5|NOT COMPLETED|Period 1||1
411419|NCT01641081|1007367|P4|NOT COMPLETED|Period 1||0
411420|NCT01641081|1007368|P3|NOT COMPLETED|Period 1||0
411421|NCT01641081|1007369|P2|NOT COMPLETED|Period 1||0
411422|NCT01641081|1007370|P1|NOT COMPLETED|Period 1||1
411423|NCT01641081|1007361|P10|COMPLETED|Period 1||14
411424|NCT01641081|1007362|P9|COMPLETED|Period 1||15
411425|NCT01641081|1007363|P8|COMPLETED|Period 1||14
411426|NCT01641081|1007364|P7|COMPLETED|Period 1||18
411427|NCT01641081|1007365|P6|COMPLETED|Period 1||19
411428|NCT01641081|1007366|P5|COMPLETED|Period 1||16
411429|NCT01641081|1007367|P4|COMPLETED|Period 1||22
411430|NCT01641081|1007368|P3|COMPLETED|Period 1||15
411431|NCT01641081|1007369|P2|COMPLETED|Period 1||18
411432|NCT01641081|1007370|P1|COMPLETED|Period 1||17
411433|NCT01641081|1007361|P10|STARTED|Period 1||14
411434|NCT01641081|1007362|P9|STARTED|Period 1||15
411435|NCT01641081|1007363|P8|STARTED|Period 1||17
411436|NCT01641081|1007364|P7|STARTED|Period 1||19
411437|NCT01641081|1007365|P6|STARTED|Period 1||19
411438|NCT01641081|1007366|P5|STARTED|Period 1||17
411439|NCT01641081|1007367|P4|STARTED|Period 1||22
411440|NCT01641081|1007368|P3|STARTED|Period 1||15
411441|NCT01641081|1007369|P2|STARTED|Period 1||18
411442|NCT01641081|1007370|P1|STARTED|Period 1||18
411443|NCT01641042|1007389|P2|NOT COMPLETED|Overall Study||0
411444|NCT01641042|1007390|P1|NOT COMPLETED|Overall Study||0
411445|NCT01641042|1007389|P2|COMPLETED|Overall Study||43
411446|NCT01641042|1007390|P1|COMPLETED|Overall Study||43
411447|NCT01641042|1007389|P2|STARTED|Overall Study||43
411448|NCT01641042|1007390|P1|STARTED|Overall Study||43
411449|NCT01640964|1007439|P3|NOT COMPLETED|Overall Study||3
411450|NCT01640964|1007440|P2|NOT COMPLETED|Overall Study||1
411451|NCT01640964|1007441|P1|NOT COMPLETED|Overall Study||1
411452|NCT01640964|1007439|P3|COMPLETED|Overall Study||3
411453|NCT01640964|1007440|P2|COMPLETED|Overall Study||19
411454|NCT01640964|1007441|P1|COMPLETED|Overall Study||19
411455|NCT01640964|1007439|P3|STARTED|Overall Study||6
411456|NCT01640964|1007440|P2|STARTED|Overall Study||20
411457|NCT01640964|1007441|P1|STARTED|Overall Study||20
411458|NCT01640951|1007464|P8|NOT COMPLETED|Overall Study||16
411459|NCT01640951|1007465|P7|NOT COMPLETED|Overall Study||18
411460|NCT01640951|1007466|P6|NOT COMPLETED|Overall Study||47
411461|NCT01640951|1007467|P5|NOT COMPLETED|Overall Study||13
411462|NCT01640951|1007468|P4|NOT COMPLETED|Overall Study||45
411463|NCT01640951|1007469|P3|NOT COMPLETED|Overall Study||42
411464|NCT01640951|1007470|P2|NOT COMPLETED|Overall Study||15
411465|NCT01640951|1007471|P1|NOT COMPLETED|Overall Study||46
411466|NCT01640951|1007464|P8|COMPLETED|Overall Study||17
411467|NCT01640951|1007465|P7|COMPLETED|Overall Study||94
411468|NCT01640951|1007466|P6|COMPLETED|Overall Study||13
411469|NCT01640951|1007467|P5|COMPLETED|Overall Study||82
411470|NCT01640951|1007468|P4|COMPLETED|Overall Study||10
411471|NCT01640951|1007469|P3|COMPLETED|Overall Study||126
411472|NCT01640951|1007470|P2|COMPLETED|Overall Study||60
411473|NCT01640951|1007471|P1|COMPLETED|Overall Study||31
411474|NCT01640951|1007464|P8|STARTED|Overall Study||33
411475|NCT01640951|1007465|P7|STARTED|Overall Study||112
411476|NCT01640951|1007466|P6|STARTED|Overall Study||60
411477|NCT01640951|1007467|P5|STARTED|Overall Study||95
411478|NCT01640951|1007468|P4|STARTED|Overall Study||55
411479|NCT01640951|1007469|P3|STARTED|Overall Study||168
411480|NCT01640951|1007470|P2|STARTED|Overall Study||75
411481|NCT01640951|1007471|P1|STARTED|Overall Study||77
411482|NCT01640925|1007573|P2|NOT COMPLETED|Overall Study||11
411483|NCT01640925|1007574|P1|NOT COMPLETED|Overall Study||14
411484|NCT01640925|1007573|P2|COMPLETED|Overall Study||164
411485|NCT01640925|1007574|P1|COMPLETED|Overall Study||161
411486|NCT01640925|1007573|P2|STARTED|Overall Study||175
411487|NCT01640925|1007574|P1|STARTED|Overall Study||175
411488|NCT01640548|1007586|P1|NOT COMPLETED|Overall Study||0
411489|NCT01640548|1007586|P1|COMPLETED|Overall Study||309
411490|NCT01640548|1007586|P1|STARTED|Overall Study||309
411491|NCT01640379|1007602|P2|NOT COMPLETED|Overall Study||12
411492|NCT01640379|1007603|P1|NOT COMPLETED|Overall Study||14
411493|NCT01640379|1007602|P2|COMPLETED|Overall Study||125
411494|NCT01640379|1007603|P1|COMPLETED|Overall Study||135
411495|NCT01640379|1007602|P2|STARTED|Overall Study||137
411496|NCT01640379|1007603|P1|STARTED|Overall Study||149
411497|NCT01640353|1007611|P1|NOT COMPLETED|Overall Study||45
411498|NCT01640353|1007611|P1|COMPLETED|Overall Study||149
411499|NCT01640353|1007611|P1|Month 18|Overall Study||150
411500|NCT01640353|1007611|P1|Month 12|Overall Study||160
411501|NCT01640353|1007611|P1|Month 6|Overall Study||168
411502|NCT01640353|1007611|P1|Month 3|Overall Study||169
411503|NCT01640353|1007611|P1|Month 1|Overall Study||171
411504|NCT01640353|1007611|P1|Treated|Overall Study||172
411505|NCT01640353|1007611|P1|STARTED|Overall Study||194
411506|NCT01640340|1007623|P2|NOT COMPLETED|Overall Study||0
411507|NCT01640340|1007624|P1|NOT COMPLETED|Overall Study||0
411508|NCT01640340|1007623|P2|COMPLETED|Overall Study||20
411509|NCT01640340|1007624|P1|COMPLETED|Overall Study||20
411510|NCT01640340|1007623|P2|Overall Complete Response Rate|Overall Study||20
411511|NCT01640340|1007624|P1|Overall Complete Response Rate|Overall Study||20
411512|NCT01640340|1007623|P2|STARTED|Overall Study||20
411513|NCT01640340|1007624|P1|STARTED|Overall Study||20
411514|NCT01640327|1007644|P2|NOT COMPLETED|Overall Study||0
411515|NCT01640327|1007645|P1|NOT COMPLETED|Overall Study||0
411516|NCT01640327|1007644|P2|COMPLETED|Overall Study||63
411517|NCT01640327|1007645|P1|COMPLETED|Overall Study||63
411518|NCT01640327|1007644|P2|STARTED|Overall Study||63
411519|NCT01640327|1007645|P1|STARTED|Overall Study||63
411520|NCT01640314|1007659|P2|NOT COMPLETED|Overall Study||1
411521|NCT01640314|1007660|P1|NOT COMPLETED|Overall Study||0
411522|NCT01640314|1007659|P2|COMPLETED|Overall Study||62
411523|NCT01640314|1007660|P1|COMPLETED|Overall Study||63
411524|NCT01640314|1007659|P2|STARTED|Overall Study||63
411525|NCT01640314|1007660|P1|STARTED|Overall Study||63
411526|NCT01640197|1007676|P2|NOT COMPLETED|Overall Study||0
411527|NCT01640197|1007677|P1|NOT COMPLETED|Overall Study||0
411528|NCT01640197|1007676|P2|COMPLETED|Overall Study||30
411529|NCT01640197|1007677|P1|COMPLETED|Overall Study||30
411530|NCT01640197|1007676|P2|STARTED|Overall Study||30
411531|NCT01640197|1007677|P1|STARTED|Overall Study||30
411532|NCT01640184|1007698|P3|NOT COMPLETED|Overall Study||2
411533|NCT01640184|1007699|P2|NOT COMPLETED|Overall Study||2
411534|NCT01640184|1007700|P1|NOT COMPLETED|Overall Study||8
411535|NCT01640184|1007698|P3|COMPLETED|Overall Study||20
411536|NCT01640184|1007699|P2|COMPLETED|Overall Study||21
411537|NCT01640184|1007700|P1|COMPLETED|Overall Study||26
411538|NCT01640184|1007698|P3|STARTED|Overall Study||22
411539|NCT01640184|1007699|P2|STARTED|Overall Study||23
411540|NCT01640184|1007700|P1|STARTED|Overall Study||34
411541|NCT01640171|1007722|P1|NOT COMPLETED|Overall Study||0
411542|NCT01640171|1007722|P1|COMPLETED|Overall Study||57
411543|NCT01640171|1007722|P1|STARTED|Overall Study||57
411544|NCT01640054|1007729|P1|NOT COMPLETED|Overall Study||6
411545|NCT01640054|1007729|P1|COMPLETED|Overall Study|Number of patients on treatment when the study was stopped.|109
411546|NCT01640054|1007729|P1|Did Not Receive Treatment|Overall Study||0
411547|NCT01640054|1007729|P1|STARTED|Overall Study|Patients who received treatment|115
411548|NCT01639833|1007739|P2|NOT COMPLETED|Overall Study||4
411549|NCT01639833|1007740|P1|NOT COMPLETED|Overall Study||6
411550|NCT01639833|1007739|P2|COMPLETED|Overall Study||41
411551|NCT01639833|1007740|P1|COMPLETED|Overall Study||39
411552|NCT01639833|1007739|P2|STARTED|Overall Study||45
411553|NCT01639833|1007740|P1|STARTED|Overall Study||45
411554|NCT01639755|1007748|P1|NOT COMPLETED|Overall Study||19
411555|NCT01639755|1007748|P1|COMPLETED|Overall Study||0
411556|NCT01639755|1007748|P1|STARTED|Overall Study||19
411557|NCT01639742|1007756|P1|NOT COMPLETED|Overall Study||18
411558|NCT01639742|1007756|P1|COMPLETED|Overall Study||0
411559|NCT01639742|1007756|P1|STARTED|Overall Study||18
411560|NCT01639729|1007764|P6|NOT COMPLETED|Overall Study||0
411561|NCT01639729|1007765|P5|NOT COMPLETED|Overall Study||0
411562|NCT01639729|1007766|P4|NOT COMPLETED|Overall Study||1
411563|NCT01639729|1007767|P3|NOT COMPLETED|Overall Study||1
411564|NCT01639729|1007768|P2|NOT COMPLETED|Overall Study||0
411565|NCT01639729|1007769|P1|NOT COMPLETED|Overall Study||1
411566|NCT01639729|1007764|P6|COMPLETED|Overall Study||4
411567|NCT01639729|1007765|P5|COMPLETED|Overall Study||4
411568|NCT01639729|1007766|P4|COMPLETED|Overall Study||4
411569|NCT01639729|1007767|P3|COMPLETED|Overall Study||3
411570|NCT01639729|1007768|P2|COMPLETED|Overall Study||4
411571|NCT01639729|1007769|P1|COMPLETED|Overall Study||3
411572|NCT01639729|1007764|P6|STARTED|Overall Study||4
411573|NCT01639729|1007765|P5|STARTED|Overall Study||4
411574|NCT01639729|1007766|P4|STARTED|Overall Study||5
411575|NCT01639729|1007767|P3|STARTED|Overall Study||4
411576|NCT01639729|1007768|P2|STARTED|Overall Study||4
411577|NCT01639729|1007769|P1|STARTED|Overall Study||4
411578|NCT01639703|1007791|P1|NOT COMPLETED|Overall Study||12
411579|NCT01639703|1007791|P1|COMPLETED|Overall Study||84
411580|NCT01639703|1007791|P1|STARTED|Overall Study||96
411581|NCT01639560|1007834|P2|NOT COMPLETED|Overall Study||29
411582|NCT01639560|1007835|P1|NOT COMPLETED|Overall Study||19
411583|NCT01639560|1007834|P2|COMPLETED|Overall Study||19
411584|NCT01639560|1007835|P1|COMPLETED|Overall Study||26
411585|NCT01639560|1007834|P2|End of Treatment|Overall Study||20
411586|NCT01639560|1007835|P1|End of Treatment|Overall Study||28
411587|NCT01639560|1007834|P2|STARTED|Overall Study||48
411588|NCT01639560|1007835|P1|STARTED|Overall Study||45
411589|NCT01639495|1007847|P1|NOT COMPLETED|Overall Study||16
411590|NCT01639495|1007847|P1|COMPLETED|Overall Study||132
411591|NCT01639495|1007847|P1|Primary Effectiveness Cohort|Overall Study||138
411592|NCT01639495|1007847|P1|Safety Cohort|Overall Study||144
411593|NCT01639495|1007847|P1|STARTED|Overall Study|Patients who signed the informed consent.|148
411594|NCT01639469|1007857|P2|NOT COMPLETED|Overall Study||3
411595|NCT01639469|1007858|P1|NOT COMPLETED|Overall Study||5
411596|NCT01639469|1007857|P2|COMPLETED|Overall Study||77
411597|NCT01639469|1007858|P1|COMPLETED|Overall Study||84
411598|NCT01639469|1007857|P2|STARTED|Overall Study||80
411599|NCT01639469|1007858|P1|STARTED|Overall Study||89
411600|NCT01639443|1007866|P2|NOT COMPLETED|Overall Study||0
411601|NCT01639443|1007867|P1|NOT COMPLETED|Overall Study||0
411602|NCT01639443|1007866|P2|COMPLETED|Overall Study|These individuals all booked appointments using typical booking.|4855
411603|NCT01639443|1007867|P1|COMPLETED|Overall Study|Intervention is limited to appointment booking, and all completed.|180
411604|NCT01639443|1007866|P2|STARTED|Overall Study|These individuals opted to not participate in Fast-tracked group, and were not consented.|4855
411605|NCT01639443|1007867|P1|STARTED|Overall Study|These individuals opted into Fast-tracked group and were consented.|180
411606|NCT01639352|1007883|P1|NOT COMPLETED|Overall Study||0
411607|NCT01639352|1007883|P1|COMPLETED|Overall Study||20
411608|NCT01639352|1007883|P1|STARTED|Overall Study||20
411609|NCT01639222|1007892|P1|NOT COMPLETED|Overall Study||0
411610|NCT01639222|1007892|P1|COMPLETED|Overall Study||55
411611|NCT01639222|1007892|P1|STARTED|Overall Study||55
411612|NCT01639157|1007902|P2|NOT COMPLETED|Overall Study||0
411613|NCT01639157|1007903|P1|NOT COMPLETED|Overall Study||0
411614|NCT01639157|1007902|P2|COMPLETED|Overall Study||5
411615|NCT01639157|1007903|P1|COMPLETED|Overall Study||4
411616|NCT01639157|1007902|P2|STARTED|Overall Study||5
411617|NCT01639157|1007903|P1|STARTED|Overall Study||4
411618|NCT01639144|1007963|P2|NOT COMPLETED|Overall Study||5
411619|NCT01639144|1007964|P1|NOT COMPLETED|Overall Study||10
411620|NCT01639144|1007963|P2|COMPLETED|Overall Study||250
411621|NCT01639144|1007964|P1|COMPLETED|Overall Study||250
411622|NCT01639144|1007963|P2|STARTED|Overall Study||255
411623|NCT01639144|1007964|P1|STARTED|Overall Study||260
411624|NCT01639040|1007972|P2|NOT COMPLETED|Overall Study||0
411625|NCT01639040|1007973|P1|NOT COMPLETED|Overall Study||1
411626|NCT01639040|1007972|P2|COMPLETED|Overall Study||21
411627|NCT01639040|1007973|P1|COMPLETED|Overall Study||9
411628|NCT01639040|1007972|P2|STARTED|Overall Study||21
411629|NCT01639040|1007973|P1|STARTED|Overall Study||10
411630|NCT01639001|1007991|P2|NOT COMPLETED|Overall Study||103
411631|NCT01639001|1007992|P1|NOT COMPLETED|Overall Study||104
411632|NCT01639001|1007991|P2|COMPLETED|Overall Study||0
411633|NCT01639001|1007992|P1|COMPLETED|Overall Study||0
411634|NCT01639001|1007991|P2|Treated|Overall Study||101
411635|NCT01639001|1007992|P1|Treated|Overall Study||104
411636|NCT01639001|1007991|P2|STARTED|Overall Study||103
411637|NCT01639001|1007992|P1|STARTED|Overall Study||104
411641|NCT01638546|1008042|P2|NOT COMPLETED|Overall Study||3
411642|NCT01638546|1008043|P1|NOT COMPLETED|Overall Study||1
411643|NCT01638546|1008042|P2|COMPLETED|Overall Study||42
411644|NCT01638546|1008043|P1|COMPLETED|Overall Study||51
411645|NCT01638546|1008042|P2|STARTED|Overall Study||45
411646|NCT01638546|1008043|P1|STARTED|Overall Study||52
411647|NCT01638507|1008051|P1|NOT COMPLETED|Overall Study||6
411648|NCT01638507|1008051|P1|COMPLETED|Overall Study||224
411649|NCT01638507|1008051|P1|STARTED|Overall Study||230
411650|NCT01638468|1008064|P1|NOT COMPLETED|Overall Study||0
411651|NCT01638468|1008064|P1|COMPLETED|Overall Study||7
411652|NCT01638468|1008064|P1|STARTED|Overall Study||7
411653|NCT01638312|1008080|P2|NOT COMPLETED|Overall Study||0
411654|NCT01638312|1008081|P1|NOT COMPLETED|Overall Study||0
411655|NCT01638312|1008080|P2|COMPLETED|Overall Study||30
411656|NCT01638312|1008081|P1|COMPLETED|Overall Study||20
411657|NCT01638312|1008080|P2|STARTED|Overall Study||30
411658|NCT01638312|1008081|P1|STARTED|Overall Study||20
411659|NCT01638000|1008089|P2|NOT COMPLETED|Overall Study||71
411660|NCT01638000|1008090|P1|NOT COMPLETED|Overall Study||60
411661|NCT01638000|1008089|P2|COMPLETED|Overall Study||873
411662|NCT01638000|1008090|P1|COMPLETED|Overall Study||883
411663|NCT01638000|1008089|P2|Received at Least 1 Double-Blind Dose|Overall Study||934
411848|NCT01635504|1008719|P1|COMPLETED|Overall Study||5
411664|NCT01638000|1008090|P1|Received at Least 1 Double-Blind Dose|Overall Study||936
411665|NCT01638000|1008089|P2|STARTED|Overall Study||944
411666|NCT01638000|1008090|P1|STARTED|Overall Study||943
411667|NCT01637961|1008188|P1|NOT COMPLETED|Overall Study||2
411668|NCT01637961|1008188|P1|COMPLETED|Overall Study|Eligible and treated patients.|21
411669|NCT01637961|1008188|P1|STARTED|Overall Study||23
411670|NCT01637935|1008203|P2|NOT COMPLETED|Overall Study||0
411671|NCT01637935|1008204|P1|NOT COMPLETED|Overall Study||0
411672|NCT01637935|1008203|P2|COMPLETED|Overall Study||158918
411673|NCT01637935|1008204|P1|COMPLETED|Overall Study||34181
411674|NCT01637935|1008203|P2|STARTED|Overall Study||158918
411675|NCT01637935|1008204|P1|STARTED|Overall Study||34181
411676|NCT01637922|1008220|P2|NOT COMPLETED|Overall Study||5
411677|NCT01637922|1008221|P1|NOT COMPLETED|Overall Study||2
411678|NCT01637922|1008220|P2|COMPLETED|Overall Study||14
411679|NCT01637922|1008221|P1|COMPLETED|Overall Study||13
411680|NCT01637922|1008220|P2|STARTED|Overall Study||19
411681|NCT01637922|1008221|P1|STARTED|Overall Study||15
411682|NCT01637870|1008244|P1|NOT COMPLETED|Overall Study||0
411683|NCT01637870|1008244|P1|COMPLETED|Overall Study||110
411684|NCT01637870|1008244|P1|STARTED|Overall Study||110
411685|NCT01637584|1008250|P2|NOT COMPLETED|Overall Study||3
411686|NCT01637584|1008251|P1|NOT COMPLETED|Overall Study||1
411687|NCT01637584|1008250|P2|COMPLETED|Overall Study||17
411688|NCT01637584|1008251|P1|COMPLETED|Overall Study||19
411689|NCT01637584|1008250|P2|STARTED|Overall Study||20
411690|NCT01637584|1008251|P1|STARTED|Overall Study||20
411691|NCT01637272|1008258|P1|NOT COMPLETED|Overall Study||20
411692|NCT01637272|1008258|P1|COMPLETED|Overall Study||23
411693|NCT01637272|1008258|P1|Completed Core But Did no Enter Ext..|Overall Study||4
411694|NCT01637272|1008258|P1|Entered Extension Phase|Overall Study||27
411695|NCT01637272|1008258|P1|Completed Core Phase (sc + LAR)|Overall Study||31
411696|NCT01637272|1008258|P1|Completed sc Phase|Overall Study||33
411697|NCT01637272|1008258|P1|STARTED|Overall Study||43
411698|NCT01637246|1008320|P1|NOT COMPLETED|Overall Study||2139
411699|NCT01637246|1008320|P1|COMPLETED|Overall Study||2246
411700|NCT01637246|1008320|P1|STARTED|Overall Study||4385
411701|NCT01637090|1008328|P1|NOT COMPLETED|Overall Study||3
411702|NCT01637090|1008328|P1|COMPLETED|Overall Study||0
411703|NCT01637090|1008328|P1|STARTED|Overall Study||3
411704|NCT01637077|1008338|P2|NOT COMPLETED|Overall Study||1
411705|NCT01637077|1008339|P1|NOT COMPLETED|Overall Study||4
411706|NCT01637077|1008338|P2|COMPLETED|Overall Study||22
411707|NCT01637077|1008339|P1|COMPLETED|Overall Study||19
411708|NCT01637077|1008338|P2|STARTED|Overall Study||23
411709|NCT01637077|1008339|P1|STARTED|Overall Study||23
411710|NCT01636986|1008367|P2|NOT COMPLETED|Overall Study||2
411711|NCT01636986|1008368|P1|NOT COMPLETED|Overall Study||0
411712|NCT01636986|1008367|P2|COMPLETED|Overall Study||30
411713|NCT01636986|1008368|P1|COMPLETED|Overall Study||30
411714|NCT01636986|1008367|P2|STARTED|Overall Study||32
411715|NCT01636986|1008368|P1|STARTED|Overall Study||30
411716|NCT01636960|1008374|P1|NOT COMPLETED|Maintenance Phase||7
411717|NCT01636960|1008374|P1|COMPLETED|Maintenance Phase||0
411718|NCT01636960|1008374|P1|STARTED|Maintenance Phase||7
411719|NCT01636960|1008374|P1|NOT COMPLETED|Induction Phase||2
411720|NCT01636960|1008374|P1|COMPLETED|Induction Phase|Participants continuing into Maintenance Phase|7
411721|NCT01636960|1008374|P1|STARTED|Induction Phase||9
411722|NCT01636947|1008382|P2|NOT COMPLETED|Overall Study||11
411723|NCT01636947|1008383|P1|NOT COMPLETED|Overall Study||12
411724|NCT01636947|1008382|P2|COMPLETED|Overall Study||239
411725|NCT01636947|1008383|P1|COMPLETED|Overall Study||232
411726|NCT01636947|1008382|P2|Treated|Overall Study||248
411727|NCT01636947|1008383|P1|Treated|Overall Study||242
411728|NCT01636947|1008382|P2|STARTED|Overall Study||250
411729|NCT01636947|1008383|P1|STARTED|Overall Study||244
411730|NCT01636882|1008403|P1|NOT COMPLETED|Overall Study||0
411731|NCT01636882|1008403|P1|COMPLETED|Overall Study||16
411732|NCT01636882|1008403|P1|STARTED|Overall Study||16
411733|NCT01636778|1008407|P3|NOT COMPLETED|Follow-up Period After Part 2||4
411734|NCT01636778|1008408|P2|NOT COMPLETED|Follow-up Period After Part 2||0
411735|NCT01636778|1008409|P1|NOT COMPLETED|Follow-up Period After Part 2||0
411736|NCT01636778|1008407|P3|COMPLETED|Follow-up Period After Part 2||37
411737|NCT01636778|1008408|P2|COMPLETED|Follow-up Period After Part 2||0
411738|NCT01636778|1008409|P1|COMPLETED|Follow-up Period After Part 2||0
411739|NCT01636778|1008407|P3|STARTED|Follow-up Period After Part 2||41
411740|NCT01636778|1008408|P2|STARTED|Follow-up Period After Part 2||0
411741|NCT01636778|1008409|P1|STARTED|Follow-up Period After Part 2||0
411742|NCT01636778|1008407|P3|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0
411743|NCT01636778|1008408|P2|NOT COMPLETED|Antiviral Treatment Period (Part 2)||10
411744|NCT01636778|1008409|P1|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0
411745|NCT01636778|1008407|P3|COMPLETED|Antiviral Treatment Period (Part 2)||0
411746|NCT01636778|1008408|P2|COMPLETED|Antiviral Treatment Period (Part 2)||31
411747|NCT01636778|1008409|P1|COMPLETED|Antiviral Treatment Period (Part 2)||0
411748|NCT01636778|1008407|P3|STARTED|Antiviral Treatment Period (Part 2)||0
411749|NCT01636778|1008408|P2|STARTED|Antiviral Treatment Period (Part 2)||41
411750|NCT01636778|1008409|P1|STARTED|Antiviral Treatment Period (Part 2)||0
411751|NCT01636778|1008407|P3|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
411752|NCT01636778|1008408|P2|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
411849|NCT01635504|1008719|P1|STARTED|Overall Study||5
411753|NCT01636778|1008409|P1|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||4
411754|NCT01636778|1008407|P3|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
411755|NCT01636778|1008408|P2|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
411756|NCT01636778|1008409|P1|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||41
411757|NCT01636778|1008407|P3|STARTED|Pre-Antiviral Treatment Period (Part 1)||0
411758|NCT01636778|1008408|P2|STARTED|Pre-Antiviral Treatment Period (Part 1)||0
411759|NCT01636778|1008409|P1|STARTED|Pre-Antiviral Treatment Period (Part 1)||45
411760|NCT01636765|1008472|P1|NOT COMPLETED|Overall Study||0
411761|NCT01636765|1008472|P1|COMPLETED|Overall Study||104
411762|NCT01636765|1008472|P1|STARTED|Overall Study||104
411763|NCT01636713|1008480|P3|NOT COMPLETED|Overall Study||23
411764|NCT01636713|1008481|P2|NOT COMPLETED|Overall Study||28
411765|NCT01636713|1008482|P1|NOT COMPLETED|Overall Study||32
411766|NCT01636713|1008480|P3|COMPLETED|Overall Study||170
411767|NCT01636713|1008481|P2|COMPLETED|Overall Study||166
411768|NCT01636713|1008482|P1|COMPLETED|Overall Study||161
411769|NCT01636713|1008480|P3|STARTED|Overall Study||193
411770|NCT01636713|1008481|P2|STARTED|Overall Study||194
411771|NCT01636713|1008482|P1|STARTED|Overall Study||193
411772|NCT01636661|1008498|P2|NOT COMPLETED|Overall Study||0
411773|NCT01636661|1008499|P1|NOT COMPLETED|Overall Study||0
411774|NCT01636661|1008498|P2|COMPLETED|Overall Study||6
411775|NCT01636661|1008499|P1|COMPLETED|Overall Study||5
411776|NCT01636661|1008498|P2|STARTED|Overall Study||6
411777|NCT01636661|1008499|P1|STARTED|Overall Study||5
411778|NCT01636466|1008509|P2|NOT COMPLETED|Overall Study||0
411779|NCT01636466|1008510|P1|NOT COMPLETED|Overall Study||1
411780|NCT01636466|1008509|P2|COMPLETED|Overall Study||0
411781|NCT01636466|1008510|P1|COMPLETED|Overall Study||0
411782|NCT01636466|1008509|P2|STARTED|Overall Study||0
411783|NCT01636466|1008510|P1|STARTED|Overall Study||1
411784|NCT01636414|1008521|P3|NOT COMPLETED|Overall Study||9
411785|NCT01636414|1008522|P2|NOT COMPLETED|Overall Study||6
411786|NCT01636414|1008523|P1|NOT COMPLETED|Overall Study||3
411787|NCT01636414|1008521|P3|COMPLETED|Overall Study||65
411788|NCT01636414|1008522|P2|COMPLETED|Overall Study||60
411789|NCT01636414|1008523|P1|COMPLETED|Overall Study||61
411790|NCT01636414|1008521|P3|STARTED|Overall Study||74
411791|NCT01636414|1008522|P2|STARTED|Overall Study||66
411792|NCT01636414|1008523|P1|STARTED|Overall Study||64
411793|NCT01636362|1008534|P1|NOT COMPLETED|Overall Study||8
411794|NCT01636362|1008534|P1|COMPLETED|Overall Study||37
411795|NCT01636362|1008534|P1|STARTED|Overall Study||45
411796|NCT01636258|1008542|P2|NOT COMPLETED|Overall Study||0
411797|NCT01636258|1008543|P1|NOT COMPLETED|Overall Study||1
411798|NCT01636258|1008542|P2|COMPLETED|Overall Study||14
411799|NCT01636258|1008543|P1|COMPLETED|Overall Study||12
411800|NCT01636258|1008542|P2|STARTED|Overall Study||14
411801|NCT01636258|1008543|P1|STARTED|Overall Study||13
411802|NCT01636206|1008559|P2|NOT COMPLETED|Overall Study||51
411803|NCT01636206|1008560|P1|NOT COMPLETED|Overall Study||19
411804|NCT01636206|1008559|P2|COMPLETED|Overall Study||170
411805|NCT01636206|1008560|P1|COMPLETED|Overall Study||92
411806|NCT01636206|1008559|P2|STARTED|Overall Study||221
411807|NCT01636206|1008560|P1|STARTED|Overall Study||111
411808|NCT01636102|1008568|P2|NOT COMPLETED|Overall Study||0
411809|NCT01636102|1008569|P1|NOT COMPLETED|Overall Study||0
411810|NCT01636102|1008568|P2|COMPLETED|Overall Study||63
411811|NCT01636102|1008569|P1|COMPLETED|Overall Study||63
411812|NCT01636102|1008568|P2|STARTED|Overall Study||63
411813|NCT01636102|1008569|P1|STARTED|Overall Study||63
411814|NCT01636076|1008583|P2|NOT COMPLETED|Overall Study||25
411815|NCT01636076|1008584|P1|NOT COMPLETED|Overall Study||17
411816|NCT01636076|1008583|P2|COMPLETED|Overall Study||288
411817|NCT01636076|1008584|P1|COMPLETED|Overall Study||299
411818|NCT01636076|1008583|P2|STARTED|Overall Study||313
411819|NCT01636076|1008584|P1|STARTED|Overall Study||316
411820|NCT01636063|1008646|P2|NOT COMPLETED|Overall Study||0
411821|NCT01636063|1008647|P1|NOT COMPLETED|Overall Study||0
411822|NCT01636063|1008646|P2|COMPLETED|Overall Study||21
411823|NCT01636063|1008647|P1|COMPLETED|Overall Study||21
411824|NCT01636063|1008646|P2|STARTED|Overall Study||21
411825|NCT01636063|1008647|P1|STARTED|Overall Study||21
411826|NCT01635933|1008655|P2|NOT COMPLETED|Overall Study||8
411827|NCT01635933|1008656|P1|NOT COMPLETED|Overall Study||2
411828|NCT01635933|1008655|P2|COMPLETED|Overall Study||177
411829|NCT01635933|1008656|P1|COMPLETED|Overall Study||176
411830|NCT01635933|1008655|P2|STARTED|Overall Study||185
411831|NCT01635933|1008656|P1|STARTED|Overall Study||178
411832|NCT01635920|1008668|P2|NOT COMPLETED|Overall Study||1
411833|NCT01635920|1008669|P1|NOT COMPLETED|Overall Study||3
411834|NCT01635920|1008668|P2|COMPLETED|Overall Study||125
411835|NCT01635920|1008669|P1|COMPLETED|Overall Study||122
411836|NCT01635920|1008668|P2|STARTED|Overall Study||126
411837|NCT01635920|1008669|P1|STARTED|Overall Study||125
411838|NCT01635881|1008677|P1|NOT COMPLETED|Overall Study||0
411839|NCT01635881|1008677|P1|COMPLETED|Overall Study||60
411840|NCT01635881|1008677|P1|STARTED|Overall Study||60
411841|NCT01635855|1008682|P1|NOT COMPLETED|Overall Study||4
411842|NCT01635855|1008682|P1|COMPLETED|Overall Study||113
411843|NCT01635855|1008682|P1|STARTED|Overall Study||117
411844|NCT01635764|1008691|P1|NOT COMPLETED|Overall Study||273
411845|NCT01635764|1008691|P1|COMPLETED|Overall Study||235
411846|NCT01635764|1008691|P1|STARTED|Overall Study||508
411847|NCT01635504|1008719|P1|NOT COMPLETED|Overall Study||0
411850|NCT01635439|1008726|P2|NOT COMPLETED|Overall Study||0
411851|NCT01635439|1008727|P1|NOT COMPLETED|Overall Study||0
411852|NCT01635439|1008726|P2|COMPLETED|Overall Study||100
411853|NCT01635439|1008727|P1|COMPLETED|Overall Study||100
411854|NCT01635439|1008726|P2|STARTED|Overall Study||100
411855|NCT01635439|1008727|P1|STARTED|Overall Study||100
411856|NCT01635244|1008744|P3|NOT COMPLETED|Overall Study||2
411857|NCT01635244|1008745|P2|NOT COMPLETED|Overall Study||1
411858|NCT01635244|1008746|P1|NOT COMPLETED|Overall Study||1
411859|NCT01635244|1008744|P3|COMPLETED|Overall Study||18
411860|NCT01635244|1008745|P2|COMPLETED|Overall Study||21
411861|NCT01635244|1008746|P1|COMPLETED|Overall Study||17
411862|NCT01635244|1008744|P3|STARTED|Overall Study||20
411863|NCT01635244|1008745|P2|STARTED|Overall Study||22
411864|NCT01635244|1008746|P1|STARTED|Overall Study||18
411865|NCT01635218|1008757|P3|NOT COMPLETED|Overall Study||6
411866|NCT01635218|1008758|P2|NOT COMPLETED|Overall Study||7
411867|NCT01635218|1008759|P1|NOT COMPLETED|Overall Study||3
411868|NCT01635218|1008757|P3|COMPLETED|Overall Study||37
411869|NCT01635218|1008758|P2|COMPLETED|Overall Study||39
411870|NCT01635218|1008759|P1|COMPLETED|Overall Study||41
411871|NCT01635218|1008757|P3|STARTED|Overall Study||43
411872|NCT01635218|1008758|P2|STARTED|Overall Study||46
411873|NCT01635218|1008759|P1|STARTED|Overall Study||44
411874|NCT01635062|1008781|P2|NOT COMPLETED|Overall Study||0
411875|NCT01635062|1008782|P1|NOT COMPLETED|Overall Study||0
411876|NCT01635062|1008781|P2|COMPLETED|Overall Study||9
411877|NCT01635062|1008782|P1|COMPLETED|Overall Study||9
411878|NCT01635062|1008781|P2|Post-Randomization Sodium Loaded|Overall Study||9
411879|NCT01635062|1008782|P1|Post-Randomization Sodium Loaded|Overall Study||9
411880|NCT01635062|1008781|P2|Post-randomization Sodium Restriction|Overall Study||9
411881|NCT01635062|1008782|P1|Post-randomization Sodium Restriction|Overall Study||9
411882|NCT01635062|1008781|P2|Sodium Loading Baseline Visit|Overall Study||9
411883|NCT01635062|1008782|P1|Sodium Loading Baseline Visit|Overall Study||9
411884|NCT01635062|1008781|P2|Sodium Restriction Baseline Visit|Overall Study||9
411885|NCT01635062|1008782|P1|Sodium Restriction Baseline Visit|Overall Study||9
411886|NCT01635062|1008781|P2|STARTED|Overall Study||9
411887|NCT01635062|1008782|P1|STARTED|Overall Study||9
411888|NCT01634854|1008794|P2|NOT COMPLETED|Overall Study||7
411889|NCT01634854|1008795|P1|NOT COMPLETED|Overall Study||2
411890|NCT01634854|1008794|P2|COMPLETED|Overall Study||59
411891|NCT01634854|1008795|P1|COMPLETED|Overall Study||62
411892|NCT01634854|1008794|P2|STARTED|Overall Study||66
411893|NCT01634854|1008795|P1|STARTED|Overall Study||64
411894|NCT01634659|1008815|P2|NOT COMPLETED|Period 2 - Second 8 Days of Wear||0
411895|NCT01634659|1008816|P1|NOT COMPLETED|Period 2 - Second 8 Days of Wear||3
411896|NCT01634659|1008815|P2|COMPLETED|Period 2 - Second 8 Days of Wear||158
411897|NCT01634659|1008816|P1|COMPLETED|Period 2 - Second 8 Days of Wear||152
411898|NCT01634659|1008815|P2|STARTED|Period 2 - Second 8 Days of Wear||158
411899|NCT01634659|1008816|P1|STARTED|Period 2 - Second 8 Days of Wear||155
411900|NCT01634659|1008815|P2|NOT COMPLETED|Period 1 - First 8 Days of Wear||0
411901|NCT01634659|1008816|P1|NOT COMPLETED|Period 1 - First 8 Days of Wear||0
411902|NCT01634659|1008815|P2|COMPLETED|Period 1 - First 8 Days of Wear||158
411903|NCT01634659|1008816|P1|COMPLETED|Period 1 - First 8 Days of Wear||155
411904|NCT01634659|1008815|P2|STARTED|Period 1 - First 8 Days of Wear||158
411905|NCT01634659|1008816|P1|STARTED|Period 1 - First 8 Days of Wear||155
411906|NCT01634620|1008826|P1|NOT COMPLETED|Overall Study||0
411907|NCT01634620|1008826|P1|COMPLETED|Overall Study||200
411908|NCT01634620|1008826|P1|STARTED|Overall Study||200
411909|NCT01634555|1008846|P1|NOT COMPLETED|Overall Study||17
411910|NCT01634555|1008846|P1|COMPLETED|Overall Study|Completed the required treatment and assessment.|12
411911|NCT01634555|1008846|P1|Drug-Drug Interaction (DDI) Population|Overall Study|Completed the required treatment in Cycle 1, Day 1 and Cycle 2, Day 1.|25
411912|NCT01634555|1008846|P1|Received at Least 1 Dose of Study Drug|Overall Study||29
411913|NCT01634555|1008846|P1|STARTED|Overall Study||29
411914|NCT01634360|1008856|P2|NOT COMPLETED|Overall Study||136
411915|NCT01634360|1008857|P1|NOT COMPLETED|Overall Study||49
411916|NCT01634360|1008856|P2|COMPLETED|Overall Study||0
411917|NCT01634360|1008857|P1|COMPLETED|Overall Study||0
411918|NCT01634360|1008856|P2|STARTED|Overall Study||136
411919|NCT01634360|1008857|P1|STARTED|Overall Study||49
411920|NCT01634256|1008869|P2|NOT COMPLETED|Overall Study||8
411921|NCT01634256|1008870|P1|NOT COMPLETED|Overall Study||4
411922|NCT01634256|1008869|P2|COMPLETED|Overall Study||22
411923|NCT01634256|1008870|P1|COMPLETED|Overall Study||26
411924|NCT01634256|1008869|P2|STARTED|Overall Study||30
411925|NCT01634256|1008870|P1|STARTED|Overall Study||30
411926|NCT01634243|1008886|P2|NOT COMPLETED|Overall Study||5
411927|NCT01634243|1008887|P1|NOT COMPLETED|Overall Study||6
411928|NCT01634243|1008886|P2|COMPLETED|Overall Study||38
411929|NCT01634243|1008887|P1|COMPLETED|Overall Study||15
411930|NCT01634243|1008886|P2|STARTED|Overall Study||43
411931|NCT01634243|1008887|P1|STARTED|Overall Study||21
411932|NCT01634165|1008913|P4|NOT COMPLETED|Period 4||0
411933|NCT01634165|1008914|P3|NOT COMPLETED|Period 4||0
411934|NCT01634165|1008915|P2|NOT COMPLETED|Period 4||0
411935|NCT01634165|1008916|P1|NOT COMPLETED|Period 4||0
411936|NCT01634165|1008913|P4|COMPLETED|Period 4||6
411937|NCT01634165|1008914|P3|COMPLETED|Period 4||6
411938|NCT01634165|1008915|P2|COMPLETED|Period 4||5
411939|NCT01634165|1008916|P1|COMPLETED|Period 4||6
411940|NCT01634165|1008913|P4|STARTED|Period 4||6
411941|NCT01634165|1008914|P3|STARTED|Period 4||6
411942|NCT01634165|1008915|P2|STARTED|Period 4||5
411943|NCT01634165|1008916|P1|STARTED|Period 4||6
411944|NCT01634165|1008913|P4|NOT COMPLETED|Period 3||0
411945|NCT01634165|1008914|P3|NOT COMPLETED|Period 3||0
411946|NCT01634165|1008915|P2|NOT COMPLETED|Period 3||0
411947|NCT01634165|1008916|P1|NOT COMPLETED|Period 3||0
411948|NCT01634165|1008913|P4|COMPLETED|Period 3||6
411949|NCT01634165|1008914|P3|COMPLETED|Period 3||6
411950|NCT01634165|1008915|P2|COMPLETED|Period 3||5
411951|NCT01634165|1008916|P1|COMPLETED|Period 3||6
411952|NCT01634165|1008913|P4|STARTED|Period 3||6
411953|NCT01634165|1008914|P3|STARTED|Period 3||6
411954|NCT01634165|1008915|P2|STARTED|Period 3||5
411955|NCT01634165|1008916|P1|STARTED|Period 3||6
411956|NCT01634165|1008913|P4|NOT COMPLETED|Period 2||0
411957|NCT01634165|1008914|P3|NOT COMPLETED|Period 2||0
411958|NCT01634165|1008915|P2|NOT COMPLETED|Period 2||1
411959|NCT01634165|1008916|P1|NOT COMPLETED|Period 2||0
411960|NCT01634165|1008913|P4|COMPLETED|Period 2||6
411961|NCT01634165|1008914|P3|COMPLETED|Period 2||6
411962|NCT01634165|1008915|P2|COMPLETED|Period 2||5
411963|NCT01634165|1008916|P1|COMPLETED|Period 2||6
411964|NCT01634165|1008913|P4|STARTED|Period 2||6
411965|NCT01634165|1008914|P3|STARTED|Period 2||6
411966|NCT01634165|1008915|P2|STARTED|Period 2||6
411967|NCT01634165|1008916|P1|STARTED|Period 2||6
411968|NCT01634165|1008913|P4|NOT COMPLETED|Period 1||0
411969|NCT01634165|1008914|P3|NOT COMPLETED|Period 1||0
411970|NCT01634165|1008915|P2|NOT COMPLETED|Period 1||0
411971|NCT01634165|1008916|P1|NOT COMPLETED|Period 1||0
411972|NCT01634165|1008913|P4|COMPLETED|Period 1||6
411973|NCT01634165|1008914|P3|COMPLETED|Period 1||6
411974|NCT01634165|1008915|P2|COMPLETED|Period 1||6
411975|NCT01634165|1008916|P1|COMPLETED|Period 1||6
411976|NCT01634165|1008913|P4|Received at Least 1 Dose of Study Drug|Period 1||6
411977|NCT01634165|1008914|P3|Received at Least 1 Dose of Study Drug|Period 1||6
411978|NCT01634165|1008915|P2|Received at Least 1 Dose of Study Drug|Period 1||6
411979|NCT01634165|1008916|P1|Received at Least 1 Dose of Study Drug|Period 1||6
411980|NCT01634165|1008913|P4|STARTED|Period 1||6
411981|NCT01634165|1008914|P3|STARTED|Period 1||6
411982|NCT01634165|1008915|P2|STARTED|Period 1||6
411983|NCT01634165|1008916|P1|STARTED|Period 1||6
411984|NCT01634152|1008949|P3|NOT COMPLETED|Overall Study||4
411985|NCT01634152|1008950|P2|NOT COMPLETED|Overall Study||1
411986|NCT01634152|1008951|P1|NOT COMPLETED|Overall Study||4
411987|NCT01634152|1008949|P3|COMPLETED|Overall Study||126
411988|NCT01634152|1008950|P2|COMPLETED|Overall Study||136
411989|NCT01634152|1008951|P1|COMPLETED|Overall Study||130
411990|NCT01634152|1008949|P3|STARTED|Overall Study||130
411991|NCT01634152|1008950|P2|STARTED|Overall Study||137
411992|NCT01634152|1008951|P1|STARTED|Overall Study||134
411993|NCT01634139|1009034|P3|NOT COMPLETED|Overall Study||5
411994|NCT01634139|1009035|P2|NOT COMPLETED|Overall Study||6
411995|NCT01634139|1009036|P1|NOT COMPLETED|Overall Study||10
411996|NCT01634139|1009034|P3|COMPLETED|Overall Study||130
411997|NCT01634139|1009035|P2|COMPLETED|Overall Study||130
411998|NCT01634139|1009036|P1|COMPLETED|Overall Study||122
411999|NCT01634139|1009034|P3|STARTED|Overall Study||135
412000|NCT01634139|1009035|P2|STARTED|Overall Study||136
412001|NCT01634139|1009036|P1|STARTED|Overall Study||132
412002|NCT01634113|1009137|P3|NOT COMPLETED|Overall Study||1
412003|NCT01634113|1009138|P2|NOT COMPLETED|Overall Study||0
412004|NCT01634113|1009139|P1|NOT COMPLETED|Overall Study||0
412005|NCT01634113|1009137|P3|COMPLETED|Overall Study||31
412006|NCT01634113|1009138|P2|COMPLETED|Overall Study||36
412007|NCT01634113|1009139|P1|COMPLETED|Overall Study||34
412008|NCT01634113|1009137|P3|STARTED|Overall Study||32
412009|NCT01634113|1009138|P2|STARTED|Overall Study||36
412010|NCT01634113|1009139|P1|STARTED|Overall Study||34
412011|NCT01634100|1009183|P6|NOT COMPLETED|Overall Study||0
412012|NCT01634100|1009184|P5|NOT COMPLETED|Overall Study||0
412013|NCT01634100|1009185|P4|NOT COMPLETED|Overall Study||0
412014|NCT01634100|1009186|P3|NOT COMPLETED|Overall Study||1
412015|NCT01634100|1009187|P2|NOT COMPLETED|Overall Study||0
412016|NCT01634100|1009188|P1|NOT COMPLETED|Overall Study||1
412017|NCT01634100|1009183|P6|COMPLETED|Overall Study||3
412018|NCT01634100|1009184|P5|COMPLETED|Overall Study||3
412019|NCT01634100|1009185|P4|COMPLETED|Overall Study||3
412020|NCT01634100|1009186|P3|COMPLETED|Overall Study||2
412021|NCT01634100|1009187|P2|COMPLETED|Overall Study||3
412022|NCT01634100|1009188|P1|COMPLETED|Overall Study||2
412023|NCT01634100|1009183|P6|Received Empa + Probenecid|Overall Study||3
412024|NCT01634100|1009184|P5|Received Empa + Probenecid|Overall Study||3
412025|NCT01634100|1009185|P4|Received Empa + Probenecid|Overall Study||3
412026|NCT01634100|1009186|P3|Received Empa + Probenecid|Overall Study||2
412027|NCT01634100|1009187|P2|Received Empa + Probenecid|Overall Study||3
412028|NCT01634100|1009188|P1|Received Empa + Probenecid|Overall Study||2
412029|NCT01634100|1009183|P6|Received Empa + Rifampicin|Overall Study||3
412030|NCT01634100|1009184|P5|Received Empa + Rifampicin|Overall Study||3
412031|NCT01634100|1009185|P4|Received Empa + Rifampicin|Overall Study||3
412032|NCT01634100|1009186|P3|Received Empa + Rifampicin|Overall Study||3
412033|NCT01634100|1009187|P2|Received Empa + Rifampicin|Overall Study||3
412034|NCT01634100|1009188|P1|Received Empa + Rifampicin|Overall Study||3
412035|NCT01634100|1009183|P6|Received Empa Alone|Overall Study||3
412036|NCT01634100|1009184|P5|Received Empa Alone|Overall Study||3
412037|NCT01634100|1009185|P4|Received Empa Alone|Overall Study||3
412038|NCT01634100|1009186|P3|Received Empa Alone|Overall Study||3
412039|NCT01634100|1009187|P2|Received Empa Alone|Overall Study||3
412040|NCT01634100|1009188|P1|Received Empa Alone|Overall Study||3
412041|NCT01634100|1009183|P6|STARTED|Overall Study||3
412042|NCT01634100|1009184|P5|STARTED|Overall Study||3
412043|NCT01634100|1009185|P4|STARTED|Overall Study||3
412044|NCT01634100|1009186|P3|STARTED|Overall Study||3
412045|NCT01634100|1009187|P2|STARTED|Overall Study||3
412046|NCT01634100|1009188|P1|STARTED|Overall Study||3
412047|NCT01633944|1009204|P3|NOT COMPLETED|Double-blind Treatment Phase||58
412048|NCT01633944|1009205|P2|NOT COMPLETED|Double-blind Treatment Phase||54
412049|NCT01633944|1009206|P1|NOT COMPLETED|Double-blind Treatment Phase||0
412050|NCT01633944|1009204|P3|COMPLETED|Double-blind Treatment Phase||174
412051|NCT01633944|1009205|P2|COMPLETED|Double-blind Treatment Phase||176
412052|NCT01633944|1009206|P1|COMPLETED|Double-blind Treatment Phase||0
412053|NCT01633944|1009204|P3|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|232
412054|NCT01633944|1009205|P2|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|230
412055|NCT01633944|1009206|P1|STARTED|Double-blind Treatment Phase|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
412056|NCT01633944|1009204|P3|NOT COMPLETED|Open-label Titration Phase||0
412057|NCT01633944|1009205|P2|NOT COMPLETED|Open-label Titration Phase||0
412058|NCT01633944|1009206|P1|NOT COMPLETED|Open-label Titration Phase||290
412059|NCT01633944|1009204|P3|COMPLETED|Open-label Titration Phase||0
412060|NCT01633944|1009205|P2|COMPLETED|Open-label Titration Phase||0
412061|NCT01633944|1009206|P1|COMPLETED|Open-label Titration Phase||462
412062|NCT01633944|1009204|P3|STARTED|Open-label Titration Phase||0
412063|NCT01633944|1009205|P2|STARTED|Open-label Titration Phase||0
412064|NCT01633944|1009206|P1|STARTED|Open-label Titration Phase||752
412065|NCT01633892|1009226|P1|NOT COMPLETED|Overall Study||0
412066|NCT01633892|1009226|P1|COMPLETED|Overall Study||5
412067|NCT01633892|1009226|P1|STARTED|Overall Study||5
412068|NCT01633853|1009236|P2|NOT COMPLETED|Overall Study||0
412069|NCT01633853|1009237|P1|NOT COMPLETED|Overall Study||0
412070|NCT01633853|1009236|P2|COMPLETED|Overall Study||100
412071|NCT01633853|1009237|P1|COMPLETED|Overall Study||104
412072|NCT01633853|1009236|P2|STARTED|Overall Study||100
412073|NCT01633853|1009237|P1|STARTED|Overall Study||104
412074|NCT01633827|1009251|P2|NOT COMPLETED|Second Intervention||0
412075|NCT01633827|1009252|P1|NOT COMPLETED|Second Intervention||0
412076|NCT01633827|1009251|P2|COMPLETED|Second Intervention||11
412077|NCT01633827|1009252|P1|COMPLETED|Second Intervention||11
412078|NCT01633827|1009251|P2|STARTED|Second Intervention||11
412079|NCT01633827|1009252|P1|STARTED|Second Intervention||11
412080|NCT01633827|1009251|P2|NOT COMPLETED|Washout Period||0
412081|NCT01633827|1009252|P1|NOT COMPLETED|Washout Period||0
412082|NCT01633827|1009251|P2|COMPLETED|Washout Period||11
412083|NCT01633827|1009252|P1|COMPLETED|Washout Period||11
412084|NCT01633827|1009251|P2|STARTED|Washout Period||11
412085|NCT01633827|1009252|P1|STARTED|Washout Period||11
412086|NCT01633827|1009251|P2|NOT COMPLETED|First Intervention||0
412087|NCT01633827|1009252|P1|NOT COMPLETED|First Intervention||0
412088|NCT01633827|1009251|P2|COMPLETED|First Intervention||11
412089|NCT01633827|1009252|P1|COMPLETED|First Intervention||11
412090|NCT01633827|1009251|P2|STARTED|First Intervention||11
412091|NCT01633827|1009252|P1|STARTED|First Intervention||11
412092|NCT01633814|1009265|P1|NOT COMPLETED|Overall Study||0
412093|NCT01633814|1009265|P1|COMPLETED|Overall Study||4
412094|NCT01633814|1009265|P1|STARTED|Overall Study||4
412095|NCT01633788|1009274|P4|NOT COMPLETED|Overall Study||13
412096|NCT01633788|1009275|P3|NOT COMPLETED|Overall Study||10
412097|NCT01633788|1009276|P2|NOT COMPLETED|Overall Study||8
412098|NCT01633788|1009277|P1|NOT COMPLETED|Overall Study||7
412099|NCT01633788|1009274|P4|COMPLETED|Overall Study||45
412100|NCT01633788|1009275|P3|COMPLETED|Overall Study||49
412101|NCT01633788|1009276|P2|COMPLETED|Overall Study||50
412102|NCT01633788|1009277|P1|COMPLETED|Overall Study||50
412103|NCT01633788|1009274|P4|STARTED|Overall Study||58
412104|NCT01633788|1009275|P3|STARTED|Overall Study||59
412105|NCT01633788|1009276|P2|STARTED|Overall Study||58
412106|NCT01633788|1009277|P1|STARTED|Overall Study||57
412107|NCT01633320|1009297|P2|NOT COMPLETED|Overall Study||0
412108|NCT01633320|1009298|P1|NOT COMPLETED|Overall Study||0
412109|NCT01633320|1009297|P2|COMPLETED|Overall Study||68
412110|NCT01633320|1009298|P1|COMPLETED|Overall Study||132
412111|NCT01633320|1009297|P2|STARTED|Overall Study||68
412112|NCT01633320|1009298|P1|STARTED|Overall Study||132
412113|NCT01632995|1009306|P1|NOT COMPLETED|Main Study Follow-up Period||120
412114|NCT01632995|1009306|P1|COMPLETED|Main Study Follow-up Period||437
412115|NCT01632995|1009306|P1|STARTED|Main Study Follow-up Period||557
412116|NCT01632995|1009306|P1|NOT COMPLETED|Pre-screening to Enrollment Period||512
412117|NCT01632995|1009306|P1|COMPLETED|Pre-screening to Enrollment Period||557
412118|NCT01632995|1009306|P1|STARTED|Pre-screening to Enrollment Period||1069
412119|NCT01632904|1009321|P2|NOT COMPLETED|Overall Study||6
412120|NCT01632904|1009322|P1|NOT COMPLETED|Overall Study||7
412121|NCT01632904|1009321|P2|COMPLETED|Overall Study|Patients still in the study as of 27MAR2014, including those who crossed over to ruxolitinib|50
412210|NCT01632345|1009420|P4|Treated|Treatment: Part I||41
412122|NCT01632904|1009322|P1|COMPLETED|Overall Study|Patients still in the study as of data cutoff, 27MAR2014.|47
412123|NCT01632904|1009321|P2|STARTED|Overall Study||56
412124|NCT01632904|1009322|P1|STARTED|Overall Study||54
412125|NCT01632878|1009333|P1|NOT COMPLETED|Treatment||158
412126|NCT01632878|1009333|P1|COMPLETED|Treatment||1105
412127|NCT01632878|1009333|P1|STARTED|Treatment||1263
412128|NCT01632878|1009333|P1|NOT COMPLETED|Screening||268
412129|NCT01632878|1009333|P1|COMPLETED|Screening||1263
412130|NCT01632878|1009333|P1|STARTED|Screening||1531
412131|NCT01632800|1009337|P1|NOT COMPLETED|Overall Study||1
412132|NCT01632800|1009337|P1|COMPLETED|Overall Study||25
412133|NCT01632800|1009337|P1|STARTED|Overall Study||26
412134|NCT01632735|1009343|P2|NOT COMPLETED|Overall Study||3
412135|NCT01632735|1009344|P1|NOT COMPLETED|Overall Study||4
412136|NCT01632735|1009343|P2|COMPLETED|Overall Study||37
412137|NCT01632735|1009344|P1|COMPLETED|Overall Study||36
412138|NCT01632735|1009343|P2|STARTED|Overall Study||40
412139|NCT01632735|1009344|P1|STARTED|Overall Study||40
412140|NCT01632709|1009360|P4|NOT COMPLETED|Overall Study||1
412141|NCT01632709|1009361|P3|NOT COMPLETED|Overall Study||0
412142|NCT01632709|1009362|P2|NOT COMPLETED|Overall Study||1
412143|NCT01632709|1009363|P1|NOT COMPLETED|Overall Study||2
412144|NCT01632709|1009360|P4|COMPLETED|Overall Study||3
412145|NCT01632709|1009361|P3|COMPLETED|Overall Study||5
412146|NCT01632709|1009362|P2|COMPLETED|Overall Study||2
412147|NCT01632709|1009363|P1|COMPLETED|Overall Study||2
412148|NCT01632709|1009360|P4|Completed Visit 2 (Received Injection)|Overall Study||3
412149|NCT01632709|1009361|P3|Completed Visit 2 (Received Injection)|Overall Study||5
412150|NCT01632709|1009362|P2|Completed Visit 2 (Received Injection)|Overall Study||2
412151|NCT01632709|1009363|P1|Completed Visit 2 (Received Injection)|Overall Study||4
412152|NCT01632709|1009360|P4|STARTED|Overall Study||4
412153|NCT01632709|1009361|P3|STARTED|Overall Study||5
412154|NCT01632709|1009362|P2|STARTED|Overall Study||3
412155|NCT01632709|1009363|P1|STARTED|Overall Study||4
412156|NCT01632683|1009389|P2|NOT COMPLETED|Overall Study||0
412157|NCT01632683|1009390|P1|NOT COMPLETED|Overall Study||0
412158|NCT01632683|1009389|P2|COMPLETED|Overall Study||552
412159|NCT01632683|1009390|P1|COMPLETED|Overall Study||548
412160|NCT01632683|1009389|P2|STARTED|Overall Study||552
412161|NCT01632683|1009390|P1|STARTED|Overall Study||548
412162|NCT01632423|1009404|P1|NOT COMPLETED|Overall Study||246
412163|NCT01632423|1009404|P1|COMPLETED|Overall Study||10091
412164|NCT01632423|1009404|P1|STARTED|Overall Study||10337
412165|NCT01632345|1009417|P7|NOT COMPLETED|Treatment: Part II||11
412166|NCT01632345|1009418|P6|NOT COMPLETED|Treatment: Part II||11
412167|NCT01632345|1009419|P5|NOT COMPLETED|Treatment: Part II||0
412168|NCT01632345|1009420|P4|NOT COMPLETED|Treatment: Part II||0
412169|NCT01632345|1009421|P3|NOT COMPLETED|Treatment: Part II||0
412170|NCT01632345|1009422|P2|NOT COMPLETED|Treatment: Part II||0
412171|NCT01632345|1009423|P1|NOT COMPLETED|Treatment: Part II||0
412172|NCT01632345|1009417|P7|COMPLETED|Treatment: Part II||55
412173|NCT01632345|1009418|P6|COMPLETED|Treatment: Part II||55
412174|NCT01632345|1009419|P5|COMPLETED|Treatment: Part II||0
412175|NCT01632345|1009420|P4|COMPLETED|Treatment: Part II||0
412176|NCT01632345|1009421|P3|COMPLETED|Treatment: Part II||0
412177|NCT01632345|1009422|P2|COMPLETED|Treatment: Part II||0
412178|NCT01632345|1009423|P1|COMPLETED|Treatment: Part II||0
412179|NCT01632345|1009417|P7|Treated|Treatment: Part II||66
412180|NCT01632345|1009418|P6|Treated|Treatment: Part II||66
412181|NCT01632345|1009419|P5|Treated|Treatment: Part II||0
412182|NCT01632345|1009420|P4|Treated|Treatment: Part II||0
412183|NCT01632345|1009421|P3|Treated|Treatment: Part II||0
412184|NCT01632345|1009422|P2|Treated|Treatment: Part II||0
412185|NCT01632345|1009423|P1|Treated|Treatment: Part II||0
412186|NCT01632345|1009417|P7|STARTED|Treatment: Part II|66 new participants enrolled at efavirenz treatment in Part II.|66
412187|NCT01632345|1009418|P6|STARTED|Treatment: Part II|66 new participants enrolled at 100 mg dose in Part II.|66
412188|NCT01632345|1009419|P5|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
412189|NCT01632345|1009420|P4|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
412190|NCT01632345|1009421|P3|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
412191|NCT01632345|1009422|P2|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
412192|NCT01632345|1009423|P1|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
412193|NCT01632345|1009417|P7|NOT COMPLETED|Treatment: Part I||0
412194|NCT01632345|1009418|P6|NOT COMPLETED|Treatment: Part I||0
412195|NCT01632345|1009419|P5|NOT COMPLETED|Treatment: Part I||13
412196|NCT01632345|1009420|P4|NOT COMPLETED|Treatment: Part I||8
412197|NCT01632345|1009421|P3|NOT COMPLETED|Treatment: Part I||10
412198|NCT01632345|1009422|P2|NOT COMPLETED|Treatment: Part I||15
412199|NCT01632345|1009423|P1|NOT COMPLETED|Treatment: Part I||12
412200|NCT01632345|1009417|P7|COMPLETED|Treatment: Part I||0
412201|NCT01632345|1009418|P6|COMPLETED|Treatment: Part I||0
412202|NCT01632345|1009419|P5|COMPLETED|Treatment: Part I||30
412203|NCT01632345|1009420|P4|COMPLETED|Treatment: Part I||33
412204|NCT01632345|1009421|P3|COMPLETED|Treatment: Part I||32
412205|NCT01632345|1009422|P2|COMPLETED|Treatment: Part I||28
412206|NCT01632345|1009423|P1|COMPLETED|Treatment: Part I||29
412207|NCT01632345|1009417|P7|Treated|Treatment: Part I||0
412208|NCT01632345|1009418|P6|Treated|Treatment: Part I||0
412209|NCT01632345|1009419|P5|Treated|Treatment: Part I||43
412211|NCT01632345|1009421|P3|Treated|Treatment: Part I||42
412212|NCT01632345|1009422|P2|Treated|Treatment: Part I||43
412213|NCT01632345|1009423|P1|Treated|Treatment: Part I||40
412214|NCT01632345|1009417|P7|STARTED|Treatment: Part I|Participants in Part II did not participate in Part I.|0
412215|NCT01632345|1009418|P6|STARTED|Treatment: Part I|Participants in Part II did not participate in Part I.|0
412216|NCT01632345|1009419|P5|STARTED|Treatment: Part I||43
412217|NCT01632345|1009420|P4|STARTED|Treatment: Part I||41
412218|NCT01632345|1009421|P3|STARTED|Treatment: Part I||42
412219|NCT01632345|1009422|P2|STARTED|Treatment: Part I||43
412220|NCT01632345|1009423|P1|STARTED|Treatment: Part I||41
412221|NCT01632345|1009417|P7|NOT COMPLETED|Randomized Participants||0
412222|NCT01632345|1009418|P6|NOT COMPLETED|Randomized Participants||0
412223|NCT01632345|1009419|P5|NOT COMPLETED|Randomized Participants||0
412224|NCT01632345|1009420|P4|NOT COMPLETED|Randomized Participants||0
412225|NCT01632345|1009421|P3|NOT COMPLETED|Randomized Participants||0
412226|NCT01632345|1009422|P2|NOT COMPLETED|Randomized Participants||0
412227|NCT01632345|1009423|P1|NOT COMPLETED|Randomized Participants||0
412228|NCT01632345|1009417|P7|COMPLETED|Randomized Participants||66
412229|NCT01632345|1009418|P6|COMPLETED|Randomized Participants||66
412230|NCT01632345|1009419|P5|COMPLETED|Randomized Participants||43
412231|NCT01632345|1009420|P4|COMPLETED|Randomized Participants||41
412232|NCT01632345|1009421|P3|COMPLETED|Randomized Participants||42
412233|NCT01632345|1009422|P2|COMPLETED|Randomized Participants||43
412234|NCT01632345|1009423|P1|COMPLETED|Randomized Participants||41
412235|NCT01632345|1009417|P7|STARTED|Randomized Participants||66
412236|NCT01632345|1009418|P6|STARTED|Randomized Participants||66
412237|NCT01632345|1009419|P5|STARTED|Randomized Participants||43
412238|NCT01632345|1009420|P4|STARTED|Randomized Participants||41
412239|NCT01632345|1009421|P3|STARTED|Randomized Participants||42
412240|NCT01632345|1009422|P2|STARTED|Randomized Participants||43
412241|NCT01632345|1009423|P1|STARTED|Randomized Participants||41
412242|NCT01632280|1009485|P2|NOT COMPLETED|Overall Study||0
412243|NCT01632280|1009486|P1|NOT COMPLETED|Overall Study||1
412244|NCT01632280|1009485|P2|COMPLETED|Overall Study||6
412245|NCT01632280|1009486|P1|COMPLETED|Overall Study||5
412246|NCT01632280|1009485|P2|STARTED|Overall Study||6
412247|NCT01632280|1009486|P1|STARTED|Overall Study||6
412248|NCT01632267|1009496|P1|NOT COMPLETED|Overall Study||7
412249|NCT01632267|1009496|P1|COMPLETED|Overall Study||97
412250|NCT01632267|1009496|P1|STARTED|Overall Study||104
412251|NCT01632215|1009502|P2|NOT COMPLETED|Overall Study||1
412252|NCT01632215|1009503|P1|NOT COMPLETED|Overall Study||2
412253|NCT01632215|1009502|P2|COMPLETED|Overall Study||19
412254|NCT01632215|1009503|P1|COMPLETED|Overall Study||18
412255|NCT01632215|1009502|P2|STARTED|Overall Study||20
412256|NCT01632215|1009503|P1|STARTED|Overall Study||20
412257|NCT01632150|1009509|P1|NOT COMPLETED|Overall Study||40
412258|NCT01632150|1009509|P1|COMPLETED|Overall Study|Completed=still receiving treatment|0
412259|NCT01632150|1009509|P1|Received Cyclophosphamide|Overall Study||11
412260|NCT01632150|1009509|P1|STARTED|Overall Study||40
412261|NCT01632020|1009518|P2|NOT COMPLETED|Overall Study||0
412262|NCT01632020|1009519|P1|NOT COMPLETED|Overall Study||2
412263|NCT01632020|1009518|P2|COMPLETED|Overall Study||3
412264|NCT01632020|1009519|P1|COMPLETED|Overall Study||2
412265|NCT01632020|1009518|P2|STARTED|Overall Study||3
412266|NCT01632020|1009519|P1|STARTED|Overall Study||4
412267|NCT01631929|1009529|P2|NOT COMPLETED|Overall Study||0
412268|NCT01631929|1009530|P1|NOT COMPLETED|Overall Study||0
412269|NCT01631929|1009529|P2|COMPLETED|Overall Study||6
412270|NCT01631929|1009530|P1|COMPLETED|Overall Study||6
412271|NCT01631929|1009529|P2|STARTED|Overall Study||6
412272|NCT01631929|1009530|P1|STARTED|Overall Study||6
412273|NCT01631864|1009538|P2|NOT COMPLETED|Overall Study||4
412274|NCT01631864|1009539|P1|NOT COMPLETED|Overall Study||2
412275|NCT01631864|1009538|P2|COMPLETED|Overall Study||44
412276|NCT01631864|1009539|P1|COMPLETED|Overall Study||48
412277|NCT01631864|1009538|P2|STARTED|Overall Study||48
412278|NCT01631864|1009539|P1|STARTED|Overall Study||50
412279|NCT01631825|1009551|P1|NOT COMPLETED|Overall Study||65
412280|NCT01631825|1009551|P1|COMPLETED|Overall Study||256
412281|NCT01631825|1009551|P1|STARTED|Overall Study||321
412282|NCT01631812|1009571|P1|NOT COMPLETED|Overall Study||37
412283|NCT01631812|1009571|P1|COMPLETED|Overall Study||93
412284|NCT01631812|1009571|P1|STARTED|Overall Study||130
412285|NCT01631682|1009583|P4|NOT COMPLETED|Overall Study||2
412286|NCT01631682|1009584|P3|NOT COMPLETED|Overall Study||31
412287|NCT01631682|1009585|P2|NOT COMPLETED|Overall Study||45
412288|NCT01631682|1009586|P1|NOT COMPLETED|Overall Study||31
412289|NCT01631682|1009583|P4|COMPLETED|Overall Study||5
412290|NCT01631682|1009584|P3|COMPLETED|Overall Study||13
412291|NCT01631682|1009585|P2|COMPLETED|Overall Study||21
412292|NCT01631682|1009586|P1|COMPLETED|Overall Study||24
412293|NCT01631682|1009583|P4|STARTED|Overall Study||7
412294|NCT01631682|1009584|P3|STARTED|Overall Study||44
412295|NCT01631682|1009585|P2|STARTED|Overall Study||66
412296|NCT01631682|1009586|P1|STARTED|Overall Study||55
412297|NCT01631656|1009598|P2|NOT COMPLETED|Overall Study||0
412298|NCT01631656|1009599|P1|NOT COMPLETED|Overall Study||0
412299|NCT01631656|1009598|P2|COMPLETED|Overall Study||5
412300|NCT01631656|1009599|P1|COMPLETED|Overall Study||5
412301|NCT01631656|1009598|P2|STARTED|Overall Study||5
412302|NCT01631656|1009599|P1|STARTED|Overall Study||5
412303|NCT01631630|1009607|P2|NOT COMPLETED|Overall Study||0
412304|NCT01631630|1009608|P1|NOT COMPLETED|Overall Study||3
412305|NCT01631630|1009607|P2|COMPLETED|Overall Study||8
412306|NCT01631630|1009608|P1|COMPLETED|Overall Study||5
412307|NCT01631630|1009607|P2|STARTED|Overall Study||8
412308|NCT01631630|1009608|P1|STARTED|Overall Study||8
412309|NCT01631435|1009718|P1|NOT COMPLETED|Overall Study||9
412310|NCT01631435|1009718|P1|COMPLETED|Overall Study||66
412311|NCT01631435|1009718|P1|STARTED|Overall Study||75
412312|NCT01631331|1009723|P1|NOT COMPLETED|Overall Study||4
412313|NCT01631331|1009723|P1|COMPLETED|Overall Study||11
412314|NCT01631331|1009723|P1|STARTED|Overall Study||15
412315|NCT01631227|1009732|P2|NOT COMPLETED|Overall Study||22
412316|NCT01631227|1009733|P1|NOT COMPLETED|Overall Study||30
412317|NCT01631227|1009732|P2|COMPLETED|Overall Study||310
412318|NCT01631227|1009733|P1|COMPLETED|Overall Study||303
412319|NCT01631227|1009732|P2|Full Analysis Set Population|Overall Study|1 patient not eligible for the Full Analysis Set due to missing post-baseline efficacy measurement|331
412320|NCT01631227|1009733|P1|Full Analysis Set Population|Overall Study|2 patients not eligible for the Full Analysis Set due to missing post-baseline efficacy measurement|330
412321|NCT01631227|1009732|P2|Safety Subject Sample|Overall Study||332
412322|NCT01631227|1009733|P1|Safety Subject Sample|Overall Study|1 patient was randomized by mistake and never received study medication.|332
412323|NCT01631227|1009732|P2|STARTED|Overall Study||332
412324|NCT01631227|1009733|P1|STARTED|Overall Study||333
412325|NCT01631149|1009741|P2|NOT COMPLETED|Overall Study||0
412326|NCT01631149|1009742|P1|NOT COMPLETED|Overall Study||0
412327|NCT01631149|1009741|P2|COMPLETED|Overall Study||12
412328|NCT01631149|1009742|P1|COMPLETED|Overall Study||12
412329|NCT01631149|1009741|P2|STARTED|Overall Study||12
412330|NCT01631149|1009742|P1|STARTED|Overall Study||12
412331|NCT01631110|1009758|P2|NOT COMPLETED|Overall Study||0
412332|NCT01631110|1009759|P1|NOT COMPLETED|Overall Study||0
412333|NCT01631110|1009758|P2|COMPLETED|Overall Study||55
412334|NCT01631110|1009759|P1|COMPLETED|Overall Study||55
412335|NCT01631110|1009758|P2|STARTED|Overall Study||55
412336|NCT01631110|1009759|P1|STARTED|Overall Study||55
412337|NCT01631071|1009773|P2|NOT COMPLETED|Overall Study||0
412338|NCT01631071|1009774|P1|NOT COMPLETED|Overall Study||0
412339|NCT01631071|1009773|P2|COMPLETED|Overall Study||55
412340|NCT01631071|1009774|P1|COMPLETED|Overall Study||55
412341|NCT01631071|1009773|P2|STARTED|Overall Study||55
412342|NCT01631071|1009774|P1|STARTED|Overall Study||55
412343|NCT01630811|1009786|P2|NOT COMPLETED|Second Washout (4 Weeks)||0
412344|NCT01630811|1009787|P1|NOT COMPLETED|Second Washout (4 Weeks)||0
412345|NCT01630811|1009786|P2|COMPLETED|Second Washout (4 Weeks)||6
412346|NCT01630811|1009787|P1|COMPLETED|Second Washout (4 Weeks)||6
412347|NCT01630811|1009786|P2|STARTED|Second Washout (4 Weeks)||6
412348|NCT01630811|1009787|P1|STARTED|Second Washout (4 Weeks)||6
412349|NCT01630811|1009786|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
412350|NCT01630811|1009787|P1|NOT COMPLETED|Second Intervention (8 Weeks)||1
412351|NCT01630811|1009786|P2|COMPLETED|Second Intervention (8 Weeks)||6
412352|NCT01630811|1009787|P1|COMPLETED|Second Intervention (8 Weeks)||6
412353|NCT01630811|1009786|P2|STARTED|Second Intervention (8 Weeks)||6
412354|NCT01630811|1009787|P1|STARTED|Second Intervention (8 Weeks)||7
412355|NCT01630811|1009786|P2|NOT COMPLETED|Washout (4 Weeks)||0
412356|NCT01630811|1009787|P1|NOT COMPLETED|Washout (4 Weeks)||0
412357|NCT01630811|1009786|P2|COMPLETED|Washout (4 Weeks)||6
412358|NCT01630811|1009787|P1|COMPLETED|Washout (4 Weeks)||7
412359|NCT01630811|1009786|P2|STARTED|Washout (4 Weeks)||6
412360|NCT01630811|1009787|P1|STARTED|Washout (4 Weeks)||7
412361|NCT01630811|1009786|P2|NOT COMPLETED|First Intervention (8 Weeks)||0
412362|NCT01630811|1009787|P1|NOT COMPLETED|First Intervention (8 Weeks)||0
412363|NCT01630811|1009786|P2|COMPLETED|First Intervention (8 Weeks)||6
412364|NCT01630811|1009787|P1|COMPLETED|First Intervention (8 Weeks)||7
412365|NCT01630811|1009786|P2|STARTED|First Intervention (8 Weeks)||6
412366|NCT01630811|1009787|P1|STARTED|First Intervention (8 Weeks)||7
412367|NCT01630694|1009799|P2|NOT COMPLETED|Overall Study||0
412368|NCT01630694|1009800|P1|NOT COMPLETED|Overall Study||0
412369|NCT01630694|1009799|P2|COMPLETED|Overall Study||16
412370|NCT01630694|1009800|P1|COMPLETED|Overall Study||12
412371|NCT01630694|1009799|P2|STARTED|Overall Study||16
412372|NCT01630694|1009800|P1|STARTED|Overall Study||12
412373|NCT01630616|1009814|P6|NOT COMPLETED|Overall Study||0
412374|NCT01630616|1009815|P5|NOT COMPLETED|Overall Study||0
412375|NCT01630616|1009816|P4|NOT COMPLETED|Overall Study||3
412376|NCT01630616|1009817|P3|NOT COMPLETED|Overall Study||0
412377|NCT01630616|1009818|P2|NOT COMPLETED|Overall Study||0
412378|NCT01630616|1009819|P1|NOT COMPLETED|Overall Study||0
412379|NCT01630616|1009814|P6|COMPLETED|Overall Study||2
412380|NCT01630616|1009815|P5|COMPLETED|Overall Study||6
412381|NCT01630616|1009816|P4|COMPLETED|Overall Study||9
412382|NCT01630616|1009817|P3|COMPLETED|Overall Study||3
412383|NCT01630616|1009818|P2|COMPLETED|Overall Study||3
412384|NCT01630616|1009819|P1|COMPLETED|Overall Study||5
412385|NCT01630616|1009814|P6|STARTED|Overall Study||2
412386|NCT01630616|1009815|P5|STARTED|Overall Study||6
412387|NCT01630616|1009816|P4|STARTED|Overall Study||12
412388|NCT01630616|1009817|P3|STARTED|Overall Study||3
412389|NCT01630616|1009818|P2|STARTED|Overall Study||3
412390|NCT01630616|1009819|P1|STARTED|Overall Study||5
412391|NCT01630135|1009894|P2|NOT COMPLETED|Overall Study||2
412392|NCT01630135|1009895|P1|NOT COMPLETED|Overall Study||0
412393|NCT01630135|1009894|P2|COMPLETED|Overall Study||128
412394|NCT01630135|1009895|P1|COMPLETED|Overall Study||131
412395|NCT01630135|1009894|P2|STARTED|Overall Study||130
412396|NCT01630135|1009895|P1|STARTED|Overall Study||131
412397|NCT01630109|1009934|P3|NOT COMPLETED|Overall Study||0
412398|NCT01630109|1009935|P2|NOT COMPLETED|Overall Study||0
412399|NCT01630109|1009936|P1|NOT COMPLETED|Overall Study||0
412400|NCT01630109|1009934|P3|COMPLETED|Overall Study||3
412401|NCT01630109|1009935|P2|COMPLETED|Overall Study||1
412402|NCT01630109|1009936|P1|COMPLETED|Overall Study||1
412403|NCT01630109|1009934|P3|STARTED|Overall Study||3
412404|NCT01630109|1009935|P2|STARTED|Overall Study||1
412405|NCT01630109|1009936|P1|STARTED|Overall Study||1
412406|NCT01629953|1009958|P2|NOT COMPLETED|Overall Study||15
412407|NCT01629953|1009959|P1|NOT COMPLETED|Overall Study||13
412408|NCT01629953|1009958|P2|COMPLETED|Overall Study||60
412409|NCT01629953|1009959|P1|COMPLETED|Overall Study||52
412410|NCT01629953|1009958|P2|STARTED|Overall Study||75
412411|NCT01629953|1009959|P1|STARTED|Overall Study||65
412412|NCT01629862|1009969|P2|NOT COMPLETED|Overall Study||2
412413|NCT01629862|1009970|P1|NOT COMPLETED|Overall Study||2
412414|NCT01629862|1009969|P2|COMPLETED|Overall Study||23
412415|NCT01629862|1009970|P1|COMPLETED|Overall Study||26
412416|NCT01629862|1009969|P2|STARTED|Overall Study||25
412417|NCT01629862|1009970|P1|STARTED|Overall Study||28
412418|NCT01629823|1009979|P3|NOT COMPLETED|Washout Period||0
412419|NCT01629823|1009980|P2|NOT COMPLETED|Washout Period||6
412420|NCT01629823|1009981|P1|NOT COMPLETED|Washout Period||3
412421|NCT01629823|1009979|P3|COMPLETED|Washout Period||50
412422|NCT01629823|1009980|P2|COMPLETED|Washout Period||51
412423|NCT01629823|1009981|P1|COMPLETED|Washout Period||51
412424|NCT01629823|1009979|P3|STARTED|Washout Period||50
412425|NCT01629823|1009980|P2|STARTED|Washout Period||57
412426|NCT01629823|1009981|P1|STARTED|Washout Period||54
412427|NCT01629823|1009979|P3|NOT COMPLETED|Trial Period||10
412428|NCT01629823|1009980|P2|NOT COMPLETED|Trial Period||13
412429|NCT01629823|1009981|P1|NOT COMPLETED|Trial Period||13
412430|NCT01629823|1009979|P3|COMPLETED|Trial Period||49
412431|NCT01629823|1009980|P2|COMPLETED|Trial Period||56
412432|NCT01629823|1009981|P1|COMPLETED|Trial Period||53
412433|NCT01629823|1009979|P3|STARTED|Trial Period||59
412434|NCT01629823|1009980|P2|STARTED|Trial Period||69
412435|NCT01629823|1009981|P1|STARTED|Trial Period||66
412436|NCT01629797|1009989|P1|NOT COMPLETED|Overall Study||18
412437|NCT01629797|1009989|P1|COMPLETED|Overall Study||82
412438|NCT01629797|1009989|P1|STARTED|Overall Study||100
412439|NCT01629784|1009996|P1|NOT COMPLETED|Overall Study||6
412440|NCT01629784|1009996|P1|COMPLETED|Overall Study||25
412441|NCT01629784|1009996|P1|STARTED|Overall Study||31
412442|NCT01629771|1010005|P2|NOT COMPLETED|Overall Study||0
412443|NCT01629771|1010006|P1|NOT COMPLETED|Overall Study||0
412444|NCT01629771|1010005|P2|COMPLETED|Overall Study||36
412445|NCT01629771|1010006|P1|COMPLETED|Overall Study||36
412446|NCT01629771|1010005|P2|STARTED|Overall Study||36
412447|NCT01629771|1010006|P1|STARTED|Overall Study||36
412448|NCT01629706|1010016|P1|NOT COMPLETED|Phase 2 Habitual||10
412449|NCT01629706|1010016|P1|COMPLETED|Phase 2 Habitual||48
412450|NCT01629706|1010016|P1|STARTED|Phase 2 Habitual|Phase 2 enrolled 48 new participants, plus 10 participants from Phase 1|58
412451|NCT01629706|1010016|P1|NOT COMPLETED|Phase 1 PureVision||9
412452|NCT01629706|1010016|P1|COMPLETED|Phase 1 PureVision||35
412453|NCT01629706|1010016|P1|STARTED|Phase 1 PureVision||44
412454|NCT01629693|1010044|P2|NOT COMPLETED|Overall Study||10
412455|NCT01629693|1010045|P1|NOT COMPLETED|Overall Study||5
412456|NCT01629693|1010044|P2|COMPLETED|Overall Study||178
412457|NCT01629693|1010045|P1|COMPLETED|Overall Study||188
412458|NCT01629693|1010044|P2|STARTED|Overall Study||188
412459|NCT01629693|1010045|P1|STARTED|Overall Study||193
412460|NCT01629667|1010054|P3|NOT COMPLETED|Overall Study||45
412461|NCT01629667|1010055|P2|NOT COMPLETED|Overall Study||41
412462|NCT01629667|1010056|P1|NOT COMPLETED|Overall Study||47
412463|NCT01629667|1010054|P3|COMPLETED|Overall Study||14
412464|NCT01629667|1010055|P2|COMPLETED|Overall Study||17
412465|NCT01629667|1010056|P1|COMPLETED|Overall Study||12
412466|NCT01629667|1010054|P3|Randomized and Treated|Overall Study||59
412467|NCT01629667|1010055|P2|Randomized and Treated|Overall Study||57
412468|NCT01629667|1010056|P1|Randomized and Treated|Overall Study||57
412469|NCT01629667|1010054|P3|STARTED|Overall Study||59
412470|NCT01629667|1010055|P2|STARTED|Overall Study||58
412471|NCT01629667|1010056|P1|STARTED|Overall Study||59
412472|NCT01629589|1010140|P2|NOT COMPLETED|Overall Study||7
412473|NCT01629589|1010141|P1|NOT COMPLETED|Overall Study||8
412474|NCT01629589|1010140|P2|COMPLETED|Overall Study||204
412475|NCT01629589|1010141|P1|COMPLETED|Overall Study|A participant received the Boostrix vaccine. Study data reported for the Boostrix vaccine group.|204
412476|NCT01629589|1010140|P2|STARTED|Overall Study||211
412477|NCT01629589|1010141|P1|STARTED|Overall Study||212
412478|NCT01629290|1010157|P1|NOT COMPLETED|Overall Study||0
412479|NCT01629290|1010157|P1|COMPLETED|Overall Study||15
412480|NCT01629290|1010157|P1|STARTED|Overall Study||15
412481|NCT01629134|1010167|P1|NOT COMPLETED|Overall Study||0
412482|NCT01629134|1010167|P1|COMPLETED|Overall Study||62
412483|NCT01629134|1010167|P1|STARTED|Overall Study||62
412484|NCT01628965|1010180|P1|NOT COMPLETED|Overall Study||49
412485|NCT01628965|1010180|P1|COMPLETED|Overall Study||94
412486|NCT01628965|1010180|P1|STARTED|Overall Study||143
412487|NCT01628926|1010189|P3|NOT COMPLETED|Overall Study||17
412488|NCT01628926|1010190|P2|NOT COMPLETED|Overall Study||23
412489|NCT01628926|1010191|P1|NOT COMPLETED|Overall Study||26
412490|NCT01628926|1010189|P3|COMPLETED|Overall Study||68
412491|NCT01628926|1010190|P2|COMPLETED|Overall Study||144
412492|NCT01628926|1010191|P1|COMPLETED|Overall Study||142
412493|NCT01628926|1010189|P3|STARTED|Overall Study||85
412494|NCT01628926|1010190|P2|STARTED|Overall Study||167
412495|NCT01628926|1010191|P1|STARTED|Overall Study||168
412496|NCT01628913|1010240|P2|NOT COMPLETED|Overall Study||31
412497|NCT01628913|1010241|P1|NOT COMPLETED|Overall Study||31
412498|NCT01628913|1010240|P2|COMPLETED|Overall Study||0
412499|NCT01628913|1010241|P1|COMPLETED|Overall Study||0
412500|NCT01628913|1010240|P2|STARTED|Overall Study||31
412501|NCT01628913|1010241|P1|STARTED|Overall Study||31
412502|NCT01628848|1010255|P2|NOT COMPLETED|Overall Study||14
412503|NCT01628848|1010256|P1|NOT COMPLETED|Overall Study||12
412504|NCT01628848|1010255|P2|COMPLETED|Overall Study||73
412505|NCT01628848|1010256|P1|COMPLETED|Overall Study||75
412506|NCT01628848|1010255|P2|STARTED|Overall Study||87
412507|NCT01628848|1010256|P1|STARTED|Overall Study||87
412508|NCT01628692|1010290|P6|NOT COMPLETED|Overall Study||9
412509|NCT01628692|1010291|P5|NOT COMPLETED|Overall Study||4
412510|NCT01628692|1010292|P4|NOT COMPLETED|Overall Study||1
412511|NCT01628692|1010293|P3|NOT COMPLETED|Overall Study||8
412512|NCT01628692|1010294|P2|NOT COMPLETED|Overall Study||6
412513|NCT01628692|1010295|P1|NOT COMPLETED|Overall Study||7
412514|NCT01628692|1010290|P6|COMPLETED|Overall Study||0
412515|NCT01628692|1010291|P5|COMPLETED|Overall Study||8
412516|NCT01628692|1010292|P4|COMPLETED|Overall Study||19
412517|NCT01628692|1010293|P3|COMPLETED|Overall Study||43
412518|NCT01628692|1010294|P2|COMPLETED|Overall Study||17
412519|NCT01628692|1010295|P1|COMPLETED|Overall Study||46
412520|NCT01628692|1010290|P6|STARTED|Overall Study||9
412521|NCT01628692|1010291|P5|STARTED|Overall Study||12
412522|NCT01628692|1010292|P4|STARTED|Overall Study||20
412523|NCT01628692|1010293|P3|STARTED|Overall Study||51
412524|NCT01628692|1010294|P2|STARTED|Overall Study||23
412525|NCT01628692|1010295|P1|STARTED|Overall Study||53
412526|NCT01628614|1010339|P1|NOT COMPLETED|Overall Study||1775
412527|NCT01628614|1010339|P1|COMPLETED|Overall Study||3037
412528|NCT01628614|1010339|P1|STARTED|Overall Study||4812
412529|NCT01628601|1010345|P1|NOT COMPLETED|Overall Study||41
412530|NCT01628601|1010345|P1|COMPLETED|Overall Study||351
412531|NCT01628601|1010345|P1|STARTED|Overall Study||392
412532|NCT01628588|1010353|P1|NOT COMPLETED|Overall Study||16
412533|NCT01628588|1010353|P1|COMPLETED|Overall Study||838
412534|NCT01628588|1010353|P1|STARTED|Overall Study||854
412535|NCT01628510|1010363|P2|NOT COMPLETED|Overall Study||5
412536|NCT01628510|1010364|P1|NOT COMPLETED|Overall Study||3
412537|NCT01628510|1010363|P2|COMPLETED|Overall Study||44
412538|NCT01628510|1010364|P1|COMPLETED|Overall Study||48
412539|NCT01628510|1010363|P2|STARTED|Overall Study||49
412540|NCT01628510|1010364|P1|STARTED|Overall Study||51
412541|NCT01628367|1010374|P2|NOT COMPLETED|Overall Study||0
412542|NCT01628367|1010375|P1|NOT COMPLETED|Overall Study||1
412543|NCT01628367|1010374|P2|COMPLETED|Overall Study||16
412544|NCT01628367|1010375|P1|COMPLETED|Overall Study||15
412545|NCT01628367|1010374|P2|STARTED|Overall Study||16
412546|NCT01628367|1010375|P1|STARTED|Overall Study||16
412547|NCT01628250|1010387|P2|NOT COMPLETED|Overall Study||0
412548|NCT01628250|1010388|P1|NOT COMPLETED|Overall Study||0
412549|NCT01628250|1010387|P2|COMPLETED|Overall Study||50
412550|NCT01628250|1010388|P1|COMPLETED|Overall Study||49
412551|NCT01628250|1010387|P2|STARTED|Overall Study||50
412552|NCT01628250|1010388|P1|STARTED|Overall Study||49
412553|NCT01628198|1010394|P1|NOT COMPLETED|Overall Study||18
412554|NCT01628198|1010394|P1|COMPLETED|Overall Study||20
412555|NCT01628198|1010394|P1|STARTED|Overall Study||38
412556|NCT01628042|1010411|P4|NOT COMPLETED|Overall Study||0
412557|NCT01628042|1010412|P3|NOT COMPLETED|Overall Study||0
412558|NCT01628042|1010413|P2|NOT COMPLETED|Overall Study||0
412559|NCT01628042|1010414|P1|NOT COMPLETED|Overall Study||0
412560|NCT01628042|1010411|P4|COMPLETED|Overall Study||8
412561|NCT01628042|1010412|P3|COMPLETED|Overall Study||8
412562|NCT01628042|1010413|P2|COMPLETED|Overall Study||8
412563|NCT01628042|1010414|P1|COMPLETED|Overall Study||8
412564|NCT01628042|1010411|P4|STARTED|Overall Study||8
412565|NCT01628042|1010412|P3|STARTED|Overall Study||8
412566|NCT01628042|1010413|P2|STARTED|Overall Study||8
412567|NCT01628042|1010414|P1|STARTED|Overall Study||8
412568|NCT01627860|1010434|P2|NOT COMPLETED|Overall Study||6
412569|NCT01627860|1010435|P1|NOT COMPLETED|Overall Study||12
412570|NCT01627860|1010434|P2|COMPLETED|Overall Study||14
412571|NCT01627860|1010435|P1|COMPLETED|Overall Study||23
412572|NCT01627860|1010434|P2|STARTED|Overall Study||20
412573|NCT01627860|1010435|P1|STARTED|Overall Study||35
412574|NCT01627782|1010449|P4|NOT COMPLETED|Overall Study||6
412575|NCT01627782|1010450|P3|NOT COMPLETED|Overall Study||15
412576|NCT01627782|1010451|P2|NOT COMPLETED|Overall Study||6
412577|NCT01627782|1010452|P1|NOT COMPLETED|Overall Study||16
412578|NCT01627782|1010449|P4|COMPLETED|Overall Study||11
412579|NCT01627782|1010450|P3|COMPLETED|Overall Study||1
412580|NCT01627782|1010451|P2|COMPLETED|Overall Study||12
412581|NCT01627782|1010452|P1|COMPLETED|Overall Study||1
412582|NCT01627782|1010449|P4|Treated|Overall Study||17
412583|NCT01627782|1010450|P3|Treated|Overall Study||16
412584|NCT01627782|1010451|P2|Treated|Overall Study||18
412585|NCT01627782|1010452|P1|Treated|Overall Study||16
412586|NCT01627782|1010449|P4|STARTED|Overall Study||17
412587|NCT01627782|1010450|P3|STARTED|Overall Study||16
412588|NCT01627782|1010451|P2|STARTED|Overall Study||18
412589|NCT01627782|1010452|P1|STARTED|Overall Study||17
412590|NCT01627561|1010510|P2|NOT COMPLETED|Overall Study||3
412591|NCT01627561|1010511|P1|NOT COMPLETED|Overall Study||0
412592|NCT01627561|1010510|P2|COMPLETED|Overall Study||71
412593|NCT01627561|1010511|P1|COMPLETED|Overall Study||74
412594|NCT01627561|1010510|P2|STARTED|Overall Study||74
412595|NCT01627561|1010511|P1|STARTED|Overall Study||74
412596|NCT01627340|1010559|P2|NOT COMPLETED|Overall Study||4
412597|NCT01627340|1010560|P1|NOT COMPLETED|Overall Study||12
412598|NCT01627340|1010559|P2|COMPLETED|Overall Study||254
412599|NCT01627340|1010560|P1|COMPLETED|Overall Study||404
412600|NCT01627340|1010559|P2|STARTED|Overall Study||258
412601|NCT01627340|1010560|P1|STARTED|Overall Study||416
412602|NCT01627327|1010578|P2|NOT COMPLETED|Overall Study||39
412603|NCT01627327|1010579|P1|NOT COMPLETED|Overall Study||19
412604|NCT01627327|1010578|P2|COMPLETED|Overall Study||274
412605|NCT01627327|1010579|P1|COMPLETED|Overall Study||291
412606|NCT01627327|1010578|P2|STARTED|Overall Study||313
412607|NCT01627327|1010579|P1|STARTED|Overall Study||310
412608|NCT01627249|1010592|P3|NOT COMPLETED|Overall Study||12
412609|NCT01627249|1010593|P2|NOT COMPLETED|Overall Study||12
412610|NCT01627249|1010594|P1|NOT COMPLETED|Overall Study||16
412611|NCT01627249|1010592|P3|COMPLETED|Overall Study||206
412612|NCT01627249|1010593|P2|COMPLETED|Overall Study||206
412613|NCT01627249|1010594|P1|COMPLETED|Overall Study||208
412614|NCT01627249|1010592|P3|STARTED|Overall Study||218
412615|NCT01627249|1010593|P2|STARTED|Overall Study||218
412616|NCT01627249|1010594|P1|STARTED|Overall Study||224
412617|NCT01627002|1010631|P9|NOT COMPLETED|Overall Study||0
412618|NCT01627002|1010632|P8|NOT COMPLETED|Overall Study||0
412619|NCT01627002|1010633|P7|NOT COMPLETED|Overall Study||0
412620|NCT01627002|1010634|P6|NOT COMPLETED|Overall Study||0
412621|NCT01627002|1010635|P5|NOT COMPLETED|Overall Study||0
412622|NCT01627002|1010636|P4|NOT COMPLETED|Overall Study||0
412623|NCT01627002|1010637|P3|NOT COMPLETED|Overall Study||0
412624|NCT01627002|1010638|P2|NOT COMPLETED|Overall Study||0
412625|NCT01627002|1010639|P1|NOT COMPLETED|Overall Study||0
412626|NCT01627002|1010631|P9|COMPLETED|Overall Study||7
412627|NCT01627002|1010632|P8|COMPLETED|Overall Study||5
412628|NCT01627002|1010633|P7|COMPLETED|Overall Study||10
412629|NCT01627002|1010634|P6|COMPLETED|Overall Study||9
412630|NCT01627002|1010635|P5|COMPLETED|Overall Study||2
412631|NCT01627002|1010636|P4|COMPLETED|Overall Study||4
412632|NCT01627002|1010637|P3|COMPLETED|Overall Study||4
412633|NCT01627002|1010638|P2|COMPLETED|Overall Study||4
412634|NCT01627002|1010639|P1|COMPLETED|Overall Study||4
412635|NCT01627002|1010631|P9|STARTED|Overall Study||7
412636|NCT01627002|1010632|P8|STARTED|Overall Study||5
412637|NCT01627002|1010633|P7|STARTED|Overall Study||10
412638|NCT01627002|1010634|P6|STARTED|Overall Study||9
412639|NCT01627002|1010635|P5|STARTED|Overall Study||2
412640|NCT01627002|1010636|P4|STARTED|Overall Study||4
412641|NCT01627002|1010637|P3|STARTED|Overall Study||4
412642|NCT01627002|1010638|P2|STARTED|Overall Study||4
412643|NCT01627002|1010639|P1|STARTED|Overall Study||4
412644|NCT01626820|1010692|P2|NOT COMPLETED|Overall Study||0
412645|NCT01626820|1010693|P1|NOT COMPLETED|Overall Study||0
412646|NCT01626820|1010692|P2|COMPLETED|Overall Study||57
412647|NCT01626820|1010693|P1|COMPLETED|Overall Study||56
412648|NCT01626820|1010692|P2|STARTED|Overall Study||57
412649|NCT01626820|1010693|P1|STARTED|Overall Study||56
412650|NCT01626690|1010715|P2|NOT COMPLETED|Overall Study||0
412651|NCT01626690|1010716|P1|NOT COMPLETED|Overall Study||2
412652|NCT01626690|1010715|P2|COMPLETED|Overall Study||51
412653|NCT01626690|1010716|P1|COMPLETED|Overall Study||47
412654|NCT01626690|1010715|P2|STARTED|Overall Study||51
412655|NCT01626690|1010716|P1|STARTED|Overall Study||49
412656|NCT01626664|1010738|P3|NOT COMPLETED|Crossover Period||0
412657|NCT01626664|1010739|P2|NOT COMPLETED|Crossover Period||0
412658|NCT01626664|1010740|P1|NOT COMPLETED|Crossover Period||0
412659|NCT01626664|1010738|P3|COMPLETED|Crossover Period||18
412660|NCT01626664|1010739|P2|COMPLETED|Crossover Period||0
412661|NCT01626664|1010740|P1|COMPLETED|Crossover Period||0
412662|NCT01626664|1010738|P3|STARTED|Crossover Period||18
412663|NCT01626664|1010739|P2|STARTED|Crossover Period||0
412664|NCT01626664|1010740|P1|STARTED|Crossover Period||0
412665|NCT01626664|1010738|P3|NOT COMPLETED|Randomization Period||0
412666|NCT01626664|1010739|P2|NOT COMPLETED|Randomization Period||0
412667|NCT01626664|1010740|P1|NOT COMPLETED|Randomization Period||0
412668|NCT01626664|1010738|P3|COMPLETED|Randomization Period||0
412669|NCT01626664|1010739|P2|COMPLETED|Randomization Period||24
412670|NCT01626664|1010740|P1|COMPLETED|Randomization Period||47
412671|NCT01626664|1010738|P3|STARTED|Randomization Period||0
412672|NCT01626664|1010739|P2|STARTED|Randomization Period||24
412673|NCT01626664|1010740|P1|STARTED|Randomization Period||47
412674|NCT01626456|1010753|P2|NOT COMPLETED|Overall Study||117
412675|NCT01626456|1010754|P1|NOT COMPLETED|Overall Study||35
412676|NCT01626456|1010753|P2|COMPLETED|Overall Study||251
412677|NCT01626456|1010754|P1|COMPLETED|Overall Study||75
412678|NCT01626456|1010753|P2|STARTED|Overall Study||368
412679|NCT01626456|1010754|P1|STARTED|Overall Study||110
412680|NCT01626391|1010784|P2|NOT COMPLETED|Overall Study||0
412681|NCT01626391|1010785|P1|NOT COMPLETED|Overall Study||2
412682|NCT01626391|1010784|P2|COMPLETED|Overall Study||4
412683|NCT01626391|1010785|P1|COMPLETED|Overall Study||3
412684|NCT01626391|1010784|P2|STARTED|Overall Study||4
412685|NCT01626391|1010785|P1|STARTED|Overall Study||5
412686|NCT01626352|1010791|P1|NOT COMPLETED|Overall Study||10
412687|NCT01626352|1010791|P1|COMPLETED|Overall Study||12
412688|NCT01626352|1010791|P1|STARTED|Overall Study||22
412689|NCT01626118|1010805|P4|NOT COMPLETED|Overall Study||3
412690|NCT01626118|1010806|P3|NOT COMPLETED|Overall Study||2
412691|NCT01626118|1010807|P2|NOT COMPLETED|Overall Study||2
412692|NCT01626118|1010808|P1|NOT COMPLETED|Overall Study||2
412693|NCT01626118|1010805|P4|COMPLETED|Overall Study||91
412694|NCT01626118|1010806|P3|COMPLETED|Overall Study||90
412695|NCT01626118|1010807|P2|COMPLETED|Overall Study||91
412696|NCT01626118|1010808|P1|COMPLETED|Overall Study||92
412697|NCT01626118|1010805|P4|STARTED|Overall Study||94
412698|NCT01626118|1010806|P3|STARTED|Overall Study||92
412699|NCT01626118|1010807|P2|STARTED|Overall Study||93
412700|NCT01626118|1010808|P1|STARTED|Overall Study||94
412701|NCT01626092|1010846|P1|NOT COMPLETED|Overall Study||0
412702|NCT01626092|1010846|P1|COMPLETED|Overall Study||3
412703|NCT01626092|1010846|P1|STARTED|Overall Study||3
412704|NCT01625910|1010854|P2|NOT COMPLETED|Overall Study||4
412705|NCT01625910|1010855|P1|NOT COMPLETED|Overall Study||3
412706|NCT01625910|1010854|P2|COMPLETED|Overall Study||33
412707|NCT01625910|1010855|P1|COMPLETED|Overall Study||32
412708|NCT01625910|1010854|P2|STARTED|Overall Study||37
412709|NCT01625910|1010855|P1|STARTED|Overall Study||35
412710|NCT01625845|1010865|P2|NOT COMPLETED|Overall Study||3
412711|NCT01625845|1010866|P1|NOT COMPLETED|Overall Study||5
412712|NCT01625845|1010865|P2|COMPLETED|Overall Study||3
412713|NCT01625845|1010866|P1|COMPLETED|Overall Study||5
412714|NCT01625845|1010865|P2|STARTED|Overall Study||6
412715|NCT01625845|1010866|P1|STARTED|Overall Study||10
412716|NCT01625689|1010886|P2|NOT COMPLETED|Overall Study||1
412717|NCT01625689|1010887|P1|NOT COMPLETED|Overall Study||2
412718|NCT01625689|1010886|P2|COMPLETED|Overall Study||149
412719|NCT01625689|1010887|P1|COMPLETED|Overall Study||148
412720|NCT01625689|1010886|P2|STARTED|Overall Study||150
412721|NCT01625689|1010887|P1|STARTED|Overall Study||150
412722|NCT01625507|1010897|P1|NOT COMPLETED|Overall Study||10
412723|NCT01625507|1010897|P1|COMPLETED|Overall Study||63
412724|NCT01625507|1010897|P1|STARTED|Overall Study||73
412725|NCT01625455|1010912|P2|NOT COMPLETED|Overall Study||0
412726|NCT01625455|1010913|P1|NOT COMPLETED|Overall Study||0
412727|NCT01625455|1010912|P2|COMPLETED|Overall Study||3
412728|NCT01625455|1010913|P1|COMPLETED|Overall Study||2
412729|NCT01625455|1010912|P2|STARTED|Overall Study||3
412730|NCT01625455|1010913|P1|STARTED|Overall Study||2
412731|NCT01625416|1010923|P2|NOT COMPLETED|Overall Study||7
412732|NCT01625416|1010924|P1|NOT COMPLETED|Overall Study||9
412733|NCT01625416|1010923|P2|COMPLETED|Overall Study||54
412734|NCT01625416|1010924|P1|COMPLETED|Overall Study||51
412735|NCT01625416|1010923|P2|STARTED|Overall Study||61
412736|NCT01625416|1010924|P1|STARTED|Overall Study||60
412737|NCT01625377|1010942|P2|NOT COMPLETED|Overall Study||22
412738|NCT01625377|1010943|P1|NOT COMPLETED|Overall Study||7
412739|NCT01625377|1010942|P2|COMPLETED|Overall Study||71
412740|NCT01625377|1010943|P1|COMPLETED|Overall Study||88
412741|NCT01625377|1010942|P2|Intent to Treat Population|Overall Study||90
412742|NCT01625377|1010943|P1|Intent to Treat Population|Overall Study||93
412743|NCT01625377|1010942|P2|Safety Set of Population|Overall Study||90
412744|NCT01625377|1010943|P1|Safety Set of Population|Overall Study||94
412745|NCT01625377|1010942|P2|STARTED|Overall Study||93
412746|NCT01625377|1010943|P1|STARTED|Overall Study|"Started indicates randomized patients."|95
412747|NCT01625338|1010976|P3|NOT COMPLETED|Overall Study||39
412748|NCT01625338|1010977|P2|NOT COMPLETED|Overall Study||44
412749|NCT01625338|1010978|P1|NOT COMPLETED|Overall Study||32
412750|NCT01625338|1010976|P3|COMPLETED|Overall Study||181
412751|NCT01625338|1010977|P2|COMPLETED|Overall Study||156
412752|NCT01625338|1010978|P1|COMPLETED|Overall Study||82
412753|NCT01625338|1010976|P3|STARTED|Overall Study||220
412754|NCT01625338|1010977|P2|STARTED|Overall Study||200
412755|NCT01625338|1010978|P1|STARTED|Overall Study||114
412756|NCT01625221|1010998|P1|NOT COMPLETED|Overall Study||7
412757|NCT01625221|1010998|P1|COMPLETED|Overall Study||28
412758|NCT01625221|1010998|P1|STARTED|Overall Study||35
412759|NCT01625182|1011005|P2|NOT COMPLETED|Overall Study||11
412760|NCT01625182|1011006|P1|NOT COMPLETED|Overall Study||20
412761|NCT01625182|1011005|P2|COMPLETED|Overall Study||41
412762|NCT01625182|1011006|P1|COMPLETED|Overall Study||34
412763|NCT01625182|1011005|P2|STARTED|Overall Study||52
412764|NCT01625182|1011006|P1|STARTED|Overall Study||54
412765|NCT01625169|1011019|P1|NOT COMPLETED|Overall Study||0
412766|NCT01625169|1011019|P1|COMPLETED|Overall Study||9
412767|NCT01625169|1011019|P1|STARTED|Overall Study||9
412768|NCT01625104|1011034|P2|NOT COMPLETED|Overall Study||0
412769|NCT01625104|1011035|P1|NOT COMPLETED|Overall Study||0
412770|NCT01625104|1011034|P2|COMPLETED|Overall Study||434
412771|NCT01625104|1011035|P1|COMPLETED|Overall Study||448
412772|NCT01625104|1011034|P2|STARTED|Overall Study||434
412773|NCT01625104|1011035|P1|STARTED|Overall Study||448
412774|NCT01625091|1011043|P2|NOT COMPLETED|Post-intervention||2
412775|NCT01625091|1011044|P1|NOT COMPLETED|Post-intervention||4
412776|NCT01625091|1011043|P2|COMPLETED|Post-intervention||85
412777|NCT01625091|1011044|P1|COMPLETED|Post-intervention||81
412778|NCT01625091|1011043|P2|7 Months|Post-intervention||85
412779|NCT01625091|1011044|P1|7 Months|Post-intervention||81
412780|NCT01625091|1011043|P2|STARTED|Post-intervention||87
412781|NCT01625091|1011044|P1|STARTED|Post-intervention||85
412782|NCT01625091|1011043|P2|NOT COMPLETED|Intervention||11
412783|NCT01625091|1011044|P1|NOT COMPLETED|Intervention||11
412784|NCT01625091|1011043|P2|COMPLETED|Intervention||87
412785|NCT01625091|1011044|P1|COMPLETED|Intervention||85
412786|NCT01625091|1011043|P2|4 Months|Intervention||87
412787|NCT01625091|1011044|P1|4 Months|Intervention||85
412788|NCT01625091|1011043|P2|2 Months|Intervention||93
412789|NCT01625091|1011044|P1|2 Months|Intervention||90
412790|NCT01625091|1011043|P2|STARTED|Intervention||98
412791|NCT01625091|1011044|P1|STARTED|Intervention||96
412792|NCT01624948|1011058|P2|NOT COMPLETED|Overall Study||0
412793|NCT01624948|1011059|P1|NOT COMPLETED|Overall Study||0
412794|NCT01624948|1011058|P2|COMPLETED|Overall Study||20
412795|NCT01624948|1011059|P1|COMPLETED|Overall Study||20
412796|NCT01624948|1011058|P2|STARTED|Overall Study||20
412797|NCT01624948|1011059|P1|STARTED|Overall Study||20
412798|NCT01624740|1011077|P2|NOT COMPLETED|Second Intervention (3-4 Days)||0
412799|NCT01624740|1011078|P1|NOT COMPLETED|Second Intervention (3-4 Days)||1
412800|NCT01624740|1011077|P2|COMPLETED|Second Intervention (3-4 Days)||9
412801|NCT01624740|1011078|P1|COMPLETED|Second Intervention (3-4 Days)||8
412802|NCT01624740|1011077|P2|STARTED|Second Intervention (3-4 Days)||9
412803|NCT01624740|1011078|P1|STARTED|Second Intervention (3-4 Days)||9
412804|NCT01624740|1011077|P2|NOT COMPLETED|Washout (1 Hour)||0
412805|NCT01624740|1011078|P1|NOT COMPLETED|Washout (1 Hour)||0
412806|NCT01624740|1011077|P2|COMPLETED|Washout (1 Hour)||9
412807|NCT01624740|1011078|P1|COMPLETED|Washout (1 Hour)||9
412808|NCT01624740|1011077|P2|STARTED|Washout (1 Hour)||9
412809|NCT01624740|1011078|P1|STARTED|Washout (1 Hour)||9
412810|NCT01624740|1011077|P2|NOT COMPLETED|First Intervention (3-4 Days)||0
412811|NCT01624740|1011078|P1|NOT COMPLETED|First Intervention (3-4 Days)||0
412812|NCT01624740|1011077|P2|COMPLETED|First Intervention (3-4 Days)||9
412813|NCT01624740|1011078|P1|COMPLETED|First Intervention (3-4 Days)||9
412814|NCT01624740|1011077|P2|STARTED|First Intervention (3-4 Days)||9
412815|NCT01624740|1011078|P1|STARTED|First Intervention (3-4 Days)||9
412816|NCT01624467|1011085|P1|NOT COMPLETED|Overall Study||31
412817|NCT01624467|1011085|P1|COMPLETED|Overall Study||44
412818|NCT01624467|1011085|P1|Received at Least One Dose of Study Drug|Overall Study||75
412819|NCT01624467|1011085|P1|STARTED|Overall Study||75
412820|NCT01624363|1011098|P1|NOT COMPLETED|Overall Study||0
412821|NCT01624363|1011098|P1|COMPLETED|Overall Study||341
412822|NCT01624363|1011098|P1|STARTED|Overall Study||341
412823|NCT01624350|1011102|P1|NOT COMPLETED|Overall Study||25
412824|NCT01624350|1011102|P1|COMPLETED|Overall Study||75
412825|NCT01624350|1011102|P1|STARTED|Overall Study||100
412826|NCT01624259|1011124|P2|NOT COMPLETED|Overall Study||31
412827|NCT01624259|1011125|P1|NOT COMPLETED|Overall Study||30
412828|NCT01624259|1011124|P2|COMPLETED|Overall Study|Completed the study on study treatment|269
412829|NCT01624259|1011125|P1|COMPLETED|Overall Study|Completed the study on study treatment|269
412830|NCT01624259|1011124|P2|Received at Least One Dose of Study Drug|Overall Study||300
412831|NCT01624259|1011125|P1|Received at Least One Dose of Study Drug|Overall Study||299
412832|NCT01624259|1011124|P2|STARTED|Overall Study||300
412833|NCT01624259|1011125|P1|STARTED|Overall Study||299
412834|NCT01624233|1011174|P1|NOT COMPLETED|Period 3 - Maintenance||7
412835|NCT01624233|1011174|P1|COMPLETED|Period 3 - Maintenance||83
412836|NCT01624233|1011174|P1|Received at Least 1 Dose of Study Drug|Period 3 - Maintenance||90
412837|NCT01624233|1011174|P1|STARTED|Period 3 - Maintenance||90
412838|NCT01624233|1011174|P1|NOT COMPLETED|Period 2 - Induction||1
412839|NCT01624233|1011174|P1|COMPLETED|Period 2 - Induction||90
412840|NCT01624233|1011174|P1|Plaque Ps|Period 2 - Induction||78
412841|NCT01624233|1011174|P1|Pustular Ps|Period 2 - Induction||5
412842|NCT01624233|1011174|P1|Erythrodermic Psoriasis (Ps)|Period 2 - Induction||8
412843|NCT01624233|1011174|P1|Received at Least 1 Dose of Study Drug|Period 2 - Induction||91
412844|NCT01624233|1011174|P1|STARTED|Period 2 - Induction||91
412845|NCT01624194|1011193|P2|NOT COMPLETED|Overall Study||0
412846|NCT01624194|1011194|P1|NOT COMPLETED|Overall Study||2
412847|NCT01624194|1011193|P2|COMPLETED|Overall Study||18
412848|NCT01624194|1011194|P1|COMPLETED|Overall Study||14
412849|NCT01624194|1011193|P2|STARTED|Overall Study||18
412850|NCT01624194|1011194|P1|STARTED|Overall Study||16
412851|NCT01624168|1011235|P3|NOT COMPLETED|Overall Study||6
412852|NCT01624168|1011236|P2|NOT COMPLETED|Overall Study||12
412853|NCT01624168|1011237|P1|NOT COMPLETED|Overall Study||4
412854|NCT01624168|1011235|P3|COMPLETED|Overall Study||22
412855|NCT01624168|1011236|P2|COMPLETED|Overall Study||16
412856|NCT01624168|1011237|P1|COMPLETED|Overall Study||15
412857|NCT01624168|1011235|P3|STARTED|Overall Study||28
412858|NCT01624168|1011236|P2|STARTED|Overall Study||28
412859|NCT01624168|1011237|P1|STARTED|Overall Study||19
412860|NCT01623869|1011260|P1|NOT COMPLETED|Overall Study||0
412861|NCT01623869|1011260|P1|COMPLETED|Overall Study||16
412862|NCT01623869|1011260|P1|STARTED|Overall Study||16
412863|NCT01623830|1011268|P2|NOT COMPLETED|Overall Study||9
412864|NCT01623830|1011269|P1|NOT COMPLETED|Overall Study||7
412865|NCT01623830|1011268|P2|COMPLETED|Overall Study||35
412866|NCT01623830|1011269|P1|COMPLETED|Overall Study||38
412867|NCT01623830|1011268|P2|STARTED|Overall Study||44
412868|NCT01623830|1011269|P1|STARTED|Overall Study||45
412869|NCT01623739|1011285|P2|NOT COMPLETED|Overall Study||4
412870|NCT01623739|1011286|P1|NOT COMPLETED|Overall Study||2
412871|NCT01623739|1011285|P2|COMPLETED|Overall Study||15
412872|NCT01623739|1011286|P1|COMPLETED|Overall Study||17
412873|NCT01623739|1011285|P2|STARTED|Overall Study||19
412874|NCT01623739|1011286|P1|STARTED|Overall Study||19
412875|NCT01623596|1011294|P2|NOT COMPLETED|Overall Study||100
412876|NCT01623596|1011295|P1|NOT COMPLETED|Overall Study||62
412877|NCT01623596|1011294|P2|COMPLETED|Overall Study||339
412878|NCT01623596|1011295|P1|COMPLETED|Overall Study||374
412879|NCT01623596|1011294|P2|On Switched Treatment|Overall Study||214
412880|NCT01623596|1011295|P1|On Switched Treatment|Overall Study||22
412881|NCT01623596|1011294|P2|On Randomized Treatment|Overall Study||125
412882|NCT01623596|1011295|P1|On Randomized Treatment|Overall Study||352
412883|NCT01623596|1011294|P2|STARTED|Overall Study||439
412884|NCT01623596|1011295|P1|STARTED|Overall Study||436
412885|NCT01623479|1011311|P1|NOT COMPLETED|Overall Study||0
412886|NCT01623479|1011311|P1|COMPLETED|Overall Study||585
412887|NCT01623479|1011311|P1|STARTED|Overall Study||585
412888|NCT01623466|1011319|P2|NOT COMPLETED|Overall Study||0
412889|NCT01623466|1011320|P1|NOT COMPLETED|Overall Study||1
412890|NCT01623466|1011319|P2|COMPLETED|Overall Study||18
412891|NCT01623466|1011320|P1|COMPLETED|Overall Study||17
412892|NCT01623466|1011319|P2|STARTED|Overall Study||18
412893|NCT01623466|1011320|P1|STARTED|Overall Study||18
412894|NCT01623323|1011334|P1|NOT COMPLETED|Overall Study||104
412895|NCT01623323|1011334|P1|COMPLETED|Overall Study||601
412896|NCT01623323|1011334|P1|STARTED|Overall Study||705
412897|NCT01623310|1011338|P1|NOT COMPLETED|Overall Study||79
412898|NCT01623310|1011338|P1|COMPLETED|Overall Study||144
412899|NCT01623310|1011338|P1|STARTED|Overall Study||223
412900|NCT01623271|1011347|P1|NOT COMPLETED|Overall Study||2
412901|NCT01623271|1011347|P1|COMPLETED|Overall Study||3
412902|NCT01623271|1011347|P1|STARTED|Overall Study||5
412903|NCT01623154|1011351|P1|NOT COMPLETED|Overall Study||4
412904|NCT01623154|1011351|P1|COMPLETED|Overall Study||95
412905|NCT01623154|1011351|P1|Available for Analysis|Overall Study||95
412906|NCT01623154|1011351|P1|STARTED|Overall Study||99
412907|NCT01623115|1011359|P2|NOT COMPLETED|Overall Study||77
412908|NCT01623115|1011360|P1|NOT COMPLETED|Overall Study||33
412909|NCT01623115|1011359|P2|COMPLETED|Overall Study||246
412910|NCT01623115|1011360|P1|COMPLETED|Overall Study||130
412911|NCT01623115|1011359|P2|Treated|Overall Study||322
412912|NCT01623115|1011360|P1|Treated|Overall Study||163
412913|NCT01623115|1011359|P2|STARTED|Overall Study|Randomized|323
412914|NCT01623115|1011360|P1|STARTED|Overall Study|Randomized|163
412915|NCT01623050|1011420|P1|NOT COMPLETED|Overall Study||9
412916|NCT01623050|1011420|P1|COMPLETED|Overall Study||27
412917|NCT01623050|1011420|P1|Treated|Overall Study||34
412918|NCT01623050|1011420|P1|STARTED|Overall Study||36
412919|NCT01622673|1011434|P6|NOT COMPLETED|Treatment Period 5||0
412920|NCT01622673|1011435|P5|NOT COMPLETED|Treatment Period 5||0
412921|NCT01622673|1011436|P4|NOT COMPLETED|Treatment Period 5||0
412922|NCT01622673|1011437|P3|NOT COMPLETED|Treatment Period 5||0
412923|NCT01622673|1011438|P2|NOT COMPLETED|Treatment Period 5||0
412924|NCT01622673|1011439|P1|NOT COMPLETED|Treatment Period 5||0
412925|NCT01622673|1011434|P6|COMPLETED|Treatment Period 5||4
412926|NCT01622673|1011435|P5|COMPLETED|Treatment Period 5||4
412927|NCT01622673|1011436|P4|COMPLETED|Treatment Period 5||4
412928|NCT01622673|1011437|P3|COMPLETED|Treatment Period 5||4
412929|NCT01622673|1011438|P2|COMPLETED|Treatment Period 5||3
412930|NCT01622673|1011439|P1|COMPLETED|Treatment Period 5||4
412931|NCT01622673|1011434|P6|STARTED|Treatment Period 5||4
412932|NCT01622673|1011435|P5|STARTED|Treatment Period 5||4
412933|NCT01622673|1011436|P4|STARTED|Treatment Period 5||4
412934|NCT01622673|1011437|P3|STARTED|Treatment Period 5||4
412935|NCT01622673|1011438|P2|STARTED|Treatment Period 5||3
412936|NCT01622673|1011439|P1|STARTED|Treatment Period 5||4
412937|NCT01622673|1011434|P6|NOT COMPLETED|Treatment Period 4||0
412938|NCT01622673|1011435|P5|NOT COMPLETED|Treatment Period 4||0
412939|NCT01622673|1011436|P4|NOT COMPLETED|Treatment Period 4||0
412940|NCT01622673|1011437|P3|NOT COMPLETED|Treatment Period 4||0
412941|NCT01622673|1011438|P2|NOT COMPLETED|Treatment Period 4||0
412942|NCT01622673|1011439|P1|NOT COMPLETED|Treatment Period 4||0
412943|NCT01622673|1011434|P6|COMPLETED|Treatment Period 4||4
412944|NCT01622673|1011435|P5|COMPLETED|Treatment Period 4||4
412945|NCT01622673|1011436|P4|COMPLETED|Treatment Period 4||4
412946|NCT01622673|1011437|P3|COMPLETED|Treatment Period 4||4
412947|NCT01622673|1011438|P2|COMPLETED|Treatment Period 4||3
412948|NCT01622673|1011439|P1|COMPLETED|Treatment Period 4||4
412949|NCT01622673|1011434|P6|STARTED|Treatment Period 4||4
412950|NCT01622673|1011435|P5|STARTED|Treatment Period 4||4
412951|NCT01622673|1011436|P4|STARTED|Treatment Period 4||4
412952|NCT01622673|1011437|P3|STARTED|Treatment Period 4||4
412953|NCT01622673|1011438|P2|STARTED|Treatment Period 4||3
412954|NCT01622673|1011439|P1|STARTED|Treatment Period 4||4
412955|NCT01622673|1011434|P6|NOT COMPLETED|Treatment Period 3||0
412956|NCT01622673|1011435|P5|NOT COMPLETED|Treatment Period 3||0
412957|NCT01622673|1011436|P4|NOT COMPLETED|Treatment Period 3||0
412958|NCT01622673|1011437|P3|NOT COMPLETED|Treatment Period 3||0
412959|NCT01622673|1011438|P2|NOT COMPLETED|Treatment Period 3||1
412960|NCT01622673|1011439|P1|NOT COMPLETED|Treatment Period 3||0
412961|NCT01622673|1011434|P6|COMPLETED|Treatment Period 3||4
412962|NCT01622673|1011435|P5|COMPLETED|Treatment Period 3||4
412963|NCT01622673|1011436|P4|COMPLETED|Treatment Period 3||4
412964|NCT01622673|1011437|P3|COMPLETED|Treatment Period 3||4
412965|NCT01622673|1011438|P2|COMPLETED|Treatment Period 3||3
412966|NCT01622673|1011439|P1|COMPLETED|Treatment Period 3||4
412967|NCT01622673|1011434|P6|STARTED|Treatment Period 3||4
412968|NCT01622673|1011435|P5|STARTED|Treatment Period 3||4
412969|NCT01622673|1011436|P4|STARTED|Treatment Period 3||4
412970|NCT01622673|1011437|P3|STARTED|Treatment Period 3||4
412971|NCT01622673|1011438|P2|STARTED|Treatment Period 3||4
412972|NCT01622673|1011439|P1|STARTED|Treatment Period 3||4
412973|NCT01622673|1011434|P6|NOT COMPLETED|Treatment Period 2||0
412974|NCT01622673|1011435|P5|NOT COMPLETED|Treatment Period 2||0
412975|NCT01622673|1011436|P4|NOT COMPLETED|Treatment Period 2||1
412976|NCT01622673|1011437|P3|NOT COMPLETED|Treatment Period 2||0
412977|NCT01622673|1011438|P2|NOT COMPLETED|Treatment Period 2||0
412978|NCT01622673|1011439|P1|NOT COMPLETED|Treatment Period 2||0
412979|NCT01622673|1011434|P6|COMPLETED|Treatment Period 2||4
412980|NCT01622673|1011435|P5|COMPLETED|Treatment Period 2||4
412981|NCT01622673|1011436|P4|COMPLETED|Treatment Period 2||4
412982|NCT01622673|1011437|P3|COMPLETED|Treatment Period 2||4
412983|NCT01622673|1011438|P2|COMPLETED|Treatment Period 2||4
412984|NCT01622673|1011439|P1|COMPLETED|Treatment Period 2||4
412985|NCT01622673|1011434|P6|STARTED|Treatment Period 2||4
412986|NCT01622673|1011435|P5|STARTED|Treatment Period 2||4
412987|NCT01622673|1011436|P4|STARTED|Treatment Period 2||5
412988|NCT01622673|1011437|P3|STARTED|Treatment Period 2||4
412989|NCT01622673|1011438|P2|STARTED|Treatment Period 2||4
412990|NCT01622673|1011439|P1|STARTED|Treatment Period 2||4
412991|NCT01622673|1011434|P6|NOT COMPLETED|Treatment Period 1||0
412992|NCT01622673|1011435|P5|NOT COMPLETED|Treatment Period 1||0
412993|NCT01622673|1011436|P4|NOT COMPLETED|Treatment Period 1||1
412994|NCT01622673|1011437|P3|NOT COMPLETED|Treatment Period 1||0
412995|NCT01622673|1011438|P2|NOT COMPLETED|Treatment Period 1||1
412996|NCT01622673|1011439|P1|NOT COMPLETED|Treatment Period 1||0
412997|NCT01622673|1011434|P6|COMPLETED|Treatment Period 1||4
412998|NCT01622673|1011435|P5|COMPLETED|Treatment Period 1||4
412999|NCT01622673|1011436|P4|COMPLETED|Treatment Period 1||5
413000|NCT01622673|1011437|P3|COMPLETED|Treatment Period 1||4
413001|NCT01622673|1011438|P2|COMPLETED|Treatment Period 1||4
413002|NCT01622673|1011439|P1|COMPLETED|Treatment Period 1||4
413003|NCT01622673|1011434|P6|STARTED|Treatment Period 1||4
413004|NCT01622673|1011435|P5|STARTED|Treatment Period 1||4
413005|NCT01622673|1011436|P4|STARTED|Treatment Period 1||6
413006|NCT01622673|1011437|P3|STARTED|Treatment Period 1||4
413007|NCT01622673|1011438|P2|STARTED|Treatment Period 1||5
413008|NCT01622673|1011439|P1|STARTED|Treatment Period 1||4
413009|NCT01622660|1011474|P1|NOT COMPLETED|Overall Study||1
413010|NCT01622660|1011474|P1|COMPLETED|Overall Study||1
413011|NCT01622660|1011474|P1|STARTED|Overall Study||2
413012|NCT01622348|1011481|P3|NOT COMPLETED|Overall Study||1
413013|NCT01622348|1011482|P2|NOT COMPLETED|Overall Study||0
413014|NCT01622348|1011483|P1|NOT COMPLETED|Overall Study||1
413015|NCT01622348|1011481|P3|COMPLETED|Overall Study||14
413016|NCT01622348|1011482|P2|COMPLETED|Overall Study||14
413017|NCT01622348|1011483|P1|COMPLETED|Overall Study||14
413018|NCT01622348|1011481|P3|STARTED|Overall Study||15
413019|NCT01622348|1011482|P2|STARTED|Overall Study||14
413020|NCT01622348|1011483|P1|STARTED|Overall Study||15
413021|NCT01622296|1011491|P2|NOT COMPLETED|Second Intervention||0
413022|NCT01622296|1011492|P1|NOT COMPLETED|Second Intervention||0
413023|NCT01622296|1011491|P2|COMPLETED|Second Intervention||10
413024|NCT01622296|1011492|P1|COMPLETED|Second Intervention||10
413025|NCT01622296|1011491|P2|STARTED|Second Intervention||10
413026|NCT01622296|1011492|P1|STARTED|Second Intervention||10
413027|NCT01622296|1011491|P2|NOT COMPLETED|Washout Period of at Least 1 Week||0
413028|NCT01622296|1011492|P1|NOT COMPLETED|Washout Period of at Least 1 Week||0
413029|NCT01622296|1011491|P2|COMPLETED|Washout Period of at Least 1 Week||10
413030|NCT01622296|1011492|P1|COMPLETED|Washout Period of at Least 1 Week||10
413031|NCT01622296|1011491|P2|STARTED|Washout Period of at Least 1 Week||10
413032|NCT01622296|1011492|P1|STARTED|Washout Period of at Least 1 Week||10
413033|NCT01622296|1011491|P2|NOT COMPLETED|First Intervention||0
413034|NCT01622296|1011492|P1|NOT COMPLETED|First Intervention||0
413035|NCT01622296|1011491|P2|COMPLETED|First Intervention||10
413036|NCT01622296|1011492|P1|COMPLETED|First Intervention||10
413037|NCT01622296|1011491|P2|STARTED|First Intervention||10
413038|NCT01622296|1011492|P1|STARTED|First Intervention||10
413039|NCT01622257|1011500|P3|NOT COMPLETED|Overall Study||0
413040|NCT01622257|1011501|P2|NOT COMPLETED|Overall Study||0
413041|NCT01622257|1011502|P1|NOT COMPLETED|Overall Study||0
413042|NCT01622257|1011500|P3|COMPLETED|Overall Study||66
413043|NCT01622257|1011501|P2|COMPLETED|Overall Study||66
413044|NCT01622257|1011502|P1|COMPLETED|Overall Study||66
413045|NCT01622257|1011500|P3|STARTED|Overall Study||66
413046|NCT01622257|1011501|P2|STARTED|Overall Study||66
413047|NCT01622257|1011502|P1|STARTED|Overall Study||66
413048|NCT01622231|1011522|P1|NOT COMPLETED|Overall Study||2
413049|NCT01622231|1011522|P1|COMPLETED|Overall Study||59
413050|NCT01622231|1011522|P1|STARTED|Overall Study||61
413051|NCT01621802|1011556|P6|NOT COMPLETED|Overall Study||12
413052|NCT01621802|1011557|P5|NOT COMPLETED|Overall Study||35
413053|NCT01621802|1011558|P4|NOT COMPLETED|Overall Study||11
413054|NCT01621802|1011559|P3|NOT COMPLETED|Overall Study||33
413055|NCT01621802|1011560|P2|NOT COMPLETED|Overall Study||23
413056|NCT01621802|1011561|P1|NOT COMPLETED|Overall Study||47
413057|NCT01621802|1011556|P6|COMPLETED|Overall Study||477
413058|NCT01621802|1011557|P5|COMPLETED|Overall Study||1284
413059|NCT01621802|1011558|P4|COMPLETED|Overall Study||292
413060|NCT01621802|1011559|P3|COMPLETED|Overall Study||763
413061|NCT01621802|1011560|P2|COMPLETED|Overall Study||275
413062|NCT01621802|1011561|P1|COMPLETED|Overall Study||755
413063|NCT01621802|1011556|P6|STARTED|Overall Study||489
413064|NCT01621802|1011557|P5|STARTED|Overall Study||1319
413065|NCT01621802|1011558|P4|STARTED|Overall Study||303
413066|NCT01621802|1011559|P3|STARTED|Overall Study||796
413067|NCT01621802|1011560|P2|STARTED|Overall Study||298
413068|NCT01621802|1011561|P1|STARTED|Overall Study||802
413069|NCT01621776|1011668|P3|NOT COMPLETED|Overall Study||0
413070|NCT01621776|1011669|P2|NOT COMPLETED|Overall Study||0
413071|NCT01621776|1011670|P1|NOT COMPLETED|Overall Study||0
413072|NCT01621776|1011668|P3|COMPLETED|Overall Study||18
413073|NCT01621776|1011669|P2|COMPLETED|Overall Study||40
413074|NCT01621776|1011670|P1|COMPLETED|Overall Study||41
413075|NCT01621776|1011668|P3|STARTED|Overall Study||18
413076|NCT01621776|1011669|P2|STARTED|Overall Study||40
413077|NCT01621776|1011670|P1|STARTED|Overall Study||41
413078|NCT01621672|1011686|P2|NOT COMPLETED|Overall Study||0
413079|NCT01621672|1011687|P1|NOT COMPLETED|Overall Study||0
413080|NCT01621672|1011686|P2|COMPLETED|Overall Study||17
413081|NCT01621672|1011687|P1|COMPLETED|Overall Study||25
413082|NCT01621672|1011686|P2|STARTED|Overall Study||17
413083|NCT01621672|1011687|P1|STARTED|Overall Study||25
413084|NCT01621633|1011697|P4|NOT COMPLETED|Overall Study||0
413085|NCT01621633|1011698|P3|NOT COMPLETED|Overall Study||0
413086|NCT01621633|1011699|P2|NOT COMPLETED|Overall Study||0
413087|NCT01621633|1011700|P1|NOT COMPLETED|Overall Study||0
413088|NCT01621633|1011697|P4|COMPLETED|Overall Study||8
413089|NCT01621633|1011698|P3|COMPLETED|Overall Study||8
413090|NCT01621633|1011699|P2|COMPLETED|Overall Study||8
413091|NCT01621633|1011700|P1|COMPLETED|Overall Study||8
413092|NCT01621633|1011697|P4|STARTED|Overall Study||8
413093|NCT01621633|1011698|P3|STARTED|Overall Study||8
413094|NCT01621633|1011699|P2|STARTED|Overall Study||8
413095|NCT01621633|1011700|P1|STARTED|Overall Study||8
413096|NCT01621477|1011722|P1|NOT COMPLETED|Overall Study||0
413097|NCT01621477|1011722|P1|COMPLETED|Overall Study||17
413098|NCT01621477|1011722|P1|STARTED|Overall Study||17
413099|NCT01621191|1011732|P1|NOT COMPLETED|Overall Study||25
413100|NCT01621191|1011732|P1|COMPLETED|Overall Study||124
413101|NCT01621191|1011732|P1|Had at Least 1 Post-Baseline Observation|Overall Study||148
413102|NCT01621191|1011732|P1|Received at Least 1 Dose of Study Drug|Overall Study||149
413103|NCT01621191|1011732|P1|STARTED|Overall Study||149
413104|NCT01621178|1011746|P3|NOT COMPLETED|Overall Study||36
413105|NCT01621178|1011747|P2|NOT COMPLETED|Overall Study||30
413106|NCT01621178|1011748|P1|NOT COMPLETED|Overall Study||31
413107|NCT01621178|1011746|P3|COMPLETED|Overall Study||157
413108|NCT01621178|1011747|P2|COMPLETED|Overall Study||160
413109|NCT01621178|1011748|P1|COMPLETED|Overall Study||163
413110|NCT01621178|1011746|P3|Modified Intent to Treat Population|Overall Study||183
413111|NCT01621178|1011747|P2|Modified Intent to Treat Population|Overall Study||180
413112|NCT01621178|1011748|P1|Modified Intent to Treat Population|Overall Study||186
413113|NCT01621178|1011746|P3|Received at Least One Dose of Study Drug|Overall Study||192
413114|NCT01621178|1011747|P2|Received at Least One Dose of Study Drug|Overall Study||190
413115|NCT01621178|1011748|P1|Received at Least One Dose of Study Drug|Overall Study||194
413116|NCT01621178|1011746|P3|STARTED|Overall Study||193
413117|NCT01621178|1011747|P2|STARTED|Overall Study||190
413118|NCT01621178|1011748|P1|STARTED|Overall Study||194
413119|NCT01621126|1011840|P1|NOT COMPLETED|Overall Study||6
413120|NCT01621126|1011840|P1|COMPLETED|Overall Study||34
413121|NCT01621126|1011840|P1|STARTED|Overall Study||40
413122|NCT01621009|1011848|P4|NOT COMPLETED|Overall Study||53
413123|NCT01621009|1011849|P3|NOT COMPLETED|Overall Study||63
413124|NCT01621009|1011850|P2|NOT COMPLETED|Overall Study||51
413125|NCT01621009|1011851|P1|NOT COMPLETED|Overall Study||43
413126|NCT01621009|1011848|P4|COMPLETED|Overall Study||60
413127|NCT01621009|1011849|P3|COMPLETED|Overall Study||58
413128|NCT01621009|1011850|P2|COMPLETED|Overall Study||65
413129|NCT01621009|1011851|P1|COMPLETED|Overall Study||70
413130|NCT01621009|1011848|P4|STARTED|Overall Study||113
413131|NCT01621009|1011849|P3|STARTED|Overall Study||121
413132|NCT01621009|1011850|P2|STARTED|Overall Study||116
413133|NCT01621009|1011851|P1|STARTED|Overall Study||113
413134|NCT01620762|1011862|P3|NOT COMPLETED|Overall Study||53
413135|NCT01620762|1011863|P2|NOT COMPLETED|Overall Study||58
413136|NCT01620762|1011864|P1|NOT COMPLETED|Overall Study||48
413137|NCT01620762|1011862|P3|COMPLETED|Overall Study||417
413138|NCT01620762|1011863|P2|COMPLETED|Overall Study||412
413139|NCT01620762|1011864|P1|COMPLETED|Overall Study||420
413140|NCT01620762|1011862|P3|STARTED|Overall Study||470
413141|NCT01620762|1011863|P2|STARTED|Overall Study||470
413142|NCT01620762|1011864|P1|STARTED|Overall Study||468
413143|NCT01620593|1011892|P2|NOT COMPLETED|Overall Study||1
413144|NCT01620593|1011893|P1|NOT COMPLETED|Overall Study||4
413145|NCT01620593|1011892|P2|COMPLETED|Overall Study||19
413146|NCT01620593|1011893|P1|COMPLETED|Overall Study||17
413147|NCT01620593|1011892|P2|STARTED|Overall Study||20
413148|NCT01620593|1011893|P1|STARTED|Overall Study||21
413149|NCT01620489|1011909|P2|NOT COMPLETED|Overall Study||34
413150|NCT01620489|1011910|P1|NOT COMPLETED|Overall Study||35
413151|NCT01620489|1011909|P2|COMPLETED|Overall Study|2 subjects did not take trial product|105
413152|NCT01620489|1011910|P1|COMPLETED|Overall Study||105
413153|NCT01620489|1011909|P2|Exposed|Overall Study|2 subjects did not take trial product|137
413154|NCT01620489|1011910|P1|Exposed|Overall Study||140
413155|NCT01620489|1011909|P2|STARTED|Overall Study||139
413156|NCT01620489|1011910|P1|STARTED|Overall Study||140
413157|NCT01620255|1011931|P5|NOT COMPLETED|Overall Study||6
413158|NCT01620255|1011932|P4|NOT COMPLETED|Overall Study||3
413159|NCT01620255|1011933|P3|NOT COMPLETED|Overall Study||2
413160|NCT01620255|1011934|P2|NOT COMPLETED|Overall Study||6
413161|NCT01620255|1011935|P1|NOT COMPLETED|Overall Study||4
413162|NCT01620255|1011931|P5|COMPLETED|Overall Study||64
413163|NCT01620255|1011932|P4|COMPLETED|Overall Study||70
413164|NCT01620255|1011933|P3|COMPLETED|Overall Study||68
413165|NCT01620255|1011934|P2|COMPLETED|Overall Study||65
413166|NCT01620255|1011935|P1|COMPLETED|Overall Study||69
413167|NCT01620255|1011931|P5|Treated|Overall Study||70
413168|NCT01620255|1011932|P4|Treated|Overall Study||73
413169|NCT01620255|1011933|P3|Treated|Overall Study||70
413170|NCT01620255|1011934|P2|Treated|Overall Study||71
413171|NCT01620255|1011935|P1|Treated|Overall Study||73
413172|NCT01620255|1011931|P5|STARTED|Overall Study||70
413173|NCT01620255|1011932|P4|STARTED|Overall Study||73
413174|NCT01620255|1011933|P3|STARTED|Overall Study||70
413175|NCT01620255|1011934|P2|STARTED|Overall Study||71
413176|NCT01620255|1011935|P1|STARTED|Overall Study||73
413177|NCT01620177|1012012|P1|NOT COMPLETED|Overall Study||79
413178|NCT01620177|1012012|P1|COMPLETED|Overall Study||19
413179|NCT01620177|1012012|P1|STARTED|Overall Study||98
413180|NCT01620138|1012037|P2|NOT COMPLETED|Overall Study||0
413181|NCT01620138|1012038|P1|NOT COMPLETED|Overall Study||6
413182|NCT01620138|1012037|P2|COMPLETED|Overall Study||9
413183|NCT01620138|1012038|P1|COMPLETED|Overall Study||6
413184|NCT01620138|1012037|P2|STARTED|Overall Study||9
413185|NCT01620138|1012038|P1|STARTED|Overall Study||12
413186|NCT01620086|1012046|P3|NOT COMPLETED|Overall Study||0
413187|NCT01620086|1012047|P2|NOT COMPLETED|Overall Study||7
413188|NCT01620086|1012048|P1|NOT COMPLETED|Overall Study||5
413189|NCT01620086|1012046|P3|COMPLETED|Overall Study||2
413190|NCT01620086|1012047|P2|COMPLETED|Overall Study||4
413191|NCT01620086|1012048|P1|COMPLETED|Overall Study||8
413192|NCT01620086|1012046|P3|STARTED|Overall Study||2
413193|NCT01620086|1012047|P2|STARTED|Overall Study||11
413194|NCT01620086|1012048|P1|STARTED|Overall Study||13
413195|NCT01620060|1012067|P1|NOT COMPLETED|Overall Study||15
413196|NCT01620060|1012067|P1|COMPLETED|Overall Study||90
413197|NCT01620060|1012067|P1|STARTED|Overall Study||105
413198|NCT01620047|1012076|P3|NOT COMPLETED|Overall Study||0
413199|NCT01620047|1012077|P2|NOT COMPLETED|Overall Study||0
413200|NCT01620047|1012078|P1|NOT COMPLETED|Overall Study||0
413201|NCT01620047|1012076|P3|COMPLETED|Overall Study||20
413202|NCT01620047|1012077|P2|COMPLETED|Overall Study||20
413203|NCT01620047|1012078|P1|COMPLETED|Overall Study||20
413204|NCT01620047|1012076|P3|STARTED|Overall Study||20
413205|NCT01620047|1012077|P2|STARTED|Overall Study||20
413206|NCT01620047|1012078|P1|STARTED|Overall Study||20
413207|NCT01619982|1012088|P2|NOT COMPLETED|Overall Study||0
413208|NCT01619982|1012089|P1|NOT COMPLETED|Overall Study||0
413209|NCT01619982|1012088|P2|COMPLETED|Overall Study||12
413210|NCT01619982|1012089|P1|COMPLETED|Overall Study||20
413211|NCT01619982|1012088|P2|STARTED|Overall Study||12
413212|NCT01619982|1012089|P1|STARTED|Overall Study||20
413213|NCT01619878|1012105|P1|NOT COMPLETED|Follow-up at 12 Months of Age||3
413214|NCT01619878|1012105|P1|COMPLETED|Follow-up at 12 Months of Age||17
413215|NCT01619878|1012105|P1|STARTED|Follow-up at 12 Months of Age||20
413216|NCT01619878|1012105|P1|NOT COMPLETED|6 Week Follow-up Phase||1
413217|NCT01619878|1012105|P1|COMPLETED|6 Week Follow-up Phase||19
413218|NCT01619878|1012105|P1|STARTED|6 Week Follow-up Phase||20
413219|NCT01619800|1012119|P2|NOT COMPLETED|Overall Study||0
413220|NCT01619800|1012120|P1|NOT COMPLETED|Overall Study||2
413221|NCT01619800|1012119|P2|COMPLETED|Overall Study||0
413222|NCT01619800|1012120|P1|COMPLETED|Overall Study||0
413223|NCT01619800|1012119|P2|STARTED|Overall Study||0
413224|NCT01619800|1012120|P1|STARTED|Overall Study||2
413225|NCT01619787|1012128|P1|NOT COMPLETED|Overall Study||5
413226|NCT01619787|1012128|P1|COMPLETED|Overall Study||212
413227|NCT01619787|1012128|P1|STARTED|Overall Study||217
413228|NCT01619774|1012137|P1|NOT COMPLETED|Overall Study||0
413229|NCT01619774|1012137|P1|COMPLETED|Overall Study||23
413230|NCT01619774|1012137|P1|STARTED|Overall Study||23
413231|NCT01619579|1012145|P2|NOT COMPLETED|Overall Study||3
413232|NCT01619579|1012146|P1|NOT COMPLETED|Overall Study||0
413233|NCT01619579|1012145|P2|COMPLETED|Overall Study||14
413234|NCT01619579|1012146|P1|COMPLETED|Overall Study||5
413235|NCT01619579|1012145|P2|STARTED|Overall Study||17
413236|NCT01619579|1012146|P1|STARTED|Overall Study||5
413237|NCT01619059|1012158|P2|NOT COMPLETED|Long-Term (LT) Treatment Period||9
413238|NCT01619059|1012159|P1|NOT COMPLETED|Long-Term (LT) Treatment Period||8
413239|NCT01619059|1012158|P2|COMPLETED|Long-Term (LT) Treatment Period||133
413240|NCT01619059|1012159|P1|COMPLETED|Long-Term (LT) Treatment Period||147
413241|NCT01619059|1012158|P2|STARTED|Long-Term (LT) Treatment Period||142
413242|NCT01619059|1012159|P1|STARTED|Long-Term (LT) Treatment Period||155
413243|NCT01619059|1012158|P2|NOT COMPLETED|Short-Term (ST) Treatment Period||11
413244|NCT01619059|1012159|P1|NOT COMPLETED|Short-Term (ST) Treatment Period||6
413245|NCT01619059|1012158|P2|COMPLETED|Short-Term (ST) Treatment Period||142
413246|NCT01619059|1012159|P1|COMPLETED|Short-Term (ST) Treatment Period||156
413247|NCT01619059|1012158|P2|STARTED|Short-Term (ST) Treatment Period||153
413248|NCT01619059|1012159|P1|STARTED|Short-Term (ST) Treatment Period||162
413249|NCT01618968|1012175|P4|NOT COMPLETED|Overall Study||1
413250|NCT01618968|1012176|P3|NOT COMPLETED|Overall Study||0
413251|NCT01618968|1012177|P2|NOT COMPLETED|Overall Study||0
413252|NCT01618968|1012178|P1|NOT COMPLETED|Overall Study||1
413253|NCT01618968|1012175|P4|COMPLETED|Overall Study||11
413254|NCT01618968|1012176|P3|COMPLETED|Overall Study||12
413255|NCT01618968|1012177|P2|COMPLETED|Overall Study||12
413256|NCT01618968|1012178|P1|COMPLETED|Overall Study||12
413257|NCT01618968|1012175|P4|Received Treatment C|Overall Study||11
413258|NCT01618968|1012176|P3|Received Treatment C|Overall Study||12
413259|NCT01618968|1012177|P2|Received Treatment C|Overall Study||12
413260|NCT01618968|1012178|P1|Received Treatment C|Overall Study||12
413261|NCT01618968|1012175|P4|Received Treatment B|Overall Study||12
413262|NCT01618968|1012176|P3|Received Treatment B|Overall Study||12
413263|NCT01618968|1012177|P2|Received Treatment B|Overall Study||12
413264|NCT01618968|1012178|P1|Received Treatment B|Overall Study||13
413265|NCT01618968|1012175|P4|Received Treatment A|Overall Study||11
413266|NCT01618968|1012176|P3|Received Treatment A|Overall Study||12
413267|NCT01618968|1012177|P2|Received Treatment A|Overall Study||12
413268|NCT01618968|1012178|P1|Received Treatment A|Overall Study||12
413269|NCT01618968|1012175|P4|STARTED|Overall Study||12
413270|NCT01618968|1012176|P3|STARTED|Overall Study||12
413271|NCT01618968|1012177|P2|STARTED|Overall Study||12
413272|NCT01618968|1012178|P1|STARTED|Overall Study||13
413273|NCT01618955|1012197|P4|NOT COMPLETED|Overall Study||0
413274|NCT01618955|1012198|P3|NOT COMPLETED|Overall Study||0
413275|NCT01618955|1012199|P2|NOT COMPLETED|Overall Study||0
413276|NCT01618955|1012200|P1|NOT COMPLETED|Overall Study||0
413277|NCT01618955|1012197|P4|COMPLETED|Overall Study||20
413278|NCT01618955|1012198|P3|COMPLETED|Overall Study||31
413279|NCT01618955|1012199|P2|COMPLETED|Overall Study||30
413280|NCT01618955|1012200|P1|COMPLETED|Overall Study||20
413281|NCT01618955|1012197|P4|STARTED|Overall Study||20
413282|NCT01618955|1012198|P3|STARTED|Overall Study||31
413283|NCT01618955|1012199|P2|STARTED|Overall Study||30
413284|NCT01618955|1012200|P1|STARTED|Overall Study||20
413285|NCT01618942|1012224|P2|NOT COMPLETED|Overall Study||0
413286|NCT01618942|1012225|P1|NOT COMPLETED|Overall Study||0
413287|NCT01618942|1012224|P2|COMPLETED|Overall Study||50
413288|NCT01618942|1012225|P1|COMPLETED|Overall Study||50
413289|NCT01618942|1012224|P2|STARTED|Overall Study||50
413290|NCT01618942|1012225|P1|STARTED|Overall Study||50
413291|NCT01618864|1012245|P1|NOT COMPLETED|Overall Study||4
413292|NCT01618864|1012245|P1|COMPLETED|Overall Study|Completed 4 weeks and 8 weeks of treatment|19
413293|NCT01618864|1012245|P1|Completed 2 Weeks|Overall Study||19
413294|NCT01618864|1012245|P1|STARTED|Overall Study||23
413295|NCT01618838|1012254|P1|NOT COMPLETED|Overall Study||4
413296|NCT01618838|1012254|P1|COMPLETED|Overall Study||0
413297|NCT01618838|1012254|P1|STARTED|Overall Study||4
413298|NCT01618708|1012260|P2|NOT COMPLETED|Overall Study||46
413299|NCT01618708|1012261|P1|NOT COMPLETED|Overall Study||44
413300|NCT01618708|1012260|P2|COMPLETED|Overall Study||136
413301|NCT01618708|1012261|P1|COMPLETED|Overall Study||131
413302|NCT01618708|1012260|P2|Treated|Overall Study||180
413303|NCT01618708|1012261|P1|Treated|Overall Study||172
413304|NCT01618708|1012260|P2|STARTED|Overall Study||182
413305|NCT01618708|1012261|P1|STARTED|Overall Study||175
413306|NCT01618669|1012275|P2|NOT COMPLETED|Overall Study||23
413307|NCT01618669|1012276|P1|NOT COMPLETED|Overall Study||34
413308|NCT01618669|1012275|P2|COMPLETED|Overall Study||546
413309|NCT01618669|1012276|P1|COMPLETED|Overall Study||544
413310|NCT01618669|1012275|P2|Received Treatment|Overall Study||567
413311|NCT01618669|1012276|P1|Received Treatment|Overall Study||575
413312|NCT01618669|1012275|P2|STARTED|Overall Study||569
413313|NCT01618669|1012276|P1|STARTED|Overall Study||578
413314|NCT01618422|1012322|P2|NOT COMPLETED|Overall Study||0
413315|NCT01618422|1012323|P1|NOT COMPLETED|Overall Study||0
413316|NCT01618422|1012322|P2|COMPLETED|Overall Study||111
413317|NCT01618422|1012323|P1|COMPLETED|Overall Study||114
413318|NCT01618422|1012322|P2|STARTED|Overall Study||111
413319|NCT01618422|1012323|P1|STARTED|Overall Study||114
413320|NCT01618344|1012329|P1|NOT COMPLETED|Overall Study||9
413321|NCT01618344|1012329|P1|COMPLETED|Overall Study||23
413322|NCT01618344|1012329|P1|STARTED|Overall Study||32
413323|NCT01618266|1012333|P1|NOT COMPLETED|Overall Study||96
413324|NCT01618266|1012333|P1|COMPLETED|Overall Study||279
413325|NCT01618266|1012333|P1|STARTED|Overall Study||375
413326|NCT01618240|1012348|P1|NOT COMPLETED|Overall Study||0
413327|NCT01618240|1012348|P1|COMPLETED|Overall Study||30
413328|NCT01618240|1012348|P1|STARTED|Overall Study||30
413329|NCT01618227|1012355|P2|NOT COMPLETED|Overall Study||2
413330|NCT01618227|1012356|P1|NOT COMPLETED|Overall Study||0
413331|NCT01618227|1012355|P2|COMPLETED|Overall Study||0
413332|NCT01618227|1012356|P1|COMPLETED|Overall Study||2
413333|NCT01618227|1012355|P2|STARTED|Overall Study||2
413334|NCT01618227|1012356|P1|STARTED|Overall Study||2
413335|NCT01618214|1012370|P2|NOT COMPLETED|Overall Study||13
413336|NCT01618214|1012371|P1|NOT COMPLETED|Overall Study||10
413337|NCT01618214|1012370|P2|COMPLETED|Overall Study||159
413338|NCT01618214|1012371|P1|COMPLETED|Overall Study||162
413339|NCT01618214|1012370|P2|Exposed|Overall Study||172
413340|NCT01618214|1012371|P1|Exposed|Overall Study||172
413341|NCT01618214|1012370|P2|STARTED|Overall Study||172
413342|NCT01618214|1012371|P1|STARTED|Overall Study||172
413343|NCT01618162|1012387|P2|NOT COMPLETED|Overall Study||35
413344|NCT01618162|1012388|P1|NOT COMPLETED|Overall Study||38
413345|NCT01618162|1012387|P2|COMPLETED|Overall Study||111
413346|NCT01618162|1012388|P1|COMPLETED|Overall Study||251
413347|NCT01618162|1012387|P2|Exposed|Overall Study||146
413348|NCT01618162|1012388|P1|Exposed|Overall Study||288
413349|NCT01618162|1012387|P2|STARTED|Overall Study||146
413350|NCT01618162|1012388|P1|STARTED|Overall Study||289
413351|NCT01618019|1012408|P2|NOT COMPLETED|Overall Study||14
413352|NCT01618019|1012409|P1|NOT COMPLETED|Overall Study||14
413353|NCT01618019|1012408|P2|COMPLETED|Overall Study||40
413354|NCT01618019|1012409|P1|COMPLETED|Overall Study||41
413355|NCT01618019|1012408|P2|STARTED|Overall Study||54
413356|NCT01618019|1012409|P1|STARTED|Overall Study||55
413357|NCT01617681|1012433|P5|NOT COMPLETED|Period 2 Open Label||6
413358|NCT01617681|1012434|P4|NOT COMPLETED|Period 2 Open Label||0
413359|NCT01617681|1012435|P3|NOT COMPLETED|Period 2 Open Label||0
413360|NCT01617681|1012436|P2|NOT COMPLETED|Period 2 Open Label||0
413361|NCT01617681|1012437|P1|NOT COMPLETED|Period 2 Open Label||0
413362|NCT01617681|1012433|P5|COMPLETED|Period 2 Open Label||114
413363|NCT01617681|1012434|P4|COMPLETED|Period 2 Open Label||0
413364|NCT01617681|1012435|P3|COMPLETED|Period 2 Open Label||0
413365|NCT01617681|1012436|P2|COMPLETED|Period 2 Open Label||0
413366|NCT01617681|1012437|P1|COMPLETED|Period 2 Open Label||0
413367|NCT01617681|1012433|P5|STARTED|Period 2 Open Label||120
413368|NCT01617681|1012434|P4|STARTED|Period 2 Open Label||0
413369|NCT01617681|1012435|P3|STARTED|Period 2 Open Label||0
413370|NCT01617681|1012436|P2|STARTED|Period 2 Open Label||0
413371|NCT01617681|1012437|P1|STARTED|Period 2 Open Label||0
413372|NCT01617681|1012433|P5|NOT COMPLETED|Period 1 Double Blind||0
413373|NCT01617681|1012434|P4|NOT COMPLETED|Period 1 Double Blind||2
413374|NCT01617681|1012435|P3|NOT COMPLETED|Period 1 Double Blind||1
413375|NCT01617681|1012436|P2|NOT COMPLETED|Period 1 Double Blind||1
413376|NCT01617681|1012437|P1|NOT COMPLETED|Period 1 Double Blind||3
413377|NCT01617681|1012433|P5|COMPLETED|Period 1 Double Blind||0
413378|NCT01617681|1012434|P4|COMPLETED|Period 1 Double Blind||29
413379|NCT01617681|1012435|P3|COMPLETED|Period 1 Double Blind||32
413380|NCT01617681|1012436|P2|COMPLETED|Period 1 Double Blind||30
413381|NCT01617681|1012437|P1|COMPLETED|Period 1 Double Blind||29
413382|NCT01617681|1012433|P5|Full Analysis Set (FAS)|Period 1 Double Blind||0
413383|NCT01617681|1012434|P4|Full Analysis Set (FAS)|Period 1 Double Blind||31
413384|NCT01617681|1012435|P3|Full Analysis Set (FAS)|Period 1 Double Blind||33
413385|NCT01617681|1012436|P2|Full Analysis Set (FAS)|Period 1 Double Blind||31
413386|NCT01617681|1012437|P1|Full Analysis Set (FAS)|Period 1 Double Blind||31
413387|NCT01617681|1012433|P5|STARTED|Period 1 Double Blind||0
413388|NCT01617681|1012434|P4|STARTED|Period 1 Double Blind||31
413389|NCT01617681|1012435|P3|STARTED|Period 1 Double Blind||33
413390|NCT01617681|1012436|P2|STARTED|Period 1 Double Blind||31
413391|NCT01617681|1012437|P1|STARTED|Period 1 Double Blind||32
413392|NCT01617668|1012458|P4|NOT COMPLETED|Overall Study||15
413393|NCT01617668|1012459|P3|NOT COMPLETED|Overall Study||23
413394|NCT01617668|1012460|P2|NOT COMPLETED|Overall Study||9
413395|NCT01617668|1012461|P1|NOT COMPLETED|Overall Study||13
413396|NCT01617668|1012458|P4|COMPLETED|Overall Study||38
413397|NCT01617668|1012459|P3|COMPLETED|Overall Study||32
413398|NCT01617668|1012460|P2|COMPLETED|Overall Study||41
413399|NCT01617668|1012461|P1|COMPLETED|Overall Study||38
413400|NCT01617668|1012458|P4|Randomized Patients|Overall Study||55
413401|NCT01617668|1012459|P3|Randomized Patients|Overall Study||55
413402|NCT01617668|1012460|P2|Randomized Patients|Overall Study||54
413403|NCT01617668|1012461|P1|Randomized Patients|Overall Study||51
413404|NCT01617668|1012458|P4|STARTED|Overall Study|55 patients were randomized and only 53 received study treatment.|53
413405|NCT01617668|1012459|P3|STARTED|Overall Study||55
413406|NCT01617668|1012460|P2|STARTED|Overall Study|54 patients were randomized and only 50 received study treatment.|50
413407|NCT01617668|1012461|P1|STARTED|Overall Study||51
413408|NCT01617655|1012502|P2|NOT COMPLETED|Overall Study||29
413409|NCT01617655|1012503|P1|NOT COMPLETED|Overall Study||9
413410|NCT01617655|1012502|P2|COMPLETED|Overall Study||43
413411|NCT01617655|1012503|P1|COMPLETED|Overall Study||26
413412|NCT01617655|1012502|P2|Treated|Overall Study||72
413413|NCT01617655|1012503|P1|Treated|Overall Study||35
413414|NCT01617655|1012502|P2|STARTED|Overall Study|Randomized|72
413415|NCT01617655|1012503|P1|STARTED|Overall Study|Randomized|35
413416|NCT01617629|1012563|P1|NOT COMPLETED|Overall Study||6
413417|NCT01617629|1012563|P1|COMPLETED|Overall Study||3
413418|NCT01617629|1012563|P1|STARTED|Overall Study||9
413419|NCT01617603|1012571|P3|NOT COMPLETED|Overall Study||1
413420|NCT01617603|1012572|P2|NOT COMPLETED|Overall Study||2
413421|NCT01617603|1012573|P1|NOT COMPLETED|Overall Study||3
413422|NCT01617603|1012571|P3|COMPLETED|Overall Study||20
413423|NCT01617603|1012572|P2|COMPLETED|Overall Study||19
413424|NCT01617603|1012573|P1|COMPLETED|Overall Study||17
413425|NCT01617603|1012571|P3|STARTED|Overall Study||21
413426|NCT01617603|1012572|P2|STARTED|Overall Study||21
413427|NCT01617603|1012573|P1|STARTED|Overall Study||20
413428|NCT01617577|1012583|P2|NOT COMPLETED|Overall Study||0
413429|NCT01617577|1012584|P1|NOT COMPLETED|Overall Study||0
413430|NCT01617577|1012583|P2|COMPLETED|Overall Study||3
413431|NCT01617577|1012584|P1|COMPLETED|Overall Study||5
413432|NCT01617577|1012583|P2|STARTED|Overall Study||3
413433|NCT01617577|1012584|P1|STARTED|Overall Study||5
413434|NCT01617460|1012591|P1|NOT COMPLETED|Overall Study||40
413435|NCT01617460|1012591|P1|COMPLETED|Overall Study||46
413436|NCT01617460|1012591|P1|STARTED|Overall Study||86
413437|NCT01617447|1012597|P2|NOT COMPLETED|Overall Study||3
413438|NCT01617447|1012598|P1|NOT COMPLETED|Overall Study||0
413439|NCT01617447|1012597|P2|COMPLETED|Overall Study||42
413440|NCT01617447|1012598|P1|COMPLETED|Overall Study||47
413441|NCT01617447|1012597|P2|STARTED|Overall Study||45
413442|NCT01617447|1012598|P1|STARTED|Overall Study||47
413443|NCT01617434|1012606|P2|NOT COMPLETED|Overall Study||51
413444|NCT01617434|1012607|P1|NOT COMPLETED|Overall Study||35
413445|NCT01617434|1012606|P2|COMPLETED|Overall Study||174
413446|NCT01617434|1012607|P1|COMPLETED|Overall Study||191
413447|NCT01617434|1012606|P2|Exposed|Overall Study||225
413448|NCT01617434|1012607|P1|Exposed|Overall Study||225
413449|NCT01617434|1012606|P2|STARTED|Overall Study||225
413450|NCT01617434|1012607|P1|STARTED|Overall Study||226
413451|NCT01617369|1012629|P1|NOT COMPLETED|Overall Study||0
413452|NCT01617369|1012629|P1|COMPLETED|Overall Study||12
413453|NCT01617369|1012629|P1|STARTED|Overall Study||12
413454|NCT01617187|1012639|P4|NOT COMPLETED|Treatment Through Study Completion||10
413455|NCT01617187|1012640|P3|NOT COMPLETED|Treatment Through Study Completion||5
413456|NCT01617187|1012641|P2|NOT COMPLETED|Treatment Through Study Completion||11
413457|NCT01617187|1012642|P1|NOT COMPLETED|Treatment Through Study Completion||11
413458|NCT01617187|1012639|P4|COMPLETED|Treatment Through Study Completion||91
413459|NCT01617187|1012640|P3|COMPLETED|Treatment Through Study Completion||41
413460|NCT01617187|1012641|P2|COMPLETED|Treatment Through Study Completion||102
413461|NCT01617187|1012642|P1|COMPLETED|Treatment Through Study Completion|Excludes the participant who did not receive study drug but completed study in database|86
413462|NCT01617187|1012639|P4|STARTED|Treatment Through Study Completion|Treated|101
413463|NCT01617187|1012640|P3|STARTED|Treatment Through Study Completion|Treated|46
413464|NCT01617187|1012641|P2|STARTED|Treatment Through Study Completion|Treated|113
413465|NCT01617187|1012642|P1|STARTED|Treatment Through Study Completion|Treated|97
413466|NCT01617187|1012639|P4|NOT COMPLETED|Randomization Through Start Treatment||2
413467|NCT01617187|1012640|P3|NOT COMPLETED|Randomization Through Start Treatment||0
413468|NCT01617187|1012641|P2|NOT COMPLETED|Randomization Through Start Treatment||0
413469|NCT01617187|1012642|P1|NOT COMPLETED|Randomization Through Start Treatment||1
413470|NCT01617187|1012639|P4|COMPLETED|Randomization Through Start Treatment||101
413471|NCT01617187|1012640|P3|COMPLETED|Randomization Through Start Treatment||46
413472|NCT01617187|1012641|P2|COMPLETED|Randomization Through Start Treatment||113
413473|NCT01617187|1012642|P1|COMPLETED|Randomization Through Start Treatment||97
413474|NCT01617187|1012639|P4|STARTED|Randomization Through Start Treatment|Randomized|103
413475|NCT01617187|1012640|P3|STARTED|Randomization Through Start Treatment|Randomized|46
413476|NCT01617187|1012641|P2|STARTED|Randomization Through Start Treatment|Randomized|113
413477|NCT01617187|1012642|P1|STARTED|Randomization Through Start Treatment|Randomized|98
413478|NCT01617083|1012715|P3|NOT COMPLETED|Overall Study||0
413479|NCT01617083|1012716|P2|NOT COMPLETED|Overall Study||0
413480|NCT01617083|1012717|P1|NOT COMPLETED|Overall Study||0
413481|NCT01617083|1012715|P3|COMPLETED|Overall Study||15
413482|NCT01617083|1012716|P2|COMPLETED|Overall Study||14
413483|NCT01617083|1012717|P1|COMPLETED|Overall Study||18
413484|NCT01617083|1012715|P3|STARTED|Overall Study||15
413485|NCT01617083|1012716|P2|STARTED|Overall Study||14
413486|NCT01617083|1012717|P1|STARTED|Overall Study||18
413487|NCT01617070|1012728|P1|NOT COMPLETED|BH4 and LNAA (4 Weeks)||1
413488|NCT01617070|1012728|P1|COMPLETED|BH4 and LNAA (4 Weeks)||9
413489|NCT01617070|1012728|P1|STARTED|BH4 and LNAA (4 Weeks)||10
413490|NCT01617070|1012728|P1|NOT COMPLETED|BH4 Therapy (4 Weeks)||0
413491|NCT01617070|1012728|P1|COMPLETED|BH4 Therapy (4 Weeks)||10
413492|NCT01617070|1012728|P1|STARTED|BH4 Therapy (4 Weeks)||10
413493|NCT01617070|1012728|P1|NOT COMPLETED|Washout (4 Weeks)||0
413494|NCT01617070|1012728|P1|COMPLETED|Washout (4 Weeks)||10
413495|NCT01617070|1012728|P1|STARTED|Washout (4 Weeks)||10
413496|NCT01617070|1012728|P1|NOT COMPLETED|LNAA (4 Weeks)||0
413497|NCT01617070|1012728|P1|COMPLETED|LNAA (4 Weeks)||10
413498|NCT01617070|1012728|P1|STARTED|LNAA (4 Weeks)||10
413499|NCT01617005|1012746|P1|NOT COMPLETED|Overall Study||2
413500|NCT01617005|1012746|P1|COMPLETED|Overall Study||48
413501|NCT01617005|1012746|P1|STARTED|Overall Study||50
413502|NCT01616953|1012755|P2|NOT COMPLETED|Overall Study||0
413503|NCT01616953|1012756|P1|NOT COMPLETED|Overall Study||2
413504|NCT01616953|1012755|P2|COMPLETED|Overall Study||8
413505|NCT01616953|1012756|P1|COMPLETED|Overall Study||8
413506|NCT01616953|1012755|P2|6 Months Post-loading|Overall Study||8
413507|NCT01616953|1012756|P1|6 Months Post-loading|Overall Study||8
413508|NCT01616953|1012755|P2|Implant Uncovery|Overall Study||8
413509|NCT01616953|1012756|P1|Implant Uncovery|Overall Study||8
413510|NCT01616953|1012755|P2|Implant Placement Surgery|Overall Study||8
413511|NCT01616953|1012756|P1|Implant Placement Surgery|Overall Study||9
413512|NCT01616953|1012755|P2|STARTED|Overall Study||8
413513|NCT01616953|1012756|P1|STARTED|Overall Study||10
413514|NCT01616771|1012764|P1|NOT COMPLETED|Smaller Sized GVL for 5 Sec||4
413515|NCT01616771|1012764|P1|COMPLETED|Smaller Sized GVL for 5 Sec||19
413516|NCT01616771|1012764|P1|STARTED|Smaller Sized GVL for 5 Sec|Four of 23 patients could not be evaluated by smaller sized GVL, because there was no smaller one.|23
413517|NCT01616771|1012764|P1|NOT COMPLETED|GVL Selected by Weight for 5 Sec||0
413518|NCT01616771|1012764|P1|COMPLETED|GVL Selected by Weight for 5 Sec||23
413519|NCT01616771|1012764|P1|STARTED|GVL Selected by Weight for 5 Sec||23
413520|NCT01616771|1012764|P1|NOT COMPLETED|Macintosh Laryngoscopy for 5 Sec||0
413521|NCT01616771|1012764|P1|COMPLETED|Macintosh Laryngoscopy for 5 Sec||23
413522|NCT01616771|1012764|P1|STARTED|Macintosh Laryngoscopy for 5 Sec||23
413523|NCT01616576|1012775|P2|NOT COMPLETED|Overall Study||0
413524|NCT01616576|1012776|P1|NOT COMPLETED|Overall Study||0
413525|NCT01616576|1012775|P2|COMPLETED|Overall Study||18
413526|NCT01616576|1012776|P1|COMPLETED|Overall Study||18
413527|NCT01616576|1012775|P2|STARTED|Overall Study||18
413528|NCT01616576|1012776|P1|STARTED|Overall Study||18
413529|NCT01616459|1012789|P4|NOT COMPLETED|Overall Study||8
413530|NCT01616459|1012790|P3|NOT COMPLETED|Overall Study||10
413531|NCT01616459|1012791|P2|NOT COMPLETED|Overall Study||17
413532|NCT01616459|1012792|P1|NOT COMPLETED|Overall Study||4
413533|NCT01616459|1012789|P4|COMPLETED|Overall Study||233
413534|NCT01616459|1012790|P3|COMPLETED|Overall Study||220
413535|NCT01616459|1012791|P2|COMPLETED|Overall Study||223
413536|NCT01616459|1012792|P1|COMPLETED|Overall Study||236
413537|NCT01616459|1012789|P4|STARTED|Overall Study||241
413538|NCT01616459|1012790|P3|STARTED|Overall Study||230
413539|NCT01616459|1012791|P2|STARTED|Overall Study||240
413540|NCT01616459|1012792|P1|STARTED|Overall Study||240
413541|NCT01616173|1012881|P3|NOT COMPLETED|Overall Study||0
413542|NCT01616173|1012882|P2|NOT COMPLETED|Overall Study||2
413543|NCT01616173|1012883|P1|NOT COMPLETED|Overall Study||0
413544|NCT01616173|1012881|P3|COMPLETED|Overall Study||27
413545|NCT01616173|1012882|P2|COMPLETED|Overall Study||24
413546|NCT01616173|1012883|P1|COMPLETED|Overall Study||27
413547|NCT01616173|1012881|P3|STARTED|Overall Study||27
413548|NCT01616173|1012882|P2|STARTED|Overall Study||26
413549|NCT01616173|1012883|P1|STARTED|Overall Study||27
413550|NCT01616160|1012897|P1|NOT COMPLETED|Overall Study||2
413551|NCT01616160|1012897|P1|COMPLETED|Overall Study||9
413552|NCT01616160|1012897|P1|STARTED|Overall Study||11
413553|NCT01616056|1012902|P1|NOT COMPLETED|Overall Study||1
413554|NCT01616056|1012902|P1|COMPLETED|Overall Study||19
413555|NCT01616056|1012902|P1|STARTED|Overall Study||20
413556|NCT01615939|1012916|P2|NOT COMPLETED|Overall Study||0
413557|NCT01615939|1012917|P1|NOT COMPLETED|Overall Study||5
413558|NCT01615939|1012916|P2|COMPLETED|Overall Study||4
413559|NCT01615939|1012917|P1|COMPLETED|Overall Study||8
413560|NCT01615939|1012916|P2|STARTED|Overall Study||4
413561|NCT01615939|1012917|P1|STARTED|Overall Study||13
413562|NCT01615822|1012930|P3|NOT COMPLETED|Period 2||2
413563|NCT01615822|1012931|P2|NOT COMPLETED|Period 2||1
413564|NCT01615822|1012932|P1|NOT COMPLETED|Period 2||0
413565|NCT01615822|1012930|P3|COMPLETED|Period 2||4
413566|NCT01615822|1012931|P2|COMPLETED|Period 2||8
413567|NCT01615822|1012932|P1|COMPLETED|Period 2||7
413568|NCT01615822|1012930|P3|STARTED|Period 2||6
413569|NCT01615822|1012931|P2|STARTED|Period 2||9
413570|NCT01615822|1012932|P1|STARTED|Period 2||7
413571|NCT01615822|1012930|P3|NOT COMPLETED|Period 1||0
413572|NCT01615822|1012931|P2|NOT COMPLETED|Period 1||2
413573|NCT01615822|1012932|P1|NOT COMPLETED|Period 1||1
413574|NCT01615822|1012930|P3|COMPLETED|Period 1||6
413575|NCT01615822|1012931|P2|COMPLETED|Period 1||9
413576|NCT01615822|1012932|P1|COMPLETED|Period 1||7
413577|NCT01615822|1012930|P3|STARTED|Period 1||6
413578|NCT01615822|1012931|P2|STARTED|Period 1||11
413579|NCT01615822|1012932|P1|STARTED|Period 1||8
413580|NCT01615809|1012949|P1|NOT COMPLETED|Overall Study||10
413581|NCT01615809|1012949|P1|COMPLETED|Overall Study||22
413582|NCT01615809|1012949|P1|STARTED|Overall Study|basal visit|32
413583|NCT01615731|1012957|P2|NOT COMPLETED|Overall Study||2
413584|NCT01615731|1012958|P1|NOT COMPLETED|Overall Study||3
413585|NCT01615731|1012957|P2|COMPLETED|Overall Study||24
413586|NCT01615731|1012958|P1|COMPLETED|Overall Study||21
413587|NCT01615731|1012957|P2|STARTED|Overall Study||26
413588|NCT01615731|1012958|P1|STARTED|Overall Study||24
413589|NCT01615484|1012980|P2|NOT COMPLETED|Overall Study||0
413590|NCT01615484|1012981|P1|NOT COMPLETED|Overall Study||0
413591|NCT01615484|1012980|P2|COMPLETED|Overall Study||24
413592|NCT01615484|1012981|P1|COMPLETED|Overall Study||0
413593|NCT01615484|1012980|P2|STARTED|Overall Study||24
413594|NCT01615484|1012981|P1|STARTED|Overall Study||0
413595|NCT01615367|1012999|P2|NOT COMPLETED|Overall Study||6
413596|NCT01615367|1013000|P1|NOT COMPLETED|Overall Study||5
413597|NCT01615367|1012999|P2|COMPLETED|Overall Study|11 TAU participants chose to participate in NEW Tx after the completion of the waitlist period.|13
413598|NCT01615367|1013000|P1|COMPLETED|Overall Study||14
413599|NCT01615367|1012999|P2|STARTED|Overall Study||19
413600|NCT01615367|1013000|P1|STARTED|Overall Study||19
413601|NCT01615328|1013020|P2|NOT COMPLETED|Overall Study||5
413602|NCT01615328|1013021|P1|NOT COMPLETED|Overall Study||3
413603|NCT01615328|1013020|P2|COMPLETED|Overall Study||38
413604|NCT01615328|1013021|P1|COMPLETED|Overall Study||39
413605|NCT01615328|1013020|P2|STARTED|Overall Study||43
413606|NCT01615328|1013021|P1|STARTED|Overall Study||42
413607|NCT01615263|1013033|P2|NOT COMPLETED|Overall Study||2
413608|NCT01615263|1013034|P1|NOT COMPLETED|Overall Study||0
413609|NCT01615263|1013033|P2|COMPLETED|Overall Study||18
413610|NCT01615263|1013034|P1|COMPLETED|Overall Study||20
413611|NCT01615263|1013033|P2|STARTED|Overall Study||20
413612|NCT01615263|1013034|P1|STARTED|Overall Study||20
413613|NCT01615198|1013048|P2|NOT COMPLETED|Overall Study||19
413614|NCT01615198|1013049|P1|NOT COMPLETED|Overall Study||24
413615|NCT01615198|1013048|P2|COMPLETED|Overall Study||273
413616|NCT01615198|1013049|P1|COMPLETED|Overall Study||272
413617|NCT01615198|1013048|P2|ABPM Dipper Status Subset|Overall Study||84
413618|NCT01615198|1013049|P1|ABPM Dipper Status Subset|Overall Study||82
413619|NCT01615198|1013048|P2|Safety Set|Overall Study||292
413620|NCT01615198|1013049|P1|Safety Set|Overall Study||296
413621|NCT01615198|1013048|P2|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||157
413622|NCT01615198|1013049|P1|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||154
413623|NCT01615198|1013048|P2|Full Analysis Set|Overall Study||292
413624|NCT01615198|1013049|P1|Full Analysis Set|Overall Study||296
413625|NCT01615198|1013048|P2|STARTED|Overall Study||292
413626|NCT01615198|1013049|P1|STARTED|Overall Study||296
413627|NCT01615029|1013082|P5|NOT COMPLETED|Overall Study||32
413628|NCT01615029|1013083|P4|NOT COMPLETED|Overall Study||3
413629|NCT01615029|1013084|P3|NOT COMPLETED|Overall Study||4
413630|NCT01615029|1013085|P2|NOT COMPLETED|Overall Study||3
413631|NCT01615029|1013086|P1|NOT COMPLETED|Overall Study||3
413632|NCT01615029|1013082|P5|COMPLETED|Overall Study||0
413633|NCT01615029|1013083|P4|COMPLETED|Overall Study||0
413634|NCT01615029|1013084|P3|COMPLETED|Overall Study||0
413635|NCT01615029|1013085|P2|COMPLETED|Overall Study||0
413636|NCT01615029|1013086|P1|COMPLETED|Overall Study||0
413637|NCT01615029|1013082|P5|STARTED|Overall Study||32
413638|NCT01615029|1013083|P4|STARTED|Overall Study||3
413639|NCT01615029|1013084|P3|STARTED|Overall Study||4
413640|NCT01615029|1013085|P2|STARTED|Overall Study||3
413641|NCT01615029|1013086|P1|STARTED|Overall Study||3
413642|NCT01614886|1013109|P2|NOT COMPLETED|Overall Study||26
413643|NCT01614886|1013110|P1|NOT COMPLETED|Overall Study||20
413644|NCT01614886|1013109|P2|COMPLETED|Overall Study||83
413645|NCT01614886|1013110|P1|COMPLETED|Overall Study||87
413646|NCT01614886|1013109|P2|Full Analysis Set (FAS)|Overall Study||105
413647|NCT01614886|1013110|P1|Full Analysis Set (FAS)|Overall Study||104
413648|NCT01614886|1013109|P2|Safety Population (SAF)|Overall Study||108
413649|NCT01614886|1013110|P1|Safety Population (SAF)|Overall Study||107
413650|NCT01614886|1013109|P2|STARTED|Overall Study||109
413651|NCT01614886|1013110|P1|STARTED|Overall Study||107
413652|NCT01614795|1013128|P4|NOT COMPLETED|Overall Study||12
413653|NCT01614795|1013129|P3|NOT COMPLETED|Overall Study||11
413654|NCT01614795|1013130|P2|NOT COMPLETED|Overall Study||12
413655|NCT01614795|1013131|P1|NOT COMPLETED|Overall Study||11
413656|NCT01614795|1013128|P4|COMPLETED|Overall Study||0
413657|NCT01614795|1013129|P3|COMPLETED|Overall Study||0
413658|NCT01614795|1013130|P2|COMPLETED|Overall Study||0
413659|NCT01614795|1013131|P1|COMPLETED|Overall Study||0
413660|NCT01614795|1013128|P4|STARTED|Overall Study||12
413661|NCT01614795|1013129|P3|STARTED|Overall Study||11
413662|NCT01614795|1013130|P2|STARTED|Overall Study||12
413663|NCT01614795|1013131|P1|STARTED|Overall Study||11
413664|NCT01614769|1013141|P6|NOT COMPLETED|Period 3||0
413665|NCT01614769|1013142|P5|NOT COMPLETED|Period 3||0
413666|NCT01614769|1013143|P4|NOT COMPLETED|Period 3||0
413667|NCT01614769|1013144|P3|NOT COMPLETED|Period 3||1
413668|NCT01614769|1013145|P2|NOT COMPLETED|Period 3||0
413669|NCT01614769|1013146|P1|NOT COMPLETED|Period 3||0
413670|NCT01614769|1013141|P6|COMPLETED|Period 3||1
413671|NCT01614769|1013142|P5|COMPLETED|Period 3||1
413672|NCT01614769|1013143|P4|COMPLETED|Period 3||0
413673|NCT01614769|1013144|P3|COMPLETED|Period 3||1
413674|NCT01614769|1013145|P2|COMPLETED|Period 3||1
413675|NCT01614769|1013146|P1|COMPLETED|Period 3||1
413676|NCT01614769|1013141|P6|STARTED|Period 3||1
413677|NCT01614769|1013142|P5|STARTED|Period 3||1
413678|NCT01614769|1013143|P4|STARTED|Period 3||0
413679|NCT01614769|1013144|P3|STARTED|Period 3||2
413680|NCT01614769|1013145|P2|STARTED|Period 3||1
413681|NCT01614769|1013146|P1|STARTED|Period 3||1
413682|NCT01614769|1013141|P6|NOT COMPLETED|7-Day Washout||0
413683|NCT01614769|1013142|P5|NOT COMPLETED|7-Day Washout||0
413684|NCT01614769|1013143|P4|NOT COMPLETED|7-Day Washout||0
413685|NCT01614769|1013144|P3|NOT COMPLETED|7-Day Washout||0
413686|NCT01614769|1013145|P2|NOT COMPLETED|7-Day Washout||0
413687|NCT01614769|1013146|P1|NOT COMPLETED|7-Day Washout||0
413688|NCT01614769|1013141|P6|COMPLETED|7-Day Washout||1
413689|NCT01614769|1013142|P5|COMPLETED|7-Day Washout||1
413690|NCT01614769|1013143|P4|COMPLETED|7-Day Washout||0
413691|NCT01614769|1013144|P3|COMPLETED|7-Day Washout||2
413692|NCT01614769|1013145|P2|COMPLETED|7-Day Washout||1
413693|NCT01614769|1013146|P1|COMPLETED|7-Day Washout||1
413694|NCT01614769|1013141|P6|STARTED|7-Day Washout||1
413695|NCT01614769|1013142|P5|STARTED|7-Day Washout||1
413696|NCT01614769|1013143|P4|STARTED|7-Day Washout||0
413697|NCT01614769|1013144|P3|STARTED|7-Day Washout||2
413698|NCT01614769|1013145|P2|STARTED|7-Day Washout||1
413699|NCT01614769|1013146|P1|STARTED|7-Day Washout||1
413700|NCT01614769|1013141|P6|NOT COMPLETED|Period 2||0
413701|NCT01614769|1013142|P5|NOT COMPLETED|Period 2||0
413702|NCT01614769|1013143|P4|NOT COMPLETED|Period 2||0
413703|NCT01614769|1013144|P3|NOT COMPLETED|Period 2||0
413704|NCT01614769|1013145|P2|NOT COMPLETED|Period 2||0
413705|NCT01614769|1013146|P1|NOT COMPLETED|Period 2||0
413706|NCT01614769|1013141|P6|COMPLETED|Period 2||1
413707|NCT01614769|1013142|P5|COMPLETED|Period 2||1
413708|NCT01614769|1013143|P4|COMPLETED|Period 2||0
413709|NCT01614769|1013144|P3|COMPLETED|Period 2||2
413710|NCT01614769|1013145|P2|COMPLETED|Period 2||1
413711|NCT01614769|1013146|P1|COMPLETED|Period 2||1
413712|NCT01614769|1013141|P6|STARTED|Period 2||1
413713|NCT01614769|1013142|P5|STARTED|Period 2||1
413714|NCT01614769|1013143|P4|STARTED|Period 2||0
413715|NCT01614769|1013144|P3|STARTED|Period 2||2
413716|NCT01614769|1013145|P2|STARTED|Period 2||1
413717|NCT01614769|1013146|P1|STARTED|Period 2||1
413718|NCT01614769|1013141|P6|NOT COMPLETED|7-Day Washout||0
413719|NCT01614769|1013142|P5|NOT COMPLETED|7-Day Washout||0
413720|NCT01614769|1013143|P4|NOT COMPLETED|7-Day Washout||0
413721|NCT01614769|1013144|P3|NOT COMPLETED|7-Day Washout||0
413722|NCT01614769|1013145|P2|NOT COMPLETED|7-Day Washout||0
413723|NCT01614769|1013146|P1|NOT COMPLETED|7-Day Washout||0
413724|NCT01614769|1013141|P6|COMPLETED|7-Day Washout||1
413725|NCT01614769|1013142|P5|COMPLETED|7-Day Washout||1
413726|NCT01614769|1013143|P4|COMPLETED|7-Day Washout||0
413727|NCT01614769|1013144|P3|COMPLETED|7-Day Washout||2
413728|NCT01614769|1013145|P2|COMPLETED|7-Day Washout||1
413729|NCT01614769|1013146|P1|COMPLETED|7-Day Washout||1
413730|NCT01614769|1013141|P6|STARTED|7-Day Washout||1
413731|NCT01614769|1013142|P5|STARTED|7-Day Washout||1
413732|NCT01614769|1013143|P4|STARTED|7-Day Washout||0
413733|NCT01614769|1013144|P3|STARTED|7-Day Washout||2
413734|NCT01614769|1013145|P2|STARTED|7-Day Washout||1
413735|NCT01614769|1013146|P1|STARTED|7-Day Washout||1
413736|NCT01614769|1013141|P6|NOT COMPLETED|Period 1||1
413737|NCT01614769|1013142|P5|NOT COMPLETED|Period 1||0
413738|NCT01614769|1013143|P4|NOT COMPLETED|Period 1||2
413739|NCT01614769|1013144|P3|NOT COMPLETED|Period 1||0
413740|NCT01614769|1013145|P2|NOT COMPLETED|Period 1||0
413741|NCT01614769|1013146|P1|NOT COMPLETED|Period 1||1
413742|NCT01614769|1013141|P6|COMPLETED|Period 1||1
413743|NCT01614769|1013142|P5|COMPLETED|Period 1||1
413744|NCT01614769|1013143|P4|COMPLETED|Period 1||0
413745|NCT01614769|1013144|P3|COMPLETED|Period 1||2
413746|NCT01614769|1013145|P2|COMPLETED|Period 1||1
413747|NCT01614769|1013146|P1|COMPLETED|Period 1||1
413748|NCT01614769|1013141|P6|STARTED|Period 1||2
413749|NCT01614769|1013142|P5|STARTED|Period 1||1
413750|NCT01614769|1013143|P4|STARTED|Period 1||2
413751|NCT01614769|1013144|P3|STARTED|Period 1||2
413752|NCT01614769|1013145|P2|STARTED|Period 1||1
413753|NCT01614769|1013146|P1|STARTED|Period 1||2
413754|NCT01614613|1013160|P1|NOT COMPLETED|Overall Study||0
413755|NCT01614613|1013160|P1|COMPLETED|Overall Study||146
413756|NCT01614613|1013160|P1|STARTED|Overall Study||146
413757|NCT01614600|1013168|P1|NOT COMPLETED|Overall Study||4
413758|NCT01614600|1013168|P1|COMPLETED|Overall Study||84
413759|NCT01614600|1013168|P1|STARTED|Overall Study||88
413760|NCT01614574|1013172|P1|NOT COMPLETED|Overall Study||0
413761|NCT01614574|1013172|P1|COMPLETED|Overall Study||6
413762|NCT01614574|1013172|P1|STARTED|Overall Study||6
413763|NCT01614509|1013188|P2|NOT COMPLETED|Overall Study||3
413764|NCT01614509|1013189|P1|NOT COMPLETED|Overall Study||1
413765|NCT01614509|1013188|P2|COMPLETED|Overall Study||18
413766|NCT01614509|1013189|P1|COMPLETED|Overall Study||23
413767|NCT01614509|1013188|P2|STARTED|Overall Study||21
413768|NCT01614509|1013189|P1|STARTED|Overall Study||24
413769|NCT01614470|1013199|P3|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
413770|NCT01614470|1013200|P2|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
413771|NCT01614470|1013201|P1|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
413772|NCT01614470|1013199|P3|COMPLETED|Part 2: Open-label Period (16 Weeks)||36
413773|NCT01614470|1013200|P2|COMPLETED|Part 2: Open-label Period (16 Weeks)||0
413774|NCT01614470|1013201|P1|COMPLETED|Part 2: Open-label Period (16 Weeks)||0
413775|NCT01614470|1013199|P3|STARTED|Part 2: Open-label Period (16 Weeks)||36
413776|NCT01614470|1013200|P2|STARTED|Part 2: Open-label Period (16 Weeks)||0
413777|NCT01614470|1013201|P1|STARTED|Part 2: Open-label Period (16 Weeks)||0
413778|NCT01614470|1013199|P3|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
413779|NCT01614470|1013200|P2|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
413780|NCT01614470|1013201|P1|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
413781|NCT01614470|1013199|P3|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
413782|NCT01614470|1013200|P2|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18
413783|NCT01614470|1013201|P1|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18
413784|NCT01614470|1013199|P3|STARTED|Part 1: Treatment Period 2 (8 Weeks)||0
413785|NCT01614470|1013200|P2|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18
413786|NCT01614470|1013201|P1|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18
413787|NCT01614470|1013199|P3|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
413788|NCT01614470|1013200|P2|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
413789|NCT01614470|1013201|P1|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
413790|NCT01614470|1013199|P3|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
413791|NCT01614470|1013200|P2|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18
413792|NCT01614470|1013201|P1|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18
413793|NCT01614470|1013199|P3|STARTED|Part 1: Washout Period (4 to 8 Weeks)||0
413794|NCT01614470|1013200|P2|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18
413795|NCT01614470|1013201|P1|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18
413796|NCT01614470|1013199|P3|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0
413797|NCT01614470|1013200|P2|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||1
413798|NCT01614470|1013201|P1|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||2
413799|NCT01614470|1013199|P3|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0
413800|NCT01614470|1013200|P2|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18
413801|NCT01614470|1013201|P1|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18
413802|NCT01614470|1013199|P3|STARTED|Part 1: Treatment Period 1 (8 Weeks)||0
413803|NCT01614470|1013200|P2|STARTED|Part 1: Treatment Period 1 (8 Weeks)||19
413804|NCT01614470|1013201|P1|STARTED|Part 1: Treatment Period 1 (8 Weeks)||20
413805|NCT01614457|1013223|P2|NOT COMPLETED|Overall Study||0
413806|NCT01614457|1013224|P1|NOT COMPLETED|Overall Study||2
413807|NCT01614457|1013223|P2|COMPLETED|Overall Study||35
413808|NCT01614457|1013224|P1|COMPLETED|Overall Study||32
413809|NCT01614457|1013223|P2|STARTED|Overall Study||35
413810|NCT01614457|1013224|P1|STARTED|Overall Study||34
413811|NCT01614249|1013242|P2|NOT COMPLETED|Overall Study||23
413812|NCT01614249|1013243|P1|NOT COMPLETED|Overall Study||11
413813|NCT01614249|1013242|P2|COMPLETED|Overall Study|End of study data analyzed for only participants who completed the 8-week trial period.|86
413814|NCT01614249|1013243|P1|COMPLETED|Overall Study|End of study data analyzed for only participants who completed the 8-week trial period.|96
413815|NCT01614249|1013242|P2|At Week-8 (End of Study Period)|Overall Study|End of study data collected for all participants who completed the 8-week trial period.|86
413816|NCT01614249|1013243|P1|At Week-8 (End of Study Period)|Overall Study|End of study data collected for all participants who completed the 8-week trial period.|96
413817|NCT01614249|1013242|P2|At Week-4|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|92
413818|NCT01614249|1013243|P1|At Week-4|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|98
413819|NCT01614249|1013242|P2|STARTED|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|109
413820|NCT01614249|1013243|P1|STARTED|Overall Study|Participants received every two-weeks supply and monitored regularly on cell-phone and face-to-face.|107
413821|NCT01614210|1013249|P1|NOT COMPLETED|Overall Study||0
413822|NCT01614210|1013249|P1|COMPLETED|Overall Study||52
413823|NCT01614210|1013249|P1|STARTED|Overall Study||52
413824|NCT01614093|1013255|P1|NOT COMPLETED|Overall Study||1
413825|NCT01614093|1013255|P1|COMPLETED|Overall Study||16
413826|NCT01614093|1013255|P1|STARTED|Overall Study||17
413827|NCT01613716|1013260|P1|NOT COMPLETED|Overall Study||7
413828|NCT01613716|1013260|P1|COMPLETED|Overall Study||23
413829|NCT01613716|1013260|P1|STARTED|Overall Study||30
413830|NCT01613599|1013265|P1|NOT COMPLETED|Overall Study||97
413831|NCT01613599|1013265|P1|COMPLETED|Overall Study||0
413832|NCT01613599|1013265|P1|STARTED|Overall Study||97
413833|NCT01613417|1013280|P2|NOT COMPLETED|Second Injection||0
413834|NCT01613417|1013281|P1|NOT COMPLETED|Second Injection||0
413835|NCT01613417|1013280|P2|COMPLETED|Second Injection||109
413836|NCT01613417|1013281|P1|COMPLETED|Second Injection||100
413837|NCT01613417|1013280|P2|STARTED|Second Injection||109
413838|NCT01613417|1013281|P1|STARTED|Second Injection||100
413839|NCT01613417|1013280|P2|NOT COMPLETED|Washout (no Second Injection/MRI)||7
413840|NCT01613417|1013281|P1|NOT COMPLETED|Washout (no Second Injection/MRI)||13
413841|NCT01613417|1013280|P2|COMPLETED|Washout (no Second Injection/MRI)||109
413842|NCT01613417|1013281|P1|COMPLETED|Washout (no Second Injection/MRI)||100
413843|NCT01613417|1013280|P2|STARTED|Washout (no Second Injection/MRI)||116
413844|NCT01613417|1013281|P1|STARTED|Washout (no Second Injection/MRI)||113
413845|NCT01613417|1013280|P2|NOT COMPLETED|First Injection||0
413846|NCT01613417|1013281|P1|NOT COMPLETED|First Injection||0
413847|NCT01613417|1013280|P2|COMPLETED|First Injection||116
413848|NCT01613417|1013281|P1|COMPLETED|First Injection||113
413849|NCT01613417|1013280|P2|STARTED|First Injection||116
413850|NCT01613417|1013281|P1|STARTED|First Injection||113
413851|NCT01613378|1013318|P1|NOT COMPLETED|Overall Study||39
413852|NCT01613378|1013318|P1|COMPLETED|Overall Study||161
413853|NCT01613378|1013318|P1|STARTED|Overall Study||200
413854|NCT01613339|1013336|P2|NOT COMPLETED|Overall Study||1
413855|NCT01613339|1013337|P1|NOT COMPLETED|Overall Study||3
413856|NCT01613339|1013336|P2|COMPLETED|Overall Study||21
413857|NCT01613339|1013337|P1|COMPLETED|Overall Study||21
413858|NCT01613339|1013336|P2|STARTED|Overall Study||22
413859|NCT01613339|1013337|P1|STARTED|Overall Study||24
413860|NCT01613326|1013348|P2|NOT COMPLETED|Overall Study||14
413861|NCT01613326|1013349|P1|NOT COMPLETED|Overall Study||13
413862|NCT01613326|1013348|P2|COMPLETED|Overall Study||316
413863|NCT01613326|1013349|P1|COMPLETED|Overall Study||314
413864|NCT01613326|1013348|P2|STARTED|Overall Study||330
413865|NCT01613326|1013349|P1|STARTED|Overall Study||327
413866|NCT01613313|1013383|P4|NOT COMPLETED|Overall Study||0
413867|NCT01613313|1013384|P3|NOT COMPLETED|Overall Study||0
413868|NCT01613313|1013385|P2|NOT COMPLETED|Overall Study||0
413869|NCT01613313|1013386|P1|NOT COMPLETED|Overall Study||0
413870|NCT01613313|1013383|P4|COMPLETED|Overall Study||4
413871|NCT01613313|1013384|P3|COMPLETED|Overall Study||4
413872|NCT01613313|1013385|P2|COMPLETED|Overall Study||4
413873|NCT01613313|1013386|P1|COMPLETED|Overall Study||2
413874|NCT01613313|1013383|P4|STARTED|Overall Study||4
413875|NCT01613313|1013384|P3|STARTED|Overall Study||4
413876|NCT01613313|1013385|P2|STARTED|Overall Study||4
413877|NCT01613313|1013386|P1|STARTED|Overall Study||2
413878|NCT01613248|1013406|P6|NOT COMPLETED|Overall Study||38
413879|NCT01613248|1013407|P5|NOT COMPLETED|Overall Study||35
413880|NCT01613248|1013408|P4|NOT COMPLETED|Overall Study||38
413881|NCT01613248|1013409|P3|NOT COMPLETED|Overall Study||33
413882|NCT01613248|1013410|P2|NOT COMPLETED|Overall Study||34
413883|NCT01613248|1013411|P1|NOT COMPLETED|Overall Study||29
413884|NCT01613248|1013406|P6|COMPLETED|Overall Study||102
413885|NCT01613248|1013407|P5|COMPLETED|Overall Study||104
413886|NCT01613248|1013408|P4|COMPLETED|Overall Study||101
413887|NCT01613248|1013409|P3|COMPLETED|Overall Study||106
413888|NCT01613248|1013410|P2|COMPLETED|Overall Study||104
413889|NCT01613248|1013411|P1|COMPLETED|Overall Study||110
413890|NCT01613248|1013406|P6|STARTED|Overall Study||140
413891|NCT01613248|1013407|P5|STARTED|Overall Study||139
413892|NCT01613248|1013408|P4|STARTED|Overall Study||139
413893|NCT01613248|1013409|P3|STARTED|Overall Study||139
413894|NCT01613248|1013410|P2|STARTED|Overall Study||138
413895|NCT01613248|1013411|P1|STARTED|Overall Study||139
413896|NCT01613131|1013511|P2|NOT COMPLETED|Overall Study||5
413897|NCT01613131|1013512|P1|NOT COMPLETED|Overall Study||3
413898|NCT01613131|1013511|P2|COMPLETED|Overall Study||13
413899|NCT01613131|1013512|P1|COMPLETED|Overall Study||17
413900|NCT01613131|1013511|P2|STARTED|Overall Study||18
413901|NCT01613131|1013512|P1|STARTED|Overall Study||20
413902|NCT01613027|1013540|P1|NOT COMPLETED|Overall Study||8
413903|NCT01613027|1013540|P1|COMPLETED|Overall Study||127
413904|NCT01613027|1013540|P1|STARTED|Overall Study||135
413905|NCT01613014|1013561|P2|NOT COMPLETED|Overall Study||12
413906|NCT01613014|1013562|P1|NOT COMPLETED|Overall Study||18
413907|NCT01613014|1013561|P2|COMPLETED|Overall Study||63
413908|NCT01613014|1013562|P1|COMPLETED|Overall Study||57
413909|NCT01613014|1013561|P2|STARTED|Overall Study||75
413910|NCT01613014|1013562|P1|STARTED|Overall Study||75
413911|NCT01612884|1013570|P2|NOT COMPLETED|Overall Study||0
413912|NCT01612884|1013571|P1|NOT COMPLETED|Overall Study||0
413913|NCT01612884|1013570|P2|COMPLETED|Overall Study||18
413914|NCT01612884|1013571|P1|COMPLETED|Overall Study||19
413915|NCT01612884|1013570|P2|STARTED|Overall Study||18
413916|NCT01612884|1013571|P1|STARTED|Overall Study||19
413917|NCT01612858|1013583|P2|NOT COMPLETED|Overall Study||1
413918|NCT01612858|1013584|P1|NOT COMPLETED|Overall Study||5
413919|NCT01612858|1013583|P2|COMPLETED|Overall Study||3
413920|NCT01612858|1013584|P1|COMPLETED|Overall Study||11
413921|NCT01612858|1013583|P2|STARTED|Overall Study||4
413922|NCT01612858|1013584|P1|STARTED|Overall Study||16
413923|NCT01612767|1013592|P1|NOT COMPLETED|Overall Study||9
413924|NCT01612767|1013592|P1|COMPLETED|Overall Study||320
413925|NCT01612767|1013592|P1|STARTED|Overall Study||329
413926|NCT01612702|1013621|P2|NOT COMPLETED|Overall Study||11
413927|NCT01612702|1013622|P1|NOT COMPLETED|Overall Study||11
413928|NCT01612702|1013621|P2|COMPLETED|Overall Study||134
413929|NCT01612702|1013622|P1|COMPLETED|Overall Study||135
413930|NCT01612702|1013621|P2|STARTED|Overall Study||145
413931|NCT01612702|1013622|P1|STARTED|Overall Study||146
413932|NCT01612676|1013636|P4|NOT COMPLETED|Overall Study||3
413933|NCT01612676|1013637|P3|NOT COMPLETED|Overall Study||1
413934|NCT01612676|1013638|P2|NOT COMPLETED|Overall Study||4
413935|NCT01612676|1013639|P1|NOT COMPLETED|Overall Study||2
413936|NCT01612676|1013636|P4|COMPLETED|Overall Study||10
413937|NCT01612676|1013637|P3|COMPLETED|Overall Study||4
413938|NCT01612676|1013638|P2|COMPLETED|Overall Study||3
413939|NCT01612676|1013639|P1|COMPLETED|Overall Study||4
413940|NCT01612676|1013636|P4|Dosed|Overall Study||13
413941|NCT01612676|1013637|P3|Dosed|Overall Study||5
413942|NCT01612676|1013638|P2|Dosed|Overall Study||7
413943|NCT01612676|1013639|P1|Dosed|Overall Study||5
413944|NCT01612676|1013636|P4|STARTED|Overall Study||13
413945|NCT01612676|1013637|P3|STARTED|Overall Study||5
413946|NCT01612676|1013638|P2|STARTED|Overall Study||7
413947|NCT01612676|1013639|P1|STARTED|Overall Study||6
413948|NCT01612546|1013695|P1|NOT COMPLETED|Overall Study||0
413949|NCT01612546|1013695|P1|COMPLETED|Overall Study||10
413950|NCT01612546|1013695|P1|STARTED|Overall Study||10
413951|NCT01612494|1013705|P2|NOT COMPLETED|Overall Study||0
413952|NCT01612494|1013706|P1|NOT COMPLETED|Overall Study||0
413953|NCT01612494|1013705|P2|COMPLETED|Overall Study||23
413954|NCT01612494|1013706|P1|COMPLETED|Overall Study||21
413955|NCT01612494|1013705|P2|STARTED|Overall Study||23
413956|NCT01612494|1013706|P1|STARTED|Overall Study||21
413957|NCT01612351|1013712|P1|NOT COMPLETED|Post-Operative Treatment||0
413958|NCT01612351|1013712|P1|COMPLETED|Post-Operative Treatment|One patient completed chemotherapy then withdrew before surgery.|39
413959|NCT01612351|1013712|P1|STARTED|Post-Operative Treatment||39
413960|NCT01612351|1013712|P1|NOT COMPLETED|Transoral Surgery||0
413961|NCT01612351|1013712|P1|COMPLETED|Transoral Surgery||39
413962|NCT01612351|1013712|P1|STARTED|Transoral Surgery|One patient completed chemotherapy then withdrew before surgery.|39
413963|NCT01612351|1013712|P1|NOT COMPLETED|Chemotherapy||0
413964|NCT01612351|1013712|P1|COMPLETED|Chemotherapy||40
413965|NCT01612351|1013712|P1|STARTED|Chemotherapy||40
413966|NCT01612221|1013726|P2|NOT COMPLETED|Overall Study||0
413967|NCT01612221|1013727|P1|NOT COMPLETED|Overall Study||0
413968|NCT01612221|1013726|P2|COMPLETED|Overall Study||50
413969|NCT01612221|1013727|P1|COMPLETED|Overall Study||50
413970|NCT01612221|1013726|P2|STARTED|Overall Study||50
413971|NCT01612221|1013727|P1|STARTED|Overall Study||50
413972|NCT01612156|1013737|P2|NOT COMPLETED|Overall Study||0
413973|NCT01612156|1013738|P1|NOT COMPLETED|Overall Study||2
413974|NCT01612156|1013737|P2|COMPLETED|Overall Study||48
413975|NCT01612156|1013738|P1|COMPLETED|Overall Study|Contraindication to urodynamics (urinary tract infection) diagnosed after randomization|40
413976|NCT01612156|1013737|P2|STARTED|Overall Study||48
413977|NCT01612156|1013738|P1|STARTED|Overall Study||42
413978|NCT01612000|1013750|P4|NOT COMPLETED|Overall Study||10
413979|NCT01612000|1013751|P3|NOT COMPLETED|Overall Study||7
413980|NCT01612000|1013752|P2|NOT COMPLETED|Overall Study||5
413981|NCT01612000|1013753|P1|NOT COMPLETED|Overall Study||9
413982|NCT01612000|1013750|P4|COMPLETED|Overall Study||76
413983|NCT01612000|1013751|P3|COMPLETED|Overall Study||78
413984|NCT01612000|1013752|P2|COMPLETED|Overall Study||81
413985|NCT01612000|1013753|P1|COMPLETED|Overall Study||75
413986|NCT01612000|1013750|P4|STARTED|Overall Study||86
413987|NCT01612000|1013751|P3|STARTED|Overall Study||85
413988|NCT01612000|1013752|P2|STARTED|Overall Study||86
413989|NCT01612000|1013753|P1|STARTED|Overall Study||84
413990|NCT01611974|1013778|P3|NOT COMPLETED|Overall Study||16
413991|NCT01611974|1013779|P2|NOT COMPLETED|Overall Study||15
413992|NCT01611974|1013780|P1|NOT COMPLETED|Overall Study||15
413993|NCT01611974|1013778|P3|COMPLETED|Overall Study||24
413994|NCT01611974|1013779|P2|COMPLETED|Overall Study||25
413995|NCT01611974|1013780|P1|COMPLETED|Overall Study||25
413996|NCT01611974|1013778|P3|STARTED|Overall Study||40
413997|NCT01611974|1013779|P2|STARTED|Overall Study||40
413998|NCT01611974|1013780|P1|STARTED|Overall Study||40
413999|NCT01611948|1013817|P2|NOT COMPLETED|Overall Study||12
414000|NCT01611948|1013818|P1|NOT COMPLETED|Overall Study||14
414001|NCT01611948|1013817|P2|COMPLETED|Overall Study||26
414002|NCT01611948|1013818|P1|COMPLETED|Overall Study||18
414003|NCT01611948|1013817|P2|STARTED|Overall Study||38
414004|NCT01611948|1013818|P1|STARTED|Overall Study||32
414005|NCT01611883|1013826|P2|NOT COMPLETED|Overall Study||1
414006|NCT01611883|1013827|P1|NOT COMPLETED|Overall Study||1
414007|NCT01611883|1013826|P2|COMPLETED|Overall Study||76
414008|NCT01611883|1013827|P1|COMPLETED|Overall Study||74
414009|NCT01611883|1013826|P2|STARTED|Overall Study||77
414010|NCT01611883|1013827|P1|STARTED|Overall Study||75
414011|NCT01611857|1013853|P2|NOT COMPLETED|Overall Study||2
414012|NCT01611857|1013854|P1|NOT COMPLETED|Overall Study||0
414013|NCT01611857|1013853|P2|COMPLETED|Overall Study||32
414014|NCT01611857|1013854|P1|COMPLETED|Overall Study||15
414015|NCT01611857|1013853|P2|Tivantinib 360 mg|Overall Study|Two participants withdrew prior to receiving drug.|32
414016|NCT01611857|1013854|P1|Tivantinib 360 mg|Overall Study||7
414017|NCT01611857|1013853|P2|Tivantinib 240 mg|Overall Study||0
414018|NCT01611857|1013854|P1|Tivantinib 240 mg|Overall Study||3
414019|NCT01611857|1013853|P2|Tivantinib 120 mg|Overall Study||0
414020|NCT01611857|1013854|P1|Tivantinib 120 mg|Overall Study||5
414021|NCT01611857|1013853|P2|STARTED|Overall Study||34
414022|NCT01611857|1013854|P1|STARTED|Overall Study|Three dose levels of tivantinib (120 mg, 240 mg, and 360 mg) were evaluated to determine the MTD.|15
414023|NCT01611792|1013866|P2|NOT COMPLETED|Followup: at 6 Months||13
414024|NCT01611792|1013867|P1|NOT COMPLETED|Followup: at 6 Months||6
414025|NCT01611792|1013866|P2|COMPLETED|Followup: at 6 Months||7
414026|NCT01611792|1013867|P1|COMPLETED|Followup: at 6 Months||11
414027|NCT01611792|1013866|P2|STARTED|Followup: at 6 Months||20
414028|NCT01611792|1013867|P1|STARTED|Followup: at 6 Months||17
414029|NCT01611792|1013866|P2|NOT COMPLETED|Follow-up: at 11 Weeks||0
414030|NCT01611792|1013867|P1|NOT COMPLETED|Follow-up: at 11 Weeks||0
414031|NCT01611792|1013866|P2|COMPLETED|Follow-up: at 11 Weeks||20
414032|NCT01611792|1013867|P1|COMPLETED|Follow-up: at 11 Weeks||17
414033|NCT01611792|1013866|P2|STARTED|Follow-up: at 11 Weeks||20
414034|NCT01611792|1013867|P1|STARTED|Follow-up: at 11 Weeks||17
414035|NCT01611792|1013866|P2|NOT COMPLETED|Initial Period: Time 0||9
414036|NCT01611792|1013867|P1|NOT COMPLETED|Initial Period: Time 0||12
414037|NCT01611792|1013866|P2|COMPLETED|Initial Period: Time 0||20
414038|NCT01611792|1013867|P1|COMPLETED|Initial Period: Time 0||17
414039|NCT01611792|1013866|P2|STARTED|Initial Period: Time 0||29
414040|NCT01611792|1013867|P1|STARTED|Initial Period: Time 0||29
414041|NCT01611779|1013883|P1|NOT COMPLETED|Overall Study||0
414042|NCT01611779|1013883|P1|COMPLETED|Overall Study||5
414043|NCT01611779|1013883|P1|STARTED|Overall Study||5
414044|NCT01611662|1013892|P1|NOT COMPLETED|Overall Study||1
414045|NCT01611662|1013892|P1|COMPLETED|Overall Study||31
414046|NCT01611662|1013892|P1|STARTED|Overall Study||32
414047|NCT01611571|1013899|P3|NOT COMPLETED|Overall Study||1
414048|NCT01611571|1013900|P2|NOT COMPLETED|Overall Study||0
414049|NCT01611571|1013901|P1|NOT COMPLETED|Overall Study||1
414050|NCT01611571|1013899|P3|COMPLETED|Overall Study||9
414051|NCT01611571|1013900|P2|COMPLETED|Overall Study||10
414052|NCT01611571|1013901|P1|COMPLETED|Overall Study||10
414053|NCT01611571|1013899|P3|STARTED|Overall Study||10
414054|NCT01611571|1013900|P2|STARTED|Overall Study||10
414055|NCT01611571|1013901|P1|STARTED|Overall Study||11
414056|NCT01611558|1013921|P1|NOT COMPLETED|Maintenance Phase||2
414057|NCT01611558|1013921|P1|COMPLETED|Maintenance Phase||0
414058|NCT01611558|1013921|P1|STARTED|Maintenance Phase||2
414059|NCT01611558|1013921|P1|NOT COMPLETED|Induction Phase||38
414060|NCT01611558|1013921|P1|COMPLETED|Induction Phase||2
414061|NCT01611558|1013921|P1|STARTED|Induction Phase||40
414062|NCT01611259|1013927|P1|NOT COMPLETED|Overall Study||14
414063|NCT01611259|1013927|P1|COMPLETED|Overall Study||34
414064|NCT01611259|1013927|P1|STARTED|Overall Study||48
414065|NCT01610791|1013931|P1|NOT COMPLETED|Overall Study||21
414066|NCT01610791|1013931|P1|COMPLETED|Overall Study||100
414067|NCT01610791|1013931|P1|STARTED|Overall Study||121
414068|NCT01610713|1013954|P2|NOT COMPLETED|Overall Study||1
414069|NCT01610713|1013955|P1|NOT COMPLETED|Overall Study||6
414070|NCT01610713|1013954|P2|COMPLETED|Overall Study||76
414071|NCT01610713|1013955|P1|COMPLETED|Overall Study||71
414072|NCT01610713|1013954|P2|STARTED|Overall Study||77
414073|NCT01610713|1013955|P1|STARTED|Overall Study||77
414074|NCT01610700|1014013|P2|NOT COMPLETED|Overall Study||3
414075|NCT01610700|1014014|P1|NOT COMPLETED|Overall Study||3
414076|NCT01610700|1014013|P2|COMPLETED|Overall Study||77
414077|NCT01610700|1014014|P1|COMPLETED|Overall Study||77
414078|NCT01610700|1014013|P2|STARTED|Overall Study||80
414079|NCT01610700|1014014|P1|STARTED|Overall Study||80
414080|NCT01610687|1014068|P1|NOT COMPLETED|Overall Study||67
414081|NCT01610687|1014068|P1|COMPLETED|Overall Study||70
414082|NCT01610687|1014068|P1|STARTED|Overall Study||137
414083|NCT01610596|1014081|P2|NOT COMPLETED|Overall Study||1
414084|NCT01610596|1014082|P1|NOT COMPLETED|Overall Study||0
414085|NCT01610596|1014081|P2|COMPLETED|Overall Study||35
414086|NCT01610596|1014082|P1|COMPLETED|Overall Study||36
414087|NCT01610596|1014081|P2|STARTED|Overall Study||36
414088|NCT01610596|1014082|P1|STARTED|Overall Study||36
414089|NCT01610570|1014098|P4|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
414090|NCT01610570|1014099|P3|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
414091|NCT01610570|1014100|P2|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
414092|NCT01610570|1014101|P1|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
414093|NCT01610570|1014098|P4|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
414094|NCT01610570|1014099|P3|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
414095|NCT01610570|1014100|P2|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
414096|NCT01610570|1014101|P1|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
414097|NCT01610570|1014098|P4|STARTED|Ph II >/= 12 mo. & </=17yrs||0
414098|NCT01610570|1014099|P3|STARTED|Ph II >/= 12 mo. & </=17yrs||0
414099|NCT01610570|1014100|P2|STARTED|Ph II >/= 12 mo. & </=17yrs||0
414100|NCT01610570|1014101|P1|STARTED|Ph II >/= 12 mo. & </=17yrs||0
414101|NCT01610570|1014098|P4|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
414102|NCT01610570|1014099|P3|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
414103|NCT01610570|1014100|P2|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
414104|NCT01610570|1014101|P1|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
414105|NCT01610570|1014098|P4|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||6
414106|NCT01610570|1014099|P3|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
414107|NCT01610570|1014100|P2|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
414108|NCT01610570|1014101|P1|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
414109|NCT01610570|1014098|P4|STARTED|Ph II >/= 18yrs of Age at Enrollment||6
414110|NCT01610570|1014099|P3|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
414111|NCT01610570|1014100|P2|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
414112|NCT01610570|1014101|P1|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
414113|NCT01610570|1014098|P4|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
414114|NCT01610570|1014099|P3|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
414115|NCT01610570|1014100|P2|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
414116|NCT01610570|1014101|P1|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
414117|NCT01610570|1014098|P4|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
414118|NCT01610570|1014099|P3|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
414119|NCT01610570|1014100|P2|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||2
414120|NCT01610570|1014101|P1|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
414121|NCT01610570|1014098|P4|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
414122|NCT01610570|1014099|P3|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
414123|NCT01610570|1014100|P2|STARTED|Ph I >/= 12 mo. Children & Adolescents||2
414124|NCT01610570|1014101|P1|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
414125|NCT01610557|1014140|P5|NOT COMPLETED|Post-36-Week Extension Phase||3
414126|NCT01610557|1014141|P4|NOT COMPLETED|Post-36-Week Extension Phase||0
414127|NCT01610557|1014142|P3|NOT COMPLETED|Post-36-Week Extension Phase||0
414128|NCT01610557|1014143|P2|NOT COMPLETED|Post-36-Week Extension Phase||0
414129|NCT01610557|1014144|P1|NOT COMPLETED|Post-36-Week Extension Phase||0
414130|NCT01610557|1014140|P5|COMPLETED|Post-36-Week Extension Phase|2 bilateral participants withdrew before their first post-36-week extension visit|52
414131|NCT01610557|1014141|P4|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
414132|NCT01610557|1014142|P3|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
414133|NCT01610557|1014143|P2|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
414134|NCT01610557|1014144|P1|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
414135|NCT01610557|1014140|P5|STARTED|Post-36-Week Extension Phase||55
414136|NCT01610557|1014141|P4|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
414137|NCT01610557|1014142|P3|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
414138|NCT01610557|1014143|P2|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
414139|NCT01610557|1014144|P1|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
414140|NCT01610557|1014140|P5|NOT COMPLETED|36-Week Randomized Crossover Phase||0
414141|NCT01610557|1014141|P4|NOT COMPLETED|36-Week Randomized Crossover Phase||0
414142|NCT01610557|1014142|P3|NOT COMPLETED|36-Week Randomized Crossover Phase||0
414143|NCT01610557|1014143|P2|NOT COMPLETED|36-Week Randomized Crossover Phase||1
414144|NCT01610557|1014144|P1|NOT COMPLETED|36-Week Randomized Crossover Phase||0
414145|NCT01610557|1014140|P5|COMPLETED|36-Week Randomized Crossover Phase|Not applicable for 36-week double-masked randomized crossover phase|0
414146|NCT01610557|1014141|P4|COMPLETED|36-Week Randomized Crossover Phase||13
414147|NCT01610557|1014142|P3|COMPLETED|36-Week Randomized Crossover Phase||14
414148|NCT01610557|1014143|P2|COMPLETED|36-Week Randomized Crossover Phase|Unilateral participant unable to return for visits after Wk 4 due to recovery from an adverse event|12
414149|NCT01610557|1014144|P1|COMPLETED|36-Week Randomized Crossover Phase||16
414150|NCT01610557|1014140|P5|STARTED|36-Week Randomized Crossover Phase|Not applicable for 36-week double-masked randomized crossover phase|0
414151|NCT01610557|1014141|P4|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 4: 11 unilateral and 2 bilateral (left eye assigned to Grp 2)|13
414152|NCT01610557|1014142|P3|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 3: 13 unilateral and 1 bilateral (left eye assigned to Grp 1)|14
414153|NCT01610557|1014143|P2|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 2: 12 unilateral and 1 bilateral (left eye assigned to Grp 4)|13
414154|NCT01610557|1014144|P1|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 1: 14 unilateral and 2 bilateral (left eye assigned to Grp 3)|16
414155|NCT01610492|1014157|P1|NOT COMPLETED|Overall Study||6
414156|NCT01610492|1014157|P1|COMPLETED|Overall Study||8
414157|NCT01610492|1014157|P1|STARTED|Overall Study||14
414158|NCT01610453|1014201|P1|NOT COMPLETED|Overall Study||0
414159|NCT01610453|1014201|P1|COMPLETED|Overall Study||150
414160|NCT01610453|1014201|P1|STARTED|Overall Study||150
414161|NCT01610414|1014208|P2|NOT COMPLETED|After Month 25||53
414162|NCT01610414|1014209|P1|NOT COMPLETED|After Month 25||48
414163|NCT01610414|1014208|P2|COMPLETED|After Month 25||871
414164|NCT01610414|1014209|P1|COMPLETED|After Month 25||874
414165|NCT01610414|1014208|P2|STARTED|After Month 25||924
414166|NCT01610414|1014209|P1|STARTED|After Month 25||922
414167|NCT01610414|1014208|P2|NOT COMPLETED|Month 13 - Month 25||70
414168|NCT01610414|1014209|P1|NOT COMPLETED|Month 13 - Month 25||65
414169|NCT01610414|1014208|P2|COMPLETED|Month 13 - Month 25||854
414170|NCT01610414|1014209|P1|COMPLETED|Month 13 - Month 25||857
414171|NCT01610414|1014208|P2|STARTED|Month 13 - Month 25||924
414172|NCT01610414|1014209|P1|STARTED|Month 13 - Month 25||922
414173|NCT01610414|1014208|P2|NOT COMPLETED|Study Start - Month 13||129
414174|NCT01610414|1014209|P1|NOT COMPLETED|Study Start - Month 13||115
414175|NCT01610414|1014208|P2|COMPLETED|Study Start - Month 13||795
414176|NCT01610414|1014209|P1|COMPLETED|Study Start - Month 13||807
414177|NCT01610414|1014208|P2|STARTED|Study Start - Month 13||924
414178|NCT01610414|1014209|P1|STARTED|Study Start - Month 13||922
414179|NCT01610297|1014238|P1|NOT COMPLETED|Overall Study||1
414180|NCT01610297|1014238|P1|COMPLETED|Overall Study||26
414181|NCT01610297|1014238|P1|STARTED|Overall Study||27
414182|NCT01610167|1014249|P3|NOT COMPLETED|Overall Study||2
414183|NCT01610167|1014250|P2|NOT COMPLETED|Overall Study||0
414184|NCT01610167|1014251|P1|NOT COMPLETED|Overall Study||0
414185|NCT01610167|1014249|P3|COMPLETED|Overall Study||48
414186|NCT01610167|1014250|P2|COMPLETED|Overall Study||49
414187|NCT01610167|1014251|P1|COMPLETED|Overall Study||52
414188|NCT01610167|1014249|P3|STARTED|Overall Study||50
414189|NCT01610167|1014250|P2|STARTED|Overall Study||49
414190|NCT01610167|1014251|P1|STARTED|Overall Study||52
414191|NCT01610154|1014271|P1|NOT COMPLETED|Overall Study||1
414192|NCT01610154|1014271|P1|COMPLETED|Overall Study||84
414193|NCT01610154|1014271|P1|STARTED|Overall Study||85
414194|NCT01610076|1014288|P2|NOT COMPLETED|Overall Study||5
414195|NCT01610076|1014289|P1|NOT COMPLETED|Overall Study||3
414196|NCT01610076|1014288|P2|COMPLETED|Overall Study||100
414197|NCT01610076|1014289|P1|COMPLETED|Overall Study||100
414198|NCT01610076|1014288|P2|STARTED|Overall Study||105
414199|NCT01610076|1014289|P1|STARTED|Overall Study||103
414200|NCT01610063|1014300|P2|NOT COMPLETED|Overall Study||20
414201|NCT01610063|1014301|P1|NOT COMPLETED|Overall Study||42
414202|NCT01610063|1014300|P2|COMPLETED|Overall Study||93
414203|NCT01610063|1014301|P1|COMPLETED|Overall Study||72
414204|NCT01610063|1014300|P2|Completed 8-week|Overall Study||93
414205|NCT01610063|1014301|P1|Completed 8-week|Overall Study||72
414206|NCT01610063|1014300|P2|Completed 4-week|Overall Study||98
414207|NCT01610063|1014301|P1|Completed 4-week|Overall Study||86
414208|NCT01610063|1014300|P2|Completed 2-week|Overall Study||105
414209|NCT01610063|1014301|P1|Completed 2-week|Overall Study||97
414210|NCT01610063|1014300|P2|Baseline|Overall Study||113
414211|NCT01610063|1014301|P1|Baseline|Overall Study||114
414212|NCT01610063|1014300|P2|STARTED|Overall Study||113
414213|NCT01610063|1014301|P1|STARTED|Overall Study||114
414214|NCT01610037|1014324|P3|NOT COMPLETED|Treatment and Follow up Period||26
414215|NCT01610037|1014325|P2|NOT COMPLETED|Treatment and Follow up Period||28
414216|NCT01610037|1014326|P1|NOT COMPLETED|Treatment and Follow up Period||25
414217|NCT01610037|1014324|P3|COMPLETED|Treatment and Follow up Period||378
414218|NCT01610037|1014325|P2|COMPLETED|Treatment and Follow up Period||377
414219|NCT01610037|1014326|P1|COMPLETED|Treatment and Follow up Period||382
414220|NCT01610037|1014324|P3|STARTED|Treatment and Follow up Period||404
414221|NCT01610037|1014325|P2|STARTED|Treatment and Follow up Period||405
414222|NCT01610037|1014326|P1|STARTED|Treatment and Follow up Period||407
414223|NCT01610037|1014324|P3|NOT COMPLETED|All Patients||84
414224|NCT01610037|1014325|P2|NOT COMPLETED|All Patients||51
414225|NCT01610037|1014326|P1|NOT COMPLETED|All Patients||59
414226|NCT01610037|1014324|P3|COMPLETED|All Patients||320
414227|NCT01610037|1014325|P2|COMPLETED|All Patients||354
414228|NCT01610037|1014326|P1|COMPLETED|All Patients||348
414229|NCT01610037|1014324|P3|Full Analysis Set (FAS)|All Patients||403
414230|NCT01610037|1014325|P2|Full Analysis Set (FAS)|All Patients||405
414231|NCT01610037|1014326|P1|Full Analysis Set (FAS)|All Patients||407
414232|NCT01610037|1014324|P3|Randomized Set (RAN)|All Patients||404
414233|NCT01610037|1014325|P2|Randomized Set (RAN)|All Patients||405
414234|NCT01610037|1014326|P1|Randomized Set (RAN)|All Patients||407
414235|NCT01610037|1014324|P3|STARTED|All Patients||404
414236|NCT01610037|1014325|P2|STARTED|All Patients||405
414237|NCT01610037|1014326|P1|STARTED|All Patients||407
414238|NCT01610011|1014369|P2|NOT COMPLETED|Overall Study||0
414239|NCT01610011|1014370|P1|NOT COMPLETED|Overall Study||10
414240|NCT01610011|1014369|P2|COMPLETED|Overall Study||2
414241|NCT01610011|1014370|P1|COMPLETED|Overall Study||9
414242|NCT01610011|1014369|P2|STARTED|Overall Study||2
414243|NCT01610011|1014370|P1|STARTED|Overall Study||19
414244|NCT01609933|1014376|P1|NOT COMPLETED|Overall Study||4
414245|NCT01609933|1014376|P1|COMPLETED|Overall Study||28
414246|NCT01609933|1014376|P1|STARTED|Overall Study||32
414247|NCT01609790|1014386|P3|NOT COMPLETED|Overall Study||8
414248|NCT01609790|1014387|P2|NOT COMPLETED|Overall Study||7
414249|NCT01609790|1014388|P1|NOT COMPLETED|Overall Study||1
414250|NCT01609790|1014386|P3|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|57
414251|NCT01609790|1014387|P2|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|58
414252|NCT01609790|1014388|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|6
414253|NCT01609790|1014386|P3|STARTED|Overall Study||65
414254|NCT01609790|1014387|P2|STARTED|Overall Study||65
414255|NCT01609790|1014388|P1|STARTED|Overall Study||7
414256|NCT01609582|1014407|P2|NOT COMPLETED|Overall Study||1604
414257|NCT01609582|1014408|P1|NOT COMPLETED|Overall Study||1603
414258|NCT01609582|1014407|P2|COMPLETED|Overall Study||0
414259|NCT01609582|1014408|P1|COMPLETED|Overall Study||0
414260|NCT01609582|1014407|P2|Treated|Overall Study||1601
414261|NCT01609582|1014408|P1|Treated|Overall Study||1603
414262|NCT01609582|1014407|P2|STARTED|Overall Study||1604
414263|NCT01609582|1014408|P1|STARTED|Overall Study||1603
414264|NCT01609543|1014416|P1|NOT COMPLETED|Overall Study||42
414265|NCT01609543|1014416|P1|COMPLETED|Overall Study||20
414266|NCT01609543|1014416|P1|STARTED|Overall Study||62
414267|NCT01609478|1014425|P3|NOT COMPLETED|Overall Study||9
414268|NCT01609478|1014426|P2|NOT COMPLETED|Overall Study||2
414269|NCT01609478|1014427|P1|NOT COMPLETED|Overall Study||7
414270|NCT01609478|1014425|P3|COMPLETED|Overall Study||107
414271|NCT01609478|1014426|P2|COMPLETED|Overall Study||106
414272|NCT01609478|1014427|P1|COMPLETED|Overall Study||104
414273|NCT01609478|1014425|P3|Full Analysis Set (FAS)|Overall Study||115
414274|NCT01609478|1014426|P2|Full Analysis Set (FAS)|Overall Study||108
414275|NCT01609478|1014427|P1|Full Analysis Set (FAS)|Overall Study||110
414276|NCT01609478|1014425|P3|STARTED|Overall Study||116
414277|NCT01609478|1014426|P2|STARTED|Overall Study||108
414278|NCT01609478|1014427|P1|STARTED|Overall Study||111
414279|NCT01609348|1014493|P2|NOT COMPLETED|Overall Study||0
414280|NCT01609348|1014494|P1|NOT COMPLETED|Overall Study||0
414281|NCT01609348|1014493|P2|COMPLETED|Overall Study||2
414282|NCT01609348|1014494|P1|COMPLETED|Overall Study||3
414283|NCT01609348|1014493|P2|STARTED|Overall Study||2
414284|NCT01609348|1014494|P1|STARTED|Overall Study||3
414285|NCT01609257|1014502|P2|NOT COMPLETED|Overall Study||8
414286|NCT01609257|1014503|P1|NOT COMPLETED|Overall Study||6
414287|NCT01609257|1014502|P2|COMPLETED|Overall Study||57
414288|NCT01609257|1014503|P1|COMPLETED|Overall Study||61
414289|NCT01609257|1014502|P2|Received Challenge Product|Overall Study||53
414290|NCT01609257|1014503|P1|Received Challenge Product|Overall Study||56
414291|NCT01609257|1014502|P2|Received 2 Doses|Overall Study||64
414292|NCT01609257|1014503|P1|Received 2 Doses|Overall Study||63
414293|NCT01609257|1014502|P2|STARTED|Overall Study||65
414294|NCT01609257|1014503|P1|STARTED|Overall Study||67
414295|NCT01609062|1014575|P2|NOT COMPLETED|Extension Phase||10
414296|NCT01609062|1014576|P1|NOT COMPLETED|Extension Phase||15
414297|NCT01609062|1014575|P2|COMPLETED|Extension Phase|EAP = Expanded Access Program|0
414298|NCT01609062|1014576|P1|COMPLETED|Extension Phase||0
414299|NCT01609062|1014575|P2|STARTED|Extension Phase||10
414300|NCT01609062|1014576|P1|STARTED|Extension Phase||15
414301|NCT01609062|1014575|P2|NOT COMPLETED|Primary Phase||0
414302|NCT01609062|1014576|P1|NOT COMPLETED|Primary Phase||0
414303|NCT01609062|1014575|P2|COMPLETED|Primary Phase||10
414304|NCT01609062|1014576|P1|COMPLETED|Primary Phase||15
414305|NCT01609062|1014575|P2|STARTED|Primary Phase||10
414306|NCT01609062|1014576|P1|STARTED|Primary Phase||15
414307|NCT01609023|1014619|P1|NOT COMPLETED|Overall Study||33
414308|NCT01609023|1014619|P1|COMPLETED|Overall Study||34
414309|NCT01609023|1014619|P1|STARTED|Overall Study||67
414310|NCT01609010|1014631|P2|NOT COMPLETED|Overall Study||37
414311|NCT01609010|1014632|P1|NOT COMPLETED|Overall Study||43
414312|NCT01609010|1014631|P2|COMPLETED|Overall Study||120
414313|NCT01609010|1014632|P1|COMPLETED|Overall Study||113
414314|NCT01609010|1014631|P2|Entering Cycle 2|Overall Study||124
414315|NCT01609010|1014632|P1|Entering Cycle 2|Overall Study||120
414316|NCT01609010|1014631|P2|STARTED|Overall Study||157
414317|NCT01609010|1014632|P1|STARTED|Overall Study||156
414318|NCT01608971|1014658|P2|NOT COMPLETED|Overall Study||0
414319|NCT01608971|1014659|P1|NOT COMPLETED|Overall Study||0
414320|NCT01608971|1014658|P2|COMPLETED|Overall Study||15
414321|NCT01608971|1014659|P1|COMPLETED|Overall Study||15
414322|NCT01608971|1014658|P2|STARTED|Overall Study||15
414323|NCT01608971|1014659|P1|STARTED|Overall Study||15
414324|NCT01608815|1014674|P3|NOT COMPLETED|Overall Study||0
414325|NCT01608815|1014675|P2|NOT COMPLETED|Overall Study||0
414326|NCT01608815|1014676|P1|NOT COMPLETED|Overall Study||0
414327|NCT01608815|1014674|P3|COMPLETED|Overall Study||5
414328|NCT01608815|1014675|P2|COMPLETED|Overall Study||7
414329|NCT01608815|1014676|P1|COMPLETED|Overall Study||188
414330|NCT01608815|1014674|P3|STARTED|Overall Study||5
414331|NCT01608815|1014675|P2|STARTED|Overall Study||7
414332|NCT01608815|1014676|P1|STARTED|Overall Study||188
414333|NCT01608724|1014693|P1|NOT COMPLETED|Overall Study||243
414334|NCT01608724|1014693|P1|COMPLETED|Overall Study||1180
414335|NCT01608724|1014693|P1|Treated|Overall Study||1361
414336|NCT01608724|1014693|P1|STARTED|Overall Study|One patient was excluded because the Informed Consent Form was destroyed by site staff by mistake.|1423
414337|NCT01608672|1014700|P1|NOT COMPLETED|Overall Study||0
414338|NCT01608672|1014700|P1|COMPLETED|Overall Study||207
414339|NCT01608672|1014700|P1|STARTED|Overall Study||207
414340|NCT01608659|1014706|P1|NOT COMPLETED|Overall Study||16
414341|NCT01608659|1014706|P1|COMPLETED|Overall Study||94
414342|NCT01608659|1014706|P1|STARTED|Overall Study||110
414343|NCT01608490|1014714|P2|NOT COMPLETED|Overall Study||0
414344|NCT01608490|1014715|P1|NOT COMPLETED|Overall Study||0
414345|NCT01608490|1014714|P2|COMPLETED|Overall Study||157
414346|NCT01608490|1014715|P1|COMPLETED|Overall Study||158
414347|NCT01608490|1014714|P2|STARTED|Overall Study||157
414348|NCT01608490|1014715|P1|STARTED|Overall Study||158
414349|NCT01608321|1014725|P2|NOT COMPLETED|Overall Study||0
414350|NCT01608321|1014726|P1|NOT COMPLETED|Overall Study||1
414351|NCT01608321|1014725|P2|COMPLETED|Overall Study||4
414352|NCT01608321|1014726|P1|COMPLETED|Overall Study||12
414353|NCT01608321|1014725|P2|STARTED|Overall Study||4
414354|NCT01608321|1014726|P1|STARTED|Overall Study||13
414355|NCT01608308|1014734|P2|NOT COMPLETED|Overall Study||2
414356|NCT01608308|1014735|P1|NOT COMPLETED|Overall Study||0
414357|NCT01608308|1014734|P2|COMPLETED|Overall Study||29
414358|NCT01608308|1014735|P1|COMPLETED|Overall Study||31
414359|NCT01608308|1014734|P2|STARTED|Overall Study||31
414360|NCT01608308|1014735|P1|STARTED|Overall Study||31
414361|NCT01608295|1014759|P2|NOT COMPLETED|Overall Study||5
414362|NCT01608295|1014760|P1|NOT COMPLETED|Overall Study||6
414363|NCT01608295|1014759|P2|COMPLETED|Overall Study||25
414364|NCT01608295|1014760|P1|COMPLETED|Overall Study||20
414365|NCT01608295|1014759|P2|STARTED|Overall Study||30
414366|NCT01608295|1014760|P1|STARTED|Overall Study||26
414367|NCT01608100|1014771|P1|NOT COMPLETED|Overall Study||0
414368|NCT01608100|1014771|P1|COMPLETED|Overall Study||1101
414369|NCT01608100|1014771|P1|STARTED|Overall Study||1101
414370|NCT01607853|1014795|P1|NOT COMPLETED|Overall Study||0
414371|NCT01607853|1014795|P1|COMPLETED|Overall Study||24
414372|NCT01607853|1014795|P1|STARTED|Overall Study||24
414373|NCT01607645|1014904|P2|NOT COMPLETED|Overall Study||0
414374|NCT01607645|1014905|P1|NOT COMPLETED|Overall Study||0
414375|NCT01607645|1014904|P2|COMPLETED|Overall Study||3
414376|NCT01607645|1014905|P1|COMPLETED|Overall Study||4
414377|NCT01607645|1014904|P2|STARTED|Overall Study||3
414378|NCT01607645|1014905|P1|STARTED|Overall Study||4
414379|NCT01607593|1014935|P1|NOT COMPLETED|Overall Study||93
414380|NCT01607593|1014935|P1|COMPLETED|Overall Study||29
414381|NCT01607593|1014935|P1|STARTED|Overall Study||122
414382|NCT01607554|1014941|P1|NOT COMPLETED|Overall Study||2
414383|NCT01607554|1014941|P1|COMPLETED|Overall Study||0
414384|NCT01607554|1014941|P1|STARTED|Overall Study||2
414385|NCT01607476|1014954|P3|NOT COMPLETED|Overall Study||3
414386|NCT01607476|1014955|P2|NOT COMPLETED|Overall Study||0
414387|NCT01607476|1014956|P1|NOT COMPLETED|Overall Study||1
414388|NCT01607476|1014954|P3|COMPLETED|Overall Study||30
414389|NCT01607476|1014955|P2|COMPLETED|Overall Study||30
414390|NCT01607476|1014956|P1|COMPLETED|Overall Study||24
414391|NCT01607476|1014954|P3|STARTED|Overall Study||33
414392|NCT01607476|1014955|P2|STARTED|Overall Study||30
414393|NCT01607476|1014956|P1|STARTED|Overall Study||25
414394|NCT01607450|1014974|P7|NOT COMPLETED|Overall Study||0
414395|NCT01607450|1014975|P6|NOT COMPLETED|Overall Study||0
414396|NCT01607450|1014976|P5|NOT COMPLETED|Overall Study||0
414397|NCT01607450|1014977|P4|NOT COMPLETED|Overall Study||0
414398|NCT01607450|1014978|P3|NOT COMPLETED|Overall Study||0
414399|NCT01607450|1014979|P2|NOT COMPLETED|Overall Study||0
414400|NCT01607450|1014980|P1|NOT COMPLETED|Overall Study||0
414401|NCT01607450|1014974|P7|COMPLETED|Overall Study||0
414402|NCT01607450|1014975|P6|COMPLETED|Overall Study||0
414403|NCT01607450|1014976|P5|COMPLETED|Overall Study||1
414404|NCT01607450|1014977|P4|COMPLETED|Overall Study||11
414405|NCT01607450|1014978|P3|COMPLETED|Overall Study||7
414406|NCT01607450|1014979|P2|COMPLETED|Overall Study||8
414407|NCT01607450|1014980|P1|COMPLETED|Overall Study||6
414408|NCT01607450|1014974|P7|STARTED|Overall Study||0
414409|NCT01607450|1014975|P6|STARTED|Overall Study||0
414410|NCT01607450|1014976|P5|STARTED|Overall Study||1
414411|NCT01607450|1014977|P4|STARTED|Overall Study||11
414412|NCT01607450|1014978|P3|STARTED|Overall Study||7
414413|NCT01607450|1014979|P2|STARTED|Overall Study||8
414414|NCT01607450|1014980|P1|STARTED|Overall Study||6
414415|NCT01607411|1015024|P4|NOT COMPLETED|Period IV||0
414416|NCT01607411|1015025|P3|NOT COMPLETED|Period IV||0
414417|NCT01607411|1015026|P2|NOT COMPLETED|Period IV||0
414418|NCT01607411|1015027|P1|NOT COMPLETED|Period IV||0
414419|NCT01607411|1015024|P4|COMPLETED|Period IV||14
414420|NCT01607411|1015025|P3|COMPLETED|Period IV||14
414421|NCT01607411|1015026|P2|COMPLETED|Period IV||14
414422|NCT01607411|1015027|P1|COMPLETED|Period IV||13
414423|NCT01607411|1015024|P4|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
414424|NCT01607411|1015025|P3|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
414425|NCT01607411|1015026|P2|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
414426|NCT01607411|1015027|P1|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|13
414427|NCT01607411|1015024|P4|NOT COMPLETED|Period III||0
414428|NCT01607411|1015025|P3|NOT COMPLETED|Period III||0
414429|NCT01607411|1015026|P2|NOT COMPLETED|Period III||0
414430|NCT01607411|1015027|P1|NOT COMPLETED|Period III||0
414431|NCT01607411|1015024|P4|COMPLETED|Period III||13
414432|NCT01607411|1015025|P3|COMPLETED|Period III||14
414433|NCT01607411|1015026|P2|COMPLETED|Period III||14
414434|NCT01607411|1015027|P1|COMPLETED|Period III||14
414435|NCT01607411|1015024|P4|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|13
414436|NCT01607411|1015025|P3|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
414437|NCT01607411|1015026|P2|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
414438|NCT01607411|1015027|P1|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
414439|NCT01607411|1015024|P4|NOT COMPLETED|Period II||0
414440|NCT01607411|1015025|P3|NOT COMPLETED|Period II||0
414441|NCT01607411|1015026|P2|NOT COMPLETED|Period II||0
414442|NCT01607411|1015027|P1|NOT COMPLETED|Period II||0
414443|NCT01607411|1015024|P4|COMPLETED|Period II||14
414444|NCT01607411|1015025|P3|COMPLETED|Period II||13
414445|NCT01607411|1015026|P2|COMPLETED|Period II||14
414446|NCT01607411|1015027|P1|COMPLETED|Period II||14
414447|NCT01607411|1015024|P4|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
414448|NCT01607411|1015025|P3|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|13
414449|NCT01607411|1015026|P2|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
414450|NCT01607411|1015027|P1|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
414451|NCT01607411|1015024|P4|NOT COMPLETED|Period I||0
414452|NCT01607411|1015025|P3|NOT COMPLETED|Period I||0
414453|NCT01607411|1015026|P2|NOT COMPLETED|Period I||0
414454|NCT01607411|1015027|P1|NOT COMPLETED|Period I||0
414455|NCT01607411|1015024|P4|COMPLETED|Period I||14
414456|NCT01607411|1015025|P3|COMPLETED|Period I||14
414457|NCT01607411|1015026|P2|COMPLETED|Period I||13
414458|NCT01607411|1015027|P1|COMPLETED|Period I||14
414459|NCT01607411|1015024|P4|STARTED|Period I||14
414460|NCT01607411|1015025|P3|STARTED|Period I||14
414461|NCT01607411|1015026|P2|STARTED|Period I||13
414462|NCT01607411|1015027|P1|STARTED|Period I||14
414463|NCT01607398|1015050|P2|NOT COMPLETED|Overall Study||2
414464|NCT01607398|1015051|P1|NOT COMPLETED|Overall Study||2
414465|NCT01607398|1015050|P2|COMPLETED|Overall Study||26
414466|NCT01607398|1015051|P1|COMPLETED|Overall Study||26
414467|NCT01607398|1015050|P2|STARTED|Overall Study||28
414468|NCT01607398|1015051|P1|STARTED|Overall Study||28
414469|NCT01607346|1015095|P1|NOT COMPLETED|Overall Study||3
414470|NCT01607346|1015095|P1|COMPLETED|Overall Study||7
414471|NCT01607346|1015095|P1|STARTED|Overall Study||10
414472|NCT01607320|1015111|P2|NOT COMPLETED|Overall Study||0
414473|NCT01607320|1015112|P1|NOT COMPLETED|Overall Study||0
414474|NCT01607320|1015111|P2|COMPLETED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
414475|NCT01607320|1015112|P1|COMPLETED|Overall Study|The study was randomized between the 2 treatments and was never unblinded,so unknown.|0
414476|NCT01607320|1015111|P2|STARTED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
414477|NCT01607320|1015112|P1|STARTED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
414478|NCT01607203|1015118|P2|NOT COMPLETED|Overall Study||0
414479|NCT01607203|1015119|P1|NOT COMPLETED|Overall Study||0
414480|NCT01607203|1015118|P2|COMPLETED|Overall Study||61
414481|NCT01607203|1015119|P1|COMPLETED|Overall Study||59
414482|NCT01607203|1015118|P2|STARTED|Overall Study||61
414483|NCT01607203|1015119|P1|STARTED|Overall Study||59
414484|NCT01607112|1015131|P2|NOT COMPLETED|Overall Study||0
414485|NCT01607112|1015132|P1|NOT COMPLETED|Overall Study||0
414486|NCT01607112|1015131|P2|COMPLETED|Overall Study||59
414487|NCT01607112|1015132|P1|COMPLETED|Overall Study||60
414488|NCT01607112|1015131|P2|STARTED|Overall Study||59
414489|NCT01607112|1015132|P1|STARTED|Overall Study||60
414490|NCT01606852|1015168|P2|NOT COMPLETED|Overall Study||0
414491|NCT01606852|1015169|P1|NOT COMPLETED|Overall Study||0
414492|NCT01606852|1015168|P2|COMPLETED|Overall Study||8
414493|NCT01606852|1015169|P1|COMPLETED|Overall Study||7
414494|NCT01606852|1015168|P2|STARTED|Overall Study||8
414495|NCT01606852|1015169|P1|STARTED|Overall Study||7
414496|NCT01606800|1015179|P2|NOT COMPLETED|Overall Study||2
414497|NCT01606800|1015180|P1|NOT COMPLETED|Overall Study||5
414498|NCT01606800|1015179|P2|COMPLETED|Overall Study||21
414499|NCT01606800|1015180|P1|COMPLETED|Overall Study||17
414500|NCT01606800|1015179|P2|Treated|Overall Study||23
414501|NCT01606800|1015180|P1|Treated|Overall Study||22
414502|NCT01606800|1015179|P2|STARTED|Overall Study||23
414503|NCT01606800|1015180|P1|STARTED|Overall Study||22
414504|NCT01606787|1015188|P2|NOT COMPLETED|Overall Study||7
414505|NCT01606787|1015189|P1|NOT COMPLETED|Overall Study||4
414506|NCT01606787|1015188|P2|COMPLETED|Overall Study||98
414507|NCT01606787|1015189|P1|COMPLETED|Overall Study||101
414508|NCT01606787|1015188|P2|STARTED|Overall Study||105
414509|NCT01606787|1015189|P1|STARTED|Overall Study||105
414510|NCT01606761|1015200|P5|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||8
414511|NCT01606761|1015201|P4|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||2
414512|NCT01606761|1015202|P3|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||17
414513|NCT01606761|1015203|P2|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||10
414514|NCT01606761|1015204|P1|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||4
414515|NCT01606761|1015200|P5|COMPLETED|Safety Follow-up Period (Week 52-68)||11
414516|NCT01606761|1015201|P4|COMPLETED|Safety Follow-up Period (Week 52-68)||7
414517|NCT01606761|1015202|P3|COMPLETED|Safety Follow-up Period (Week 52-68)||45
414518|NCT01606761|1015203|P2|COMPLETED|Safety Follow-up Period (Week 52-68)||55
414519|NCT01606761|1015204|P1|COMPLETED|Safety Follow-up Period (Week 52-68)||24
414520|NCT01606761|1015200|P5|Safety Population|Safety Follow-up Period (Week 52-68)||19
414521|NCT01606761|1015201|P4|Safety Population|Safety Follow-up Period (Week 52-68)||7
414522|NCT01606761|1015202|P3|Safety Population|Safety Follow-up Period (Week 52-68)||62
414523|NCT01606761|1015203|P2|Safety Population|Safety Follow-up Period (Week 52-68)||65
414524|NCT01606761|1015204|P1|Safety Population|Safety Follow-up Period (Week 52-68)||28
414525|NCT01606761|1015200|P5|STARTED|Safety Follow-up Period (Week 52-68)||19
414526|NCT01606761|1015201|P4|STARTED|Safety Follow-up Period (Week 52-68)||9
414527|NCT01606761|1015202|P3|STARTED|Safety Follow-up Period (Week 52-68)||62
414528|NCT01606761|1015203|P2|STARTED|Safety Follow-up Period (Week 52-68)||65
414529|NCT01606761|1015204|P1|STARTED|Safety Follow-up Period (Week 52-68)||28
414530|NCT01606761|1015200|P5|NOT COMPLETED|Week 24 to Week 52||20
414531|NCT01606761|1015201|P4|NOT COMPLETED|Week 24 to Week 52||17
414532|NCT01606761|1015202|P3|NOT COMPLETED|Week 24 to Week 52||33
414533|NCT01606761|1015203|P2|NOT COMPLETED|Week 24 to Week 52||33
414534|NCT01606761|1015204|P1|NOT COMPLETED|Week 24 to Week 52||0
414535|NCT01606761|1015200|P5|COMPLETED|Week 24 to Week 52||106
414536|NCT01606761|1015201|P4|COMPLETED|Week 24 to Week 52||109
414537|NCT01606761|1015202|P3|COMPLETED|Week 24 to Week 52||212
414538|NCT01606761|1015203|P2|COMPLETED|Week 24 to Week 52||204
414539|NCT01606761|1015204|P1|COMPLETED|Week 24 to Week 52||0
414540|NCT01606761|1015200|P5|Treated|Week 24 to Week 52||126
414541|NCT01606761|1015201|P4|Treated|Week 24 to Week 52||124
414542|NCT01606761|1015202|P3|Treated|Week 24 to Week 52||245
414543|NCT01606761|1015203|P2|Treated|Week 24 to Week 52||237
414544|NCT01606761|1015204|P1|Treated|Week 24 to Week 52||0
414545|NCT01606761|1015200|P5|STARTED|Week 24 to Week 52|Participants re-randomized at Week 18 (48) and Week 24 (78) were included.|126
414546|NCT01606761|1015201|P4|STARTED|Week 24 to Week 52|Participants re-randomized at Week 18 (46) and Week 24 (80) were included.|126
414547|NCT01606761|1015202|P3|STARTED|Week 24 to Week 52||245
414548|NCT01606761|1015203|P2|STARTED|Week 24 to Week 52||237
414549|NCT01606761|1015204|P1|STARTED|Week 24 to Week 52||0
414550|NCT01606761|1015200|P5|NOT COMPLETED|Prior to Week 24||0
414551|NCT01606761|1015201|P4|NOT COMPLETED|Prior to Week 24||0
414552|NCT01606761|1015202|P3|NOT COMPLETED|Prior to Week 24||47
414553|NCT01606761|1015203|P2|NOT COMPLETED|Prior to Week 24||55
414554|NCT01606761|1015204|P1|NOT COMPLETED|Prior to Week 24||42
414555|NCT01606761|1015200|P5|COMPLETED|Prior to Week 24||0
414556|NCT01606761|1015201|P4|COMPLETED|Prior to Week 24||0
414557|NCT01606761|1015202|P3|COMPLETED|Prior to Week 24||245
414558|NCT01606761|1015203|P2|COMPLETED|Prior to Week 24||237
414559|NCT01606761|1015204|P1|COMPLETED|Prior to Week 24||252
414560|NCT01606761|1015200|P5|Participants Re-randomized at Week 18|Prior to Week 24||0
414561|NCT01606761|1015201|P4|Participants Re-randomized at Week 18|Prior to Week 24||0
414562|NCT01606761|1015202|P3|Participants Re-randomized at Week 18|Prior to Week 24||0
414563|NCT01606761|1015203|P2|Participants Re-randomized at Week 18|Prior to Week 24||0
414564|NCT01606761|1015204|P1|Participants Re-randomized at Week 18|Prior to Week 24|Out of 94, 46 were re-randomized to sirukumab 50 mg and 48 were re-randomized to 100 mg group.|94
414565|NCT01606761|1015200|P5|STARTED|Prior to Week 24||0
414566|NCT01606761|1015201|P4|STARTED|Prior to Week 24||0
414567|NCT01606761|1015202|P3|STARTED|Prior to Week 24||292
414568|NCT01606761|1015203|P2|STARTED|Prior to Week 24||292
414569|NCT01606761|1015204|P1|STARTED|Prior to Week 24||294
414570|NCT01606748|1015230|P2|NOT COMPLETED|Overall Study||0
414571|NCT01606748|1015231|P1|NOT COMPLETED|Overall Study||3
414572|NCT01606748|1015230|P2|COMPLETED|Overall Study||17
414573|NCT01606748|1015231|P1|COMPLETED|Overall Study||15
414574|NCT01606748|1015230|P2|Received at Least 1 Dose of Study Drug|Overall Study||17
414575|NCT01606748|1015231|P1|Received at Least 1 Dose of Study Drug|Overall Study||18
414576|NCT01606748|1015230|P2|STARTED|Overall Study||17
414577|NCT01606748|1015231|P1|STARTED|Overall Study||18
414578|NCT01606735|1015262|P3|NOT COMPLETED|Overall Study||0
414579|NCT01606735|1015263|P2|NOT COMPLETED|Overall Study||0
414580|NCT01606735|1015264|P1|NOT COMPLETED|Overall Study||0
414581|NCT01606735|1015262|P3|COMPLETED|Overall Study||58
414582|NCT01606735|1015263|P2|COMPLETED|Overall Study||56
414583|NCT01606735|1015264|P1|COMPLETED|Overall Study||58
414584|NCT01606735|1015262|P3|STARTED|Overall Study||58
414585|NCT01606735|1015263|P2|STARTED|Overall Study||56
414586|NCT01606735|1015264|P1|STARTED|Overall Study||58
414587|NCT01606670|1015272|P1|NOT COMPLETED|Overall Study||16
414588|NCT01606670|1015272|P1|COMPLETED|Overall Study||77
414589|NCT01606670|1015272|P1|Full Analysis Set|Overall Study||70
414590|NCT01606670|1015272|P1|Safety Set|Overall Study||93
414591|NCT01606670|1015272|P1|STARTED|Overall Study||93
414592|NCT01606319|1015282|P2|NOT COMPLETED|Overall Study||40
414593|NCT01606319|1015283|P1|NOT COMPLETED|Overall Study||34
414594|NCT01606319|1015282|P2|COMPLETED|Overall Study||110
414595|NCT01606319|1015283|P1|COMPLETED|Overall Study||116
414596|NCT01606319|1015282|P2|STARTED|Overall Study||150
414597|NCT01606319|1015283|P1|STARTED|Overall Study||150
414598|NCT01606306|1015301|P6|NOT COMPLETED|Overall Study||11
414599|NCT01606306|1015302|P5|NOT COMPLETED|Overall Study||11
414600|NCT01606306|1015303|P4|NOT COMPLETED|Overall Study||13
414601|NCT01606306|1015304|P3|NOT COMPLETED|Overall Study||14
414602|NCT01606306|1015305|P2|NOT COMPLETED|Overall Study||10
414603|NCT01606306|1015306|P1|NOT COMPLETED|Overall Study||15
414604|NCT01606306|1015301|P6|COMPLETED|Overall Study||36
414605|NCT01606306|1015302|P5|COMPLETED|Overall Study||41
414606|NCT01606306|1015303|P4|COMPLETED|Overall Study||38
414607|NCT01606306|1015304|P3|COMPLETED|Overall Study||37
414608|NCT01606306|1015305|P2|COMPLETED|Overall Study||39
414609|NCT01606306|1015306|P1|COMPLETED|Overall Study||35
414610|NCT01606306|1015301|P6|Completed Third Treatment Period|Overall Study||36
414611|NCT01606306|1015302|P5|Completed Third Treatment Period|Overall Study||41
414612|NCT01606306|1015303|P4|Completed Third Treatment Period|Overall Study||38
414613|NCT01606306|1015304|P3|Completed Third Treatment Period|Overall Study||37
414614|NCT01606306|1015305|P2|Completed Third Treatment Period|Overall Study||39
414615|NCT01606306|1015306|P1|Completed Third Treatment Period|Overall Study||35
414616|NCT01606306|1015301|P6|Completed Second Treatment Period|Overall Study||41
414617|NCT01606306|1015302|P5|Completed Second Treatment Period|Overall Study||46
414618|NCT01606306|1015303|P4|Completed Second Treatment Period|Overall Study||44
414619|NCT01606306|1015304|P3|Completed Second Treatment Period|Overall Study||43
414620|NCT01606306|1015305|P2|Completed Second Treatment Period|Overall Study||38
414621|NCT01606306|1015306|P1|Completed Second Treatment Period|Overall Study||41
414622|NCT01606306|1015301|P6|Completed First Treatment Period|Overall Study||44
414623|NCT01606306|1015302|P5|Completed First Treatment Period|Overall Study||47
414624|NCT01606306|1015303|P4|Completed First Treatment Period|Overall Study||45
414625|NCT01606306|1015304|P3|Completed First Treatment Period|Overall Study||47
414626|NCT01606306|1015305|P2|Completed First Treatment Period|Overall Study||47
414627|NCT01606306|1015306|P1|Completed First Treatment Period|Overall Study||43
414628|NCT01606306|1015301|P6|STARTED|Overall Study||47
414629|NCT01606306|1015302|P5|STARTED|Overall Study||52
414630|NCT01606306|1015303|P4|STARTED|Overall Study||51
414631|NCT01606306|1015304|P3|STARTED|Overall Study||51
414632|NCT01606306|1015305|P2|STARTED|Overall Study||49
414633|NCT01606306|1015306|P1|STARTED|Overall Study||50
414634|NCT01606254|1015316|P4|NOT COMPLETED|Overall Study||3
414635|NCT01606254|1015317|P3|NOT COMPLETED|Overall Study||0
414636|NCT01606254|1015318|P2|NOT COMPLETED|Overall Study||4
414637|NCT01606254|1015319|P1|NOT COMPLETED|Overall Study||2
414638|NCT01606254|1015316|P4|COMPLETED|Overall Study||11
414639|NCT01606254|1015317|P3|COMPLETED|Overall Study||14
414640|NCT01606254|1015318|P2|COMPLETED|Overall Study||10
414641|NCT01606254|1015319|P1|COMPLETED|Overall Study||12
414642|NCT01606254|1015316|P4|STARTED|Overall Study||14
414643|NCT01606254|1015317|P3|STARTED|Overall Study||14
414644|NCT01606254|1015318|P2|STARTED|Overall Study||14
414645|NCT01606254|1015319|P1|STARTED|Overall Study||14
414646|NCT01606228|1015401|P1|NOT COMPLETED|Overall Study||29
414647|NCT01606228|1015401|P1|COMPLETED|Overall Study||159
414648|NCT01606228|1015401|P1|STARTED|Overall Study||188
414649|NCT01606202|1015418|P2|NOT COMPLETED|Overall Study||3
414650|NCT01606202|1015419|P1|NOT COMPLETED|Overall Study||7
414651|NCT01606202|1015418|P2|COMPLETED|Overall Study||57
414652|NCT01606202|1015419|P1|COMPLETED|Overall Study||49
414653|NCT01606202|1015418|P2|STARTED|Overall Study||60
414654|NCT01606202|1015419|P1|STARTED|Overall Study||56
414655|NCT01606189|1015451|P6|NOT COMPLETED|Third Intenvention (14-20 Days)||1
414656|NCT01606189|1015452|P5|NOT COMPLETED|Third Intenvention (14-20 Days)||0
414657|NCT01606189|1015453|P4|NOT COMPLETED|Third Intenvention (14-20 Days)||0
414658|NCT01606189|1015454|P3|NOT COMPLETED|Third Intenvention (14-20 Days)||0
414659|NCT01606189|1015455|P2|NOT COMPLETED|Third Intenvention (14-20 Days)||0
414660|NCT01606189|1015456|P1|NOT COMPLETED|Third Intenvention (14-20 Days)||0
414661|NCT01606189|1015451|P6|COMPLETED|Third Intenvention (14-20 Days)||6
414662|NCT01606189|1015452|P5|COMPLETED|Third Intenvention (14-20 Days)||8
414663|NCT01606189|1015453|P4|COMPLETED|Third Intenvention (14-20 Days)||8
414664|NCT01606189|1015454|P3|COMPLETED|Third Intenvention (14-20 Days)||8
414665|NCT01606189|1015455|P2|COMPLETED|Third Intenvention (14-20 Days)||8
414666|NCT01606189|1015456|P1|COMPLETED|Third Intenvention (14-20 Days)||8
414667|NCT01606189|1015451|P6|STARTED|Third Intenvention (14-20 Days)||7
414668|NCT01606189|1015452|P5|STARTED|Third Intenvention (14-20 Days)||8
414669|NCT01606189|1015453|P4|STARTED|Third Intenvention (14-20 Days)||8
414670|NCT01606189|1015454|P3|STARTED|Third Intenvention (14-20 Days)||8
414671|NCT01606189|1015455|P2|STARTED|Third Intenvention (14-20 Days)||8
414672|NCT01606189|1015456|P1|STARTED|Third Intenvention (14-20 Days)||8
414673|NCT01606189|1015451|P6|NOT COMPLETED|Second Intenvention (14-20 Days)||1
414674|NCT01606189|1015452|P5|NOT COMPLETED|Second Intenvention (14-20 Days)||0
414675|NCT01606189|1015453|P4|NOT COMPLETED|Second Intenvention (14-20 Days)||0
414676|NCT01606189|1015454|P3|NOT COMPLETED|Second Intenvention (14-20 Days)||0
414677|NCT01606189|1015455|P2|NOT COMPLETED|Second Intenvention (14-20 Days)||0
414678|NCT01606189|1015456|P1|NOT COMPLETED|Second Intenvention (14-20 Days)||0
414679|NCT01606189|1015451|P6|COMPLETED|Second Intenvention (14-20 Days)||7
414680|NCT01606189|1015452|P5|COMPLETED|Second Intenvention (14-20 Days)||8
414681|NCT01606189|1015453|P4|COMPLETED|Second Intenvention (14-20 Days)||8
414682|NCT01606189|1015454|P3|COMPLETED|Second Intenvention (14-20 Days)||8
414683|NCT01606189|1015455|P2|COMPLETED|Second Intenvention (14-20 Days)||8
414684|NCT01606189|1015456|P1|COMPLETED|Second Intenvention (14-20 Days)||8
414685|NCT01606189|1015451|P6|STARTED|Second Intenvention (14-20 Days)||8
414686|NCT01606189|1015452|P5|STARTED|Second Intenvention (14-20 Days)||8
414687|NCT01606189|1015453|P4|STARTED|Second Intenvention (14-20 Days)||8
414688|NCT01606189|1015454|P3|STARTED|Second Intenvention (14-20 Days)||8
414689|NCT01606189|1015455|P2|STARTED|Second Intenvention (14-20 Days)||8
414690|NCT01606189|1015456|P1|STARTED|Second Intenvention (14-20 Days)||8
414691|NCT01606189|1015451|P6|NOT COMPLETED|First Intenvention (14-20 Days)||0
414692|NCT01606189|1015452|P5|NOT COMPLETED|First Intenvention (14-20 Days)||0
414693|NCT01606189|1015453|P4|NOT COMPLETED|First Intenvention (14-20 Days)||0
414694|NCT01606189|1015454|P3|NOT COMPLETED|First Intenvention (14-20 Days)||0
414695|NCT01606189|1015455|P2|NOT COMPLETED|First Intenvention (14-20 Days)||0
414696|NCT01606189|1015456|P1|NOT COMPLETED|First Intenvention (14-20 Days)||0
414697|NCT01606189|1015451|P6|COMPLETED|First Intenvention (14-20 Days)||8
414698|NCT01606189|1015452|P5|COMPLETED|First Intenvention (14-20 Days)||8
414699|NCT01606189|1015453|P4|COMPLETED|First Intenvention (14-20 Days)||8
414700|NCT01606189|1015454|P3|COMPLETED|First Intenvention (14-20 Days)||8
414701|NCT01606189|1015455|P2|COMPLETED|First Intenvention (14-20 Days)||8
414702|NCT01606189|1015456|P1|COMPLETED|First Intenvention (14-20 Days)||8
414703|NCT01606189|1015451|P6|STARTED|First Intenvention (14-20 Days)||8
414704|NCT01606189|1015452|P5|STARTED|First Intenvention (14-20 Days)||8
414705|NCT01606189|1015453|P4|STARTED|First Intenvention (14-20 Days)||8
414706|NCT01606189|1015454|P3|STARTED|First Intenvention (14-20 Days)||8
414707|NCT01606189|1015455|P2|STARTED|First Intenvention (14-20 Days)||8
414708|NCT01606189|1015456|P1|STARTED|First Intenvention (14-20 Days)||8
414709|NCT01606176|1015490|P2|NOT COMPLETED|Overall Study||3
414710|NCT01606176|1015491|P1|NOT COMPLETED|Overall Study||4
414711|NCT01606176|1015490|P2|COMPLETED|Overall Study||31
414712|NCT01606176|1015491|P1|COMPLETED|Overall Study||32
414713|NCT01606176|1015490|P2|STARTED|Overall Study||34
414714|NCT01606176|1015491|P1|STARTED|Overall Study||36
414715|NCT01606150|1015527|P2|NOT COMPLETED|Overall Study||0
414716|NCT01606150|1015528|P1|NOT COMPLETED|Overall Study||0
414717|NCT01606150|1015527|P2|COMPLETED|Overall Study|Enrollment was only for two months in 2012 due to technical and enrollment problems|0
414718|NCT01606150|1015528|P1|COMPLETED|Overall Study|Enrollment was only for two months in 2012 due to technical and enrollment problems|0
414719|NCT01606150|1015527|P2|STARTED|Overall Study||0
414720|NCT01606150|1015528|P1|STARTED|Overall Study||0
414721|NCT01606137|1015536|P1|NOT COMPLETED|Overall Study||262
414722|NCT01606137|1015536|P1|COMPLETED|Overall Study||245
414723|NCT01606137|1015536|P1|STARTED|Overall Study||507
414724|NCT01606124|1015558|P2|NOT COMPLETED|Overall Study||0
414725|NCT01606124|1015559|P1|NOT COMPLETED|Overall Study||0
414726|NCT01606124|1015558|P2|COMPLETED|Overall Study||20
414727|NCT01606124|1015559|P1|COMPLETED|Overall Study||19
414728|NCT01606124|1015558|P2|STARTED|Overall Study||20
414729|NCT01606124|1015559|P1|STARTED|Overall Study||19
414730|NCT01606007|1015570|P3|NOT COMPLETED|Overall Study||10
414731|NCT01606007|1015571|P2|NOT COMPLETED|Overall Study||19
414732|NCT01606007|1015572|P1|NOT COMPLETED|Overall Study||15
414733|NCT01606007|1015570|P3|COMPLETED|Overall Study||169
414734|NCT01606007|1015571|P2|COMPLETED|Overall Study||160
414735|NCT01606007|1015572|P1|COMPLETED|Overall Study||161
414736|NCT01606007|1015570|P3|STARTED|Overall Study||179
414737|NCT01606007|1015571|P2|STARTED|Overall Study||179
414738|NCT01606007|1015572|P1|STARTED|Overall Study||176
414739|NCT01605942|1015594|P2|NOT COMPLETED|Overall Study||0
414740|NCT01605942|1015595|P1|NOT COMPLETED|Overall Study||0
414741|NCT01605942|1015594|P2|COMPLETED|Overall Study||2
414742|NCT01605942|1015595|P1|COMPLETED|Overall Study||6
414743|NCT01605942|1015594|P2|STARTED|Overall Study||2
414744|NCT01605942|1015595|P1|STARTED|Overall Study||6
414745|NCT01605916|1015607|P5|NOT COMPLETED|Overall Study||6
414746|NCT01605916|1015608|P4|NOT COMPLETED|Overall Study||6
414747|NCT01605916|1015609|P3|NOT COMPLETED|Overall Study||3
414748|NCT01605916|1015610|P2|NOT COMPLETED|Overall Study||4
414749|NCT01605916|1015611|P1|NOT COMPLETED|Overall Study||4
414750|NCT01605916|1015607|P5|COMPLETED|Overall Study|Subject ongoing the study at data cut off|1
414751|NCT01605916|1015608|P4|COMPLETED|Overall Study||0
414752|NCT01605916|1015609|P3|COMPLETED|Overall Study|Subject ongoing the study at data cut off|1
414753|NCT01605916|1015610|P2|COMPLETED|Overall Study||0
414754|NCT01605916|1015611|P1|COMPLETED|Overall Study||0
414755|NCT01605916|1015607|P5|STARTED|Overall Study||7
414756|NCT01605916|1015608|P4|STARTED|Overall Study||6
414757|NCT01605916|1015609|P3|STARTED|Overall Study||4
414758|NCT01605916|1015610|P2|STARTED|Overall Study||4
414759|NCT01605916|1015611|P1|STARTED|Overall Study||4
414760|NCT01605903|1015686|P2|NOT COMPLETED|Overall Study||0
414761|NCT01605903|1015687|P1|NOT COMPLETED|Overall Study||0
414762|NCT01605903|1015686|P2|COMPLETED|Overall Study||343
414763|NCT01605903|1015687|P1|COMPLETED|Overall Study||345
414764|NCT01605903|1015686|P2|STARTED|Overall Study||343
414765|NCT01605903|1015687|P1|STARTED|Overall Study||345
414766|NCT01605877|1015693|P1|NOT COMPLETED|Overall Study||1
414767|NCT01605877|1015693|P1|COMPLETED|Overall Study||63
414768|NCT01605877|1015693|P1|STARTED|Overall Study||64
414769|NCT01605825|1015757|P2|NOT COMPLETED|Overall Study||3
414770|NCT01605825|1015758|P1|NOT COMPLETED|Overall Study||10
414771|NCT01605825|1015757|P2|COMPLETED|Overall Study||25
414772|NCT01605825|1015758|P1|COMPLETED|Overall Study||45
414773|NCT01605825|1015757|P2|STARTED|Overall Study||28
414774|NCT01605825|1015758|P1|STARTED|Overall Study||55
414775|NCT01605799|1015766|P2|NOT COMPLETED|Overall Study||1
414776|NCT01605799|1015767|P1|NOT COMPLETED|Overall Study||2
414777|NCT01605799|1015766|P2|COMPLETED|Overall Study||15
414778|NCT01605799|1015767|P1|COMPLETED|Overall Study||15
414779|NCT01605799|1015766|P2|STARTED|Overall Study||16
414780|NCT01605799|1015767|P1|STARTED|Overall Study||17
414781|NCT01605669|1015775|P1|NOT COMPLETED|Overall Study||0
414782|NCT01605669|1015775|P1|COMPLETED|Overall Study||50
414783|NCT01605669|1015775|P1|STARTED|Overall Study||50
414784|NCT01605617|1015782|P2|NOT COMPLETED|Second Intervention||0
414785|NCT01605617|1015783|P1|NOT COMPLETED|Second Intervention||0
414786|NCT01605617|1015782|P2|COMPLETED|Second Intervention||0
414787|NCT01605617|1015783|P1|COMPLETED|Second Intervention||0
414788|NCT01605617|1015782|P2|STARTED|Second Intervention||0
414789|NCT01605617|1015783|P1|STARTED|Second Intervention||0
414790|NCT01605617|1015782|P2|NOT COMPLETED|Washout Period of 4 Weeks||1
414791|NCT01605617|1015783|P1|NOT COMPLETED|Washout Period of 4 Weeks||2
414792|NCT01605617|1015782|P2|COMPLETED|Washout Period of 4 Weeks||0
414793|NCT01605617|1015783|P1|COMPLETED|Washout Period of 4 Weeks||0
414794|NCT01605617|1015782|P2|STARTED|Washout Period of 4 Weeks||1
414795|NCT01605617|1015783|P1|STARTED|Washout Period of 4 Weeks||2
414796|NCT01605617|1015782|P2|NOT COMPLETED|First Intervention||1
414797|NCT01605617|1015783|P1|NOT COMPLETED|First Intervention||0
414798|NCT01605617|1015782|P2|COMPLETED|First Intervention||1
414799|NCT01605617|1015783|P1|COMPLETED|First Intervention||2
414800|NCT01605617|1015782|P2|STARTED|First Intervention||2
414801|NCT01605617|1015783|P1|STARTED|First Intervention||2
414802|NCT01605552|1015803|P2|NOT COMPLETED|Overall Study||2
414803|NCT01605552|1015804|P1|NOT COMPLETED|Overall Study||6
414804|NCT01605552|1015803|P2|COMPLETED|Overall Study||14
414805|NCT01605552|1015804|P1|COMPLETED|Overall Study|4 dropped out before the first BtB visit; it is unlikely that the treatment was the cause of dropout|7
414806|NCT01605552|1015803|P2|STARTED|Overall Study||16
414807|NCT01605552|1015804|P1|STARTED|Overall Study||13
414808|NCT01605539|1015818|P3|NOT COMPLETED|Overall Study||0
414809|NCT01605539|1015819|P2|NOT COMPLETED|Overall Study||1
414810|NCT01605539|1015820|P1|NOT COMPLETED|Overall Study||0
414811|NCT01605539|1015818|P3|COMPLETED|Overall Study||4
414812|NCT01605539|1015819|P2|COMPLETED|Overall Study||2
414813|NCT01605539|1015820|P1|COMPLETED|Overall Study||3
414814|NCT01605539|1015818|P3|STARTED|Overall Study||4
414815|NCT01605539|1015819|P2|STARTED|Overall Study||3
414816|NCT01605539|1015820|P1|STARTED|Overall Study||3
414817|NCT01605461|1015842|P1|NOT COMPLETED|Overall Study||4
414818|NCT01605461|1015842|P1|COMPLETED|Overall Study||8
414819|NCT01605461|1015842|P1|STARTED|Overall Study||12
414820|NCT01605370|1015853|P2|NOT COMPLETED|Overall Study||0
414821|NCT01605370|1015854|P1|NOT COMPLETED|Overall Study||1
414822|NCT01605370|1015853|P2|COMPLETED|Overall Study||0
414823|NCT01605370|1015854|P1|COMPLETED|Overall Study||0
414824|NCT01605370|1015853|P2|STARTED|Overall Study||0
414825|NCT01605370|1015854|P1|STARTED|Overall Study||1
414826|NCT01605292|1015862|P2|NOT COMPLETED|Overall Study||0
414827|NCT01605292|1015863|P1|NOT COMPLETED|Overall Study||0
414828|NCT01605292|1015862|P2|COMPLETED|Overall Study||347
414829|NCT01605292|1015863|P1|COMPLETED|Overall Study||351
414830|NCT01605292|1015862|P2|STARTED|Overall Study||347
414831|NCT01605292|1015863|P1|STARTED|Overall Study||351
414832|NCT01605227|1015889|P2|NOT COMPLETED|Overall Study||329
414833|NCT01605227|1015890|P1|NOT COMPLETED|Overall Study||621
414834|NCT01605227|1015889|P2|COMPLETED|Overall Study||17
414835|NCT01605227|1015890|P1|COMPLETED|Overall Study||61
414836|NCT01605227|1015889|P2|STARTED|Overall Study||346
414837|NCT01605227|1015890|P1|STARTED|Overall Study||682
414838|NCT01604941|1015902|P6|NOT COMPLETED|Overall Study||7
414839|NCT01604941|1015903|P5|NOT COMPLETED|Overall Study||1
414840|NCT01604941|1015904|P4|NOT COMPLETED|Overall Study||3
414841|NCT01604941|1015905|P3|NOT COMPLETED|Overall Study||3
414842|NCT01604941|1015906|P2|NOT COMPLETED|Overall Study||4
414843|NCT01604941|1015907|P1|NOT COMPLETED|Overall Study||11
414844|NCT01604941|1015902|P6|COMPLETED|Overall Study||0
414845|NCT01604941|1015903|P5|COMPLETED|Overall Study||3
414846|NCT01604941|1015904|P4|COMPLETED|Overall Study||0
414847|NCT01604941|1015905|P3|COMPLETED|Overall Study||0
414848|NCT01604941|1015906|P2|COMPLETED|Overall Study||0
414849|NCT01604941|1015907|P1|COMPLETED|Overall Study||0
414850|NCT01604941|1015902|P6|STARTED|Overall Study||7
414851|NCT01604941|1015903|P5|STARTED|Overall Study||4
414852|NCT01604941|1015904|P4|STARTED|Overall Study||3
414853|NCT01604941|1015905|P3|STARTED|Overall Study||3
414854|NCT01604941|1015906|P2|STARTED|Overall Study||4
414855|NCT01604941|1015907|P1|STARTED|Overall Study||11
414856|NCT01604850|1015935|P2|NOT COMPLETED|Overall Study||30
414857|NCT01604850|1015936|P1|NOT COMPLETED|Overall Study||52
414858|NCT01604850|1015935|P2|COMPLETED|Overall Study||69
414859|NCT01604850|1015936|P1|COMPLETED|Overall Study||51
414860|NCT01604850|1015935|P2|Enrolled and Treated|Overall Study||98
414861|NCT01604850|1015936|P1|Enrolled and Treated|Overall Study||103
414862|NCT01604850|1015935|P2|STARTED|Overall Study||99
414863|NCT01604850|1015936|P1|STARTED|Overall Study||103
414864|NCT01604772|1015952|P1|NOT COMPLETED|Overall Study||0
414865|NCT01604772|1015952|P1|COMPLETED|Overall Study||16
414866|NCT01604772|1015952|P1|STARTED|Overall Study||16
414867|NCT01604408|1015960|P2|NOT COMPLETED|Observation Period||3
414868|NCT01604408|1015961|P1|NOT COMPLETED|Observation Period||1
414869|NCT01604408|1015960|P2|COMPLETED|Observation Period||84
414870|NCT01604408|1015961|P1|COMPLETED|Observation Period||85
414871|NCT01604408|1015960|P2|STARTED|Observation Period||87
414872|NCT01604408|1015961|P1|STARTED|Observation Period||86
414873|NCT01604408|1015960|P2|NOT COMPLETED|Treatment Period 6||2
414874|NCT01604408|1015961|P1|NOT COMPLETED|Treatment Period 6||2
414875|NCT01604408|1015960|P2|COMPLETED|Treatment Period 6||87
414876|NCT01604408|1015961|P1|COMPLETED|Treatment Period 6||86
414877|NCT01604408|1015960|P2|STARTED|Treatment Period 6||89
414878|NCT01604408|1015961|P1|STARTED|Treatment Period 6||88
414879|NCT01604408|1015960|P2|NOT COMPLETED|Treatment Period 5||0
414880|NCT01604408|1015961|P1|NOT COMPLETED|Treatment Period 5||4
414881|NCT01604408|1015960|P2|COMPLETED|Treatment Period 5||89
414882|NCT01604408|1015961|P1|COMPLETED|Treatment Period 5||88
414883|NCT01604408|1015960|P2|STARTED|Treatment Period 5||89
414884|NCT01604408|1015961|P1|STARTED|Treatment Period 5||92
414885|NCT01604408|1015960|P2|NOT COMPLETED|Treatment Period 4||2
414886|NCT01604408|1015961|P1|NOT COMPLETED|Treatment Period 4||3
414887|NCT01604408|1015960|P2|COMPLETED|Treatment Period 4||89
414888|NCT01604408|1015961|P1|COMPLETED|Treatment Period 4||92
414889|NCT01604408|1015960|P2|STARTED|Treatment Period 4||91
414890|NCT01604408|1015961|P1|STARTED|Treatment Period 4||95
414891|NCT01604408|1015960|P2|NOT COMPLETED|Treatment Period 3||5
414892|NCT01604408|1015961|P1|NOT COMPLETED|Treatment Period 3||5
414893|NCT01604408|1015960|P2|COMPLETED|Treatment Period 3||91
414894|NCT01604408|1015961|P1|COMPLETED|Treatment Period 3||95
414895|NCT01604408|1015960|P2|STARTED|Treatment Period 3||96
414896|NCT01604408|1015961|P1|STARTED|Treatment Period 3||100
414897|NCT01604408|1015960|P2|NOT COMPLETED|Treatment Period 2||2
414898|NCT01604408|1015961|P1|NOT COMPLETED|Treatment Period 2||2
414899|NCT01604408|1015960|P2|COMPLETED|Treatment Period 2||96
414900|NCT01604408|1015961|P1|COMPLETED|Treatment Period 2||100
414901|NCT01604408|1015960|P2|STARTED|Treatment Period 2||98
414902|NCT01604408|1015961|P1|STARTED|Treatment Period 2||102
414903|NCT01604408|1015960|P2|NOT COMPLETED|Treatment Period 1||1
414904|NCT01604408|1015961|P1|NOT COMPLETED|Treatment Period 1||0
414905|NCT01604408|1015960|P2|COMPLETED|Treatment Period 1||98
414906|NCT01604408|1015961|P1|COMPLETED|Treatment Period 1||102
414907|NCT01604408|1015960|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||99
414908|NCT01604408|1015961|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||102
414909|NCT01604408|1015960|P2|STARTED|Treatment Period 1||99
414910|NCT01604408|1015961|P1|STARTED|Treatment Period 1||102
414911|NCT01604343|1015976|P5|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||29
414912|NCT01604343|1015977|P4|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||10
414913|NCT01604343|1015978|P3|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||33
414914|NCT01604343|1015979|P2|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||7
414915|NCT01604343|1015980|P1|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||30
414916|NCT01604343|1015976|P5|COMPLETED|Safety Follow-up Period (Week 104-120)||85
414917|NCT01604343|1015977|P4|COMPLETED|Safety Follow-up Period (Week 104-120)||26
414918|NCT01604343|1015978|P3|COMPLETED|Safety Follow-up Period (Week 104-120)||72
414919|NCT01604343|1015979|P2|COMPLETED|Safety Follow-up Period (Week 104-120)||20
414920|NCT01604343|1015980|P1|COMPLETED|Safety Follow-up Period (Week 104-120)||79
414921|NCT01604343|1015976|P5|Safety Population|Safety Follow-up Period (Week 104-120)||114
414922|NCT01604343|1015977|P4|Safety Population|Safety Follow-up Period (Week 104-120)||36
414923|NCT01604343|1015978|P3|Safety Population|Safety Follow-up Period (Week 104-120)||105
414924|NCT01604343|1015979|P2|Safety Population|Safety Follow-up Period (Week 104-120)||26
414925|NCT01604343|1015980|P1|Safety Population|Safety Follow-up Period (Week 104-120)||109
414926|NCT01604343|1015976|P5|STARTED|Safety Follow-up Period (Week 104-120)||114
414927|NCT01604343|1015977|P4|STARTED|Safety Follow-up Period (Week 104-120)||36
414928|NCT01604343|1015978|P3|STARTED|Safety Follow-up Period (Week 104-120)||105
414929|NCT01604343|1015979|P2|STARTED|Safety Follow-up Period (Week 104-120)||27
414930|NCT01604343|1015980|P1|STARTED|Safety Follow-up Period (Week 104-120)||109
414931|NCT01604343|1015976|P5|NOT COMPLETED|Week 52 to Week 104||41
414932|NCT01604343|1015977|P4|NOT COMPLETED|Week 52 to Week 104||46
414933|NCT01604343|1015978|P3|NOT COMPLETED|Week 52 to Week 104||67
414934|NCT01604343|1015979|P2|NOT COMPLETED|Week 52 to Week 104||43
414935|NCT01604343|1015980|P1|NOT COMPLETED|Week 52 to Week 104||0
414936|NCT01604343|1015976|P5|COMPLETED|Week 52 to Week 104||429
414937|NCT01604343|1015977|P4|COMPLETED|Week 52 to Week 104||195
414938|NCT01604343|1015978|P3|COMPLETED|Week 52 to Week 104||414
414939|NCT01604343|1015979|P2|COMPLETED|Week 52 to Week 104||200
414940|NCT01604343|1015980|P1|COMPLETED|Week 52 to Week 104||0
414941|NCT01604343|1015976|P5|Treated|Week 52 to Week 104||470
414942|NCT01604343|1015977|P4|Treated|Week 52 to Week 104||241
414943|NCT01604343|1015978|P3|Treated|Week 52 to Week 104||481
414944|NCT01604343|1015979|P2|Treated|Week 52 to Week 104||242
414945|NCT01604343|1015980|P1|Treated|Week 52 to Week 104||0
414946|NCT01604343|1015976|P5|STARTED|Week 52 to Week 104||470
414947|NCT01604343|1015977|P4|STARTED|Week 52 to Week 104|Participants re-randomized at Week 18 (92), 40 (12) and 52 were included|241
414948|NCT01604343|1015978|P3|STARTED|Week 52 to Week 104||481
414949|NCT01604343|1015979|P2|STARTED|Week 52 to Week 104|Participants re-randomized at Week 18 (95), 40 (12) and 52 were included|243
414950|NCT01604343|1015980|P1|STARTED|Week 52 to Week 104||0
414951|NCT01604343|1015976|P5|NOT COMPLETED|Prior to W52 Administration(Through W52)||87
414952|NCT01604343|1015977|P4|NOT COMPLETED|Prior to W52 Administration(Through W52)||0
414953|NCT01604343|1015978|P3|NOT COMPLETED|Prior to W52 Administration(Through W52)||76
414954|NCT01604343|1015979|P2|NOT COMPLETED|Prior to W52 Administration(Through W52)||0
414955|NCT01604343|1015980|P1|NOT COMPLETED|Prior to W52 Administration(Through W52)||98
414956|NCT01604343|1015976|P5|COMPLETED|Prior to W52 Administration(Through W52)||470
414957|NCT01604343|1015977|P4|COMPLETED|Prior to W52 Administration(Through W52)||0
414958|NCT01604343|1015978|P3|COMPLETED|Prior to W52 Administration(Through W52)||481
414959|NCT01604343|1015979|P2|COMPLETED|Prior to W52 Administration(Through W52)||0
414960|NCT01604343|1015980|P1|COMPLETED|Prior to W52 Administration(Through W52)||458
414961|NCT01604343|1015976|P5|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
414962|NCT01604343|1015977|P4|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
414963|NCT01604343|1015978|P3|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
414964|NCT01604343|1015979|P2|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
414965|NCT01604343|1015980|P1|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)|Out of 24, 12 were re-randomized to sirukumab 50 mg and 12 were re-randomized to 100 mg group.|24
414966|NCT01604343|1015976|P5|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
414967|NCT01604343|1015977|P4|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
414968|NCT01604343|1015978|P3|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
414969|NCT01604343|1015979|P2|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
414970|NCT01604343|1015980|P1|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)|Out of 187, 95 were re-randomized to sirukumab 50 mg and 92 were re-randomized to 100 mg group.|187
414971|NCT01604343|1015976|P5|STARTED|Prior to W52 Administration(Through W52)||557
414972|NCT01604343|1015977|P4|STARTED|Prior to W52 Administration(Through W52)||0
414973|NCT01604343|1015978|P3|STARTED|Prior to W52 Administration(Through W52)||557
414974|NCT01604343|1015979|P2|STARTED|Prior to W52 Administration(Through W52)||0
414975|NCT01604343|1015980|P1|STARTED|Prior to W52 Administration(Through W52)||556
414976|NCT01604278|1016091|P2|NOT COMPLETED|Overall Study||13
414977|NCT01604278|1016092|P1|NOT COMPLETED|Overall Study||14
414978|NCT01604278|1016091|P2|COMPLETED|Overall Study||210
414979|NCT01604278|1016092|P1|COMPLETED|Overall Study||212
414980|NCT01604278|1016091|P2|Full Analysis Set|Overall Study|Three randomized participants excluded: 2 who did not receive study drug; 1 with a major deviation.|220
414981|NCT01604278|1016092|P1|Full Analysis Set|Overall Study||226
414982|NCT01604278|1016091|P2|Safety Set|Overall Study|Two randomized participants who did not receive study drug were excluded from this set.|221
414983|NCT01604278|1016092|P1|Safety Set|Overall Study||226
414984|NCT01604278|1016091|P2|STARTED|Overall Study||223
414985|NCT01604278|1016092|P1|STARTED|Overall Study||226
414986|NCT01604265|1016118|P2|NOT COMPLETED|Overall Study||0
414987|NCT01604265|1016119|P1|NOT COMPLETED|Overall Study||2
414988|NCT01604265|1016118|P2|COMPLETED|Overall Study||32
414989|NCT01604265|1016119|P1|COMPLETED|Overall Study||32
414990|NCT01604265|1016118|P2|STARTED|Overall Study||32
414991|NCT01604265|1016119|P1|STARTED|Overall Study||34
414992|NCT01604122|1016155|P2|NOT COMPLETED|Overall Study||0
414993|NCT01604122|1016156|P1|NOT COMPLETED|Overall Study||0
414994|NCT01604122|1016155|P2|COMPLETED|Overall Study||32
414995|NCT01604122|1016156|P1|COMPLETED|Overall Study||60
414996|NCT01604122|1016155|P2|STARTED|Overall Study||32
414997|NCT01604122|1016156|P1|STARTED|Overall Study||60
414998|NCT01604109|1016203|P2|NOT COMPLETED|Overall Study||34
414999|NCT01604109|1016204|P1|NOT COMPLETED|Overall Study||33
415000|NCT01604109|1016203|P2|COMPLETED|Overall Study||112
415001|NCT01604109|1016204|P1|COMPLETED|Overall Study||117
415002|NCT01604109|1016203|P2|STARTED|Overall Study||146
415003|NCT01604109|1016204|P1|STARTED|Overall Study||150
415004|NCT01603940|1016212|P2|NOT COMPLETED|Overall Study||0
415005|NCT01603940|1016213|P1|NOT COMPLETED|Overall Study||0
415006|NCT01603940|1016212|P2|COMPLETED|Overall Study||14
415007|NCT01603940|1016213|P1|COMPLETED|Overall Study||16
415008|NCT01603940|1016212|P2|STARTED|Overall Study||14
415009|NCT01603940|1016213|P1|STARTED|Overall Study||16
415010|NCT01603875|1016230|P3|NOT COMPLETED|Overall Study||9
415011|NCT01603875|1016231|P2|NOT COMPLETED|Overall Study||8
415012|NCT01603875|1016232|P1|NOT COMPLETED|Overall Study||7
415013|NCT01603875|1016230|P3|COMPLETED|Overall Study||26
415014|NCT01603875|1016231|P2|COMPLETED|Overall Study||27
415015|NCT01603875|1016232|P1|COMPLETED|Overall Study||28
415016|NCT01603875|1016230|P3|STARTED|Overall Study||35
415017|NCT01603875|1016231|P2|STARTED|Overall Study||35
415018|NCT01603875|1016232|P1|STARTED|Overall Study||35
415019|NCT01603459|1016252|P1|NOT COMPLETED|Overall Study||18
415020|NCT01603459|1016252|P1|COMPLETED|Overall Study||137
415021|NCT01603459|1016252|P1|STARTED|Overall Study||155
415022|NCT01603420|1016374|P2|NOT COMPLETED|Overall Study||0
415023|NCT01603420|1016375|P1|NOT COMPLETED|Overall Study||0
415024|NCT01603420|1016374|P2|COMPLETED|Overall Study||1
415025|NCT01603420|1016375|P1|COMPLETED|Overall Study||1
415026|NCT01603420|1016374|P2|STARTED|Overall Study||1
415027|NCT01603420|1016375|P1|STARTED|Overall Study||1
415028|NCT01603394|1016403|P1|NOT COMPLETED|Overall Study||1
415029|NCT01603394|1016403|P1|COMPLETED|Overall Study||8
415030|NCT01603394|1016403|P1|STARTED|Overall Study||9
415031|NCT01603277|1016420|P2|NOT COMPLETED|Overall Study||18
415032|NCT01603277|1016421|P1|NOT COMPLETED|Overall Study||14
415033|NCT01603277|1016420|P2|COMPLETED|Overall Study||64
415034|NCT01603277|1016421|P1|COMPLETED|Overall Study||64
415035|NCT01603277|1016420|P2|STARTED|Overall Study||82
415036|NCT01603277|1016421|P1|STARTED|Overall Study||78
415037|NCT01603121|1016427|P2|NOT COMPLETED|Second Intervention, 10 Hours||0
415038|NCT01603121|1016428|P1|NOT COMPLETED|Second Intervention, 10 Hours||1
415039|NCT01603121|1016427|P2|COMPLETED|Second Intervention, 10 Hours||0
415040|NCT01603121|1016428|P1|COMPLETED|Second Intervention, 10 Hours||0
415041|NCT01603121|1016427|P2|STARTED|Second Intervention, 10 Hours||0
415042|NCT01603121|1016428|P1|STARTED|Second Intervention, 10 Hours||1
415043|NCT01603121|1016427|P2|NOT COMPLETED|First Intervention, 10 Hours||0
415044|NCT01603121|1016428|P1|NOT COMPLETED|First Intervention, 10 Hours||0
415045|NCT01603121|1016427|P2|COMPLETED|First Intervention, 10 Hours||0
415046|NCT01603121|1016428|P1|COMPLETED|First Intervention, 10 Hours||1
415047|NCT01603121|1016427|P2|STARTED|First Intervention, 10 Hours||0
415048|NCT01603121|1016428|P1|STARTED|First Intervention, 10 Hours||1
415049|NCT01603082|1016440|P2|NOT COMPLETED|Overall Study||1
415050|NCT01603082|1016441|P1|NOT COMPLETED|Overall Study||2
415051|NCT01603082|1016440|P2|COMPLETED|Overall Study|Completed the study|48
415052|NCT01603082|1016441|P1|COMPLETED|Overall Study|Completed the study.|49
415053|NCT01603082|1016440|P2|STARTED|Overall Study|Randomized|49
415054|NCT01603082|1016441|P1|STARTED|Overall Study|Randomized|51
415055|NCT01603056|1016451|P2|NOT COMPLETED|Overall Study||14
415056|NCT01603056|1016452|P1|NOT COMPLETED|Overall Study||34
415057|NCT01603056|1016451|P2|COMPLETED|Overall Study||190
415058|NCT01603056|1016452|P1|COMPLETED|Overall Study||379
415059|NCT01603056|1016451|P2|STARTED|Overall Study||204
415060|NCT01603056|1016452|P1|STARTED|Overall Study||413
415061|NCT01603043|1016482|P2|NOT COMPLETED|Overall Study||3
415062|NCT01603043|1016483|P1|NOT COMPLETED|Overall Study||7
415063|NCT01603043|1016482|P2|COMPLETED|Overall Study||0
415064|NCT01603043|1016483|P1|COMPLETED|Overall Study||0
415065|NCT01603043|1016482|P2|STARTED|Overall Study||3
415066|NCT01603043|1016483|P1|STARTED|Overall Study||7
415067|NCT01602965|1016495|P2|NOT COMPLETED|Overall Study||2
415068|NCT01602965|1016496|P1|NOT COMPLETED|Overall Study||4
415069|NCT01602965|1016495|P2|COMPLETED|Overall Study||18
415070|NCT01602965|1016496|P1|COMPLETED|Overall Study||16
415071|NCT01602965|1016495|P2|STARTED|Overall Study||20
415072|NCT01602965|1016496|P1|STARTED|Overall Study||20
415073|NCT01602744|1016504|P2|NOT COMPLETED|Overall Study||23
415074|NCT01602744|1016505|P1|NOT COMPLETED|Overall Study||30
415075|NCT01602744|1016504|P2|COMPLETED|Overall Study||160
415076|NCT01602744|1016505|P1|COMPLETED|Overall Study||146
415077|NCT01602744|1016504|P2|STARTED|Overall Study||183
415078|NCT01602744|1016505|P1|STARTED|Overall Study||176
415079|NCT01602731|1016521|P1|NOT COMPLETED|Overall Study||30
415080|NCT01602731|1016521|P1|COMPLETED|Overall Study||15
415081|NCT01602731|1016521|P1|Poor Medication Adherence|Overall Study|24 out of 35 patients who completed 1-month pill counts had medication adherence <88%.|24
415082|NCT01602731|1016521|P1|Cognitive Impairment|Overall Study|After repeat cognitive testing, additional 1 patient had no cognitive impairment and did not proceed|44
415083|NCT01602731|1016521|P1|STARTED|Overall Study||45
415084|NCT01602562|1016529|P2|NOT COMPLETED|Overall Study||3
415085|NCT01602562|1016530|P1|NOT COMPLETED|Overall Study||5
415086|NCT01602562|1016529|P2|COMPLETED|Overall Study||16
415087|NCT01602562|1016530|P1|COMPLETED|Overall Study||16
415088|NCT01602562|1016529|P2|STARTED|Overall Study||19
415089|NCT01602562|1016530|P1|STARTED|Overall Study||21
415090|NCT01602549|1016566|P2|NOT COMPLETED|Overall Study||1
415091|NCT01602549|1016567|P1|NOT COMPLETED|Overall Study||1
415092|NCT01602549|1016566|P2|COMPLETED|Overall Study||37
415093|NCT01602549|1016567|P1|COMPLETED|Overall Study||18
415094|NCT01602549|1016566|P2|STARTED|Overall Study||38
415095|NCT01602549|1016567|P1|STARTED|Overall Study||19
415096|NCT01602510|1016646|P3|NOT COMPLETED|Randomized Phase||73
415097|NCT01602510|1016647|P2|NOT COMPLETED|Randomized Phase||74
415098|NCT01602510|1016648|P1|NOT COMPLETED|Randomized Phase||0
415099|NCT01602510|1016646|P3|COMPLETED|Randomized Phase||58
415100|NCT01602510|1016647|P2|COMPLETED|Randomized Phase||59
415101|NCT01602510|1016648|P1|COMPLETED|Randomized Phase||0
415102|NCT01602510|1016646|P3|STARTED|Randomized Phase||131
415103|NCT01602510|1016647|P2|STARTED|Randomized Phase||133
415104|NCT01602510|1016648|P1|STARTED|Randomized Phase||0
415105|NCT01602510|1016646|P3|NOT COMPLETED|Open Label Phase||0
415106|NCT01602510|1016647|P2|NOT COMPLETED|Open Label Phase||0
415107|NCT01602510|1016648|P1|NOT COMPLETED|Open Label Phase||303
415108|NCT01602510|1016646|P3|COMPLETED|Open Label Phase||0
415109|NCT01602510|1016647|P2|COMPLETED|Open Label Phase||0
415110|NCT01602510|1016648|P1|COMPLETED|Open Label Phase||117
415111|NCT01602510|1016646|P3|STARTED|Open Label Phase||0
415112|NCT01602510|1016647|P2|STARTED|Open Label Phase||0
415113|NCT01602510|1016648|P1|STARTED|Open Label Phase||420
415114|NCT01602484|1016674|P2|NOT COMPLETED|Overall Study||1
415115|NCT01602484|1016675|P1|NOT COMPLETED|Overall Study||0
415116|NCT01602484|1016674|P2|COMPLETED|Overall Study||24
415117|NCT01602484|1016675|P1|COMPLETED|Overall Study||25
415118|NCT01602484|1016674|P2|STARTED|Overall Study||25
415119|NCT01602484|1016675|P1|STARTED|Overall Study||25
415120|NCT01602471|1016687|P1|NOT COMPLETED|Overall Study||0
415121|NCT01602471|1016687|P1|COMPLETED|Overall Study||4
415122|NCT01602471|1016687|P1|STARTED|Overall Study||4
415123|NCT01602380|1016693|P2|NOT COMPLETED|Overall Study||101
415124|NCT01602380|1016694|P1|NOT COMPLETED|Overall Study||93
415125|NCT01602380|1016693|P2|COMPLETED|Overall Study|Completed: number of patients ongoing in the study at data cut-off for the primary analysis|131
415126|NCT01602380|1016694|P1|COMPLETED|Overall Study|Completed: number of patients ongoing in the study at data cut-off for the primary analysis|137
415127|NCT01602380|1016693|P2|STARTED|Overall Study||232
415128|NCT01602380|1016694|P1|STARTED|Overall Study||230
415129|NCT01602341|1016718|P2|NOT COMPLETED|Overall Study||1
415130|NCT01602341|1016719|P1|NOT COMPLETED|Overall Study||0
415131|NCT01602341|1016718|P2|COMPLETED|Overall Study||41
415132|NCT01602341|1016719|P1|COMPLETED|Overall Study||44
415133|NCT01602341|1016718|P2|STARTED|Overall Study||42
415134|NCT01602341|1016719|P1|STARTED|Overall Study||44
415135|NCT01602315|1016760|P7|NOT COMPLETED|Overall Study||29
415136|NCT01602315|1016761|P6|NOT COMPLETED|Overall Study||35
415137|NCT01602315|1016762|P5|NOT COMPLETED|Overall Study||71
415138|NCT01602315|1016763|P4|NOT COMPLETED|Overall Study||6
415139|NCT01602315|1016764|P3|NOT COMPLETED|Overall Study||18
415140|NCT01602315|1016765|P2|NOT COMPLETED|Overall Study||5
415141|NCT01602315|1016766|P1|NOT COMPLETED|Overall Study||16
415142|NCT01602315|1016760|P7|COMPLETED|Overall Study||0
415143|NCT01602315|1016761|P6|COMPLETED|Overall Study||0
415144|NCT01602315|1016762|P5|COMPLETED|Overall Study||0
415145|NCT01602315|1016763|P4|COMPLETED|Overall Study||0
415146|NCT01602315|1016764|P3|COMPLETED|Overall Study||0
415147|NCT01602315|1016765|P2|COMPLETED|Overall Study||0
415148|NCT01602315|1016766|P1|COMPLETED|Overall Study||0
415149|NCT01602315|1016760|P7|STARTED|Overall Study||29
415150|NCT01602315|1016761|P6|STARTED|Overall Study||35
415151|NCT01602315|1016762|P5|STARTED|Overall Study||71
415152|NCT01602315|1016763|P4|STARTED|Overall Study||6
415153|NCT01602315|1016764|P3|STARTED|Overall Study||18
415154|NCT01602315|1016765|P2|STARTED|Overall Study||5
415155|NCT01602315|1016766|P1|STARTED|Overall Study||16
415156|NCT01602198|1016854|P2|NOT COMPLETED|Overall Study||0
415157|NCT01602198|1016855|P1|NOT COMPLETED|Overall Study||0
415158|NCT01602198|1016854|P2|COMPLETED|Overall Study||1
415159|NCT01602198|1016855|P1|COMPLETED|Overall Study||0
415160|NCT01602198|1016854|P2|STARTED|Overall Study||1
415161|NCT01602198|1016855|P1|STARTED|Overall Study||0
415162|NCT01602068|1016863|P2|NOT COMPLETED|Overall Study||0
415163|NCT01602068|1016864|P1|NOT COMPLETED|Overall Study||0
415164|NCT01602068|1016863|P2|COMPLETED|Overall Study||22
415165|NCT01602068|1016864|P1|COMPLETED|Overall Study||23
415166|NCT01602068|1016863|P2|STARTED|Overall Study|Day before surgery|22
415167|NCT01602068|1016864|P1|STARTED|Overall Study|Day before surgery|23
415168|NCT01602016|1016870|P1|NOT COMPLETED|Overall Study||0
415169|NCT01602016|1016870|P1|COMPLETED|Overall Study||0
415170|NCT01602016|1016870|P1|STARTED|Overall Study||0
415171|NCT01601977|1016877|P1|NOT COMPLETED|Overall Study||0
415172|NCT01601977|1016877|P1|COMPLETED|Overall Study||10
415173|NCT01601977|1016877|P1|STARTED|Overall Study|5 patients consented for study participation but did not attend for study assessments.|10
415174|NCT01601847|1016897|P2|NOT COMPLETED|Overall Study||10
415175|NCT01601847|1016898|P1|NOT COMPLETED|Overall Study||13
415176|NCT01601847|1016897|P2|COMPLETED|Overall Study||137
415177|NCT01601847|1016898|P1|COMPLETED|Overall Study||140
415178|NCT01601847|1016897|P2|STARTED|Overall Study||147
415179|NCT01601847|1016898|P1|STARTED|Overall Study||153
415180|NCT01601821|1016910|P2|NOT COMPLETED|Overall Study||29
415181|NCT01601821|1016911|P1|NOT COMPLETED|Overall Study||29
415182|NCT01601821|1016910|P2|COMPLETED|Overall Study||91
415183|NCT01601821|1016911|P1|COMPLETED|Overall Study||96
415184|NCT01601821|1016910|P2|STARTED|Overall Study||120
415185|NCT01601821|1016911|P1|STARTED|Overall Study||125
415186|NCT01601782|1016941|P1|NOT COMPLETED|Overall Study||0
415187|NCT01601782|1016941|P1|COMPLETED|Overall Study||16
415188|NCT01601782|1016941|P1|STARTED|Overall Study||16
415189|NCT01601704|1016947|P2|NOT COMPLETED|Overall Study||4
415190|NCT01601704|1016948|P1|NOT COMPLETED|Overall Study||1
415191|NCT01601704|1016947|P2|COMPLETED|Overall Study||4450
415192|NCT01601704|1016948|P1|COMPLETED|Overall Study||4455
415193|NCT01601704|1016947|P2|Treated|Overall Study||4450
415194|NCT01601704|1016948|P1|Treated|Overall Study||4455
415195|NCT01601704|1016947|P2|STARTED|Overall Study||4454
415196|NCT01601704|1016948|P1|STARTED|Overall Study||4456
415197|NCT01601691|1016962|P1|NOT COMPLETED|Overall Study||0
415198|NCT01601691|1016962|P1|COMPLETED|Overall Study||10
415199|NCT01601691|1016962|P1|STARTED|Overall Study||10
415200|NCT01601626|1016969|P3|NOT COMPLETED|Overall Study||2
415201|NCT01601626|1016970|P2|NOT COMPLETED|Overall Study||5
415202|NCT01601626|1016971|P1|NOT COMPLETED|Overall Study||3
415203|NCT01601626|1016969|P3|COMPLETED|Overall Study||21
415204|NCT01601626|1016970|P2|COMPLETED|Overall Study||19
415205|NCT01601626|1016971|P1|COMPLETED|Overall Study||21
415206|NCT01601626|1016969|P3|STARTED|Overall Study||23
415207|NCT01601626|1016970|P2|STARTED|Overall Study||24
415208|NCT01601626|1016971|P1|STARTED|Overall Study||24
415209|NCT01601470|1017054|P1|NOT COMPLETED|Period 3 - LCZ696+Sildenafil||0
415210|NCT01601470|1017054|P1|COMPLETED|Period 3 - LCZ696+Sildenafil||27
415211|NCT01601470|1017054|P1|Safety Set|Period 3 - LCZ696+Sildenafil||27
415212|NCT01601470|1017054|P1|PK Analysis Set|Period 3 - LCZ696+Sildenafil||27
415213|NCT01601470|1017054|P1|STARTED|Period 3 - LCZ696+Sildenafil||27
415214|NCT01601470|1017054|P1|NOT COMPLETED|Period 2 - LCZ696||1
415215|NCT01601470|1017054|P1|COMPLETED|Period 2 - LCZ696||27
415216|NCT01601470|1017054|P1|Safety Set|Period 2 - LCZ696||27
415217|NCT01601470|1017054|P1|PK Analysis Set|Period 2 - LCZ696||27
415218|NCT01601470|1017054|P1|STARTED|Period 2 - LCZ696||28
415219|NCT01601470|1017054|P1|NOT COMPLETED|Period 1 - Sildenafil||0
415220|NCT01601470|1017054|P1|COMPLETED|Period 1 - Sildenafil||28
415221|NCT01601470|1017054|P1|Safety Set|Period 1 - Sildenafil||28
415222|NCT01601470|1017054|P1|PK Analysis Set|Period 1 - Sildenafil||28
415223|NCT01601470|1017054|P1|STARTED|Period 1 - Sildenafil||28
415224|NCT01601431|1017071|P2|NOT COMPLETED|Overall Study||3
415225|NCT01601431|1017072|P1|NOT COMPLETED|Overall Study||12
415226|NCT01601431|1017071|P2|COMPLETED|Overall Study||214
415227|NCT01601431|1017072|P1|COMPLETED|Overall Study||211
415228|NCT01601431|1017071|P2|STARTED|Overall Study||217
415229|NCT01601431|1017072|P1|STARTED|Overall Study||223
415230|NCT01601236|1017084|P6|NOT COMPLETED|Overall Study||1
415231|NCT01601236|1017085|P5|NOT COMPLETED|Overall Study||3
415232|NCT01601236|1017086|P4|NOT COMPLETED|Overall Study||2
415233|NCT01601236|1017087|P3|NOT COMPLETED|Overall Study||6
415234|NCT01601236|1017088|P2|NOT COMPLETED|Overall Study||1
415235|NCT01601236|1017089|P1|NOT COMPLETED|Overall Study||5
415236|NCT01601236|1017084|P6|COMPLETED|Overall Study||0
415237|NCT01601236|1017085|P5|COMPLETED|Overall Study||0
415238|NCT01601236|1017086|P4|COMPLETED|Overall Study||4
415239|NCT01601236|1017087|P3|COMPLETED|Overall Study||8
415240|NCT01601236|1017088|P2|COMPLETED|Overall Study||2
415241|NCT01601236|1017089|P1|COMPLETED|Overall Study||2
415242|NCT01601236|1017084|P6|STARTED|Overall Study||1
415243|NCT01601236|1017085|P5|STARTED|Overall Study||3
415244|NCT01601236|1017086|P4|STARTED|Overall Study||6
415245|NCT01601236|1017087|P3|STARTED|Overall Study||14
415246|NCT01601236|1017088|P2|STARTED|Overall Study||3
415247|NCT01601236|1017089|P1|STARTED|Overall Study||7
415248|NCT01601132|1017125|P1|NOT COMPLETED|Overall Study||2
415249|NCT01601132|1017125|P1|COMPLETED|Overall Study||28
415250|NCT01601132|1017125|P1|STARTED|Overall Study||30
415251|NCT01600950|1017142|P2|NOT COMPLETED|Period 2||0
415252|NCT01600950|1017143|P1|NOT COMPLETED|Period 2||0
415253|NCT01600950|1017142|P2|COMPLETED|Period 2||10
415254|NCT01600950|1017143|P1|COMPLETED|Period 2||10
415255|NCT01600950|1017142|P2|STARTED|Period 2||10
415256|NCT01600950|1017143|P1|STARTED|Period 2||10
415257|NCT01600950|1017142|P2|NOT COMPLETED|Period 1||0
415258|NCT01600950|1017143|P1|NOT COMPLETED|Period 1||0
415259|NCT01600950|1017142|P2|COMPLETED|Period 1||10
415260|NCT01600950|1017143|P1|COMPLETED|Period 1||10
415261|NCT01600950|1017142|P2|STARTED|Period 1||10
415262|NCT01600950|1017143|P1|STARTED|Period 1||10
415263|NCT01600885|1017159|P2|NOT COMPLETED|Second Period||0
415264|NCT01600885|1017160|P1|NOT COMPLETED|Second Period||0
415265|NCT01600885|1017159|P2|COMPLETED|Second Period||8
415266|NCT01600885|1017160|P1|COMPLETED|Second Period||8
415267|NCT01600885|1017159|P2|STARTED|Second Period||8
415268|NCT01600885|1017160|P1|STARTED|Second Period||8
415269|NCT01600885|1017159|P2|NOT COMPLETED|Wash Out Period||0
415270|NCT01600885|1017160|P1|NOT COMPLETED|Wash Out Period||0
415271|NCT01600885|1017159|P2|COMPLETED|Wash Out Period||8
415272|NCT01600885|1017160|P1|COMPLETED|Wash Out Period||8
415273|NCT01600885|1017159|P2|STARTED|Wash Out Period||8
415274|NCT01600885|1017160|P1|STARTED|Wash Out Period||8
415275|NCT01600885|1017159|P2|NOT COMPLETED|First Period||1
415276|NCT01600885|1017160|P1|NOT COMPLETED|First Period||2
415277|NCT01600885|1017159|P2|COMPLETED|First Period||8
415278|NCT01600885|1017160|P1|COMPLETED|First Period||8
415279|NCT01600885|1017159|P2|STARTED|First Period||9
415280|NCT01600885|1017160|P1|STARTED|First Period||10
415281|NCT01600729|1017170|P1|NOT COMPLETED|Overall Study||1
415282|NCT01600729|1017170|P1|COMPLETED|Overall Study||65
415283|NCT01600729|1017170|P1|STARTED|Overall Study||66
415284|NCT01600716|1017177|P2|NOT COMPLETED|Overall Study||7
415285|NCT01600716|1017178|P1|NOT COMPLETED|Overall Study||7
415286|NCT01600716|1017177|P2|COMPLETED|Overall Study||71
415287|NCT01600716|1017178|P1|COMPLETED|Overall Study||59
415288|NCT01600716|1017177|P2|STARTED|Overall Study||78
415289|NCT01600716|1017178|P1|STARTED|Overall Study||66
415290|NCT01600703|1017194|P2|NOT COMPLETED|Second Intervention||0
415291|NCT01600703|1017195|P1|NOT COMPLETED|Second Intervention||0
415292|NCT01600703|1017194|P2|COMPLETED|Second Intervention||8
415293|NCT01600703|1017195|P1|COMPLETED|Second Intervention||7
415294|NCT01600703|1017194|P2|STARTED|Second Intervention||8
415295|NCT01600703|1017195|P1|STARTED|Second Intervention||7
415296|NCT01600703|1017194|P2|NOT COMPLETED|First Intervention||0
415297|NCT01600703|1017195|P1|NOT COMPLETED|First Intervention||0
415298|NCT01600703|1017194|P2|COMPLETED|First Intervention||8
415299|NCT01600703|1017195|P1|COMPLETED|First Intervention||7
415300|NCT01600703|1017194|P2|STARTED|First Intervention||8
415301|NCT01600703|1017195|P1|STARTED|First Intervention||7
415302|NCT01600677|1017205|P2|NOT COMPLETED|Overall Study||0
415303|NCT01600677|1017206|P1|NOT COMPLETED|Overall Study||0
415304|NCT01600677|1017205|P2|COMPLETED|Overall Study||4
415305|NCT01600677|1017206|P1|COMPLETED|Overall Study||7
415306|NCT01600677|1017205|P2|STARTED|Overall Study||4
415307|NCT01600677|1017206|P1|STARTED|Overall Study||7
415308|NCT01600586|1017218|P2|NOT COMPLETED|Overall Study||3
415309|NCT01600586|1017219|P1|NOT COMPLETED|Overall Study||3
415310|NCT01600586|1017218|P2|COMPLETED|Overall Study||48
415311|NCT01600586|1017219|P1|COMPLETED|Overall Study||46
415312|NCT01600586|1017218|P2|STARTED|Overall Study||51
415313|NCT01600586|1017219|P1|STARTED|Overall Study||49
415314|NCT01600495|1017235|P2|NOT COMPLETED|Overall Study||0
415315|NCT01600495|1017236|P1|NOT COMPLETED|Overall Study||0
415316|NCT01600495|1017235|P2|COMPLETED|Overall Study|We finished the job with 23 patients for each group (treated and control)|23
415317|NCT01600495|1017236|P1|COMPLETED|Overall Study|We finished the job with 23 patients for each group (treated and control)|23
415318|NCT01600495|1017235|P2|STARTED|Overall Study|We start with the prediction of collecting 20 control patients|23
415319|NCT01600495|1017236|P1|STARTED|Overall Study|We start with the prediction of collecting 20 patients in the treated group|23
415320|NCT01600482|1017250|P2|NOT COMPLETED|Overall Study||0
415321|NCT01600482|1017251|P1|NOT COMPLETED|Overall Study||0
415322|NCT01600482|1017250|P2|COMPLETED|Overall Study||59
415323|NCT01600482|1017251|P1|COMPLETED|Overall Study|Last 26 patients allocated to CELT ACD|148
415324|NCT01600482|1017250|P2|STARTED|Overall Study|Last 26 patients allocated to CELT ACD|59
415325|NCT01600482|1017251|P1|STARTED|Overall Study||148
415326|NCT01600326|1017271|P2|NOT COMPLETED|Overall Study||1
415327|NCT01600326|1017272|P1|NOT COMPLETED|Overall Study||1
415328|NCT01600326|1017271|P2|COMPLETED|Overall Study||14
415329|NCT01600326|1017272|P1|COMPLETED|Overall Study||14
415330|NCT01600326|1017271|P2|Primary Outcome Measure Data Collection|Overall Study||15
415331|NCT01600326|1017272|P1|Primary Outcome Measure Data Collection|Overall Study||15
415332|NCT01600326|1017271|P2|STARTED|Overall Study||15
415333|NCT01600326|1017272|P1|STARTED|Overall Study||15
415334|NCT01600287|1017282|P2|NOT COMPLETED|Overall Study||0
415335|NCT01600287|1017283|P1|NOT COMPLETED|Overall Study||0
415336|NCT01600287|1017282|P2|COMPLETED|Overall Study||20
415337|NCT01600287|1017283|P1|COMPLETED|Overall Study||20
415338|NCT01600287|1017282|P2|STARTED|Overall Study||20
415339|NCT01600287|1017283|P1|STARTED|Overall Study||20
415340|NCT01600222|1017323|P1|NOT COMPLETED|Overall Study||2
415341|NCT01600222|1017323|P1|COMPLETED|Overall Study||35
415342|NCT01600222|1017323|P1|STARTED|Overall Study||37
415343|NCT01600092|1017348|P2|NOT COMPLETED|Overall Study||16
415344|NCT01600092|1017349|P1|NOT COMPLETED|Overall Study||18
415345|NCT01600092|1017348|P2|COMPLETED|Overall Study||491
415346|NCT01600092|1017349|P1|COMPLETED|Overall Study||495
415347|NCT01600092|1017348|P2|Received All 3 Vaccinations|Overall Study||494
415348|NCT01600092|1017349|P1|Received All 3 Vaccinations|Overall Study||500
415349|NCT01600092|1017348|P2|Received at Least 1 Vaccination|Overall Study||504
415350|NCT01600092|1017349|P1|Received at Least 1 Vaccination|Overall Study|1 participant received RotaTeq™ existing formulation as their first vaccination|510
415351|NCT01600092|1017348|P2|STARTED|Overall Study||507
415352|NCT01600092|1017349|P1|STARTED|Overall Study||513
415353|NCT01600053|1017363|P1|NOT COMPLETED|Overall Study||11
415354|NCT01600053|1017363|P1|COMPLETED|Overall Study||0
415355|NCT01600053|1017363|P1|STARTED|Overall Study||11
415356|NCT01600014|1017368|P2|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||0
415357|NCT01600014|1017369|P1|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||3
415358|NCT01600014|1017368|P2|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||20
415359|NCT01600014|1017369|P1|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||39
415360|NCT01600014|1017368|P2|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||20
415361|NCT01600014|1017369|P1|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||42
415362|NCT01600014|1017368|P2|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||10
415363|NCT01600014|1017369|P1|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||12
415364|NCT01600014|1017368|P2|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||39
415365|NCT01600014|1017369|P1|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||80
415366|NCT01600014|1017368|P2|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||49
415367|NCT01600014|1017369|P1|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||92
415368|NCT01600014|1017368|P2|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||0
415369|NCT01600014|1017369|P1|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||288
415370|NCT01600014|1017368|P2|COMPLETED|1. Cycle & Observation Period D1 to W52||0
415371|NCT01600014|1017369|P1|COMPLETED|1. Cycle & Observation Period D1 to W52||162
415372|NCT01600014|1017368|P2|STARTED|1. Cycle & Observation Period D1 to W52||0
415373|NCT01600014|1017369|P1|STARTED|1. Cycle & Observation Period D1 to W52|Subjects completing W52 without having been administered a 2nd cycle are counted as completers.|450
415374|NCT01599832|1017387|P1|NOT COMPLETED|Overall Study||0
415375|NCT01599832|1017387|P1|COMPLETED|Overall Study||20
415376|NCT01599832|1017387|P1|STARTED|Overall Study||20
415377|NCT01599806|1017397|P2|NOT COMPLETED|Overall Study||41
415378|NCT01599806|1017398|P1|NOT COMPLETED|Overall Study||43
415379|NCT01599806|1017397|P2|COMPLETED|Overall Study||476
415380|NCT01599806|1017398|P1|COMPLETED|Overall Study||473
415381|NCT01599806|1017397|P2|STARTED|Overall Study||517
415382|NCT01599806|1017398|P1|STARTED|Overall Study||516
415383|NCT01599741|1017522|P1|NOT COMPLETED|Overall Study||3
415384|NCT01599741|1017522|P1|COMPLETED|Overall Study||48
415385|NCT01599741|1017522|P1|Collected Dose and Image Information|Overall Study||48
415386|NCT01599741|1017522|P1|STARTED|Overall Study||51
415387|NCT01599650|1017531|P3|NOT COMPLETED|Overall Study||27
415388|NCT01599650|1017532|P2|NOT COMPLETED|Overall Study||26
415389|NCT01599650|1017533|P1|NOT COMPLETED|Overall Study||22
415390|NCT01599650|1017531|P3|COMPLETED|Overall Study||65
415391|NCT01599650|1017532|P2|COMPLETED|Overall Study||154
415392|NCT01599650|1017533|P1|COMPLETED|Overall Study||161
415393|NCT01599650|1017531|P3|Completed 6 Mos|Overall Study||80
415394|NCT01599650|1017532|P2|Completed 6 Mos|Overall Study||170
415395|NCT01599650|1017533|P1|Completed 6 Mos|Overall Study||174
415396|NCT01599650|1017531|P3|STARTED|Overall Study||92
415397|NCT01599650|1017532|P2|STARTED|Overall Study||180
415398|NCT01599650|1017533|P1|STARTED|Overall Study||183
415399|NCT01599637|1017572|P3|NOT COMPLETED|Overall Study||0
415400|NCT01599637|1017573|P2|NOT COMPLETED|Overall Study||2
415401|NCT01599637|1017574|P1|NOT COMPLETED|Overall Study||1
415402|NCT01599637|1017572|P3|COMPLETED|Overall Study||10
415403|NCT01599637|1017573|P2|COMPLETED|Overall Study||8
415404|NCT01599637|1017574|P1|COMPLETED|Overall Study||19
415405|NCT01599637|1017572|P3|STARTED|Overall Study||10
415406|NCT01599637|1017573|P2|STARTED|Overall Study||10
415407|NCT01599637|1017574|P1|STARTED|Overall Study|" started indicates randomized safety, pharmacodynamics and pharmocokinetics set"|20
415408|NCT01599585|1017621|P2|NOT COMPLETED|Overall Study||17
415409|NCT01599585|1017622|P1|NOT COMPLETED|Overall Study||22
415410|NCT01599585|1017621|P2|COMPLETED|Overall Study||42
415411|NCT01599585|1017622|P1|COMPLETED|Overall Study||40
415412|NCT01599585|1017621|P2|STARTED|Overall Study||59
415413|NCT01599585|1017622|P1|STARTED|Overall Study||62
415414|NCT01599325|1017660|P1|NOT COMPLETED|Overall Study||57
415415|NCT01599325|1017660|P1|COMPLETED|Overall Study|Participants still on study treatment at time of study closure|15
415416|NCT01599325|1017660|P1|Pharmacokinetic (PK) Population|Overall Study|Includes all participants with evaluable azacitidine plasma PK profiles.|12
415417|NCT01599325|1017660|P1|Intent to Treat (ITT) Population|Overall Study|Includes all participants who were enrolled into the study|72
415418|NCT01599325|1017660|P1|STARTED|Overall Study||72
415419|NCT01599234|1017682|P2|NOT COMPLETED|Overall Study||15
415420|NCT01599234|1017683|P1|NOT COMPLETED|Overall Study||17
415421|NCT01599234|1017682|P2|COMPLETED|Overall Study||155
415422|NCT01599234|1017683|P1|COMPLETED|Overall Study||150
415423|NCT01599234|1017682|P2|STARTED|Overall Study||170
415424|NCT01599234|1017683|P1|STARTED|Overall Study||167
415425|NCT01599104|1017708|P3|NOT COMPLETED|Overall Study||26
415426|NCT01599104|1017709|P2|NOT COMPLETED|Overall Study||14
415427|NCT01599104|1017710|P1|NOT COMPLETED|Overall Study||16
415428|NCT01599104|1017708|P3|COMPLETED|Overall Study||363
415429|NCT01599104|1017709|P2|COMPLETED|Overall Study||371
415430|NCT01599104|1017710|P1|COMPLETED|Overall Study||371
415431|NCT01599104|1017708|P3|STARTED|Overall Study||389
415432|NCT01599104|1017709|P2|STARTED|Overall Study||385
415433|NCT01599104|1017710|P1|STARTED|Overall Study||387
415434|NCT01598987|1017748|P1|NOT COMPLETED|Baseline to 24 Month||8
415435|NCT01598987|1017748|P1|COMPLETED|Baseline to 24 Month||48
415436|NCT01598987|1017748|P1|STARTED|Baseline to 24 Month||56
415437|NCT01598987|1017748|P1|NOT COMPLETED|Baseline to Month 12||6
415438|NCT01598987|1017748|P1|COMPLETED|Baseline to Month 12||50
415439|NCT01598987|1017748|P1|STARTED|Baseline to Month 12||56
415440|NCT01598779|1017782|P1|NOT COMPLETED|Overall Study||0
415441|NCT01598779|1017782|P1|COMPLETED|Overall Study||150
415442|NCT01598779|1017782|P1|STARTED|Overall Study||150
415443|NCT01598740|1017788|P2|NOT COMPLETED|Period 2||0
415444|NCT01598740|1017789|P1|NOT COMPLETED|Period 2||1
415445|NCT01598740|1017788|P2|COMPLETED|Period 2||9
415446|NCT01598740|1017789|P1|COMPLETED|Period 2||7
415447|NCT01598740|1017788|P2|STARTED|Period 2||9
415448|NCT01598740|1017789|P1|STARTED|Period 2|1 subject discontinued during the washout period prior to starting treatment period 2.|8
415449|NCT01598740|1017788|P2|NOT COMPLETED|Period 1||0
415450|NCT01598740|1017789|P1|NOT COMPLETED|Period 1||0
415451|NCT01598740|1017788|P2|COMPLETED|Period 1||9
415452|NCT01598740|1017789|P1|COMPLETED|Period 1||9
415453|NCT01598740|1017788|P2|STARTED|Period 1||9
415454|NCT01598740|1017789|P1|STARTED|Period 1||9
415455|NCT01598701|1017799|P2|NOT COMPLETED|Overall Study||9
415456|NCT01598701|1017800|P1|NOT COMPLETED|Overall Study||5
415457|NCT01598701|1017799|P2|COMPLETED|Overall Study||41
415458|NCT01598701|1017800|P1|COMPLETED|Overall Study||45
415459|NCT01598701|1017799|P2|STARTED|Overall Study||50
415460|NCT01598701|1017800|P1|STARTED|Overall Study||50
415461|NCT01598610|1017814|P1|NOT COMPLETED|Overall Study||1
415462|NCT01598610|1017814|P1|COMPLETED|Overall Study||219
415463|NCT01598610|1017814|P1|STARTED|Overall Study||220
415464|NCT01598545|1017823|P1|NOT COMPLETED|Overall Study||0
415465|NCT01598545|1017823|P1|COMPLETED|Overall Study||20
415466|NCT01598545|1017823|P1|STARTED|Overall Study||20
415467|NCT01598532|1017831|P1|NOT COMPLETED|Overall Study||11
415468|NCT01598532|1017831|P1|COMPLETED|Overall Study||11
415469|NCT01598532|1017831|P1|STARTED|Overall Study||22
415470|NCT01598506|1017840|P1|NOT COMPLETED|Overall Study||2
415471|NCT01598506|1017840|P1|COMPLETED|Overall Study||20
415472|NCT01598506|1017840|P1|STARTED|Overall Study||22
415473|NCT01598428|1017845|P1|NOT COMPLETED|Overall Study||0
415474|NCT01598428|1017845|P1|COMPLETED|Overall Study||20
415475|NCT01598428|1017845|P1|STARTED|Overall Study||20
415476|NCT01598350|1017854|P1|NOT COMPLETED|Overall Study||0
415477|NCT01598350|1017854|P1|COMPLETED|Overall Study||6
415478|NCT01598350|1017854|P1|STARTED|Overall Study||6
415479|NCT01598311|1017860|P2|NOT COMPLETED|Overall Study||61
415480|NCT01598311|1017861|P1|NOT COMPLETED|Overall Study||47
415481|NCT01598311|1017860|P2|COMPLETED|Overall Study||244
415482|NCT01598311|1017861|P1|COMPLETED|Overall Study||256
415483|NCT01598311|1017860|P2|Treated and Confirmed CDAD|Overall Study||292
415484|NCT01598311|1017861|P1|Treated and Confirmed CDAD|Overall Study||285
415485|NCT01598311|1017860|P2|Treated|Overall Study||301
415486|NCT01598311|1017861|P1|Treated|Overall Study||294
415487|NCT01598311|1017860|P2|STARTED|Overall Study||305
415488|NCT01598311|1017861|P1|STARTED|Overall Study||303
415489|NCT01598298|1017877|P2|NOT COMPLETED|Overall Study||41
415490|NCT01598298|1017878|P1|NOT COMPLETED|Overall Study||40
415491|NCT01598298|1017877|P2|COMPLETED|Overall Study||108
415492|NCT01598298|1017878|P1|COMPLETED|Overall Study||110
415493|NCT01598298|1017877|P2|Patients Evaluable for Adverse Events|Overall Study||141
415494|NCT01598298|1017878|P1|Patients Evaluable for Adverse Events|Overall Study||138
415495|NCT01598298|1017877|P2|Patients Evaluable for Primary Endpoint|Overall Study||128
415496|NCT01598298|1017878|P1|Patients Evaluable for Primary Endpoint|Overall Study||127
415497|NCT01598298|1017877|P2|STARTED|Overall Study||149
415498|NCT01598298|1017878|P1|STARTED|Overall Study||150
415499|NCT01598207|1017890|P2|NOT COMPLETED|Overall Study||0
415500|NCT01598207|1017891|P1|NOT COMPLETED|Overall Study||1
415501|NCT01598207|1017890|P2|COMPLETED|Overall Study||6
415502|NCT01598207|1017891|P1|COMPLETED|Overall Study||6
415503|NCT01598207|1017890|P2|STARTED|Overall Study||6
415504|NCT01598207|1017891|P1|STARTED|Overall Study||7
415505|NCT01598129|1017909|P1|NOT COMPLETED|Overall Study||9
415506|NCT01598129|1017909|P1|COMPLETED|Overall Study||3
415507|NCT01598129|1017909|P1|STARTED|Overall Study||12
415508|NCT01598064|1017920|P2|NOT COMPLETED|Overall Study||0
415509|NCT01598064|1017921|P1|NOT COMPLETED|Overall Study||0
415510|NCT01598064|1017920|P2|COMPLETED|Overall Study||24
415511|NCT01598064|1017921|P1|COMPLETED|Overall Study||25
415512|NCT01598064|1017920|P2|STARTED|Overall Study||24
415513|NCT01598064|1017921|P1|STARTED|Overall Study||25
415514|NCT01598025|1017931|P2|NOT COMPLETED|Overall Study||3
415515|NCT01598025|1017932|P1|NOT COMPLETED|Overall Study||0
415516|NCT01598025|1017931|P2|COMPLETED|Overall Study||0
415517|NCT01598025|1017932|P1|COMPLETED|Overall Study||0
415518|NCT01598025|1017931|P2|STARTED|Overall Study||3
415519|NCT01598025|1017932|P1|STARTED|Overall Study||0
415520|NCT01597908|1017942|P2|NOT COMPLETED|Overall Study||352
415521|NCT01597908|1017943|P1|NOT COMPLETED|Overall Study||352
415522|NCT01597908|1017942|P2|COMPLETED|Overall Study||0
415523|NCT01597908|1017943|P1|COMPLETED|Overall Study||0
415524|NCT01597908|1017942|P2|Ongoing|Overall Study||202
415525|NCT01597908|1017943|P1|Ongoing|Overall Study||236
415526|NCT01597908|1017942|P2|STARTED|Overall Study||352
415527|NCT01597908|1017943|P1|STARTED|Overall Study||352
415528|NCT01597843|1017958|P3|NOT COMPLETED|Overall Study||0
415529|NCT01597843|1017959|P2|NOT COMPLETED|Overall Study||0
415530|NCT01597843|1017960|P1|NOT COMPLETED|Overall Study||0
415531|NCT01597843|1017958|P3|COMPLETED|Overall Study||81
415532|NCT01597843|1017959|P2|COMPLETED|Overall Study||122
415533|NCT01597843|1017960|P1|COMPLETED|Overall Study||79
415534|NCT01597843|1017958|P3|Survey 3 Responses|Overall Study||76
415535|NCT01597843|1017959|P2|Survey 3 Responses|Overall Study||56
415536|NCT01597843|1017960|P1|Survey 3 Responses|Overall Study||65
415537|NCT01597843|1017958|P3|Survey 2 Responses|Overall Study||58
415538|NCT01597843|1017959|P2|Survey 2 Responses|Overall Study||42
415539|NCT01597843|1017960|P1|Survey 2 Responses|Overall Study||52
415540|NCT01597843|1017958|P3|Survey 1 Responses|Overall Study||59
415541|NCT01597843|1017959|P2|Survey 1 Responses|Overall Study||71
415542|NCT01597843|1017960|P1|Survey 1 Responses|Overall Study||45
415543|NCT01597843|1017958|P3|STARTED|Overall Study||81
415544|NCT01597843|1017959|P2|STARTED|Overall Study||122
415545|NCT01597843|1017960|P1|STARTED|Overall Study||79
415546|NCT01597791|1017970|P2|NOT COMPLETED|Overall Study||10
415547|NCT01597791|1017971|P1|NOT COMPLETED|Overall Study||8
415548|NCT01597791|1017970|P2|COMPLETED|Overall Study||18
415549|NCT01597791|1017971|P1|COMPLETED|Overall Study||20
415550|NCT01597791|1017970|P2|STARTED|Overall Study||28
415551|NCT01597791|1017971|P1|STARTED|Overall Study||28
415552|NCT01597635|1017980|P3|NOT COMPLETED|Part B||4
415553|NCT01597635|1017981|P2|NOT COMPLETED|Part B||6
415554|NCT01597635|1017982|P1|NOT COMPLETED|Part B||0
415555|NCT01597635|1017980|P3|COMPLETED|Part B||15
415556|NCT01597635|1017981|P2|COMPLETED|Part B||14
415557|NCT01597635|1017982|P1|COMPLETED|Part B||0
415558|NCT01597635|1017980|P3|STARTED|Part B||19
415559|NCT01597635|1017981|P2|STARTED|Part B||20
415560|NCT01597635|1017982|P1|STARTED|Part B||0
415561|NCT01597635|1017980|P3|NOT COMPLETED|Part A||0
415562|NCT01597635|1017981|P2|NOT COMPLETED|Part A||0
415563|NCT01597635|1017982|P1|NOT COMPLETED|Part A||3
415564|NCT01597635|1017980|P3|COMPLETED|Part A||0
415565|NCT01597635|1017981|P2|COMPLETED|Part A||0
415566|NCT01597635|1017982|P1|COMPLETED|Part A||2
415567|NCT01597635|1017980|P3|STARTED|Part A||0
415568|NCT01597635|1017981|P2|STARTED|Part A||0
415569|NCT01597635|1017982|P1|STARTED|Part A||5
415570|NCT01597596|1018047|P2|NOT COMPLETED|Overall Study||1
415571|NCT01597596|1018048|P1|NOT COMPLETED|Overall Study||1
415572|NCT01597596|1018047|P2|COMPLETED|Overall Study||2
415573|NCT01597596|1018048|P1|COMPLETED|Overall Study||0
415574|NCT01597596|1018047|P2|STARTED|Overall Study||3
415575|NCT01597596|1018048|P1|STARTED|Overall Study||1
415576|NCT01597505|1018062|P2|NOT COMPLETED|Overall Study||33
415577|NCT01597505|1018063|P1|NOT COMPLETED|Overall Study||44
415578|NCT01597505|1018062|P2|COMPLETED|Overall Study||265
415579|NCT01597505|1018063|P1|COMPLETED|Overall Study||264
415580|NCT01597505|1018062|P2|Treated|Overall Study||286
415581|NCT01597505|1018063|P1|Treated|Overall Study|One participant was instead randomized to vancomycin|305
415582|NCT01597505|1018062|P2|STARTED|Overall Study|Randomized participants|298
415583|NCT01597505|1018063|P1|STARTED|Overall Study|Randomized participants|308
415584|NCT01597492|1018097|P2|NOT COMPLETED|Overall Study||4
415585|NCT01597492|1018098|P1|NOT COMPLETED|Overall Study||6
415586|NCT01597492|1018097|P2|COMPLETED|Overall Study||41
415587|NCT01597492|1018098|P1|COMPLETED|Overall Study||28
415588|NCT01597492|1018097|P2|STARTED|Overall Study||45
415589|NCT01597492|1018098|P1|STARTED|Overall Study||34
415590|NCT01597479|1018106|P2|NOT COMPLETED|Overall Study||0
415591|NCT01597479|1018107|P1|NOT COMPLETED|Overall Study||2
415592|NCT01597479|1018106|P2|COMPLETED|Overall Study||26
415593|NCT01597479|1018107|P1|COMPLETED|Overall Study||24
415594|NCT01597479|1018106|P2|STARTED|Overall Study||26
415595|NCT01597479|1018107|P1|STARTED|Overall Study||26
415596|NCT01597440|1018116|P2|NOT COMPLETED|Overall Study||0
415597|NCT01597440|1018117|P1|NOT COMPLETED|Overall Study||0
415598|NCT01597440|1018116|P2|COMPLETED|Overall Study||0
415599|NCT01597440|1018117|P1|COMPLETED|Overall Study||1
415600|NCT01597440|1018116|P2|STARTED|Overall Study||0
415601|NCT01597440|1018117|P1|STARTED|Overall Study||1
415602|NCT01597245|1018129|P13|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||12
415603|NCT01597245|1018130|P12|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||19
415604|NCT01597245|1018131|P11|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||22
415605|NCT01597245|1018132|P10|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||118
415606|NCT01597245|1018133|P9|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||20
415607|NCT01597245|1018134|P8|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||3
415608|NCT01597245|1018135|P7|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||37
415609|NCT01597245|1018136|P6|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||89
415610|NCT01597245|1018137|P5|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||159
415611|NCT01597245|1018138|P4|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
415612|NCT01597245|1018139|P3|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
415613|NCT01597245|1018140|P2|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
415614|NCT01597245|1018141|P1|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
415615|NCT01597245|1018129|P13|COMPLETED|Maintenance Period (Week 12 to Week 60)||37
415616|NCT01597245|1018130|P12|COMPLETED|Maintenance Period (Week 12 to Week 60)||56
415617|NCT01597245|1018131|P11|COMPLETED|Maintenance Period (Week 12 to Week 60)||178
415618|NCT01597245|1018132|P10|COMPLETED|Maintenance Period (Week 12 to Week 60)||14
415619|NCT01597245|1018133|P9|COMPLETED|Maintenance Period (Week 12 to Week 60)||135
415620|NCT01597245|1018134|P8|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
415621|NCT01597245|1018135|P7|COMPLETED|Maintenance Period (Week 12 to Week 60)||150
415622|NCT01597245|1018136|P6|COMPLETED|Maintenance Period (Week 12 to Week 60)||92
415623|NCT01597245|1018137|P5|COMPLETED|Maintenance Period (Week 12 to Week 60)||17
415624|NCT01597245|1018138|P4|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
415625|NCT01597245|1018139|P3|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
415626|NCT01597245|1018140|P2|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
415627|NCT01597245|1018141|P1|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
415628|NCT01597245|1018129|P13|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||49
415629|NCT01597245|1018130|P12|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||75
415630|NCT01597245|1018131|P11|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||200
415631|NCT01597245|1018132|P10|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||132
415632|NCT01597245|1018133|P9|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||155
415633|NCT01597245|1018134|P8|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||3
415634|NCT01597245|1018135|P7|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||187
415635|NCT01597245|1018136|P6|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||181
415636|NCT01597245|1018137|P5|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||176
415637|NCT01597245|1018138|P4|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
415638|NCT01597245|1018139|P3|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
415639|NCT01597245|1018140|P2|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
415640|NCT01597245|1018141|P1|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
415641|NCT01597245|1018129|P13|STARTED|Maintenance Period (Week 12 to Week 60)||49
415642|NCT01597245|1018130|P12|STARTED|Maintenance Period (Week 12 to Week 60)||75
415643|NCT01597245|1018131|P11|STARTED|Maintenance Period (Week 12 to Week 60)||200
415644|NCT01597245|1018132|P10|STARTED|Maintenance Period (Week 12 to Week 60)||132
415645|NCT01597245|1018133|P9|STARTED|Maintenance Period (Week 12 to Week 60)||155
415646|NCT01597245|1018134|P8|STARTED|Maintenance Period (Week 12 to Week 60)||3
415647|NCT01597245|1018135|P7|STARTED|Maintenance Period (Week 12 to Week 60)||187
415648|NCT01597245|1018136|P6|STARTED|Maintenance Period (Week 12 to Week 60)||181
415649|NCT01597245|1018137|P5|STARTED|Maintenance Period (Week 12 to Week 60)||176
415650|NCT01597245|1018138|P4|STARTED|Maintenance Period (Week 12 to Week 60)||0
415651|NCT01597245|1018139|P3|STARTED|Maintenance Period (Week 12 to Week 60)||0
415652|NCT01597245|1018140|P2|STARTED|Maintenance Period (Week 12 to Week 60)||0
415653|NCT01597245|1018141|P1|STARTED|Maintenance Period (Week 12 to Week 60)||0
415654|NCT01597245|1018129|P13|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
415655|NCT01597245|1018130|P12|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
415656|NCT01597245|1018131|P11|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
415657|NCT01597245|1018132|P10|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
415658|NCT01597245|1018133|P9|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
415659|NCT01597245|1018134|P8|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
415660|NCT01597245|1018135|P7|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
415661|NCT01597245|1018136|P6|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
415662|NCT01597245|1018137|P5|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
415663|NCT01597245|1018138|P4|NOT COMPLETED|Induction Period (Week 0 - Week 12)||9
415664|NCT01597245|1018139|P3|NOT COMPLETED|Induction Period (Week 0 - Week 12)||19
415665|NCT01597245|1018140|P2|NOT COMPLETED|Induction Period (Week 0 - Week 12)||25
415666|NCT01597245|1018141|P1|NOT COMPLETED|Induction Period (Week 0 - Week 12)||10
415667|NCT01597245|1018129|P13|COMPLETED|Induction Period (Week 0 - Week 12)||0
415668|NCT01597245|1018130|P12|COMPLETED|Induction Period (Week 0 - Week 12)||0
415669|NCT01597245|1018131|P11|COMPLETED|Induction Period (Week 0 - Week 12)||0
415670|NCT01597245|1018132|P10|COMPLETED|Induction Period (Week 0 - Week 12)||0
415671|NCT01597245|1018133|P9|COMPLETED|Induction Period (Week 0 - Week 12)||0
415672|NCT01597245|1018134|P8|COMPLETED|Induction Period (Week 0 - Week 12)||0
415673|NCT01597245|1018135|P7|COMPLETED|Induction Period (Week 0 - Week 12)||0
415674|NCT01597245|1018136|P6|COMPLETED|Induction Period (Week 0 - Week 12)||0
415675|NCT01597245|1018137|P5|COMPLETED|Induction Period (Week 0 - Week 12)||0
415676|NCT01597245|1018138|P4|COMPLETED|Induction Period (Week 0 - Week 12)|2 participants discontinued after IND completion and prior to randomizing into maintenance period.|342
415677|NCT01597245|1018139|P3|COMPLETED|Induction Period (Week 0 - Week 12)||328
415678|NCT01597245|1018140|P2|COMPLETED|Induction Period (Week 0 - Week 12)|1 participant randomized to maintenance period but did not receive a dose in the maintenance period.|333
415679|NCT01597245|1018141|P1|COMPLETED|Induction Period (Week 0 - Week 12)||158
415680|NCT01597245|1018129|P13|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
415681|NCT01597245|1018130|P12|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
415682|NCT01597245|1018131|P11|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
415683|NCT01597245|1018132|P10|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
415684|NCT01597245|1018133|P9|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
415685|NCT01597245|1018134|P8|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
415686|NCT01597245|1018135|P7|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
415687|NCT01597245|1018136|P6|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
415688|NCT01597245|1018137|P5|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
415689|NCT01597245|1018138|P4|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||350
415690|NCT01597245|1018139|P3|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||347
415691|NCT01597245|1018140|P2|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||357
415692|NCT01597245|1018141|P1|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||167
415693|NCT01597245|1018129|P13|STARTED|Induction Period (Week 0 - Week 12)||0
415694|NCT01597245|1018130|P12|STARTED|Induction Period (Week 0 - Week 12)||0
415695|NCT01597245|1018131|P11|STARTED|Induction Period (Week 0 - Week 12)||0
415696|NCT01597245|1018132|P10|STARTED|Induction Period (Week 0 - Week 12)||0
415697|NCT01597245|1018133|P9|STARTED|Induction Period (Week 0 - Week 12)||0
415698|NCT01597245|1018134|P8|STARTED|Induction Period (Week 0 - Week 12)||0
415699|NCT01597245|1018135|P7|STARTED|Induction Period (Week 0 - Week 12)||0
415700|NCT01597245|1018136|P6|STARTED|Induction Period (Week 0 - Week 12)||0
415701|NCT01597245|1018137|P5|STARTED|Induction Period (Week 0 - Week 12)||0
415702|NCT01597245|1018138|P4|STARTED|Induction Period (Week 0 - Week 12)||351
415703|NCT01597245|1018139|P3|STARTED|Induction Period (Week 0 - Week 12)||347
415704|NCT01597245|1018140|P2|STARTED|Induction Period (Week 0 - Week 12)||358
415705|NCT01597245|1018141|P1|STARTED|Induction Period (Week 0 - Week 12)||168
415706|NCT01597141|1018226|P2|NOT COMPLETED|Overall Study||0
415707|NCT01597141|1018227|P1|NOT COMPLETED|Overall Study||0
415708|NCT01597141|1018226|P2|COMPLETED|Overall Study||50
415709|NCT01597141|1018227|P1|COMPLETED|Overall Study||50
415710|NCT01597141|1018226|P2|STARTED|Overall Study||50
415711|NCT01597141|1018227|P1|STARTED|Overall Study||50
415712|NCT01597128|1018237|P2|NOT COMPLETED|Overall Study||0
415713|NCT01597128|1018238|P1|NOT COMPLETED|Overall Study||0
415714|NCT01597128|1018237|P2|COMPLETED|Overall Study||17
415715|NCT01597128|1018238|P1|COMPLETED|Overall Study||18
415716|NCT01597128|1018237|P2|STARTED|Overall Study||17
415717|NCT01597128|1018238|P1|STARTED|Overall Study||18
415718|NCT01597050|1018264|P2|NOT COMPLETED|Overall Study||0
415719|NCT01597050|1018265|P1|NOT COMPLETED|Overall Study||1
415720|NCT01597050|1018264|P2|COMPLETED|Overall Study||18
415721|NCT01597050|1018265|P1|COMPLETED|Overall Study||35
415722|NCT01597050|1018264|P2|STARTED|Overall Study||18
415723|NCT01597050|1018265|P1|STARTED|Overall Study||36
415724|NCT01596972|1018273|P2|NOT COMPLETED|Overall Study||14
415725|NCT01596972|1018274|P1|NOT COMPLETED|Overall Study||1
415726|NCT01596972|1018273|P2|COMPLETED|Overall Study||12
415727|NCT01596972|1018274|P1|COMPLETED|Overall Study||24
415728|NCT01596972|1018273|P2|STARTED|Overall Study||26
415729|NCT01596972|1018274|P1|STARTED|Overall Study||25
415730|NCT01596842|1018286|P2|NOT COMPLETED|Overall Study||0
415731|NCT01596842|1018287|P1|NOT COMPLETED|Overall Study||2
415732|NCT01596842|1018286|P2|COMPLETED|Overall Study||7
415733|NCT01596842|1018287|P1|COMPLETED|Overall Study||8
415734|NCT01596842|1018286|P2|STARTED|Overall Study||7
415735|NCT01596842|1018287|P1|STARTED|Overall Study||10
415736|NCT01596582|1018297|P2|NOT COMPLETED|Overall Study||7
415737|NCT01596582|1018298|P1|NOT COMPLETED|Overall Study||4
415738|NCT01596582|1018297|P2|COMPLETED|Overall Study||173
415739|NCT01596582|1018298|P1|COMPLETED|Overall Study||168
415740|NCT01596582|1018297|P2|STARTED|Overall Study||180
415741|NCT01596582|1018298|P1|STARTED|Overall Study||172
415742|NCT01596504|1018325|P3|NOT COMPLETED|Overall Study||1
415743|NCT01596504|1018326|P2|NOT COMPLETED|Overall Study||3
415744|NCT01596504|1018327|P1|NOT COMPLETED|Overall Study||2
415745|NCT01596504|1018325|P3|COMPLETED|Overall Study||46
415746|NCT01596504|1018326|P2|COMPLETED|Overall Study||44
415747|NCT01596504|1018327|P1|COMPLETED|Overall Study||46
415748|NCT01596504|1018325|P3|STARTED|Overall Study||47
415749|NCT01596504|1018326|P2|STARTED|Overall Study||47
415750|NCT01596504|1018327|P1|STARTED|Overall Study||48
415751|NCT01596283|1018385|P2|NOT COMPLETED|Overall Study||0
415752|NCT01596283|1018386|P1|NOT COMPLETED|Overall Study||0
415753|NCT01596283|1018385|P2|COMPLETED|Overall Study||66
415754|NCT01596283|1018386|P1|COMPLETED|Overall Study||69
415755|NCT01596283|1018385|P2|STARTED|Overall Study||66
415756|NCT01596283|1018386|P1|STARTED|Overall Study||69
415757|NCT01596231|1018402|P2|NOT COMPLETED|Overall Study||0
415758|NCT01596231|1018403|P1|NOT COMPLETED|Overall Study||0
415759|NCT01596231|1018402|P2|COMPLETED|Overall Study||10
415760|NCT01596231|1018403|P1|COMPLETED|Overall Study||10
415761|NCT01596231|1018402|P2|STARTED|Overall Study||10
415762|NCT01596231|1018403|P1|STARTED|Overall Study||10
415763|NCT01596127|1018409|P1|NOT COMPLETED|Overall Study||1
415764|NCT01596127|1018409|P1|COMPLETED|Overall Study||3
415765|NCT01596127|1018409|P1|STARTED|Overall Study||4
415766|NCT01596088|1018414|P1|NOT COMPLETED|Overall Study||0
415767|NCT01596088|1018414|P1|COMPLETED|Overall Study||2
415768|NCT01596088|1018414|P1|STARTED|Overall Study||2
415769|NCT01596062|1018421|P3|NOT COMPLETED|Overall Study||3
415770|NCT01596062|1018422|P2|NOT COMPLETED|Overall Study||0
415771|NCT01596062|1018423|P1|NOT COMPLETED|Overall Study||1
415772|NCT01596062|1018421|P3|COMPLETED|Overall Study||4
415773|NCT01596062|1018422|P2|COMPLETED|Overall Study||6
415774|NCT01596062|1018423|P1|COMPLETED|Overall Study||2
415775|NCT01596062|1018421|P3|STARTED|Overall Study||7
415776|NCT01596062|1018422|P2|STARTED|Overall Study||6
415777|NCT01596062|1018423|P1|STARTED|Overall Study||3
415778|NCT01595854|1018460|P5|NOT COMPLETED|Overall Study||0
415779|NCT01595854|1018461|P4|NOT COMPLETED|Overall Study||0
415780|NCT01595854|1018462|P3|NOT COMPLETED|Overall Study||0
415781|NCT01595854|1018463|P2|NOT COMPLETED|Overall Study||0
415782|NCT01595854|1018464|P1|NOT COMPLETED|Overall Study||0
415783|NCT01595854|1018460|P5|COMPLETED|Overall Study||12
415784|NCT01595854|1018461|P4|COMPLETED|Overall Study||4
415785|NCT01595854|1018462|P3|COMPLETED|Overall Study||8
415786|NCT01595854|1018463|P2|COMPLETED|Overall Study||4
415787|NCT01595854|1018464|P1|COMPLETED|Overall Study||8
415788|NCT01595854|1018460|P5|STARTED|Overall Study||12
415789|NCT01595854|1018461|P4|STARTED|Overall Study||4
415790|NCT01595854|1018462|P3|STARTED|Overall Study||8
415791|NCT01595854|1018463|P2|STARTED|Overall Study||4
415792|NCT01595854|1018464|P1|STARTED|Overall Study||8
415793|NCT01595646|1018487|P3|NOT COMPLETED|Overall Study||0
415794|NCT01595646|1018488|P2|NOT COMPLETED|Overall Study||0
415795|NCT01595646|1018489|P1|NOT COMPLETED|Overall Study||1
415796|NCT01595646|1018487|P3|COMPLETED|Overall Study||12
415797|NCT01595646|1018488|P2|COMPLETED|Overall Study||12
415798|NCT01595646|1018489|P1|COMPLETED|Overall Study||12
415799|NCT01595646|1018487|P3|STARTED|Overall Study||12
415800|NCT01595646|1018488|P2|STARTED|Overall Study||12
415801|NCT01595646|1018489|P1|STARTED|Overall Study||13
415802|NCT01595438|1018511|P2|NOT COMPLETED|Overall Study||41
415803|NCT01595438|1018512|P1|NOT COMPLETED|Overall Study||43
415804|NCT01595438|1018511|P2|COMPLETED|Overall Study||476
415805|NCT01595438|1018512|P1|COMPLETED|Overall Study||473
415806|NCT01595438|1018511|P2|STARTED|Overall Study||517
415807|NCT01595438|1018512|P1|STARTED|Overall Study||516
415808|NCT01595386|1018638|P2|NOT COMPLETED|Overall Study||0
415809|NCT01595386|1018639|P1|NOT COMPLETED|Overall Study||0
415810|NCT01595386|1018638|P2|COMPLETED|Overall Study||19
415811|NCT01595386|1018639|P1|COMPLETED|Overall Study||21
415812|NCT01595386|1018638|P2|STARTED|Overall Study||19
415813|NCT01595386|1018639|P1|STARTED|Overall Study||21
415814|NCT01595282|1018667|P2|NOT COMPLETED|Overall Study||0
415815|NCT01595282|1018668|P1|NOT COMPLETED|Overall Study||0
415816|NCT01595282|1018667|P2|COMPLETED|Overall Study||47
415817|NCT01595282|1018668|P1|COMPLETED|Overall Study||47
415818|NCT01595282|1018667|P2|STARTED|Overall Study||47
415819|NCT01595282|1018668|P1|STARTED|Overall Study||47
415820|NCT01594970|1018681|P3|NOT COMPLETED|Overall Study||66
415821|NCT01594970|1018682|P2|NOT COMPLETED|Overall Study||82
415822|NCT01594970|1018683|P1|NOT COMPLETED|Overall Study||75
415823|NCT01594970|1018681|P3|COMPLETED|Overall Study||191
415824|NCT01594970|1018682|P2|COMPLETED|Overall Study||166
415825|NCT01594970|1018683|P1|COMPLETED|Overall Study||220
415826|NCT01594970|1018681|P3|STARTED|Overall Study||257
415827|NCT01594970|1018682|P2|STARTED|Overall Study||248
415828|NCT01594970|1018683|P1|STARTED|Overall Study||295
415829|NCT01594762|1018702|P2|NOT COMPLETED|Overall Study||10
415830|NCT01594762|1018703|P1|NOT COMPLETED|Overall Study||11
415831|NCT01594762|1018702|P2|COMPLETED|Overall Study||93
415832|NCT01594762|1018703|P1|COMPLETED|Overall Study||86
415833|NCT01594762|1018702|P2|STARTED|Overall Study||103
415834|NCT01594762|1018703|P1|STARTED|Overall Study||97
415835|NCT01594749|1018715|P2|NOT COMPLETED|Overall Study||18
415836|NCT01594749|1018716|P1|NOT COMPLETED|Overall Study||22
415837|NCT01594749|1018715|P2|COMPLETED|Overall Study||490
415838|NCT01594749|1018716|P1|COMPLETED|Overall Study||485
415839|NCT01594749|1018715|P2|Treated|Overall Study||498
415840|NCT01594749|1018716|P1|Treated|Overall Study||503
415841|NCT01594749|1018715|P2|STARTED|Overall Study||508
415842|NCT01594749|1018716|P1|STARTED|Overall Study||507
415843|NCT01594515|1018742|P10|NOT COMPLETED|Overall Study||0
415844|NCT01594515|1018743|P9|NOT COMPLETED|Overall Study||0
415845|NCT01594515|1018744|P8|NOT COMPLETED|Overall Study||0
415846|NCT01594515|1018745|P7|NOT COMPLETED|Overall Study||0
415847|NCT01594515|1018746|P6|NOT COMPLETED|Overall Study||0
415848|NCT01594515|1018747|P5|NOT COMPLETED|Overall Study||0
415849|NCT01594515|1018748|P4|NOT COMPLETED|Overall Study||0
415850|NCT01594515|1018749|P3|NOT COMPLETED|Overall Study||0
415851|NCT01594515|1018750|P2|NOT COMPLETED|Overall Study||0
415852|NCT01594515|1018751|P1|NOT COMPLETED|Overall Study||0
415853|NCT01594515|1018742|P10|COMPLETED|Overall Study||16
415854|NCT01594515|1018743|P9|COMPLETED|Overall Study||6
415855|NCT01594515|1018744|P8|COMPLETED|Overall Study||6
415856|NCT01594515|1018745|P7|COMPLETED|Overall Study||6
415857|NCT01594515|1018746|P6|COMPLETED|Overall Study||6
415858|NCT01594515|1018747|P5|COMPLETED|Overall Study||6
415859|NCT01594515|1018748|P4|COMPLETED|Overall Study||6
415860|NCT01594515|1018749|P3|COMPLETED|Overall Study||6
415861|NCT01594515|1018750|P2|COMPLETED|Overall Study||6
415862|NCT01594515|1018751|P1|COMPLETED|Overall Study||6
415863|NCT01594515|1018742|P10|STARTED|Overall Study||16
415864|NCT01594515|1018743|P9|STARTED|Overall Study||6
415865|NCT01594515|1018744|P8|STARTED|Overall Study||6
415866|NCT01594515|1018745|P7|STARTED|Overall Study||6
415867|NCT01594515|1018746|P6|STARTED|Overall Study||6
415868|NCT01594515|1018747|P5|STARTED|Overall Study||6
415869|NCT01594515|1018748|P4|STARTED|Overall Study||6
415870|NCT01594515|1018749|P3|STARTED|Overall Study||6
415871|NCT01594515|1018750|P2|STARTED|Overall Study||6
415872|NCT01594515|1018751|P1|STARTED|Overall Study||6
415873|NCT01594424|1018841|P1|NOT COMPLETED|Overall Study||2
415874|NCT01594424|1018841|P1|COMPLETED|Overall Study||8
415875|NCT01594424|1018841|P1|STARTED|Overall Study||10
415876|NCT01594411|1018845|P1|NOT COMPLETED|Overall Study||2
415877|NCT01594411|1018845|P1|COMPLETED|Overall Study||249
415878|NCT01594411|1018845|P1|STARTED|Overall Study||251
415879|NCT01594385|1018854|P2|NOT COMPLETED|Overall Study||0
415880|NCT01594385|1018855|P1|NOT COMPLETED|Overall Study||0
415881|NCT01594385|1018854|P2|COMPLETED|Overall Study||13
415882|NCT01594385|1018855|P1|COMPLETED|Overall Study||17
415883|NCT01594385|1018854|P2|STARTED|Overall Study||13
415884|NCT01594385|1018855|P1|STARTED|Overall Study||17
415885|NCT01594294|1018879|P2|NOT COMPLETED|Overall Study||4
415886|NCT01594294|1018880|P1|NOT COMPLETED|Overall Study||3
415887|NCT01594294|1018879|P2|COMPLETED|Overall Study||36
415888|NCT01594294|1018880|P1|COMPLETED|Overall Study||36
415889|NCT01594294|1018879|P2|STARTED|Overall Study||40
415890|NCT01594294|1018880|P1|STARTED|Overall Study||39
415891|NCT01594125|1018899|P5|NOT COMPLETED|Overall Study||7
415892|NCT01594125|1018900|P4|NOT COMPLETED|Overall Study||4
415893|NCT01594125|1018901|P3|NOT COMPLETED|Overall Study||3
415894|NCT01594125|1018902|P2|NOT COMPLETED|Overall Study||12
415895|NCT01594125|1018903|P1|NOT COMPLETED|Overall Study||4
415896|NCT01594125|1018899|P5|COMPLETED|Overall Study||0
415897|NCT01594125|1018900|P4|COMPLETED|Overall Study||0
415898|NCT01594125|1018901|P3|COMPLETED|Overall Study||0
415899|NCT01594125|1018902|P2|COMPLETED|Overall Study||0
415900|NCT01594125|1018903|P1|COMPLETED|Overall Study||0
415901|NCT01594125|1018899|P5|STARTED|Overall Study||7
415902|NCT01594125|1018900|P4|STARTED|Overall Study||4
415903|NCT01594125|1018901|P3|STARTED|Overall Study||3
415904|NCT01594125|1018902|P2|STARTED|Overall Study||12
415905|NCT01594125|1018903|P1|STARTED|Overall Study||4
415906|NCT01593852|1018937|P2|NOT COMPLETED|Overall Study||0
415907|NCT01593852|1018938|P1|NOT COMPLETED|Overall Study||0
415908|NCT01593852|1018937|P2|COMPLETED|Overall Study||68
415909|NCT01593852|1018938|P1|COMPLETED|Overall Study||68
415910|NCT01593852|1018937|P2|STARTED|Overall Study||68
415911|NCT01593852|1018938|P1|STARTED|Overall Study||68
415912|NCT01593787|1018963|P3|NOT COMPLETED|Overall Study||0
415913|NCT01593787|1018964|P2|NOT COMPLETED|Overall Study||0
415914|NCT01593787|1018965|P1|NOT COMPLETED|Overall Study||1
415915|NCT01593787|1018963|P3|COMPLETED|Overall Study||18
415916|NCT01593787|1018964|P2|COMPLETED|Overall Study||8
415917|NCT01593787|1018965|P1|COMPLETED|Overall Study||5
415918|NCT01593787|1018963|P3|STARTED|Overall Study||18
415919|NCT01593787|1018964|P2|STARTED|Overall Study||8
415920|NCT01593787|1018965|P1|STARTED|Overall Study||6
415921|NCT01593722|1019005|P2|NOT COMPLETED|Overall Study||0
415922|NCT01593722|1019006|P1|NOT COMPLETED|Overall Study||0
415923|NCT01593722|1019005|P2|COMPLETED|Overall Study||6
415924|NCT01593722|1019006|P1|COMPLETED|Overall Study||6
415925|NCT01593722|1019005|P2|STARTED|Overall Study||6
415926|NCT01593722|1019006|P1|STARTED|Overall Study||6
415927|NCT01593670|1019020|P1|NOT COMPLETED|Overall Study||0
415928|NCT01593670|1019020|P1|COMPLETED|Overall Study||9
415929|NCT01593670|1019020|P1|STARTED|Overall Study||9
415930|NCT01593592|1019030|P2|NOT COMPLETED|Overall Study||0
415931|NCT01593592|1019031|P1|NOT COMPLETED|Overall Study||0
415932|NCT01593592|1019030|P2|COMPLETED|Overall Study||35
415933|NCT01593592|1019031|P1|COMPLETED|Overall Study||35
415934|NCT01593592|1019030|P2|STARTED|Overall Study||35
415935|NCT01593592|1019031|P1|STARTED|Overall Study||35
415936|NCT01593215|1019043|P2|NOT COMPLETED|Overall Study||0
415937|NCT01593215|1019044|P1|NOT COMPLETED|Overall Study||1
415938|NCT01593215|1019043|P2|COMPLETED|Overall Study||25
415939|NCT01593215|1019044|P1|COMPLETED|Overall Study||24
415940|NCT01593215|1019043|P2|STARTED|Overall Study||25
415941|NCT01593215|1019044|P1|STARTED|Overall Study||25
415942|NCT01592864|1019052|P2|NOT COMPLETED|Overall Study||1
415943|NCT01592864|1019053|P1|NOT COMPLETED|Overall Study||0
415944|NCT01592864|1019052|P2|COMPLETED|Overall Study||57
415945|NCT01592864|1019053|P1|COMPLETED|Overall Study||60
415946|NCT01592864|1019052|P2|STARTED|Overall Study||58
415947|NCT01592864|1019053|P1|STARTED|Overall Study||60
415948|NCT01592851|1019067|P2|NOT COMPLETED|Overall Study||0
415949|NCT01592851|1019068|P1|NOT COMPLETED|Overall Study||0
415950|NCT01592851|1019067|P2|COMPLETED|Overall Study||57
415951|NCT01592851|1019068|P1|COMPLETED|Overall Study||56
415952|NCT01592851|1019067|P2|STARTED|Overall Study||57
415953|NCT01592851|1019068|P1|STARTED|Overall Study||56
415954|NCT01592786|1019084|P1|NOT COMPLETED|Overall Study||138
415955|NCT01592786|1019084|P1|COMPLETED|Overall Study||765
415956|NCT01592786|1019084|P1|STARTED|Overall Study|Participants in the Safety Population are being presented.|903
415957|NCT01592773|1019088|P1|NOT COMPLETED|Overall Study||666
415958|NCT01592773|1019088|P1|COMPLETED|Overall Study||81
415959|NCT01592773|1019088|P1|STARTED|Overall Study|All enrolled patients received at least 1 dose of investigational product (Safety Population).|747
415960|NCT01592760|1019095|P3|NOT COMPLETED|24-hour Follow-Up||2
415961|NCT01592760|1019096|P2|NOT COMPLETED|24-hour Follow-Up||3
415962|NCT01592760|1019097|P1|NOT COMPLETED|24-hour Follow-Up||4
415963|NCT01592760|1019095|P3|COMPLETED|24-hour Follow-Up||43
415964|NCT01592760|1019096|P2|COMPLETED|24-hour Follow-Up||87
415965|NCT01592760|1019097|P1|COMPLETED|24-hour Follow-Up||86
415966|NCT01592760|1019095|P3|STARTED|24-hour Follow-Up||45
415967|NCT01592760|1019096|P2|STARTED|24-hour Follow-Up||90
415968|NCT01592760|1019097|P1|STARTED|24-hour Follow-Up||90
415969|NCT01592760|1019095|P3|NOT COMPLETED|Perioperative to Discharge||0
415970|NCT01592760|1019096|P2|NOT COMPLETED|Perioperative to Discharge||0
415971|NCT01592760|1019097|P1|NOT COMPLETED|Perioperative to Discharge||0
415972|NCT01592760|1019095|P3|COMPLETED|Perioperative to Discharge||45
415973|NCT01592760|1019096|P2|COMPLETED|Perioperative to Discharge||90
415974|NCT01592760|1019097|P1|COMPLETED|Perioperative to Discharge||90
415975|NCT01592760|1019095|P3|STARTED|Perioperative to Discharge||45
415976|NCT01592760|1019096|P2|STARTED|Perioperative to Discharge||90
415977|NCT01592760|1019097|P1|STARTED|Perioperative to Discharge||90
415978|NCT01592708|1019140|P2|NOT COMPLETED|Overall Study||0
415979|NCT01592708|1019141|P1|NOT COMPLETED|Overall Study||3
415980|NCT01592708|1019140|P2|COMPLETED|Overall Study||137
415981|NCT01592708|1019141|P1|COMPLETED|Overall Study||93
415982|NCT01592708|1019140|P2|STARTED|Overall Study||137
415983|NCT01592708|1019141|P1|STARTED|Overall Study||96
415984|NCT01592695|1019157|P2|NOT COMPLETED|Overall Study||4
415985|NCT01592695|1019158|P1|NOT COMPLETED|Overall Study||8
415986|NCT01592695|1019157|P2|COMPLETED|Overall Study||28
415987|NCT01592695|1019158|P1|COMPLETED|Overall Study||23
415988|NCT01592695|1019157|P2|STARTED|Overall Study||32
415989|NCT01592695|1019158|P1|STARTED|Overall Study||31
415990|NCT01592435|1019176|P1|NOT COMPLETED|Overall Study||0
415991|NCT01592435|1019176|P1|COMPLETED|Overall Study||76
415992|NCT01592435|1019176|P1|STARTED|Overall Study||76
415993|NCT01592396|1019184|P2|NOT COMPLETED|Overall Study||0
415994|NCT01592396|1019185|P1|NOT COMPLETED|Overall Study||0
415995|NCT01592396|1019184|P2|COMPLETED|Overall Study||10
415996|NCT01592396|1019185|P1|COMPLETED|Overall Study||10
415997|NCT01592396|1019184|P2|STARTED|Overall Study||10
415998|NCT01592396|1019185|P1|STARTED|Overall Study||10
415999|NCT01592344|1019202|P2|NOT COMPLETED|Overall Study||5
416000|NCT01592344|1019203|P1|NOT COMPLETED|Overall Study||4
416001|NCT01592344|1019202|P2|COMPLETED|Overall Study||44
416002|NCT01592344|1019203|P1|COMPLETED|Overall Study||41
416003|NCT01592344|1019202|P2|STARTED|Overall Study||49
416004|NCT01592344|1019203|P1|STARTED|Overall Study||45
416005|NCT01592292|1019217|P4|NOT COMPLETED|Overall Study||1
416006|NCT01592292|1019218|P3|NOT COMPLETED|Overall Study||3
416007|NCT01592292|1019219|P2|NOT COMPLETED|Overall Study||5
416008|NCT01592292|1019220|P1|NOT COMPLETED|Overall Study||6
416009|NCT01592292|1019217|P4|COMPLETED|Overall Study||10
416010|NCT01592292|1019218|P3|COMPLETED|Overall Study||10
416011|NCT01592292|1019219|P2|COMPLETED|Overall Study||15
416012|NCT01592292|1019220|P1|COMPLETED|Overall Study|Participants who completed 12 months visit.|40
416013|NCT01592292|1019217|P4|Standard Population Set (SPS)|Overall Study||7
416014|NCT01592292|1019218|P3|Standard Population Set (SPS)|Overall Study||7
416015|NCT01592292|1019219|P2|Standard Population Set (SPS)|Overall Study||10
416016|NCT01592292|1019220|P1|Standard Population Set (SPS)|Overall Study|Excluding participants with change of administration drug or suspension of drug administration.|31
416017|NCT01592292|1019217|P4|Intention to Treat (ITT) Set|Overall Study||8
416018|NCT01592292|1019218|P3|Intention to Treat (ITT) Set|Overall Study||10
416019|NCT01592292|1019219|P2|Intention to Treat (ITT) Set|Overall Study||13
416020|NCT01592292|1019220|P1|Intention to Treat (ITT) Set|Overall Study|Excluding primary effect evaluation omission.|34
416021|NCT01592292|1019217|P4|STARTED|Overall Study||11
416022|NCT01592292|1019218|P3|STARTED|Overall Study||13
416023|NCT01592292|1019219|P2|STARTED|Overall Study||20
416024|NCT01592292|1019220|P1|STARTED|Overall Study||46
416025|NCT01592240|1019259|P7|NOT COMPLETED|Overall Study||3
416026|NCT01592240|1019260|P6|NOT COMPLETED|Overall Study||3
416027|NCT01592240|1019261|P5|NOT COMPLETED|Overall Study||7
416028|NCT01592240|1019262|P4|NOT COMPLETED|Overall Study||3
416029|NCT01592240|1019263|P3|NOT COMPLETED|Overall Study||7
416030|NCT01592240|1019264|P2|NOT COMPLETED|Overall Study||11
416031|NCT01592240|1019265|P1|NOT COMPLETED|Overall Study||3
416032|NCT01592240|1019259|P7|COMPLETED|Overall Study||48
416033|NCT01592240|1019260|P6|COMPLETED|Overall Study||47
416034|NCT01592240|1019261|P5|COMPLETED|Overall Study||44
416035|NCT01592240|1019262|P4|COMPLETED|Overall Study||47
416036|NCT01592240|1019263|P3|COMPLETED|Overall Study||45
416037|NCT01592240|1019264|P2|COMPLETED|Overall Study||39
416038|NCT01592240|1019265|P1|COMPLETED|Overall Study||47
416039|NCT01592240|1019259|P7|STARTED|Overall Study||51
416040|NCT01592240|1019260|P6|STARTED|Overall Study||50
416041|NCT01592240|1019261|P5|STARTED|Overall Study||51
416042|NCT01592240|1019262|P4|STARTED|Overall Study||50
416043|NCT01592240|1019263|P3|STARTED|Overall Study||52
416044|NCT01592240|1019264|P2|STARTED|Overall Study||50
416045|NCT01592240|1019265|P1|STARTED|Overall Study||50
416046|NCT01592071|1019445|P1|NOT COMPLETED|Overall Study||0
416047|NCT01592071|1019445|P1|COMPLETED|Overall Study||120
416048|NCT01592071|1019445|P1|STARTED|Overall Study||120
416049|NCT01592045|1019458|P2|NOT COMPLETED|Overall Study||2
416050|NCT01592045|1019459|P1|NOT COMPLETED|Overall Study||5
416051|NCT01592045|1019458|P2|COMPLETED|Overall Study||12
416052|NCT01592045|1019459|P1|COMPLETED|Overall Study||9
416053|NCT01592045|1019458|P2|Completed Course 5|Overall Study||12
416054|NCT01592045|1019459|P1|Completed Course 5|Overall Study||9
416055|NCT01592045|1019458|P2|Completed Course 4|Overall Study||12
416056|NCT01592045|1019459|P1|Completed Course 4|Overall Study||11
416057|NCT01592045|1019458|P2|Completed Course 3|Overall Study||13
416058|NCT01592045|1019459|P1|Completed Course 3|Overall Study||11
416059|NCT01592045|1019458|P2|Completed Course 2|Overall Study||13
416060|NCT01592045|1019459|P1|Completed Course 2|Overall Study||13
416061|NCT01592045|1019458|P2|Completed Course 1|Overall Study||14
416062|NCT01592045|1019459|P1|Completed Course 1|Overall Study||13
416063|NCT01592045|1019458|P2|STARTED|Overall Study||14
416064|NCT01592045|1019459|P1|STARTED|Overall Study||14
416065|NCT01592006|1019467|P1|NOT COMPLETED|Overall Study||0
416066|NCT01592006|1019467|P1|COMPLETED|Overall Study||3
416067|NCT01592006|1019467|P1|STARTED|Overall Study||3
416068|NCT01591954|1019472|P1|NOT COMPLETED|Overall Study||0
416069|NCT01591954|1019472|P1|COMPLETED|Overall Study||1
416070|NCT01591954|1019472|P1|STARTED|Overall Study||1
416071|NCT01591863|1019477|P1|NOT COMPLETED|Overall Study||14
416072|NCT01591863|1019477|P1|COMPLETED|Overall Study||24
416073|NCT01591863|1019477|P1|STARTED|Overall Study||38
416074|NCT01591837|1019489|P2|NOT COMPLETED|Overall Study||0
416075|NCT01591837|1019490|P1|NOT COMPLETED|Overall Study||0
416076|NCT01591837|1019489|P2|COMPLETED|Overall Study||60
416077|NCT01591837|1019490|P1|COMPLETED|Overall Study||60
416078|NCT01591837|1019489|P2|STARTED|Overall Study||60
416079|NCT01591837|1019490|P1|STARTED|Overall Study||60
416080|NCT01591733|1019504|P1|NOT COMPLETED|Overall Study||0
416081|NCT01591733|1019504|P1|COMPLETED|Overall Study||48
416082|NCT01591733|1019504|P1|STARTED|Overall Study||48
416083|NCT01591681|1019515|P1|NOT COMPLETED|Overall Study||4
416084|NCT01591681|1019515|P1|COMPLETED|Overall Study||45
416085|NCT01591681|1019515|P1|STARTED|Overall Study||49
416086|NCT01591616|1019541|P1|NOT COMPLETED|Overall Study||1
416087|NCT01591616|1019541|P1|COMPLETED|Overall Study||15
416088|NCT01591616|1019541|P1|STARTED|Overall Study||16
416089|NCT01591499|1019682|P4|NOT COMPLETED|Second Intervention (up to 24 Days)||3
416090|NCT01591499|1019683|P3|NOT COMPLETED|Second Intervention (up to 24 Days)||3
416091|NCT01591499|1019684|P2|NOT COMPLETED|Second Intervention (up to 24 Days)||3
416092|NCT01591499|1019685|P1|NOT COMPLETED|Second Intervention (up to 24 Days)||6
416093|NCT01591499|1019682|P4|COMPLETED|Second Intervention (up to 24 Days)||34
416094|NCT01591499|1019683|P3|COMPLETED|Second Intervention (up to 24 Days)||28
416095|NCT01591499|1019684|P2|COMPLETED|Second Intervention (up to 24 Days)||34
416096|NCT01591499|1019685|P1|COMPLETED|Second Intervention (up to 24 Days)||27
416097|NCT01591499|1019682|P4|STARTED|Second Intervention (up to 24 Days)||37
416098|NCT01591499|1019683|P3|STARTED|Second Intervention (up to 24 Days)||31
416099|NCT01591499|1019684|P2|STARTED|Second Intervention (up to 24 Days)||37
416100|NCT01591499|1019685|P1|STARTED|Second Intervention (up to 24 Days)||33
416101|NCT01591499|1019682|P4|NOT COMPLETED|First Intervention (up to 24 Days)||0
416102|NCT01591499|1019683|P3|NOT COMPLETED|First Intervention (up to 24 Days)||0
416103|NCT01591499|1019684|P2|NOT COMPLETED|First Intervention (up to 24 Days)||0
416104|NCT01591499|1019685|P1|NOT COMPLETED|First Intervention (up to 24 Days)||0
416105|NCT01591499|1019682|P4|COMPLETED|First Intervention (up to 24 Days)||37
416106|NCT01591499|1019683|P3|COMPLETED|First Intervention (up to 24 Days)||31
416107|NCT01591499|1019684|P2|COMPLETED|First Intervention (up to 24 Days)||37
416108|NCT01591499|1019685|P1|COMPLETED|First Intervention (up to 24 Days)||33
416109|NCT01591499|1019682|P4|STARTED|First Intervention (up to 24 Days)||37
416110|NCT01591499|1019683|P3|STARTED|First Intervention (up to 24 Days)||31
416111|NCT01591499|1019684|P2|STARTED|First Intervention (up to 24 Days)||37
416112|NCT01591499|1019685|P1|STARTED|First Intervention (up to 24 Days)||33
416113|NCT01591499|1019682|P4|NOT COMPLETED|Baseline Visit||2
416114|NCT01591499|1019683|P3|NOT COMPLETED|Baseline Visit||0
416115|NCT01591499|1019684|P2|NOT COMPLETED|Baseline Visit||2
416116|NCT01591499|1019685|P1|NOT COMPLETED|Baseline Visit||0
416117|NCT01591499|1019682|P4|COMPLETED|Baseline Visit||37
416118|NCT01591499|1019683|P3|COMPLETED|Baseline Visit||31
416119|NCT01591499|1019684|P2|COMPLETED|Baseline Visit||37
416120|NCT01591499|1019685|P1|COMPLETED|Baseline Visit||33
416121|NCT01591499|1019682|P4|STARTED|Baseline Visit||39
416122|NCT01591499|1019683|P3|STARTED|Baseline Visit||31
416123|NCT01591499|1019684|P2|STARTED|Baseline Visit||39
416124|NCT01591499|1019685|P1|STARTED|Baseline Visit||33
416125|NCT01591460|1019751|P1|NOT COMPLETED|Overall Study||26
416126|NCT01591460|1019751|P1|COMPLETED|Overall Study|The number who completed PEG-IFN, as scheduled according to response-guided treatment, is presented.|139
416127|NCT01591460|1019751|P1|STARTED|Overall Study|Those with elevated (Week 12) or detectable (Week 24) virus discontinued due to the Futility Rule.|165
416128|NCT01591408|1019833|P2|NOT COMPLETED|Overall Study||8
416129|NCT01591408|1019834|P1|NOT COMPLETED|Overall Study||12
416130|NCT01591408|1019833|P2|COMPLETED|Overall Study||24
416131|NCT01591408|1019834|P1|COMPLETED|Overall Study||24
416132|NCT01591408|1019833|P2|STARTED|Overall Study||32
416133|NCT01591408|1019834|P1|STARTED|Overall Study||36
416134|NCT01591382|1019842|P2|NOT COMPLETED|Overall Study||2
416135|NCT01591382|1019843|P1|NOT COMPLETED|Overall Study||3
416136|NCT01591382|1019842|P2|COMPLETED|Overall Study||30
416137|NCT01591382|1019843|P1|COMPLETED|Overall Study||29
416138|NCT01591382|1019842|P2|STARTED|Overall Study||32
416139|NCT01591382|1019843|P1|STARTED|Overall Study||32
416140|NCT01591317|1019860|P3|NOT COMPLETED|Overall Study||0
416141|NCT01591317|1019861|P2|NOT COMPLETED|Overall Study||0
416142|NCT01591317|1019862|P1|NOT COMPLETED|Overall Study||0
416143|NCT01591317|1019860|P3|COMPLETED|Overall Study||10
416144|NCT01591317|1019861|P2|COMPLETED|Overall Study||10
416145|NCT01591317|1019862|P1|COMPLETED|Overall Study||10
416146|NCT01591317|1019860|P3|STARTED|Overall Study||10
416147|NCT01591317|1019861|P2|STARTED|Overall Study||10
416148|NCT01591317|1019862|P1|STARTED|Overall Study||10
416149|NCT01591096|1019888|P1|NOT COMPLETED|Overall Study||1
416150|NCT01591096|1019888|P1|COMPLETED|Overall Study||0
416151|NCT01591096|1019888|P1|STARTED|Overall Study||1
416152|NCT01591044|1019897|P3|NOT COMPLETED|Overall Study||4
416153|NCT01591044|1019898|P2|NOT COMPLETED|Overall Study||9
416154|NCT01591044|1019899|P1|NOT COMPLETED|Overall Study||7
416155|NCT01591044|1019897|P3|COMPLETED|Overall Study||96
416156|NCT01591044|1019898|P2|COMPLETED|Overall Study||91
416157|NCT01591044|1019899|P1|COMPLETED|Overall Study||94
416158|NCT01591044|1019897|P3|STARTED|Overall Study||100
416159|NCT01591044|1019898|P2|STARTED|Overall Study||100
416160|NCT01591044|1019899|P1|STARTED|Overall Study||101
416161|NCT01591018|1019909|P2|NOT COMPLETED|Overall Study||0
416162|NCT01591018|1019910|P1|NOT COMPLETED|Overall Study||0
416163|NCT01591018|1019909|P2|COMPLETED|Overall Study||60
416164|NCT01591018|1019910|P1|COMPLETED|Overall Study||60
416165|NCT01591018|1019909|P2|STARTED|Overall Study||60
416166|NCT01591018|1019910|P1|STARTED|Overall Study||60
416167|NCT01591005|1019924|P4|NOT COMPLETED|Overall Study||0
416168|NCT01591005|1019925|P3|NOT COMPLETED|Overall Study||0
416169|NCT01591005|1019926|P2|NOT COMPLETED|Overall Study||0
416170|NCT01591005|1019927|P1|NOT COMPLETED|Overall Study||0
416171|NCT01591005|1019924|P4|COMPLETED|Overall Study||68
416172|NCT01591005|1019925|P3|COMPLETED|Overall Study||68
416173|NCT01591005|1019926|P2|COMPLETED|Overall Study||53
416174|NCT01591005|1019927|P1|COMPLETED|Overall Study||53
416175|NCT01591005|1019924|P4|STARTED|Overall Study||68
416176|NCT01591005|1019925|P3|STARTED|Overall Study||68
416177|NCT01591005|1019926|P2|STARTED|Overall Study||53
416178|NCT01591005|1019927|P1|STARTED|Overall Study||53
416179|NCT01590979|1019963|P2|NOT COMPLETED|Overall Study||0
416180|NCT01590979|1019964|P1|NOT COMPLETED|Overall Study||0
416181|NCT01590979|1019963|P2|COMPLETED|Overall Study||27
416182|NCT01590979|1019964|P1|COMPLETED|Overall Study||27
416183|NCT01590979|1019963|P2|STARTED|Overall Study||27
416184|NCT01590979|1019964|P1|STARTED|Overall Study||27
416185|NCT01590888|1019973|P3|NOT COMPLETED|Overall Study||1
416186|NCT01590888|1019974|P2|NOT COMPLETED|Overall Study||0
416187|NCT01590888|1019975|P1|NOT COMPLETED|Overall Study||4
416188|NCT01590888|1019973|P3|COMPLETED|Overall Study||34
416189|NCT01590888|1019974|P2|COMPLETED|Overall Study||38
416190|NCT01590888|1019975|P1|COMPLETED|Overall Study||32
416191|NCT01590888|1019973|P3|STARTED|Overall Study||35
416192|NCT01590888|1019974|P2|STARTED|Overall Study||38
416193|NCT01590888|1019975|P1|STARTED|Overall Study||36
416194|NCT01590875|1020021|P2|NOT COMPLETED|Overall Study||0
416195|NCT01590875|1020022|P1|NOT COMPLETED|Overall Study||0
416196|NCT01590875|1020021|P2|COMPLETED|Overall Study||10
416197|NCT01590875|1020022|P1|COMPLETED|Overall Study||10
416198|NCT01590875|1020021|P2|STARTED|Overall Study||10
416199|NCT01590875|1020022|P1|STARTED|Overall Study||10
416200|NCT01590810|1020035|P5|NOT COMPLETED|Overall Study||0
416201|NCT01590810|1020036|P4|NOT COMPLETED|Overall Study||0
416202|NCT01590810|1020037|P3|NOT COMPLETED|Overall Study||1
416203|NCT01590810|1020038|P2|NOT COMPLETED|Overall Study||1
416204|NCT01590810|1020039|P1|NOT COMPLETED|Overall Study||0
416205|NCT01590810|1020035|P5|COMPLETED|Overall Study||2
416206|NCT01590810|1020036|P4|COMPLETED|Overall Study||8
416207|NCT01590810|1020037|P3|COMPLETED|Overall Study||7
416208|NCT01590810|1020038|P2|COMPLETED|Overall Study||7
416209|NCT01590810|1020039|P1|COMPLETED|Overall Study||8
416210|NCT01590810|1020035|P5|STARTED|Overall Study||2
416211|NCT01590810|1020036|P4|STARTED|Overall Study||8
416212|NCT01590810|1020037|P3|STARTED|Overall Study||8
416213|NCT01590810|1020038|P2|STARTED|Overall Study||8
416214|NCT01590810|1020039|P1|STARTED|Overall Study||8
416215|NCT01590797|1020184|P2|NOT COMPLETED|Overall Study||16
416216|NCT01590797|1020185|P1|NOT COMPLETED|Overall Study||17
416217|NCT01590797|1020184|P2|COMPLETED|Overall Study||217
416218|NCT01590797|1020185|P1|COMPLETED|Overall Study||217
416219|NCT01590797|1020184|P2|STARTED|Overall Study||233
416220|NCT01590797|1020185|P1|STARTED|Overall Study||234
416221|NCT01590771|1020201|P2|NOT COMPLETED|Overall Study||39
416222|NCT01590771|1020202|P1|NOT COMPLETED|Overall Study||19
416223|NCT01590771|1020201|P2|COMPLETED|Overall Study||210
416224|NCT01590771|1020202|P1|COMPLETED|Overall Study||230
416225|NCT01590771|1020201|P2|STARTED|Overall Study||249
416226|NCT01590771|1020202|P1|STARTED|Overall Study||249
416227|NCT01590758|1020230|P2|NOT COMPLETED|Overall Study||7
416228|NCT01590758|1020231|P1|NOT COMPLETED|Overall Study||5
416229|NCT01590758|1020230|P2|COMPLETED|Overall Study||97
416230|NCT01590758|1020231|P1|COMPLETED|Overall Study||80
416231|NCT01590758|1020230|P2|STARTED|Overall Study||104
416232|NCT01590758|1020231|P1|STARTED|Overall Study||85
416233|NCT01590563|1020241|P1|NOT COMPLETED|Overall Study||1
416234|NCT01590563|1020241|P1|COMPLETED|Overall Study||14
416235|NCT01590563|1020241|P1|STARTED|Overall Study||15
416236|NCT01590550|1020247|P1|NOT COMPLETED|Overall Study||0
416237|NCT01590550|1020247|P1|COMPLETED|Overall Study||18
416238|NCT01590550|1020247|P1|STARTED|Overall Study||18
416239|NCT01590394|1020253|P1|NOT COMPLETED|Overall Study||0
416240|NCT01590394|1020253|P1|COMPLETED|Overall Study||3
416241|NCT01590394|1020253|P1|STARTED|Overall Study||3
416242|NCT01590264|1020257|P1|NOT COMPLETED|Overall Study||0
416243|NCT01590264|1020257|P1|COMPLETED|Overall Study||5
416244|NCT01590264|1020257|P1|STARTED|Overall Study||5
416245|NCT01590238|1020262|P1|NOT COMPLETED|Overall Study||2
416246|NCT01590238|1020262|P1|COMPLETED|Overall Study||13
416247|NCT01590238|1020262|P1|STARTED|Overall Study||15
416248|NCT01590212|1020269|P3|NOT COMPLETED|Overall Study||5
416249|NCT01590212|1020270|P2|NOT COMPLETED|Overall Study||4
416250|NCT01590212|1020271|P1|NOT COMPLETED|Overall Study||3
416251|NCT01590212|1020269|P3|COMPLETED|Overall Study||9
416252|NCT01590212|1020270|P2|COMPLETED|Overall Study||5
416253|NCT01590212|1020271|P1|COMPLETED|Overall Study|Includes 2 contacted who failed contact at post-intervention data collection point|9
416254|NCT01590212|1020269|P3|Post-intervention|Overall Study|failed contact=1|10
416255|NCT01590212|1020270|P2|Post-intervention|Overall Study|failed contact=2; withdrew=1|6
416256|NCT01590212|1020271|P1|Post-intervention|Overall Study|failed contact=3|7
416257|NCT01590212|1020269|P3|Baseline (Pre-intervention)|Overall Study|failed contact=2|12
416258|NCT01590212|1020270|P2|Baseline (Pre-intervention)|Overall Study||9
416259|NCT01590212|1020271|P1|Baseline (Pre-intervention)|Overall Study|withdrew=2|10
416260|NCT01590212|1020269|P3|STARTED|Overall Study||14
416261|NCT01590212|1020270|P2|STARTED|Overall Study||9
416262|NCT01590212|1020271|P1|STARTED|Overall Study||12
416263|NCT01589978|1020288|P1|NOT COMPLETED|Overall Study||0
416264|NCT01589978|1020288|P1|COMPLETED|Overall Study||2681
416265|NCT01589978|1020288|P1|STARTED|Overall Study||2681
416266|NCT01589822|1020315|P3|NOT COMPLETED|Overall Study||1
416267|NCT01589822|1020316|P2|NOT COMPLETED|Overall Study||3
416268|NCT01589822|1020317|P1|NOT COMPLETED|Overall Study||4
416269|NCT01589822|1020315|P3|COMPLETED|Overall Study||40
416270|NCT01589822|1020316|P2|COMPLETED|Overall Study||86
416271|NCT01589822|1020317|P1|COMPLETED|Overall Study||80
416272|NCT01589822|1020315|P3|STARTED|Overall Study||41
416273|NCT01589822|1020316|P2|STARTED|Overall Study||89
416274|NCT01589822|1020317|P1|STARTED|Overall Study||84
416275|NCT01589653|1020336|P2|NOT COMPLETED|Overall Study||11
416276|NCT01589653|1020337|P1|NOT COMPLETED|Overall Study||7
416277|NCT01589653|1020336|P2|COMPLETED|Overall Study||68
416278|NCT01589653|1020337|P1|COMPLETED|Overall Study||69
416279|NCT01589653|1020336|P2|Exposed|Overall Study||78
416280|NCT01589653|1020337|P1|Exposed|Overall Study||76
416281|NCT01589653|1020336|P2|STARTED|Overall Study||79
416282|NCT01589653|1020337|P1|STARTED|Overall Study||76
416283|NCT01589601|1020353|P2|NOT COMPLETED|Overall Study||49
416284|NCT01589601|1020354|P1|NOT COMPLETED|Overall Study||47
416285|NCT01589601|1020353|P2|COMPLETED|Overall Study||26
416286|NCT01589601|1020354|P1|COMPLETED|Overall Study||28
416287|NCT01589601|1020353|P2|STARTED|Overall Study||75
416288|NCT01589601|1020354|P1|STARTED|Overall Study||75
416289|NCT01589510|1020370|P1|NOT COMPLETED|Overall Study||33
416290|NCT01589510|1020370|P1|COMPLETED|Overall Study||386
416291|NCT01589510|1020370|P1|STARTED|Overall Study||419
416292|NCT01589497|1020385|P4|NOT COMPLETED|Overall Study||1
416293|NCT01589497|1020386|P3|NOT COMPLETED|Overall Study||1
416294|NCT01589497|1020387|P2|NOT COMPLETED|Overall Study||1
416295|NCT01589497|1020388|P1|NOT COMPLETED|Overall Study||1
416296|NCT01589497|1020385|P4|COMPLETED|Overall Study||17
416297|NCT01589497|1020386|P3|COMPLETED|Overall Study||15
416298|NCT01589497|1020387|P2|COMPLETED|Overall Study|1 participant who completed study but had insufficient sputum volume was excluded from the analyses|16
416299|NCT01589497|1020388|P1|COMPLETED|Overall Study|1 participant who completed study but had insufficient sputum volume was excluded from the analyses|17
416300|NCT01589497|1020385|P4|STARTED|Overall Study||18
416301|NCT01589497|1020386|P3|STARTED|Overall Study||16
416302|NCT01589497|1020387|P2|STARTED|Overall Study||17
416303|NCT01589497|1020388|P1|STARTED|Overall Study||18
416304|NCT01589484|1020489|P1|NOT COMPLETED|Overall Study||4
416305|NCT01589484|1020489|P1|COMPLETED|Overall Study||100
416306|NCT01589484|1020489|P1|STARTED|Overall Study||104
416307|NCT01589445|1020494|P1|NOT COMPLETED|002 (Metformin)-3 Months||9
416308|NCT01589445|1020494|P1|COMPLETED|002 (Metformin)-3 Months|61 patients completed the drug 002.9 patients dropped out.|61
416309|NCT01589445|1020494|P1|STARTED|002 (Metformin)-3 Months|70 patients participated for trial of drug 002.|70
416310|NCT01589445|1020494|P1|NOT COMPLETED|001 (Pioglitazone) -3 Months||7
416311|NCT01589445|1020494|P1|COMPLETED|001 (Pioglitazone) -3 Months|dropped out 7 patients|70
416312|NCT01589445|1020494|P1|STARTED|001 (Pioglitazone) -3 Months||77
416313|NCT01589237|1020514|P4|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4
416314|NCT01589237|1020515|P3|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4
416315|NCT01589237|1020516|P2|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||6
416316|NCT01589237|1020517|P1|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||5
416317|NCT01589237|1020514|P4|COMPLETED|Part B (Planned for 78 Week-terminated)||0
416318|NCT01589237|1020515|P3|COMPLETED|Part B (Planned for 78 Week-terminated)||0
416319|NCT01589237|1020516|P2|COMPLETED|Part B (Planned for 78 Week-terminated)||0
416320|NCT01589237|1020517|P1|COMPLETED|Part B (Planned for 78 Week-terminated)||0
416321|NCT01589237|1020514|P4|STARTED|Part B (Planned for 78 Week-terminated)||4
416322|NCT01589237|1020515|P3|STARTED|Part B (Planned for 78 Week-terminated)||4
416323|NCT01589237|1020516|P2|STARTED|Part B (Planned for 78 Week-terminated)||6
416324|NCT01589237|1020517|P1|STARTED|Part B (Planned for 78 Week-terminated)||5
416325|NCT01589237|1020514|P4|NOT COMPLETED|Part A (52 Weeks)||0
416326|NCT01589237|1020515|P3|NOT COMPLETED|Part A (52 Weeks)||2
416327|NCT01589237|1020516|P2|NOT COMPLETED|Part A (52 Weeks)||3
416328|NCT01589237|1020517|P1|NOT COMPLETED|Part A (52 Weeks)||2
416329|NCT01589237|1020514|P4|COMPLETED|Part A (52 Weeks)||5
416330|NCT01589237|1020515|P3|COMPLETED|Part A (52 Weeks)||8
416331|NCT01589237|1020516|P2|COMPLETED|Part A (52 Weeks)||9
416332|NCT01589237|1020517|P1|COMPLETED|Part A (52 Weeks)||9
416333|NCT01589237|1020514|P4|STARTED|Part A (52 Weeks)||5
416334|NCT01589237|1020515|P3|STARTED|Part A (52 Weeks)||10
416335|NCT01589237|1020516|P2|STARTED|Part A (52 Weeks)||12
416336|NCT01589237|1020517|P1|STARTED|Part A (52 Weeks)|"Started = Full analysis set/safety set"|11
416337|NCT01588951|1020566|P3|NOT COMPLETED|Overall Study||1
416338|NCT01588951|1020567|P2|NOT COMPLETED|Overall Study||0
416339|NCT01588951|1020568|P1|NOT COMPLETED|Overall Study||0
416340|NCT01588951|1020566|P3|COMPLETED|Overall Study||5
416341|NCT01588951|1020567|P2|COMPLETED|Overall Study||2
416342|NCT01588951|1020568|P1|COMPLETED|Overall Study||2
416343|NCT01588951|1020566|P3|STARTED|Overall Study||6
416344|NCT01588951|1020567|P2|STARTED|Overall Study||2
416345|NCT01588951|1020568|P1|STARTED|Overall Study||2
416346|NCT01588821|1020576|P1|NOT COMPLETED|Overall Study||0
416347|NCT01588821|1020576|P1|COMPLETED|Overall Study||37
416348|NCT01588821|1020576|P1|STARTED|Overall Study||37
416349|NCT01588561|1020581|P2|NOT COMPLETED|Overall Study||0
416350|NCT01588561|1020582|P1|NOT COMPLETED|Overall Study||0
416351|NCT01588561|1020581|P2|COMPLETED|Overall Study||1
416352|NCT01588561|1020582|P1|COMPLETED|Overall Study||14
416353|NCT01588561|1020581|P2|Second Injection (Visit 2)|Overall Study||1
416354|NCT01588561|1020582|P1|Second Injection (Visit 2)|Overall Study||14
416355|NCT01588561|1020581|P2|Rest Period|Overall Study||1
416356|NCT01588561|1020582|P1|Rest Period|Overall Study||14
416357|NCT01588561|1020581|P2|First Injection (Visit 1)|Overall Study||1
416358|NCT01588561|1020582|P1|First Injection (Visit 1)|Overall Study||14
416359|NCT01588561|1020581|P2|STARTED|Overall Study||1
416360|NCT01588561|1020582|P1|STARTED|Overall Study||14
416361|NCT01588548|1020599|P6|NOT COMPLETED|Overall Study||6
416362|NCT01588548|1020600|P5|NOT COMPLETED|Overall Study||6
416363|NCT01588548|1020601|P4|NOT COMPLETED|Overall Study||7
416364|NCT01588548|1020602|P3|NOT COMPLETED|Overall Study||6
416365|NCT01588548|1020603|P2|NOT COMPLETED|Overall Study||7
416366|NCT01588548|1020604|P1|NOT COMPLETED|Overall Study||3
416367|NCT01588548|1020599|P6|COMPLETED|Overall Study||0
416368|NCT01588548|1020600|P5|COMPLETED|Overall Study||0
416369|NCT01588548|1020601|P4|COMPLETED|Overall Study||0
416370|NCT01588548|1020602|P3|COMPLETED|Overall Study||0
416371|NCT01588548|1020603|P2|COMPLETED|Overall Study||0
416372|NCT01588548|1020604|P1|COMPLETED|Overall Study||0
416373|NCT01588548|1020599|P6|Cycle 1 Day 21|Overall Study||3
416374|NCT01588548|1020600|P5|Cycle 1 Day 21|Overall Study||3
416375|NCT01588548|1020601|P4|Cycle 1 Day 21|Overall Study||5
416376|NCT01588548|1020602|P3|Cycle 1 Day 21|Overall Study||2
416377|NCT01588548|1020603|P2|Cycle 1 Day 21|Overall Study||5
416378|NCT01588548|1020604|P1|Cycle 1 Day 21|Overall Study||3
416379|NCT01588548|1020599|P6|STARTED|Overall Study||6
416380|NCT01588548|1020600|P5|STARTED|Overall Study||6
416381|NCT01588548|1020601|P4|STARTED|Overall Study||7
416382|NCT01588548|1020602|P3|STARTED|Overall Study||6
416383|NCT01588548|1020603|P2|STARTED|Overall Study||7
416384|NCT01588548|1020604|P1|STARTED|Overall Study||3
416385|NCT01588496|1020621|P3|NOT COMPLETED|Overall Study||0
416386|NCT01588496|1020622|P2|NOT COMPLETED|Overall Study||1
416387|NCT01588496|1020623|P1|NOT COMPLETED|Overall Study||0
416388|NCT01588496|1020621|P3|COMPLETED|Overall Study||33
416389|NCT01588496|1020622|P2|COMPLETED|Overall Study||16
416390|NCT01588496|1020623|P1|COMPLETED|Overall Study||8
416391|NCT01588496|1020621|P3|Received Treatment|Overall Study||33
416392|NCT01588496|1020622|P2|Received Treatment|Overall Study||16
416393|NCT01588496|1020623|P1|Received Treatment|Overall Study||8
416394|NCT01588496|1020621|P3|STARTED|Overall Study||33
416395|NCT01588496|1020622|P2|STARTED|Overall Study||17
416396|NCT01588496|1020623|P1|STARTED|Overall Study||8
416397|NCT01588470|1020648|P1|NOT COMPLETED|Overall Study||80
416398|NCT01588470|1020648|P1|COMPLETED|Overall Study|Completed Dec. 2011|50
416399|NCT01588470|1020648|P1|STARTED|Overall Study|First enrolled April 2007|130
416400|NCT01588444|1020659|P2|NOT COMPLETED|Overall Study||0
416401|NCT01588444|1020660|P1|NOT COMPLETED|Overall Study||0
416402|NCT01588444|1020659|P2|COMPLETED|Overall Study||20
416403|NCT01588444|1020660|P1|COMPLETED|Overall Study||20
416404|NCT01588444|1020659|P2|STARTED|Overall Study||20
416405|NCT01588444|1020660|P1|STARTED|Overall Study||20
416406|NCT01588418|1020666|P2|NOT COMPLETED|Overall Study||0
416407|NCT01588418|1020667|P1|NOT COMPLETED|Overall Study||0
416408|NCT01588418|1020666|P2|COMPLETED|Overall Study||4
416409|NCT01588418|1020667|P1|COMPLETED|Overall Study||11
416410|NCT01588418|1020666|P2|STARTED|Overall Study||4
416411|NCT01588418|1020667|P1|STARTED|Overall Study||11
416412|NCT01588405|1020673|P1|NOT COMPLETED|Overall Study||2
416413|NCT01588405|1020673|P1|COMPLETED|Overall Study||31
416414|NCT01588405|1020673|P1|STARTED|Overall Study||33
416415|NCT01588353|1020700|P3|NOT COMPLETED|Step3||2
416416|NCT01588353|1020701|P2|NOT COMPLETED|Step3||0
416417|NCT01588353|1020702|P1|NOT COMPLETED|Step3||0
416418|NCT01588353|1020700|P3|COMPLETED|Step3||23
416419|NCT01588353|1020701|P2|COMPLETED|Step3||0
416420|NCT01588353|1020702|P1|COMPLETED|Step3||0
416421|NCT01588353|1020700|P3|STARTED|Step3||25
416422|NCT01588353|1020701|P2|STARTED|Step3||0
416423|NCT01588353|1020702|P1|STARTED|Step3||0
416424|NCT01588353|1020700|P3|NOT COMPLETED|Step2||0
416425|NCT01588353|1020701|P2|NOT COMPLETED|Step2||1
416426|NCT01588353|1020702|P1|NOT COMPLETED|Step2||0
416427|NCT01588353|1020700|P3|COMPLETED|Step2||0
416428|NCT01588353|1020701|P2|COMPLETED|Step2||70
416429|NCT01588353|1020702|P1|COMPLETED|Step2||0
416430|NCT01588353|1020700|P3|STARTED|Step2||0
416431|NCT01588353|1020701|P2|STARTED|Step2||71
416432|NCT01588353|1020702|P1|STARTED|Step2||0
416433|NCT01588353|1020700|P3|NOT COMPLETED|Step1||0
416434|NCT01588353|1020701|P2|NOT COMPLETED|Step1||0
416435|NCT01588353|1020702|P1|NOT COMPLETED|Step1||0
416436|NCT01588353|1020700|P3|COMPLETED|Step1||0
416437|NCT01588353|1020701|P2|COMPLETED|Step1||0
416438|NCT01588353|1020702|P1|COMPLETED|Step1||6
416439|NCT01588353|1020700|P3|STARTED|Step1||0
416440|NCT01588353|1020701|P2|STARTED|Step1||0
416441|NCT01588353|1020702|P1|STARTED|Step1||6
416442|NCT01588158|1020720|P2|NOT COMPLETED|Overall Study||0
416443|NCT01588158|1020721|P1|NOT COMPLETED|Overall Study||0
416444|NCT01588158|1020720|P2|COMPLETED|Overall Study||3
416445|NCT01588158|1020721|P1|COMPLETED|Overall Study||4
416446|NCT01588158|1020720|P2|STARTED|Overall Study||3
416447|NCT01588158|1020721|P1|STARTED|Overall Study||4
416448|NCT01588106|1020745|P2|NOT COMPLETED|Overall Study||4
416449|NCT01588106|1020746|P1|NOT COMPLETED|Overall Study||5
416450|NCT01588106|1020745|P2|COMPLETED|Overall Study||72
416451|NCT01588106|1020746|P1|COMPLETED|Overall Study||73
416452|NCT01588106|1020745|P2|STARTED|Overall Study||76
416453|NCT01588106|1020746|P1|STARTED|Overall Study||78
416454|NCT01587989|1020754|P3|NOT COMPLETED|Randomized Study Treatment||1
416455|NCT01587989|1020755|P2|NOT COMPLETED|Randomized Study Treatment||2
416456|NCT01587989|1020756|P1|NOT COMPLETED|Randomized Study Treatment||0
416457|NCT01587989|1020754|P3|COMPLETED|Randomized Study Treatment||32
416458|NCT01587989|1020755|P2|COMPLETED|Randomized Study Treatment||30
416459|NCT01587989|1020756|P1|COMPLETED|Randomized Study Treatment||0
416460|NCT01587989|1020754|P3|STARTED|Randomized Study Treatment||33
416461|NCT01587989|1020755|P2|STARTED|Randomized Study Treatment||32
416462|NCT01587989|1020756|P1|STARTED|Randomized Study Treatment||0
416463|NCT01587989|1020754|P3|NOT COMPLETED|12-Week Open-Label Run-In Period||0
416464|NCT01587989|1020755|P2|NOT COMPLETED|12-Week Open-Label Run-In Period||0
416465|NCT01587989|1020756|P1|NOT COMPLETED|12-Week Open-Label Run-In Period||12
416466|NCT01587989|1020754|P3|COMPLETED|12-Week Open-Label Run-In Period||0
416467|NCT01587989|1020755|P2|COMPLETED|12-Week Open-Label Run-In Period||0
416468|NCT01587989|1020756|P1|COMPLETED|12-Week Open-Label Run-In Period||65
416469|NCT01587989|1020754|P3|STARTED|12-Week Open-Label Run-In Period||0
416470|NCT01587989|1020755|P2|STARTED|12-Week Open-Label Run-In Period||0
416471|NCT01587989|1020756|P1|STARTED|12-Week Open-Label Run-In Period||77
416472|NCT01587963|1020780|P2|NOT COMPLETED|Overall Study||0
416473|NCT01587963|1020781|P1|NOT COMPLETED|Overall Study||1
416474|NCT01587963|1020780|P2|COMPLETED|Overall Study||4
416475|NCT01587963|1020781|P1|COMPLETED|Overall Study||6
416476|NCT01587963|1020780|P2|STARTED|Overall Study||4
416477|NCT01587963|1020781|P1|STARTED|Overall Study||7
416478|NCT01587950|1020787|P1|NOT COMPLETED|Period 3||0
416479|NCT01587950|1020787|P1|COMPLETED|Period 3||12
416480|NCT01587950|1020787|P1|Received 2.5% KNO3 Solution (5 Minutes)|Period 3||5
416481|NCT01587950|1020787|P1|Received 2.5% KNO3 Solution (10 Minutes)|Period 3||3
416482|NCT01587950|1020787|P1|Received 5% KNO3 Solution (2 Minutes)|Period 3||3
416483|NCT01587950|1020787|P1|Received 5% KNO3 Solution (5 Minutes)|Period 3||5
416484|NCT01587950|1020787|P1|Received Sterile Water (5 Minutes)|Period 3||5
416485|NCT01587950|1020787|P1|Received 5% KNO3 Solution (10 Minutes)|Period 3||4
416486|NCT01587950|1020787|P1|Received Sterile Water (2 Minutes)|Period 3||2
416487|NCT01587950|1020787|P1|Received Sterile Water (10 Minutes)|Period 3||5
416488|NCT01587950|1020787|P1|Received 2.5% KNO3 Solution (2 Minutes)|Period 3||4
416489|NCT01587950|1020787|P1|STARTED|Period 3||12
416490|NCT01587950|1020787|P1|NOT COMPLETED|Washout 2||0
416491|NCT01587950|1020787|P1|COMPLETED|Washout 2||12
416492|NCT01587950|1020787|P1|STARTED|Washout 2||12
416493|NCT01587950|1020787|P1|NOT COMPLETED|Period 2||0
416494|NCT01587950|1020787|P1|COMPLETED|Period 2||12
416495|NCT01587950|1020787|P1|Received 5% KNO3 Solution (5 Minutes)|Period 2||2
416496|NCT01587950|1020787|P1|Received Sterile Water (10 Minutes)|Period 2||2
416497|NCT01587950|1020787|P1|Received 2.5% KNO3 Solution (2 Minutes)|Period 2||4
416498|NCT01587950|1020787|P1|Received Sterile Water (5 Minutes)|Period 2||2
416499|NCT01587950|1020787|P1|Received 5% KNO3 Solution (2 Minutes)|Period 2||6
416500|NCT01587950|1020787|P1|Received 2.5% KNO3 Solution (10 Minutes)|Period 2||6
416501|NCT01587950|1020787|P1|Received 2.5% KNO3 Solution (5 Minutes)|Period 2||2
416502|NCT01587950|1020787|P1|Received 5% KNO3 Solution (10 Minutes)|Period 2||4
416503|NCT01587950|1020787|P1|Received Sterile Water (2 Minutes)|Period 2||8
416504|NCT01587950|1020787|P1|STARTED|Period 2||12
416505|NCT01587950|1020787|P1|NOT COMPLETED|Washout 1||0
416506|NCT01587950|1020787|P1|COMPLETED|Washout 1||12
416507|NCT01587950|1020787|P1|STARTED|Washout 1||12
416508|NCT01587950|1020787|P1|NOT COMPLETED|Period 1||0
416509|NCT01587950|1020787|P1|COMPLETED|Period 1||12
416510|NCT01587950|1020787|P1|Received Sterile Water (5 Minutes)|Period 1||5
416511|NCT01587950|1020787|P1|Received 2.5% KNO3 Solution (5 Minutes)|Period 1||5
416512|NCT01587950|1020787|P1|Received Sterile Water (10 Minutes)|Period 1||5
416513|NCT01587950|1020787|P1|Received 2.5% KNO3 Solution (10 Minutes)|Period 1||3
416514|NCT01587950|1020787|P1|Received 2.5% KNO3 Solution (2 Minutes)|Period 1||4
416515|NCT01587950|1020787|P1|Received 5% KNO3 Solution (10 Minutes)|Period 1||4
416516|NCT01587950|1020787|P1|Received Sterile Water (2 Minutes)|Period 1||2
416517|NCT01587950|1020787|P1|Received 5% KNO3 Solution (2 Minutes)|Period 1||3
416518|NCT01587950|1020787|P1|Received 5% KNO3 Solution (5 Minutes)|Period 1||5
416519|NCT01587950|1020787|P1|STARTED|Period 1||12
416520|NCT01587924|1020821|P4|NOT COMPLETED|Overall Study||1
416521|NCT01587924|1020822|P3|NOT COMPLETED|Overall Study||4
416522|NCT01587924|1020823|P2|NOT COMPLETED|Overall Study||4
416523|NCT01587924|1020824|P1|NOT COMPLETED|Overall Study||4
416524|NCT01587924|1020821|P4|COMPLETED|Overall Study||19
416525|NCT01587924|1020822|P3|COMPLETED|Overall Study||17
416526|NCT01587924|1020823|P2|COMPLETED|Overall Study||17
416527|NCT01587924|1020824|P1|COMPLETED|Overall Study||17
416528|NCT01587924|1020821|P4|STARTED|Overall Study||20
416529|NCT01587924|1020822|P3|STARTED|Overall Study||21
416530|NCT01587924|1020823|P2|STARTED|Overall Study||21
416531|NCT01587924|1020824|P1|STARTED|Overall Study||21
416532|NCT01587898|1020925|P4|NOT COMPLETED|Overall Study||2
416533|NCT01587898|1020926|P3|NOT COMPLETED|Overall Study||2
416534|NCT01587898|1020927|P2|NOT COMPLETED|Overall Study||5
416535|NCT01587898|1020928|P1|NOT COMPLETED|Overall Study||4
416536|NCT01587898|1020925|P4|COMPLETED|Overall Study||17
416537|NCT01587898|1020926|P3|COMPLETED|Overall Study||16
416538|NCT01587898|1020927|P2|COMPLETED|Overall Study||12
416539|NCT01587898|1020928|P1|COMPLETED|Overall Study||14
416540|NCT01587898|1020925|P4|STARTED|Overall Study||19
416541|NCT01587898|1020926|P3|STARTED|Overall Study||18
416542|NCT01587898|1020927|P2|STARTED|Overall Study||17
416543|NCT01587898|1020928|P1|STARTED|Overall Study||18
416544|NCT01587885|1021104|P2|NOT COMPLETED|Treatment Period 2||0
416545|NCT01587885|1021105|P1|NOT COMPLETED|Treatment Period 2||0
416546|NCT01587885|1021104|P2|COMPLETED|Treatment Period 2||19
416547|NCT01587885|1021105|P1|COMPLETED|Treatment Period 2||26
416548|NCT01587885|1021104|P2|STARTED|Treatment Period 2||19
416549|NCT01587885|1021105|P1|STARTED|Treatment Period 2||26
416550|NCT01587885|1021104|P2|NOT COMPLETED|Treatment Period 1||3
416551|NCT01587885|1021105|P1|NOT COMPLETED|Treatment Period 1||0
416552|NCT01587885|1021104|P2|COMPLETED|Treatment Period 1||19
416553|NCT01587885|1021105|P1|COMPLETED|Treatment Period 1||26
416554|NCT01587885|1021104|P2|STARTED|Treatment Period 1||22
416555|NCT01587885|1021105|P1|STARTED|Treatment Period 1||26
416556|NCT01587651|1021121|P3|NOT COMPLETED|Overall Study||1
416557|NCT01587651|1021122|P2|NOT COMPLETED|Overall Study||3
416558|NCT01587651|1021123|P1|NOT COMPLETED|Overall Study||0
416559|NCT01587651|1021121|P3|COMPLETED|Overall Study||34
416560|NCT01587651|1021122|P2|COMPLETED|Overall Study||38
416561|NCT01587651|1021123|P1|COMPLETED|Overall Study||34
416562|NCT01587651|1021121|P3|STARTED|Overall Study||35
416563|NCT01587651|1021122|P2|STARTED|Overall Study||41
416564|NCT01587651|1021123|P1|STARTED|Overall Study||34
416565|NCT01587118|1021150|P1|NOT COMPLETED|Overall Study||7
416566|NCT01587118|1021150|P1|COMPLETED|Overall Study||11
416567|NCT01587118|1021150|P1|STARTED|Overall Study|31 signed consent and 18 were deemed eligible and initiated treatment with adjunctive asenapine.|18
416568|NCT01587105|1021157|P2|NOT COMPLETED|Overall Study||43
416569|NCT01587105|1021158|P1|NOT COMPLETED|Overall Study||6
416570|NCT01587105|1021157|P2|COMPLETED|Overall Study||138
416571|NCT01587105|1021158|P1|COMPLETED|Overall Study||144
416572|NCT01587105|1021157|P2|STARTED|Overall Study||181
416573|NCT01587105|1021158|P1|STARTED|Overall Study||150
416574|NCT01587079|1021174|P1|NOT COMPLETED|Overall Study||39
416575|NCT01587079|1021174|P1|COMPLETED|Overall Study||120
416576|NCT01587079|1021174|P1|STARTED|Overall Study||159
416577|NCT01587027|1021298|P2|NOT COMPLETED|Discharge (1 Day)||0
416578|NCT01587027|1021299|P1|NOT COMPLETED|Discharge (1 Day)||0
416579|NCT01587027|1021298|P2|COMPLETED|Discharge (1 Day)||8
416580|NCT01587027|1021299|P1|COMPLETED|Discharge (1 Day)||8
416581|NCT01587027|1021298|P2|STARTED|Discharge (1 Day)||8
416582|NCT01587027|1021299|P1|STARTED|Discharge (1 Day)||8
416583|NCT01587027|1021298|P2|NOT COMPLETED|Third Intervention (1 Day)||0
416584|NCT01587027|1021299|P1|NOT COMPLETED|Third Intervention (1 Day)||0
416585|NCT01587027|1021298|P2|COMPLETED|Third Intervention (1 Day)||8
416586|NCT01587027|1021299|P1|COMPLETED|Third Intervention (1 Day)||8
416587|NCT01587027|1021298|P2|STARTED|Third Intervention (1 Day)||8
416588|NCT01587027|1021299|P1|STARTED|Third Intervention (1 Day)||8
416589|NCT01587027|1021298|P2|NOT COMPLETED|Washout (1 Day)||0
416590|NCT01587027|1021299|P1|NOT COMPLETED|Washout (1 Day)||0
416591|NCT01587027|1021298|P2|COMPLETED|Washout (1 Day)||8
416592|NCT01587027|1021299|P1|COMPLETED|Washout (1 Day)||8
416593|NCT01587027|1021298|P2|STARTED|Washout (1 Day)||8
416594|NCT01587027|1021299|P1|STARTED|Washout (1 Day)||8
416595|NCT01587027|1021298|P2|NOT COMPLETED|Second Intervention (1 Day)||0
416596|NCT01587027|1021299|P1|NOT COMPLETED|Second Intervention (1 Day)||0
416597|NCT01587027|1021298|P2|COMPLETED|Second Intervention (1 Day)||8
416598|NCT01587027|1021299|P1|COMPLETED|Second Intervention (1 Day)||8
416599|NCT01587027|1021298|P2|STARTED|Second Intervention (1 Day)||8
416600|NCT01587027|1021299|P1|STARTED|Second Intervention (1 Day)||8
416601|NCT01587027|1021298|P2|NOT COMPLETED|Washout (1 Day)||0
416602|NCT01587027|1021299|P1|NOT COMPLETED|Washout (1 Day)||0
416603|NCT01587027|1021298|P2|COMPLETED|Washout (1 Day)||8
416604|NCT01587027|1021299|P1|COMPLETED|Washout (1 Day)||8
416605|NCT01587027|1021298|P2|STARTED|Washout (1 Day)||8
416606|NCT01587027|1021299|P1|STARTED|Washout (1 Day)||8
416607|NCT01587027|1021298|P2|NOT COMPLETED|First Intervention (1 Day)||0
416608|NCT01587027|1021299|P1|NOT COMPLETED|First Intervention (1 Day)||0
416609|NCT01587027|1021298|P2|COMPLETED|First Intervention (1 Day)||8
416610|NCT01587027|1021299|P1|COMPLETED|First Intervention (1 Day)||8
416611|NCT01587027|1021298|P2|STARTED|First Intervention (1 Day)||8
416612|NCT01587027|1021299|P1|STARTED|First Intervention (1 Day)||8
416613|NCT01587014|1021305|P1|NOT COMPLETED|Overall Study||2
416614|NCT01587014|1021305|P1|COMPLETED|Overall Study||24
416615|NCT01587014|1021305|P1|STARTED|Overall Study||26
416616|NCT01587001|1021312|P2|NOT COMPLETED|Overall Study||1
416617|NCT01587001|1021313|P1|NOT COMPLETED|Overall Study||6
416618|NCT01587001|1021312|P2|COMPLETED|Overall Study||2
416619|NCT01587001|1021313|P1|COMPLETED|Overall Study||8
416620|NCT01587001|1021312|P2|STARTED|Overall Study||3
416621|NCT01587001|1021313|P1|STARTED|Overall Study||14
416622|NCT01586975|1021324|P3|NOT COMPLETED|Overall Study||0
416623|NCT01586975|1021325|P2|NOT COMPLETED|Overall Study||0
416624|NCT01586975|1021326|P1|NOT COMPLETED|Overall Study||0
416625|NCT01586975|1021324|P3|COMPLETED|Overall Study||46
416626|NCT01586975|1021325|P2|COMPLETED|Overall Study||32
416627|NCT01586975|1021326|P1|COMPLETED|Overall Study||15
416628|NCT01586975|1021324|P3|STARTED|Overall Study||46
416629|NCT01586975|1021325|P2|STARTED|Overall Study||32
416630|NCT01586975|1021326|P1|STARTED|Overall Study||15
416631|NCT01586962|1021334|P1|NOT COMPLETED|Overall Study||0
416632|NCT01586962|1021334|P1|COMPLETED|Overall Study||56
416633|NCT01586962|1021334|P1|STARTED|Overall Study||56
416634|NCT01586897|1021342|P2|NOT COMPLETED|Overall Study||0
416635|NCT01586897|1021343|P1|NOT COMPLETED|Overall Study||0
416636|NCT01586897|1021342|P2|COMPLETED|Overall Study||26
416637|NCT01586897|1021343|P1|COMPLETED|Overall Study||26
416638|NCT01586897|1021342|P2|STARTED|Overall Study||26
416639|NCT01586897|1021343|P1|STARTED|Overall Study||26
416640|NCT01586819|1021361|P2|NOT COMPLETED|Overall Study||0
416641|NCT01586819|1021362|P1|NOT COMPLETED|Overall Study||1
416642|NCT01586819|1021361|P2|COMPLETED|Overall Study||14
416643|NCT01586819|1021362|P1|COMPLETED|Overall Study||11
416644|NCT01586819|1021361|P2|STARTED|Overall Study||14
416645|NCT01586819|1021362|P1|STARTED|Overall Study||12
416646|NCT01586806|1021373|P3|NOT COMPLETED|Overall Study||2
416647|NCT01586806|1021374|P2|NOT COMPLETED|Overall Study||4
416648|NCT01586806|1021375|P1|NOT COMPLETED|Overall Study||3
416649|NCT01586806|1021373|P3|COMPLETED|Overall Study||63
416650|NCT01586806|1021374|P2|COMPLETED|Overall Study||61
416651|NCT01586806|1021375|P1|COMPLETED|Overall Study||62
416652|NCT01586806|1021373|P3|STARTED|Overall Study||65
416653|NCT01586806|1021374|P2|STARTED|Overall Study||65
416654|NCT01586806|1021375|P1|STARTED|Overall Study||65
416655|NCT01586364|1021395|P1|NOT COMPLETED|Overall Study||117
416656|NCT01586364|1021395|P1|COMPLETED|Overall Study||184
416657|NCT01586364|1021395|P1|STARTED|Overall Study||301
416658|NCT01586338|1021448|P1|NOT COMPLETED|Overall Study||8
416659|NCT01586338|1021448|P1|COMPLETED|Overall Study||229
416660|NCT01586338|1021448|P1|STARTED|Overall Study||237
416661|NCT01586312|1021460|P2|NOT COMPLETED|Overall Study||0
416662|NCT01586312|1021461|P1|NOT COMPLETED|Overall Study||0
416663|NCT01586312|1021460|P2|COMPLETED|Overall Study||15
416664|NCT01586312|1021461|P1|COMPLETED|Overall Study||15
416665|NCT01586312|1021460|P2|STARTED|Overall Study||15
416666|NCT01586312|1021461|P1|STARTED|Overall Study||15
416667|NCT01586195|1021471|P1|NOT COMPLETED|Overall Study||26
416668|NCT01586195|1021471|P1|COMPLETED|Overall Study||5
416669|NCT01586195|1021471|P1|STARTED|Overall Study||31
416670|NCT01586156|1021485|P3|NOT COMPLETED|Overall Study||0
416671|NCT01586156|1021486|P2|NOT COMPLETED|Overall Study||1
416672|NCT01586156|1021487|P1|NOT COMPLETED|Overall Study||0
416673|NCT01586156|1021485|P3|COMPLETED|Overall Study||10
416674|NCT01586156|1021486|P2|COMPLETED|Overall Study||9
416675|NCT01586156|1021487|P1|COMPLETED|Overall Study||10
416676|NCT01586156|1021485|P3|STARTED|Overall Study||10
416677|NCT01586156|1021486|P2|STARTED|Overall Study||10
416678|NCT01586156|1021487|P1|STARTED|Overall Study||10
416679|NCT01586026|1021513|P3|NOT COMPLETED|Overall Study||0
416680|NCT01586026|1021514|P2|NOT COMPLETED|Overall Study||0
416681|NCT01586026|1021515|P1|NOT COMPLETED|Overall Study||0
416682|NCT01586026|1021513|P3|COMPLETED|Overall Study||271
416683|NCT01586026|1021514|P2|COMPLETED|Overall Study||414
416684|NCT01586026|1021515|P1|COMPLETED|Overall Study||350
416685|NCT01586026|1021513|P3|STARTED|Overall Study||271
416686|NCT01586026|1021514|P2|STARTED|Overall Study||414
416687|NCT01586026|1021515|P1|STARTED|Overall Study||350
416688|NCT01585987|1021525|P2|NOT COMPLETED|Treated||49
416689|NCT01585987|1021526|P1|NOT COMPLETED|Treated||54
416690|NCT01585987|1021525|P2|COMPLETED|Treated||2
416691|NCT01585987|1021526|P1|COMPLETED|Treated||3
416692|NCT01585987|1021525|P2|STARTED|Treated||51
416693|NCT01585987|1021526|P1|STARTED|Treated||57
416694|NCT01585987|1021525|P2|NOT COMPLETED|Randomized||6
416695|NCT01585987|1021526|P1|NOT COMPLETED|Randomized||0
416696|NCT01585987|1021525|P2|COMPLETED|Randomized||51
416697|NCT01585987|1021526|P1|COMPLETED|Randomized||57
416698|NCT01585987|1021525|P2|STARTED|Randomized||57
416699|NCT01585987|1021526|P1|STARTED|Randomized||57
416700|NCT01585961|1021541|P1|NOT COMPLETED|Overall Study||33
416701|NCT01585961|1021541|P1|COMPLETED|Overall Study||478
416702|NCT01585961|1021541|P1|Safety|Overall Study|Patients ablated with study catheter|508
416703|NCT01585961|1021541|P1|STARTED|Overall Study||511
416704|NCT01585779|1021558|P2|NOT COMPLETED|Overall Study||7
416705|NCT01585779|1021559|P1|NOT COMPLETED|Overall Study||10
416706|NCT01585779|1021558|P2|COMPLETED|Overall Study||21
416707|NCT01585779|1021559|P1|COMPLETED|Overall Study||26
416708|NCT01585779|1021558|P2|STARTED|Overall Study||28
416709|NCT01585779|1021559|P1|STARTED|Overall Study||36
416710|NCT01585597|1021613|P1|NOT COMPLETED|Overall Study||0
416711|NCT01585597|1021613|P1|COMPLETED|Overall Study||20
416712|NCT01585597|1021613|P1|STARTED|Overall Study||20
416713|NCT01585584|1021618|P1|NOT COMPLETED|Overall Study||4
416714|NCT01585584|1021618|P1|COMPLETED|Overall Study||6
416715|NCT01585584|1021618|P1|STARTED|Overall Study||10
416716|NCT01585558|1021625|P3|NOT COMPLETED|Overall Study||15
416717|NCT01585558|1021626|P2|NOT COMPLETED|Overall Study||12
416718|NCT01585558|1021627|P1|NOT COMPLETED|Overall Study||13
416719|NCT01585558|1021625|P3|COMPLETED|Overall Study||34
416720|NCT01585558|1021626|P2|COMPLETED|Overall Study||57
416721|NCT01585558|1021627|P1|COMPLETED|Overall Study||49
416722|NCT01585558|1021625|P3|STARTED|Overall Study||49
416723|NCT01585558|1021626|P2|STARTED|Overall Study||69
416724|NCT01585558|1021627|P1|STARTED|Overall Study||62
416725|NCT01585441|1021808|P2|NOT COMPLETED|Overall Study||0
416726|NCT01585441|1021809|P1|NOT COMPLETED|Overall Study||0
416727|NCT01585441|1021808|P2|COMPLETED|Overall Study|Defined as completing the Month 3 masked phase of the study and/or the final safety visit|3
416728|NCT01585441|1021809|P1|COMPLETED|Overall Study|Defined as completing the Month 3 masked phase of the study and/or the final safety visit|3
416729|NCT01585441|1021808|P2|Final Study Safety Visit|Overall Study|A final study visit was not required for the placebo participant who completed the study at Month 3.|2
416730|NCT01585441|1021809|P1|Final Study Safety Visit|Overall Study||3
416731|NCT01585441|1021808|P2|Received Finasteride at Month 3|Overall Study||2
416732|NCT01585441|1021809|P1|Received Finasteride at Month 3|Overall Study||2
416733|NCT01585441|1021808|P2|Month 3|Overall Study||3
416734|NCT01585441|1021809|P1|Month 3|Overall Study|One participant was not evaluated at Month 3 but at the final visit due to study terminating early.|2
416735|NCT01585441|1021808|P2|STARTED|Overall Study||3
416736|NCT01585441|1021809|P1|STARTED|Overall Study||3
416737|NCT01585428|1021861|P2|NOT COMPLETED|Overall Study||0
416738|NCT01585428|1021862|P1|NOT COMPLETED|Overall Study||1
416739|NCT01585428|1021861|P2|COMPLETED|Overall Study||11
416740|NCT01585428|1021862|P1|COMPLETED|Overall Study||17
416741|NCT01585428|1021861|P2|STARTED|Overall Study||11
416742|NCT01585428|1021862|P1|STARTED|Overall Study||18
416743|NCT01585324|1021870|P1|NOT COMPLETED|Overall Study||0
416744|NCT01585324|1021870|P1|COMPLETED|Overall Study||30
416745|NCT01585324|1021870|P1|STARTED|Overall Study||30
416746|NCT01585272|1021886|P1|NOT COMPLETED|Overall Study||39
416747|NCT01585272|1021886|P1|COMPLETED|Overall Study||82
416748|NCT01585272|1021886|P1|Exelon Patch 10 cm2|Overall Study||96
416749|NCT01585272|1021886|P1|Exelon Patch 5 cm2|Overall Study||114
416750|NCT01585272|1021886|P1|Safety Set|Overall Study|Subjects received 3 mg bid Exelon caps for more than 4 weeks & used at least 1 dose of Exelon patch.|102
416751|NCT01585272|1021886|P1|STARTED|Overall Study||121
416752|NCT01585246|1021899|P5|NOT COMPLETED|Overall Study||2
416753|NCT01585246|1021900|P4|NOT COMPLETED|Overall Study||4
416754|NCT01585246|1021901|P3|NOT COMPLETED|Overall Study||4
416755|NCT01585246|1021902|P2|NOT COMPLETED|Overall Study||1
416756|NCT01585246|1021903|P1|NOT COMPLETED|Overall Study||0
416757|NCT01585246|1021899|P5|COMPLETED|Overall Study||9
416758|NCT01585246|1021900|P4|COMPLETED|Overall Study||6
416759|NCT01585246|1021901|P3|COMPLETED|Overall Study||16
416760|NCT01585246|1021902|P2|COMPLETED|Overall Study||3
416761|NCT01585246|1021903|P1|COMPLETED|Overall Study||3
416762|NCT01585246|1021899|P5|STARTED|Overall Study||11
416763|NCT01585246|1021900|P4|STARTED|Overall Study||10
416764|NCT01585246|1021901|P3|STARTED|Overall Study||20
416765|NCT01585246|1021902|P2|STARTED|Overall Study||4
416766|NCT01585246|1021903|P1|STARTED|Overall Study||3
416767|NCT01585207|1021918|P1|NOT COMPLETED|Overall Study||0
416768|NCT01585207|1021918|P1|COMPLETED|Overall Study||4
416769|NCT01585207|1021918|P1|STARTED|Overall Study||4
416770|NCT01585168|1021924|P4|NOT COMPLETED|Overall Study||1
416771|NCT01585168|1021925|P3|NOT COMPLETED|Overall Study||1
416772|NCT01585168|1021926|P2|NOT COMPLETED|Overall Study||1
416773|NCT01585168|1021927|P1|NOT COMPLETED|Overall Study||3
416774|NCT01585168|1021924|P4|COMPLETED|Overall Study||18
416775|NCT01585168|1021925|P3|COMPLETED|Overall Study||15
416776|NCT01585168|1021926|P2|COMPLETED|Overall Study||17
416777|NCT01585168|1021927|P1|COMPLETED|Overall Study||15
416778|NCT01585168|1021924|P4|STARTED|Overall Study||19
416779|NCT01585168|1021925|P3|STARTED|Overall Study||16
416780|NCT01585168|1021926|P2|STARTED|Overall Study||18
416781|NCT01585168|1021927|P1|STARTED|Overall Study||18
416782|NCT01585129|1021949|P2|NOT COMPLETED|Overall Study||0
416783|NCT01585129|1021950|P1|NOT COMPLETED|Overall Study||0
416784|NCT01585129|1021949|P2|COMPLETED|Overall Study||39
416785|NCT01585129|1021950|P1|COMPLETED|Overall Study||41
416786|NCT01585129|1021949|P2|STARTED|Overall Study||39
416787|NCT01585129|1021950|P1|STARTED|Overall Study||41
416788|NCT01585038|1021962|P2|NOT COMPLETED|Overall Study||2
416789|NCT01585038|1021963|P1|NOT COMPLETED|Overall Study||2
416790|NCT01585038|1021962|P2|COMPLETED|Overall Study||18
416791|NCT01585038|1021963|P1|COMPLETED|Overall Study||18
416792|NCT01585038|1021962|P2|STARTED|Overall Study||20
416793|NCT01585038|1021963|P1|STARTED|Overall Study||20
416794|NCT01584843|1021979|P6|NOT COMPLETED|Second Treatment Period||1
416795|NCT01584843|1021980|P5|NOT COMPLETED|Second Treatment Period||0
416796|NCT01584843|1021981|P4|NOT COMPLETED|Second Treatment Period||0
416797|NCT01584843|1021982|P3|NOT COMPLETED|Second Treatment Period||0
416798|NCT01584843|1021983|P2|NOT COMPLETED|Second Treatment Period||0
416799|NCT01584843|1021984|P1|NOT COMPLETED|Second Treatment Period||0
416800|NCT01584843|1021979|P6|COMPLETED|Second Treatment Period||0
416801|NCT01584843|1021980|P5|COMPLETED|Second Treatment Period||3
416802|NCT01584843|1021981|P4|COMPLETED|Second Treatment Period||6
416803|NCT01584843|1021982|P3|COMPLETED|Second Treatment Period||2
416804|NCT01584843|1021983|P2|COMPLETED|Second Treatment Period||1
416805|NCT01584843|1021984|P1|COMPLETED|Second Treatment Period||2
416806|NCT01584843|1021979|P6|STARTED|Second Treatment Period||1
416807|NCT01584843|1021980|P5|STARTED|Second Treatment Period||3
416808|NCT01584843|1021981|P4|STARTED|Second Treatment Period||6
416809|NCT01584843|1021982|P3|STARTED|Second Treatment Period||2
416810|NCT01584843|1021983|P2|STARTED|Second Treatment Period||1
416811|NCT01584843|1021984|P1|STARTED|Second Treatment Period||2
416812|NCT01584843|1021979|P6|NOT COMPLETED|First Treatment Period||2
416813|NCT01584843|1021980|P5|NOT COMPLETED|First Treatment Period||0
416814|NCT01584843|1021981|P4|NOT COMPLETED|First Treatment Period||0
416815|NCT01584843|1021982|P3|NOT COMPLETED|First Treatment Period||1
416816|NCT01584843|1021983|P2|NOT COMPLETED|First Treatment Period||0
416817|NCT01584843|1021984|P1|NOT COMPLETED|First Treatment Period||0
416818|NCT01584843|1021979|P6|COMPLETED|First Treatment Period||9
416819|NCT01584843|1021980|P5|COMPLETED|First Treatment Period||10
416820|NCT01584843|1021981|P4|COMPLETED|First Treatment Period||10
416821|NCT01584843|1021982|P3|COMPLETED|First Treatment Period||2
416822|NCT01584843|1021983|P2|COMPLETED|First Treatment Period||4
416823|NCT01584843|1021984|P1|COMPLETED|First Treatment Period||3
416824|NCT01584843|1021979|P6|STARTED|First Treatment Period||11
416825|NCT01584843|1021980|P5|STARTED|First Treatment Period||10
416826|NCT01584843|1021981|P4|STARTED|First Treatment Period||10
416827|NCT01584843|1021982|P3|STARTED|First Treatment Period||3
416828|NCT01584843|1021983|P2|STARTED|First Treatment Period||4
416829|NCT01584843|1021984|P1|STARTED|First Treatment Period||3
416830|NCT01584648|1022095|P2|NOT COMPLETED|Overall Study||212
416831|NCT01584648|1022096|P1|NOT COMPLETED|Overall Study||211
416832|NCT01584648|1022095|P2|COMPLETED|Overall Study||0
416833|NCT01584648|1022096|P1|COMPLETED|Overall Study||0
416834|NCT01584648|1022095|P2|Ongoing|Overall Study||147
416835|NCT01584648|1022096|P1|Ongoing|Overall Study||154
416836|NCT01584648|1022095|P2|STARTED|Overall Study||212
416837|NCT01584648|1022096|P1|STARTED|Overall Study||211
416838|NCT01584544|1022139|P5|NOT COMPLETED|Overall Study||0
416839|NCT01584544|1022140|P4|NOT COMPLETED|Overall Study||0
416840|NCT01584544|1022141|P3|NOT COMPLETED|Overall Study||0
416841|NCT01584544|1022142|P2|NOT COMPLETED|Overall Study||0
416842|NCT01584544|1022143|P1|NOT COMPLETED|Overall Study||0
416843|NCT01584544|1022139|P5|COMPLETED|Overall Study||6
416844|NCT01584544|1022140|P4|COMPLETED|Overall Study||3
416845|NCT01584544|1022141|P3|COMPLETED|Overall Study||6
416846|NCT01584544|1022142|P2|COMPLETED|Overall Study||6
416847|NCT01584544|1022143|P1|COMPLETED|Overall Study||3
416848|NCT01584544|1022139|P5|STARTED|Overall Study||6
416849|NCT01584544|1022140|P4|STARTED|Overall Study||3
416850|NCT01584544|1022141|P3|STARTED|Overall Study||6
416851|NCT01584544|1022142|P2|STARTED|Overall Study||6
416852|NCT01584544|1022143|P1|STARTED|Overall Study||3
416853|NCT01584518|1022157|P2|NOT COMPLETED|Overall Study||0
416854|NCT01584518|1022158|P1|NOT COMPLETED|Overall Study||0
416855|NCT01584518|1022157|P2|COMPLETED|Overall Study||25
416856|NCT01584518|1022158|P1|COMPLETED|Overall Study||25
416857|NCT01584518|1022157|P2|STARTED|Overall Study||25
416858|NCT01584518|1022158|P1|STARTED|Overall Study||25
416859|NCT01584479|1022168|P4|NOT COMPLETED|Overall Study||0
416860|NCT01584479|1022169|P3|NOT COMPLETED|Overall Study||0
416861|NCT01584479|1022170|P2|NOT COMPLETED|Overall Study||0
416862|NCT01584479|1022171|P1|NOT COMPLETED|Overall Study||0
416863|NCT01584479|1022168|P4|COMPLETED|Overall Study||1847
416864|NCT01584479|1022169|P3|COMPLETED|Overall Study||852
416865|NCT01584479|1022170|P2|COMPLETED|Overall Study||1686
416866|NCT01584479|1022171|P1|COMPLETED|Overall Study||732
416867|NCT01584479|1022168|P4|STARTED|Overall Study||1847
416868|NCT01584479|1022169|P3|STARTED|Overall Study||852
416869|NCT01584479|1022170|P2|STARTED|Overall Study||1686
416870|NCT01584479|1022171|P1|STARTED|Overall Study||732
416871|NCT01584388|1022181|P1|NOT COMPLETED|Overall Study||0
416872|NCT01584388|1022181|P1|COMPLETED|Overall Study||30
416873|NCT01584388|1022181|P1|STARTED|Overall Study||30
416874|NCT01584232|1022201|P2|NOT COMPLETED|Overall Study||3
416875|NCT01584232|1022202|P1|NOT COMPLETED|Overall Study||8
416876|NCT01584232|1022201|P2|COMPLETED|Overall Study||177
416877|NCT01584232|1022202|P1|COMPLETED|Overall Study||173
416878|NCT01584232|1022201|P2|Received at Least 1 Dose of Study Drug|Overall Study||180
416879|NCT01584232|1022202|P1|Received at Least 1 Dose of Study Drug|Overall Study||181
416880|NCT01584232|1022201|P2|STARTED|Overall Study||180
416881|NCT01584232|1022202|P1|STARTED|Overall Study||181
416882|NCT01583894|1022218|P1|NOT COMPLETED|Overall Study||15
416883|NCT01583894|1022218|P1|COMPLETED|Overall Study||813
416884|NCT01583894|1022218|P1|STARTED|Overall Study||828
416885|NCT01583647|1022222|P2|NOT COMPLETED|Overall Study||0
416886|NCT01583647|1022223|P1|NOT COMPLETED|Overall Study||0
416887|NCT01583647|1022222|P2|COMPLETED|Overall Study||0
416888|NCT01583647|1022223|P1|COMPLETED|Overall Study||10
416889|NCT01583647|1022222|P2|STARTED|Overall Study|Study terminated prior to Panel B being conducted.|0
416890|NCT01583647|1022223|P1|STARTED|Overall Study||10
416891|NCT01583543|1022235|P1|NOT COMPLETED|Overall Study||0
416892|NCT01583543|1022235|P1|COMPLETED|Overall Study||12
416893|NCT01583543|1022235|P1|STARTED|Overall Study||12
416894|NCT01583530|1022248|P6|NOT COMPLETED|Overall Study||3
416895|NCT01583530|1022249|P5|NOT COMPLETED|Overall Study||5
416896|NCT01583530|1022250|P4|NOT COMPLETED|Overall Study||1
416897|NCT01583530|1022251|P3|NOT COMPLETED|Overall Study||0
416898|NCT01583530|1022252|P2|NOT COMPLETED|Overall Study||3
416899|NCT01583530|1022253|P1|NOT COMPLETED|Overall Study||0
416900|NCT01583530|1022248|P6|COMPLETED|Overall Study||17
416901|NCT01583530|1022249|P5|COMPLETED|Overall Study||15
416902|NCT01583530|1022250|P4|COMPLETED|Overall Study||18
416903|NCT01583530|1022251|P3|COMPLETED|Overall Study||20
416904|NCT01583530|1022252|P2|COMPLETED|Overall Study||17
416905|NCT01583530|1022253|P1|COMPLETED|Overall Study||19
416906|NCT01583530|1022248|P6|STARTED|Overall Study||20
416907|NCT01583530|1022249|P5|STARTED|Overall Study||20
416908|NCT01583530|1022250|P4|STARTED|Overall Study||19
416909|NCT01583530|1022251|P3|STARTED|Overall Study||20
416910|NCT01583530|1022252|P2|STARTED|Overall Study||20
416911|NCT01583530|1022253|P1|STARTED|Overall Study||19
416912|NCT01583452|1022299|P2|NOT COMPLETED|Overall Study||0
416913|NCT01583452|1022300|P1|NOT COMPLETED|Overall Study||0
416914|NCT01583452|1022299|P2|COMPLETED|Overall Study||20
416915|NCT01583452|1022300|P1|COMPLETED|Overall Study||21
416916|NCT01583452|1022299|P2|STARTED|Overall Study||20
416917|NCT01583452|1022300|P1|STARTED|Overall Study||21
416918|NCT01583374|1022315|P3|NOT COMPLETED|Overall Study||25
416919|NCT01583374|1022316|P2|NOT COMPLETED|Overall Study||16
416920|NCT01583374|1022317|P1|NOT COMPLETED|Overall Study||19
416921|NCT01583374|1022315|P3|COMPLETED|Overall Study|Completed = those who completed the Placebo-controlled Treatment Phase – Weeks 0 to 24|138
416922|NCT01583374|1022316|P2|COMPLETED|Overall Study|Completed = those who completed the Placebo-controlled Treatment Phase – Weeks 0 to 24|147
416923|NCT01583374|1022317|P1|COMPLETED|Overall Study|Completed = those who completed the Placebo-controlled Treatment Phase – Weeks 0 to 24|145
416924|NCT01583374|1022315|P3|Early Escape at Week 16|Overall Study|One participant who escaped early did not complete Week 24|49
416925|NCT01583374|1022316|P2|Early Escape at Week 16|Overall Study||49
416926|NCT01583374|1022317|P1|Early Escape at Week 16|Overall Study|One participant who escaped early did not complete Week 24|51
416927|NCT01583374|1022315|P3|Completed Week 16|Overall Study||144
416928|NCT01583374|1022316|P2|Completed Week 16|Overall Study||151
416929|NCT01583374|1022317|P1|Completed Week 16|Overall Study||150
416930|NCT01583374|1022315|P3|Received Treatment|Overall Study||163
416931|NCT01583374|1022316|P2|Received Treatment|Overall Study||163
416932|NCT01583374|1022317|P1|Received Treatment|Overall Study||164
416933|NCT01583374|1022315|P3|STARTED|Overall Study||163
416934|NCT01583374|1022316|P2|STARTED|Overall Study||163
416935|NCT01583374|1022317|P1|STARTED|Overall Study||164
416936|NCT01583218|1022329|P2|NOT COMPLETED|Overall Study||283
416937|NCT01583218|1022330|P1|NOT COMPLETED|Overall Study||289
416938|NCT01583218|1022329|P2|COMPLETED|Overall Study||3471
416939|NCT01583218|1022330|P1|COMPLETED|Overall Study||3470
416940|NCT01583218|1022329|P2|STARTED|Overall Study||3754
416941|NCT01583218|1022330|P1|STARTED|Overall Study||3759
416942|NCT01583101|1022350|P2|NOT COMPLETED|Overall Study||0
416943|NCT01583101|1022351|P1|NOT COMPLETED|Overall Study||0
416944|NCT01583101|1022350|P2|COMPLETED|Overall Study||1161
416945|NCT01583101|1022351|P1|COMPLETED|Overall Study||1076
416946|NCT01583101|1022350|P2|STARTED|Overall Study||1161
416947|NCT01583101|1022351|P1|STARTED|Overall Study||1076
416948|NCT01582971|1022359|P2|NOT COMPLETED|Overall Study||37
416949|NCT01582971|1022360|P1|NOT COMPLETED|Overall Study||39
416950|NCT01582971|1022359|P2|COMPLETED|Overall Study||91
416951|NCT01582971|1022360|P1|COMPLETED|Overall Study||89
416952|NCT01582971|1022359|P2|STARTED|Overall Study||128
416953|NCT01582971|1022360|P1|STARTED|Overall Study||128
416954|NCT01582945|1022378|P1|NOT COMPLETED|Overall Study||2
416955|NCT01582945|1022378|P1|COMPLETED|Overall Study||12
416956|NCT01582945|1022378|P1|STARTED|Overall Study||14
416957|NCT01582880|1022382|P1|NOT COMPLETED|Overall Study||0
416958|NCT01582880|1022382|P1|COMPLETED|Overall Study||1
416959|NCT01582880|1022382|P1|STARTED|Overall Study||1
416960|NCT01582854|1022392|P2|NOT COMPLETED|Overall Study||34
416961|NCT01582854|1022393|P1|NOT COMPLETED|Overall Study||36
416962|NCT01582854|1022392|P2|COMPLETED|Overall Study||221
416963|NCT01582854|1022393|P1|COMPLETED|Overall Study||212
416964|NCT01582854|1022392|P2|STARTED|Overall Study||255
416965|NCT01582854|1022393|P1|STARTED|Overall Study||248
416966|NCT01582789|1022421|P2|NOT COMPLETED|Second Intervention (14 Days)||0
416967|NCT01582789|1022422|P1|NOT COMPLETED|Second Intervention (14 Days)||1
416968|NCT01582789|1022421|P2|COMPLETED|Second Intervention (14 Days)||27
416969|NCT01582789|1022422|P1|COMPLETED|Second Intervention (14 Days)||33
416970|NCT01582789|1022421|P2|STARTED|Second Intervention (14 Days)||27
416971|NCT01582789|1022422|P1|STARTED|Second Intervention (14 Days)||34
416972|NCT01582789|1022421|P2|NOT COMPLETED|First Intervention (14 Days)||0
416973|NCT01582789|1022422|P1|NOT COMPLETED|First Intervention (14 Days)||0
416974|NCT01582789|1022421|P2|COMPLETED|First Intervention (14 Days)||27
416975|NCT01582789|1022422|P1|COMPLETED|First Intervention (14 Days)||34
416976|NCT01582789|1022421|P2|STARTED|First Intervention (14 Days)||27
416977|NCT01582789|1022422|P1|STARTED|First Intervention (14 Days)||34
416978|NCT01582490|1022440|P2|NOT COMPLETED|Overall Study||1
416979|NCT01582490|1022441|P1|NOT COMPLETED|Overall Study||1
416980|NCT01582490|1022440|P2|COMPLETED|Overall Study||9
416981|NCT01582490|1022441|P1|COMPLETED|Overall Study||8
416982|NCT01582490|1022440|P2|STARTED|Overall Study||10
416983|NCT01582490|1022441|P1|STARTED|Overall Study||9
416984|NCT01582477|1022463|P2|NOT COMPLETED|Overall Study||0
416985|NCT01582477|1022464|P1|NOT COMPLETED|Overall Study||0
416986|NCT01582477|1022463|P2|COMPLETED|Overall Study||12
416987|NCT01582477|1022464|P1|COMPLETED|Overall Study||12
416988|NCT01582477|1022463|P2|STARTED|Overall Study||12
416989|NCT01582477|1022464|P1|STARTED|Overall Study||12
416990|NCT01582451|1022482|P2|NOT COMPLETED|Overall Study||20
416991|NCT01582451|1022483|P1|NOT COMPLETED|Overall Study||32
416992|NCT01582451|1022482|P2|COMPLETED|Overall Study||139
416993|NCT01582451|1022483|P1|COMPLETED|Overall Study||275
416994|NCT01582451|1022482|P2|Received at Least 1 Dose of Study Drug|Overall Study||159
416995|NCT01582451|1022483|P1|Received at Least 1 Dose of Study Drug|Overall Study||305
416996|NCT01582451|1022482|P2|STARTED|Overall Study||159
416997|NCT01582451|1022483|P1|STARTED|Overall Study||307
416998|NCT01582308|1022525|P10|NOT COMPLETED|Period 5||0
416999|NCT01582308|1022526|P9|NOT COMPLETED|Period 5||0
417000|NCT01582308|1022527|P8|NOT COMPLETED|Period 5||0
417001|NCT01582308|1022528|P7|NOT COMPLETED|Period 5||0
417002|NCT01582308|1022529|P6|NOT COMPLETED|Period 5||0
417003|NCT01582308|1022530|P5|NOT COMPLETED|Period 5||0
417004|NCT01582308|1022531|P4|NOT COMPLETED|Period 5||0
417005|NCT01582308|1022532|P3|NOT COMPLETED|Period 5||0
417006|NCT01582308|1022533|P2|NOT COMPLETED|Period 5||0
417007|NCT01582308|1022534|P1|NOT COMPLETED|Period 5||0
417008|NCT01582308|1022525|P10|COMPLETED|Period 5||1
417009|NCT01582308|1022526|P9|COMPLETED|Period 5||2
417010|NCT01582308|1022527|P8|COMPLETED|Period 5||2
417011|NCT01582308|1022528|P7|COMPLETED|Period 5||2
417012|NCT01582308|1022529|P6|COMPLETED|Period 5||1
417013|NCT01582308|1022530|P5|COMPLETED|Period 5||2
417014|NCT01582308|1022531|P4|COMPLETED|Period 5||2
417015|NCT01582308|1022532|P3|COMPLETED|Period 5||2
417016|NCT01582308|1022533|P2|COMPLETED|Period 5||2
417017|NCT01582308|1022534|P1|COMPLETED|Period 5||1
417018|NCT01582308|1022525|P10|STARTED|Period 5||1
417019|NCT01582308|1022526|P9|STARTED|Period 5||2
417020|NCT01582308|1022527|P8|STARTED|Period 5||2
417021|NCT01582308|1022528|P7|STARTED|Period 5||2
417022|NCT01582308|1022529|P6|STARTED|Period 5||1
417023|NCT01582308|1022530|P5|STARTED|Period 5||2
417024|NCT01582308|1022531|P4|STARTED|Period 5||2
417025|NCT01582308|1022532|P3|STARTED|Period 5||2
417026|NCT01582308|1022533|P2|STARTED|Period 5||2
417027|NCT01582308|1022534|P1|STARTED|Period 5||1
417028|NCT01582308|1022525|P10|NOT COMPLETED|10-day Washout Following Period 4||0
417029|NCT01582308|1022526|P9|NOT COMPLETED|10-day Washout Following Period 4||0
417030|NCT01582308|1022527|P8|NOT COMPLETED|10-day Washout Following Period 4||0
417031|NCT01582308|1022528|P7|NOT COMPLETED|10-day Washout Following Period 4||0
417032|NCT01582308|1022529|P6|NOT COMPLETED|10-day Washout Following Period 4||0
417033|NCT01582308|1022530|P5|NOT COMPLETED|10-day Washout Following Period 4||0
417034|NCT01582308|1022531|P4|NOT COMPLETED|10-day Washout Following Period 4||0
417035|NCT01582308|1022532|P3|NOT COMPLETED|10-day Washout Following Period 4||0
417036|NCT01582308|1022533|P2|NOT COMPLETED|10-day Washout Following Period 4||0
417037|NCT01582308|1022534|P1|NOT COMPLETED|10-day Washout Following Period 4||0
417038|NCT01582308|1022525|P10|COMPLETED|10-day Washout Following Period 4||1
417039|NCT01582308|1022526|P9|COMPLETED|10-day Washout Following Period 4||2
417040|NCT01582308|1022527|P8|COMPLETED|10-day Washout Following Period 4||2
417041|NCT01582308|1022528|P7|COMPLETED|10-day Washout Following Period 4||2
417042|NCT01582308|1022529|P6|COMPLETED|10-day Washout Following Period 4||1
417043|NCT01582308|1022530|P5|COMPLETED|10-day Washout Following Period 4||2
417044|NCT01582308|1022531|P4|COMPLETED|10-day Washout Following Period 4||2
417045|NCT01582308|1022532|P3|COMPLETED|10-day Washout Following Period 4||2
417046|NCT01582308|1022533|P2|COMPLETED|10-day Washout Following Period 4||2
417047|NCT01582308|1022534|P1|COMPLETED|10-day Washout Following Period 4||1
417048|NCT01582308|1022525|P10|STARTED|10-day Washout Following Period 4||1
417049|NCT01582308|1022526|P9|STARTED|10-day Washout Following Period 4||2
417050|NCT01582308|1022527|P8|STARTED|10-day Washout Following Period 4||2
417051|NCT01582308|1022528|P7|STARTED|10-day Washout Following Period 4||2
417052|NCT01582308|1022529|P6|STARTED|10-day Washout Following Period 4||1
417053|NCT01582308|1022530|P5|STARTED|10-day Washout Following Period 4||2
417054|NCT01582308|1022531|P4|STARTED|10-day Washout Following Period 4||2
417055|NCT01582308|1022532|P3|STARTED|10-day Washout Following Period 4||2
417056|NCT01582308|1022533|P2|STARTED|10-day Washout Following Period 4||2
417057|NCT01582308|1022534|P1|STARTED|10-day Washout Following Period 4||1
417058|NCT01582308|1022525|P10|NOT COMPLETED|Period 4||1
417059|NCT01582308|1022526|P9|NOT COMPLETED|Period 4||0
417060|NCT01582308|1022527|P8|NOT COMPLETED|Period 4||0
417061|NCT01582308|1022528|P7|NOT COMPLETED|Period 4||0
417062|NCT01582308|1022529|P6|NOT COMPLETED|Period 4||1
417063|NCT01582308|1022530|P5|NOT COMPLETED|Period 4||0
417064|NCT01582308|1022531|P4|NOT COMPLETED|Period 4||0
417065|NCT01582308|1022532|P3|NOT COMPLETED|Period 4||0
417066|NCT01582308|1022533|P2|NOT COMPLETED|Period 4||0
417067|NCT01582308|1022534|P1|NOT COMPLETED|Period 4||1
417068|NCT01582308|1022525|P10|COMPLETED|Period 4||1
417069|NCT01582308|1022526|P9|COMPLETED|Period 4||2
417070|NCT01582308|1022527|P8|COMPLETED|Period 4||2
417071|NCT01582308|1022528|P7|COMPLETED|Period 4||2
417072|NCT01582308|1022529|P6|COMPLETED|Period 4||1
417073|NCT01582308|1022530|P5|COMPLETED|Period 4||2
417074|NCT01582308|1022531|P4|COMPLETED|Period 4||2
417075|NCT01582308|1022532|P3|COMPLETED|Period 4||2
417076|NCT01582308|1022533|P2|COMPLETED|Period 4||2
417077|NCT01582308|1022534|P1|COMPLETED|Period 4||1
417078|NCT01582308|1022525|P10|STARTED|Period 4||2
417079|NCT01582308|1022526|P9|STARTED|Period 4||2
417080|NCT01582308|1022527|P8|STARTED|Period 4||2
417081|NCT01582308|1022528|P7|STARTED|Period 4||2
417082|NCT01582308|1022529|P6|STARTED|Period 4||2
417083|NCT01582308|1022530|P5|STARTED|Period 4||2
417084|NCT01582308|1022531|P4|STARTED|Period 4||2
417085|NCT01582308|1022532|P3|STARTED|Period 4||2
417086|NCT01582308|1022533|P2|STARTED|Period 4||2
417087|NCT01582308|1022534|P1|STARTED|Period 4||2
417088|NCT01582308|1022525|P10|NOT COMPLETED|10-day Washout Following Period 3||0
417089|NCT01582308|1022526|P9|NOT COMPLETED|10-day Washout Following Period 3||0
417090|NCT01582308|1022527|P8|NOT COMPLETED|10-day Washout Following Period 3||0
417091|NCT01582308|1022528|P7|NOT COMPLETED|10-day Washout Following Period 3||0
417092|NCT01582308|1022529|P6|NOT COMPLETED|10-day Washout Following Period 3||0
417093|NCT01582308|1022530|P5|NOT COMPLETED|10-day Washout Following Period 3||0
417094|NCT01582308|1022531|P4|NOT COMPLETED|10-day Washout Following Period 3||0
417095|NCT01582308|1022532|P3|NOT COMPLETED|10-day Washout Following Period 3||0
417096|NCT01582308|1022533|P2|NOT COMPLETED|10-day Washout Following Period 3||0
417097|NCT01582308|1022534|P1|NOT COMPLETED|10-day Washout Following Period 3||0
417098|NCT01582308|1022525|P10|COMPLETED|10-day Washout Following Period 3||2
417099|NCT01582308|1022526|P9|COMPLETED|10-day Washout Following Period 3||2
417100|NCT01582308|1022527|P8|COMPLETED|10-day Washout Following Period 3||2
417101|NCT01582308|1022528|P7|COMPLETED|10-day Washout Following Period 3||2
417102|NCT01582308|1022529|P6|COMPLETED|10-day Washout Following Period 3||2
417103|NCT01582308|1022530|P5|COMPLETED|10-day Washout Following Period 3||2
417104|NCT01582308|1022531|P4|COMPLETED|10-day Washout Following Period 3||2
417105|NCT01582308|1022532|P3|COMPLETED|10-day Washout Following Period 3||2
417106|NCT01582308|1022533|P2|COMPLETED|10-day Washout Following Period 3||2
417107|NCT01582308|1022534|P1|COMPLETED|10-day Washout Following Period 3||2
417108|NCT01582308|1022525|P10|STARTED|10-day Washout Following Period 3||2
417109|NCT01582308|1022526|P9|STARTED|10-day Washout Following Period 3||2
417110|NCT01582308|1022527|P8|STARTED|10-day Washout Following Period 3||2
417111|NCT01582308|1022528|P7|STARTED|10-day Washout Following Period 3||2
417112|NCT01582308|1022529|P6|STARTED|10-day Washout Following Period 3||2
417113|NCT01582308|1022530|P5|STARTED|10-day Washout Following Period 3||2
417114|NCT01582308|1022531|P4|STARTED|10-day Washout Following Period 3||2
417115|NCT01582308|1022532|P3|STARTED|10-day Washout Following Period 3||2
417116|NCT01582308|1022533|P2|STARTED|10-day Washout Following Period 3||2
417117|NCT01582308|1022534|P1|STARTED|10-day Washout Following Period 3||2
417118|NCT01582308|1022525|P10|NOT COMPLETED|Period 3||0
417119|NCT01582308|1022526|P9|NOT COMPLETED|Period 3||0
417120|NCT01582308|1022527|P8|NOT COMPLETED|Period 3||0
417121|NCT01582308|1022528|P7|NOT COMPLETED|Period 3||0
417122|NCT01582308|1022529|P6|NOT COMPLETED|Period 3||0
417123|NCT01582308|1022530|P5|NOT COMPLETED|Period 3||0
417124|NCT01582308|1022531|P4|NOT COMPLETED|Period 3||0
417125|NCT01582308|1022532|P3|NOT COMPLETED|Period 3||0
417126|NCT01582308|1022533|P2|NOT COMPLETED|Period 3||0
417127|NCT01582308|1022534|P1|NOT COMPLETED|Period 3||0
417128|NCT01582308|1022525|P10|COMPLETED|Period 3||2
417129|NCT01582308|1022526|P9|COMPLETED|Period 3||2
417130|NCT01582308|1022527|P8|COMPLETED|Period 3||2
417131|NCT01582308|1022528|P7|COMPLETED|Period 3||2
417132|NCT01582308|1022529|P6|COMPLETED|Period 3||2
417133|NCT01582308|1022530|P5|COMPLETED|Period 3||2
417134|NCT01582308|1022531|P4|COMPLETED|Period 3||2
417135|NCT01582308|1022532|P3|COMPLETED|Period 3||2
417136|NCT01582308|1022533|P2|COMPLETED|Period 3||2
417137|NCT01582308|1022534|P1|COMPLETED|Period 3||2
417138|NCT01582308|1022525|P10|STARTED|Period 3||2
417139|NCT01582308|1022526|P9|STARTED|Period 3||2
417140|NCT01582308|1022527|P8|STARTED|Period 3||2
417141|NCT01582308|1022528|P7|STARTED|Period 3||2
417142|NCT01582308|1022529|P6|STARTED|Period 3||2
417143|NCT01582308|1022530|P5|STARTED|Period 3||2
417144|NCT01582308|1022531|P4|STARTED|Period 3||2
417145|NCT01582308|1022532|P3|STARTED|Period 3||2
417146|NCT01582308|1022533|P2|STARTED|Period 3||2
417147|NCT01582308|1022534|P1|STARTED|Period 3||2
417148|NCT01582308|1022525|P10|NOT COMPLETED|10-day Washout Following Period 2||0
417149|NCT01582308|1022526|P9|NOT COMPLETED|10-day Washout Following Period 2||0
417150|NCT01582308|1022527|P8|NOT COMPLETED|10-day Washout Following Period 2||0
417151|NCT01582308|1022528|P7|NOT COMPLETED|10-day Washout Following Period 2||0
417152|NCT01582308|1022529|P6|NOT COMPLETED|10-day Washout Following Period 2||0
417153|NCT01582308|1022530|P5|NOT COMPLETED|10-day Washout Following Period 2||0
417154|NCT01582308|1022531|P4|NOT COMPLETED|10-day Washout Following Period 2||0
417155|NCT01582308|1022532|P3|NOT COMPLETED|10-day Washout Following Period 2||0
417156|NCT01582308|1022533|P2|NOT COMPLETED|10-day Washout Following Period 2||0
417157|NCT01582308|1022534|P1|NOT COMPLETED|10-day Washout Following Period 2||0
417158|NCT01582308|1022525|P10|COMPLETED|10-day Washout Following Period 2||2
417159|NCT01582308|1022526|P9|COMPLETED|10-day Washout Following Period 2||2
417160|NCT01582308|1022527|P8|COMPLETED|10-day Washout Following Period 2||2
417161|NCT01582308|1022528|P7|COMPLETED|10-day Washout Following Period 2||2
417162|NCT01582308|1022529|P6|COMPLETED|10-day Washout Following Period 2||2
417163|NCT01582308|1022530|P5|COMPLETED|10-day Washout Following Period 2||2
417164|NCT01582308|1022531|P4|COMPLETED|10-day Washout Following Period 2||2
417165|NCT01582308|1022532|P3|COMPLETED|10-day Washout Following Period 2||2
417166|NCT01582308|1022533|P2|COMPLETED|10-day Washout Following Period 2||2
417167|NCT01582308|1022534|P1|COMPLETED|10-day Washout Following Period 2||2
417168|NCT01582308|1022525|P10|STARTED|10-day Washout Following Period 2||2
417169|NCT01582308|1022526|P9|STARTED|10-day Washout Following Period 2||2
417170|NCT01582308|1022527|P8|STARTED|10-day Washout Following Period 2||2
417171|NCT01582308|1022528|P7|STARTED|10-day Washout Following Period 2||2
417172|NCT01582308|1022529|P6|STARTED|10-day Washout Following Period 2||2
417173|NCT01582308|1022530|P5|STARTED|10-day Washout Following Period 2||2
417174|NCT01582308|1022531|P4|STARTED|10-day Washout Following Period 2||2
417175|NCT01582308|1022532|P3|STARTED|10-day Washout Following Period 2||2
417176|NCT01582308|1022533|P2|STARTED|10-day Washout Following Period 2||2
417177|NCT01582308|1022534|P1|STARTED|10-day Washout Following Period 2||2
417178|NCT01582308|1022525|P10|NOT COMPLETED|Period 2||0
417179|NCT01582308|1022526|P9|NOT COMPLETED|Period 2||0
417180|NCT01582308|1022527|P8|NOT COMPLETED|Period 2||0
417181|NCT01582308|1022528|P7|NOT COMPLETED|Period 2||0
417182|NCT01582308|1022529|P6|NOT COMPLETED|Period 2||0
417183|NCT01582308|1022530|P5|NOT COMPLETED|Period 2||0
417184|NCT01582308|1022531|P4|NOT COMPLETED|Period 2||0
417185|NCT01582308|1022532|P3|NOT COMPLETED|Period 2||0
417186|NCT01582308|1022533|P2|NOT COMPLETED|Period 2||0
417187|NCT01582308|1022534|P1|NOT COMPLETED|Period 2||0
417188|NCT01582308|1022525|P10|COMPLETED|Period 2||2
417189|NCT01582308|1022526|P9|COMPLETED|Period 2||2
417190|NCT01582308|1022527|P8|COMPLETED|Period 2||2
417191|NCT01582308|1022528|P7|COMPLETED|Period 2||2
417192|NCT01582308|1022529|P6|COMPLETED|Period 2||2
417193|NCT01582308|1022530|P5|COMPLETED|Period 2||2
417194|NCT01582308|1022531|P4|COMPLETED|Period 2||2
417195|NCT01582308|1022532|P3|COMPLETED|Period 2||2
417196|NCT01582308|1022533|P2|COMPLETED|Period 2||2
417197|NCT01582308|1022534|P1|COMPLETED|Period 2||2
417198|NCT01582308|1022525|P10|STARTED|Period 2||2
417199|NCT01582308|1022526|P9|STARTED|Period 2||2
417200|NCT01582308|1022527|P8|STARTED|Period 2||2
417201|NCT01582308|1022528|P7|STARTED|Period 2||2
417202|NCT01582308|1022529|P6|STARTED|Period 2||2
417203|NCT01582308|1022530|P5|STARTED|Period 2||2
417204|NCT01582308|1022531|P4|STARTED|Period 2||2
417205|NCT01582308|1022532|P3|STARTED|Period 2||2
417206|NCT01582308|1022533|P2|STARTED|Period 2||2
417207|NCT01582308|1022534|P1|STARTED|Period 2||2
417208|NCT01582308|1022525|P10|NOT COMPLETED|10-day Washout Following Period 1||0
417209|NCT01582308|1022526|P9|NOT COMPLETED|10-day Washout Following Period 1||0
417210|NCT01582308|1022527|P8|NOT COMPLETED|10-day Washout Following Period 1||0
417211|NCT01582308|1022528|P7|NOT COMPLETED|10-day Washout Following Period 1||0
417212|NCT01582308|1022529|P6|NOT COMPLETED|10-day Washout Following Period 1||0
417213|NCT01582308|1022530|P5|NOT COMPLETED|10-day Washout Following Period 1||1
417214|NCT01582308|1022531|P4|NOT COMPLETED|10-day Washout Following Period 1||0
417215|NCT01582308|1022532|P3|NOT COMPLETED|10-day Washout Following Period 1||0
417216|NCT01582308|1022533|P2|NOT COMPLETED|10-day Washout Following Period 1||0
417217|NCT01582308|1022534|P1|NOT COMPLETED|10-day Washout Following Period 1||0
417218|NCT01582308|1022525|P10|COMPLETED|10-day Washout Following Period 1||2
417219|NCT01582308|1022526|P9|COMPLETED|10-day Washout Following Period 1||2
417220|NCT01582308|1022527|P8|COMPLETED|10-day Washout Following Period 1||2
417221|NCT01582308|1022528|P7|COMPLETED|10-day Washout Following Period 1||2
417222|NCT01582308|1022529|P6|COMPLETED|10-day Washout Following Period 1||2
417223|NCT01582308|1022530|P5|COMPLETED|10-day Washout Following Period 1||2
417224|NCT01582308|1022531|P4|COMPLETED|10-day Washout Following Period 1||2
417225|NCT01582308|1022532|P3|COMPLETED|10-day Washout Following Period 1||2
417226|NCT01582308|1022533|P2|COMPLETED|10-day Washout Following Period 1||2
417227|NCT01582308|1022534|P1|COMPLETED|10-day Washout Following Period 1||2
417228|NCT01582308|1022525|P10|STARTED|10-day Washout Following Period 1||2
417229|NCT01582308|1022526|P9|STARTED|10-day Washout Following Period 1||2
417230|NCT01582308|1022527|P8|STARTED|10-day Washout Following Period 1||2
417231|NCT01582308|1022528|P7|STARTED|10-day Washout Following Period 1||2
417232|NCT01582308|1022529|P6|STARTED|10-day Washout Following Period 1||2
417233|NCT01582308|1022530|P5|STARTED|10-day Washout Following Period 1||3
417234|NCT01582308|1022531|P4|STARTED|10-day Washout Following Period 1||2
417235|NCT01582308|1022532|P3|STARTED|10-day Washout Following Period 1||2
417236|NCT01582308|1022533|P2|STARTED|10-day Washout Following Period 1||2
417237|NCT01582308|1022534|P1|STARTED|10-day Washout Following Period 1||2
417238|NCT01582308|1022525|P10|NOT COMPLETED|Period 1||0
417239|NCT01582308|1022526|P9|NOT COMPLETED|Period 1||0
417240|NCT01582308|1022527|P8|NOT COMPLETED|Period 1||0
417241|NCT01582308|1022528|P7|NOT COMPLETED|Period 1||1
417242|NCT01582308|1022529|P6|NOT COMPLETED|Period 1||0
417243|NCT01582308|1022530|P5|NOT COMPLETED|Period 1||0
417244|NCT01582308|1022531|P4|NOT COMPLETED|Period 1||0
417245|NCT01582308|1022532|P3|NOT COMPLETED|Period 1||0
417246|NCT01582308|1022533|P2|NOT COMPLETED|Period 1||0
417247|NCT01582308|1022534|P1|NOT COMPLETED|Period 1||0
417248|NCT01582308|1022525|P10|COMPLETED|Period 1||2
417249|NCT01582308|1022526|P9|COMPLETED|Period 1||2
417250|NCT01582308|1022527|P8|COMPLETED|Period 1||2
417251|NCT01582308|1022528|P7|COMPLETED|Period 1||2
417252|NCT01582308|1022529|P6|COMPLETED|Period 1||2
417253|NCT01582308|1022530|P5|COMPLETED|Period 1||3
417254|NCT01582308|1022531|P4|COMPLETED|Period 1||2
417255|NCT01582308|1022532|P3|COMPLETED|Period 1||2
417256|NCT01582308|1022533|P2|COMPLETED|Period 1||2
417257|NCT01582308|1022534|P1|COMPLETED|Period 1||2
417258|NCT01582308|1022525|P10|STARTED|Period 1||2
417259|NCT01582308|1022526|P9|STARTED|Period 1||2
417260|NCT01582308|1022527|P8|STARTED|Period 1||2
417261|NCT01582308|1022528|P7|STARTED|Period 1|Includes replacement for a participant who discontinued during period 1|3
417262|NCT01582308|1022529|P6|STARTED|Period 1||2
417263|NCT01582308|1022530|P5|STARTED|Period 1|Includes replacement for a participant who discontinued after period 1|3
417264|NCT01582308|1022531|P4|STARTED|Period 1||2
417265|NCT01582308|1022532|P3|STARTED|Period 1||2
417266|NCT01582308|1022533|P2|STARTED|Period 1||2
417267|NCT01582308|1022534|P1|STARTED|Period 1||2
417268|NCT01582282|1022562|P3|NOT COMPLETED|Overall Study||0
417269|NCT01582282|1022563|P2|NOT COMPLETED|Overall Study||2
417270|NCT01582282|1022564|P1|NOT COMPLETED|Overall Study||2
417271|NCT01582282|1022562|P3|COMPLETED|Overall Study||8
417272|NCT01582282|1022563|P2|COMPLETED|Overall Study||12
417273|NCT01582282|1022564|P1|COMPLETED|Overall Study||13
417274|NCT01582282|1022562|P3|STARTED|Overall Study||8
417275|NCT01582282|1022563|P2|STARTED|Overall Study||14
417276|NCT01582282|1022564|P1|STARTED|Overall Study||15
417277|NCT01582243|1022587|P1|NOT COMPLETED|Overall Study||3
417278|NCT01582243|1022587|P1|COMPLETED|Overall Study||37
417279|NCT01582243|1022587|P1|STARTED|Overall Study||40
417280|NCT01582178|1022598|P2|NOT COMPLETED|Overall Study||5
417281|NCT01582178|1022599|P1|NOT COMPLETED|Overall Study||6
417282|NCT01582178|1022598|P2|COMPLETED|Overall Study||101
417283|NCT01582178|1022599|P1|COMPLETED|Overall Study||100
417284|NCT01582178|1022598|P2|STARTED|Overall Study||106
417285|NCT01582178|1022599|P1|STARTED|Overall Study||106
417286|NCT01582139|1022607|P2|NOT COMPLETED|Overall Study||0
417287|NCT01582139|1022608|P1|NOT COMPLETED|Overall Study||0
417288|NCT01582139|1022607|P2|COMPLETED|Overall Study||6
417289|NCT01582139|1022608|P1|COMPLETED|Overall Study||6
417290|NCT01582139|1022607|P2|STARTED|Overall Study||6
417291|NCT01582139|1022608|P1|STARTED|Overall Study||6
417292|NCT01582100|1022620|P1|NOT COMPLETED|Overall Study||2
417293|NCT01582100|1022620|P1|COMPLETED|Overall Study||0
417294|NCT01582100|1022620|P1|STARTED|Overall Study||2
417295|NCT01582061|1022626|P2|NOT COMPLETED|Overall Study||36
417296|NCT01582061|1022627|P1|NOT COMPLETED|Overall Study||28
417297|NCT01582061|1022626|P2|COMPLETED|Overall Study||19
417298|NCT01582061|1022627|P1|COMPLETED|Overall Study||21
417299|NCT01582061|1022626|P2|STARTED|Overall Study||55
417300|NCT01582061|1022627|P1|STARTED|Overall Study||49
417301|NCT01582009|1022677|P1|NOT COMPLETED|Overall Study||2
417302|NCT01582009|1022677|P1|COMPLETED|Overall Study||24
417303|NCT01582009|1022677|P1|STARTED|Overall Study||26
417304|NCT01581931|1022685|P2|NOT COMPLETED|Second Period||0
417305|NCT01581931|1022686|P1|NOT COMPLETED|Second Period||0
417306|NCT01581931|1022685|P2|COMPLETED|Second Period||15
417307|NCT01581931|1022686|P1|COMPLETED|Second Period||16
417308|NCT01581931|1022685|P2|STARTED|Second Period||15
417309|NCT01581931|1022686|P1|STARTED|Second Period||16
417310|NCT01581931|1022685|P2|NOT COMPLETED|Washout||1
417311|NCT01581931|1022686|P1|NOT COMPLETED|Washout||0
417312|NCT01581931|1022685|P2|COMPLETED|Washout||15
417313|NCT01581931|1022686|P1|COMPLETED|Washout||16
417314|NCT01581931|1022685|P2|STARTED|Washout||16
417315|NCT01581931|1022686|P1|STARTED|Washout||16
417316|NCT01581931|1022685|P2|NOT COMPLETED|First Period||0
417317|NCT01581931|1022686|P1|NOT COMPLETED|First Period||0
417318|NCT01581931|1022685|P2|COMPLETED|First Period||16
417319|NCT01581931|1022686|P1|COMPLETED|First Period||16
417320|NCT01581931|1022685|P2|STARTED|First Period||16
417321|NCT01581931|1022686|P1|STARTED|First Period||16
417322|NCT01581710|1022700|P2|NOT COMPLETED|Second Intervention (14days)||2
417323|NCT01581710|1022701|P1|NOT COMPLETED|Second Intervention (14days)||0
417324|NCT01581710|1022700|P2|COMPLETED|Second Intervention (14days)||12
417325|NCT01581710|1022701|P1|COMPLETED|Second Intervention (14days)||18
417326|NCT01581710|1022700|P2|STARTED|Second Intervention (14days)||14
417327|NCT01581710|1022701|P1|STARTED|Second Intervention (14days)||18
417328|NCT01581710|1022700|P2|NOT COMPLETED|Washout Period (14days)||0
417329|NCT01581710|1022701|P1|NOT COMPLETED|Washout Period (14days)||0
417330|NCT01581710|1022700|P2|COMPLETED|Washout Period (14days)||14
417331|NCT01581710|1022701|P1|COMPLETED|Washout Period (14days)||18
417332|NCT01581710|1022700|P2|STARTED|Washout Period (14days)||14
417333|NCT01581710|1022701|P1|STARTED|Washout Period (14days)||18
417334|NCT01581710|1022700|P2|NOT COMPLETED|First Intervention (14days)||0
417335|NCT01581710|1022701|P1|NOT COMPLETED|First Intervention (14days)||0
417336|NCT01581710|1022700|P2|COMPLETED|First Intervention (14days)||14
417337|NCT01581710|1022701|P1|COMPLETED|First Intervention (14days)||18
417338|NCT01581710|1022700|P2|STARTED|First Intervention (14days)||14
417339|NCT01581710|1022701|P1|STARTED|First Intervention (14days)||18
417340|NCT01581684|1022739|P10|NOT COMPLETED|Overall Study||0
417341|NCT01581684|1022740|P9|NOT COMPLETED|Overall Study||1
417342|NCT01581684|1022741|P8|NOT COMPLETED|Overall Study||0
417343|NCT01581684|1022742|P7|NOT COMPLETED|Overall Study||0
417344|NCT01581684|1022743|P6|NOT COMPLETED|Overall Study||0
417345|NCT01581684|1022744|P5|NOT COMPLETED|Overall Study||0
417346|NCT01581684|1022745|P4|NOT COMPLETED|Overall Study||0
417347|NCT01581684|1022746|P3|NOT COMPLETED|Overall Study||0
417348|NCT01581684|1022747|P2|NOT COMPLETED|Overall Study||0
417349|NCT01581684|1022748|P1|NOT COMPLETED|Overall Study||0
417350|NCT01581684|1022739|P10|COMPLETED|Overall Study||5
417351|NCT01581684|1022740|P9|COMPLETED|Overall Study||0
417352|NCT01581684|1022741|P8|COMPLETED|Overall Study||6
417353|NCT01581684|1022742|P7|COMPLETED|Overall Study||6
417354|NCT01581684|1022743|P6|COMPLETED|Overall Study||6
417355|NCT01581684|1022744|P5|COMPLETED|Overall Study||6
417356|NCT01581684|1022745|P4|COMPLETED|Overall Study||6
417357|NCT01581684|1022746|P3|COMPLETED|Overall Study||6
417358|NCT01581684|1022747|P2|COMPLETED|Overall Study||6
417359|NCT01581684|1022748|P1|COMPLETED|Overall Study||14
417360|NCT01581684|1022739|P10|STARTED|Overall Study||5
417361|NCT01581684|1022740|P9|STARTED|Overall Study||1
417362|NCT01581684|1022741|P8|STARTED|Overall Study||6
417363|NCT01581684|1022742|P7|STARTED|Overall Study||6
417364|NCT01581684|1022743|P6|STARTED|Overall Study||6
417365|NCT01581684|1022744|P5|STARTED|Overall Study||6
417366|NCT01581684|1022745|P4|STARTED|Overall Study||6
417367|NCT01581684|1022746|P3|STARTED|Overall Study||6
417368|NCT01581684|1022747|P2|STARTED|Overall Study||6
417369|NCT01581684|1022748|P1|STARTED|Overall Study||14
417370|NCT01581658|1022823|P4|NOT COMPLETED|Overall Study||0
417371|NCT01581658|1022824|P3|NOT COMPLETED|Overall Study||0
417372|NCT01581658|1022825|P2|NOT COMPLETED|Overall Study||0
417373|NCT01581658|1022826|P1|NOT COMPLETED|Overall Study||0
417374|NCT01581658|1022823|P4|COMPLETED|Overall Study||8
417375|NCT01581658|1022824|P3|COMPLETED|Overall Study||8
417376|NCT01581658|1022825|P2|COMPLETED|Overall Study||8
417377|NCT01581658|1022826|P1|COMPLETED|Overall Study||8
417378|NCT01581658|1022823|P4|STARTED|Overall Study||8
417379|NCT01581658|1022824|P3|STARTED|Overall Study||8
417380|NCT01581658|1022825|P2|STARTED|Overall Study||8
417381|NCT01581658|1022826|P1|STARTED|Overall Study||8
417382|NCT01581619|1022844|P1|NOT COMPLETED|Overall Study||2
417383|NCT01581619|1022844|P1|COMPLETED|Overall Study||52
417384|NCT01581619|1022844|P1|STARTED|Overall Study||54
417385|NCT01581541|1022852|P11|NOT COMPLETED|Overall Study||0
417386|NCT01581541|1022853|P10|NOT COMPLETED|Overall Study||0
417387|NCT01581541|1022854|P9|NOT COMPLETED|Overall Study||0
417388|NCT01581541|1022855|P8|NOT COMPLETED|Overall Study||0
417389|NCT01581541|1022856|P7|NOT COMPLETED|Overall Study||0
417390|NCT01581541|1022857|P6|NOT COMPLETED|Overall Study||0
417391|NCT01581541|1022858|P5|NOT COMPLETED|Overall Study||0
417392|NCT01581541|1022859|P4|NOT COMPLETED|Overall Study||0
417393|NCT01581541|1022860|P3|NOT COMPLETED|Overall Study||0
417394|NCT01581541|1022861|P2|NOT COMPLETED|Overall Study||0
417395|NCT01581541|1022862|P1|NOT COMPLETED|Overall Study||0
417396|NCT01581541|1022852|P11|COMPLETED|Overall Study||1
417397|NCT01581541|1022853|P10|COMPLETED|Overall Study||3
417398|NCT01581541|1022854|P9|COMPLETED|Overall Study||1
417399|NCT01581541|1022855|P8|COMPLETED|Overall Study||2
417400|NCT01581541|1022856|P7|COMPLETED|Overall Study||1
417401|NCT01581541|1022857|P6|COMPLETED|Overall Study||3
417402|NCT01581541|1022858|P5|COMPLETED|Overall Study||2
417403|NCT01581541|1022859|P4|COMPLETED|Overall Study||1
417404|NCT01581541|1022860|P3|COMPLETED|Overall Study||1
417405|NCT01581541|1022861|P2|COMPLETED|Overall Study||1
417406|NCT01581541|1022862|P1|COMPLETED|Overall Study||1
417407|NCT01581541|1022852|P11|STARTED|Overall Study||1
417408|NCT01581541|1022853|P10|STARTED|Overall Study||3
417409|NCT01581541|1022854|P9|STARTED|Overall Study||1
417410|NCT01581541|1022855|P8|STARTED|Overall Study||2
417411|NCT01581541|1022856|P7|STARTED|Overall Study||1
417412|NCT01581541|1022857|P6|STARTED|Overall Study||3
417413|NCT01581541|1022858|P5|STARTED|Overall Study||2
417414|NCT01581541|1022859|P4|STARTED|Overall Study||1
417415|NCT01581541|1022860|P3|STARTED|Overall Study||1
417416|NCT01581541|1022861|P2|STARTED|Overall Study||1
417417|NCT01581541|1022862|P1|STARTED|Overall Study||1
417418|NCT01581437|1022986|P1|NOT COMPLETED|Overall Study||0
417419|NCT01581437|1022986|P1|COMPLETED|Overall Study||78
417420|NCT01581437|1022986|P1|STARTED|Overall Study||78
417421|NCT01581307|1022997|P1|NOT COMPLETED|Overall Study||1
417422|NCT01581307|1022997|P1|COMPLETED|Overall Study||8
417423|NCT01581307|1022997|P1|STARTED|Overall Study||9
417424|NCT01581281|1023006|P3|NOT COMPLETED|Overall Study||12
417425|NCT01581281|1023007|P2|NOT COMPLETED|Overall Study||6
417426|NCT01581281|1023008|P1|NOT COMPLETED|Overall Study||15
417427|NCT01581281|1023006|P3|COMPLETED|Overall Study||132
417428|NCT01581281|1023007|P2|COMPLETED|Overall Study||66
417429|NCT01581281|1023008|P1|COMPLETED|Overall Study||130
417430|NCT01581281|1023006|P3|STARTED|Overall Study||144
417431|NCT01581281|1023007|P2|STARTED|Overall Study||72
417432|NCT01581281|1023008|P1|STARTED|Overall Study||145
417433|NCT01581021|1023030|P2|NOT COMPLETED|Overall Study||11
417434|NCT01581021|1023031|P1|NOT COMPLETED|Overall Study||10
417435|NCT01581021|1023030|P2|COMPLETED|Overall Study||18
417436|NCT01581021|1023031|P1|COMPLETED|Overall Study||19
417437|NCT01581021|1023030|P2|STARTED|Overall Study||29
417438|NCT01581021|1023031|P1|STARTED|Overall Study||29
417439|NCT01581008|1023045|P2|NOT COMPLETED|Overall Study||6
417440|NCT01581008|1023046|P1|NOT COMPLETED|Overall Study||1
417441|NCT01581008|1023045|P2|COMPLETED|Overall Study||7
417442|NCT01581008|1023046|P1|COMPLETED|Overall Study||16
417443|NCT01581008|1023045|P2|STARTED|Overall Study||13
417444|NCT01581008|1023046|P1|STARTED|Overall Study||17
417445|NCT01580995|1023057|P2|NOT COMPLETED|Overall Study||2
417446|NCT01580995|1023058|P1|NOT COMPLETED|Overall Study||2
417447|NCT01580995|1023057|P2|COMPLETED|Overall Study||7
417448|NCT01580995|1023058|P1|COMPLETED|Overall Study||8
417449|NCT01580995|1023057|P2|STARTED|Overall Study||9
417450|NCT01580995|1023058|P1|STARTED|Overall Study||10
417451|NCT01580904|1023066|P2|NOT COMPLETED|Overall Study||7
417452|NCT01580904|1023067|P1|NOT COMPLETED|Overall Study||4
417453|NCT01580904|1023066|P2|COMPLETED|Overall Study||42
417454|NCT01580904|1023067|P1|COMPLETED|Overall Study||47
417455|NCT01580904|1023066|P2|STARTED|Overall Study||49
417456|NCT01580904|1023067|P1|STARTED|Overall Study||51
417457|NCT01580618|1023081|P2|NOT COMPLETED|Overall Study||0
417458|NCT01580618|1023082|P1|NOT COMPLETED|Overall Study||1
417459|NCT01580618|1023081|P2|COMPLETED|Overall Study||12
417460|NCT01580618|1023082|P1|COMPLETED|Overall Study|One patient was switched from the normal saline to TNKase arm at attending physician request.|7
417461|NCT01580618|1023081|P2|STARTED|Overall Study||12
417462|NCT01580618|1023082|P1|STARTED|Overall Study||8
417463|NCT01580592|1023098|P3|NOT COMPLETED|Overall Study||0
417464|NCT01580592|1023099|P2|NOT COMPLETED|Overall Study||0
417465|NCT01580592|1023100|P1|NOT COMPLETED|Overall Study||0
417466|NCT01580592|1023098|P3|COMPLETED|Overall Study||12
417467|NCT01580592|1023099|P2|COMPLETED|Overall Study||9
417468|NCT01580592|1023100|P1|COMPLETED|Overall Study||10
417469|NCT01580592|1023098|P3|STARTED|Overall Study||12
417470|NCT01580592|1023099|P2|STARTED|Overall Study||9
417471|NCT01580592|1023100|P1|STARTED|Overall Study||10
417472|NCT01580488|1023111|P1|NOT COMPLETED|Overall Study||1
417473|NCT01580488|1023111|P1|COMPLETED|Overall Study||23
417474|NCT01580488|1023111|P1|STARTED|Overall Study||24
417475|NCT01580423|1023155|P2|NOT COMPLETED|Second Intervention||0
417476|NCT01580423|1023156|P1|NOT COMPLETED|Second Intervention||0
417477|NCT01580423|1023155|P2|COMPLETED|Second Intervention||8
417478|NCT01580423|1023156|P1|COMPLETED|Second Intervention||8
417479|NCT01580423|1023155|P2|STARTED|Second Intervention||8
417480|NCT01580423|1023156|P1|STARTED|Second Intervention||8
417481|NCT01580423|1023155|P2|NOT COMPLETED|First Intervention||0
417482|NCT01580423|1023156|P1|NOT COMPLETED|First Intervention||0
417483|NCT01580423|1023155|P2|COMPLETED|First Intervention||8
417484|NCT01580423|1023156|P1|COMPLETED|First Intervention||8
417485|NCT01580423|1023155|P2|STARTED|First Intervention||8
417486|NCT01580423|1023156|P1|STARTED|First Intervention||8
417493|NCT01580306|1023185|P4|NOT COMPLETED|Overall Study||0
417494|NCT01580306|1023186|P3|NOT COMPLETED|Overall Study||0
417495|NCT01580306|1023187|P2|NOT COMPLETED|Overall Study||0
417496|NCT01580306|1023188|P1|NOT COMPLETED|Overall Study||0
417497|NCT01580306|1023185|P4|COMPLETED|Overall Study||8
417498|NCT01580306|1023186|P3|COMPLETED|Overall Study||8
417499|NCT01580306|1023187|P2|COMPLETED|Overall Study||8
417500|NCT01580306|1023188|P1|COMPLETED|Overall Study||8
417501|NCT01580306|1023185|P4|STARTED|Overall Study||8
417502|NCT01580306|1023186|P3|STARTED|Overall Study||8
417503|NCT01580306|1023187|P2|STARTED|Overall Study||8
417504|NCT01580306|1023188|P1|STARTED|Overall Study||8
417505|NCT01580098|1023212|P3|NOT COMPLETED|Overall Study||3
417506|NCT01580098|1023213|P2|NOT COMPLETED|Overall Study||13
417507|NCT01580098|1023214|P1|NOT COMPLETED|Overall Study||15
417508|NCT01580098|1023212|P3|COMPLETED|Overall Study|Due to high age and bad health conditions no patients finished (nursing)|0
417509|NCT01580098|1023213|P2|COMPLETED|Overall Study||101
417510|NCT01580098|1023214|P1|COMPLETED|Overall Study||61
417511|NCT01580098|1023212|P3|STARTED|Overall Study||3
417512|NCT01580098|1023213|P2|STARTED|Overall Study||114
417513|NCT01580098|1023214|P1|STARTED|Overall Study||76
417514|NCT01580072|1023237|P3|NOT COMPLETED|Overall Study||0
417515|NCT01580072|1023238|P2|NOT COMPLETED|Overall Study||9
417516|NCT01580072|1023239|P1|NOT COMPLETED|Overall Study||12
417517|NCT01580072|1023237|P3|COMPLETED|Overall Study||0
417518|NCT01580072|1023238|P2|COMPLETED|Overall Study||28
417519|NCT01580072|1023239|P1|COMPLETED|Overall Study||16
417520|NCT01580072|1023237|P3|STARTED|Overall Study||0
417521|NCT01580072|1023238|P2|STARTED|Overall Study||37
417522|NCT01580072|1023239|P1|STARTED|Overall Study||28
417523|NCT01580020|1023267|P4|NOT COMPLETED|Overall Study||2
417524|NCT01580020|1023268|P3|NOT COMPLETED|Overall Study||4
417525|NCT01580020|1023269|P2|NOT COMPLETED|Overall Study||7
417526|NCT01580020|1023270|P1|NOT COMPLETED|Overall Study||1
417527|NCT01580020|1023267|P4|COMPLETED|Overall Study||20
417528|NCT01580020|1023268|P3|COMPLETED|Overall Study||57
417529|NCT01580020|1023269|P2|COMPLETED|Overall Study||33
417530|NCT01580020|1023270|P1|COMPLETED|Overall Study||51
417531|NCT01580020|1023267|P4|STARTED|Overall Study||22
417532|NCT01580020|1023268|P3|STARTED|Overall Study||61
417533|NCT01580020|1023269|P2|STARTED|Overall Study||40
417534|NCT01580020|1023270|P1|STARTED|Overall Study||52
417535|NCT01579916|1023314|P2|NOT COMPLETED|Overall Study||2
417536|NCT01579916|1023315|P1|NOT COMPLETED|Overall Study||8
417537|NCT01579916|1023314|P2|COMPLETED|Overall Study||59
417538|NCT01579916|1023315|P1|COMPLETED|Overall Study||234
417539|NCT01579916|1023314|P2|STARTED|Overall Study||61
417540|NCT01579916|1023315|P1|STARTED|Overall Study||242
417541|NCT01579812|1023341|P1|NOT COMPLETED|Overall Study||52
417542|NCT01579812|1023341|P1|COMPLETED|Overall Study||38
417543|NCT01579812|1023341|P1|STARTED|Overall Study||90
417544|NCT01579747|1023351|P2|NOT COMPLETED|Overall Study||0
417545|NCT01579747|1023352|P1|NOT COMPLETED|Overall Study||0
417546|NCT01579747|1023351|P2|COMPLETED|Overall Study||12
417547|NCT01579747|1023352|P1|COMPLETED|Overall Study||12
417548|NCT01579747|1023351|P2|STARTED|Overall Study||12
417549|NCT01579747|1023352|P1|STARTED|Overall Study||12
417550|NCT01579669|1023362|P2|NOT COMPLETED|Overall Study||0
417551|NCT01579669|1023363|P1|NOT COMPLETED|Overall Study||36
417552|NCT01579669|1023362|P2|COMPLETED|Overall Study||41
417553|NCT01579669|1023363|P1|COMPLETED|Overall Study||134
417554|NCT01579669|1023362|P2|STARTED|Overall Study||41
417555|NCT01579669|1023363|P1|STARTED|Overall Study||170
417556|NCT01579578|1023375|P2|NOT COMPLETED|Overall Study||12
417557|NCT01579578|1023376|P1|NOT COMPLETED|Overall Study||13
417558|NCT01579578|1023375|P2|COMPLETED|Overall Study||0
417559|NCT01579578|1023376|P1|COMPLETED|Overall Study||0
417560|NCT01579578|1023375|P2|Ongoing|Overall Study||0
417561|NCT01579578|1023376|P1|Ongoing|Overall Study||3
417562|NCT01579578|1023375|P2|STARTED|Overall Study||12
417563|NCT01579578|1023376|P1|STARTED|Overall Study||13
417564|NCT01579565|1023388|P2|NOT COMPLETED|Treated||3
417565|NCT01579565|1023389|P1|NOT COMPLETED|Treated||2
417566|NCT01579565|1023388|P2|COMPLETED|Treated||201
417567|NCT01579565|1023389|P1|COMPLETED|Treated||200
417568|NCT01579565|1023388|P2|STARTED|Treated||204
417569|NCT01579565|1023389|P1|STARTED|Treated||202
417570|NCT01579565|1023388|P2|NOT COMPLETED|Randomized||5
417571|NCT01579565|1023389|P1|NOT COMPLETED|Randomized||5
417572|NCT01579565|1023388|P2|COMPLETED|Randomized||204
417573|NCT01579565|1023389|P1|COMPLETED|Randomized||202
417574|NCT01579565|1023388|P2|STARTED|Randomized||209
417575|NCT01579565|1023389|P1|STARTED|Randomized||207
417576|NCT01579474|1023423|P6|NOT COMPLETED|Overall Study||1
417577|NCT01579474|1023424|P5|NOT COMPLETED|Overall Study||1
417578|NCT01579474|1023425|P4|NOT COMPLETED|Overall Study||0
417579|NCT01579474|1023426|P3|NOT COMPLETED|Overall Study||2
417580|NCT01579474|1023427|P2|NOT COMPLETED|Overall Study||13
417581|NCT01579474|1023428|P1|NOT COMPLETED|Overall Study||3
417582|NCT01579474|1023423|P6|COMPLETED|Overall Study||1
417583|NCT01579474|1023424|P5|COMPLETED|Overall Study||9
417584|NCT01579474|1023425|P4|COMPLETED|Overall Study||3
417585|NCT01579474|1023426|P3|COMPLETED|Overall Study||27
417586|NCT01579474|1023427|P2|COMPLETED|Overall Study||30
417587|NCT01579474|1023428|P1|COMPLETED|Overall Study||41
417588|NCT01579474|1023423|P6|STARTED|Overall Study||2
417589|NCT01579474|1023424|P5|STARTED|Overall Study||10
417590|NCT01579474|1023425|P4|STARTED|Overall Study||3
417591|NCT01579474|1023426|P3|STARTED|Overall Study||29
417592|NCT01579474|1023427|P2|STARTED|Overall Study||43
417593|NCT01579474|1023428|P1|STARTED|Overall Study||44
417594|NCT01579318|1023502|P1|NOT COMPLETED|Overall Study||1
417595|NCT01579318|1023502|P1|COMPLETED|Overall Study||1
417596|NCT01579318|1023502|P1|STARTED|Overall Study||2
417597|NCT01579305|1023515|P2|NOT COMPLETED|Overall Study||27
417598|NCT01579305|1023516|P1|NOT COMPLETED|Overall Study||21
417599|NCT01579305|1023515|P2|COMPLETED|Overall Study||115
417600|NCT01579305|1023516|P1|COMPLETED|Overall Study||118
417601|NCT01579305|1023515|P2|Continued After Treatment|Overall Study||141
417602|NCT01579305|1023516|P1|Continued After Treatment|Overall Study||139
417603|NCT01579305|1023515|P2|Discontinued Before Treatment|Overall Study||1
417604|NCT01579305|1023516|P1|Discontinued Before Treatment|Overall Study||0
417605|NCT01579305|1023515|P2|STARTED|Overall Study|Subjects that signed Informed Consent, passed screening criteria, and were randomized.|142
417606|NCT01579305|1023516|P1|STARTED|Overall Study|Subjects that signed Informed Consent, passed screening criteria, and were randomized.|139
417607|NCT01579214|1023524|P2|NOT COMPLETED|Overall Study||0
417608|NCT01579214|1023525|P1|NOT COMPLETED|Overall Study||0
417609|NCT01579214|1023524|P2|COMPLETED|Overall Study||138
417610|NCT01579214|1023525|P1|COMPLETED|Overall Study||45
417611|NCT01579214|1023524|P2|STARTED|Overall Study||138
417612|NCT01579214|1023525|P1|STARTED|Overall Study||45
417613|NCT01579084|1023543|P10|NOT COMPLETED|Overall Study||0
417614|NCT01579084|1023544|P9|NOT COMPLETED|Overall Study||0
417615|NCT01579084|1023545|P8|NOT COMPLETED|Overall Study||0
417616|NCT01579084|1023546|P7|NOT COMPLETED|Overall Study||0
417617|NCT01579084|1023547|P6|NOT COMPLETED|Overall Study||0
417618|NCT01579084|1023548|P5|NOT COMPLETED|Overall Study||0
417619|NCT01579084|1023549|P4|NOT COMPLETED|Overall Study||0
417620|NCT01579084|1023550|P3|NOT COMPLETED|Overall Study||0
417621|NCT01579084|1023551|P2|NOT COMPLETED|Overall Study||0
417622|NCT01579084|1023552|P1|NOT COMPLETED|Overall Study||0
417623|NCT01579084|1023543|P10|COMPLETED|Overall Study||4
417624|NCT01579084|1023544|P9|COMPLETED|Overall Study||4
417625|NCT01579084|1023545|P8|COMPLETED|Overall Study||4
417626|NCT01579084|1023546|P7|COMPLETED|Overall Study||4
417627|NCT01579084|1023547|P6|COMPLETED|Overall Study||8
417628|NCT01579084|1023548|P5|COMPLETED|Overall Study||8
417629|NCT01579084|1023549|P4|COMPLETED|Overall Study||8
417630|NCT01579084|1023550|P3|COMPLETED|Overall Study||8
417631|NCT01579084|1023551|P2|COMPLETED|Overall Study||8
417632|NCT01579084|1023552|P1|COMPLETED|Overall Study||8
417633|NCT01579084|1023543|P10|STARTED|Overall Study||4
417634|NCT01579084|1023544|P9|STARTED|Overall Study||4
417635|NCT01579084|1023545|P8|STARTED|Overall Study||4
417636|NCT01579084|1023546|P7|STARTED|Overall Study||4
417637|NCT01579084|1023547|P6|STARTED|Overall Study||8
417638|NCT01579084|1023548|P5|STARTED|Overall Study||8
417639|NCT01579084|1023549|P4|STARTED|Overall Study||8
417640|NCT01579084|1023550|P3|STARTED|Overall Study||8
417641|NCT01579084|1023551|P2|STARTED|Overall Study||8
417642|NCT01579084|1023552|P1|STARTED|Overall Study||8
417643|NCT01579045|1023580|P1|NOT COMPLETED|Overall Study||0
417644|NCT01579045|1023580|P1|COMPLETED|Overall Study||24
417645|NCT01579045|1023580|P1|STARTED|Overall Study||24
417646|NCT01579006|1023597|P1|NOT COMPLETED|Overall Study||33
417647|NCT01579006|1023597|P1|COMPLETED|Overall Study||151
417648|NCT01579006|1023597|P1|STARTED|Overall Study||184
417649|NCT01578993|1023636|P1|NOT COMPLETED|Overall Study||0
417650|NCT01578993|1023636|P1|COMPLETED|Overall Study||101
417651|NCT01578993|1023636|P1|STARTED|Overall Study||101
417652|NCT01578980|1023640|P1|NOT COMPLETED|Overall Study||0
417653|NCT01578980|1023640|P1|COMPLETED|Overall Study||20
417654|NCT01578980|1023640|P1|STARTED|Overall Study||20
417655|NCT01578967|1023645|P1|NOT COMPLETED|Overall Study||0
417656|NCT01578967|1023645|P1|COMPLETED|Overall Study||41
417657|NCT01578967|1023645|P1|STARTED|Overall Study||41
417658|NCT01578850|1023656|P3|NOT COMPLETED|Period 2||14
417659|NCT01578850|1023657|P2|NOT COMPLETED|Period 2||13
417660|NCT01578850|1023658|P1|NOT COMPLETED|Period 2||0
417661|NCT01578850|1023656|P3|COMPLETED|Period 2||162
417662|NCT01578850|1023657|P2|COMPLETED|Period 2||154
417663|NCT01578850|1023658|P1|COMPLETED|Period 2||0
417664|NCT01578850|1023656|P3|STARTED|Period 2|One participants in PBO did not receive treatment.|176
417665|NCT01578850|1023657|P2|STARTED|Period 2|Two participants in ETN did not receive treatment.|167
417666|NCT01578850|1023658|P1|STARTED|Period 2||0
417667|NCT01578850|1023656|P3|NOT COMPLETED|Period 1||0
417668|NCT01578850|1023657|P2|NOT COMPLETED|Period 1||0
417669|NCT01578850|1023658|P1|NOT COMPLETED|Period 1||37
417670|NCT01578850|1023656|P3|COMPLETED|Period 1||0
417671|NCT01578850|1023657|P2|COMPLETED|Period 1||0
417672|NCT01578850|1023658|P1|COMPLETED|Period 1||452
417673|NCT01578850|1023656|P3|STARTED|Period 1||0
417674|NCT01578850|1023657|P2|STARTED|Period 1||0
417675|NCT01578850|1023658|P1|STARTED|Period 1|491 participants were enrolled in open-label treatment but 2 did not receive study medication.|489
417676|NCT01578785|1023710|P2|NOT COMPLETED|Overall Study||119
417677|NCT01578785|1023711|P1|NOT COMPLETED|Overall Study||59
417678|NCT01578785|1023710|P2|COMPLETED|Overall Study||0
417679|NCT01578785|1023711|P1|COMPLETED|Overall Study||0
417680|NCT01578785|1023710|P2|STARTED|Overall Study||119
417681|NCT01578785|1023711|P1|STARTED|Overall Study||59
417682|NCT01578772|1023723|P1|NOT COMPLETED|Overall Study||0
417683|NCT01578772|1023723|P1|COMPLETED|Overall Study||17
417684|NCT01578772|1023723|P1|STARTED|Overall Study||17
417685|NCT01578707|1023732|P2|NOT COMPLETED|Overall Study||0
417686|NCT01578707|1023733|P1|NOT COMPLETED|Overall Study||0
417687|NCT01578707|1023732|P2|COMPLETED|Overall Study||195
417688|NCT01578707|1023733|P1|COMPLETED|Overall Study||196
417689|NCT01578707|1023732|P2|STARTED|Overall Study||195
417690|NCT01578707|1023733|P1|STARTED|Overall Study||196
417691|NCT01578499|1023743|P2|NOT COMPLETED|Overall Study||65
417692|NCT01578499|1023744|P1|NOT COMPLETED|Overall Study||66
417693|NCT01578499|1023743|P2|COMPLETED|Overall Study||0
417694|NCT01578499|1023744|P1|COMPLETED|Overall Study||0
417695|NCT01578499|1023743|P2|Intent to Treat Population: CD30+|Overall Study||64
417696|NCT01578499|1023744|P1|Intent to Treat Population: CD30+|Overall Study||64
417697|NCT01578499|1023743|P2|Safety Population: Treated|Overall Study||62
417698|NCT01578499|1023744|P1|Safety Population: Treated|Overall Study||66
417699|NCT01578499|1023743|P2|STARTED|Overall Study||65
417700|NCT01578499|1023744|P1|STARTED|Overall Study||66
417701|NCT01578486|1023778|P1|NOT COMPLETED|Overall Study||5
417702|NCT01578486|1023778|P1|COMPLETED|Overall Study||8
417703|NCT01578486|1023778|P1|STARTED|Overall Study||13
417704|NCT01578330|1023789|P1|NOT COMPLETED|Overall Study||7
417705|NCT01578330|1023789|P1|COMPLETED|Overall Study||35
417706|NCT01578330|1023789|P1|Per Protocol Population|Overall Study||35
417707|NCT01578330|1023789|P1|STARTED|Overall Study||42
417708|NCT01578239|1023798|P2|NOT COMPLETED|Overall Study||25
417709|NCT01578239|1023799|P1|NOT COMPLETED|Overall Study||22
417710|NCT01578239|1023798|P2|COMPLETED|Overall Study||88
417711|NCT01578239|1023799|P1|COMPLETED|Overall Study||94
417712|NCT01578239|1023798|P2|STARTED|Overall Study||113
417713|NCT01578239|1023799|P1|STARTED|Overall Study||116
417714|NCT01578187|1023805|P1|NOT COMPLETED|Usability Phase||1
417715|NCT01578187|1023805|P1|COMPLETED|Usability Phase||47
417716|NCT01578187|1023805|P1|STARTED|Usability Phase||48
417717|NCT01578187|1023805|P1|NOT COMPLETED|Label Comprehension Phase||0
417718|NCT01578187|1023805|P1|COMPLETED|Label Comprehension Phase||63
417719|NCT01578187|1023805|P1|STARTED|Label Comprehension Phase||63
417720|NCT01578044|1023813|P2|NOT COMPLETED|Overall Study||0
417721|NCT01578044|1023814|P1|NOT COMPLETED|Overall Study||0
417722|NCT01578044|1023813|P2|COMPLETED|Overall Study||6
417723|NCT01578044|1023814|P1|COMPLETED|Overall Study||6
417724|NCT01578044|1023813|P2|STARTED|Overall Study||6
417725|NCT01578044|1023814|P1|STARTED|Overall Study||6
417726|NCT01578031|1023824|P4|NOT COMPLETED|Overall Study||0
417727|NCT01578031|1023825|P3|NOT COMPLETED|Overall Study||0
417728|NCT01578031|1023826|P2|NOT COMPLETED|Overall Study||34
417729|NCT01578031|1023827|P1|NOT COMPLETED|Overall Study||62
417730|NCT01578031|1023824|P4|COMPLETED|Overall Study|Only baseline data collected|30
417731|NCT01578031|1023825|P3|COMPLETED|Overall Study|Only baseline data collected|12
417732|NCT01578031|1023826|P2|COMPLETED|Overall Study|Follow-up obtained only in subjects with average PAP use at least 4 hr/day|35
417733|NCT01578031|1023827|P1|COMPLETED|Overall Study|Follow-up obtained only in subjects with average PAP use at least 4 hr/day|67
417734|NCT01578031|1023824|P4|STARTED|Overall Study||30
417735|NCT01578031|1023825|P3|STARTED|Overall Study||12
417736|NCT01578031|1023826|P2|STARTED|Overall Study||69
417737|NCT01578031|1023827|P1|STARTED|Overall Study||129
417738|NCT01577966|1023835|P1|NOT COMPLETED|Overall Study||0
417739|NCT01577966|1023835|P1|COMPLETED|Overall Study||9
417740|NCT01577966|1023835|P1|STARTED|Overall Study||9
417741|NCT01577758|1023839|P8|NOT COMPLETED|mCRC Expansion Phase||25
417742|NCT01577758|1023840|P7|NOT COMPLETED|mCRC Expansion Phase||0
417743|NCT01577758|1023841|P6|NOT COMPLETED|mCRC Expansion Phase||0
417744|NCT01577758|1023842|P5|NOT COMPLETED|mCRC Expansion Phase||0
417745|NCT01577758|1023843|P4|NOT COMPLETED|mCRC Expansion Phase||0
417746|NCT01577758|1023844|P3|NOT COMPLETED|mCRC Expansion Phase||0
417747|NCT01577758|1023845|P2|NOT COMPLETED|mCRC Expansion Phase||0
417748|NCT01577758|1023846|P1|NOT COMPLETED|mCRC Expansion Phase||0
417749|NCT01577758|1023839|P8|COMPLETED|mCRC Expansion Phase||0
417750|NCT01577758|1023840|P7|COMPLETED|mCRC Expansion Phase||0
417751|NCT01577758|1023841|P6|COMPLETED|mCRC Expansion Phase||0
417752|NCT01577758|1023842|P5|COMPLETED|mCRC Expansion Phase||0
417753|NCT01577758|1023843|P4|COMPLETED|mCRC Expansion Phase||0
417754|NCT01577758|1023844|P3|COMPLETED|mCRC Expansion Phase||0
417755|NCT01577758|1023845|P2|COMPLETED|mCRC Expansion Phase||0
417756|NCT01577758|1023846|P1|COMPLETED|mCRC Expansion Phase||0
417757|NCT01577758|1023839|P8|STARTED|mCRC Expansion Phase||25
417758|NCT01577758|1023840|P7|STARTED|mCRC Expansion Phase||0
417759|NCT01577758|1023841|P6|STARTED|mCRC Expansion Phase||0
417760|NCT01577758|1023842|P5|STARTED|mCRC Expansion Phase||0
417761|NCT01577758|1023843|P4|STARTED|mCRC Expansion Phase||0
417762|NCT01577758|1023844|P3|STARTED|mCRC Expansion Phase||0
417763|NCT01577758|1023845|P2|STARTED|mCRC Expansion Phase||0
417764|NCT01577758|1023846|P1|STARTED|mCRC Expansion Phase||0
417765|NCT01577758|1023839|P8|NOT COMPLETED|Dose Escalation Phase||0
417766|NCT01577758|1023840|P7|NOT COMPLETED|Dose Escalation Phase||1
417767|NCT01577758|1023841|P6|NOT COMPLETED|Dose Escalation Phase||4
417768|NCT01577758|1023842|P5|NOT COMPLETED|Dose Escalation Phase||6
417769|NCT01577758|1023843|P4|NOT COMPLETED|Dose Escalation Phase||2
417770|NCT01577758|1023844|P3|NOT COMPLETED|Dose Escalation Phase||2
417771|NCT01577758|1023845|P2|NOT COMPLETED|Dose Escalation Phase||2
417772|NCT01577758|1023846|P1|NOT COMPLETED|Dose Escalation Phase||2
417773|NCT01577758|1023839|P8|COMPLETED|Dose Escalation Phase||0
417774|NCT01577758|1023840|P7|COMPLETED|Dose Escalation Phase||0
417775|NCT01577758|1023841|P6|COMPLETED|Dose Escalation Phase||0
417776|NCT01577758|1023842|P5|COMPLETED|Dose Escalation Phase||0
417777|NCT01577758|1023843|P4|COMPLETED|Dose Escalation Phase||0
417778|NCT01577758|1023844|P3|COMPLETED|Dose Escalation Phase||0
417779|NCT01577758|1023845|P2|COMPLETED|Dose Escalation Phase||0
417780|NCT01577758|1023846|P1|COMPLETED|Dose Escalation Phase||0
417781|NCT01577758|1023839|P8|STARTED|Dose Escalation Phase||0
417782|NCT01577758|1023840|P7|STARTED|Dose Escalation Phase||1
417783|NCT01577758|1023841|P6|STARTED|Dose Escalation Phase||4
417784|NCT01577758|1023842|P5|STARTED|Dose Escalation Phase||6
417785|NCT01577758|1023843|P4|STARTED|Dose Escalation Phase||2
417786|NCT01577758|1023844|P3|STARTED|Dose Escalation Phase||2
417787|NCT01577758|1023845|P2|STARTED|Dose Escalation Phase||2
417788|NCT01577758|1023846|P1|STARTED|Dose Escalation Phase||2
417789|NCT01577745|1023885|P6|NOT COMPLETED|Overall Study||4
417790|NCT01577745|1023886|P5|NOT COMPLETED|Overall Study||5
417791|NCT01577745|1023887|P4|NOT COMPLETED|Overall Study||6
417792|NCT01577745|1023888|P3|NOT COMPLETED|Overall Study||2
417793|NCT01577745|1023889|P2|NOT COMPLETED|Overall Study||3
417794|NCT01577745|1023890|P1|NOT COMPLETED|Overall Study||3
417795|NCT01577745|1023885|P6|COMPLETED|Overall Study||1
417796|NCT01577745|1023886|P5|COMPLETED|Overall Study||0
417797|NCT01577745|1023887|P4|COMPLETED|Overall Study||0
417798|NCT01577745|1023888|P3|COMPLETED|Overall Study||1
417799|NCT01577745|1023889|P2|COMPLETED|Overall Study||0
417800|NCT01577745|1023890|P1|COMPLETED|Overall Study||0
417801|NCT01577745|1023885|P6|STARTED|Overall Study||5
417802|NCT01577745|1023886|P5|STARTED|Overall Study||5
417803|NCT01577745|1023887|P4|STARTED|Overall Study||6
417804|NCT01577745|1023888|P3|STARTED|Overall Study||3
417805|NCT01577745|1023889|P2|STARTED|Overall Study||3
417806|NCT01577745|1023890|P1|STARTED|Overall Study||3
417807|NCT01577732|1024007|P1|NOT COMPLETED|Overall Study||0
417808|NCT01577732|1024007|P1|COMPLETED|Overall Study||300
417809|NCT01577732|1024007|P1|STARTED|Overall Study||300
417810|NCT01577706|1024014|P3|NOT COMPLETED|Third Intervention (1 Day)||0
417811|NCT01577706|1024015|P2|NOT COMPLETED|Third Intervention (1 Day)||0
417812|NCT01577706|1024016|P1|NOT COMPLETED|Third Intervention (1 Day)||0
417813|NCT01577706|1024014|P3|COMPLETED|Third Intervention (1 Day)||3
417814|NCT01577706|1024015|P2|COMPLETED|Third Intervention (1 Day)||1
417815|NCT01577706|1024016|P1|COMPLETED|Third Intervention (1 Day)||3
417816|NCT01577706|1024014|P3|STARTED|Third Intervention (1 Day)||3
417817|NCT01577706|1024015|P2|STARTED|Third Intervention (1 Day)||1
417818|NCT01577706|1024016|P1|STARTED|Third Intervention (1 Day)||3
417819|NCT01577706|1024014|P3|NOT COMPLETED|Washout (at Least 1 Week)||0
417820|NCT01577706|1024015|P2|NOT COMPLETED|Washout (at Least 1 Week)||0
417821|NCT01577706|1024016|P1|NOT COMPLETED|Washout (at Least 1 Week)||0
417822|NCT01577706|1024014|P3|COMPLETED|Washout (at Least 1 Week)||3
417823|NCT01577706|1024015|P2|COMPLETED|Washout (at Least 1 Week)||1
417824|NCT01577706|1024016|P1|COMPLETED|Washout (at Least 1 Week)||3
417825|NCT01577706|1024014|P3|STARTED|Washout (at Least 1 Week)||3
417826|NCT01577706|1024015|P2|STARTED|Washout (at Least 1 Week)||1
417827|NCT01577706|1024016|P1|STARTED|Washout (at Least 1 Week)||3
417828|NCT01577706|1024014|P3|NOT COMPLETED|Second Intervention (1 Day)||0
417829|NCT01577706|1024015|P2|NOT COMPLETED|Second Intervention (1 Day)||0
417830|NCT01577706|1024016|P1|NOT COMPLETED|Second Intervention (1 Day)||0
417831|NCT01577706|1024014|P3|COMPLETED|Second Intervention (1 Day)||3
417832|NCT01577706|1024015|P2|COMPLETED|Second Intervention (1 Day)||1
417833|NCT01577706|1024016|P1|COMPLETED|Second Intervention (1 Day)||3
417834|NCT01577706|1024014|P3|STARTED|Second Intervention (1 Day)||3
417835|NCT01577706|1024015|P2|STARTED|Second Intervention (1 Day)||1
417836|NCT01577706|1024016|P1|STARTED|Second Intervention (1 Day)||3
417837|NCT01577706|1024014|P3|NOT COMPLETED|Washout (at Least 1 Week)||0
417838|NCT01577706|1024015|P2|NOT COMPLETED|Washout (at Least 1 Week)||0
417839|NCT01577706|1024016|P1|NOT COMPLETED|Washout (at Least 1 Week)||0
417840|NCT01577706|1024014|P3|COMPLETED|Washout (at Least 1 Week)||3
417841|NCT01577706|1024015|P2|COMPLETED|Washout (at Least 1 Week)||1
417842|NCT01577706|1024016|P1|COMPLETED|Washout (at Least 1 Week)||3
417843|NCT01577706|1024014|P3|STARTED|Washout (at Least 1 Week)||3
417844|NCT01577706|1024015|P2|STARTED|Washout (at Least 1 Week)||1
417845|NCT01577706|1024016|P1|STARTED|Washout (at Least 1 Week)||3
417846|NCT01577706|1024014|P3|NOT COMPLETED|First Intervention (1 Day)||0
417847|NCT01577706|1024015|P2|NOT COMPLETED|First Intervention (1 Day)||0
417848|NCT01577706|1024016|P1|NOT COMPLETED|First Intervention (1 Day)||0
417849|NCT01577706|1024014|P3|COMPLETED|First Intervention (1 Day)||3
417850|NCT01577706|1024015|P2|COMPLETED|First Intervention (1 Day)||1
417851|NCT01577706|1024016|P1|COMPLETED|First Intervention (1 Day)||3
417852|NCT01577706|1024014|P3|STARTED|First Intervention (1 Day)||3
417853|NCT01577706|1024015|P2|STARTED|First Intervention (1 Day)||1
417854|NCT01577706|1024016|P1|STARTED|First Intervention (1 Day)||3
417855|NCT01577628|1024044|P3|NOT COMPLETED|Overall Study||2
417856|NCT01577628|1024045|P2|NOT COMPLETED|Overall Study||0
417857|NCT01577628|1024046|P1|NOT COMPLETED|Overall Study||0
417858|NCT01577628|1024044|P3|COMPLETED|Overall Study||0
417859|NCT01577628|1024045|P2|COMPLETED|Overall Study||0
417860|NCT01577628|1024046|P1|COMPLETED|Overall Study||0
417861|NCT01577628|1024044|P3|STARTED|Overall Study||2
417862|NCT01577628|1024045|P2|STARTED|Overall Study||0
417863|NCT01577628|1024046|P1|STARTED|Overall Study||0
417864|NCT01577381|1024074|P4|NOT COMPLETED|Overall Study||2
417865|NCT01577381|1024075|P3|NOT COMPLETED|Overall Study||3
417866|NCT01577381|1024076|P2|NOT COMPLETED|Overall Study||3
417867|NCT01577381|1024077|P1|NOT COMPLETED|Overall Study||2
417868|NCT01577381|1024074|P4|COMPLETED|Overall Study||0
417869|NCT01577381|1024075|P3|COMPLETED|Overall Study||0
417870|NCT01577381|1024076|P2|COMPLETED|Overall Study||0
417871|NCT01577381|1024077|P1|COMPLETED|Overall Study||0
417872|NCT01577381|1024074|P4|STARTED|Overall Study||2
417873|NCT01577381|1024075|P3|STARTED|Overall Study||3
417874|NCT01577381|1024076|P2|STARTED|Overall Study||3
417875|NCT01577381|1024077|P1|STARTED|Overall Study||2
417876|NCT01577329|1024208|P2|NOT COMPLETED|Overall Study||0
417877|NCT01577329|1024209|P1|NOT COMPLETED|Overall Study||3
417878|NCT01577329|1024208|P2|COMPLETED|Overall Study||22
417879|NCT01577329|1024209|P1|COMPLETED|Overall Study||16
417880|NCT01577329|1024208|P2|STARTED|Overall Study||22
417881|NCT01577329|1024209|P1|STARTED|Overall Study||19
417882|NCT01577186|1024215|P1|NOT COMPLETED|Overall Study||130
417883|NCT01577186|1024215|P1|COMPLETED|Overall Study||350
417884|NCT01577186|1024215|P1|STARTED|Overall Study||480
417885|NCT01577160|1024223|P1|NOT COMPLETED|Overall Study||98
417886|NCT01577160|1024223|P1|COMPLETED|Overall Study||255
417887|NCT01577160|1024223|P1|STARTED|Overall Study||353
417888|NCT01577108|1024233|P2|NOT COMPLETED|Overall Study||6
417889|NCT01577108|1024234|P1|NOT COMPLETED|Overall Study||5
417890|NCT01577108|1024233|P2|COMPLETED|Overall Study||50
417891|NCT01577108|1024234|P1|COMPLETED|Overall Study||49
417892|NCT01577108|1024233|P2|STARTED|Overall Study||56
417893|NCT01577108|1024234|P1|STARTED|Overall Study||54
417894|NCT01576952|1024242|P2|NOT COMPLETED|Overall Study||55
417895|NCT01576952|1024243|P1|NOT COMPLETED|Overall Study||41
417896|NCT01576952|1024242|P2|COMPLETED|Overall Study||33
417897|NCT01576952|1024243|P1|COMPLETED|Overall Study||139
417898|NCT01576952|1024242|P2|mITT Population|Overall Study||85
417899|NCT01576952|1024243|P1|mITT Population|Overall Study||168
417900|NCT01576952|1024242|P2|Safety Population|Overall Study||85
417901|NCT01576952|1024243|P1|Safety Population|Overall Study||169
417902|NCT01576952|1024242|P2|STARTED|Overall Study||88
417903|NCT01576952|1024243|P1|STARTED|Overall Study||180
417904|NCT01576939|1024249|P1|NOT COMPLETED|Overall Study||0
417905|NCT01576939|1024249|P1|COMPLETED|Overall Study||30
417906|NCT01576939|1024249|P1|STARTED|Overall Study||30
417907|NCT01576809|1024257|P1|NOT COMPLETED|Overall Study||0
417908|NCT01576809|1024257|P1|COMPLETED|Overall Study||51
417909|NCT01576809|1024257|P1|STARTED|Overall Study||51
417910|NCT01576718|1024269|P7|NOT COMPLETED|Treatment Period||30
417911|NCT01576718|1024270|P6|NOT COMPLETED|Treatment Period||48
417912|NCT01576718|1024271|P5|NOT COMPLETED|Treatment Period||27
417913|NCT01576718|1024272|P4|NOT COMPLETED|Treatment Period||31
417914|NCT01576718|1024273|P3|NOT COMPLETED|Treatment Period||20
417915|NCT01576718|1024274|P2|NOT COMPLETED|Treatment Period||25
417916|NCT01576718|1024275|P1|NOT COMPLETED|Treatment Period||0
417917|NCT01576718|1024269|P7|COMPLETED|Treatment Period||77
417918|NCT01576718|1024270|P6|COMPLETED|Treatment Period||58
417919|NCT01576718|1024271|P5|COMPLETED|Treatment Period||80
417920|NCT01576718|1024272|P4|COMPLETED|Treatment Period||75
417921|NCT01576718|1024273|P3|COMPLETED|Treatment Period||87
417922|NCT01576718|1024274|P2|COMPLETED|Treatment Period||82
417923|NCT01576718|1024275|P1|COMPLETED|Treatment Period||0
417924|NCT01576718|1024269|P7|Efficacy Population (Full Analysis Set)|Treatment Period||103
417925|NCT01576718|1024270|P6|Efficacy Population (Full Analysis Set)|Treatment Period||105
417926|NCT01576718|1024271|P5|Efficacy Population (Full Analysis Set)|Treatment Period||107
417927|NCT01576718|1024272|P4|Efficacy Population (Full Analysis Set)|Treatment Period||102
417928|NCT01576718|1024273|P3|Efficacy Population (Full Analysis Set)|Treatment Period||106
417929|NCT01576718|1024274|P2|Efficacy Population (Full Analysis Set)|Treatment Period||107
417930|NCT01576718|1024275|P1|Efficacy Population (Full Analysis Set)|Treatment Period||0
417931|NCT01576718|1024269|P7|Safety Population|Treatment Period||106
417932|NCT01576718|1024270|P6|Safety Population|Treatment Period||106
417933|NCT01576718|1024271|P5|Safety Population|Treatment Period||107
417934|NCT01576718|1024272|P4|Safety Population|Treatment Period||106
417935|NCT01576718|1024273|P3|Safety Population|Treatment Period||107
417936|NCT01576718|1024274|P2|Safety Population|Treatment Period||107
417937|NCT01576718|1024275|P1|Safety Population|Treatment Period||0
417938|NCT01576718|1024269|P7|STARTED|Treatment Period||107
417939|NCT01576718|1024270|P6|STARTED|Treatment Period||106
417940|NCT01576718|1024271|P5|STARTED|Treatment Period||107
417941|NCT01576718|1024272|P4|STARTED|Treatment Period||106
417942|NCT01576718|1024273|P3|STARTED|Treatment Period||107
417943|NCT01576718|1024274|P2|STARTED|Treatment Period||107
417944|NCT01576718|1024275|P1|STARTED|Treatment Period||0
417945|NCT01576718|1024269|P7|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
417946|NCT01576718|1024270|P6|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
417947|NCT01576718|1024271|P5|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
417948|NCT01576718|1024272|P4|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
417949|NCT01576718|1024273|P3|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
417950|NCT01576718|1024274|P2|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
417951|NCT01576718|1024275|P1|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||249
417952|NCT01576718|1024269|P7|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
417953|NCT01576718|1024270|P6|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
417954|NCT01576718|1024271|P5|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
417955|NCT01576718|1024272|P4|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
417956|NCT01576718|1024273|P3|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
417957|NCT01576718|1024274|P2|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
417958|NCT01576718|1024275|P1|COMPLETED|Pre-Assignment Period (Run-In Placebo)|Participants randomized into the Treatment Period|640
417959|NCT01576718|1024269|P7|STARTED|Pre-Assignment Period (Run-In Placebo)||0
417960|NCT01576718|1024270|P6|STARTED|Pre-Assignment Period (Run-In Placebo)||0
417961|NCT01576718|1024271|P5|STARTED|Pre-Assignment Period (Run-In Placebo)||0
417962|NCT01576718|1024272|P4|STARTED|Pre-Assignment Period (Run-In Placebo)||0
417963|NCT01576718|1024273|P3|STARTED|Pre-Assignment Period (Run-In Placebo)||0
417964|NCT01576718|1024274|P2|STARTED|Pre-Assignment Period (Run-In Placebo)||0
417965|NCT01576718|1024275|P1|STARTED|Pre-Assignment Period (Run-In Placebo)||889
417966|NCT01576549|1024367|P1|NOT COMPLETED|Overall Study||2
417967|NCT01576549|1024367|P1|COMPLETED|Overall Study||0
417968|NCT01576549|1024367|P1|Completed Post-Treatment Follow-Up|Overall Study|Each participant discontinued dosing and completed the Post-Treatment Follow-Up Period.|2
417969|NCT01576549|1024367|P1|Received at Least 1 Dose of Study Drug|Overall Study||2
417970|NCT01576549|1024367|P1|STARTED|Overall Study||2
417971|NCT01576471|1024377|P2|NOT COMPLETED|Overall Study||9
417972|NCT01576471|1024378|P1|NOT COMPLETED|Overall Study||8
417973|NCT01576471|1024377|P2|COMPLETED|Overall Study||116
417974|NCT01576471|1024378|P1|COMPLETED|Overall Study||117
417975|NCT01576471|1024377|P2|STARTED|Overall Study||125
417976|NCT01576471|1024378|P1|STARTED|Overall Study||125
417977|NCT01576367|1024384|P1|NOT COMPLETED|Overall Study||3
417978|NCT01576367|1024384|P1|COMPLETED|Overall Study||14
417979|NCT01576367|1024384|P1|STARTED|Overall Study||17
417980|NCT01576341|1024392|P1|NOT COMPLETED|Overall Study||93
417981|NCT01576341|1024392|P1|COMPLETED|Overall Study||324
417982|NCT01576341|1024392|P1|STARTED|Overall Study||417
417989|NCT01576159|1024413|P4|NOT COMPLETED|Overall Study||1
417990|NCT01576159|1024414|P3|NOT COMPLETED|Overall Study||1
417991|NCT01576159|1024415|P2|NOT COMPLETED|Overall Study||1
417992|NCT01576159|1024416|P1|NOT COMPLETED|Overall Study||1
417993|NCT01576159|1024413|P4|COMPLETED|Overall Study||11
417994|NCT01576159|1024414|P3|COMPLETED|Overall Study||11
417995|NCT01576159|1024415|P2|COMPLETED|Overall Study||11
417996|NCT01576159|1024416|P1|COMPLETED|Overall Study||11
417997|NCT01576159|1024413|P4|STARTED|Overall Study||12
417998|NCT01576159|1024414|P3|STARTED|Overall Study||12
417999|NCT01576159|1024415|P2|STARTED|Overall Study||12
418000|NCT01576159|1024416|P1|STARTED|Overall Study||12
418001|NCT01576146|1024434|P1|NOT COMPLETED|Extension Period 2||17
418002|NCT01576146|1024434|P1|COMPLETED|Extension Period 2||0
418003|NCT01576146|1024434|P1|STARTED|Extension Period 2|Three participants who completed Extension Period 1 did not enroll in Period 2|17
418004|NCT01576146|1024434|P1|NOT COMPLETED|Extension Period 1||10
418005|NCT01576146|1024434|P1|COMPLETED|Extension Period 1||20
418006|NCT01576146|1024434|P1|STARTED|Extension Period 1||30
418007|NCT01576120|1024443|P2|NOT COMPLETED|Overall Study||0
418008|NCT01576120|1024444|P1|NOT COMPLETED|Overall Study||0
418009|NCT01576120|1024443|P2|COMPLETED|Overall Study||19
418010|NCT01576120|1024444|P1|COMPLETED|Overall Study||21
418011|NCT01576120|1024443|P2|STARTED|Overall Study||19
418012|NCT01576120|1024444|P1|STARTED|Overall Study||21
418013|NCT01576055|1024452|P2|NOT COMPLETED|Overall Study||6
418014|NCT01576055|1024453|P1|NOT COMPLETED|Overall Study||19
418015|NCT01576055|1024452|P2|COMPLETED|Overall Study||64
418016|NCT01576055|1024453|P1|COMPLETED|Overall Study||178
418017|NCT01576055|1024452|P2|STARTED|Overall Study||70
418018|NCT01576055|1024453|P1|STARTED|Overall Study||197
418019|NCT01576042|1024467|P2|NOT COMPLETED|Overall Study||0
418020|NCT01576042|1024468|P1|NOT COMPLETED|Overall Study||2
418021|NCT01576042|1024467|P2|COMPLETED|Overall Study||14
418022|NCT01576042|1024468|P1|COMPLETED|Overall Study||11
418023|NCT01576042|1024467|P2|Switched to the Other Arm|Overall Study||1
418024|NCT01576042|1024468|P1|Switched to the Other Arm|Overall Study||5
418025|NCT01576042|1024467|P2|STARTED|Overall Study||14
418026|NCT01576042|1024468|P1|STARTED|Overall Study||13
418027|NCT01575912|1024491|P3|NOT COMPLETED|Overall Study||0
418028|NCT01575912|1024492|P2|NOT COMPLETED|Overall Study||0
418029|NCT01575912|1024493|P1|NOT COMPLETED|Overall Study||0
418030|NCT01575912|1024491|P3|COMPLETED|Overall Study||30
418031|NCT01575912|1024492|P2|COMPLETED|Overall Study||32
418032|NCT01575912|1024493|P1|COMPLETED|Overall Study||30
418033|NCT01575912|1024491|P3|STARTED|Overall Study||30
418034|NCT01575912|1024492|P2|STARTED|Overall Study||32
418035|NCT01575912|1024493|P1|STARTED|Overall Study||30
418036|NCT01575899|1024504|P3|NOT COMPLETED|Overall Study||2
418037|NCT01575899|1024505|P2|NOT COMPLETED|Overall Study||5
418038|NCT01575899|1024506|P1|NOT COMPLETED|Overall Study||5
418039|NCT01575899|1024504|P3|COMPLETED|Overall Study||60
418040|NCT01575899|1024505|P2|COMPLETED|Overall Study||68
418041|NCT01575899|1024506|P1|COMPLETED|Overall Study||68
418042|NCT01575899|1024504|P3|STARTED|Overall Study|Included patients still with Hp infection after previous therapy without levofloxacin and Augmentin.|62
418043|NCT01575899|1024505|P2|STARTED|Overall Study||73
418044|NCT01575899|1024506|P1|STARTED|Overall Study||73
418045|NCT01575808|1024518|P2|NOT COMPLETED|Overall Study||0
418046|NCT01575808|1024519|P1|NOT COMPLETED|Overall Study||3
418047|NCT01575808|1024518|P2|COMPLETED|Overall Study||68
418048|NCT01575808|1024519|P1|COMPLETED|Overall Study|Study ongoing. All 103 assessed for primary invasiveness endpoints,100 for primary efficacy endpoint|100
418049|NCT01575808|1024518|P2|STARTED|Overall Study||68
418050|NCT01575808|1024519|P1|STARTED|Overall Study||103
418051|NCT01575769|1024566|P1|NOT COMPLETED|Overall Study||41
418052|NCT01575769|1024566|P1|COMPLETED|Overall Study||0
418053|NCT01575769|1024566|P1|STARTED|Overall Study||41
418054|NCT01575756|1024592|P2|NOT COMPLETED|Treatment Period 2||0
418055|NCT01575756|1024593|P1|NOT COMPLETED|Treatment Period 2||0
418056|NCT01575756|1024592|P2|COMPLETED|Treatment Period 2||11
418057|NCT01575756|1024593|P1|COMPLETED|Treatment Period 2||11
418058|NCT01575756|1024592|P2|STARTED|Treatment Period 2||11
418059|NCT01575756|1024593|P1|STARTED|Treatment Period 2||11
418060|NCT01575756|1024592|P2|NOT COMPLETED|Treatment Period 1||0
418061|NCT01575756|1024593|P1|NOT COMPLETED|Treatment Period 1||0
418062|NCT01575756|1024592|P2|COMPLETED|Treatment Period 1||11
418063|NCT01575756|1024593|P1|COMPLETED|Treatment Period 1||11
418064|NCT01575756|1024592|P2|STARTED|Treatment Period 1||11
418065|NCT01575756|1024593|P1|STARTED|Treatment Period 1||11
418066|NCT01575561|1024624|P1|NOT COMPLETED|Overall Study||39
418067|NCT01575561|1024624|P1|COMPLETED|Overall Study||338
418068|NCT01575561|1024624|P1|STARTED|Overall Study||377
418069|NCT01575522|1024636|P1|NOT COMPLETED|Overall Study||0
418070|NCT01575522|1024636|P1|COMPLETED|Overall Study||22
418071|NCT01575522|1024636|P1|STARTED|Overall Study||22
418072|NCT01575197|1024647|P3|NOT COMPLETED|Overall Study||6
418073|NCT01575197|1024648|P2|NOT COMPLETED|Overall Study||9
418074|NCT01575197|1024649|P1|NOT COMPLETED|Overall Study||3
418075|NCT01575197|1024647|P3|COMPLETED|Overall Study||146
418076|NCT01575197|1024648|P2|COMPLETED|Overall Study||143
418077|NCT01575197|1024649|P1|COMPLETED|Overall Study||149
418078|NCT01575197|1024647|P3|STARTED|Overall Study||152
418079|NCT01575197|1024648|P2|STARTED|Overall Study||152
418080|NCT01575197|1024649|P1|STARTED|Overall Study||152
418081|NCT01575106|1024662|P1|NOT COMPLETED|Overall Study||14
418082|NCT01575106|1024662|P1|COMPLETED|Overall Study||24
418083|NCT01575106|1024662|P1|STARTED|Overall Study||38
418084|NCT01575080|1024668|P1|NOT COMPLETED|Overall Study||0
418085|NCT01575080|1024668|P1|COMPLETED|Overall Study||102
418086|NCT01575080|1024668|P1|STARTED|Overall Study||102
418087|NCT01575054|1024677|P2|NOT COMPLETED|Overall Study||26
418088|NCT01575054|1024678|P1|NOT COMPLETED|Overall Study||29
418089|NCT01575054|1024677|P2|COMPLETED|Overall Study||209
418090|NCT01575054|1024678|P1|COMPLETED|Overall Study||204
418091|NCT01575054|1024677|P2|STARTED|Overall Study||235
418092|NCT01575054|1024678|P1|STARTED|Overall Study||233
418093|NCT01575028|1024694|P2|NOT COMPLETED|Overall Study||1
418094|NCT01575028|1024695|P1|NOT COMPLETED|Overall Study||0
418095|NCT01575028|1024694|P2|COMPLETED|Overall Study||0
418096|NCT01575028|1024695|P1|COMPLETED|Overall Study||2
418097|NCT01575028|1024694|P2|STARTED|Overall Study||1
418098|NCT01575028|1024695|P1|STARTED|Overall Study||2
418099|NCT01574703|1024705|P4|NOT COMPLETED|Overall Study||114
418100|NCT01574703|1024706|P3|NOT COMPLETED|Overall Study||105
418101|NCT01574703|1024707|P2|NOT COMPLETED|Overall Study||112
418102|NCT01574703|1024708|P1|NOT COMPLETED|Overall Study||125
418103|NCT01574703|1024705|P4|COMPLETED|Overall Study||1007
418104|NCT01574703|1024706|P3|COMPLETED|Overall Study||1011
418105|NCT01574703|1024707|P2|COMPLETED|Overall Study||1054
418106|NCT01574703|1024708|P1|COMPLETED|Overall Study||1067
418107|NCT01574703|1024705|P4|STARTED|Overall Study||1121
418108|NCT01574703|1024706|P3|STARTED|Overall Study||1116
418109|NCT01574703|1024707|P2|STARTED|Overall Study||1166
418110|NCT01574703|1024708|P1|STARTED|Overall Study||1192
418111|NCT01574651|1024752|P2|NOT COMPLETED|Overall Study||52
418112|NCT01574651|1024753|P1|NOT COMPLETED|Overall Study||61
418113|NCT01574651|1024752|P2|COMPLETED|Overall Study||406
418114|NCT01574651|1024753|P1|COMPLETED|Overall Study||415
418115|NCT01574651|1024752|P2|Per Protocol Set (PPS)|Overall Study||374
418116|NCT01574651|1024753|P1|Per Protocol Set (PPS)|Overall Study||373
418117|NCT01574651|1024752|P2|Full Analysis Set (FAS)|Overall Study||458
418118|NCT01574651|1024753|P1|Full Analysis Set (FAS)|Overall Study||476
418119|NCT01574651|1024752|P2|STARTED|Overall Study||458
418120|NCT01574651|1024753|P1|STARTED|Overall Study||476
418121|NCT01574612|1024775|P1|NOT COMPLETED|Overall Study||8
418122|NCT01574612|1024775|P1|COMPLETED|Overall Study||46
418123|NCT01574612|1024775|P1|STARTED|Overall Study|patients who were identified as having the appropriate medical history of herpes labialis|54
418124|NCT01574326|1024781|P2|NOT COMPLETED|Overall Study||19
418125|NCT01574326|1024782|P1|NOT COMPLETED|Overall Study||16
418126|NCT01574326|1024781|P2|COMPLETED|Overall Study||31
418127|NCT01574326|1024782|P1|COMPLETED|Overall Study||35
418128|NCT01574326|1024781|P2|Treated|Overall Study||49
418129|NCT01574326|1024782|P1|Treated|Overall Study||51
418130|NCT01574326|1024781|P2|STARTED|Overall Study||50
418131|NCT01574326|1024782|P1|STARTED|Overall Study||51
418132|NCT01574248|1024795|P2|NOT COMPLETED|Overall Study||0
418133|NCT01574248|1024796|P1|NOT COMPLETED|Overall Study||3
418134|NCT01574248|1024795|P2|COMPLETED|Overall Study||18
418135|NCT01574248|1024796|P1|COMPLETED|Overall Study||12
418136|NCT01574248|1024795|P2|STARTED|Overall Study||18
418137|NCT01574248|1024796|P1|STARTED|Overall Study||15
418138|NCT01574183|1024816|P2|NOT COMPLETED|Overall Study||18
418139|NCT01574183|1024817|P1|NOT COMPLETED|Overall Study||27
418140|NCT01574183|1024816|P2|COMPLETED|Overall Study||17
418141|NCT01574183|1024817|P1|COMPLETED|Overall Study||14
418142|NCT01574183|1024816|P2|STARTED|Overall Study||35
418143|NCT01574183|1024817|P1|STARTED|Overall Study||41
418144|NCT01574105|1024829|P2|NOT COMPLETED|Overall Study||0
418145|NCT01574105|1024830|P1|NOT COMPLETED|Overall Study||0
418146|NCT01574105|1024829|P2|COMPLETED|Overall Study||37
418147|NCT01574105|1024830|P1|COMPLETED|Overall Study||29
418148|NCT01574105|1024829|P2|STARTED|Overall Study||37
418149|NCT01574105|1024830|P1|STARTED|Overall Study||29
418150|NCT01574079|1024840|P2|NOT COMPLETED|Overall Study||2
418151|NCT01574079|1024841|P1|NOT COMPLETED|Overall Study||1
418152|NCT01574079|1024840|P2|COMPLETED|Overall Study||13
418153|NCT01574079|1024841|P1|COMPLETED|Overall Study||17
418154|NCT01574079|1024840|P2|STARTED|Overall Study||15
418155|NCT01574079|1024841|P1|STARTED|Overall Study||18
418156|NCT01573910|1024853|P2|NOT COMPLETED|Overall Study||17
418157|NCT01573910|1024854|P1|NOT COMPLETED|Overall Study||20
418158|NCT01573910|1024853|P2|COMPLETED|Overall Study||476
418159|NCT01573910|1024854|P1|COMPLETED|Overall Study||469
418160|NCT01573910|1024853|P2|STARTED|Overall Study||493
418161|NCT01573910|1024854|P1|STARTED|Overall Study||489
418162|NCT01573767|1024866|P4|NOT COMPLETED|Overall Study||24
418163|NCT01573767|1024867|P3|NOT COMPLETED|Overall Study||14
418164|NCT01573767|1024868|P2|NOT COMPLETED|Overall Study||21
418165|NCT01573767|1024869|P1|NOT COMPLETED|Overall Study||22
418166|NCT01573767|1024866|P4|COMPLETED|Overall Study||90
418167|NCT01573767|1024867|P3|COMPLETED|Overall Study||99
418168|NCT01573767|1024868|P2|COMPLETED|Overall Study||93
418169|NCT01573767|1024869|P1|COMPLETED|Overall Study||93
418170|NCT01573767|1024866|P4|STARTED|Overall Study||114
418171|NCT01573767|1024867|P3|STARTED|Overall Study||113
418172|NCT01573767|1024868|P2|STARTED|Overall Study||114
418173|NCT01573767|1024869|P1|STARTED|Overall Study||115
418174|NCT01573624|1024903|P7|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
418175|NCT01573624|1024904|P6|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||1
418176|NCT01573624|1024905|P5|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||2
418177|NCT01573624|1024906|P4|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
418178|NCT01573624|1024907|P3|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
418179|NCT01573624|1024908|P2|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
418180|NCT01573624|1024909|P1|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||1
418181|NCT01573624|1024903|P7|COMPLETED|Period 6 : Follow-up Period (7 Days)||48
418182|NCT01573624|1024904|P6|COMPLETED|Period 6 : Follow-up Period (7 Days)||38
418183|NCT01573624|1024905|P5|COMPLETED|Period 6 : Follow-up Period (7 Days)||49
418184|NCT01573624|1024906|P4|COMPLETED|Period 6 : Follow-up Period (7 Days)||53
418185|NCT01573624|1024907|P3|COMPLETED|Period 6 : Follow-up Period (7 Days)||43
418186|NCT01573624|1024908|P2|COMPLETED|Period 6 : Follow-up Period (7 Days)||47
418187|NCT01573624|1024909|P1|COMPLETED|Period 6 : Follow-up Period (7 Days)||45
418188|NCT01573624|1024903|P7|STARTED|Period 6 : Follow-up Period (7 Days)||48
418189|NCT01573624|1024904|P6|STARTED|Period 6 : Follow-up Period (7 Days)||39
418190|NCT01573624|1024905|P5|STARTED|Period 6 : Follow-up Period (7 Days)||51
418191|NCT01573624|1024906|P4|STARTED|Period 6 : Follow-up Period (7 Days)||53
418192|NCT01573624|1024907|P3|STARTED|Period 6 : Follow-up Period (7 Days)||43
418193|NCT01573624|1024908|P2|STARTED|Period 6 : Follow-up Period (7 Days)||47
418194|NCT01573624|1024909|P1|STARTED|Period 6 : Follow-up Period (7 Days)||46
418195|NCT01573624|1024903|P7|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||4
418196|NCT01573624|1024904|P6|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||2
418197|NCT01573624|1024905|P5|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||1
418198|NCT01573624|1024906|P4|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||0
418199|NCT01573624|1024907|P3|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||0
418200|NCT01573624|1024908|P2|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||1
418201|NCT01573624|1024909|P1|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||3
418202|NCT01573624|1024903|P7|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||48
418203|NCT01573624|1024904|P6|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||39
418204|NCT01573624|1024905|P5|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||51
418205|NCT01573624|1024906|P4|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||53
418206|NCT01573624|1024907|P3|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||43
418207|NCT01573624|1024908|P2|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||47
418208|NCT01573624|1024909|P1|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||46
418209|NCT01573624|1024903|P7|STARTED|Period 5 : Treatment Period 3 (14 Days)||52
418210|NCT01573624|1024904|P6|STARTED|Period 5 : Treatment Period 3 (14 Days)||41
418211|NCT01573624|1024905|P5|STARTED|Period 5 : Treatment Period 3 (14 Days)||52
418212|NCT01573624|1024906|P4|STARTED|Period 5 : Treatment Period 3 (14 Days)||53
418213|NCT01573624|1024907|P3|STARTED|Period 5 : Treatment Period 3 (14 Days)||43
418214|NCT01573624|1024908|P2|STARTED|Period 5 : Treatment Period 3 (14 Days)||48
418215|NCT01573624|1024909|P1|STARTED|Period 5 : Treatment Period 3 (14 Days)||49
418216|NCT01573624|1024903|P7|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||3
418217|NCT01573624|1024904|P6|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
418218|NCT01573624|1024905|P5|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||1
418219|NCT01573624|1024906|P4|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
418220|NCT01573624|1024907|P3|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
418221|NCT01573624|1024908|P2|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||4
418222|NCT01573624|1024909|P1|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||1
418223|NCT01573624|1024903|P7|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||52
418224|NCT01573624|1024904|P6|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||41
418225|NCT01573624|1024905|P5|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||52
418226|NCT01573624|1024906|P4|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||53
418227|NCT01573624|1024907|P3|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||43
418228|NCT01573624|1024908|P2|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||48
418229|NCT01573624|1024909|P1|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||49
418230|NCT01573624|1024903|P7|STARTED|Period 4 : Washout Period 2 (12-14 Days)||55
418231|NCT01573624|1024904|P6|STARTED|Period 4 : Washout Period 2 (12-14 Days)||43
418232|NCT01573624|1024905|P5|STARTED|Period 4 : Washout Period 2 (12-14 Days)||53
418233|NCT01573624|1024906|P4|STARTED|Period 4 : Washout Period 2 (12-14 Days)||55
418234|NCT01573624|1024907|P3|STARTED|Period 4 : Washout Period 2 (12-14 Days)||45
418235|NCT01573624|1024908|P2|STARTED|Period 4 : Washout Period 2 (12-14 Days)||52
418236|NCT01573624|1024909|P1|STARTED|Period 4 : Washout Period 2 (12-14 Days)||50
418237|NCT01573624|1024903|P7|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||0
418238|NCT01573624|1024904|P6|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||5
418239|NCT01573624|1024905|P5|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||3
418240|NCT01573624|1024906|P4|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||1
418241|NCT01573624|1024907|P3|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||3
418242|NCT01573624|1024908|P2|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||6
418243|NCT01573624|1024909|P1|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||7
418244|NCT01573624|1024903|P7|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||55
418245|NCT01573624|1024904|P6|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||43
418246|NCT01573624|1024905|P5|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||53
418247|NCT01573624|1024906|P4|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||55
418248|NCT01573624|1024907|P3|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||45
418249|NCT01573624|1024908|P2|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||52
418250|NCT01573624|1024909|P1|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||50
418251|NCT01573624|1024903|P7|STARTED|Period 3 : Treatment Period 2 (14 Days)||55
418252|NCT01573624|1024904|P6|STARTED|Period 3 : Treatment Period 2 (14 Days)||48
418253|NCT01573624|1024905|P5|STARTED|Period 3 : Treatment Period 2 (14 Days)||56
418254|NCT01573624|1024906|P4|STARTED|Period 3 : Treatment Period 2 (14 Days)||56
418255|NCT01573624|1024907|P3|STARTED|Period 3 : Treatment Period 2 (14 Days)||48
418256|NCT01573624|1024908|P2|STARTED|Period 3 : Treatment Period 2 (14 Days)||58
418257|NCT01573624|1024909|P1|STARTED|Period 3 : Treatment Period 2 (14 Days)||57
418258|NCT01573624|1024903|P7|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||2
418259|NCT01573624|1024904|P6|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||3
418260|NCT01573624|1024905|P5|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||0
418261|NCT01573624|1024906|P4|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||5
418262|NCT01573624|1024907|P3|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||3
418263|NCT01573624|1024908|P2|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||1
418264|NCT01573624|1024909|P1|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||1
418265|NCT01573624|1024903|P7|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||55
418266|NCT01573624|1024904|P6|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||48
418267|NCT01573624|1024905|P5|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||56
418268|NCT01573624|1024906|P4|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||56
418269|NCT01573624|1024907|P3|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||48
418270|NCT01573624|1024908|P2|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||58
418271|NCT01573624|1024909|P1|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||57
418272|NCT01573624|1024903|P7|STARTED|Period 2 : Washout Period 1 (12-14 Days)||57
418273|NCT01573624|1024904|P6|STARTED|Period 2 : Washout Period 1 (12-14 Days)||51
418274|NCT01573624|1024905|P5|STARTED|Period 2 : Washout Period 1 (12-14 Days)||56
418275|NCT01573624|1024906|P4|STARTED|Period 2 : Washout Period 1 (12-14 Days)||61
418276|NCT01573624|1024907|P3|STARTED|Period 2 : Washout Period 1 (12-14 Days)||51
418277|NCT01573624|1024908|P2|STARTED|Period 2 : Washout Period 1 (12-14 Days)||59
418278|NCT01573624|1024909|P1|STARTED|Period 2 : Washout Period 1 (12-14 Days)||58
418279|NCT01573624|1024903|P7|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
418280|NCT01573624|1024904|P6|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||4
418281|NCT01573624|1024905|P5|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
418282|NCT01573624|1024906|P4|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
418283|NCT01573624|1024907|P3|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||9
418284|NCT01573624|1024908|P2|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||3
418285|NCT01573624|1024909|P1|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||6
418286|NCT01573624|1024903|P7|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||57
418287|NCT01573624|1024904|P6|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||51
418288|NCT01573624|1024905|P5|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||56
418289|NCT01573624|1024906|P4|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||61
418290|NCT01573624|1024907|P3|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||51
418291|NCT01573624|1024908|P2|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||59
418292|NCT01573624|1024909|P1|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||58
418293|NCT01573624|1024903|P7|STARTED|Period 1 : Treatment Period 1 (14 Days)||59
418294|NCT01573624|1024904|P6|STARTED|Period 1 : Treatment Period 1 (14 Days)||55
418295|NCT01573624|1024905|P5|STARTED|Period 1 : Treatment Period 1 (14 Days)||58
418296|NCT01573624|1024906|P4|STARTED|Period 1 : Treatment Period 1 (14 Days)||63
418297|NCT01573624|1024907|P3|STARTED|Period 1 : Treatment Period 1 (14 Days)||60
418298|NCT01573624|1024908|P2|STARTED|Period 1 : Treatment Period 1 (14 Days)||62
418299|NCT01573624|1024909|P1|STARTED|Period 1 : Treatment Period 1 (14 Days)||64
418300|NCT01573325|1024956|P1|NOT COMPLETED|Overall Study||0
418301|NCT01573325|1024956|P1|COMPLETED|Overall Study||50
418302|NCT01573325|1024956|P1|STARTED|Overall Study||50
418303|NCT01573260|1024963|P2|NOT COMPLETED|Overall Study||0
418304|NCT01573260|1024964|P1|NOT COMPLETED|Overall Study||0
418305|NCT01573260|1024963|P2|COMPLETED|Overall Study||15
418306|NCT01573260|1024964|P1|COMPLETED|Overall Study||18
418307|NCT01573260|1024963|P2|STARTED|Overall Study||15
418308|NCT01573260|1024964|P1|STARTED|Overall Study||18
418309|NCT01573000|1024998|P2|NOT COMPLETED|Long-Term Follow-Up||1
418310|NCT01573000|1024999|P1|NOT COMPLETED|Long-Term Follow-Up||3
418311|NCT01573000|1024998|P2|COMPLETED|Long-Term Follow-Up|One participant who received crossover treatment was lost to follow up.|4
418312|NCT01573000|1024999|P1|COMPLETED|Long-Term Follow-Up||11
418313|NCT01573000|1024998|P2|STARTED|Long-Term Follow-Up|5 of the 35 participants withdrawing from Study BEX104515 enrolled in long-term follow-up study.|5
418314|NCT01573000|1024999|P1|STARTED|Long-Term Follow-Up|14 of the 35 participants withdrawing from Study BEX104515 enrolled in long-term follow-up study.|14
418315|NCT01573000|1024998|P2|NOT COMPLETED|Crossover Phase||18
418316|NCT01573000|1024999|P1|NOT COMPLETED|Crossover Phase||0
418317|NCT01573000|1024998|P2|COMPLETED|Crossover Phase|This participant completed 2 years of follow up and enrolled in BEX104526.|1
418318|NCT01573000|1024999|P1|COMPLETED|Crossover Phase||0
418319|NCT01573000|1024998|P2|STARTED|Crossover Phase|19 of 36 par. randomized to receive Unlabeled TST crossed over to receive TST and Iodine I 131 TST.|19
418320|NCT01573000|1024999|P1|STARTED|Crossover Phase||0
418321|NCT01573000|1024998|P2|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35
418322|NCT01573000|1024999|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35
418323|NCT01573000|1024998|P2|COMPLETED|Dosimetric and Therapeutic Treatment|These participants completed 2 years of follow up and enrolled in BEX104526.|1
418324|NCT01573000|1024999|P1|COMPLETED|Dosimetric and Therapeutic Treatment|These participants completed 2 years of follow up and enrolled in BEX104526.|7
418325|NCT01573000|1024998|P2|STARTED|Dosimetric and Therapeutic Treatment||36
418326|NCT01573000|1024999|P1|STARTED|Dosimetric and Therapeutic Treatment||42
418327|NCT01572948|1025095|P2|NOT COMPLETED|Overall Study||1
418328|NCT01572948|1025096|P1|NOT COMPLETED|Overall Study||1
418329|NCT01572948|1025095|P2|COMPLETED|Overall Study||15
418330|NCT01572948|1025096|P1|COMPLETED|Overall Study||10
418331|NCT01572948|1025095|P2|STARTED|Overall Study||16
418332|NCT01572948|1025096|P1|STARTED|Overall Study||11
418333|NCT01572844|1025112|P2|NOT COMPLETED|Overall Study||1
418334|NCT01572844|1025113|P1|NOT COMPLETED|Overall Study||1
418335|NCT01572844|1025112|P2|COMPLETED|Overall Study||2
418336|NCT01572844|1025113|P1|COMPLETED|Overall Study||2
418337|NCT01572844|1025112|P2|STARTED|Overall Study||3
418338|NCT01572844|1025113|P1|STARTED|Overall Study||3
418339|NCT01572792|1025131|P5|NOT COMPLETED|Extension Study||32
418340|NCT01572792|1025132|P4|NOT COMPLETED|Extension Study||29
418341|NCT01572792|1025133|P3|NOT COMPLETED|Extension Study||26
418342|NCT01572792|1025134|P2|NOT COMPLETED|Extension Study||29
418343|NCT01572792|1025135|P1|NOT COMPLETED|Extension Study||25
418344|NCT01572792|1025131|P5|COMPLETED|Extension Study||160
418345|NCT01572792|1025132|P4|COMPLETED|Extension Study||165
418346|NCT01572792|1025133|P3|COMPLETED|Extension Study||179
418347|NCT01572792|1025134|P2|COMPLETED|Extension Study||155
418348|NCT01572792|1025135|P1|COMPLETED|Extension Study||121
418349|NCT01572792|1025131|P5|STARTED|Extension Study||192
418350|NCT01572792|1025132|P4|STARTED|Extension Study||194
418351|NCT01572792|1025133|P3|STARTED|Extension Study||205
418352|NCT01572792|1025134|P2|STARTED|Extension Study||184
418353|NCT01572792|1025135|P1|STARTED|Extension Study||146
418354|NCT01572792|1025131|P5|NOT COMPLETED|Lead-in Study||69
418355|NCT01572792|1025132|P4|NOT COMPLETED|Lead-in Study||72
418356|NCT01572792|1025133|P3|NOT COMPLETED|Lead-in Study||62
418357|NCT01572792|1025134|P2|NOT COMPLETED|Lead-in Study||66
418358|NCT01572792|1025135|P1|NOT COMPLETED|Lead-in Study||101
418359|NCT01572792|1025131|P5|COMPLETED|Lead-in Study||270
418360|NCT01572792|1025132|P4|COMPLETED|Lead-in Study||268
418361|NCT01572792|1025133|P3|COMPLETED|Lead-in Study||276
418362|NCT01572792|1025134|P2|COMPLETED|Lead-in Study||272
418363|NCT01572792|1025135|P1|COMPLETED|Lead-in Study||236
418364|NCT01572792|1025131|P5|STARTED|Lead-in Study||339
418365|NCT01572792|1025132|P4|STARTED|Lead-in Study||340
418366|NCT01572792|1025133|P3|STARTED|Lead-in Study||338
418367|NCT01572792|1025134|P2|STARTED|Lead-in Study||338
418368|NCT01572792|1025135|P1|STARTED|Lead-in Study||337
418369|NCT01572740|1025184|P2|NOT COMPLETED|Overall Study||5
418370|NCT01572740|1025185|P1|NOT COMPLETED|Overall Study||6
418371|NCT01572740|1025184|P2|COMPLETED|Overall Study||125
418372|NCT01572740|1025185|P1|COMPLETED|Overall Study||121
418373|NCT01572740|1025184|P2|STARTED|Overall Study||130
418374|NCT01572740|1025185|P1|STARTED|Overall Study||127
418375|NCT01572727|1025215|P2|NOT COMPLETED|Overall Study||209
418376|NCT01572727|1025216|P1|NOT COMPLETED|Overall Study||207
418377|NCT01572727|1025215|P2|COMPLETED|Overall Study||0
418378|NCT01572727|1025216|P1|COMPLETED|Overall Study||0
418379|NCT01572727|1025215|P2|Pts With Treatment + Safety Assessment|Overall Study|patients who received study treatment and had at least one post-baseline safety assessment|201
418380|NCT01572727|1025216|P1|Pts With Treatment + Safety Assessment|Overall Study|patients who received study treatment and had at least one post-baseline safety assessment|202
418381|NCT01572727|1025215|P2|STARTED|Overall Study||209
418382|NCT01572727|1025216|P1|STARTED|Overall Study||207
418383|NCT01572675|1025238|P2|NOT COMPLETED|Overall Study||223
418384|NCT01572675|1025239|P1|NOT COMPLETED|Overall Study||237
418385|NCT01572675|1025238|P2|COMPLETED|Overall Study||56
418386|NCT01572675|1025239|P1|COMPLETED|Overall Study||31
418387|NCT01572675|1025238|P2|STARTED|Overall Study||279
418388|NCT01572675|1025239|P1|STARTED|Overall Study||268
418389|NCT01572389|1025338|P2|NOT COMPLETED|Overall Study||21
418390|NCT01572389|1025339|P1|NOT COMPLETED|Overall Study||46
418391|NCT01572389|1025338|P2|COMPLETED|Overall Study||68
418392|NCT01572389|1025339|P1|COMPLETED|Overall Study||90
418393|NCT01572389|1025338|P2|STARTED|Overall Study||89
418394|NCT01572389|1025339|P1|STARTED|Overall Study||136
418395|NCT01572298|1025349|P2|NOT COMPLETED|Overall Study||1
418396|NCT01572298|1025350|P1|NOT COMPLETED|Overall Study||2
418397|NCT01572298|1025349|P2|COMPLETED|Overall Study||12
418398|NCT01572298|1025350|P1|COMPLETED|Overall Study||12
418399|NCT01572298|1025349|P2|STARTED|Overall Study||13
418400|NCT01572298|1025350|P1|STARTED|Overall Study||14
418401|NCT01572207|1025360|P2|NOT COMPLETED|Overall Study||3
418402|NCT01572207|1025361|P1|NOT COMPLETED|Overall Study||2
418403|NCT01572207|1025360|P2|COMPLETED|Overall Study||13
418404|NCT01572207|1025361|P1|COMPLETED|Overall Study||12
418405|NCT01572207|1025360|P2|STARTED|Overall Study||16
418406|NCT01572207|1025361|P1|STARTED|Overall Study||14
418407|NCT01571557|1025371|P1|NOT COMPLETED|Overall Study||0
418408|NCT01571557|1025371|P1|COMPLETED|Overall Study||573
418409|NCT01571557|1025371|P1|STARTED|Overall Study||573
418410|NCT01571453|1025380|P2|NOT COMPLETED|Overall Study||62
418411|NCT01571453|1025381|P1|NOT COMPLETED|Overall Study||38
418412|NCT01571453|1025380|P2|COMPLETED|Overall Study||164
418413|NCT01571453|1025381|P1|COMPLETED|Overall Study||173
418414|NCT01571453|1025380|P2|STARTED|Overall Study||226
418415|NCT01571453|1025381|P1|STARTED|Overall Study||211
418416|NCT01571362|1025397|P3|NOT COMPLETED|Double-Blind Treatment Period||39
418417|NCT01571362|1025398|P2|NOT COMPLETED|Double-Blind Treatment Period||53
418418|NCT01571362|1025399|P1|NOT COMPLETED|Double-Blind Treatment Period||0
418419|NCT01571362|1025397|P3|COMPLETED|Double-Blind Treatment Period||107
418420|NCT01571362|1025398|P2|COMPLETED|Double-Blind Treatment Period||81
418421|NCT01571362|1025399|P1|COMPLETED|Double-Blind Treatment Period|This phase preceded the Double-Blind Treatment Period.|0
418422|NCT01571362|1025397|P3|STARTED|Double-Blind Treatment Period||146
418423|NCT01571362|1025398|P2|STARTED|Double-Blind Treatment Period||134
418424|NCT01571362|1025399|P1|STARTED|Double-Blind Treatment Period|This phase preceded the Double-Blind Treatment Period.|0
418425|NCT01571362|1025397|P3|NOT COMPLETED|Open-Label Conversion + Titration Period||0
418426|NCT01571362|1025398|P2|NOT COMPLETED|Open-Label Conversion + Titration Period||0
418427|NCT01571362|1025399|P1|NOT COMPLETED|Open-Label Conversion + Titration Period||129
418428|NCT01571362|1025397|P3|COMPLETED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
418429|NCT01571362|1025398|P2|COMPLETED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
418430|NCT01571362|1025399|P1|COMPLETED|Open-Label Conversion + Titration Period||281
418431|NCT01571362|1025397|P3|STARTED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
418432|NCT01571362|1025398|P2|STARTED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
418433|NCT01571362|1025399|P1|STARTED|Open-Label Conversion + Titration Period||410
418434|NCT01571284|1025569|P1|NOT COMPLETED|Overall Study||169
418435|NCT01571284|1025569|P1|COMPLETED|Overall Study|403 participants with DP and 209 with adverse events were considered as completed.|612
418436|NCT01571284|1025569|P1|Safety Population|Overall Study||779
418437|NCT01571284|1025569|P1|STARTED|Overall Study||781
418438|NCT01571232|1025592|P2|NOT COMPLETED|Overall Study||1
418439|NCT01571232|1025593|P1|NOT COMPLETED|Overall Study||1
418440|NCT01571232|1025592|P2|COMPLETED|Overall Study||9
418441|NCT01571232|1025593|P1|COMPLETED|Overall Study||9
418442|NCT01571232|1025592|P2|STARTED|Overall Study||10
418443|NCT01571232|1025593|P1|STARTED|Overall Study||10
418444|NCT01570751|1025605|P2|NOT COMPLETED|Period B (16 Weeks)||1
418445|NCT01570751|1025606|P1|NOT COMPLETED|Period B (16 Weeks)||1
418446|NCT01570751|1025605|P2|COMPLETED|Period B (16 Weeks)||66
418447|NCT01570751|1025606|P1|COMPLETED|Period B (16 Weeks)||69
418448|NCT01570751|1025605|P2|Exposed|Period B (16 Weeks)||67
418449|NCT01570751|1025606|P1|Exposed|Period B (16 Weeks)||70
418450|NCT01570751|1025605|P2|STARTED|Period B (16 Weeks)||67
418451|NCT01570751|1025606|P1|STARTED|Period B (16 Weeks)||70
418452|NCT01570751|1025605|P2|NOT COMPLETED|Period A (16 Weeks)||5
418453|NCT01570751|1025606|P1|NOT COMPLETED|Period A (16 Weeks)||3
418454|NCT01570751|1025605|P2|COMPLETED|Period A (16 Weeks)||67
418455|NCT01570751|1025606|P1|COMPLETED|Period A (16 Weeks)||70
418456|NCT01570751|1025605|P2|Exposed|Period A (16 Weeks)||72
418457|NCT01570751|1025606|P1|Exposed|Period A (16 Weeks)||73
418458|NCT01570751|1025605|P2|STARTED|Period A (16 Weeks)||72
418459|NCT01570751|1025606|P1|STARTED|Period A (16 Weeks)||73
418460|NCT01570686|1025624|P2|NOT COMPLETED|Overall Study||16
418461|NCT01570686|1025625|P1|NOT COMPLETED|Overall Study||22
418462|NCT01570686|1025624|P2|COMPLETED|Overall Study||278
418463|NCT01570686|1025625|P1|COMPLETED|Overall Study||274
418464|NCT01570686|1025624|P2|Safety and Full Analysis Set (FAS)|Overall Study||294
418465|NCT01570686|1025625|P1|Safety and Full Analysis Set (FAS)|Overall Study|One patient was mis-randomized and never received study drug. Hence not included in Safety or FAS.|295
418466|NCT01570686|1025624|P2|STARTED|Overall Study||294
418467|NCT01570686|1025625|P1|STARTED|Overall Study||296
418468|NCT01570634|1025651|P1|NOT COMPLETED|Overall Study||0
418469|NCT01570634|1025651|P1|COMPLETED|Overall Study||2
418470|NCT01570634|1025651|P1|STARTED|Overall Study||2
418471|NCT01570309|1025661|P2|NOT COMPLETED|Overall Study||3
418472|NCT01570309|1025662|P1|NOT COMPLETED|Overall Study||3
418473|NCT01570309|1025661|P2|COMPLETED|Overall Study||45
418474|NCT01570309|1025662|P1|COMPLETED|Overall Study||45
418475|NCT01570309|1025661|P2|STARTED|Overall Study||48
418476|NCT01570309|1025662|P1|STARTED|Overall Study||48
418477|NCT01570244|1025676|P1|NOT COMPLETED|Microgynon+Faldaprevir||1
418478|NCT01570244|1025676|P1|COMPLETED|Microgynon+Faldaprevir||15
418479|NCT01570244|1025676|P1|STARTED|Microgynon+Faldaprevir||16
418480|NCT01570244|1025676|P1|NOT COMPLETED|Microgynon||0
418481|NCT01570244|1025676|P1|COMPLETED|Microgynon||16
418482|NCT01570244|1025676|P1|STARTED|Microgynon||16
418483|NCT01570192|1025698|P2|NOT COMPLETED|Overall Study||13
418484|NCT01570192|1025699|P1|NOT COMPLETED|Overall Study||7
418485|NCT01570192|1025698|P2|COMPLETED|Overall Study||17
418486|NCT01570192|1025699|P1|COMPLETED|Overall Study||6
418487|NCT01570192|1025698|P2|STARTED|Overall Study||30
418488|NCT01570192|1025699|P1|STARTED|Overall Study||13
418489|NCT01569841|1025737|P2|NOT COMPLETED|Period B (6 Weeks)||0
418490|NCT01569841|1025738|P1|NOT COMPLETED|Period B (6 Weeks)||0
418491|NCT01569841|1025737|P2|COMPLETED|Period B (6 Weeks)||11
418492|NCT01569841|1025738|P1|COMPLETED|Period B (6 Weeks)||12
418493|NCT01569841|1025737|P2|Exposed|Period B (6 Weeks)||11
418494|NCT01569841|1025738|P1|Exposed|Period B (6 Weeks)||12
418495|NCT01569841|1025737|P2|STARTED|Period B (6 Weeks)||11
418496|NCT01569841|1025738|P1|STARTED|Period B (6 Weeks)||12
418497|NCT01569841|1025737|P2|NOT COMPLETED|Period A (6 Weeks)||1
418498|NCT01569841|1025738|P1|NOT COMPLETED|Period A (6 Weeks)||0
418499|NCT01569841|1025737|P2|COMPLETED|Period A (6 Weeks)||11
418500|NCT01569841|1025738|P1|COMPLETED|Period A (6 Weeks)||12
418501|NCT01569841|1025737|P2|Exposed|Period A (6 Weeks)||12
418502|NCT01569841|1025738|P1|Exposed|Period A (6 Weeks)||12
418503|NCT01569841|1025737|P2|STARTED|Period A (6 Weeks)||12
418504|NCT01569841|1025738|P1|STARTED|Period A (6 Weeks)||12
418505|NCT01569828|1025756|P2|NOT COMPLETED|Overall Study||0
418506|NCT01569828|1025757|P1|NOT COMPLETED|Overall Study||0
418507|NCT01569828|1025756|P2|COMPLETED|Overall Study||6
418508|NCT01569828|1025757|P1|COMPLETED|Overall Study||6
418509|NCT01569828|1025756|P2|STARTED|Overall Study||6
418510|NCT01569828|1025757|P1|STARTED|Overall Study||6
418511|NCT01569815|1025779|P4|NOT COMPLETED|Overall Study||0
418512|NCT01569815|1025780|P3|NOT COMPLETED|Overall Study||0
418513|NCT01569815|1025781|P2|NOT COMPLETED|Overall Study||0
418514|NCT01569815|1025782|P1|NOT COMPLETED|Overall Study||0
418515|NCT01569815|1025779|P4|COMPLETED|Overall Study||8
418516|NCT01569815|1025780|P3|COMPLETED|Overall Study||8
418517|NCT01569815|1025781|P2|COMPLETED|Overall Study||8
418518|NCT01569815|1025782|P1|COMPLETED|Overall Study||8
418519|NCT01569815|1025779|P4|STARTED|Overall Study||8
418520|NCT01569815|1025780|P3|STARTED|Overall Study||8
418521|NCT01569815|1025781|P2|STARTED|Overall Study||8
418522|NCT01569815|1025782|P1|STARTED|Overall Study||8
418523|NCT01569763|1025827|P2|NOT COMPLETED|Overall Study||7
418524|NCT01569763|1025828|P1|NOT COMPLETED|Overall Study||3
418525|NCT01569763|1025827|P2|COMPLETED|Overall Study|Completed 12 Months of Follow-up|44
418526|NCT01569763|1025828|P1|COMPLETED|Overall Study|Completed 12 Months of Follow-up|99
418527|NCT01569763|1025827|P2|Treated|Overall Study||51
418528|NCT01569763|1025828|P1|Treated|Overall Study||102
418529|NCT01569763|1025827|P2|STARTED|Overall Study||51
418530|NCT01569763|1025828|P1|STARTED|Overall Study||102
418531|NCT01569607|1025840|P2|NOT COMPLETED|Overall Study||1
418532|NCT01569607|1025841|P1|NOT COMPLETED|Overall Study||1
418533|NCT01569607|1025840|P2|COMPLETED|Overall Study||10
418534|NCT01569607|1025841|P1|COMPLETED|Overall Study||10
418535|NCT01569607|1025840|P2|STARTED|Overall Study||11
418536|NCT01569607|1025841|P1|STARTED|Overall Study||11
418537|NCT01569568|1025865|P2|NOT COMPLETED|Overall Study||2
418538|NCT01569568|1025866|P1|NOT COMPLETED|Overall Study||0
418539|NCT01569568|1025865|P2|COMPLETED|Overall Study||27
418540|NCT01569568|1025866|P1|COMPLETED|Overall Study||20
418541|NCT01569568|1025865|P2|STARTED|Overall Study||29
418542|NCT01569568|1025866|P1|STARTED|Overall Study||20
418543|NCT01569529|1025880|P2|NOT COMPLETED|Overall Study||0
418544|NCT01569529|1025881|P1|NOT COMPLETED|Overall Study||0
418545|NCT01569529|1025880|P2|COMPLETED|Overall Study||394
418546|NCT01569529|1025881|P1|COMPLETED|Overall Study||2676
418547|NCT01569529|1025880|P2|STARTED|Overall Study||394
418548|NCT01569529|1025881|P1|STARTED|Overall Study||2676
418549|NCT01569464|1025889|P2|NOT COMPLETED|Overall Study||5
418550|NCT01569464|1025890|P1|NOT COMPLETED|Overall Study||10
418551|NCT01569464|1025889|P2|COMPLETED|Overall Study||44
418552|NCT01569464|1025890|P1|COMPLETED|Overall Study||91
418553|NCT01569464|1025889|P2|STARTED|Overall Study||49
418554|NCT01569464|1025890|P1|STARTED|Overall Study||101
418555|NCT01569451|1025928|P2|NOT COMPLETED|Overall Study||13
418556|NCT01569451|1025929|P1|NOT COMPLETED|Overall Study||14
418557|NCT01569451|1025928|P2|COMPLETED|Overall Study||14
418558|NCT01569451|1025929|P1|COMPLETED|Overall Study||12
418559|NCT01569451|1025928|P2|STARTED|Overall Study||27
418560|NCT01569451|1025929|P1|STARTED|Overall Study||26
418561|NCT01569438|1025957|P2|NOT COMPLETED|Overall Study||9
418562|NCT01569438|1025958|P1|NOT COMPLETED|Overall Study||2
418563|NCT01569438|1025957|P2|COMPLETED|Overall Study||27
418564|NCT01569438|1025958|P1|COMPLETED|Overall Study||36
418565|NCT01569438|1025957|P2|STARTED|Overall Study||36
418566|NCT01569438|1025958|P1|STARTED|Overall Study||38
418567|NCT01569295|1025972|P2|NOT COMPLETED|Overall Study||67
418568|NCT01569295|1025973|P1|NOT COMPLETED|Overall Study||134
418569|NCT01569295|1025972|P2|COMPLETED|Overall Study||142
418570|NCT01569295|1025973|P1|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint (progressive disease or death)|73
418571|NCT01569295|1025972|P2|STARTED|Overall Study||209
418572|NCT01569295|1025973|P1|STARTED|Overall Study||207
418573|NCT01569191|1025989|P2|NOT COMPLETED|Overall Study||0
418574|NCT01569191|1025990|P1|NOT COMPLETED|Overall Study||0
418575|NCT01569191|1025989|P2|COMPLETED|Overall Study||7
418576|NCT01569191|1025990|P1|COMPLETED|Overall Study||11
418577|NCT01569191|1025989|P2|STARTED|Overall Study||7
418578|NCT01569191|1025990|P1|STARTED|Overall Study||11
418579|NCT01569152|1026010|P3|NOT COMPLETED|Safety Extension, Period 3||55
418580|NCT01569152|1026011|P2|NOT COMPLETED|Safety Extension, Period 3||0
418581|NCT01569152|1026012|P1|NOT COMPLETED|Safety Extension, Period 3||0
418582|NCT01569152|1026010|P3|COMPLETED|Safety Extension, Period 3||0
418583|NCT01569152|1026011|P2|COMPLETED|Safety Extension, Period 3||0
418584|NCT01569152|1026012|P1|COMPLETED|Safety Extension, Period 3||0
418585|NCT01569152|1026010|P3|STARTED|Safety Extension, Period 3|Includes 29 completers and 26 early escapees from Base Study Phase IIa|55
418586|NCT01569152|1026011|P2|STARTED|Safety Extension, Period 3||0
418587|NCT01569152|1026012|P1|STARTED|Safety Extension, Period 3||0
418588|NCT01569152|1026010|P3|NOT COMPLETED|Phase IIa, Period 1||0
418589|NCT01569152|1026011|P2|NOT COMPLETED|Phase IIa, Period 1||32
418590|NCT01569152|1026012|P1|NOT COMPLETED|Phase IIa, Period 1||21
418591|NCT01569152|1026010|P3|COMPLETED|Phase IIa, Period 1||0
418592|NCT01569152|1026011|P2|COMPLETED|Phase IIa, Period 1||9
418593|NCT01569152|1026012|P1|COMPLETED|Phase IIa, Period 1||20
418594|NCT01569152|1026010|P3|STARTED|Phase IIa, Period 1||0
418595|NCT01569152|1026011|P2|STARTED|Phase IIa, Period 1||41
418596|NCT01569152|1026012|P1|STARTED|Phase IIa, Period 1||41
418597|NCT01569126|1026075|P6|NOT COMPLETED|Overall Study||0
418598|NCT01569126|1026076|P5|NOT COMPLETED|Overall Study||0
418599|NCT01569126|1026077|P4|NOT COMPLETED|Overall Study||0
418600|NCT01569126|1026078|P3|NOT COMPLETED|Overall Study||0
418601|NCT01569126|1026079|P2|NOT COMPLETED|Overall Study||0
418602|NCT01569126|1026080|P1|NOT COMPLETED|Overall Study||0
418603|NCT01569126|1026075|P6|COMPLETED|Overall Study||12
418604|NCT01569126|1026076|P5|COMPLETED|Overall Study||12
418605|NCT01569126|1026077|P4|COMPLETED|Overall Study||8
418606|NCT01569126|1026078|P3|COMPLETED|Overall Study||8
418607|NCT01569126|1026079|P2|COMPLETED|Overall Study||8
418608|NCT01569126|1026080|P1|COMPLETED|Overall Study||8
418609|NCT01569126|1026075|P6|Received at Least 1 Dose of Study Drug|Overall Study||12
418610|NCT01569126|1026076|P5|Received at Least 1 Dose of Study Drug|Overall Study||12
418611|NCT01569126|1026077|P4|Received at Least 1 Dose of Study Drug|Overall Study||8
418612|NCT01569126|1026078|P3|Received at Least 1 Dose of Study Drug|Overall Study||8
418613|NCT01569126|1026079|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
418614|NCT01569126|1026080|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
418615|NCT01569126|1026075|P6|STARTED|Overall Study||12
418616|NCT01569126|1026076|P5|STARTED|Overall Study||12
418617|NCT01569126|1026077|P4|STARTED|Overall Study||8
418618|NCT01569126|1026078|P3|STARTED|Overall Study||8
418619|NCT01569126|1026079|P2|STARTED|Overall Study||8
418620|NCT01569126|1026080|P1|STARTED|Overall Study||8
418621|NCT01569087|1026118|P3|NOT COMPLETED|Overall Study||1
418622|NCT01569087|1026119|P2|NOT COMPLETED|Overall Study||0
418623|NCT01569087|1026120|P1|NOT COMPLETED|Overall Study||1
418624|NCT01569087|1026118|P3|COMPLETED|Overall Study||18
418625|NCT01569087|1026119|P2|COMPLETED|Overall Study||20
418626|NCT01569087|1026120|P1|COMPLETED|Overall Study||20
418627|NCT01569087|1026118|P3|STARTED|Overall Study||19
418628|NCT01569087|1026119|P2|STARTED|Overall Study||20
418629|NCT01569087|1026120|P1|STARTED|Overall Study||21
418630|NCT01569074|1026148|P5|NOT COMPLETED|Overall Study||8
418631|NCT01569074|1026149|P4|NOT COMPLETED|Overall Study||8
418632|NCT01569074|1026150|P3|NOT COMPLETED|Overall Study||12
418633|NCT01569074|1026151|P2|NOT COMPLETED|Overall Study||9
418634|NCT01569074|1026152|P1|NOT COMPLETED|Overall Study||7
418635|NCT01569074|1026148|P5|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|25
418636|NCT01569074|1026149|P4|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|25
418637|NCT01569074|1026150|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|21
418638|NCT01569074|1026151|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|24
418639|NCT01569074|1026152|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|24
418640|NCT01569074|1026148|P5|Randomised But Did Not Receive Treatment|Overall Study||0
418641|NCT01569074|1026149|P4|Randomised But Did Not Receive Treatment|Overall Study||0
418642|NCT01569074|1026150|P3|Randomised But Did Not Receive Treatment|Overall Study||0
418643|NCT01569074|1026151|P2|Randomised But Did Not Receive Treatment|Overall Study||0
418644|NCT01569074|1026152|P1|Randomised But Did Not Receive Treatment|Overall Study||0
418645|NCT01569074|1026148|P5|STARTED|Overall Study|Patients who received treatment|33
418646|NCT01569074|1026149|P4|STARTED|Overall Study|Patients who received treatment|33
418647|NCT01569074|1026150|P3|STARTED|Overall Study|Patients who received treatment|33
418648|NCT01569074|1026151|P2|STARTED|Overall Study|Patients who received treatment|33
418649|NCT01569074|1026152|P1|STARTED|Overall Study|Patients who received treatment|31
418650|NCT01569022|1026208|P2|NOT COMPLETED|Second Intervention||2
418651|NCT01569022|1026209|P1|NOT COMPLETED|Second Intervention||2
418652|NCT01569022|1026208|P2|COMPLETED|Second Intervention||18
418653|NCT01569022|1026209|P1|COMPLETED|Second Intervention||17
418654|NCT01569022|1026208|P2|STARTED|Second Intervention||20
418655|NCT01569022|1026209|P1|STARTED|Second Intervention||19
418656|NCT01569022|1026208|P2|NOT COMPLETED|First Intervention||1
418657|NCT01569022|1026209|P1|NOT COMPLETED|First Intervention||2
418658|NCT01569022|1026208|P2|COMPLETED|First Intervention||20
418659|NCT01569022|1026209|P1|COMPLETED|First Intervention||19
418660|NCT01569022|1026208|P2|STARTED|First Intervention||21
418661|NCT01569022|1026209|P1|STARTED|First Intervention||21
418662|NCT01568905|1026224|P3|NOT COMPLETED|Overall Study||0
418663|NCT01568905|1026225|P2|NOT COMPLETED|Overall Study||0
418664|NCT01568905|1026226|P1|NOT COMPLETED|Overall Study||1
418665|NCT01568905|1026224|P3|COMPLETED|Overall Study||12
418666|NCT01568905|1026225|P2|COMPLETED|Overall Study||11
418667|NCT01568905|1026226|P1|COMPLETED|Overall Study||12
418668|NCT01568905|1026224|P3|STARTED|Overall Study||12
418669|NCT01568905|1026225|P2|STARTED|Overall Study||11
418670|NCT01568905|1026226|P1|STARTED|Overall Study||13
418671|NCT01568892|1026245|P2|NOT COMPLETED|Open-label Phase||3
418672|NCT01568892|1026246|P1|NOT COMPLETED|Open-label Phase||6
418673|NCT01568892|1026245|P2|COMPLETED|Open-label Phase||13
418674|NCT01568892|1026246|P1|COMPLETED|Open-label Phase||7
418675|NCT01568892|1026245|P2|STARTED|Open-label Phase||16
418676|NCT01568892|1026246|P1|STARTED|Open-label Phase|One participant completing the DB Phase withdrew on Day 8 and did not enter the Open-label Phase.|13
418677|NCT01568892|1026245|P2|NOT COMPLETED|Double-blind Phase||0
418678|NCT01568892|1026246|P1|NOT COMPLETED|Double-blind Phase||0
418679|NCT01568892|1026245|P2|COMPLETED|Double-blind Phase||16
418680|NCT01568892|1026246|P1|COMPLETED|Double-blind Phase||14
418681|NCT01568892|1026245|P2|STARTED|Double-blind Phase||16
418682|NCT01568892|1026246|P1|STARTED|Double-blind Phase||14
418683|NCT01568866|1026316|P2|NOT COMPLETED|Overall Study||416
418684|NCT01568866|1026317|P1|NOT COMPLETED|Overall Study||438
418685|NCT01568866|1026316|P2|COMPLETED|Overall Study|Indicates participants still receiving treatment|48
418686|NCT01568866|1026317|P1|COMPLETED|Overall Study|Indicates participants still receiving treatment|27
418687|NCT01568866|1026316|P2|Received Treatment|Overall Study||463
418688|NCT01568866|1026317|P1|Received Treatment|Overall Study||456
418689|NCT01568866|1026316|P2|STARTED|Overall Study||464
418690|NCT01568866|1026317|P1|STARTED|Overall Study||465
418691|NCT01568827|1026339|P2|NOT COMPLETED|Intervention 2 (5 Days)||0
418692|NCT01568827|1026340|P1|NOT COMPLETED|Intervention 2 (5 Days)||0
418693|NCT01568827|1026339|P2|COMPLETED|Intervention 2 (5 Days)||5
418694|NCT01568827|1026340|P1|COMPLETED|Intervention 2 (5 Days)||5
418695|NCT01568827|1026339|P2|STARTED|Intervention 2 (5 Days)||5
418696|NCT01568827|1026340|P1|STARTED|Intervention 2 (5 Days)||5
418697|NCT01568827|1026339|P2|NOT COMPLETED|Washout (2 Days)||0
418698|NCT01568827|1026340|P1|NOT COMPLETED|Washout (2 Days)||0
418699|NCT01568827|1026339|P2|COMPLETED|Washout (2 Days)||5
418700|NCT01568827|1026340|P1|COMPLETED|Washout (2 Days)||5
418701|NCT01568827|1026339|P2|STARTED|Washout (2 Days)||5
418702|NCT01568827|1026340|P1|STARTED|Washout (2 Days)||5
418703|NCT01568827|1026339|P2|NOT COMPLETED|First Intervention (6 Days)||0
418704|NCT01568827|1026340|P1|NOT COMPLETED|First Intervention (6 Days)||0
418705|NCT01568827|1026339|P2|COMPLETED|First Intervention (6 Days)||5
418706|NCT01568827|1026340|P1|COMPLETED|First Intervention (6 Days)||5
418707|NCT01568827|1026339|P2|STARTED|First Intervention (6 Days)||5
418708|NCT01568827|1026340|P1|STARTED|First Intervention (6 Days)||5
418709|NCT01568593|1026348|P2|NOT COMPLETED|Overall Study||3
418710|NCT01568593|1026349|P1|NOT COMPLETED|Overall Study||7
418711|NCT01568593|1026348|P2|COMPLETED|Overall Study||42
418712|NCT01568593|1026349|P1|COMPLETED|Overall Study||41
418713|NCT01568593|1026348|P2|STARTED|Overall Study||45
418714|NCT01568593|1026349|P1|STARTED|Overall Study||48
418715|NCT01568424|1026355|P1|NOT COMPLETED|Overall Study||0
418716|NCT01568424|1026355|P1|COMPLETED|Overall Study||25
418717|NCT01568424|1026355|P1|STARTED|Overall Study||25
418718|NCT01568112|1026369|P4|NOT COMPLETED|Overall Study||12
418719|NCT01568112|1026370|P3|NOT COMPLETED|Overall Study||7
418720|NCT01568112|1026371|P2|NOT COMPLETED|Overall Study||8
418721|NCT01568112|1026372|P1|NOT COMPLETED|Overall Study||5
418722|NCT01568112|1026369|P4|COMPLETED|Overall Study||30
418723|NCT01568112|1026370|P3|COMPLETED|Overall Study||36
418724|NCT01568112|1026371|P2|COMPLETED|Overall Study||36
418725|NCT01568112|1026372|P1|COMPLETED|Overall Study||39
418726|NCT01568112|1026369|P4|STARTED|Overall Study||42
418727|NCT01568112|1026370|P3|STARTED|Overall Study||43
418728|NCT01568112|1026371|P2|STARTED|Overall Study||44
418729|NCT01568112|1026372|P1|STARTED|Overall Study||44
418730|NCT01568073|1026495|P5|NOT COMPLETED|Overall Study||9
418731|NCT01568073|1026496|P4|NOT COMPLETED|Overall Study||11
418732|NCT01568073|1026497|P3|NOT COMPLETED|Overall Study||12
418733|NCT01568073|1026498|P2|NOT COMPLETED|Overall Study||15
418734|NCT01568073|1026499|P1|NOT COMPLETED|Overall Study||11
418735|NCT01568073|1026495|P5|COMPLETED|Overall Study||107
418736|NCT01568073|1026496|P4|COMPLETED|Overall Study||108
418737|NCT01568073|1026497|P3|COMPLETED|Overall Study||110
418738|NCT01568073|1026498|P2|COMPLETED|Overall Study||107
418739|NCT01568073|1026499|P1|COMPLETED|Overall Study||110
418740|NCT01568073|1026495|P5|STARTED|Overall Study||116
418741|NCT01568073|1026496|P4|STARTED|Overall Study||119
418742|NCT01568073|1026497|P3|STARTED|Overall Study||122
418743|NCT01568073|1026498|P2|STARTED|Overall Study||122
418744|NCT01568073|1026499|P1|STARTED|Overall Study||121
418745|NCT01568047|1026530|P4|NOT COMPLETED|Overall Study||1
418746|NCT01568047|1026531|P3|NOT COMPLETED|Overall Study||1
418747|NCT01568047|1026532|P2|NOT COMPLETED|Overall Study||1
418748|NCT01568047|1026533|P1|NOT COMPLETED|Overall Study||1
418749|NCT01568047|1026530|P4|COMPLETED|Overall Study||9
418750|NCT01568047|1026531|P3|COMPLETED|Overall Study||9
418751|NCT01568047|1026532|P2|COMPLETED|Overall Study||9
418752|NCT01568047|1026533|P1|COMPLETED|Overall Study||9
418753|NCT01568047|1026530|P4|STARTED|Overall Study||10
418754|NCT01568047|1026531|P3|STARTED|Overall Study||10
418755|NCT01568047|1026532|P2|STARTED|Overall Study||10
418756|NCT01568047|1026533|P1|STARTED|Overall Study||10
418757|NCT01568034|1026551|P4|NOT COMPLETED|Overall Study||0
418758|NCT01568034|1026552|P3|NOT COMPLETED|Overall Study||0
418759|NCT01568034|1026553|P2|NOT COMPLETED|Overall Study||0
418760|NCT01568034|1026554|P1|NOT COMPLETED|Overall Study||1
418761|NCT01568034|1026551|P4|COMPLETED|Overall Study||3
418762|NCT01568034|1026552|P3|COMPLETED|Overall Study||3
418763|NCT01568034|1026553|P2|COMPLETED|Overall Study||2
418764|NCT01568034|1026554|P1|COMPLETED|Overall Study||1
418765|NCT01568034|1026551|P4|Placebo|Overall Study||3
418766|NCT01568034|1026552|P3|Placebo|Overall Study||3
418767|NCT01568034|1026553|P2|Placebo|Overall Study||2
418768|NCT01568034|1026554|P1|Placebo|Overall Study||1
418769|NCT01568034|1026551|P4|100 mg BIA 9-1067|Overall Study||3
418770|NCT01568034|1026552|P3|100 mg BIA 9-1067|Overall Study||3
418771|NCT01568034|1026553|P2|100 mg BIA 9-1067|Overall Study||2
418772|NCT01568034|1026554|P1|100 mg BIA 9-1067|Overall Study||2
418773|NCT01568034|1026551|P4|50 mg BIA 9-1067|Overall Study||3
418774|NCT01568034|1026552|P3|50 mg BIA 9-1067|Overall Study||3
418775|NCT01568034|1026553|P2|50 mg BIA 9-1067|Overall Study||2
418776|NCT01568034|1026554|P1|50 mg BIA 9-1067|Overall Study||2
418777|NCT01568034|1026551|P4|25 mg BIA 9-1067|Overall Study||3
418778|NCT01568034|1026552|P3|25 mg BIA 9-1067|Overall Study||3
418779|NCT01568034|1026553|P2|25 mg BIA 9-1067|Overall Study||2
418780|NCT01568034|1026554|P1|25 mg BIA 9-1067|Overall Study||2
418781|NCT01568034|1026551|P4|STARTED|Overall Study||3
418782|NCT01568034|1026552|P3|STARTED|Overall Study||3
418783|NCT01568034|1026553|P2|STARTED|Overall Study||2
418784|NCT01568034|1026554|P1|STARTED|Overall Study||2
418785|NCT01568021|1026572|P1|NOT COMPLETED|Overall Study||16
418786|NCT01568021|1026572|P1|COMPLETED|Overall Study||83
418787|NCT01568021|1026572|P1|STARTED|Overall Study||99
418788|NCT01568008|1026578|P1|NOT COMPLETED|Overall Study||234
418789|NCT01568008|1026578|P1|COMPLETED|Overall Study||699
418790|NCT01568008|1026578|P1|STARTED|Overall Study||933
418791|NCT01567943|1026589|P3|NOT COMPLETED|Overall Study||0
418792|NCT01567943|1026590|P2|NOT COMPLETED|Overall Study||10
418793|NCT01567943|1026591|P1|NOT COMPLETED|Overall Study||14
418794|NCT01567943|1026589|P3|COMPLETED|Overall Study||44
418795|NCT01567943|1026590|P2|COMPLETED|Overall Study||29
418796|NCT01567943|1026591|P1|COMPLETED|Overall Study||26
418797|NCT01567943|1026589|P3|STARTED|Overall Study||44
418798|NCT01567943|1026590|P2|STARTED|Overall Study||39
418799|NCT01567943|1026591|P1|STARTED|Overall Study||40
418800|NCT01567852|1026601|P2|NOT COMPLETED|Overall Study||7
418801|NCT01567852|1026602|P1|NOT COMPLETED|Overall Study||4
418802|NCT01567852|1026601|P2|COMPLETED|Overall Study||5
418803|NCT01567852|1026602|P1|COMPLETED|Overall Study||4
418804|NCT01567852|1026601|P2|STARTED|Overall Study||12
418805|NCT01567852|1026602|P1|STARTED|Overall Study||8
418806|NCT01567839|1026610|P1|NOT COMPLETED|Overall Study||0
418807|NCT01567839|1026610|P1|COMPLETED|Overall Study||60
418808|NCT01567839|1026610|P1|STARTED|Overall Study||60
418809|NCT01567826|1026620|P2|NOT COMPLETED|Overall Study||2
418810|NCT01567826|1026621|P1|NOT COMPLETED|Overall Study||3
418811|NCT01567826|1026620|P2|COMPLETED|Overall Study||42
418812|NCT01567826|1026621|P1|COMPLETED|Overall Study||40
418813|NCT01567826|1026620|P2|STARTED|Overall Study||44
418814|NCT01567826|1026621|P1|STARTED|Overall Study||43
418815|NCT01567462|1026647|P2|NOT COMPLETED|Overall Study||7
418816|NCT01567462|1026648|P1|NOT COMPLETED|Overall Study||4
418817|NCT01567462|1026647|P2|COMPLETED|Overall Study||38
418818|NCT01567462|1026648|P1|COMPLETED|Overall Study||41
418819|NCT01567462|1026647|P2|STARTED|Overall Study||45
418820|NCT01567462|1026648|P1|STARTED|Overall Study||45
418821|NCT01567371|1026660|P1|NOT COMPLETED|Overall Study||0
418822|NCT01567371|1026660|P1|COMPLETED|Overall Study||30
418823|NCT01567371|1026660|P1|STARTED|Overall Study||30
418824|NCT01567163|1026665|P1|NOT COMPLETED|Overall Study||4
418825|NCT01567163|1026665|P1|COMPLETED|Overall Study||18
418826|NCT01567163|1026665|P1|Drug-Drug Interaction Population|Overall Study|Completed Cycle 1, Day 1 and Cycle 2, Day 1 treatment with required assessments.|18
418827|NCT01567163|1026665|P1|Received at Least 1 Dose of Study Drug|Overall Study||22
418828|NCT01567163|1026665|P1|STARTED|Overall Study||22
418829|NCT01567150|1026677|P2|NOT COMPLETED|Overall Study||2
418830|NCT01567150|1026678|P1|NOT COMPLETED|Overall Study||2
418831|NCT01567150|1026677|P2|COMPLETED|Overall Study||16
418832|NCT01567150|1026678|P1|COMPLETED|Overall Study||19
418833|NCT01567150|1026677|P2|STARTED|Overall Study||18
418834|NCT01567150|1026678|P1|STARTED|Overall Study||21
418835|NCT01567020|1026690|P4|NOT COMPLETED|Overall Study||1
418836|NCT01567020|1026691|P3|NOT COMPLETED|Overall Study||2
418837|NCT01567020|1026692|P2|NOT COMPLETED|Overall Study||5
418838|NCT01567020|1026693|P1|NOT COMPLETED|Overall Study||7
418839|NCT01567020|1026690|P4|COMPLETED|Overall Study||10
418840|NCT01567020|1026691|P3|COMPLETED|Overall Study||18
418841|NCT01567020|1026692|P2|COMPLETED|Overall Study||41
418842|NCT01567020|1026693|P1|COMPLETED|Overall Study||21
418843|NCT01567020|1026690|P4|STARTED|Overall Study||11
418844|NCT01567020|1026691|P3|STARTED|Overall Study||20
418845|NCT01567020|1026692|P2|STARTED|Overall Study||46
418846|NCT01567020|1026693|P1|STARTED|Overall Study||28
418847|NCT01566981|1026705|P2|NOT COMPLETED|Overall Study||8
418848|NCT01566981|1026706|P1|NOT COMPLETED|Overall Study||5
418849|NCT01566981|1026705|P2|COMPLETED|Overall Study||54
418850|NCT01566981|1026706|P1|COMPLETED|Overall Study||53
418851|NCT01566981|1026705|P2|STARTED|Overall Study||62
418852|NCT01566981|1026706|P1|STARTED|Overall Study||58
418853|NCT01566838|1026718|P2|NOT COMPLETED|Overall Study||0
418854|NCT01566838|1026719|P1|NOT COMPLETED|Overall Study||3
418855|NCT01566838|1026718|P2|COMPLETED|Overall Study||42
418856|NCT01566838|1026719|P1|COMPLETED|Overall Study||38
418857|NCT01566838|1026718|P2|STARTED|Overall Study||42
418858|NCT01566838|1026719|P1|STARTED|Overall Study||41
418859|NCT01566773|1026735|P1|NOT COMPLETED|Overall Study||30
418860|NCT01566773|1026735|P1|COMPLETED|Overall Study||110
418861|NCT01566773|1026735|P1|Spiriva® Handihaler®|Overall Study||62
418862|NCT01566773|1026735|P1|Placebo MDI|Overall Study||62
418863|NCT01566773|1026735|P1|GP MDI 0.6 µg BID|Overall Study||59
418864|NCT01566773|1026735|P1|GP MDI 1.2 µg BID|Overall Study||57
418865|NCT01566773|1026735|P1|GP MDI 2.4 µg BID|Overall Study||64
418866|NCT01566773|1026735|P1|GP MDI 4.6 µg BID|Overall Study||62
418867|NCT01566773|1026735|P1|GP MDI 9 µg BID|Overall Study||64
418868|NCT01566773|1026735|P1|GP MDI 18 µg BID|Overall Study||64
418869|NCT01566773|1026735|P1|STARTED|Overall Study||140
418870|NCT01566721|1026944|P2|NOT COMPLETED|Overall Study||710
418871|NCT01566721|1026945|P1|NOT COMPLETED|Overall Study||1867
418872|NCT01566721|1026944|P2|COMPLETED|Overall Study||0
418873|NCT01566721|1026945|P1|COMPLETED|Overall Study||0
418874|NCT01566721|1026944|P2|Received Treatment|Overall Study||709
418875|NCT01566721|1026945|P1|Received Treatment|Overall Study||1864
418876|NCT01566721|1026944|P2|STARTED|Overall Study||710
418877|NCT01566721|1026945|P1|STARTED|Overall Study||1867
418878|NCT01566630|1026970|P2|NOT COMPLETED|Overall Study||0
418879|NCT01566630|1026971|P1|NOT COMPLETED|Overall Study||0
418880|NCT01566630|1026970|P2|COMPLETED|Overall Study||1
418881|NCT01566630|1026971|P1|COMPLETED|Overall Study||2
418882|NCT01566630|1026970|P2|STARTED|Overall Study||1
418883|NCT01566630|1026971|P1|STARTED|Overall Study||2
418884|NCT01566604|1027027|P2|NOT COMPLETED|Overall Study||11
418885|NCT01566604|1027028|P1|NOT COMPLETED|Overall Study||24
418886|NCT01566604|1027027|P2|COMPLETED|Overall Study||143
418887|NCT01566604|1027028|P1|COMPLETED|Overall Study||282
418888|NCT01566604|1027027|P2|FAS, Serial Spirometry Subgroup|Overall Study||58
418889|NCT01566604|1027028|P1|FAS, Serial Spirometry Subgroup|Overall Study||134
418890|NCT01566604|1027027|P2|Full Analysis Set (FAS)|Overall Study||154
418891|NCT01566604|1027028|P1|Full Analysis Set (FAS)|Overall Study||305
418892|NCT01566604|1027027|P2|Safety Set|Overall Study||154
418893|NCT01566604|1027028|P1|Safety Set|Overall Study||305
418894|NCT01566604|1027027|P2|STARTED|Overall Study||154
418895|NCT01566604|1027028|P1|STARTED|Overall Study||306
418896|NCT01566539|1027062|P9|NOT COMPLETED|Within Subject Group||0
418897|NCT01566539|1027063|P8|NOT COMPLETED|Within Subject Group||0
418898|NCT01566539|1027064|P7|NOT COMPLETED|Within Subject Group||0
418899|NCT01566539|1027065|P6|NOT COMPLETED|Within Subject Group||0
418900|NCT01566539|1027066|P5|NOT COMPLETED|Within Subject Group||0
418901|NCT01566539|1027067|P4|NOT COMPLETED|Within Subject Group||3
418902|NCT01566539|1027068|P3|NOT COMPLETED|Within Subject Group||0
418903|NCT01566539|1027069|P2|NOT COMPLETED|Within Subject Group||0
418904|NCT01566539|1027070|P1|NOT COMPLETED|Within Subject Group||0
418905|NCT01566539|1027062|P9|COMPLETED|Within Subject Group||0
418906|NCT01566539|1027063|P8|COMPLETED|Within Subject Group||0
418907|NCT01566539|1027064|P7|COMPLETED|Within Subject Group||0
418908|NCT01566539|1027065|P6|COMPLETED|Within Subject Group||0
418909|NCT01566539|1027066|P5|COMPLETED|Within Subject Group||0
418910|NCT01566539|1027067|P4|COMPLETED|Within Subject Group|Participants can move from Healthy Volunteers-AVP, OT and Placebo groups to the within subject group|153
418911|NCT01566539|1027068|P3|COMPLETED|Within Subject Group||0
418912|NCT01566539|1027069|P2|COMPLETED|Within Subject Group||0
418913|NCT01566539|1027070|P1|COMPLETED|Within Subject Group||0
418914|NCT01566539|1027062|P9|STARTED|Within Subject Group||0
418915|NCT01566539|1027063|P8|STARTED|Within Subject Group||0
418916|NCT01566539|1027064|P7|STARTED|Within Subject Group||0
418917|NCT01566539|1027065|P6|STARTED|Within Subject Group||0
418918|NCT01566539|1027066|P5|STARTED|Within Subject Group||0
418919|NCT01566539|1027067|P4|STARTED|Within Subject Group|Participants can move from Healthy Volunteers-AVP, OT and Placebo groups to the within subject group|156
418920|NCT01566539|1027068|P3|STARTED|Within Subject Group||0
418921|NCT01566539|1027069|P2|STARTED|Within Subject Group||0
418922|NCT01566539|1027070|P1|STARTED|Within Subject Group||0
418923|NCT01566539|1027062|P9|NOT COMPLETED|Main Study Period||0
418924|NCT01566539|1027063|P8|NOT COMPLETED|Main Study Period||0
418925|NCT01566539|1027064|P7|NOT COMPLETED|Main Study Period||0
418926|NCT01566539|1027065|P6|NOT COMPLETED|Main Study Period||3
418927|NCT01566539|1027066|P5|NOT COMPLETED|Main Study Period||0
418928|NCT01566539|1027067|P4|NOT COMPLETED|Main Study Period||0
418929|NCT01566539|1027068|P3|NOT COMPLETED|Main Study Period||0
418930|NCT01566539|1027069|P2|NOT COMPLETED|Main Study Period||0
418931|NCT01566539|1027070|P1|NOT COMPLETED|Main Study Period||1
418932|NCT01566539|1027062|P9|COMPLETED|Main Study Period||1
418933|NCT01566539|1027063|P8|COMPLETED|Main Study Period||30
418934|NCT01566539|1027064|P7|COMPLETED|Main Study Period||30
418935|NCT01566539|1027065|P6|COMPLETED|Main Study Period||40
418936|NCT01566539|1027066|P5|COMPLETED|Main Study Period||40
418937|NCT01566539|1027067|P4|COMPLETED|Main Study Period||0
418938|NCT01566539|1027068|P3|COMPLETED|Main Study Period||104
418939|NCT01566539|1027069|P2|COMPLETED|Main Study Period||100
418940|NCT01566539|1027070|P1|COMPLETED|Main Study Period||100
418941|NCT01566539|1027062|P9|STARTED|Main Study Period||1
418942|NCT01566539|1027063|P8|STARTED|Main Study Period||30
418943|NCT01566539|1027064|P7|STARTED|Main Study Period||30
418944|NCT01566539|1027065|P6|STARTED|Main Study Period||43
418945|NCT01566539|1027066|P5|STARTED|Main Study Period||40
418946|NCT01566539|1027067|P4|STARTED|Main Study Period||0
418947|NCT01566539|1027068|P3|STARTED|Main Study Period||104
418948|NCT01566539|1027069|P2|STARTED|Main Study Period||100
418949|NCT01566539|1027070|P1|STARTED|Main Study Period||101
418950|NCT01566526|1027123|P1|NOT COMPLETED|Overall Study||0
418951|NCT01566526|1027123|P1|COMPLETED|Overall Study||26
418952|NCT01566526|1027123|P1|STARTED|Overall Study||26
418953|NCT01566500|1027133|P1|NOT COMPLETED|Overall Study||0
418954|NCT01566500|1027133|P1|COMPLETED|Overall Study||140
418955|NCT01566500|1027133|P1|STARTED|Overall Study||140
418956|NCT01566461|1027139|P2|NOT COMPLETED|IN.PACT SFA II Phase||5
418957|NCT01566461|1027140|P1|NOT COMPLETED|IN.PACT SFA II Phase||12
418958|NCT01566461|1027139|P2|COMPLETED|IN.PACT SFA II Phase||55
418959|NCT01566461|1027140|P1|COMPLETED|IN.PACT SFA II Phase||109
418960|NCT01566461|1027139|P2|STARTED|IN.PACT SFA II Phase||60
418961|NCT01566461|1027140|P1|STARTED|IN.PACT SFA II Phase||121
418962|NCT01566461|1027139|P2|NOT COMPLETED|IN.PACT SFA I Phase||2
418963|NCT01566461|1027140|P1|NOT COMPLETED|IN.PACT SFA I Phase||11
418964|NCT01566461|1027139|P2|COMPLETED|IN.PACT SFA I Phase||49
418965|NCT01566461|1027140|P1|COMPLETED|IN.PACT SFA I Phase||88
418966|NCT01566461|1027139|P2|STARTED|IN.PACT SFA I Phase||51
418967|NCT01566461|1027140|P1|STARTED|IN.PACT SFA I Phase||99
418968|NCT01566435|1027184|P1|NOT COMPLETED|ACF Definitive Chemoradiation-cetuximab||0
418969|NCT01566435|1027184|P1|COMPLETED|ACF Definitive Chemoradiation-cetuximab||2
418970|NCT01566435|1027184|P1|STARTED|ACF Definitive Chemoradiation-cetuximab||2
418971|NCT01566435|1027184|P1|NOT COMPLETED|ACF Definitive Chemoradiation-cisplatin||1
418972|NCT01566435|1027184|P1|COMPLETED|ACF Definitive Chemoradiation-cisplatin||27
418973|NCT01566435|1027184|P1|STARTED|ACF Definitive Chemoradiation-cisplatin||28
418974|NCT01566435|1027184|P1|NOT COMPLETED|ACF Induction Therapy||0
418975|NCT01566435|1027184|P1|COMPLETED|ACF Induction Therapy||30
418976|NCT01566435|1027184|P1|STARTED|ACF Induction Therapy||30
418977|NCT01566409|1027200|P2|NOT COMPLETED|Overall Study||5
418978|NCT01566409|1027201|P1|NOT COMPLETED|Overall Study||2
418979|NCT01566409|1027200|P2|COMPLETED|Overall Study||48
418980|NCT01566409|1027201|P1|COMPLETED|Overall Study||47
418981|NCT01566409|1027200|P2|STARTED|Overall Study||53
418982|NCT01566409|1027201|P1|STARTED|Overall Study||49
418983|NCT01566370|1027209|P2|NOT COMPLETED|Overall Study||1
418984|NCT01566370|1027210|P1|NOT COMPLETED|Overall Study||2
418985|NCT01566370|1027209|P2|COMPLETED|Overall Study||0
418986|NCT01566370|1027210|P1|COMPLETED|Overall Study||0
418987|NCT01566370|1027209|P2|STARTED|Overall Study||1
418988|NCT01566370|1027210|P1|STARTED|Overall Study||2
418989|NCT01566331|1027236|P2|NOT COMPLETED|Overall Study||0
418990|NCT01566331|1027237|P1|NOT COMPLETED|Overall Study||0
418991|NCT01566331|1027236|P2|COMPLETED|Overall Study||40
418992|NCT01566331|1027237|P1|COMPLETED|Overall Study||40
418993|NCT01566331|1027236|P2|STARTED|Overall Study||40
418994|NCT01566331|1027237|P1|STARTED|Overall Study||40
418995|NCT01566162|1027243|P1|NOT COMPLETED|Overall Study||36
418996|NCT01566162|1027243|P1|COMPLETED|Overall Study||155
418997|NCT01566162|1027243|P1|STARTED|Overall Study||191
418998|NCT01566149|1027257|P2|NOT COMPLETED|Overall Study||2
418999|NCT01566149|1027258|P1|NOT COMPLETED|Overall Study||3
419000|NCT01566149|1027257|P2|COMPLETED|Overall Study||23
419001|NCT01566149|1027258|P1|COMPLETED|Overall Study||21
419002|NCT01566149|1027257|P2|STARTED|Overall Study||25
419003|NCT01566149|1027258|P1|STARTED|Overall Study||24
419004|NCT01566084|1027274|P2|NOT COMPLETED|Overall Study||0
419005|NCT01566084|1027275|P1|NOT COMPLETED|Overall Study||0
419006|NCT01566084|1027274|P2|COMPLETED|Overall Study||10
419007|NCT01566084|1027275|P1|COMPLETED|Overall Study||7
419008|NCT01566084|1027274|P2|STARTED|Overall Study||10
419009|NCT01566084|1027275|P1|STARTED|Overall Study||7
419010|NCT01565993|1027291|P2|NOT COMPLETED|Overall Study||3
419011|NCT01565993|1027292|P1|NOT COMPLETED|Overall Study||0
419012|NCT01565993|1027291|P2|COMPLETED|Overall Study||39
419013|NCT01565993|1027292|P1|COMPLETED|Overall Study|A total of 105 polypectomies were performed on 98 patients|66
419014|NCT01565993|1027291|P2|STARTED|Overall Study|3 patients were excluded for failing to meet the inclusion criteria|42
419015|NCT01565993|1027292|P1|STARTED|Overall Study||66
419016|NCT01565980|1027300|P2|NOT COMPLETED|Overall Study||4
419017|NCT01565980|1027301|P1|NOT COMPLETED|Overall Study||4
419018|NCT01565980|1027300|P2|COMPLETED|Overall Study||16
419019|NCT01565980|1027301|P1|COMPLETED|Overall Study||16
419020|NCT01565980|1027300|P2|STARTED|Overall Study|Three patients had started the intervention protocol at the time of study withdrawal.|20
419021|NCT01565980|1027301|P1|STARTED|Overall Study||20
419022|NCT01565941|1027321|P2|NOT COMPLETED|Overall Study||4
419023|NCT01565941|1027322|P1|NOT COMPLETED|Overall Study||11
419024|NCT01565941|1027321|P2|COMPLETED|Overall Study||349
419025|NCT01565941|1027322|P1|COMPLETED|Overall Study||349
419026|NCT01565941|1027321|P2|STARTED|Overall Study||353
419027|NCT01565941|1027322|P1|STARTED|Overall Study||360
419028|NCT01565902|1027364|P4|NOT COMPLETED|Overall Study||0
419029|NCT01565902|1027365|P3|NOT COMPLETED|Overall Study||0
419030|NCT01565902|1027366|P2|NOT COMPLETED|Overall Study||0
419031|NCT01565902|1027367|P1|NOT COMPLETED|Overall Study||0
419032|NCT01565902|1027364|P4|COMPLETED|Overall Study||16
419033|NCT01565902|1027365|P3|COMPLETED|Overall Study||8
419034|NCT01565902|1027366|P2|COMPLETED|Overall Study||8
419035|NCT01565902|1027367|P1|COMPLETED|Overall Study||8
419036|NCT01565902|1027364|P4|STARTED|Overall Study||16
419037|NCT01565902|1027365|P3|STARTED|Overall Study||8
419038|NCT01565902|1027366|P2|STARTED|Overall Study||8
419039|NCT01565902|1027367|P1|STARTED|Overall Study||8
419040|NCT01565889|1027401|P6|NOT COMPLETED|Part B||4
419041|NCT01565889|1027402|P5|NOT COMPLETED|Part B||0
419042|NCT01565889|1027403|P4|NOT COMPLETED|Part B||0
419043|NCT01565889|1027404|P3|NOT COMPLETED|Part B||0
419044|NCT01565889|1027405|P2|NOT COMPLETED|Part B||0
419045|NCT01565889|1027406|P1|NOT COMPLETED|Part B||0
419046|NCT01565889|1027401|P6|COMPLETED|Part B||19
419047|NCT01565889|1027402|P5|COMPLETED|Part B||0
419048|NCT01565889|1027403|P4|COMPLETED|Part B||0
419049|NCT01565889|1027404|P3|COMPLETED|Part B||0
419050|NCT01565889|1027405|P2|COMPLETED|Part B||0
419051|NCT01565889|1027406|P1|COMPLETED|Part B||0
419052|NCT01565889|1027401|P6|STARTED|Part B|9 participants in this group transferred from a Part A cohort, and 14 participants joined the study.|23
419053|NCT01565889|1027402|P5|STARTED|Part B||0
419054|NCT01565889|1027403|P4|STARTED|Part B||0
419055|NCT01565889|1027404|P3|STARTED|Part B||0
419056|NCT01565889|1027405|P2|STARTED|Part B||0
419057|NCT01565889|1027406|P1|STARTED|Part B||0
419058|NCT01565889|1027401|P6|NOT COMPLETED|Part A||0
419059|NCT01565889|1027402|P5|NOT COMPLETED|Part A||0
419060|NCT01565889|1027403|P4|NOT COMPLETED|Part A||0
419061|NCT01565889|1027404|P3|NOT COMPLETED|Part A||0
419062|NCT01565889|1027405|P2|NOT COMPLETED|Part A||0
419063|NCT01565889|1027406|P1|NOT COMPLETED|Part A||1
419064|NCT01565889|1027401|P6|COMPLETED|Part A||0
419065|NCT01565889|1027402|P5|COMPLETED|Part A|1 participant from this group continued in the Part B: SOF+PEG+RBV group.|7
419066|NCT01565889|1027403|P4|COMPLETED|Part A|2 participants from this group continued in the Part B: SOF+PEG+RBV group.|7
419067|NCT01565889|1027404|P3|COMPLETED|Part A|3 participants from this group continued in the Part B: SOF+PEG+RBV group.|8
419068|NCT01565889|1027405|P2|COMPLETED|Part A|No participants from this group continued in the Part B: SOF+PEG+RBV group.|4
419069|NCT01565889|1027406|P1|COMPLETED|Part A|3 participants from this group continued in the Part B: SOF+PEG+RBV group.|11
419070|NCT01565889|1027401|P6|STARTED|Part A||0
419071|NCT01565889|1027402|P5|STARTED|Part A||7
419072|NCT01565889|1027403|P4|STARTED|Part A||7
419073|NCT01565889|1027404|P3|STARTED|Part A||8
419074|NCT01565889|1027405|P2|STARTED|Part A||4
419075|NCT01565889|1027406|P1|STARTED|Part A||12
419076|NCT01565850|1027437|P2|NOT COMPLETED|Overall Study||8
419077|NCT01565850|1027438|P1|NOT COMPLETED|Overall Study||20
419078|NCT01565850|1027437|P2|COMPLETED|Overall Study||42
419079|NCT01565850|1027438|P1|COMPLETED|Overall Study||83
419080|NCT01565850|1027437|P2|STARTED|Overall Study||50
419081|NCT01565850|1027438|P1|STARTED|Overall Study||103
419082|NCT01565707|1027458|P4|NOT COMPLETED|Overall Study||5
419083|NCT01565707|1027459|P3|NOT COMPLETED|Overall Study||3
419084|NCT01565707|1027460|P2|NOT COMPLETED|Overall Study||8
419085|NCT01565707|1027461|P1|NOT COMPLETED|Overall Study||9
419086|NCT01565707|1027458|P4|COMPLETED|Overall Study||17
419087|NCT01565707|1027459|P3|COMPLETED|Overall Study||16
419088|NCT01565707|1027460|P2|COMPLETED|Overall Study||65
419089|NCT01565707|1027461|P1|COMPLETED|Overall Study||66
419090|NCT01565707|1027458|P4|Treated|Overall Study||22
419091|NCT01565707|1027459|P3|Treated|Overall Study||19
419092|NCT01565707|1027460|P2|Treated|Overall Study||73
419093|NCT01565707|1027461|P1|Treated|Overall Study||73
419094|NCT01565707|1027458|P4|STARTED|Overall Study||22
419095|NCT01565707|1027459|P3|STARTED|Overall Study||19
419096|NCT01565707|1027460|P2|STARTED|Overall Study||73
419097|NCT01565707|1027461|P1|STARTED|Overall Study||75
419098|NCT01565616|1027552|P1|NOT COMPLETED|Overall Study||0
419099|NCT01565616|1027552|P1|COMPLETED|Overall Study||22
419100|NCT01565616|1027552|P1|Second Component: Related or Unrelated|Overall Study||17
419101|NCT01565616|1027552|P1|First Component: 5 Related Donors|Overall Study||5
419102|NCT01565616|1027552|P1|STARTED|Overall Study||22
419103|NCT01565564|1027565|P2|NOT COMPLETED|Overall Study||1
419104|NCT01565564|1027566|P1|NOT COMPLETED|Overall Study||5
419105|NCT01565564|1027565|P2|COMPLETED|Overall Study||361
419106|NCT01565564|1027566|P1|COMPLETED|Overall Study||339
419107|NCT01565564|1027565|P2|STARTED|Overall Study||362
419108|NCT01565564|1027566|P1|STARTED|Overall Study||344
419109|NCT01565551|1027576|P2|NOT COMPLETED|Overall Study||0
419110|NCT01565551|1027577|P1|NOT COMPLETED|Overall Study||0
419111|NCT01565551|1027576|P2|COMPLETED|Overall Study||51
419112|NCT01565551|1027577|P1|COMPLETED|Overall Study||586
419113|NCT01565551|1027576|P2|6-Month Outcomes|Overall Study||30
419114|NCT01565551|1027577|P1|6-Month Outcomes|Overall Study||412
419115|NCT01565551|1027576|P2|Neuroimaging|Overall Study||25
419116|NCT01565551|1027577|P1|Neuroimaging|Overall Study||233
419117|NCT01565551|1027576|P2|Biospecimens/Biomarkers|Overall Study||22
419118|NCT01565551|1027577|P1|Biospecimens/Biomarkers|Overall Study||479
419119|NCT01565551|1027576|P2|Clinical/Demographics|Overall Study||51
419120|NCT01565551|1027577|P1|Clinical/Demographics|Overall Study||586
419121|NCT01565551|1027576|P2|STARTED|Overall Study||51
419122|NCT01565551|1027577|P1|STARTED|Overall Study||586
419123|NCT01565538|1027585|P2|NOT COMPLETED|Overall Study||0
419124|NCT01565538|1027586|P1|NOT COMPLETED|Overall Study||0
419125|NCT01565538|1027585|P2|COMPLETED|Overall Study||62
419126|NCT01565538|1027586|P1|COMPLETED|Overall Study||61
419127|NCT01565538|1027585|P2|STARTED|Overall Study||62
419128|NCT01565538|1027586|P1|STARTED|Overall Study||61
419129|NCT01565382|1027596|P2|NOT COMPLETED|Overall Study||0
419130|NCT01565382|1027597|P1|NOT COMPLETED|Overall Study||0
419131|NCT01565382|1027596|P2|COMPLETED|Overall Study||7
419132|NCT01565382|1027597|P1|COMPLETED|Overall Study||40
419133|NCT01565382|1027596|P2|STARTED|Overall Study||7
419134|NCT01565382|1027597|P1|STARTED|Overall Study||40
419135|NCT01565369|1027602|P1|NOT COMPLETED|Overall Study||0
419136|NCT01565369|1027602|P1|COMPLETED|Overall Study||35
419137|NCT01565369|1027602|P1|STARTED|Overall Study||35
419138|NCT01565356|1027608|P1|NOT COMPLETED|Overall Study||0
419139|NCT01565356|1027608|P1|COMPLETED|Overall Study||41
419140|NCT01565356|1027608|P1|STARTED|Overall Study||41
419141|NCT01565343|1027616|P3|NOT COMPLETED|Overall Study||0
419142|NCT01565343|1027617|P2|NOT COMPLETED|Overall Study||0
419143|NCT01565343|1027618|P1|NOT COMPLETED|Overall Study||1
419144|NCT01565343|1027616|P3|COMPLETED|Overall Study||10
419145|NCT01565343|1027617|P2|COMPLETED|Overall Study||4
419146|NCT01565343|1027618|P1|COMPLETED|Overall Study||10
419147|NCT01565343|1027616|P3|STARTED|Overall Study||10
419148|NCT01565343|1027617|P2|STARTED|Overall Study||4
419149|NCT01565343|1027618|P1|STARTED|Overall Study||11
419150|NCT01565330|1027629|P4|NOT COMPLETED|Overall Study||0
419151|NCT01565330|1027630|P3|NOT COMPLETED|Overall Study||0
419152|NCT01565330|1027631|P2|NOT COMPLETED|Overall Study||0
419153|NCT01565330|1027632|P1|NOT COMPLETED|Overall Study||0
419154|NCT01565330|1027629|P4|COMPLETED|Overall Study||7
419155|NCT01565330|1027630|P3|COMPLETED|Overall Study||4
419156|NCT01565330|1027631|P2|COMPLETED|Overall Study||4
419157|NCT01565330|1027632|P1|COMPLETED|Overall Study||5
419158|NCT01565330|1027629|P4|STARTED|Overall Study||7
419159|NCT01565330|1027630|P3|STARTED|Overall Study||4
419160|NCT01565330|1027631|P2|STARTED|Overall Study||4
419161|NCT01565330|1027632|P1|STARTED|Overall Study||5
419162|NCT01565291|1027648|P2|NOT COMPLETED|Overall Study||0
419163|NCT01565291|1027649|P1|NOT COMPLETED|Overall Study||1
419164|NCT01565291|1027648|P2|COMPLETED|Overall Study||16
419165|NCT01565291|1027649|P1|COMPLETED|Overall Study||15
419166|NCT01565291|1027648|P2|STARTED|Overall Study||16
419167|NCT01565291|1027649|P1|STARTED|Overall Study||16
419168|NCT01565148|1027661|P4|NOT COMPLETED|Overall Study||13
419169|NCT01565148|1027662|P3|NOT COMPLETED|Overall Study||7
419170|NCT01565148|1027663|P2|NOT COMPLETED|Overall Study||15
419171|NCT01565148|1027664|P1|NOT COMPLETED|Overall Study||15
419172|NCT01565148|1027661|P4|COMPLETED|Overall Study||32
419173|NCT01565148|1027662|P3|COMPLETED|Overall Study||40
419174|NCT01565148|1027663|P2|COMPLETED|Overall Study||31
419175|NCT01565148|1027664|P1|COMPLETED|Overall Study||32
419176|NCT01565148|1027661|P4|STARTED|Overall Study||45
419177|NCT01565148|1027662|P3|STARTED|Overall Study||47
419178|NCT01565148|1027663|P2|STARTED|Overall Study||46
419179|NCT01565148|1027664|P1|STARTED|Overall Study||47
419180|NCT01565083|1027700|P2|NOT COMPLETED|Overall Study||39
419181|NCT01565083|1027701|P1|NOT COMPLETED|Overall Study||33
419182|NCT01565083|1027700|P2|COMPLETED|Overall Study||68
419183|NCT01565083|1027701|P1|COMPLETED|Overall Study||73
419184|NCT01565083|1027700|P2|STARTED|Overall Study||107
419185|NCT01565083|1027701|P1|STARTED|Overall Study||106
419186|NCT01564953|1027727|P1|NOT COMPLETED|Overall Study||0
419187|NCT01564953|1027727|P1|COMPLETED|Overall Study||143
419188|NCT01564953|1027727|P1|STARTED|Overall Study||143
419189|NCT01564862|1027738|P3|NOT COMPLETED|Overall Study||30
419190|NCT01564862|1027739|P2|NOT COMPLETED|Overall Study||34
419191|NCT01564862|1027740|P1|NOT COMPLETED|Overall Study||30
419192|NCT01564862|1027738|P3|COMPLETED|Overall Study||164
419193|NCT01564862|1027739|P2|COMPLETED|Overall Study||176
419194|NCT01564862|1027740|P1|COMPLETED|Overall Study||168
419195|NCT01564862|1027738|P3|Received Treatment|Overall Study||191
419196|NCT01564862|1027739|P2|Received Treatment|Overall Study||207
419197|NCT01564862|1027740|P1|Received Treatment|Overall Study||196
419198|NCT01564862|1027738|P3|STARTED|Overall Study||194
419199|NCT01564862|1027739|P2|STARTED|Overall Study||210
419200|NCT01564862|1027740|P1|STARTED|Overall Study||198
419201|NCT01564784|1027791|P2|NOT COMPLETED|Overall Study||133
419202|NCT01564784|1027792|P1|NOT COMPLETED|Overall Study||134
419203|NCT01564784|1027791|P2|COMPLETED|Overall Study||10
419204|NCT01564784|1027792|P1|COMPLETED|Overall Study||30
419205|NCT01564784|1027791|P2|STARTED|Overall Study|Treated (162 randomized)|143
419206|NCT01564784|1027792|P1|STARTED|Overall Study|Treated (164 randomized)|164
419207|NCT01564758|1027819|P1|NOT COMPLETED|Overall Study||14
419208|NCT01564758|1027819|P1|COMPLETED|Overall Study||85
419209|NCT01564758|1027819|P1|STARTED|Overall Study||99
419210|NCT01564732|1027826|P2|NOT COMPLETED|Overall Study||5
419211|NCT01564732|1027827|P1|NOT COMPLETED|Overall Study||6
419212|NCT01564732|1027826|P2|COMPLETED|Overall Study||0
419213|NCT01564732|1027827|P1|COMPLETED|Overall Study||0
419214|NCT01564732|1027826|P2|STARTED|Overall Study||5
419215|NCT01564732|1027827|P1|STARTED|Overall Study||6
419216|NCT01564706|1027843|P1|NOT COMPLETED|Overall Study||0
419217|NCT01564706|1027843|P1|COMPLETED|Overall Study||9
419218|NCT01564706|1027843|P1|STARTED|Overall Study||9
419219|NCT01564693|1027850|P3|NOT COMPLETED|Overall Study||0
419220|NCT01564693|1027851|P2|NOT COMPLETED|Overall Study||0
419221|NCT01564693|1027852|P1|NOT COMPLETED|Overall Study||0
419222|NCT01564693|1027850|P3|COMPLETED|Overall Study||2
419223|NCT01564693|1027851|P2|COMPLETED|Overall Study||4
419224|NCT01564693|1027852|P1|COMPLETED|Overall Study||9
419225|NCT01564693|1027850|P3|STARTED|Overall Study|Only 2 patients were found necessary to give statistical relevance to the patients' results.|2
419226|NCT01564693|1027851|P2|STARTED|Overall Study||4
419227|NCT01564693|1027852|P1|STARTED|Overall Study|Originally we planned to study 4 patients. We expanded to 9 to improve consistency of the results.|9
419228|NCT01564537|1027862|P2|NOT COMPLETED|Overall Study||6
419229|NCT01564537|1027863|P1|NOT COMPLETED|Overall Study||6
419230|NCT01564537|1027862|P2|COMPLETED|Overall Study|Completed=Participants who are ongoing as of 30 October 2014 or who have died on study.|356
419231|NCT01564537|1027863|P1|COMPLETED|Overall Study|Completed=Participants who are ongoing as of 30 October 2014 or who have died on study.|354
419232|NCT01564537|1027862|P2|Safety Population: Received Study Drug|Overall Study||360
419233|NCT01564537|1027863|P1|Safety Population: Received Study Drug|Overall Study||360
419234|NCT01564537|1027862|P2|STARTED|Overall Study||362
419235|NCT01564537|1027863|P1|STARTED|Overall Study||360
419236|NCT01564459|1027886|P3|NOT COMPLETED|Double-blind Treatment||1
419237|NCT01564459|1027887|P2|NOT COMPLETED|Double-blind Treatment||0
419238|NCT01564459|1027888|P1|NOT COMPLETED|Double-blind Treatment||0
419239|NCT01564459|1027886|P3|COMPLETED|Double-blind Treatment||82
419240|NCT01564459|1027887|P2|COMPLETED|Double-blind Treatment||87
419241|NCT01564459|1027888|P1|COMPLETED|Double-blind Treatment||0
419242|NCT01564459|1027886|P3|STARTED|Double-blind Treatment|1 participant randomized to placebo arm received MK-6096 10 mg|83
419243|NCT01564459|1027887|P2|STARTED|Double-blind Treatment|1 participant randomized to placebo arm received MK-6096 10 mg|87
419244|NCT01564459|1027888|P1|STARTED|Double-blind Treatment||0
419245|NCT01564459|1027886|P3|NOT COMPLETED|Run-In||0
419246|NCT01564459|1027887|P2|NOT COMPLETED|Run-In||0
419247|NCT01564459|1027888|P1|NOT COMPLETED|Run-In||12
419248|NCT01564459|1027886|P3|COMPLETED|Run-In||83
419249|NCT01564459|1027887|P2|COMPLETED|Run-In||87
419250|NCT01564459|1027888|P1|COMPLETED|Run-In||0
419251|NCT01564459|1027886|P3|STARTED|Run-In|1 participant randomized to placebo arm received MK-6096 10 mg|83
419252|NCT01564459|1027887|P2|STARTED|Run-In|1 participant randomized to placebo arm received MK-6096 10 mg|87
419253|NCT01564459|1027888|P1|STARTED|Run-In||12
419254|NCT01564407|1027912|P5|NOT COMPLETED|Overall Study||0
419255|NCT01564407|1027913|P4|NOT COMPLETED|Overall Study||1
419256|NCT01564407|1027914|P3|NOT COMPLETED|Overall Study||0
419257|NCT01564407|1027915|P2|NOT COMPLETED|Overall Study||2
419258|NCT01564407|1027916|P1|NOT COMPLETED|Overall Study||0
419259|NCT01564407|1027912|P5|COMPLETED|Overall Study||0
419260|NCT01564407|1027913|P4|COMPLETED|Overall Study||1
419261|NCT01564407|1027914|P3|COMPLETED|Overall Study||4
419262|NCT01564407|1027915|P2|COMPLETED|Overall Study||3
419263|NCT01564407|1027916|P1|COMPLETED|Overall Study||4
419264|NCT01564407|1027912|P5|STARTED|Overall Study||0
419265|NCT01564407|1027913|P4|STARTED|Overall Study||2
419266|NCT01564407|1027914|P3|STARTED|Overall Study||4
419267|NCT01564407|1027915|P2|STARTED|Overall Study||5
419268|NCT01564407|1027916|P1|STARTED|Overall Study||4
419269|NCT01564394|1027957|P2|NOT COMPLETED|Overall Study||10
419270|NCT01564394|1027958|P1|NOT COMPLETED|Overall Study||6
419271|NCT01564394|1027957|P2|COMPLETED|Overall Study|Prostate cancer survivors n=13, family n=7.|20
419272|NCT01564394|1027958|P1|COMPLETED|Overall Study|Prostate cancer survivors n=16, family n=8.|24
419273|NCT01564394|1027957|P2|STARTED|Overall Study|Prostate cancer survivors n=20, family n=10. Only survivors were randomized.|30
419274|NCT01564394|1027958|P1|STARTED|Overall Study|Prostate cancer survivors n=20, family n=10. Only survivors were randomized.|30
419275|NCT01564277|1027972|P2|NOT COMPLETED|Overall Study||1
419276|NCT01564277|1027973|P1|NOT COMPLETED|Overall Study||1
419277|NCT01564277|1027972|P2|COMPLETED|Overall Study||11
419278|NCT01564277|1027973|P1|COMPLETED|Overall Study||11
419279|NCT01564277|1027972|P2|STARTED|Overall Study||12
419280|NCT01564277|1027973|P1|STARTED|Overall Study||12
419281|NCT01563978|1027991|P2|NOT COMPLETED|Overall Study||2
419282|NCT01563978|1027992|P1|NOT COMPLETED|Overall Study||4
419283|NCT01563978|1027991|P2|COMPLETED|Overall Study||65
419284|NCT01563978|1027992|P1|COMPLETED|Overall Study||64
419285|NCT01563978|1027991|P2|Randomised But Did Not Receive Treatment|Overall Study||0
419286|NCT01563978|1027992|P1|Randomised But Did Not Receive Treatment|Overall Study||0
419287|NCT01563978|1027991|P2|STARTED|Overall Study|Patients who received treatment.|67
419288|NCT01563978|1027992|P1|STARTED|Overall Study|Patients who received treatment.|68
419295|NCT01563536|1028031|P2|NOT COMPLETED|Overall Study||2
419296|NCT01563536|1028032|P1|NOT COMPLETED|Overall Study||1
419297|NCT01563536|1028031|P2|COMPLETED|Overall Study||4
419298|NCT01563536|1028032|P1|COMPLETED|Overall Study||5
419299|NCT01563536|1028031|P2|STARTED|Overall Study||6
419300|NCT01563536|1028032|P1|STARTED|Overall Study||6
419301|NCT01563406|1028064|P4|NOT COMPLETED|Overall Study||0
419302|NCT01563406|1028065|P3|NOT COMPLETED|Overall Study||0
419303|NCT01563406|1028066|P2|NOT COMPLETED|Overall Study||0
419304|NCT01563406|1028067|P1|NOT COMPLETED|Overall Study||0
419305|NCT01563406|1028064|P4|COMPLETED|Overall Study|112 hubs|29
419306|NCT01563406|1028065|P3|COMPLETED|Overall Study|101 hubs|30
419307|NCT01563406|1028066|P2|COMPLETED|Overall Study|102 hubs|30
419308|NCT01563406|1028067|P1|COMPLETED|Overall Study|194 hubs|60
419309|NCT01563406|1028064|P4|STARTED|Overall Study|112 hubs|29
419310|NCT01563406|1028065|P3|STARTED|Overall Study|101 hubs|30
419311|NCT01563406|1028066|P2|STARTED|Overall Study|102 hubs|30
419312|NCT01563406|1028067|P1|STARTED|Overall Study|194 hubs|60
419313|NCT01563198|1028085|P1|NOT COMPLETED|After Training||0
419314|NCT01563198|1028085|P1|COMPLETED|After Training||47979
419315|NCT01563198|1028085|P1|STARTED|After Training||47979
419316|NCT01563198|1028085|P1|NOT COMPLETED|Baseline||0
419317|NCT01563198|1028085|P1|COMPLETED|Baseline||49733
419318|NCT01563198|1028085|P1|STARTED|Baseline||49733
419319|NCT01563185|1028091|P1|NOT COMPLETED|Overall Study||2
419320|NCT01563185|1028091|P1|COMPLETED|Overall Study||10
419321|NCT01563185|1028091|P1|STARTED|Overall Study||12
419322|NCT01563172|1028105|P1|NOT COMPLETED|Overall Study||13
419323|NCT01563172|1028105|P1|COMPLETED|Overall Study||52
419324|NCT01563172|1028105|P1|Control Dentifrice|Overall Study||60
419325|NCT01563172|1028105|P1|Experimental Dentifrice 1.5g/ 45 Sec|Overall Study||58
419326|NCT01563172|1028105|P1|Experimental Dentifrice 1.5g/ 2min|Overall Study||58
419327|NCT01563172|1028105|P1|Experimental Dentifrice 0.5g/45 Sec|Overall Study||59
419328|NCT01563172|1028105|P1|Experimental Dentifrice 0.5g/2 Min|Overall Study||59
419329|NCT01563172|1028105|P1|STARTED|Overall Study||65
419330|NCT01563081|1028134|P2|NOT COMPLETED|Overall Study||0
419331|NCT01563081|1028135|P1|NOT COMPLETED|Overall Study||0
419332|NCT01563081|1028134|P2|COMPLETED|Overall Study||30
419333|NCT01563081|1028135|P1|COMPLETED|Overall Study||30
419334|NCT01563081|1028134|P2|STARTED|Overall Study||30
419335|NCT01563081|1028135|P1|STARTED|Overall Study||30
419336|NCT01563055|1028148|P1|NOT COMPLETED|Overall Study||0
419337|NCT01563055|1028148|P1|COMPLETED|Overall Study||10
419338|NCT01563055|1028148|P1|STARTED|Overall Study||10
419339|NCT01563029|1028211|P5|NOT COMPLETED|Overall Study||29
419340|NCT01563029|1028212|P4|NOT COMPLETED|Overall Study||33
419341|NCT01563029|1028213|P3|NOT COMPLETED|Overall Study||33
419342|NCT01563029|1028214|P2|NOT COMPLETED|Overall Study||24
419343|NCT01563029|1028215|P1|NOT COMPLETED|Overall Study||53
419344|NCT01563029|1028211|P5|COMPLETED|Overall Study||89
419345|NCT01563029|1028212|P4|COMPLETED|Overall Study||85
419346|NCT01563029|1028213|P3|COMPLETED|Overall Study||87
419347|NCT01563029|1028214|P2|COMPLETED|Overall Study||94
419348|NCT01563029|1028215|P1|COMPLETED|Overall Study||66
419349|NCT01563029|1028211|P5|STARTED|Overall Study||118
419350|NCT01563029|1028212|P4|STARTED|Overall Study||118
419351|NCT01563029|1028213|P3|STARTED|Overall Study||120
419352|NCT01563029|1028214|P2|STARTED|Overall Study||118
419353|NCT01563029|1028215|P1|STARTED|Overall Study||119
419354|NCT01563003|1028265|P2|NOT COMPLETED|Overall Study||0
419355|NCT01563003|1028266|P1|NOT COMPLETED|Overall Study||0
419356|NCT01563003|1028265|P2|COMPLETED|Overall Study||15
419357|NCT01563003|1028266|P1|COMPLETED|Overall Study||16
419358|NCT01563003|1028265|P2|STARTED|Overall Study||15
419359|NCT01563003|1028266|P1|STARTED|Overall Study||16
419360|NCT01562886|1028276|P1|NOT COMPLETED|Overall Study||1
419361|NCT01562886|1028276|P1|COMPLETED|Overall Study||13
419362|NCT01562886|1028276|P1|STARTED|Overall Study||14
419363|NCT01562873|1028281|P2|NOT COMPLETED|Overall Study||0
419364|NCT01562873|1028282|P1|NOT COMPLETED|Overall Study||21
419365|NCT01562873|1028281|P2|COMPLETED|Overall Study||0
419366|NCT01562873|1028282|P1|COMPLETED|Overall Study||0
419367|NCT01562873|1028281|P2|STARTED|Overall Study|The observed number of objective responses in Cohort A was not sufficient for Cohort B to open.|0
419368|NCT01562873|1028282|P1|STARTED|Overall Study||21
419369|NCT01562756|1028289|P1|NOT COMPLETED|Overall Study||0
419370|NCT01562756|1028289|P1|COMPLETED|Overall Study||6
419371|NCT01562756|1028289|P1|STARTED|Overall Study||6
419372|NCT01562743|1028294|P1|NOT COMPLETED|Overall Study||52
419373|NCT01562743|1028294|P1|COMPLETED|Overall Study||133
419374|NCT01562743|1028294|P1|STARTED|Overall Study||185
419375|NCT01562678|1028306|P2|NOT COMPLETED|Overall Study||2
419376|NCT01562678|1028307|P1|NOT COMPLETED|Overall Study||6
419377|NCT01562678|1028306|P2|COMPLETED|Overall Study||12
419378|NCT01562678|1028307|P1|COMPLETED|Overall Study||8
419379|NCT01562678|1028306|P2|STARTED|Overall Study||14
419380|NCT01562678|1028307|P1|STARTED|Overall Study||14
419381|NCT01562613|1028313|P1|NOT COMPLETED|Overall Study||4
419382|NCT01562613|1028313|P1|COMPLETED|Overall Study||529
419383|NCT01562613|1028313|P1|STARTED|Overall Study||533
419384|NCT01562548|1028323|P4|NOT COMPLETED|Overall Study||0
419385|NCT01562548|1028324|P3|NOT COMPLETED|Overall Study||1
419386|NCT01562548|1028325|P2|NOT COMPLETED|Overall Study||0
419387|NCT01562548|1028326|P1|NOT COMPLETED|Overall Study||0
419388|NCT01562548|1028323|P4|COMPLETED|Overall Study||14
419389|NCT01562548|1028324|P3|COMPLETED|Overall Study||24
419390|NCT01562548|1028325|P2|COMPLETED|Overall Study||15
419391|NCT01562548|1028326|P1|COMPLETED|Overall Study||25
419392|NCT01562548|1028323|P4|STARTED|Overall Study||14
419393|NCT01562548|1028324|P3|STARTED|Overall Study||25
419394|NCT01562548|1028325|P2|STARTED|Overall Study||15
419395|NCT01562548|1028326|P1|STARTED|Overall Study||25
419396|NCT01562327|1028376|P1|NOT COMPLETED|Overall Study||8
419397|NCT01562327|1028376|P1|COMPLETED|Overall Study||42
419398|NCT01562327|1028376|P1|STARTED|Overall Study||50
419399|NCT01562314|1028406|P2|NOT COMPLETED|Overall Study||8
419400|NCT01562314|1028407|P1|NOT COMPLETED|Overall Study||13
419401|NCT01562314|1028406|P2|COMPLETED|Overall Study||23
419402|NCT01562314|1028407|P1|COMPLETED|Overall Study||16
419403|NCT01562314|1028406|P2|STARTED|Overall Study||31
419404|NCT01562314|1028407|P1|STARTED|Overall Study||29
419405|NCT01562275|1028494|P13|NOT COMPLETED|Stage 2||5
419406|NCT01562275|1028495|P12|NOT COMPLETED|Stage 2||14
419407|NCT01562275|1028496|P11|NOT COMPLETED|Stage 2||0
419408|NCT01562275|1028497|P10|NOT COMPLETED|Stage 2||0
419409|NCT01562275|1028498|P9|NOT COMPLETED|Stage 2||0
419410|NCT01562275|1028499|P8|NOT COMPLETED|Stage 2||0
419411|NCT01562275|1028500|P7|NOT COMPLETED|Stage 2||0
419412|NCT01562275|1028501|P6|NOT COMPLETED|Stage 2||0
419413|NCT01562275|1028502|P5|NOT COMPLETED|Stage 2||0
419414|NCT01562275|1028503|P4|NOT COMPLETED|Stage 2||0
419415|NCT01562275|1028504|P3|NOT COMPLETED|Stage 2||0
419416|NCT01562275|1028505|P2|NOT COMPLETED|Stage 2||0
419417|NCT01562275|1028506|P1|NOT COMPLETED|Stage 2||0
419418|NCT01562275|1028494|P13|COMPLETED|Stage 2||0
419419|NCT01562275|1028495|P12|COMPLETED|Stage 2||0
419420|NCT01562275|1028496|P11|COMPLETED|Stage 2||0
419421|NCT01562275|1028497|P10|COMPLETED|Stage 2||0
419422|NCT01562275|1028498|P9|COMPLETED|Stage 2||0
419423|NCT01562275|1028499|P8|COMPLETED|Stage 2||0
419424|NCT01562275|1028500|P7|COMPLETED|Stage 2||0
419425|NCT01562275|1028501|P6|COMPLETED|Stage 2||0
419426|NCT01562275|1028502|P5|COMPLETED|Stage 2||0
419427|NCT01562275|1028503|P4|COMPLETED|Stage 2||0
419428|NCT01562275|1028504|P3|COMPLETED|Stage 2||0
419429|NCT01562275|1028505|P2|COMPLETED|Stage 2||0
419430|NCT01562275|1028506|P1|COMPLETED|Stage 2||0
419431|NCT01562275|1028494|P13|STARTED|Stage 2||5
419432|NCT01562275|1028495|P12|STARTED|Stage 2||14
419433|NCT01562275|1028496|P11|STARTED|Stage 2||0
419434|NCT01562275|1028497|P10|STARTED|Stage 2||0
419435|NCT01562275|1028498|P9|STARTED|Stage 2||0
419436|NCT01562275|1028499|P8|STARTED|Stage 2||0
419437|NCT01562275|1028500|P7|STARTED|Stage 2||0
419438|NCT01562275|1028501|P6|STARTED|Stage 2||0
419439|NCT01562275|1028502|P5|STARTED|Stage 2||0
419440|NCT01562275|1028503|P4|STARTED|Stage 2||0
419441|NCT01562275|1028504|P3|STARTED|Stage 2||0
419442|NCT01562275|1028505|P2|STARTED|Stage 2||0
419443|NCT01562275|1028506|P1|STARTED|Stage 2||0
419444|NCT01562275|1028494|P13|NOT COMPLETED|Stage 1||0
419445|NCT01562275|1028495|P12|NOT COMPLETED|Stage 1||0
419446|NCT01562275|1028496|P11|NOT COMPLETED|Stage 1||3
419447|NCT01562275|1028497|P10|NOT COMPLETED|Stage 1||7
419448|NCT01562275|1028498|P9|NOT COMPLETED|Stage 1||3
419449|NCT01562275|1028499|P8|NOT COMPLETED|Stage 1||7
419450|NCT01562275|1028500|P7|NOT COMPLETED|Stage 1||3
419451|NCT01562275|1028501|P6|NOT COMPLETED|Stage 1||4
419452|NCT01562275|1028502|P5|NOT COMPLETED|Stage 1||4
419453|NCT01562275|1028503|P4|NOT COMPLETED|Stage 1||4
419454|NCT01562275|1028504|P3|NOT COMPLETED|Stage 1||3
419455|NCT01562275|1028505|P2|NOT COMPLETED|Stage 1||7
419456|NCT01562275|1028506|P1|NOT COMPLETED|Stage 1||3
419457|NCT01562275|1028494|P13|COMPLETED|Stage 1||0
419458|NCT01562275|1028495|P12|COMPLETED|Stage 1||0
419459|NCT01562275|1028496|P11|COMPLETED|Stage 1||0
419460|NCT01562275|1028497|P10|COMPLETED|Stage 1||0
419461|NCT01562275|1028498|P9|COMPLETED|Stage 1||0
419462|NCT01562275|1028499|P8|COMPLETED|Stage 1||0
419463|NCT01562275|1028500|P7|COMPLETED|Stage 1||0
419464|NCT01562275|1028501|P6|COMPLETED|Stage 1||0
419465|NCT01562275|1028502|P5|COMPLETED|Stage 1||0
419466|NCT01562275|1028503|P4|COMPLETED|Stage 1||0
419467|NCT01562275|1028504|P3|COMPLETED|Stage 1||0
419468|NCT01562275|1028505|P2|COMPLETED|Stage 1||0
419469|NCT01562275|1028506|P1|COMPLETED|Stage 1||0
419470|NCT01562275|1028494|P13|STARTED|Stage 1||0
419471|NCT01562275|1028495|P12|STARTED|Stage 1||0
419472|NCT01562275|1028496|P11|STARTED|Stage 1||3
419473|NCT01562275|1028497|P10|STARTED|Stage 1||7
419474|NCT01562275|1028498|P9|STARTED|Stage 1||3
419475|NCT01562275|1028499|P8|STARTED|Stage 1||7
419476|NCT01562275|1028500|P7|STARTED|Stage 1||3
419477|NCT01562275|1028501|P6|STARTED|Stage 1||4
419478|NCT01562275|1028502|P5|STARTED|Stage 1||4
419479|NCT01562275|1028503|P4|STARTED|Stage 1||4
419480|NCT01562275|1028504|P3|STARTED|Stage 1||3
419481|NCT01562275|1028505|P2|STARTED|Stage 1||7
419482|NCT01562275|1028506|P1|STARTED|Stage 1||3
419483|NCT01562132|1028638|P2|NOT COMPLETED|Overall Study||0
419484|NCT01562132|1028639|P1|NOT COMPLETED|Overall Study||0
419485|NCT01562132|1028638|P2|COMPLETED|Overall Study||3
419486|NCT01562132|1028639|P1|COMPLETED|Overall Study||3
419487|NCT01562132|1028638|P2|STARTED|Overall Study||3
419488|NCT01562132|1028639|P1|STARTED|Overall Study||3
419489|NCT01561976|1028651|P6|NOT COMPLETED|Period 3||0
419490|NCT01561976|1028652|P5|NOT COMPLETED|Period 3||0
419491|NCT01561976|1028653|P4|NOT COMPLETED|Period 3||0
419492|NCT01561976|1028654|P3|NOT COMPLETED|Period 3||0
419493|NCT01561976|1028655|P2|NOT COMPLETED|Period 3||0
419494|NCT01561976|1028656|P1|NOT COMPLETED|Period 3||0
419495|NCT01561976|1028651|P6|COMPLETED|Period 3||4
419496|NCT01561976|1028652|P5|COMPLETED|Period 3||5
419497|NCT01561976|1028653|P4|COMPLETED|Period 3||4
419498|NCT01561976|1028654|P3|COMPLETED|Period 3||3
419499|NCT01561976|1028655|P2|COMPLETED|Period 3||5
419500|NCT01561976|1028656|P1|COMPLETED|Period 3||4
419501|NCT01561976|1028651|P6|STARTED|Period 3||4
419502|NCT01561976|1028652|P5|STARTED|Period 3||5
419503|NCT01561976|1028653|P4|STARTED|Period 3||4
419504|NCT01561976|1028654|P3|STARTED|Period 3||3
419505|NCT01561976|1028655|P2|STARTED|Period 3||5
419506|NCT01561976|1028656|P1|STARTED|Period 3||4
419507|NCT01561976|1028651|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
419508|NCT01561976|1028652|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
419509|NCT01561976|1028653|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
419510|NCT01561976|1028654|P3|NOT COMPLETED|Washout Period 2 (7 Days)||1
419511|NCT01561976|1028655|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
419512|NCT01561976|1028656|P1|NOT COMPLETED|Washout Period 2 (7 Days)||1
419513|NCT01561976|1028651|P6|COMPLETED|Washout Period 2 (7 Days)||4
419514|NCT01561976|1028652|P5|COMPLETED|Washout Period 2 (7 Days)||5
419515|NCT01561976|1028653|P4|COMPLETED|Washout Period 2 (7 Days)||4
419516|NCT01561976|1028654|P3|COMPLETED|Washout Period 2 (7 Days)||3
419517|NCT01561976|1028655|P2|COMPLETED|Washout Period 2 (7 Days)||5
419518|NCT01561976|1028656|P1|COMPLETED|Washout Period 2 (7 Days)||4
419519|NCT01561976|1028651|P6|STARTED|Washout Period 2 (7 Days)||4
419520|NCT01561976|1028652|P5|STARTED|Washout Period 2 (7 Days)||5
419521|NCT01561976|1028653|P4|STARTED|Washout Period 2 (7 Days)||4
419522|NCT01561976|1028654|P3|STARTED|Washout Period 2 (7 Days)||4
419523|NCT01561976|1028655|P2|STARTED|Washout Period 2 (7 Days)||5
419524|NCT01561976|1028656|P1|STARTED|Washout Period 2 (7 Days)||5
419525|NCT01561976|1028651|P6|NOT COMPLETED|Period 2||0
419526|NCT01561976|1028652|P5|NOT COMPLETED|Period 2||0
419527|NCT01561976|1028653|P4|NOT COMPLETED|Period 2||0
419528|NCT01561976|1028654|P3|NOT COMPLETED|Period 2||0
419529|NCT01561976|1028655|P2|NOT COMPLETED|Period 2||0
419530|NCT01561976|1028656|P1|NOT COMPLETED|Period 2||0
419531|NCT01561976|1028651|P6|COMPLETED|Period 2||4
419532|NCT01561976|1028652|P5|COMPLETED|Period 2||5
419533|NCT01561976|1028653|P4|COMPLETED|Period 2||4
419534|NCT01561976|1028654|P3|COMPLETED|Period 2||4
419535|NCT01561976|1028655|P2|COMPLETED|Period 2||5
419536|NCT01561976|1028656|P1|COMPLETED|Period 2||5
419537|NCT01561976|1028651|P6|STARTED|Period 2||4
419538|NCT01561976|1028652|P5|STARTED|Period 2||5
419539|NCT01561976|1028653|P4|STARTED|Period 2||4
419540|NCT01561976|1028654|P3|STARTED|Period 2||4
419541|NCT01561976|1028655|P2|STARTED|Period 2||5
419542|NCT01561976|1028656|P1|STARTED|Period 2||5
419543|NCT01561976|1028651|P6|NOT COMPLETED|Washout Period 1 (7 Days)||1
419544|NCT01561976|1028652|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
419545|NCT01561976|1028653|P4|NOT COMPLETED|Washout Period 1 (7 Days)||1
419546|NCT01561976|1028654|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
419547|NCT01561976|1028655|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
419548|NCT01561976|1028656|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
419549|NCT01561976|1028651|P6|COMPLETED|Washout Period 1 (7 Days)||4
419550|NCT01561976|1028652|P5|COMPLETED|Washout Period 1 (7 Days)||5
419551|NCT01561976|1028653|P4|COMPLETED|Washout Period 1 (7 Days)||4
419552|NCT01561976|1028654|P3|COMPLETED|Washout Period 1 (7 Days)||4
419553|NCT01561976|1028655|P2|COMPLETED|Washout Period 1 (7 Days)||5
419554|NCT01561976|1028656|P1|COMPLETED|Washout Period 1 (7 Days)||5
419555|NCT01561976|1028651|P6|STARTED|Washout Period 1 (7 Days)||5
419556|NCT01561976|1028652|P5|STARTED|Washout Period 1 (7 Days)||5
419557|NCT01561976|1028653|P4|STARTED|Washout Period 1 (7 Days)||5
419558|NCT01561976|1028654|P3|STARTED|Washout Period 1 (7 Days)||4
419559|NCT01561976|1028655|P2|STARTED|Washout Period 1 (7 Days)||5
419560|NCT01561976|1028656|P1|STARTED|Washout Period 1 (7 Days)||5
419561|NCT01561976|1028651|P6|NOT COMPLETED|Period 1||0
419562|NCT01561976|1028652|P5|NOT COMPLETED|Period 1||0
419563|NCT01561976|1028653|P4|NOT COMPLETED|Period 1||0
419564|NCT01561976|1028654|P3|NOT COMPLETED|Period 1||1
419565|NCT01561976|1028655|P2|NOT COMPLETED|Period 1||0
419566|NCT01561976|1028656|P1|NOT COMPLETED|Period 1||0
419567|NCT01561976|1028651|P6|COMPLETED|Period 1||5
419568|NCT01561976|1028652|P5|COMPLETED|Period 1||5
419569|NCT01561976|1028653|P4|COMPLETED|Period 1||5
419570|NCT01561976|1028654|P3|COMPLETED|Period 1||4
419571|NCT01561976|1028655|P2|COMPLETED|Period 1||5
419572|NCT01561976|1028656|P1|COMPLETED|Period 1||5
419573|NCT01561976|1028651|P6|STARTED|Period 1||5
419574|NCT01561976|1028652|P5|STARTED|Period 1||5
419575|NCT01561976|1028653|P4|STARTED|Period 1||5
419576|NCT01561976|1028654|P3|STARTED|Period 1||5
419577|NCT01561976|1028655|P2|STARTED|Period 1||5
419578|NCT01561976|1028656|P1|STARTED|Period 1||5
419579|NCT01561898|1028689|P4|NOT COMPLETED|Overall Study||20
419580|NCT01561898|1028690|P3|NOT COMPLETED|Overall Study||44
419581|NCT01561898|1028691|P2|NOT COMPLETED|Overall Study||41
419582|NCT01561898|1028692|P1|NOT COMPLETED|Overall Study||2
419583|NCT01561898|1028689|P4|COMPLETED|Overall Study||12
419584|NCT01561898|1028690|P3|COMPLETED|Overall Study||53
419585|NCT01561898|1028691|P2|COMPLETED|Overall Study||51
419586|NCT01561898|1028692|P1|COMPLETED|Overall Study||5
419587|NCT01561898|1028689|P4|STARTED|Overall Study||32
419588|NCT01561898|1028690|P3|STARTED|Overall Study||97
419589|NCT01561898|1028691|P2|STARTED|Overall Study||92
419590|NCT01561898|1028692|P1|STARTED|Overall Study||7
419591|NCT01561755|1028706|P2|NOT COMPLETED|Overall Study||1
419592|NCT01561755|1028707|P1|NOT COMPLETED|Overall Study||0
419593|NCT01561755|1028706|P2|COMPLETED|Overall Study||5
419594|NCT01561755|1028707|P1|COMPLETED|Overall Study||6
419595|NCT01561755|1028706|P2|STARTED|Overall Study||6
419596|NCT01561755|1028707|P1|STARTED|Overall Study||6
419597|NCT01561716|1028731|P6|NOT COMPLETED|Overall Study||0
419598|NCT01561716|1028732|P5|NOT COMPLETED|Overall Study||0
419599|NCT01561716|1028733|P4|NOT COMPLETED|Overall Study||0
419600|NCT01561716|1028734|P3|NOT COMPLETED|Overall Study||0
419601|NCT01561716|1028735|P2|NOT COMPLETED|Overall Study||0
419602|NCT01561716|1028736|P1|NOT COMPLETED|Overall Study||0
419603|NCT01561716|1028731|P6|COMPLETED|Overall Study||5
419604|NCT01561716|1028732|P5|COMPLETED|Overall Study||5
419605|NCT01561716|1028733|P4|COMPLETED|Overall Study||5
419606|NCT01561716|1028734|P3|COMPLETED|Overall Study||5
419607|NCT01561716|1028735|P2|COMPLETED|Overall Study||5
419608|NCT01561716|1028736|P1|COMPLETED|Overall Study||5
419609|NCT01561716|1028731|P6|STARTED|Overall Study||5
419610|NCT01561716|1028732|P5|STARTED|Overall Study||5
419611|NCT01561716|1028733|P4|STARTED|Overall Study||5
419612|NCT01561716|1028734|P3|STARTED|Overall Study||5
419613|NCT01561716|1028735|P2|STARTED|Overall Study||5
419614|NCT01561716|1028736|P1|STARTED|Overall Study||5
419615|NCT01561703|1028752|P2|NOT COMPLETED|Overall Study||6
419616|NCT01561703|1028753|P1|NOT COMPLETED|Overall Study||8
419617|NCT01561703|1028752|P2|COMPLETED|Overall Study||24
419618|NCT01561703|1028753|P1|COMPLETED|Overall Study||20
419619|NCT01561703|1028752|P2|STARTED|Overall Study||30
419620|NCT01561703|1028753|P1|STARTED|Overall Study||28
419621|NCT01561560|1028759|P2|NOT COMPLETED|Second Two Weeks of Wear||1
419622|NCT01561560|1028760|P1|NOT COMPLETED|Second Two Weeks of Wear||0
419623|NCT01561560|1028759|P2|COMPLETED|Second Two Weeks of Wear||58
419624|NCT01561560|1028760|P1|COMPLETED|Second Two Weeks of Wear||60
419625|NCT01561560|1028759|P2|STARTED|Second Two Weeks of Wear||59
419626|NCT01561560|1028760|P1|STARTED|Second Two Weeks of Wear||60
419627|NCT01561560|1028759|P2|NOT COMPLETED|First Two Weeks of Wear||2
419628|NCT01561560|1028760|P1|NOT COMPLETED|First Two Weeks of Wear||0
419629|NCT01561560|1028759|P2|COMPLETED|First Two Weeks of Wear||59
419630|NCT01561560|1028760|P1|COMPLETED|First Two Weeks of Wear||60
419631|NCT01561560|1028759|P2|STARTED|First Two Weeks of Wear||61
419632|NCT01561560|1028760|P1|STARTED|First Two Weeks of Wear||60
419633|NCT01561469|1028768|P2|NOT COMPLETED|Overall Study||0
419634|NCT01561469|1028769|P1|NOT COMPLETED|Overall Study||0
419635|NCT01561469|1028768|P2|COMPLETED|Overall Study||87
419636|NCT01561469|1028769|P1|COMPLETED|Overall Study||101
419637|NCT01561469|1028768|P2|STARTED|Overall Study||87
419638|NCT01561469|1028769|P1|STARTED|Overall Study||101
419639|NCT01561430|1028791|P4|NOT COMPLETED|Overall Study||13
419640|NCT01561430|1028792|P3|NOT COMPLETED|Overall Study||17
419641|NCT01561430|1028793|P2|NOT COMPLETED|Overall Study||15
419642|NCT01561430|1028794|P1|NOT COMPLETED|Overall Study||1
419643|NCT01561430|1028791|P4|COMPLETED|Overall Study||7
419644|NCT01561430|1028792|P3|COMPLETED|Overall Study||1
419645|NCT01561430|1028793|P2|COMPLETED|Overall Study||8
419646|NCT01561430|1028794|P1|COMPLETED|Overall Study||8
419647|NCT01561430|1028791|P4|Received at Least One Dose of Study Drug|Overall Study||20
419648|NCT01561430|1028792|P3|Received at Least One Dose of Study Drug|Overall Study||18
419649|NCT01561430|1028793|P2|Received at Least One Dose of Study Drug|Overall Study||23
419650|NCT01561430|1028794|P1|Received at Least One Dose of Study Drug|Overall Study||9
419651|NCT01561430|1028791|P4|STARTED|Overall Study||20
419652|NCT01561430|1028792|P3|STARTED|Overall Study||18
419653|NCT01561430|1028793|P2|STARTED|Overall Study||23
419654|NCT01561430|1028794|P1|STARTED|Overall Study||9
419655|NCT01561313|1028834|P2|NOT COMPLETED|Overall Study||0
419656|NCT01561313|1028835|P1|NOT COMPLETED|Overall Study||2
419657|NCT01561313|1028834|P2|COMPLETED|Overall Study||31
419658|NCT01561313|1028835|P1|COMPLETED|Overall Study||31
419659|NCT01561313|1028834|P2|STARTED|Overall Study||31
419660|NCT01561313|1028835|P1|STARTED|Overall Study||33
419661|NCT01561300|1028853|P2|NOT COMPLETED|Second Intervention||0
419662|NCT01561300|1028854|P1|NOT COMPLETED|Second Intervention||0
419663|NCT01561300|1028853|P2|COMPLETED|Second Intervention||15
419664|NCT01561300|1028854|P1|COMPLETED|Second Intervention||14
419665|NCT01561300|1028853|P2|STARTED|Second Intervention||15
419666|NCT01561300|1028854|P1|STARTED|Second Intervention||14
419667|NCT01561300|1028853|P2|NOT COMPLETED|Washout on Placebo||0
419668|NCT01561300|1028854|P1|NOT COMPLETED|Washout on Placebo||0
419669|NCT01561300|1028853|P2|COMPLETED|Washout on Placebo||15
419670|NCT01561300|1028854|P1|COMPLETED|Washout on Placebo||14
419671|NCT01561300|1028853|P2|STARTED|Washout on Placebo||15
419672|NCT01561300|1028854|P1|STARTED|Washout on Placebo||14
419673|NCT01561300|1028853|P2|NOT COMPLETED|First Intervention||0
419674|NCT01561300|1028854|P1|NOT COMPLETED|First Intervention||0
419675|NCT01561300|1028853|P2|COMPLETED|First Intervention||15
419676|NCT01561300|1028854|P1|COMPLETED|First Intervention||14
419677|NCT01561300|1028853|P2|STARTED|First Intervention||15
419678|NCT01561300|1028854|P1|STARTED|First Intervention||14
419679|NCT01561300|1028853|P2|NOT COMPLETED|Run in on Placebo||0
419680|NCT01561300|1028854|P1|NOT COMPLETED|Run in on Placebo||1
419681|NCT01561300|1028853|P2|COMPLETED|Run in on Placebo||15
419682|NCT01561300|1028854|P1|COMPLETED|Run in on Placebo||14
419683|NCT01561300|1028853|P2|STARTED|Run in on Placebo||15
419684|NCT01561300|1028854|P1|STARTED|Run in on Placebo||15
419685|NCT01561079|1028865|P1|NOT COMPLETED|Overall Study||78
419686|NCT01561079|1028865|P1|COMPLETED|Overall Study||49
419687|NCT01561079|1028865|P1|STARTED|Overall Study||127
419688|NCT01560988|1028908|P2|NOT COMPLETED|Second Intervention (Six Weeks)||2
419689|NCT01560988|1028909|P1|NOT COMPLETED|Second Intervention (Six Weeks)||2
419690|NCT01560988|1028908|P2|COMPLETED|Second Intervention (Six Weeks)||22
419691|NCT01560988|1028909|P1|COMPLETED|Second Intervention (Six Weeks)||18
419692|NCT01560988|1028908|P2|STARTED|Second Intervention (Six Weeks)||24
419693|NCT01560988|1028909|P1|STARTED|Second Intervention (Six Weeks)||20
419694|NCT01560988|1028908|P2|NOT COMPLETED|Washout (Six Weeks)||2
419695|NCT01560988|1028909|P1|NOT COMPLETED|Washout (Six Weeks)||2
419696|NCT01560988|1028908|P2|COMPLETED|Washout (Six Weeks)||24
419697|NCT01560988|1028909|P1|COMPLETED|Washout (Six Weeks)||20
419698|NCT01560988|1028908|P2|STARTED|Washout (Six Weeks)||26
419699|NCT01560988|1028909|P1|STARTED|Washout (Six Weeks)||22
419700|NCT01560988|1028908|P2|NOT COMPLETED|First Intervention (Six Weeks)||4
419701|NCT01560988|1028909|P1|NOT COMPLETED|First Intervention (Six Weeks)||10
419702|NCT01560988|1028908|P2|COMPLETED|First Intervention (Six Weeks)||26
419703|NCT01560988|1028909|P1|COMPLETED|First Intervention (Six Weeks)||22
419704|NCT01560988|1028908|P2|STARTED|First Intervention (Six Weeks)||30
419705|NCT01560988|1028909|P1|STARTED|First Intervention (Six Weeks)||32
419706|NCT01560975|1028932|P1|NOT COMPLETED|Overall Study||0
419707|NCT01560975|1028932|P1|COMPLETED|Overall Study||10
419708|NCT01560975|1028932|P1|STARTED|Overall Study||10
419709|NCT01560819|1028947|P2|NOT COMPLETED|Overall Study||0
419710|NCT01560819|1028948|P1|NOT COMPLETED|Overall Study||1
419711|NCT01560819|1028947|P2|COMPLETED|Overall Study||10
419712|NCT01560819|1028948|P1|COMPLETED|Overall Study||9
419713|NCT01560819|1028947|P2|STARTED|Overall Study||10
419714|NCT01560819|1028948|P1|STARTED|Overall Study||10
419715|NCT01560507|1028955|P3|NOT COMPLETED|Overall Study||2
419716|NCT01560507|1028956|P2|NOT COMPLETED|Overall Study||2
419717|NCT01560507|1028957|P1|NOT COMPLETED|Overall Study||4
419718|NCT01560507|1028955|P3|COMPLETED|Overall Study||0
419719|NCT01560507|1028956|P2|COMPLETED|Overall Study||0
419720|NCT01560507|1028957|P1|COMPLETED|Overall Study||1
419721|NCT01560507|1028955|P3|STARTED|Overall Study||2
419722|NCT01560507|1028956|P2|STARTED|Overall Study||2
419723|NCT01560507|1028957|P1|STARTED|Overall Study||5
419724|NCT01560429|1028970|P2|NOT COMPLETED|Overall Study||6
419725|NCT01560429|1028971|P1|NOT COMPLETED|Overall Study||3
419726|NCT01560429|1028970|P2|COMPLETED|Overall Study||20
419727|NCT01560429|1028971|P1|COMPLETED|Overall Study||23
419728|NCT01560429|1028970|P2|STARTED|Overall Study||26
419729|NCT01560429|1028971|P1|STARTED|Overall Study||26
419730|NCT01560403|1028981|P2|NOT COMPLETED|Overall Study||1
419731|NCT01560403|1028982|P1|NOT COMPLETED|Overall Study||0
419732|NCT01560403|1028981|P2|COMPLETED|Overall Study||8
419733|NCT01560403|1028982|P1|COMPLETED|Overall Study||5
419734|NCT01560403|1028981|P2|STARTED|Overall Study||9
419735|NCT01560403|1028982|P1|STARTED|Overall Study||5
419736|NCT01560260|1028988|P1|NOT COMPLETED|Overall Study||0
419737|NCT01560260|1028988|P1|COMPLETED|Overall Study||20
419738|NCT01560260|1028988|P1|STARTED|Overall Study||20
419739|NCT01560234|1029000|P8|NOT COMPLETED|Overall Study||2
419740|NCT01560234|1029001|P7|NOT COMPLETED|Overall Study||0
419741|NCT01560234|1029002|P6|NOT COMPLETED|Overall Study||2
419742|NCT01560234|1029003|P5|NOT COMPLETED|Overall Study||0
419743|NCT01560234|1029004|P4|NOT COMPLETED|Overall Study||0
419744|NCT01560234|1029005|P3|NOT COMPLETED|Overall Study||1
419745|NCT01560234|1029006|P2|NOT COMPLETED|Overall Study||0
419746|NCT01560234|1029007|P1|NOT COMPLETED|Overall Study||3
419747|NCT01560234|1029000|P8|COMPLETED|Overall Study||6
419748|NCT01560234|1029001|P7|COMPLETED|Overall Study||4
419749|NCT01560234|1029002|P6|COMPLETED|Overall Study||2
419750|NCT01560234|1029003|P5|COMPLETED|Overall Study||4
419751|NCT01560234|1029004|P4|COMPLETED|Overall Study||3
419752|NCT01560234|1029005|P3|COMPLETED|Overall Study||3
419753|NCT01560234|1029006|P2|COMPLETED|Overall Study||4
419754|NCT01560234|1029007|P1|COMPLETED|Overall Study||13
419755|NCT01560234|1029000|P8|STARTED|Overall Study||8
419756|NCT01560234|1029001|P7|STARTED|Overall Study||4
419757|NCT01560234|1029002|P6|STARTED|Overall Study||4
419758|NCT01560234|1029003|P5|STARTED|Overall Study||4
419759|NCT01560234|1029004|P4|STARTED|Overall Study||3
419760|NCT01560234|1029005|P3|STARTED|Overall Study||4
419761|NCT01560234|1029006|P2|STARTED|Overall Study||4
419762|NCT01560234|1029007|P1|STARTED|Overall Study||16
419763|NCT01560143|1029081|P1|NOT COMPLETED|Overall Study||0
419764|NCT01560143|1029081|P1|COMPLETED|Overall Study||12
419765|NCT01560143|1029081|P1|STARTED|Overall Study||12
419766|NCT01559935|1029085|P1|NOT COMPLETED|Maintenance Phase||54
419767|NCT01559935|1029085|P1|COMPLETED|Maintenance Phase||0
419768|NCT01559935|1029085|P1|STARTED|Maintenance Phase||54
419769|NCT01559935|1029085|P1|NOT COMPLETED|BiRD Phase||4
419770|NCT01559935|1029085|P1|COMPLETED|BiRD Phase||54
419771|NCT01559935|1029085|P1|STARTED|BiRD Phase||58
419772|NCT01559935|1029085|P1|NOT COMPLETED|Car Phase||14
419773|NCT01559935|1029085|P1|COMPLETED|Car Phase||58
419774|NCT01559935|1029085|P1|STARTED|Car Phase||72
419775|NCT01559922|1029095|P2|NOT COMPLETED|Overall Study||10
419776|NCT01559922|1029096|P1|NOT COMPLETED|Overall Study||4
419777|NCT01559922|1029095|P2|COMPLETED|Overall Study||87
419778|NCT01559922|1029096|P1|COMPLETED|Overall Study||46
419779|NCT01559922|1029095|P2|STARTED|Overall Study||97
419780|NCT01559922|1029096|P1|STARTED|Overall Study||50
419781|NCT01559857|1029104|P2|NOT COMPLETED|Overall Study||0
419782|NCT01559857|1029105|P1|NOT COMPLETED|Overall Study||0
419783|NCT01559857|1029104|P2|COMPLETED|Overall Study||18
419784|NCT01559857|1029105|P1|COMPLETED|Overall Study||19
419785|NCT01559857|1029104|P2|STARTED|Overall Study||18
419786|NCT01559857|1029105|P1|STARTED|Overall Study||19
419787|NCT01559844|1029121|P1|NOT COMPLETED|Overall Study||25
419788|NCT01559844|1029121|P1|COMPLETED|Overall Study||36
419789|NCT01559844|1029121|P1|STARTED|Overall Study||61
419790|NCT01559675|1029134|P2|NOT COMPLETED|Overall Study||14
419791|NCT01559675|1029135|P1|NOT COMPLETED|Overall Study||15
419792|NCT01559675|1029134|P2|COMPLETED|Overall Study||49
419793|NCT01559675|1029135|P1|COMPLETED|Overall Study||43
419794|NCT01559675|1029134|P2|STARTED|Overall Study||63
419795|NCT01559675|1029135|P1|STARTED|Overall Study||58
419796|NCT01559649|1029143|P2|NOT COMPLETED|Overall Study||6
419797|NCT01559649|1029144|P1|NOT COMPLETED|Overall Study||19
419798|NCT01559649|1029143|P2|COMPLETED|Overall Study||9
419891|NCT01558492|1029405|P1|NOT COMPLETED|Overall Study||0
419892|NCT01558492|1029405|P1|COMPLETED|Overall Study||3
419799|NCT01559649|1029144|P1|COMPLETED|Overall Study|Screening not completed in 11, VFSS not completed in 2, 6 excluded from analysis. N=250 analyzed|250
419800|NCT01559649|1029143|P2|STARTED|Overall Study|Started with 10 nurses. As an RN dropped out due to scheduling, etc, RN replaced with another RN|15
419801|NCT01559649|1029144|P1|STARTED|Overall Study||269
419802|NCT01559506|1029157|P2|NOT COMPLETED|Overall Study||3
419803|NCT01559506|1029158|P1|NOT COMPLETED|Overall Study||0
419804|NCT01559506|1029157|P2|COMPLETED|Overall Study||18
419805|NCT01559506|1029158|P1|COMPLETED|Overall Study||20
419806|NCT01559506|1029157|P2|STARTED|Overall Study||21
419807|NCT01559506|1029158|P1|STARTED|Overall Study||20
419808|NCT01559454|1029166|P2|NOT COMPLETED|Overall Study||6
419809|NCT01559454|1029167|P1|NOT COMPLETED|Overall Study||3
419810|NCT01559454|1029166|P2|COMPLETED|Overall Study||4
419811|NCT01559454|1029167|P1|COMPLETED|Overall Study||6
419812|NCT01559454|1029166|P2|STARTED|Overall Study||10
419813|NCT01559454|1029167|P1|STARTED|Overall Study||9
419814|NCT01559311|1029186|P3|NOT COMPLETED|Overall Study||8
419815|NCT01559311|1029187|P2|NOT COMPLETED|Overall Study||6
419816|NCT01559311|1029188|P1|NOT COMPLETED|Overall Study||3
419817|NCT01559311|1029186|P3|COMPLETED|Overall Study|12-Month|26
419818|NCT01559311|1029187|P2|COMPLETED|Overall Study|12-Month|28
419819|NCT01559311|1029188|P1|COMPLETED|Overall Study|12-Month|27
419820|NCT01559311|1029186|P3|6-Month|Overall Study||28
419821|NCT01559311|1029187|P2|6-Month|Overall Study||33
419822|NCT01559311|1029188|P1|6-Month|Overall Study||27
419823|NCT01559311|1029186|P3|3-Month|Overall Study||29
419824|NCT01559311|1029187|P2|3-Month|Overall Study||34
419825|NCT01559311|1029188|P1|3-Month|Overall Study||27
419826|NCT01559311|1029186|P3|1-Month|Overall Study||29
419827|NCT01559311|1029187|P2|1-Month|Overall Study||34
419828|NCT01559311|1029188|P1|1-Month|Overall Study||27
419829|NCT01559311|1029186|P3|Implant|Overall Study||32
419830|NCT01559311|1029187|P2|Implant|Overall Study||34
419831|NCT01559311|1029188|P1|Implant|Overall Study||28
419832|NCT01559311|1029186|P3|STARTED|Overall Study|Enrollment & Baseline|34
419833|NCT01559311|1029187|P2|STARTED|Overall Study|Enrollment & Baseline|34
419834|NCT01559311|1029188|P1|STARTED|Overall Study|Enrollment & Baseline|30
419835|NCT01559116|1029199|P1|NOT COMPLETED|Overall Study||26
419836|NCT01559116|1029199|P1|COMPLETED|Overall Study|Completed all 4 treatment periods|193
419837|NCT01559116|1029199|P1|STARTED|Overall Study|Randomised|219
419838|NCT01559064|1029270|P3|NOT COMPLETED|Overall Study||2
419839|NCT01559064|1029271|P2|NOT COMPLETED|Overall Study||1
419840|NCT01559064|1029272|P1|NOT COMPLETED|Overall Study||1
419841|NCT01559064|1029270|P3|COMPLETED|Overall Study||57
419842|NCT01559064|1029271|P2|COMPLETED|Overall Study||39
419843|NCT01559064|1029272|P1|COMPLETED|Overall Study||15
419844|NCT01559064|1029270|P3|STARTED|Overall Study||59
419845|NCT01559064|1029271|P2|STARTED|Overall Study||40
419846|NCT01559064|1029272|P1|STARTED|Overall Study||16
419847|NCT01559012|1029282|P2|NOT COMPLETED|Overall Study||1
419848|NCT01559012|1029283|P1|NOT COMPLETED|Overall Study||0
419849|NCT01559012|1029282|P2|COMPLETED|Overall Study|Patient N. 2 withdrew from study for alleged side effects at day 1 of placebo cycle.|6
419850|NCT01559012|1029283|P1|COMPLETED|Overall Study||6
419851|NCT01559012|1029282|P2|STARTED|Overall Study|1 more patient added to randomization list to reach the pre-assignment number of treated patients|7
419852|NCT01559012|1029283|P1|STARTED|Overall Study||6
419853|NCT01558791|1029308|P2|NOT COMPLETED|Overall Study||0
419854|NCT01558791|1029309|P1|NOT COMPLETED|Overall Study||0
419855|NCT01558791|1029308|P2|COMPLETED|Overall Study||629
419856|NCT01558791|1029309|P1|COMPLETED|Overall Study||607
419857|NCT01558791|1029308|P2|STARTED|Overall Study||629
419858|NCT01558791|1029309|P1|STARTED|Overall Study||607
419859|NCT01558739|1029319|P1|NOT COMPLETED|Overall Study||17
419860|NCT01558739|1029319|P1|COMPLETED|Overall Study||31
419861|NCT01558739|1029319|P1|STARTED|Overall Study||48
419862|NCT01558700|1029333|P2|NOT COMPLETED|Overall Study||0
419863|NCT01558700|1029334|P1|NOT COMPLETED|Overall Study||0
419864|NCT01558700|1029333|P2|COMPLETED|Overall Study||21
419865|NCT01558700|1029334|P1|COMPLETED|Overall Study||19
419866|NCT01558700|1029333|P2|STARTED|Overall Study||21
419867|NCT01558700|1029334|P1|STARTED|Overall Study||19
419868|NCT01558674|1029344|P2|NOT COMPLETED|Part 2||0
419869|NCT01558674|1029345|P1|NOT COMPLETED|Part 2||0
419870|NCT01558674|1029344|P2|COMPLETED|Part 2||0
419871|NCT01558674|1029345|P1|COMPLETED|Part 2||0
419872|NCT01558674|1029344|P2|STARTED|Part 2||0
419873|NCT01558674|1029345|P1|STARTED|Part 2||0
419874|NCT01558674|1029344|P2|NOT COMPLETED|Part 1||0
419875|NCT01558674|1029345|P1|NOT COMPLETED|Part 1||11
419876|NCT01558674|1029344|P2|COMPLETED|Part 1||0
419877|NCT01558674|1029345|P1|COMPLETED|Part 1||0
419878|NCT01558674|1029344|P2|STARTED|Part 1||0
419879|NCT01558674|1029345|P1|STARTED|Part 1||11
419880|NCT01558661|1029389|P1|NOT COMPLETED|Overall Study||0
419881|NCT01558661|1029389|P1|COMPLETED|Overall Study||33
419882|NCT01558661|1029389|P1|Second Stage|Overall Study||15
419883|NCT01558661|1029389|P1|First Stage|Overall Study||18
419884|NCT01558661|1029389|P1|STARTED|Overall Study||33
419885|NCT01558596|1029398|P2|NOT COMPLETED|Overall Study||1
419886|NCT01558596|1029399|P1|NOT COMPLETED|Overall Study||3
419887|NCT01558596|1029398|P2|COMPLETED|Overall Study||100
419888|NCT01558596|1029399|P1|COMPLETED|Overall Study||101
419889|NCT01558596|1029398|P2|STARTED|Overall Study||101
419890|NCT01558596|1029399|P1|STARTED|Overall Study||104
419893|NCT01558492|1029405|P1|STARTED|Overall Study||3
419894|NCT01558297|1029414|P3|NOT COMPLETED|Overall Study||1
419895|NCT01558297|1029415|P2|NOT COMPLETED|Overall Study||2
419896|NCT01558297|1029416|P1|NOT COMPLETED|Overall Study||2
419897|NCT01558297|1029414|P3|COMPLETED|Overall Study||29
419898|NCT01558297|1029415|P2|COMPLETED|Overall Study||27
419899|NCT01558297|1029416|P1|COMPLETED|Overall Study||28
419900|NCT01558297|1029414|P3|STARTED|Overall Study||30
419901|NCT01558297|1029415|P2|STARTED|Overall Study||29
419902|NCT01558297|1029416|P1|STARTED|Overall Study||30
419903|NCT01558271|1029433|P3|NOT COMPLETED|Overall Study||17
419904|NCT01558271|1029434|P2|NOT COMPLETED|Overall Study||11
419905|NCT01558271|1029435|P1|NOT COMPLETED|Overall Study||18
419906|NCT01558271|1029433|P3|COMPLETED|Overall Study||124
419907|NCT01558271|1029434|P2|COMPLETED|Overall Study||59
419908|NCT01558271|1029435|P1|COMPLETED|Overall Study||263
419909|NCT01558271|1029433|P3|Completed 26 Weeks|Overall Study||128
419910|NCT01558271|1029434|P2|Completed 26 Weeks|Overall Study||63
419911|NCT01558271|1029435|P1|Completed 26 Weeks|Overall Study||271
419912|NCT01558271|1029433|P3|Received at Least 1 Dose of Study Drug|Overall Study||137
419913|NCT01558271|1029434|P2|Received at Least 1 Dose of Study Drug|Overall Study||70
419914|NCT01558271|1029435|P1|Received at Least 1 Dose of Study Drug|Overall Study||280
419915|NCT01558271|1029433|P3|STARTED|Overall Study||141
419916|NCT01558271|1029434|P2|STARTED|Overall Study||70
419917|NCT01558271|1029435|P1|STARTED|Overall Study||281
419918|NCT01558128|1029497|P1|NOT COMPLETED|Overall Study||0
419919|NCT01558128|1029497|P1|COMPLETED|Overall Study||1
419920|NCT01558128|1029497|P1|STARTED|Overall Study||1
419921|NCT01558089|1029501|P1|NOT COMPLETED|Overall Study||13
419922|NCT01558089|1029501|P1|COMPLETED|Overall Study||63
419923|NCT01558089|1029501|P1|STARTED|Overall Study||76
419927|NCT01557946|1029522|P2|NOT COMPLETED|Overall Study||0
419928|NCT01557946|1029523|P1|NOT COMPLETED|Overall Study||3
419929|NCT01557946|1029522|P2|COMPLETED|Overall Study|2 subjects with unusable imaging data.|12
419930|NCT01557946|1029523|P1|COMPLETED|Overall Study|20 consented and scanned - 1 subject's data not used due to ongoing neurological condition.|17
419931|NCT01557946|1029522|P2|STARTED|Overall Study||12
419932|NCT01557946|1029523|P1|STARTED|Overall Study||20
419933|NCT01557920|1029529|P2|NOT COMPLETED|Overall Study||3
419934|NCT01557920|1029530|P1|NOT COMPLETED|Overall Study||3
419935|NCT01557920|1029529|P2|COMPLETED|Overall Study||6
419936|NCT01557920|1029530|P1|COMPLETED|Overall Study||6
419937|NCT01557920|1029529|P2|STARTED|Overall Study||9
419938|NCT01557920|1029530|P1|STARTED|Overall Study||9
419939|NCT01557894|1029565|P2|NOT COMPLETED|Overall Study||5
419940|NCT01557894|1029566|P1|NOT COMPLETED|Overall Study||3
419941|NCT01557894|1029565|P2|COMPLETED|Overall Study||33
419942|NCT01557894|1029566|P1|COMPLETED|Overall Study||35
419943|NCT01557894|1029565|P2|STARTED|Overall Study||38
419944|NCT01557894|1029566|P1|STARTED|Overall Study||38
419945|NCT01557868|1029582|P2|NOT COMPLETED|Overall Study||30
419946|NCT01557868|1029583|P1|NOT COMPLETED|Overall Study||27
419947|NCT01557868|1029582|P2|COMPLETED|Overall Study||65
419948|NCT01557868|1029583|P1|COMPLETED|Overall Study||76
419949|NCT01557868|1029582|P2|STARTED|Overall Study||95
419950|NCT01557868|1029583|P1|STARTED|Overall Study||103
419951|NCT01557842|1029593|P2|NOT COMPLETED|Overall Study||6
419952|NCT01557842|1029594|P1|NOT COMPLETED|Overall Study||9
419953|NCT01557842|1029593|P2|COMPLETED|Overall Study||0
419954|NCT01557842|1029594|P1|COMPLETED|Overall Study||0
419955|NCT01557842|1029593|P2|STARTED|Overall Study||6
419956|NCT01557842|1029594|P1|STARTED|Overall Study||9
419957|NCT01557751|1029602|P1|NOT COMPLETED|Overall Study||3
419958|NCT01557751|1029602|P1|COMPLETED|Overall Study||153
419959|NCT01557751|1029602|P1|STARTED|Overall Study||156
419960|NCT01557699|1029609|P3|NOT COMPLETED|Overall Study||0
419961|NCT01557699|1029610|P2|NOT COMPLETED|Overall Study||0
419962|NCT01557699|1029611|P1|NOT COMPLETED|Overall Study||0
419963|NCT01557699|1029609|P3|COMPLETED|Overall Study||20
419964|NCT01557699|1029610|P2|COMPLETED|Overall Study||20
419965|NCT01557699|1029611|P1|COMPLETED|Overall Study||20
419966|NCT01557699|1029609|P3|STARTED|Overall Study||20
419967|NCT01557699|1029610|P2|STARTED|Overall Study||20
419968|NCT01557699|1029611|P1|STARTED|Overall Study||20
419969|NCT01557595|1029643|P1|NOT COMPLETED|Overall Study||8
419970|NCT01557595|1029643|P1|COMPLETED|Overall Study||14
419971|NCT01557595|1029643|P1|STARTED|Overall Study||22
419972|NCT01557582|1029647|P1|NOT COMPLETED|Overall Study||6
419973|NCT01557582|1029647|P1|COMPLETED|Overall Study||97
419974|NCT01557582|1029647|P1|STARTED|Overall Study||103
419975|NCT01557569|1029655|P2|NOT COMPLETED|Overall Study||7
419976|NCT01557569|1029656|P1|NOT COMPLETED|Overall Study||5
419977|NCT01557569|1029655|P2|COMPLETED|Overall Study||0
419978|NCT01557569|1029656|P1|COMPLETED|Overall Study||1
419979|NCT01557569|1029655|P2|Completed 2-wk Residential Stay|Overall Study||1
419980|NCT01557569|1029656|P1|Completed 2-wk Residential Stay|Overall Study||3
419981|NCT01557569|1029655|P2|STARTED|Overall Study|Those who received at least one dose of medication|7
419982|NCT01557569|1029656|P1|STARTED|Overall Study|Those who received at least one dose of medication|6
419983|NCT01557504|1029664|P2|NOT COMPLETED|Overall Study||0
419984|NCT01557504|1029665|P1|NOT COMPLETED|Overall Study||1
419985|NCT01557504|1029664|P2|COMPLETED|Overall Study||12
419986|NCT01557504|1029665|P1|COMPLETED|Overall Study||12
419987|NCT01557504|1029664|P2|STARTED|Overall Study||12
419988|NCT01557504|1029665|P1|STARTED|Overall Study||13
419989|NCT01557348|1029690|P2|NOT COMPLETED|Overall Study||90
419990|NCT01557348|1029691|P1|NOT COMPLETED|Overall Study||80
419991|NCT01557348|1029690|P2|COMPLETED|Overall Study||417
419992|NCT01557348|1029691|P1|COMPLETED|Overall Study||524
419993|NCT01557348|1029690|P2|Safety Population|Overall Study||507
419994|NCT01557348|1029691|P1|Safety Population|Overall Study||604
419995|NCT01557348|1029690|P2|STARTED|Overall Study||507
419996|NCT01557348|1029691|P1|STARTED|Overall Study||604
419997|NCT01557322|1029733|P2|NOT COMPLETED|Overall Study||0
419998|NCT01557322|1029734|P1|NOT COMPLETED|Overall Study||0
419999|NCT01557322|1029733|P2|COMPLETED|Overall Study||1543
420000|NCT01557322|1029734|P1|COMPLETED|Overall Study||211
420001|NCT01557322|1029733|P2|STARTED|Overall Study||1543
420002|NCT01557322|1029734|P1|STARTED|Overall Study||211
420003|NCT01557283|1029808|P1|NOT COMPLETED|Overall Study||44
420004|NCT01557283|1029808|P1|COMPLETED|Overall Study||96
420005|NCT01557283|1029808|P1|STARTED|Overall Study||140
420006|NCT01557166|1029820|P2|NOT COMPLETED|Overall Study||37
420007|NCT01557166|1029821|P1|NOT COMPLETED|Overall Study||46
420008|NCT01557166|1029820|P2|COMPLETED|Overall Study||142
420009|NCT01557166|1029821|P1|COMPLETED|Overall Study||134
420010|NCT01557166|1029820|P2|Exposed|Overall Study||179
420011|NCT01557166|1029821|P1|Exposed|Overall Study||176
420012|NCT01557166|1029820|P2|STARTED|Overall Study||179
420013|NCT01557166|1029821|P1|STARTED|Overall Study||180
420014|NCT01556997|1029836|P3|NOT COMPLETED|Overall Study||32
420015|NCT01556997|1029837|P2|NOT COMPLETED|Overall Study||28
420016|NCT01556997|1029838|P1|NOT COMPLETED|Overall Study||26
420017|NCT01556997|1029836|P3|COMPLETED|Overall Study||246
420018|NCT01556997|1029837|P2|COMPLETED|Overall Study||252
420019|NCT01556997|1029838|P1|COMPLETED|Overall Study||253
420020|NCT01556997|1029836|P3|STARTED|Overall Study||278
420021|NCT01556997|1029837|P2|STARTED|Overall Study||280
420022|NCT01556997|1029838|P1|STARTED|Overall Study||279
420023|NCT01556932|1029849|P2|NOT COMPLETED|Second Treament||0
420024|NCT01556932|1029850|P1|NOT COMPLETED|Second Treament||0
420025|NCT01556932|1029849|P2|COMPLETED|Second Treament||8
420026|NCT01556932|1029850|P1|COMPLETED|Second Treament||12
420027|NCT01556932|1029849|P2|Recieved|Second Treament||8
420028|NCT01556932|1029850|P1|Recieved|Second Treament||12
420029|NCT01556932|1029849|P2|STARTED|Second Treament||8
420030|NCT01556932|1029850|P1|STARTED|Second Treament||12
420031|NCT01556932|1029849|P2|NOT COMPLETED|Time Point 60 Minutes||1
420032|NCT01556932|1029850|P1|NOT COMPLETED|Time Point 60 Minutes||1
420033|NCT01556932|1029849|P2|COMPLETED|Time Point 60 Minutes||8
420034|NCT01556932|1029850|P1|COMPLETED|Time Point 60 Minutes||12
420035|NCT01556932|1029849|P2|Recieved|Time Point 60 Minutes||8
420036|NCT01556932|1029850|P1|Recieved|Time Point 60 Minutes||12
420037|NCT01556932|1029849|P2|STARTED|Time Point 60 Minutes|1 subject withdrew and never started second treatment.|9
420038|NCT01556932|1029850|P1|STARTED|Time Point 60 Minutes|1 subject withdrew and never started second treatment.|13
420039|NCT01556932|1029849|P2|NOT COMPLETED|Baseline First Treatment||0
420040|NCT01556932|1029850|P1|NOT COMPLETED|Baseline First Treatment||0
420041|NCT01556932|1029849|P2|COMPLETED|Baseline First Treatment||9
420042|NCT01556932|1029850|P1|COMPLETED|Baseline First Treatment||13
420043|NCT01556932|1029849|P2|Recieved|Baseline First Treatment||9
420044|NCT01556932|1029850|P1|Recieved|Baseline First Treatment||13
420045|NCT01556932|1029849|P2|STARTED|Baseline First Treatment||9
420046|NCT01556932|1029850|P1|STARTED|Baseline First Treatment||13
420047|NCT01556906|1029855|P1|NOT COMPLETED|Overall Study||0
420048|NCT01556906|1029855|P1|COMPLETED|Overall Study||6
420049|NCT01556906|1029855|P1|STARTED|Overall Study||6
420050|NCT01556763|1029876|P3|NOT COMPLETED|Overall Study||0
420051|NCT01556763|1029877|P2|NOT COMPLETED|Overall Study||1
420052|NCT01556763|1029878|P1|NOT COMPLETED|Overall Study||0
420053|NCT01556763|1029876|P3|COMPLETED|Overall Study||8
420054|NCT01556763|1029877|P2|COMPLETED|Overall Study||8
420055|NCT01556763|1029878|P1|COMPLETED|Overall Study||4
420056|NCT01556763|1029876|P3|STARTED|Overall Study||8
420057|NCT01556763|1029877|P2|STARTED|Overall Study||9
420058|NCT01556763|1029878|P1|STARTED|Overall Study||4
420059|NCT01556724|1029916|P2|NOT COMPLETED|Overall Study||0
420060|NCT01556724|1029917|P1|NOT COMPLETED|Overall Study||0
420061|NCT01556724|1029916|P2|COMPLETED|Overall Study||14
420062|NCT01556724|1029917|P1|COMPLETED|Overall Study||16
420063|NCT01556724|1029916|P2|STARTED|Overall Study||14
420064|NCT01556724|1029917|P1|STARTED|Overall Study||16
420065|NCT01556633|1029933|P2|NOT COMPLETED|Overall Study||0
420066|NCT01556633|1029934|P1|NOT COMPLETED|Overall Study||0
420067|NCT01556633|1029933|P2|COMPLETED|Overall Study||6
420068|NCT01556633|1029934|P1|COMPLETED|Overall Study||10
420069|NCT01556633|1029933|P2|STARTED|Overall Study||6
420070|NCT01556633|1029934|P1|STARTED|Overall Study||10
420071|NCT01556594|1029959|P3|NOT COMPLETED|Overall Study||0
420072|NCT01556594|1029960|P2|NOT COMPLETED|Overall Study||0
420073|NCT01556594|1029961|P1|NOT COMPLETED|Overall Study||0
420074|NCT01556594|1029959|P3|COMPLETED|Overall Study||6
420075|NCT01556594|1029960|P2|COMPLETED|Overall Study||2
420076|NCT01556594|1029961|P1|COMPLETED|Overall Study||10
420077|NCT01556594|1029959|P3|STARTED|Overall Study||6
420078|NCT01556594|1029960|P2|STARTED|Overall Study||2
420079|NCT01556594|1029961|P1|STARTED|Overall Study||10
420080|NCT01556451|1029979|P1|NOT COMPLETED|Overall Study||0
420081|NCT01556451|1029979|P1|COMPLETED|Overall Study||180
420082|NCT01556451|1029979|P1|STARTED|Overall Study||180
420083|NCT01556425|1029990|P4|NOT COMPLETED|Overall Study||0
420084|NCT01556425|1029991|P3|NOT COMPLETED|Overall Study||0
420085|NCT01556425|1029992|P2|NOT COMPLETED|Overall Study||0
420086|NCT01556425|1029993|P1|NOT COMPLETED|Overall Study||0
420087|NCT01556425|1029990|P4|COMPLETED|Overall Study||18
420088|NCT01556425|1029991|P3|COMPLETED|Overall Study||18
420089|NCT01556425|1029992|P2|COMPLETED|Overall Study||23
420090|NCT01556425|1029993|P1|COMPLETED|Overall Study||25
420091|NCT01556425|1029990|P4|STARTED|Overall Study||18
420092|NCT01556425|1029991|P3|STARTED|Overall Study||18
420093|NCT01556425|1029992|P2|STARTED|Overall Study||23
420094|NCT01556425|1029993|P1|STARTED|Overall Study||25
420095|NCT01556347|1030007|P1|NOT COMPLETED|Recovery Phase||0
420096|NCT01556347|1030007|P1|COMPLETED|Recovery Phase||2
420097|NCT01556347|1030007|P1|STARTED|Recovery Phase||2
420098|NCT01556347|1030007|P1|NOT COMPLETED|Bortezomib Treatment Phase||0
420099|NCT01556347|1030007|P1|COMPLETED|Bortezomib Treatment Phase||2
420100|NCT01556347|1030007|P1|STARTED|Bortezomib Treatment Phase||2
420101|NCT01556347|1030007|P1|NOT COMPLETED|Induction Immunotherapy||0
420102|NCT01556347|1030007|P1|COMPLETED|Induction Immunotherapy||2
420103|NCT01556347|1030007|P1|STARTED|Induction Immunotherapy||2
420104|NCT01556204|1030037|P2|NOT COMPLETED|Overall Study||0
420105|NCT01556204|1030038|P1|NOT COMPLETED|Overall Study||0
420106|NCT01556204|1030037|P2|COMPLETED|Overall Study||38
420107|NCT01556204|1030038|P1|COMPLETED|Overall Study||35
420108|NCT01556204|1030037|P2|STARTED|Overall Study||38
420109|NCT01556204|1030038|P1|STARTED|Overall Study||35
420110|NCT01556165|1030048|P2|NOT COMPLETED|Overall Study||7
420111|NCT01556165|1030049|P1|NOT COMPLETED|Overall Study||12
420112|NCT01556165|1030048|P2|COMPLETED|Overall Study||58
420113|NCT01556165|1030049|P1|COMPLETED|Overall Study||53
420114|NCT01556165|1030048|P2|STARTED|Overall Study||65
420115|NCT01556165|1030049|P1|STARTED|Overall Study||65
420116|NCT01556100|1030061|P1|NOT COMPLETED|Overall Study||6
420117|NCT01556100|1030061|P1|COMPLETED|Overall Study||34
420118|NCT01556100|1030061|P1|STARTED|Overall Study||40
420119|NCT01556061|1030068|P2|NOT COMPLETED|Overall Study||0
420120|NCT01556061|1030069|P1|NOT COMPLETED|Overall Study||0
420121|NCT01556061|1030068|P2|COMPLETED|Overall Study||25
420122|NCT01556061|1030069|P1|COMPLETED|Overall Study||25
420123|NCT01556061|1030068|P2|STARTED|Overall Study||25
420124|NCT01556061|1030069|P1|STARTED|Overall Study||25
420125|NCT01555983|1030079|P6|NOT COMPLETED|Overall Study||1
420126|NCT01555983|1030080|P5|NOT COMPLETED|Overall Study||1
420127|NCT01555983|1030081|P4|NOT COMPLETED|Overall Study||0
420128|NCT01555983|1030082|P3|NOT COMPLETED|Overall Study||0
420129|NCT01555983|1030083|P2|NOT COMPLETED|Overall Study||0
420130|NCT01555983|1030084|P1|NOT COMPLETED|Overall Study||1
420131|NCT01555983|1030079|P6|COMPLETED|Overall Study|One subject completed the 6.7%THC session, then dropped out.|6
420132|NCT01555983|1030080|P5|COMPLETED|Overall Study|One subject complete 6.7%THC and placebo sessions, then dropped out|4
420133|NCT01555983|1030081|P4|COMPLETED|Overall Study||7
420134|NCT01555983|1030082|P3|COMPLETED|Overall Study||7
420135|NCT01555983|1030083|P2|COMPLETED|Overall Study||7
420136|NCT01555983|1030084|P1|COMPLETED|Overall Study|One subject only finished the placebo session, then dropped out of study|8
420137|NCT01555983|1030079|P6|STARTED|Overall Study||7
420138|NCT01555983|1030080|P5|STARTED|Overall Study||5
420139|NCT01555983|1030081|P4|STARTED|Overall Study||7
420140|NCT01555983|1030082|P3|STARTED|Overall Study||7
420141|NCT01555983|1030083|P2|STARTED|Overall Study||7
420142|NCT01555983|1030084|P1|STARTED|Overall Study||9
420143|NCT01555931|1030094|P2|NOT COMPLETED|Overall Study||5
420144|NCT01555931|1030095|P1|NOT COMPLETED|Overall Study||2
420145|NCT01555931|1030094|P2|COMPLETED|Overall Study||13
420146|NCT01555931|1030095|P1|COMPLETED|Overall Study||15
420147|NCT01555931|1030094|P2|STARTED|Overall Study||18
420148|NCT01555931|1030095|P1|STARTED|Overall Study||17
420149|NCT01555567|1030107|P4|NOT COMPLETED|Return to Activity||1
420150|NCT01555567|1030108|P3|NOT COMPLETED|Return to Activity||0
420151|NCT01555567|1030109|P2|NOT COMPLETED|Return to Activity||2
420152|NCT01555567|1030110|P1|NOT COMPLETED|Return to Activity||1
420153|NCT01555567|1030107|P4|COMPLETED|Return to Activity||8
420154|NCT01555567|1030108|P3|COMPLETED|Return to Activity||8
420155|NCT01555567|1030109|P2|COMPLETED|Return to Activity||10
420156|NCT01555567|1030110|P1|COMPLETED|Return to Activity||10
420157|NCT01555567|1030107|P4|STARTED|Return to Activity||9
420158|NCT01555567|1030108|P3|STARTED|Return to Activity||8
420159|NCT01555567|1030109|P2|STARTED|Return to Activity||12
420160|NCT01555567|1030110|P1|STARTED|Return to Activity||11
420161|NCT01555567|1030107|P4|NOT COMPLETED|12 Week||0
420162|NCT01555567|1030108|P3|NOT COMPLETED|12 Week||1
420163|NCT01555567|1030109|P2|NOT COMPLETED|12 Week||1
420164|NCT01555567|1030110|P1|NOT COMPLETED|12 Week||1
420165|NCT01555567|1030107|P4|COMPLETED|12 Week||9
420166|NCT01555567|1030108|P3|COMPLETED|12 Week||8
420167|NCT01555567|1030109|P2|COMPLETED|12 Week||12
420168|NCT01555567|1030110|P1|COMPLETED|12 Week||11
420169|NCT01555567|1030107|P4|STARTED|12 Week||9
420170|NCT01555567|1030108|P3|STARTED|12 Week||9
420171|NCT01555567|1030109|P2|STARTED|12 Week||13
420172|NCT01555567|1030110|P1|STARTED|12 Week||12
420173|NCT01555463|1030126|P2|NOT COMPLETED|Follow up||45
420174|NCT01555463|1030127|P1|NOT COMPLETED|Follow up||38
420175|NCT01555463|1030126|P2|COMPLETED|Follow up||394
420176|NCT01555463|1030127|P1|COMPLETED|Follow up||409
420177|NCT01555463|1030126|P2|STARTED|Follow up|Treatment completers and non-completers were asked to participate in the follow-up phase.|439
420178|NCT01555463|1030127|P1|STARTED|Follow up|Treatment completers and non-completers were asked to participate in the follow-up phase.|447
420179|NCT01555463|1030126|P2|NOT COMPLETED|Treatment||79
420180|NCT01555463|1030127|P1|NOT COMPLETED|Treatment||64
420181|NCT01555463|1030126|P2|COMPLETED|Treatment||399
420182|NCT01555463|1030127|P1|COMPLETED|Treatment||419
420183|NCT01555463|1030126|P2|STARTED|Treatment||478
420184|NCT01555463|1030127|P1|STARTED|Treatment||483
420185|NCT01555164|1030169|P2|NOT COMPLETED|Overall Study||35
420186|NCT01555164|1030170|P1|NOT COMPLETED|Overall Study||40
420187|NCT01555164|1030169|P2|COMPLETED|Overall Study||185
420188|NCT01555164|1030170|P1|COMPLETED|Overall Study||182
420189|NCT01555164|1030169|P2|STARTED|Overall Study||220
420190|NCT01555164|1030170|P1|STARTED|Overall Study||222
420191|NCT01555151|1030184|P4|NOT COMPLETED|Overall Study||10
420192|NCT01555151|1030185|P3|NOT COMPLETED|Overall Study||6
420193|NCT01555151|1030186|P2|NOT COMPLETED|Overall Study||8
420194|NCT01555151|1030187|P1|NOT COMPLETED|Overall Study||13
420195|NCT01555151|1030184|P4|COMPLETED|Overall Study||176
420196|NCT01555151|1030185|P3|COMPLETED|Overall Study||178
420197|NCT01555151|1030186|P2|COMPLETED|Overall Study||173
420198|NCT01555151|1030187|P1|COMPLETED|Overall Study||175
420199|NCT01555151|1030184|P4|Safety Set (SAF)|Overall Study||186
420200|NCT01555151|1030185|P3|Safety Set (SAF)|Overall Study||183
420201|NCT01555151|1030186|P2|Safety Set (SAF)|Overall Study||180
420202|NCT01555151|1030187|P1|Safety Set (SAF)|Overall Study||186
420203|NCT01555151|1030184|P4|STARTED|Overall Study||186
420204|NCT01555151|1030185|P3|STARTED|Overall Study||184
420205|NCT01555151|1030186|P2|STARTED|Overall Study||181
420206|NCT01555151|1030187|P1|STARTED|Overall Study||188
420207|NCT01555138|1030240|P2|NOT COMPLETED|Overall Study||38
420208|NCT01555138|1030241|P1|NOT COMPLETED|Overall Study||47
420209|NCT01555138|1030240|P2|COMPLETED|Overall Study||250
420210|NCT01555138|1030241|P1|COMPLETED|Overall Study||246
420211|NCT01555138|1030240|P2|STARTED|Overall Study||288
420212|NCT01555138|1030241|P1|STARTED|Overall Study||293
420213|NCT01555073|1030271|P4|NOT COMPLETED|Overall Study||5
420214|NCT01555073|1030272|P3|NOT COMPLETED|Overall Study||0
420215|NCT01555073|1030273|P2|NOT COMPLETED|Overall Study||2
420216|NCT01555073|1030274|P1|NOT COMPLETED|Overall Study||1
420217|NCT01555073|1030271|P4|COMPLETED|Overall Study||1
420218|NCT01555073|1030272|P3|COMPLETED|Overall Study||7
420219|NCT01555073|1030273|P2|COMPLETED|Overall Study||1
420220|NCT01555073|1030274|P1|COMPLETED|Overall Study||6
420221|NCT01555073|1030271|P4|STARTED|Overall Study||6
420222|NCT01555073|1030272|P3|STARTED|Overall Study||7
420223|NCT01555073|1030273|P2|STARTED|Overall Study||3
420224|NCT01555073|1030274|P1|STARTED|Overall Study||7
420225|NCT01554982|1030288|P1|NOT COMPLETED|Overall Study||43
420226|NCT01554982|1030288|P1|COMPLETED|Overall Study||125
420227|NCT01554982|1030288|P1|Received Drug|Overall Study||166
420228|NCT01554982|1030288|P1|STARTED|Overall Study||168
420229|NCT01554904|1030301|P1|NOT COMPLETED|Overall Study||4
420230|NCT01554904|1030301|P1|COMPLETED|Overall Study||14
420231|NCT01554904|1030301|P1|Home Sleep Study 2|Overall Study||14
420232|NCT01554904|1030301|P1|Complete 6 Weeks of Facial Training|Overall Study|3 subjects withdrew during training|14
420233|NCT01554904|1030301|P1|Start 6 Weeks of Facial Training|Overall Study|1 participant was found to have obstructive sleep apnea on the home sleep study #1|17
420234|NCT01554904|1030301|P1|Home Sleep Study 1|Overall Study|After informed consent signed.|18
420235|NCT01554904|1030301|P1|STARTED|Overall Study||18
420236|NCT01554891|1030309|P3|NOT COMPLETED|Overall Study||2
420237|NCT01554891|1030310|P2|NOT COMPLETED|Overall Study||5
420238|NCT01554891|1030311|P1|NOT COMPLETED|Overall Study||7
420239|NCT01554891|1030309|P3|COMPLETED|Overall Study||55
420240|NCT01554891|1030310|P2|COMPLETED|Overall Study||115
420241|NCT01554891|1030311|P1|COMPLETED|Overall Study||98
420242|NCT01554891|1030309|P3|STARTED|Overall Study||57
420243|NCT01554891|1030310|P2|STARTED|Overall Study||120
420244|NCT01554891|1030311|P1|STARTED|Overall Study||105
420245|NCT01554579|1030321|P2|NOT COMPLETED|Overall Study||27
420246|NCT01554579|1030322|P1|NOT COMPLETED|Overall Study||10
420247|NCT01554579|1030321|P2|COMPLETED|Overall Study||58
420248|NCT01554579|1030322|P1|COMPLETED|Overall Study||76
420249|NCT01554579|1030321|P2|STARTED|Overall Study||85
420250|NCT01554579|1030322|P1|STARTED|Overall Study||86
420251|NCT01554241|1030336|P4|NOT COMPLETED|Overall Study||1
420252|NCT01554241|1030337|P3|NOT COMPLETED|Overall Study||4
420253|NCT01554241|1030338|P2|NOT COMPLETED|Overall Study||1
420254|NCT01554241|1030339|P1|NOT COMPLETED|Overall Study||3
420255|NCT01554241|1030336|P4|COMPLETED|Overall Study||13
420256|NCT01554241|1030337|P3|COMPLETED|Overall Study||20
420257|NCT01554241|1030338|P2|COMPLETED|Overall Study||19
420258|NCT01554241|1030339|P1|COMPLETED|Overall Study||20
420259|NCT01554241|1030336|P4|STARTED|Overall Study||14
420260|NCT01554241|1030337|P3|STARTED|Overall Study||24
420261|NCT01554241|1030338|P2|STARTED|Overall Study||20
420262|NCT01554241|1030339|P1|STARTED|Overall Study||23
420263|NCT01554176|1030355|P5|NOT COMPLETED|Run-out Phase||0
420264|NCT01554176|1030356|P4|NOT COMPLETED|Run-out Phase||1
420265|NCT01554176|1030357|P3|NOT COMPLETED|Run-out Phase||0
420266|NCT01554176|1030358|P2|NOT COMPLETED|Run-out Phase||0
420267|NCT01554176|1030359|P1|NOT COMPLETED|Run-out Phase||0
420268|NCT01554176|1030355|P5|COMPLETED|Run-out Phase||59
420269|NCT01554176|1030356|P4|COMPLETED|Run-out Phase||27
420270|NCT01554176|1030357|P3|COMPLETED|Run-out Phase||29
420271|NCT01554176|1030358|P2|COMPLETED|Run-out Phase||0
420272|NCT01554176|1030359|P1|COMPLETED|Run-out Phase||0
420273|NCT01554176|1030355|P5|Treated|Run-out Phase||59
420274|NCT01554176|1030356|P4|Treated|Run-out Phase||28
420275|NCT01554176|1030357|P3|Treated|Run-out Phase||29
420276|NCT01554176|1030358|P2|Treated|Run-out Phase||0
420277|NCT01554176|1030359|P1|Treated|Run-out Phase||0
420278|NCT01554176|1030355|P5|STARTED|Run-out Phase||59
420279|NCT01554176|1030356|P4|STARTED|Run-out Phase||28
420280|NCT01554176|1030357|P3|STARTED|Run-out Phase||29
420281|NCT01554176|1030358|P2|STARTED|Run-out Phase||0
420282|NCT01554176|1030359|P1|STARTED|Run-out Phase||0
420283|NCT01554176|1030355|P5|NOT COMPLETED|Treatment Phase||0
420284|NCT01554176|1030356|P4|NOT COMPLETED|Treatment Phase||0
420285|NCT01554176|1030357|P3|NOT COMPLETED|Treatment Phase||0
420286|NCT01554176|1030358|P2|NOT COMPLETED|Treatment Phase||5
420287|NCT01554176|1030359|P1|NOT COMPLETED|Treatment Phase||8
420288|NCT01554176|1030355|P5|COMPLETED|Treatment Phase||0
420289|NCT01554176|1030356|P4|COMPLETED|Treatment Phase||0
420290|NCT01554176|1030357|P3|COMPLETED|Treatment Phase||0
420291|NCT01554176|1030358|P2|COMPLETED|Treatment Phase||59
420292|NCT01554176|1030359|P1|COMPLETED|Treatment Phase||57
420293|NCT01554176|1030355|P5|Treated|Treatment Phase||0
420294|NCT01554176|1030356|P4|Treated|Treatment Phase||0
420295|NCT01554176|1030357|P3|Treated|Treatment Phase||0
420296|NCT01554176|1030358|P2|Treated|Treatment Phase||64
420297|NCT01554176|1030359|P1|Treated|Treatment Phase||64
420298|NCT01554176|1030355|P5|STARTED|Treatment Phase||0
420299|NCT01554176|1030356|P4|STARTED|Treatment Phase||0
420300|NCT01554176|1030357|P3|STARTED|Treatment Phase||0
420301|NCT01554176|1030358|P2|STARTED|Treatment Phase||64
420302|NCT01554176|1030359|P1|STARTED|Treatment Phase||65
420303|NCT01554163|1030386|P2|NOT COMPLETED|Overall Study||10
420304|NCT01554163|1030387|P1|NOT COMPLETED|Overall Study||8
420305|NCT01554163|1030386|P2|COMPLETED|Overall Study||109
420306|NCT01554163|1030387|P1|COMPLETED|Overall Study||112
420307|NCT01554163|1030386|P2|Number Treated|Overall Study||119
420308|NCT01554163|1030387|P1|Number Treated|Overall Study||119
420309|NCT01554163|1030386|P2|STARTED|Overall Study||119
420310|NCT01554163|1030387|P1|STARTED|Overall Study||120
420311|NCT01553916|1030405|P1|NOT COMPLETED|Overall Study||3
420312|NCT01553916|1030405|P1|COMPLETED|Overall Study||16
420313|NCT01553916|1030405|P1|STARTED|Overall Study||19
420314|NCT01553851|1030418|P1|NOT COMPLETED|Overall Study||3
420315|NCT01553851|1030418|P1|COMPLETED|Overall Study||17
420316|NCT01553851|1030418|P1|STARTED|Overall Study||20
420317|NCT01553708|1030432|P2|NOT COMPLETED|Overall Study||0
420318|NCT01553708|1030433|P1|NOT COMPLETED|Overall Study||0
420319|NCT01553708|1030432|P2|COMPLETED|Overall Study||17
420320|NCT01553708|1030433|P1|COMPLETED|Overall Study||17
420321|NCT01553708|1030432|P2|STARTED|Overall Study||17
420322|NCT01553708|1030433|P1|STARTED|Overall Study||17
420323|NCT01553539|1030439|P1|NOT COMPLETED|Overall Study||0
420324|NCT01553539|1030439|P1|COMPLETED|Overall Study||20
420325|NCT01553539|1030439|P1|STARTED|Overall Study||20
420326|NCT01553318|1030449|P2|NOT COMPLETED|Overall Study||2
420327|NCT01553318|1030450|P1|NOT COMPLETED|Overall Study||3
420328|NCT01553318|1030449|P2|COMPLETED|Overall Study||25
420329|NCT01553318|1030450|P1|COMPLETED|Overall Study||21
420330|NCT01553318|1030449|P2|STARTED|Overall Study||27
420331|NCT01553318|1030450|P1|STARTED|Overall Study||24
420332|NCT01553292|1030462|P1|NOT COMPLETED|Overall Study||0
420333|NCT01553292|1030462|P1|COMPLETED|Overall Study||21
420334|NCT01553292|1030462|P1|STARTED|Overall Study||21
420335|NCT01553240|1030478|P1|NOT COMPLETED|Overall Study||0
420336|NCT01553240|1030478|P1|COMPLETED|Overall Study||0
420337|NCT01553240|1030478|P1|STARTED|Overall Study||0
420338|NCT01553136|1030485|P2|NOT COMPLETED|Overall Study||22
420339|NCT01553136|1030486|P1|NOT COMPLETED|Overall Study||16
420340|NCT01553136|1030485|P2|COMPLETED|Overall Study||45
420341|NCT01553136|1030486|P1|COMPLETED|Overall Study||48
420342|NCT01553136|1030485|P2|Completed Treatment|Overall Study||50
420343|NCT01553136|1030486|P1|Completed Treatment|Overall Study||55
420344|NCT01553136|1030485|P2|STARTED|Overall Study||67
420345|NCT01553136|1030486|P1|STARTED|Overall Study||64
420346|NCT01553058|1030503|P3|NOT COMPLETED|Overall Study||3
420347|NCT01553058|1030504|P2|NOT COMPLETED|Overall Study||1
420348|NCT01553058|1030505|P1|NOT COMPLETED|Overall Study||1
420349|NCT01553058|1030503|P3|COMPLETED|Overall Study||30
420350|NCT01553058|1030504|P2|COMPLETED|Overall Study||30
420351|NCT01553058|1030505|P1|COMPLETED|Overall Study||32
420352|NCT01553058|1030503|P3|STARTED|Overall Study||33
420353|NCT01553058|1030504|P2|STARTED|Overall Study||31
420354|NCT01553058|1030505|P1|STARTED|Overall Study||33
420355|NCT01552954|1030566|P2|NOT COMPLETED|Overall Study||6
420356|NCT01552954|1030567|P1|NOT COMPLETED|Overall Study||5
420357|NCT01552954|1030566|P2|COMPLETED|Overall Study||119
420358|NCT01552954|1030567|P1|COMPLETED|Overall Study||126
420359|NCT01552954|1030566|P2|STARTED|Overall Study||125
420454|NCT01552603|1030792|P1|NOT COMPLETED|Overall Study||1
420360|NCT01552954|1030567|P1|STARTED|Overall Study|A total of 13 patients were withdrawn from 269 patients. The remained 256 patients were randomized.|131
420361|NCT01552928|1030583|P4|NOT COMPLETED|Period 4||0
420362|NCT01552928|1030584|P3|NOT COMPLETED|Period 4||0
420363|NCT01552928|1030585|P2|NOT COMPLETED|Period 4||0
420364|NCT01552928|1030586|P1|NOT COMPLETED|Period 4||0
420365|NCT01552928|1030583|P4|COMPLETED|Period 4||16
420366|NCT01552928|1030584|P3|COMPLETED|Period 4||14
420367|NCT01552928|1030585|P2|COMPLETED|Period 4||15
420368|NCT01552928|1030586|P1|COMPLETED|Period 4||14
420369|NCT01552928|1030583|P4|STARTED|Period 4||16
420370|NCT01552928|1030584|P3|STARTED|Period 4||14
420371|NCT01552928|1030585|P2|STARTED|Period 4||15
420372|NCT01552928|1030586|P1|STARTED|Period 4||14
420373|NCT01552928|1030583|P4|NOT COMPLETED|Period 3||0
420374|NCT01552928|1030584|P3|NOT COMPLETED|Period 3||1
420375|NCT01552928|1030585|P2|NOT COMPLETED|Period 3||0
420376|NCT01552928|1030586|P1|NOT COMPLETED|Period 3||0
420377|NCT01552928|1030583|P4|COMPLETED|Period 3||16
420378|NCT01552928|1030584|P3|COMPLETED|Period 3||14
420379|NCT01552928|1030585|P2|COMPLETED|Period 3||15
420380|NCT01552928|1030586|P1|COMPLETED|Period 3||14
420381|NCT01552928|1030583|P4|STARTED|Period 3||16
420382|NCT01552928|1030584|P3|STARTED|Period 3||15
420383|NCT01552928|1030585|P2|STARTED|Period 3||15
420384|NCT01552928|1030586|P1|STARTED|Period 3||14
420385|NCT01552928|1030583|P4|NOT COMPLETED|Period 2||0
420386|NCT01552928|1030584|P3|NOT COMPLETED|Period 2||0
420387|NCT01552928|1030585|P2|NOT COMPLETED|Period 2||0
420388|NCT01552928|1030586|P1|NOT COMPLETED|Period 2||0
420389|NCT01552928|1030583|P4|COMPLETED|Period 2||16
420390|NCT01552928|1030584|P3|COMPLETED|Period 2||15
420391|NCT01552928|1030585|P2|COMPLETED|Period 2||15
420392|NCT01552928|1030586|P1|COMPLETED|Period 2||14
420393|NCT01552928|1030583|P4|STARTED|Period 2||16
420394|NCT01552928|1030584|P3|STARTED|Period 2||15
420395|NCT01552928|1030585|P2|STARTED|Period 2||15
420396|NCT01552928|1030586|P1|STARTED|Period 2||14
420397|NCT01552928|1030583|P4|NOT COMPLETED|Period 1||0
420398|NCT01552928|1030584|P3|NOT COMPLETED|Period 1||0
420399|NCT01552928|1030585|P2|NOT COMPLETED|Period 1||0
420400|NCT01552928|1030586|P1|NOT COMPLETED|Period 1||0
420401|NCT01552928|1030583|P4|COMPLETED|Period 1||16
420402|NCT01552928|1030584|P3|COMPLETED|Period 1||15
420403|NCT01552928|1030585|P2|COMPLETED|Period 1||15
420404|NCT01552928|1030586|P1|COMPLETED|Period 1||14
420405|NCT01552928|1030583|P4|STARTED|Period 1||16
420406|NCT01552928|1030584|P3|STARTED|Period 1||15
420407|NCT01552928|1030585|P2|STARTED|Period 1||15
420408|NCT01552928|1030586|P1|STARTED|Period 1||14
420409|NCT01552915|1030633|P3|NOT COMPLETED|Overall Study||27
420410|NCT01552915|1030634|P2|NOT COMPLETED|Overall Study||29
420411|NCT01552915|1030635|P1|NOT COMPLETED|Overall Study||23
420412|NCT01552915|1030633|P3|COMPLETED|Overall Study||157
420413|NCT01552915|1030634|P2|COMPLETED|Overall Study||155
420414|NCT01552915|1030635|P1|COMPLETED|Overall Study||68
420415|NCT01552915|1030633|P3|STARTED|Overall Study|This population is from the Safety Set. One randomized subject was not dosed and was excluded.|184
420416|NCT01552915|1030634|P2|STARTED|Overall Study|This population is from the Safety Set. Two randomized subjects were not dosed and were excluded.|184
420417|NCT01552915|1030635|P1|STARTED|Overall Study|This population is from the Safety Set. Two randomized subjects were not dosed and were excluded.|91
420418|NCT01552902|1030658|P3|NOT COMPLETED|Overall Study||33
420419|NCT01552902|1030659|P2|NOT COMPLETED|Overall Study||37
420420|NCT01552902|1030660|P1|NOT COMPLETED|Overall Study||13
420421|NCT01552902|1030658|P3|COMPLETED|Overall Study||186
420422|NCT01552902|1030659|P2|COMPLETED|Overall Study||181
420423|NCT01552902|1030660|P1|COMPLETED|Overall Study||97
420424|NCT01552902|1030658|P3|STARTED|Overall Study||219
420425|NCT01552902|1030659|P2|STARTED|Overall Study||218
420426|NCT01552902|1030660|P1|STARTED|Overall Study||110
420427|NCT01552889|1030682|P2|NOT COMPLETED|Overall Study||5
420428|NCT01552889|1030683|P1|NOT COMPLETED|Overall Study||11
420429|NCT01552889|1030682|P2|COMPLETED|Overall Study||95
420430|NCT01552889|1030683|P1|COMPLETED|Overall Study||90
420431|NCT01552889|1030682|P2|STARTED|Overall Study||100
420432|NCT01552889|1030683|P1|STARTED|Overall Study||101
420433|NCT01552876|1030693|P2|NOT COMPLETED|Overall Study||0
420434|NCT01552876|1030694|P1|NOT COMPLETED|Overall Study||0
420435|NCT01552876|1030693|P2|COMPLETED|Overall Study||20
420436|NCT01552876|1030694|P1|COMPLETED|Overall Study||20
420437|NCT01552876|1030693|P2|STARTED|Overall Study||20
420438|NCT01552876|1030694|P1|STARTED|Overall Study||20
420439|NCT01552772|1030710|P1|NOT COMPLETED|Overall Study||4
420440|NCT01552772|1030710|P1|COMPLETED|Overall Study|Participants who completed the Day 28 visit were defined as completers for the trial.|56
420441|NCT01552772|1030710|P1|STARTED|Overall Study||60
420442|NCT01552694|1030726|P2|NOT COMPLETED|Overall Study||2
420443|NCT01552694|1030727|P1|NOT COMPLETED|Overall Study||0
420444|NCT01552694|1030726|P2|COMPLETED|Overall Study||18
420445|NCT01552694|1030727|P1|COMPLETED|Overall Study||18
420446|NCT01552694|1030726|P2|STARTED|Overall Study||20
420447|NCT01552694|1030727|P1|STARTED|Overall Study||18
420448|NCT01552681|1030743|P2|NOT COMPLETED|Overall Study||1
420449|NCT01552681|1030744|P1|NOT COMPLETED|Overall Study||5
420450|NCT01552681|1030743|P2|COMPLETED|Overall Study||18
420451|NCT01552681|1030744|P1|COMPLETED|Overall Study||28
420452|NCT01552681|1030743|P2|STARTED|Overall Study||19
420453|NCT01552681|1030744|P1|STARTED|Overall Study||33
420455|NCT01552603|1030792|P1|COMPLETED|Overall Study||13
420456|NCT01552603|1030792|P1|STARTED|Overall Study||14
420457|NCT01552343|1030799|P2|NOT COMPLETED|Overall Study||0
420458|NCT01552343|1030800|P1|NOT COMPLETED|Overall Study||0
420459|NCT01552343|1030799|P2|COMPLETED|Overall Study||27
420460|NCT01552343|1030800|P1|COMPLETED|Overall Study||29
420461|NCT01552343|1030799|P2|STARTED|Overall Study||27
420462|NCT01552343|1030800|P1|STARTED|Overall Study||29
420463|NCT01552057|1030823|P2|NOT COMPLETED|Overall Study||48
420464|NCT01552057|1030824|P1|NOT COMPLETED|Overall Study||30
420465|NCT01552057|1030823|P2|COMPLETED|Overall Study||149
420466|NCT01552057|1030824|P1|COMPLETED|Overall Study||166
420467|NCT01552057|1030823|P2|Received at Least 1 Dose of Study Drug|Overall Study||196
420468|NCT01552057|1030824|P1|Received at Least 1 Dose of Study Drug|Overall Study||194
420469|NCT01552057|1030823|P2|STARTED|Overall Study||197
420470|NCT01552057|1030824|P1|STARTED|Overall Study||196
420471|NCT01551979|1030858|P2|NOT COMPLETED|Overall Study||2
420472|NCT01551979|1030859|P1|NOT COMPLETED|Overall Study||2
420473|NCT01551979|1030858|P2|COMPLETED|Overall Study||5
420474|NCT01551979|1030859|P1|COMPLETED|Overall Study||8
420475|NCT01551979|1030858|P2|1 Week Post Treatment|Overall Study||6
420476|NCT01551979|1030859|P1|1 Week Post Treatment|Overall Study||10
420477|NCT01551979|1030858|P2|Last Day of Treatment (After 5 Days)|Overall Study||7
420478|NCT01551979|1030859|P1|Last Day of Treatment (After 5 Days)|Overall Study||10
420479|NCT01551979|1030858|P2|STARTED|Overall Study||7
420480|NCT01551979|1030859|P1|STARTED|Overall Study||10
420481|NCT01551888|1030875|P2|NOT COMPLETED|Period 2||0
420482|NCT01551888|1030876|P1|NOT COMPLETED|Period 2||0
420483|NCT01551888|1030875|P2|COMPLETED|Period 2||12
420484|NCT01551888|1030876|P1|COMPLETED|Period 2||12
420485|NCT01551888|1030875|P2|STARTED|Period 2||12
420486|NCT01551888|1030876|P1|STARTED|Period 2||12
420487|NCT01551888|1030875|P2|NOT COMPLETED|Period 1||0
420488|NCT01551888|1030876|P1|NOT COMPLETED|Period 1||0
420489|NCT01551888|1030875|P2|COMPLETED|Period 1||12
420490|NCT01551888|1030876|P1|COMPLETED|Period 1||12
420491|NCT01551888|1030875|P2|STARTED|Period 1||12
420492|NCT01551888|1030876|P1|STARTED|Period 1||12
420493|NCT01551758|1030890|P2|NOT COMPLETED|Overall Study||105
420494|NCT01551758|1030891|P1|NOT COMPLETED|Overall Study||94
420495|NCT01551758|1030890|P2|COMPLETED|Overall Study||1291
420496|NCT01551758|1030891|P1|COMPLETED|Overall Study||1309
420497|NCT01551758|1030890|P2|STARTED|Overall Study||1396
420498|NCT01551758|1030891|P1|STARTED|Overall Study||1403
420499|NCT01551745|1030929|P1|NOT COMPLETED|Overall Study||3
420500|NCT01551745|1030929|P1|COMPLETED|Overall Study|"Completed means subject had been given all manufactured doses"|2
420501|NCT01551745|1030929|P1|STARTED|Overall Study||5
420502|NCT01551693|1030938|P2|NOT COMPLETED|Overall Study||2
420503|NCT01551693|1030939|P1|NOT COMPLETED|Overall Study||1
420504|NCT01551693|1030938|P2|COMPLETED|Overall Study||0
420505|NCT01551693|1030939|P1|COMPLETED|Overall Study||0
420506|NCT01551693|1030938|P2|STARTED|Overall Study||2
420507|NCT01551693|1030939|P1|STARTED|Overall Study||1
420508|NCT01551355|1030955|P6|NOT COMPLETED|Overall Study||6
420509|NCT01551355|1030956|P5|NOT COMPLETED|Overall Study||9
420510|NCT01551355|1030957|P4|NOT COMPLETED|Overall Study||24
420511|NCT01551355|1030958|P3|NOT COMPLETED|Overall Study||34
420512|NCT01551355|1030959|P2|NOT COMPLETED|Overall Study||49
420513|NCT01551355|1030960|P1|NOT COMPLETED|Overall Study||51
420514|NCT01551355|1030955|P6|COMPLETED|Overall Study||65
420515|NCT01551355|1030956|P5|COMPLETED|Overall Study||55
420516|NCT01551355|1030957|P4|COMPLETED|Overall Study||411
420517|NCT01551355|1030958|P3|COMPLETED|Overall Study||459
420518|NCT01551355|1030959|P2|COMPLETED|Overall Study||545
420519|NCT01551355|1030960|P1|COMPLETED|Overall Study||571
420520|NCT01551355|1030955|P6|STARTED|Overall Study||71
420521|NCT01551355|1030956|P5|STARTED|Overall Study||64
420522|NCT01551355|1030957|P4|STARTED|Overall Study||435
420523|NCT01551355|1030958|P3|STARTED|Overall Study||493
420524|NCT01551355|1030959|P2|STARTED|Overall Study||594
420525|NCT01551355|1030960|P1|STARTED|Overall Study||622
420526|NCT01551303|1030974|P2|NOT COMPLETED|Overall Study||7
420527|NCT01551303|1030975|P1|NOT COMPLETED|Overall Study||4
420528|NCT01551303|1030974|P2|COMPLETED|Overall Study||15
420529|NCT01551303|1030975|P1|COMPLETED|Overall Study||21
420530|NCT01551303|1030974|P2|STARTED|Overall Study||22
420531|NCT01551303|1030975|P1|STARTED|Overall Study||25
420532|NCT01551199|1030981|P1|NOT COMPLETED|Overall Study||5
420533|NCT01551199|1030981|P1|COMPLETED|Overall Study||2
420534|NCT01551199|1030981|P1|STARTED|Overall Study||7
420535|NCT01551173|1030989|P2|NOT COMPLETED|Overall Study||32
420536|NCT01551173|1030990|P1|NOT COMPLETED|Overall Study||28
420537|NCT01551173|1030989|P2|COMPLETED|Overall Study||186
420538|NCT01551173|1030990|P1|COMPLETED|Overall Study||190
420539|NCT01551173|1030989|P2|Full Analysis Set (FAS)|Overall Study||214
420540|NCT01551173|1030990|P1|Full Analysis Set (FAS)|Overall Study|Patients took at least 1 dose of study drug & had at least 1 post-randomization efficacy parameter|210
420541|NCT01551173|1030989|P2|STARTED|Overall Study||218
420542|NCT01551173|1030990|P1|STARTED|Overall Study|"Started indicates randomized"|218
420543|NCT01551095|1031001|P1|NOT COMPLETED|Overall Study||0
420544|NCT01551095|1031001|P1|COMPLETED|Overall Study||7
420545|NCT01551095|1031001|P1|STARTED|Overall Study||7
420546|NCT01551082|1031006|P1|NOT COMPLETED|Overall Study||0
420547|NCT01551082|1031006|P1|COMPLETED|Overall Study||12
420548|NCT01551082|1031006|P1|STARTED|Overall Study||12
420549|NCT01551056|1031012|P2|NOT COMPLETED|Overall Study||0
420550|NCT01551056|1031013|P1|NOT COMPLETED|Overall Study||2
420551|NCT01551056|1031012|P2|COMPLETED|Overall Study||45
420552|NCT01551056|1031013|P1|COMPLETED|Overall Study||44
420553|NCT01551056|1031012|P2|STARTED|Overall Study||45
420554|NCT01551056|1031013|P1|STARTED|Overall Study||46
420555|NCT01550965|1031067|P1|NOT COMPLETED|Overall Study||110
420556|NCT01550965|1031067|P1|COMPLETED|Overall Study||353
420557|NCT01550965|1031067|P1|STARTED|Overall Study||463
420558|NCT01550952|1031086|P1|NOT COMPLETED|Overall Study||0
420559|NCT01550952|1031086|P1|COMPLETED|Overall Study||10
420560|NCT01550952|1031086|P1|STARTED|Overall Study||10
420561|NCT01550809|1031096|P2|NOT COMPLETED|Overall Study||0
420562|NCT01550809|1031097|P1|NOT COMPLETED|Overall Study||0
420563|NCT01550809|1031096|P2|COMPLETED|Overall Study||6
420564|NCT01550809|1031097|P1|COMPLETED|Overall Study||6
420565|NCT01550809|1031096|P2|STARTED|Overall Study|Six patients started with the iBolus, the others with the tBolus, according to a crossover design.|6
420566|NCT01550809|1031097|P1|STARTED|Overall Study|Six patients started with the tBolus, the others with the iBolus, according to a crossover design.|6
420567|NCT01550757|1031111|P4|NOT COMPLETED|Overall Study||54
420568|NCT01550757|1031112|P3|NOT COMPLETED|Overall Study||45
420569|NCT01550757|1031113|P2|NOT COMPLETED|Overall Study||14
420570|NCT01550757|1031114|P1|NOT COMPLETED|Overall Study||23
420571|NCT01550757|1031111|P4|COMPLETED|Overall Study||90
420572|NCT01550757|1031112|P3|COMPLETED|Overall Study||85
420573|NCT01550757|1031113|P2|COMPLETED|Overall Study||38
420574|NCT01550757|1031114|P1|COMPLETED|Overall Study||33
420575|NCT01550757|1031111|P4|STARTED|Overall Study||144
420576|NCT01550757|1031112|P3|STARTED|Overall Study||130
420577|NCT01550757|1031113|P2|STARTED|Overall Study||52
420578|NCT01550757|1031114|P1|STARTED|Overall Study||56
420579|NCT01550744|1031124|P3|NOT COMPLETED|Double-Blind||67
420580|NCT01550744|1031125|P2|NOT COMPLETED|Double-Blind||17
420581|NCT01550744|1031126|P1|NOT COMPLETED|Double-Blind||0
420582|NCT01550744|1031124|P3|COMPLETED|Double-Blind||235
420583|NCT01550744|1031125|P2|COMPLETED|Double-Blind||59
420584|NCT01550744|1031126|P1|COMPLETED|Double-Blind||0
420585|NCT01550744|1031124|P3|STARTED|Double-Blind||302
420586|NCT01550744|1031125|P2|STARTED|Double-Blind||76
420587|NCT01550744|1031126|P1|STARTED|Double-Blind||0
420588|NCT01550744|1031124|P3|NOT COMPLETED|Open-Label||0
420589|NCT01550744|1031125|P2|NOT COMPLETED|Open-Label||0
420590|NCT01550744|1031126|P1|NOT COMPLETED|Open-Label||100
420591|NCT01550744|1031124|P3|COMPLETED|Open-Label||0
420592|NCT01550744|1031125|P2|COMPLETED|Open-Label||0
420593|NCT01550744|1031126|P1|COMPLETED|Open-Label||378
420594|NCT01550744|1031124|P3|STARTED|Open-Label||0
420595|NCT01550744|1031125|P2|STARTED|Open-Label||0
420596|NCT01550744|1031126|P1|STARTED|Open-Label||478
420597|NCT01550705|1031139|P1|NOT COMPLETED|Overall Study||1
420598|NCT01550705|1031139|P1|COMPLETED|Overall Study||10
420599|NCT01550705|1031139|P1|STARTED|Overall Study||11
420600|NCT01550549|1031144|P1|NOT COMPLETED|Overall Study||0
420601|NCT01550549|1031144|P1|COMPLETED|Overall Study||151
420602|NCT01550549|1031144|P1|STARTED|Overall Study||151
420603|NCT01550302|1031158|P2|NOT COMPLETED|Overall Study||0
420604|NCT01550302|1031159|P1|NOT COMPLETED|Overall Study||0
420605|NCT01550302|1031158|P2|COMPLETED|Overall Study||5
420606|NCT01550302|1031159|P1|COMPLETED|Overall Study||5
420607|NCT01550302|1031158|P2|STARTED|Overall Study||5
420608|NCT01550302|1031159|P1|STARTED|Overall Study||5
420609|NCT01550289|1031179|P2|NOT COMPLETED|Overall Study||4
420610|NCT01550289|1031180|P1|NOT COMPLETED|Overall Study||13
420611|NCT01550289|1031179|P2|COMPLETED|Overall Study||57
420612|NCT01550289|1031180|P1|COMPLETED|Overall Study||115
420613|NCT01550289|1031179|P2|STARTED|Overall Study||61
420614|NCT01550289|1031180|P1|STARTED|Overall Study||128
420615|NCT01549977|1031212|P2|NOT COMPLETED|Overall Study||0
420616|NCT01549977|1031213|P1|NOT COMPLETED|Overall Study||0
420617|NCT01549977|1031212|P2|COMPLETED|Overall Study||0
420618|NCT01549977|1031213|P1|COMPLETED|Overall Study||1
420619|NCT01549977|1031212|P2|STARTED|Overall Study||0
420620|NCT01549977|1031213|P1|STARTED|Overall Study||1
420621|NCT01549964|1031231|P4|NOT COMPLETED|80-Week Extension Period||137
420622|NCT01549964|1031232|P3|NOT COMPLETED|80-Week Extension Period||140
420623|NCT01549964|1031233|P2|NOT COMPLETED|80-Week Extension Period||138
420624|NCT01549964|1031234|P1|NOT COMPLETED|80-Week Extension Period||66
420625|NCT01549964|1031231|P4|COMPLETED|80-Week Extension Period||0
420626|NCT01549964|1031232|P3|COMPLETED|80-Week Extension Period||0
420627|NCT01549964|1031233|P2|COMPLETED|80-Week Extension Period||0
420628|NCT01549964|1031234|P1|COMPLETED|80-Week Extension Period||0
420629|NCT01549964|1031231|P4|STARTED|80-Week Extension Period||137
420630|NCT01549964|1031232|P3|STARTED|80-Week Extension Period||140
420631|NCT01549964|1031233|P2|STARTED|80-Week Extension Period||138
420632|NCT01549964|1031234|P1|STARTED|80-Week Extension Period||66
420633|NCT01549964|1031231|P4|NOT COMPLETED|24-Week Treatment Period||121
420634|NCT01549964|1031232|P3|NOT COMPLETED|24-Week Treatment Period||116
420635|NCT01549964|1031233|P2|NOT COMPLETED|24-Week Treatment Period||111
420636|NCT01549964|1031234|P1|NOT COMPLETED|24-Week Treatment Period||61
420637|NCT01549964|1031231|P4|COMPLETED|24-Week Treatment Period||140
420638|NCT01549964|1031232|P3|COMPLETED|24-Week Treatment Period||147
420639|NCT01549964|1031233|P2|COMPLETED|24-Week Treatment Period||149
420640|NCT01549964|1031234|P1|COMPLETED|24-Week Treatment Period||71
420641|NCT01549964|1031231|P4|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260
420642|NCT01549964|1031232|P3|Safety Analysis Set=Received Treatment|24-Week Treatment Period||263
420643|NCT01549964|1031233|P2|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260
420644|NCT01549964|1031234|P1|Safety Analysis Set=Received Treatment|24-Week Treatment Period||132
420645|NCT01549964|1031231|P4|STARTED|24-Week Treatment Period||261
420646|NCT01549964|1031232|P3|STARTED|24-Week Treatment Period||263
420647|NCT01549964|1031233|P2|STARTED|24-Week Treatment Period||260
420648|NCT01549964|1031234|P1|STARTED|24-Week Treatment Period||132
420649|NCT01549951|1031252|P1|NOT COMPLETED|Overall Study||50
420650|NCT01549951|1031252|P1|COMPLETED|Overall Study||0
420651|NCT01549951|1031252|P1|Primary Reason Off Study Treatment|Overall Study||50
420652|NCT01549951|1031252|P1|STARTED|Overall Study||50
420653|NCT01549925|1031270|P2|NOT COMPLETED|Overall Study||0
420654|NCT01549925|1031271|P1|NOT COMPLETED|Overall Study||0
420655|NCT01549925|1031270|P2|COMPLETED|Overall Study||25
420656|NCT01549925|1031271|P1|COMPLETED|Overall Study||25
420657|NCT01549925|1031270|P2|STARTED|Overall Study||25
420658|NCT01549925|1031271|P1|STARTED|Overall Study||25
420659|NCT01549873|1031279|P2|NOT COMPLETED|Overall Study||1
420660|NCT01549873|1031280|P1|NOT COMPLETED|Overall Study||0
420661|NCT01549873|1031279|P2|COMPLETED|Overall Study||14
420662|NCT01549873|1031280|P1|COMPLETED|Overall Study||15
420663|NCT01549873|1031279|P2|STARTED|Overall Study||15
420664|NCT01549873|1031280|P1|STARTED|Overall Study||15
420665|NCT01549860|1031292|P2|NOT COMPLETED|Overall Study||1
420666|NCT01549860|1031293|P1|NOT COMPLETED|Overall Study||2
420667|NCT01549860|1031292|P2|COMPLETED|Overall Study||40
420668|NCT01549860|1031293|P1|COMPLETED|Overall Study||38
420669|NCT01549860|1031292|P2|STARTED|Overall Study||41
420670|NCT01549860|1031293|P1|STARTED|Overall Study||40
420671|NCT01549613|1031305|P2|NOT COMPLETED|Overall Study||11
420672|NCT01549613|1031306|P1|NOT COMPLETED|Overall Study||11
420673|NCT01549613|1031305|P2|COMPLETED|Overall Study||39
420674|NCT01549613|1031306|P1|COMPLETED|Overall Study||39
420675|NCT01549613|1031305|P2|STARTED|Overall Study||50
420676|NCT01549613|1031306|P1|STARTED|Overall Study||50
420677|NCT01549405|1031314|P2|NOT COMPLETED|Overall Study||0
420678|NCT01549405|1031315|P1|NOT COMPLETED|Overall Study||0
420679|NCT01549405|1031314|P2|COMPLETED|Overall Study||20
420680|NCT01549405|1031315|P1|COMPLETED|Overall Study||20
420681|NCT01549405|1031314|P2|STARTED|Overall Study||20
420682|NCT01549405|1031315|P1|STARTED|Overall Study||20
420683|NCT01549392|1031325|P2|NOT COMPLETED|Overall Study||0
420684|NCT01549392|1031326|P1|NOT COMPLETED|Overall Study||1
420685|NCT01549392|1031325|P2|COMPLETED|Overall Study||0
420686|NCT01549392|1031326|P1|COMPLETED|Overall Study||2
420687|NCT01549392|1031325|P2|STARTED|Overall Study||0
420688|NCT01549392|1031326|P1|STARTED|Overall Study||3
420689|NCT01549340|1031332|P1|NOT COMPLETED|Overall Study||8405
420690|NCT01549340|1031332|P1|COMPLETED|Overall Study|Completed 5 years of AIT|385
420691|NCT01549340|1031332|P1|Started AIT|Overall Study||3182
420692|NCT01549340|1031332|P1|STARTED|Overall Study|Advised to receive AIT|8790
420693|NCT01549275|1031345|P2|NOT COMPLETED|Overall Study||0
420694|NCT01549275|1031346|P1|NOT COMPLETED|Overall Study||1
420695|NCT01549275|1031345|P2|COMPLETED|Overall Study||29
420696|NCT01549275|1031346|P1|COMPLETED|Overall Study||75
420697|NCT01549275|1031345|P2|STARTED|Overall Study||29
420698|NCT01549275|1031346|P1|STARTED|Overall Study||76
420699|NCT01549223|1031358|P2|NOT COMPLETED|Overall Study||0
420700|NCT01549223|1031359|P1|NOT COMPLETED|Overall Study||0
420701|NCT01549223|1031358|P2|COMPLETED|Overall Study||30
420702|NCT01549223|1031359|P1|COMPLETED|Overall Study||30
420703|NCT01549223|1031358|P2|STARTED|Overall Study||30
420704|NCT01549223|1031359|P1|STARTED|Overall Study||30
420705|NCT01549041|1031369|P2|NOT COMPLETED|Overall Study||8
420706|NCT01549041|1031370|P1|NOT COMPLETED|Overall Study||2
420707|NCT01549041|1031369|P2|COMPLETED|Overall Study||10
420708|NCT01549041|1031370|P1|COMPLETED|Overall Study||10
420709|NCT01549041|1031369|P2|STARTED|Overall Study||18
420710|NCT01549041|1031370|P1|STARTED|Overall Study||12
420711|NCT01549002|1031380|P2|NOT COMPLETED|Overall Study||4
420712|NCT01549002|1031381|P1|NOT COMPLETED|Overall Study||0
420713|NCT01549002|1031380|P2|COMPLETED|Overall Study||6
420714|NCT01549002|1031381|P1|COMPLETED|Overall Study||10
420715|NCT01549002|1031380|P2|STARTED|Overall Study||10
420716|NCT01549002|1031381|P1|STARTED|Overall Study||10
420717|NCT01548885|1031391|P1|NOT COMPLETED|Overall Study||0
420718|NCT01548885|1031391|P1|COMPLETED|Overall Study||146
420719|NCT01548885|1031391|P1|STARTED|Overall Study||146
420720|NCT01548833|1031396|P1|NOT COMPLETED|Overall Study||0
420721|NCT01548833|1031396|P1|COMPLETED|Overall Study||39
420722|NCT01548833|1031396|P1|STARTED|Overall Study||39
420723|NCT01548742|1031406|P2|NOT COMPLETED|Overall Study||4
420724|NCT01548742|1031407|P1|NOT COMPLETED|Overall Study||13
420725|NCT01548742|1031406|P2|COMPLETED|Overall Study||54
420726|NCT01548742|1031407|P1|COMPLETED|Overall Study||45
420727|NCT01548742|1031406|P2|STARTED|Overall Study||58
420728|NCT01548742|1031407|P1|STARTED|Overall Study||58
420729|NCT01548638|1031421|P1|NOT COMPLETED|Overall Study||4
420730|NCT01548638|1031421|P1|COMPLETED|Overall Study||9
420731|NCT01548638|1031421|P1|STARTED|Overall Study||13
420732|NCT01548573|1031431|P1|NOT COMPLETED|Overall Study||5
420733|NCT01548573|1031431|P1|COMPLETED|Overall Study||14
420734|NCT01548573|1031431|P1|STARTED|Overall Study||19
420735|NCT01548417|1031440|P2|NOT COMPLETED|Overall Study||2
420736|NCT01548417|1031441|P1|NOT COMPLETED|Overall Study||0
420737|NCT01548417|1031440|P2|COMPLETED|Overall Study||26
420738|NCT01548417|1031441|P1|COMPLETED|Overall Study||28
420739|NCT01548417|1031440|P2|STARTED|Overall Study||28
420740|NCT01548417|1031441|P1|STARTED|Overall Study||28
420741|NCT01548287|1031453|P5|NOT COMPLETED|Randomized Period||0
420742|NCT01548287|1031454|P4|NOT COMPLETED|Randomized Period||0
420743|NCT01548287|1031455|P3|NOT COMPLETED|Randomized Period||7
420744|NCT01548287|1031456|P2|NOT COMPLETED|Randomized Period||2
420745|NCT01548287|1031457|P1|NOT COMPLETED|Randomized Period||0
420746|NCT01548287|1031453|P5|COMPLETED|Randomized Period||0
420747|NCT01548287|1031454|P4|COMPLETED|Randomized Period||20
420748|NCT01548287|1031455|P3|COMPLETED|Randomized Period||13
420749|NCT01548287|1031456|P2|COMPLETED|Randomized Period||20
420750|NCT01548287|1031457|P1|COMPLETED|Randomized Period||19
420751|NCT01548287|1031453|P5|STARTED|Randomized Period||0
420752|NCT01548287|1031454|P4|STARTED|Randomized Period||20
420753|NCT01548287|1031455|P3|STARTED|Randomized Period||20
420754|NCT01548287|1031456|P2|STARTED|Randomized Period||22
420755|NCT01548287|1031457|P1|STARTED|Randomized Period||19
420756|NCT01548287|1031453|P5|NOT COMPLETED|Screening||83
420757|NCT01548287|1031454|P4|NOT COMPLETED|Screening||0
420758|NCT01548287|1031455|P3|NOT COMPLETED|Screening||0
420759|NCT01548287|1031456|P2|NOT COMPLETED|Screening||0
420760|NCT01548287|1031457|P1|NOT COMPLETED|Screening||0
420761|NCT01548287|1031453|P5|COMPLETED|Screening||0
420762|NCT01548287|1031454|P4|COMPLETED|Screening||20
420763|NCT01548287|1031455|P3|COMPLETED|Screening||20
420764|NCT01548287|1031456|P2|COMPLETED|Screening||22
420765|NCT01548287|1031457|P1|COMPLETED|Screening||19
420766|NCT01548287|1031453|P5|STARTED|Screening||83
420767|NCT01548287|1031454|P4|STARTED|Screening||20
420768|NCT01548287|1031455|P3|STARTED|Screening||20
420769|NCT01548287|1031456|P2|STARTED|Screening||22
420770|NCT01548287|1031457|P1|STARTED|Screening||19
420771|NCT01548040|1031489|P2|NOT COMPLETED|Overall Study||10
420772|NCT01548040|1031490|P1|NOT COMPLETED|Overall Study||13
420773|NCT01548040|1031489|P2|COMPLETED|Overall Study||45
420774|NCT01548040|1031490|P1|COMPLETED|Overall Study||43
420775|NCT01548040|1031489|P2|STARTED|Overall Study||55
420776|NCT01548040|1031490|P1|STARTED|Overall Study||56
420777|NCT01547806|1031498|P1|NOT COMPLETED|Overall Study||0
420778|NCT01547806|1031498|P1|COMPLETED|Overall Study||49
420779|NCT01547806|1031498|P1|STARTED|Overall Study||49
420780|NCT01547728|1031514|P1|NOT COMPLETED|Overall Study||41
420781|NCT01547728|1031514|P1|COMPLETED|Overall Study||1
420782|NCT01547728|1031514|P1|STARTED|Overall Study||42
420783|NCT01547715|1031521|P3|NOT COMPLETED|Overall Study||0
420784|NCT01547715|1031522|P2|NOT COMPLETED|Overall Study||0
420785|NCT01547715|1031523|P1|NOT COMPLETED|Overall Study||0
420786|NCT01547715|1031521|P3|COMPLETED|Overall Study||60
420787|NCT01547715|1031522|P2|COMPLETED|Overall Study||60
420788|NCT01547715|1031523|P1|COMPLETED|Overall Study||60
420789|NCT01547715|1031521|P3|STARTED|Overall Study||60
420790|NCT01547715|1031522|P2|STARTED|Overall Study||60
420791|NCT01547715|1031523|P1|STARTED|Overall Study||60
420792|NCT01547598|1031623|P2|NOT COMPLETED|Overall Study||5
420793|NCT01547598|1031624|P1|NOT COMPLETED|Overall Study||6
420794|NCT01547598|1031623|P2|COMPLETED|Overall Study||63
420795|NCT01547598|1031624|P1|COMPLETED|Overall Study||61
420796|NCT01547598|1031623|P2|STARTED|Overall Study||68
420797|NCT01547598|1031624|P1|STARTED|Overall Study||67
420804|NCT01547299|1031652|P2|NOT COMPLETED|Overall Study||2
420805|NCT01547299|1031653|P1|NOT COMPLETED|Overall Study||2
420806|NCT01547299|1031652|P2|COMPLETED|Overall Study||25
420807|NCT01547299|1031653|P1|COMPLETED|Overall Study||23
420808|NCT01547299|1031652|P2|STARTED|Overall Study||27
420809|NCT01547299|1031653|P1|STARTED|Overall Study||25
420810|NCT01547286|1031719|P1|NOT COMPLETED|Overall Study||2
420811|NCT01547286|1031719|P1|COMPLETED|Overall Study||5
420812|NCT01547286|1031719|P1|STARTED|Overall Study||7
420813|NCT01547247|1031728|P2|NOT COMPLETED|Overall Study||6
420814|NCT01547247|1031729|P1|NOT COMPLETED|Overall Study||6
420815|NCT01547247|1031728|P2|COMPLETED|Overall Study||98
420816|NCT01547247|1031729|P1|COMPLETED|Overall Study||98
420817|NCT01547247|1031728|P2|STARTED|Overall Study||104
420818|NCT01547247|1031729|P1|STARTED|Overall Study||104
420819|NCT01547130|1031739|P2|NOT COMPLETED|Overall Study||5
420820|NCT01547130|1031740|P1|NOT COMPLETED|Overall Study||9
420821|NCT01547130|1031739|P2|COMPLETED|Overall Study||68
420822|NCT01547130|1031740|P1|COMPLETED|Overall Study||65
420823|NCT01547130|1031739|P2|STARTED|Overall Study||73
420824|NCT01547130|1031740|P1|STARTED|Overall Study||74
420825|NCT01547000|1031756|P2|NOT COMPLETED|Overall Study||0
420826|NCT01547000|1031757|P1|NOT COMPLETED|Overall Study||0
420827|NCT01547000|1031756|P2|COMPLETED|Overall Study||16
420828|NCT01547000|1031757|P1|COMPLETED|Overall Study||18
420829|NCT01547000|1031756|P2|STARTED|Overall Study||16
420830|NCT01547000|1031757|P1|STARTED|Overall Study||18
420831|NCT01546922|1031763|P2|NOT COMPLETED|Second Period of 10 Weeks||3
420832|NCT01546922|1031764|P1|NOT COMPLETED|Second Period of 10 Weeks||3
420833|NCT01546922|1031763|P2|COMPLETED|Second Period of 10 Weeks||25
420834|NCT01546922|1031764|P1|COMPLETED|Second Period of 10 Weeks||22
420835|NCT01546922|1031763|P2|STARTED|Second Period of 10 Weeks||28
420836|NCT01546922|1031764|P1|STARTED|Second Period of 10 Weeks||25
420837|NCT01546922|1031763|P2|NOT COMPLETED|First Period of 10 Weeks||2
420838|NCT01546922|1031764|P1|NOT COMPLETED|First Period of 10 Weeks||5
420839|NCT01546922|1031763|P2|COMPLETED|First Period of 10 Weeks||28
420840|NCT01546922|1031764|P1|COMPLETED|First Period of 10 Weeks||25
420841|NCT01546922|1031763|P2|STARTED|First Period of 10 Weeks||30
420842|NCT01546922|1031764|P1|STARTED|First Period of 10 Weeks||30
420843|NCT01546883|1031770|P1|NOT COMPLETED|Overall Study||12
420844|NCT01546883|1031770|P1|COMPLETED|Overall Study||2
420845|NCT01546883|1031770|P1|STARTED|Overall Study||14
420846|NCT01546688|1031776|P2|NOT COMPLETED|Overall Study||5
420847|NCT01546688|1031777|P1|NOT COMPLETED|Overall Study||3
420848|NCT01546688|1031776|P2|COMPLETED|Overall Study||28
420849|NCT01546688|1031777|P1|COMPLETED|Overall Study||15
420850|NCT01546688|1031776|P2|STARTED|Overall Study||33
420851|NCT01546688|1031777|P1|STARTED|Overall Study||18
420852|NCT01546675|1031791|P2|NOT COMPLETED|Overall Study||0
420853|NCT01546675|1031792|P1|NOT COMPLETED|Overall Study||0
420854|NCT01546675|1031791|P2|COMPLETED|Overall Study||1
420855|NCT01546675|1031792|P1|COMPLETED|Overall Study||1
420856|NCT01546675|1031791|P2|STARTED|Overall Study||1
420857|NCT01546675|1031792|P1|STARTED|Overall Study||1
420858|NCT01546649|1031809|P2|NOT COMPLETED|Overall Study||9
420859|NCT01546649|1031810|P1|NOT COMPLETED|Overall Study||8
420860|NCT01546649|1031809|P2|COMPLETED|Overall Study||75
420861|NCT01546649|1031810|P1|COMPLETED|Overall Study||75
420862|NCT01546649|1031809|P2|STARTED|Overall Study||84
420863|NCT01546649|1031810|P1|STARTED|Overall Study||83
420864|NCT01546636|1031832|P2|NOT COMPLETED|Overall Study||0
420865|NCT01546636|1031833|P1|NOT COMPLETED|Overall Study||0
420866|NCT01546636|1031832|P2|COMPLETED|Overall Study||34
420867|NCT01546636|1031833|P1|COMPLETED|Overall Study||36
420868|NCT01546636|1031832|P2|STARTED|Overall Study||34
420869|NCT01546636|1031833|P1|STARTED|Overall Study||36
420870|NCT01546623|1031845|P2|NOT COMPLETED|Overall Study||6
420871|NCT01546623|1031846|P1|NOT COMPLETED|Overall Study||6
420872|NCT01546623|1031845|P2|COMPLETED|Overall Study||74
420873|NCT01546623|1031846|P1|COMPLETED|Overall Study||76
420874|NCT01546623|1031845|P2|Received Study Drug|Overall Study||79
420875|NCT01546623|1031846|P1|Received Study Drug|Overall Study||81
420876|NCT01546623|1031845|P2|STARTED|Overall Study||80
420877|NCT01546623|1031846|P1|STARTED|Overall Study||82
420878|NCT01546519|1031876|P4|NOT COMPLETED|Overall Study||6
420879|NCT01546519|1031877|P3|NOT COMPLETED|Overall Study||8
420880|NCT01546519|1031878|P2|NOT COMPLETED|Overall Study||8
420881|NCT01546519|1031879|P1|NOT COMPLETED|Overall Study||9
420882|NCT01546519|1031876|P4|COMPLETED|Overall Study||0
420883|NCT01546519|1031877|P3|COMPLETED|Overall Study||0
420884|NCT01546519|1031878|P2|COMPLETED|Overall Study||0
420885|NCT01546519|1031879|P1|COMPLETED|Overall Study||0
420886|NCT01546519|1031876|P4|Safety-Evaluable Participants|Overall Study||6
420887|NCT01546519|1031877|P3|Safety-Evaluable Participants|Overall Study||8
420888|NCT01546519|1031878|P2|Safety-Evaluable Participants|Overall Study||8
420889|NCT01546519|1031879|P1|Safety-Evaluable Participants|Overall Study||9
420890|NCT01546519|1031876|P4|STARTED|Overall Study||6
420891|NCT01546519|1031877|P3|STARTED|Overall Study||8
420892|NCT01546519|1031878|P2|STARTED|Overall Study||8
420893|NCT01546519|1031879|P1|STARTED|Overall Study||9
420894|NCT01546454|1031921|P1|NOT COMPLETED|Estrogen/Progesterone Replacement Cycle||0
420895|NCT01546454|1031921|P1|COMPLETED|Estrogen/Progesterone Replacement Cycle||4
420896|NCT01546454|1031921|P1|STARTED|Estrogen/Progesterone Replacement Cycle||4
420897|NCT01546454|1031921|P1|NOT COMPLETED|Eligard Treatment||0
420898|NCT01546454|1031921|P1|COMPLETED|Eligard Treatment||4
420899|NCT01546454|1031921|P1|STARTED|Eligard Treatment||4
420900|NCT01546454|1031921|P1|NOT COMPLETED|Oral Contraceptive Cycle||0
420901|NCT01546454|1031921|P1|COMPLETED|Oral Contraceptive Cycle||4
420902|NCT01546454|1031921|P1|STARTED|Oral Contraceptive Cycle||4
420903|NCT01546454|1031921|P1|NOT COMPLETED|Natural Menstrual Cycle||0
420904|NCT01546454|1031921|P1|COMPLETED|Natural Menstrual Cycle||4
420905|NCT01546454|1031921|P1|STARTED|Natural Menstrual Cycle||4
420906|NCT01546402|1031929|P2|NOT COMPLETED|Overall Study||0
420907|NCT01546402|1031930|P1|NOT COMPLETED|Overall Study||0
420908|NCT01546402|1031929|P2|COMPLETED|Overall Study||10
420909|NCT01546402|1031930|P1|COMPLETED|Overall Study||10
420910|NCT01546402|1031929|P2|STARTED|Overall Study||10
420911|NCT01546402|1031930|P1|STARTED|Overall Study||10
420912|NCT01546285|1031938|P1|NOT COMPLETED|Overall Study||0
420913|NCT01546285|1031938|P1|COMPLETED|Overall Study||66
420914|NCT01546285|1031938|P1|STARTED|Overall Study||66
420915|NCT01546207|1031944|P1|NOT COMPLETED|Overall Study||1
420916|NCT01546207|1031944|P1|COMPLETED|Overall Study||3
420917|NCT01546207|1031944|P1|STARTED|Overall Study||4
420918|NCT01546194|1031950|P2|NOT COMPLETED|Overall Study||35
420919|NCT01546194|1031951|P1|NOT COMPLETED|Overall Study||36
420920|NCT01546194|1031950|P2|COMPLETED|Overall Study||65
420921|NCT01546194|1031951|P1|COMPLETED|Overall Study||64
420922|NCT01546194|1031950|P2|STARTED|Overall Study||100
420923|NCT01546194|1031951|P1|STARTED|Overall Study||100
420924|NCT01546168|1031959|P2|NOT COMPLETED|Overall Study||0
420925|NCT01546168|1031960|P1|NOT COMPLETED|Overall Study||4
420926|NCT01546168|1031959|P2|COMPLETED|Overall Study||33
420927|NCT01546168|1031960|P1|COMPLETED|Overall Study||51
420928|NCT01546168|1031959|P2|STARTED|Overall Study||33
420929|NCT01546168|1031960|P1|STARTED|Overall Study||55
420930|NCT01546155|1031972|P1|NOT COMPLETED|Overall Study||3
420931|NCT01546155|1031972|P1|COMPLETED|Overall Study||8
420932|NCT01546155|1031972|P1|STARTED|Overall Study||11
420933|NCT01546142|1031978|P2|NOT COMPLETED|Overall Study||34
420934|NCT01546142|1031979|P1|NOT COMPLETED|Overall Study||44
420935|NCT01546142|1031978|P2|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|224
420936|NCT01546142|1031979|P1|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|214
420937|NCT01546142|1031978|P2|Received Treatment|Overall Study||257
420938|NCT01546142|1031979|P1|Received Treatment|Overall Study||257
420939|NCT01546142|1031978|P2|STARTED|Overall Study||258
420940|NCT01546142|1031979|P1|STARTED|Overall Study||258
420941|NCT01546038|1031997|P9|NOT COMPLETED|Overall Study||44
420942|NCT01546038|1031998|P8|NOT COMPLETED|Overall Study||88
420943|NCT01546038|1031999|P7|NOT COMPLETED|Overall Study||71
420944|NCT01546038|1032000|P6|NOT COMPLETED|Overall Study||6
420945|NCT01546038|1032001|P5|NOT COMPLETED|Overall Study||16
420946|NCT01546038|1032002|P4|NOT COMPLETED|Overall Study||3
420947|NCT01546038|1032003|P3|NOT COMPLETED|Overall Study||4
420948|NCT01546038|1032004|P2|NOT COMPLETED|Overall Study||6
420949|NCT01546038|1032005|P1|NOT COMPLETED|Overall Study||17
420950|NCT01546038|1031997|P9|COMPLETED|Overall Study||0
420951|NCT01546038|1031998|P8|COMPLETED|Overall Study||0
420952|NCT01546038|1031999|P7|COMPLETED|Overall Study||0
420953|NCT01546038|1032000|P6|COMPLETED|Overall Study||0
420954|NCT01546038|1032001|P5|COMPLETED|Overall Study||0
420955|NCT01546038|1032002|P4|COMPLETED|Overall Study||0
420956|NCT01546038|1032003|P3|COMPLETED|Overall Study||0
420957|NCT01546038|1032004|P2|COMPLETED|Overall Study||0
420958|NCT01546038|1032005|P1|COMPLETED|Overall Study||0
420959|NCT01546038|1031997|P9|Received Treatment|Overall Study||41
420960|NCT01546038|1031998|P8|Received Treatment|Overall Study||84
420961|NCT01546038|1031999|P7|Received Treatment|Overall Study||69
420962|NCT01546038|1032000|P6|Received Treatment|Overall Study||6
420963|NCT01546038|1032001|P5|Received Treatment|Overall Study||16
420964|NCT01546038|1032002|P4|Received Treatment|Overall Study||3
420965|NCT01546038|1032003|P3|Received Treatment|Overall Study||4
420966|NCT01546038|1032004|P2|Received Treatment|Overall Study||6
420967|NCT01546038|1032005|P1|Received Treatment|Overall Study||17
420968|NCT01546038|1031997|P9|STARTED|Overall Study||44
420969|NCT01546038|1031998|P8|STARTED|Overall Study||88
420970|NCT01546038|1031999|P7|STARTED|Overall Study||71
420971|NCT01546038|1032000|P6|STARTED|Overall Study||6
420972|NCT01546038|1032001|P5|STARTED|Overall Study||16
420973|NCT01546038|1032002|P4|STARTED|Overall Study||3
420974|NCT01546038|1032003|P3|STARTED|Overall Study||4
420975|NCT01546038|1032004|P2|STARTED|Overall Study||6
420976|NCT01546038|1032005|P1|STARTED|Overall Study||17
420977|NCT01545843|1032168|P3|NOT COMPLETED|Overall Study||4
420978|NCT01545843|1032169|P2|NOT COMPLETED|Overall Study||7
420979|NCT01545843|1032170|P1|NOT COMPLETED|Overall Study||3
420980|NCT01545843|1032168|P3|COMPLETED|Overall Study||21
420981|NCT01545843|1032169|P2|COMPLETED|Overall Study||17
420982|NCT01545843|1032170|P1|COMPLETED|Overall Study||16
420983|NCT01545843|1032168|P3|STARTED|Overall Study||25
420984|NCT01545843|1032169|P2|STARTED|Overall Study||24
420985|NCT01545843|1032170|P1|STARTED|Overall Study||19
420986|NCT01545765|1032199|P1|NOT COMPLETED|Overall Study||0
420987|NCT01545765|1032199|P1|COMPLETED|Overall Study||31
420988|NCT01545765|1032199|P1|STARTED|Overall Study||31
420989|NCT01545700|1032216|P6|NOT COMPLETED|Overall Study||0
420990|NCT01545700|1032217|P5|NOT COMPLETED|Overall Study||1
420991|NCT01545700|1032218|P4|NOT COMPLETED|Overall Study||0
420992|NCT01545700|1032219|P3|NOT COMPLETED|Overall Study||2
420993|NCT01545700|1032220|P2|NOT COMPLETED|Overall Study||1
420994|NCT01545700|1032221|P1|NOT COMPLETED|Overall Study||1
420995|NCT01545700|1032216|P6|COMPLETED|Overall Study||33
420996|NCT01545700|1032217|P5|COMPLETED|Overall Study||32
420997|NCT01545700|1032218|P4|COMPLETED|Overall Study||34
420998|NCT01545700|1032219|P3|COMPLETED|Overall Study||31
420999|NCT01545700|1032220|P2|COMPLETED|Overall Study||32
421000|NCT01545700|1032221|P1|COMPLETED|Overall Study||33
421001|NCT01545700|1032216|P6|STARTED|Overall Study||33
421002|NCT01545700|1032217|P5|STARTED|Overall Study||33
421003|NCT01545700|1032218|P4|STARTED|Overall Study||34
421004|NCT01545700|1032219|P3|STARTED|Overall Study||33
421005|NCT01545700|1032220|P2|STARTED|Overall Study||33
421006|NCT01545700|1032221|P1|STARTED|Overall Study||34
421007|NCT01545518|1032255|P1|NOT COMPLETED|Overall Study||0
421008|NCT01545518|1032255|P1|COMPLETED|Overall Study||20
421009|NCT01545518|1032255|P1|STARTED|Overall Study||20
421010|NCT01545388|1032262|P3|NOT COMPLETED|Overall Study||8
421011|NCT01545388|1032263|P2|NOT COMPLETED|Overall Study||11
421012|NCT01545388|1032264|P1|NOT COMPLETED|Overall Study||8
421013|NCT01545388|1032262|P3|COMPLETED|Overall Study||58
421014|NCT01545388|1032263|P2|COMPLETED|Overall Study||122
421015|NCT01545388|1032264|P1|COMPLETED|Overall Study||130
421016|NCT01545388|1032262|P3|STARTED|Overall Study||66
421017|NCT01545388|1032263|P2|STARTED|Overall Study||133
421018|NCT01545388|1032264|P1|STARTED|Overall Study||138
421019|NCT01545375|1032283|P2|NOT COMPLETED|Overall Study||90
421020|NCT01545375|1032284|P1|NOT COMPLETED|Overall Study||97
421021|NCT01545375|1032283|P2|COMPLETED|Overall Study||813
421022|NCT01545375|1032284|P1|COMPLETED|Overall Study||803
421023|NCT01545375|1032283|P2|STARTED|Overall Study||903
421024|NCT01545375|1032284|P1|STARTED|Overall Study||900
421025|NCT01545336|1032334|P2|NOT COMPLETED|Overall Study||0
421026|NCT01545336|1032335|P1|NOT COMPLETED|Overall Study||0
421027|NCT01545336|1032334|P2|COMPLETED|Overall Study||6
421028|NCT01545336|1032335|P1|COMPLETED|Overall Study||12
421029|NCT01545336|1032334|P2|STARTED|Overall Study||6
421030|NCT01545336|1032335|P1|STARTED|Overall Study||12
421031|NCT01545232|1032347|P2|NOT COMPLETED|Overall Study||0
421032|NCT01545232|1032348|P1|NOT COMPLETED|Overall Study||0
421033|NCT01545232|1032347|P2|COMPLETED|Overall Study||342
421034|NCT01545232|1032348|P1|COMPLETED|Overall Study||338
421035|NCT01545232|1032347|P2|STARTED|Overall Study||342
421036|NCT01545232|1032348|P1|STARTED|Overall Study||338
421037|NCT01545193|1032378|P2|NOT COMPLETED|Overall Study||1
421038|NCT01545193|1032379|P1|NOT COMPLETED|Overall Study||0
421039|NCT01545193|1032378|P2|COMPLETED|Overall Study||149
421040|NCT01545193|1032379|P1|COMPLETED|Overall Study||150
421041|NCT01545193|1032378|P2|STARTED|Overall Study||150
421042|NCT01545193|1032379|P1|STARTED|Overall Study||150
421043|NCT01544998|1032391|P2|NOT COMPLETED|Second Intervention (3 Hours)||0
421044|NCT01544998|1032392|P1|NOT COMPLETED|Second Intervention (3 Hours)||0
421045|NCT01544998|1032391|P2|COMPLETED|Second Intervention (3 Hours)||15
421046|NCT01544998|1032392|P1|COMPLETED|Second Intervention (3 Hours)||26
421047|NCT01544998|1032391|P2|STARTED|Second Intervention (3 Hours)||15
421048|NCT01544998|1032392|P1|STARTED|Second Intervention (3 Hours)||26
421049|NCT01544998|1032391|P2|NOT COMPLETED|Washout (1 Week)||0
421050|NCT01544998|1032392|P1|NOT COMPLETED|Washout (1 Week)||0
421051|NCT01544998|1032391|P2|COMPLETED|Washout (1 Week)||15
421052|NCT01544998|1032392|P1|COMPLETED|Washout (1 Week)||26
421053|NCT01544998|1032391|P2|STARTED|Washout (1 Week)||15
421054|NCT01544998|1032392|P1|STARTED|Washout (1 Week)||26
421055|NCT01544998|1032391|P2|NOT COMPLETED|First Intervention (3 Hours)||0
421056|NCT01544998|1032392|P1|NOT COMPLETED|First Intervention (3 Hours)||0
421057|NCT01544998|1032391|P2|COMPLETED|First Intervention (3 Hours)||15
421058|NCT01544998|1032392|P1|COMPLETED|First Intervention (3 Hours)||26
421059|NCT01544998|1032391|P2|STARTED|First Intervention (3 Hours)||15
421060|NCT01544998|1032392|P1|STARTED|First Intervention (3 Hours)||26
421061|NCT01544920|1032412|P2|NOT COMPLETED|Overall Study||23
421062|NCT01544920|1032413|P1|NOT COMPLETED|Overall Study||19
421063|NCT01544920|1032412|P2|COMPLETED|Overall Study||346
421064|NCT01544920|1032413|P1|COMPLETED|Overall Study||349
421065|NCT01544920|1032412|P2|STARTED|Overall Study||369
421066|NCT01544920|1032413|P1|STARTED|Overall Study||368
421067|NCT01544582|1032424|P4|NOT COMPLETED|Analysis Population||39
421068|NCT01544582|1032425|P3|NOT COMPLETED|Analysis Population||102
421069|NCT01544582|1032426|P2|NOT COMPLETED|Analysis Population||118
421070|NCT01544582|1032427|P1|NOT COMPLETED|Analysis Population||0
421071|NCT01544582|1032424|P4|COMPLETED|Analysis Population||35
421072|NCT01544582|1032425|P3|COMPLETED|Analysis Population||205
421073|NCT01544582|1032426|P2|COMPLETED|Analysis Population||180
421074|NCT01544582|1032427|P1|COMPLETED|Analysis Population||0
421075|NCT01544582|1032424|P4|STARTED|Analysis Population||74
421076|NCT01544582|1032425|P3|STARTED|Analysis Population||307
421077|NCT01544582|1032426|P2|STARTED|Analysis Population||298
421078|NCT01544582|1032427|P1|STARTED|Analysis Population|Analysis Population was grouped into Boceprevir+PR, Telaprevir+PR, or PR Alone|0
421079|NCT01544582|1032424|P4|NOT COMPLETED|Screening/Eligibility||0
421080|NCT01544582|1032425|P3|NOT COMPLETED|Screening/Eligibility||0
421081|NCT01544582|1032426|P2|NOT COMPLETED|Screening/Eligibility||0
421082|NCT01544582|1032427|P1|NOT COMPLETED|Screening/Eligibility||34
421083|NCT01544582|1032424|P4|COMPLETED|Screening/Eligibility||0
421084|NCT01544582|1032425|P3|COMPLETED|Screening/Eligibility||0
421085|NCT01544582|1032426|P2|COMPLETED|Screening/Eligibility||0
421086|NCT01544582|1032427|P1|COMPLETED|Screening/Eligibility|Completed means met criteria for Analysis Population|679
421087|NCT01544582|1032424|P4|Analysis Population|Screening/Eligibility||0
421088|NCT01544582|1032425|P3|Analysis Population|Screening/Eligibility||0
421089|NCT01544582|1032426|P2|Analysis Population|Screening/Eligibility||0
421090|NCT01544582|1032427|P1|Analysis Population|Screening/Eligibility||679
421091|NCT01544582|1032424|P4|STARTED|Screening/Eligibility||0
421092|NCT01544582|1032425|P3|STARTED|Screening/Eligibility||0
421093|NCT01544582|1032426|P2|STARTED|Screening/Eligibility||0
421094|NCT01544582|1032427|P1|STARTED|Screening/Eligibility||713
421095|NCT01544478|1032485|P1|NOT COMPLETED|Overall Study||118
421096|NCT01544478|1032485|P1|COMPLETED|Overall Study||912
421097|NCT01544478|1032485|P1|Vaccination 3|Overall Study||1019
421098|NCT01544478|1032485|P1|Vaccination 2|Overall Study||1026
421099|NCT01544478|1032485|P1|Vaccination 1|Overall Study||1030
421100|NCT01544478|1032485|P1|STARTED|Overall Study||1030
421101|NCT01544361|1032494|P5|NOT COMPLETED|Overall Study||0
421102|NCT01544361|1032495|P4|NOT COMPLETED|Overall Study||0
421103|NCT01544361|1032496|P3|NOT COMPLETED|Overall Study||0
421104|NCT01544361|1032497|P2|NOT COMPLETED|Overall Study||0
421105|NCT01544361|1032498|P1|NOT COMPLETED|Overall Study||0
421106|NCT01544361|1032494|P5|COMPLETED|Overall Study||6
421107|NCT01544361|1032495|P4|COMPLETED|Overall Study||6
421108|NCT01544361|1032496|P3|COMPLETED|Overall Study||6
421109|NCT01544361|1032497|P2|COMPLETED|Overall Study||6
421110|NCT01544361|1032498|P1|COMPLETED|Overall Study||8
421111|NCT01544361|1032494|P5|STARTED|Overall Study||6
421112|NCT01544361|1032495|P4|STARTED|Overall Study||6
421113|NCT01544361|1032496|P3|STARTED|Overall Study||6
421114|NCT01544361|1032497|P2|STARTED|Overall Study||6
421115|NCT01544361|1032498|P1|STARTED|Overall Study||8
421116|NCT01544348|1032528|P8|NOT COMPLETED|Overall Study||0
421117|NCT01544348|1032529|P7|NOT COMPLETED|Overall Study||2
421118|NCT01544348|1032530|P6|NOT COMPLETED|Overall Study||3
421119|NCT01544348|1032531|P5|NOT COMPLETED|Overall Study||1
421120|NCT01544348|1032532|P4|NOT COMPLETED|Overall Study||0
421121|NCT01544348|1032533|P3|NOT COMPLETED|Overall Study||0
421122|NCT01544348|1032534|P2|NOT COMPLETED|Overall Study||0
421123|NCT01544348|1032535|P1|NOT COMPLETED|Overall Study||2
421124|NCT01544348|1032528|P8|COMPLETED|Overall Study||8
421125|NCT01544348|1032529|P7|COMPLETED|Overall Study||12
421126|NCT01544348|1032530|P6|COMPLETED|Overall Study||16
421127|NCT01544348|1032531|P5|COMPLETED|Overall Study||15
421128|NCT01544348|1032532|P4|COMPLETED|Overall Study||3
421129|NCT01544348|1032533|P3|COMPLETED|Overall Study||3
421130|NCT01544348|1032534|P2|COMPLETED|Overall Study||6
421131|NCT01544348|1032535|P1|COMPLETED|Overall Study||15
421132|NCT01544348|1032528|P8|Treated|Overall Study||8
421133|NCT01544348|1032529|P7|Treated|Overall Study||14
421134|NCT01544348|1032530|P6|Treated|Overall Study||18
421135|NCT01544348|1032531|P5|Treated|Overall Study||15
421136|NCT01544348|1032532|P4|Treated|Overall Study||3
421137|NCT01544348|1032533|P3|Treated|Overall Study||3
421138|NCT01544348|1032534|P2|Treated|Overall Study||6
421139|NCT01544348|1032535|P1|Treated|Overall Study||17
421140|NCT01544348|1032528|P8|STARTED|Overall Study||8
421141|NCT01544348|1032529|P7|STARTED|Overall Study||14
421142|NCT01544348|1032530|P6|STARTED|Overall Study||19
421143|NCT01544348|1032531|P5|STARTED|Overall Study||16
421144|NCT01544348|1032532|P4|STARTED|Overall Study||3
421145|NCT01544348|1032533|P3|STARTED|Overall Study||3
421146|NCT01544348|1032534|P2|STARTED|Overall Study||6
421147|NCT01544348|1032535|P1|STARTED|Overall Study||17
421148|NCT01544309|1032577|P2|NOT COMPLETED|Overall Study||11
421149|NCT01544309|1032578|P1|NOT COMPLETED|Overall Study||20
421150|NCT01544309|1032577|P2|COMPLETED|Overall Study||514
421151|NCT01544309|1032578|P1|COMPLETED|Overall Study||504
421152|NCT01544309|1032577|P2|STARTED|Overall Study||525
421153|NCT01544309|1032578|P1|STARTED|Overall Study||524
421154|NCT01544179|1032616|P2|NOT COMPLETED|Overall Study||46
421155|NCT01544179|1032617|P1|NOT COMPLETED|Overall Study||63
421156|NCT01544179|1032616|P2|COMPLETED|Overall Study|Patients are ongoing in the study|86
421157|NCT01544179|1032617|P1|COMPLETED|Overall Study|Patients are ongoing in the study|70
421158|NCT01544179|1032616|P2|Did Not Receive Treatment|Overall Study||0
421159|NCT01544179|1032617|P1|Did Not Receive Treatment|Overall Study||1
421160|NCT01544179|1032616|P2|Received Treatment|Overall Study||132
421161|NCT01544179|1032617|P1|Received Treatment|Overall Study||132
421162|NCT01544179|1032616|P2|STARTED|Overall Study||132
421163|NCT01544179|1032617|P1|STARTED|Overall Study||133
421164|NCT01544166|1032645|P1|NOT COMPLETED|Overall Study||0
421165|NCT01544166|1032645|P1|COMPLETED|Overall Study||44
421166|NCT01544166|1032645|P1|STARTED|Overall Study||44
421167|NCT01544153|1032710|P4|NOT COMPLETED|Overall Study||0
421168|NCT01544153|1032711|P3|NOT COMPLETED|Overall Study||1
421169|NCT01544153|1032712|P2|NOT COMPLETED|Overall Study||1
421170|NCT01544153|1032713|P1|NOT COMPLETED|Overall Study||0
421171|NCT01544153|1032710|P4|COMPLETED|Overall Study||1317
421172|NCT01544153|1032711|P3|COMPLETED|Overall Study||1313
421173|NCT01544153|1032712|P2|COMPLETED|Overall Study||1323
421174|NCT01544153|1032713|P1|COMPLETED|Overall Study||1337
421175|NCT01544153|1032710|P4|STARTED|Overall Study||1317
421176|NCT01544153|1032711|P3|STARTED|Overall Study||1314
421177|NCT01544153|1032712|P2|STARTED|Overall Study||1324
421178|NCT01544153|1032713|P1|STARTED|Overall Study||1337
421179|NCT01544114|1032730|P3|NOT COMPLETED|Overall Study||5
421180|NCT01544114|1032731|P2|NOT COMPLETED|Overall Study||4
421181|NCT01544114|1032732|P1|NOT COMPLETED|Overall Study||1
421182|NCT01544114|1032730|P3|COMPLETED|Overall Study|completed study and received 6 months of study drug|17
421183|NCT01544114|1032731|P2|COMPLETED|Overall Study|completed study and received 6 months of study drug|16
421184|NCT01544114|1032732|P1|COMPLETED|Overall Study|completed study and received 6 months of study drug|3
421185|NCT01544114|1032730|P3|STARTED|Overall Study||22
421186|NCT01544114|1032731|P2|STARTED|Overall Study||20
421187|NCT01544114|1032732|P1|STARTED|Overall Study||4
421188|NCT01544062|1032763|P2|NOT COMPLETED|Overall Study||0
421189|NCT01544062|1032764|P1|NOT COMPLETED|Overall Study||0
421190|NCT01544062|1032763|P2|COMPLETED|Overall Study||35
421191|NCT01544062|1032764|P1|COMPLETED|Overall Study||33
421192|NCT01544062|1032763|P2|STARTED|Overall Study||35
421193|NCT01544062|1032764|P1|STARTED|Overall Study||33
421194|NCT01544023|1032810|P1|NOT COMPLETED|Overall Study||0
421195|NCT01544023|1032810|P1|COMPLETED|Overall Study||207
421196|NCT01544023|1032810|P1|STARTED|Overall Study|retrospective|207
421197|NCT01543958|1032815|P1|NOT COMPLETED|Overall Study||4
421198|NCT01543958|1032815|P1|COMPLETED|Overall Study||36
421199|NCT01543958|1032815|P1|STARTED|Overall Study||40
421200|NCT01543828|1032870|P2|NOT COMPLETED|Treatment 2||0
421201|NCT01543828|1032871|P1|NOT COMPLETED|Treatment 2||1
421202|NCT01543828|1032870|P2|COMPLETED|Treatment 2||19
421203|NCT01543828|1032871|P1|COMPLETED|Treatment 2||19
421204|NCT01543828|1032870|P2|STARTED|Treatment 2|1 participant completed treatment 1, had an adverse event, and did not receive treatment 2.|19
421205|NCT01543828|1032871|P1|STARTED|Treatment 2||20
421206|NCT01543828|1032870|P2|NOT COMPLETED|Treatment 1||0
421207|NCT01543828|1032871|P1|NOT COMPLETED|Treatment 1||0
421208|NCT01543828|1032870|P2|COMPLETED|Treatment 1||20
421209|NCT01543828|1032871|P1|COMPLETED|Treatment 1||20
421210|NCT01543828|1032870|P2|STARTED|Treatment 1||20
421211|NCT01543828|1032871|P1|STARTED|Treatment 1||20
421212|NCT01543685|1032884|P5|NOT COMPLETED|Overall Study||4
421213|NCT01543685|1032885|P4|NOT COMPLETED|Overall Study||0
421214|NCT01543685|1032886|P3|NOT COMPLETED|Overall Study||2
421215|NCT01543685|1032887|P2|NOT COMPLETED|Overall Study||3
421216|NCT01543685|1032888|P1|NOT COMPLETED|Overall Study||3
421217|NCT01543685|1032884|P5|COMPLETED|Overall Study||90
421218|NCT01543685|1032885|P4|COMPLETED|Overall Study||93
421219|NCT01543685|1032886|P3|COMPLETED|Overall Study||89
421220|NCT01543685|1032887|P2|COMPLETED|Overall Study||88
421221|NCT01543685|1032888|P1|COMPLETED|Overall Study||90
421222|NCT01543685|1032884|P5|STARTED|Overall Study||94
421223|NCT01543685|1032885|P4|STARTED|Overall Study||93
421224|NCT01543685|1032886|P3|STARTED|Overall Study||91
421225|NCT01543685|1032887|P2|STARTED|Overall Study||91
421226|NCT01543685|1032888|P1|STARTED|Overall Study||93
421227|NCT01543607|1032935|P1|NOT COMPLETED|Overall Study||0
421228|NCT01543607|1032935|P1|COMPLETED|Overall Study||1
421229|NCT01543607|1032935|P1|STARTED|Overall Study||1
421230|NCT01543581|1032941|P2|NOT COMPLETED|Overall Study||0
421231|NCT01543581|1032942|P1|NOT COMPLETED|Overall Study||0
421232|NCT01543581|1032941|P2|COMPLETED|Overall Study||0
421233|NCT01543581|1032942|P1|COMPLETED|Overall Study||1
421234|NCT01543581|1032941|P2|STARTED|Overall Study||0
421235|NCT01543581|1032942|P1|STARTED|Overall Study||1
421236|NCT01543568|1032948|P1|NOT COMPLETED|Overall Study||1
421237|NCT01543568|1032948|P1|COMPLETED|Overall Study||45
421238|NCT01543568|1032948|P1|STARTED|Overall Study||46
421239|NCT01543503|1032960|P2|NOT COMPLETED|Overall Study||87
421240|NCT01543503|1032961|P1|NOT COMPLETED|Overall Study||76
421241|NCT01543503|1032960|P2|COMPLETED|Overall Study||711
421242|NCT01543503|1032961|P1|COMPLETED|Overall Study||350
421243|NCT01543503|1032960|P2|STARTED|Overall Study||798
421244|NCT01543503|1032961|P1|STARTED|Overall Study||426
421245|NCT01543204|1033005|P1|NOT COMPLETED|Overall Study||8
421246|NCT01543204|1033005|P1|COMPLETED|Overall Study||56
421247|NCT01543204|1033005|P1|STARTED|Overall Study||64
421248|NCT01543178|1033052|P3|NOT COMPLETED|Double-blind Period||37
421249|NCT01543178|1033053|P2|NOT COMPLETED|Double-blind Period||44
421250|NCT01543178|1033054|P1|NOT COMPLETED|Double-blind Period||0
421251|NCT01543178|1033052|P3|COMPLETED|Double-blind Period|283 completed 1st double-blind retreatment and 271 completed 2nd double-blind retreatment.|271
421252|NCT01543178|1033053|P2|COMPLETED|Double-blind Period|295 completed 1st double-blind retreatment and 284 completed 2nd double-blind retreatment.|284
421253|NCT01543178|1033054|P1|COMPLETED|Double-blind Period||0
421254|NCT01543178|1033052|P3|STARTED|Double-blind Period|636 subjects had recurrence in open-label period; 308 randomized to placebo.|308
421255|NCT01543178|1033053|P2|STARTED|Double-blind Period|636 subjects had recurrence in open-label period; 328 randomized to rifaximin.|328
421256|NCT01543178|1033054|P1|STARTED|Double-blind Period|The open-label rifaximin arm/group is not applicable to the double-blind period.|0
421257|NCT01543178|1033052|P3|NOT COMPLETED|Open-label Period||0
421258|NCT01543178|1033053|P2|NOT COMPLETED|Open-label Period||0
421259|NCT01543178|1033054|P1|NOT COMPLETED|Open-label Period||1947
421260|NCT01543178|1033052|P3|COMPLETED|Open-label Period||0
421261|NCT01543178|1033053|P2|COMPLETED|Open-label Period||0
421262|NCT01543178|1033054|P1|COMPLETED|Open-label Period||636
421263|NCT01543178|1033052|P3|STARTED|Open-label Period|The double-blind placebo arm/group is not applicable to the open-label period.|0
421264|NCT01543178|1033053|P2|STARTED|Open-label Period|The double-blind rifaximin arm/group is not applicable to the open-label period.|0
421265|NCT01543178|1033054|P1|STARTED|Open-label Period|2583 subjects entered the open-label period, but 4 received no rifaximin; 2579 received rifaximin.|2583
421266|NCT01543074|1033065|P4|NOT COMPLETED|Overall Study||0
421267|NCT01543074|1033066|P3|NOT COMPLETED|Overall Study||0
421268|NCT01543074|1033067|P2|NOT COMPLETED|Overall Study||0
421269|NCT01543074|1033068|P1|NOT COMPLETED|Overall Study||0
421270|NCT01543074|1033065|P4|COMPLETED|Overall Study||6
421271|NCT01543074|1033066|P3|COMPLETED|Overall Study||5
421272|NCT01543074|1033067|P2|COMPLETED|Overall Study||7
421273|NCT01543074|1033068|P1|COMPLETED|Overall Study||5
421274|NCT01543074|1033065|P4|STARTED|Overall Study||6
421275|NCT01543074|1033066|P3|STARTED|Overall Study||5
421276|NCT01543074|1033067|P2|STARTED|Overall Study||7
421277|NCT01543074|1033068|P1|STARTED|Overall Study||5
421278|NCT01542957|1033084|P2|NOT COMPLETED|12-month Follow-up||13
421279|NCT01542957|1033085|P1|NOT COMPLETED|12-month Follow-up||16
421280|NCT01542957|1033084|P2|COMPLETED|12-month Follow-up||40
421281|NCT01542957|1033085|P1|COMPLETED|12-month Follow-up||37
421282|NCT01542957|1033084|P2|STARTED|12-month Follow-up||53
421283|NCT01542957|1033085|P1|STARTED|12-month Follow-up||53
421284|NCT01542957|1033084|P2|NOT COMPLETED|3-month Follow-up||8
421285|NCT01542957|1033085|P1|NOT COMPLETED|3-month Follow-up||3
421286|NCT01542957|1033084|P2|COMPLETED|3-month Follow-up||45
421287|NCT01542957|1033085|P1|COMPLETED|3-month Follow-up||50
421288|NCT01542957|1033084|P2|STARTED|3-month Follow-up||53
421289|NCT01542957|1033085|P1|STARTED|3-month Follow-up||53
421290|NCT01542957|1033084|P2|NOT COMPLETED|End of Therapy||10
421291|NCT01542957|1033085|P1|NOT COMPLETED|End of Therapy||12
421292|NCT01542957|1033084|P2|COMPLETED|End of Therapy||53
421293|NCT01542957|1033085|P1|COMPLETED|End of Therapy||53
421294|NCT01542957|1033084|P2|STARTED|End of Therapy||63
421295|NCT01542957|1033085|P1|STARTED|End of Therapy||65
421296|NCT01542788|1033097|P2|NOT COMPLETED|Overall Study||71
421297|NCT01542788|1033098|P1|NOT COMPLETED|Overall Study||55
421298|NCT01542788|1033097|P2|COMPLETED|Overall Study||0
421299|NCT01542788|1033098|P1|COMPLETED|Overall Study||154
421300|NCT01542788|1033097|P2|Randomized and Treated|Overall Study||71
421301|NCT01542788|1033098|P1|Randomized and Treated|Overall Study||207
421302|NCT01542788|1033097|P2|STARTED|Overall Study||71
421303|NCT01542788|1033098|P1|STARTED|Overall Study||209
421304|NCT01542684|1033114|P1|NOT COMPLETED|Overall Study||0
421305|NCT01542684|1033114|P1|COMPLETED|Overall Study||8
421306|NCT01542684|1033114|P1|STARTED|Overall Study||8
421307|NCT01542645|1033120|P2|NOT COMPLETED|Overall Study||3
421308|NCT01542645|1033121|P1|NOT COMPLETED|Overall Study||5
421309|NCT01542645|1033120|P2|COMPLETED|Overall Study||79
421310|NCT01542645|1033121|P1|COMPLETED|Overall Study||77
421311|NCT01542645|1033120|P2|STARTED|Overall Study||82
421312|NCT01542645|1033121|P1|STARTED|Overall Study||82
421313|NCT01542632|1033137|P6|NOT COMPLETED|Overall Study||0
421314|NCT01542632|1033138|P5|NOT COMPLETED|Overall Study||4
421315|NCT01542632|1033139|P4|NOT COMPLETED|Overall Study||2
421316|NCT01542632|1033140|P3|NOT COMPLETED|Overall Study||1
421317|NCT01542632|1033141|P2|NOT COMPLETED|Overall Study||1
421318|NCT01542632|1033142|P1|NOT COMPLETED|Overall Study||0
421319|NCT01542632|1033137|P6|COMPLETED|Overall Study||24
421320|NCT01542632|1033138|P5|COMPLETED|Overall Study||17
421321|NCT01542632|1033139|P4|COMPLETED|Overall Study||19
421322|NCT01542632|1033140|P3|COMPLETED|Overall Study||23
421323|NCT01542632|1033141|P2|COMPLETED|Overall Study||24
421324|NCT01542632|1033142|P1|COMPLETED|Overall Study||25
421325|NCT01542632|1033137|P6|STARTED|Overall Study||24
421326|NCT01542632|1033138|P5|STARTED|Overall Study||21
421327|NCT01542632|1033139|P4|STARTED|Overall Study||21
421328|NCT01542632|1033140|P3|STARTED|Overall Study||24
421329|NCT01542632|1033141|P2|STARTED|Overall Study||25
421330|NCT01542632|1033142|P1|STARTED|Overall Study||25
421331|NCT01542541|1033188|P2|NOT COMPLETED|Overall Study||0
421332|NCT01542541|1033189|P1|NOT COMPLETED|Overall Study||8
421333|NCT01542541|1033188|P2|COMPLETED|Overall Study||30
421334|NCT01542541|1033189|P1|COMPLETED|Overall Study||30
421335|NCT01542541|1033188|P2|STARTED|Overall Study||30
421336|NCT01542541|1033189|P1|STARTED|Overall Study||38
421337|NCT01542528|1033199|P2|NOT COMPLETED|Overall Study||7
421338|NCT01542528|1033200|P1|NOT COMPLETED|Overall Study||12
421339|NCT01542528|1033199|P2|COMPLETED|Overall Study||49
421340|NCT01542528|1033200|P1|COMPLETED|Overall Study||49
421341|NCT01542528|1033199|P2|STARTED|Overall Study||56
421342|NCT01542528|1033200|P1|STARTED|Overall Study||61
421343|NCT01542502|1033208|P2|NOT COMPLETED|Overall Study||0
421344|NCT01542502|1033209|P1|NOT COMPLETED|Overall Study||0
421345|NCT01542502|1033208|P2|COMPLETED|Overall Study||6
421346|NCT01542502|1033209|P1|COMPLETED|Overall Study||6
421347|NCT01542502|1033208|P2|STARTED|Overall Study||6
421348|NCT01542502|1033209|P1|STARTED|Overall Study||6
421349|NCT01542372|1033217|P2|NOT COMPLETED|Overall Study||0
421350|NCT01542372|1033218|P1|NOT COMPLETED|Overall Study||0
421351|NCT01542372|1033217|P2|COMPLETED|Overall Study||11
421352|NCT01542372|1033218|P1|COMPLETED|Overall Study||11
421353|NCT01542372|1033217|P2|STARTED|Overall Study||11
421354|NCT01542372|1033218|P1|STARTED|Overall Study||11
421355|NCT01542307|1033233|P2|NOT COMPLETED|Overall Study||0
421356|NCT01542307|1033234|P1|NOT COMPLETED|Overall Study||0
421357|NCT01542307|1033233|P2|COMPLETED|Overall Study||22
421358|NCT01542307|1033234|P1|COMPLETED|Overall Study||22
421359|NCT01542307|1033233|P2|STARTED|Overall Study|Each subject inhaled Medical Air for 30 minutes in blinded fashion for 2 of the 4 migraine attacks|22
421360|NCT01542307|1033234|P1|STARTED|Overall Study|Each subject inhaled Oxygen for 30 minutes in blinded fashion for 2 of the 4 migraine attacks|22
421361|NCT01542255|1033254|P1|NOT COMPLETED|Overall Study||0
421362|NCT01542255|1033254|P1|COMPLETED|Overall Study||7
421363|NCT01542255|1033254|P1|Analyzed for Time to Progression|Overall Study||7
421364|NCT01542255|1033254|P1|STARTED|Overall Study||7
421365|NCT01542125|1033260|P2|NOT COMPLETED|Overall Study||0
421366|NCT01542125|1033261|P1|NOT COMPLETED|Overall Study||0
421367|NCT01542125|1033260|P2|COMPLETED|Overall Study||141
421368|NCT01542125|1033261|P1|COMPLETED|Overall Study||140
421369|NCT01542125|1033260|P2|STARTED|Overall Study||141
421370|NCT01542125|1033261|P1|STARTED|Overall Study||140
421371|NCT01542034|1033269|P2|NOT COMPLETED|Overall Study||23
421372|NCT01542034|1033270|P1|NOT COMPLETED|Overall Study||30
421373|NCT01542034|1033269|P2|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|227
421374|NCT01542034|1033270|P1|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|226
421375|NCT01542034|1033269|P2|Received Treatment|Overall Study||249
421376|NCT01542034|1033270|P1|Received Treatment|Overall Study||256
421377|NCT01542034|1033269|P2|STARTED|Overall Study||250
421378|NCT01542034|1033270|P1|STARTED|Overall Study||256
421379|NCT01541969|1033284|P2|NOT COMPLETED|Open Label Extension (12-36 Weeks)||13
421380|NCT01541969|1033285|P1|NOT COMPLETED|Open Label Extension (12-36 Weeks)||11
421381|NCT01541969|1033284|P2|COMPLETED|Open Label Extension (12-36 Weeks)||35
421382|NCT01541969|1033285|P1|COMPLETED|Open Label Extension (12-36 Weeks)||33
421383|NCT01541969|1033284|P2|STARTED|Open Label Extension (12-36 Weeks)||48
421384|NCT01541969|1033285|P1|STARTED|Open Label Extension (12-36 Weeks)||44
421385|NCT01541969|1033284|P2|NOT COMPLETED|Double-blind (0-12 Weeks)||2
421386|NCT01541969|1033285|P1|NOT COMPLETED|Double-blind (0-12 Weeks)||6
421387|NCT01541969|1033284|P2|COMPLETED|Double-blind (0-12 Weeks)||48
421388|NCT01541969|1033285|P1|COMPLETED|Double-blind (0-12 Weeks)||44
421389|NCT01541969|1033284|P2|STARTED|Double-blind (0-12 Weeks)||50
421390|NCT01541969|1033285|P1|STARTED|Double-blind (0-12 Weeks)||50
421391|NCT01541930|1033301|P1|NOT COMPLETED|Overall Study||1
421392|NCT01541930|1033301|P1|COMPLETED|Overall Study||20
421393|NCT01541930|1033301|P1|STARTED|Overall Study||21
421394|NCT01541917|1033323|P2|NOT COMPLETED|Overall Study||9
421395|NCT01541917|1033324|P1|NOT COMPLETED|Overall Study||15
421396|NCT01541917|1033323|P2|COMPLETED|Overall Study||136
421397|NCT01541917|1033324|P1|COMPLETED|Overall Study||129
421398|NCT01541917|1033323|P2|STARTED|Overall Study||145
421399|NCT01541917|1033324|P1|STARTED|Overall Study||144
421400|NCT01541865|1033340|P1|NOT COMPLETED|Overall Study||22
421401|NCT01541865|1033340|P1|COMPLETED|Overall Study||124
421402|NCT01541865|1033340|P1|STARTED|Overall Study||146
421403|NCT01541826|1033358|P3|NOT COMPLETED|Overall Study||0
421404|NCT01541826|1033359|P2|NOT COMPLETED|Overall Study||3
421405|NCT01541826|1033360|P1|NOT COMPLETED|Overall Study||4
421406|NCT01541826|1033358|P3|COMPLETED|Overall Study||6
421407|NCT01541826|1033359|P2|COMPLETED|Overall Study||25
421408|NCT01541826|1033360|P1|COMPLETED|Overall Study||24
421409|NCT01541826|1033358|P3|STARTED|Overall Study||6
421410|NCT01541826|1033359|P2|STARTED|Overall Study||28
421411|NCT01541826|1033360|P1|STARTED|Overall Study||28
421412|NCT01541735|1033429|P2|NOT COMPLETED|Overall Study||0
421413|NCT01541735|1033430|P1|NOT COMPLETED|Overall Study||0
421414|NCT01541735|1033429|P2|COMPLETED|Overall Study||7
421415|NCT01541735|1033430|P1|COMPLETED|Overall Study||7
421416|NCT01541735|1033429|P2|STARTED|Overall Study||7
421417|NCT01541735|1033430|P1|STARTED|Overall Study||7
421418|NCT01541644|1033442|P1|NOT COMPLETED|Overall Study||3
421419|NCT01541644|1033442|P1|COMPLETED|Overall Study||24
421420|NCT01541644|1033442|P1|STARTED|Overall Study||27
421421|NCT01541553|1033448|P2|NOT COMPLETED|Overall Study||14
421422|NCT01541553|1033449|P1|NOT COMPLETED|Overall Study||12
421423|NCT01541553|1033448|P2|COMPLETED|Overall Study||148
421424|NCT01541553|1033449|P1|COMPLETED|Overall Study||155
421425|NCT01541553|1033448|P2|STARTED|Overall Study||162
421426|NCT01541553|1033449|P1|STARTED|Overall Study||167
421427|NCT01541397|1033461|P2|NOT COMPLETED|Overall Study||2
421428|NCT01541397|1033462|P1|NOT COMPLETED|Overall Study||4
421429|NCT01541397|1033461|P2|COMPLETED|Overall Study||0
421430|NCT01541397|1033462|P1|COMPLETED|Overall Study||0
421431|NCT01541397|1033461|P2|STARTED|Overall Study||2
421432|NCT01541397|1033462|P1|STARTED|Overall Study||4
421433|NCT01541384|1033477|P3|NOT COMPLETED|Overall Study||2
421434|NCT01541384|1033478|P2|NOT COMPLETED|Overall Study||1
421435|NCT01541384|1033479|P1|NOT COMPLETED|Overall Study||0
421436|NCT01541384|1033477|P3|COMPLETED|Overall Study||38
421437|NCT01541384|1033478|P2|COMPLETED|Overall Study||39
421438|NCT01541384|1033479|P1|COMPLETED|Overall Study||40
421439|NCT01541384|1033477|P3|STARTED|Overall Study||40
421440|NCT01541384|1033478|P2|STARTED|Overall Study||40
421441|NCT01541384|1033479|P1|STARTED|Overall Study||40
421442|NCT01541371|1033487|P1|NOT COMPLETED|Overall Study||77
421443|NCT01541371|1033487|P1|COMPLETED|Overall Study||326
421444|NCT01541371|1033487|P1|Full Analysis Set|Overall Study||394
421445|NCT01541371|1033487|P1|STARTED|Overall Study||403
421446|NCT01541358|1033510|P1|NOT COMPLETED|Overall Study||0
421447|NCT01541358|1033510|P1|COMPLETED|Overall Study||2
421448|NCT01541358|1033510|P1|STARTED|Overall Study||2
421449|NCT01541254|1033516|P1|NOT COMPLETED|Overall Study||6
421450|NCT01541254|1033516|P1|COMPLETED|Overall Study||30
421451|NCT01541254|1033516|P1|STARTED|Overall Study||36
421452|NCT01540981|1033523|P2|NOT COMPLETED|Overall Study||0
421453|NCT01540981|1033524|P1|NOT COMPLETED|Overall Study||1
421454|NCT01540981|1033523|P2|COMPLETED|Overall Study||6
421455|NCT01540981|1033524|P1|COMPLETED|Overall Study||5
421456|NCT01540981|1033523|P2|STARTED|Overall Study||6
421457|NCT01540981|1033524|P1|STARTED|Overall Study||6
421458|NCT01540851|1033534|P2|NOT COMPLETED|Overall Study||18
421459|NCT01540851|1033535|P1|NOT COMPLETED|Overall Study||21
421460|NCT01540851|1033534|P2|COMPLETED|Overall Study||136
421461|NCT01540851|1033535|P1|COMPLETED|Overall Study||133
421462|NCT01540851|1033534|P2|STARTED|Overall Study||154
421463|NCT01540851|1033535|P1|STARTED|Overall Study||154
421464|NCT01540825|1033556|P11|NOT COMPLETED|Overall Study||0
421465|NCT01540825|1033557|P10|NOT COMPLETED|Overall Study||0
421466|NCT01540825|1033558|P9|NOT COMPLETED|Overall Study||0
421467|NCT01540825|1033559|P8|NOT COMPLETED|Overall Study||0
421468|NCT01540825|1033560|P7|NOT COMPLETED|Overall Study||0
421469|NCT01540825|1033561|P6|NOT COMPLETED|Overall Study||0
421470|NCT01540825|1033562|P5|NOT COMPLETED|Overall Study||0
421471|NCT01540825|1033563|P4|NOT COMPLETED|Overall Study||0
421472|NCT01540825|1033564|P3|NOT COMPLETED|Overall Study||0
421473|NCT01540825|1033565|P2|NOT COMPLETED|Overall Study||0
421474|NCT01540825|1033566|P1|NOT COMPLETED|Overall Study||0
421475|NCT01540825|1033556|P11|COMPLETED|Overall Study||6
421476|NCT01540825|1033557|P10|COMPLETED|Overall Study||6
421477|NCT01540825|1033558|P9|COMPLETED|Overall Study||6
421478|NCT01540825|1033559|P8|COMPLETED|Overall Study||6
421479|NCT01540825|1033560|P7|COMPLETED|Overall Study||6
421480|NCT01540825|1033561|P6|COMPLETED|Overall Study||6
421481|NCT01540825|1033562|P5|COMPLETED|Overall Study||6
421482|NCT01540825|1033563|P4|COMPLETED|Overall Study||6
421483|NCT01540825|1033564|P3|COMPLETED|Overall Study||6
421484|NCT01540825|1033565|P2|COMPLETED|Overall Study||6
421485|NCT01540825|1033566|P1|COMPLETED|Overall Study||20
421486|NCT01540825|1033556|P11|STARTED|Overall Study||6
421487|NCT01540825|1033557|P10|STARTED|Overall Study||6
421488|NCT01540825|1033558|P9|STARTED|Overall Study||6
421489|NCT01540825|1033559|P8|STARTED|Overall Study||6
421490|NCT01540825|1033560|P7|STARTED|Overall Study||6
421491|NCT01540825|1033561|P6|STARTED|Overall Study||6
421492|NCT01540825|1033562|P5|STARTED|Overall Study||6
421493|NCT01540825|1033563|P4|STARTED|Overall Study||6
421494|NCT01540825|1033564|P3|STARTED|Overall Study||6
421495|NCT01540825|1033565|P2|STARTED|Overall Study||6
421496|NCT01540825|1033566|P1|STARTED|Overall Study||20
421497|NCT01540773|1033662|P2|NOT COMPLETED|Second Intervention||0
421498|NCT01540773|1033663|P1|NOT COMPLETED|Second Intervention||0
421499|NCT01540773|1033662|P2|COMPLETED|Second Intervention||8
421500|NCT01540773|1033663|P1|COMPLETED|Second Intervention||8
421501|NCT01540773|1033662|P2|STARTED|Second Intervention||8
421502|NCT01540773|1033663|P1|STARTED|Second Intervention||8
421503|NCT01540773|1033662|P2|NOT COMPLETED|Wash Out Period of 1 Week||0
421504|NCT01540773|1033663|P1|NOT COMPLETED|Wash Out Period of 1 Week||0
421505|NCT01540773|1033662|P2|COMPLETED|Wash Out Period of 1 Week||8
421506|NCT01540773|1033663|P1|COMPLETED|Wash Out Period of 1 Week||8
421507|NCT01540773|1033662|P2|STARTED|Wash Out Period of 1 Week||8
421508|NCT01540773|1033663|P1|STARTED|Wash Out Period of 1 Week||8
421509|NCT01540773|1033662|P2|NOT COMPLETED|First Intervention||0
421510|NCT01540773|1033663|P1|NOT COMPLETED|First Intervention||0
421511|NCT01540773|1033662|P2|COMPLETED|First Intervention||8
421512|NCT01540773|1033663|P1|COMPLETED|First Intervention||8
421513|NCT01540773|1033662|P2|STARTED|First Intervention||8
421514|NCT01540773|1033663|P1|STARTED|First Intervention||8
421515|NCT01540513|1033671|P1|NOT COMPLETED|Overall Study||0
421516|NCT01540513|1033671|P1|COMPLETED|Overall Study||12
421517|NCT01540513|1033671|P1|STARTED|Overall Study||12
421518|NCT01540487|1033680|P2|NOT COMPLETED|Overall Study||0
421519|NCT01540487|1033681|P1|NOT COMPLETED|Overall Study||1
421520|NCT01540487|1033680|P2|COMPLETED|Overall Study||24
421521|NCT01540487|1033681|P1|COMPLETED|Overall Study||23
421522|NCT01540487|1033680|P2|STARTED|Overall Study||24
421523|NCT01540487|1033681|P1|STARTED|Overall Study||24
421524|NCT01540370|1033715|P1|NOT COMPLETED|Overall Study||2
421525|NCT01540370|1033715|P1|COMPLETED|Overall Study||100
421526|NCT01540370|1033715|P1|STARTED|Overall Study||102
421527|NCT01540266|1033726|P6|NOT COMPLETED|Overall Study||0
421528|NCT01540266|1033727|P5|NOT COMPLETED|Overall Study||0
421529|NCT01540266|1033728|P4|NOT COMPLETED|Overall Study||0
421530|NCT01540266|1033729|P3|NOT COMPLETED|Overall Study||1
421531|NCT01540266|1033730|P2|NOT COMPLETED|Overall Study||1
421532|NCT01540266|1033731|P1|NOT COMPLETED|Overall Study||6
421533|NCT01540266|1033726|P6|COMPLETED|Overall Study||19
421534|NCT01540266|1033727|P5|COMPLETED|Overall Study||20
421535|NCT01540266|1033728|P4|COMPLETED|Overall Study||38
421536|NCT01540266|1033729|P3|COMPLETED|Overall Study||59
421537|NCT01540266|1033730|P2|COMPLETED|Overall Study||41
421538|NCT01540266|1033731|P1|COMPLETED|Overall Study||57
421539|NCT01540266|1033726|P6|STARTED|Overall Study||19
421540|NCT01540266|1033727|P5|STARTED|Overall Study||20
421541|NCT01540266|1033728|P4|STARTED|Overall Study||38
421542|NCT01540266|1033729|P3|STARTED|Overall Study||60
421543|NCT01540266|1033730|P2|STARTED|Overall Study||42
421544|NCT01540266|1033731|P1|STARTED|Overall Study||63
421545|NCT01540162|1033747|P2|NOT COMPLETED|Overall Study||0
421546|NCT01540162|1033748|P1|NOT COMPLETED|Overall Study||0
421547|NCT01540162|1033747|P2|COMPLETED|Overall Study||32
421548|NCT01540162|1033748|P1|COMPLETED|Overall Study||30
421549|NCT01540162|1033747|P2|STARTED|Overall Study||32
421550|NCT01540162|1033748|P1|STARTED|Overall Study||30
421551|NCT01540045|1033758|P1|NOT COMPLETED|Overall Study||0
421552|NCT01540045|1033758|P1|COMPLETED|Overall Study||40
421553|NCT01540045|1033758|P1|STARTED|Overall Study||40
421554|NCT01539980|1033797|P1|NOT COMPLETED|Overall Study||0
421555|NCT01539980|1033797|P1|COMPLETED|Overall Study||30
421556|NCT01539980|1033797|P1|STARTED|Overall Study||30
421557|NCT01539811|1033807|P2|NOT COMPLETED|Overall Study||0
421558|NCT01539811|1033808|P1|NOT COMPLETED|Overall Study||0
421559|NCT01539811|1033807|P2|COMPLETED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
421560|NCT01539811|1033808|P1|COMPLETED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
421561|NCT01539811|1033807|P2|STARTED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
421562|NCT01539811|1033808|P1|STARTED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
421563|NCT01539759|1033816|P2|NOT COMPLETED|Overall Study||8
421564|NCT01539759|1033817|P1|NOT COMPLETED|Overall Study||6
421565|NCT01539759|1033816|P2|COMPLETED|Overall Study||48
421566|NCT01539759|1033817|P1|COMPLETED|Overall Study||50
421567|NCT01539759|1033816|P2|IUD in Place at 6 Months Posptartum|Overall Study||40
421568|NCT01539759|1033817|P1|IUD in Place at 6 Months Posptartum|Overall Study||32
421569|NCT01539759|1033816|P2|IUD Removal|Overall Study||7
421570|NCT01539759|1033817|P1|IUD Removal|Overall Study||2
421571|NCT01539759|1033816|P2|IUD Expulsion|Overall Study||4
421572|NCT01539759|1033817|P1|IUD Expulsion|Overall Study||1
421573|NCT01539759|1033816|P2|Had Successful IUD Placement|Overall Study||53
421574|NCT01539759|1033817|P1|Had Successful IUD Placement|Overall Study||34
421575|NCT01539759|1033816|P2|STARTED|Overall Study||56
421576|NCT01539759|1033817|P1|STARTED|Overall Study||56
421577|NCT01539642|1033829|P2|NOT COMPLETED|Overall Study||31
421578|NCT01539642|1033830|P1|NOT COMPLETED|Overall Study||36
421579|NCT01539642|1033829|P2|COMPLETED|Overall Study||27
421580|NCT01539642|1033830|P1|COMPLETED|Overall Study||78
421581|NCT01539642|1033829|P2|STARTED|Overall Study||58
421582|NCT01539642|1033830|P1|STARTED|Overall Study||114
421583|NCT01539590|1033838|P2|NOT COMPLETED|Overall Study||0
421584|NCT01539590|1033839|P1|NOT COMPLETED|Overall Study||3
421585|NCT01539590|1033838|P2|COMPLETED|Overall Study||2
421586|NCT01539590|1033839|P1|COMPLETED|Overall Study||0
421587|NCT01539590|1033838|P2|Complete Study Treatment|Overall Study||2
421588|NCT01539590|1033839|P1|Complete Study Treatment|Overall Study||1
421589|NCT01539590|1033838|P2|STARTED|Overall Study||2
421590|NCT01539590|1033839|P1|STARTED|Overall Study||3
421591|NCT01539538|1033847|P2|NOT COMPLETED|Overall Study||44
421592|NCT01539538|1033848|P1|NOT COMPLETED|Overall Study||31
421593|NCT01539538|1033847|P2|COMPLETED|Overall Study||136
421594|NCT01539538|1033848|P1|COMPLETED|Overall Study||146
421595|NCT01539538|1033847|P2|STARTED|Overall Study||180
421596|NCT01539538|1033848|P1|STARTED|Overall Study||177
421597|NCT01539525|1033857|P3|NOT COMPLETED|Overall Study||17
421598|NCT01539525|1033858|P2|NOT COMPLETED|Overall Study||16
421599|NCT01539525|1033859|P1|NOT COMPLETED|Overall Study||20
421600|NCT01539525|1033857|P3|COMPLETED|Overall Study||134
421601|NCT01539525|1033858|P2|COMPLETED|Overall Study||127
421602|NCT01539525|1033859|P1|COMPLETED|Overall Study||125
421603|NCT01539525|1033857|P3|STARTED|Overall Study||151
421604|NCT01539525|1033858|P2|STARTED|Overall Study||143
421605|NCT01539525|1033859|P1|STARTED|Overall Study||145
421606|NCT01539512|1033878|P2|NOT COMPLETED|Overall Study||13
421607|NCT01539512|1033879|P1|NOT COMPLETED|Overall Study||23
421608|NCT01539512|1033878|P2|COMPLETED|Overall Study|Completed=reached primary efficacy endpoint (progressive disease or death) or finished study period.|97
421609|NCT01539512|1033879|P1|COMPLETED|Overall Study|Completed=reached primary efficacy endpoint (progressive disease or death) or finished study period.|87
421610|NCT01539512|1033878|P2|STARTED|Overall Study||110
421611|NCT01539512|1033879|P1|STARTED|Overall Study||110
421612|NCT01539317|1033895|P2|NOT COMPLETED|Overall Study||0
421613|NCT01539317|1033896|P1|NOT COMPLETED|Overall Study||1
421614|NCT01539317|1033895|P2|COMPLETED|Overall Study||25
421615|NCT01539317|1033896|P1|COMPLETED|Overall Study||24
421616|NCT01539317|1033895|P2|STARTED|Overall Study||25
421617|NCT01539317|1033896|P1|STARTED|Overall Study||25
421618|NCT01539135|1033913|P2|NOT COMPLETED|Overall Study||0
421619|NCT01539135|1033914|P1|NOT COMPLETED|Overall Study||0
421620|NCT01539135|1033913|P2|COMPLETED|Overall Study||37
421621|NCT01539135|1033914|P1|COMPLETED|Overall Study||43
421622|NCT01539135|1033913|P2|STARTED|Overall Study||37
421623|NCT01539135|1033914|P1|STARTED|Overall Study||43
421624|NCT01539083|1033926|P3|NOT COMPLETED|After Randomization (TP and VTP)||11
421625|NCT01539083|1033927|P2|NOT COMPLETED|After Randomization (TP and VTP)||13
421626|NCT01539083|1033928|P1|NOT COMPLETED|After Randomization (TP and VTP)||0
421627|NCT01539083|1033926|P3|COMPLETED|After Randomization (TP and VTP)||92
421628|NCT01539083|1033927|P2|COMPLETED|After Randomization (TP and VTP)||87
421629|NCT01539083|1033928|P1|COMPLETED|After Randomization (TP and VTP)||0
421630|NCT01539083|1033926|P3|Safety Population|After Randomization (TP and VTP)||103
421631|NCT01539083|1033927|P2|Safety Population|After Randomization (TP and VTP)|One participant was randomized but not treated. Hence, was not included in safety population.|99
421632|NCT01539083|1033928|P1|Safety Population|After Randomization (TP and VTP)||0
421633|NCT01539083|1033926|P3|STARTED|After Randomization (TP and VTP)|Participants who completed induction phase were randomized for the consolidated treatment.|103
421634|NCT01539083|1033927|P2|STARTED|After Randomization (TP and VTP)|Participants who completed induction phase were randomized for the consolidated treatment.|100
421635|NCT01539083|1033928|P1|STARTED|After Randomization (TP and VTP)||0
421636|NCT01539083|1033926|P3|NOT COMPLETED|Before Randomization (VCD Induction)||0
421637|NCT01539083|1033927|P2|NOT COMPLETED|Before Randomization (VCD Induction)||0
421638|NCT01539083|1033928|P1|NOT COMPLETED|Before Randomization (VCD Induction)||53
421639|NCT01539083|1033926|P3|COMPLETED|Before Randomization (VCD Induction)||0
421640|NCT01539083|1033927|P2|COMPLETED|Before Randomization (VCD Induction)||0
421641|NCT01539083|1033928|P1|COMPLETED|Before Randomization (VCD Induction)||203
421642|NCT01539083|1033926|P3|Treated|Before Randomization (VCD Induction)||0
421643|NCT01539083|1033927|P2|Treated|Before Randomization (VCD Induction)||0
421644|NCT01539083|1033928|P1|Treated|Before Randomization (VCD Induction)||254
421645|NCT01539083|1033926|P3|STARTED|Before Randomization (VCD Induction)||0
421646|NCT01539083|1033927|P2|STARTED|Before Randomization (VCD Induction)||0
421647|NCT01539083|1033928|P1|STARTED|Before Randomization (VCD Induction)||256
421648|NCT01539070|1033951|P2|NOT COMPLETED|Overall Study||39
421649|NCT01539070|1033952|P1|NOT COMPLETED|Overall Study||59
421650|NCT01539070|1033951|P2|COMPLETED|Overall Study||99
421651|NCT01539070|1033952|P1|COMPLETED|Overall Study||109
421652|NCT01539070|1033951|P2|STARTED|Overall Study||138
421653|NCT01539070|1033952|P1|STARTED|Overall Study||168
421654|NCT01538862|1033964|P1|NOT COMPLETED|Overall Study||0
421655|NCT01538862|1033964|P1|COMPLETED|Overall Study||7
421656|NCT01538862|1033964|P1|STARTED|Overall Study||7
421657|NCT01538719|1033972|P2|NOT COMPLETED|Overall Study||0
421658|NCT01538719|1033973|P1|NOT COMPLETED|Overall Study||2
421659|NCT01538719|1033972|P2|COMPLETED|Overall Study||12
421660|NCT01538719|1033973|P1|COMPLETED|Overall Study||5
421661|NCT01538719|1033972|P2|STARTED|Overall Study||12
421662|NCT01538719|1033973|P1|STARTED|Overall Study||7
421663|NCT01538615|1033983|P2|NOT COMPLETED|Overall Study||12
421664|NCT01538615|1033984|P1|NOT COMPLETED|Overall Study||22
421665|NCT01538615|1033983|P2|COMPLETED|Overall Study||146
421666|NCT01538615|1033984|P1|COMPLETED|Overall Study||140
421667|NCT01538615|1033983|P2|STARTED|Overall Study||158
421668|NCT01538615|1033984|P1|STARTED|Overall Study||162
421669|NCT01538472|1033996|P1|NOT COMPLETED|Overall Study||4
421670|NCT01538472|1033996|P1|COMPLETED|Overall Study||36
421671|NCT01538472|1033996|P1|STARTED|Overall Study||40
421672|NCT01538199|1034007|P4|NOT COMPLETED|Overall Study||2
421673|NCT01538199|1034008|P3|NOT COMPLETED|Overall Study||1
421674|NCT01538199|1034009|P2|NOT COMPLETED|Overall Study||3
421675|NCT01538199|1034010|P1|NOT COMPLETED|Overall Study||2
421676|NCT01538199|1034007|P4|COMPLETED|Overall Study|Completer excluded from analyses because determined to be not eligible at end of study.|1
421677|NCT01538199|1034008|P3|COMPLETED|Overall Study|1 non-completer included in analyses because only missed follow up, completed all treatment visits.|3
421678|NCT01538199|1034009|P2|COMPLETED|Overall Study|"1 completed study but was excluded as a completer from analyses because started a new treatment"|8
421679|NCT01538199|1034010|P1|COMPLETED|Overall Study|"1 completed study but was excluded as a completer from analyses because started a new treatment"|8
421680|NCT01538199|1034007|P4|STARTED|Overall Study||3
421681|NCT01538199|1034008|P3|STARTED|Overall Study||4
421682|NCT01538199|1034009|P2|STARTED|Overall Study||11
421683|NCT01538199|1034010|P1|STARTED|Overall Study||10
421684|NCT01537900|1034033|P1|NOT COMPLETED|Overall Study||0
421685|NCT01537900|1034033|P1|COMPLETED|Overall Study||4
421686|NCT01537900|1034033|P1|STARTED|Overall Study||4
421687|NCT01537835|1034047|P3|NOT COMPLETED|Overall Study||0
421688|NCT01537835|1034048|P2|NOT COMPLETED|Overall Study||0
421689|NCT01537835|1034049|P1|NOT COMPLETED|Overall Study||0
421690|NCT01537835|1034047|P3|COMPLETED|Overall Study||35
421691|NCT01537835|1034048|P2|COMPLETED|Overall Study||37
421692|NCT01537835|1034049|P1|COMPLETED|Overall Study||37
421693|NCT01537835|1034047|P3|STARTED|Overall Study||35
421694|NCT01537835|1034048|P2|STARTED|Overall Study||37
421695|NCT01537835|1034049|P1|STARTED|Overall Study||37
421696|NCT01537783|1034062|P2|NOT COMPLETED|Overall Study||2
421697|NCT01537783|1034063|P1|NOT COMPLETED|Overall Study||11
421698|NCT01537783|1034062|P2|COMPLETED|Overall Study||23
421699|NCT01537783|1034063|P1|COMPLETED|Overall Study||14
421700|NCT01537783|1034062|P2|STARTED|Overall Study||25
421701|NCT01537783|1034063|P1|STARTED|Overall Study||25
421702|NCT01537666|1034073|P4|NOT COMPLETED|Overall Study||0
421703|NCT01537666|1034074|P3|NOT COMPLETED|Overall Study||0
421704|NCT01537666|1034075|P2|NOT COMPLETED|Overall Study||0
421705|NCT01537666|1034076|P1|NOT COMPLETED|Overall Study||0
421706|NCT01537666|1034073|P4|COMPLETED|Overall Study|1 patient withdrew after a 32 mg dose and was replaced by a patient who only received an 80 mg dose.|7
421707|NCT01537666|1034074|P3|COMPLETED|Overall Study||6
421708|NCT01537666|1034075|P2|COMPLETED|Overall Study||6
421709|NCT01537666|1034076|P1|COMPLETED|Overall Study||6
421710|NCT01537666|1034073|P4|STARTED|Overall Study|5 of 7 patients received a 32 mg dose of AeroVanc followed by a dose of 80 mg at least 1 week later.|7
421711|NCT01537666|1034074|P3|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
421712|NCT01537666|1034075|P2|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
421713|NCT01537666|1034076|P1|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
421714|NCT01537549|1034114|P1|NOT COMPLETED|Overall Study||3
421715|NCT01537549|1034114|P1|COMPLETED|Overall Study||8
421716|NCT01537549|1034114|P1|STARTED|Overall Study||11
421717|NCT01537432|1034122|P2|NOT COMPLETED|Overall Study||2
421718|NCT01537432|1034123|P1|NOT COMPLETED|Overall Study||6
421719|NCT01537432|1034122|P2|COMPLETED|Overall Study||10
421720|NCT01537432|1034123|P1|COMPLETED|Overall Study||18
421721|NCT01537432|1034122|P2|STARTED|Overall Study||12
421722|NCT01537432|1034123|P1|STARTED|Overall Study||24
421723|NCT01537419|1034133|P2|NOT COMPLETED|Overall Study||12
421724|NCT01537419|1034134|P1|NOT COMPLETED|Overall Study||11
421725|NCT01537419|1034133|P2|COMPLETED|Overall Study||54
421726|NCT01537419|1034134|P1|COMPLETED|Overall Study||52
421727|NCT01537419|1034133|P2|STARTED|Overall Study||66
421728|NCT01537419|1034134|P1|STARTED|Overall Study||63
421729|NCT01537393|1034146|P2|NOT COMPLETED|Overall Study||191
421730|NCT01537393|1034147|P1|NOT COMPLETED|Overall Study||154
421731|NCT01537393|1034146|P2|COMPLETED|Overall Study||507
421732|NCT01537393|1034147|P1|COMPLETED|Overall Study||553
421733|NCT01537393|1034146|P2|STARTED|Overall Study||698
421734|NCT01537393|1034147|P1|STARTED|Overall Study||707
421735|NCT01537367|1034158|P3|NOT COMPLETED|Overall Study||0
421736|NCT01537367|1034159|P2|NOT COMPLETED|Overall Study||0
421737|NCT01537367|1034160|P1|NOT COMPLETED|Overall Study||0
421738|NCT01537367|1034158|P3|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|613
421739|NCT01537367|1034159|P2|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|610
421740|NCT01537367|1034160|P1|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|615
421741|NCT01537367|1034158|P3|STARTED|Overall Study||613
421742|NCT01537367|1034159|P2|STARTED|Overall Study||610
421743|NCT01537367|1034160|P1|STARTED|Overall Study||615
421744|NCT01537315|1034176|P2|NOT COMPLETED|Overall Study||0
421745|NCT01537315|1034177|P1|NOT COMPLETED|Overall Study||0
421746|NCT01537315|1034176|P2|COMPLETED|Overall Study||7
421747|NCT01537315|1034177|P1|COMPLETED|Overall Study||1
421748|NCT01537315|1034176|P2|STARTED|Overall Study||7
421749|NCT01537315|1034177|P1|STARTED|Overall Study||1
421750|NCT01537302|1034183|P1|NOT COMPLETED|Overall Study||2
421751|NCT01537302|1034183|P1|COMPLETED|Overall Study||199
421752|NCT01537302|1034183|P1|STARTED|Overall Study||201
421753|NCT01537198|1034190|P1|NOT COMPLETED|Overall Study||154
421754|NCT01537198|1034190|P1|COMPLETED|Overall Study||463
421755|NCT01537198|1034190|P1|STARTED|Overall Study||617
421756|NCT01537185|1034198|P4|NOT COMPLETED|Overall Study||2
421757|NCT01537185|1034199|P3|NOT COMPLETED|Overall Study||6
421758|NCT01537185|1034200|P2|NOT COMPLETED|Overall Study||6
421759|NCT01537185|1034201|P1|NOT COMPLETED|Overall Study||3
421760|NCT01537185|1034198|P4|COMPLETED|Overall Study||8
421761|NCT01537185|1034199|P3|COMPLETED|Overall Study||4
421762|NCT01537185|1034200|P2|COMPLETED|Overall Study||6
421763|NCT01537185|1034201|P1|COMPLETED|Overall Study||7
421764|NCT01537185|1034198|P4|STARTED|Overall Study||10
421765|NCT01537185|1034199|P3|STARTED|Overall Study||10
421766|NCT01537185|1034200|P2|STARTED|Overall Study||12
421767|NCT01537185|1034201|P1|STARTED|Overall Study||10
421768|NCT01537133|1034219|P4|NOT COMPLETED|Overall Study||0
421769|NCT01537133|1034220|P3|NOT COMPLETED|Overall Study||0
421770|NCT01537133|1034221|P2|NOT COMPLETED|Overall Study||0
421771|NCT01537133|1034222|P1|NOT COMPLETED|Overall Study||3
421772|NCT01537133|1034219|P4|COMPLETED|Overall Study||21
421773|NCT01537133|1034220|P3|COMPLETED|Overall Study||21
421774|NCT01537133|1034221|P2|COMPLETED|Overall Study||14
421775|NCT01537133|1034222|P1|COMPLETED|Overall Study||25
421776|NCT01537133|1034219|P4|STARTED|Overall Study||21
421777|NCT01537133|1034220|P3|STARTED|Overall Study||21
421778|NCT01537133|1034221|P2|STARTED|Overall Study||14
421779|NCT01537133|1034222|P1|STARTED|Overall Study||28
421780|NCT01537120|1034238|P1|NOT COMPLETED|12 Weeks Vildagliptin||0
421781|NCT01537120|1034238|P1|COMPLETED|12 Weeks Vildagliptin||23
421782|NCT01537120|1034238|P1|STARTED|12 Weeks Vildagliptin||23
421783|NCT01537120|1034238|P1|NOT COMPLETED|3 Weeks Placebo||1
421784|NCT01537120|1034238|P1|COMPLETED|3 Weeks Placebo||23
421785|NCT01537120|1034238|P1|STARTED|3 Weeks Placebo||24
421786|NCT01537120|1034238|P1|NOT COMPLETED|8 Weeks Washout||1
421787|NCT01537120|1034238|P1|COMPLETED|8 Weeks Washout||24
421788|NCT01537120|1034238|P1|STARTED|8 Weeks Washout||25
421789|NCT01537120|1034238|P1|NOT COMPLETED|Enrolled||0
421790|NCT01537120|1034238|P1|COMPLETED|Enrolled||25
421791|NCT01537120|1034238|P1|STARTED|Enrolled||25
421792|NCT01537081|1034251|P3|NOT COMPLETED|Overall Study||16
421793|NCT01537081|1034252|P2|NOT COMPLETED|Overall Study||38
421794|NCT01537081|1034253|P1|NOT COMPLETED|Overall Study||39
421795|NCT01537081|1034251|P3|COMPLETED|Overall Study||547
421796|NCT01537081|1034252|P2|COMPLETED|Overall Study||1086
421797|NCT01537081|1034253|P1|COMPLETED|Overall Study||1084
421798|NCT01537081|1034251|P3|Modified Intent to Treat Population|Overall Study||556
421799|NCT01537081|1034252|P2|Modified Intent to Treat Population|Overall Study||1109
421800|NCT01537081|1034253|P1|Modified Intent to Treat Population|Overall Study||1106
421801|NCT01537081|1034251|P3|Safety Population|Overall Study||561
421802|NCT01537081|1034252|P2|Safety Population|Overall Study||1122
421803|NCT01537081|1034253|P1|Safety Population|Overall Study||1122
421804|NCT01537081|1034251|P3|STARTED|Overall Study||563
421805|NCT01537081|1034252|P2|STARTED|Overall Study||1124
421806|NCT01537081|1034253|P1|STARTED|Overall Study||1123
421807|NCT01537068|1034266|P2|NOT COMPLETED|Overall Study||3
421808|NCT01537068|1034267|P1|NOT COMPLETED|Overall Study||4
421809|NCT01537068|1034266|P2|COMPLETED|Overall Study||26
421810|NCT01537068|1034267|P1|COMPLETED|Overall Study||26
421811|NCT01537068|1034266|P2|STARTED|Overall Study||29
421812|NCT01537068|1034267|P1|STARTED|Overall Study||30
421813|NCT01537042|1034279|P2|NOT COMPLETED|Overall Study||5
421814|NCT01537042|1034280|P1|NOT COMPLETED|Overall Study||0
421815|NCT01537042|1034279|P2|COMPLETED|Overall Study||15
421816|NCT01537042|1034280|P1|COMPLETED|Overall Study||10
421817|NCT01537042|1034279|P2|STARTED|Overall Study||20
421818|NCT01537042|1034280|P1|STARTED|Overall Study||10
421819|NCT01536951|1034318|P9|NOT COMPLETED|Third Intervention||0
421820|NCT01536951|1034319|P8|NOT COMPLETED|Third Intervention||0
421821|NCT01536951|1034320|P7|NOT COMPLETED|Third Intervention||0
421822|NCT01536951|1034321|P6|NOT COMPLETED|Third Intervention||0
421823|NCT01536951|1034322|P5|NOT COMPLETED|Third Intervention||0
421824|NCT01536951|1034323|P4|NOT COMPLETED|Third Intervention||0
421825|NCT01536951|1034324|P3|NOT COMPLETED|Third Intervention||0
421826|NCT01536951|1034325|P2|NOT COMPLETED|Third Intervention||0
421827|NCT01536951|1034326|P1|NOT COMPLETED|Third Intervention||0
421828|NCT01536951|1034318|P9|COMPLETED|Third Intervention||9
421829|NCT01536951|1034319|P8|COMPLETED|Third Intervention||8
421830|NCT01536951|1034320|P7|COMPLETED|Third Intervention||9
421831|NCT01536951|1034321|P6|COMPLETED|Third Intervention||9
421832|NCT01536951|1034322|P5|COMPLETED|Third Intervention||9
421833|NCT01536951|1034323|P4|COMPLETED|Third Intervention||8
421834|NCT01536951|1034324|P3|COMPLETED|Third Intervention||2
421835|NCT01536951|1034325|P2|COMPLETED|Third Intervention||3
421836|NCT01536951|1034326|P1|COMPLETED|Third Intervention||3
421837|NCT01536951|1034318|P9|STARTED|Third Intervention||9
421838|NCT01536951|1034319|P8|STARTED|Third Intervention||8
421839|NCT01536951|1034320|P7|STARTED|Third Intervention||9
421840|NCT01536951|1034321|P6|STARTED|Third Intervention||9
421841|NCT01536951|1034322|P5|STARTED|Third Intervention||9
421842|NCT01536951|1034323|P4|STARTED|Third Intervention||8
421843|NCT01536951|1034324|P3|STARTED|Third Intervention||2
421844|NCT01536951|1034325|P2|STARTED|Third Intervention||3
421845|NCT01536951|1034326|P1|STARTED|Third Intervention||3
421846|NCT01536951|1034318|P9|NOT COMPLETED|Second Intervention and Washout Period 2||0
421847|NCT01536951|1034319|P8|NOT COMPLETED|Second Intervention and Washout Period 2||1
421848|NCT01536951|1034320|P7|NOT COMPLETED|Second Intervention and Washout Period 2||0
421849|NCT01536951|1034321|P6|NOT COMPLETED|Second Intervention and Washout Period 2||0
421850|NCT01536951|1034322|P5|NOT COMPLETED|Second Intervention and Washout Period 2||0
421851|NCT01536951|1034323|P4|NOT COMPLETED|Second Intervention and Washout Period 2||0
421852|NCT01536951|1034324|P3|NOT COMPLETED|Second Intervention and Washout Period 2||0
421853|NCT01536951|1034325|P2|NOT COMPLETED|Second Intervention and Washout Period 2||0
421854|NCT01536951|1034326|P1|NOT COMPLETED|Second Intervention and Washout Period 2||0
421855|NCT01536951|1034318|P9|COMPLETED|Second Intervention and Washout Period 2||9
421856|NCT01536951|1034319|P8|COMPLETED|Second Intervention and Washout Period 2||8
421857|NCT01536951|1034320|P7|COMPLETED|Second Intervention and Washout Period 2||9
421858|NCT01536951|1034321|P6|COMPLETED|Second Intervention and Washout Period 2||9
421859|NCT01536951|1034322|P5|COMPLETED|Second Intervention and Washout Period 2||9
421860|NCT01536951|1034323|P4|COMPLETED|Second Intervention and Washout Period 2||8
421861|NCT01536951|1034324|P3|COMPLETED|Second Intervention and Washout Period 2||2
421862|NCT01536951|1034325|P2|COMPLETED|Second Intervention and Washout Period 2||3
421863|NCT01536951|1034326|P1|COMPLETED|Second Intervention and Washout Period 2||3
421864|NCT01536951|1034318|P9|STARTED|Second Intervention and Washout Period 2||9
421865|NCT01536951|1034319|P8|STARTED|Second Intervention and Washout Period 2||9
421866|NCT01536951|1034320|P7|STARTED|Second Intervention and Washout Period 2||9
421867|NCT01536951|1034321|P6|STARTED|Second Intervention and Washout Period 2||9
421868|NCT01536951|1034322|P5|STARTED|Second Intervention and Washout Period 2||9
421869|NCT01536951|1034323|P4|STARTED|Second Intervention and Washout Period 2||8
421870|NCT01536951|1034324|P3|STARTED|Second Intervention and Washout Period 2||2
421871|NCT01536951|1034325|P2|STARTED|Second Intervention and Washout Period 2||3
421872|NCT01536951|1034326|P1|STARTED|Second Intervention and Washout Period 2||3
421873|NCT01536951|1034318|P9|NOT COMPLETED|First Intervention and Washout Period 1||0
421874|NCT01536951|1034319|P8|NOT COMPLETED|First Intervention and Washout Period 1||0
421875|NCT01536951|1034320|P7|NOT COMPLETED|First Intervention and Washout Period 1||0
421876|NCT01536951|1034321|P6|NOT COMPLETED|First Intervention and Washout Period 1||0
421877|NCT01536951|1034322|P5|NOT COMPLETED|First Intervention and Washout Period 1||0
421878|NCT01536951|1034323|P4|NOT COMPLETED|First Intervention and Washout Period 1||0
421879|NCT01536951|1034324|P3|NOT COMPLETED|First Intervention and Washout Period 1||1
421880|NCT01536951|1034325|P2|NOT COMPLETED|First Intervention and Washout Period 1||0
421881|NCT01536951|1034326|P1|NOT COMPLETED|First Intervention and Washout Period 1||0
421882|NCT01536951|1034318|P9|COMPLETED|First Intervention and Washout Period 1||9
421883|NCT01536951|1034319|P8|COMPLETED|First Intervention and Washout Period 1||9
421884|NCT01536951|1034320|P7|COMPLETED|First Intervention and Washout Period 1||9
421885|NCT01536951|1034321|P6|COMPLETED|First Intervention and Washout Period 1||9
421886|NCT01536951|1034322|P5|COMPLETED|First Intervention and Washout Period 1||9
421887|NCT01536951|1034323|P4|COMPLETED|First Intervention and Washout Period 1||8
421888|NCT01536951|1034324|P3|COMPLETED|First Intervention and Washout Period 1||2
421889|NCT01536951|1034325|P2|COMPLETED|First Intervention and Washout Period 1||3
421890|NCT01536951|1034326|P1|COMPLETED|First Intervention and Washout Period 1||3
421891|NCT01536951|1034318|P9|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
421892|NCT01536951|1034319|P8|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
421893|NCT01536951|1034320|P7|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
421894|NCT01536951|1034321|P6|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
421895|NCT01536951|1034322|P5|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
421896|NCT01536951|1034323|P4|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||8
421897|NCT01536951|1034324|P3|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3
421898|NCT01536951|1034325|P2|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3
421899|NCT01536951|1034326|P1|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1|Across all reporting groups, study drug is LY3009104, moxifloxacin, or placebo.|3
421900|NCT01536951|1034318|P9|STARTED|First Intervention and Washout Period 1||9
421901|NCT01536951|1034319|P8|STARTED|First Intervention and Washout Period 1||9
421902|NCT01536951|1034320|P7|STARTED|First Intervention and Washout Period 1||9
421903|NCT01536951|1034321|P6|STARTED|First Intervention and Washout Period 1||9
421904|NCT01536951|1034322|P5|STARTED|First Intervention and Washout Period 1||9
421905|NCT01536951|1034323|P4|STARTED|First Intervention and Washout Period 1||8
421906|NCT01536951|1034324|P3|STARTED|First Intervention and Washout Period 1||3
421907|NCT01536951|1034325|P2|STARTED|First Intervention and Washout Period 1||3
421908|NCT01536951|1034326|P1|STARTED|First Intervention and Washout Period 1||3
421909|NCT01536938|1034356|P3|NOT COMPLETED|Overall Study||8
421910|NCT01536938|1034357|P2|NOT COMPLETED|Overall Study||7
421911|NCT01536938|1034358|P1|NOT COMPLETED|Overall Study||6
421912|NCT01536938|1034356|P3|COMPLETED|Overall Study||93
421913|NCT01536938|1034357|P2|COMPLETED|Overall Study||94
421914|NCT01536938|1034358|P1|COMPLETED|Overall Study||94
421915|NCT01536938|1034356|P3|STARTED|Overall Study||101
421916|NCT01536938|1034357|P2|STARTED|Overall Study||101
421917|NCT01536938|1034358|P1|STARTED|Overall Study||100
421918|NCT01536886|1034370|P4|NOT COMPLETED|Overall Study||3
421919|NCT01536886|1034371|P3|NOT COMPLETED|Overall Study||2
421920|NCT01536886|1034372|P2|NOT COMPLETED|Overall Study||8
421921|NCT01536886|1034373|P1|NOT COMPLETED|Overall Study||5
421922|NCT01536886|1034370|P4|COMPLETED|Overall Study||48
421923|NCT01536886|1034371|P3|COMPLETED|Overall Study||47
421924|NCT01536886|1034372|P2|COMPLETED|Overall Study||127
421925|NCT01536886|1034373|P1|COMPLETED|Overall Study||136
421926|NCT01536886|1034370|P4|STARTED|Overall Study||51
421927|NCT01536886|1034371|P3|STARTED|Overall Study||49
421928|NCT01536886|1034372|P2|STARTED|Overall Study||135
421929|NCT01536886|1034373|P1|STARTED|Overall Study||141
421930|NCT01536860|1034383|P3|NOT COMPLETED|Third Intervention (1 Day)||0
421931|NCT01536860|1034384|P2|NOT COMPLETED|Third Intervention (1 Day)||0
421932|NCT01536860|1034385|P1|NOT COMPLETED|Third Intervention (1 Day)||0
421933|NCT01536860|1034383|P3|COMPLETED|Third Intervention (1 Day)||4
421934|NCT01536860|1034384|P2|COMPLETED|Third Intervention (1 Day)||4
421935|NCT01536860|1034385|P1|COMPLETED|Third Intervention (1 Day)||3
421936|NCT01536860|1034383|P3|STARTED|Third Intervention (1 Day)||4
421937|NCT01536860|1034384|P2|STARTED|Third Intervention (1 Day)||4
421938|NCT01536860|1034385|P1|STARTED|Third Intervention (1 Day)||3
421939|NCT01536860|1034383|P3|NOT COMPLETED|Washout Period (3 Days)||0
421940|NCT01536860|1034384|P2|NOT COMPLETED|Washout Period (3 Days)||0
421941|NCT01536860|1034385|P1|NOT COMPLETED|Washout Period (3 Days)||1
421942|NCT01536860|1034383|P3|COMPLETED|Washout Period (3 Days)||4
421943|NCT01536860|1034384|P2|COMPLETED|Washout Period (3 Days)||4
421944|NCT01536860|1034385|P1|COMPLETED|Washout Period (3 Days)||3
421945|NCT01536860|1034383|P3|STARTED|Washout Period (3 Days)||4
421946|NCT01536860|1034384|P2|STARTED|Washout Period (3 Days)||4
421947|NCT01536860|1034385|P1|STARTED|Washout Period (3 Days)||4
421948|NCT01536860|1034383|P3|NOT COMPLETED|Second Intervention (1 Day)||0
421949|NCT01536860|1034384|P2|NOT COMPLETED|Second Intervention (1 Day)||0
421950|NCT01536860|1034385|P1|NOT COMPLETED|Second Intervention (1 Day)||0
421951|NCT01536860|1034383|P3|COMPLETED|Second Intervention (1 Day)||4
421952|NCT01536860|1034384|P2|COMPLETED|Second Intervention (1 Day)||4
421953|NCT01536860|1034385|P1|COMPLETED|Second Intervention (1 Day)||4
421954|NCT01536860|1034383|P3|STARTED|Second Intervention (1 Day)||4
421955|NCT01536860|1034384|P2|STARTED|Second Intervention (1 Day)||4
421956|NCT01536860|1034385|P1|STARTED|Second Intervention (1 Day)||4
421957|NCT01536860|1034383|P3|NOT COMPLETED|Washout Period (3 Days)||0
421958|NCT01536860|1034384|P2|NOT COMPLETED|Washout Period (3 Days)||0
421959|NCT01536860|1034385|P1|NOT COMPLETED|Washout Period (3 Days)||0
421960|NCT01536860|1034383|P3|COMPLETED|Washout Period (3 Days)||4
421961|NCT01536860|1034384|P2|COMPLETED|Washout Period (3 Days)||4
421962|NCT01536860|1034385|P1|COMPLETED|Washout Period (3 Days)||4
421963|NCT01536860|1034383|P3|STARTED|Washout Period (3 Days)||4
421964|NCT01536860|1034384|P2|STARTED|Washout Period (3 Days)||4
421965|NCT01536860|1034385|P1|STARTED|Washout Period (3 Days)||4
421966|NCT01536860|1034383|P3|NOT COMPLETED|First Intervention (1 Day)||0
421967|NCT01536860|1034384|P2|NOT COMPLETED|First Intervention (1 Day)||0
421968|NCT01536860|1034385|P1|NOT COMPLETED|First Intervention (1 Day)||0
421969|NCT01536860|1034383|P3|COMPLETED|First Intervention (1 Day)||4
421970|NCT01536860|1034384|P2|COMPLETED|First Intervention (1 Day)||4
421971|NCT01536860|1034385|P1|COMPLETED|First Intervention (1 Day)||4
421972|NCT01536860|1034383|P3|STARTED|First Intervention (1 Day)||4
421973|NCT01536860|1034384|P2|STARTED|First Intervention (1 Day)||4
421974|NCT01536860|1034385|P1|STARTED|First Intervention (1 Day)||4
421975|NCT01536704|1034393|P4|NOT COMPLETED|Period 4||0
421976|NCT01536704|1034394|P3|NOT COMPLETED|Period 4||0
421977|NCT01536704|1034395|P2|NOT COMPLETED|Period 4||0
421978|NCT01536704|1034396|P1|NOT COMPLETED|Period 4||0
421979|NCT01536704|1034393|P4|COMPLETED|Period 4||10
421980|NCT01536704|1034394|P3|COMPLETED|Period 4||10
421981|NCT01536704|1034395|P2|COMPLETED|Period 4||11
421982|NCT01536704|1034396|P1|COMPLETED|Period 4||12
421983|NCT01536704|1034393|P4|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
421984|NCT01536704|1034394|P3|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
421985|NCT01536704|1034395|P2|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
421986|NCT01536704|1034396|P1|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|12
421987|NCT01536704|1034393|P4|NOT COMPLETED|Washout Period 3||0
421988|NCT01536704|1034394|P3|NOT COMPLETED|Washout Period 3||1
421989|NCT01536704|1034395|P2|NOT COMPLETED|Washout Period 3||0
421990|NCT01536704|1034396|P1|NOT COMPLETED|Washout Period 3||0
421991|NCT01536704|1034393|P4|COMPLETED|Washout Period 3||10
421992|NCT01536704|1034394|P3|COMPLETED|Washout Period 3||11
421993|NCT01536704|1034395|P2|COMPLETED|Washout Period 3||12
421994|NCT01536704|1034396|P1|COMPLETED|Washout Period 3||10
421995|NCT01536704|1034393|P4|STARTED|Washout Period 3||10
421996|NCT01536704|1034394|P3|STARTED|Washout Period 3||12
421997|NCT01536704|1034395|P2|STARTED|Washout Period 3||12
421998|NCT01536704|1034396|P1|STARTED|Washout Period 3||10
421999|NCT01536704|1034393|P4|NOT COMPLETED|Period 3||1
422000|NCT01536704|1034394|P3|NOT COMPLETED|Period 3||0
422001|NCT01536704|1034395|P2|NOT COMPLETED|Period 3||0
422002|NCT01536704|1034396|P1|NOT COMPLETED|Period 3||0
422003|NCT01536704|1034393|P4|COMPLETED|Period 3||10
422004|NCT01536704|1034394|P3|COMPLETED|Period 3||12
422005|NCT01536704|1034395|P2|COMPLETED|Period 3||12
422006|NCT01536704|1034396|P1|COMPLETED|Period 3||10
422007|NCT01536704|1034393|P4|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|11
422008|NCT01536704|1034394|P3|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
422009|NCT01536704|1034395|P2|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
422010|NCT01536704|1034396|P1|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|10
422011|NCT01536704|1034393|P4|NOT COMPLETED|Washout Period 2||1
422012|NCT01536704|1034394|P3|NOT COMPLETED|Washout Period 2||0
422013|NCT01536704|1034395|P2|NOT COMPLETED|Washout Period 2||0
422014|NCT01536704|1034396|P1|NOT COMPLETED|Washout Period 2||1
422015|NCT01536704|1034393|P4|COMPLETED|Washout Period 2||12
422016|NCT01536704|1034394|P3|COMPLETED|Washout Period 2||10
422017|NCT01536704|1034395|P2|COMPLETED|Washout Period 2||11
422018|NCT01536704|1034396|P1|COMPLETED|Washout Period 2||12
422019|NCT01536704|1034393|P4|STARTED|Washout Period 2||13
422020|NCT01536704|1034394|P3|STARTED|Washout Period 2||10
422021|NCT01536704|1034395|P2|STARTED|Washout Period 2||11
422022|NCT01536704|1034396|P1|STARTED|Washout Period 2||13
422023|NCT01536704|1034393|P4|NOT COMPLETED|Period 2||0
422024|NCT01536704|1034394|P3|NOT COMPLETED|Period 2||0
422025|NCT01536704|1034395|P2|NOT COMPLETED|Period 2||0
422026|NCT01536704|1034396|P1|NOT COMPLETED|Period 2||0
422027|NCT01536704|1034393|P4|COMPLETED|Period 2||13
422028|NCT01536704|1034394|P3|COMPLETED|Period 2||10
422029|NCT01536704|1034395|P2|COMPLETED|Period 2||11
422030|NCT01536704|1034396|P1|COMPLETED|Period 2||13
422031|NCT01536704|1034393|P4|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
422032|NCT01536704|1034394|P3|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|10
422033|NCT01536704|1034395|P2|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|11
422034|NCT01536704|1034396|P1|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
422035|NCT01536704|1034393|P4|NOT COMPLETED|Washout Period 1||0
422036|NCT01536704|1034394|P3|NOT COMPLETED|Washout Period 1||0
422037|NCT01536704|1034395|P2|NOT COMPLETED|Washout Period 1||2
422038|NCT01536704|1034396|P1|NOT COMPLETED|Washout Period 1||1
422039|NCT01536704|1034393|P4|COMPLETED|Washout Period 1||13
422040|NCT01536704|1034394|P3|COMPLETED|Washout Period 1||13
422041|NCT01536704|1034395|P2|COMPLETED|Washout Period 1||10
422042|NCT01536704|1034396|P1|COMPLETED|Washout Period 1||11
422043|NCT01536704|1034393|P4|STARTED|Washout Period 1||13
422044|NCT01536704|1034394|P3|STARTED|Washout Period 1||13
422045|NCT01536704|1034395|P2|STARTED|Washout Period 1||12
422046|NCT01536704|1034396|P1|STARTED|Washout Period 1||12
422047|NCT01536704|1034393|P4|NOT COMPLETED|Period 1||0
422048|NCT01536704|1034394|P3|NOT COMPLETED|Period 1||0
422049|NCT01536704|1034395|P2|NOT COMPLETED|Period 1||0
422050|NCT01536704|1034396|P1|NOT COMPLETED|Period 1||0
422051|NCT01536704|1034393|P4|COMPLETED|Period 1||13
422052|NCT01536704|1034394|P3|COMPLETED|Period 1||13
422053|NCT01536704|1034395|P2|COMPLETED|Period 1||12
422054|NCT01536704|1034396|P1|COMPLETED|Period 1||12
422055|NCT01536704|1034393|P4|STARTED|Period 1||13
422056|NCT01536704|1034394|P3|STARTED|Period 1||13
422057|NCT01536704|1034395|P2|STARTED|Period 1||12
422058|NCT01536704|1034396|P1|STARTED|Period 1||12
422059|NCT01536587|1034426|P1|NOT COMPLETED|Overall Study||2
422060|NCT01536587|1034426|P1|COMPLETED|Overall Study||30
422061|NCT01536587|1034426|P1|STARTED|Overall Study||32
422062|NCT01536574|1034465|P2|NOT COMPLETED|Overall Study||7
422063|NCT01536574|1034466|P1|NOT COMPLETED|Overall Study||6
422064|NCT01536574|1034465|P2|COMPLETED|Overall Study||126
422065|NCT01536574|1034466|P1|COMPLETED|Overall Study||156
422066|NCT01536574|1034465|P2|STARTED|Overall Study||133
422067|NCT01536574|1034466|P1|STARTED|Overall Study||162
422068|NCT01536561|1034484|P1|NOT COMPLETED|Long-Term Follow-Up||0
422069|NCT01536561|1034484|P1|COMPLETED|Long-Term Follow-Up||13
422070|NCT01536561|1034484|P1|STARTED|Long-Term Follow-Up||13
422071|NCT01536561|1034484|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||59
422072|NCT01536561|1034484|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
422073|NCT01536561|1034484|P1|STARTED|Dosimetric and Therapeutic Treatment||59
422074|NCT01536496|1034524|P2|NOT COMPLETED|Overall Study||1
422075|NCT01536496|1034525|P1|NOT COMPLETED|Overall Study||2
422076|NCT01536496|1034524|P2|COMPLETED|Overall Study||56
422077|NCT01536496|1034525|P1|COMPLETED|Overall Study||55
422078|NCT01536496|1034524|P2|STARTED|Overall Study||57
422079|NCT01536496|1034525|P1|STARTED|Overall Study||57
422080|NCT01536418|1034561|P2|NOT COMPLETED|Overall Study||66
422081|NCT01536418|1034562|P1|NOT COMPLETED|Overall Study||69
422082|NCT01536418|1034561|P2|COMPLETED|Overall Study||60
422083|NCT01536418|1034562|P1|COMPLETED|Overall Study||58
422084|NCT01536418|1034561|P2|STARTED|Overall Study||126
422085|NCT01536418|1034562|P1|STARTED|Overall Study||127
422086|NCT01536405|1034582|P2|NOT COMPLETED|Visit 4 to Extended Study Follow-up||23
422087|NCT01536405|1034583|P1|NOT COMPLETED|Visit 4 to Extended Study Follow-up||20
422088|NCT01536405|1034582|P2|COMPLETED|Visit 4 to Extended Study Follow-up||595
422089|NCT01536405|1034583|P1|COMPLETED|Visit 4 to Extended Study Follow-up||595
422090|NCT01536405|1034582|P2|STARTED|Visit 4 to Extended Study Follow-up||618
422091|NCT01536405|1034583|P1|STARTED|Visit 4 to Extended Study Follow-up||615
422092|NCT01536405|1034582|P2|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||16
422093|NCT01536405|1034583|P1|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||20
422094|NCT01536405|1034582|P2|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||618
422095|NCT01536405|1034583|P1|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||615
422096|NCT01536405|1034582|P2|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||632
422097|NCT01536405|1034583|P1|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||634
422098|NCT01536405|1034582|P2|STARTED|Visit 3 (Vaccination 2) to Visit 4||634
422099|NCT01536405|1034583|P1|STARTED|Visit 3 (Vaccination 2) to Visit 4||635
422100|NCT01536405|1034582|P2|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||28
422101|NCT01536405|1034583|P1|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||31
422102|NCT01536405|1034582|P2|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||634
422103|NCT01536405|1034583|P1|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||635
422104|NCT01536405|1034582|P2|STARTED|Visit 2 to Visit 3 (Vaccination 2)||662
422105|NCT01536405|1034583|P1|STARTED|Visit 2 to Visit 3 (Vaccination 2)||666
422106|NCT01536405|1034582|P2|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||40
422107|NCT01536405|1034583|P1|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||32
422108|NCT01536405|1034582|P2|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||662
422109|NCT01536405|1034583|P1|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||666
422110|NCT01536405|1034582|P2|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||702
422111|NCT01536405|1034583|P1|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||698
422112|NCT01536405|1034582|P2|STARTED|Visit 1 (Vaccination 1) to Visit 2||702
422113|NCT01536405|1034583|P1|STARTED|Visit 1 (Vaccination 1) to Visit 2||698
422114|NCT01536405|1034582|P2|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||4
422115|NCT01536405|1034583|P1|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||8
422116|NCT01536405|1034582|P2|COMPLETED|Randomization to Visit 1 (Vaccination 1)||702
422117|NCT01536405|1034583|P1|COMPLETED|Randomization to Visit 1 (Vaccination 1)||698
422118|NCT01536405|1034582|P2|STARTED|Randomization to Visit 1 (Vaccination 1)||706
422119|NCT01536405|1034583|P1|STARTED|Randomization to Visit 1 (Vaccination 1)||706
422120|NCT01536379|1034621|P2|NOT COMPLETED|Overall Study||3
422121|NCT01536379|1034622|P1|NOT COMPLETED|Overall Study||2
422122|NCT01536379|1034621|P2|COMPLETED|Overall Study||9
422123|NCT01536379|1034622|P1|COMPLETED|Overall Study||11
422124|NCT01536379|1034621|P2|STARTED|Overall Study||12
422125|NCT01536379|1034622|P1|STARTED|Overall Study||13
422126|NCT01536366|1034698|P2|NOT COMPLETED|Overall Study||4
422127|NCT01536366|1034699|P1|NOT COMPLETED|Overall Study||13
422128|NCT01536366|1034698|P2|COMPLETED|Overall Study||9
422129|NCT01536366|1034699|P1|COMPLETED|Overall Study||1
422130|NCT01536366|1034698|P2|Follow-up|Overall Study||9
422131|NCT01536366|1034699|P1|Follow-up|Overall Study||13
422132|NCT01536366|1034698|P2|Repaglinide|Overall Study||13
422133|NCT01536366|1034699|P1|Repaglinide|Overall Study||14
422134|NCT01536366|1034698|P2|BIA 9-1067 + Repaglinide|Overall Study||10
422135|NCT01536366|1034699|P1|BIA 9-1067 + Repaglinide|Overall Study||14
422136|NCT01536366|1034698|P2|STARTED|Overall Study||13
422137|NCT01536366|1034699|P1|STARTED|Overall Study||14
422138|NCT01536262|1034714|P3|NOT COMPLETED|Overall Study||2
422139|NCT01536262|1034715|P2|NOT COMPLETED|Overall Study||2
422140|NCT01536262|1034716|P1|NOT COMPLETED|Overall Study||8
422141|NCT01536262|1034714|P3|COMPLETED|Overall Study||39
422142|NCT01536262|1034715|P2|COMPLETED|Overall Study||38
422143|NCT01536262|1034716|P1|COMPLETED|Overall Study||33
422144|NCT01536262|1034714|P3|STARTED|Overall Study||41
422145|NCT01536262|1034715|P2|STARTED|Overall Study||40
422146|NCT01536262|1034716|P1|STARTED|Overall Study||41
422147|NCT01536197|1034732|P2|NOT COMPLETED|Overall Study||0
422148|NCT01536197|1034733|P1|NOT COMPLETED|Overall Study||0
422149|NCT01536197|1034732|P2|COMPLETED|Overall Study||10
422150|NCT01536197|1034733|P1|COMPLETED|Overall Study||23
422151|NCT01536197|1034732|P2|STARTED|Overall Study||10
422152|NCT01536197|1034733|P1|STARTED|Overall Study||23
422153|NCT01536184|1034743|P2|NOT COMPLETED|Overall Study||0
422154|NCT01536184|1034744|P1|NOT COMPLETED|Overall Study||0
422155|NCT01536184|1034743|P2|COMPLETED|Overall Study||4
422156|NCT01536184|1034744|P1|COMPLETED|Overall Study||8
422157|NCT01536184|1034743|P2|STARTED|Overall Study||4
422158|NCT01536184|1034744|P1|STARTED|Overall Study||8
422159|NCT01536171|1034758|P1|NOT COMPLETED|Overall Study||1
422160|NCT01536171|1034758|P1|COMPLETED|Overall Study||21
422161|NCT01536171|1034758|P1|STARTED|Overall Study||22
422162|NCT01536145|1034763|P11|NOT COMPLETED|Overall Study||10
422163|NCT01536145|1034764|P10|NOT COMPLETED|Overall Study||6
422164|NCT01536145|1034765|P9|NOT COMPLETED|Overall Study||3
422165|NCT01536145|1034766|P8|NOT COMPLETED|Overall Study||4
422166|NCT01536145|1034767|P7|NOT COMPLETED|Overall Study||2
422167|NCT01536145|1034768|P6|NOT COMPLETED|Overall Study||3
422168|NCT01536145|1034769|P5|NOT COMPLETED|Overall Study||2
422169|NCT01536145|1034770|P4|NOT COMPLETED|Overall Study||2
422170|NCT01536145|1034771|P3|NOT COMPLETED|Overall Study||2
422171|NCT01536145|1034772|P2|NOT COMPLETED|Overall Study||4
422172|NCT01536145|1034773|P1|NOT COMPLETED|Overall Study||3
422173|NCT01536145|1034763|P11|COMPLETED|Overall Study||0
422174|NCT01536145|1034764|P10|COMPLETED|Overall Study||1
422175|NCT01536145|1034765|P9|COMPLETED|Overall Study||0
422176|NCT01536145|1034766|P8|COMPLETED|Overall Study||0
422177|NCT01536145|1034767|P7|COMPLETED|Overall Study||1
422178|NCT01536145|1034768|P6|COMPLETED|Overall Study||0
422179|NCT01536145|1034769|P5|COMPLETED|Overall Study||2
422180|NCT01536145|1034770|P4|COMPLETED|Overall Study||1
422181|NCT01536145|1034771|P3|COMPLETED|Overall Study||1
422182|NCT01536145|1034772|P2|COMPLETED|Overall Study||0
422183|NCT01536145|1034773|P1|COMPLETED|Overall Study||0
422184|NCT01536145|1034763|P11|STARTED|Overall Study||10
422185|NCT01536145|1034764|P10|STARTED|Overall Study||7
422186|NCT01536145|1034765|P9|STARTED|Overall Study||3
422187|NCT01536145|1034766|P8|STARTED|Overall Study||4
422188|NCT01536145|1034767|P7|STARTED|Overall Study||3
422189|NCT01536145|1034768|P6|STARTED|Overall Study||3
422190|NCT01536145|1034769|P5|STARTED|Overall Study||4
422191|NCT01536145|1034770|P4|STARTED|Overall Study||3
422192|NCT01536145|1034771|P3|STARTED|Overall Study||3
422193|NCT01536145|1034772|P2|STARTED|Overall Study||4
422194|NCT01536145|1034773|P1|STARTED|Overall Study||3
422195|NCT01536119|1034880|P2|NOT COMPLETED|Overall Study||14
422196|NCT01536119|1034881|P1|NOT COMPLETED|Overall Study||17
422197|NCT01536119|1034880|P2|COMPLETED|Overall Study|105 mothers + 95 fathers = 200 participants 2 mothers + 12 fathers = 14 did not complete the study|200
422198|NCT01536119|1034881|P1|COMPLETED|Overall Study|104 Mothers + 93 fathers = 197 participants 3 mothers + 14 fathers = 17 did not complete the study|197
422199|NCT01536119|1034880|P2|STARTED|Overall Study|(107*2=214) (107 mothers and 107 fathers)|214
422200|NCT01536119|1034881|P1|STARTED|Overall Study|(107*2= 214) (107 mothers and 107 fathers)|214
422201|NCT01536093|1034907|P2|NOT COMPLETED|Overall Study||3
422202|NCT01536093|1034908|P1|NOT COMPLETED|Overall Study||3
422203|NCT01536093|1034907|P2|COMPLETED|Overall Study||21
422204|NCT01536093|1034908|P1|COMPLETED|Overall Study||21
422205|NCT01536093|1034907|P2|STARTED|Overall Study||24
422206|NCT01536093|1034908|P1|STARTED|Overall Study||24
422207|NCT01536067|1034924|P1|NOT COMPLETED|Overall Study||1
422208|NCT01536067|1034924|P1|COMPLETED|Overall Study||2
422209|NCT01536067|1034924|P1|STARTED|Overall Study||3
422210|NCT01536015|1034937|P2|NOT COMPLETED|Overall Study||10
422211|NCT01536015|1034938|P1|NOT COMPLETED|Overall Study||8
422212|NCT01536015|1034937|P2|COMPLETED|Overall Study||3
422213|NCT01536015|1034938|P1|COMPLETED|Overall Study||4
422214|NCT01536015|1034937|P2|STARTED|Overall Study||13
422215|NCT01536015|1034938|P1|STARTED|Overall Study||12
422216|NCT01535976|1034956|P2|NOT COMPLETED|Overall Study||1
422217|NCT01535976|1034957|P1|NOT COMPLETED|Overall Study||1
422218|NCT01535976|1034956|P2|COMPLETED|Overall Study||26
422219|NCT01535976|1034957|P1|COMPLETED|Overall Study||26
422220|NCT01535976|1034956|P2|STARTED|Overall Study||27
422221|NCT01535976|1034957|P1|STARTED|Overall Study||27
422222|NCT01535807|1034965|P2|NOT COMPLETED|Overall Study||2
422223|NCT01535807|1034966|P1|NOT COMPLETED|Overall Study||2
422224|NCT01535807|1034965|P2|COMPLETED|Overall Study||20
422225|NCT01535807|1034966|P1|COMPLETED|Overall Study||20
422226|NCT01535807|1034965|P2|STARTED|Overall Study||22
422227|NCT01535807|1034966|P1|STARTED|Overall Study||22
422228|NCT01535729|1034972|P1|NOT COMPLETED|Overall Study||416
422229|NCT01535729|1034972|P1|COMPLETED|Overall Study||49
422230|NCT01535729|1034972|P1|Treated|Overall Study||385
422231|NCT01535729|1034972|P1|STARTED|Overall Study||465
422232|NCT01535664|1034999|P1|NOT COMPLETED|Overall Study||0
422233|NCT01535664|1034999|P1|COMPLETED|Overall Study||20
422234|NCT01535664|1034999|P1|STARTED|Overall Study||20
422235|NCT01535638|1035013|P6|NOT COMPLETED|Treatment 3 (Single Dose)||0
422236|NCT01535638|1035014|P5|NOT COMPLETED|Treatment 3 (Single Dose)||0
422237|NCT01535638|1035015|P4|NOT COMPLETED|Treatment 3 (Single Dose)||1
422238|NCT01535638|1035016|P3|NOT COMPLETED|Treatment 3 (Single Dose)||0
422239|NCT01535638|1035017|P2|NOT COMPLETED|Treatment 3 (Single Dose)||0
422240|NCT01535638|1035018|P1|NOT COMPLETED|Treatment 3 (Single Dose)||0
422241|NCT01535638|1035013|P6|COMPLETED|Treatment 3 (Single Dose)||2
422242|NCT01535638|1035014|P5|COMPLETED|Treatment 3 (Single Dose)||3
422243|NCT01535638|1035015|P4|COMPLETED|Treatment 3 (Single Dose)||2
422244|NCT01535638|1035016|P3|COMPLETED|Treatment 3 (Single Dose)||3
422245|NCT01535638|1035017|P2|COMPLETED|Treatment 3 (Single Dose)||3
422246|NCT01535638|1035018|P1|COMPLETED|Treatment 3 (Single Dose)||3
422247|NCT01535638|1035013|P6|STARTED|Treatment 3 (Single Dose)||2
422248|NCT01535638|1035014|P5|STARTED|Treatment 3 (Single Dose)||3
422249|NCT01535638|1035015|P4|STARTED|Treatment 3 (Single Dose)||3
422250|NCT01535638|1035016|P3|STARTED|Treatment 3 (Single Dose)||3
422251|NCT01535638|1035017|P2|STARTED|Treatment 3 (Single Dose)||3
422252|NCT01535638|1035018|P1|STARTED|Treatment 3 (Single Dose)||3
422253|NCT01535638|1035013|P6|NOT COMPLETED|Treatment 2 (Single Dose)||0
422254|NCT01535638|1035014|P5|NOT COMPLETED|Treatment 2 (Single Dose)||0
422255|NCT01535638|1035015|P4|NOT COMPLETED|Treatment 2 (Single Dose)||0
422256|NCT01535638|1035016|P3|NOT COMPLETED|Treatment 2 (Single Dose)||0
422257|NCT01535638|1035017|P2|NOT COMPLETED|Treatment 2 (Single Dose)||0
422258|NCT01535638|1035018|P1|NOT COMPLETED|Treatment 2 (Single Dose)||0
422259|NCT01535638|1035013|P6|COMPLETED|Treatment 2 (Single Dose)||2
422260|NCT01535638|1035014|P5|COMPLETED|Treatment 2 (Single Dose)||3
422261|NCT01535638|1035015|P4|COMPLETED|Treatment 2 (Single Dose)||3
422262|NCT01535638|1035016|P3|COMPLETED|Treatment 2 (Single Dose)||3
422263|NCT01535638|1035017|P2|COMPLETED|Treatment 2 (Single Dose)||3
422264|NCT01535638|1035018|P1|COMPLETED|Treatment 2 (Single Dose)||3
422265|NCT01535638|1035013|P6|STARTED|Treatment 2 (Single Dose)||2
422266|NCT01535638|1035014|P5|STARTED|Treatment 2 (Single Dose)||3
422267|NCT01535638|1035015|P4|STARTED|Treatment 2 (Single Dose)||3
422268|NCT01535638|1035016|P3|STARTED|Treatment 2 (Single Dose)||3
422269|NCT01535638|1035017|P2|STARTED|Treatment 2 (Single Dose)||3
422270|NCT01535638|1035018|P1|STARTED|Treatment 2 (Single Dose)||3
422271|NCT01535638|1035013|P6|NOT COMPLETED|Treatment 1 (Single Dose)||1
422272|NCT01535638|1035014|P5|NOT COMPLETED|Treatment 1 (Single Dose)||0
422273|NCT01535638|1035015|P4|NOT COMPLETED|Treatment 1 (Single Dose)||0
422274|NCT01535638|1035016|P3|NOT COMPLETED|Treatment 1 (Single Dose)||0
422275|NCT01535638|1035017|P2|NOT COMPLETED|Treatment 1 (Single Dose)||0
422276|NCT01535638|1035018|P1|NOT COMPLETED|Treatment 1 (Single Dose)||0
422277|NCT01535638|1035013|P6|COMPLETED|Treatment 1 (Single Dose)||2
422278|NCT01535638|1035014|P5|COMPLETED|Treatment 1 (Single Dose)||3
422279|NCT01535638|1035015|P4|COMPLETED|Treatment 1 (Single Dose)||3
422280|NCT01535638|1035016|P3|COMPLETED|Treatment 1 (Single Dose)||3
422281|NCT01535638|1035017|P2|COMPLETED|Treatment 1 (Single Dose)||3
422282|NCT01535638|1035018|P1|COMPLETED|Treatment 1 (Single Dose)||3
422283|NCT01535638|1035013|P6|STARTED|Treatment 1 (Single Dose)||3
422284|NCT01535638|1035014|P5|STARTED|Treatment 1 (Single Dose)||3
422285|NCT01535638|1035015|P4|STARTED|Treatment 1 (Single Dose)||3
422286|NCT01535638|1035016|P3|STARTED|Treatment 1 (Single Dose)||3
422287|NCT01535638|1035017|P2|STARTED|Treatment 1 (Single Dose)||3
422288|NCT01535638|1035018|P1|STARTED|Treatment 1 (Single Dose)||3
422289|NCT01535599|1035032|P2|NOT COMPLETED|Overall Study||96
422290|NCT01535599|1035033|P1|NOT COMPLETED|Overall Study||50
422291|NCT01535599|1035032|P2|COMPLETED|Overall Study||250
422292|NCT01535599|1035033|P1|COMPLETED|Overall Study||297
422293|NCT01535599|1035032|P2|STARTED|Overall Study||346
422294|NCT01535599|1035033|P1|STARTED|Overall Study||347
422295|NCT01535560|1035045|P2|NOT COMPLETED|Overall Study||96
422296|NCT01535560|1035046|P1|NOT COMPLETED|Overall Study||37
422297|NCT01535560|1035045|P2|COMPLETED|Overall Study||179
422298|NCT01535560|1035046|P1|COMPLETED|Overall Study||237
422299|NCT01535560|1035045|P2|STARTED|Overall Study||275
422300|NCT01535560|1035046|P1|STARTED|Overall Study||274
422301|NCT01535365|1035058|P2|NOT COMPLETED|Overall Study||0
422302|NCT01535365|1035059|P1|NOT COMPLETED|Overall Study||0
422303|NCT01535365|1035058|P2|COMPLETED|Overall Study||29
422304|NCT01535365|1035059|P1|COMPLETED|Overall Study||31
422305|NCT01535365|1035058|P2|STARTED|Overall Study||29
422306|NCT01535365|1035059|P1|STARTED|Overall Study||31
422307|NCT01535326|1035070|P3|NOT COMPLETED|Overall Study||0
422308|NCT01535326|1035071|P2|NOT COMPLETED|Overall Study||0
422309|NCT01535326|1035072|P1|NOT COMPLETED|Overall Study||0
422310|NCT01535326|1035070|P3|COMPLETED|Overall Study||90
422311|NCT01535326|1035071|P2|COMPLETED|Overall Study||90
422312|NCT01535326|1035072|P1|COMPLETED|Overall Study||90
422313|NCT01535326|1035070|P3|STARTED|Overall Study||90
422314|NCT01535326|1035071|P2|STARTED|Overall Study||90
422315|NCT01535326|1035072|P1|STARTED|Overall Study||90
422316|NCT01535261|1035089|P1|NOT COMPLETED|Overall Study||50
422317|NCT01535261|1035089|P1|COMPLETED|Overall Study||307
422318|NCT01535261|1035089|P1|STARTED|Overall Study||357
422319|NCT01535235|1035102|P2|NOT COMPLETED|Overall Study||0
422320|NCT01535235|1035103|P1|NOT COMPLETED|Overall Study||1
422321|NCT01535235|1035102|P2|COMPLETED|Overall Study||15
422322|NCT01535235|1035103|P1|COMPLETED|Overall Study||15
422323|NCT01535235|1035102|P2|STARTED|Overall Study||15
422324|NCT01535235|1035103|P1|STARTED|Overall Study||16
422325|NCT01535222|1035117|P6|NOT COMPLETED|Overall Study||0
422326|NCT01535222|1035118|P5|NOT COMPLETED|Overall Study||0
422327|NCT01535222|1035119|P4|NOT COMPLETED|Overall Study||0
422328|NCT01535222|1035120|P3|NOT COMPLETED|Overall Study||1
422329|NCT01535222|1035121|P2|NOT COMPLETED|Overall Study||0
422330|NCT01535222|1035122|P1|NOT COMPLETED|Overall Study||0
422331|NCT01535222|1035117|P6|COMPLETED|Overall Study||8
422332|NCT01535222|1035118|P5|COMPLETED|Overall Study||6
422333|NCT01535222|1035119|P4|COMPLETED|Overall Study||6
422334|NCT01535222|1035120|P3|COMPLETED|Overall Study||6
422335|NCT01535222|1035121|P2|COMPLETED|Overall Study||3
422336|NCT01535222|1035122|P1|COMPLETED|Overall Study||3
422337|NCT01535222|1035117|P6|STARTED|Overall Study||8
422338|NCT01535222|1035118|P5|STARTED|Overall Study||6
422339|NCT01535222|1035119|P4|STARTED|Overall Study||6
422340|NCT01535222|1035120|P3|STARTED|Overall Study|Patient randomized but did not meet inclusion/exclusion criteria and did not receive study drug|7
422341|NCT01535222|1035121|P2|STARTED|Overall Study||3
422342|NCT01535222|1035122|P1|STARTED|Overall Study||3
422343|NCT01535118|1035142|P1|NOT COMPLETED|Overall Study||0
422344|NCT01535118|1035142|P1|COMPLETED|Overall Study||2765
422345|NCT01535118|1035142|P1|STARTED|Overall Study||2765
422346|NCT01535040|1035153|P2|NOT COMPLETED|Overall Study||21
422347|NCT01535040|1035154|P1|NOT COMPLETED|Overall Study||30
422348|NCT01535040|1035153|P2|COMPLETED|Overall Study||44
422349|NCT01535040|1035154|P1|COMPLETED|Overall Study||35
422350|NCT01535040|1035153|P2|STARTED|Overall Study||65
422351|NCT01535040|1035154|P1|STARTED|Overall Study||65
422352|NCT01535001|1035168|P2|NOT COMPLETED|Overall Study||6
422353|NCT01535001|1035169|P1|NOT COMPLETED|Overall Study||3
422354|NCT01535001|1035168|P2|COMPLETED|Overall Study||44
422355|NCT01535001|1035169|P1|COMPLETED|Overall Study||47
422356|NCT01535001|1035168|P2|STARTED|Overall Study||50
422357|NCT01535001|1035169|P1|STARTED|Overall Study||50
422358|NCT01534975|1035195|P4|NOT COMPLETED|Overall Study||0
422359|NCT01534975|1035196|P3|NOT COMPLETED|Overall Study||0
422360|NCT01534975|1035197|P2|NOT COMPLETED|Overall Study||0
422361|NCT01534975|1035198|P1|NOT COMPLETED|Overall Study||0
422362|NCT01534975|1035195|P4|COMPLETED|Overall Study||84
422363|NCT01534975|1035196|P3|COMPLETED|Overall Study||160
422364|NCT01534975|1035197|P2|COMPLETED|Overall Study||133
422365|NCT01534975|1035198|P1|COMPLETED|Overall Study||136
422366|NCT01534975|1035195|P4|STARTED|Overall Study||84
422367|NCT01534975|1035196|P3|STARTED|Overall Study||160
422368|NCT01534975|1035197|P2|STARTED|Overall Study||133
422369|NCT01534975|1035198|P1|STARTED|Overall Study||136
422370|NCT01534962|1035212|P4|NOT COMPLETED|Overall Study||32
422371|NCT01534962|1035213|P3|NOT COMPLETED|Overall Study||24
422372|NCT01534962|1035214|P2|NOT COMPLETED|Overall Study||26
422373|NCT01534962|1035215|P1|NOT COMPLETED|Overall Study||37
422374|NCT01534962|1035212|P4|COMPLETED|Overall Study||24
422375|NCT01534962|1035213|P3|COMPLETED|Overall Study||34
422376|NCT01534962|1035214|P2|COMPLETED|Overall Study||34
422377|NCT01534962|1035215|P1|COMPLETED|Overall Study||30
422378|NCT01534962|1035212|P4|STARTED|Overall Study||56
422379|NCT01534962|1035213|P3|STARTED|Overall Study||58
422380|NCT01534962|1035214|P2|STARTED|Overall Study||60
422381|NCT01534962|1035215|P1|STARTED|Overall Study||67
422382|NCT01534910|1035247|P2|NOT COMPLETED|Overall Study||4
422383|NCT01534910|1035248|P1|NOT COMPLETED|Overall Study||4
422384|NCT01534910|1035247|P2|COMPLETED|Overall Study||28
422385|NCT01534910|1035248|P1|COMPLETED|Overall Study||29
422386|NCT01534910|1035247|P2|STARTED|Overall Study||32
422387|NCT01534910|1035248|P1|STARTED|Overall Study||33
422388|NCT01534897|1035256|P1|NOT COMPLETED|Overall Study||0
422389|NCT01534897|1035256|P1|COMPLETED|Overall Study||10
422390|NCT01534897|1035256|P1|Day 37 Iodine-131 Treatment|Overall Study||6
422391|NCT01534897|1035256|P1|Day 25 Iodine-131 Scan|Overall Study||10
422392|NCT01534897|1035256|P1|STARTED|Overall Study||10
422393|NCT01534689|1035264|P1|NOT COMPLETED|Overall Study||0
422394|NCT01534689|1035264|P1|COMPLETED|Overall Study||105
422395|NCT01534689|1035264|P1|STARTED|Overall Study||105
422396|NCT01534676|1035272|P2|NOT COMPLETED|Overall Study||1
422397|NCT01534676|1035273|P1|NOT COMPLETED|Overall Study||2
422398|NCT01534676|1035272|P2|COMPLETED|Overall Study||0
422399|NCT01534676|1035273|P1|COMPLETED|Overall Study||0
422400|NCT01534676|1035272|P2|STARTED|Overall Study||1
422401|NCT01534676|1035273|P1|STARTED|Overall Study||2
422402|NCT01534637|1035279|P1|NOT COMPLETED|Overall Study||9
422403|NCT01534637|1035279|P1|COMPLETED|Overall Study||13
422404|NCT01534637|1035279|P1|STARTED|Overall Study||22
422405|NCT01534533|1035289|P4|NOT COMPLETED|Overall Study||4
422406|NCT01534533|1035290|P3|NOT COMPLETED|Overall Study||8
422407|NCT01534533|1035291|P2|NOT COMPLETED|Overall Study||3
422408|NCT01534533|1035292|P1|NOT COMPLETED|Overall Study||8
422409|NCT01534533|1035289|P4|COMPLETED|Overall Study||44
422410|NCT01534533|1035290|P3|COMPLETED|Overall Study||40
422411|NCT01534533|1035291|P2|COMPLETED|Overall Study||45
422412|NCT01534533|1035292|P1|COMPLETED|Overall Study||40
422413|NCT01534533|1035289|P4|STARTED|Overall Study||48
422414|NCT01534533|1035290|P3|STARTED|Overall Study||48
422415|NCT01534533|1035291|P2|STARTED|Overall Study||48
422416|NCT01534533|1035292|P1|STARTED|Overall Study||48
422417|NCT01534520|1035320|P2|NOT COMPLETED|Overall Study||1
422418|NCT01534520|1035321|P1|NOT COMPLETED|Overall Study||0
422419|NCT01534520|1035320|P2|COMPLETED|Overall Study|1 subject withdrew consent at time of uterine sound attempt due to intolerable pain|28
422420|NCT01534520|1035321|P1|COMPLETED|Overall Study||30
422421|NCT01534520|1035320|P2|STARTED|Overall Study||29
422422|NCT01534520|1035321|P1|STARTED|Overall Study||30
422423|NCT01534416|1035335|P2|NOT COMPLETED|Overall Study||0
422424|NCT01534416|1035336|P1|NOT COMPLETED|Overall Study||0
422425|NCT01534416|1035335|P2|COMPLETED|Overall Study||64
422426|NCT01534416|1035336|P1|COMPLETED|Overall Study||68
422427|NCT01534416|1035335|P2|STARTED|Overall Study||64
422428|NCT01534416|1035336|P1|STARTED|Overall Study||68
422429|NCT01534351|1035355|P3|NOT COMPLETED|Overall Study||0
422430|NCT01534351|1035356|P2|NOT COMPLETED|Overall Study||0
422431|NCT01534351|1035357|P1|NOT COMPLETED|Overall Study||1
422432|NCT01534351|1035355|P3|COMPLETED|Overall Study||0
422433|NCT01534351|1035356|P2|COMPLETED|Overall Study||0
422434|NCT01534351|1035357|P1|COMPLETED|Overall Study||0
422435|NCT01534351|1035355|P3|STARTED|Overall Study||0
422436|NCT01534351|1035356|P2|STARTED|Overall Study||0
422437|NCT01534351|1035357|P1|STARTED|Overall Study||1
422438|NCT01534208|1035376|P2|NOT COMPLETED|Overall Study||49
422439|NCT01534208|1035377|P1|NOT COMPLETED|Overall Study||57
422440|NCT01534208|1035376|P2|COMPLETED|Overall Study||234
422441|NCT01534208|1035377|P1|COMPLETED|Overall Study||159
422442|NCT01534208|1035376|P2|STARTED|Overall Study||283
422443|NCT01534208|1035377|P1|STARTED|Overall Study||216
422444|NCT01534182|1035395|P2|NOT COMPLETED|Overall Study||10
422445|NCT01534182|1035396|P1|NOT COMPLETED|Overall Study||12
422446|NCT01534182|1035395|P2|COMPLETED|Overall Study||58
422447|NCT01534182|1035396|P1|COMPLETED|Overall Study||218
422448|NCT01534182|1035395|P2|Full Analysis Set|Overall Study||62
422449|NCT01534182|1035396|P1|Full Analysis Set|Overall Study||229
422450|NCT01534182|1035395|P2|Safety Set|Overall Study||64
422451|NCT01534182|1035396|P1|Safety Set|Overall Study||230
422452|NCT01534182|1035395|P2|STARTED|Overall Study||68
422453|NCT01534182|1035396|P1|STARTED|Overall Study||230
422454|NCT01534143|1035411|P1|NOT COMPLETED|Overall Study||0
422455|NCT01534143|1035411|P1|COMPLETED|Overall Study||1
422456|NCT01534143|1035411|P1|STARTED|Overall Study||1
422457|NCT01534078|1035427|P1|NOT COMPLETED|Overall Study||2
422458|NCT01534078|1035427|P1|COMPLETED|Overall Study||32
422459|NCT01534078|1035427|P1|STARTED|Overall Study||34
422460|NCT01534052|1035434|P1|NOT COMPLETED|Overall Study||0
422461|NCT01534052|1035434|P1|COMPLETED|Overall Study||52
422462|NCT01534052|1035434|P1|Treatment Received|Overall Study||52
422463|NCT01534052|1035434|P1|STARTED|Overall Study||52
422464|NCT01533974|1035440|P2|NOT COMPLETED|Overall Study||50
422465|NCT01533974|1035441|P1|NOT COMPLETED|Overall Study||51
422466|NCT01533974|1035440|P2|COMPLETED|Overall Study||176
422467|NCT01533974|1035441|P1|COMPLETED|Overall Study||173
422468|NCT01533974|1035440|P2|STARTED|Overall Study||226
422469|NCT01533974|1035441|P1|STARTED|Overall Study||224
422470|NCT01533948|1035447|P1|NOT COMPLETED|Overall Study||0
422471|NCT01533948|1035447|P1|COMPLETED|Overall Study||25
422472|NCT01533948|1035447|P1|STARTED|Overall Study||25
422473|NCT01533935|1035455|P5|NOT COMPLETED|Overall Study||8
422474|NCT01533935|1035456|P4|NOT COMPLETED|Overall Study||7
422475|NCT01533935|1035457|P3|NOT COMPLETED|Overall Study||8
422476|NCT01533935|1035458|P2|NOT COMPLETED|Overall Study||13
422477|NCT01533935|1035459|P1|NOT COMPLETED|Overall Study||6
422478|NCT01533935|1035455|P5|COMPLETED|Overall Study|All treatment periods|50
422479|NCT01533935|1035456|P4|COMPLETED|Overall Study|All treatment periods|52
422480|NCT01533935|1035457|P3|COMPLETED|Overall Study|All treatment periods|50
422481|NCT01533935|1035458|P2|COMPLETED|Overall Study|All treatment periods|45
422482|NCT01533935|1035459|P1|COMPLETED|Overall Study|All treatment periods|52
422483|NCT01533935|1035455|P5|Received Tio+Olo 5/5|Overall Study||55
422484|NCT01533935|1035456|P4|Received Tio+Olo 5/5|Overall Study||54
422485|NCT01533935|1035457|P3|Received Tio+Olo 5/5|Overall Study|One patient received Tio+Olo 5/5 instead of Tio+Olo 2.5/5 by mistake.|1
422486|NCT01533935|1035458|P2|Received Tio+Olo 5/5|Overall Study||58
422487|NCT01533935|1035459|P1|Received Tio+Olo 5/5|Overall Study||56
422488|NCT01533935|1035455|P5|Received Tio+Olo 2.5/5|Overall Study||56
422489|NCT01533935|1035456|P4|Received Tio+Olo 2.5/5|Overall Study||56
422490|NCT01533935|1035457|P3|Received Tio+Olo 2.5/5|Overall Study||49
422491|NCT01533935|1035458|P2|Received Tio+Olo 2.5/5|Overall Study||0
422492|NCT01533935|1035459|P1|Received Tio+Olo 2.5/5|Overall Study||58
422493|NCT01533935|1035455|P5|Received Tio 5|Overall Study||52
422494|NCT01533935|1035456|P4|Received Tio 5|Overall Study||0
422495|NCT01533935|1035457|P3|Received Tio 5|Overall Study||58
422496|NCT01533935|1035458|P2|Received Tio 5|Overall Study||54
422497|NCT01533935|1035459|P1|Received Tio 5|Overall Study||54
422498|NCT01533935|1035455|P5|Received Olo 5|Overall Study||0
422499|NCT01533935|1035456|P4|Received Olo 5|Overall Study||59
422500|NCT01533935|1035457|P3|Received Olo 5|Overall Study||55
422501|NCT01533935|1035458|P2|Received Olo 5|Overall Study||52
422502|NCT01533935|1035459|P1|Received Olo 5|Overall Study||52
422503|NCT01533935|1035455|P5|Received Placebo|Overall Study||58
422504|NCT01533935|1035456|P4|Received Placebo|Overall Study||57
422505|NCT01533935|1035457|P3|Received Placebo|Overall Study||52
422506|NCT01533935|1035458|P2|Received Placebo|Overall Study||47
422507|NCT01533935|1035459|P1|Received Placebo|Overall Study||0
422508|NCT01533935|1035455|P5|STARTED|Overall Study||58
422509|NCT01533935|1035456|P4|STARTED|Overall Study||59
422510|NCT01533935|1035457|P3|STARTED|Overall Study||58
422511|NCT01533935|1035458|P2|STARTED|Overall Study||58
422512|NCT01533935|1035459|P1|STARTED|Overall Study||58
422513|NCT01533922|1035486|P5|NOT COMPLETED|Overall Study||6
422514|NCT01533922|1035487|P4|NOT COMPLETED|Overall Study||5
422515|NCT01533922|1035488|P3|NOT COMPLETED|Overall Study||10
422516|NCT01533922|1035489|P2|NOT COMPLETED|Overall Study||12
422517|NCT01533922|1035490|P1|NOT COMPLETED|Overall Study||10
422518|NCT01533922|1035486|P5|COMPLETED|Overall Study|Completed all treatment arms|53
422519|NCT01533922|1035487|P4|COMPLETED|Overall Study|Completed all treatment arms|53
422520|NCT01533922|1035488|P3|COMPLETED|Overall Study|Completed all treatment arms|50
422521|NCT01533922|1035489|P2|COMPLETED|Overall Study|Completed all treatment arms|47
422522|NCT01533922|1035490|P1|COMPLETED|Overall Study|Completed all treatment arms|49
422523|NCT01533922|1035486|P5|Received Tio+Olo 5/5|Overall Study||56
422524|NCT01533922|1035487|P4|Received Tio+Olo 5/5|Overall Study||53
422525|NCT01533922|1035488|P3|Received Tio+Olo 5/5|Overall Study||0
422526|NCT01533922|1035489|P2|Received Tio+Olo 5/5|Overall Study||59
422527|NCT01533922|1035490|P1|Received Tio+Olo 5/5|Overall Study||58
422528|NCT01533922|1035486|P5|Received Tio+Olo 2.5/5|Overall Study||56
422529|NCT01533922|1035487|P4|Received Tio+Olo 2.5/5|Overall Study||55
422530|NCT01533922|1035488|P3|Received Tio+Olo 2.5/5|Overall Study||52
422531|NCT01533922|1035489|P2|Received Tio+Olo 2.5/5|Overall Study||0
422532|NCT01533922|1035490|P1|Received Tio+Olo 2.5/5|Overall Study||59
422533|NCT01533922|1035486|P5|Received Tio 5|Overall Study||54
422534|NCT01533922|1035487|P4|Received Tio 5|Overall Study|One patient received Tio 5 instead of Olo 5 by mistake.|1
422535|NCT01533922|1035488|P3|Received Tio 5|Overall Study||59
422536|NCT01533922|1035489|P2|Received Tio 5|Overall Study||58
422537|NCT01533922|1035490|P1|Received Tio 5|Overall Study||54
422538|NCT01533922|1035486|P5|Received Olo 5|Overall Study||0
422539|NCT01533922|1035487|P4|Received Olo 5|Overall Study||57
422540|NCT01533922|1035488|P3|Received Olo 5|Overall Study||57
422541|NCT01533922|1035489|P2|Received Olo 5|Overall Study||52
422542|NCT01533922|1035490|P1|Received Olo 5|Overall Study||51
422543|NCT01533922|1035486|P5|Received Placebo|Overall Study||59
422544|NCT01533922|1035487|P4|Received Placebo|Overall Study||57
422545|NCT01533922|1035488|P3|Received Placebo|Overall Study||57
422546|NCT01533922|1035489|P2|Received Placebo|Overall Study||49
422547|NCT01533922|1035490|P1|Received Placebo|Overall Study||0
422548|NCT01533922|1035486|P5|STARTED|Overall Study||59
422549|NCT01533922|1035487|P4|STARTED|Overall Study||58
422550|NCT01533922|1035488|P3|STARTED|Overall Study||60
422551|NCT01533922|1035489|P2|STARTED|Overall Study||59
422552|NCT01533922|1035490|P1|STARTED|Overall Study||59
422553|NCT01533753|1035519|P2|NOT COMPLETED|Overall Study||0
422554|NCT01533753|1035520|P1|NOT COMPLETED|Overall Study||0
422555|NCT01533753|1035519|P2|COMPLETED|Overall Study||3
422556|NCT01533753|1035520|P1|COMPLETED|Overall Study||2
422557|NCT01533753|1035519|P2|STARTED|Overall Study||3
422558|NCT01533753|1035520|P1|STARTED|Overall Study||2
422559|NCT01533597|1035534|P2|NOT COMPLETED|Overall Study||10
422560|NCT01533597|1035535|P1|NOT COMPLETED|Overall Study||6
422561|NCT01533597|1035534|P2|COMPLETED|Overall Study||25
422562|NCT01533597|1035535|P1|COMPLETED|Overall Study||29
422563|NCT01533597|1035534|P2|STARTED|Overall Study||35
422564|NCT01533597|1035535|P1|STARTED|Overall Study||35
422565|NCT01533493|1035553|P2|NOT COMPLETED|Overall Study||3
422566|NCT01533493|1035554|P1|NOT COMPLETED|Overall Study||5
422567|NCT01533493|1035553|P2|COMPLETED|Overall Study||11
422568|NCT01533493|1035554|P1|COMPLETED|Overall Study||7
422569|NCT01533493|1035553|P2|STARTED|Overall Study||14
422570|NCT01533493|1035554|P1|STARTED|Overall Study||12
422571|NCT01533428|1035562|P2|NOT COMPLETED|Overall Study||8
422572|NCT01533428|1035563|P1|NOT COMPLETED|Overall Study||9
422573|NCT01533428|1035562|P2|COMPLETED|Overall Study||175
422574|NCT01533428|1035563|P1|COMPLETED|Overall Study||177
422575|NCT01533428|1035562|P2|STARTED|Overall Study||183
422576|NCT01533428|1035563|P1|STARTED|Overall Study||186
422577|NCT01533259|1035603|P1|NOT COMPLETED|Overall Study||0
422578|NCT01533259|1035603|P1|COMPLETED|Overall Study||48
422579|NCT01533259|1035603|P1|STARTED|Overall Study||48
422580|NCT01533246|1035609|P1|NOT COMPLETED|Overall Study||2
422581|NCT01533246|1035609|P1|COMPLETED|Overall Study||15
422582|NCT01533246|1035609|P1|STARTED|Overall Study||17
422583|NCT01533181|1035620|P2|NOT COMPLETED|Overall Study||1
422584|NCT01533181|1035621|P1|NOT COMPLETED|Overall Study||1
422585|NCT01533181|1035620|P2|COMPLETED|Overall Study||28
422586|NCT01533181|1035621|P1|COMPLETED|Overall Study||14
422587|NCT01533181|1035620|P2|STARTED|Overall Study||29
422588|NCT01533181|1035621|P1|STARTED|Overall Study||15
422589|NCT01533116|1035637|P4|NOT COMPLETED|Overall Study||0
422590|NCT01533116|1035638|P3|NOT COMPLETED|Overall Study||1
422591|NCT01533116|1035639|P2|NOT COMPLETED|Overall Study||1
422592|NCT01533116|1035640|P1|NOT COMPLETED|Overall Study||2
422593|NCT01533116|1035637|P4|COMPLETED|Overall Study||12
422594|NCT01533116|1035638|P3|COMPLETED|Overall Study||12
422595|NCT01533116|1035639|P2|COMPLETED|Overall Study||12
422596|NCT01533116|1035640|P1|COMPLETED|Overall Study||12
422597|NCT01533116|1035637|P4|STARTED|Overall Study||12
422598|NCT01533116|1035638|P3|STARTED|Overall Study||13
422599|NCT01533116|1035639|P2|STARTED|Overall Study||13
422600|NCT01533116|1035640|P1|STARTED|Overall Study||14
422601|NCT01533077|1035670|P4|NOT COMPLETED|Overall Study||0
422602|NCT01533077|1035671|P3|NOT COMPLETED|Overall Study||0
422603|NCT01533077|1035672|P2|NOT COMPLETED|Overall Study||1
422604|NCT01533077|1035673|P1|NOT COMPLETED|Overall Study||1
422605|NCT01533077|1035670|P4|COMPLETED|Overall Study||4
422606|NCT01533077|1035671|P3|COMPLETED|Overall Study||4
422607|NCT01533077|1035672|P2|COMPLETED|Overall Study||4
422608|NCT01533077|1035673|P1|COMPLETED|Overall Study||4
422609|NCT01533077|1035670|P4|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4
422610|NCT01533077|1035671|P3|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4
422611|NCT01533077|1035672|P2|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5
422612|NCT01533077|1035673|P1|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5
422613|NCT01533077|1035670|P4|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
422614|NCT01533077|1035671|P3|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
422615|NCT01533077|1035672|P2|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
422616|NCT01533077|1035673|P1|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
422617|NCT01533077|1035670|P4|Sinemet® 100/25|Overall Study||4
422618|NCT01533077|1035671|P3|Sinemet® 100/25|Overall Study||4
422619|NCT01533077|1035672|P2|Sinemet® 100/25|Overall Study||5
422620|NCT01533077|1035673|P1|Sinemet® 100/25|Overall Study||4
422621|NCT01533077|1035670|P4|BIA 9-1067 50 mg|Overall Study||4
422622|NCT01533077|1035671|P3|BIA 9-1067 50 mg|Overall Study||4
422623|NCT01533077|1035672|P2|BIA 9-1067 50 mg|Overall Study||5
422624|NCT01533077|1035673|P1|BIA 9-1067 50 mg|Overall Study||5
422625|NCT01533077|1035670|P4|STARTED|Overall Study||4
422626|NCT01533077|1035671|P3|STARTED|Overall Study||4
422627|NCT01533077|1035672|P2|STARTED|Overall Study||5
422628|NCT01533077|1035673|P1|STARTED|Overall Study||5
422629|NCT01533038|1035729|P2|NOT COMPLETED|Overall Study||1
422630|NCT01533038|1035730|P1|NOT COMPLETED|Overall Study||0
422631|NCT01533038|1035729|P2|COMPLETED|Overall Study||34
422632|NCT01533038|1035730|P1|COMPLETED|Overall Study||45
422633|NCT01533038|1035729|P2|STARTED|Overall Study||35
422634|NCT01533038|1035730|P1|STARTED|Overall Study||45
422635|NCT01532999|1035738|P2|NOT COMPLETED|Overall Study||18
422636|NCT01532999|1035739|P1|NOT COMPLETED|Overall Study||31
422637|NCT01532999|1035738|P2|COMPLETED|Overall Study||77
422638|NCT01532999|1035739|P1|COMPLETED|Overall Study||65
422639|NCT01532999|1035738|P2|STARTED|Overall Study||95
422640|NCT01532999|1035739|P1|STARTED|Overall Study||96
422641|NCT01532973|1035770|P10|NOT COMPLETED|Part 3||0
422642|NCT01532973|1035771|P9|NOT COMPLETED|Part 3||0
422643|NCT01532973|1035772|P8|NOT COMPLETED|Part 3||0
422644|NCT01532973|1035773|P7|NOT COMPLETED|Part 3||0
422645|NCT01532973|1035774|P6|NOT COMPLETED|Part 3||0
422646|NCT01532973|1035775|P5|NOT COMPLETED|Part 3||0
422647|NCT01532973|1035776|P4|NOT COMPLETED|Part 3||0
422648|NCT01532973|1035777|P3|NOT COMPLETED|Part 3||0
422649|NCT01532973|1035778|P2|NOT COMPLETED|Part 3||0
422650|NCT01532973|1035779|P1|NOT COMPLETED|Part 3||0
422651|NCT01532973|1035770|P10|COMPLETED|Part 3||6
422652|NCT01532973|1035771|P9|COMPLETED|Part 3||6
422653|NCT01532973|1035772|P8|COMPLETED|Part 3||0
422654|NCT01532973|1035773|P7|COMPLETED|Part 3||0
422655|NCT01532973|1035774|P6|COMPLETED|Part 3||0
422656|NCT01532973|1035775|P5|COMPLETED|Part 3||0
422657|NCT01532973|1035776|P4|COMPLETED|Part 3||0
422658|NCT01532973|1035777|P3|COMPLETED|Part 3||0
422659|NCT01532973|1035778|P2|COMPLETED|Part 3||0
422660|NCT01532973|1035779|P1|COMPLETED|Part 3||0
422661|NCT01532973|1035770|P10|STARTED|Part 3||6
422662|NCT01532973|1035771|P9|STARTED|Part 3||6
422663|NCT01532973|1035772|P8|STARTED|Part 3||0
422664|NCT01532973|1035773|P7|STARTED|Part 3||0
422665|NCT01532973|1035774|P6|STARTED|Part 3||0
422666|NCT01532973|1035775|P5|STARTED|Part 3||0
422667|NCT01532973|1035776|P4|STARTED|Part 3||0
422668|NCT01532973|1035777|P3|STARTED|Part 3||0
422669|NCT01532973|1035778|P2|STARTED|Part 3||0
422670|NCT01532973|1035779|P1|STARTED|Part 3||0
422671|NCT01532973|1035770|P10|NOT COMPLETED|Part 2||0
422672|NCT01532973|1035771|P9|NOT COMPLETED|Part 2||0
422673|NCT01532973|1035772|P8|NOT COMPLETED|Part 2||0
422674|NCT01532973|1035773|P7|NOT COMPLETED|Part 2||0
422675|NCT01532973|1035774|P6|NOT COMPLETED|Part 2||0
422676|NCT01532973|1035775|P5|NOT COMPLETED|Part 2||0
422677|NCT01532973|1035776|P4|NOT COMPLETED|Part 2||0
422678|NCT01532973|1035777|P3|NOT COMPLETED|Part 2||0
422679|NCT01532973|1035778|P2|NOT COMPLETED|Part 2||0
422680|NCT01532973|1035779|P1|NOT COMPLETED|Part 2||0
422681|NCT01532973|1035770|P10|COMPLETED|Part 2||0
422682|NCT01532973|1035771|P9|COMPLETED|Part 2||0
422683|NCT01532973|1035772|P8|COMPLETED|Part 2||0
422684|NCT01532973|1035773|P7|COMPLETED|Part 2||6
422685|NCT01532973|1035774|P6|COMPLETED|Part 2||6
422686|NCT01532973|1035775|P5|COMPLETED|Part 2||6
422687|NCT01532973|1035776|P4|COMPLETED|Part 2||0
422688|NCT01532973|1035777|P3|COMPLETED|Part 2||0
422689|NCT01532973|1035778|P2|COMPLETED|Part 2||0
422690|NCT01532973|1035779|P1|COMPLETED|Part 2||0
422691|NCT01532973|1035770|P10|STARTED|Part 2||0
422692|NCT01532973|1035771|P9|STARTED|Part 2||0
422693|NCT01532973|1035772|P8|STARTED|Part 2|Planned panel not performed. No participants were enrolled.|0
422694|NCT01532973|1035773|P7|STARTED|Part 2||6
422695|NCT01532973|1035774|P6|STARTED|Part 2||6
422696|NCT01532973|1035775|P5|STARTED|Part 2||6
422697|NCT01532973|1035776|P4|STARTED|Part 2||0
422698|NCT01532973|1035777|P3|STARTED|Part 2||0
422699|NCT01532973|1035778|P2|STARTED|Part 2||0
422700|NCT01532973|1035779|P1|STARTED|Part 2||0
422701|NCT01532973|1035770|P10|NOT COMPLETED|Part 1||0
422702|NCT01532973|1035771|P9|NOT COMPLETED|Part 1||0
422703|NCT01532973|1035772|P8|NOT COMPLETED|Part 1||0
422704|NCT01532973|1035773|P7|NOT COMPLETED|Part 1||0
422705|NCT01532973|1035774|P6|NOT COMPLETED|Part 1||0
422706|NCT01532973|1035775|P5|NOT COMPLETED|Part 1||0
422707|NCT01532973|1035776|P4|NOT COMPLETED|Part 1||0
422708|NCT01532973|1035777|P3|NOT COMPLETED|Part 1||0
422709|NCT01532973|1035778|P2|NOT COMPLETED|Part 1||0
422710|NCT01532973|1035779|P1|NOT COMPLETED|Part 1||0
422711|NCT01532973|1035770|P10|COMPLETED|Part 1||0
422712|NCT01532973|1035771|P9|COMPLETED|Part 1||0
422713|NCT01532973|1035772|P8|COMPLETED|Part 1||0
422714|NCT01532973|1035773|P7|COMPLETED|Part 1||0
422715|NCT01532973|1035774|P6|COMPLETED|Part 1||0
422716|NCT01532973|1035775|P5|COMPLETED|Part 1||0
422717|NCT01532973|1035776|P4|COMPLETED|Part 1||0
422718|NCT01532973|1035777|P3|COMPLETED|Part 1||6
422719|NCT01532973|1035778|P2|COMPLETED|Part 1||6
422720|NCT01532973|1035779|P1|COMPLETED|Part 1||6
422721|NCT01532973|1035770|P10|STARTED|Part 1||0
422722|NCT01532973|1035771|P9|STARTED|Part 1||0
422723|NCT01532973|1035772|P8|STARTED|Part 1||0
422724|NCT01532973|1035773|P7|STARTED|Part 1||0
422725|NCT01532973|1035774|P6|STARTED|Part 1||0
422726|NCT01532973|1035775|P5|STARTED|Part 1||0
422727|NCT01532973|1035776|P4|STARTED|Part 1|Planned panel not performed. No participants were enrolled.|0
422728|NCT01532973|1035777|P3|STARTED|Part 1||6
422729|NCT01532973|1035778|P2|STARTED|Part 1||6
422730|NCT01532973|1035779|P1|STARTED|Part 1||6
422731|NCT01532934|1035821|P2|NOT COMPLETED|Overall Study||13
422732|NCT01532934|1035822|P1|NOT COMPLETED|Overall Study||14
422733|NCT01532934|1035821|P2|COMPLETED|Overall Study||39
422734|NCT01532934|1035822|P1|COMPLETED|Overall Study||39
422735|NCT01532934|1035821|P2|STARTED|Overall Study||52
422736|NCT01532934|1035822|P1|STARTED|Overall Study||53
422737|NCT01532869|1035834|P2|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||3
422738|NCT01532869|1035835|P1|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||7
422739|NCT01532869|1035834|P2|COMPLETED|Open-label Period (Week 48 to Week 96)|Number of participants who completed study to Week 96.|27
422740|NCT01532869|1035835|P1|COMPLETED|Open-label Period (Week 48 to Week 96)|Number of participants who completed study to Week 96.|24
422741|NCT01532869|1035834|P2|STARTED|Open-label Period (Week 48 to Week 96)||30
422742|NCT01532869|1035835|P1|STARTED|Open-label Period (Week 48 to Week 96)|Two participants did not start the open label extension period.|31
422743|NCT01532869|1035834|P2|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||13
422744|NCT01532869|1035835|P1|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||11
422745|NCT01532869|1035834|P2|COMPLETED|Blinded-Treatment Period (Up to Week 48)|Number of participants who completed 48 weeks of blinded-treatment period.|30
422746|NCT01532869|1035835|P1|COMPLETED|Blinded-Treatment Period (Up to Week 48)|Number of participants who completed 48 weeks of blinded-treatment period.|33
422747|NCT01532869|1035834|P2|STARTED|Blinded-Treatment Period (Up to Week 48)||43
422748|NCT01532869|1035835|P1|STARTED|Blinded-Treatment Period (Up to Week 48)||44
422749|NCT01532869|1035834|P2|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8
422750|NCT01532869|1035835|P1|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8
422751|NCT01532869|1035834|P2|COMPLETED|Blinded-Treatment Period (Up to Week 24)|Number of participants who completed the first 24 weeks of full 48 weeks blinded-treatment period.|35
422752|NCT01532869|1035835|P1|COMPLETED|Blinded-Treatment Period (Up to Week 24)|Number of participants who completed the first 24 weeks of full 48 weeks blinded-treatment period.|36
422753|NCT01532869|1035834|P2|STARTED|Blinded-Treatment Period (Up to Week 24)||43
422754|NCT01532869|1035835|P1|STARTED|Blinded-Treatment Period (Up to Week 24)||44
422755|NCT01532830|1035872|P1|NOT COMPLETED|Overall Study||4
422756|NCT01532830|1035872|P1|COMPLETED|Overall Study||26
422757|NCT01532830|1035872|P1|STARTED|Overall Study||30
422758|NCT01532817|1035881|P1|NOT COMPLETED|Overall Study||0
422759|NCT01532817|1035881|P1|COMPLETED|Overall Study||30
422760|NCT01532817|1035881|P1|STARTED|Overall Study||30
422761|NCT01532635|1035885|P1|NOT COMPLETED|Overall Study||0
422762|NCT01532635|1035885|P1|COMPLETED|Overall Study||4
422763|NCT01532635|1035885|P1|STARTED|Overall Study||4
422764|NCT01532570|1035901|P4|NOT COMPLETED|Overall Study||0
422765|NCT01532570|1035902|P3|NOT COMPLETED|Overall Study||0
422766|NCT01532570|1035903|P2|NOT COMPLETED|Overall Study||1
422767|NCT01532570|1035904|P1|NOT COMPLETED|Overall Study||1
422768|NCT01532570|1035901|P4|COMPLETED|Overall Study||4
422769|NCT01532570|1035902|P3|COMPLETED|Overall Study||1
422770|NCT01532570|1035903|P2|COMPLETED|Overall Study||1
422771|NCT01532570|1035904|P1|COMPLETED|Overall Study||10
422772|NCT01532570|1035901|P4|STARTED|Overall Study||4
422773|NCT01532570|1035902|P3|STARTED|Overall Study||1
422774|NCT01532570|1035903|P2|STARTED|Overall Study||2
422775|NCT01532570|1035904|P1|STARTED|Overall Study||11
422776|NCT01532453|1035937|P2|NOT COMPLETED|Overall Study||70
422777|NCT01532453|1035938|P1|NOT COMPLETED|Overall Study||27
422778|NCT01532453|1035937|P2|COMPLETED|Overall Study||90
422779|NCT01532453|1035938|P1|COMPLETED|Overall Study||54
422780|NCT01532453|1035937|P2|STARTED|Overall Study||160
422781|NCT01532453|1035938|P1|STARTED|Overall Study||81
422782|NCT01532414|1035949|P3|NOT COMPLETED|Overall Study||3
422783|NCT01532414|1035950|P2|NOT COMPLETED|Overall Study||2
422784|NCT01532414|1035951|P1|NOT COMPLETED|Overall Study||7
422785|NCT01532414|1035949|P3|COMPLETED|Overall Study||35
422786|NCT01532414|1035950|P2|COMPLETED|Overall Study||19
422787|NCT01532414|1035951|P1|COMPLETED|Overall Study||85
422788|NCT01532414|1035949|P3|STARTED|Overall Study||38
422789|NCT01532414|1035950|P2|STARTED|Overall Study|Up-titrated at 6 weeks from a starting dose of 12.5 mg due to morning testosterone <300 ng/dL|21
422790|NCT01532414|1035951|P1|STARTED|Overall Study||92
422791|NCT01532362|1035961|P2|NOT COMPLETED|Overall Study||0
422792|NCT01532362|1035962|P1|NOT COMPLETED|Overall Study||0
422793|NCT01532362|1035961|P2|COMPLETED|Overall Study||0
422794|NCT01532362|1035962|P1|COMPLETED|Overall Study||1
422795|NCT01532362|1035961|P2|STARTED|Overall Study||0
422796|NCT01532362|1035962|P1|STARTED|Overall Study||1
422797|NCT01532349|1035970|P2|NOT COMPLETED|Overall Study||5
422798|NCT01532349|1035971|P1|NOT COMPLETED|Overall Study||2
422799|NCT01532349|1035970|P2|COMPLETED|Overall Study||12
422800|NCT01532349|1035971|P1|COMPLETED|Overall Study||15
422801|NCT01532349|1035970|P2|STARTED|Overall Study||17
422802|NCT01532349|1035971|P1|STARTED|Overall Study||17
422803|NCT01532141|1035980|P3|NOT COMPLETED|Overall Study||0
422804|NCT01532141|1035981|P2|NOT COMPLETED|Overall Study||0
422805|NCT01532141|1035982|P1|NOT COMPLETED|Overall Study||1
422806|NCT01532141|1035980|P3|COMPLETED|Overall Study||8
422807|NCT01532141|1035981|P2|COMPLETED|Overall Study||8
422808|NCT01532141|1035982|P1|COMPLETED|Overall Study||8
422809|NCT01532141|1035980|P3|Period 3|Overall Study||8
422810|NCT01532141|1035981|P2|Period 3|Overall Study||8
422811|NCT01532141|1035982|P1|Period 3|Overall Study||8
422812|NCT01532141|1035980|P3|Period 2|Overall Study||8
422813|NCT01532141|1035981|P2|Period 2|Overall Study||8
422814|NCT01532141|1035982|P1|Period 2|Overall Study||8
422815|NCT01532141|1035980|P3|Period 1|Overall Study||8
422816|NCT01532141|1035981|P2|Period 1|Overall Study||8
422817|NCT01532141|1035982|P1|Period 1|Overall Study||9
422818|NCT01532141|1035980|P3|STARTED|Overall Study||8
422819|NCT01532141|1035981|P2|STARTED|Overall Study||8
422820|NCT01532141|1035982|P1|STARTED|Overall Study||9
422821|NCT01532128|1036000|P3|NOT COMPLETED|Overall Study||0
422822|NCT01532128|1036001|P2|NOT COMPLETED|Overall Study||0
422823|NCT01532128|1036002|P1|NOT COMPLETED|Overall Study||0
422824|NCT01532128|1036000|P3|COMPLETED|Overall Study||8
422825|NCT01532128|1036001|P2|COMPLETED|Overall Study||8
422826|NCT01532128|1036002|P1|COMPLETED|Overall Study||8
422827|NCT01532128|1036000|P3|STARTED|Overall Study||8
422828|NCT01532128|1036001|P2|STARTED|Overall Study||8
422829|NCT01532128|1036002|P1|STARTED|Overall Study||8
422830|NCT01531998|1036017|P1|NOT COMPLETED|Overall Study||3
422831|NCT01531998|1036017|P1|COMPLETED|Overall Study||8
422832|NCT01531998|1036017|P1|STARTED|Overall Study||11
422833|NCT01531725|1036022|P1|NOT COMPLETED|Overall Study||5
422834|NCT01531725|1036022|P1|COMPLETED|Overall Study||197
422835|NCT01531725|1036022|P1|STARTED|Overall Study|5 patients with protocol violation were excluded.|202
422836|NCT01531673|1036040|P13|NOT COMPLETED|Overall Study||0
422837|NCT01531673|1036041|P12|NOT COMPLETED|Overall Study||0
422838|NCT01531673|1036042|P11|NOT COMPLETED|Overall Study||0
422839|NCT01531673|1036043|P10|NOT COMPLETED|Overall Study||1
422840|NCT01531673|1036044|P9|NOT COMPLETED|Overall Study||0
422841|NCT01531673|1036045|P8|NOT COMPLETED|Overall Study||0
422842|NCT01531673|1036046|P7|NOT COMPLETED|Overall Study||0
422843|NCT01531673|1036047|P6|NOT COMPLETED|Overall Study||1
422844|NCT01531673|1036048|P5|NOT COMPLETED|Overall Study||1
422845|NCT01531673|1036049|P4|NOT COMPLETED|Overall Study||1
422846|NCT01531673|1036050|P3|NOT COMPLETED|Overall Study||0
422847|NCT01531673|1036051|P2|NOT COMPLETED|Overall Study||1
422848|NCT01531673|1036052|P1|NOT COMPLETED|Overall Study||0
422849|NCT01531673|1036040|P13|COMPLETED|Overall Study||14
422850|NCT01531673|1036041|P12|COMPLETED|Overall Study||4
422851|NCT01531673|1036042|P11|COMPLETED|Overall Study||16
422852|NCT01531673|1036043|P10|COMPLETED|Overall Study||18
422853|NCT01531673|1036044|P9|COMPLETED|Overall Study||17
422854|NCT01531673|1036045|P8|COMPLETED|Overall Study||9
422855|NCT01531673|1036046|P7|COMPLETED|Overall Study||17
422856|NCT01531673|1036047|P6|COMPLETED|Overall Study||18
422857|NCT01531673|1036048|P5|COMPLETED|Overall Study||7
422858|NCT01531673|1036049|P4|COMPLETED|Overall Study||17
422859|NCT01531673|1036050|P3|COMPLETED|Overall Study||8
422860|NCT01531673|1036051|P2|COMPLETED|Overall Study||7
422861|NCT01531673|1036052|P1|COMPLETED|Overall Study||33
422862|NCT01531673|1036040|P13|STARTED|Overall Study||14
422863|NCT01531673|1036041|P12|STARTED|Overall Study||4
422864|NCT01531673|1036042|P11|STARTED|Overall Study||16
422865|NCT01531673|1036043|P10|STARTED|Overall Study||19
422866|NCT01531673|1036044|P9|STARTED|Overall Study||17
422867|NCT01531673|1036045|P8|STARTED|Overall Study||9
422868|NCT01531673|1036046|P7|STARTED|Overall Study||17
422869|NCT01531673|1036047|P6|STARTED|Overall Study||19
422870|NCT01531673|1036048|P5|STARTED|Overall Study||8
422871|NCT01531673|1036049|P4|STARTED|Overall Study||18
422872|NCT01531673|1036050|P3|STARTED|Overall Study||8
422873|NCT01531673|1036051|P2|STARTED|Overall Study||8
422874|NCT01531673|1036052|P1|STARTED|Overall Study||33
422875|NCT01531387|1036163|P2|NOT COMPLETED|Overall Study||11
422876|NCT01531387|1036164|P1|NOT COMPLETED|Overall Study||11
422877|NCT01531387|1036163|P2|COMPLETED|Overall Study||0
422878|NCT01531387|1036164|P1|COMPLETED|Overall Study||0
422879|NCT01531387|1036163|P2|STARTED|Overall Study||11
422880|NCT01531387|1036164|P1|STARTED|Overall Study||11
422881|NCT01531374|1036181|P3|NOT COMPLETED|Overall Study||283
422882|NCT01531374|1036182|P2|NOT COMPLETED|Overall Study||142
422883|NCT01531374|1036183|P1|NOT COMPLETED|Overall Study||364
422884|NCT01531374|1036181|P3|COMPLETED|Overall Study||836
422885|NCT01531374|1036182|P2|COMPLETED|Overall Study||231
422886|NCT01531374|1036183|P1|COMPLETED|Overall Study||921
422887|NCT01531374|1036181|P3|STARTED|Overall Study||1119
422888|NCT01531374|1036182|P2|STARTED|Overall Study||373
422889|NCT01531374|1036183|P1|STARTED|Overall Study||1285
422890|NCT01531335|1036247|P2|NOT COMPLETED|Overall Study||0
422891|NCT01531335|1036248|P1|NOT COMPLETED|Overall Study||0
422892|NCT01531335|1036247|P2|COMPLETED|Overall Study||40
422893|NCT01531335|1036248|P1|COMPLETED|Overall Study||40
422894|NCT01531335|1036247|P2|STARTED|Overall Study||40
422895|NCT01531335|1036248|P1|STARTED|Overall Study||40
422896|NCT01531205|1036256|P1|NOT COMPLETED|Overall Study||1
422897|NCT01531205|1036256|P1|COMPLETED|Overall Study||1
422898|NCT01531205|1036256|P1|STARTED|Overall Study||2
422899|NCT01530997|1036265|P1|NOT COMPLETED|Overall Study||2
422900|NCT01530997|1036265|P1|COMPLETED|Overall Study||43
422901|NCT01530997|1036265|P1|STARTED|Overall Study||45
422902|NCT01530880|1036285|P1|NOT COMPLETED|Overall Study||0
422903|NCT01530880|1036285|P1|COMPLETED|Overall Study||35
422904|NCT01530880|1036285|P1|STARTED|Overall Study||35
422905|NCT01530477|1036299|P3|NOT COMPLETED|Overall Study||0
422906|NCT01530477|1036300|P2|NOT COMPLETED|Overall Study||0
422907|NCT01530477|1036301|P1|NOT COMPLETED|Overall Study||0
422908|NCT01530477|1036299|P3|COMPLETED|Overall Study|53 subjects completed the imaging in both the Skeletal and Body Composition cohorts.|53
422909|NCT01530477|1036300|P2|COMPLETED|Overall Study|12 subjects completed imaging in the Body Composition cohort only.|12
422910|NCT01530477|1036301|P1|COMPLETED|Overall Study|17 subjects completed imaging in the Skeletal cohort only.|17
422911|NCT01530477|1036299|P3|STARTED|Overall Study|53 subjects consented to both the Skeletal and body Composition cohorts.|53
422912|NCT01530477|1036300|P2|STARTED|Overall Study|12 subjects consented to the Body Composition cohort only.|12
422913|NCT01530477|1036301|P1|STARTED|Overall Study|17 subjects consented to the Skeletal cohort only.|17
422914|NCT01530464|1036309|P2|NOT COMPLETED|Washout (24h)||1
422915|NCT01530464|1036310|P1|NOT COMPLETED|Washout (24h)||0
422916|NCT01530464|1036309|P2|COMPLETED|Washout (24h)|1 subject withdrew consent and left due to family emergencies|7
422917|NCT01530464|1036310|P1|COMPLETED|Washout (24h)||9
422918|NCT01530464|1036309|P2|STARTED|Washout (24h)||8
422919|NCT01530464|1036310|P1|STARTED|Washout (24h)||9
422920|NCT01530464|1036309|P2|NOT COMPLETED|Third Intervention (24h)||0
422921|NCT01530464|1036310|P1|NOT COMPLETED|Third Intervention (24h)||0
422922|NCT01530464|1036309|P2|COMPLETED|Third Intervention (24h)||8
422923|NCT01530464|1036310|P1|COMPLETED|Third Intervention (24h)||9
422924|NCT01530464|1036309|P2|STARTED|Third Intervention (24h)||8
422925|NCT01530464|1036310|P1|STARTED|Third Intervention (24h)||9
422926|NCT01530464|1036309|P2|NOT COMPLETED|Washout (24h)||0
422927|NCT01530464|1036310|P1|NOT COMPLETED|Washout (24h)||1
422928|NCT01530464|1036309|P2|COMPLETED|Washout (24h)||8
422929|NCT01530464|1036310|P1|COMPLETED|Washout (24h)|1 subject withdrew consent and left due to family emergencies|9
422930|NCT01530464|1036309|P2|STARTED|Washout (24h)||8
422931|NCT01530464|1036310|P1|STARTED|Washout (24h)||10
422932|NCT01530464|1036309|P2|NOT COMPLETED|Second Intervention (24h)||0
422933|NCT01530464|1036310|P1|NOT COMPLETED|Second Intervention (24h)||0
422934|NCT01530464|1036309|P2|COMPLETED|Second Intervention (24h)||8
422935|NCT01530464|1036310|P1|COMPLETED|Second Intervention (24h)||10
422936|NCT01530464|1036309|P2|STARTED|Second Intervention (24h)||8
422937|NCT01530464|1036310|P1|STARTED|Second Intervention (24h)||10
422938|NCT01530464|1036309|P2|NOT COMPLETED|Washout (24h)||0
422939|NCT01530464|1036310|P1|NOT COMPLETED|Washout (24h)||0
422940|NCT01530464|1036309|P2|COMPLETED|Washout (24h)||8
422941|NCT01530464|1036310|P1|COMPLETED|Washout (24h)||10
422942|NCT01530464|1036309|P2|STARTED|Washout (24h)||8
422943|NCT01530464|1036310|P1|STARTED|Washout (24h)||10
422944|NCT01530464|1036309|P2|NOT COMPLETED|First Intervention (24h)||0
422945|NCT01530464|1036310|P1|NOT COMPLETED|First Intervention (24h)||0
422946|NCT01530464|1036309|P2|COMPLETED|First Intervention (24h)||8
422947|NCT01530464|1036310|P1|COMPLETED|First Intervention (24h)||10
422948|NCT01530464|1036309|P2|STARTED|First Intervention (24h)||8
422949|NCT01530464|1036310|P1|STARTED|First Intervention (24h)||10
422950|NCT01530399|1036343|P6|NOT COMPLETED|Overall Study||1
422951|NCT01530399|1036344|P5|NOT COMPLETED|Overall Study||0
422952|NCT01530399|1036345|P4|NOT COMPLETED|Overall Study||0
422953|NCT01530399|1036346|P3|NOT COMPLETED|Overall Study||1
422954|NCT01530399|1036347|P2|NOT COMPLETED|Overall Study||2
422955|NCT01530399|1036348|P1|NOT COMPLETED|Overall Study||1
422956|NCT01530399|1036343|P6|COMPLETED|Overall Study||6
422957|NCT01530399|1036344|P5|COMPLETED|Overall Study||6
422958|NCT01530399|1036345|P4|COMPLETED|Overall Study||10
422959|NCT01530399|1036346|P3|COMPLETED|Overall Study||7
422960|NCT01530399|1036347|P2|COMPLETED|Overall Study||8
422961|NCT01530399|1036348|P1|COMPLETED|Overall Study||7
422962|NCT01530399|1036343|P6|STARTED|Overall Study||7
422963|NCT01530399|1036344|P5|STARTED|Overall Study||6
422964|NCT01530399|1036345|P4|STARTED|Overall Study||10
422965|NCT01530399|1036346|P3|STARTED|Overall Study||8
422966|NCT01530399|1036347|P2|STARTED|Overall Study||10
422967|NCT01530399|1036348|P1|STARTED|Overall Study||8
422968|NCT01530334|1036362|P1|NOT COMPLETED|Overall Study||51
422969|NCT01530334|1036362|P1|COMPLETED|Overall Study||10
422970|NCT01530334|1036362|P1|STARTED|Overall Study||61
422971|NCT01530243|1036375|P4|NOT COMPLETED|Overall Study||2
422972|NCT01530243|1036376|P3|NOT COMPLETED|Overall Study||3
422973|NCT01530243|1036377|P2|NOT COMPLETED|Overall Study||3
422974|NCT01530243|1036378|P1|NOT COMPLETED|Overall Study||2
422975|NCT01530243|1036375|P4|COMPLETED|Overall Study||24
422976|NCT01530243|1036376|P3|COMPLETED|Overall Study||23
422977|NCT01530243|1036377|P2|COMPLETED|Overall Study||23
422978|NCT01530243|1036378|P1|COMPLETED|Overall Study||24
422979|NCT01530243|1036375|P4|STARTED|Overall Study||26
422980|NCT01530243|1036376|P3|STARTED|Overall Study||26
422981|NCT01530243|1036377|P2|STARTED|Overall Study||26
422982|NCT01530243|1036378|P1|STARTED|Overall Study||26
422983|NCT01530087|1036396|P1|NOT COMPLETED|Overall Study||2
422984|NCT01530087|1036396|P1|COMPLETED|Overall Study||1
422985|NCT01530087|1036396|P1|STARTED|Overall Study||3
422989|NCT01529645|1036418|P10|NOT COMPLETED|Overall Study||0
422990|NCT01529645|1036419|P9|NOT COMPLETED|Overall Study||1
422991|NCT01529645|1036420|P8|NOT COMPLETED|Overall Study||0
422992|NCT01529645|1036421|P7|NOT COMPLETED|Overall Study||2
422993|NCT01529645|1036422|P6|NOT COMPLETED|Overall Study||1
422994|NCT01529645|1036423|P5|NOT COMPLETED|Overall Study||2
422995|NCT01529645|1036424|P4|NOT COMPLETED|Overall Study||2
422996|NCT01529645|1036425|P3|NOT COMPLETED|Overall Study||2
422997|NCT01529645|1036426|P2|NOT COMPLETED|Overall Study||1
422998|NCT01529645|1036427|P1|NOT COMPLETED|Overall Study||2
422999|NCT01529645|1036418|P10|COMPLETED|Overall Study||42
423000|NCT01529645|1036419|P9|COMPLETED|Overall Study||41
423001|NCT01529645|1036420|P8|COMPLETED|Overall Study||42
423002|NCT01529645|1036421|P7|COMPLETED|Overall Study||40
423003|NCT01529645|1036422|P6|COMPLETED|Overall Study||41
423004|NCT01529645|1036423|P5|COMPLETED|Overall Study||40
423005|NCT01529645|1036424|P4|COMPLETED|Overall Study||40
423006|NCT01529645|1036425|P3|COMPLETED|Overall Study||40
423007|NCT01529645|1036426|P2|COMPLETED|Overall Study||41
423008|NCT01529645|1036427|P1|COMPLETED|Overall Study||40
423009|NCT01529645|1036418|P10|STARTED|Overall Study||42
423010|NCT01529645|1036419|P9|STARTED|Overall Study||42
423011|NCT01529645|1036420|P8|STARTED|Overall Study||42
423012|NCT01529645|1036421|P7|STARTED|Overall Study||42
423013|NCT01529645|1036422|P6|STARTED|Overall Study||42
423014|NCT01529645|1036423|P5|STARTED|Overall Study||42
423015|NCT01529645|1036424|P4|STARTED|Overall Study||42
423016|NCT01529645|1036425|P3|STARTED|Overall Study||42
423017|NCT01529645|1036426|P2|STARTED|Overall Study||42
423018|NCT01529645|1036427|P1|STARTED|Overall Study||42
423019|NCT01529632|1036525|P2|NOT COMPLETED|Overall Study||3
423020|NCT01529632|1036526|P1|NOT COMPLETED|Overall Study||3
423021|NCT01529632|1036525|P2|COMPLETED|Overall Study||100
423022|NCT01529632|1036526|P1|COMPLETED|Overall Study||87
423023|NCT01529632|1036525|P2|STARTED|Overall Study||103
423024|NCT01529632|1036526|P1|STARTED|Overall Study||90
423025|NCT01529515|1036546|P4|NOT COMPLETED|DOUBLE BLIND PHASE||12
423026|NCT01529515|1036547|P3|NOT COMPLETED|DOUBLE BLIND PHASE||23
423027|NCT01529515|1036548|P2|NOT COMPLETED|DOUBLE BLIND PHASE||0
423028|NCT01529515|1036549|P1|NOT COMPLETED|DOUBLE BLIND PHASE||0
423029|NCT01529515|1036546|P4|COMPLETED|DOUBLE BLIND PHASE||148
423030|NCT01529515|1036547|P3|COMPLETED|DOUBLE BLIND PHASE||122
423031|NCT01529515|1036548|P2|COMPLETED|DOUBLE BLIND PHASE||0
423032|NCT01529515|1036549|P1|COMPLETED|DOUBLE BLIND PHASE||0
423033|NCT01529515|1036546|P4|STARTED|DOUBLE BLIND PHASE||160
423034|NCT01529515|1036547|P3|STARTED|DOUBLE BLIND PHASE||145
423035|NCT01529515|1036548|P2|STARTED|DOUBLE BLIND PHASE||0
423036|NCT01529515|1036549|P1|STARTED|DOUBLE BLIND PHASE||0
423037|NCT01529515|1036546|P4|NOT COMPLETED|MAINTENANCE PHASE||0
423038|NCT01529515|1036547|P3|NOT COMPLETED|MAINTENANCE PHASE||0
423039|NCT01529515|1036548|P2|NOT COMPLETED|MAINTENANCE PHASE||74
423040|NCT01529515|1036549|P1|NOT COMPLETED|MAINTENANCE PHASE||0
423041|NCT01529515|1036546|P4|COMPLETED|MAINTENANCE PHASE||0
423042|NCT01529515|1036547|P3|COMPLETED|MAINTENANCE PHASE||0
423043|NCT01529515|1036548|P2|COMPLETED|MAINTENANCE PHASE||305
423044|NCT01529515|1036549|P1|COMPLETED|MAINTENANCE PHASE||0
423045|NCT01529515|1036546|P4|STARTED|MAINTENANCE PHASE||0
423046|NCT01529515|1036547|P3|STARTED|MAINTENANCE PHASE||0
423047|NCT01529515|1036548|P2|STARTED|MAINTENANCE PHASE||379
423048|NCT01529515|1036549|P1|STARTED|MAINTENANCE PHASE||0
423049|NCT01529515|1036546|P4|NOT COMPLETED|TRANSITION PHASE||0
423050|NCT01529515|1036547|P3|NOT COMPLETED|TRANSITION PHASE||0
423051|NCT01529515|1036548|P2|NOT COMPLETED|TRANSITION PHASE||0
423052|NCT01529515|1036549|P1|NOT COMPLETED|TRANSITION PHASE||127
423053|NCT01529515|1036546|P4|COMPLETED|TRANSITION PHASE||0
423054|NCT01529515|1036547|P3|COMPLETED|TRANSITION PHASE||0
423055|NCT01529515|1036548|P2|COMPLETED|TRANSITION PHASE||0
423056|NCT01529515|1036549|P1|COMPLETED|TRANSITION PHASE||379
423057|NCT01529515|1036546|P4|STARTED|TRANSITION PHASE||0
423058|NCT01529515|1036547|P3|STARTED|TRANSITION PHASE||0
423059|NCT01529515|1036548|P2|STARTED|TRANSITION PHASE||0
423060|NCT01529515|1036549|P1|STARTED|TRANSITION PHASE||506
423061|NCT01529502|1036568|P6|NOT COMPLETED|Overall Study||0
423062|NCT01529502|1036569|P5|NOT COMPLETED|Overall Study||0
423063|NCT01529502|1036570|P4|NOT COMPLETED|Overall Study||2
423064|NCT01529502|1036571|P3|NOT COMPLETED|Overall Study||0
423065|NCT01529502|1036572|P2|NOT COMPLETED|Overall Study||0
423066|NCT01529502|1036573|P1|NOT COMPLETED|Overall Study||0
423067|NCT01529502|1036568|P6|COMPLETED|Overall Study||2
423068|NCT01529502|1036569|P5|COMPLETED|Overall Study||2
423069|NCT01529502|1036570|P4|COMPLETED|Overall Study||1
423070|NCT01529502|1036571|P3|COMPLETED|Overall Study||2
423071|NCT01529502|1036572|P2|COMPLETED|Overall Study||3
423072|NCT01529502|1036573|P1|COMPLETED|Overall Study||2
423073|NCT01529502|1036568|P6|STARTED|Overall Study||2
423074|NCT01529502|1036569|P5|STARTED|Overall Study||2
423075|NCT01529502|1036570|P4|STARTED|Overall Study||3
423076|NCT01529502|1036571|P3|STARTED|Overall Study||2
423077|NCT01529502|1036572|P2|STARTED|Overall Study||3
423078|NCT01529502|1036573|P1|STARTED|Overall Study||2
423079|NCT01529450|1036586|P2|NOT COMPLETED|Overall Study||2
423080|NCT01529450|1036587|P1|NOT COMPLETED|Overall Study||0
423081|NCT01529450|1036586|P2|COMPLETED|Overall Study||6
423082|NCT01529450|1036587|P1|COMPLETED|Overall Study||3
423083|NCT01529450|1036586|P2|STARTED|Overall Study||8
423084|NCT01529450|1036587|P1|STARTED|Overall Study||3
423085|NCT01529385|1036596|P2|NOT COMPLETED|Overall Study||1
423086|NCT01529385|1036597|P1|NOT COMPLETED|Overall Study||2
423087|NCT01529385|1036596|P2|COMPLETED|Overall Study||39
423088|NCT01529385|1036597|P1|COMPLETED|Overall Study||38
423089|NCT01529385|1036596|P2|Received Intervention|Overall Study||40
423090|NCT01529385|1036597|P1|Received Intervention|Overall Study|1 participant failed to show up to treatment allocation visit and was subsequently lost to follow up|39
423091|NCT01529385|1036596|P2|STARTED|Overall Study||40
423092|NCT01529385|1036597|P1|STARTED|Overall Study||40
423093|NCT01529346|1036626|P5|NOT COMPLETED|Overall Study||0
423094|NCT01529346|1036627|P4|NOT COMPLETED|Overall Study||0
423095|NCT01529346|1036628|P3|NOT COMPLETED|Overall Study||2
423096|NCT01529346|1036629|P2|NOT COMPLETED|Overall Study||1
423097|NCT01529346|1036630|P1|NOT COMPLETED|Overall Study||2
423098|NCT01529346|1036626|P5|COMPLETED|Overall Study||36
423099|NCT01529346|1036627|P4|COMPLETED|Overall Study||36
423100|NCT01529346|1036628|P3|COMPLETED|Overall Study||52
423101|NCT01529346|1036629|P2|COMPLETED|Overall Study||53
423102|NCT01529346|1036630|P1|COMPLETED|Overall Study||53
423103|NCT01529346|1036626|P5|STARTED|Overall Study||36
423104|NCT01529346|1036627|P4|STARTED|Overall Study||36
423105|NCT01529346|1036628|P3|STARTED|Overall Study||54
423106|NCT01529346|1036629|P2|STARTED|Overall Study||54
423107|NCT01529346|1036630|P1|STARTED|Overall Study||55
423108|NCT01529268|1036718|P2|NOT COMPLETED|Overall Study||3
423109|NCT01529268|1036719|P1|NOT COMPLETED|Overall Study||12
423110|NCT01529268|1036718|P2|COMPLETED|Overall Study||78
423111|NCT01529268|1036719|P1|COMPLETED|Overall Study||76
423112|NCT01529268|1036718|P2|Completed 52-week Biopsy|Overall Study||75
423113|NCT01529268|1036719|P1|Completed 52-week Biopsy|Overall Study||71
423114|NCT01529268|1036718|P2|STARTED|Overall Study||81
423115|NCT01529268|1036719|P1|STARTED|Overall Study||88
423116|NCT01529203|1036773|P1|NOT COMPLETED|Overall Study||3
423117|NCT01529203|1036773|P1|COMPLETED|Overall Study||57
423118|NCT01529203|1036773|P1|STARTED|Overall Study||60
423119|NCT01529112|1036781|P2|NOT COMPLETED|Overall Study||41
423120|NCT01529112|1036782|P1|NOT COMPLETED|Overall Study||69
423121|NCT01529112|1036781|P2|COMPLETED|Overall Study|Discontinued treatment-continued follow-up=5 (data cut-off date 21 January 2014)|5
423122|NCT01529112|1036782|P1|COMPLETED|Overall Study|On treatment=2, Discontinued treatment-continued follow-up=18 (data cut-off date 21 January 2014)|20
423123|NCT01529112|1036781|P2|STARTED|Overall Study||46
423124|NCT01529112|1036782|P1|STARTED|Overall Study||89
423125|NCT01528969|1036809|P2|NOT COMPLETED|Overall Study||0
423126|NCT01528969|1036810|P1|NOT COMPLETED|Overall Study||2
423127|NCT01528969|1036809|P2|COMPLETED|Overall Study||38
423128|NCT01528969|1036810|P1|COMPLETED|Overall Study||35
423129|NCT01528969|1036809|P2|STARTED|Overall Study||38
423130|NCT01528969|1036810|P1|STARTED|Overall Study||37
423131|NCT01528891|1036818|P2|NOT COMPLETED|Overall Study||0
423132|NCT01528891|1036819|P1|NOT COMPLETED|Overall Study||0
423133|NCT01528891|1036818|P2|COMPLETED|Overall Study||200
423134|NCT01528891|1036819|P1|COMPLETED|Overall Study||200
423135|NCT01528891|1036818|P2|STARTED|Overall Study||200
423136|NCT01528891|1036819|P1|STARTED|Overall Study||200
423137|NCT01528878|1036831|P1|NOT COMPLETED|Overall Study||0
423138|NCT01528878|1036831|P1|COMPLETED|Overall Study||30
423139|NCT01528878|1036831|P1|STARTED|Overall Study||30
423140|NCT01528787|1036843|P4|NOT COMPLETED|Overall Study||1
423141|NCT01528787|1036844|P3|NOT COMPLETED|Overall Study||1
423142|NCT01528787|1036845|P2|NOT COMPLETED|Overall Study||0
423143|NCT01528787|1036846|P1|NOT COMPLETED|Overall Study||0
423144|NCT01528787|1036843|P4|COMPLETED|Overall Study||22
423145|NCT01528787|1036844|P3|COMPLETED|Overall Study||18
423146|NCT01528787|1036845|P2|COMPLETED|Overall Study||21
423147|NCT01528787|1036846|P1|COMPLETED|Overall Study||22
423148|NCT01528787|1036843|P4|STARTED|Overall Study||23
423149|NCT01528787|1036844|P3|STARTED|Overall Study||19
423150|NCT01528787|1036845|P2|STARTED|Overall Study||21
423151|NCT01528787|1036846|P1|STARTED|Overall Study||22
423152|NCT01528735|1036858|P2|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||0
423153|NCT01528735|1036859|P1|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||1
423154|NCT01528735|1036858|P2|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||12
423155|NCT01528735|1036859|P1|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||10
423156|NCT01528735|1036858|P2|STARTED|Treatment Period 2: Faldap/PegIFN/RBV|One patient was treated with only PegIFN/RBV, as faldaprevir was discontinued due to adverse events|12
423157|NCT01528735|1036859|P1|STARTED|Treatment Period 2: Faldap/PegIFN/RBV||11
423158|NCT01528735|1036858|P2|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1
423159|NCT01528735|1036859|P1|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1
423160|NCT01528735|1036858|P2|COMPLETED|Treatment Period 1: Faldap/Del/RBV||12
423161|NCT01528735|1036859|P1|COMPLETED|Treatment Period 1: Faldap/Del/RBV||11
423162|NCT01528735|1036858|P2|STARTED|Treatment Period 1: Faldap/Del/RBV||13
423163|NCT01528735|1036859|P1|STARTED|Treatment Period 1: Faldap/Del/RBV||12
423164|NCT01528696|1036961|P2|NOT COMPLETED|Overall Study||19
423165|NCT01528696|1036962|P1|NOT COMPLETED|Overall Study||18
423166|NCT01528696|1036961|P2|COMPLETED|Overall Study||0
423167|NCT01528696|1036962|P1|COMPLETED|Overall Study||0
423168|NCT01528696|1036961|P2|Hospital Stay (2-5 Days)|Overall Study||19
423169|NCT01528696|1036962|P1|Hospital Stay (2-5 Days)|Overall Study||18
423170|NCT01528696|1036961|P2|STARTED|Overall Study||19
423171|NCT01528696|1036962|P1|STARTED|Overall Study||18
423172|NCT01528605|1036978|P6|NOT COMPLETED|Overall Study||0
423173|NCT01528605|1036979|P5|NOT COMPLETED|Overall Study||0
423174|NCT01528605|1036980|P4|NOT COMPLETED|Overall Study||1
423175|NCT01528605|1036981|P3|NOT COMPLETED|Overall Study||1
423176|NCT01528605|1036982|P2|NOT COMPLETED|Overall Study||0
423177|NCT01528605|1036983|P1|NOT COMPLETED|Overall Study||2
423178|NCT01528605|1036978|P6|COMPLETED|Overall Study||28
423179|NCT01528605|1036979|P5|COMPLETED|Overall Study||28
423180|NCT01528605|1036980|P4|COMPLETED|Overall Study||27
423181|NCT01528605|1036981|P3|COMPLETED|Overall Study||27
423182|NCT01528605|1036982|P2|COMPLETED|Overall Study||28
423183|NCT01528605|1036983|P1|COMPLETED|Overall Study||26
423184|NCT01528605|1036978|P6|STARTED|Overall Study||28
423185|NCT01528605|1036979|P5|STARTED|Overall Study||28
423186|NCT01528605|1036980|P4|STARTED|Overall Study||28
423187|NCT01528605|1036981|P3|STARTED|Overall Study||28
423188|NCT01528605|1036982|P2|STARTED|Overall Study||28
423189|NCT01528605|1036983|P1|STARTED|Overall Study||28
423190|NCT01528592|1037007|P1|NOT COMPLETED|Overall Study||0
423191|NCT01528592|1037007|P1|COMPLETED|Overall Study||18
423192|NCT01528592|1037007|P1|STARTED|Overall Study||18
423193|NCT01528345|1037013|P2|NOT COMPLETED|Overall Study||50
423194|NCT01528345|1037014|P1|NOT COMPLETED|Overall Study||47
423195|NCT01528345|1037013|P2|COMPLETED|Overall Study||0
423196|NCT01528345|1037014|P1|COMPLETED|Overall Study||0
423197|NCT01528345|1037013|P2|STARTED|Overall Study||50
423198|NCT01528345|1037014|P1|STARTED|Overall Study||47
423199|NCT01528332|1037032|P2|NOT COMPLETED|Overall Study||2
423200|NCT01528332|1037033|P1|NOT COMPLETED|Overall Study||4
423201|NCT01528332|1037032|P2|COMPLETED|Overall Study||84
423202|NCT01528332|1037033|P1|COMPLETED|Overall Study||81
423203|NCT01528332|1037032|P2|STARTED|Overall Study||86
423204|NCT01528332|1037033|P1|STARTED|Overall Study||85
423205|NCT01528319|1037039|P1|NOT COMPLETED|Overall Study||1
423206|NCT01528319|1037039|P1|COMPLETED|Overall Study||23
423207|NCT01528319|1037039|P1|12 Weeks After Surgery|Overall Study||24
423208|NCT01528319|1037039|P1|STARTED|Overall Study||24
423209|NCT01528293|1037050|P2|NOT COMPLETED|Overall Study||0
423210|NCT01528293|1037051|P1|NOT COMPLETED|Overall Study||1
423211|NCT01528293|1037050|P2|COMPLETED|Overall Study||1
423212|NCT01528293|1037051|P1|COMPLETED|Overall Study||0
423213|NCT01528293|1037050|P2|STARTED|Overall Study||1
423214|NCT01528293|1037051|P1|STARTED|Overall Study||1
423215|NCT01528215|1037065|P2|NOT COMPLETED|Overall Study||1
423216|NCT01528215|1037066|P1|NOT COMPLETED|Overall Study||4
423217|NCT01528215|1037065|P2|COMPLETED|Overall Study||60
423218|NCT01528215|1037066|P1|COMPLETED|Overall Study||55
423219|NCT01528215|1037065|P2|STARTED|Overall Study||61
423220|NCT01528215|1037066|P1|STARTED|Overall Study||59
423221|NCT01528150|1037072|P1|NOT COMPLETED|Overall Study||44
423222|NCT01528150|1037072|P1|COMPLETED|Overall Study||422
423223|NCT01528150|1037072|P1|STARTED|Overall Study||466
423224|NCT01527942|1037078|P2|NOT COMPLETED|Overall Study||0
423225|NCT01527942|1037079|P1|NOT COMPLETED|Overall Study||0
423226|NCT01527942|1037078|P2|COMPLETED|Overall Study||18
423227|NCT01527942|1037079|P1|COMPLETED|Overall Study||16
423228|NCT01527942|1037078|P2|STARTED|Overall Study||18
423229|NCT01527942|1037079|P1|STARTED|Overall Study||16
423230|NCT01527513|1037091|P2|NOT COMPLETED|Eligible for 1-Year Open Label Period||17
423231|NCT01527513|1037092|P1|NOT COMPLETED|Eligible for 1-Year Open Label Period||0
423232|NCT01527513|1037091|P2|COMPLETED|Eligible for 1-Year Open Label Period||95
423233|NCT01527513|1037092|P1|COMPLETED|Eligible for 1-Year Open Label Period||0
423234|NCT01527513|1037091|P2|STARTED|Eligible for 1-Year Open Label Period|Participants that were eligible to participate in for 1-Year Open Label Period - Part II|112
423235|NCT01527513|1037092|P1|STARTED|Eligible for 1-Year Open Label Period||0
423236|NCT01527513|1037091|P2|NOT COMPLETED|Double Blind Period (DB) - Part I||8
423237|NCT01527513|1037092|P1|NOT COMPLETED|Double Blind Period (DB) - Part I||3
423238|NCT01527513|1037091|P2|COMPLETED|Double Blind Period (DB) - Part I||75
423239|NCT01527513|1037092|P1|COMPLETED|Double Blind Period (DB) - Part I||37
423240|NCT01527513|1037091|P2|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||66
423241|NCT01527513|1037092|P1|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||36
423242|NCT01527513|1037091|P2|Efficacy PP Population|Double Blind Period (DB) - Part I||67
423243|NCT01527513|1037092|P1|Efficacy PP Population|Double Blind Period (DB) - Part I||37
423244|NCT01527513|1037091|P2|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||75
423245|NCT01527513|1037092|P1|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||37
423246|NCT01527513|1037091|P2|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||75
423247|NCT01527513|1037092|P1|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||37
423248|NCT01527513|1037091|P2|Entered Maintenance Period|Double Blind Period (DB) - Part I||76
423249|NCT01527513|1037092|P1|Entered Maintenance Period|Double Blind Period (DB) - Part I||40
423250|NCT01527513|1037091|P2|Safety Population|Double Blind Period (DB) - Part I||83
423251|NCT01527513|1037092|P1|Safety Population|Double Blind Period (DB) - Part I||40
423252|NCT01527513|1037091|P2|Randomized|Double Blind Period (DB) - Part I||83
423253|NCT01527513|1037092|P1|Randomized|Double Blind Period (DB) - Part I||40
423254|NCT01527513|1037091|P2|STARTED|Double Blind Period (DB) - Part I||83
423255|NCT01527513|1037092|P1|STARTED|Double Blind Period (DB) - Part I||40
423256|NCT01527487|1037104|P2|NOT COMPLETED|Overall Study||7
423257|NCT01527487|1037105|P1|NOT COMPLETED|Overall Study||8
423258|NCT01527487|1037104|P2|COMPLETED|Overall Study||15
423259|NCT01527487|1037105|P1|COMPLETED|Overall Study|Patients who completed 6 cycles plus surgery.|46
423260|NCT01527487|1037104|P2|STARTED|Overall Study||22
423261|NCT01527487|1037105|P1|STARTED|Overall Study|Includes 10 patients from safety lead-in.|54
423262|NCT01527370|1037117|P1|NOT COMPLETED|Overall Study||6
423263|NCT01527370|1037117|P1|COMPLETED|Overall Study||244
423264|NCT01527370|1037117|P1|STARTED|Overall Study||250
423265|NCT01527162|1037123|P2|NOT COMPLETED|Overall Study||0
423266|NCT01527162|1037124|P1|NOT COMPLETED|Overall Study||0
423267|NCT01527162|1037123|P2|COMPLETED|Overall Study||5
423268|NCT01527162|1037124|P1|COMPLETED|Overall Study||6
423269|NCT01527162|1037123|P2|STARTED|Overall Study||5
423270|NCT01527162|1037124|P1|STARTED|Overall Study||6
423271|NCT01527110|1037134|P1|NOT COMPLETED|Overall Study||1
423272|NCT01527110|1037134|P1|COMPLETED|Overall Study||20
423273|NCT01527110|1037134|P1|STARTED|Overall Study||21
423274|NCT01527006|1037181|P2|NOT COMPLETED|Extension Phase||8
423275|NCT01527006|1037182|P1|NOT COMPLETED|Extension Phase||6
423276|NCT01527006|1037181|P2|COMPLETED|Extension Phase||14
423277|NCT01527006|1037182|P1|COMPLETED|Extension Phase||13
423278|NCT01527006|1037181|P2|STARTED|Extension Phase||22
423279|NCT01527006|1037182|P1|STARTED|Extension Phase|Of the 20 subjects who completed the Core Study, 19 subjects continued into the Extension Phase.|19
423280|NCT01527006|1037181|P2|NOT COMPLETED|Core Study||6
423281|NCT01527006|1037182|P1|NOT COMPLETED|Core Study||2
423282|NCT01527006|1037181|P2|COMPLETED|Core Study||22
423283|NCT01527006|1037182|P1|COMPLETED|Core Study||20
423284|NCT01527006|1037181|P2|STARTED|Core Study||28
423285|NCT01527006|1037182|P1|STARTED|Core Study||22
423286|NCT01526902|1037232|P2|NOT COMPLETED|Overall Study||0
423287|NCT01526902|1037233|P1|NOT COMPLETED|Overall Study||0
423288|NCT01526902|1037232|P2|COMPLETED|Overall Study||24
423289|NCT01526902|1037233|P1|COMPLETED|Overall Study||25
423290|NCT01526902|1037232|P2|STARTED|Overall Study||24
423291|NCT01526902|1037233|P1|STARTED|Overall Study||25
423292|NCT01526785|1037249|P1|NOT COMPLETED|Overall Study||13
423293|NCT01526785|1037249|P1|COMPLETED|Overall Study||100
423294|NCT01526785|1037249|P1|STARTED|Overall Study||113
423295|NCT01526733|1037259|P2|NOT COMPLETED|Phase 2||0
423296|NCT01526733|1037260|P1|NOT COMPLETED|Phase 2||0
423297|NCT01526733|1037259|P2|COMPLETED|Phase 2||12
423298|NCT01526733|1037260|P1|COMPLETED|Phase 2||10
423299|NCT01526733|1037259|P2|STARTED|Phase 2||12
423300|NCT01526733|1037260|P1|STARTED|Phase 2||10
423301|NCT01526733|1037259|P2|NOT COMPLETED|Washout Period of 5 to 21 Days||0
423302|NCT01526733|1037260|P1|NOT COMPLETED|Washout Period of 5 to 21 Days||0
423303|NCT01526733|1037259|P2|COMPLETED|Washout Period of 5 to 21 Days||12
423304|NCT01526733|1037260|P1|COMPLETED|Washout Period of 5 to 21 Days||10
423305|NCT01526733|1037259|P2|STARTED|Washout Period of 5 to 21 Days||12
423306|NCT01526733|1037260|P1|STARTED|Washout Period of 5 to 21 Days||10
423307|NCT01526733|1037259|P2|NOT COMPLETED|Phase 1||1
423308|NCT01526733|1037260|P1|NOT COMPLETED|Phase 1||2
423309|NCT01526733|1037259|P2|COMPLETED|Phase 1||12
423310|NCT01526733|1037260|P1|COMPLETED|Phase 1||10
423311|NCT01526733|1037259|P2|Received at Least 1 Dose of Study Drug|Phase 1||13
423312|NCT01526733|1037260|P1|Received at Least 1 Dose of Study Drug|Phase 1||12
423313|NCT01526733|1037259|P2|STARTED|Phase 1|One participant discontinued after receiving insulin-sham and before receiving insulin-rHuPH20.|13
423314|NCT01526733|1037260|P1|STARTED|Phase 1||12
423315|NCT01526629|1037278|P1|NOT COMPLETED|Overall Study||46
423316|NCT01526629|1037278|P1|COMPLETED|Overall Study||308
423317|NCT01526629|1037278|P1|STARTED|Overall Study||354
423318|NCT01526551|1037282|P1|NOT COMPLETED|Overall Study||424
423319|NCT01526551|1037282|P1|COMPLETED|Overall Study||511
423320|NCT01526551|1037282|P1|STARTED|Overall Study||935
423321|NCT01526538|1037289|P2|NOT COMPLETED|Overall Study||4
423322|NCT01526538|1037290|P1|NOT COMPLETED|Overall Study||9
423323|NCT01526538|1037289|P2|COMPLETED|Overall Study||18
423324|NCT01526538|1037290|P1|COMPLETED|Overall Study||21
423325|NCT01526538|1037289|P2|STARTED|Overall Study||22
423326|NCT01526538|1037290|P1|STARTED|Overall Study||30
423327|NCT01526343|1037300|P1|NOT COMPLETED|Overall Study||0
423328|NCT01526343|1037300|P1|COMPLETED|Overall Study||47
423329|NCT01526343|1037300|P1|STARTED|Overall Study||47
423330|NCT01526213|1037311|P6|NOT COMPLETED|Period 3 (5 Days)||0
423331|NCT01526213|1037312|P5|NOT COMPLETED|Period 3 (5 Days)||0
423332|NCT01526213|1037313|P4|NOT COMPLETED|Period 3 (5 Days)||0
423333|NCT01526213|1037314|P3|NOT COMPLETED|Period 3 (5 Days)||0
423334|NCT01526213|1037315|P2|NOT COMPLETED|Period 3 (5 Days)||0
423335|NCT01526213|1037316|P1|NOT COMPLETED|Period 3 (5 Days)||0
423336|NCT01526213|1037311|P6|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
423337|NCT01526213|1037312|P5|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
423338|NCT01526213|1037313|P4|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
423339|NCT01526213|1037314|P3|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
423340|NCT01526213|1037315|P2|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
423497|NCT01525420|1037618|P1|STARTED|Overall Study||59
423341|NCT01526213|1037316|P1|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
423342|NCT01526213|1037311|P6|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
423343|NCT01526213|1037312|P5|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
423344|NCT01526213|1037313|P4|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
423345|NCT01526213|1037314|P3|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
423346|NCT01526213|1037315|P2|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
423347|NCT01526213|1037316|P1|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
423348|NCT01526213|1037311|P6|NOT COMPLETED|Washout 2 (10 Days)||0
423349|NCT01526213|1037312|P5|NOT COMPLETED|Washout 2 (10 Days)||0
423350|NCT01526213|1037313|P4|NOT COMPLETED|Washout 2 (10 Days)||0
423351|NCT01526213|1037314|P3|NOT COMPLETED|Washout 2 (10 Days)||0
423352|NCT01526213|1037315|P2|NOT COMPLETED|Washout 2 (10 Days)||0
423353|NCT01526213|1037316|P1|NOT COMPLETED|Washout 2 (10 Days)||0
423354|NCT01526213|1037311|P6|COMPLETED|Washout 2 (10 Days)||3
423355|NCT01526213|1037312|P5|COMPLETED|Washout 2 (10 Days)||3
423356|NCT01526213|1037313|P4|COMPLETED|Washout 2 (10 Days)||3
423357|NCT01526213|1037314|P3|COMPLETED|Washout 2 (10 Days)||3
423358|NCT01526213|1037315|P2|COMPLETED|Washout 2 (10 Days)||3
423359|NCT01526213|1037316|P1|COMPLETED|Washout 2 (10 Days)||3
423360|NCT01526213|1037311|P6|STARTED|Washout 2 (10 Days)||3
423361|NCT01526213|1037312|P5|STARTED|Washout 2 (10 Days)||3
423362|NCT01526213|1037313|P4|STARTED|Washout 2 (10 Days)||3
423363|NCT01526213|1037314|P3|STARTED|Washout 2 (10 Days)||3
423364|NCT01526213|1037315|P2|STARTED|Washout 2 (10 Days)||3
423365|NCT01526213|1037316|P1|STARTED|Washout 2 (10 Days)||3
423366|NCT01526213|1037311|P6|NOT COMPLETED|Period 2 (5 Days)||0
423367|NCT01526213|1037312|P5|NOT COMPLETED|Period 2 (5 Days)||0
423368|NCT01526213|1037313|P4|NOT COMPLETED|Period 2 (5 Days)||0
423369|NCT01526213|1037314|P3|NOT COMPLETED|Period 2 (5 Days)||0
423370|NCT01526213|1037315|P2|NOT COMPLETED|Period 2 (5 Days)||0
423371|NCT01526213|1037316|P1|NOT COMPLETED|Period 2 (5 Days)||0
423372|NCT01526213|1037311|P6|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
423373|NCT01526213|1037312|P5|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
423374|NCT01526213|1037313|P4|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
423375|NCT01526213|1037314|P3|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
423376|NCT01526213|1037315|P2|COMPLETED|Period 2 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
423377|NCT01526213|1037316|P1|COMPLETED|Period 2 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
423378|NCT01526213|1037311|P6|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
423379|NCT01526213|1037312|P5|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
423380|NCT01526213|1037313|P4|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
423381|NCT01526213|1037314|P3|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
423382|NCT01526213|1037315|P2|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
423383|NCT01526213|1037316|P1|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
423384|NCT01526213|1037311|P6|NOT COMPLETED|Washout 1 (10 Days)||0
423385|NCT01526213|1037312|P5|NOT COMPLETED|Washout 1 (10 Days)||0
423386|NCT01526213|1037313|P4|NOT COMPLETED|Washout 1 (10 Days)||0
423387|NCT01526213|1037314|P3|NOT COMPLETED|Washout 1 (10 Days)||0
423388|NCT01526213|1037315|P2|NOT COMPLETED|Washout 1 (10 Days)||0
423389|NCT01526213|1037316|P1|NOT COMPLETED|Washout 1 (10 Days)||0
423390|NCT01526213|1037311|P6|COMPLETED|Washout 1 (10 Days)||3
423391|NCT01526213|1037312|P5|COMPLETED|Washout 1 (10 Days)||3
423392|NCT01526213|1037313|P4|COMPLETED|Washout 1 (10 Days)||3
423393|NCT01526213|1037314|P3|COMPLETED|Washout 1 (10 Days)||3
423394|NCT01526213|1037315|P2|COMPLETED|Washout 1 (10 Days)||3
423395|NCT01526213|1037316|P1|COMPLETED|Washout 1 (10 Days)||3
423396|NCT01526213|1037311|P6|STARTED|Washout 1 (10 Days)||3
423397|NCT01526213|1037312|P5|STARTED|Washout 1 (10 Days)||3
423398|NCT01526213|1037313|P4|STARTED|Washout 1 (10 Days)||3
423399|NCT01526213|1037314|P3|STARTED|Washout 1 (10 Days)||3
423400|NCT01526213|1037315|P2|STARTED|Washout 1 (10 Days)||3
423401|NCT01526213|1037316|P1|STARTED|Washout 1 (10 Days)||3
423402|NCT01526213|1037311|P6|NOT COMPLETED|Period 1 (5 Days)||0
423403|NCT01526213|1037312|P5|NOT COMPLETED|Period 1 (5 Days)||0
423404|NCT01526213|1037313|P4|NOT COMPLETED|Period 1 (5 Days)||0
423405|NCT01526213|1037314|P3|NOT COMPLETED|Period 1 (5 Days)||0
423406|NCT01526213|1037315|P2|NOT COMPLETED|Period 1 (5 Days)||0
423407|NCT01526213|1037316|P1|NOT COMPLETED|Period 1 (5 Days)||0
423408|NCT01526213|1037311|P6|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
423409|NCT01526213|1037312|P5|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
423410|NCT01526213|1037313|P4|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
423411|NCT01526213|1037314|P3|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
423498|NCT01525407|1037626|P2|NOT COMPLETED|Overall Study||4
423412|NCT01526213|1037315|P2|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
423413|NCT01526213|1037316|P1|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
423414|NCT01526213|1037311|P6|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to (and completed) one of six sequences.|3
423415|NCT01526213|1037312|P5|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
423416|NCT01526213|1037313|P4|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
423417|NCT01526213|1037314|P3|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
423418|NCT01526213|1037315|P2|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
423419|NCT01526213|1037316|P1|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
423420|NCT01526148|1037329|P2|NOT COMPLETED|Overall Study||13
423421|NCT01526148|1037330|P1|NOT COMPLETED|Overall Study||14
423422|NCT01526148|1037329|P2|COMPLETED|Overall Study||11
423423|NCT01526148|1037330|P1|COMPLETED|Overall Study||4
423424|NCT01526148|1037329|P2|STARTED|Overall Study||24
423425|NCT01526148|1037330|P1|STARTED|Overall Study||18
423426|NCT01525927|1037340|P1|NOT COMPLETED|Overall Study||0
423427|NCT01525927|1037340|P1|COMPLETED|Overall Study||0
423428|NCT01525927|1037340|P1|STARTED|Overall Study||0
423429|NCT01525849|1037354|P2|NOT COMPLETED|Overall Study||16
423430|NCT01525849|1037355|P1|NOT COMPLETED|Overall Study||5
423431|NCT01525849|1037354|P2|COMPLETED|Overall Study||59
423432|NCT01525849|1037355|P1|COMPLETED|Overall Study||71
423433|NCT01525849|1037354|P2|6-Months|Overall Study||60
423434|NCT01525849|1037355|P1|6-Months|Overall Study||73
423435|NCT01525849|1037354|P2|Treated|Overall Study|14 withdrew before treatment: 8 didn't want FESS, 1 too busy, 2 medical issues, 3 excl. criteria.|61
423436|NCT01525849|1037355|P1|Treated|Overall Study|2 withdrew before treatment: 1 didn't want balloon dilation, 1 unrelated medical issue.|74
423437|NCT01525849|1037354|P2|STARTED|Overall Study||75
423438|NCT01525849|1037355|P1|STARTED|Overall Study||76
423439|NCT01525745|1037371|P2|NOT COMPLETED|Overall Study||1
423440|NCT01525745|1037372|P1|NOT COMPLETED|Overall Study||1
423441|NCT01525745|1037371|P2|COMPLETED|Overall Study||1
423442|NCT01525745|1037372|P1|COMPLETED|Overall Study||3
423443|NCT01525745|1037371|P2|STARTED|Overall Study||2
423444|NCT01525745|1037372|P1|STARTED|Overall Study||4
423445|NCT01525667|1037389|P3|NOT COMPLETED|Overall Study||0
423446|NCT01525667|1037390|P2|NOT COMPLETED|Overall Study||0
423447|NCT01525667|1037391|P1|NOT COMPLETED|Overall Study||0
423448|NCT01525667|1037389|P3|COMPLETED|Overall Study||7
423449|NCT01525667|1037390|P2|COMPLETED|Overall Study||6
423450|NCT01525667|1037391|P1|COMPLETED|Overall Study||7
423451|NCT01525667|1037389|P3|STARTED|Overall Study||7
423452|NCT01525667|1037390|P2|STARTED|Overall Study||6
423453|NCT01525667|1037391|P1|STARTED|Overall Study||7
423454|NCT01525641|1037411|P1|NOT COMPLETED|Overall Study||180
423455|NCT01525641|1037411|P1|COMPLETED|Overall Study||435
423456|NCT01525641|1037411|P1|STARTED|Overall Study||615
423457|NCT01525628|1037425|P5|NOT COMPLETED|Overall Study||3
423458|NCT01525628|1037426|P4|NOT COMPLETED|Overall Study||4
423459|NCT01525628|1037427|P3|NOT COMPLETED|Overall Study||5
423460|NCT01525628|1037428|P2|NOT COMPLETED|Overall Study||5
423461|NCT01525628|1037429|P1|NOT COMPLETED|Overall Study||2
423462|NCT01525628|1037425|P5|COMPLETED|Overall Study||4
423463|NCT01525628|1037426|P4|COMPLETED|Overall Study||10
423464|NCT01525628|1037427|P3|COMPLETED|Overall Study||11
423465|NCT01525628|1037428|P2|COMPLETED|Overall Study||14
423466|NCT01525628|1037429|P1|COMPLETED|Overall Study||14
423467|NCT01525628|1037425|P5|STARTED|Overall Study||7
423468|NCT01525628|1037426|P4|STARTED|Overall Study||14
423469|NCT01525628|1037427|P3|STARTED|Overall Study||16
423470|NCT01525628|1037428|P2|STARTED|Overall Study||19
423471|NCT01525628|1037429|P1|STARTED|Overall Study||16
423472|NCT01525615|1037496|P3|NOT COMPLETED|Overall Study||6
423473|NCT01525615|1037497|P2|NOT COMPLETED|Overall Study||7
423474|NCT01525615|1037498|P1|NOT COMPLETED|Overall Study||14
423475|NCT01525615|1037496|P3|COMPLETED|Overall Study||133
423476|NCT01525615|1037497|P2|COMPLETED|Overall Study||126
423477|NCT01525615|1037498|P1|COMPLETED|Overall Study||118
423478|NCT01525615|1037496|P3|STARTED|Overall Study||139
423479|NCT01525615|1037497|P2|STARTED|Overall Study||133
423480|NCT01525615|1037498|P1|STARTED|Overall Study||132
423481|NCT01525563|1037542|P1|NOT COMPLETED|Overall Study||212
423482|NCT01525563|1037542|P1|COMPLETED|Overall Study|6 Months Follow-up|788
423483|NCT01525563|1037542|P1|3 Months Follow-up|Overall Study|Only patients who had cycle regularization at end of treatment were allowed to continue.|838
423484|NCT01525563|1037542|P1|End of Treatment|Overall Study|Only patients who had cycle regularization at end of treatment were allowed to continue.|910
423485|NCT01525563|1037542|P1|STARTED|Overall Study||1000
423486|NCT01525550|1037554|P2|NOT COMPLETED|Overall Study||45
423487|NCT01525550|1037555|P1|NOT COMPLETED|Overall Study||61
423488|NCT01525550|1037554|P2|COMPLETED|Overall Study||0
423489|NCT01525550|1037555|P1|COMPLETED|Overall Study||0
423490|NCT01525550|1037554|P2|STARTED|Overall Study||45
423491|NCT01525550|1037555|P1|STARTED|Overall Study||61
423492|NCT01525420|1037617|P2|NOT COMPLETED|Overall Study||24
423493|NCT01525420|1037618|P1|NOT COMPLETED|Overall Study||16
423494|NCT01525420|1037617|P2|COMPLETED|Overall Study||38
423495|NCT01525420|1037618|P1|COMPLETED|Overall Study||43
423496|NCT01525420|1037617|P2|STARTED|Overall Study||62
423499|NCT01525407|1037627|P1|NOT COMPLETED|Overall Study||3
423500|NCT01525407|1037626|P2|COMPLETED|Overall Study||38
423501|NCT01525407|1037627|P1|COMPLETED|Overall Study||38
423502|NCT01525407|1037626|P2|STARTED|Overall Study||42
423503|NCT01525407|1037627|P1|STARTED|Overall Study||41
423504|NCT01525238|1037644|P3|NOT COMPLETED|Overall Study||0
423505|NCT01525238|1037645|P2|NOT COMPLETED|Overall Study||0
423506|NCT01525238|1037646|P1|NOT COMPLETED|Overall Study||1
423507|NCT01525238|1037644|P3|COMPLETED|Overall Study||8
423508|NCT01525238|1037645|P2|COMPLETED|Overall Study||8
423509|NCT01525238|1037646|P1|COMPLETED|Overall Study||7
423510|NCT01525238|1037644|P3|STARTED|Overall Study||8
423511|NCT01525238|1037645|P2|STARTED|Overall Study||8
423512|NCT01525238|1037646|P1|STARTED|Overall Study||8
423513|NCT01525225|1037711|P1|NOT COMPLETED|Treated||0
423514|NCT01525225|1037711|P1|COMPLETED|Treated||2
423515|NCT01525225|1037711|P1|STARTED|Treated||2
423516|NCT01525225|1037711|P1|NOT COMPLETED|Enrollment||2
423517|NCT01525225|1037711|P1|COMPLETED|Enrollment||2
423518|NCT01525225|1037711|P1|STARTED|Enrollment||4
423519|NCT01525173|1037718|P2|NOT COMPLETED|Overall Study||5
423520|NCT01525173|1037719|P1|NOT COMPLETED|Overall Study||7
423521|NCT01525173|1037718|P2|COMPLETED|Overall Study||62
423522|NCT01525173|1037719|P1|COMPLETED|Overall Study||63
423523|NCT01525173|1037718|P2|STARTED|Overall Study||67
423524|NCT01525173|1037719|P1|STARTED|Overall Study||70
423525|NCT01524978|1037736|P11|NOT COMPLETED|Overall Study||28
423526|NCT01524978|1037737|P10|NOT COMPLETED|Overall Study||9
423527|NCT01524978|1037738|P9|NOT COMPLETED|Overall Study||12
423528|NCT01524978|1037739|P8|NOT COMPLETED|Overall Study||12
423529|NCT01524978|1037740|P7|NOT COMPLETED|Overall Study||26
423530|NCT01524978|1037741|P6|NOT COMPLETED|Overall Study||9
423531|NCT01524978|1037742|P5|NOT COMPLETED|Overall Study||9
423532|NCT01524978|1037743|P4|NOT COMPLETED|Overall Study||27
423533|NCT01524978|1037744|P3|NOT COMPLETED|Overall Study||10
423534|NCT01524978|1037745|P2|NOT COMPLETED|Overall Study||4
423535|NCT01524978|1037746|P1|NOT COMPLETED|Overall Study||62
423536|NCT01524978|1037736|P11|COMPLETED|Overall Study||0
423537|NCT01524978|1037737|P10|COMPLETED|Overall Study||0
423538|NCT01524978|1037738|P9|COMPLETED|Overall Study||0
423539|NCT01524978|1037739|P8|COMPLETED|Overall Study||0
423540|NCT01524978|1037740|P7|COMPLETED|Overall Study||0
423541|NCT01524978|1037741|P6|COMPLETED|Overall Study||0
423542|NCT01524978|1037742|P5|COMPLETED|Overall Study||0
423543|NCT01524978|1037743|P4|COMPLETED|Overall Study||0
423544|NCT01524978|1037744|P3|COMPLETED|Overall Study||0
423545|NCT01524978|1037745|P2|COMPLETED|Overall Study||0
423546|NCT01524978|1037746|P1|COMPLETED|Overall Study||0
423547|NCT01524978|1037736|P11|STARTED|Overall Study||28
423548|NCT01524978|1037737|P10|STARTED|Overall Study||9
423549|NCT01524978|1037738|P9|STARTED|Overall Study||12
423550|NCT01524978|1037739|P8|STARTED|Overall Study||12
423551|NCT01524978|1037740|P7|STARTED|Overall Study||26
423552|NCT01524978|1037741|P6|STARTED|Overall Study||9
423553|NCT01524978|1037742|P5|STARTED|Overall Study||9
423554|NCT01524978|1037743|P4|STARTED|Overall Study||27
423555|NCT01524978|1037744|P3|STARTED|Overall Study||10
423556|NCT01524978|1037745|P2|STARTED|Overall Study||4
423557|NCT01524978|1037746|P1|STARTED|Overall Study||62
423558|NCT01524913|1037874|P3|NOT COMPLETED|Overall Study||0
423559|NCT01524913|1037875|P2|NOT COMPLETED|Overall Study||0
423560|NCT01524913|1037876|P1|NOT COMPLETED|Overall Study||4
423561|NCT01524913|1037874|P3|COMPLETED|Overall Study||31
423562|NCT01524913|1037875|P2|COMPLETED|Overall Study||36
423563|NCT01524913|1037876|P1|COMPLETED|Overall Study||31
423564|NCT01524913|1037874|P3|STARTED|Overall Study||31
423565|NCT01524913|1037875|P2|STARTED|Overall Study||36
423566|NCT01524913|1037876|P1|STARTED|Overall Study||35
423567|NCT01524900|1037898|P5|NOT COMPLETED|Overall Study||0
423568|NCT01524900|1037899|P4|NOT COMPLETED|Overall Study||1
423569|NCT01524900|1037900|P3|NOT COMPLETED|Overall Study||1
423570|NCT01524900|1037901|P2|NOT COMPLETED|Overall Study||14
423571|NCT01524900|1037902|P1|NOT COMPLETED|Overall Study||6
423572|NCT01524900|1037898|P5|COMPLETED|Overall Study||40
423573|NCT01524900|1037899|P4|COMPLETED|Overall Study||21
423574|NCT01524900|1037900|P3|COMPLETED|Overall Study||29
423575|NCT01524900|1037901|P2|COMPLETED|Overall Study||232
423576|NCT01524900|1037902|P1|COMPLETED|Overall Study||43
423577|NCT01524900|1037898|P5|STARTED|Overall Study||40
423578|NCT01524900|1037899|P4|STARTED|Overall Study||22
423579|NCT01524900|1037900|P3|STARTED|Overall Study||30
423580|NCT01524900|1037901|P2|STARTED|Overall Study||246
423581|NCT01524900|1037902|P1|STARTED|Overall Study||49
423582|NCT01524887|1037947|P3|NOT COMPLETED|Overall Study||86
423583|NCT01524887|1037948|P2|NOT COMPLETED|Overall Study||90
423584|NCT01524887|1037949|P1|NOT COMPLETED|Overall Study||85
423585|NCT01524887|1037947|P3|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
423586|NCT01524887|1037948|P2|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
423587|NCT01524887|1037949|P1|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
423588|NCT01524887|1037947|P3|Received Treatment|Overall Study||83
423589|NCT01524887|1037948|P2|Received Treatment|Overall Study||85
423590|NCT01524887|1037949|P1|Received Treatment|Overall Study||83
423591|NCT01524887|1037947|P3|STARTED|Overall Study||86
423592|NCT01524887|1037948|P2|STARTED|Overall Study||90
423593|NCT01524887|1037949|P1|STARTED|Overall Study||85
423594|NCT01524796|1037993|P1|NOT COMPLETED|Overall Study||28
423595|NCT01524796|1037993|P1|COMPLETED|Overall Study||100
423596|NCT01524796|1037993|P1|STARTED|Overall Study||128
423597|NCT01524783|1038008|P2|NOT COMPLETED|Randomized and Treated||84
423598|NCT01524783|1038009|P1|NOT COMPLETED|Randomized and Treated||155
423599|NCT01524783|1038008|P2|COMPLETED|Randomized and Treated|Completed = Patients with ongoing treatment at the time of data cut-off of 28-Nov-2014.|13
423600|NCT01524783|1038009|P1|COMPLETED|Randomized and Treated|Completed = Patients with ongoing treatment at the time of data cut-off of 28-Nov-2014.|48
423601|NCT01524783|1038008|P2|STARTED|Randomized and Treated||97
423602|NCT01524783|1038009|P1|STARTED|Randomized and Treated||203
423603|NCT01524783|1038008|P2|NOT COMPLETED|Randomized But Not Treated||0
423604|NCT01524783|1038009|P1|NOT COMPLETED|Randomized But Not Treated||2
423605|NCT01524783|1038008|P2|COMPLETED|Randomized But Not Treated|Completed = Participants randomized and treated with study drug|97
423606|NCT01524783|1038009|P1|COMPLETED|Randomized But Not Treated|Completed = Participants randomized and treated with study drug|203
423607|NCT01524783|1038008|P2|STARTED|Randomized But Not Treated||97
423608|NCT01524783|1038009|P1|STARTED|Randomized But Not Treated||205
423609|NCT01524770|1038031|P2|NOT COMPLETED|Second Intervention||0
423610|NCT01524770|1038032|P1|NOT COMPLETED|Second Intervention||0
423611|NCT01524770|1038031|P2|COMPLETED|Second Intervention||23
423612|NCT01524770|1038032|P1|COMPLETED|Second Intervention||23
423613|NCT01524770|1038031|P2|STARTED|Second Intervention||23
423614|NCT01524770|1038032|P1|STARTED|Second Intervention||23
423615|NCT01524770|1038031|P2|NOT COMPLETED|Washout Period of at Least 28 Days||0
423616|NCT01524770|1038032|P1|NOT COMPLETED|Washout Period of at Least 28 Days||0
423617|NCT01524770|1038031|P2|COMPLETED|Washout Period of at Least 28 Days||23
423618|NCT01524770|1038032|P1|COMPLETED|Washout Period of at Least 28 Days||23
423619|NCT01524770|1038031|P2|STARTED|Washout Period of at Least 28 Days||23
423620|NCT01524770|1038032|P1|STARTED|Washout Period of at Least 28 Days||23
423621|NCT01524770|1038031|P2|NOT COMPLETED|First Intervention||1
423622|NCT01524770|1038032|P1|NOT COMPLETED|First Intervention||3
423623|NCT01524770|1038031|P2|COMPLETED|First Intervention||23
423624|NCT01524770|1038032|P1|COMPLETED|First Intervention||23
423625|NCT01524770|1038031|P2|Received at Least 1 Dose of Study Drug|First Intervention||24
423626|NCT01524770|1038032|P1|Received at Least 1 Dose of Study Drug|First Intervention||26
423627|NCT01524770|1038031|P2|STARTED|First Intervention||24
423628|NCT01524770|1038032|P1|STARTED|First Intervention||26
423629|NCT01524692|1038042|P1|NOT COMPLETED|Overall Study||3
423630|NCT01524692|1038042|P1|COMPLETED|Overall Study||32
423631|NCT01524692|1038042|P1|STARTED|Overall Study||35
423632|NCT01524627|1038052|P2|NOT COMPLETED|Overall Study||2
423633|NCT01524627|1038053|P1|NOT COMPLETED|Overall Study||1
423634|NCT01524627|1038052|P2|COMPLETED|Overall Study||19
423635|NCT01524627|1038053|P1|COMPLETED|Overall Study||21
423636|NCT01524627|1038052|P2|STARTED|Overall Study||21
423637|NCT01524627|1038053|P1|STARTED|Overall Study||22
423638|NCT01524302|1038061|P2|NOT COMPLETED|Overall Study||0
423639|NCT01524302|1038062|P1|NOT COMPLETED|Overall Study||0
423640|NCT01524302|1038061|P2|COMPLETED|Overall Study||6
423641|NCT01524302|1038062|P1|COMPLETED|Overall Study||6
423642|NCT01524302|1038061|P2|STARTED|Overall Study||6
423643|NCT01524302|1038062|P1|STARTED|Overall Study||6
423644|NCT01524198|1038080|P2|NOT COMPLETED|Overall Study||16
423645|NCT01524198|1038081|P1|NOT COMPLETED|Overall Study||23
423646|NCT01524198|1038080|P2|COMPLETED|Overall Study||458
423647|NCT01524198|1038081|P1|COMPLETED|Overall Study||448
423648|NCT01524198|1038080|P2|STARTED|Overall Study||474
423649|NCT01524198|1038081|P1|STARTED|Overall Study||471
423650|NCT01524133|1038092|P3|NOT COMPLETED|Overall Study 52 Weeks||27
423651|NCT01524133|1038093|P2|NOT COMPLETED|Overall Study 52 Weeks||20
423652|NCT01524133|1038094|P1|NOT COMPLETED|Overall Study 52 Weeks||21
423653|NCT01524133|1038092|P3|COMPLETED|Overall Study 52 Weeks||40
423654|NCT01524133|1038093|P2|COMPLETED|Overall Study 52 Weeks||49
423655|NCT01524133|1038094|P1|COMPLETED|Overall Study 52 Weeks||50
423656|NCT01524133|1038092|P3|STARTED|Overall Study 52 Weeks||67
423657|NCT01524133|1038093|P2|STARTED|Overall Study 52 Weeks||69
423658|NCT01524133|1038094|P1|STARTED|Overall Study 52 Weeks||71
423659|NCT01524133|1038092|P3|NOT COMPLETED|Treatment Phase||36
423660|NCT01524133|1038093|P2|NOT COMPLETED|Treatment Phase||32
423661|NCT01524133|1038094|P1|NOT COMPLETED|Treatment Phase||19
423662|NCT01524133|1038092|P3|COMPLETED|Treatment Phase|Completed both assigned treatments|31
423663|NCT01524133|1038093|P2|COMPLETED|Treatment Phase|Completed Both Assigned Treatments|37
423664|NCT01524133|1038094|P1|COMPLETED|Treatment Phase|Completed Both Assigned treatment|52
423665|NCT01524133|1038092|P3|STARTED|Treatment Phase||67
423666|NCT01524133|1038093|P2|STARTED|Treatment Phase||69
423667|NCT01524133|1038094|P1|STARTED|Treatment Phase||71
423668|NCT01523964|1038109|P4|NOT COMPLETED|Overall Study||0
423669|NCT01523964|1038110|P3|NOT COMPLETED|Overall Study||0
423670|NCT01523964|1038111|P2|NOT COMPLETED|Overall Study||0
423671|NCT01523964|1038112|P1|NOT COMPLETED|Overall Study||0
423672|NCT01523964|1038109|P4|COMPLETED|Overall Study||15
423673|NCT01523964|1038110|P3|COMPLETED|Overall Study||16
423674|NCT01523964|1038111|P2|COMPLETED|Overall Study||30
423675|NCT01523964|1038112|P1|COMPLETED|Overall Study||31
423676|NCT01523964|1038109|P4|STARTED|Overall Study||15
423677|NCT01523964|1038110|P3|STARTED|Overall Study||16
423678|NCT01523964|1038111|P2|STARTED|Overall Study||30
423679|NCT01523964|1038112|P1|STARTED|Overall Study||31
423680|NCT01523899|1038124|P2|NOT COMPLETED|Overall Study||0
423681|NCT01523899|1038125|P1|NOT COMPLETED|Overall Study||0
423682|NCT01523899|1038124|P2|COMPLETED|Overall Study||126
423683|NCT01523899|1038125|P1|COMPLETED|Overall Study||126
423684|NCT01523899|1038124|P2|STARTED|Overall Study||126
423685|NCT01523899|1038125|P1|STARTED|Overall Study||126
423686|NCT01523886|1038137|P2|NOT COMPLETED|Overall Study||1
423687|NCT01523886|1038138|P1|NOT COMPLETED|Overall Study||0
423688|NCT01523886|1038137|P2|COMPLETED|Overall Study||23
423689|NCT01523886|1038138|P1|COMPLETED|Overall Study||25
423690|NCT01523886|1038137|P2|STARTED|Overall Study||24
423691|NCT01523886|1038138|P1|STARTED|Overall Study||25
423692|NCT01523873|1038144|P1|NOT COMPLETED|Overall Study||422
423693|NCT01523873|1038144|P1|COMPLETED|Overall Study||35499
423694|NCT01523873|1038144|P1|Administered With Dotarem|Overall Study||35474
423695|NCT01523873|1038144|P1|STARTED|Overall Study||35921
423696|NCT01523782|1038154|P3|NOT COMPLETED|Overall Study||5
423697|NCT01523782|1038155|P2|NOT COMPLETED|Overall Study||0
423698|NCT01523782|1038156|P1|NOT COMPLETED|Overall Study||1
423699|NCT01523782|1038154|P3|COMPLETED|Overall Study||9
423700|NCT01523782|1038155|P2|COMPLETED|Overall Study||13
423701|NCT01523782|1038156|P1|COMPLETED|Overall Study||2
423702|NCT01523782|1038154|P3|STARTED|Overall Study||14
423703|NCT01523782|1038155|P2|STARTED|Overall Study||13
423704|NCT01523782|1038156|P1|STARTED|Overall Study||3
423705|NCT01523756|1038203|P2|NOT COMPLETED|Test Period 2||1
423706|NCT01523756|1038204|P1|NOT COMPLETED|Test Period 2||0
423707|NCT01523756|1038203|P2|COMPLETED|Test Period 2||7
423708|NCT01523756|1038204|P1|COMPLETED|Test Period 2||10
423709|NCT01523756|1038203|P2|STARTED|Test Period 2||8
423710|NCT01523756|1038204|P1|STARTED|Test Period 2||10
423711|NCT01523756|1038203|P2|NOT COMPLETED|Test Period 1||0
423712|NCT01523756|1038204|P1|NOT COMPLETED|Test Period 1||1
423713|NCT01523756|1038203|P2|COMPLETED|Test Period 1||8
423714|NCT01523756|1038204|P1|COMPLETED|Test Period 1||10
423715|NCT01523756|1038203|P2|STARTED|Test Period 1||8
423716|NCT01523756|1038204|P1|STARTED|Test Period 1||11
423717|NCT01523756|1038203|P2|NOT COMPLETED|Baseline Period||1
423718|NCT01523756|1038204|P1|NOT COMPLETED|Baseline Period||0
423719|NCT01523756|1038203|P2|COMPLETED|Baseline Period||8
423720|NCT01523756|1038204|P1|COMPLETED|Baseline Period||11
423721|NCT01523756|1038203|P2|STARTED|Baseline Period||9
423722|NCT01523756|1038204|P1|STARTED|Baseline Period||11
423723|NCT01523743|1038212|P2|NOT COMPLETED|Period 2||2
423724|NCT01523743|1038213|P1|NOT COMPLETED|Period 2||1
423725|NCT01523743|1038212|P2|COMPLETED|Period 2||58
423726|NCT01523743|1038213|P1|COMPLETED|Period 2||52
423727|NCT01523743|1038212|P2|STARTED|Period 2||60
423728|NCT01523743|1038213|P1|STARTED|Period 2||53
423729|NCT01523743|1038212|P2|NOT COMPLETED|Period 1||2
423730|NCT01523743|1038213|P1|NOT COMPLETED|Period 1||10
423731|NCT01523743|1038212|P2|COMPLETED|Period 1||60
423732|NCT01523743|1038213|P1|COMPLETED|Period 1||53
423733|NCT01523743|1038212|P2|STARTED|Period 1||62
423734|NCT01523743|1038213|P1|STARTED|Period 1||63
423735|NCT01523613|1038222|P3|NOT COMPLETED|Overall Study||12
423736|NCT01523613|1038223|P2|NOT COMPLETED|Overall Study||5
423737|NCT01523613|1038224|P1|NOT COMPLETED|Overall Study||7
423738|NCT01523613|1038222|P3|COMPLETED|Overall Study|- 42 paired restorations (21R and 21F)|21
423739|NCT01523613|1038223|P2|COMPLETED|Overall Study|- 25 single restorations (25F)|25
423740|NCT01523613|1038224|P1|COMPLETED|Overall Study|- 23 single restorations (23R)|23
423741|NCT01523613|1038222|P3|STARTED|Overall Study|- 66 paired restorations (33R + 33F)|33
423742|NCT01523613|1038223|P2|STARTED|Overall Study|- 30 single restorations (30 F)|30
423743|NCT01523613|1038224|P1|STARTED|Overall Study|- 30 single restorations (30 R)|30
423744|NCT01523587|1038236|P2|NOT COMPLETED|Overall Study||54
423745|NCT01523587|1038237|P1|NOT COMPLETED|Overall Study||87
423746|NCT01523587|1038236|P2|COMPLETED|Overall Study|Pts that withdrew due to PD (RECIST 1.1), PD (non RECIST1.1) and ongoing were considered Completed.|280
423747|NCT01523587|1038237|P1|COMPLETED|Overall Study|Pts that withdrew due to PD (RECIST 1.1), PD (non RECIST1.1) and ongoing were considered Completed.|248
423748|NCT01523587|1038236|P2|STARTED|Overall Study||334
423749|NCT01523587|1038237|P1|STARTED|Overall Study||335
423750|NCT01523496|1038259|P4|NOT COMPLETED|Overall Study||3
423751|NCT01523496|1038260|P3|NOT COMPLETED|Overall Study||12
423752|NCT01523496|1038261|P2|NOT COMPLETED|Overall Study||4
423753|NCT01523496|1038262|P1|NOT COMPLETED|Overall Study||10
423754|NCT01523496|1038259|P4|COMPLETED|Overall Study||27
423755|NCT01523496|1038260|P3|COMPLETED|Overall Study||46
423756|NCT01523496|1038261|P2|COMPLETED|Overall Study||32
423757|NCT01523496|1038262|P1|COMPLETED|Overall Study||56
423758|NCT01523496|1038259|P4|STARTED|Overall Study||30
423759|NCT01523496|1038260|P3|STARTED|Overall Study|The supplementation group includes medium and high dose vitamin D supplementation|58
423760|NCT01523496|1038261|P2|STARTED|Overall Study||36
423761|NCT01523496|1038262|P1|STARTED|Overall Study|The supplementation group includes medium and high dose vitamin D supplementation|66
423762|NCT01523457|1038278|P2|NOT COMPLETED|Overall Study||2
423763|NCT01523457|1038279|P1|NOT COMPLETED|Overall Study||7
423764|NCT01523457|1038278|P2|COMPLETED|Overall Study||29
423765|NCT01523457|1038279|P1|COMPLETED|Overall Study||37
423766|NCT01523457|1038278|P2|STARTED|Overall Study||31
423767|NCT01523457|1038279|P1|STARTED|Overall Study||44
423768|NCT01523392|1038297|P2|NOT COMPLETED|Treatment Period 2||0
423769|NCT01523392|1038298|P1|NOT COMPLETED|Treatment Period 2||0
423770|NCT01523392|1038297|P2|COMPLETED|Treatment Period 2||14
423771|NCT01523392|1038298|P1|COMPLETED|Treatment Period 2||17
423772|NCT01523392|1038297|P2|STARTED|Treatment Period 2||14
423773|NCT01523392|1038298|P1|STARTED|Treatment Period 2||17
423774|NCT01523392|1038297|P2|NOT COMPLETED|Washout Period - 10 to 14 Days||0
423775|NCT01523392|1038298|P1|NOT COMPLETED|Washout Period - 10 to 14 Days||1
423776|NCT01523392|1038297|P2|COMPLETED|Washout Period - 10 to 14 Days||14
423777|NCT01523392|1038298|P1|COMPLETED|Washout Period - 10 to 14 Days||17
423778|NCT01523392|1038297|P2|STARTED|Washout Period - 10 to 14 Days||14
423779|NCT01523392|1038298|P1|STARTED|Washout Period - 10 to 14 Days|1 patient did not complete 7-9 days of Period 1 treatment but continued in the Washout and Period 2|18
423780|NCT01523392|1038297|P2|NOT COMPLETED|Treatment Period 1||0
423781|NCT01523392|1038298|P1|NOT COMPLETED|Treatment Period 1||3
423782|NCT01523392|1038297|P2|COMPLETED|Treatment Period 1||14
423783|NCT01523392|1038298|P1|COMPLETED|Treatment Period 1||17
423784|NCT01523392|1038297|P2|STARTED|Treatment Period 1||14
423785|NCT01523392|1038298|P1|STARTED|Treatment Period 1||20
423786|NCT01523366|1038314|P2|NOT COMPLETED|Treatment Period 2||0
423787|NCT01523366|1038315|P1|NOT COMPLETED|Treatment Period 2||1
423788|NCT01523366|1038314|P2|COMPLETED|Treatment Period 2||20
423789|NCT01523366|1038315|P1|COMPLETED|Treatment Period 2||18
423790|NCT01523366|1038314|P2|STARTED|Treatment Period 2||20
423791|NCT01523366|1038315|P1|STARTED|Treatment Period 2||19
423792|NCT01523366|1038314|P2|NOT COMPLETED|Washout Period - 10-14 Days||0
423793|NCT01523366|1038315|P1|NOT COMPLETED|Washout Period - 10-14 Days||0
423794|NCT01523366|1038314|P2|COMPLETED|Washout Period - 10-14 Days||20
423795|NCT01523366|1038315|P1|COMPLETED|Washout Period - 10-14 Days||19
423796|NCT01523366|1038314|P2|STARTED|Washout Period - 10-14 Days||20
423797|NCT01523366|1038315|P1|STARTED|Washout Period - 10-14 Days||19
423798|NCT01523366|1038314|P2|NOT COMPLETED|Treatment Period 1||0
423799|NCT01523366|1038315|P1|NOT COMPLETED|Treatment Period 1||1
423800|NCT01523366|1038314|P2|COMPLETED|Treatment Period 1||20
423801|NCT01523366|1038315|P1|COMPLETED|Treatment Period 1||19
423802|NCT01523366|1038314|P2|STARTED|Treatment Period 1||20
423803|NCT01523366|1038315|P1|STARTED|Treatment Period 1||20
423804|NCT01523301|1038331|P2|NOT COMPLETED|Overall Study||32
423805|NCT01523301|1038332|P1|NOT COMPLETED|Overall Study||35
423806|NCT01523301|1038331|P2|COMPLETED|Overall Study||164
423807|NCT01523301|1038332|P1|COMPLETED|Overall Study||149
423808|NCT01523301|1038331|P2|STARTED|Overall Study||196
423809|NCT01523301|1038332|P1|STARTED|Overall Study||184
423810|NCT01522976|1038353|P3|NOT COMPLETED|Overall Study||93
423811|NCT01522976|1038354|P2|NOT COMPLETED|Overall Study||92
423812|NCT01522976|1038355|P1|NOT COMPLETED|Overall Study||97
423813|NCT01522976|1038353|P3|COMPLETED|Overall Study||0
423814|NCT01522976|1038354|P2|COMPLETED|Overall Study||0
423815|NCT01522976|1038355|P1|COMPLETED|Overall Study||0
423816|NCT01522976|1038353|P3|STARTED|Overall Study||93
423817|NCT01522976|1038354|P2|STARTED|Overall Study||92
423818|NCT01522976|1038355|P1|STARTED|Overall Study||97
423819|NCT01522963|1038382|P4|NOT COMPLETED|Overall Study||6
423820|NCT01522963|1038383|P3|NOT COMPLETED|Overall Study||3
423821|NCT01522963|1038384|P2|NOT COMPLETED|Overall Study||3
423822|NCT01522963|1038385|P1|NOT COMPLETED|Overall Study||2
423823|NCT01522963|1038382|P4|COMPLETED|Overall Study||18
423824|NCT01522963|1038383|P3|COMPLETED|Overall Study||22
423825|NCT01522963|1038384|P2|COMPLETED|Overall Study||22
423826|NCT01522963|1038385|P1|COMPLETED|Overall Study||22
423827|NCT01522963|1038382|P4|STARTED|Overall Study||24
423828|NCT01522963|1038383|P3|STARTED|Overall Study||25
423829|NCT01522963|1038384|P2|STARTED|Overall Study||25
423830|NCT01522963|1038385|P1|STARTED|Overall Study||24
423831|NCT01522937|1038397|P1|NOT COMPLETED|Overall Study||0
423832|NCT01522937|1038397|P1|COMPLETED|Overall Study||146
423833|NCT01522937|1038397|P1|STARTED|Overall Study||146
423834|NCT01522924|1038407|P2|NOT COMPLETED|Overall Study||0
423835|NCT01522924|1038408|P1|NOT COMPLETED|Overall Study||0
423836|NCT01522924|1038407|P2|COMPLETED|Overall Study|There were 52 dental students who completed the second survey after the lecture.|52
423837|NCT01522924|1038408|P1|COMPLETED|Overall Study|There were 42 dental students who completed the second survey after the intervention.|42
423838|NCT01522924|1038407|P2|STARTED|Overall Study|There were 52 dental students in the control group.|52
423839|NCT01522924|1038408|P1|STARTED|Overall Study|There were 42 dental students in the intervention group.|42
423840|NCT01522703|1038428|P2|NOT COMPLETED|Overall Study||6
423841|NCT01522703|1038429|P1|NOT COMPLETED|Overall Study||5
423842|NCT01522703|1038428|P2|COMPLETED|Overall Study||20
423843|NCT01522703|1038429|P1|COMPLETED|Overall Study||20
423844|NCT01522703|1038428|P2|STARTED|Overall Study||26
423845|NCT01522703|1038429|P1|STARTED|Overall Study||25
423846|NCT01522456|1038435|P1|NOT COMPLETED|Overall Study||8
423847|NCT01522456|1038435|P1|COMPLETED|Overall Study||65
423848|NCT01522456|1038435|P1|STARTED|Overall Study||73
423849|NCT01522443|1038498|P2|NOT COMPLETED|Overall Study||55
423850|NCT01522443|1038499|P1|NOT COMPLETED|Overall Study||53
423851|NCT01522443|1038498|P2|COMPLETED|Overall Study||3
423852|NCT01522443|1038499|P1|COMPLETED|Overall Study||8
423853|NCT01522443|1038498|P2|STARTED|Overall Study||58
423854|NCT01522443|1038499|P1|STARTED|Overall Study||61
423855|NCT01522339|1038509|P1|NOT COMPLETED|Overall Study||0
423856|NCT01522339|1038509|P1|COMPLETED|Overall Study||15
423857|NCT01522339|1038509|P1|STARTED|Overall Study||15
423858|NCT01522235|1038516|P2|NOT COMPLETED|Overall Study||1
423859|NCT01522235|1038517|P1|NOT COMPLETED|Overall Study||1
423860|NCT01522235|1038516|P2|COMPLETED|Overall Study||2
423861|NCT01522235|1038517|P1|COMPLETED|Overall Study||2
423862|NCT01522235|1038516|P2|Randomized|Overall Study||3
423863|NCT01522235|1038517|P1|Randomized|Overall Study||2
423864|NCT01522235|1038516|P2|STARTED|Overall Study||3
423865|NCT01522235|1038517|P1|STARTED|Overall Study||3
423866|NCT01522131|1038535|P2|NOT COMPLETED|Overall Study||0
423867|NCT01522131|1038536|P1|NOT COMPLETED|Overall Study||2
423868|NCT01522131|1038535|P2|COMPLETED|Overall Study||17
423869|NCT01522131|1038536|P1|COMPLETED|Overall Study||14
423870|NCT01522131|1038535|P2|STARTED|Overall Study||17
423871|NCT01522131|1038536|P1|STARTED|Overall Study||16
423872|NCT01521949|1038544|P1|NOT COMPLETED|Overall Study||0
423873|NCT01521949|1038544|P1|COMPLETED|Overall Study||21
423874|NCT01521949|1038544|P1|STARTED|Overall Study||21
423875|NCT01521923|1038553|P4|NOT COMPLETED|Overall Study||13
423876|NCT01521923|1038554|P3|NOT COMPLETED|Overall Study||15
423877|NCT01521923|1038555|P2|NOT COMPLETED|Overall Study||9
423878|NCT01521923|1038556|P1|NOT COMPLETED|Overall Study||7
423879|NCT01521923|1038553|P4|COMPLETED|Overall Study||70
423880|NCT01521923|1038554|P3|COMPLETED|Overall Study||112
423881|NCT01521923|1038555|P2|COMPLETED|Overall Study||72
423882|NCT01521923|1038556|P1|COMPLETED|Overall Study||59
423883|NCT01521923|1038553|P4|STARTED|Overall Study||83
423884|NCT01521923|1038554|P3|STARTED|Overall Study||127
423885|NCT01521923|1038555|P2|STARTED|Overall Study||81
423886|NCT01521923|1038556|P1|STARTED|Overall Study||66
423887|NCT01521897|1038676|P1|NOT COMPLETED|Overall Study||23
423888|NCT01521897|1038676|P1|COMPLETED|Overall Study||1120
423889|NCT01521897|1038676|P1|STARTED|Overall Study||1143
423890|NCT01521884|1038688|P1|NOT COMPLETED|Overall Study||27
423891|NCT01521884|1038688|P1|COMPLETED|Overall Study||35
423892|NCT01521884|1038688|P1|STARTED|Overall Study||62
423893|NCT01521871|1038707|P2|NOT COMPLETED|Overall Study||0
423894|NCT01521871|1038708|P1|NOT COMPLETED|Overall Study||0
423895|NCT01521871|1038707|P2|COMPLETED|Overall Study||32
423896|NCT01521871|1038708|P1|COMPLETED|Overall Study||32
423897|NCT01521871|1038707|P2|STARTED|Overall Study||32
423898|NCT01521871|1038708|P1|STARTED|Overall Study||32
423899|NCT01521845|1038748|P2|NOT COMPLETED|Overall Study||5
423900|NCT01521845|1038749|P1|NOT COMPLETED|Overall Study||9
423901|NCT01521845|1038748|P2|COMPLETED|Overall Study||47
423902|NCT01521845|1038749|P1|COMPLETED|Overall Study||43
423903|NCT01521845|1038748|P2|STARTED|Overall Study||52
423904|NCT01521845|1038749|P1|STARTED|Overall Study||52
423905|NCT01521780|1038759|P3|NOT COMPLETED|Overall Study||0
423906|NCT01521780|1038760|P2|NOT COMPLETED|Overall Study||0
423907|NCT01521780|1038761|P1|NOT COMPLETED|Overall Study||0
423908|NCT01521780|1038759|P3|COMPLETED|Overall Study||2
423909|NCT01521780|1038760|P2|COMPLETED|Overall Study||1
423910|NCT01521780|1038761|P1|COMPLETED|Overall Study||9
423911|NCT01521780|1038759|P3|STARTED|Overall Study||2
423912|NCT01521780|1038760|P2|STARTED|Overall Study||1
423913|NCT01521780|1038761|P1|STARTED|Overall Study||9
423914|NCT01521559|1038785|P2|NOT COMPLETED|Overall Study||18
423915|NCT01521559|1038786|P1|NOT COMPLETED|Overall Study||15
423916|NCT01521559|1038785|P2|COMPLETED|Overall Study||73
423917|NCT01521559|1038786|P1|COMPLETED|Overall Study||77
423918|NCT01521559|1038785|P2|Completed Week 52|Overall Study||73
423919|NCT01521559|1038786|P1|Completed Week 52|Overall Study||77
423920|NCT01521559|1038785|P2|Completed Week 24|Overall Study||85
423921|NCT01521559|1038786|P1|Completed Week 24|Overall Study||83
423922|NCT01521559|1038785|P2|STARTED|Overall Study||91
423923|NCT01521559|1038786|P1|STARTED|Overall Study||92
423924|NCT01521546|1038800|P2|NOT COMPLETED|Overall Study||0
423925|NCT01521546|1038801|P1|NOT COMPLETED|Overall Study||2
423926|NCT01521546|1038800|P2|COMPLETED|Overall Study||20
423927|NCT01521546|1038801|P1|COMPLETED|Overall Study||20
423928|NCT01521546|1038800|P2|STARTED|Overall Study||20
423929|NCT01521546|1038801|P1|STARTED|Overall Study||22
423930|NCT01521507|1038809|P2|NOT COMPLETED|Stage 2: Observational Design||2
423931|NCT01521507|1038810|P1|NOT COMPLETED|Stage 2: Observational Design||4
423932|NCT01521507|1038809|P2|COMPLETED|Stage 2: Observational Design||92
423933|NCT01521507|1038810|P1|COMPLETED|Stage 2: Observational Design||94
423934|NCT01521507|1038809|P2|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||1
423935|NCT01521507|1038810|P1|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||2
423936|NCT01521507|1038809|P2|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||9
423937|NCT01521507|1038810|P1|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||11
423938|NCT01521507|1038809|P2|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||82
423939|NCT01521507|1038810|P1|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||81
423940|NCT01521507|1038809|P2|Received Crossover LipiFlow Tx|Stage 2: Observational Design||93
423941|NCT01521507|1038810|P1|Received Crossover LipiFlow Tx|Stage 2: Observational Design||0
423942|NCT01521507|1038809|P2|STARTED|Stage 2: Observational Design||94
423943|NCT01521507|1038810|P1|STARTED|Stage 2: Observational Design||98
423944|NCT01521507|1038809|P2|NOT COMPLETED|Stage 1: Randomized Design||5
423945|NCT01521507|1038810|P1|NOT COMPLETED|Stage 1: Randomized Design||3
423946|NCT01521507|1038809|P2|COMPLETED|Stage 1: Randomized Design||94
423947|NCT01521507|1038810|P1|COMPLETED|Stage 1: Randomized Design||98
423948|NCT01521507|1038809|P2|Received Initial Treatment (Tx)|Stage 1: Randomized Design||98
423949|NCT01521507|1038810|P1|Received Initial Treatment (Tx)|Stage 1: Randomized Design||99
423950|NCT01521507|1038809|P2|STARTED|Stage 1: Randomized Design||99
423951|NCT01521507|1038810|P1|STARTED|Stage 1: Randomized Design||101
423952|NCT01521364|1038827|P1|NOT COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||1
423953|NCT01521364|1038827|P1|COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||5
423954|NCT01521364|1038827|P1|STARTED|Linezolid + 500mg Claritromycin (wk 4&5)||6
423955|NCT01521364|1038827|P1|NOT COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||1
423956|NCT01521364|1038827|P1|COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||6
423957|NCT01521364|1038827|P1|STARTED|Linezolid + 250mg Claritromycin (wk 2&3)||7
423958|NCT01521364|1038827|P1|NOT COMPLETED|Linezolid Without Clarithromycin (1 wk)||0
423959|NCT01521364|1038827|P1|COMPLETED|Linezolid Without Clarithromycin (1 wk)||7
423960|NCT01521364|1038827|P1|STARTED|Linezolid Without Clarithromycin (1 wk)||7
423961|NCT01521260|1038840|P2|NOT COMPLETED|Overall Study||0
423962|NCT01521260|1038841|P1|NOT COMPLETED|Overall Study||0
423963|NCT01521260|1038840|P2|COMPLETED|Overall Study||15
423964|NCT01521260|1038841|P1|COMPLETED|Overall Study||15
423965|NCT01521260|1038840|P2|STARTED|Overall Study||15
423966|NCT01521260|1038841|P1|STARTED|Overall Study||15
423967|NCT01521143|1038851|P4|NOT COMPLETED|Overall Study||7
423968|NCT01521143|1038852|P3|NOT COMPLETED|Overall Study||8
423969|NCT01521143|1038853|P2|NOT COMPLETED|Overall Study||26
423970|NCT01521143|1038854|P1|NOT COMPLETED|Overall Study||29
423971|NCT01521143|1038851|P4|COMPLETED|Overall Study||0
423972|NCT01521143|1038852|P3|COMPLETED|Overall Study||0
423973|NCT01521143|1038853|P2|COMPLETED|Overall Study||10
423974|NCT01521143|1038854|P1|COMPLETED|Overall Study||11
423975|NCT01521143|1038851|P4|Received Treatment|Overall Study||4
423976|NCT01521143|1038852|P3|Received Treatment|Overall Study||3
423977|NCT01521143|1038853|P2|Received Treatment|Overall Study||20
423978|NCT01521143|1038854|P1|Received Treatment|Overall Study||20
423979|NCT01521143|1038851|P4|STARTED|Overall Study||7
423980|NCT01521143|1038852|P3|STARTED|Overall Study||8
423981|NCT01521143|1038853|P2|STARTED|Overall Study||36
423982|NCT01521143|1038854|P1|STARTED|Overall Study||40
423983|NCT01521026|1038886|P2|NOT COMPLETED|Overall Study||3
423984|NCT01521026|1038887|P1|NOT COMPLETED|Overall Study||15
423985|NCT01521026|1038886|P2|COMPLETED|Overall Study||28
423986|NCT01521026|1038887|P1|COMPLETED|Overall Study||23
423987|NCT01521026|1038886|P2|STARTED|Overall Study||31
423988|NCT01521026|1038887|P1|STARTED|Overall Study||38
423989|NCT01520987|1038903|P8|NOT COMPLETED|Overall Study||0
423990|NCT01520987|1038904|P7|NOT COMPLETED|Overall Study||0
423991|NCT01520987|1038905|P6|NOT COMPLETED|Overall Study||1
423992|NCT01520987|1038906|P5|NOT COMPLETED|Overall Study||0
423993|NCT01520987|1038907|P4|NOT COMPLETED|Overall Study||0
423994|NCT01520987|1038908|P3|NOT COMPLETED|Overall Study||0
423995|NCT01520987|1038909|P2|NOT COMPLETED|Overall Study||0
423996|NCT01520987|1038910|P1|NOT COMPLETED|Overall Study||1
423997|NCT01520987|1038903|P8|COMPLETED|Overall Study||14
423998|NCT01520987|1038904|P7|COMPLETED|Overall Study||12
423999|NCT01520987|1038905|P6|COMPLETED|Overall Study||13
424000|NCT01520987|1038906|P5|COMPLETED|Overall Study||14
424001|NCT01520987|1038907|P4|COMPLETED|Overall Study||15
424002|NCT01520987|1038908|P3|COMPLETED|Overall Study||11
424003|NCT01520987|1038909|P2|COMPLETED|Overall Study||12
424004|NCT01520987|1038910|P1|COMPLETED|Overall Study||12
424005|NCT01520987|1038903|P8|Dosed|Overall Study||14
424006|NCT01520987|1038904|P7|Dosed|Overall Study||12
424007|NCT01520987|1038905|P6|Dosed|Overall Study||14
424008|NCT01520987|1038906|P5|Dosed|Overall Study||14
424009|NCT01520987|1038907|P4|Dosed|Overall Study||15
424010|NCT01520987|1038908|P3|Dosed|Overall Study||11
424011|NCT01520987|1038909|P2|Dosed|Overall Study||12
424012|NCT01520987|1038910|P1|Dosed|Overall Study||13
424013|NCT01520987|1038903|P8|STARTED|Overall Study||14
424014|NCT01520987|1038904|P7|STARTED|Overall Study||12
424015|NCT01520987|1038905|P6|STARTED|Overall Study||14
424016|NCT01520987|1038906|P5|STARTED|Overall Study||14
424017|NCT01520987|1038907|P4|STARTED|Overall Study||15
424018|NCT01520987|1038908|P3|STARTED|Overall Study||11
424019|NCT01520987|1038909|P2|STARTED|Overall Study||12
424020|NCT01520987|1038910|P1|STARTED|Overall Study||13
424021|NCT01520922|1038970|P2|NOT COMPLETED|Survival Follow-up||0
424022|NCT01520922|1038971|P1|NOT COMPLETED|Survival Follow-up||1
424023|NCT01520922|1038970|P2|COMPLETED|Survival Follow-up||40
424024|NCT01520922|1038971|P1|COMPLETED|Survival Follow-up||20
424025|NCT01520922|1038970|P2|STARTED|Survival Follow-up||40
424026|NCT01520922|1038971|P1|STARTED|Survival Follow-up||21
424027|NCT01520922|1038970|P2|NOT COMPLETED|Follow up||1
424028|NCT01520922|1038971|P1|NOT COMPLETED|Follow up||0
424029|NCT01520922|1038970|P2|COMPLETED|Follow up||44
424030|NCT01520922|1038971|P1|COMPLETED|Follow up||44
424031|NCT01520922|1038970|P2|STARTED|Follow up||45
424032|NCT01520922|1038971|P1|STARTED|Follow up||44
424033|NCT01520922|1038970|P2|NOT COMPLETED|Treatment Phase||8
424034|NCT01520922|1038971|P1|NOT COMPLETED|Treatment Phase||5
424035|NCT01520922|1038970|P2|COMPLETED|Treatment Phase|Completed 6 Cycles of Study Treatment|45
424036|NCT01520922|1038971|P1|COMPLETED|Treatment Phase|Completed 6 Cycles of Study Treatment|39
424037|NCT01520922|1038970|P2|STARTED|Treatment Phase||53
424038|NCT01520922|1038971|P1|STARTED|Treatment Phase||44
424039|NCT01520909|1039033|P3|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||7
424040|NCT01520909|1039034|P2|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
424041|NCT01520909|1039035|P1|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
424042|NCT01520909|1039033|P3|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||80
424043|NCT01520909|1039034|P2|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
424044|NCT01520909|1039035|P1|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
424045|NCT01520909|1039033|P3|STARTED|Part 2 (Open-Label Period)-Eltrombopag|Two participants that completed Part 1 did not start Part 2 because of lack of efficacy.|87
424046|NCT01520909|1039034|P2|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0
424047|NCT01520909|1039035|P1|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0
424048|NCT01520909|1039033|P3|NOT COMPLETED|Part 1 (Randomized Period)||0
424049|NCT01520909|1039034|P2|NOT COMPLETED|Part 1 (Randomized Period)||2
424050|NCT01520909|1039035|P1|NOT COMPLETED|Part 1 (Randomized Period)||1
424051|NCT01520909|1039033|P3|COMPLETED|Part 1 (Randomized Period)||0
424052|NCT01520909|1039034|P2|COMPLETED|Part 1 (Randomized Period)||61
424053|NCT01520909|1039035|P1|COMPLETED|Part 1 (Randomized Period)||28
424054|NCT01520909|1039033|P3|STARTED|Part 1 (Randomized Period)||0
424055|NCT01520909|1039034|P2|STARTED|Part 1 (Randomized Period)||63
424056|NCT01520909|1039035|P1|STARTED|Part 1 (Randomized Period)||29
424057|NCT01520727|1039106|P9|NOT COMPLETED|Overall Study||0
424058|NCT01520727|1039107|P8|NOT COMPLETED|Overall Study||0
424059|NCT01520727|1039108|P7|NOT COMPLETED|Overall Study||0
424060|NCT01520727|1039109|P6|NOT COMPLETED|Overall Study||0
424061|NCT01520727|1039110|P5|NOT COMPLETED|Overall Study||0
424062|NCT01520727|1039111|P4|NOT COMPLETED|Overall Study||0
424063|NCT01520727|1039112|P3|NOT COMPLETED|Overall Study||0
424064|NCT01520727|1039113|P2|NOT COMPLETED|Overall Study||0
424065|NCT01520727|1039114|P1|NOT COMPLETED|Overall Study||0
424066|NCT01520727|1039106|P9|COMPLETED|Overall Study||16
424067|NCT01520727|1039107|P8|COMPLETED|Overall Study||6
424068|NCT01520727|1039108|P7|COMPLETED|Overall Study||6
424069|NCT01520727|1039109|P6|COMPLETED|Overall Study||6
424070|NCT01520727|1039110|P5|COMPLETED|Overall Study||6
424071|NCT01520727|1039111|P4|COMPLETED|Overall Study||6
424072|NCT01520727|1039112|P3|COMPLETED|Overall Study||6
424073|NCT01520727|1039113|P2|COMPLETED|Overall Study||6
424074|NCT01520727|1039114|P1|COMPLETED|Overall Study||6
424075|NCT01520727|1039106|P9|STARTED|Overall Study||16
424076|NCT01520727|1039107|P8|STARTED|Overall Study||6
424077|NCT01520727|1039108|P7|STARTED|Overall Study||6
424078|NCT01520727|1039109|P6|STARTED|Overall Study||6
424079|NCT01520727|1039110|P5|STARTED|Overall Study||6
424080|NCT01520727|1039111|P4|STARTED|Overall Study||6
424081|NCT01520727|1039112|P3|STARTED|Overall Study||6
424082|NCT01520727|1039113|P2|STARTED|Overall Study||6
424083|NCT01520727|1039114|P1|STARTED|Overall Study||6
424084|NCT01520714|1039152|P2|NOT COMPLETED|Overall Study||6
424085|NCT01520714|1039153|P1|NOT COMPLETED|Overall Study||0
424086|NCT01520714|1039152|P2|COMPLETED|Overall Study||5
424087|NCT01520714|1039153|P1|COMPLETED|Overall Study||0
424088|NCT01520714|1039152|P2|STARTED|Overall Study||11
424089|NCT01520714|1039153|P1|STARTED|Overall Study||0
424090|NCT01520558|1039162|P3|NOT COMPLETED|Overall Study||3
424091|NCT01520558|1039163|P2|NOT COMPLETED|Overall Study||2
424092|NCT01520558|1039164|P1|NOT COMPLETED|Overall Study||2
424093|NCT01520558|1039162|P3|COMPLETED|Overall Study||3
424094|NCT01520558|1039163|P2|COMPLETED|Overall Study||1
424095|NCT01520558|1039164|P1|COMPLETED|Overall Study||1
424096|NCT01520558|1039162|P3|STARTED|Overall Study||6
424097|NCT01520558|1039163|P2|STARTED|Overall Study||3
424098|NCT01520558|1039164|P1|STARTED|Overall Study||3
424099|NCT01520532|1039172|P1|NOT COMPLETED|Overall Study||0
424100|NCT01520532|1039172|P1|COMPLETED|Overall Study||60
424101|NCT01520532|1039172|P1|STARTED|Overall Study|Subjects who underwent an ablation and had post-procedure MRI|60
424102|NCT01520506|1039178|P1|NOT COMPLETED|Overall Study||6
424103|NCT01520506|1039178|P1|COMPLETED|Overall Study||44
424104|NCT01520506|1039178|P1|STARTED|Overall Study||50
424105|NCT01520454|1039188|P4|NOT COMPLETED|Overall Study||0
424106|NCT01520454|1039189|P3|NOT COMPLETED|Overall Study||0
424107|NCT01520454|1039190|P2|NOT COMPLETED|Overall Study||0
424108|NCT01520454|1039191|P1|NOT COMPLETED|Overall Study||0
424109|NCT01520454|1039188|P4|COMPLETED|Overall Study||6
424110|NCT01520454|1039189|P3|COMPLETED|Overall Study||5
424111|NCT01520454|1039190|P2|COMPLETED|Overall Study||6
424112|NCT01520454|1039191|P1|COMPLETED|Overall Study||9
424113|NCT01520454|1039188|P4|STARTED|Overall Study||6
424114|NCT01520454|1039189|P3|STARTED|Overall Study||5
424115|NCT01520454|1039190|P2|STARTED|Overall Study||6
424116|NCT01520454|1039191|P1|STARTED|Overall Study||9
424117|NCT01520402|1039233|P1|NOT COMPLETED|Overall Study||5
424118|NCT01520402|1039233|P1|COMPLETED|Overall Study||30
424119|NCT01520402|1039233|P1|STARTED|Overall Study||35
424120|NCT01520207|1039246|P2|NOT COMPLETED|Overall Study||0
424121|NCT01520207|1039247|P1|NOT COMPLETED|Overall Study||2
424122|NCT01520207|1039246|P2|COMPLETED|Overall Study||25
424123|NCT01520207|1039247|P1|COMPLETED|Overall Study||25
424124|NCT01520207|1039246|P2|STARTED|Overall Study||25
424125|NCT01520207|1039247|P1|STARTED|Overall Study||27
424126|NCT01519960|1039256|P3|NOT COMPLETED|Overall Study||10
424127|NCT01519960|1039257|P2|NOT COMPLETED|Overall Study||50
424128|NCT01519960|1039258|P1|NOT COMPLETED|Overall Study||101
424129|NCT01519960|1039256|P3|COMPLETED|Overall Study||0
424130|NCT01519960|1039257|P2|COMPLETED|Overall Study||0
424131|NCT01519960|1039258|P1|COMPLETED|Overall Study||0
424132|NCT01519960|1039256|P3|Completed FU Week 24|Overall Study||10
424133|NCT01519960|1039257|P2|Completed FU Week 24|Overall Study||15
424134|NCT01519960|1039258|P1|Completed FU Week 24|Overall Study||101
424135|NCT01519960|1039256|P3|Completed Follow-Up (FU) Week 12|Overall Study||10
424136|NCT01519960|1039257|P2|Completed Follow-Up (FU) Week 12|Overall Study||26
424137|NCT01519960|1039258|P1|Completed Follow-Up (FU) Week 12|Overall Study||101
424138|NCT01519960|1039256|P3|Completed Week 48|Overall Study||10
424139|NCT01519960|1039257|P2|Completed Week 48|Overall Study||47
424140|NCT01519960|1039258|P1|Completed Week 48|Overall Study||99
424141|NCT01519960|1039256|P3|STARTED|Overall Study||10
424142|NCT01519960|1039257|P2|STARTED|Overall Study||50
424143|NCT01519960|1039258|P1|STARTED|Overall Study||101
424144|NCT01519934|1039364|P1|NOT COMPLETED|Overall Study||3
424145|NCT01519934|1039364|P1|COMPLETED|Overall Study||45
424146|NCT01519934|1039364|P1|STARTED|Overall Study||48
424147|NCT01519921|1039373|P2|NOT COMPLETED|Overall Study||15
424148|NCT01519921|1039374|P1|NOT COMPLETED|Overall Study||21
424149|NCT01519921|1039373|P2|COMPLETED|Overall Study||49
424150|NCT01519921|1039374|P1|COMPLETED|Overall Study||65
424151|NCT01519921|1039373|P2|STARTED|Overall Study||64
424152|NCT01519921|1039374|P1|STARTED|Overall Study||86
424153|NCT01519882|1039398|P2|NOT COMPLETED|Overall Study||0
424154|NCT01519882|1039399|P1|NOT COMPLETED|Overall Study||0
424155|NCT01519882|1039398|P2|COMPLETED|Overall Study||0
424156|NCT01519882|1039399|P1|COMPLETED|Overall Study||1
424157|NCT01519882|1039398|P2|STARTED|Overall Study||0
424158|NCT01519882|1039399|P1|STARTED|Overall Study||1
424159|NCT01519817|1039423|P4|NOT COMPLETED|Overall Study||1
424160|NCT01519817|1039424|P3|NOT COMPLETED|Overall Study||0
424161|NCT01519817|1039425|P2|NOT COMPLETED|Overall Study||0
424162|NCT01519817|1039426|P1|NOT COMPLETED|Overall Study||1
424163|NCT01519817|1039423|P4|COMPLETED|Overall Study||10
424164|NCT01519817|1039424|P3|COMPLETED|Overall Study||16
424165|NCT01519817|1039425|P2|COMPLETED|Overall Study||3
424166|NCT01519817|1039426|P1|COMPLETED|Overall Study||3
424167|NCT01519817|1039423|P4|STARTED|Overall Study||11
424168|NCT01519817|1039424|P3|STARTED|Overall Study||16
424169|NCT01519817|1039425|P2|STARTED|Overall Study||3
424170|NCT01519817|1039426|P1|STARTED|Overall Study||4
424171|NCT01519791|1039466|P2|NOT COMPLETED|Overall Study||368
424172|NCT01519791|1039467|P1|NOT COMPLETED|Overall Study||152
424173|NCT01519791|1039466|P2|COMPLETED|Overall Study||292
424174|NCT01519791|1039467|P1|COMPLETED|Overall Study||67
424175|NCT01519791|1039466|P2|Completed Week 52|Overall Study||500
424176|NCT01519791|1039467|P1|Completed Week 52|Overall Study||143
424177|NCT01519791|1039466|P2|STARTED|Overall Study||660
424178|NCT01519791|1039467|P1|STARTED|Overall Study||219
424179|NCT01519778|1039531|P1|NOT COMPLETED|Overall Study||14
424180|NCT01519778|1039531|P1|COMPLETED|Overall Study||186
424181|NCT01519778|1039531|P1|STARTED|Overall Study||200
424182|NCT01519765|1039537|P2|NOT COMPLETED|Overall Study||2
424183|NCT01519765|1039538|P1|NOT COMPLETED|Overall Study||3
424184|NCT01519765|1039537|P2|COMPLETED|Overall Study||34
424185|NCT01519765|1039538|P1|COMPLETED|Overall Study||34
424186|NCT01519765|1039537|P2|STARTED|Overall Study||36
424187|NCT01519765|1039538|P1|STARTED|Overall Study||37
424188|NCT01519713|1039587|P3|NOT COMPLETED|Overall Study||0
424189|NCT01519713|1039588|P2|NOT COMPLETED|Overall Study||0
424190|NCT01519713|1039589|P1|NOT COMPLETED|Overall Study||0
424191|NCT01519713|1039587|P3|COMPLETED|Overall Study||4
424192|NCT01519713|1039588|P2|COMPLETED|Overall Study||2
424193|NCT01519713|1039589|P1|COMPLETED|Overall Study||194
424194|NCT01519713|1039587|P3|STARTED|Overall Study||4
424195|NCT01519713|1039588|P2|STARTED|Overall Study||2
424196|NCT01519713|1039589|P1|STARTED|Overall Study||194
424197|NCT01519700|1039616|P4|NOT COMPLETED|Overall Study||7
424198|NCT01519700|1039617|P3|NOT COMPLETED|Overall Study||7
424199|NCT01519700|1039618|P2|NOT COMPLETED|Overall Study||6
424200|NCT01519700|1039619|P1|NOT COMPLETED|Overall Study||9
424201|NCT01519700|1039616|P4|COMPLETED|Overall Study||47
424202|NCT01519700|1039617|P3|COMPLETED|Overall Study||48
424203|NCT01519700|1039618|P2|COMPLETED|Overall Study||49
424204|NCT01519700|1039619|P1|COMPLETED|Overall Study||45
424205|NCT01519700|1039616|P4|Treated Cycle 6 Neupogen|Overall Study||49
424206|NCT01519700|1039617|P3|Treated Cycle 6 Neupogen|Overall Study||0
424207|NCT01519700|1039618|P2|Treated Cycle 6 Neupogen|Overall Study||49
424208|NCT01519700|1039619|P1|Treated Cycle 6 Neupogen|Overall Study||0
424209|NCT01519700|1039616|P4|Treated Cycle 6 EP2006|Overall Study||0
424210|NCT01519700|1039617|P3|Treated Cycle 6 EP2006|Overall Study||48
424211|NCT01519700|1039618|P2|Treated Cycle 6 EP2006|Overall Study||0
424212|NCT01519700|1039619|P1|Treated Cycle 6 EP2006|Overall Study||45
424213|NCT01519700|1039616|P4|Treated Cycle 5 Neupogen|Overall Study||50
424214|NCT01519700|1039617|P3|Treated Cycle 5 Neupogen|Overall Study||48
424215|NCT01519700|1039618|P2|Treated Cycle 5 Neupogen|Overall Study||0
424216|NCT01519700|1039619|P1|Treated Cycle 5 Neupogen|Overall Study||0
424217|NCT01519700|1039616|P4|Treated Cycle 5 EP2006|Overall Study||0
424218|NCT01519700|1039617|P3|Treated Cycle 5 EP2006|Overall Study||0
424219|NCT01519700|1039618|P2|Treated Cycle 5 EP2006|Overall Study||49
424220|NCT01519700|1039619|P1|Treated Cycle 5 EP2006|Overall Study||46
424221|NCT01519700|1039616|P4|Treated Cycle 4 Neupogen|Overall Study||50
424222|NCT01519700|1039617|P3|Treated Cycle 4 Neupogen|Overall Study||0
424223|NCT01519700|1039618|P2|Treated Cycle 4 Neupogen|Overall Study||51
424224|NCT01519700|1039619|P1|Treated Cycle 4 Neupogen|Overall Study||0
424225|NCT01519700|1039616|P4|Treated Cycle 4 EP2006|Overall Study||0
424226|NCT01519700|1039617|P3|Treated Cycle 4 EP2006|Overall Study||50
424227|NCT01519700|1039618|P2|Treated Cycle 4 EP2006|Overall Study||0
424228|NCT01519700|1039619|P1|Treated Cycle 4 EP2006|Overall Study||51
424229|NCT01519700|1039616|P4|Treated Cycle 3 Neupogen|Overall Study||51
424230|NCT01519700|1039617|P3|Treated Cycle 3 Neupogen|Overall Study||54
424231|NCT01519700|1039618|P2|Treated Cycle 3 Neupogen|Overall Study||0
424232|NCT01519700|1039619|P1|Treated Cycle 3 Neupogen|Overall Study||0
424233|NCT01519700|1039616|P4|Treated Cycle 3 EP2006|Overall Study||0
424234|NCT01519700|1039617|P3|Treated Cycle 3 EP2006|Overall Study||0
424235|NCT01519700|1039618|P2|Treated Cycle 3 EP2006|Overall Study||51
424236|NCT01519700|1039619|P1|Treated Cycle 3 EP2006|Overall Study||51
424237|NCT01519700|1039616|P4|Treated Cycle 2 Neupogen|Overall Study||51
424238|NCT01519700|1039617|P3|Treated Cycle 2 Neupogen|Overall Study||0
424239|NCT01519700|1039618|P2|Treated Cycle 2 Neupogen|Overall Study||52
424240|NCT01519700|1039619|P1|Treated Cycle 2 Neupogen|Overall Study||0
424241|NCT01519700|1039616|P4|Treated Cycle 2 EP2006|Overall Study||0
424242|NCT01519700|1039617|P3|Treated Cycle 2 EP2006|Overall Study||55
424243|NCT01519700|1039618|P2|Treated Cycle 2 EP2006|Overall Study||0
424244|NCT01519700|1039619|P1|Treated Cycle 2 EP2006|Overall Study||52
424245|NCT01519700|1039616|P4|Treated Cycle 1 Neupogen|Overall Study||52
424246|NCT01519700|1039617|P3|Treated Cycle 1 Neupogen|Overall Study||55
424247|NCT01519700|1039618|P2|Treated Cycle 1 Neupogen|Overall Study||0
424248|NCT01519700|1039619|P1|Treated Cycle 1 Neupogen|Overall Study||0
424249|NCT01519700|1039616|P4|Treated Cycle 1 EP2006|Overall Study||0
424250|NCT01519700|1039617|P3|Treated Cycle 1 EP2006|Overall Study||0
424251|NCT01519700|1039618|P2|Treated Cycle 1 EP2006|Overall Study||54
424252|NCT01519700|1039619|P1|Treated Cycle 1 EP2006|Overall Study||53
424253|NCT01519700|1039616|P4|STARTED|Overall Study||54
424254|NCT01519700|1039617|P3|STARTED|Overall Study||55
424255|NCT01519700|1039618|P2|STARTED|Overall Study||55
424256|NCT01519700|1039619|P1|STARTED|Overall Study||54
424257|NCT01519674|1039654|P3|NOT COMPLETED|Overall Study||12
424258|NCT01519674|1039655|P2|NOT COMPLETED|Overall Study||13
424259|NCT01519674|1039656|P1|NOT COMPLETED|Overall Study||21
424260|NCT01519674|1039654|P3|COMPLETED|Overall Study||181
424261|NCT01519674|1039655|P2|COMPLETED|Overall Study||182
424262|NCT01519674|1039656|P1|COMPLETED|Overall Study||173
424263|NCT01519674|1039654|P3|Exposed|Overall Study||190
424264|NCT01519674|1039655|P2|Exposed|Overall Study||193
424265|NCT01519674|1039656|P1|Exposed|Overall Study||192
424266|NCT01519674|1039654|P3|STARTED|Overall Study||193
424267|NCT01519674|1039655|P2|STARTED|Overall Study||195
424268|NCT01519674|1039656|P1|STARTED|Overall Study||194
424269|NCT01519661|1039694|P1|NOT COMPLETED|Overall Study||61
424270|NCT01519661|1039694|P1|COMPLETED|Overall Study||96
424271|NCT01519661|1039694|P1|STARTED|Overall Study||157
424272|NCT01519648|1039711|P2|NOT COMPLETED|Overall Study||0
424273|NCT01519648|1039712|P1|NOT COMPLETED|Overall Study||0
424274|NCT01519648|1039711|P2|COMPLETED|Overall Study||306
424275|NCT01519648|1039712|P1|COMPLETED|Overall Study||502
424276|NCT01519648|1039711|P2|STARTED|Overall Study||306
424277|NCT01519648|1039712|P1|STARTED|Overall Study||502
424278|NCT01519518|1039720|P2|NOT COMPLETED|Overall Study||10
424279|NCT01519518|1039721|P1|NOT COMPLETED|Overall Study||7
424280|NCT01519518|1039720|P2|COMPLETED|Overall Study||905
424281|NCT01519518|1039721|P1|COMPLETED|Overall Study||907
424282|NCT01519518|1039720|P2|STARTED|Overall Study||915
424283|NCT01519518|1039721|P1|STARTED|Overall Study||914
424284|NCT01519466|1039735|P2|NOT COMPLETED|Overall Study||0
424285|NCT01519466|1039736|P1|NOT COMPLETED|Overall Study||0
424286|NCT01519466|1039735|P2|COMPLETED|Overall Study||16
424287|NCT01519466|1039736|P1|COMPLETED|Overall Study||33
424288|NCT01519466|1039735|P2|STARTED|Overall Study||16
424289|NCT01519466|1039736|P1|STARTED|Overall Study||33
424290|NCT01519427|1039746|P1|NOT COMPLETED|Overall Study||2
424291|NCT01519427|1039746|P1|COMPLETED|Overall Study||0
424292|NCT01519427|1039746|P1|STARTED|Overall Study||2
424293|NCT01519323|1039753|P2|NOT COMPLETED|Overall Study||3
424294|NCT01519323|1039754|P1|NOT COMPLETED|Overall Study||3
424295|NCT01519323|1039753|P2|COMPLETED|Overall Study||0
424296|NCT01519323|1039754|P1|COMPLETED|Overall Study||0
424297|NCT01519323|1039753|P2|STARTED|Overall Study||3
424298|NCT01519323|1039754|P1|STARTED|Overall Study||3
424299|NCT01519284|1039770|P5|NOT COMPLETED|Overall Study||0
424300|NCT01519284|1039771|P4|NOT COMPLETED|Overall Study||0
424301|NCT01519284|1039772|P3|NOT COMPLETED|Overall Study||2
424302|NCT01519284|1039773|P2|NOT COMPLETED|Overall Study||0
424303|NCT01519284|1039774|P1|NOT COMPLETED|Overall Study||0
424304|NCT01519284|1039770|P5|COMPLETED|Overall Study||16
424305|NCT01519284|1039771|P4|COMPLETED|Overall Study||16
424306|NCT01519284|1039772|P3|COMPLETED|Overall Study||16
424307|NCT01519284|1039773|P2|COMPLETED|Overall Study||16
424308|NCT01519284|1039774|P1|COMPLETED|Overall Study||16
424309|NCT01519284|1039770|P5|STARTED|Overall Study||16
424310|NCT01519284|1039771|P4|STARTED|Overall Study||16
424311|NCT01519284|1039772|P3|STARTED|Overall Study||18
424312|NCT01519284|1039773|P2|STARTED|Overall Study||16
424313|NCT01519284|1039774|P1|STARTED|Overall Study||16
424314|NCT01519271|1039803|P2|NOT COMPLETED|Phase 2||0
424315|NCT01519271|1039804|P1|NOT COMPLETED|Phase 2||0
424316|NCT01519271|1039803|P2|COMPLETED|Phase 2||14
424317|NCT01519271|1039804|P1|COMPLETED|Phase 2||12
424318|NCT01519271|1039803|P2|STARTED|Phase 2||14
424319|NCT01519271|1039804|P1|STARTED|Phase 2|2 participants discontinued after Phase 1|12
424320|NCT01519271|1039803|P2|NOT COMPLETED|Phase 1||1
424321|NCT01519271|1039804|P1|NOT COMPLETED|Phase 1||0
424322|NCT01519271|1039803|P2|COMPLETED|Phase 1|1 participant discontinued participation in the middle of phase 1.|13
424323|NCT01519271|1039804|P1|COMPLETED|Phase 1||14
424324|NCT01519271|1039803|P2|STARTED|Phase 1||14
424325|NCT01519271|1039804|P1|STARTED|Phase 1||14
424326|NCT01519245|1039814|P2|NOT COMPLETED|Overall Study||2
424327|NCT01519245|1039815|P1|NOT COMPLETED|Overall Study||1
424328|NCT01519245|1039814|P2|COMPLETED|Overall Study||18
424329|NCT01519245|1039815|P1|COMPLETED|Overall Study||23
424330|NCT01519245|1039814|P2|Received Post-pump IV TXA|Overall Study|A break in protocol, dosing was given in the operating room at the surgeon's preference.|2
424331|NCT01519245|1039815|P1|Received Post-pump IV TXA|Overall Study|A break in protocol, dosing was given in the operating room at the surgeon's preference.|6
424332|NCT01519245|1039814|P2|Received Pre-pump IV TXA|Overall Study|All patients meeting inclusion criteria received appropriate dosing, as per protocol.|18
424333|NCT01519245|1039815|P1|Received Pre-pump IV TXA|Overall Study|Two patients included in in the final analysis did not receive pre-pump IV TXA.|21
424334|NCT01519245|1039814|P2|STARTED|Overall Study||20
424335|NCT01519245|1039815|P1|STARTED|Overall Study||24
424336|NCT01519206|1039827|P1|NOT COMPLETED|Overall Study||5
424337|NCT01519206|1039827|P1|COMPLETED|Overall Study||27
424338|NCT01519206|1039827|P1|STARTED|Overall Study||32
424339|NCT01519167|1039841|P2|NOT COMPLETED|Overall Study||8
424340|NCT01519167|1039842|P1|NOT COMPLETED|Overall Study||0
424341|NCT01519167|1039841|P2|COMPLETED|Overall Study||81
424342|NCT01519167|1039842|P1|COMPLETED|Overall Study||1
424343|NCT01519167|1039841|P2|STARTED|Overall Study||89
424344|NCT01519167|1039842|P1|STARTED|Overall Study||1
424345|NCT01519089|1039868|P2|NOT COMPLETED|Overall Study||15
424346|NCT01519089|1039869|P1|NOT COMPLETED|Overall Study||7
424347|NCT01519089|1039868|P2|COMPLETED|Overall Study||33
424348|NCT01519089|1039869|P1|COMPLETED|Overall Study||40
424349|NCT01519089|1039868|P2|Received Treatment|Overall Study||47
424350|NCT01519089|1039869|P1|Received Treatment|Overall Study||47
424351|NCT01519089|1039868|P2|STARTED|Overall Study||48
424352|NCT01519089|1039869|P1|STARTED|Overall Study||47
424353|NCT01518946|1039990|P3|NOT COMPLETED|Randomized Phase (Second Intervention)||0
424354|NCT01518946|1039991|P2|NOT COMPLETED|Randomized Phase (Second Intervention)||0
424355|NCT01518946|1039992|P1|NOT COMPLETED|Randomized Phase (Second Intervention)||0
424356|NCT01518946|1039990|P3|COMPLETED|Randomized Phase (Second Intervention)||10
424357|NCT01518946|1039991|P2|COMPLETED|Randomized Phase (Second Intervention)||9
424358|NCT01518946|1039992|P1|COMPLETED|Randomized Phase (Second Intervention)||0
424359|NCT01518946|1039990|P3|STARTED|Randomized Phase (Second Intervention)||10
424360|NCT01518946|1039991|P2|STARTED|Randomized Phase (Second Intervention)||9
424361|NCT01518946|1039992|P1|STARTED|Randomized Phase (Second Intervention)||0
424362|NCT01518946|1039990|P3|NOT COMPLETED|Randomized Phase (First Intervention)||0
424363|NCT01518946|1039991|P2|NOT COMPLETED|Randomized Phase (First Intervention)||1
424364|NCT01518946|1039992|P1|NOT COMPLETED|Randomized Phase (First Intervention)||0
424365|NCT01518946|1039990|P3|COMPLETED|Randomized Phase (First Intervention)||10
424366|NCT01518946|1039991|P2|COMPLETED|Randomized Phase (First Intervention)||9
424367|NCT01518946|1039992|P1|COMPLETED|Randomized Phase (First Intervention)||0
424368|NCT01518946|1039990|P3|STARTED|Randomized Phase (First Intervention)||10
424369|NCT01518946|1039991|P2|STARTED|Randomized Phase (First Intervention)||10
424370|NCT01518946|1039992|P1|STARTED|Randomized Phase (First Intervention)||0
424371|NCT01518946|1039990|P3|NOT COMPLETED|Open-label Phase||0
424372|NCT01518946|1039991|P2|NOT COMPLETED|Open-label Phase||0
424373|NCT01518946|1039992|P1|NOT COMPLETED|Open-label Phase||4
424374|NCT01518946|1039990|P3|COMPLETED|Open-label Phase||0
424375|NCT01518946|1039991|P2|COMPLETED|Open-label Phase||0
424376|NCT01518946|1039992|P1|COMPLETED|Open-label Phase||20
424377|NCT01518946|1039990|P3|STARTED|Open-label Phase||0
424378|NCT01518946|1039991|P2|STARTED|Open-label Phase||0
424379|NCT01518946|1039992|P1|STARTED|Open-label Phase||24
424380|NCT01518530|1039999|P1|NOT COMPLETED|Post-Treatment Follow-up||0
424381|NCT01518530|1039999|P1|COMPLETED|Post-Treatment Follow-up||9
424382|NCT01518530|1039999|P1|STARTED|Post-Treatment Follow-up||9
424383|NCT01518530|1039999|P1|NOT COMPLETED|Active Treatment Period||1
424384|NCT01518530|1039999|P1|COMPLETED|Active Treatment Period||9
424385|NCT01518530|1039999|P1|STARTED|Active Treatment Period||10
424386|NCT01518374|1040003|P1|NOT COMPLETED|Overall Study||7
424387|NCT01518374|1040003|P1|COMPLETED|Overall Study||1761
424388|NCT01518374|1040003|P1|STARTED|Overall Study||1768
424389|NCT01518322|1040007|P1|NOT COMPLETED|Overall Study||13
424390|NCT01518322|1040007|P1|COMPLETED|Overall Study||222
424391|NCT01518322|1040007|P1|STARTED|Overall Study||235
424392|NCT01518270|1040020|P1|NOT COMPLETED|Overall Study||0
424393|NCT01518270|1040020|P1|COMPLETED|Overall Study||179
424394|NCT01518270|1040020|P1|STARTED|Overall Study||179
424395|NCT01518257|1040028|P2|NOT COMPLETED|Overall Study||0
424396|NCT01518257|1040029|P1|NOT COMPLETED|Overall Study||2
424397|NCT01518257|1040028|P2|COMPLETED|Overall Study||60
424398|NCT01518257|1040029|P1|COMPLETED|Overall Study||59
424399|NCT01518257|1040028|P2|STARTED|Overall Study||60
424400|NCT01518257|1040029|P1|STARTED|Overall Study||61
424401|NCT01518244|1040051|P1|NOT COMPLETED|Overall Study||3
424402|NCT01518244|1040051|P1|COMPLETED|Overall Study||47
424403|NCT01518244|1040051|P1|STARTED|Overall Study||50
424404|NCT01518192|1040059|P3|NOT COMPLETED|Overall Study||35
424405|NCT01518192|1040060|P2|NOT COMPLETED|Overall Study||26
424406|NCT01518192|1040061|P1|NOT COMPLETED|Overall Study||29
424407|NCT01518192|1040059|P3|COMPLETED|Overall Study||224
424408|NCT01518192|1040060|P2|COMPLETED|Overall Study||114
424409|NCT01518192|1040061|P1|COMPLETED|Overall Study||116
424410|NCT01518192|1040059|P3|STARTED|Overall Study||259
424411|NCT01518192|1040060|P2|STARTED|Overall Study||140
424412|NCT01518192|1040061|P1|STARTED|Overall Study||145
424413|NCT01518153|1040082|P3|NOT COMPLETED|Donor Lymphocyte Infusion||1
424414|NCT01518153|1040083|P2|NOT COMPLETED|Donor Lymphocyte Infusion||2
424415|NCT01518153|1040084|P1|NOT COMPLETED|Donor Lymphocyte Infusion||0
424416|NCT01518153|1040082|P3|COMPLETED|Donor Lymphocyte Infusion||3
424417|NCT01518153|1040083|P2|COMPLETED|Donor Lymphocyte Infusion||1
424418|NCT01518153|1040084|P1|COMPLETED|Donor Lymphocyte Infusion||0
424419|NCT01518153|1040082|P3|STARTED|Donor Lymphocyte Infusion||4
424420|NCT01518153|1040083|P2|STARTED|Donor Lymphocyte Infusion||3
424421|NCT01518153|1040084|P1|STARTED|Donor Lymphocyte Infusion||0
424422|NCT01518153|1040082|P3|NOT COMPLETED|Stem Cell Transplant||0
424423|NCT01518153|1040083|P2|NOT COMPLETED|Stem Cell Transplant||0
424424|NCT01518153|1040084|P1|NOT COMPLETED|Stem Cell Transplant||9
424425|NCT01518153|1040082|P3|COMPLETED|Stem Cell Transplant||0
424426|NCT01518153|1040083|P2|COMPLETED|Stem Cell Transplant||0
424427|NCT01518153|1040084|P1|COMPLETED|Stem Cell Transplant||7
424428|NCT01518153|1040082|P3|STARTED|Stem Cell Transplant||0
424429|NCT01518153|1040083|P2|STARTED|Stem Cell Transplant||0
424430|NCT01518153|1040084|P1|STARTED|Stem Cell Transplant||16
424431|NCT01517984|1040095|P4|NOT COMPLETED|Overall Study||1
424432|NCT01517984|1040096|P3|NOT COMPLETED|Overall Study||4
424433|NCT01517984|1040097|P2|NOT COMPLETED|Overall Study||23
424434|NCT01517984|1040098|P1|NOT COMPLETED|Overall Study||5
424435|NCT01517984|1040095|P4|COMPLETED|Overall Study||6
424436|NCT01517984|1040096|P3|COMPLETED|Overall Study||10
424437|NCT01517984|1040097|P2|COMPLETED|Overall Study||3
424438|NCT01517984|1040098|P1|COMPLETED|Overall Study||0
424439|NCT01517984|1040095|P4|STARTED|Overall Study||7
424440|NCT01517984|1040096|P3|STARTED|Overall Study||14
424441|NCT01517984|1040097|P2|STARTED|Overall Study||26
424442|NCT01517984|1040098|P1|STARTED|Overall Study||5
424443|NCT01517893|1040124|P2|NOT COMPLETED|Overall Study||1
424444|NCT01517893|1040125|P1|NOT COMPLETED|Overall Study||2
424445|NCT01517893|1040124|P2|COMPLETED|Overall Study||6
424446|NCT01517893|1040125|P1|COMPLETED|Overall Study||6
424447|NCT01517893|1040124|P2|STARTED|Overall Study||7
424448|NCT01517893|1040125|P1|STARTED|Overall Study||8
424449|NCT01517867|1040133|P2|NOT COMPLETED|Overall Study||65
424450|NCT01517867|1040134|P1|NOT COMPLETED|Overall Study||63
424451|NCT01517867|1040133|P2|COMPLETED|Overall Study||15
424452|NCT01517867|1040134|P1|COMPLETED|Overall Study||18
424453|NCT01517867|1040133|P2|STARTED|Overall Study||80
424454|NCT01517867|1040134|P1|STARTED|Overall Study||81
424455|NCT01517750|1040146|P4|NOT COMPLETED|Overall Study||1
424456|NCT01517750|1040147|P3|NOT COMPLETED|Overall Study||4
424457|NCT01517750|1040148|P2|NOT COMPLETED|Overall Study||2
424458|NCT01517750|1040149|P1|NOT COMPLETED|Overall Study||1
424459|NCT01517750|1040146|P4|COMPLETED|Overall Study||18
424460|NCT01517750|1040147|P3|COMPLETED|Overall Study||17
424461|NCT01517750|1040148|P2|COMPLETED|Overall Study||17
424462|NCT01517750|1040149|P1|COMPLETED|Overall Study||20
424463|NCT01517750|1040146|P4|STARTED|Overall Study||19
424464|NCT01517750|1040147|P3|STARTED|Overall Study||21
424465|NCT01517750|1040148|P2|STARTED|Overall Study||19
424466|NCT01517750|1040149|P1|STARTED|Overall Study||21
424467|NCT01517529|1040179|P1|NOT COMPLETED|Overall Study||0
424468|NCT01517529|1040179|P1|COMPLETED|Overall Study||10
424469|NCT01517529|1040179|P1|STARTED|Overall Study||10
424470|NCT01517412|1040186|P2|NOT COMPLETED|Overall Study||24
424471|NCT01517412|1040187|P1|NOT COMPLETED|Overall Study||36
424472|NCT01517412|1040186|P2|COMPLETED|Overall Study||202
424473|NCT01517412|1040187|P1|COMPLETED|Overall Study||189
424474|NCT01517412|1040186|P2|STARTED|Overall Study||226
424475|NCT01517412|1040187|P1|STARTED|Overall Study||225
424476|NCT01517373|1040216|P6|NOT COMPLETED|Treatment Period||7
424477|NCT01517373|1040217|P5|NOT COMPLETED|Treatment Period||6
424478|NCT01517373|1040218|P4|NOT COMPLETED|Treatment Period||7
424479|NCT01517373|1040219|P3|NOT COMPLETED|Treatment Period||6
424480|NCT01517373|1040220|P2|NOT COMPLETED|Treatment Period||4
424481|NCT01517373|1040221|P1|NOT COMPLETED|Treatment Period||0
424482|NCT01517373|1040216|P6|COMPLETED|Treatment Period||54
424483|NCT01517373|1040217|P5|COMPLETED|Treatment Period||55
424484|NCT01517373|1040218|P4|COMPLETED|Treatment Period||54
424485|NCT01517373|1040219|P3|COMPLETED|Treatment Period||54
424486|NCT01517373|1040220|P2|COMPLETED|Treatment Period||57
424487|NCT01517373|1040221|P1|COMPLETED|Treatment Period||0
424488|NCT01517373|1040216|P6|STARTED|Treatment Period||61
424489|NCT01517373|1040217|P5|STARTED|Treatment Period||61
424490|NCT01517373|1040218|P4|STARTED|Treatment Period||61
424491|NCT01517373|1040219|P3|STARTED|Treatment Period||60
424492|NCT01517373|1040220|P2|STARTED|Treatment Period||61
424493|NCT01517373|1040221|P1|STARTED|Treatment Period||0
424494|NCT01517373|1040216|P6|NOT COMPLETED|Run-in Period||0
424495|NCT01517373|1040217|P5|NOT COMPLETED|Run-in Period||0
424496|NCT01517373|1040218|P4|NOT COMPLETED|Run-in Period||0
424497|NCT01517373|1040219|P3|NOT COMPLETED|Run-in Period||0
424498|NCT01517373|1040220|P2|NOT COMPLETED|Run-in Period||0
424499|NCT01517373|1040221|P1|NOT COMPLETED|Run-in Period||57
424500|NCT01517373|1040216|P6|COMPLETED|Run-in Period||0
424501|NCT01517373|1040217|P5|COMPLETED|Run-in Period||0
424502|NCT01517373|1040218|P4|COMPLETED|Run-in Period||0
424503|NCT01517373|1040219|P3|COMPLETED|Run-in Period||0
424504|NCT01517373|1040220|P2|COMPLETED|Run-in Period||0
424505|NCT01517373|1040221|P1|COMPLETED|Run-in Period||304
424506|NCT01517373|1040216|P6|STARTED|Run-in Period||0
424507|NCT01517373|1040217|P5|STARTED|Run-in Period||0
424508|NCT01517373|1040218|P4|STARTED|Run-in Period||0
424509|NCT01517373|1040219|P3|STARTED|Run-in Period||0
424510|NCT01517373|1040220|P2|STARTED|Run-in Period||0
424511|NCT01517373|1040221|P1|STARTED|Run-in Period||361
424512|NCT01517295|1040291|P2|NOT COMPLETED|Overall Study||0
424513|NCT01517295|1040292|P1|NOT COMPLETED|Overall Study||1
424514|NCT01517295|1040291|P2|COMPLETED|Overall Study||14
424515|NCT01517295|1040292|P1|COMPLETED|Overall Study||15
424516|NCT01517295|1040291|P2|STARTED|Overall Study||14
424517|NCT01517295|1040292|P1|STARTED|Overall Study||16
424518|NCT01517282|1040306|P4|NOT COMPLETED|Overall Study||1
424519|NCT01517282|1040307|P3|NOT COMPLETED|Overall Study||1
424520|NCT01517282|1040308|P2|NOT COMPLETED|Overall Study||1
424521|NCT01517282|1040309|P1|NOT COMPLETED|Overall Study||1
424522|NCT01517282|1040306|P4|COMPLETED|Overall Study||5
424523|NCT01517282|1040307|P3|COMPLETED|Overall Study||8
424524|NCT01517282|1040308|P2|COMPLETED|Overall Study||7
424525|NCT01517282|1040309|P1|COMPLETED|Overall Study||8
424526|NCT01517282|1040306|P4|STARTED|Overall Study||6
424527|NCT01517282|1040307|P3|STARTED|Overall Study|1 patient completed the trial, but received only 4 doses of medication and 2 MRIs due to pregnancy|9
424528|NCT01517282|1040308|P2|STARTED|Overall Study||8
424529|NCT01517282|1040309|P1|STARTED|Overall Study|One patient was randomized but did not receive study medication based on the investigator's decision|9
424530|NCT01517178|1040343|P2|NOT COMPLETED|Period 2||2
424531|NCT01517178|1040344|P1|NOT COMPLETED|Period 2||6
424532|NCT01517178|1040343|P2|COMPLETED|Period 2||4
424533|NCT01517178|1040344|P1|COMPLETED|Period 2||5
424534|NCT01517178|1040343|P2|STARTED|Period 2||6
424535|NCT01517178|1040344|P1|STARTED|Period 2|One subject discontinued during run-in and did not start period 2.|11
424536|NCT01517178|1040343|P2|NOT COMPLETED|Period 1||5
424537|NCT01517178|1040344|P1|NOT COMPLETED|Period 1||4
424538|NCT01517178|1040343|P2|COMPLETED|Period 1||6
424539|NCT01517178|1040344|P1|COMPLETED|Period 1||12
424540|NCT01517178|1040343|P2|STARTED|Period 1||11
424541|NCT01517178|1040344|P1|STARTED|Period 1|One subject (who discontinued due to an adverse event) actually used New ostomy base plate.|16
424542|NCT01517074|1040350|P1|NOT COMPLETED|Overall Study||0
424543|NCT01517074|1040350|P1|COMPLETED|Overall Study||5
424544|NCT01517074|1040350|P1|STARTED|Overall Study||5
424545|NCT01516970|1040363|P2|NOT COMPLETED|Overall Study||21
424546|NCT01516970|1040364|P1|NOT COMPLETED|Overall Study||18
424547|NCT01516970|1040363|P2|COMPLETED|Overall Study||132
424548|NCT01516970|1040364|P1|COMPLETED|Overall Study||141
424549|NCT01516970|1040363|P2|STARTED|Overall Study||153
424550|NCT01516970|1040364|P1|STARTED|Overall Study||159
424551|NCT01516892|1040376|P1|NOT COMPLETED|Overall Study||343
424552|NCT01516892|1040376|P1|COMPLETED|Overall Study||373
424553|NCT01516892|1040376|P1|STARTED|Overall Study||716
424554|NCT01516879|1040384|P2|NOT COMPLETED|Overall Study||34
424555|NCT01516879|1040385|P1|NOT COMPLETED|Overall Study||16
424556|NCT01516879|1040384|P2|COMPLETED|Overall Study||568
424557|NCT01516879|1040385|P1|COMPLETED|Overall Study||287
424558|NCT01516879|1040384|P2|Received Treatment|Overall Study||599
424559|NCT01516879|1040385|P1|Received Treatment|Overall Study||302
424560|NCT01516879|1040384|P2|STARTED|Overall Study||602
424561|NCT01516879|1040385|P1|STARTED|Overall Study||303
424562|NCT01516749|1040419|P1|NOT COMPLETED|Follow-up Off Therapy||1
424563|NCT01516749|1040419|P1|COMPLETED|Follow-up Off Therapy||4
424564|NCT01516749|1040419|P1|STARTED|Follow-up Off Therapy||5
424565|NCT01516749|1040419|P1|NOT COMPLETED|Active Therapy||1
424566|NCT01516749|1040419|P1|COMPLETED|Active Therapy||5
424567|NCT01516749|1040419|P1|STARTED|Active Therapy||6
424568|NCT01516736|1040428|P2|NOT COMPLETED|Overall Study||13
424569|NCT01516736|1040429|P1|NOT COMPLETED|Overall Study||20
424570|NCT01516736|1040428|P2|COMPLETED|Overall Study||140
424571|NCT01516736|1040429|P1|COMPLETED|Overall Study||135
424572|NCT01516736|1040428|P2|STARTED|Overall Study||153
424573|NCT01516736|1040429|P1|STARTED|Overall Study||155
424574|NCT01516632|1040451|P2|NOT COMPLETED|Overall Study||15
424575|NCT01516632|1040452|P1|NOT COMPLETED|Overall Study||24
424576|NCT01516632|1040451|P2|COMPLETED|Overall Study||48
424577|NCT01516632|1040452|P1|COMPLETED|Overall Study||77
424578|NCT01516632|1040451|P2|STARTED|Overall Study||63
424579|NCT01516632|1040452|P1|STARTED|Overall Study||101
424580|NCT01516437|1040466|P4|NOT COMPLETED|Overall Study||1
424581|NCT01516437|1040467|P3|NOT COMPLETED|Overall Study||1
424582|NCT01516437|1040468|P2|NOT COMPLETED|Overall Study||0
424583|NCT01516437|1040469|P1|NOT COMPLETED|Overall Study||0
424584|NCT01516437|1040466|P4|COMPLETED|Overall Study||6
424585|NCT01516437|1040467|P3|COMPLETED|Overall Study||14
424586|NCT01516437|1040468|P2|COMPLETED|Overall Study||24
424587|NCT01516437|1040469|P1|COMPLETED|Overall Study||24
424588|NCT01516437|1040466|P4|STARTED|Overall Study||7
424589|NCT01516437|1040467|P3|STARTED|Overall Study||15
424590|NCT01516437|1040468|P2|STARTED|Overall Study||24
424591|NCT01516437|1040469|P1|STARTED|Overall Study||24
424592|NCT01516268|1040525|P2|NOT COMPLETED|Overall Study||0
424593|NCT01516268|1040526|P1|NOT COMPLETED|Overall Study||0
424594|NCT01516268|1040525|P2|COMPLETED|Overall Study||25
424595|NCT01516268|1040526|P1|COMPLETED|Overall Study||25
424596|NCT01516268|1040525|P2|STARTED|Overall Study||25
424597|NCT01516268|1040526|P1|STARTED|Overall Study||25
424598|NCT01516034|1040532|P1|NOT COMPLETED|Overall Study||8
424599|NCT01516034|1040532|P1|COMPLETED|Overall Study||0
424600|NCT01516034|1040532|P1|STARTED|Overall Study||8
424601|NCT01516008|1040539|P3|NOT COMPLETED|Overall Study||18
424602|NCT01516008|1040540|P2|NOT COMPLETED|Overall Study||16
424603|NCT01516008|1040541|P1|NOT COMPLETED|Overall Study||45
424604|NCT01516008|1040539|P3|COMPLETED|Overall Study||99
424605|NCT01516008|1040540|P2|COMPLETED|Overall Study||105
424606|NCT01516008|1040541|P1|COMPLETED|Overall Study||69
424607|NCT01516008|1040539|P3|STARTED|Overall Study||117
424608|NCT01516008|1040540|P2|STARTED|Overall Study||121
424609|NCT01516008|1040541|P1|STARTED|Overall Study||114
424610|NCT01515956|1040573|P1|NOT COMPLETED|Overall Study||0
424611|NCT01515956|1040573|P1|COMPLETED|Overall Study||15
424612|NCT01515956|1040573|P1|STARTED|Overall Study||15
424613|NCT01515943|1040582|P3|NOT COMPLETED|Overall Study||13
424614|NCT01515943|1040583|P2|NOT COMPLETED|Overall Study||16
424615|NCT01515943|1040584|P1|NOT COMPLETED|Overall Study||6
424616|NCT01515943|1040582|P3|COMPLETED|Overall Study||31
424617|NCT01515943|1040583|P2|COMPLETED|Overall Study||69
424618|NCT01515943|1040584|P1|COMPLETED|Overall Study||69
424619|NCT01515943|1040582|P3|STARTED|Overall Study||44
424620|NCT01515943|1040583|P2|STARTED|Overall Study||85
424621|NCT01515943|1040584|P1|STARTED|Overall Study||75
424622|NCT01515891|1040630|P1|NOT COMPLETED|Overall Study||0
424623|NCT01515891|1040630|P1|COMPLETED|Overall Study||4
424624|NCT01515891|1040630|P1|STARTED|Overall Study||4
424625|NCT01515865|1040637|P3|NOT COMPLETED|Part C (Randomized)||0
424626|NCT01515865|1040638|P2|NOT COMPLETED|Part C (Randomized)||0
424627|NCT01515865|1040639|P1|NOT COMPLETED|Part C (Randomized)||0
424628|NCT01515865|1040637|P3|COMPLETED|Part C (Randomized)||34
424629|NCT01515865|1040638|P2|COMPLETED|Part C (Randomized)||33
424630|NCT01515865|1040639|P1|COMPLETED|Part C (Randomized)||0
424631|NCT01515865|1040637|P3|STARTED|Part C (Randomized)||34
424632|NCT01515865|1040638|P2|STARTED|Part C (Randomized)|A total of two subjects from Part B did not meet the criteria required to be enrolled into Part C.|33
424633|NCT01515865|1040639|P1|STARTED|Part C (Randomized)||0
424634|NCT01515865|1040637|P3|NOT COMPLETED|Part B (Open-label)||0
424635|NCT01515865|1040638|P2|NOT COMPLETED|Part B (Open-label)||0
424636|NCT01515865|1040639|P1|NOT COMPLETED|Part B (Open-label)||2
424637|NCT01515865|1040637|P3|COMPLETED|Part B (Open-label)||0
424638|NCT01515865|1040638|P2|COMPLETED|Part B (Open-label)||0
424639|NCT01515865|1040639|P1|COMPLETED|Part B (Open-label)||69
424640|NCT01515865|1040637|P3|STARTED|Part B (Open-label)||0
424641|NCT01515865|1040638|P2|STARTED|Part B (Open-label)||0
424642|NCT01515865|1040639|P1|STARTED|Part B (Open-label)|Twenty-four subjects from Part A did not meet the criteria required to be enrolled into Part B.|71
424643|NCT01515865|1040637|P3|NOT COMPLETED|Part A (Open-label)||0
424644|NCT01515865|1040638|P2|NOT COMPLETED|Part A (Open-label)||0
424645|NCT01515865|1040639|P1|NOT COMPLETED|Part A (Open-label)||3
424646|NCT01515865|1040637|P3|COMPLETED|Part A (Open-label)||0
424647|NCT01515865|1040638|P2|COMPLETED|Part A (Open-label)||0
424648|NCT01515865|1040639|P1|COMPLETED|Part A (Open-label)||95
424649|NCT01515865|1040637|P3|STARTED|Part A (Open-label)||0
424650|NCT01515865|1040638|P2|STARTED|Part A (Open-label)||0
424651|NCT01515865|1040639|P1|STARTED|Part A (Open-label)||98
424652|NCT01515696|1040649|P2|NOT COMPLETED|Overall Study||10
424653|NCT01515696|1040650|P1|NOT COMPLETED|Overall Study||8
424654|NCT01515696|1040649|P2|COMPLETED|Overall Study||39
424655|NCT01515696|1040650|P1|COMPLETED|Overall Study||39
424656|NCT01515696|1040649|P2|STARTED|Overall Study||49
424657|NCT01515696|1040650|P1|STARTED|Overall Study||47
424658|NCT01515657|1040660|P3|NOT COMPLETED|Third Intervention||0
424659|NCT01515657|1040661|P2|NOT COMPLETED|Third Intervention||0
424660|NCT01515657|1040662|P1|NOT COMPLETED|Third Intervention||1
424661|NCT01515657|1040660|P3|COMPLETED|Third Intervention||13
424662|NCT01515657|1040661|P2|COMPLETED|Third Intervention||11
424663|NCT01515657|1040662|P1|COMPLETED|Third Intervention||13
424664|NCT01515657|1040660|P3|STARTED|Third Intervention||13
424665|NCT01515657|1040661|P2|STARTED|Third Intervention||11
424666|NCT01515657|1040662|P1|STARTED|Third Intervention||14
424667|NCT01515657|1040660|P3|NOT COMPLETED|Second Intervention||0
424668|NCT01515657|1040661|P2|NOT COMPLETED|Second Intervention||1
424669|NCT01515657|1040662|P1|NOT COMPLETED|Second Intervention||0
424670|NCT01515657|1040660|P3|COMPLETED|Second Intervention||13
424671|NCT01515657|1040661|P2|COMPLETED|Second Intervention||11
424672|NCT01515657|1040662|P1|COMPLETED|Second Intervention||14
424673|NCT01515657|1040660|P3|STARTED|Second Intervention||13
424674|NCT01515657|1040661|P2|STARTED|Second Intervention||12
424675|NCT01515657|1040662|P1|STARTED|Second Intervention||14
424676|NCT01515657|1040660|P3|NOT COMPLETED|First Intervention||0
424677|NCT01515657|1040661|P2|NOT COMPLETED|First Intervention||1
424678|NCT01515657|1040662|P1|NOT COMPLETED|First Intervention||0
424679|NCT01515657|1040660|P3|COMPLETED|First Intervention||13
424680|NCT01515657|1040661|P2|COMPLETED|First Intervention||12
424681|NCT01515657|1040662|P1|COMPLETED|First Intervention||14
424682|NCT01515657|1040660|P3|STARTED|First Intervention||13
424683|NCT01515657|1040661|P2|STARTED|First Intervention||13
424684|NCT01515657|1040662|P1|STARTED|First Intervention||14
424685|NCT01515566|1040672|P2|NOT COMPLETED|Overall Study||0
424686|NCT01515566|1040673|P1|NOT COMPLETED|Overall Study||0
424687|NCT01515566|1040672|P2|COMPLETED|Overall Study||10
424688|NCT01515566|1040673|P1|COMPLETED|Overall Study||10
424689|NCT01515566|1040672|P2|STARTED|Overall Study||10
424690|NCT01515566|1040673|P1|STARTED|Overall Study||10
424691|NCT01515540|1040685|P2|NOT COMPLETED|Overall Study||3
424692|NCT01515540|1040686|P1|NOT COMPLETED|Overall Study||5
424693|NCT01515540|1040685|P2|COMPLETED|Overall Study||15
424694|NCT01515540|1040686|P1|COMPLETED|Overall Study||15
424695|NCT01515540|1040685|P2|STARTED|Overall Study||18
424696|NCT01515540|1040686|P1|STARTED|Overall Study||20
424697|NCT01515488|1040694|P2|NOT COMPLETED|Overall Study||0
424698|NCT01515488|1040695|P1|NOT COMPLETED|Overall Study||0
424699|NCT01515488|1040694|P2|COMPLETED|Overall Study||200
424700|NCT01515488|1040695|P1|COMPLETED|Overall Study||200
424701|NCT01515488|1040694|P2|STARTED|Overall Study||200
424702|NCT01515488|1040695|P1|STARTED|Overall Study||200
424703|NCT01515423|1040707|P3|NOT COMPLETED|DOUBLE BLIND||92
424704|NCT01515423|1040708|P2|NOT COMPLETED|DOUBLE BLIND||82
424705|NCT01515423|1040709|P1|NOT COMPLETED|DOUBLE BLIND||0
424706|NCT01515423|1040707|P3|COMPLETED|DOUBLE BLIND||420
424707|NCT01515423|1040708|P2|COMPLETED|DOUBLE BLIND||422
424708|NCT01515423|1040709|P1|COMPLETED|DOUBLE BLIND||0
424709|NCT01515423|1040707|P3|STARTED|DOUBLE BLIND||512
424710|NCT01515423|1040708|P2|STARTED|DOUBLE BLIND||504
424711|NCT01515423|1040709|P1|STARTED|DOUBLE BLIND||0
424712|NCT01515423|1040707|P3|NOT COMPLETED|Open Label Phase||0
424713|NCT01515423|1040708|P2|NOT COMPLETED|Open Label Phase||0
424714|NCT01515423|1040709|P1|NOT COMPLETED|Open Label Phase||413
424715|NCT01515423|1040707|P3|COMPLETED|Open Label Phase||0
424716|NCT01515423|1040708|P2|COMPLETED|Open Label Phase||0
424717|NCT01515423|1040709|P1|COMPLETED|Open Label Phase||1016
424718|NCT01515423|1040707|P3|STARTED|Open Label Phase||0
424719|NCT01515423|1040708|P2|STARTED|Open Label Phase||0
424720|NCT01515423|1040709|P1|STARTED|Open Label Phase||1429
424721|NCT01515410|1040728|P2|NOT COMPLETED|Overall Study||0
424722|NCT01515410|1040729|P1|NOT COMPLETED|Overall Study||0
424723|NCT01515410|1040728|P2|COMPLETED|Overall Study||15
424724|NCT01515410|1040729|P1|COMPLETED|Overall Study||19
424725|NCT01515410|1040728|P2|STARTED|Overall Study||15
424726|NCT01515410|1040729|P1|STARTED|Overall Study||19
424727|NCT01515345|1040737|P2|NOT COMPLETED|Overall Study||0
424728|NCT01515345|1040738|P1|NOT COMPLETED|Overall Study||1
424729|NCT01515345|1040737|P2|COMPLETED|Overall Study||343
424730|NCT01515345|1040738|P1|COMPLETED|Overall Study||664
424731|NCT01515345|1040737|P2|STARTED|Overall Study||343
424732|NCT01515345|1040738|P1|STARTED|Overall Study||665
424733|NCT01515306|1040750|P2|NOT COMPLETED|Overall Study||14
424734|NCT01515306|1040751|P1|NOT COMPLETED|Overall Study||12
424735|NCT01515306|1040750|P2|COMPLETED|Overall Study||2
424736|NCT01515306|1040751|P1|COMPLETED|Overall Study|Completed the required treatment in Cycle 1 Day 1 and Cycle 2 Day 1 and assessment.|12
424737|NCT01515306|1040750|P2|Drug-Drug Interaction Population|Overall Study|Drug-drug interaction was only assessed in Part A.|0
424738|NCT01515306|1040751|P1|Drug-Drug Interaction Population|Overall Study|Completed Cycle 1 Day 1 and Cycle 2 Day 1 treatment.|21
424739|NCT01515306|1040750|P2|Received at Least 1 Dose of Study Drug|Overall Study||16
424740|NCT01515306|1040751|P1|Received at Least 1 Dose of Study Drug|Overall Study||24
424741|NCT01515306|1040750|P2|STARTED|Overall Study||16
424742|NCT01515306|1040751|P1|STARTED|Overall Study||24
424743|NCT01515189|1040764|P2|NOT COMPLETED|First Re-Induction Phase||15
424744|NCT01515189|1040765|P1|NOT COMPLETED|First Re-Induction Phase||14
424745|NCT01515189|1040764|P2|COMPLETED|First Re-Induction Phase||17
424746|NCT01515189|1040765|P1|COMPLETED|First Re-Induction Phase||9
424747|NCT01515189|1040764|P2|STARTED|First Re-Induction Phase||32
424748|NCT01515189|1040765|P1|STARTED|First Re-Induction Phase||23
424749|NCT01515189|1040764|P2|NOT COMPLETED|Induction||232
424750|NCT01515189|1040765|P1|NOT COMPLETED|Induction||237
424751|NCT01515189|1040764|P2|COMPLETED|Induction||130
424752|NCT01515189|1040765|P1|COMPLETED|Induction||128
424753|NCT01515189|1040764|P2|STARTED|Induction||362
424754|NCT01515189|1040765|P1|STARTED|Induction|Includes 1 subject who was randomized but not treated due to an Adverse Event before treatment|365
424755|NCT01515176|1040787|P2|NOT COMPLETED|Overall Study||0
424756|NCT01515176|1040788|P1|NOT COMPLETED|Overall Study||0
424757|NCT01515176|1040787|P2|COMPLETED|Overall Study||32
424758|NCT01515176|1040788|P1|COMPLETED|Overall Study||4
424759|NCT01515176|1040787|P2|STARTED|Overall Study||32
424760|NCT01515176|1040788|P1|STARTED|Overall Study||4
424761|NCT01515072|1040802|P2|NOT COMPLETED|Overall Study||0
424762|NCT01515072|1040803|P1|NOT COMPLETED|Overall Study||0
424763|NCT01515072|1040802|P2|COMPLETED|Overall Study|There were 513 total organs transplanted and 235 kidneys transplanted in the RIPC group|155
424764|NCT01515072|1040803|P1|COMPLETED|Overall Study|There were 566 total organs transplanted and 248 kidneys transplanted in the No RIPC group.|166
424765|NCT01515072|1040802|P2|STARTED|Overall Study||155
424766|NCT01515072|1040803|P1|STARTED|Overall Study||166
424767|NCT01515046|1040843|P1|NOT COMPLETED|Overall Study||0
424768|NCT01515046|1040843|P1|COMPLETED|Overall Study||1
424769|NCT01515046|1040843|P1|STARTED|Overall Study||1
424770|NCT01514864|1040853|P2|NOT COMPLETED|Overall Study||5
424771|NCT01514864|1040854|P1|NOT COMPLETED|Overall Study||9
424772|NCT01514864|1040853|P2|COMPLETED|Overall Study||0
424773|NCT01514864|1040854|P1|COMPLETED|Overall Study|Study was terminated; no patients completed study treatment|0
424774|NCT01514864|1040853|P2|STARTED|Overall Study||5
424775|NCT01514864|1040854|P1|STARTED|Overall Study||9
424776|NCT01514786|1040872|P2|NOT COMPLETED|Overall Study||0
424777|NCT01514786|1040873|P1|NOT COMPLETED|Overall Study||0
424778|NCT01514786|1040872|P2|COMPLETED|Overall Study||284
424779|NCT01514786|1040873|P1|COMPLETED|Overall Study||286
424780|NCT01514786|1040872|P2|STARTED|Overall Study||284
424781|NCT01514786|1040873|P1|STARTED|Overall Study||286
424782|NCT01514760|1040879|P1|NOT COMPLETED|Overall Study||2
424783|NCT01514760|1040879|P1|COMPLETED|Overall Study||20
424784|NCT01514760|1040879|P1|STARTED|Overall Study||22
424785|NCT01514734|1040886|P1|NOT COMPLETED|Overall Study||0
424786|NCT01514734|1040886|P1|COMPLETED|Overall Study||9
424787|NCT01514734|1040886|P1|STARTED|Overall Study||9
424788|NCT01514682|1040892|P2|NOT COMPLETED|Overall Study||6
424789|NCT01514682|1040893|P1|NOT COMPLETED|Overall Study||6
424790|NCT01514682|1040892|P2|COMPLETED|Overall Study||14
424791|NCT01514682|1040893|P1|COMPLETED|Overall Study||13
424792|NCT01514682|1040892|P2|STARTED|Overall Study||20
424793|NCT01514682|1040893|P1|STARTED|Overall Study||19
424794|NCT01514630|1040909|P1|NOT COMPLETED|Overall Study||3
424795|NCT01514630|1040909|P1|COMPLETED|Overall Study||11
424796|NCT01514630|1040909|P1|STARTED|Overall Study||14
424797|NCT01514513|1040915|P2|NOT COMPLETED|Overall Study||1
424798|NCT01514513|1040916|P1|NOT COMPLETED|Overall Study||1
424799|NCT01514513|1040915|P2|COMPLETED|Overall Study||20
424800|NCT01514513|1040916|P1|COMPLETED|Overall Study||20
424801|NCT01514513|1040915|P2|STARTED|Overall Study||21
424802|NCT01514513|1040916|P1|STARTED|Overall Study||21
424803|NCT01514461|1040927|P3|NOT COMPLETED|Overall Study||4
424804|NCT01514461|1040928|P2|NOT COMPLETED|Overall Study||3
424805|NCT01514461|1040929|P1|NOT COMPLETED|Overall Study||5
424806|NCT01514461|1040927|P3|COMPLETED|Overall Study||11
424807|NCT01514461|1040928|P2|COMPLETED|Overall Study||12
424808|NCT01514461|1040929|P1|COMPLETED|Overall Study||10
424809|NCT01514461|1040927|P3|STARTED|Overall Study||15
424810|NCT01514461|1040928|P2|STARTED|Overall Study||15
424811|NCT01514461|1040929|P1|STARTED|Overall Study||15
424812|NCT01514448|1040968|P2|NOT COMPLETED|Overall Study||8
424813|NCT01514448|1040969|P1|NOT COMPLETED|Overall Study||12
424814|NCT01514448|1040968|P2|COMPLETED|Overall Study||5
424815|NCT01514448|1040969|P1|COMPLETED|Overall Study||4
424816|NCT01514448|1040968|P2|Full Analysis Set (FAS)|Overall Study||13
424817|NCT01514448|1040969|P1|Full Analysis Set (FAS)|Overall Study||12
424818|NCT01514448|1040968|P2|STARTED|Overall Study||13
424819|NCT01514448|1040969|P1|STARTED|Overall Study||16
424820|NCT01514422|1040984|P1|NOT COMPLETED|Overall Study||1
424821|NCT01514422|1040984|P1|COMPLETED|Overall Study||19
424822|NCT01514422|1040984|P1|STARTED|Overall Study||20
424823|NCT01514357|1040992|P2|NOT COMPLETED|Overall Study||0
424824|NCT01514357|1040993|P1|NOT COMPLETED|Overall Study||4
424825|NCT01514357|1040992|P2|COMPLETED|Overall Study||0
424826|NCT01514357|1040993|P1|COMPLETED|Overall Study||8
424827|NCT01514357|1040992|P2|STARTED|Overall Study||0
424828|NCT01514357|1040993|P1|STARTED|Overall Study||12
424829|NCT01514318|1040999|P1|NOT COMPLETED|Overall Study||0
424830|NCT01514318|1040999|P1|COMPLETED|Overall Study||8
424831|NCT01514318|1040999|P1|STARTED|Overall Study||8
424832|NCT01514292|1041005|P1|NOT COMPLETED|Overall Study||0
424833|NCT01514292|1041005|P1|COMPLETED|Overall Study||72
424834|NCT01514292|1041005|P1|STARTED|Overall Study||72
424835|NCT01514240|1041011|P2|NOT COMPLETED|Overall Study||11
424836|NCT01514240|1041012|P1|NOT COMPLETED|Overall Study||6
424837|NCT01514240|1041011|P2|COMPLETED|Overall Study||45
424838|NCT01514240|1041012|P1|COMPLETED|Overall Study||50
424839|NCT01514240|1041011|P2|STARTED|Overall Study||56
424840|NCT01514240|1041012|P1|STARTED|Overall Study||56
424841|NCT01514162|1041086|P1|NOT COMPLETED|Overall Study||85
424842|NCT01514162|1041086|P1|COMPLETED|Overall Study||160
424843|NCT01514162|1041086|P1|STARTED|Overall Study||245
424844|NCT01514149|1041097|P5|NOT COMPLETED|Overall Study||1
424845|NCT01514149|1041098|P4|NOT COMPLETED|Overall Study||1
424846|NCT01514149|1041099|P3|NOT COMPLETED|Overall Study||3
424847|NCT01514149|1041100|P2|NOT COMPLETED|Overall Study||1
424848|NCT01514149|1041101|P1|NOT COMPLETED|Overall Study||3
424849|NCT01514149|1041097|P5|COMPLETED|Overall Study||14
424850|NCT01514149|1041098|P4|COMPLETED|Overall Study||13
424851|NCT01514149|1041099|P3|COMPLETED|Overall Study||11
424852|NCT01514149|1041100|P2|COMPLETED|Overall Study||14
424853|NCT01514149|1041101|P1|COMPLETED|Overall Study||12
424854|NCT01514149|1041097|P5|STARTED|Overall Study||15
424855|NCT01514149|1041098|P4|STARTED|Overall Study||14
424856|NCT01514149|1041099|P3|STARTED|Overall Study||14
424857|NCT01514149|1041100|P2|STARTED|Overall Study||15
424858|NCT01514149|1041101|P1|STARTED|Overall Study||15
424859|NCT01514136|1041125|P8|NOT COMPLETED|Test Period; Test D*||0
424860|NCT01514136|1041126|P7|NOT COMPLETED|Test Period; Test D*||0
424861|NCT01514136|1041127|P6|NOT COMPLETED|Test Period; Test D*||0
424862|NCT01514136|1041128|P5|NOT COMPLETED|Test Period; Test D*||0
424863|NCT01514136|1041129|P4|NOT COMPLETED|Test Period; Test D*||0
424864|NCT01514136|1041130|P3|NOT COMPLETED|Test Period; Test D*||0
424865|NCT01514136|1041131|P2|NOT COMPLETED|Test Period; Test D*||0
424866|NCT01514136|1041132|P1|NOT COMPLETED|Test Period; Test D*||0
424867|NCT01514136|1041125|P8|COMPLETED|Test Period; Test D*||23
424868|NCT01514136|1041126|P7|COMPLETED|Test Period; Test D*||0
424869|NCT01514136|1041127|P6|COMPLETED|Test Period; Test D*||0
424870|NCT01514136|1041128|P5|COMPLETED|Test Period; Test D*||0
424871|NCT01514136|1041129|P4|COMPLETED|Test Period; Test D*||0
424872|NCT01514136|1041130|P3|COMPLETED|Test Period; Test D*||0
424873|NCT01514136|1041131|P2|COMPLETED|Test Period; Test D*||0
424874|NCT01514136|1041132|P1|COMPLETED|Test Period; Test D*||0
424875|NCT01514136|1041125|P8|STARTED|Test Period; Test D*||23
424876|NCT01514136|1041126|P7|STARTED|Test Period; Test D*||0
424877|NCT01514136|1041127|P6|STARTED|Test Period; Test D*||0
424878|NCT01514136|1041128|P5|STARTED|Test Period; Test D*||0
424879|NCT01514136|1041129|P4|STARTED|Test Period; Test D*||0
424880|NCT01514136|1041130|P3|STARTED|Test Period; Test D*||0
424881|NCT01514136|1041131|P2|STARTED|Test Period; Test D*||0
424882|NCT01514136|1041132|P1|STARTED|Test Period; Test D*||0
424883|NCT01514136|1041125|P8|NOT COMPLETED|Test Period 2; Test C*||0
424884|NCT01514136|1041126|P7|NOT COMPLETED|Test Period 2; Test C*||3
424885|NCT01514136|1041127|P6|NOT COMPLETED|Test Period 2; Test C*||0
424886|NCT01514136|1041128|P5|NOT COMPLETED|Test Period 2; Test C*||0
424887|NCT01514136|1041129|P4|NOT COMPLETED|Test Period 2; Test C*||0
424888|NCT01514136|1041130|P3|NOT COMPLETED|Test Period 2; Test C*||0
424889|NCT01514136|1041131|P2|NOT COMPLETED|Test Period 2; Test C*||0
424890|NCT01514136|1041132|P1|NOT COMPLETED|Test Period 2; Test C*||0
424891|NCT01514136|1041125|P8|COMPLETED|Test Period 2; Test C*||0
424892|NCT01514136|1041126|P7|COMPLETED|Test Period 2; Test C*||23
424893|NCT01514136|1041127|P6|COMPLETED|Test Period 2; Test C*||0
424894|NCT01514136|1041128|P5|COMPLETED|Test Period 2; Test C*||0
424895|NCT01514136|1041129|P4|COMPLETED|Test Period 2; Test C*||0
424896|NCT01514136|1041130|P3|COMPLETED|Test Period 2; Test C*||0
424897|NCT01514136|1041131|P2|COMPLETED|Test Period 2; Test C*||0
424898|NCT01514136|1041132|P1|COMPLETED|Test Period 2; Test C*||0
424899|NCT01514136|1041125|P8|STARTED|Test Period 2; Test C*||0
424900|NCT01514136|1041126|P7|STARTED|Test Period 2; Test C*||26
424901|NCT01514136|1041127|P6|STARTED|Test Period 2; Test C*||0
424902|NCT01514136|1041128|P5|STARTED|Test Period 2; Test C*||0
424903|NCT01514136|1041129|P4|STARTED|Test Period 2; Test C*||0
424904|NCT01514136|1041130|P3|STARTED|Test Period 2; Test C*||0
424905|NCT01514136|1041131|P2|STARTED|Test Period 2; Test C*||0
424906|NCT01514136|1041132|P1|STARTED|Test Period 2; Test C*||0
424907|NCT01514136|1041125|P8|NOT COMPLETED|Test Period 2; Test B*||0
424908|NCT01514136|1041126|P7|NOT COMPLETED|Test Period 2; Test B*||0
424909|NCT01514136|1041127|P6|NOT COMPLETED|Test Period 2; Test B*||2
424910|NCT01514136|1041128|P5|NOT COMPLETED|Test Period 2; Test B*||0
424911|NCT01514136|1041129|P4|NOT COMPLETED|Test Period 2; Test B*||0
424912|NCT01514136|1041130|P3|NOT COMPLETED|Test Period 2; Test B*||0
424913|NCT01514136|1041131|P2|NOT COMPLETED|Test Period 2; Test B*||0
424914|NCT01514136|1041132|P1|NOT COMPLETED|Test Period 2; Test B*||0
424915|NCT01514136|1041125|P8|COMPLETED|Test Period 2; Test B*||0
424916|NCT01514136|1041126|P7|COMPLETED|Test Period 2; Test B*||0
424917|NCT01514136|1041127|P6|COMPLETED|Test Period 2; Test B*||26
424918|NCT01514136|1041128|P5|COMPLETED|Test Period 2; Test B*||0
424919|NCT01514136|1041129|P4|COMPLETED|Test Period 2; Test B*||0
424920|NCT01514136|1041130|P3|COMPLETED|Test Period 2; Test B*||0
424921|NCT01514136|1041131|P2|COMPLETED|Test Period 2; Test B*||0
424922|NCT01514136|1041132|P1|COMPLETED|Test Period 2; Test B*||0
424923|NCT01514136|1041125|P8|STARTED|Test Period 2; Test B*||0
424924|NCT01514136|1041126|P7|STARTED|Test Period 2; Test B*||0
424925|NCT01514136|1041127|P6|STARTED|Test Period 2; Test B*|Two subjects did not test test A*, but had a break and continued again on Test B*|28
424926|NCT01514136|1041128|P5|STARTED|Test Period 2; Test B*||0
424927|NCT01514136|1041129|P4|STARTED|Test Period 2; Test B*||0
424928|NCT01514136|1041130|P3|STARTED|Test Period 2; Test B*||0
424929|NCT01514136|1041131|P2|STARTED|Test Period 2; Test B*||0
424930|NCT01514136|1041132|P1|STARTED|Test Period 2; Test B*||0
424931|NCT01514136|1041125|P8|NOT COMPLETED|Test Period 2; Test A*||0
424932|NCT01514136|1041126|P7|NOT COMPLETED|Test Period 2; Test A*||0
424933|NCT01514136|1041127|P6|NOT COMPLETED|Test Period 2; Test A*||0
424934|NCT01514136|1041128|P5|NOT COMPLETED|Test Period 2; Test A*||2
424935|NCT01514136|1041129|P4|NOT COMPLETED|Test Period 2; Test A*||0
424936|NCT01514136|1041130|P3|NOT COMPLETED|Test Period 2; Test A*||0
424937|NCT01514136|1041131|P2|NOT COMPLETED|Test Period 2; Test A*||0
424938|NCT01514136|1041132|P1|NOT COMPLETED|Test Period 2; Test A*||0
424939|NCT01514136|1041125|P8|COMPLETED|Test Period 2; Test A*||0
424940|NCT01514136|1041126|P7|COMPLETED|Test Period 2; Test A*||0
424941|NCT01514136|1041127|P6|COMPLETED|Test Period 2; Test A*||0
424942|NCT01514136|1041128|P5|COMPLETED|Test Period 2; Test A*||26
424943|NCT01514136|1041129|P4|COMPLETED|Test Period 2; Test A*||0
424944|NCT01514136|1041130|P3|COMPLETED|Test Period 2; Test A*||0
424945|NCT01514136|1041131|P2|COMPLETED|Test Period 2; Test A*||0
424946|NCT01514136|1041132|P1|COMPLETED|Test Period 2; Test A*||0
424947|NCT01514136|1041125|P8|STARTED|Test Period 2; Test A*||0
424948|NCT01514136|1041126|P7|STARTED|Test Period 2; Test A*||0
424949|NCT01514136|1041127|P6|STARTED|Test Period 2; Test A*||0
424950|NCT01514136|1041128|P5|STARTED|Test Period 2; Test A*|4 new subjects were included in the investigation|28
424951|NCT01514136|1041129|P4|STARTED|Test Period 2; Test A*||0
424952|NCT01514136|1041130|P3|STARTED|Test Period 2; Test A*||0
424953|NCT01514136|1041131|P2|STARTED|Test Period 2; Test A*||0
424954|NCT01514136|1041132|P1|STARTED|Test Period 2; Test A*||0
424955|NCT01514136|1041125|P8|NOT COMPLETED|Test Period 1; Test D||0
424956|NCT01514136|1041126|P7|NOT COMPLETED|Test Period 1; Test D||0
424957|NCT01514136|1041127|P6|NOT COMPLETED|Test Period 1; Test D||0
424958|NCT01514136|1041128|P5|NOT COMPLETED|Test Period 1; Test D||0
424959|NCT01514136|1041129|P4|NOT COMPLETED|Test Period 1; Test D||2
424960|NCT01514136|1041130|P3|NOT COMPLETED|Test Period 1; Test D||0
424961|NCT01514136|1041131|P2|NOT COMPLETED|Test Period 1; Test D||0
424962|NCT01514136|1041132|P1|NOT COMPLETED|Test Period 1; Test D||0
424963|NCT01514136|1041125|P8|COMPLETED|Test Period 1; Test D||0
424964|NCT01514136|1041126|P7|COMPLETED|Test Period 1; Test D||0
424965|NCT01514136|1041127|P6|COMPLETED|Test Period 1; Test D||0
424966|NCT01514136|1041128|P5|COMPLETED|Test Period 1; Test D||0
424967|NCT01514136|1041129|P4|COMPLETED|Test Period 1; Test D||24
424968|NCT01514136|1041130|P3|COMPLETED|Test Period 1; Test D||0
424969|NCT01514136|1041131|P2|COMPLETED|Test Period 1; Test D||0
424970|NCT01514136|1041132|P1|COMPLETED|Test Period 1; Test D||0
424971|NCT01514136|1041125|P8|STARTED|Test Period 1; Test D||0
424972|NCT01514136|1041126|P7|STARTED|Test Period 1; Test D||0
424973|NCT01514136|1041127|P6|STARTED|Test Period 1; Test D||0
424974|NCT01514136|1041128|P5|STARTED|Test Period 1; Test D||0
424975|NCT01514136|1041129|P4|STARTED|Test Period 1; Test D|The two subject that were on holiday after test A re-entered the investigation|26
424976|NCT01514136|1041130|P3|STARTED|Test Period 1; Test D||0
424977|NCT01514136|1041131|P2|STARTED|Test Period 1; Test D||0
424978|NCT01514136|1041132|P1|STARTED|Test Period 1; Test D||0
424979|NCT01514136|1041125|P8|NOT COMPLETED|Test Period 1; Test C||0
424980|NCT01514136|1041126|P7|NOT COMPLETED|Test Period 1; Test C||0
424981|NCT01514136|1041127|P6|NOT COMPLETED|Test Period 1; Test C||0
424982|NCT01514136|1041128|P5|NOT COMPLETED|Test Period 1; Test C||0
424983|NCT01514136|1041129|P4|NOT COMPLETED|Test Period 1; Test C||0
424984|NCT01514136|1041130|P3|NOT COMPLETED|Test Period 1; Test C||0
424985|NCT01514136|1041131|P2|NOT COMPLETED|Test Period 1; Test C||0
424986|NCT01514136|1041132|P1|NOT COMPLETED|Test Period 1; Test C||0
424987|NCT01514136|1041125|P8|COMPLETED|Test Period 1; Test C||0
424988|NCT01514136|1041126|P7|COMPLETED|Test Period 1; Test C||0
424989|NCT01514136|1041127|P6|COMPLETED|Test Period 1; Test C||0
424990|NCT01514136|1041128|P5|COMPLETED|Test Period 1; Test C||0
424991|NCT01514136|1041129|P4|COMPLETED|Test Period 1; Test C||0
424992|NCT01514136|1041130|P3|COMPLETED|Test Period 1; Test C||24
424993|NCT01514136|1041131|P2|COMPLETED|Test Period 1; Test C||0
424994|NCT01514136|1041132|P1|COMPLETED|Test Period 1; Test C||0
424995|NCT01514136|1041125|P8|STARTED|Test Period 1; Test C||0
424996|NCT01514136|1041126|P7|STARTED|Test Period 1; Test C||0
424997|NCT01514136|1041127|P6|STARTED|Test Period 1; Test C||0
424998|NCT01514136|1041128|P5|STARTED|Test Period 1; Test C||0
424999|NCT01514136|1041129|P4|STARTED|Test Period 1; Test C||0
425000|NCT01514136|1041130|P3|STARTED|Test Period 1; Test C|1 new subject was included in the investigation|24
425001|NCT01514136|1041131|P2|STARTED|Test Period 1; Test C||0
425002|NCT01514136|1041132|P1|STARTED|Test Period 1; Test C||0
425003|NCT01514136|1041125|P8|NOT COMPLETED|Test Period 1; Test B||0
425004|NCT01514136|1041126|P7|NOT COMPLETED|Test Period 1; Test B||0
425005|NCT01514136|1041127|P6|NOT COMPLETED|Test Period 1; Test B||0
425006|NCT01514136|1041128|P5|NOT COMPLETED|Test Period 1; Test B||0
425007|NCT01514136|1041129|P4|NOT COMPLETED|Test Period 1; Test B||0
425008|NCT01514136|1041130|P3|NOT COMPLETED|Test Period 1; Test B||0
425009|NCT01514136|1041131|P2|NOT COMPLETED|Test Period 1; Test B||1
425010|NCT01514136|1041132|P1|NOT COMPLETED|Test Period 1; Test B||0
425011|NCT01514136|1041125|P8|COMPLETED|Test Period 1; Test B||0
425012|NCT01514136|1041126|P7|COMPLETED|Test Period 1; Test B||0
425013|NCT01514136|1041127|P6|COMPLETED|Test Period 1; Test B||0
425014|NCT01514136|1041128|P5|COMPLETED|Test Period 1; Test B||0
425015|NCT01514136|1041129|P4|COMPLETED|Test Period 1; Test B||0
425016|NCT01514136|1041130|P3|COMPLETED|Test Period 1; Test B||0
425017|NCT01514136|1041131|P2|COMPLETED|Test Period 1; Test B||23
425018|NCT01514136|1041132|P1|COMPLETED|Test Period 1; Test B||0
425019|NCT01514136|1041125|P8|STARTED|Test Period 1; Test B||0
425020|NCT01514136|1041126|P7|STARTED|Test Period 1; Test B||0
425021|NCT01514136|1041127|P6|STARTED|Test Period 1; Test B||0
425022|NCT01514136|1041128|P5|STARTED|Test Period 1; Test B||0
425023|NCT01514136|1041129|P4|STARTED|Test Period 1; Test B||0
425024|NCT01514136|1041130|P3|STARTED|Test Period 1; Test B||0
425025|NCT01514136|1041131|P2|STARTED|Test Period 1; Test B|2 new subjects were entered the investigation|24
425026|NCT01514136|1041132|P1|STARTED|Test Period 1; Test B||0
425027|NCT01514136|1041125|P8|NOT COMPLETED|Test Period 1; Test A||0
425028|NCT01514136|1041126|P7|NOT COMPLETED|Test Period 1; Test A||0
425029|NCT01514136|1041127|P6|NOT COMPLETED|Test Period 1; Test A||0
425030|NCT01514136|1041128|P5|NOT COMPLETED|Test Period 1; Test A||0
425031|NCT01514136|1041129|P4|NOT COMPLETED|Test Period 1; Test A||0
425032|NCT01514136|1041130|P3|NOT COMPLETED|Test Period 1; Test A||0
425033|NCT01514136|1041131|P2|NOT COMPLETED|Test Period 1; Test A||0
425034|NCT01514136|1041132|P1|NOT COMPLETED|Test Period 1; Test A||3
425035|NCT01514136|1041125|P8|COMPLETED|Test Period 1; Test A||0
425036|NCT01514136|1041126|P7|COMPLETED|Test Period 1; Test A||0
425037|NCT01514136|1041127|P6|COMPLETED|Test Period 1; Test A||0
425038|NCT01514136|1041128|P5|COMPLETED|Test Period 1; Test A||0
425039|NCT01514136|1041129|P4|COMPLETED|Test Period 1; Test A||0
425040|NCT01514136|1041130|P3|COMPLETED|Test Period 1; Test A||0
425041|NCT01514136|1041131|P2|COMPLETED|Test Period 1; Test A||0
425042|NCT01514136|1041132|P1|COMPLETED|Test Period 1; Test A||22
425043|NCT01514136|1041125|P8|STARTED|Test Period 1; Test A||0
425044|NCT01514136|1041126|P7|STARTED|Test Period 1; Test A||0
425045|NCT01514136|1041127|P6|STARTED|Test Period 1; Test A||0
425046|NCT01514136|1041128|P5|STARTED|Test Period 1; Test A||0
425047|NCT01514136|1041129|P4|STARTED|Test Period 1; Test A||0
425048|NCT01514136|1041130|P3|STARTED|Test Period 1; Test A||0
425049|NCT01514136|1041131|P2|STARTED|Test Period 1; Test A||0
425050|NCT01514136|1041132|P1|STARTED|Test Period 1; Test A|26 subjects tested Test A|25
425051|NCT01513902|1041161|P3|NOT COMPLETED|Overall Study||0
425052|NCT01513902|1041162|P2|NOT COMPLETED|Overall Study||0
425053|NCT01513902|1041163|P1|NOT COMPLETED|Overall Study||0
425054|NCT01513902|1041161|P3|COMPLETED|Overall Study||9
425055|NCT01513902|1041162|P2|COMPLETED|Overall Study||9
425056|NCT01513902|1041163|P1|COMPLETED|Overall Study||8
425057|NCT01513902|1041161|P3|STARTED|Overall Study||9
425058|NCT01513902|1041162|P2|STARTED|Overall Study||9
425059|NCT01513902|1041163|P1|STARTED|Overall Study||8
425060|NCT01513590|1041200|P2|NOT COMPLETED|Overall Study||13
425061|NCT01513590|1041201|P1|NOT COMPLETED|Overall Study||10
425062|NCT01513590|1041200|P2|COMPLETED|Overall Study||184
425063|NCT01513590|1041201|P1|COMPLETED|Overall Study||187
425064|NCT01513590|1041200|P2|Exposed|Overall Study|"Two (2) subjects were withdrawn prior to exposure due to withdrawal of consent"|195
425065|NCT01513590|1041201|P1|Exposed|Overall Study|One (1) subject was withdrawn prior to exposure due to “non fulfilment of inclusion criteria”|196
425066|NCT01513590|1041200|P2|STARTED|Overall Study||197
425067|NCT01513590|1041201|P1|STARTED|Overall Study||197
425068|NCT01513538|1041219|P1|NOT COMPLETED|Overall Study||5
425069|NCT01513538|1041219|P1|COMPLETED|Overall Study||573
425070|NCT01513538|1041219|P1|STARTED|Overall Study||578
425071|NCT01513473|1041225|P2|NOT COMPLETED|Extension Trial (26 Weeks)||6
425072|NCT01513473|1041226|P1|NOT COMPLETED|Extension Trial (26 Weeks)||1
425073|NCT01513473|1041225|P2|COMPLETED|Extension Trial (26 Weeks)||122
425074|NCT01513473|1041226|P1|COMPLETED|Extension Trial (26 Weeks)||151
425075|NCT01513473|1041225|P2|STARTED|Extension Trial (26 Weeks)|37 subjects did not consent to participate in the extension trial.|128
425076|NCT01513473|1041226|P1|STARTED|Extension Trial (26 Weeks)|18 subjects did not consent to participate in the extension trial.|152
425077|NCT01513473|1041225|P2|NOT COMPLETED|Main Trial (26 Weeks)||11
425078|NCT01513473|1041226|P1|NOT COMPLETED|Main Trial (26 Weeks)||4
425079|NCT01513473|1041225|P2|COMPLETED|Main Trial (26 Weeks)||165
425080|NCT01513473|1041226|P1|COMPLETED|Main Trial (26 Weeks)||170
425081|NCT01513473|1041225|P2|Exposed|Main Trial (26 Weeks)||175
425082|NCT01513473|1041226|P1|Exposed|Main Trial (26 Weeks)||174
425083|NCT01513473|1041225|P2|STARTED|Main Trial (26 Weeks)|1 subject was randomised but withdrew before the drug exposure.|176
425084|NCT01513473|1041226|P1|STARTED|Main Trial (26 Weeks)||174
425085|NCT01513460|1041253|P3|NOT COMPLETED|Overall Study||56
425086|NCT01513460|1041254|P2|NOT COMPLETED|Overall Study||32
425087|NCT01513460|1041255|P1|NOT COMPLETED|Overall Study||29
425088|NCT01513460|1041253|P3|COMPLETED|Overall Study||201
425089|NCT01513460|1041254|P2|COMPLETED|Overall Study||226
425090|NCT01513460|1041255|P1|COMPLETED|Overall Study||229
425091|NCT01513460|1041253|P3|Per-protocol Set|Overall Study||166
425092|NCT01513460|1041254|P2|Per-protocol Set|Overall Study||186
425093|NCT01513460|1041255|P1|Per-protocol Set|Overall Study||196
425094|NCT01513460|1041253|P3|Full Analysis Set|Overall Study||257
425095|NCT01513460|1041254|P2|Full Analysis Set|Overall Study||258
425096|NCT01513460|1041255|P1|Full Analysis Set|Overall Study||257
425097|NCT01513460|1041253|P3|STARTED|Overall Study||257
425098|NCT01513460|1041254|P2|STARTED|Overall Study||258
425099|NCT01513460|1041255|P1|STARTED|Overall Study||258
425100|NCT01513447|1041281|P2|NOT COMPLETED|Overall Study||0
425101|NCT01513447|1041282|P1|NOT COMPLETED|Overall Study||0
425102|NCT01513447|1041281|P2|COMPLETED|Overall Study||5
425103|NCT01513447|1041282|P1|COMPLETED|Overall Study||3
425104|NCT01513447|1041281|P2|STARTED|Overall Study||5
425105|NCT01513447|1041282|P1|STARTED|Overall Study||3
425106|NCT01513330|1041290|P2|NOT COMPLETED|Standard Care First,||4
425107|NCT01513330|1041291|P1|NOT COMPLETED|Standard Care First,||4
425108|NCT01513330|1041290|P2|COMPLETED|Standard Care First,||52
425109|NCT01513330|1041291|P1|COMPLETED|Standard Care First,||56
425110|NCT01513330|1041290|P2|STARTED|Standard Care First,||56
425111|NCT01513330|1041291|P1|STARTED|Standard Care First,||60
425112|NCT01513330|1041290|P2|NOT COMPLETED|SenSura Mio First,||2
425113|NCT01513330|1041291|P1|NOT COMPLETED|SenSura Mio First,||4
425114|NCT01513330|1041290|P2|COMPLETED|SenSura Mio First,||56
425115|NCT01513330|1041291|P1|COMPLETED|SenSura Mio First,||60
425116|NCT01513330|1041290|P2|STARTED|SenSura Mio First,||58
425117|NCT01513330|1041291|P1|STARTED|SenSura Mio First,||64
425118|NCT01513317|1041299|P2|NOT COMPLETED|Overall Study||24
425119|NCT01513317|1041300|P1|NOT COMPLETED|Overall Study||34
425120|NCT01513317|1041299|P2|COMPLETED|Overall Study||2
425121|NCT01513317|1041300|P1|COMPLETED|Overall Study||16
425122|NCT01513317|1041299|P2|STARTED|Overall Study||26
425123|NCT01513317|1041300|P1|STARTED|Overall Study||50
425124|NCT01513291|1041318|P5|NOT COMPLETED|Run-out Period||0
425125|NCT01513291|1041319|P4|NOT COMPLETED|Run-out Period||2
425126|NCT01513291|1041320|P3|NOT COMPLETED|Run-out Period||0
425127|NCT01513291|1041321|P2|NOT COMPLETED|Run-out Period||0
425128|NCT01513291|1041322|P1|NOT COMPLETED|Run-out Period||0
425129|NCT01513291|1041318|P5|COMPLETED|Run-out Period||101
425130|NCT01513291|1041319|P4|COMPLETED|Run-out Period||45
425131|NCT01513291|1041320|P3|COMPLETED|Run-out Period||50
425132|NCT01513291|1041321|P2|COMPLETED|Run-out Period||0
425133|NCT01513291|1041322|P1|COMPLETED|Run-out Period||0
425134|NCT01513291|1041318|P5|STARTED|Run-out Period|These participants were completers from the Treatment Period: Placebo group|101
425135|NCT01513291|1041319|P4|STARTED|Run-out Period|These participants were pre-randomized from participants in the Treatment Period: MK-6096 group|47
425136|NCT01513291|1041320|P3|STARTED|Run-out Period|These participants were pre-randomized from participants in the Treatment Period: MK-6096 group|50
425137|NCT01513291|1041321|P2|STARTED|Run-out Period||0
425138|NCT01513291|1041322|P1|STARTED|Run-out Period||0
425139|NCT01513291|1041318|P5|NOT COMPLETED|Treatment Period||0
425140|NCT01513291|1041319|P4|NOT COMPLETED|Treatment Period||0
425141|NCT01513291|1041320|P3|NOT COMPLETED|Treatment Period||0
425142|NCT01513291|1041321|P2|NOT COMPLETED|Treatment Period||16
425143|NCT01513291|1041322|P1|NOT COMPLETED|Treatment Period||23
425144|NCT01513291|1041318|P5|COMPLETED|Treatment Period||0
425145|NCT01513291|1041319|P4|COMPLETED|Treatment Period||0
425146|NCT01513291|1041320|P3|COMPLETED|Treatment Period||0
425147|NCT01513291|1041321|P2|COMPLETED|Treatment Period||101
425148|NCT01513291|1041322|P1|COMPLETED|Treatment Period||97
425149|NCT01513291|1041318|P5|Treated|Treatment Period||0
425150|NCT01513291|1041319|P4|Treated|Treatment Period||0
425151|NCT01513291|1041320|P3|Treated|Treatment Period||0
425152|NCT01513291|1041321|P2|Treated|Treatment Period||115
425153|NCT01513291|1041322|P1|Treated|Treatment Period||120
425154|NCT01513291|1041318|P5|STARTED|Treatment Period||0
425155|NCT01513291|1041319|P4|STARTED|Treatment Period||0
425156|NCT01513291|1041320|P3|STARTED|Treatment Period||0
425157|NCT01513291|1041321|P2|STARTED|Treatment Period||117
425158|NCT01513291|1041322|P1|STARTED|Treatment Period||120
425159|NCT01513239|1041350|P6|NOT COMPLETED|Period 2: 9 Month Extension Phase||5
425160|NCT01513239|1041351|P5|NOT COMPLETED|Period 2: 9 Month Extension Phase||10
425161|NCT01513239|1041352|P4|NOT COMPLETED|Period 2: 9 Month Extension Phase||10
425162|NCT01513239|1041353|P3|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
425163|NCT01513239|1041354|P2|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
425164|NCT01513239|1041355|P1|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
425165|NCT01513239|1041350|P6|COMPLETED|Period 2: 9 Month Extension Phase||78
425166|NCT01513239|1041351|P5|COMPLETED|Period 2: 9 Month Extension Phase||90
425167|NCT01513239|1041352|P4|COMPLETED|Period 2: 9 Month Extension Phase||102
425168|NCT01513239|1041353|P3|COMPLETED|Period 2: 9 Month Extension Phase||0
425169|NCT01513239|1041354|P2|COMPLETED|Period 2: 9 Month Extension Phase||0
425170|NCT01513239|1041355|P1|COMPLETED|Period 2: 9 Month Extension Phase||0
425171|NCT01513239|1041350|P6|STARTED|Period 2: 9 Month Extension Phase||83
425172|NCT01513239|1041351|P5|STARTED|Period 2: 9 Month Extension Phase||100
425173|NCT01513239|1041352|P4|STARTED|Period 2: 9 Month Extension Phase||112
425174|NCT01513239|1041353|P3|STARTED|Period 2: 9 Month Extension Phase||0
425175|NCT01513239|1041354|P2|STARTED|Period 2: 9 Month Extension Phase||0
425176|NCT01513239|1041355|P1|STARTED|Period 2: 9 Month Extension Phase||0
425177|NCT01513239|1041350|P6|NOT COMPLETED|Period 1: Main Phase||0
425178|NCT01513239|1041351|P5|NOT COMPLETED|Period 1: Main Phase||0
425179|NCT01513239|1041352|P4|NOT COMPLETED|Period 1: Main Phase||0
425180|NCT01513239|1041353|P3|NOT COMPLETED|Period 1: Main Phase||88
425181|NCT01513239|1041354|P2|NOT COMPLETED|Period 1: Main Phase||70
425182|NCT01513239|1041355|P1|NOT COMPLETED|Period 1: Main Phase||75
425183|NCT01513239|1041350|P6|COMPLETED|Period 1: Main Phase||0
425184|NCT01513239|1041351|P5|COMPLETED|Period 1: Main Phase||0
425185|NCT01513239|1041352|P4|COMPLETED|Period 1: Main Phase||0
425186|NCT01513239|1041353|P3|COMPLETED|Period 1: Main Phase||311
425187|NCT01513239|1041354|P2|COMPLETED|Period 1: Main Phase||337
425188|NCT01513239|1041355|P1|COMPLETED|Period 1: Main Phase||322
425189|NCT01513239|1041350|P6|All Participants as Treated|Period 1: Main Phase||0
425190|NCT01513239|1041351|P5|All Participants as Treated|Period 1: Main Phase||0
425191|NCT01513239|1041352|P4|All Participants as Treated|Period 1: Main Phase||0
425192|NCT01513239|1041353|P3|All Participants as Treated|Period 1: Main Phase|Treatment actually received|381
425193|NCT01513239|1041354|P2|All Participants as Treated|Period 1: Main Phase|Treatment actually received|396
425194|NCT01513239|1041355|P1|All Participants as Treated|Period 1: Main Phase|One participant randomized to receive MK-3415A (MK-3415 plus MK-6072) received only MK-3415|390
425195|NCT01513239|1041350|P6|Treated|Period 1: Main Phase||0
425196|NCT01513239|1041351|P5|Treated|Period 1: Main Phase||0
425197|NCT01513239|1041352|P4|Treated|Period 1: Main Phase||0
425198|NCT01513239|1041353|P3|Treated|Period 1: Main Phase|Treated participants|381
425199|NCT01513239|1041354|P2|Treated|Period 1: Main Phase|Treated participants|396
425200|NCT01513239|1041355|P1|Treated|Period 1: Main Phase|Treated participants|391
425201|NCT01513239|1041350|P6|STARTED|Period 1: Main Phase||0
425202|NCT01513239|1041351|P5|STARTED|Period 1: Main Phase||0
425203|NCT01513239|1041352|P4|STARTED|Period 1: Main Phase||0
425204|NCT01513239|1041353|P3|STARTED|Period 1: Main Phase|Randomized participants|399
425205|NCT01513239|1041354|P2|STARTED|Period 1: Main Phase|Randomized participants|407
425206|NCT01513239|1041355|P1|STARTED|Period 1: Main Phase|Randomized participants|397
425207|NCT01513148|1041408|P2|NOT COMPLETED|Overall Study||2
425208|NCT01513148|1041409|P1|NOT COMPLETED|Overall Study||2
425209|NCT01513148|1041408|P2|COMPLETED|Overall Study||14
425210|NCT01513148|1041409|P1|COMPLETED|Overall Study||14
425211|NCT01513148|1041408|P2|STARTED|Overall Study||16
425212|NCT01513148|1041409|P1|STARTED|Overall Study||16
425213|NCT01513122|1041457|P2|NOT COMPLETED|Overall Study||3
425214|NCT01513122|1041458|P1|NOT COMPLETED|Overall Study||11
425215|NCT01513122|1041457|P2|COMPLETED|Overall Study||105
425216|NCT01513122|1041458|P1|COMPLETED|Overall Study||91
425217|NCT01513122|1041457|P2|STARTED|Overall Study||108
425218|NCT01513122|1041458|P1|STARTED|Overall Study||102
425219|NCT01512979|1041476|P2|NOT COMPLETED|Overall Study||22
425220|NCT01512979|1041477|P1|NOT COMPLETED|Overall Study||19
425221|NCT01512979|1041476|P2|COMPLETED|Overall Study||135
425222|NCT01512979|1041477|P1|COMPLETED|Overall Study||140
425223|NCT01512979|1041476|P2|STARTED|Overall Study|Randomised and treated|157
425224|NCT01512979|1041477|P1|STARTED|Overall Study|Randomised and treated|159
425225|NCT01512849|1041497|P4|NOT COMPLETED|Crossover Period 2||0
425226|NCT01512849|1041498|P3|NOT COMPLETED|Crossover Period 2||0
425227|NCT01512849|1041499|P2|NOT COMPLETED|Crossover Period 2||0
425228|NCT01512849|1041500|P1|NOT COMPLETED|Crossover Period 2||0
425229|NCT01512849|1041497|P4|COMPLETED|Crossover Period 2||6
425230|NCT01512849|1041498|P3|COMPLETED|Crossover Period 2||6
425231|NCT01512849|1041499|P2|COMPLETED|Crossover Period 2||6
425232|NCT01512849|1041500|P1|COMPLETED|Crossover Period 2||6
425233|NCT01512849|1041497|P4|STARTED|Crossover Period 2||6
425234|NCT01512849|1041498|P3|STARTED|Crossover Period 2||6
425235|NCT01512849|1041499|P2|STARTED|Crossover Period 2||6
425236|NCT01512849|1041500|P1|STARTED|Crossover Period 2||6
425237|NCT01512849|1041497|P4|NOT COMPLETED|Crossover Period 1||0
425238|NCT01512849|1041498|P3|NOT COMPLETED|Crossover Period 1||0
425239|NCT01512849|1041499|P2|NOT COMPLETED|Crossover Period 1||0
425240|NCT01512849|1041500|P1|NOT COMPLETED|Crossover Period 1||0
425241|NCT01512849|1041497|P4|COMPLETED|Crossover Period 1||6
425242|NCT01512849|1041498|P3|COMPLETED|Crossover Period 1||6
425243|NCT01512849|1041499|P2|COMPLETED|Crossover Period 1||6
425244|NCT01512849|1041500|P1|COMPLETED|Crossover Period 1||6
425245|NCT01512849|1041497|P4|STARTED|Crossover Period 1||6
425246|NCT01512849|1041498|P3|STARTED|Crossover Period 1||6
425247|NCT01512849|1041499|P2|STARTED|Crossover Period 1||6
425248|NCT01512849|1041500|P1|STARTED|Crossover Period 1||6
425249|NCT01512797|1041524|P2|NOT COMPLETED|Overall Study||0
425250|NCT01512797|1041525|P1|NOT COMPLETED|Overall Study||0
425251|NCT01512797|1041524|P2|COMPLETED|Overall Study||16
425252|NCT01512797|1041525|P1|COMPLETED|Overall Study||16
425253|NCT01512797|1041524|P2|STARTED|Overall Study||16
425254|NCT01512797|1041525|P1|STARTED|Overall Study||16
425255|NCT01512745|1041541|P2|NOT COMPLETED|Overall Study||20
425256|NCT01512745|1041542|P1|NOT COMPLETED|Overall Study||40
425257|NCT01512745|1041541|P2|COMPLETED|Overall Study||71
425258|NCT01512745|1041542|P1|COMPLETED|Overall Study||136
425259|NCT01512745|1041541|P2|STARTED|Overall Study||91
425260|NCT01512745|1041542|P1|STARTED|Overall Study||176
425261|NCT01512693|1041558|P2|NOT COMPLETED|Overall Study||1
425262|NCT01512693|1041559|P1|NOT COMPLETED|Overall Study||0
425263|NCT01512693|1041558|P2|COMPLETED|Overall Study||8
425264|NCT01512693|1041559|P1|COMPLETED|Overall Study||8
425265|NCT01512693|1041558|P2|STARTED|Overall Study||9
425266|NCT01512693|1041559|P1|STARTED|Overall Study||8
425267|NCT01512667|1041573|P2|NOT COMPLETED|Overall Study||0
425268|NCT01512667|1041574|P1|NOT COMPLETED|Overall Study||0
425269|NCT01512667|1041573|P2|COMPLETED|Overall Study||12
425270|NCT01512667|1041574|P1|COMPLETED|Overall Study||13
425271|NCT01512667|1041573|P2|Unmatched Participants|Overall Study||0
425272|NCT01512667|1041574|P1|Unmatched Participants|Overall Study|Participant was not matched to a healthy control participant.|1
425273|NCT01512667|1041573|P2|Matched Participants|Overall Study||12
425274|NCT01512667|1041574|P1|Matched Participants|Overall Study||12
425275|NCT01512667|1041573|P2|STARTED|Overall Study||12
425276|NCT01512667|1041574|P1|STARTED|Overall Study||13
425277|NCT01512368|1041586|P1|NOT COMPLETED|Overall Study||3
425278|NCT01512368|1041586|P1|COMPLETED|Overall Study||60
425279|NCT01512368|1041586|P1|STARTED|Overall Study||63
425280|NCT01512251|1041597|P2|NOT COMPLETED|Phase II||0
425281|NCT01512251|1041598|P1|NOT COMPLETED|Phase II||0
425282|NCT01512251|1041597|P2|COMPLETED|Phase II||0
425283|NCT01512251|1041598|P1|COMPLETED|Phase II||0
425284|NCT01512251|1041597|P2|STARTED|Phase II||0
425285|NCT01512251|1041598|P1|STARTED|Phase II||0
425286|NCT01512251|1041597|P2|NOT COMPLETED|Phase I, Dose 4||0
425287|NCT01512251|1041598|P1|NOT COMPLETED|Phase I, Dose 4||0
425288|NCT01512251|1041597|P2|COMPLETED|Phase I, Dose 4||0
425289|NCT01512251|1041598|P1|COMPLETED|Phase I, Dose 4||0
425290|NCT01512251|1041597|P2|STARTED|Phase I, Dose 4||0
425291|NCT01512251|1041598|P1|STARTED|Phase I, Dose 4||0
425292|NCT01512251|1041597|P2|NOT COMPLETED|Phase I, Dose 3||0
425293|NCT01512251|1041598|P1|NOT COMPLETED|Phase I, Dose 3||0
425294|NCT01512251|1041597|P2|COMPLETED|Phase I, Dose 3||0
425295|NCT01512251|1041598|P1|COMPLETED|Phase I, Dose 3||0
425296|NCT01512251|1041597|P2|STARTED|Phase I, Dose 3||0
425297|NCT01512251|1041598|P1|STARTED|Phase I, Dose 3||0
425298|NCT01512251|1041597|P2|NOT COMPLETED|Phase I, Dose 2||0
425299|NCT01512251|1041598|P1|NOT COMPLETED|Phase I, Dose 2||0
425300|NCT01512251|1041597|P2|COMPLETED|Phase I, Dose 2||0
425301|NCT01512251|1041598|P1|COMPLETED|Phase I, Dose 2||0
425302|NCT01512251|1041597|P2|STARTED|Phase I, Dose 2||0
425303|NCT01512251|1041598|P1|STARTED|Phase I, Dose 2||0
425304|NCT01512251|1041597|P2|NOT COMPLETED|Phase I, Dose 1||5
425305|NCT01512251|1041598|P1|NOT COMPLETED|Phase I, Dose 1||3
425306|NCT01512251|1041597|P2|COMPLETED|Phase I, Dose 1||0
425307|NCT01512251|1041598|P1|COMPLETED|Phase I, Dose 1||0
425308|NCT01512251|1041597|P2|STARTED|Phase I, Dose 1||5
425309|NCT01512251|1041598|P1|STARTED|Phase I, Dose 1||3
425310|NCT01512251|1041597|P2|NOT COMPLETED|Dose Level -1||0
425311|NCT01512251|1041598|P1|NOT COMPLETED|Dose Level -1||0
425312|NCT01512251|1041597|P2|COMPLETED|Dose Level -1||5
425313|NCT01512251|1041598|P1|COMPLETED|Dose Level -1||3
425314|NCT01512251|1041597|P2|STARTED|Dose Level -1||5
425315|NCT01512251|1041598|P1|STARTED|Dose Level -1||3
425316|NCT01512225|1041619|P2|NOT COMPLETED|Overall Study||0
425317|NCT01512225|1041620|P1|NOT COMPLETED|Overall Study||0
425318|NCT01512225|1041619|P2|COMPLETED|Overall Study||45
425319|NCT01512225|1041620|P1|COMPLETED|Overall Study||45
425320|NCT01512225|1041619|P2|Provided Day 14 Volume|Overall Study||40
425321|NCT01512225|1041620|P1|Provided Day 14 Volume|Overall Study||45
425322|NCT01512225|1041619|P2|STARTED|Overall Study||45
425323|NCT01512225|1041620|P1|STARTED|Overall Study||45
425324|NCT01512160|1041644|P4|NOT COMPLETED|Overall Study||1
425325|NCT01512160|1041645|P3|NOT COMPLETED|Overall Study||0
425326|NCT01512160|1041646|P2|NOT COMPLETED|Overall Study||0
425327|NCT01512160|1041647|P1|NOT COMPLETED|Overall Study||2
425328|NCT01512160|1041644|P4|COMPLETED|Overall Study||22
425329|NCT01512160|1041645|P3|COMPLETED|Overall Study||22
425330|NCT01512160|1041646|P2|COMPLETED|Overall Study||23
425331|NCT01512160|1041647|P1|COMPLETED|Overall Study||20
425332|NCT01512160|1041644|P4|STARTED|Overall Study||23
425333|NCT01512160|1041645|P3|STARTED|Overall Study||22
425334|NCT01512160|1041646|P2|STARTED|Overall Study||23
425335|NCT01512160|1041647|P1|STARTED|Overall Study||22
425336|NCT01512108|1041739|P2|NOT COMPLETED|Overall Study||9
425337|NCT01512108|1041740|P1|NOT COMPLETED|Overall Study||22
425338|NCT01512108|1041739|P2|COMPLETED|Overall Study||111
425339|NCT01512108|1041740|P1|COMPLETED|Overall Study||221
425340|NCT01512108|1041739|P2|Exposed|Overall Study||120
425341|NCT01512108|1041740|P1|Exposed|Overall Study|3 subjects withdrew prior to exposure to trial drug|240
425342|NCT01512108|1041739|P2|STARTED|Overall Study||120
425343|NCT01512108|1041740|P1|STARTED|Overall Study||243
425344|NCT01511978|1041754|P2|NOT COMPLETED|Overall Study||0
425345|NCT01511978|1041755|P1|NOT COMPLETED|Overall Study||0
425346|NCT01511978|1041754|P2|COMPLETED|Overall Study||18
425347|NCT01511978|1041755|P1|COMPLETED|Overall Study||14
425348|NCT01511978|1041754|P2|STARTED|Overall Study||18
425349|NCT01511978|1041755|P1|STARTED|Overall Study||14
425350|NCT01511939|1041766|P3|NOT COMPLETED|Overall Study||0
425351|NCT01511939|1041767|P2|NOT COMPLETED|Overall Study||1
425352|NCT01511939|1041768|P1|NOT COMPLETED|Overall Study||2
425353|NCT01511939|1041766|P3|COMPLETED|Overall Study||8
425354|NCT01511939|1041767|P2|COMPLETED|Overall Study||4
425355|NCT01511939|1041768|P1|COMPLETED|Overall Study||7
425356|NCT01511939|1041766|P3|STARTED|Overall Study||8
425357|NCT01511939|1041767|P2|STARTED|Overall Study|Includes one patient who was also taking aspirin.|5
425358|NCT01511939|1041768|P1|STARTED|Overall Study|Includes 1 subject who was also taking aspirin.|9
425359|NCT01511809|1041787|P2|NOT COMPLETED|Overall Study||7
425360|NCT01511809|1041788|P1|NOT COMPLETED|Overall Study||7
425361|NCT01511809|1041787|P2|COMPLETED|Overall Study||52
425362|NCT01511809|1041788|P1|COMPLETED|Overall Study||51
425363|NCT01511809|1041787|P2|STARTED|Overall Study||59
425364|NCT01511809|1041788|P1|STARTED|Overall Study||58
425365|NCT01511536|1041797|P3|NOT COMPLETED|Phase 2||9
425366|NCT01511536|1041798|P2|NOT COMPLETED|Phase 2||0
425367|NCT01511536|1041799|P1|NOT COMPLETED|Phase 2||0
425368|NCT01511536|1041797|P3|COMPLETED|Phase 2|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|18
425369|NCT01511536|1041798|P2|COMPLETED|Phase 2||0
425370|NCT01511536|1041799|P1|COMPLETED|Phase 2||0
425371|NCT01511536|1041797|P3|STARTED|Phase 2||27
425372|NCT01511536|1041798|P2|STARTED|Phase 2||0
425373|NCT01511536|1041799|P1|STARTED|Phase 2||0
425374|NCT01511536|1041797|P3|NOT COMPLETED|Phase 1||0
425375|NCT01511536|1041798|P2|NOT COMPLETED|Phase 1||1
425376|NCT01511536|1041799|P1|NOT COMPLETED|Phase 1||0
425377|NCT01511536|1041797|P3|COMPLETED|Phase 1||0
425378|NCT01511536|1041798|P2|COMPLETED|Phase 1|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|6
425379|NCT01511536|1041799|P1|COMPLETED|Phase 1|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|3
425380|NCT01511536|1041797|P3|STARTED|Phase 1|Phase 1 and phase 2 are separate populations.|0
425381|NCT01511536|1041798|P2|STARTED|Phase 1||7
425382|NCT01511536|1041799|P1|STARTED|Phase 1||3
425383|NCT01511445|1041821|P2|NOT COMPLETED|Overall Study||4
425384|NCT01511445|1041822|P1|NOT COMPLETED|Overall Study||5
425385|NCT01511445|1041821|P2|COMPLETED|Overall Study|Data analysis was completed in February, 2016|47
425386|NCT01511445|1041822|P1|COMPLETED|Overall Study|Data analysis was completed in February, 2016|48
425387|NCT01511445|1041821|P2|Follow-up Completion|Overall Study|Two year follow-up was completed in November, 2015|47
425388|NCT01511445|1041822|P1|Follow-up Completion|Overall Study|Two year follow-up was completed in November, 2015|48
425389|NCT01511445|1041821|P2|Primary Completion October, 2014|Overall Study|3 protocol violations. 1 lost to follow-up.|47
425390|NCT01511445|1041822|P1|Primary Completion October, 2014|Overall Study|1 was excluded Bechterew's disease. 1 protocol violation. 3 were lost to follow-up.|48
425391|NCT01511445|1041821|P2|Surgeries Completed|Overall Study|All surgeries were completed by October, 2013.|51
425392|NCT01511445|1041822|P1|Surgeries Completed|Overall Study|All surgeries were completed by October, 2013.|53
425393|NCT01511445|1041821|P2|STARTED|Overall Study|Patient enrollment started in December, 2011.|51
425394|NCT01511445|1041822|P1|STARTED|Overall Study|Patient enrollment started in December, 2011.|53
425395|NCT01511315|1041830|P1|NOT COMPLETED|Overall Study||4
425396|NCT01511315|1041830|P1|COMPLETED|Overall Study||32
425397|NCT01511315|1041830|P1|STARTED|Overall Study||36
425398|NCT01511250|1041850|P10|NOT COMPLETED|Overall Study||5
425399|NCT01511250|1041851|P9|NOT COMPLETED|Overall Study||14
425400|NCT01511250|1041852|P8|NOT COMPLETED|Overall Study||4
425401|NCT01511250|1041853|P7|NOT COMPLETED|Overall Study||2
425402|NCT01511250|1041854|P6|NOT COMPLETED|Overall Study||0
425403|NCT01511250|1041855|P5|NOT COMPLETED|Overall Study||0
425404|NCT01511250|1041856|P4|NOT COMPLETED|Overall Study||3
425405|NCT01511250|1041857|P3|NOT COMPLETED|Overall Study||4
425406|NCT01511250|1041858|P2|NOT COMPLETED|Overall Study||5
425407|NCT01511250|1041859|P1|NOT COMPLETED|Overall Study||9
425408|NCT01511250|1041850|P10|COMPLETED|Overall Study||48
425409|NCT01511250|1041851|P9|COMPLETED|Overall Study||145
425410|NCT01511250|1041852|P8|COMPLETED|Overall Study||9
425411|NCT01511250|1041853|P7|COMPLETED|Overall Study||21
425412|NCT01511250|1041854|P6|COMPLETED|Overall Study||17
425413|NCT01511250|1041855|P5|COMPLETED|Overall Study||21
425414|NCT01511250|1041856|P4|COMPLETED|Overall Study||11
425415|NCT01511250|1041857|P3|COMPLETED|Overall Study||18
425416|NCT01511250|1041858|P2|COMPLETED|Overall Study||9
425417|NCT01511250|1041859|P1|COMPLETED|Overall Study||15
425418|NCT01511250|1041850|P10|STARTED|Overall Study||53
425419|NCT01511250|1041851|P9|STARTED|Overall Study||159
425420|NCT01511250|1041852|P8|STARTED|Overall Study||13
425421|NCT01511250|1041853|P7|STARTED|Overall Study||23
425422|NCT01511250|1041854|P6|STARTED|Overall Study||17
425423|NCT01511250|1041855|P5|STARTED|Overall Study||21
425424|NCT01511250|1041856|P4|STARTED|Overall Study||14
425425|NCT01511250|1041857|P3|STARTED|Overall Study||22
425426|NCT01511250|1041858|P2|STARTED|Overall Study||14
425427|NCT01511250|1041859|P1|STARTED|Overall Study||24
425428|NCT01511107|1042007|P2|NOT COMPLETED|Overall Study||41
425429|NCT01511107|1042008|P1|NOT COMPLETED|Overall Study||22
425430|NCT01511107|1042007|P2|COMPLETED|Overall Study|Completed - Assessed at a final visit in Sep or at the end of the respiratory season in Apr or May.|219
425431|NCT01511107|1042008|P1|COMPLETED|Overall Study|Completed - Assessed at a final visit in Sep or at the end of the respiratory season in Apr or May.|238
425432|NCT01511107|1042007|P2|STARTED|Overall Study|Randomized to the treatment group.|260
425433|NCT01511107|1042008|P1|STARTED|Overall Study|Randomized to the treatment group.|260
425434|NCT01511081|1042058|P2|NOT COMPLETED|Overall Study||0
425435|NCT01511081|1042059|P1|NOT COMPLETED|Overall Study||0
425436|NCT01511081|1042058|P2|COMPLETED|Overall Study||9
425437|NCT01511081|1042059|P1|COMPLETED|Overall Study||8
425438|NCT01511081|1042058|P2|STARTED|Overall Study||9
425439|NCT01511081|1042059|P1|STARTED|Overall Study||8
425440|NCT01511016|1042069|P2|NOT COMPLETED|Overall Study||2
425441|NCT01511016|1042070|P1|NOT COMPLETED|Overall Study||2
425442|NCT01511016|1042069|P2|COMPLETED|Overall Study||7
425443|NCT01511016|1042070|P1|COMPLETED|Overall Study||6
425444|NCT01511016|1042069|P2|STARTED|Overall Study||9
425445|NCT01511016|1042070|P1|STARTED|Overall Study||8
425446|NCT01510912|1042086|P1|NOT COMPLETED|Overall Study||242
425447|NCT01510912|1042086|P1|COMPLETED|Overall Study||360
425448|NCT01510912|1042086|P1|STARTED|Overall Study||602
425449|NCT01510834|1042092|P1|NOT COMPLETED|Overall Study||33
425450|NCT01510834|1042092|P1|COMPLETED|Overall Study||57
425451|NCT01510834|1042092|P1|STARTED|Overall Study||90
425452|NCT01510769|1042102|P3|NOT COMPLETED|Overall Study||22
425453|NCT01510769|1042103|P2|NOT COMPLETED|Overall Study||25
425454|NCT01510769|1042104|P1|NOT COMPLETED|Overall Study||27
425455|NCT01510769|1042102|P3|COMPLETED|Overall Study||87
425456|NCT01510769|1042103|P2|COMPLETED|Overall Study||84
425457|NCT01510769|1042104|P1|COMPLETED|Overall Study||79
425458|NCT01510769|1042102|P3|STARTED|Overall Study||109
425459|NCT01510769|1042103|P2|STARTED|Overall Study||109
425460|NCT01510769|1042104|P1|STARTED|Overall Study||106
425461|NCT01510756|1042121|P1|NOT COMPLETED|Overall Study||4
425462|NCT01510756|1042121|P1|COMPLETED|Overall Study||0
425463|NCT01510756|1042121|P1|STARTED|Overall Study||4
425464|NCT01510717|1042129|P2|NOT COMPLETED|Overall Study||5
425465|NCT01510717|1042130|P1|NOT COMPLETED|Overall Study||2
425466|NCT01510717|1042129|P2|COMPLETED|Overall Study||160
425467|NCT01510717|1042130|P1|COMPLETED|Overall Study||153
425468|NCT01510717|1042129|P2|STARTED|Overall Study||165
425469|NCT01510717|1042130|P1|STARTED|Overall Study||155
425470|NCT01510704|1042158|P4|NOT COMPLETED|Overall Study||0
425471|NCT01510704|1042159|P3|NOT COMPLETED|Overall Study||0
425472|NCT01510704|1042160|P2|NOT COMPLETED|Overall Study||0
425473|NCT01510704|1042161|P1|NOT COMPLETED|Overall Study||0
425474|NCT01510704|1042158|P4|COMPLETED|Overall Study||53
425475|NCT01510704|1042159|P3|COMPLETED|Overall Study||50
425476|NCT01510704|1042160|P2|COMPLETED|Overall Study||58
425477|NCT01510704|1042161|P1|COMPLETED|Overall Study||54
425478|NCT01510704|1042158|P4|STARTED|Overall Study||53
425479|NCT01510704|1042159|P3|STARTED|Overall Study||50
425480|NCT01510704|1042160|P2|STARTED|Overall Study||58
425481|NCT01510704|1042161|P1|STARTED|Overall Study||54
425482|NCT01510652|1042173|P2|NOT COMPLETED|Overall Study||67
425483|NCT01510652|1042174|P1|NOT COMPLETED|Overall Study||92
425484|NCT01510652|1042173|P2|COMPLETED|Overall Study||288
425485|NCT01510652|1042174|P1|COMPLETED|Overall Study||627
425486|NCT01510652|1042173|P2|Baseline|Overall Study||348
425487|NCT01510652|1042174|P1|Baseline|Overall Study||718
425488|NCT01510652|1042173|P2|STARTED|Overall Study||355
425489|NCT01510652|1042174|P1|STARTED|Overall Study||719
425490|NCT01510457|1042186|P2|NOT COMPLETED|Overall Study||3
425491|NCT01510457|1042187|P1|NOT COMPLETED|Overall Study||5
425492|NCT01510457|1042186|P2|COMPLETED|Overall Study||26
425493|NCT01510457|1042187|P1|COMPLETED|Overall Study||12
425494|NCT01510457|1042186|P2|STARTED|Overall Study||29
425495|NCT01510457|1042187|P1|STARTED|Overall Study||17
425496|NCT01510379|1042207|P2|NOT COMPLETED|Overall Study||0
425497|NCT01510379|1042208|P1|NOT COMPLETED|Overall Study||0
425498|NCT01510379|1042207|P2|COMPLETED|Overall Study||51
425499|NCT01510379|1042208|P1|COMPLETED|Overall Study||49
425500|NCT01510379|1042207|P2|STARTED|Overall Study||51
425501|NCT01510379|1042208|P1|STARTED|Overall Study||49
425502|NCT01510327|1042216|P1|NOT COMPLETED|Overall Study||0
425503|NCT01510327|1042216|P1|COMPLETED|Overall Study||22
425504|NCT01510327|1042216|P1|STARTED|Overall Study||22
425505|NCT01510158|1042250|P3|NOT COMPLETED|Overall Study||50
425506|NCT01510158|1042251|P2|NOT COMPLETED|Overall Study||53
425507|NCT01510158|1042252|P1|NOT COMPLETED|Overall Study||51
425508|NCT01510158|1042250|P3|COMPLETED|Overall Study||152
425509|NCT01510158|1042251|P2|COMPLETED|Overall Study||150
425510|NCT01510158|1042252|P1|COMPLETED|Overall Study||151
425511|NCT01510158|1042250|P3|STARTED|Overall Study||202
425512|NCT01510158|1042251|P2|STARTED|Overall Study||203
425513|NCT01510158|1042252|P1|STARTED|Overall Study||202
425514|NCT01510145|1042266|P1|NOT COMPLETED|Overall Study||18
425515|NCT01510145|1042266|P1|COMPLETED|Overall Study||173
425516|NCT01510145|1042266|P1|STARTED|Overall Study||191
425517|NCT01509807|1042273|P2|NOT COMPLETED|Overall Study||1
425518|NCT01509807|1042274|P1|NOT COMPLETED|Overall Study||1
425519|NCT01509807|1042273|P2|COMPLETED|Overall Study||16
425520|NCT01509807|1042274|P1|COMPLETED|Overall Study||15
425521|NCT01509807|1042273|P2|STARTED|Overall Study||17
425522|NCT01509807|1042274|P1|STARTED|Overall Study||16
425523|NCT01509664|1042300|P2|NOT COMPLETED|Overall Study||21
425524|NCT01509664|1042301|P1|NOT COMPLETED|Overall Study||15
425525|NCT01509664|1042300|P2|COMPLETED|Overall Study||28
425526|NCT01509664|1042301|P1|COMPLETED|Overall Study||34
425527|NCT01509664|1042300|P2|T3 Follow-up|Overall Study||33
425528|NCT01509664|1042301|P1|T3 Follow-up|Overall Study||40
425529|NCT01509664|1042300|P2|T2 Follow-up|Overall Study||38
425530|NCT01509664|1042301|P1|T2 Follow-up|Overall Study||45
425531|NCT01509664|1042300|P2|STARTED|Overall Study||49
425532|NCT01509664|1042301|P1|STARTED|Overall Study||49
425533|NCT01509638|1042309|P2|NOT COMPLETED|Overall Study||2
425534|NCT01509638|1042310|P1|NOT COMPLETED|Overall Study||3
425535|NCT01509638|1042309|P2|COMPLETED|Overall Study||24
425536|NCT01509638|1042310|P1|COMPLETED|Overall Study||20
425537|NCT01509638|1042309|P2|STARTED|Overall Study||26
425538|NCT01509638|1042310|P1|STARTED|Overall Study||23
425539|NCT01509625|1042334|P1|NOT COMPLETED|Overall Study||9
425540|NCT01509625|1042334|P1|COMPLETED|Overall Study||263
425541|NCT01509625|1042334|P1|STARTED|Overall Study||272
425542|NCT01509586|1042352|P2|NOT COMPLETED|Overall Study||0
425543|NCT01509586|1042353|P1|NOT COMPLETED|Overall Study||0
425544|NCT01509586|1042352|P2|COMPLETED|Overall Study|final intent to treat sample|610
425545|NCT01509586|1042353|P1|COMPLETED|Overall Study|final intent to treat sample|626
425546|NCT01509586|1042352|P2|Week 58 (Month 12)|Overall Study||499
425547|NCT01509586|1042353|P1|Week 58 (Month 12)|Overall Study||492
425548|NCT01509586|1042352|P2|Week 46|Overall Study||494
425549|NCT01509586|1042353|P1|Week 46|Overall Study||483
425550|NCT01509586|1042352|P2|Week 32 (Month 6)|Overall Study||523
425551|NCT01509586|1042353|P1|Week 32 (Month 6)|Overall Study||504
425552|NCT01509586|1042352|P2|Week18|Overall Study||555
425553|NCT01509586|1042353|P1|Week18|Overall Study||529
425554|NCT01509586|1042352|P2|Week 14|Overall Study||566
425555|NCT01509586|1042353|P1|Week 14|Overall Study||528
425556|NCT01509586|1042352|P2|Week 10|Overall Study||574
425557|NCT01509586|1042353|P1|Week 10|Overall Study||537
425558|NCT01509586|1042352|P2|Week 6|Overall Study||585
425559|NCT01509586|1042353|P1|Week 6|Overall Study||551
425560|NCT01509586|1042352|P2|Week 3|Overall Study||585
425561|NCT01509586|1042353|P1|Week 3|Overall Study||574
425562|NCT01509586|1042352|P2|STARTED|Overall Study|Week 0|610
425563|NCT01509586|1042353|P1|STARTED|Overall Study|Week 0|626
425564|NCT01509183|1042361|P2|NOT COMPLETED|Overall Study||111
425565|NCT01509183|1042362|P1|NOT COMPLETED|Overall Study||109
425566|NCT01509183|1042361|P2|COMPLETED|Overall Study||134
425567|NCT01509183|1042362|P1|COMPLETED|Overall Study||141
425568|NCT01509183|1042361|P2|STARTED|Overall Study||245
425569|NCT01509183|1042362|P1|STARTED|Overall Study||250
425570|NCT01509105|1042370|P1|NOT COMPLETED|Overall Study||0
425571|NCT01509105|1042370|P1|COMPLETED|Overall Study||649
425572|NCT01509105|1042370|P1|STARTED|Overall Study||649
425573|NCT01509079|1042387|P2|NOT COMPLETED|Overall Study||3
425574|NCT01509079|1042388|P1|NOT COMPLETED|Overall Study||0
425575|NCT01509079|1042387|P2|COMPLETED|Overall Study||56
425576|NCT01509079|1042388|P1|COMPLETED|Overall Study||57
425577|NCT01509079|1042387|P2|STARTED|Overall Study||59
425578|NCT01509079|1042388|P1|STARTED|Overall Study||57
425579|NCT01509053|1042404|P1|NOT COMPLETED|Aripiprazole IM Depot Extension Phase(C)||3
425580|NCT01509053|1042404|P1|COMPLETED|Aripiprazole IM Depot Extension Phase(C)||0
425581|NCT01509053|1042404|P1|STARTED|Aripiprazole IM Depot Extension Phase(C)||3
425582|NCT01509053|1042404|P1|NOT COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||16
425583|NCT01509053|1042404|P1|COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||3
425584|NCT01509053|1042404|P1|STARTED|Aripiprazole IM Depot Treatment Phase(B)|Includes 8 patients from Phase A + 11 patients who entered directly into Phase B.|19
425585|NCT01509053|1042404|P1|NOT COMPLETED|Oral Aripirazole (Phase A)||11
425586|NCT01509053|1042404|P1|COMPLETED|Oral Aripirazole (Phase A)||8
425587|NCT01509053|1042404|P1|STARTED|Oral Aripirazole (Phase A)||19
425588|NCT01509040|1042418|P3|NOT COMPLETED|Overall Study||0
425589|NCT01509040|1042419|P2|NOT COMPLETED|Overall Study||1
425590|NCT01509040|1042420|P1|NOT COMPLETED|Overall Study||0
425591|NCT01509040|1042418|P3|COMPLETED|Overall Study||0
425592|NCT01509040|1042419|P2|COMPLETED|Overall Study||1
425593|NCT01509040|1042420|P1|COMPLETED|Overall Study||0
425594|NCT01509040|1042418|P3|STARTED|Overall Study||0
425595|NCT01509040|1042419|P2|STARTED|Overall Study||2
425596|NCT01509040|1042420|P1|STARTED|Overall Study||0
425597|NCT01508936|1042466|P2|NOT COMPLETED|Overall Study||79
425598|NCT01508936|1042467|P1|NOT COMPLETED|Overall Study||23
425599|NCT01508936|1042466|P2|COMPLETED|Overall Study||330
425600|NCT01508936|1042467|P1|COMPLETED|Overall Study||79
425601|NCT01508936|1042466|P2|FEV1 Subpopulation Analysis Set|Overall Study||346
425602|NCT01508936|1042467|P1|FEV1 Subpopulation Analysis Set|Overall Study||91
425603|NCT01508936|1042466|P2|Full Analysis Set|Overall Study||395
425604|NCT01508936|1042467|P1|Full Analysis Set|Overall Study||97
425605|NCT01508936|1042466|P2|Safety Analysis Set|Overall Study||395
425606|NCT01508936|1042467|P1|Safety Analysis Set|Overall Study||97
425607|NCT01508936|1042466|P2|Randomized, Not Treated|Overall Study||3
425608|NCT01508936|1042467|P1|Randomized, Not Treated|Overall Study||1
425609|NCT01508936|1042466|P2|Randomized|Overall Study||398
425610|NCT01508936|1042467|P1|Randomized|Overall Study||98
425611|NCT01508936|1042466|P2|Randomized, Not Analyzed|Overall Study|Participants from two centers were omitted from all analyses.|11
425612|NCT01508936|1042467|P1|Randomized, Not Analyzed|Overall Study|Participants from two centers were omitted from all analyses.|4
425613|NCT01508936|1042466|P2|STARTED|Overall Study||409
425614|NCT01508936|1042467|P1|STARTED|Overall Study||102
425615|NCT01508910|1042506|P4|NOT COMPLETED|Treatment||3
425616|NCT01508910|1042507|P3|NOT COMPLETED|Treatment||10
425617|NCT01508910|1042508|P2|NOT COMPLETED|Treatment||4
425618|NCT01508910|1042509|P1|NOT COMPLETED|Treatment||2
425619|NCT01508910|1042506|P4|COMPLETED|Treatment||3
425620|NCT01508910|1042507|P3|COMPLETED|Treatment||18
425621|NCT01508910|1042508|P2|COMPLETED|Treatment||24
425622|NCT01508910|1042509|P1|COMPLETED|Treatment||48
425623|NCT01508910|1042506|P4|STARTED|Treatment|3 moved from Treatment (Tx) to Active Control (AC) Arm; 6 in Not injected Arm(4 from Tx ; 2 from AC)|6
425624|NCT01508910|1042507|P3|STARTED|Treatment||28
425625|NCT01508910|1042508|P2|STARTED|Treatment||28
425626|NCT01508910|1042509|P1|STARTED|Treatment||50
425627|NCT01508910|1042506|P4|NOT COMPLETED|Randomization||0
425628|NCT01508910|1042507|P3|NOT COMPLETED|Randomization||0
425629|NCT01508910|1042508|P2|NOT COMPLETED|Randomization||0
425630|NCT01508910|1042509|P1|NOT COMPLETED|Randomization||0
425631|NCT01508910|1042506|P4|COMPLETED|Randomization||0
425632|NCT01508910|1042507|P3|COMPLETED|Randomization||28
425633|NCT01508910|1042508|P2|COMPLETED|Randomization||27
425634|NCT01508910|1042509|P1|COMPLETED|Randomization||57
425635|NCT01508910|1042506|P4|STARTED|Randomization|Participants not randomized into Not Injected arm, but some were re-assigned here during treatment.|0
425636|NCT01508910|1042507|P3|STARTED|Randomization||28
425637|NCT01508910|1042508|P2|STARTED|Randomization||27
425638|NCT01508910|1042509|P1|STARTED|Randomization||57
425639|NCT01508832|1042533|P2|NOT COMPLETED|Overall Study||0
425640|NCT01508832|1042534|P1|NOT COMPLETED|Overall Study||0
425641|NCT01508832|1042533|P2|COMPLETED|Overall Study||6
425642|NCT01508832|1042534|P1|COMPLETED|Overall Study||6
425643|NCT01508832|1042533|P2|STARTED|Overall Study||6
425644|NCT01508832|1042534|P1|STARTED|Overall Study||6
425645|NCT01508702|1042542|P2|NOT COMPLETED|Overall Study||13
425646|NCT01508702|1042543|P1|NOT COMPLETED|Overall Study||23
425647|NCT01508702|1042542|P2|COMPLETED|Overall Study||94
425648|NCT01508702|1042543|P1|COMPLETED|Overall Study||84
425649|NCT01508702|1042542|P2|STARTED|Overall Study||107
425650|NCT01508702|1042543|P1|STARTED|Overall Study||107
425651|NCT01508676|1042551|P2|NOT COMPLETED|Phase II (2 Weeks)||1
425652|NCT01508676|1042552|P1|NOT COMPLETED|Phase II (2 Weeks)||1
425653|NCT01508676|1042551|P2|COMPLETED|Phase II (2 Weeks)||13
425654|NCT01508676|1042552|P1|COMPLETED|Phase II (2 Weeks)||15
425655|NCT01508676|1042551|P2|STARTED|Phase II (2 Weeks)||14
425656|NCT01508676|1042552|P1|STARTED|Phase II (2 Weeks)||16
425657|NCT01508676|1042551|P2|NOT COMPLETED|Washout Period (1 Week)||0
425658|NCT01508676|1042552|P1|NOT COMPLETED|Washout Period (1 Week)||0
425659|NCT01508676|1042551|P2|COMPLETED|Washout Period (1 Week)||14
425660|NCT01508676|1042552|P1|COMPLETED|Washout Period (1 Week)||16
425661|NCT01508676|1042551|P2|STARTED|Washout Period (1 Week)||14
425662|NCT01508676|1042552|P1|STARTED|Washout Period (1 Week)||16
425663|NCT01508676|1042551|P2|NOT COMPLETED|Phase I (2 Weeks)||3
425664|NCT01508676|1042552|P1|NOT COMPLETED|Phase I (2 Weeks)||2
425665|NCT01508676|1042551|P2|COMPLETED|Phase I (2 Weeks)||14
425666|NCT01508676|1042552|P1|COMPLETED|Phase I (2 Weeks)||16
425667|NCT01508676|1042551|P2|STARTED|Phase I (2 Weeks)||17
425668|NCT01508676|1042552|P1|STARTED|Phase I (2 Weeks)||18
425669|NCT01508455|1042562|P1|NOT COMPLETED|Overall Study||0
425670|NCT01508455|1042562|P1|COMPLETED|Overall Study||6
425671|NCT01508455|1042562|P1|STARTED|Overall Study||6
425672|NCT01508325|1042573|P2|NOT COMPLETED|Overall Study||21
425673|NCT01508325|1042574|P1|NOT COMPLETED|Overall Study||18
425674|NCT01508325|1042573|P2|COMPLETED|Overall Study||72
425675|NCT01508325|1042574|P1|COMPLETED|Overall Study||75
425676|NCT01508325|1042573|P2|STARTED|Overall Study||93
425677|NCT01508325|1042574|P1|STARTED|Overall Study||93
425678|NCT01508169|1042604|P2|NOT COMPLETED|Overall Study||2
425679|NCT01508169|1042605|P1|NOT COMPLETED|Overall Study||3
425680|NCT01508169|1042604|P2|COMPLETED|Overall Study||45
425681|NCT01508169|1042605|P1|COMPLETED|Overall Study||44
425682|NCT01508169|1042604|P2|STARTED|Overall Study||47
425683|NCT01508169|1042605|P1|STARTED|Overall Study||47
425684|NCT01508130|1042619|P2|NOT COMPLETED|Overall Study||69
425685|NCT01508130|1042620|P1|NOT COMPLETED|Overall Study||227
425686|NCT01508130|1042619|P2|COMPLETED|Overall Study||73
425687|NCT01508130|1042620|P1|COMPLETED|Overall Study||266
425688|NCT01508130|1042619|P2|mTRT|Overall Study||142
425689|NCT01508130|1042620|P1|mTRT|Overall Study||493
425690|NCT01508130|1042619|P2|STARTED|Overall Study||142
425691|NCT01508130|1042620|P1|STARTED|Overall Study||493
425692|NCT01508117|1042662|P1|NOT COMPLETED|Overall Study||0
425693|NCT01508117|1042662|P1|COMPLETED|Overall Study||1
425694|NCT01508117|1042662|P1|STARTED|Overall Study||1
425695|NCT01508052|1042668|P2|NOT COMPLETED|Overall Study||0
425696|NCT01508052|1042669|P1|NOT COMPLETED|Overall Study||0
425697|NCT01508052|1042668|P2|COMPLETED|Overall Study||20
425698|NCT01508052|1042669|P1|COMPLETED|Overall Study||20
425699|NCT01508052|1042668|P2|STARTED|Overall Study||20
425700|NCT01508052|1042669|P1|STARTED|Overall Study||20
425701|NCT01508013|1042677|P2|NOT COMPLETED|Overall Study||23
425702|NCT01508013|1042678|P1|NOT COMPLETED|Overall Study||32
425703|NCT01508013|1042677|P2|COMPLETED|Overall Study||206
425704|NCT01508013|1042678|P1|COMPLETED|Overall Study||182
425705|NCT01508013|1042677|P2|STARTED|Overall Study||229
425706|NCT01508013|1042678|P1|STARTED|Overall Study||214
425707|NCT01507896|1042688|P1|NOT COMPLETED|Overall Study||2
425708|NCT01507896|1042688|P1|COMPLETED|Overall Study|28 unique participants had 38 surgeries (participants could have multiple surgeries).|28
425709|NCT01507896|1042688|P1|STARTED|Overall Study|30 unique participants had 40 surgeries planned (participants could have multiple surgeries).|30
425710|NCT01507831|1042731|P2|NOT COMPLETED|Overall Study||440
425711|NCT01507831|1042732|P1|NOT COMPLETED|Overall Study||193
425712|NCT01507831|1042731|P2|COMPLETED|Overall Study||1113
425713|NCT01507831|1042732|P1|COMPLETED|Overall Study||595
425714|NCT01507831|1042731|P2|Treated|Overall Study||1550
425715|NCT01507831|1042732|P1|Treated|Overall Study||788
425716|NCT01507831|1042731|P2|STARTED|Overall Study|Randomized|1553
425717|NCT01507831|1042732|P1|STARTED|Overall Study|Randomized|788
425724|NCT01507493|1042811|P2|NOT COMPLETED|Overall Study||0
425725|NCT01507493|1042812|P1|NOT COMPLETED|Overall Study||0
425726|NCT01507493|1042811|P2|COMPLETED|Overall Study||178
425727|NCT01507493|1042812|P1|COMPLETED|Overall Study||22
425728|NCT01507493|1042811|P2|STARTED|Overall Study||178
425729|NCT01507493|1042812|P1|STARTED|Overall Study||22
425730|NCT01507246|1042828|P2|NOT COMPLETED|Overall Study||1
425731|NCT01507246|1042829|P1|NOT COMPLETED|Overall Study||2
425732|NCT01507246|1042828|P2|COMPLETED|Overall Study||21
425733|NCT01507246|1042829|P1|COMPLETED|Overall Study||18
425734|NCT01507246|1042828|P2|STARTED|Overall Study||22
425735|NCT01507246|1042829|P1|STARTED|Overall Study||20
425736|NCT01507233|1042843|P2|NOT COMPLETED|Overall Study||0
425737|NCT01507233|1042844|P1|NOT COMPLETED|Overall Study||0
425738|NCT01507233|1042843|P2|COMPLETED|Overall Study||0
425739|NCT01507233|1042844|P1|COMPLETED|Overall Study||5
425740|NCT01507233|1042843|P2|STARTED|Overall Study||0
425741|NCT01507233|1042844|P1|STARTED|Overall Study||5
425742|NCT01507220|1042856|P2|NOT COMPLETED|Overall Study||0
425743|NCT01507220|1042857|P1|NOT COMPLETED|Overall Study||0
425744|NCT01507220|1042856|P2|COMPLETED|Overall Study||0
425745|NCT01507220|1042857|P1|COMPLETED|Overall Study||2
425746|NCT01507220|1042856|P2|STARTED|Overall Study||0
425747|NCT01507220|1042857|P1|STARTED|Overall Study||2
425748|NCT01507181|1042871|P2|NOT COMPLETED|Overall Study||0
425749|NCT01507181|1042872|P1|NOT COMPLETED|Overall Study||0
425750|NCT01507181|1042871|P2|COMPLETED|Overall Study||12
425751|NCT01507181|1042872|P1|COMPLETED|Overall Study||12
425752|NCT01507181|1042871|P2|STARTED|Overall Study||12
425753|NCT01507181|1042872|P1|STARTED|Overall Study||12
425754|NCT01507155|1042892|P2|NOT COMPLETED|Overall Study||0
425755|NCT01507155|1042893|P1|NOT COMPLETED|Overall Study||0
425756|NCT01507155|1042892|P2|COMPLETED|Overall Study||60
425757|NCT01507155|1042893|P1|COMPLETED|Overall Study||625
425758|NCT01507155|1042892|P2|STARTED|Overall Study||60
425759|NCT01507155|1042893|P1|STARTED|Overall Study||625
425760|NCT01507103|1042902|P3|NOT COMPLETED|Overall Study||0
425761|NCT01507103|1042903|P2|NOT COMPLETED|Overall Study||0
425762|NCT01507103|1042904|P1|NOT COMPLETED|Overall Study||0
425763|NCT01507103|1042902|P3|COMPLETED|Overall Study||42
425764|NCT01507103|1042903|P2|COMPLETED|Overall Study||41
425765|NCT01507103|1042904|P1|COMPLETED|Overall Study||41
425766|NCT01507103|1042902|P3|STARTED|Overall Study||42
425767|NCT01507103|1042903|P2|STARTED|Overall Study||41
425768|NCT01507103|1042904|P1|STARTED|Overall Study||41
425769|NCT01507090|1042927|P1|NOT COMPLETED|Overall Study||18
425770|NCT01507090|1042927|P1|COMPLETED|Overall Study||624
425771|NCT01507090|1042927|P1|STARTED|Overall Study||642
425772|NCT01507051|1042966|P4|NOT COMPLETED|Overall Study||7
425773|NCT01507051|1042967|P3|NOT COMPLETED|Overall Study||1
425774|NCT01507051|1042968|P2|NOT COMPLETED|Overall Study||3
425775|NCT01507051|1042969|P1|NOT COMPLETED|Overall Study||2
425776|NCT01507051|1042966|P4|COMPLETED|Overall Study||0
425777|NCT01507051|1042967|P3|COMPLETED|Overall Study||28
425778|NCT01507051|1042968|P2|COMPLETED|Overall Study||28
425779|NCT01507051|1042969|P1|COMPLETED|Overall Study||27
425780|NCT01507051|1042966|P4|Received Placebo or Rivaroxaban|Overall Study||0
425781|NCT01507051|1042967|P3|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG3|28
425782|NCT01507051|1042968|P2|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG2 and in RG4|28
425783|NCT01507051|1042969|P1|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG1 and in RG4 (RG = Reporting Group for Safety Data)|28
425784|NCT01507051|1042966|P4|Warfarin run-in Phase|Overall Study|Safety Population: in RG4|7
425785|NCT01507051|1042967|P3|Warfarin run-in Phase|Overall Study||0
425786|NCT01507051|1042968|P2|Warfarin run-in Phase|Overall Study||28
425787|NCT01507051|1042969|P1|Warfarin run-in Phase|Overall Study||28
425788|NCT01507051|1042966|P4|STARTED|Overall Study||7
425789|NCT01507051|1042967|P3|STARTED|Overall Study||29
425790|NCT01507051|1042968|P2|STARTED|Overall Study||31
425791|NCT01507051|1042969|P1|STARTED|Overall Study||29
425792|NCT01506960|1043087|P1|NOT COMPLETED|Overall Study||47
425793|NCT01506960|1043087|P1|COMPLETED|Overall Study||17
425794|NCT01506960|1043087|P1|STARTED|Overall Study||64
425795|NCT01506947|1043093|P1|NOT COMPLETED|Overall Study||16
425796|NCT01506947|1043093|P1|COMPLETED|Overall Study||49
425797|NCT01506947|1043093|P1|STARTED|Overall Study||65
425798|NCT01506908|1043111|P2|NOT COMPLETED|Overall Study||0
425799|NCT01506908|1043112|P1|NOT COMPLETED|Overall Study||1
425800|NCT01506908|1043111|P2|COMPLETED|Overall Study||161
425801|NCT01506908|1043112|P1|COMPLETED|Overall Study||161
425802|NCT01506908|1043111|P2|STARTED|Overall Study||161
425803|NCT01506908|1043112|P1|STARTED|Overall Study||162
425804|NCT01506882|1043130|P2|NOT COMPLETED|Overall Study||7
425805|NCT01506882|1043131|P1|NOT COMPLETED|Overall Study||22
425806|NCT01506882|1043130|P2|COMPLETED|Overall Study||3
425807|NCT01506882|1043131|P1|COMPLETED|Overall Study||39
425808|NCT01506882|1043130|P2|STARTED|Overall Study||10
425809|NCT01506882|1043131|P1|STARTED|Overall Study||61
425810|NCT01506726|1043145|P2|NOT COMPLETED|Overall Study||2
425811|NCT01506726|1043146|P1|NOT COMPLETED|Overall Study||1
425812|NCT01506726|1043145|P2|COMPLETED|Overall Study||3
425813|NCT01506726|1043146|P1|COMPLETED|Overall Study||5
425814|NCT01506726|1043145|P2|STARTED|Overall Study||5
425815|NCT01506726|1043146|P1|STARTED|Overall Study||6
425816|NCT01506596|1043186|P1|NOT COMPLETED|Overall Study||1
425817|NCT01506596|1043186|P1|COMPLETED|Overall Study|One enrolled patient had ineligible pathology after starting treatment; was removed from treatment.|41
425818|NCT01506596|1043186|P1|STARTED|Overall Study||42
425819|NCT01506479|1043197|P3|NOT COMPLETED|Overall Study||3
425820|NCT01506479|1043198|P2|NOT COMPLETED|Overall Study||5
425821|NCT01506479|1043199|P1|NOT COMPLETED|Overall Study||3
425822|NCT01506479|1043197|P3|COMPLETED|Overall Study||42
425823|NCT01506479|1043198|P2|COMPLETED|Overall Study||38
425824|NCT01506479|1043199|P1|COMPLETED|Overall Study||37
425825|NCT01506479|1043197|P3|STARTED|Overall Study||45
425826|NCT01506479|1043198|P2|STARTED|Overall Study||43
425827|NCT01506479|1043199|P1|STARTED|Overall Study||40
425828|NCT01506362|1043211|P1|NOT COMPLETED|Overall Study||6
425829|NCT01506362|1043211|P1|COMPLETED|Overall Study||16
425830|NCT01506362|1043211|P1|STARTED|Overall Study||22
425831|NCT01506323|1043217|P2|NOT COMPLETED|Overall Study||13
425832|NCT01506323|1043218|P1|NOT COMPLETED|Overall Study||24
425833|NCT01506323|1043217|P2|COMPLETED|Overall Study||71
425834|NCT01506323|1043218|P1|COMPLETED|Overall Study||65
425835|NCT01506323|1043217|P2|Post-treatment Completed CAPS|Overall Study||72
425836|NCT01506323|1043218|P1|Post-treatment Completed CAPS|Overall Study||68
425837|NCT01506323|1043217|P2|Post-treatment Completers|Overall Study||72
425838|NCT01506323|1043218|P1|Post-treatment Completers|Overall Study||69
425839|NCT01506323|1043217|P2|STARTED|Overall Study||84
425840|NCT01506323|1043218|P1|STARTED|Overall Study||89
425841|NCT01506193|1043247|P3|NOT COMPLETED|Overall Study||14
425842|NCT01506193|1043248|P2|NOT COMPLETED|Overall Study||4
425843|NCT01506193|1043249|P1|NOT COMPLETED|Overall Study||14
425844|NCT01506193|1043247|P3|COMPLETED|Overall Study||168
425845|NCT01506193|1043248|P2|COMPLETED|Overall Study||179
425846|NCT01506193|1043249|P1|COMPLETED|Overall Study||337
425847|NCT01506193|1043247|P3|STARTED|Overall Study||182
425848|NCT01506193|1043248|P2|STARTED|Overall Study||183
425849|NCT01506193|1043249|P1|STARTED|Overall Study||351
425850|NCT01505881|1043282|P2|NOT COMPLETED|Overall Study||1
425851|NCT01505881|1043283|P1|NOT COMPLETED|Overall Study||4
425852|NCT01505881|1043282|P2|COMPLETED|Overall Study||58
425853|NCT01505881|1043283|P1|COMPLETED|Overall Study||95
425854|NCT01505881|1043282|P2|STARTED|Overall Study||59
425855|NCT01505881|1043283|P1|STARTED|Overall Study||99
425856|NCT01505764|1043297|P2|NOT COMPLETED|Overall Study||1
425857|NCT01505764|1043298|P1|NOT COMPLETED|Overall Study||3
425858|NCT01505764|1043297|P2|COMPLETED|Overall Study||2
425859|NCT01505764|1043298|P1|COMPLETED|Overall Study||3
425860|NCT01505764|1043297|P2|STARTED|Overall Study||3
425861|NCT01505764|1043298|P1|STARTED|Overall Study||6
425862|NCT01505673|1043328|P2|NOT COMPLETED|Overall Study||2
425863|NCT01505673|1043329|P1|NOT COMPLETED|Overall Study||3
425864|NCT01505673|1043328|P2|COMPLETED|Overall Study||34
425865|NCT01505673|1043329|P1|COMPLETED|Overall Study||32
425866|NCT01505673|1043328|P2|STARTED|Overall Study||36
425867|NCT01505673|1043329|P1|STARTED|Overall Study||35
425868|NCT01505647|1043389|P2|NOT COMPLETED|Day 43 Through Day 182 Follow-up||3
425869|NCT01505647|1043390|P1|NOT COMPLETED|Day 43 Through Day 182 Follow-up||1
425870|NCT01505647|1043389|P2|COMPLETED|Day 43 Through Day 182 Follow-up||163
425871|NCT01505647|1043390|P1|COMPLETED|Day 43 Through Day 182 Follow-up||328
425872|NCT01505647|1043389|P2|STARTED|Day 43 Through Day 182 Follow-up||166
425873|NCT01505647|1043390|P1|STARTED|Day 43 Through Day 182 Follow-up||329
425874|NCT01505647|1043389|P2|NOT COMPLETED|Day 1 Through Day 42 Follow-up||0
425875|NCT01505647|1043390|P1|NOT COMPLETED|Day 1 Through Day 42 Follow-up||3
425876|NCT01505647|1043389|P2|COMPLETED|Day 1 Through Day 42 Follow-up||166
425877|NCT01505647|1043390|P1|COMPLETED|Day 1 Through Day 42 Follow-up||329
425878|NCT01505647|1043389|P2|Vaccinated|Day 1 Through Day 42 Follow-up||166
425879|NCT01505647|1043390|P1|Vaccinated|Day 1 Through Day 42 Follow-up||331
425880|NCT01505647|1043389|P2|STARTED|Day 1 Through Day 42 Follow-up||166
425881|NCT01505647|1043390|P1|STARTED|Day 1 Through Day 42 Follow-up||332
425882|NCT01505608|1043406|P2|NOT COMPLETED|Phase II||2
425883|NCT01505608|1043407|P1|NOT COMPLETED|Phase II||2
425884|NCT01505608|1043406|P2|COMPLETED|Phase II||2
425885|NCT01505608|1043407|P1|COMPLETED|Phase II||0
425886|NCT01505608|1043406|P2|STARTED|Phase II|Phase 2 was new enrollment, not the same patients from Phase 1.|4
425887|NCT01505608|1043407|P1|STARTED|Phase II|Phase 2 was new enrollment, not the same patients from Phase 1.|2
425888|NCT01505608|1043406|P2|NOT COMPLETED|Phase I||6
425889|NCT01505608|1043407|P1|NOT COMPLETED|Phase I||0
425890|NCT01505608|1043406|P2|COMPLETED|Phase I||2
425891|NCT01505608|1043407|P1|COMPLETED|Phase I||0
425892|NCT01505608|1043406|P2|STARTED|Phase I||8
425893|NCT01505608|1043407|P1|STARTED|Phase I|Randomization to Arm A began in Phase 2. All patients in Phase I were enrolled to receive TPI 287.|0
425894|NCT01505530|1043426|P3|NOT COMPLETED|Overall Study||41
425895|NCT01505530|1043427|P2|NOT COMPLETED|Overall Study||43
425896|NCT01505530|1043428|P1|NOT COMPLETED|Overall Study||41
425897|NCT01505530|1043426|P3|COMPLETED|Overall Study||0
425898|NCT01505530|1043427|P2|COMPLETED|Overall Study||0
425899|NCT01505530|1043428|P1|COMPLETED|Overall Study||0
425900|NCT01505530|1043426|P3|Completed One Cycle of Study Drug|Overall Study||31
425901|NCT01505530|1043427|P2|Completed One Cycle of Study Drug|Overall Study||27
425902|NCT01505530|1043428|P1|Completed One Cycle of Study Drug|Overall Study||29
425903|NCT01505530|1043426|P3|Received At Least One Dose of Study Drug|Overall Study||41
425904|NCT01505530|1043427|P2|Received At Least One Dose of Study Drug|Overall Study||42
425905|NCT01505530|1043428|P1|Received At Least One Dose of Study Drug|Overall Study||41
425906|NCT01505530|1043426|P3|STARTED|Overall Study||41
425907|NCT01505530|1043427|P2|STARTED|Overall Study||43
425908|NCT01505530|1043428|P1|STARTED|Overall Study||41
425909|NCT01505465|1043471|P2|NOT COMPLETED|Overall Study||7
425910|NCT01505465|1043472|P1|NOT COMPLETED|Overall Study||6
425911|NCT01505465|1043471|P2|COMPLETED|Overall Study||18
425912|NCT01505465|1043472|P1|COMPLETED|Overall Study||19
425913|NCT01505465|1043471|P2|STARTED|Overall Study||25
425914|NCT01505465|1043472|P1|STARTED|Overall Study||25
425915|NCT01505387|1043488|P2|NOT COMPLETED|Overall Study||1
425916|NCT01505387|1043489|P1|NOT COMPLETED|Overall Study||2
425917|NCT01505387|1043488|P2|COMPLETED|Overall Study||24
425918|NCT01505387|1043489|P1|COMPLETED|Overall Study|1 subject not included in intention to treat population as violated inclusion criteria|23
425919|NCT01505387|1043488|P2|Treated|Overall Study||24
425920|NCT01505387|1043489|P1|Treated|Overall Study||24
425921|NCT01505387|1043488|P2|STARTED|Overall Study||25
425922|NCT01505387|1043489|P1|STARTED|Overall Study||25
425923|NCT01505374|1043495|P2|NOT COMPLETED|Overall Study||0
425924|NCT01505374|1043496|P1|NOT COMPLETED|Overall Study||1
425925|NCT01505374|1043495|P2|COMPLETED|Overall Study||30
425926|NCT01505374|1043496|P1|COMPLETED|Overall Study||29
425927|NCT01505374|1043495|P2|STARTED|Overall Study||30
425928|NCT01505374|1043496|P1|STARTED|Overall Study||30
425929|NCT01505166|1043513|P3|NOT COMPLETED|Overall Study||0
425930|NCT01505166|1043514|P2|NOT COMPLETED|Overall Study||0
425931|NCT01505166|1043515|P1|NOT COMPLETED|Overall Study||0
425932|NCT01505166|1043513|P3|COMPLETED|Overall Study||0
425933|NCT01505166|1043514|P2|COMPLETED|Overall Study||0
425934|NCT01505166|1043515|P1|COMPLETED|Overall Study|"Completed means subject had successful Vigil manufacturing and had been given all the doses."|3
425935|NCT01505166|1043513|P3|STARTED|Overall Study||0
425936|NCT01505166|1043514|P2|STARTED|Overall Study||0
425937|NCT01505166|1043515|P1|STARTED|Overall Study||3
425938|NCT01505114|1043531|P4|NOT COMPLETED|Overall Study||23
425939|NCT01505114|1043532|P3|NOT COMPLETED|Overall Study||18
425940|NCT01505114|1043533|P2|NOT COMPLETED|Overall Study||13
425941|NCT01505114|1043534|P1|NOT COMPLETED|Overall Study||25
425942|NCT01505114|1043531|P4|COMPLETED|Overall Study||128
425943|NCT01505114|1043532|P3|COMPLETED|Overall Study||129
425944|NCT01505114|1043533|P2|COMPLETED|Overall Study||135
425945|NCT01505114|1043534|P1|COMPLETED|Overall Study||123
425946|NCT01505114|1043531|P4|STARTED|Overall Study||151
425947|NCT01505114|1043532|P3|STARTED|Overall Study||147
425948|NCT01505114|1043533|P2|STARTED|Overall Study||148
425949|NCT01505114|1043534|P1|STARTED|Overall Study||148
425950|NCT01504997|1043544|P1|NOT COMPLETED|Overall Study||0
425951|NCT01504997|1043544|P1|COMPLETED|Overall Study||18
425952|NCT01504997|1043544|P1|STARTED|Overall Study||18
425953|NCT01504971|1043548|P1|NOT COMPLETED|Overall Study||13
425954|NCT01504971|1043548|P1|COMPLETED|Overall Study||82
425955|NCT01504971|1043548|P1|STARTED|Overall Study||95
425956|NCT01504958|1043559|P3|NOT COMPLETED|Overall Study||0
425957|NCT01504958|1043560|P2|NOT COMPLETED|Overall Study||0
425958|NCT01504958|1043561|P1|NOT COMPLETED|Overall Study||0
425959|NCT01504958|1043559|P3|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|6
425960|NCT01504958|1043560|P2|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|6
425961|NCT01504958|1043561|P1|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|10
425962|NCT01504958|1043559|P3|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|6
425963|NCT01504958|1043560|P2|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|6
425964|NCT01504958|1043561|P1|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|10
425965|NCT01504867|1043577|P2|NOT COMPLETED|Overall Study||3
425966|NCT01504867|1043578|P1|NOT COMPLETED|Overall Study||7
425967|NCT01504867|1043577|P2|COMPLETED|Overall Study||195
425968|NCT01504867|1043578|P1|COMPLETED|Overall Study||195
425969|NCT01504867|1043577|P2|STARTED|Overall Study||198
425970|NCT01504867|1043578|P1|STARTED|Overall Study||202
425971|NCT01504854|1043598|P2|NOT COMPLETED|Overall Study||7
425972|NCT01504854|1043599|P1|NOT COMPLETED|Overall Study||8
425973|NCT01504854|1043598|P2|COMPLETED|Overall Study||48
425974|NCT01504854|1043599|P1|COMPLETED|Overall Study||56
425975|NCT01504854|1043598|P2|STARTED|Overall Study||55
425976|NCT01504854|1043599|P1|STARTED|Overall Study||64
425977|NCT01504204|1043615|P2|NOT COMPLETED|Overall Study||1
425978|NCT01504204|1043616|P1|NOT COMPLETED|Overall Study||1
425979|NCT01504204|1043615|P2|COMPLETED|Overall Study||9
425980|NCT01504204|1043616|P1|COMPLETED|Overall Study||9
425981|NCT01504204|1043615|P2|STARTED|Overall Study||10
425982|NCT01504204|1043616|P1|STARTED|Overall Study||10
425983|NCT01503749|1043629|P3|NOT COMPLETED|Overall Study||0
425984|NCT01503749|1043630|P2|NOT COMPLETED|Overall Study||0
425985|NCT01503749|1043631|P1|NOT COMPLETED|Overall Study||0
425986|NCT01503749|1043629|P3|COMPLETED|Overall Study||3
425987|NCT01503749|1043630|P2|COMPLETED|Overall Study||3
425988|NCT01503749|1043631|P1|COMPLETED|Overall Study||3
425989|NCT01503749|1043629|P3|STARTED|Overall Study||3
425990|NCT01503749|1043630|P2|STARTED|Overall Study||3
425991|NCT01503749|1043631|P1|STARTED|Overall Study||3
425992|NCT01503164|1043644|P2|NOT COMPLETED|Overall Study||1
425993|NCT01503164|1043645|P1|NOT COMPLETED|Overall Study||2
425994|NCT01503164|1043644|P2|COMPLETED|Overall Study||55
425995|NCT01503164|1043645|P1|COMPLETED|Overall Study||53
425996|NCT01503164|1043644|P2|STARTED|Overall Study||56
425997|NCT01503164|1043645|P1|STARTED|Overall Study||55
425998|NCT01503021|1043675|P2|NOT COMPLETED|Overall Study||26
425999|NCT01503021|1043676|P1|NOT COMPLETED|Overall Study||27
426000|NCT01503021|1043675|P2|COMPLETED|Overall Study||332
426001|NCT01503021|1043676|P1|COMPLETED|Overall Study||333
426002|NCT01503021|1043675|P2|Completed Treatment|Overall Study|One patient completed the treatment period but discontinued prior to completing the follow-up visit.|333
426003|NCT01503021|1043676|P1|Completed Treatment|Overall Study||333
426004|NCT01503021|1043675|P2|Dosed|Overall Study||352
426005|NCT01503021|1043676|P1|Dosed|Overall Study||351
426006|NCT01503021|1043675|P2|STARTED|Overall Study||358
426007|NCT01503021|1043676|P1|STARTED|Overall Study||360
426008|NCT01502956|1043725|P2|NOT COMPLETED|Overall Study||26
426009|NCT01502956|1043726|P1|NOT COMPLETED|Overall Study||24
426010|NCT01502956|1043725|P2|COMPLETED|Overall Study||168
426011|NCT01502956|1043726|P1|COMPLETED|Overall Study||168
426012|NCT01502956|1043725|P2|STARTED|Overall Study||194
426013|NCT01502956|1043726|P1|STARTED|Overall Study||192
426014|NCT01502787|1043750|P2|NOT COMPLETED|Overall Study||0
426015|NCT01502787|1043751|P1|NOT COMPLETED|Overall Study||0
426016|NCT01502787|1043750|P2|COMPLETED|Overall Study||10
426017|NCT01502787|1043751|P1|COMPLETED|Overall Study||11
426018|NCT01502787|1043750|P2|STARTED|Overall Study||10
426019|NCT01502787|1043751|P1|STARTED|Overall Study||11
426020|NCT01502761|1043765|P4|NOT COMPLETED|Overall Study||0
426021|NCT01502761|1043766|P3|NOT COMPLETED|Overall Study||0
426022|NCT01502761|1043767|P2|NOT COMPLETED|Overall Study||0
426023|NCT01502761|1043768|P1|NOT COMPLETED|Overall Study||0
426024|NCT01502761|1043765|P4|COMPLETED|Overall Study||0
426025|NCT01502761|1043766|P3|COMPLETED|Overall Study||0
426026|NCT01502761|1043767|P2|COMPLETED|Overall Study||0
426027|NCT01502761|1043768|P1|COMPLETED|Overall Study||4
426028|NCT01502761|1043765|P4|STARTED|Overall Study||0
426029|NCT01502761|1043766|P3|STARTED|Overall Study||0
426030|NCT01502761|1043767|P2|STARTED|Overall Study||0
426031|NCT01502761|1043768|P1|STARTED|Overall Study||4
426032|NCT01502709|1043784|P2|NOT COMPLETED|Overall Study||0
426033|NCT01502709|1043785|P1|NOT COMPLETED|Overall Study||4
426034|NCT01502709|1043784|P2|COMPLETED|Overall Study||0
426035|NCT01502709|1043785|P1|COMPLETED|Overall Study||1
426036|NCT01502709|1043784|P2|STARTED|Overall Study||0
426037|NCT01502709|1043785|P1|STARTED|Overall Study||5
426038|NCT01502644|1043798|P4|NOT COMPLETED|Assigned to NA Groups||8
426039|NCT01502644|1043799|P3|NOT COMPLETED|Assigned to NA Groups||3
426040|NCT01502644|1043800|P2|NOT COMPLETED|Assigned to NA Groups||6
426041|NCT01502644|1043801|P1|NOT COMPLETED|Assigned to NA Groups||0
426042|NCT01502644|1043798|P4|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|24
426043|NCT01502644|1043799|P3|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|7
426044|NCT01502644|1043800|P2|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|24
426045|NCT01502644|1043801|P1|COMPLETED|Assigned to NA Groups||0
426046|NCT01502644|1043798|P4|STARTED|Assigned to NA Groups||32
426047|NCT01502644|1043799|P3|STARTED|Assigned to NA Groups||10
426048|NCT01502644|1043800|P2|STARTED|Assigned to NA Groups||30
426049|NCT01502644|1043801|P1|STARTED|Assigned to NA Groups||0
426050|NCT01502644|1043798|P4|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
426051|NCT01502644|1043799|P3|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
426052|NCT01502644|1043800|P2|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
426053|NCT01502644|1043801|P1|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||9
426054|NCT01502644|1043798|P4|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
426055|NCT01502644|1043799|P3|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
426056|NCT01502644|1043800|P2|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
426057|NCT01502644|1043801|P1|COMPLETED|Enrolled at Visit 1 After Pre-screening|Participants who completed Visit 1 were assigned to 1 of the 3 NA groups for remainder of the trial|72
426058|NCT01502644|1043798|P4|STARTED|Enrolled at Visit 1 After Pre-screening||0
426059|NCT01502644|1043799|P3|STARTED|Enrolled at Visit 1 After Pre-screening||0
426060|NCT01502644|1043800|P2|STARTED|Enrolled at Visit 1 After Pre-screening||0
426061|NCT01502644|1043801|P1|STARTED|Enrolled at Visit 1 After Pre-screening||81
426062|NCT01502423|1043811|P2|NOT COMPLETED|Overall Study||1
426063|NCT01502423|1043812|P1|NOT COMPLETED|Overall Study||0
426064|NCT01502423|1043811|P2|COMPLETED|Overall Study||29
426065|NCT01502423|1043812|P1|COMPLETED|Overall Study||31
426066|NCT01502423|1043811|P2|STARTED|Overall Study||30
426067|NCT01502423|1043812|P1|STARTED|Overall Study||31
426068|NCT01502410|1043834|P4|NOT COMPLETED|Overall Study||0
426069|NCT01502410|1043835|P3|NOT COMPLETED|Overall Study||0
426070|NCT01502410|1043836|P2|NOT COMPLETED|Overall Study||10
426071|NCT01502410|1043837|P1|NOT COMPLETED|Overall Study||10
426072|NCT01502410|1043834|P4|COMPLETED|Overall Study||0
426073|NCT01502410|1043835|P3|COMPLETED|Overall Study||0
426074|NCT01502410|1043836|P2|COMPLETED|Overall Study||0
426075|NCT01502410|1043837|P1|COMPLETED|Overall Study||0
426076|NCT01502410|1043834|P4|STARTED|Overall Study||0
426077|NCT01502410|1043835|P3|STARTED|Overall Study||0
426078|NCT01502410|1043836|P2|STARTED|Overall Study||10
426079|NCT01502410|1043837|P1|STARTED|Overall Study||10
426080|NCT01502371|1043855|P5|NOT COMPLETED|Overall Study||52
426081|NCT01502371|1043856|P4|NOT COMPLETED|Overall Study||37
426082|NCT01502371|1043857|P3|NOT COMPLETED|Overall Study||25
426083|NCT01502371|1043858|P2|NOT COMPLETED|Overall Study||32
426084|NCT01502371|1043859|P1|NOT COMPLETED|Overall Study||41
426085|NCT01502371|1043855|P5|COMPLETED|Overall Study||60
426086|NCT01502371|1043856|P4|COMPLETED|Overall Study||88
426087|NCT01502371|1043857|P3|COMPLETED|Overall Study||83
426088|NCT01502371|1043858|P2|COMPLETED|Overall Study||81
426089|NCT01502371|1043859|P1|COMPLETED|Overall Study||79
426090|NCT01502371|1043855|P5|STARTED|Overall Study||112
426091|NCT01502371|1043856|P4|STARTED|Overall Study||125
426092|NCT01502371|1043857|P3|STARTED|Overall Study||108
426093|NCT01502371|1043858|P2|STARTED|Overall Study||113
426094|NCT01502371|1043859|P1|STARTED|Overall Study||120
426095|NCT01502332|1043884|P2|NOT COMPLETED|Overall Study||0
426096|NCT01502332|1043885|P1|NOT COMPLETED|Overall Study||0
426097|NCT01502332|1043884|P2|COMPLETED|Overall Study||163
426098|NCT01502332|1043885|P1|COMPLETED|Overall Study||157
426099|NCT01502332|1043884|P2|STARTED|Overall Study||163
426100|NCT01502332|1043885|P1|STARTED|Overall Study||157
426101|NCT01502228|1043899|P1|NOT COMPLETED|Overall Study||1
426102|NCT01502228|1043899|P1|COMPLETED|Overall Study||13
426103|NCT01502228|1043899|P1|STARTED|Overall Study||14
426104|NCT01502033|1043904|P1|NOT COMPLETED|Overall Study||3
426105|NCT01502033|1043904|P1|COMPLETED|Overall Study|Milestone (10 participants) met|7
426106|NCT01502033|1043904|P1|STARTED|Overall Study|Milestone (10 participants) met.|10
426107|NCT01501162|1043912|P2|NOT COMPLETED|Overall Study||5
426108|NCT01501162|1043913|P1|NOT COMPLETED|Overall Study||8
426109|NCT01501162|1043912|P2|COMPLETED|Overall Study||60
426110|NCT01501162|1043913|P1|COMPLETED|Overall Study||57
426111|NCT01501162|1043912|P2|STARTED|Overall Study||65
426112|NCT01501162|1043913|P1|STARTED|Overall Study||65
426113|NCT01501110|1043923|P2|NOT COMPLETED|Overall Study||1
426114|NCT01501110|1043924|P1|NOT COMPLETED|Overall Study||0
426115|NCT01501110|1043923|P2|COMPLETED|Overall Study||33
426116|NCT01501110|1043924|P1|COMPLETED|Overall Study||34
426117|NCT01501110|1043923|P2|STARTED|Overall Study||34
426118|NCT01501110|1043924|P1|STARTED|Overall Study||34
426119|NCT01500772|1043930|P1|NOT COMPLETED|Overall Study||6
426120|NCT01500772|1043930|P1|COMPLETED|Overall Study||0
426121|NCT01500772|1043930|P1|STARTED|Overall Study||6
426122|NCT01500746|1043939|P2|NOT COMPLETED|Overall Study||0
426123|NCT01500746|1043940|P1|NOT COMPLETED|Overall Study||0
426124|NCT01500746|1043939|P2|COMPLETED|Overall Study||4
426125|NCT01500746|1043940|P1|COMPLETED|Overall Study||4
426126|NCT01500746|1043939|P2|STARTED|Overall Study||4
426127|NCT01500746|1043940|P1|STARTED|Overall Study||4
426128|NCT01500720|1043948|P2|NOT COMPLETED|Overall Study||9
426129|NCT01500720|1043949|P1|NOT COMPLETED|Overall Study||5
426130|NCT01500720|1043948|P2|COMPLETED|Overall Study|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|80
426131|NCT01500720|1043949|P1|COMPLETED|Overall Study|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|85
426132|NCT01500720|1043948|P2|Treated|Overall Study||88
426133|NCT01500720|1043949|P1|Treated|Overall Study||89
426134|NCT01500720|1043948|P2|STARTED|Overall Study|Randomized|89
426135|NCT01500720|1043949|P1|STARTED|Overall Study|Randomized|90
426136|NCT01500694|1043963|P2|NOT COMPLETED|Overall Study||29
426137|NCT01500694|1043964|P1|NOT COMPLETED|Overall Study||52
426138|NCT01500694|1043963|P2|COMPLETED|Overall Study||54
426139|NCT01500694|1043964|P1|COMPLETED|Overall Study||79
426140|NCT01500694|1043963|P2|STARTED|Overall Study|Participants who received treatment were reported as Started.|83
426141|NCT01500694|1043964|P1|STARTED|Overall Study||131
426142|NCT01500629|1043990|P2|NOT COMPLETED|Period 2 (Single Dose)||0
426143|NCT01500629|1043991|P1|NOT COMPLETED|Period 2 (Single Dose)||0
426144|NCT01500629|1043990|P2|COMPLETED|Period 2 (Single Dose)||10
426145|NCT01500629|1043991|P1|COMPLETED|Period 2 (Single Dose)||10
426146|NCT01500629|1043990|P2|STARTED|Period 2 (Single Dose)||10
426147|NCT01500629|1043991|P1|STARTED|Period 2 (Single Dose)||10
426148|NCT01500629|1043990|P2|NOT COMPLETED|Washout Period of 14 to 30 Days||0
426149|NCT01500629|1043991|P1|NOT COMPLETED|Washout Period of 14 to 30 Days||1
426150|NCT01500629|1043990|P2|COMPLETED|Washout Period of 14 to 30 Days||10
426151|NCT01500629|1043991|P1|COMPLETED|Washout Period of 14 to 30 Days||10
426152|NCT01500629|1043990|P2|STARTED|Washout Period of 14 to 30 Days||10
426153|NCT01500629|1043991|P1|STARTED|Washout Period of 14 to 30 Days||11
426154|NCT01500629|1043990|P2|NOT COMPLETED|Period 1 (Single Dose)||0
426155|NCT01500629|1043991|P1|NOT COMPLETED|Period 1 (Single Dose)||0
426156|NCT01500629|1043990|P2|COMPLETED|Period 1 (Single Dose)||10
426157|NCT01500629|1043991|P1|COMPLETED|Period 1 (Single Dose)||11
426158|NCT01500629|1043990|P2|STARTED|Period 1 (Single Dose)||10
426159|NCT01500629|1043991|P1|STARTED|Period 1 (Single Dose)||11
426160|NCT01500434|1044075|P1|NOT COMPLETED|Overall Study||7
426161|NCT01500434|1044075|P1|COMPLETED|Overall Study||95
426162|NCT01500434|1044075|P1|STARTED|Overall Study||102
426163|NCT01500382|1044108|P4|NOT COMPLETED|Treatment Period 2||0
426164|NCT01500382|1044109|P3|NOT COMPLETED|Treatment Period 2||0
426165|NCT01500382|1044110|P2|NOT COMPLETED|Treatment Period 2||0
426166|NCT01500382|1044111|P1|NOT COMPLETED|Treatment Period 2||0
426167|NCT01500382|1044108|P4|COMPLETED|Treatment Period 2||1
426168|NCT01500382|1044109|P3|COMPLETED|Treatment Period 2||0
426169|NCT01500382|1044110|P2|COMPLETED|Treatment Period 2||1
426170|NCT01500382|1044111|P1|COMPLETED|Treatment Period 2||1
426171|NCT01500382|1044108|P4|STARTED|Treatment Period 2||1
426172|NCT01500382|1044109|P3|STARTED|Treatment Period 2||0
426173|NCT01500382|1044110|P2|STARTED|Treatment Period 2||1
426174|NCT01500382|1044111|P1|STARTED|Treatment Period 2||1
426175|NCT01500382|1044108|P4|NOT COMPLETED|Washout Period||0
426176|NCT01500382|1044109|P3|NOT COMPLETED|Washout Period||1
426177|NCT01500382|1044110|P2|NOT COMPLETED|Washout Period||0
426178|NCT01500382|1044111|P1|NOT COMPLETED|Washout Period||0
426179|NCT01500382|1044108|P4|COMPLETED|Washout Period||1
426180|NCT01500382|1044109|P3|COMPLETED|Washout Period||0
426181|NCT01500382|1044110|P2|COMPLETED|Washout Period||1
426182|NCT01500382|1044111|P1|COMPLETED|Washout Period||1
426183|NCT01500382|1044108|P4|STARTED|Washout Period||1
426184|NCT01500382|1044109|P3|STARTED|Washout Period||1
426185|NCT01500382|1044110|P2|STARTED|Washout Period||1
426186|NCT01500382|1044111|P1|STARTED|Washout Period||1
426187|NCT01500382|1044108|P4|NOT COMPLETED|Treatment Period 1||0
426188|NCT01500382|1044109|P3|NOT COMPLETED|Treatment Period 1||0
426189|NCT01500382|1044110|P2|NOT COMPLETED|Treatment Period 1||0
426190|NCT01500382|1044111|P1|NOT COMPLETED|Treatment Period 1||0
426191|NCT01500382|1044108|P4|COMPLETED|Treatment Period 1||1
426192|NCT01500382|1044109|P3|COMPLETED|Treatment Period 1||1
426193|NCT01500382|1044110|P2|COMPLETED|Treatment Period 1||1
426194|NCT01500382|1044111|P1|COMPLETED|Treatment Period 1||1
426195|NCT01500382|1044108|P4|STARTED|Treatment Period 1||1
426196|NCT01500382|1044109|P3|STARTED|Treatment Period 1||1
426197|NCT01500382|1044110|P2|STARTED|Treatment Period 1||1
426198|NCT01500382|1044111|P1|STARTED|Treatment Period 1||1
426199|NCT01500317|1044136|P3|NOT COMPLETED|Overall Study||0
426200|NCT01500317|1044137|P2|NOT COMPLETED|Overall Study||2
426201|NCT01500317|1044138|P1|NOT COMPLETED|Overall Study||3
426202|NCT01500317|1044136|P3|COMPLETED|Overall Study||13
426203|NCT01500317|1044137|P2|COMPLETED|Overall Study||10
426204|NCT01500317|1044138|P1|COMPLETED|Overall Study||10
426205|NCT01500317|1044136|P3|STARTED|Overall Study||13
426206|NCT01500317|1044137|P2|STARTED|Overall Study||12
426207|NCT01500317|1044138|P1|STARTED|Overall Study||13
426208|NCT01500278|1044160|P2|NOT COMPLETED|Week 13 - Week 104||126
426209|NCT01500278|1044161|P1|NOT COMPLETED|Week 13 - Week 104||139
426210|NCT01500278|1044160|P2|COMPLETED|Week 13 - Week 104||302
426211|NCT01500278|1044161|P1|COMPLETED|Week 13 - Week 104||287
426212|NCT01500278|1044160|P2|STARTED|Week 13 - Week 104||428
426213|NCT01500278|1044161|P1|STARTED|Week 13 - Week 104||426
426214|NCT01500278|1044160|P2|NOT COMPLETED|Week 0 - Week 12||30
426215|NCT01500278|1044161|P1|NOT COMPLETED|Week 0 - Week 12||31
426216|NCT01500278|1044160|P2|COMPLETED|Week 0 - Week 12||428
426217|NCT01500278|1044161|P1|COMPLETED|Week 0 - Week 12||426
426218|NCT01500278|1044160|P2|STARTED|Week 0 - Week 12||458
426219|NCT01500278|1044161|P1|STARTED|Week 0 - Week 12||457
426220|NCT01500252|1044185|P2|NOT COMPLETED|Overall Study||6
426221|NCT01500252|1044186|P1|NOT COMPLETED|Overall Study||9
426222|NCT01500252|1044185|P2|COMPLETED|Overall Study|2 participant deceased by 5 years; no further deaths between 5 & 10 years for a total of 2 deaths|11
426223|NCT01500252|1044186|P1|COMPLETED|Overall Study|2 participants died within 5 years; 2 participants died between 5 & 10 years for a total of 4 deaths|12
426224|NCT01500252|1044185|P2|Ten Years|Overall Study||11
426225|NCT01500252|1044186|P1|Ten Years|Overall Study||12
426226|NCT01500252|1044185|P2|Five Years|Overall Study||13
426227|NCT01500252|1044186|P1|Five Years|Overall Study||17
426228|NCT01500252|1044185|P2|One Years|Overall Study||16
426229|NCT01500252|1044186|P1|One Years|Overall Study||20
426230|NCT01500252|1044185|P2|STARTED|Overall Study||17
426231|NCT01500252|1044186|P1|STARTED|Overall Study||21
426232|NCT01500226|1044212|P2|NOT COMPLETED|Overall Study||494
426233|NCT01500226|1044213|P1|NOT COMPLETED|Overall Study||499
426234|NCT01500226|1044212|P2|COMPLETED|Overall Study||191
426235|NCT01500226|1044213|P1|COMPLETED|Overall Study|Number of patients who completed 6 cycles|185
426236|NCT01500226|1044212|P2|STARTED|Overall Study||685
426237|NCT01500226|1044213|P1|STARTED|Overall Study|Number of randomized patients|684
426238|NCT01500213|1044225|P2|NOT COMPLETED|Overall Study||224
426239|NCT01500213|1044226|P1|NOT COMPLETED|Overall Study||217
426240|NCT01500213|1044225|P2|COMPLETED|Overall Study||53
426241|NCT01500213|1044226|P1|COMPLETED|Overall Study|Number of patients who completed 6 cycles|61
426242|NCT01500213|1044225|P2|STARTED|Overall Study||277
426243|NCT01500213|1044226|P1|STARTED|Overall Study|Number of randomized patients|278
426244|NCT01500135|1044238|P2|NOT COMPLETED|Overall Study||11
426245|NCT01500135|1044239|P1|NOT COMPLETED|Overall Study||17
426246|NCT01500135|1044238|P2|COMPLETED|Overall Study||39
426247|NCT01500135|1044239|P1|COMPLETED|Overall Study||83
426248|NCT01500135|1044238|P2|STARTED|Overall Study||50
426249|NCT01500135|1044239|P1|STARTED|Overall Study||100
426250|NCT01500109|1044252|P3|NOT COMPLETED|Overall Study||0
426251|NCT01500109|1044253|P2|NOT COMPLETED|Overall Study||0
426252|NCT01500109|1044254|P1|NOT COMPLETED|Overall Study||0
426253|NCT01500109|1044252|P3|COMPLETED|Overall Study||16
426254|NCT01500109|1044253|P2|COMPLETED|Overall Study||14
426255|NCT01500109|1044254|P1|COMPLETED|Overall Study||15
426256|NCT01500109|1044252|P3|STARTED|Overall Study||16
426257|NCT01500109|1044253|P2|STARTED|Overall Study||14
426258|NCT01500109|1044254|P1|STARTED|Overall Study||15
426259|NCT01500096|1044266|P4|NOT COMPLETED|Overall Study||2
426260|NCT01500096|1044267|P3|NOT COMPLETED|Overall Study||0
426261|NCT01500096|1044268|P2|NOT COMPLETED|Overall Study||0
426262|NCT01500096|1044269|P1|NOT COMPLETED|Overall Study||1
426263|NCT01500096|1044266|P4|COMPLETED|Overall Study||14
426264|NCT01500096|1044267|P3|COMPLETED|Overall Study||31
426265|NCT01500096|1044268|P2|COMPLETED|Overall Study||17
426266|NCT01500096|1044269|P1|COMPLETED|Overall Study||31
426267|NCT01500096|1044266|P4|STARTED|Overall Study||16
426268|NCT01500096|1044267|P3|STARTED|Overall Study||31
426269|NCT01500096|1044268|P2|STARTED|Overall Study||17
426270|NCT01500096|1044269|P1|STARTED|Overall Study||32
426271|NCT01500083|1044321|P2|NOT COMPLETED|Overall Study||43
426272|NCT01500083|1044322|P1|NOT COMPLETED|Overall Study||12
426273|NCT01500083|1044321|P2|COMPLETED|Overall Study||31
426274|NCT01500083|1044322|P1|COMPLETED|Overall Study||4
426275|NCT01500083|1044321|P2|STARTED|Overall Study||74
426276|NCT01500083|1044322|P1|STARTED|Overall Study||16
426277|NCT01500057|1044330|P2|NOT COMPLETED|Overall Study||4
426278|NCT01500057|1044331|P1|NOT COMPLETED|Overall Study||6
426279|NCT01500057|1044330|P2|COMPLETED|Overall Study||31
426280|NCT01500057|1044331|P1|COMPLETED|Overall Study||25
426281|NCT01500057|1044330|P2|STARTED|Overall Study||35
426282|NCT01500057|1044331|P1|STARTED|Overall Study||31
426283|NCT01500031|1044341|P1|NOT COMPLETED|Overall Study||5
426284|NCT01500031|1044341|P1|COMPLETED|Overall Study||87
426285|NCT01500031|1044341|P1|STARTED|Overall Study||92
426286|NCT01499862|1044356|P1|NOT COMPLETED|Overall Study||0
426287|NCT01499862|1044356|P1|COMPLETED|Overall Study||3
426288|NCT01499862|1044356|P1|STARTED|Overall Study||3
426289|NCT01499849|1044376|P2|NOT COMPLETED|Overall Study||226
426290|NCT01499849|1044377|P1|NOT COMPLETED|Overall Study||224
426291|NCT01499849|1044376|P2|COMPLETED|Overall Study||40
426292|NCT01499849|1044377|P1|COMPLETED|Overall Study|Number of patients who completed 6 cycles|42
426293|NCT01499849|1044376|P2|STARTED|Overall Study||266
426294|NCT01499849|1044377|P1|STARTED|Overall Study|Number of randomized patients|266
426295|NCT01499810|1044387|P1|NOT COMPLETED|Overall Study||12
426296|NCT01499810|1044387|P1|COMPLETED|Overall Study||41
426297|NCT01499810|1044387|P1|STARTED|Overall Study||53
426298|NCT01499667|1044437|P3|NOT COMPLETED|Overall Study||10
426299|NCT01499667|1044438|P2|NOT COMPLETED|Overall Study||11
426300|NCT01499667|1044439|P1|NOT COMPLETED|Overall Study||9
426301|NCT01499667|1044437|P3|COMPLETED|Overall Study||40
426302|NCT01499667|1044438|P2|COMPLETED|Overall Study||31
426303|NCT01499667|1044439|P1|COMPLETED|Overall Study||41
426304|NCT01499667|1044437|P3|Modified Full Analysis Set|Overall Study||39
426305|NCT01499667|1044438|P2|Modified Full Analysis Set|Overall Study||29
426306|NCT01499667|1044439|P1|Modified Full Analysis Set|Overall Study|mFAS included all FAS patients who completed 8 wks of fingolimod treatment with MRI scan|41
426307|NCT01499667|1044437|P3|Full Analysis Set (FAS)|Overall Study||50
426308|NCT01499667|1044438|P2|Full Analysis Set (FAS)|Overall Study||42
426309|NCT01499667|1044439|P1|Full Analysis Set (FAS)|Overall Study|One randomized patient did not receive natalizumub at screening, which was a requirement for FAS.|49
426310|NCT01499667|1044437|P3|STARTED|Overall Study||50
426311|NCT01499667|1044438|P2|STARTED|Overall Study||42
426312|NCT01499667|1044439|P1|STARTED|Overall Study|Started” indicates randomized as well as safety population.|50
426313|NCT01499654|1044468|P1|NOT COMPLETED|Overall Study||0
426314|NCT01499654|1044468|P1|COMPLETED|Overall Study||64
426315|NCT01499654|1044468|P1|STARTED|Overall Study||64
426316|NCT01499576|1044487|P1|NOT COMPLETED|Overall Study||21
426317|NCT01499576|1044487|P1|COMPLETED|Overall Study||105
426318|NCT01499576|1044487|P1|STARTED|Overall Study||126
426319|NCT01499498|1044493|P1|NOT COMPLETED|Overall Study||0
426320|NCT01499498|1044493|P1|COMPLETED|Overall Study||13
426321|NCT01499498|1044493|P1|STARTED|Overall Study||13
426322|NCT01499355|1044501|P4|NOT COMPLETED|Double-Blind Period||23
426323|NCT01499355|1044502|P3|NOT COMPLETED|Double-Blind Period||25
426324|NCT01499355|1044503|P2|NOT COMPLETED|Double-Blind Period||23
426325|NCT01499355|1044504|P1|NOT COMPLETED|Double-Blind Period||0
426326|NCT01499355|1044501|P4|COMPLETED|Double-Blind Period||39
426327|NCT01499355|1044502|P3|COMPLETED|Double-Blind Period||38
426328|NCT01499355|1044503|P2|COMPLETED|Double-Blind Period||40
426329|NCT01499355|1044504|P1|COMPLETED|Double-Blind Period||0
426330|NCT01499355|1044501|P4|STARTED|Double-Blind Period||62
426331|NCT01499355|1044502|P3|STARTED|Double-Blind Period||63
426332|NCT01499355|1044503|P2|STARTED|Double-Blind Period||63
426333|NCT01499355|1044504|P1|STARTED|Double-Blind Period||0
426334|NCT01499355|1044501|P4|NOT COMPLETED|Run-In Period||0
426335|NCT01499355|1044502|P3|NOT COMPLETED|Run-In Period||0
426336|NCT01499355|1044503|P2|NOT COMPLETED|Run-In Period||0
426337|NCT01499355|1044504|P1|NOT COMPLETED|Run-In Period||31
426338|NCT01499355|1044501|P4|COMPLETED|Run-In Period||0
426339|NCT01499355|1044502|P3|COMPLETED|Run-In Period||0
426340|NCT01499355|1044503|P2|COMPLETED|Run-In Period||0
426341|NCT01499355|1044504|P1|COMPLETED|Run-In Period||245
426342|NCT01499355|1044501|P4|STARTED|Run-In Period||0
426343|NCT01499355|1044502|P3|STARTED|Run-In Period||0
426344|NCT01499355|1044503|P2|STARTED|Run-In Period||0
426345|NCT01499355|1044504|P1|STARTED|Run-In Period||276
426346|NCT01499303|1044537|P2|NOT COMPLETED|Overall Study||7
426347|NCT01499303|1044538|P1|NOT COMPLETED|Overall Study||3
426348|NCT01499303|1044537|P2|COMPLETED|Overall Study||40
426349|NCT01499303|1044538|P1|COMPLETED|Overall Study||18
426350|NCT01499303|1044537|P2|STARTED|Overall Study||47
426351|NCT01499303|1044538|P1|STARTED|Overall Study||21
426352|NCT01499290|1044546|P2|NOT COMPLETED|Overall Study||35
426353|NCT01499290|1044547|P1|NOT COMPLETED|Overall Study||55
426354|NCT01499290|1044546|P2|COMPLETED|Overall Study|(Numbers indicate patients who completed treatment)|494
426355|NCT01499290|1044547|P1|COMPLETED|Overall Study|(Numbers indicate patients who completed treatment)|474
426356|NCT01499290|1044546|P2|STARTED|Overall Study|Patients dosed in pooled protocols D4280C00001/D4280C00005 (NCT01499290/NCT01500239) agreed with FDA|529
426357|NCT01499290|1044547|P1|STARTED|Overall Study|Patients dosed in pooled protocols D4280C00001/D4280C00005 (NCT01499290/NCT01500239) agreed with FDA|529
426358|NCT01499277|1044597|P2|NOT COMPLETED|Overall Study||32
426359|NCT01499277|1044598|P1|NOT COMPLETED|Overall Study||47
426360|NCT01499277|1044597|P2|COMPLETED|Overall Study||223
426361|NCT01499277|1044598|P1|COMPLETED|Overall Study||459
426362|NCT01499277|1044597|P2|STARTED|Overall Study||255
426363|NCT01499277|1044598|P1|STARTED|Overall Study||506
426364|NCT01499199|1044620|P1|NOT COMPLETED|Overall Study||2
426365|NCT01499199|1044620|P1|COMPLETED|Overall Study||11
426366|NCT01499199|1044620|P1|STARTED|Overall Study||13
426367|NCT01499173|1044639|P1|NOT COMPLETED|Overall Study||37
426368|NCT01499173|1044639|P1|COMPLETED|Overall Study||64
426369|NCT01499173|1044639|P1|STARTED|Overall Study||101
426370|NCT01499160|1044649|P1|NOT COMPLETED|Overall Study||2
426371|NCT01499160|1044649|P1|COMPLETED|Overall Study|"1 pt-withdrew consent~1pt-had cardiac toxicity"|5
426372|NCT01499160|1044649|P1|STARTED|Overall Study||7
426373|NCT01499147|1044656|P2|NOT COMPLETED|Overall Study||5
426374|NCT01499147|1044657|P1|NOT COMPLETED|Overall Study||15
426375|NCT01499147|1044656|P2|COMPLETED|Overall Study||12
426376|NCT01499147|1044657|P1|COMPLETED|Overall Study||18
426377|NCT01499147|1044656|P2|STARTED|Overall Study||17
426378|NCT01499147|1044657|P1|STARTED|Overall Study||33
426379|NCT01499134|1044672|P2|NOT COMPLETED|Overall Study||1
426380|NCT01499134|1044673|P1|NOT COMPLETED|Overall Study||0
426381|NCT01499134|1044672|P2|COMPLETED|Overall Study||7
426382|NCT01499134|1044673|P1|COMPLETED|Overall Study||9
426383|NCT01499134|1044672|P2|STARTED|Overall Study||8
426384|NCT01499134|1044673|P1|STARTED|Overall Study||9
426385|NCT01499095|1044695|P2|NOT COMPLETED|Overall Study||93
426386|NCT01499095|1044696|P1|NOT COMPLETED|Overall Study||89
426387|NCT01499095|1044695|P2|COMPLETED|Overall Study||314
426388|NCT01499095|1044696|P1|COMPLETED|Overall Study||315
426389|NCT01499095|1044695|P2|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|405
426390|NCT01499095|1044696|P1|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|403
426391|NCT01499095|1044695|P2|Participated in Substudy|Overall Study||0
426392|NCT01499095|1044696|P1|Participated in Substudy|Overall Study|45 participants received adaptable dosing regimen and 44 participants received fixed dosing regimen|89
426393|NCT01499095|1044695|P2|Treated|Overall Study||406
426394|NCT01499095|1044696|P1|Treated|Overall Study||403
426395|NCT01499095|1044695|P2|STARTED|Overall Study||407
426396|NCT01499095|1044696|P1|STARTED|Overall Study||404
426397|NCT01499082|1044726|P2|NOT COMPLETED|Overall Study||48
426398|NCT01499082|1044727|P1|NOT COMPLETED|Overall Study||45
426399|NCT01499082|1044726|P2|COMPLETED|Overall Study||355
426400|NCT01499082|1044727|P1|COMPLETED|Overall Study||359
426401|NCT01499082|1044726|P2|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|400
426402|NCT01499082|1044727|P1|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|404
426403|NCT01499082|1044726|P2|Participated in Substudy|Overall Study||0
426404|NCT01499082|1044727|P1|Participated in Substudy|Overall Study|56 participants received adaptable dosing regimen and 53 participants received fixed dosing regimen|109
426405|NCT01499082|1044726|P2|Treated|Overall Study||402
426406|NCT01499082|1044727|P1|Treated|Overall Study||404
426407|NCT01499082|1044726|P2|STARTED|Overall Study||403
426408|NCT01499082|1044727|P1|STARTED|Overall Study||404
426409|NCT01498978|1044755|P1|NOT COMPLETED|Overall Study||2
426410|NCT01498978|1044755|P1|COMPLETED|Overall Study||8
426411|NCT01498978|1044755|P1|STARTED|Overall Study||10
426412|NCT01498822|1044777|P2|NOT COMPLETED|Overall Study||56
426413|NCT01498822|1044778|P1|NOT COMPLETED|Overall Study||54
426414|NCT01498822|1044777|P2|COMPLETED|Overall Study||122
426415|NCT01498822|1044778|P1|COMPLETED|Overall Study||121
426416|NCT01498822|1044777|P2|STARTED|Overall Study||178
426417|NCT01498822|1044778|P1|STARTED|Overall Study||175
426418|NCT01498744|1044792|P2|NOT COMPLETED|Overall Study||0
426419|NCT01498744|1044793|P1|NOT COMPLETED|Overall Study||0
426420|NCT01498744|1044792|P2|COMPLETED|Overall Study||31
426421|NCT01498744|1044793|P1|COMPLETED|Overall Study||22
426422|NCT01498744|1044792|P2|STARTED|Overall Study||31
426423|NCT01498744|1044793|P1|STARTED|Overall Study||22
426424|NCT01498692|1044805|P1|NOT COMPLETED|Overall Study||8
426425|NCT01498692|1044805|P1|COMPLETED|Overall Study||86
426426|NCT01498692|1044805|P1|STARTED|Overall Study||94
426427|NCT01498679|1044836|P2|NOT COMPLETED|Overall Study||22
426428|NCT01498679|1044837|P1|NOT COMPLETED|Overall Study||89
426429|NCT01498679|1044836|P2|COMPLETED|Overall Study||131
426430|NCT01498679|1044837|P1|COMPLETED|Overall Study||65
426431|NCT01498679|1044836|P2|STARTED|Overall Study||153
426432|NCT01498679|1044837|P1|STARTED|Overall Study||154
426433|NCT01498653|1044853|P2|NOT COMPLETED|Overall Study||35
426434|NCT01498653|1044854|P1|NOT COMPLETED|Overall Study||19
426435|NCT01498653|1044853|P2|COMPLETED|Overall Study||119
426436|NCT01498653|1044854|P1|COMPLETED|Overall Study||136
426437|NCT01498653|1044853|P2|STARTED|Overall Study||154
426438|NCT01498653|1044854|P1|STARTED|Overall Study||155
426439|NCT01498640|1044868|P1|NOT COMPLETED|Overall Study||5
426440|NCT01498640|1044868|P1|COMPLETED|Overall Study||47
426441|NCT01498640|1044868|P1|STARTED|Overall Study||52
426442|NCT01498601|1044884|P2|NOT COMPLETED|Overall Study||0
426443|NCT01498601|1044885|P1|NOT COMPLETED|Overall Study||0
426444|NCT01498601|1044884|P2|COMPLETED|Overall Study||32
426445|NCT01498601|1044885|P1|COMPLETED|Overall Study||51
426446|NCT01498601|1044884|P2|STARTED|Overall Study||32
426447|NCT01498601|1044885|P1|STARTED|Overall Study||51
426448|NCT01498588|1044891|P1|NOT COMPLETED|Overall Study||0
426449|NCT01498588|1044891|P1|COMPLETED|Overall Study||7
426450|NCT01498588|1044891|P1|STARTED|Overall Study||7
426451|NCT01498575|1044898|P2|NOT COMPLETED|On the Road Driving Assessment (ODA)||24
426452|NCT01498575|1044899|P1|NOT COMPLETED|On the Road Driving Assessment (ODA)||42
426453|NCT01498575|1044898|P2|COMPLETED|On the Road Driving Assessment (ODA)||65
426454|NCT01498575|1044899|P1|COMPLETED|On the Road Driving Assessment (ODA)||86
426455|NCT01498575|1044898|P2|STARTED|On the Road Driving Assessment (ODA)||89
426456|NCT01498575|1044899|P1|STARTED|On the Road Driving Assessment (ODA)||128
426457|NCT01498575|1044898|P2|NOT COMPLETED|Overall Sample||14
426458|NCT01498575|1044899|P1|NOT COMPLETED|Overall Sample||60
426459|NCT01498575|1044898|P2|COMPLETED|Overall Sample||400
426460|NCT01498575|1044899|P1|COMPLETED|Overall Sample||550
426461|NCT01498575|1044898|P2|STARTED|Overall Sample||414
426462|NCT01498575|1044899|P1|STARTED|Overall Sample||610
426463|NCT01498549|1044905|P1|NOT COMPLETED|Overall Study||4
426464|NCT01498549|1044905|P1|COMPLETED|Overall Study||35
426465|NCT01498549|1044905|P1|Sugar Pill 0 mg|Overall Study||36
426466|NCT01498549|1044905|P1|Atomoxetine 80 mg|Overall Study||37
426467|NCT01498549|1044905|P1|Atomoxetine 40 mg|Overall Study||39
426468|NCT01498549|1044905|P1|STARTED|Overall Study||39
426469|NCT01498458|1044916|P1|NOT COMPLETED|Overall Study||7
426470|NCT01498458|1044916|P1|COMPLETED|Overall Study|only 1 patient was in the study at the end. 7 left due to Adverse Events or Investigators Decision.|1
426471|NCT01498458|1044916|P1|STARTED|Overall Study|9 patients took part in the study of which 8 received pazopanib.|8
426472|NCT01498419|1044929|P4|NOT COMPLETED|Overall Study||19
426473|NCT01498419|1044930|P3|NOT COMPLETED|Overall Study||18
426474|NCT01498419|1044931|P2|NOT COMPLETED|Overall Study||23
426475|NCT01498419|1044932|P1|NOT COMPLETED|Overall Study||18
426476|NCT01498419|1044929|P4|COMPLETED|Overall Study||7
426477|NCT01498419|1044930|P3|COMPLETED|Overall Study||41
426478|NCT01498419|1044931|P2|COMPLETED|Overall Study||39
426479|NCT01498419|1044932|P1|COMPLETED|Overall Study||42
426480|NCT01498419|1044929|P4|STARTED|Overall Study||26
426481|NCT01498419|1044930|P3|STARTED|Overall Study||59
426482|NCT01498419|1044931|P2|STARTED|Overall Study||62
426483|NCT01498419|1044932|P1|STARTED|Overall Study||60
426484|NCT01498185|1044971|P5|NOT COMPLETED|Overall Study||3
426485|NCT01498185|1044972|P4|NOT COMPLETED|Overall Study||3
426486|NCT01498185|1044973|P3|NOT COMPLETED|Overall Study||0
426487|NCT01498185|1044974|P2|NOT COMPLETED|Overall Study||1
426488|NCT01498185|1044975|P1|NOT COMPLETED|Overall Study||1
426489|NCT01498185|1044971|P5|COMPLETED|Overall Study||12
426490|NCT01498185|1044972|P4|COMPLETED|Overall Study||11
426491|NCT01498185|1044973|P3|COMPLETED|Overall Study||15
426492|NCT01498185|1044974|P2|COMPLETED|Overall Study||12
426493|NCT01498185|1044975|P1|COMPLETED|Overall Study||12
426494|NCT01498185|1044971|P5|STARTED|Overall Study||15
426495|NCT01498185|1044972|P4|STARTED|Overall Study||14
426496|NCT01498185|1044973|P3|STARTED|Overall Study||15
426497|NCT01498185|1044974|P2|STARTED|Overall Study||13
426498|NCT01498185|1044975|P1|STARTED|Overall Study||13
426499|NCT01498120|1045015|P1|NOT COMPLETED|Overall Study||13
426500|NCT01498120|1045015|P1|COMPLETED|Overall Study||1
426501|NCT01498120|1045015|P1|STARTED|Overall Study||14
426502|NCT01498068|1045022|P2|NOT COMPLETED|Overall Study||1
426503|NCT01498068|1045023|P1|NOT COMPLETED|Overall Study||1
426504|NCT01498068|1045022|P2|COMPLETED|Overall Study||19
426505|NCT01498068|1045023|P1|COMPLETED|Overall Study||15
426506|NCT01498068|1045022|P2|STARTED|Overall Study||20
426507|NCT01498068|1045023|P1|STARTED|Overall Study||16
426508|NCT01497938|1045041|P2|NOT COMPLETED|Overall Study||2
426509|NCT01497938|1045042|P1|NOT COMPLETED|Overall Study||5
426510|NCT01497938|1045041|P2|COMPLETED|Overall Study||124
426511|NCT01497938|1045042|P1|COMPLETED|Overall Study||116
426512|NCT01497938|1045041|P2|STARTED|Overall Study||126
426513|NCT01497938|1045042|P1|STARTED|Overall Study||121
426514|NCT01497899|1045054|P4|NOT COMPLETED|Open-Label Extension Phase||5
426515|NCT01497899|1045055|P3|NOT COMPLETED|Open-Label Extension Phase||9
426516|NCT01497899|1045056|P2|NOT COMPLETED|Open-Label Extension Phase||7
426517|NCT01497899|1045057|P1|NOT COMPLETED|Open-Label Extension Phase||19
426518|NCT01497899|1045054|P4|COMPLETED|Open-Label Extension Phase||33
426519|NCT01497899|1045055|P3|COMPLETED|Open-Label Extension Phase||61
426520|NCT01497899|1045056|P2|COMPLETED|Open-Label Extension Phase||46
426521|NCT01497899|1045057|P1|COMPLETED|Open-Label Extension Phase||86
426522|NCT01497899|1045054|P4|STARTED|Open-Label Extension Phase|Participants enrolled from other Gilead-sponsored Study GS-US-299-0102.|38
426523|NCT01497899|1045055|P3|STARTED|Open-Label Extension Phase|Participants enrolled from other Gilead-sponsored Study GS-US-299-0102.|70
426524|NCT01497899|1045056|P2|STARTED|Open-Label Extension Phase||53
426525|NCT01497899|1045057|P1|STARTED|Open-Label Extension Phase|2 participants completed the Double-Blind Phase, but did not continue in the Open-Label Extension.|105
426526|NCT01497899|1045054|P4|NOT COMPLETED|Double-Blind Phase||0
426527|NCT01497899|1045055|P3|NOT COMPLETED|Double-Blind Phase||0
426528|NCT01497899|1045056|P2|NOT COMPLETED|Double-Blind Phase||5
426529|NCT01497899|1045057|P1|NOT COMPLETED|Double-Blind Phase||6
426530|NCT01497899|1045054|P4|COMPLETED|Double-Blind Phase||0
426531|NCT01497899|1045055|P3|COMPLETED|Double-Blind Phase||0
426532|NCT01497899|1045056|P2|COMPLETED|Double-Blind Phase||53
426533|NCT01497899|1045057|P1|COMPLETED|Double-Blind Phase||107
426534|NCT01497899|1045054|P4|STARTED|Double-Blind Phase||0
426535|NCT01497899|1045055|P3|STARTED|Double-Blind Phase||0
426536|NCT01497899|1045056|P2|STARTED|Double-Blind Phase||58
426537|NCT01497899|1045057|P1|STARTED|Double-Blind Phase||113
426538|NCT01497756|1045070|P1|NOT COMPLETED|Overall Study||0
426539|NCT01497756|1045070|P1|COMPLETED|Overall Study||10
426540|NCT01497756|1045070|P1|STARTED|Overall Study||10
426541|NCT01497665|1045075|P1|NOT COMPLETED|Overall Study||0
426542|NCT01497665|1045075|P1|COMPLETED|Overall Study||16
426543|NCT01497665|1045075|P1|Completed Effifcacy Assessment|Overall Study|Number of patients who completed efficacy assessment with CNS lesions per Overall RECIST 1.1.|10
426544|NCT01497665|1045075|P1|STARTED|Overall Study||16
426545|NCT01497613|1045085|P2|NOT COMPLETED|Overall Study||19
426546|NCT01497613|1045086|P1|NOT COMPLETED|Overall Study||37
426547|NCT01497613|1045085|P2|COMPLETED|Overall Study||131
426548|NCT01497613|1045086|P1|COMPLETED|Overall Study||113
426549|NCT01497613|1045085|P2|STARTED|Overall Study||150
426550|NCT01497613|1045086|P1|STARTED|Overall Study||150
426551|NCT01497366|1045124|P2|NOT COMPLETED|Overall Study||88
426552|NCT01497366|1045125|P1|NOT COMPLETED|Overall Study||39
426553|NCT01497366|1045124|P2|COMPLETED|Overall Study||176
426554|NCT01497366|1045125|P1|COMPLETED|Overall Study||224
426555|NCT01497366|1045124|P2|Randomized But Not Treated|Overall Study||21
426556|NCT01497366|1045125|P1|Randomized But Not Treated|Overall Study||7
426557|NCT01497366|1045124|P2|STARTED|Overall Study||264
426558|NCT01497366|1045125|P1|STARTED|Overall Study||263
426559|NCT01497275|1045143|P1|NOT COMPLETED|Overall Study||2
426560|NCT01497275|1045143|P1|COMPLETED|Overall Study||3
426561|NCT01497275|1045143|P1|STARTED|Overall Study||5
426562|NCT01497262|1045150|P1|NOT COMPLETED|Overall Study||11
426563|NCT01497262|1045150|P1|COMPLETED|Overall Study||151
426564|NCT01497262|1045150|P1|STARTED|Overall Study||162
426565|NCT01497197|1045157|P2|NOT COMPLETED|Overall Study||15
426566|NCT01497197|1045158|P1|NOT COMPLETED|Overall Study||17
426567|NCT01497197|1045157|P2|COMPLETED|Overall Study||70
426568|NCT01497197|1045158|P1|COMPLETED|Overall Study||72
426569|NCT01497197|1045157|P2|STARTED|Overall Study||85
426570|NCT01497197|1045158|P1|STARTED|Overall Study||89
426571|NCT01497171|1045186|P2|NOT COMPLETED|Overall Study||0
426572|NCT01497171|1045187|P1|NOT COMPLETED|Overall Study||0
426573|NCT01497171|1045186|P2|COMPLETED|Overall Study||3
426574|NCT01497171|1045187|P1|COMPLETED|Overall Study||2
426575|NCT01497171|1045186|P2|STARTED|Overall Study||3
426576|NCT01497171|1045187|P1|STARTED|Overall Study||2
426577|NCT01496846|1045199|P6|NOT COMPLETED|Supplemental Buccal Infiltration||0
426578|NCT01496846|1045200|P5|NOT COMPLETED|Supplemental Buccal Infiltration||0
426579|NCT01496846|1045201|P4|NOT COMPLETED|Supplemental Buccal Infiltration||0
426580|NCT01496846|1045202|P3|NOT COMPLETED|Supplemental Buccal Infiltration||0
426581|NCT01496846|1045203|P2|NOT COMPLETED|Supplemental Buccal Infiltration||0
426582|NCT01496846|1045204|P1|NOT COMPLETED|Supplemental Buccal Infiltration||0
426583|NCT01496846|1045199|P6|COMPLETED|Supplemental Buccal Infiltration||38
426584|NCT01496846|1045200|P5|COMPLETED|Supplemental Buccal Infiltration||35
426585|NCT01496846|1045201|P4|COMPLETED|Supplemental Buccal Infiltration||40
426586|NCT01496846|1045202|P3|COMPLETED|Supplemental Buccal Infiltration||36
426587|NCT01496846|1045203|P2|COMPLETED|Supplemental Buccal Infiltration||0
426588|NCT01496846|1045204|P1|COMPLETED|Supplemental Buccal Infiltration||0
426589|NCT01496846|1045199|P6|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|38
426590|NCT01496846|1045200|P5|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|35
426591|NCT01496846|1045201|P4|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|40
426592|NCT01496846|1045202|P3|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|36
426593|NCT01496846|1045203|P2|STARTED|Supplemental Buccal Infiltration|No participants with successful IANB initially were brought forward to supplemental anesthetic|0
426594|NCT01496846|1045204|P1|STARTED|Supplemental Buccal Infiltration|No participants with successful IANB initially were brought forward to supplemental anesthetic|0
426595|NCT01496846|1045199|P6|NOT COMPLETED|IANB Articaine (All Participants)||0
426596|NCT01496846|1045200|P5|NOT COMPLETED|IANB Articaine (All Participants)||0
426597|NCT01496846|1045201|P4|NOT COMPLETED|IANB Articaine (All Participants)||0
426598|NCT01496846|1045202|P3|NOT COMPLETED|IANB Articaine (All Participants)||0
426599|NCT01496846|1045203|P2|NOT COMPLETED|IANB Articaine (All Participants)||1
426600|NCT01496846|1045204|P1|NOT COMPLETED|IANB Articaine (All Participants)||1
426601|NCT01496846|1045199|P6|COMPLETED|IANB Articaine (All Participants)||38
426602|NCT01496846|1045200|P5|COMPLETED|IANB Articaine (All Participants)||35
426603|NCT01496846|1045201|P4|COMPLETED|IANB Articaine (All Participants)||40
426604|NCT01496846|1045202|P3|COMPLETED|IANB Articaine (All Participants)||36
426605|NCT01496846|1045203|P2|COMPLETED|IANB Articaine (All Participants)||23
426606|NCT01496846|1045204|P1|COMPLETED|IANB Articaine (All Participants)||27
426607|NCT01496846|1045199|P6|STARTED|IANB Articaine (All Participants)||38
426608|NCT01496846|1045200|P5|STARTED|IANB Articaine (All Participants)||35
426609|NCT01496846|1045201|P4|STARTED|IANB Articaine (All Participants)||40
426610|NCT01496846|1045202|P3|STARTED|IANB Articaine (All Participants)||36
426611|NCT01496846|1045203|P2|STARTED|IANB Articaine (All Participants)||24
426612|NCT01496846|1045204|P1|STARTED|IANB Articaine (All Participants)||28
426613|NCT01496807|1045215|P1|NOT COMPLETED|Overall Study||30
426614|NCT01496807|1045215|P1|COMPLETED|Overall Study||1
426615|NCT01496807|1045215|P1|STARTED|Overall Study||31
426616|NCT01496469|1045227|P2|NOT COMPLETED|Overall Study||8
426617|NCT01496469|1045228|P1|NOT COMPLETED|Overall Study||10
426618|NCT01496469|1045227|P2|COMPLETED|Overall Study||53
426619|NCT01496469|1045228|P1|COMPLETED|Overall Study||50
426620|NCT01496469|1045227|P2|STARTED|Overall Study||61
426621|NCT01496469|1045228|P1|STARTED|Overall Study||60
426622|NCT01496456|1045238|P1|NOT COMPLETED|Overall Study||8
426623|NCT01496456|1045238|P1|COMPLETED|Overall Study||9
426624|NCT01496456|1045238|P1|3-yr Final Recall|Overall Study||9
426625|NCT01496456|1045238|P1|2-yr Recall|Overall Study||10
426626|NCT01496456|1045238|P1|1-yr Recall|Overall Study||12
426627|NCT01496456|1045238|P1|Baseline|Overall Study|Baseline group started with 16 patients.|16
426628|NCT01496456|1045238|P1|STARTED|Overall Study||17
426629|NCT01496430|1045251|P3|NOT COMPLETED|Overall Study||10
426630|NCT01496430|1045252|P2|NOT COMPLETED|Overall Study||5
426631|NCT01496430|1045253|P1|NOT COMPLETED|Overall Study||6
426632|NCT01496430|1045251|P3|COMPLETED|Overall Study||25
426633|NCT01496430|1045252|P2|COMPLETED|Overall Study||30
426634|NCT01496430|1045253|P1|COMPLETED|Overall Study||29
426635|NCT01496430|1045251|P3|STARTED|Overall Study||35
426636|NCT01496430|1045252|P2|STARTED|Overall Study||35
426637|NCT01496430|1045253|P1|STARTED|Overall Study||35
426638|NCT01496352|1045329|P2|NOT COMPLETED|Overall Study||0
426639|NCT01496352|1045330|P1|NOT COMPLETED|Overall Study||0
426640|NCT01496352|1045329|P2|COMPLETED|Overall Study||6
426641|NCT01496352|1045330|P1|COMPLETED|Overall Study||24
426642|NCT01496352|1045329|P2|STARTED|Overall Study||6
426643|NCT01496352|1045330|P1|STARTED|Overall Study||24
426644|NCT01496313|1045348|P2|NOT COMPLETED|Overall Study||15
426645|NCT01496313|1045349|P1|NOT COMPLETED|Overall Study||5
426646|NCT01496313|1045348|P2|COMPLETED|Overall Study||26
426647|NCT01496313|1045349|P1|COMPLETED|Overall Study||35
426648|NCT01496313|1045348|P2|STARTED|Overall Study||41
426649|NCT01496313|1045349|P1|STARTED|Overall Study||40
426650|NCT01496287|1045365|P1|NOT COMPLETED|Overall Study||6
426651|NCT01496287|1045365|P1|COMPLETED|Overall Study||64
426652|NCT01496287|1045365|P1|STARTED|Overall Study||70
426653|NCT01496274|1045375|P2|NOT COMPLETED|Overall Study||5
426654|NCT01496274|1045376|P1|NOT COMPLETED|Overall Study||3
426655|NCT01496274|1045375|P2|COMPLETED|Overall Study||18
426656|NCT01496274|1045376|P1|COMPLETED|Overall Study||37
426657|NCT01496274|1045375|P2|STARTED|Overall Study||23
426658|NCT01496274|1045376|P1|STARTED|Overall Study||40
426659|NCT01496248|1045408|P1|NOT COMPLETED|Overall Study||10
426660|NCT01496248|1045408|P1|COMPLETED|Overall Study||25
426661|NCT01496248|1045408|P1|STARTED|Overall Study||35
426662|NCT01496183|1045421|P2|NOT COMPLETED|Overall Study||2
426663|NCT01496183|1045422|P1|NOT COMPLETED|Overall Study||3
426664|NCT01496183|1045421|P2|COMPLETED|Overall Study||13
426665|NCT01496183|1045422|P1|COMPLETED|Overall Study||6
426666|NCT01496183|1045421|P2|STARTED|Overall Study||15
426667|NCT01496183|1045422|P1|STARTED|Overall Study||9
426668|NCT01496131|1045450|P2|NOT COMPLETED|Overall Study||0
426669|NCT01496131|1045451|P1|NOT COMPLETED|Overall Study||0
426670|NCT01496131|1045450|P2|COMPLETED|Overall Study||14
426671|NCT01496131|1045451|P1|COMPLETED|Overall Study||14
426672|NCT01496131|1045450|P2|STARTED|Overall Study||14
426673|NCT01496131|1045451|P1|STARTED|Overall Study||14
426680|NCT01495988|1045489|P4|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
426681|NCT01495988|1045490|P3|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
426682|NCT01495988|1045491|P2|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
426683|NCT01495988|1045492|P1|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
426684|NCT01495988|1045489|P4|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
426685|NCT01495988|1045490|P3|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
426686|NCT01495988|1045491|P2|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||2
426687|NCT01495988|1045492|P1|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
426688|NCT01495988|1045489|P4|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
426689|NCT01495988|1045490|P3|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
426690|NCT01495988|1045491|P2|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||2
426691|NCT01495988|1045492|P1|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
426692|NCT01495988|1045489|P4|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
426693|NCT01495988|1045490|P3|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
426694|NCT01495988|1045491|P2|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
426695|NCT01495988|1045492|P1|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
426696|NCT01495988|1045489|P4|COMPLETED|Vem +/- Bev (Protocol v2.0)||3
426697|NCT01495988|1045490|P3|COMPLETED|Vem +/- Bev (Protocol v2.0)||5
426698|NCT01495988|1045491|P2|COMPLETED|Vem +/- Bev (Protocol v2.0)||0
426699|NCT01495988|1045492|P1|COMPLETED|Vem +/- Bev (Protocol v2.0)||0
426700|NCT01495988|1045489|P4|STARTED|Vem +/- Bev (Protocol v2.0)||3
426701|NCT01495988|1045490|P3|STARTED|Vem +/- Bev (Protocol v2.0)||5
426702|NCT01495988|1045491|P2|STARTED|Vem +/- Bev (Protocol v2.0)||0
426703|NCT01495988|1045492|P1|STARTED|Vem +/- Bev (Protocol v2.0)||0
426704|NCT01495975|1045528|P2|NOT COMPLETED|Overall Study||0
426705|NCT01495975|1045529|P1|NOT COMPLETED|Overall Study||1
426706|NCT01495975|1045528|P2|COMPLETED|Overall Study||14
426707|NCT01495975|1045529|P1|COMPLETED|Overall Study||14
426708|NCT01495975|1045528|P2|STARTED|Overall Study||14
426709|NCT01495975|1045529|P1|STARTED|Overall Study||15
426710|NCT01495923|1045537|P2|NOT COMPLETED|Overall Study||0
426711|NCT01495923|1045538|P1|NOT COMPLETED|Overall Study||0
426712|NCT01495923|1045537|P2|COMPLETED|Overall Study||72
426713|NCT01495923|1045538|P1|COMPLETED|Overall Study||73
426714|NCT01495923|1045537|P2|STARTED|Overall Study||72
426715|NCT01495923|1045538|P1|STARTED|Overall Study||73
426716|NCT01495858|1045571|P3|NOT COMPLETED|Overall Study||0
426717|NCT01495858|1045572|P2|NOT COMPLETED|Overall Study||0
426718|NCT01495858|1045573|P1|NOT COMPLETED|Overall Study||0
426719|NCT01495858|1045571|P3|COMPLETED|Overall Study||54
426720|NCT01495858|1045572|P2|COMPLETED|Overall Study||106
426721|NCT01495858|1045573|P1|COMPLETED|Overall Study||107
426722|NCT01495858|1045571|P3|STARTED|Overall Study||54
426723|NCT01495858|1045572|P2|STARTED|Overall Study||106
426724|NCT01495858|1045573|P1|STARTED|Overall Study||107
426725|NCT01495793|1045653|P1|NOT COMPLETED|Overall Study||2
426726|NCT01495793|1045653|P1|COMPLETED|Overall Study||22
426727|NCT01495793|1045653|P1|STARTED|Overall Study||24
426728|NCT01495702|1045666|P2|NOT COMPLETED|Extension Phase||0
426729|NCT01495702|1045667|P1|NOT COMPLETED|Extension Phase||0
426730|NCT01495702|1045666|P2|COMPLETED|Extension Phase||2
426731|NCT01495702|1045667|P1|COMPLETED|Extension Phase||26
426732|NCT01495702|1045666|P2|STARTED|Extension Phase||2
426733|NCT01495702|1045667|P1|STARTED|Extension Phase||26
426734|NCT01495702|1045666|P2|NOT COMPLETED|Randomized Phase||28
426735|NCT01495702|1045667|P1|NOT COMPLETED|Randomized Phase||26
426736|NCT01495702|1045666|P2|COMPLETED|Randomized Phase||119
426737|NCT01495702|1045667|P1|COMPLETED|Randomized Phase||266
426738|NCT01495702|1045666|P2|STARTED|Randomized Phase||147
426739|NCT01495702|1045667|P1|STARTED|Randomized Phase||292
426740|NCT01495689|1045682|P2|NOT COMPLETED|Overall Study||7
426741|NCT01495689|1045683|P1|NOT COMPLETED|Overall Study||10
426742|NCT01495689|1045682|P2|COMPLETED|Overall Study||16
426743|NCT01495689|1045683|P1|COMPLETED|Overall Study||16
426744|NCT01495689|1045682|P2|STARTED|Overall Study||23
426745|NCT01495689|1045683|P1|STARTED|Overall Study||26
426746|NCT01495585|1045692|P3|NOT COMPLETED|Overall Study||0
426747|NCT01495585|1045693|P2|NOT COMPLETED|Overall Study||0
426748|NCT01495585|1045694|P1|NOT COMPLETED|Overall Study||0
426749|NCT01495585|1045692|P3|COMPLETED|Overall Study||4
426750|NCT01495585|1045693|P2|COMPLETED|Overall Study||6
426751|NCT01495585|1045694|P1|COMPLETED|Overall Study||4
426752|NCT01495585|1045692|P3|Open Label Lonafarnib 200 mg|Overall Study||0
426753|NCT01495585|1045693|P2|Open Label Lonafarnib 200 mg|Overall Study||0
426754|NCT01495585|1045694|P1|Open Label Lonafarnib 200 mg|Overall Study||2
426755|NCT01495585|1045692|P3|STARTED|Overall Study||4
426756|NCT01495585|1045693|P2|STARTED|Overall Study||6
426757|NCT01495585|1045694|P1|STARTED|Overall Study||4
426758|NCT01495572|1045707|P2|NOT COMPLETED|Overall Study||0
426759|NCT01495572|1045708|P1|NOT COMPLETED|Overall Study||0
426760|NCT01495572|1045707|P2|COMPLETED|Overall Study||5
426761|NCT01495572|1045708|P1|COMPLETED|Overall Study||0
426762|NCT01495572|1045707|P2|STARTED|Overall Study||5
426763|NCT01495572|1045708|P1|STARTED|Overall Study||0
426764|NCT01495481|1045716|P1|NOT COMPLETED|Dexmedetomidine||0
426765|NCT01495481|1045716|P1|COMPLETED|Dexmedetomidine||22
426766|NCT01495481|1045716|P1|STARTED|Dexmedetomidine||22
426767|NCT01495481|1045716|P1|NOT COMPLETED|Washout||0
426768|NCT01495481|1045716|P1|COMPLETED|Washout||22
426769|NCT01495481|1045716|P1|STARTED|Washout||22
426770|NCT01495481|1045716|P1|NOT COMPLETED|Adenosine||0
426771|NCT01495481|1045716|P1|COMPLETED|Adenosine||22
426772|NCT01495481|1045716|P1|STARTED|Adenosine|Patients first received adenosine and then dexmedetomidine.|22
426773|NCT01495286|1045728|P1|NOT COMPLETED|Overall Study||0
426774|NCT01495286|1045728|P1|COMPLETED|Overall Study||30
426775|NCT01495286|1045728|P1|STARTED|Overall Study||30
426776|NCT01495000|1045738|P2|NOT COMPLETED|Overall Study||12
426777|NCT01495000|1045739|P1|NOT COMPLETED|Overall Study||13
426778|NCT01495000|1045738|P2|COMPLETED|Overall Study||114
426779|NCT01495000|1045739|P1|COMPLETED|Overall Study||111
426780|NCT01495000|1045738|P2|STARTED|Overall Study||126
426781|NCT01495000|1045739|P1|STARTED|Overall Study||124
426782|NCT01494987|1045781|P2|NOT COMPLETED|Overall Study||28
426783|NCT01494987|1045782|P1|NOT COMPLETED|Overall Study||28
426784|NCT01494987|1045781|P2|COMPLETED|Overall Study||187
426785|NCT01494987|1045782|P1|COMPLETED|Overall Study||188
426786|NCT01494987|1045781|P2|STARTED|Overall Study||215
426787|NCT01494987|1045782|P1|STARTED|Overall Study||216
426788|NCT01494818|1045796|P2|NOT COMPLETED|Overall Study||2
426789|NCT01494818|1045797|P1|NOT COMPLETED|Overall Study||2
426790|NCT01494818|1045796|P2|COMPLETED|Overall Study||37
426791|NCT01494818|1045797|P1|COMPLETED|Overall Study||37
426792|NCT01494818|1045796|P2|STARTED|Overall Study||39
426793|NCT01494818|1045797|P1|STARTED|Overall Study||39
426794|NCT01494753|1045819|P2|NOT COMPLETED|Day42-Day84||0
426795|NCT01494753|1045820|P1|NOT COMPLETED|Day42-Day84||0
426796|NCT01494753|1045819|P2|COMPLETED|Day42-Day84||15
426797|NCT01494753|1045820|P1|COMPLETED|Day42-Day84||15
426798|NCT01494753|1045819|P2|STARTED|Day42-Day84||15
426799|NCT01494753|1045820|P1|STARTED|Day42-Day84||15
426800|NCT01494753|1045819|P2|NOT COMPLETED|Day0-Day42||0
426801|NCT01494753|1045820|P1|NOT COMPLETED|Day0-Day42||0
426802|NCT01494753|1045819|P2|COMPLETED|Day0-Day42||15
426803|NCT01494753|1045820|P1|COMPLETED|Day0-Day42||15
426804|NCT01494753|1045819|P2|STARTED|Day0-Day42||15
426805|NCT01494753|1045820|P1|STARTED|Day0-Day42||15
426806|NCT01494649|1045828|P2|NOT COMPLETED|Overall Study||1
426807|NCT01494649|1045829|P1|NOT COMPLETED|Overall Study||0
426808|NCT01494649|1045828|P2|COMPLETED|Overall Study||58
426809|NCT01494649|1045829|P1|COMPLETED|Overall Study||59
426810|NCT01494649|1045828|P2|STARTED|Overall Study||59
426811|NCT01494649|1045829|P1|STARTED|Overall Study||59
426812|NCT01494610|1045845|P2|NOT COMPLETED|Period 4||0
426813|NCT01494610|1045846|P1|NOT COMPLETED|Period 4||1
426814|NCT01494610|1045845|P2|COMPLETED|Period 4||28
426815|NCT01494610|1045846|P1|COMPLETED|Period 4||27
426816|NCT01494610|1045845|P2|STARTED|Period 4||28
426817|NCT01494610|1045846|P1|STARTED|Period 4||28
426818|NCT01494610|1045845|P2|NOT COMPLETED|Period 3||0
426819|NCT01494610|1045846|P1|NOT COMPLETED|Period 3||2
426820|NCT01494610|1045845|P2|COMPLETED|Period 3||28
426821|NCT01494610|1045846|P1|COMPLETED|Period 3||28
426822|NCT01494610|1045845|P2|STARTED|Period 3||28
426823|NCT01494610|1045846|P1|STARTED|Period 3||30
426824|NCT01494610|1045845|P2|NOT COMPLETED|Period 2||0
426825|NCT01494610|1045846|P1|NOT COMPLETED|Period 2||0
426826|NCT01494610|1045845|P2|COMPLETED|Period 2||28
426827|NCT01494610|1045846|P1|COMPLETED|Period 2||30
426828|NCT01494610|1045845|P2|STARTED|Period 2||28
426829|NCT01494610|1045846|P1|STARTED|Period 2||30
426830|NCT01494610|1045845|P2|NOT COMPLETED|Period 1||1
426831|NCT01494610|1045846|P1|NOT COMPLETED|Period 1||1
426832|NCT01494610|1045845|P2|COMPLETED|Period 1||28
426833|NCT01494610|1045846|P1|COMPLETED|Period 1||30
426834|NCT01494610|1045845|P2|STARTED|Period 1||29
426835|NCT01494610|1045846|P1|STARTED|Period 1||31
426836|NCT01494584|1045914|P1|NOT COMPLETED|Overall Study||1
426837|NCT01494584|1045914|P1|COMPLETED|Overall Study||4
426838|NCT01494584|1045914|P1|STARTED|Overall Study||5
426839|NCT01494545|1046003|P1|NOT COMPLETED|Overall Study||10
426840|NCT01494545|1046003|P1|COMPLETED|Overall Study||92
426841|NCT01494545|1046003|P1|STARTED|Overall Study||102
426842|NCT01494532|1046046|P6|NOT COMPLETED|Overall Study||0
426843|NCT01494532|1046047|P5|NOT COMPLETED|Overall Study||12
426844|NCT01494532|1046048|P4|NOT COMPLETED|Overall Study||15
426845|NCT01494532|1046049|P3|NOT COMPLETED|Overall Study||17
426846|NCT01494532|1046050|P2|NOT COMPLETED|Overall Study||4
426847|NCT01494532|1046051|P1|NOT COMPLETED|Overall Study||10
426848|NCT01494532|1046046|P6|COMPLETED|Overall Study||25
426849|NCT01494532|1046047|P5|COMPLETED|Overall Study||64
426850|NCT01494532|1046048|P4|COMPLETED|Overall Study||60
426851|NCT01494532|1046049|P3|COMPLETED|Overall Study||59
426852|NCT01494532|1046050|P2|COMPLETED|Overall Study||21
426853|NCT01494532|1046051|P1|COMPLETED|Overall Study||65
426854|NCT01494532|1046046|P6|STARTED|Overall Study||25
426855|NCT01494532|1046047|P5|STARTED|Overall Study||76
426856|NCT01494532|1046048|P4|STARTED|Overall Study||75
426857|NCT01494532|1046049|P3|STARTED|Overall Study||76
426858|NCT01494532|1046050|P2|STARTED|Overall Study||25
426859|NCT01494532|1046051|P1|STARTED|Overall Study||75
426860|NCT01494506|1046206|P3|NOT COMPLETED|Overall Study||103
426861|NCT01494506|1046207|P2|NOT COMPLETED|Overall Study||143
426862|NCT01494506|1046208|P1|NOT COMPLETED|Overall Study||148
426863|NCT01494506|1046206|P3|COMPLETED|Overall Study||14
426864|NCT01494506|1046207|P2|COMPLETED|Overall Study||6
426865|NCT01494506|1046208|P1|COMPLETED|Overall Study|Completed = Subjects remaining on treatment at the time of the primary analysis data cut off.|3
426866|NCT01494506|1046206|P3|Treated Population|Overall Study|2 randomized Arm C patients did not receive study drug. 1 patient each in A and B received Arm C.|117
426867|NCT01494506|1046207|P2|Treated Population|Overall Study||134
426868|NCT01494506|1046208|P1|Treated Population|Overall Study|Treated population: Patients who received at least 1 dose of study drug.|147
426869|NCT01494506|1046206|P3|STARTED|Overall Study||117
426870|NCT01494506|1046207|P2|STARTED|Overall Study||149
426871|NCT01494506|1046208|P1|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|151
426872|NCT01494467|1046245|P2|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
426873|NCT01494467|1046246|P1|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
426874|NCT01494467|1046245|P2|COMPLETED|Part C Safety Follow up (4 Weeks)||159
426875|NCT01494467|1046246|P1|COMPLETED|Part C Safety Follow up (4 Weeks)||353
426876|NCT01494467|1046245|P2|STARTED|Part C Safety Follow up (4 Weeks)||159
426877|NCT01494467|1046246|P1|STARTED|Part C Safety Follow up (4 Weeks)||353
426878|NCT01494467|1046245|P2|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||49
426879|NCT01494467|1046246|P1|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||75
426880|NCT01494467|1046245|P2|COMPLETED|Part B Long Term Active Control 40 Weeks||159
426881|NCT01494467|1046246|P1|COMPLETED|Part B Long Term Active Control 40 Weeks||353
426882|NCT01494467|1046245|P2|STARTED|Part B Long Term Active Control 40 Weeks||208
426883|NCT01494467|1046246|P1|STARTED|Part B Long Term Active Control 40 Weeks|429 completed Part A. Subsequently, one subject discontinued so only 428 entered Part B|428
426884|NCT01494467|1046245|P2|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||21
426885|NCT01494467|1046246|P1|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||30
426886|NCT01494467|1046245|P2|COMPLETED|Part A Vehicle Control (12 Weeks)||208
426887|NCT01494467|1046246|P1|COMPLETED|Part A Vehicle Control (12 Weeks)||429
426888|NCT01494467|1046245|P2|STARTED|Part A Vehicle Control (12 Weeks)||229
426889|NCT01494467|1046246|P1|STARTED|Part A Vehicle Control (12 Weeks)||459
426890|NCT01494350|1046262|P1|NOT COMPLETED|Overall Study||1
426891|NCT01494350|1046262|P1|COMPLETED|Overall Study||49
426892|NCT01494350|1046262|P1|STARTED|Overall Study||50
426893|NCT01494298|1046272|P2|NOT COMPLETED|Overall Study||8
426894|NCT01494298|1046273|P1|NOT COMPLETED|Overall Study||2
426895|NCT01494298|1046272|P2|COMPLETED|Overall Study||47
426896|NCT01494298|1046273|P1|COMPLETED|Overall Study||54
426897|NCT01494298|1046272|P2|STARTED|Overall Study||55
426898|NCT01494298|1046273|P1|STARTED|Overall Study||56
426899|NCT01493960|1046285|P2|NOT COMPLETED|Overall Study||18
426900|NCT01493960|1046286|P1|NOT COMPLETED|Overall Study||32
426901|NCT01493960|1046285|P2|COMPLETED|Overall Study||26
426902|NCT01493960|1046286|P1|COMPLETED|Overall Study||55
426903|NCT01493960|1046285|P2|Received Study Drug|Overall Study||43
426904|NCT01493960|1046286|P1|Received Study Drug|Overall Study||87
426905|NCT01493960|1046285|P2|STARTED|Overall Study||44
426906|NCT01493960|1046286|P1|STARTED|Overall Study||87
426907|NCT01493947|1046306|P2|NOT COMPLETED|Period B Extension Period||32
426908|NCT01493947|1046307|P1|NOT COMPLETED|Period B Extension Period||33
426909|NCT01493947|1046306|P2|COMPLETED|Period B Extension Period||326
426910|NCT01493947|1046307|P1|COMPLETED|Period B Extension Period||366
426911|NCT01493947|1046306|P2|STARTED|Period B Extension Period|358 / 456 subjects were eligible to enter in Period B (i.e IGA =0 or 1 at end of Period A).|358
426912|NCT01493947|1046307|P1|STARTED|Period B Extension Period|Only 399 /446 subjects were eligible to enter in Period B (i.e IGA=0 or1 at end of Period A).|399
426913|NCT01493947|1046306|P2|NOT COMPLETED|Period A Efficacy and Safety Data||28
426914|NCT01493947|1046307|P1|NOT COMPLETED|Period A Efficacy and Safety Data||32
426915|NCT01493947|1046306|P2|COMPLETED|Period A Efficacy and Safety Data||456
426916|NCT01493947|1046307|P1|COMPLETED|Period A Efficacy and Safety Data||446
426917|NCT01493947|1046306|P2|STARTED|Period A Efficacy and Safety Data||484
426918|NCT01493947|1046307|P1|STARTED|Period A Efficacy and Safety Data||478
426919|NCT01493687|1046319|P2|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||1
426920|NCT01493687|1046320|P1|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
426921|NCT01493687|1046319|P2|COMPLETED|Part C Safety Follow up (4 Weeks)||174
426922|NCT01493687|1046320|P1|COMPLETED|Part C Safety Follow up (4 Weeks)||350
426923|NCT01493687|1046319|P2|STARTED|Part C Safety Follow up (4 Weeks)||175
426924|NCT01493687|1046320|P1|STARTED|Part C Safety Follow up (4 Weeks)|351 completed Part B. Then 1 discontinued (subject request) prior to Part C.|350
426925|NCT01493687|1046319|P2|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||35
426926|NCT01493687|1046320|P1|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||61
426927|NCT01493687|1046319|P2|COMPLETED|Part B Long Term Active Control 40 Weeks||175
426928|NCT01493687|1046320|P1|COMPLETED|Part B Long Term Active Control 40 Weeks||351
426929|NCT01493687|1046319|P2|STARTED|Part B Long Term Active Control 40 Weeks||210
426930|NCT01493687|1046320|P1|STARTED|Part B Long Term Active Control 40 Weeks|414 completed Part A. Then 2 discontinued (lack of efficacy, subject request) prior to Part B.|412
426931|NCT01493687|1046319|P2|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||22
426932|NCT01493687|1046320|P1|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||37
426933|NCT01493687|1046319|P2|COMPLETED|Part A Vehicle Control (12 Weeks)||210
426934|NCT01493687|1046320|P1|COMPLETED|Part A Vehicle Control (12 Weeks)||414
426935|NCT01493687|1046319|P2|STARTED|Part A Vehicle Control (12 Weeks)||232
426936|NCT01493687|1046320|P1|STARTED|Part A Vehicle Control (12 Weeks)||451
426937|NCT01493557|1046339|P3|NOT COMPLETED|Adding the Second Strategy||0
426938|NCT01493557|1046340|P2|NOT COMPLETED|Adding the Second Strategy||4
426939|NCT01493557|1046341|P1|NOT COMPLETED|Adding the Second Strategy||2
426940|NCT01493557|1046339|P3|COMPLETED|Adding the Second Strategy||0
426941|NCT01493557|1046340|P2|COMPLETED|Adding the Second Strategy||11
426942|NCT01493557|1046341|P1|COMPLETED|Adding the Second Strategy||12
426943|NCT01493557|1046339|P3|STARTED|Adding the Second Strategy||0
426944|NCT01493557|1046340|P2|STARTED|Adding the Second Strategy||15
426945|NCT01493557|1046341|P1|STARTED|Adding the Second Strategy||14
426946|NCT01493557|1046339|P3|NOT COMPLETED|Randomized to Management Strategies||0
426947|NCT01493557|1046340|P2|NOT COMPLETED|Randomized to Management Strategies||11
426948|NCT01493557|1046341|P1|NOT COMPLETED|Randomized to Management Strategies||15
426949|NCT01493557|1046339|P3|COMPLETED|Randomized to Management Strategies||0
426950|NCT01493557|1046340|P2|COMPLETED|Randomized to Management Strategies||47
426951|NCT01493557|1046341|P1|COMPLETED|Randomized to Management Strategies||44
426952|NCT01493557|1046339|P3|STARTED|Randomized to Management Strategies||0
426953|NCT01493557|1046340|P2|STARTED|Randomized to Management Strategies||58
426954|NCT01493557|1046341|P1|STARTED|Randomized to Management Strategies||59
426955|NCT01493557|1046339|P3|NOT COMPLETED|Not Randomized to Management Strategies||134
426956|NCT01493557|1046340|P2|NOT COMPLETED|Not Randomized to Management Strategies||0
426957|NCT01493557|1046341|P1|NOT COMPLETED|Not Randomized to Management Strategies||0
426958|NCT01493557|1046339|P3|COMPLETED|Not Randomized to Management Strategies||816
426959|NCT01493557|1046340|P2|COMPLETED|Not Randomized to Management Strategies||0
426960|NCT01493557|1046341|P1|COMPLETED|Not Randomized to Management Strategies||0
426961|NCT01493557|1046339|P3|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies|26 patients completed (GIS resolved ) and 4 patients completed (GIS not resolved ) the trial.|48
426962|NCT01493557|1046340|P2|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0
426963|NCT01493557|1046341|P1|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0
426964|NCT01493557|1046339|P3|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies|32 patients completed the trial.|48
426965|NCT01493557|1046340|P2|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0
426966|NCT01493557|1046341|P1|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0
426967|NCT01493557|1046339|P3|Without Experiencing GIS|Not Randomized to Management Strategies|754 patients completed the trial.|854
426968|NCT01493557|1046340|P2|Without Experiencing GIS|Not Randomized to Management Strategies||0
426969|NCT01493557|1046341|P1|Without Experiencing GIS|Not Randomized to Management Strategies||0
426970|NCT01493557|1046339|P3|STARTED|Not Randomized to Management Strategies||950
426971|NCT01493557|1046340|P2|STARTED|Not Randomized to Management Strategies||0
426972|NCT01493557|1046341|P1|STARTED|Not Randomized to Management Strategies||0
426973|NCT01493531|1046369|P3|NOT COMPLETED|Overall Study||48
426974|NCT01493531|1046370|P2|NOT COMPLETED|Overall Study||50
426975|NCT01493531|1046371|P1|NOT COMPLETED|Overall Study||41
426976|NCT01493531|1046369|P3|COMPLETED|Overall Study||158
426977|NCT01493531|1046370|P2|COMPLETED|Overall Study||150
426978|NCT01493531|1046371|P1|COMPLETED|Overall Study||163
426979|NCT01493531|1046369|P3|STARTED|Overall Study||206
426980|NCT01493531|1046370|P2|STARTED|Overall Study||200
426981|NCT01493531|1046371|P1|STARTED|Overall Study||204
426982|NCT01493427|1046385|P1|NOT COMPLETED|Overall Study||20
426983|NCT01493427|1046385|P1|COMPLETED|Overall Study||179
426984|NCT01493427|1046385|P1|STARTED|Overall Study||199
426985|NCT01493284|1046390|P1|NOT COMPLETED|Overall Study||61
426986|NCT01493284|1046390|P1|COMPLETED|Overall Study||161
426987|NCT01493284|1046390|P1|STARTED|Overall Study||222
426988|NCT01493180|1046399|P2|NOT COMPLETED|Overall Study||2
426989|NCT01493180|1046400|P1|NOT COMPLETED|Overall Study||3
426990|NCT01493180|1046399|P2|COMPLETED|Overall Study||49
426991|NCT01493180|1046400|P1|COMPLETED|Overall Study||48
426992|NCT01493180|1046399|P2|STARTED|Overall Study||51
426993|NCT01493180|1046400|P1|STARTED|Overall Study||51
426994|NCT01493167|1046406|P1|NOT COMPLETED|Overall Study||0
426995|NCT01493167|1046406|P1|COMPLETED|Overall Study||97
426996|NCT01493167|1046406|P1|STARTED|Overall Study||97
426997|NCT01493089|1046412|P2|NOT COMPLETED|Overall Study||3
426998|NCT01493089|1046413|P1|NOT COMPLETED|Overall Study||3
426999|NCT01493089|1046412|P2|COMPLETED|Overall Study||114
427000|NCT01493089|1046413|P1|COMPLETED|Overall Study||119
427001|NCT01493089|1046412|P2|STARTED|Overall Study||117
427002|NCT01493089|1046413|P1|STARTED|Overall Study||122
427015|NCT01492439|1046512|P2|NOT COMPLETED|Overall Study||9
427016|NCT01492439|1046513|P1|NOT COMPLETED|Overall Study||4
427017|NCT01492439|1046512|P2|COMPLETED|Overall Study||9
427018|NCT01492439|1046513|P1|COMPLETED|Overall Study||15
427019|NCT01492439|1046512|P2|Post-intervention|Overall Study||13
427020|NCT01492439|1046513|P1|Post-intervention|Overall Study||18
427021|NCT01492439|1046512|P2|STARTED|Overall Study||18
427022|NCT01492439|1046513|P1|STARTED|Overall Study||19
427023|NCT01492426|1046561|P2|NOT COMPLETED|Follow-Up||10
427024|NCT01492426|1046562|P1|NOT COMPLETED|Follow-Up||25
427025|NCT01492426|1046561|P2|COMPLETED|Follow-Up||181
427026|NCT01492426|1046562|P1|COMPLETED|Follow-Up||359
427027|NCT01492426|1046561|P2|STARTED|Follow-Up|This total number includes 160 who completed treatment plus 31 who rejoined for follow-up.|191
427028|NCT01492426|1046562|P1|STARTED|Follow-Up|This total number includes 319 who completed treatment plus 65 who rejoined for follow-up.|384
427029|NCT01492426|1046561|P2|NOT COMPLETED|Treatment||40
427030|NCT01492426|1046562|P1|NOT COMPLETED|Treatment||83
427031|NCT01492426|1046561|P2|COMPLETED|Treatment||160
427032|NCT01492426|1046562|P1|COMPLETED|Treatment||319
427033|NCT01492426|1046561|P2|STARTED|Treatment||200
427034|NCT01492426|1046562|P1|STARTED|Treatment||402
427035|NCT01492400|1046580|P2|NOT COMPLETED|Overall Study||16
427036|NCT01492400|1046581|P1|NOT COMPLETED|Overall Study||16
427037|NCT01492400|1046580|P2|COMPLETED|Overall Study||166
427038|NCT01492400|1046581|P1|COMPLETED|Overall Study||165
427039|NCT01492400|1046580|P2|STARTED|Overall Study||182
427040|NCT01492400|1046581|P1|STARTED|Overall Study||181
427041|NCT01492309|1046593|P2|NOT COMPLETED|Overall Study||0
427042|NCT01492309|1046594|P1|NOT COMPLETED|Overall Study||0
427043|NCT01492309|1046593|P2|COMPLETED|Overall Study||11
427044|NCT01492309|1046594|P1|COMPLETED|Overall Study||11
427045|NCT01492309|1046593|P2|STARTED|Overall Study||11
427046|NCT01492309|1046594|P1|STARTED|Overall Study||11
427047|NCT01492088|1046605|P3|NOT COMPLETED|Overall Study||13
427048|NCT01492088|1046606|P2|NOT COMPLETED|Overall Study||14
427049|NCT01492088|1046607|P1|NOT COMPLETED|Overall Study||3
427050|NCT01492088|1046605|P3|COMPLETED|Overall Study||4
427051|NCT01492088|1046606|P2|COMPLETED|Overall Study||2
427052|NCT01492088|1046607|P1|COMPLETED|Overall Study||0
427053|NCT01492088|1046605|P3|STARTED|Overall Study||17
427054|NCT01492088|1046606|P2|STARTED|Overall Study||16
427055|NCT01492088|1046607|P1|STARTED|Overall Study||3
427056|NCT01491984|1046667|P2|NOT COMPLETED|Overall Study||1
427057|NCT01491984|1046668|P1|NOT COMPLETED|Overall Study||2
427058|NCT01491984|1046667|P2|COMPLETED|Overall Study||44
427059|NCT01491984|1046668|P1|COMPLETED|Overall Study||47
427060|NCT01491984|1046667|P2|STARTED|Overall Study||45
427061|NCT01491984|1046668|P1|STARTED|Overall Study||49
427062|NCT01491958|1046676|P2|NOT COMPLETED|Overall Study||0
427063|NCT01491958|1046677|P1|NOT COMPLETED|Overall Study||0
427064|NCT01491958|1046676|P2|COMPLETED|Overall Study||40
427065|NCT01491958|1046677|P1|COMPLETED|Overall Study||40
427066|NCT01491958|1046676|P2|STARTED|Overall Study||40
427067|NCT01491958|1046677|P1|STARTED|Overall Study||40
427068|NCT01491919|1046688|P3|NOT COMPLETED|Overall Study||1
427069|NCT01491919|1046689|P2|NOT COMPLETED|Overall Study||2
427070|NCT01491919|1046690|P1|NOT COMPLETED|Overall Study||1
427071|NCT01491919|1046688|P3|COMPLETED|Overall Study||2
427072|NCT01491919|1046689|P2|COMPLETED|Overall Study||8
427073|NCT01491919|1046690|P1|COMPLETED|Overall Study||12
427074|NCT01491919|1046688|P3|STARTED|Overall Study||3
427075|NCT01491919|1046689|P2|STARTED|Overall Study||10
427076|NCT01491919|1046690|P1|STARTED|Overall Study||13
427077|NCT01491802|1046736|P2|NOT COMPLETED|Overall Study||2
427078|NCT01491802|1046737|P1|NOT COMPLETED|Overall Study||1
427079|NCT01491802|1046736|P2|COMPLETED|Overall Study||6
427080|NCT01491802|1046737|P1|COMPLETED|Overall Study||8
427081|NCT01491802|1046736|P2|STARTED|Overall Study||8
427082|NCT01491802|1046737|P1|STARTED|Overall Study||9
427083|NCT01491737|1046764|P2|NOT COMPLETED|Overall Study||50
427084|NCT01491737|1046765|P1|NOT COMPLETED|Overall Study||49
427085|NCT01491737|1046764|P2|COMPLETED|Overall Study||79
427086|NCT01491737|1046765|P1|COMPLETED|Overall Study||80
427087|NCT01491737|1046764|P2|STARTED|Overall Study||129
427088|NCT01491737|1046765|P1|STARTED|Overall Study||129
427089|NCT01491672|1046788|P3|NOT COMPLETED|Overall Study||11
427090|NCT01491672|1046789|P2|NOT COMPLETED|Overall Study||60
427091|NCT01491672|1046790|P1|NOT COMPLETED|Overall Study||56
427092|NCT01491672|1046788|P3|COMPLETED|Overall Study||3
427093|NCT01491672|1046789|P2|COMPLETED|Overall Study||2
427094|NCT01491672|1046790|P1|COMPLETED|Overall Study||2
427095|NCT01491672|1046788|P3|Safety Set|Overall Study||14
427096|NCT01491672|1046789|P2|Safety Set|Overall Study||61
427097|NCT01491672|1046790|P1|Safety Set|Overall Study||58
427098|NCT01491672|1046788|P3|STARTED|Overall Study||14
427099|NCT01491672|1046789|P2|STARTED|Overall Study|1 participant died prior to treatment initiation.|62
427100|NCT01491672|1046790|P1|STARTED|Overall Study||58
427101|NCT01491633|1046815|P1|NOT COMPLETED|Overall Study||5
427102|NCT01491633|1046815|P1|COMPLETED|Overall Study||0
427103|NCT01491633|1046815|P1|STARTED|Overall Study||5
427104|NCT01491607|1046827|P1|NOT COMPLETED|Overall Study||10
427105|NCT01491607|1046827|P1|COMPLETED|Overall Study||190
427106|NCT01491607|1046827|P1|STARTED|Overall Study||200
427107|NCT01491490|1046925|P2|NOT COMPLETED|Overall Study||0
427108|NCT01491490|1046926|P1|NOT COMPLETED|Overall Study||0
427109|NCT01491490|1046925|P2|COMPLETED|Overall Study||1
427110|NCT01491490|1046926|P1|COMPLETED|Overall Study||1
427111|NCT01491490|1046925|P2|STARTED|Overall Study||1
427112|NCT01491490|1046926|P1|STARTED|Overall Study||1
427113|NCT01491178|1046932|P1|NOT COMPLETED|Overall Study||2794
427114|NCT01491178|1046932|P1|COMPLETED|Overall Study|Completed is defined as 104 weeks follow-up after enrollment.|3649
427115|NCT01491178|1046932|P1|STARTED|Overall Study|Started are the enrolled subjects who followed registration rule and for who eCRF was collected.|6443
427116|NCT01491113|1046942|P5|NOT COMPLETED|Overall Study||0
427117|NCT01491113|1046943|P4|NOT COMPLETED|Overall Study||0
427118|NCT01491113|1046944|P3|NOT COMPLETED|Overall Study||0
427119|NCT01491113|1046945|P2|NOT COMPLETED|Overall Study||0
427120|NCT01491113|1046946|P1|NOT COMPLETED|Overall Study||0
427121|NCT01491113|1046942|P5|COMPLETED|Overall Study||6
427122|NCT01491113|1046943|P4|COMPLETED|Overall Study||6
427123|NCT01491113|1046944|P3|COMPLETED|Overall Study||6
427124|NCT01491113|1046945|P2|COMPLETED|Overall Study||6
427125|NCT01491113|1046946|P1|COMPLETED|Overall Study||6
427126|NCT01491113|1046942|P5|STARTED|Overall Study||6
427127|NCT01491113|1046943|P4|STARTED|Overall Study||6
427128|NCT01491113|1046944|P3|STARTED|Overall Study||6
427129|NCT01491113|1046945|P2|STARTED|Overall Study||6
427130|NCT01491113|1046946|P1|STARTED|Overall Study||6
427131|NCT01491035|1047041|P8|NOT COMPLETED|Overall Study||0
427132|NCT01491035|1047042|P7|NOT COMPLETED|Overall Study||0
427133|NCT01491035|1047043|P6|NOT COMPLETED|Overall Study||0
427134|NCT01491035|1047044|P5|NOT COMPLETED|Overall Study||1
427135|NCT01491035|1047045|P4|NOT COMPLETED|Overall Study||0
427136|NCT01491035|1047046|P3|NOT COMPLETED|Overall Study||0
427137|NCT01491035|1047047|P2|NOT COMPLETED|Overall Study||0
427138|NCT01491035|1047048|P1|NOT COMPLETED|Overall Study||0
427139|NCT01491035|1047041|P8|COMPLETED|Overall Study||6
427140|NCT01491035|1047042|P7|COMPLETED|Overall Study||6
427141|NCT01491035|1047043|P6|COMPLETED|Overall Study||6
427142|NCT01491035|1047044|P5|COMPLETED|Overall Study||5
427143|NCT01491035|1047045|P4|COMPLETED|Overall Study||6
427144|NCT01491035|1047046|P3|COMPLETED|Overall Study||6
427145|NCT01491035|1047047|P2|COMPLETED|Overall Study||6
427146|NCT01491035|1047048|P1|COMPLETED|Overall Study||6
427147|NCT01491035|1047041|P8|STARTED|Overall Study||6
427148|NCT01491035|1047042|P7|STARTED|Overall Study||6
427149|NCT01491035|1047043|P6|STARTED|Overall Study||6
427150|NCT01491035|1047044|P5|STARTED|Overall Study||6
427151|NCT01491035|1047045|P4|STARTED|Overall Study||6
427152|NCT01491035|1047046|P3|STARTED|Overall Study||6
427153|NCT01491035|1047047|P2|STARTED|Overall Study||6
427154|NCT01491035|1047048|P1|STARTED|Overall Study||6
427155|NCT01491022|1047116|P2|NOT COMPLETED|Intervention 2||0
427156|NCT01491022|1047117|P1|NOT COMPLETED|Intervention 2||1
427157|NCT01491022|1047116|P2|COMPLETED|Intervention 2||11
427158|NCT01491022|1047117|P1|COMPLETED|Intervention 2||8
427159|NCT01491022|1047116|P2|STARTED|Intervention 2||11
427160|NCT01491022|1047117|P1|STARTED|Intervention 2||9
427161|NCT01491022|1047116|P2|NOT COMPLETED|2 Week Washout||0
427162|NCT01491022|1047117|P1|NOT COMPLETED|2 Week Washout||0
427163|NCT01491022|1047116|P2|COMPLETED|2 Week Washout||11
427164|NCT01491022|1047117|P1|COMPLETED|2 Week Washout||9
427165|NCT01491022|1047116|P2|STARTED|2 Week Washout||11
427166|NCT01491022|1047117|P1|STARTED|2 Week Washout||9
427167|NCT01491022|1047116|P2|NOT COMPLETED|Intervention 1||1
427168|NCT01491022|1047117|P1|NOT COMPLETED|Intervention 1||1
427169|NCT01491022|1047116|P2|COMPLETED|Intervention 1||11
427170|NCT01491022|1047117|P1|COMPLETED|Intervention 1||9
427171|NCT01491022|1047116|P2|STARTED|Intervention 1||12
427172|NCT01491022|1047117|P1|STARTED|Intervention 1||10
427173|NCT01490931|1047133|P1|NOT COMPLETED|Overall Study||0
427174|NCT01490931|1047133|P1|COMPLETED|Overall Study||25
427175|NCT01490931|1047133|P1|STARTED|Overall Study||25
427176|NCT01490866|1047149|P1|NOT COMPLETED|Axitinib Maintenance Therapy||49
427177|NCT01490866|1047149|P1|COMPLETED|Axitinib Maintenance Therapy|No protocol defined endpoint to Axitinib maintenance treatment.|0
427178|NCT01490866|1047149|P1|STARTED|Axitinib Maintenance Therapy||49
427179|NCT01490866|1047149|P1|NOT COMPLETED|FOLFOX/Bevacizumab Treatment||21
427180|NCT01490866|1047149|P1|COMPLETED|FOLFOX/Bevacizumab Treatment||49
427181|NCT01490866|1047149|P1|STARTED|FOLFOX/Bevacizumab Treatment||70
427182|NCT01490840|1047160|P2|NOT COMPLETED|Phase 2||6
427183|NCT01490840|1047161|P1|NOT COMPLETED|Phase 2||6
427184|NCT01490840|1047160|P2|COMPLETED|Phase 2||68
427185|NCT01490840|1047161|P1|COMPLETED|Phase 2||75
427186|NCT01490840|1047160|P2|STARTED|Phase 2|4 participants discontinued between phase 1 and phase 2|74
427187|NCT01490840|1047161|P1|STARTED|Phase 2|3 participants discontinued between phase 1 and phase 2|81
427188|NCT01490840|1047160|P2|NOT COMPLETED|Phase 1||6
427189|NCT01490840|1047161|P1|NOT COMPLETED|Phase 1||10
427190|NCT01490840|1047160|P2|COMPLETED|Phase 1||78
427191|NCT01490840|1047161|P1|COMPLETED|Phase 1||84
427192|NCT01490840|1047160|P2|Modified Full Analysis Set|Phase 1||83
427193|NCT01490840|1047161|P1|Modified Full Analysis Set|Phase 1||56
427194|NCT01490840|1047160|P2|STARTED|Phase 1||84
427195|NCT01490840|1047161|P1|STARTED|Phase 1||94
427196|NCT01490697|1047185|P2|NOT COMPLETED|Overall Study||2
427197|NCT01490697|1047186|P1|NOT COMPLETED|Overall Study||1
427198|NCT01490697|1047185|P2|COMPLETED|Overall Study||16
427199|NCT01490697|1047186|P1|COMPLETED|Overall Study||15
427200|NCT01490697|1047185|P2|STARTED|Overall Study||18
427201|NCT01490697|1047186|P1|STARTED|Overall Study||16
427202|NCT01490632|1047199|P20|NOT COMPLETED|Part D: Re-Treatment Period||7
427203|NCT01490632|1047200|P19|NOT COMPLETED|Part D: Re-Treatment Period||7
427204|NCT01490632|1047201|P18|NOT COMPLETED|Part D: Re-Treatment Period||5
427205|NCT01490632|1047202|P17|NOT COMPLETED|Part D: Re-Treatment Period||0
427206|NCT01490632|1047203|P16|NOT COMPLETED|Part D: Re-Treatment Period||0
427207|NCT01490632|1047204|P15|NOT COMPLETED|Part D: Re-Treatment Period||0
427208|NCT01490632|1047205|P14|NOT COMPLETED|Part D: Re-Treatment Period||0
427209|NCT01490632|1047206|P13|NOT COMPLETED|Part D: Re-Treatment Period||0
427210|NCT01490632|1047207|P12|NOT COMPLETED|Part D: Re-Treatment Period||0
427211|NCT01490632|1047208|P11|NOT COMPLETED|Part D: Re-Treatment Period||0
427212|NCT01490632|1047209|P10|NOT COMPLETED|Part D: Re-Treatment Period||0
427213|NCT01490632|1047210|P9|NOT COMPLETED|Part D: Re-Treatment Period||0
427214|NCT01490632|1047211|P8|NOT COMPLETED|Part D: Re-Treatment Period||0
427215|NCT01490632|1047212|P7|NOT COMPLETED|Part D: Re-Treatment Period||0
427216|NCT01490632|1047213|P6|NOT COMPLETED|Part D: Re-Treatment Period||0
427217|NCT01490632|1047214|P5|NOT COMPLETED|Part D: Re-Treatment Period||0
427218|NCT01490632|1047215|P4|NOT COMPLETED|Part D: Re-Treatment Period||0
427219|NCT01490632|1047216|P3|NOT COMPLETED|Part D: Re-Treatment Period||0
427220|NCT01490632|1047217|P2|NOT COMPLETED|Part D: Re-Treatment Period||0
427221|NCT01490632|1047218|P1|NOT COMPLETED|Part D: Re-Treatment Period||0
427222|NCT01490632|1047199|P20|COMPLETED|Part D: Re-Treatment Period||30
427223|NCT01490632|1047200|P19|COMPLETED|Part D: Re-Treatment Period||12
427224|NCT01490632|1047201|P18|COMPLETED|Part D: Re-Treatment Period||8
427225|NCT01490632|1047202|P17|COMPLETED|Part D: Re-Treatment Period||3
427226|NCT01490632|1047203|P16|COMPLETED|Part D: Re-Treatment Period||0
427227|NCT01490632|1047204|P15|COMPLETED|Part D: Re-Treatment Period||0
427228|NCT01490632|1047205|P14|COMPLETED|Part D: Re-Treatment Period||0
427229|NCT01490632|1047206|P13|COMPLETED|Part D: Re-Treatment Period||0
427230|NCT01490632|1047207|P12|COMPLETED|Part D: Re-Treatment Period||0
427231|NCT01490632|1047208|P11|COMPLETED|Part D: Re-Treatment Period||0
427232|NCT01490632|1047209|P10|COMPLETED|Part D: Re-Treatment Period||0
427233|NCT01490632|1047210|P9|COMPLETED|Part D: Re-Treatment Period||0
427234|NCT01490632|1047211|P8|COMPLETED|Part D: Re-Treatment Period||0
427235|NCT01490632|1047212|P7|COMPLETED|Part D: Re-Treatment Period||0
427236|NCT01490632|1047213|P6|COMPLETED|Part D: Re-Treatment Period||0
427237|NCT01490632|1047214|P5|COMPLETED|Part D: Re-Treatment Period||0
427238|NCT01490632|1047215|P4|COMPLETED|Part D: Re-Treatment Period||0
427239|NCT01490632|1047216|P3|COMPLETED|Part D: Re-Treatment Period||0
427240|NCT01490632|1047217|P2|COMPLETED|Part D: Re-Treatment Period||0
427241|NCT01490632|1047218|P1|COMPLETED|Part D: Re-Treatment Period||0
427242|NCT01490632|1047199|P20|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 10 mg.|37
427243|NCT01490632|1047200|P19|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 8 mg.|19
427244|NCT01490632|1047201|P18|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 4 mg.|13
427245|NCT01490632|1047202|P17|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 2 mg.|3
427246|NCT01490632|1047203|P16|STARTED|Part D: Re-Treatment Period|Responders receiving 8 or 10 mg were re-randomized to receive 4 mg.|0
427247|NCT01490632|1047204|P15|STARTED|Part D: Re-Treatment Period|Responders receiving 8 or 10 mg were re-randomized to receive placebo.|0
427248|NCT01490632|1047205|P14|STARTED|Part D: Re-Treatment Period|Responders receiving 2 or 4 mg were re-randomized to receive half of the dose from Part B.|0
427249|NCT01490632|1047206|P13|STARTED|Part D: Re-Treatment Period|Responders receiving 2 or 4 mg were re-randomized to receive placebo.|0
427250|NCT01490632|1047207|P12|STARTED|Part D: Re-Treatment Period||0
427251|NCT01490632|1047208|P11|STARTED|Part D: Re-Treatment Period||0
427252|NCT01490632|1047209|P10|STARTED|Part D: Re-Treatment Period||0
427253|NCT01490632|1047210|P9|STARTED|Part D: Re-Treatment Period||0
427254|NCT01490632|1047211|P8|STARTED|Part D: Re-Treatment Period||0
427255|NCT01490632|1047212|P7|STARTED|Part D: Re-Treatment Period||0
427256|NCT01490632|1047213|P6|STARTED|Part D: Re-Treatment Period||0
427257|NCT01490632|1047214|P5|STARTED|Part D: Re-Treatment Period||0
427258|NCT01490632|1047215|P4|STARTED|Part D: Re-Treatment Period||0
427259|NCT01490632|1047216|P3|STARTED|Part D: Re-Treatment Period||0
427260|NCT01490632|1047217|P2|STARTED|Part D: Re-Treatment Period||0
427261|NCT01490632|1047218|P1|STARTED|Part D: Re-Treatment Period||0
427262|NCT01490632|1047199|P20|NOT COMPLETED|Part C: Washout or Step-Down Period||0
427263|NCT01490632|1047200|P19|NOT COMPLETED|Part C: Washout or Step-Down Period||0
427264|NCT01490632|1047201|P18|NOT COMPLETED|Part C: Washout or Step-Down Period||0
427265|NCT01490632|1047202|P17|NOT COMPLETED|Part C: Washout or Step-Down Period||0
427266|NCT01490632|1047203|P16|NOT COMPLETED|Part C: Washout or Step-Down Period||37
427267|NCT01490632|1047204|P15|NOT COMPLETED|Part C: Washout or Step-Down Period||18
427268|NCT01490632|1047205|P14|NOT COMPLETED|Part C: Washout or Step-Down Period||10
427269|NCT01490632|1047206|P13|NOT COMPLETED|Part C: Washout or Step-Down Period||5
427270|NCT01490632|1047207|P12|NOT COMPLETED|Part C: Washout or Step-Down Period||0
427271|NCT01490632|1047208|P11|NOT COMPLETED|Part C: Washout or Step-Down Period||0
427272|NCT01490632|1047209|P10|NOT COMPLETED|Part C: Washout or Step-Down Period||0
427273|NCT01490632|1047210|P9|NOT COMPLETED|Part C: Washout or Step-Down Period||0
427274|NCT01490632|1047211|P8|NOT COMPLETED|Part C: Washout or Step-Down Period||0
427275|NCT01490632|1047212|P7|NOT COMPLETED|Part C: Washout or Step-Down Period||0
427276|NCT01490632|1047213|P6|NOT COMPLETED|Part C: Washout or Step-Down Period||0
427277|NCT01490632|1047214|P5|NOT COMPLETED|Part C: Washout or Step-Down Period||0
427278|NCT01490632|1047215|P4|NOT COMPLETED|Part C: Washout or Step-Down Period||0
427279|NCT01490632|1047216|P3|NOT COMPLETED|Part C: Washout or Step-Down Period||0
427280|NCT01490632|1047217|P2|NOT COMPLETED|Part C: Washout or Step-Down Period||0
427281|NCT01490632|1047218|P1|NOT COMPLETED|Part C: Washout or Step-Down Period||0
427282|NCT01490632|1047199|P20|COMPLETED|Part C: Washout or Step-Down Period||0
427283|NCT01490632|1047200|P19|COMPLETED|Part C: Washout or Step-Down Period||0
427284|NCT01490632|1047201|P18|COMPLETED|Part C: Washout or Step-Down Period||0
427285|NCT01490632|1047202|P17|COMPLETED|Part C: Washout or Step-Down Period||0
427286|NCT01490632|1047203|P16|COMPLETED|Part C: Washout or Step-Down Period||18
427287|NCT01490632|1047204|P15|COMPLETED|Part C: Washout or Step-Down Period||37
427288|NCT01490632|1047205|P14|COMPLETED|Part C: Washout or Step-Down Period||6
427289|NCT01490632|1047206|P13|COMPLETED|Part C: Washout or Step-Down Period||10
427290|NCT01490632|1047207|P12|COMPLETED|Part C: Washout or Step-Down Period||0
427291|NCT01490632|1047208|P11|COMPLETED|Part C: Washout or Step-Down Period||0
427292|NCT01490632|1047209|P10|COMPLETED|Part C: Washout or Step-Down Period||0
427293|NCT01490632|1047210|P9|COMPLETED|Part C: Washout or Step-Down Period||0
427294|NCT01490632|1047211|P8|COMPLETED|Part C: Washout or Step-Down Period||0
427295|NCT01490632|1047212|P7|COMPLETED|Part C: Washout or Step-Down Period||0
427296|NCT01490632|1047213|P6|COMPLETED|Part C: Washout or Step-Down Period||0
427297|NCT01490632|1047214|P5|COMPLETED|Part C: Washout or Step-Down Period||0
427298|NCT01490632|1047215|P4|COMPLETED|Part C: Washout or Step-Down Period||0
427299|NCT01490632|1047216|P3|COMPLETED|Part C: Washout or Step-Down Period||0
427300|NCT01490632|1047217|P2|COMPLETED|Part C: Washout or Step-Down Period||0
427301|NCT01490632|1047218|P1|COMPLETED|Part C: Washout or Step-Down Period||0
427302|NCT01490632|1047199|P20|STARTED|Part C: Washout or Step-Down Period||0
427303|NCT01490632|1047200|P19|STARTED|Part C: Washout or Step-Down Period||0
427304|NCT01490632|1047201|P18|STARTED|Part C: Washout or Step-Down Period||0
427305|NCT01490632|1047202|P17|STARTED|Part C: Washout or Step-Down Period||0
427306|NCT01490632|1047203|P16|STARTED|Part C: Washout or Step-Down Period|Responders receiving 8 or 10 mg were re-randomized to receive 4 mg.|55
427307|NCT01490632|1047204|P15|STARTED|Part C: Washout or Step-Down Period|Responders receiving 8 or 10 mg were re-randomized to receive placebo.|55
427308|NCT01490632|1047205|P14|STARTED|Part C: Washout or Step-Down Period|Responders receiving 2 or 4 mg were re-randomized to receive half of the dose from Part B.|16
427309|NCT01490632|1047206|P13|STARTED|Part C: Washout or Step-Down Period|Responders receiving 2 or 4 mg were re-randomized to receive placebo.|15
427310|NCT01490632|1047207|P12|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to Placebo remained on Placebo.|0
427311|NCT01490632|1047208|P11|STARTED|Part C: Washout or Step-Down Period|Part A 10 mg non-responders were discontinued from the study.|0
427312|NCT01490632|1047209|P10|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI <50 were re-randomized to 8 mg or 10 mg.|0
427313|NCT01490632|1047210|P9|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥50 to <75 remained on 2 mg or 4 mg.|0
427314|NCT01490632|1047211|P8|STARTED|Part C: Washout or Step-Down Period|Placebo participants in Part A with a PASI <75 were re-randomized to 8 mg or 10 mg.|0
427315|NCT01490632|1047212|P7|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 8 mg or 10 mg with a PASI ≥75 remained on 8 mg or 10 mg.|0
427316|NCT01490632|1047213|P6|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥75 remained on 2 mg or 4 mg.|0
427317|NCT01490632|1047214|P5|STARTED|Part C: Washout or Step-Down Period|One participant completed Part B but discontinued without receiving a Part C treatment assignment.|0
427318|NCT01490632|1047215|P4|STARTED|Part C: Washout or Step-Down Period||0
427319|NCT01490632|1047216|P3|STARTED|Part C: Washout or Step-Down Period||0
427320|NCT01490632|1047217|P2|STARTED|Part C: Washout or Step-Down Period||0
427321|NCT01490632|1047218|P1|STARTED|Part C: Washout or Step-Down Period||0
427322|NCT01490632|1047199|P20|NOT COMPLETED|Part B: Extension or Step-Up Period||0
427323|NCT01490632|1047200|P19|NOT COMPLETED|Part B: Extension or Step-Up Period||0
427324|NCT01490632|1047201|P18|NOT COMPLETED|Part B: Extension or Step-Up Period||0
427325|NCT01490632|1047202|P17|NOT COMPLETED|Part B: Extension or Step-Up Period||0
427326|NCT01490632|1047203|P16|NOT COMPLETED|Part B: Extension or Step-Up Period||0
427327|NCT01490632|1047204|P15|NOT COMPLETED|Part B: Extension or Step-Up Period||0
427328|NCT01490632|1047205|P14|NOT COMPLETED|Part B: Extension or Step-Up Period||0
427329|NCT01490632|1047206|P13|NOT COMPLETED|Part B: Extension or Step-Up Period||0
427330|NCT01490632|1047207|P12|NOT COMPLETED|Part B: Extension or Step-Up Period||8
427331|NCT01490632|1047208|P11|NOT COMPLETED|Part B: Extension or Step-Up Period||21
427332|NCT01490632|1047209|P10|NOT COMPLETED|Part B: Extension or Step-Up Period||25
427333|NCT01490632|1047210|P9|NOT COMPLETED|Part B: Extension or Step-Up Period||10
427334|NCT01490632|1047211|P8|NOT COMPLETED|Part B: Extension or Step-Up Period||6
427335|NCT01490632|1047212|P7|NOT COMPLETED|Part B: Extension or Step-Up Period||13
427336|NCT01490632|1047213|P6|NOT COMPLETED|Part B: Extension or Step-Up Period||4
427337|NCT01490632|1047214|P5|NOT COMPLETED|Part B: Extension or Step-Up Period||0
427338|NCT01490632|1047215|P4|NOT COMPLETED|Part B: Extension or Step-Up Period||0
427339|NCT01490632|1047216|P3|NOT COMPLETED|Part B: Extension or Step-Up Period||0
427340|NCT01490632|1047217|P2|NOT COMPLETED|Part B: Extension or Step-Up Period||0
427341|NCT01490632|1047218|P1|NOT COMPLETED|Part B: Extension or Step-Up Period||0
427342|NCT01490632|1047199|P20|COMPLETED|Part B: Extension or Step-Up Period||0
427343|NCT01490632|1047200|P19|COMPLETED|Part B: Extension or Step-Up Period||0
427344|NCT01490632|1047201|P18|COMPLETED|Part B: Extension or Step-Up Period||0
427345|NCT01490632|1047202|P17|COMPLETED|Part B: Extension or Step-Up Period||0
427346|NCT01490632|1047203|P16|COMPLETED|Part B: Extension or Step-Up Period||0
427347|NCT01490632|1047204|P15|COMPLETED|Part B: Extension or Step-Up Period||0
427348|NCT01490632|1047205|P14|COMPLETED|Part B: Extension or Step-Up Period||0
427349|NCT01490632|1047206|P13|COMPLETED|Part B: Extension or Step-Up Period||0
427350|NCT01490632|1047207|P12|COMPLETED|Part B: Extension or Step-Up Period||0
427351|NCT01490632|1047208|P11|COMPLETED|Part B: Extension or Step-Up Period||22
427352|NCT01490632|1047209|P10|COMPLETED|Part B: Extension or Step-Up Period||25
427353|NCT01490632|1047210|P9|COMPLETED|Part B: Extension or Step-Up Period||6
427354|NCT01490632|1047211|P8|COMPLETED|Part B: Extension or Step-Up Period||13
427355|NCT01490632|1047212|P7|COMPLETED|Part B: Extension or Step-Up Period||51
427356|NCT01490632|1047213|P6|COMPLETED|Part B: Extension or Step-Up Period||25
427357|NCT01490632|1047214|P5|COMPLETED|Part B: Extension or Step-Up Period||0
427358|NCT01490632|1047215|P4|COMPLETED|Part B: Extension or Step-Up Period||0
427359|NCT01490632|1047216|P3|COMPLETED|Part B: Extension or Step-Up Period||0
427360|NCT01490632|1047217|P2|COMPLETED|Part B: Extension or Step-Up Period||0
427361|NCT01490632|1047218|P1|COMPLETED|Part B: Extension or Step-Up Period||0
427362|NCT01490632|1047199|P20|STARTED|Part B: Extension or Step-Up Period||0
427363|NCT01490632|1047200|P19|STARTED|Part B: Extension or Step-Up Period||0
427364|NCT01490632|1047201|P18|STARTED|Part B: Extension or Step-Up Period||0
427365|NCT01490632|1047202|P17|STARTED|Part B: Extension or Step-Up Period||0
427366|NCT01490632|1047203|P16|STARTED|Part B: Extension or Step-Up Period||0
427367|NCT01490632|1047204|P15|STARTED|Part B: Extension or Step-Up Period||0
427368|NCT01490632|1047205|P14|STARTED|Part B: Extension or Step-Up Period||0
427369|NCT01490632|1047206|P13|STARTED|Part B: Extension or Step-Up Period||0
427370|NCT01490632|1047207|P12|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to Placebo remained on Placebo.|8
427371|NCT01490632|1047208|P11|STARTED|Part B: Extension or Step-Up Period|Part A 10 mg non-responders were discontinued from the study.|43
427372|NCT01490632|1047209|P10|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI <50 were re-randomized to 8 mg or 10 mg.|50
427373|NCT01490632|1047210|P9|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥50 to <75 remained on 2 mg or 4 mg.|16
427374|NCT01490632|1047211|P8|STARTED|Part B: Extension or Step-Up Period|Placebo participants in Part A with a PASI <75 were re-randomized to 8 mg or 10 mg.|19
427375|NCT01490632|1047212|P7|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 8 mg or 10 mg with a PASI ≥75 remained on 8 mg or 10 mg.|64
427376|NCT01490632|1047213|P6|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥75 remained on 2 mg or 4 mg.|29
427377|NCT01490632|1047214|P5|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
427378|NCT01490632|1047215|P4|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
427379|NCT01490632|1047216|P3|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
427380|NCT01490632|1047217|P2|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
427381|NCT01490632|1047218|P1|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
427382|NCT01490632|1047199|P20|NOT COMPLETED|Part A: Initial Treatment Period||0
427383|NCT01490632|1047200|P19|NOT COMPLETED|Part A: Initial Treatment Period||0
427384|NCT01490632|1047201|P18|NOT COMPLETED|Part A: Initial Treatment Period||0
427385|NCT01490632|1047202|P17|NOT COMPLETED|Part A: Initial Treatment Period||0
427386|NCT01490632|1047203|P16|NOT COMPLETED|Part A: Initial Treatment Period||0
427387|NCT01490632|1047204|P15|NOT COMPLETED|Part A: Initial Treatment Period||0
427388|NCT01490632|1047205|P14|NOT COMPLETED|Part A: Initial Treatment Period||0
427389|NCT01490632|1047206|P13|NOT COMPLETED|Part A: Initial Treatment Period||0
427390|NCT01490632|1047207|P12|NOT COMPLETED|Part A: Initial Treatment Period||0
427391|NCT01490632|1047208|P11|NOT COMPLETED|Part A: Initial Treatment Period||0
427392|NCT01490632|1047209|P10|NOT COMPLETED|Part A: Initial Treatment Period||0
427393|NCT01490632|1047210|P9|NOT COMPLETED|Part A: Initial Treatment Period||0
427394|NCT01490632|1047211|P8|NOT COMPLETED|Part A: Initial Treatment Period||0
427395|NCT01490632|1047212|P7|NOT COMPLETED|Part A: Initial Treatment Period||0
427396|NCT01490632|1047213|P6|NOT COMPLETED|Part A: Initial Treatment Period||0
427397|NCT01490632|1047214|P5|NOT COMPLETED|Part A: Initial Treatment Period||17
427398|NCT01490632|1047215|P4|NOT COMPLETED|Part A: Initial Treatment Period||9
427399|NCT01490632|1047216|P3|NOT COMPLETED|Part A: Initial Treatment Period||5
427400|NCT01490632|1047217|P2|NOT COMPLETED|Part A: Initial Treatment Period||4
427401|NCT01490632|1047218|P1|NOT COMPLETED|Part A: Initial Treatment Period||7
427402|NCT01490632|1047199|P20|COMPLETED|Part A: Initial Treatment Period||0
427403|NCT01490632|1047200|P19|COMPLETED|Part A: Initial Treatment Period||0
427404|NCT01490632|1047201|P18|COMPLETED|Part A: Initial Treatment Period||0
427405|NCT01490632|1047202|P17|COMPLETED|Part A: Initial Treatment Period||0
427406|NCT01490632|1047203|P16|COMPLETED|Part A: Initial Treatment Period||0
427407|NCT01490632|1047204|P15|COMPLETED|Part A: Initial Treatment Period||0
427408|NCT01490632|1047205|P14|COMPLETED|Part A: Initial Treatment Period||0
427409|NCT01490632|1047206|P13|COMPLETED|Part A: Initial Treatment Period||0
427410|NCT01490632|1047207|P12|COMPLETED|Part A: Initial Treatment Period||0
427411|NCT01490632|1047208|P11|COMPLETED|Part A: Initial Treatment Period||0
427412|NCT01490632|1047209|P10|COMPLETED|Part A: Initial Treatment Period||0
427413|NCT01490632|1047210|P9|COMPLETED|Part A: Initial Treatment Period||0
427414|NCT01490632|1047211|P8|COMPLETED|Part A: Initial Treatment Period||0
427415|NCT01490632|1047212|P7|COMPLETED|Part A: Initial Treatment Period||0
427416|NCT01490632|1047213|P6|COMPLETED|Part A: Initial Treatment Period||0
427417|NCT01490632|1047214|P5|COMPLETED|Part A: Initial Treatment Period|Includes participants who completed Part A, but discontinued per protocol using Part A PASI score.|52
427418|NCT01490632|1047215|P4|COMPLETED|Part A: Initial Treatment Period||55
427419|NCT01490632|1047216|P3|COMPLETED|Part A: Initial Treatment Period||67
427420|NCT01490632|1047217|P2|COMPLETED|Part A: Initial Treatment Period||28
427421|NCT01490632|1047218|P1|COMPLETED|Part A: Initial Treatment Period||27
427422|NCT01490632|1047199|P20|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
427423|NCT01490632|1047200|P19|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
427424|NCT01490632|1047201|P18|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
427425|NCT01490632|1047202|P17|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
427426|NCT01490632|1047203|P16|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
427427|NCT01490632|1047204|P15|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
427428|NCT01490632|1047205|P14|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
427429|NCT01490632|1047206|P13|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
427430|NCT01490632|1047207|P12|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
427431|NCT01490632|1047208|P11|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
427432|NCT01490632|1047209|P10|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
427433|NCT01490632|1047210|P9|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
427434|NCT01490632|1047211|P8|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
427435|NCT01490632|1047212|P7|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
427436|NCT01490632|1047213|P6|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
427437|NCT01490632|1047214|P5|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||69
427438|NCT01490632|1047215|P4|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||64
427439|NCT01490632|1047216|P3|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||72
427440|NCT01490632|1047217|P2|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||32
427441|NCT01490632|1047218|P1|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||34
427442|NCT01490632|1047199|P20|STARTED|Part A: Initial Treatment Period||0
427443|NCT01490632|1047200|P19|STARTED|Part A: Initial Treatment Period||0
427444|NCT01490632|1047201|P18|STARTED|Part A: Initial Treatment Period||0
427445|NCT01490632|1047202|P17|STARTED|Part A: Initial Treatment Period||0
427446|NCT01490632|1047203|P16|STARTED|Part A: Initial Treatment Period||0
427447|NCT01490632|1047204|P15|STARTED|Part A: Initial Treatment Period||0
427448|NCT01490632|1047205|P14|STARTED|Part A: Initial Treatment Period||0
427449|NCT01490632|1047206|P13|STARTED|Part A: Initial Treatment Period||0
427450|NCT01490632|1047207|P12|STARTED|Part A: Initial Treatment Period||0
427451|NCT01490632|1047208|P11|STARTED|Part A: Initial Treatment Period||0
427452|NCT01490632|1047209|P10|STARTED|Part A: Initial Treatment Period||0
427453|NCT01490632|1047210|P9|STARTED|Part A: Initial Treatment Period||0
427454|NCT01490632|1047211|P8|STARTED|Part A: Initial Treatment Period||0
427455|NCT01490632|1047212|P7|STARTED|Part A: Initial Treatment Period||0
427456|NCT01490632|1047213|P6|STARTED|Part A: Initial Treatment Period||0
427457|NCT01490632|1047214|P5|STARTED|Part A: Initial Treatment Period||69
427458|NCT01490632|1047215|P4|STARTED|Part A: Initial Treatment Period||64
427459|NCT01490632|1047216|P3|STARTED|Part A: Initial Treatment Period||72
427460|NCT01490632|1047217|P2|STARTED|Part A: Initial Treatment Period||32
427461|NCT01490632|1047218|P1|STARTED|Part A: Initial Treatment Period||34
427462|NCT01490359|1047348|P2|NOT COMPLETED|Overall Study||17
427463|NCT01490359|1047349|P1|NOT COMPLETED|Overall Study||24
427464|NCT01490359|1047348|P2|COMPLETED|Overall Study||555
427465|NCT01490359|1047349|P1|COMPLETED|Overall Study||585
427466|NCT01490359|1047348|P2|Followed-up at 12 mo|Overall Study||537
427467|NCT01490359|1047349|P1|Followed-up at 12 mo|Overall Study||569
427468|NCT01490359|1047348|P2|Followed-up at 6 mo|Overall Study||535
427469|NCT01490359|1047349|P1|Followed-up at 6 mo|Overall Study||558
427470|NCT01490359|1047348|P2|STARTED|Overall Study||572
427471|NCT01490359|1047349|P1|STARTED|Overall Study||609
427472|NCT01490294|1047373|P4|NOT COMPLETED|Overall Study||1
427473|NCT01490294|1047374|P3|NOT COMPLETED|Overall Study||1
427474|NCT01490294|1047375|P2|NOT COMPLETED|Overall Study||0
427475|NCT01490294|1047376|P1|NOT COMPLETED|Overall Study||5
427476|NCT01490294|1047373|P4|COMPLETED|Overall Study||54
427477|NCT01490294|1047374|P3|COMPLETED|Overall Study||58
427478|NCT01490294|1047375|P2|COMPLETED|Overall Study||60
427479|NCT01490294|1047376|P1|COMPLETED|Overall Study||53
427480|NCT01490294|1047373|P4|Participant Received Treatment|Overall Study||54
427481|NCT01490294|1047374|P3|Participant Received Treatment|Overall Study||58
427482|NCT01490294|1047375|P2|Participant Received Treatment|Overall Study||60
427483|NCT01490294|1047376|P1|Participant Received Treatment|Overall Study||54
427484|NCT01490294|1047373|P4|STARTED|Overall Study||55
427485|NCT01490294|1047374|P3|STARTED|Overall Study||59
427486|NCT01490294|1047375|P2|STARTED|Overall Study||60
427487|NCT01490294|1047376|P1|STARTED|Overall Study||58
427488|NCT01490190|1047610|P1|NOT COMPLETED|Overall Study||48
427489|NCT01490190|1047610|P1|COMPLETED|Overall Study||204
427490|NCT01490190|1047610|P1|STARTED|Overall Study||252
427491|NCT01490151|1047631|P1|NOT COMPLETED|Overall Study||0
427492|NCT01490151|1047631|P1|COMPLETED|Overall Study||22
427493|NCT01490151|1047631|P1|STARTED|Overall Study||22
427494|NCT01490125|1047637|P6|NOT COMPLETED|Period III||0
427495|NCT01490125|1047638|P5|NOT COMPLETED|Period III||1
427496|NCT01490125|1047639|P4|NOT COMPLETED|Period III||2
427497|NCT01490125|1047640|P3|NOT COMPLETED|Period III||0
427498|NCT01490125|1047641|P2|NOT COMPLETED|Period III||1
427499|NCT01490125|1047642|P1|NOT COMPLETED|Period III||3
427500|NCT01490125|1047637|P6|COMPLETED|Period III||35
427501|NCT01490125|1047638|P5|COMPLETED|Period III||31
427502|NCT01490125|1047639|P4|COMPLETED|Period III||28
427503|NCT01490125|1047640|P3|COMPLETED|Period III||34
427504|NCT01490125|1047641|P2|COMPLETED|Period III||32
427505|NCT01490125|1047642|P1|COMPLETED|Period III||31
427506|NCT01490125|1047637|P6|STARTED|Period III||35
427507|NCT01490125|1047638|P5|STARTED|Period III||32
427508|NCT01490125|1047639|P4|STARTED|Period III||30
427509|NCT01490125|1047640|P3|STARTED|Period III||34
427510|NCT01490125|1047641|P2|STARTED|Period III||33
427511|NCT01490125|1047642|P1|STARTED|Period III||34
427512|NCT01490125|1047637|P6|NOT COMPLETED|Period II||2
427513|NCT01490125|1047638|P5|NOT COMPLETED|Period II||4
427514|NCT01490125|1047639|P4|NOT COMPLETED|Period II||3
427515|NCT01490125|1047640|P3|NOT COMPLETED|Period II||3
427516|NCT01490125|1047641|P2|NOT COMPLETED|Period II||4
427517|NCT01490125|1047642|P1|NOT COMPLETED|Period II||3
427518|NCT01490125|1047637|P6|COMPLETED|Period II||35
427519|NCT01490125|1047638|P5|COMPLETED|Period II||32
427520|NCT01490125|1047639|P4|COMPLETED|Period II||30
427521|NCT01490125|1047640|P3|COMPLETED|Period II||34
427522|NCT01490125|1047641|P2|COMPLETED|Period II||33
427523|NCT01490125|1047642|P1|COMPLETED|Period II||34
427524|NCT01490125|1047637|P6|STARTED|Period II||37
427525|NCT01490125|1047638|P5|STARTED|Period II||36
427526|NCT01490125|1047639|P4|STARTED|Period II||33
427527|NCT01490125|1047640|P3|STARTED|Period II||37
427528|NCT01490125|1047641|P2|STARTED|Period II||37
427529|NCT01490125|1047642|P1|STARTED|Period II||37
427530|NCT01490125|1047637|P6|NOT COMPLETED|Period I||5
427531|NCT01490125|1047638|P5|NOT COMPLETED|Period I||4
427532|NCT01490125|1047639|P4|NOT COMPLETED|Period I||5
427533|NCT01490125|1047640|P3|NOT COMPLETED|Period I||4
427534|NCT01490125|1047641|P2|NOT COMPLETED|Period I||5
427535|NCT01490125|1047642|P1|NOT COMPLETED|Period I||6
427536|NCT01490125|1047637|P6|COMPLETED|Period I||37
427537|NCT01490125|1047638|P5|COMPLETED|Period I||36
427538|NCT01490125|1047639|P4|COMPLETED|Period I||33
427539|NCT01490125|1047640|P3|COMPLETED|Period I||37
427540|NCT01490125|1047641|P2|COMPLETED|Period I||37
427541|NCT01490125|1047642|P1|COMPLETED|Period I||37
427542|NCT01490125|1047637|P6|STARTED|Period I||42
427543|NCT01490125|1047638|P5|STARTED|Period I||40
427544|NCT01490125|1047639|P4|STARTED|Period I||38
427545|NCT01490125|1047640|P3|STARTED|Period I||41
427546|NCT01490125|1047641|P2|STARTED|Period I||42
427547|NCT01490125|1047642|P1|STARTED|Period I||43
427548|NCT01490086|1047670|P5|NOT COMPLETED|Overall Study||11
427549|NCT01490086|1047671|P4|NOT COMPLETED|Overall Study||7
427550|NCT01490086|1047672|P3|NOT COMPLETED|Overall Study||7
427551|NCT01490086|1047673|P2|NOT COMPLETED|Overall Study||15
427552|NCT01490086|1047674|P1|NOT COMPLETED|Overall Study||8
427553|NCT01490086|1047670|P5|COMPLETED|Overall Study||28
427554|NCT01490086|1047671|P4|COMPLETED|Overall Study||13
427555|NCT01490086|1047672|P3|COMPLETED|Overall Study||51
427556|NCT01490086|1047673|P2|COMPLETED|Overall Study||44
427557|NCT01490086|1047674|P1|COMPLETED|Overall Study||50
427558|NCT01490086|1047670|P5|STARTED|Overall Study||39
427559|NCT01490086|1047671|P4|STARTED|Overall Study||20
427560|NCT01490086|1047672|P3|STARTED|Overall Study||58
427561|NCT01490086|1047673|P2|STARTED|Overall Study||59
427562|NCT01490086|1047674|P1|STARTED|Overall Study||58
427563|NCT01490060|1047708|P4|NOT COMPLETED|Cycle 2||0
427564|NCT01490060|1047709|P3|NOT COMPLETED|Cycle 2||1
427565|NCT01490060|1047710|P2|NOT COMPLETED|Cycle 2||1
427566|NCT01490060|1047711|P1|NOT COMPLETED|Cycle 2||2
427567|NCT01490060|1047708|P4|COMPLETED|Cycle 2||8
427568|NCT01490060|1047709|P3|COMPLETED|Cycle 2||8
427569|NCT01490060|1047710|P2|COMPLETED|Cycle 2||11
427570|NCT01490060|1047711|P1|COMPLETED|Cycle 2||9
427571|NCT01490060|1047708|P4|STARTED|Cycle 2||8
427572|NCT01490060|1047709|P3|STARTED|Cycle 2||9
427573|NCT01490060|1047710|P2|STARTED|Cycle 2||12
427574|NCT01490060|1047711|P1|STARTED|Cycle 2||11
427575|NCT01490060|1047708|P4|NOT COMPLETED|Cycle 1||3
427576|NCT01490060|1047709|P3|NOT COMPLETED|Cycle 1||3
427577|NCT01490060|1047710|P2|NOT COMPLETED|Cycle 1||1
427578|NCT01490060|1047711|P1|NOT COMPLETED|Cycle 1||0
427579|NCT01490060|1047708|P4|COMPLETED|Cycle 1||8
427580|NCT01490060|1047709|P3|COMPLETED|Cycle 1||9
427581|NCT01490060|1047710|P2|COMPLETED|Cycle 1||12
427582|NCT01490060|1047711|P1|COMPLETED|Cycle 1||11
427583|NCT01490060|1047708|P4|STARTED|Cycle 1||11
427584|NCT01490060|1047709|P3|STARTED|Cycle 1||12
427585|NCT01490060|1047710|P2|STARTED|Cycle 1||13
427586|NCT01490060|1047711|P1|STARTED|Cycle 1||11
427587|NCT01489969|1047722|P3|NOT COMPLETED|Overall Study||1
427588|NCT01489969|1047723|P2|NOT COMPLETED|Overall Study||4
427589|NCT01489969|1047724|P1|NOT COMPLETED|Overall Study||5
427590|NCT01489969|1047722|P3|COMPLETED|Overall Study||44
427591|NCT01489969|1047723|P2|COMPLETED|Overall Study||43
427592|NCT01489969|1047724|P1|COMPLETED|Overall Study||40
427593|NCT01489969|1047722|P3|STARTED|Overall Study||45
427594|NCT01489969|1047723|P2|STARTED|Overall Study||47
427595|NCT01489969|1047724|P1|STARTED|Overall Study||45
427596|NCT01489956|1047740|P3|NOT COMPLETED|Overall Study||1
427597|NCT01489956|1047741|P2|NOT COMPLETED|Overall Study||0
427598|NCT01489956|1047742|P1|NOT COMPLETED|Overall Study||1
427599|NCT01489956|1047740|P3|COMPLETED|Overall Study||5
427600|NCT01489956|1047741|P2|COMPLETED|Overall Study||0
427601|NCT01489956|1047742|P1|COMPLETED|Overall Study||12
427602|NCT01489956|1047740|P3|STARTED|Overall Study|These 6 subjects had Immucothel alone since Montanide was not needed for the 10 participants dosed.|6
427603|NCT01489956|1047741|P2|STARTED|Overall Study|Nine of the 10 participants receiving Immucothel alone had a response, so Montanide was not used.|0
427604|NCT01489956|1047742|P1|STARTED|Overall Study|Ten of the 13 participants were considered evaluable.|13
427605|NCT01489891|1047779|P2|NOT COMPLETED|Overall Study||0
427606|NCT01489891|1047780|P1|NOT COMPLETED|Overall Study||1
427607|NCT01489891|1047779|P2|COMPLETED|Overall Study||60
427608|NCT01489891|1047780|P1|COMPLETED|Overall Study||59
427609|NCT01489891|1047779|P2|STARTED|Overall Study||60
427610|NCT01489891|1047780|P1|STARTED|Overall Study||60
427611|NCT01489826|1047801|P9|NOT COMPLETED|Overall Study||0
427612|NCT01489826|1047802|P8|NOT COMPLETED|Overall Study||0
427613|NCT01489826|1047803|P7|NOT COMPLETED|Overall Study||0
427614|NCT01489826|1047804|P6|NOT COMPLETED|Overall Study||0
427615|NCT01489826|1047805|P5|NOT COMPLETED|Overall Study||0
427616|NCT01489826|1047806|P4|NOT COMPLETED|Overall Study||0
427617|NCT01489826|1047807|P3|NOT COMPLETED|Overall Study||0
427618|NCT01489826|1047808|P2|NOT COMPLETED|Overall Study||0
427619|NCT01489826|1047809|P1|NOT COMPLETED|Overall Study||0
427620|NCT01489826|1047801|P9|COMPLETED|Overall Study||6
427621|NCT01489826|1047802|P8|COMPLETED|Overall Study||3
427622|NCT01489826|1047803|P7|COMPLETED|Overall Study||9
427623|NCT01489826|1047804|P6|COMPLETED|Overall Study||3
427624|NCT01489826|1047805|P5|COMPLETED|Overall Study||3
427625|NCT01489826|1047806|P4|COMPLETED|Overall Study||7
427626|NCT01489826|1047807|P3|COMPLETED|Overall Study||3
427627|NCT01489826|1047808|P2|COMPLETED|Overall Study||3
427628|NCT01489826|1047809|P1|COMPLETED|Overall Study||3
427629|NCT01489826|1047801|P9|STARTED|Overall Study||6
427630|NCT01489826|1047802|P8|STARTED|Overall Study||3
427631|NCT01489826|1047803|P7|STARTED|Overall Study||9
427632|NCT01489826|1047804|P6|STARTED|Overall Study||3
427633|NCT01489826|1047805|P5|STARTED|Overall Study||3
427634|NCT01489826|1047806|P4|STARTED|Overall Study||7
427635|NCT01489826|1047807|P3|STARTED|Overall Study||3
427636|NCT01489826|1047808|P2|STARTED|Overall Study||3
427637|NCT01489826|1047809|P1|STARTED|Overall Study||3
427638|NCT01489670|1047906|P1|NOT COMPLETED|Overall Study||53
427639|NCT01489670|1047906|P1|COMPLETED|Overall Study||334
427640|NCT01489670|1047906|P1|STARTED|Overall Study||387
427641|NCT01489527|1047918|P2|NOT COMPLETED|Overall Study||26
427642|NCT01489527|1047919|P1|NOT COMPLETED|Overall Study||22
427643|NCT01489527|1047918|P2|COMPLETED|Overall Study||175
427644|NCT01489527|1047919|P1|COMPLETED|Overall Study||183
427645|NCT01489527|1047918|P2|STARTED|Overall Study||201
427646|NCT01489527|1047919|P1|STARTED|Overall Study||205
427647|NCT01489358|1047936|P3|NOT COMPLETED|Overall Study||2
427648|NCT01489358|1047937|P2|NOT COMPLETED|Overall Study||0
427649|NCT01489358|1047938|P1|NOT COMPLETED|Overall Study||0
427650|NCT01489358|1047936|P3|COMPLETED|Overall Study||8
427651|NCT01489358|1047937|P2|COMPLETED|Overall Study||10
427652|NCT01489358|1047938|P1|COMPLETED|Overall Study||5
427653|NCT01489358|1047936|P3|STARTED|Overall Study||10
427654|NCT01489358|1047937|P2|STARTED|Overall Study||10
427655|NCT01489358|1047938|P1|STARTED|Overall Study||5
427656|NCT01489254|1047988|P4|NOT COMPLETED|Open-label Extension Part||58
427657|NCT01489254|1047989|P3|NOT COMPLETED|Open-label Extension Part||0
427658|NCT01489254|1047990|P2|NOT COMPLETED|Open-label Extension Part||0
427659|NCT01489254|1047991|P1|NOT COMPLETED|Open-label Extension Part||0
427660|NCT01489254|1047988|P4|COMPLETED|Open-label Extension Part||670
427661|NCT01489254|1047989|P3|COMPLETED|Open-label Extension Part||0
427662|NCT01489254|1047990|P2|COMPLETED|Open-label Extension Part||0
427663|NCT01489254|1047991|P1|COMPLETED|Open-label Extension Part||0
427664|NCT01489254|1047988|P4|STARTED|Open-label Extension Part|735 completed the DB part, 729 were eligible to continue in the OL part, 1 opted not to continue|728
427665|NCT01489254|1047989|P3|STARTED|Open-label Extension Part||0
427666|NCT01489254|1047990|P2|STARTED|Open-label Extension Part||0
427667|NCT01489254|1047991|P1|STARTED|Open-label Extension Part||0
427668|NCT01489254|1047988|P4|NOT COMPLETED|Double-blind Part||0
427669|NCT01489254|1047989|P3|NOT COMPLETED|Double-blind Part||3
427670|NCT01489254|1047990|P2|NOT COMPLETED|Double-blind Part||33
427671|NCT01489254|1047991|P1|NOT COMPLETED|Double-blind Part||25
427672|NCT01489254|1047988|P4|COMPLETED|Double-blind Part||0
427673|NCT01489254|1047989|P3|COMPLETED|Double-blind Part||81
427674|NCT01489254|1047990|P2|COMPLETED|Double-blind Part||324
427675|NCT01489254|1047991|P1|COMPLETED|Double-blind Part||330
427676|NCT01489254|1047988|P4|STARTED|Double-blind Part||0
427677|NCT01489254|1047989|P3|STARTED|Double-blind Part||84
427678|NCT01489254|1047990|P2|STARTED|Double-blind Part||357
427679|NCT01489254|1047991|P1|STARTED|Double-blind Part||355
427680|NCT01489189|1048002|P2|NOT COMPLETED|Overall Study||35
427681|NCT01489189|1048003|P1|NOT COMPLETED|Overall Study||31
427682|NCT01489189|1048002|P2|COMPLETED|Overall Study|Number of Eyes|168
427683|NCT01489189|1048003|P1|COMPLETED|Overall Study|Number of Eyes|160
427684|NCT01489189|1048002|P2|STARTED|Overall Study|Number of Eyes|203
427685|NCT01489189|1048003|P1|STARTED|Overall Study|Number of Eyes|191
427686|NCT01488994|1048030|P2|NOT COMPLETED|Overall Study||1
427687|NCT01488994|1048031|P1|NOT COMPLETED|Overall Study||0
427688|NCT01488994|1048030|P2|COMPLETED|Overall Study||11
427689|NCT01488994|1048031|P1|COMPLETED|Overall Study||11
427690|NCT01488994|1048030|P2|STARTED|Overall Study||12
427691|NCT01488994|1048031|P1|STARTED|Overall Study||11
427692|NCT01488877|1048118|P3|NOT COMPLETED|Re-randomization||0
427693|NCT01488877|1048119|P2|NOT COMPLETED|Re-randomization||0
427694|NCT01488877|1048120|P1|NOT COMPLETED|Re-randomization||0
427695|NCT01488877|1048118|P3|COMPLETED|Re-randomization||3
427696|NCT01488877|1048119|P2|COMPLETED|Re-randomization||0
427697|NCT01488877|1048120|P1|COMPLETED|Re-randomization||0
427698|NCT01488877|1048118|P3|STARTED|Re-randomization|Three participants were re-randomized from PF-03882845 3 mg arm.|3
427699|NCT01488877|1048119|P2|STARTED|Re-randomization||0
427700|NCT01488877|1048120|P1|STARTED|Re-randomization||0
427701|NCT01488877|1048118|P3|NOT COMPLETED|Initial Randomization||0
427702|NCT01488877|1048119|P2|NOT COMPLETED|Initial Randomization||0
427703|NCT01488877|1048120|P1|NOT COMPLETED|Initial Randomization||0
427704|NCT01488877|1048118|P3|COMPLETED|Initial Randomization||0
427705|NCT01488877|1048119|P2|COMPLETED|Initial Randomization||5
427706|NCT01488877|1048120|P1|COMPLETED|Initial Randomization||1
427707|NCT01488877|1048118|P3|STARTED|Initial Randomization||0
427708|NCT01488877|1048119|P2|STARTED|Initial Randomization||5
427709|NCT01488877|1048120|P1|STARTED|Initial Randomization||1
427710|NCT01488708|1048137|P2|NOT COMPLETED|Overall Study||578
427711|NCT01488708|1048138|P1|NOT COMPLETED|Overall Study||940
427712|NCT01488708|1048137|P2|COMPLETED|Overall Study||0
427713|NCT01488708|1048138|P1|COMPLETED|Overall Study||0
427714|NCT01488708|1048137|P2|Participated in Follow Up|Overall Study||526
427715|NCT01488708|1048138|P1|Participated in Follow Up|Overall Study||810
427716|NCT01488708|1048137|P2|Received at Least 1 Dose of Study Drug|Overall Study||578
427717|NCT01488708|1048138|P1|Received at Least 1 Dose of Study Drug|Overall Study||937
427718|NCT01488708|1048137|P2|STARTED|Overall Study||578
427719|NCT01488708|1048138|P1|STARTED|Overall Study||940
427720|NCT01488578|1048158|P1|NOT COMPLETED|Overall Study||1836
427721|NCT01488578|1048158|P1|COMPLETED|Overall Study||9321
427722|NCT01488578|1048158|P1|STARTED|Overall Study||11157
427723|NCT01488487|1048192|P1|NOT COMPLETED|Overall Study||9
427724|NCT01488487|1048192|P1|COMPLETED|Overall Study||15
427725|NCT01488487|1048192|P1|Received Treatment|Overall Study||24
427726|NCT01488487|1048192|P1|STARTED|Overall Study||24
427727|NCT01488448|1048201|P2|NOT COMPLETED|Overall Study||17
427728|NCT01488448|1048202|P1|NOT COMPLETED|Overall Study||20
427729|NCT01488448|1048201|P2|COMPLETED|Overall Study||97
427730|NCT01488448|1048202|P1|COMPLETED|Overall Study||93
427731|NCT01488448|1048201|P2|STARTED|Overall Study||114
427732|NCT01488448|1048202|P1|STARTED|Overall Study||113
427733|NCT01488409|1048226|P2|NOT COMPLETED|Overall Study||4
427734|NCT01488409|1048227|P1|NOT COMPLETED|Overall Study||4
427735|NCT01488409|1048226|P2|COMPLETED|Overall Study||15
427736|NCT01488409|1048227|P1|COMPLETED|Overall Study||16
427737|NCT01488409|1048226|P2|STARTED|Overall Study||19
427738|NCT01488409|1048227|P1|STARTED|Overall Study||20
427739|NCT01488370|1048244|P3|NOT COMPLETED|Overall Study||1
427740|NCT01488370|1048245|P2|NOT COMPLETED|Overall Study||1
427741|NCT01488370|1048246|P1|NOT COMPLETED|Overall Study||0
427742|NCT01488370|1048244|P3|COMPLETED|Overall Study||19
427743|NCT01488370|1048245|P2|COMPLETED|Overall Study||22
427744|NCT01488370|1048246|P1|COMPLETED|Overall Study||22
427745|NCT01488370|1048244|P3|STARTED|Overall Study||20
427746|NCT01488370|1048245|P2|STARTED|Overall Study||23
427747|NCT01488370|1048246|P1|STARTED|Overall Study||22
427748|NCT01488318|1048266|P1|NOT COMPLETED|Overall Study||0
427749|NCT01488318|1048266|P1|COMPLETED|Overall Study||14
427750|NCT01488318|1048266|P1|STARTED|Overall Study||14
427751|NCT01488279|1048275|P2|NOT COMPLETED|Overall Study||0
427752|NCT01488279|1048276|P1|NOT COMPLETED|Overall Study||0
427753|NCT01488279|1048275|P2|COMPLETED|Overall Study||5
427754|NCT01488279|1048276|P1|COMPLETED|Overall Study||5
427755|NCT01488279|1048275|P2|STARTED|Overall Study||5
427756|NCT01488279|1048276|P1|STARTED|Overall Study||5
427757|NCT01488188|1048292|P2|NOT COMPLETED|Overall Study||0
427758|NCT01488188|1048293|P1|NOT COMPLETED|Overall Study||0
427759|NCT01488188|1048292|P2|COMPLETED|Overall Study||20
427760|NCT01488188|1048293|P1|COMPLETED|Overall Study||20
427761|NCT01488188|1048292|P2|STARTED|Overall Study||20
427762|NCT01488188|1048293|P1|STARTED|Overall Study||20
427763|NCT01488097|1048305|P1|NOT COMPLETED|Long-term Treatment (Beyond Week 104)||6
427764|NCT01488097|1048305|P1|COMPLETED|Long-term Treatment (Beyond Week 104)|This period is ongoing.|2
427765|NCT01488097|1048305|P1|STARTED|Long-term Treatment (Beyond Week 104)||8
427766|NCT01488097|1048305|P1|NOT COMPLETED|Long-term Treatment (up to Week 104)||0
427767|NCT01488097|1048305|P1|COMPLETED|Long-term Treatment (up to Week 104)||8
427768|NCT01488097|1048305|P1|STARTED|Long-term Treatment (up to Week 104)||8
427769|NCT01488071|1048317|P2|NOT COMPLETED|Overall Study||63
427770|NCT01488071|1048318|P1|NOT COMPLETED|Overall Study||53
427771|NCT01488071|1048317|P2|COMPLETED|Overall Study||179
427772|NCT01488071|1048318|P1|COMPLETED|Overall Study||200
427773|NCT01488071|1048317|P2|STARTED|Overall Study|APTS|242
427774|NCT01488071|1048318|P1|STARTED|Overall Study|all-patients-treated set (APTS)|253
427775|NCT01488019|1048352|P2|NOT COMPLETED|Overall Study||304
427776|NCT01488019|1048353|P1|NOT COMPLETED|Overall Study||247
427777|NCT01488019|1048352|P2|COMPLETED|Overall Study||226
427778|NCT01488019|1048353|P1|COMPLETED|Overall Study||294
427779|NCT01488019|1048352|P2|STARTED|Overall Study||530
427780|NCT01488019|1048353|P1|STARTED|Overall Study||541
427781|NCT01487954|1048387|P2|NOT COMPLETED|Overall Study||0
427782|NCT01487954|1048388|P1|NOT COMPLETED|Overall Study||0
427783|NCT01487954|1048387|P2|COMPLETED|Overall Study||16
427784|NCT01487954|1048388|P1|COMPLETED|Overall Study||29
427785|NCT01487954|1048387|P2|Safety lead-in|Overall Study|Only the first 10 patients in the alkaline group were analyzed, as that was the experimental group.|0
427786|NCT01487954|1048388|P1|Safety lead-in|Overall Study||10
427787|NCT01487954|1048387|P2|STARTED|Overall Study||16
427788|NCT01487954|1048388|P1|STARTED|Overall Study||29
427789|NCT01487863|1048398|P2|NOT COMPLETED|Overall Study||19
427790|NCT01487863|1048399|P1|NOT COMPLETED|Overall Study||19
427791|NCT01487863|1048398|P2|COMPLETED|Overall Study||15
427792|NCT01487863|1048399|P1|COMPLETED|Overall Study||16
427793|NCT01487863|1048398|P2|Rcvd ≥1 Leukapheresis (Safety Analysis)|Overall Study||34
427794|NCT01487863|1048399|P1|Rcvd ≥1 Leukapheresis (Safety Analysis)|Overall Study||35
427795|NCT01487863|1048398|P2|Subjects Randomized (Efficacy Analysis)|Overall Study||34
427796|NCT01487863|1048399|P1|Subjects Randomized (Efficacy Analysis)|Overall Study||35
427797|NCT01487863|1048398|P2|STARTED|Overall Study||34
427798|NCT01487863|1048399|P1|STARTED|Overall Study||35
427799|NCT01487668|1048407|P2|NOT COMPLETED|Overall Study||17
427800|NCT01487668|1048408|P1|NOT COMPLETED|Overall Study||25
427801|NCT01487668|1048407|P2|COMPLETED|Overall Study||124
427802|NCT01487668|1048408|P1|COMPLETED|Overall Study||121
427803|NCT01487668|1048407|P2|STARTED|Overall Study||141
427804|NCT01487668|1048408|P1|STARTED|Overall Study||146
427805|NCT01487577|1048416|P1|NOT COMPLETED|Overall Study||1
427806|NCT01487577|1048416|P1|COMPLETED|Overall Study|One participant became ineligible after signing consent, but before receiving protocol therapy.|18
427807|NCT01487577|1048416|P1|STARTED|Overall Study||19
427808|NCT01487525|1048430|P2|NOT COMPLETED|Overall Study||1
427809|NCT01487525|1048431|P1|NOT COMPLETED|Overall Study||0
427810|NCT01487525|1048430|P2|COMPLETED|Overall Study||19
427811|NCT01487525|1048431|P1|COMPLETED|Overall Study||22
427812|NCT01487525|1048430|P2|STARTED|Overall Study||20
427813|NCT01487525|1048431|P1|STARTED|Overall Study||22
427814|NCT01487499|1048441|P1|NOT COMPLETED|Overall Study||0
427815|NCT01487499|1048441|P1|COMPLETED|Overall Study||4
427816|NCT01487499|1048441|P1|STARTED|Overall Study||4
427817|NCT01487265|1048447|P1|NOT COMPLETED|Overall Study||37
427818|NCT01487265|1048447|P1|COMPLETED|Overall Study||0
427819|NCT01487265|1048447|P1|STARTED|Overall Study||37
427820|NCT01487161|1048459|P4|NOT COMPLETED|Overall Study||2
427821|NCT01487161|1048460|P3|NOT COMPLETED|Overall Study||1
427822|NCT01487161|1048461|P2|NOT COMPLETED|Overall Study||2
427823|NCT01487161|1048462|P1|NOT COMPLETED|Overall Study||2
427824|NCT01487161|1048459|P4|COMPLETED|Overall Study||50
427825|NCT01487161|1048460|P3|COMPLETED|Overall Study||59
427826|NCT01487161|1048461|P2|COMPLETED|Overall Study||57
427827|NCT01487161|1048462|P1|COMPLETED|Overall Study||56
427828|NCT01487161|1048459|P4|STARTED|Overall Study||52
427829|NCT01487161|1048460|P3|STARTED|Overall Study||60
427830|NCT01487161|1048461|P2|STARTED|Overall Study||59
427831|NCT01487161|1048462|P1|STARTED|Overall Study||58
427832|NCT01486966|1048527|P2|NOT COMPLETED|Overall Study||2
427833|NCT01486966|1048528|P1|NOT COMPLETED|Overall Study||0
427834|NCT01486966|1048527|P2|COMPLETED|Overall Study||27
427835|NCT01486966|1048528|P1|COMPLETED|Overall Study||29
427836|NCT01486966|1048527|P2|STARTED|Overall Study||29
427837|NCT01486966|1048528|P1|STARTED|Overall Study||29
427838|NCT01486927|1048552|P1|NOT COMPLETED|Overall Study||13
427839|NCT01486927|1048552|P1|COMPLETED|Overall Study||161
427840|NCT01486927|1048552|P1|STARTED|Overall Study||174
427841|NCT01486758|1048585|P2|NOT COMPLETED|Overall Study||1
427842|NCT01486758|1048586|P1|NOT COMPLETED|Overall Study||0
427843|NCT01486758|1048585|P2|COMPLETED|Overall Study||19
427844|NCT01486758|1048586|P1|COMPLETED|Overall Study||20
427845|NCT01486758|1048585|P2|STARTED|Overall Study||20
427846|NCT01486758|1048586|P1|STARTED|Overall Study||20
427847|NCT01486615|1048610|P4|NOT COMPLETED|Overall Study||2
427848|NCT01486615|1048611|P3|NOT COMPLETED|Overall Study||2
427849|NCT01486615|1048612|P2|NOT COMPLETED|Overall Study||1
427850|NCT01486615|1048613|P1|NOT COMPLETED|Overall Study||0
427851|NCT01486615|1048610|P4|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|18
427852|NCT01486615|1048611|P3|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|18
427853|NCT01486615|1048612|P2|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|19
427854|NCT01486615|1048613|P1|COMPLETED|Overall Study||20
427855|NCT01486615|1048610|P4|STARTED|Overall Study||20
427856|NCT01486615|1048611|P3|STARTED|Overall Study||20
427857|NCT01486615|1048612|P2|STARTED|Overall Study||20
427858|NCT01486615|1048613|P1|STARTED|Overall Study||20
427859|NCT01486446|1048653|P2|NOT COMPLETED|Overall Study||0
427860|NCT01486446|1048654|P1|NOT COMPLETED|Overall Study||1
427861|NCT01486446|1048653|P2|COMPLETED|Overall Study||1
427862|NCT01486446|1048654|P1|COMPLETED|Overall Study||6
427863|NCT01486446|1048653|P2|STARTED|Overall Study||1
427864|NCT01486446|1048654|P1|STARTED|Overall Study||7
427865|NCT01486238|1048676|P2|NOT COMPLETED|Overall Study||6
427866|NCT01486238|1048677|P1|NOT COMPLETED|Overall Study||2
427867|NCT01486238|1048676|P2|COMPLETED|Overall Study||43
427868|NCT01486238|1048677|P1|COMPLETED|Overall Study||21
427869|NCT01486238|1048676|P2|STARTED|Overall Study||49
427870|NCT01486238|1048677|P1|STARTED|Overall Study||23
427871|NCT01486199|1048685|P2|NOT COMPLETED|Study Day at t= 2 Years||0
427872|NCT01486199|1048686|P1|NOT COMPLETED|Study Day at t= 2 Years||0
427873|NCT01486199|1048685|P2|COMPLETED|Study Day at t= 2 Years||0
427874|NCT01486199|1048686|P1|COMPLETED|Study Day at t= 2 Years||9
427875|NCT01486199|1048685|P2|STARTED|Study Day at t= 2 Years||0
427876|NCT01486199|1048686|P1|STARTED|Study Day at t= 2 Years||9
427877|NCT01486199|1048685|P2|NOT COMPLETED|Two Year Period Between Study Days||0
427878|NCT01486199|1048686|P1|NOT COMPLETED|Two Year Period Between Study Days||1
427879|NCT01486199|1048685|P2|COMPLETED|Two Year Period Between Study Days||0
427880|NCT01486199|1048686|P1|COMPLETED|Two Year Period Between Study Days||9
427881|NCT01486199|1048685|P2|STARTED|Two Year Period Between Study Days||0
427882|NCT01486199|1048686|P1|STARTED|Two Year Period Between Study Days||10
427883|NCT01486199|1048685|P2|NOT COMPLETED|Baseline Study Day||1
427884|NCT01486199|1048686|P1|NOT COMPLETED|Baseline Study Day||0
427885|NCT01486199|1048685|P2|COMPLETED|Baseline Study Day||9
427886|NCT01486199|1048686|P1|COMPLETED|Baseline Study Day||10
427887|NCT01486199|1048685|P2|STARTED|Baseline Study Day||10
427888|NCT01486199|1048686|P1|STARTED|Baseline Study Day||10
427889|NCT01486043|1048698|P1|NOT COMPLETED|Overall Study||2
427890|NCT01486043|1048698|P1|COMPLETED|Overall Study|Study terminated due to insufficient recruitment|2
427891|NCT01486043|1048698|P1|STARTED|Overall Study||4
427892|NCT01485991|1048706|P2|NOT COMPLETED|Overall Study||36
427893|NCT01485991|1048707|P1|NOT COMPLETED|Overall Study||32
427894|NCT01485991|1048706|P2|COMPLETED|Overall Study||350
427895|NCT01485991|1048707|P1|COMPLETED|Overall Study||353
427896|NCT01485991|1048706|P2|Treated|Overall Study||384
427897|NCT01485991|1048707|P1|Treated|Overall Study||379
427898|NCT01485991|1048706|P2|STARTED|Overall Study||386
427899|NCT01485991|1048707|P1|STARTED|Overall Study||385
427900|NCT01485887|1048717|P1|NOT COMPLETED|Overall Study||12
427901|NCT01485887|1048717|P1|COMPLETED|Overall Study||38
427902|NCT01485887|1048717|P1|STARTED|Overall Study||50
427903|NCT01485796|1048729|P1|NOT COMPLETED|Overall Trial (Incl. Safety Follow-up)||12
427904|NCT01485796|1048729|P1|COMPLETED|Overall Trial (Incl. Safety Follow-up)|1 subject who completed Epoch 2 + 24 subjects who completed the safety follow-up|25
427905|NCT01485796|1048729|P1|Completed Safety Follow-up|Overall Trial (Incl. Safety Follow-up)||24
427906|NCT01485796|1048729|P1|Switch to Safety Follow-up|Overall Trial (Incl. Safety Follow-up)||26
427907|NCT01485796|1048729|P1|Completed Epoch 2|Overall Trial (Incl. Safety Follow-up)||1
427908|NCT01485796|1048729|P1|Treated in Epoch 2|Overall Trial (Incl. Safety Follow-up)||36
427909|NCT01485796|1048729|P1|Started Epoch 2|Overall Trial (Incl. Safety Follow-up)||36
427910|NCT01485796|1048729|P1|Completed Epoch 1 (Ramp-up)|Overall Trial (Incl. Safety Follow-up)||36
427911|NCT01485796|1048729|P1|Treated in Epoch 1 (Ramp-up)|Overall Trial (Incl. Safety Follow-up)||37
427912|NCT01485796|1048729|P1|STARTED|Overall Trial (Incl. Safety Follow-up)||37
427913|NCT01485796|1048729|P1|NOT COMPLETED|Period 2: Epoch 2||35
427914|NCT01485796|1048729|P1|COMPLETED|Period 2: Epoch 2||1
427915|NCT01485796|1048729|P1|Treated in Epoch 2|Period 2: Epoch 2||36
427916|NCT01485796|1048729|P1|STARTED|Period 2: Epoch 2||36
427917|NCT01485796|1048729|P1|NOT COMPLETED|Period 1: Epoch 1 (Ramp-up)||1
427918|NCT01485796|1048729|P1|COMPLETED|Period 1: Epoch 1 (Ramp-up)||36
427919|NCT01485796|1048729|P1|Treated in Epoch 1|Period 1: Epoch 1 (Ramp-up)||37
427920|NCT01485796|1048729|P1|STARTED|Period 1: Epoch 1 (Ramp-up)||37
427921|NCT01485640|1048751|P1|NOT COMPLETED|Overall Study||122
427922|NCT01485640|1048751|P1|COMPLETED|Overall Study||40
427923|NCT01485640|1048751|P1|STARTED|Overall Study||162
427924|NCT01485536|1048756|P1|NOT COMPLETED|Overall Study||4
427925|NCT01485536|1048756|P1|COMPLETED|Overall Study||17
427926|NCT01485536|1048756|P1|STARTED|Overall Study||21
427927|NCT01485380|1048761|P1|NOT COMPLETED|Overall Study||3
427928|NCT01485380|1048761|P1|COMPLETED|Overall Study||17
427929|NCT01485380|1048761|P1|STARTED|Overall Study||20
427930|NCT01485354|1048765|P1|NOT COMPLETED|Overall Study||5
427931|NCT01485354|1048765|P1|COMPLETED|Overall Study||12
427932|NCT01485354|1048765|P1|STARTED|Overall Study||17
427933|NCT01485172|1048779|P6|NOT COMPLETED|Overall Study||4
427934|NCT01485172|1048780|P5|NOT COMPLETED|Overall Study||5
427935|NCT01485172|1048781|P4|NOT COMPLETED|Overall Study||8
427936|NCT01485172|1048782|P3|NOT COMPLETED|Overall Study||7
427937|NCT01485172|1048783|P2|NOT COMPLETED|Overall Study||1
427938|NCT01485172|1048784|P1|NOT COMPLETED|Overall Study||7
427939|NCT01485172|1048779|P6|COMPLETED|Overall Study||9
427940|NCT01485172|1048780|P5|COMPLETED|Overall Study||34
427941|NCT01485172|1048781|P4|COMPLETED|Overall Study||32
427942|NCT01485172|1048782|P3|COMPLETED|Overall Study||34
427943|NCT01485172|1048783|P2|COMPLETED|Overall Study||12
427944|NCT01485172|1048784|P1|COMPLETED|Overall Study||33
427945|NCT01485172|1048779|P6|STARTED|Overall Study||13
427946|NCT01485172|1048780|P5|STARTED|Overall Study||39
427947|NCT01485172|1048781|P4|STARTED|Overall Study||40
427948|NCT01485172|1048782|P3|STARTED|Overall Study||41
427949|NCT01485172|1048783|P2|STARTED|Overall Study||13
427950|NCT01485172|1048784|P1|STARTED|Overall Study||40
427951|NCT01485094|1048861|P3|NOT COMPLETED|Overall Study||1
427952|NCT01485094|1048862|P2|NOT COMPLETED|Overall Study||2
427953|NCT01485094|1048863|P1|NOT COMPLETED|Overall Study||3
427954|NCT01485094|1048861|P3|COMPLETED|Overall Study||18
427955|NCT01485094|1048862|P2|COMPLETED|Overall Study||18
427956|NCT01485094|1048863|P1|COMPLETED|Overall Study||17
427957|NCT01485094|1048861|P3|STARTED|Overall Study||19
427958|NCT01485094|1048862|P2|STARTED|Overall Study||20
427959|NCT01485094|1048863|P1|STARTED|Overall Study||20
427960|NCT01484977|1048904|P1|NOT COMPLETED|Overall Study||27
427961|NCT01484977|1048904|P1|COMPLETED|Overall Study||93
427962|NCT01484977|1048904|P1|STARTED|Overall Study||120
427963|NCT01484951|1048908|P1|NOT COMPLETED|Overall Study||5
427964|NCT01484951|1048908|P1|COMPLETED|Overall Study||69
427965|NCT01484951|1048908|P1|STARTED|Overall Study||74
427966|NCT01484938|1048913|P1|NOT COMPLETED|Overall Study||4
427967|NCT01484938|1048913|P1|COMPLETED|Overall Study||171
427968|NCT01484938|1048913|P1|STARTED|Overall Study||175
427969|NCT01484912|1048920|P2|NOT COMPLETED|Overall Study||1
427970|NCT01484912|1048921|P1|NOT COMPLETED|Overall Study||1
427971|NCT01484912|1048920|P2|COMPLETED|Overall Study||39
427972|NCT01484912|1048921|P1|COMPLETED|Overall Study||38
427973|NCT01484912|1048920|P2|STARTED|Overall Study||40
427974|NCT01484912|1048921|P1|STARTED|Overall Study||39
427975|NCT01484873|1048931|P1|NOT COMPLETED|Overall Study||2
427976|NCT01484873|1048931|P1|COMPLETED|Overall Study||8
427977|NCT01484873|1048931|P1|STARTED|Overall Study||10
427978|NCT01484834|1048943|P4|NOT COMPLETED|Overall Study||4
427979|NCT01484834|1048944|P3|NOT COMPLETED|Overall Study||1
427980|NCT01484834|1048945|P2|NOT COMPLETED|Overall Study||8
427981|NCT01484834|1048946|P1|NOT COMPLETED|Overall Study||5
427982|NCT01484834|1048943|P4|COMPLETED|Overall Study||20
427983|NCT01484834|1048944|P3|COMPLETED|Overall Study||38
427984|NCT01484834|1048945|P2|COMPLETED|Overall Study||54
427985|NCT01484834|1048946|P1|COMPLETED|Overall Study||60
427986|NCT01484834|1048943|P4|STARTED|Overall Study||24
427987|NCT01484834|1048944|P3|STARTED|Overall Study||39
427988|NCT01484834|1048945|P2|STARTED|Overall Study||62
427989|NCT01484834|1048946|P1|STARTED|Overall Study||65
427990|NCT01484652|1048974|P2|NOT COMPLETED|Overall Study||21
427991|NCT01484652|1048975|P1|NOT COMPLETED|Overall Study||15
427992|NCT01484652|1048974|P2|COMPLETED|Overall Study||142
427993|NCT01484652|1048975|P1|COMPLETED|Overall Study||151
427994|NCT01484652|1048974|P2|STARTED|Overall Study||163
427995|NCT01484652|1048975|P1|STARTED|Overall Study||166
427996|NCT01484561|1048983|P2|NOT COMPLETED|Overall Study||6
427997|NCT01484561|1048984|P1|NOT COMPLETED|Overall Study||9
427998|NCT01484561|1048983|P2|COMPLETED|Overall Study||45
427999|NCT01484561|1048984|P1|COMPLETED|Overall Study||88
428000|NCT01484561|1048983|P2|STARTED|Overall Study||51
428001|NCT01484561|1048984|P1|STARTED|Overall Study||97
428002|NCT01484496|1049074|P4|NOT COMPLETED|Period 2||22
428003|NCT01484496|1049075|P3|NOT COMPLETED|Period 2||15
428004|NCT01484496|1049076|P2|NOT COMPLETED|Period 2||0
428005|NCT01484496|1049077|P1|NOT COMPLETED|Period 2||0
428006|NCT01484496|1049074|P4|COMPLETED|Period 2||434
428007|NCT01484496|1049075|P3|COMPLETED|Period 2||191
428008|NCT01484496|1049076|P2|COMPLETED|Period 2||0
428009|NCT01484496|1049077|P1|COMPLETED|Period 2||0
428010|NCT01484496|1049074|P4|STARTED|Period 2||456
428011|NCT01484496|1049075|P3|STARTED|Period 2||206
428012|NCT01484496|1049076|P2|STARTED|Period 2||0
428013|NCT01484496|1049077|P1|STARTED|Period 2||0
428014|NCT01484496|1049074|P4|NOT COMPLETED|Period 1||0
428015|NCT01484496|1049075|P3|NOT COMPLETED|Period 1||0
428016|NCT01484496|1049076|P2|NOT COMPLETED|Period 1||93
428017|NCT01484496|1049077|P1|NOT COMPLETED|Period 1||66
428018|NCT01484496|1049074|P4|COMPLETED|Period 1||0
428019|NCT01484496|1049075|P3|COMPLETED|Period 1||0
428020|NCT01484496|1049076|P2|COMPLETED|Period 1||463
428021|NCT01484496|1049077|P1|COMPLETED|Period 1||214
428022|NCT01484496|1049074|P4|STARTED|Period 1||0
428023|NCT01484496|1049075|P3|STARTED|Period 1||0
428024|NCT01484496|1049076|P2|STARTED|Period 1||556
428025|NCT01484496|1049077|P1|STARTED|Period 1||280
428026|NCT01484314|1049089|P1|NOT COMPLETED|Overall Study||0
428027|NCT01484314|1049089|P1|COMPLETED|Overall Study||1
428028|NCT01484314|1049089|P1|STARTED|Overall Study||1
428029|NCT01484197|1049095|P4|NOT COMPLETED|Treatment Period 4||0
428030|NCT01484197|1049096|P3|NOT COMPLETED|Treatment Period 4||0
428031|NCT01484197|1049097|P2|NOT COMPLETED|Treatment Period 4||0
428032|NCT01484197|1049098|P1|NOT COMPLETED|Treatment Period 4||0
428033|NCT01484197|1049095|P4|COMPLETED|Treatment Period 4||6
428034|NCT01484197|1049096|P3|COMPLETED|Treatment Period 4||9
428035|NCT01484197|1049097|P2|COMPLETED|Treatment Period 4||8
428036|NCT01484197|1049098|P1|COMPLETED|Treatment Period 4||7
428037|NCT01484197|1049095|P4|STARTED|Treatment Period 4|2 patients completed Period 3 but did not enter Period 4 due to a Protocol deviation and an AE.|6
428038|NCT01484197|1049096|P3|STARTED|Treatment Period 4||9
428039|NCT01484197|1049097|P2|STARTED|Treatment Period 4||8
428040|NCT01484197|1049098|P1|STARTED|Treatment Period 4||7
428041|NCT01484197|1049095|P4|NOT COMPLETED|Treatment Period 3||0
428042|NCT01484197|1049096|P3|NOT COMPLETED|Treatment Period 3||0
428043|NCT01484197|1049097|P2|NOT COMPLETED|Treatment Period 3||0
428044|NCT01484197|1049098|P1|NOT COMPLETED|Treatment Period 3||0
428045|NCT01484197|1049095|P4|COMPLETED|Treatment Period 3||8
428046|NCT01484197|1049096|P3|COMPLETED|Treatment Period 3||9
428047|NCT01484197|1049097|P2|COMPLETED|Treatment Period 3||8
428048|NCT01484197|1049098|P1|COMPLETED|Treatment Period 3||7
428049|NCT01484197|1049095|P4|STARTED|Treatment Period 3||8
428050|NCT01484197|1049096|P3|STARTED|Treatment Period 3||9
428051|NCT01484197|1049097|P2|STARTED|Treatment Period 3||8
428052|NCT01484197|1049098|P1|STARTED|Treatment Period 3||7
428053|NCT01484197|1049095|P4|NOT COMPLETED|Treatment Period 2||1
428054|NCT01484197|1049096|P3|NOT COMPLETED|Treatment Period 2||0
428055|NCT01484197|1049097|P2|NOT COMPLETED|Treatment Period 2||0
428056|NCT01484197|1049098|P1|NOT COMPLETED|Treatment Period 2||0
428057|NCT01484197|1049095|P4|COMPLETED|Treatment Period 2||8
428058|NCT01484197|1049096|P3|COMPLETED|Treatment Period 2||9
428059|NCT01484197|1049097|P2|COMPLETED|Treatment Period 2||8
428060|NCT01484197|1049098|P1|COMPLETED|Treatment Period 2||7
428061|NCT01484197|1049095|P4|STARTED|Treatment Period 2||9
428062|NCT01484197|1049096|P3|STARTED|Treatment Period 2||9
428063|NCT01484197|1049097|P2|STARTED|Treatment Period 2|1 patient completed Period 1 but did not enter Period 2 due to an Adverse event (AE).|8
428064|NCT01484197|1049098|P1|STARTED|Treatment Period 2|1 patient completed Period 1 but did not enter Period 2 due to a Protocol deviation.|7
428065|NCT01484197|1049095|P4|NOT COMPLETED|Treatment Period 1||0
428066|NCT01484197|1049096|P3|NOT COMPLETED|Treatment Period 1||0
428067|NCT01484197|1049097|P2|NOT COMPLETED|Treatment Period 1||0
428068|NCT01484197|1049098|P1|NOT COMPLETED|Treatment Period 1||1
428069|NCT01484197|1049095|P4|COMPLETED|Treatment Period 1||9
428070|NCT01484197|1049096|P3|COMPLETED|Treatment Period 1||9
428071|NCT01484197|1049097|P2|COMPLETED|Treatment Period 1||9
428072|NCT01484197|1049098|P1|COMPLETED|Treatment Period 1||8
428073|NCT01484197|1049095|P4|STARTED|Treatment Period 1||9
428074|NCT01484197|1049096|P3|STARTED|Treatment Period 1||9
428075|NCT01484197|1049097|P2|STARTED|Treatment Period 1||9
428076|NCT01484197|1049098|P1|STARTED|Treatment Period 1||9
428077|NCT01484132|1049181|P1|NOT COMPLETED|Overall Study||22
428078|NCT01484132|1049181|P1|COMPLETED|Overall Study|91 subjects had at least one pre-treatment and at least one post-treatment urine sample.|91
428079|NCT01484132|1049181|P1|Pre-treatment Urine Sample|Overall Study|Urine samples were collected twice pre-treatment. 101 subjects completed at least one urine sample.|101
428080|NCT01484132|1049181|P1|STARTED|Overall Study||113
428081|NCT01484054|1049189|P2|NOT COMPLETED|Period 2||0
428082|NCT01484054|1049190|P1|NOT COMPLETED|Period 2||0
428083|NCT01484054|1049189|P2|COMPLETED|Period 2||49
428084|NCT01484054|1049190|P1|COMPLETED|Period 2||50
428085|NCT01484054|1049189|P2|STARTED|Period 2||49
428086|NCT01484054|1049190|P1|STARTED|Period 2||50
428087|NCT01484054|1049189|P2|NOT COMPLETED|Period 1||1
428088|NCT01484054|1049190|P1|NOT COMPLETED|Period 1||0
428089|NCT01484054|1049189|P2|COMPLETED|Period 1||49
428090|NCT01484054|1049190|P1|COMPLETED|Period 1||50
428091|NCT01484054|1049189|P2|STARTED|Period 1||50
428092|NCT01484054|1049190|P1|STARTED|Period 1||50
428093|NCT01484041|1049200|P1|NOT COMPLETED|Overall Study||0
428094|NCT01484041|1049200|P1|COMPLETED|Overall Study||12
428095|NCT01484041|1049200|P1|STARTED|Overall Study||12
428096|NCT01484028|1049208|P4|NOT COMPLETED|Period 2||0
428097|NCT01484028|1049209|P3|NOT COMPLETED|Period 2||0
428098|NCT01484028|1049210|P2|NOT COMPLETED|Period 2||0
428099|NCT01484028|1049211|P1|NOT COMPLETED|Period 2||0
428100|NCT01484028|1049208|P4|COMPLETED|Period 2||66
428101|NCT01484028|1049209|P3|COMPLETED|Period 2||64
428102|NCT01484028|1049210|P2|COMPLETED|Period 2||67
428103|NCT01484028|1049211|P1|COMPLETED|Period 2||66
428104|NCT01484028|1049208|P4|STARTED|Period 2||66
428105|NCT01484028|1049209|P3|STARTED|Period 2||64
428106|NCT01484028|1049210|P2|STARTED|Period 2||67
428107|NCT01484028|1049211|P1|STARTED|Period 2||66
428108|NCT01484028|1049208|P4|NOT COMPLETED|Period 1||1
428109|NCT01484028|1049209|P3|NOT COMPLETED|Period 1||0
428110|NCT01484028|1049210|P2|NOT COMPLETED|Period 1||3
428111|NCT01484028|1049211|P1|NOT COMPLETED|Period 1||0
428112|NCT01484028|1049208|P4|COMPLETED|Period 1||66
428113|NCT01484028|1049209|P3|COMPLETED|Period 1||64
428114|NCT01484028|1049210|P2|COMPLETED|Period 1||67
428115|NCT01484028|1049211|P1|COMPLETED|Period 1||66
428116|NCT01484028|1049208|P4|STARTED|Period 1||67
428117|NCT01484028|1049209|P3|STARTED|Period 1||64
428118|NCT01484028|1049210|P2|STARTED|Period 1||70
428119|NCT01484028|1049211|P1|STARTED|Period 1||66
428120|NCT01483963|1049226|P5|NOT COMPLETED|Overall Study||0
428121|NCT01483963|1049227|P4|NOT COMPLETED|Overall Study||0
428122|NCT01483963|1049228|P3|NOT COMPLETED|Overall Study||0
428123|NCT01483963|1049229|P2|NOT COMPLETED|Overall Study||0
428124|NCT01483963|1049230|P1|NOT COMPLETED|Overall Study||0
428125|NCT01483963|1049226|P5|COMPLETED|Overall Study||10
428126|NCT01483963|1049227|P4|COMPLETED|Overall Study||10
428127|NCT01483963|1049228|P3|COMPLETED|Overall Study||10
428128|NCT01483963|1049229|P2|COMPLETED|Overall Study||10
428129|NCT01483963|1049230|P1|COMPLETED|Overall Study||10
428130|NCT01483963|1049226|P5|STARTED|Overall Study||10
428131|NCT01483963|1049227|P4|STARTED|Overall Study||10
428132|NCT01483963|1049228|P3|STARTED|Overall Study||10
428133|NCT01483963|1049229|P2|STARTED|Overall Study||10
428134|NCT01483963|1049230|P1|STARTED|Overall Study||10
428135|NCT01483937|1049304|P2|NOT COMPLETED|Overall Study||3
428136|NCT01483937|1049305|P1|NOT COMPLETED|Overall Study||4
428137|NCT01483937|1049304|P2|COMPLETED|Overall Study||14
428138|NCT01483937|1049305|P1|COMPLETED|Overall Study||11
428139|NCT01483937|1049304|P2|STARTED|Overall Study||17
428140|NCT01483937|1049305|P1|STARTED|Overall Study||15
428141|NCT01483924|1049332|P5|NOT COMPLETED|Overall Study||2
428142|NCT01483924|1049333|P4|NOT COMPLETED|Overall Study||4
428143|NCT01483924|1049334|P3|NOT COMPLETED|Overall Study||1
428144|NCT01483924|1049335|P2|NOT COMPLETED|Overall Study||0
428145|NCT01483924|1049336|P1|NOT COMPLETED|Overall Study||2
428146|NCT01483924|1049332|P5|COMPLETED|Overall Study||10
428147|NCT01483924|1049333|P4|COMPLETED|Overall Study||8
428148|NCT01483924|1049334|P3|COMPLETED|Overall Study||11
428149|NCT01483924|1049335|P2|COMPLETED|Overall Study||12
428150|NCT01483924|1049336|P1|COMPLETED|Overall Study||10
428151|NCT01483924|1049332|P5|STARTED|Overall Study||12
428152|NCT01483924|1049333|P4|STARTED|Overall Study||12
428153|NCT01483924|1049334|P3|STARTED|Overall Study||12
428154|NCT01483924|1049335|P2|STARTED|Overall Study||12
428155|NCT01483924|1049336|P1|STARTED|Overall Study||12
428156|NCT01483820|1049384|P1|NOT COMPLETED|Overall Study||8
428157|NCT01483820|1049384|P1|COMPLETED|Overall Study||0
428158|NCT01483820|1049384|P1|STARTED|Overall Study||8
428159|NCT01483651|1049393|P6|NOT COMPLETED|Overall Study||1
428160|NCT01483651|1049394|P5|NOT COMPLETED|Overall Study||0
428161|NCT01483651|1049395|P4|NOT COMPLETED|Overall Study||0
428162|NCT01483651|1049396|P3|NOT COMPLETED|Overall Study||1
428163|NCT01483651|1049397|P2|NOT COMPLETED|Overall Study||1
428164|NCT01483651|1049398|P1|NOT COMPLETED|Overall Study||0
428165|NCT01483651|1049393|P6|COMPLETED|Overall Study||1
428166|NCT01483651|1049394|P5|COMPLETED|Overall Study||2
428167|NCT01483651|1049395|P4|COMPLETED|Overall Study||1
428168|NCT01483651|1049396|P3|COMPLETED|Overall Study||1
428169|NCT01483651|1049397|P2|COMPLETED|Overall Study||2
428170|NCT01483651|1049398|P1|COMPLETED|Overall Study||1
428171|NCT01483651|1049393|P6|STARTED|Overall Study||2
428172|NCT01483651|1049394|P5|STARTED|Overall Study||2
428173|NCT01483651|1049395|P4|STARTED|Overall Study||1
428174|NCT01483651|1049396|P3|STARTED|Overall Study||2
428175|NCT01483651|1049397|P2|STARTED|Overall Study||3
428176|NCT01483651|1049398|P1|STARTED|Overall Study||1
428177|NCT01483625|1049408|P2|NOT COMPLETED|Overall Study||2
428178|NCT01483625|1049409|P1|NOT COMPLETED|Overall Study||4
428179|NCT01483625|1049408|P2|COMPLETED|Overall Study||66
428180|NCT01483625|1049409|P1|COMPLETED|Overall Study||68
428181|NCT01483625|1049408|P2|STARTED|Overall Study||68
428182|NCT01483625|1049409|P1|STARTED|Overall Study||72
428183|NCT01483599|1049432|P14|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||7
428184|NCT01483599|1049433|P13|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||3
428185|NCT01483599|1049434|P12|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||1
428186|NCT01483599|1049435|P11|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||2
428187|NCT01483599|1049436|P10|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||4
428188|NCT01483599|1049437|P9|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||9
428189|NCT01483599|1049438|P8|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||2
428190|NCT01483599|1049439|P7|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
428191|NCT01483599|1049440|P6|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
428358|NCT01482429|1049710|P2|STARTED|Protocol||0
428192|NCT01483599|1049441|P5|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
428193|NCT01483599|1049442|P4|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
428194|NCT01483599|1049443|P3|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
428195|NCT01483599|1049444|P2|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
428196|NCT01483599|1049445|P1|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
428197|NCT01483599|1049432|P14|COMPLETED|After Controlled Period(Week 16-Week 40)||32
428198|NCT01483599|1049433|P13|COMPLETED|After Controlled Period(Week 16-Week 40)||35
428199|NCT01483599|1049434|P12|COMPLETED|After Controlled Period(Week 16-Week 40)||39
428200|NCT01483599|1049435|P11|COMPLETED|After Controlled Period(Week 16-Week 40)||37
428201|NCT01483599|1049436|P10|COMPLETED|After Controlled Period(Week 16-Week 40)||37
428202|NCT01483599|1049437|P9|COMPLETED|After Controlled Period(Week 16-Week 40)||29
428203|NCT01483599|1049438|P8|COMPLETED|After Controlled Period(Week 16-Week 40)||37
428204|NCT01483599|1049439|P7|COMPLETED|After Controlled Period(Week 16-Week 40)||0
428205|NCT01483599|1049440|P6|COMPLETED|After Controlled Period(Week 16-Week 40)||0
428206|NCT01483599|1049441|P5|COMPLETED|After Controlled Period(Week 16-Week 40)||0
428207|NCT01483599|1049442|P4|COMPLETED|After Controlled Period(Week 16-Week 40)||0
428208|NCT01483599|1049443|P3|COMPLETED|After Controlled Period(Week 16-Week 40)||0
428209|NCT01483599|1049444|P2|COMPLETED|After Controlled Period(Week 16-Week 40)||0
428210|NCT01483599|1049445|P1|COMPLETED|After Controlled Period(Week 16-Week 40)||0
428211|NCT01483599|1049432|P14|STARTED|After Controlled Period(Week 16-Week 40)||39
428212|NCT01483599|1049433|P13|STARTED|After Controlled Period(Week 16-Week 40)||38
428213|NCT01483599|1049434|P12|STARTED|After Controlled Period(Week 16-Week 40)||40
428214|NCT01483599|1049435|P11|STARTED|After Controlled Period(Week 16-Week 40)||39
428215|NCT01483599|1049436|P10|STARTED|After Controlled Period(Week 16-Week 40)||41
428216|NCT01483599|1049437|P9|STARTED|After Controlled Period(Week 16-Week 40)||38
428217|NCT01483599|1049438|P8|STARTED|After Controlled Period(Week 16-Week 40)||39
428218|NCT01483599|1049439|P7|STARTED|After Controlled Period(Week 16-Week 40)||0
428219|NCT01483599|1049440|P6|STARTED|After Controlled Period(Week 16-Week 40)||0
428220|NCT01483599|1049441|P5|STARTED|After Controlled Period(Week 16-Week 40)||0
428221|NCT01483599|1049442|P4|STARTED|After Controlled Period(Week 16-Week 40)||0
428222|NCT01483599|1049443|P3|STARTED|After Controlled Period(Week 16-Week 40)||0
428223|NCT01483599|1049444|P2|STARTED|After Controlled Period(Week 16-Week 40)||0
428224|NCT01483599|1049445|P1|STARTED|After Controlled Period(Week 16-Week 40)||0
428225|NCT01483599|1049432|P14|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
428226|NCT01483599|1049433|P13|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
428227|NCT01483599|1049434|P12|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
428228|NCT01483599|1049435|P11|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
428229|NCT01483599|1049436|P10|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
428230|NCT01483599|1049437|P9|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
428231|NCT01483599|1049438|P8|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
428232|NCT01483599|1049439|P7|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||4
428233|NCT01483599|1049440|P6|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||4
428234|NCT01483599|1049441|P5|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||2
428235|NCT01483599|1049442|P4|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
428236|NCT01483599|1049443|P3|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
428237|NCT01483599|1049444|P2|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
428238|NCT01483599|1049445|P1|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
428239|NCT01483599|1049432|P14|COMPLETED|Controlled Period (CP) (up to Week 16)||0
428240|NCT01483599|1049433|P13|COMPLETED|Controlled Period (CP) (up to Week 16)||0
428241|NCT01483599|1049434|P12|COMPLETED|Controlled Period (CP) (up to Week 16)||0
428242|NCT01483599|1049435|P11|COMPLETED|Controlled Period (CP) (up to Week 16)||0
428243|NCT01483599|1049436|P10|COMPLETED|Controlled Period (CP) (up to Week 16)||0
428244|NCT01483599|1049437|P9|COMPLETED|Controlled Period (CP) (up to Week 16)||0
428245|NCT01483599|1049438|P8|COMPLETED|Controlled Period (CP) (up to Week 16)||0
428246|NCT01483599|1049439|P7|COMPLETED|Controlled Period (CP) (up to Week 16)||39
428247|NCT01483599|1049440|P6|COMPLETED|Controlled Period (CP) (up to Week 16)||38
428248|NCT01483599|1049441|P5|COMPLETED|Controlled Period (CP) (up to Week 16)||40
428249|NCT01483599|1049442|P4|COMPLETED|Controlled Period (CP) (up to Week 16)||39
428250|NCT01483599|1049443|P3|COMPLETED|Controlled Period (CP) (up to Week 16)||41
428251|NCT01483599|1049444|P2|COMPLETED|Controlled Period (CP) (up to Week 16)||38
428252|NCT01483599|1049445|P1|COMPLETED|Controlled Period (CP) (up to Week 16)||39
428253|NCT01483599|1049432|P14|Treated|Controlled Period (CP) (up to Week 16)||0
428254|NCT01483599|1049433|P13|Treated|Controlled Period (CP) (up to Week 16)||0
428255|NCT01483599|1049434|P12|Treated|Controlled Period (CP) (up to Week 16)||0
428256|NCT01483599|1049435|P11|Treated|Controlled Period (CP) (up to Week 16)||0
428257|NCT01483599|1049436|P10|Treated|Controlled Period (CP) (up to Week 16)||0
428258|NCT01483599|1049437|P9|Treated|Controlled Period (CP) (up to Week 16)||0
428259|NCT01483599|1049438|P8|Treated|Controlled Period (CP) (up to Week 16)||0
428260|NCT01483599|1049439|P7|Treated|Controlled Period (CP) (up to Week 16)||43
428261|NCT01483599|1049440|P6|Treated|Controlled Period (CP) (up to Week 16)||41
428262|NCT01483599|1049441|P5|Treated|Controlled Period (CP) (up to Week 16)||42
428263|NCT01483599|1049442|P4|Treated|Controlled Period (CP) (up to Week 16)||42
428264|NCT01483599|1049443|P3|Treated|Controlled Period (CP) (up to Week 16)||41
428265|NCT01483599|1049444|P2|Treated|Controlled Period (CP) (up to Week 16)||41
428266|NCT01483599|1049445|P1|Treated|Controlled Period (CP) (up to Week 16)||42
428267|NCT01483599|1049432|P14|STARTED|Controlled Period (CP) (up to Week 16)||0
428268|NCT01483599|1049433|P13|STARTED|Controlled Period (CP) (up to Week 16)||0
428269|NCT01483599|1049434|P12|STARTED|Controlled Period (CP) (up to Week 16)||0
428270|NCT01483599|1049435|P11|STARTED|Controlled Period (CP) (up to Week 16)||0
428271|NCT01483599|1049436|P10|STARTED|Controlled Period (CP) (up to Week 16)||0
428272|NCT01483599|1049437|P9|STARTED|Controlled Period (CP) (up to Week 16)||0
428273|NCT01483599|1049438|P8|STARTED|Controlled Period (CP) (up to Week 16)||0
428274|NCT01483599|1049439|P7|STARTED|Controlled Period (CP) (up to Week 16)||43
428275|NCT01483599|1049440|P6|STARTED|Controlled Period (CP) (up to Week 16)||42
428276|NCT01483599|1049441|P5|STARTED|Controlled Period (CP) (up to Week 16)||42
428277|NCT01483599|1049442|P4|STARTED|Controlled Period (CP) (up to Week 16)||42
428278|NCT01483599|1049443|P3|STARTED|Controlled Period (CP) (up to Week 16)||41
428279|NCT01483599|1049444|P2|STARTED|Controlled Period (CP) (up to Week 16)||41
428280|NCT01483599|1049445|P1|STARTED|Controlled Period (CP) (up to Week 16)||42
428281|NCT01483378|1049494|P2|NOT COMPLETED|Overall Study||0
428282|NCT01483378|1049495|P1|NOT COMPLETED|Overall Study||0
428283|NCT01483378|1049494|P2|COMPLETED|Overall Study||66
428284|NCT01483378|1049495|P1|COMPLETED|Overall Study||100
428285|NCT01483378|1049494|P2|STARTED|Overall Study||66
428286|NCT01483378|1049495|P1|STARTED|Overall Study||100
428287|NCT01483352|1049501|P1|NOT COMPLETED|Overall Study||0
428288|NCT01483352|1049501|P1|COMPLETED|Overall Study||12
428289|NCT01483352|1049501|P1|STARTED|Overall Study||12
428290|NCT01483209|1049520|P1|NOT COMPLETED|Overall Study||1
428291|NCT01483209|1049520|P1|COMPLETED|Overall Study||1
428292|NCT01483209|1049520|P1|STARTED|Overall Study||2
428293|NCT01483183|1049535|P10|NOT COMPLETED|Overall Study||1
428294|NCT01483183|1049536|P9|NOT COMPLETED|Overall Study||0
428295|NCT01483183|1049537|P8|NOT COMPLETED|Overall Study||0
428296|NCT01483183|1049538|P7|NOT COMPLETED|Overall Study||2
428297|NCT01483183|1049539|P6|NOT COMPLETED|Overall Study||0
428298|NCT01483183|1049540|P5|NOT COMPLETED|Overall Study||0
428299|NCT01483183|1049541|P4|NOT COMPLETED|Overall Study||0
428300|NCT01483183|1049542|P3|NOT COMPLETED|Overall Study||0
428301|NCT01483183|1049543|P2|NOT COMPLETED|Overall Study||0
428302|NCT01483183|1049544|P1|NOT COMPLETED|Overall Study||0
428303|NCT01483183|1049535|P10|COMPLETED|Overall Study||4
428304|NCT01483183|1049536|P9|COMPLETED|Overall Study||4
428305|NCT01483183|1049537|P8|COMPLETED|Overall Study||4
428306|NCT01483183|1049538|P7|COMPLETED|Overall Study||4
428307|NCT01483183|1049539|P6|COMPLETED|Overall Study||4
428308|NCT01483183|1049540|P5|COMPLETED|Overall Study||4
428309|NCT01483183|1049541|P4|COMPLETED|Overall Study||3
428310|NCT01483183|1049542|P3|COMPLETED|Overall Study||5
428311|NCT01483183|1049543|P2|COMPLETED|Overall Study||1
428312|NCT01483183|1049544|P1|COMPLETED|Overall Study||4
428313|NCT01483183|1049535|P10|STARTED|Overall Study||5
428314|NCT01483183|1049536|P9|STARTED|Overall Study||4
428315|NCT01483183|1049537|P8|STARTED|Overall Study||4
428316|NCT01483183|1049538|P7|STARTED|Overall Study||6
428317|NCT01483183|1049539|P6|STARTED|Overall Study||4
428318|NCT01483183|1049540|P5|STARTED|Overall Study||4
428319|NCT01483183|1049541|P4|STARTED|Overall Study||3
428320|NCT01483183|1049542|P3|STARTED|Overall Study||5
428321|NCT01483183|1049543|P2|STARTED|Overall Study||1
428322|NCT01483183|1049544|P1|STARTED|Overall Study||4
428323|NCT01483118|1049614|P2|NOT COMPLETED|Overall Study||16
428324|NCT01483118|1049615|P1|NOT COMPLETED|Overall Study||12
428325|NCT01483118|1049614|P2|COMPLETED|Overall Study||6
428326|NCT01483118|1049615|P1|COMPLETED|Overall Study||11
428327|NCT01483118|1049614|P2|Completed 3 Months|Overall Study||11
428328|NCT01483118|1049615|P1|Completed 3 Months|Overall Study||15
428329|NCT01483118|1049614|P2|STARTED|Overall Study||22
428330|NCT01483118|1049615|P1|STARTED|Overall Study||23
428331|NCT01482910|1049627|P2|NOT COMPLETED|Overall Study||9
428332|NCT01482910|1049628|P1|NOT COMPLETED|Overall Study||15
428333|NCT01482910|1049627|P2|COMPLETED|Overall Study||67
428334|NCT01482910|1049628|P1|COMPLETED|Overall Study||213
428335|NCT01482910|1049627|P2|Completed Week 28|Overall Study||71
428336|NCT01482910|1049628|P1|Completed Week 28|Overall Study||216
428337|NCT01482910|1049627|P2|STARTED|Overall Study||76
428338|NCT01482910|1049628|P1|STARTED|Overall Study||228
428339|NCT01482884|1049640|P2|NOT COMPLETED|Overall Study||18
428340|NCT01482884|1049641|P1|NOT COMPLETED|Overall Study||13
428341|NCT01482884|1049640|P2|COMPLETED|Overall Study||37
428342|NCT01482884|1049641|P1|COMPLETED|Overall Study||43
428343|NCT01482884|1049640|P2|STARTED|Overall Study||55
428344|NCT01482884|1049641|P1|STARTED|Overall Study|One participant did not receive study treatment|56
428345|NCT01482819|1049667|P1|NOT COMPLETED|Overall Study||2
428346|NCT01482819|1049667|P1|COMPLETED|Overall Study||19
428347|NCT01482819|1049667|P1|STARTED|Overall Study||21
428348|NCT01482767|1049687|P2|NOT COMPLETED|Overall Study||49
428349|NCT01482767|1049688|P1|NOT COMPLETED|Overall Study||54
428350|NCT01482767|1049687|P2|COMPLETED|Overall Study||78
428351|NCT01482767|1049688|P1|COMPLETED|Overall Study||81
428352|NCT01482767|1049687|P2|STARTED|Overall Study||127
428353|NCT01482767|1049688|P1|STARTED|Overall Study||135
428354|NCT01482429|1049710|P2|NOT COMPLETED|Protocol||0
428355|NCT01482429|1049711|P1|NOT COMPLETED|Protocol||275
428356|NCT01482429|1049710|P2|COMPLETED|Protocol||0
428357|NCT01482429|1049711|P1|COMPLETED|Protocol||139
428359|NCT01482429|1049711|P1|STARTED|Protocol||414
428360|NCT01482429|1049710|P2|NOT COMPLETED|Care Usual||173
428361|NCT01482429|1049711|P1|NOT COMPLETED|Care Usual||0
428362|NCT01482429|1049710|P2|COMPLETED|Care Usual||96
428363|NCT01482429|1049711|P1|COMPLETED|Care Usual||0
428364|NCT01482429|1049710|P2|STARTED|Care Usual||269
428365|NCT01482429|1049711|P1|STARTED|Care Usual||0
428366|NCT01482325|1049719|P1|NOT COMPLETED|Overall Study||0
428367|NCT01482325|1049719|P1|COMPLETED|Overall Study||31
428368|NCT01482325|1049719|P1|STARTED|Overall Study||31
428369|NCT01482312|1049723|P3|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
428370|NCT01482312|1049724|P2|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
428371|NCT01482312|1049725|P1|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
428372|NCT01482312|1049723|P3|COMPLETED|Period 3, 90 Minutes of Wear||9
428373|NCT01482312|1049724|P2|COMPLETED|Period 3, 90 Minutes of Wear||9
428374|NCT01482312|1049725|P1|COMPLETED|Period 3, 90 Minutes of Wear||8
428375|NCT01482312|1049723|P3|STARTED|Period 3, 90 Minutes of Wear||9
428376|NCT01482312|1049724|P2|STARTED|Period 3, 90 Minutes of Wear||9
428377|NCT01482312|1049725|P1|STARTED|Period 3, 90 Minutes of Wear||8
428378|NCT01482312|1049723|P3|NOT COMPLETED|Period 2, 90 Minutes of Wear||0
428379|NCT01482312|1049724|P2|NOT COMPLETED|Period 2, 90 Minutes of Wear||0
428380|NCT01482312|1049725|P1|NOT COMPLETED|Period 2, 90 Minutes of Wear||1
428381|NCT01482312|1049723|P3|COMPLETED|Period 2, 90 Minutes of Wear||9
428382|NCT01482312|1049724|P2|COMPLETED|Period 2, 90 Minutes of Wear||9
428383|NCT01482312|1049725|P1|COMPLETED|Period 2, 90 Minutes of Wear||8
428384|NCT01482312|1049723|P3|STARTED|Period 2, 90 Minutes of Wear|One participant discontinued between Period 1 and Period 2|9
428385|NCT01482312|1049724|P2|STARTED|Period 2, 90 Minutes of Wear||9
428386|NCT01482312|1049725|P1|STARTED|Period 2, 90 Minutes of Wear||9
428387|NCT01482312|1049723|P3|NOT COMPLETED|Period 1, 90 Minutes of Wear||0
428388|NCT01482312|1049724|P2|NOT COMPLETED|Period 1, 90 Minutes of Wear||0
428389|NCT01482312|1049725|P1|NOT COMPLETED|Period 1, 90 Minutes of Wear||1
428390|NCT01482312|1049723|P3|COMPLETED|Period 1, 90 Minutes of Wear||10
428391|NCT01482312|1049724|P2|COMPLETED|Period 1, 90 Minutes of Wear||9
428392|NCT01482312|1049725|P1|COMPLETED|Period 1, 90 Minutes of Wear||9
428393|NCT01482312|1049723|P3|STARTED|Period 1, 90 Minutes of Wear||10
428394|NCT01482312|1049724|P2|STARTED|Period 1, 90 Minutes of Wear||9
428395|NCT01482312|1049725|P1|STARTED|Period 1, 90 Minutes of Wear||10
428396|NCT01482221|1049739|P3|NOT COMPLETED|Overall Study||23
428397|NCT01482221|1049740|P2|NOT COMPLETED|Overall Study||20
428398|NCT01482221|1049741|P1|NOT COMPLETED|Overall Study||21
428399|NCT01482221|1049739|P3|COMPLETED|Overall Study||77
428400|NCT01482221|1049740|P2|COMPLETED|Overall Study||81
428401|NCT01482221|1049741|P1|COMPLETED|Overall Study||80
428402|NCT01482221|1049739|P3|STARTED|Overall Study||100
428403|NCT01482221|1049740|P2|STARTED|Overall Study||101
428404|NCT01482221|1049741|P1|STARTED|Overall Study||101
428405|NCT01482169|1049782|P1|NOT COMPLETED|Overall Study||2
428406|NCT01482169|1049782|P1|COMPLETED|Overall Study||46
428407|NCT01482169|1049782|P1|STARTED|Overall Study||48
428408|NCT01482091|1049791|P2|NOT COMPLETED|Overall Study||0
428409|NCT01482091|1049792|P1|NOT COMPLETED|Overall Study||0
428410|NCT01482091|1049791|P2|COMPLETED|Overall Study||24
428411|NCT01482091|1049792|P1|COMPLETED|Overall Study||25
428412|NCT01482091|1049791|P2|STARTED|Overall Study||24
428413|NCT01482091|1049792|P1|STARTED|Overall Study||25
428414|NCT01482065|1049824|P2|NOT COMPLETED|Overall Study||1
428415|NCT01482065|1049825|P1|NOT COMPLETED|Overall Study||0
428416|NCT01482065|1049824|P2|COMPLETED|Overall Study||4
428417|NCT01482065|1049825|P1|COMPLETED|Overall Study||4
428418|NCT01482065|1049824|P2|STARTED|Overall Study||5
428419|NCT01482065|1049825|P1|STARTED|Overall Study||4
428420|NCT01481935|1049839|P2|NOT COMPLETED|Overall Study||0
428421|NCT01481935|1049840|P1|NOT COMPLETED|Overall Study||0
428422|NCT01481935|1049839|P2|COMPLETED|Overall Study||93
428423|NCT01481935|1049840|P1|COMPLETED|Overall Study||97
428424|NCT01481935|1049839|P2|STARTED|Overall Study||93
428425|NCT01481935|1049840|P1|STARTED|Overall Study||97
428426|NCT01481896|1049846|P1|NOT COMPLETED|Overall Study||12
428427|NCT01481896|1049846|P1|COMPLETED|Overall Study|The 114 participants includes 5 participants with bilateral hip replacements for a total of 119 THAs|114
428428|NCT01481896|1049846|P1|Min 4.75 yr Follow-up, Revised or Dead|Overall Study|114 participants with 119 THAs had at least 4.75 year follow-up or were known revised or deceased|114
428429|NCT01481896|1049846|P1|STARTED|Overall Study|The 126 participants includes 5 participants with bilateral hip replacements for a total of 131 THAs|126
428430|NCT01481779|1049862|P2|NOT COMPLETED|Overall Study||28
428431|NCT01481779|1049863|P1|NOT COMPLETED|Overall Study||70
428432|NCT01481779|1049862|P2|COMPLETED|Overall Study||132
428433|NCT01481779|1049863|P1|COMPLETED|Overall Study||225
428434|NCT01481779|1049862|P2|Received at Least 1 Dose of Study Drug|Overall Study||159
428435|NCT01481779|1049863|P1|Received at Least 1 Dose of Study Drug|Overall Study||294
428436|NCT01481779|1049862|P2|STARTED|Overall Study||160
428437|NCT01481779|1049863|P1|STARTED|Overall Study||295
428438|NCT01481740|1049911|P2|NOT COMPLETED|Overall Study||7
428439|NCT01481740|1049912|P1|NOT COMPLETED|Overall Study||11
428440|NCT01481740|1049911|P2|COMPLETED|Overall Study||81
428441|NCT01481740|1049912|P1|COMPLETED|Overall Study||79
428442|NCT01481740|1049911|P2|STARTED|Overall Study||88
428443|NCT01481740|1049912|P1|STARTED|Overall Study||90
428444|NCT01481558|1049930|P2|NOT COMPLETED|Overall Study||0
428445|NCT01481558|1049931|P1|NOT COMPLETED|Overall Study||0
428446|NCT01481558|1049930|P2|COMPLETED|Overall Study||20
428447|NCT01481558|1049931|P1|COMPLETED|Overall Study||20
428448|NCT01481558|1049930|P2|STARTED|Overall Study||20
428449|NCT01481558|1049931|P1|STARTED|Overall Study||20
428450|NCT01481376|1049937|P1|NOT COMPLETED|Overall Study||31
428451|NCT01481376|1049937|P1|COMPLETED|Overall Study||169
428452|NCT01481376|1049937|P1|STARTED|Overall Study||200
428453|NCT01481324|1049948|P3|NOT COMPLETED|Overall Study||2
428454|NCT01481324|1049949|P2|NOT COMPLETED|Overall Study||2
428455|NCT01481324|1049950|P1|NOT COMPLETED|Overall Study||0
428456|NCT01481324|1049948|P3|COMPLETED|Overall Study||20
428457|NCT01481324|1049949|P2|COMPLETED|Overall Study||22
428458|NCT01481324|1049950|P1|COMPLETED|Overall Study||21
428459|NCT01481324|1049948|P3|Month 3-Wear Rate Data|Overall Study||6
428460|NCT01481324|1049949|P2|Month 3-Wear Rate Data|Overall Study||11
428461|NCT01481324|1049950|P1|Month 3-Wear Rate Data|Overall Study||7
428462|NCT01481324|1049948|P3|Month 2-Wear Rate Data|Overall Study||7
428463|NCT01481324|1049949|P2|Month 2-Wear Rate Data|Overall Study||13
428464|NCT01481324|1049950|P1|Month 2-Wear Rate Data|Overall Study||9
428465|NCT01481324|1049948|P3|Month 1-Wear Rate Data|Overall Study||8
428466|NCT01481324|1049949|P2|Month 1-Wear Rate Data|Overall Study||16
428467|NCT01481324|1049950|P1|Month 1-Wear Rate Data|Overall Study||15
428468|NCT01481324|1049948|P3|STARTED|Overall Study||22
428469|NCT01481324|1049949|P2|STARTED|Overall Study||24
428470|NCT01481324|1049950|P1|STARTED|Overall Study||21
428471|NCT01481129|1049958|P1|NOT COMPLETED|Overall Study||0
428472|NCT01481129|1049958|P1|COMPLETED|Overall Study||22
428473|NCT01481129|1049958|P1|STARTED|Overall Study||22
428474|NCT01481116|1049969|P3|NOT COMPLETED|Overall Study||813
428475|NCT01481116|1049970|P2|NOT COMPLETED|Overall Study||817
428476|NCT01481116|1049971|P1|NOT COMPLETED|Overall Study||824
428477|NCT01481116|1049969|P3|COMPLETED|Overall Study||0
428478|NCT01481116|1049970|P2|COMPLETED|Overall Study||0
428479|NCT01481116|1049971|P1|COMPLETED|Overall Study||0
428480|NCT01481116|1049969|P3|Treated|Overall Study||813
428481|NCT01481116|1049970|P2|Treated|Overall Study||816
428482|NCT01481116|1049971|P1|Treated|Overall Study||822
428483|NCT01481116|1049969|P3|STARTED|Overall Study||813
428484|NCT01481116|1049970|P2|STARTED|Overall Study||817
428485|NCT01481116|1049971|P1|STARTED|Overall Study||824
428486|NCT01480843|1049997|P1|NOT COMPLETED|Overall Study||5
428487|NCT01480843|1049997|P1|COMPLETED|Overall Study||60
428488|NCT01480843|1049997|P1|STARTED|Overall Study||65
428489|NCT01480674|1050002|P1|NOT COMPLETED|Overall Study||35
428490|NCT01480674|1050002|P1|COMPLETED|Overall Study||125
428491|NCT01480674|1050002|P1|Analysed Set|Overall Study||128
428492|NCT01480674|1050002|P1|Safety Set|Overall Study||154
428493|NCT01480674|1050002|P1|STARTED|Overall Study||160
428494|NCT01480596|1050016|P2|NOT COMPLETED|Overall Study||2
428495|NCT01480596|1050017|P1|NOT COMPLETED|Overall Study||5
428496|NCT01480596|1050016|P2|COMPLETED|Overall Study||16
428497|NCT01480596|1050017|P1|COMPLETED|Overall Study||17
428498|NCT01480596|1050016|P2|STARTED|Overall Study||18
428499|NCT01480596|1050017|P1|STARTED|Overall Study||22
428500|NCT01480297|1050059|P1|NOT COMPLETED|Overall Study||0
428501|NCT01480297|1050059|P1|COMPLETED|Overall Study||8
428502|NCT01480297|1050059|P1|STARTED|Overall Study||8
428503|NCT01480284|1050065|P2|NOT COMPLETED|Overall Study||0
428504|NCT01480284|1050066|P1|NOT COMPLETED|Overall Study||8
428505|NCT01480284|1050065|P2|COMPLETED|Overall Study||56
428506|NCT01480284|1050066|P1|COMPLETED|Overall Study||102
428507|NCT01480284|1050065|P2|STARTED|Overall Study||56
428508|NCT01480284|1050066|P1|STARTED|Overall Study||110
428509|NCT01480232|1050098|P4|NOT COMPLETED|Overall Study||19
428510|NCT01480232|1050099|P3|NOT COMPLETED|Overall Study||17
428511|NCT01480232|1050100|P2|NOT COMPLETED|Overall Study||22
428512|NCT01480232|1050101|P1|NOT COMPLETED|Overall Study||18
428513|NCT01480232|1050098|P4|COMPLETED|Overall Study||22
428514|NCT01480232|1050099|P3|COMPLETED|Overall Study||21
428515|NCT01480232|1050100|P2|COMPLETED|Overall Study||19
428516|NCT01480232|1050101|P1|COMPLETED|Overall Study||22
428517|NCT01480232|1050098|P4|STARTED|Overall Study||41
428518|NCT01480232|1050099|P3|STARTED|Overall Study||38
428519|NCT01480232|1050100|P2|STARTED|Overall Study||41
428520|NCT01480232|1050101|P1|STARTED|Overall Study||40
428521|NCT01480219|1050129|P2|NOT COMPLETED|Overall Study||0
428522|NCT01480219|1050130|P1|NOT COMPLETED|Overall Study||0
428523|NCT01480219|1050129|P2|COMPLETED|Overall Study||142
428524|NCT01480219|1050130|P1|COMPLETED|Overall Study||325
428525|NCT01480219|1050129|P2|STARTED|Overall Study||142
428526|NCT01480219|1050130|P1|STARTED|Overall Study||325
428527|NCT01480089|1050138|P2|NOT COMPLETED|Overall Study||0
428528|NCT01480089|1050139|P1|NOT COMPLETED|Overall Study||0
428529|NCT01480089|1050138|P2|COMPLETED|Overall Study||30
428530|NCT01480089|1050139|P1|COMPLETED|Overall Study||25
428531|NCT01480089|1050138|P2|STARTED|Overall Study||30
428532|NCT01480089|1050139|P1|STARTED|Overall Study||25
428533|NCT01480076|1050149|P1|NOT COMPLETED|Overall Study||290
428534|NCT01480076|1050149|P1|COMPLETED|Overall Study||611
428535|NCT01480076|1050149|P1|Intent to Treat Population|Overall Study|Received ≥1 dose of study drug & provided ≥1 efficacy assessment at Baseline & the 3-month visit.|835
428536|NCT01480076|1050149|P1|STARTED|Overall Study|enrolled and started run-in treatment|901
428537|NCT01479868|1050268|P1|NOT COMPLETED|Overall Study||9
428538|NCT01479868|1050268|P1|COMPLETED|Overall Study||97
428539|NCT01479868|1050268|P1|STARTED|Overall Study|Restricted to subject who received at least one dose of treatment (TMC435/RBV/PegIFN).|106
428540|NCT01479777|1050283|P1|NOT COMPLETED|Overall Study||2
428541|NCT01479777|1050283|P1|COMPLETED|Overall Study||10
428542|NCT01479777|1050283|P1|STARTED|Overall Study||12
428543|NCT01479764|1050295|P2|NOT COMPLETED|Treated||2
428544|NCT01479764|1050296|P1|NOT COMPLETED|Treated||0
428545|NCT01479764|1050295|P2|COMPLETED|Treated||75
428546|NCT01479764|1050296|P1|COMPLETED|Treated||74
428547|NCT01479764|1050295|P2|STARTED|Treated||77
428548|NCT01479764|1050296|P1|STARTED|Treated||74
428549|NCT01479764|1050295|P2|NOT COMPLETED|Randomized||1
428550|NCT01479764|1050296|P1|NOT COMPLETED|Randomized||2
428551|NCT01479764|1050295|P2|COMPLETED|Randomized|1 randomized participant did not receive study drug|77
428552|NCT01479764|1050296|P1|COMPLETED|Randomized|2 randomized participants did not receive study drug|74
428553|NCT01479764|1050295|P2|STARTED|Randomized||78
428554|NCT01479764|1050296|P1|STARTED|Randomized||76
428555|NCT01479725|1050306|P2|NOT COMPLETED|Overall Study||1
428556|NCT01479725|1050307|P1|NOT COMPLETED|Overall Study||2
428557|NCT01479725|1050306|P2|COMPLETED|Overall Study||1
428558|NCT01479725|1050307|P1|COMPLETED|Overall Study||4
428559|NCT01479725|1050306|P2|STARTED|Overall Study||2
428560|NCT01479725|1050307|P1|STARTED|Overall Study||6
428561|NCT01479621|1050319|P7|NOT COMPLETED|Treatment Period||20
428562|NCT01479621|1050320|P6|NOT COMPLETED|Treatment Period||41
428563|NCT01479621|1050321|P5|NOT COMPLETED|Treatment Period||21
428564|NCT01479621|1050322|P4|NOT COMPLETED|Treatment Period||12
428565|NCT01479621|1050323|P3|NOT COMPLETED|Treatment Period||21
428566|NCT01479621|1050324|P2|NOT COMPLETED|Treatment Period||24
428567|NCT01479621|1050325|P1|NOT COMPLETED|Treatment Period||0
428568|NCT01479621|1050319|P7|COMPLETED|Treatment Period||84
428569|NCT01479621|1050320|P6|COMPLETED|Treatment Period||63
428570|NCT01479621|1050321|P5|COMPLETED|Treatment Period||82
428571|NCT01479621|1050322|P4|COMPLETED|Treatment Period||92
428572|NCT01479621|1050323|P3|COMPLETED|Treatment Period||83
428573|NCT01479621|1050324|P2|COMPLETED|Treatment Period||79
428574|NCT01479621|1050325|P1|COMPLETED|Treatment Period||0
428575|NCT01479621|1050319|P7|Full Analysis Set|Treatment Period||102
428576|NCT01479621|1050320|P6|Full Analysis Set|Treatment Period||102
428577|NCT01479621|1050321|P5|Full Analysis Set|Treatment Period||102
428578|NCT01479621|1050322|P4|Full Analysis Set|Treatment Period||102
428579|NCT01479621|1050323|P3|Full Analysis Set|Treatment Period||101
428580|NCT01479621|1050324|P2|Full Analysis Set|Treatment Period||102
428581|NCT01479621|1050325|P1|Full Analysis Set|Treatment Period||0
428582|NCT01479621|1050319|P7|Safety Population|Treatment Period||104
428583|NCT01479621|1050320|P6|Safety Population|Treatment Period||104
428584|NCT01479621|1050321|P5|Safety Population|Treatment Period||103
428585|NCT01479621|1050322|P4|Safety Population|Treatment Period||104
428586|NCT01479621|1050323|P3|Safety Population|Treatment Period||104
428587|NCT01479621|1050324|P2|Safety Population|Treatment Period||103
428588|NCT01479621|1050325|P1|Safety Population|Treatment Period||0
428589|NCT01479621|1050319|P7|STARTED|Treatment Period||104
428590|NCT01479621|1050320|P6|STARTED|Treatment Period||104
428591|NCT01479621|1050321|P5|STARTED|Treatment Period||103
428592|NCT01479621|1050322|P4|STARTED|Treatment Period||104
428593|NCT01479621|1050323|P3|STARTED|Treatment Period||104
428594|NCT01479621|1050324|P2|STARTED|Treatment Period||103
428595|NCT01479621|1050325|P1|STARTED|Treatment Period||0
428596|NCT01479621|1050319|P7|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
428597|NCT01479621|1050320|P6|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
428598|NCT01479621|1050321|P5|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
428599|NCT01479621|1050322|P4|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
428600|NCT01479621|1050323|P3|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
428601|NCT01479621|1050324|P2|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
428602|NCT01479621|1050325|P1|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||287
428603|NCT01479621|1050319|P7|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
428604|NCT01479621|1050320|P6|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
428605|NCT01479621|1050321|P5|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
428606|NCT01479621|1050322|P4|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
428607|NCT01479621|1050323|P3|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
428608|NCT01479621|1050324|P2|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
428609|NCT01479621|1050325|P1|COMPLETED|Pre-Assignment Period (Run-In Placebo)||622
428610|NCT01479621|1050319|P7|STARTED|Pre-Assignment Period (Run-In Placebo)||0
428611|NCT01479621|1050320|P6|STARTED|Pre-Assignment Period (Run-In Placebo)||0
428612|NCT01479621|1050321|P5|STARTED|Pre-Assignment Period (Run-In Placebo)||0
428613|NCT01479621|1050322|P4|STARTED|Pre-Assignment Period (Run-In Placebo)||0
428614|NCT01479621|1050323|P3|STARTED|Pre-Assignment Period (Run-In Placebo)||0
428615|NCT01479621|1050324|P2|STARTED|Pre-Assignment Period (Run-In Placebo)||0
428616|NCT01479621|1050325|P1|STARTED|Pre-Assignment Period (Run-In Placebo)||909
428617|NCT01479595|1050413|P2|NOT COMPLETED|Overall Study||2
428618|NCT01479595|1050414|P1|NOT COMPLETED|Overall Study||2
428619|NCT01479595|1050413|P2|COMPLETED|Overall Study||19
428620|NCT01479595|1050414|P1|COMPLETED|Overall Study||42
428621|NCT01479595|1050413|P2|Per Protocol Analysis Set|Overall Study||20
428622|NCT01479595|1050414|P1|Per Protocol Analysis Set|Overall Study||41
428623|NCT01479595|1050413|P2|PK Analysis Set|Overall Study||0
428624|NCT01479595|1050414|P1|PK Analysis Set|Overall Study||42
428625|NCT01479595|1050413|P2|STARTED|Overall Study||21
428626|NCT01479595|1050414|P1|STARTED|Overall Study||44
428627|NCT01479543|1050441|P5|NOT COMPLETED|Overall Study||1
428628|NCT01479543|1050442|P4|NOT COMPLETED|Overall Study||0
428629|NCT01479543|1050443|P3|NOT COMPLETED|Overall Study||1
428630|NCT01479543|1050444|P2|NOT COMPLETED|Overall Study||0
428631|NCT01479543|1050445|P1|NOT COMPLETED|Overall Study||1
428632|NCT01479543|1050441|P5|COMPLETED|Overall Study||20
428633|NCT01479543|1050442|P4|COMPLETED|Overall Study||20
428634|NCT01479543|1050443|P3|COMPLETED|Overall Study||20
428635|NCT01479543|1050444|P2|COMPLETED|Overall Study||20
428636|NCT01479543|1050445|P1|COMPLETED|Overall Study||20
428637|NCT01479543|1050441|P5|STARTED|Overall Study||21
428638|NCT01479543|1050442|P4|STARTED|Overall Study||20
428639|NCT01479543|1050443|P3|STARTED|Overall Study||21
428640|NCT01479543|1050444|P2|STARTED|Overall Study||20
428641|NCT01479543|1050445|P1|STARTED|Overall Study||21
428642|NCT01479530|1050459|P2|NOT COMPLETED|Overall Study||12
428643|NCT01479530|1050460|P1|NOT COMPLETED|Overall Study||10
428644|NCT01479530|1050459|P2|COMPLETED|Overall Study||151
428645|NCT01479530|1050460|P1|COMPLETED|Overall Study||148
428646|NCT01479530|1050459|P2|STARTED|Overall Study||163
428647|NCT01479530|1050460|P1|STARTED|Overall Study||158
428648|NCT01479517|1050475|P3|NOT COMPLETED|Overall Study||0
428649|NCT01479517|1050476|P2|NOT COMPLETED|Overall Study||0
428650|NCT01479517|1050477|P1|NOT COMPLETED|Overall Study||0
428651|NCT01479517|1050475|P3|COMPLETED|Overall Study||10
428652|NCT01479517|1050476|P2|COMPLETED|Overall Study||10
428653|NCT01479517|1050477|P1|COMPLETED|Overall Study||10
428654|NCT01479517|1050475|P3|STARTED|Overall Study||10
428655|NCT01479517|1050476|P2|STARTED|Overall Study||10
428656|NCT01479517|1050477|P1|STARTED|Overall Study||10
428657|NCT01479374|1050497|P3|NOT COMPLETED|Overall Study||5
428658|NCT01479374|1050498|P2|NOT COMPLETED|Overall Study||8
428659|NCT01479374|1050499|P1|NOT COMPLETED|Overall Study||3
428660|NCT01479374|1050497|P3|COMPLETED|Overall Study||63
428661|NCT01479374|1050498|P2|COMPLETED|Overall Study||60
428662|NCT01479374|1050499|P1|COMPLETED|Overall Study||63
428663|NCT01479374|1050497|P3|STARTED|Overall Study||68
428664|NCT01479374|1050498|P2|STARTED|Overall Study||68
428665|NCT01479374|1050499|P1|STARTED|Overall Study||66
428666|NCT01479127|1050525|P1|NOT COMPLETED|Overall Study||3
428667|NCT01479127|1050525|P1|COMPLETED|Overall Study||5
428668|NCT01479127|1050525|P1|Started LCIG|Overall Study||6
428669|NCT01479127|1050525|P1|STARTED|Overall Study|started oral study drug (full safety sample)|8
428670|NCT01479010|1050559|P1|NOT COMPLETED|Overall Study||1
428671|NCT01479010|1050559|P1|COMPLETED|Overall Study||1
428672|NCT01479010|1050559|P1|STARTED|Overall Study||2
428673|NCT01478971|1050570|P1|NOT COMPLETED|Peginesatide Treatment Period||14
428674|NCT01478971|1050570|P1|COMPLETED|Peginesatide Treatment Period||143
428675|NCT01478971|1050570|P1|STARTED|Peginesatide Treatment Period|2 participants terminated the study before transitioning to peginesatide for unknown reasons|157
428676|NCT01478971|1050570|P1|NOT COMPLETED|Standard of Care Period||25
428677|NCT01478971|1050570|P1|COMPLETED|Standard of Care Period||159
428678|NCT01478971|1050570|P1|Received Treatment|Standard of Care Period||178
428679|NCT01478971|1050570|P1|STARTED|Standard of Care Period||184
428680|NCT01478958|1050587|P3|NOT COMPLETED|Overall Study||3
428681|NCT01478958|1050588|P2|NOT COMPLETED|Overall Study||2
428682|NCT01478958|1050589|P1|NOT COMPLETED|Overall Study||2
428683|NCT01478958|1050587|P3|COMPLETED|Overall Study||66
428684|NCT01478958|1050588|P2|COMPLETED|Overall Study||64
428685|NCT01478958|1050589|P1|COMPLETED|Overall Study||65
428686|NCT01478958|1050587|P3|STARTED|Overall Study||69
428687|NCT01478958|1050588|P2|STARTED|Overall Study||66
428688|NCT01478958|1050589|P1|STARTED|Overall Study||67
428689|NCT01478828|1050597|P1|NOT COMPLETED|Overall Study||1
428690|NCT01478828|1050597|P1|COMPLETED|Overall Study||1
428691|NCT01478828|1050597|P1|STARTED|Overall Study||2
428692|NCT01478620|1050602|P1|NOT COMPLETED|Overall Study||6
428693|NCT01478620|1050602|P1|COMPLETED|Overall Study||119
428694|NCT01478620|1050602|P1|STARTED|Overall Study||125
428695|NCT01478594|1050608|P2|NOT COMPLETED|Overall Study||28
428696|NCT01478594|1050609|P1|NOT COMPLETED|Overall Study||65
428697|NCT01478594|1050608|P2|COMPLETED|Overall Study|Participants still on study as of 28 February 2014|60
428698|NCT01478594|1050609|P1|COMPLETED|Overall Study|Participants still on study as of 28 February 2014|112
428699|NCT01478594|1050608|P2|Treated|Overall Study||87
428700|NCT01478594|1050609|P1|Treated|Overall Study||177
428701|NCT01478594|1050608|P2|STARTED|Overall Study||88
428702|NCT01478594|1050609|P1|STARTED|Overall Study||177
428703|NCT01478581|1050685|P4|NOT COMPLETED|Overall Study||0
428704|NCT01478581|1050686|P3|NOT COMPLETED|Overall Study||0
428705|NCT01478581|1050687|P2|NOT COMPLETED|Overall Study||0
428706|NCT01478581|1050688|P1|NOT COMPLETED|Overall Study||0
428707|NCT01478581|1050685|P4|COMPLETED|Overall Study||43
428708|NCT01478581|1050686|P3|COMPLETED|Overall Study||18
428709|NCT01478581|1050687|P2|COMPLETED|Overall Study||18
428710|NCT01478581|1050688|P1|COMPLETED|Overall Study||13
428711|NCT01478581|1050685|P4|STARTED|Overall Study|Simon 2-stage design - cohort 4 expansion per stage 1 data (≥3 Clinical Benefit Responders observed|43
428712|NCT01478581|1050686|P3|STARTED|Overall Study||18
428713|NCT01478581|1050687|P2|STARTED|Overall Study||18
428714|NCT01478581|1050688|P1|STARTED|Overall Study||13
428715|NCT01478373|1050734|P1|NOT COMPLETED|Survival Phase||38
428716|NCT01478373|1050734|P1|COMPLETED|Survival Phase||0
428717|NCT01478373|1050734|P1|STARTED|Survival Phase||38
428718|NCT01478373|1050734|P1|NOT COMPLETED|Treatment Phase||1
428719|NCT01478373|1050734|P1|COMPLETED|Treatment Phase||38
428720|NCT01478373|1050734|P1|STARTED|Treatment Phase||39
428721|NCT01478360|1050747|P2|NOT COMPLETED|Overall Study||3
428722|NCT01478360|1050748|P1|NOT COMPLETED|Overall Study||2
428723|NCT01478360|1050747|P2|COMPLETED|Overall Study||12
428724|NCT01478360|1050748|P1|COMPLETED|Overall Study||29
428725|NCT01478360|1050747|P2|PK (Pharmacokinetics) Analysis Set|Overall Study||0
428726|NCT01478360|1050748|P1|PK (Pharmacokinetics) Analysis Set|Overall Study|Serum samples were collected during the study and analyzed only for the AIN457 group|31
428727|NCT01478360|1050747|P2|PD (Pharmacodynamic) Analysis Set|Overall Study||15
428728|NCT01478360|1050748|P1|PD (Pharmacodynamic) Analysis Set|Overall Study||31
428729|NCT01478360|1050747|P2|STARTED|Overall Study||15
428730|NCT01478360|1050748|P1|STARTED|Overall Study||31
428731|NCT01478347|1050754|P1|NOT COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||8
428732|NCT01478347|1050754|P1|COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||4
428733|NCT01478347|1050754|P1|STARTED|Visit 4-Visit 7 (Day 151-331) - Part II||12
428734|NCT01478347|1050754|P1|NOT COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||1
428735|NCT01478347|1050754|P1|COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||17
428736|NCT01478347|1050754|P1|STARTED|Visit 1-Visit 3 (Day 0-91) - Part I||18
428737|NCT01478256|1050761|P2|NOT COMPLETED|Overall Study||0
428738|NCT01478256|1050762|P1|NOT COMPLETED|Overall Study||0
428739|NCT01478256|1050761|P2|COMPLETED|Overall Study||15
428740|NCT01478256|1050762|P1|COMPLETED|Overall Study||15
428741|NCT01478256|1050761|P2|STARTED|Overall Study||15
428742|NCT01478256|1050762|P1|STARTED|Overall Study||15
428743|NCT01478113|1050772|P2|NOT COMPLETED|Overall Study||1
428744|NCT01478113|1050773|P1|NOT COMPLETED|Overall Study||1
428745|NCT01478113|1050772|P2|COMPLETED|Overall Study||1
428746|NCT01478113|1050773|P1|COMPLETED|Overall Study||1
428747|NCT01478113|1050772|P2|STARTED|Overall Study||2
428748|NCT01478113|1050773|P1|STARTED|Overall Study||2
428749|NCT01478087|1050791|P1|NOT COMPLETED|Overall Study||1
428750|NCT01478087|1050791|P1|COMPLETED|Overall Study||2
428751|NCT01478087|1050791|P1|STARTED|Overall Study||3
428752|NCT01478048|1050798|P2|NOT COMPLETED|Overall Study||75
428753|NCT01478048|1050799|P1|NOT COMPLETED|Overall Study||77
428754|NCT01478048|1050798|P2|COMPLETED|Overall Study||0
428755|NCT01478048|1050799|P1|COMPLETED|Overall Study||0
428756|NCT01478048|1050798|P2|Received Treatment|Overall Study|1 randomized to E-Bd but received Bd. Included in E-Bd group for efficacy and Bd group for safety|74
428757|NCT01478048|1050799|P1|Received Treatment|Overall Study|1 randomized to E-Bd but received Bd. Included in E-Bd group for efficacy and Bd group for safety|76
428758|NCT01478048|1050798|P2|STARTED|Overall Study||75
428759|NCT01478048|1050799|P1|STARTED|Overall Study||77
428760|NCT01478009|1050817|P2|NOT COMPLETED|Overall Study||1
428761|NCT01478009|1050818|P1|NOT COMPLETED|Overall Study||1
428762|NCT01478009|1050817|P2|COMPLETED|Overall Study||49
428763|NCT01478009|1050818|P1|COMPLETED|Overall Study||49
428764|NCT01478009|1050817|P2|STARTED|Overall Study||50
428765|NCT01478009|1050818|P1|STARTED|Overall Study||50
428766|NCT01477892|1050828|P2|NOT COMPLETED|Overall Study||2
428767|NCT01477892|1050829|P1|NOT COMPLETED|Overall Study||0
428768|NCT01477892|1050828|P2|COMPLETED|Overall Study||5
428769|NCT01477892|1050829|P1|COMPLETED|Overall Study||7
428770|NCT01477892|1050828|P2|STARTED|Overall Study||7
428771|NCT01477892|1050829|P1|STARTED|Overall Study||7
428772|NCT01477853|1050840|P3|NOT COMPLETED|Phase B||11
428773|NCT01477853|1050841|P2|NOT COMPLETED|Phase B||11
428774|NCT01477853|1050842|P1|NOT COMPLETED|Phase B||12
428775|NCT01477853|1050840|P3|COMPLETED|Phase B||0
428776|NCT01477853|1050841|P2|COMPLETED|Phase B||0
428777|NCT01477853|1050842|P1|COMPLETED|Phase B||0
428778|NCT01477853|1050840|P3|STARTED|Phase B||11
428779|NCT01477853|1050841|P2|STARTED|Phase B||11
428780|NCT01477853|1050842|P1|STARTED|Phase B||12
428781|NCT01477853|1050840|P3|NOT COMPLETED|Phase A||44
428782|NCT01477853|1050841|P2|NOT COMPLETED|Phase A||45
428783|NCT01477853|1050842|P1|NOT COMPLETED|Phase A||43
428784|NCT01477853|1050840|P3|COMPLETED|Phase A||11
428785|NCT01477853|1050841|P2|COMPLETED|Phase A||11
428786|NCT01477853|1050842|P1|COMPLETED|Phase A||12
428787|NCT01477853|1050840|P3|STARTED|Phase A||55
428788|NCT01477853|1050841|P2|STARTED|Phase A||56
428789|NCT01477853|1050842|P1|STARTED|Phase A||55
428790|NCT01477762|1050884|P4|NOT COMPLETED|Overall Study||2
428791|NCT01477762|1050885|P3|NOT COMPLETED|Overall Study||4
428792|NCT01477762|1050886|P2|NOT COMPLETED|Overall Study||13
428793|NCT01477762|1050887|P1|NOT COMPLETED|Overall Study||9
428794|NCT01477762|1050884|P4|COMPLETED|Overall Study||11
428795|NCT01477762|1050885|P3|COMPLETED|Overall Study||16
428796|NCT01477762|1050886|P2|COMPLETED|Overall Study||20
428797|NCT01477762|1050887|P1|COMPLETED|Overall Study||16
428798|NCT01477762|1050884|P4|STARTED|Overall Study||13
428799|NCT01477762|1050885|P3|STARTED|Overall Study||20
428800|NCT01477762|1050886|P2|STARTED|Overall Study||33
428801|NCT01477762|1050887|P1|STARTED|Overall Study||25
428802|NCT01477749|1050909|P1|NOT COMPLETED|Overall Study||4
428803|NCT01477749|1050909|P1|COMPLETED|Overall Study||43
428804|NCT01477749|1050909|P1|STARTED|Overall Study||47
428805|NCT01477710|1050916|P1|NOT COMPLETED|Overall Study||0
428806|NCT01477710|1050916|P1|COMPLETED|Overall Study||30
428807|NCT01477710|1050916|P1|STARTED|Overall Study||30
428808|NCT01477567|1050931|P7|NOT COMPLETED|Overall Study||0
428809|NCT01477567|1050932|P6|NOT COMPLETED|Overall Study||0
428810|NCT01477567|1050933|P5|NOT COMPLETED|Overall Study||0
428811|NCT01477567|1050934|P4|NOT COMPLETED|Overall Study||0
428812|NCT01477567|1050935|P3|NOT COMPLETED|Overall Study||0
428813|NCT01477567|1050936|P2|NOT COMPLETED|Overall Study||0
428814|NCT01477567|1050937|P1|NOT COMPLETED|Overall Study||0
428815|NCT01477567|1050931|P7|COMPLETED|Overall Study||6
428816|NCT01477567|1050932|P6|COMPLETED|Overall Study||5
428817|NCT01477567|1050933|P5|COMPLETED|Overall Study||6
428818|NCT01477567|1050934|P4|COMPLETED|Overall Study||6
428819|NCT01477567|1050935|P3|COMPLETED|Overall Study||6
428820|NCT01477567|1050936|P2|COMPLETED|Overall Study||6
428821|NCT01477567|1050937|P1|COMPLETED|Overall Study||5
428822|NCT01477567|1050931|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
428823|NCT01477567|1050932|P6|Received at Least 1 Dose of Study Drug|Overall Study||5
428824|NCT01477567|1050933|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
428825|NCT01477567|1050934|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
428826|NCT01477567|1050935|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
428827|NCT01477567|1050936|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
428828|NCT01477567|1050937|P1|Received at Least 1 Dose of Study Drug|Overall Study||5
428829|NCT01477567|1050931|P7|STARTED|Overall Study||6
428830|NCT01477567|1050932|P6|STARTED|Overall Study||5
428831|NCT01477567|1050933|P5|STARTED|Overall Study||6
428832|NCT01477567|1050934|P4|STARTED|Overall Study||6
428833|NCT01477567|1050935|P3|STARTED|Overall Study||6
428834|NCT01477567|1050936|P2|STARTED|Overall Study||6
428835|NCT01477567|1050937|P1|STARTED|Overall Study||5
428836|NCT01477463|1050993|P2|NOT COMPLETED|Overall Study||0
428837|NCT01477463|1050994|P1|NOT COMPLETED|Overall Study||0
428838|NCT01477463|1050993|P2|COMPLETED|Overall Study||6
428839|NCT01477463|1050994|P1|COMPLETED|Overall Study||18
428840|NCT01477463|1050993|P2|STARTED|Overall Study||6
428841|NCT01477463|1050994|P1|STARTED|Overall Study||18
428842|NCT01477450|1051007|P3|NOT COMPLETED|Overall Study||0
428843|NCT01477450|1051008|P2|NOT COMPLETED|Overall Study||0
428844|NCT01477450|1051009|P1|NOT COMPLETED|Overall Study||0
428845|NCT01477450|1051007|P3|COMPLETED|Overall Study||10
428846|NCT01477450|1051008|P2|COMPLETED|Overall Study||10
428847|NCT01477450|1051009|P1|COMPLETED|Overall Study||10
428848|NCT01477450|1051007|P3|STARTED|Overall Study||10
428849|NCT01477450|1051008|P2|STARTED|Overall Study||10
428850|NCT01477450|1051009|P1|STARTED|Overall Study||10
428851|NCT01477333|1051017|P1|NOT COMPLETED|Overall Study||3
428852|NCT01477333|1051017|P1|COMPLETED|Overall Study||15
428853|NCT01477333|1051017|P1|STARTED|Overall Study||18
428854|NCT01477320|1051035|P2|NOT COMPLETED|Overall Study||15
428855|NCT01477320|1051036|P1|NOT COMPLETED|Overall Study||7
428856|NCT01477320|1051035|P2|COMPLETED|Overall Study||47
428857|NCT01477320|1051036|P1|COMPLETED|Overall Study||55
428858|NCT01477320|1051035|P2|STARTED|Overall Study||62
428859|NCT01477320|1051036|P1|STARTED|Overall Study||62
428860|NCT01476748|1051047|P3|NOT COMPLETED|Overall Study||0
428861|NCT01476748|1051048|P2|NOT COMPLETED|Overall Study||0
428862|NCT01476748|1051049|P1|NOT COMPLETED|Overall Study||0
428863|NCT01476748|1051047|P3|COMPLETED|Overall Study||5
428864|NCT01476748|1051048|P2|COMPLETED|Overall Study||5
428865|NCT01476748|1051049|P1|COMPLETED|Overall Study||5
428866|NCT01476748|1051047|P3|STARTED|Overall Study||5
428867|NCT01476748|1051048|P2|STARTED|Overall Study||5
428868|NCT01476748|1051049|P1|STARTED|Overall Study||5
428869|NCT01476722|1051060|P1|NOT COMPLETED|Overall Study||1
428870|NCT01476722|1051060|P1|COMPLETED|Overall Study||124
428871|NCT01476722|1051060|P1|STARTED|Overall Study||125
428872|NCT01476696|1051067|P3|NOT COMPLETED|Overall Study||0
428873|NCT01476696|1051068|P2|NOT COMPLETED|Overall Study||1
428874|NCT01476696|1051069|P1|NOT COMPLETED|Overall Study||3
428875|NCT01476696|1051067|P3|COMPLETED|Overall Study||9
428876|NCT01476696|1051068|P2|COMPLETED|Overall Study||8
428877|NCT01476696|1051069|P1|COMPLETED|Overall Study||12
428878|NCT01476696|1051067|P3|Received at Least 1 Dose of Study Drug|Overall Study||9
428879|NCT01476696|1051068|P2|Received at Least 1 Dose of Study Drug|Overall Study||9
428880|NCT01476696|1051069|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
428881|NCT01476696|1051067|P3|STARTED|Overall Study||9
428882|NCT01476696|1051068|P2|STARTED|Overall Study||9
428883|NCT01476696|1051069|P1|STARTED|Overall Study||15
428884|NCT01476475|1051085|P2|NOT COMPLETED|Overall Study||3
428885|NCT01476475|1051086|P1|NOT COMPLETED|Overall Study||11
428886|NCT01476475|1051085|P2|COMPLETED|Overall Study||159
428887|NCT01476475|1051086|P1|COMPLETED|Overall Study||150
428888|NCT01476475|1051085|P2|STARTED|Overall Study||162
428889|NCT01476475|1051086|P1|STARTED|Overall Study||161
428890|NCT01476345|1051118|P2|NOT COMPLETED|Period 4||0
428891|NCT01476345|1051119|P1|NOT COMPLETED|Period 4||0
428892|NCT01476345|1051118|P2|COMPLETED|Period 4||39
428893|NCT01476345|1051119|P1|COMPLETED|Period 4||39
428894|NCT01476345|1051118|P2|STARTED|Period 4||39
428895|NCT01476345|1051119|P1|STARTED|Period 4||39
428896|NCT01476345|1051118|P2|NOT COMPLETED|Period 3||0
428897|NCT01476345|1051119|P1|NOT COMPLETED|Period 3||0
428898|NCT01476345|1051118|P2|COMPLETED|Period 3||39
428899|NCT01476345|1051119|P1|COMPLETED|Period 3||39
428900|NCT01476345|1051118|P2|STARTED|Period 3||39
428901|NCT01476345|1051119|P1|STARTED|Period 3||39
428902|NCT01476345|1051118|P2|NOT COMPLETED|Period 2||0
428903|NCT01476345|1051119|P1|NOT COMPLETED|Period 2||0
428904|NCT01476345|1051118|P2|COMPLETED|Period 2|1 did not enter Period 3 due to participant's decision.|40
428905|NCT01476345|1051119|P1|COMPLETED|Period 2|1 did not enter Period 3 due to participant's decision.|40
428906|NCT01476345|1051118|P2|STARTED|Period 2||40
428907|NCT01476345|1051119|P1|STARTED|Period 2||40
428908|NCT01476345|1051118|P2|NOT COMPLETED|Period 1||0
428909|NCT01476345|1051119|P1|NOT COMPLETED|Period 1||0
428910|NCT01476345|1051118|P2|COMPLETED|Period 1||40
428911|NCT01476345|1051119|P1|COMPLETED|Period 1||40
428912|NCT01476345|1051118|P2|Received at Least 1 Dose of Study Drug|Period 1||40
428913|NCT01476345|1051119|P1|Received at Least 1 Dose of Study Drug|Period 1||40
428914|NCT01476345|1051118|P2|STARTED|Period 1||40
428915|NCT01476345|1051119|P1|STARTED|Period 1||40
428916|NCT01476202|1051134|P3|NOT COMPLETED|Overall Study||0
428917|NCT01476202|1051135|P2|NOT COMPLETED|Overall Study||0
428918|NCT01476202|1051136|P1|NOT COMPLETED|Overall Study||0
428919|NCT01476202|1051134|P3|COMPLETED|Overall Study||40
428920|NCT01476202|1051135|P2|COMPLETED|Overall Study||40
428921|NCT01476202|1051136|P1|COMPLETED|Overall Study||40
428922|NCT01476202|1051134|P3|STARTED|Overall Study||40
428923|NCT01476202|1051135|P2|STARTED|Overall Study||40
428924|NCT01476202|1051136|P1|STARTED|Overall Study||40
428925|NCT01475955|1051152|P5|NOT COMPLETED|Overall Study||0
428926|NCT01475955|1051153|P4|NOT COMPLETED|Overall Study||0
428927|NCT01475955|1051154|P3|NOT COMPLETED|Overall Study||3
428928|NCT01475955|1051155|P2|NOT COMPLETED|Overall Study||0
428929|NCT01475955|1051156|P1|NOT COMPLETED|Overall Study||1
428930|NCT01475955|1051152|P5|COMPLETED|Overall Study||46
428931|NCT01475955|1051153|P4|COMPLETED|Overall Study||46
428932|NCT01475955|1051154|P3|COMPLETED|Overall Study||44
428933|NCT01475955|1051155|P2|COMPLETED|Overall Study||48
428934|NCT01475955|1051156|P1|COMPLETED|Overall Study||47
428935|NCT01475955|1051152|P5|STARTED|Overall Study||46
428936|NCT01475955|1051153|P4|STARTED|Overall Study||46
428937|NCT01475955|1051154|P3|STARTED|Overall Study||47
428938|NCT01475955|1051155|P2|STARTED|Overall Study||48
428939|NCT01475955|1051156|P1|STARTED|Overall Study||48
428940|NCT01475851|1051515|P2|NOT COMPLETED|Overall Study||0
428941|NCT01475851|1051516|P1|NOT COMPLETED|Overall Study||1
428942|NCT01475851|1051515|P2|COMPLETED|Overall Study||21
428943|NCT01475851|1051516|P1|COMPLETED|Overall Study||12
428944|NCT01475851|1051515|P2|STARTED|Overall Study||21
428945|NCT01475851|1051516|P1|STARTED|Overall Study||13
428946|NCT01475838|1051544|P2|NOT COMPLETED|Extension Phase||0
428947|NCT01475838|1051545|P1|NOT COMPLETED|Extension Phase||1
428948|NCT01475838|1051544|P2|COMPLETED|Extension Phase||20
428949|NCT01475838|1051545|P1|COMPLETED|Extension Phase||41
428950|NCT01475838|1051544|P2|STARTED|Extension Phase||20
428951|NCT01475838|1051545|P1|STARTED|Extension Phase||42
428952|NCT01475838|1051544|P2|NOT COMPLETED|Randomized Phase||36
428953|NCT01475838|1051545|P1|NOT COMPLETED|Randomized Phase||30
428954|NCT01475838|1051544|P2|COMPLETED|Randomized Phase||109
428955|NCT01475838|1051545|P1|COMPLETED|Randomized Phase||263
428956|NCT01475838|1051544|P2|STARTED|Randomized Phase||145
428957|NCT01475838|1051545|P1|STARTED|Randomized Phase||293
428958|NCT01475734|1051560|P2|NOT COMPLETED|Overall Study||1
428959|NCT01475734|1051561|P1|NOT COMPLETED|Overall Study||2
428960|NCT01475734|1051560|P2|COMPLETED|Overall Study||21
428961|NCT01475734|1051561|P1|COMPLETED|Overall Study||20
428962|NCT01475734|1051560|P2|STARTED|Overall Study||22
428963|NCT01475734|1051561|P1|STARTED|Overall Study||22
428964|NCT01475721|1051589|P2|NOT COMPLETED|Overall Study||14
428965|NCT01475721|1051590|P1|NOT COMPLETED|Overall Study||11
428966|NCT01475721|1051589|P2|COMPLETED|Overall Study||5831
428967|NCT01475721|1051590|P1|COMPLETED|Overall Study||5823
428968|NCT01475721|1051589|P2|STARTED|Overall Study||5845
428969|NCT01475721|1051590|P1|STARTED|Overall Study||5834
428970|NCT01475487|1051606|P2|NOT COMPLETED|Overall Study||1
428971|NCT01475487|1051607|P1|NOT COMPLETED|Overall Study||2
428972|NCT01475487|1051606|P2|COMPLETED|Overall Study||24
428973|NCT01475487|1051607|P1|COMPLETED|Overall Study||23
428974|NCT01475487|1051606|P2|STARTED|Overall Study||25
428975|NCT01475487|1051607|P1|STARTED|Overall Study||25
428976|NCT01475474|1051619|P1|NOT COMPLETED|Return to Baseline Period - 4 Weeks||2
428977|NCT01475474|1051619|P1|COMPLETED|Return to Baseline Period - 4 Weeks||71
428978|NCT01475474|1051619|P1|STARTED|Return to Baseline Period - 4 Weeks||73
428979|NCT01475474|1051619|P1|NOT COMPLETED|Treatment Period - 12 Weeks||18
428980|NCT01475474|1051619|P1|COMPLETED|Treatment Period - 12 Weeks||73
428981|NCT01475474|1051619|P1|STARTED|Treatment Period - 12 Weeks||91
428982|NCT01475474|1051619|P1|NOT COMPLETED|Baseline Period - 4 Weeks||6
428983|NCT01475474|1051619|P1|COMPLETED|Baseline Period - 4 Weeks||91
428984|NCT01475474|1051619|P1|STARTED|Baseline Period - 4 Weeks||97
428985|NCT01475461|1051630|P7|NOT COMPLETED|Treatment Period||2
428986|NCT01475461|1051631|P6|NOT COMPLETED|Treatment Period||5
428987|NCT01475461|1051632|P5|NOT COMPLETED|Treatment Period||4
428988|NCT01475461|1051633|P4|NOT COMPLETED|Treatment Period||8
428989|NCT01475461|1051634|P3|NOT COMPLETED|Treatment Period||4
428990|NCT01475461|1051635|P2|NOT COMPLETED|Treatment Period||9
428991|NCT01475461|1051636|P1|NOT COMPLETED|Treatment Period||0
428992|NCT01475461|1051630|P7|COMPLETED|Treatment Period||53
428993|NCT01475461|1051631|P6|COMPLETED|Treatment Period||51
428994|NCT01475461|1051632|P5|COMPLETED|Treatment Period||52
428995|NCT01475461|1051633|P4|COMPLETED|Treatment Period||46
428996|NCT01475461|1051634|P3|COMPLETED|Treatment Period||53
428997|NCT01475461|1051635|P2|COMPLETED|Treatment Period||48
428998|NCT01475461|1051636|P1|COMPLETED|Treatment Period||0
428999|NCT01475461|1051630|P7|STARTED|Treatment Period||55
429000|NCT01475461|1051631|P6|STARTED|Treatment Period||56
429001|NCT01475461|1051632|P5|STARTED|Treatment Period||56
429002|NCT01475461|1051633|P4|STARTED|Treatment Period||54
429003|NCT01475461|1051634|P3|STARTED|Treatment Period||57
429004|NCT01475461|1051635|P2|STARTED|Treatment Period||57
429005|NCT01475461|1051636|P1|STARTED|Treatment Period||0
429006|NCT01475461|1051630|P7|NOT COMPLETED|Run-in Period||0
429007|NCT01475461|1051631|P6|NOT COMPLETED|Run-in Period||0
429008|NCT01475461|1051632|P5|NOT COMPLETED|Run-in Period||0
429009|NCT01475461|1051633|P4|NOT COMPLETED|Run-in Period||0
429010|NCT01475461|1051634|P3|NOT COMPLETED|Run-in Period||0
429011|NCT01475461|1051635|P2|NOT COMPLETED|Run-in Period||0
429012|NCT01475461|1051636|P1|NOT COMPLETED|Run-in Period||41
429013|NCT01475461|1051630|P7|COMPLETED|Run-in Period||0
429014|NCT01475461|1051631|P6|COMPLETED|Run-in Period||0
429015|NCT01475461|1051632|P5|COMPLETED|Run-in Period||0
429016|NCT01475461|1051633|P4|COMPLETED|Run-in Period||0
429017|NCT01475461|1051634|P3|COMPLETED|Run-in Period||0
429018|NCT01475461|1051635|P2|COMPLETED|Run-in Period||0
429019|NCT01475461|1051636|P1|COMPLETED|Run-in Period||335
429020|NCT01475461|1051630|P7|STARTED|Run-in Period||0
429021|NCT01475461|1051631|P6|STARTED|Run-in Period||0
429022|NCT01475461|1051632|P5|STARTED|Run-in Period||0
429023|NCT01475461|1051633|P4|STARTED|Run-in Period||0
429024|NCT01475461|1051634|P3|STARTED|Run-in Period||0
429025|NCT01475461|1051635|P2|STARTED|Run-in Period||0
429026|NCT01475461|1051636|P1|STARTED|Run-in Period||376
429027|NCT01475331|1051716|P2|NOT COMPLETED|Overall Study||2
429028|NCT01475331|1051717|P1|NOT COMPLETED|Overall Study||5
429029|NCT01475331|1051716|P2|COMPLETED|Overall Study||21
429030|NCT01475331|1051717|P1|COMPLETED|Overall Study||18
429031|NCT01475331|1051716|P2|STARTED|Overall Study||23
429032|NCT01475331|1051717|P1|STARTED|Overall Study||23
429033|NCT01475305|1051725|P2|NOT COMPLETED|Overall Study||0
429034|NCT01475305|1051726|P1|NOT COMPLETED|Overall Study||0
429035|NCT01475305|1051725|P2|COMPLETED|Overall Study||3
429036|NCT01475305|1051726|P1|COMPLETED|Overall Study||4
429037|NCT01475305|1051725|P2|End of Quarantine, Day 15|Overall Study||3
429038|NCT01475305|1051726|P1|End of Quarantine, Day 15|Overall Study||4
429039|NCT01475305|1051725|P2|STARTED|Overall Study||3
429040|NCT01475305|1051726|P1|STARTED|Overall Study||4
429041|NCT01475253|1051769|P4|NOT COMPLETED|Open Label Extension||0
429042|NCT01475253|1051770|P3|NOT COMPLETED|Open Label Extension||0
429043|NCT01475253|1051771|P2|NOT COMPLETED|Open Label Extension||0
429044|NCT01475253|1051772|P1|NOT COMPLETED|Open Label Extension||0
429045|NCT01475253|1051769|P4|COMPLETED|Open Label Extension||56
429046|NCT01475253|1051770|P3|COMPLETED|Open Label Extension||0
429047|NCT01475253|1051771|P2|COMPLETED|Open Label Extension||0
429048|NCT01475253|1051772|P1|COMPLETED|Open Label Extension||0
429049|NCT01475253|1051769|P4|STARTED|Open Label Extension||56
429050|NCT01475253|1051770|P3|STARTED|Open Label Extension||0
429051|NCT01475253|1051771|P2|STARTED|Open Label Extension||0
429052|NCT01475253|1051772|P1|STARTED|Open Label Extension||0
429053|NCT01475253|1051769|P4|NOT COMPLETED|Randomized, Blinded Study||0
429054|NCT01475253|1051770|P3|NOT COMPLETED|Randomized, Blinded Study||0
429055|NCT01475253|1051771|P2|NOT COMPLETED|Randomized, Blinded Study||1
429056|NCT01475253|1051772|P1|NOT COMPLETED|Randomized, Blinded Study||2
429057|NCT01475253|1051769|P4|COMPLETED|Randomized, Blinded Study||0
429058|NCT01475253|1051770|P3|COMPLETED|Randomized, Blinded Study||11
429059|NCT01475253|1051771|P2|COMPLETED|Randomized, Blinded Study||45
429060|NCT01475253|1051772|P1|COMPLETED|Randomized, Blinded Study||45
429061|NCT01475253|1051769|P4|STARTED|Randomized, Blinded Study||0
429062|NCT01475253|1051770|P3|STARTED|Randomized, Blinded Study||11
429063|NCT01475253|1051771|P2|STARTED|Randomized, Blinded Study||46
429064|NCT01475253|1051772|P1|STARTED|Randomized, Blinded Study||47
429065|NCT01475214|1051801|P3|NOT COMPLETED|Overall Study||2
429066|NCT01475214|1051802|P2|NOT COMPLETED|Overall Study||4
429067|NCT01475214|1051803|P1|NOT COMPLETED|Overall Study||5
429068|NCT01475214|1051801|P3|COMPLETED|Overall Study||79
429069|NCT01475214|1051802|P2|COMPLETED|Overall Study||75
429070|NCT01475214|1051803|P1|COMPLETED|Overall Study||79
429071|NCT01475214|1051801|P3|STARTED|Overall Study||81
429072|NCT01475214|1051802|P2|STARTED|Overall Study||79
429073|NCT01475214|1051803|P1|STARTED|Overall Study||84
429074|NCT01475175|1051814|P1|NOT COMPLETED|Overall Study||0
429075|NCT01475175|1051814|P1|COMPLETED|Overall Study||12
429076|NCT01475175|1051814|P1|STARTED|Overall Study||12
429077|NCT01475097|1051828|P2|NOT COMPLETED|Overall Study||1
429078|NCT01475097|1051829|P1|NOT COMPLETED|Overall Study||1
429079|NCT01475097|1051828|P2|COMPLETED|Overall Study||126
429080|NCT01475097|1051829|P1|COMPLETED|Overall Study||127
429081|NCT01475097|1051828|P2|STARTED|Overall Study||127
429082|NCT01475097|1051829|P1|STARTED|Overall Study||128
429083|NCT01475071|1051837|P1|NOT COMPLETED|Overall Study||8
429084|NCT01475071|1051837|P1|COMPLETED|Overall Study||92
429085|NCT01475071|1051837|P1|STARTED|Overall Study||100
429086|NCT01474993|1051847|P2|NOT COMPLETED|Overall Study||3
429087|NCT01474993|1051848|P1|NOT COMPLETED|Overall Study||1
429088|NCT01474993|1051847|P2|COMPLETED|Overall Study||26
429089|NCT01474993|1051848|P1|COMPLETED|Overall Study||14
429090|NCT01474993|1051847|P2|STARTED|Overall Study||29
429091|NCT01474993|1051848|P1|STARTED|Overall Study||15
429092|NCT01474915|1051874|P2|NOT COMPLETED|Overall Study||10
429093|NCT01474915|1051875|P1|NOT COMPLETED|Overall Study||10
429094|NCT01474915|1051874|P2|COMPLETED|Overall Study||51
429095|NCT01474915|1051875|P1|COMPLETED|Overall Study||50
429096|NCT01474915|1051874|P2|STARTED|Overall Study||61
429097|NCT01474915|1051875|P1|STARTED|Overall Study||60
429098|NCT01474876|1051886|P3|NOT COMPLETED|Overall Study||0
429099|NCT01474876|1051887|P2|NOT COMPLETED|Overall Study||23
429100|NCT01474876|1051888|P1|NOT COMPLETED|Overall Study||66
429101|NCT01474876|1051886|P3|COMPLETED|Overall Study||1
429102|NCT01474876|1051887|P2|COMPLETED|Overall Study||128
429103|NCT01474876|1051888|P1|COMPLETED|Overall Study||337
429104|NCT01474876|1051886|P3|STARTED|Overall Study||1
429105|NCT01474876|1051887|P2|STARTED|Overall Study||151
429106|NCT01474876|1051888|P1|STARTED|Overall Study||403
429107|NCT01474863|1051922|P3|NOT COMPLETED|Overall Study||0
429108|NCT01474863|1051923|P2|NOT COMPLETED|Overall Study||0
429109|NCT01474863|1051924|P1|NOT COMPLETED|Overall Study||0
429110|NCT01474863|1051922|P3|COMPLETED|Overall Study||24
429111|NCT01474863|1051923|P2|COMPLETED|Overall Study||22
429112|NCT01474863|1051924|P1|COMPLETED|Overall Study||26
429113|NCT01474863|1051922|P3|STARTED|Overall Study||24
429114|NCT01474863|1051923|P2|STARTED|Overall Study||22
429115|NCT01474863|1051924|P1|STARTED|Overall Study||26
429116|NCT01474772|1051934|P2|NOT COMPLETED|Follow-up||1
429117|NCT01474772|1051935|P1|NOT COMPLETED|Follow-up||0
429118|NCT01474772|1051934|P2|COMPLETED|Follow-up||86
429119|NCT01474772|1051935|P1|COMPLETED|Follow-up||77
429120|NCT01474772|1051934|P2|STARTED|Follow-up||87
429121|NCT01474772|1051935|P1|STARTED|Follow-up||77
429122|NCT01474772|1051934|P2|NOT COMPLETED|Period 2||10
429123|NCT01474772|1051935|P1|NOT COMPLETED|Period 2||9
429124|NCT01474772|1051934|P2|COMPLETED|Period 2||87
429125|NCT01474772|1051935|P1|COMPLETED|Period 2||77
429126|NCT01474772|1051934|P2|STARTED|Period 2||97
429127|NCT01474772|1051935|P1|STARTED|Period 2||86
429128|NCT01474772|1051934|P2|NOT COMPLETED|Washout||2
429129|NCT01474772|1051935|P1|NOT COMPLETED|Washout||3
429130|NCT01474772|1051934|P2|COMPLETED|Washout||97
429131|NCT01474772|1051935|P1|COMPLETED|Washout||86
429132|NCT01474772|1051934|P2|STARTED|Washout||99
429133|NCT01474772|1051935|P1|STARTED|Washout||89
429134|NCT01474772|1051934|P2|NOT COMPLETED|Period 1||3
429135|NCT01474772|1051935|P1|NOT COMPLETED|Period 1||12
429136|NCT01474772|1051934|P2|COMPLETED|Period 1||99
429137|NCT01474772|1051935|P1|COMPLETED|Period 1||89
429138|NCT01474772|1051934|P2|STARTED|Period 1|STARTED=treated|102
429139|NCT01474772|1051935|P1|STARTED|Period 1|STARTED=treated. In Period 1 a participant discontinued due to an AE and later died due to the AE.|101
429140|NCT01474746|1051985|P2|NOT COMPLETED|Overall Study||2
429141|NCT01474746|1051986|P1|NOT COMPLETED|Overall Study||3
429142|NCT01474746|1051985|P2|COMPLETED|Overall Study||25
429143|NCT01474746|1051986|P1|COMPLETED|Overall Study||27
429144|NCT01474746|1051985|P2|STARTED|Overall Study||27
429145|NCT01474746|1051986|P1|STARTED|Overall Study||30
429146|NCT01474681|1052050|P4|NOT COMPLETED|Overall Study||6
429147|NCT01474681|1052051|P3|NOT COMPLETED|Overall Study||2
429148|NCT01474681|1052052|P2|NOT COMPLETED|Overall Study||3
429149|NCT01474681|1052053|P1|NOT COMPLETED|Overall Study||0
429150|NCT01474681|1052050|P4|COMPLETED|Overall Study||9
429151|NCT01474681|1052051|P3|COMPLETED|Overall Study||1
429152|NCT01474681|1052052|P2|COMPLETED|Overall Study||5
429153|NCT01474681|1052053|P1|COMPLETED|Overall Study||1
429154|NCT01474681|1052050|P4|STARTED|Overall Study||15
429155|NCT01474681|1052051|P3|STARTED|Overall Study||3
429156|NCT01474681|1052052|P2|STARTED|Overall Study||8
429157|NCT01474681|1052053|P1|STARTED|Overall Study||1
429158|NCT01474590|1052097|P2|NOT COMPLETED|Overall Study||17
429159|NCT01474590|1052098|P1|NOT COMPLETED|Overall Study||28
429160|NCT01474590|1052097|P2|COMPLETED|Overall Study||116
429161|NCT01474590|1052098|P1|COMPLETED|Overall Study||105
429162|NCT01474590|1052097|P2|STARTED|Overall Study||133
429163|NCT01474590|1052098|P1|STARTED|Overall Study||133
429164|NCT01474551|1052104|P1|NOT COMPLETED|Overall Study||1
429165|NCT01474551|1052104|P1|COMPLETED|Overall Study||1
429166|NCT01474551|1052104|P1|STARTED|Overall Study||2
429167|NCT01474538|1052110|P2|NOT COMPLETED|Treatment Period 2||2
429168|NCT01474538|1052111|P1|NOT COMPLETED|Treatment Period 2||6
429169|NCT01474538|1052110|P2|COMPLETED|Treatment Period 2||56
429170|NCT01474538|1052111|P1|COMPLETED|Treatment Period 2||51
429171|NCT01474538|1052110|P2|Received at Least 1 Dose of Study Drug|Treatment Period 2||58
429172|NCT01474538|1052111|P1|Received at Least 1 Dose of Study Drug|Treatment Period 2||57
429173|NCT01474538|1052110|P2|STARTED|Treatment Period 2||58
429174|NCT01474538|1052111|P1|STARTED|Treatment Period 2||57
429175|NCT01474538|1052110|P2|NOT COMPLETED|Treatment Period 1||4
429176|NCT01474538|1052111|P1|NOT COMPLETED|Treatment Period 1||3
429177|NCT01474538|1052110|P2|COMPLETED|Treatment Period 1||58
429178|NCT01474538|1052111|P1|COMPLETED|Treatment Period 1||57
429179|NCT01474538|1052110|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||62
429180|NCT01474538|1052111|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||60
429181|NCT01474538|1052110|P2|STARTED|Treatment Period 1||62
429182|NCT01474538|1052111|P1|STARTED|Treatment Period 1||60
429183|NCT01474512|1052128|P10|NOT COMPLETED|Maintenance Period||18
429184|NCT01474512|1052129|P9|NOT COMPLETED|Maintenance Period||16
429185|NCT01474512|1052130|P8|NOT COMPLETED|Maintenance Period||41
429186|NCT01474512|1052131|P7|NOT COMPLETED|Maintenance Period||10
429187|NCT01474512|1052132|P6|NOT COMPLETED|Maintenance Period||52
429188|NCT01474512|1052133|P5|NOT COMPLETED|Maintenance Period||119
429189|NCT01474512|1052134|P4|NOT COMPLETED|Maintenance Period||202
429190|NCT01474512|1052135|P3|NOT COMPLETED|Maintenance Period||0
429191|NCT01474512|1052136|P2|NOT COMPLETED|Maintenance Period||0
429192|NCT01474512|1052137|P1|NOT COMPLETED|Maintenance Period||0
429193|NCT01474512|1052128|P10|COMPLETED|Maintenance Period||44
429194|NCT01474512|1052129|P9|COMPLETED|Maintenance Period||62
429195|NCT01474512|1052130|P8|COMPLETED|Maintenance Period||350
429196|NCT01474512|1052131|P7|COMPLETED|Maintenance Period||6
429197|NCT01474512|1052132|P6|COMPLETED|Maintenance Period||177
429198|NCT01474512|1052133|P5|COMPLETED|Maintenance Period||108
429199|NCT01474512|1052134|P4|COMPLETED|Maintenance Period||24
429200|NCT01474512|1052135|P3|COMPLETED|Maintenance Period||0
429201|NCT01474512|1052136|P2|COMPLETED|Maintenance Period||0
429202|NCT01474512|1052137|P1|COMPLETED|Maintenance Period||0
429203|NCT01474512|1052128|P10|Received Study Drug|Maintenance Period||62
429204|NCT01474512|1052129|P9|Received Study Drug|Maintenance Period||78
429205|NCT01474512|1052130|P8|Received Study Drug|Maintenance Period||391
429206|NCT01474512|1052131|P7|Received Study Drug|Maintenance Period||16
429207|NCT01474512|1052132|P6|Received Study Drug|Maintenance Period||229
429208|NCT01474512|1052133|P5|Received Study Drug|Maintenance Period||227
429209|NCT01474512|1052134|P4|Received Study Drug|Maintenance Period||226
429210|NCT01474512|1052135|P3|Received Study Drug|Maintenance Period||0
429211|NCT01474512|1052136|P2|Received Study Drug|Maintenance Period||0
429212|NCT01474512|1052137|P1|Received Study Drug|Maintenance Period||0
429213|NCT01474512|1052128|P10|STARTED|Maintenance Period||62
429214|NCT01474512|1052129|P9|STARTED|Maintenance Period||78
429215|NCT01474512|1052130|P8|STARTED|Maintenance Period||391
429216|NCT01474512|1052131|P7|STARTED|Maintenance Period||16
429217|NCT01474512|1052132|P6|STARTED|Maintenance Period||229
429218|NCT01474512|1052133|P5|STARTED|Maintenance Period|One participant withdrew end of Induction but re-randomized and treated with maintenance dose ixe.|227
429219|NCT01474512|1052134|P4|STARTED|Maintenance Period||226
429220|NCT01474512|1052135|P3|STARTED|Maintenance Period||0
429221|NCT01474512|1052136|P2|STARTED|Maintenance Period||0
429222|NCT01474512|1052137|P1|STARTED|Maintenance Period||0
429223|NCT01474512|1052128|P10|NOT COMPLETED|Induction Period||0
429224|NCT01474512|1052129|P9|NOT COMPLETED|Induction Period||0
429225|NCT01474512|1052130|P8|NOT COMPLETED|Induction Period||0
429226|NCT01474512|1052131|P7|NOT COMPLETED|Induction Period||0
429227|NCT01474512|1052132|P6|NOT COMPLETED|Induction Period||0
429228|NCT01474512|1052133|P5|NOT COMPLETED|Induction Period||0
429229|NCT01474512|1052134|P4|NOT COMPLETED|Induction Period||0
429230|NCT01474512|1052135|P3|NOT COMPLETED|Induction Period||18
429231|NCT01474512|1052136|P2|NOT COMPLETED|Induction Period||24
429232|NCT01474512|1052137|P1|NOT COMPLETED|Induction Period||24
429233|NCT01474512|1052128|P10|COMPLETED|Induction Period||0
429234|NCT01474512|1052129|P9|COMPLETED|Induction Period||0
429235|NCT01474512|1052130|P8|COMPLETED|Induction Period||0
429236|NCT01474512|1052131|P7|COMPLETED|Induction Period||0
429237|NCT01474512|1052132|P6|COMPLETED|Induction Period||0
429238|NCT01474512|1052133|P5|COMPLETED|Induction Period||0
429239|NCT01474512|1052134|P4|COMPLETED|Induction Period||0
429240|NCT01474512|1052135|P3|COMPLETED|Induction Period||415
429241|NCT01474512|1052136|P2|COMPLETED|Induction Period||408
429242|NCT01474512|1052137|P1|COMPLETED|Induction Period||407
429243|NCT01474512|1052128|P10|Received Study Drug|Induction Period||0
429244|NCT01474512|1052129|P9|Received Study Drug|Induction Period||0
429245|NCT01474512|1052130|P8|Received Study Drug|Induction Period||0
429246|NCT01474512|1052131|P7|Received Study Drug|Induction Period||0
429247|NCT01474512|1052132|P6|Received Study Drug|Induction Period||0
429248|NCT01474512|1052133|P5|Received Study Drug|Induction Period||0
429249|NCT01474512|1052134|P4|Received Study Drug|Induction Period||0
429250|NCT01474512|1052135|P3|Received Study Drug|Induction Period||433
429251|NCT01474512|1052136|P2|Received Study Drug|Induction Period||432
429252|NCT01474512|1052137|P1|Received Study Drug|Induction Period||431
429253|NCT01474512|1052128|P10|STARTED|Induction Period||0
429254|NCT01474512|1052129|P9|STARTED|Induction Period||0
429255|NCT01474512|1052130|P8|STARTED|Induction Period||0
429256|NCT01474512|1052131|P7|STARTED|Induction Period||0
429257|NCT01474512|1052132|P6|STARTED|Induction Period||0
429258|NCT01474512|1052133|P5|STARTED|Induction Period||0
429259|NCT01474512|1052134|P4|STARTED|Induction Period||0
429260|NCT01474512|1052135|P3|STARTED|Induction Period||433
429261|NCT01474512|1052136|P2|STARTED|Induction Period||432
429262|NCT01474512|1052137|P1|STARTED|Induction Period||431
429263|NCT01474434|1052206|P4|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
429264|NCT01474434|1052207|P3|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
429265|NCT01474434|1052208|P2|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
429266|NCT01474434|1052209|P1|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
429267|NCT01474434|1052206|P4|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||11
429268|NCT01474434|1052207|P3|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||10
429269|NCT01474434|1052208|P2|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||9
429270|NCT01474434|1052209|P1|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||7
429271|NCT01474434|1052206|P4|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||11
429272|NCT01474434|1052207|P3|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||10
429273|NCT01474434|1052208|P2|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||9
429274|NCT01474434|1052209|P1|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||7
429275|NCT01474434|1052206|P4|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||2
429276|NCT01474434|1052207|P3|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1
429277|NCT01474434|1052208|P2|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||0
429278|NCT01474434|1052209|P1|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1
429279|NCT01474434|1052206|P4|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||11
429280|NCT01474434|1052207|P3|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||10
429281|NCT01474434|1052208|P2|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||9
429282|NCT01474434|1052209|P1|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||7
429283|NCT01474434|1052206|P4|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||13
429284|NCT01474434|1052207|P3|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||11
429285|NCT01474434|1052208|P2|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||9
429286|NCT01474434|1052209|P1|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||8
429287|NCT01474317|1052251|P1|NOT COMPLETED|Overall Study||2
429288|NCT01474317|1052251|P1|COMPLETED|Overall Study||224
429289|NCT01474317|1052251|P1|STARTED|Overall Study||226
429290|NCT01474291|1052260|P1|NOT COMPLETED|Overall Study||220
429291|NCT01474291|1052260|P1|COMPLETED|Overall Study||383
429292|NCT01474291|1052260|P1|Evaluable for Efficacy|Overall Study|Received tocilizumab infusion and met all inclusion/exclusion criteria|577
429293|NCT01474291|1052260|P1|STARTED|Overall Study||603
429294|NCT01474239|1052304|P2|NOT COMPLETED|Overall Study||32
429295|NCT01474239|1052305|P1|NOT COMPLETED|Overall Study||59
429296|NCT01474239|1052304|P2|COMPLETED|Overall Study||0
429297|NCT01474239|1052305|P1|COMPLETED|Overall Study||0
429298|NCT01474239|1052304|P2|STARTED|Overall Study||32
429299|NCT01474239|1052305|P1|STARTED|Overall Study||59
429300|NCT01474213|1052343|P2|NOT COMPLETED|Overall Study||0
429301|NCT01474213|1052344|P1|NOT COMPLETED|Overall Study||0
429302|NCT01474213|1052343|P2|COMPLETED|Overall Study||20
429303|NCT01474213|1052344|P1|COMPLETED|Overall Study||20
429304|NCT01474213|1052343|P2|STARTED|Overall Study||20
429305|NCT01474213|1052344|P1|STARTED|Overall Study||20
429306|NCT01474200|1052368|P2|NOT COMPLETED|Overall Study||30
429307|NCT01474200|1052369|P1|NOT COMPLETED|Overall Study||29
429308|NCT01474200|1052368|P2|COMPLETED|Overall Study||84
429309|NCT01474200|1052369|P1|COMPLETED|Overall Study||81
429310|NCT01474200|1052368|P2|STARTED|Overall Study||114
429311|NCT01474200|1052369|P1|STARTED|Overall Study||110
429312|NCT01474122|1052422|P3|NOT COMPLETED|Period 2: Week 16 to End of Study||15
429313|NCT01474122|1052423|P2|NOT COMPLETED|Period 2: Week 16 to End of Study||13
429314|NCT01474122|1052424|P1|NOT COMPLETED|Period 2: Week 16 to End of Study||17
429315|NCT01474122|1052422|P3|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|73
429316|NCT01474122|1052423|P2|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|73
429317|NCT01474122|1052424|P1|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|70
429318|NCT01474122|1052422|P3|STARTED|Period 2: Week 16 to End of Study||88
429319|NCT01474122|1052423|P2|STARTED|Period 2: Week 16 to End of Study||86
429320|NCT01474122|1052424|P1|STARTED|Period 2: Week 16 to End of Study||87
429321|NCT01474122|1052422|P3|NOT COMPLETED|Period 1: Baseline to Week 16||1
429322|NCT01474122|1052423|P2|NOT COMPLETED|Period 1: Baseline to Week 16||2
429323|NCT01474122|1052424|P1|NOT COMPLETED|Period 1: Baseline to Week 16||1
429324|NCT01474122|1052422|P3|COMPLETED|Period 1: Baseline to Week 16||88
429325|NCT01474122|1052423|P2|COMPLETED|Period 1: Baseline to Week 16||86
429326|NCT01474122|1052424|P1|COMPLETED|Period 1: Baseline to Week 16||87
429327|NCT01474122|1052422|P3|STARTED|Period 1: Baseline to Week 16||89
429328|NCT01474122|1052423|P2|STARTED|Period 1: Baseline to Week 16|One patient was randomised but did not receive study treatment|88
429329|NCT01474122|1052424|P1|STARTED|Period 1: Baseline to Week 16||88
429330|NCT01474109|1052450|P3|NOT COMPLETED|Period 2: Week 16 to End of Study||12
429331|NCT01474109|1052451|P2|NOT COMPLETED|Period 2: Week 16 to End of Study||18
429332|NCT01474109|1052452|P1|NOT COMPLETED|Period 2: Week 16 to End of Study||18
429333|NCT01474109|1052450|P3|COMPLETED|Period 2: Week 16 to End of Study||83
429334|NCT01474109|1052451|P2|COMPLETED|Period 2: Week 16 to End of Study||73
429335|NCT01474109|1052452|P1|COMPLETED|Period 2: Week 16 to End of Study||70
429336|NCT01474109|1052450|P3|STARTED|Period 2: Week 16 to End of Study||95
429337|NCT01474109|1052451|P2|STARTED|Period 2: Week 16 to End of Study||91
429338|NCT01474109|1052452|P1|STARTED|Period 2: Week 16 to End of Study||88
429339|NCT01474109|1052450|P3|NOT COMPLETED|Period 1: Baseline to Week 16||2
429340|NCT01474109|1052451|P2|NOT COMPLETED|Period 1: Baseline to Week 16||6
429341|NCT01474109|1052452|P1|NOT COMPLETED|Period 1: Baseline to Week 16||7
429342|NCT01474109|1052450|P3|COMPLETED|Period 1: Baseline to Week 16||95
429343|NCT01474109|1052451|P2|COMPLETED|Period 1: Baseline to Week 16||91
429344|NCT01474109|1052452|P1|COMPLETED|Period 1: Baseline to Week 16||88
429345|NCT01474109|1052450|P3|STARTED|Period 1: Baseline to Week 16||97
429346|NCT01474109|1052451|P2|STARTED|Period 1: Baseline to Week 16||97
429347|NCT01474109|1052452|P1|STARTED|Period 1: Baseline to Week 16||95
429348|NCT01473992|1052477|P3|NOT COMPLETED|Overall Study||0
429349|NCT01473992|1052478|P2|NOT COMPLETED|Overall Study||0
429350|NCT01473992|1052479|P1|NOT COMPLETED|Overall Study||0
429351|NCT01473992|1052477|P3|COMPLETED|Overall Study||5
429352|NCT01473992|1052478|P2|COMPLETED|Overall Study||10
429353|NCT01473992|1052479|P1|COMPLETED|Overall Study||10
429354|NCT01473992|1052477|P3|STARTED|Overall Study||5
429355|NCT01473992|1052478|P2|STARTED|Overall Study||10
429356|NCT01473992|1052479|P1|STARTED|Overall Study||10
429357|NCT01473953|1052499|P5|NOT COMPLETED|Overall Study||0
429358|NCT01473953|1052500|P4|NOT COMPLETED|Overall Study||0
429359|NCT01473953|1052501|P3|NOT COMPLETED|Overall Study||0
429360|NCT01473953|1052502|P2|NOT COMPLETED|Overall Study||0
429361|NCT01473953|1052503|P1|NOT COMPLETED|Overall Study||1
429362|NCT01473953|1052499|P5|COMPLETED|Overall Study||8
429363|NCT01473953|1052500|P4|COMPLETED|Overall Study||5
429364|NCT01473953|1052501|P3|COMPLETED|Overall Study||6
429365|NCT01473953|1052502|P2|COMPLETED|Overall Study||6
429366|NCT01473953|1052503|P1|COMPLETED|Overall Study||5
429367|NCT01473953|1052499|P5|STARTED|Overall Study||8
429368|NCT01473953|1052500|P4|STARTED|Overall Study||5
429369|NCT01473953|1052501|P3|STARTED|Overall Study||6
429370|NCT01473953|1052502|P2|STARTED|Overall Study||6
429371|NCT01473953|1052503|P1|STARTED|Overall Study||6
429372|NCT01473836|1052545|P1|NOT COMPLETED|Overall Study||6
429373|NCT01473836|1052545|P1|COMPLETED|Overall Study||32
429374|NCT01473836|1052545|P1|STARTED|Overall Study||38
429375|NCT01473758|1052556|P4|NOT COMPLETED|Cycle 2||0
429376|NCT01473758|1052557|P3|NOT COMPLETED|Cycle 2||5
429377|NCT01473758|1052558|P2|NOT COMPLETED|Cycle 2||0
429378|NCT01473758|1052559|P1|NOT COMPLETED|Cycle 2||0
429379|NCT01473758|1052556|P4|COMPLETED|Cycle 2||4
429380|NCT01473758|1052557|P3|COMPLETED|Cycle 2||5
429381|NCT01473758|1052558|P2|COMPLETED|Cycle 2||0
429382|NCT01473758|1052559|P1|COMPLETED|Cycle 2||0
429383|NCT01473758|1052556|P4|STARTED|Cycle 2||4
429384|NCT01473758|1052557|P3|STARTED|Cycle 2||10
429385|NCT01473758|1052558|P2|STARTED|Cycle 2||0
429386|NCT01473758|1052559|P1|STARTED|Cycle 2||0
429387|NCT01473758|1052556|P4|NOT COMPLETED|Cycle 1||0
429388|NCT01473758|1052557|P3|NOT COMPLETED|Cycle 1||0
429389|NCT01473758|1052558|P2|NOT COMPLETED|Cycle 1||3
429390|NCT01473758|1052559|P1|NOT COMPLETED|Cycle 1||11
429391|NCT01473758|1052556|P4|COMPLETED|Cycle 1||0
429392|NCT01473758|1052557|P3|COMPLETED|Cycle 1||0
429393|NCT01473758|1052558|P2|COMPLETED|Cycle 1||40
429394|NCT01473758|1052559|P1|COMPLETED|Cycle 1||27
429395|NCT01473758|1052556|P4|STARTED|Cycle 1||0
429396|NCT01473758|1052557|P3|STARTED|Cycle 1||0
429397|NCT01473758|1052558|P2|STARTED|Cycle 1||43
429398|NCT01473758|1052559|P1|STARTED|Cycle 1||38
429399|NCT01473745|1052683|P2|NOT COMPLETED|Overall Study||0
429400|NCT01473745|1052684|P1|NOT COMPLETED|Overall Study||0
429401|NCT01473745|1052683|P2|COMPLETED|Overall Study||24
429402|NCT01473745|1052684|P1|COMPLETED|Overall Study||24
429403|NCT01473745|1052683|P2|STARTED|Overall Study||24
429404|NCT01473745|1052684|P1|STARTED|Overall Study||24
429405|NCT01473602|1052696|P2|NOT COMPLETED|Overall Study||8
429406|NCT01473602|1052697|P1|NOT COMPLETED|Overall Study||8
429407|NCT01473602|1052696|P2|COMPLETED|Overall Study||13
429408|NCT01473602|1052697|P1|COMPLETED|Overall Study||10
429409|NCT01473602|1052696|P2|Completed 12 Months|Overall Study||13
429410|NCT01473602|1052697|P1|Completed 12 Months|Overall Study||10
429411|NCT01473602|1052696|P2|Completed 6 Months|Overall Study||15
429412|NCT01473602|1052697|P1|Completed 6 Months|Overall Study||12
429413|NCT01473602|1052696|P2|Received at Least 1 Dose of Study Drug|Overall Study||20
429414|NCT01473602|1052697|P1|Received at Least 1 Dose of Study Drug|Overall Study||18
429415|NCT01473602|1052696|P2|STARTED|Overall Study||21
429416|NCT01473602|1052697|P1|STARTED|Overall Study||18
429417|NCT01473589|1052733|P2|NOT COMPLETED|Overall Study||16
429418|NCT01473589|1052734|P1|NOT COMPLETED|Overall Study||11
429419|NCT01473589|1052733|P2|COMPLETED|Overall Study||46
429420|NCT01473589|1052734|P1|COMPLETED|Overall Study||49
429421|NCT01473589|1052733|P2|Completed 12 Months|Overall Study||48
429422|NCT01473589|1052734|P1|Completed 12 Months|Overall Study||49
429423|NCT01473589|1052733|P2|Completed 6 Months|Overall Study||54
429424|NCT01473589|1052734|P1|Completed 6 Months|Overall Study||51
429425|NCT01473589|1052733|P2|Received at Least 1 Dose of Study Drug|Overall Study|Randomized participants who received at least 1 dose of study drug.|61
429426|NCT01473589|1052734|P1|Received at Least 1 Dose of Study Drug|Overall Study|Randomized participants who received at least 1 dose of study drug.|60
429427|NCT01473589|1052733|P2|STARTED|Overall Study||62
429428|NCT01473589|1052734|P1|STARTED|Overall Study||60
429429|NCT01473563|1052768|P1|NOT COMPLETED|Overall Study||1
429430|NCT01473563|1052768|P1|COMPLETED|Overall Study||51
429431|NCT01473563|1052768|P1|Received at Least 1 Dose of Study Drug|Overall Study||52
429432|NCT01473563|1052768|P1|STARTED|Overall Study||52
429433|NCT01473524|1052790|P3|NOT COMPLETED|Overall Study||3
429434|NCT01473524|1052791|P2|NOT COMPLETED|Overall Study||9
429435|NCT01473524|1052792|P1|NOT COMPLETED|Overall Study||7
429436|NCT01473524|1052790|P3|COMPLETED|Overall Study||70
429437|NCT01473524|1052791|P2|COMPLETED|Overall Study||64
429438|NCT01473524|1052792|P1|COMPLETED|Overall Study||64
429439|NCT01473524|1052790|P3|STARTED|Overall Study||73
429440|NCT01473524|1052791|P2|STARTED|Overall Study||73
429441|NCT01473524|1052792|P1|STARTED|Overall Study||71
429442|NCT01473420|1052825|P2|NOT COMPLETED|Maintenance Period (16 Weeks)||17
429443|NCT01473420|1052826|P1|NOT COMPLETED|Maintenance Period (16 Weeks)||18
429444|NCT01473420|1052825|P2|COMPLETED|Maintenance Period (16 Weeks)||105
429445|NCT01473420|1052826|P1|COMPLETED|Maintenance Period (16 Weeks)||106
429446|NCT01473420|1052825|P2|STARTED|Maintenance Period (16 Weeks)||122
429447|NCT01473420|1052826|P1|STARTED|Maintenance Period (16 Weeks)||124
429448|NCT01473420|1052825|P2|NOT COMPLETED|Titration Period (18 Weeks)||38
429449|NCT01473420|1052826|P1|NOT COMPLETED|Titration Period (18 Weeks)||36
429450|NCT01473420|1052825|P2|COMPLETED|Titration Period (18 Weeks)||122
429451|NCT01473420|1052826|P1|COMPLETED|Titration Period (18 Weeks)||124
429452|NCT01473420|1052825|P2|Treated|Titration Period (18 Weeks)||86
429453|NCT01473420|1052826|P1|Treated|Titration Period (18 Weeks)||80
429454|NCT01473420|1052825|P2|STARTED|Titration Period (18 Weeks)||160
429455|NCT01473420|1052826|P1|STARTED|Titration Period (18 Weeks)||160
429456|NCT01473394|1052910|P2|NOT COMPLETED|Overall Study||43
429457|NCT01473394|1052911|P1|NOT COMPLETED|Overall Study||45
429458|NCT01473394|1052910|P2|COMPLETED|Overall Study||212
429459|NCT01473394|1052911|P1|COMPLETED|Overall Study||208
429460|NCT01473394|1052910|P2|STARTED|Overall Study||255
429461|NCT01473394|1052911|P1|STARTED|Overall Study||253
429462|NCT01473381|1052925|P4|NOT COMPLETED|Overall Study||89
429463|NCT01473381|1052926|P3|NOT COMPLETED|Overall Study||102
429464|NCT01473381|1052927|P2|NOT COMPLETED|Overall Study||93
429465|NCT01473381|1052928|P1|NOT COMPLETED|Overall Study||80
429466|NCT01473381|1052925|P4|COMPLETED|Overall Study||200
429467|NCT01473381|1052926|P3|COMPLETED|Overall Study||189
429468|NCT01473381|1052927|P2|COMPLETED|Overall Study||199
429469|NCT01473381|1052928|P1|COMPLETED|Overall Study||210
429470|NCT01473381|1052925|P4|Safety Population|Overall Study||282
429471|NCT01473381|1052926|P3|Safety Population|Overall Study||287
429472|NCT01473381|1052927|P2|Safety Population|Overall Study||288
429473|NCT01473381|1052928|P1|Safety Population|Overall Study||281
429474|NCT01473381|1052925|P4|STARTED|Overall Study||289
429475|NCT01473381|1052926|P3|STARTED|Overall Study||291
429476|NCT01473381|1052927|P2|STARTED|Overall Study||292
429477|NCT01473381|1052928|P1|STARTED|Overall Study||290
429478|NCT01473368|1052950|P4|NOT COMPLETED|Overall Study||0
429479|NCT01473368|1052951|P3|NOT COMPLETED|Overall Study||3
429480|NCT01473368|1052952|P2|NOT COMPLETED|Overall Study||0
429481|NCT01473368|1052953|P1|NOT COMPLETED|Overall Study||1
429482|NCT01473368|1052950|P4|COMPLETED|Overall Study||12
429483|NCT01473368|1052951|P3|COMPLETED|Overall Study||12
429484|NCT01473368|1052952|P2|COMPLETED|Overall Study||12
429485|NCT01473368|1052953|P1|COMPLETED|Overall Study||13
429486|NCT01473368|1052950|P4|STARTED|Overall Study||12
429487|NCT01473368|1052951|P3|STARTED|Overall Study||15
429488|NCT01473368|1052952|P2|STARTED|Overall Study||12
429489|NCT01473368|1052953|P1|STARTED|Overall Study||14
429490|NCT01473160|1052990|P1|NOT COMPLETED|Overall Study||0
429491|NCT01473160|1052990|P1|COMPLETED|Overall Study||9
429492|NCT01473160|1052990|P1|STARTED|Overall Study||9
429493|NCT01472965|1053010|P2|NOT COMPLETED|Overall Study||0
429494|NCT01472965|1053011|P1|NOT COMPLETED|Overall Study||1
429495|NCT01472965|1053010|P2|COMPLETED|Overall Study||46
429496|NCT01472965|1053011|P1|COMPLETED|Overall Study||48
429497|NCT01472965|1053010|P2|STARTED|Overall Study||46
429498|NCT01472965|1053011|P1|STARTED|Overall Study||49
429499|NCT01472939|1053031|P4|NOT COMPLETED|Overall Study||20
429500|NCT01472939|1053032|P3|NOT COMPLETED|Overall Study||11
429501|NCT01472939|1053033|P2|NOT COMPLETED|Overall Study||14
429502|NCT01472939|1053034|P1|NOT COMPLETED|Overall Study||20
429503|NCT01472939|1053031|P4|COMPLETED|Overall Study||99
429504|NCT01472939|1053032|P3|COMPLETED|Overall Study||108
429505|NCT01472939|1053033|P2|COMPLETED|Overall Study||105
429506|NCT01472939|1053034|P1|COMPLETED|Overall Study||103
429507|NCT01472939|1053031|P4|STARTED|Overall Study||119
429508|NCT01472939|1053032|P3|STARTED|Overall Study||119
429509|NCT01472939|1053033|P2|STARTED|Overall Study||119
429510|NCT01472939|1053034|P1|STARTED|Overall Study||123
429511|NCT01472874|1053061|P1|NOT COMPLETED|Overall Study||0
429512|NCT01472874|1053061|P1|COMPLETED|Overall Study||8
429513|NCT01472874|1053061|P1|STARTED|Overall Study||8
429514|NCT01472835|1053078|P2|NOT COMPLETED|Overall Study||0
429515|NCT01472835|1053079|P1|NOT COMPLETED|Overall Study||2
429516|NCT01472835|1053078|P2|COMPLETED|Overall Study||36
429517|NCT01472835|1053079|P1|COMPLETED|Overall Study||35
429518|NCT01472835|1053078|P2|STARTED|Overall Study||36
429519|NCT01472835|1053079|P1|STARTED|Overall Study||37
429520|NCT01472822|1053095|P2|NOT COMPLETED|Overall Study||2
429521|NCT01472822|1053096|P1|NOT COMPLETED|Overall Study||2
429522|NCT01472822|1053095|P2|COMPLETED|Overall Study||28
429523|NCT01472822|1053096|P1|COMPLETED|Overall Study||28
429524|NCT01472822|1053095|P2|STARTED|Overall Study||30
429525|NCT01472822|1053096|P1|STARTED|Overall Study||30
429526|NCT01472562|1053110|P1|NOT COMPLETED|Maintenance Phase (Week 49 to PD)||23
429527|NCT01472562|1053110|P1|COMPLETED|Maintenance Phase (Week 49 to PD)||4
429528|NCT01472562|1053110|P1|STARTED|Maintenance Phase (Week 49 to PD)||27
429529|NCT01472562|1053110|P1|NOT COMPLETED|Induction Phase (Week 1- 48)||11
429530|NCT01472562|1053110|P1|COMPLETED|Induction Phase (Week 1- 48)||27
429531|NCT01472562|1053110|P1|STARTED|Induction Phase (Week 1- 48)||38
429532|NCT01472432|1053117|P2|NOT COMPLETED|Overall Study||0
429533|NCT01472432|1053118|P1|NOT COMPLETED|Overall Study||0
429534|NCT01472432|1053117|P2|COMPLETED|Overall Study||53
429535|NCT01472432|1053118|P1|COMPLETED|Overall Study||53
429536|NCT01472432|1053117|P2|Ulcer Reduction|Overall Study||33
429537|NCT01472432|1053118|P1|Ulcer Reduction|Overall Study||13
429538|NCT01472432|1053117|P2|STARTED|Overall Study||53
429539|NCT01472432|1053118|P1|STARTED|Overall Study||53
429540|NCT01472380|1053134|P1|NOT COMPLETED|Efavirenz and FFA||0
429541|NCT01472380|1053134|P1|COMPLETED|Efavirenz and FFA||28
429542|NCT01472380|1053134|P1|STARTED|Efavirenz and FFA||28
429543|NCT01472380|1053134|P1|NOT COMPLETED|1 Day Period Between Dosing||1
429544|NCT01472380|1053134|P1|COMPLETED|1 Day Period Between Dosing||28
429545|NCT01472380|1053134|P1|STARTED|1 Day Period Between Dosing||29
429546|NCT01472380|1053134|P1|NOT COMPLETED|Fenofibric Acid (FFA) Alone||0
429547|NCT01472380|1053134|P1|COMPLETED|Fenofibric Acid (FFA) Alone||29
429548|NCT01472380|1053134|P1|STARTED|Fenofibric Acid (FFA) Alone||29
429549|NCT01472380|1053134|P1|NOT COMPLETED|Efavirenz Alone||1
429550|NCT01472380|1053134|P1|COMPLETED|Efavirenz Alone||29
429551|NCT01472380|1053134|P1|STARTED|Efavirenz Alone||30
429552|NCT01472341|1053145|P1|NOT COMPLETED|Overall Study||272
429553|NCT01472341|1053145|P1|COMPLETED|Overall Study||235
429554|NCT01472341|1053145|P1|STARTED|Overall Study||507
429555|NCT01472289|1053151|P1|NOT COMPLETED|Overall Study||2
429556|NCT01472289|1053151|P1|COMPLETED|Overall Study||15
429557|NCT01472289|1053151|P1|STARTED|Overall Study||17
429558|NCT01472185|1053163|P2|NOT COMPLETED|Overall Study||34
429559|NCT01472185|1053164|P1|NOT COMPLETED|Overall Study||34
429560|NCT01472185|1053163|P2|COMPLETED|Overall Study||199
429561|NCT01472185|1053164|P1|COMPLETED|Overall Study||198
429562|NCT01472185|1053163|P2|STARTED|Overall Study||233
429563|NCT01472185|1053164|P1|STARTED|Overall Study||232
429564|NCT01471782|1053184|P6|NOT COMPLETED|Overall Study||41
429565|NCT01471782|1053185|P5|NOT COMPLETED|Overall Study||26
429566|NCT01471782|1053186|P4|NOT COMPLETED|Overall Study||5
429567|NCT01471782|1053187|P3|NOT COMPLETED|Overall Study||5
429568|NCT01471782|1053188|P2|NOT COMPLETED|Overall Study||6
429569|NCT01471782|1053189|P1|NOT COMPLETED|Overall Study||5
429570|NCT01471782|1053184|P6|COMPLETED|Overall Study|Completed 5 cycles|3
429571|NCT01471782|1053185|P5|COMPLETED|Overall Study|Completed 5 cycles|0
429572|NCT01471782|1053186|P4|COMPLETED|Overall Study|Completed 5 cycles|1
429573|NCT01471782|1053187|P3|COMPLETED|Overall Study|Completed 5 cycles|0
429574|NCT01471782|1053188|P2|COMPLETED|Overall Study|Completed 5 cycles|1
429575|NCT01471782|1053189|P1|COMPLETED|Overall Study|Completed 5 cycles|0
429576|NCT01471782|1053184|P6|STARTED|Overall Study||44
429577|NCT01471782|1053185|P5|STARTED|Overall Study||26
429578|NCT01471782|1053186|P4|STARTED|Overall Study||6
429579|NCT01471782|1053187|P3|STARTED|Overall Study||5
429580|NCT01471782|1053188|P2|STARTED|Overall Study||7
429581|NCT01471782|1053189|P1|STARTED|Overall Study||5
429582|NCT01471691|1053243|P2|NOT COMPLETED|Overall Study||1
429583|NCT01471691|1053244|P1|NOT COMPLETED|Overall Study||0
429584|NCT01471691|1053243|P2|COMPLETED|Overall Study||5
429585|NCT01471691|1053244|P1|COMPLETED|Overall Study||8
429586|NCT01471691|1053243|P2|STARTED|Overall Study||6
429587|NCT01471691|1053244|P1|STARTED|Overall Study||8
429588|NCT01471379|1053253|P3|NOT COMPLETED|Overall Study||0
429589|NCT01471379|1053254|P2|NOT COMPLETED|Overall Study||1
429590|NCT01471379|1053255|P1|NOT COMPLETED|Overall Study||1
429591|NCT01471379|1053253|P3|COMPLETED|Overall Study||0
429592|NCT01471379|1053254|P2|COMPLETED|Overall Study||0
429593|NCT01471379|1053255|P1|COMPLETED|Overall Study||0
429594|NCT01471379|1053253|P3|STARTED|Overall Study||0
429595|NCT01471379|1053254|P2|STARTED|Overall Study||1
429596|NCT01471379|1053255|P1|STARTED|Overall Study||1
429597|NCT01471353|1053275|P1|NOT COMPLETED|Overall Study||3
429598|NCT01471353|1053275|P1|COMPLETED|Overall Study||39
429599|NCT01471353|1053275|P1|STARTED|Overall Study||42
429600|NCT01471340|1053283|P2|NOT COMPLETED|Overall Study||6
429601|NCT01471340|1053284|P1|NOT COMPLETED|Overall Study||6
429602|NCT01471340|1053283|P2|COMPLETED|Overall Study||5855
429603|NCT01471340|1053284|P1|COMPLETED|Overall Study||5862
429604|NCT01471340|1053283|P2|STARTED|Overall Study|This value corresponds to randomized participants who received at least of dose of study medication|5861
429605|NCT01471340|1053284|P1|STARTED|Overall Study|This value corresponds to randomized participants who received at least of dose of study medication|5868
429606|NCT01471639|1053294|P1|NOT COMPLETED|Overall Study||0
429607|NCT01471639|1053294|P1|COMPLETED|Overall Study||37
429608|NCT01471639|1053294|P1|STARTED|Overall Study||37
429609|NCT01471626|1053299|P1|NOT COMPLETED|Overall Study||0
429610|NCT01471626|1053299|P1|COMPLETED|Overall Study||21
429611|NCT01471626|1053299|P1|STARTED|Overall Study||21
429612|NCT01471574|1053307|P4|NOT COMPLETED|Follow-up Period||3
429613|NCT01471574|1053308|P3|NOT COMPLETED|Follow-up Period||7
429614|NCT01471574|1053309|P2|NOT COMPLETED|Follow-up Period||2
429615|NCT01471574|1053310|P1|NOT COMPLETED|Follow-up Period||7
429616|NCT01471574|1053307|P4|COMPLETED|Follow-up Period||21
429617|NCT01471574|1053308|P3|COMPLETED|Follow-up Period||95
429618|NCT01471574|1053309|P2|COMPLETED|Follow-up Period||32
429619|NCT01471574|1053310|P1|COMPLETED|Follow-up Period||114
429620|NCT01471574|1053307|P4|STARTED|Follow-up Period||24
429621|NCT01471574|1053308|P3|STARTED|Follow-up Period||102
429622|NCT01471574|1053309|P2|STARTED|Follow-up Period||34
429623|NCT01471574|1053310|P1|STARTED|Follow-up Period||121
429624|NCT01471574|1053307|P4|NOT COMPLETED|Treatment Period||3
429625|NCT01471574|1053308|P3|NOT COMPLETED|Treatment Period||24
429626|NCT01471574|1053309|P2|NOT COMPLETED|Treatment Period||10
429627|NCT01471574|1053310|P1|NOT COMPLETED|Treatment Period||31
429628|NCT01471574|1053307|P4|COMPLETED|Treatment Period||21
429629|NCT01471574|1053308|P3|COMPLETED|Treatment Period||82
429630|NCT01471574|1053309|P2|COMPLETED|Treatment Period||29
429631|NCT01471574|1053310|P1|COMPLETED|Treatment Period||101
429632|NCT01471574|1053307|P4|STARTED|Treatment Period||24
429633|NCT01471574|1053308|P3|STARTED|Treatment Period||106
429634|NCT01471574|1053309|P2|STARTED|Treatment Period||39
429635|NCT01471574|1053310|P1|STARTED|Treatment Period||132
429636|NCT01471197|1053341|P2|NOT COMPLETED|Overall Study||2
429637|NCT01471197|1053342|P1|NOT COMPLETED|Overall Study||6
429638|NCT01471197|1053341|P2|COMPLETED|Overall Study||0
429639|NCT01471197|1053342|P1|COMPLETED|Overall Study||0
429640|NCT01471197|1053341|P2|STARTED|Overall Study||2
429641|NCT01471197|1053342|P1|STARTED|Overall Study||6
429642|NCT01471171|1053352|P2|NOT COMPLETED|Treatment Period 2||0
429643|NCT01471171|1053353|P1|NOT COMPLETED|Treatment Period 2||1
429644|NCT01471171|1053352|P2|COMPLETED|Treatment Period 2||54
429645|NCT01471171|1053353|P1|COMPLETED|Treatment Period 2||52
429646|NCT01471171|1053352|P2|STARTED|Treatment Period 2||54
429647|NCT01471171|1053353|P1|STARTED|Treatment Period 2||53
429648|NCT01471171|1053352|P2|NOT COMPLETED|Treatment Period 1||1
429649|NCT01471171|1053353|P1|NOT COMPLETED|Treatment Period 1||4
429650|NCT01471171|1053352|P2|COMPLETED|Treatment Period 1||54
429651|NCT01471171|1053353|P1|COMPLETED|Treatment Period 1||53
429652|NCT01471171|1053352|P2|STARTED|Treatment Period 1||55
429653|NCT01471171|1053353|P1|STARTED|Treatment Period 1||57
429654|NCT01471041|1053363|P1|NOT COMPLETED|Overall Study||7
429655|NCT01471041|1053363|P1|COMPLETED|Overall Study||47
429656|NCT01471041|1053363|P1|STARTED|Overall Study||54
429657|NCT01471015|1053371|P3|NOT COMPLETED|Overall Study||1
429658|NCT01471015|1053372|P2|NOT COMPLETED|Overall Study||1
429659|NCT01471015|1053373|P1|NOT COMPLETED|Overall Study||0
429660|NCT01471015|1053371|P3|COMPLETED|Overall Study||9
429661|NCT01471015|1053372|P2|COMPLETED|Overall Study||9
429662|NCT01471015|1053373|P1|COMPLETED|Overall Study||10
429663|NCT01471015|1053371|P3|STARTED|Overall Study||10
429664|NCT01471015|1053372|P2|STARTED|Overall Study||10
429665|NCT01471015|1053373|P1|STARTED|Overall Study||10
429666|NCT01470859|1053387|P2|NOT COMPLETED|Overall Study||0
429667|NCT01470859|1053388|P1|NOT COMPLETED|Overall Study||1
429668|NCT01470859|1053387|P2|COMPLETED|Overall Study||15
429669|NCT01470859|1053388|P1|COMPLETED|Overall Study||14
429670|NCT01470859|1053387|P2|STARTED|Overall Study||15
429671|NCT01470859|1053388|P1|STARTED|Overall Study||15
429672|NCT01470651|1053404|P2|NOT COMPLETED|Overall Study||3
429673|NCT01470651|1053405|P1|NOT COMPLETED|Overall Study||7
429674|NCT01470651|1053404|P2|COMPLETED|Overall Study||10
429675|NCT01470651|1053405|P1|COMPLETED|Overall Study||6
429676|NCT01470651|1053404|P2|STARTED|Overall Study||13
429677|NCT01470651|1053405|P1|STARTED|Overall Study||13
429678|NCT01470599|1053415|P2|NOT COMPLETED|Overall Study||43
429679|NCT01470599|1053416|P1|NOT COMPLETED|Overall Study||19
429680|NCT01470599|1053415|P2|COMPLETED|Overall Study||45
429681|NCT01470599|1053416|P1|COMPLETED|Overall Study||43
429682|NCT01470599|1053415|P2|STARTED|Overall Study||88
429683|NCT01470599|1053416|P1|STARTED|Overall Study||62
429684|NCT01470469|1053480|P2|NOT COMPLETED|Overall Study||24
429685|NCT01470469|1053481|P1|NOT COMPLETED|Overall Study||10
429686|NCT01470469|1053480|P2|COMPLETED|Overall Study||38
429687|NCT01470469|1053481|P1|COMPLETED|Overall Study||11
429688|NCT01470469|1053480|P2|STARTED|Overall Study||62
429689|NCT01470469|1053481|P1|STARTED|Overall Study||21
429690|NCT01470417|1053501|P2|NOT COMPLETED|Overall Study||2
429691|NCT01470417|1053502|P1|NOT COMPLETED|Overall Study||0
429692|NCT01470417|1053501|P2|COMPLETED|Overall Study||5
429693|NCT01470417|1053502|P1|COMPLETED|Overall Study||3
429694|NCT01470417|1053501|P2|STARTED|Overall Study||7
429695|NCT01470417|1053502|P1|STARTED|Overall Study||3
429696|NCT01470248|1053514|P1|NOT COMPLETED|Overall Study||1
429697|NCT01470248|1053514|P1|COMPLETED|Overall Study||19
429698|NCT01470248|1053514|P1|STARTED|Overall Study||20
429699|NCT01470196|1053521|P1|NOT COMPLETED|Overall Study||0
429700|NCT01470196|1053521|P1|COMPLETED|Overall Study||31
429701|NCT01470196|1053521|P1|STARTED|Overall Study||31
429702|NCT01470170|1053534|P5|NOT COMPLETED|Overall Study||0
429703|NCT01470170|1053535|P4|NOT COMPLETED|Overall Study||0
429704|NCT01470170|1053536|P3|NOT COMPLETED|Overall Study||0
429705|NCT01470170|1053537|P2|NOT COMPLETED|Overall Study||0
429706|NCT01470170|1053538|P1|NOT COMPLETED|Overall Study||0
429707|NCT01470170|1053534|P5|COMPLETED|Overall Study||34
429708|NCT01470170|1053535|P4|COMPLETED|Overall Study||36
429709|NCT01470170|1053536|P3|COMPLETED|Overall Study||34
429710|NCT01470170|1053537|P2|COMPLETED|Overall Study||35
429711|NCT01470170|1053538|P1|COMPLETED|Overall Study||34
429712|NCT01470170|1053534|P5|STARTED|Overall Study||34
429713|NCT01470170|1053535|P4|STARTED|Overall Study||36
429714|NCT01470170|1053536|P3|STARTED|Overall Study||34
429715|NCT01470170|1053537|P2|STARTED|Overall Study||35
429716|NCT01470170|1053538|P1|STARTED|Overall Study||34
429717|NCT01470144|1053570|P1|NOT COMPLETED|Overall Study||10
429718|NCT01470144|1053570|P1|COMPLETED|Overall Study|"Completed corresponds to subjects switching to commercial EFI upon market approval/reimbursement"|31
429719|NCT01470144|1053570|P1|STARTED|Overall Study||41
429720|NCT01470118|1053578|P3|NOT COMPLETED|Overall Study||2
429721|NCT01470118|1053579|P2|NOT COMPLETED|Overall Study||5
429722|NCT01470118|1053580|P1|NOT COMPLETED|Overall Study||5
429723|NCT01470118|1053578|P3|COMPLETED|Overall Study||39
429724|NCT01470118|1053579|P2|COMPLETED|Overall Study||38
429725|NCT01470118|1053580|P1|COMPLETED|Overall Study||38
429726|NCT01470118|1053578|P3|STARTED|Overall Study||41
429727|NCT01470118|1053579|P2|STARTED|Overall Study||43
429728|NCT01470118|1053580|P1|STARTED|Overall Study||43
429729|NCT01470027|1053615|P3|NOT COMPLETED|Overall Study||1
429730|NCT01470027|1053616|P2|NOT COMPLETED|Overall Study||1
429731|NCT01470027|1053617|P1|NOT COMPLETED|Overall Study||1
429732|NCT01470027|1053615|P3|COMPLETED|Overall Study||15
429733|NCT01470027|1053616|P2|COMPLETED|Overall Study||14
429734|NCT01470027|1053617|P1|COMPLETED|Overall Study||15
429735|NCT01470027|1053615|P3|STARTED|Overall Study||16
429736|NCT01470027|1053616|P2|STARTED|Overall Study||15
429737|NCT01470027|1053617|P1|STARTED|Overall Study||16
429738|NCT01470001|1053675|P2|NOT COMPLETED|Overall Study||2
429739|NCT01470001|1053676|P1|NOT COMPLETED|Overall Study||5
429740|NCT01470001|1053675|P2|COMPLETED|Overall Study||58
429741|NCT01470001|1053676|P1|COMPLETED|Overall Study||53
429742|NCT01470001|1053675|P2|STARTED|Overall Study||60
429743|NCT01470001|1053676|P1|STARTED|Overall Study||58
429744|NCT01469819|1053686|P1|NOT COMPLETED|Overall Study||8
429745|NCT01469819|1053686|P1|COMPLETED|Overall Study||29
429746|NCT01469819|1053686|P1|STARTED|Overall Study||37
429747|NCT01469767|1053696|P1|NOT COMPLETED|Overall Study||0
429748|NCT01469767|1053696|P1|COMPLETED|Overall Study||10
429749|NCT01469767|1053696|P1|STARTED|Overall Study||10
429750|NCT01469715|1053704|P1|NOT COMPLETED|Overall Study||0
429751|NCT01469715|1053704|P1|COMPLETED|Overall Study||16
429752|NCT01469715|1053704|P1|STARTED|Overall Study||16
429753|NCT01469637|1053710|P2|NOT COMPLETED|Second Intervention||0
429754|NCT01469637|1053711|P1|NOT COMPLETED|Second Intervention||1
429755|NCT01469637|1053710|P2|COMPLETED|Second Intervention||21
429756|NCT01469637|1053711|P1|COMPLETED|Second Intervention||21
429757|NCT01469637|1053710|P2|STARTED|Second Intervention||21
429758|NCT01469637|1053711|P1|STARTED|Second Intervention||22
429759|NCT01469637|1053710|P2|NOT COMPLETED|First Intervention||1
429760|NCT01469637|1053711|P1|NOT COMPLETED|First Intervention||0
429761|NCT01469637|1053710|P2|COMPLETED|First Intervention||21
429762|NCT01469637|1053711|P1|COMPLETED|First Intervention||22
429763|NCT01469637|1053710|P2|STARTED|First Intervention||22
429764|NCT01469637|1053711|P1|STARTED|First Intervention||22
429765|NCT01469546|1053719|P1|NOT COMPLETED|Dose Escalation to 10 mg||0
429766|NCT01469546|1053719|P1|COMPLETED|Dose Escalation to 10 mg||19
429767|NCT01469546|1053719|P1|STARTED|Dose Escalation to 10 mg||19
429768|NCT01469546|1053719|P1|NOT COMPLETED|Received 5 mg Dose||23
429769|NCT01469546|1053719|P1|COMPLETED|Received 5 mg Dose||19
429770|NCT01469546|1053719|P1|Completed First Cycle|Received 5 mg Dose||30
429771|NCT01469546|1053719|P1|STARTED|Received 5 mg Dose||42
429772|NCT01469377|1053729|P3|NOT COMPLETED|Overall Study||66
429773|NCT01469377|1053730|P2|NOT COMPLETED|Overall Study||48
429774|NCT01469377|1053731|P1|NOT COMPLETED|Overall Study||35
429775|NCT01469377|1053729|P3|COMPLETED|Overall Study||210
429776|NCT01469377|1053730|P2|COMPLETED|Overall Study||226
429777|NCT01469377|1053731|P1|COMPLETED|Overall Study||234
429778|NCT01469377|1053729|P3|STARTED|Overall Study||276
429779|NCT01469377|1053730|P2|STARTED|Overall Study||274
429780|NCT01469377|1053731|P1|STARTED|Overall Study||269
429781|NCT01469364|1053742|P1|NOT COMPLETED|Overall Study||2
429782|NCT01469364|1053742|P1|COMPLETED|Overall Study||28
429783|NCT01469364|1053742|P1|STARTED|Overall Study||30
429784|NCT01469234|1053760|P3|NOT COMPLETED|Overall Study||0
429785|NCT01469234|1053761|P2|NOT COMPLETED|Overall Study||0
429786|NCT01469234|1053762|P1|NOT COMPLETED|Overall Study||0
429787|NCT01469234|1053760|P3|COMPLETED|Overall Study||85
429788|NCT01469234|1053761|P2|COMPLETED|Overall Study||85
429789|NCT01469234|1053762|P1|COMPLETED|Overall Study||85
429790|NCT01469234|1053760|P3|STARTED|Overall Study||85
429791|NCT01469234|1053761|P2|STARTED|Overall Study||85
429792|NCT01469234|1053762|P1|STARTED|Overall Study||85
429793|NCT01469221|1053793|P3|NOT COMPLETED|Double Blind Phase||0
429794|NCT01469221|1053794|P2|NOT COMPLETED|Double Blind Phase||17
429795|NCT01469221|1053795|P1|NOT COMPLETED|Double Blind Phase||14
429796|NCT01469221|1053793|P3|COMPLETED|Double Blind Phase||0
429797|NCT01469221|1053794|P2|COMPLETED|Double Blind Phase||0
429798|NCT01469221|1053795|P1|COMPLETED|Double Blind Phase||0
429799|NCT01469221|1053793|P3|STARTED|Double Blind Phase||0
429800|NCT01469221|1053794|P2|STARTED|Double Blind Phase||17
429801|NCT01469221|1053795|P1|STARTED|Double Blind Phase||14
429802|NCT01469221|1053793|P3|NOT COMPLETED|Open Label Phase||3
429803|NCT01469221|1053794|P2|NOT COMPLETED|Open Label Phase||0
429804|NCT01469221|1053795|P1|NOT COMPLETED|Open Label Phase||0
429805|NCT01469221|1053793|P3|COMPLETED|Open Label Phase||44
429806|NCT01469221|1053794|P2|COMPLETED|Open Label Phase||0
429807|NCT01469221|1053795|P1|COMPLETED|Open Label Phase||0
429808|NCT01469221|1053793|P3|STARTED|Open Label Phase||47
429809|NCT01469221|1053794|P2|STARTED|Open Label Phase||0
429810|NCT01469221|1053795|P1|STARTED|Open Label Phase||0
429811|NCT01469182|1053806|P2|NOT COMPLETED|Overall Study||6
429812|NCT01469182|1053807|P1|NOT COMPLETED|Overall Study||35
429813|NCT01469182|1053806|P2|COMPLETED|Overall Study||298
429814|NCT01469182|1053807|P1|COMPLETED|Overall Study||575
429815|NCT01469182|1053806|P2|Treated|Overall Study||304
429816|NCT01469182|1053807|P1|Treated|Overall Study||609
429817|NCT01469182|1053806|P2|STARTED|Overall Study||304
429818|NCT01469182|1053807|P1|STARTED|Overall Study||610
429819|NCT01469065|1053834|P5|NOT COMPLETED|Overall Study||1
429820|NCT01469065|1053835|P4|NOT COMPLETED|Overall Study||0
429821|NCT01469065|1053836|P3|NOT COMPLETED|Overall Study||0
429822|NCT01469065|1053837|P2|NOT COMPLETED|Overall Study||1
429823|NCT01469065|1053838|P1|NOT COMPLETED|Overall Study||0
429824|NCT01469065|1053834|P5|COMPLETED|Overall Study||16
429825|NCT01469065|1053835|P4|COMPLETED|Overall Study||16
429826|NCT01469065|1053836|P3|COMPLETED|Overall Study||16
429827|NCT01469065|1053837|P2|COMPLETED|Overall Study||16
429828|NCT01469065|1053838|P1|COMPLETED|Overall Study||16
429829|NCT01469065|1053834|P5|STARTED|Overall Study||17
429830|NCT01469065|1053835|P4|STARTED|Overall Study||16
429831|NCT01469065|1053836|P3|STARTED|Overall Study||16
429832|NCT01469065|1053837|P2|STARTED|Overall Study||17
429833|NCT01469065|1053838|P1|STARTED|Overall Study||16
429834|NCT01469052|1053934|P6|NOT COMPLETED|Overall Study||6
429835|NCT01469052|1053935|P5|NOT COMPLETED|Overall Study||8
429836|NCT01469052|1053936|P4|NOT COMPLETED|Overall Study||5
429837|NCT01469052|1053937|P3|NOT COMPLETED|Overall Study||6
429838|NCT01469052|1053938|P2|NOT COMPLETED|Overall Study||4
429839|NCT01469052|1053939|P1|NOT COMPLETED|Overall Study||6
429840|NCT01469052|1053934|P6|COMPLETED|Overall Study||0
429841|NCT01469052|1053935|P5|COMPLETED|Overall Study||0
429842|NCT01469052|1053936|P4|COMPLETED|Overall Study||1
429843|NCT01469052|1053937|P3|COMPLETED|Overall Study||0
429844|NCT01469052|1053938|P2|COMPLETED|Overall Study||0
429845|NCT01469052|1053939|P1|COMPLETED|Overall Study||0
429846|NCT01469052|1053934|P6|STARTED|Overall Study||6
429847|NCT01469052|1053935|P5|STARTED|Overall Study||8
429848|NCT01469052|1053936|P4|STARTED|Overall Study||6
429849|NCT01469052|1053937|P3|STARTED|Overall Study||6
429850|NCT01469052|1053938|P2|STARTED|Overall Study||4
429851|NCT01469052|1053939|P1|STARTED|Overall Study||6
429852|NCT01469039|1053986|P3|NOT COMPLETED|Overall Study||113
429853|NCT01469039|1053987|P2|NOT COMPLETED|Overall Study||73
429854|NCT01469039|1053988|P1|NOT COMPLETED|Overall Study||77
429855|NCT01469039|1053986|P3|COMPLETED|Overall Study||95
429856|NCT01469039|1053987|P2|COMPLETED|Overall Study||135
429857|NCT01469039|1053988|P1|COMPLETED|Overall Study||130
429858|NCT01469039|1053986|P3|STARTED|Overall Study||208
429859|NCT01469039|1053987|P2|STARTED|Overall Study||208
429860|NCT01469039|1053988|P1|STARTED|Overall Study||207
429861|NCT01469000|1054001|P2|NOT COMPLETED|Overall Study||9
429862|NCT01469000|1054002|P1|NOT COMPLETED|Overall Study||33
429863|NCT01469000|1054001|P2|COMPLETED|Overall Study||57
429864|NCT01469000|1054002|P1|COMPLETED|Overall Study||96
429865|NCT01469000|1054001|P2|Received at Least 1 Dose of Study Drug|Overall Study||65
429866|NCT01469000|1054002|P1|Received at Least 1 Dose of Study Drug|Overall Study||126
429867|NCT01469000|1054001|P2|STARTED|Overall Study||66
429868|NCT01469000|1054002|P1|STARTED|Overall Study||129
429869|NCT01468987|1054018|P2|NOT COMPLETED|Overall Study||60
429870|NCT01468987|1054019|P1|NOT COMPLETED|Overall Study||71
429871|NCT01468987|1054018|P2|COMPLETED|Overall Study||618
429872|NCT01468987|1054019|P1|COMPLETED|Overall Study||620
429873|NCT01468987|1054018|P2|Received at Least 1 Dose of Study Drug|Overall Study||677
429874|NCT01468987|1054019|P1|Received at Least 1 Dose of Study Drug|Overall Study||691
429875|NCT01468987|1054018|P2|STARTED|Overall Study||678
429876|NCT01468987|1054019|P1|STARTED|Overall Study||691
429877|NCT01468896|1054065|P2|NOT COMPLETED|Overall Study||0
429878|NCT01468896|1054066|P1|NOT COMPLETED|Overall Study||0
429879|NCT01468896|1054065|P2|COMPLETED|Overall Study||17
429880|NCT01468896|1054066|P1|COMPLETED|Overall Study||6
429881|NCT01468896|1054065|P2|STARTED|Overall Study||17
429882|NCT01468896|1054066|P1|STARTED|Overall Study||6
429883|NCT01468818|1054082|P1|NOT COMPLETED|Overall Study||2
429884|NCT01468818|1054082|P1|COMPLETED|Overall Study||16
429885|NCT01468818|1054082|P1|STARTED|Overall Study||18
429886|NCT01468675|1054089|P2|NOT COMPLETED|Overall Study||1372
429887|NCT01468675|1054090|P1|NOT COMPLETED|Overall Study||1000
429888|NCT01468675|1054089|P2|COMPLETED|Overall Study||2004
429889|NCT01468675|1054090|P1|COMPLETED|Overall Study||1699
429890|NCT01468675|1054089|P2|STARTED|Overall Study||3376
429891|NCT01468675|1054090|P1|STARTED|Overall Study||2699
429892|NCT01468584|1054096|P1|NOT COMPLETED|Overall Study||0
429893|NCT01468584|1054096|P1|COMPLETED|Overall Study||10
429894|NCT01468584|1054096|P1|STARTED|Overall Study||10
429895|NCT01468558|1054100|P1|NOT COMPLETED|Overall Study||2
429896|NCT01468558|1054100|P1|COMPLETED|Overall Study||22
429897|NCT01468558|1054100|P1|STARTED|Overall Study||24
429898|NCT01468350|1054115|P4|NOT COMPLETED|(PART B) Day 1, Day 15||0
429899|NCT01468350|1054116|P3|NOT COMPLETED|(PART B) Day 1, Day 15||0
429900|NCT01468350|1054117|P2|NOT COMPLETED|(PART B) Day 1, Day 15||0
429901|NCT01468350|1054118|P1|NOT COMPLETED|(PART B) Day 1, Day 15||0
429902|NCT01468350|1054115|P4|COMPLETED|(PART B) Day 1, Day 15||12
429903|NCT01468350|1054116|P3|COMPLETED|(PART B) Day 1, Day 15||12
429904|NCT01468350|1054117|P2|COMPLETED|(PART B) Day 1, Day 15||0
429905|NCT01468350|1054118|P1|COMPLETED|(PART B) Day 1, Day 15||0
429906|NCT01468350|1054115|P4|STARTED|(PART B) Day 1, Day 15||12
429907|NCT01468350|1054116|P3|STARTED|(PART B) Day 1, Day 15||12
429908|NCT01468350|1054117|P2|STARTED|(PART B) Day 1, Day 15||0
429909|NCT01468350|1054118|P1|STARTED|(PART B) Day 1, Day 15||0
429910|NCT01468350|1054115|P4|NOT COMPLETED|(PART A) Day 1, Day 3||0
429911|NCT01468350|1054116|P3|NOT COMPLETED|(PART A) Day 1, Day 3||0
429912|NCT01468350|1054117|P2|NOT COMPLETED|(PART A) Day 1, Day 3||0
429913|NCT01468350|1054118|P1|NOT COMPLETED|(PART A) Day 1, Day 3||0
429914|NCT01468350|1054115|P4|COMPLETED|(PART A) Day 1, Day 3||0
429915|NCT01468350|1054116|P3|COMPLETED|(PART A) Day 1, Day 3||0
429916|NCT01468350|1054117|P2|COMPLETED|(PART A) Day 1, Day 3||5
429917|NCT01468350|1054118|P1|COMPLETED|(PART A) Day 1, Day 3||6
429918|NCT01468350|1054115|P4|STARTED|(PART A) Day 1, Day 3||0
429919|NCT01468350|1054116|P3|STARTED|(PART A) Day 1, Day 3||0
429920|NCT01468350|1054117|P2|STARTED|(PART A) Day 1, Day 3||5
429921|NCT01468350|1054118|P1|STARTED|(PART A) Day 1, Day 3||6
429922|NCT01468337|1054128|P1|NOT COMPLETED|Overall Study||0
429923|NCT01468337|1054128|P1|COMPLETED|Overall Study||5
429924|NCT01468337|1054128|P1|Week 48|Overall Study|Two participants did not have a Week 48 visit but completed the study.|3
429925|NCT01468337|1054128|P1|Received Interferon Gamma-1b After Wk 8|Overall Study|Two participants had 2 Interferon gamma-1b dosing cycles after Wk 8|4
429926|NCT01468337|1054128|P1|Received Interferon Gamma-1b at Week 4|Overall Study|One participant received additional Interferon gamma-1b dosing at Week 4 and after Week 8|2
429927|NCT01468337|1054128|P1|Week 2|Overall Study||5
429928|NCT01468337|1054128|P1|STARTED|Overall Study||5
429929|NCT01468311|1054140|P1|NOT COMPLETED|Overall Study||2
429930|NCT01468311|1054140|P1|COMPLETED|Overall Study||4
429931|NCT01468311|1054140|P1|STARTED|Overall Study||6
429932|NCT01468233|1054152|P6|NOT COMPLETED|Treatment Period 2||23
429933|NCT01468233|1054153|P5|NOT COMPLETED|Treatment Period 2||28
429934|NCT01468233|1054154|P4|NOT COMPLETED|Treatment Period 2||28
429935|NCT01468233|1054155|P3|NOT COMPLETED|Treatment Period 2||111
429936|NCT01468233|1054156|P2|NOT COMPLETED|Treatment Period 2||0
429937|NCT01468233|1054157|P1|NOT COMPLETED|Treatment Period 2||0
429938|NCT01468233|1054152|P6|COMPLETED|Treatment Period 2||28
429939|NCT01468233|1054153|P5|COMPLETED|Treatment Period 2||25
429940|NCT01468233|1054154|P4|COMPLETED|Treatment Period 2||23
429941|NCT01468233|1054155|P3|COMPLETED|Treatment Period 2||40
429942|NCT01468233|1054156|P2|COMPLETED|Treatment Period 2||0
429943|NCT01468233|1054157|P1|COMPLETED|Treatment Period 2||0
429944|NCT01468233|1054152|P6|STARTED|Treatment Period 2||51
429945|NCT01468233|1054153|P5|STARTED|Treatment Period 2||53
429946|NCT01468233|1054154|P4|STARTED|Treatment Period 2||51
429947|NCT01468233|1054155|P3|STARTED|Treatment Period 2||151
429948|NCT01468233|1054156|P2|STARTED|Treatment Period 2||0
429949|NCT01468233|1054157|P1|STARTED|Treatment Period 2||0
429950|NCT01468233|1054152|P6|NOT COMPLETED|Treatment Period 1||0
429951|NCT01468233|1054153|P5|NOT COMPLETED|Treatment Period 1||0
429952|NCT01468233|1054154|P4|NOT COMPLETED|Treatment Period 1||0
429953|NCT01468233|1054155|P3|NOT COMPLETED|Treatment Period 1||0
429954|NCT01468233|1054156|P2|NOT COMPLETED|Treatment Period 1||8
429955|NCT01468233|1054157|P1|NOT COMPLETED|Treatment Period 1||12
429956|NCT01468233|1054152|P6|COMPLETED|Treatment Period 1||0
429957|NCT01468233|1054153|P5|COMPLETED|Treatment Period 1||0
429958|NCT01468233|1054154|P4|COMPLETED|Treatment Period 1||0
429959|NCT01468233|1054155|P3|COMPLETED|Treatment Period 1||0
429960|NCT01468233|1054156|P2|COMPLETED|Treatment Period 1||155
429961|NCT01468233|1054157|P1|COMPLETED|Treatment Period 1||151
429962|NCT01468233|1054152|P6|STARTED|Treatment Period 1||0
429963|NCT01468233|1054153|P5|STARTED|Treatment Period 1||0
429964|NCT01468233|1054154|P4|STARTED|Treatment Period 1||0
429965|NCT01468233|1054155|P3|STARTED|Treatment Period 1||0
429966|NCT01468233|1054156|P2|STARTED|Treatment Period 1||163
429967|NCT01468233|1054157|P1|STARTED|Treatment Period 1||163
429968|NCT01468207|1054179|P6|NOT COMPLETED|Treatment Period 2||20
429969|NCT01468207|1054180|P5|NOT COMPLETED|Treatment Period 2||21
429970|NCT01468207|1054181|P4|NOT COMPLETED|Treatment Period 2||27
429971|NCT01468207|1054182|P3|NOT COMPLETED|Treatment Period 2||52
429972|NCT01468207|1054183|P2|NOT COMPLETED|Treatment Period 2||0
429973|NCT01468207|1054184|P1|NOT COMPLETED|Treatment Period 2||0
429974|NCT01468207|1054179|P6|COMPLETED|Treatment Period 2||28
429975|NCT01468207|1054180|P5|COMPLETED|Treatment Period 2||27
429976|NCT01468207|1054181|P4|COMPLETED|Treatment Period 2||22
429977|NCT01468207|1054182|P3|COMPLETED|Treatment Period 2||93
429978|NCT01468207|1054183|P2|COMPLETED|Treatment Period 2||0
429979|NCT01468207|1054184|P1|COMPLETED|Treatment Period 2||0
429980|NCT01468207|1054179|P6|STARTED|Treatment Period 2||48
429981|NCT01468207|1054180|P5|STARTED|Treatment Period 2||48
429982|NCT01468207|1054181|P4|STARTED|Treatment Period 2||49
429983|NCT01468207|1054182|P3|STARTED|Treatment Period 2||145
429984|NCT01468207|1054183|P2|STARTED|Treatment Period 2||0
429985|NCT01468207|1054184|P1|STARTED|Treatment Period 2||0
429986|NCT01468207|1054179|P6|NOT COMPLETED|Treatment Period 1||0
429987|NCT01468207|1054180|P5|NOT COMPLETED|Treatment Period 1||0
429988|NCT01468207|1054181|P4|NOT COMPLETED|Treatment Period 1||0
429989|NCT01468207|1054182|P3|NOT COMPLETED|Treatment Period 1||0
429990|NCT01468207|1054183|P2|NOT COMPLETED|Treatment Period 1||8
429991|NCT01468207|1054184|P1|NOT COMPLETED|Treatment Period 1||9
429992|NCT01468207|1054179|P6|COMPLETED|Treatment Period 1||0
429993|NCT01468207|1054180|P5|COMPLETED|Treatment Period 1||0
429994|NCT01468207|1054181|P4|COMPLETED|Treatment Period 1||0
429995|NCT01468207|1054182|P3|COMPLETED|Treatment Period 1||0
429996|NCT01468207|1054183|P2|COMPLETED|Treatment Period 1||145
429997|NCT01468207|1054184|P1|COMPLETED|Treatment Period 1||145
429998|NCT01468207|1054179|P6|Received Study Drug|Treatment Period 1||0
429999|NCT01468207|1054180|P5|Received Study Drug|Treatment Period 1||0
430000|NCT01468207|1054181|P4|Received Study Drug|Treatment Period 1||0
430001|NCT01468207|1054182|P3|Received Study Drug|Treatment Period 1||0
430002|NCT01468207|1054183|P2|Received Study Drug|Treatment Period 1||153
430003|NCT01468207|1054184|P1|Received Study Drug|Treatment Period 1||152
430004|NCT01468207|1054179|P6|STARTED|Treatment Period 1||0
430005|NCT01468207|1054180|P5|STARTED|Treatment Period 1||0
430006|NCT01468207|1054181|P4|STARTED|Treatment Period 1||0
430007|NCT01468207|1054182|P3|STARTED|Treatment Period 1||0
430008|NCT01468207|1054183|P2|STARTED|Treatment Period 1||153
430009|NCT01468207|1054184|P1|STARTED|Treatment Period 1||154
430010|NCT01468181|1054209|P5|NOT COMPLETED|Overall Study||5
430011|NCT01468181|1054210|P4|NOT COMPLETED|Overall Study||3
430012|NCT01468181|1054211|P3|NOT COMPLETED|Overall Study||8
430013|NCT01468181|1054212|P2|NOT COMPLETED|Overall Study||2
430014|NCT01468181|1054213|P1|NOT COMPLETED|Overall Study||10
430015|NCT01468181|1054209|P5|COMPLETED|Overall Study||66
430016|NCT01468181|1054210|P4|COMPLETED|Overall Study||63
430017|NCT01468181|1054211|P3|COMPLETED|Overall Study||57
430018|NCT01468181|1054212|P2|COMPLETED|Overall Study||59
430019|NCT01468181|1054213|P1|COMPLETED|Overall Study||121
430020|NCT01468181|1054209|P5|Received at Least 1 Dose of Study Drug|Overall Study||71
430021|NCT01468181|1054210|P4|Received at Least 1 Dose of Study Drug|Overall Study||66
430022|NCT01468181|1054211|P3|Received at Least 1 Dose of Study Drug|Overall Study||65
430023|NCT01468181|1054212|P2|Received at Least 1 Dose of Study Drug|Overall Study||61
430024|NCT01468181|1054213|P1|Received at Least 1 Dose of Study Drug|Overall Study||131
430025|NCT01468181|1054209|P5|STARTED|Overall Study||71
430026|NCT01468181|1054210|P4|STARTED|Overall Study||66
430027|NCT01468181|1054211|P3|STARTED|Overall Study||65
430028|NCT01468181|1054212|P2|STARTED|Overall Study||61
430029|NCT01468181|1054213|P1|STARTED|Overall Study||131
430030|NCT01468077|1054262|P2|NOT COMPLETED|Overall Study||3
430031|NCT01468077|1054263|P1|NOT COMPLETED|Overall Study||4
430032|NCT01468077|1054262|P2|COMPLETED|Overall Study||22
430033|NCT01468077|1054263|P1|COMPLETED|Overall Study||18
430034|NCT01468077|1054262|P2|STARTED|Overall Study||25
430035|NCT01468077|1054263|P1|STARTED|Overall Study||22
430036|NCT01468012|1054302|P3|NOT COMPLETED|Overall Study||4
430037|NCT01468012|1054303|P2|NOT COMPLETED|Overall Study||1
430038|NCT01468012|1054304|P1|NOT COMPLETED|Overall Study||2
430039|NCT01468012|1054302|P3|COMPLETED|Overall Study||0
430040|NCT01468012|1054303|P2|COMPLETED|Overall Study||9
430041|NCT01468012|1054304|P1|COMPLETED|Overall Study||7
430042|NCT01468012|1054302|P3|STARTED|Overall Study||4
430043|NCT01468012|1054303|P2|STARTED|Overall Study||10
430044|NCT01468012|1054304|P1|STARTED|Overall Study||9
430045|NCT01467960|1054321|P6|NOT COMPLETED|Overall Study||30
430046|NCT01467960|1054322|P5|NOT COMPLETED|Overall Study||30
430047|NCT01467960|1054323|P4|NOT COMPLETED|Overall Study||30
430048|NCT01467960|1054324|P3|NOT COMPLETED|Overall Study||0
430049|NCT01467960|1054325|P2|NOT COMPLETED|Overall Study||0
430050|NCT01467960|1054326|P1|NOT COMPLETED|Overall Study||0
430051|NCT01467960|1054321|P6|COMPLETED|Overall Study||0
430052|NCT01467960|1054322|P5|COMPLETED|Overall Study||0
430053|NCT01467960|1054323|P4|COMPLETED|Overall Study||0
430054|NCT01467960|1054324|P3|COMPLETED|Overall Study||30
430055|NCT01467960|1054325|P2|COMPLETED|Overall Study||30
430056|NCT01467960|1054326|P1|COMPLETED|Overall Study||30
430057|NCT01467960|1054321|P6|STARTED|Overall Study||30
430058|NCT01467960|1054322|P5|STARTED|Overall Study||30
430059|NCT01467960|1054323|P4|STARTED|Overall Study||30
430060|NCT01467960|1054324|P3|STARTED|Overall Study||30
430061|NCT01467960|1054325|P2|STARTED|Overall Study||30
430062|NCT01467960|1054326|P1|STARTED|Overall Study||30
430063|NCT01467947|1054340|P1|NOT COMPLETED|Overall Study||0
430064|NCT01467947|1054340|P1|COMPLETED|Overall Study||46
430065|NCT01467947|1054340|P1|STARTED|Overall Study||46
430066|NCT01467934|1054348|P3|NOT COMPLETED|Overall Study||0
430067|NCT01467934|1054349|P2|NOT COMPLETED|Overall Study||0
430068|NCT01467934|1054350|P1|NOT COMPLETED|Overall Study||0
430069|NCT01467934|1054348|P3|COMPLETED|Overall Study||110
430070|NCT01467934|1054349|P2|COMPLETED|Overall Study||212
430071|NCT01467934|1054350|P1|COMPLETED|Overall Study||208
430072|NCT01467934|1054348|P3|STARTED|Overall Study||110
430073|NCT01467934|1054349|P2|STARTED|Overall Study||212
430074|NCT01467934|1054350|P1|STARTED|Overall Study||208
430075|NCT01467882|1054358|P1|NOT COMPLETED|Overall Study||0
430076|NCT01467882|1054358|P1|COMPLETED|Overall Study||44
430077|NCT01467882|1054358|P1|STARTED|Overall Study||44
430078|NCT01467713|1054385|P4|NOT COMPLETED|Overall Study||109
430079|NCT01467713|1054386|P3|NOT COMPLETED|Overall Study||102
430080|NCT01467713|1054387|P2|NOT COMPLETED|Overall Study||104
430081|NCT01467713|1054388|P1|NOT COMPLETED|Overall Study||102
430082|NCT01467713|1054385|P4|COMPLETED|Overall Study||45
430083|NCT01467713|1054386|P3|COMPLETED|Overall Study||58
430084|NCT01467713|1054387|P2|COMPLETED|Overall Study||60
430085|NCT01467713|1054388|P1|COMPLETED|Overall Study||62
430086|NCT01467713|1054385|P4|Safety Analysis Set: Received Treatment|Overall Study||154
430087|NCT01467713|1054386|P3|Safety Analysis Set: Received Treatment|Overall Study||159
430088|NCT01467713|1054387|P2|Safety Analysis Set: Received Treatment|Overall Study||164
430089|NCT01467713|1054388|P1|Safety Analysis Set: Received Treatment|Overall Study||163
430090|NCT01467713|1054385|P4|STARTED|Overall Study||154
430091|NCT01467713|1054386|P3|STARTED|Overall Study||160
430092|NCT01467713|1054387|P2|STARTED|Overall Study||164
430093|NCT01467713|1054388|P1|STARTED|Overall Study||164
430094|NCT01467700|1054442|P4|NOT COMPLETED|Overall Study||27
430095|NCT01467700|1054443|P3|NOT COMPLETED|Overall Study||27
430096|NCT01467700|1054444|P2|NOT COMPLETED|Overall Study||28
430097|NCT01467700|1054445|P1|NOT COMPLETED|Overall Study||29
430098|NCT01467700|1054442|P4|COMPLETED|Overall Study||96
430099|NCT01467700|1054443|P3|COMPLETED|Overall Study||97
430100|NCT01467700|1054444|P2|COMPLETED|Overall Study||100
430101|NCT01467700|1054445|P1|COMPLETED|Overall Study||86
430102|NCT01467700|1054442|P4|Safety Set - Received Treatment|Overall Study||123
430103|NCT01467700|1054443|P3|Safety Set - Received Treatment|Overall Study||124
430104|NCT01467700|1054444|P2|Safety Set - Received Treatment|Overall Study||127
430105|NCT01467700|1054445|P1|Safety Set - Received Treatment|Overall Study||115
430106|NCT01467700|1054442|P4|STARTED|Overall Study||123
430107|NCT01467700|1054443|P3|STARTED|Overall Study||124
430108|NCT01467700|1054444|P2|STARTED|Overall Study||128
430109|NCT01467700|1054445|P1|STARTED|Overall Study||115
430110|NCT01467661|1054487|P1|NOT COMPLETED|Overall Study||21
430111|NCT01467661|1054487|P1|COMPLETED|Overall Study|Completed study SPD422-309 (NCT01467661)|32
430112|NCT01467661|1054487|P1|Started Post Marketing Trial|Overall Study||33
430113|NCT01467661|1054487|P1|Started SPD422-309 (NCT01467661)|Overall Study||41
430114|NCT01467661|1054487|P1|Completed SPD422-308 (NCT01214915)|Overall Study||42
430115|NCT01467661|1054487|P1|STARTED|Overall Study|Started Study SPD422-308 (NCT01214915)|53
430116|NCT01467583|1054507|P3|NOT COMPLETED|Overall Study||2
430117|NCT01467583|1054508|P2|NOT COMPLETED|Overall Study||1
430118|NCT01467583|1054509|P1|NOT COMPLETED|Overall Study||2
430119|NCT01467583|1054507|P3|COMPLETED|Overall Study||10
430120|NCT01467583|1054508|P2|COMPLETED|Overall Study|Death unrelated to study drug on day #3. Data to that point is included in the results|3
430121|NCT01467583|1054509|P1|COMPLETED|Overall Study|Both patients completed > 1 dose and so their data was included in the results.|14
430122|NCT01467583|1054507|P3|STARTED|Overall Study||12
430123|NCT01467583|1054508|P2|STARTED|Overall Study||4
430124|NCT01467583|1054509|P1|STARTED|Overall Study||16
430125|NCT01467570|1054522|P2|NOT COMPLETED|Overall Study||9
430126|NCT01467570|1054523|P1|NOT COMPLETED|Overall Study||8
430127|NCT01467570|1054522|P2|COMPLETED|Overall Study||63
430128|NCT01467570|1054523|P1|COMPLETED|Overall Study||67
430129|NCT01467570|1054522|P2|STARTED|Overall Study||72
430130|NCT01467570|1054523|P1|STARTED|Overall Study||75
430131|NCT01467557|1054549|P2|NOT COMPLETED|Overall Study||107
430132|NCT01467557|1054550|P1|NOT COMPLETED|Overall Study||99
430133|NCT01467557|1054549|P2|COMPLETED|Overall Study||463
430134|NCT01467557|1054550|P1|COMPLETED|Overall Study||502
430135|NCT01467557|1054549|P2|12 Month Survey Completed|Overall Study||463
430136|NCT01467557|1054550|P1|12 Month Survey Completed|Overall Study||502
430137|NCT01467557|1054549|P2|4 Month Survey Completed|Overall Study||493
430138|NCT01467557|1054550|P1|4 Month Survey Completed|Overall Study||533
430139|NCT01467557|1054549|P2|2 Week Survey Completed|Overall Study||522
430140|NCT01467557|1054550|P1|2 Week Survey Completed|Overall Study||551
430141|NCT01467557|1054549|P2|STARTED|Overall Study||570
430142|NCT01467557|1054550|P1|STARTED|Overall Study||601
430143|NCT01467505|1054560|P2|NOT COMPLETED|Overall Study||3
430144|NCT01467505|1054561|P1|NOT COMPLETED|Overall Study||33
430145|NCT01467505|1054560|P2|COMPLETED|Overall Study||7
430146|NCT01467505|1054561|P1|COMPLETED|Overall Study||18
430147|NCT01467505|1054560|P2|STARTED|Overall Study||10
430148|NCT01467505|1054561|P1|STARTED|Overall Study||51
430149|NCT01467492|1054593|P2|NOT COMPLETED|Overall Study||13
430150|NCT01467492|1054594|P1|NOT COMPLETED|Overall Study||22
430151|NCT01467492|1054593|P2|COMPLETED|Overall Study||25
430152|NCT01467492|1054594|P1|COMPLETED|Overall Study||61
430153|NCT01467492|1054593|P2|STARTED|Overall Study||38
430154|NCT01467492|1054594|P1|STARTED|Overall Study||83
430155|NCT01467479|1054618|P3|NOT COMPLETED|Overall Study||16
430156|NCT01467479|1054619|P2|NOT COMPLETED|Overall Study||17
430157|NCT01467479|1054620|P1|NOT COMPLETED|Overall Study||9
430158|NCT01467479|1054618|P3|COMPLETED|Overall Study||45
430159|NCT01467479|1054619|P2|COMPLETED|Overall Study||52
430160|NCT01467479|1054620|P1|COMPLETED|Overall Study||46
430161|NCT01467479|1054618|P3|Treated|Overall Study||59
430162|NCT01467479|1054619|P2|Treated|Overall Study||69
430163|NCT01467479|1054620|P1|Treated|Overall Study||54
430164|NCT01467479|1054618|P3|STARTED|Overall Study||61
430165|NCT01467479|1054619|P2|STARTED|Overall Study||69
430166|NCT01467479|1054620|P1|STARTED|Overall Study||55
430167|NCT01467427|1054649|P2|NOT COMPLETED|Overall Study||13
430168|NCT01467427|1054650|P1|NOT COMPLETED|Overall Study||12
430169|NCT01467427|1054649|P2|COMPLETED|Overall Study||0
430170|NCT01467427|1054650|P1|COMPLETED|Overall Study||0
430171|NCT01467427|1054649|P2|Completed Main Phase|Overall Study||13
430172|NCT01467427|1054650|P1|Completed Main Phase|Overall Study||11
430173|NCT01467427|1054649|P2|STARTED|Overall Study||13
430174|NCT01467427|1054650|P1|STARTED|Overall Study||12
430175|NCT01467076|1054671|P3|NOT COMPLETED|Overall Study||0
430176|NCT01467076|1054672|P2|NOT COMPLETED|Overall Study||0
430177|NCT01467076|1054673|P1|NOT COMPLETED|Overall Study||1
430178|NCT01467076|1054671|P3|COMPLETED|Overall Study||2
430179|NCT01467076|1054672|P2|COMPLETED|Overall Study||2
430180|NCT01467076|1054673|P1|COMPLETED|Overall Study||2
430181|NCT01467076|1054671|P3|STARTED|Overall Study||2
430182|NCT01467076|1054672|P2|STARTED|Overall Study||2
430183|NCT01467076|1054673|P1|STARTED|Overall Study||3
430184|NCT01467037|1054683|P1|NOT COMPLETED|Overall Study||0
430185|NCT01467037|1054683|P1|COMPLETED|Overall Study||374
430186|NCT01467037|1054683|P1|STARTED|Overall Study||374
430187|NCT01466881|1054690|P1|NOT COMPLETED|Overall Study||40
430188|NCT01466881|1054690|P1|COMPLETED|Overall Study||2
430189|NCT01466881|1054690|P1|Eligible and Treated|Overall Study||37
430190|NCT01466881|1054690|P1|STARTED|Overall Study||42
430191|NCT01466790|1054707|P8|NOT COMPLETED|Overall Study||1
430192|NCT01466790|1054708|P7|NOT COMPLETED|Overall Study||1
430193|NCT01466790|1054709|P6|NOT COMPLETED|Overall Study||0
430194|NCT01466790|1054710|P5|NOT COMPLETED|Overall Study||3
430195|NCT01466790|1054711|P4|NOT COMPLETED|Overall Study||0
430196|NCT01466790|1054712|P3|NOT COMPLETED|Overall Study||0
430197|NCT01466790|1054713|P2|NOT COMPLETED|Overall Study||1
430198|NCT01466790|1054714|P1|NOT COMPLETED|Overall Study||4
430199|NCT01466790|1054707|P8|COMPLETED|Overall Study||13
430200|NCT01466790|1054708|P7|COMPLETED|Overall Study||26
430201|NCT01466790|1054709|P6|COMPLETED|Overall Study||16
430202|NCT01466790|1054710|P5|COMPLETED|Overall Study||27
430203|NCT01466790|1054711|P4|COMPLETED|Overall Study||14
430204|NCT01466790|1054712|P3|COMPLETED|Overall Study||27
430205|NCT01466790|1054713|P2|COMPLETED|Overall Study||14
430206|NCT01466790|1054714|P1|COMPLETED|Overall Study||20
430207|NCT01466790|1054707|P8|STARTED|Overall Study||14
430208|NCT01466790|1054708|P7|STARTED|Overall Study||27
430209|NCT01466790|1054709|P6|STARTED|Overall Study||16
430210|NCT01466790|1054710|P5|STARTED|Overall Study||30
430211|NCT01466790|1054711|P4|STARTED|Overall Study||14
430212|NCT01466790|1054712|P3|STARTED|Overall Study||27
430213|NCT01466790|1054713|P2|STARTED|Overall Study||15
430214|NCT01466790|1054714|P1|STARTED|Overall Study|Not including 1 participant who was randomized to this group, but never received treatment.|24
430215|NCT01466764|1054778|P2|NOT COMPLETED|Overall Study||0
430216|NCT01466764|1054779|P1|NOT COMPLETED|Overall Study||0
430217|NCT01466764|1054778|P2|COMPLETED|Overall Study||5
430218|NCT01466764|1054779|P1|COMPLETED|Overall Study||5
430219|NCT01466764|1054778|P2|STARTED|Overall Study||5
430220|NCT01466764|1054779|P1|STARTED|Overall Study||5
430221|NCT01466673|1054799|P2|NOT COMPLETED|Overall Study||6
430222|NCT01466673|1054800|P1|NOT COMPLETED|Overall Study||7
430223|NCT01466673|1054799|P2|COMPLETED|Overall Study||95
430224|NCT01466673|1054800|P1|COMPLETED|Overall Study||93
430225|NCT01466673|1054799|P2|STARTED|Overall Study||101
430226|NCT01466673|1054800|P1|STARTED|Overall Study||100
430227|NCT01466660|1054826|P2|NOT COMPLETED|Overall Study||151
430228|NCT01466660|1054827|P1|NOT COMPLETED|Overall Study||146
430229|NCT01466660|1054826|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date, 08 April 2016|8
430230|NCT01466660|1054827|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date, 08 April 2016|14
430231|NCT01466660|1054826|P2|STARTED|Overall Study||159
430232|NCT01466660|1054827|P1|STARTED|Overall Study||160
430233|NCT01466595|1054853|P2|NOT COMPLETED|Overall Study||1
430234|NCT01466595|1054854|P1|NOT COMPLETED|Overall Study||0
430235|NCT01466595|1054853|P2|COMPLETED|Overall Study||23
430236|NCT01466595|1054854|P1|COMPLETED|Overall Study||49
430237|NCT01466595|1054853|P2|STARTED|Overall Study||24
430238|NCT01466595|1054854|P1|STARTED|Overall Study||49
430239|NCT01466491|1054948|P4|NOT COMPLETED|Overall Study||0
430240|NCT01466491|1054949|P3|NOT COMPLETED|Overall Study||3
430241|NCT01466491|1054950|P2|NOT COMPLETED|Overall Study||3
430242|NCT01466491|1054951|P1|NOT COMPLETED|Overall Study||0
430243|NCT01466491|1054948|P4|COMPLETED|Overall Study||83
430244|NCT01466491|1054949|P3|COMPLETED|Overall Study||80
430245|NCT01466491|1054950|P2|COMPLETED|Overall Study||80
430246|NCT01466491|1054951|P1|COMPLETED|Overall Study||83
430247|NCT01466491|1054948|P4|STARTED|Overall Study||83
430248|NCT01466491|1054949|P3|STARTED|Overall Study||83
430249|NCT01466491|1054950|P2|STARTED|Overall Study||83
430250|NCT01466491|1054951|P1|STARTED|Overall Study||83
430251|NCT01466387|1054971|P6|NOT COMPLETED|Overall Study||1
430252|NCT01466387|1054972|P5|NOT COMPLETED|Overall Study||0
430253|NCT01466387|1054973|P4|NOT COMPLETED|Overall Study||2
430254|NCT01466387|1054974|P3|NOT COMPLETED|Overall Study||1
430255|NCT01466387|1054975|P2|NOT COMPLETED|Overall Study||0
430256|NCT01466387|1054976|P1|NOT COMPLETED|Overall Study||1
430257|NCT01466387|1054971|P6|COMPLETED|Overall Study||99
430258|NCT01466387|1054972|P5|COMPLETED|Overall Study||51
430259|NCT01466387|1054973|P4|COMPLETED|Overall Study||99
430260|NCT01466387|1054974|P3|COMPLETED|Overall Study||98
430261|NCT01466387|1054975|P2|COMPLETED|Overall Study||100
430262|NCT01466387|1054976|P1|COMPLETED|Overall Study||100
430263|NCT01466387|1054971|P6|STARTED|Overall Study||100
430264|NCT01466387|1054972|P5|STARTED|Overall Study||51
430265|NCT01466387|1054973|P4|STARTED|Overall Study||101
430266|NCT01466387|1054974|P3|STARTED|Overall Study||99
430267|NCT01466387|1054975|P2|STARTED|Overall Study||100
430268|NCT01466387|1054976|P1|STARTED|Overall Study||101
430269|NCT01466361|1055018|P4|NOT COMPLETED|Overall Study||0
430270|NCT01466361|1055019|P3|NOT COMPLETED|Overall Study||0
430271|NCT01466361|1055020|P2|NOT COMPLETED|Overall Study||0
430272|NCT01466361|1055021|P1|NOT COMPLETED|Overall Study||0
430273|NCT01466361|1055018|P4|COMPLETED|Overall Study||41
430274|NCT01466361|1055019|P3|COMPLETED|Overall Study||60
430275|NCT01466361|1055020|P2|COMPLETED|Overall Study||34
430276|NCT01466361|1055021|P1|COMPLETED|Overall Study||52
430277|NCT01466361|1055018|P4|STARTED|Overall Study||41
430278|NCT01466361|1055019|P3|STARTED|Overall Study||60
430279|NCT01466361|1055020|P2|STARTED|Overall Study||34
430280|NCT01466361|1055021|P1|STARTED|Overall Study||52
430281|NCT01466348|1055037|P2|NOT COMPLETED|Period II - Second Intervention||0
430282|NCT01466348|1055038|P1|NOT COMPLETED|Period II - Second Intervention||0
430283|NCT01466348|1055037|P2|COMPLETED|Period II - Second Intervention||36
430284|NCT01466348|1055038|P1|COMPLETED|Period II - Second Intervention||35
430285|NCT01466348|1055037|P2|STARTED|Period II - Second Intervention||36
430286|NCT01466348|1055038|P1|STARTED|Period II - Second Intervention||35
430287|NCT01466348|1055037|P2|NOT COMPLETED|Period I - First Intervention||1
430288|NCT01466348|1055038|P1|NOT COMPLETED|Period I - First Intervention||0
430289|NCT01466348|1055037|P2|COMPLETED|Period I - First Intervention||35
430290|NCT01466348|1055038|P1|COMPLETED|Period I - First Intervention||36
430291|NCT01466348|1055037|P2|Intent To Treat (ITT) Population|Period I - First Intervention|1 participant withdrew prior receiving the treatment|35
430292|NCT01466348|1055038|P1|Intent To Treat (ITT) Population|Period I - First Intervention||36
430293|NCT01466348|1055037|P2|STARTED|Period I - First Intervention||36
430294|NCT01466348|1055038|P1|STARTED|Period I - First Intervention||36
430295|NCT01466270|1055066|P2|NOT COMPLETED|Overall Study||6
430296|NCT01466270|1055067|P1|NOT COMPLETED|Overall Study||12
430297|NCT01466270|1055066|P2|COMPLETED|Overall Study||25
430298|NCT01466270|1055067|P1|COMPLETED|Overall Study||19
430299|NCT01466270|1055066|P2|STARTED|Overall Study||31
430300|NCT01466270|1055067|P1|STARTED|Overall Study||31
430301|NCT01466192|1055079|P1|NOT COMPLETED|Overall Study||4
430302|NCT01466192|1055079|P1|COMPLETED|Overall Study||104
430303|NCT01466192|1055079|P1|STARTED|Overall Study||108
430304|NCT01466179|1055083|P1|NOT COMPLETED|Overall Study||179
430305|NCT01466179|1055083|P1|COMPLETED|Overall Study|Completed 5 cycles of treatment; Data as of the time of the data cut-off date (10 October 2013).|10
430306|NCT01466179|1055083|P1|STARTED|Overall Study|Participants enrolled during the first 3 stages of the study|189
430307|NCT01466153|1055106|P3|NOT COMPLETED|Overall Study||25
430308|NCT01466153|1055107|P2|NOT COMPLETED|Overall Study||24
430309|NCT01466153|1055108|P1|NOT COMPLETED|Overall Study||29
430310|NCT01466153|1055106|P3|COMPLETED|Overall Study||36
430311|NCT01466153|1055107|P2|COMPLETED|Overall Study||12
430312|NCT01466153|1055108|P1|COMPLETED|Overall Study||33
430313|NCT01466153|1055106|P3|STARTED|Overall Study||61
430314|NCT01466153|1055107|P2|STARTED|Overall Study||36
430315|NCT01466153|1055108|P1|STARTED|Overall Study||62
430316|NCT01466127|1055149|P2|NOT COMPLETED|Overall Study||16
430317|NCT01466127|1055150|P1|NOT COMPLETED|Overall Study||14
430318|NCT01466127|1055149|P2|COMPLETED|Overall Study||14
430319|NCT01466127|1055150|P1|COMPLETED|Overall Study||16
430320|NCT01466127|1055149|P2|STARTED|Overall Study||30
430321|NCT01466127|1055150|P1|STARTED|Overall Study||30
430322|NCT01466075|1055156|P1|NOT COMPLETED|Overall Study||0
430323|NCT01466075|1055156|P1|COMPLETED|Overall Study||207
430324|NCT01466075|1055156|P1|STARTED|Overall Study||207
430325|NCT01466062|1055163|P1|NOT COMPLETED|Overall Study||2
430326|NCT01466062|1055163|P1|COMPLETED|Overall Study||26
430327|NCT01466062|1055163|P1|STARTED|Overall Study||28
430328|NCT01465997|1055186|P2|NOT COMPLETED|Overall Study||89
430329|NCT01465997|1055187|P1|NOT COMPLETED|Overall Study||68
430330|NCT01465997|1055186|P2|COMPLETED|Overall Study||180
430331|NCT01465997|1055187|P1|COMPLETED|Overall Study||211
430332|NCT01465997|1055186|P2|STARTED|Overall Study||269
430333|NCT01465997|1055187|P1|STARTED|Overall Study||279
430334|NCT01465958|1055197|P2|NOT COMPLETED|Subcutaneous (SC) Phase||1
430335|NCT01465958|1055198|P1|NOT COMPLETED|Subcutaneous (SC) Phase||0
430336|NCT01465958|1055197|P2|COMPLETED|Subcutaneous (SC) Phase||10
430337|NCT01465958|1055198|P1|COMPLETED|Subcutaneous (SC) Phase||0
430338|NCT01465958|1055197|P2|STARTED|Subcutaneous (SC) Phase|Eleven subjects completed the IV phase and entered the SC phase.|11
430339|NCT01465958|1055198|P1|STARTED|Subcutaneous (SC) Phase|After completing the intravenous (IV) phase, subjects entered the subcutaneous (SC) phase.|0
430340|NCT01465958|1055197|P2|NOT COMPLETED|Intravenous (IV) Phase||0
430341|NCT01465958|1055198|P1|NOT COMPLETED|Intravenous (IV) Phase||0
430342|NCT01465958|1055197|P2|COMPLETED|Intravenous (IV) Phase||0
430343|NCT01465958|1055198|P1|COMPLETED|Intravenous (IV) Phase||11
430344|NCT01465958|1055197|P2|STARTED|Intravenous (IV) Phase||0
430345|NCT01465958|1055198|P1|STARTED|Intravenous (IV) Phase|One subject entered the IV phase directly.|11
430346|NCT01465958|1055197|P2|NOT COMPLETED|Run-in Phase||0
430347|NCT01465958|1055198|P1|NOT COMPLETED|Run-in Phase||1
430348|NCT01465958|1055197|P2|COMPLETED|Run-in Phase||0
430349|NCT01465958|1055198|P1|COMPLETED|Run-in Phase||10
430350|NCT01465958|1055197|P2|STARTED|Run-in Phase||0
430351|NCT01465958|1055198|P1|STARTED|Run-in Phase||11
430352|NCT01465802|1055211|P5|NOT COMPLETED|Overall Study||12
430353|NCT01465802|1055212|P4|NOT COMPLETED|Overall Study||29
430354|NCT01465802|1055213|P3|NOT COMPLETED|Overall Study||0
430355|NCT01465802|1055214|P2|NOT COMPLETED|Overall Study||24
430356|NCT01465802|1055215|P1|NOT COMPLETED|Overall Study||33
430357|NCT01465802|1055211|P5|COMPLETED|Overall Study||13
430358|NCT01465802|1055212|P4|COMPLETED|Overall Study||38
430359|NCT01465802|1055213|P3|COMPLETED|Overall Study||7
430360|NCT01465802|1055214|P2|COMPLETED|Overall Study||42
430361|NCT01465802|1055215|P1|COMPLETED|Overall Study||33
430362|NCT01465802|1055211|P5|STARTED|Overall Study||25
430363|NCT01465802|1055212|P4|STARTED|Overall Study|An additional 5 participants were enrolled in Cohort II but not treated.|67
430364|NCT01465802|1055213|P3|STARTED|Overall Study||7
430365|NCT01465802|1055214|P2|STARTED|Overall Study||66
430366|NCT01465802|1055215|P1|STARTED|Overall Study||66
430367|NCT01465763|1055267|P3|NOT COMPLETED|Overall Study||4
430368|NCT01465763|1055268|P2|NOT COMPLETED|Overall Study||1
430369|NCT01465763|1055269|P1|NOT COMPLETED|Overall Study||31
430370|NCT01465763|1055267|P3|COMPLETED|Overall Study||118
430371|NCT01465763|1055268|P2|COMPLETED|Overall Study||15
430372|NCT01465763|1055269|P1|COMPLETED|Overall Study||445
430373|NCT01465763|1055267|P3|STARTED|Overall Study||122
430374|NCT01465763|1055268|P2|STARTED|Overall Study||16
430375|NCT01465763|1055269|P1|STARTED|Overall Study||476
430376|NCT01465412|1055298|P4|NOT COMPLETED|Overall Study||0
430377|NCT01465412|1055299|P3|NOT COMPLETED|Overall Study||0
430378|NCT01465412|1055300|P2|NOT COMPLETED|Overall Study||0
430379|NCT01465412|1055301|P1|NOT COMPLETED|Overall Study||0
430380|NCT01465412|1055298|P4|COMPLETED|Overall Study||9
430381|NCT01465412|1055299|P3|COMPLETED|Overall Study||9
430382|NCT01465412|1055300|P2|COMPLETED|Overall Study||12
430383|NCT01465412|1055301|P1|COMPLETED|Overall Study||12
430384|NCT01465412|1055298|P4|STARTED|Overall Study||9
430385|NCT01465412|1055299|P3|STARTED|Overall Study||9
430386|NCT01465412|1055300|P2|STARTED|Overall Study||12
430387|NCT01465412|1055301|P1|STARTED|Overall Study||12
430388|NCT01465386|1055339|P1|NOT COMPLETED|Overall Study||4
430389|NCT01465386|1055339|P1|COMPLETED|Overall Study||2
430390|NCT01465386|1055339|P1|STARTED|Overall Study||6
430391|NCT01465347|1055343|P2|NOT COMPLETED|Overall Study||3
430392|NCT01465347|1055344|P1|NOT COMPLETED|Overall Study||1
430393|NCT01465347|1055343|P2|COMPLETED|Overall Study||53
430394|NCT01465347|1055344|P1|COMPLETED|Overall Study||2
430395|NCT01465347|1055343|P2|STARTED|Overall Study||56
430396|NCT01465347|1055344|P1|STARTED|Overall Study||3
430397|NCT01465230|1055354|P1|NOT COMPLETED|Overall Study||2
430398|NCT01465230|1055354|P1|COMPLETED|Overall Study||0
430399|NCT01465230|1055354|P1|STARTED|Overall Study||2
430400|NCT01465178|1055360|P2|NOT COMPLETED|Overall Study||0
430401|NCT01465178|1055361|P1|NOT COMPLETED|Overall Study||1
430402|NCT01465178|1055360|P2|COMPLETED|Overall Study||31
430403|NCT01465178|1055361|P1|COMPLETED|Overall Study||30
430404|NCT01465178|1055360|P2|STARTED|Overall Study||31
430405|NCT01465178|1055361|P1|STARTED|Overall Study||31
430406|NCT01465048|1055372|P3|NOT COMPLETED|Overall Study||0
430407|NCT01465048|1055373|P2|NOT COMPLETED|Overall Study||0
430408|NCT01465048|1055374|P1|NOT COMPLETED|Overall Study||0
430409|NCT01465048|1055372|P3|COMPLETED|Overall Study||6
430410|NCT01465048|1055373|P2|COMPLETED|Overall Study||6
430411|NCT01465048|1055374|P1|COMPLETED|Overall Study||6
430412|NCT01465048|1055372|P3|STARTED|Overall Study||6
430413|NCT01465048|1055373|P2|STARTED|Overall Study||6
430414|NCT01465048|1055374|P1|STARTED|Overall Study||6
430415|NCT01465022|1055385|P3|NOT COMPLETED|Overall Study||70
430416|NCT01465022|1055386|P2|NOT COMPLETED|Overall Study||23
430417|NCT01465022|1055387|P1|NOT COMPLETED|Overall Study||23
430418|NCT01465022|1055385|P3|COMPLETED|Overall Study||0
430419|NCT01465022|1055386|P2|COMPLETED|Overall Study||40
430420|NCT01465022|1055387|P1|COMPLETED|Overall Study||41
430421|NCT01465022|1055385|P3|STARTED|Overall Study||70
430422|NCT01465022|1055386|P2|STARTED|Overall Study||63
430423|NCT01465022|1055387|P1|STARTED|Overall Study||64
430424|NCT01464996|1055401|P1|NOT COMPLETED|Overall Study||0
430425|NCT01464996|1055401|P1|COMPLETED|Overall Study||24
430426|NCT01464996|1055401|P1|OptiBond FL|Overall Study||24
430427|NCT01464996|1055401|P1|OptiBond XTR|Overall Study||23
430428|NCT01464996|1055401|P1|STARTED|Overall Study||24
430429|NCT01464931|1055421|P2|NOT COMPLETED|Overall Study||0
430430|NCT01464931|1055422|P1|NOT COMPLETED|Overall Study||1
430431|NCT01464931|1055421|P2|COMPLETED|Overall Study||16
430432|NCT01464931|1055422|P1|COMPLETED|Overall Study||15
430433|NCT01464931|1055421|P2|STARTED|Overall Study||16
430434|NCT01464931|1055422|P1|STARTED|Overall Study||16
430435|NCT01464879|1055459|P1|NOT COMPLETED|Overall Study||2
430436|NCT01464879|1055459|P1|COMPLETED|Overall Study||18
430437|NCT01464879|1055459|P1|Applicator Application (3.75 mL)|Overall Study||18
430438|NCT01464879|1055459|P1|Applicator Application (2.50 mL)|Overall Study|One subject discontinued due to physician's decision.|18
430439|NCT01464879|1055459|P1|Applicator Application (1.25 mL)|Overall Study|One subject discontinued due to non-compliance.|19
430440|NCT01464879|1055459|P1|Washout Period|Overall Study||20
430441|NCT01464879|1055459|P1|Hand Application (2.50 mL)|Overall Study||20
430442|NCT01464879|1055459|P1|STARTED|Overall Study||20
430443|NCT01464840|1055496|P3|NOT COMPLETED|Overall Study||0
430444|NCT01464840|1055497|P2|NOT COMPLETED|Overall Study||0
430445|NCT01464840|1055498|P1|NOT COMPLETED|Overall Study||0
430446|NCT01464840|1055496|P3|COMPLETED|Overall Study||10
430447|NCT01464840|1055497|P2|COMPLETED|Overall Study||10
430448|NCT01464840|1055498|P1|COMPLETED|Overall Study||10
430449|NCT01464840|1055496|P3|STARTED|Overall Study||10
430450|NCT01464840|1055497|P2|STARTED|Overall Study||10
430451|NCT01464840|1055498|P1|STARTED|Overall Study||10
430452|NCT01464827|1055520|P14|NOT COMPLETED|Overall Study||3
430453|NCT01464827|1055521|P13|NOT COMPLETED|Overall Study||2
430454|NCT01464827|1055522|P12|NOT COMPLETED|Overall Study||2
430455|NCT01464827|1055523|P11|NOT COMPLETED|Overall Study||2
430456|NCT01464827|1055524|P10|NOT COMPLETED|Overall Study||3
430457|NCT01464827|1055525|P9|NOT COMPLETED|Overall Study||3
430458|NCT01464827|1055526|P8|NOT COMPLETED|Overall Study||3
430459|NCT01464827|1055527|P7|NOT COMPLETED|Overall Study||4
430460|NCT01464827|1055528|P6|NOT COMPLETED|Overall Study||1
430461|NCT01464827|1055529|P5|NOT COMPLETED|Overall Study||8
430462|NCT01464827|1055530|P4|NOT COMPLETED|Overall Study||4
430463|NCT01464827|1055531|P3|NOT COMPLETED|Overall Study||0
430464|NCT01464827|1055532|P2|NOT COMPLETED|Overall Study||7
430465|NCT01464827|1055533|P1|NOT COMPLETED|Overall Study||3
430466|NCT01464827|1055520|P14|COMPLETED|Overall Study||19
430467|NCT01464827|1055521|P13|COMPLETED|Overall Study||21
430468|NCT01464827|1055522|P12|COMPLETED|Overall Study||21
430469|NCT01464827|1055523|P11|COMPLETED|Overall Study||21
430470|NCT01464827|1055524|P10|COMPLETED|Overall Study||44
430471|NCT01464827|1055525|P9|COMPLETED|Overall Study||37
430472|NCT01464827|1055526|P8|COMPLETED|Overall Study||37
430473|NCT01464827|1055527|P7|COMPLETED|Overall Study||37
430474|NCT01464827|1055528|P6|COMPLETED|Overall Study||38
430475|NCT01464827|1055529|P5|COMPLETED|Overall Study||72
430476|NCT01464827|1055530|P4|COMPLETED|Overall Study||36
430477|NCT01464827|1055531|P3|COMPLETED|Overall Study||39
430478|NCT01464827|1055532|P2|COMPLETED|Overall Study||36
430479|NCT01464827|1055533|P1|COMPLETED|Overall Study||77
430480|NCT01464827|1055520|P14|Treated|Overall Study||20
430481|NCT01464827|1055521|P13|Treated|Overall Study||23
430482|NCT01464827|1055522|P12|Treated|Overall Study||22
430483|NCT01464827|1055523|P11|Treated|Overall Study||23
430484|NCT01464827|1055524|P10|Treated|Overall Study||45
430485|NCT01464827|1055525|P9|Treated|Overall Study||40
430486|NCT01464827|1055526|P8|Treated|Overall Study||40
430487|NCT01464827|1055527|P7|Treated|Overall Study||40
430488|NCT01464827|1055528|P6|Treated|Overall Study||39
430489|NCT01464827|1055529|P5|Treated|Overall Study||79
430490|NCT01464827|1055530|P4|Treated|Overall Study||40
430491|NCT01464827|1055531|P3|Treated|Overall Study||39
430492|NCT01464827|1055532|P2|Treated|Overall Study||41
430493|NCT01464827|1055533|P1|Treated|Overall Study||80
430494|NCT01464827|1055520|P14|STARTED|Overall Study||22
430495|NCT01464827|1055521|P13|STARTED|Overall Study||23
430496|NCT01464827|1055522|P12|STARTED|Overall Study||23
430497|NCT01464827|1055523|P11|STARTED|Overall Study||23
430498|NCT01464827|1055524|P10|STARTED|Overall Study||47
430499|NCT01464827|1055525|P9|STARTED|Overall Study||40
430500|NCT01464827|1055526|P8|STARTED|Overall Study||40
430501|NCT01464827|1055527|P7|STARTED|Overall Study||41
430502|NCT01464827|1055528|P6|STARTED|Overall Study||39
430503|NCT01464827|1055529|P5|STARTED|Overall Study||80
430504|NCT01464827|1055530|P4|STARTED|Overall Study||40
430505|NCT01464827|1055531|P3|STARTED|Overall Study||39
430506|NCT01464827|1055532|P2|STARTED|Overall Study||43
430507|NCT01464827|1055533|P1|STARTED|Overall Study||80
430508|NCT01464788|1055580|P3|NOT COMPLETED|Overall Study||0
430509|NCT01464788|1055581|P2|NOT COMPLETED|Overall Study||2
430510|NCT01464788|1055582|P1|NOT COMPLETED|Overall Study||0
430511|NCT01464788|1055580|P3|COMPLETED|Overall Study||29
430512|NCT01464788|1055581|P2|COMPLETED|Overall Study||29
430513|NCT01464788|1055582|P1|COMPLETED|Overall Study||30
430514|NCT01464788|1055580|P3|STARTED|Overall Study||29
430515|NCT01464788|1055581|P2|STARTED|Overall Study||31
430516|NCT01464788|1055582|P1|STARTED|Overall Study||30
430517|NCT01464619|1055595|P2|NOT COMPLETED|Overall Study||4
430518|NCT01464619|1055596|P1|NOT COMPLETED|Overall Study||3
430519|NCT01464619|1055595|P2|COMPLETED|Overall Study||25
430520|NCT01464619|1055596|P1|COMPLETED|Overall Study||29
430521|NCT01464619|1055595|P2|STARTED|Overall Study||29
430522|NCT01464619|1055596|P1|STARTED|Overall Study||32
430523|NCT01464424|1055616|P2|NOT COMPLETED|Period 2, Second 6 Weeks||0
430524|NCT01464424|1055617|P1|NOT COMPLETED|Period 2, Second 6 Weeks||0
430525|NCT01464424|1055616|P2|COMPLETED|Period 2, Second 6 Weeks||41
430526|NCT01464424|1055617|P1|COMPLETED|Period 2, Second 6 Weeks||42
430527|NCT01464424|1055616|P2|STARTED|Period 2, Second 6 Weeks||41
430528|NCT01464424|1055617|P1|STARTED|Period 2, Second 6 Weeks||42
430529|NCT01464424|1055616|P2|NOT COMPLETED|Period 1, First 6 Weeks||1
430530|NCT01464424|1055617|P1|NOT COMPLETED|Period 1, First 6 Weeks||0
430531|NCT01464424|1055616|P2|COMPLETED|Period 1, First 6 Weeks||41
430532|NCT01464424|1055617|P1|COMPLETED|Period 1, First 6 Weeks||42
430533|NCT01464424|1055616|P2|STARTED|Period 1, First 6 Weeks||42
430534|NCT01464424|1055617|P1|STARTED|Period 1, First 6 Weeks||42
430535|NCT01464359|1055625|P1|NOT COMPLETED|Overall Study||0
430536|NCT01464359|1055625|P1|COMPLETED|Overall Study||3
430537|NCT01464359|1055625|P1|STARTED|Overall Study||3
430538|NCT01464346|1055637|P3|NOT COMPLETED|Overall Study||1
430539|NCT01464346|1055638|P2|NOT COMPLETED|Overall Study||0
430540|NCT01464346|1055639|P1|NOT COMPLETED|Overall Study||0
430541|NCT01464346|1055637|P3|COMPLETED|Overall Study||28
430542|NCT01464346|1055638|P2|COMPLETED|Overall Study||32
430543|NCT01464346|1055639|P1|COMPLETED|Overall Study||29
430544|NCT01464346|1055637|P3|STARTED|Overall Study||29
430545|NCT01464346|1055638|P2|STARTED|Overall Study||32
430546|NCT01464346|1055639|P1|STARTED|Overall Study||29
430547|NCT01464307|1055650|P2|NOT COMPLETED|Open-Label Extension Period||0
430548|NCT01464307|1055651|P1|NOT COMPLETED|Open-Label Extension Period||51
430549|NCT01464307|1055650|P2|COMPLETED|Open-Label Extension Period||0
430550|NCT01464307|1055651|P1|COMPLETED|Open-Label Extension Period||218
430551|NCT01464307|1055650|P2|Treated|Open-Label Extension Period||0
430552|NCT01464307|1055651|P1|Treated|Open-Label Extension Period||269
430553|NCT01464307|1055650|P2|STARTED|Open-Label Extension Period||0
430554|NCT01464307|1055651|P1|STARTED|Open-Label Extension Period||269
430555|NCT01464307|1055650|P2|NOT COMPLETED|Main Period||5
430556|NCT01464307|1055651|P1|NOT COMPLETED|Main Period||15
430557|NCT01464307|1055650|P2|COMPLETED|Main Period||140
430558|NCT01464307|1055651|P1|COMPLETED|Main Period||129
430559|NCT01464307|1055650|P2|Treated|Main Period||145
430560|NCT01464307|1055651|P1|Treated|Main Period||144
430561|NCT01464307|1055650|P2|STARTED|Main Period||145
430562|NCT01464307|1055651|P1|STARTED|Main Period||144
430563|NCT01464255|1055666|P2|NOT COMPLETED|Overall Study||1
430564|NCT01464255|1055667|P1|NOT COMPLETED|Overall Study||0
430565|NCT01464255|1055666|P2|COMPLETED|Overall Study||24
430566|NCT01464255|1055667|P1|COMPLETED|Overall Study||25
430567|NCT01464255|1055666|P2|STARTED|Overall Study||25
430568|NCT01464255|1055667|P1|STARTED|Overall Study||25
430569|NCT01464229|1055692|P2|NOT COMPLETED|Overall Study||2
430570|NCT01464229|1055693|P1|NOT COMPLETED|Overall Study||5
430571|NCT01464229|1055692|P2|COMPLETED|Overall Study||8
430572|NCT01464229|1055693|P1|COMPLETED|Overall Study||5
430573|NCT01464229|1055692|P2|STARTED|Overall Study||10
430574|NCT01464229|1055693|P1|STARTED|Overall Study||10
430575|NCT01464190|1055701|P2|NOT COMPLETED|Overall Study||41
430576|NCT01464190|1055702|P1|NOT COMPLETED|Overall Study||69
430577|NCT01464190|1055701|P2|COMPLETED|Overall Study||227
430578|NCT01464190|1055702|P1|COMPLETED|Overall Study||322
430579|NCT01464190|1055701|P2|STARTED|Overall Study||268
430580|NCT01464190|1055702|P1|STARTED|Overall Study||391
430581|NCT01464021|1055712|P1|NOT COMPLETED|Overall Study||26
430582|NCT01464021|1055712|P1|COMPLETED|Overall Study||0
430583|NCT01464021|1055712|P1|STARTED|Overall Study||26
430584|NCT01463982|1055728|P4|NOT COMPLETED|Overall Study||0
430585|NCT01463982|1055729|P3|NOT COMPLETED|Overall Study||2
430586|NCT01463982|1055730|P2|NOT COMPLETED|Overall Study||1
430587|NCT01463982|1055731|P1|NOT COMPLETED|Overall Study||0
430588|NCT01463982|1055728|P4|COMPLETED|Overall Study||6
430589|NCT01463982|1055729|P3|COMPLETED|Overall Study||2
430590|NCT01463982|1055730|P2|COMPLETED|Overall Study||7
430591|NCT01463982|1055731|P1|COMPLETED|Overall Study||3
430592|NCT01463982|1055728|P4|STARTED|Overall Study||6
430593|NCT01463982|1055729|P3|STARTED|Overall Study||4
430594|NCT01463982|1055730|P2|STARTED|Overall Study||8
430595|NCT01463982|1055731|P1|STARTED|Overall Study||3
430596|NCT01463878|1055747|P2|NOT COMPLETED|Overall Study||2
430597|NCT01463878|1055748|P1|NOT COMPLETED|Overall Study||2
430598|NCT01463878|1055747|P2|COMPLETED|Overall Study||7
430599|NCT01463878|1055748|P1|COMPLETED|Overall Study||7
430600|NCT01463878|1055747|P2|STARTED|Overall Study||9
430601|NCT01463878|1055748|P1|STARTED|Overall Study||9
430602|NCT01463696|1055762|P8|NOT COMPLETED|Overall Study||4
430603|NCT01463696|1055763|P7|NOT COMPLETED|Overall Study||10
430604|NCT01463696|1055764|P6|NOT COMPLETED|Overall Study||3
430605|NCT01463696|1055765|P5|NOT COMPLETED|Overall Study||1
430606|NCT01463696|1055766|P4|NOT COMPLETED|Overall Study||4
430607|NCT01463696|1055767|P3|NOT COMPLETED|Overall Study||1
430608|NCT01463696|1055768|P2|NOT COMPLETED|Overall Study||2
430609|NCT01463696|1055769|P1|NOT COMPLETED|Overall Study||0
430610|NCT01463696|1055762|P8|COMPLETED|Overall Study||2
430611|NCT01463696|1055763|P7|COMPLETED|Overall Study||6
430612|NCT01463696|1055764|P6|COMPLETED|Overall Study||3
430613|NCT01463696|1055765|P5|COMPLETED|Overall Study||2
430614|NCT01463696|1055766|P4|COMPLETED|Overall Study||3
430615|NCT01463696|1055767|P3|COMPLETED|Overall Study||2
430616|NCT01463696|1055768|P2|COMPLETED|Overall Study||4
430617|NCT01463696|1055769|P1|COMPLETED|Overall Study||1
430618|NCT01463696|1055762|P8|Treated|Overall Study||6
430619|NCT01463696|1055763|P7|Treated|Overall Study||15
430620|NCT01463696|1055764|P6|Treated|Overall Study||6
430621|NCT01463696|1055765|P5|Treated|Overall Study||3
430622|NCT01463696|1055766|P4|Treated|Overall Study||7
430623|NCT01463696|1055767|P3|Treated|Overall Study||3
430624|NCT01463696|1055768|P2|Treated|Overall Study||6
430625|NCT01463696|1055769|P1|Treated|Overall Study||1
430626|NCT01463696|1055762|P8|STARTED|Overall Study||6
430627|NCT01463696|1055763|P7|STARTED|Overall Study||16
430628|NCT01463696|1055764|P6|STARTED|Overall Study||6
430629|NCT01463696|1055765|P5|STARTED|Overall Study||3
430630|NCT01463696|1055766|P4|STARTED|Overall Study||7
430631|NCT01463696|1055767|P3|STARTED|Overall Study||3
430632|NCT01463696|1055768|P2|STARTED|Overall Study||6
430633|NCT01463696|1055769|P1|STARTED|Overall Study||1
430634|NCT01463683|1055822|P3|NOT COMPLETED|Overall Study||11
430635|NCT01463683|1055823|P2|NOT COMPLETED|Overall Study||31
430636|NCT01463683|1055824|P1|NOT COMPLETED|Overall Study||19
430637|NCT01463683|1055822|P3|COMPLETED|Overall Study||93
430638|NCT01463683|1055823|P2|COMPLETED|Overall Study||278
430639|NCT01463683|1055824|P1|COMPLETED|Overall Study||290
430640|NCT01463683|1055822|P3|Received Vaccination 3 (Month 6)|Overall Study||93
430641|NCT01463683|1055823|P2|Received Vaccination 3 (Month 6)|Overall Study||281
430642|NCT01463683|1055824|P1|Received Vaccination 3 (Month 6)|Overall Study||290
430643|NCT01463683|1055822|P3|Received Vaccination 2 (Month 1)|Overall Study||103
430644|NCT01463683|1055823|P2|Received Vaccination 2 (Month 1)|Overall Study||300
430645|NCT01463683|1055824|P1|Received Vaccination 2 (Month 1)|Overall Study||302
430646|NCT01463683|1055822|P3|Received Vaccination 1 (Day 1)|Overall Study||104
430647|NCT01463683|1055823|P2|Received Vaccination 1 (Day 1)|Overall Study||308
430648|NCT01463683|1055824|P1|Received Vaccination 1 (Day 1)|Overall Study||309
430649|NCT01463683|1055822|P3|STARTED|Overall Study||104
430650|NCT01463683|1055823|P2|STARTED|Overall Study||309
430651|NCT01463683|1055824|P1|STARTED|Overall Study||309
430652|NCT01463527|1055839|P2|NOT COMPLETED|Overall Study||7
430653|NCT01463527|1055840|P1|NOT COMPLETED|Overall Study||6
430654|NCT01463527|1055839|P2|COMPLETED|Overall Study||77
430655|NCT01463527|1055840|P1|COMPLETED|Overall Study||77
430656|NCT01463527|1055839|P2|STARTED|Overall Study||84
430657|NCT01463527|1055840|P1|STARTED|Overall Study||83
430658|NCT01463384|1055848|P1|NOT COMPLETED|Overall Study||0
430659|NCT01463384|1055848|P1|COMPLETED|Overall Study||13
430660|NCT01463384|1055848|P1|STARTED|Overall Study||13
430661|NCT01463293|1055863|P3|NOT COMPLETED|Overall Study||12
430662|NCT01463293|1055864|P2|NOT COMPLETED|Overall Study||16
430663|NCT01463293|1055865|P1|NOT COMPLETED|Overall Study||6
430664|NCT01463293|1055863|P3|COMPLETED|Overall Study||59
430665|NCT01463293|1055864|P2|COMPLETED|Overall Study||63
430666|NCT01463293|1055865|P1|COMPLETED|Overall Study||68
430667|NCT01463293|1055863|P3|STARTED|Overall Study||71
430668|NCT01463293|1055864|P2|STARTED|Overall Study||79
430669|NCT01463293|1055865|P1|STARTED|Overall Study||74
430670|NCT01463202|1055875|P2|NOT COMPLETED|Overall Study||0
430671|NCT01463202|1055876|P1|NOT COMPLETED|Overall Study||0
430672|NCT01463202|1055875|P2|COMPLETED|Overall Study||78
430673|NCT01463202|1055876|P1|COMPLETED|Overall Study||79
430674|NCT01463202|1055875|P2|STARTED|Overall Study||78
430675|NCT01463202|1055876|P1|STARTED|Overall Study||79
430676|NCT01463111|1055888|P1|NOT COMPLETED|Overall Study||9
430677|NCT01463111|1055888|P1|COMPLETED|Overall Study||17
430678|NCT01463111|1055888|P1|STARTED|Overall Study||26
430679|NCT01463033|1055898|P2|NOT COMPLETED|Overall Study||6
430680|NCT01463033|1055899|P1|NOT COMPLETED|Overall Study||7
430681|NCT01463033|1055898|P2|COMPLETED|Overall Study|2 deaths, 4 lost to follow up|54
430682|NCT01463033|1055899|P1|COMPLETED|Overall Study|3 deaths, 4 lost to follow up|59
430683|NCT01463033|1055898|P2|STARTED|Overall Study||60
430684|NCT01463033|1055899|P1|STARTED|Overall Study||66
430685|NCT01463007|1055906|P1|NOT COMPLETED|Overall Study||1
430686|NCT01463007|1055906|P1|COMPLETED|Overall Study||40
430687|NCT01463007|1055906|P1|STARTED|Overall Study||41
430688|NCT01462942|1055917|P5|NOT COMPLETED|Overall Study||45
430689|NCT01462942|1055918|P4|NOT COMPLETED|Overall Study||50
430690|NCT01462942|1055919|P3|NOT COMPLETED|Overall Study||40
430691|NCT01462942|1055920|P2|NOT COMPLETED|Overall Study||34
430692|NCT01462942|1055921|P1|NOT COMPLETED|Overall Study||34
430693|NCT01462942|1055917|P5|COMPLETED|Overall Study||339
430694|NCT01462942|1055918|P4|COMPLETED|Overall Study||335
430695|NCT01462942|1055919|P3|COMPLETED|Overall Study||341
430696|NCT01462942|1055920|P2|COMPLETED|Overall Study||351
430697|NCT01462942|1055921|P1|COMPLETED|Overall Study||160
430698|NCT01462942|1055917|P5|STARTED|Overall Study||384
430699|NCT01462942|1055918|P4|STARTED|Overall Study||385
430700|NCT01462942|1055919|P3|STARTED|Overall Study||381
430701|NCT01462942|1055920|P2|STARTED|Overall Study||385
430702|NCT01462942|1055921|P1|STARTED|Overall Study||194
430703|NCT01462929|1055951|P3|NOT COMPLETED|Overall Study||5
430704|NCT01462929|1055952|P2|NOT COMPLETED|Overall Study||4
430705|NCT01462929|1055953|P1|NOT COMPLETED|Overall Study||5
430706|NCT01462929|1055951|P3|COMPLETED|Overall Study||80
430707|NCT01462929|1055952|P2|COMPLETED|Overall Study||154
430708|NCT01462929|1055953|P1|COMPLETED|Overall Study||166
430709|NCT01462929|1055951|P3|STARTED|Overall Study||85
430710|NCT01462929|1055952|P2|STARTED|Overall Study||158
430711|NCT01462929|1055953|P1|STARTED|Overall Study||171
430712|NCT01462877|1055964|P1|NOT COMPLETED|Overall Study||71
430713|NCT01462877|1055964|P1|COMPLETED|Overall Study||435
430714|NCT01462877|1055964|P1|Per-protocol Set|Overall Study||364
430715|NCT01462877|1055964|P1|Full Analysis Set|Overall Study||468
430716|NCT01462877|1055964|P1|Safety Set|Overall Study||492
430717|NCT01462877|1055964|P1|STARTED|Overall Study||506
430718|NCT01462812|1055980|P2|NOT COMPLETED|Overall Study||1
430719|NCT01462812|1055981|P1|NOT COMPLETED|Overall Study||0
430720|NCT01462812|1055980|P2|COMPLETED|Overall Study||111
430721|NCT01462812|1055981|P1|COMPLETED|Overall Study||111
430722|NCT01462812|1055980|P2|STARTED|Overall Study||112
430723|NCT01462812|1055981|P1|STARTED|Overall Study||111
430724|NCT01462773|1055987|P1|NOT COMPLETED|Overall Study||0
430725|NCT01462773|1055987|P1|COMPLETED|Overall Study||16
430726|NCT01462773|1055987|P1|STARTED|Overall Study||16
430727|NCT01462695|1055994|P2|NOT COMPLETED|Overall Study||13
430728|NCT01462695|1055995|P1|NOT COMPLETED|Overall Study||17
430729|NCT01462695|1055994|P2|COMPLETED|Overall Study||0
430730|NCT01462695|1055995|P1|COMPLETED|Overall Study||0
430731|NCT01462695|1055994|P2|STARTED|Overall Study||13
430732|NCT01462695|1055995|P1|STARTED|Overall Study||17
430733|NCT01462565|1056001|P1|NOT COMPLETED|Overall Study||0
430734|NCT01462565|1056001|P1|COMPLETED|Overall Study||16
430735|NCT01462565|1056001|P1|STARTED|Overall Study||16
430736|NCT01462435|1056023|P4|NOT COMPLETED|Overall Study||5
430737|NCT01462435|1056024|P3|NOT COMPLETED|Overall Study||1
430738|NCT01462435|1056025|P2|NOT COMPLETED|Overall Study||0
430739|NCT01462435|1056026|P1|NOT COMPLETED|Overall Study||1
430740|NCT01462435|1056023|P4|COMPLETED|Overall Study||101
430741|NCT01462435|1056024|P3|COMPLETED|Overall Study||106
430742|NCT01462435|1056025|P2|COMPLETED|Overall Study||109
430743|NCT01462435|1056026|P1|COMPLETED|Overall Study||105
430744|NCT01462435|1056023|P4|STARTED|Overall Study||106
430745|NCT01462435|1056024|P3|STARTED|Overall Study||107
430746|NCT01462435|1056025|P2|STARTED|Overall Study||109
430747|NCT01462435|1056026|P1|STARTED|Overall Study||106
430748|NCT01462370|1056064|P2|NOT COMPLETED|Overall Study||5
430749|NCT01462370|1056065|P1|NOT COMPLETED|Overall Study||1
430750|NCT01462370|1056064|P2|COMPLETED|Overall Study||65
430751|NCT01462370|1056065|P1|COMPLETED|Overall Study||68
430752|NCT01462370|1056064|P2|STARTED|Overall Study||70
430753|NCT01462370|1056065|P1|STARTED|Overall Study||69
430754|NCT01462357|1056100|P3|NOT COMPLETED|Month 36||0
430755|NCT01462357|1056101|P2|NOT COMPLETED|Month 36||0
430756|NCT01462357|1056102|P1|NOT COMPLETED|Month 36||0
430757|NCT01462357|1056100|P3|COMPLETED|Month 36||346
430758|NCT01462357|1056101|P2|COMPLETED|Month 36||339
430759|NCT01462357|1056102|P1|COMPLETED|Month 36||351
430760|NCT01462357|1056100|P3|STARTED|Month 36||346
430761|NCT01462357|1056101|P2|STARTED|Month 36||339
430762|NCT01462357|1056102|P1|STARTED|Month 36||351
430763|NCT01462357|1056100|P3|NOT COMPLETED|Month 24||9
430764|NCT01462357|1056101|P2|NOT COMPLETED|Month 24||14
430765|NCT01462357|1056102|P1|NOT COMPLETED|Month 24||4
430766|NCT01462357|1056100|P3|COMPLETED|Month 24||349
430767|NCT01462357|1056101|P2|COMPLETED|Month 24||344
430768|NCT01462357|1056102|P1|COMPLETED|Month 24||355
430769|NCT01462357|1056100|P3|STARTED|Month 24||358
430770|NCT01462357|1056101|P2|STARTED|Month 24||358
430771|NCT01462357|1056102|P1|STARTED|Month 24||359
430772|NCT01462357|1056100|P3|NOT COMPLETED|Month 18||9
430773|NCT01462357|1056101|P2|NOT COMPLETED|Month 18||11
430774|NCT01462357|1056102|P1|NOT COMPLETED|Month 18||3
430775|NCT01462357|1056100|P3|COMPLETED|Month 18||349
430776|NCT01462357|1056101|P2|COMPLETED|Month 18||347
430777|NCT01462357|1056102|P1|COMPLETED|Month 18||356
430778|NCT01462357|1056100|P3|STARTED|Month 18||358
430779|NCT01462357|1056101|P2|STARTED|Month 18||358
430780|NCT01462357|1056102|P1|STARTED|Month 18||359
430781|NCT01462357|1056100|P3|NOT COMPLETED|Month 12||8
430782|NCT01462357|1056101|P2|NOT COMPLETED|Month 12||10
430783|NCT01462357|1056102|P1|NOT COMPLETED|Month 12||3
430784|NCT01462357|1056100|P3|COMPLETED|Month 12||350
430785|NCT01462357|1056101|P2|COMPLETED|Month 12||348
430786|NCT01462357|1056102|P1|COMPLETED|Month 12||356
430787|NCT01462357|1056100|P3|STARTED|Month 12||358
430788|NCT01462357|1056101|P2|STARTED|Month 12||358
430789|NCT01462357|1056102|P1|STARTED|Month 12||359
430790|NCT01462357|1056100|P3|NOT COMPLETED|Month 7||6
430791|NCT01462357|1056101|P2|NOT COMPLETED|Month 7||5
430792|NCT01462357|1056102|P1|NOT COMPLETED|Month 7||1
430793|NCT01462357|1056100|P3|COMPLETED|Month 7||352
430794|NCT01462357|1056101|P2|COMPLETED|Month 7||353
430795|NCT01462357|1056102|P1|COMPLETED|Month 7||358
430796|NCT01462357|1056100|P3|STARTED|Month 7||358
430797|NCT01462357|1056101|P2|STARTED|Month 7||358
430798|NCT01462357|1056102|P1|STARTED|Month 7||359
430799|NCT01462344|1056175|P2|NOT COMPLETED|Overall Study||350
430800|NCT01462344|1056176|P1|NOT COMPLETED|Overall Study||383
430801|NCT01462344|1056175|P2|COMPLETED|Overall Study||2751
430802|NCT01462344|1056176|P1|COMPLETED|Overall Study||2724
430803|NCT01462344|1056175|P2|STARTED|Overall Study||3101
430804|NCT01462344|1056176|P1|STARTED|Overall Study||3107
430805|NCT01462318|1056198|P3|NOT COMPLETED|Extension Phase||45
430806|NCT01462318|1056199|P2|NOT COMPLETED|Extension Phase||0
430807|NCT01462318|1056200|P1|NOT COMPLETED|Extension Phase||0
430808|NCT01462318|1056198|P3|COMPLETED|Extension Phase||70
430809|NCT01462318|1056199|P2|COMPLETED|Extension Phase||0
430810|NCT01462318|1056200|P1|COMPLETED|Extension Phase||0
430811|NCT01462318|1056198|P3|STARTED|Extension Phase|10 participants from the Main Study did not enter the Extension Phase.|115
430812|NCT01462318|1056199|P2|STARTED|Extension Phase|20 participants from the TP-DI Study entered the Extension Phase|0
430813|NCT01462318|1056200|P1|STARTED|Extension Phase|95 participants from the Main Study entered the Extension Phase|0
430814|NCT01462318|1056198|P3|NOT COMPLETED|Main Study / TP-DI Study||0
430815|NCT01462318|1056199|P2|NOT COMPLETED|Main Study / TP-DI Study||0
430816|NCT01462318|1056200|P1|NOT COMPLETED|Main Study / TP-DI Study||8
430817|NCT01462318|1056198|P3|COMPLETED|Main Study / TP-DI Study||0
430818|NCT01462318|1056199|P2|COMPLETED|Main Study / TP-DI Study||20
430819|NCT01462318|1056200|P1|COMPLETED|Main Study / TP-DI Study||105
430820|NCT01462318|1056198|P3|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||0
430821|NCT01462318|1056199|P2|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||0
430822|NCT01462318|1056200|P1|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||26
430823|NCT01462318|1056198|P3|STARTED|Main Study / TP-DI Study||0
430824|NCT01462318|1056199|P2|STARTED|Main Study / TP-DI Study||20
430825|NCT01462318|1056200|P1|STARTED|Main Study / TP-DI Study||113
430826|NCT01462292|1056220|P3|NOT COMPLETED|Overall Study||0
430827|NCT01462292|1056221|P2|NOT COMPLETED|Overall Study||0
430828|NCT01462292|1056222|P1|NOT COMPLETED|Overall Study||0
430829|NCT01462292|1056220|P3|COMPLETED|Overall Study||18
430830|NCT01462292|1056221|P2|COMPLETED|Overall Study||17
430831|NCT01462292|1056222|P1|COMPLETED|Overall Study||16
430832|NCT01462292|1056220|P3|STARTED|Overall Study||18
430833|NCT01462292|1056221|P2|STARTED|Overall Study||17
430834|NCT01462292|1056222|P1|STARTED|Overall Study||16
430835|NCT01462279|1056281|P1|NOT COMPLETED|Overall Study||3
430836|NCT01462279|1056281|P1|COMPLETED|Overall Study||17
430837|NCT01462279|1056281|P1|STARTED|Overall Study||20
430838|NCT01462266|1056288|P2|NOT COMPLETED|Overall Study||27
430839|NCT01462266|1056289|P1|NOT COMPLETED|Overall Study||35
430840|NCT01462266|1056288|P2|COMPLETED|Overall Study||303
430841|NCT01462266|1056289|P1|COMPLETED|Overall Study||295
430842|NCT01462266|1056288|P2|Treated|Overall Study|One participant was randomized in error and did not receive study medication.|329
430843|NCT01462266|1056289|P1|Treated|Overall Study|One participant was randomized in error and did not receive study medication.|329
430844|NCT01462266|1056288|P2|STARTED|Overall Study||330
430845|NCT01462266|1056289|P1|STARTED|Overall Study||330
430846|NCT01462227|1056305|P4|NOT COMPLETED|Second Assignment||0
430847|NCT01462227|1056306|P3|NOT COMPLETED|Second Assignment||1
430848|NCT01462227|1056307|P2|NOT COMPLETED|Second Assignment||1
430849|NCT01462227|1056308|P1|NOT COMPLETED|Second Assignment||1
430850|NCT01462227|1056305|P4|COMPLETED|Second Assignment||5
430851|NCT01462227|1056306|P3|COMPLETED|Second Assignment||5
430852|NCT01462227|1056307|P2|COMPLETED|Second Assignment||1
430853|NCT01462227|1056308|P1|COMPLETED|Second Assignment||3
430854|NCT01462227|1056305|P4|STARTED|Second Assignment||5
430855|NCT01462227|1056306|P3|STARTED|Second Assignment||6
430856|NCT01462227|1056307|P2|STARTED|Second Assignment||2
430857|NCT01462227|1056308|P1|STARTED|Second Assignment||4
430858|NCT01462227|1056305|P4|NOT COMPLETED|First Assignment||0
430859|NCT01462227|1056306|P3|NOT COMPLETED|First Assignment||0
430860|NCT01462227|1056307|P2|NOT COMPLETED|First Assignment||0
430861|NCT01462227|1056308|P1|NOT COMPLETED|First Assignment||0
430862|NCT01462227|1056305|P4|COMPLETED|First Assignment||5
430863|NCT01462227|1056306|P3|COMPLETED|First Assignment||6
430864|NCT01462227|1056307|P2|COMPLETED|First Assignment||2
430865|NCT01462227|1056308|P1|COMPLETED|First Assignment||4
430866|NCT01462227|1056305|P4|STARTED|First Assignment||5
430867|NCT01462227|1056306|P3|STARTED|First Assignment||6
430868|NCT01462227|1056307|P2|STARTED|First Assignment||2
430869|NCT01462227|1056308|P1|STARTED|First Assignment||4
430870|NCT01462162|1056326|P1|NOT COMPLETED|Overall Study||12
430871|NCT01462162|1056326|P1|COMPLETED|Overall Study||108
430872|NCT01462162|1056326|P1|STARTED|Overall Study||120
430873|NCT01462084|1056351|P2|NOT COMPLETED|Overall Study||1
430874|NCT01462084|1056352|P1|NOT COMPLETED|Overall Study||2
430875|NCT01462084|1056351|P2|COMPLETED|Overall Study||9
430876|NCT01462084|1056352|P1|COMPLETED|Overall Study||9
430877|NCT01462084|1056351|P2|Included for Analysis|Overall Study||9
430878|NCT01462084|1056352|P1|Included for Analysis|Overall Study||9
430879|NCT01462084|1056351|P2|STARTED|Overall Study||10
430880|NCT01462084|1056352|P1|STARTED|Overall Study||11
430881|NCT01462045|1056363|P3|NOT COMPLETED|Overall Study||0
430882|NCT01462045|1056364|P2|NOT COMPLETED|Overall Study||1
430883|NCT01462045|1056365|P1|NOT COMPLETED|Overall Study||0
430884|NCT01462045|1056363|P3|COMPLETED|Overall Study||7
430885|NCT01462045|1056364|P2|COMPLETED|Overall Study||10
430886|NCT01462045|1056365|P1|COMPLETED|Overall Study||11
430887|NCT01462045|1056363|P3|STARTED|Overall Study||7
430888|NCT01462045|1056364|P2|STARTED|Overall Study||11
430889|NCT01462045|1056365|P1|STARTED|Overall Study||11
430890|NCT01461993|1056379|P3|NOT COMPLETED|Overall Study||64
430891|NCT01461993|1056380|P2|NOT COMPLETED|Overall Study||157
430892|NCT01461993|1056381|P1|NOT COMPLETED|Overall Study||151
430893|NCT01461993|1056379|P3|COMPLETED|Overall Study||438
430894|NCT01461993|1056380|P2|COMPLETED|Overall Study||841
430895|NCT01461993|1056381|P1|COMPLETED|Overall Study||848
430896|NCT01461993|1056379|P3|STARTED|Overall Study||502
430897|NCT01461993|1056380|P2|STARTED|Overall Study||998
430898|NCT01461993|1056381|P1|STARTED|Overall Study||999
430899|NCT01461980|1056406|P3|NOT COMPLETED|Overall Study||165
430900|NCT01461980|1056407|P2|NOT COMPLETED|Overall Study||145
430901|NCT01461980|1056408|P1|NOT COMPLETED|Overall Study||166
430902|NCT01461980|1056406|P3|COMPLETED|Overall Study||717
430903|NCT01461980|1056407|P2|COMPLETED|Overall Study||733
430904|NCT01461980|1056408|P1|COMPLETED|Overall Study||722
430905|NCT01461980|1056406|P3|Vaccination 3|Overall Study||748
430906|NCT01461980|1056407|P2|Vaccination 3|Overall Study||777
430907|NCT01461980|1056408|P1|Vaccination 3|Overall Study||757
430908|NCT01461980|1056406|P3|Vaccination 2|Overall Study||799
430909|NCT01461980|1056407|P2|Vaccination 2|Overall Study||819
430910|NCT01461980|1056408|P1|Vaccination 2|Overall Study||802
430911|NCT01461980|1056406|P3|Vaccination 1|Overall Study||875
430912|NCT01461980|1056407|P2|Vaccination 1|Overall Study||870
430913|NCT01461980|1056408|P1|Vaccination 1|Overall Study||884
430914|NCT01461980|1056406|P3|STARTED|Overall Study||882
430915|NCT01461980|1056407|P2|STARTED|Overall Study||878
430916|NCT01461980|1056408|P1|STARTED|Overall Study||888
430917|NCT01461824|1056441|P3|NOT COMPLETED|Overall Study||3
430918|NCT01461824|1056442|P2|NOT COMPLETED|Overall Study||4
430919|NCT01461824|1056443|P1|NOT COMPLETED|Overall Study||2
430920|NCT01461824|1056441|P3|COMPLETED|Overall Study||8
430921|NCT01461824|1056442|P2|COMPLETED|Overall Study||7
430922|NCT01461824|1056443|P1|COMPLETED|Overall Study||10
430923|NCT01461824|1056441|P3|STARTED|Overall Study||11
430924|NCT01461824|1056442|P2|STARTED|Overall Study||11
430925|NCT01461824|1056443|P1|STARTED|Overall Study||12
430926|NCT01461811|1056459|P2|NOT COMPLETED|Overall Study||3
430927|NCT01461811|1056460|P1|NOT COMPLETED|Overall Study||4
430928|NCT01461811|1056459|P2|COMPLETED|Overall Study||46
430929|NCT01461811|1056460|P1|COMPLETED|Overall Study||91
430930|NCT01461811|1056459|P2|STARTED|Overall Study||49
430931|NCT01461811|1056460|P1|STARTED|Overall Study||95
430932|NCT01461733|1056490|P2|NOT COMPLETED|Overall Study||4
430933|NCT01461733|1056491|P1|NOT COMPLETED|Overall Study||4
430934|NCT01461733|1056490|P2|COMPLETED|Overall Study||8
430935|NCT01461733|1056491|P1|COMPLETED|Overall Study||8
430936|NCT01461733|1056490|P2|STARTED|Overall Study||12
430937|NCT01461733|1056491|P1|STARTED|Overall Study||12
430938|NCT01461707|1056499|P2|NOT COMPLETED|Overall Study||0
430939|NCT01461707|1056500|P1|NOT COMPLETED|Overall Study||1
430940|NCT01461707|1056499|P2|COMPLETED|Overall Study||15
430941|NCT01461707|1056500|P1|COMPLETED|Overall Study||14
430942|NCT01461707|1056499|P2|STARTED|Overall Study||15
430943|NCT01461707|1056500|P1|STARTED|Overall Study||15
430944|NCT01461668|1056510|P2|NOT COMPLETED|Overall Study||1
430945|NCT01461668|1056511|P1|NOT COMPLETED|Overall Study||2
430946|NCT01461668|1056510|P2|COMPLETED|Overall Study||25
430947|NCT01461668|1056511|P1|COMPLETED|Overall Study||25
430948|NCT01461668|1056510|P2|STARTED|Overall Study||26
430949|NCT01461668|1056511|P1|STARTED|Overall Study||27
430950|NCT01461655|1056517|P1|NOT COMPLETED|Overall Study||0
430951|NCT01461655|1056517|P1|COMPLETED|Overall Study||40
430952|NCT01461655|1056517|P1|STARTED|Overall Study||40
430953|NCT01461551|1056537|P3|NOT COMPLETED|Overall Study||2
430954|NCT01461551|1056538|P2|NOT COMPLETED|Overall Study||1
430955|NCT01461551|1056539|P1|NOT COMPLETED|Overall Study||2
430956|NCT01461551|1056537|P3|COMPLETED|Overall Study||33
430957|NCT01461551|1056538|P2|COMPLETED|Overall Study||34
430958|NCT01461551|1056539|P1|COMPLETED|Overall Study||33
430959|NCT01461551|1056537|P3|STARTED|Overall Study||35
430960|NCT01461551|1056538|P2|STARTED|Overall Study||35
430961|NCT01461551|1056539|P1|STARTED|Overall Study||35
430962|NCT01461538|1056550|P3|NOT COMPLETED|Overall Study||2
430963|NCT01461538|1056551|P2|NOT COMPLETED|Overall Study||8
430964|NCT01461538|1056552|P1|NOT COMPLETED|Overall Study||18
430965|NCT01461538|1056550|P3|COMPLETED|Overall Study||7
430966|NCT01461538|1056551|P2|COMPLETED|Overall Study||20
430967|NCT01461538|1056552|P1|COMPLETED|Overall Study||28
430968|NCT01461538|1056550|P3|STARTED|Overall Study||9
430969|NCT01461538|1056551|P2|STARTED|Overall Study||28
430970|NCT01461538|1056552|P1|STARTED|Overall Study||46
430971|NCT01461499|1056590|P2|NOT COMPLETED|Overall Study||4
430972|NCT01461499|1056591|P1|NOT COMPLETED|Overall Study||8
430973|NCT01461499|1056590|P2|COMPLETED|Overall Study||114
430974|NCT01461499|1056591|P1|COMPLETED|Overall Study||111
430975|NCT01461499|1056590|P2|STARTED|Overall Study||118
430976|NCT01461499|1056591|P1|STARTED|Overall Study||119
430977|NCT01461473|1056601|P2|NOT COMPLETED|Overall Study||4
430978|NCT01461473|1056602|P1|NOT COMPLETED|Overall Study||5
430979|NCT01461473|1056601|P2|COMPLETED|Overall Study||55
430980|NCT01461473|1056602|P1|COMPLETED|Overall Study||67
430981|NCT01461473|1056601|P2|STARTED|Overall Study||59
430982|NCT01461473|1056602|P1|STARTED|Overall Study||72
430983|NCT01461369|1056621|P3|NOT COMPLETED|Overall Study||17
430984|NCT01461369|1056622|P2|NOT COMPLETED|Overall Study||17
430985|NCT01461369|1056623|P1|NOT COMPLETED|Overall Study||13
430986|NCT01461369|1056621|P3|COMPLETED|Overall Study||86
430987|NCT01461369|1056622|P2|COMPLETED|Overall Study||81
430988|NCT01461369|1056623|P1|COMPLETED|Overall Study||91
430989|NCT01461369|1056621|P3|STARTED|Overall Study||103
430990|NCT01461369|1056622|P2|STARTED|Overall Study||98
430991|NCT01461369|1056623|P1|STARTED|Overall Study||104
430992|NCT01461096|1056648|P2|NOT COMPLETED|Overall Study||61
430993|NCT01461096|1056649|P1|NOT COMPLETED|Overall Study||62
430994|NCT01461096|1056648|P2|COMPLETED|Overall Study||226
430995|NCT01461096|1056649|P1|COMPLETED|Overall Study||226
430996|NCT01461096|1056648|P2|Did Not Start Treatment|Overall Study|Randomized but never started treatment and was discontinued from the study|1
430997|NCT01461096|1056649|P1|Did Not Start Treatment|Overall Study||0
430998|NCT01461096|1056648|P2|STARTED|Overall Study||287
430999|NCT01461096|1056649|P1|STARTED|Overall Study||288
431000|NCT01461057|1056665|P2|NOT COMPLETED|Overall Study||15
431001|NCT01461057|1056666|P1|NOT COMPLETED|Overall Study||15
431002|NCT01461057|1056665|P2|COMPLETED|Overall Study||0
431003|NCT01461057|1056666|P1|COMPLETED|Overall Study||0
431004|NCT01461057|1056665|P2|STARTED|Overall Study||15
431005|NCT01461057|1056666|P1|STARTED|Overall Study||15
431006|NCT01461044|1056676|P2|NOT COMPLETED|Overall Study||40
431007|NCT01461044|1056677|P1|NOT COMPLETED|Overall Study||70
431008|NCT01461044|1056676|P2|COMPLETED|Overall Study||37
431009|NCT01461044|1056677|P1|COMPLETED|Overall Study||80
431010|NCT01461044|1056676|P2|Participants Alive at Inclusion|Overall Study||58
431011|NCT01461044|1056677|P1|Participants Alive at Inclusion|Overall Study||127
431012|NCT01461044|1056676|P2|STARTED|Overall Study||77
431013|NCT01461044|1056677|P1|STARTED|Overall Study||150
431014|NCT01460940|1056750|P1|NOT COMPLETED|Overall Study||0
431015|NCT01460940|1056750|P1|COMPLETED|Overall Study||24
431016|NCT01460940|1056750|P1|STARTED|Overall Study||24
431017|NCT01460927|1056756|P1|NOT COMPLETED|Overall Study||0
431018|NCT01460927|1056756|P1|COMPLETED|Overall Study||25
431019|NCT01460927|1056756|P1|STARTED|Overall Study||25
431020|NCT01460732|1056764|P1|NOT COMPLETED|Overall Study||0
431021|NCT01460732|1056764|P1|COMPLETED|Overall Study||81
431022|NCT01460732|1056764|P1|STARTED|Overall Study||81
431023|NCT01460628|1056777|P1|NOT COMPLETED|Overall Study||5
431024|NCT01460628|1056777|P1|COMPLETED|Overall Study||20
431025|NCT01460628|1056777|P1|STARTED|Overall Study||25
431026|NCT01460446|1056789|P2|NOT COMPLETED|Overall Study||20
431027|NCT01460446|1056790|P1|NOT COMPLETED|Overall Study||5
431028|NCT01460446|1056789|P2|COMPLETED|Overall Study||93
431029|NCT01460446|1056790|P1|COMPLETED|Overall Study||100
431030|NCT01460446|1056789|P2|STARTED|Overall Study||113
431031|NCT01460446|1056790|P1|STARTED|Overall Study||105
431032|NCT01460342|1056819|P2|NOT COMPLETED|Overall Study||14
431033|NCT01460342|1056820|P1|NOT COMPLETED|Overall Study||11
431034|NCT01460342|1056819|P2|COMPLETED|Overall Study||292
431035|NCT01460342|1056820|P1|COMPLETED|Overall Study||293
431036|NCT01460342|1056819|P2|Received at Least 1 Dose of Study Drug|Overall Study||306
431037|NCT01460342|1056820|P1|Received at Least 1 Dose of Study Drug|Overall Study||304
431038|NCT01460342|1056819|P2|STARTED|Overall Study||306
431039|NCT01460342|1056820|P1|STARTED|Overall Study||304
431040|NCT01460303|1056842|P2|NOT COMPLETED|Overall Study||0
431041|NCT01460303|1056843|P1|NOT COMPLETED|Overall Study||0
431042|NCT01460303|1056842|P2|COMPLETED|Overall Study||24
431043|NCT01460303|1056843|P1|COMPLETED|Overall Study||25
431044|NCT01460303|1056842|P2|STARTED|Overall Study||24
431045|NCT01460303|1056843|P1|STARTED|Overall Study||25
431046|NCT01460290|1056851|P1|NOT COMPLETED|Overall Study||4
431047|NCT01460290|1056851|P1|COMPLETED|Overall Study||11
431048|NCT01460290|1056851|P1|STARTED|Overall Study||15
431049|NCT01459913|1056875|P4|NOT COMPLETED|Overall Study||33
431050|NCT01459913|1056876|P3|NOT COMPLETED|Overall Study||13
431051|NCT01459913|1056877|P2|NOT COMPLETED|Overall Study||20
431052|NCT01459913|1056878|P1|NOT COMPLETED|Overall Study||41
431053|NCT01459913|1056875|P4|COMPLETED|Overall Study||29
431054|NCT01459913|1056876|P3|COMPLETED|Overall Study||6
431055|NCT01459913|1056877|P2|COMPLETED|Overall Study||32
431056|NCT01459913|1056878|P1|COMPLETED|Overall Study||65
431057|NCT01459913|1056875|P4|STARTED|Overall Study||62
431058|NCT01459913|1056876|P3|STARTED|Overall Study||19
431059|NCT01459913|1056877|P2|STARTED|Overall Study||52
431060|NCT01459913|1056878|P1|STARTED|Overall Study||106
431061|NCT01459796|1056909|P2|NOT COMPLETED|Overall Study||126
431062|NCT01459796|1056910|P1|NOT COMPLETED|Overall Study||94
431063|NCT01459796|1056909|P2|COMPLETED|Overall Study||0
431064|NCT01459796|1056910|P1|COMPLETED|Overall Study||0
431065|NCT01459796|1056909|P2|STARTED|Overall Study||126
431066|NCT01459796|1056910|P1|STARTED|Overall Study||94
431067|NCT01459783|1056928|P2|NOT COMPLETED|6 Months to 12 Months||30
431068|NCT01459783|1056929|P1|NOT COMPLETED|6 Months to 12 Months||19
431069|NCT01459783|1056928|P2|COMPLETED|6 Months to 12 Months||23
431070|NCT01459783|1056929|P1|COMPLETED|6 Months to 12 Months||20
431071|NCT01459783|1056928|P2|STARTED|6 Months to 12 Months||53
431072|NCT01459783|1056929|P1|STARTED|6 Months to 12 Months||39
431073|NCT01459783|1056928|P2|NOT COMPLETED|Baseline to 6 Months||20
431074|NCT01459783|1056929|P1|NOT COMPLETED|Baseline to 6 Months||32
431075|NCT01459783|1056928|P2|COMPLETED|Baseline to 6 Months||53
431076|NCT01459783|1056929|P1|COMPLETED|Baseline to 6 Months||39
431077|NCT01459783|1056928|P2|STARTED|Baseline to 6 Months||73
431078|NCT01459783|1056929|P1|STARTED|Baseline to 6 Months||71
431079|NCT01459705|1056940|P3|NOT COMPLETED|Overall Study||7
431080|NCT01459705|1056941|P2|NOT COMPLETED|Overall Study||24
431081|NCT01459705|1056942|P1|NOT COMPLETED|Overall Study||22
431082|NCT01459705|1056940|P3|COMPLETED|Overall Study||47
431083|NCT01459705|1056941|P2|COMPLETED|Overall Study||30
431084|NCT01459705|1056942|P1|COMPLETED|Overall Study||32
431085|NCT01459705|1056940|P3|STARTED|Overall Study||54
431086|NCT01459705|1056941|P2|STARTED|Overall Study||54
431087|NCT01459705|1056942|P1|STARTED|Overall Study||54
431088|NCT01459653|1056960|P1|NOT COMPLETED|Overall Study||668
431089|NCT01459653|1056960|P1|COMPLETED|Overall Study||828
431090|NCT01459653|1056960|P1|STARTED|Overall Study||1496
431091|NCT01459588|1057110|P4|NOT COMPLETED|Overall Study||1
431092|NCT01459588|1057111|P3|NOT COMPLETED|Overall Study||1
431093|NCT01459588|1057112|P2|NOT COMPLETED|Overall Study||2
431094|NCT01459588|1057113|P1|NOT COMPLETED|Overall Study||1
431095|NCT01459588|1057110|P4|COMPLETED|Overall Study||55
431096|NCT01459588|1057111|P3|COMPLETED|Overall Study||102
431097|NCT01459588|1057112|P2|COMPLETED|Overall Study||49
431098|NCT01459588|1057113|P1|COMPLETED|Overall Study||104
431099|NCT01459588|1057110|P4|STARTED|Overall Study||56
431100|NCT01459588|1057111|P3|STARTED|Overall Study||103
431101|NCT01459588|1057112|P2|STARTED|Overall Study||51
431102|NCT01459588|1057113|P1|STARTED|Overall Study||105
431103|NCT01459068|1057141|P2|NOT COMPLETED|Overall Study||34
431104|NCT01459068|1057142|P1|NOT COMPLETED|Overall Study||39
431105|NCT01459068|1057141|P2|COMPLETED|Overall Study||148
431106|NCT01459068|1057142|P1|COMPLETED|Overall Study||126
431107|NCT01459068|1057141|P2|STARTED|Overall Study||182
431108|NCT01459068|1057142|P1|STARTED|Overall Study||165
431109|NCT01459016|1057158|P1|NOT COMPLETED|Overall Study||15
431110|NCT01459016|1057158|P1|COMPLETED|Overall Study||41
431111|NCT01459016|1057158|P1|STARTED|Overall Study||56
431112|NCT01458990|1057174|P2|NOT COMPLETED|Overall Study||0
431113|NCT01458990|1057175|P1|NOT COMPLETED|Overall Study||0
431114|NCT01458990|1057174|P2|COMPLETED|Overall Study||15
431115|NCT01458990|1057175|P1|COMPLETED|Overall Study||45
431116|NCT01458990|1057174|P2|STARTED|Overall Study||15
431117|NCT01458990|1057175|P1|STARTED|Overall Study||45
431118|NCT01458951|1057186|P3|NOT COMPLETED|Overall Study||15
431119|NCT01458951|1057187|P2|NOT COMPLETED|Overall Study||1
431120|NCT01458951|1057188|P1|NOT COMPLETED|Overall Study||32
431121|NCT01458951|1057186|P3|COMPLETED|Overall Study||97
431122|NCT01458951|1057187|P2|COMPLETED|Overall Study||5
431123|NCT01458951|1057188|P1|COMPLETED|Overall Study||397
431124|NCT01458951|1057186|P3|STARTED|Overall Study||112
431125|NCT01458951|1057187|P2|STARTED|Overall Study||6
431126|NCT01458951|1057188|P1|STARTED|Overall Study||429
431127|NCT01458639|1057213|P1|NOT COMPLETED|Overall Study||6
431128|NCT01458639|1057213|P1|COMPLETED|Overall Study||12
431129|NCT01458639|1057213|P1|STARTED|Overall Study||18
431130|NCT01458587|1057225|P2|NOT COMPLETED|Overall Study||0
431131|NCT01458587|1057226|P1|NOT COMPLETED|Overall Study||1
431132|NCT01458587|1057225|P2|COMPLETED|Overall Study||35
431133|NCT01458587|1057226|P1|COMPLETED|Overall Study||34
431134|NCT01458587|1057225|P2|STARTED|Overall Study||35
431135|NCT01458587|1057226|P1|STARTED|Overall Study||35
431136|NCT01458574|1057389|P3|NOT COMPLETED|Overall Study||145
431137|NCT01458574|1057390|P2|NOT COMPLETED|Overall Study||71
431138|NCT01458574|1057391|P1|NOT COMPLETED|Overall Study||87
431139|NCT01458574|1057389|P3|COMPLETED|Overall Study||53
431140|NCT01458574|1057390|P2|COMPLETED|Overall Study||126
431141|NCT01458574|1057391|P1|COMPLETED|Overall Study||111
431142|NCT01458574|1057389|P3|Treated|Overall Study||198
431143|NCT01458574|1057390|P2|Treated|Overall Study||196
431144|NCT01458574|1057391|P1|Treated|Overall Study||198
431145|NCT01458574|1057389|P3|STARTED|Overall Study||198
431146|NCT01458574|1057390|P2|STARTED|Overall Study||197
431147|NCT01458574|1057391|P1|STARTED|Overall Study||198
431148|NCT01458561|1057476|P2|NOT COMPLETED|Overall Study||0
431149|NCT01458561|1057477|P1|NOT COMPLETED|Overall Study||0
431150|NCT01458561|1057476|P2|COMPLETED|Overall Study||1
431151|NCT01458561|1057477|P1|COMPLETED|Overall Study||0
431152|NCT01458561|1057476|P2|STARTED|Overall Study||1
431153|NCT01458561|1057477|P1|STARTED|Overall Study||0
431154|NCT01458535|1057521|P6|NOT COMPLETED|Overall Study||4
431155|NCT01458535|1057522|P5|NOT COMPLETED|Overall Study||4
431156|NCT01458535|1057523|P4|NOT COMPLETED|Overall Study||4
431157|NCT01458535|1057524|P3|NOT COMPLETED|Overall Study||2
431158|NCT01458535|1057525|P2|NOT COMPLETED|Overall Study||2
431159|NCT01458535|1057526|P1|NOT COMPLETED|Overall Study||0
431160|NCT01458535|1057521|P6|COMPLETED|Overall Study||7
431161|NCT01458535|1057522|P5|COMPLETED|Overall Study||6
431162|NCT01458535|1057523|P4|COMPLETED|Overall Study||6
431163|NCT01458535|1057524|P3|COMPLETED|Overall Study||8
431164|NCT01458535|1057525|P2|COMPLETED|Overall Study||8
431165|NCT01458535|1057526|P1|COMPLETED|Overall Study||10
431166|NCT01458535|1057521|P6|STARTED|Overall Study||11
431167|NCT01458535|1057522|P5|STARTED|Overall Study||10
431168|NCT01458535|1057523|P4|STARTED|Overall Study||10
431169|NCT01458535|1057524|P3|STARTED|Overall Study||10
431170|NCT01458535|1057525|P2|STARTED|Overall Study||10
431171|NCT01458535|1057526|P1|STARTED|Overall Study||10
431172|NCT01458522|1057578|P2|NOT COMPLETED|Overall Study||11
431173|NCT01458522|1057579|P1|NOT COMPLETED|Overall Study||3
431174|NCT01458522|1057578|P2|COMPLETED|Overall Study||26
431175|NCT01458522|1057579|P1|COMPLETED|Overall Study||34
431176|NCT01458522|1057578|P2|Crossover to Second Drug|Overall Study||10
431177|NCT01458522|1057579|P1|Crossover to Second Drug|Overall Study||15
431178|NCT01458522|1057578|P2|Received First Drug|Overall Study||35
431179|NCT01458522|1057579|P1|Received First Drug|Overall Study||35
431180|NCT01458522|1057578|P2|STARTED|Overall Study||37
431181|NCT01458522|1057579|P1|STARTED|Overall Study||37
431182|NCT01458392|1057608|P3|NOT COMPLETED|Overall Study||31
431183|NCT01458392|1057609|P2|NOT COMPLETED|Overall Study||13
431184|NCT01458392|1057610|P1|NOT COMPLETED|Overall Study||2
431185|NCT01458392|1057608|P3|COMPLETED|Overall Study||0
431186|NCT01458392|1057609|P2|COMPLETED|Overall Study||0
431187|NCT01458392|1057610|P1|COMPLETED|Overall Study||0
431188|NCT01458392|1057608|P3|STARTED|Overall Study||31
431189|NCT01458392|1057609|P2|STARTED|Overall Study||13
431190|NCT01458392|1057610|P1|STARTED|Overall Study||2
431191|NCT01458288|1057630|P1|NOT COMPLETED|Overall Study||0
431192|NCT01458288|1057630|P1|COMPLETED|Overall Study||12
431193|NCT01458288|1057630|P1|STARTED|Overall Study||12
431194|NCT01458275|1057642|P3|NOT COMPLETED|Overall Study||9
431195|NCT01458275|1057643|P2|NOT COMPLETED|Overall Study||13
431196|NCT01458275|1057644|P1|NOT COMPLETED|Overall Study||14
431197|NCT01458275|1057642|P3|COMPLETED|Overall Study||273
431198|NCT01458275|1057643|P2|COMPLETED|Overall Study||269
431199|NCT01458275|1057644|P1|COMPLETED|Overall Study||269
431200|NCT01458275|1057642|P3|STARTED|Overall Study||282
431201|NCT01458275|1057643|P2|STARTED|Overall Study||282
431202|NCT01458275|1057644|P1|STARTED|Overall Study||283
431203|NCT01458249|1057686|P1|NOT COMPLETED|Overall Study||8
431204|NCT01458249|1057686|P1|COMPLETED|Overall Study||44
431205|NCT01458249|1057686|P1|Participants Treated|Overall Study||51
431206|NCT01458249|1057686|P1|STARTED|Overall Study||52
431207|NCT01458210|1057705|P1|NOT COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||3
431208|NCT01458210|1057705|P1|COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||15
431209|NCT01458210|1057705|P1|STARTED|Ortho-Cyclen + Dulaglutide (Period 2)|1 participant received Ortho-Cyclen, discontinued due to Adverse Event before receiving Dulaglutide.|18
431210|NCT01458210|1057705|P1|NOT COMPLETED|Ortho-Cyclen Alone (Period 1)||4
431211|NCT01458210|1057705|P1|COMPLETED|Ortho-Cyclen Alone (Period 1)||18
431212|NCT01458210|1057705|P1|STARTED|Ortho-Cyclen Alone (Period 1)||22
431213|NCT01458210|1057705|P1|NOT COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||0
431214|NCT01458210|1057705|P1|COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||22
431215|NCT01458210|1057705|P1|Received at Least One Dose of Study Drug|Lead-in (1st Course of Ortho-Cyclen)||22
431216|NCT01458210|1057705|P1|STARTED|Lead-in (1st Course of Ortho-Cyclen)||22
431217|NCT01458171|1057722|P1|NOT COMPLETED|Overall Study||1
431218|NCT01458171|1057722|P1|COMPLETED|Overall Study||22
431219|NCT01458171|1057722|P1|STARTED|Overall Study||23
431220|NCT01458106|1057745|P2|NOT COMPLETED|Overall Study||1
431221|NCT01458106|1057746|P1|NOT COMPLETED|Overall Study||3
431222|NCT01458106|1057745|P2|COMPLETED|Overall Study||34
431223|NCT01458106|1057746|P1|COMPLETED|Overall Study||33
431224|NCT01458106|1057745|P2|Non-PK Subgroup|Overall Study||0
431225|NCT01458106|1057746|P1|Non-PK Subgroup|Overall Study||11
431226|NCT01458106|1057745|P2|PK Subgroup|Overall Study||35
431227|NCT01458106|1057746|P1|PK Subgroup|Overall Study||25
431228|NCT01458106|1057745|P2|STARTED|Overall Study||35
431229|NCT01458106|1057746|P1|STARTED|Overall Study||36
431230|NCT01457950|1057823|P4|NOT COMPLETED|Open-Label Phase||2
431231|NCT01457950|1057824|P3|NOT COMPLETED|Open-Label Phase||2
431232|NCT01457950|1057825|P2|NOT COMPLETED|Open-Label Phase||0
431233|NCT01457950|1057826|P1|NOT COMPLETED|Open-Label Phase||0
431234|NCT01457950|1057823|P4|COMPLETED|Open-Label Phase||61
431235|NCT01457950|1057824|P3|COMPLETED|Open-Label Phase||58
431236|NCT01457950|1057825|P2|COMPLETED|Open-Label Phase||0
431237|NCT01457950|1057826|P1|COMPLETED|Open-Label Phase||0
431238|NCT01457950|1057823|P4|STARTED|Open-Label Phase||63
431239|NCT01457950|1057824|P3|STARTED|Open-Label Phase||60
431240|NCT01457950|1057825|P2|STARTED|Open-Label Phase||0
431241|NCT01457950|1057826|P1|STARTED|Open-Label Phase||0
431242|NCT01457950|1057823|P4|NOT COMPLETED|Double-Blind Phase||0
431243|NCT01457950|1057824|P3|NOT COMPLETED|Double-Blind Phase||0
431244|NCT01457950|1057825|P2|NOT COMPLETED|Double-Blind Phase||3
431245|NCT01457950|1057826|P1|NOT COMPLETED|Double-Blind Phase||9
431246|NCT01457950|1057823|P4|COMPLETED|Double-Blind Phase||0
431247|NCT01457950|1057824|P3|COMPLETED|Double-Blind Phase||0
431248|NCT01457950|1057825|P2|COMPLETED|Double-Blind Phase|“Completed” refers to par. that did not have a withdraw reason at the 6 month visit.|63
431249|NCT01457950|1057826|P1|COMPLETED|Double-Blind Phase|“Completed” refers to par. that did not have a withdraw reason at the 6 month visit.|60
431250|NCT01457950|1057823|P4|Completed the 6 Month Assessment|Double-Blind Phase||0
431251|NCT01457950|1057824|P3|Completed the 6 Month Assessment|Double-Blind Phase||0
431252|NCT01457950|1057825|P2|Completed the 6 Month Assessment|Double-Blind Phase|“Completed 6 month assessment” refers to par. that completed at least one 6 month assessment.|64
431253|NCT01457950|1057826|P1|Completed the 6 Month Assessment|Double-Blind Phase|“Completed 6 month assessment” refers to par. that completed at least one 6 month assessment.|62
431254|NCT01457950|1057823|P4|STARTED|Double-Blind Phase||0
431255|NCT01457950|1057824|P3|STARTED|Double-Blind Phase||0
431256|NCT01457950|1057825|P2|STARTED|Double-Blind Phase||66
431257|NCT01457950|1057826|P1|STARTED|Double-Blind Phase||69
431258|NCT01457924|1057905|P5|NOT COMPLETED|Individualized FUP (Weeks 48+)||6
431259|NCT01457924|1057906|P4|NOT COMPLETED|Individualized FUP (Weeks 48+)||5
431260|NCT01457924|1057907|P3|NOT COMPLETED|Individualized FUP (Weeks 48+)||4
431261|NCT01457924|1057908|P2|NOT COMPLETED|Individualized FUP (Weeks 48+)||4
431262|NCT01457924|1057909|P1|NOT COMPLETED|Individualized FUP (Weeks 48+)||5
431263|NCT01457924|1057905|P5|COMPLETED|Individualized FUP (Weeks 48+)||36
431264|NCT01457924|1057906|P4|COMPLETED|Individualized FUP (Weeks 48+)||15
431265|NCT01457924|1057907|P3|COMPLETED|Individualized FUP (Weeks 48+)||12
431266|NCT01457924|1057908|P2|COMPLETED|Individualized FUP (Weeks 48+)||14
431267|NCT01457924|1057909|P1|COMPLETED|Individualized FUP (Weeks 48+)||11
431268|NCT01457924|1057905|P5|STARTED|Individualized FUP (Weeks 48+)||42
431269|NCT01457924|1057906|P4|STARTED|Individualized FUP (Weeks 48+)||20
431270|NCT01457924|1057907|P3|STARTED|Individualized FUP (Weeks 48+)||16
431271|NCT01457924|1057908|P2|STARTED|Individualized FUP (Weeks 48+)||18
431272|NCT01457924|1057909|P1|STARTED|Individualized FUP (Weeks 48+)||16
431273|NCT01457924|1057905|P5|NOT COMPLETED|FUP (Weeks 24-48)||2
431274|NCT01457924|1057906|P4|NOT COMPLETED|FUP (Weeks 24-48)||1
431275|NCT01457924|1057907|P3|NOT COMPLETED|FUP (Weeks 24-48)||2
431276|NCT01457924|1057908|P2|NOT COMPLETED|FUP (Weeks 24-48)||1
431277|NCT01457924|1057909|P1|NOT COMPLETED|FUP (Weeks 24-48)||3
431278|NCT01457924|1057905|P5|COMPLETED|FUP (Weeks 24-48)||57
431279|NCT01457924|1057906|P4|COMPLETED|FUP (Weeks 24-48)||32
431280|NCT01457924|1057907|P3|COMPLETED|FUP (Weeks 24-48)||30
431281|NCT01457924|1057908|P2|COMPLETED|FUP (Weeks 24-48)||30
431282|NCT01457924|1057909|P1|COMPLETED|FUP (Weeks 24-48)||63
431283|NCT01457924|1057905|P5|STARTED|FUP (Weeks 24-48)||59
431284|NCT01457924|1057906|P4|STARTED|FUP (Weeks 24-48)||33
431285|NCT01457924|1057907|P3|STARTED|FUP (Weeks 24-48)||32
431286|NCT01457924|1057908|P2|STARTED|FUP (Weeks 24-48)||31
431287|NCT01457924|1057909|P1|STARTED|FUP (Weeks 24-48)||66
431288|NCT01457924|1057905|P5|NOT COMPLETED|Treatment Phase (Weeks 0-24)||6
431289|NCT01457924|1057906|P4|NOT COMPLETED|Treatment Phase (Weeks 0-24)||1
431290|NCT01457924|1057907|P3|NOT COMPLETED|Treatment Phase (Weeks 0-24)||2
431291|NCT01457924|1057908|P2|NOT COMPLETED|Treatment Phase (Weeks 0-24)||5
431292|NCT01457924|1057909|P1|NOT COMPLETED|Treatment Phase (Weeks 0-24)||3
431293|NCT01457924|1057905|P5|COMPLETED|Treatment Phase (Weeks 0-24)||58
431294|NCT01457924|1057906|P4|COMPLETED|Treatment Phase (Weeks 0-24)||33
431295|NCT01457924|1057907|P3|COMPLETED|Treatment Phase (Weeks 0-24)||30
431296|NCT01457924|1057908|P2|COMPLETED|Treatment Phase (Weeks 0-24)||29
431297|NCT01457924|1057909|P1|COMPLETED|Treatment Phase (Weeks 0-24)||64
431298|NCT01457924|1057905|P5|Completed to Week 12|Treatment Phase (Weeks 0-24)||60
431299|NCT01457924|1057906|P4|Completed to Week 12|Treatment Phase (Weeks 0-24)||33
431300|NCT01457924|1057907|P3|Completed to Week 12|Treatment Phase (Weeks 0-24)||30
431301|NCT01457924|1057908|P2|Completed to Week 12|Treatment Phase (Weeks 0-24)||31
431302|NCT01457924|1057909|P1|Completed to Week 12|Treatment Phase (Weeks 0-24)||65
431303|NCT01457924|1057905|P5|STARTED|Treatment Phase (Weeks 0-24)||64
431304|NCT01457924|1057906|P4|STARTED|Treatment Phase (Weeks 0-24)||34
431305|NCT01457924|1057907|P3|STARTED|Treatment Phase (Weeks 0-24)||32
431306|NCT01457924|1057908|P2|STARTED|Treatment Phase (Weeks 0-24)||34
431307|NCT01457924|1057909|P1|STARTED|Treatment Phase (Weeks 0-24)||67
431308|NCT01457885|1057971|P1|NOT COMPLETED|Overall Study||0
431309|NCT01457885|1057971|P1|COMPLETED|Overall Study||74
431310|NCT01457885|1057971|P1|STARTED|Overall Study||74
431311|NCT01457846|1057979|P2|NOT COMPLETED|Overall Study||30
431312|NCT01457846|1057980|P1|NOT COMPLETED|Overall Study||41
431313|NCT01457846|1057979|P2|COMPLETED|Overall Study||0
431314|NCT01457846|1057980|P1|COMPLETED|Overall Study||0
431315|NCT01457846|1057979|P2|Ongoing Treatment at Data Cut-off|Overall Study||1
431316|NCT01457846|1057980|P1|Ongoing Treatment at Data Cut-off|Overall Study||1
431317|NCT01457846|1057979|P2|Did Not Receive Treatment|Overall Study||3
431318|NCT01457846|1057980|P1|Did Not Receive Treatment|Overall Study||1
431319|NCT01457846|1057979|P2|Received Treatment|Overall Study||27
431320|NCT01457846|1057980|P1|Received Treatment|Overall Study||40
431321|NCT01457846|1057979|P2|STARTED|Overall Study||30
431322|NCT01457846|1057980|P1|STARTED|Overall Study||41
431323|NCT01457703|1057996|P2|NOT COMPLETED|Overall Study||11
431324|NCT01457703|1057997|P1|NOT COMPLETED|Overall Study||6
431325|NCT01457703|1057996|P2|COMPLETED|Overall Study||22
431326|NCT01457703|1057997|P1|COMPLETED|Overall Study||23
431327|NCT01457703|1057996|P2|STARTED|Overall Study||33
431328|NCT01457703|1057997|P1|STARTED|Overall Study||29
431329|NCT01457573|1058011|P1|NOT COMPLETED|Overall Study||0
431330|NCT01457573|1058011|P1|COMPLETED|Overall Study||10
431331|NCT01457573|1058011|P1|STARTED|Overall Study||10
431332|NCT01457521|1058027|P2|NOT COMPLETED|Overall Study||10
431333|NCT01457521|1058028|P1|NOT COMPLETED|Overall Study||12
431334|NCT01457521|1058027|P2|COMPLETED|Overall Study||117
431335|NCT01457521|1058028|P1|COMPLETED|Overall Study||111
431336|NCT01457521|1058027|P2|STARTED|Overall Study||127
431337|NCT01457521|1058028|P1|STARTED|Overall Study||123
431338|NCT01457430|1058034|P1|NOT COMPLETED|Overall Study||0
431339|NCT01457430|1058034|P1|COMPLETED|Overall Study||19
431340|NCT01457430|1058034|P1|STARTED|Overall Study||19
431341|NCT01457417|1058046|P5|NOT COMPLETED|Overall Study||0
431342|NCT01457417|1058047|P4|NOT COMPLETED|Overall Study||0
431343|NCT01457417|1058048|P3|NOT COMPLETED|Overall Study||0
431344|NCT01457417|1058049|P2|NOT COMPLETED|Overall Study||0
431345|NCT01457417|1058050|P1|NOT COMPLETED|Overall Study||0
431346|NCT01457417|1058046|P5|COMPLETED|Overall Study||19
431347|NCT01457417|1058047|P4|COMPLETED|Overall Study||3
431348|NCT01457417|1058048|P3|COMPLETED|Overall Study||4
431349|NCT01457417|1058049|P2|COMPLETED|Overall Study||3
431350|NCT01457417|1058050|P1|COMPLETED|Overall Study||3
431351|NCT01457417|1058046|P5|STARTED|Overall Study||19
431352|NCT01457417|1058047|P4|STARTED|Overall Study||3
431353|NCT01457417|1058048|P3|STARTED|Overall Study||4
431354|NCT01457417|1058049|P2|STARTED|Overall Study||3
431355|NCT01457417|1058050|P1|STARTED|Overall Study||3
431356|NCT01457339|1058108|P2|NOT COMPLETED|Period 6 (250 mg)||1
431357|NCT01457339|1058109|P1|NOT COMPLETED|Period 6 (250 mg)||1
431358|NCT01457339|1058108|P2|COMPLETED|Period 6 (250 mg)||21
431359|NCT01457339|1058109|P1|COMPLETED|Period 6 (250 mg)||6
431360|NCT01457339|1058108|P2|STARTED|Period 6 (250 mg)||22
431361|NCT01457339|1058109|P1|STARTED|Period 6 (250 mg)||7
431362|NCT01457339|1058108|P2|NOT COMPLETED|Period 5 (200 mg)||1
431363|NCT01457339|1058109|P1|NOT COMPLETED|Period 5 (200 mg)||0
431364|NCT01457339|1058108|P2|COMPLETED|Period 5 (200 mg)||22
431365|NCT01457339|1058109|P1|COMPLETED|Period 5 (200 mg)||7
431366|NCT01457339|1058108|P2|STARTED|Period 5 (200 mg)||23
431367|NCT01457339|1058109|P1|STARTED|Period 5 (200 mg)||7
431368|NCT01457339|1058108|P2|NOT COMPLETED|Period 4 (150 mg)||0
431369|NCT01457339|1058109|P1|NOT COMPLETED|Period 4 (150 mg)||0
431370|NCT01457339|1058108|P2|COMPLETED|Period 4 (150 mg)||23
431371|NCT01457339|1058109|P1|COMPLETED|Period 4 (150 mg)||7
431372|NCT01457339|1058108|P2|STARTED|Period 4 (150 mg)||23
431373|NCT01457339|1058109|P1|STARTED|Period 4 (150 mg)||7
431374|NCT01457339|1058108|P2|NOT COMPLETED|Period 3 (100 mg)||1
431375|NCT01457339|1058109|P1|NOT COMPLETED|Period 3 (100 mg)||0
431376|NCT01457339|1058108|P2|COMPLETED|Period 3 (100 mg)||23
431377|NCT01457339|1058109|P1|COMPLETED|Period 3 (100 mg)||7
431378|NCT01457339|1058108|P2|STARTED|Period 3 (100 mg)||24
431379|NCT01457339|1058109|P1|STARTED|Period 3 (100 mg)||7
431380|NCT01457339|1058108|P2|NOT COMPLETED|Period 2 (70 mg)||0
431381|NCT01457339|1058109|P1|NOT COMPLETED|Period 2 (70 mg)||0
431382|NCT01457339|1058108|P2|COMPLETED|Period 2 (70 mg)||24
431383|NCT01457339|1058109|P1|COMPLETED|Period 2 (70 mg)||7
431384|NCT01457339|1058108|P2|STARTED|Period 2 (70 mg)||24
431385|NCT01457339|1058109|P1|STARTED|Period 2 (70 mg)||7
431386|NCT01457339|1058108|P2|NOT COMPLETED|Period 1 (50 mg)||0
431387|NCT01457339|1058109|P1|NOT COMPLETED|Period 1 (50 mg)||0
431388|NCT01457339|1058108|P2|COMPLETED|Period 1 (50 mg)||24
431389|NCT01457339|1058109|P1|COMPLETED|Period 1 (50 mg)||7
431390|NCT01457339|1058108|P2|STARTED|Period 1 (50 mg)||24
431391|NCT01457339|1058109|P1|STARTED|Period 1 (50 mg)||7
431392|NCT01457053|1058275|P2|NOT COMPLETED|Overall Study||1
431393|NCT01457053|1058276|P1|NOT COMPLETED|Overall Study||1
431394|NCT01457053|1058275|P2|COMPLETED|Overall Study||1
431395|NCT01457053|1058276|P1|COMPLETED|Overall Study||1
431396|NCT01457053|1058275|P2|STARTED|Overall Study||2
431397|NCT01457053|1058276|P1|STARTED|Overall Study||2
431398|NCT01457014|1058282|P4|NOT COMPLETED|Fourth Night||0
431399|NCT01457014|1058283|P3|NOT COMPLETED|Fourth Night||0
431400|NCT01457014|1058284|P2|NOT COMPLETED|Fourth Night||0
431401|NCT01457014|1058285|P1|NOT COMPLETED|Fourth Night||0
431402|NCT01457014|1058282|P4|COMPLETED|Fourth Night||11
431403|NCT01457014|1058283|P3|COMPLETED|Fourth Night||12
431404|NCT01457014|1058284|P2|COMPLETED|Fourth Night||11
431405|NCT01457014|1058285|P1|COMPLETED|Fourth Night|The Diagnostic PSG was only completed on the First night|0
431406|NCT01457014|1058282|P4|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
431407|NCT01457014|1058283|P3|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
431408|NCT01457014|1058284|P2|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
431409|NCT01457014|1058285|P1|STARTED|Fourth Night|The Diagnostic PSG was only completed on the First night|0
431410|NCT01457014|1058282|P4|NOT COMPLETED|Third Night||0
431411|NCT01457014|1058283|P3|NOT COMPLETED|Third Night||0
431412|NCT01457014|1058284|P2|NOT COMPLETED|Third Night||0
431413|NCT01457014|1058285|P1|NOT COMPLETED|Third Night||0
431414|NCT01457014|1058282|P4|COMPLETED|Third Night||12
431415|NCT01457014|1058283|P3|COMPLETED|Third Night||11
431416|NCT01457014|1058284|P2|COMPLETED|Third Night||11
431417|NCT01457014|1058285|P1|COMPLETED|Third Night|The Diagnostic PSG was only completed on the First night|0
431418|NCT01457014|1058282|P4|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
431419|NCT01457014|1058283|P3|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
431420|NCT01457014|1058284|P2|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
431421|NCT01457014|1058285|P1|STARTED|Third Night|The Diagnostic PSG was only completed on the First night|0
431422|NCT01457014|1058282|P4|NOT COMPLETED|Second Night||0
431423|NCT01457014|1058283|P3|NOT COMPLETED|Second Night||0
431424|NCT01457014|1058284|P2|NOT COMPLETED|Second Night||0
431425|NCT01457014|1058285|P1|NOT COMPLETED|Second Night||0
431426|NCT01457014|1058282|P4|COMPLETED|Second Night||11
431427|NCT01457014|1058283|P3|COMPLETED|Second Night||11
431428|NCT01457014|1058284|P2|COMPLETED|Second Night||12
431429|NCT01457014|1058285|P1|COMPLETED|Second Night|The Diagnostic PSG was only completed on the First night|0
431430|NCT01457014|1058282|P4|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
431431|NCT01457014|1058283|P3|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
431432|NCT01457014|1058284|P2|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
431433|NCT01457014|1058285|P1|STARTED|Second Night|The Diagnostic PSG was only completed on the First night|0
431434|NCT01457014|1058282|P4|NOT COMPLETED|First Night||0
431435|NCT01457014|1058283|P3|NOT COMPLETED|First Night||0
431436|NCT01457014|1058284|P2|NOT COMPLETED|First Night||0
431437|NCT01457014|1058285|P1|NOT COMPLETED|First Night||40
431438|NCT01457014|1058282|P4|COMPLETED|First Night||0
431439|NCT01457014|1058283|P3|COMPLETED|First Night||0
431440|NCT01457014|1058284|P2|COMPLETED|First Night||0
431441|NCT01457014|1058285|P1|COMPLETED|First Night||34
431442|NCT01457014|1058282|P4|STARTED|First Night||0
431443|NCT01457014|1058283|P3|STARTED|First Night||0
431444|NCT01457014|1058284|P2|STARTED|First Night||0
431445|NCT01457014|1058285|P1|STARTED|First Night||74
431446|NCT01456962|1058302|P2|NOT COMPLETED|Overall Study||1
431447|NCT01456962|1058303|P1|NOT COMPLETED|Overall Study||2
431448|NCT01456962|1058302|P2|COMPLETED|Overall Study||19
431449|NCT01456962|1058303|P1|COMPLETED|Overall Study||14
431450|NCT01456962|1058302|P2|STARTED|Overall Study||20
431451|NCT01456962|1058303|P1|STARTED|Overall Study||16
431452|NCT01456936|1058313|P4|NOT COMPLETED|Overall Study||483
431453|NCT01456936|1058314|P3|NOT COMPLETED|Overall Study||481
431454|NCT01456936|1058315|P2|NOT COMPLETED|Overall Study||448
431455|NCT01456936|1058316|P1|NOT COMPLETED|Overall Study||439
431456|NCT01456936|1058313|P4|COMPLETED|Overall Study||1552
431457|NCT01456936|1058314|P3|COMPLETED|Overall Study||1557
431458|NCT01456936|1058315|P2|COMPLETED|Overall Study||1586
431459|NCT01456936|1058316|P1|COMPLETED|Overall Study||1598
431460|NCT01456936|1058313|P4|Randomized and Treated|Overall Study||2014
431461|NCT01456936|1058314|P3|Randomized and Treated|Overall Study||2022
431462|NCT01456936|1058315|P2|Randomized and Treated|Overall Study||2006
431463|NCT01456936|1058316|P1|Randomized and Treated|Overall Study||2016
431464|NCT01456936|1058313|P4|STARTED|Overall Study||2035
431465|NCT01456936|1058314|P3|STARTED|Overall Study||2038
431466|NCT01456936|1058315|P2|STARTED|Overall Study||2034
431467|NCT01456936|1058316|P1|STARTED|Overall Study||2037
431468|NCT01456780|1058425|P3|NOT COMPLETED|Overall Study||0
431469|NCT01456780|1058426|P2|NOT COMPLETED|Overall Study||3
431470|NCT01456780|1058427|P1|NOT COMPLETED|Overall Study||3
431471|NCT01456780|1058425|P3|COMPLETED|Overall Study||20
431472|NCT01456780|1058426|P2|COMPLETED|Overall Study||17
431473|NCT01456780|1058427|P1|COMPLETED|Overall Study||17
431474|NCT01456780|1058425|P3|STARTED|Overall Study||20
431475|NCT01456780|1058426|P2|STARTED|Overall Study||20
431476|NCT01456780|1058427|P1|STARTED|Overall Study||20
431477|NCT01456299|1058447|P3|NOT COMPLETED|Overall Study||1
431478|NCT01456299|1058448|P2|NOT COMPLETED|Overall Study||1
431479|NCT01456299|1058449|P1|NOT COMPLETED|Overall Study||0
431480|NCT01456299|1058447|P3|COMPLETED|Overall Study||33
431481|NCT01456299|1058448|P2|COMPLETED|Overall Study||33
431482|NCT01456299|1058449|P1|COMPLETED|Overall Study||34
431483|NCT01456299|1058447|P3|STARTED|Overall Study||34
431484|NCT01456299|1058448|P2|STARTED|Overall Study||34
431485|NCT01456299|1058449|P1|STARTED|Overall Study||34
431486|NCT01456195|1058460|P3|NOT COMPLETED|Overall Study||14
431487|NCT01456195|1058461|P2|NOT COMPLETED|Overall Study||10
431488|NCT01456195|1058462|P1|NOT COMPLETED|Overall Study||11
431489|NCT01456195|1058460|P3|COMPLETED|Overall Study||127
431490|NCT01456195|1058461|P2|COMPLETED|Overall Study||127
431491|NCT01456195|1058462|P1|COMPLETED|Overall Study||132
431492|NCT01456195|1058460|P3|STARTED|Overall Study||141
431493|NCT01456195|1058461|P2|STARTED|Overall Study||137
431494|NCT01456195|1058462|P1|STARTED|Overall Study||143
431495|NCT01456169|1058482|P3|NOT COMPLETED|Overall Study||12
431496|NCT01456169|1058483|P2|NOT COMPLETED|Overall Study||5
431497|NCT01456169|1058484|P1|NOT COMPLETED|Overall Study||10
431498|NCT01456169|1058482|P3|COMPLETED|Overall Study||123
431499|NCT01456169|1058483|P2|COMPLETED|Overall Study||122
431500|NCT01456169|1058484|P1|COMPLETED|Overall Study||123
431501|NCT01456169|1058482|P3|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|135
431502|NCT01456169|1058483|P2|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|127
431503|NCT01456169|1058484|P1|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|133
431504|NCT01456143|1058535|P1|NOT COMPLETED|Overall Study||0
431505|NCT01456143|1058535|P1|COMPLETED|Overall Study||33
431506|NCT01456143|1058535|P1|STARTED|Overall Study||33
431507|NCT01456130|1058544|P1|NOT COMPLETED|Overall Study||10
431508|NCT01456130|1058544|P1|COMPLETED|Overall Study||57
431509|NCT01456130|1058544|P1|STARTED|Overall Study||67
431510|NCT01456052|1058554|P3|NOT COMPLETED|Overall Study||5
431511|NCT01456052|1058555|P2|NOT COMPLETED|Overall Study||5
431512|NCT01456052|1058556|P1|NOT COMPLETED|Overall Study||2
431513|NCT01456052|1058554|P3|COMPLETED|Overall Study||19
431514|NCT01456052|1058555|P2|COMPLETED|Overall Study||20
431515|NCT01456052|1058556|P1|COMPLETED|Overall Study||8
431516|NCT01456052|1058554|P3|STARTED|Overall Study||24
431517|NCT01456052|1058555|P2|STARTED|Overall Study|One subject did not receive any study drug. That subject is not included in the safety population.|25
431518|NCT01456052|1058556|P1|STARTED|Overall Study||10
431519|NCT01456039|1058576|P3|NOT COMPLETED|Phase 2 (Second Step)||33
431520|NCT01456039|1058577|P2|NOT COMPLETED|Phase 2 (Second Step)||0
431521|NCT01456039|1058578|P1|NOT COMPLETED|Phase 2 (Second Step)||0
431522|NCT01456039|1058576|P3|COMPLETED|Phase 2 (Second Step)||7
431523|NCT01456039|1058577|P2|COMPLETED|Phase 2 (Second Step)||0
431524|NCT01456039|1058578|P1|COMPLETED|Phase 2 (Second Step)||0
431525|NCT01456039|1058576|P3|STARTED|Phase 2 (Second Step)||40
431526|NCT01456039|1058577|P2|STARTED|Phase 2 (Second Step)||0
431527|NCT01456039|1058578|P1|STARTED|Phase 2 (Second Step)||0
431528|NCT01456039|1058576|P3|NOT COMPLETED|Phase 1 (First Step)||0
431529|NCT01456039|1058577|P2|NOT COMPLETED|Phase 1 (First Step)||7
431530|NCT01456039|1058578|P1|NOT COMPLETED|Phase 1 (First Step)||2
431531|NCT01456039|1058576|P3|COMPLETED|Phase 1 (First Step)||0
431532|NCT01456039|1058577|P2|COMPLETED|Phase 1 (First Step)|Completed = on treatment|1
431533|NCT01456039|1058578|P1|COMPLETED|Phase 1 (First Step)|Completed = on treatment|1
431534|NCT01456039|1058576|P3|STARTED|Phase 1 (First Step)||0
431535|NCT01456039|1058577|P2|STARTED|Phase 1 (First Step)||8
431536|NCT01456039|1058578|P1|STARTED|Phase 1 (First Step)||3
431537|NCT01456000|1058650|P2|NOT COMPLETED|Overall Study||3
431538|NCT01456000|1058651|P1|NOT COMPLETED|Overall Study||8
431539|NCT01456000|1058650|P2|COMPLETED|Overall Study||172
431540|NCT01456000|1058651|P1|COMPLETED|Overall Study||170
431541|NCT01456000|1058650|P2|STARTED|Overall Study||175
431542|NCT01456000|1058651|P1|STARTED|Overall Study||178
431543|NCT01455545|1058657|P2|NOT COMPLETED|Overall Study||0
431544|NCT01455545|1058658|P1|NOT COMPLETED|Overall Study||0
431545|NCT01455545|1058657|P2|COMPLETED|Overall Study||45
431546|NCT01455545|1058658|P1|COMPLETED|Overall Study||55
431547|NCT01455545|1058657|P2|STARTED|Overall Study||45
431548|NCT01455545|1058658|P1|STARTED|Overall Study||55
431549|NCT01455519|1058688|P2|NOT COMPLETED|Overall Study||5
431550|NCT01455519|1058689|P1|NOT COMPLETED|Overall Study||4
431551|NCT01455519|1058688|P2|COMPLETED|Overall Study||18
431552|NCT01455519|1058689|P1|COMPLETED|Overall Study||8
431553|NCT01455519|1058688|P2|STARTED|Overall Study||23
431554|NCT01455519|1058689|P1|STARTED|Overall Study||12
431555|NCT01455428|1058721|P2|NOT COMPLETED|Overall Study||18
431556|NCT01455428|1058722|P1|NOT COMPLETED|Overall Study||14
431557|NCT01455428|1058721|P2|COMPLETED|Overall Study||92
431558|NCT01455428|1058722|P1|COMPLETED|Overall Study||98
431559|NCT01455428|1058721|P2|Treated|Overall Study||109
431560|NCT01455428|1058722|P1|Treated|Overall Study||111
431561|NCT01455428|1058721|P2|STARTED|Overall Study||110
431562|NCT01455428|1058722|P1|STARTED|Overall Study||112
431563|NCT01455415|1058778|P2|NOT COMPLETED|Follow-up||2
431564|NCT01455415|1058779|P1|NOT COMPLETED|Follow-up||3
431565|NCT01455415|1058778|P2|COMPLETED|Follow-up||104
431566|NCT01455415|1058779|P1|COMPLETED|Follow-up||111
431567|NCT01455415|1058778|P2|STARTED|Follow-up||106
431568|NCT01455415|1058779|P1|STARTED|Follow-up||114
431569|NCT01455415|1058778|P2|NOT COMPLETED|Period 2||10
431570|NCT01455415|1058779|P1|NOT COMPLETED|Period 2||13
431571|NCT01455415|1058778|P2|COMPLETED|Period 2||106
431572|NCT01455415|1058779|P1|COMPLETED|Period 2||114
431573|NCT01455415|1058778|P2|STARTED|Period 2||116
431574|NCT01455415|1058779|P1|STARTED|Period 2||127
431575|NCT01455415|1058778|P2|NOT COMPLETED|Washout||7
431576|NCT01455415|1058779|P1|NOT COMPLETED|Washout||8
431577|NCT01455415|1058778|P2|COMPLETED|Washout||116
431578|NCT01455415|1058779|P1|COMPLETED|Washout||127
431579|NCT01455415|1058778|P2|STARTED|Washout||123
431580|NCT01455415|1058779|P1|STARTED|Washout||135
431581|NCT01455415|1058778|P2|NOT COMPLETED|Period 1||24
431582|NCT01455415|1058779|P1|NOT COMPLETED|Period 1||19
431583|NCT01455415|1058778|P2|COMPLETED|Period 1||123
431584|NCT01455415|1058779|P1|COMPLETED|Period 1||135
431585|NCT01455415|1058778|P2|STARTED|Period 1|Started=Treated|147
431586|NCT01455415|1058779|P1|STARTED|Period 1|Started=Treated|154
431587|NCT01455220|1058829|P1|NOT COMPLETED|Overall Study||30
431588|NCT01455220|1058829|P1|COMPLETED|Overall Study||15
431589|NCT01455220|1058829|P1|STARTED|Overall Study||45
431590|NCT01455194|1058839|P4|NOT COMPLETED|Overall Study||28
431591|NCT01455194|1058840|P3|NOT COMPLETED|Overall Study||30
431592|NCT01455194|1058841|P2|NOT COMPLETED|Overall Study||31
431593|NCT01455194|1058842|P1|NOT COMPLETED|Overall Study||153
431594|NCT01455194|1058839|P4|COMPLETED|Overall Study||97
431595|NCT01455194|1058840|P3|COMPLETED|Overall Study||92
431596|NCT01455194|1058841|P2|COMPLETED|Overall Study||89
431597|NCT01455194|1058842|P1|COMPLETED|Overall Study||0
431598|NCT01455194|1058839|P4|STARTED|Overall Study||125
431599|NCT01455194|1058840|P3|STARTED|Overall Study||122
431600|NCT01455194|1058841|P2|STARTED|Overall Study||120
431601|NCT01455194|1058842|P1|STARTED|Overall Study||153
431602|NCT01455181|1058891|P1|NOT COMPLETED|Overall Study||0
431603|NCT01455181|1058891|P1|COMPLETED|Overall Study||24
431604|NCT01455181|1058891|P1|STARTED|Overall Study||24
431605|NCT01455064|1058899|P1|NOT COMPLETED|Overall Study||1
431606|NCT01455064|1058899|P1|COMPLETED|Overall Study||30
431607|NCT01455064|1058899|P1|STARTED|Overall Study||31
431608|NCT01455012|1058905|P2|NOT COMPLETED|Overall Study||4
431609|NCT01455012|1058906|P1|NOT COMPLETED|Overall Study||11
431610|NCT01455012|1058905|P2|COMPLETED|Overall Study||36
431611|NCT01455012|1058906|P1|COMPLETED|Overall Study||30
431612|NCT01455012|1058905|P2|STARTED|Overall Study||40
431613|NCT01455012|1058906|P1|STARTED|Overall Study||41
431614|NCT01454947|1058946|P8|NOT COMPLETED|Overall Study||5
431615|NCT01454947|1058947|P7|NOT COMPLETED|Overall Study||1
431616|NCT01454947|1058948|P6|NOT COMPLETED|Overall Study||3
431617|NCT01454947|1058949|P5|NOT COMPLETED|Overall Study||1
431618|NCT01454947|1058950|P4|NOT COMPLETED|Overall Study||1
431619|NCT01454947|1058951|P3|NOT COMPLETED|Overall Study||3
431620|NCT01454947|1058952|P2|NOT COMPLETED|Overall Study||4
431621|NCT01454947|1058953|P1|NOT COMPLETED|Overall Study||3
431622|NCT01454947|1058946|P8|COMPLETED|Overall Study||23
431623|NCT01454947|1058947|P7|COMPLETED|Overall Study||26
431624|NCT01454947|1058948|P6|COMPLETED|Overall Study||32
431625|NCT01454947|1058949|P5|COMPLETED|Overall Study||33
431626|NCT01454947|1058950|P4|COMPLETED|Overall Study||19
431627|NCT01454947|1058951|P3|COMPLETED|Overall Study||32
431628|NCT01454947|1058952|P2|COMPLETED|Overall Study||38
431629|NCT01454947|1058953|P1|COMPLETED|Overall Study||24
431630|NCT01454947|1058946|P8|STARTED|Overall Study||28
431631|NCT01454947|1058947|P7|STARTED|Overall Study||27
431632|NCT01454947|1058948|P6|STARTED|Overall Study||35
431633|NCT01454947|1058949|P5|STARTED|Overall Study||34
431634|NCT01454947|1058950|P4|STARTED|Overall Study||20
431635|NCT01454947|1058951|P3|STARTED|Overall Study||35
431636|NCT01454947|1058952|P2|STARTED|Overall Study||42
431637|NCT01454947|1058953|P1|STARTED|Overall Study||27
431638|NCT01454934|1058973|P2|NOT COMPLETED|Overall Study||270
431639|NCT01454934|1058974|P1|NOT COMPLETED|Overall Study||270
431640|NCT01454934|1058973|P2|COMPLETED|Overall Study||0
431641|NCT01454934|1058974|P1|COMPLETED|Overall Study||0
431642|NCT01454934|1058973|P2|STARTED|Overall Study||270
431643|NCT01454934|1058974|P1|STARTED|Overall Study||270
431644|NCT01454830|1058986|P2|NOT COMPLETED|Overall Study||27
431645|NCT01454830|1058987|P1|NOT COMPLETED|Overall Study||31
431646|NCT01454830|1058986|P2|COMPLETED|Overall Study||30
431647|NCT01454830|1058987|P1|COMPLETED|Overall Study||30
431648|NCT01454830|1058986|P2|STARTED|Overall Study||57
431649|NCT01454830|1058987|P1|STARTED|Overall Study||61
431650|NCT01454791|1059007|P2|NOT COMPLETED|Overall Study||0
431651|NCT01454791|1059008|P1|NOT COMPLETED|Overall Study||0
431652|NCT01454791|1059007|P2|COMPLETED|Overall Study|20 subjects started with placebo, then switched to Diclofenac|20
431653|NCT01454791|1059008|P1|COMPLETED|Overall Study|20 subjects started with Diclofenac, then switched to placebo|20
431654|NCT01454791|1059007|P2|STARTED|Overall Study||20
431655|NCT01454791|1059008|P1|STARTED|Overall Study||20
431656|NCT01454778|1059018|P1|NOT COMPLETED|Overall Study||3
431657|NCT01454778|1059018|P1|COMPLETED|Overall Study||47
431658|NCT01454778|1059018|P1|STARTED|Overall Study||50
431659|NCT01454726|1059029|P2|NOT COMPLETED|Overall Study||1
431660|NCT01454726|1059030|P1|NOT COMPLETED|Overall Study||0
431661|NCT01454726|1059029|P2|COMPLETED|Overall Study||10
431662|NCT01454726|1059030|P1|COMPLETED|Overall Study||16
431663|NCT01454726|1059029|P2|STARTED|Overall Study||11
431664|NCT01454726|1059030|P1|STARTED|Overall Study||16
431665|NCT01454583|1059039|P3|NOT COMPLETED|3rd Year||297
431666|NCT01454583|1059040|P2|NOT COMPLETED|3rd Year||512
431667|NCT01454583|1059041|P1|NOT COMPLETED|3rd Year||1959
431668|NCT01454583|1059039|P3|COMPLETED|3rd Year||285
431669|NCT01454583|1059040|P2|COMPLETED|3rd Year||470
431670|NCT01454583|1059041|P1|COMPLETED|3rd Year||1832
431671|NCT01454583|1059039|P3|STARTED|3rd Year||582
431672|NCT01454583|1059040|P2|STARTED|3rd Year||982
431673|NCT01454583|1059041|P1|STARTED|3rd Year||3791
431674|NCT01454583|1059039|P3|NOT COMPLETED|2nd Year||737
431675|NCT01454583|1059040|P2|NOT COMPLETED|2nd Year||1049
431676|NCT01454583|1059041|P1|NOT COMPLETED|2nd Year||3965
431677|NCT01454583|1059039|P3|COMPLETED|2nd Year||1376
431678|NCT01454583|1059040|P2|COMPLETED|2nd Year||1647
431679|NCT01454583|1059041|P1|COMPLETED|2nd Year||6212
431680|NCT01454583|1059039|P3|STARTED|2nd Year||2113
431681|NCT01454583|1059040|P2|STARTED|2nd Year||2696
431682|NCT01454583|1059041|P1|STARTED|2nd Year||10177
431683|NCT01454583|1059039|P3|NOT COMPLETED|1st Year||180
431684|NCT01454583|1059040|P2|NOT COMPLETED|1st Year||318
431685|NCT01454583|1059041|P1|NOT COMPLETED|1st Year||1057
431686|NCT01454583|1059039|P3|COMPLETED|1st Year||1933
431687|NCT01454583|1059040|P2|COMPLETED|1st Year||2378
431688|NCT01454583|1059041|P1|COMPLETED|1st Year||9120
431689|NCT01454583|1059039|P3|STARTED|1st Year||2113
431690|NCT01454583|1059040|P2|STARTED|1st Year||2696
431691|NCT01454583|1059041|P1|STARTED|1st Year|From initially 15337 pat. 351 withdrawed from the registry, 14986 pat. were assigned to the groups.|10177
431692|NCT01454531|1059109|P1|NOT COMPLETED|Overall Study||23
431693|NCT01454531|1059109|P1|COMPLETED|Overall Study||173
431694|NCT01454531|1059109|P1|Subjects Treated|Overall Study||192
431695|NCT01454531|1059109|P1|STARTED|Overall Study||196
431696|NCT01454505|1059121|P4|NOT COMPLETED|Overall Study||0
431697|NCT01454505|1059122|P3|NOT COMPLETED|Overall Study||0
431698|NCT01454505|1059123|P2|NOT COMPLETED|Overall Study||0
431699|NCT01454505|1059124|P1|NOT COMPLETED|Overall Study||0
431700|NCT01454505|1059121|P4|COMPLETED|Overall Study||20
431701|NCT01454505|1059122|P3|COMPLETED|Overall Study||40
431702|NCT01454505|1059123|P2|COMPLETED|Overall Study||15
431703|NCT01454505|1059124|P1|COMPLETED|Overall Study||35
431704|NCT01454505|1059121|P4|STARTED|Overall Study||20
431705|NCT01454505|1059122|P3|STARTED|Overall Study||40
431706|NCT01454505|1059123|P2|STARTED|Overall Study||15
431707|NCT01454505|1059124|P1|STARTED|Overall Study||35
431708|NCT01454414|1059138|P2|NOT COMPLETED|Overall Study||16
431709|NCT01454414|1059139|P1|NOT COMPLETED|Overall Study||13
431710|NCT01454414|1059138|P2|COMPLETED|Overall Study||64
431711|NCT01454414|1059139|P1|COMPLETED|Overall Study||66
431712|NCT01454414|1059138|P2|Baseline: Subjects That Sent Uniforms|Overall Study||66
431713|NCT01454414|1059139|P1|Baseline: Subjects That Sent Uniforms|Overall Study||67
431714|NCT01454414|1059138|P2|STARTED|Overall Study||80
431715|NCT01454414|1059139|P1|STARTED|Overall Study||79
431716|NCT01454401|1059145|P1|NOT COMPLETED|Overall Study||5
431717|NCT01454401|1059145|P1|COMPLETED|Overall Study|Per Protocol (PP)|39
431718|NCT01454401|1059145|P1|STARTED|Overall Study|ITT|44
431719|NCT01454284|1059152|P2|NOT COMPLETED|Overall Study||73
431720|NCT01454284|1059153|P1|NOT COMPLETED|Overall Study||116
431721|NCT01454284|1059152|P2|COMPLETED|Overall Study||377
431722|NCT01454284|1059153|P1|COMPLETED|Overall Study||548
431723|NCT01454284|1059152|P2|Received at Least 1 Dose of Study Drug|Overall Study||449
431724|NCT01454284|1059153|P1|Received at Least 1 Dose of Study Drug|Overall Study||663
431725|NCT01454284|1059152|P2|STARTED|Overall Study||450
431726|NCT01454284|1059153|P1|STARTED|Overall Study||664
431727|NCT01454258|1059201|P1|NOT COMPLETED|Overall Study||997
431728|NCT01454258|1059201|P1|COMPLETED|Overall Study||9103
431729|NCT01454258|1059201|P1|STARTED|Overall Study||10100
431730|NCT01454076|1059212|P5|NOT COMPLETED|Overall Study||6
431731|NCT01454076|1059213|P4|NOT COMPLETED|Overall Study||2
431732|NCT01454076|1059214|P3|NOT COMPLETED|Overall Study||9
431733|NCT01454076|1059215|P2|NOT COMPLETED|Overall Study||6
431734|NCT01454076|1059216|P1|NOT COMPLETED|Overall Study||13
431735|NCT01454076|1059212|P5|COMPLETED|Overall Study||15
431736|NCT01454076|1059213|P4|COMPLETED|Overall Study||16
431737|NCT01454076|1059214|P3|COMPLETED|Overall Study||15
431738|NCT01454076|1059215|P2|COMPLETED|Overall Study||14
431739|NCT01454076|1059216|P1|COMPLETED|Overall Study||16
431740|NCT01454076|1059212|P5|STARTED|Overall Study||21
431741|NCT01454076|1059213|P4|STARTED|Overall Study||18
431742|NCT01454076|1059214|P3|STARTED|Overall Study||24
431743|NCT01454076|1059215|P2|STARTED|Overall Study||20
431744|NCT01454076|1059216|P1|STARTED|Overall Study||29
431745|NCT01454063|1059269|P2|NOT COMPLETED|Treated||0
431746|NCT01454063|1059270|P1|NOT COMPLETED|Treated||2
431747|NCT01454063|1059269|P2|COMPLETED|Treated||201
431748|NCT01454063|1059270|P1|COMPLETED|Treated||199
431749|NCT01454063|1059269|P2|STARTED|Treated||201
431750|NCT01454063|1059270|P1|STARTED|Treated||201
431751|NCT01454063|1059269|P2|NOT COMPLETED|Randomized||2
431752|NCT01454063|1059270|P1|NOT COMPLETED|Randomized||1
431753|NCT01454063|1059269|P2|COMPLETED|Randomized||201
431754|NCT01454063|1059270|P1|COMPLETED|Randomized||201
431755|NCT01454063|1059269|P2|STARTED|Randomized||203
431756|NCT01454063|1059270|P1|STARTED|Randomized||202
431757|NCT01453998|1059291|P3|NOT COMPLETED|After Protocol Amendment 2.||0
431758|NCT01453998|1059292|P2|NOT COMPLETED|After Protocol Amendment 2.||0
431759|NCT01453998|1059293|P1|NOT COMPLETED|After Protocol Amendment 2.||1
431760|NCT01453998|1059291|P3|COMPLETED|After Protocol Amendment 2.||183
431761|NCT01453998|1059292|P2|COMPLETED|After Protocol Amendment 2.||99
431762|NCT01453998|1059293|P1|COMPLETED|After Protocol Amendment 2.||102
431763|NCT01453998|1059291|P3|STARTED|After Protocol Amendment 2.||183
431764|NCT01453998|1059292|P2|STARTED|After Protocol Amendment 2.||99
431765|NCT01453998|1059293|P1|STARTED|After Protocol Amendment 2.||103
431766|NCT01453998|1059291|P3|NOT COMPLETED|Before Protocol Amendment 2||0
431767|NCT01453998|1059292|P2|NOT COMPLETED|Before Protocol Amendment 2||0
431768|NCT01453998|1059293|P1|NOT COMPLETED|Before Protocol Amendment 2||0
431769|NCT01453998|1059291|P3|COMPLETED|Before Protocol Amendment 2||99
431770|NCT01453998|1059292|P2|COMPLETED|Before Protocol Amendment 2||88
431771|NCT01453998|1059293|P1|COMPLETED|Before Protocol Amendment 2||85
431772|NCT01453998|1059291|P3|STARTED|Before Protocol Amendment 2||99
431773|NCT01453998|1059292|P2|STARTED|Before Protocol Amendment 2||88
431774|NCT01453998|1059293|P1|STARTED|Before Protocol Amendment 2||85
431775|NCT01453946|1059358|P1|NOT COMPLETED|Overall Study||9
431776|NCT01453946|1059358|P1|COMPLETED|Overall Study||41
431777|NCT01453946|1059358|P1|STARTED|Overall Study||50
431778|NCT01453894|1059366|P2|NOT COMPLETED|Overall Study||0
431779|NCT01453894|1059367|P1|NOT COMPLETED|Overall Study||0
431780|NCT01453894|1059366|P2|COMPLETED|Overall Study||225
431781|NCT01453894|1059367|P1|COMPLETED|Overall Study||225
431782|NCT01453894|1059366|P2|STARTED|Overall Study||225
431783|NCT01453894|1059367|P1|STARTED|Overall Study||225
431784|NCT01453855|1059375|P2|NOT COMPLETED|Overall Study||14
431785|NCT01453855|1059376|P1|NOT COMPLETED|Overall Study||10
431786|NCT01453855|1059375|P2|COMPLETED|Overall Study||408
431787|NCT01453855|1059376|P1|COMPLETED|Overall Study||432
431788|NCT01453855|1059375|P2|STARTED|Overall Study||422
431789|NCT01453855|1059376|P1|STARTED|Overall Study||442
431790|NCT01453725|1059384|P2|NOT COMPLETED|Overall Study||11
431791|NCT01453725|1059385|P1|NOT COMPLETED|Overall Study||13
431792|NCT01453725|1059384|P2|COMPLETED|Overall Study||89
431793|NCT01453725|1059385|P1|COMPLETED|Overall Study||85
431794|NCT01453725|1059384|P2|STARTED|Overall Study||100
431795|NCT01453725|1059385|P1|STARTED|Overall Study||98
431796|NCT01453595|1059408|P3|NOT COMPLETED|Overall Study||2
431797|NCT01453595|1059409|P2|NOT COMPLETED|Overall Study||1
431798|NCT01453595|1059410|P1|NOT COMPLETED|Overall Study||2
431799|NCT01453595|1059408|P3|COMPLETED|Overall Study||0
431800|NCT01453595|1059409|P2|COMPLETED|Overall Study||5
431801|NCT01453595|1059410|P1|COMPLETED|Overall Study||0
431802|NCT01453595|1059408|P3|STARTED|Overall Study||2
431803|NCT01453595|1059409|P2|STARTED|Overall Study||6
431804|NCT01453595|1059410|P1|STARTED|Overall Study||2
431805|NCT01453569|1059419|P3|NOT COMPLETED|Overall Study||7
431806|NCT01453569|1059420|P2|NOT COMPLETED|Overall Study||14
431807|NCT01453569|1059421|P1|NOT COMPLETED|Overall Study||11
431808|NCT01453569|1059419|P3|COMPLETED|Overall Study||78
431809|NCT01453569|1059420|P2|COMPLETED|Overall Study||70
431810|NCT01453569|1059421|P1|COMPLETED|Overall Study||75
431811|NCT01453569|1059419|P3|STARTED|Overall Study||85
431812|NCT01453569|1059420|P2|STARTED|Overall Study||84
431813|NCT01453569|1059421|P1|STARTED|Overall Study||86
431814|NCT01453413|1059438|P1|NOT COMPLETED|Overall Study||0
431815|NCT01453413|1059438|P1|COMPLETED|Overall Study||297
431816|NCT01453413|1059438|P1|STARTED|Overall Study||297
431817|NCT01453387|1059445|P2|NOT COMPLETED|Overall Study||0
431818|NCT01453387|1059446|P1|NOT COMPLETED|Overall Study||0
431819|NCT01453387|1059445|P2|COMPLETED|Overall Study||7
431820|NCT01453387|1059446|P1|COMPLETED|Overall Study||21
431821|NCT01453387|1059445|P2|STARTED|Overall Study||7
431822|NCT01453387|1059446|P1|STARTED|Overall Study||21
431823|NCT01453374|1059529|P1|NOT COMPLETED|Overall Study||18
431824|NCT01453374|1059529|P1|COMPLETED|Overall Study|Defined as receiving 7 injections and 2 follow-up visits.|9
431825|NCT01453374|1059529|P1|STARTED|Overall Study||27
431826|NCT01453361|1059545|P1|NOT COMPLETED|Overall Study||16
431827|NCT01453361|1059545|P1|COMPLETED|Overall Study||2
431828|NCT01453361|1059545|P1|STARTED|Overall Study||18
431829|NCT01453348|1059553|P3|NOT COMPLETED|Overall Study||1
431830|NCT01453348|1059554|P2|NOT COMPLETED|Overall Study||1
431831|NCT01453348|1059555|P1|NOT COMPLETED|Overall Study||1
431832|NCT01453348|1059553|P3|COMPLETED|Overall Study||83
431833|NCT01453348|1059554|P2|COMPLETED|Overall Study||83
431834|NCT01453348|1059555|P1|COMPLETED|Overall Study||83
431835|NCT01453348|1059553|P3|STARTED|Overall Study||84
431836|NCT01453348|1059554|P2|STARTED|Overall Study||84
431837|NCT01453348|1059555|P1|STARTED|Overall Study||84
431838|NCT01453296|1059571|P2|NOT COMPLETED|Treatment Period 2||0
431839|NCT01453296|1059572|P1|NOT COMPLETED|Treatment Period 2||2
431840|NCT01453296|1059571|P2|COMPLETED|Treatment Period 2||13
431841|NCT01453296|1059572|P1|COMPLETED|Treatment Period 2||11
431842|NCT01453296|1059571|P2|STARTED|Treatment Period 2||13
431843|NCT01453296|1059572|P1|STARTED|Treatment Period 2||13
431844|NCT01453296|1059571|P2|NOT COMPLETED|Washout Period||0
431845|NCT01453296|1059572|P1|NOT COMPLETED|Washout Period||0
431846|NCT01453296|1059571|P2|COMPLETED|Washout Period||13
431847|NCT01453296|1059572|P1|COMPLETED|Washout Period||13
431848|NCT01453296|1059571|P2|STARTED|Washout Period||13
431849|NCT01453296|1059572|P1|STARTED|Washout Period||13
431850|NCT01453296|1059571|P2|NOT COMPLETED|Treatment Period 1||1
431851|NCT01453296|1059572|P1|NOT COMPLETED|Treatment Period 1||1
431852|NCT01453296|1059571|P2|COMPLETED|Treatment Period 1||13
431853|NCT01453296|1059572|P1|COMPLETED|Treatment Period 1||13
431854|NCT01453296|1059571|P2|STARTED|Treatment Period 1||14
431855|NCT01453296|1059572|P1|STARTED|Treatment Period 1||14
431856|NCT01453205|1059639|P3|NOT COMPLETED|Overall Study||54
431857|NCT01453205|1059640|P2|NOT COMPLETED|Overall Study||52
431858|NCT01453205|1059641|P1|NOT COMPLETED|Overall Study||80
431859|NCT01453205|1059639|P3|COMPLETED|Overall Study||1
431860|NCT01453205|1059640|P2|COMPLETED|Overall Study||0
431861|NCT01453205|1059641|P1|COMPLETED|Overall Study||0
431862|NCT01453205|1059639|P3|STARTED|Overall Study||55
431863|NCT01453205|1059640|P2|STARTED|Overall Study||52
431864|NCT01453205|1059641|P1|STARTED|Overall Study||80
431865|NCT01453166|1059692|P3|NOT COMPLETED|Overall Study||1
431866|NCT01453166|1059693|P2|NOT COMPLETED|Overall Study||2
431867|NCT01453166|1059694|P1|NOT COMPLETED|Overall Study||2
431868|NCT01453166|1059692|P3|COMPLETED|Overall Study||38
431869|NCT01453166|1059693|P2|COMPLETED|Overall Study||39
431870|NCT01453166|1059694|P1|COMPLETED|Overall Study||40
431871|NCT01453166|1059692|P3|STARTED|Overall Study||39
431872|NCT01453166|1059693|P2|STARTED|Overall Study||41
431873|NCT01453166|1059694|P1|STARTED|Overall Study||42
431874|NCT01453075|1059716|P2|NOT COMPLETED|Overall Study||1
431875|NCT01453075|1059717|P1|NOT COMPLETED|Overall Study||5
431876|NCT01453075|1059716|P2|COMPLETED|Overall Study||14
431877|NCT01453075|1059717|P1|COMPLETED|Overall Study||11
431878|NCT01453075|1059716|P2|STARTED|Overall Study||15
431879|NCT01453075|1059717|P1|STARTED|Overall Study||16
431880|NCT01453049|1059725|P2|NOT COMPLETED|Overall Study||42
431881|NCT01453049|1059726|P1|NOT COMPLETED|Overall Study||41
431882|NCT01453049|1059725|P2|COMPLETED|Overall Study||2
431883|NCT01453049|1059726|P1|COMPLETED|Overall Study||1
431884|NCT01453049|1059725|P2|STARTED|Overall Study||44
431885|NCT01453049|1059726|P1|STARTED|Overall Study||42
431886|NCT01453036|1059799|P3|NOT COMPLETED|Overall Study||31
431887|NCT01453036|1059800|P2|NOT COMPLETED|Overall Study||115
431888|NCT01453036|1059801|P1|NOT COMPLETED|Overall Study||26
431889|NCT01453036|1059799|P3|COMPLETED|Overall Study||277
431890|NCT01453036|1059800|P2|COMPLETED|Overall Study||193
431891|NCT01453036|1059801|P1|COMPLETED|Overall Study||282
431892|NCT01453036|1059799|P3|STARTED|Overall Study||308
431893|NCT01453036|1059800|P2|STARTED|Overall Study||308
431894|NCT01453036|1059801|P1|STARTED|Overall Study||308
431895|NCT01453023|1059809|P2|NOT COMPLETED|Treatment Period 2||1
431896|NCT01453023|1059810|P1|NOT COMPLETED|Treatment Period 2||0
431897|NCT01453023|1059809|P2|COMPLETED|Treatment Period 2||11
431898|NCT01453023|1059810|P1|COMPLETED|Treatment Period 2||12
431899|NCT01453023|1059809|P2|STARTED|Treatment Period 2||12
431900|NCT01453023|1059810|P1|STARTED|Treatment Period 2||12
431901|NCT01453023|1059809|P2|NOT COMPLETED|Washout Period||0
431902|NCT01453023|1059810|P1|NOT COMPLETED|Washout Period||0
431903|NCT01453023|1059809|P2|COMPLETED|Washout Period||12
431904|NCT01453023|1059810|P1|COMPLETED|Washout Period||12
431905|NCT01453023|1059809|P2|STARTED|Washout Period||12
431906|NCT01453023|1059810|P1|STARTED|Washout Period||12
431907|NCT01453023|1059809|P2|NOT COMPLETED|Treatment Period (TP) 1||1
431908|NCT01453023|1059810|P1|NOT COMPLETED|Treatment Period (TP) 1||1
431909|NCT01453023|1059809|P2|COMPLETED|Treatment Period (TP) 1||12
431910|NCT01453023|1059810|P1|COMPLETED|Treatment Period (TP) 1||12
431911|NCT01453023|1059809|P2|STARTED|Treatment Period (TP) 1||13
431912|NCT01453023|1059810|P1|STARTED|Treatment Period (TP) 1||13
431913|NCT01452854|1059878|P1|NOT COMPLETED|Overall Study||0
431914|NCT01452854|1059878|P1|COMPLETED|Overall Study||2
431915|NCT01452854|1059878|P1|STARTED|Overall Study||2
431916|NCT01452529|1059884|P3|NOT COMPLETED|Double-blind (DB) Period||82
431917|NCT01452529|1059885|P2|NOT COMPLETED|Double-blind (DB) Period||67
431918|NCT01452529|1059886|P1|NOT COMPLETED|Double-blind (DB) Period||0
431919|NCT01452529|1059884|P3|COMPLETED|Double-blind (DB) Period||210
431920|NCT01452529|1059885|P2|COMPLETED|Double-blind (DB) Period|4 subjects who did not receive DB medication were still counted as discontinued in the DB period|229
431921|NCT01452529|1059886|P1|COMPLETED|Double-blind (DB) Period||0
431922|NCT01452529|1059884|P3|STARTED|Double-blind (DB) Period||292
431923|NCT01452529|1059885|P2|STARTED|Double-blind (DB) Period|Four subjects were randomized but did not receive DB medication|296
431924|NCT01452529|1059886|P1|STARTED|Double-blind (DB) Period||0
431925|NCT01452529|1059884|P3|NOT COMPLETED|Run-in Period||0
431926|NCT01452529|1059885|P2|NOT COMPLETED|Run-in Period||0
431927|NCT01452529|1059886|P1|NOT COMPLETED|Run-in Period||313
431928|NCT01452529|1059884|P3|COMPLETED|Run-in Period||0
431929|NCT01452529|1059885|P2|COMPLETED|Run-in Period||0
431930|NCT01452529|1059886|P1|COMPLETED|Run-in Period||592
431931|NCT01452529|1059884|P3|STARTED|Run-in Period||0
431932|NCT01452529|1059885|P2|STARTED|Run-in Period||0
431933|NCT01452529|1059886|P1|STARTED|Run-in Period||905
431934|NCT01452425|1059901|P1|NOT COMPLETED|Overall Study||0
431935|NCT01452425|1059901|P1|COMPLETED|Overall Study||10
431936|NCT01452425|1059901|P1|STARTED|Overall Study||10
431937|NCT01452347|1059908|P2|NOT COMPLETED|Overall Study||7
431938|NCT01452347|1059909|P1|NOT COMPLETED|Overall Study||17
431939|NCT01452347|1059908|P2|COMPLETED|Overall Study||77
431940|NCT01452347|1059909|P1|COMPLETED|Overall Study||151
431941|NCT01452347|1059908|P2|STARTED|Overall Study||84
431942|NCT01452347|1059909|P1|STARTED|Overall Study||168
431943|NCT01452269|1059927|P2|NOT COMPLETED|Overall Study||5
431944|NCT01452269|1059928|P1|NOT COMPLETED|Overall Study||1
431945|NCT01452269|1059927|P2|COMPLETED|Overall Study||51
431946|NCT01452269|1059928|P1|COMPLETED|Overall Study||47
431947|NCT01452269|1059927|P2|STARTED|Overall Study||56
431948|NCT01452269|1059928|P1|STARTED|Overall Study||48
431949|NCT01452152|1059941|P3|NOT COMPLETED|Overall Study||4
431950|NCT01452152|1059942|P2|NOT COMPLETED|Overall Study||0
431951|NCT01452152|1059943|P1|NOT COMPLETED|Overall Study||5
431952|NCT01452152|1059941|P3|COMPLETED|Overall Study||0
431953|NCT01452152|1059942|P2|COMPLETED|Overall Study||0
431954|NCT01452152|1059943|P1|COMPLETED|Overall Study||0
431955|NCT01452152|1059941|P3|STARTED|Overall Study||4
431956|NCT01452152|1059942|P2|STARTED|Overall Study||0
431957|NCT01452152|1059943|P1|STARTED|Overall Study||5
431958|NCT01452126|1059966|P1|NOT COMPLETED|Overall Study||0
431959|NCT01452126|1059966|P1|COMPLETED|Overall Study||49
431960|NCT01452126|1059966|P1|STARTED|Overall Study||49
431961|NCT01451996|1059978|P4|NOT COMPLETED|Overall Study||0
431962|NCT01451996|1059979|P3|NOT COMPLETED|Overall Study||0
431963|NCT01451996|1059980|P2|NOT COMPLETED|Overall Study||0
431964|NCT01451996|1059981|P1|NOT COMPLETED|Overall Study||0
431965|NCT01451996|1059978|P4|COMPLETED|Overall Study||85
431966|NCT01451996|1059979|P3|COMPLETED|Overall Study||85
431967|NCT01451996|1059980|P2|COMPLETED|Overall Study||87
431968|NCT01451996|1059981|P1|COMPLETED|Overall Study||83
431969|NCT01451996|1059978|P4|STARTED|Overall Study||85
431970|NCT01451996|1059979|P3|STARTED|Overall Study||85
431971|NCT01451996|1059980|P2|STARTED|Overall Study||87
431972|NCT01451996|1059981|P1|STARTED|Overall Study||83
431973|NCT01451983|1059999|P4|NOT COMPLETED|Overall Study||0
431974|NCT01451983|1060000|P3|NOT COMPLETED|Overall Study||0
431975|NCT01451983|1060001|P2|NOT COMPLETED|Overall Study||0
431976|NCT01451983|1060002|P1|NOT COMPLETED|Overall Study||0
431977|NCT01451983|1059999|P4|COMPLETED|Overall Study||24
431978|NCT01451983|1060000|P3|COMPLETED|Overall Study||61
431979|NCT01451983|1060001|P2|COMPLETED|Overall Study||27
431980|NCT01451983|1060002|P1|COMPLETED|Overall Study||26
431981|NCT01451983|1059999|P4|STARTED|Overall Study||24
431982|NCT01451983|1060000|P3|STARTED|Overall Study||61
431983|NCT01451983|1060001|P2|STARTED|Overall Study||27
431984|NCT01451983|1060002|P1|STARTED|Overall Study||26
431985|NCT01451931|1060015|P3|NOT COMPLETED|Overall Study||43
431986|NCT01451931|1060016|P2|NOT COMPLETED|Overall Study||58
431987|NCT01451931|1060017|P1|NOT COMPLETED|Overall Study||33
431988|NCT01451931|1060015|P3|COMPLETED|Overall Study||923
431989|NCT01451931|1060016|P2|COMPLETED|Overall Study||843
431990|NCT01451931|1060017|P1|COMPLETED|Overall Study||876
431991|NCT01451931|1060015|P3|6-month Follow up|Overall Study||923
431992|NCT01451931|1060016|P2|6-month Follow up|Overall Study||843
431993|NCT01451931|1060017|P1|6-month Follow up|Overall Study||876
431994|NCT01451931|1060015|P3|Baseline Data Collection|Overall Study||958
431995|NCT01451931|1060016|P2|Baseline Data Collection|Overall Study||893
431996|NCT01451931|1060017|P1|Baseline Data Collection|Overall Study||908
431997|NCT01451931|1060015|P3|STARTED|Overall Study||966
431998|NCT01451931|1060016|P2|STARTED|Overall Study||901
431999|NCT01451931|1060017|P1|STARTED|Overall Study||909
432000|NCT01451814|1060039|P2|NOT COMPLETED|Overall Study||5
432001|NCT01451814|1060040|P1|NOT COMPLETED|Overall Study||6
432002|NCT01451814|1060039|P2|COMPLETED|Overall Study||26
432003|NCT01451814|1060040|P1|COMPLETED|Overall Study||29
432004|NCT01451814|1060039|P2|Attended a Session|Overall Study||31
432005|NCT01451814|1060040|P1|Attended a Session|Overall Study||35
432006|NCT01451814|1060039|P2|STARTED|Overall Study||31
432007|NCT01451814|1060040|P1|STARTED|Overall Study||35
432008|NCT01451775|1060050|P6|NOT COMPLETED|Overall Study||0
432009|NCT01451775|1060051|P5|NOT COMPLETED|Overall Study||0
432010|NCT01451775|1060052|P4|NOT COMPLETED|Overall Study||0
432011|NCT01451775|1060053|P3|NOT COMPLETED|Overall Study||0
432012|NCT01451775|1060054|P2|NOT COMPLETED|Overall Study||0
432013|NCT01451775|1060055|P1|NOT COMPLETED|Overall Study||0
432014|NCT01451775|1060050|P6|COMPLETED|Overall Study||3
432015|NCT01451775|1060051|P5|COMPLETED|Overall Study||3
432016|NCT01451775|1060052|P4|COMPLETED|Overall Study||3
432017|NCT01451775|1060053|P3|COMPLETED|Overall Study||3
432018|NCT01451775|1060054|P2|COMPLETED|Overall Study||3
432019|NCT01451775|1060055|P1|COMPLETED|Overall Study||3
432020|NCT01451775|1060050|P6|STARTED|Overall Study||3
432021|NCT01451775|1060051|P5|STARTED|Overall Study||3
432022|NCT01451775|1060052|P4|STARTED|Overall Study||3
432023|NCT01451775|1060053|P3|STARTED|Overall Study||3
432024|NCT01451775|1060054|P2|STARTED|Overall Study||3
432025|NCT01451775|1060055|P1|STARTED|Overall Study||3
432026|NCT01451762|1060072|P3|NOT COMPLETED|Overall Study||6
432027|NCT01451762|1060073|P2|NOT COMPLETED|Overall Study||6
432028|NCT01451762|1060074|P1|NOT COMPLETED|Overall Study||3
432029|NCT01451762|1060072|P3|COMPLETED|Overall Study||24
432030|NCT01451762|1060073|P2|COMPLETED|Overall Study||24
432031|NCT01451762|1060074|P1|COMPLETED|Overall Study||27
432032|NCT01451762|1060072|P3|STARTED|Overall Study||30
432033|NCT01451762|1060073|P2|STARTED|Overall Study||30
432034|NCT01451762|1060074|P1|STARTED|Overall Study||30
432035|NCT01451749|1060084|P2|NOT COMPLETED|Overall Study||14
432036|NCT01451749|1060085|P1|NOT COMPLETED|Overall Study||32
432037|NCT01451749|1060084|P2|COMPLETED|Overall Study||94
432038|NCT01451749|1060085|P1|COMPLETED|Overall Study||184
432039|NCT01451749|1060084|P2|STARTED|Overall Study||108
432040|NCT01451749|1060085|P1|STARTED|Overall Study||216
432041|NCT01451723|1060097|P2|NOT COMPLETED|Overall Study||5
432042|NCT01451723|1060098|P1|NOT COMPLETED|Overall Study||6
432043|NCT01451723|1060097|P2|COMPLETED|Overall Study||0
432044|NCT01451723|1060098|P1|COMPLETED|Overall Study||0
432045|NCT01451723|1060097|P2|STARTED|Overall Study||5
432046|NCT01451723|1060098|P1|STARTED|Overall Study||6
432047|NCT01451645|1060108|P2|NOT COMPLETED|Overall Study||8
432048|NCT01451645|1060109|P1|NOT COMPLETED|Overall Study||9
432049|NCT01451645|1060108|P2|COMPLETED|Overall Study||33
432050|NCT01451645|1060109|P1|COMPLETED|Overall Study||32
432051|NCT01451645|1060108|P2|STARTED|Overall Study||41
432052|NCT01451645|1060109|P1|STARTED|Overall Study||41
432053|NCT01451632|1060123|P10|NOT COMPLETED|Overall Study||0
432054|NCT01451632|1060124|P9|NOT COMPLETED|Overall Study||0
432055|NCT01451632|1060125|P8|NOT COMPLETED|Overall Study||0
432056|NCT01451632|1060126|P7|NOT COMPLETED|Overall Study||0
432057|NCT01451632|1060127|P6|NOT COMPLETED|Overall Study||0
432058|NCT01451632|1060128|P5|NOT COMPLETED|Overall Study||0
432059|NCT01451632|1060129|P4|NOT COMPLETED|Overall Study||0
432060|NCT01451632|1060130|P3|NOT COMPLETED|Overall Study||0
432061|NCT01451632|1060131|P2|NOT COMPLETED|Overall Study||0
432062|NCT01451632|1060132|P1|NOT COMPLETED|Overall Study||0
432063|NCT01451632|1060123|P10|COMPLETED|Overall Study||4
432064|NCT01451632|1060124|P9|COMPLETED|Overall Study||4
432065|NCT01451632|1060125|P8|COMPLETED|Overall Study||6
432066|NCT01451632|1060126|P7|COMPLETED|Overall Study||8
432067|NCT01451632|1060127|P6|COMPLETED|Overall Study||4
432068|NCT01451632|1060128|P5|COMPLETED|Overall Study||4
432069|NCT01451632|1060129|P4|COMPLETED|Overall Study||3
432070|NCT01451632|1060130|P3|COMPLETED|Overall Study||3
432071|NCT01451632|1060131|P2|COMPLETED|Overall Study||4
432072|NCT01451632|1060132|P1|COMPLETED|Overall Study||8
432073|NCT01451632|1060123|P10|STARTED|Overall Study||4
432074|NCT01451632|1060124|P9|STARTED|Overall Study||4
432075|NCT01451632|1060125|P8|STARTED|Overall Study||6
432076|NCT01451632|1060126|P7|STARTED|Overall Study||8
432077|NCT01451632|1060127|P6|STARTED|Overall Study||4
432078|NCT01451632|1060128|P5|STARTED|Overall Study||4
432079|NCT01451632|1060129|P4|STARTED|Overall Study||3
432080|NCT01451632|1060130|P3|STARTED|Overall Study||3
432081|NCT01451632|1060131|P2|STARTED|Overall Study||4
432082|NCT01451632|1060132|P1|STARTED|Overall Study||8
432083|NCT01451606|1060180|P2|NOT COMPLETED|Overall Study||3
432084|NCT01451606|1060181|P1|NOT COMPLETED|Overall Study||4
432085|NCT01451606|1060180|P2|COMPLETED|Overall Study||15
432086|NCT01451606|1060181|P1|COMPLETED|Overall Study||12
432087|NCT01451606|1060180|P2|STARTED|Overall Study||18
432088|NCT01451606|1060181|P1|STARTED|Overall Study||16
432089|NCT01451554|1060191|P2|NOT COMPLETED|Overall Study||9
432090|NCT01451554|1060192|P1|NOT COMPLETED|Overall Study||14
432091|NCT01451554|1060191|P2|COMPLETED|Overall Study||23
432092|NCT01451554|1060192|P1|COMPLETED|Overall Study||19
432093|NCT01451554|1060191|P2|STARTED|Overall Study||32
432094|NCT01451554|1060192|P1|STARTED|Overall Study||33
432095|NCT01451541|1060203|P3|NOT COMPLETED|Overall Study||27
432096|NCT01451541|1060204|P2|NOT COMPLETED|Overall Study||25
432097|NCT01451541|1060205|P1|NOT COMPLETED|Overall Study||36
432098|NCT01451541|1060203|P3|COMPLETED|Overall Study||254
432099|NCT01451541|1060204|P2|COMPLETED|Overall Study||257
432100|NCT01451541|1060205|P1|COMPLETED|Overall Study||247
432101|NCT01451541|1060203|P3|STARTED|Overall Study|283 randomized. ITT = 281 (2 subjects discontinued prior to study medication).|281
432102|NCT01451541|1060204|P2|STARTED|Overall Study||282
432103|NCT01451541|1060205|P1|STARTED|Overall Study||283
432104|NCT01451463|1060245|P1|NOT COMPLETED|Overall Study||0
432105|NCT01451463|1060245|P1|COMPLETED|Overall Study||11
432106|NCT01451463|1060245|P1|STARTED|Overall Study||11
432107|NCT01451437|1060263|P9|NOT COMPLETED|Overall Study||4
432108|NCT01451437|1060264|P8|NOT COMPLETED|Overall Study||3
432109|NCT01451437|1060265|P7|NOT COMPLETED|Overall Study||6
432110|NCT01451437|1060266|P6|NOT COMPLETED|Overall Study||3
432111|NCT01451437|1060267|P5|NOT COMPLETED|Overall Study||4
432112|NCT01451437|1060268|P4|NOT COMPLETED|Overall Study||1
432113|NCT01451437|1060269|P3|NOT COMPLETED|Overall Study||3
432114|NCT01451437|1060270|P2|NOT COMPLETED|Overall Study||1
432115|NCT01451437|1060271|P1|NOT COMPLETED|Overall Study||1
432116|NCT01451437|1060263|P9|COMPLETED|Overall Study||0
432117|NCT01451437|1060264|P8|COMPLETED|Overall Study||0
432118|NCT01451437|1060265|P7|COMPLETED|Overall Study||0
432119|NCT01451437|1060266|P6|COMPLETED|Overall Study||0
432120|NCT01451437|1060267|P5|COMPLETED|Overall Study||0
432121|NCT01451437|1060268|P4|COMPLETED|Overall Study||0
432122|NCT01451437|1060269|P3|COMPLETED|Overall Study||0
432123|NCT01451437|1060270|P2|COMPLETED|Overall Study||0
432124|NCT01451437|1060271|P1|COMPLETED|Overall Study||0
432125|NCT01451437|1060263|P9|STARTED|Overall Study||4
432126|NCT01451437|1060264|P8|STARTED|Overall Study||3
432127|NCT01451437|1060265|P7|STARTED|Overall Study||6
432128|NCT01451437|1060266|P6|STARTED|Overall Study||3
432129|NCT01451437|1060267|P5|STARTED|Overall Study||4
432130|NCT01451437|1060268|P4|STARTED|Overall Study||1
432131|NCT01451437|1060269|P3|STARTED|Overall Study||3
432132|NCT01451437|1060270|P2|STARTED|Overall Study||1
432133|NCT01451437|1060271|P1|STARTED|Overall Study||1
432134|NCT01451424|1060403|P4|NOT COMPLETED|Overall Study||5
432135|NCT01451424|1060404|P3|NOT COMPLETED|Overall Study||1
432136|NCT01451424|1060405|P2|NOT COMPLETED|Overall Study||2
432137|NCT01451424|1060406|P1|NOT COMPLETED|Overall Study||1
432138|NCT01451424|1060403|P4|COMPLETED|Overall Study||5
432139|NCT01451424|1060404|P3|COMPLETED|Overall Study||11
432140|NCT01451424|1060405|P2|COMPLETED|Overall Study||7
432141|NCT01451424|1060406|P1|COMPLETED|Overall Study||8
432142|NCT01451424|1060403|P4|STARTED|Overall Study||10
432143|NCT01451424|1060404|P3|STARTED|Overall Study||12
432144|NCT01451424|1060405|P2|STARTED|Overall Study||9
432145|NCT01451424|1060406|P1|STARTED|Overall Study||9
432146|NCT01451411|1060439|P2|NOT COMPLETED|Overall Study||0
432147|NCT01451411|1060440|P1|NOT COMPLETED|Overall Study||0
432148|NCT01451411|1060439|P2|COMPLETED|Overall Study||1
432149|NCT01451411|1060440|P1|COMPLETED|Overall Study||3
432150|NCT01451411|1060439|P2|STARTED|Overall Study||1
432151|NCT01451411|1060440|P1|STARTED|Overall Study||3
432152|NCT01451398|1060464|P2|NOT COMPLETED|Overall Study||37
432153|NCT01451398|1060465|P1|NOT COMPLETED|Overall Study||27
432154|NCT01451398|1060464|P2|COMPLETED|Overall Study||139
432155|NCT01451398|1060465|P1|COMPLETED|Overall Study||150
432156|NCT01451398|1060464|P2|STARTED|Overall Study||176
432157|NCT01451398|1060465|P1|STARTED|Overall Study||177
432158|NCT01451203|1060499|P2|NOT COMPLETED|Post-treatment Period||34
432159|NCT01451203|1060500|P1|NOT COMPLETED|Post-treatment Period||14
432160|NCT01451203|1060499|P2|COMPLETED|Post-treatment Period||74
432161|NCT01451203|1060500|P1|COMPLETED|Post-treatment Period||57
432162|NCT01451203|1060499|P2|Received Rescue Treatment|Post-treatment Period|Participants who presented with flares at any time were dropped out of study schedule.|28
432163|NCT01451203|1060500|P1|Received Rescue Treatment|Post-treatment Period|Participants who presented with flares at any time were dropped out of study schedule.|12
432164|NCT01451203|1060499|P2|STARTED|Post-treatment Period|Three participants received rescue treatment and did not enter this period.|108
432165|NCT01451203|1060500|P1|STARTED|Post-treatment Period|Two participants received rescue treatment and did not enter this period.|71
432166|NCT01451203|1060499|P2|NOT COMPLETED|Double-blind Treatment Period||50
432167|NCT01451203|1060500|P1|NOT COMPLETED|Double-blind Treatment Period||85
432168|NCT01451203|1060499|P2|COMPLETED|Double-blind Treatment Period||111
432169|NCT01451203|1060500|P1|COMPLETED|Double-blind Treatment Period||73
432170|NCT01451203|1060499|P2|Received Rescue Treatment|Double-blind Treatment Period|Participants who did not achieve improvement at & after Week 24 were dropped out of study schedule.|36
432171|NCT01451203|1060500|P1|Received Rescue Treatment|Double-blind Treatment Period|Participants who did not achieve improvement at & after Week 24 were dropped out of study schedule.|70
432172|NCT01451203|1060499|P2|Received Treatment|Double-blind Treatment Period||159
432173|NCT01451203|1060500|P1|Received Treatment|Double-blind Treatment Period||157
432174|NCT01451203|1060499|P2|STARTED|Double-blind Treatment Period||161
432175|NCT01451203|1060500|P1|STARTED|Double-blind Treatment Period||158
432176|NCT01450826|1060516|P2|NOT COMPLETED|Overall Study||0
432177|NCT01450826|1060517|P1|NOT COMPLETED|Overall Study||0
432178|NCT01450826|1060516|P2|COMPLETED|Overall Study||66
432179|NCT01450826|1060517|P1|COMPLETED|Overall Study||70
432180|NCT01450826|1060516|P2|STARTED|Overall Study||66
432181|NCT01450826|1060517|P1|STARTED|Overall Study||70
432182|NCT01450813|1060533|P4|NOT COMPLETED|Overall Study||3
432183|NCT01450813|1060534|P3|NOT COMPLETED|Overall Study||0
432184|NCT01450813|1060535|P2|NOT COMPLETED|Overall Study||1
432185|NCT01450813|1060536|P1|NOT COMPLETED|Overall Study||1
432186|NCT01450813|1060533|P4|COMPLETED|Overall Study||17
432187|NCT01450813|1060534|P3|COMPLETED|Overall Study||20
432188|NCT01450813|1060535|P2|COMPLETED|Overall Study||19
432189|NCT01450813|1060536|P1|COMPLETED|Overall Study||19
432190|NCT01450813|1060533|P4|STARTED|Overall Study||20
432191|NCT01450813|1060534|P3|STARTED|Overall Study||20
432192|NCT01450813|1060535|P2|STARTED|Overall Study||20
432193|NCT01450813|1060536|P1|STARTED|Overall Study||20
432194|NCT01450800|1060550|P2|NOT COMPLETED|Overall Study||3
432195|NCT01450800|1060551|P1|NOT COMPLETED|Overall Study||1
432196|NCT01450800|1060550|P2|COMPLETED|Overall Study||78
432197|NCT01450800|1060551|P1|COMPLETED|Overall Study||81
432198|NCT01450800|1060550|P2|STARTED|Overall Study|81 participants were randomized to placebo|81
432199|NCT01450800|1060551|P1|STARTED|Overall Study|82 participants were randomized to nitrofurantoin|82
432200|NCT01450787|1060567|P2|NOT COMPLETED|Overall Study||0
432201|NCT01450787|1060568|P1|NOT COMPLETED|Overall Study||0
432202|NCT01450787|1060567|P2|COMPLETED|Overall Study||25
432203|NCT01450787|1060568|P1|COMPLETED|Overall Study||38
432204|NCT01450787|1060567|P2|STARTED|Overall Study||25
432205|NCT01450787|1060568|P1|STARTED|Overall Study||38
432206|NCT01450761|1060586|P2|NOT COMPLETED|Treatment With Blinded Study Therapy||476
432207|NCT01450761|1060587|P1|NOT COMPLETED|Treatment With Blinded Study Therapy||478
432208|NCT01450761|1060586|P2|COMPLETED|Treatment With Blinded Study Therapy||0
432209|NCT01450761|1060587|P1|COMPLETED|Treatment With Blinded Study Therapy||0
432210|NCT01450761|1060586|P2|STARTED|Treatment With Blinded Study Therapy||476
432211|NCT01450761|1060587|P1|STARTED|Treatment With Blinded Study Therapy||478
432212|NCT01450761|1060586|P2|NOT COMPLETED|Lead-in Chemotherapy||85
432213|NCT01450761|1060587|P1|NOT COMPLETED|Lead-in Chemotherapy||84
432214|NCT01450761|1060586|P2|COMPLETED|Lead-in Chemotherapy||476
432215|NCT01450761|1060587|P1|COMPLETED|Lead-in Chemotherapy||478
432216|NCT01450761|1060586|P2|STARTED|Lead-in Chemotherapy||561
432217|NCT01450761|1060587|P1|STARTED|Lead-in Chemotherapy||562
432218|NCT01450761|1060586|P2|NOT COMPLETED|Randomization||5
432219|NCT01450761|1060587|P1|NOT COMPLETED|Randomization||4
432220|NCT01450761|1060586|P2|COMPLETED|Randomization||561
432221|NCT01450761|1060587|P1|COMPLETED|Randomization||562
432222|NCT01450761|1060586|P2|STARTED|Randomization||566
432223|NCT01450761|1060587|P1|STARTED|Randomization||566
432224|NCT01450696|1060599|P2|NOT COMPLETED|Overall Study||148
432225|NCT01450696|1060600|P1|NOT COMPLETED|Overall Study||148
432226|NCT01450696|1060599|P2|COMPLETED|Overall Study||0
432227|NCT01450696|1060600|P1|COMPLETED|Overall Study||0
432228|NCT01450696|1060599|P2|Treated (Safety Population)|Overall Study||147
432229|NCT01450696|1060600|P1|Treated (Safety Population)|Overall Study||147
432230|NCT01450696|1060599|P2|STARTED|Overall Study||148
432231|NCT01450696|1060600|P1|STARTED|Overall Study||148
432232|NCT01450683|1060622|P1|NOT COMPLETED|Overall Study||2
432233|NCT01450683|1060622|P1|COMPLETED|Overall Study||2
432234|NCT01450683|1060622|P1|STARTED|Overall Study||4
432235|NCT01450631|1060628|P2|NOT COMPLETED|Overall Study||4
432236|NCT01450631|1060629|P1|NOT COMPLETED|Overall Study||3
432237|NCT01450631|1060628|P2|COMPLETED|Overall Study||42
432238|NCT01450631|1060629|P1|COMPLETED|Overall Study||43
432239|NCT01450631|1060628|P2|STARTED|Overall Study||46
432240|NCT01450631|1060629|P1|STARTED|Overall Study||46
432241|NCT01450397|1060637|P1|NOT COMPLETED|Overall Study||0
432242|NCT01450397|1060637|P1|COMPLETED|Overall Study||5
432243|NCT01450397|1060637|P1|STARTED|Overall Study||5
432244|NCT01450319|1060641|P1|NOT COMPLETED|Overall Study||0
432245|NCT01450319|1060641|P1|COMPLETED|Overall Study||70
432246|NCT01450319|1060641|P1|STARTED|Overall Study||70
432247|NCT01450306|1060654|P2|NOT COMPLETED|Overall Study||0
432248|NCT01450306|1060655|P1|NOT COMPLETED|Overall Study||0
432249|NCT01450306|1060654|P2|COMPLETED|Overall Study||10
432250|NCT01450306|1060655|P1|COMPLETED|Overall Study||10
432251|NCT01450306|1060654|P2|STARTED|Overall Study||10
432252|NCT01450306|1060655|P1|STARTED|Overall Study||10
432253|NCT01450189|1060668|P3|NOT COMPLETED|Overall Study||0
432254|NCT01450189|1060669|P2|NOT COMPLETED|Overall Study||0
432255|NCT01450189|1060670|P1|NOT COMPLETED|Overall Study||0
432256|NCT01450189|1060668|P3|COMPLETED|Overall Study||19
432257|NCT01450189|1060669|P2|COMPLETED|Overall Study||18
432258|NCT01450189|1060670|P1|COMPLETED|Overall Study||9
432259|NCT01450189|1060668|P3|STARTED|Overall Study||19
432260|NCT01450189|1060669|P2|STARTED|Overall Study||18
432261|NCT01450189|1060670|P1|STARTED|Overall Study||9
432262|NCT01450007|1060760|P3|NOT COMPLETED|Overall Study||3
432263|NCT01450007|1060761|P2|NOT COMPLETED|Overall Study||5
432264|NCT01450007|1060762|P1|NOT COMPLETED|Overall Study||2
432265|NCT01450007|1060760|P3|COMPLETED|Overall Study||41
432266|NCT01450007|1060761|P2|COMPLETED|Overall Study||37
432267|NCT01450007|1060762|P1|COMPLETED|Overall Study||42
432268|NCT01450007|1060760|P3|STARTED|Overall Study||44
432269|NCT01450007|1060761|P2|STARTED|Overall Study||42
432270|NCT01450007|1060762|P1|STARTED|Overall Study||44
432271|NCT01449955|1060781|P2|NOT COMPLETED|Overall Study||2
432272|NCT01449955|1060782|P1|NOT COMPLETED|Overall Study||1
432273|NCT01449955|1060781|P2|COMPLETED|Overall Study||24
432274|NCT01449955|1060782|P1|COMPLETED|Overall Study||27
432275|NCT01449955|1060781|P2|STARTED|Overall Study||26
432276|NCT01449955|1060782|P1|STARTED|Overall Study||28
432277|NCT01449929|1060790|P3|NOT COMPLETED|Extension Phase Approximately 3 Years||8
432278|NCT01449929|1060791|P2|NOT COMPLETED|Extension Phase Approximately 3 Years||0
432279|NCT01449929|1060792|P1|NOT COMPLETED|Extension Phase Approximately 3 Years||0
432280|NCT01449929|1060790|P3|COMPLETED|Extension Phase Approximately 3 Years||115
432281|NCT01449929|1060791|P2|COMPLETED|Extension Phase Approximately 3 Years||0
432282|NCT01449929|1060792|P1|COMPLETED|Extension Phase Approximately 3 Years||0
432283|NCT01449929|1060790|P3|STARTED|Extension Phase Approximately 3 Years||123
432284|NCT01449929|1060791|P2|STARTED|Extension Phase Approximately 3 Years||0
432285|NCT01449929|1060792|P1|STARTED|Extension Phase Approximately 3 Years||0
432286|NCT01449929|1060790|P3|NOT COMPLETED|Randomization Phase 96 Week||0
432287|NCT01449929|1060791|P2|NOT COMPLETED|Randomization Phase 96 Week||53
432288|NCT01449929|1060792|P1|NOT COMPLETED|Randomization Phase 96 Week||33
432289|NCT01449929|1060790|P3|COMPLETED|Randomization Phase 96 Week||0
432290|NCT01449929|1060791|P2|COMPLETED|Randomization Phase 96 Week||189
432291|NCT01449929|1060792|P1|COMPLETED|Randomization Phase 96 Week||209
432292|NCT01449929|1060790|P3|STARTED|Randomization Phase 96 Week||0
432293|NCT01449929|1060791|P2|STARTED|Randomization Phase 96 Week||242
432294|NCT01449929|1060792|P1|STARTED|Randomization Phase 96 Week||242
432295|NCT01449812|1060832|P3|NOT COMPLETED|Overall Study||1
432296|NCT01449812|1060833|P2|NOT COMPLETED|Overall Study||0
432297|NCT01449812|1060834|P1|NOT COMPLETED|Overall Study||2
432298|NCT01449812|1060832|P3|COMPLETED|Overall Study||279
432299|NCT01449812|1060833|P2|COMPLETED|Overall Study||273
432300|NCT01449812|1060834|P1|COMPLETED|Overall Study||270
432301|NCT01449812|1060832|P3|STARTED|Overall Study||280
432302|NCT01449812|1060833|P2|STARTED|Overall Study||273
432303|NCT01449812|1060834|P1|STARTED|Overall Study||272
432304|NCT01449747|1060928|P2|NOT COMPLETED|Overall Study||0
432305|NCT01449747|1060929|P1|NOT COMPLETED|Overall Study||0
432306|NCT01449747|1060928|P2|COMPLETED|Overall Study||12
432307|NCT01449747|1060929|P1|COMPLETED|Overall Study||12
432308|NCT01449747|1060928|P2|STARTED|Overall Study||12
432309|NCT01449747|1060929|P1|STARTED|Overall Study||12
432310|NCT01449734|1060943|P1|NOT COMPLETED|Overall Study||0
432311|NCT01449734|1060943|P1|COMPLETED|Overall Study||215
432312|NCT01449734|1060943|P1|STARTED|Overall Study||215
432313|NCT01449721|1060949|P2|NOT COMPLETED|Overall Study||2
432314|NCT01449721|1060950|P1|NOT COMPLETED|Overall Study||0
432315|NCT01449721|1060949|P2|COMPLETED|Overall Study||28
432316|NCT01449721|1060950|P1|COMPLETED|Overall Study||112
432317|NCT01449721|1060949|P2|STARTED|Overall Study||30
432318|NCT01449721|1060950|P1|STARTED|Overall Study||112
432319|NCT01449708|1060962|P2|NOT COMPLETED|Overall Study||3
432320|NCT01449708|1060963|P1|NOT COMPLETED|Overall Study||2
432321|NCT01449708|1060962|P2|COMPLETED|Overall Study||60
432322|NCT01449708|1060963|P1|COMPLETED|Overall Study||59
432323|NCT01449708|1060962|P2|STARTED|Overall Study||63
432324|NCT01449708|1060963|P1|STARTED|Overall Study||61
432325|NCT01449682|1060974|P2|NOT COMPLETED|Overall Study||1
432326|NCT01449682|1060975|P1|NOT COMPLETED|Overall Study||1
432327|NCT01449682|1060974|P2|COMPLETED|Overall Study||4
432328|NCT01449682|1060975|P1|COMPLETED|Overall Study||4
432329|NCT01449682|1060974|P2|STARTED|Overall Study||5
432330|NCT01449682|1060975|P1|STARTED|Overall Study||5
432331|NCT01449539|1060987|P1|NOT COMPLETED|Overall Study||4
432332|NCT01449539|1060987|P1|COMPLETED|Overall Study||4
432333|NCT01449539|1060987|P1|STARTED|Overall Study||8
432334|NCT01449526|1060993|P2|NOT COMPLETED|Overall Study||6
432335|NCT01449526|1060994|P1|NOT COMPLETED|Overall Study||2
432336|NCT01449526|1060993|P2|COMPLETED|Overall Study||77
432337|NCT01449526|1060994|P1|COMPLETED|Overall Study||81
432338|NCT01449526|1060993|P2|STARTED|Overall Study||83
432339|NCT01449526|1060994|P1|STARTED|Overall Study||83
432340|NCT01449513|1061004|P2|NOT COMPLETED|Overall Study||0
432341|NCT01449513|1061005|P1|NOT COMPLETED|Overall Study||0
432342|NCT01449513|1061004|P2|COMPLETED|Overall Study||8
432343|NCT01449513|1061005|P1|COMPLETED|Overall Study||16
432344|NCT01449513|1061004|P2|STARTED|Overall Study||8
432345|NCT01449513|1061005|P1|STARTED|Overall Study||16
432346|NCT01449461|1061063|P6|NOT COMPLETED|Overall Study||15
432347|NCT01449461|1061064|P5|NOT COMPLETED|Overall Study||48
432348|NCT01449461|1061065|P4|NOT COMPLETED|Overall Study||32
432349|NCT01449461|1061066|P3|NOT COMPLETED|Overall Study||18
432350|NCT01449461|1061067|P2|NOT COMPLETED|Overall Study||18
432351|NCT01449461|1061068|P1|NOT COMPLETED|Overall Study||6
432352|NCT01449461|1061063|P6|COMPLETED|Overall Study||0
432353|NCT01449461|1061064|P5|COMPLETED|Overall Study||0
432354|NCT01449461|1061065|P4|COMPLETED|Overall Study||0
432355|NCT01449461|1061066|P3|COMPLETED|Overall Study||0
432356|NCT01449461|1061067|P2|COMPLETED|Overall Study||0
432357|NCT01449461|1061068|P1|COMPLETED|Overall Study||0
432358|NCT01449461|1061063|P6|STARTED|Overall Study||15
432359|NCT01449461|1061064|P5|STARTED|Overall Study||48
432360|NCT01449461|1061065|P4|STARTED|Overall Study||32
432361|NCT01449461|1061066|P3|STARTED|Overall Study||18
432362|NCT01449461|1061067|P2|STARTED|Overall Study||18
432363|NCT01449461|1061068|P1|STARTED|Overall Study||6
432364|NCT01449370|1061205|P25|NOT COMPLETED|Overall Study||8
432365|NCT01449370|1061206|P24|NOT COMPLETED|Overall Study||10
432366|NCT01449370|1061207|P23|NOT COMPLETED|Overall Study||4
432367|NCT01449370|1061208|P22|NOT COMPLETED|Overall Study||4
432368|NCT01449370|1061209|P21|NOT COMPLETED|Overall Study||6
432369|NCT01449370|1061210|P20|NOT COMPLETED|Overall Study||3
432370|NCT01449370|1061211|P19|NOT COMPLETED|Overall Study||3
432371|NCT01449370|1061212|P18|NOT COMPLETED|Overall Study||3
432372|NCT01449370|1061213|P17|NOT COMPLETED|Overall Study||7
432373|NCT01449370|1061214|P16|NOT COMPLETED|Overall Study||3
432374|NCT01449370|1061215|P15|NOT COMPLETED|Overall Study||3
432375|NCT01449370|1061216|P14|NOT COMPLETED|Overall Study||11
432376|NCT01449370|1061217|P13|NOT COMPLETED|Overall Study||3
432377|NCT01449370|1061218|P12|NOT COMPLETED|Overall Study||3
432378|NCT01449370|1061219|P11|NOT COMPLETED|Overall Study||3
432379|NCT01449370|1061220|P10|NOT COMPLETED|Overall Study||3
432380|NCT01449370|1061221|P9|NOT COMPLETED|Overall Study||12
432381|NCT01449370|1061222|P8|NOT COMPLETED|Overall Study||3
432382|NCT01449370|1061223|P7|NOT COMPLETED|Overall Study||3
432383|NCT01449370|1061224|P6|NOT COMPLETED|Overall Study||3
432384|NCT01449370|1061225|P5|NOT COMPLETED|Overall Study||3
432385|NCT01449370|1061226|P4|NOT COMPLETED|Overall Study||4
432386|NCT01449370|1061227|P3|NOT COMPLETED|Overall Study||8
432387|NCT01449370|1061228|P2|NOT COMPLETED|Overall Study||6
432388|NCT01449370|1061229|P1|NOT COMPLETED|Overall Study||6
432389|NCT01449370|1061205|P25|COMPLETED|Overall Study||0
432390|NCT01449370|1061206|P24|COMPLETED|Overall Study||0
432391|NCT01449370|1061207|P23|COMPLETED|Overall Study||0
432392|NCT01449370|1061208|P22|COMPLETED|Overall Study||0
432393|NCT01449370|1061209|P21|COMPLETED|Overall Study||0
432394|NCT01449370|1061210|P20|COMPLETED|Overall Study||0
432395|NCT01449370|1061211|P19|COMPLETED|Overall Study||0
432396|NCT01449370|1061212|P18|COMPLETED|Overall Study||0
432397|NCT01449370|1061213|P17|COMPLETED|Overall Study||0
432398|NCT01449370|1061214|P16|COMPLETED|Overall Study||0
432399|NCT01449370|1061215|P15|COMPLETED|Overall Study||0
432400|NCT01449370|1061216|P14|COMPLETED|Overall Study||0
432401|NCT01449370|1061217|P13|COMPLETED|Overall Study||0
432402|NCT01449370|1061218|P12|COMPLETED|Overall Study||0
432403|NCT01449370|1061219|P11|COMPLETED|Overall Study||0
432404|NCT01449370|1061220|P10|COMPLETED|Overall Study||0
432405|NCT01449370|1061221|P9|COMPLETED|Overall Study||0
432406|NCT01449370|1061222|P8|COMPLETED|Overall Study||0
432407|NCT01449370|1061223|P7|COMPLETED|Overall Study||0
432408|NCT01449370|1061224|P6|COMPLETED|Overall Study||0
432409|NCT01449370|1061225|P5|COMPLETED|Overall Study||0
432410|NCT01449370|1061226|P4|COMPLETED|Overall Study||0
432411|NCT01449370|1061227|P3|COMPLETED|Overall Study||0
432412|NCT01449370|1061228|P2|COMPLETED|Overall Study||0
432413|NCT01449370|1061229|P1|COMPLETED|Overall Study||0
432414|NCT01449370|1061205|P25|STARTED|Overall Study||8
432415|NCT01449370|1061206|P24|STARTED|Overall Study||10
432416|NCT01449370|1061207|P23|STARTED|Overall Study||4
432417|NCT01449370|1061208|P22|STARTED|Overall Study||4
432418|NCT01449370|1061209|P21|STARTED|Overall Study||6
432419|NCT01449370|1061210|P20|STARTED|Overall Study||3
432420|NCT01449370|1061211|P19|STARTED|Overall Study||3
432421|NCT01449370|1061212|P18|STARTED|Overall Study||3
432422|NCT01449370|1061213|P17|STARTED|Overall Study||7
432423|NCT01449370|1061214|P16|STARTED|Overall Study||3
432424|NCT01449370|1061215|P15|STARTED|Overall Study||3
432425|NCT01449370|1061216|P14|STARTED|Overall Study||11
432426|NCT01449370|1061217|P13|STARTED|Overall Study||3
432427|NCT01449370|1061218|P12|STARTED|Overall Study||3
432428|NCT01449370|1061219|P11|STARTED|Overall Study||3
432429|NCT01449370|1061220|P10|STARTED|Overall Study||3
432430|NCT01449370|1061221|P9|STARTED|Overall Study||12
432431|NCT01449370|1061222|P8|STARTED|Overall Study||3
432432|NCT01449370|1061223|P7|STARTED|Overall Study||3
432433|NCT01449370|1061224|P6|STARTED|Overall Study||3
432434|NCT01449370|1061225|P5|STARTED|Overall Study||3
432435|NCT01449370|1061226|P4|STARTED|Overall Study||4
432436|NCT01449370|1061227|P3|STARTED|Overall Study||8
432437|NCT01449370|1061228|P2|STARTED|Overall Study||6
432438|NCT01449370|1061229|P1|STARTED|Overall Study||6
432439|NCT01449305|1061602|P1|NOT COMPLETED|Overall Study||2
432440|NCT01449305|1061602|P1|COMPLETED|Overall Study||42
432441|NCT01449305|1061602|P1|STARTED|Overall Study||44
432442|NCT01449279|1061607|P1|NOT COMPLETED|Overall Study||7
432443|NCT01449279|1061607|P1|COMPLETED|Overall Study||15
432444|NCT01449279|1061607|P1|STARTED|Overall Study||22
432445|NCT01449266|1061618|P1|NOT COMPLETED|Overall Study||0
432446|NCT01449266|1061618|P1|COMPLETED|Overall Study||10
432447|NCT01449266|1061618|P1|STARTED|Overall Study||10
432448|NCT01449240|1061625|P1|NOT COMPLETED|Overall Study||0
432449|NCT01449240|1061625|P1|COMPLETED|Overall Study||10
432450|NCT01449240|1061625|P1|STARTED|Overall Study||10
432451|NCT01449006|1061632|P2|NOT COMPLETED|Overall Study||0
432452|NCT01449006|1061633|P1|NOT COMPLETED|Overall Study||3
432453|NCT01449006|1061632|P2|COMPLETED|Overall Study||9
432454|NCT01449006|1061633|P1|COMPLETED|Overall Study||5
432455|NCT01449006|1061632|P2|STARTED|Overall Study||9
432456|NCT01449006|1061633|P1|STARTED|Overall Study||8
432457|NCT01448850|1061647|P2|NOT COMPLETED|Overall Study||40
432458|NCT01448850|1061648|P1|NOT COMPLETED|Overall Study||34
432459|NCT01448850|1061647|P2|COMPLETED|Overall Study||120
432460|NCT01448850|1061648|P1|COMPLETED|Overall Study||130
432461|NCT01448850|1061647|P2|STARTED|Overall Study||160
432462|NCT01448850|1061648|P1|STARTED|Overall Study||164
432463|NCT01448707|1061673|P2|NOT COMPLETED|Overall Study||18
432464|NCT01448707|1061674|P1|NOT COMPLETED|Overall Study||18
432465|NCT01448707|1061673|P2|COMPLETED|Overall Study||118
432466|NCT01448707|1061674|P1|COMPLETED|Overall Study||119
432467|NCT01448707|1061673|P2|STARTED|Overall Study||136
432468|NCT01448707|1061674|P1|STARTED|Overall Study||137
432469|NCT01448616|1061695|P4|NOT COMPLETED|Study Drug (Treatment Phase)||4
432470|NCT01448616|1061696|P3|NOT COMPLETED|Study Drug (Treatment Phase)||4
432471|NCT01448616|1061697|P2|NOT COMPLETED|Study Drug (Treatment Phase)||2
432472|NCT01448616|1061698|P1|NOT COMPLETED|Study Drug (Treatment Phase)||0
432473|NCT01448616|1061695|P4|COMPLETED|Study Drug (Treatment Phase)||9
432474|NCT01448616|1061696|P3|COMPLETED|Study Drug (Treatment Phase)||23
432475|NCT01448616|1061697|P2|COMPLETED|Study Drug (Treatment Phase)||22
432476|NCT01448616|1061698|P1|COMPLETED|Study Drug (Treatment Phase)||0
432477|NCT01448616|1061695|P4|STARTED|Study Drug (Treatment Phase)||13
432478|NCT01448616|1061696|P3|STARTED|Study Drug (Treatment Phase)||27
432479|NCT01448616|1061697|P2|STARTED|Study Drug (Treatment Phase)||24
432480|NCT01448616|1061698|P1|STARTED|Study Drug (Treatment Phase)|All qualifying participants from this group moved to treatment group.|0
432481|NCT01448616|1061695|P4|NOT COMPLETED|Lead-In (Observational Phase)||0
432482|NCT01448616|1061696|P3|NOT COMPLETED|Lead-In (Observational Phase)||0
432483|NCT01448616|1061697|P2|NOT COMPLETED|Lead-In (Observational Phase)||0
432484|NCT01448616|1061698|P1|NOT COMPLETED|Lead-In (Observational Phase)||9
432485|NCT01448616|1061695|P4|COMPLETED|Lead-In (Observational Phase)||0
432486|NCT01448616|1061696|P3|COMPLETED|Lead-In (Observational Phase)||0
432487|NCT01448616|1061697|P2|COMPLETED|Lead-In (Observational Phase)|completed >90% of sample collection to qualify for randomization for next phase|0
432488|NCT01448616|1061698|P1|COMPLETED|Lead-In (Observational Phase)|Participants who swabbed >90% completed this phase and were randomized to treatment 2:2:1.|64
432577|NCT01447719|1061815|P1|NOT COMPLETED|Overall Study||93
432489|NCT01448616|1061695|P4|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
432490|NCT01448616|1061696|P3|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
432491|NCT01448616|1061697|P2|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
432492|NCT01448616|1061698|P1|STARTED|Lead-In (Observational Phase)||73
432493|NCT01448525|1061718|P2|NOT COMPLETED|Overall Study||2
432494|NCT01448525|1061719|P1|NOT COMPLETED|Overall Study||1
432495|NCT01448525|1061718|P2|COMPLETED|Overall Study||42
432496|NCT01448525|1061719|P1|COMPLETED|Overall Study||43
432497|NCT01448525|1061718|P2|STARTED|Overall Study||44
432498|NCT01448525|1061719|P1|STARTED|Overall Study||44
432499|NCT01448486|1061729|P2|NOT COMPLETED|Overall Study||0
432500|NCT01448486|1061730|P1|NOT COMPLETED|Overall Study||0
432501|NCT01448486|1061729|P2|COMPLETED|Overall Study||3
432502|NCT01448486|1061730|P1|COMPLETED|Overall Study||3
432503|NCT01448486|1061729|P2|STARTED|Overall Study||3
432504|NCT01448486|1061730|P1|STARTED|Overall Study||3
432505|NCT01448356|1061738|P1|NOT COMPLETED|Overall Study||0
432506|NCT01448356|1061738|P1|COMPLETED|Overall Study|cross-over|10
432507|NCT01448356|1061738|P1|STARTED|Overall Study||10
432508|NCT01448213|1061745|P2|NOT COMPLETED|Overall Study||22
432509|NCT01448213|1061746|P1|NOT COMPLETED|Overall Study||17
432510|NCT01448213|1061745|P2|COMPLETED|Overall Study||112
432511|NCT01448213|1061746|P1|COMPLETED|Overall Study||113
432512|NCT01448213|1061745|P2|STARTED|Overall Study||134
432513|NCT01448213|1061746|P1|STARTED|Overall Study||130
432514|NCT01448057|1061756|P2|NOT COMPLETED|Overall Study||4
432515|NCT01448057|1061757|P1|NOT COMPLETED|Overall Study||8
432516|NCT01448057|1061756|P2|COMPLETED|Overall Study||167
432517|NCT01448057|1061757|P1|COMPLETED|Overall Study||162
432518|NCT01448057|1061756|P2|STARTED|Overall Study||171
432519|NCT01448057|1061757|P1|STARTED|Overall Study||170
432520|NCT01448044|1061767|P2|NOT COMPLETED|Follow Up Period||14
432521|NCT01448044|1061768|P1|NOT COMPLETED|Follow Up Period||12
432522|NCT01448044|1061767|P2|COMPLETED|Follow Up Period||26
432523|NCT01448044|1061768|P1|COMPLETED|Follow Up Period||65
432524|NCT01448044|1061767|P2|STARTED|Follow Up Period|Out of 42 participants who entered the treatment period, 40 continued in the follow-up period.|40
432525|NCT01448044|1061768|P1|STARTED|Follow Up Period|Out of 82 participants who entered the treatment period, 77 continued in the follow-up period.|77
432526|NCT01448044|1061767|P2|NOT COMPLETED|Treatment Period||16
432527|NCT01448044|1061768|P1|NOT COMPLETED|Treatment Period||23
432528|NCT01448044|1061767|P2|COMPLETED|Treatment Period||26
432529|NCT01448044|1061768|P1|COMPLETED|Treatment Period||59
432530|NCT01448044|1061767|P2|STARTED|Treatment Period||42
432531|NCT01448044|1061768|P1|STARTED|Treatment Period||82
432532|NCT01447927|1061784|P2|NOT COMPLETED|Overall Study||3
432533|NCT01447927|1061785|P1|NOT COMPLETED|Overall Study||5
432534|NCT01447927|1061784|P2|COMPLETED|Overall Study||33
432535|NCT01447927|1061785|P1|COMPLETED|Overall Study||33
432536|NCT01447927|1061784|P2|STARTED|Overall Study||36
432537|NCT01447927|1061785|P1|STARTED|Overall Study||38
432538|NCT01447914|1061793|P1|NOT COMPLETED|Overall Study||0
432539|NCT01447914|1061793|P1|COMPLETED|Overall Study||16
432540|NCT01447914|1061793|P1|STARTED|Overall Study||16
432541|NCT01447849|1061802|P4|NOT COMPLETED|Second Intervention||0
432542|NCT01447849|1061803|P3|NOT COMPLETED|Second Intervention||0
432543|NCT01447849|1061804|P2|NOT COMPLETED|Second Intervention||0
432544|NCT01447849|1061805|P1|NOT COMPLETED|Second Intervention||0
432545|NCT01447849|1061802|P4|COMPLETED|Second Intervention||10
432546|NCT01447849|1061803|P3|COMPLETED|Second Intervention||10
432547|NCT01447849|1061804|P2|COMPLETED|Second Intervention||10
432548|NCT01447849|1061805|P1|COMPLETED|Second Intervention||10
432549|NCT01447849|1061802|P4|STARTED|Second Intervention||10
432550|NCT01447849|1061803|P3|STARTED|Second Intervention||10
432551|NCT01447849|1061804|P2|STARTED|Second Intervention||10
432552|NCT01447849|1061805|P1|STARTED|Second Intervention||10
432553|NCT01447849|1061802|P4|NOT COMPLETED|Washout Period for 1 Week||0
432554|NCT01447849|1061803|P3|NOT COMPLETED|Washout Period for 1 Week||0
432555|NCT01447849|1061804|P2|NOT COMPLETED|Washout Period for 1 Week||0
432556|NCT01447849|1061805|P1|NOT COMPLETED|Washout Period for 1 Week||0
432557|NCT01447849|1061802|P4|COMPLETED|Washout Period for 1 Week||10
432558|NCT01447849|1061803|P3|COMPLETED|Washout Period for 1 Week||10
432559|NCT01447849|1061804|P2|COMPLETED|Washout Period for 1 Week||10
432560|NCT01447849|1061805|P1|COMPLETED|Washout Period for 1 Week||10
432561|NCT01447849|1061802|P4|STARTED|Washout Period for 1 Week||10
432562|NCT01447849|1061803|P3|STARTED|Washout Period for 1 Week||10
432563|NCT01447849|1061804|P2|STARTED|Washout Period for 1 Week||10
432564|NCT01447849|1061805|P1|STARTED|Washout Period for 1 Week||10
432565|NCT01447849|1061802|P4|NOT COMPLETED|First Intervention||0
432566|NCT01447849|1061803|P3|NOT COMPLETED|First Intervention||0
432567|NCT01447849|1061804|P2|NOT COMPLETED|First Intervention||0
432568|NCT01447849|1061805|P1|NOT COMPLETED|First Intervention||0
432569|NCT01447849|1061802|P4|COMPLETED|First Intervention||10
432570|NCT01447849|1061803|P3|COMPLETED|First Intervention||10
432571|NCT01447849|1061804|P2|COMPLETED|First Intervention||10
432572|NCT01447849|1061805|P1|COMPLETED|First Intervention||10
432573|NCT01447849|1061802|P4|STARTED|First Intervention||10
432574|NCT01447849|1061803|P3|STARTED|First Intervention||10
432575|NCT01447849|1061804|P2|STARTED|First Intervention||10
432576|NCT01447849|1061805|P1|STARTED|First Intervention||10
432578|NCT01447719|1061815|P1|COMPLETED|Overall Study||59
432579|NCT01447719|1061815|P1|Deceased <2 Years After AV-45 Scan|Overall Study||66
432580|NCT01447719|1061815|P1|Valid AV-45 Scan Acquired|Overall Study||147
432581|NCT01447719|1061815|P1|STARTED|Overall Study||152
432582|NCT01447706|1061828|P2|NOT COMPLETED|Overall Study||3
432583|NCT01447706|1061829|P1|NOT COMPLETED|Overall Study||0
432584|NCT01447706|1061828|P2|COMPLETED|Overall Study||80
432585|NCT01447706|1061829|P1|COMPLETED|Overall Study||140
432586|NCT01447706|1061828|P2|STARTED|Overall Study|3 patients enrolled but not dosed|83
432587|NCT01447706|1061829|P1|STARTED|Overall Study||140
432588|NCT01447576|1061841|P1|NOT COMPLETED|Overall Study||476
432589|NCT01447576|1061841|P1|COMPLETED|Overall Study||560
432590|NCT01447576|1061841|P1|STARTED|Overall Study||1036
432591|NCT01447511|1061852|P5|NOT COMPLETED|Rifampin Period||0
432592|NCT01447511|1061853|P4|NOT COMPLETED|Rifampin Period||1
432593|NCT01447511|1061854|P3|NOT COMPLETED|Rifampin Period||0
432594|NCT01447511|1061855|P2|NOT COMPLETED|Rifampin Period||0
432595|NCT01447511|1061856|P1|NOT COMPLETED|Rifampin Period||0
432596|NCT01447511|1061852|P5|COMPLETED|Rifampin Period||4
432597|NCT01447511|1061853|P4|COMPLETED|Rifampin Period||2
432598|NCT01447511|1061854|P3|COMPLETED|Rifampin Period||8
432599|NCT01447511|1061855|P2|COMPLETED|Rifampin Period||5
432600|NCT01447511|1061856|P1|COMPLETED|Rifampin Period||8
432601|NCT01447511|1061852|P5|STARTED|Rifampin Period||4
432602|NCT01447511|1061853|P4|STARTED|Rifampin Period||3
432603|NCT01447511|1061854|P3|STARTED|Rifampin Period||8
432604|NCT01447511|1061855|P2|STARTED|Rifampin Period||5
432605|NCT01447511|1061856|P1|STARTED|Rifampin Period||8
432606|NCT01447511|1061852|P5|NOT COMPLETED|Fluconazole Period||0
432607|NCT01447511|1061853|P4|NOT COMPLETED|Fluconazole Period||0
432608|NCT01447511|1061854|P3|NOT COMPLETED|Fluconazole Period||1
432609|NCT01447511|1061855|P2|NOT COMPLETED|Fluconazole Period||0
432610|NCT01447511|1061856|P1|NOT COMPLETED|Fluconazole Period||0
432611|NCT01447511|1061852|P5|COMPLETED|Fluconazole Period||4
432612|NCT01447511|1061853|P4|COMPLETED|Fluconazole Period||3
432613|NCT01447511|1061854|P3|COMPLETED|Fluconazole Period||8
432614|NCT01447511|1061855|P2|COMPLETED|Fluconazole Period||0
432615|NCT01447511|1061856|P1|COMPLETED|Fluconazole Period||8
432616|NCT01447511|1061852|P5|STARTED|Fluconazole Period||4
432617|NCT01447511|1061853|P4|STARTED|Fluconazole Period||3
432618|NCT01447511|1061854|P3|STARTED|Fluconazole Period||9
432619|NCT01447511|1061855|P2|STARTED|Fluconazole Period||0
432620|NCT01447511|1061856|P1|STARTED|Fluconazole Period||8
432621|NCT01447511|1061852|P5|NOT COMPLETED|Control Period||0
432622|NCT01447511|1061853|P4|NOT COMPLETED|Control Period||0
432623|NCT01447511|1061854|P3|NOT COMPLETED|Control Period||0
432624|NCT01447511|1061855|P2|NOT COMPLETED|Control Period||0
432625|NCT01447511|1061856|P1|NOT COMPLETED|Control Period||0
432626|NCT01447511|1061852|P5|COMPLETED|Control Period||4
432627|NCT01447511|1061853|P4|COMPLETED|Control Period||3
432628|NCT01447511|1061854|P3|COMPLETED|Control Period||9
432629|NCT01447511|1061855|P2|COMPLETED|Control Period||5
432630|NCT01447511|1061856|P1|COMPLETED|Control Period||8
432631|NCT01447511|1061852|P5|STARTED|Control Period||4
432632|NCT01447511|1061853|P4|STARTED|Control Period||3
432633|NCT01447511|1061854|P3|STARTED|Control Period||9
432634|NCT01447511|1061855|P2|STARTED|Control Period||5
432635|NCT01447511|1061856|P1|STARTED|Control Period||8
432636|NCT01447446|1061874|P6|NOT COMPLETED|Overall Study||32
432637|NCT01447446|1061875|P5|NOT COMPLETED|Overall Study||211
432638|NCT01447446|1061876|P4|NOT COMPLETED|Overall Study||33
432639|NCT01447446|1061877|P3|NOT COMPLETED|Overall Study||100
432640|NCT01447446|1061878|P2|NOT COMPLETED|Overall Study||165
432641|NCT01447446|1061879|P1|NOT COMPLETED|Overall Study||722
432642|NCT01447446|1061874|P6|COMPLETED|Overall Study||54
432643|NCT01447446|1061875|P5|COMPLETED|Overall Study||610
432644|NCT01447446|1061876|P4|COMPLETED|Overall Study||60
432645|NCT01447446|1061877|P3|COMPLETED|Overall Study||192
432646|NCT01447446|1061878|P2|COMPLETED|Overall Study|Insuff.=Insufficient VR= Virological response TRT.=Treatment SVR= Sustained Virological Response|331
432647|NCT01447446|1061879|P1|COMPLETED|Overall Study|Completed means the participants who completed the 24- weeks of follow-up period.|1590
432648|NCT01447446|1061874|P6|STARTED|Overall Study||86
432649|NCT01447446|1061875|P5|STARTED|Overall Study||821
432650|NCT01447446|1061876|P4|STARTED|Overall Study||93
432651|NCT01447446|1061877|P3|STARTED|Overall Study||292
432652|NCT01447446|1061878|P2|STARTED|Overall Study||496
432653|NCT01447446|1061879|P1|STARTED|Overall Study|Started means participants who started treatment and included in core population.|2312
432654|NCT01447433|1061969|P2|NOT COMPLETED|Overall Study||6
432655|NCT01447433|1061970|P1|NOT COMPLETED|Overall Study||4
432656|NCT01447433|1061969|P2|COMPLETED|Overall Study||21
432657|NCT01447433|1061970|P1|COMPLETED|Overall Study||22
432658|NCT01447433|1061969|P2|STARTED|Overall Study||27
432659|NCT01447433|1061970|P1|STARTED|Overall Study||26
432660|NCT01447420|1061997|P3|NOT COMPLETED|Overall Study||10
432661|NCT01447420|1061998|P2|NOT COMPLETED|Overall Study||27
432662|NCT01447420|1061999|P1|NOT COMPLETED|Overall Study||10
432663|NCT01447420|1061997|P3|COMPLETED|Overall Study||8
432664|NCT01447420|1061998|P2|COMPLETED|Overall Study||45
432665|NCT01447420|1061999|P1|COMPLETED|Overall Study||29
432666|NCT01447420|1061997|P3|STARTED|Overall Study||18
432667|NCT01447420|1061998|P2|STARTED|Overall Study||72
432668|NCT01447420|1061999|P1|STARTED|Overall Study||39
432669|NCT01447225|1062019|P10|NOT COMPLETED|Overall Study||0
432670|NCT01447225|1062020|P9|NOT COMPLETED|Overall Study||0
432671|NCT01447225|1062021|P8|NOT COMPLETED|Overall Study||0
432672|NCT01447225|1062022|P7|NOT COMPLETED|Overall Study||0
432673|NCT01447225|1062023|P6|NOT COMPLETED|Overall Study||0
432674|NCT01447225|1062024|P5|NOT COMPLETED|Overall Study||0
432675|NCT01447225|1062025|P4|NOT COMPLETED|Overall Study||0
432676|NCT01447225|1062026|P3|NOT COMPLETED|Overall Study||0
432677|NCT01447225|1062027|P2|NOT COMPLETED|Overall Study||0
432678|NCT01447225|1062028|P1|NOT COMPLETED|Overall Study||0
432679|NCT01447225|1062019|P10|COMPLETED|Overall Study||4
432680|NCT01447225|1062020|P9|COMPLETED|Overall Study||3
432681|NCT01447225|1062021|P8|COMPLETED|Overall Study||4
432682|NCT01447225|1062022|P7|COMPLETED|Overall Study||7
432683|NCT01447225|1062023|P6|COMPLETED|Overall Study||3
432684|NCT01447225|1062024|P5|COMPLETED|Overall Study||3
432685|NCT01447225|1062025|P4|COMPLETED|Overall Study||3
432686|NCT01447225|1062026|P3|COMPLETED|Overall Study||5
432687|NCT01447225|1062027|P2|COMPLETED|Overall Study||8
432688|NCT01447225|1062028|P1|COMPLETED|Overall Study||3
432689|NCT01447225|1062019|P10|STARTED|Overall Study||4
432690|NCT01447225|1062020|P9|STARTED|Overall Study||3
432691|NCT01447225|1062021|P8|STARTED|Overall Study||4
432692|NCT01447225|1062022|P7|STARTED|Overall Study||7
432693|NCT01447225|1062023|P6|STARTED|Overall Study||3
432694|NCT01447225|1062024|P5|STARTED|Overall Study||3
432695|NCT01447225|1062025|P4|STARTED|Overall Study||3
432696|NCT01447225|1062026|P3|STARTED|Overall Study||5
432697|NCT01447225|1062027|P2|STARTED|Overall Study||8
432698|NCT01447225|1062028|P1|STARTED|Overall Study||3
432699|NCT01447121|1062098|P1|NOT COMPLETED|Overall Study||0
432700|NCT01447121|1062098|P1|COMPLETED|Overall Study||118
432701|NCT01447121|1062098|P1|STARTED|Overall Study||118
432702|NCT01447017|1062105|P2|NOT COMPLETED|Overall Study||10
432703|NCT01447017|1062106|P1|NOT COMPLETED|Overall Study||10
432704|NCT01447017|1062105|P2|COMPLETED|Overall Study|In safety analysis: 24. In efficacy analyses: 24 in full analysis set, and 22 in per-protocol set.|14
432705|NCT01447017|1062106|P1|COMPLETED|Overall Study|In safety analysis: 42. In efficacy analyses: 40 in full analysis set, and 39 in per-protocol set.|35
432706|NCT01447017|1062105|P2|Performed Visit 2|Overall Study||24
432707|NCT01447017|1062106|P1|Performed Visit 2|Overall Study||43
432708|NCT01447017|1062105|P2|STARTED|Overall Study||24
432709|NCT01447017|1062106|P1|STARTED|Overall Study||45
432710|NCT01446874|1062115|P3|NOT COMPLETED|Overall Study||21
432711|NCT01446874|1062116|P2|NOT COMPLETED|Overall Study||4
432712|NCT01446874|1062117|P1|NOT COMPLETED|Overall Study||2
432713|NCT01446874|1062115|P3|COMPLETED|Overall Study||60
432714|NCT01446874|1062116|P2|COMPLETED|Overall Study||46
432715|NCT01446874|1062117|P1|COMPLETED|Overall Study||18
432716|NCT01446874|1062115|P3|STARTED|Overall Study||81
432717|NCT01446874|1062116|P2|STARTED|Overall Study||50
432718|NCT01446874|1062117|P1|STARTED|Overall Study||20
432719|NCT01446796|1062143|P2|NOT COMPLETED|Overall Study||0
432720|NCT01446796|1062144|P1|NOT COMPLETED|Overall Study||1
432721|NCT01446796|1062143|P2|COMPLETED|Overall Study|Study terminated early|0
432722|NCT01446796|1062144|P1|COMPLETED|Overall Study|"Study terminated early~One subject of three withdrew prior to randomization and did not start"|2
432723|NCT01446796|1062143|P2|STARTED|Overall Study||0
432724|NCT01446796|1062144|P1|STARTED|Overall Study||3
432725|NCT01446705|1062158|P2|NOT COMPLETED|Overall Study||0
432726|NCT01446705|1062159|P1|NOT COMPLETED|Overall Study||0
432727|NCT01446705|1062158|P2|COMPLETED|Overall Study||6627
432728|NCT01446705|1062159|P1|COMPLETED|Overall Study||50446
432729|NCT01446705|1062158|P2|STARTED|Overall Study||6627
432730|NCT01446705|1062159|P1|STARTED|Overall Study||50446
432731|NCT01446419|1062169|P2|NOT COMPLETED|Overall Study||1
432732|NCT01446419|1062170|P1|NOT COMPLETED|Overall Study||5
432733|NCT01446419|1062169|P2|COMPLETED|Overall Study||77
432734|NCT01446419|1062170|P1|COMPLETED|Overall Study||142
432735|NCT01446419|1062169|P2|12 Month Follow-up|Overall Study||77
432736|NCT01446419|1062170|P1|12 Month Follow-up|Overall Study||142
432737|NCT01446419|1062169|P2|6 Month Follow-up|Overall Study||77
432738|NCT01446419|1062170|P1|6 Month Follow-up|Overall Study||144
432739|NCT01446419|1062169|P2|3 Month Follow-up|Overall Study||77
432740|NCT01446419|1062170|P1|3 Month Follow-up|Overall Study||146
432741|NCT01446419|1062169|P2|STARTED|Overall Study||78
432742|NCT01446419|1062170|P1|STARTED|Overall Study||147
432743|NCT01446289|1062184|P4|NOT COMPLETED|Overall Study||0
432744|NCT01446289|1062185|P3|NOT COMPLETED|Overall Study||1
432745|NCT01446289|1062186|P2|NOT COMPLETED|Overall Study||0
432746|NCT01446289|1062187|P1|NOT COMPLETED|Overall Study||1
432747|NCT01446289|1062184|P4|COMPLETED|Overall Study||35
432748|NCT01446289|1062185|P3|COMPLETED|Overall Study||50
432749|NCT01446289|1062186|P2|COMPLETED|Overall Study||35
432750|NCT01446289|1062187|P1|COMPLETED|Overall Study||50
432751|NCT01446289|1062184|P4|STARTED|Overall Study||35
432752|NCT01446289|1062185|P3|STARTED|Overall Study||51
432753|NCT01446289|1062186|P2|STARTED|Overall Study||35
432754|NCT01446289|1062187|P1|STARTED|Overall Study||51
432755|NCT01446250|1062215|P4|NOT COMPLETED|Follow-up||6
432756|NCT01446250|1062216|P3|NOT COMPLETED|Follow-up||0
432757|NCT01446250|1062217|P2|NOT COMPLETED|Follow-up||0
432758|NCT01446250|1062218|P1|NOT COMPLETED|Follow-up||0
432759|NCT01446250|1062215|P4|COMPLETED|Follow-up||0
432760|NCT01446250|1062216|P3|COMPLETED|Follow-up||0
432761|NCT01446250|1062217|P2|COMPLETED|Follow-up||0
432762|NCT01446250|1062218|P1|COMPLETED|Follow-up||0
432763|NCT01446250|1062215|P4|STARTED|Follow-up||6
432764|NCT01446250|1062216|P3|STARTED|Follow-up||0
432765|NCT01446250|1062217|P2|STARTED|Follow-up||0
432766|NCT01446250|1062218|P1|STARTED|Follow-up||0
432767|NCT01446250|1062215|P4|NOT COMPLETED|Treatment Period 2||0
432768|NCT01446250|1062216|P3|NOT COMPLETED|Treatment Period 2||0
432769|NCT01446250|1062217|P2|NOT COMPLETED|Treatment Period 2||1
432770|NCT01446250|1062218|P1|NOT COMPLETED|Treatment Period 2||0
432771|NCT01446250|1062215|P4|COMPLETED|Treatment Period 2||0
432772|NCT01446250|1062216|P3|COMPLETED|Treatment Period 2||0
432773|NCT01446250|1062217|P2|COMPLETED|Treatment Period 2||6
432774|NCT01446250|1062218|P1|COMPLETED|Treatment Period 2||0
432775|NCT01446250|1062215|P4|STARTED|Treatment Period 2||0
432776|NCT01446250|1062216|P3|STARTED|Treatment Period 2||0
432777|NCT01446250|1062217|P2|STARTED|Treatment Period 2||7
432778|NCT01446250|1062218|P1|STARTED|Treatment Period 2||0
432779|NCT01446250|1062215|P4|NOT COMPLETED|Clinical Hold||0
432780|NCT01446250|1062216|P3|NOT COMPLETED|Clinical Hold||0
432781|NCT01446250|1062217|P2|NOT COMPLETED|Clinical Hold||0
432782|NCT01446250|1062218|P1|NOT COMPLETED|Clinical Hold||0
432783|NCT01446250|1062215|P4|COMPLETED|Clinical Hold||0
432784|NCT01446250|1062216|P3|COMPLETED|Clinical Hold||5
432785|NCT01446250|1062217|P2|COMPLETED|Clinical Hold||2
432786|NCT01446250|1062218|P1|COMPLETED|Clinical Hold||0
432787|NCT01446250|1062215|P4|STARTED|Clinical Hold||0
432788|NCT01446250|1062216|P3|STARTED|Clinical Hold||5
432789|NCT01446250|1062217|P2|STARTED|Clinical Hold||2
432790|NCT01446250|1062218|P1|STARTED|Clinical Hold||0
432791|NCT01446250|1062215|P4|NOT COMPLETED|Treatment Period 1||0
432792|NCT01446250|1062216|P3|NOT COMPLETED|Treatment Period 1||0
432793|NCT01446250|1062217|P2|NOT COMPLETED|Treatment Period 1||1
432794|NCT01446250|1062218|P1|NOT COMPLETED|Treatment Period 1||0
432795|NCT01446250|1062215|P4|COMPLETED|Treatment Period 1||0
432796|NCT01446250|1062216|P3|COMPLETED|Treatment Period 1||0
432797|NCT01446250|1062217|P2|COMPLETED|Treatment Period 1||2
432798|NCT01446250|1062218|P1|COMPLETED|Treatment Period 1||5
432799|NCT01446250|1062215|P4|STARTED|Treatment Period 1||0
432800|NCT01446250|1062216|P3|STARTED|Treatment Period 1||0
432801|NCT01446250|1062217|P2|STARTED|Treatment Period 1||3
432802|NCT01446250|1062218|P1|STARTED|Treatment Period 1||5
432803|NCT01446237|1062230|P1|NOT COMPLETED|Overall Study||10
432804|NCT01446237|1062230|P1|COMPLETED|Overall Study||115
432805|NCT01446237|1062230|P1|STARTED|Overall Study||125
432806|NCT01446042|1062241|P3|NOT COMPLETED|Overall Study||9
432807|NCT01446042|1062242|P2|NOT COMPLETED|Overall Study||3
432808|NCT01446042|1062243|P1|NOT COMPLETED|Overall Study||20
432809|NCT01446042|1062241|P3|COMPLETED|Overall Study||69
432810|NCT01446042|1062242|P2|COMPLETED|Overall Study||83
432811|NCT01446042|1062243|P1|COMPLETED|Overall Study||122
432812|NCT01446042|1062241|P3|STARTED|Overall Study||78
432813|NCT01446042|1062242|P2|STARTED|Overall Study||86
432814|NCT01446042|1062243|P1|STARTED|Overall Study||142
432815|NCT01446003|1062254|P2|NOT COMPLETED|Period 2||0
432816|NCT01446003|1062255|P1|NOT COMPLETED|Period 2||1
432817|NCT01446003|1062254|P2|COMPLETED|Period 2||15
432818|NCT01446003|1062255|P1|COMPLETED|Period 2||13
432819|NCT01446003|1062254|P2|STARTED|Period 2||15
432820|NCT01446003|1062255|P1|STARTED|Period 2||14
432821|NCT01446003|1062254|P2|NOT COMPLETED|Period 1||0
432822|NCT01446003|1062255|P1|NOT COMPLETED|Period 1||2
432823|NCT01446003|1062254|P2|COMPLETED|Period 1||15
432824|NCT01446003|1062255|P1|COMPLETED|Period 1||14
432825|NCT01446003|1062254|P2|STARTED|Period 1||15
432826|NCT01446003|1062255|P1|STARTED|Period 1||16
432827|NCT01445951|1062276|P3|NOT COMPLETED|Overall Study||19
432828|NCT01445951|1062277|P2|NOT COMPLETED|Overall Study||36
432829|NCT01445951|1062278|P1|NOT COMPLETED|Overall Study||44
432830|NCT01445951|1062276|P3|COMPLETED|Overall Study||151
432831|NCT01445951|1062277|P2|COMPLETED|Overall Study||138
432832|NCT01445951|1062278|P1|COMPLETED|Overall Study||130
432833|NCT01445951|1062276|P3|STARTED|Overall Study||170
432834|NCT01445951|1062277|P2|STARTED|Overall Study||174
432835|NCT01445951|1062278|P1|STARTED|Overall Study||174
432836|NCT01445873|1062316|P1|NOT COMPLETED|Overall Study||0
432837|NCT01445873|1062316|P1|COMPLETED|Overall Study||36
432838|NCT01445873|1062316|P1|STARTED|Overall Study||36
432839|NCT01445847|1062346|P2|NOT COMPLETED|Overall Study||14
432840|NCT01445847|1062347|P1|NOT COMPLETED|Overall Study||14
432841|NCT01445847|1062346|P2|COMPLETED|Overall Study||36
432842|NCT01445847|1062347|P1|COMPLETED|Overall Study||36
432843|NCT01445847|1062346|P2|STARTED|Overall Study||50
432844|NCT01445847|1062347|P1|STARTED|Overall Study||50
432845|NCT01445769|1062353|P1|NOT COMPLETED|Overall Study||8
432846|NCT01445769|1062353|P1|COMPLETED|Overall Study||37
432847|NCT01445769|1062353|P1|STARTED|Overall Study||45
432848|NCT01445678|1062373|P2|NOT COMPLETED|Overall Study||21
432849|NCT01445678|1062374|P1|NOT COMPLETED|Overall Study||30
432850|NCT01445678|1062373|P2|COMPLETED|Overall Study||476
432851|NCT01445678|1062374|P1|COMPLETED|Overall Study||452
432852|NCT01445678|1062373|P2|STARTED|Overall Study||497
432853|NCT01445678|1062374|P1|STARTED|Overall Study||482
432854|NCT01445652|1062392|P2|NOT COMPLETED|Overall Study||3
432855|NCT01445652|1062393|P1|NOT COMPLETED|Overall Study||10
432856|NCT01445652|1062392|P2|COMPLETED|Overall Study||50
432857|NCT01445652|1062393|P1|COMPLETED|Overall Study||47
432858|NCT01445652|1062392|P2|STARTED|Overall Study||53
432859|NCT01445652|1062393|P1|STARTED|Overall Study||57
432860|NCT01445626|1062401|P1|NOT COMPLETED|Overall Study||0
432861|NCT01445626|1062401|P1|COMPLETED|Overall Study||87
432862|NCT01445626|1062401|P1|STARTED|Overall Study||87
432863|NCT01445613|1062411|P1|NOT COMPLETED|1-year Follow-up||77
432864|NCT01445613|1062411|P1|COMPLETED|1-year Follow-up||1088
432865|NCT01445613|1062411|P1|STARTED|1-year Follow-up||1165
432866|NCT01445613|1062411|P1|NOT COMPLETED|30-day Follow-up||35
432867|NCT01445613|1062411|P1|COMPLETED|30-day Follow-up||1165
432868|NCT01445613|1062411|P1|STARTED|30-day Follow-up||1200
432869|NCT01445548|1062429|P1|NOT COMPLETED|Overall Study||1
432870|NCT01445548|1062429|P1|COMPLETED|Overall Study||5
432871|NCT01445548|1062429|P1|STARTED|Overall Study||6
432872|NCT01445301|1062453|P3|NOT COMPLETED|Overall Study||9
432873|NCT01445301|1062454|P2|NOT COMPLETED|Overall Study||35
432874|NCT01445301|1062455|P1|NOT COMPLETED|Overall Study||21
432875|NCT01445301|1062453|P3|COMPLETED|Overall Study||290
432876|NCT01445301|1062454|P2|COMPLETED|Overall Study||262
432877|NCT01445301|1062455|P1|COMPLETED|Overall Study||183
432878|NCT01445301|1062453|P3|STARTED|Overall Study||299
432879|NCT01445301|1062454|P2|STARTED|Overall Study||297
432880|NCT01445301|1062455|P1|STARTED|Overall Study||204
432881|NCT01445028|1062492|P2|NOT COMPLETED|Overall Study||3
432882|NCT01445028|1062493|P1|NOT COMPLETED|Overall Study||0
432883|NCT01445028|1062492|P2|COMPLETED|Overall Study||51
432884|NCT01445028|1062493|P1|COMPLETED|Overall Study||58
432885|NCT01445028|1062492|P2|STARTED|Overall Study||54
432886|NCT01445028|1062493|P1|STARTED|Overall Study||58
432887|NCT01444924|1062501|P2|NOT COMPLETED|Overall Study||0
432888|NCT01444924|1062502|P1|NOT COMPLETED|Overall Study||0
432889|NCT01444924|1062501|P2|COMPLETED|Overall Study||33
432890|NCT01444924|1062502|P1|COMPLETED|Overall Study||31
432891|NCT01444924|1062501|P2|STARTED|Overall Study||33
432892|NCT01444924|1062502|P1|STARTED|Overall Study||31
432893|NCT01444911|1062512|P2|NOT COMPLETED|Overall Study||0
432894|NCT01444911|1062513|P1|NOT COMPLETED|Overall Study||8
432895|NCT01444911|1062512|P2|COMPLETED|Overall Study||13
432896|NCT01444911|1062513|P1|COMPLETED|Overall Study||8
432897|NCT01444911|1062512|P2|STARTED|Overall Study||13
432898|NCT01444911|1062513|P1|STARTED|Overall Study||16
432899|NCT01444898|1062525|P1|NOT COMPLETED|Overall Study||1
432900|NCT01444898|1062525|P1|COMPLETED|Overall Study||9
432901|NCT01444898|1062525|P1|STARTED|Overall Study||10
432902|NCT01444781|1062540|P3|NOT COMPLETED|Overall Study||3
432903|NCT01444781|1062541|P2|NOT COMPLETED|Overall Study||4
432904|NCT01444781|1062542|P1|NOT COMPLETED|Overall Study||3
432905|NCT01444781|1062540|P3|COMPLETED|Overall Study||272
432906|NCT01444781|1062541|P2|COMPLETED|Overall Study||411
432907|NCT01444781|1062542|P1|COMPLETED|Overall Study||413
432908|NCT01444781|1062540|P3|STARTED|Overall Study||275
432909|NCT01444781|1062541|P2|STARTED|Overall Study||415
432910|NCT01444781|1062542|P1|STARTED|Overall Study||416
432911|NCT01444742|1062580|P1|NOT COMPLETED|Overall Study||1
432912|NCT01444742|1062580|P1|COMPLETED|Overall Study||80
432913|NCT01444742|1062580|P1|STARTED|Overall Study||81
432914|NCT01444651|1062587|P2|NOT COMPLETED|Overall Study||9
432915|NCT01444651|1062588|P1|NOT COMPLETED|Overall Study||11
432916|NCT01444651|1062587|P2|COMPLETED|Overall Study||28
432917|NCT01444651|1062588|P1|COMPLETED|Overall Study||25
432918|NCT01444651|1062587|P2|STARTED|Overall Study||37
432919|NCT01444651|1062588|P1|STARTED|Overall Study||36
432920|NCT01444456|1062604|P1|NOT COMPLETED|Overall Study||285
432921|NCT01444456|1062604|P1|COMPLETED|Overall Study|Defined as 4 weeks after last dose of ESA or chemotherapy or 13 weeks after enrolment|977
432922|NCT01444456|1062604|P1|Received Darbepoetin Alfa|Overall Study||1134
432923|NCT01444456|1062604|P1|Received Darbepoetin Alfa or Other ESA|Overall Study||1158
432924|NCT01444456|1062604|P1|STARTED|Overall Study||1262
432925|NCT01444430|1062615|P2|NOT COMPLETED|Overall Study||81
432926|NCT01444430|1062616|P1|NOT COMPLETED|Overall Study||61
432927|NCT01444430|1062615|P2|COMPLETED|Overall Study||5766
432928|NCT01444430|1062616|P1|COMPLETED|Overall Study||5785
432929|NCT01444430|1062615|P2|STARTED|Overall Study||5847
432930|NCT01444430|1062616|P1|STARTED|Overall Study||5846
432931|NCT01444417|1062638|P2|NOT COMPLETED|Overall Study||1
432932|NCT01444417|1062639|P1|NOT COMPLETED|Overall Study||2
432933|NCT01444417|1062638|P2|COMPLETED|Overall Study||41
432934|NCT01444417|1062639|P1|COMPLETED|Overall Study||18
432935|NCT01444417|1062638|P2|Received Treatment|Overall Study||42
432936|NCT01444417|1062639|P1|Received Treatment|Overall Study||19
432937|NCT01444417|1062638|P2|STARTED|Overall Study||42
432938|NCT01444417|1062639|P1|STARTED|Overall Study||20
432939|NCT01444391|1062655|P1|NOT COMPLETED|Overall Study||1
432940|NCT01444391|1062655|P1|COMPLETED|Overall Study||41
432941|NCT01444391|1062655|P1|STARTED|Overall Study||42
432942|NCT01444378|1062663|P1|NOT COMPLETED|Overall Study||17
432943|NCT01444378|1062663|P1|COMPLETED|Overall Study||124
432944|NCT01444378|1062663|P1|STARTED|Overall Study|A total of 141 patients were enrolled into MOMENTUM|141
432945|NCT01444300|1062775|P2|NOT COMPLETED|Overall Study||0
432946|NCT01444300|1062776|P1|NOT COMPLETED|Overall Study||4
432947|NCT01444300|1062775|P2|COMPLETED|Overall Study||12
432948|NCT01444300|1062776|P1|COMPLETED|Overall Study||8
432949|NCT01444300|1062775|P2|STARTED|Overall Study||12
432950|NCT01444300|1062776|P1|STARTED|Overall Study||12
432951|NCT01444287|1062786|P1|NOT COMPLETED|Period 4||0
432952|NCT01444287|1062786|P1|COMPLETED|Period 4||22
432953|NCT01444287|1062786|P1|STARTED|Period 4||22
432954|NCT01444287|1062786|P1|NOT COMPLETED|Period 3||0
432955|NCT01444287|1062786|P1|COMPLETED|Period 3||22
432956|NCT01444287|1062786|P1|STARTED|Period 3||22
432957|NCT01444287|1062786|P1|NOT COMPLETED|Period 2||0
432958|NCT01444287|1062786|P1|COMPLETED|Period 2||22
432959|NCT01444287|1062786|P1|STARTED|Period 2||22
432960|NCT01444287|1062786|P1|NOT COMPLETED|Period 1||0
432961|NCT01444287|1062786|P1|COMPLETED|Period 1||22
432962|NCT01444287|1062786|P1|STARTED|Period 1||22
432963|NCT01444092|1062808|P1|NOT COMPLETED|Overall Study||17
432964|NCT01444092|1062808|P1|COMPLETED|Overall Study||91
432965|NCT01444092|1062808|P1|INFORMED CONSENT OBTAINED|Overall Study||108
432966|NCT01444092|1062808|P1|STARTED|Overall Study||108
432967|NCT01444027|1062817|P3|NOT COMPLETED|Overall Study||38
432968|NCT01444027|1062818|P2|NOT COMPLETED|Overall Study||30
432969|NCT01444027|1062819|P1|NOT COMPLETED|Overall Study||30
432970|NCT01444027|1062817|P3|COMPLETED|Overall Study||133
432971|NCT01444027|1062818|P2|COMPLETED|Overall Study||141
432972|NCT01444027|1062819|P1|COMPLETED|Overall Study||142
432973|NCT01444027|1062817|P3|3 Month Follow-up|Overall Study||133
432974|NCT01444027|1062818|P2|3 Month Follow-up|Overall Study||141
432975|NCT01444027|1062819|P1|3 Month Follow-up|Overall Study||142
432976|NCT01444027|1062817|P3|1 Month Follow-up|Overall Study||141
432977|NCT01444027|1062818|P2|1 Month Follow-up|Overall Study||159
432978|NCT01444027|1062819|P1|1 Month Follow-up|Overall Study||160
432979|NCT01444027|1062817|P3|Received Intervention as Assigned|Overall Study||147
432980|NCT01444027|1062818|P2|Received Intervention as Assigned|Overall Study||161
432981|NCT01444027|1062819|P1|Received Intervention as Assigned|Overall Study||168
432982|NCT01444027|1062817|P3|STARTED|Overall Study||171
432983|NCT01444027|1062818|P2|STARTED|Overall Study||171
432984|NCT01444027|1062819|P1|STARTED|Overall Study||172
432985|NCT01443923|1062841|P2|NOT COMPLETED|Overall Study||0
432986|NCT01443923|1062842|P1|NOT COMPLETED|Overall Study||1
432987|NCT01443923|1062841|P2|COMPLETED|Overall Study||1
432988|NCT01443923|1062842|P1|COMPLETED|Overall Study||2
432989|NCT01443923|1062841|P2|STARTED|Overall Study||1
432990|NCT01443923|1062842|P1|STARTED|Overall Study||3
432991|NCT01443858|1062859|P3|NOT COMPLETED|Overall Study||7
432992|NCT01443858|1062860|P2|NOT COMPLETED|Overall Study||13
432993|NCT01443858|1062861|P1|NOT COMPLETED|Overall Study||15
432994|NCT01443858|1062859|P3|COMPLETED|Overall Study||18
432995|NCT01443858|1062860|P2|COMPLETED|Overall Study||12
432996|NCT01443858|1062861|P1|COMPLETED|Overall Study||10
432997|NCT01443858|1062859|P3|STARTED|Overall Study||25
432998|NCT01443858|1062860|P2|STARTED|Overall Study||25
432999|NCT01443858|1062861|P1|STARTED|Overall Study||25
433000|NCT01443845|1062883|P2|NOT COMPLETED|Overall Study||337
433001|NCT01443845|1062884|P1|NOT COMPLETED|Overall Study||254
433002|NCT01443845|1062883|P2|COMPLETED|Overall Study||841
433003|NCT01443845|1062884|P1|COMPLETED|Overall Study||922
433004|NCT01443845|1062883|P2|STARTED|Overall Study||1178
433005|NCT01443845|1062884|P1|STARTED|Overall Study||1176
433006|NCT01443494|1062896|P1|NOT COMPLETED|Overall Study||0
433007|NCT01443494|1062896|P1|COMPLETED|Overall Study||19
433008|NCT01443494|1062896|P1|STARTED|Overall Study||19
433009|NCT01443403|1062905|P4|NOT COMPLETED|Overall Study||9
433010|NCT01443403|1062906|P3|NOT COMPLETED|Overall Study||7
433011|NCT01443403|1062907|P2|NOT COMPLETED|Overall Study||6
433012|NCT01443403|1062908|P1|NOT COMPLETED|Overall Study||6
433013|NCT01443403|1062905|P4|COMPLETED|Overall Study||52
433014|NCT01443403|1062906|P3|COMPLETED|Overall Study||54
433015|NCT01443403|1062907|P2|COMPLETED|Overall Study||55
433016|NCT01443403|1062908|P1|COMPLETED|Overall Study||55
433017|NCT01443403|1062905|P4|Received Treatment|Overall Study||61
433018|NCT01443403|1062906|P3|Received Treatment|Overall Study||60
433019|NCT01443403|1062907|P2|Received Treatment|Overall Study||61
433020|NCT01443403|1062908|P1|Received Treatment|Overall Study||61
433021|NCT01443403|1062905|P4|STARTED|Overall Study||61
433022|NCT01443403|1062906|P3|STARTED|Overall Study||61
433023|NCT01443403|1062907|P2|STARTED|Overall Study||61
433024|NCT01443403|1062908|P1|STARTED|Overall Study||61
433025|NCT01443364|1063055|P1|NOT COMPLETED|Overall Study||41
433026|NCT01443364|1063055|P1|COMPLETED|Overall Study||91
433027|NCT01443364|1063055|P1|STARTED|Overall Study||132
433028|NCT01443130|1063184|P6|NOT COMPLETED|Overall Study||34
433029|NCT01443130|1063185|P5|NOT COMPLETED|Overall Study||44
433030|NCT01443130|1063186|P4|NOT COMPLETED|Overall Study||39
433031|NCT01443130|1063187|P3|NOT COMPLETED|Overall Study||77
433032|NCT01443130|1063188|P2|NOT COMPLETED|Overall Study||69
433033|NCT01443130|1063189|P1|NOT COMPLETED|Overall Study||68
433034|NCT01443130|1063184|P6|COMPLETED|Overall Study||225
433035|NCT01443130|1063185|P5|COMPLETED|Overall Study||230
433036|NCT01443130|1063186|P4|COMPLETED|Overall Study||231
433037|NCT01443130|1063187|P3|COMPLETED|Overall Study||223
433038|NCT01443130|1063188|P2|COMPLETED|Overall Study||231
433039|NCT01443130|1063189|P1|COMPLETED|Overall Study||232
433040|NCT01443130|1063184|P6|STARTED|Overall Study||259
433041|NCT01443130|1063185|P5|STARTED|Overall Study||274
433042|NCT01443130|1063186|P4|STARTED|Overall Study||270
433043|NCT01443130|1063187|P3|STARTED|Overall Study||300
433044|NCT01443130|1063188|P2|STARTED|Overall Study||300
433045|NCT01443130|1063189|P1|STARTED|Overall Study||300
433046|NCT01443078|1063239|P1|NOT COMPLETED|Overall Study||29
433047|NCT01443078|1063239|P1|COMPLETED|Overall Study||13
433048|NCT01443078|1063239|P1|STARTED|Overall Study||42
433049|NCT01443026|1063245|P2|NOT COMPLETED|Overall Study||5
433050|NCT01443026|1063246|P1|NOT COMPLETED|Overall Study||3
433051|NCT01443026|1063245|P2|COMPLETED|Overall Study||32
433052|NCT01443026|1063246|P1|COMPLETED|Overall Study||26
433053|NCT01443026|1063245|P2|STARTED|Overall Study||37
433054|NCT01443026|1063246|P1|STARTED|Overall Study||29
433055|NCT01442844|1063254|P2|NOT COMPLETED|Overall Study||0
433056|NCT01442844|1063255|P1|NOT COMPLETED|Overall Study||0
433057|NCT01442844|1063254|P2|COMPLETED|Overall Study||2
433058|NCT01442844|1063255|P1|COMPLETED|Overall Study||1
433059|NCT01442844|1063254|P2|STARTED|Overall Study||2
433060|NCT01442844|1063255|P1|STARTED|Overall Study||1
433061|NCT01442779|1063261|P1|NOT COMPLETED|Overall Study||7
433062|NCT01442779|1063261|P1|COMPLETED|Overall Study||11
433063|NCT01442779|1063261|P1|STARTED|Overall Study||18
433064|NCT01442714|1063267|P1|NOT COMPLETED|Overall Study||12
433065|NCT01442714|1063267|P1|COMPLETED|Overall Study||21
433066|NCT01442714|1063267|P1|STARTED|Overall Study||33
433067|NCT01442688|1063275|P2|NOT COMPLETED|Second Intervention||0
433068|NCT01442688|1063276|P1|NOT COMPLETED|Second Intervention||1
433069|NCT01442688|1063275|P2|COMPLETED|Second Intervention||31
433070|NCT01442688|1063276|P1|COMPLETED|Second Intervention||28
433071|NCT01442688|1063275|P2|STARTED|Second Intervention||31
433072|NCT01442688|1063276|P1|STARTED|Second Intervention||29
433073|NCT01442688|1063275|P2|NOT COMPLETED|First Intervention||0
433074|NCT01442688|1063276|P1|NOT COMPLETED|First Intervention||2
433075|NCT01442688|1063275|P2|COMPLETED|First Intervention||31
433076|NCT01442688|1063276|P1|COMPLETED|First Intervention||29
433077|NCT01442688|1063275|P2|STARTED|First Intervention||31
433078|NCT01442688|1063276|P1|STARTED|First Intervention||31
433079|NCT01442675|1063284|P1|NOT COMPLETED|Overall Study||12
433080|NCT01442675|1063284|P1|COMPLETED|Overall Study||822
433081|NCT01442675|1063284|P1|Per-Protocol Analysis Set|Overall Study|The Per-Protocol Analysis Set are subjects with no pre-defined protocol deviations.|781
433082|NCT01442675|1063284|P1|Safety Analysis Set|Overall Study|Safety Analysis Set are subjects who received study vaccine and for whom safety data were available.|831
433083|NCT01442675|1063284|P1|STARTED|Overall Study||834
433084|NCT01442493|1063296|P2|NOT COMPLETED|Overall Study||2
433085|NCT01442493|1063297|P1|NOT COMPLETED|Overall Study||3
433086|NCT01442493|1063296|P2|COMPLETED|Overall Study||149
433087|NCT01442493|1063297|P1|COMPLETED|Overall Study||146
433088|NCT01442493|1063296|P2|STARTED|Overall Study||151
433089|NCT01442493|1063297|P1|STARTED|Overall Study||149
433090|NCT01442376|1063318|P3|NOT COMPLETED|Overall Study||5
433091|NCT01442376|1063319|P2|NOT COMPLETED|Overall Study||9
433092|NCT01442376|1063320|P1|NOT COMPLETED|Overall Study||3
433093|NCT01442376|1063318|P3|COMPLETED|Overall Study||159
433094|NCT01442376|1063319|P2|COMPLETED|Overall Study||160
433095|NCT01442376|1063320|P1|COMPLETED|Overall Study||166
433096|NCT01442376|1063318|P3|STARTED|Overall Study|Randomized patients|164
433097|NCT01442376|1063319|P2|STARTED|Overall Study|Randomized patients|169
433098|NCT01442376|1063320|P1|STARTED|Overall Study|Randomized patients|169
433099|NCT01442181|1063333|P2|NOT COMPLETED|Overall Study||3
433100|NCT01442181|1063334|P1|NOT COMPLETED|Overall Study||4
433101|NCT01442181|1063333|P2|COMPLETED|Overall Study||8
433102|NCT01442181|1063334|P1|COMPLETED|Overall Study||10
433103|NCT01442181|1063333|P2|STARTED|Overall Study||11
433104|NCT01442181|1063334|P1|STARTED|Overall Study||14
433105|NCT01442155|1063358|P1|NOT COMPLETED|Overall Study||65
433106|NCT01442155|1063358|P1|COMPLETED|Overall Study||9
433107|NCT01442155|1063358|P1|STARTED|Overall Study||74
433108|NCT01442129|1063365|P2|NOT COMPLETED|Overall Study||0
433109|NCT01442129|1063366|P1|NOT COMPLETED|Overall Study||0
433110|NCT01442129|1063365|P2|COMPLETED|Overall Study||10
433111|NCT01442129|1063366|P1|COMPLETED|Overall Study|Treatment withheld from 1 patient randomized before results of screening PRA known|20
433112|NCT01442129|1063365|P2|STARTED|Overall Study||10
433113|NCT01442129|1063366|P1|STARTED|Overall Study||20
433114|NCT01442103|1063374|P1|NOT COMPLETED|Overall Study||2
433115|NCT01442103|1063374|P1|COMPLETED|Overall Study||8
433116|NCT01442103|1063374|P1|STARTED|Overall Study||10
433117|NCT01442064|1063384|P6|NOT COMPLETED|Overall Study||99
433118|NCT01442064|1063385|P5|NOT COMPLETED|Overall Study||106
433119|NCT01442064|1063386|P4|NOT COMPLETED|Overall Study||98
433120|NCT01442064|1063387|P3|NOT COMPLETED|Overall Study||104
433121|NCT01442064|1063388|P2|NOT COMPLETED|Overall Study||101
433122|NCT01442064|1063389|P1|NOT COMPLETED|Overall Study||97
433123|NCT01442064|1063384|P6|COMPLETED|Overall Study||0
433124|NCT01442064|1063385|P5|COMPLETED|Overall Study||1
433125|NCT01442064|1063386|P4|COMPLETED|Overall Study||0
433126|NCT01442064|1063387|P3|COMPLETED|Overall Study||0
433127|NCT01442064|1063388|P2|COMPLETED|Overall Study||2
433128|NCT01442064|1063389|P1|COMPLETED|Overall Study||0
433129|NCT01442064|1063384|P6|Received Study Drug in Extension Study|Overall Study||81
433130|NCT01442064|1063385|P5|Received Study Drug in Extension Study|Overall Study||89
433131|NCT01442064|1063386|P4|Received Study Drug in Extension Study|Overall Study||70
433132|NCT01442064|1063387|P3|Received Study Drug in Extension Study|Overall Study||60
433133|NCT01442064|1063388|P2|Received Study Drug in Extension Study|Overall Study||70
433134|NCT01442064|1063389|P1|Received Study Drug in Extension Study|Overall Study||61
433135|NCT01442064|1063384|P6|Ranibizumab-Treated Subjects|Overall Study||99
433136|NCT01442064|1063385|P5|Ranibizumab-Treated Subjects|Overall Study||107
433137|NCT01442064|1063386|P4|Ranibizumab-Treated Subjects|Overall Study||96
433138|NCT01442064|1063387|P3|Ranibizumab-Treated Subjects|Overall Study||104
433139|NCT01442064|1063388|P2|Ranibizumab-Treated Subjects|Overall Study||103
433140|NCT01442064|1063389|P1|Ranibizumab-Treated Subjects|Overall Study|Includes participants who received Ranibizumab in either the initial studies or the extension study.|93
433141|NCT01442064|1063384|P6|STARTED|Overall Study||99
433142|NCT01442064|1063385|P5|STARTED|Overall Study||107
433143|NCT01442064|1063386|P4|STARTED|Overall Study||98
433144|NCT01442064|1063387|P3|STARTED|Overall Study||104
433145|NCT01442064|1063388|P2|STARTED|Overall Study||103
433146|NCT01442064|1063389|P1|STARTED|Overall Study||97
433147|NCT01442038|1063426|P2|NOT COMPLETED|Overall Study||279
433148|NCT01442038|1063427|P1|NOT COMPLETED|Overall Study||303
433149|NCT01442038|1063426|P2|COMPLETED|Overall Study||1040
433150|NCT01442038|1063427|P1|COMPLETED|Overall Study||1029
433151|NCT01442038|1063426|P2|STARTED|Overall Study||1319
433152|NCT01442038|1063427|P1|STARTED|Overall Study||1332
433153|NCT01441973|1063441|P2|NOT COMPLETED|Overall Study||16
433154|NCT01441973|1063442|P1|NOT COMPLETED|Overall Study||15
433155|NCT01441973|1063441|P2|COMPLETED|Overall Study|Still receiving treatment|0
433156|NCT01441973|1063442|P1|COMPLETED|Overall Study|Still receiving treatment|0
433157|NCT01441973|1063441|P2|STARTED|Overall Study||16
433158|NCT01441973|1063442|P1|STARTED|Overall Study||15
433159|NCT01441960|1063464|P2|NOT COMPLETED|Second Neuromuscular Blocking Agent||0
433160|NCT01441960|1063465|P1|NOT COMPLETED|Second Neuromuscular Blocking Agent||0
433161|NCT01441960|1063464|P2|COMPLETED|Second Neuromuscular Blocking Agent||13
433162|NCT01441960|1063465|P1|COMPLETED|Second Neuromuscular Blocking Agent||18
433163|NCT01441960|1063464|P2|STARTED|Second Neuromuscular Blocking Agent||13
433164|NCT01441960|1063465|P1|STARTED|Second Neuromuscular Blocking Agent||18
433165|NCT01441960|1063464|P2|NOT COMPLETED|First Neuromuscular Blocking Agent:||6
433166|NCT01441960|1063465|P1|NOT COMPLETED|First Neuromuscular Blocking Agent:||8
433167|NCT01441960|1063464|P2|COMPLETED|First Neuromuscular Blocking Agent:||13
433168|NCT01441960|1063465|P1|COMPLETED|First Neuromuscular Blocking Agent:||18
433169|NCT01441960|1063464|P2|STARTED|First Neuromuscular Blocking Agent:||19
433170|NCT01441960|1063465|P1|STARTED|First Neuromuscular Blocking Agent:||26
433171|NCT01441882|1063475|P1|NOT COMPLETED|Overall Study||6
433172|NCT01441882|1063475|P1|COMPLETED|Overall Study||13
433173|NCT01441882|1063475|P1|STARTED|Overall Study||19
433174|NCT01441843|1063481|P2|NOT COMPLETED|Overall Study||5
433175|NCT01441843|1063482|P1|NOT COMPLETED|Overall Study||12
433176|NCT01441843|1063481|P2|COMPLETED|Overall Study||195
433177|NCT01441843|1063482|P1|COMPLETED|Overall Study||188
433178|NCT01441843|1063481|P2|STARTED|Overall Study||200
433179|NCT01441843|1063482|P1|STARTED|Overall Study||200
433180|NCT01441765|1063490|P2|NOT COMPLETED|Overall Study||0
433181|NCT01441765|1063491|P1|NOT COMPLETED|Overall Study||1
433182|NCT01441765|1063490|P2|COMPLETED|Overall Study|not opened|0
433183|NCT01441765|1063491|P1|COMPLETED|Overall Study||10
433184|NCT01441765|1063490|P2|STARTED|Overall Study|not opened|0
433185|NCT01441765|1063491|P1|STARTED|Overall Study||11
433186|NCT01441596|1063508|P3|NOT COMPLETED|Overall Study||4
433187|NCT01441596|1063509|P2|NOT COMPLETED|Overall Study||3
433188|NCT01441596|1063510|P1|NOT COMPLETED|Overall Study||4
433189|NCT01441596|1063508|P3|COMPLETED|Overall Study||39
433190|NCT01441596|1063509|P2|COMPLETED|Overall Study||35
433191|NCT01441596|1063510|P1|COMPLETED|Overall Study||36
433192|NCT01441596|1063508|P3|STARTED|Overall Study||43
433193|NCT01441596|1063509|P2|STARTED|Overall Study||38
433194|NCT01441596|1063510|P1|STARTED|Overall Study||40
433195|NCT01441570|1063526|P2|NOT COMPLETED|Overall Study||0
433196|NCT01441570|1063527|P1|NOT COMPLETED|Overall Study||0
433197|NCT01441570|1063526|P2|COMPLETED|Overall Study||5
433198|NCT01441570|1063527|P1|COMPLETED|Overall Study||6
433199|NCT01441570|1063526|P2|STARTED|Overall Study||5
433200|NCT01441570|1063527|P1|STARTED|Overall Study||6
433201|NCT01441466|1063537|P2|NOT COMPLETED|Overall Study||0
433202|NCT01441466|1063538|P1|NOT COMPLETED|Overall Study||0
433203|NCT01441466|1063537|P2|COMPLETED|Overall Study||11
433204|NCT01441466|1063538|P1|COMPLETED|Overall Study||37
433205|NCT01441466|1063537|P2|STARTED|Overall Study||11
433206|NCT01441466|1063538|P1|STARTED|Overall Study||37
433207|NCT01441440|1063557|P3|NOT COMPLETED|Overall Study||22
433208|NCT01441440|1063558|P2|NOT COMPLETED|Overall Study||23
433209|NCT01441440|1063559|P1|NOT COMPLETED|Overall Study||17
433210|NCT01441440|1063557|P3|COMPLETED|Overall Study||158
433211|NCT01441440|1063558|P2|COMPLETED|Overall Study||151
433212|NCT01441440|1063559|P1|COMPLETED|Overall Study||166
433213|NCT01441440|1063557|P3|STARTED|Overall Study|Safety analysis set|180
433214|NCT01441440|1063558|P2|STARTED|Overall Study|Safety analysis set|174
433215|NCT01441440|1063559|P1|STARTED|Overall Study|Safety analysis set|183
433216|NCT01441414|1063582|P1|NOT COMPLETED|Overall Study||15
433217|NCT01441414|1063582|P1|COMPLETED|Overall Study||3
433218|NCT01441414|1063582|P1|STARTED|Overall Study||18
433219|NCT01441401|1063607|P1|NOT COMPLETED|Overall Study||0
433220|NCT01441401|1063607|P1|COMPLETED|Overall Study|Number of participants whose survey form was collected was presented.|82
433221|NCT01441401|1063607|P1|STARTED|Overall Study||82
433222|NCT01441245|1063635|P2|NOT COMPLETED|Overall Study||0
433223|NCT01441245|1063636|P1|NOT COMPLETED|Overall Study||0
433224|NCT01441245|1063635|P2|COMPLETED|Overall Study||27
433225|NCT01441245|1063636|P1|COMPLETED|Overall Study||30
433226|NCT01441245|1063635|P2|STARTED|Overall Study||27
433227|NCT01441245|1063636|P1|STARTED|Overall Study||30
433228|NCT01441180|1063661|P3|NOT COMPLETED|Overall Study||3
433229|NCT01441180|1063662|P2|NOT COMPLETED|Overall Study||1
433230|NCT01441180|1063663|P1|NOT COMPLETED|Overall Study||1
433231|NCT01441180|1063661|P3|COMPLETED|Overall Study||22
433232|NCT01441180|1063662|P2|COMPLETED|Overall Study||24
433233|NCT01441180|1063663|P1|COMPLETED|Overall Study||9
433234|NCT01441180|1063661|P3|STARTED|Overall Study||25
433235|NCT01441180|1063662|P2|STARTED|Overall Study||25
433236|NCT01441180|1063663|P1|STARTED|Overall Study||10
433237|NCT01441102|1063674|P1|NOT COMPLETED|Overall Study||3
433238|NCT01441102|1063674|P1|COMPLETED|Overall Study||4
433239|NCT01441102|1063674|P1|STARTED|Overall Study|Two participants withdrew prior to Month 6; therefore, two additional participants were enrolled.|7
433240|NCT01441076|1063694|P1|NOT COMPLETED|Overall Study||2
433241|NCT01441076|1063694|P1|COMPLETED|Overall Study||4
433242|NCT01441076|1063694|P1|STARTED|Overall Study||6
433243|NCT01440972|1063714|P2|NOT COMPLETED|Overall Study||2
433244|NCT01440972|1063715|P1|NOT COMPLETED|Overall Study||3
433245|NCT01440972|1063714|P2|COMPLETED|Overall Study||19
433246|NCT01440972|1063715|P1|COMPLETED|Overall Study||21
433247|NCT01440972|1063714|P2|STARTED|Overall Study||21
433248|NCT01440972|1063715|P1|STARTED|Overall Study||24
433249|NCT01440959|1063729|P1|NOT COMPLETED|Overall Study||0
433250|NCT01440959|1063729|P1|COMPLETED|Overall Study||30
433251|NCT01440959|1063729|P1|STARTED|Overall Study||30
433252|NCT01440946|1063739|P2|NOT COMPLETED|Overall Study||1
433253|NCT01440946|1063740|P1|NOT COMPLETED|Overall Study||2
433254|NCT01440946|1063739|P2|COMPLETED|Overall Study||14
433255|NCT01440946|1063740|P1|COMPLETED|Overall Study||13
433256|NCT01440946|1063739|P2|STARTED|Overall Study||15
433257|NCT01440946|1063740|P1|STARTED|Overall Study||15
433258|NCT01440881|1063779|P2|NOT COMPLETED|Overall Study||1
433259|NCT01440881|1063780|P1|NOT COMPLETED|Overall Study||0
433260|NCT01440881|1063779|P2|COMPLETED|Overall Study||14
433261|NCT01440881|1063780|P1|COMPLETED|Overall Study||14
433262|NCT01440881|1063779|P2|STARTED|Overall Study||15
433263|NCT01440881|1063780|P1|STARTED|Overall Study||14
433264|NCT01440816|1063794|P2|NOT COMPLETED|Overall Study||11
433265|NCT01440816|1063795|P1|NOT COMPLETED|Overall Study||1
433266|NCT01440816|1063794|P2|COMPLETED|Overall Study||1
433267|NCT01440816|1063795|P1|COMPLETED|Overall Study||2
433268|NCT01440816|1063794|P2|STARTED|Overall Study||12
433269|NCT01440816|1063795|P1|STARTED|Overall Study||3
433270|NCT01440764|1063811|P7|NOT COMPLETED|Test Day 3||0
433271|NCT01440764|1063812|P6|NOT COMPLETED|Test Day 3||0
433272|NCT01440764|1063813|P5|NOT COMPLETED|Test Day 3||0
433273|NCT01440764|1063814|P4|NOT COMPLETED|Test Day 3||0
433274|NCT01440764|1063815|P3|NOT COMPLETED|Test Day 3||0
433275|NCT01440764|1063816|P2|NOT COMPLETED|Test Day 3||0
433276|NCT01440764|1063817|P1|NOT COMPLETED|Test Day 3||0
433277|NCT01440764|1063811|P7|COMPLETED|Test Day 3||3
433278|NCT01440764|1063812|P6|COMPLETED|Test Day 3||5
433279|NCT01440764|1063813|P5|COMPLETED|Test Day 3||3
433280|NCT01440764|1063814|P4|COMPLETED|Test Day 3||1
433281|NCT01440764|1063815|P3|COMPLETED|Test Day 3||6
433282|NCT01440764|1063816|P2|COMPLETED|Test Day 3||2
433283|NCT01440764|1063817|P1|COMPLETED|Test Day 3||3
433284|NCT01440764|1063811|P7|STARTED|Test Day 3||3
433285|NCT01440764|1063812|P6|STARTED|Test Day 3||5
433286|NCT01440764|1063813|P5|STARTED|Test Day 3||3
433287|NCT01440764|1063814|P4|STARTED|Test Day 3||1
433288|NCT01440764|1063815|P3|STARTED|Test Day 3||6
433289|NCT01440764|1063816|P2|STARTED|Test Day 3||2
433290|NCT01440764|1063817|P1|STARTED|Test Day 3||3
433291|NCT01440764|1063811|P7|NOT COMPLETED|Test Day 2||0
433292|NCT01440764|1063812|P6|NOT COMPLETED|Test Day 2||0
433293|NCT01440764|1063813|P5|NOT COMPLETED|Test Day 2||0
433294|NCT01440764|1063814|P4|NOT COMPLETED|Test Day 2||0
433295|NCT01440764|1063815|P3|NOT COMPLETED|Test Day 2||0
433296|NCT01440764|1063816|P2|NOT COMPLETED|Test Day 2||0
433297|NCT01440764|1063817|P1|NOT COMPLETED|Test Day 2||0
433298|NCT01440764|1063811|P7|COMPLETED|Test Day 2||3
433299|NCT01440764|1063812|P6|COMPLETED|Test Day 2||5
433300|NCT01440764|1063813|P5|COMPLETED|Test Day 2||3
433301|NCT01440764|1063814|P4|COMPLETED|Test Day 2||1
433302|NCT01440764|1063815|P3|COMPLETED|Test Day 2||6
433303|NCT01440764|1063816|P2|COMPLETED|Test Day 2||2
433304|NCT01440764|1063817|P1|COMPLETED|Test Day 2||3
433305|NCT01440764|1063811|P7|STARTED|Test Day 2||3
433306|NCT01440764|1063812|P6|STARTED|Test Day 2||5
433307|NCT01440764|1063813|P5|STARTED|Test Day 2||3
433308|NCT01440764|1063814|P4|STARTED|Test Day 2||1
433309|NCT01440764|1063815|P3|STARTED|Test Day 2||6
433310|NCT01440764|1063816|P2|STARTED|Test Day 2||2
433311|NCT01440764|1063817|P1|STARTED|Test Day 2|Following Test Day 1, 1 subject withdrew from the study before beginning Test Day 2.|3
433312|NCT01440764|1063811|P7|NOT COMPLETED|Test Day 1||0
433313|NCT01440764|1063812|P6|NOT COMPLETED|Test Day 1||0
433314|NCT01440764|1063813|P5|NOT COMPLETED|Test Day 1||0
433315|NCT01440764|1063814|P4|NOT COMPLETED|Test Day 1||0
433316|NCT01440764|1063815|P3|NOT COMPLETED|Test Day 1||0
433317|NCT01440764|1063816|P2|NOT COMPLETED|Test Day 1||0
433318|NCT01440764|1063817|P1|NOT COMPLETED|Test Day 1||0
433319|NCT01440764|1063811|P7|COMPLETED|Test Day 1||3
433320|NCT01440764|1063812|P6|COMPLETED|Test Day 1||5
433321|NCT01440764|1063813|P5|COMPLETED|Test Day 1||3
433322|NCT01440764|1063814|P4|COMPLETED|Test Day 1||1
433323|NCT01440764|1063815|P3|COMPLETED|Test Day 1||6
433324|NCT01440764|1063816|P2|COMPLETED|Test Day 1||2
433325|NCT01440764|1063817|P1|COMPLETED|Test Day 1||4
433326|NCT01440764|1063811|P7|STARTED|Test Day 1||3
433327|NCT01440764|1063812|P6|STARTED|Test Day 1||5
433328|NCT01440764|1063813|P5|STARTED|Test Day 1||3
433329|NCT01440764|1063814|P4|STARTED|Test Day 1||1
433330|NCT01440764|1063815|P3|STARTED|Test Day 1||6
433331|NCT01440764|1063816|P2|STARTED|Test Day 1||2
433332|NCT01440764|1063817|P1|STARTED|Test Day 1||4
433333|NCT01440647|1063838|P2|NOT COMPLETED|Overall Study||3
433334|NCT01440647|1063839|P1|NOT COMPLETED|Overall Study||2
433335|NCT01440647|1063838|P2|COMPLETED|Overall Study||15
433336|NCT01440647|1063839|P1|COMPLETED|Overall Study||14
433337|NCT01440647|1063838|P2|STARTED|Overall Study||18
433338|NCT01440647|1063839|P1|STARTED|Overall Study||16
433339|NCT01440634|1063849|P2|NOT COMPLETED|Randomization Phase||10
433340|NCT01440634|1063850|P1|NOT COMPLETED|Randomization Phase||6
433341|NCT01440634|1063849|P2|COMPLETED|Randomization Phase||14
433342|NCT01440634|1063850|P1|COMPLETED|Randomization Phase||24
433343|NCT01440634|1063849|P2|STARTED|Randomization Phase||24
433344|NCT01440634|1063850|P1|STARTED|Randomization Phase||30
433345|NCT01440634|1063849|P2|NOT COMPLETED|Cross Sectional Phase||0
433346|NCT01440634|1063850|P1|NOT COMPLETED|Cross Sectional Phase||0
433347|NCT01440634|1063849|P2|COMPLETED|Cross Sectional Phase||347
433348|NCT01440634|1063850|P1|COMPLETED|Cross Sectional Phase||0
433349|NCT01440634|1063849|P2|STARTED|Cross Sectional Phase||347
433350|NCT01440634|1063850|P1|STARTED|Cross Sectional Phase||0
433351|NCT01440595|1063858|P3|NOT COMPLETED|Overall Study||1
433352|NCT01440595|1063859|P2|NOT COMPLETED|Overall Study||3
433353|NCT01440595|1063860|P1|NOT COMPLETED|Overall Study||1
433354|NCT01440595|1063858|P3|COMPLETED|Overall Study||0
433355|NCT01440595|1063859|P2|COMPLETED|Overall Study||0
433356|NCT01440595|1063860|P1|COMPLETED|Overall Study||0
433357|NCT01440595|1063858|P3|STARTED|Overall Study||1
433358|NCT01440595|1063859|P2|STARTED|Overall Study||3
433359|NCT01440595|1063860|P1|STARTED|Overall Study||1
433360|NCT01440569|1063880|P2|NOT COMPLETED|Open-Label Rollover Phase||6
433361|NCT01440569|1063881|P1|NOT COMPLETED|Open-Label Rollover Phase||47
433362|NCT01440569|1063880|P2|COMPLETED|Open-Label Rollover Phase||7
433363|NCT01440569|1063881|P1|COMPLETED|Open-Label Rollover Phase||204
433364|NCT01440569|1063880|P2|STARTED|Open-Label Rollover Phase|1 participant who completed the Main Study did not enroll into the Rollover Phase.|13
433365|NCT01440569|1063881|P1|STARTED|Open-Label Rollover Phase|9 participants who completed the Main Study did not enroll into the Rollover Phase.|251
433366|NCT01440569|1063880|P2|NOT COMPLETED|Main Study||4
433367|NCT01440569|1063881|P1|NOT COMPLETED|Main Study||36
433368|NCT01440569|1063880|P2|COMPLETED|Main Study||14
433369|NCT01440569|1063881|P1|COMPLETED|Main Study||260
433370|NCT01440569|1063880|P2|Enrolled and Treated|Main Study||18
433371|NCT01440569|1063881|P1|Enrolled and Treated|Main Study||295
433372|NCT01440569|1063880|P2|STARTED|Main Study||18
433373|NCT01440569|1063881|P1|STARTED|Main Study||296
433374|NCT01440543|1063903|P4|NOT COMPLETED|Overall Study||6
433375|NCT01440543|1063904|P3|NOT COMPLETED|Overall Study||2
433376|NCT01440543|1063905|P2|NOT COMPLETED|Overall Study||4
433377|NCT01440543|1063906|P1|NOT COMPLETED|Overall Study||4
433378|NCT01440543|1063903|P4|COMPLETED|Overall Study||101
433379|NCT01440543|1063904|P3|COMPLETED|Overall Study||100
433380|NCT01440543|1063905|P2|COMPLETED|Overall Study||101
433381|NCT01440543|1063906|P1|COMPLETED|Overall Study||102
433382|NCT01440543|1063903|P4|STARTED|Overall Study||107
433383|NCT01440543|1063904|P3|STARTED|Overall Study||102
433384|NCT01440543|1063905|P2|STARTED|Overall Study||105
433385|NCT01440543|1063906|P1|STARTED|Overall Study||106
433386|NCT01440517|1063916|P1|NOT COMPLETED|Overall Study||1
433387|NCT01440517|1063916|P1|COMPLETED|Overall Study||4
433388|NCT01440517|1063916|P1|STARTED|Overall Study||5
433389|NCT01440387|1063923|P2|NOT COMPLETED|Overall Study||0
433390|NCT01440387|1063924|P1|NOT COMPLETED|Overall Study||0
433391|NCT01440387|1063923|P2|COMPLETED|Overall Study||56
433392|NCT01440387|1063924|P1|COMPLETED|Overall Study||56
433393|NCT01440387|1063923|P2|STARTED|Overall Study||56
433394|NCT01440387|1063924|P1|STARTED|Overall Study||56
433395|NCT01440374|1063947|P4|NOT COMPLETED|Part 3: Extension||32
433396|NCT01440374|1063948|P3|NOT COMPLETED|Part 3: Extension||0
433397|NCT01440374|1063949|P2|NOT COMPLETED|Part 3: Extension||0
433398|NCT01440374|1063950|P1|NOT COMPLETED|Part 3: Extension||0
433399|NCT01440374|1063947|P4|COMPLETED|Part 3: Extension||27
433400|NCT01440374|1063948|P3|COMPLETED|Part 3: Extension||0
433401|NCT01440374|1063949|P2|COMPLETED|Part 3: Extension||0
433402|NCT01440374|1063950|P1|COMPLETED|Part 3: Extension||0
433403|NCT01440374|1063947|P4|STARTED|Part 3: Extension||59
433404|NCT01440374|1063948|P3|STARTED|Part 3: Extension||0
433405|NCT01440374|1063949|P2|STARTED|Part 3: Extension||0
433406|NCT01440374|1063950|P1|STARTED|Part 3: Extension||0
433407|NCT01440374|1063947|P4|NOT COMPLETED|Part 2; Double-blind Phase||0
433408|NCT01440374|1063948|P3|NOT COMPLETED|Part 2; Double-blind Phase||55
433409|NCT01440374|1063949|P2|NOT COMPLETED|Part 2; Double-blind Phase||20
433410|NCT01440374|1063950|P1|NOT COMPLETED|Part 2; Double-blind Phase||0
433411|NCT01440374|1063947|P4|COMPLETED|Part 2; Double-blind Phase||0
433412|NCT01440374|1063948|P3|COMPLETED|Part 2; Double-blind Phase||43
433413|NCT01440374|1063949|P2|COMPLETED|Part 2; Double-blind Phase||27
433414|NCT01440374|1063950|P1|COMPLETED|Part 2; Double-blind Phase||0
433415|NCT01440374|1063947|P4|STARTED|Part 2; Double-blind Phase||0
433416|NCT01440374|1063948|P3|STARTED|Part 2; Double-blind Phase||98
433417|NCT01440374|1063949|P2|STARTED|Part 2; Double-blind Phase||47
433418|NCT01440374|1063950|P1|STARTED|Part 2; Double-blind Phase||0
433419|NCT01440374|1063947|P4|NOT COMPLETED|Part 1: Open-label Phase||0
433420|NCT01440374|1063948|P3|NOT COMPLETED|Part 1: Open-label Phase||0
433421|NCT01440374|1063949|P2|NOT COMPLETED|Part 1: Open-label Phase||0
433422|NCT01440374|1063950|P1|NOT COMPLETED|Part 1: Open-label Phase||6
433423|NCT01440374|1063947|P4|COMPLETED|Part 1: Open-label Phase||0
433424|NCT01440374|1063948|P3|COMPLETED|Part 1: Open-label Phase||0
433425|NCT01440374|1063949|P2|COMPLETED|Part 1: Open-label Phase||0
433426|NCT01440374|1063950|P1|COMPLETED|Part 1: Open-label Phase||11
433427|NCT01440374|1063947|P4|STARTED|Part 1: Open-label Phase||0
433428|NCT01440374|1063948|P3|STARTED|Part 1: Open-label Phase||0
433429|NCT01440374|1063949|P2|STARTED|Part 1: Open-label Phase||0
433430|NCT01440374|1063950|P1|STARTED|Part 1: Open-label Phase||17
433431|NCT01440322|1063985|P2|NOT COMPLETED|Overall Study||1
433432|NCT01440322|1063986|P1|NOT COMPLETED|Overall Study||7
433433|NCT01440322|1063985|P2|COMPLETED|Overall Study||49
433434|NCT01440322|1063986|P1|COMPLETED|Overall Study||90
433435|NCT01440322|1063985|P2|STARTED|Overall Study||50
433436|NCT01440322|1063986|P1|STARTED|Overall Study||97
433437|NCT01440283|1064008|P1|NOT COMPLETED|Overall Study||10
433438|NCT01440283|1064008|P1|COMPLETED|Overall Study||4
433439|NCT01440283|1064008|P1|STARTED|Overall Study||14
433440|NCT01440101|1064023|P3|NOT COMPLETED|Overall Study||1
433441|NCT01440101|1064024|P2|NOT COMPLETED|Overall Study||4
433442|NCT01440101|1064025|P1|NOT COMPLETED|Overall Study||2
433443|NCT01440101|1064023|P3|COMPLETED|Overall Study||46
433444|NCT01440101|1064024|P2|COMPLETED|Overall Study||43
433445|NCT01440101|1064025|P1|COMPLETED|Overall Study||10
433446|NCT01440101|1064023|P3|STARTED|Overall Study||47
433447|NCT01440101|1064024|P2|STARTED|Overall Study||47
433448|NCT01440101|1064025|P1|STARTED|Overall Study||12
433449|NCT01440049|1064058|P1|NOT COMPLETED|Overall Study||5
433450|NCT01440049|1064058|P1|COMPLETED|Overall Study||155
433451|NCT01440049|1064058|P1|STARTED|Overall Study||160
433452|NCT01439971|1064090|P5|NOT COMPLETED|Overall Study||1
433453|NCT01439971|1064091|P4|NOT COMPLETED|Overall Study||0
433454|NCT01439971|1064092|P3|NOT COMPLETED|Overall Study||2
433455|NCT01439971|1064093|P2|NOT COMPLETED|Overall Study||1
433456|NCT01439971|1064094|P1|NOT COMPLETED|Overall Study||0
433457|NCT01439971|1064090|P5|COMPLETED|Overall Study||6
433458|NCT01439971|1064091|P4|COMPLETED|Overall Study||6
433459|NCT01439971|1064092|P3|COMPLETED|Overall Study||6
433460|NCT01439971|1064093|P2|COMPLETED|Overall Study||6
433461|NCT01439971|1064094|P1|COMPLETED|Overall Study||1
433462|NCT01439971|1064090|P5|Received Treatment|Overall Study||6
433463|NCT01439971|1064091|P4|Received Treatment|Overall Study||6
433464|NCT01439971|1064092|P3|Received Treatment|Overall Study||6
433465|NCT01439971|1064093|P2|Received Treatment|Overall Study||6
433466|NCT01439971|1064094|P1|Received Treatment|Overall Study||1
433467|NCT01439971|1064090|P5|STARTED|Overall Study||7
433468|NCT01439971|1064091|P4|STARTED|Overall Study||6
433469|NCT01439971|1064092|P3|STARTED|Overall Study||8
433470|NCT01439971|1064093|P2|STARTED|Overall Study||7
433471|NCT01439971|1064094|P1|STARTED|Overall Study||1
433472|NCT01439945|1064274|P4|NOT COMPLETED|Optional Continuation Phase||0
433473|NCT01439945|1064275|P3|NOT COMPLETED|Optional Continuation Phase||0
433474|NCT01439945|1064276|P2|NOT COMPLETED|Optional Continuation Phase||0
433475|NCT01439945|1064277|P1|NOT COMPLETED|Optional Continuation Phase||0
433476|NCT01439945|1064274|P4|COMPLETED|Optional Continuation Phase||0
433477|NCT01439945|1064275|P3|COMPLETED|Optional Continuation Phase||0
433478|NCT01439945|1064276|P2|COMPLETED|Optional Continuation Phase||44
433479|NCT01439945|1064277|P1|COMPLETED|Optional Continuation Phase||72
433480|NCT01439945|1064274|P4|STARTED|Optional Continuation Phase||0
433481|NCT01439945|1064275|P3|STARTED|Optional Continuation Phase||0
433482|NCT01439945|1064276|P2|STARTED|Optional Continuation Phase||44
433483|NCT01439945|1064277|P1|STARTED|Optional Continuation Phase||72
433484|NCT01439945|1064274|P4|NOT COMPLETED|Double-Blind Treatment Phase||2
433485|NCT01439945|1064275|P3|NOT COMPLETED|Double-Blind Treatment Phase||3
433486|NCT01439945|1064276|P2|NOT COMPLETED|Double-Blind Treatment Phase||5
433487|NCT01439945|1064277|P1|NOT COMPLETED|Double-Blind Treatment Phase||4
433488|NCT01439945|1064274|P4|COMPLETED|Double-Blind Treatment Phase||46
433489|NCT01439945|1064275|P3|COMPLETED|Double-Blind Treatment Phase||45
433490|NCT01439945|1064276|P2|COMPLETED|Double-Blind Treatment Phase||91
433491|NCT01439945|1064277|P1|COMPLETED|Double-Blind Treatment Phase||93
433492|NCT01439945|1064274|P4|STARTED|Double-Blind Treatment Phase||48
433493|NCT01439945|1064275|P3|STARTED|Double-Blind Treatment Phase||48
433494|NCT01439945|1064276|P2|STARTED|Double-Blind Treatment Phase||96
433495|NCT01439945|1064277|P1|STARTED|Double-Blind Treatment Phase||97
433496|NCT01439867|1064302|P2|NOT COMPLETED|Overall Study||8
433497|NCT01439867|1064303|P1|NOT COMPLETED|Overall Study||6
433498|NCT01439867|1064302|P2|COMPLETED|Overall Study||2
433499|NCT01439867|1064303|P1|COMPLETED|Overall Study||2
433500|NCT01439867|1064302|P2|Received Treatment|Overall Study||10
433501|NCT01439867|1064303|P1|Received Treatment|Overall Study||7
433502|NCT01439867|1064302|P2|STARTED|Overall Study||10
433503|NCT01439867|1064303|P1|STARTED|Overall Study||8
433504|NCT01439724|1064344|P2|NOT COMPLETED|Overall Study||8
433505|NCT01439724|1064345|P1|NOT COMPLETED|Overall Study||9
433506|NCT01439724|1064344|P2|COMPLETED|Overall Study||39
433507|NCT01439724|1064345|P1|COMPLETED|Overall Study||38
433508|NCT01439724|1064344|P2|STARTED|Overall Study||47
433509|NCT01439724|1064345|P1|STARTED|Overall Study||47
433510|NCT01439711|1064351|P1|NOT COMPLETED|Overall Study||40
433511|NCT01439711|1064351|P1|COMPLETED|Overall Study||68
433512|NCT01439711|1064351|P1|STARTED|Overall Study||108
433513|NCT01439672|1064362|P1|NOT COMPLETED|Overall Study||24
433514|NCT01439672|1064362|P1|COMPLETED|Overall Study||11
433515|NCT01439672|1064362|P1|STARTED|Overall Study||35
433516|NCT01439373|1064368|P2|NOT COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||0
433517|NCT01439373|1064369|P1|NOT COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||2
433518|NCT01439373|1064368|P2|COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||4
433519|NCT01439373|1064369|P1|COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||9
433520|NCT01439373|1064368|P2|STARTED|Combined With PEG and RIBA (Day 2 to 28)||4
433521|NCT01439373|1064369|P1|STARTED|Combined With PEG and RIBA (Day 2 to 28)||11
433522|NCT01439373|1064368|P2|NOT COMPLETED|Monotherapy (Day 1)||1
433523|NCT01439373|1064369|P1|NOT COMPLETED|Monotherapy (Day 1)||0
433524|NCT01439373|1064368|P2|COMPLETED|Monotherapy (Day 1)||4
433525|NCT01439373|1064369|P1|COMPLETED|Monotherapy (Day 1)||11
433526|NCT01439373|1064368|P2|STARTED|Monotherapy (Day 1)||5
433527|NCT01439373|1064369|P1|STARTED|Monotherapy (Day 1)||11
433528|NCT01439360|1064412|P2|NOT COMPLETED|Overall Study||208
433529|NCT01439360|1064413|P1|NOT COMPLETED|Overall Study||198
433530|NCT01439360|1064412|P2|COMPLETED|Overall Study||5804
433531|NCT01439360|1064413|P1|COMPLETED|Overall Study||5808
433532|NCT01439360|1064412|P2|STARTED|Overall Study||6012
433533|NCT01439360|1064413|P1|STARTED|Overall Study||6006
433534|NCT01439282|1064463|P2|NOT COMPLETED|Overall Study||1
433535|NCT01439282|1064464|P1|NOT COMPLETED|Overall Study||8
433536|NCT01439282|1064463|P2|COMPLETED|Overall Study||9
433537|NCT01439282|1064464|P1|COMPLETED|Overall Study||59
433538|NCT01439282|1064463|P2|STARTED|Overall Study||10
433539|NCT01439282|1064464|P1|STARTED|Overall Study||67
433540|NCT01439204|1064474|P2|NOT COMPLETED|Overall Study||3
433541|NCT01439204|1064475|P1|NOT COMPLETED|Overall Study||4
433542|NCT01439204|1064474|P2|COMPLETED|Overall Study||33
433543|NCT01439204|1064475|P1|COMPLETED|Overall Study||32
433544|NCT01439204|1064474|P2|STARTED|Overall Study||36
433545|NCT01439204|1064475|P1|STARTED|Overall Study||36
433546|NCT01439165|1064509|P2|NOT COMPLETED|Overall Study||2
433547|NCT01439165|1064510|P1|NOT COMPLETED|Overall Study||21
433548|NCT01439165|1064509|P2|COMPLETED|Overall Study||326
433549|NCT01439165|1064510|P1|COMPLETED|Overall Study||981
433550|NCT01439165|1064509|P2|STARTED|Overall Study||328
433551|NCT01439165|1064510|P1|STARTED|Overall Study||1002
433552|NCT01439126|1064524|P2|NOT COMPLETED|Overall Study||42
433553|NCT01439126|1064525|P1|NOT COMPLETED|Overall Study||31
433554|NCT01439126|1064524|P2|COMPLETED|Overall Study||25
433555|NCT01439126|1064525|P1|COMPLETED|Overall Study||37
433556|NCT01439126|1064524|P2|STARTED|Overall Study||67
433557|NCT01439126|1064525|P1|STARTED|Overall Study||68
433558|NCT01439074|1064547|P2|NOT COMPLETED|Overall Study||13
433559|NCT01439074|1064548|P1|NOT COMPLETED|Overall Study||9
433560|NCT01439074|1064547|P2|COMPLETED|Overall Study||74
433561|NCT01439074|1064548|P1|COMPLETED|Overall Study||66
433562|NCT01439074|1064547|P2|STARTED|Overall Study||87
433563|NCT01439074|1064548|P1|STARTED|Overall Study||75
433564|NCT01438996|1064563|P3|NOT COMPLETED|Overall Study||0
433565|NCT01438996|1064564|P2|NOT COMPLETED|Overall Study||1
433566|NCT01438996|1064565|P1|NOT COMPLETED|Overall Study||4
433567|NCT01438996|1064563|P3|COMPLETED|Overall Study||20
433568|NCT01438996|1064564|P2|COMPLETED|Overall Study||12
433569|NCT01438996|1064565|P1|COMPLETED|Overall Study||14
433570|NCT01438996|1064563|P3|STARTED|Overall Study||20
433571|NCT01438996|1064564|P2|STARTED|Overall Study||13
433572|NCT01438996|1064565|P1|STARTED|Overall Study||18
433573|NCT01438840|1064599|P3|NOT COMPLETED|Extension Phase||10
433574|NCT01438840|1064600|P2|NOT COMPLETED|Extension Phase||0
433575|NCT01438840|1064601|P1|NOT COMPLETED|Extension Phase||0
433576|NCT01438840|1064599|P3|COMPLETED|Extension Phase||29
433577|NCT01438840|1064600|P2|COMPLETED|Extension Phase||0
433578|NCT01438840|1064601|P1|COMPLETED|Extension Phase||0
433579|NCT01438840|1064599|P3|STARTED|Extension Phase|39 participants met eligibility criteria for the Extension Phase.|39
433580|NCT01438840|1064600|P2|STARTED|Extension Phase||0
433581|NCT01438840|1064601|P1|STARTED|Extension Phase||0
433582|NCT01438840|1064599|P3|NOT COMPLETED|Core Study||0
433583|NCT01438840|1064600|P2|NOT COMPLETED|Core Study||10
433584|NCT01438840|1064601|P1|NOT COMPLETED|Core Study||16
433585|NCT01438840|1064599|P3|COMPLETED|Core Study||0
433586|NCT01438840|1064600|P2|COMPLETED|Core Study||22
433587|NCT01438840|1064601|P1|COMPLETED|Core Study||1
433588|NCT01438840|1064599|P3|STARTED|Core Study||0
433589|NCT01438840|1064600|P2|STARTED|Core Study||32
433590|NCT01438840|1064601|P1|STARTED|Core Study||17
433591|NCT01438814|1064614|P2|NOT COMPLETED|Overall Study||14
433592|NCT01438814|1064615|P1|NOT COMPLETED|Overall Study||14
433593|NCT01438814|1064614|P2|COMPLETED|Overall Study||331
433594|NCT01438814|1064615|P1|COMPLETED|Overall Study||330
433595|NCT01438814|1064614|P2|STARTED|Overall Study||345
433596|NCT01438814|1064615|P1|STARTED|Overall Study||344
433597|NCT01438710|1064645|P2|NOT COMPLETED|Second Week of Treatment||0
433598|NCT01438710|1064646|P1|NOT COMPLETED|Second Week of Treatment||1
433599|NCT01438710|1064645|P2|COMPLETED|Second Week of Treatment|Patients are only treated with LCP-Tacro during the second week.|0
433600|NCT01438710|1064646|P1|COMPLETED|Second Week of Treatment||40
433601|NCT01438710|1064645|P2|STARTED|Second Week of Treatment|Patients are only treated with LCP-Tacro during the second week.|0
433602|NCT01438710|1064646|P1|STARTED|Second Week of Treatment|Patients completing the first week will continue on LCP-Tacro treatment during the second week.|41
433603|NCT01438710|1064645|P2|NOT COMPLETED|First Week of Treatment||3
433604|NCT01438710|1064646|P1|NOT COMPLETED|First Week of Treatment||0
433605|NCT01438710|1064645|P2|COMPLETED|First Week of Treatment||41
433606|NCT01438710|1064646|P1|COMPLETED|First Week of Treatment|Patients are only treated with Prograf/generic Tacrolimus during the first week.|0
433607|NCT01438710|1064645|P2|STARTED|First Week of Treatment||44
433608|NCT01438710|1064646|P1|STARTED|First Week of Treatment|Patients are only treated with Prograf/generic Tacrolimus during the first week.|0
433609|NCT01438541|1064651|P1|NOT COMPLETED|Overall Study||7
433610|NCT01438541|1064651|P1|COMPLETED|Overall Study||22
433611|NCT01438541|1064651|P1|STARTED|Overall Study||29
433612|NCT01438489|1064660|P3|NOT COMPLETED|Overall Study||19
433613|NCT01438489|1064661|P2|NOT COMPLETED|Overall Study||16
433614|NCT01438489|1064662|P1|NOT COMPLETED|Overall Study||26
433615|NCT01438489|1064660|P3|COMPLETED|Overall Study||85
433616|NCT01438489|1064661|P2|COMPLETED|Overall Study||84
433617|NCT01438489|1064662|P1|COMPLETED|Overall Study||77
433618|NCT01438489|1064660|P3|STARTED|Overall Study||104
433619|NCT01438489|1064661|P2|STARTED|Overall Study||100
433620|NCT01438489|1064662|P1|STARTED|Overall Study||103
433621|NCT01438424|1064705|P1|NOT COMPLETED|Overall Study||417
433622|NCT01438424|1064705|P1|COMPLETED|Overall Study|Completed treatment|634
433623|NCT01438424|1064705|P1|STARTED|Overall Study|Received treatment|1051
433624|NCT01438307|1064743|P2|NOT COMPLETED|Overall Study||1
433625|NCT01438307|1064744|P1|NOT COMPLETED|Overall Study||1
433626|NCT01438307|1064743|P2|COMPLETED|Overall Study||13
433627|NCT01438307|1064744|P1|COMPLETED|Overall Study||13
433628|NCT01438307|1064743|P2|STARTED|Overall Study||14
433629|NCT01438307|1064744|P1|STARTED|Overall Study||14
433630|NCT01438294|1064758|P2|NOT COMPLETED|Overall Study||7
433631|NCT01438294|1064759|P1|NOT COMPLETED|Overall Study||3
433632|NCT01438294|1064758|P2|COMPLETED|Overall Study||13
433633|NCT01438294|1064759|P1|COMPLETED|Overall Study||13
433634|NCT01438294|1064758|P2|STARTED|Overall Study||20
433635|NCT01438294|1064759|P1|STARTED|Overall Study||16
433636|NCT01438229|1064769|P1|NOT COMPLETED|Overall Study||3
433637|NCT01438229|1064769|P1|COMPLETED|Overall Study||44
433638|NCT01438229|1064769|P1|Underwent Procedure|Overall Study||46
433639|NCT01438229|1064769|P1|Excluded Due to Renal Artery Anatomy|Overall Study||1
433640|NCT01438229|1064769|P1|STARTED|Overall Study||47
433641|NCT01438177|1064802|P1|NOT COMPLETED|Overall Study||2
433642|NCT01438177|1064802|P1|COMPLETED|Overall Study|Patients who were off due to disease progression|9
433643|NCT01438177|1064802|P1|STARTED|Overall Study||11
433644|NCT01438151|1064808|P1|NOT COMPLETED|Overall Study||8
433645|NCT01438151|1064808|P1|COMPLETED|Overall Study||3
433646|NCT01438151|1064808|P1|STARTED|Overall Study||11
433647|NCT01438060|1064814|P2|NOT COMPLETED|On Study Beyond Week 140||8
433648|NCT01438060|1064815|P1|NOT COMPLETED|On Study Beyond Week 140||0
433649|NCT01438060|1064814|P2|COMPLETED|On Study Beyond Week 140||1
433650|NCT01438060|1064815|P1|COMPLETED|On Study Beyond Week 140||0
433651|NCT01438060|1064814|P2|STARTED|On Study Beyond Week 140|9 participants in France who showed improvement at Week 140 continued treatment beyond 140 weeks|9
433652|NCT01438060|1064815|P1|STARTED|On Study Beyond Week 140||0
433653|NCT01438060|1064814|P2|NOT COMPLETED|Extension Phase: Week 10 to Week 130||56
433654|NCT01438060|1064815|P1|NOT COMPLETED|Extension Phase: Week 10 to Week 130||58
433655|NCT01438060|1064814|P2|COMPLETED|Extension Phase: Week 10 to Week 130||25
433656|NCT01438060|1064815|P1|COMPLETED|Extension Phase: Week 10 to Week 130||22
433657|NCT01438060|1064814|P2|STARTED|Extension Phase: Week 10 to Week 130|Of the 88 participants, who completed Acute Phase, 81 opted to enter 130-week extension phase|81
433658|NCT01438060|1064815|P1|STARTED|Extension Phase: Week 10 to Week 130|80 out of the 84 participants entered extension phase. All were treated with open-label aripiprazole|80
433659|NCT01438060|1064814|P2|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18
433660|NCT01438060|1064815|P1|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18
433661|NCT01438060|1064814|P2|COMPLETED|Acute Phase: Double-blind, 10 Weeks||88
433662|NCT01438060|1064815|P1|COMPLETED|Acute Phase: Double-blind, 10 Weeks||84
433663|NCT01438060|1064814|P2|STARTED|Acute Phase: Double-blind, 10 Weeks||106
433664|NCT01438060|1064815|P1|STARTED|Acute Phase: Double-blind, 10 Weeks||102
433665|NCT01437995|1064896|P3|NOT COMPLETED|Overall Study||20
433666|NCT01437995|1064897|P2|NOT COMPLETED|Overall Study||18
433667|NCT01437995|1064898|P1|NOT COMPLETED|Overall Study||11
433668|NCT01437995|1064896|P3|COMPLETED|Overall Study||135
433669|NCT01437995|1064897|P2|COMPLETED|Overall Study||131
433670|NCT01437995|1064898|P1|COMPLETED|Overall Study||140
433671|NCT01437995|1064896|P3|Included in Treatment Failure Analysis|Overall Study||151
433672|NCT01437995|1064897|P2|Included in Treatment Failure Analysis|Overall Study||146
433673|NCT01437995|1064898|P1|Included in Treatment Failure Analysis|Overall Study||150
433674|NCT01437995|1064896|P3|STARTED|Overall Study||155
433675|NCT01437995|1064897|P2|STARTED|Overall Study||149
433676|NCT01437995|1064898|P1|STARTED|Overall Study||151
433677|NCT01437943|1064920|P2|NOT COMPLETED|Overall Study||2
433678|NCT01437943|1064921|P1|NOT COMPLETED|Overall Study||7
433679|NCT01437943|1064920|P2|COMPLETED|Overall Study||1
433680|NCT01437943|1064921|P1|COMPLETED|Overall Study||0
433681|NCT01437943|1064920|P2|STARTED|Overall Study||3
433682|NCT01437943|1064921|P1|STARTED|Overall Study||7
433683|NCT01437878|1064929|P2|NOT COMPLETED|Overall Study||0
433684|NCT01437878|1064930|P1|NOT COMPLETED|Overall Study||1
433685|NCT01437878|1064929|P2|COMPLETED|Overall Study||1
433686|NCT01437878|1064930|P1|COMPLETED|Overall Study||0
433687|NCT01437878|1064929|P2|STARTED|Overall Study||1
433688|NCT01437878|1064930|P1|STARTED|Overall Study|Patient discontinued the study prior to initiation of study treatment|1
433689|NCT01437540|1064972|P2|NOT COMPLETED|Overall Study||65
433690|NCT01437540|1064973|P1|NOT COMPLETED|Overall Study||127
433691|NCT01437540|1064972|P2|COMPLETED|Overall Study||133
433692|NCT01437540|1064973|P1|COMPLETED|Overall Study||265
433693|NCT01437540|1064972|P2|STARTED|Overall Study||198
433694|NCT01437540|1064973|P1|STARTED|Overall Study||392
433695|NCT01437501|1064987|P2|NOT COMPLETED|Overall Study||11
433696|NCT01437501|1064988|P1|NOT COMPLETED|Overall Study||13
433697|NCT01437501|1064987|P2|COMPLETED|Overall Study||132
433698|NCT01437501|1064988|P1|COMPLETED|Overall Study||135
433699|NCT01437501|1064987|P2|STARTED|Overall Study||143
433700|NCT01437501|1064988|P1|STARTED|Overall Study||148
433701|NCT01437488|1064996|P1|NOT COMPLETED|Overall Study||0
433702|NCT01437488|1064996|P1|COMPLETED|Overall Study||14
433703|NCT01437488|1064996|P1|STARTED|Overall Study||14
433704|NCT01437423|1065003|P1|NOT COMPLETED|Overall Study||15
433705|NCT01437423|1065003|P1|COMPLETED|Overall Study||647
433706|NCT01437423|1065003|P1|STARTED|Overall Study||662
433707|NCT01437397|1065015|P5|NOT COMPLETED|Overall Study||101
433708|NCT01437397|1065016|P4|NOT COMPLETED|Overall Study||69
433709|NCT01437397|1065017|P3|NOT COMPLETED|Overall Study||72
433710|NCT01437397|1065018|P2|NOT COMPLETED|Overall Study||62
433711|NCT01437397|1065019|P1|NOT COMPLETED|Overall Study||66
433712|NCT01437397|1065015|P5|COMPLETED|Overall Study||236
433713|NCT01437397|1065016|P4|COMPLETED|Overall Study||270
433714|NCT01437397|1065017|P3|COMPLETED|Overall Study||268
433715|NCT01437397|1065018|P2|COMPLETED|Overall Study||276
433716|NCT01437397|1065019|P1|COMPLETED|Overall Study||272
433717|NCT01437397|1065015|P5|STARTED|Overall Study||337
433718|NCT01437397|1065016|P4|STARTED|Overall Study||339
433719|NCT01437397|1065017|P3|STARTED|Overall Study||340
433720|NCT01437397|1065018|P2|STARTED|Overall Study||338
433721|NCT01437397|1065019|P1|STARTED|Overall Study||338
433722|NCT01437319|1065046|P3|NOT COMPLETED|Phase II||37
433723|NCT01437319|1065047|P2|NOT COMPLETED|Phase II||44
433724|NCT01437319|1065048|P1|NOT COMPLETED|Phase II||0
433725|NCT01437319|1065046|P3|COMPLETED|Phase II||75
433726|NCT01437319|1065047|P2|COMPLETED|Phase II||71
433727|NCT01437319|1065048|P1|COMPLETED|Phase II||0
433728|NCT01437319|1065046|P3|STARTED|Phase II||112
433729|NCT01437319|1065047|P2|STARTED|Phase II||115
433730|NCT01437319|1065048|P1|STARTED|Phase II||0
433731|NCT01437319|1065046|P3|NOT COMPLETED|Phase I||0
433732|NCT01437319|1065047|P2|NOT COMPLETED|Phase I||0
433733|NCT01437319|1065048|P1|NOT COMPLETED|Phase I||55
433734|NCT01437319|1065046|P3|COMPLETED|Phase I||0
433735|NCT01437319|1065047|P2|COMPLETED|Phase I||0
433736|NCT01437319|1065048|P1|COMPLETED|Phase I||227
433737|NCT01437319|1065046|P3|STARTED|Phase I||0
433738|NCT01437319|1065047|P2|STARTED|Phase I||0
433739|NCT01437319|1065048|P1|STARTED|Phase I||282
433740|NCT01437267|1065063|P6|NOT COMPLETED|Overall Study||0
433741|NCT01437267|1065064|P5|NOT COMPLETED|Overall Study||0
433742|NCT01437267|1065065|P4|NOT COMPLETED|Overall Study||1
433743|NCT01437267|1065066|P3|NOT COMPLETED|Overall Study||0
433744|NCT01437267|1065067|P2|NOT COMPLETED|Overall Study||1
433745|NCT01437267|1065068|P1|NOT COMPLETED|Overall Study||0
433746|NCT01437267|1065063|P6|COMPLETED|Overall Study||20
433747|NCT01437267|1065064|P5|COMPLETED|Overall Study||20
433748|NCT01437267|1065065|P4|COMPLETED|Overall Study||19
433749|NCT01437267|1065066|P3|COMPLETED|Overall Study||20
433750|NCT01437267|1065067|P2|COMPLETED|Overall Study||19
433751|NCT01437267|1065068|P1|COMPLETED|Overall Study||20
433752|NCT01437267|1065063|P6|STARTED|Overall Study||20
433753|NCT01437267|1065064|P5|STARTED|Overall Study||20
433754|NCT01437267|1065065|P4|STARTED|Overall Study||20
433755|NCT01437267|1065066|P3|STARTED|Overall Study||20
433756|NCT01437267|1065067|P2|STARTED|Overall Study||20
433757|NCT01437267|1065068|P1|STARTED|Overall Study||20
433758|NCT01437124|1065106|P1|NOT COMPLETED|Overall Study||0
433759|NCT01437124|1065106|P1|COMPLETED|Overall Study||83
433760|NCT01437124|1065106|P1|STARTED|Overall Study||83
433761|NCT01437111|1065111|P1|NOT COMPLETED|Overall Study||18
433762|NCT01437111|1065111|P1|COMPLETED|Overall Study||182
433763|NCT01437111|1065111|P1|Treated Participants|Overall Study||198
433764|NCT01437111|1065111|P1|STARTED|Overall Study||200
433765|NCT01437098|1065122|P1|NOT COMPLETED|Overall Study||13
433766|NCT01437098|1065122|P1|COMPLETED|Overall Study||42
433767|NCT01437098|1065122|P1|36 Months|Overall Study||36
433768|NCT01437098|1065122|P1|24 Months|Overall Study||42
433769|NCT01437098|1065122|P1|12 Months|Overall Study||45
433770|NCT01437098|1065122|P1|6 Months|Overall Study||47
433771|NCT01437098|1065122|P1|30 Days|Overall Study||51
433772|NCT01437098|1065122|P1|STARTED|Overall Study||55
433773|NCT01436799|1065179|P2|NOT COMPLETED|Overall Study||0
433774|NCT01436799|1065180|P1|NOT COMPLETED|Overall Study||0
433775|NCT01436799|1065179|P2|COMPLETED|Overall Study||20
433776|NCT01436799|1065180|P1|COMPLETED|Overall Study||20
433777|NCT01436799|1065179|P2|STARTED|Overall Study||20
433778|NCT01436799|1065180|P1|STARTED|Overall Study||20
433779|NCT01436643|1065189|P4|NOT COMPLETED|Core Phase (16 Weeks)||0
433780|NCT01436643|1065190|P3|NOT COMPLETED|Core Phase (16 Weeks)||3
433781|NCT01436643|1065191|P2|NOT COMPLETED|Core Phase (16 Weeks)||4
433782|NCT01436643|1065192|P1|NOT COMPLETED|Core Phase (16 Weeks)||1
433783|NCT01436643|1065189|P4|COMPLETED|Core Phase (16 Weeks)||0
433784|NCT01436643|1065190|P3|COMPLETED|Core Phase (16 Weeks)||17
433785|NCT01436643|1065191|P2|COMPLETED|Core Phase (16 Weeks)||11
433786|NCT01436643|1065192|P1|COMPLETED|Core Phase (16 Weeks)||16
433787|NCT01436643|1065189|P4|STARTED|Core Phase (16 Weeks)||0
433788|NCT01436643|1065190|P3|STARTED|Core Phase (16 Weeks)||20
433789|NCT01436643|1065191|P2|STARTED|Core Phase (16 Weeks)||15
433790|NCT01436643|1065192|P1|STARTED|Core Phase (16 Weeks)||17
433791|NCT01436643|1065189|P4|NOT COMPLETED|2-week Pre-treatment||10
433792|NCT01436643|1065190|P3|NOT COMPLETED|2-week Pre-treatment||0
433793|NCT01436643|1065191|P2|NOT COMPLETED|2-week Pre-treatment||0
433794|NCT01436643|1065192|P1|NOT COMPLETED|2-week Pre-treatment||0
433795|NCT01436643|1065189|P4|COMPLETED|2-week Pre-treatment||44
433796|NCT01436643|1065190|P3|COMPLETED|2-week Pre-treatment||0
433797|NCT01436643|1065191|P2|COMPLETED|2-week Pre-treatment||0
433798|NCT01436643|1065192|P1|COMPLETED|2-week Pre-treatment||0
433799|NCT01436643|1065189|P4|STARTED|2-week Pre-treatment||54
433800|NCT01436643|1065190|P3|STARTED|2-week Pre-treatment||0
433801|NCT01436643|1065191|P2|STARTED|2-week Pre-treatment||0
433802|NCT01436643|1065192|P1|STARTED|2-week Pre-treatment||0
433803|NCT01436526|1065204|P2|NOT COMPLETED|Period 2||0
433804|NCT01436526|1065205|P1|NOT COMPLETED|Period 2||0
433805|NCT01436526|1065204|P2|COMPLETED|Period 2||13
433806|NCT01436526|1065205|P1|COMPLETED|Period 2||13
433807|NCT01436526|1065204|P2|Participants Received Treatment|Period 2||13
433808|NCT01436526|1065205|P1|Participants Received Treatment|Period 2||13
433809|NCT01436526|1065204|P2|STARTED|Period 2|1 participant withdrew his consent after completing the first period.|13
433810|NCT01436526|1065205|P1|STARTED|Period 2|1 participant withdrew his consent after completing the first period.|13
433811|NCT01436526|1065204|P2|NOT COMPLETED|Period 1||0
433812|NCT01436526|1065205|P1|NOT COMPLETED|Period 1||0
433813|NCT01436526|1065204|P2|COMPLETED|Period 1||14
433814|NCT01436526|1065205|P1|COMPLETED|Period 1||14
433815|NCT01436526|1065204|P2|Participants Received Treatment|Period 1||14
433816|NCT01436526|1065205|P1|Participants Received Treatment|Period 1||14
433817|NCT01436526|1065204|P2|STARTED|Period 1||14
433818|NCT01436526|1065205|P1|STARTED|Period 1||14
433819|NCT01436500|1065227|P5|NOT COMPLETED|Overall Study||4
433820|NCT01436500|1065228|P4|NOT COMPLETED|Overall Study||1
433821|NCT01436500|1065229|P3|NOT COMPLETED|Overall Study||5
433822|NCT01436500|1065230|P2|NOT COMPLETED|Overall Study||3
433823|NCT01436500|1065231|P1|NOT COMPLETED|Overall Study||3
433824|NCT01436500|1065227|P5|COMPLETED|Overall Study||9
433825|NCT01436500|1065228|P4|COMPLETED|Overall Study||5
433826|NCT01436500|1065229|P3|COMPLETED|Overall Study||7
433827|NCT01436500|1065230|P2|COMPLETED|Overall Study||9
433828|NCT01436500|1065231|P1|COMPLETED|Overall Study||9
433829|NCT01436500|1065227|P5|STARTED|Overall Study||13
433830|NCT01436500|1065228|P4|STARTED|Overall Study||6
433831|NCT01436500|1065229|P3|STARTED|Overall Study||12
433832|NCT01436500|1065230|P2|STARTED|Overall Study||12
433833|NCT01436500|1065231|P1|STARTED|Overall Study||12
433834|NCT01436435|1065264|P1|NOT COMPLETED|Overall Study||64
433835|NCT01436435|1065264|P1|COMPLETED|Overall Study||177
433836|NCT01436435|1065264|P1|STARTED|Overall Study||241
433837|NCT01436370|1065281|P8|NOT COMPLETED|Overall Study||0
433838|NCT01436370|1065282|P7|NOT COMPLETED|Overall Study||0
433839|NCT01436370|1065283|P6|NOT COMPLETED|Overall Study||0
433840|NCT01436370|1065284|P5|NOT COMPLETED|Overall Study||1
433841|NCT01436370|1065285|P4|NOT COMPLETED|Overall Study||0
433842|NCT01436370|1065286|P3|NOT COMPLETED|Overall Study||0
433843|NCT01436370|1065287|P2|NOT COMPLETED|Overall Study||0
433844|NCT01436370|1065288|P1|NOT COMPLETED|Overall Study||0
433845|NCT01436370|1065281|P8|COMPLETED|Overall Study||16
433846|NCT01436370|1065282|P7|COMPLETED|Overall Study||16
433847|NCT01436370|1065283|P6|COMPLETED|Overall Study||19
433848|NCT01436370|1065284|P5|COMPLETED|Overall Study||18
433849|NCT01436370|1065285|P4|COMPLETED|Overall Study||10
433850|NCT01436370|1065286|P3|COMPLETED|Overall Study||10
433851|NCT01436370|1065287|P2|COMPLETED|Overall Study||6
433852|NCT01436370|1065288|P1|COMPLETED|Overall Study||6
433853|NCT01436370|1065281|P8|STARTED|Overall Study||16
433854|NCT01436370|1065282|P7|STARTED|Overall Study||16
433855|NCT01436370|1065283|P6|STARTED|Overall Study||19
433856|NCT01436370|1065284|P5|STARTED|Overall Study||19
433857|NCT01436370|1065285|P4|STARTED|Overall Study||10
433858|NCT01436370|1065286|P3|STARTED|Overall Study||10
433859|NCT01436370|1065287|P2|STARTED|Overall Study||6
433860|NCT01436370|1065288|P1|STARTED|Overall Study||6
433861|NCT01436305|1065369|P3|NOT COMPLETED|Overall Study||0
433862|NCT01436305|1065370|P2|NOT COMPLETED|Overall Study||4
433863|NCT01436305|1065371|P1|NOT COMPLETED|Overall Study||2
433864|NCT01436305|1065369|P3|COMPLETED|Overall Study||7
433865|NCT01436305|1065370|P2|COMPLETED|Overall Study||2
433866|NCT01436305|1065371|P1|COMPLETED|Overall Study||4
433867|NCT01436305|1065369|P3|STARTED|Overall Study||7
433868|NCT01436305|1065370|P2|STARTED|Overall Study||6
433869|NCT01436305|1065371|P1|STARTED|Overall Study||6
433870|NCT01436279|1065468|P2|NOT COMPLETED|Overall Study||0
433871|NCT01436279|1065469|P1|NOT COMPLETED|Overall Study||0
433872|NCT01436279|1065468|P2|COMPLETED|Overall Study||20
433873|NCT01436279|1065469|P1|COMPLETED|Overall Study||30
433874|NCT01436279|1065468|P2|STARTED|Overall Study||20
433875|NCT01436279|1065469|P1|STARTED|Overall Study||30
433876|NCT01436266|1065491|P2|NOT COMPLETED|Overall Study||0
433877|NCT01436266|1065492|P1|NOT COMPLETED|Overall Study||0
433878|NCT01436266|1065491|P2|COMPLETED|Overall Study||1
433879|NCT01436266|1065492|P1|COMPLETED|Overall Study||1
433880|NCT01436266|1065491|P2|STARTED|Overall Study||1
433881|NCT01436266|1065492|P1|STARTED|Overall Study||1
433882|NCT01436253|1065498|P1|NOT COMPLETED|Overall Study||299
433883|NCT01436253|1065498|P1|COMPLETED|Overall Study||1897
433884|NCT01436253|1065498|P1|STARTED|Overall Study||2196
433885|NCT01436201|1065503|P1|NOT COMPLETED|Overall Study||4
433886|NCT01436201|1065503|P1|COMPLETED|Overall Study||20
433887|NCT01436201|1065503|P1|Received at Least 1 Dose of Study Drug|Overall Study||24
433888|NCT01436201|1065503|P1|STARTED|Overall Study||24
433889|NCT01436175|1065513|P1|NOT COMPLETED|Overall Study||1270
433890|NCT01436175|1065513|P1|COMPLETED|Overall Study||300
433891|NCT01436175|1065513|P1|STARTED|Overall Study||1570
433892|NCT01436162|1065540|P3|NOT COMPLETED|Randomized Phase||25
433893|NCT01436162|1065541|P2|NOT COMPLETED|Randomized Phase||31
433894|NCT01436162|1065542|P1|NOT COMPLETED|Randomized Phase||44
433895|NCT01436162|1065540|P3|COMPLETED|Randomized Phase||189
433896|NCT01436162|1065541|P2|COMPLETED|Randomized Phase||181
433897|NCT01436162|1065542|P1|COMPLETED|Randomized Phase||353
433898|NCT01436162|1065540|P3|STARTED|Randomized Phase|One subject was randomized to this arm but did not receive at least 1 dose of double-blind treatment|214
433899|NCT01436162|1065541|P2|STARTED|Randomized Phase|One subject was randomized to this arm but did not receive at least 1 dose of double-blind treatment|212
433900|NCT01436162|1065542|P1|STARTED|Randomized Phase|These subjects were not included in the Safety Analysis Set or Full Analysis Set.|397
433901|NCT01436162|1065540|P3|NOT COMPLETED|Single-blind Lead-in Phase||0
433902|NCT01436162|1065541|P2|NOT COMPLETED|Single-blind Lead-in Phase||0
433903|NCT01436162|1065542|P1|NOT COMPLETED|Single-blind Lead-in Phase||282
433904|NCT01436162|1065540|P3|COMPLETED|Single-blind Lead-in Phase||0
433905|NCT01436162|1065541|P2|COMPLETED|Single-blind Lead-in Phase||0
433906|NCT01436162|1065542|P1|COMPLETED|Single-blind Lead-in Phase||823
433907|NCT01436162|1065540|P3|STARTED|Single-blind Lead-in Phase||0
433908|NCT01436162|1065541|P2|STARTED|Single-blind Lead-in Phase||0
433909|NCT01436162|1065542|P1|STARTED|Single-blind Lead-in Phase|Ten subjects were enrolled but not dosed.|1105
433910|NCT01436149|1065576|P3|NOT COMPLETED|Randomized Phase||42
433911|NCT01436149|1065577|P2|NOT COMPLETED|Randomized Phase||38
433912|NCT01436149|1065578|P1|NOT COMPLETED|Randomized Phase||77
433913|NCT01436149|1065576|P3|COMPLETED|Randomized Phase|1 subject completed the study without a Visit 14 MADRS and was not included in the completers set.|160
433914|NCT01436149|1065577|P2|COMPLETED|Randomized Phase||164
433915|NCT01436149|1065578|P1|COMPLETED|Randomized Phase||415
433916|NCT01436149|1065576|P3|STARTED|Randomized Phase|One subject did not receive at least 1 dose of double-blind treatment.|202
433917|NCT01436149|1065577|P2|STARTED|Randomized Phase|One subject did not receive at least 1 dose of double-blind treatment.|202
433918|NCT01436149|1065578|P1|STARTED|Randomized Phase|These subjects were not included in the Safety Analysis Set or Full Analysis Set.|492
433919|NCT01436149|1065576|P3|NOT COMPLETED|Antidepressant Lead-in Phase||0
433920|NCT01436149|1065577|P2|NOT COMPLETED|Antidepressant Lead-in Phase||0
433921|NCT01436149|1065578|P1|NOT COMPLETED|Antidepressant Lead-in Phase||366
433922|NCT01436149|1065576|P3|COMPLETED|Antidepressant Lead-in Phase||0
433923|NCT01436149|1065577|P2|COMPLETED|Antidepressant Lead-in Phase||0
433924|NCT01436149|1065578|P1|COMPLETED|Antidepressant Lead-in Phase||896
433925|NCT01436149|1065576|P3|STARTED|Antidepressant Lead-in Phase||0
433926|NCT01436149|1065577|P2|STARTED|Antidepressant Lead-in Phase||0
433927|NCT01436149|1065578|P1|STARTED|Antidepressant Lead-in Phase|Twenty-three subjects were enrolled but not dosed.|1262
433928|NCT01436110|1065609|P3|NOT COMPLETED|Overall Study||23
433929|NCT01436110|1065610|P2|NOT COMPLETED|Overall Study||26
433930|NCT01436110|1065611|P1|NOT COMPLETED|Overall Study||39
433931|NCT01436110|1065609|P3|COMPLETED|Overall Study||95
433932|NCT01436110|1065610|P2|COMPLETED|Overall Study||91
433933|NCT01436110|1065611|P1|COMPLETED|Overall Study||77
433934|NCT01436110|1065609|P3|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|115
433935|NCT01436110|1065610|P2|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|117
433936|NCT01436110|1065611|P1|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|115
433937|NCT01436110|1065609|P3|STARTED|Overall Study|These participants were randomized to trial medication.|118
433938|NCT01436110|1065610|P2|STARTED|Overall Study|These participants were randomized to trial medication.|117
433939|NCT01436110|1065611|P1|STARTED|Overall Study|These participants were randomized to trial medication.|116
433940|NCT01436084|1065634|P1|NOT COMPLETED|Overall Study||4
433941|NCT01436084|1065634|P1|COMPLETED|Overall Study||0
433942|NCT01436084|1065634|P1|STARTED|Overall Study||4
433943|NCT01436071|1065640|P2|NOT COMPLETED|Overall Study||14
433944|NCT01436071|1065641|P1|NOT COMPLETED|Overall Study||26
433945|NCT01436071|1065640|P2|COMPLETED|Overall Study||110
433946|NCT01436071|1065641|P1|COMPLETED|Overall Study||98
434124|NCT01434680|1066133|P1|STARTED|Overall Study||299
433947|NCT01436071|1065640|P2|Safety Population|Overall Study|These randomized participants received at least a single dose of trial medication.|121
433948|NCT01436071|1065641|P1|Safety Population|Overall Study|These randomized participants received at least a single dose of trial medication.|121
433949|NCT01436071|1065640|P2|STARTED|Overall Study|These participants were randomized to trial medication.|124
433950|NCT01436071|1065641|P1|STARTED|Overall Study|These participants were randomized to trial medication.|124
433951|NCT01436045|1065657|P2|NOT COMPLETED|Overall Study||0
433952|NCT01436045|1065658|P1|NOT COMPLETED|Overall Study||0
433953|NCT01436045|1065657|P2|COMPLETED|Overall Study||6
433954|NCT01436045|1065658|P1|COMPLETED|Overall Study||6
433955|NCT01436045|1065657|P2|STARTED|Overall Study||6
433956|NCT01436045|1065658|P1|STARTED|Overall Study||6
433957|NCT01436006|1065669|P1|NOT COMPLETED|Overall Study||37
433958|NCT01436006|1065669|P1|COMPLETED|Overall Study||6663
433959|NCT01436006|1065669|P1|STARTED|Overall Study||6700
433960|NCT01435928|1065683|P3|NOT COMPLETED|Double Blind Phase - 28 Weeks||121
433961|NCT01435928|1065684|P2|NOT COMPLETED|Double Blind Phase - 28 Weeks||116
433962|NCT01435928|1065685|P1|NOT COMPLETED|Double Blind Phase - 28 Weeks||0
433963|NCT01435928|1065683|P3|COMPLETED|Double Blind Phase - 28 Weeks||20
433964|NCT01435928|1065684|P2|COMPLETED|Double Blind Phase - 28 Weeks||28
433965|NCT01435928|1065685|P1|COMPLETED|Double Blind Phase - 28 Weeks||0
433966|NCT01435928|1065683|P3|STARTED|Double Blind Phase - 28 Weeks||141
433967|NCT01435928|1065684|P2|STARTED|Double Blind Phase - 28 Weeks||144
433968|NCT01435928|1065685|P1|STARTED|Double Blind Phase - 28 Weeks||0
433969|NCT01435928|1065683|P3|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0
433970|NCT01435928|1065684|P2|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0
433971|NCT01435928|1065685|P1|NOT COMPLETED|Open Label Phase - up to 24 Weeks||389
433972|NCT01435928|1065683|P3|COMPLETED|Open Label Phase - up to 24 Weeks||0
433973|NCT01435928|1065684|P2|COMPLETED|Open Label Phase - up to 24 Weeks||0
433974|NCT01435928|1065685|P1|COMPLETED|Open Label Phase - up to 24 Weeks||287
433975|NCT01435928|1065683|P3|STARTED|Open Label Phase - up to 24 Weeks||0
433976|NCT01435928|1065684|P2|STARTED|Open Label Phase - up to 24 Weeks||0
433977|NCT01435928|1065685|P1|STARTED|Open Label Phase - up to 24 Weeks||676
433978|NCT01435798|1065712|P1|NOT COMPLETED|Overall Study||1
433979|NCT01435798|1065712|P1|COMPLETED|Overall Study|Crossover design|25
433980|NCT01435798|1065712|P1|100% MTD|Overall Study||25
433981|NCT01435798|1065712|P1|50% MTD|Overall Study||25
433982|NCT01435798|1065712|P1|25% MTD|Overall Study||26
433983|NCT01435798|1065712|P1|0% MTD|Overall Study||25
433984|NCT01435798|1065712|P1|STARTED|Overall Study|Crossover design|26
433985|NCT01435772|1065729|P3|NOT COMPLETED|Overall Study||15
433986|NCT01435772|1065730|P2|NOT COMPLETED|Overall Study||3
433987|NCT01435772|1065731|P1|NOT COMPLETED|Overall Study||3
433988|NCT01435772|1065729|P3|COMPLETED|Overall Study||0
433989|NCT01435772|1065730|P2|COMPLETED|Overall Study||0
433990|NCT01435772|1065731|P1|COMPLETED|Overall Study||0
433991|NCT01435772|1065729|P3|STARTED|Overall Study||15
433992|NCT01435772|1065730|P2|STARTED|Overall Study||3
433993|NCT01435772|1065731|P1|STARTED|Overall Study||3
433994|NCT01435759|1065781|P6|NOT COMPLETED|Double-blind Phase||9
433995|NCT01435759|1065782|P5|NOT COMPLETED|Double-blind Phase||9
433996|NCT01435759|1065783|P4|NOT COMPLETED|Double-blind Phase||9
433997|NCT01435759|1065784|P3|NOT COMPLETED|Double-blind Phase||7
433998|NCT01435759|1065785|P2|NOT COMPLETED|Double-blind Phase||7
433999|NCT01435759|1065786|P1|NOT COMPLETED|Double-blind Phase||66
434000|NCT01435759|1065781|P6|COMPLETED|Double-blind Phase||71
434001|NCT01435759|1065782|P5|COMPLETED|Double-blind Phase||69
434002|NCT01435759|1065783|P4|COMPLETED|Double-blind Phase||69
434003|NCT01435759|1065784|P3|COMPLETED|Double-blind Phase||71
434004|NCT01435759|1065785|P2|COMPLETED|Double-blind Phase||71
434005|NCT01435759|1065786|P1|COMPLETED|Double-blind Phase||397
434006|NCT01435759|1065781|P6|STARTED|Double-blind Phase||80
434007|NCT01435759|1065782|P5|STARTED|Double-blind Phase||78
434008|NCT01435759|1065783|P4|STARTED|Double-blind Phase|Two subjects were not dosed.|78
434009|NCT01435759|1065784|P3|STARTED|Double-blind Phase|One subject was not dosed.|78
434010|NCT01435759|1065785|P2|STARTED|Double-blind Phase||78
434011|NCT01435759|1065786|P1|STARTED|Double-blind Phase|These subjects were not included in the Safety Dose Response Evaluable Set or Safety Analysis Set.|463
434012|NCT01435759|1065781|P6|NOT COMPLETED|Antidepressant Lead-in Phase||0
434013|NCT01435759|1065782|P5|NOT COMPLETED|Antidepressant Lead-in Phase||0
434014|NCT01435759|1065783|P4|NOT COMPLETED|Antidepressant Lead-in Phase||0
434015|NCT01435759|1065784|P3|NOT COMPLETED|Antidepressant Lead-in Phase||0
434016|NCT01435759|1065785|P2|NOT COMPLETED|Antidepressant Lead-in Phase||0
434017|NCT01435759|1065786|P1|NOT COMPLETED|Antidepressant Lead-in Phase||342
434018|NCT01435759|1065781|P6|COMPLETED|Antidepressant Lead-in Phase||0
434019|NCT01435759|1065782|P5|COMPLETED|Antidepressant Lead-in Phase||0
434020|NCT01435759|1065783|P4|COMPLETED|Antidepressant Lead-in Phase||0
434021|NCT01435759|1065784|P3|COMPLETED|Antidepressant Lead-in Phase||0
434022|NCT01435759|1065785|P2|COMPLETED|Antidepressant Lead-in Phase||0
434023|NCT01435759|1065786|P1|COMPLETED|Antidepressant Lead-in Phase||855
434024|NCT01435759|1065781|P6|STARTED|Antidepressant Lead-in Phase||0
434025|NCT01435759|1065782|P5|STARTED|Antidepressant Lead-in Phase||0
434026|NCT01435759|1065783|P4|STARTED|Antidepressant Lead-in Phase||0
434027|NCT01435759|1065784|P3|STARTED|Antidepressant Lead-in Phase||0
434028|NCT01435759|1065785|P2|STARTED|Antidepressant Lead-in Phase||0
434125|NCT01434654|1066150|P2|NOT COMPLETED|Overall Study||0
434029|NCT01435759|1065786|P1|STARTED|Antidepressant Lead-in Phase|Of these 1197 subjects, 19 subjects were not dosed.|1197
434030|NCT01435655|1065813|P1|NOT COMPLETED|Overall Study||3
434031|NCT01435655|1065813|P1|COMPLETED|Overall Study||7
434032|NCT01435655|1065813|P1|STARTED|Overall Study||10
434033|NCT01435616|1065827|P2|NOT COMPLETED|Overall Study||80
434034|NCT01435616|1065828|P1|NOT COMPLETED|Overall Study||171
434035|NCT01435616|1065827|P2|COMPLETED|Overall Study||455
434036|NCT01435616|1065828|P1|COMPLETED|Overall Study||832
434037|NCT01435616|1065827|P2|Received at Least 1 Dose of Study Drug|Overall Study||535
434038|NCT01435616|1065828|P1|Received at Least 1 Dose of Study Drug|Overall Study||1003
434039|NCT01435616|1065827|P2|STARTED|Overall Study||535
434040|NCT01435616|1065828|P1|STARTED|Overall Study||1003
434041|NCT01435603|1065874|P2|NOT COMPLETED|Overall Study||35
434042|NCT01435603|1065875|P1|NOT COMPLETED|Overall Study||39
434043|NCT01435603|1065874|P2|COMPLETED|Overall Study||129
434044|NCT01435603|1065875|P1|COMPLETED|Overall Study||128
434045|NCT01435603|1065874|P2|STARTED|Overall Study||164
434046|NCT01435603|1065875|P1|STARTED|Overall Study||167
434047|NCT01435577|1065883|P2|NOT COMPLETED|Overall Study||52
434048|NCT01435577|1065884|P1|NOT COMPLETED|Overall Study||17
434049|NCT01435577|1065883|P2|COMPLETED|Overall Study||13
434050|NCT01435577|1065884|P1|COMPLETED|Overall Study||47
434051|NCT01435577|1065883|P2|STARTED|Overall Study||65
434052|NCT01435577|1065884|P1|STARTED|Overall Study||64
434053|NCT01435460|1065934|P2|NOT COMPLETED|Overall Study||6
434054|NCT01435460|1065935|P1|NOT COMPLETED|Overall Study||11
434055|NCT01435460|1065934|P2|COMPLETED|Overall Study||143
434056|NCT01435460|1065935|P1|COMPLETED|Overall Study||140
434057|NCT01435460|1065934|P2|STARTED|Overall Study||149
434058|NCT01435460|1065935|P1|STARTED|Overall Study||151
434059|NCT01435304|1065949|P2|NOT COMPLETED|Overall Study||0
434060|NCT01435304|1065950|P1|NOT COMPLETED|Overall Study||0
434061|NCT01435304|1065949|P2|COMPLETED|Overall Study||50
434062|NCT01435304|1065950|P1|COMPLETED|Overall Study||50
434063|NCT01435304|1065949|P2|STARTED|Overall Study||50
434064|NCT01435304|1065950|P1|STARTED|Overall Study||50
434065|NCT01435265|1065968|P2|NOT COMPLETED|Overall Study||1
434066|NCT01435265|1065969|P1|NOT COMPLETED|Overall Study||0
434067|NCT01435265|1065968|P2|COMPLETED|Overall Study||3
434068|NCT01435265|1065969|P1|COMPLETED|Overall Study||3
434069|NCT01435265|1065968|P2|STARTED|Overall Study||4
434070|NCT01435265|1065969|P1|STARTED|Overall Study||3
434071|NCT01435174|1065979|P1|NOT COMPLETED|Overall Study||9
434072|NCT01435174|1065979|P1|COMPLETED|Overall Study||8
434073|NCT01435174|1065979|P1|STARTED|Overall Study||17
434074|NCT01435122|1065983|P1|NOT COMPLETED|Overall Study||8
434075|NCT01435122|1065983|P1|COMPLETED|Overall Study||22
434076|NCT01435122|1065983|P1|STARTED|Overall Study||30
434077|NCT01435031|1065992|P1|NOT COMPLETED|ITT at 4 Years||7
434078|NCT01435031|1065992|P1|COMPLETED|ITT at 4 Years||171
434079|NCT01435031|1065992|P1|STARTED|ITT at 4 Years||178
434080|NCT01435031|1065992|P1|NOT COMPLETED|ITT at 3 Years||11
434081|NCT01435031|1065992|P1|COMPLETED|ITT at 3 Years||178
434082|NCT01435031|1065992|P1|STARTED|ITT at 3 Years||189
434083|NCT01435031|1065992|P1|NOT COMPLETED|ITT at 2 Years||13
434084|NCT01435031|1065992|P1|COMPLETED|ITT at 2 Years||189
434085|NCT01435031|1065992|P1|STARTED|ITT at 2 Years||202
434086|NCT01435031|1065992|P1|NOT COMPLETED|ITT at 1 Year||9
434087|NCT01435031|1065992|P1|COMPLETED|ITT at 1 Year||202
434088|NCT01435031|1065992|P1|STARTED|ITT at 1 Year||211
434089|NCT01435031|1065992|P1|NOT COMPLETED|ITT at 6 Months||5
434090|NCT01435031|1065992|P1|COMPLETED|ITT at 6 Months||211
434091|NCT01435031|1065992|P1|STARTED|ITT at 6 Months||216
434092|NCT01435031|1065992|P1|NOT COMPLETED|ITT at 1 Month||6
434093|NCT01435031|1065992|P1|COMPLETED|ITT at 1 Month||216
434094|NCT01435031|1065992|P1|STARTED|ITT at 1 Month|ITT population|222
434095|NCT01434823|1066092|P2|NOT COMPLETED|Overall Study||7
434096|NCT01434823|1066093|P1|NOT COMPLETED|Overall Study||4
434097|NCT01434823|1066092|P2|COMPLETED|Overall Study||778
434098|NCT01434823|1066093|P1|COMPLETED|Overall Study||820
434099|NCT01434823|1066092|P2|STARTED|Overall Study||785
434100|NCT01434823|1066093|P1|STARTED|Overall Study||824
434101|NCT01434693|1066113|P4|NOT COMPLETED|Overall Study||1
434102|NCT01434693|1066114|P3|NOT COMPLETED|Overall Study||1
434103|NCT01434693|1066115|P2|NOT COMPLETED|Overall Study||0
434104|NCT01434693|1066116|P1|NOT COMPLETED|Overall Study||3
434105|NCT01434693|1066113|P4|COMPLETED|Overall Study||8
434106|NCT01434693|1066114|P3|COMPLETED|Overall Study||8
434107|NCT01434693|1066115|P2|COMPLETED|Overall Study||9
434108|NCT01434693|1066116|P1|COMPLETED|Overall Study||6
434109|NCT01434693|1066113|P4|STARTED|Overall Study||9
434110|NCT01434693|1066114|P3|STARTED|Overall Study||9
434111|NCT01434693|1066115|P2|STARTED|Overall Study||9
434112|NCT01434693|1066116|P1|STARTED|Overall Study||9
434113|NCT01434680|1066130|P4|NOT COMPLETED|Overall Study||0
434114|NCT01434680|1066131|P3|NOT COMPLETED|Overall Study||2
434115|NCT01434680|1066132|P2|NOT COMPLETED|Overall Study||2
434116|NCT01434680|1066133|P1|NOT COMPLETED|Overall Study||3
434117|NCT01434680|1066130|P4|COMPLETED|Overall Study||119
434118|NCT01434680|1066131|P3|COMPLETED|Overall Study||304
434119|NCT01434680|1066132|P2|COMPLETED|Overall Study||266
434120|NCT01434680|1066133|P1|COMPLETED|Overall Study||296
434121|NCT01434680|1066130|P4|STARTED|Overall Study||119
434122|NCT01434680|1066131|P3|STARTED|Overall Study||306
434123|NCT01434680|1066132|P2|STARTED|Overall Study||268
434126|NCT01434654|1066151|P1|NOT COMPLETED|Overall Study||2
434127|NCT01434654|1066150|P2|COMPLETED|Overall Study||12
434128|NCT01434654|1066151|P1|COMPLETED|Overall Study||5
434129|NCT01434654|1066150|P2|STARTED|Overall Study||12
434130|NCT01434654|1066151|P1|STARTED|Overall Study||7
434131|NCT01434641|1066163|P1|NOT COMPLETED|Overall Study||0
434132|NCT01434641|1066163|P1|COMPLETED|Overall Study||102
434133|NCT01434641|1066163|P1|STARTED|Overall Study||102
434134|NCT01434511|1066168|P1|NOT COMPLETED|Overall Study||0
434135|NCT01434511|1066168|P1|COMPLETED|Overall Study||1
434136|NCT01434511|1066168|P1|STARTED|Overall Study||1
434137|NCT01434342|1066187|P2|NOT COMPLETED|Overall Study||17
434138|NCT01434342|1066188|P1|NOT COMPLETED|Overall Study||48
434139|NCT01434342|1066187|P2|COMPLETED|Overall Study||31
434140|NCT01434342|1066188|P1|COMPLETED|Overall Study||50
434141|NCT01434342|1066187|P2|STARTED|Overall Study||48
434142|NCT01434342|1066188|P1|STARTED|Overall Study||98
434143|NCT01434290|1066198|P2|NOT COMPLETED|Overall Study||7
434144|NCT01434290|1066199|P1|NOT COMPLETED|Overall Study||8
434145|NCT01434290|1066198|P2|COMPLETED|Overall Study|Eligible subjects included in analysis|121
434146|NCT01434290|1066199|P1|COMPLETED|Overall Study|Eligible subjects included in analysis|119
434147|NCT01434290|1066198|P2|STARTED|Overall Study||128
434148|NCT01434290|1066199|P1|STARTED|Overall Study||127
434149|NCT01434186|1066227|P2|NOT COMPLETED|Overall Study||0
434150|NCT01434186|1066228|P1|NOT COMPLETED|Overall Study||0
434151|NCT01434186|1066227|P2|COMPLETED|Overall Study||4
434152|NCT01434186|1066228|P1|COMPLETED|Overall Study||2
434153|NCT01434186|1066227|P2|STARTED|Overall Study||4
434154|NCT01434186|1066228|P1|STARTED|Overall Study||2
434155|NCT01434121|1066237|P3|NOT COMPLETED|Overall Study||0
434156|NCT01434121|1066238|P2|NOT COMPLETED|Overall Study||0
434157|NCT01434121|1066239|P1|NOT COMPLETED|Overall Study||0
434158|NCT01434121|1066237|P3|COMPLETED|Overall Study||8
434159|NCT01434121|1066238|P2|COMPLETED|Overall Study||8
434160|NCT01434121|1066239|P1|COMPLETED|Overall Study||8
434161|NCT01434121|1066237|P3|STARTED|Overall Study||8
434162|NCT01434121|1066238|P2|STARTED|Overall Study||8
434163|NCT01434121|1066239|P1|STARTED|Overall Study||8
434164|NCT01434030|1066265|P1|NOT COMPLETED|Overall Study||1
434165|NCT01434030|1066265|P1|COMPLETED|Overall Study||56
434166|NCT01434030|1066265|P1|STARTED|Overall Study||57
434167|NCT01433978|1066272|P3|NOT COMPLETED|Extension Phase||6
434168|NCT01433978|1066273|P2|NOT COMPLETED|Extension Phase||0
434169|NCT01433978|1066274|P1|NOT COMPLETED|Extension Phase||0
434170|NCT01433978|1066272|P3|COMPLETED|Extension Phase||0
434171|NCT01433978|1066273|P2|COMPLETED|Extension Phase||0
434172|NCT01433978|1066274|P1|COMPLETED|Extension Phase||0
434173|NCT01433978|1066272|P3|STARTED|Extension Phase||6
434174|NCT01433978|1066273|P2|STARTED|Extension Phase||0
434175|NCT01433978|1066274|P1|STARTED|Extension Phase||0
434176|NCT01433978|1066272|P3|NOT COMPLETED|Core Study||0
434177|NCT01433978|1066273|P2|NOT COMPLETED|Core Study||11
434178|NCT01433978|1066274|P1|NOT COMPLETED|Core Study||11
434179|NCT01433978|1066272|P3|COMPLETED|Core Study||0
434180|NCT01433978|1066273|P2|COMPLETED|Core Study||1
434181|NCT01433978|1066274|P1|COMPLETED|Core Study||0
434182|NCT01433978|1066272|P3|STARTED|Core Study||0
434183|NCT01433978|1066273|P2|STARTED|Core Study||12
434184|NCT01433978|1066274|P1|STARTED|Core Study||11
434185|NCT01433913|1066283|P2|NOT COMPLETED|Overall Study||0
434186|NCT01433913|1066284|P1|NOT COMPLETED|Overall Study||1
434187|NCT01433913|1066283|P2|COMPLETED|Overall Study||10
434188|NCT01433913|1066284|P1|COMPLETED|Overall Study||9
434189|NCT01433913|1066283|P2|STARTED|Overall Study||10
434190|NCT01433913|1066284|P1|STARTED|Overall Study||10
434191|NCT01433731|1066320|P4|NOT COMPLETED|Overall Study||0
434192|NCT01433731|1066321|P3|NOT COMPLETED|Overall Study||0
434193|NCT01433731|1066322|P2|NOT COMPLETED|Overall Study||0
434194|NCT01433731|1066323|P1|NOT COMPLETED|Overall Study||0
434195|NCT01433731|1066320|P4|COMPLETED|Overall Study||5
434196|NCT01433731|1066321|P3|COMPLETED|Overall Study||5
434197|NCT01433731|1066322|P2|COMPLETED|Overall Study||5
434198|NCT01433731|1066323|P1|COMPLETED|Overall Study||3
434199|NCT01433731|1066320|P4|STARTED|Overall Study||5
434200|NCT01433731|1066321|P3|STARTED|Overall Study||5
434201|NCT01433731|1066322|P2|STARTED|Overall Study||5
434202|NCT01433731|1066323|P1|STARTED|Overall Study||3
434203|NCT01433549|1066331|P2|NOT COMPLETED|Phase 2: Second Study Product||1
434204|NCT01433549|1066332|P1|NOT COMPLETED|Phase 2: Second Study Product||0
434205|NCT01433549|1066331|P2|COMPLETED|Phase 2: Second Study Product||12
434206|NCT01433549|1066332|P1|COMPLETED|Phase 2: Second Study Product||12
434207|NCT01433549|1066331|P2|STARTED|Phase 2: Second Study Product||13
434208|NCT01433549|1066332|P1|STARTED|Phase 2: Second Study Product||12
434209|NCT01433549|1066331|P2|NOT COMPLETED|Phase 1: First Study Product||0
434210|NCT01433549|1066332|P1|NOT COMPLETED|Phase 1: First Study Product||0
434211|NCT01433549|1066331|P2|COMPLETED|Phase 1: First Study Product||13
434212|NCT01433549|1066332|P1|COMPLETED|Phase 1: First Study Product||12
434213|NCT01433549|1066331|P2|STARTED|Phase 1: First Study Product||13
434214|NCT01433549|1066332|P1|STARTED|Phase 1: First Study Product||12
434215|NCT01433471|1066342|P2|NOT COMPLETED|Overall Study||1
434216|NCT01433471|1066343|P1|NOT COMPLETED|Overall Study||0
434217|NCT01433471|1066342|P2|COMPLETED|Overall Study||1
434218|NCT01433471|1066343|P1|COMPLETED|Overall Study||2
434219|NCT01433471|1066342|P2|STARTED|Overall Study||2
434220|NCT01433471|1066343|P1|STARTED|Overall Study||2
434221|NCT01433354|1066359|P1|NOT COMPLETED|Overall Study||119
434222|NCT01433354|1066359|P1|COMPLETED|Overall Study||0
434223|NCT01433354|1066359|P1|STARTED|Overall Study|120 enrolled of which 119 were administered drug|119
434224|NCT01433263|1066375|P2|NOT COMPLETED|Overall Study||12
434225|NCT01433263|1066376|P1|NOT COMPLETED|Overall Study||19
434226|NCT01433263|1066375|P2|COMPLETED|Overall Study||16
434227|NCT01433263|1066376|P1|COMPLETED|Overall Study||10
434228|NCT01433263|1066375|P2|STARTED|Overall Study||28
434229|NCT01433263|1066376|P1|STARTED|Overall Study||29
434230|NCT01433250|1066405|P2|NOT COMPLETED|Overall Study||3
434231|NCT01433250|1066406|P1|NOT COMPLETED|Overall Study||3
434232|NCT01433250|1066405|P2|COMPLETED|Overall Study||14
434233|NCT01433250|1066406|P1|COMPLETED|Overall Study||19
434234|NCT01433250|1066405|P2|STARTED|Overall Study||17
434235|NCT01433250|1066406|P1|STARTED|Overall Study||22
434236|NCT01433172|1066425|P3|NOT COMPLETED|Overall Study||1
434237|NCT01433172|1066426|P2|NOT COMPLETED|Overall Study||3
434238|NCT01433172|1066427|P1|NOT COMPLETED|Overall Study||0
434239|NCT01433172|1066425|P3|COMPLETED|Overall Study||32
434240|NCT01433172|1066426|P2|COMPLETED|Overall Study||34
434241|NCT01433172|1066427|P1|COMPLETED|Overall Study||3
434242|NCT01433172|1066425|P3|STARTED|Overall Study||33
434243|NCT01433172|1066426|P2|STARTED|Overall Study||37
434244|NCT01433172|1066427|P1|STARTED|Overall Study||3
434245|NCT01433159|1066439|P2|NOT COMPLETED|Overall Study||1
434246|NCT01433159|1066440|P1|NOT COMPLETED|Overall Study||2
434247|NCT01433159|1066439|P2|COMPLETED|Overall Study||9
434248|NCT01433159|1066440|P1|COMPLETED|Overall Study||7
434249|NCT01433159|1066439|P2|STARTED|Overall Study||10
434250|NCT01433159|1066440|P1|STARTED|Overall Study||9
434251|NCT01433107|1066448|P2|NOT COMPLETED|Overall Study||17
434252|NCT01433107|1066449|P1|NOT COMPLETED|Overall Study||27
434253|NCT01433107|1066448|P2|COMPLETED|Overall Study||128
434254|NCT01433107|1066449|P1|COMPLETED|Overall Study||118
434255|NCT01433107|1066448|P2|STARTED|Overall Study||145
434256|NCT01433107|1066449|P1|STARTED|Overall Study||145
434257|NCT01433081|1066461|P2|NOT COMPLETED|Overall Study||2
434258|NCT01433081|1066462|P1|NOT COMPLETED|Overall Study||2
434259|NCT01433081|1066461|P2|COMPLETED|Overall Study||23
434260|NCT01433081|1066462|P1|COMPLETED|Overall Study||23
434261|NCT01433081|1066461|P2|STARTED|Overall Study||25
434262|NCT01433081|1066462|P1|STARTED|Overall Study||25
434263|NCT01433055|1066472|P2|NOT COMPLETED|Overall Study||0
434264|NCT01433055|1066473|P1|NOT COMPLETED|Overall Study||2
434265|NCT01433055|1066472|P2|COMPLETED|Overall Study||23
434266|NCT01433055|1066473|P1|COMPLETED|Overall Study||27
434267|NCT01433055|1066472|P2|STARTED|Overall Study||23
434268|NCT01433055|1066473|P1|STARTED|Overall Study||29
434269|NCT01433042|1066487|P1|NOT COMPLETED|Overall Study||1
434270|NCT01433042|1066487|P1|COMPLETED|Overall Study||224
434271|NCT01433042|1066487|P1|STARTED|Overall Study||225
434272|NCT01433016|1066491|P1|NOT COMPLETED|Overall Study||0
434273|NCT01433016|1066491|P1|COMPLETED|Overall Study||20
434274|NCT01433016|1066491|P1|STARTED|Overall Study||20
434275|NCT01432938|1066495|P2|NOT COMPLETED|Second Intervention||0
434276|NCT01432938|1066496|P1|NOT COMPLETED|Second Intervention||1
434277|NCT01432938|1066495|P2|COMPLETED|Second Intervention||14
434278|NCT01432938|1066496|P1|COMPLETED|Second Intervention||11
434279|NCT01432938|1066495|P2|STARTED|Second Intervention||14
434280|NCT01432938|1066496|P1|STARTED|Second Intervention||12
434281|NCT01432938|1066495|P2|NOT COMPLETED|Washout Period of at Least 24 Days||0
434282|NCT01432938|1066496|P1|NOT COMPLETED|Washout Period of at Least 24 Days||0
434283|NCT01432938|1066495|P2|COMPLETED|Washout Period of at Least 24 Days||14
434284|NCT01432938|1066496|P1|COMPLETED|Washout Period of at Least 24 Days||12
434285|NCT01432938|1066495|P2|STARTED|Washout Period of at Least 24 Days||14
434286|NCT01432938|1066496|P1|STARTED|Washout Period of at Least 24 Days||12
434287|NCT01432938|1066495|P2|NOT COMPLETED|First Intervention||0
434288|NCT01432938|1066496|P1|NOT COMPLETED|First Intervention||2
434289|NCT01432938|1066495|P2|COMPLETED|First Intervention||14
434290|NCT01432938|1066496|P1|COMPLETED|First Intervention||12
434291|NCT01432938|1066495|P2|Received at Least 1 Dose of Study Drug|First Intervention||14
434292|NCT01432938|1066496|P1|Received at Least 1 Dose of Study Drug|First Intervention||14
434293|NCT01432938|1066495|P2|STARTED|First Intervention||14
434294|NCT01432938|1066496|P1|STARTED|First Intervention||14
434295|NCT01432886|1066513|P2|NOT COMPLETED|Overall Study||0
434296|NCT01432886|1066514|P1|NOT COMPLETED|Overall Study||0
434297|NCT01432886|1066513|P2|COMPLETED|Overall Study|Discontinuation met per discontinuation criteria|6
434298|NCT01432886|1066514|P1|COMPLETED|Overall Study|Discontinuation met per discontinuation criteria|6
434299|NCT01432886|1066513|P2|STARTED|Overall Study||6
434300|NCT01432886|1066514|P1|STARTED|Overall Study||6
434301|NCT01432756|1066526|P4|NOT COMPLETED|Overall Study||1
434302|NCT01432756|1066527|P3|NOT COMPLETED|Overall Study||2
434303|NCT01432756|1066528|P2|NOT COMPLETED|Overall Study||0
434304|NCT01432756|1066529|P1|NOT COMPLETED|Overall Study||1
434305|NCT01432756|1066526|P4|COMPLETED|Overall Study||33
434306|NCT01432756|1066527|P3|COMPLETED|Overall Study||30
434307|NCT01432756|1066528|P2|COMPLETED|Overall Study||34
434308|NCT01432756|1066529|P1|COMPLETED|Overall Study||31
434309|NCT01432756|1066526|P4|STARTED|Overall Study||34
434310|NCT01432756|1066527|P3|STARTED|Overall Study||32
434311|NCT01432756|1066528|P2|STARTED|Overall Study||34
434312|NCT01432756|1066529|P1|STARTED|Overall Study||32
434313|NCT01432626|1066537|P1|NOT COMPLETED|Overall Study||7
434314|NCT01432626|1066537|P1|COMPLETED|Overall Study|Completed both images|3
434315|NCT01432626|1066537|P1|STARTED|Overall Study||10
434316|NCT01432600|1066544|P3|NOT COMPLETED|Overall Study||1
434317|NCT01432600|1066545|P2|NOT COMPLETED|Overall Study||1
434318|NCT01432600|1066546|P1|NOT COMPLETED|Overall Study||0
434319|NCT01432600|1066544|P3|COMPLETED|Overall Study||33
434320|NCT01432600|1066545|P2|COMPLETED|Overall Study||35
434321|NCT01432600|1066546|P1|COMPLETED|Overall Study||10
434322|NCT01432600|1066544|P3|STARTED|Overall Study||34
434323|NCT01432600|1066545|P2|STARTED|Overall Study||36
434324|NCT01432600|1066546|P1|STARTED|Overall Study||10
434325|NCT01432574|1066562|P1|NOT COMPLETED|Overall Study||3
434326|NCT01432574|1066562|P1|COMPLETED|Overall Study||147
434327|NCT01432574|1066562|P1|STARTED|Overall Study||150
434328|NCT01432561|1066568|P1|NOT COMPLETED|Overall Study||0
434329|NCT01432561|1066568|P1|COMPLETED|Overall Study||8
434330|NCT01432561|1066568|P1|STARTED|Overall Study||8
434331|NCT01432535|1066577|P3|NOT COMPLETED|Overall Study||0
434332|NCT01432535|1066578|P2|NOT COMPLETED|Overall Study||0
434333|NCT01432535|1066579|P1|NOT COMPLETED|Overall Study||0
434334|NCT01432535|1066577|P3|COMPLETED|Overall Study||6
434335|NCT01432535|1066578|P2|COMPLETED|Overall Study||7
434336|NCT01432535|1066579|P1|COMPLETED|Overall Study||12
434337|NCT01432535|1066577|P3|STARTED|Overall Study||6
434338|NCT01432535|1066578|P2|STARTED|Overall Study|One participant later determined ineligible is not included in baseline/efficacy analyses.|7
434339|NCT01432535|1066579|P1|STARTED|Overall Study||12
434340|NCT01432457|1066608|P3|NOT COMPLETED|Overall Study||59
434341|NCT01432457|1066609|P2|NOT COMPLETED|Overall Study||48
434342|NCT01432457|1066610|P1|NOT COMPLETED|Overall Study||37
434343|NCT01432457|1066608|P3|COMPLETED|Overall Study||253
434344|NCT01432457|1066609|P2|COMPLETED|Overall Study||258
434345|NCT01432457|1066610|P1|COMPLETED|Overall Study||269
434346|NCT01432457|1066608|P3|STARTED|Overall Study||312
434347|NCT01432457|1066609|P2|STARTED|Overall Study||306
434348|NCT01432457|1066610|P1|STARTED|Overall Study||306
434349|NCT01432444|1066639|P3|NOT COMPLETED|Extension Phase||192
434350|NCT01432444|1066640|P2|NOT COMPLETED|Extension Phase||0
434351|NCT01432444|1066641|P1|NOT COMPLETED|Extension Phase||0
434352|NCT01432444|1066639|P3|COMPLETED|Extension Phase||0
434353|NCT01432444|1066640|P2|COMPLETED|Extension Phase||0
434354|NCT01432444|1066641|P1|COMPLETED|Extension Phase||0
434355|NCT01432444|1066639|P3|STARTED|Extension Phase||192
434356|NCT01432444|1066640|P2|STARTED|Extension Phase||0
434357|NCT01432444|1066641|P1|STARTED|Extension Phase||0
434358|NCT01432444|1066639|P3|NOT COMPLETED|Treatment Phase||0
434359|NCT01432444|1066640|P2|NOT COMPLETED|Treatment Phase||140
434360|NCT01432444|1066641|P1|NOT COMPLETED|Treatment Phase||0
434361|NCT01432444|1066639|P3|COMPLETED|Treatment Phase||0
434362|NCT01432444|1066640|P2|COMPLETED|Treatment Phase||293
434363|NCT01432444|1066641|P1|COMPLETED|Treatment Phase||0
434364|NCT01432444|1066639|P3|STARTED|Treatment Phase||0
434365|NCT01432444|1066640|P2|STARTED|Treatment Phase||433
434366|NCT01432444|1066641|P1|STARTED|Treatment Phase||0
434367|NCT01432444|1066639|P3|NOT COMPLETED|Tolerability/Cross-titration Phase||0
434368|NCT01432444|1066640|P2|NOT COMPLETED|Tolerability/Cross-titration Phase||0
434369|NCT01432444|1066641|P1|NOT COMPLETED|Tolerability/Cross-titration Phase||60
434370|NCT01432444|1066639|P3|COMPLETED|Tolerability/Cross-titration Phase||0
434371|NCT01432444|1066640|P2|COMPLETED|Tolerability/Cross-titration Phase||0
434372|NCT01432444|1066641|P1|COMPLETED|Tolerability/Cross-titration Phase||265
434373|NCT01432444|1066639|P3|STARTED|Tolerability/Cross-titration Phase||0
434374|NCT01432444|1066640|P2|STARTED|Tolerability/Cross-titration Phase||0
434375|NCT01432444|1066641|P1|STARTED|Tolerability/Cross-titration Phase||325
434376|NCT01432405|1066653|P2|NOT COMPLETED|Overall Study||2
434377|NCT01432405|1066654|P1|NOT COMPLETED|Overall Study||1
434378|NCT01432405|1066653|P2|COMPLETED|Overall Study||10
434379|NCT01432405|1066654|P1|COMPLETED|Overall Study||11
434380|NCT01432405|1066653|P2|STARTED|Overall Study||12
434381|NCT01432405|1066654|P1|STARTED|Overall Study||12
434382|NCT01432379|1066662|P1|NOT COMPLETED|Overall Study||385
434383|NCT01432379|1066662|P1|COMPLETED|Overall Study||783
434384|NCT01432379|1066662|P1|STARTED|Overall Study||1168
434385|NCT01432366|1066667|P1|NOT COMPLETED|Overall Study||68
434386|NCT01432366|1066667|P1|COMPLETED|Overall Study||392
434387|NCT01432366|1066667|P1|STARTED|Overall Study||460
434388|NCT01432327|1066689|P4|NOT COMPLETED|Posttest 1 Year||23
434389|NCT01432327|1066690|P3|NOT COMPLETED|Posttest 1 Year||20
434390|NCT01432327|1066691|P2|NOT COMPLETED|Posttest 1 Year||28
434391|NCT01432327|1066692|P1|NOT COMPLETED|Posttest 1 Year||24
434392|NCT01432327|1066689|P4|COMPLETED|Posttest 1 Year||31
434393|NCT01432327|1066690|P3|COMPLETED|Posttest 1 Year||30
434394|NCT01432327|1066691|P2|COMPLETED|Posttest 1 Year||27
434395|NCT01432327|1066692|P1|COMPLETED|Posttest 1 Year||28
434396|NCT01432327|1066689|P4|STARTED|Posttest 1 Year||54
434397|NCT01432327|1066690|P3|STARTED|Posttest 1 Year||50
434398|NCT01432327|1066691|P2|STARTED|Posttest 1 Year||55
434399|NCT01432327|1066692|P1|STARTED|Posttest 1 Year||52
434400|NCT01432327|1066689|P4|NOT COMPLETED|Posttest 6 Months||2
434401|NCT01432327|1066690|P3|NOT COMPLETED|Posttest 6 Months||5
434402|NCT01432327|1066691|P2|NOT COMPLETED|Posttest 6 Months||0
434403|NCT01432327|1066692|P1|NOT COMPLETED|Posttest 6 Months||0
434404|NCT01432327|1066689|P4|COMPLETED|Posttest 6 Months||54
434405|NCT01432327|1066690|P3|COMPLETED|Posttest 6 Months||50
434406|NCT01432327|1066691|P2|COMPLETED|Posttest 6 Months||55
434407|NCT01432327|1066692|P1|COMPLETED|Posttest 6 Months||52
434408|NCT01432327|1066689|P4|STARTED|Posttest 6 Months||56
434409|NCT01432327|1066690|P3|STARTED|Posttest 6 Months||55
434410|NCT01432327|1066691|P2|STARTED|Posttest 6 Months||55
434411|NCT01432327|1066692|P1|STARTED|Posttest 6 Months||52
434412|NCT01432327|1066689|P4|NOT COMPLETED|Posttest 3 Months||1
434413|NCT01432327|1066690|P3|NOT COMPLETED|Posttest 3 Months||2
434414|NCT01432327|1066691|P2|NOT COMPLETED|Posttest 3 Months||2
434415|NCT01432327|1066692|P1|NOT COMPLETED|Posttest 3 Months||4
434416|NCT01432327|1066689|P4|COMPLETED|Posttest 3 Months||56
434417|NCT01432327|1066690|P3|COMPLETED|Posttest 3 Months||55
434418|NCT01432327|1066691|P2|COMPLETED|Posttest 3 Months||55
434419|NCT01432327|1066692|P1|COMPLETED|Posttest 3 Months||52
434420|NCT01432327|1066689|P4|STARTED|Posttest 3 Months||57
434421|NCT01432327|1066690|P3|STARTED|Posttest 3 Months||57
434422|NCT01432327|1066691|P2|STARTED|Posttest 3 Months||57
434423|NCT01432327|1066692|P1|STARTED|Posttest 3 Months||56
434424|NCT01432327|1066689|P4|NOT COMPLETED|Baseline||0
434425|NCT01432327|1066690|P3|NOT COMPLETED|Baseline||0
434426|NCT01432327|1066691|P2|NOT COMPLETED|Baseline||0
434427|NCT01432327|1066692|P1|NOT COMPLETED|Baseline||0
434428|NCT01432327|1066689|P4|COMPLETED|Baseline||57
434429|NCT01432327|1066690|P3|COMPLETED|Baseline||57
434430|NCT01432327|1066691|P2|COMPLETED|Baseline||57
434431|NCT01432327|1066692|P1|COMPLETED|Baseline||56
434432|NCT01432327|1066689|P4|STARTED|Baseline||57
434433|NCT01432327|1066690|P3|STARTED|Baseline||57
434434|NCT01432327|1066691|P2|STARTED|Baseline||57
434435|NCT01432327|1066692|P1|STARTED|Baseline||56
434436|NCT01432275|1066702|P2|NOT COMPLETED|ADC With Calculator (10 Days)||2
434437|NCT01432275|1066703|P1|NOT COMPLETED|ADC With Calculator (10 Days)||3
434438|NCT01432275|1066702|P2|COMPLETED|ADC With Calculator (10 Days)||79
434439|NCT01432275|1066703|P1|COMPLETED|ADC With Calculator (10 Days)||85
434440|NCT01432275|1066702|P2|STARTED|ADC With Calculator (10 Days)||81
434441|NCT01432275|1066703|P1|STARTED|ADC With Calculator (10 Days)||88
434442|NCT01432275|1066702|P2|NOT COMPLETED|Second BG Meter System (7 Days)||3
434443|NCT01432275|1066703|P1|NOT COMPLETED|Second BG Meter System (7 Days)||2
434444|NCT01432275|1066702|P2|COMPLETED|Second BG Meter System (7 Days)||81
434445|NCT01432275|1066703|P1|COMPLETED|Second BG Meter System (7 Days)||88
434446|NCT01432275|1066702|P2|STARTED|Second BG Meter System (7 Days)||84
434447|NCT01432275|1066703|P1|STARTED|Second BG Meter System (7 Days)||90
434448|NCT01432275|1066702|P2|NOT COMPLETED|First BG Meter System (7 Days)||3
434449|NCT01432275|1066703|P1|NOT COMPLETED|First BG Meter System (7 Days)||0
434450|NCT01432275|1066702|P2|COMPLETED|First BG Meter System (7 Days)||84
434451|NCT01432275|1066703|P1|COMPLETED|First BG Meter System (7 Days)||90
434452|NCT01432275|1066702|P2|STARTED|First BG Meter System (7 Days)||87
434453|NCT01432275|1066703|P1|STARTED|First BG Meter System (7 Days)||90
434454|NCT01432262|1066712|P2|NOT COMPLETED|Overall Study||1
434455|NCT01432262|1066713|P1|NOT COMPLETED|Overall Study||2
434456|NCT01432262|1066712|P2|COMPLETED|Overall Study||161
434457|NCT01432262|1066713|P1|COMPLETED|Overall Study||160
434458|NCT01432262|1066712|P2|Vaccinated|Overall Study||161
434459|NCT01432262|1066713|P1|Vaccinated|Overall Study||162
434460|NCT01432262|1066712|P2|STARTED|Overall Study||162
434461|NCT01432262|1066713|P1|STARTED|Overall Study||162
434462|NCT01432236|1066731|P2|NOT COMPLETED|Overall Study||18
434463|NCT01432236|1066732|P1|NOT COMPLETED|Overall Study||26
434464|NCT01432236|1066731|P2|COMPLETED|Overall Study||79
434465|NCT01432236|1066732|P1|COMPLETED|Overall Study||70
434466|NCT01432236|1066731|P2|STARTED|Overall Study||97
434467|NCT01432236|1066732|P1|STARTED|Overall Study||96
434468|NCT01432015|1066779|P2|NOT COMPLETED|Overall Study||0
434469|NCT01432015|1066780|P1|NOT COMPLETED|Overall Study||0
434470|NCT01432015|1066779|P2|COMPLETED|Overall Study||10
434471|NCT01432015|1066780|P1|COMPLETED|Overall Study||10
434472|NCT01432015|1066779|P2|STARTED|Overall Study||10
434473|NCT01432015|1066780|P1|STARTED|Overall Study||10
434474|NCT01431989|1066788|P2|NOT COMPLETED|Period 2||0
434475|NCT01431989|1066789|P1|NOT COMPLETED|Period 2||0
434476|NCT01431989|1066788|P2|COMPLETED|Period 2||14
434477|NCT01431989|1066789|P1|COMPLETED|Period 2||14
434478|NCT01431989|1066788|P2|STARTED|Period 2||14
434479|NCT01431989|1066789|P1|STARTED|Period 2||14
434480|NCT01431989|1066788|P2|NOT COMPLETED|14-Day Washout Period||0
434481|NCT01431989|1066789|P1|NOT COMPLETED|14-Day Washout Period||0
434482|NCT01431989|1066788|P2|COMPLETED|14-Day Washout Period||14
434483|NCT01431989|1066789|P1|COMPLETED|14-Day Washout Period||14
434484|NCT01431989|1066788|P2|STARTED|14-Day Washout Period||14
434485|NCT01431989|1066789|P1|STARTED|14-Day Washout Period||14
434486|NCT01431989|1066788|P2|NOT COMPLETED|Period 1||0
434487|NCT01431989|1066789|P1|NOT COMPLETED|Period 1||0
434488|NCT01431989|1066788|P2|COMPLETED|Period 1||14
434489|NCT01431989|1066789|P1|COMPLETED|Period 1||14
434490|NCT01431989|1066788|P2|STARTED|Period 1||14
434491|NCT01431989|1066789|P1|STARTED|Period 1||14
434492|NCT01431976|1066807|P1|NOT COMPLETED|Overall Study||14
434493|NCT01431976|1066807|P1|COMPLETED|Overall Study||6
434494|NCT01431976|1066807|P1|STARTED|Overall Study||20
434495|NCT01431963|1066818|P1|NOT COMPLETED|Overall Study||35
434496|NCT01431963|1066818|P1|COMPLETED|Overall Study||32
434497|NCT01431963|1066818|P1|Complete ExP (gt= 24 Weeks)|Overall Study|(>=24 weeks); gt= abbreviation for greater than or equal to|19
434498|NCT01431963|1066818|P1|Begin Extension Phase (ExP; gt= 24weeks)|Overall Study|Only Japanese participants in ExP,lamotrigine monotherapy was available in Korea. (>=24weeks)|19
434499|NCT01431963|1066818|P1|Complete MP (24 Weeks)|Overall Study||42
434500|NCT01431963|1066818|P1|Begin Maintenance Phase (MP; 24 Weeks)|Overall Study||52
434501|NCT01431963|1066818|P1|Complete EP (6 Weeks)|Overall Study||52
434502|NCT01431963|1066818|P1|Received Treatment|Overall Study||65
434503|NCT01431963|1066818|P1|Begin Escalation Phase (EP; 6 Weeks)|Overall Study||67
434504|NCT01431963|1066818|P1|STARTED|Overall Study||67
434505|NCT01431950|1066826|P2|NOT COMPLETED|Overall Study||15
434506|NCT01431950|1066827|P1|NOT COMPLETED|Overall Study||19
434507|NCT01431950|1066826|P2|COMPLETED|Overall Study||104
434508|NCT01431950|1066827|P1|COMPLETED|Overall Study||100
434509|NCT01431950|1066826|P2|STARTED|Overall Study||119
434510|NCT01431950|1066827|P1|STARTED|Overall Study||119
434511|NCT01431846|1066844|P3|NOT COMPLETED|Overall Study||0
434512|NCT01431846|1066845|P2|NOT COMPLETED|Overall Study||0
434513|NCT01431846|1066846|P1|NOT COMPLETED|Overall Study||0
434514|NCT01431846|1066844|P3|COMPLETED|Overall Study||8
434515|NCT01431846|1066845|P2|COMPLETED|Overall Study||3
434516|NCT01431846|1066846|P1|COMPLETED|Overall Study||8
434517|NCT01431846|1066844|P3|STARTED|Overall Study||8
434518|NCT01431846|1066845|P2|STARTED|Overall Study||3
434519|NCT01431846|1066846|P1|STARTED|Overall Study||8
434520|NCT01431755|1066854|P1|NOT COMPLETED|Overall Study||5
434521|NCT01431755|1066854|P1|COMPLETED|Overall Study||49
434522|NCT01431755|1066854|P1|STARTED|Overall Study||54
434523|NCT01431716|1066865|P1|NOT COMPLETED|Overall Study||1
434524|NCT01431716|1066865|P1|COMPLETED|Overall Study||41
434525|NCT01431716|1066865|P1|STARTED|Overall Study||42
434526|NCT01431703|1066882|P1|NOT COMPLETED|Overall Study||0
434527|NCT01431703|1066882|P1|COMPLETED|Overall Study||326
434528|NCT01431703|1066882|P1|STARTED|Overall Study||326
434529|NCT01431521|1066890|P4|NOT COMPLETED|Overall Study||0
434530|NCT01431521|1066891|P3|NOT COMPLETED|Overall Study||1
434531|NCT01431521|1066892|P2|NOT COMPLETED|Overall Study||0
434532|NCT01431521|1066893|P1|NOT COMPLETED|Overall Study||0
434533|NCT01431521|1066890|P4|COMPLETED|Overall Study||5
434534|NCT01431521|1066891|P3|COMPLETED|Overall Study||10
434535|NCT01431521|1066892|P2|COMPLETED|Overall Study||5
434536|NCT01431521|1066893|P1|COMPLETED|Overall Study||10
434537|NCT01431521|1066890|P4|Treated|Overall Study||5
434538|NCT01431521|1066891|P3|Treated|Overall Study||10
434539|NCT01431521|1066892|P2|Treated|Overall Study||5
434540|NCT01431521|1066893|P1|Treated|Overall Study||10
434541|NCT01431521|1066890|P4|STARTED|Overall Study||5
434542|NCT01431521|1066891|P3|STARTED|Overall Study||11
434543|NCT01431521|1066892|P2|STARTED|Overall Study||5
434544|NCT01431521|1066893|P1|STARTED|Overall Study||10
434545|NCT01431508|1066914|P1|NOT COMPLETED|Overall Study||2
434546|NCT01431508|1066914|P1|COMPLETED|Overall Study||13
434547|NCT01431508|1066914|P1|STARTED|Overall Study||15
434548|NCT01431391|1066920|P2|NOT COMPLETED|Overall Study||4
434549|NCT01431391|1066921|P1|NOT COMPLETED|Overall Study||8
434550|NCT01431391|1066920|P2|COMPLETED|Overall Study||30
434551|NCT01431391|1066921|P1|COMPLETED|Overall Study||26
434552|NCT01431391|1066920|P2|Received ≥1 Leaukapheresis|Overall Study||34
434553|NCT01431391|1066921|P1|Received ≥1 Leaukapheresis|Overall Study||34
434554|NCT01431391|1066920|P2|STARTED|Overall Study||34
434555|NCT01431391|1066921|P1|STARTED|Overall Study||34
434556|NCT01431339|1066931|P2|NOT COMPLETED|Overall Study||35
434557|NCT01431339|1066932|P1|NOT COMPLETED|Overall Study||39
434558|NCT01431339|1066931|P2|COMPLETED|Overall Study||333
434559|NCT01431339|1066932|P1|COMPLETED|Overall Study||332
434560|NCT01431339|1066931|P2|Safety Population|Overall Study||367
434561|NCT01431339|1066932|P1|Safety Population|Overall Study||368
434562|NCT01431339|1066931|P2|STARTED|Overall Study||368
434563|NCT01431339|1066932|P1|STARTED|Overall Study||371
434564|NCT01431300|1066947|P3|NOT COMPLETED|Overall Study||0
434565|NCT01431300|1066948|P2|NOT COMPLETED|Overall Study||0
434566|NCT01431300|1066949|P1|NOT COMPLETED|Overall Study||1
434567|NCT01431300|1066947|P3|COMPLETED|Overall Study||10
434568|NCT01431300|1066948|P2|COMPLETED|Overall Study||10
434569|NCT01431300|1066949|P1|COMPLETED|Overall Study||10
434570|NCT01431300|1066947|P3|STARTED|Overall Study||10
434571|NCT01431300|1066948|P2|STARTED|Overall Study||10
434572|NCT01431300|1066949|P1|STARTED|Overall Study|One subject with indeterminate pregnancy test, subject declined to proceed|11
434573|NCT01431287|1066965|P5|NOT COMPLETED|Overall Study||77
434574|NCT01431287|1066966|P4|NOT COMPLETED|Overall Study||63
434575|NCT01431287|1066967|P3|NOT COMPLETED|Overall Study||97
434576|NCT01431287|1066968|P2|NOT COMPLETED|Overall Study||98
434577|NCT01431287|1066969|P1|NOT COMPLETED|Overall Study||98
434578|NCT01431287|1066965|P5|COMPLETED|Overall Study||430
434579|NCT01431287|1066966|P4|COMPLETED|Overall Study||445
434580|NCT01431287|1066967|P3|COMPLETED|Overall Study||410
434581|NCT01431287|1066968|P2|COMPLETED|Overall Study||409
434582|NCT01431287|1066969|P1|COMPLETED|Overall Study||412
434583|NCT01431287|1066965|P5|STARTED|Overall Study||507
434584|NCT01431287|1066966|P4|STARTED|Overall Study||508
434585|NCT01431287|1066967|P3|STARTED|Overall Study||507
434586|NCT01431287|1066968|P2|STARTED|Overall Study||507
434587|NCT01431287|1066969|P1|STARTED|Overall Study|started are actually the randomized|510
434588|NCT01431274|1067131|P5|NOT COMPLETED|Overall Study||56
434589|NCT01431274|1067132|P4|NOT COMPLETED|Overall Study||60
434590|NCT01431274|1067133|P3|NOT COMPLETED|Overall Study||72
434591|NCT01431274|1067134|P2|NOT COMPLETED|Overall Study||77
434592|NCT01431274|1067135|P1|NOT COMPLETED|Overall Study||97
434593|NCT01431274|1067131|P5|COMPLETED|Overall Study||466
434594|NCT01431274|1067132|P4|COMPLETED|Overall Study||462
434595|NCT01431274|1067133|P3|COMPLETED|Overall Study||455
434596|NCT01431274|1067134|P2|COMPLETED|Overall Study||448
434597|NCT01431274|1067135|P1|COMPLETED|Overall Study||431
434598|NCT01431274|1067131|P5|STARTED|Overall Study||522
434599|NCT01431274|1067132|P4|STARTED|Overall Study||522
434600|NCT01431274|1067133|P3|STARTED|Overall Study||527
434601|NCT01431274|1067134|P2|STARTED|Overall Study||525
434602|NCT01431274|1067135|P1|STARTED|Overall Study||528
434603|NCT01431170|1067294|P2|NOT COMPLETED|Overall Study||1
434604|NCT01431170|1067295|P1|NOT COMPLETED|Overall Study||3
434605|NCT01431170|1067294|P2|COMPLETED|Overall Study||11
434606|NCT01431170|1067295|P1|COMPLETED|Overall Study||9
434607|NCT01431170|1067294|P2|STARTED|Overall Study||12
434608|NCT01431170|1067295|P1|STARTED|Overall Study||12
434609|NCT01431144|1067313|P2|NOT COMPLETED|Overall Study||0
434610|NCT01431144|1067314|P1|NOT COMPLETED|Overall Study||2
434611|NCT01431144|1067313|P2|COMPLETED|Overall Study||14
434612|NCT01431144|1067314|P1|COMPLETED|Overall Study||11
434613|NCT01431144|1067313|P2|STARTED|Overall Study||14
434614|NCT01431144|1067314|P1|STARTED|Overall Study||13
434615|NCT01431131|1067322|P2|NOT COMPLETED|Overall Study||0
434616|NCT01431131|1067323|P1|NOT COMPLETED|Overall Study||0
434617|NCT01431131|1067322|P2|COMPLETED|Overall Study||12
434618|NCT01431131|1067323|P1|COMPLETED|Overall Study||12
434619|NCT01431131|1067322|P2|STARTED|Overall Study||12
434620|NCT01431131|1067323|P1|STARTED|Overall Study||12
434621|NCT01431079|1067333|P2|NOT COMPLETED|Overall Study||39
434622|NCT01431079|1067334|P1|NOT COMPLETED|Overall Study||35
434623|NCT01431079|1067333|P2|COMPLETED|Overall Study||6
434624|NCT01431079|1067334|P1|COMPLETED|Overall Study||10
434625|NCT01431079|1067333|P2|Post-test|Overall Study||45
434626|NCT01431079|1067334|P1|Post-test|Overall Study||45
434627|NCT01431079|1067333|P2|STARTED|Overall Study||45
434628|NCT01431079|1067334|P1|STARTED|Overall Study||45
434629|NCT01431014|1067388|P2|NOT COMPLETED|Overall Study||9
434630|NCT01431014|1067389|P1|NOT COMPLETED|Overall Study||3
434631|NCT01431014|1067388|P2|COMPLETED|Overall Study||25
434632|NCT01431014|1067389|P1|COMPLETED|Overall Study||31
434633|NCT01431014|1067388|P2|STARTED|Overall Study||34
434634|NCT01431014|1067389|P1|STARTED|Overall Study||34
434635|NCT01430819|1067397|P2|NOT COMPLETED|Overall Study||0
434636|NCT01430819|1067398|P1|NOT COMPLETED|Overall Study||0
434637|NCT01430819|1067397|P2|COMPLETED|Overall Study||150
434638|NCT01430819|1067398|P1|COMPLETED|Overall Study||150
434639|NCT01430819|1067397|P2|STARTED|Overall Study||150
434640|NCT01430819|1067398|P1|STARTED|Overall Study||150
434641|NCT01430754|1067413|P2|NOT COMPLETED|Randomized Phase||0
434642|NCT01430754|1067414|P1|NOT COMPLETED|Randomized Phase||0
434643|NCT01430754|1067413|P2|COMPLETED|Randomized Phase||10
434644|NCT01430754|1067414|P1|COMPLETED|Randomized Phase||10
434645|NCT01430754|1067413|P2|STARTED|Randomized Phase||10
434646|NCT01430754|1067414|P1|STARTED|Randomized Phase||10
434647|NCT01430754|1067413|P2|NOT COMPLETED|Run-In Phase||0
434648|NCT01430754|1067414|P1|NOT COMPLETED|Run-In Phase||37
434649|NCT01430754|1067413|P2|COMPLETED|Run-In Phase||0
434650|NCT01430754|1067414|P1|COMPLETED|Run-In Phase|Defined as the number of patients who entered the randomized-withdrawal phase|20
434651|NCT01430754|1067413|P2|Entrained - After Run-In Phase|Run-In Phase||0
434652|NCT01430754|1067414|P1|Entrained - After Run-In Phase|Run-In Phase||24
434653|NCT01430754|1067413|P2|STARTED|Run-In Phase|During the run-in phase, participants were treated with tasimelteon only.|0
434654|NCT01430754|1067414|P1|STARTED|Run-In Phase||57
434667|NCT01430624|1067472|P3|NOT COMPLETED|Overall Study||29
434668|NCT01430624|1067473|P2|NOT COMPLETED|Overall Study||34
434669|NCT01430624|1067474|P1|NOT COMPLETED|Overall Study||28
434670|NCT01430624|1067472|P3|COMPLETED|Overall Study|Completed one or more follow-ups|52
434671|NCT01430624|1067473|P2|COMPLETED|Overall Study|Completed one or more follow-ups|48
434672|NCT01430624|1067474|P1|COMPLETED|Overall Study|Completed one or more follow-ups|54
434673|NCT01430624|1067472|P3|Eligible Baseline Completes|Overall Study||79
434674|NCT01430624|1067473|P2|Eligible Baseline Completes|Overall Study||77
434675|NCT01430624|1067474|P1|Eligible Baseline Completes|Overall Study||77
434676|NCT01430624|1067472|P3|STARTED|Overall Study||81
434677|NCT01430624|1067473|P2|STARTED|Overall Study||82
434678|NCT01430624|1067474|P1|STARTED|Overall Study|Initial potential eligible screened enrolled|82
434679|NCT01430611|1067505|P2|NOT COMPLETED|Overall Study||15
434680|NCT01430611|1067506|P1|NOT COMPLETED|Overall Study||17
434681|NCT01430611|1067505|P2|COMPLETED|Overall Study||318
434682|NCT01430611|1067506|P1|COMPLETED|Overall Study||315
434683|NCT01430611|1067505|P2|STARTED|Overall Study||333
434684|NCT01430611|1067506|P1|STARTED|Overall Study||332
434685|NCT01430585|1067524|P1|NOT COMPLETED|Overall Study||14
434686|NCT01430585|1067524|P1|COMPLETED|Overall Study||0
434687|NCT01430585|1067524|P1|STARTED|Overall Study||14
434688|NCT01430468|1067559|P2|NOT COMPLETED|Overall Study||2
434689|NCT01430468|1067560|P1|NOT COMPLETED|Overall Study||3
434690|NCT01430468|1067559|P2|COMPLETED|Overall Study||16
434691|NCT01430468|1067560|P1|COMPLETED|Overall Study||15
434692|NCT01430468|1067559|P2|STARTED|Overall Study||18
434693|NCT01430468|1067560|P1|STARTED|Overall Study||18
434694|NCT01430455|1067566|P1|NOT COMPLETED|Overall Study||2
434695|NCT01430455|1067566|P1|COMPLETED|Overall Study||5
434696|NCT01430455|1067566|P1|STARTED|Overall Study||7
434697|NCT01430403|1067573|P3|NOT COMPLETED|Overall Study||8
434698|NCT01430403|1067574|P2|NOT COMPLETED|Overall Study||9
434699|NCT01430403|1067575|P1|NOT COMPLETED|Overall Study||17
434700|NCT01430403|1067573|P3|COMPLETED|Overall Study||81
434701|NCT01430403|1067574|P2|COMPLETED|Overall Study||121
434702|NCT01430403|1067575|P1|COMPLETED|Overall Study||242
434703|NCT01430403|1067573|P3|STARTED|Overall Study|Intent-to-treat|89
434704|NCT01430403|1067574|P2|STARTED|Overall Study|Intent-to-treat|130
434705|NCT01430403|1067575|P1|STARTED|Overall Study|Intent-to-treat|259
434706|NCT01430325|1067628|P4|NOT COMPLETED|Overall Study||0
434707|NCT01430325|1067629|P3|NOT COMPLETED|Overall Study||0
434708|NCT01430325|1067630|P2|NOT COMPLETED|Overall Study||0
434709|NCT01430325|1067631|P1|NOT COMPLETED|Overall Study||0
434710|NCT01430325|1067628|P4|COMPLETED|Overall Study||12
434711|NCT01430325|1067629|P3|COMPLETED|Overall Study||8
434712|NCT01430325|1067630|P2|COMPLETED|Overall Study||12
434713|NCT01430325|1067631|P1|COMPLETED|Overall Study||10
434714|NCT01430325|1067628|P4|STARTED|Overall Study||12
434715|NCT01430325|1067629|P3|STARTED|Overall Study||8
434716|NCT01430325|1067630|P2|STARTED|Overall Study||12
434717|NCT01430325|1067631|P1|STARTED|Overall Study||10
434718|NCT01430299|1067651|P2|NOT COMPLETED|Overall Study||2
434719|NCT01430299|1067652|P1|NOT COMPLETED|Overall Study||4
434720|NCT01430299|1067651|P2|COMPLETED|Overall Study||21
434721|NCT01430299|1067652|P1|COMPLETED|Overall Study||16
434722|NCT01430299|1067651|P2|STARTED|Overall Study||23
434723|NCT01430299|1067652|P1|STARTED|Overall Study||20
434724|NCT01430182|1067660|P2|NOT COMPLETED|Overall Study||0
434725|NCT01430182|1067661|P1|NOT COMPLETED|Overall Study||0
434726|NCT01430182|1067660|P2|COMPLETED|Overall Study||8
434727|NCT01430182|1067661|P1|COMPLETED|Overall Study||9
434728|NCT01430182|1067660|P2|STARTED|Overall Study||8
434729|NCT01430182|1067661|P1|STARTED|Overall Study||9
434730|NCT01430169|1067667|P1|NOT COMPLETED|Overall Study||0
434731|NCT01430169|1067667|P1|COMPLETED|Overall Study||20
434732|NCT01430169|1067667|P1|STARTED|Overall Study||20
434733|NCT01430130|1067682|P1|NOT COMPLETED|Overall Study||2
434734|NCT01430130|1067682|P1|COMPLETED|Overall Study||10
434735|NCT01430130|1067682|P1|STARTED|Overall Study||12
434736|NCT01430104|1067688|P1|NOT COMPLETED|28-Day Teriparatide Treatment Period||1
434737|NCT01430104|1067688|P1|COMPLETED|28-Day Teriparatide Treatment Period||28
434738|NCT01430104|1067688|P1|Received at Least 1 Dose of Teriparatide|28-Day Teriparatide Treatment Period||29
434739|NCT01430104|1067688|P1|STARTED|28-Day Teriparatide Treatment Period|1 participant withdrew from the study after completing the 14-day Lead-in Period.|29
434740|NCT01430104|1067688|P1|NOT COMPLETED|14-Day Lead-In Period||0
434741|NCT01430104|1067688|P1|COMPLETED|14-Day Lead-In Period||30
434742|NCT01430104|1067688|P1|STARTED|14-Day Lead-In Period||30
434743|NCT01430091|1067700|P1|NOT COMPLETED|Overall Study||0
434744|NCT01430091|1067700|P1|COMPLETED|Overall Study||18
434745|NCT01430091|1067700|P1|STARTED|Overall Study||18
434746|NCT01429987|1067726|P4|NOT COMPLETED|Overall Study||66
434747|NCT01429987|1067727|P3|NOT COMPLETED|Overall Study||36
434748|NCT01429987|1067728|P2|NOT COMPLETED|Overall Study||62
434749|NCT01429987|1067729|P1|NOT COMPLETED|Overall Study||49
434750|NCT01429987|1067726|P4|COMPLETED|Overall Study||171
434751|NCT01429987|1067727|P3|COMPLETED|Overall Study||202
434752|NCT01429987|1067728|P2|COMPLETED|Overall Study||176
434753|NCT01429987|1067729|P1|COMPLETED|Overall Study||189
434754|NCT01429987|1067726|P4|STARTED|Overall Study||237
434755|NCT01429987|1067727|P3|STARTED|Overall Study||238
434756|NCT01429987|1067728|P2|STARTED|Overall Study||238
434757|NCT01429987|1067729|P1|STARTED|Overall Study||238
434758|NCT01429623|1067741|P2|NOT COMPLETED|Overall Study||59
434759|NCT01429623|1067742|P1|NOT COMPLETED|Overall Study||51
434760|NCT01429623|1067741|P2|COMPLETED|Overall Study||48
434761|NCT01429623|1067742|P1|COMPLETED|Overall Study||51
434762|NCT01429623|1067741|P2|Converted to Alzheimer's|Overall Study|21 of 103|21
434763|NCT01429623|1067742|P1|Converted to Alzheimer's|Overall Study|14 of 99|14
434764|NCT01429623|1067741|P2|STARTED|Overall Study|107 allocated, 4 lacked post baseline data|107
434765|NCT01429623|1067742|P1|STARTED|Overall Study|103 allocated, 1 withdrew consent prior to first dose, 4 lacked post baseline data|102
434766|NCT01429584|1067756|P2|NOT COMPLETED|Overall Study||1
434767|NCT01429584|1067757|P1|NOT COMPLETED|Overall Study||1
434768|NCT01429584|1067756|P2|COMPLETED|Overall Study||14
434769|NCT01429584|1067757|P1|COMPLETED|Overall Study||14
434770|NCT01429584|1067756|P2|STARTED|Overall Study||15
434771|NCT01429584|1067757|P1|STARTED|Overall Study||15
434772|NCT01429532|1067770|P3|NOT COMPLETED|Overall Study||0
434773|NCT01429532|1067771|P2|NOT COMPLETED|Overall Study||0
434774|NCT01429532|1067772|P1|NOT COMPLETED|Overall Study||0
434775|NCT01429532|1067770|P3|COMPLETED|Overall Study||40
434776|NCT01429532|1067771|P2|COMPLETED|Overall Study||40
434777|NCT01429532|1067772|P1|COMPLETED|Overall Study||40
434778|NCT01429532|1067770|P3|STARTED|Overall Study||40
434779|NCT01429532|1067771|P2|STARTED|Overall Study||40
434780|NCT01429532|1067772|P1|STARTED|Overall Study||40
434781|NCT01429441|1067788|P2|NOT COMPLETED|Overall Study||23
434782|NCT01429441|1067789|P1|NOT COMPLETED|Overall Study||38
434783|NCT01429441|1067788|P2|COMPLETED|Overall Study||51
434784|NCT01429441|1067789|P1|COMPLETED|Overall Study||108
434785|NCT01429441|1067788|P2|STARTED|Overall Study||74
434786|NCT01429441|1067789|P1|STARTED|Overall Study||146
434787|NCT01429298|1067799|P2|NOT COMPLETED|Overall Study||6
434788|NCT01429298|1067800|P1|NOT COMPLETED|Overall Study||4
434789|NCT01429298|1067799|P2|COMPLETED|Overall Study||169
434790|NCT01429298|1067800|P1|COMPLETED|Overall Study||171
434791|NCT01429298|1067799|P2|Given IV Opioids|Overall Study|6 never given IV opioids|169
434792|NCT01429298|1067800|P1|Given IV Opioids|Overall Study|4 never given IV opioids|171
434793|NCT01429298|1067799|P2|STARTED|Overall Study||175
434794|NCT01429298|1067800|P1|STARTED|Overall Study||175
434795|NCT01429285|1067816|P2|NOT COMPLETED|Overall Study||9
434796|NCT01429285|1067817|P1|NOT COMPLETED|Overall Study||22
434797|NCT01429285|1067816|P2|COMPLETED|Overall Study||166
434798|NCT01429285|1067817|P1|COMPLETED|Overall Study||153
434799|NCT01429285|1067816|P2|Confirmation of no Duplicate Enrollment|Overall Study|2 patients were enrolled twice, at two separate ED visits, which was only noted at study conclusion|166
434800|NCT01429285|1067817|P1|Confirmation of no Duplicate Enrollment|Overall Study|8 patients were enrolled twice at two separate ED visits, which was only noted at study conclusion.|153
434801|NCT01429285|1067816|P2|Completed Primary Outcome Data|Overall Study|3 patients had missing data|168
434802|NCT01429285|1067817|P1|Completed Primary Outcome Data|Overall Study|5 patients had missing data|161
434803|NCT01429285|1067816|P2|Given IV Opioids|Overall Study|4 patients never given IV opioids|171
434804|NCT01429285|1067817|P1|Given IV Opioids|Overall Study|9 patients never given IV opioids|166
434805|NCT01429285|1067816|P2|STARTED|Overall Study||175
434806|NCT01429285|1067817|P1|STARTED|Overall Study||175
434807|NCT01429272|1067839|P4|NOT COMPLETED|Overall Study||5
434808|NCT01429272|1067840|P3|NOT COMPLETED|Overall Study||4
434809|NCT01429272|1067841|P2|NOT COMPLETED|Overall Study||9
434810|NCT01429272|1067842|P1|NOT COMPLETED|Overall Study||6
434811|NCT01429272|1067839|P4|COMPLETED|Overall Study||14
434812|NCT01429272|1067840|P3|COMPLETED|Overall Study||15
434813|NCT01429272|1067841|P2|COMPLETED|Overall Study||22
434814|NCT01429272|1067842|P1|COMPLETED|Overall Study||24
434815|NCT01429272|1067839|P4|STARTED|Overall Study||19
434816|NCT01429272|1067840|P3|STARTED|Overall Study||19
434817|NCT01429272|1067841|P2|STARTED|Overall Study||31
434818|NCT01429272|1067842|P1|STARTED|Overall Study||30
434819|NCT01429259|1067856|P1|NOT COMPLETED|Overall Study||0
434820|NCT01429259|1067856|P1|COMPLETED|Overall Study||30
434821|NCT01429259|1067856|P1|STARTED|Overall Study||30
434822|NCT01429077|1067863|P2|NOT COMPLETED|Overall Study||3
434823|NCT01429077|1067864|P1|NOT COMPLETED|Overall Study||0
434824|NCT01429077|1067863|P2|COMPLETED|Overall Study||14
434825|NCT01429077|1067864|P1|COMPLETED|Overall Study||19
434826|NCT01429077|1067863|P2|Completed 6-week Intervention|Overall Study||17
434827|NCT01429077|1067864|P1|Completed 6-week Intervention|Overall Study||19
434828|NCT01429077|1067863|P2|STARTED|Overall Study||17
434829|NCT01429077|1067864|P1|STARTED|Overall Study||19
434830|NCT01429064|1067874|P4|NOT COMPLETED|Overall Study||0
434831|NCT01429064|1067875|P3|NOT COMPLETED|Overall Study||0
434832|NCT01429064|1067876|P2|NOT COMPLETED|Overall Study||0
434833|NCT01429064|1067877|P1|NOT COMPLETED|Overall Study||0
434834|NCT01429064|1067874|P4|COMPLETED|Overall Study||16
434835|NCT01429064|1067875|P3|COMPLETED|Overall Study||19
434836|NCT01429064|1067876|P2|COMPLETED|Overall Study||22
434837|NCT01429064|1067877|P1|COMPLETED|Overall Study||19
434838|NCT01429064|1067874|P4|STARTED|Overall Study||16
434839|NCT01429064|1067875|P3|STARTED|Overall Study||19
434840|NCT01429064|1067876|P2|STARTED|Overall Study||22
434841|NCT01429064|1067877|P1|STARTED|Overall Study||19
434842|NCT01429051|1067887|P1|NOT COMPLETED|Tolerability Phase||15
434843|NCT01429051|1067887|P1|COMPLETED|Tolerability Phase||16
434844|NCT01429051|1067887|P1|STARTED|Tolerability Phase|Participants entered directly from the Titration or Efficacy Phase|31
434845|NCT01429051|1067887|P1|NOT COMPLETED|Efficacy Phase||2
434846|NCT01429051|1067887|P1|COMPLETED|Efficacy Phase||13
434847|NCT01429051|1067887|P1|STARTED|Efficacy Phase|Participants titrated to 200 or 400 μg INFS in Titration Phase|15
434848|NCT01429051|1067887|P1|NOT COMPLETED|Titration Phase||12
434849|NCT01429051|1067887|P1|COMPLETED|Titration Phase||33
434850|NCT01429051|1067887|P1|STARTED|Titration Phase||45
434851|NCT01428882|1067910|P2|NOT COMPLETED|Overall Study||10
434852|NCT01428882|1067911|P1|NOT COMPLETED|Overall Study||6
434853|NCT01428882|1067910|P2|COMPLETED|Overall Study||58
434854|NCT01428882|1067911|P1|COMPLETED|Overall Study||61
434855|NCT01428882|1067910|P2|STARTED|Overall Study||68
434856|NCT01428882|1067911|P1|STARTED|Overall Study||67
434857|NCT01428765|1067923|P1|NOT COMPLETED|Overall Study||0
434858|NCT01428765|1067923|P1|COMPLETED|Overall Study||1063
434859|NCT01428765|1067923|P1|STARTED|Overall Study||1063
434860|NCT01428713|1067934|P2|NOT COMPLETED|Overall Study||5
434861|NCT01428713|1067935|P1|NOT COMPLETED|Overall Study||3
434862|NCT01428713|1067934|P2|COMPLETED|Overall Study||3
434863|NCT01428713|1067935|P1|COMPLETED|Overall Study||6
434864|NCT01428713|1067934|P2|STARTED|Overall Study||8
434865|NCT01428713|1067935|P1|STARTED|Overall Study||9
434866|NCT01428661|1067944|P3|NOT COMPLETED|Open Label Extension||320
434867|NCT01428661|1067945|P2|NOT COMPLETED|Open Label Extension||0
434868|NCT01428661|1067946|P1|NOT COMPLETED|Open Label Extension||0
434869|NCT01428661|1067944|P3|COMPLETED|Open Label Extension||19
434870|NCT01428661|1067945|P2|COMPLETED|Open Label Extension|Does not apply.|0
434871|NCT01428661|1067946|P1|COMPLETED|Open Label Extension|Does not apply.|0
434872|NCT01428661|1067944|P3|STARTED|Open Label Extension||339
434873|NCT01428661|1067945|P2|STARTED|Open Label Extension|Does not apply.|0
434874|NCT01428661|1067946|P1|STARTED|Open Label Extension|Does not apply.|0
434875|NCT01428661|1067944|P3|NOT COMPLETED|Double-Masked Phase||0
434876|NCT01428661|1067945|P2|NOT COMPLETED|Double-Masked Phase||49
434877|NCT01428661|1067946|P1|NOT COMPLETED|Double-Masked Phase||57
434878|NCT01428661|1067944|P3|COMPLETED|Double-Masked Phase|Does not apply.|0
434879|NCT01428661|1067945|P2|COMPLETED|Double-Masked Phase||204
434880|NCT01428661|1067946|P1|COMPLETED|Double-Masked Phase||197
434881|NCT01428661|1067944|P3|STARTED|Double-Masked Phase|Does not apply.|0
434882|NCT01428661|1067945|P2|STARTED|Double-Masked Phase||253
434883|NCT01428661|1067946|P1|STARTED|Double-Masked Phase||254
434884|NCT01428583|1067954|P1|NOT COMPLETED|Overall Study||237
434885|NCT01428583|1067954|P1|COMPLETED|Overall Study||158
434886|NCT01428583|1067954|P1|STARTED|Overall Study||395
434887|NCT01428336|1067978|P2|NOT COMPLETED|Overall Study||0
434888|NCT01428336|1067979|P1|NOT COMPLETED|Overall Study||0
434889|NCT01428336|1067978|P2|COMPLETED|Overall Study||12
434890|NCT01428336|1067979|P1|COMPLETED|Overall Study||10
434891|NCT01428336|1067978|P2|STARTED|Overall Study||12
434892|NCT01428336|1067979|P1|STARTED|Overall Study||10
434893|NCT01428258|1067991|P2|NOT COMPLETED|Intervention 2||0
434894|NCT01428258|1067992|P1|NOT COMPLETED|Intervention 2||0
434895|NCT01428258|1067991|P2|COMPLETED|Intervention 2||15
434896|NCT01428258|1067992|P1|COMPLETED|Intervention 2||15
434897|NCT01428258|1067991|P2|STARTED|Intervention 2||15
434898|NCT01428258|1067992|P1|STARTED|Intervention 2||15
434899|NCT01428258|1067991|P2|NOT COMPLETED|Intervention 1||0
434900|NCT01428258|1067992|P1|NOT COMPLETED|Intervention 1||2
434901|NCT01428258|1067991|P2|COMPLETED|Intervention 1||15
434902|NCT01428258|1067992|P1|COMPLETED|Intervention 1||15
434903|NCT01428258|1067991|P2|STARTED|Intervention 1||15
434904|NCT01428258|1067992|P1|STARTED|Intervention 1||17
434905|NCT01428219|1068010|P1|NOT COMPLETED|Overall Study||3
434906|NCT01428219|1068010|P1|COMPLETED|Overall Study||22
434907|NCT01428219|1068010|P1|STARTED|Overall Study||25
434908|NCT01428193|1068021|P1|NOT COMPLETED|Overall Study||2
434909|NCT01428193|1068021|P1|COMPLETED|Overall Study||2
434910|NCT01428193|1068021|P1|STARTED|Overall Study||4
434911|NCT01428128|1068025|P1|NOT COMPLETED|Overall Study||17
434912|NCT01428128|1068025|P1|COMPLETED|Overall Study||33
434913|NCT01428128|1068025|P1|STARTED|Overall Study||50
434914|NCT01428115|1068030|P1|NOT COMPLETED|Overall Study||21
434915|NCT01428115|1068030|P1|COMPLETED|Overall Study||62
434916|NCT01428115|1068030|P1|STARTED|Overall Study||83
434917|NCT01428076|1068045|P2|NOT COMPLETED|Overall Study||1
434918|NCT01428076|1068046|P1|NOT COMPLETED|Overall Study||0
434919|NCT01428076|1068045|P2|COMPLETED|Overall Study||11
434920|NCT01428076|1068046|P1|COMPLETED|Overall Study||9
434921|NCT01428076|1068045|P2|STARTED|Overall Study||12
434922|NCT01428076|1068046|P1|STARTED|Overall Study||9
434923|NCT01428063|1068057|P3|NOT COMPLETED|Overall Study||1
434924|NCT01428063|1068058|P2|NOT COMPLETED|Overall Study||10
434925|NCT01428063|1068059|P1|NOT COMPLETED|Overall Study||10
434926|NCT01428063|1068057|P3|COMPLETED|Overall Study||5
434927|NCT01428063|1068058|P2|COMPLETED|Overall Study||112
434928|NCT01428063|1068059|P1|COMPLETED|Overall Study||89
434929|NCT01428063|1068057|P3|STARTED|Overall Study||6
434930|NCT01428063|1068058|P2|STARTED|Overall Study||122
434931|NCT01428063|1068059|P1|STARTED|Overall Study||99
434932|NCT01427933|1068130|P2|NOT COMPLETED|Overall Study||13
434933|NCT01427933|1068131|P1|NOT COMPLETED|Overall Study||8
434934|NCT01427933|1068130|P2|COMPLETED|Overall Study||57
434935|NCT01427933|1068131|P1|COMPLETED|Overall Study||63
434936|NCT01427933|1068130|P2|Received at Least 1 Dose of Study Drug|Overall Study||65
434937|NCT01427933|1068131|P1|Received at Least 1 Dose of Study Drug|Overall Study||69
434938|NCT01427933|1068130|P2|STARTED|Overall Study||70
434939|NCT01427933|1068131|P1|STARTED|Overall Study||71
434940|NCT01427920|1068151|P2|NOT COMPLETED|Overall Study||17
434941|NCT01427920|1068152|P1|NOT COMPLETED|Overall Study||9
434942|NCT01427920|1068151|P2|COMPLETED|Overall Study||157
434943|NCT01427920|1068152|P1|COMPLETED|Overall Study||165
434944|NCT01427920|1068151|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|173
434945|NCT01427920|1068152|P1|Exposed|Overall Study||174
434946|NCT01427920|1068151|P2|STARTED|Overall Study||174
434947|NCT01427920|1068152|P1|STARTED|Overall Study||174
434948|NCT01427907|1068172|P2|NOT COMPLETED|Overall Study||4
434949|NCT01427907|1068173|P1|NOT COMPLETED|Overall Study||3
434950|NCT01427907|1068172|P2|COMPLETED|Overall Study|Completed study|14
434951|NCT01427907|1068173|P1|COMPLETED|Overall Study|Completed study|17
434952|NCT01427907|1068172|P2|STARTED|Overall Study|Randomized|18
434953|NCT01427907|1068173|P1|STARTED|Overall Study|Randomized|20
434954|NCT01427881|1068179|P1|NOT COMPLETED|Overall Study||0
434955|NCT01427881|1068179|P1|COMPLETED|Overall Study||43
434956|NCT01427881|1068179|P1|STARTED|Overall Study||43
434957|NCT01427803|1068194|P2|NOT COMPLETED|Overall Study||26
434958|NCT01427803|1068195|P1|NOT COMPLETED|Overall Study||63
434959|NCT01427803|1068194|P2|COMPLETED|Overall Study|130 participants interviewed. Remaining subjects continued in trial to collect safety information.|226
434960|NCT01427803|1068195|P1|COMPLETED|Overall Study||463
434961|NCT01427803|1068194|P2|Took Product|Overall Study|Those who took at least one dose of investigational product as logged in e diary & 1 on Health Log.|237
434962|NCT01427803|1068195|P1|Took Product|Overall Study|Those who took at least one dose of investigational product. Only 502 qualified for data analysis.|508
434963|NCT01427803|1068194|P2|Baseline Assessment|Overall Study|only interviewed participants were assessed|130
434964|NCT01427803|1068195|P1|Baseline Assessment|Overall Study||516
434965|NCT01427803|1068194|P2|Purchased Product|Overall Study||252
434966|NCT01427803|1068195|P1|Purchased Product|Overall Study|Only 516 participants used e-diary|525
434967|NCT01427803|1068194|P2|STARTED|Overall Study||252
434968|NCT01427803|1068195|P1|STARTED|Overall Study||526
434969|NCT01427751|1068209|P2|NOT COMPLETED|Overall Study||14
434970|NCT01427751|1068210|P1|NOT COMPLETED|Overall Study||42
434971|NCT01427751|1068209|P2|COMPLETED|Overall Study||139
434972|NCT01427751|1068210|P1|COMPLETED|Overall Study||112
434973|NCT01427751|1068209|P2|STARTED|Overall Study||153
434974|NCT01427751|1068210|P1|STARTED|Overall Study||154
434975|NCT01427738|1068230|P2|NOT COMPLETED|Overall Study||21
434976|NCT01427738|1068231|P1|NOT COMPLETED|Overall Study||19
434977|NCT01427738|1068230|P2|COMPLETED|Overall Study||90
434978|NCT01427738|1068231|P1|COMPLETED|Overall Study||91
434979|NCT01427738|1068230|P2|STARTED|Overall Study||111
434980|NCT01427738|1068231|P1|STARTED|Overall Study||110
434981|NCT01427517|1068252|P3|NOT COMPLETED|Overall Study||0
434982|NCT01427517|1068253|P2|NOT COMPLETED|Overall Study||0
434983|NCT01427517|1068254|P1|NOT COMPLETED|Overall Study||0
434984|NCT01427517|1068252|P3|COMPLETED|Overall Study||3
434985|NCT01427517|1068253|P2|COMPLETED|Overall Study||3
434986|NCT01427517|1068254|P1|COMPLETED|Overall Study||3
434987|NCT01427517|1068252|P3|STARTED|Overall Study||3
434988|NCT01427517|1068253|P2|STARTED|Overall Study||3
434989|NCT01427517|1068254|P1|STARTED|Overall Study||3
434990|NCT01427504|1068268|P6|NOT COMPLETED|Overall Study||2
434991|NCT01427504|1068269|P5|NOT COMPLETED|Overall Study||1
434992|NCT01427504|1068270|P4|NOT COMPLETED|Overall Study||1
434993|NCT01427504|1068271|P3|NOT COMPLETED|Overall Study||1
434994|NCT01427504|1068272|P2|NOT COMPLETED|Overall Study||1
434995|NCT01427504|1068273|P1|NOT COMPLETED|Overall Study||0
434996|NCT01427504|1068268|P6|COMPLETED|Overall Study||4
434997|NCT01427504|1068269|P5|COMPLETED|Overall Study||2
434998|NCT01427504|1068270|P4|COMPLETED|Overall Study||5
434999|NCT01427504|1068271|P3|COMPLETED|Overall Study||3
435000|NCT01427504|1068272|P2|COMPLETED|Overall Study||2
435001|NCT01427504|1068273|P1|COMPLETED|Overall Study||4
435002|NCT01427504|1068268|P6|Received Combination|Overall Study||6
435003|NCT01427504|1068269|P5|Received Combination|Overall Study||3
435004|NCT01427504|1068270|P4|Received Combination|Overall Study||6
435005|NCT01427504|1068271|P3|Received Combination|Overall Study||3
435006|NCT01427504|1068272|P2|Received Combination|Overall Study||3
435007|NCT01427504|1068273|P1|Received Combination|Overall Study||4
435008|NCT01427504|1068268|P6|Received Etravirine|Overall Study||4
435009|NCT01427504|1068269|P5|Received Etravirine|Overall Study||2
435010|NCT01427504|1068270|P4|Received Etravirine|Overall Study||6
435011|NCT01427504|1068271|P3|Received Etravirine|Overall Study||4
435012|NCT01427504|1068272|P2|Received Etravirine|Overall Study||2
435013|NCT01427504|1068273|P1|Received Etravirine|Overall Study||4
435014|NCT01427504|1068268|P6|Received Boceprevir|Overall Study||4
435015|NCT01427504|1068269|P5|Received Boceprevir|Overall Study||2
435016|NCT01427504|1068270|P4|Received Boceprevir|Overall Study||5
435017|NCT01427504|1068271|P3|Received Boceprevir|Overall Study||3
435018|NCT01427504|1068272|P2|Received Boceprevir|Overall Study||3
435019|NCT01427504|1068273|P1|Received Boceprevir|Overall Study||4
435020|NCT01427504|1068268|P6|STARTED|Overall Study||6
435021|NCT01427504|1068269|P5|STARTED|Overall Study||3
435022|NCT01427504|1068270|P4|STARTED|Overall Study||6
435023|NCT01427504|1068271|P3|STARTED|Overall Study||4
435024|NCT01427504|1068272|P2|STARTED|Overall Study||3
435025|NCT01427504|1068273|P1|STARTED|Overall Study||4
435026|NCT01427309|1068294|P4|NOT COMPLETED|Overall Study||376
435027|NCT01427309|1068295|P3|NOT COMPLETED|Overall Study||361
435028|NCT01427309|1068296|P2|NOT COMPLETED|Overall Study||407
435029|NCT01427309|1068297|P1|NOT COMPLETED|Overall Study||372
435030|NCT01427309|1068294|P4|COMPLETED|Overall Study||8373
435031|NCT01427309|1068295|P3|COMPLETED|Overall Study||8376
435032|NCT01427309|1068296|P2|COMPLETED|Overall Study||6837
435033|NCT01427309|1068297|P1|COMPLETED|Overall Study||6881
435034|NCT01427309|1068294|P4|STARTED|Overall Study||8749
435035|NCT01427309|1068295|P3|STARTED|Overall Study||8737
435036|NCT01427309|1068296|P2|STARTED|Overall Study||7244
435037|NCT01427309|1068297|P1|STARTED|Overall Study||7253
435038|NCT01427296|1068337|P2|NOT COMPLETED|Overall Study||0
435039|NCT01427296|1068338|P1|NOT COMPLETED|Overall Study||0
435040|NCT01427296|1068337|P2|COMPLETED|Overall Study||1051
435041|NCT01427296|1068338|P1|COMPLETED|Overall Study||1041
435042|NCT01427296|1068337|P2|STARTED|Overall Study||1051
435043|NCT01427296|1068338|P1|STARTED|Overall Study||1041
435044|NCT01426958|1068344|P1|NOT COMPLETED|Overall Study||2
435045|NCT01426958|1068344|P1|COMPLETED|Overall Study||22
435046|NCT01426958|1068344|P1|STARTED|Overall Study||24
435047|NCT01426867|1068361|P3|NOT COMPLETED|Overall Study||0
435048|NCT01426867|1068362|P2|NOT COMPLETED|Overall Study||0
435049|NCT01426867|1068363|P1|NOT COMPLETED|Overall Study||0
435050|NCT01426867|1068361|P3|COMPLETED|Overall Study||34
435051|NCT01426867|1068362|P2|COMPLETED|Overall Study||34
435052|NCT01426867|1068363|P1|COMPLETED|Overall Study||33
435053|NCT01426867|1068361|P3|STARTED|Overall Study||34
435054|NCT01426867|1068362|P2|STARTED|Overall Study||34
435055|NCT01426867|1068363|P1|STARTED|Overall Study||33
435056|NCT01426854|1068373|P2|NOT COMPLETED|Overall Study||31
435057|NCT01426854|1068374|P1|NOT COMPLETED|Overall Study||12
435058|NCT01426854|1068373|P2|COMPLETED|Overall Study||98
435059|NCT01426854|1068374|P1|COMPLETED|Overall Study||119
435060|NCT01426854|1068373|P2|STARTED|Overall Study||129
435061|NCT01426854|1068374|P1|STARTED|Overall Study||131
435062|NCT01426789|1068384|P6|NOT COMPLETED|Part 2||0
435063|NCT01426789|1068385|P5|NOT COMPLETED|Part 2||8
435064|NCT01426789|1068386|P4|NOT COMPLETED|Part 2||1
435065|NCT01426789|1068387|P3|NOT COMPLETED|Part 2||15
435066|NCT01426789|1068388|P2|NOT COMPLETED|Part 2||0
435067|NCT01426789|1068389|P1|NOT COMPLETED|Part 2||0
435068|NCT01426789|1068384|P6|COMPLETED|Part 2||1
435069|NCT01426789|1068385|P5|COMPLETED|Part 2||19
435070|NCT01426789|1068386|P4|COMPLETED|Part 2||12
435071|NCT01426789|1068387|P3|COMPLETED|Part 2||34
435072|NCT01426789|1068388|P2|COMPLETED|Part 2||0
435073|NCT01426789|1068389|P1|COMPLETED|Part 2||0
435074|NCT01426789|1068384|P6|STARTED|Part 2||1
435075|NCT01426789|1068385|P5|STARTED|Part 2||27
435076|NCT01426789|1068386|P4|STARTED|Part 2||13
435077|NCT01426789|1068387|P3|STARTED|Part 2||49
435078|NCT01426789|1068388|P2|STARTED|Part 2||0
435079|NCT01426789|1068389|P1|STARTED|Part 2||0
435080|NCT01426789|1068384|P6|NOT COMPLETED|Part 1||0
435081|NCT01426789|1068385|P5|NOT COMPLETED|Part 1||0
435082|NCT01426789|1068386|P4|NOT COMPLETED|Part 1||0
435083|NCT01426789|1068387|P3|NOT COMPLETED|Part 1||0
435084|NCT01426789|1068388|P2|NOT COMPLETED|Part 1||4
435085|NCT01426789|1068389|P1|NOT COMPLETED|Part 1||6
435086|NCT01426789|1068384|P6|COMPLETED|Part 1||0
435087|NCT01426789|1068385|P5|COMPLETED|Part 1||0
435088|NCT01426789|1068386|P4|COMPLETED|Part 1||0
435089|NCT01426789|1068387|P3|COMPLETED|Part 1||0
435090|NCT01426789|1068388|P2|COMPLETED|Part 1||28
435091|NCT01426789|1068389|P1|COMPLETED|Part 1||62
435092|NCT01426789|1068384|P6|STARTED|Part 1||0
435093|NCT01426789|1068385|P5|STARTED|Part 1||0
435094|NCT01426789|1068386|P4|STARTED|Part 1||0
435095|NCT01426789|1068387|P3|STARTED|Part 1||0
435096|NCT01426789|1068388|P2|STARTED|Part 1||32
435097|NCT01426789|1068389|P1|STARTED|Part 1||68
435098|NCT01426763|1068405|P2|NOT COMPLETED|Overall Study||0
435099|NCT01426763|1068406|P1|NOT COMPLETED|Overall Study||0
435100|NCT01426763|1068405|P2|COMPLETED|Overall Study||6
435101|NCT01426763|1068406|P1|COMPLETED|Overall Study||6
435102|NCT01426763|1068405|P2|STARTED|Overall Study||6
435103|NCT01426763|1068406|P1|STARTED|Overall Study||6
435104|NCT01426555|1068414|P2|NOT COMPLETED|Overall Study||15
435105|NCT01426555|1068415|P1|NOT COMPLETED|Overall Study||18
435106|NCT01426555|1068414|P2|COMPLETED|Overall Study||20
435107|NCT01426555|1068415|P1|COMPLETED|Overall Study||17
435108|NCT01426555|1068414|P2|STARTED|Overall Study||35
435109|NCT01426555|1068415|P1|STARTED|Overall Study||35
435110|NCT01426516|1068425|P2|NOT COMPLETED|Overall Study||0
435111|NCT01426516|1068426|P1|NOT COMPLETED|Overall Study||0
435112|NCT01426516|1068425|P2|COMPLETED|Overall Study||17
435113|NCT01426516|1068426|P1|COMPLETED|Overall Study||12
435114|NCT01426516|1068425|P2|STARTED|Overall Study||17
435115|NCT01426516|1068426|P1|STARTED|Overall Study||12
435116|NCT01426438|1068434|P2|NOT COMPLETED|Overall Study||10
435117|NCT01426438|1068435|P1|NOT COMPLETED|Overall Study||15
435118|NCT01426438|1068434|P2|COMPLETED|Overall Study||39
435119|NCT01426438|1068435|P1|COMPLETED|Overall Study||35
435120|NCT01426438|1068434|P2|STARTED|Overall Study||49
435121|NCT01426438|1068435|P1|STARTED|Overall Study||50
435122|NCT01426425|1068467|P1|NOT COMPLETED|Overall Study||175
435123|NCT01426425|1068467|P1|COMPLETED|Overall Study|The pre-specified modified intent-to-treat analysis set was used for the primary objectives.|397
435124|NCT01426425|1068467|P1|Intent to Treat|Overall Study|Met all inclusion and no exclusion criteria.|399
435125|NCT01426425|1068467|P1|EP Study|Overall Study|EP study used to assess inclusion and exclusion criteria.|550
435126|NCT01426425|1068467|P1|STARTED|Overall Study||572
435127|NCT01426373|1068473|P1|NOT COMPLETED|Overall Study||34
435128|NCT01426373|1068473|P1|COMPLETED|Overall Study|Completed the last follow-up visit 12 months after last treatment|131
435129|NCT01426373|1068473|P1|STARTED|Overall Study||165
435130|NCT01426360|1068491|P2|NOT COMPLETED|Overall Study||0
435131|NCT01426360|1068492|P1|NOT COMPLETED|Overall Study||0
435132|NCT01426360|1068491|P2|COMPLETED|Overall Study||41
435133|NCT01426360|1068492|P1|COMPLETED|Overall Study||38
435134|NCT01426360|1068491|P2|STARTED|Overall Study||41
435135|NCT01426360|1068492|P1|STARTED|Overall Study||38
435136|NCT01426347|1068506|P2|NOT COMPLETED|Overall Study||3
435137|NCT01426347|1068507|P1|NOT COMPLETED|Overall Study||7
435138|NCT01426347|1068506|P2|COMPLETED|Overall Study||39
435139|NCT01426347|1068507|P1|COMPLETED|Overall Study||34
435140|NCT01426347|1068506|P2|STARTED|Overall Study||42
435141|NCT01426347|1068507|P1|STARTED|Overall Study||41
435142|NCT01426269|1068515|P3|NOT COMPLETED|Period 2: 40 Weeks||47
435143|NCT01426269|1068516|P2|NOT COMPLETED|Period 2: 40 Weeks||38
435144|NCT01426269|1068517|P1|NOT COMPLETED|Period 2: 40 Weeks||0
435145|NCT01426269|1068515|P3|COMPLETED|Period 2: 40 Weeks||18
435146|NCT01426269|1068516|P2|COMPLETED|Period 2: 40 Weeks||27
435147|NCT01426269|1068517|P1|COMPLETED|Period 2: 40 Weeks||0
435148|NCT01426269|1068515|P3|STARTED|Period 2: 40 Weeks||65
435149|NCT01426269|1068516|P2|STARTED|Period 2: 40 Weeks||65
435150|NCT01426269|1068517|P1|STARTED|Period 2: 40 Weeks||0
435151|NCT01426269|1068515|P3|NOT COMPLETED|Eligibility for Period 2, Randomization||0
435152|NCT01426269|1068516|P2|NOT COMPLETED|Eligibility for Period 2, Randomization||0
435153|NCT01426269|1068517|P1|NOT COMPLETED|Eligibility for Period 2, Randomization||50
435154|NCT01426269|1068515|P3|COMPLETED|Eligibility for Period 2, Randomization||0
435155|NCT01426269|1068516|P2|COMPLETED|Eligibility for Period 2, Randomization||0
435156|NCT01426269|1068517|P1|COMPLETED|Eligibility for Period 2, Randomization||130
435157|NCT01426269|1068515|P3|STARTED|Eligibility for Period 2, Randomization||0
435158|NCT01426269|1068516|P2|STARTED|Eligibility for Period 2, Randomization||0
435159|NCT01426269|1068517|P1|STARTED|Eligibility for Period 2, Randomization||180
435160|NCT01426269|1068515|P3|NOT COMPLETED|Period 1: 12 Weeks||0
435161|NCT01426269|1068516|P2|NOT COMPLETED|Period 1: 12 Weeks||0
435162|NCT01426269|1068517|P1|NOT COMPLETED|Period 1: 12 Weeks||55
435163|NCT01426269|1068515|P3|COMPLETED|Period 1: 12 Weeks||0
435164|NCT01426269|1068516|P2|COMPLETED|Period 1: 12 Weeks||0
435165|NCT01426269|1068517|P1|COMPLETED|Period 1: 12 Weeks||180
435166|NCT01426269|1068515|P3|STARTED|Period 1: 12 Weeks||0
435167|NCT01426269|1068516|P2|STARTED|Period 1: 12 Weeks||0
435168|NCT01426269|1068517|P1|STARTED|Period 1: 12 Weeks||235
435169|NCT01426230|1068544|P2|NOT COMPLETED|Overall Study||27
435170|NCT01426230|1068545|P1|NOT COMPLETED|Overall Study||31
435171|NCT01426230|1068544|P2|COMPLETED|Overall Study||84
435172|NCT01426230|1068545|P1|COMPLETED|Overall Study||55
435173|NCT01426230|1068544|P2|STARTED|Overall Study||111
435174|NCT01426230|1068545|P1|STARTED|Overall Study|90 patients were enrolled, but only 86 received study treatment.|86
435175|NCT01426113|1068552|P2|NOT COMPLETED|Overall Study||2
435176|NCT01426113|1068553|P1|NOT COMPLETED|Overall Study||1
435177|NCT01426113|1068552|P2|COMPLETED|Overall Study||1
435178|NCT01426113|1068553|P1|COMPLETED|Overall Study||2
435179|NCT01426113|1068552|P2|STARTED|Overall Study||3
435180|NCT01426113|1068553|P1|STARTED|Overall Study||3
435181|NCT01426009|1068559|P1|NOT COMPLETED|Washout 4||1
435182|NCT01426009|1068559|P1|COMPLETED|Washout 4||126
435183|NCT01426009|1068559|P1|STARTED|Washout 4||127
435184|NCT01426009|1068559|P1|NOT COMPLETED|Period 4-Fourth Intervention (7 Days)||1
435185|NCT01426009|1068559|P1|COMPLETED|Period 4-Fourth Intervention (7 Days)||127
435186|NCT01426009|1068559|P1|Placebo|Period 4-Fourth Intervention (7 Days)||10
435187|NCT01426009|1068559|P1|Tiotropium Bromide|Period 4-Fourth Intervention (7 Days)||76
435188|NCT01426009|1068559|P1|Ipratropium Bromide|Period 4-Fourth Intervention (7 Days)||8
435189|NCT01426009|1068559|P1|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||9
435190|NCT01426009|1068559|P1|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||8
435191|NCT01426009|1068559|P1|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||7
435192|NCT01426009|1068559|P1|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||10
435193|NCT01426009|1068559|P1|STARTED|Period 4-Fourth Intervention (7 Days)||128
435194|NCT01426009|1068559|P1|NOT COMPLETED|Washout 3||1
435195|NCT01426009|1068559|P1|COMPLETED|Washout 3||128
435196|NCT01426009|1068559|P1|STARTED|Washout 3||129
435197|NCT01426009|1068559|P1|NOT COMPLETED|Period 3-Third Intervention (7 Days)||0
435198|NCT01426009|1068559|P1|COMPLETED|Period 3-Third Intervention (7 Days)||129
435199|NCT01426009|1068559|P1|Placebo|Period 3-Third Intervention (7 Days)||22
435200|NCT01426009|1068559|P1|Ipratropium Bromide|Period 3-Third Intervention (7 Days)||23
435201|NCT01426009|1068559|P1|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||20
435202|NCT01426009|1068559|P1|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||22
435203|NCT01426009|1068559|P1|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||23
435204|NCT01426009|1068559|P1|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||19
435205|NCT01426009|1068559|P1|STARTED|Period 3-Third Intervention (7 Days)||129
435206|NCT01426009|1068559|P1|NOT COMPLETED|Washout 2||1
435207|NCT01426009|1068559|P1|COMPLETED|Washout 2||129
435208|NCT01426009|1068559|P1|STARTED|Washout 2||130
435209|NCT01426009|1068559|P1|NOT COMPLETED|Period 2-Second Intervention (7 Days)||5
435210|NCT01426009|1068559|P1|COMPLETED|Period 2-Second Intervention (7 Days)||130
435211|NCT01426009|1068559|P1|Placebo|Period 2-Second Intervention (7 Days)||21
435212|NCT01426009|1068559|P1|Ipratropium Bromide|Period 2-Second Intervention (7 Days)||21
435213|NCT01426009|1068559|P1|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||23
435214|NCT01426009|1068559|P1|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||24
435215|NCT01426009|1068559|P1|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||24
435216|NCT01426009|1068559|P1|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||22
435217|NCT01426009|1068559|P1|STARTED|Period 2-Second Intervention (7 Days)||135
435218|NCT01426009|1068559|P1|NOT COMPLETED|Washout 1||2
435219|NCT01426009|1068559|P1|COMPLETED|Washout 1||135
435220|NCT01426009|1068559|P1|STARTED|Washout 1||137
435221|NCT01426009|1068559|P1|NOT COMPLETED|Period 1-First Intervention (7 Days)||2
435222|NCT01426009|1068559|P1|COMPLETED|Period 1-First Intervention (7 Days)||137
435223|NCT01426009|1068559|P1|Placebo|Period 1-First Intervention (7 Days)||24
435224|NCT01426009|1068559|P1|Ipratropium Bromide|Period 1-First Intervention (7 Days)||23
435225|NCT01426009|1068559|P1|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||23
435226|NCT01426009|1068559|P1|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||22
435227|NCT01426009|1068559|P1|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||24
435228|NCT01426009|1068559|P1|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||23
435229|NCT01426009|1068559|P1|STARTED|Period 1-First Intervention (7 Days)||139
435230|NCT01425879|1068615|P1|NOT COMPLETED|Overall Study||0
435231|NCT01425879|1068615|P1|COMPLETED|Overall Study||8
435232|NCT01425879|1068615|P1|STARTED|Overall Study||8
435233|NCT01425853|1068624|P2|NOT COMPLETED|Overall Study||77
435234|NCT01425853|1068625|P1|NOT COMPLETED|Overall Study||64
435235|NCT01425853|1068624|P2|COMPLETED|Overall Study||225
435236|NCT01425853|1068625|P1|COMPLETED|Overall Study||240
435237|NCT01425853|1068624|P2|Per Protocol (PP)|Overall Study||258
435238|NCT01425853|1068625|P1|Per Protocol (PP)|Overall Study||264
435239|NCT01425853|1068624|P2|Safety Population|Overall Study||299
435240|NCT01425853|1068625|P1|Safety Population|Overall Study||304
435241|NCT01425853|1068624|P2|STARTED|Overall Study||302
435242|NCT01425853|1068625|P1|STARTED|Overall Study||304
435243|NCT01425814|1068655|P6|NOT COMPLETED|Period 5||1
435244|NCT01425814|1068656|P5|NOT COMPLETED|Period 5||0
435245|NCT01425814|1068657|P4|NOT COMPLETED|Period 5||0
435246|NCT01425814|1068658|P3|NOT COMPLETED|Period 5||1
435247|NCT01425814|1068659|P2|NOT COMPLETED|Period 5||0
435248|NCT01425814|1068660|P1|NOT COMPLETED|Period 5||0
435249|NCT01425814|1068655|P6|COMPLETED|Period 5||11
435250|NCT01425814|1068656|P5|COMPLETED|Period 5||12
435251|NCT01425814|1068657|P4|COMPLETED|Period 5||10
435252|NCT01425814|1068658|P3|COMPLETED|Period 5||10
435253|NCT01425814|1068659|P2|COMPLETED|Period 5||9
435254|NCT01425814|1068660|P1|COMPLETED|Period 5||11
435255|NCT01425814|1068655|P6|STARTED|Period 5||12
435256|NCT01425814|1068656|P5|STARTED|Period 5||12
435257|NCT01425814|1068657|P4|STARTED|Period 5||10
435258|NCT01425814|1068658|P3|STARTED|Period 5||11
435259|NCT01425814|1068659|P2|STARTED|Period 5||9
435260|NCT01425814|1068660|P1|STARTED|Period 5||11
435261|NCT01425814|1068655|P6|NOT COMPLETED|Period 4||0
435262|NCT01425814|1068656|P5|NOT COMPLETED|Period 4||0
435263|NCT01425814|1068657|P4|NOT COMPLETED|Period 4||0
435264|NCT01425814|1068658|P3|NOT COMPLETED|Period 4||1
435265|NCT01425814|1068659|P2|NOT COMPLETED|Period 4||0
435266|NCT01425814|1068660|P1|NOT COMPLETED|Period 4||1
435267|NCT01425814|1068655|P6|COMPLETED|Period 4||12
435268|NCT01425814|1068656|P5|COMPLETED|Period 4||12
435269|NCT01425814|1068657|P4|COMPLETED|Period 4||10
435270|NCT01425814|1068658|P3|COMPLETED|Period 4||11
435271|NCT01425814|1068659|P2|COMPLETED|Period 4||9
435272|NCT01425814|1068660|P1|COMPLETED|Period 4||11
435273|NCT01425814|1068655|P6|STARTED|Period 4||12
435274|NCT01425814|1068656|P5|STARTED|Period 4||12
435275|NCT01425814|1068657|P4|STARTED|Period 4||10
435276|NCT01425814|1068658|P3|STARTED|Period 4||12
435277|NCT01425814|1068659|P2|STARTED|Period 4||9
435278|NCT01425814|1068660|P1|STARTED|Period 4||12
435279|NCT01425814|1068655|P6|NOT COMPLETED|Period 3||1
435280|NCT01425814|1068656|P5|NOT COMPLETED|Period 3||0
435281|NCT01425814|1068657|P4|NOT COMPLETED|Period 3||0
435282|NCT01425814|1068658|P3|NOT COMPLETED|Period 3||0
435283|NCT01425814|1068659|P2|NOT COMPLETED|Period 3||0
435284|NCT01425814|1068660|P1|NOT COMPLETED|Period 3||0
435285|NCT01425814|1068655|P6|COMPLETED|Period 3||12
435286|NCT01425814|1068656|P5|COMPLETED|Period 3||12
435287|NCT01425814|1068657|P4|COMPLETED|Period 3||10
435288|NCT01425814|1068658|P3|COMPLETED|Period 3||12
435289|NCT01425814|1068659|P2|COMPLETED|Period 3||9
435290|NCT01425814|1068660|P1|COMPLETED|Period 3||12
435291|NCT01425814|1068655|P6|STARTED|Period 3||13
435292|NCT01425814|1068656|P5|STARTED|Period 3||12
435293|NCT01425814|1068657|P4|STARTED|Period 3||10
435294|NCT01425814|1068658|P3|STARTED|Period 3||12
435295|NCT01425814|1068659|P2|STARTED|Period 3||9
435296|NCT01425814|1068660|P1|STARTED|Period 3||12
435297|NCT01425814|1068655|P6|NOT COMPLETED|Period 2||0
435298|NCT01425814|1068656|P5|NOT COMPLETED|Period 2||0
435299|NCT01425814|1068657|P4|NOT COMPLETED|Period 2||0
435300|NCT01425814|1068658|P3|NOT COMPLETED|Period 2||0
435301|NCT01425814|1068659|P2|NOT COMPLETED|Period 2||1
435302|NCT01425814|1068660|P1|NOT COMPLETED|Period 2||0
435303|NCT01425814|1068655|P6|COMPLETED|Period 2||13
435304|NCT01425814|1068656|P5|COMPLETED|Period 2||12
435305|NCT01425814|1068657|P4|COMPLETED|Period 2||10
435306|NCT01425814|1068658|P3|COMPLETED|Period 2||12
435307|NCT01425814|1068659|P2|COMPLETED|Period 2||9
435308|NCT01425814|1068660|P1|COMPLETED|Period 2||12
435309|NCT01425814|1068655|P6|STARTED|Period 2||13
435310|NCT01425814|1068656|P5|STARTED|Period 2||12
435311|NCT01425814|1068657|P4|STARTED|Period 2||10
435312|NCT01425814|1068658|P3|STARTED|Period 2||12
435313|NCT01425814|1068659|P2|STARTED|Period 2||10
435314|NCT01425814|1068660|P1|STARTED|Period 2||12
435315|NCT01425814|1068655|P6|NOT COMPLETED|Period 1||0
435316|NCT01425814|1068656|P5|NOT COMPLETED|Period 1||0
435317|NCT01425814|1068657|P4|NOT COMPLETED|Period 1||0
435318|NCT01425814|1068658|P3|NOT COMPLETED|Period 1||0
435319|NCT01425814|1068659|P2|NOT COMPLETED|Period 1||1
435320|NCT01425814|1068660|P1|NOT COMPLETED|Period 1||0
435321|NCT01425814|1068655|P6|COMPLETED|Period 1||13
435322|NCT01425814|1068656|P5|COMPLETED|Period 1||12
435323|NCT01425814|1068657|P4|COMPLETED|Period 1||10
435324|NCT01425814|1068658|P3|COMPLETED|Period 1||12
435325|NCT01425814|1068659|P2|COMPLETED|Period 1||10
435326|NCT01425814|1068660|P1|COMPLETED|Period 1||12
435327|NCT01425814|1068655|P6|STARTED|Period 1||13
435328|NCT01425814|1068656|P5|STARTED|Period 1||12
435329|NCT01425814|1068657|P4|STARTED|Period 1||10
435330|NCT01425814|1068658|P3|STARTED|Period 1||12
435331|NCT01425814|1068659|P2|STARTED|Period 1||11
435332|NCT01425814|1068660|P1|STARTED|Period 1||12
435333|NCT01425801|1068752|P6|NOT COMPLETED|Period 6||0
435334|NCT01425801|1068753|P5|NOT COMPLETED|Period 6||0
435335|NCT01425801|1068754|P4|NOT COMPLETED|Period 6||0
435336|NCT01425801|1068755|P3|NOT COMPLETED|Period 6||0
435337|NCT01425801|1068756|P2|NOT COMPLETED|Period 6||0
435338|NCT01425801|1068757|P1|NOT COMPLETED|Period 6||0
435339|NCT01425801|1068752|P6|COMPLETED|Period 6||10
435340|NCT01425801|1068753|P5|COMPLETED|Period 6||11
435341|NCT01425801|1068754|P4|COMPLETED|Period 6||12
435342|NCT01425801|1068755|P3|COMPLETED|Period 6||7
435343|NCT01425801|1068756|P2|COMPLETED|Period 6||9
435344|NCT01425801|1068757|P1|COMPLETED|Period 6||9
435345|NCT01425801|1068752|P6|STARTED|Period 6||10
435346|NCT01425801|1068753|P5|STARTED|Period 6||11
435347|NCT01425801|1068754|P4|STARTED|Period 6||12
435348|NCT01425801|1068755|P3|STARTED|Period 6||7
435349|NCT01425801|1068756|P2|STARTED|Period 6||9
435350|NCT01425801|1068757|P1|STARTED|Period 6||9
435351|NCT01425801|1068752|P6|NOT COMPLETED|Period 5||0
435352|NCT01425801|1068753|P5|NOT COMPLETED|Period 5||0
435353|NCT01425801|1068754|P4|NOT COMPLETED|Period 5||0
435354|NCT01425801|1068755|P3|NOT COMPLETED|Period 5||0
435355|NCT01425801|1068756|P2|NOT COMPLETED|Period 5||0
435356|NCT01425801|1068757|P1|NOT COMPLETED|Period 5||0
435357|NCT01425801|1068752|P6|COMPLETED|Period 5||10
435358|NCT01425801|1068753|P5|COMPLETED|Period 5||11
435359|NCT01425801|1068754|P4|COMPLETED|Period 5||12
435360|NCT01425801|1068755|P3|COMPLETED|Period 5||7
435361|NCT01425801|1068756|P2|COMPLETED|Period 5||9
435362|NCT01425801|1068757|P1|COMPLETED|Period 5||9
435363|NCT01425801|1068752|P6|STARTED|Period 5||10
435364|NCT01425801|1068753|P5|STARTED|Period 5||11
435365|NCT01425801|1068754|P4|STARTED|Period 5||12
435366|NCT01425801|1068755|P3|STARTED|Period 5||7
435367|NCT01425801|1068756|P2|STARTED|Period 5||9
435368|NCT01425801|1068757|P1|STARTED|Period 5||9
435369|NCT01425801|1068752|P6|NOT COMPLETED|Period 4||0
435370|NCT01425801|1068753|P5|NOT COMPLETED|Period 4||0
435371|NCT01425801|1068754|P4|NOT COMPLETED|Period 4||0
435372|NCT01425801|1068755|P3|NOT COMPLETED|Period 4||1
435373|NCT01425801|1068756|P2|NOT COMPLETED|Period 4||0
435374|NCT01425801|1068757|P1|NOT COMPLETED|Period 4||0
435375|NCT01425801|1068752|P6|COMPLETED|Period 4||10
435376|NCT01425801|1068753|P5|COMPLETED|Period 4||11
435377|NCT01425801|1068754|P4|COMPLETED|Period 4||12
435378|NCT01425801|1068755|P3|COMPLETED|Period 4||7
435379|NCT01425801|1068756|P2|COMPLETED|Period 4||9
435380|NCT01425801|1068757|P1|COMPLETED|Period 4||9
435381|NCT01425801|1068752|P6|STARTED|Period 4||10
435382|NCT01425801|1068753|P5|STARTED|Period 4||11
435383|NCT01425801|1068754|P4|STARTED|Period 4||12
435384|NCT01425801|1068755|P3|STARTED|Period 4||8
435385|NCT01425801|1068756|P2|STARTED|Period 4||9
435386|NCT01425801|1068757|P1|STARTED|Period 4||9
435387|NCT01425801|1068752|P6|NOT COMPLETED|Period 3||0
435388|NCT01425801|1068753|P5|NOT COMPLETED|Period 3||0
435389|NCT01425801|1068754|P4|NOT COMPLETED|Period 3||0
435390|NCT01425801|1068755|P3|NOT COMPLETED|Period 3||1
435391|NCT01425801|1068756|P2|NOT COMPLETED|Period 3||0
435392|NCT01425801|1068757|P1|NOT COMPLETED|Period 3||0
435393|NCT01425801|1068752|P6|COMPLETED|Period 3||10
435394|NCT01425801|1068753|P5|COMPLETED|Period 3||11
435395|NCT01425801|1068754|P4|COMPLETED|Period 3||12
435396|NCT01425801|1068755|P3|COMPLETED|Period 3||8
435397|NCT01425801|1068756|P2|COMPLETED|Period 3||9
435398|NCT01425801|1068757|P1|COMPLETED|Period 3||9
435399|NCT01425801|1068752|P6|STARTED|Period 3||10
435400|NCT01425801|1068753|P5|STARTED|Period 3||11
435401|NCT01425801|1068754|P4|STARTED|Period 3||12
435402|NCT01425801|1068755|P3|STARTED|Period 3||9
435403|NCT01425801|1068756|P2|STARTED|Period 3||9
435404|NCT01425801|1068757|P1|STARTED|Period 3||9
435405|NCT01425801|1068752|P6|NOT COMPLETED|Period 2||0
435406|NCT01425801|1068753|P5|NOT COMPLETED|Period 2||1
435407|NCT01425801|1068754|P4|NOT COMPLETED|Period 2||0
435408|NCT01425801|1068755|P3|NOT COMPLETED|Period 2||0
435409|NCT01425801|1068756|P2|NOT COMPLETED|Period 2||0
435410|NCT01425801|1068757|P1|NOT COMPLETED|Period 2||0
435411|NCT01425801|1068752|P6|COMPLETED|Period 2||10
435412|NCT01425801|1068753|P5|COMPLETED|Period 2||11
435413|NCT01425801|1068754|P4|COMPLETED|Period 2||12
435414|NCT01425801|1068755|P3|COMPLETED|Period 2||9
435415|NCT01425801|1068756|P2|COMPLETED|Period 2||9
435416|NCT01425801|1068757|P1|COMPLETED|Period 2||9
435417|NCT01425801|1068752|P6|STARTED|Period 2||10
435418|NCT01425801|1068753|P5|STARTED|Period 2||12
435419|NCT01425801|1068754|P4|STARTED|Period 2||12
435420|NCT01425801|1068755|P3|STARTED|Period 2||9
435421|NCT01425801|1068756|P2|STARTED|Period 2||9
435422|NCT01425801|1068757|P1|STARTED|Period 2||9
435423|NCT01425801|1068752|P6|NOT COMPLETED|Period 1||0
435424|NCT01425801|1068753|P5|NOT COMPLETED|Period 1||1
435425|NCT01425801|1068754|P4|NOT COMPLETED|Period 1||0
435426|NCT01425801|1068755|P3|NOT COMPLETED|Period 1||0
435427|NCT01425801|1068756|P2|NOT COMPLETED|Period 1||0
435428|NCT01425801|1068757|P1|NOT COMPLETED|Period 1||0
435429|NCT01425801|1068752|P6|COMPLETED|Period 1||10
435430|NCT01425801|1068753|P5|COMPLETED|Period 1||12
435431|NCT01425801|1068754|P4|COMPLETED|Period 1||12
435432|NCT01425801|1068755|P3|COMPLETED|Period 1||9
435433|NCT01425801|1068756|P2|COMPLETED|Period 1||9
435434|NCT01425801|1068757|P1|COMPLETED|Period 1||9
435435|NCT01425801|1068752|P6|STARTED|Period 1||10
435436|NCT01425801|1068753|P5|STARTED|Period 1||13
435437|NCT01425801|1068754|P4|STARTED|Period 1||12
435438|NCT01425801|1068755|P3|STARTED|Period 1||9
435439|NCT01425801|1068756|P2|STARTED|Period 1||9
435440|NCT01425801|1068757|P1|STARTED|Period 1||9
435441|NCT01425749|1068863|P2|NOT COMPLETED|Overall Study||1
435442|NCT01425749|1068864|P1|NOT COMPLETED|Overall Study||0
435443|NCT01425749|1068863|P2|COMPLETED|Overall Study||11
435444|NCT01425749|1068864|P1|COMPLETED|Overall Study||13
435445|NCT01425749|1068863|P2|STARTED|Overall Study||12
435446|NCT01425749|1068864|P1|STARTED|Overall Study||13
435447|NCT01425632|1068882|P3|NOT COMPLETED|Overall Study||4
435448|NCT01425632|1068883|P2|NOT COMPLETED|Overall Study||1
435449|NCT01425632|1068884|P1|NOT COMPLETED|Overall Study||1
435450|NCT01425632|1068882|P3|COMPLETED|Overall Study||159
435451|NCT01425632|1068883|P2|COMPLETED|Overall Study||165
435452|NCT01425632|1068884|P1|COMPLETED|Overall Study||160
435453|NCT01425632|1068882|P3|STARTED|Overall Study||163
435454|NCT01425632|1068883|P2|STARTED|Overall Study||166
435455|NCT01425632|1068884|P1|STARTED|Overall Study||161
435456|NCT01425528|1068894|P2|NOT COMPLETED|Overall Study||1
435457|NCT01425528|1068895|P1|NOT COMPLETED|Overall Study||1
435458|NCT01425528|1068894|P2|COMPLETED|Overall Study||5
435459|NCT01425528|1068895|P1|COMPLETED|Overall Study||5
435460|NCT01425528|1068894|P2|STARTED|Overall Study||6
435461|NCT01425528|1068895|P1|STARTED|Overall Study||6
435462|NCT01425463|1068903|P2|NOT COMPLETED|Overall Study||24
435463|NCT01425463|1068904|P1|NOT COMPLETED|Overall Study||24
435464|NCT01425463|1068903|P2|COMPLETED|Overall Study||102
435465|NCT01425463|1068904|P1|COMPLETED|Overall Study||106
435466|NCT01425463|1068903|P2|Full Analysis Set|Overall Study||116
435467|NCT01425463|1068904|P1|Full Analysis Set|Overall Study||122
435468|NCT01425463|1068903|P2|Safety Set|Overall Study||122
435469|NCT01425463|1068904|P1|Safety Set|Overall Study||126
435470|NCT01425463|1068903|P2|STARTED|Overall Study||126
435471|NCT01425463|1068904|P1|STARTED|Overall Study||130
435472|NCT01425359|1068920|P2|NOT COMPLETED|Overall Study||22
435473|NCT01425359|1068921|P1|NOT COMPLETED|Overall Study||19
435474|NCT01425359|1068920|P2|COMPLETED|Overall Study||451
435475|NCT01425359|1068921|P1|COMPLETED|Overall Study||457
435476|NCT01425359|1068920|P2|STARTED|Overall Study||473
435477|NCT01425359|1068921|P1|STARTED|Overall Study||476
435478|NCT01425307|1068939|P2|NOT COMPLETED|Overall Study||19
435479|NCT01425307|1068940|P1|NOT COMPLETED|Overall Study||19
435480|NCT01425307|1068939|P2|COMPLETED|Overall Study|Treatment Phase: 41; 6-Month Follow-up:59|41
435481|NCT01425307|1068940|P1|COMPLETED|Overall Study|Treatment Phase: 42; 6-Month Follow up: 58|42
435482|NCT01425307|1068939|P2|STARTED|Overall Study|Randomized Sample: 60; Intention-to Treat Sample:60|60
435483|NCT01425307|1068940|P1|STARTED|Overall Study|Randomized Sample: 61; Intention-to Treat Sample:61|61
435484|NCT01425268|1068952|P2|NOT COMPLETED|Overall Study||0
435485|NCT01425268|1068953|P1|NOT COMPLETED|Overall Study||8
435486|NCT01425268|1068952|P2|COMPLETED|Overall Study||52
435487|NCT01425268|1068953|P1|COMPLETED|Overall Study||98
435488|NCT01425268|1068952|P2|STARTED|Overall Study|52 Subjects Randomized to Saline Arm / 52 Subjects Treated (Implanted)|52
435489|NCT01425268|1068953|P1|STARTED|Overall Study|106 Subjects Randomized to AeroForm Arm / 98 Subjects Treated (Implanted)|106
435490|NCT01425229|1068961|P1|NOT COMPLETED|Bosentan During Clarithromycin||0
435491|NCT01425229|1068961|P1|COMPLETED|Bosentan During Clarithromycin||16
435492|NCT01425229|1068961|P1|STARTED|Bosentan During Clarithromycin||16
435493|NCT01425229|1068961|P1|NOT COMPLETED|Bosentan Steady-state||0
435494|NCT01425229|1068961|P1|COMPLETED|Bosentan Steady-state||16
435495|NCT01425229|1068961|P1|STARTED|Bosentan Steady-state||16
435496|NCT01425229|1068961|P1|NOT COMPLETED|Bosentan Single Dose||0
435497|NCT01425229|1068961|P1|COMPLETED|Bosentan Single Dose||16
435498|NCT01425229|1068961|P1|STARTED|Bosentan Single Dose||16
435499|NCT01425203|1068974|P3|NOT COMPLETED|Follow-up Phase||0
435500|NCT01425203|1068975|P2|NOT COMPLETED|Follow-up Phase||0
435501|NCT01425203|1068976|P1|NOT COMPLETED|Follow-up Phase||0
435502|NCT01425203|1068974|P3|COMPLETED|Follow-up Phase||27
435503|NCT01425203|1068975|P2|COMPLETED|Follow-up Phase||49
435504|NCT01425203|1068976|P1|COMPLETED|Follow-up Phase||153
435505|NCT01425203|1068974|P3|STARTED|Follow-up Phase|All participants treated in crossover arm entered follow-up.|27
435506|NCT01425203|1068975|P2|STARTED|Follow-up Phase|27 starting treatment in PBO+PR Control arm switched to Crossover arm and 2 did not enter follow-up|49
435507|NCT01425203|1068976|P1|STARTED|Follow-up Phase|6 participants who started treatment in RGT BOC + PR arm did not enter follow-up.|153
435508|NCT01425203|1068974|P3|NOT COMPLETED|Crossover Phase||6
435509|NCT01425203|1068975|P2|NOT COMPLETED|Crossover Phase||0
435510|NCT01425203|1068976|P1|NOT COMPLETED|Crossover Phase||0
435511|NCT01425203|1068974|P3|COMPLETED|Crossover Phase||21
435512|NCT01425203|1068975|P2|COMPLETED|Crossover Phase||0
435513|NCT01425203|1068976|P1|COMPLETED|Crossover Phase||0
435514|NCT01425203|1068974|P3|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|27
435515|NCT01425203|1068975|P2|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|0
435516|NCT01425203|1068976|P1|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|0
435517|NCT01425203|1068974|P3|NOT COMPLETED|Treatment Phase||0
435518|NCT01425203|1068975|P2|NOT COMPLETED|Treatment Phase||37
435519|NCT01425203|1068976|P1|NOT COMPLETED|Treatment Phase||27
435520|NCT01425203|1068974|P3|COMPLETED|Treatment Phase||0
435521|NCT01425203|1068975|P2|COMPLETED|Treatment Phase||42
435522|NCT01425203|1068976|P1|COMPLETED|Treatment Phase||132
435523|NCT01425203|1068974|P3|Treated (FAS)|Treatment Phase||0
435524|NCT01425203|1068975|P2|Treated (FAS)|Treatment Phase||78
435525|NCT01425203|1068976|P1|Treated (FAS)|Treatment Phase||159
435526|NCT01425203|1068974|P3|STARTED|Treatment Phase||0
435527|NCT01425203|1068975|P2|STARTED|Treatment Phase||79
435528|NCT01425203|1068976|P1|STARTED|Treatment Phase||159
435529|NCT01425190|1068993|P3|NOT COMPLETED|Overall Study||0
435530|NCT01425190|1068994|P2|NOT COMPLETED|Overall Study||0
435531|NCT01425190|1068995|P1|NOT COMPLETED|Overall Study||1
435532|NCT01425190|1068993|P3|COMPLETED|Overall Study||0
435533|NCT01425190|1068994|P2|COMPLETED|Overall Study||0
435534|NCT01425190|1068995|P1|COMPLETED|Overall Study||15
435535|NCT01425190|1068993|P3|STARTED|Overall Study|The study was terminated prior to enrolling participants in Cohort 3.|0
435536|NCT01425190|1068994|P2|STARTED|Overall Study|The study was terminated prior to enrolling participants in Cohort 2.|0
435537|NCT01425190|1068995|P1|STARTED|Overall Study||16
435538|NCT01424943|1069014|P2|NOT COMPLETED|Overall Study||1
435539|NCT01424943|1069015|P1|NOT COMPLETED|Overall Study||13
435540|NCT01424943|1069014|P2|COMPLETED|Overall Study||23
435541|NCT01424943|1069015|P1|COMPLETED|Overall Study||12
435542|NCT01424943|1069014|P2|STARTED|Overall Study||24
435543|NCT01424943|1069015|P1|STARTED|Overall Study||25
435544|NCT01424930|1069031|P2|NOT COMPLETED|Overall Study||14
435545|NCT01424930|1069032|P1|NOT COMPLETED|Overall Study||4
435546|NCT01424930|1069031|P2|COMPLETED|Overall Study||4
435547|NCT01424930|1069032|P1|COMPLETED|Overall Study||3
435548|NCT01424930|1069031|P2|Completed Food Safety Evaluation|Overall Study||18
435549|NCT01424930|1069032|P1|Completed Food Safety Evaluation|Overall Study||6
435550|NCT01424930|1069031|P2|STARTED|Overall Study||18
435551|NCT01424930|1069032|P1|STARTED|Overall Study||7
435552|NCT01424813|1069046|P2|NOT COMPLETED|Overall Study||2
435553|NCT01424813|1069047|P1|NOT COMPLETED|Overall Study||5
435554|NCT01424813|1069046|P2|COMPLETED|Overall Study||77
435555|NCT01424813|1069047|P1|COMPLETED|Overall Study||74
435556|NCT01424813|1069046|P2|Treated|Overall Study|Safety set and full analysis set|78
435557|NCT01424813|1069047|P1|Treated|Overall Study|Safety set and full analysis set|79
435558|NCT01424813|1069046|P2|STARTED|Overall Study||79
435559|NCT01424813|1069047|P1|STARTED|Overall Study||79
435560|NCT01424644|1069067|P2|NOT COMPLETED|Overall Study||27
435561|NCT01424644|1069068|P1|NOT COMPLETED|Overall Study||33
435562|NCT01424644|1069067|P2|COMPLETED|Overall Study||372
435563|NCT01424644|1069068|P1|COMPLETED|Overall Study||369
435564|NCT01424644|1069067|P2|STARTED|Overall Study||399
435565|NCT01424644|1069068|P1|STARTED|Overall Study||402
435566|NCT01424566|1069082|P3|NOT COMPLETED|Double-blind Treatment||15
435567|NCT01424566|1069083|P2|NOT COMPLETED|Double-blind Treatment||25
435568|NCT01424566|1069084|P1|NOT COMPLETED|Double-blind Treatment||0
435569|NCT01424566|1069082|P3|COMPLETED|Double-blind Treatment||88
435570|NCT01424566|1069083|P2|COMPLETED|Double-blind Treatment||78
435571|NCT01424566|1069084|P1|COMPLETED|Double-blind Treatment||0
435572|NCT01424566|1069082|P3|ITT Population|Double-blind Treatment||103
435573|NCT01424566|1069083|P2|ITT Population|Double-blind Treatment||103
435574|NCT01424566|1069084|P1|ITT Population|Double-blind Treatment||0
435575|NCT01424566|1069082|P3|Randomized Safety Population|Double-blind Treatment||103
435576|NCT01424566|1069083|P2|Randomized Safety Population|Double-blind Treatment||103
435577|NCT01424566|1069084|P1|Randomized Safety Population|Double-blind Treatment||0
435578|NCT01424566|1069082|P3|Received at Least 1 Dose of Study Drug|Double-blind Treatment||103
435579|NCT01424566|1069083|P2|Received at Least 1 Dose of Study Drug|Double-blind Treatment||103
435580|NCT01424566|1069084|P1|Received at Least 1 Dose of Study Drug|Double-blind Treatment||0
435581|NCT01424566|1069082|P3|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|103
435582|NCT01424566|1069083|P2|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|103
435583|NCT01424566|1069084|P1|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the double-blind period.|0
435584|NCT01424566|1069082|P3|NOT COMPLETED|Single-blind Treatment||0
435585|NCT01424566|1069083|P2|NOT COMPLETED|Single-blind Treatment||0
435586|NCT01424566|1069084|P1|NOT COMPLETED|Single-blind Treatment||200
435587|NCT01424566|1069082|P3|COMPLETED|Single-blind Treatment||0
435588|NCT01424566|1069083|P2|COMPLETED|Single-blind Treatment||0
435589|NCT01424566|1069084|P1|COMPLETED|Single-blind Treatment||206
435590|NCT01424566|1069082|P3|Met Randomization Criteria|Single-blind Treatment||0
435591|NCT01424566|1069083|P2|Met Randomization Criteria|Single-blind Treatment||0
435592|NCT01424566|1069084|P1|Met Randomization Criteria|Single-blind Treatment||206
435593|NCT01424566|1069082|P3|Single-blind Safety Population|Single-blind Treatment||0
435594|NCT01424566|1069083|P2|Single-blind Safety Population|Single-blind Treatment||0
435595|NCT01424566|1069084|P1|Single-blind Safety Population|Single-blind Treatment||404
435596|NCT01424566|1069082|P3|Received at Least 1 Dose of Study Drug|Single-blind Treatment||0
435597|NCT01424566|1069083|P2|Received at Least 1 Dose of Study Drug|Single-blind Treatment||0
435598|NCT01424566|1069084|P1|Received at Least 1 Dose of Study Drug|Single-blind Treatment|Two participants did not administer any study drug.|404
435599|NCT01424566|1069082|P3|STARTED|Single-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|0
435600|NCT01424566|1069083|P2|STARTED|Single-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|0
435601|NCT01424566|1069084|P1|STARTED|Single-blind Treatment||406
435602|NCT01424514|1069111|P2|NOT COMPLETED|Period 3:Intervention Period 2 (14 Days)||0
435603|NCT01424514|1069112|P1|NOT COMPLETED|Period 3:Intervention Period 2 (14 Days)||1
435604|NCT01424514|1069111|P2|COMPLETED|Period 3:Intervention Period 2 (14 Days)||19
435605|NCT01424514|1069112|P1|COMPLETED|Period 3:Intervention Period 2 (14 Days)||18
435606|NCT01424514|1069111|P2|STARTED|Period 3:Intervention Period 2 (14 Days)||19
435607|NCT01424514|1069112|P1|STARTED|Period 3:Intervention Period 2 (14 Days)||19
435608|NCT01424514|1069111|P2|NOT COMPLETED|Period 2:Washout Period (4 Weeks)||0
435609|NCT01424514|1069112|P1|NOT COMPLETED|Period 2:Washout Period (4 Weeks)||0
435610|NCT01424514|1069111|P2|COMPLETED|Period 2:Washout Period (4 Weeks)||19
435611|NCT01424514|1069112|P1|COMPLETED|Period 2:Washout Period (4 Weeks)||19
435612|NCT01424514|1069111|P2|STARTED|Period 2:Washout Period (4 Weeks)||19
435613|NCT01424514|1069112|P1|STARTED|Period 2:Washout Period (4 Weeks)||19
435614|NCT01424514|1069111|P2|NOT COMPLETED|Period 1:Intervention Period 1 (14 Days)||1
435615|NCT01424514|1069112|P1|NOT COMPLETED|Period 1:Intervention Period 1 (14 Days)||1
435616|NCT01424514|1069111|P2|COMPLETED|Period 1:Intervention Period 1 (14 Days)||19
435617|NCT01424514|1069112|P1|COMPLETED|Period 1:Intervention Period 1 (14 Days)||19
435618|NCT01424514|1069111|P2|STARTED|Period 1:Intervention Period 1 (14 Days)||20
435619|NCT01424514|1069112|P1|STARTED|Period 1:Intervention Period 1 (14 Days)||20
435620|NCT01424501|1069157|P6|NOT COMPLETED|Overall Study||0
435621|NCT01424501|1069158|P5|NOT COMPLETED|Overall Study||0
435622|NCT01424501|1069159|P4|NOT COMPLETED|Overall Study||0
435623|NCT01424501|1069160|P3|NOT COMPLETED|Overall Study||2
435624|NCT01424501|1069161|P2|NOT COMPLETED|Overall Study||1
435625|NCT01424501|1069162|P1|NOT COMPLETED|Overall Study||1
435626|NCT01424501|1069157|P6|COMPLETED|Overall Study||40
435627|NCT01424501|1069158|P5|COMPLETED|Overall Study||40
435628|NCT01424501|1069159|P4|COMPLETED|Overall Study||25
435629|NCT01424501|1069160|P3|COMPLETED|Overall Study||22
435630|NCT01424501|1069161|P2|COMPLETED|Overall Study||5
435631|NCT01424501|1069162|P1|COMPLETED|Overall Study||6
435632|NCT01424501|1069157|P6|STARTED|Overall Study||40
435633|NCT01424501|1069158|P5|STARTED|Overall Study||40
435634|NCT01424501|1069159|P4|STARTED|Overall Study||25
435635|NCT01424501|1069160|P3|STARTED|Overall Study||24
435636|NCT01424501|1069161|P2|STARTED|Overall Study||6
435637|NCT01424501|1069162|P1|STARTED|Overall Study||7
435638|NCT01424306|1069326|P6|NOT COMPLETED|Overall Study||0
435639|NCT01424306|1069327|P5|NOT COMPLETED|Overall Study||1
435640|NCT01424306|1069328|P4|NOT COMPLETED|Overall Study||0
435641|NCT01424306|1069329|P3|NOT COMPLETED|Overall Study||0
435642|NCT01424306|1069330|P2|NOT COMPLETED|Overall Study||0
435643|NCT01424306|1069331|P1|NOT COMPLETED|Overall Study||0
435644|NCT01424306|1069326|P6|COMPLETED|Overall Study||6
435645|NCT01424306|1069327|P5|COMPLETED|Overall Study||4
435646|NCT01424306|1069328|P4|COMPLETED|Overall Study||3
435647|NCT01424306|1069329|P3|COMPLETED|Overall Study||3
435648|NCT01424306|1069330|P2|COMPLETED|Overall Study||4
435649|NCT01424306|1069331|P1|COMPLETED|Overall Study||4
435650|NCT01424306|1069326|P6|STARTED|Overall Study||6
435651|NCT01424306|1069327|P5|STARTED|Overall Study||5
435652|NCT01424306|1069328|P4|STARTED|Overall Study||3
435653|NCT01424306|1069329|P3|STARTED|Overall Study||3
435654|NCT01424306|1069330|P2|STARTED|Overall Study||4
435655|NCT01424306|1069331|P1|STARTED|Overall Study||4
435656|NCT01424228|1069380|P2|NOT COMPLETED|Overall Study||47
435657|NCT01424228|1069381|P1|NOT COMPLETED|Overall Study||56
435658|NCT01424228|1069380|P2|COMPLETED|Overall Study||135
435659|NCT01424228|1069381|P1|COMPLETED|Overall Study||126
435660|NCT01424228|1069380|P2|STARTED|Overall Study||182
435661|NCT01424228|1069381|P1|STARTED|Overall Study||182
435668|NCT01424072|1069437|P3|NOT COMPLETED|Overall Study||0
435669|NCT01424072|1069438|P2|NOT COMPLETED|Overall Study||0
435670|NCT01424072|1069439|P1|NOT COMPLETED|Overall Study||0
435671|NCT01424072|1069437|P3|COMPLETED|Overall Study||22
435672|NCT01424072|1069438|P2|COMPLETED|Overall Study||26
435673|NCT01424072|1069439|P1|COMPLETED|Overall Study||27
435674|NCT01424072|1069437|P3|STARTED|Overall Study||22
435675|NCT01424072|1069438|P2|STARTED|Overall Study||26
435676|NCT01424072|1069439|P1|STARTED|Overall Study||27
435677|NCT01424033|1069456|P1|NOT COMPLETED|Overall Study||5
435678|NCT01424033|1069456|P1|COMPLETED|Overall Study||0
435679|NCT01424033|1069456|P1|STARTED|Overall Study||5
435680|NCT01423916|1069463|P3|NOT COMPLETED|Overall Study||7
435681|NCT01423916|1069464|P2|NOT COMPLETED|Overall Study||20
435682|NCT01423916|1069465|P1|NOT COMPLETED|Overall Study||11
435683|NCT01423916|1069463|P3|COMPLETED|Overall Study||64
435684|NCT01423916|1069464|P2|COMPLETED|Overall Study||53
435685|NCT01423916|1069465|P1|COMPLETED|Overall Study||63
435686|NCT01423916|1069463|P3|STARTED|Overall Study||71
435687|NCT01423916|1069464|P2|STARTED|Overall Study||73
435688|NCT01423916|1069465|P1|STARTED|Overall Study||74
435689|NCT01423812|1069521|P2|NOT COMPLETED|Overall Study||4
435690|NCT01423812|1069522|P1|NOT COMPLETED|Overall Study||3
435691|NCT01423812|1069521|P2|COMPLETED|Overall Study||26
435692|NCT01423812|1069522|P1|COMPLETED|Overall Study||27
435693|NCT01423812|1069521|P2|STARTED|Overall Study||30
435694|NCT01423812|1069522|P1|STARTED|Overall Study||30
435695|NCT01423773|1069530|P2|NOT COMPLETED|Period 2, 2 Days||0
435696|NCT01423773|1069531|P1|NOT COMPLETED|Period 2, 2 Days||0
435697|NCT01423773|1069530|P2|COMPLETED|Period 2, 2 Days||10
435698|NCT01423773|1069531|P1|COMPLETED|Period 2, 2 Days||10
435699|NCT01423773|1069530|P2|STARTED|Period 2, 2 Days||10
435700|NCT01423773|1069531|P1|STARTED|Period 2, 2 Days||10
435701|NCT01423773|1069530|P2|NOT COMPLETED|Period One, 2 Days||0
435702|NCT01423773|1069531|P1|NOT COMPLETED|Period One, 2 Days||0
435703|NCT01423773|1069530|P2|COMPLETED|Period One, 2 Days||10
435704|NCT01423773|1069531|P1|COMPLETED|Period One, 2 Days||10
435705|NCT01423773|1069530|P2|STARTED|Period One, 2 Days||10
435706|NCT01423773|1069531|P1|STARTED|Period One, 2 Days||10
435707|NCT01423760|1069539|P2|NOT COMPLETED|Overall Study||0
435708|NCT01423760|1069540|P1|NOT COMPLETED|Overall Study||0
435709|NCT01423760|1069539|P2|COMPLETED|Overall Study||13
435710|NCT01423760|1069540|P1|COMPLETED|Overall Study||14
435711|NCT01423760|1069539|P2|Safety Analysis Set|Overall Study||8
435712|NCT01423760|1069540|P1|Safety Analysis Set|Overall Study||12
435713|NCT01423760|1069539|P2|Number of Non-treatment Subjects|Overall Study||5
435714|NCT01423760|1069540|P1|Number of Non-treatment Subjects|Overall Study||2
435715|NCT01423760|1069539|P2|Number of Tecemotide Subjects|Overall Study||8
435716|NCT01423760|1069540|P1|Number of Tecemotide Subjects|Overall Study||12
435717|NCT01423760|1069539|P2|STARTED|Overall Study||13
435718|NCT01423760|1069540|P1|STARTED|Overall Study||14
435719|NCT01423617|1069550|P2|NOT COMPLETED|Overall Study||1
435720|NCT01423617|1069551|P1|NOT COMPLETED|Overall Study||0
435721|NCT01423617|1069550|P2|COMPLETED|Overall Study||45
435722|NCT01423617|1069551|P1|COMPLETED|Overall Study||46
435723|NCT01423617|1069550|P2|STARTED|Overall Study||46
435724|NCT01423617|1069551|P1|STARTED|Overall Study||46
435725|NCT01423604|1069568|P2|NOT COMPLETED|Randomized||63
435726|NCT01423604|1069569|P1|NOT COMPLETED|Randomized||63
435727|NCT01423604|1069568|P2|COMPLETED|Randomized||0
435728|NCT01423604|1069569|P1|COMPLETED|Randomized|As of 07August2015, 1 subject was receiving treatment in the randomized portion.|1
435729|NCT01423604|1069568|P2|STARTED|Randomized||63
435730|NCT01423604|1069569|P1|STARTED|Randomized||64
435731|NCT01423604|1069568|P2|NOT COMPLETED|Safety Run-In||0
435732|NCT01423604|1069569|P1|NOT COMPLETED|Safety Run-In||9
435733|NCT01423604|1069568|P2|COMPLETED|Safety Run-In||0
435734|NCT01423604|1069569|P1|COMPLETED|Safety Run-In||0
435735|NCT01423604|1069568|P2|STARTED|Safety Run-In||0
435736|NCT01423604|1069569|P1|STARTED|Safety Run-In||9
435737|NCT01423253|1069584|P1|NOT COMPLETED|Overall Study||9
435738|NCT01423253|1069584|P1|COMPLETED|Overall Study||39
435739|NCT01423253|1069584|P1|STARTED|Overall Study||48
435740|NCT01423162|1069597|P2|NOT COMPLETED|Overall Study||0
435741|NCT01423162|1069598|P1|NOT COMPLETED|Overall Study||0
435742|NCT01423162|1069597|P2|COMPLETED|Overall Study|Crossover design: All subjects (n=20) completed both arms|9
435743|NCT01423162|1069598|P1|COMPLETED|Overall Study|Crossover design: All subjects (n=20) completed both arms|11
435744|NCT01423162|1069597|P2|STARTED|Overall Study||9
435745|NCT01423162|1069598|P1|STARTED|Overall Study||11
435746|NCT01423084|1069606|P2|NOT COMPLETED|Overall Study||4
435747|NCT01423084|1069607|P1|NOT COMPLETED|Overall Study||2
435748|NCT01423084|1069606|P2|COMPLETED|Overall Study||170
435749|NCT01423084|1069607|P1|COMPLETED|Overall Study||168
435750|NCT01423084|1069606|P2|STARTED|Overall Study||174
435751|NCT01423084|1069607|P1|STARTED|Overall Study||170
435752|NCT01422915|1069637|P1|NOT COMPLETED|Overall Study||1
435753|NCT01422915|1069637|P1|COMPLETED|Overall Study||3
435754|NCT01422915|1069637|P1|STARTED|Overall Study|1 subject with abnormal liver chemistries removed during the first period.|4
435755|NCT01422889|1069642|P1|NOT COMPLETED|Overall Study||9
435756|NCT01422889|1069642|P1|COMPLETED|Overall Study|9 subjects did not receive a study stent therefore 1111 subjects were eligible for follow up.|1111
435757|NCT01422889|1069642|P1|STARTED|Overall Study||1120
435758|NCT01422876|1069657|P10|NOT COMPLETED|Week 52||17
435759|NCT01422876|1069658|P9|NOT COMPLETED|Week 52||21
435760|NCT01422876|1069659|P8|NOT COMPLETED|Week 52||23
435761|NCT01422876|1069660|P7|NOT COMPLETED|Week 52||16
435762|NCT01422876|1069661|P6|NOT COMPLETED|Week 52||17
435763|NCT01422876|1069662|P5|NOT COMPLETED|Week 52||15
435764|NCT01422876|1069663|P4|NOT COMPLETED|Week 52||18
435765|NCT01422876|1069664|P3|NOT COMPLETED|Week 52||13
435766|NCT01422876|1069665|P2|NOT COMPLETED|Week 52||10
435767|NCT01422876|1069666|P1|NOT COMPLETED|Week 52||12
435768|NCT01422876|1069657|P10|COMPLETED|Week 52||118
435769|NCT01422876|1069658|P9|COMPLETED|Week 52||113
435770|NCT01422876|1069659|P8|COMPLETED|Week 52||112
435771|NCT01422876|1069660|P7|COMPLETED|Week 52||120
435772|NCT01422876|1069661|P6|COMPLETED|Week 52||120
435773|NCT01422876|1069662|P5|COMPLETED|Week 52||117
435774|NCT01422876|1069663|P4|COMPLETED|Week 52||122
435775|NCT01422876|1069664|P3|COMPLETED|Week 52||128
435776|NCT01422876|1069665|P2|COMPLETED|Week 52||126
435777|NCT01422876|1069666|P1|COMPLETED|Week 52||125
435778|NCT01422876|1069657|P10|STARTED|Week 52||135
435779|NCT01422876|1069658|P9|STARTED|Week 52||134
435780|NCT01422876|1069659|P8|STARTED|Week 52||135
435781|NCT01422876|1069660|P7|STARTED|Week 52||136
435782|NCT01422876|1069661|P6|STARTED|Week 52||137
435783|NCT01422876|1069662|P5|STARTED|Week 52||132
435784|NCT01422876|1069663|P4|STARTED|Week 52||140
435785|NCT01422876|1069664|P3|STARTED|Week 52||141
435786|NCT01422876|1069665|P2|STARTED|Week 52||136
435787|NCT01422876|1069666|P1|STARTED|Week 52||137
435788|NCT01422876|1069657|P10|NOT COMPLETED|Week 24||10
435789|NCT01422876|1069658|P9|NOT COMPLETED|Week 24||6
435790|NCT01422876|1069659|P8|NOT COMPLETED|Week 24||7
435791|NCT01422876|1069660|P7|NOT COMPLETED|Week 24||6
435792|NCT01422876|1069661|P6|NOT COMPLETED|Week 24||6
435793|NCT01422876|1069662|P5|NOT COMPLETED|Week 24||7
435794|NCT01422876|1069663|P4|NOT COMPLETED|Week 24||8
435795|NCT01422876|1069664|P3|NOT COMPLETED|Week 24||5
435796|NCT01422876|1069665|P2|NOT COMPLETED|Week 24||3
435797|NCT01422876|1069666|P1|NOT COMPLETED|Week 24||6
435798|NCT01422876|1069657|P10|COMPLETED|Week 24||125
435799|NCT01422876|1069658|P9|COMPLETED|Week 24||128
435800|NCT01422876|1069659|P8|COMPLETED|Week 24||128
435801|NCT01422876|1069660|P7|COMPLETED|Week 24||130
435802|NCT01422876|1069661|P6|COMPLETED|Week 24||131
435803|NCT01422876|1069662|P5|COMPLETED|Week 24||125
435804|NCT01422876|1069663|P4|COMPLETED|Week 24||132
435805|NCT01422876|1069664|P3|COMPLETED|Week 24||136
435806|NCT01422876|1069665|P2|COMPLETED|Week 24||133
435807|NCT01422876|1069666|P1|COMPLETED|Week 24||131
435808|NCT01422876|1069657|P10|STARTED|Week 24||135
435809|NCT01422876|1069658|P9|STARTED|Week 24||134
435810|NCT01422876|1069659|P8|STARTED|Week 24||135
435811|NCT01422876|1069660|P7|STARTED|Week 24||136
435812|NCT01422876|1069661|P6|STARTED|Week 24||137
435813|NCT01422876|1069662|P5|STARTED|Week 24||132
435814|NCT01422876|1069663|P4|STARTED|Week 24||140
435815|NCT01422876|1069664|P3|STARTED|Week 24||141
435816|NCT01422876|1069665|P2|STARTED|Week 24||136
435817|NCT01422876|1069666|P1|STARTED|Week 24||137
435818|NCT01422850|1069713|P1|NOT COMPLETED|Overall Study||3
435819|NCT01422850|1069713|P1|COMPLETED|Overall Study||18
435820|NCT01422850|1069713|P1|Week 15|Overall Study|One patient withdrawn by PI due to increased PSA. Started bicalutamide treatment.|18
435821|NCT01422850|1069713|P1|Week 14 - Third Treatment|Overall Study|One patient withdrawn by PI and referred to external radiotherapy due to progressive disease.|19
435822|NCT01422850|1069713|P1|Week 9 - Second Treatment|Overall Study||20
435823|NCT01422850|1069713|P1|Week 5|Overall Study|One patient withdrawn by PI due to progressive disease|20
435824|NCT01422850|1069713|P1|Week 4 - First Treatment|Overall Study||21
435825|NCT01422850|1069713|P1|STARTED|Overall Study||21
435826|NCT01422824|1069719|P1|NOT COMPLETED|Overall Study||38
435827|NCT01422824|1069719|P1|COMPLETED|Overall Study||147
435828|NCT01422824|1069719|P1|Treated|Overall Study||184
435829|NCT01422824|1069719|P1|STARTED|Overall Study||185
435830|NCT01422720|1069724|P1|NOT COMPLETED|Overall Study||22
435831|NCT01422720|1069724|P1|COMPLETED|Overall Study||50
435832|NCT01422720|1069724|P1|Per-Protocol Set (PPS)|Overall Study||55
435833|NCT01422720|1069724|P1|Full Analysis Set (FAS)|Overall Study||71
435834|NCT01422720|1069724|P1|Safety Set|Overall Study||72
435835|NCT01422720|1069724|P1|STARTED|Overall Study||72
435836|NCT01422538|1069735|P3|NOT COMPLETED|Overall Study||2
435837|NCT01422538|1069736|P2|NOT COMPLETED|Overall Study||2
435838|NCT01422538|1069737|P1|NOT COMPLETED|Overall Study||0
435839|NCT01422538|1069735|P3|COMPLETED|Overall Study||8
435840|NCT01422538|1069736|P2|COMPLETED|Overall Study||8
435841|NCT01422538|1069737|P1|COMPLETED|Overall Study||10
435842|NCT01422538|1069735|P3|STARTED|Overall Study||10
435843|NCT01422538|1069736|P2|STARTED|Overall Study||10
435844|NCT01422538|1069737|P1|STARTED|Overall Study||10
435845|NCT01422434|1069762|P3|NOT COMPLETED|Overall Study||6
435846|NCT01422434|1069763|P2|NOT COMPLETED|Overall Study||5
435847|NCT01422434|1069764|P1|NOT COMPLETED|Overall Study||11
435848|NCT01422434|1069762|P3|COMPLETED|Overall Study||217
435849|NCT01422434|1069763|P2|COMPLETED|Overall Study||221
435850|NCT01422434|1069764|P1|COMPLETED|Overall Study||216
435851|NCT01422434|1069762|P3|STARTED|Overall Study||223
435852|NCT01422434|1069763|P2|STARTED|Overall Study||226
435853|NCT01422434|1069764|P1|STARTED|Overall Study||227
435854|NCT01422408|1069781|P1|NOT COMPLETED|Overall Study||4
435855|NCT01422408|1069781|P1|COMPLETED|Overall Study||30
435856|NCT01422408|1069781|P1|STARTED|Overall Study||34
435857|NCT01422382|1069810|P1|NOT COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||1
435858|NCT01422382|1069810|P1|COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||27
435859|NCT01422382|1069810|P1|STARTED|NK-104 4mg QD and Diltiazem 240 mg QD||28
435860|NCT01422382|1069810|P1|NOT COMPLETED|Diltiazem 240 mg QD||0
435861|NCT01422382|1069810|P1|COMPLETED|Diltiazem 240 mg QD||28
435862|NCT01422382|1069810|P1|STARTED|Diltiazem 240 mg QD||28
435863|NCT01422382|1069810|P1|NOT COMPLETED|NK-104 4mg Once Daily (QD)||0
435864|NCT01422382|1069810|P1|COMPLETED|NK-104 4mg Once Daily (QD)||28
435865|NCT01422382|1069810|P1|STARTED|NK-104 4mg Once Daily (QD)||28
435866|NCT01422369|1069815|P1|NOT COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||1
435867|NCT01422369|1069815|P1|COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||27
435868|NCT01422369|1069815|P1|STARTED|NK-104 4mg QD & Prezista 800mg/100mg QD||28
435869|NCT01422369|1069815|P1|NOT COMPLETED|Prezista 800mg/100mg QD||0
435870|NCT01422369|1069815|P1|COMPLETED|Prezista 800mg/100mg QD||28
435871|NCT01422369|1069815|P1|STARTED|Prezista 800mg/100mg QD||28
435872|NCT01422369|1069815|P1|NOT COMPLETED|NK-104 4mg QD||0
435873|NCT01422369|1069815|P1|COMPLETED|NK-104 4mg QD||28
435874|NCT01422369|1069815|P1|STARTED|NK-104 4mg QD||28
435875|NCT01422356|1069820|P1|NOT COMPLETED|Overall Study||31
435876|NCT01422356|1069820|P1|COMPLETED|Overall Study||169
435877|NCT01422356|1069820|P1|STARTED|Overall Study||200
435878|NCT01422304|1069826|P2|NOT COMPLETED|Overall Study||37
435879|NCT01422304|1069827|P1|NOT COMPLETED|Overall Study||24
435880|NCT01422304|1069826|P2|COMPLETED|Overall Study||563
435881|NCT01422304|1069827|P1|COMPLETED|Overall Study||574
435882|NCT01422304|1069826|P2|Treated|Overall Study|1 given sugammadex; thus All Participants as Treated (APaT) Ns are 596 Sugammadex, 588 Usual Care|589
435883|NCT01422304|1069827|P1|Treated|Overall Study||595
435884|NCT01422304|1069826|P2|STARTED|Overall Study|Randomized|600
435885|NCT01422304|1069827|P1|STARTED|Overall Study|Randomized|598
435886|NCT01422239|1069859|P2|NOT COMPLETED|Overall Study||3
435887|NCT01422239|1069860|P1|NOT COMPLETED|Overall Study||4
435888|NCT01422239|1069859|P2|COMPLETED|Overall Study||3
435889|NCT01422239|1069860|P1|COMPLETED|Overall Study||10
435890|NCT01422239|1069859|P2|STARTED|Overall Study||6
435891|NCT01422239|1069860|P1|STARTED|Overall Study||14
435892|NCT01422226|1069872|P2|NOT COMPLETED|Overall Study||0
435893|NCT01422226|1069873|P1|NOT COMPLETED|Overall Study||0
435894|NCT01422226|1069872|P2|COMPLETED|Overall Study||2
435895|NCT01422226|1069873|P1|COMPLETED|Overall Study||1
435896|NCT01422226|1069872|P2|STARTED|Overall Study||2
435897|NCT01422226|1069873|P1|STARTED|Overall Study||1
435898|NCT01422213|1069882|P3|NOT COMPLETED|Overall Study||29
435899|NCT01422213|1069883|P2|NOT COMPLETED|Overall Study||22
435900|NCT01422213|1069884|P1|NOT COMPLETED|Overall Study||33
435901|NCT01422213|1069882|P3|COMPLETED|Overall Study||178
435902|NCT01422213|1069883|P2|COMPLETED|Overall Study||173
435903|NCT01422213|1069884|P1|COMPLETED|Overall Study||163
435904|NCT01422213|1069882|P3|STARTED|Overall Study||207
435905|NCT01422213|1069883|P2|STARTED|Overall Study||195
435906|NCT01422213|1069884|P1|STARTED|Overall Study||196
435907|NCT01422187|1069945|P3|NOT COMPLETED|Overall Study||0
435908|NCT01422187|1069946|P2|NOT COMPLETED|Overall Study||1
435909|NCT01422187|1069947|P1|NOT COMPLETED|Overall Study||1
435910|NCT01422187|1069945|P3|COMPLETED|Overall Study||2
435911|NCT01422187|1069946|P2|COMPLETED|Overall Study||8
435912|NCT01422187|1069947|P1|COMPLETED|Overall Study||7
435913|NCT01422187|1069945|P3|STARTED|Overall Study||2
435914|NCT01422187|1069946|P2|STARTED|Overall Study||9
435915|NCT01422187|1069947|P1|STARTED|Overall Study||8
435916|NCT01422070|1069966|P2|NOT COMPLETED|Overall Study||0
435917|NCT01422070|1069967|P1|NOT COMPLETED|Overall Study||0
435918|NCT01422070|1069966|P2|COMPLETED|Overall Study||803
435919|NCT01422070|1069967|P1|COMPLETED|Overall Study||5031
435920|NCT01422070|1069966|P2|STARTED|Overall Study|Number of patients admitted to 27 intensive care units.|803
435921|NCT01422070|1069967|P1|STARTED|Overall Study|Number of patients admitted to 140 intensive care units|5031
435922|NCT01421719|1069978|P1|NOT COMPLETED|Overall Study||4
435923|NCT01421719|1069978|P1|COMPLETED|Overall Study||16
435924|NCT01421719|1069978|P1|STARTED|Overall Study||20
435925|NCT01421667|1069987|P4|NOT COMPLETED|Overall Study||1
435926|NCT01421667|1069988|P3|NOT COMPLETED|Overall Study||2
435927|NCT01421667|1069989|P2|NOT COMPLETED|Overall Study||2
435928|NCT01421667|1069990|P1|NOT COMPLETED|Overall Study||0
435929|NCT01421667|1069987|P4|COMPLETED|Overall Study|Completed per protocol due to death [7] or study termination by sponsor [8]|15
435930|NCT01421667|1069988|P3|COMPLETED|Overall Study|Completed per protocol due to death [33] or study termination by sponsor [18]|51
435931|NCT01421667|1069989|P2|COMPLETED|Overall Study|Completed per protocol due to death [45] or study termination by sponsor [21]|66
435932|NCT01421667|1069990|P1|COMPLETED|Overall Study|Completed per protocol due to death [24] or study termination by sponsor [11]|35
435933|NCT01421667|1069987|P4|STARTED|Overall Study||16
435934|NCT01421667|1069988|P3|STARTED|Overall Study||53
435935|NCT01421667|1069989|P2|STARTED|Overall Study||68
435936|NCT01421667|1069990|P1|STARTED|Overall Study||35
435937|NCT01421654|1070042|P2|NOT COMPLETED|Overall Study||0
435938|NCT01421654|1070043|P1|NOT COMPLETED|Overall Study||0
435939|NCT01421654|1070042|P2|COMPLETED|Overall Study|10 subjects completed study, but 1 subject was found to not meet IEC at the end; data was not used.|9
435940|NCT01421654|1070043|P1|COMPLETED|Overall Study||11
435941|NCT01421654|1070042|P2|STARTED|Overall Study||9
435942|NCT01421654|1070043|P1|STARTED|Overall Study||11
435943|NCT01421641|1070051|P2|NOT COMPLETED|Overall Study||2
435944|NCT01421641|1070052|P1|NOT COMPLETED|Overall Study||2
435945|NCT01421641|1070051|P2|COMPLETED|Overall Study||35
435946|NCT01421641|1070052|P1|COMPLETED|Overall Study||35
435947|NCT01421641|1070051|P2|STARTED|Overall Study||37
435948|NCT01421641|1070052|P1|STARTED|Overall Study||37
435949|NCT01421589|1070062|P1|NOT COMPLETED|Overall Study||0
435950|NCT01421589|1070062|P1|COMPLETED|Overall Study||15
435951|NCT01421589|1070062|P1|STARTED|Overall Study||15
435952|NCT01421511|1070074|P2|NOT COMPLETED|Overall Study||28
435953|NCT01421511|1070075|P1|NOT COMPLETED|Overall Study||19
435954|NCT01421511|1070074|P2|COMPLETED|Overall Study||306
435955|NCT01421511|1070075|P1|COMPLETED|Overall Study||313
435956|NCT01421511|1070074|P2|STARTED|Overall Study||334
435957|NCT01421511|1070075|P1|STARTED|Overall Study||332
435958|NCT01421498|1070097|P2|NOT COMPLETED|Overall Study||11
435959|NCT01421498|1070098|P1|NOT COMPLETED|Overall Study||12
435960|NCT01421498|1070097|P2|COMPLETED|Overall Study||284
435961|NCT01421498|1070098|P1|COMPLETED|Overall Study||281
435962|NCT01421498|1070097|P2|STARTED|Overall Study||295
435963|NCT01421498|1070098|P1|STARTED|Overall Study||293
435964|NCT01421472|1070110|P4|NOT COMPLETED|Overall Study||0
435965|NCT01421472|1070111|P3|NOT COMPLETED|Overall Study||0
435966|NCT01421472|1070112|P2|NOT COMPLETED|Overall Study||0
435967|NCT01421472|1070113|P1|NOT COMPLETED|Overall Study||0
435968|NCT01421472|1070110|P4|COMPLETED|Overall Study||32
435969|NCT01421472|1070111|P3|COMPLETED|Overall Study||64
435970|NCT01421472|1070112|P2|COMPLETED|Overall Study||33
435971|NCT01421472|1070113|P1|COMPLETED|Overall Study||67
435972|NCT01421472|1070110|P4|STARTED|Overall Study||32
435973|NCT01421472|1070111|P3|STARTED|Overall Study||64
435974|NCT01421472|1070112|P2|STARTED|Overall Study||33
435975|NCT01421472|1070113|P1|STARTED|Overall Study||67
435976|NCT01421459|1070125|P2|NOT COMPLETED|Overall Study||52
435977|NCT01421459|1070126|P1|NOT COMPLETED|Overall Study||45
435978|NCT01421459|1070125|P2|COMPLETED|Overall Study||328
435979|NCT01421459|1070126|P1|COMPLETED|Overall Study||334
435980|NCT01421459|1070125|P2|Received at Least 1 Dose of Study Drug|Overall Study||380
435981|NCT01421459|1070126|P1|Received at Least 1 Dose of Study Drug|Overall Study||376
435982|NCT01421459|1070125|P2|STARTED|Overall Study||380
435983|NCT01421459|1070126|P1|STARTED|Overall Study||379
435984|NCT01421355|1070160|P1|NOT COMPLETED|Overall Study||6
435985|NCT01421355|1070160|P1|COMPLETED|Overall Study||15
435986|NCT01421355|1070160|P1|STARTED|Overall Study||21
435987|NCT01421342|1070167|P3|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||65
435988|NCT01421342|1070168|P2|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||59
435989|NCT01421342|1070169|P1|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||52
435990|NCT01421342|1070167|P3|COMPLETED|Continuation of Treatment (Week 12 - 36)||203
435991|NCT01421342|1070168|P2|COMPLETED|Continuation of Treatment (Week 12 - 36)||194
435992|NCT01421342|1070169|P1|COMPLETED|Continuation of Treatment (Week 12 - 36)||152
435993|NCT01421342|1070167|P3|STARTED|Continuation of Treatment (Week 12 - 36)||268
435994|NCT01421342|1070168|P2|STARTED|Continuation of Treatment (Week 12 - 36)||253
435995|NCT01421342|1070169|P1|STARTED|Continuation of Treatment (Week 12 - 36)||204
435996|NCT01421342|1070167|P3|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||138
435997|NCT01421342|1070168|P2|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||125
435998|NCT01421342|1070169|P1|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||149
435999|NCT01421342|1070167|P3|COMPLETED|Completed to Week 12 But Then Withdrawn||268
436000|NCT01421342|1070168|P2|COMPLETED|Completed to Week 12 But Then Withdrawn||253
436001|NCT01421342|1070169|P1|COMPLETED|Completed to Week 12 But Then Withdrawn||204
436002|NCT01421342|1070167|P3|STARTED|Completed to Week 12 But Then Withdrawn||406
436003|NCT01421342|1070168|P2|STARTED|Completed to Week 12 But Then Withdrawn||378
436004|NCT01421342|1070169|P1|STARTED|Completed to Week 12 But Then Withdrawn||353
436005|NCT01421342|1070167|P3|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||99
436006|NCT01421342|1070168|P2|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||128
436007|NCT01421342|1070169|P1|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||158
436008|NCT01421342|1070167|P3|COMPLETED|Acute Treatment Phase (12 Weeks)||406
436009|NCT01421342|1070168|P2|COMPLETED|Acute Treatment Phase (12 Weeks)||378
436010|NCT01421342|1070169|P1|COMPLETED|Acute Treatment Phase (12 Weeks)||353
436011|NCT01421342|1070167|P3|STARTED|Acute Treatment Phase (12 Weeks)||505
436012|NCT01421342|1070168|P2|STARTED|Acute Treatment Phase (12 Weeks)||506
436013|NCT01421342|1070169|P1|STARTED|Acute Treatment Phase (12 Weeks)||511
436014|NCT01421303|1070186|P1|NOT COMPLETED|Overall Study||22
436015|NCT01421303|1070186|P1|COMPLETED|Overall Study||58
436016|NCT01421303|1070186|P1|STARTED|Overall Study||80
436017|NCT01421277|1070213|P2|NOT COMPLETED|Overall Study||92
436018|NCT01421277|1070214|P1|NOT COMPLETED|Overall Study||0
436019|NCT01421277|1070213|P2|COMPLETED|Overall Study|Completed the online survey for at least one migraine attack.|99
436020|NCT01421277|1070214|P1|COMPLETED|Overall Study|Completed the online survey for at least one migraine attack.|25
436021|NCT01421277|1070213|P2|STARTED|Overall Study||191
436022|NCT01421277|1070214|P1|STARTED|Overall Study||25
436023|NCT01421147|1070226|P2|NOT COMPLETED|Extension Period||11
436024|NCT01421147|1070227|P1|NOT COMPLETED|Extension Period||8
436025|NCT01421147|1070226|P2|COMPLETED|Extension Period||245
436026|NCT01421147|1070227|P1|COMPLETED|Extension Period||245
436027|NCT01421147|1070226|P2|STARTED|Extension Period||256
436028|NCT01421147|1070227|P1|STARTED|Extension Period||253
436029|NCT01421147|1070226|P2|NOT COMPLETED|Treatment Period||11
436030|NCT01421147|1070227|P1|NOT COMPLETED|Treatment Period||16
436031|NCT01421147|1070226|P2|COMPLETED|Treatment Period||256
436032|NCT01421147|1070227|P1|COMPLETED|Treatment Period||253
436033|NCT01421147|1070226|P2|Received at Least 1 Dose of Study Drug|Treatment Period||267
436034|NCT01421147|1070227|P1|Received at Least 1 Dose of Study Drug|Treatment Period||268
436035|NCT01421147|1070226|P2|STARTED|Treatment Period||267
436036|NCT01421147|1070227|P1|STARTED|Treatment Period||269
436037|NCT01421134|1070259|P2|NOT COMPLETED|Overall Study||15
436038|NCT01421134|1070260|P1|NOT COMPLETED|Overall Study||7
436039|NCT01421134|1070259|P2|COMPLETED|Overall Study||87
436040|NCT01421134|1070260|P1|COMPLETED|Overall Study||102
436041|NCT01421134|1070259|P2|STARTED|Overall Study||102
436042|NCT01421134|1070260|P1|STARTED|Overall Study||109
436043|NCT01420926|1070280|P2|NOT COMPLETED|Overall Study||65
436044|NCT01420926|1070281|P1|NOT COMPLETED|Overall Study||60
436045|NCT01420926|1070280|P2|COMPLETED|Overall Study||16
436046|NCT01420926|1070281|P1|COMPLETED|Overall Study||22
436047|NCT01420926|1070280|P2|STARTED|Overall Study||81
436048|NCT01420926|1070281|P1|STARTED|Overall Study||82
436049|NCT01420848|1070298|P3|NOT COMPLETED|Overall Study||0
436050|NCT01420848|1070299|P2|NOT COMPLETED|Overall Study||0
436051|NCT01420848|1070300|P1|NOT COMPLETED|Overall Study||0
436052|NCT01420848|1070298|P3|COMPLETED|Overall Study||22
436053|NCT01420848|1070299|P2|COMPLETED|Overall Study||25
436054|NCT01420848|1070300|P1|COMPLETED|Overall Study||24
436055|NCT01420848|1070298|P3|STARTED|Overall Study||22
436056|NCT01420848|1070299|P2|STARTED|Overall Study||25
436057|NCT01420848|1070300|P1|STARTED|Overall Study||24
436058|NCT01420289|1070313|P2|NOT COMPLETED|Overall Study||0
436059|NCT01420289|1070314|P1|NOT COMPLETED|Overall Study||0
436060|NCT01420289|1070313|P2|COMPLETED|Overall Study||16
436061|NCT01420289|1070314|P1|COMPLETED|Overall Study||18
436062|NCT01420289|1070313|P2|STARTED|Overall Study||16
436063|NCT01420289|1070314|P1|STARTED|Overall Study||18
436064|NCT01420146|1070326|P1|NOT COMPLETED|Overall Study||0
436065|NCT01420146|1070326|P1|COMPLETED|Overall Study||20
436066|NCT01420146|1070326|P1|STARTED|Overall Study||20
436067|NCT01420081|1070339|P9|NOT COMPLETED|Overall Study||3
436068|NCT01420081|1070340|P8|NOT COMPLETED|Overall Study||3
436069|NCT01420081|1070341|P7|NOT COMPLETED|Overall Study||3
436070|NCT01420081|1070342|P6|NOT COMPLETED|Overall Study||20
436071|NCT01420081|1070343|P5|NOT COMPLETED|Overall Study||20
436072|NCT01420081|1070344|P4|NOT COMPLETED|Overall Study||3
436073|NCT01420081|1070345|P3|NOT COMPLETED|Overall Study||11
436074|NCT01420081|1070346|P2|NOT COMPLETED|Overall Study||1
436075|NCT01420081|1070347|P1|NOT COMPLETED|Overall Study||3
436076|NCT01420081|1070339|P9|COMPLETED|Overall Study||0
436077|NCT01420081|1070340|P8|COMPLETED|Overall Study||0
436078|NCT01420081|1070341|P7|COMPLETED|Overall Study||0
436079|NCT01420081|1070342|P6|COMPLETED|Overall Study||0
436080|NCT01420081|1070343|P5|COMPLETED|Overall Study||0
436081|NCT01420081|1070344|P4|COMPLETED|Overall Study||0
436082|NCT01420081|1070345|P3|COMPLETED|Overall Study||0
436083|NCT01420081|1070346|P2|COMPLETED|Overall Study||0
436084|NCT01420081|1070347|P1|COMPLETED|Overall Study||0
436085|NCT01420081|1070339|P9|STARTED|Overall Study||3
436086|NCT01420081|1070340|P8|STARTED|Overall Study||3
436087|NCT01420081|1070341|P7|STARTED|Overall Study||3
436088|NCT01420081|1070342|P6|STARTED|Overall Study||20
436089|NCT01420081|1070343|P5|STARTED|Overall Study||20
436090|NCT01420081|1070344|P4|STARTED|Overall Study||3
436091|NCT01420081|1070345|P3|STARTED|Overall Study||11
436092|NCT01420081|1070346|P2|STARTED|Overall Study||1
436093|NCT01420081|1070347|P1|STARTED|Overall Study||3
436094|NCT01419977|1070428|P2|NOT COMPLETED|Overall Study||0
436095|NCT01419977|1070429|P1|NOT COMPLETED|Overall Study||0
436096|NCT01419977|1070428|P2|COMPLETED|Overall Study||13
436097|NCT01419977|1070429|P1|COMPLETED|Overall Study||16
436098|NCT01419977|1070428|P2|STARTED|Overall Study||13
436099|NCT01419977|1070429|P1|STARTED|Overall Study||16
436100|NCT01419795|1070443|P2|NOT COMPLETED|Overall Study||0
436101|NCT01419795|1070444|P1|NOT COMPLETED|Overall Study||0
436102|NCT01419795|1070443|P2|COMPLETED|Overall Study||0
436103|NCT01419795|1070444|P1|COMPLETED|Overall Study||3
436104|NCT01419795|1070443|P2|STARTED|Overall Study||0
436105|NCT01419795|1070444|P1|STARTED|Overall Study||3
436106|NCT01419769|1070466|P1|NOT COMPLETED|Overall Study||4
436107|NCT01419769|1070466|P1|COMPLETED|Overall Study||29
436108|NCT01419769|1070466|P1|STARTED|Overall Study||33
436109|NCT01419639|1070479|P1|NOT COMPLETED|Overall Study||1
436110|NCT01419639|1070479|P1|COMPLETED|Overall Study||9
436111|NCT01419639|1070479|P1|STARTED|Overall Study||10
436112|NCT01419314|1070487|P2|NOT COMPLETED|Follow-up at Week 6 of the Trial||2
436113|NCT01419314|1070488|P1|NOT COMPLETED|Follow-up at Week 6 of the Trial||1
436114|NCT01419314|1070487|P2|COMPLETED|Follow-up at Week 6 of the Trial||19
436115|NCT01419314|1070488|P1|COMPLETED|Follow-up at Week 6 of the Trial|2 people who missed the first follow-up, returned for the final follow-up at week 6 (n=18).|16
436116|NCT01419314|1070487|P2|STARTED|Follow-up at Week 6 of the Trial|2 participants did not return for their final follow-up|21
436117|NCT01419314|1070488|P1|STARTED|Follow-up at Week 6 of the Trial||17
436118|NCT01419314|1070487|P2|NOT COMPLETED|Follow-up at Week 3 of the Trial||1
436119|NCT01419314|1070488|P1|NOT COMPLETED|Follow-up at Week 3 of the Trial||6
436120|NCT01419314|1070487|P2|COMPLETED|Follow-up at Week 3 of the Trial||21
436121|NCT01419314|1070488|P1|COMPLETED|Follow-up at Week 3 of the Trial||17
436122|NCT01419314|1070487|P2|STARTED|Follow-up at Week 3 of the Trial|one participant failed to return for the 3 week follow-up|22
436123|NCT01419314|1070488|P1|STARTED|Follow-up at Week 3 of the Trial|3 participants discontinued the trial, 3 failed to return for additional follow-ups.|23
436124|NCT01419314|1070487|P2|NOT COMPLETED|Start of Study||0
436125|NCT01419314|1070488|P1|NOT COMPLETED|Start of Study||0
436126|NCT01419314|1070487|P2|COMPLETED|Start of Study||22
436127|NCT01419314|1070488|P1|COMPLETED|Start of Study||23
436128|NCT01419314|1070487|P2|STARTED|Start of Study|No comfort issues reported.|22
436129|NCT01419314|1070488|P1|STARTED|Start of Study|minor comfort issues were reported within the first 2 weeks of the trial|23
436130|NCT01419275|1070508|P1|NOT COMPLETED|Overall Study||0
436131|NCT01419275|1070508|P1|COMPLETED|Overall Study||126
436132|NCT01419275|1070508|P1|STARTED|Overall Study||126
436133|NCT01419249|1070514|P2|NOT COMPLETED|Overall Study||0
436134|NCT01419249|1070515|P1|NOT COMPLETED|Overall Study||0
436135|NCT01419249|1070514|P2|COMPLETED|Overall Study||140
436136|NCT01419249|1070515|P1|COMPLETED|Overall Study||318
436137|NCT01419249|1070514|P2|STARTED|Overall Study||140
436138|NCT01419249|1070515|P1|STARTED|Overall Study||318
436139|NCT01419236|1070529|P2|NOT COMPLETED|Overall Study||5
436140|NCT01419236|1070530|P1|NOT COMPLETED|Overall Study||5
436141|NCT01419236|1070529|P2|COMPLETED|Overall Study||35
436142|NCT01419236|1070530|P1|COMPLETED|Overall Study||31
436143|NCT01419236|1070529|P2|Received at Least 1 Dose of Study Drug|Overall Study||39
436144|NCT01419236|1070530|P1|Received at Least 1 Dose of Study Drug|Overall Study||35
436145|NCT01419236|1070529|P2|STARTED|Overall Study||40
436146|NCT01419236|1070530|P1|STARTED|Overall Study||36
436147|NCT01419197|1070554|P2|NOT COMPLETED|Overall Study||198
436148|NCT01419197|1070555|P1|NOT COMPLETED|Overall Study||404
436149|NCT01419197|1070554|P2|COMPLETED|Overall Study||0
436150|NCT01419197|1070555|P1|COMPLETED|Overall Study||0
436151|NCT01419197|1070554|P2|Switched to Trastuzumab Emtansine|Overall Study||94
436152|NCT01419197|1070555|P1|Switched to Trastuzumab Emtansine|Overall Study||0
436153|NCT01419197|1070554|P2|STARTED|Overall Study||198
436154|NCT01419197|1070555|P1|STARTED|Overall Study||404
436155|NCT01419184|1070580|P2|NOT COMPLETED|Overall Study||15
436156|NCT01419184|1070581|P1|NOT COMPLETED|Overall Study||10
436157|NCT01419184|1070580|P2|COMPLETED|Overall Study|13 participants did not complete the study due to no valid infection-related length of stay (IRLOS)|106
436158|NCT01419184|1070581|P1|COMPLETED|Overall Study|6 participants did not complete the study due to no valid infection-related length of stay (IRLOS)|118
436159|NCT01419184|1070580|P2|Received at Least 1 Dose of Study Drug|Overall Study||106
436160|NCT01419184|1070581|P1|Received at Least 1 Dose of Study Drug|Overall Study||118
436161|NCT01419184|1070580|P2|STARTED|Overall Study||121
436162|NCT01419184|1070581|P1|STARTED|Overall Study||128
436163|NCT01419171|1070597|P1|NOT COMPLETED|Overall Study||0
436164|NCT01419171|1070597|P1|COMPLETED|Overall Study||328
436165|NCT01419171|1070597|P1|STARTED|Overall Study||328
436166|NCT01419028|1070614|P1|NOT COMPLETED|Overall Study||0
436167|NCT01419028|1070614|P1|COMPLETED|Overall Study||48
436168|NCT01419028|1070614|P1|STARTED|Overall Study||48
436169|NCT01418937|1070619|P1|NOT COMPLETED|Overall Study||8
436170|NCT01418937|1070619|P1|COMPLETED|Overall Study||156
436171|NCT01418937|1070619|P1|STARTED|Overall Study||164
436172|NCT01418703|1070628|P4|NOT COMPLETED|Overall Study||0
436173|NCT01418703|1070629|P3|NOT COMPLETED|Overall Study||0
436174|NCT01418703|1070630|P2|NOT COMPLETED|Overall Study||0
436175|NCT01418703|1070631|P1|NOT COMPLETED|Overall Study||0
436176|NCT01418703|1070628|P4|COMPLETED|Overall Study||6
436177|NCT01418703|1070629|P3|COMPLETED|Overall Study||6
436178|NCT01418703|1070630|P2|COMPLETED|Overall Study||13
436179|NCT01418703|1070631|P1|COMPLETED|Overall Study||13
436180|NCT01418703|1070628|P4|STARTED|Overall Study||6
436181|NCT01418703|1070629|P3|STARTED|Overall Study||6
436182|NCT01418703|1070630|P2|STARTED|Overall Study||13
436183|NCT01418703|1070631|P1|STARTED|Overall Study||13
436184|NCT01418482|1070642|P1|NOT COMPLETED|Overall Study||0
436185|NCT01418482|1070642|P1|COMPLETED|Overall Study||15
436186|NCT01418482|1070642|P1|STARTED|Overall Study||15
436187|NCT01418365|1070650|P2|NOT COMPLETED|Second Intervention||1
436188|NCT01418365|1070651|P1|NOT COMPLETED|Second Intervention||0
436189|NCT01418365|1070650|P2|COMPLETED|Second Intervention||13
436190|NCT01418365|1070651|P1|COMPLETED|Second Intervention||14
436191|NCT01418365|1070650|P2|STARTED|Second Intervention||14
436192|NCT01418365|1070651|P1|STARTED|Second Intervention||14
436193|NCT01418365|1070650|P2|NOT COMPLETED|First Intervention||1
436194|NCT01418365|1070651|P1|NOT COMPLETED|First Intervention||1
436195|NCT01418365|1070650|P2|COMPLETED|First Intervention||14
436196|NCT01418365|1070651|P1|COMPLETED|First Intervention||14
436197|NCT01418365|1070650|P2|STARTED|First Intervention||15
436198|NCT01418365|1070651|P1|STARTED|First Intervention||15
436199|NCT01418209|1070662|P3|NOT COMPLETED|Overall Study||4
436200|NCT01418209|1070663|P2|NOT COMPLETED|Overall Study||3
436201|NCT01418209|1070664|P1|NOT COMPLETED|Overall Study||2
436202|NCT01418209|1070662|P3|COMPLETED|Overall Study||142
436203|NCT01418209|1070663|P2|COMPLETED|Overall Study||93
436204|NCT01418209|1070664|P1|COMPLETED|Overall Study||95
436205|NCT01418209|1070662|P3|STARTED|Overall Study||146
436206|NCT01418209|1070663|P2|STARTED|Overall Study||96
436207|NCT01418209|1070664|P1|STARTED|Overall Study||97
436208|NCT01418001|1070693|P1|NOT COMPLETED|Overall Study||0
436209|NCT01418001|1070693|P1|COMPLETED|Overall Study||5
436210|NCT01418001|1070693|P1|STARTED|Overall Study||5
436211|NCT01417936|1070698|P1|NOT COMPLETED|Overall Study||0
436212|NCT01417936|1070698|P1|COMPLETED|Overall Study||26
436213|NCT01417936|1070698|P1|STARTED|Overall Study||26
436214|NCT01417481|1070719|P2|NOT COMPLETED|Second Period (8 Weeks)||0
436215|NCT01417481|1070720|P1|NOT COMPLETED|Second Period (8 Weeks)||0
436216|NCT01417481|1070719|P2|COMPLETED|Second Period (8 Weeks)||5
436217|NCT01417481|1070720|P1|COMPLETED|Second Period (8 Weeks)||8
436218|NCT01417481|1070719|P2|STARTED|Second Period (8 Weeks)||5
436219|NCT01417481|1070720|P1|STARTED|Second Period (8 Weeks)||8
436220|NCT01417481|1070719|P2|NOT COMPLETED|Washout (2 Weeks)||0
436221|NCT01417481|1070720|P1|NOT COMPLETED|Washout (2 Weeks)||0
436222|NCT01417481|1070719|P2|COMPLETED|Washout (2 Weeks)||5
436223|NCT01417481|1070720|P1|COMPLETED|Washout (2 Weeks)||8
436224|NCT01417481|1070719|P2|STARTED|Washout (2 Weeks)||5
436225|NCT01417481|1070720|P1|STARTED|Washout (2 Weeks)||8
436226|NCT01417481|1070719|P2|NOT COMPLETED|First Intervention (8 Weeks)||2
436227|NCT01417481|1070720|P1|NOT COMPLETED|First Intervention (8 Weeks)||0
436228|NCT01417481|1070719|P2|COMPLETED|First Intervention (8 Weeks)||5
436229|NCT01417481|1070720|P1|COMPLETED|First Intervention (8 Weeks)||8
436230|NCT01417481|1070719|P2|STARTED|First Intervention (8 Weeks)||7
436231|NCT01417481|1070720|P1|STARTED|First Intervention (8 Weeks)||8
436232|NCT01417455|1070752|P8|NOT COMPLETED|Overall Study||0
436233|NCT01417455|1070753|P7|NOT COMPLETED|Overall Study||0
436234|NCT01417455|1070754|P6|NOT COMPLETED|Overall Study||0
436235|NCT01417455|1070755|P5|NOT COMPLETED|Overall Study||0
436236|NCT01417455|1070756|P4|NOT COMPLETED|Overall Study||0
436237|NCT01417455|1070757|P3|NOT COMPLETED|Overall Study||0
436238|NCT01417455|1070758|P2|NOT COMPLETED|Overall Study||0
436239|NCT01417455|1070759|P1|NOT COMPLETED|Overall Study||0
436240|NCT01417455|1070752|P8|COMPLETED|Overall Study||25
436241|NCT01417455|1070753|P7|COMPLETED|Overall Study||13
436242|NCT01417455|1070754|P6|COMPLETED|Overall Study||13
436243|NCT01417455|1070755|P5|COMPLETED|Overall Study||30
436244|NCT01417455|1070756|P4|COMPLETED|Overall Study||17
436245|NCT01417455|1070757|P3|COMPLETED|Overall Study||17
436246|NCT01417455|1070758|P2|COMPLETED|Overall Study||16
436247|NCT01417455|1070759|P1|COMPLETED|Overall Study||16
436248|NCT01417455|1070752|P8|STARTED|Overall Study||25
436249|NCT01417455|1070753|P7|STARTED|Overall Study||13
436250|NCT01417455|1070754|P6|STARTED|Overall Study||13
436251|NCT01417455|1070755|P5|STARTED|Overall Study||30
436252|NCT01417455|1070756|P4|STARTED|Overall Study||17
436253|NCT01417455|1070757|P3|STARTED|Overall Study||17
436254|NCT01417455|1070758|P2|STARTED|Overall Study||16
436255|NCT01417455|1070759|P1|STARTED|Overall Study||16
436256|NCT01417377|1070785|P1|NOT COMPLETED|Overall Study||13
436257|NCT01417377|1070785|P1|COMPLETED|Overall Study||9
436258|NCT01417377|1070785|P1|Treated|Overall Study||21
436259|NCT01417377|1070785|P1|STARTED|Overall Study||22
436260|NCT01417195|1070794|P2|NOT COMPLETED|Overall Study||1
436261|NCT01417195|1070795|P1|NOT COMPLETED|Overall Study||3
436262|NCT01417195|1070794|P2|COMPLETED|Overall Study||61
436263|NCT01417195|1070795|P1|COMPLETED|Overall Study||57
436264|NCT01417195|1070794|P2|STARTED|Overall Study||62
436265|NCT01417195|1070795|P1|STARTED|Overall Study||60
436266|NCT01417156|1070811|P1|NOT COMPLETED|Overall Study||14
436267|NCT01417156|1070811|P1|COMPLETED|Overall Study||6
436268|NCT01417156|1070811|P1|STARTED|Overall Study||20
436269|NCT01417104|1070821|P2|NOT COMPLETED|Overall Study||2
436270|NCT01417104|1070822|P1|NOT COMPLETED|Overall Study||6
436271|NCT01417104|1070821|P2|COMPLETED|Overall Study||35
436272|NCT01417104|1070822|P1|COMPLETED|Overall Study||28
436273|NCT01417104|1070821|P2|STARTED|Overall Study||37
436274|NCT01417104|1070822|P1|STARTED|Overall Study||34
436275|NCT01417078|1070832|P1|NOT COMPLETED|Overall Study||1
436276|NCT01417078|1070832|P1|COMPLETED|Overall Study||30
436277|NCT01417078|1070832|P1|STARTED|Overall Study||31
436278|NCT01417026|1070844|P2|NOT COMPLETED|Overall Study||0
436279|NCT01417026|1070845|P1|NOT COMPLETED|Overall Study||2
436280|NCT01417026|1070844|P2|COMPLETED|Overall Study||13
436281|NCT01417026|1070845|P1|COMPLETED|Overall Study||14
436282|NCT01417026|1070844|P2|STARTED|Overall Study||13
436283|NCT01417026|1070845|P1|STARTED|Overall Study||16
436284|NCT01417000|1070857|P2|NOT COMPLETED|Overall Study||29
436285|NCT01417000|1070858|P1|NOT COMPLETED|Overall Study||61
436286|NCT01417000|1070857|P2|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/death/study close, so no subjects completed study."|0
436287|NCT01417000|1070858|P1|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/death/study close, so no subjects completed study."|0
436288|NCT01417000|1070857|P2|STARTED|Overall Study|31 subjects randomized into Cy/GVAX arm; 29 subjects received ≥ 1 protocol-specified drug.|29
436289|NCT01417000|1070858|P1|STARTED|Overall Study|62 subjects randomized into Cy/GVAX + CRS-207 arm; 61 subjects received ≥ 1 protocol-specified drug.|61
436290|NCT01416610|1070866|P1|NOT COMPLETED|Overall Study||43
436291|NCT01416610|1070866|P1|COMPLETED|Overall Study||45
436292|NCT01416610|1070866|P1|Completed Follow-up|Overall Study||45
436293|NCT01416610|1070866|P1|Completed Treatment|Overall Study||47
436294|NCT01416610|1070866|P1|Per Protocol|Overall Study||83
436295|NCT01416610|1070866|P1|Safety Population|Overall Study||86
436296|NCT01416610|1070866|P1|Intention to Treat|Overall Study||88
436297|NCT01416610|1070866|P1|STARTED|Overall Study||88
436298|NCT01416584|1070883|P3|NOT COMPLETED|Overall Study||1
436299|NCT01416584|1070884|P2|NOT COMPLETED|Overall Study||2
436300|NCT01416584|1070885|P1|NOT COMPLETED|Overall Study||3
436301|NCT01416584|1070883|P3|COMPLETED|Overall Study||32
436302|NCT01416584|1070884|P2|COMPLETED|Overall Study||33
436303|NCT01416584|1070885|P1|COMPLETED|Overall Study||27
436304|NCT01416584|1070883|P3|STARTED|Overall Study||33
436305|NCT01416584|1070884|P2|STARTED|Overall Study||35
436306|NCT01416584|1070885|P1|STARTED|Overall Study||30
436307|NCT01416571|1070920|P1|NOT COMPLETED|Overall Study||2
436308|NCT01416571|1070920|P1|COMPLETED|Overall Study|Number of subjects completed at Day 385.|76
436309|NCT01416571|1070920|P1|STARTED|Overall Study||78
436310|NCT01416389|1070949|P2|NOT COMPLETED|Overall Study||0
436311|NCT01416389|1070950|P1|NOT COMPLETED|Overall Study||3
436312|NCT01416389|1070949|P2|COMPLETED|Overall Study||13
436313|NCT01416389|1070950|P1|COMPLETED|Overall Study||23
436314|NCT01416389|1070949|P2|Received at Least 1 Dose of Study Drug|Overall Study||13
436315|NCT01416389|1070950|P1|Received at Least 1 Dose of Study Drug|Overall Study||26
436316|NCT01416389|1070949|P2|STARTED|Overall Study||13
436317|NCT01416389|1070950|P1|STARTED|Overall Study||26
436318|NCT01416272|1070967|P1|NOT COMPLETED|Overall Study||4
436319|NCT01416272|1070967|P1|COMPLETED|Overall Study||8
436320|NCT01416272|1070967|P1|STARTED|Overall Study||12
436321|NCT01416181|1070975|P2|NOT COMPLETED|Part 2||286
436322|NCT01416181|1070976|P1|NOT COMPLETED|Part 2||271
436323|NCT01416181|1070975|P2|COMPLETED|Part 2||6
436324|NCT01416181|1070976|P1|COMPLETED|Part 2||3
436325|NCT01416181|1070975|P2|Completed Treatment for > 96 Weeks|Part 2||0
436326|NCT01416181|1070976|P1|Completed Treatment for > 96 Weeks|Part 2||1
436327|NCT01416181|1070975|P2|Completed Treatment for 96 Weeks|Part 2|completed study treatment for 96 weeks in Part 2|0
436328|NCT01416181|1070976|P1|Completed Treatment for 96 Weeks|Part 2|completed study treatment for 96 weeks in Part 2|1
436329|NCT01416181|1070975|P2|Completed Treatment for 48 Weeks|Part 2|completed study treatment for 48 weeks in Part 2|111
436330|NCT01416181|1070976|P1|Completed Treatment for 48 Weeks|Part 2|completed study treatment for 48 weeks in Part 2|98
436331|NCT01416181|1070975|P2|STARTED|Part 2||292
436332|NCT01416181|1070976|P1|STARTED|Part 2||274
436333|NCT01416181|1070975|P2|NOT COMPLETED|Part 1||114
436334|NCT01416181|1070976|P1|NOT COMPLETED|Part 1||137
436335|NCT01416181|1070975|P2|COMPLETED|Part 1|Completed Study through Week 108|326
436336|NCT01416181|1070976|P1|COMPLETED|Part 1|Completed Study through Week 108|312
436337|NCT01416181|1070975|P2|Withdrew Prior to Dosing|Part 1||1
436338|NCT01416181|1070976|P1|Withdrew Prior to Dosing|Part 1||0
436339|NCT01416181|1070975|P2|STARTED|Part 1||440
436340|NCT01416181|1070976|P1|STARTED|Part 1||449
436341|NCT01416155|1071038|P1|NOT COMPLETED|Overall Study||58
436342|NCT01416155|1071038|P1|COMPLETED|Overall Study||39
436343|NCT01416155|1071038|P1|STARTED|Overall Study||97
436344|NCT01416142|1071045|P3|NOT COMPLETED|PureVision2 HD||1
436345|NCT01416142|1071046|P2|NOT COMPLETED|PureVision2 HD||0
436346|NCT01416142|1071047|P1|NOT COMPLETED|PureVision2 HD||0
436347|NCT01416142|1071045|P3|COMPLETED|PureVision2 HD||62
436348|NCT01416142|1071046|P2|COMPLETED|PureVision2 HD||0
436349|NCT01416142|1071047|P1|COMPLETED|PureVision2 HD||0
436350|NCT01416142|1071045|P3|STARTED|PureVision2 HD||63
436351|NCT01416142|1071046|P2|STARTED|PureVision2 HD||0
436352|NCT01416142|1071047|P1|STARTED|PureVision2 HD||0
436353|NCT01416142|1071045|P3|NOT COMPLETED|Cross Over at Movie Intermission||0
436354|NCT01416142|1071046|P2|NOT COMPLETED|Cross Over at Movie Intermission||0
436355|NCT01416142|1071047|P1|NOT COMPLETED|Cross Over at Movie Intermission||0
436356|NCT01416142|1071045|P3|COMPLETED|Cross Over at Movie Intermission||0
436357|NCT01416142|1071046|P2|COMPLETED|Cross Over at Movie Intermission||31
436358|NCT01416142|1071047|P1|COMPLETED|Cross Over at Movie Intermission||32
436359|NCT01416142|1071045|P3|STARTED|Cross Over at Movie Intermission||0
436360|NCT01416142|1071046|P2|STARTED|Cross Over at Movie Intermission||31
436361|NCT01416142|1071047|P1|STARTED|Cross Over at Movie Intermission||32
436362|NCT01416129|1071058|P2|NOT COMPLETED|Experimental Condition: Brimless||0
436363|NCT01416129|1071059|P1|NOT COMPLETED|Experimental Condition: Brimless||0
436364|NCT01416129|1071058|P2|COMPLETED|Experimental Condition: Brimless||5
436365|NCT01416129|1071059|P1|COMPLETED|Experimental Condition: Brimless||5
436366|NCT01416129|1071058|P2|STARTED|Experimental Condition: Brimless||5
436367|NCT01416129|1071059|P1|STARTED|Experimental Condition: Brimless||5
436368|NCT01416129|1071058|P2|NOT COMPLETED|Control Condition: Ischial Containment||0
436369|NCT01416129|1071059|P1|NOT COMPLETED|Control Condition: Ischial Containment||0
436370|NCT01416129|1071058|P2|COMPLETED|Control Condition: Ischial Containment||5
436371|NCT01416129|1071059|P1|COMPLETED|Control Condition: Ischial Containment||5
436372|NCT01416129|1071058|P2|STARTED|Control Condition: Ischial Containment||5
436373|NCT01416129|1071059|P1|STARTED|Control Condition: Ischial Containment||5
436374|NCT01416025|1071067|P2|NOT COMPLETED|Overall Study||0
436375|NCT01416025|1071068|P1|NOT COMPLETED|Overall Study||0
436376|NCT01416025|1071067|P2|COMPLETED|Overall Study||15
436377|NCT01416025|1071068|P1|COMPLETED|Overall Study||14
436378|NCT01416025|1071067|P2|STARTED|Overall Study||15
436379|NCT01416025|1071068|P1|STARTED|Overall Study||14
436380|NCT01415986|1071074|P1|NOT COMPLETED|Overall Study||1
436381|NCT01415986|1071074|P1|COMPLETED|Overall Study|Study terminated|0
436382|NCT01415986|1071074|P1|STARTED|Overall Study||1
436383|NCT01415960|1071079|P1|NOT COMPLETED|Overall Study||12
436384|NCT01415960|1071079|P1|COMPLETED|Overall Study|Patients completed Study (151) Per protocol Patients (146)|151
436385|NCT01415960|1071079|P1|PK Subgroup|Overall Study||30
436386|NCT01415960|1071079|P1|ITT|Overall Study||161
436387|NCT01415960|1071079|P1|STARTED|Overall Study||163
436388|NCT01415921|1071091|P2|NOT COMPLETED|Overall Study||3
436389|NCT01415921|1071092|P1|NOT COMPLETED|Overall Study||3
436390|NCT01415921|1071091|P2|COMPLETED|Overall Study||14
436391|NCT01415921|1071092|P1|COMPLETED|Overall Study||13
436392|NCT01415921|1071091|P2|STARTED|Overall Study||17
436393|NCT01415921|1071092|P1|STARTED|Overall Study||16
436394|NCT01415908|1071102|P2|NOT COMPLETED|Overall Study||0
436395|NCT01415908|1071103|P1|NOT COMPLETED|Overall Study||1
436396|NCT01415908|1071102|P2|COMPLETED|Overall Study||4
436397|NCT01415908|1071103|P1|COMPLETED|Overall Study||10
436398|NCT01415908|1071102|P2|STARTED|Overall Study||4
436399|NCT01415908|1071103|P1|STARTED|Overall Study||11
436400|NCT01415583|1071131|P2|NOT COMPLETED|Overall Study||0
436401|NCT01415583|1071132|P1|NOT COMPLETED|Overall Study||0
436402|NCT01415583|1071131|P2|COMPLETED|Overall Study||157
436403|NCT01415583|1071132|P1|COMPLETED|Overall Study||157
436404|NCT01415583|1071131|P2|STARTED|Overall Study||157
436405|NCT01415583|1071132|P1|STARTED|Overall Study||157
436406|NCT01415531|1071140|P2|NOT COMPLETED|Overall Study||37
436407|NCT01415531|1071141|P1|NOT COMPLETED|Overall Study||25
436408|NCT01415531|1071140|P2|COMPLETED|Overall Study||390
436409|NCT01415531|1071141|P1|COMPLETED|Overall Study||189
436410|NCT01415531|1071140|P2|STARTED|Overall Study||427
436411|NCT01415531|1071141|P1|STARTED|Overall Study||214
436412|NCT01415518|1071151|P2|NOT COMPLETED|Overall Study||31
436413|NCT01415518|1071152|P1|NOT COMPLETED|Overall Study||16
436414|NCT01415518|1071151|P2|COMPLETED|Overall Study||261
436415|NCT01415518|1071152|P1|COMPLETED|Overall Study||276
436416|NCT01415518|1071151|P2|Pts With Correct Randomized Treatment|Overall Study|Efficacy analysis used 292 patients. Safety analysis used 292-3=289 patients.|289
436417|NCT01415518|1071152|P1|Pts With Correct Randomized Treatment|Overall Study|Efficacy analysis used 290 patients. Safety analysis used 290+3=293 patients.|290
436418|NCT01415518|1071151|P2|Patients Who Received Study Treatment|Overall Study||292
436419|NCT01415518|1071152|P1|Patients Who Received Study Treatment|Overall Study||290
436420|NCT01415518|1071151|P2|STARTED|Overall Study||292
436421|NCT01415518|1071152|P1|STARTED|Overall Study||292
436422|NCT01415453|1071204|P1|NOT COMPLETED|Overall Study||0
436423|NCT01415453|1071204|P1|COMPLETED|Overall Study||1
436424|NCT01415453|1071204|P1|Imaging Study|Overall Study||1
436425|NCT01415453|1071204|P1|STARTED|Overall Study||1
436426|NCT01415427|1071212|P4|NOT COMPLETED|Overall Study||56
436427|NCT01415427|1071213|P3|NOT COMPLETED|Overall Study||58
436428|NCT01415427|1071214|P2|NOT COMPLETED|Overall Study||29
436429|NCT01415427|1071215|P1|NOT COMPLETED|Overall Study||29
436430|NCT01415427|1071212|P4|COMPLETED|Overall Study||0
436431|NCT01415427|1071213|P3|COMPLETED|Overall Study||1
436432|NCT01415427|1071214|P2|COMPLETED|Overall Study||0
436433|NCT01415427|1071215|P1|COMPLETED|Overall Study||0
436434|NCT01415427|1071212|P4|STARTED|Overall Study||56
436435|NCT01415427|1071213|P3|STARTED|Overall Study||59
436436|NCT01415427|1071214|P2|STARTED|Overall Study||29
436437|NCT01415427|1071215|P1|STARTED|Overall Study||29
436438|NCT01415401|1071252|P1|NOT COMPLETED|Overall Study||7
436439|NCT01415401|1071252|P1|COMPLETED|Overall Study||47
436440|NCT01415401|1071252|P1|STARTED|Overall Study||54
436441|NCT01415349|1071257|P2|NOT COMPLETED|Treatment Period 2||0
436442|NCT01415349|1071258|P1|NOT COMPLETED|Treatment Period 2||0
436443|NCT01415349|1071257|P2|COMPLETED|Treatment Period 2||19
436444|NCT01415349|1071258|P1|COMPLETED|Treatment Period 2||21
436445|NCT01415349|1071257|P2|STARTED|Treatment Period 2||19
436446|NCT01415349|1071258|P1|STARTED|Treatment Period 2||21
436447|NCT01415349|1071257|P2|NOT COMPLETED|Treatment Period 1||2
436448|NCT01415349|1071258|P1|NOT COMPLETED|Treatment Period 1||0
436449|NCT01415349|1071257|P2|COMPLETED|Treatment Period 1||19
436450|NCT01415349|1071258|P1|COMPLETED|Treatment Period 1||21
436451|NCT01415349|1071257|P2|STARTED|Treatment Period 1||21
436452|NCT01415349|1071258|P1|STARTED|Treatment Period 1||21
436453|NCT01415232|1071266|P1|NOT COMPLETED|Overall Study||0
436454|NCT01415232|1071266|P1|COMPLETED|Overall Study||160
436455|NCT01415232|1071266|P1|STARTED|Overall Study||160
436456|NCT01414855|1071270|P1|NOT COMPLETED|Overall Study||29
436457|NCT01414855|1071270|P1|COMPLETED|Overall Study||71
436458|NCT01414855|1071270|P1|STARTED|Overall Study||100
436459|NCT01414634|1071286|P8|NOT COMPLETED|Overall Study||0
436460|NCT01414634|1071287|P7|NOT COMPLETED|Overall Study||0
436461|NCT01414634|1071288|P6|NOT COMPLETED|Overall Study||0
436462|NCT01414634|1071289|P5|NOT COMPLETED|Overall Study||0
436463|NCT01414634|1071290|P4|NOT COMPLETED|Overall Study||0
436464|NCT01414634|1071291|P3|NOT COMPLETED|Overall Study||0
436465|NCT01414634|1071292|P2|NOT COMPLETED|Overall Study||0
436466|NCT01414634|1071293|P1|NOT COMPLETED|Overall Study||0
436467|NCT01414634|1071286|P8|COMPLETED|Overall Study||1
436468|NCT01414634|1071287|P7|COMPLETED|Overall Study||1
436469|NCT01414634|1071288|P6|COMPLETED|Overall Study||2
436470|NCT01414634|1071289|P5|COMPLETED|Overall Study||1
436471|NCT01414634|1071290|P4|COMPLETED|Overall Study||1
436472|NCT01414634|1071291|P3|COMPLETED|Overall Study||1
436473|NCT01414634|1071292|P2|COMPLETED|Overall Study||1
436474|NCT01414634|1071293|P1|COMPLETED|Overall Study||1
436475|NCT01414634|1071286|P8|STARTED|Overall Study||1
436476|NCT01414634|1071287|P7|STARTED|Overall Study||1
436477|NCT01414634|1071288|P6|STARTED|Overall Study||2
436478|NCT01414634|1071289|P5|STARTED|Overall Study||1
436479|NCT01414634|1071290|P4|STARTED|Overall Study||1
436480|NCT01414634|1071291|P3|STARTED|Overall Study||1
436481|NCT01414634|1071292|P2|STARTED|Overall Study||1
436482|NCT01414634|1071293|P1|STARTED|Overall Study||1
436483|NCT01414413|1071306|P2|NOT COMPLETED|Overall Study||0
436484|NCT01414413|1071307|P1|NOT COMPLETED|Overall Study||0
436485|NCT01414413|1071306|P2|COMPLETED|Overall Study|Adult population denominator for cluster randomised trial|8466
436486|NCT01414413|1071307|P1|COMPLETED|Overall Study|Adult population denominator for cluster randomised trial|8194
436487|NCT01414413|1071306|P2|STARTED|Overall Study|Adult population denominator for cluster randomised trial|8466
436488|NCT01414413|1071307|P1|STARTED|Overall Study|Adult population denominator for cluster randomised trial|8194
436489|NCT01414244|1071321|P2|NOT COMPLETED|Overall Study||0
436490|NCT01414244|1071322|P1|NOT COMPLETED|Overall Study||0
436491|NCT01414244|1071321|P2|COMPLETED|Overall Study||52
436492|NCT01414244|1071322|P1|COMPLETED|Overall Study||54
436493|NCT01414244|1071321|P2|STARTED|Overall Study||52
436494|NCT01414244|1071322|P1|STARTED|Overall Study||54
436495|NCT01414205|1071336|P2|NOT COMPLETED|Overall Study||7
436496|NCT01414205|1071337|P1|NOT COMPLETED|Overall Study||7
436497|NCT01414205|1071336|P2|COMPLETED|Overall Study||32
436498|NCT01414205|1071337|P1|COMPLETED|Overall Study||34
436499|NCT01414205|1071336|P2|Received Study Drug|Overall Study||38
436500|NCT01414205|1071337|P1|Received Study Drug|Overall Study||40
436501|NCT01414205|1071336|P2|STARTED|Overall Study||39
436502|NCT01414205|1071337|P1|STARTED|Overall Study||41
436503|NCT01414192|1071373|P4|NOT COMPLETED|Overall Study||0
436504|NCT01414192|1071374|P3|NOT COMPLETED|Overall Study||0
436505|NCT01414192|1071375|P2|NOT COMPLETED|Overall Study||0
436506|NCT01414192|1071376|P1|NOT COMPLETED|Overall Study||0
436507|NCT01414192|1071373|P4|COMPLETED|Overall Study||1726
436508|NCT01414192|1071374|P3|COMPLETED|Overall Study||424
436509|NCT01414192|1071375|P2|COMPLETED|Overall Study||575
436510|NCT01414192|1071376|P1|COMPLETED|Overall Study||490
436511|NCT01414192|1071373|P4|STARTED|Overall Study||1726
436512|NCT01414192|1071374|P3|STARTED|Overall Study||424
436513|NCT01414192|1071375|P2|STARTED|Overall Study||575
436514|NCT01414192|1071376|P1|STARTED|Overall Study||490
436515|NCT01414166|1071406|P2|NOT COMPLETED|Overall Study||83
436516|NCT01414166|1071407|P1|NOT COMPLETED|Overall Study||91
436517|NCT01414166|1071406|P2|COMPLETED|Overall Study||39
436518|NCT01414166|1071407|P1|COMPLETED|Overall Study||31
436519|NCT01414166|1071406|P2|Treated|Overall Study||121
436520|NCT01414166|1071407|P1|Treated|Overall Study||120
436521|NCT01414166|1071406|P2|STARTED|Overall Study||122
436522|NCT01414166|1071407|P1|STARTED|Overall Study||122
436523|NCT01414153|1071433|P4|NOT COMPLETED|Overall Study||4
436524|NCT01414153|1071434|P3|NOT COMPLETED|Overall Study||4
436525|NCT01414153|1071435|P2|NOT COMPLETED|Overall Study||2
436526|NCT01414153|1071436|P1|NOT COMPLETED|Overall Study||8
436527|NCT01414153|1071433|P4|COMPLETED|Overall Study||37
436528|NCT01414153|1071434|P3|COMPLETED|Overall Study||35
436529|NCT01414153|1071435|P2|COMPLETED|Overall Study||38
436530|NCT01414153|1071436|P1|COMPLETED|Overall Study||30
436531|NCT01414153|1071433|P4|STARTED|Overall Study||41
436532|NCT01414153|1071434|P3|STARTED|Overall Study||39
436533|NCT01414153|1071435|P2|STARTED|Overall Study||40
436534|NCT01414153|1071436|P1|STARTED|Overall Study||38
436535|NCT01414114|1071470|P1|NOT COMPLETED|Overall Study||5
436536|NCT01414114|1071470|P1|COMPLETED|Overall Study|Completed 12-week treatment period|32
436537|NCT01414114|1071470|P1|STARTED|Overall Study||37
436538|NCT01414036|1071490|P2|NOT COMPLETED|Completed 3 Month Survey||5
436539|NCT01414036|1071491|P1|NOT COMPLETED|Completed 3 Month Survey||9
436540|NCT01414036|1071490|P2|COMPLETED|Completed 3 Month Survey||19
436541|NCT01414036|1071491|P1|COMPLETED|Completed 3 Month Survey||14
436542|NCT01414036|1071490|P2|STARTED|Completed 3 Month Survey||24
436543|NCT01414036|1071491|P1|STARTED|Completed 3 Month Survey||23
436544|NCT01414036|1071490|P2|NOT COMPLETED|Received Allocated Intervention||13
436545|NCT01414036|1071491|P1|NOT COMPLETED|Received Allocated Intervention||0
436546|NCT01414036|1071490|P2|COMPLETED|Received Allocated Intervention||11
436547|NCT01414036|1071491|P1|COMPLETED|Received Allocated Intervention||23
436548|NCT01414036|1071490|P2|STARTED|Received Allocated Intervention||24
436549|NCT01414036|1071491|P1|STARTED|Received Allocated Intervention||23
436550|NCT01414010|1071505|P4|NOT COMPLETED|Overall Study||0
436551|NCT01414010|1071506|P3|NOT COMPLETED|Overall Study||0
436552|NCT01414010|1071507|P2|NOT COMPLETED|Overall Study||0
436553|NCT01414010|1071508|P1|NOT COMPLETED|Overall Study||2
436554|NCT01414010|1071505|P4|COMPLETED|Overall Study||8
436555|NCT01414010|1071506|P3|COMPLETED|Overall Study||8
436556|NCT01414010|1071507|P2|COMPLETED|Overall Study||8
436557|NCT01414010|1071508|P1|COMPLETED|Overall Study||6
436558|NCT01414010|1071505|P4|STARTED|Overall Study||8
436559|NCT01414010|1071506|P3|STARTED|Overall Study||8
436560|NCT01414010|1071507|P2|STARTED|Overall Study||8
436561|NCT01414010|1071508|P1|STARTED|Overall Study||8
436562|NCT01413958|1071526|P2|NOT COMPLETED|Overall Study||1
436563|NCT01413958|1071527|P1|NOT COMPLETED|Overall Study||0
436564|NCT01413958|1071526|P2|COMPLETED|Overall Study||286
436565|NCT01413958|1071527|P1|COMPLETED|Overall Study||288
436566|NCT01413958|1071526|P2|STARTED|Overall Study||287
436567|NCT01413958|1071527|P1|STARTED|Overall Study||288
436568|NCT01413750|1071562|P4|NOT COMPLETED|Overall Study||0
436569|NCT01413750|1071563|P3|NOT COMPLETED|Overall Study||0
436570|NCT01413750|1071564|P2|NOT COMPLETED|Overall Study||0
436571|NCT01413750|1071565|P1|NOT COMPLETED|Overall Study||0
436572|NCT01413750|1071562|P4|COMPLETED|Overall Study||7
436573|NCT01413750|1071563|P3|COMPLETED|Overall Study||4
436574|NCT01413750|1071564|P2|COMPLETED|Overall Study||6
436575|NCT01413750|1071565|P1|COMPLETED|Overall Study||6
436576|NCT01413750|1071562|P4|STARTED|Overall Study||7
436577|NCT01413750|1071563|P3|STARTED|Overall Study||4
436578|NCT01413750|1071564|P2|STARTED|Overall Study||6
436579|NCT01413750|1071565|P1|STARTED|Overall Study||6
436580|NCT01413542|1071578|P4|NOT COMPLETED|Overall Study||1
436581|NCT01413542|1071579|P3|NOT COMPLETED|Overall Study||3
436582|NCT01413542|1071580|P2|NOT COMPLETED|Overall Study||0
436583|NCT01413542|1071581|P1|NOT COMPLETED|Overall Study||1
436584|NCT01413542|1071578|P4|COMPLETED|Overall Study||7
436585|NCT01413542|1071579|P3|COMPLETED|Overall Study||6
436586|NCT01413542|1071580|P2|COMPLETED|Overall Study||6
436587|NCT01413542|1071581|P1|COMPLETED|Overall Study||5
436588|NCT01413542|1071578|P4|STARTED|Overall Study||8
436589|NCT01413542|1071579|P3|STARTED|Overall Study||9
436590|NCT01413542|1071580|P2|STARTED|Overall Study||6
436591|NCT01413542|1071581|P1|STARTED|Overall Study||6
436592|NCT01413516|1071596|P2|NOT COMPLETED|Overall Study||0
436593|NCT01413516|1071597|P1|NOT COMPLETED|Overall Study||0
436594|NCT01413516|1071596|P2|COMPLETED|Overall Study||9
436595|NCT01413516|1071597|P1|COMPLETED|Overall Study||8
436596|NCT01413516|1071596|P2|STARTED|Overall Study||9
436597|NCT01413516|1071597|P1|STARTED|Overall Study||8
436598|NCT01413360|1071603|P1|NOT COMPLETED|Overall Study||3
436599|NCT01413360|1071603|P1|COMPLETED|Overall Study||7
436600|NCT01413360|1071603|P1|STARTED|Overall Study||10
436601|NCT01413204|1071611|P3|NOT COMPLETED|Overall Study||19
436602|NCT01413204|1071612|P2|NOT COMPLETED|Overall Study||6
436603|NCT01413204|1071613|P1|NOT COMPLETED|Overall Study||6
436604|NCT01413204|1071611|P3|COMPLETED|Overall Study||74
436605|NCT01413204|1071612|P2|COMPLETED|Overall Study||83
436606|NCT01413204|1071613|P1|COMPLETED|Overall Study||84
436607|NCT01413204|1071611|P3|STARTED|Overall Study||93
436608|NCT01413204|1071612|P2|STARTED|Overall Study||89
436609|NCT01413204|1071613|P1|STARTED|Overall Study||90
436610|NCT01413191|1071621|P1|NOT COMPLETED|Overall Study||11
436611|NCT01413191|1071621|P1|COMPLETED|Overall Study||7
436612|NCT01413191|1071621|P1|STARTED|Overall Study||18
436613|NCT01412983|1071625|P2|NOT COMPLETED|2nd Period||0
436614|NCT01412983|1071626|P1|NOT COMPLETED|2nd Period||0
436615|NCT01412983|1071625|P2|COMPLETED|2nd Period||46
436616|NCT01412983|1071626|P1|COMPLETED|2nd Period||50
436617|NCT01412983|1071625|P2|STARTED|2nd Period||46
436618|NCT01412983|1071626|P1|STARTED|2nd Period||50
436619|NCT01412983|1071625|P2|NOT COMPLETED|1st Period||4
436620|NCT01412983|1071626|P1|NOT COMPLETED|1st Period||0
436621|NCT01412983|1071625|P2|COMPLETED|1st Period||46
436622|NCT01412983|1071626|P1|COMPLETED|1st Period||50
436623|NCT01412983|1071625|P2|STARTED|1st Period||50
436624|NCT01412983|1071626|P1|STARTED|1st Period||50
436625|NCT01412957|1071636|P2|NOT COMPLETED|Overall Study||157
436626|NCT01412957|1071637|P1|NOT COMPLETED|Overall Study||149
436627|NCT01412957|1071636|P2|COMPLETED|Overall Study|Participants continuing study at the time of data cut-off|31
436628|NCT01412957|1071637|P1|COMPLETED|Overall Study|Participants continuing study at the time of data cut-off|40
436629|NCT01412957|1071636|P2|STARTED|Overall Study||188
436630|NCT01412957|1071637|P1|STARTED|Overall Study||189
436631|NCT01412944|1071659|P6|NOT COMPLETED|Follow-up||0
436632|NCT01412944|1071660|P5|NOT COMPLETED|Follow-up||0
436633|NCT01412944|1071661|P4|NOT COMPLETED|Follow-up||0
436634|NCT01412944|1071662|P3|NOT COMPLETED|Follow-up||0
436635|NCT01412944|1071663|P2|NOT COMPLETED|Follow-up||0
436636|NCT01412944|1071664|P1|NOT COMPLETED|Follow-up||0
436637|NCT01412944|1071659|P6|COMPLETED|Follow-up||0
436638|NCT01412944|1071660|P5|COMPLETED|Follow-up||2
436639|NCT01412944|1071661|P4|COMPLETED|Follow-up||1
436640|NCT01412944|1071662|P3|COMPLETED|Follow-up||2
436641|NCT01412944|1071663|P2|COMPLETED|Follow-up||0
436642|NCT01412944|1071664|P1|COMPLETED|Follow-up||0
436643|NCT01412944|1071659|P6|STARTED|Follow-up||0
436644|NCT01412944|1071660|P5|STARTED|Follow-up||2
436645|NCT01412944|1071661|P4|STARTED|Follow-up||1
436646|NCT01412944|1071662|P3|STARTED|Follow-up||2
436647|NCT01412944|1071663|P2|STARTED|Follow-up||0
436648|NCT01412944|1071664|P1|STARTED|Follow-up||0
436649|NCT01412944|1071659|P6|NOT COMPLETED|Entire: IV + Maintenance||0
436650|NCT01412944|1071660|P5|NOT COMPLETED|Entire: IV + Maintenance||0
436651|NCT01412944|1071661|P4|NOT COMPLETED|Entire: IV + Maintenance||0
436652|NCT01412944|1071662|P3|NOT COMPLETED|Entire: IV + Maintenance||0
436653|NCT01412944|1071663|P2|NOT COMPLETED|Entire: IV + Maintenance||5
436654|NCT01412944|1071664|P1|NOT COMPLETED|Entire: IV + Maintenance||2
436655|NCT01412944|1071659|P6|COMPLETED|Entire: IV + Maintenance||0
436656|NCT01412944|1071660|P5|COMPLETED|Entire: IV + Maintenance||0
436657|NCT01412944|1071661|P4|COMPLETED|Entire: IV + Maintenance||0
436658|NCT01412944|1071662|P3|COMPLETED|Entire: IV + Maintenance||0
436659|NCT01412944|1071663|P2|COMPLETED|Entire: IV + Maintenance||17
436660|NCT01412944|1071664|P1|COMPLETED|Entire: IV + Maintenance||19
436661|NCT01412944|1071659|P6|STARTED|Entire: IV + Maintenance||0
436662|NCT01412944|1071660|P5|STARTED|Entire: IV + Maintenance||0
436663|NCT01412944|1071661|P4|STARTED|Entire: IV + Maintenance||0
436664|NCT01412944|1071662|P3|STARTED|Entire: IV + Maintenance||0
436665|NCT01412944|1071663|P2|STARTED|Entire: IV + Maintenance||22
436666|NCT01412944|1071664|P1|STARTED|Entire: IV + Maintenance||21
436667|NCT01412944|1071659|P6|NOT COMPLETED|Entire: IV + Maintenance||2
436668|NCT01412944|1071660|P5|NOT COMPLETED|Entire: IV + Maintenance||3
436669|NCT01412944|1071661|P4|NOT COMPLETED|Entire: IV + Maintenance||1
436670|NCT01412944|1071662|P3|NOT COMPLETED|Entire: IV + Maintenance||1
436671|NCT01412944|1071663|P2|NOT COMPLETED|Entire: IV + Maintenance||0
436672|NCT01412944|1071664|P1|NOT COMPLETED|Entire: IV + Maintenance||0
436673|NCT01412944|1071659|P6|COMPLETED|Entire: IV + Maintenance||6
436674|NCT01412944|1071660|P5|COMPLETED|Entire: IV + Maintenance||11
436675|NCT01412944|1071661|P4|COMPLETED|Entire: IV + Maintenance||5
436676|NCT01412944|1071662|P3|COMPLETED|Entire: IV + Maintenance||14
436677|NCT01412944|1071663|P2|COMPLETED|Entire: IV + Maintenance||0
436678|NCT01412944|1071664|P1|COMPLETED|Entire: IV + Maintenance||0
436679|NCT01412944|1071659|P6|STARTED|Entire: IV + Maintenance||8
436680|NCT01412944|1071660|P5|STARTED|Entire: IV + Maintenance||14
436681|NCT01412944|1071661|P4|STARTED|Entire: IV + Maintenance||6
436682|NCT01412944|1071662|P3|STARTED|Entire: IV + Maintenance||15
436683|NCT01412944|1071663|P2|STARTED|Entire: IV + Maintenance||0
436684|NCT01412944|1071664|P1|STARTED|Entire: IV + Maintenance||0
436685|NCT01412944|1071659|P6|NOT COMPLETED|IV: Per CAIN457A2307||0
436686|NCT01412944|1071660|P5|NOT COMPLETED|IV: Per CAIN457A2307||0
436687|NCT01412944|1071661|P4|NOT COMPLETED|IV: Per CAIN457A2307||0
436688|NCT01412944|1071662|P3|NOT COMPLETED|IV: Per CAIN457A2307||0
436689|NCT01412944|1071663|P2|NOT COMPLETED|IV: Per CAIN457A2307||2
436690|NCT01412944|1071664|P1|NOT COMPLETED|IV: Per CAIN457A2307||1
436691|NCT01412944|1071659|P6|COMPLETED|IV: Per CAIN457A2307||0
436692|NCT01412944|1071660|P5|COMPLETED|IV: Per CAIN457A2307||0
436693|NCT01412944|1071661|P4|COMPLETED|IV: Per CAIN457A2307||0
436694|NCT01412944|1071662|P3|COMPLETED|IV: Per CAIN457A2307||0
436695|NCT01412944|1071663|P2|COMPLETED|IV: Per CAIN457A2307||20
436696|NCT01412944|1071664|P1|COMPLETED|IV: Per CAIN457A2307||20
436697|NCT01412944|1071659|P6|STARTED|IV: Per CAIN457A2307||0
436698|NCT01412944|1071660|P5|STARTED|IV: Per CAIN457A2307||0
436699|NCT01412944|1071661|P4|STARTED|IV: Per CAIN457A2307||0
436700|NCT01412944|1071662|P3|STARTED|IV: Per CAIN457A2307||0
436701|NCT01412944|1071663|P2|STARTED|IV: Per CAIN457A2307||22
436702|NCT01412944|1071664|P1|STARTED|IV: Per CAIN457A2307||21
436703|NCT01412944|1071659|P6|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||2
436704|NCT01412944|1071660|P5|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
436705|NCT01412944|1071661|P4|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
436706|NCT01412944|1071662|P3|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||1
436707|NCT01412944|1071663|P2|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
436708|NCT01412944|1071664|P1|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
436709|NCT01412944|1071659|P6|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6
436710|NCT01412944|1071660|P5|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14
436711|NCT01412944|1071661|P4|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6
436712|NCT01412944|1071662|P3|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14
436713|NCT01412944|1071663|P2|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
436714|NCT01412944|1071664|P1|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
436715|NCT01412944|1071659|P6|STARTED|IV: Per Previous CAIN457A2304 Treatment||8
436716|NCT01412944|1071660|P5|STARTED|IV: Per Previous CAIN457A2304 Treatment||14
436717|NCT01412944|1071661|P4|STARTED|IV: Per Previous CAIN457A2304 Treatment||6
436718|NCT01412944|1071662|P3|STARTED|IV: Per Previous CAIN457A2304 Treatment||15
436719|NCT01412944|1071663|P2|STARTED|IV: Per Previous CAIN457A2304 Treatment||0
436720|NCT01412944|1071664|P1|STARTED|IV: Per Previous CAIN457A2304 Treatment||0
436721|NCT01412918|1071700|P2|NOT COMPLETED|Overall Study||0
436722|NCT01412918|1071701|P1|NOT COMPLETED|Overall Study||0
436723|NCT01412918|1071700|P2|COMPLETED|Overall Study||1
436724|NCT01412918|1071701|P1|COMPLETED|Overall Study||20
436725|NCT01412918|1071700|P2|STARTED|Overall Study||1
436726|NCT01412918|1071701|P1|STARTED|Overall Study||20
436727|NCT01412879|1071710|P3|NOT COMPLETED|Consolidation Therapy||0
436728|NCT01412879|1071711|P2|NOT COMPLETED|Consolidation Therapy||0
436729|NCT01412879|1071712|P1|NOT COMPLETED|Consolidation Therapy||0
436730|NCT01412879|1071710|P3|COMPLETED|Consolidation Therapy||26
436731|NCT01412879|1071711|P2|COMPLETED|Consolidation Therapy||0
436732|NCT01412879|1071712|P1|COMPLETED|Consolidation Therapy||0
436733|NCT01412879|1071710|P3|STARTED|Consolidation Therapy|Only eligible patients who are able to have stem cell harvested receive consolidation therapy.|26
436734|NCT01412879|1071711|P2|STARTED|Consolidation Therapy||0
436735|NCT01412879|1071712|P1|STARTED|Consolidation Therapy||0
436736|NCT01412879|1071710|P3|NOT COMPLETED|Initial Registration (Induction Therapy)||0
436737|NCT01412879|1071711|P2|NOT COMPLETED|Initial Registration (Induction Therapy)||8
436738|NCT01412879|1071712|P1|NOT COMPLETED|Initial Registration (Induction Therapy)||13
436739|NCT01412879|1071710|P3|COMPLETED|Initial Registration (Induction Therapy)||0
436740|NCT01412879|1071711|P2|COMPLETED|Initial Registration (Induction Therapy)||27
436741|NCT01412879|1071712|P1|COMPLETED|Initial Registration (Induction Therapy)||5
436742|NCT01412879|1071710|P3|Treatment Started|Initial Registration (Induction Therapy)||0
436743|NCT01412879|1071711|P2|Treatment Started|Initial Registration (Induction Therapy)||35
436744|NCT01412879|1071712|P1|Treatment Started|Initial Registration (Induction Therapy)||17
436745|NCT01412879|1071710|P3|STARTED|Initial Registration (Induction Therapy)||0
436746|NCT01412879|1071711|P2|STARTED|Initial Registration (Induction Therapy)||35
436747|NCT01412879|1071712|P1|STARTED|Initial Registration (Induction Therapy)||18
436748|NCT01412801|1071732|P6|NOT COMPLETED|Overall Study||3
436749|NCT01412801|1071733|P5|NOT COMPLETED|Overall Study||3
436750|NCT01412801|1071734|P4|NOT COMPLETED|Overall Study||4
436751|NCT01412801|1071735|P3|NOT COMPLETED|Overall Study||7
436752|NCT01412801|1071736|P2|NOT COMPLETED|Overall Study||5
436753|NCT01412801|1071737|P1|NOT COMPLETED|Overall Study||4
436754|NCT01412801|1071732|P6|COMPLETED|Overall Study||84
436755|NCT01412801|1071733|P5|COMPLETED|Overall Study||85
436756|NCT01412801|1071734|P4|COMPLETED|Overall Study||87
436757|NCT01412801|1071735|P3|COMPLETED|Overall Study||83
436758|NCT01412801|1071736|P2|COMPLETED|Overall Study||84
436759|NCT01412801|1071737|P1|COMPLETED|Overall Study||87
436760|NCT01412801|1071732|P6|STARTED|Overall Study||87
436761|NCT01412801|1071733|P5|STARTED|Overall Study||88
436762|NCT01412801|1071734|P4|STARTED|Overall Study||91
436763|NCT01412801|1071735|P3|STARTED|Overall Study||90
436764|NCT01412801|1071736|P2|STARTED|Overall Study||89
436765|NCT01412801|1071737|P1|STARTED|Overall Study||91
436766|NCT01412710|1071776|P2|NOT COMPLETED|Overall Study||5
436767|NCT01412710|1071777|P1|NOT COMPLETED|Overall Study||4
436768|NCT01412710|1071776|P2|COMPLETED|Overall Study||22
436769|NCT01412710|1071777|P1|COMPLETED|Overall Study||46
436770|NCT01412710|1071776|P2|STARTED|Overall Study||27
436771|NCT01412710|1071777|P1|STARTED|Overall Study||50
436772|NCT01412541|1071787|P2|NOT COMPLETED|Overall Study||20
436773|NCT01412541|1071788|P1|NOT COMPLETED|Overall Study||36
436774|NCT01412541|1071787|P2|COMPLETED|Overall Study||140
436775|NCT01412541|1071788|P1|COMPLETED|Overall Study||280
436776|NCT01412541|1071787|P2|STARTED|Overall Study||160
436777|NCT01412541|1071788|P1|STARTED|Overall Study||316
436778|NCT01412424|1071896|P1|NOT COMPLETED|Extension Treatment Period||6
436779|NCT01412424|1071896|P1|COMPLETED|Extension Treatment Period||82
436780|NCT01412424|1071896|P1|STARTED|Extension Treatment Period|86% of participants who completed the core period voluntarily entered the optional extension period.|88
436781|NCT01412424|1071896|P1|NOT COMPLETED|Core Treatment Period||53
436782|NCT01412424|1071896|P1|COMPLETED|Core Treatment Period||102
436783|NCT01412424|1071896|P1|STARTED|Core Treatment Period||155
436784|NCT01412333|1071914|P2|NOT COMPLETED|Overall Study||57
436785|NCT01412333|1071915|P1|NOT COMPLETED|Overall Study||98
436786|NCT01412333|1071914|P2|COMPLETED|Overall Study||360
436787|NCT01412333|1071915|P1|COMPLETED|Overall Study||320
436788|NCT01412333|1071914|P2|STARTED|Overall Study||417
436789|NCT01412333|1071915|P1|STARTED|Overall Study||418
436790|NCT01412281|1071950|P4|NOT COMPLETED|Overall Study||0
436791|NCT01412281|1071951|P3|NOT COMPLETED|Overall Study||0
436792|NCT01412281|1071952|P2|NOT COMPLETED|Overall Study||0
436793|NCT01412281|1071953|P1|NOT COMPLETED|Overall Study||0
436794|NCT01412281|1071950|P4|COMPLETED|Overall Study||110
436795|NCT01412281|1071951|P3|COMPLETED|Overall Study||110
436796|NCT01412281|1071952|P2|COMPLETED|Overall Study||110
436797|NCT01412281|1071953|P1|COMPLETED|Overall Study||110
436798|NCT01412281|1071950|P4|STARTED|Overall Study||110
436799|NCT01412281|1071951|P3|STARTED|Overall Study||110
436800|NCT01412281|1071952|P2|STARTED|Overall Study||110
436801|NCT01412281|1071953|P1|STARTED|Overall Study||110
436802|NCT01412229|1071975|P1|NOT COMPLETED|Overall Study||1
436803|NCT01412229|1071975|P1|COMPLETED|Overall Study||38
436804|NCT01412229|1071975|P1|STARTED|Overall Study||39
436805|NCT01412164|1071987|P1|NOT COMPLETED|Overall Study||18
436806|NCT01412164|1071987|P1|COMPLETED|Overall Study||712
436807|NCT01412164|1071987|P1|STARTED|Overall Study||730
436808|NCT01412151|1071991|P1|NOT COMPLETED|Week 306 - 310 - Washout Period||2
436809|NCT01412151|1071991|P1|COMPLETED|Week 306 - 310 - Washout Period||3
436810|NCT01412151|1071991|P1|STARTED|Week 306 - 310 - Washout Period||5
436811|NCT01412151|1071991|P1|NOT COMPLETED|Week 0 - 306 - Treatment Period||5
436812|NCT01412151|1071991|P1|COMPLETED|Week 0 - 306 - Treatment Period||5
436813|NCT01412151|1071991|P1|STARTED|Week 0 - 306 - Treatment Period||10
436814|NCT01412086|1071997|P1|NOT COMPLETED|Overall Study||0
436815|NCT01412086|1071997|P1|COMPLETED|Overall Study||112
436816|NCT01412086|1071997|P1|STARTED|Overall Study||112
436817|NCT01411995|1072004|P2|NOT COMPLETED|Overall Study||1
436818|NCT01411995|1072005|P1|NOT COMPLETED|Overall Study||0
436819|NCT01411995|1072004|P2|COMPLETED|Overall Study||99
436820|NCT01411995|1072005|P1|COMPLETED|Overall Study||100
436821|NCT01411995|1072004|P2|STARTED|Overall Study||100
436822|NCT01411995|1072005|P1|STARTED|Overall Study||100
436823|NCT01411891|1072013|P2|NOT COMPLETED|Overall Study||2
436824|NCT01411891|1072014|P1|NOT COMPLETED|Overall Study||3
436825|NCT01411891|1072013|P2|COMPLETED|Overall Study||48
436826|NCT01411891|1072014|P1|COMPLETED|Overall Study||47
436827|NCT01411891|1072013|P2|STARTED|Overall Study||50
436828|NCT01411891|1072014|P1|STARTED|Overall Study||50
436829|NCT01411852|1072022|P2|NOT COMPLETED|Hospital Intervention Phase||18
436830|NCT01411852|1072023|P1|NOT COMPLETED|Hospital Intervention Phase||24
436831|NCT01411852|1072022|P2|COMPLETED|Hospital Intervention Phase|18 patients had intervention stopped prior to 2 hours after arrival or hemorrhage control|71
436832|NCT01411852|1072023|P1|COMPLETED|Hospital Intervention Phase|24 patients had intervention stopped prior to 2 hours after arrival or hemorrhage control|59
436833|NCT01411852|1072022|P2|STARTED|Hospital Intervention Phase||89
436834|NCT01411852|1072023|P1|STARTED|Hospital Intervention Phase||83
436835|NCT01411852|1072022|P2|NOT COMPLETED|Prehospital Intervention Phase||7
436836|NCT01411852|1072023|P1|NOT COMPLETED|Prehospital Intervention Phase||12
436837|NCT01411852|1072022|P2|COMPLETED|Prehospital Intervention Phase|7 patients had intervention stopped prior to hospital arrival|89
436838|NCT01411852|1072023|P1|COMPLETED|Prehospital Intervention Phase|12 patients had the intervention stopped prior to hospital arrival|83
436839|NCT01411852|1072022|P2|STARTED|Prehospital Intervention Phase|One patient was in police custody at the time of enrollment. Patient's data omitted from analyses.|96
436840|NCT01411852|1072023|P1|STARTED|Prehospital Intervention Phase|1 patient randomized to 2000 mL bolus arm but received 250 mL bolus. Analyzed in 2000 mL arm.|95
436841|NCT01411839|1072068|P2|NOT COMPLETED|Overall Study||3
436842|NCT01411839|1072069|P1|NOT COMPLETED|Overall Study||4
436843|NCT01411839|1072068|P2|COMPLETED|Overall Study||17
436844|NCT01411839|1072069|P1|COMPLETED|Overall Study||16
436845|NCT01411839|1072068|P2|STARTED|Overall Study||20
436846|NCT01411839|1072069|P1|STARTED|Overall Study||20
436847|NCT01411774|1072081|P2|NOT COMPLETED|Overall Study||3
436848|NCT01411774|1072082|P1|NOT COMPLETED|Overall Study||0
436849|NCT01411774|1072081|P2|COMPLETED|Overall Study||67
436850|NCT01411774|1072082|P1|COMPLETED|Overall Study||72
436851|NCT01411774|1072081|P2|STARTED|Overall Study||70
436852|NCT01411774|1072082|P1|STARTED|Overall Study||72
436853|NCT01411696|1072090|P1|NOT COMPLETED|Overall Study||0
436854|NCT01411696|1072090|P1|COMPLETED|Overall Study||289
436855|NCT01411696|1072090|P1|STARTED|Overall Study||289
436856|NCT01411592|1072099|P2|NOT COMPLETED|Overall Study||0
436857|NCT01411592|1072100|P1|NOT COMPLETED|Overall Study||0
436858|NCT01411592|1072099|P2|COMPLETED|Overall Study||16
436859|NCT01411592|1072100|P1|COMPLETED|Overall Study||14
436860|NCT01411592|1072099|P2|5-Year Time Frame|Overall Study||16
436861|NCT01411592|1072100|P1|5-Year Time Frame|Overall Study||14
436862|NCT01411592|1072099|P2|STARTED|Overall Study||16
436863|NCT01411592|1072100|P1|STARTED|Overall Study||14
436864|NCT01411501|1072112|P4|NOT COMPLETED|Overall Study||7
436865|NCT01411501|1072113|P3|NOT COMPLETED|Overall Study||6
436866|NCT01411501|1072114|P2|NOT COMPLETED|Overall Study||6
436867|NCT01411501|1072115|P1|NOT COMPLETED|Overall Study||10
436868|NCT01411501|1072112|P4|COMPLETED|Overall Study||163
436869|NCT01411501|1072113|P3|COMPLETED|Overall Study||159
436870|NCT01411501|1072114|P2|COMPLETED|Overall Study||166
436871|NCT01411501|1072115|P1|COMPLETED|Overall Study||158
436872|NCT01411501|1072112|P4|STARTED|Overall Study||170
436873|NCT01411501|1072113|P3|STARTED|Overall Study||165
436874|NCT01411501|1072114|P2|STARTED|Overall Study||172
436875|NCT01411501|1072115|P1|STARTED|Overall Study||168
436876|NCT01411488|1072147|P2|NOT COMPLETED|Overall Study||5
436877|NCT01411488|1072148|P1|NOT COMPLETED|Overall Study||6
436878|NCT01411488|1072147|P2|COMPLETED|Overall Study||38
436879|NCT01411488|1072148|P1|COMPLETED|Overall Study||41
436880|NCT01411488|1072147|P2|STARTED|Overall Study||43
436881|NCT01411488|1072148|P1|STARTED|Overall Study||47
436882|NCT01411228|1072157|P3|NOT COMPLETED|Overall Study||1
436883|NCT01411228|1072158|P2|NOT COMPLETED|Overall Study||0
436884|NCT01411228|1072159|P1|NOT COMPLETED|Overall Study||1
436885|NCT01411228|1072157|P3|COMPLETED|Overall Study||4
436886|NCT01411228|1072158|P2|COMPLETED|Overall Study||5
436887|NCT01411228|1072159|P1|COMPLETED|Overall Study||4
436888|NCT01411228|1072157|P3|STARTED|Overall Study||5
436889|NCT01411228|1072158|P2|STARTED|Overall Study||5
436890|NCT01411228|1072159|P1|STARTED|Overall Study||5
436891|NCT01411215|1072181|P2|NOT COMPLETED|Overall Study||84
436892|NCT01411215|1072182|P1|NOT COMPLETED|Overall Study||66
436893|NCT01411215|1072181|P2|COMPLETED|Overall Study||7
436894|NCT01411215|1072182|P1|COMPLETED|Overall Study||3
436895|NCT01411215|1072181|P2|Treated|Overall Study|1 participant was considered as screen failure and therefore not treated.|90
436896|NCT01411215|1072182|P1|Treated|Overall Study||69
436897|NCT01411215|1072181|P2|STARTED|Overall Study||91
436898|NCT01411215|1072182|P1|STARTED|Overall Study||69
436899|NCT01411137|1072215|P1|NOT COMPLETED|Part 3: Open-Label Extension||0
436900|NCT01411137|1072215|P1|COMPLETED|Part 3: Open-Label Extension||12
436901|NCT01411137|1072215|P1|STARTED|Part 3: Open-Label Extension|Two sites with 11 completers of Part 2 did not participate in Part 3. Two subjects lost contact.|12
436902|NCT01411137|1072215|P1|NOT COMPLETED|Part 2: Open-Label Extension||7
436903|NCT01411137|1072215|P1|COMPLETED|Part 2: Open-Label Extension||25
436904|NCT01411137|1072215|P1|STARTED|Part 2: Open-Label Extension|1 subject who completed Part 1 did not elect to continue into Part 2.|32
436905|NCT01411137|1072215|P1|NOT COMPLETED|Part 1: Dose Conversion||10
436906|NCT01411137|1072215|P1|COMPLETED|Part 1: Dose Conversion||33
436907|NCT01411137|1072215|P1|STARTED|Part 1: Dose Conversion||43
436908|NCT01411085|1072234|P1|NOT COMPLETED|Overall Study||3
436909|NCT01411085|1072234|P1|COMPLETED|Overall Study||7
436910|NCT01411085|1072234|P1|STARTED|Overall Study||10
436911|NCT01410773|1072238|P1|NOT COMPLETED|Overall Study||0
436912|NCT01410773|1072238|P1|COMPLETED|Overall Study||110
436913|NCT01410773|1072238|P1|STARTED|Overall Study||110
436914|NCT01410604|1072245|P2|NOT COMPLETED|Overall Study||2
436915|NCT01410604|1072246|P1|NOT COMPLETED|Overall Study||3
436916|NCT01410604|1072245|P2|COMPLETED|Overall Study||14
436917|NCT01410604|1072246|P1|COMPLETED|Overall Study||12
436918|NCT01410604|1072245|P2|STARTED|Overall Study||16
436919|NCT01410604|1072246|P1|STARTED|Overall Study||15
436920|NCT01410565|1072268|P3|NOT COMPLETED|Double Blind Phase||0
436921|NCT01410565|1072269|P2|NOT COMPLETED|Double Blind Phase||15
436922|NCT01410565|1072270|P1|NOT COMPLETED|Double Blind Phase||13
436923|NCT01410565|1072268|P3|COMPLETED|Double Blind Phase||0
436924|NCT01410565|1072269|P2|COMPLETED|Double Blind Phase||0
436925|NCT01410565|1072270|P1|COMPLETED|Double Blind Phase||0
436926|NCT01410565|1072268|P3|STARTED|Double Blind Phase||0
436927|NCT01410565|1072269|P2|STARTED|Double Blind Phase||15
436928|NCT01410565|1072270|P1|STARTED|Double Blind Phase|All 66 patients received one dose of Apaziquone in the open label phase.|13
436929|NCT01410565|1072268|P3|NOT COMPLETED|Open Label Phase Apaziquone||8
436930|NCT01410565|1072269|P2|NOT COMPLETED|Open Label Phase Apaziquone||0
436931|NCT01410565|1072270|P1|NOT COMPLETED|Open Label Phase Apaziquone||0
436932|NCT01410565|1072268|P3|COMPLETED|Open Label Phase Apaziquone||58
436933|NCT01410565|1072269|P2|COMPLETED|Open Label Phase Apaziquone||0
436934|NCT01410565|1072270|P1|COMPLETED|Open Label Phase Apaziquone||0
436935|NCT01410565|1072268|P3|STARTED|Open Label Phase Apaziquone||66
436936|NCT01410565|1072269|P2|STARTED|Open Label Phase Apaziquone||0
436937|NCT01410565|1072270|P1|STARTED|Open Label Phase Apaziquone||0
436938|NCT01410552|1072280|P1|NOT COMPLETED|Overall Study||136
436939|NCT01410552|1072280|P1|COMPLETED|Overall Study||877
436940|NCT01410552|1072280|P1|STARTED|Overall Study||1013
436941|NCT01410474|1072287|P2|NOT COMPLETED|Overall Study||1
436942|NCT01410474|1072288|P1|NOT COMPLETED|Overall Study||0
436943|NCT01410474|1072287|P2|COMPLETED|Overall Study||167
436944|NCT01410474|1072288|P1|COMPLETED|Overall Study||173
436945|NCT01410474|1072287|P2|STARTED|Overall Study||168
436946|NCT01410474|1072288|P1|STARTED|Overall Study||173
436947|NCT01410448|1072311|P2|NOT COMPLETED|Overall Study||35
436948|NCT01410448|1072312|P1|NOT COMPLETED|Overall Study||12
436949|NCT01410448|1072311|P2|COMPLETED|Overall Study||155
436950|NCT01410448|1072312|P1|COMPLETED|Overall Study||181
436951|NCT01410448|1072311|P2|Modified ITT Analysis Set|Overall Study||149
436952|NCT01410448|1072312|P1|Modified ITT Analysis Set|Overall Study||161
436953|NCT01410448|1072311|P2|Intent-to Treat (ITT) Analysis Set|Overall Study||190
436954|NCT01410448|1072312|P1|Intent-to Treat (ITT) Analysis Set|Overall Study||193
436955|NCT01410448|1072311|P2|STARTED|Overall Study||190
436956|NCT01410448|1072312|P1|STARTED|Overall Study||193
436957|NCT01410409|1072352|P2|NOT COMPLETED|Overall Study||4
436958|NCT01410409|1072353|P1|NOT COMPLETED|Overall Study||1
436959|NCT01410409|1072352|P2|COMPLETED|Overall Study||46
436960|NCT01410409|1072353|P1|COMPLETED|Overall Study||49
436961|NCT01410409|1072352|P2|STARTED|Overall Study||50
436962|NCT01410409|1072353|P1|STARTED|Overall Study||50
436963|NCT01410357|1072377|P2|NOT COMPLETED|Overall Study||24
436964|NCT01410357|1072378|P1|NOT COMPLETED|Overall Study||26
436965|NCT01410357|1072377|P2|COMPLETED|Overall Study||76
436966|NCT01410357|1072378|P1|COMPLETED|Overall Study||74
436967|NCT01410357|1072377|P2|STARTED|Overall Study||100
436968|NCT01410357|1072378|P1|STARTED|Overall Study||100
436969|NCT01410344|1072432|P1|NOT COMPLETED|Overall Study||3
436970|NCT01410344|1072432|P1|COMPLETED|Overall Study||17
436971|NCT01410344|1072432|P1|STARTED|Overall Study||20
436972|NCT01410240|1072439|P3|NOT COMPLETED|Overall Study||2
436973|NCT01410240|1072440|P2|NOT COMPLETED|Overall Study||1
436974|NCT01410240|1072441|P1|NOT COMPLETED|Overall Study||1
436975|NCT01410240|1072439|P3|COMPLETED|Overall Study||10
436976|NCT01410240|1072440|P2|COMPLETED|Overall Study||52
436977|NCT01410240|1072441|P1|COMPLETED|Overall Study||52
436978|NCT01410240|1072439|P3|STARTED|Overall Study||12
436979|NCT01410240|1072440|P2|STARTED|Overall Study||53
436980|NCT01410240|1072441|P1|STARTED|Overall Study||53
436981|NCT01410227|1072512|P4|NOT COMPLETED|Overall Study||1
436982|NCT01410227|1072513|P3|NOT COMPLETED|Overall Study||2
436983|NCT01410227|1072514|P2|NOT COMPLETED|Overall Study||0
436984|NCT01410227|1072515|P1|NOT COMPLETED|Overall Study||4
436985|NCT01410227|1072512|P4|COMPLETED|Overall Study||5
436986|NCT01410227|1072513|P3|COMPLETED|Overall Study||13
436987|NCT01410227|1072514|P2|COMPLETED|Overall Study||8
436988|NCT01410227|1072515|P1|COMPLETED|Overall Study||4
436989|NCT01410227|1072512|P4|STARTED|Overall Study||6
436990|NCT01410227|1072513|P3|STARTED|Overall Study||15
436991|NCT01410227|1072514|P2|STARTED|Overall Study||8
436992|NCT01410227|1072515|P1|STARTED|Overall Study||8
436993|NCT01410110|1072587|P2|NOT COMPLETED|Overall Study||2
436994|NCT01410110|1072588|P1|NOT COMPLETED|Overall Study||4
436995|NCT01410110|1072587|P2|COMPLETED|Overall Study||22
436996|NCT01410110|1072588|P1|COMPLETED|Overall Study||20
436997|NCT01410110|1072587|P2|6 Month Follow-up|Overall Study||22
436998|NCT01410110|1072588|P1|6 Month Follow-up|Overall Study||20
436999|NCT01410110|1072587|P2|3 Months (End of Intervention)|Overall Study||22
437000|NCT01410110|1072588|P1|3 Months (End of Intervention)|Overall Study||20
437001|NCT01410110|1072587|P2|Randomization|Overall Study||24
437002|NCT01410110|1072588|P1|Randomization|Overall Study||24
437003|NCT01410110|1072587|P2|STARTED|Overall Study||24
437004|NCT01410110|1072588|P1|STARTED|Overall Study||24
437005|NCT01410097|1072612|P2|NOT COMPLETED|Overall Study||3
437006|NCT01410097|1072613|P1|NOT COMPLETED|Overall Study||5
437007|NCT01410097|1072612|P2|COMPLETED|Overall Study||530
437008|NCT01410097|1072613|P1|COMPLETED|Overall Study||551
437009|NCT01410097|1072612|P2|STARTED|Overall Study||533
437010|NCT01410097|1072613|P1|STARTED|Overall Study||556
437011|NCT01409993|1072637|P4|NOT COMPLETED|Overall Study||5
437012|NCT01409993|1072638|P3|NOT COMPLETED|Overall Study||3
437013|NCT01409993|1072639|P2|NOT COMPLETED|Overall Study||5
437014|NCT01409993|1072640|P1|NOT COMPLETED|Overall Study||4
437015|NCT01409993|1072637|P4|COMPLETED|Overall Study||8
437016|NCT01409993|1072638|P3|COMPLETED|Overall Study||11
437017|NCT01409993|1072639|P2|COMPLETED|Overall Study||21
437018|NCT01409993|1072640|P1|COMPLETED|Overall Study||21
437019|NCT01409993|1072637|P4|STARTED|Overall Study||13
437020|NCT01409993|1072638|P3|STARTED|Overall Study||14
437021|NCT01409993|1072639|P2|STARTED|Overall Study||26
437022|NCT01409993|1072640|P1|STARTED|Overall Study||25
437023|NCT01409837|1072660|P2|NOT COMPLETED|Overall Study||2
437024|NCT01409837|1072661|P1|NOT COMPLETED|Overall Study||3
437025|NCT01409837|1072660|P2|COMPLETED|Overall Study||14
437026|NCT01409837|1072661|P1|COMPLETED|Overall Study||14
437027|NCT01409837|1072660|P2|282nd Week|Overall Study||14
437028|NCT01409837|1072661|P1|282nd Week|Overall Study||14
437029|NCT01409837|1072660|P2|186th Week|Overall Study||14
437030|NCT01409837|1072661|P1|186th Week|Overall Study|Moved away to another location|14
437031|NCT01409837|1072660|P2|138th Week|Overall Study||14
437032|NCT01409837|1072661|P1|138th Week|Overall Study||15
437033|NCT01409837|1072660|P2|114th Week|Overall Study||14
437034|NCT01409837|1072661|P1|114th Week|Overall Study||15
437035|NCT01409837|1072660|P2|102nd Week|Overall Study|Married another wife|14
437036|NCT01409837|1072661|P1|102nd Week|Overall Study||15
437037|NCT01409837|1072660|P2|96th Week|Overall Study||15
437038|NCT01409837|1072661|P1|96th Week|Overall Study||15
437039|NCT01409837|1072660|P2|48th Week|Overall Study||15
437040|NCT01409837|1072661|P1|48th Week|Overall Study|Lost to follow-up|15
437041|NCT01409837|1072660|P2|24th Week|Overall Study|Diagnosed with Lymphocytic Lymphoma and withdrawn|15
437042|NCT01409837|1072661|P1|24th Week|Overall Study||16
437043|NCT01409837|1072660|P2|12th Week|Overall Study||16
437044|NCT01409837|1072661|P1|12th Week|Overall Study|Moved away to another location|16
437045|NCT01409837|1072660|P2|6th Week|Overall Study||16
437046|NCT01409837|1072661|P1|6th Week|Overall Study||17
437047|NCT01409837|1072660|P2|STARTED|Overall Study||16
437048|NCT01409837|1072661|P1|STARTED|Overall Study||17
437049|NCT01409707|1072686|P3|NOT COMPLETED|Overall Study||16
437050|NCT01409707|1072687|P2|NOT COMPLETED|Overall Study||17
437051|NCT01409707|1072688|P1|NOT COMPLETED|Overall Study||5
437052|NCT01409707|1072686|P3|COMPLETED|Overall Study||24
437053|NCT01409707|1072687|P2|COMPLETED|Overall Study||28
437054|NCT01409707|1072688|P1|COMPLETED|Overall Study||36
437055|NCT01409707|1072686|P3|STARTED|Overall Study||40
437056|NCT01409707|1072687|P2|STARTED|Overall Study||45
437057|NCT01409707|1072688|P1|STARTED|Overall Study||41
437058|NCT01409564|1072700|P2|NOT COMPLETED|Overall Study||5
437059|NCT01409564|1072701|P1|NOT COMPLETED|Overall Study||5
437060|NCT01409564|1072700|P2|COMPLETED|Overall Study||18
437061|NCT01409564|1072701|P1|COMPLETED|Overall Study||18
437062|NCT01409564|1072700|P2|STARTED|Overall Study||23
437063|NCT01409564|1072701|P1|STARTED|Overall Study||23
437064|NCT01409434|1072719|P1|NOT COMPLETED|Overall Study||4
437065|NCT01409434|1072719|P1|COMPLETED|Overall Study||40
437066|NCT01409434|1072719|P1|STARTED|Overall Study||44
437067|NCT01409382|1072729|P2|NOT COMPLETED|Overall Study||80
437068|NCT01409382|1072730|P1|NOT COMPLETED|Overall Study||81
437069|NCT01409382|1072729|P2|COMPLETED|Overall Study||160
437070|NCT01409382|1072730|P1|COMPLETED|Overall Study||159
437071|NCT01409382|1072729|P2|STARTED|Overall Study||240
437072|NCT01409382|1072730|P1|STARTED|Overall Study||240
437073|NCT01409291|1072744|P2|NOT COMPLETED|Overall Study||9
437074|NCT01409291|1072745|P1|NOT COMPLETED|Overall Study||7
437075|NCT01409291|1072744|P2|COMPLETED|Overall Study||19
437076|NCT01409291|1072745|P1|COMPLETED|Overall Study||29
437077|NCT01409291|1072744|P2|STARTED|Overall Study||28
437078|NCT01409291|1072745|P1|STARTED|Overall Study||36
437079|NCT01409239|1072755|P2|NOT COMPLETED|Overall Study||0
437080|NCT01409239|1072756|P1|NOT COMPLETED|Overall Study||0
437081|NCT01409239|1072755|P2|COMPLETED|Overall Study||17
437082|NCT01409239|1072756|P1|COMPLETED|Overall Study||16
437083|NCT01409239|1072755|P2|STARTED|Overall Study||17
437084|NCT01409239|1072756|P1|STARTED|Overall Study||16
437085|NCT01409213|1072762|P1|NOT COMPLETED|Overall Study||0
437086|NCT01409213|1072762|P1|COMPLETED|Overall Study||1523
437087|NCT01409213|1072762|P1|STARTED|Overall Study||1523
437088|NCT01409096|1072769|P2|NOT COMPLETED|Overall Study||5
437089|NCT01409096|1072770|P1|NOT COMPLETED|Overall Study||2
437090|NCT01409096|1072769|P2|COMPLETED|Overall Study||35
437091|NCT01409096|1072770|P1|COMPLETED|Overall Study||38
437092|NCT01409096|1072769|P2|STARTED|Overall Study||40
437093|NCT01409096|1072770|P1|STARTED|Overall Study||40
437094|NCT01408992|1072782|P1|NOT COMPLETED|Overall Study||0
437095|NCT01408992|1072782|P1|COMPLETED|Overall Study||558
437096|NCT01408992|1072782|P1|STARTED|Overall Study||558
437097|NCT01408914|1072797|P3|NOT COMPLETED|Overall Study||13
437098|NCT01408914|1072798|P2|NOT COMPLETED|Overall Study||12
437099|NCT01408914|1072799|P1|NOT COMPLETED|Overall Study||12
437100|NCT01408914|1072797|P3|COMPLETED|Overall Study||47
437101|NCT01408914|1072798|P2|COMPLETED|Overall Study||48
437102|NCT01408914|1072799|P1|COMPLETED|Overall Study||48
437103|NCT01408914|1072797|P3|STARTED|Overall Study||60
437104|NCT01408914|1072798|P2|STARTED|Overall Study||60
437105|NCT01408914|1072799|P1|STARTED|Overall Study||60
437106|NCT01408888|1072813|P2|NOT COMPLETED|Second Intervention||0
437107|NCT01408888|1072814|P1|NOT COMPLETED|Second Intervention||2
437108|NCT01408888|1072813|P2|COMPLETED|Second Intervention||8
437109|NCT01408888|1072814|P1|COMPLETED|Second Intervention||16
437110|NCT01408888|1072813|P2|STARTED|Second Intervention||8
437111|NCT01408888|1072814|P1|STARTED|Second Intervention||18
437112|NCT01408888|1072813|P2|NOT COMPLETED|Washout of at Least 21 Days||0
437113|NCT01408888|1072814|P1|NOT COMPLETED|Washout of at Least 21 Days||0
437114|NCT01408888|1072813|P2|COMPLETED|Washout of at Least 21 Days||8
437115|NCT01408888|1072814|P1|COMPLETED|Washout of at Least 21 Days||18
437116|NCT01408888|1072813|P2|STARTED|Washout of at Least 21 Days||8
437117|NCT01408888|1072814|P1|STARTED|Washout of at Least 21 Days||18
437118|NCT01408888|1072813|P2|NOT COMPLETED|First Intervention||3
437119|NCT01408888|1072814|P1|NOT COMPLETED|First Intervention||0
437120|NCT01408888|1072813|P2|COMPLETED|First Intervention||8
437121|NCT01408888|1072814|P1|COMPLETED|First Intervention||18
437122|NCT01408888|1072813|P2|Received at Least 1 Dose of Drug|First Intervention||11
437123|NCT01408888|1072814|P1|Received at Least 1 Dose of Drug|First Intervention||18
437124|NCT01408888|1072813|P2|STARTED|First Intervention||11
437125|NCT01408888|1072814|P1|STARTED|First Intervention||18
437126|NCT01408862|1072837|P1|NOT COMPLETED|Overall Study||0
437127|NCT01408862|1072837|P1|COMPLETED|Overall Study||20
437128|NCT01408862|1072837|P1|STARTED|Overall Study||20
437129|NCT01408732|1072842|P2|NOT COMPLETED|Overall Study||2
437130|NCT01408732|1072843|P1|NOT COMPLETED|Overall Study||2
437131|NCT01408732|1072842|P2|COMPLETED|Overall Study||7
437132|NCT01408732|1072843|P1|COMPLETED|Overall Study||7
437133|NCT01408732|1072842|P2|STARTED|Overall Study||9
437134|NCT01408732|1072843|P1|STARTED|Overall Study||9
437135|NCT01408719|1072869|P20|NOT COMPLETED|Fourth Intervention (35 Days)||0
437136|NCT01408719|1072870|P19|NOT COMPLETED|Fourth Intervention (35 Days)||0
437137|NCT01408719|1072871|P18|NOT COMPLETED|Fourth Intervention (35 Days)||0
437138|NCT01408719|1072872|P17|NOT COMPLETED|Fourth Intervention (35 Days)||0
437139|NCT01408719|1072873|P16|NOT COMPLETED|Fourth Intervention (35 Days)||0
437140|NCT01408719|1072874|P15|NOT COMPLETED|Fourth Intervention (35 Days)||0
437141|NCT01408719|1072875|P14|NOT COMPLETED|Fourth Intervention (35 Days)||0
437142|NCT01408719|1072876|P13|NOT COMPLETED|Fourth Intervention (35 Days)||0
437143|NCT01408719|1072877|P12|NOT COMPLETED|Fourth Intervention (35 Days)||0
437144|NCT01408719|1072878|P11|NOT COMPLETED|Fourth Intervention (35 Days)||0
437145|NCT01408719|1072879|P10|NOT COMPLETED|Fourth Intervention (35 Days)||0
437146|NCT01408719|1072880|P9|NOT COMPLETED|Fourth Intervention (35 Days)||0
437147|NCT01408719|1072881|P8|NOT COMPLETED|Fourth Intervention (35 Days)||0
437148|NCT01408719|1072882|P7|NOT COMPLETED|Fourth Intervention (35 Days)||0
437149|NCT01408719|1072883|P6|NOT COMPLETED|Fourth Intervention (35 Days)||0
437150|NCT01408719|1072884|P5|NOT COMPLETED|Fourth Intervention (35 Days)||0
437151|NCT01408719|1072885|P4|NOT COMPLETED|Fourth Intervention (35 Days)||0
437152|NCT01408719|1072886|P3|NOT COMPLETED|Fourth Intervention (35 Days)||0
437153|NCT01408719|1072887|P2|NOT COMPLETED|Fourth Intervention (35 Days)||0
437154|NCT01408719|1072888|P1|NOT COMPLETED|Fourth Intervention (35 Days)||0
437155|NCT01408719|1072869|P20|COMPLETED|Fourth Intervention (35 Days)||1
437156|NCT01408719|1072870|P19|COMPLETED|Fourth Intervention (35 Days)||0
437157|NCT01408719|1072871|P18|COMPLETED|Fourth Intervention (35 Days)||2
437158|NCT01408719|1072872|P17|COMPLETED|Fourth Intervention (35 Days)||2
437159|NCT01408719|1072873|P16|COMPLETED|Fourth Intervention (35 Days)||1
437160|NCT01408719|1072874|P15|COMPLETED|Fourth Intervention (35 Days)||1
437161|NCT01408719|1072875|P14|COMPLETED|Fourth Intervention (35 Days)||3
437162|NCT01408719|1072876|P13|COMPLETED|Fourth Intervention (35 Days)||1
437163|NCT01408719|1072877|P12|COMPLETED|Fourth Intervention (35 Days)||2
437164|NCT01408719|1072878|P11|COMPLETED|Fourth Intervention (35 Days)||2
437165|NCT01408719|1072879|P10|COMPLETED|Fourth Intervention (35 Days)||1
437166|NCT01408719|1072880|P9|COMPLETED|Fourth Intervention (35 Days)||1
437167|NCT01408719|1072881|P8|COMPLETED|Fourth Intervention (35 Days)||2
437168|NCT01408719|1072882|P7|COMPLETED|Fourth Intervention (35 Days)||2
437169|NCT01408719|1072883|P6|COMPLETED|Fourth Intervention (35 Days)||3
437170|NCT01408719|1072884|P5|COMPLETED|Fourth Intervention (35 Days)||3
437171|NCT01408719|1072885|P4|COMPLETED|Fourth Intervention (35 Days)||2
437172|NCT01408719|1072886|P3|COMPLETED|Fourth Intervention (35 Days)||1
437173|NCT01408719|1072887|P2|COMPLETED|Fourth Intervention (35 Days)||3
437174|NCT01408719|1072888|P1|COMPLETED|Fourth Intervention (35 Days)||2
437175|NCT01408719|1072869|P20|STARTED|Fourth Intervention (35 Days)||1
437176|NCT01408719|1072870|P19|STARTED|Fourth Intervention (35 Days)||0
437177|NCT01408719|1072871|P18|STARTED|Fourth Intervention (35 Days)||2
437178|NCT01408719|1072872|P17|STARTED|Fourth Intervention (35 Days)||2
437179|NCT01408719|1072873|P16|STARTED|Fourth Intervention (35 Days)||1
437180|NCT01408719|1072874|P15|STARTED|Fourth Intervention (35 Days)||1
437181|NCT01408719|1072875|P14|STARTED|Fourth Intervention (35 Days)||3
437182|NCT01408719|1072876|P13|STARTED|Fourth Intervention (35 Days)||1
437183|NCT01408719|1072877|P12|STARTED|Fourth Intervention (35 Days)||2
437184|NCT01408719|1072878|P11|STARTED|Fourth Intervention (35 Days)||2
437185|NCT01408719|1072879|P10|STARTED|Fourth Intervention (35 Days)||1
437186|NCT01408719|1072880|P9|STARTED|Fourth Intervention (35 Days)||1
437187|NCT01408719|1072881|P8|STARTED|Fourth Intervention (35 Days)||2
437188|NCT01408719|1072882|P7|STARTED|Fourth Intervention (35 Days)||2
437189|NCT01408719|1072883|P6|STARTED|Fourth Intervention (35 Days)||3
437190|NCT01408719|1072884|P5|STARTED|Fourth Intervention (35 Days)||3
437191|NCT01408719|1072885|P4|STARTED|Fourth Intervention (35 Days)||2
437192|NCT01408719|1072886|P3|STARTED|Fourth Intervention (35 Days)||1
437193|NCT01408719|1072887|P2|STARTED|Fourth Intervention (35 Days)||3
437194|NCT01408719|1072888|P1|STARTED|Fourth Intervention (35 Days)||2
437195|NCT01408719|1072869|P20|NOT COMPLETED|Washout Period (28 Days)||0
437196|NCT01408719|1072870|P19|NOT COMPLETED|Washout Period (28 Days)||0
437197|NCT01408719|1072871|P18|NOT COMPLETED|Washout Period (28 Days)||0
437198|NCT01408719|1072872|P17|NOT COMPLETED|Washout Period (28 Days)||0
437199|NCT01408719|1072873|P16|NOT COMPLETED|Washout Period (28 Days)||0
437200|NCT01408719|1072874|P15|NOT COMPLETED|Washout Period (28 Days)||0
437201|NCT01408719|1072875|P14|NOT COMPLETED|Washout Period (28 Days)||0
437202|NCT01408719|1072876|P13|NOT COMPLETED|Washout Period (28 Days)||0
437203|NCT01408719|1072877|P12|NOT COMPLETED|Washout Period (28 Days)||0
437204|NCT01408719|1072878|P11|NOT COMPLETED|Washout Period (28 Days)||0
437205|NCT01408719|1072879|P10|NOT COMPLETED|Washout Period (28 Days)||0
437206|NCT01408719|1072880|P9|NOT COMPLETED|Washout Period (28 Days)||0
437207|NCT01408719|1072881|P8|NOT COMPLETED|Washout Period (28 Days)||0
437208|NCT01408719|1072882|P7|NOT COMPLETED|Washout Period (28 Days)||0
437209|NCT01408719|1072883|P6|NOT COMPLETED|Washout Period (28 Days)||0
437210|NCT01408719|1072884|P5|NOT COMPLETED|Washout Period (28 Days)||0
437211|NCT01408719|1072885|P4|NOT COMPLETED|Washout Period (28 Days)||0
437212|NCT01408719|1072886|P3|NOT COMPLETED|Washout Period (28 Days)||0
437213|NCT01408719|1072887|P2|NOT COMPLETED|Washout Period (28 Days)||0
437214|NCT01408719|1072888|P1|NOT COMPLETED|Washout Period (28 Days)||0
437215|NCT01408719|1072869|P20|COMPLETED|Washout Period (28 Days)||1
437216|NCT01408719|1072870|P19|COMPLETED|Washout Period (28 Days)||0
437217|NCT01408719|1072871|P18|COMPLETED|Washout Period (28 Days)||2
437218|NCT01408719|1072872|P17|COMPLETED|Washout Period (28 Days)||2
437219|NCT01408719|1072873|P16|COMPLETED|Washout Period (28 Days)||1
437220|NCT01408719|1072874|P15|COMPLETED|Washout Period (28 Days)||1
437221|NCT01408719|1072875|P14|COMPLETED|Washout Period (28 Days)||3
437222|NCT01408719|1072876|P13|COMPLETED|Washout Period (28 Days)||1
437223|NCT01408719|1072877|P12|COMPLETED|Washout Period (28 Days)||2
437224|NCT01408719|1072878|P11|COMPLETED|Washout Period (28 Days)||2
437225|NCT01408719|1072879|P10|COMPLETED|Washout Period (28 Days)||1
437226|NCT01408719|1072880|P9|COMPLETED|Washout Period (28 Days)||1
437227|NCT01408719|1072881|P8|COMPLETED|Washout Period (28 Days)||2
437228|NCT01408719|1072882|P7|COMPLETED|Washout Period (28 Days)||2
437229|NCT01408719|1072883|P6|COMPLETED|Washout Period (28 Days)||3
437230|NCT01408719|1072884|P5|COMPLETED|Washout Period (28 Days)||3
437231|NCT01408719|1072885|P4|COMPLETED|Washout Period (28 Days)||2
437232|NCT01408719|1072886|P3|COMPLETED|Washout Period (28 Days)||1
437233|NCT01408719|1072887|P2|COMPLETED|Washout Period (28 Days)||3
437234|NCT01408719|1072888|P1|COMPLETED|Washout Period (28 Days)||2
437235|NCT01408719|1072869|P20|STARTED|Washout Period (28 Days)||1
437236|NCT01408719|1072870|P19|STARTED|Washout Period (28 Days)||0
437237|NCT01408719|1072871|P18|STARTED|Washout Period (28 Days)||2
437238|NCT01408719|1072872|P17|STARTED|Washout Period (28 Days)||2
437239|NCT01408719|1072873|P16|STARTED|Washout Period (28 Days)||1
437240|NCT01408719|1072874|P15|STARTED|Washout Period (28 Days)||1
437241|NCT01408719|1072875|P14|STARTED|Washout Period (28 Days)||3
437242|NCT01408719|1072876|P13|STARTED|Washout Period (28 Days)||1
437243|NCT01408719|1072877|P12|STARTED|Washout Period (28 Days)||2
437244|NCT01408719|1072878|P11|STARTED|Washout Period (28 Days)||2
437245|NCT01408719|1072879|P10|STARTED|Washout Period (28 Days)||1
437246|NCT01408719|1072880|P9|STARTED|Washout Period (28 Days)||1
437247|NCT01408719|1072881|P8|STARTED|Washout Period (28 Days)||2
437248|NCT01408719|1072882|P7|STARTED|Washout Period (28 Days)||2
437249|NCT01408719|1072883|P6|STARTED|Washout Period (28 Days)||3
437250|NCT01408719|1072884|P5|STARTED|Washout Period (28 Days)||3
437251|NCT01408719|1072885|P4|STARTED|Washout Period (28 Days)||2
437252|NCT01408719|1072886|P3|STARTED|Washout Period (28 Days)||1
437253|NCT01408719|1072887|P2|STARTED|Washout Period (28 Days)||3
437254|NCT01408719|1072888|P1|STARTED|Washout Period (28 Days)||2
437255|NCT01408719|1072869|P20|NOT COMPLETED|Third Intervention (35 Days)||0
437256|NCT01408719|1072870|P19|NOT COMPLETED|Third Intervention (35 Days)||0
437257|NCT01408719|1072871|P18|NOT COMPLETED|Third Intervention (35 Days)||0
437258|NCT01408719|1072872|P17|NOT COMPLETED|Third Intervention (35 Days)||0
437259|NCT01408719|1072873|P16|NOT COMPLETED|Third Intervention (35 Days)||0
437260|NCT01408719|1072874|P15|NOT COMPLETED|Third Intervention (35 Days)||0
437261|NCT01408719|1072875|P14|NOT COMPLETED|Third Intervention (35 Days)||0
437262|NCT01408719|1072876|P13|NOT COMPLETED|Third Intervention (35 Days)||0
437263|NCT01408719|1072877|P12|NOT COMPLETED|Third Intervention (35 Days)||0
437264|NCT01408719|1072878|P11|NOT COMPLETED|Third Intervention (35 Days)||0
437265|NCT01408719|1072879|P10|NOT COMPLETED|Third Intervention (35 Days)||0
437266|NCT01408719|1072880|P9|NOT COMPLETED|Third Intervention (35 Days)||0
437267|NCT01408719|1072881|P8|NOT COMPLETED|Third Intervention (35 Days)||1
437268|NCT01408719|1072882|P7|NOT COMPLETED|Third Intervention (35 Days)||0
437269|NCT01408719|1072883|P6|NOT COMPLETED|Third Intervention (35 Days)||0
437270|NCT01408719|1072884|P5|NOT COMPLETED|Third Intervention (35 Days)||0
437271|NCT01408719|1072885|P4|NOT COMPLETED|Third Intervention (35 Days)||0
437272|NCT01408719|1072886|P3|NOT COMPLETED|Third Intervention (35 Days)||0
437273|NCT01408719|1072887|P2|NOT COMPLETED|Third Intervention (35 Days)||0
437274|NCT01408719|1072888|P1|NOT COMPLETED|Third Intervention (35 Days)||0
437275|NCT01408719|1072869|P20|COMPLETED|Third Intervention (35 Days)||1
437276|NCT01408719|1072870|P19|COMPLETED|Third Intervention (35 Days)||0
437277|NCT01408719|1072871|P18|COMPLETED|Third Intervention (35 Days)||2
437278|NCT01408719|1072872|P17|COMPLETED|Third Intervention (35 Days)||2
437279|NCT01408719|1072873|P16|COMPLETED|Third Intervention (35 Days)||1
437280|NCT01408719|1072874|P15|COMPLETED|Third Intervention (35 Days)||1
437281|NCT01408719|1072875|P14|COMPLETED|Third Intervention (35 Days)||3
437282|NCT01408719|1072876|P13|COMPLETED|Third Intervention (35 Days)||2
437283|NCT01408719|1072877|P12|COMPLETED|Third Intervention (35 Days)||2
437284|NCT01408719|1072878|P11|COMPLETED|Third Intervention (35 Days)||2
437285|NCT01408719|1072879|P10|COMPLETED|Third Intervention (35 Days)||1
437286|NCT01408719|1072880|P9|COMPLETED|Third Intervention (35 Days)||1
437287|NCT01408719|1072881|P8|COMPLETED|Third Intervention (35 Days)||2
437288|NCT01408719|1072882|P7|COMPLETED|Third Intervention (35 Days)||2
437289|NCT01408719|1072883|P6|COMPLETED|Third Intervention (35 Days)||3
437290|NCT01408719|1072884|P5|COMPLETED|Third Intervention (35 Days)||3
437291|NCT01408719|1072885|P4|COMPLETED|Third Intervention (35 Days)||2
437292|NCT01408719|1072886|P3|COMPLETED|Third Intervention (35 Days)||1
437293|NCT01408719|1072887|P2|COMPLETED|Third Intervention (35 Days)||3
437294|NCT01408719|1072888|P1|COMPLETED|Third Intervention (35 Days)||2
437295|NCT01408719|1072869|P20|STARTED|Third Intervention (35 Days)||1
437296|NCT01408719|1072870|P19|STARTED|Third Intervention (35 Days)||0
437297|NCT01408719|1072871|P18|STARTED|Third Intervention (35 Days)||2
437298|NCT01408719|1072872|P17|STARTED|Third Intervention (35 Days)||2
437299|NCT01408719|1072873|P16|STARTED|Third Intervention (35 Days)||1
437300|NCT01408719|1072874|P15|STARTED|Third Intervention (35 Days)||1
437301|NCT01408719|1072875|P14|STARTED|Third Intervention (35 Days)||3
437302|NCT01408719|1072876|P13|STARTED|Third Intervention (35 Days)||2
437303|NCT01408719|1072877|P12|STARTED|Third Intervention (35 Days)||2
437304|NCT01408719|1072878|P11|STARTED|Third Intervention (35 Days)||2
437305|NCT01408719|1072879|P10|STARTED|Third Intervention (35 Days)||1
437306|NCT01408719|1072880|P9|STARTED|Third Intervention (35 Days)||1
437307|NCT01408719|1072881|P8|STARTED|Third Intervention (35 Days)||3
437308|NCT01408719|1072882|P7|STARTED|Third Intervention (35 Days)||2
437309|NCT01408719|1072883|P6|STARTED|Third Intervention (35 Days)||3
437310|NCT01408719|1072884|P5|STARTED|Third Intervention (35 Days)||3
437311|NCT01408719|1072885|P4|STARTED|Third Intervention (35 Days)||2
437312|NCT01408719|1072886|P3|STARTED|Third Intervention (35 Days)||1
437313|NCT01408719|1072887|P2|STARTED|Third Intervention (35 Days)||3
437314|NCT01408719|1072888|P1|STARTED|Third Intervention (35 Days)||2
437315|NCT01408719|1072869|P20|NOT COMPLETED|Washout Period (28 Days)||0
437316|NCT01408719|1072870|P19|NOT COMPLETED|Washout Period (28 Days)||0
437317|NCT01408719|1072871|P18|NOT COMPLETED|Washout Period (28 Days)||0
437318|NCT01408719|1072872|P17|NOT COMPLETED|Washout Period (28 Days)||0
437319|NCT01408719|1072873|P16|NOT COMPLETED|Washout Period (28 Days)||0
437320|NCT01408719|1072874|P15|NOT COMPLETED|Washout Period (28 Days)||0
437321|NCT01408719|1072875|P14|NOT COMPLETED|Washout Period (28 Days)||0
437322|NCT01408719|1072876|P13|NOT COMPLETED|Washout Period (28 Days)||0
437323|NCT01408719|1072877|P12|NOT COMPLETED|Washout Period (28 Days)||0
437324|NCT01408719|1072878|P11|NOT COMPLETED|Washout Period (28 Days)||0
437325|NCT01408719|1072879|P10|NOT COMPLETED|Washout Period (28 Days)||0
437326|NCT01408719|1072880|P9|NOT COMPLETED|Washout Period (28 Days)||0
437327|NCT01408719|1072881|P8|NOT COMPLETED|Washout Period (28 Days)||0
437328|NCT01408719|1072882|P7|NOT COMPLETED|Washout Period (28 Days)||0
437329|NCT01408719|1072883|P6|NOT COMPLETED|Washout Period (28 Days)||0
437330|NCT01408719|1072884|P5|NOT COMPLETED|Washout Period (28 Days)||0
437331|NCT01408719|1072885|P4|NOT COMPLETED|Washout Period (28 Days)||0
437332|NCT01408719|1072886|P3|NOT COMPLETED|Washout Period (28 Days)||0
437333|NCT01408719|1072887|P2|NOT COMPLETED|Washout Period (28 Days)||0
437334|NCT01408719|1072888|P1|NOT COMPLETED|Washout Period (28 Days)||0
437335|NCT01408719|1072869|P20|COMPLETED|Washout Period (28 Days)||1
437336|NCT01408719|1072870|P19|COMPLETED|Washout Period (28 Days)||0
437337|NCT01408719|1072871|P18|COMPLETED|Washout Period (28 Days)||2
437338|NCT01408719|1072872|P17|COMPLETED|Washout Period (28 Days)||2
437339|NCT01408719|1072873|P16|COMPLETED|Washout Period (28 Days)||1
437340|NCT01408719|1072874|P15|COMPLETED|Washout Period (28 Days)||1
437341|NCT01408719|1072875|P14|COMPLETED|Washout Period (28 Days)||3
437342|NCT01408719|1072876|P13|COMPLETED|Washout Period (28 Days)||2
437343|NCT01408719|1072877|P12|COMPLETED|Washout Period (28 Days)||2
437344|NCT01408719|1072878|P11|COMPLETED|Washout Period (28 Days)||2
437345|NCT01408719|1072879|P10|COMPLETED|Washout Period (28 Days)||1
437346|NCT01408719|1072880|P9|COMPLETED|Washout Period (28 Days)||1
437347|NCT01408719|1072881|P8|COMPLETED|Washout Period (28 Days)||3
437348|NCT01408719|1072882|P7|COMPLETED|Washout Period (28 Days)||2
437349|NCT01408719|1072883|P6|COMPLETED|Washout Period (28 Days)||3
437350|NCT01408719|1072884|P5|COMPLETED|Washout Period (28 Days)||3
437351|NCT01408719|1072885|P4|COMPLETED|Washout Period (28 Days)||2
437352|NCT01408719|1072886|P3|COMPLETED|Washout Period (28 Days)||1
437353|NCT01408719|1072887|P2|COMPLETED|Washout Period (28 Days)||3
437354|NCT01408719|1072888|P1|COMPLETED|Washout Period (28 Days)||2
437355|NCT01408719|1072869|P20|STARTED|Washout Period (28 Days)||1
437356|NCT01408719|1072870|P19|STARTED|Washout Period (28 Days)||0
437357|NCT01408719|1072871|P18|STARTED|Washout Period (28 Days)||2
437358|NCT01408719|1072872|P17|STARTED|Washout Period (28 Days)||2
437359|NCT01408719|1072873|P16|STARTED|Washout Period (28 Days)||1
437360|NCT01408719|1072874|P15|STARTED|Washout Period (28 Days)||1
437361|NCT01408719|1072875|P14|STARTED|Washout Period (28 Days)||3
437362|NCT01408719|1072876|P13|STARTED|Washout Period (28 Days)||2
437363|NCT01408719|1072877|P12|STARTED|Washout Period (28 Days)||2
437364|NCT01408719|1072878|P11|STARTED|Washout Period (28 Days)||2
437365|NCT01408719|1072879|P10|STARTED|Washout Period (28 Days)||1
437366|NCT01408719|1072880|P9|STARTED|Washout Period (28 Days)||1
437367|NCT01408719|1072881|P8|STARTED|Washout Period (28 Days)||3
437368|NCT01408719|1072882|P7|STARTED|Washout Period (28 Days)||2
437369|NCT01408719|1072883|P6|STARTED|Washout Period (28 Days)||3
437370|NCT01408719|1072884|P5|STARTED|Washout Period (28 Days)||3
437371|NCT01408719|1072885|P4|STARTED|Washout Period (28 Days)||2
437372|NCT01408719|1072886|P3|STARTED|Washout Period (28 Days)||1
437373|NCT01408719|1072887|P2|STARTED|Washout Period (28 Days)||3
437374|NCT01408719|1072888|P1|STARTED|Washout Period (28 Days)||2
437375|NCT01408719|1072869|P20|NOT COMPLETED|Second Intervention (35 Days)||0
437376|NCT01408719|1072870|P19|NOT COMPLETED|Second Intervention (35 Days)||0
437377|NCT01408719|1072871|P18|NOT COMPLETED|Second Intervention (35 Days)||0
437378|NCT01408719|1072872|P17|NOT COMPLETED|Second Intervention (35 Days)||0
437379|NCT01408719|1072873|P16|NOT COMPLETED|Second Intervention (35 Days)||0
437380|NCT01408719|1072874|P15|NOT COMPLETED|Second Intervention (35 Days)||0
437381|NCT01408719|1072875|P14|NOT COMPLETED|Second Intervention (35 Days)||1
437382|NCT01408719|1072876|P13|NOT COMPLETED|Second Intervention (35 Days)||0
437383|NCT01408719|1072877|P12|NOT COMPLETED|Second Intervention (35 Days)||0
437384|NCT01408719|1072878|P11|NOT COMPLETED|Second Intervention (35 Days)||0
437385|NCT01408719|1072879|P10|NOT COMPLETED|Second Intervention (35 Days)||0
437386|NCT01408719|1072880|P9|NOT COMPLETED|Second Intervention (35 Days)||0
437387|NCT01408719|1072881|P8|NOT COMPLETED|Second Intervention (35 Days)||0
437388|NCT01408719|1072882|P7|NOT COMPLETED|Second Intervention (35 Days)||0
437389|NCT01408719|1072883|P6|NOT COMPLETED|Second Intervention (35 Days)||0
437390|NCT01408719|1072884|P5|NOT COMPLETED|Second Intervention (35 Days)||0
437391|NCT01408719|1072885|P4|NOT COMPLETED|Second Intervention (35 Days)||0
437392|NCT01408719|1072886|P3|NOT COMPLETED|Second Intervention (35 Days)||0
437393|NCT01408719|1072887|P2|NOT COMPLETED|Second Intervention (35 Days)||0
437394|NCT01408719|1072888|P1|NOT COMPLETED|Second Intervention (35 Days)||0
437395|NCT01408719|1072869|P20|COMPLETED|Second Intervention (35 Days)||1
437396|NCT01408719|1072870|P19|COMPLETED|Second Intervention (35 Days)||0
437397|NCT01408719|1072871|P18|COMPLETED|Second Intervention (35 Days)||2
437398|NCT01408719|1072872|P17|COMPLETED|Second Intervention (35 Days)||2
437399|NCT01408719|1072873|P16|COMPLETED|Second Intervention (35 Days)||2
437400|NCT01408719|1072874|P15|COMPLETED|Second Intervention (35 Days)||1
437401|NCT01408719|1072875|P14|COMPLETED|Second Intervention (35 Days)||3
437402|NCT01408719|1072876|P13|COMPLETED|Second Intervention (35 Days)||2
437403|NCT01408719|1072877|P12|COMPLETED|Second Intervention (35 Days)||2
437404|NCT01408719|1072878|P11|COMPLETED|Second Intervention (35 Days)||2
437405|NCT01408719|1072879|P10|COMPLETED|Second Intervention (35 Days)||1
437406|NCT01408719|1072880|P9|COMPLETED|Second Intervention (35 Days)||1
437407|NCT01408719|1072881|P8|COMPLETED|Second Intervention (35 Days)||3
437408|NCT01408719|1072882|P7|COMPLETED|Second Intervention (35 Days)||2
437409|NCT01408719|1072883|P6|COMPLETED|Second Intervention (35 Days)||3
437410|NCT01408719|1072884|P5|COMPLETED|Second Intervention (35 Days)||3
437411|NCT01408719|1072885|P4|COMPLETED|Second Intervention (35 Days)||2
437412|NCT01408719|1072886|P3|COMPLETED|Second Intervention (35 Days)||1
437413|NCT01408719|1072887|P2|COMPLETED|Second Intervention (35 Days)||3
437414|NCT01408719|1072888|P1|COMPLETED|Second Intervention (35 Days)||2
437415|NCT01408719|1072869|P20|STARTED|Second Intervention (35 Days)||1
437416|NCT01408719|1072870|P19|STARTED|Second Intervention (35 Days)||0
437417|NCT01408719|1072871|P18|STARTED|Second Intervention (35 Days)||2
437418|NCT01408719|1072872|P17|STARTED|Second Intervention (35 Days)||2
437419|NCT01408719|1072873|P16|STARTED|Second Intervention (35 Days)||2
437420|NCT01408719|1072874|P15|STARTED|Second Intervention (35 Days)||1
437421|NCT01408719|1072875|P14|STARTED|Second Intervention (35 Days)||4
437422|NCT01408719|1072876|P13|STARTED|Second Intervention (35 Days)||2
437423|NCT01408719|1072877|P12|STARTED|Second Intervention (35 Days)||2
437424|NCT01408719|1072878|P11|STARTED|Second Intervention (35 Days)||2
437425|NCT01408719|1072879|P10|STARTED|Second Intervention (35 Days)||1
437426|NCT01408719|1072880|P9|STARTED|Second Intervention (35 Days)||1
437427|NCT01408719|1072881|P8|STARTED|Second Intervention (35 Days)||3
437428|NCT01408719|1072882|P7|STARTED|Second Intervention (35 Days)||2
437429|NCT01408719|1072883|P6|STARTED|Second Intervention (35 Days)||3
437430|NCT01408719|1072884|P5|STARTED|Second Intervention (35 Days)||3
437431|NCT01408719|1072885|P4|STARTED|Second Intervention (35 Days)||2
437432|NCT01408719|1072886|P3|STARTED|Second Intervention (35 Days)||1
437433|NCT01408719|1072887|P2|STARTED|Second Intervention (35 Days)||3
437434|NCT01408719|1072888|P1|STARTED|Second Intervention (35 Days)||2
437435|NCT01408719|1072869|P20|NOT COMPLETED|Washout Period (28 Days)||0
437436|NCT01408719|1072870|P19|NOT COMPLETED|Washout Period (28 Days)||0
437437|NCT01408719|1072871|P18|NOT COMPLETED|Washout Period (28 Days)||0
437438|NCT01408719|1072872|P17|NOT COMPLETED|Washout Period (28 Days)||0
437439|NCT01408719|1072873|P16|NOT COMPLETED|Washout Period (28 Days)||0
437440|NCT01408719|1072874|P15|NOT COMPLETED|Washout Period (28 Days)||0
437441|NCT01408719|1072875|P14|NOT COMPLETED|Washout Period (28 Days)||0
437442|NCT01408719|1072876|P13|NOT COMPLETED|Washout Period (28 Days)||0
437443|NCT01408719|1072877|P12|NOT COMPLETED|Washout Period (28 Days)||0
437444|NCT01408719|1072878|P11|NOT COMPLETED|Washout Period (28 Days)||0
437445|NCT01408719|1072879|P10|NOT COMPLETED|Washout Period (28 Days)||0
437446|NCT01408719|1072880|P9|NOT COMPLETED|Washout Period (28 Days)||0
437447|NCT01408719|1072881|P8|NOT COMPLETED|Washout Period (28 Days)||0
437448|NCT01408719|1072882|P7|NOT COMPLETED|Washout Period (28 Days)||0
437449|NCT01408719|1072883|P6|NOT COMPLETED|Washout Period (28 Days)||0
437450|NCT01408719|1072884|P5|NOT COMPLETED|Washout Period (28 Days)||0
437451|NCT01408719|1072885|P4|NOT COMPLETED|Washout Period (28 Days)||0
437452|NCT01408719|1072886|P3|NOT COMPLETED|Washout Period (28 Days)||0
437453|NCT01408719|1072887|P2|NOT COMPLETED|Washout Period (28 Days)||0
437454|NCT01408719|1072888|P1|NOT COMPLETED|Washout Period (28 Days)||0
437455|NCT01408719|1072869|P20|COMPLETED|Washout Period (28 Days)||1
437456|NCT01408719|1072870|P19|COMPLETED|Washout Period (28 Days)||0
437457|NCT01408719|1072871|P18|COMPLETED|Washout Period (28 Days)||2
437458|NCT01408719|1072872|P17|COMPLETED|Washout Period (28 Days)||2
437459|NCT01408719|1072873|P16|COMPLETED|Washout Period (28 Days)||2
437460|NCT01408719|1072874|P15|COMPLETED|Washout Period (28 Days)||1
437461|NCT01408719|1072875|P14|COMPLETED|Washout Period (28 Days)||4
437462|NCT01408719|1072876|P13|COMPLETED|Washout Period (28 Days)||2
437463|NCT01408719|1072877|P12|COMPLETED|Washout Period (28 Days)||2
437464|NCT01408719|1072878|P11|COMPLETED|Washout Period (28 Days)||2
437465|NCT01408719|1072879|P10|COMPLETED|Washout Period (28 Days)||1
437466|NCT01408719|1072880|P9|COMPLETED|Washout Period (28 Days)||1
437467|NCT01408719|1072881|P8|COMPLETED|Washout Period (28 Days)||3
437468|NCT01408719|1072882|P7|COMPLETED|Washout Period (28 Days)||2
437469|NCT01408719|1072883|P6|COMPLETED|Washout Period (28 Days)||3
437470|NCT01408719|1072884|P5|COMPLETED|Washout Period (28 Days)||3
437471|NCT01408719|1072885|P4|COMPLETED|Washout Period (28 Days)||2
437472|NCT01408719|1072886|P3|COMPLETED|Washout Period (28 Days)||1
437473|NCT01408719|1072887|P2|COMPLETED|Washout Period (28 Days)||3
437474|NCT01408719|1072888|P1|COMPLETED|Washout Period (28 Days)||2
437475|NCT01408719|1072869|P20|STARTED|Washout Period (28 Days)||1
437476|NCT01408719|1072870|P19|STARTED|Washout Period (28 Days)||0
437477|NCT01408719|1072871|P18|STARTED|Washout Period (28 Days)||2
437478|NCT01408719|1072872|P17|STARTED|Washout Period (28 Days)||2
437479|NCT01408719|1072873|P16|STARTED|Washout Period (28 Days)||2
437480|NCT01408719|1072874|P15|STARTED|Washout Period (28 Days)||1
437481|NCT01408719|1072875|P14|STARTED|Washout Period (28 Days)||4
437482|NCT01408719|1072876|P13|STARTED|Washout Period (28 Days)||2
437483|NCT01408719|1072877|P12|STARTED|Washout Period (28 Days)||2
437484|NCT01408719|1072878|P11|STARTED|Washout Period (28 Days)||2
437485|NCT01408719|1072879|P10|STARTED|Washout Period (28 Days)||1
437486|NCT01408719|1072880|P9|STARTED|Washout Period (28 Days)||1
437487|NCT01408719|1072881|P8|STARTED|Washout Period (28 Days)||3
437488|NCT01408719|1072882|P7|STARTED|Washout Period (28 Days)||2
437489|NCT01408719|1072883|P6|STARTED|Washout Period (28 Days)||3
437490|NCT01408719|1072884|P5|STARTED|Washout Period (28 Days)||3
437491|NCT01408719|1072885|P4|STARTED|Washout Period (28 Days)||2
437492|NCT01408719|1072886|P3|STARTED|Washout Period (28 Days)||1
437493|NCT01408719|1072887|P2|STARTED|Washout Period (28 Days)||3
437494|NCT01408719|1072888|P1|STARTED|Washout Period (28 Days)||2
437495|NCT01408719|1072869|P20|NOT COMPLETED|First Intervention (35 Days)||0
437496|NCT01408719|1072870|P19|NOT COMPLETED|First Intervention (35 Days)||1
437497|NCT01408719|1072871|P18|NOT COMPLETED|First Intervention (35 Days)||0
437498|NCT01408719|1072872|P17|NOT COMPLETED|First Intervention (35 Days)||1
437499|NCT01408719|1072873|P16|NOT COMPLETED|First Intervention (35 Days)||0
437500|NCT01408719|1072874|P15|NOT COMPLETED|First Intervention (35 Days)||0
437501|NCT01408719|1072875|P14|NOT COMPLETED|First Intervention (35 Days)||1
437502|NCT01408719|1072876|P13|NOT COMPLETED|First Intervention (35 Days)||0
437503|NCT01408719|1072877|P12|NOT COMPLETED|First Intervention (35 Days)||0
437504|NCT01408719|1072878|P11|NOT COMPLETED|First Intervention (35 Days)||0
437505|NCT01408719|1072879|P10|NOT COMPLETED|First Intervention (35 Days)||0
437506|NCT01408719|1072880|P9|NOT COMPLETED|First Intervention (35 Days)||1
437507|NCT01408719|1072881|P8|NOT COMPLETED|First Intervention (35 Days)||0
437508|NCT01408719|1072882|P7|NOT COMPLETED|First Intervention (35 Days)||0
437509|NCT01408719|1072883|P6|NOT COMPLETED|First Intervention (35 Days)||0
437510|NCT01408719|1072884|P5|NOT COMPLETED|First Intervention (35 Days)||1
437511|NCT01408719|1072885|P4|NOT COMPLETED|First Intervention (35 Days)||0
437512|NCT01408719|1072886|P3|NOT COMPLETED|First Intervention (35 Days)||1
437513|NCT01408719|1072887|P2|NOT COMPLETED|First Intervention (35 Days)||0
437514|NCT01408719|1072888|P1|NOT COMPLETED|First Intervention (35 Days)||0
437515|NCT01408719|1072869|P20|COMPLETED|First Intervention (35 Days)||1
437516|NCT01408719|1072870|P19|COMPLETED|First Intervention (35 Days)||0
437517|NCT01408719|1072871|P18|COMPLETED|First Intervention (35 Days)||2
437518|NCT01408719|1072872|P17|COMPLETED|First Intervention (35 Days)||2
437519|NCT01408719|1072873|P16|COMPLETED|First Intervention (35 Days)||2
437520|NCT01408719|1072874|P15|COMPLETED|First Intervention (35 Days)||1
437521|NCT01408719|1072875|P14|COMPLETED|First Intervention (35 Days)||4
437522|NCT01408719|1072876|P13|COMPLETED|First Intervention (35 Days)||2
437523|NCT01408719|1072877|P12|COMPLETED|First Intervention (35 Days)||2
437524|NCT01408719|1072878|P11|COMPLETED|First Intervention (35 Days)||2
437525|NCT01408719|1072879|P10|COMPLETED|First Intervention (35 Days)||1
437526|NCT01408719|1072880|P9|COMPLETED|First Intervention (35 Days)||1
437527|NCT01408719|1072881|P8|COMPLETED|First Intervention (35 Days)||3
437528|NCT01408719|1072882|P7|COMPLETED|First Intervention (35 Days)||2
437529|NCT01408719|1072883|P6|COMPLETED|First Intervention (35 Days)||3
437530|NCT01408719|1072884|P5|COMPLETED|First Intervention (35 Days)||3
437531|NCT01408719|1072885|P4|COMPLETED|First Intervention (35 Days)||2
437532|NCT01408719|1072886|P3|COMPLETED|First Intervention (35 Days)||1
437533|NCT01408719|1072887|P2|COMPLETED|First Intervention (35 Days)||3
437534|NCT01408719|1072888|P1|COMPLETED|First Intervention (35 Days)||2
437535|NCT01408719|1072869|P20|STARTED|First Intervention (35 Days)||1
437536|NCT01408719|1072870|P19|STARTED|First Intervention (35 Days)||1
437537|NCT01408719|1072871|P18|STARTED|First Intervention (35 Days)||2
437538|NCT01408719|1072872|P17|STARTED|First Intervention (35 Days)||3
437539|NCT01408719|1072873|P16|STARTED|First Intervention (35 Days)||2
437540|NCT01408719|1072874|P15|STARTED|First Intervention (35 Days)||1
437541|NCT01408719|1072875|P14|STARTED|First Intervention (35 Days)||5
437542|NCT01408719|1072876|P13|STARTED|First Intervention (35 Days)||2
437543|NCT01408719|1072877|P12|STARTED|First Intervention (35 Days)||2
437544|NCT01408719|1072878|P11|STARTED|First Intervention (35 Days)||2
437545|NCT01408719|1072879|P10|STARTED|First Intervention (35 Days)||1
437546|NCT01408719|1072880|P9|STARTED|First Intervention (35 Days)||2
437547|NCT01408719|1072881|P8|STARTED|First Intervention (35 Days)||3
437548|NCT01408719|1072882|P7|STARTED|First Intervention (35 Days)||2
437549|NCT01408719|1072883|P6|STARTED|First Intervention (35 Days)||3
437550|NCT01408719|1072884|P5|STARTED|First Intervention (35 Days)||4
437551|NCT01408719|1072885|P4|STARTED|First Intervention (35 Days)||2
437552|NCT01408719|1072886|P3|STARTED|First Intervention (35 Days)||2
437553|NCT01408719|1072887|P2|STARTED|First Intervention (35 Days)||3
437554|NCT01408719|1072888|P1|STARTED|First Intervention (35 Days)||2
437555|NCT01408706|1072900|P2|NOT COMPLETED|Overall Study||0
437556|NCT01408706|1072901|P1|NOT COMPLETED|Overall Study||1
437557|NCT01408706|1072900|P2|COMPLETED|Overall Study||30
437558|NCT01408706|1072901|P1|COMPLETED|Overall Study||29
437559|NCT01408706|1072900|P2|STARTED|Overall Study||30
437560|NCT01408706|1072901|P1|STARTED|Overall Study||30
437561|NCT01408641|1072913|P2|NOT COMPLETED|Overall Study||0
437562|NCT01408641|1072914|P1|NOT COMPLETED|Overall Study||1
437563|NCT01408641|1072913|P2|COMPLETED|Overall Study||0
437564|NCT01408641|1072914|P1|COMPLETED|Overall Study||0
437565|NCT01408641|1072913|P2|STARTED|Overall Study||0
437566|NCT01408641|1072914|P1|STARTED|Overall Study||1
437567|NCT01408628|1072922|P1|NOT COMPLETED|Completed 6 Month Follow-Up||14
437568|NCT01408628|1072922|P1|COMPLETED|Completed 6 Month Follow-Up||25
437569|NCT01408628|1072922|P1|STARTED|Completed 6 Month Follow-Up||39
437570|NCT01408628|1072922|P1|NOT COMPLETED|Started Classes/Intervention||0
437571|NCT01408628|1072922|P1|COMPLETED|Started Classes/Intervention||39
437572|NCT01408628|1072922|P1|STARTED|Started Classes/Intervention||39
437573|NCT01408628|1072922|P1|NOT COMPLETED|Consented||12
437574|NCT01408628|1072922|P1|COMPLETED|Consented||39
437575|NCT01408628|1072922|P1|STARTED|Consented||51
437576|NCT01408537|1072928|P1|NOT COMPLETED|Overall Study||8
437577|NCT01408537|1072928|P1|COMPLETED|Overall Study||144
437578|NCT01408537|1072928|P1|STARTED|Overall Study||152
437579|NCT01408485|1072944|P1|NOT COMPLETED|Overall Study||21
437580|NCT01408485|1072944|P1|COMPLETED|Overall Study||179
437581|NCT01408485|1072944|P1|STARTED|Overall Study||200
437582|NCT01408329|1072952|P2|NOT COMPLETED|Overall Study||4
437583|NCT01408329|1072953|P1|NOT COMPLETED|Overall Study||3
437584|NCT01408329|1072952|P2|COMPLETED|Overall Study||11
437585|NCT01408329|1072953|P1|COMPLETED|Overall Study||10
437586|NCT01408329|1072952|P2|STARTED|Overall Study||15
437587|NCT01408329|1072953|P1|STARTED|Overall Study||13
437588|NCT01408303|1072962|P3|NOT COMPLETED|Overall Study||6
437589|NCT01408303|1072963|P2|NOT COMPLETED|Overall Study||12
437590|NCT01408303|1072964|P1|NOT COMPLETED|Overall Study||6
437591|NCT01408303|1072962|P3|COMPLETED|Overall Study||210
437592|NCT01408303|1072963|P2|COMPLETED|Overall Study||204
437593|NCT01408303|1072964|P1|COMPLETED|Overall Study||209
437594|NCT01408303|1072962|P3|STARTED|Overall Study||216
437595|NCT01408303|1072963|P2|STARTED|Overall Study||216
437596|NCT01408303|1072964|P1|STARTED|Overall Study||215
437597|NCT01408277|1072974|P2|NOT COMPLETED|Overall Study||4
437598|NCT01408277|1072975|P1|NOT COMPLETED|Overall Study||8
437599|NCT01408277|1072974|P2|COMPLETED|Overall Study||23
437600|NCT01408277|1072975|P1|COMPLETED|Overall Study||20
437601|NCT01408277|1072974|P2|STARTED|Overall Study||27
437602|NCT01408277|1072975|P1|STARTED|Overall Study||28
437603|NCT01407575|1072983|P2|NOT COMPLETED|Overall Study||1
437604|NCT01407575|1072984|P1|NOT COMPLETED|Overall Study||2
437605|NCT01407575|1072983|P2|COMPLETED|Overall Study||5
437606|NCT01407575|1072984|P1|COMPLETED|Overall Study||5
437607|NCT01407575|1072983|P2|STARTED|Overall Study||6
437608|NCT01407575|1072984|P1|STARTED|Overall Study||7
437609|NCT01407523|1073002|P1|NOT COMPLETED|Overall Study||0
437610|NCT01407523|1073002|P1|COMPLETED|Overall Study||16
437611|NCT01407523|1073002|P1|STARTED|Overall Study||16
437612|NCT01407354|1073012|P2|NOT COMPLETED|Second Intervention||2
437613|NCT01407354|1073013|P1|NOT COMPLETED|Second Intervention||0
437614|NCT01407354|1073012|P2|COMPLETED|Second Intervention||13
437615|NCT01407354|1073013|P1|COMPLETED|Second Intervention||18
437616|NCT01407354|1073012|P2|STARTED|Second Intervention||15
437617|NCT01407354|1073013|P1|STARTED|Second Intervention||18
437618|NCT01407354|1073012|P2|NOT COMPLETED|First Intervention||2
437619|NCT01407354|1073013|P1|NOT COMPLETED|First Intervention||2
437620|NCT01407354|1073012|P2|COMPLETED|First Intervention||15
437621|NCT01407354|1073013|P1|COMPLETED|First Intervention||18
437622|NCT01407354|1073012|P2|STARTED|First Intervention||17
437623|NCT01407354|1073013|P1|STARTED|First Intervention||20
437624|NCT01407276|1073029|P8|NOT COMPLETED|Overall Study||1
437625|NCT01407276|1073030|P7|NOT COMPLETED|Overall Study||0
437626|NCT01407276|1073031|P6|NOT COMPLETED|Overall Study||0
437627|NCT01407276|1073032|P5|NOT COMPLETED|Overall Study||0
437628|NCT01407276|1073033|P4|NOT COMPLETED|Overall Study||0
437629|NCT01407276|1073034|P3|NOT COMPLETED|Overall Study||0
437630|NCT01407276|1073035|P2|NOT COMPLETED|Overall Study||0
437631|NCT01407276|1073036|P1|NOT COMPLETED|Overall Study||0
437632|NCT01407276|1073029|P8|COMPLETED|Overall Study||6
437633|NCT01407276|1073030|P7|COMPLETED|Overall Study||6
437634|NCT01407276|1073031|P6|COMPLETED|Overall Study||6
437635|NCT01407276|1073032|P5|COMPLETED|Overall Study||6
437636|NCT01407276|1073033|P4|COMPLETED|Overall Study||6
437637|NCT01407276|1073034|P3|COMPLETED|Overall Study||6
437638|NCT01407276|1073035|P2|COMPLETED|Overall Study||6
437639|NCT01407276|1073036|P1|COMPLETED|Overall Study||6
437640|NCT01407276|1073029|P8|STARTED|Overall Study||7
437641|NCT01407276|1073030|P7|STARTED|Overall Study||6
437642|NCT01407276|1073031|P6|STARTED|Overall Study||6
437643|NCT01407276|1073032|P5|STARTED|Overall Study||6
437644|NCT01407276|1073033|P4|STARTED|Overall Study||6
437645|NCT01407276|1073034|P3|STARTED|Overall Study||6
437646|NCT01407276|1073035|P2|STARTED|Overall Study||6
437647|NCT01407276|1073036|P1|STARTED|Overall Study||6
437648|NCT01407068|1073160|P1|NOT COMPLETED|Overall Study||0
437649|NCT01407068|1073160|P1|COMPLETED|Overall Study||60
437650|NCT01407068|1073160|P1|STARTED|Overall Study||60
437651|NCT01406990|1073169|P1|NOT COMPLETED|Overall Study||0
437652|NCT01406990|1073169|P1|COMPLETED|Overall Study||15
437653|NCT01406990|1073169|P1|STARTED|Overall Study||15
437654|NCT01406938|1073175|P6|NOT COMPLETED|Follow up||3
437655|NCT01406938|1073176|P5|NOT COMPLETED|Follow up||9
437656|NCT01406938|1073177|P4|NOT COMPLETED|Follow up||3
437657|NCT01406938|1073178|P3|NOT COMPLETED|Follow up||8
437658|NCT01406938|1073179|P2|NOT COMPLETED|Follow up||5
437659|NCT01406938|1073180|P1|NOT COMPLETED|Follow up||8
437660|NCT01406938|1073175|P6|COMPLETED|Follow up||32
437661|NCT01406938|1073176|P5|COMPLETED|Follow up||31
437662|NCT01406938|1073177|P4|COMPLETED|Follow up||36
437663|NCT01406938|1073178|P3|COMPLETED|Follow up||32
437664|NCT01406938|1073179|P2|COMPLETED|Follow up||18
437665|NCT01406938|1073180|P1|COMPLETED|Follow up||18
437666|NCT01406938|1073175|P6|STARTED|Follow up||35
437667|NCT01406938|1073176|P5|STARTED|Follow up||40
437668|NCT01406938|1073177|P4|STARTED|Follow up||39
437669|NCT01406938|1073178|P3|STARTED|Follow up||40
437670|NCT01406938|1073179|P2|STARTED|Follow up||23
437671|NCT01406938|1073180|P1|STARTED|Follow up||26
437672|NCT01406938|1073175|P6|NOT COMPLETED|Maintenance Period||16
437673|NCT01406938|1073176|P5|NOT COMPLETED|Maintenance Period||25
437674|NCT01406938|1073177|P4|NOT COMPLETED|Maintenance Period||18
437675|NCT01406938|1073178|P3|NOT COMPLETED|Maintenance Period||17
437676|NCT01406938|1073179|P2|NOT COMPLETED|Maintenance Period||0
437677|NCT01406938|1073180|P1|NOT COMPLETED|Maintenance Period||0
437678|NCT01406938|1073175|P6|COMPLETED|Maintenance Period||201
437679|NCT01406938|1073176|P5|COMPLETED|Maintenance Period||181
437680|NCT01406938|1073177|P4|COMPLETED|Maintenance Period||199
437681|NCT01406938|1073178|P3|COMPLETED|Maintenance Period||186
437682|NCT01406938|1073179|P2|COMPLETED|Maintenance Period||0
437683|NCT01406938|1073180|P1|COMPLETED|Maintenance Period||0
437684|NCT01406938|1073175|P6|FAS: Patients Assigned Treatment Drug|Maintenance Period||217
437685|NCT01406938|1073176|P5|FAS: Patients Assigned Treatment Drug|Maintenance Period||206
437686|NCT01406938|1073177|P4|FAS: Patients Assigned Treatment Drug|Maintenance Period||216
437687|NCT01406938|1073178|P3|FAS: Patients Assigned Treatment Drug|Maintenance Period||203
437688|NCT01406938|1073179|P2|FAS: Patients Assigned Treatment Drug|Maintenance Period||0
437689|NCT01406938|1073180|P1|FAS: Patients Assigned Treatment Drug|Maintenance Period||0
437690|NCT01406938|1073175|P6|STARTED|Maintenance Period||217
437691|NCT01406938|1073176|P5|STARTED|Maintenance Period||206
437692|NCT01406938|1073177|P4|STARTED|Maintenance Period||217
437693|NCT01406938|1073178|P3|STARTED|Maintenance Period||203
437694|NCT01406938|1073179|P2|STARTED|Maintenance Period||0
437695|NCT01406938|1073180|P1|STARTED|Maintenance Period||0
437696|NCT01406938|1073175|P6|NOT COMPLETED|Induction Period||0
437697|NCT01406938|1073176|P5|NOT COMPLETED|Induction Period||0
437698|NCT01406938|1073177|P4|NOT COMPLETED|Induction Period||0
437699|NCT01406938|1073178|P3|NOT COMPLETED|Induction Period||0
437700|NCT01406938|1073179|P2|NOT COMPLETED|Induction Period||20
437701|NCT01406938|1073180|P1|NOT COMPLETED|Induction Period||18
437702|NCT01406938|1073175|P6|COMPLETED|Induction Period||0
437703|NCT01406938|1073176|P5|COMPLETED|Induction Period||0
437704|NCT01406938|1073177|P4|COMPLETED|Induction Period||0
437705|NCT01406938|1073178|P3|COMPLETED|Induction Period||0
437706|NCT01406938|1073179|P2|COMPLETED|Induction Period||464
437707|NCT01406938|1073180|P1|COMPLETED|Induction Period||464
437708|NCT01406938|1073175|P6|FAS:Patients Assigned Study Treatment|Induction Period||0
437709|NCT01406938|1073176|P5|FAS:Patients Assigned Study Treatment|Induction Period||0
437710|NCT01406938|1073177|P4|FAS:Patients Assigned Study Treatment|Induction Period||0
437711|NCT01406938|1073178|P3|FAS:Patients Assigned Study Treatment|Induction Period||0
437712|NCT01406938|1073179|P2|FAS:Patients Assigned Study Treatment|Induction Period||483
437713|NCT01406938|1073180|P1|FAS:Patients Assigned Study Treatment|Induction Period||482
437714|NCT01406938|1073175|P6|STARTED|Induction Period||0
437715|NCT01406938|1073176|P5|STARTED|Induction Period||0
437716|NCT01406938|1073177|P4|STARTED|Induction Period||0
437717|NCT01406938|1073178|P3|STARTED|Induction Period||0
437718|NCT01406938|1073179|P2|STARTED|Induction Period||484
437719|NCT01406938|1073180|P1|STARTED|Induction Period||482
437720|NCT01406873|1073298|P2|NOT COMPLETED|Overall Study||1
437721|NCT01406873|1073299|P1|NOT COMPLETED|Overall Study||1
437722|NCT01406873|1073298|P2|COMPLETED|Overall Study||20
437723|NCT01406873|1073299|P1|COMPLETED|Overall Study||20
437724|NCT01406873|1073298|P2|STARTED|Overall Study||21
437725|NCT01406873|1073299|P1|STARTED|Overall Study||21
437726|NCT01406860|1073317|P2|NOT COMPLETED|Overall Study||0
437727|NCT01406860|1073318|P1|NOT COMPLETED|Overall Study||0
437728|NCT01406860|1073317|P2|COMPLETED|Overall Study||8
437729|NCT01406860|1073318|P1|COMPLETED|Overall Study||11
437730|NCT01406860|1073317|P2|STARTED|Overall Study||8
437731|NCT01406860|1073318|P1|STARTED|Overall Study||11
437732|NCT01406795|1073330|P1|NOT COMPLETED|Overall Study||1
437733|NCT01406795|1073330|P1|COMPLETED|Overall Study||0
437734|NCT01406795|1073330|P1|STARTED|Overall Study||1
437735|NCT01406574|1073344|P4|NOT COMPLETED|Overall Study||4
437736|NCT01406574|1073345|P3|NOT COMPLETED|Overall Study||1
437737|NCT01406574|1073346|P2|NOT COMPLETED|Overall Study||1
437738|NCT01406574|1073347|P1|NOT COMPLETED|Overall Study||1
437739|NCT01406574|1073344|P4|COMPLETED|Overall Study||1
437740|NCT01406574|1073345|P3|COMPLETED|Overall Study||6
437741|NCT01406574|1073346|P2|COMPLETED|Overall Study||3
437742|NCT01406574|1073347|P1|COMPLETED|Overall Study||6
437743|NCT01406574|1073344|P4|STARTED|Overall Study||5
437744|NCT01406574|1073345|P3|STARTED|Overall Study||7
437745|NCT01406574|1073346|P2|STARTED|Overall Study||4
437746|NCT01406574|1073347|P1|STARTED|Overall Study||7
437747|NCT01406223|1073363|P4|NOT COMPLETED|Overall Study||16
437748|NCT01406223|1073364|P3|NOT COMPLETED|Overall Study||18
437749|NCT01406223|1073365|P2|NOT COMPLETED|Overall Study||12
437750|NCT01406223|1073366|P1|NOT COMPLETED|Overall Study||12
437751|NCT01406223|1073363|P4|COMPLETED|Overall Study||3
437752|NCT01406223|1073364|P3|COMPLETED|Overall Study||2
437753|NCT01406223|1073365|P2|COMPLETED|Overall Study||7
437754|NCT01406223|1073366|P1|COMPLETED|Overall Study||6
437755|NCT01406223|1073363|P4|STARTED|Overall Study||19
437756|NCT01406223|1073364|P3|STARTED|Overall Study||20
437757|NCT01406223|1073365|P2|STARTED|Overall Study||19
437758|NCT01406223|1073366|P1|STARTED|Overall Study||18
437759|NCT01406015|1073382|P2|NOT COMPLETED|Overall Study||3
437760|NCT01406015|1073383|P1|NOT COMPLETED|Overall Study||3
437761|NCT01406015|1073382|P2|COMPLETED|Overall Study||16
437762|NCT01406015|1073383|P1|COMPLETED|Overall Study||16
437763|NCT01406015|1073382|P2|STARTED|Overall Study||19
437764|NCT01406015|1073383|P1|STARTED|Overall Study||19
437765|NCT01405950|1073399|P4|NOT COMPLETED|Overall Study||0
437766|NCT01405950|1073400|P3|NOT COMPLETED|Overall Study||0
437767|NCT01405950|1073401|P2|NOT COMPLETED|Overall Study||0
437768|NCT01405950|1073402|P1|NOT COMPLETED|Overall Study||1
437769|NCT01405950|1073399|P4|COMPLETED|Overall Study||0
437770|NCT01405950|1073400|P3|COMPLETED|Overall Study||0
437771|NCT01405950|1073401|P2|COMPLETED|Overall Study||2
437772|NCT01405950|1073402|P1|COMPLETED|Overall Study||7
437773|NCT01405950|1073399|P4|STARTED|Overall Study||0
437774|NCT01405950|1073400|P3|STARTED|Overall Study||0
437775|NCT01405950|1073401|P2|STARTED|Overall Study||2
437776|NCT01405950|1073402|P1|STARTED|Overall Study||8
437777|NCT01405937|1073416|P2|NOT COMPLETED|Overall Study||0
437778|NCT01405937|1073417|P1|NOT COMPLETED|Overall Study||0
437779|NCT01405937|1073416|P2|COMPLETED|Overall Study||26
437780|NCT01405937|1073417|P1|COMPLETED|Overall Study||25
437781|NCT01405937|1073416|P2|STARTED|Overall Study||26
437782|NCT01405937|1073417|P1|STARTED|Overall Study||25
437783|NCT01405924|1073437|P1|NOT COMPLETED|Overall Study||10
437784|NCT01405924|1073437|P1|COMPLETED|Overall Study||101
437785|NCT01405924|1073437|P1|STARTED|Overall Study||111
437786|NCT01405898|1073449|P2|NOT COMPLETED|Overall Study||2
437787|NCT01405898|1073450|P1|NOT COMPLETED|Overall Study||2
437788|NCT01405898|1073449|P2|COMPLETED|Overall Study||32
437789|NCT01405898|1073450|P1|COMPLETED|Overall Study||32
437790|NCT01405898|1073449|P2|STARTED|Overall Study||34
437791|NCT01405898|1073450|P1|STARTED|Overall Study||34
437792|NCT01405820|1073474|P6|NOT COMPLETED|Open-Label Treatment Period||2
437793|NCT01405820|1073475|P5|NOT COMPLETED|Open-Label Treatment Period||2
437794|NCT01405820|1073476|P4|NOT COMPLETED|Open-Label Treatment Period||5
437795|NCT01405820|1073477|P3|NOT COMPLETED|Open-Label Treatment Period||3
437796|NCT01405820|1073478|P2|NOT COMPLETED|Open-Label Treatment Period||2
437797|NCT01405820|1073479|P1|NOT COMPLETED|Open-Label Treatment Period||4
437798|NCT01405820|1073474|P6|COMPLETED|Open-Label Treatment Period||30
437799|NCT01405820|1073475|P5|COMPLETED|Open-Label Treatment Period||40
437800|NCT01405820|1073476|P4|COMPLETED|Open-Label Treatment Period||37
437801|NCT01405820|1073477|P3|COMPLETED|Open-Label Treatment Period||39
437802|NCT01405820|1073478|P2|COMPLETED|Open-Label Treatment Period||33
437803|NCT01405820|1073479|P1|COMPLETED|Open-Label Treatment Period||40
437804|NCT01405820|1073474|P6|STARTED|Open-Label Treatment Period||32
437805|NCT01405820|1073475|P5|STARTED|Open-Label Treatment Period||42
437806|NCT01405820|1073476|P4|STARTED|Open-Label Treatment Period||42
437807|NCT01405820|1073477|P3|STARTED|Open-Label Treatment Period||42
437808|NCT01405820|1073478|P2|STARTED|Open-Label Treatment Period||35
437809|NCT01405820|1073479|P1|STARTED|Open-Label Treatment Period|1 participant discontinued randomized period due to an adverse event but entered open-label period.|44
437810|NCT01405820|1073474|P6|NOT COMPLETED|Randomized Treatment Period||37
437811|NCT01405820|1073475|P5|NOT COMPLETED|Randomized Treatment Period||45
437812|NCT01405820|1073476|P4|NOT COMPLETED|Randomized Treatment Period||51
437813|NCT01405820|1073477|P3|NOT COMPLETED|Randomized Treatment Period||43
437814|NCT01405820|1073478|P2|NOT COMPLETED|Randomized Treatment Period||10
437815|NCT01405820|1073479|P1|NOT COMPLETED|Randomized Treatment Period||11
437816|NCT01405820|1073474|P6|COMPLETED|Randomized Treatment Period||1
437817|NCT01405820|1073475|P5|COMPLETED|Randomized Treatment Period||2
437818|NCT01405820|1073476|P4|COMPLETED|Randomized Treatment Period||3
437819|NCT01405820|1073477|P3|COMPLETED|Randomized Treatment Period||9
437820|NCT01405820|1073478|P2|COMPLETED|Randomized Treatment Period||35
437821|NCT01405820|1073479|P1|COMPLETED|Randomized Treatment Period||43
437822|NCT01405820|1073474|P6|Safety Population|Randomized Treatment Period||38
437823|NCT01405820|1073475|P5|Safety Population|Randomized Treatment Period||47
437824|NCT01405820|1073476|P4|Safety Population|Randomized Treatment Period|1 participant did not receive any study medication.|53
437825|NCT01405820|1073477|P3|Safety Population|Randomized Treatment Period||52
437826|NCT01405820|1073478|P2|Safety Population|Randomized Treatment Period||45
437827|NCT01405820|1073479|P1|Safety Population|Randomized Treatment Period||54
437828|NCT01405820|1073474|P6|STARTED|Randomized Treatment Period||38
437829|NCT01405820|1073475|P5|STARTED|Randomized Treatment Period||47
437830|NCT01405820|1073476|P4|STARTED|Randomized Treatment Period||54
437831|NCT01405820|1073477|P3|STARTED|Randomized Treatment Period||52
437832|NCT01405820|1073478|P2|STARTED|Randomized Treatment Period||45
437833|NCT01405820|1073479|P1|STARTED|Randomized Treatment Period||54
437834|NCT01405794|1073499|P1|NOT COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||0
437835|NCT01405794|1073499|P1|COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||12
437836|NCT01405794|1073499|P1|STARTED|Second Dose 32ppm Oral Silver (14 Days)||12
437837|NCT01405794|1073499|P1|NOT COMPLETED|72 hr Washout||0
437838|NCT01405794|1073499|P1|COMPLETED|72 hr Washout||12
437839|NCT01405794|1073499|P1|STARTED|72 hr Washout||12
437840|NCT01405794|1073499|P1|NOT COMPLETED|First Dose Placebo (14 Days)||0
437841|NCT01405794|1073499|P1|COMPLETED|First Dose Placebo (14 Days)||12
437842|NCT01405794|1073499|P1|STARTED|First Dose Placebo (14 Days)||12
437843|NCT01405768|1073575|P2|NOT COMPLETED|Overall Study||0
437844|NCT01405768|1073576|P1|NOT COMPLETED|Overall Study||4
437845|NCT01405768|1073575|P2|COMPLETED|Overall Study||28
437846|NCT01405768|1073576|P1|COMPLETED|Overall Study||24
437847|NCT01405768|1073575|P2|STARTED|Overall Study||28
437848|NCT01405768|1073576|P1|STARTED|Overall Study||28
437849|NCT01405742|1073588|P2|NOT COMPLETED|Overall Study||0
437850|NCT01405742|1073589|P1|NOT COMPLETED|Overall Study||1
437851|NCT01405742|1073588|P2|COMPLETED|Overall Study||2
437852|NCT01405742|1073589|P1|COMPLETED|Overall Study||1
437853|NCT01405742|1073588|P2|STARTED|Overall Study||2
437854|NCT01405742|1073589|P1|STARTED|Overall Study||2
437855|NCT01405560|1073599|P1|NOT COMPLETED|Overall Study||1
437856|NCT01405560|1073599|P1|COMPLETED|Overall Study||41
437857|NCT01405560|1073599|P1|STARTED|Overall Study||42
437858|NCT01405508|1073614|P4|NOT COMPLETED|Overall Study||0
437859|NCT01405508|1073615|P3|NOT COMPLETED|Overall Study||0
437860|NCT01405508|1073616|P2|NOT COMPLETED|Overall Study||1
437861|NCT01405508|1073617|P1|NOT COMPLETED|Overall Study||1
437862|NCT01405508|1073614|P4|COMPLETED|Overall Study||26
437863|NCT01405508|1073615|P3|COMPLETED|Overall Study||27
437864|NCT01405508|1073616|P2|COMPLETED|Overall Study||25
437865|NCT01405508|1073617|P1|COMPLETED|Overall Study||25
437866|NCT01405508|1073614|P4|STARTED|Overall Study||26
437867|NCT01405508|1073615|P3|STARTED|Overall Study||27
437868|NCT01405508|1073616|P2|STARTED|Overall Study||26
437869|NCT01405508|1073617|P1|STARTED|Overall Study||26
437870|NCT01405469|1073635|P1|NOT COMPLETED|Overall Study||0
437871|NCT01405469|1073635|P1|COMPLETED|Overall Study||16
437872|NCT01405469|1073635|P1|STARTED|Overall Study||16
437873|NCT01405456|1073649|P2|NOT COMPLETED|Overall Study||1
437874|NCT01405456|1073650|P1|NOT COMPLETED|Overall Study||3
437875|NCT01405456|1073649|P2|COMPLETED|Overall Study||20
437876|NCT01405456|1073650|P1|COMPLETED|Overall Study||22
437877|NCT01405456|1073649|P2|STARTED|Overall Study||21
437878|NCT01405456|1073650|P1|STARTED|Overall Study||25
437879|NCT01405313|1073678|P1|NOT COMPLETED|Overall Study||0
437880|NCT01405313|1073678|P1|COMPLETED|Overall Study||21
437881|NCT01405313|1073678|P1|STARTED|Overall Study||21
437882|NCT01405196|1073690|P4|NOT COMPLETED|Overall Study||9
437883|NCT01405196|1073691|P3|NOT COMPLETED|Overall Study||23
437884|NCT01405196|1073692|P2|NOT COMPLETED|Overall Study||12
437885|NCT01405196|1073693|P1|NOT COMPLETED|Overall Study||11
437886|NCT01405196|1073690|P4|COMPLETED|Overall Study||36
437887|NCT01405196|1073691|P3|COMPLETED|Overall Study||23
437888|NCT01405196|1073692|P2|COMPLETED|Overall Study||35
437889|NCT01405196|1073693|P1|COMPLETED|Overall Study||34
437890|NCT01405196|1073690|P4|STARTED|Overall Study||45
437891|NCT01405196|1073691|P3|STARTED|Overall Study||46
437892|NCT01405196|1073692|P2|STARTED|Overall Study||47
437893|NCT01405196|1073693|P1|STARTED|Overall Study||45
437894|NCT01405027|1073780|P2|NOT COMPLETED|Overall Study||51
437895|NCT01405027|1073781|P1|NOT COMPLETED|Overall Study||32
437896|NCT01405027|1073780|P2|COMPLETED|Overall Study||62
437897|NCT01405027|1073781|P1|COMPLETED|Overall Study||52
437898|NCT01405027|1073780|P2|STARTED|Overall Study||113
437899|NCT01405027|1073781|P1|STARTED|Overall Study||84
437900|NCT01404988|1073798|P3|NOT COMPLETED|Overall Study||3
437901|NCT01404988|1073799|P2|NOT COMPLETED|Overall Study||4
437902|NCT01404988|1073800|P1|NOT COMPLETED|Overall Study||6
437903|NCT01404988|1073798|P3|COMPLETED|Overall Study||30
437904|NCT01404988|1073799|P2|COMPLETED|Overall Study||29
437905|NCT01404988|1073800|P1|COMPLETED|Overall Study||27
437906|NCT01404988|1073798|P3|STARTED|Overall Study||33
437907|NCT01404988|1073799|P2|STARTED|Overall Study||33
437908|NCT01404988|1073800|P1|STARTED|Overall Study||33
437909|NCT01404936|1073817|P1|NOT COMPLETED|Overall Study||0
437910|NCT01404936|1073817|P1|COMPLETED|Overall Study||30
437911|NCT01404936|1073817|P1|STARTED|Overall Study||30
437912|NCT01404923|1073823|P2|NOT COMPLETED|Overall Study||17
437913|NCT01404923|1073824|P1|NOT COMPLETED|Overall Study||23
437914|NCT01404923|1073823|P2|COMPLETED|Overall Study||197
437915|NCT01404923|1073824|P1|COMPLETED|Overall Study||199
437916|NCT01404923|1073823|P2|STARTED|Overall Study||214
437917|NCT01404923|1073824|P1|STARTED|Overall Study||222
437918|NCT01404832|1073832|P1|NOT COMPLETED|Overall Study||0
437919|NCT01404832|1073832|P1|COMPLETED|Overall Study||21
437920|NCT01404832|1073832|P1|STARTED|Overall Study||21
437921|NCT01404650|1073837|P1|NOT COMPLETED|Overall Study||0
437922|NCT01404650|1073837|P1|COMPLETED|Overall Study||25
437923|NCT01404650|1073837|P1|STARTED|Overall Study|Twenty-five patients received a median of 2 cycles of AUY922.|25
437924|NCT01404611|1073847|P3|NOT COMPLETED|Overall Study||5
437925|NCT01404611|1073848|P2|NOT COMPLETED|Overall Study||19
437926|NCT01404611|1073849|P1|NOT COMPLETED|Overall Study||8
437927|NCT01404611|1073847|P3|COMPLETED|Overall Study||106
437928|NCT01404611|1073848|P2|COMPLETED|Overall Study||89
437929|NCT01404611|1073849|P1|COMPLETED|Overall Study||104
437930|NCT01404611|1073847|P3|STARTED|Overall Study||111
437931|NCT01404611|1073848|P2|STARTED|Overall Study||108
437932|NCT01404611|1073849|P1|STARTED|Overall Study||112
437933|NCT01404572|1073857|P3|NOT COMPLETED|Overall Study||0
437934|NCT01404572|1073858|P2|NOT COMPLETED|Overall Study||0
437935|NCT01404572|1073859|P1|NOT COMPLETED|Overall Study||0
437936|NCT01404572|1073857|P3|COMPLETED|Overall Study||4
437937|NCT01404572|1073858|P2|COMPLETED|Overall Study||4
437938|NCT01404572|1073859|P1|COMPLETED|Overall Study||4
437939|NCT01404572|1073857|P3|STARTED|Overall Study||4
437940|NCT01404572|1073858|P2|STARTED|Overall Study||4
437941|NCT01404572|1073859|P1|STARTED|Overall Study||4
437942|NCT01404559|1073890|P4|NOT COMPLETED|Overall Study||0
437943|NCT01404559|1073891|P3|NOT COMPLETED|Overall Study||0
437944|NCT01404559|1073892|P2|NOT COMPLETED|Overall Study||0
437945|NCT01404559|1073893|P1|NOT COMPLETED|Overall Study||0
437946|NCT01404559|1073890|P4|COMPLETED|Overall Study||14
437947|NCT01404559|1073891|P3|COMPLETED|Overall Study||4
437948|NCT01404559|1073892|P2|COMPLETED|Overall Study||5
437949|NCT01404559|1073893|P1|COMPLETED|Overall Study||5
437950|NCT01404559|1073890|P4|STARTED|Overall Study||14
437951|NCT01404559|1073891|P3|STARTED|Overall Study||4
437952|NCT01404559|1073892|P2|STARTED|Overall Study||5
437953|NCT01404559|1073893|P1|STARTED|Overall Study||5
437954|NCT01404429|1073906|P2|NOT COMPLETED|Overall Study||7
437955|NCT01404429|1073907|P1|NOT COMPLETED|Overall Study||9
437956|NCT01404429|1073906|P2|COMPLETED|Overall Study||46
437957|NCT01404429|1073907|P1|COMPLETED|Overall Study||38
437958|NCT01404429|1073906|P2|STARTED|Overall Study||53
437959|NCT01404429|1073907|P1|STARTED|Overall Study||47
437960|NCT01404260|1073921|P2|NOT COMPLETED|Overall Study||9
437961|NCT01404260|1073922|P1|NOT COMPLETED|Overall Study||3
437962|NCT01404260|1073921|P2|COMPLETED|Overall Study||101
437963|NCT01404260|1073922|P1|COMPLETED|Overall Study||106
437964|NCT01404260|1073921|P2|STARTED|Overall Study||110
437965|NCT01404260|1073922|P1|STARTED|Overall Study||109
437966|NCT01404234|1073928|P1|NOT COMPLETED|Overall Study||2
437967|NCT01404234|1073928|P1|COMPLETED|Overall Study||59
437968|NCT01404234|1073928|P1|STARTED|Overall Study||61
437969|NCT01404208|1073944|P2|NOT COMPLETED|Overall Study||0
437970|NCT01404208|1073945|P1|NOT COMPLETED|Overall Study||3
437971|NCT01404208|1073944|P2|COMPLETED|Overall Study||72
437972|NCT01404208|1073945|P1|COMPLETED|Overall Study||67
437973|NCT01404208|1073944|P2|STARTED|Overall Study||72
437974|NCT01404208|1073945|P1|STARTED|Overall Study||70
437975|NCT01404078|1073955|P2|NOT COMPLETED|Overall Study||20
437976|NCT01404078|1073956|P1|NOT COMPLETED|Overall Study||18
437977|NCT01404078|1073955|P2|COMPLETED|Overall Study||237
437978|NCT01404078|1073956|P1|COMPLETED|Overall Study||243
437979|NCT01404078|1073955|P2|STARTED|Overall Study|725 Started on Phase 1 run in low dose polycap 645 started on phase 2 run in full dose polycap|257
437980|NCT01404078|1073956|P1|STARTED|Overall Study|725 Started on Phase 1 run in low dose polycap 645 started on phase 2 run in full dose polycap|261
437981|NCT01404039|1073971|P13|NOT COMPLETED|Overall Study||0
437982|NCT01404039|1073972|P12|NOT COMPLETED|Overall Study||0
437983|NCT01404039|1073973|P11|NOT COMPLETED|Overall Study||1
437984|NCT01404039|1073974|P10|NOT COMPLETED|Overall Study||1
437985|NCT01404039|1073975|P9|NOT COMPLETED|Overall Study||0
437986|NCT01404039|1073976|P8|NOT COMPLETED|Overall Study||0
437987|NCT01404039|1073977|P7|NOT COMPLETED|Overall Study||0
437988|NCT01404039|1073978|P6|NOT COMPLETED|Overall Study||0
437989|NCT01404039|1073979|P5|NOT COMPLETED|Overall Study||0
437990|NCT01404039|1073980|P4|NOT COMPLETED|Overall Study||0
437991|NCT01404039|1073981|P3|NOT COMPLETED|Overall Study||0
437992|NCT01404039|1073982|P2|NOT COMPLETED|Overall Study||0
437993|NCT01404039|1073983|P1|NOT COMPLETED|Overall Study||1
437994|NCT01404039|1073971|P13|COMPLETED|Overall Study||0
437995|NCT01404039|1073972|P12|COMPLETED|Overall Study||0
437996|NCT01404039|1073973|P11|COMPLETED|Overall Study||14
437997|NCT01404039|1073974|P10|COMPLETED|Overall Study||14
437998|NCT01404039|1073975|P9|COMPLETED|Overall Study||15
437999|NCT01404039|1073976|P8|COMPLETED|Overall Study||15
438000|NCT01404039|1073977|P7|COMPLETED|Overall Study||10
438001|NCT01404039|1073978|P6|COMPLETED|Overall Study||10
438002|NCT01404039|1073979|P5|COMPLETED|Overall Study||10
438003|NCT01404039|1073980|P4|COMPLETED|Overall Study||10
438004|NCT01404039|1073981|P3|COMPLETED|Overall Study||5
438005|NCT01404039|1073982|P2|COMPLETED|Overall Study||5
438006|NCT01404039|1073983|P1|COMPLETED|Overall Study||4
438007|NCT01404039|1073971|P13|STARTED|Overall Study||0
438008|NCT01404039|1073972|P12|STARTED|Overall Study||0
438009|NCT01404039|1073973|P11|STARTED|Overall Study||15
438010|NCT01404039|1073974|P10|STARTED|Overall Study||15
438011|NCT01404039|1073975|P9|STARTED|Overall Study||15
438012|NCT01404039|1073976|P8|STARTED|Overall Study||15
438013|NCT01404039|1073977|P7|STARTED|Overall Study||10
438014|NCT01404039|1073978|P6|STARTED|Overall Study||10
438015|NCT01404039|1073979|P5|STARTED|Overall Study||10
438016|NCT01404039|1073980|P4|STARTED|Overall Study||10
438017|NCT01404039|1073981|P3|STARTED|Overall Study||5
438018|NCT01404039|1073982|P2|STARTED|Overall Study||5
438019|NCT01404039|1073983|P1|STARTED|Overall Study||5
438020|NCT01403987|1074010|P3|NOT COMPLETED|Overall Study||18
438021|NCT01403987|1074011|P2|NOT COMPLETED|Overall Study||17
438022|NCT01403987|1074012|P1|NOT COMPLETED|Overall Study||18
438023|NCT01403987|1074010|P3|COMPLETED|Overall Study||50
438024|NCT01403987|1074011|P2|COMPLETED|Overall Study||17
438025|NCT01403987|1074012|P1|COMPLETED|Overall Study||16
438026|NCT01403987|1074010|P3|STARTED|Overall Study||68
438027|NCT01403987|1074011|P2|STARTED|Overall Study||34
438028|NCT01403987|1074012|P1|STARTED|Overall Study||34
438029|NCT01403805|1074028|P2|NOT COMPLETED|Overall Study||7
438030|NCT01403805|1074029|P1|NOT COMPLETED|Overall Study||0
438031|NCT01403805|1074028|P2|COMPLETED|Overall Study||98
438032|NCT01403805|1074029|P1|COMPLETED|Overall Study||94
438033|NCT01403805|1074028|P2|Pneumonia Diagnosis|Overall Study||2
438034|NCT01403805|1074029|P1|Pneumonia Diagnosis|Overall Study||21
438035|NCT01403805|1074028|P2|STARTED|Overall Study||105
438036|NCT01403805|1074029|P1|STARTED|Overall Study||94
438037|NCT01403441|1074041|P1|NOT COMPLETED|Overall Study||0
438038|NCT01403441|1074041|P1|COMPLETED|Overall Study||3
438039|NCT01403441|1074041|P1|STARTED|Overall Study||3
438040|NCT01403376|1074051|P3|NOT COMPLETED|Overall Study||0
438041|NCT01403376|1074052|P2|NOT COMPLETED|Overall Study||0
438042|NCT01403376|1074053|P1|NOT COMPLETED|Overall Study||0
438043|NCT01403376|1074051|P3|COMPLETED|Overall Study||46
438044|NCT01403376|1074052|P2|COMPLETED|Overall Study||41
438045|NCT01403376|1074053|P1|COMPLETED|Overall Study||41
438046|NCT01403376|1074051|P3|STARTED|Overall Study||46
438047|NCT01403376|1074052|P2|STARTED|Overall Study||41
438048|NCT01403376|1074053|P1|STARTED|Overall Study||41
438049|NCT01403194|1074073|P1|NOT COMPLETED|Overall Study||10
438050|NCT01403194|1074073|P1|COMPLETED|Overall Study||1
438051|NCT01403194|1074073|P1|STARTED|Overall Study||11
438052|NCT01403090|1074079|P1|NOT COMPLETED|Overall Study||0
438053|NCT01403090|1074079|P1|COMPLETED|Overall Study||8
438054|NCT01403090|1074079|P1|STARTED|Overall Study||8
438055|NCT01403051|1074085|P2|NOT COMPLETED|Overall Study||6
438056|NCT01403051|1074086|P1|NOT COMPLETED|Overall Study||10
438057|NCT01403051|1074085|P2|COMPLETED|Overall Study||80
438058|NCT01403051|1074086|P1|COMPLETED|Overall Study||71
438059|NCT01403051|1074085|P2|Initiated Study Treatment|Overall Study||86
438060|NCT01403051|1074086|P1|Initiated Study Treatment|Overall Study||81
438061|NCT01403051|1074085|P2|STARTED|Overall Study||86
438062|NCT01403051|1074086|P1|STARTED|Overall Study||81
438063|NCT01402986|1074122|P4|NOT COMPLETED|Overall Study||22
438064|NCT01402986|1074123|P3|NOT COMPLETED|Overall Study||8
438065|NCT01402986|1074124|P2|NOT COMPLETED|Overall Study||15
438066|NCT01402986|1074125|P1|NOT COMPLETED|Overall Study||9
438067|NCT01402986|1074122|P4|COMPLETED|Overall Study||129
438068|NCT01402986|1074123|P3|COMPLETED|Overall Study||67
438069|NCT01402986|1074124|P2|COMPLETED|Overall Study||135
438070|NCT01402986|1074125|P1|COMPLETED|Overall Study||67
438071|NCT01402986|1074122|P4|STARTED|Overall Study||151
438072|NCT01402986|1074123|P3|STARTED|Overall Study||75
438073|NCT01402986|1074124|P2|STARTED|Overall Study||150
438074|NCT01402986|1074125|P1|STARTED|Overall Study||76
438075|NCT01402947|1074260|P2|NOT COMPLETED|Second Intervention||0
438076|NCT01402947|1074261|P1|NOT COMPLETED|Second Intervention||0
438077|NCT01402947|1074260|P2|COMPLETED|Second Intervention||14
438078|NCT01402947|1074261|P1|COMPLETED|Second Intervention||15
438079|NCT01402947|1074260|P2|STARTED|Second Intervention||14
438080|NCT01402947|1074261|P1|STARTED|Second Intervention||15
438081|NCT01402947|1074260|P2|NOT COMPLETED|First Intervention||1
438082|NCT01402947|1074261|P1|NOT COMPLETED|First Intervention||0
438083|NCT01402947|1074260|P2|COMPLETED|First Intervention||14
438084|NCT01402947|1074261|P1|COMPLETED|First Intervention||15
438085|NCT01402947|1074260|P2|STARTED|First Intervention||15
438086|NCT01402947|1074261|P1|STARTED|First Intervention||15
438087|NCT01402869|1074272|P3|NOT COMPLETED|Overall Study||1
438088|NCT01402869|1074273|P2|NOT COMPLETED|Overall Study||0
438089|NCT01402869|1074274|P1|NOT COMPLETED|Overall Study||0
438090|NCT01402869|1074272|P3|COMPLETED|Overall Study||30
438091|NCT01402869|1074273|P2|COMPLETED|Overall Study||30
438092|NCT01402869|1074274|P1|COMPLETED|Overall Study||30
438093|NCT01402869|1074272|P3|STARTED|Overall Study||31
438094|NCT01402869|1074273|P2|STARTED|Overall Study||30
438095|NCT01402869|1074274|P1|STARTED|Overall Study||30
438096|NCT01402817|1074288|P1|NOT COMPLETED|Overall Study||11
438097|NCT01402817|1074288|P1|COMPLETED|Overall Study||8
438098|NCT01402817|1074288|P1|STARTED|Overall Study||19
438099|NCT01402700|1074293|P1|NOT COMPLETED|Overall Study||7
438100|NCT01402700|1074293|P1|COMPLETED|Overall Study||68
438101|NCT01402700|1074293|P1|STARTED|Overall Study||75
438102|NCT01402570|1074297|P1|NOT COMPLETED|Overall Study||1
438103|NCT01402570|1074297|P1|COMPLETED|Overall Study||19
438104|NCT01402570|1074297|P1|STARTED|Overall Study||20
438105|NCT01402427|1074306|P2|NOT COMPLETED|Overall Study||0
438106|NCT01402427|1074307|P1|NOT COMPLETED|Overall Study||0
438107|NCT01402427|1074306|P2|COMPLETED|Overall Study||294
438108|NCT01402427|1074307|P1|COMPLETED|Overall Study||297
438109|NCT01402427|1074306|P2|STARTED|Overall Study||294
438110|NCT01402427|1074307|P1|STARTED|Overall Study||297
438111|NCT01402375|1074331|P6|NOT COMPLETED|Overall Study||0
438112|NCT01402375|1074332|P5|NOT COMPLETED|Overall Study||0
438113|NCT01402375|1074333|P4|NOT COMPLETED|Overall Study||0
438114|NCT01402375|1074334|P3|NOT COMPLETED|Overall Study||0
438115|NCT01402375|1074335|P2|NOT COMPLETED|Overall Study||0
438116|NCT01402375|1074336|P1|NOT COMPLETED|Overall Study||0
438117|NCT01402375|1074331|P6|COMPLETED|Overall Study||120
438118|NCT01402375|1074332|P5|COMPLETED|Overall Study||120
438119|NCT01402375|1074333|P4|COMPLETED|Overall Study||120
438120|NCT01402375|1074334|P3|COMPLETED|Overall Study||120
438121|NCT01402375|1074335|P2|COMPLETED|Overall Study||120
438122|NCT01402375|1074336|P1|COMPLETED|Overall Study||120
438123|NCT01402375|1074331|P6|STARTED|Overall Study||120
438124|NCT01402375|1074332|P5|STARTED|Overall Study||120
438125|NCT01402375|1074333|P4|STARTED|Overall Study||120
438126|NCT01402375|1074334|P3|STARTED|Overall Study||120
438127|NCT01402375|1074335|P2|STARTED|Overall Study||120
438128|NCT01402375|1074336|P1|STARTED|Overall Study||120
438129|NCT01402284|1074368|P1|NOT COMPLETED|Overall Study||15
438130|NCT01402284|1074368|P1|COMPLETED|Overall Study||30
438131|NCT01402284|1074368|P1|STARTED|Overall Study||45
438132|NCT01402141|1074381|P2|NOT COMPLETED|Overall Study||2
438133|NCT01402141|1074382|P1|NOT COMPLETED|Overall Study||1
438134|NCT01402141|1074381|P2|COMPLETED|Overall Study||28
438135|NCT01402141|1074382|P1|COMPLETED|Overall Study||29
438136|NCT01402141|1074381|P2|STARTED|Overall Study||30
438137|NCT01402141|1074382|P1|STARTED|Overall Study||30
438138|NCT01402128|1074404|P2|NOT COMPLETED|Overall Study||0
438139|NCT01402128|1074405|P1|NOT COMPLETED|Overall Study||1
438140|NCT01402128|1074404|P2|COMPLETED|Overall Study||40
438141|NCT01402128|1074405|P1|COMPLETED|Overall Study||39
438142|NCT01402128|1074404|P2|STARTED|Overall Study||40
438143|NCT01402128|1074405|P1|STARTED|Overall Study||40
438144|NCT01402115|1074433|P2|NOT COMPLETED|Overall Study||1
438145|NCT01402115|1074434|P1|NOT COMPLETED|Overall Study||1
438146|NCT01402115|1074433|P2|COMPLETED|Overall Study||29
438147|NCT01402115|1074434|P1|COMPLETED|Overall Study||29
438148|NCT01402115|1074433|P2|STARTED|Overall Study||30
438149|NCT01402115|1074434|P1|STARTED|Overall Study||30
438150|NCT01402102|1074450|P2|NOT COMPLETED|Overall Study||3
438151|NCT01402102|1074451|P1|NOT COMPLETED|Overall Study||2
438152|NCT01402102|1074450|P2|COMPLETED|Overall Study||27
438153|NCT01402102|1074451|P1|COMPLETED|Overall Study||28
438154|NCT01402102|1074450|P2|STARTED|Overall Study||30
438155|NCT01402102|1074451|P1|STARTED|Overall Study||30
438156|NCT01402063|1074471|P2|NOT COMPLETED|Overall Study||3
438157|NCT01402063|1074472|P1|NOT COMPLETED|Overall Study||3
438158|NCT01402063|1074471|P2|COMPLETED|Overall Study||18
438159|NCT01402063|1074472|P1|COMPLETED|Overall Study||39
438160|NCT01402063|1074471|P2|STARTED|Overall Study||21
438161|NCT01402063|1074472|P1|STARTED|Overall Study||42
438162|NCT01401959|1074481|P3|NOT COMPLETED|Treated||5
438163|NCT01401959|1074482|P2|NOT COMPLETED|Treated||8
438164|NCT01401959|1074483|P1|NOT COMPLETED|Treated||7
438165|NCT01401959|1074481|P3|COMPLETED|Treated||26
438166|NCT01401959|1074482|P2|COMPLETED|Treated||34
438167|NCT01401959|1074483|P1|COMPLETED|Treated||46
438168|NCT01401959|1074481|P3|STARTED|Treated||31
438169|NCT01401959|1074482|P2|STARTED|Treated||42
438170|NCT01401959|1074483|P1|STARTED|Treated||53
438171|NCT01401959|1074481|P3|NOT COMPLETED|Enrolled||0
438172|NCT01401959|1074482|P2|NOT COMPLETED|Enrolled||0
438173|NCT01401959|1074483|P1|NOT COMPLETED|Enrolled||1
438174|NCT01401959|1074481|P3|COMPLETED|Enrolled||31
438175|NCT01401959|1074482|P2|COMPLETED|Enrolled||42
438176|NCT01401959|1074483|P1|COMPLETED|Enrolled||53
438177|NCT01401959|1074481|P3|STARTED|Enrolled||31
438178|NCT01401959|1074482|P2|STARTED|Enrolled||42
438179|NCT01401959|1074483|P1|STARTED|Enrolled||54
438188|NCT01401842|1074520|P2|NOT COMPLETED|Overall Study||67
438189|NCT01401842|1074521|P1|NOT COMPLETED|Overall Study||68
438190|NCT01401842|1074520|P2|COMPLETED|Overall Study||217
438191|NCT01401842|1074521|P1|COMPLETED|Overall Study||230
438192|NCT01401842|1074520|P2|STARTED|Overall Study||284
438193|NCT01401842|1074521|P1|STARTED|Overall Study||298
438194|NCT01401647|1074534|P3|NOT COMPLETED|Overall Study||3
438195|NCT01401647|1074535|P2|NOT COMPLETED|Overall Study||8
438196|NCT01401647|1074536|P1|NOT COMPLETED|Overall Study||4
438197|NCT01401647|1074534|P3|COMPLETED|Overall Study||1056
438198|NCT01401647|1074535|P2|COMPLETED|Overall Study||985
438199|NCT01401647|1074536|P1|COMPLETED|Overall Study||968
438200|NCT01401647|1074534|P3|STARTED|Overall Study||1059
438201|NCT01401647|1074535|P2|STARTED|Overall Study||993
438202|NCT01401647|1074536|P1|STARTED|Overall Study||972
438203|NCT01401595|1074549|P2|NOT COMPLETED|Imaging and Treatment (for NE Arm)||0
438204|NCT01401595|1074550|P1|NOT COMPLETED|Imaging and Treatment (for NE Arm)||14
438205|NCT01401595|1074549|P2|COMPLETED|Imaging and Treatment (for NE Arm)||10
438206|NCT01401595|1074550|P1|COMPLETED|Imaging and Treatment (for NE Arm)||18
438207|NCT01401595|1074549|P2|STARTED|Imaging and Treatment (for NE Arm)||10
438208|NCT01401595|1074550|P1|STARTED|Imaging and Treatment (for NE Arm)||32
438209|NCT01401595|1074549|P2|NOT COMPLETED|Recruitment and Screening||2
438210|NCT01401595|1074550|P1|NOT COMPLETED|Recruitment and Screening||43
438211|NCT01401595|1074549|P2|COMPLETED|Recruitment and Screening|10 of the 12 remained eligible/interested after the initial screening visit.|10
438212|NCT01401595|1074550|P1|COMPLETED|Recruitment and Screening|Of the 75, 32 remained interested/eligible after the initial screening period.|32
438213|NCT01401595|1074549|P2|STARTED|Recruitment and Screening|Of 32 calls, 12 control subjects attended an initial screening visit.|12
438214|NCT01401595|1074550|P1|STARTED|Recruitment and Screening|Of 345 calls, 75 potential NES subjects attended the screening visit and provided informed consent.|75
438215|NCT01401582|1074561|P2|NOT COMPLETED|Overall Study||117
438216|NCT01401582|1074562|P1|NOT COMPLETED|Overall Study||110
438217|NCT01401582|1074561|P2|COMPLETED|Overall Study||291
438218|NCT01401582|1074562|P1|COMPLETED|Overall Study||116
438219|NCT01401582|1074561|P2|Baseline Completed|Overall Study||348
438220|NCT01401582|1074562|P1|Baseline Completed|Overall Study||168
438221|NCT01401582|1074561|P2|STARTED|Overall Study||408
438222|NCT01401582|1074562|P1|STARTED|Overall Study||226
438223|NCT01401517|1074581|P3|NOT COMPLETED|Overall Study||3
438224|NCT01401517|1074582|P2|NOT COMPLETED|Overall Study||2
438225|NCT01401517|1074583|P1|NOT COMPLETED|Overall Study||3
438226|NCT01401517|1074581|P3|COMPLETED|Overall Study||15
438227|NCT01401517|1074582|P2|COMPLETED|Overall Study||17
438228|NCT01401517|1074583|P1|COMPLETED|Overall Study||15
438229|NCT01401517|1074581|P3|STARTED|Overall Study||18
438230|NCT01401517|1074582|P2|STARTED|Overall Study||19
438231|NCT01401517|1074583|P1|STARTED|Overall Study||18
438232|NCT01401478|1074591|P1|NOT COMPLETED|Overall Study||31
438233|NCT01401478|1074591|P1|COMPLETED|Overall Study||55
438234|NCT01401478|1074591|P1|STARTED|Overall Study||86
438235|NCT01401465|1074604|P2|NOT COMPLETED|Treatment Period 2||2
438236|NCT01401465|1074605|P1|NOT COMPLETED|Treatment Period 2||0
438237|NCT01401465|1074604|P2|COMPLETED|Treatment Period 2||144
438238|NCT01401465|1074605|P1|COMPLETED|Treatment Period 2||150
438239|NCT01401465|1074604|P2|STARTED|Treatment Period 2||146
438240|NCT01401465|1074605|P1|STARTED|Treatment Period 2||150
438241|NCT01401465|1074604|P2|NOT COMPLETED|Washout||0
438242|NCT01401465|1074605|P1|NOT COMPLETED|Washout||0
438243|NCT01401465|1074604|P2|COMPLETED|Washout||146
438244|NCT01401465|1074605|P1|COMPLETED|Washout||150
438245|NCT01401465|1074604|P2|STARTED|Washout||146
438246|NCT01401465|1074605|P1|STARTED|Washout||150
438247|NCT01401465|1074604|P2|NOT COMPLETED|Treatment Period 1||16
438248|NCT01401465|1074605|P1|NOT COMPLETED|Treatment Period 1||15
438249|NCT01401465|1074604|P2|COMPLETED|Treatment Period 1||146
438250|NCT01401465|1074605|P1|COMPLETED|Treatment Period 1||150
438251|NCT01401465|1074604|P2|STARTED|Treatment Period 1||162
438252|NCT01401465|1074605|P1|STARTED|Treatment Period 1||165
438253|NCT01401452|1074668|P1|NOT COMPLETED|Overall Study||72
438254|NCT01401452|1074668|P1|COMPLETED|Overall Study||174
438255|NCT01401452|1074668|P1|Visit 5 (9 Months)|Overall Study||175
438256|NCT01401452|1074668|P1|Visit 4 (6 Months)|Overall Study||172
438257|NCT01401452|1074668|P1|Visit 3 (3 Months)|Overall Study||217
438258|NCT01401452|1074668|P1|Visit 2 (1 Month)|Overall Study||225
438259|NCT01401452|1074668|P1|Visit 1 (Baseline)|Overall Study||246
438260|NCT01401452|1074668|P1|STARTED|Overall Study||246
438261|NCT01401361|1074680|P1|NOT COMPLETED|Overall Study||28
438262|NCT01401361|1074680|P1|COMPLETED|Overall Study|16 subjects were withdrawn prior to the use of the investigational device|122
438263|NCT01401361|1074680|P1|STARTED|Overall Study||150
438264|NCT01401322|1074686|P1|NOT COMPLETED|Overall Study||2
438265|NCT01401322|1074686|P1|COMPLETED|Overall Study||3
438266|NCT01401322|1074686|P1|STARTED|Overall Study||5
438267|NCT01401283|1074692|P2|NOT COMPLETED|Overall Study||10
438268|NCT01401283|1074693|P1|NOT COMPLETED|Overall Study||10
438269|NCT01401283|1074692|P2|COMPLETED|Overall Study||81
438270|NCT01401283|1074693|P1|COMPLETED|Overall Study||79
438271|NCT01401283|1074692|P2|STARTED|Overall Study||91
438272|NCT01401283|1074693|P1|STARTED|Overall Study||89
438273|NCT01401257|1074705|P4|NOT COMPLETED|Overall Study||2
438274|NCT01401257|1074706|P3|NOT COMPLETED|Overall Study||3
438275|NCT01401257|1074707|P2|NOT COMPLETED|Overall Study||2
438276|NCT01401257|1074708|P1|NOT COMPLETED|Overall Study||0
438277|NCT01401257|1074705|P4|COMPLETED|Overall Study||17
438278|NCT01401257|1074706|P3|COMPLETED|Overall Study||16
438279|NCT01401257|1074707|P2|COMPLETED|Overall Study||19
438280|NCT01401257|1074708|P1|COMPLETED|Overall Study||21
438281|NCT01401257|1074705|P4|STARTED|Overall Study||19
438282|NCT01401257|1074706|P3|STARTED|Overall Study||19
438283|NCT01401257|1074707|P2|STARTED|Overall Study||21
438284|NCT01401257|1074708|P1|STARTED|Overall Study||21
438285|NCT01401166|1074720|P4|NOT COMPLETED|Safety Follow-Up Period||19
438286|NCT01401166|1074721|P3|NOT COMPLETED|Safety Follow-Up Period||17
438287|NCT01401166|1074722|P2|NOT COMPLETED|Safety Follow-Up Period||18
438288|NCT01401166|1074723|P1|NOT COMPLETED|Safety Follow-Up Period||25
438289|NCT01401166|1074720|P4|COMPLETED|Safety Follow-Up Period||100
438290|NCT01401166|1074721|P3|COMPLETED|Safety Follow-Up Period||104
438291|NCT01401166|1074722|P2|COMPLETED|Safety Follow-Up Period||106
438292|NCT01401166|1074723|P1|COMPLETED|Safety Follow-Up Period||99
438293|NCT01401166|1074720|P4|STARTED|Safety Follow-Up Period|All 119 randomized participants entered follow-up regardless of whether they received treatment.|119
438294|NCT01401166|1074721|P3|STARTED|Safety Follow-Up Period|All 121 randomized participants entered follow-up regardless of whether they received treatment.|121
438295|NCT01401166|1074722|P2|STARTED|Safety Follow-Up Period|All 124 randomized participants entered follow-up regardless of whether they received treatment.|124
438296|NCT01401166|1074723|P1|STARTED|Safety Follow-Up Period|All 124 randomized participants entered follow-up regardless of whether they received treatment.|124
438297|NCT01401166|1074720|P4|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||3
438298|NCT01401166|1074721|P3|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||2
438299|NCT01401166|1074722|P2|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||7
438300|NCT01401166|1074723|P1|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||4
438301|NCT01401166|1074720|P4|COMPLETED|Continuation Treatment (Cycles 9 to 18)||102
438302|NCT01401166|1074721|P3|COMPLETED|Continuation Treatment (Cycles 9 to 18)||105
438303|NCT01401166|1074722|P2|COMPLETED|Continuation Treatment (Cycles 9 to 18)||109
438304|NCT01401166|1074723|P1|COMPLETED|Continuation Treatment (Cycles 9 to 18)||109
438305|NCT01401166|1074720|P4|STARTED|Continuation Treatment (Cycles 9 to 18)||105
438306|NCT01401166|1074721|P3|STARTED|Continuation Treatment (Cycles 9 to 18)||107
438307|NCT01401166|1074722|P2|STARTED|Continuation Treatment (Cycles 9 to 18)||116
438308|NCT01401166|1074723|P1|STARTED|Continuation Treatment (Cycles 9 to 18)||113
438309|NCT01401166|1074720|P4|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||11
438310|NCT01401166|1074721|P3|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||12
438311|NCT01401166|1074722|P2|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||4
438312|NCT01401166|1074723|P1|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||6
438313|NCT01401166|1074720|P4|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||105
438314|NCT01401166|1074721|P3|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||107
438315|NCT01401166|1074722|P2|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||116
438316|NCT01401166|1074723|P1|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||113
438317|NCT01401166|1074720|P4|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||116
438318|NCT01401166|1074721|P3|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||119
438319|NCT01401166|1074722|P2|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||120
438320|NCT01401166|1074723|P1|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||119
438321|NCT01401166|1074720|P4|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
438322|NCT01401166|1074721|P3|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
438323|NCT01401166|1074722|P2|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
438324|NCT01401166|1074723|P1|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||3
438325|NCT01401166|1074720|P4|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||116
438326|NCT01401166|1074721|P3|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||119
438327|NCT01401166|1074722|P2|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||120
438328|NCT01401166|1074723|P1|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||119
438329|NCT01401166|1074720|P4|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 119 participants were randomized, but 1 did not receive any treatment.|118
438330|NCT01401166|1074721|P3|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 121 participants were randomized who all received study treatment.|121
438331|NCT01401166|1074722|P2|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 124 participants were randomized, but 2 did not receive any treatment.|122
438332|NCT01401166|1074723|P1|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 124 participants were randomized, but 2 did not receive any treatment.|122
438333|NCT01401153|1074759|P2|NOT COMPLETED|Second Test Day||5
438334|NCT01401153|1074760|P1|NOT COMPLETED|Second Test Day||0
438335|NCT01401153|1074759|P2|COMPLETED|Second Test Day||60
438336|NCT01401153|1074760|P1|COMPLETED|Second Test Day||45
438337|NCT01401153|1074759|P2|STARTED|Second Test Day||65
438338|NCT01401153|1074760|P1|STARTED|Second Test Day||45
438339|NCT01401153|1074759|P2|NOT COMPLETED|First Test Day||10
438340|NCT01401153|1074760|P1|NOT COMPLETED|First Test Day||1
438341|NCT01401153|1074759|P2|COMPLETED|First Test Day||45
438342|NCT01401153|1074760|P1|COMPLETED|First Test Day||65
438343|NCT01401153|1074759|P2|STARTED|First Test Day||55
438344|NCT01401153|1074760|P1|STARTED|First Test Day||66
438345|NCT01401101|1074794|P2|NOT COMPLETED|Overall Study||27
438346|NCT01401101|1074795|P1|NOT COMPLETED|Overall Study||22
438347|NCT01401101|1074794|P2|COMPLETED|Overall Study||171
438348|NCT01401101|1074795|P1|COMPLETED|Overall Study||184
438349|NCT01401101|1074794|P2|STARTED|Overall Study||198
438350|NCT01401101|1074795|P1|STARTED|Overall Study||206
438351|NCT01401062|1074807|P2|NOT COMPLETED|Overall Study||8
438352|NCT01401062|1074808|P1|NOT COMPLETED|Overall Study||11
438353|NCT01401062|1074807|P2|COMPLETED|Overall Study|At time of data entry, these 4 patients are still undergoing follow-up|4
438354|NCT01401062|1074808|P1|COMPLETED|Overall Study||0
438355|NCT01401062|1074807|P2|STARTED|Overall Study||12
438356|NCT01401062|1074808|P1|STARTED|Overall Study||11
438357|NCT01401049|1074816|P2|NOT COMPLETED|Overall Study||0
438358|NCT01401049|1074817|P1|NOT COMPLETED|Overall Study||0
438359|NCT01401049|1074816|P2|COMPLETED|Overall Study||0
438360|NCT01401049|1074817|P1|COMPLETED|Overall Study||0
438361|NCT01401049|1074816|P2|STARTED|Overall Study|Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|0
438362|NCT01401049|1074817|P1|STARTED|Overall Study|Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|0
438363|NCT01401023|1074825|P1|NOT COMPLETED|Overall Study||0
438364|NCT01401023|1074825|P1|COMPLETED|Overall Study||10
438365|NCT01401023|1074825|P1|STARTED|Overall Study||10
438366|NCT01401010|1074835|P2|NOT COMPLETED|Overall Study||0
438367|NCT01401010|1074836|P1|NOT COMPLETED|Overall Study||1
438368|NCT01401010|1074835|P2|COMPLETED|Overall Study||6
438369|NCT01401010|1074836|P1|COMPLETED|Overall Study||5
438370|NCT01401010|1074835|P2|STARTED|Overall Study||6
438371|NCT01401010|1074836|P1|STARTED|Overall Study||6
438372|NCT01400958|1074861|P2|NOT COMPLETED|Overall Study||2
438373|NCT01400958|1074862|P1|NOT COMPLETED|Overall Study||1
438374|NCT01400958|1074861|P2|COMPLETED|Overall Study||1
438375|NCT01400958|1074862|P1|COMPLETED|Overall Study||2
438376|NCT01400958|1074861|P2|STARTED|Overall Study||3
438377|NCT01400958|1074862|P1|STARTED|Overall Study||3
438378|NCT01400932|1074872|P2|NOT COMPLETED|Overall Study||15
438379|NCT01400932|1074873|P1|NOT COMPLETED|Overall Study||14
438380|NCT01400932|1074872|P2|COMPLETED|Overall Study||167
438381|NCT01400932|1074873|P1|COMPLETED|Overall Study||164
438382|NCT01400932|1074872|P2|STARTED|Overall Study||182
438383|NCT01400932|1074873|P1|STARTED|Overall Study||178
438384|NCT01400919|1074895|P1|NOT COMPLETED|Overall Study||8
438385|NCT01400919|1074895|P1|COMPLETED|Overall Study||67
438386|NCT01400919|1074895|P1|STARTED|Overall Study||75
438387|NCT01400906|1074899|P6|NOT COMPLETED|Treatment Period 3||0
438388|NCT01400906|1074900|P5|NOT COMPLETED|Treatment Period 3||0
438389|NCT01400906|1074901|P4|NOT COMPLETED|Treatment Period 3||0
438390|NCT01400906|1074902|P3|NOT COMPLETED|Treatment Period 3||0
438391|NCT01400906|1074903|P2|NOT COMPLETED|Treatment Period 3||0
438392|NCT01400906|1074904|P1|NOT COMPLETED|Treatment Period 3||0
438393|NCT01400906|1074899|P6|COMPLETED|Treatment Period 3||5
438394|NCT01400906|1074900|P5|COMPLETED|Treatment Period 3||6
438395|NCT01400906|1074901|P4|COMPLETED|Treatment Period 3||6
438396|NCT01400906|1074902|P3|COMPLETED|Treatment Period 3||6
438397|NCT01400906|1074903|P2|COMPLETED|Treatment Period 3||6
438398|NCT01400906|1074904|P1|COMPLETED|Treatment Period 3||6
438399|NCT01400906|1074899|P6|STARTED|Treatment Period 3||5
438400|NCT01400906|1074900|P5|STARTED|Treatment Period 3||6
438401|NCT01400906|1074901|P4|STARTED|Treatment Period 3||6
438402|NCT01400906|1074902|P3|STARTED|Treatment Period 3||6
438403|NCT01400906|1074903|P2|STARTED|Treatment Period 3||6
438404|NCT01400906|1074904|P1|STARTED|Treatment Period 3||6
438405|NCT01400906|1074899|P6|NOT COMPLETED|Washout Period 2||0
438406|NCT01400906|1074900|P5|NOT COMPLETED|Washout Period 2||0
438407|NCT01400906|1074901|P4|NOT COMPLETED|Washout Period 2||0
438408|NCT01400906|1074902|P3|NOT COMPLETED|Washout Period 2||0
438409|NCT01400906|1074903|P2|NOT COMPLETED|Washout Period 2||0
438410|NCT01400906|1074904|P1|NOT COMPLETED|Washout Period 2||0
438411|NCT01400906|1074899|P6|COMPLETED|Washout Period 2||5
438412|NCT01400906|1074900|P5|COMPLETED|Washout Period 2||6
438413|NCT01400906|1074901|P4|COMPLETED|Washout Period 2||6
438414|NCT01400906|1074902|P3|COMPLETED|Washout Period 2||6
438415|NCT01400906|1074903|P2|COMPLETED|Washout Period 2||6
438416|NCT01400906|1074904|P1|COMPLETED|Washout Period 2||6
438417|NCT01400906|1074899|P6|STARTED|Washout Period 2||5
438418|NCT01400906|1074900|P5|STARTED|Washout Period 2||6
438419|NCT01400906|1074901|P4|STARTED|Washout Period 2||6
438420|NCT01400906|1074902|P3|STARTED|Washout Period 2||6
438421|NCT01400906|1074903|P2|STARTED|Washout Period 2||6
438422|NCT01400906|1074904|P1|STARTED|Washout Period 2||6
438423|NCT01400906|1074899|P6|NOT COMPLETED|Treatment Period 2||0
438424|NCT01400906|1074900|P5|NOT COMPLETED|Treatment Period 2||0
438425|NCT01400906|1074901|P4|NOT COMPLETED|Treatment Period 2||0
438426|NCT01400906|1074902|P3|NOT COMPLETED|Treatment Period 2||0
438427|NCT01400906|1074903|P2|NOT COMPLETED|Treatment Period 2||0
438428|NCT01400906|1074904|P1|NOT COMPLETED|Treatment Period 2||0
438429|NCT01400906|1074899|P6|COMPLETED|Treatment Period 2||5
438430|NCT01400906|1074900|P5|COMPLETED|Treatment Period 2||6
438431|NCT01400906|1074901|P4|COMPLETED|Treatment Period 2||6
438432|NCT01400906|1074902|P3|COMPLETED|Treatment Period 2||6
438433|NCT01400906|1074903|P2|COMPLETED|Treatment Period 2||6
438434|NCT01400906|1074904|P1|COMPLETED|Treatment Period 2||6
438435|NCT01400906|1074899|P6|STARTED|Treatment Period 2||5
438436|NCT01400906|1074900|P5|STARTED|Treatment Period 2||6
438437|NCT01400906|1074901|P4|STARTED|Treatment Period 2||6
438438|NCT01400906|1074902|P3|STARTED|Treatment Period 2||6
438439|NCT01400906|1074903|P2|STARTED|Treatment Period 2||6
438440|NCT01400906|1074904|P1|STARTED|Treatment Period 2||6
438441|NCT01400906|1074899|P6|NOT COMPLETED|Washout Period 1||0
438442|NCT01400906|1074900|P5|NOT COMPLETED|Washout Period 1||0
438443|NCT01400906|1074901|P4|NOT COMPLETED|Washout Period 1||0
438444|NCT01400906|1074902|P3|NOT COMPLETED|Washout Period 1||0
438445|NCT01400906|1074903|P2|NOT COMPLETED|Washout Period 1||0
438446|NCT01400906|1074904|P1|NOT COMPLETED|Washout Period 1||0
438447|NCT01400906|1074899|P6|COMPLETED|Washout Period 1||5
438448|NCT01400906|1074900|P5|COMPLETED|Washout Period 1||6
438449|NCT01400906|1074901|P4|COMPLETED|Washout Period 1||6
438450|NCT01400906|1074902|P3|COMPLETED|Washout Period 1||6
438451|NCT01400906|1074903|P2|COMPLETED|Washout Period 1||6
438452|NCT01400906|1074904|P1|COMPLETED|Washout Period 1||6
438453|NCT01400906|1074899|P6|STARTED|Washout Period 1||5
438454|NCT01400906|1074900|P5|STARTED|Washout Period 1||6
438455|NCT01400906|1074901|P4|STARTED|Washout Period 1||6
438456|NCT01400906|1074902|P3|STARTED|Washout Period 1||6
438457|NCT01400906|1074903|P2|STARTED|Washout Period 1||6
438458|NCT01400906|1074904|P1|STARTED|Washout Period 1||6
438459|NCT01400906|1074899|P6|NOT COMPLETED|Treatment Period 1||0
438460|NCT01400906|1074900|P5|NOT COMPLETED|Treatment Period 1||0
438461|NCT01400906|1074901|P4|NOT COMPLETED|Treatment Period 1||0
438462|NCT01400906|1074902|P3|NOT COMPLETED|Treatment Period 1||0
438463|NCT01400906|1074903|P2|NOT COMPLETED|Treatment Period 1||0
438464|NCT01400906|1074904|P1|NOT COMPLETED|Treatment Period 1||0
438465|NCT01400906|1074899|P6|COMPLETED|Treatment Period 1||5
438466|NCT01400906|1074900|P5|COMPLETED|Treatment Period 1||6
438467|NCT01400906|1074901|P4|COMPLETED|Treatment Period 1||6
438468|NCT01400906|1074902|P3|COMPLETED|Treatment Period 1||6
438469|NCT01400906|1074903|P2|COMPLETED|Treatment Period 1||6
438470|NCT01400906|1074904|P1|COMPLETED|Treatment Period 1||6
438471|NCT01400906|1074899|P6|STARTED|Treatment Period 1||5
438472|NCT01400906|1074900|P5|STARTED|Treatment Period 1||6
438473|NCT01400906|1074901|P4|STARTED|Treatment Period 1||6
438474|NCT01400906|1074902|P3|STARTED|Treatment Period 1||6
438475|NCT01400906|1074903|P2|STARTED|Treatment Period 1||6
438476|NCT01400906|1074904|P1|STARTED|Treatment Period 1||6
438477|NCT01400893|1074938|P2|NOT COMPLETED|Overall Study||27
438478|NCT01400893|1074939|P1|NOT COMPLETED|Overall Study||27
438479|NCT01400893|1074938|P2|COMPLETED|Overall Study||38
438480|NCT01400893|1074939|P1|COMPLETED|Overall Study||42
438481|NCT01400893|1074938|P2|STARTED|Overall Study||65
438482|NCT01400893|1074939|P1|STARTED|Overall Study||69
438483|NCT01400880|1074947|P1|NOT COMPLETED|Overall Study||2
438484|NCT01400880|1074947|P1|COMPLETED|Overall Study|patients were added throughout the study. There was not a set number of patients that we began with|101
438485|NCT01400880|1074947|P1|STARTED|Overall Study|patients were added throughout the study. There was not a set number of patients that we began with|103
438486|NCT01400841|1074951|P1|NOT COMPLETED|Extended Study Phase (2 Years)||2
438487|NCT01400841|1074951|P1|COMPLETED|Extended Study Phase (2 Years)||11
438488|NCT01400841|1074951|P1|STARTED|Extended Study Phase (2 Years)|"1 subject refused further participation~1 subject death prior to agreeing to extended follow-up"|13
438489|NCT01400841|1074951|P1|NOT COMPLETED|Initial Study Phase (6 Months)||1
438490|NCT01400841|1074951|P1|COMPLETED|Initial Study Phase (6 Months)||15
438491|NCT01400841|1074951|P1|STARTED|Initial Study Phase (6 Months)|2 of the 18 consented subjects did not receive the device|16
438492|NCT01400698|1074989|P6|NOT COMPLETED|Overall Study||6
438493|NCT01400698|1074990|P5|NOT COMPLETED|Overall Study||7
438494|NCT01400698|1074991|P4|NOT COMPLETED|Overall Study||8
438495|NCT01400698|1074992|P3|NOT COMPLETED|Overall Study||2
438496|NCT01400698|1074993|P2|NOT COMPLETED|Overall Study||11
438497|NCT01400698|1074994|P1|NOT COMPLETED|Overall Study||15
438498|NCT01400698|1074989|P6|COMPLETED|Overall Study||9
438499|NCT01400698|1074990|P5|COMPLETED|Overall Study||7
438500|NCT01400698|1074991|P4|COMPLETED|Overall Study||6
438501|NCT01400698|1074992|P3|COMPLETED|Overall Study||0
438502|NCT01400698|1074993|P2|COMPLETED|Overall Study||12
438503|NCT01400698|1074994|P1|COMPLETED|Overall Study||8
438504|NCT01400698|1074989|P6|STARTED|Overall Study||15
438505|NCT01400698|1074990|P5|STARTED|Overall Study||14
438506|NCT01400698|1074991|P4|STARTED|Overall Study||14
438507|NCT01400698|1074992|P3|STARTED|Overall Study||2
438508|NCT01400698|1074993|P2|STARTED|Overall Study||23
438509|NCT01400698|1074994|P1|STARTED|Overall Study||23
438510|NCT01400516|1075018|P2|NOT COMPLETED|Extension Trial||0
438511|NCT01400516|1075019|P1|NOT COMPLETED|Extension Trial||0
438512|NCT01400516|1075018|P2|COMPLETED|Extension Trial||7
438513|NCT01400516|1075019|P1|COMPLETED|Extension Trial||6
438514|NCT01400516|1075018|P2|STARTED|Extension Trial|Only 7 participants in the Teriparatide arm entered the Extension Trial.|7
438515|NCT01400516|1075019|P1|STARTED|Extension Trial|Only 6 participants in the Control arm entered the Extension Trial.|6
438516|NCT01400516|1075018|P2|NOT COMPLETED|Primary Trial||2
438517|NCT01400516|1075019|P1|NOT COMPLETED|Primary Trial||0
438518|NCT01400516|1075018|P2|COMPLETED|Primary Trial||12
438519|NCT01400516|1075019|P1|COMPLETED|Primary Trial||12
438520|NCT01400516|1075018|P2|STARTED|Primary Trial||14
438521|NCT01400516|1075019|P1|STARTED|Primary Trial||12
438522|NCT01400503|1075029|P1|NOT COMPLETED|Overall Study||60
438523|NCT01400503|1075029|P1|COMPLETED|Overall Study||0
438524|NCT01400503|1075029|P1|STARTED|Overall Study||60
438525|NCT01400451|1075041|P3|NOT COMPLETED|Combination Treatment (or Intended)||2
438526|NCT01400451|1075042|P2|NOT COMPLETED|Combination Treatment (or Intended)||4
438527|NCT01400451|1075043|P1|NOT COMPLETED|Combination Treatment (or Intended)||6
438528|NCT01400451|1075041|P3|COMPLETED|Combination Treatment (or Intended)||0
438529|NCT01400451|1075042|P2|COMPLETED|Combination Treatment (or Intended)||0
438530|NCT01400451|1075043|P1|COMPLETED|Combination Treatment (or Intended)||0
438531|NCT01400451|1075041|P3|STARTED|Combination Treatment (or Intended)|Did not start Ipilimumab but remained on vemurafenib alone.|2
438532|NCT01400451|1075042|P2|STARTED|Combination Treatment (or Intended)||4
438533|NCT01400451|1075043|P1|STARTED|Combination Treatment (or Intended)||6
438534|NCT01400451|1075041|P3|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
438535|NCT01400451|1075042|P2|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
438536|NCT01400451|1075043|P1|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
438537|NCT01400451|1075041|P3|COMPLETED|28 Day Lead In With Vemurafenib Alone||2
438538|NCT01400451|1075042|P2|COMPLETED|28 Day Lead In With Vemurafenib Alone||4
438539|NCT01400451|1075043|P1|COMPLETED|28 Day Lead In With Vemurafenib Alone||6
438540|NCT01400451|1075041|P3|STARTED|28 Day Lead In With Vemurafenib Alone||2
438541|NCT01400451|1075042|P2|STARTED|28 Day Lead In With Vemurafenib Alone||4
438542|NCT01400451|1075043|P1|STARTED|28 Day Lead In With Vemurafenib Alone||6
438543|NCT01400425|1075057|P1|NOT COMPLETED|Overall Study||10
438544|NCT01400425|1075057|P1|COMPLETED|Overall Study||229
438545|NCT01400425|1075057|P1|STARTED|Overall Study||239
438546|NCT01400412|1075070|P2|NOT COMPLETED|Overall Study||17
438547|NCT01400412|1075071|P1|NOT COMPLETED|Overall Study||10
438548|NCT01400412|1075070|P2|COMPLETED|Overall Study||115
438549|NCT01400412|1075071|P1|COMPLETED|Overall Study||120
438550|NCT01400412|1075070|P2|STARTED|Overall Study||132
438551|NCT01400412|1075071|P1|STARTED|Overall Study||130
438552|NCT01400243|1075117|P2|NOT COMPLETED|Overall Study||11
438553|NCT01400243|1075118|P1|NOT COMPLETED|Overall Study||8
438554|NCT01400243|1075117|P2|COMPLETED|Overall Study||52
438555|NCT01400243|1075118|P1|COMPLETED|Overall Study||56
438556|NCT01400243|1075117|P2|STARTED|Overall Study||63
438557|NCT01400243|1075118|P1|STARTED|Overall Study||64
438558|NCT01400139|1075140|P1|NOT COMPLETED|HYD Extension Period||23
438559|NCT01400139|1075140|P1|COMPLETED|HYD Extension Period||83
438560|NCT01400139|1075140|P1|STARTED|HYD Extension Period|Subjects completing the Core Study were offered an option to enter the 24-week open-label Extension|106
438561|NCT01400139|1075140|P1|NOT COMPLETED|HYD Core Study||512
438562|NCT01400139|1075140|P1|COMPLETED|HYD Core Study||410
438563|NCT01400139|1075140|P1|STARTED|HYD Core Study||922
438564|NCT01400113|1075150|P2|NOT COMPLETED|Overall Study||1
438565|NCT01400113|1075151|P1|NOT COMPLETED|Overall Study||1
438566|NCT01400113|1075150|P2|COMPLETED|Overall Study||59
438567|NCT01400113|1075151|P1|COMPLETED|Overall Study||59
438568|NCT01400113|1075150|P2|STARTED|Overall Study||60
438569|NCT01400113|1075151|P1|STARTED|Overall Study||60
438570|NCT01399866|1075159|P2|NOT COMPLETED|Overall Study||2
438571|NCT01399866|1075160|P1|NOT COMPLETED|Overall Study||4
438572|NCT01399866|1075159|P2|COMPLETED|Overall Study||28
438573|NCT01399866|1075160|P1|COMPLETED|Overall Study||28
438574|NCT01399866|1075159|P2|STARTED|Overall Study||30
438575|NCT01399866|1075160|P1|STARTED|Overall Study||32
438576|NCT01399788|1075176|P2|NOT COMPLETED|Second Intervention Period||0
438577|NCT01399788|1075177|P1|NOT COMPLETED|Second Intervention Period||0
438578|NCT01399788|1075176|P2|COMPLETED|Second Intervention Period||18
438579|NCT01399788|1075177|P1|COMPLETED|Second Intervention Period||17
438580|NCT01399788|1075176|P2|STARTED|Second Intervention Period||18
438581|NCT01399788|1075177|P1|STARTED|Second Intervention Period||17
438582|NCT01399788|1075176|P2|NOT COMPLETED|Washout Period (at Least 1 Week)||0
438583|NCT01399788|1075177|P1|NOT COMPLETED|Washout Period (at Least 1 Week)||0
438584|NCT01399788|1075176|P2|COMPLETED|Washout Period (at Least 1 Week)||18
438585|NCT01399788|1075177|P1|COMPLETED|Washout Period (at Least 1 Week)||17
438586|NCT01399788|1075176|P2|STARTED|Washout Period (at Least 1 Week)||18
438587|NCT01399788|1075177|P1|STARTED|Washout Period (at Least 1 Week)||17
438588|NCT01399788|1075176|P2|NOT COMPLETED|First Intervention Period||0
438589|NCT01399788|1075177|P1|NOT COMPLETED|First Intervention Period||1
438590|NCT01399788|1075176|P2|COMPLETED|First Intervention Period||18
438591|NCT01399788|1075177|P1|COMPLETED|First Intervention Period||17
438592|NCT01399788|1075176|P2|STARTED|First Intervention Period||18
438593|NCT01399788|1075177|P1|STARTED|First Intervention Period||18
438594|NCT01399723|1075199|P2|NOT COMPLETED|Overall Study||1
438595|NCT01399723|1075200|P1|NOT COMPLETED|Overall Study||0
438596|NCT01399723|1075199|P2|COMPLETED|Overall Study||263
438597|NCT01399723|1075200|P1|COMPLETED|Overall Study||263
438598|NCT01399723|1075199|P2|STARTED|Overall Study||264
438599|NCT01399723|1075200|P1|STARTED|Overall Study||263
438600|NCT01399697|1075213|P3|NOT COMPLETED|Overall Study||4
438601|NCT01399697|1075214|P2|NOT COMPLETED|Overall Study||3
438602|NCT01399697|1075215|P1|NOT COMPLETED|Overall Study||41
438603|NCT01399697|1075213|P3|COMPLETED|Overall Study||78
438604|NCT01399697|1075214|P2|COMPLETED|Overall Study||80
438605|NCT01399697|1075215|P1|COMPLETED|Overall Study||55
438606|NCT01399697|1075213|P3|STARTED|Overall Study||82
438607|NCT01399697|1075214|P2|STARTED|Overall Study||83
438608|NCT01399697|1075215|P1|STARTED|Overall Study||96
438609|NCT01399619|1075242|P4|NOT COMPLETED|Overall Study||17
438610|NCT01399619|1075243|P3|NOT COMPLETED|Overall Study||12
438611|NCT01399619|1075244|P2|NOT COMPLETED|Overall Study||0
438612|NCT01399619|1075245|P1|NOT COMPLETED|Overall Study||25
438613|NCT01399619|1075242|P4|COMPLETED|Overall Study||0
438614|NCT01399619|1075243|P3|COMPLETED|Overall Study||74
438615|NCT01399619|1075244|P2|COMPLETED|Overall Study||84
438616|NCT01399619|1075245|P1|COMPLETED|Overall Study||98
438617|NCT01399619|1075242|P4|STARTED|Overall Study||17
438618|NCT01399619|1075243|P3|STARTED|Overall Study||86
438619|NCT01399619|1075244|P2|STARTED|Overall Study||84
438620|NCT01399619|1075245|P1|STARTED|Overall Study||123
438621|NCT01399593|1075308|P2|NOT COMPLETED|Overall Study||2
438622|NCT01399593|1075309|P1|NOT COMPLETED|Overall Study||3
438623|NCT01399593|1075308|P2|COMPLETED|Overall Study||49
438624|NCT01399593|1075309|P1|COMPLETED|Overall Study||48
438625|NCT01399593|1075308|P2|STARTED|Overall Study||51
438626|NCT01399593|1075309|P1|STARTED|Overall Study||51
438627|NCT01399268|1075317|P2|NOT COMPLETED|Overall Study||0
438628|NCT01399268|1075318|P1|NOT COMPLETED|Overall Study||0
438629|NCT01399268|1075317|P2|COMPLETED|Overall Study||15
438630|NCT01399268|1075318|P1|COMPLETED|Overall Study||15
438631|NCT01399268|1075317|P2|STARTED|Overall Study||15
438632|NCT01399268|1075318|P1|STARTED|Overall Study||15
438633|NCT01399229|1075336|P3|NOT COMPLETED|Overall Study||0
438634|NCT01399229|1075337|P2|NOT COMPLETED|Overall Study||0
438635|NCT01399229|1075338|P1|NOT COMPLETED|Overall Study||0
438636|NCT01399229|1075336|P3|COMPLETED|Overall Study||5
438637|NCT01399229|1075337|P2|COMPLETED|Overall Study||5
438638|NCT01399229|1075338|P1|COMPLETED|Overall Study||20
438639|NCT01399229|1075336|P3|STARTED|Overall Study||5
438640|NCT01399229|1075337|P2|STARTED|Overall Study||5
438641|NCT01399229|1075338|P1|STARTED|Overall Study||20
438642|NCT01399190|1075342|P1|NOT COMPLETED|Overall Study||20
438643|NCT01399190|1075342|P1|COMPLETED|Overall Study||48
438644|NCT01399190|1075342|P1|Evaluable for Primary Endpoint Analysis|Overall Study||60
438645|NCT01399190|1075342|P1|Included in Final Analysis|Overall Study||63
438646|NCT01399190|1075342|P1|STARTED|Overall Study||68
438647|NCT01399125|1075350|P2|NOT COMPLETED|Overall Study||60
438648|NCT01399125|1075351|P1|NOT COMPLETED|Overall Study||51
438649|NCT01399125|1075350|P2|COMPLETED|Overall Study||193
438650|NCT01399125|1075351|P1|COMPLETED|Overall Study||197
438651|NCT01399125|1075350|P2|Per Protocol (PP) Population|Overall Study||188
438652|NCT01399125|1075351|P1|Per Protocol (PP) Population|Overall Study||192
438653|NCT01399125|1075350|P2|STARTED|Overall Study||253
438654|NCT01399125|1075351|P1|STARTED|Overall Study||248
438655|NCT01399099|1075365|P1|NOT COMPLETED|Overall Study||31
438656|NCT01399099|1075365|P1|COMPLETED|Overall Study||36
438657|NCT01399099|1075365|P1|6 Months|Overall Study||47
438658|NCT01399099|1075365|P1|STARTED|Overall Study||67
438659|NCT01399047|1075372|P2|NOT COMPLETED|Overall Study||1
438660|NCT01399047|1075373|P1|NOT COMPLETED|Overall Study||0
438661|NCT01399047|1075372|P2|COMPLETED|Overall Study||8
438662|NCT01399047|1075373|P1|COMPLETED|Overall Study||10
438663|NCT01399047|1075372|P2|STARTED|Overall Study||9
438664|NCT01399047|1075373|P1|STARTED|Overall Study||10
438665|NCT01399008|1075382|P3|NOT COMPLETED|Overall Study||2
438666|NCT01399008|1075383|P2|NOT COMPLETED|Overall Study||5
438667|NCT01399008|1075384|P1|NOT COMPLETED|Overall Study||3
438668|NCT01399008|1075382|P3|COMPLETED|Overall Study||31
438669|NCT01399008|1075383|P2|COMPLETED|Overall Study||27
438670|NCT01399008|1075384|P1|COMPLETED|Overall Study||32
438671|NCT01399008|1075382|P3|STARTED|Overall Study||33
438672|NCT01399008|1075383|P2|STARTED|Overall Study||32
438673|NCT01399008|1075384|P1|STARTED|Overall Study||35
438674|NCT01398982|1075394|P2|NOT COMPLETED|Overall Study||2
438675|NCT01398982|1075395|P1|NOT COMPLETED|Overall Study||6
438676|NCT01398982|1075394|P2|COMPLETED|Overall Study||47
438677|NCT01398982|1075395|P1|COMPLETED|Overall Study||38
438678|NCT01398982|1075394|P2|STARTED|Overall Study||49
438679|NCT01398982|1075395|P1|STARTED|Overall Study||44
438680|NCT01398956|1075401|P1|NOT COMPLETED|Overall Study||10
438681|NCT01398956|1075401|P1|COMPLETED|Overall Study||34
438682|NCT01398956|1075401|P1|STARTED|Overall Study||44
438683|NCT01398943|1075409|P4|NOT COMPLETED|Second Intervention (1 Day)||0
438684|NCT01398943|1075410|P3|NOT COMPLETED|Second Intervention (1 Day)||0
438685|NCT01398943|1075411|P2|NOT COMPLETED|Second Intervention (1 Day)||0
438686|NCT01398943|1075412|P1|NOT COMPLETED|Second Intervention (1 Day)||0
438687|NCT01398943|1075409|P4|COMPLETED|Second Intervention (1 Day)||15
438688|NCT01398943|1075410|P3|COMPLETED|Second Intervention (1 Day)||15
438689|NCT01398943|1075411|P2|COMPLETED|Second Intervention (1 Day)||15
438690|NCT01398943|1075412|P1|COMPLETED|Second Intervention (1 Day)||15
438691|NCT01398943|1075409|P4|STARTED|Second Intervention (1 Day)||15
438692|NCT01398943|1075410|P3|STARTED|Second Intervention (1 Day)||15
438693|NCT01398943|1075411|P2|STARTED|Second Intervention (1 Day)||15
438694|NCT01398943|1075412|P1|STARTED|Second Intervention (1 Day)||15
438695|NCT01398943|1075409|P4|NOT COMPLETED|Washout (2-7 Days)||0
438696|NCT01398943|1075410|P3|NOT COMPLETED|Washout (2-7 Days)||0
438697|NCT01398943|1075411|P2|NOT COMPLETED|Washout (2-7 Days)||0
438698|NCT01398943|1075412|P1|NOT COMPLETED|Washout (2-7 Days)||0
438699|NCT01398943|1075409|P4|COMPLETED|Washout (2-7 Days)||15
438700|NCT01398943|1075410|P3|COMPLETED|Washout (2-7 Days)||15
438701|NCT01398943|1075411|P2|COMPLETED|Washout (2-7 Days)||15
438702|NCT01398943|1075412|P1|COMPLETED|Washout (2-7 Days)||15
438703|NCT01398943|1075409|P4|STARTED|Washout (2-7 Days)||15
438704|NCT01398943|1075410|P3|STARTED|Washout (2-7 Days)||15
438705|NCT01398943|1075411|P2|STARTED|Washout (2-7 Days)||15
438706|NCT01398943|1075412|P1|STARTED|Washout (2-7 Days)||15
438707|NCT01398943|1075409|P4|NOT COMPLETED|First Intervention (1 Day)||0
438708|NCT01398943|1075410|P3|NOT COMPLETED|First Intervention (1 Day)||0
438709|NCT01398943|1075411|P2|NOT COMPLETED|First Intervention (1 Day)||0
438710|NCT01398943|1075412|P1|NOT COMPLETED|First Intervention (1 Day)||0
438711|NCT01398943|1075409|P4|COMPLETED|First Intervention (1 Day)||15
438712|NCT01398943|1075410|P3|COMPLETED|First Intervention (1 Day)||15
438713|NCT01398943|1075411|P2|COMPLETED|First Intervention (1 Day)||15
438714|NCT01398943|1075412|P1|COMPLETED|First Intervention (1 Day)||15
438715|NCT01398943|1075409|P4|STARTED|First Intervention (1 Day)||15
438716|NCT01398943|1075410|P3|STARTED|First Intervention (1 Day)||15
438717|NCT01398943|1075411|P2|STARTED|First Intervention (1 Day)||15
438718|NCT01398943|1075412|P1|STARTED|First Intervention (1 Day)||15
438719|NCT01398852|1075420|P1|NOT COMPLETED|Overall Study||372
438720|NCT01398852|1075420|P1|COMPLETED|Overall Study||0
438721|NCT01398852|1075420|P1|STARTED|Overall Study|Due to termination of the study the exact number of participants enrolled is unknown at this time.|372
438722|NCT01398839|1075426|P2|NOT COMPLETED|Overall Study||0
438723|NCT01398839|1075427|P1|NOT COMPLETED|Overall Study||0
438724|NCT01398839|1075426|P2|COMPLETED|Overall Study|The study was terminated. The exact number of patients completing all visits is unknown.|37
438725|NCT01398839|1075427|P1|COMPLETED|Overall Study|The study was terminated. The exact number of patients completing all visits is unknown.|35
438726|NCT01398839|1075426|P2|STARTED|Overall Study||37
438727|NCT01398839|1075427|P1|STARTED|Overall Study||35
438728|NCT01398787|1075433|P1|NOT COMPLETED|Overall Study||1
438729|NCT01398787|1075433|P1|COMPLETED|Overall Study||197
438730|NCT01398787|1075433|P1|STARTED|Overall Study||198
438731|NCT01398514|1075451|P2|NOT COMPLETED|Overall Study||6
438732|NCT01398514|1075452|P1|NOT COMPLETED|Overall Study||8
438733|NCT01398514|1075451|P2|COMPLETED|Overall Study||20
438734|NCT01398514|1075452|P1|COMPLETED|Overall Study||18
438735|NCT01398514|1075451|P2|STARTED|Overall Study||26
438736|NCT01398514|1075452|P1|STARTED|Overall Study||26
438737|NCT01398475|1075464|P4|NOT COMPLETED|Overall Study||0
438738|NCT01398475|1075465|P3|NOT COMPLETED|Overall Study||0
438739|NCT01398475|1075466|P2|NOT COMPLETED|Overall Study||0
438740|NCT01398475|1075467|P1|NOT COMPLETED|Overall Study||0
438741|NCT01398475|1075464|P4|COMPLETED|Overall Study||4
438742|NCT01398475|1075465|P3|COMPLETED|Overall Study||4
438743|NCT01398475|1075466|P2|COMPLETED|Overall Study||3
438744|NCT01398475|1075467|P1|COMPLETED|Overall Study||4
438745|NCT01398475|1075464|P4|Received Fourth Intervention|Overall Study||4
438746|NCT01398475|1075465|P3|Received Fourth Intervention|Overall Study||4
438747|NCT01398475|1075466|P2|Received Fourth Intervention|Overall Study||3
438748|NCT01398475|1075467|P1|Received Fourth Intervention|Overall Study||4
438749|NCT01398475|1075464|P4|Received Third Intervention|Overall Study||4
438750|NCT01398475|1075465|P3|Received Third Intervention|Overall Study||4
438751|NCT01398475|1075466|P2|Received Third Intervention|Overall Study||3
438752|NCT01398475|1075467|P1|Received Third Intervention|Overall Study||4
438753|NCT01398475|1075464|P4|Received Second Intervention|Overall Study||4
438754|NCT01398475|1075465|P3|Received Second Intervention|Overall Study||4
438755|NCT01398475|1075466|P2|Received Second Intervention|Overall Study||3
438756|NCT01398475|1075467|P1|Received Second Intervention|Overall Study||4
438757|NCT01398475|1075464|P4|Received First Intervention|Overall Study||4
438758|NCT01398475|1075465|P3|Received First Intervention|Overall Study||4
438759|NCT01398475|1075466|P2|Received First Intervention|Overall Study||3
438760|NCT01398475|1075467|P1|Received First Intervention|Overall Study||4
438761|NCT01398475|1075464|P4|STARTED|Overall Study||4
438762|NCT01398475|1075465|P3|STARTED|Overall Study||4
438763|NCT01398475|1075466|P2|STARTED|Overall Study||3
438764|NCT01398475|1075467|P1|STARTED|Overall Study||4
438765|NCT01398410|1075487|P2|NOT COMPLETED|Overall Study||56
438766|NCT01398410|1075488|P1|NOT COMPLETED|Overall Study||58
438767|NCT01398410|1075487|P2|COMPLETED|Overall Study||148
438768|NCT01398410|1075488|P1|COMPLETED|Overall Study||143
438769|NCT01398410|1075487|P2|STARTED|Overall Study||204
438770|NCT01398410|1075488|P1|STARTED|Overall Study|Treated participants (all participants who received at least one dose of rabeprazole).|201
438771|NCT01398358|1075499|P3|NOT COMPLETED|Overall Study||21
438772|NCT01398358|1075500|P2|NOT COMPLETED|Overall Study||23
438773|NCT01398358|1075501|P1|NOT COMPLETED|Overall Study||15
438774|NCT01398358|1075499|P3|COMPLETED|Overall Study||234
438775|NCT01398358|1075500|P2|COMPLETED|Overall Study||201
438776|NCT01398358|1075501|P1|COMPLETED|Overall Study||203
438777|NCT01398358|1075499|P3|STARTED|Overall Study||255
438778|NCT01398358|1075500|P2|STARTED|Overall Study||224
438779|NCT01398358|1075501|P1|STARTED|Overall Study||218
438780|NCT01398176|1075514|P2|NOT COMPLETED|Overall Study||6
438781|NCT01398176|1075515|P1|NOT COMPLETED|Overall Study||3
438782|NCT01398176|1075514|P2|COMPLETED|Overall Study||19
438783|NCT01398176|1075515|P1|COMPLETED|Overall Study||23
438784|NCT01398176|1075514|P2|STARTED|Overall Study||25
438785|NCT01398176|1075515|P1|STARTED|Overall Study||26
438786|NCT01397890|1075523|P2|NOT COMPLETED|Overall Study||31
438787|NCT01397890|1075524|P1|NOT COMPLETED|Overall Study||23
438788|NCT01397890|1075523|P2|COMPLETED|Overall Study||260
438789|NCT01397890|1075524|P1|COMPLETED|Overall Study||264
438790|NCT01397890|1075523|P2|Received Correct Randomized Treatment|Overall Study|'Safety Analysis Set' =291+1-3=289.|287
438791|NCT01397890|1075524|P1|Received Correct Randomized Treatment|Overall Study|'Safety Analysis Set' =287+3-1=289. 3 and 1 pts in respective groups received opposite treatment.|286
438792|NCT01397890|1075523|P2|Post-baseline Efficacy Data Collected|Overall Study|'Full Analysis Set' used for efficacy analysis|290
438793|NCT01397890|1075524|P1|Post-baseline Efficacy Data Collected|Overall Study|'Full Analysis Set' used for efficacy analysis|287
438794|NCT01397890|1075523|P2|STARTED|Overall Study||291
438795|NCT01397890|1075524|P1|STARTED|Overall Study||287
438796|NCT01397851|1075578|P2|NOT COMPLETED|Overall Study||46
438797|NCT01397851|1075579|P1|NOT COMPLETED|Overall Study||79
438798|NCT01397851|1075578|P2|COMPLETED|Overall Study||39917
438799|NCT01397851|1075579|P1|COMPLETED|Overall Study||41555
438800|NCT01397851|1075578|P2|STARTED|Overall Study||39963
438801|NCT01397851|1075579|P1|STARTED|Overall Study||41634
438802|NCT01397825|1075595|P5|NOT COMPLETED|Overall Study||0
438803|NCT01397825|1075596|P4|NOT COMPLETED|Overall Study||3
438804|NCT01397825|1075597|P3|NOT COMPLETED|Overall Study||25
438805|NCT01397825|1075598|P2|NOT COMPLETED|Overall Study||4
438806|NCT01397825|1075599|P1|NOT COMPLETED|Overall Study||13
438807|NCT01397825|1075595|P5|COMPLETED|Overall Study||0
438808|NCT01397825|1075596|P4|COMPLETED|Overall Study||0
438809|NCT01397825|1075597|P3|COMPLETED|Overall Study||0
438810|NCT01397825|1075598|P2|COMPLETED|Overall Study||0
438811|NCT01397825|1075599|P1|COMPLETED|Overall Study||0
438812|NCT01397825|1075595|P5|STARTED|Overall Study||0
438813|NCT01397825|1075596|P4|STARTED|Overall Study||3
438814|NCT01397825|1075597|P3|STARTED|Overall Study||25
438815|NCT01397825|1075598|P2|STARTED|Overall Study||4
438816|NCT01397825|1075599|P1|STARTED|Overall Study||13
438817|NCT01397786|1075669|P3|NOT COMPLETED|Phase B||138
438818|NCT01397786|1075670|P2|NOT COMPLETED|Phase B||95
438819|NCT01397786|1075671|P1|NOT COMPLETED|Phase B||303
438820|NCT01397786|1075669|P3|COMPLETED|Phase B||91
438821|NCT01397786|1075670|P2|COMPLETED|Phase B||109
438822|NCT01397786|1075671|P1|COMPLETED|Phase B||308
438823|NCT01397786|1075669|P3|STARTED|Phase B||229
438824|NCT01397786|1075670|P2|STARTED|Phase B||204
438825|NCT01397786|1075671|P1|STARTED|Phase B||611
438826|NCT01397786|1075669|P3|NOT COMPLETED|Phase A||28
438827|NCT01397786|1075670|P2|NOT COMPLETED|Phase A||0
438828|NCT01397786|1075671|P1|NOT COMPLETED|Phase A||0
438829|NCT01397786|1075669|P3|COMPLETED|Phase A||199
438830|NCT01397786|1075670|P2|COMPLETED|Phase A||0
438831|NCT01397786|1075671|P1|COMPLETED|Phase A||12
438832|NCT01397786|1075669|P3|STARTED|Phase A||227
438833|NCT01397786|1075670|P2|STARTED|Phase A||0
438834|NCT01397786|1075671|P1|STARTED|Phase A|Subjects in NCT01668797 Phase A at IA-related study termination rolled over to NCT01397786 Phase A.|12
438835|NCT01397747|1075737|P1|NOT COMPLETED|Overall Study||1027
438836|NCT01397747|1075737|P1|COMPLETED|Overall Study||9989
438837|NCT01397747|1075737|P1|STARTED|Overall Study||11016
438838|NCT01397617|1075745|P3|NOT COMPLETED|Overall Study||29
438839|NCT01397617|1075746|P2|NOT COMPLETED|Overall Study||23
438840|NCT01397617|1075747|P1|NOT COMPLETED|Overall Study||31
438841|NCT01397617|1075745|P3|COMPLETED|Overall Study||31
438842|NCT01397617|1075746|P2|COMPLETED|Overall Study||30
438843|NCT01397617|1075747|P1|COMPLETED|Overall Study||33
438844|NCT01397617|1075745|P3|STARTED|Overall Study||60
438845|NCT01397617|1075746|P2|STARTED|Overall Study||53
438846|NCT01397617|1075747|P1|STARTED|Overall Study||64
438847|NCT01397591|1075758|P1|NOT COMPLETED|Overall Study||0
438848|NCT01397591|1075758|P1|COMPLETED|Overall Study||2
438849|NCT01397591|1075758|P1|STARTED|Overall Study||2
438850|NCT01397461|1075769|P3|NOT COMPLETED|Overall Study||2
438851|NCT01397461|1075770|P2|NOT COMPLETED|Overall Study||6
438852|NCT01397461|1075771|P1|NOT COMPLETED|Overall Study||2
438853|NCT01397461|1075769|P3|COMPLETED|Overall Study||152
438854|NCT01397461|1075770|P2|COMPLETED|Overall Study||150
438855|NCT01397461|1075771|P1|COMPLETED|Overall Study||153
438856|NCT01397461|1075769|P3|STARTED|Overall Study||154
438857|NCT01397461|1075770|P2|STARTED|Overall Study||156
438858|NCT01397461|1075771|P1|STARTED|Overall Study||155
438859|NCT01397448|1075782|P3|NOT COMPLETED|Overall Study||18
438860|NCT01397448|1075783|P2|NOT COMPLETED|Overall Study||15
438861|NCT01397448|1075784|P1|NOT COMPLETED|Overall Study||18
438862|NCT01397448|1075782|P3|COMPLETED|Overall Study||140
438863|NCT01397448|1075783|P2|COMPLETED|Overall Study||142
438864|NCT01397448|1075784|P1|COMPLETED|Overall Study||138
438865|NCT01397448|1075782|P3|STARTED|Overall Study||158
438866|NCT01397448|1075783|P2|STARTED|Overall Study|158 participants were randomized but 1 participant was not treated with drug.|157
438867|NCT01397448|1075784|P1|STARTED|Overall Study||156
438868|NCT01397422|1075799|P4|NOT COMPLETED|Overall Study||8
438869|NCT01397422|1075800|P3|NOT COMPLETED|Overall Study||3
438870|NCT01397422|1075801|P2|NOT COMPLETED|Overall Study||3
438871|NCT01397422|1075802|P1|NOT COMPLETED|Overall Study||2
438872|NCT01397422|1075799|P4|COMPLETED|Overall Study||12
438873|NCT01397422|1075800|P3|COMPLETED|Overall Study|AE = adverse event; eGFR = estimated glomerular filtration rate|18
438874|NCT01397422|1075801|P2|COMPLETED|Overall Study||17
438875|NCT01397422|1075802|P1|COMPLETED|Overall Study||20
438876|NCT01397422|1075799|P4|STARTED|Overall Study||20
438877|NCT01397422|1075800|P3|STARTED|Overall Study|Of the 3 participants who discontinued, 1 withdrew due to both an AE and an eGFR < 50 mL/min/1.73m^2|21
438878|NCT01397422|1075801|P2|STARTED|Overall Study||20
438879|NCT01397422|1075802|P1|STARTED|Overall Study||22
438880|NCT01397409|1075842|P10|NOT COMPLETED|Stage 3||0
438881|NCT01397409|1075843|P9|NOT COMPLETED|Stage 3||0
438882|NCT01397409|1075844|P8|NOT COMPLETED|Stage 3||2
438883|NCT01397409|1075845|P7|NOT COMPLETED|Stage 3||0
438884|NCT01397409|1075846|P6|NOT COMPLETED|Stage 3||0
438885|NCT01397409|1075847|P5|NOT COMPLETED|Stage 3||0
438886|NCT01397409|1075848|P4|NOT COMPLETED|Stage 3||0
438887|NCT01397409|1075849|P3|NOT COMPLETED|Stage 3||0
438888|NCT01397409|1075850|P2|NOT COMPLETED|Stage 3||0
438889|NCT01397409|1075851|P1|NOT COMPLETED|Stage 3||0
438890|NCT01397409|1075842|P10|COMPLETED|Stage 3||16
438891|NCT01397409|1075843|P9|COMPLETED|Stage 3||25
438892|NCT01397409|1075844|P8|COMPLETED|Stage 3||21
438893|NCT01397409|1075845|P7|COMPLETED|Stage 3||0
438894|NCT01397409|1075846|P6|COMPLETED|Stage 3||0
438895|NCT01397409|1075847|P5|COMPLETED|Stage 3||0
438896|NCT01397409|1075848|P4|COMPLETED|Stage 3||0
438897|NCT01397409|1075849|P3|COMPLETED|Stage 3||0
438898|NCT01397409|1075850|P2|COMPLETED|Stage 3||0
438899|NCT01397409|1075851|P1|COMPLETED|Stage 3||0
438900|NCT01397409|1075842|P10|STARTED|Stage 3||16
438901|NCT01397409|1075843|P9|STARTED|Stage 3||25
438902|NCT01397409|1075844|P8|STARTED|Stage 3||23
438903|NCT01397409|1075845|P7|STARTED|Stage 3||0
438904|NCT01397409|1075846|P6|STARTED|Stage 3||0
438905|NCT01397409|1075847|P5|STARTED|Stage 3||0
438906|NCT01397409|1075848|P4|STARTED|Stage 3||0
438907|NCT01397409|1075849|P3|STARTED|Stage 3||0
438908|NCT01397409|1075850|P2|STARTED|Stage 3||0
438909|NCT01397409|1075851|P1|STARTED|Stage 3||0
438910|NCT01397409|1075842|P10|NOT COMPLETED|Stage 2||0
438911|NCT01397409|1075843|P9|NOT COMPLETED|Stage 2||0
438912|NCT01397409|1075844|P8|NOT COMPLETED|Stage 2||0
438913|NCT01397409|1075845|P7|NOT COMPLETED|Stage 2||0
438914|NCT01397409|1075846|P6|NOT COMPLETED|Stage 2||4
438915|NCT01397409|1075847|P5|NOT COMPLETED|Stage 2||8
438916|NCT01397409|1075848|P4|NOT COMPLETED|Stage 2||0
438917|NCT01397409|1075849|P3|NOT COMPLETED|Stage 2||0
438918|NCT01397409|1075850|P2|NOT COMPLETED|Stage 2||0
438919|NCT01397409|1075851|P1|NOT COMPLETED|Stage 2||0
438920|NCT01397409|1075842|P10|COMPLETED|Stage 2||0
438921|NCT01397409|1075843|P9|COMPLETED|Stage 2||0
438922|NCT01397409|1075844|P8|COMPLETED|Stage 2||0
438923|NCT01397409|1075845|P7|COMPLETED|Stage 2||58
438924|NCT01397409|1075846|P6|COMPLETED|Stage 2||54
438925|NCT01397409|1075847|P5|COMPLETED|Stage 2||59
438926|NCT01397409|1075848|P4|COMPLETED|Stage 2||0
438927|NCT01397409|1075849|P3|COMPLETED|Stage 2||0
438928|NCT01397409|1075850|P2|COMPLETED|Stage 2||0
438929|NCT01397409|1075851|P1|COMPLETED|Stage 2||0
438930|NCT01397409|1075842|P10|STARTED|Stage 2||0
438931|NCT01397409|1075843|P9|STARTED|Stage 2||0
438932|NCT01397409|1075844|P8|STARTED|Stage 2||0
438933|NCT01397409|1075845|P7|STARTED|Stage 2||58
438934|NCT01397409|1075846|P6|STARTED|Stage 2||58
438935|NCT01397409|1075847|P5|STARTED|Stage 2||67
438936|NCT01397409|1075848|P4|STARTED|Stage 2||0
438937|NCT01397409|1075849|P3|STARTED|Stage 2||0
438938|NCT01397409|1075850|P2|STARTED|Stage 2||0
438939|NCT01397409|1075851|P1|STARTED|Stage 2||0
438940|NCT01397409|1075842|P10|NOT COMPLETED|Stage 1||0
438941|NCT01397409|1075843|P9|NOT COMPLETED|Stage 1||0
438942|NCT01397409|1075844|P8|NOT COMPLETED|Stage 1||0
438943|NCT01397409|1075845|P7|NOT COMPLETED|Stage 1||0
438944|NCT01397409|1075846|P6|NOT COMPLETED|Stage 1||0
438945|NCT01397409|1075847|P5|NOT COMPLETED|Stage 1||0
438946|NCT01397409|1075848|P4|NOT COMPLETED|Stage 1||0
438947|NCT01397409|1075849|P3|NOT COMPLETED|Stage 1||0
438948|NCT01397409|1075850|P2|NOT COMPLETED|Stage 1||0
438949|NCT01397409|1075851|P1|NOT COMPLETED|Stage 1||0
438950|NCT01397409|1075842|P10|COMPLETED|Stage 1||0
438951|NCT01397409|1075843|P9|COMPLETED|Stage 1||0
438952|NCT01397409|1075844|P8|COMPLETED|Stage 1||0
438953|NCT01397409|1075845|P7|COMPLETED|Stage 1||0
438954|NCT01397409|1075846|P6|COMPLETED|Stage 1||0
438955|NCT01397409|1075847|P5|COMPLETED|Stage 1||0
438956|NCT01397409|1075848|P4|COMPLETED|Stage 1||3
438957|NCT01397409|1075849|P3|COMPLETED|Stage 1||6
438958|NCT01397409|1075850|P2|COMPLETED|Stage 1||6
438959|NCT01397409|1075851|P1|COMPLETED|Stage 1||9
438960|NCT01397409|1075842|P10|STARTED|Stage 1||0
438961|NCT01397409|1075843|P9|STARTED|Stage 1||0
438962|NCT01397409|1075844|P8|STARTED|Stage 1||0
438963|NCT01397409|1075845|P7|STARTED|Stage 1||0
438964|NCT01397409|1075846|P6|STARTED|Stage 1||0
438965|NCT01397409|1075847|P5|STARTED|Stage 1||0
438966|NCT01397409|1075848|P4|STARTED|Stage 1||3
438967|NCT01397409|1075849|P3|STARTED|Stage 1||6
438968|NCT01397409|1075850|P2|STARTED|Stage 1||6
438969|NCT01397409|1075851|P1|STARTED|Stage 1||9
438970|NCT01397253|1075891|P2|NOT COMPLETED|Overall Study||149
438971|NCT01397253|1075892|P1|NOT COMPLETED|Overall Study||126
438972|NCT01397253|1075891|P2|COMPLETED|Overall Study|Primary analysis, remaining patients included in a sensitivity analysis|243
438973|NCT01397253|1075892|P1|COMPLETED|Overall Study|Primary analysis, remaining patients included in a sensitivity analysis|317
438974|NCT01397253|1075891|P2|STARTED|Overall Study||392
438975|NCT01397253|1075892|P1|STARTED|Overall Study||443
438976|NCT01397084|1075898|P1|NOT COMPLETED|Overall Study||8
438977|NCT01397084|1075898|P1|COMPLETED|Overall Study||100
438978|NCT01397084|1075898|P1|STARTED|Overall Study||108
438979|NCT01396525|1075905|P1|NOT COMPLETED|Overall Study||26
438980|NCT01396525|1075905|P1|COMPLETED|Overall Study||127
438981|NCT01396525|1075905|P1|STARTED|Overall Study||153
438982|NCT01396512|1076005|P2|NOT COMPLETED|Overall Study||1
438983|NCT01396512|1076006|P1|NOT COMPLETED|Overall Study||0
438984|NCT01396512|1076005|P2|COMPLETED|Overall Study||136
438985|NCT01396512|1076006|P1|COMPLETED|Overall Study||137
438986|NCT01396512|1076005|P2|STARTED|Overall Study||137
438987|NCT01396512|1076006|P1|STARTED|Overall Study||137
438988|NCT01396447|1076022|P4|NOT COMPLETED|Overall Study||52
438989|NCT01396447|1076023|P3|NOT COMPLETED|Overall Study||30
438990|NCT01396447|1076024|P2|NOT COMPLETED|Overall Study||40
438991|NCT01396447|1076025|P1|NOT COMPLETED|Overall Study||43
438992|NCT01396447|1076022|P4|COMPLETED|Overall Study||94
438993|NCT01396447|1076023|P3|COMPLETED|Overall Study||117
438994|NCT01396447|1076024|P2|COMPLETED|Overall Study||103
438995|NCT01396447|1076025|P1|COMPLETED|Overall Study||105
438996|NCT01396447|1076022|P4|Received Treatment|Overall Study||146
438997|NCT01396447|1076023|P3|Received Treatment|Overall Study||146
438998|NCT01396447|1076024|P2|Received Treatment|Overall Study||141
438999|NCT01396447|1076025|P1|Received Treatment|Overall Study||145
439000|NCT01396447|1076022|P4|STARTED|Overall Study||146
439001|NCT01396447|1076023|P3|STARTED|Overall Study||147
439002|NCT01396447|1076024|P2|STARTED|Overall Study||143
439003|NCT01396447|1076025|P1|STARTED|Overall Study||148
439004|NCT01396434|1076042|P3|NOT COMPLETED|Overall Study||0
439005|NCT01396434|1076043|P2|NOT COMPLETED|Overall Study||0
439006|NCT01396434|1076044|P1|NOT COMPLETED|Overall Study||11
439007|NCT01396434|1076042|P3|COMPLETED|Overall Study||14
439008|NCT01396434|1076043|P2|COMPLETED|Overall Study||175
439009|NCT01396434|1076044|P1|COMPLETED|Overall Study||2806
439010|NCT01396434|1076042|P3|STARTED|Overall Study||14
439011|NCT01396434|1076043|P2|STARTED|Overall Study||175
439012|NCT01396434|1076044|P1|STARTED|Overall Study||2817
439013|NCT01396421|1076056|P4|NOT COMPLETED|Overall Study||75
439014|NCT01396421|1076057|P3|NOT COMPLETED|Overall Study||34
439015|NCT01396421|1076058|P2|NOT COMPLETED|Overall Study||58
439016|NCT01396421|1076059|P1|NOT COMPLETED|Overall Study||59
439017|NCT01396421|1076056|P4|COMPLETED|Overall Study||109
439018|NCT01396421|1076057|P3|COMPLETED|Overall Study||56
439019|NCT01396421|1076058|P2|COMPLETED|Overall Study||124
439020|NCT01396421|1076059|P1|COMPLETED|Overall Study||121
439021|NCT01396421|1076056|P4|STARTED|Overall Study||184
439022|NCT01396421|1076057|P3|STARTED|Overall Study||90
439023|NCT01396421|1076058|P2|STARTED|Overall Study||182
439024|NCT01396421|1076059|P1|STARTED|Overall Study||180
439025|NCT01396395|1076131|P2|NOT COMPLETED|Overall Study||27
439026|NCT01396395|1076132|P1|NOT COMPLETED|Overall Study||40
439027|NCT01396395|1076131|P2|COMPLETED|Overall Study||175
439028|NCT01396395|1076132|P1|COMPLETED|Overall Study||160
439029|NCT01396395|1076131|P2|Safety Analysis Set|Overall Study|4 subjects randomized to standard+nicorandil were included in standard as no nicorandil was received|205
439030|NCT01396395|1076132|P1|Safety Analysis Set|Overall Study|1 subject randomized to standard was included in standard+nicorandil as nicorandil was received.|197
439031|NCT01396395|1076131|P2|STARTED|Overall Study||202
439032|NCT01396395|1076132|P1|STARTED|Overall Study||200
439033|NCT01396382|1076167|P1|NOT COMPLETED|Overall Study||0
439034|NCT01396382|1076167|P1|COMPLETED|Overall Study||97
439035|NCT01396382|1076167|P1|STARTED|Overall Study||97
439036|NCT01396317|1076174|P2|NOT COMPLETED|Overall Study||0
439037|NCT01396317|1076175|P1|NOT COMPLETED|Overall Study||1
439038|NCT01396317|1076174|P2|COMPLETED|Overall Study||10
439039|NCT01396317|1076175|P1|COMPLETED|Overall Study||9
439040|NCT01396317|1076174|P2|STARTED|Overall Study||10
439041|NCT01396317|1076175|P1|STARTED|Overall Study||10
439042|NCT01396265|1076189|P1|NOT COMPLETED|Rifa+Afatinib||1
439043|NCT01396265|1076189|P1|COMPLETED|Rifa+Afatinib||21
439044|NCT01396265|1076189|P1|STARTED|Rifa+Afatinib||22
439045|NCT01396265|1076189|P1|NOT COMPLETED|Washout||0
439046|NCT01396265|1076189|P1|COMPLETED|Washout||22
439047|NCT01396265|1076189|P1|STARTED|Washout||22
439048|NCT01396265|1076189|P1|NOT COMPLETED|Afatinib||0
439049|NCT01396265|1076189|P1|COMPLETED|Afatinib||22
439050|NCT01396265|1076189|P1|STARTED|Afatinib||22
439051|NCT01396239|1076216|P4|NOT COMPLETED|Overall Study||0
439052|NCT01396239|1076217|P3|NOT COMPLETED|Overall Study||0
439053|NCT01396239|1076218|P2|NOT COMPLETED|Overall Study||0
439054|NCT01396239|1076219|P1|NOT COMPLETED|Overall Study||0
439055|NCT01396239|1076216|P4|COMPLETED|Overall Study||2
439056|NCT01396239|1076217|P3|COMPLETED|Overall Study||4
439057|NCT01396239|1076218|P2|COMPLETED|Overall Study||2
439058|NCT01396239|1076219|P1|COMPLETED|Overall Study||4
439059|NCT01396239|1076216|P4|STARTED|Overall Study||2
439060|NCT01396239|1076217|P3|STARTED|Overall Study||4
439061|NCT01396239|1076218|P2|STARTED|Overall Study||2
439062|NCT01396239|1076219|P1|STARTED|Overall Study||4
439063|NCT01396226|1076242|P2|NOT COMPLETED|Overall Study||0
439064|NCT01396226|1076243|P1|NOT COMPLETED|Overall Study||0
439065|NCT01396226|1076242|P2|COMPLETED|Overall Study||6
439066|NCT01396226|1076243|P1|COMPLETED|Overall Study||12
439067|NCT01396226|1076242|P2|Patients Who Completed Treatment|Overall Study||6
439068|NCT01396226|1076243|P1|Patients Who Completed Treatment|Overall Study||12
439069|NCT01396226|1076242|P2|Patients Who Received Treatment|Overall Study||6
439070|NCT01396226|1076243|P1|Patients Who Received Treatment|Overall Study||12
439071|NCT01396226|1076242|P2|STARTED|Overall Study||6
439072|NCT01396226|1076243|P1|STARTED|Overall Study||12
439073|NCT01396187|1076278|P5|NOT COMPLETED|Overall Study||1
439074|NCT01396187|1076279|P4|NOT COMPLETED|Overall Study||0
439075|NCT01396187|1076280|P3|NOT COMPLETED|Overall Study||1
439076|NCT01396187|1076281|P2|NOT COMPLETED|Overall Study||3
439077|NCT01396187|1076282|P1|NOT COMPLETED|Overall Study||1
439078|NCT01396187|1076278|P5|COMPLETED|Overall Study||9
439079|NCT01396187|1076279|P4|COMPLETED|Overall Study||10
439080|NCT01396187|1076280|P3|COMPLETED|Overall Study||9
439081|NCT01396187|1076281|P2|COMPLETED|Overall Study||9
439082|NCT01396187|1076282|P1|COMPLETED|Overall Study||7
439083|NCT01396187|1076278|P5|STARTED|Overall Study||10
439084|NCT01396187|1076279|P4|STARTED|Overall Study||10
439085|NCT01396187|1076280|P3|STARTED|Overall Study||10
439086|NCT01396187|1076281|P2|STARTED|Overall Study||12
439087|NCT01396187|1076282|P1|STARTED|Overall Study||8
439088|NCT01396161|1076382|P7|NOT COMPLETED|Overall Study||1
439089|NCT01396161|1076383|P6|NOT COMPLETED|Overall Study||0
439090|NCT01396161|1076384|P5|NOT COMPLETED|Overall Study||1
439091|NCT01396161|1076385|P4|NOT COMPLETED|Overall Study||0
439092|NCT01396161|1076386|P3|NOT COMPLETED|Overall Study||0
439093|NCT01396161|1076387|P2|NOT COMPLETED|Overall Study||0
439094|NCT01396161|1076388|P1|NOT COMPLETED|Overall Study||0
439095|NCT01396161|1076382|P7|COMPLETED|Overall Study||10
439096|NCT01396161|1076383|P6|COMPLETED|Overall Study||9
439097|NCT01396161|1076384|P5|COMPLETED|Overall Study||8
439098|NCT01396161|1076385|P4|COMPLETED|Overall Study||9
439099|NCT01396161|1076386|P3|COMPLETED|Overall Study||9
439100|NCT01396161|1076387|P2|COMPLETED|Overall Study||5
439101|NCT01396161|1076388|P1|COMPLETED|Overall Study||12
439102|NCT01396161|1076382|P7|STARTED|Overall Study||11
439103|NCT01396161|1076383|P6|STARTED|Overall Study||9
439104|NCT01396161|1076384|P5|STARTED|Overall Study||9
439105|NCT01396161|1076385|P4|STARTED|Overall Study||9
439106|NCT01396161|1076386|P3|STARTED|Overall Study||9
439107|NCT01396161|1076387|P2|STARTED|Overall Study||5
439108|NCT01396161|1076388|P1|STARTED|Overall Study||12
439109|NCT01396148|1076441|P1|NOT COMPLETED|Overall Study||1
439110|NCT01396148|1076441|P1|COMPLETED|Overall Study||5
439111|NCT01396148|1076441|P1|STARTED|Overall Study||6
439112|NCT01396083|1076468|P2|NOT COMPLETED|Overall Study||47
439113|NCT01396083|1076469|P1|NOT COMPLETED|Overall Study||11
439114|NCT01396083|1076468|P2|COMPLETED|Overall Study||72
439115|NCT01396083|1076469|P1|COMPLETED|Overall Study||113
439116|NCT01396083|1076468|P2|STARTED|Overall Study||119
439117|NCT01396083|1076469|P1|STARTED|Overall Study||124
439118|NCT01396070|1076493|P1|NOT COMPLETED|Overall Study||19
439119|NCT01396070|1076493|P1|COMPLETED|Overall Study||17
439120|NCT01396070|1076493|P1|STARTED|Overall Study||36
439121|NCT01396057|1076502|P2|NOT COMPLETED|Overall Study||18
439122|NCT01396057|1076503|P1|NOT COMPLETED|Overall Study||11
439123|NCT01396057|1076502|P2|COMPLETED|Overall Study||100
439124|NCT01396057|1076503|P1|COMPLETED|Overall Study||115
439125|NCT01396057|1076502|P2|STARTED|Overall Study||118
439126|NCT01396057|1076503|P1|STARTED|Overall Study||126
439127|NCT01396044|1076529|P2|NOT COMPLETED|Overall Study||0
439128|NCT01396044|1076530|P1|NOT COMPLETED|Overall Study||0
439129|NCT01396044|1076529|P2|COMPLETED|Overall Study||171
439130|NCT01396044|1076530|P1|COMPLETED|Overall Study||125
439131|NCT01396044|1076529|P2|STARTED|Overall Study||171
439132|NCT01396044|1076530|P1|STARTED|Overall Study||125
439133|NCT01396005|1076552|P2|NOT COMPLETED|Overall Study||2
439134|NCT01396005|1076553|P1|NOT COMPLETED|Overall Study||0
439135|NCT01396005|1076552|P2|COMPLETED|Overall Study||9
439136|NCT01396005|1076553|P1|COMPLETED|Overall Study||10
439137|NCT01396005|1076552|P2|STARTED|Overall Study||11
439138|NCT01396005|1076553|P1|STARTED|Overall Study||10
439139|NCT01395966|1076572|P3|NOT COMPLETED|Overall Study||8
439140|NCT01395966|1076573|P2|NOT COMPLETED|Overall Study||19
439141|NCT01395966|1076574|P1|NOT COMPLETED|Overall Study||10
439142|NCT01395966|1076572|P3|COMPLETED|Overall Study||104
439143|NCT01395966|1076573|P2|COMPLETED|Overall Study||91
439144|NCT01395966|1076574|P1|COMPLETED|Overall Study||99
439145|NCT01395966|1076572|P3|STARTED|Overall Study||112
439146|NCT01395966|1076573|P2|STARTED|Overall Study||110
439147|NCT01395966|1076574|P1|STARTED|Overall Study||109
439148|NCT01395914|1076584|P2|NOT COMPLETED|Overall Study||37
439149|NCT01395914|1076585|P1|NOT COMPLETED|Overall Study||72
439150|NCT01395914|1076584|P2|COMPLETED|Overall Study||131
439151|NCT01395914|1076585|P1|COMPLETED|Overall Study||273
439152|NCT01395914|1076584|P2|Safety Population|Overall Study||167
439153|NCT01395914|1076585|P1|Safety Population|Overall Study||343
439154|NCT01395914|1076584|P2|ITT Population|Overall Study||168
439155|NCT01395914|1076585|P1|ITT Population|Overall Study||345
439156|NCT01395914|1076584|P2|STARTED|Overall Study||168
439157|NCT01395914|1076585|P1|STARTED|Overall Study||345
439158|NCT01395901|1076599|P2|NOT COMPLETED|Overall Study||5
439159|NCT01395901|1076600|P1|NOT COMPLETED|Overall Study||10
439160|NCT01395901|1076599|P2|COMPLETED|Overall Study|Treated patients completing the study|329
439161|NCT01395901|1076600|P1|COMPLETED|Overall Study|Treated patients completing the study|326
439162|NCT01395901|1076599|P2|STARTED|Overall Study|Randomized Population|334
439163|NCT01395901|1076600|P1|STARTED|Overall Study|Randomized Population|336
439164|NCT01395888|1076616|P3|NOT COMPLETED|Treatment Period (TP)||17
439165|NCT01395888|1076617|P2|NOT COMPLETED|Treatment Period (TP)||15
439166|NCT01395888|1076618|P1|NOT COMPLETED|Treatment Period (TP)||0
439167|NCT01395888|1076616|P3|COMPLETED|Treatment Period (TP)|Par. completed the study if they completed the TP and a safety follow-up phone contact 1 week later.|113
439168|NCT01395888|1076617|P2|COMPLETED|Treatment Period (TP)|Par. completed the study if they completed the TP and a safety follow-up phone contact 1 week later.|112
439169|NCT01395888|1076618|P1|COMPLETED|Treatment Period (TP)||0
439170|NCT01395888|1076616|P3|Completed the Treatment Period|Treatment Period (TP)|Participants were considered to have completed the TP if they attended Visit 5 (Week 12).|113
439258|NCT01395394|1076747|P3|COMPLETED|Study Visit 2 (Non-responders Only)||0
439171|NCT01395888|1076617|P2|Completed the Treatment Period|Treatment Period (TP)|Participants were considered to have completed the TP if they attended Visit 5 (Week 12).|112
439172|NCT01395888|1076618|P1|Completed the Treatment Period|Treatment Period (TP)||0
439173|NCT01395888|1076616|P3|STARTED|Treatment Period (TP)||130
439174|NCT01395888|1076617|P2|STARTED|Treatment Period (TP)||127
439175|NCT01395888|1076618|P1|STARTED|Treatment Period (TP)||0
439176|NCT01395888|1076616|P3|NOT COMPLETED|2-week Run-in Period||0
439177|NCT01395888|1076617|P2|NOT COMPLETED|2-week Run-in Period||0
439178|NCT01395888|1076618|P1|NOT COMPLETED|2-week Run-in Period||22
439179|NCT01395888|1076616|P3|COMPLETED|2-week Run-in Period||0
439180|NCT01395888|1076617|P2|COMPLETED|2-week Run-in Period||0
439181|NCT01395888|1076618|P1|COMPLETED|2-week Run-in Period||257
439182|NCT01395888|1076616|P3|STARTED|2-week Run-in Period||0
439183|NCT01395888|1076617|P2|STARTED|2-week Run-in Period||0
439184|NCT01395888|1076618|P1|STARTED|2-week Run-in Period||279
439185|NCT01395823|1076626|P2|NOT COMPLETED|Overall Study||9
439186|NCT01395823|1076627|P1|NOT COMPLETED|Overall Study||15
439187|NCT01395823|1076626|P2|COMPLETED|Overall Study||130
439188|NCT01395823|1076627|P1|COMPLETED|Overall Study||122
439189|NCT01395823|1076626|P2|STARTED|Overall Study||139
439190|NCT01395823|1076627|P1|STARTED|Overall Study||137
439191|NCT01395810|1076637|P4|NOT COMPLETED|Overall Study||0
439192|NCT01395810|1076638|P3|NOT COMPLETED|Overall Study||0
439193|NCT01395810|1076639|P2|NOT COMPLETED|Overall Study||4
439194|NCT01395810|1076640|P1|NOT COMPLETED|Overall Study||2
439195|NCT01395810|1076637|P4|COMPLETED|Overall Study||5
439196|NCT01395810|1076638|P3|COMPLETED|Overall Study||0
439197|NCT01395810|1076639|P2|COMPLETED|Overall Study||44
439198|NCT01395810|1076640|P1|COMPLETED|Overall Study||16
439199|NCT01395810|1076637|P4|After Switching the Arms|Overall Study||5
439200|NCT01395810|1076638|P3|After Switching the Arms|Overall Study|No subjects started in this arm initially, 2 patients in 40 IU/kg arm switched to this arm.|2
439201|NCT01395810|1076639|P2|After Switching the Arms|Overall Study|48 subjects started in this arm, 3 subjects in 10 IU/kg+1 subject in on-demand switched to this arm|52
439202|NCT01395810|1076640|P1|After Switching the Arms|Overall Study|18 subjects started in this arm and additional 3 subjects from 40 IU/kg switched to this arm|21
439203|NCT01395810|1076637|P4|STARTED|Overall Study||5
439204|NCT01395810|1076638|P3|STARTED|Overall Study||0
439205|NCT01395810|1076639|P2|STARTED|Overall Study||48
439206|NCT01395810|1076640|P1|STARTED|Overall Study||18
439207|NCT01395797|1076674|P6|NOT COMPLETED|Overall Study||3
439208|NCT01395797|1076675|P5|NOT COMPLETED|Overall Study||2
439209|NCT01395797|1076676|P4|NOT COMPLETED|Overall Study||2
439210|NCT01395797|1076677|P3|NOT COMPLETED|Overall Study||4
439211|NCT01395797|1076678|P2|NOT COMPLETED|Overall Study||1
439212|NCT01395797|1076679|P1|NOT COMPLETED|Overall Study||3
439213|NCT01395797|1076674|P6|COMPLETED|Overall Study||14
439214|NCT01395797|1076675|P5|COMPLETED|Overall Study||7
439215|NCT01395797|1076676|P4|COMPLETED|Overall Study||13
439216|NCT01395797|1076677|P3|COMPLETED|Overall Study||14
439217|NCT01395797|1076678|P2|COMPLETED|Overall Study||3
439218|NCT01395797|1076679|P1|COMPLETED|Overall Study||16
439219|NCT01395797|1076674|P6|STARTED|Overall Study||17
439220|NCT01395797|1076675|P5|STARTED|Overall Study||9
439221|NCT01395797|1076676|P4|STARTED|Overall Study||15
439222|NCT01395797|1076677|P3|STARTED|Overall Study||18
439223|NCT01395797|1076678|P2|STARTED|Overall Study||4
439224|NCT01395797|1076679|P1|STARTED|Overall Study||19
439225|NCT01395784|1076699|P1|NOT COMPLETED|Overall Study||15
439226|NCT01395784|1076699|P1|COMPLETED|Overall Study||17
439227|NCT01395784|1076699|P1|STARTED|Overall Study||32
439228|NCT01395758|1076706|P3|NOT COMPLETED|Crossover Period||0
439229|NCT01395758|1076707|P2|NOT COMPLETED|Crossover Period||0
439230|NCT01395758|1076708|P1|NOT COMPLETED|Crossover Period||0
439231|NCT01395758|1076706|P3|COMPLETED|Crossover Period||26
439232|NCT01395758|1076707|P2|COMPLETED|Crossover Period||0
439233|NCT01395758|1076708|P1|COMPLETED|Crossover Period||0
439234|NCT01395758|1076706|P3|STARTED|Crossover Period||26
439235|NCT01395758|1076707|P2|STARTED|Crossover Period||0
439236|NCT01395758|1076708|P1|STARTED|Crossover Period||0
439237|NCT01395758|1076706|P3|NOT COMPLETED|Open-label Treatment Period||0
439238|NCT01395758|1076707|P2|NOT COMPLETED|Open-label Treatment Period||0
439239|NCT01395758|1076708|P1|NOT COMPLETED|Open-label Treatment Period||4
439240|NCT01395758|1076706|P3|COMPLETED|Open-label Treatment Period||0
439241|NCT01395758|1076707|P2|COMPLETED|Open-label Treatment Period||45
439242|NCT01395758|1076708|P1|COMPLETED|Open-label Treatment Period||47
439243|NCT01395758|1076706|P3|STARTED|Open-label Treatment Period||0
439244|NCT01395758|1076707|P2|STARTED|Open-label Treatment Period||45
439245|NCT01395758|1076708|P1|STARTED|Open-label Treatment Period||51
439246|NCT01395524|1076722|P3|NOT COMPLETED|Overall Study||17
439247|NCT01395524|1076723|P2|NOT COMPLETED|Overall Study||16
439248|NCT01395524|1076724|P1|NOT COMPLETED|Overall Study||18
439249|NCT01395524|1076722|P3|COMPLETED|Overall Study||89
439250|NCT01395524|1076723|P2|COMPLETED|Overall Study||83
439251|NCT01395524|1076724|P1|COMPLETED|Overall Study||79
439252|NCT01395524|1076722|P3|STARTED|Overall Study||106
439253|NCT01395524|1076723|P2|STARTED|Overall Study||99
439254|NCT01395524|1076724|P1|STARTED|Overall Study||97
439255|NCT01395394|1076747|P3|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
439256|NCT01395394|1076748|P2|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
439257|NCT01395394|1076749|P1|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
439259|NCT01395394|1076748|P2|COMPLETED|Study Visit 2 (Non-responders Only)||0
439260|NCT01395394|1076749|P1|COMPLETED|Study Visit 2 (Non-responders Only)||3
439261|NCT01395394|1076747|P3|STARTED|Study Visit 2 (Non-responders Only)||0
439262|NCT01395394|1076748|P2|STARTED|Study Visit 2 (Non-responders Only)||0
439263|NCT01395394|1076749|P1|STARTED|Study Visit 2 (Non-responders Only)||3
439264|NCT01395394|1076747|P3|NOT COMPLETED|Baseline Study Visit||0
439265|NCT01395394|1076748|P2|NOT COMPLETED|Baseline Study Visit||0
439266|NCT01395394|1076749|P1|NOT COMPLETED|Baseline Study Visit||1
439267|NCT01395394|1076747|P3|COMPLETED|Baseline Study Visit||5
439268|NCT01395394|1076748|P2|COMPLETED|Baseline Study Visit||3
439269|NCT01395394|1076749|P1|COMPLETED|Baseline Study Visit||3
439270|NCT01395394|1076747|P3|STARTED|Baseline Study Visit||5
439271|NCT01395394|1076748|P2|STARTED|Baseline Study Visit||3
439272|NCT01395394|1076749|P1|STARTED|Baseline Study Visit||4
439273|NCT01395368|1076760|P1|NOT COMPLETED|Overall Study||16
439274|NCT01395368|1076760|P1|COMPLETED|Overall Study||92
439275|NCT01395368|1076760|P1|STARTED|Overall Study||108
439276|NCT01395277|1076766|P2|NOT COMPLETED|Overall Study||0
439277|NCT01395277|1076767|P1|NOT COMPLETED|Overall Study||0
439278|NCT01395277|1076766|P2|COMPLETED|Overall Study||15
439279|NCT01395277|1076767|P1|COMPLETED|Overall Study||15
439280|NCT01395277|1076766|P2|STARTED|Overall Study||15
439281|NCT01395277|1076767|P1|STARTED|Overall Study||15
439282|NCT01395043|1076775|P1|NOT COMPLETED|Overall Study||0
439283|NCT01395043|1076775|P1|COMPLETED|Overall Study||15
439284|NCT01395043|1076775|P1|STARTED|Overall Study||15
439285|NCT01395017|1076782|P2|NOT COMPLETED|Overall Study||102
439286|NCT01395017|1076783|P1|NOT COMPLETED|Overall Study||100
439287|NCT01395017|1076782|P2|COMPLETED|Overall Study||0
439288|NCT01395017|1076783|P1|COMPLETED|Overall Study||0
439289|NCT01395017|1076782|P2|Treated|Overall Study||101
439290|NCT01395017|1076783|P1|Treated|Overall Study||98
439291|NCT01395017|1076782|P2|STARTED|Overall Study||102
439292|NCT01395017|1076783|P1|STARTED|Overall Study||100
439293|NCT01394991|1076793|P2|NOT COMPLETED|Overall Study||72
439294|NCT01394991|1076794|P1|NOT COMPLETED|Overall Study||59
439295|NCT01394991|1076793|P2|COMPLETED|Overall Study||190
439296|NCT01394991|1076794|P1|COMPLETED|Overall Study||183
439297|NCT01394991|1076793|P2|STARTED|Overall Study||262
439298|NCT01394991|1076794|P1|STARTED|Overall Study||242
439299|NCT01394978|1076816|P2|NOT COMPLETED|Overall Study||31
439300|NCT01394978|1076817|P1|NOT COMPLETED|Overall Study||21
439301|NCT01394978|1076816|P2|COMPLETED|Overall Study||245
439302|NCT01394978|1076817|P1|COMPLETED|Overall Study||147
439303|NCT01394978|1076816|P2|STARTED|Overall Study||276
439304|NCT01394978|1076817|P1|STARTED|Overall Study||168
439305|NCT01394926|1076823|P1|NOT COMPLETED|Overall Study||0
439306|NCT01394926|1076823|P1|COMPLETED|Overall Study||21
439307|NCT01394926|1076823|P1|STARTED|Overall Study||21
439308|NCT01394718|1076834|P2|NOT COMPLETED|Overall Study||1
439309|NCT01394718|1076835|P1|NOT COMPLETED|Overall Study||2
439310|NCT01394718|1076834|P2|COMPLETED|Overall Study||29
439311|NCT01394718|1076835|P1|COMPLETED|Overall Study||28
439312|NCT01394718|1076834|P2|STARTED|Overall Study||30
439313|NCT01394718|1076835|P1|STARTED|Overall Study||30
439314|NCT01394692|1076849|P2|NOT COMPLETED|Overall Study||0
439315|NCT01394692|1076850|P1|NOT COMPLETED|Overall Study||0
439316|NCT01394692|1076849|P2|COMPLETED|Overall Study||29
439317|NCT01394692|1076850|P1|COMPLETED|Overall Study||29
439318|NCT01394692|1076849|P2|STARTED|Overall Study||29
439319|NCT01394692|1076850|P1|STARTED|Overall Study||29
439320|NCT01394627|1076856|P2|NOT COMPLETED|Second Intervention (1 Day)||0
439321|NCT01394627|1076857|P1|NOT COMPLETED|Second Intervention (1 Day)||0
439322|NCT01394627|1076856|P2|COMPLETED|Second Intervention (1 Day)||12
439323|NCT01394627|1076857|P1|COMPLETED|Second Intervention (1 Day)||7
439324|NCT01394627|1076856|P2|STARTED|Second Intervention (1 Day)||12
439325|NCT01394627|1076857|P1|STARTED|Second Intervention (1 Day)||7
439326|NCT01394627|1076856|P2|NOT COMPLETED|Washout (1-3 Months)||0
439327|NCT01394627|1076857|P1|NOT COMPLETED|Washout (1-3 Months)||1
439328|NCT01394627|1076856|P2|COMPLETED|Washout (1-3 Months)||12
439329|NCT01394627|1076857|P1|COMPLETED|Washout (1-3 Months)||7
439330|NCT01394627|1076856|P2|STARTED|Washout (1-3 Months)||12
439331|NCT01394627|1076857|P1|STARTED|Washout (1-3 Months)||8
439332|NCT01394627|1076856|P2|NOT COMPLETED|First Intervention (1 Day)||1
439333|NCT01394627|1076857|P1|NOT COMPLETED|First Intervention (1 Day)||0
439334|NCT01394627|1076856|P2|COMPLETED|First Intervention (1 Day)||12
439335|NCT01394627|1076857|P1|COMPLETED|First Intervention (1 Day)||8
439336|NCT01394627|1076856|P2|STARTED|First Intervention (1 Day)||13
439337|NCT01394627|1076857|P1|STARTED|First Intervention (1 Day)||8
439338|NCT01394614|1076867|P2|NOT COMPLETED|Overall Study||0
439339|NCT01394614|1076868|P1|NOT COMPLETED|Overall Study||0
439340|NCT01394614|1076867|P2|COMPLETED|Overall Study||16
439341|NCT01394614|1076868|P1|COMPLETED|Overall Study||8
439342|NCT01394614|1076867|P2|STARTED|Overall Study||16
439343|NCT01394614|1076868|P1|STARTED|Overall Study||8
439344|NCT01394523|1076877|P3|NOT COMPLETED|Overall Study||0
439345|NCT01394523|1076878|P2|NOT COMPLETED|Overall Study||0
439346|NCT01394523|1076879|P1|NOT COMPLETED|Overall Study||1
439347|NCT01394523|1076877|P3|COMPLETED|Overall Study||13
439348|NCT01394523|1076878|P2|COMPLETED|Overall Study||13
439349|NCT01394523|1076879|P1|COMPLETED|Overall Study||12
439350|NCT01394523|1076877|P3|STARTED|Overall Study||13
439351|NCT01394523|1076878|P2|STARTED|Overall Study||13
439352|NCT01394523|1076879|P1|STARTED|Overall Study||13
439353|NCT01394510|1076887|P1|NOT COMPLETED|Overall Study||0
439354|NCT01394510|1076887|P1|COMPLETED|Overall Study||13
439355|NCT01394510|1076887|P1|STARTED|Overall Study||13
439356|NCT01394276|1076893|P1|NOT COMPLETED|Overall Study||62
439357|NCT01394276|1076893|P1|COMPLETED|Overall Study||260
439358|NCT01394276|1076893|P1|STARTED|Overall Study||322
439359|NCT01394250|1076917|P2|NOT COMPLETED|Successful IV Placement & Follow-Up||11
439360|NCT01394250|1076918|P1|NOT COMPLETED|Successful IV Placement & Follow-Up||6
439361|NCT01394250|1076917|P2|COMPLETED|Successful IV Placement & Follow-Up||110
439362|NCT01394250|1076918|P1|COMPLETED|Successful IV Placement & Follow-Up||114
439363|NCT01394250|1076917|P2|STARTED|Successful IV Placement & Follow-Up||121
439364|NCT01394250|1076918|P1|STARTED|Successful IV Placement & Follow-Up||120
439365|NCT01394250|1076917|P2|NOT COMPLETED|Randomization and IV Placement Attempt||13
439366|NCT01394250|1076918|P1|NOT COMPLETED|Randomization and IV Placement Attempt||14
439367|NCT01394250|1076917|P2|COMPLETED|Randomization and IV Placement Attempt||121
439368|NCT01394250|1076918|P1|COMPLETED|Randomization and IV Placement Attempt||120
439369|NCT01394250|1076917|P2|STARTED|Randomization and IV Placement Attempt||134
439370|NCT01394250|1076918|P1|STARTED|Randomization and IV Placement Attempt||134
439371|NCT01394185|1076926|P6|NOT COMPLETED|Overall Study||1
439372|NCT01394185|1076927|P5|NOT COMPLETED|Overall Study||4
439373|NCT01394185|1076928|P4|NOT COMPLETED|Overall Study||1
439374|NCT01394185|1076929|P3|NOT COMPLETED|Overall Study||0
439375|NCT01394185|1076930|P2|NOT COMPLETED|Overall Study||0
439376|NCT01394185|1076931|P1|NOT COMPLETED|Overall Study||6
439377|NCT01394185|1076926|P6|COMPLETED|Overall Study||2
439378|NCT01394185|1076927|P5|COMPLETED|Overall Study||2
439379|NCT01394185|1076928|P4|COMPLETED|Overall Study||3
439380|NCT01394185|1076929|P3|COMPLETED|Overall Study||2
439381|NCT01394185|1076930|P2|COMPLETED|Overall Study||2
439382|NCT01394185|1076931|P1|COMPLETED|Overall Study||2
439383|NCT01394185|1076926|P6|STARTED|Overall Study||3
439384|NCT01394185|1076927|P5|STARTED|Overall Study||6
439385|NCT01394185|1076928|P4|STARTED|Overall Study||4
439386|NCT01394185|1076929|P3|STARTED|Overall Study||2
439387|NCT01394185|1076930|P2|STARTED|Overall Study||2
439388|NCT01394185|1076931|P1|STARTED|Overall Study||8
439389|NCT01394159|1076944|P2|NOT COMPLETED|Overall Study||0
439390|NCT01394159|1076945|P1|NOT COMPLETED|Overall Study||0
439391|NCT01394159|1076944|P2|COMPLETED|Overall Study||28
439392|NCT01394159|1076945|P1|COMPLETED|Overall Study||28
439393|NCT01394159|1076944|P2|STARTED|Overall Study||28
439394|NCT01394159|1076945|P1|STARTED|Overall Study||28
439395|NCT01394081|1076957|P2|NOT COMPLETED|Overall Study||0
439396|NCT01394081|1076958|P1|NOT COMPLETED|Overall Study||0
439397|NCT01394081|1076957|P2|COMPLETED|Overall Study||102
439398|NCT01394081|1076958|P1|COMPLETED|Overall Study||101
439399|NCT01394081|1076957|P2|STARTED|Overall Study||102
439400|NCT01394081|1076958|P1|STARTED|Overall Study||101
439401|NCT01393964|1076969|P3|NOT COMPLETED|Overall Study||9
439402|NCT01393964|1076970|P2|NOT COMPLETED|Overall Study||9
439403|NCT01393964|1076971|P1|NOT COMPLETED|Overall Study||8
439404|NCT01393964|1076969|P3|COMPLETED|Overall Study|Completed=treatment on-going|0
439405|NCT01393964|1076970|P2|COMPLETED|Overall Study|Completed=treatment on-going|0
439406|NCT01393964|1076971|P1|COMPLETED|Overall Study|Completed=treatment on-going|0
439407|NCT01393964|1076969|P3|STARTED|Overall Study||9
439408|NCT01393964|1076970|P2|STARTED|Overall Study||9
439409|NCT01393964|1076971|P1|STARTED|Overall Study||8
439410|NCT01393899|1077012|P3|NOT COMPLETED|Overall Study||23
439411|NCT01393899|1077013|P2|NOT COMPLETED|Overall Study||28
439412|NCT01393899|1077014|P1|NOT COMPLETED|Overall Study||32
439413|NCT01393899|1077012|P3|COMPLETED|Overall Study||38
439414|NCT01393899|1077013|P2|COMPLETED|Overall Study||32
439415|NCT01393899|1077014|P1|COMPLETED|Overall Study||27
439416|NCT01393899|1077012|P3|STARTED|Overall Study||61
439417|NCT01393899|1077013|P2|STARTED|Overall Study||60
439418|NCT01393899|1077014|P1|STARTED|Overall Study||59
439419|NCT01393743|1077068|P3|NOT COMPLETED|Extension Phase||60
439420|NCT01393743|1077069|P2|NOT COMPLETED|Extension Phase||0
439421|NCT01393743|1077070|P1|NOT COMPLETED|Extension Phase||0
439422|NCT01393743|1077068|P3|COMPLETED|Extension Phase||78
439423|NCT01393743|1077069|P2|COMPLETED|Extension Phase||0
439424|NCT01393743|1077070|P1|COMPLETED|Extension Phase||0
439425|NCT01393743|1077068|P3|STARTED|Extension Phase|Continuation into the Extension Phase was optional.|138
439426|NCT01393743|1077069|P2|STARTED|Extension Phase||0
439427|NCT01393743|1077070|P1|STARTED|Extension Phase||0
439428|NCT01393743|1077068|P3|NOT COMPLETED|Core Study||0
439429|NCT01393743|1077069|P2|NOT COMPLETED|Core Study||13
439430|NCT01393743|1077070|P1|NOT COMPLETED|Core Study||10
439431|NCT01393743|1077068|P3|COMPLETED|Core Study||0
439432|NCT01393743|1077069|P2|COMPLETED|Core Study||68
439433|NCT01393743|1077070|P1|COMPLETED|Core Study||72
439434|NCT01393743|1077068|P3|STARTED|Core Study||0
439435|NCT01393743|1077069|P2|STARTED|Core Study|Treated|81
439436|NCT01393743|1077070|P1|STARTED|Core Study|Treated|82
439437|NCT01393730|1077093|P1|NOT COMPLETED|Overall Study||6
439438|NCT01393730|1077093|P1|COMPLETED|Overall Study||34
439439|NCT01393730|1077093|P1|Evaluable AR Mutation|Overall Study||14
439440|NCT01393730|1077093|P1|Evaluable AR Amplification|Overall Study||21
439441|NCT01393730|1077093|P1|Treated|Overall Study||38
439442|NCT01393730|1077093|P1|STARTED|Overall Study||40
439443|NCT01393717|1077105|P2|NOT COMPLETED|Overall Study||0
439444|NCT01393717|1077106|P1|NOT COMPLETED|Overall Study||0
439445|NCT01393717|1077105|P2|COMPLETED|Overall Study||20
439446|NCT01393717|1077106|P1|COMPLETED|Overall Study||37
439447|NCT01393717|1077105|P2|STARTED|Overall Study||20
439448|NCT01393717|1077106|P1|STARTED|Overall Study||37
439449|NCT01393704|1077120|P2|NOT COMPLETED|Overall Study||0
439450|NCT01393704|1077121|P1|NOT COMPLETED|Overall Study||0
439451|NCT01393704|1077120|P2|COMPLETED|Overall Study||76
439452|NCT01393704|1077121|P1|COMPLETED|Overall Study||76
439453|NCT01393704|1077120|P2|STARTED|Overall Study||76
439454|NCT01393704|1077121|P1|STARTED|Overall Study||76
439455|NCT01393626|1077139|P4|NOT COMPLETED|Overall Study||1
439456|NCT01393626|1077140|P3|NOT COMPLETED|Overall Study||12
439457|NCT01393626|1077141|P2|NOT COMPLETED|Overall Study||12
439458|NCT01393626|1077142|P1|NOT COMPLETED|Overall Study||18
439459|NCT01393626|1077139|P4|COMPLETED|Overall Study||15
439460|NCT01393626|1077140|P3|COMPLETED|Overall Study||74
439461|NCT01393626|1077141|P2|COMPLETED|Overall Study||74
439462|NCT01393626|1077142|P1|COMPLETED|Overall Study||73
439463|NCT01393626|1077139|P4|STARTED|Overall Study||16
439464|NCT01393626|1077140|P3|STARTED|Overall Study||86
439465|NCT01393626|1077141|P2|STARTED|Overall Study||86
439466|NCT01393626|1077142|P1|STARTED|Overall Study||91
439467|NCT01393613|1077222|P4|NOT COMPLETED|Overall Study||66
439468|NCT01393613|1077223|P3|NOT COMPLETED|Overall Study||54
439469|NCT01393613|1077224|P2|NOT COMPLETED|Overall Study||57
439470|NCT01393613|1077225|P1|NOT COMPLETED|Overall Study||39
439471|NCT01393613|1077222|P4|COMPLETED|Overall Study||118
439472|NCT01393613|1077223|P3|COMPLETED|Overall Study||130
439473|NCT01393613|1077224|P2|COMPLETED|Overall Study||129
439474|NCT01393613|1077225|P1|COMPLETED|Overall Study||81
439475|NCT01393613|1077222|P4|STARTED|Overall Study||184
439476|NCT01393613|1077223|P3|STARTED|Overall Study||184
439477|NCT01393613|1077224|P2|STARTED|Overall Study||186
439478|NCT01393613|1077225|P1|STARTED|Overall Study||120
439479|NCT01393600|1077287|P4|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
439480|NCT01393600|1077288|P3|NOT COMPLETED|Follow-up Period (Day 29 to 35)||1
439481|NCT01393600|1077289|P2|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
439482|NCT01393600|1077290|P1|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
439483|NCT01393600|1077287|P4|COMPLETED|Follow-up Period (Day 29 to 35)||8
439484|NCT01393600|1077288|P3|COMPLETED|Follow-up Period (Day 29 to 35)||6
439485|NCT01393600|1077289|P2|COMPLETED|Follow-up Period (Day 29 to 35)||7
439486|NCT01393600|1077290|P1|COMPLETED|Follow-up Period (Day 29 to 35)||9
439487|NCT01393600|1077287|P4|STARTED|Follow-up Period (Day 29 to 35)||8
439488|NCT01393600|1077288|P3|STARTED|Follow-up Period (Day 29 to 35)||7
439489|NCT01393600|1077289|P2|STARTED|Follow-up Period (Day 29 to 35)||7
439490|NCT01393600|1077290|P1|STARTED|Follow-up Period (Day 29 to 35)||9
439491|NCT01393600|1077287|P4|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||1
439492|NCT01393600|1077288|P3|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||2
439493|NCT01393600|1077289|P2|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||0
439494|NCT01393600|1077290|P1|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||0
439495|NCT01393600|1077287|P4|COMPLETED|Treatment Period 2 (Day 15 to 28)||8
439496|NCT01393600|1077288|P3|COMPLETED|Treatment Period 2 (Day 15 to 28)||7
439497|NCT01393600|1077289|P2|COMPLETED|Treatment Period 2 (Day 15 to 28)||7
439498|NCT01393600|1077290|P1|COMPLETED|Treatment Period 2 (Day 15 to 28)||9
439499|NCT01393600|1077287|P4|STARTED|Treatment Period 2 (Day 15 to 28)||9
439500|NCT01393600|1077288|P3|STARTED|Treatment Period 2 (Day 15 to 28)||9
439501|NCT01393600|1077289|P2|STARTED|Treatment Period 2 (Day 15 to 28)||7
439502|NCT01393600|1077290|P1|STARTED|Treatment Period 2 (Day 15 to 28)||9
439503|NCT01393600|1077287|P4|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
439504|NCT01393600|1077288|P3|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
439505|NCT01393600|1077289|P2|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
439506|NCT01393600|1077290|P1|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||0
439507|NCT01393600|1077287|P4|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
439508|NCT01393600|1077288|P3|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
439509|NCT01393600|1077289|P2|COMPLETED|Treatment Period 1 (Day 1 to 14)||7
439510|NCT01393600|1077290|P1|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
439511|NCT01393600|1077287|P4|STARTED|Treatment Period 1 (Day 1 to 14)||10
439512|NCT01393600|1077288|P3|STARTED|Treatment Period 1 (Day 1 to 14)||10
439513|NCT01393600|1077289|P2|STARTED|Treatment Period 1 (Day 1 to 14)||8
439514|NCT01393600|1077290|P1|STARTED|Treatment Period 1 (Day 1 to 14)||9
439515|NCT01393457|1077309|P4|NOT COMPLETED|Overall Study||12
439516|NCT01393457|1077310|P3|NOT COMPLETED|Overall Study||15
439517|NCT01393457|1077311|P2|NOT COMPLETED|Overall Study||12
439518|NCT01393457|1077312|P1|NOT COMPLETED|Overall Study||12
439519|NCT01393457|1077309|P4|COMPLETED|Overall Study||15
439520|NCT01393457|1077310|P3|COMPLETED|Overall Study||16
439521|NCT01393457|1077311|P2|COMPLETED|Overall Study||14
439522|NCT01393457|1077312|P1|COMPLETED|Overall Study||14
439523|NCT01393457|1077309|P4|STARTED|Overall Study||27
439524|NCT01393457|1077310|P3|STARTED|Overall Study||31
439525|NCT01393457|1077311|P2|STARTED|Overall Study||26
439526|NCT01393457|1077312|P1|STARTED|Overall Study||26
439527|NCT01393444|1077326|P1|NOT COMPLETED|Overall Study||3
439528|NCT01393444|1077326|P1|COMPLETED|Overall Study|2015: Third implanted subject completed the study. This fulfilled the requirements of our grant.|3
439529|NCT01393444|1077326|P1|Sixth (3rd Implanted) Subject|Overall Study|2014: Individual with brachial plexus injury enrolled and was eligible. Implanted in 2015.|1
439530|NCT01393444|1077326|P1|Fifth (2nd Implanted) Subject Enrolled|Overall Study|2013: Individual with ALS enrolled and was eligible. Implanted in 2014.|1
439531|NCT01393444|1077326|P1|Fourth Subject Enrolled|Overall Study|2013: Fourth participant enrolled. Ineligible.|1
439532|NCT01393444|1077326|P1|Third Subject Enrolled|Overall Study|2013: Third participant enrolled. Withdrew due to family commitments.|1
439533|NCT01393444|1077326|P1|Second Subject Enrolled|Overall Study|2012: Second participant enrolled. Ineligible.|1
439534|NCT01393444|1077326|P1|First (1st Implanted) Subject Enrolled|Overall Study|2011: Individual with cervical spinal cord injury enrolled and was eligible. Implanted in 2011.|1
439535|NCT01393444|1077326|P1|STARTED|Overall Study||6
439536|NCT01393405|1077331|P3|NOT COMPLETED|Maintenance Period Week||24
439537|NCT01393405|1077332|P2|NOT COMPLETED|Maintenance Period Week||29
439538|NCT01393405|1077333|P1|NOT COMPLETED|Maintenance Period Week||0
439539|NCT01393405|1077331|P3|COMPLETED|Maintenance Period Week||16
439540|NCT01393405|1077332|P2|COMPLETED|Maintenance Period Week||15
439541|NCT01393405|1077333|P1|COMPLETED|Maintenance Period Week||0
439542|NCT01393405|1077331|P3|STARTED|Maintenance Period Week||40
439543|NCT01393405|1077332|P2|STARTED|Maintenance Period Week||44
439544|NCT01393405|1077333|P1|STARTED|Maintenance Period Week||0
439545|NCT01393405|1077331|P3|NOT COMPLETED|Induction Period (week1-16)||0
439546|NCT01393405|1077332|P2|NOT COMPLETED|Induction Period (week1-16)||0
439547|NCT01393405|1077333|P1|NOT COMPLETED|Induction Period (week1-16)||95
439548|NCT01393405|1077331|P3|COMPLETED|Induction Period (week1-16)||0
439549|NCT01393405|1077332|P2|COMPLETED|Induction Period (week1-16)||0
439550|NCT01393405|1077333|P1|COMPLETED|Induction Period (week1-16)||84
439551|NCT01393405|1077331|P3|STARTED|Induction Period (week1-16)||0
439552|NCT01393405|1077332|P2|STARTED|Induction Period (week1-16)||0
439553|NCT01393405|1077333|P1|STARTED|Induction Period (week1-16)||179
439554|NCT01393132|1077352|P2|NOT COMPLETED|Overall Study||0
439555|NCT01393132|1077353|P1|NOT COMPLETED|Overall Study||0
439556|NCT01393132|1077352|P2|COMPLETED|Overall Study||3
439557|NCT01393132|1077353|P1|COMPLETED|Overall Study||6
439558|NCT01393132|1077352|P2|STARTED|Overall Study||3
439559|NCT01393132|1077353|P1|STARTED|Overall Study||6
439560|NCT01393106|1077365|P1|NOT COMPLETED|Overall Study||5
439561|NCT01393106|1077365|P1|COMPLETED|Overall Study|Completed: Disease Progression/Death|20
439562|NCT01393106|1077365|P1|STARTED|Overall Study||25
439563|NCT01392742|1077382|P1|NOT COMPLETED|Overall Study||201
439564|NCT01392742|1077382|P1|COMPLETED|Overall Study||242
439565|NCT01392742|1077382|P1|STARTED|Overall Study||443
439566|NCT01392703|1077397|P3|NOT COMPLETED|Day 9||0
439567|NCT01392703|1077398|P2|NOT COMPLETED|Day 9||0
439568|NCT01392703|1077399|P1|NOT COMPLETED|Day 9||0
439569|NCT01392703|1077397|P3|COMPLETED|Day 9||25
439570|NCT01392703|1077398|P2|COMPLETED|Day 9||26
439571|NCT01392703|1077399|P1|COMPLETED|Day 9||26
439572|NCT01392703|1077397|P3|STARTED|Day 9||25
439573|NCT01392703|1077398|P2|STARTED|Day 9||26
439574|NCT01392703|1077399|P1|STARTED|Day 9||26
439575|NCT01392703|1077397|P3|NOT COMPLETED|Day 5||0
439576|NCT01392703|1077398|P2|NOT COMPLETED|Day 5||0
439577|NCT01392703|1077399|P1|NOT COMPLETED|Day 5||0
439578|NCT01392703|1077397|P3|COMPLETED|Day 5||26
439579|NCT01392703|1077398|P2|COMPLETED|Day 5||25
439580|NCT01392703|1077399|P1|COMPLETED|Day 5||26
439581|NCT01392703|1077397|P3|STARTED|Day 5||26
439582|NCT01392703|1077398|P2|STARTED|Day 5|1 participant no longer met dosing criteria and dropped out during washout period prior to Day 5.|25
439583|NCT01392703|1077399|P1|STARTED|Day 5||26
439584|NCT01392703|1077397|P3|NOT COMPLETED|Day 1||0
439585|NCT01392703|1077398|P2|NOT COMPLETED|Day 1||0
439586|NCT01392703|1077399|P1|NOT COMPLETED|Day 1||0
439587|NCT01392703|1077397|P3|COMPLETED|Day 1||26
439588|NCT01392703|1077398|P2|COMPLETED|Day 1||26
439589|NCT01392703|1077399|P1|COMPLETED|Day 1||26
439590|NCT01392703|1077397|P3|STARTED|Day 1||26
439591|NCT01392703|1077398|P2|STARTED|Day 1||26
439592|NCT01392703|1077399|P1|STARTED|Day 1||26
439593|NCT01392677|1077428|P2|NOT COMPLETED|Overall Study||8
439594|NCT01392677|1077429|P1|NOT COMPLETED|Overall Study||8
439595|NCT01392677|1077428|P2|COMPLETED|Overall Study||101
439596|NCT01392677|1077429|P1|COMPLETED|Overall Study||101
439597|NCT01392677|1077428|P2|STARTED|Overall Study||109
439598|NCT01392677|1077429|P1|STARTED|Overall Study||109
439599|NCT01392625|1077445|P2|NOT COMPLETED|Overall Study||1
439600|NCT01392625|1077446|P1|NOT COMPLETED|Overall Study||2
439601|NCT01392625|1077445|P2|COMPLETED|Overall Study||18
439602|NCT01392625|1077446|P1|COMPLETED|Overall Study||16
439603|NCT01392625|1077445|P2|STARTED|Overall Study||19
439604|NCT01392625|1077446|P1|STARTED|Overall Study||18
439605|NCT01392573|1077464|P2|NOT COMPLETED|Overall Study||35
439606|NCT01392573|1077465|P1|NOT COMPLETED|Overall Study||32
439607|NCT01392573|1077464|P2|COMPLETED|Overall Study||171
439608|NCT01392573|1077465|P1|COMPLETED|Overall Study||175
439609|NCT01392573|1077464|P2|Exposed|Overall Study||206
439610|NCT01392573|1077465|P1|Exposed|Overall Study||207
439611|NCT01392573|1077464|P2|STARTED|Overall Study||206
439612|NCT01392573|1077465|P1|STARTED|Overall Study||207
439613|NCT01392560|1077473|P1|NOT COMPLETED|Overall Study||12
439614|NCT01392560|1077473|P1|COMPLETED|Overall Study||40
439615|NCT01392560|1077473|P1|STARTED|Overall Study||52
439616|NCT01392547|1077479|P1|NOT COMPLETED|Overall Study||8
439617|NCT01392547|1077479|P1|COMPLETED|Overall Study||64
439618|NCT01392547|1077479|P1|STARTED|Overall Study|567 bleeds by 69 subjects, 340 were treated with vatreptacog alfa and 227 with rFVIIa|72
439619|NCT01392495|1077493|P1|NOT COMPLETED|Overall Study||16
439620|NCT01392495|1077493|P1|COMPLETED|Overall Study||1
439621|NCT01392495|1077493|P1|Received 400 mg|Overall Study||13
439622|NCT01392495|1077493|P1|Received 200 mg|Overall Study||4
439623|NCT01392495|1077493|P1|STARTED|Overall Study||17
439624|NCT01392378|1077510|P5|NOT COMPLETED|Toddler Dose||1
439625|NCT01392378|1077511|P4|NOT COMPLETED|Toddler Dose||2
439626|NCT01392378|1077512|P3|NOT COMPLETED|Toddler Dose||0
439627|NCT01392378|1077513|P2|NOT COMPLETED|Toddler Dose||1
439628|NCT01392378|1077514|P1|NOT COMPLETED|Toddler Dose||0
439629|NCT01392378|1077510|P5|COMPLETED|Toddler Dose||208
439630|NCT01392378|1077511|P4|COMPLETED|Toddler Dose||173
439631|NCT01392378|1077512|P3|COMPLETED|Toddler Dose||170
439632|NCT01392378|1077513|P2|COMPLETED|Toddler Dose||172
439633|NCT01392378|1077514|P1|COMPLETED|Toddler Dose||169
439634|NCT01392378|1077510|P5|STARTED|Toddler Dose||209
439635|NCT01392378|1077511|P4|STARTED|Toddler Dose||175
439636|NCT01392378|1077512|P3|STARTED|Toddler Dose||170
439637|NCT01392378|1077513|P2|STARTED|Toddler Dose||173
439638|NCT01392378|1077514|P1|STARTED|Toddler Dose||169
439639|NCT01392378|1077510|P5|NOT COMPLETED|After Infant Series||1
439640|NCT01392378|1077511|P4|NOT COMPLETED|After Infant Series||0
439641|NCT01392378|1077512|P3|NOT COMPLETED|After Infant Series||2
439642|NCT01392378|1077513|P2|NOT COMPLETED|After Infant Series||1
439643|NCT01392378|1077514|P1|NOT COMPLETED|After Infant Series||0
439644|NCT01392378|1077510|P5|COMPLETED|After Infant Series||209
439645|NCT01392378|1077511|P4|COMPLETED|After Infant Series||175
439646|NCT01392378|1077512|P3|COMPLETED|After Infant Series||170
439647|NCT01392378|1077513|P2|COMPLETED|After Infant Series||173
439648|NCT01392378|1077514|P1|COMPLETED|After Infant Series||169
439649|NCT01392378|1077510|P5|STARTED|After Infant Series||210
439650|NCT01392378|1077511|P4|STARTED|After Infant Series||175
439651|NCT01392378|1077512|P3|STARTED|After Infant Series||172
439652|NCT01392378|1077513|P2|STARTED|After Infant Series||174
439653|NCT01392378|1077514|P1|STARTED|After Infant Series||169
439654|NCT01392378|1077510|P5|NOT COMPLETED|Infant Series||0
439655|NCT01392378|1077511|P4|NOT COMPLETED|Infant Series||2
439656|NCT01392378|1077512|P3|NOT COMPLETED|Infant Series||0
439657|NCT01392378|1077513|P2|NOT COMPLETED|Infant Series||2
439658|NCT01392378|1077514|P1|NOT COMPLETED|Infant Series||4
439659|NCT01392378|1077510|P5|COMPLETED|Infant Series||210
439660|NCT01392378|1077511|P4|COMPLETED|Infant Series||175
439661|NCT01392378|1077512|P3|COMPLETED|Infant Series||172
439662|NCT01392378|1077513|P2|COMPLETED|Infant Series||174
439663|NCT01392378|1077514|P1|COMPLETED|Infant Series||169
439664|NCT01392378|1077510|P5|Vaccinated Dose 3|Infant Series||210
439665|NCT01392378|1077511|P4|Vaccinated Dose 3|Infant Series||176
439666|NCT01392378|1077512|P3|Vaccinated Dose 3|Infant Series||172
439667|NCT01392378|1077513|P2|Vaccinated Dose 3|Infant Series||174
439668|NCT01392378|1077514|P1|Vaccinated Dose 3|Infant Series||170
439669|NCT01392378|1077510|P5|Vaccinated Dose 2|Infant Series||210
439670|NCT01392378|1077511|P4|Vaccinated Dose 2|Infant Series||177
439671|NCT01392378|1077512|P3|Vaccinated Dose 2|Infant Series||172
439672|NCT01392378|1077513|P2|Vaccinated Dose 2|Infant Series||174
439673|NCT01392378|1077514|P1|Vaccinated Dose 2|Infant Series||171
439674|NCT01392378|1077510|P5|Vaccinated Dose 1|Infant Series||210
439675|NCT01392378|1077511|P4|Vaccinated Dose 1|Infant Series||177
439676|NCT01392378|1077512|P3|Vaccinated Dose 1|Infant Series||172
439677|NCT01392378|1077513|P2|Vaccinated Dose 1|Infant Series||176
439678|NCT01392378|1077514|P1|Vaccinated Dose 1|Infant Series||173
439679|NCT01392378|1077510|P5|STARTED|Infant Series||210
439680|NCT01392378|1077511|P4|STARTED|Infant Series||177
439681|NCT01392378|1077512|P3|STARTED|Infant Series||172
439682|NCT01392378|1077513|P2|STARTED|Infant Series||176
439683|NCT01392378|1077514|P1|STARTED|Infant Series||173
439684|NCT01392326|1077654|P3|NOT COMPLETED|Overall Study||48
439685|NCT01392326|1077655|P2|NOT COMPLETED|Overall Study||35
439686|NCT01392326|1077656|P1|NOT COMPLETED|Overall Study||47
439687|NCT01392326|1077654|P3|COMPLETED|Overall Study||154
439688|NCT01392326|1077655|P2|COMPLETED|Overall Study||167
439689|NCT01392326|1077656|P1|COMPLETED|Overall Study||155
439690|NCT01392326|1077654|P3|STARTED|Overall Study||202
439691|NCT01392326|1077655|P2|STARTED|Overall Study||202
439692|NCT01392326|1077656|P1|STARTED|Overall Study||202
439693|NCT01392300|1077693|P3|NOT COMPLETED|Open Label Extension (OLEX) Period||51
439694|NCT01392300|1077694|P2|NOT COMPLETED|Open Label Extension (OLEX) Period||0
439695|NCT01392300|1077695|P1|NOT COMPLETED|Open Label Extension (OLEX) Period||0
439696|NCT01392300|1077693|P3|COMPLETED|Open Label Extension (OLEX) Period||248
439697|NCT01392300|1077694|P2|COMPLETED|Open Label Extension (OLEX) Period||0
439698|NCT01392300|1077695|P1|COMPLETED|Open Label Extension (OLEX) Period||0
439699|NCT01392300|1077693|P3|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|299
439700|NCT01392300|1077694|P2|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|0
439701|NCT01392300|1077695|P1|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|0
439702|NCT01392300|1077693|P3|NOT COMPLETED|Main Period (MP)||0
439703|NCT01392300|1077694|P2|NOT COMPLETED|Main Period (MP)||7
439704|NCT01392300|1077695|P1|NOT COMPLETED|Main Period (MP)||11
439705|NCT01392300|1077693|P3|COMPLETED|Main Period (MP)||0
439706|NCT01392300|1077694|P2|COMPLETED|Main Period (MP)||100
439707|NCT01392300|1077695|P1|COMPLETED|Main Period (MP)||199
439708|NCT01392300|1077693|P3|STARTED|Main Period (MP)||0
439709|NCT01392300|1077694|P2|STARTED|Main Period (MP)||107
439710|NCT01392300|1077695|P1|STARTED|Main Period (MP)||210
439711|NCT01392170|1077800|P1|NOT COMPLETED|Overall Study||2
439712|NCT01392170|1077800|P1|COMPLETED|Overall Study||0
439713|NCT01392170|1077800|P1|STARTED|Overall Study||2
439714|NCT01392053|1077806|P2|NOT COMPLETED|Overall Study||0
439715|NCT01392053|1077807|P1|NOT COMPLETED|Overall Study||0
439716|NCT01392053|1077806|P2|COMPLETED|Overall Study||23
439717|NCT01392053|1077807|P1|COMPLETED|Overall Study||23
439718|NCT01392053|1077806|P2|STARTED|Overall Study||23
439719|NCT01392053|1077807|P1|STARTED|Overall Study||23
439720|NCT01391858|1077827|P2|NOT COMPLETED|Overall Study||0
439721|NCT01391858|1077828|P1|NOT COMPLETED|Overall Study||2
439722|NCT01391858|1077827|P2|COMPLETED|Overall Study||24
439723|NCT01391858|1077828|P1|COMPLETED|Overall Study||23
439724|NCT01391858|1077827|P2|STARTED|Overall Study||24
439725|NCT01391858|1077828|P1|STARTED|Overall Study||25
439726|NCT01391819|1077848|P1|NOT COMPLETED|Overall Study||402
439727|NCT01391819|1077848|P1|COMPLETED|Overall Study||1714
439728|NCT01391819|1077848|P1|STARTED|Overall Study||2116
439729|NCT01391663|1077879|P4|NOT COMPLETED|Overall Study||0
439730|NCT01391663|1077880|P3|NOT COMPLETED|Overall Study||1
439731|NCT01391663|1077881|P2|NOT COMPLETED|Overall Study||0
439732|NCT01391663|1077882|P1|NOT COMPLETED|Overall Study||0
439733|NCT01391663|1077879|P4|COMPLETED|Overall Study||12
439734|NCT01391663|1077880|P3|COMPLETED|Overall Study||11
439735|NCT01391663|1077881|P2|COMPLETED|Overall Study||12
439736|NCT01391663|1077882|P1|COMPLETED|Overall Study||12
439737|NCT01391663|1077879|P4|STARTED|Overall Study||12
439738|NCT01391663|1077880|P3|STARTED|Overall Study||12
439739|NCT01391663|1077881|P2|STARTED|Overall Study||12
439740|NCT01391663|1077882|P1|STARTED|Overall Study||12
439741|NCT01391611|1077912|P1|NOT COMPLETED|Overall Study||22
439742|NCT01391611|1077912|P1|COMPLETED|Overall Study||3
439743|NCT01391611|1077912|P1|STARTED|Overall Study||25
439744|NCT01391559|1077917|P2|NOT COMPLETED|Second Intervention||0
439745|NCT01391559|1077918|P1|NOT COMPLETED|Second Intervention||0
439746|NCT01391559|1077917|P2|COMPLETED|Second Intervention||10
439747|NCT01391559|1077918|P1|COMPLETED|Second Intervention||10
439748|NCT01391559|1077917|P2|STARTED|Second Intervention||10
439749|NCT01391559|1077918|P1|STARTED|Second Intervention||10
439750|NCT01391559|1077917|P2|NOT COMPLETED|First Intervention||0
439751|NCT01391559|1077918|P1|NOT COMPLETED|First Intervention||0
439752|NCT01391559|1077917|P2|COMPLETED|First Intervention||10
439753|NCT01391559|1077918|P1|COMPLETED|First Intervention||10
439754|NCT01391559|1077917|P2|STARTED|First Intervention||10
439755|NCT01391559|1077918|P1|STARTED|First Intervention||10
439756|NCT01391546|1077926|P2|NOT COMPLETED|Overall Study||0
439757|NCT01391546|1077927|P1|NOT COMPLETED|Overall Study||1
439758|NCT01391546|1077926|P2|COMPLETED|Overall Study||177
439759|NCT01391546|1077927|P1|COMPLETED|Overall Study||176
439760|NCT01391546|1077926|P2|Vaccinated|Overall Study||177
439761|NCT01391546|1077927|P1|Vaccinated|Overall Study||176
439762|NCT01391546|1077926|P2|STARTED|Overall Study||177
439763|NCT01391546|1077927|P1|STARTED|Overall Study||177
439764|NCT01391507|1077949|P4|NOT COMPLETED|Overall Study||7
439765|NCT01391507|1077950|P3|NOT COMPLETED|Overall Study||4
439766|NCT01391507|1077951|P2|NOT COMPLETED|Overall Study||4
439767|NCT01391507|1077952|P1|NOT COMPLETED|Overall Study||4
439768|NCT01391507|1077949|P4|COMPLETED|Overall Study||5
439769|NCT01391507|1077950|P3|COMPLETED|Overall Study||2
439770|NCT01391507|1077951|P2|COMPLETED|Overall Study||4
439771|NCT01391507|1077952|P1|COMPLETED|Overall Study||6
439772|NCT01391507|1077949|P4|STARTED|Overall Study||12
439773|NCT01391507|1077950|P3|STARTED|Overall Study||6
439774|NCT01391507|1077951|P2|STARTED|Overall Study||8
439775|NCT01391507|1077952|P1|STARTED|Overall Study||10
439776|NCT01391468|1078000|P2|NOT COMPLETED|Overall Study||2
439777|NCT01391468|1078001|P1|NOT COMPLETED|Overall Study||6
439778|NCT01391468|1078000|P2|COMPLETED|Overall Study||21
439779|NCT01391468|1078001|P1|COMPLETED|Overall Study||18
439780|NCT01391468|1078000|P2|STARTED|Overall Study||23
439781|NCT01391468|1078001|P1|STARTED|Overall Study||24
439782|NCT01391325|1078013|P1|NOT COMPLETED|Overall Study||494
439783|NCT01391325|1078013|P1|COMPLETED|Overall Study||1238
439784|NCT01391325|1078013|P1|STARTED|Overall Study||1732
439785|NCT01391312|1078022|P2|NOT COMPLETED|Overall Study||1
439786|NCT01391312|1078023|P1|NOT COMPLETED|Overall Study||2
439787|NCT01391312|1078022|P2|COMPLETED|Overall Study||19
439788|NCT01391312|1078023|P1|COMPLETED|Overall Study||18
439789|NCT01391312|1078022|P2|STARTED|Overall Study||20
439790|NCT01391312|1078023|P1|STARTED|Overall Study||20
439791|NCT01391299|1078036|P3|NOT COMPLETED|Overall Study||2
439792|NCT01391299|1078037|P2|NOT COMPLETED|Overall Study||1
439793|NCT01391299|1078038|P1|NOT COMPLETED|Overall Study||0
439794|NCT01391299|1078036|P3|COMPLETED|Overall Study||56
439795|NCT01391299|1078037|P2|COMPLETED|Overall Study||59
439796|NCT01391299|1078038|P1|COMPLETED|Overall Study||57
439797|NCT01391299|1078036|P3|STARTED|Overall Study||58
439798|NCT01391299|1078037|P2|STARTED|Overall Study||60
439799|NCT01391299|1078038|P1|STARTED|Overall Study||57
439800|NCT01391286|1078060|P2|NOT COMPLETED|Overall Study||0
439801|NCT01391286|1078061|P1|NOT COMPLETED|Overall Study||0
439802|NCT01391286|1078060|P2|COMPLETED|Overall Study||18
439803|NCT01391286|1078061|P1|COMPLETED|Overall Study||18
439804|NCT01391286|1078060|P2|STARTED|Overall Study||18
439805|NCT01391286|1078061|P1|STARTED|Overall Study||18
439806|NCT01391273|1078075|P2|NOT COMPLETED|Overall Study||2
439807|NCT01391273|1078076|P1|NOT COMPLETED|Overall Study||4
439808|NCT01391273|1078075|P2|COMPLETED|Overall Study||83
439809|NCT01391273|1078076|P1|COMPLETED|Overall Study||84
439810|NCT01391273|1078075|P2|STARTED|Overall Study||85
439811|NCT01391273|1078076|P1|STARTED|Overall Study||88
439812|NCT01391013|1078090|P2|NOT COMPLETED|Overall Study||0
439813|NCT01391013|1078091|P1|NOT COMPLETED|Overall Study||0
439814|NCT01391013|1078090|P2|COMPLETED|Overall Study||15
439815|NCT01391013|1078091|P1|COMPLETED|Overall Study||15
439816|NCT01391013|1078090|P2|STARTED|Overall Study||15
439817|NCT01391013|1078091|P1|STARTED|Overall Study||15
439818|NCT01391000|1078131|P2|NOT COMPLETED|Overall Study||0
439819|NCT01391000|1078132|P1|NOT COMPLETED|Overall Study||2
439820|NCT01391000|1078131|P2|COMPLETED|Overall Study||35
439821|NCT01391000|1078132|P1|COMPLETED|Overall Study||33
439822|NCT01391000|1078131|P2|STARTED|Overall Study||35
439823|NCT01391000|1078132|P1|STARTED|Overall Study||35
439824|NCT01390948|1078145|P3|NOT COMPLETED|Overall Study||3
439825|NCT01390948|1078146|P2|NOT COMPLETED|Overall Study||62
439826|NCT01390948|1078147|P1|NOT COMPLETED|Overall Study||59
439827|NCT01390948|1078145|P3|COMPLETED|Overall Study||0
439828|NCT01390948|1078146|P2|COMPLETED|Overall Study||0
439829|NCT01390948|1078147|P1|COMPLETED|Overall Study||0
439830|NCT01390948|1078145|P3|Treated|Overall Study||3
439831|NCT01390948|1078146|P2|Treated|Overall Study||60
439832|NCT01390948|1078147|P1|Treated|Overall Study||56
439833|NCT01390948|1078145|P3|STARTED|Overall Study||3
439834|NCT01390948|1078146|P2|STARTED|Overall Study||62
439835|NCT01390948|1078147|P1|STARTED|Overall Study||59
439836|NCT01390909|1078186|P6|NOT COMPLETED|Overall Study||0
439837|NCT01390909|1078187|P5|NOT COMPLETED|Overall Study||0
439838|NCT01390909|1078188|P4|NOT COMPLETED|Overall Study||0
439839|NCT01390909|1078189|P3|NOT COMPLETED|Overall Study||0
439840|NCT01390909|1078190|P2|NOT COMPLETED|Overall Study||0
439841|NCT01390909|1078191|P1|NOT COMPLETED|Overall Study||0
439842|NCT01390909|1078186|P6|COMPLETED|Overall Study||613
439843|NCT01390909|1078187|P5|COMPLETED|Overall Study||613
439844|NCT01390909|1078188|P4|COMPLETED|Overall Study||602
439845|NCT01390909|1078189|P3|COMPLETED|Overall Study||3552
439846|NCT01390909|1078190|P2|COMPLETED|Overall Study||3552
439847|NCT01390909|1078191|P1|COMPLETED|Overall Study||3454
439848|NCT01390909|1078186|P6|Participants in Subgroup|Overall Study||0
439849|NCT01390909|1078187|P5|Participants in Subgroup|Overall Study||602
439850|NCT01390909|1078188|P4|Participants in Subgroup|Overall Study||0
439851|NCT01390909|1078189|P3|Participants in Subgroup|Overall Study||0
439852|NCT01390909|1078190|P2|Participants in Subgroup|Overall Study||3454
439853|NCT01390909|1078191|P1|Participants in Subgroup|Overall Study||0
439854|NCT01390909|1078186|P6|STARTED|Overall Study||613
439855|NCT01390909|1078187|P5|STARTED|Overall Study||613
439856|NCT01390909|1078188|P4|STARTED|Overall Study||602
439857|NCT01390909|1078189|P3|STARTED|Overall Study||3552
439858|NCT01390909|1078190|P2|STARTED|Overall Study||3552
439859|NCT01390909|1078191|P1|STARTED|Overall Study||3454
439860|NCT01390870|1078209|P1|NOT COMPLETED|Overall Study||0
439861|NCT01390870|1078209|P1|COMPLETED|Overall Study||400
439862|NCT01390870|1078209|P1|STARTED|Overall Study||400
439863|NCT01390857|1078213|P1|NOT COMPLETED|Overall Study||10
439864|NCT01390857|1078213|P1|COMPLETED|Overall Study||369
439865|NCT01390857|1078213|P1|STARTED|Overall Study||379
439866|NCT01390844|1078224|P4|NOT COMPLETED|Follow-Up Phase||0
439867|NCT01390844|1078225|P3|NOT COMPLETED|Follow-Up Phase||1
439868|NCT01390844|1078226|P2|NOT COMPLETED|Follow-Up Phase||1
439869|NCT01390844|1078227|P1|NOT COMPLETED|Follow-Up Phase||1
439870|NCT01390844|1078224|P4|COMPLETED|Follow-Up Phase||8
439871|NCT01390844|1078225|P3|COMPLETED|Follow-Up Phase||25
439872|NCT01390844|1078226|P2|COMPLETED|Follow-Up Phase||36
439873|NCT01390844|1078227|P1|COMPLETED|Follow-Up Phase||92
439874|NCT01390844|1078224|P4|STARTED|Follow-Up Phase||8
439875|NCT01390844|1078225|P3|STARTED|Follow-Up Phase||26
439876|NCT01390844|1078226|P2|STARTED|Follow-Up Phase||37
439877|NCT01390844|1078227|P1|STARTED|Follow-Up Phase||93
439878|NCT01390844|1078224|P4|NOT COMPLETED|Treatment Phase||19
439879|NCT01390844|1078225|P3|NOT COMPLETED|Treatment Phase||31
439880|NCT01390844|1078226|P2|NOT COMPLETED|Treatment Phase||28
439881|NCT01390844|1078227|P1|NOT COMPLETED|Treatment Phase||40
439882|NCT01390844|1078224|P4|COMPLETED|Treatment Phase||8
439883|NCT01390844|1078225|P3|COMPLETED|Treatment Phase||26
439884|NCT01390844|1078226|P2|COMPLETED|Treatment Phase||37
439885|NCT01390844|1078227|P1|COMPLETED|Treatment Phase||93
439886|NCT01390844|1078224|P4|Followed Good Clinical Practice (GCP)|Treatment Phase||24
439887|NCT01390844|1078225|P3|Followed Good Clinical Practice (GCP)|Treatment Phase||47
439888|NCT01390844|1078226|P2|Followed Good Clinical Practice (GCP)|Treatment Phase||65
439889|NCT01390844|1078227|P1|Followed Good Clinical Practice (GCP)|Treatment Phase||133
439890|NCT01390844|1078224|P4|STARTED|Treatment Phase||27
439891|NCT01390844|1078225|P3|STARTED|Treatment Phase||57
439892|NCT01390844|1078226|P2|STARTED|Treatment Phase||65
439893|NCT01390844|1078227|P1|STARTED|Treatment Phase||133
439894|NCT01390818|1078268|P15|NOT COMPLETED|Overall Study||0
439895|NCT01390818|1078269|P14|NOT COMPLETED|Overall Study||0
439896|NCT01390818|1078270|P13|NOT COMPLETED|Overall Study||0
439897|NCT01390818|1078271|P12|NOT COMPLETED|Overall Study||0
439898|NCT01390818|1078272|P11|NOT COMPLETED|Overall Study||0
439899|NCT01390818|1078273|P10|NOT COMPLETED|Overall Study||0
439900|NCT01390818|1078274|P9|NOT COMPLETED|Overall Study||0
439901|NCT01390818|1078275|P8|NOT COMPLETED|Overall Study||0
439902|NCT01390818|1078276|P7|NOT COMPLETED|Overall Study||0
439903|NCT01390818|1078277|P6|NOT COMPLETED|Overall Study||0
439904|NCT01390818|1078278|P5|NOT COMPLETED|Overall Study||0
439905|NCT01390818|1078279|P4|NOT COMPLETED|Overall Study||0
439906|NCT01390818|1078280|P3|NOT COMPLETED|Overall Study||0
439907|NCT01390818|1078281|P2|NOT COMPLETED|Overall Study||0
439908|NCT01390818|1078282|P1|NOT COMPLETED|Overall Study||0
439909|NCT01390818|1078268|P15|COMPLETED|Overall Study||15
439910|NCT01390818|1078269|P14|COMPLETED|Overall Study||18
439911|NCT01390818|1078270|P13|COMPLETED|Overall Study||24
439912|NCT01390818|1078271|P12|COMPLETED|Overall Study||26
439913|NCT01390818|1078272|P11|COMPLETED|Overall Study||4
439914|NCT01390818|1078273|P10|COMPLETED|Overall Study||3
439915|NCT01390818|1078274|P9|COMPLETED|Overall Study||3
439916|NCT01390818|1078275|P8|COMPLETED|Overall Study||14
439917|NCT01390818|1078276|P7|COMPLETED|Overall Study||19
439918|NCT01390818|1078277|P6|COMPLETED|Overall Study||3
439919|NCT01390818|1078278|P5|COMPLETED|Overall Study||4
439920|NCT01390818|1078279|P4|COMPLETED|Overall Study||4
439921|NCT01390818|1078280|P3|COMPLETED|Overall Study||3
439922|NCT01390818|1078281|P2|COMPLETED|Overall Study||3
439923|NCT01390818|1078282|P1|COMPLETED|Overall Study||3
439924|NCT01390818|1078268|P15|STARTED|Overall Study||15
439925|NCT01390818|1078269|P14|STARTED|Overall Study||18
439926|NCT01390818|1078270|P13|STARTED|Overall Study||24
439927|NCT01390818|1078271|P12|STARTED|Overall Study||26
439928|NCT01390818|1078272|P11|STARTED|Overall Study||4
439929|NCT01390818|1078273|P10|STARTED|Overall Study||3
439930|NCT01390818|1078274|P9|STARTED|Overall Study||3
439931|NCT01390818|1078275|P8|STARTED|Overall Study||14
439932|NCT01390818|1078276|P7|STARTED|Overall Study||19
439933|NCT01390818|1078277|P6|STARTED|Overall Study||3
439934|NCT01390818|1078278|P5|STARTED|Overall Study||4
439935|NCT01390818|1078279|P4|STARTED|Overall Study||4
439936|NCT01390818|1078280|P3|STARTED|Overall Study||3
439937|NCT01390818|1078281|P2|STARTED|Overall Study||3
439938|NCT01390818|1078282|P1|STARTED|Overall Study||3
439939|NCT01390779|1078554|P1|NOT COMPLETED|Overall Study||1
439940|NCT01390779|1078554|P1|COMPLETED|Overall Study||32
439941|NCT01390779|1078554|P1|STARTED|Overall Study||33
439942|NCT01390649|1078559|P1|NOT COMPLETED|Overall Study||1
439943|NCT01390649|1078559|P1|COMPLETED|Overall Study||56
439944|NCT01390649|1078559|P1|STARTED|Overall Study|Subjects treated with Privigen|57
439945|NCT01390441|1078569|P5|NOT COMPLETED|Extension Period||0
439946|NCT01390441|1078570|P4|NOT COMPLETED|Extension Period||1
439947|NCT01390441|1078571|P3|NOT COMPLETED|Extension Period||0
439948|NCT01390441|1078572|P2|NOT COMPLETED|Extension Period||1
439949|NCT01390441|1078573|P1|NOT COMPLETED|Extension Period||3
439950|NCT01390441|1078569|P5|COMPLETED|Extension Period||3
439951|NCT01390441|1078570|P4|COMPLETED|Extension Period||0
439952|NCT01390441|1078571|P3|COMPLETED|Extension Period||1
439953|NCT01390441|1078572|P2|COMPLETED|Extension Period||12
439954|NCT01390441|1078573|P1|COMPLETED|Extension Period||12
439955|NCT01390441|1078569|P5|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|3
439956|NCT01390441|1078570|P4|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|1
439957|NCT01390441|1078571|P3|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|1
439958|NCT01390441|1078572|P2|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|13
439959|NCT01390441|1078573|P1|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|15
439960|NCT01390441|1078569|P5|NOT COMPLETED|Treatment Period||11
439961|NCT01390441|1078570|P4|NOT COMPLETED|Treatment Period||13
439962|NCT01390441|1078571|P3|NOT COMPLETED|Treatment Period||10
439963|NCT01390441|1078572|P2|NOT COMPLETED|Treatment Period||1
439964|NCT01390441|1078573|P1|NOT COMPLETED|Treatment Period||1
439965|NCT01390441|1078569|P5|COMPLETED|Treatment Period||7
439966|NCT01390441|1078570|P4|COMPLETED|Treatment Period||6
439967|NCT01390441|1078571|P3|COMPLETED|Treatment Period||8
439968|NCT01390441|1078572|P2|COMPLETED|Treatment Period||21
439969|NCT01390441|1078573|P1|COMPLETED|Treatment Period||22
439970|NCT01390441|1078569|P5|STARTED|Treatment Period||18
439971|NCT01390441|1078570|P4|STARTED|Treatment Period||19
439972|NCT01390441|1078571|P3|STARTED|Treatment Period||18
439973|NCT01390441|1078572|P2|STARTED|Treatment Period||22
439974|NCT01390441|1078573|P1|STARTED|Treatment Period||23
439975|NCT01390428|1078638|P6|NOT COMPLETED|Overall Study||0
439976|NCT01390428|1078639|P5|NOT COMPLETED|Overall Study||1
439977|NCT01390428|1078640|P4|NOT COMPLETED|Overall Study||0
439978|NCT01390428|1078641|P3|NOT COMPLETED|Overall Study||1
439979|NCT01390428|1078642|P2|NOT COMPLETED|Overall Study||0
439980|NCT01390428|1078643|P1|NOT COMPLETED|Overall Study||0
439981|NCT01390428|1078638|P6|COMPLETED|Overall Study||8
439982|NCT01390428|1078639|P5|COMPLETED|Overall Study||7
439983|NCT01390428|1078640|P4|COMPLETED|Overall Study||9
439984|NCT01390428|1078641|P3|COMPLETED|Overall Study||8
439985|NCT01390428|1078642|P2|COMPLETED|Overall Study||8
439986|NCT01390428|1078643|P1|COMPLETED|Overall Study||8
439987|NCT01390428|1078638|P6|STARTED|Overall Study||8
439988|NCT01390428|1078639|P5|STARTED|Overall Study||8
439989|NCT01390428|1078640|P4|STARTED|Overall Study||9
439990|NCT01390428|1078641|P3|STARTED|Overall Study||9
439991|NCT01390428|1078642|P2|STARTED|Overall Study||8
439992|NCT01390428|1078643|P1|STARTED|Overall Study||8
439993|NCT01390415|1078695|P2|NOT COMPLETED|Overall Study||0
439994|NCT01390415|1078696|P1|NOT COMPLETED|Overall Study||0
439995|NCT01390415|1078695|P2|COMPLETED|Overall Study||37
439996|NCT01390415|1078696|P1|COMPLETED|Overall Study||99
439997|NCT01390415|1078695|P2|STARTED|Overall Study||37
439998|NCT01390415|1078696|P1|STARTED|Overall Study||99
439999|NCT01390402|1078706|P1|NOT COMPLETED|Overall Study||5
440000|NCT01390402|1078706|P1|COMPLETED|Overall Study||1
440001|NCT01390402|1078706|P1|STARTED|Overall Study||6
440002|NCT01390389|1078712|P2|NOT COMPLETED|Overall Study||1
440003|NCT01390389|1078713|P1|NOT COMPLETED|Overall Study||4
440004|NCT01390389|1078712|P2|COMPLETED|Overall Study||8
440005|NCT01390389|1078713|P1|COMPLETED|Overall Study||6
440006|NCT01390389|1078712|P2|STARTED|Overall Study||9
440007|NCT01390389|1078713|P1|STARTED|Overall Study||10
440008|NCT01390259|1078723|P2|NOT COMPLETED|Overall Study||0
440009|NCT01390259|1078724|P1|NOT COMPLETED|Overall Study||0
440010|NCT01390259|1078723|P2|COMPLETED|Overall Study||6
440011|NCT01390259|1078724|P1|COMPLETED|Overall Study||5
440012|NCT01390259|1078723|P2|STARTED|Overall Study||6
440013|NCT01390259|1078724|P1|STARTED|Overall Study||5
440014|NCT01390246|1078735|P2|NOT COMPLETED|Overall Study||25
440015|NCT01390246|1078736|P1|NOT COMPLETED|Overall Study||20
440016|NCT01390246|1078735|P2|COMPLETED|Overall Study||10
440017|NCT01390246|1078736|P1|COMPLETED|Overall Study||10
440018|NCT01390246|1078735|P2|Visit 7: 36-38 Weeks Gestation|Overall Study||10
440019|NCT01390246|1078736|P1|Visit 7: 36-38 Weeks Gestation|Overall Study||10
440020|NCT01390246|1078735|P2|Visit 6: End of Treatment|Overall Study||15
440021|NCT01390246|1078736|P1|Visit 6: End of Treatment|Overall Study||15
440022|NCT01390246|1078735|P2|Visit 2: Quit Day|Overall Study||24
440023|NCT01390246|1078736|P1|Visit 2: Quit Day|Overall Study||24
440024|NCT01390246|1078735|P2|STARTED|Overall Study||35
440025|NCT01390246|1078736|P1|STARTED|Overall Study||30
440026|NCT01390233|1078751|P3|NOT COMPLETED|Overall Study||6
440027|NCT01390233|1078752|P2|NOT COMPLETED|Overall Study||2
440028|NCT01390233|1078753|P1|NOT COMPLETED|Overall Study||5
440029|NCT01390233|1078751|P3|COMPLETED|Overall Study||30
440030|NCT01390233|1078752|P2|COMPLETED|Overall Study||29
440031|NCT01390233|1078753|P1|COMPLETED|Overall Study||30
440032|NCT01390233|1078751|P3|STARTED|Overall Study||36
440033|NCT01390233|1078752|P2|STARTED|Overall Study||31
440034|NCT01390233|1078753|P1|STARTED|Overall Study||35
440035|NCT01390181|1078761|P1|NOT COMPLETED|Overall Study||4
440036|NCT01390181|1078761|P1|COMPLETED|Overall Study||0
440037|NCT01390181|1078761|P1|STARTED|Overall Study||4
440038|NCT01390038|1078765|P1|NOT COMPLETED|Overall Study||8
440039|NCT01390038|1078765|P1|COMPLETED|Overall Study||149
440040|NCT01390038|1078765|P1|STARTED|Overall Study||157
440041|NCT01389973|1078775|P1|NOT COMPLETED|Overall Study||20
440042|NCT01389973|1078775|P1|COMPLETED|Overall Study||0
440043|NCT01389973|1078775|P1|STARTED|Overall Study||20
440044|NCT01389882|1078785|P2|NOT COMPLETED|Overall Study||4
440045|NCT01389882|1078786|P1|NOT COMPLETED|Overall Study||1
440046|NCT01389882|1078785|P2|COMPLETED|Overall Study||7
440047|NCT01389882|1078786|P1|COMPLETED|Overall Study||12
440048|NCT01389882|1078785|P2|STARTED|Overall Study||11
440049|NCT01389882|1078786|P1|STARTED|Overall Study||13
440050|NCT01389856|1078816|P2|NOT COMPLETED|Overall Study||0
440051|NCT01389856|1078817|P1|NOT COMPLETED|Overall Study||0
440052|NCT01389856|1078816|P2|COMPLETED|Overall Study||8
440053|NCT01389856|1078817|P1|COMPLETED|Overall Study||13
440054|NCT01389856|1078816|P2|STARTED|Overall Study|Randomized and treated.|8
440055|NCT01389856|1078817|P1|STARTED|Overall Study|Randomized and treated. An additional 2 patients were randomized but not treated.|13
440056|NCT01389817|1078874|P2|NOT COMPLETED|Overall Study||0
440057|NCT01389817|1078875|P1|NOT COMPLETED|Overall Study||4
440058|NCT01389817|1078874|P2|COMPLETED|Overall Study||0
440059|NCT01389817|1078875|P1|COMPLETED|Overall Study||0
440060|NCT01389817|1078874|P2|STARTED|Overall Study||0
440061|NCT01389817|1078875|P1|STARTED|Overall Study||4
440062|NCT01389596|1078884|P3|NOT COMPLETED|Overall Study||10
440063|NCT01389596|1078885|P2|NOT COMPLETED|Overall Study||16
440064|NCT01389596|1078886|P1|NOT COMPLETED|Overall Study||10
440065|NCT01389596|1078884|P3|COMPLETED|Overall Study||84
440066|NCT01389596|1078885|P2|COMPLETED|Overall Study||81
440067|NCT01389596|1078886|P1|COMPLETED|Overall Study||94
440068|NCT01389596|1078884|P3|STARTED|Overall Study||94
440069|NCT01389596|1078885|P2|STARTED|Overall Study||97
440070|NCT01389596|1078886|P1|STARTED|Overall Study||104
440071|NCT01389323|1078945|P1|NOT COMPLETED|Follow-up Period (up to 48 Weeks)||37
440072|NCT01389323|1078945|P1|COMPLETED|Follow-up Period (up to 48 Weeks)||184
440073|NCT01389323|1078945|P1|STARTED|Follow-up Period (up to 48 Weeks)|Out of 246 participants who entered the treatment period, 221 continued in the follow-up period.|221
440074|NCT01389323|1078945|P1|NOT COMPLETED|Treatment Period (up to 48 Weeks)||95
440075|NCT01389323|1078945|P1|COMPLETED|Treatment Period (up to 48 Weeks)||151
440076|NCT01389323|1078945|P1|STARTED|Treatment Period (up to 48 Weeks)||246
440077|NCT01389284|1078968|P3|NOT COMPLETED|Overall Study||0
440078|NCT01389284|1078969|P2|NOT COMPLETED|Overall Study||0
440079|NCT01389284|1078970|P1|NOT COMPLETED|Overall Study||0
440080|NCT01389284|1078968|P3|COMPLETED|Overall Study||60
440081|NCT01389284|1078969|P2|COMPLETED|Overall Study||120
440082|NCT01389284|1078970|P1|COMPLETED|Overall Study||120
440083|NCT01389284|1078968|P3|STARTED|Overall Study||60
440084|NCT01389284|1078969|P2|STARTED|Overall Study||120
440085|NCT01389284|1078970|P1|STARTED|Overall Study||120
440086|NCT01389102|1079008|P6|NOT COMPLETED|Overall Study||8
440087|NCT01389102|1079009|P5|NOT COMPLETED|Overall Study||13
440088|NCT01389102|1079010|P4|NOT COMPLETED|Overall Study||7
440089|NCT01389102|1079011|P3|NOT COMPLETED|Overall Study||19
440090|NCT01389102|1079012|P2|NOT COMPLETED|Overall Study||12
440091|NCT01389102|1079013|P1|NOT COMPLETED|Overall Study||18
440092|NCT01389102|1079008|P6|COMPLETED|Overall Study||68
440093|NCT01389102|1079009|P5|COMPLETED|Overall Study||61
440094|NCT01389102|1079010|P4|COMPLETED|Overall Study||69
440095|NCT01389102|1079011|P3|COMPLETED|Overall Study||58
440096|NCT01389102|1079012|P2|COMPLETED|Overall Study||64
440097|NCT01389102|1079013|P1|COMPLETED|Overall Study||57
440098|NCT01389102|1079008|P6|STARTED|Overall Study||76
440099|NCT01389102|1079009|P5|STARTED|Overall Study||74
440100|NCT01389102|1079010|P4|STARTED|Overall Study||76
440101|NCT01389102|1079011|P3|STARTED|Overall Study||77
440102|NCT01389102|1079012|P2|STARTED|Overall Study||76
440103|NCT01389102|1079013|P1|STARTED|Overall Study||75
440104|NCT01389076|1079033|P1|NOT COMPLETED|Overall Study||0
440105|NCT01389076|1079033|P1|COMPLETED|Overall Study||22
440106|NCT01389076|1079033|P1|STARTED|Overall Study||22
440107|NCT01388946|1079043|P2|NOT COMPLETED|Overall Study||3
440108|NCT01388946|1079044|P1|NOT COMPLETED|Overall Study||6
440109|NCT01388946|1079043|P2|COMPLETED|Overall Study||52
440110|NCT01388946|1079044|P1|COMPLETED|Overall Study||49
440111|NCT01388946|1079043|P2|STARTED|Overall Study||55
440112|NCT01388946|1079044|P1|STARTED|Overall Study||55
440113|NCT01388920|1079079|P3|NOT COMPLETED|Overall Study||0
440114|NCT01388920|1079080|P2|NOT COMPLETED|Overall Study||0
440115|NCT01388920|1079081|P1|NOT COMPLETED|Overall Study||0
440116|NCT01388920|1079079|P3|COMPLETED|Overall Study||0
440117|NCT01388920|1079080|P2|COMPLETED|Overall Study||1
440118|NCT01388920|1079081|P1|COMPLETED|Overall Study||1
440119|NCT01388920|1079079|P3|STARTED|Overall Study||0
440120|NCT01388920|1079080|P2|STARTED|Overall Study||1
440121|NCT01388920|1079081|P1|STARTED|Overall Study||1
440122|NCT01388907|1079091|P2|NOT COMPLETED|Overall Study||0
440123|NCT01388907|1079092|P1|NOT COMPLETED|Overall Study||2
440124|NCT01388907|1079091|P2|COMPLETED|Overall Study||28
440125|NCT01388907|1079092|P1|COMPLETED|Overall Study||31
440126|NCT01388907|1079091|P2|STARTED|Overall Study||28
440127|NCT01388907|1079092|P1|STARTED|Overall Study||33
440128|NCT01388816|1079108|P4|NOT COMPLETED|Overall Study||0
440129|NCT01388816|1079109|P3|NOT COMPLETED|Overall Study||3
440130|NCT01388816|1079110|P2|NOT COMPLETED|Overall Study||4
440131|NCT01388816|1079111|P1|NOT COMPLETED|Overall Study||2
440132|NCT01388816|1079108|P4|COMPLETED|Overall Study||44
440133|NCT01388816|1079109|P3|COMPLETED|Overall Study||41
440134|NCT01388816|1079110|P2|COMPLETED|Overall Study||39
440135|NCT01388816|1079111|P1|COMPLETED|Overall Study||43
440136|NCT01388816|1079108|P4|STARTED|Overall Study||44
440137|NCT01388816|1079109|P3|STARTED|Overall Study||44
440138|NCT01388816|1079110|P2|STARTED|Overall Study||43
440139|NCT01388816|1079111|P1|STARTED|Overall Study||45
440140|NCT01388790|1079140|P1|NOT COMPLETED|Overall Study||8
440141|NCT01388790|1079140|P1|COMPLETED|Overall Study||32
440142|NCT01388790|1079140|P1|STARTED|Overall Study||40
440143|NCT01388647|1079147|P2|NOT COMPLETED|Overall Study||2
440144|NCT01388647|1079148|P1|NOT COMPLETED|Overall Study||1
440145|NCT01388647|1079147|P2|COMPLETED|Overall Study|two subjects ended study treatment due to adverse events|4
440146|NCT01388647|1079148|P1|COMPLETED|Overall Study|one subject ended study treatment due to adverse events|5
440147|NCT01388647|1079147|P2|STARTED|Overall Study||6
440148|NCT01388647|1079148|P1|STARTED|Overall Study||6
440149|NCT01388530|1079159|P1|NOT COMPLETED|Overall Study||5
440150|NCT01388530|1079159|P1|COMPLETED|Overall Study||20
440151|NCT01388530|1079159|P1|STARTED|Overall Study||25
440152|NCT01388491|1079168|P2|NOT COMPLETED|Overall Study||29
440153|NCT01388491|1079169|P1|NOT COMPLETED|Overall Study||34
440154|NCT01388491|1079168|P2|COMPLETED|Overall Study||114
440155|NCT01388491|1079169|P1|COMPLETED|Overall Study||116
440156|NCT01388491|1079168|P2|Per Protocol (PP) Population|Overall Study||121
440157|NCT01388491|1079169|P1|Per Protocol (PP) Population|Overall Study|PP: all data from ITT participants obtained prior to any major protocol violations|125
440158|NCT01388491|1079168|P2|Intent-to-Treat (ITT) Population|Overall Study||136
440159|NCT01388491|1079169|P1|Intent-to-Treat (ITT) Population|Overall Study|ITT:participants in safety population with baseline (BL) + ≥1 post-BL prothrombin fragment 1+2 value|140
440160|NCT01388491|1079168|P2|Safety Population|Overall Study||142
440161|NCT01388491|1079169|P1|Safety Population|Overall Study|Safety: all randomized participants who took 1 or more doses of study drug|145
440162|NCT01388491|1079168|P2|STARTED|Overall Study||143
440163|NCT01388491|1079169|P1|STARTED|Overall Study|number randomized|150
440164|NCT01388361|1079204|P3|NOT COMPLETED|Overall Study||14
440165|NCT01388361|1079205|P2|NOT COMPLETED|Overall Study||12
440166|NCT01388361|1079206|P1|NOT COMPLETED|Overall Study||12
440167|NCT01388361|1079204|P3|COMPLETED|Overall Study||75
440168|NCT01388361|1079205|P2|COMPLETED|Overall Study||76
440169|NCT01388361|1079206|P1|COMPLETED|Overall Study||224
440170|NCT01388361|1079204|P3|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug.|86
440171|NCT01388361|1079205|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug.|87
440172|NCT01388361|1079206|P1|Exposed|Overall Study|Two subjects withdrew prior to exposure to IDeg during NN1250-3948|234
440173|NCT01388361|1079204|P3|STARTED|Overall Study||89
440174|NCT01388361|1079205|P2|STARTED|Overall Study||88
440175|NCT01388361|1079206|P1|STARTED|Overall Study||236
440176|NCT01388166|1079223|P1|NOT COMPLETED|Overall Study||59
440177|NCT01388166|1079223|P1|COMPLETED|Overall Study||1194
440178|NCT01388166|1079223|P1|STARTED|Overall Study||1253
440179|NCT01387789|1079229|P1|NOT COMPLETED|Overall Study||8
440180|NCT01387789|1079229|P1|COMPLETED|Overall Study||63
440181|NCT01387789|1079229|P1|STARTED|Overall Study||71
440182|NCT01387737|1079243|P2|NOT COMPLETED|Overall Study||74
440183|NCT01387737|1079244|P1|NOT COMPLETED|Overall Study||52
440184|NCT01387737|1079243|P2|COMPLETED|Overall Study||641
440185|NCT01387737|1079244|P1|COMPLETED|Overall Study||532
440186|NCT01387737|1079243|P2|STARTED|Overall Study||715
440187|NCT01387737|1079244|P1|STARTED|Overall Study||584
440188|NCT01387672|1079256|P6|NOT COMPLETED|Overall Study||0
440189|NCT01387672|1079257|P5|NOT COMPLETED|Overall Study||4
440190|NCT01387672|1079258|P4|NOT COMPLETED|Overall Study||4
440191|NCT01387672|1079259|P3|NOT COMPLETED|Overall Study||5
440192|NCT01387672|1079260|P2|NOT COMPLETED|Overall Study||7
440193|NCT01387672|1079261|P1|NOT COMPLETED|Overall Study||7
440194|NCT01387672|1079256|P6|COMPLETED|Overall Study||37
440195|NCT01387672|1079257|P5|COMPLETED|Overall Study||34
440196|NCT01387672|1079258|P4|COMPLETED|Overall Study||35
440197|NCT01387672|1079259|P3|COMPLETED|Overall Study||33
440198|NCT01387672|1079260|P2|COMPLETED|Overall Study||31
440199|NCT01387672|1079261|P1|COMPLETED|Overall Study||32
440200|NCT01387672|1079256|P6|STARTED|Overall Study||37
440201|NCT01387672|1079257|P5|STARTED|Overall Study||38
440202|NCT01387672|1079258|P4|STARTED|Overall Study||39
440203|NCT01387672|1079259|P3|STARTED|Overall Study||38
440204|NCT01387672|1079260|P2|STARTED|Overall Study||38
440205|NCT01387672|1079261|P1|STARTED|Overall Study||39
440206|NCT01387594|1079278|P2|NOT COMPLETED|Overall Study||3
440207|NCT01387594|1079279|P1|NOT COMPLETED|Overall Study||0
440208|NCT01387594|1079278|P2|COMPLETED|Overall Study||36
440209|NCT01387594|1079279|P1|COMPLETED|Overall Study||10
440210|NCT01387594|1079278|P2|STARTED|Overall Study||39
440211|NCT01387594|1079279|P1|STARTED|Overall Study||10
440212|NCT01387581|1079294|P3|NOT COMPLETED|Overall Study||3
440213|NCT01387581|1079295|P2|NOT COMPLETED|Overall Study||6
440214|NCT01387581|1079296|P1|NOT COMPLETED|Overall Study||7
440215|NCT01387581|1079294|P3|COMPLETED|Overall Study||9
440216|NCT01387581|1079295|P2|COMPLETED|Overall Study||101
440217|NCT01387581|1079296|P1|COMPLETED|Overall Study||101
440218|NCT01387581|1079294|P3|STARTED|Overall Study||12
440219|NCT01387581|1079295|P2|STARTED|Overall Study||107
440220|NCT01387581|1079296|P1|STARTED|Overall Study||108
440221|NCT01387542|1079307|P1|NOT COMPLETED|Overall Study||8
440222|NCT01387542|1079307|P1|COMPLETED|Overall Study||32
440223|NCT01387542|1079307|P1|Treated|Overall Study||38
440224|NCT01387542|1079307|P1|STARTED|Overall Study||40
440225|NCT01387464|1079316|P2|NOT COMPLETED|Overall Study||1
440226|NCT01387464|1079317|P1|NOT COMPLETED|Overall Study||1
440227|NCT01387464|1079316|P2|COMPLETED|Overall Study||29
440228|NCT01387464|1079317|P1|COMPLETED|Overall Study||29
440229|NCT01387464|1079316|P2|Per-Protocol Population|Overall Study||29
440230|NCT01387464|1079317|P1|Per-Protocol Population|Overall Study|Safety subjects who completed surgery|29
440231|NCT01387464|1079316|P2|Safety Population|Overall Study||29
440232|NCT01387464|1079317|P1|Safety Population|Overall Study||30
440233|NCT01387464|1079316|P2|STARTED|Overall Study||30
440234|NCT01387464|1079317|P1|STARTED|Overall Study||30
440235|NCT01387347|1079325|P2|NOT COMPLETED|Overall Study||1
440236|NCT01387347|1079326|P1|NOT COMPLETED|Overall Study||2
440237|NCT01387347|1079325|P2|COMPLETED|Overall Study||35
440238|NCT01387347|1079326|P1|COMPLETED|Overall Study||34
440239|NCT01387347|1079325|P2|STARTED|Overall Study||36
440240|NCT01387347|1079326|P1|STARTED|Overall Study||36
440241|NCT01387282|1079338|P2|NOT COMPLETED|Overall Study||47
440242|NCT01387282|1079339|P1|NOT COMPLETED|Overall Study||97
440243|NCT01387282|1079338|P2|COMPLETED|Overall Study||118
440244|NCT01387282|1079339|P1|COMPLETED|Overall Study||233
440245|NCT01387282|1079338|P2|Safety Population|Overall Study||161
440246|NCT01387282|1079339|P1|Safety Population|Overall Study||330
440247|NCT01387282|1079338|P2|MITT Population|Overall Study||136
440248|NCT01387282|1079339|P1|MITT Population|Overall Study||268
440249|NCT01387282|1079338|P2|ITT Population|Overall Study||165
440250|NCT01387282|1079339|P1|ITT Population|Overall Study||330
440251|NCT01387282|1079338|P2|STARTED|Overall Study||165
440252|NCT01387282|1079339|P1|STARTED|Overall Study||330
440253|NCT01387269|1079355|P2|NOT COMPLETED|Overall Study||40
440254|NCT01387269|1079356|P1|NOT COMPLETED|Overall Study||92
440255|NCT01387269|1079355|P2|COMPLETED|Overall Study||121
440256|NCT01387269|1079356|P1|COMPLETED|Overall Study||231
440257|NCT01387269|1079355|P2|Safety Population|Overall Study||161
440258|NCT01387269|1079356|P1|Safety Population|Overall Study||320
440259|NCT01387269|1079355|P2|MITT Population|Overall Study||141
440260|NCT01387269|1079356|P1|MITT Population|Overall Study||284
440261|NCT01387269|1079355|P2|ITT Population|Overall Study||161
440262|NCT01387269|1079356|P1|ITT Population|Overall Study||323
440263|NCT01387269|1079355|P2|STARTED|Overall Study||161
440264|NCT01387269|1079356|P1|STARTED|Overall Study||323
440265|NCT01387230|1079373|P3|NOT COMPLETED|Overall Study||13
440266|NCT01387230|1079374|P2|NOT COMPLETED|Overall Study||7
440267|NCT01387230|1079375|P1|NOT COMPLETED|Overall Study||18
440268|NCT01387230|1079373|P3|COMPLETED|Overall Study||56
440269|NCT01387230|1079374|P2|COMPLETED|Overall Study||62
440270|NCT01387230|1079375|P1|COMPLETED|Overall Study||50
440271|NCT01387230|1079373|P3|STARTED|Overall Study||69
440272|NCT01387230|1079374|P2|STARTED|Overall Study||69
440273|NCT01387230|1079375|P1|STARTED|Overall Study||68
440274|NCT01387178|1079391|P2|NOT COMPLETED|Overall Study||0
440275|NCT01387178|1079392|P1|NOT COMPLETED|Overall Study||0
440276|NCT01387178|1079391|P2|COMPLETED|Overall Study||10641
440277|NCT01387178|1079392|P1|COMPLETED|Overall Study||11582
440278|NCT01387178|1079391|P2|STARTED|Overall Study||10641
440279|NCT01387178|1079392|P1|STARTED|Overall Study||11582
440280|NCT01387139|1079404|P2|NOT COMPLETED|Overall Study||0
440281|NCT01387139|1079405|P1|NOT COMPLETED|Overall Study||0
440282|NCT01387139|1079404|P2|COMPLETED|Overall Study||84
440283|NCT01387139|1079405|P1|COMPLETED|Overall Study||99
440284|NCT01387139|1079404|P2|STARTED|Overall Study||84
440285|NCT01387139|1079405|P1|STARTED|Overall Study||99
440286|NCT01387074|1079421|P1|NOT COMPLETED|Overall Study||8
440287|NCT01387074|1079421|P1|COMPLETED|Overall Study||100
440288|NCT01387074|1079421|P1|STARTED|Overall Study||108
440289|NCT01387022|1079434|P2|NOT COMPLETED|Overall Study||4
440290|NCT01387022|1079435|P1|NOT COMPLETED|Overall Study||1
440291|NCT01387022|1079434|P2|COMPLETED|Overall Study||26
440292|NCT01387022|1079435|P1|COMPLETED|Overall Study||28
440293|NCT01387022|1079434|P2|STARTED|Overall Study||30
440294|NCT01387022|1079435|P1|STARTED|Overall Study||29
440295|NCT01386983|1079453|P2|NOT COMPLETED|Overall Study||0
440296|NCT01386983|1079454|P1|NOT COMPLETED|Overall Study||0
440297|NCT01386983|1079453|P2|COMPLETED|Overall Study||68
440298|NCT01386983|1079454|P1|COMPLETED|Overall Study||264
440299|NCT01386983|1079453|P2|STARTED|Overall Study||68
440300|NCT01386983|1079454|P1|STARTED|Overall Study||264
440301|NCT01386944|1079462|P1|NOT COMPLETED|Overall Study||56
440302|NCT01386944|1079462|P1|COMPLETED|Overall Study||46
440303|NCT01386944|1079462|P1|STARTED|Overall Study||102
440304|NCT01386788|1079472|P1|NOT COMPLETED|Overall Study||2
440305|NCT01386788|1079472|P1|COMPLETED|Overall Study||100
440306|NCT01386788|1079472|P1|STARTED|Overall Study||102
440307|NCT01386684|1079477|P1|NOT COMPLETED|Overall Study||293
440308|NCT01386684|1079477|P1|COMPLETED|Overall Study||259
440309|NCT01386684|1079477|P1|STARTED|Overall Study||552
440310|NCT01386632|1079518|P2|NOT COMPLETED|Overall Study||4
440311|NCT01386632|1079519|P1|NOT COMPLETED|Overall Study||5
440312|NCT01386632|1079518|P2|COMPLETED|Overall Study||21
440313|NCT01386632|1079519|P1|COMPLETED|Overall Study||20
440314|NCT01386632|1079518|P2|STARTED|Overall Study||25
440315|NCT01386632|1079519|P1|STARTED|Overall Study||25
440316|NCT01386606|1079531|P4|NOT COMPLETED|Overall Study||1
440317|NCT01386606|1079532|P3|NOT COMPLETED|Overall Study||3
440318|NCT01386606|1079533|P2|NOT COMPLETED|Overall Study||4
440319|NCT01386606|1079534|P1|NOT COMPLETED|Overall Study||4
440320|NCT01386606|1079531|P4|COMPLETED|Overall Study||13
440321|NCT01386606|1079532|P3|COMPLETED|Overall Study||13
440322|NCT01386606|1079533|P2|COMPLETED|Overall Study||10
440323|NCT01386606|1079534|P1|COMPLETED|Overall Study||12
440324|NCT01386606|1079531|P4|STARTED|Overall Study||14
440325|NCT01386606|1079532|P3|STARTED|Overall Study||16
440326|NCT01386606|1079533|P2|STARTED|Overall Study||14
440327|NCT01386606|1079534|P1|STARTED|Overall Study||16
440328|NCT01386554|1079565|P3|NOT COMPLETED|Overall Study||6
440329|NCT01386554|1079566|P2|NOT COMPLETED|Overall Study||9
440330|NCT01386554|1079567|P1|NOT COMPLETED|Overall Study||3
440331|NCT01386554|1079565|P3|COMPLETED|Overall Study||15
440332|NCT01386554|1079566|P2|COMPLETED|Overall Study||26
440333|NCT01386554|1079567|P1|COMPLETED|Overall Study||1
440334|NCT01386554|1079565|P3|STARTED|Overall Study||21
440335|NCT01386554|1079566|P2|STARTED|Overall Study||35
440336|NCT01386554|1079567|P1|STARTED|Overall Study||4
440337|NCT01386528|1079581|P1|NOT COMPLETED|Overall Study||0
440338|NCT01386528|1079581|P1|COMPLETED|Overall Study||13
440339|NCT01386528|1079581|P1|STARTED|Overall Study||13
440340|NCT01386125|1079593|P2|NOT COMPLETED|Overall Study||37
440341|NCT01386125|1079594|P1|NOT COMPLETED|Overall Study||25
440342|NCT01386125|1079593|P2|COMPLETED|Overall Study||336
440343|NCT01386125|1079594|P1|COMPLETED|Overall Study||350
440344|NCT01386125|1079593|P2|STARTED|Overall Study||373
440345|NCT01386125|1079594|P1|STARTED|Overall Study||375
440346|NCT01386008|1079602|P1|NOT COMPLETED|Overall Study||20
440347|NCT01386008|1079602|P1|COMPLETED|Overall Study||0
440348|NCT01386008|1079602|P1|STARTED|Overall Study||20
440349|NCT01385995|1079611|P2|NOT COMPLETED|Period 2, 2 Months||0
440350|NCT01385995|1079612|P1|NOT COMPLETED|Period 2, 2 Months||0
440351|NCT01385995|1079611|P2|COMPLETED|Period 2, 2 Months||25
440352|NCT01385995|1079612|P1|COMPLETED|Period 2, 2 Months||24
440353|NCT01385995|1079611|P2|STARTED|Period 2, 2 Months||25
440354|NCT01385995|1079612|P1|STARTED|Period 2, 2 Months||24
440355|NCT01385995|1079611|P2|NOT COMPLETED|Washout Period, 1 Month||0
440356|NCT01385995|1079612|P1|NOT COMPLETED|Washout Period, 1 Month||0
440357|NCT01385995|1079611|P2|COMPLETED|Washout Period, 1 Month||25
440358|NCT01385995|1079612|P1|COMPLETED|Washout Period, 1 Month||24
440359|NCT01385995|1079611|P2|STARTED|Washout Period, 1 Month||25
440360|NCT01385995|1079612|P1|STARTED|Washout Period, 1 Month||24
440361|NCT01385995|1079611|P2|NOT COMPLETED|Period 1, 2 Months||0
440362|NCT01385995|1079612|P1|NOT COMPLETED|Period 1, 2 Months||1
440363|NCT01385995|1079611|P2|COMPLETED|Period 1, 2 Months||25
440364|NCT01385995|1079612|P1|COMPLETED|Period 1, 2 Months||24
440365|NCT01385995|1079611|P2|STARTED|Period 1, 2 Months||25
440366|NCT01385995|1079612|P1|STARTED|Period 1, 2 Months||25
440367|NCT01385748|1079629|P3|NOT COMPLETED|Overall Study||13
440368|NCT01385748|1079630|P2|NOT COMPLETED|Overall Study||14
440369|NCT01385748|1079631|P1|NOT COMPLETED|Overall Study||15
440370|NCT01385748|1079629|P3|COMPLETED|Overall Study||49
440371|NCT01385748|1079630|P2|COMPLETED|Overall Study||51
440372|NCT01385748|1079631|P1|COMPLETED|Overall Study||41
440373|NCT01385748|1079629|P3|STARTED|Overall Study||62
440374|NCT01385748|1079630|P2|STARTED|Overall Study||65
440375|NCT01385748|1079631|P1|STARTED|Overall Study||56
440376|NCT01385696|1079676|P2|NOT COMPLETED|Overall Study||0
440377|NCT01385696|1079677|P1|NOT COMPLETED|Overall Study||0
440378|NCT01385696|1079676|P2|COMPLETED|Overall Study||64
440379|NCT01385696|1079677|P1|COMPLETED|Overall Study||66
440380|NCT01385696|1079676|P2|STARTED|Overall Study|1 patient used Handihaler® once only, Genuair® zero times, & was excluded from the safety population|64
440381|NCT01385696|1079677|P1|STARTED|Overall Study||66
440382|NCT01385644|1079688|P2|NOT COMPLETED|Overall Study||0
440383|NCT01385644|1079689|P1|NOT COMPLETED|Overall Study||0
440384|NCT01385644|1079688|P2|COMPLETED|Overall Study||4
440385|NCT01385644|1079689|P1|COMPLETED|Overall Study||4
440386|NCT01385644|1079688|P2|STARTED|Overall Study||4
440387|NCT01385644|1079689|P1|STARTED|Overall Study||4
440388|NCT01385579|1079703|P2|NOT COMPLETED|Overall Study||0
440389|NCT01385579|1079704|P1|NOT COMPLETED|Overall Study||0
440390|NCT01385579|1079703|P2|COMPLETED|Overall Study||104
440391|NCT01385579|1079704|P1|COMPLETED|Overall Study||98
440392|NCT01385579|1079703|P2|STARTED|Overall Study||104
440393|NCT01385579|1079704|P1|STARTED|Overall Study||98
440394|NCT01385566|1079716|P6|NOT COMPLETED|Overall Study||0
440395|NCT01385566|1079717|P5|NOT COMPLETED|Overall Study||0
440396|NCT01385566|1079718|P4|NOT COMPLETED|Overall Study||1
440397|NCT01385566|1079719|P3|NOT COMPLETED|Overall Study||0
440398|NCT01385566|1079720|P2|NOT COMPLETED|Overall Study||0
440399|NCT01385566|1079721|P1|NOT COMPLETED|Overall Study||1
440400|NCT01385566|1079716|P6|COMPLETED|Overall Study||34
440401|NCT01385566|1079717|P5|COMPLETED|Overall Study||34
440402|NCT01385566|1079718|P4|COMPLETED|Overall Study||34
440403|NCT01385566|1079719|P3|COMPLETED|Overall Study||34
440404|NCT01385566|1079720|P2|COMPLETED|Overall Study||34
440405|NCT01385566|1079721|P1|COMPLETED|Overall Study||51
440406|NCT01385566|1079716|P6|STARTED|Overall Study||34
440407|NCT01385566|1079717|P5|STARTED|Overall Study||34
440408|NCT01385566|1079718|P4|STARTED|Overall Study||35
440409|NCT01385566|1079719|P3|STARTED|Overall Study||34
440410|NCT01385566|1079720|P2|STARTED|Overall Study||34
440411|NCT01385566|1079721|P1|STARTED|Overall Study||52
440412|NCT01385371|1079775|P2|NOT COMPLETED|Overall Study||97
440413|NCT01385371|1079776|P1|NOT COMPLETED|Overall Study||149
440414|NCT01385371|1079775|P2|COMPLETED|Overall Study||652
440415|NCT01385371|1079776|P1|COMPLETED|Overall Study||603
440416|NCT01385371|1079775|P2|STARTED|Overall Study||749
440417|NCT01385371|1079776|P1|STARTED|Overall Study||752
440418|NCT01385293|1079796|P1|NOT COMPLETED|Overall Study||0
440419|NCT01385293|1079796|P1|COMPLETED|Overall Study||30
440420|NCT01385293|1079796|P1|STARTED|Overall Study||30
440421|NCT01385202|1079806|P1|NOT COMPLETED|Overall Study||18
440422|NCT01385202|1079806|P1|COMPLETED|Overall Study||154
440423|NCT01385202|1079806|P1|Undergoing Ablation|Overall Study||160
440424|NCT01385202|1079806|P1|Study Catheter Inserted|Overall Study||161
440425|NCT01385202|1079806|P1|STARTED|Overall Study|Per protocol, enrolled subjects were defined as those who signed inform consent form.|172
440426|NCT01385189|1079818|P5|NOT COMPLETED|Overall Study||2
440427|NCT01385189|1079819|P4|NOT COMPLETED|Overall Study||1
440428|NCT01385189|1079820|P3|NOT COMPLETED|Overall Study||0
440429|NCT01385189|1079821|P2|NOT COMPLETED|Overall Study||1
440430|NCT01385189|1079822|P1|NOT COMPLETED|Overall Study||1
440431|NCT01385189|1079818|P5|COMPLETED|Overall Study||6
440432|NCT01385189|1079819|P4|COMPLETED|Overall Study||3
440433|NCT01385189|1079820|P3|COMPLETED|Overall Study||4
440434|NCT01385189|1079821|P2|COMPLETED|Overall Study||11
440435|NCT01385189|1079822|P1|COMPLETED|Overall Study||11
440436|NCT01385189|1079818|P5|STARTED|Overall Study||8
440437|NCT01385189|1079819|P4|STARTED|Overall Study||4
440438|NCT01385189|1079820|P3|STARTED|Overall Study||4
440439|NCT01385189|1079821|P2|STARTED|Overall Study||12
440440|NCT01385189|1079822|P1|STARTED|Overall Study||12
440441|NCT01385137|1079843|P2|NOT COMPLETED|Evaluable for Primary Endpoint||24
440442|NCT01385137|1079844|P1|NOT COMPLETED|Evaluable for Primary Endpoint||29
440443|NCT01385137|1079843|P2|COMPLETED|Evaluable for Primary Endpoint||107
440444|NCT01385137|1079844|P1|COMPLETED|Evaluable for Primary Endpoint||102
440445|NCT01385137|1079843|P2|STARTED|Evaluable for Primary Endpoint||131
440446|NCT01385137|1079844|P1|STARTED|Evaluable for Primary Endpoint||131
440447|NCT01385137|1079843|P2|NOT COMPLETED|Evaluable at Baseline||4
440448|NCT01385137|1079844|P1|NOT COMPLETED|Evaluable at Baseline||9
440449|NCT01385137|1079843|P2|COMPLETED|Evaluable at Baseline||127
440450|NCT01385137|1079844|P1|COMPLETED|Evaluable at Baseline||122
440451|NCT01385137|1079843|P2|STARTED|Evaluable at Baseline||131
440452|NCT01385137|1079844|P1|STARTED|Evaluable at Baseline||131
440453|NCT01385098|1079858|P1|NOT COMPLETED|Overall Study||14
440454|NCT01385098|1079858|P1|COMPLETED|Overall Study|14 subjects did not complete. 4 subjects loss to follow-up & 10 subjects could not tolerate suppl.|23
440455|NCT01385098|1079858|P1|STARTED|Overall Study||37
440456|NCT01385033|1079866|P6|NOT COMPLETED|Part III||0
440457|NCT01385033|1079867|P5|NOT COMPLETED|Part III||0
440458|NCT01385033|1079868|P4|NOT COMPLETED|Part III||0
440459|NCT01385033|1079869|P3|NOT COMPLETED|Part III||0
440460|NCT01385033|1079870|P2|NOT COMPLETED|Part III||0
440461|NCT01385033|1079871|P1|NOT COMPLETED|Part III||0
440462|NCT01385033|1079866|P6|COMPLETED|Part III||0
440463|NCT01385033|1079867|P5|COMPLETED|Part III||0
440464|NCT01385033|1079868|P4|COMPLETED|Part III||0
440465|NCT01385033|1079869|P3|COMPLETED|Part III||0
440466|NCT01385033|1079870|P2|COMPLETED|Part III||0
440467|NCT01385033|1079871|P1|COMPLETED|Part III||0
440468|NCT01385033|1079866|P6|STARTED|Part III||0
440469|NCT01385033|1079867|P5|STARTED|Part III||0
440470|NCT01385033|1079868|P4|STARTED|Part III||0
440471|NCT01385033|1079869|P3|STARTED|Part III||0
440472|NCT01385033|1079870|P2|STARTED|Part III||0
440473|NCT01385033|1079871|P1|STARTED|Part III||0
440474|NCT01385033|1079866|P6|NOT COMPLETED|Part II||0
440475|NCT01385033|1079867|P5|NOT COMPLETED|Part II||0
440476|NCT01385033|1079868|P4|NOT COMPLETED|Part II||0
440477|NCT01385033|1079869|P3|NOT COMPLETED|Part II||0
440478|NCT01385033|1079870|P2|NOT COMPLETED|Part II||0
440479|NCT01385033|1079871|P1|NOT COMPLETED|Part II||0
440480|NCT01385033|1079866|P6|COMPLETED|Part II||0
440481|NCT01385033|1079867|P5|COMPLETED|Part II||0
440482|NCT01385033|1079868|P4|COMPLETED|Part II||0
440483|NCT01385033|1079869|P3|COMPLETED|Part II||0
440484|NCT01385033|1079870|P2|COMPLETED|Part II||0
440485|NCT01385033|1079871|P1|COMPLETED|Part II||0
440486|NCT01385033|1079866|P6|STARTED|Part II||0
440487|NCT01385033|1079867|P5|STARTED|Part II||0
440488|NCT01385033|1079868|P4|STARTED|Part II||0
440489|NCT01385033|1079869|P3|STARTED|Part II||0
440490|NCT01385033|1079870|P2|STARTED|Part II||0
440491|NCT01385033|1079871|P1|STARTED|Part II||0
440492|NCT01385033|1079866|P6|NOT COMPLETED|Part I||0
440493|NCT01385033|1079867|P5|NOT COMPLETED|Part I||0
440494|NCT01385033|1079868|P4|NOT COMPLETED|Part I||0
440495|NCT01385033|1079869|P3|NOT COMPLETED|Part I||0
440496|NCT01385033|1079870|P2|NOT COMPLETED|Part I||0
440497|NCT01385033|1079871|P1|NOT COMPLETED|Part I||0
440498|NCT01385033|1079866|P6|COMPLETED|Part I||0
440499|NCT01385033|1079867|P5|COMPLETED|Part I||0
440500|NCT01385033|1079868|P4|COMPLETED|Part I||0
440501|NCT01385033|1079869|P3|COMPLETED|Part I||0
440502|NCT01385033|1079870|P2|COMPLETED|Part I||14
440503|NCT01385033|1079871|P1|COMPLETED|Part I||6
440504|NCT01385033|1079866|P6|STARTED|Part I||0
440505|NCT01385033|1079867|P5|STARTED|Part I||0
440506|NCT01385033|1079868|P4|STARTED|Part I||0
440507|NCT01385033|1079869|P3|STARTED|Part I||0
440508|NCT01385033|1079870|P2|STARTED|Part I|These subjects did not participate in Part II or III|14
440509|NCT01385033|1079871|P1|STARTED|Part I|These subjects did not participate in Part II or III|6
440510|NCT01384760|1079880|P2|NOT COMPLETED|Overall Study||6
440511|NCT01384760|1079881|P1|NOT COMPLETED|Overall Study||16
440512|NCT01384760|1079880|P2|COMPLETED|Overall Study||37
440513|NCT01384760|1079881|P1|COMPLETED|Overall Study||45
440514|NCT01384760|1079880|P2|Randomized|Overall Study||43
440515|NCT01384760|1079881|P1|Randomized|Overall Study||61
440516|NCT01384760|1079880|P2|STARTED|Overall Study||43
440517|NCT01384760|1079881|P1|STARTED|Overall Study||61
440518|NCT01384591|1079892|P3|NOT COMPLETED|Overall Study||0
440519|NCT01384591|1079893|P2|NOT COMPLETED|Overall Study||0
440520|NCT01384591|1079894|P1|NOT COMPLETED|Overall Study||0
440521|NCT01384591|1079892|P3|COMPLETED|Overall Study||2
440522|NCT01384591|1079893|P2|COMPLETED|Overall Study||2
440523|NCT01384591|1079894|P1|COMPLETED|Overall Study||2
440524|NCT01384591|1079892|P3|STARTED|Overall Study||2
440525|NCT01384591|1079893|P2|STARTED|Overall Study||2
440526|NCT01384591|1079894|P1|STARTED|Overall Study||2
440527|NCT01384539|1080024|P2|NOT COMPLETED|Overall Study||7
440528|NCT01384539|1080025|P1|NOT COMPLETED|Overall Study||6
440529|NCT01384539|1080024|P2|COMPLETED|Overall Study||57
440530|NCT01384539|1080025|P1|COMPLETED|Overall Study||58
440531|NCT01384539|1080024|P2|STARTED|Overall Study||64
440532|NCT01384539|1080025|P1|STARTED|Overall Study||64
440533|NCT01384292|1080034|P3|NOT COMPLETED|Part B||0
440534|NCT01384292|1080035|P2|NOT COMPLETED|Part B||0
440535|NCT01384292|1080036|P1|NOT COMPLETED|Part B||1
440536|NCT01384292|1080034|P3|COMPLETED|Part B||0
440537|NCT01384292|1080035|P2|COMPLETED|Part B||6
440538|NCT01384292|1080036|P1|COMPLETED|Part B||2
440539|NCT01384292|1080034|P3|STARTED|Part B||0
440540|NCT01384292|1080035|P2|STARTED|Part B||6
440541|NCT01384292|1080036|P1|STARTED|Part B||3
440542|NCT01384292|1080034|P3|NOT COMPLETED|Part A||0
440543|NCT01384292|1080035|P2|NOT COMPLETED|Part A||0
440544|NCT01384292|1080036|P1|NOT COMPLETED|Part A||0
440545|NCT01384292|1080034|P3|COMPLETED|Part A||4
440546|NCT01384292|1080035|P2|COMPLETED|Part A||5
440547|NCT01384292|1080036|P1|COMPLETED|Part A||5
440548|NCT01384292|1080034|P3|STARTED|Part A||4
440549|NCT01384292|1080035|P2|STARTED|Part A||5
440550|NCT01384292|1080036|P1|STARTED|Part A||5
440551|NCT01384019|1080048|P2|NOT COMPLETED|Overall Study||6
440552|NCT01384019|1080049|P1|NOT COMPLETED|Overall Study||10
440553|NCT01384019|1080048|P2|COMPLETED|Overall Study||55
440554|NCT01384019|1080049|P1|COMPLETED|Overall Study||55
440555|NCT01384019|1080048|P2|STARTED|Overall Study||61
440556|NCT01384019|1080049|P1|STARTED|Overall Study||65
440557|NCT01383993|1080058|P3|NOT COMPLETED|Overall Study||1
440558|NCT01383993|1080059|P2|NOT COMPLETED|Overall Study||1
440559|NCT01383993|1080060|P1|NOT COMPLETED|Overall Study||3
440560|NCT01383993|1080058|P3|COMPLETED|Overall Study||1
440561|NCT01383993|1080059|P2|COMPLETED|Overall Study||3
440562|NCT01383993|1080060|P1|COMPLETED|Overall Study||12
440563|NCT01383993|1080058|P3|STARTED|Overall Study||2
440564|NCT01383993|1080059|P2|STARTED|Overall Study||4
440565|NCT01383993|1080060|P1|STARTED|Overall Study||15
440566|NCT01383954|1080107|P1|NOT COMPLETED|Overall Study||14
440567|NCT01383954|1080107|P1|COMPLETED|Overall Study||38
440568|NCT01383954|1080107|P1|Safety Population: Received Treatment|Overall Study||48
440569|NCT01383954|1080107|P1|STARTED|Overall Study||52
440570|NCT01383928|1080115|P3|NOT COMPLETED|Phase 2||40
440571|NCT01383928|1080116|P2|NOT COMPLETED|Phase 2||0
440572|NCT01383928|1080117|P1|NOT COMPLETED|Phase 2||0
440573|NCT01383928|1080115|P3|COMPLETED|Phase 2||10
440574|NCT01383928|1080116|P2|COMPLETED|Phase 2||0
440575|NCT01383928|1080117|P1|COMPLETED|Phase 2||0
440576|NCT01383928|1080115|P3|STARTED|Phase 2||50
440577|NCT01383928|1080116|P2|STARTED|Phase 2||0
440578|NCT01383928|1080117|P1|STARTED|Phase 2||0
440579|NCT01383928|1080115|P3|NOT COMPLETED|Phase 1||0
440580|NCT01383928|1080116|P2|NOT COMPLETED|Phase 1||7
440581|NCT01383928|1080117|P1|NOT COMPLETED|Phase 1||5
440582|NCT01383928|1080115|P3|COMPLETED|Phase 1||0
440583|NCT01383928|1080116|P2|COMPLETED|Phase 1||0
440584|NCT01383928|1080117|P1|COMPLETED|Phase 1||2
440585|NCT01383928|1080115|P3|STARTED|Phase 1||0
440586|NCT01383928|1080116|P2|STARTED|Phase 1||7
440587|NCT01383928|1080117|P1|STARTED|Phase 1||7
440588|NCT01383720|1080159|P1|NOT COMPLETED|Overall Study||0
440589|NCT01383720|1080159|P1|COMPLETED|Overall Study|Study is continuing to 5 years. All patients are still in the study.|11
440590|NCT01383720|1080159|P1|Primary Endpoint (Discharge/7 Days)|Overall Study||11
440591|NCT01383720|1080159|P1|STARTED|Overall Study||11
440592|NCT01383707|1080181|P1|NOT COMPLETED|Overall Study||72
440593|NCT01383707|1080181|P1|COMPLETED|Overall Study||5
440594|NCT01383707|1080181|P1|STARTED|Overall Study||77
440595|NCT01383681|1080190|P1|NOT COMPLETED|Overall Study||46
440596|NCT01383681|1080190|P1|COMPLETED|Overall Study||189
440597|NCT01383681|1080190|P1|STARTED|Overall Study||235
440598|NCT01383616|1080197|P2|NOT COMPLETED|Overall Study||23
440599|NCT01383616|1080198|P1|NOT COMPLETED|Overall Study||17
440600|NCT01383616|1080197|P2|COMPLETED|Overall Study||21
440601|NCT01383616|1080198|P1|COMPLETED|Overall Study||23
440602|NCT01383616|1080197|P2|STARTED|Overall Study||44
440603|NCT01383616|1080198|P1|STARTED|Overall Study||40
440604|NCT01383499|1080221|P4|NOT COMPLETED|Period 3 (4 Weeks)||0
440605|NCT01383499|1080222|P3|NOT COMPLETED|Period 3 (4 Weeks)||0
440606|NCT01383499|1080223|P2|NOT COMPLETED|Period 3 (4 Weeks)||0
440607|NCT01383499|1080224|P1|NOT COMPLETED|Period 3 (4 Weeks)||0
440608|NCT01383499|1080221|P4|COMPLETED|Period 3 (4 Weeks)||25
440609|NCT01383499|1080222|P3|COMPLETED|Period 3 (4 Weeks)||25
440610|NCT01383499|1080223|P2|COMPLETED|Period 3 (4 Weeks)||24
440611|NCT01383499|1080224|P1|COMPLETED|Period 3 (4 Weeks)||26
440612|NCT01383499|1080221|P4|STARTED|Period 3 (4 Weeks)||25
440613|NCT01383499|1080222|P3|STARTED|Period 3 (4 Weeks)||25
440614|NCT01383499|1080223|P2|STARTED|Period 3 (4 Weeks)||24
440615|NCT01383499|1080224|P1|STARTED|Period 3 (4 Weeks)||26
440616|NCT01383499|1080221|P4|NOT COMPLETED|Period 2 (4 Weeks)||0
440617|NCT01383499|1080222|P3|NOT COMPLETED|Period 2 (4 Weeks)||0
440618|NCT01383499|1080223|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
440619|NCT01383499|1080224|P1|NOT COMPLETED|Period 2 (4 Weeks)||0
440620|NCT01383499|1080221|P4|COMPLETED|Period 2 (4 Weeks)||25
440621|NCT01383499|1080222|P3|COMPLETED|Period 2 (4 Weeks)||25
440622|NCT01383499|1080223|P2|COMPLETED|Period 2 (4 Weeks)||24
440623|NCT01383499|1080224|P1|COMPLETED|Period 2 (4 Weeks)||26
440624|NCT01383499|1080221|P4|STARTED|Period 2 (4 Weeks)||25
440625|NCT01383499|1080222|P3|STARTED|Period 2 (4 Weeks)||25
440626|NCT01383499|1080223|P2|STARTED|Period 2 (4 Weeks)||24
440627|NCT01383499|1080224|P1|STARTED|Period 2 (4 Weeks)||26
440628|NCT01383499|1080221|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
440629|NCT01383499|1080222|P3|NOT COMPLETED|Period 1 (4 Weeks)||0
440630|NCT01383499|1080223|P2|NOT COMPLETED|Period 1 (4 Weeks)||0
440631|NCT01383499|1080224|P1|NOT COMPLETED|Period 1 (4 Weeks)||1
440632|NCT01383499|1080221|P4|COMPLETED|Period 1 (4 Weeks)||25
440633|NCT01383499|1080222|P3|COMPLETED|Period 1 (4 Weeks)||25
440634|NCT01383499|1080223|P2|COMPLETED|Period 1 (4 Weeks)||24
440635|NCT01383499|1080224|P1|COMPLETED|Period 1 (4 Weeks)||26
440636|NCT01383499|1080221|P4|STARTED|Period 1 (4 Weeks)||25
440637|NCT01383499|1080222|P3|STARTED|Period 1 (4 Weeks)||25
440638|NCT01383499|1080223|P2|STARTED|Period 1 (4 Weeks)||24
440639|NCT01383499|1080224|P1|STARTED|Period 1 (4 Weeks)||27
440640|NCT01383486|1080274|P1|NOT COMPLETED|Overall Study||18
440641|NCT01383486|1080274|P1|COMPLETED|Overall Study|Took any study medication and gave estimated duration of pain (Selection Evaluation Population)|235
440642|NCT01383486|1080274|P1|Treated|Overall Study|Number of participants who took any study medication (Safety Population)|237
440643|NCT01383486|1080274|P1|STARTED|Overall Study|Number of participants who were provided with investigational products|253
440644|NCT01383447|1080280|P1|NOT COMPLETED|Overall Study||2
440645|NCT01383447|1080280|P1|COMPLETED|Overall Study||0
440646|NCT01383447|1080280|P1|STARTED|Overall Study||2
440647|NCT01383421|1080288|P1|NOT COMPLETED|Overall Study||346
440648|NCT01383421|1080288|P1|COMPLETED|Overall Study||679
440649|NCT01383421|1080288|P1|STARTED|Overall Study|ITT population: all enrolled participants who received at least 1 dose of study drug.|1025
440650|NCT01383356|1080351|P2|NOT COMPLETED|Period 2||0
440651|NCT01383356|1080352|P1|NOT COMPLETED|Period 2||0
440652|NCT01383356|1080351|P2|COMPLETED|Period 2|Completed period 2.|23
440653|NCT01383356|1080352|P1|COMPLETED|Period 2|Completed period 2.|21
440654|NCT01383356|1080351|P2|STARTED|Period 2|Entered and treated.|23
440655|NCT01383356|1080352|P1|STARTED|Period 2|Entered and treated.|21
440656|NCT01383356|1080351|P2|NOT COMPLETED|Washout Period (at Least 35 Days)||0
440657|NCT01383356|1080352|P1|NOT COMPLETED|Washout Period (at Least 35 Days)||0
440658|NCT01383356|1080351|P2|COMPLETED|Washout Period (at Least 35 Days)||23
440659|NCT01383356|1080352|P1|COMPLETED|Washout Period (at Least 35 Days)||21
440660|NCT01383356|1080351|P2|STARTED|Washout Period (at Least 35 Days)||23
440661|NCT01383356|1080352|P1|STARTED|Washout Period (at Least 35 Days)||21
440662|NCT01383356|1080351|P2|NOT COMPLETED|Period 1||6
440663|NCT01383356|1080352|P1|NOT COMPLETED|Period 1||8
440664|NCT01383356|1080351|P2|COMPLETED|Period 1|Completed period 1.|23
440665|NCT01383356|1080352|P1|COMPLETED|Period 1|Completed period 1.|21
440666|NCT01383356|1080351|P2|STARTED|Period 1|Entered and treated.|29
440667|NCT01383356|1080352|P1|STARTED|Period 1|Entered and treated.|29
440668|NCT01383317|1080364|P2|NOT COMPLETED|Overall Study||2
440669|NCT01383317|1080365|P1|NOT COMPLETED|Overall Study||3
440670|NCT01383317|1080364|P2|COMPLETED|Overall Study||33
440671|NCT01383317|1080365|P1|COMPLETED|Overall Study||26
440672|NCT01383317|1080364|P2|STARTED|Overall Study||35
440673|NCT01383317|1080365|P1|STARTED|Overall Study||29
440674|NCT01383213|1080389|P2|NOT COMPLETED|Overall Study||0
440675|NCT01383213|1080390|P1|NOT COMPLETED|Overall Study||0
440676|NCT01383213|1080389|P2|COMPLETED|Overall Study||41
440677|NCT01383213|1080390|P1|COMPLETED|Overall Study||40
440678|NCT01383213|1080389|P2|STARTED|Overall Study||41
440679|NCT01383213|1080390|P1|STARTED|Overall Study||40
440680|NCT01383200|1080398|P2|NOT COMPLETED|Overall Study||0
440681|NCT01383200|1080399|P1|NOT COMPLETED|Overall Study||0
440682|NCT01383200|1080398|P2|COMPLETED|Overall Study||6
440683|NCT01383200|1080399|P1|COMPLETED|Overall Study||5
440684|NCT01383200|1080398|P2|STARTED|Overall Study||6
440685|NCT01383200|1080399|P1|STARTED|Overall Study||5
440686|NCT01383174|1080407|P2|NOT COMPLETED|6 Month Assessment||1
440687|NCT01383174|1080408|P1|NOT COMPLETED|6 Month Assessment||5
440688|NCT01383174|1080407|P2|COMPLETED|6 Month Assessment|These 73 completed the 6 month assessment and completed the study.|73
440689|NCT01383174|1080408|P1|COMPLETED|6 Month Assessment|These 71 completed the 6 month assessment and completed the study.|71
440690|NCT01383174|1080407|P2|STARTED|6 Month Assessment||74
440691|NCT01383174|1080408|P1|STARTED|6 Month Assessment|All 76 people were contacted at 6 months;1 person returned and 5 did not return to study at 6 months|76
440692|NCT01383174|1080407|P2|NOT COMPLETED|3 Month Assessment||1
440693|NCT01383174|1080408|P1|NOT COMPLETED|3 Month Assessment||6
440694|NCT01383174|1080407|P2|COMPLETED|3 Month Assessment|These 74 completed the 3 month assessment and continued in the study.|74
440695|NCT01383174|1080408|P1|COMPLETED|3 Month Assessment|These 70 completed the 3 month assessment and continued in the study.|70
440696|NCT01383174|1080407|P2|STARTED|3 Month Assessment||75
440697|NCT01383174|1080408|P1|STARTED|3 Month Assessment||76
440698|NCT01383174|1080407|P2|NOT COMPLETED|Baseline Assessment||0
440699|NCT01383174|1080408|P1|NOT COMPLETED|Baseline Assessment||0
440700|NCT01383174|1080407|P2|COMPLETED|Baseline Assessment|These 75 completed the baseline assessment and continued in the study.|75
440701|NCT01383174|1080408|P1|COMPLETED|Baseline Assessment|These 76 completed the baseline assessment and continued in the study.|76
440702|NCT01383174|1080407|P2|STARTED|Baseline Assessment||75
440703|NCT01383174|1080408|P1|STARTED|Baseline Assessment||76
440704|NCT01383161|1080434|P2|NOT COMPLETED|Overall Study||4
440705|NCT01383161|1080435|P1|NOT COMPLETED|Overall Study||5
440706|NCT01383161|1080434|P2|COMPLETED|Overall Study||17
440707|NCT01383161|1080435|P1|COMPLETED|Overall Study||20
440708|NCT01383161|1080434|P2|STARTED|Overall Study||21
440709|NCT01383161|1080435|P1|STARTED|Overall Study||25
440710|NCT01383096|1080454|P3|NOT COMPLETED|Fifth Intervention (8 Days)||0
440711|NCT01383096|1080455|P2|NOT COMPLETED|Fifth Intervention (8 Days)||0
440712|NCT01383096|1080456|P1|NOT COMPLETED|Fifth Intervention (8 Days)||2
440713|NCT01383096|1080454|P3|COMPLETED|Fifth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
440714|NCT01383096|1080455|P2|COMPLETED|Fifth Intervention (8 Days)|Only 4 interventions in Cohort 2.|0
440715|NCT01383096|1080456|P1|COMPLETED|Fifth Intervention (8 Days)||11
440716|NCT01383096|1080454|P3|STARTED|Fifth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
440717|NCT01383096|1080455|P2|STARTED|Fifth Intervention (8 Days)|Only 4 interventions in Cohort 2.|0
440718|NCT01383096|1080456|P1|STARTED|Fifth Intervention (8 Days)||13
440719|NCT01383096|1080454|P3|NOT COMPLETED|Fourth Intervention (8 Days)||0
440720|NCT01383096|1080455|P2|NOT COMPLETED|Fourth Intervention (8 Days)||0
440721|NCT01383096|1080456|P1|NOT COMPLETED|Fourth Intervention (8 Days)||2
440722|NCT01383096|1080454|P3|COMPLETED|Fourth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
440723|NCT01383096|1080455|P2|COMPLETED|Fourth Intervention (8 Days)||12
440724|NCT01383096|1080456|P1|COMPLETED|Fourth Intervention (8 Days)||13
440725|NCT01383096|1080454|P3|STARTED|Fourth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
440726|NCT01383096|1080455|P2|STARTED|Fourth Intervention (8 Days)||12
440727|NCT01383096|1080456|P1|STARTED|Fourth Intervention (8 Days)||15
440728|NCT01383096|1080454|P3|NOT COMPLETED|Third Intervention (8 Days)||0
440729|NCT01383096|1080455|P2|NOT COMPLETED|Third Intervention (8 Days)||4
440730|NCT01383096|1080456|P1|NOT COMPLETED|Third Intervention (8 Days)||4
440731|NCT01383096|1080454|P3|COMPLETED|Third Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
440732|NCT01383096|1080455|P2|COMPLETED|Third Intervention (8 Days)||12
440733|NCT01383096|1080456|P1|COMPLETED|Third Intervention (8 Days)||15
440734|NCT01383096|1080454|P3|STARTED|Third Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
440735|NCT01383096|1080455|P2|STARTED|Third Intervention (8 Days)||16
440736|NCT01383096|1080456|P1|STARTED|Third Intervention (8 Days)||19
440737|NCT01383096|1080454|P3|NOT COMPLETED|Second Intervention (8 Days)||2
440738|NCT01383096|1080455|P2|NOT COMPLETED|Second Intervention (8 Days)||1
440739|NCT01383096|1080456|P1|NOT COMPLETED|Second Intervention (8 Days)||0
440740|NCT01383096|1080454|P3|COMPLETED|Second Intervention (8 Days)||14
440741|NCT01383096|1080455|P2|COMPLETED|Second Intervention (8 Days)||16
440742|NCT01383096|1080456|P1|COMPLETED|Second Intervention (8 Days)||19
440743|NCT01383096|1080454|P3|STARTED|Second Intervention (8 Days)||16
440744|NCT01383096|1080455|P2|STARTED|Second Intervention (8 Days)||17
440745|NCT01383096|1080456|P1|STARTED|Second Intervention (8 Days)||19
440746|NCT01383096|1080454|P3|NOT COMPLETED|First Intervention (8 Days)||0
440747|NCT01383096|1080455|P2|NOT COMPLETED|First Intervention (8 Days)||0
440748|NCT01383096|1080456|P1|NOT COMPLETED|First Intervention (8 Days)||0
440749|NCT01383096|1080454|P3|COMPLETED|First Intervention (8 Days)||16
440750|NCT01383096|1080455|P2|COMPLETED|First Intervention (8 Days)||17
440751|NCT01383096|1080456|P1|COMPLETED|First Intervention (8 Days)||19
440752|NCT01383096|1080454|P3|STARTED|First Intervention (8 Days)||16
440753|NCT01383096|1080455|P2|STARTED|First Intervention (8 Days)||17
440754|NCT01383096|1080456|P1|STARTED|First Intervention (8 Days)||19
440755|NCT01383005|1080504|P2|NOT COMPLETED|Overall Study||0
440756|NCT01383005|1080505|P1|NOT COMPLETED|Overall Study||0
440757|NCT01383005|1080504|P2|COMPLETED|Overall Study||60
440758|NCT01383005|1080505|P1|COMPLETED|Overall Study||34
440759|NCT01383005|1080504|P2|STARTED|Overall Study||60
440760|NCT01383005|1080505|P1|STARTED|Overall Study||34
440761|NCT01382940|1080524|P1|NOT COMPLETED|Overall Study||73
440762|NCT01382940|1080524|P1|COMPLETED|Overall Study||278
440763|NCT01382940|1080524|P1|Received Day 182 Infusion|Overall Study||278
440764|NCT01382940|1080524|P1|Received Day 168 Infusion|Overall Study||290
440765|NCT01382940|1080524|P1|Received Day 15 Infusions|Overall Study||341
440766|NCT01382940|1080524|P1|Received Day 1 Infusion|Overall Study||351
440767|NCT01382940|1080524|P1|STARTED|Overall Study||351
440768|NCT01382901|1080536|P2|NOT COMPLETED|Overall Study||14
440769|NCT01382901|1080537|P1|NOT COMPLETED|Overall Study||17
440770|NCT01382901|1080536|P2|COMPLETED|Overall Study||7
440771|NCT01382901|1080537|P1|COMPLETED|Overall Study||7
440772|NCT01382901|1080536|P2|STARTED|Overall Study||21
440773|NCT01382901|1080537|P1|STARTED|Overall Study||24
440774|NCT01382719|1080547|P4|NOT COMPLETED|Overall Study||33
440775|NCT01382719|1080548|P3|NOT COMPLETED|Overall Study||34
440776|NCT01382719|1080549|P2|NOT COMPLETED|Overall Study||19
440777|NCT01382719|1080550|P1|NOT COMPLETED|Overall Study||18
440778|NCT01382719|1080547|P4|COMPLETED|Overall Study||66
440779|NCT01382719|1080548|P3|COMPLETED|Overall Study||66
440780|NCT01382719|1080549|P2|COMPLETED|Overall Study||81
440781|NCT01382719|1080550|P1|COMPLETED|Overall Study||80
440782|NCT01382719|1080547|P4|Subjects Not Dosed|Overall Study||1
440783|NCT01382719|1080548|P3|Subjects Not Dosed|Overall Study||1
440784|NCT01382719|1080549|P2|Subjects Not Dosed|Overall Study||0
440785|NCT01382719|1080550|P1|Subjects Not Dosed|Overall Study||1
440786|NCT01382719|1080547|P4|STARTED|Overall Study||99
440787|NCT01382719|1080548|P3|STARTED|Overall Study||100
440788|NCT01382719|1080549|P2|STARTED|Overall Study||100
440789|NCT01382719|1080550|P1|STARTED|Overall Study||98
440790|NCT01382602|1080586|P2|NOT COMPLETED|Overall Study||4
440791|NCT01382602|1080587|P1|NOT COMPLETED|Overall Study||0
440792|NCT01382602|1080586|P2|COMPLETED|Overall Study||46
440793|NCT01382602|1080587|P1|COMPLETED|Overall Study||93
440794|NCT01382602|1080586|P2|STARTED|Overall Study||50
440795|NCT01382602|1080587|P1|STARTED|Overall Study||93
440796|NCT01382446|1080595|P2|NOT COMPLETED|Overall Study||4
440797|NCT01382446|1080596|P1|NOT COMPLETED|Overall Study||3
440798|NCT01382446|1080595|P2|COMPLETED|Overall Study||29
440799|NCT01382446|1080596|P1|COMPLETED|Overall Study||30
440800|NCT01382446|1080595|P2|STARTED|Overall Study||33
440801|NCT01382446|1080596|P1|STARTED|Overall Study||33
440802|NCT01382303|1080604|P2|NOT COMPLETED|Overall Study||17
440803|NCT01382303|1080605|P1|NOT COMPLETED|Overall Study||35
440804|NCT01382303|1080604|P2|COMPLETED|Overall Study||70
440805|NCT01382303|1080605|P1|COMPLETED|Overall Study||52
440806|NCT01382303|1080604|P2|STARTED|Overall Study||87
440807|NCT01382303|1080605|P1|STARTED|Overall Study||87
440808|NCT01382251|1080623|P2|NOT COMPLETED|Overall Study||21
440809|NCT01382251|1080624|P1|NOT COMPLETED|Overall Study||21
440810|NCT01382251|1080623|P2|COMPLETED|Overall Study||102
440811|NCT01382251|1080624|P1|COMPLETED|Overall Study||102
440812|NCT01382251|1080623|P2|STARTED|Overall Study||123
440813|NCT01382251|1080624|P1|STARTED|Overall Study||123
440814|NCT01382225|1080637|P2|NOT COMPLETED|Overall Study||7
440815|NCT01382225|1080638|P1|NOT COMPLETED|Overall Study||14
440816|NCT01382225|1080637|P2|COMPLETED|Overall Study||722
440817|NCT01382225|1080638|P1|COMPLETED|Overall Study||711
440818|NCT01382225|1080637|P2|STARTED|Overall Study||729
440819|NCT01382225|1080638|P1|STARTED|Overall Study||725
440820|NCT01382212|1080660|P1|NOT COMPLETED|Overall Study||2
440821|NCT01382212|1080660|P1|COMPLETED|Overall Study||11
440822|NCT01382212|1080660|P1|STARTED|Overall Study||13
440823|NCT01382186|1080686|P2|NOT COMPLETED|Overall Study||0
440824|NCT01382186|1080687|P1|NOT COMPLETED|Overall Study||1
440825|NCT01382186|1080686|P2|COMPLETED|Overall Study||819
440826|NCT01382186|1080687|P1|COMPLETED|Overall Study||32
440827|NCT01382186|1080686|P2|STARTED|Overall Study||819
440828|NCT01382186|1080687|P1|STARTED|Overall Study||33
440829|NCT01382108|1080703|P2|NOT COMPLETED|Overall Study||0
440830|NCT01382108|1080704|P1|NOT COMPLETED|Overall Study||0
440831|NCT01382108|1080703|P2|COMPLETED|Overall Study||19
440832|NCT01382108|1080704|P1|COMPLETED|Overall Study||20
440833|NCT01382108|1080703|P2|STARTED|Overall Study||19
440834|NCT01382108|1080704|P1|STARTED|Overall Study||20
440835|NCT01381952|1080714|P1|NOT COMPLETED|Overall Study||0
440836|NCT01381952|1080714|P1|COMPLETED|Overall Study||20
440837|NCT01381952|1080714|P1|Collected Dose and Image Information|Overall Study||20
440838|NCT01381952|1080714|P1|STARTED|Overall Study||20
440839|NCT01381926|1080723|P2|NOT COMPLETED|Low/High Dose of 2nd Treatment (2months)||0
440840|NCT01381926|1080724|P1|NOT COMPLETED|Low/High Dose of 2nd Treatment (2months)||0
440841|NCT01381926|1080723|P2|COMPLETED|Low/High Dose of 2nd Treatment (2months)||4
440842|NCT01381926|1080724|P1|COMPLETED|Low/High Dose of 2nd Treatment (2months)||3
440843|NCT01381926|1080723|P2|STARTED|Low/High Dose of 2nd Treatment (2months)||4
440844|NCT01381926|1080724|P1|STARTED|Low/High Dose of 2nd Treatment (2months)||3
440845|NCT01381926|1080723|P2|NOT COMPLETED|Low/High Dose of 1st Treatment (2months)||1
440846|NCT01381926|1080724|P1|NOT COMPLETED|Low/High Dose of 1st Treatment (2months)||2
440847|NCT01381926|1080723|P2|COMPLETED|Low/High Dose of 1st Treatment (2months)||4
440848|NCT01381926|1080724|P1|COMPLETED|Low/High Dose of 1st Treatment (2months)||3
440849|NCT01381926|1080723|P2|STARTED|Low/High Dose of 1st Treatment (2months)||5
440850|NCT01381926|1080724|P1|STARTED|Low/High Dose of 1st Treatment (2months)||5
440851|NCT01381900|1080737|P3|NOT COMPLETED|Overall Study||12
440852|NCT01381900|1080738|P2|NOT COMPLETED|Overall Study||9
440853|NCT01381900|1080739|P1|NOT COMPLETED|Overall Study||9
440854|NCT01381900|1080737|P3|COMPLETED|Overall Study||215
440855|NCT01381900|1080738|P2|COMPLETED|Overall Study||214
440856|NCT01381900|1080739|P1|COMPLETED|Overall Study||217
440857|NCT01381900|1080737|P3|STARTED|Overall Study||227
440858|NCT01381900|1080738|P2|STARTED|Overall Study||223
440859|NCT01381900|1080739|P1|STARTED|Overall Study||226
440860|NCT01381679|1080759|P1|NOT COMPLETED|Overall Study||888
440861|NCT01381679|1080759|P1|COMPLETED|Overall Study||794
440862|NCT01381679|1080759|P1|STARTED|Overall Study||1682
440863|NCT01381575|1080774|P3|NOT COMPLETED|Overall Study||7
440864|NCT01381575|1080775|P2|NOT COMPLETED|Overall Study||10
440865|NCT01381575|1080776|P1|NOT COMPLETED|Overall Study||2
440866|NCT01381575|1080774|P3|COMPLETED|Overall Study||408
440867|NCT01381575|1080775|P2|COMPLETED|Overall Study||472
440868|NCT01381575|1080776|P1|COMPLETED|Overall Study||548
440869|NCT01381575|1080774|P3|STARTED|Overall Study||415
440870|NCT01381575|1080775|P2|STARTED|Overall Study||482
440871|NCT01381575|1080776|P1|STARTED|Overall Study||550
440872|NCT01381562|1080833|P3|NOT COMPLETED|Overall Study||0
440873|NCT01381562|1080834|P2|NOT COMPLETED|Overall Study||1
440874|NCT01381562|1080835|P1|NOT COMPLETED|Overall Study||0
440875|NCT01381562|1080833|P3|COMPLETED|Overall Study||5
440876|NCT01381562|1080834|P2|COMPLETED|Overall Study||3
440877|NCT01381562|1080835|P1|COMPLETED|Overall Study||5
440878|NCT01381562|1080833|P3|STARTED|Overall Study||5
440879|NCT01381562|1080834|P2|STARTED|Overall Study||4
440880|NCT01381562|1080835|P1|STARTED|Overall Study||5
440881|NCT01381549|1080903|P3|NOT COMPLETED|Overall Study||1
440882|NCT01381549|1080904|P2|NOT COMPLETED|Overall Study||0
440883|NCT01381549|1080905|P1|NOT COMPLETED|Overall Study||0
440884|NCT01381549|1080903|P3|COMPLETED|Overall Study||5
440885|NCT01381549|1080904|P2|COMPLETED|Overall Study||8
440886|NCT01381549|1080905|P1|COMPLETED|Overall Study||6
440887|NCT01381549|1080903|P3|STARTED|Overall Study||6
440888|NCT01381549|1080904|P2|STARTED|Overall Study||8
440889|NCT01381549|1080905|P1|STARTED|Overall Study||6
440890|NCT01381471|1081000|P1|NOT COMPLETED|Overall Study||0
440891|NCT01381471|1081000|P1|COMPLETED|Overall Study||11060
440892|NCT01381471|1081000|P1|STARTED|Overall Study||11060
440893|NCT01381406|1081007|P2|NOT COMPLETED|Overall Study||0
440894|NCT01381406|1081008|P1|NOT COMPLETED|Overall Study||0
440895|NCT01381406|1081007|P2|COMPLETED|Overall Study||852
440896|NCT01381406|1081008|P1|COMPLETED|Overall Study||2481
440897|NCT01381406|1081007|P2|STARTED|Overall Study||852
440898|NCT01381406|1081008|P1|STARTED|Overall Study||2481
440899|NCT01381120|1081020|P2|NOT COMPLETED|Overall Study||9
440900|NCT01381120|1081021|P1|NOT COMPLETED|Overall Study||11
440901|NCT01381120|1081020|P2|COMPLETED|Overall Study||18
440902|NCT01381120|1081021|P1|COMPLETED|Overall Study||39
440903|NCT01381120|1081020|P2|STARTED|Overall Study||27
440904|NCT01381120|1081021|P1|STARTED|Overall Study||50
440905|NCT01381016|1081031|P2|NOT COMPLETED|Overall Study||6
440906|NCT01381016|1081032|P1|NOT COMPLETED|Overall Study||3
440907|NCT01381016|1081031|P2|COMPLETED|Overall Study||11
440908|NCT01381016|1081032|P1|COMPLETED|Overall Study||10
440909|NCT01381016|1081031|P2|STARTED|Overall Study||17
440910|NCT01381016|1081032|P1|STARTED|Overall Study||13
440911|NCT01380834|1081042|P2|NOT COMPLETED|Overall Study||0
440912|NCT01380834|1081043|P1|NOT COMPLETED|Overall Study||1
440913|NCT01380834|1081042|P2|COMPLETED|Overall Study||42
440914|NCT01380834|1081043|P1|COMPLETED|Overall Study||41
440915|NCT01380834|1081042|P2|STARTED|Overall Study||42
440916|NCT01380834|1081043|P1|STARTED|Overall Study||42
440917|NCT01380782|1081055|P4|NOT COMPLETED|Overall Study||4
440918|NCT01380782|1081056|P3|NOT COMPLETED|Overall Study||11
440919|NCT01380782|1081057|P2|NOT COMPLETED|Overall Study||10
440920|NCT01380782|1081058|P1|NOT COMPLETED|Overall Study||12
440921|NCT01380782|1081055|P4|COMPLETED|Overall Study||0
440922|NCT01380782|1081056|P3|COMPLETED|Overall Study||0
440923|NCT01380782|1081057|P2|COMPLETED|Overall Study||0
440924|NCT01380782|1081058|P1|COMPLETED|Overall Study||0
440925|NCT01380782|1081055|P4|STARTED|Overall Study||4
440926|NCT01380782|1081056|P3|STARTED|Overall Study||11
440927|NCT01380782|1081057|P2|STARTED|Overall Study||10
440928|NCT01380782|1081058|P1|STARTED|Overall Study||12
440929|NCT01380769|1081081|P2|NOT COMPLETED|Overall Study||14
440930|NCT01380769|1081082|P1|NOT COMPLETED|Overall Study||9
440931|NCT01380769|1081081|P2|COMPLETED|Overall Study|subjects in ITT with reported date of death, alive with progression, or alive without progression|43
440932|NCT01380769|1081082|P1|COMPLETED|Overall Study|subjects in ITT with reported date of death, alive with progression, or alive without progression|91
440933|NCT01380769|1081081|P2|STARTED|Overall Study||57
440934|NCT01380769|1081082|P1|STARTED|Overall Study||100
440935|NCT01380730|1081098|P8|NOT COMPLETED|Overall Study||0
440936|NCT01380730|1081099|P7|NOT COMPLETED|Overall Study||0
440937|NCT01380730|1081100|P6|NOT COMPLETED|Overall Study||0
440938|NCT01380730|1081101|P5|NOT COMPLETED|Overall Study||1
440939|NCT01380730|1081102|P4|NOT COMPLETED|Overall Study||0
440940|NCT01380730|1081103|P3|NOT COMPLETED|Overall Study||0
440941|NCT01380730|1081104|P2|NOT COMPLETED|Overall Study||0
440942|NCT01380730|1081105|P1|NOT COMPLETED|Overall Study||0
440943|NCT01380730|1081098|P8|COMPLETED|Overall Study||80
440944|NCT01380730|1081099|P7|COMPLETED|Overall Study||79
440945|NCT01380730|1081100|P6|COMPLETED|Overall Study||79
440946|NCT01380730|1081101|P5|COMPLETED|Overall Study||77
440947|NCT01380730|1081102|P4|COMPLETED|Overall Study||79
440948|NCT01380730|1081103|P3|COMPLETED|Overall Study||79
440949|NCT01380730|1081104|P2|COMPLETED|Overall Study||79
440950|NCT01380730|1081105|P1|COMPLETED|Overall Study||78
440951|NCT01380730|1081098|P8|Received Treatment|Overall Study||80
440952|NCT01380730|1081099|P7|Received Treatment|Overall Study||79
440953|NCT01380730|1081100|P6|Received Treatment|Overall Study||79
440954|NCT01380730|1081101|P5|Received Treatment|Overall Study||78
440955|NCT01380730|1081102|P4|Received Treatment|Overall Study||79
440956|NCT01380730|1081103|P3|Received Treatment|Overall Study||79
440957|NCT01380730|1081104|P2|Received Treatment|Overall Study|2 participants did not receive treatment but were followed until the end of study|77
440958|NCT01380730|1081105|P1|Received Treatment|Overall Study||78
440959|NCT01380730|1081098|P8|STARTED|Overall Study||80
440960|NCT01380730|1081099|P7|STARTED|Overall Study||79
440961|NCT01380730|1081100|P6|STARTED|Overall Study||79
440962|NCT01380730|1081101|P5|STARTED|Overall Study||78
440963|NCT01380730|1081102|P4|STARTED|Overall Study||79
440964|NCT01380730|1081103|P3|STARTED|Overall Study||79
440965|NCT01380730|1081104|P2|STARTED|Overall Study||79
440966|NCT01380730|1081105|P1|STARTED|Overall Study||78
440967|NCT01380639|1081165|P2|NOT COMPLETED|Overall Study||4
440968|NCT01380639|1081166|P1|NOT COMPLETED|Overall Study||6
440969|NCT01380639|1081165|P2|COMPLETED|Overall Study||36
440970|NCT01380639|1081166|P1|COMPLETED|Overall Study||36
440971|NCT01380639|1081165|P2|STARTED|Overall Study||40
440972|NCT01380639|1081166|P1|STARTED|Overall Study||42
440973|NCT01380379|1081172|P1|NOT COMPLETED|Overall Study||1
440974|NCT01380379|1081172|P1|COMPLETED|Overall Study||8
440975|NCT01380379|1081172|P1|STARTED|Overall Study||9
440976|NCT01380366|1081177|P1|NOT COMPLETED|Overall Study||0
440977|NCT01380366|1081177|P1|COMPLETED|Overall Study||15
440978|NCT01380366|1081177|P1|STARTED|Overall Study||15
440979|NCT01380327|1081185|P3|NOT COMPLETED|Overall Study||7
440980|NCT01380327|1081186|P2|NOT COMPLETED|Overall Study||3
440981|NCT01380327|1081187|P1|NOT COMPLETED|Overall Study||3
440982|NCT01380327|1081185|P3|COMPLETED|Overall Study||21
440983|NCT01380327|1081186|P2|COMPLETED|Overall Study||28
440984|NCT01380327|1081187|P1|COMPLETED|Overall Study||27
440985|NCT01380327|1081185|P3|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|28
440986|NCT01380327|1081186|P2|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|31
440987|NCT01380327|1081187|P1|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|30
440988|NCT01380197|1081209|P2|NOT COMPLETED|Overall Study||0
440989|NCT01380197|1081210|P1|NOT COMPLETED|Overall Study||0
440990|NCT01380197|1081209|P2|COMPLETED|Overall Study||20
440991|NCT01380197|1081210|P1|COMPLETED|Overall Study||20
440992|NCT01380197|1081209|P2|STARTED|Overall Study||20
440993|NCT01380197|1081210|P1|STARTED|Overall Study||20
440994|NCT01380145|1081218|P1|NOT COMPLETED|Overall Study||4
440995|NCT01380145|1081218|P1|COMPLETED|Overall Study||9
440996|NCT01380145|1081218|P1|STARTED|Overall Study||13
440997|NCT01380093|1081226|P9|NOT COMPLETED|Treatment Phase: Third Intervention||2
440998|NCT01380093|1081227|P8|NOT COMPLETED|Treatment Phase: Third Intervention||0
440999|NCT01380093|1081228|P7|NOT COMPLETED|Treatment Phase: Third Intervention||0
441000|NCT01380093|1081229|P6|NOT COMPLETED|Treatment Phase: Third Intervention||0
441001|NCT01380093|1081230|P5|NOT COMPLETED|Treatment Phase: Third Intervention||0
441002|NCT01380093|1081231|P4|NOT COMPLETED|Treatment Phase: Third Intervention||0
441003|NCT01380093|1081232|P3|NOT COMPLETED|Treatment Phase: Third Intervention||0
441004|NCT01380093|1081233|P2|NOT COMPLETED|Treatment Phase: Third Intervention||0
441005|NCT01380093|1081234|P1|NOT COMPLETED|Treatment Phase: Third Intervention||0
441006|NCT01380093|1081226|P9|COMPLETED|Treatment Phase: Third Intervention||4
441007|NCT01380093|1081227|P8|COMPLETED|Treatment Phase: Third Intervention||6
441008|NCT01380093|1081228|P7|COMPLETED|Treatment Phase: Third Intervention||6
441009|NCT01380093|1081229|P6|COMPLETED|Treatment Phase: Third Intervention||6
441010|NCT01380093|1081230|P5|COMPLETED|Treatment Phase: Third Intervention||6
441011|NCT01380093|1081231|P4|COMPLETED|Treatment Phase: Third Intervention||5
441012|NCT01380093|1081232|P3|COMPLETED|Treatment Phase: Third Intervention||0
441013|NCT01380093|1081233|P2|COMPLETED|Treatment Phase: Third Intervention||0
441014|NCT01380093|1081234|P1|COMPLETED|Treatment Phase: Third Intervention||0
441015|NCT01380093|1081226|P9|STARTED|Treatment Phase: Third Intervention||6
441016|NCT01380093|1081227|P8|STARTED|Treatment Phase: Third Intervention||6
441017|NCT01380093|1081228|P7|STARTED|Treatment Phase: Third Intervention||6
441018|NCT01380093|1081229|P6|STARTED|Treatment Phase: Third Intervention||6
441019|NCT01380093|1081230|P5|STARTED|Treatment Phase: Third Intervention||6
441020|NCT01380093|1081231|P4|STARTED|Treatment Phase: Third Intervention||5
441021|NCT01380093|1081232|P3|STARTED|Treatment Phase: Third Intervention||0
441022|NCT01380093|1081233|P2|STARTED|Treatment Phase: Third Intervention||0
441023|NCT01380093|1081234|P1|STARTED|Treatment Phase: Third Intervention||0
441024|NCT01380093|1081226|P9|NOT COMPLETED|Treatment Phase: Washout Period||0
441025|NCT01380093|1081227|P8|NOT COMPLETED|Treatment Phase: Washout Period||0
441026|NCT01380093|1081228|P7|NOT COMPLETED|Treatment Phase: Washout Period||0
441027|NCT01380093|1081229|P6|NOT COMPLETED|Treatment Phase: Washout Period||0
441028|NCT01380093|1081230|P5|NOT COMPLETED|Treatment Phase: Washout Period||0
441029|NCT01380093|1081231|P4|NOT COMPLETED|Treatment Phase: Washout Period||0
441030|NCT01380093|1081232|P3|NOT COMPLETED|Treatment Phase: Washout Period||0
441031|NCT01380093|1081233|P2|NOT COMPLETED|Treatment Phase: Washout Period||0
441032|NCT01380093|1081234|P1|NOT COMPLETED|Treatment Phase: Washout Period||0
441033|NCT01380093|1081226|P9|COMPLETED|Treatment Phase: Washout Period||6
441034|NCT01380093|1081227|P8|COMPLETED|Treatment Phase: Washout Period||6
441035|NCT01380093|1081228|P7|COMPLETED|Treatment Phase: Washout Period||6
441036|NCT01380093|1081229|P6|COMPLETED|Treatment Phase: Washout Period||6
441037|NCT01380093|1081230|P5|COMPLETED|Treatment Phase: Washout Period||6
441038|NCT01380093|1081231|P4|COMPLETED|Treatment Phase: Washout Period||5
441039|NCT01380093|1081232|P3|COMPLETED|Treatment Phase: Washout Period||0
441040|NCT01380093|1081233|P2|COMPLETED|Treatment Phase: Washout Period||0
441041|NCT01380093|1081234|P1|COMPLETED|Treatment Phase: Washout Period||0
441042|NCT01380093|1081226|P9|STARTED|Treatment Phase: Washout Period||6
441043|NCT01380093|1081227|P8|STARTED|Treatment Phase: Washout Period||6
441044|NCT01380093|1081228|P7|STARTED|Treatment Phase: Washout Period||6
441045|NCT01380093|1081229|P6|STARTED|Treatment Phase: Washout Period||6
441046|NCT01380093|1081230|P5|STARTED|Treatment Phase: Washout Period||6
441047|NCT01380093|1081231|P4|STARTED|Treatment Phase: Washout Period||5
441048|NCT01380093|1081232|P3|STARTED|Treatment Phase: Washout Period||0
441049|NCT01380093|1081233|P2|STARTED|Treatment Phase: Washout Period||0
441050|NCT01380093|1081234|P1|STARTED|Treatment Phase: Washout Period||0
441051|NCT01380093|1081226|P9|NOT COMPLETED|Treatment Phase: Second Intervention||0
441052|NCT01380093|1081227|P8|NOT COMPLETED|Treatment Phase: Second Intervention||0
441053|NCT01380093|1081228|P7|NOT COMPLETED|Treatment Phase: Second Intervention||0
441054|NCT01380093|1081229|P6|NOT COMPLETED|Treatment Phase: Second Intervention||0
441055|NCT01380093|1081230|P5|NOT COMPLETED|Treatment Phase: Second Intervention||0
441056|NCT01380093|1081231|P4|NOT COMPLETED|Treatment Phase: Second Intervention||1
441057|NCT01380093|1081232|P3|NOT COMPLETED|Treatment Phase: Second Intervention||0
441058|NCT01380093|1081233|P2|NOT COMPLETED|Treatment Phase: Second Intervention||0
441059|NCT01380093|1081234|P1|NOT COMPLETED|Treatment Phase: Second Intervention||0
441060|NCT01380093|1081226|P9|COMPLETED|Treatment Phase: Second Intervention||6
441061|NCT01380093|1081227|P8|COMPLETED|Treatment Phase: Second Intervention||6
441062|NCT01380093|1081228|P7|COMPLETED|Treatment Phase: Second Intervention||6
441063|NCT01380093|1081229|P6|COMPLETED|Treatment Phase: Second Intervention||6
441064|NCT01380093|1081230|P5|COMPLETED|Treatment Phase: Second Intervention||6
441065|NCT01380093|1081231|P4|COMPLETED|Treatment Phase: Second Intervention||5
441066|NCT01380093|1081232|P3|COMPLETED|Treatment Phase: Second Intervention||0
441067|NCT01380093|1081233|P2|COMPLETED|Treatment Phase: Second Intervention||0
441068|NCT01380093|1081234|P1|COMPLETED|Treatment Phase: Second Intervention||0
441147|NCT01380093|1081232|P3|COMPLETED|Drug Discrimination Phase: Day 2||16
441069|NCT01380093|1081226|P9|STARTED|Treatment Phase: Second Intervention||6
441070|NCT01380093|1081227|P8|STARTED|Treatment Phase: Second Intervention||6
441071|NCT01380093|1081228|P7|STARTED|Treatment Phase: Second Intervention||6
441072|NCT01380093|1081229|P6|STARTED|Treatment Phase: Second Intervention||6
441073|NCT01380093|1081230|P5|STARTED|Treatment Phase: Second Intervention||6
441074|NCT01380093|1081231|P4|STARTED|Treatment Phase: Second Intervention||6
441075|NCT01380093|1081232|P3|STARTED|Treatment Phase: Second Intervention||0
441076|NCT01380093|1081233|P2|STARTED|Treatment Phase: Second Intervention||0
441077|NCT01380093|1081234|P1|STARTED|Treatment Phase: Second Intervention||0
441078|NCT01380093|1081226|P9|NOT COMPLETED|Treatment Phase: Washout Period||0
441079|NCT01380093|1081227|P8|NOT COMPLETED|Treatment Phase: Washout Period||0
441080|NCT01380093|1081228|P7|NOT COMPLETED|Treatment Phase: Washout Period||0
441081|NCT01380093|1081229|P6|NOT COMPLETED|Treatment Phase: Washout Period||0
441082|NCT01380093|1081230|P5|NOT COMPLETED|Treatment Phase: Washout Period||0
441083|NCT01380093|1081231|P4|NOT COMPLETED|Treatment Phase: Washout Period||0
441084|NCT01380093|1081232|P3|NOT COMPLETED|Treatment Phase: Washout Period||0
441085|NCT01380093|1081233|P2|NOT COMPLETED|Treatment Phase: Washout Period||0
441086|NCT01380093|1081234|P1|NOT COMPLETED|Treatment Phase: Washout Period||0
441087|NCT01380093|1081226|P9|COMPLETED|Treatment Phase: Washout Period||6
441088|NCT01380093|1081227|P8|COMPLETED|Treatment Phase: Washout Period||6
441089|NCT01380093|1081228|P7|COMPLETED|Treatment Phase: Washout Period||6
441090|NCT01380093|1081229|P6|COMPLETED|Treatment Phase: Washout Period||6
441091|NCT01380093|1081230|P5|COMPLETED|Treatment Phase: Washout Period||6
441092|NCT01380093|1081231|P4|COMPLETED|Treatment Phase: Washout Period||6
441093|NCT01380093|1081232|P3|COMPLETED|Treatment Phase: Washout Period||0
441094|NCT01380093|1081233|P2|COMPLETED|Treatment Phase: Washout Period||0
441095|NCT01380093|1081234|P1|COMPLETED|Treatment Phase: Washout Period||0
441096|NCT01380093|1081226|P9|STARTED|Treatment Phase: Washout Period||6
441097|NCT01380093|1081227|P8|STARTED|Treatment Phase: Washout Period||6
441098|NCT01380093|1081228|P7|STARTED|Treatment Phase: Washout Period||6
441099|NCT01380093|1081229|P6|STARTED|Treatment Phase: Washout Period||6
441100|NCT01380093|1081230|P5|STARTED|Treatment Phase: Washout Period||6
441101|NCT01380093|1081231|P4|STARTED|Treatment Phase: Washout Period||6
441102|NCT01380093|1081232|P3|STARTED|Treatment Phase: Washout Period||0
441103|NCT01380093|1081233|P2|STARTED|Treatment Phase: Washout Period||0
441104|NCT01380093|1081234|P1|STARTED|Treatment Phase: Washout Period||0
441105|NCT01380093|1081226|P9|NOT COMPLETED|Treatment Phase: First Intervention||0
441106|NCT01380093|1081227|P8|NOT COMPLETED|Treatment Phase: First Intervention||0
441107|NCT01380093|1081228|P7|NOT COMPLETED|Treatment Phase: First Intervention||0
441108|NCT01380093|1081229|P6|NOT COMPLETED|Treatment Phase: First Intervention||0
441109|NCT01380093|1081230|P5|NOT COMPLETED|Treatment Phase: First Intervention||0
441110|NCT01380093|1081231|P4|NOT COMPLETED|Treatment Phase: First Intervention||0
441111|NCT01380093|1081232|P3|NOT COMPLETED|Treatment Phase: First Intervention||0
441112|NCT01380093|1081233|P2|NOT COMPLETED|Treatment Phase: First Intervention||0
441113|NCT01380093|1081234|P1|NOT COMPLETED|Treatment Phase: First Intervention||0
441114|NCT01380093|1081226|P9|COMPLETED|Treatment Phase: First Intervention||6
441115|NCT01380093|1081227|P8|COMPLETED|Treatment Phase: First Intervention||6
441116|NCT01380093|1081228|P7|COMPLETED|Treatment Phase: First Intervention||6
441117|NCT01380093|1081229|P6|COMPLETED|Treatment Phase: First Intervention||6
441118|NCT01380093|1081230|P5|COMPLETED|Treatment Phase: First Intervention||6
441119|NCT01380093|1081231|P4|COMPLETED|Treatment Phase: First Intervention||6
441120|NCT01380093|1081232|P3|COMPLETED|Treatment Phase: First Intervention||0
441121|NCT01380093|1081233|P2|COMPLETED|Treatment Phase: First Intervention||0
441122|NCT01380093|1081234|P1|COMPLETED|Treatment Phase: First Intervention||0
441123|NCT01380093|1081226|P9|STARTED|Treatment Phase: First Intervention||6
441124|NCT01380093|1081227|P8|STARTED|Treatment Phase: First Intervention||6
441125|NCT01380093|1081228|P7|STARTED|Treatment Phase: First Intervention||6
441126|NCT01380093|1081229|P6|STARTED|Treatment Phase: First Intervention||6
441127|NCT01380093|1081230|P5|STARTED|Treatment Phase: First Intervention||6
441128|NCT01380093|1081231|P4|STARTED|Treatment Phase: First Intervention||6
441129|NCT01380093|1081232|P3|STARTED|Treatment Phase: First Intervention||0
441130|NCT01380093|1081233|P2|STARTED|Treatment Phase: First Intervention||0
441131|NCT01380093|1081234|P1|STARTED|Treatment Phase: First Intervention||0
441132|NCT01380093|1081226|P9|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
441133|NCT01380093|1081227|P8|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
441134|NCT01380093|1081228|P7|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
441135|NCT01380093|1081229|P6|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
441136|NCT01380093|1081230|P5|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
441137|NCT01380093|1081231|P4|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
441138|NCT01380093|1081232|P3|NOT COMPLETED|Drug Discrimination Phase: Day 2||13
441139|NCT01380093|1081233|P2|NOT COMPLETED|Drug Discrimination Phase: Day 2||9
441140|NCT01380093|1081234|P1|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
441141|NCT01380093|1081226|P9|COMPLETED|Drug Discrimination Phase: Day 2||0
441142|NCT01380093|1081227|P8|COMPLETED|Drug Discrimination Phase: Day 2||0
441143|NCT01380093|1081228|P7|COMPLETED|Drug Discrimination Phase: Day 2||0
441144|NCT01380093|1081229|P6|COMPLETED|Drug Discrimination Phase: Day 2||0
441145|NCT01380093|1081230|P5|COMPLETED|Drug Discrimination Phase: Day 2||0
441146|NCT01380093|1081231|P4|COMPLETED|Drug Discrimination Phase: Day 2||0
441148|NCT01380093|1081233|P2|COMPLETED|Drug Discrimination Phase: Day 2||20
441149|NCT01380093|1081234|P1|COMPLETED|Drug Discrimination Phase: Day 2||0
441150|NCT01380093|1081226|P9|STARTED|Drug Discrimination Phase: Day 2||0
441151|NCT01380093|1081227|P8|STARTED|Drug Discrimination Phase: Day 2||0
441152|NCT01380093|1081228|P7|STARTED|Drug Discrimination Phase: Day 2||0
441153|NCT01380093|1081229|P6|STARTED|Drug Discrimination Phase: Day 2||0
441154|NCT01380093|1081230|P5|STARTED|Drug Discrimination Phase: Day 2||0
441155|NCT01380093|1081231|P4|STARTED|Drug Discrimination Phase: Day 2||0
441156|NCT01380093|1081232|P3|STARTED|Drug Discrimination Phase: Day 2||29
441157|NCT01380093|1081233|P2|STARTED|Drug Discrimination Phase: Day 2||29
441158|NCT01380093|1081234|P1|STARTED|Drug Discrimination Phase: Day 2||0
441159|NCT01380093|1081226|P9|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
441160|NCT01380093|1081227|P8|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
441161|NCT01380093|1081228|P7|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
441162|NCT01380093|1081229|P6|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
441163|NCT01380093|1081230|P5|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
441164|NCT01380093|1081231|P4|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
441165|NCT01380093|1081232|P3|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
441166|NCT01380093|1081233|P2|NOT COMPLETED|Drug Discrimination Phase: Day 1||1
441167|NCT01380093|1081234|P1|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
441168|NCT01380093|1081226|P9|COMPLETED|Drug Discrimination Phase: Day 1||0
441169|NCT01380093|1081227|P8|COMPLETED|Drug Discrimination Phase: Day 1||0
441170|NCT01380093|1081228|P7|COMPLETED|Drug Discrimination Phase: Day 1||0
441171|NCT01380093|1081229|P6|COMPLETED|Drug Discrimination Phase: Day 1||0
441172|NCT01380093|1081230|P5|COMPLETED|Drug Discrimination Phase: Day 1||0
441173|NCT01380093|1081231|P4|COMPLETED|Drug Discrimination Phase: Day 1||0
441174|NCT01380093|1081232|P3|COMPLETED|Drug Discrimination Phase: Day 1||29
441175|NCT01380093|1081233|P2|COMPLETED|Drug Discrimination Phase: Day 1||29
441176|NCT01380093|1081234|P1|COMPLETED|Drug Discrimination Phase: Day 1||0
441177|NCT01380093|1081226|P9|STARTED|Drug Discrimination Phase: Day 1||0
441178|NCT01380093|1081227|P8|STARTED|Drug Discrimination Phase: Day 1||0
441179|NCT01380093|1081228|P7|STARTED|Drug Discrimination Phase: Day 1||0
441180|NCT01380093|1081229|P6|STARTED|Drug Discrimination Phase: Day 1||0
441181|NCT01380093|1081230|P5|STARTED|Drug Discrimination Phase: Day 1||0
441182|NCT01380093|1081231|P4|STARTED|Drug Discrimination Phase: Day 1||0
441183|NCT01380093|1081232|P3|STARTED|Drug Discrimination Phase: Day 1||29
441184|NCT01380093|1081233|P2|STARTED|Drug Discrimination Phase: Day 1||30
441185|NCT01380093|1081234|P1|STARTED|Drug Discrimination Phase: Day 1||0
441186|NCT01380093|1081226|P9|NOT COMPLETED|Naloxone Challenge Phase||0
441187|NCT01380093|1081227|P8|NOT COMPLETED|Naloxone Challenge Phase||0
441188|NCT01380093|1081228|P7|NOT COMPLETED|Naloxone Challenge Phase||0
441189|NCT01380093|1081229|P6|NOT COMPLETED|Naloxone Challenge Phase||0
441190|NCT01380093|1081230|P5|NOT COMPLETED|Naloxone Challenge Phase||0
441191|NCT01380093|1081231|P4|NOT COMPLETED|Naloxone Challenge Phase||0
441192|NCT01380093|1081232|P3|NOT COMPLETED|Naloxone Challenge Phase||0
441193|NCT01380093|1081233|P2|NOT COMPLETED|Naloxone Challenge Phase||0
441194|NCT01380093|1081234|P1|NOT COMPLETED|Naloxone Challenge Phase||21
441195|NCT01380093|1081226|P9|COMPLETED|Naloxone Challenge Phase||0
441196|NCT01380093|1081227|P8|COMPLETED|Naloxone Challenge Phase||0
441197|NCT01380093|1081228|P7|COMPLETED|Naloxone Challenge Phase||0
441198|NCT01380093|1081229|P6|COMPLETED|Naloxone Challenge Phase||0
441199|NCT01380093|1081230|P5|COMPLETED|Naloxone Challenge Phase||0
441200|NCT01380093|1081231|P4|COMPLETED|Naloxone Challenge Phase||0
441201|NCT01380093|1081232|P3|COMPLETED|Naloxone Challenge Phase||0
441202|NCT01380093|1081233|P2|COMPLETED|Naloxone Challenge Phase||0
441203|NCT01380093|1081234|P1|COMPLETED|Naloxone Challenge Phase||59
441204|NCT01380093|1081226|P9|TREATED|Naloxone Challenge Phase||0
441205|NCT01380093|1081227|P8|TREATED|Naloxone Challenge Phase||0
441206|NCT01380093|1081228|P7|TREATED|Naloxone Challenge Phase||0
441207|NCT01380093|1081229|P6|TREATED|Naloxone Challenge Phase||0
441208|NCT01380093|1081230|P5|TREATED|Naloxone Challenge Phase||0
441209|NCT01380093|1081231|P4|TREATED|Naloxone Challenge Phase||0
441210|NCT01380093|1081232|P3|TREATED|Naloxone Challenge Phase||0
441211|NCT01380093|1081233|P2|TREATED|Naloxone Challenge Phase||0
441212|NCT01380093|1081234|P1|TREATED|Naloxone Challenge Phase||59
441213|NCT01380093|1081226|P9|STARTED|Naloxone Challenge Phase||0
441214|NCT01380093|1081227|P8|STARTED|Naloxone Challenge Phase||0
441215|NCT01380093|1081228|P7|STARTED|Naloxone Challenge Phase||0
441216|NCT01380093|1081229|P6|STARTED|Naloxone Challenge Phase||0
441217|NCT01380093|1081230|P5|STARTED|Naloxone Challenge Phase||0
441218|NCT01380093|1081231|P4|STARTED|Naloxone Challenge Phase||0
441219|NCT01380093|1081232|P3|STARTED|Naloxone Challenge Phase||0
441220|NCT01380093|1081233|P2|STARTED|Naloxone Challenge Phase||0
441221|NCT01380093|1081234|P1|STARTED|Naloxone Challenge Phase||80
441222|NCT01380080|1081526|P2|NOT COMPLETED|Overall Study||23
441223|NCT01380080|1081527|P1|NOT COMPLETED|Overall Study||33
441224|NCT01380080|1081526|P2|COMPLETED|Overall Study||403
441225|NCT01380080|1081527|P1|COMPLETED|Overall Study||391
441226|NCT01380080|1081526|P2|STARTED|Overall Study||426
441227|NCT01380080|1081527|P1|STARTED|Overall Study||424
441228|NCT01379963|1081543|P1|NOT COMPLETED|Overall Study||0
441229|NCT01379963|1081543|P1|COMPLETED|Overall Study||780
441230|NCT01379963|1081543|P1|STARTED|Overall Study||780
441231|NCT01379937|1081552|P4|NOT COMPLETED|Overall Study||1
441232|NCT01379937|1081553|P3|NOT COMPLETED|Overall Study||2
441233|NCT01379937|1081554|P2|NOT COMPLETED|Overall Study||3
441234|NCT01379937|1081555|P1|NOT COMPLETED|Overall Study||1
441235|NCT01379937|1081552|P4|COMPLETED|Overall Study||103
441236|NCT01379937|1081553|P3|COMPLETED|Overall Study||102
441237|NCT01379937|1081554|P2|COMPLETED|Overall Study||153
441238|NCT01379937|1081555|P1|COMPLETED|Overall Study||155
441239|NCT01379937|1081552|P4|STARTED|Overall Study||104
441240|NCT01379937|1081553|P3|STARTED|Overall Study||104
441241|NCT01379937|1081554|P2|STARTED|Overall Study||156
441242|NCT01379937|1081555|P1|STARTED|Overall Study||156
441243|NCT01379781|1081637|P2|NOT COMPLETED|Overall Study||8
441244|NCT01379781|1081638|P1|NOT COMPLETED|Overall Study||11
441245|NCT01379781|1081637|P2|COMPLETED|Overall Study||19
441246|NCT01379781|1081638|P1|COMPLETED|Overall Study||16
441247|NCT01379781|1081637|P2|STARTED|Overall Study||27
441248|NCT01379781|1081638|P1|STARTED|Overall Study||27
441249|NCT01379768|1081647|P3|NOT COMPLETED|Overall Study||0
441250|NCT01379768|1081648|P2|NOT COMPLETED|Overall Study||1
441251|NCT01379768|1081649|P1|NOT COMPLETED|Overall Study||3
441252|NCT01379768|1081647|P3|COMPLETED|Overall Study||20
441253|NCT01379768|1081648|P2|COMPLETED|Overall Study||21
441254|NCT01379768|1081649|P1|COMPLETED|Overall Study||20
441255|NCT01379768|1081647|P3|STARTED|Overall Study||20
441256|NCT01379768|1081648|P2|STARTED|Overall Study||22
441257|NCT01379768|1081649|P1|STARTED|Overall Study||23
441258|NCT01379703|1081672|P3|NOT COMPLETED|9 Months Through 18 Months||0
441259|NCT01379703|1081673|P2|NOT COMPLETED|9 Months Through 18 Months||230
441260|NCT01379703|1081674|P1|NOT COMPLETED|9 Months Through 18 Months||0
441261|NCT01379703|1081672|P3|COMPLETED|9 Months Through 18 Months||0
441262|NCT01379703|1081673|P2|COMPLETED|9 Months Through 18 Months||854
441263|NCT01379703|1081674|P1|COMPLETED|9 Months Through 18 Months||0
441264|NCT01379703|1081672|P3|STARTED|9 Months Through 18 Months|Participants in this subgroup were followed for 9 months.|0
441265|NCT01379703|1081673|P2|STARTED|9 Months Through 18 Months|Participants taking the capsule formulation were followed for an additional 9 months (up to 18 mos).|1084
441266|NCT01379703|1081674|P1|STARTED|9 Months Through 18 Months|Participants in this subgroup were followed for 9 months.|0
441267|NCT01379703|1081672|P3|NOT COMPLETED|Study Start Through 9 Months||143
441268|NCT01379703|1081673|P2|NOT COMPLETED|Study Start Through 9 Months||122
441269|NCT01379703|1081674|P1|NOT COMPLETED|Study Start Through 9 Months||4
441270|NCT01379703|1081672|P3|COMPLETED|Study Start Through 9 Months||873
441271|NCT01379703|1081673|P2|COMPLETED|Study Start Through 9 Months|Participants taking the capsule formulation were followed for an additional 9 months (up to 18 mos).|1084
441272|NCT01379703|1081674|P1|COMPLETED|Study Start Through 9 Months||62
441273|NCT01379703|1081672|P3|STARTED|Study Start Through 9 Months|Participants taking the lopinavir/ritonavir tablet formulation (only) during study (1016/2288)|1016
441274|NCT01379703|1081673|P2|STARTED|Study Start Through 9 Months|Participants taking the lopinavir/ritonavir capsule formulation (only) during study (1206/2288)|1206
441275|NCT01379703|1081674|P1|STARTED|Study Start Through 9 Months|Participants taking lopinavir/ritonavir tablets/capsules or oral solution during the study (66/2288)|66
441276|NCT01379664|1081737|P2|NOT COMPLETED|Overall Study||0
441277|NCT01379664|1081738|P1|NOT COMPLETED|Overall Study||0
441278|NCT01379664|1081737|P2|COMPLETED|Overall Study||870
441279|NCT01379664|1081738|P1|COMPLETED|Overall Study||714
441280|NCT01379664|1081737|P2|STARTED|Overall Study||870
441281|NCT01379664|1081738|P1|STARTED|Overall Study||714
441282|NCT01379651|1081750|P2|NOT COMPLETED|Overall Study||0
441283|NCT01379651|1081751|P1|NOT COMPLETED|Overall Study||0
441284|NCT01379651|1081750|P2|COMPLETED|Overall Study||10
441285|NCT01379651|1081751|P1|COMPLETED|Overall Study||10
441286|NCT01379651|1081750|P2|STARTED|Overall Study||10
441287|NCT01379651|1081751|P1|STARTED|Overall Study||10
441288|NCT01379625|1081761|P2|NOT COMPLETED|Overall Study||0
441289|NCT01379625|1081762|P1|NOT COMPLETED|Overall Study||0
441290|NCT01379625|1081761|P2|COMPLETED|Overall Study||16
441291|NCT01379625|1081762|P1|COMPLETED|Overall Study||16
441292|NCT01379625|1081761|P2|STARTED|Overall Study||16
441293|NCT01379625|1081762|P1|STARTED|Overall Study||16
441294|NCT01379534|1081774|P2|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||2
441295|NCT01379534|1081775|P1|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||4
441296|NCT01379534|1081774|P2|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0
441297|NCT01379534|1081775|P1|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0
441298|NCT01379534|1081774|P2|STARTED|Tumor Assessment Follow-up (f/u) Phase||2
441299|NCT01379534|1081775|P1|STARTED|Tumor Assessment Follow-up (f/u) Phase|All participants discontinued the Treatment Phase. Of these, only 6 qualified for f/u tumor assess..|4
441300|NCT01379534|1081774|P2|NOT COMPLETED|Treatment Phase||31
441301|NCT01379534|1081775|P1|NOT COMPLETED|Treatment Phase||22
441302|NCT01379534|1081774|P2|COMPLETED|Treatment Phase||0
441303|NCT01379534|1081775|P1|COMPLETED|Treatment Phase||0
441304|NCT01379534|1081774|P2|STARTED|Treatment Phase||31
441305|NCT01379534|1081775|P1|STARTED|Treatment Phase||22
441306|NCT01379521|1081795|P2|NOT COMPLETED|Post-Treatment Evaluations||21
441307|NCT01379521|1081796|P1|NOT COMPLETED|Post-Treatment Evaluations||25
441308|NCT01379521|1081795|P2|COMPLETED|Post-Treatment Evaluations||0
441309|NCT01379521|1081796|P1|COMPLETED|Post-Treatment Evaluations||0
441310|NCT01379521|1081795|P2|STARTED|Post-Treatment Evaluations||21
441311|NCT01379521|1081796|P1|STARTED|Post-Treatment Evaluations||25
441312|NCT01379521|1081795|P2|NOT COMPLETED|Overall Study -Treatment Period||26
441313|NCT01379521|1081796|P1|NOT COMPLETED|Overall Study -Treatment Period||33
441314|NCT01379521|1081795|P2|COMPLETED|Overall Study -Treatment Period||0
441315|NCT01379521|1081796|P1|COMPLETED|Overall Study -Treatment Period||0
441316|NCT01379521|1081795|P2|STARTED|Overall Study -Treatment Period||26
441317|NCT01379521|1081796|P1|STARTED|Overall Study -Treatment Period||33
441318|NCT01379183|1081816|P2|NOT COMPLETED|Overall Study||0
441319|NCT01379183|1081817|P1|NOT COMPLETED|Overall Study||0
441320|NCT01379183|1081816|P2|COMPLETED|Overall Study||21
441321|NCT01379183|1081817|P1|COMPLETED|Overall Study||19
441322|NCT01379183|1081816|P2|STARTED|Overall Study||21
441323|NCT01379183|1081817|P1|STARTED|Overall Study||19
441324|NCT01378988|1081835|P2|NOT COMPLETED|Overall Study||0
441325|NCT01378988|1081836|P1|NOT COMPLETED|Overall Study||0
441326|NCT01378988|1081835|P2|COMPLETED|Overall Study||3
441327|NCT01378988|1081836|P1|COMPLETED|Overall Study||2
441328|NCT01378988|1081835|P2|STARTED|Overall Study||3
441329|NCT01378988|1081836|P1|STARTED|Overall Study||2
441330|NCT01378975|1081866|P2|NOT COMPLETED|Overall Study||50
441331|NCT01378975|1081867|P1|NOT COMPLETED|Overall Study||86
441332|NCT01378975|1081866|P2|COMPLETED|Overall Study||6
441333|NCT01378975|1081867|P1|COMPLETED|Overall Study||4
441334|NCT01378975|1081866|P2|STARTED|Overall Study||56
441335|NCT01378975|1081867|P1|STARTED|Overall Study||90
441336|NCT01378962|1081893|P1|NOT COMPLETED|Overall Study||17
441337|NCT01378962|1081893|P1|COMPLETED|Overall Study||33
441338|NCT01378962|1081893|P1|STARTED|Overall Study||50
441339|NCT01378520|1081906|P2|NOT COMPLETED|Second Intervention (Day 4-6)||0
441340|NCT01378520|1081907|P1|NOT COMPLETED|Second Intervention (Day 4-6)||0
441341|NCT01378520|1081906|P2|COMPLETED|Second Intervention (Day 4-6)||10
441342|NCT01378520|1081907|P1|COMPLETED|Second Intervention (Day 4-6)||10
441343|NCT01378520|1081906|P2|STARTED|Second Intervention (Day 4-6)||10
441344|NCT01378520|1081907|P1|STARTED|Second Intervention (Day 4-6)||10
441345|NCT01378520|1081906|P2|NOT COMPLETED|First Intervention (Day 2-3)||0
441346|NCT01378520|1081907|P1|NOT COMPLETED|First Intervention (Day 2-3)||0
441347|NCT01378520|1081906|P2|COMPLETED|First Intervention (Day 2-3)||10
441348|NCT01378520|1081907|P1|COMPLETED|First Intervention (Day 2-3)||10
441349|NCT01378520|1081906|P2|STARTED|First Intervention (Day 2-3)||10
441350|NCT01378520|1081907|P1|STARTED|First Intervention (Day 2-3)||10
441351|NCT01378429|1081919|P2|NOT COMPLETED|Overall Study||0
441352|NCT01378429|1081920|P1|NOT COMPLETED|Overall Study||1
441353|NCT01378429|1081919|P2|COMPLETED|Overall Study||47
441354|NCT01378429|1081920|P1|COMPLETED|Overall Study||41
441355|NCT01378429|1081919|P2|STARTED|Overall Study||47
441356|NCT01378429|1081920|P1|STARTED|Overall Study||42
441357|NCT01378416|1081952|P1|NOT COMPLETED|Overall Study||0
441358|NCT01378416|1081952|P1|COMPLETED|Overall Study||16
441359|NCT01378416|1081952|P1|STARTED|Overall Study||16
441360|NCT01378325|1081962|P2|NOT COMPLETED|Overall Study||1
441361|NCT01378325|1081963|P1|NOT COMPLETED|Overall Study||0
441362|NCT01378325|1081962|P2|COMPLETED|Overall Study||39
441363|NCT01378325|1081963|P1|COMPLETED|Overall Study||40
441364|NCT01378325|1081962|P2|STARTED|Overall Study||40
441365|NCT01378325|1081963|P1|STARTED|Overall Study||40
441366|NCT01378221|1081971|P2|NOT COMPLETED|Overall Study||9
441367|NCT01378221|1081972|P1|NOT COMPLETED|Overall Study||7
441368|NCT01378221|1081971|P2|COMPLETED|Overall Study||30
441369|NCT01378221|1081972|P1|COMPLETED|Overall Study||29
441370|NCT01378221|1081971|P2|STARTED|Overall Study||39
441371|NCT01378221|1081972|P1|STARTED|Overall Study||36
441372|NCT01378195|1081980|P2|NOT COMPLETED|Overall Study||18
441373|NCT01378195|1081981|P1|NOT COMPLETED|Overall Study||29
441374|NCT01378195|1081980|P2|COMPLETED|Overall Study||57
441375|NCT01378195|1081981|P1|COMPLETED|Overall Study||46
441376|NCT01378195|1081980|P2|STARTED|Overall Study||75
441377|NCT01378195|1081981|P1|STARTED|Overall Study||75
441378|NCT01378117|1081994|P3|NOT COMPLETED|Overall Study||3
441379|NCT01378117|1081995|P2|NOT COMPLETED|Overall Study||1
441380|NCT01378117|1081996|P1|NOT COMPLETED|Overall Study||4
441381|NCT01378117|1081994|P3|COMPLETED|Overall Study||26
441382|NCT01378117|1081995|P2|COMPLETED|Overall Study||29
441383|NCT01378117|1081996|P1|COMPLETED|Overall Study||27
441384|NCT01378117|1081994|P3|STARTED|Overall Study||29
441385|NCT01378117|1081995|P2|STARTED|Overall Study||30
441386|NCT01378117|1081996|P1|STARTED|Overall Study||31
441387|NCT01378104|1082006|P2|NOT COMPLETED|Overall Study||26
441388|NCT01378104|1082007|P1|NOT COMPLETED|Overall Study||27
441389|NCT01378104|1082006|P2|COMPLETED|Overall Study||60
441390|NCT01378104|1082007|P1|COMPLETED|Overall Study||65
441391|NCT01378104|1082006|P2|STARTED|Overall Study||86
441392|NCT01378104|1082007|P1|STARTED|Overall Study||92
441393|NCT01378065|1082015|P1|NOT COMPLETED|Overall Study||0
441394|NCT01378065|1082015|P1|COMPLETED|Overall Study||30
441395|NCT01378065|1082015|P1|12 Months|Overall Study||30
441396|NCT01378065|1082015|P1|6 Months|Overall Study||30
441397|NCT01378065|1082015|P1|3 Months|Overall Study||30
441398|NCT01378065|1082015|P1|6 Week|Overall Study||30
441399|NCT01378065|1082015|P1|STARTED|Overall Study|31 subjects were enrolled/consented. However, 1 subject was not implanted with a study device.|30
441400|NCT01377987|1082052|P2|NOT COMPLETED|Second Intervention (7 Days)||0
441401|NCT01377987|1082053|P1|NOT COMPLETED|Second Intervention (7 Days)||0
441402|NCT01377987|1082052|P2|COMPLETED|Second Intervention (7 Days)||14
441403|NCT01377987|1082053|P1|COMPLETED|Second Intervention (7 Days)||13
441404|NCT01377987|1082052|P2|STARTED|Second Intervention (7 Days)||14
441405|NCT01377987|1082053|P1|STARTED|Second Intervention (7 Days)||13
441406|NCT01377987|1082052|P2|NOT COMPLETED|Washout (7 Days)||1
441407|NCT01377987|1082053|P1|NOT COMPLETED|Washout (7 Days)||1
441408|NCT01377987|1082052|P2|COMPLETED|Washout (7 Days)||14
441409|NCT01377987|1082053|P1|COMPLETED|Washout (7 Days)||13
441410|NCT01377987|1082052|P2|STARTED|Washout (7 Days)||15
441411|NCT01377987|1082053|P1|STARTED|Washout (7 Days)||14
441412|NCT01377987|1082052|P2|NOT COMPLETED|First Intervention (7 Days)||0
441413|NCT01377987|1082053|P1|NOT COMPLETED|First Intervention (7 Days)||0
441414|NCT01377987|1082052|P2|COMPLETED|First Intervention (7 Days)||15
441415|NCT01377987|1082053|P1|COMPLETED|First Intervention (7 Days)||14
441416|NCT01377987|1082052|P2|STARTED|First Intervention (7 Days)||15
441417|NCT01377987|1082053|P1|STARTED|First Intervention (7 Days)||14
441418|NCT01377922|1082071|P2|NOT COMPLETED|Overall Study||0
441419|NCT01377922|1082072|P1|NOT COMPLETED|Overall Study||1
441420|NCT01377922|1082071|P2|COMPLETED|Overall Study||16
441421|NCT01377922|1082072|P1|COMPLETED|Overall Study||21
441422|NCT01377922|1082071|P2|STARTED|Overall Study||16
441423|NCT01377922|1082072|P1|STARTED|Overall Study||22
441424|NCT01377636|1082084|P1|NOT COMPLETED|Overall Study||0
441425|NCT01377636|1082084|P1|COMPLETED|Overall Study||20
441426|NCT01377636|1082084|P1|STARTED|Overall Study||20
441427|NCT01377623|1082098|P2|NOT COMPLETED|Overall Study||5
441428|NCT01377623|1082099|P1|NOT COMPLETED|Overall Study||7
441429|NCT01377623|1082098|P2|COMPLETED|Overall Study||28
441430|NCT01377623|1082099|P1|COMPLETED|Overall Study||26
441431|NCT01377623|1082098|P2|STARTED|Overall Study||33
441432|NCT01377623|1082099|P1|STARTED|Overall Study||33
441433|NCT01377584|1082119|P6|NOT COMPLETED|Overall Study||3
441434|NCT01377584|1082120|P5|NOT COMPLETED|Overall Study||3
441435|NCT01377584|1082121|P4|NOT COMPLETED|Overall Study||4
441436|NCT01377584|1082122|P3|NOT COMPLETED|Overall Study||4
441437|NCT01377584|1082123|P2|NOT COMPLETED|Overall Study||3
441438|NCT01377584|1082124|P1|NOT COMPLETED|Overall Study||3
441439|NCT01377584|1082119|P6|COMPLETED|Overall Study||9
441440|NCT01377584|1082120|P5|COMPLETED|Overall Study||9
441441|NCT01377584|1082121|P4|COMPLETED|Overall Study||6
441442|NCT01377584|1082122|P3|COMPLETED|Overall Study||6
441443|NCT01377584|1082123|P2|COMPLETED|Overall Study||5
441444|NCT01377584|1082124|P1|COMPLETED|Overall Study||5
441445|NCT01377584|1082119|P6|STARTED|Overall Study||12
441446|NCT01377584|1082120|P5|STARTED|Overall Study||12
441447|NCT01377584|1082121|P4|STARTED|Overall Study||10
441448|NCT01377584|1082122|P3|STARTED|Overall Study||10
441449|NCT01377584|1082123|P2|STARTED|Overall Study||8
441450|NCT01377584|1082124|P1|STARTED|Overall Study||8
441451|NCT01377480|1082157|P4|NOT COMPLETED|Overall Study||11
441452|NCT01377480|1082158|P3|NOT COMPLETED|Overall Study||10
441453|NCT01377480|1082159|P2|NOT COMPLETED|Overall Study||1
441454|NCT01377480|1082160|P1|NOT COMPLETED|Overall Study||0
441455|NCT01377480|1082157|P4|COMPLETED|Overall Study||19
441456|NCT01377480|1082158|P3|COMPLETED|Overall Study||18
441457|NCT01377480|1082159|P2|COMPLETED|Overall Study||29
441458|NCT01377480|1082160|P1|COMPLETED|Overall Study||32
441459|NCT01377480|1082157|P4|STARTED|Overall Study||30
441460|NCT01377480|1082158|P3|STARTED|Overall Study|2 participants received only POS and were analyzed as part of the posaconazole group|28
441461|NCT01377480|1082159|P2|STARTED|Overall Study||30
441462|NCT01377480|1082160|P1|STARTED|Overall Study|Includes 2 participants randomized to POS + BNZ but who only received POS|32
441463|NCT01377467|1082172|P2|NOT COMPLETED|Overall Study||0
441464|NCT01377467|1082173|P1|NOT COMPLETED|Overall Study||0
441465|NCT01377467|1082172|P2|COMPLETED|Overall Study||44
441466|NCT01377467|1082173|P1|COMPLETED|Overall Study||46
441467|NCT01377467|1082172|P2|STARTED|Overall Study||44
441468|NCT01377467|1082173|P1|STARTED|Overall Study||46
441469|NCT01377441|1082221|P2|NOT COMPLETED|Overall Study||0
441470|NCT01377441|1082222|P1|NOT COMPLETED|Overall Study||0
441471|NCT01377441|1082221|P2|COMPLETED|Overall Study|All data for this study was lost after Hurricane Sandy.|0
441472|NCT01377441|1082222|P1|COMPLETED|Overall Study|All data for this study was lost after Hurricane Sandy.|0
441473|NCT01377441|1082221|P2|STARTED|Overall Study||0
441474|NCT01377441|1082222|P1|STARTED|Overall Study||0
441475|NCT01377402|1082230|P1|NOT COMPLETED|Overall Study||0
441476|NCT01377402|1082230|P1|COMPLETED|Overall Study||982
441477|NCT01377402|1082230|P1|STARTED|Overall Study||982
441478|NCT01377233|1082241|P5|NOT COMPLETED|Double-blind||2
441479|NCT01377233|1082242|P4|NOT COMPLETED|Double-blind||4
441480|NCT01377233|1082243|P3|NOT COMPLETED|Double-blind||2
441481|NCT01377233|1082244|P2|NOT COMPLETED|Double-blind||1
441482|NCT01377233|1082245|P1|NOT COMPLETED|Double-blind||0
441483|NCT01377233|1082241|P5|COMPLETED|Double-blind||8
441484|NCT01377233|1082242|P4|COMPLETED|Double-blind||7
441485|NCT01377233|1082243|P3|COMPLETED|Double-blind||8
441486|NCT01377233|1082244|P2|COMPLETED|Double-blind||10
441487|NCT01377233|1082245|P1|COMPLETED|Double-blind||0
441488|NCT01377233|1082241|P5|STARTED|Double-blind||10
441489|NCT01377233|1082242|P4|STARTED|Double-blind||11
441490|NCT01377233|1082243|P3|STARTED|Double-blind||10
441491|NCT01377233|1082244|P2|STARTED|Double-blind||11
441492|NCT01377233|1082245|P1|STARTED|Double-blind||0
441493|NCT01377233|1082241|P5|NOT COMPLETED|Open-label||0
441494|NCT01377233|1082242|P4|NOT COMPLETED|Open-label||0
441495|NCT01377233|1082243|P3|NOT COMPLETED|Open-label||0
441496|NCT01377233|1082244|P2|NOT COMPLETED|Open-label||0
441497|NCT01377233|1082245|P1|NOT COMPLETED|Open-label||4
441498|NCT01377233|1082241|P5|COMPLETED|Open-label||0
441499|NCT01377233|1082242|P4|COMPLETED|Open-label||0
441500|NCT01377233|1082243|P3|COMPLETED|Open-label||0
441501|NCT01377233|1082244|P2|COMPLETED|Open-label||0
441502|NCT01377233|1082245|P1|COMPLETED|Open-label||42
441503|NCT01377233|1082241|P5|STARTED|Open-label||0
441504|NCT01377233|1082242|P4|STARTED|Open-label||0
441505|NCT01377233|1082243|P3|STARTED|Open-label||0
441506|NCT01377233|1082244|P2|STARTED|Open-label||0
441507|NCT01377233|1082245|P1|STARTED|Open-label||46
441508|NCT01377194|1082272|P3|NOT COMPLETED|Overall Study||46
441509|NCT01377194|1082273|P2|NOT COMPLETED|Overall Study||43
441510|NCT01377194|1082274|P1|NOT COMPLETED|Overall Study||32
441511|NCT01377194|1082272|P3|COMPLETED|Overall Study||142
441512|NCT01377194|1082273|P2|COMPLETED|Overall Study||145
441513|NCT01377194|1082274|P1|COMPLETED|Overall Study||154
441514|NCT01377194|1082272|P3|STARTED|Overall Study||188
441515|NCT01377194|1082273|P2|STARTED|Overall Study||188
441516|NCT01377194|1082274|P1|STARTED|Overall Study||186
441517|NCT01377012|1082288|P3|NOT COMPLETED|Extension Study, Weeks 104-260||68
441518|NCT01377012|1082289|P2|NOT COMPLETED|Extension Study, Weeks 104-260||71
441519|NCT01377012|1082290|P1|NOT COMPLETED|Extension Study, Weeks 104-260||57
441520|NCT01377012|1082288|P3|COMPLETED|Extension Study, Weeks 104-260||0
441521|NCT01377012|1082289|P2|COMPLETED|Extension Study, Weeks 104-260||0
441522|NCT01377012|1082290|P1|COMPLETED|Extension Study, Weeks 104-260||0
441523|NCT01377012|1082288|P3|STARTED|Extension Study, Weeks 104-260||68
441524|NCT01377012|1082289|P2|STARTED|Extension Study, Weeks 104-260||71
441525|NCT01377012|1082290|P1|STARTED|Extension Study, Weeks 104-260||57
441526|NCT01377012|1082288|P3|NOT COMPLETED|Core Study||134
441527|NCT01377012|1082289|P2|NOT COMPLETED|Core Study||132
441528|NCT01377012|1082290|P1|NOT COMPLETED|Core Study||134
441529|NCT01377012|1082288|P3|COMPLETED|Core Study||80
441530|NCT01377012|1082289|P2|COMPLETED|Core Study||81
441531|NCT01377012|1082290|P1|COMPLETED|Core Study||76
441532|NCT01377012|1082288|P3|wk 24 Re-randomized to AIN 150 mg Res|Core Study||34
441533|NCT01377012|1082289|P2|wk 24 Re-randomized to AIN 150 mg Res|Core Study||0
441534|NCT01377012|1082290|P1|wk 24 Re-randomized to AIN 150 mg Res|Core Study||0
441535|NCT01377012|1082288|P3|wk 24 Re-randomized to AIN 75 mg Res|Core Study|Res= responder|38
441536|NCT01377012|1082289|P2|wk 24 Re-randomized to AIN 75 mg Res|Core Study||0
441537|NCT01377012|1082290|P1|wk 24 Re-randomized to AIN 75 mg Res|Core Study||0
441538|NCT01377012|1082288|P3|wk16 Re-randomized to AIN 150mg NR|Core Study||53
441539|NCT01377012|1082289|P2|wk16 Re-randomized to AIN 150mg NR|Core Study||0
441540|NCT01377012|1082290|P1|wk16 Re-randomized to AIN 150mg NR|Core Study||0
441541|NCT01377012|1082288|P3|wk16 Re-randomized to AIN 75mg NR|Core Study|NR=Non-responder|56
441542|NCT01377012|1082289|P2|wk16 Re-randomized to AIN 75mg NR|Core Study||0
441543|NCT01377012|1082290|P1|wk16 Re-randomized to AIN 75mg NR|Core Study||0
441544|NCT01377012|1082288|P3|STARTED|Core Study||214
441545|NCT01377012|1082289|P2|STARTED|Core Study||213
441546|NCT01377012|1082290|P1|STARTED|Core Study||210
441547|NCT01376908|1082327|P2|NOT COMPLETED|Overall Study||3
441548|NCT01376908|1082328|P1|NOT COMPLETED|Overall Study||2
441549|NCT01376908|1082327|P2|COMPLETED|Overall Study||26
441550|NCT01376908|1082328|P1|COMPLETED|Overall Study||25
441551|NCT01376908|1082327|P2|STARTED|Overall Study||29
441552|NCT01376908|1082328|P1|STARTED|Overall Study||27
441553|NCT01376804|1082361|P1|NOT COMPLETED|Follow-up Period||0
441554|NCT01376804|1082361|P1|COMPLETED|Follow-up Period||55
441555|NCT01376804|1082361|P1|STARTED|Follow-up Period|6 of the 7 patients who withdrew from treatment continued to the Follow-up Period.|55
441556|NCT01376804|1082361|P1|NOT COMPLETED|Treatment Period||8
441557|NCT01376804|1082361|P1|COMPLETED|Treatment Period||49
441558|NCT01376804|1082361|P1|Received Study Drug|Treatment Period||56
441559|NCT01376804|1082361|P1|STARTED|Treatment Period||57
441560|NCT01376700|1082372|P1|NOT COMPLETED|Overall Study||16
441561|NCT01376700|1082372|P1|COMPLETED|Overall Study||3
441562|NCT01376700|1082372|P1|STARTED|Overall Study||19
441563|NCT01376557|1082393|P5|NOT COMPLETED|Overall Study||7
441564|NCT01376557|1082394|P4|NOT COMPLETED|Overall Study||6
441565|NCT01376557|1082395|P3|NOT COMPLETED|Overall Study||5
441566|NCT01376557|1082396|P2|NOT COMPLETED|Overall Study||6
441567|NCT01376557|1082397|P1|NOT COMPLETED|Overall Study||8
441568|NCT01376557|1082393|P5|COMPLETED|Overall Study||53
441569|NCT01376557|1082394|P4|COMPLETED|Overall Study||54
441570|NCT01376557|1082395|P3|COMPLETED|Overall Study||55
441571|NCT01376557|1082396|P2|COMPLETED|Overall Study||54
441572|NCT01376557|1082397|P1|COMPLETED|Overall Study||51
441573|NCT01376557|1082393|P5|STARTED|Overall Study||60
441574|NCT01376557|1082394|P4|STARTED|Overall Study||60
441575|NCT01376557|1082395|P3|STARTED|Overall Study||60
441576|NCT01376557|1082396|P2|STARTED|Overall Study||60
441577|NCT01376557|1082397|P1|STARTED|Overall Study||59
441578|NCT01376388|1082434|P1|NOT COMPLETED|Overall Study||18
441579|NCT01376388|1082434|P1|COMPLETED|Overall Study||112
441580|NCT01376388|1082434|P1|STARTED|Overall Study||130
441581|NCT01376362|1082449|P1|NOT COMPLETED|Overall Study||0
441582|NCT01376362|1082449|P1|COMPLETED|Overall Study||5
441583|NCT01376362|1082449|P1|STARTED|Overall Study||5
441584|NCT01376349|1082472|P3|NOT COMPLETED|Optional Continuation Phase||0
441585|NCT01376349|1082473|P2|NOT COMPLETED|Optional Continuation Phase||0
441586|NCT01376349|1082474|P1|NOT COMPLETED|Optional Continuation Phase||0
441587|NCT01376349|1082472|P3|COMPLETED|Optional Continuation Phase||94
441588|NCT01376349|1082473|P2|COMPLETED|Optional Continuation Phase||0
441589|NCT01376349|1082474|P1|COMPLETED|Optional Continuation Phase||0
441590|NCT01376349|1082472|P3|STARTED|Optional Continuation Phase|Patients completing Arm III Placebo were offered the option of continuing High Dose DHEA|94
441591|NCT01376349|1082473|P2|STARTED|Optional Continuation Phase||0
441592|NCT01376349|1082474|P1|STARTED|Optional Continuation Phase||0
441593|NCT01376349|1082472|P3|NOT COMPLETED|Raondomized Treatment||29
441594|NCT01376349|1082473|P2|NOT COMPLETED|Raondomized Treatment||35
441595|NCT01376349|1082474|P1|NOT COMPLETED|Raondomized Treatment||24
441596|NCT01376349|1082472|P3|COMPLETED|Raondomized Treatment||118
441597|NCT01376349|1082473|P2|COMPLETED|Raondomized Treatment||114
441598|NCT01376349|1082474|P1|COMPLETED|Raondomized Treatment||123
441599|NCT01376349|1082472|P3|STARTED|Raondomized Treatment||147
441600|NCT01376349|1082473|P2|STARTED|Raondomized Treatment||149
441601|NCT01376349|1082474|P1|STARTED|Raondomized Treatment||147
441602|NCT01376323|1082488|P5|NOT COMPLETED|Overall Study||1
441603|NCT01376323|1082489|P4|NOT COMPLETED|Overall Study||5
441604|NCT01376323|1082490|P3|NOT COMPLETED|Overall Study||3
441605|NCT01376323|1082491|P2|NOT COMPLETED|Overall Study||1
441606|NCT01376323|1082492|P1|NOT COMPLETED|Overall Study||2
441607|NCT01376323|1082488|P5|COMPLETED|Overall Study||17
441608|NCT01376323|1082489|P4|COMPLETED|Overall Study||14
441609|NCT01376323|1082490|P3|COMPLETED|Overall Study||16
441610|NCT01376323|1082491|P2|COMPLETED|Overall Study||17
441611|NCT01376323|1082492|P1|COMPLETED|Overall Study||18
441612|NCT01376323|1082488|P5|STARTED|Overall Study||18
441613|NCT01376323|1082489|P4|STARTED|Overall Study||19
441614|NCT01376323|1082490|P3|STARTED|Overall Study||19
441615|NCT01376323|1082491|P2|STARTED|Overall Study||18
441616|NCT01376323|1082492|P1|STARTED|Overall Study||20
441617|NCT01376297|1082576|P2|NOT COMPLETED|Overall Study||49
441618|NCT01376297|1082577|P1|NOT COMPLETED|Overall Study||128
441619|NCT01376297|1082576|P2|COMPLETED|Overall Study|number of patients completing planned/unplanned chemotherapy cycles|55
441620|NCT01376297|1082577|P1|COMPLETED|Overall Study|number of patients completing planned/unplanned chemotherapy cycles|181
441621|NCT01376297|1082576|P2|STARTED|Overall Study|number of randomised patients|104
441622|NCT01376297|1082577|P1|STARTED|Overall Study|number of randomised patients|309
441623|NCT01376245|1082587|P5|NOT COMPLETED|24-week, Double-blind Treatment Period||26
441624|NCT01376245|1082588|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||23
441625|NCT01376245|1082589|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||25
441626|NCT01376245|1082590|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||32
441627|NCT01376245|1082591|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
441628|NCT01376245|1082587|P5|COMPLETED|24-week, Double-blind Treatment Period||134
441629|NCT01376245|1082588|P4|COMPLETED|24-week, Double-blind Treatment Period||138
441630|NCT01376245|1082589|P3|COMPLETED|24-week, Double-blind Treatment Period||135
441631|NCT01376245|1082590|P2|COMPLETED|24-week, Double-blind Treatment Period||130
441632|NCT01376245|1082591|P1|COMPLETED|24-week, Double-blind Treatment Period||0
441633|NCT01376245|1082587|P5|STARTED|24-week, Double-blind Treatment Period||160
441634|NCT01376245|1082588|P4|STARTED|24-week, Double-blind Treatment Period||161
441635|NCT01376245|1082589|P3|STARTED|24-week, Double-blind Treatment Period||160
441636|NCT01376245|1082590|P2|STARTED|24-week, Double-blind Treatment Period||162
441637|NCT01376245|1082591|P1|STARTED|24-week, Double-blind Treatment Period||0
441638|NCT01376245|1082587|P5|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
441639|NCT01376245|1082588|P4|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
441640|NCT01376245|1082589|P3|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
441641|NCT01376245|1082590|P2|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
441642|NCT01376245|1082591|P1|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||101
441643|NCT01376245|1082587|P5|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
441644|NCT01376245|1082588|P4|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
441645|NCT01376245|1082589|P3|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
441646|NCT01376245|1082590|P2|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
441647|NCT01376245|1082591|P1|COMPLETED|2-wk Single-blind Placebo Run-in Period||643
441648|NCT01376245|1082587|P5|STARTED|2-wk Single-blind Placebo Run-in Period||0
441649|NCT01376245|1082588|P4|STARTED|2-wk Single-blind Placebo Run-in Period||0
441650|NCT01376245|1082589|P3|STARTED|2-wk Single-blind Placebo Run-in Period||0
441651|NCT01376245|1082590|P2|STARTED|2-wk Single-blind Placebo Run-in Period||0
441652|NCT01376245|1082591|P1|STARTED|2-wk Single-blind Placebo Run-in Period||744
441653|NCT01376167|1082608|P3|NOT COMPLETED|Overall Study||6
441654|NCT01376167|1082609|P2|NOT COMPLETED|Overall Study||10
441655|NCT01376167|1082610|P1|NOT COMPLETED|Overall Study||4
441656|NCT01376167|1082608|P3|COMPLETED|Overall Study||123
441657|NCT01376167|1082609|P2|COMPLETED|Overall Study||250
441658|NCT01376167|1082610|P1|COMPLETED|Overall Study||129
441659|NCT01376167|1082608|P3|STARTED|Overall Study||129
441660|NCT01376167|1082609|P2|STARTED|Overall Study||260
441661|NCT01376167|1082610|P1|STARTED|Overall Study||133
441662|NCT01376089|1082681|P2|NOT COMPLETED|Overall Study||4
441663|NCT01376089|1082682|P1|NOT COMPLETED|Overall Study||3
441664|NCT01376089|1082681|P2|COMPLETED|Overall Study||144
441665|NCT01376089|1082682|P1|COMPLETED|Overall Study||148
441666|NCT01376089|1082681|P2|STARTED|Overall Study||148
441667|NCT01376089|1082682|P1|STARTED|Overall Study||151
441668|NCT01376050|1082694|P2|NOT COMPLETED|Overall Study||0
441669|NCT01376050|1082695|P1|NOT COMPLETED|Overall Study||0
441670|NCT01376050|1082694|P2|COMPLETED|Overall Study||11
441671|NCT01376050|1082695|P1|COMPLETED|Overall Study||13
441672|NCT01376050|1082694|P2|STARTED|Overall Study||11
441673|NCT01376050|1082695|P1|STARTED|Overall Study||13
441674|NCT01376037|1082705|P2|NOT COMPLETED|Overall Study||2
441675|NCT01376037|1082706|P1|NOT COMPLETED|Overall Study||0
441676|NCT01376037|1082705|P2|COMPLETED|Overall Study||29
441677|NCT01376037|1082706|P1|COMPLETED|Overall Study||31
441678|NCT01376037|1082705|P2|STARTED|Overall Study||31
441679|NCT01376037|1082706|P1|STARTED|Overall Study||31
441680|NCT01375946|1082712|P1|NOT COMPLETED|Overall Study||0
441681|NCT01375946|1082712|P1|COMPLETED|Overall Study||24
441682|NCT01375946|1082712|P1|STARTED|Overall Study||24
441683|NCT01375777|1082729|P9|NOT COMPLETED|Overall Study||2
441684|NCT01375777|1082730|P8|NOT COMPLETED|Overall Study||2
441685|NCT01375777|1082731|P7|NOT COMPLETED|Overall Study||2
441686|NCT01375777|1082732|P6|NOT COMPLETED|Overall Study||1
441687|NCT01375777|1082733|P5|NOT COMPLETED|Overall Study||1
441688|NCT01375777|1082734|P4|NOT COMPLETED|Overall Study||0
441689|NCT01375777|1082735|P3|NOT COMPLETED|Overall Study||1
441690|NCT01375777|1082736|P2|NOT COMPLETED|Overall Study||3
441691|NCT01375777|1082737|P1|NOT COMPLETED|Overall Study||2
441692|NCT01375777|1082729|P9|COMPLETED|Overall Study||44
441693|NCT01375777|1082730|P8|COMPLETED|Overall Study||44
441694|NCT01375777|1082731|P7|COMPLETED|Overall Study||44
441695|NCT01375777|1082732|P6|COMPLETED|Overall Study||44
441696|NCT01375777|1082733|P5|COMPLETED|Overall Study||45
441697|NCT01375777|1082734|P4|COMPLETED|Overall Study||45
441698|NCT01375777|1082735|P3|COMPLETED|Overall Study||45
441699|NCT01375777|1082736|P2|COMPLETED|Overall Study||42
441700|NCT01375777|1082737|P1|COMPLETED|Overall Study||44
441701|NCT01375777|1082729|P9|Received Treatment|Overall Study||45
441702|NCT01375777|1082730|P8|Received Treatment|Overall Study||45
441703|NCT01375777|1082731|P7|Received Treatment|Overall Study||45
441704|NCT01375777|1082732|P6|Received Treatment|Overall Study||45
441705|NCT01375777|1082733|P5|Received Treatment|Overall Study||46
441706|NCT01375777|1082734|P4|Received Treatment|Overall Study||45
441707|NCT01375777|1082735|P3|Received Treatment|Overall Study||45
441708|NCT01375777|1082736|P2|Received Treatment|Overall Study||45
441709|NCT01375777|1082737|P1|Received Treatment|Overall Study||45
441710|NCT01375777|1082729|P9|STARTED|Overall Study||46
441711|NCT01375777|1082730|P8|STARTED|Overall Study||46
441712|NCT01375777|1082731|P7|STARTED|Overall Study||46
441713|NCT01375777|1082732|P6|STARTED|Overall Study||45
441714|NCT01375777|1082733|P5|STARTED|Overall Study||46
441715|NCT01375777|1082734|P4|STARTED|Overall Study||45
441716|NCT01375777|1082735|P3|STARTED|Overall Study||46
441717|NCT01375777|1082736|P2|STARTED|Overall Study||45
441718|NCT01375777|1082737|P1|STARTED|Overall Study||46
441719|NCT01375764|1082807|P5|NOT COMPLETED|Overall Study||1
441720|NCT01375764|1082808|P4|NOT COMPLETED|Overall Study||1
441721|NCT01375764|1082809|P3|NOT COMPLETED|Overall Study||0
441722|NCT01375764|1082810|P2|NOT COMPLETED|Overall Study||1
441723|NCT01375764|1082811|P1|NOT COMPLETED|Overall Study||2
441724|NCT01375764|1082807|P5|COMPLETED|Overall Study||31
441725|NCT01375764|1082808|P4|COMPLETED|Overall Study||31
441726|NCT01375764|1082809|P3|COMPLETED|Overall Study||32
441727|NCT01375764|1082810|P2|COMPLETED|Overall Study||30
441728|NCT01375764|1082811|P1|COMPLETED|Overall Study||31
441729|NCT01375764|1082807|P5|Received Treatment|Overall Study||32
441730|NCT01375764|1082808|P4|Received Treatment|Overall Study||31
441731|NCT01375764|1082809|P3|Received Treatment|Overall Study||32
441732|NCT01375764|1082810|P2|Received Treatment|Overall Study||30
441733|NCT01375764|1082811|P1|Received Treatment|Overall Study||32
441734|NCT01375764|1082807|P5|STARTED|Overall Study||32
441735|NCT01375764|1082808|P4|STARTED|Overall Study||32
441736|NCT01375764|1082809|P3|STARTED|Overall Study||32
441737|NCT01375764|1082810|P2|STARTED|Overall Study||31
441738|NCT01375764|1082811|P1|STARTED|Overall Study||33
441739|NCT01375751|1082857|P3|NOT COMPLETED|Overall Study||0
441740|NCT01375751|1082858|P2|NOT COMPLETED|Overall Study||1
441741|NCT01375751|1082859|P1|NOT COMPLETED|Overall Study||0
441742|NCT01375751|1082857|P3|COMPLETED|Overall Study||56
441743|NCT01375751|1082858|P2|COMPLETED|Overall Study||55
441744|NCT01375751|1082859|P1|COMPLETED|Overall Study||56
441745|NCT01375751|1082857|P3|Received Treatment|Overall Study||56
441746|NCT01375751|1082858|P2|Received Treatment|Overall Study||55
441747|NCT01375751|1082859|P1|Received Treatment|Overall Study||56
441748|NCT01375751|1082857|P3|STARTED|Overall Study||56
441749|NCT01375751|1082858|P2|STARTED|Overall Study||56
441750|NCT01375751|1082859|P1|STARTED|Overall Study||56
441751|NCT01375660|1082884|P2|NOT COMPLETED|Overall Study||16
441752|NCT01375660|1082885|P1|NOT COMPLETED|Overall Study||16
441753|NCT01375660|1082884|P2|COMPLETED|Overall Study||87
441754|NCT01375660|1082885|P1|COMPLETED|Overall Study||86
441755|NCT01375660|1082884|P2|STARTED|Overall Study||103
441756|NCT01375660|1082885|P1|STARTED|Overall Study||102
441757|NCT01375608|1082903|P1|NOT COMPLETED|Overall Study||2
441758|NCT01375608|1082903|P1|COMPLETED|Overall Study||8
441759|NCT01375608|1082903|P1|STARTED|Overall Study||10
441760|NCT01375569|1082907|P1|NOT COMPLETED|Overall Study||0
441761|NCT01375569|1082907|P1|COMPLETED|Overall Study||11
441762|NCT01375569|1082907|P1|STARTED|Overall Study||11
441763|NCT01375374|1082912|P1|NOT COMPLETED|Overall Study||1
441764|NCT01375374|1082912|P1|COMPLETED|Overall Study||10
441765|NCT01375374|1082912|P1|STARTED|Overall Study||11
441766|NCT01375127|1082925|P6|NOT COMPLETED|Overall Study||0
441767|NCT01375127|1082926|P5|NOT COMPLETED|Overall Study||0
441768|NCT01375127|1082927|P4|NOT COMPLETED|Overall Study||0
441769|NCT01375127|1082928|P3|NOT COMPLETED|Overall Study||0
441770|NCT01375127|1082929|P2|NOT COMPLETED|Overall Study||0
441771|NCT01375127|1082930|P1|NOT COMPLETED|Overall Study||0
441772|NCT01375127|1082925|P6|COMPLETED|Overall Study||3
441773|NCT01375127|1082926|P5|COMPLETED|Overall Study||5
441774|NCT01375127|1082927|P4|COMPLETED|Overall Study||33
441775|NCT01375127|1082928|P3|COMPLETED|Overall Study||40
441776|NCT01375127|1082929|P2|COMPLETED|Overall Study||1
441777|NCT01375127|1082930|P1|COMPLETED|Overall Study||1
441778|NCT01375127|1082925|P6|STARTED|Overall Study||3
441779|NCT01375127|1082926|P5|STARTED|Overall Study||5
441780|NCT01375127|1082927|P4|STARTED|Overall Study||33
441781|NCT01375127|1082928|P3|STARTED|Overall Study||40
441782|NCT01375127|1082929|P2|STARTED|Overall Study||1
441783|NCT01375127|1082930|P1|STARTED|Overall Study||1
441784|NCT01375049|1082962|P1|NOT COMPLETED|Overall Study||50
441785|NCT01375049|1082962|P1|COMPLETED|Overall Study||55
441786|NCT01375049|1082962|P1|STARTED|Overall Study||105
441787|NCT01374971|1082977|P1|NOT COMPLETED|Overall Study||1
441788|NCT01374971|1082977|P1|COMPLETED|Overall Study||11
441789|NCT01374971|1082977|P1|STARTED|Overall Study||12
441790|NCT01374919|1082982|P1|NOT COMPLETED|Overall Study||2
441791|NCT01374919|1082982|P1|COMPLETED|Overall Study||58
441792|NCT01374919|1082982|P1|STARTED|Overall Study||60
441793|NCT01374906|1082989|P2|NOT COMPLETED|Overall Study||48
441794|NCT01374906|1082990|P1|NOT COMPLETED|Overall Study||40
441795|NCT01374906|1082989|P2|COMPLETED|Overall Study||28
441796|NCT01374906|1082990|P1|COMPLETED|Overall Study||34
441797|NCT01374906|1082989|P2|Completed Extension Phase|Overall Study||15
441798|NCT01374906|1082990|P1|Completed Extension Phase|Overall Study||24
441799|NCT01374906|1082989|P2|DC Dur Ext Phs at/Prior to Data Cutoff|Overall Study||26
441800|NCT01374906|1082990|P1|DC Dur Ext Phs at/Prior to Data Cutoff|Overall Study||16
441801|NCT01374906|1082989|P2|Completed Core Phase/Entered Ext. Phase|Overall Study||41
441802|NCT01374906|1082990|P1|Completed Core Phase/Entered Ext. Phase|Overall Study||40
441803|NCT01374906|1082989|P2|Completed Core/Did Not Enter Ext. Phase|Overall Study||13
441804|NCT01374906|1082990|P1|Completed Core/Did Not Enter Ext. Phase|Overall Study||10
441805|NCT01374906|1082989|P2|Completed Core Phase|Overall Study||54
441806|NCT01374906|1082990|P1|Completed Core Phase|Overall Study||50
441807|NCT01374906|1082989|P2|DC Dur Core Phs at/Prior to Data Cutoff|Overall Study||22
441808|NCT01374906|1082990|P1|DC Dur Core Phs at/Prior to Data Cutoff|Overall Study||24
441809|NCT01374906|1082989|P2|STARTED|Overall Study||76
441810|NCT01374906|1082990|P1|STARTED|Overall Study||74
441811|NCT01374802|1083057|P1|NOT COMPLETED|Overall Study||0
441812|NCT01374802|1083057|P1|COMPLETED|Overall Study||14
441813|NCT01374802|1083057|P1|STARTED|Overall Study||14
441814|NCT01374568|1083071|P2|NOT COMPLETED|Overall Study||2
441815|NCT01374568|1083072|P1|NOT COMPLETED|Overall Study||0
441816|NCT01374568|1083071|P2|COMPLETED|Overall Study||1
441817|NCT01374568|1083072|P1|COMPLETED|Overall Study||2
441818|NCT01374568|1083071|P2|STARTED|Overall Study||3
441819|NCT01374568|1083072|P1|STARTED|Overall Study||2
441820|NCT01374451|1083082|P2|NOT COMPLETED|Overall Study||0
441821|NCT01374451|1083083|P1|NOT COMPLETED|Overall Study||1
441822|NCT01374451|1083082|P2|COMPLETED|Overall Study||81
441823|NCT01374451|1083083|P1|COMPLETED|Overall Study||78
441824|NCT01374451|1083082|P2|STARTED|Overall Study||81
441825|NCT01374451|1083083|P1|STARTED|Overall Study||79
441826|NCT01374438|1083112|P2|NOT COMPLETED|Overall Study||0
441827|NCT01374438|1083113|P1|NOT COMPLETED|Overall Study||0
441828|NCT01374438|1083112|P2|COMPLETED|Overall Study||13
441829|NCT01374438|1083113|P1|COMPLETED|Overall Study||16
441830|NCT01374438|1083112|P2|STARTED|Overall Study||13
441831|NCT01374438|1083113|P1|STARTED|Overall Study||16
441832|NCT01374425|1083129|P2|NOT COMPLETED|Overall Study||188
441833|NCT01374425|1083130|P1|NOT COMPLETED|Overall Study||188
441834|NCT01374425|1083129|P2|COMPLETED|Overall Study||0
441835|NCT01374425|1083130|P1|COMPLETED|Overall Study||0
441836|NCT01374425|1083129|P2|STARTED|Overall Study||188
441837|NCT01374425|1083130|P1|STARTED|Overall Study||188
441838|NCT01374269|1083210|P2|NOT COMPLETED|Overall Study||5
441839|NCT01374269|1083211|P1|NOT COMPLETED|Overall Study||6
441840|NCT01374269|1083210|P2|COMPLETED|Overall Study||39
441841|NCT01374269|1083211|P1|COMPLETED|Overall Study||40
441842|NCT01374269|1083210|P2|STARTED|Overall Study||44
441843|NCT01374269|1083211|P1|STARTED|Overall Study||46
441844|NCT01374178|1083339|P2|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||0
441845|NCT01374178|1083340|P1|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||2
441846|NCT01374178|1083339|P2|COMPLETED|Period 2 (up to 24 Hours After Dosing)||5
441847|NCT01374178|1083340|P1|COMPLETED|Period 2 (up to 24 Hours After Dosing)||8
441848|NCT01374178|1083339|P2|STARTED|Period 2 (up to 24 Hours After Dosing)||5
441849|NCT01374178|1083340|P1|STARTED|Period 2 (up to 24 Hours After Dosing)||10
441850|NCT01374178|1083339|P2|NOT COMPLETED|Washout Period of at Least 7 Days||0
441851|NCT01374178|1083340|P1|NOT COMPLETED|Washout Period of at Least 7 Days||1
441852|NCT01374178|1083339|P2|COMPLETED|Washout Period of at Least 7 Days||5
441853|NCT01374178|1083340|P1|COMPLETED|Washout Period of at Least 7 Days||10
441854|NCT01374178|1083339|P2|STARTED|Washout Period of at Least 7 Days||5
441855|NCT01374178|1083340|P1|STARTED|Washout Period of at Least 7 Days||11
441856|NCT01374178|1083339|P2|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0
441857|NCT01374178|1083340|P1|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0
441858|NCT01374178|1083339|P2|COMPLETED|Period 1 (up to 24 Hours After Dosing)||5
441859|NCT01374178|1083340|P1|COMPLETED|Period 1 (up to 24 Hours After Dosing)||11
441860|NCT01374178|1083339|P2|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||5
441861|NCT01374178|1083340|P1|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||11
441862|NCT01374178|1083339|P2|STARTED|Period 1 (up to 24 Hours After Dosing)||5
441863|NCT01374178|1083340|P1|STARTED|Period 1 (up to 24 Hours After Dosing)||11
441864|NCT01374087|1083358|P2|NOT COMPLETED|Overall Study||16
441865|NCT01374087|1083359|P1|NOT COMPLETED|Overall Study||15
441866|NCT01374087|1083358|P2|COMPLETED|Overall Study||0
441867|NCT01374087|1083359|P1|COMPLETED|Overall Study||0
441868|NCT01374087|1083358|P2|STARTED|Overall Study||16
441869|NCT01374087|1083359|P1|STARTED|Overall Study||15
441870|NCT01373918|1083369|P2|NOT COMPLETED|Overall Study||1
441871|NCT01373918|1083370|P1|NOT COMPLETED|Overall Study||0
441872|NCT01373918|1083369|P2|COMPLETED|Overall Study||15
441873|NCT01373918|1083370|P1|COMPLETED|Overall Study||20
441874|NCT01373918|1083369|P2|STARTED|Overall Study||16
441875|NCT01373918|1083370|P1|STARTED|Overall Study||20
441876|NCT01373671|1083382|P1|NOT COMPLETED|Overall Study||92
441877|NCT01373671|1083382|P1|COMPLETED|Overall Study||672
441878|NCT01373671|1083382|P1|STARTED|Overall Study||764
441879|NCT01373580|1083387|P1|NOT COMPLETED|Overall Study||56
441880|NCT01373580|1083387|P1|COMPLETED|Overall Study||317
441881|NCT01373580|1083387|P1|STARTED|Overall Study||373
441882|NCT01373450|1083393|P6|NOT COMPLETED|Crossover Period 4||0
441883|NCT01373450|1083394|P5|NOT COMPLETED|Crossover Period 4||0
441884|NCT01373450|1083395|P4|NOT COMPLETED|Crossover Period 4||0
441885|NCT01373450|1083396|P3|NOT COMPLETED|Crossover Period 4||0
441886|NCT01373450|1083397|P2|NOT COMPLETED|Crossover Period 4||0
441887|NCT01373450|1083398|P1|NOT COMPLETED|Crossover Period 4||0
441888|NCT01373450|1083393|P6|COMPLETED|Crossover Period 4||2
441889|NCT01373450|1083394|P5|COMPLETED|Crossover Period 4||2
441890|NCT01373450|1083395|P4|COMPLETED|Crossover Period 4||2
441891|NCT01373450|1083396|P3|COMPLETED|Crossover Period 4||2
441892|NCT01373450|1083397|P2|COMPLETED|Crossover Period 4||2
441893|NCT01373450|1083398|P1|COMPLETED|Crossover Period 4||2
441894|NCT01373450|1083393|P6|STARTED|Crossover Period 4||2
441895|NCT01373450|1083394|P5|STARTED|Crossover Period 4||2
441896|NCT01373450|1083395|P4|STARTED|Crossover Period 4||2
441897|NCT01373450|1083396|P3|STARTED|Crossover Period 4||2
441898|NCT01373450|1083397|P2|STARTED|Crossover Period 4||2
441899|NCT01373450|1083398|P1|STARTED|Crossover Period 4||2
441900|NCT01373450|1083393|P6|NOT COMPLETED|7 Day Wash-out||0
441901|NCT01373450|1083394|P5|NOT COMPLETED|7 Day Wash-out||0
441902|NCT01373450|1083395|P4|NOT COMPLETED|7 Day Wash-out||0
441903|NCT01373450|1083396|P3|NOT COMPLETED|7 Day Wash-out||0
441904|NCT01373450|1083397|P2|NOT COMPLETED|7 Day Wash-out||0
441905|NCT01373450|1083398|P1|NOT COMPLETED|7 Day Wash-out||0
441906|NCT01373450|1083393|P6|COMPLETED|7 Day Wash-out||2
441907|NCT01373450|1083394|P5|COMPLETED|7 Day Wash-out||2
441908|NCT01373450|1083395|P4|COMPLETED|7 Day Wash-out||2
441909|NCT01373450|1083396|P3|COMPLETED|7 Day Wash-out||2
441910|NCT01373450|1083397|P2|COMPLETED|7 Day Wash-out||2
441911|NCT01373450|1083398|P1|COMPLETED|7 Day Wash-out||2
441912|NCT01373450|1083393|P6|STARTED|7 Day Wash-out||2
441913|NCT01373450|1083394|P5|STARTED|7 Day Wash-out||2
441914|NCT01373450|1083395|P4|STARTED|7 Day Wash-out||2
441915|NCT01373450|1083396|P3|STARTED|7 Day Wash-out||2
441916|NCT01373450|1083397|P2|STARTED|7 Day Wash-out||2
441917|NCT01373450|1083398|P1|STARTED|7 Day Wash-out||2
441918|NCT01373450|1083393|P6|NOT COMPLETED|Crossover Period 3||0
441919|NCT01373450|1083394|P5|NOT COMPLETED|Crossover Period 3||0
441920|NCT01373450|1083395|P4|NOT COMPLETED|Crossover Period 3||0
441921|NCT01373450|1083396|P3|NOT COMPLETED|Crossover Period 3||0
441922|NCT01373450|1083397|P2|NOT COMPLETED|Crossover Period 3||0
441923|NCT01373450|1083398|P1|NOT COMPLETED|Crossover Period 3||0
441924|NCT01373450|1083393|P6|COMPLETED|Crossover Period 3||2
441925|NCT01373450|1083394|P5|COMPLETED|Crossover Period 3||2
441926|NCT01373450|1083395|P4|COMPLETED|Crossover Period 3||2
441927|NCT01373450|1083396|P3|COMPLETED|Crossover Period 3||2
441928|NCT01373450|1083397|P2|COMPLETED|Crossover Period 3||2
441929|NCT01373450|1083398|P1|COMPLETED|Crossover Period 3||2
441930|NCT01373450|1083393|P6|STARTED|Crossover Period 3||2
441931|NCT01373450|1083394|P5|STARTED|Crossover Period 3||2
441932|NCT01373450|1083395|P4|STARTED|Crossover Period 3||2
441933|NCT01373450|1083396|P3|STARTED|Crossover Period 3||2
441934|NCT01373450|1083397|P2|STARTED|Crossover Period 3||2
441935|NCT01373450|1083398|P1|STARTED|Crossover Period 3||2
441936|NCT01373450|1083393|P6|NOT COMPLETED|7 Day Wash-out||0
441937|NCT01373450|1083394|P5|NOT COMPLETED|7 Day Wash-out||0
441938|NCT01373450|1083395|P4|NOT COMPLETED|7 Day Wash-out||0
441939|NCT01373450|1083396|P3|NOT COMPLETED|7 Day Wash-out||0
441940|NCT01373450|1083397|P2|NOT COMPLETED|7 Day Wash-out||0
441941|NCT01373450|1083398|P1|NOT COMPLETED|7 Day Wash-out||0
441942|NCT01373450|1083393|P6|COMPLETED|7 Day Wash-out||2
441943|NCT01373450|1083394|P5|COMPLETED|7 Day Wash-out||2
441944|NCT01373450|1083395|P4|COMPLETED|7 Day Wash-out||2
441945|NCT01373450|1083396|P3|COMPLETED|7 Day Wash-out||2
441946|NCT01373450|1083397|P2|COMPLETED|7 Day Wash-out||2
441947|NCT01373450|1083398|P1|COMPLETED|7 Day Wash-out||2
441948|NCT01373450|1083393|P6|STARTED|7 Day Wash-out||2
441949|NCT01373450|1083394|P5|STARTED|7 Day Wash-out||2
441950|NCT01373450|1083395|P4|STARTED|7 Day Wash-out||2
441951|NCT01373450|1083396|P3|STARTED|7 Day Wash-out||2
441952|NCT01373450|1083397|P2|STARTED|7 Day Wash-out||2
441953|NCT01373450|1083398|P1|STARTED|7 Day Wash-out||2
441954|NCT01373450|1083393|P6|NOT COMPLETED|Crossover Period 2||0
441955|NCT01373450|1083394|P5|NOT COMPLETED|Crossover Period 2||0
441956|NCT01373450|1083395|P4|NOT COMPLETED|Crossover Period 2||0
441957|NCT01373450|1083396|P3|NOT COMPLETED|Crossover Period 2||0
441958|NCT01373450|1083397|P2|NOT COMPLETED|Crossover Period 2||0
441959|NCT01373450|1083398|P1|NOT COMPLETED|Crossover Period 2||0
441960|NCT01373450|1083393|P6|COMPLETED|Crossover Period 2||2
441961|NCT01373450|1083394|P5|COMPLETED|Crossover Period 2||2
441962|NCT01373450|1083395|P4|COMPLETED|Crossover Period 2||2
441963|NCT01373450|1083396|P3|COMPLETED|Crossover Period 2||2
441964|NCT01373450|1083397|P2|COMPLETED|Crossover Period 2||2
441965|NCT01373450|1083398|P1|COMPLETED|Crossover Period 2||2
441966|NCT01373450|1083393|P6|STARTED|Crossover Period 2||2
441967|NCT01373450|1083394|P5|STARTED|Crossover Period 2||2
441968|NCT01373450|1083395|P4|STARTED|Crossover Period 2||2
441969|NCT01373450|1083396|P3|STARTED|Crossover Period 2||2
441970|NCT01373450|1083397|P2|STARTED|Crossover Period 2||2
441971|NCT01373450|1083398|P1|STARTED|Crossover Period 2||2
441972|NCT01373450|1083393|P6|NOT COMPLETED|7 Day Wash-out||0
441973|NCT01373450|1083394|P5|NOT COMPLETED|7 Day Wash-out||0
441974|NCT01373450|1083395|P4|NOT COMPLETED|7 Day Wash-out||0
441975|NCT01373450|1083396|P3|NOT COMPLETED|7 Day Wash-out||0
441976|NCT01373450|1083397|P2|NOT COMPLETED|7 Day Wash-out||0
441977|NCT01373450|1083398|P1|NOT COMPLETED|7 Day Wash-out||0
441978|NCT01373450|1083393|P6|COMPLETED|7 Day Wash-out||2
441979|NCT01373450|1083394|P5|COMPLETED|7 Day Wash-out||2
441980|NCT01373450|1083395|P4|COMPLETED|7 Day Wash-out||2
441981|NCT01373450|1083396|P3|COMPLETED|7 Day Wash-out||2
441982|NCT01373450|1083397|P2|COMPLETED|7 Day Wash-out||2
441983|NCT01373450|1083398|P1|COMPLETED|7 Day Wash-out||2
441984|NCT01373450|1083393|P6|STARTED|7 Day Wash-out||2
441985|NCT01373450|1083394|P5|STARTED|7 Day Wash-out||2
441986|NCT01373450|1083395|P4|STARTED|7 Day Wash-out||2
441987|NCT01373450|1083396|P3|STARTED|7 Day Wash-out||2
441988|NCT01373450|1083397|P2|STARTED|7 Day Wash-out||2
441989|NCT01373450|1083398|P1|STARTED|7 Day Wash-out||2
441990|NCT01373450|1083393|P6|NOT COMPLETED|Crossover Period 1||0
441991|NCT01373450|1083394|P5|NOT COMPLETED|Crossover Period 1||0
441992|NCT01373450|1083395|P4|NOT COMPLETED|Crossover Period 1||0
441993|NCT01373450|1083396|P3|NOT COMPLETED|Crossover Period 1||0
441994|NCT01373450|1083397|P2|NOT COMPLETED|Crossover Period 1||0
441995|NCT01373450|1083398|P1|NOT COMPLETED|Crossover Period 1||0
441996|NCT01373450|1083393|P6|COMPLETED|Crossover Period 1||2
441997|NCT01373450|1083394|P5|COMPLETED|Crossover Period 1||2
441998|NCT01373450|1083395|P4|COMPLETED|Crossover Period 1||2
441999|NCT01373450|1083396|P3|COMPLETED|Crossover Period 1||2
442000|NCT01373450|1083397|P2|COMPLETED|Crossover Period 1||2
442001|NCT01373450|1083398|P1|COMPLETED|Crossover Period 1||2
442002|NCT01373450|1083393|P6|STARTED|Crossover Period 1||2
442003|NCT01373450|1083394|P5|STARTED|Crossover Period 1||2
442004|NCT01373450|1083395|P4|STARTED|Crossover Period 1||2
442005|NCT01373450|1083396|P3|STARTED|Crossover Period 1||2
442006|NCT01373450|1083397|P2|STARTED|Crossover Period 1||2
442007|NCT01373450|1083398|P1|STARTED|Crossover Period 1||2
442008|NCT01373346|1083420|P1|NOT COMPLETED|Overall Study||1
442009|NCT01373346|1083420|P1|COMPLETED|Overall Study||14
442010|NCT01373346|1083420|P1|STARTED|Overall Study||15
442011|NCT01373294|1083443|P2|NOT COMPLETED|Overall Study||0
442012|NCT01373294|1083444|P1|NOT COMPLETED|Overall Study||1
442013|NCT01373294|1083443|P2|COMPLETED|Overall Study||2
442014|NCT01373294|1083444|P1|COMPLETED|Overall Study||14
442015|NCT01373294|1083443|P2|STARTED|Overall Study||2
442016|NCT01373294|1083444|P1|STARTED|Overall Study||15
442017|NCT01373281|1083453|P2|NOT COMPLETED|Overall Study||45
442018|NCT01373281|1083454|P1|NOT COMPLETED|Overall Study||79
442019|NCT01373281|1083453|P2|COMPLETED|Overall Study||3379
442020|NCT01373281|1083454|P1|COMPLETED|Overall Study||6772
442021|NCT01373281|1083453|P2|STARTED|Overall Study||3424
442022|NCT01373281|1083454|P1|STARTED|Overall Study||6851
442023|NCT01373229|1083470|P1|NOT COMPLETED|Overall Study||6
442024|NCT01373229|1083470|P1|COMPLETED|Overall Study||9
442025|NCT01373229|1083470|P1|STARTED|Overall Study||15
442026|NCT01373164|1083484|P5|NOT COMPLETED|Overall Study||2
442027|NCT01373164|1083485|P4|NOT COMPLETED|Overall Study||12
442028|NCT01373164|1083486|P3|NOT COMPLETED|Overall Study||1
442029|NCT01373164|1083487|P2|NOT COMPLETED|Overall Study||1
442030|NCT01373164|1083488|P1|NOT COMPLETED|Overall Study||0
442031|NCT01373164|1083484|P5|COMPLETED|Overall Study||50
442032|NCT01373164|1083485|P4|COMPLETED|Overall Study||92
442033|NCT01373164|1083486|P3|COMPLETED|Overall Study||4
442034|NCT01373164|1083487|P2|COMPLETED|Overall Study||3
442035|NCT01373164|1083488|P1|COMPLETED|Overall Study||5
442036|NCT01373164|1083484|P5|Received at Least One Dose|Overall Study||52
442037|NCT01373164|1083485|P4|Received at Least One Dose|Overall Study||103
442038|NCT01373164|1083486|P3|Received at Least One Dose|Overall Study||5
442039|NCT01373164|1083487|P2|Received at Least One Dose|Overall Study||4
442040|NCT01373164|1083488|P1|Received at Least One Dose|Overall Study||5
442041|NCT01373164|1083484|P5|STARTED|Overall Study||52
442042|NCT01373164|1083485|P4|STARTED|Overall Study||104
442043|NCT01373164|1083486|P3|STARTED|Overall Study||5
442044|NCT01373164|1083487|P2|STARTED|Overall Study||4
442045|NCT01373164|1083488|P1|STARTED|Overall Study||5
442046|NCT01372995|1083522|P3|NOT COMPLETED|Overall Study||1
442047|NCT01372995|1083523|P2|NOT COMPLETED|Overall Study||1
442048|NCT01372995|1083524|P1|NOT COMPLETED|Overall Study||0
442049|NCT01372995|1083522|P3|COMPLETED|Overall Study|The transferred participant was included in the intent to treat analyses.|10
442050|NCT01372995|1083523|P2|COMPLETED|Overall Study||9
442051|NCT01372995|1083524|P1|COMPLETED|Overall Study||10
442052|NCT01372995|1083522|P3|STARTED|Overall Study|One participant was transferred to comfort care prior to completing the intervention.|11
442053|NCT01372995|1083523|P2|STARTED|Overall Study||10
442054|NCT01372995|1083524|P1|STARTED|Overall Study||10
442055|NCT01372878|1083571|P1|NOT COMPLETED|Overall Study||184
442056|NCT01372878|1083571|P1|COMPLETED|Overall Study||700
442057|NCT01372878|1083571|P1|STARTED|Overall Study||884
442058|NCT01372813|1083576|P1|NOT COMPLETED|Overall Study||0
442059|NCT01372813|1083576|P1|COMPLETED|Overall Study||3
442060|NCT01372813|1083576|P1|STARTED|Overall Study||3
442061|NCT01372748|1083591|P2|NOT COMPLETED|Overall Study||39
442062|NCT01372748|1083592|P1|NOT COMPLETED|Overall Study||23
442063|NCT01372748|1083591|P2|COMPLETED|Overall Study|defined as having vital status|12603
442064|NCT01372748|1083592|P1|COMPLETED|Overall Study|defined as having vital status|11022
442065|NCT01372748|1083591|P2|STARTED|Overall Study||12642
442066|NCT01372748|1083592|P1|STARTED|Overall Study||11045
442067|NCT01372618|1083600|P1|NOT COMPLETED|Overall Study||9
442068|NCT01372618|1083600|P1|COMPLETED|Overall Study||0
442069|NCT01372618|1083600|P1|STARTED|Overall Study||9
442070|NCT01372605|1083608|P2|NOT COMPLETED|Overall Study||10
442071|NCT01372605|1083609|P1|NOT COMPLETED|Overall Study||12
442072|NCT01372605|1083608|P2|COMPLETED|Overall Study||145
442073|NCT01372605|1083609|P1|COMPLETED|Overall Study||137
442074|NCT01372605|1083608|P2|STARTED|Overall Study||155
442075|NCT01372605|1083609|P1|STARTED|Overall Study||149
442076|NCT01372501|1083635|P1|NOT COMPLETED|Overall Study||5
442077|NCT01372501|1083635|P1|COMPLETED|Overall Study||14
442078|NCT01372501|1083635|P1|STARTED|Overall Study||19
442079|NCT01372462|1083640|P1|NOT COMPLETED|No Treatment Control||0
442080|NCT01372462|1083640|P1|COMPLETED|No Treatment Control||15
442081|NCT01372462|1083640|P1|STARTED|No Treatment Control||15
442082|NCT01372462|1083640|P1|NOT COMPLETED|Oxygen Nasal Cannula||0
442083|NCT01372462|1083640|P1|COMPLETED|Oxygen Nasal Cannula||15
442084|NCT01372462|1083640|P1|STARTED|Oxygen Nasal Cannula||15
442085|NCT01372462|1083640|P1|NOT COMPLETED|NIOV - Oxygen||0
442086|NCT01372462|1083640|P1|COMPLETED|NIOV - Oxygen||15
442087|NCT01372462|1083640|P1|STARTED|NIOV - Oxygen||15
442088|NCT01372462|1083640|P1|NOT COMPLETED|NIOV - Room Air||0
442089|NCT01372462|1083640|P1|COMPLETED|NIOV - Room Air||15
442090|NCT01372462|1083640|P1|STARTED|NIOV - Room Air||15
442091|NCT01372410|1083658|P8|NOT COMPLETED|Treatment Period 3 (7 Days)||0
442092|NCT01372410|1083659|P7|NOT COMPLETED|Treatment Period 3 (7 Days)||0
442093|NCT01372410|1083660|P6|NOT COMPLETED|Treatment Period 3 (7 Days)||1
442094|NCT01372410|1083661|P5|NOT COMPLETED|Treatment Period 3 (7 Days)||0
442095|NCT01372410|1083662|P4|NOT COMPLETED|Treatment Period 3 (7 Days)||0
442096|NCT01372410|1083663|P3|NOT COMPLETED|Treatment Period 3 (7 Days)||1
442097|NCT01372410|1083664|P2|NOT COMPLETED|Treatment Period 3 (7 Days)||0
442098|NCT01372410|1083665|P1|NOT COMPLETED|Treatment Period 3 (7 Days)||0
442099|NCT01372410|1083658|P8|COMPLETED|Treatment Period 3 (7 Days)||18
442100|NCT01372410|1083659|P7|COMPLETED|Treatment Period 3 (7 Days)||15
442101|NCT01372410|1083660|P6|COMPLETED|Treatment Period 3 (7 Days)||18
442102|NCT01372410|1083661|P5|COMPLETED|Treatment Period 3 (7 Days)||20
442103|NCT01372410|1083662|P4|COMPLETED|Treatment Period 3 (7 Days)||22
442104|NCT01372410|1083663|P3|COMPLETED|Treatment Period 3 (7 Days)||15
442105|NCT01372410|1083664|P2|COMPLETED|Treatment Period 3 (7 Days)||18
442106|NCT01372410|1083665|P1|COMPLETED|Treatment Period 3 (7 Days)||21
442107|NCT01372410|1083658|P8|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|18
442108|NCT01372410|1083659|P7|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|15
442109|NCT01372410|1083660|P6|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
442110|NCT01372410|1083661|P5|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|20
442111|NCT01372410|1083662|P4|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|22
442112|NCT01372410|1083663|P3|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|16
442113|NCT01372410|1083664|P2|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|18
442114|NCT01372410|1083665|P1|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
442115|NCT01372410|1083658|P8|NOT COMPLETED|Washout Period 2 (10-14 Days)||2
442116|NCT01372410|1083659|P7|NOT COMPLETED|Washout Period 2 (10-14 Days)||1
442117|NCT01372410|1083660|P6|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
442118|NCT01372410|1083661|P5|NOT COMPLETED|Washout Period 2 (10-14 Days)||2
442119|NCT01372410|1083662|P4|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
442120|NCT01372410|1083663|P3|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
442121|NCT01372410|1083664|P2|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
442122|NCT01372410|1083665|P1|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
442123|NCT01372410|1083658|P8|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
442124|NCT01372410|1083659|P7|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
442125|NCT01372410|1083660|P6|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|16
442126|NCT01372410|1083661|P5|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
442127|NCT01372410|1083662|P4|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
442128|NCT01372410|1083663|P3|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|22
442129|NCT01372410|1083664|P2|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
442130|NCT01372410|1083665|P1|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
442131|NCT01372410|1083658|P8|STARTED|Washout Period 2 (10-14 Days)||19
442132|NCT01372410|1083659|P7|STARTED|Washout Period 2 (10-14 Days)||21
442133|NCT01372410|1083660|P6|STARTED|Washout Period 2 (10-14 Days)||16
442134|NCT01372410|1083661|P5|STARTED|Washout Period 2 (10-14 Days)||19
442135|NCT01372410|1083662|P4|STARTED|Washout Period 2 (10-14 Days)||17
442136|NCT01372410|1083663|P3|STARTED|Washout Period 2 (10-14 Days)||22
442137|NCT01372410|1083664|P2|STARTED|Washout Period 2 (10-14 Days)||21
442138|NCT01372410|1083665|P1|STARTED|Washout Period 2 (10-14 Days)||19
442139|NCT01372410|1083658|P8|NOT COMPLETED|Treatment Period 2 (7 Days)||0
442140|NCT01372410|1083659|P7|NOT COMPLETED|Treatment Period 2 (7 Days)||0
442141|NCT01372410|1083660|P6|NOT COMPLETED|Treatment Period 2 (7 Days)||0
442142|NCT01372410|1083661|P5|NOT COMPLETED|Treatment Period 2 (7 Days)||0
442143|NCT01372410|1083662|P4|NOT COMPLETED|Treatment Period 2 (7 Days)||0
442144|NCT01372410|1083663|P3|NOT COMPLETED|Treatment Period 2 (7 Days)||0
442145|NCT01372410|1083664|P2|NOT COMPLETED|Treatment Period 2 (7 Days)||0
442146|NCT01372410|1083665|P1|NOT COMPLETED|Treatment Period 2 (7 Days)||0
442147|NCT01372410|1083658|P8|COMPLETED|Treatment Period 2 (7 Days)||19
442148|NCT01372410|1083659|P7|COMPLETED|Treatment Period 2 (7 Days)||21
442149|NCT01372410|1083660|P6|COMPLETED|Treatment Period 2 (7 Days)||16
442150|NCT01372410|1083661|P5|COMPLETED|Treatment Period 2 (7 Days)||19
442151|NCT01372410|1083662|P4|COMPLETED|Treatment Period 2 (7 Days)||17
442152|NCT01372410|1083663|P3|COMPLETED|Treatment Period 2 (7 Days)||22
442153|NCT01372410|1083664|P2|COMPLETED|Treatment Period 2 (7 Days)||21
442154|NCT01372410|1083665|P1|COMPLETED|Treatment Period 2 (7 Days)||19
442155|NCT01372410|1083658|P8|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
442156|NCT01372410|1083659|P7|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
442157|NCT01372410|1083660|P6|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|16
442158|NCT01372410|1083661|P5|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
442159|NCT01372410|1083662|P4|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|17
442160|NCT01372410|1083663|P3|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|22
442161|NCT01372410|1083664|P2|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
442162|NCT01372410|1083665|P1|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
442163|NCT01372410|1083658|P8|NOT COMPLETED|Washout Period 1 (10-14 Days)||1
442164|NCT01372410|1083659|P7|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
442165|NCT01372410|1083660|P6|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
442166|NCT01372410|1083661|P5|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
442167|NCT01372410|1083662|P4|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
442168|NCT01372410|1083663|P3|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
442169|NCT01372410|1083664|P2|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
442170|NCT01372410|1083665|P1|NOT COMPLETED|Washout Period 1 (10-14 Days)||1
442171|NCT01372410|1083658|P8|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
442172|NCT01372410|1083659|P7|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
442173|NCT01372410|1083660|P6|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
442174|NCT01372410|1083661|P5|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
442175|NCT01372410|1083662|P4|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
442176|NCT01372410|1083663|P3|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
442177|NCT01372410|1083664|P2|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
442178|NCT01372410|1083665|P1|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
442179|NCT01372410|1083658|P8|STARTED|Washout Period 1 (10-14 Days)||19
442180|NCT01372410|1083659|P7|STARTED|Washout Period 1 (10-14 Days)||20
442181|NCT01372410|1083660|P6|STARTED|Washout Period 1 (10-14 Days)||21
442182|NCT01372410|1083661|P5|STARTED|Washout Period 1 (10-14 Days)||19
442183|NCT01372410|1083662|P4|STARTED|Washout Period 1 (10-14 Days)||20
442184|NCT01372410|1083663|P3|STARTED|Washout Period 1 (10-14 Days)||19
442185|NCT01372410|1083664|P2|STARTED|Washout Period 1 (10-14 Days)||19
442186|NCT01372410|1083665|P1|STARTED|Washout Period 1 (10-14 Days)||19
442187|NCT01372410|1083658|P8|NOT COMPLETED|Treatment Period 1 (7 Days)||0
442188|NCT01372410|1083659|P7|NOT COMPLETED|Treatment Period 1 (7 Days)||2
442189|NCT01372410|1083660|P6|NOT COMPLETED|Treatment Period 1 (7 Days)||0
442190|NCT01372410|1083661|P5|NOT COMPLETED|Treatment Period 1 (7 Days)||2
442191|NCT01372410|1083662|P4|NOT COMPLETED|Treatment Period 1 (7 Days)||0
442192|NCT01372410|1083663|P3|NOT COMPLETED|Treatment Period 1 (7 Days)||0
442193|NCT01372410|1083664|P2|NOT COMPLETED|Treatment Period 1 (7 Days)||2
442194|NCT01372410|1083665|P1|NOT COMPLETED|Treatment Period 1 (7 Days)||1
442195|NCT01372410|1083658|P8|COMPLETED|Treatment Period 1 (7 Days)||19
442196|NCT01372410|1083659|P7|COMPLETED|Treatment Period 1 (7 Days)||20
442197|NCT01372410|1083660|P6|COMPLETED|Treatment Period 1 (7 Days)||21
442198|NCT01372410|1083661|P5|COMPLETED|Treatment Period 1 (7 Days)||19
442199|NCT01372410|1083662|P4|COMPLETED|Treatment Period 1 (7 Days)||20
442200|NCT01372410|1083663|P3|COMPLETED|Treatment Period 1 (7 Days)||19
442201|NCT01372410|1083664|P2|COMPLETED|Treatment Period 1 (7 Days)||19
442202|NCT01372410|1083665|P1|COMPLETED|Treatment Period 1 (7 Days)||19
442203|NCT01372410|1083658|P8|STARTED|Treatment Period 1 (7 Days)||19
442204|NCT01372410|1083659|P7|STARTED|Treatment Period 1 (7 Days)||22
442205|NCT01372410|1083660|P6|STARTED|Treatment Period 1 (7 Days)||21
442206|NCT01372410|1083661|P5|STARTED|Treatment Period 1 (7 Days)||21
442207|NCT01372410|1083662|P4|STARTED|Treatment Period 1 (7 Days)||20
442208|NCT01372410|1083663|P3|STARTED|Treatment Period 1 (7 Days)||19
442209|NCT01372410|1083664|P2|STARTED|Treatment Period 1 (7 Days)||21
442210|NCT01372410|1083665|P1|STARTED|Treatment Period 1 (7 Days)||20
442211|NCT01372384|1083702|P1|NOT COMPLETED|Overall Study||3
442212|NCT01372384|1083702|P1|COMPLETED|Overall Study||3
442213|NCT01372384|1083702|P1|STARTED|Overall Study||6
442214|NCT01372202|1083712|P3|NOT COMPLETED|Overall Study||0
442215|NCT01372202|1083713|P2|NOT COMPLETED|Overall Study||0
442216|NCT01372202|1083714|P1|NOT COMPLETED|Overall Study||0
442217|NCT01372202|1083712|P3|COMPLETED|Overall Study||9
442218|NCT01372202|1083713|P2|COMPLETED|Overall Study||9
442219|NCT01372202|1083714|P1|COMPLETED|Overall Study||13
442220|NCT01372202|1083712|P3|STARTED|Overall Study||9
442221|NCT01372202|1083713|P2|STARTED|Overall Study||9
442222|NCT01372202|1083714|P1|STARTED|Overall Study||13
442223|NCT01372150|1083725|P3|NOT COMPLETED|Overall Study||16
442224|NCT01372150|1083726|P2|NOT COMPLETED|Overall Study||14
442225|NCT01372150|1083727|P1|NOT COMPLETED|Overall Study||13
442226|NCT01372150|1083725|P3|COMPLETED|Overall Study||99
442227|NCT01372150|1083726|P2|COMPLETED|Overall Study||99
442228|NCT01372150|1083727|P1|COMPLETED|Overall Study||99
442229|NCT01372150|1083725|P3|Treated|Overall Study||115
442230|NCT01372150|1083726|P2|Treated|Overall Study||112
442231|NCT01372150|1083727|P1|Treated|Overall Study||112
442232|NCT01372150|1083725|P3|STARTED|Overall Study||115
442233|NCT01372150|1083726|P2|STARTED|Overall Study||113
442234|NCT01372150|1083727|P1|STARTED|Overall Study||112
442235|NCT01371994|1083746|P2|NOT COMPLETED|Overall Study||42
442236|NCT01371994|1083747|P1|NOT COMPLETED|Overall Study||57
442237|NCT01371994|1083746|P2|COMPLETED|Overall Study||278
442238|NCT01371994|1083747|P1|COMPLETED|Overall Study||263
442239|NCT01371994|1083746|P2|Received Treatment|Overall Study||313
442240|NCT01371994|1083747|P1|Received Treatment|Overall Study||310
442241|NCT01371994|1083746|P2|STARTED|Overall Study||320
442242|NCT01371994|1083747|P1|STARTED|Overall Study||320
442243|NCT01371877|1083791|P2|NOT COMPLETED|Overall Study||4
442244|NCT01371877|1083792|P1|NOT COMPLETED|Overall Study||0
442245|NCT01371877|1083791|P2|COMPLETED|Overall Study||17
442246|NCT01371877|1083792|P1|COMPLETED|Overall Study||21
442247|NCT01371877|1083791|P2|STARTED|Overall Study||21
442248|NCT01371877|1083792|P1|STARTED|Overall Study||21
442249|NCT01371851|1083804|P2|NOT COMPLETED|Overall Study||9
442250|NCT01371851|1083805|P1|NOT COMPLETED|Overall Study||8
442251|NCT01371851|1083804|P2|COMPLETED|Overall Study||2
442252|NCT01371851|1083805|P1|COMPLETED|Overall Study||3
442253|NCT01371851|1083804|P2|STARTED|Overall Study|Eligible participants who showed up on day 1 of week 1 and received at least one dose of study med.|11
442254|NCT01371851|1083805|P1|STARTED|Overall Study|Eligible participants who showed up on day 1 of week 1 and received at least one dose of study med.|11
442255|NCT01371838|1083813|P2|NOT COMPLETED|Overall Study||66
442256|NCT01371838|1083814|P1|NOT COMPLETED|Overall Study||49
442257|NCT01371838|1083813|P2|COMPLETED|Overall Study||317
442258|NCT01371838|1083814|P1|COMPLETED|Overall Study||332
442259|NCT01371838|1083813|P2|STARTED|Overall Study||383
442260|NCT01371838|1083814|P1|STARTED|Overall Study||381
442261|NCT01371825|1083850|P1|NOT COMPLETED|Long-term Treatment Period||0
442262|NCT01371825|1083850|P1|COMPLETED|Long-term Treatment Period|This period is currently ongoing.|6
442263|NCT01371825|1083850|P1|STARTED|Long-term Treatment Period||6
442264|NCT01371825|1083850|P1|NOT COMPLETED|Primary Efficacy Analysis Period||3
442265|NCT01371825|1083850|P1|COMPLETED|Primary Efficacy Analysis Period||6
442266|NCT01371825|1083850|P1|STARTED|Primary Efficacy Analysis Period||9
442267|NCT01371786|1083864|P2|NOT COMPLETED|Overall Study||0
442268|NCT01371786|1083865|P1|NOT COMPLETED|Overall Study||0
442269|NCT01371786|1083864|P2|COMPLETED|Overall Study||7
442270|NCT01371786|1083865|P1|COMPLETED|Overall Study||7
442271|NCT01371786|1083864|P2|STARTED|Overall Study||7
442272|NCT01371786|1083865|P1|STARTED|Overall Study||7
442273|NCT01371747|1083885|P6|NOT COMPLETED|Overall Study||14
442274|NCT01371747|1083886|P5|NOT COMPLETED|Overall Study||7
442275|NCT01371747|1083887|P4|NOT COMPLETED|Overall Study||9
442276|NCT01371747|1083888|P3|NOT COMPLETED|Overall Study||24
442277|NCT01371747|1083889|P2|NOT COMPLETED|Overall Study||23
442278|NCT01371747|1083890|P1|NOT COMPLETED|Overall Study||18
442279|NCT01371747|1083885|P6|COMPLETED|Overall Study||16
442280|NCT01371747|1083886|P5|COMPLETED|Overall Study||21
442281|NCT01371747|1083887|P4|COMPLETED|Overall Study||17
442282|NCT01371747|1083888|P3|COMPLETED|Overall Study||50
442283|NCT01371747|1083889|P2|COMPLETED|Overall Study||51
442284|NCT01371747|1083890|P1|COMPLETED|Overall Study||56
442285|NCT01371747|1083885|P6|STARTED|Overall Study||30
442286|NCT01371747|1083886|P5|STARTED|Overall Study||28
442287|NCT01371747|1083887|P4|STARTED|Overall Study||26
442288|NCT01371747|1083888|P3|STARTED|Overall Study||74
442289|NCT01371747|1083889|P2|STARTED|Overall Study||74
442290|NCT01371747|1083890|P1|STARTED|Overall Study||74
442291|NCT01371734|1083955|P3|NOT COMPLETED|Overall Study||17
442292|NCT01371734|1083956|P2|NOT COMPLETED|Overall Study||19
442293|NCT01371734|1083957|P1|NOT COMPLETED|Overall Study||23
442294|NCT01371734|1083955|P3|COMPLETED|Overall Study||104
442295|NCT01371734|1083956|P2|COMPLETED|Overall Study||103
442296|NCT01371734|1083957|P1|COMPLETED|Overall Study||97
442297|NCT01371734|1083955|P3|STARTED|Overall Study||121
442298|NCT01371734|1083956|P2|STARTED|Overall Study||122
442299|NCT01371734|1083957|P1|STARTED|Overall Study||120
442300|NCT01371721|1083977|P3|NOT COMPLETED|Overall Study||30
442301|NCT01371721|1083978|P2|NOT COMPLETED|Overall Study||24
442302|NCT01371721|1083979|P1|NOT COMPLETED|Overall Study||29
442303|NCT01371721|1083977|P3|COMPLETED|Overall Study||62
442304|NCT01371721|1083978|P2|COMPLETED|Overall Study||65
442305|NCT01371721|1083979|P1|COMPLETED|Overall Study||59
442306|NCT01371721|1083977|P3|Treated|Overall Study||92
442307|NCT01371721|1083978|P2|Treated|Overall Study||89
442308|NCT01371721|1083979|P1|Treated|Overall Study||87
442309|NCT01371721|1083977|P3|STARTED|Overall Study||92
442310|NCT01371721|1083978|P2|STARTED|Overall Study||89
442311|NCT01371721|1083979|P1|STARTED|Overall Study||88
442312|NCT01371708|1084012|P3|NOT COMPLETED|Overall Study||39
442313|NCT01371708|1084013|P2|NOT COMPLETED|Overall Study||30
442314|NCT01371708|1084014|P1|NOT COMPLETED|Overall Study||26
442315|NCT01371708|1084012|P3|COMPLETED|Overall Study||59
442316|NCT01371708|1084013|P2|COMPLETED|Overall Study||63
442317|NCT01371708|1084014|P1|COMPLETED|Overall Study||66
442318|NCT01371708|1084012|P3|Received Treatment|Overall Study||97
442319|NCT01371708|1084013|P2|Received Treatment|Overall Study||93
442320|NCT01371708|1084014|P1|Received Treatment|Overall Study||91
442321|NCT01371708|1084012|P3|STARTED|Overall Study||98
442322|NCT01371708|1084013|P2|STARTED|Overall Study||93
442323|NCT01371708|1084014|P1|STARTED|Overall Study||92
442324|NCT01371656|1084046|P2|NOT COMPLETED|Overall Study||14
442325|NCT01371656|1084047|P1|NOT COMPLETED|Overall Study||64
442326|NCT01371656|1084046|P2|COMPLETED|Overall Study||296
442327|NCT01371656|1084047|P1|COMPLETED|Overall Study||250
442328|NCT01371656|1084046|P2|STARTED|Overall Study||310
442329|NCT01371656|1084047|P1|STARTED|Overall Study||314
442330|NCT01371643|1084067|P2|NOT COMPLETED|Overall Study||0
442331|NCT01371643|1084068|P1|NOT COMPLETED|Overall Study||3
442332|NCT01371643|1084067|P2|COMPLETED|Overall Study||26
442333|NCT01371643|1084068|P1|COMPLETED|Overall Study||12
442334|NCT01371643|1084067|P2|STARTED|Overall Study||26
442335|NCT01371643|1084068|P1|STARTED|Overall Study||15
442336|NCT01371565|1084078|P1|NOT COMPLETED|Overall Study||3
442337|NCT01371565|1084078|P1|COMPLETED|Overall Study||1
442338|NCT01371565|1084078|P1|STARTED|Overall Study||4
442339|NCT01371552|1084082|P6|NOT COMPLETED|Part 2, One Week||0
442340|NCT01371552|1084083|P5|NOT COMPLETED|Part 2, One Week||0
442341|NCT01371552|1084084|P4|NOT COMPLETED|Part 2, One Week||0
442342|NCT01371552|1084085|P3|NOT COMPLETED|Part 2, One Week||0
442343|NCT01371552|1084086|P2|NOT COMPLETED|Part 2, One Week||0
442344|NCT01371552|1084087|P1|NOT COMPLETED|Part 2, One Week||0
442345|NCT01371552|1084082|P6|COMPLETED|Part 2, One Week||18
442346|NCT01371552|1084083|P5|COMPLETED|Part 2, One Week||15
442347|NCT01371552|1084084|P4|COMPLETED|Part 2, One Week||20
442348|NCT01371552|1084085|P3|COMPLETED|Part 2, One Week||18
442349|NCT01371552|1084086|P2|COMPLETED|Part 2, One Week||17
442350|NCT01371552|1084087|P1|COMPLETED|Part 2, One Week||18
442351|NCT01371552|1084082|P6|STARTED|Part 2, One Week||18
442352|NCT01371552|1084083|P5|STARTED|Part 2, One Week||15
442353|NCT01371552|1084084|P4|STARTED|Part 2, One Week||20
442354|NCT01371552|1084085|P3|STARTED|Part 2, One Week||18
442355|NCT01371552|1084086|P2|STARTED|Part 2, One Week||17
442356|NCT01371552|1084087|P1|STARTED|Part 2, One Week|One participant discontinued between Part 1 and Part 2 due to inconvenience|18
442357|NCT01371552|1084082|P6|NOT COMPLETED|Part 1, Third 3 Days||1
442358|NCT01371552|1084083|P5|NOT COMPLETED|Part 1, Third 3 Days||1
442359|NCT01371552|1084084|P4|NOT COMPLETED|Part 1, Third 3 Days||0
442360|NCT01371552|1084085|P3|NOT COMPLETED|Part 1, Third 3 Days||0
442361|NCT01371552|1084086|P2|NOT COMPLETED|Part 1, Third 3 Days||0
442362|NCT01371552|1084087|P1|NOT COMPLETED|Part 1, Third 3 Days||0
442363|NCT01371552|1084082|P6|COMPLETED|Part 1, Third 3 Days|One subject did not complete period due to discomfort, but continued into Part 2.|17
442364|NCT01371552|1084083|P5|COMPLETED|Part 1, Third 3 Days|One subject did not complete period due to randomization error, but continued into Part 2.|14
442365|NCT01371552|1084084|P4|COMPLETED|Part 1, Third 3 Days||20
442366|NCT01371552|1084085|P3|COMPLETED|Part 1, Third 3 Days||18
442367|NCT01371552|1084086|P2|COMPLETED|Part 1, Third 3 Days||17
442368|NCT01371552|1084087|P1|COMPLETED|Part 1, Third 3 Days||19
442369|NCT01371552|1084082|P6|STARTED|Part 1, Third 3 Days||18
442370|NCT01371552|1084083|P5|STARTED|Part 1, Third 3 Days||15
442371|NCT01371552|1084084|P4|STARTED|Part 1, Third 3 Days||20
442372|NCT01371552|1084085|P3|STARTED|Part 1, Third 3 Days||18
442373|NCT01371552|1084086|P2|STARTED|Part 1, Third 3 Days||17
442374|NCT01371552|1084087|P1|STARTED|Part 1, Third 3 Days||19
442375|NCT01371552|1084082|P6|NOT COMPLETED|Part 1, Second 3 Days||0
442376|NCT01371552|1084083|P5|NOT COMPLETED|Part 1, Second 3 Days||0
442377|NCT01371552|1084084|P4|NOT COMPLETED|Part 1, Second 3 Days||0
442378|NCT01371552|1084085|P3|NOT COMPLETED|Part 1, Second 3 Days||0
442379|NCT01371552|1084086|P2|NOT COMPLETED|Part 1, Second 3 Days||0
442380|NCT01371552|1084087|P1|NOT COMPLETED|Part 1, Second 3 Days||1
442381|NCT01371552|1084082|P6|COMPLETED|Part 1, Second 3 Days||18
442382|NCT01371552|1084083|P5|COMPLETED|Part 1, Second 3 Days||15
442383|NCT01371552|1084084|P4|COMPLETED|Part 1, Second 3 Days||20
442384|NCT01371552|1084085|P3|COMPLETED|Part 1, Second 3 Days||18
442385|NCT01371552|1084086|P2|COMPLETED|Part 1, Second 3 Days||17
442386|NCT01371552|1084087|P1|COMPLETED|Part 1, Second 3 Days|One subject did not complete period due to discomfort but continued to next, as allowed by protocol|18
442387|NCT01371552|1084082|P6|STARTED|Part 1, Second 3 Days||18
442388|NCT01371552|1084083|P5|STARTED|Part 1, Second 3 Days||15
442389|NCT01371552|1084084|P4|STARTED|Part 1, Second 3 Days||20
442390|NCT01371552|1084085|P3|STARTED|Part 1, Second 3 Days|1 subject discontinued after First 3 days due to positive slit lamp findings unrelated to lens wear|18
442391|NCT01371552|1084086|P2|STARTED|Part 1, Second 3 Days||17
442392|NCT01371552|1084087|P1|STARTED|Part 1, Second 3 Days||19
442393|NCT01371552|1084082|P6|NOT COMPLETED|Part 1, First 3 Days||0
442394|NCT01371552|1084083|P5|NOT COMPLETED|Part 1, First 3 Days||0
442395|NCT01371552|1084084|P4|NOT COMPLETED|Part 1, First 3 Days||0
442396|NCT01371552|1084085|P3|NOT COMPLETED|Part 1, First 3 Days||1
442397|NCT01371552|1084086|P2|NOT COMPLETED|Part 1, First 3 Days||0
442398|NCT01371552|1084087|P1|NOT COMPLETED|Part 1, First 3 Days||0
442399|NCT01371552|1084082|P6|COMPLETED|Part 1, First 3 Days||18
442400|NCT01371552|1084083|P5|COMPLETED|Part 1, First 3 Days||15
442401|NCT01371552|1084084|P4|COMPLETED|Part 1, First 3 Days||20
442402|NCT01371552|1084085|P3|COMPLETED|Part 1, First 3 Days||19
442403|NCT01371552|1084086|P2|COMPLETED|Part 1, First 3 Days||17
442404|NCT01371552|1084087|P1|COMPLETED|Part 1, First 3 Days||19
442405|NCT01371552|1084082|P6|STARTED|Part 1, First 3 Days||18
442406|NCT01371552|1084083|P5|STARTED|Part 1, First 3 Days||15
442407|NCT01371552|1084084|P4|STARTED|Part 1, First 3 Days||20
442408|NCT01371552|1084085|P3|STARTED|Part 1, First 3 Days||20
442409|NCT01371552|1084086|P2|STARTED|Part 1, First 3 Days||17
442410|NCT01371552|1084087|P1|STARTED|Part 1, First 3 Days||19
442411|NCT01371539|1084114|P2|NOT COMPLETED|Period Two: One Week||3
442412|NCT01371539|1084115|P1|NOT COMPLETED|Period Two: One Week||0
442413|NCT01371539|1084114|P2|COMPLETED|Period Two: One Week||47
442414|NCT01371539|1084115|P1|COMPLETED|Period Two: One Week||53
442415|NCT01371539|1084114|P2|STARTED|Period Two: One Week||50
442416|NCT01371539|1084115|P1|STARTED|Period Two: One Week||53
442417|NCT01371539|1084114|P2|NOT COMPLETED|Period One: One Week||1
442418|NCT01371539|1084115|P1|NOT COMPLETED|Period One: One Week||0
442419|NCT01371539|1084114|P2|COMPLETED|Period One: One Week||50
442420|NCT01371539|1084115|P1|COMPLETED|Period One: One Week||53
442421|NCT01371539|1084114|P2|STARTED|Period One: One Week||51
442422|NCT01371539|1084115|P1|STARTED|Period One: One Week||53
442423|NCT01371110|1084125|P2|NOT COMPLETED|Overall Study||0
442424|NCT01371110|1084126|P1|NOT COMPLETED|Overall Study||0
442425|NCT01371110|1084125|P2|COMPLETED|Overall Study||2
442426|NCT01371110|1084126|P1|COMPLETED|Overall Study||1
442427|NCT01371110|1084125|P2|STARTED|Overall Study||2
442428|NCT01371110|1084126|P1|STARTED|Overall Study||1
442429|NCT01371006|1084136|P2|NOT COMPLETED|Overall Study||0
442430|NCT01371006|1084137|P1|NOT COMPLETED|Overall Study||1
442431|NCT01371006|1084136|P2|COMPLETED|Overall Study||15
442432|NCT01371006|1084137|P1|COMPLETED|Overall Study||13
442433|NCT01371006|1084136|P2|STARTED|Overall Study||15
442434|NCT01371006|1084137|P1|STARTED|Overall Study||14
442435|NCT01370863|1084178|P2|NOT COMPLETED|Overall Study||3
442436|NCT01370863|1084179|P1|NOT COMPLETED|Overall Study||2
442437|NCT01370863|1084178|P2|COMPLETED|Overall Study||30
442438|NCT01370863|1084179|P1|COMPLETED|Overall Study||32
442439|NCT01370863|1084178|P2|STARTED|Overall Study||33
442440|NCT01370863|1084179|P1|STARTED|Overall Study||34
442441|NCT01370837|1084192|P3|NOT COMPLETED|Overall Study||0
442442|NCT01370837|1084193|P2|NOT COMPLETED|Overall Study||0
442443|NCT01370837|1084194|P1|NOT COMPLETED|Overall Study||0
442444|NCT01370837|1084192|P3|COMPLETED|Overall Study||17
442445|NCT01370837|1084193|P2|COMPLETED|Overall Study||12
442446|NCT01370837|1084194|P1|COMPLETED|Overall Study||12
442447|NCT01370837|1084192|P3|STARTED|Overall Study||17
442448|NCT01370837|1084193|P2|STARTED|Overall Study||12
442449|NCT01370837|1084194|P1|STARTED|Overall Study||12
442450|NCT01370733|1084204|P2|NOT COMPLETED|Overall Study||22
442451|NCT01370733|1084205|P1|NOT COMPLETED|Overall Study||17
442452|NCT01370733|1084204|P2|COMPLETED|Overall Study||77
442453|NCT01370733|1084205|P1|COMPLETED|Overall Study||86
442454|NCT01370733|1084204|P2|STARTED|Overall Study||99
442455|NCT01370733|1084205|P1|STARTED|Overall Study||103
442456|NCT01370694|1084227|P1|NOT COMPLETED|Overall Study||6
442457|NCT01370694|1084227|P1|COMPLETED|Overall Study||1
442458|NCT01370694|1084227|P1|STARTED|Overall Study||7
442459|NCT01370655|1084249|P12|NOT COMPLETED|Period 2||0
442460|NCT01370655|1084250|P11|NOT COMPLETED|Period 2||1
442461|NCT01370655|1084251|P10|NOT COMPLETED|Period 2||0
442462|NCT01370655|1084252|P9|NOT COMPLETED|Period 2||2
442463|NCT01370655|1084253|P8|NOT COMPLETED|Period 2||1
442464|NCT01370655|1084254|P7|NOT COMPLETED|Period 2||1
442465|NCT01370655|1084255|P6|NOT COMPLETED|Period 2||0
442466|NCT01370655|1084256|P5|NOT COMPLETED|Period 2||1
442467|NCT01370655|1084257|P4|NOT COMPLETED|Period 2||0
442468|NCT01370655|1084258|P3|NOT COMPLETED|Period 2||2
442469|NCT01370655|1084259|P2|NOT COMPLETED|Period 2||0
442470|NCT01370655|1084260|P1|NOT COMPLETED|Period 2||0
442471|NCT01370655|1084249|P12|COMPLETED|Period 2||3
442472|NCT01370655|1084250|P11|COMPLETED|Period 2||2
442473|NCT01370655|1084251|P10|COMPLETED|Period 2||2
442474|NCT01370655|1084252|P9|COMPLETED|Period 2||1
442475|NCT01370655|1084253|P8|COMPLETED|Period 2||3
442476|NCT01370655|1084254|P7|COMPLETED|Period 2||2
442477|NCT01370655|1084255|P6|COMPLETED|Period 2||4
442478|NCT01370655|1084256|P5|COMPLETED|Period 2||2
442479|NCT01370655|1084257|P4|COMPLETED|Period 2||3
442480|NCT01370655|1084258|P3|COMPLETED|Period 2||1
442481|NCT01370655|1084259|P2|COMPLETED|Period 2||7
442482|NCT01370655|1084260|P1|COMPLETED|Period 2||5
442483|NCT01370655|1084249|P12|STARTED|Period 2||3
442484|NCT01370655|1084250|P11|STARTED|Period 2||3
442485|NCT01370655|1084251|P10|STARTED|Period 2||2
442486|NCT01370655|1084252|P9|STARTED|Period 2||3
442487|NCT01370655|1084253|P8|STARTED|Period 2||4
442488|NCT01370655|1084254|P7|STARTED|Period 2||3
442489|NCT01370655|1084255|P6|STARTED|Period 2||4
442490|NCT01370655|1084256|P5|STARTED|Period 2||3
442491|NCT01370655|1084257|P4|STARTED|Period 2||3
442492|NCT01370655|1084258|P3|STARTED|Period 2||3
442493|NCT01370655|1084259|P2|STARTED|Period 2||7
442494|NCT01370655|1084260|P1|STARTED|Period 2||5
442495|NCT01370655|1084249|P12|NOT COMPLETED|Period 1||0
442496|NCT01370655|1084250|P11|NOT COMPLETED|Period 1||0
442497|NCT01370655|1084251|P10|NOT COMPLETED|Period 1||0
442498|NCT01370655|1084252|P9|NOT COMPLETED|Period 1||0
442499|NCT01370655|1084253|P8|NOT COMPLETED|Period 1||0
442500|NCT01370655|1084254|P7|NOT COMPLETED|Period 1||1
442501|NCT01370655|1084255|P6|NOT COMPLETED|Period 1||0
442502|NCT01370655|1084256|P5|NOT COMPLETED|Period 1||0
442503|NCT01370655|1084257|P4|NOT COMPLETED|Period 1||0
442504|NCT01370655|1084258|P3|NOT COMPLETED|Period 1||0
442505|NCT01370655|1084259|P2|NOT COMPLETED|Period 1||0
442506|NCT01370655|1084260|P1|NOT COMPLETED|Period 1||2
442507|NCT01370655|1084249|P12|COMPLETED|Period 1||3
442508|NCT01370655|1084250|P11|COMPLETED|Period 1||3
442509|NCT01370655|1084251|P10|COMPLETED|Period 1||2
442510|NCT01370655|1084252|P9|COMPLETED|Period 1||3
442511|NCT01370655|1084253|P8|COMPLETED|Period 1||4
442512|NCT01370655|1084254|P7|COMPLETED|Period 1||3
442513|NCT01370655|1084255|P6|COMPLETED|Period 1||4
442514|NCT01370655|1084256|P5|COMPLETED|Period 1||3
442515|NCT01370655|1084257|P4|COMPLETED|Period 1||3
442516|NCT01370655|1084258|P3|COMPLETED|Period 1||3
442517|NCT01370655|1084259|P2|COMPLETED|Period 1||7
442518|NCT01370655|1084260|P1|COMPLETED|Period 1||5
442519|NCT01370655|1084249|P12|STARTED|Period 1||3
442520|NCT01370655|1084250|P11|STARTED|Period 1||3
442521|NCT01370655|1084251|P10|STARTED|Period 1||2
442522|NCT01370655|1084252|P9|STARTED|Period 1||3
442523|NCT01370655|1084253|P8|STARTED|Period 1||4
442524|NCT01370655|1084254|P7|STARTED|Period 1||4
442525|NCT01370655|1084255|P6|STARTED|Period 1||4
442526|NCT01370655|1084256|P5|STARTED|Period 1||3
442527|NCT01370655|1084257|P4|STARTED|Period 1||3
442528|NCT01370655|1084258|P3|STARTED|Period 1||3
442529|NCT01370655|1084259|P2|STARTED|Period 1||7
442530|NCT01370655|1084260|P1|STARTED|Period 1||7
442531|NCT01370642|1084297|P3|NOT COMPLETED|Overall Study||29
442532|NCT01370642|1084298|P2|NOT COMPLETED|Overall Study||6
442533|NCT01370642|1084299|P1|NOT COMPLETED|Overall Study||8
442534|NCT01370642|1084297|P3|COMPLETED|Overall Study||69
442535|NCT01370642|1084298|P2|COMPLETED|Overall Study||92
442536|NCT01370642|1084299|P1|COMPLETED|Overall Study||90
442537|NCT01370642|1084297|P3|FAS Population|Overall Study||98
442538|NCT01370642|1084298|P2|FAS Population|Overall Study||97
442539|NCT01370642|1084299|P1|FAS Population|Overall Study||98
442540|NCT01370642|1084297|P3|STARTED|Overall Study||98
442541|NCT01370642|1084298|P2|STARTED|Overall Study||98
442542|NCT01370642|1084299|P1|STARTED|Overall Study||98
442543|NCT01370616|1084330|P2|NOT COMPLETED|Overall Study||67
442544|NCT01370616|1084331|P1|NOT COMPLETED|Overall Study||62
442545|NCT01370616|1084330|P2|COMPLETED|Overall Study||216
442546|NCT01370616|1084331|P1|COMPLETED|Overall Study||220
442547|NCT01370616|1084330|P2|Treated|Overall Study||275
442548|NCT01370616|1084331|P1|Treated|Overall Study||275
442549|NCT01370616|1084330|P2|STARTED|Overall Study|Participants randomized|283
442550|NCT01370616|1084331|P1|STARTED|Overall Study|Participants randomized|282
442551|NCT01370603|1084355|P2|NOT COMPLETED|Period 2||4
442552|NCT01370603|1084356|P1|NOT COMPLETED|Period 2||3
442553|NCT01370603|1084355|P2|COMPLETED|Period 2||146
442554|NCT01370603|1084356|P1|COMPLETED|Period 2||138
442555|NCT01370603|1084355|P2|STARTED|Period 2||150
442556|NCT01370603|1084356|P1|STARTED|Period 2||141
442557|NCT01370603|1084355|P2|NOT COMPLETED|Crossover Washout||4
442558|NCT01370603|1084356|P1|NOT COMPLETED|Crossover Washout||9
442559|NCT01370603|1084355|P2|COMPLETED|Crossover Washout||150
442560|NCT01370603|1084356|P1|COMPLETED|Crossover Washout||141
442561|NCT01370603|1084355|P2|STARTED|Crossover Washout||154
442562|NCT01370603|1084356|P1|STARTED|Crossover Washout||150
442563|NCT01370603|1084355|P2|NOT COMPLETED|Period 1||10
442564|NCT01370603|1084356|P1|NOT COMPLETED|Period 1||14
442565|NCT01370603|1084355|P2|COMPLETED|Period 1||154
442566|NCT01370603|1084356|P1|COMPLETED|Period 1||150
442567|NCT01370603|1084355|P2|STARTED|Period 1||164
442568|NCT01370603|1084356|P1|STARTED|Period 1||164
442569|NCT01370590|1084374|P2|NOT COMPLETED|Period 2||2
442570|NCT01370590|1084375|P1|NOT COMPLETED|Period 2||1
442571|NCT01370590|1084374|P2|COMPLETED|Period 2||184
442572|NCT01370590|1084375|P1|COMPLETED|Period 2||180
442573|NCT01370590|1084374|P2|STARTED|Period 2||186
442574|NCT01370590|1084375|P1|STARTED|Period 2||181
442575|NCT01370590|1084374|P2|NOT COMPLETED|Crossover Washout Period||6
442576|NCT01370590|1084375|P1|NOT COMPLETED|Crossover Washout Period||6
442577|NCT01370590|1084374|P2|COMPLETED|Crossover Washout Period||186
442578|NCT01370590|1084375|P1|COMPLETED|Crossover Washout Period||181
442579|NCT01370590|1084374|P2|STARTED|Crossover Washout Period||192
442580|NCT01370590|1084375|P1|STARTED|Crossover Washout Period||187
442581|NCT01370590|1084374|P2|NOT COMPLETED|Period 1||11
442582|NCT01370590|1084375|P1|NOT COMPLETED|Period 1||16
442583|NCT01370590|1084374|P2|COMPLETED|Period 1||192
442584|NCT01370590|1084375|P1|COMPLETED|Period 1||187
442585|NCT01370590|1084374|P2|STARTED|Period 1||203
442586|NCT01370590|1084375|P1|STARTED|Period 1||203
442587|NCT01370538|1084393|P2|NOT COMPLETED|Overall Study||19
442588|NCT01370538|1084394|P1|NOT COMPLETED|Overall Study||19
442589|NCT01370538|1084393|P2|COMPLETED|Overall Study||152
442590|NCT01370538|1084394|P1|COMPLETED|Overall Study||151
442591|NCT01370538|1084393|P2|Patients Who Completed Treatment|Overall Study||152
442592|NCT01370538|1084394|P1|Patients Who Completed Treatment|Overall Study||151
442593|NCT01370538|1084393|P2|Patients Who Received Treatment|Overall Study||161
442594|NCT01370538|1084394|P1|Patients Who Received Treatment|Overall Study||165
442595|NCT01370538|1084393|P2|STARTED|Overall Study||171
442596|NCT01370538|1084394|P1|STARTED|Overall Study||170
442597|NCT01370525|1084410|P2|NOT COMPLETED|Overall Study||11
442598|NCT01370525|1084411|P1|NOT COMPLETED|Overall Study||8
442599|NCT01370525|1084410|P2|COMPLETED|Overall Study||158
442600|NCT01370525|1084411|P1|COMPLETED|Overall Study||163
442601|NCT01370525|1084410|P2|Patients Who Completed Treatment|Overall Study||158
442602|NCT01370525|1084411|P1|Patients Who Completed Treatment|Overall Study||163
442603|NCT01370525|1084410|P2|Patients Who Received Treatment|Overall Study||163
442604|NCT01370525|1084411|P1|Patients Who Received Treatment|Overall Study||168
442605|NCT01370525|1084410|P2|STARTED|Overall Study||169
442606|NCT01370525|1084411|P1|STARTED|Overall Study||171
442607|NCT01370460|1084427|P2|NOT COMPLETED|Overall Study||0
442608|NCT01370460|1084428|P1|NOT COMPLETED|Overall Study||0
442609|NCT01370460|1084427|P2|COMPLETED|Overall Study||51
442610|NCT01370460|1084428|P1|COMPLETED|Overall Study||50
442611|NCT01370460|1084427|P2|STARTED|Overall Study||51
442612|NCT01370460|1084428|P1|STARTED|Overall Study||50
442613|NCT01370408|1084435|P1|NOT COMPLETED|Overall Study||9
442614|NCT01370408|1084435|P1|COMPLETED|Overall Study||76
442615|NCT01370408|1084435|P1|STARTED|Overall Study||85
442616|NCT01370369|1084446|P1|NOT COMPLETED|Overall Study||0
442617|NCT01370369|1084446|P1|COMPLETED|Overall Study||20
442618|NCT01370369|1084446|P1|STARTED|Overall Study||20
442619|NCT01370356|1084495|P2|NOT COMPLETED|Overall Study||227
442620|NCT01370356|1084496|P1|NOT COMPLETED|Overall Study||192
442621|NCT01370356|1084495|P2|COMPLETED|Overall Study||515
442622|NCT01370356|1084496|P1|COMPLETED|Overall Study||559
442623|NCT01370356|1084495|P2|STARTED|Overall Study||742
442624|NCT01370356|1084496|P1|STARTED|Overall Study||751
442625|NCT01370265|1084510|P2|NOT COMPLETED|Second Intervention||0
442626|NCT01370265|1084511|P1|NOT COMPLETED|Second Intervention||0
442627|NCT01370265|1084510|P2|COMPLETED|Second Intervention||5
442628|NCT01370265|1084511|P1|COMPLETED|Second Intervention||5
442629|NCT01370265|1084510|P2|STARTED|Second Intervention||5
442630|NCT01370265|1084511|P1|STARTED|Second Intervention||5
442631|NCT01370265|1084510|P2|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
442632|NCT01370265|1084511|P1|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
442633|NCT01370265|1084510|P2|COMPLETED|Washout Period (50-minute Period Decay)||5
442634|NCT01370265|1084511|P1|COMPLETED|Washout Period (50-minute Period Decay)||5
442635|NCT01370265|1084510|P2|STARTED|Washout Period (50-minute Period Decay)||5
442636|NCT01370265|1084511|P1|STARTED|Washout Period (50-minute Period Decay)||5
442637|NCT01370265|1084510|P2|NOT COMPLETED|First Intervention||1
442638|NCT01370265|1084511|P1|NOT COMPLETED|First Intervention||1
442639|NCT01370265|1084510|P2|COMPLETED|First Intervention||5
442640|NCT01370265|1084511|P1|COMPLETED|First Intervention||5
442641|NCT01370265|1084510|P2|STARTED|First Intervention||6
442642|NCT01370265|1084511|P1|STARTED|First Intervention||6
442643|NCT01370265|1084510|P2|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
442644|NCT01370265|1084511|P1|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
442645|NCT01370265|1084510|P2|COMPLETED|Washout Period (50-minute Period Decay)||6
442646|NCT01370265|1084511|P1|COMPLETED|Washout Period (50-minute Period Decay)||6
442647|NCT01370265|1084510|P2|STARTED|Washout Period (50-minute Period Decay)||6
442648|NCT01370265|1084511|P1|STARTED|Washout Period (50-minute Period Decay)||6
442649|NCT01370265|1084510|P2|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0
442650|NCT01370265|1084511|P1|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0
442651|NCT01370265|1084510|P2|COMPLETED|Resting Myocardial Blood Flow (MBF)||6
442652|NCT01370265|1084511|P1|COMPLETED|Resting Myocardial Blood Flow (MBF)||6
442653|NCT01370265|1084510|P2|STARTED|Resting Myocardial Blood Flow (MBF)||6
442654|NCT01370265|1084511|P1|STARTED|Resting Myocardial Blood Flow (MBF)||6
442655|NCT01370083|1084530|P2|NOT COMPLETED|Overall Study||1
442656|NCT01370083|1084531|P1|NOT COMPLETED|Overall Study||2
442657|NCT01370083|1084530|P2|COMPLETED|Overall Study||6
442658|NCT01370083|1084531|P1|COMPLETED|Overall Study||5
442659|NCT01370083|1084530|P2|STARTED|Overall Study||7
442660|NCT01370083|1084531|P1|STARTED|Overall Study||7
442661|NCT01370005|1084544|P3|NOT COMPLETED|Overall Study||11
442662|NCT01370005|1084545|P2|NOT COMPLETED|Overall Study||11
442663|NCT01370005|1084546|P1|NOT COMPLETED|Overall Study||16
442664|NCT01370005|1084544|P3|COMPLETED|Overall Study||266
442665|NCT01370005|1084545|P2|COMPLETED|Overall Study||265
442666|NCT01370005|1084546|P1|COMPLETED|Overall Study||256
442667|NCT01370005|1084544|P3|STARTED|Overall Study||277
442668|NCT01370005|1084545|P2|STARTED|Overall Study||276
442669|NCT01370005|1084546|P1|STARTED|Overall Study||272
442670|NCT01369888|1084603|P4|NOT COMPLETED|Overall Study||0
442671|NCT01369888|1084604|P3|NOT COMPLETED|Overall Study||0
442672|NCT01369888|1084605|P2|NOT COMPLETED|Overall Study||0
442673|NCT01369888|1084606|P1|NOT COMPLETED|Overall Study||0
442674|NCT01369888|1084603|P4|COMPLETED|Overall Study||0
442675|NCT01369888|1084604|P3|COMPLETED|Overall Study||0
442676|NCT01369888|1084605|P2|COMPLETED|Overall Study||2
442677|NCT01369888|1084606|P1|COMPLETED|Overall Study||1
442678|NCT01369888|1084603|P4|STARTED|Overall Study||0
442679|NCT01369888|1084604|P3|STARTED|Overall Study||0
442680|NCT01369888|1084605|P2|STARTED|Overall Study||2
442681|NCT01369888|1084606|P1|STARTED|Overall Study||1
442682|NCT01369875|1084616|P2|NOT COMPLETED|Overall Study||0
442683|NCT01369875|1084617|P1|NOT COMPLETED|Overall Study||0
442684|NCT01369875|1084616|P2|COMPLETED|Overall Study||1
442685|NCT01369875|1084617|P1|COMPLETED|Overall Study||1
442686|NCT01369875|1084616|P2|STARTED|Overall Study||1
442687|NCT01369875|1084617|P1|STARTED|Overall Study||1
442688|NCT01369849|1084628|P3|NOT COMPLETED|Overall Study||1
442689|NCT01369849|1084629|P2|NOT COMPLETED|Overall Study||1
442690|NCT01369849|1084630|P1|NOT COMPLETED|Overall Study||0
442691|NCT01369849|1084628|P3|COMPLETED|Overall Study||4
442692|NCT01369849|1084629|P2|COMPLETED|Overall Study||3
442693|NCT01369849|1084630|P1|COMPLETED|Overall Study||6
442694|NCT01369849|1084628|P3|STARTED|Overall Study||5
442695|NCT01369849|1084629|P2|STARTED|Overall Study||4
442696|NCT01369849|1084630|P1|STARTED|Overall Study||6
442697|NCT01369784|1084652|P1|NOT COMPLETED|Overall Study||12
442698|NCT01369784|1084652|P1|COMPLETED|Overall Study||146
442699|NCT01369784|1084652|P1|STARTED|Overall Study||158
442700|NCT01369758|1084677|P1|NOT COMPLETED|Overall Study||0
442701|NCT01369758|1084677|P1|COMPLETED|Overall Study||290
442702|NCT01369758|1084677|P1|STARTED|Overall Study||290
442703|NCT01369745|1084687|P5|NOT COMPLETED|Overall Study||18
442704|NCT01369745|1084688|P4|NOT COMPLETED|Overall Study||20
442705|NCT01369745|1084689|P3|NOT COMPLETED|Overall Study||2
442706|NCT01369745|1084690|P2|NOT COMPLETED|Overall Study||13
442707|NCT01369745|1084691|P1|NOT COMPLETED|Overall Study||7
442708|NCT01369745|1084687|P5|COMPLETED|Overall Study||65
442709|NCT01369745|1084688|P4|COMPLETED|Overall Study||64
442710|NCT01369745|1084689|P3|COMPLETED|Overall Study||16
442711|NCT01369745|1084690|P2|COMPLETED|Overall Study||28
442712|NCT01369745|1084691|P1|COMPLETED|Overall Study||25
442713|NCT01369745|1084687|P5|STARTED|Overall Study||83
442714|NCT01369745|1084688|P4|STARTED|Overall Study||84
442715|NCT01369745|1084689|P3|STARTED|Overall Study||18
442716|NCT01369745|1084690|P2|STARTED|Overall Study||41
442717|NCT01369745|1084691|P1|STARTED|Overall Study||32
442718|NCT01369732|1084725|P2|NOT COMPLETED|Overall Study||2
442719|NCT01369732|1084726|P1|NOT COMPLETED|Overall Study||4
442720|NCT01369732|1084725|P2|COMPLETED|Overall Study||31
442721|NCT01369732|1084726|P1|COMPLETED|Overall Study||29
442722|NCT01369732|1084725|P2|STARTED|Overall Study||33
442723|NCT01369732|1084726|P1|STARTED|Overall Study||33
442724|NCT01369706|1084732|P1|NOT COMPLETED|Overall Study||0
442725|NCT01369706|1084732|P1|COMPLETED|Overall Study||388
442726|NCT01369706|1084732|P1|STARTED|Overall Study||388
442727|NCT01369680|1084740|P4|NOT COMPLETED|Overall Study||2
442728|NCT01369680|1084741|P3|NOT COMPLETED|Overall Study||1
442729|NCT01369680|1084742|P2|NOT COMPLETED|Overall Study||0
442730|NCT01369680|1084743|P1|NOT COMPLETED|Overall Study||0
442731|NCT01369680|1084740|P4|COMPLETED|Overall Study||1
442732|NCT01369680|1084741|P3|COMPLETED|Overall Study||2
442733|NCT01369680|1084742|P2|COMPLETED|Overall Study||3
442734|NCT01369680|1084743|P1|COMPLETED|Overall Study||3
442735|NCT01369680|1084740|P4|STARTED|Overall Study||3
442736|NCT01369680|1084741|P3|STARTED|Overall Study||3
442737|NCT01369680|1084742|P2|STARTED|Overall Study||3
442738|NCT01369680|1084743|P1|STARTED|Overall Study||3
442739|NCT01369641|1084764|P1|NOT COMPLETED|Overall Study||1
442740|NCT01369641|1084764|P1|COMPLETED|Overall Study||0
442741|NCT01369641|1084764|P1|STARTED|Overall Study||1
442742|NCT01369615|1084770|P2|NOT COMPLETED|Overall Study||2
442743|NCT01369615|1084771|P1|NOT COMPLETED|Overall Study||0
442744|NCT01369615|1084770|P2|COMPLETED|Overall Study||12
442745|NCT01369615|1084771|P1|COMPLETED|Overall Study||9
442746|NCT01369615|1084770|P2|STARTED|Overall Study||14
442747|NCT01369615|1084771|P1|STARTED|Overall Study||9
442748|NCT01369511|1084781|P4|NOT COMPLETED|Overall Study||11
442749|NCT01369511|1084782|P3|NOT COMPLETED|Overall Study||11
442750|NCT01369511|1084783|P2|NOT COMPLETED|Overall Study||13
442751|NCT01369511|1084784|P1|NOT COMPLETED|Overall Study||13
442752|NCT01369511|1084781|P4|COMPLETED|Overall Study||89
442753|NCT01369511|1084782|P3|COMPLETED|Overall Study||87
442754|NCT01369511|1084783|P2|COMPLETED|Overall Study||91
442755|NCT01369511|1084784|P1|COMPLETED|Overall Study||85
442756|NCT01369511|1084781|P4|Received at Least 1 Dose of Study Drug|Overall Study||100
442757|NCT01369511|1084782|P3|Received at Least 1 Dose of Study Drug|Overall Study||98
442758|NCT01369511|1084783|P2|Received at Least 1 Dose of Study Drug|Overall Study|One participant was a screen failure and inadvertently randomized but did not receive study drug.|103
442759|NCT01369511|1084784|P1|Received at Least 1 Dose of Study Drug|Overall Study||98
442760|NCT01369511|1084781|P4|STARTED|Overall Study||100
442761|NCT01369511|1084782|P3|STARTED|Overall Study||98
442762|NCT01369511|1084783|P2|STARTED|Overall Study||104
442763|NCT01369511|1084784|P1|STARTED|Overall Study||98
442764|NCT01369485|1084800|P2|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||40
442765|NCT01369485|1084801|P1|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||33
442766|NCT01369485|1084800|P2|COMPLETED|Open Label Phase (Week 12 to Month 12)||26
442767|NCT01369485|1084801|P1|COMPLETED|Open Label Phase (Week 12 to Month 12)||24
442768|NCT01369485|1084800|P2|STARTED|Open Label Phase (Week 12 to Month 12)||66
442769|NCT01369485|1084801|P1|STARTED|Open Label Phase (Week 12 to Month 12)||57
442770|NCT01369485|1084800|P2|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||17
442771|NCT01369485|1084801|P1|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||23
442772|NCT01369485|1084800|P2|COMPLETED|Randomized Phase (Day 0 to Week 12)||66
442773|NCT01369485|1084801|P1|COMPLETED|Randomized Phase (Day 0 to Week 12)||57
442774|NCT01369485|1084800|P2|STARTED|Randomized Phase (Day 0 to Week 12)||83
442775|NCT01369485|1084801|P1|STARTED|Randomized Phase (Day 0 to Week 12)||80
442776|NCT01369355|1084847|P6|NOT COMPLETED|Overall Study||272
442777|NCT01369355|1084848|P5|NOT COMPLETED|Overall Study||154
442778|NCT01369355|1084849|P4|NOT COMPLETED|Overall Study||30
442779|NCT01369355|1084850|P3|NOT COMPLETED|Overall Study||31
442780|NCT01369355|1084851|P2|NOT COMPLETED|Overall Study||29
442781|NCT01369355|1084852|P1|NOT COMPLETED|Overall Study||31
442782|NCT01369355|1084847|P6|COMPLETED|Overall Study||204
442783|NCT01369355|1084848|P5|COMPLETED|Overall Study||131
442784|NCT01369355|1084849|P4|COMPLETED|Overall Study||93
442785|NCT01369355|1084850|P3|COMPLETED|Overall Study||101
442786|NCT01369355|1084851|P2|COMPLETED|Overall Study||103
442787|NCT01369355|1084852|P1|COMPLETED|Overall Study||102
442788|NCT01369355|1084847|P6|Treated|Overall Study||476
442789|NCT01369355|1084848|P5|Treated|Overall Study||285
442790|NCT01369355|1084849|P4|Treated|Overall Study||123
442791|NCT01369355|1084850|P3|Treated|Overall Study||131
442792|NCT01369355|1084851|P2|Treated|Overall Study||132
442793|NCT01369355|1084852|P1|Treated|Overall Study||133
442794|NCT01369355|1084847|P6|STARTED|Overall Study||476
442795|NCT01369355|1084848|P5|STARTED|Overall Study||285
442796|NCT01369355|1084849|P4|STARTED|Overall Study||123
442797|NCT01369355|1084850|P3|STARTED|Overall Study||132
442798|NCT01369355|1084851|P2|STARTED|Overall Study||132
442799|NCT01369355|1084852|P1|STARTED|Overall Study||133
442800|NCT01369342|1084881|P3|NOT COMPLETED|Overall Study||3
442801|NCT01369342|1084882|P2|NOT COMPLETED|Overall Study||9
442802|NCT01369342|1084883|P1|NOT COMPLETED|Overall Study||13
442803|NCT01369342|1084881|P3|COMPLETED|Overall Study||210
442804|NCT01369342|1084882|P2|COMPLETED|Overall Study||204
442805|NCT01369342|1084883|P1|COMPLETED|Overall Study||201
442806|NCT01369342|1084881|P3|STARTED|Overall Study||213
442807|NCT01369342|1084882|P2|STARTED|Overall Study||213
442808|NCT01369342|1084883|P1|STARTED|Overall Study||214
442809|NCT01369329|1084906|P3|NOT COMPLETED|Overall Study||14
442810|NCT01369329|1084907|P2|NOT COMPLETED|Overall Study||11
442811|NCT01369329|1084908|P1|NOT COMPLETED|Overall Study||12
442812|NCT01369329|1084906|P3|COMPLETED|Overall Study||245
442813|NCT01369329|1084907|P2|COMPLETED|Overall Study||243
442814|NCT01369329|1084908|P1|COMPLETED|Overall Study||244
442815|NCT01369329|1084906|P3|STARTED|Overall Study||259
442816|NCT01369329|1084907|P2|STARTED|Overall Study||254
442817|NCT01369329|1084908|P1|STARTED|Overall Study||256
442818|NCT01369225|1084934|P6|NOT COMPLETED|Overall Study||0
442819|NCT01369225|1084935|P5|NOT COMPLETED|Overall Study||2
442820|NCT01369225|1084936|P4|NOT COMPLETED|Overall Study||2
442821|NCT01369225|1084937|P3|NOT COMPLETED|Overall Study||3
442822|NCT01369225|1084938|P2|NOT COMPLETED|Overall Study||0
442823|NCT01369225|1084939|P1|NOT COMPLETED|Overall Study||2
442824|NCT01369225|1084934|P6|COMPLETED|Overall Study||9
442825|NCT01369225|1084935|P5|COMPLETED|Overall Study||10
442826|NCT01369225|1084936|P4|COMPLETED|Overall Study||8
442827|NCT01369225|1084937|P3|COMPLETED|Overall Study||9
442828|NCT01369225|1084938|P2|COMPLETED|Overall Study||3
442829|NCT01369225|1084939|P1|COMPLETED|Overall Study||4
442830|NCT01369225|1084934|P6|STARTED|Overall Study||9
442831|NCT01369225|1084935|P5|STARTED|Overall Study||12
442832|NCT01369225|1084936|P4|STARTED|Overall Study||10
442833|NCT01369225|1084937|P3|STARTED|Overall Study||12
442834|NCT01369225|1084938|P2|STARTED|Overall Study||3
442835|NCT01369225|1084939|P1|STARTED|Overall Study||6
442836|NCT01369108|1085031|P1|NOT COMPLETED|Overall Study||11
442837|NCT01369108|1085031|P1|COMPLETED|Overall Study||49
442838|NCT01369108|1085031|P1|STARTED|Overall Study|120 teeth|60
442839|NCT01369030|1085038|P1|NOT COMPLETED|Overall Study||40
442840|NCT01369030|1085038|P1|COMPLETED|Overall Study||554
442841|NCT01369030|1085038|P1|STARTED|Overall Study||594
442842|NCT01368965|1085044|P1|NOT COMPLETED|Overall Study||12
442843|NCT01368965|1085044|P1|COMPLETED|Overall Study||40
442844|NCT01368965|1085044|P1|Subject Withdrawal Prior to Treatment|Overall Study||2
442845|NCT01368965|1085044|P1|STARTED|Overall Study|Two subjects withdrew consent prior to study treatment. Data analyses are based on 52 subjects.|52
442846|NCT01368900|1085053|P1|NOT COMPLETED|Overall Study||7
442847|NCT01368900|1085053|P1|COMPLETED|Overall Study||61
442848|NCT01368900|1085053|P1|STARTED|Overall Study||68
442849|NCT01368874|1085066|P3|NOT COMPLETED|Overall Study||1
442850|NCT01368874|1085067|P2|NOT COMPLETED|Overall Study||0
442851|NCT01368874|1085068|P1|NOT COMPLETED|Overall Study||3
442852|NCT01368874|1085066|P3|COMPLETED|Overall Study||24
442853|NCT01368874|1085067|P2|COMPLETED|Overall Study||5
442854|NCT01368874|1085068|P1|COMPLETED|Overall Study||31
442855|NCT01368874|1085066|P3|STARTED|Overall Study||25
442856|NCT01368874|1085067|P2|STARTED|Overall Study||5
442857|NCT01368874|1085068|P1|STARTED|Overall Study||34
442858|NCT01368835|1085128|P1|NOT COMPLETED|Overall Study||33
442859|NCT01368835|1085128|P1|COMPLETED|Overall Study||70
442860|NCT01368835|1085128|P1|STARTED|Overall Study|103 Subjects Enrolled|103
442861|NCT01368809|1085137|P2|NOT COMPLETED|Overall Study||0
442862|NCT01368809|1085138|P1|NOT COMPLETED|Overall Study||0
442863|NCT01368809|1085137|P2|COMPLETED|Overall Study||50
442864|NCT01368809|1085138|P1|COMPLETED|Overall Study||50
442865|NCT01368809|1085137|P2|STARTED|Overall Study||50
442866|NCT01368809|1085138|P1|STARTED|Overall Study||50
442867|NCT01368653|1085150|P2|NOT COMPLETED|Overall Study||9
442868|NCT01368653|1085151|P1|NOT COMPLETED|Overall Study||6
442869|NCT01368653|1085150|P2|COMPLETED|Overall Study||37
442870|NCT01368653|1085151|P1|COMPLETED|Overall Study||41
442871|NCT01368653|1085150|P2|Randomized to Advice Only in Phase 2|Overall Study||10
442872|NCT01368653|1085151|P1|Randomized to Advice Only in Phase 2|Overall Study||10
442873|NCT01368653|1085150|P2|Randomized to VLNC in Phase 2|Overall Study|VLNC=6-week supply of Very Low Nicotine Cigarettes plus Advice to Quit (vs. Advice Only)|9
442874|NCT01368653|1085151|P1|Randomized to VLNC in Phase 2|Overall Study|VLNC=6-week supply of Very Low Nicotine Cigarettes plus Advice to Quit (vs. Advice Only)|11
442875|NCT01368653|1085150|P2|Randomized to Phase 2|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|19
442876|NCT01368653|1085151|P1|Randomized to Phase 2|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|21
442877|NCT01368653|1085150|P2|Smoked in Past 7 Days at 4-weeks|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|20
442878|NCT01368653|1085151|P1|Smoked in Past 7 Days at 4-weeks|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|29
442879|NCT01368653|1085150|P2|Completed 4-week Follow-up|Overall Study||37
442880|NCT01368653|1085151|P1|Completed 4-week Follow-up|Overall Study||44
442881|NCT01368653|1085150|P2|STARTED|Overall Study||46
442882|NCT01368653|1085151|P1|STARTED|Overall Study||47
442883|NCT01368536|1085170|P3|NOT COMPLETED|Overall Study||59
442884|NCT01368536|1085171|P2|NOT COMPLETED|Overall Study||59
442885|NCT01368536|1085172|P1|NOT COMPLETED|Overall Study||51
442886|NCT01368536|1085170|P3|COMPLETED|Overall Study||83
442887|NCT01368536|1085171|P2|COMPLETED|Overall Study||78
442888|NCT01368536|1085172|P1|COMPLETED|Overall Study||87
442889|NCT01368536|1085170|P3|Full Analysis Set|Overall Study|One patient was excluded from efficacy analysis as there was no post baseline data|141
442890|NCT01368536|1085171|P2|Full Analysis Set|Overall Study||137
442891|NCT01368536|1085172|P1|Full Analysis Set|Overall Study||138
442892|NCT01368536|1085170|P3|STARTED|Overall Study||142
442893|NCT01368536|1085171|P2|STARTED|Overall Study||137
442894|NCT01368536|1085172|P1|STARTED|Overall Study||138
442895|NCT01368432|1085195|P2|NOT COMPLETED|Overall Study||1
442896|NCT01368432|1085196|P1|NOT COMPLETED|Overall Study||0
442897|NCT01368432|1085195|P2|COMPLETED|Overall Study||7
442898|NCT01368432|1085196|P1|COMPLETED|Overall Study||6
442899|NCT01368432|1085195|P2|STARTED|Overall Study||8
442900|NCT01368432|1085196|P1|STARTED|Overall Study||6
442901|NCT01368406|1085230|P2|NOT COMPLETED|Overall Study||13
442902|NCT01368406|1085231|P1|NOT COMPLETED|Overall Study||21
442903|NCT01368406|1085230|P2|COMPLETED|Overall Study||66
442904|NCT01368406|1085231|P1|COMPLETED|Overall Study||60
442905|NCT01368406|1085230|P2|STARTED|Overall Study||79
442906|NCT01368406|1085231|P1|STARTED|Overall Study||81
442907|NCT01368276|1085239|P2|NOT COMPLETED|Overall Study||10
442908|NCT01368276|1085240|P1|NOT COMPLETED|Overall Study||1
442909|NCT01368276|1085239|P2|COMPLETED|Overall Study||18
442910|NCT01368276|1085240|P1|COMPLETED|Overall Study||2
442911|NCT01368276|1085239|P2|STARTED|Overall Study||28
442912|NCT01368276|1085240|P1|STARTED|Overall Study||3
442913|NCT01368263|1085253|P3|NOT COMPLETED|Overall Study||0
442914|NCT01368263|1085254|P2|NOT COMPLETED|Overall Study||0
442915|NCT01368263|1085255|P1|NOT COMPLETED|Overall Study||0
442916|NCT01368263|1085253|P3|COMPLETED|Overall Study||1
442917|NCT01368263|1085254|P2|COMPLETED|Overall Study||1
442918|NCT01368263|1085255|P1|COMPLETED|Overall Study||6
442919|NCT01368263|1085253|P3|STARTED|Overall Study||1
442920|NCT01368263|1085254|P2|STARTED|Overall Study||1
442921|NCT01368263|1085255|P1|STARTED|Overall Study||6
442922|NCT01368211|1085277|P2|NOT COMPLETED|Second Platelets Transfusion||2
442923|NCT01368211|1085278|P1|NOT COMPLETED|Second Platelets Transfusion||1
442924|NCT01368211|1085277|P2|COMPLETED|Second Platelets Transfusion||5
442925|NCT01368211|1085278|P1|COMPLETED|Second Platelets Transfusion||7
442926|NCT01368211|1085277|P2|STARTED|Second Platelets Transfusion||7
442927|NCT01368211|1085278|P1|STARTED|Second Platelets Transfusion||8
442928|NCT01368211|1085277|P2|NOT COMPLETED|First Platelets Transfusion||0
442929|NCT01368211|1085278|P1|NOT COMPLETED|First Platelets Transfusion||0
442930|NCT01368211|1085277|P2|COMPLETED|First Platelets Transfusion||7
442931|NCT01368211|1085278|P1|COMPLETED|First Platelets Transfusion||8
442932|NCT01368211|1085277|P2|STARTED|First Platelets Transfusion||7
442933|NCT01368211|1085278|P1|STARTED|First Platelets Transfusion||8
442934|NCT01368185|1085286|P1|NOT COMPLETED|Overall Study||0
442935|NCT01368185|1085286|P1|COMPLETED|Overall Study||1705
442936|NCT01368185|1085286|P1|STARTED|Overall Study||1705
442937|NCT01368081|1085306|P13|NOT COMPLETED|Overall Study||7
442938|NCT01368081|1085307|P12|NOT COMPLETED|Overall Study||3
442939|NCT01368081|1085308|P11|NOT COMPLETED|Overall Study||9
442940|NCT01368081|1085309|P10|NOT COMPLETED|Overall Study||10
442941|NCT01368081|1085310|P9|NOT COMPLETED|Overall Study||8
442942|NCT01368081|1085311|P8|NOT COMPLETED|Overall Study||7
442943|NCT01368081|1085312|P7|NOT COMPLETED|Overall Study||12
442944|NCT01368081|1085313|P6|NOT COMPLETED|Overall Study||10
442945|NCT01368081|1085314|P5|NOT COMPLETED|Overall Study||2
442946|NCT01368081|1085315|P4|NOT COMPLETED|Overall Study||5
442947|NCT01368081|1085316|P3|NOT COMPLETED|Overall Study||4
442948|NCT01368081|1085317|P2|NOT COMPLETED|Overall Study||9
442949|NCT01368081|1085318|P1|NOT COMPLETED|Overall Study||10
442950|NCT01368081|1085306|P13|COMPLETED|Overall Study||63
442951|NCT01368081|1085307|P12|COMPLETED|Overall Study||67
442952|NCT01368081|1085308|P11|COMPLETED|Overall Study||62
442953|NCT01368081|1085309|P10|COMPLETED|Overall Study||58
442954|NCT01368081|1085310|P9|COMPLETED|Overall Study||62
442955|NCT01368081|1085311|P8|COMPLETED|Overall Study||62
442956|NCT01368081|1085312|P7|COMPLETED|Overall Study||124
442957|NCT01368081|1085313|P6|COMPLETED|Overall Study||127
442958|NCT01368081|1085314|P5|COMPLETED|Overall Study||63
442959|NCT01368081|1085315|P4|COMPLETED|Overall Study||63
442960|NCT01368081|1085316|P3|COMPLETED|Overall Study||59
442961|NCT01368081|1085317|P2|COMPLETED|Overall Study||128
442962|NCT01368081|1085318|P1|COMPLETED|Overall Study||126
442963|NCT01368081|1085306|P13|STARTED|Overall Study||70
442964|NCT01368081|1085307|P12|STARTED|Overall Study||70
442965|NCT01368081|1085308|P11|STARTED|Overall Study||71
442966|NCT01368081|1085309|P10|STARTED|Overall Study||68
442967|NCT01368081|1085310|P9|STARTED|Overall Study||70
442968|NCT01368081|1085311|P8|STARTED|Overall Study||69
442969|NCT01368081|1085312|P7|STARTED|Overall Study||136
442970|NCT01368081|1085313|P6|STARTED|Overall Study||137
442971|NCT01368081|1085314|P5|STARTED|Overall Study||65
442972|NCT01368081|1085315|P4|STARTED|Overall Study||68
442973|NCT01368081|1085316|P3|STARTED|Overall Study||63
442974|NCT01368081|1085317|P2|STARTED|Overall Study||137
442975|NCT01368081|1085318|P1|STARTED|Overall Study||136
442976|NCT01368042|1085372|P1|NOT COMPLETED|Overall Study||30
442977|NCT01368042|1085372|P1|COMPLETED|Overall Study||235
442978|NCT01368042|1085372|P1|STARTED|Overall Study||265
442979|NCT01367886|1085392|P1|NOT COMPLETED|Overall Study||7
442980|NCT01367886|1085392|P1|COMPLETED|Overall Study||14
442981|NCT01367886|1085392|P1|STARTED|Overall Study||21
442982|NCT01367860|1085401|P2|NOT COMPLETED|Overall Study||0
442983|NCT01367860|1085402|P1|NOT COMPLETED|Overall Study||0
442984|NCT01367860|1085401|P2|COMPLETED|Overall Study||20
442985|NCT01367860|1085402|P1|COMPLETED|Overall Study||20
442986|NCT01367860|1085401|P2|STARTED|Overall Study||20
442987|NCT01367860|1085402|P1|STARTED|Overall Study||20
442988|NCT01367834|1085442|P2|NOT COMPLETED|Overall Study||3
442989|NCT01367834|1085443|P1|NOT COMPLETED|Overall Study||2
442990|NCT01367834|1085442|P2|COMPLETED|Overall Study||3
442991|NCT01367834|1085443|P1|COMPLETED|Overall Study||9
442992|NCT01367834|1085442|P2|STARTED|Overall Study||6
442993|NCT01367834|1085443|P1|STARTED|Overall Study||11
442994|NCT01367704|1085467|P2|NOT COMPLETED|Overall Study||161
442995|NCT01367704|1085468|P1|NOT COMPLETED|Overall Study||47
442996|NCT01367704|1085467|P2|COMPLETED|Overall Study||847
442997|NCT01367704|1085468|P1|COMPLETED|Overall Study||951
442998|NCT01367704|1085467|P2|STARTED|Overall Study||1008
442999|NCT01367704|1085468|P1|STARTED|Overall Study||998
443000|NCT01367457|1085481|P3|NOT COMPLETED|Overall Study||0
443001|NCT01367457|1085482|P2|NOT COMPLETED|Overall Study||0
443002|NCT01367457|1085483|P1|NOT COMPLETED|Overall Study||188
443003|NCT01367457|1085481|P3|COMPLETED|Overall Study||26
443004|NCT01367457|1085482|P2|COMPLETED|Overall Study||23
443005|NCT01367457|1085483|P1|COMPLETED|Overall Study||5
443006|NCT01367457|1085481|P3|STARTED|Overall Study||26
443007|NCT01367457|1085482|P2|STARTED|Overall Study||23
443008|NCT01367457|1085483|P1|STARTED|Overall Study||193
443009|NCT01367249|1085505|P2|NOT COMPLETED|Overall Study||16
443010|NCT01367249|1085506|P1|NOT COMPLETED|Overall Study||9
443011|NCT01367249|1085505|P2|COMPLETED|Overall Study||202
443012|NCT01367249|1085506|P1|COMPLETED|Overall Study||213
443013|NCT01367249|1085505|P2|STARTED|Overall Study||218
443014|NCT01367249|1085506|P1|STARTED|Overall Study||222
443015|NCT01367158|1085525|P11|NOT COMPLETED|Overall Study||1
443016|NCT01367158|1085526|P10|NOT COMPLETED|Overall Study||0
443017|NCT01367158|1085527|P9|NOT COMPLETED|Overall Study||0
443018|NCT01367158|1085528|P8|NOT COMPLETED|Overall Study||2
443019|NCT01367158|1085529|P7|NOT COMPLETED|Overall Study||0
443020|NCT01367158|1085530|P6|NOT COMPLETED|Overall Study||2
443021|NCT01367158|1085531|P5|NOT COMPLETED|Overall Study||2
443022|NCT01367158|1085532|P4|NOT COMPLETED|Overall Study||1
443023|NCT01367158|1085533|P3|NOT COMPLETED|Overall Study||1
443024|NCT01367158|1085534|P2|NOT COMPLETED|Overall Study||3
443025|NCT01367158|1085535|P1|NOT COMPLETED|Overall Study||0
443026|NCT01367158|1085525|P11|COMPLETED|Overall Study||72
443027|NCT01367158|1085526|P10|COMPLETED|Overall Study||50
443028|NCT01367158|1085527|P9|COMPLETED|Overall Study||23
443029|NCT01367158|1085528|P8|COMPLETED|Overall Study||47
443030|NCT01367158|1085529|P7|COMPLETED|Overall Study||25
443031|NCT01367158|1085530|P6|COMPLETED|Overall Study||46
443032|NCT01367158|1085531|P5|COMPLETED|Overall Study||23
443033|NCT01367158|1085532|P4|COMPLETED|Overall Study||48
443034|NCT01367158|1085533|P3|COMPLETED|Overall Study||23
443035|NCT01367158|1085534|P2|COMPLETED|Overall Study||46
443036|NCT01367158|1085535|P1|COMPLETED|Overall Study||25
443037|NCT01367158|1085525|P11|STARTED|Overall Study||73
443038|NCT01367158|1085526|P10|STARTED|Overall Study||50
443039|NCT01367158|1085527|P9|STARTED|Overall Study||23
443040|NCT01367158|1085528|P8|STARTED|Overall Study||49
443041|NCT01367158|1085529|P7|STARTED|Overall Study||25
443042|NCT01367158|1085530|P6|STARTED|Overall Study||48
443043|NCT01367158|1085531|P5|STARTED|Overall Study||25
443044|NCT01367158|1085532|P4|STARTED|Overall Study||49
443045|NCT01367158|1085533|P3|STARTED|Overall Study||24
443046|NCT01367158|1085534|P2|STARTED|Overall Study||49
443047|NCT01367158|1085535|P1|STARTED|Overall Study||25
443048|NCT01367119|1085679|P2|NOT COMPLETED|Overall Study||1
443049|NCT01367119|1085680|P1|NOT COMPLETED|Overall Study||2
443050|NCT01367119|1085679|P2|COMPLETED|Overall Study||16
443051|NCT01367119|1085680|P1|COMPLETED|Overall Study||19
443052|NCT01367119|1085679|P2|STARTED|Overall Study||17
443053|NCT01367119|1085680|P1|STARTED|Overall Study||21
443054|NCT01367080|1085692|P2|NOT COMPLETED|2nd Administration||0
443055|NCT01367080|1085693|P1|NOT COMPLETED|2nd Administration||0
443056|NCT01367080|1085692|P2|COMPLETED|2nd Administration||6
443057|NCT01367080|1085693|P1|COMPLETED|2nd Administration||6
443058|NCT01367080|1085692|P2|STARTED|2nd Administration||6
443059|NCT01367080|1085693|P1|STARTED|2nd Administration||6
443060|NCT01367080|1085692|P2|NOT COMPLETED|1st Administration||0
443061|NCT01367080|1085693|P1|NOT COMPLETED|1st Administration||0
443062|NCT01367080|1085692|P2|COMPLETED|1st Administration||6
443063|NCT01367080|1085693|P1|COMPLETED|1st Administration||6
443064|NCT01367080|1085692|P2|STARTED|1st Administration||6
443065|NCT01367080|1085693|P1|STARTED|1st Administration||6
443066|NCT01366976|1085707|P2|NOT COMPLETED|Overall Study||0
443067|NCT01366976|1085708|P1|NOT COMPLETED|Overall Study||0
443068|NCT01366976|1085707|P2|COMPLETED|Overall Study||30
443069|NCT01366976|1085708|P1|COMPLETED|Overall Study||30
443070|NCT01366976|1085707|P2|STARTED|Overall Study||30
443071|NCT01366976|1085708|P1|STARTED|Overall Study||30
443072|NCT01366885|1085720|P1|NOT COMPLETED|Overall Study||1
443073|NCT01366885|1085720|P1|COMPLETED|Overall Study|We completed our study when the last child born had reached 36 months of age.|19
443074|NCT01366885|1085720|P1|STARTED|Overall Study|We started recruiting in February 2008 and recruited 20 mothers.|20
443075|NCT01366872|1085725|P1|NOT COMPLETED|Overall Study||0
443076|NCT01366872|1085725|P1|COMPLETED|Overall Study||50
443077|NCT01366872|1085725|P1|STARTED|Overall Study||50
443078|NCT01366846|1085735|P4|NOT COMPLETED|Overall Study||1
443079|NCT01366846|1085736|P3|NOT COMPLETED|Overall Study||1
443080|NCT01366846|1085737|P2|NOT COMPLETED|Overall Study||4
443081|NCT01366846|1085738|P1|NOT COMPLETED|Overall Study||3
443082|NCT01366846|1085735|P4|COMPLETED|Overall Study||45
443083|NCT01366846|1085736|P3|COMPLETED|Overall Study||46
443084|NCT01366846|1085737|P2|COMPLETED|Overall Study||224
443085|NCT01366846|1085738|P1|COMPLETED|Overall Study||232
443086|NCT01366846|1085735|P4|STARTED|Overall Study||46
443087|NCT01366846|1085736|P3|STARTED|Overall Study||47
443088|NCT01366846|1085737|P2|STARTED|Overall Study||228
443089|NCT01366846|1085738|P1|STARTED|Overall Study||235
443090|NCT01366638|1085761|P3|NOT COMPLETED|Overall Study||6
443091|NCT01366638|1085762|P2|NOT COMPLETED|Overall Study||0
443092|NCT01366638|1085763|P1|NOT COMPLETED|Overall Study||1
443093|NCT01366638|1085761|P3|COMPLETED|Overall Study||20
443094|NCT01366638|1085762|P2|COMPLETED|Overall Study||29
443095|NCT01366638|1085763|P1|COMPLETED|Overall Study||23
443096|NCT01366638|1085761|P3|STARTED|Overall Study||26
443097|NCT01366638|1085762|P2|STARTED|Overall Study||29
443098|NCT01366638|1085763|P1|STARTED|Overall Study||24
443099|NCT01366534|1085800|P3|NOT COMPLETED|Overall Study||0
443100|NCT01366534|1085801|P2|NOT COMPLETED|Overall Study||2
443101|NCT01366534|1085802|P1|NOT COMPLETED|Overall Study||2
443102|NCT01366534|1085800|P3|COMPLETED|Overall Study||12
443103|NCT01366534|1085801|P2|COMPLETED|Overall Study||25
443104|NCT01366534|1085802|P1|COMPLETED|Overall Study||26
443105|NCT01366534|1085800|P3|STARTED|Overall Study||12
443106|NCT01366534|1085801|P2|STARTED|Overall Study||27
443107|NCT01366534|1085802|P1|STARTED|Overall Study||28
443108|NCT01366521|1085852|P4|NOT COMPLETED|Overall Study||0
443109|NCT01366521|1085853|P3|NOT COMPLETED|Overall Study||2
443110|NCT01366521|1085854|P2|NOT COMPLETED|Overall Study||1
443111|NCT01366521|1085855|P1|NOT COMPLETED|Overall Study||1
443112|NCT01366521|1085852|P4|COMPLETED|Overall Study||11
443113|NCT01366521|1085853|P3|COMPLETED|Overall Study||21
443114|NCT01366521|1085854|P2|COMPLETED|Overall Study||14
443115|NCT01366521|1085855|P1|COMPLETED|Overall Study||20
443116|NCT01366521|1085852|P4|STARTED|Overall Study||11
443117|NCT01366521|1085853|P3|STARTED|Overall Study||23
443118|NCT01366521|1085854|P2|STARTED|Overall Study||15
443119|NCT01366521|1085855|P1|STARTED|Overall Study||21
443120|NCT01366443|1085930|P1|NOT COMPLETED|Overall Study||3
443121|NCT01366443|1085930|P1|COMPLETED|Overall Study||285
443122|NCT01366443|1085930|P1|STARTED|Overall Study||288
443123|NCT01366417|1085935|P1|NOT COMPLETED|Overall Study||18
443124|NCT01366417|1085935|P1|COMPLETED|Overall Study|25 subjects included in the analysis|25
443125|NCT01366417|1085935|P1|Excluded From Analysis|Overall Study|3 subjects did not have qualifying Treatment Day microbial counts and were excluded from analysis|3
443126|NCT01366417|1085935|P1|Discontinued Prior to Treatment|Overall Study|5 eligible subjects were not treated because enrollment target of 25 was met and enrollment closed.|5
443127|NCT01366417|1085935|P1|Completed the Study|Overall Study|treatment baseline microbial counts not available until after treatment; subjects not evaluable|28
443128|NCT01366417|1085935|P1|Completed Treatment Visit|Overall Study|28 subjects were treated with ChloraPrep and 70% Isopropyl Alcohol (single topical treatment)|28
443129|NCT01366417|1085935|P1|Completed Screen Visit|Overall Study|33 subjects had qualifying screening bacterial counts and were eligible for the Treatment Visit|33
443130|NCT01366417|1085935|P1|Signed Informed Consent|Overall Study|Microbial samples were taken from 43 subjects for screening baseline.|43
443131|NCT01366417|1085935|P1|STARTED|Overall Study||43
443132|NCT01366209|1085944|P2|NOT COMPLETED|Overall Study||36
443133|NCT01366209|1085945|P1|NOT COMPLETED|Overall Study||35
443134|NCT01366209|1085944|P2|COMPLETED|Overall Study||241
443135|NCT01366209|1085945|P1|COMPLETED|Overall Study|Participants completing study assessment at Week 52 were completers, even if treatment was withdrawn|243
443136|NCT01366209|1085944|P2|STARTED|Overall Study||277
443137|NCT01366209|1085945|P1|STARTED|Overall Study||278
443138|NCT01366196|1085953|P2|NOT COMPLETED|Overall Study||0
443139|NCT01366196|1085954|P1|NOT COMPLETED|Overall Study||0
443140|NCT01366196|1085953|P2|COMPLETED|Overall Study||43
443141|NCT01366196|1085954|P1|COMPLETED|Overall Study||43
443142|NCT01366196|1085953|P2|STARTED|Overall Study||43
443143|NCT01366196|1085954|P1|STARTED|Overall Study||43
443144|NCT01366092|1085968|P1|NOT COMPLETED|Overall Study||4
443145|NCT01366092|1085968|P1|COMPLETED|Overall Study||31
443146|NCT01366092|1085968|P1|STARTED|Overall Study||35
443147|NCT01365910|1085977|P1|NOT COMPLETED|Overall Study||30
443148|NCT01365910|1085977|P1|COMPLETED|Overall Study||0
443149|NCT01365910|1085977|P1|STARTED|Overall Study||30
443168|NCT01365819|1085993|P2|NOT COMPLETED|Overall Study||13
443169|NCT01365819|1085994|P1|NOT COMPLETED|Overall Study||13
443170|NCT01365819|1085993|P2|COMPLETED|Overall Study||14
443171|NCT01365819|1085994|P1|COMPLETED|Overall Study||12
443172|NCT01365819|1085993|P2|STARTED|Overall Study||27
443173|NCT01365819|1085994|P1|STARTED|Overall Study||25
443174|NCT01365793|1086012|P4|NOT COMPLETED|Overall Study||2
443175|NCT01365793|1086013|P3|NOT COMPLETED|Overall Study||7
443176|NCT01365793|1086014|P2|NOT COMPLETED|Overall Study||7
443177|NCT01365793|1086015|P1|NOT COMPLETED|Overall Study||2
443178|NCT01365793|1086012|P4|COMPLETED|Overall Study||347
443179|NCT01365793|1086013|P3|COMPLETED|Overall Study||338
443180|NCT01365793|1086014|P2|COMPLETED|Overall Study||344
443181|NCT01365793|1086015|P1|COMPLETED|Overall Study||342
443182|NCT01365793|1086012|P4|STARTED|Overall Study||349
443183|NCT01365793|1086013|P3|STARTED|Overall Study||345
443184|NCT01365793|1086014|P2|STARTED|Overall Study||351
443185|NCT01365793|1086015|P1|STARTED|Overall Study||344
443186|NCT01365650|1086041|P1|NOT COMPLETED|Treatment C||0
443187|NCT01365650|1086041|P1|COMPLETED|Treatment C||24
443188|NCT01365650|1086041|P1|STARTED|Treatment C||24
443189|NCT01365650|1086041|P1|NOT COMPLETED|Treatment B||0
443190|NCT01365650|1086041|P1|COMPLETED|Treatment B||24
443191|NCT01365650|1086041|P1|STARTED|Treatment B||24
443192|NCT01365650|1086041|P1|NOT COMPLETED|Treatment A||0
443193|NCT01365650|1086041|P1|COMPLETED|Treatment A||24
443194|NCT01365650|1086041|P1|STARTED|Treatment A||24
443195|NCT01365624|1086066|P2|NOT COMPLETED|Overall Study||0
443196|NCT01365624|1086067|P1|NOT COMPLETED|Overall Study||0
443197|NCT01365624|1086066|P2|COMPLETED|Overall Study||15
443198|NCT01365624|1086067|P1|COMPLETED|Overall Study||15
443199|NCT01365624|1086066|P2|STARTED|Overall Study||15
443200|NCT01365624|1086067|P1|STARTED|Overall Study||15
443201|NCT01365611|1086083|P1|NOT COMPLETED|Overall Study||0
443202|NCT01365611|1086083|P1|COMPLETED|Overall Study||36
443203|NCT01365611|1086083|P1|STARTED|Overall Study||36
443204|NCT01365585|1086099|P1|NOT COMPLETED|Overall Study||0
443205|NCT01365585|1086099|P1|COMPLETED|Overall Study||227
443206|NCT01365585|1086099|P1|STARTED|Overall Study||227
443207|NCT01365546|1086113|P1|NOT COMPLETED|Overall Study||11
443208|NCT01365546|1086113|P1|COMPLETED|Overall Study||30
443209|NCT01365546|1086113|P1|STARTED|Overall Study|in this study 41 patients were screened but only 30 patients completed the study.|41
443210|NCT01365507|1086123|P2|NOT COMPLETED|Overall Study||9
443211|NCT01365507|1086124|P1|NOT COMPLETED|Overall Study||9
443212|NCT01365507|1086123|P2|COMPLETED|Overall Study||131
443213|NCT01365507|1086124|P1|COMPLETED|Overall Study||127
443214|NCT01365507|1086123|P2|Exposed|Overall Study||140
443215|NCT01365507|1086124|P1|Exposed|Overall Study|Two subjects withdrew before exposure to trial drug|134
443216|NCT01365507|1086123|P2|STARTED|Overall Study||140
443217|NCT01365507|1086124|P1|STARTED|Overall Study||136
443218|NCT01365494|1086140|P2|NOT COMPLETED|Overall Study||3
443219|NCT01365494|1086141|P1|NOT COMPLETED|Overall Study||2
443220|NCT01365494|1086140|P2|COMPLETED|Overall Study||121
443221|NCT01365494|1086141|P1|COMPLETED|Overall Study||124
443222|NCT01365494|1086140|P2|STARTED|Overall Study||124
443223|NCT01365494|1086141|P1|STARTED|Overall Study||126
443224|NCT01365481|1086157|P4|NOT COMPLETED|Overall Study||7
443225|NCT01365481|1086158|P3|NOT COMPLETED|Overall Study||4
443226|NCT01365481|1086159|P2|NOT COMPLETED|Overall Study||15
443227|NCT01365481|1086160|P1|NOT COMPLETED|Overall Study||7
443228|NCT01365481|1086157|P4|COMPLETED|Overall Study||50
443229|NCT01365481|1086158|P3|COMPLETED|Overall Study||14
443230|NCT01365481|1086159|P2|COMPLETED|Overall Study||37
443231|NCT01365481|1086160|P1|COMPLETED|Overall Study||16
443232|NCT01365481|1086157|P4|STARTED|Overall Study||57
443233|NCT01365481|1086158|P3|STARTED|Overall Study||18
443234|NCT01365481|1086159|P2|STARTED|Overall Study||52
443235|NCT01365481|1086160|P1|STARTED|Overall Study||23
443236|NCT01365468|1086180|P2|NOT COMPLETED|Overall Study||0
443237|NCT01365468|1086181|P1|NOT COMPLETED|Overall Study||4
443238|NCT01365468|1086180|P2|COMPLETED|Overall Study||5
443239|NCT01365468|1086181|P1|COMPLETED|Overall Study||0
443240|NCT01365468|1086180|P2|STARTED|Overall Study||5
443241|NCT01365468|1086181|P1|STARTED|Overall Study||4
443242|NCT01365455|1086196|P5|NOT COMPLETED|Follow-up Period||0
443243|NCT01365455|1086197|P4|NOT COMPLETED|Follow-up Period||0
443244|NCT01365455|1086198|P3|NOT COMPLETED|Follow-up Period||0
443245|NCT01365455|1086199|P2|NOT COMPLETED|Follow-up Period||0
443246|NCT01365455|1086200|P1|NOT COMPLETED|Follow-up Period||0
443247|NCT01365455|1086196|P5|COMPLETED|Follow-up Period||0
443248|NCT01365455|1086197|P4|COMPLETED|Follow-up Period||0
443249|NCT01365455|1086198|P3|COMPLETED|Follow-up Period||18
443250|NCT01365455|1086199|P2|COMPLETED|Follow-up Period||47
443251|NCT01365455|1086200|P1|COMPLETED|Follow-up Period||58
443252|NCT01365455|1086196|P5|STARTED|Follow-up Period||0
443253|NCT01365455|1086197|P4|STARTED|Follow-up Period||0
443254|NCT01365455|1086198|P3|STARTED|Follow-up Period||18
443255|NCT01365455|1086199|P2|STARTED|Follow-up Period||47
443256|NCT01365455|1086200|P1|STARTED|Follow-up Period||58
443257|NCT01365455|1086196|P5|NOT COMPLETED|Maintenance Period||13
443258|NCT01365455|1086197|P4|NOT COMPLETED|Maintenance Period||9
443259|NCT01365455|1086198|P3|NOT COMPLETED|Maintenance Period||3
443260|NCT01365455|1086199|P2|NOT COMPLETED|Maintenance Period||23
443261|NCT01365455|1086200|P1|NOT COMPLETED|Maintenance Period||29
443262|NCT01365455|1086196|P5|COMPLETED|Maintenance Period||92
443263|NCT01365455|1086197|P4|COMPLETED|Maintenance Period||100
443264|NCT01365455|1086198|P3|COMPLETED|Maintenance Period||15
443265|NCT01365455|1086199|P2|COMPLETED|Maintenance Period||215
443266|NCT01365455|1086200|P1|COMPLETED|Maintenance Period||201
443267|NCT01365455|1086196|P5|STARTED|Maintenance Period||105
443268|NCT01365455|1086197|P4|STARTED|Maintenance Period||109
443269|NCT01365455|1086198|P3|STARTED|Maintenance Period||18
443270|NCT01365455|1086199|P2|STARTED|Maintenance Period||238
443271|NCT01365455|1086200|P1|STARTED|Maintenance Period||230
443272|NCT01365455|1086196|P5|NOT COMPLETED|Induction Period||0
443273|NCT01365455|1086197|P4|NOT COMPLETED|Induction Period||0
443274|NCT01365455|1086198|P3|NOT COMPLETED|Induction Period||16
443275|NCT01365455|1086199|P2|NOT COMPLETED|Induction Period||7
443276|NCT01365455|1086200|P1|NOT COMPLETED|Induction Period||15
443277|NCT01365455|1086196|P5|COMPLETED|Induction Period||0
443278|NCT01365455|1086197|P4|COMPLETED|Induction Period||0
443279|NCT01365455|1086198|P3|COMPLETED|Induction Period||232
443280|NCT01365455|1086199|P2|COMPLETED|Induction Period||238
443281|NCT01365455|1086200|P1|COMPLETED|Induction Period||230
443282|NCT01365455|1086196|P5|STARTED|Induction Period||0
443283|NCT01365455|1086197|P4|STARTED|Induction Period||0
443284|NCT01365455|1086198|P3|STARTED|Induction Period||248
443285|NCT01365455|1086199|P2|STARTED|Induction Period||245
443286|NCT01365455|1086200|P1|STARTED|Induction Period||245
443287|NCT01365273|1086290|P2|NOT COMPLETED|Overall Study||1
443288|NCT01365273|1086291|P1|NOT COMPLETED|Overall Study||2
443289|NCT01365273|1086290|P2|COMPLETED|Overall Study||20
443290|NCT01365273|1086291|P1|COMPLETED|Overall Study||20
443291|NCT01365273|1086290|P2|Compl. Pts, Not Evaluable for Pain.|Overall Study||4
443292|NCT01365273|1086291|P1|Compl. Pts, Not Evaluable for Pain.|Overall Study||2
443293|NCT01365273|1086290|P2|STARTED|Overall Study||21
443294|NCT01365273|1086291|P1|STARTED|Overall Study||22
443295|NCT01365130|1086301|P1|NOT COMPLETED|Overall Study||2
443296|NCT01365130|1086301|P1|COMPLETED|Overall Study||13
443297|NCT01365130|1086301|P1|STARTED|Overall Study|15 patients were enrolled to the study but only 13 went on to begin treatment|15
443298|NCT01365091|1086310|P4|NOT COMPLETED|Period 2||0
443299|NCT01365091|1086311|P3|NOT COMPLETED|Period 2||1
443300|NCT01365091|1086312|P2|NOT COMPLETED|Period 2||0
443301|NCT01365091|1086313|P1|NOT COMPLETED|Period 2||1
443302|NCT01365091|1086310|P4|COMPLETED|Period 2||25
443303|NCT01365091|1086311|P3|COMPLETED|Period 2||24
443304|NCT01365091|1086312|P2|COMPLETED|Period 2||26
443305|NCT01365091|1086313|P1|COMPLETED|Period 2||25
443306|NCT01365091|1086310|P4|STARTED|Period 2||25
443307|NCT01365091|1086311|P3|STARTED|Period 2||25
443308|NCT01365091|1086312|P2|STARTED|Period 2||26
443309|NCT01365091|1086313|P1|STARTED|Period 2||26
443310|NCT01365091|1086310|P4|NOT COMPLETED|Period 1||3
443311|NCT01365091|1086311|P3|NOT COMPLETED|Period 1||3
443312|NCT01365091|1086312|P2|NOT COMPLETED|Period 1||2
443313|NCT01365091|1086313|P1|NOT COMPLETED|Period 1||2
443314|NCT01365091|1086310|P4|COMPLETED|Period 1||25
443315|NCT01365091|1086311|P3|COMPLETED|Period 1||25
443316|NCT01365091|1086312|P2|COMPLETED|Period 1||26
443317|NCT01365091|1086313|P1|COMPLETED|Period 1||26
443318|NCT01365091|1086310|P4|STARTED|Period 1||28
443319|NCT01365091|1086311|P3|STARTED|Period 1||28
443320|NCT01365091|1086312|P2|STARTED|Period 1||28
443321|NCT01365091|1086313|P1|STARTED|Period 1||28
443322|NCT01365052|1086341|P2|NOT COMPLETED|Overall Study||4
443323|NCT01365052|1086342|P1|NOT COMPLETED|Overall Study||4
443324|NCT01365052|1086341|P2|COMPLETED|Overall Study||105
443325|NCT01365052|1086342|P1|COMPLETED|Overall Study||213
443326|NCT01365052|1086341|P2|STARTED|Overall Study||109
443327|NCT01365052|1086342|P1|STARTED|Overall Study||217
443328|NCT01365039|1086358|P2|NOT COMPLETED|Overall Study||0
443329|NCT01365039|1086359|P1|NOT COMPLETED|Overall Study||1
443330|NCT01365039|1086358|P2|COMPLETED|Overall Study||87
443331|NCT01365039|1086359|P1|COMPLETED|Overall Study||85
443332|NCT01365039|1086358|P2|STARTED|Overall Study||87
443333|NCT01365039|1086359|P1|STARTED|Overall Study||86
443334|NCT01364922|1086370|P3|NOT COMPLETED|Double-Blind (DB) Period||5
443335|NCT01364922|1086371|P2|NOT COMPLETED|Double-Blind (DB) Period||5
443336|NCT01364922|1086372|P1|NOT COMPLETED|Double-Blind (DB) Period||0
443337|NCT01364922|1086370|P3|COMPLETED|Double-Blind (DB) Period||42
443338|NCT01364922|1086371|P2|COMPLETED|Double-Blind (DB) Period||94
443339|NCT01364922|1086372|P1|COMPLETED|Double-Blind (DB) Period||0
443340|NCT01364922|1086370|P3|STARTED|Double-Blind (DB) Period||47
443341|NCT01364922|1086371|P2|STARTED|Double-Blind (DB) Period||99
443342|NCT01364922|1086372|P1|STARTED|Double-Blind (DB) Period||0
443343|NCT01364922|1086370|P3|NOT COMPLETED|Open-label (OL) Period||0
443344|NCT01364922|1086371|P2|NOT COMPLETED|Open-label (OL) Period||0
443345|NCT01364922|1086372|P1|NOT COMPLETED|Open-label (OL) Period||22
443346|NCT01364922|1086370|P3|COMPLETED|Open-label (OL) Period||0
443347|NCT01364922|1086371|P2|COMPLETED|Open-label (OL) Period||0
443348|NCT01364922|1086372|P1|COMPLETED|Open-label (OL) Period||146
443349|NCT01364922|1086370|P3|STARTED|Open-label (OL) Period||0
443350|NCT01364922|1086371|P2|STARTED|Open-label (OL) Period||0
443351|NCT01364922|1086372|P1|STARTED|Open-label (OL) Period||168
443352|NCT01364896|1086383|P1|NOT COMPLETED|Overall Study||0
443353|NCT01364896|1086383|P1|COMPLETED|Overall Study||46
443354|NCT01364896|1086383|P1|STARTED|Overall Study||46
443355|NCT01364870|1086394|P3|NOT COMPLETED|Overall Study||14
443356|NCT01364870|1086395|P2|NOT COMPLETED|Overall Study||30
443357|NCT01364870|1086396|P1|NOT COMPLETED|Overall Study||22
443358|NCT01364870|1086394|P3|COMPLETED|Overall Study||58
443359|NCT01364870|1086395|P2|COMPLETED|Overall Study||93
443360|NCT01364870|1086396|P1|COMPLETED|Overall Study||100
443361|NCT01364870|1086394|P3|STARTED|Overall Study||72
443362|NCT01364870|1086395|P2|STARTED|Overall Study||123
443363|NCT01364870|1086396|P1|STARTED|Overall Study||122
443364|NCT01364740|1086407|P1|NOT COMPLETED|Overall Study||0
443365|NCT01364740|1086407|P1|COMPLETED|Overall Study||10
443366|NCT01364740|1086407|P1|STARTED|Overall Study||10
443367|NCT01364727|1086415|P1|NOT COMPLETED|Overall Study||2
443368|NCT01364727|1086415|P1|COMPLETED|Overall Study||33
443369|NCT01364727|1086415|P1|STARTED|Overall Study||35
443370|NCT01364649|1086423|P2|NOT COMPLETED|Overall Study||43
443371|NCT01364649|1086424|P1|NOT COMPLETED|Overall Study||56
443372|NCT01364649|1086423|P2|COMPLETED|Overall Study||179
443373|NCT01364649|1086424|P1|COMPLETED|Overall Study||169
443374|NCT01364649|1086423|P2|STARTED|Overall Study||222
443375|NCT01364649|1086424|P1|STARTED|Overall Study||225
443376|NCT01364558|1086434|P3|NOT COMPLETED|Dose Three||0
443377|NCT01364558|1086435|P2|NOT COMPLETED|Dose Three||0
443378|NCT01364558|1086436|P1|NOT COMPLETED|Dose Three||0
443379|NCT01364558|1086434|P3|COMPLETED|Dose Three||8
443380|NCT01364558|1086435|P2|COMPLETED|Dose Three||8
443381|NCT01364558|1086436|P1|COMPLETED|Dose Three||8
443382|NCT01364558|1086434|P3|STARTED|Dose Three||8
443383|NCT01364558|1086435|P2|STARTED|Dose Three||8
443384|NCT01364558|1086436|P1|STARTED|Dose Three||8
443385|NCT01364558|1086434|P3|NOT COMPLETED|Dose Two||0
443386|NCT01364558|1086435|P2|NOT COMPLETED|Dose Two||0
443387|NCT01364558|1086436|P1|NOT COMPLETED|Dose Two||0
443388|NCT01364558|1086434|P3|COMPLETED|Dose Two||8
443389|NCT01364558|1086435|P2|COMPLETED|Dose Two||8
443390|NCT01364558|1086436|P1|COMPLETED|Dose Two||8
443391|NCT01364558|1086434|P3|STARTED|Dose Two||8
443392|NCT01364558|1086435|P2|STARTED|Dose Two||8
443393|NCT01364558|1086436|P1|STARTED|Dose Two||8
443394|NCT01364558|1086434|P3|NOT COMPLETED|Dose One||0
443395|NCT01364558|1086435|P2|NOT COMPLETED|Dose One||0
443396|NCT01364558|1086436|P1|NOT COMPLETED|Dose One||0
443397|NCT01364558|1086434|P3|COMPLETED|Dose One||8
443398|NCT01364558|1086435|P2|COMPLETED|Dose One||8
443399|NCT01364558|1086436|P1|COMPLETED|Dose One||8
443400|NCT01364558|1086434|P3|STARTED|Dose One||8
443401|NCT01364558|1086435|P2|STARTED|Dose One||8
443402|NCT01364558|1086436|P1|STARTED|Dose One||8
443403|NCT01364428|1086446|P2|NOT COMPLETED|Overall Study||15
443404|NCT01364428|1086447|P1|NOT COMPLETED|Overall Study||20
443405|NCT01364428|1086446|P2|COMPLETED|Overall Study||172
443406|NCT01364428|1086447|P1|COMPLETED|Overall Study||166
443407|NCT01364428|1086446|P2|Exposed|Overall Study||187
443408|NCT01364428|1086447|P1|Exposed|Overall Study|Two subjects were randomised in error and withdrew prior to exposure to drug|184
443409|NCT01364428|1086446|P2|STARTED|Overall Study||187
443410|NCT01364428|1086447|P1|STARTED|Overall Study||186
443411|NCT01364389|1086464|P3|NOT COMPLETED|Overall Study||1
443412|NCT01364389|1086465|P2|NOT COMPLETED|Overall Study||1
443413|NCT01364389|1086466|P1|NOT COMPLETED|Overall Study||2
443414|NCT01364389|1086464|P3|COMPLETED|Overall Study||4
443415|NCT01364389|1086465|P2|COMPLETED|Overall Study||5
443416|NCT01364389|1086466|P1|COMPLETED|Overall Study||3
443417|NCT01364389|1086464|P3|Pharmacodynamic (PD) Analysis Set|Overall Study|One patient excluded: did not receive study drug; received placebo caps. and infusion only in error.|4
443418|NCT01364389|1086465|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||6
443419|NCT01364389|1086466|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||5
443420|NCT01364389|1086464|P3|STARTED|Overall Study||5
443421|NCT01364389|1086465|P2|STARTED|Overall Study||6
443422|NCT01364389|1086466|P1|STARTED|Overall Study||5
443423|NCT01364298|1086485|P2|NOT COMPLETED|Overall Study||23
443424|NCT01364298|1086486|P1|NOT COMPLETED|Overall Study||14
443425|NCT01364298|1086485|P2|COMPLETED|Overall Study||154
443426|NCT01364298|1086486|P1|COMPLETED|Overall Study||162
443427|NCT01364298|1086485|P2|Treated|Overall Study||174
443428|NCT01364298|1086486|P1|Treated|Overall Study||174
443429|NCT01364298|1086485|P2|STARTED|Overall Study||177
443430|NCT01364298|1086486|P1|STARTED|Overall Study||176
443431|NCT01364259|1086510|P2|NOT COMPLETED|Overall Study||0
443432|NCT01364259|1086511|P1|NOT COMPLETED|Overall Study||0
443433|NCT01364259|1086510|P2|COMPLETED|Overall Study||8
443434|NCT01364259|1086511|P1|COMPLETED|Overall Study||9
443435|NCT01364259|1086510|P2|STARTED|Overall Study||8
443436|NCT01364259|1086511|P1|STARTED|Overall Study||9
443437|NCT01364207|1086519|P2|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0
443438|NCT01364207|1086520|P1|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0
443439|NCT01364207|1086519|P2|COMPLETED|Second Visit (~1.5-2 Hours)||54
443440|NCT01364207|1086520|P1|COMPLETED|Second Visit (~1.5-2 Hours)||52
443441|NCT01364207|1086519|P2|STARTED|Second Visit (~1.5-2 Hours)||54
443442|NCT01364207|1086520|P1|STARTED|Second Visit (~1.5-2 Hours)||52
443443|NCT01364207|1086519|P2|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||4
443444|NCT01364207|1086520|P1|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||2
443445|NCT01364207|1086519|P2|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||54
443446|NCT01364207|1086520|P1|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||52
443447|NCT01364207|1086519|P2|STARTED|Time Between Visits (2 Days to 4 Weeks)||58
443448|NCT01364207|1086520|P1|STARTED|Time Between Visits (2 Days to 4 Weeks)||54
443449|NCT01364207|1086519|P2|NOT COMPLETED|First Visit (~1.5-2 Hours)||0
443450|NCT01364207|1086520|P1|NOT COMPLETED|First Visit (~1.5-2 Hours)||0
443451|NCT01364207|1086519|P2|COMPLETED|First Visit (~1.5-2 Hours)||58
443452|NCT01364207|1086520|P1|COMPLETED|First Visit (~1.5-2 Hours)||54
443453|NCT01364207|1086519|P2|STARTED|First Visit (~1.5-2 Hours)||58
443454|NCT01364207|1086520|P1|STARTED|First Visit (~1.5-2 Hours)||54
443455|NCT01364090|1086531|P3|NOT COMPLETED|Overall Study||6
443456|NCT01364090|1086532|P2|NOT COMPLETED|Overall Study||3
443457|NCT01364090|1086533|P1|NOT COMPLETED|Overall Study||14
443458|NCT01364090|1086531|P3|COMPLETED|Overall Study||0
443459|NCT01364090|1086532|P2|COMPLETED|Overall Study||58
443460|NCT01364090|1086533|P1|COMPLETED|Overall Study||12
443461|NCT01364090|1086531|P3|STARTED|Overall Study||6
443462|NCT01364090|1086532|P2|STARTED|Overall Study||61
443463|NCT01364090|1086533|P1|STARTED|Overall Study||26
443464|NCT01363986|1086541|P1|NOT COMPLETED|Overall Study||1
443465|NCT01363986|1086541|P1|COMPLETED|Overall Study||2
443466|NCT01363986|1086541|P1|STARTED|Overall Study||3
443467|NCT01363908|1086551|P2|NOT COMPLETED|Chronic Dosing (CD) Phase||6
443468|NCT01363908|1086552|P1|NOT COMPLETED|Chronic Dosing (CD) Phase||10
443469|NCT01363908|1086551|P2|COMPLETED|Chronic Dosing (CD) Phase||10
443470|NCT01363908|1086552|P1|COMPLETED|Chronic Dosing (CD) Phase||3
443471|NCT01363908|1086551|P2|STARTED|Chronic Dosing (CD) Phase|The CD phase enrolled willing participants who completed the PK phase plus additional participants.|16
443472|NCT01363908|1086552|P1|STARTED|Chronic Dosing (CD) Phase|The CD phase enrolled willing participants who completed the PK phase plus additional participants.|13
443473|NCT01363908|1086551|P2|NOT COMPLETED|Pharmacokinetic (PK) Phase||0
443474|NCT01363908|1086552|P1|NOT COMPLETED|Pharmacokinetic (PK) Phase||0
443475|NCT01363908|1086551|P2|COMPLETED|Pharmacokinetic (PK) Phase||8
443476|NCT01363908|1086552|P1|COMPLETED|Pharmacokinetic (PK) Phase||8
443477|NCT01363908|1086551|P2|STARTED|Pharmacokinetic (PK) Phase|Per study design, at least 8 participants in each age cohort participated in the PK phase.|8
443478|NCT01363908|1086552|P1|STARTED|Pharmacokinetic (PK) Phase|Per study design, at least 8 participants in each age cohort participated in the PK phase.|8
443479|NCT01363908|1086551|P2|NOT COMPLETED|Screening/Enrollment||0
443480|NCT01363908|1086552|P1|NOT COMPLETED|Screening/Enrollment||1
443481|NCT01363908|1086551|P2|COMPLETED|Screening/Enrollment||16
443482|NCT01363908|1086552|P1|COMPLETED|Screening/Enrollment|One participant did not receive investigational product.|13
443483|NCT01363908|1086551|P2|STARTED|Screening/Enrollment||16
443484|NCT01363908|1086552|P1|STARTED|Screening/Enrollment||14
443485|NCT01363843|1086582|P1|NOT COMPLETED|Overall Study||1
443486|NCT01363843|1086582|P1|COMPLETED|Overall Study|39 enrolled, 36 completed 8 cycles of mFOLFOX6, 35 completed chemo-radiation, 38 underwent surgery.|38
443487|NCT01363843|1086582|P1|STARTED|Overall Study||39
443488|NCT01363765|1086588|P2|NOT COMPLETED|Overall Study||4731
443489|NCT01363765|1086589|P1|NOT COMPLETED|Overall Study||5800
443490|NCT01363765|1086588|P2|COMPLETED|Overall Study|Samples contributing to observation arm. Excluded were duplicates, non-residents, missing age.|11705
443491|NCT01363765|1086589|P1|COMPLETED|Overall Study|Excluded were duplicates, non-residents, missing age, unavailability of system (smears done instead)|12522
443492|NCT01363765|1086588|P2|STARTED|Overall Study|This is number of participants enrolled, each with one sample considered in baseline arm.|16436
443493|NCT01363765|1086589|P1|STARTED|Overall Study|This is number of participants enrolled, each with one sample submitted to Xpert in intervention arm|18322
443494|NCT01363713|1086601|P1|NOT COMPLETED|Overall Study||6
443495|NCT01363713|1086601|P1|COMPLETED|Overall Study|Analysed (n=130)|124
443496|NCT01363713|1086601|P1|ALLOCATED|Overall Study||130
443497|NCT01363713|1086601|P1|STARTED|Overall Study|Assessed for eligibility|130
443498|NCT01363700|1086610|P5|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
443499|NCT01363700|1086611|P4|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
443500|NCT01363700|1086612|P3|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
443501|NCT01363700|1086613|P2|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
443502|NCT01363700|1086614|P1|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
443503|NCT01363700|1086610|P5|COMPLETED|Epinastine vs Olopatadine Period2||43
443504|NCT01363700|1086611|P4|COMPLETED|Epinastine vs Olopatadine Period2||43
443505|NCT01363700|1086612|P3|COMPLETED|Epinastine vs Olopatadine Period2||0
443506|NCT01363700|1086613|P2|COMPLETED|Epinastine vs Olopatadine Period2||0
443507|NCT01363700|1086614|P1|COMPLETED|Epinastine vs Olopatadine Period2||0
443508|NCT01363700|1086610|P5|STARTED|Epinastine vs Olopatadine Period2||43
443509|NCT01363700|1086611|P4|STARTED|Epinastine vs Olopatadine Period2||43
443510|NCT01363700|1086612|P3|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
443511|NCT01363700|1086613|P2|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
443512|NCT01363700|1086614|P1|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
443513|NCT01363700|1086610|P5|NOT COMPLETED|Epinastine vs Placebo Period1||0
443514|NCT01363700|1086611|P4|NOT COMPLETED|Epinastine vs Placebo Period1||0
443515|NCT01363700|1086612|P3|NOT COMPLETED|Epinastine vs Placebo Period1||0
443516|NCT01363700|1086613|P2|NOT COMPLETED|Epinastine vs Placebo Period1||1
443517|NCT01363700|1086614|P1|NOT COMPLETED|Epinastine vs Placebo Period1||0
443518|NCT01363700|1086610|P5|COMPLETED|Epinastine vs Placebo Period1||0
443519|NCT01363700|1086611|P4|COMPLETED|Epinastine vs Placebo Period1||0
443520|NCT01363700|1086612|P3|COMPLETED|Epinastine vs Placebo Period1||22
443521|NCT01363700|1086613|P2|COMPLETED|Epinastine vs Placebo Period1||21
443522|NCT01363700|1086614|P1|COMPLETED|Epinastine vs Placebo Period1||43
443523|NCT01363700|1086610|P5|STARTED|Epinastine vs Placebo Period1|No Allocation|0
443524|NCT01363700|1086611|P4|STARTED|Epinastine vs Placebo Period1|No Allocation|0
443525|NCT01363700|1086612|P3|STARTED|Epinastine vs Placebo Period1||22
443526|NCT01363700|1086613|P2|STARTED|Epinastine vs Placebo Period1||22
443527|NCT01363700|1086614|P1|STARTED|Epinastine vs Placebo Period1||43
443528|NCT01363661|1086633|P2|NOT COMPLETED|Overall Study||4
443529|NCT01363661|1086634|P1|NOT COMPLETED|Overall Study||14
443530|NCT01363661|1086633|P2|COMPLETED|Overall Study||28
443531|NCT01363661|1086634|P1|COMPLETED|Overall Study||18
443532|NCT01363661|1086633|P2|STARTED|Overall Study||32
443533|NCT01363661|1086634|P1|STARTED|Overall Study||32
443534|NCT01363492|1086650|P1|NOT COMPLETED|Overall Study||0
443535|NCT01363492|1086650|P1|COMPLETED|Overall Study||14
443536|NCT01363492|1086650|P1|STARTED|Overall Study||14
443537|NCT01363479|1086665|P2|NOT COMPLETED|Overall Study||21
443538|NCT01363479|1086666|P1|NOT COMPLETED|Overall Study||12
443539|NCT01363479|1086665|P2|COMPLETED|Overall Study||351
443540|NCT01363479|1086666|P1|COMPLETED|Overall Study||359
443541|NCT01363479|1086665|P2|STARTED|Overall Study|number of randomised patients|372
443542|NCT01363479|1086666|P1|STARTED|Overall Study|number of randomised patients|371
443543|NCT01363440|1086675|P3|NOT COMPLETED|Overall Study||27
443544|NCT01363440|1086676|P2|NOT COMPLETED|Overall Study||31
443545|NCT01363440|1086677|P1|NOT COMPLETED|Overall Study||23
443546|NCT01363440|1086675|P3|COMPLETED|Overall Study|Completed Week 100|127
443547|NCT01363440|1086676|P2|COMPLETED|Overall Study|Completed Week 100|125
443548|NCT01363440|1086677|P1|COMPLETED|Overall Study|Completed Week 100|133
443549|NCT01363440|1086675|P3|Completed Week 100|Overall Study||127
443550|NCT01363440|1086676|P2|Completed Week 100|Overall Study||125
443551|NCT01363440|1086677|P1|Completed Week 100|Overall Study||133
443552|NCT01363440|1086675|P3|Completed Week 52|Overall Study||144
443553|NCT01363440|1086676|P2|Completed Week 52|Overall Study||146
443554|NCT01363440|1086677|P1|Completed Week 52|Overall Study||145
443555|NCT01363440|1086675|P3|Participants Received Treatment|Overall Study|safety analysis set (SAF)|152
443556|NCT01363440|1086676|P2|Participants Received Treatment|Overall Study|safety analysis set (SAF)|155
443557|NCT01363440|1086677|P1|Participants Received Treatment|Overall Study|safety analysis set (SAF)|154
443558|NCT01363440|1086675|P3|STARTED|Overall Study|randomized|154
443559|NCT01363440|1086676|P2|STARTED|Overall Study|randomized|156
443560|NCT01363440|1086677|P1|STARTED|Overall Study|randomized|156
443561|NCT01363401|1086708|P2|NOT COMPLETED|Overall Study||4
443562|NCT01363401|1086709|P1|NOT COMPLETED|Overall Study||2
443563|NCT01363401|1086708|P2|COMPLETED|Overall Study||27
443564|NCT01363401|1086709|P1|COMPLETED|Overall Study||39
443565|NCT01363401|1086708|P2|STARTED|Overall Study||31
443566|NCT01363401|1086709|P1|STARTED|Overall Study|"Including 8 subjects of Phase 1 safety assessment. (Called Modified ITT in this clinical trials)"|41
443567|NCT01363349|1086723|P2|NOT COMPLETED|Overall Study||70
443568|NCT01363349|1086724|P1|NOT COMPLETED|Overall Study||67
443569|NCT01363349|1086723|P2|COMPLETED|Overall Study||66
443570|NCT01363349|1086724|P1|COMPLETED|Overall Study||66
443571|NCT01363349|1086723|P2|Randomized|Overall Study||136
443572|NCT01363349|1086724|P1|Randomized|Overall Study||133
443573|NCT01363349|1086723|P2|STARTED|Overall Study||136
443574|NCT01363349|1086724|P1|STARTED|Overall Study||133
443575|NCT01363297|1086735|P5|NOT COMPLETED|Overall Study||31
443576|NCT01363297|1086736|P4|NOT COMPLETED|Overall Study||10
443577|NCT01363297|1086737|P3|NOT COMPLETED|Overall Study||6
443578|NCT01363297|1086738|P2|NOT COMPLETED|Overall Study||6
443579|NCT01363297|1086739|P1|NOT COMPLETED|Overall Study||3
443580|NCT01363297|1086735|P5|COMPLETED|Overall Study||4
443581|NCT01363297|1086736|P4|COMPLETED|Overall Study||3
443582|NCT01363297|1086737|P3|COMPLETED|Overall Study||3
443583|NCT01363297|1086738|P2|COMPLETED|Overall Study||6
443584|NCT01363297|1086739|P1|COMPLETED|Overall Study||0
443585|NCT01363297|1086735|P5|STARTED|Overall Study||35
443586|NCT01363297|1086736|P4|STARTED|Overall Study||13
443587|NCT01363297|1086737|P3|STARTED|Overall Study||9
443588|NCT01363297|1086738|P2|STARTED|Overall Study||12
443589|NCT01363297|1086739|P1|STARTED|Overall Study||3
443590|NCT01363258|1086831|P2|NOT COMPLETED|Overall Study||0
443591|NCT01363258|1086832|P1|NOT COMPLETED|Overall Study||0
443592|NCT01363258|1086831|P2|COMPLETED|Overall Study||46
443593|NCT01363258|1086832|P1|COMPLETED|Overall Study||54
443594|NCT01363258|1086831|P2|STARTED|Overall Study||46
443595|NCT01363258|1086832|P1|STARTED|Overall Study||54
443596|NCT01363076|1086842|P2|NOT COMPLETED|Overall Study||1
443597|NCT01363076|1086843|P1|NOT COMPLETED|Overall Study||0
443598|NCT01363076|1086842|P2|COMPLETED|Overall Study||12
443599|NCT01363076|1086843|P1|COMPLETED|Overall Study||7
443600|NCT01363076|1086842|P2|STARTED|Overall Study||13
443601|NCT01363076|1086843|P1|STARTED|Overall Study||7
443602|NCT01363050|1086861|P1|NOT COMPLETED|Overall Study||0
443603|NCT01363050|1086861|P1|COMPLETED|Overall Study||15
443604|NCT01363050|1086861|P1|STARTED|Overall Study||15
443605|NCT01363011|1086875|P2|NOT COMPLETED|Extension Phase||8
443606|NCT01363011|1086876|P1|NOT COMPLETED|Extension Phase||5
443607|NCT01363011|1086875|P2|COMPLETED|Extension Phase||41
443608|NCT01363011|1086876|P1|COMPLETED|Extension Phase||13
443609|NCT01363011|1086875|P2|STARTED|Extension Phase|15 participants who completed the main study did not enroll into the extension phase.|49
443610|NCT01363011|1086876|P1|STARTED|Extension Phase|11 participants who completed the main study did not enroll into the extension phase.|18
443611|NCT01363011|1086875|P2|NOT COMPLETED|Main Study||9
443612|NCT01363011|1086876|P1|NOT COMPLETED|Main Study||4
443613|NCT01363011|1086875|P2|COMPLETED|Main Study||64
443614|NCT01363011|1086876|P1|COMPLETED|Main Study||29
443615|NCT01363011|1086875|P2|STARTED|Main Study||73
443616|NCT01363011|1086876|P1|STARTED|Main Study||33
443617|NCT01362946|1086916|P2|NOT COMPLETED|Second Behavior Modification Block||0
443618|NCT01362946|1086917|P1|NOT COMPLETED|Second Behavior Modification Block||0
443619|NCT01362946|1086916|P2|COMPLETED|Second Behavior Modification Block||24
443620|NCT01362946|1086917|P1|COMPLETED|Second Behavior Modification Block||23
443621|NCT01362946|1086916|P2|STARTED|Second Behavior Modification Block||24
443622|NCT01362946|1086917|P1|STARTED|Second Behavior Modification Block|1 participant withdrew after last but before this treatment period - illness unrelated to study.|23
443623|NCT01362946|1086916|P2|NOT COMPLETED|First Behavior Modification Block||0
443624|NCT01362946|1086917|P1|NOT COMPLETED|First Behavior Modification Block||0
443625|NCT01362946|1086916|P2|COMPLETED|First Behavior Modification Block||24
443626|NCT01362946|1086917|P1|COMPLETED|First Behavior Modification Block||24
443627|NCT01362946|1086916|P2|STARTED|First Behavior Modification Block||24
443628|NCT01362946|1086917|P1|STARTED|First Behavior Modification Block||24
443629|NCT01362907|1086950|P2|NOT COMPLETED|Period 2, One Week||0
443630|NCT01362907|1086951|P1|NOT COMPLETED|Period 2, One Week||0
443631|NCT01362907|1086950|P2|COMPLETED|Period 2, One Week||20
443632|NCT01362907|1086951|P1|COMPLETED|Period 2, One Week||20
443633|NCT01362907|1086950|P2|STARTED|Period 2, One Week||20
443634|NCT01362907|1086951|P1|STARTED|Period 2, One Week||20
443635|NCT01362907|1086950|P2|NOT COMPLETED|Period 1, One Week||0
443636|NCT01362907|1086951|P1|NOT COMPLETED|Period 1, One Week||0
443637|NCT01362907|1086950|P2|COMPLETED|Period 1, One Week||20
443638|NCT01362907|1086951|P1|COMPLETED|Period 1, One Week||20
443639|NCT01362907|1086950|P2|STARTED|Period 1, One Week||20
443640|NCT01362907|1086951|P1|STARTED|Period 1, One Week||20
443641|NCT01362894|1086965|P2|NOT COMPLETED|Period Two, 1 Week||0
443642|NCT01362894|1086966|P1|NOT COMPLETED|Period Two, 1 Week||0
443643|NCT01362894|1086965|P2|COMPLETED|Period Two, 1 Week||115
443644|NCT01362894|1086966|P1|COMPLETED|Period Two, 1 Week||118
443645|NCT01362894|1086965|P2|STARTED|Period Two, 1 Week|Three participants discontinued between Periods 1 and 2 due to unacceptable vision.|115
443646|NCT01362894|1086966|P1|STARTED|Period Two, 1 Week|Two participants discontinued between Periods 1 and 2 due to discomfort (1) and poor fit (1).|118
443647|NCT01362894|1086965|P2|NOT COMPLETED|Period One, 1 Week||0
443648|NCT01362894|1086966|P1|NOT COMPLETED|Period One, 1 Week||0
443649|NCT01362894|1086965|P2|COMPLETED|Period One, 1 Week||117
443650|NCT01362894|1086966|P1|COMPLETED|Period One, 1 Week||119
443651|NCT01362894|1086965|P2|STARTED|Period One, 1 Week|One participant was not dispensed lenses until Period 2.|117
443652|NCT01362894|1086966|P1|STARTED|Period One, 1 Week|One participant was not dispensed lenses until Period 2.|119
443653|NCT01362686|1086983|P3|NOT COMPLETED|Overall Study||10
443654|NCT01362686|1086984|P2|NOT COMPLETED|Overall Study||12
443655|NCT01362686|1086985|P1|NOT COMPLETED|Overall Study||8
443656|NCT01362686|1086983|P3|COMPLETED|Overall Study||53
443657|NCT01362686|1086984|P2|COMPLETED|Overall Study||54
443658|NCT01362686|1086985|P1|COMPLETED|Overall Study||59
443659|NCT01362686|1086983|P3|STARTED|Overall Study||63
443660|NCT01362686|1086984|P2|STARTED|Overall Study||66
443661|NCT01362686|1086985|P1|STARTED|Overall Study||67
443662|NCT01362608|1087001|P2|NOT COMPLETED|Overall Study||8
443663|NCT01362608|1087002|P1|NOT COMPLETED|Overall Study||4
443664|NCT01362608|1087001|P2|COMPLETED|Overall Study||61
443665|NCT01362608|1087002|P1|COMPLETED|Overall Study||63
443666|NCT01362608|1087001|P2|STARTED|Overall Study||69
443667|NCT01362608|1087002|P1|STARTED|Overall Study||67
443668|NCT01362530|1087040|P2|NOT COMPLETED|Optional Extension (Cycles 2-6)||0
443669|NCT01362530|1087041|P1|NOT COMPLETED|Optional Extension (Cycles 2-6)||125
443670|NCT01362530|1087040|P2|COMPLETED|Optional Extension (Cycles 2-6)||0
443671|NCT01362530|1087041|P1|COMPLETED|Optional Extension (Cycles 2-6)||46
443672|NCT01362530|1087040|P2|STARTED|Optional Extension (Cycles 2-6)||0
443673|NCT01362530|1087041|P1|STARTED|Optional Extension (Cycles 2-6)||171
443674|NCT01362530|1087040|P2|NOT COMPLETED|Base Study (Cycle 1)||3
443675|NCT01362530|1087041|P1|NOT COMPLETED|Base Study (Cycle 1)||5
443676|NCT01362530|1087040|P2|COMPLETED|Base Study (Cycle 1)||149
443677|NCT01362530|1087041|P1|COMPLETED|Base Study (Cycle 1)||150
443678|NCT01362530|1087040|P2|Received Study Treatment|Base Study (Cycle 1)||150
443679|NCT01362530|1087041|P1|Received Study Treatment|Base Study (Cycle 1)||152
443680|NCT01362530|1087040|P2|STARTED|Base Study (Cycle 1)||152
443681|NCT01362530|1087041|P1|STARTED|Base Study (Cycle 1)||155
443682|NCT01362517|1087054|P1|NOT COMPLETED|Overall Study||2
443683|NCT01362517|1087054|P1|COMPLETED|Overall Study||129
443684|NCT01362517|1087054|P1|STARTED|Overall Study||131
443685|NCT01362491|1087065|P3|NOT COMPLETED|Overall Study||0
443686|NCT01362491|1087066|P2|NOT COMPLETED|Overall Study||0
443687|NCT01362491|1087067|P1|NOT COMPLETED|Overall Study||1
443688|NCT01362491|1087065|P3|COMPLETED|Overall Study||46
443689|NCT01362491|1087066|P2|COMPLETED|Overall Study||89
443690|NCT01362491|1087067|P1|COMPLETED|Overall Study||90
443691|NCT01362491|1087065|P3|STARTED|Overall Study||46
443692|NCT01362491|1087066|P2|STARTED|Overall Study||89
443693|NCT01362491|1087067|P1|STARTED|Overall Study||91
443694|NCT01362439|1087115|P1|NOT COMPLETED|Overall Study||15
443695|NCT01362439|1087115|P1|COMPLETED|Overall Study||118
443696|NCT01362439|1087115|P1|STARTED|Overall Study||133
443697|NCT01362348|1087130|P1|NOT COMPLETED|Overall Study||14
443698|NCT01362348|1087130|P1|COMPLETED|Overall Study||5
443699|NCT01362348|1087130|P1|STARTED|Overall Study||19
443700|NCT01362296|1087149|P4|NOT COMPLETED|Crossover Phase||2
443701|NCT01362296|1087150|P3|NOT COMPLETED|Crossover Phase||23
443702|NCT01362296|1087151|P2|NOT COMPLETED|Crossover Phase||0
443703|NCT01362296|1087152|P1|NOT COMPLETED|Crossover Phase||0
443704|NCT01362296|1087149|P4|COMPLETED|Crossover Phase||0
443705|NCT01362296|1087150|P3|COMPLETED|Crossover Phase||0
443706|NCT01362296|1087151|P2|COMPLETED|Crossover Phase||0
443707|NCT01362296|1087152|P1|COMPLETED|Crossover Phase||0
443708|NCT01362296|1087149|P4|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|2
443709|NCT01362296|1087150|P3|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|23
443710|NCT01362296|1087151|P2|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|0
443711|NCT01362296|1087152|P1|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|0
443712|NCT01362296|1087149|P4|NOT COMPLETED|Randomized Phase (RP)||0
443713|NCT01362296|1087150|P3|NOT COMPLETED|Randomized Phase (RP)||0
443714|NCT01362296|1087151|P2|NOT COMPLETED|Randomized Phase (RP)||43
443715|NCT01362296|1087152|P1|NOT COMPLETED|Randomized Phase (RP)||87
443716|NCT01362296|1087149|P4|COMPLETED|Randomized Phase (RP)||0
443717|NCT01362296|1087150|P3|COMPLETED|Randomized Phase (RP)||0
443718|NCT01362296|1087151|P2|COMPLETED|Randomized Phase (RP)||0
443719|NCT01362296|1087152|P1|COMPLETED|Randomized Phase (RP)||0
443720|NCT01362296|1087149|P4|STARTED|Randomized Phase (RP)||0
443721|NCT01362296|1087150|P3|STARTED|Randomized Phase (RP)||0
443722|NCT01362296|1087151|P2|STARTED|Randomized Phase (RP)||43
443723|NCT01362296|1087152|P1|STARTED|Randomized Phase (RP)||87
443724|NCT01362244|1087200|P2|NOT COMPLETED|Overall Study||32
443725|NCT01362244|1087201|P1|NOT COMPLETED|Overall Study||32
443726|NCT01362244|1087200|P2|COMPLETED|Overall Study||19
443727|NCT01362244|1087201|P1|COMPLETED|Overall Study||22
443728|NCT01362244|1087200|P2|STARTED|Overall Study||51
443729|NCT01362244|1087201|P1|STARTED|Overall Study||54
443730|NCT01362205|1087274|P2|NOT COMPLETED|Overall Study||0
443731|NCT01362205|1087275|P1|NOT COMPLETED|Overall Study||0
443732|NCT01362205|1087274|P2|COMPLETED|Overall Study||27
443733|NCT01362205|1087275|P1|COMPLETED|Overall Study||22
443734|NCT01362205|1087274|P2|STARTED|Overall Study||27
443735|NCT01362205|1087275|P1|STARTED|Overall Study||22
443736|NCT01362192|1087301|P1|NOT COMPLETED|Overall Study||4
443737|NCT01362192|1087301|P1|COMPLETED|Overall Study||16
443738|NCT01362192|1087301|P1|STARTED|Overall Study||20
443739|NCT01362140|1087313|P2|NOT COMPLETED|Overall Study||11
443740|NCT01362140|1087314|P1|NOT COMPLETED|Overall Study||10
443741|NCT01362140|1087313|P2|COMPLETED|Overall Study|Completed treatment in the double-blind treatment period|87
443742|NCT01362140|1087314|P1|COMPLETED|Overall Study|Completed treatment in the double-blind treatment period|39
443743|NCT01362140|1087313|P2|Received Treatment|Overall Study||97
443744|NCT01362140|1087314|P1|Received Treatment|Overall Study||49
443745|NCT01362140|1087313|P2|STARTED|Overall Study||98
443746|NCT01362140|1087314|P1|STARTED|Overall Study||49
443747|NCT01362062|1087338|P2|NOT COMPLETED|Overall Study||0
443748|NCT01362062|1087339|P1|NOT COMPLETED|Overall Study||26
443749|NCT01362062|1087338|P2|COMPLETED|Overall Study||62
443750|NCT01362062|1087339|P1|COMPLETED|Overall Study||22
443751|NCT01362062|1087338|P2|STARTED|Overall Study||62
443752|NCT01362062|1087339|P1|STARTED|Overall Study||48
443753|NCT01362049|1087360|P4|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||3
443754|NCT01362049|1087361|P3|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||2
443755|NCT01362049|1087362|P2|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||3
443756|NCT01362049|1087363|P1|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||5
443757|NCT01362049|1087360|P4|COMPLETED|Follow-Up at 52 Weeks (12 Months)||21
443758|NCT01362049|1087361|P3|COMPLETED|Follow-Up at 52 Weeks (12 Months)||28
443759|NCT01362049|1087362|P2|COMPLETED|Follow-Up at 52 Weeks (12 Months)||13
443760|NCT01362049|1087363|P1|COMPLETED|Follow-Up at 52 Weeks (12 Months)||18
443761|NCT01362049|1087360|P4|STARTED|Follow-Up at 52 Weeks (12 Months)||24
443762|NCT01362049|1087361|P3|STARTED|Follow-Up at 52 Weeks (12 Months)||30
443763|NCT01362049|1087362|P2|STARTED|Follow-Up at 52 Weeks (12 Months)||16
443764|NCT01362049|1087363|P1|STARTED|Follow-Up at 52 Weeks (12 Months)||23
443765|NCT01362049|1087360|P4|NOT COMPLETED|Follow-Up at 7 Weeks||1
443766|NCT01362049|1087361|P3|NOT COMPLETED|Follow-Up at 7 Weeks||2
443767|NCT01362049|1087362|P2|NOT COMPLETED|Follow-Up at 7 Weeks||3
443768|NCT01362049|1087363|P1|NOT COMPLETED|Follow-Up at 7 Weeks||3
443769|NCT01362049|1087360|P4|COMPLETED|Follow-Up at 7 Weeks||24
443770|NCT01362049|1087361|P3|COMPLETED|Follow-Up at 7 Weeks||30
443771|NCT01362049|1087362|P2|COMPLETED|Follow-Up at 7 Weeks||16
443772|NCT01362049|1087363|P1|COMPLETED|Follow-Up at 7 Weeks||23
443773|NCT01362049|1087360|P4|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||25
443774|NCT01362049|1087361|P3|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||32
443775|NCT01362049|1087362|P2|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||18
443776|NCT01362049|1087363|P1|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||26
443777|NCT01362049|1087360|P4|STARTED|Follow-Up at 7 Weeks||25
443778|NCT01362049|1087361|P3|STARTED|Follow-Up at 7 Weeks||32
443779|NCT01362049|1087362|P2|STARTED|Follow-Up at 7 Weeks||19
443780|NCT01362049|1087363|P1|STARTED|Follow-Up at 7 Weeks||26
443781|NCT01361867|1087401|P1|NOT COMPLETED|Overall Study||0
443782|NCT01361867|1087401|P1|COMPLETED|Overall Study||15
443783|NCT01361867|1087401|P1|STARTED|Overall Study||15
443784|NCT01361854|1087406|P2|NOT COMPLETED|Second Intervention||0
443785|NCT01361854|1087407|P1|NOT COMPLETED|Second Intervention||0
443786|NCT01361854|1087406|P2|COMPLETED|Second Intervention||48
443787|NCT01361854|1087407|P1|COMPLETED|Second Intervention||47
443788|NCT01361854|1087406|P2|STARTED|Second Intervention||48
443789|NCT01361854|1087407|P1|STARTED|Second Intervention||47
443790|NCT01361854|1087406|P2|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0
443791|NCT01361854|1087407|P1|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0
443792|NCT01361854|1087406|P2|COMPLETED|Wash-out, Maximum 2 Weeks||48
443793|NCT01361854|1087407|P1|COMPLETED|Wash-out, Maximum 2 Weeks||47
443794|NCT01361854|1087406|P2|STARTED|Wash-out, Maximum 2 Weeks||48
443795|NCT01361854|1087407|P1|STARTED|Wash-out, Maximum 2 Weeks||47
443796|NCT01361854|1087406|P2|NOT COMPLETED|Day 1||3
443797|NCT01361854|1087407|P1|NOT COMPLETED|Day 1||4
443798|NCT01361854|1087406|P2|COMPLETED|Day 1||48
443799|NCT01361854|1087407|P1|COMPLETED|Day 1||47
443800|NCT01361854|1087406|P2|STARTED|Day 1||51
443801|NCT01361854|1087407|P1|STARTED|Day 1||51
443802|NCT01361633|1087415|P2|NOT COMPLETED|Overall Study||3
443803|NCT01361633|1087416|P1|NOT COMPLETED|Overall Study||6
443804|NCT01361633|1087415|P2|COMPLETED|Overall Study||23
443805|NCT01361633|1087416|P1|COMPLETED|Overall Study||19
443806|NCT01361633|1087415|P2|STARTED|Overall Study||26
443807|NCT01361633|1087416|P1|STARTED|Overall Study||25
443808|NCT01361620|1087422|P1|NOT COMPLETED|Overall Study||0
443809|NCT01361620|1087422|P1|COMPLETED|Overall Study||132
443810|NCT01361620|1087422|P1|STARTED|Overall Study||132
443811|NCT01361607|1087428|P2|NOT COMPLETED|Overall Study||41
443812|NCT01361607|1087429|P1|NOT COMPLETED|Overall Study||64
443813|NCT01361607|1087428|P2|COMPLETED|Overall Study||158
443814|NCT01361607|1087429|P1|COMPLETED|Overall Study||136
443815|NCT01361607|1087428|P2|ITT Population|Overall Study|One participant randomized to placebo received nabiximols Day 1 but analyzed as placebo-treated|199
443816|NCT01361607|1087429|P1|ITT Population|Overall Study||198
443817|NCT01361607|1087428|P2|Safety Population|Overall Study|One participant randomized to placebo received nabiximols Day 1 but analyzed as nabiximols-treated|198
443818|NCT01361607|1087429|P1|Safety Population|Overall Study|One participant randomized to nabiximols received placebo Day 22 but analyzed as nabiximols-treated|199
443819|NCT01361607|1087428|P2|Received at Least 1 Dose of Study Drug|Overall Study||199
443820|NCT01361607|1087429|P1|Received at Least 1 Dose of Study Drug|Overall Study||198
443821|NCT01361607|1087428|P2|STARTED|Overall Study||199
443822|NCT01361607|1087429|P1|STARTED|Overall Study|Two participants randomized to nabiximols did not receive any study drug|200
443823|NCT01361594|1087457|P2|NOT COMPLETED|Overall Study||2
443824|NCT01361594|1087458|P1|NOT COMPLETED|Overall Study||1
443825|NCT01361594|1087457|P2|COMPLETED|Overall Study||151
443826|NCT01361594|1087458|P1|COMPLETED|Overall Study||151
443827|NCT01361594|1087457|P2|STARTED|Overall Study||153
443828|NCT01361594|1087458|P1|STARTED|Overall Study||152
443829|NCT01361568|1087472|P6|NOT COMPLETED|Overall Study||2
443830|NCT01361568|1087473|P5|NOT COMPLETED|Overall Study||1
443831|NCT01361568|1087474|P4|NOT COMPLETED|Overall Study||0
443832|NCT01361568|1087475|P3|NOT COMPLETED|Overall Study||0
443833|NCT01361568|1087476|P2|NOT COMPLETED|Overall Study||1
443834|NCT01361568|1087477|P1|NOT COMPLETED|Overall Study||2
443835|NCT01361568|1087472|P6|COMPLETED|Overall Study||11
443836|NCT01361568|1087473|P5|COMPLETED|Overall Study||6
443837|NCT01361568|1087474|P4|COMPLETED|Overall Study||21
443838|NCT01361568|1087475|P3|COMPLETED|Overall Study||20
443839|NCT01361568|1087476|P2|COMPLETED|Overall Study||70
443840|NCT01361568|1087477|P1|COMPLETED|Overall Study||69
443841|NCT01361568|1087472|P6|STARTED|Overall Study||13
443842|NCT01361568|1087473|P5|STARTED|Overall Study||7
443843|NCT01361568|1087474|P4|STARTED|Overall Study||21
443844|NCT01361568|1087475|P3|STARTED|Overall Study||20
443845|NCT01361568|1087476|P2|STARTED|Overall Study||71
443846|NCT01361568|1087477|P1|STARTED|Overall Study||71
443847|NCT01361464|1087507|P1|NOT COMPLETED|Overall Study||3
443848|NCT01361464|1087507|P1|COMPLETED|Overall Study||18
443849|NCT01361464|1087507|P1|STARTED|Overall Study||21
443850|NCT01361308|1087516|P2|NOT COMPLETED|Overall Study||30
443851|NCT01361308|1087517|P1|NOT COMPLETED|Overall Study||35
443852|NCT01361308|1087516|P2|COMPLETED|Overall Study||278
443853|NCT01361308|1087517|P1|COMPLETED|Overall Study||271
443854|NCT01361308|1087516|P2|STARTED|Overall Study||308
443855|NCT01361308|1087517|P1|STARTED|Overall Study||306
443859|NCT01361178|1087565|P2|NOT COMPLETED|Overall Study||0
443860|NCT01361178|1087566|P1|NOT COMPLETED|Overall Study||13
443861|NCT01361178|1087565|P2|COMPLETED|Overall Study||11
443862|NCT01361178|1087566|P1|COMPLETED|Overall Study||109
443863|NCT01361178|1087565|P2|STARTED|Overall Study||11
443864|NCT01361178|1087566|P1|STARTED|Overall Study||122
443865|NCT01361126|1087574|P2|NOT COMPLETED|Overall Study||2
443866|NCT01361126|1087575|P1|NOT COMPLETED|Overall Study||0
443867|NCT01361126|1087574|P2|COMPLETED|Overall Study||2
443868|NCT01361126|1087575|P1|COMPLETED|Overall Study||13
443869|NCT01361126|1087574|P2|STARTED|Overall Study||4
443870|NCT01361126|1087575|P1|STARTED|Overall Study||13
443871|NCT01361113|1087590|P1|NOT COMPLETED|Overall Study||0
443872|NCT01361113|1087590|P1|COMPLETED|Overall Study||21
443873|NCT01361113|1087590|P1|STARTED|Overall Study||21
443874|NCT01361048|1087601|P3|NOT COMPLETED|Overall Study||1
443875|NCT01361048|1087602|P2|NOT COMPLETED|Overall Study||0
443876|NCT01361048|1087603|P1|NOT COMPLETED|Overall Study||0
443877|NCT01361048|1087601|P3|COMPLETED|Overall Study||9
443878|NCT01361048|1087602|P2|COMPLETED|Overall Study||10
443879|NCT01361048|1087603|P1|COMPLETED|Overall Study||20
443880|NCT01361048|1087601|P3|STARTED|Overall Study||10
443881|NCT01361048|1087602|P2|STARTED|Overall Study||10
443882|NCT01361048|1087603|P1|STARTED|Overall Study||20
443883|NCT01361009|1087614|P1|NOT COMPLETED|Overall Study||116
443884|NCT01361009|1087614|P1|COMPLETED|Overall Study||1901
443885|NCT01361009|1087614|P1|STARTED|Overall Study||2017
443886|NCT01360996|1087624|P3|NOT COMPLETED|Overall Study||2
443887|NCT01360996|1087625|P2|NOT COMPLETED|Overall Study||3
443888|NCT01360996|1087626|P1|NOT COMPLETED|Overall Study||6
443889|NCT01360996|1087624|P3|COMPLETED|Overall Study||21
443890|NCT01360996|1087625|P2|COMPLETED|Overall Study||18
443891|NCT01360996|1087626|P1|COMPLETED|Overall Study||14
443892|NCT01360996|1087624|P3|STARTED|Overall Study||23
443893|NCT01360996|1087625|P2|STARTED|Overall Study||21
443894|NCT01360996|1087626|P1|STARTED|Overall Study||20
443895|NCT01360840|1087648|P3|NOT COMPLETED|Overall Study||9
443896|NCT01360840|1087649|P2|NOT COMPLETED|Overall Study||10
443897|NCT01360840|1087650|P1|NOT COMPLETED|Overall Study||10
443898|NCT01360840|1087648|P3|COMPLETED|Overall Study||51
443899|NCT01360840|1087649|P2|COMPLETED|Overall Study||50
443900|NCT01360840|1087650|P1|COMPLETED|Overall Study||50
443901|NCT01360840|1087648|P3|STARTED|Overall Study||60
443902|NCT01360840|1087649|P2|STARTED|Overall Study||60
443903|NCT01360840|1087650|P1|STARTED|Overall Study||60
443904|NCT01360645|1087702|P4|NOT COMPLETED|Phase A+||24
443905|NCT01360645|1087703|P3|NOT COMPLETED|Phase A+||0
443906|NCT01360645|1087704|P2|NOT COMPLETED|Phase A+||0
443907|NCT01360645|1087705|P1|NOT COMPLETED|Phase A+||0
443908|NCT01360645|1087702|P4|COMPLETED|Phase A+||307
443909|NCT01360645|1087703|P3|COMPLETED|Phase A+||0
443910|NCT01360645|1087704|P2|COMPLETED|Phase A+||0
443911|NCT01360645|1087705|P1|COMPLETED|Phase A+||0
443912|NCT01360645|1087702|P4|STARTED|Phase A+||331
443913|NCT01360645|1087703|P3|STARTED|Phase A+||0
443914|NCT01360645|1087704|P2|STARTED|Phase A+||0
443915|NCT01360645|1087705|P1|STARTED|Phase A+||0
443916|NCT01360645|1087702|P4|NOT COMPLETED|Phase B (6 Weeks)||0
443917|NCT01360645|1087703|P3|NOT COMPLETED|Phase B (6 Weeks)||13
443918|NCT01360645|1087704|P2|NOT COMPLETED|Phase B (6 Weeks)||14
443919|NCT01360645|1087705|P1|NOT COMPLETED|Phase B (6 Weeks)||0
443920|NCT01360645|1087702|P4|COMPLETED|Phase B (6 Weeks)||0
443921|NCT01360645|1087703|P3|COMPLETED|Phase B (6 Weeks)||178
443922|NCT01360645|1087704|P2|COMPLETED|Phase B (6 Weeks)||174
443923|NCT01360645|1087705|P1|COMPLETED|Phase B (6 Weeks)||0
443924|NCT01360645|1087702|P4|STARTED|Phase B (6 Weeks)||0
443925|NCT01360645|1087703|P3|STARTED|Phase B (6 Weeks)||191
443926|NCT01360645|1087704|P2|STARTED|Phase B (6 Weeks)||188
443927|NCT01360645|1087705|P1|STARTED|Phase B (6 Weeks)||0
443928|NCT01360645|1087702|P4|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
443929|NCT01360645|1087703|P3|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
443930|NCT01360645|1087704|P2|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
443931|NCT01360645|1087705|P1|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||114
443932|NCT01360645|1087702|P4|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
443933|NCT01360645|1087703|P3|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
443934|NCT01360645|1087704|P2|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
443935|NCT01360645|1087705|P1|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||710
443936|NCT01360645|1087702|P4|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
443937|NCT01360645|1087703|P3|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
443938|NCT01360645|1087704|P2|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
443939|NCT01360645|1087705|P1|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)|826 participants were enrolled but 2 participants discontinued trial before taking study medication.|824
443940|NCT01360632|1087760|P5|NOT COMPLETED|Phase A+||25
443941|NCT01360632|1087761|P4|NOT COMPLETED|Phase A+||0
443942|NCT01360632|1087762|P3|NOT COMPLETED|Phase A+||0
443943|NCT01360632|1087763|P2|NOT COMPLETED|Phase A+||0
443944|NCT01360632|1087764|P1|NOT COMPLETED|Phase A+||0
443945|NCT01360632|1087760|P5|COMPLETED|Phase A+||575
443946|NCT01360632|1087761|P4|COMPLETED|Phase A+||0
443947|NCT01360632|1087762|P3|COMPLETED|Phase A+||0
443948|NCT01360632|1087763|P2|COMPLETED|Phase A+||0
443949|NCT01360632|1087764|P1|COMPLETED|Phase A+||0
443950|NCT01360632|1087760|P5|STARTED|Phase A+||600
443951|NCT01360632|1087761|P4|STARTED|Phase A+||0
443952|NCT01360632|1087762|P3|STARTED|Phase A+||0
443953|NCT01360632|1087763|P2|STARTED|Phase A+||0
443954|NCT01360632|1087764|P1|STARTED|Phase A+||0
443955|NCT01360632|1087760|P5|NOT COMPLETED|Phase B (6 Weeks)||0
443956|NCT01360632|1087761|P4|NOT COMPLETED|Phase B (6 Weeks)||13
443957|NCT01360632|1087762|P3|NOT COMPLETED|Phase B (6 Weeks)||20
443958|NCT01360632|1087763|P2|NOT COMPLETED|Phase B (6 Weeks)||10
443959|NCT01360632|1087764|P1|NOT COMPLETED|Phase B (6 Weeks)||0
443960|NCT01360632|1087760|P5|COMPLETED|Phase B (6 Weeks)||0
443961|NCT01360632|1087761|P4|COMPLETED|Phase B (6 Weeks)||208
443962|NCT01360632|1087762|P3|COMPLETED|Phase B (6 Weeks)||210
443963|NCT01360632|1087763|P2|COMPLETED|Phase B (6 Weeks)||216
443964|NCT01360632|1087764|P1|COMPLETED|Phase B (6 Weeks)||0
443965|NCT01360632|1087760|P5|STARTED|Phase B (6 Weeks)||0
443966|NCT01360632|1087761|P4|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|221
443967|NCT01360632|1087762|P3|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|230
443968|NCT01360632|1087763|P2|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|226
443969|NCT01360632|1087764|P1|STARTED|Phase B (6 Weeks)||0
443970|NCT01360632|1087760|P5|NOT COMPLETED|Phase A (8 Weeks)||0
443971|NCT01360632|1087761|P4|NOT COMPLETED|Phase A (8 Weeks)||0
443972|NCT01360632|1087762|P3|NOT COMPLETED|Phase A (8 Weeks)||0
443973|NCT01360632|1087763|P2|NOT COMPLETED|Phase A (8 Weeks)||0
443974|NCT01360632|1087764|P1|NOT COMPLETED|Phase A (8 Weeks)||255
443975|NCT01360632|1087760|P5|COMPLETED|Phase A (8 Weeks)||0
443976|NCT01360632|1087761|P4|COMPLETED|Phase A (8 Weeks)||0
443977|NCT01360632|1087762|P3|COMPLETED|Phase A (8 Weeks)||0
443978|NCT01360632|1087763|P2|COMPLETED|Phase A (8 Weeks)||0
443979|NCT01360632|1087764|P1|COMPLETED|Phase A (8 Weeks)||1277
443980|NCT01360632|1087760|P5|STARTED|Phase A (8 Weeks)||0
443981|NCT01360632|1087761|P4|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
443982|NCT01360632|1087762|P3|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
443983|NCT01360632|1087763|P2|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
443984|NCT01360632|1087764|P1|STARTED|Phase A (8 Weeks)|A total of 1539 participants were enrolled, 7 discontinued before taking any sponsor-provided ADT|1532
443985|NCT01360554|1087843|P2|NOT COMPLETED|Overall Study||439
443986|NCT01360554|1087844|P1|NOT COMPLETED|Overall Study||439
443987|NCT01360554|1087843|P2|COMPLETED|Overall Study||0
443988|NCT01360554|1087844|P1|COMPLETED|Overall Study||0
443989|NCT01360554|1087843|P2|Treated|Overall Study||436
443990|NCT01360554|1087844|P1|Treated|Overall Study||436
443991|NCT01360554|1087843|P2|STARTED|Overall Study|Three participants were randomized but not treated.|439
443992|NCT01360554|1087844|P1|STARTED|Overall Study|Three participants were randomized but not treated.|439
443993|NCT01360450|1087882|P2|NOT COMPLETED|Overall Study||0
443994|NCT01360450|1087883|P1|NOT COMPLETED|Overall Study||0
443995|NCT01360450|1087882|P2|COMPLETED|Overall Study||6
443996|NCT01360450|1087883|P1|COMPLETED|Overall Study||6
443997|NCT01360450|1087882|P2|Completed Treatment|Overall Study||6
443998|NCT01360450|1087883|P1|Completed Treatment|Overall Study||6
443999|NCT01360450|1087882|P2|STARTED|Overall Study||6
444000|NCT01360450|1087883|P1|STARTED|Overall Study||6
444001|NCT01360021|1087896|P3|NOT COMPLETED|Overall Study||7
444002|NCT01360021|1087897|P2|NOT COMPLETED|Overall Study||4
444003|NCT01360021|1087898|P1|NOT COMPLETED|Overall Study||8
444004|NCT01360021|1087896|P3|COMPLETED|Overall Study|Patients who completed study|65
444005|NCT01360021|1087897|P2|COMPLETED|Overall Study|Patients who completed study|67
444006|NCT01360021|1087898|P1|COMPLETED|Overall Study|Patients who completed study|63
444007|NCT01360021|1087896|P3|STARTED|Overall Study|Patients randomized|72
444008|NCT01360021|1087897|P2|STARTED|Overall Study|Patients randomized|71
444009|NCT01360021|1087898|P1|STARTED|Overall Study|Patients randomized|71
444010|NCT01359943|1087924|P3|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8
444011|NCT01359943|1087925|P2|NOT COMPLETED|Follow-up (Weeks 52 - 60)||15
444012|NCT01359943|1087926|P1|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8
444013|NCT01359943|1087924|P3|COMPLETED|Follow-up (Weeks 52 - 60)||36
444014|NCT01359943|1087925|P2|COMPLETED|Follow-up (Weeks 52 - 60)||69
444015|NCT01359943|1087926|P1|COMPLETED|Follow-up (Weeks 52 - 60)||78
444016|NCT01359943|1087924|P3|STARTED|Follow-up (Weeks 52 - 60)||44
444017|NCT01359943|1087925|P2|STARTED|Follow-up (Weeks 52 - 60)||84
444018|NCT01359943|1087926|P1|STARTED|Follow-up (Weeks 52 - 60)||86
444019|NCT01359943|1087924|P3|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8
444020|NCT01359943|1087925|P2|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||13
444021|NCT01359943|1087926|P1|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8
444022|NCT01359943|1087924|P3|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||36
444023|NCT01359943|1087925|P2|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||71
444024|NCT01359943|1087926|P1|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||78
444025|NCT01359943|1087924|P3|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||44
444026|NCT01359943|1087925|P2|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)|One participant, who was continuing as of week 12, did not receive study drug at week 16.|84
444027|NCT01359943|1087926|P1|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||86
444028|NCT01359943|1087924|P3|NOT COMPLETED|Double-blind (Weeks 0 - 16)||0
444029|NCT01359943|1087925|P2|NOT COMPLETED|Double-blind (Weeks 0 - 16)||4
444030|NCT01359943|1087926|P1|NOT COMPLETED|Double-blind (Weeks 0 - 16)||2
444031|NCT01359943|1087924|P3|COMPLETED|Double-blind (Weeks 0 - 16)||44
444032|NCT01359943|1087925|P2|COMPLETED|Double-blind (Weeks 0 - 16)||85
444033|NCT01359943|1087926|P1|COMPLETED|Double-blind (Weeks 0 - 16)||86
444034|NCT01359943|1087924|P3|STARTED|Double-blind (Weeks 0 - 16)||44
444035|NCT01359943|1087925|P2|STARTED|Double-blind (Weeks 0 - 16)||89
444036|NCT01359943|1087926|P1|STARTED|Double-blind (Weeks 0 - 16)||88
444037|NCT01359904|1087974|P2|NOT COMPLETED|Overall Study||0
444038|NCT01359904|1087975|P1|NOT COMPLETED|Overall Study||1
444039|NCT01359904|1087974|P2|COMPLETED|Overall Study||19
444040|NCT01359904|1087975|P1|COMPLETED|Overall Study||14
444041|NCT01359904|1087974|P2|STARTED|Overall Study||19
444042|NCT01359904|1087975|P1|STARTED|Overall Study||15
444043|NCT01359748|1087991|P4|NOT COMPLETED|Overall Study||0
444044|NCT01359748|1087992|P3|NOT COMPLETED|Overall Study||0
444045|NCT01359748|1087993|P2|NOT COMPLETED|Overall Study||0
444046|NCT01359748|1087994|P1|NOT COMPLETED|Overall Study||0
444047|NCT01359748|1087991|P4|COMPLETED|Overall Study||11
444048|NCT01359748|1087992|P3|COMPLETED|Overall Study||10
444049|NCT01359748|1087993|P2|COMPLETED|Overall Study||20
444050|NCT01359748|1087994|P1|COMPLETED|Overall Study||48
444051|NCT01359748|1087991|P4|STARTED|Overall Study||11
444052|NCT01359748|1087992|P3|STARTED|Overall Study||10
444053|NCT01359748|1087993|P2|STARTED|Overall Study||20
444054|NCT01359748|1087994|P1|STARTED|Overall Study||48
444055|NCT01359735|1088004|P2|NOT COMPLETED|Overall Study||0
444056|NCT01359735|1088005|P1|NOT COMPLETED|Overall Study||0
444057|NCT01359735|1088004|P2|COMPLETED|Overall Study||4
444058|NCT01359735|1088005|P1|COMPLETED|Overall Study||4
444059|NCT01359735|1088004|P2|STARTED|Overall Study||4
444060|NCT01359735|1088005|P1|STARTED|Overall Study||4
444061|NCT01359644|1088029|P10|NOT COMPLETED|Follow-up Period||0
444062|NCT01359644|1088030|P9|NOT COMPLETED|Follow-up Period||0
444063|NCT01359644|1088031|P8|NOT COMPLETED|Follow-up Period||2
444064|NCT01359644|1088032|P7|NOT COMPLETED|Follow-up Period||1
444065|NCT01359644|1088033|P6|NOT COMPLETED|Follow-up Period||1
444066|NCT01359644|1088034|P5|NOT COMPLETED|Follow-up Period||0
444067|NCT01359644|1088035|P4|NOT COMPLETED|Follow-up Period||0
444068|NCT01359644|1088036|P3|NOT COMPLETED|Follow-up Period||0
444069|NCT01359644|1088037|P2|NOT COMPLETED|Follow-up Period||0
444070|NCT01359644|1088038|P1|NOT COMPLETED|Follow-up Period||0
444071|NCT01359644|1088029|P10|COMPLETED|Follow-up Period||20
444072|NCT01359644|1088030|P9|COMPLETED|Follow-up Period||21
444073|NCT01359644|1088031|P8|COMPLETED|Follow-up Period||39
444074|NCT01359644|1088032|P7|COMPLETED|Follow-up Period||40
444075|NCT01359644|1088033|P6|COMPLETED|Follow-up Period||12
444076|NCT01359644|1088034|P5|COMPLETED|Follow-up Period||15
444077|NCT01359644|1088035|P4|COMPLETED|Follow-up Period||14
444078|NCT01359644|1088036|P3|COMPLETED|Follow-up Period||14
444079|NCT01359644|1088037|P2|COMPLETED|Follow-up Period||16
444080|NCT01359644|1088038|P1|COMPLETED|Follow-up Period||15
444081|NCT01359644|1088029|P10|STARTED|Follow-up Period||20
444082|NCT01359644|1088030|P9|STARTED|Follow-up Period||21
444083|NCT01359644|1088031|P8|STARTED|Follow-up Period||41
444084|NCT01359644|1088032|P7|STARTED|Follow-up Period||41
444085|NCT01359644|1088033|P6|STARTED|Follow-up Period||13
444086|NCT01359644|1088034|P5|STARTED|Follow-up Period||15
444087|NCT01359644|1088035|P4|STARTED|Follow-up Period||14
444088|NCT01359644|1088036|P3|STARTED|Follow-up Period||14
444089|NCT01359644|1088037|P2|STARTED|Follow-up Period||16
444090|NCT01359644|1088038|P1|STARTED|Follow-up Period||15
444091|NCT01359644|1088029|P10|NOT COMPLETED|Treatment Period||0
444092|NCT01359644|1088030|P9|NOT COMPLETED|Treatment Period||0
444093|NCT01359644|1088031|P8|NOT COMPLETED|Treatment Period||0
444094|NCT01359644|1088032|P7|NOT COMPLETED|Treatment Period||0
444095|NCT01359644|1088033|P6|NOT COMPLETED|Treatment Period||2
444096|NCT01359644|1088034|P5|NOT COMPLETED|Treatment Period||0
444097|NCT01359644|1088035|P4|NOT COMPLETED|Treatment Period||0
444098|NCT01359644|1088036|P3|NOT COMPLETED|Treatment Period||1
444099|NCT01359644|1088037|P2|NOT COMPLETED|Treatment Period||1
444100|NCT01359644|1088038|P1|NOT COMPLETED|Treatment Period||0
444101|NCT01359644|1088029|P10|COMPLETED|Treatment Period||20
444102|NCT01359644|1088030|P9|COMPLETED|Treatment Period||21
444103|NCT01359644|1088031|P8|COMPLETED|Treatment Period||41
444104|NCT01359644|1088032|P7|COMPLETED|Treatment Period||41
444105|NCT01359644|1088033|P6|COMPLETED|Treatment Period||12
444106|NCT01359644|1088034|P5|COMPLETED|Treatment Period||15
444107|NCT01359644|1088035|P4|COMPLETED|Treatment Period||14
444108|NCT01359644|1088036|P3|COMPLETED|Treatment Period||13
444109|NCT01359644|1088037|P2|COMPLETED|Treatment Period||15
444110|NCT01359644|1088038|P1|COMPLETED|Treatment Period||15
444111|NCT01359644|1088029|P10|STARTED|Treatment Period||20
444112|NCT01359644|1088030|P9|STARTED|Treatment Period||21
444113|NCT01359644|1088031|P8|STARTED|Treatment Period||41
444114|NCT01359644|1088032|P7|STARTED|Treatment Period||41
444115|NCT01359644|1088033|P6|STARTED|Treatment Period||14
444116|NCT01359644|1088034|P5|STARTED|Treatment Period||15
444117|NCT01359644|1088035|P4|STARTED|Treatment Period||14
444118|NCT01359644|1088036|P3|STARTED|Treatment Period||14
444119|NCT01359644|1088037|P2|STARTED|Treatment Period||16
444120|NCT01359644|1088038|P1|STARTED|Treatment Period||15
444121|NCT01359449|1088082|P2|NOT COMPLETED|Overall Study||4
444122|NCT01359449|1088083|P1|NOT COMPLETED|Overall Study||4
444123|NCT01359449|1088082|P2|COMPLETED|Overall Study||58
444124|NCT01359449|1088083|P1|COMPLETED|Overall Study||57
444125|NCT01359449|1088082|P2|STARTED|Overall Study||62
444126|NCT01359449|1088083|P1|STARTED|Overall Study||61
444127|NCT01359410|1088107|P2|NOT COMPLETED|Overall Study||0
444128|NCT01359410|1088108|P1|NOT COMPLETED|Overall Study||0
444129|NCT01359410|1088107|P2|COMPLETED|Overall Study||46
444130|NCT01359410|1088108|P1|COMPLETED|Overall Study||54
444131|NCT01359410|1088107|P2|STARTED|Overall Study||46
444132|NCT01359410|1088108|P1|STARTED|Overall Study||54
444133|NCT01359371|1088122|P1|NOT COMPLETED|Overall Study||0
444134|NCT01359371|1088122|P1|COMPLETED|Overall Study||41
444135|NCT01359371|1088122|P1|STARTED|Overall Study||41
444136|NCT01359254|1088129|P2|NOT COMPLETED|Overall Study||0
444137|NCT01359254|1088130|P1|NOT COMPLETED|Overall Study||1
444138|NCT01359254|1088129|P2|COMPLETED|Overall Study||0
444139|NCT01359254|1088130|P1|COMPLETED|Overall Study||0
444140|NCT01359254|1088129|P2|STARTED|Overall Study||0
444141|NCT01359254|1088130|P1|STARTED|Overall Study||1
444142|NCT01359150|1088140|P2|NOT COMPLETED|Overall Study||5
444143|NCT01359150|1088141|P1|NOT COMPLETED|Overall Study||7
444144|NCT01359150|1088140|P2|COMPLETED|Overall Study||106
444145|NCT01359150|1088141|P1|COMPLETED|Overall Study||105
444146|NCT01359150|1088140|P2|STARTED|Overall Study||111
444147|NCT01359150|1088141|P1|STARTED|Overall Study||112
444148|NCT01359111|1088163|P1|NOT COMPLETED|Overall Study||0
444149|NCT01359111|1088163|P1|COMPLETED|Overall Study||20
444150|NCT01359111|1088163|P1|STARTED|Overall Study||20
444151|NCT01359007|1088170|P1|NOT COMPLETED|Overall Study||2
444152|NCT01359007|1088170|P1|COMPLETED|Overall Study||3
444153|NCT01359007|1088170|P1|STARTED|Overall Study||5
444154|NCT01358877|1088180|P2|NOT COMPLETED|Overall Study||2404
444155|NCT01358877|1088181|P1|NOT COMPLETED|Overall Study||2400
444156|NCT01358877|1088180|P2|COMPLETED|Overall Study||0
444157|NCT01358877|1088181|P1|COMPLETED|Overall Study||0
444239|NCT01358578|1088458|P4|NOT COMPLETED|Follow-up Period||19
444158|NCT01358877|1088180|P2|Received Study Drug (Safety Population)|Overall Study|38 pertuzumab participants did not receive pertuzumab and were included in placebo arm.|2405
444159|NCT01358877|1088181|P1|Received Study Drug (Safety Population)|Overall Study|24 placebo participants received at least 1 dose of pertuzumab and were included in pertuzumab arm.|2364
444160|NCT01358877|1088180|P2|Did Not Receive Study Drug|Overall Study||13
444161|NCT01358877|1088181|P1|Did Not Receive Study Drug|Overall Study||22
444162|NCT01358877|1088180|P2|STARTED|Overall Study||2404
444163|NCT01358877|1088181|P1|STARTED|Overall Study||2400
444164|NCT01358864|1088251|P8|NOT COMPLETED|Overall Study||55
444165|NCT01358864|1088252|P7|NOT COMPLETED|Overall Study||65
444166|NCT01358864|1088253|P6|NOT COMPLETED|Overall Study||13
444167|NCT01358864|1088254|P5|NOT COMPLETED|Overall Study||11
444168|NCT01358864|1088255|P4|NOT COMPLETED|Overall Study||19
444169|NCT01358864|1088256|P3|NOT COMPLETED|Overall Study||16
444170|NCT01358864|1088257|P2|NOT COMPLETED|Overall Study||13
444171|NCT01358864|1088258|P1|NOT COMPLETED|Overall Study||31
444172|NCT01358864|1088251|P8|COMPLETED|Overall Study||85
444173|NCT01358864|1088252|P7|COMPLETED|Overall Study||81
444174|NCT01358864|1088253|P6|COMPLETED|Overall Study||42
444175|NCT01358864|1088254|P5|COMPLETED|Overall Study||46
444176|NCT01358864|1088255|P4|COMPLETED|Overall Study||10
444177|NCT01358864|1088256|P3|COMPLETED|Overall Study||87
444178|NCT01358864|1088257|P2|COMPLETED|Overall Study||86
444179|NCT01358864|1088258|P1|COMPLETED|Overall Study||18
444180|NCT01358864|1088251|P8|STARTED|Overall Study||140
444181|NCT01358864|1088252|P7|STARTED|Overall Study||146
444182|NCT01358864|1088253|P6|STARTED|Overall Study||55
444183|NCT01358864|1088254|P5|STARTED|Overall Study||57
444184|NCT01358864|1088255|P4|STARTED|Overall Study||29
444185|NCT01358864|1088256|P3|STARTED|Overall Study||103
444186|NCT01358864|1088257|P2|STARTED|Overall Study||99
444187|NCT01358864|1088258|P1|STARTED|Overall Study||49
444188|NCT01358825|1088349|P2|NOT COMPLETED|Overall Study||1
444189|NCT01358825|1088350|P1|NOT COMPLETED|Overall Study||0
444190|NCT01358825|1088349|P2|COMPLETED|Overall Study||45
444191|NCT01358825|1088350|P1|COMPLETED|Overall Study||12
444192|NCT01358825|1088349|P2|STARTED|Overall Study||46
444193|NCT01358825|1088350|P1|STARTED|Overall Study||12
444194|NCT01358760|1088374|P3|NOT COMPLETED|Overall Study||25
444195|NCT01358760|1088375|P2|NOT COMPLETED|Overall Study||20
444196|NCT01358760|1088376|P1|NOT COMPLETED|Overall Study||22
444197|NCT01358760|1088374|P3|COMPLETED|Overall Study||125
444198|NCT01358760|1088375|P2|COMPLETED|Overall Study||128
444199|NCT01358760|1088376|P1|COMPLETED|Overall Study||130
444200|NCT01358760|1088374|P3|ITT Population|Overall Study||134
444201|NCT01358760|1088375|P2|ITT Population|Overall Study||134
444202|NCT01358760|1088376|P1|ITT Population|Overall Study||139
444203|NCT01358760|1088374|P3|Safety Population|Overall Study||148
444204|NCT01358760|1088375|P2|Safety Population|Overall Study||143
444205|NCT01358760|1088376|P1|Safety Population|Overall Study||150
444206|NCT01358760|1088374|P3|STARTED|Overall Study||150
444207|NCT01358760|1088375|P2|STARTED|Overall Study||148
444208|NCT01358760|1088376|P1|STARTED|Overall Study||152
444209|NCT01358734|1088411|P3|NOT COMPLETED|Overall Study||29
444210|NCT01358734|1088412|P2|NOT COMPLETED|Overall Study||37
444211|NCT01358734|1088413|P1|NOT COMPLETED|Overall Study||15
444212|NCT01358734|1088411|P3|COMPLETED|Overall Study|Includes participants still receiving study treatment|5
444213|NCT01358734|1088412|P2|COMPLETED|Overall Study|Includes participants still receiving study treatment|2
444214|NCT01358734|1088413|P1|COMPLETED|Overall Study||0
444215|NCT01358734|1088411|P3|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|32
444216|NCT01358734|1088412|P2|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|38
444217|NCT01358734|1088413|P1|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|14
444218|NCT01358734|1088411|P3|STARTED|Overall Study||34
444219|NCT01358734|1088412|P2|STARTED|Overall Study||39
444220|NCT01358734|1088413|P1|STARTED|Overall Study||15
444221|NCT01358708|1088432|P2|NOT COMPLETED|Open-Label Treatment Phase||0
444222|NCT01358708|1088433|P1|NOT COMPLETED|Open-Label Treatment Phase||0
444223|NCT01358708|1088432|P2|COMPLETED|Open-Label Treatment Phase||12
444224|NCT01358708|1088433|P1|COMPLETED|Open-Label Treatment Phase||5
444225|NCT01358708|1088432|P2|STARTED|Open-Label Treatment Phase|Number of subjects on PLACEBO during double-blind treatment and entering the Open-Label Phase|12
444226|NCT01358708|1088433|P1|STARTED|Open-Label Treatment Phase|Number of subjects on LACTEOL® during double-blind treatment and entering the Open-Label Phase|5
444227|NCT01358708|1088432|P2|NOT COMPLETED|Double-Blind Treatment Phase||0
444228|NCT01358708|1088433|P1|NOT COMPLETED|Double-Blind Treatment Phase||3
444229|NCT01358708|1088432|P2|COMPLETED|Double-Blind Treatment Phase||13
444230|NCT01358708|1088433|P1|COMPLETED|Double-Blind Treatment Phase||10
444231|NCT01358708|1088432|P2|Received Study Medication|Double-Blind Treatment Phase||13
444232|NCT01358708|1088433|P1|Received Study Medication|Double-Blind Treatment Phase|For 1 subject, unused med not returned to the site and intake of study medication not confirmed.|12
444233|NCT01358708|1088432|P2|Randomized|Double-Blind Treatment Phase||13
444234|NCT01358708|1088433|P1|Randomized|Double-Blind Treatment Phase||13
444235|NCT01358708|1088432|P2|STARTED|Double-Blind Treatment Phase||13
444236|NCT01358708|1088433|P1|STARTED|Double-Blind Treatment Phase||13
444237|NCT01358578|1088456|P6|NOT COMPLETED|Follow-up Period||0
444238|NCT01358578|1088457|P5|NOT COMPLETED|Follow-up Period||0
444240|NCT01358578|1088459|P3|NOT COMPLETED|Follow-up Period||5
444241|NCT01358578|1088460|P2|NOT COMPLETED|Follow-up Period||6
444242|NCT01358578|1088461|P1|NOT COMPLETED|Follow-up Period||10
444243|NCT01358578|1088456|P6|COMPLETED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
444244|NCT01358578|1088457|P5|COMPLETED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
444245|NCT01358578|1088458|P4|COMPLETED|Follow-up Period|contains patients who completed follow up period from induction and maintenance|260
444246|NCT01358578|1088459|P3|COMPLETED|Follow-up Period|contains patients who completed follow up period from induction and maintenance|21
444247|NCT01358578|1088460|P2|COMPLETED|Follow-up Period||119
444248|NCT01358578|1088461|P1|COMPLETED|Follow-up Period||138
444249|NCT01358578|1088456|P6|STARTED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
444250|NCT01358578|1088457|P5|STARTED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
444251|NCT01358578|1088458|P4|STARTED|Follow-up Period|contains patients who participated in follow up period from induction and maintenance|279
444252|NCT01358578|1088459|P3|STARTED|Follow-up Period|contains patients who participated in follow up period from induction and maintenance|26
444253|NCT01358578|1088460|P2|STARTED|Follow-up Period|Patients prior to follow up who did not enter the extension study but received the 300 mg dose|125
444254|NCT01358578|1088461|P1|STARTED|Follow-up Period|Patients prior to follow up who did not enter the extension study but received the 150 mg dose|148
444255|NCT01358578|1088456|P6|NOT COMPLETED|Maintenance Period||11
444256|NCT01358578|1088457|P5|NOT COMPLETED|Maintenance Period||17
444257|NCT01358578|1088458|P4|NOT COMPLETED|Maintenance Period||42
444258|NCT01358578|1088459|P3|NOT COMPLETED|Maintenance Period||2
444259|NCT01358578|1088460|P2|NOT COMPLETED|Maintenance Period||22
444260|NCT01358578|1088461|P1|NOT COMPLETED|Maintenance Period||39
444261|NCT01358578|1088456|P6|COMPLETED|Maintenance Period||131
444262|NCT01358578|1088457|P5|COMPLETED|Maintenance Period||125
444263|NCT01358578|1088458|P4|COMPLETED|Maintenance Period||263
444264|NCT01358578|1088459|P3|COMPLETED|Maintenance Period||15
444265|NCT01358578|1088460|P2|COMPLETED|Maintenance Period||290
444266|NCT01358578|1088461|P1|COMPLETED|Maintenance Period||276
444267|NCT01358578|1088456|P6|STARTED|Maintenance Period||142
444268|NCT01358578|1088457|P5|STARTED|Maintenance Period||142
444269|NCT01358578|1088458|P4|STARTED|Maintenance Period||305
444270|NCT01358578|1088459|P3|STARTED|Maintenance Period||17
444271|NCT01358578|1088460|P2|STARTED|Maintenance Period||312
444272|NCT01358578|1088461|P1|STARTED|Maintenance Period||315
444273|NCT01358578|1088456|P6|NOT COMPLETED|Induction Period||0
444274|NCT01358578|1088457|P5|NOT COMPLETED|Induction Period||0
444275|NCT01358578|1088458|P4|NOT COMPLETED|Induction Period||21
444276|NCT01358578|1088459|P3|NOT COMPLETED|Induction Period||25
444277|NCT01358578|1088460|P2|NOT COMPLETED|Induction Period||15
444278|NCT01358578|1088461|P1|NOT COMPLETED|Induction Period||12
444279|NCT01358578|1088456|P6|COMPLETED|Induction Period|These groups are populated after the induction period|0
444280|NCT01358578|1088457|P5|COMPLETED|Induction Period|These groups are populated after the induction period|0
444281|NCT01358578|1088458|P4|COMPLETED|Induction Period||305
444282|NCT01358578|1088459|P3|COMPLETED|Induction Period||301
444283|NCT01358578|1088460|P2|COMPLETED|Induction Period||312
444284|NCT01358578|1088461|P1|COMPLETED|Induction Period||315
444285|NCT01358578|1088456|P6|STARTED|Induction Period|These groups are populated after the induction period|0
444286|NCT01358578|1088457|P5|STARTED|Induction Period|These groups are populated after the induction period|0
444287|NCT01358578|1088458|P4|STARTED|Induction Period||326
444288|NCT01358578|1088459|P3|STARTED|Induction Period||326
444289|NCT01358578|1088460|P2|STARTED|Induction Period||327
444290|NCT01358578|1088461|P1|STARTED|Induction Period||327
444291|NCT01358526|1088513|P3|NOT COMPLETED|Double-blind Phase||121
444292|NCT01358526|1088514|P2|NOT COMPLETED|Double-blind Phase||80
444293|NCT01358526|1088515|P1|NOT COMPLETED|Double-blind Phase||0
444294|NCT01358526|1088513|P3|COMPLETED|Double-blind Phase||181
444295|NCT01358526|1088514|P2|COMPLETED|Double-blind Phase||218
444296|NCT01358526|1088515|P1|COMPLETED|Double-blind Phase||0
444297|NCT01358526|1088513|P3|STARTED|Double-blind Phase|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|302
444298|NCT01358526|1088514|P2|STARTED|Double-blind Phase|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|298
444299|NCT01358526|1088515|P1|STARTED|Double-blind Phase||0
444300|NCT01358526|1088513|P3|NOT COMPLETED|Open-label Titration Period||0
444301|NCT01358526|1088514|P2|NOT COMPLETED|Open-label Titration Period||0
444302|NCT01358526|1088515|P1|NOT COMPLETED|Open-label Titration Period||494
444303|NCT01358526|1088513|P3|COMPLETED|Open-label Titration Period||0
444304|NCT01358526|1088514|P2|COMPLETED|Open-label Titration Period||0
444305|NCT01358526|1088515|P1|COMPLETED|Open-label Titration Period|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|601
444306|NCT01358526|1088513|P3|STARTED|Open-label Titration Period||0
444307|NCT01358526|1088514|P2|STARTED|Open-label Titration Period||0
444308|NCT01358526|1088515|P1|STARTED|Open-label Titration Period||1095
444309|NCT01358357|1088532|P3|NOT COMPLETED|Double-Blind Phase||0
444310|NCT01358357|1088533|P2|NOT COMPLETED|Double-Blind Phase||100
444311|NCT01358357|1088534|P1|NOT COMPLETED|Double-Blind Phase||80
444312|NCT01358357|1088532|P3|COMPLETED|Double-Blind Phase||0
444313|NCT01358357|1088533|P2|COMPLETED|Double-Blind Phase||150
444314|NCT01358357|1088534|P1|COMPLETED|Double-Blind Phase||166
444315|NCT01358357|1088532|P3|STARTED|Double-Blind Phase||0
444316|NCT01358357|1088533|P2|STARTED|Double-Blind Phase||250
444317|NCT01358357|1088534|P1|STARTED|Double-Blind Phase||246
444318|NCT01358357|1088532|P3|NOT COMPLETED|Open Label Phase||462
444319|NCT01358357|1088533|P2|NOT COMPLETED|Open Label Phase||0
444320|NCT01358357|1088534|P1|NOT COMPLETED|Open Label Phase||0
444321|NCT01358357|1088532|P3|COMPLETED|Open Label Phase||503
444322|NCT01358357|1088533|P2|COMPLETED|Open Label Phase||0
444323|NCT01358357|1088534|P1|COMPLETED|Open Label Phase||0
444324|NCT01358357|1088532|P3|STARTED|Open Label Phase||965
444325|NCT01358357|1088533|P2|STARTED|Open Label Phase||0
444326|NCT01358357|1088534|P1|STARTED|Open Label Phase||0
444327|NCT01358175|1088570|P3|NOT COMPLETED|Overall Study||32
444328|NCT01358175|1088571|P2|NOT COMPLETED|Overall Study||28
444329|NCT01358175|1088572|P1|NOT COMPLETED|Overall Study||21
444330|NCT01358175|1088570|P3|COMPLETED|Overall Study||90
444331|NCT01358175|1088571|P2|COMPLETED|Overall Study||97
444332|NCT01358175|1088572|P1|COMPLETED|Overall Study||103
444333|NCT01358175|1088570|P3|STARTED|Overall Study||122
444334|NCT01358175|1088571|P2|STARTED|Overall Study||125
444335|NCT01358175|1088572|P1|STARTED|Overall Study||124
444336|NCT01357980|1088609|P4|NOT COMPLETED|Overall Study||0
444337|NCT01357980|1088610|P3|NOT COMPLETED|Overall Study||1
444338|NCT01357980|1088611|P2|NOT COMPLETED|Overall Study||1
444339|NCT01357980|1088612|P1|NOT COMPLETED|Overall Study||0
444340|NCT01357980|1088609|P4|COMPLETED|Overall Study||7
444341|NCT01357980|1088610|P3|COMPLETED|Overall Study||16
444342|NCT01357980|1088611|P2|COMPLETED|Overall Study||6
444343|NCT01357980|1088612|P1|COMPLETED|Overall Study||16
444344|NCT01357980|1088609|P4|STARTED|Overall Study||7
444345|NCT01357980|1088610|P3|STARTED|Overall Study||17
444346|NCT01357980|1088611|P2|STARTED|Overall Study||7
444347|NCT01357980|1088612|P1|STARTED|Overall Study||16
444348|NCT01357915|1088656|P2|NOT COMPLETED|Overall Study||0
444349|NCT01357915|1088657|P1|NOT COMPLETED|Overall Study||3
444350|NCT01357915|1088656|P2|COMPLETED|Overall Study||17
444351|NCT01357915|1088657|P1|COMPLETED|Overall Study||27
444352|NCT01357915|1088656|P2|STARTED|Overall Study||17
444353|NCT01357915|1088657|P1|STARTED|Overall Study||30
444354|NCT01357889|1088672|P2|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||4
444355|NCT01357889|1088673|P1|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||3
444356|NCT01357889|1088672|P2|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138
444357|NCT01357889|1088673|P1|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138
444358|NCT01357889|1088672|P2|STARTED|Follow-up Phase (FUP) (8 Weeks)|All participants who started the MDP entered the FUP, regardless of MDP completion status.|142
444359|NCT01357889|1088673|P1|STARTED|Follow-up Phase (FUP) (8 Weeks)|All participants who started the MDP entered the FUP, regardless of MDP completion status.|141
444360|NCT01357889|1088672|P2|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16
444361|NCT01357889|1088673|P1|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16
444362|NCT01357889|1088672|P2|COMPLETED|Multiple-dose Phase (MDP) (Overall)||126
444363|NCT01357889|1088673|P1|COMPLETED|Multiple-dose Phase (MDP) (Overall)||125
444364|NCT01357889|1088672|P2|STARTED|Multiple-dose Phase (MDP) (Overall)|After completion of the BE Phase, additional participants were randomized to the Overall Phase.|142
444365|NCT01357889|1088673|P1|STARTED|Multiple-dose Phase (MDP) (Overall)|After completion of the BE Phase, additional participants were randomized to the Overall Phase.|141
444366|NCT01357889|1088672|P2|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||2
444367|NCT01357889|1088673|P1|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||4
444368|NCT01357889|1088672|P2|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||79
444369|NCT01357889|1088673|P1|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||82
444370|NCT01357889|1088672|P2|STARTED|Single-dose Phase (BE Phase: 28 Days)||81
444371|NCT01357889|1088673|P1|STARTED|Single-dose Phase (BE Phase: 28 Days)||86
444372|NCT01357850|1088717|P4|NOT COMPLETED|Overall Study||0
444373|NCT01357850|1088718|P3|NOT COMPLETED|Overall Study||0
444374|NCT01357850|1088719|P2|NOT COMPLETED|Overall Study||0
444375|NCT01357850|1088720|P1|NOT COMPLETED|Overall Study||1
444376|NCT01357850|1088717|P4|COMPLETED|Overall Study||27
444377|NCT01357850|1088718|P3|COMPLETED|Overall Study||13
444378|NCT01357850|1088719|P2|COMPLETED|Overall Study||12
444379|NCT01357850|1088720|P1|COMPLETED|Overall Study||29
444380|NCT01357850|1088717|P4|STARTED|Overall Study||27
444381|NCT01357850|1088718|P3|STARTED|Overall Study||13
444382|NCT01357850|1088719|P2|STARTED|Overall Study||12
444383|NCT01357850|1088720|P1|STARTED|Overall Study||30
444384|NCT01357720|1088794|P2|NOT COMPLETED|Overall Study||5
444385|NCT01357720|1088795|P1|NOT COMPLETED|Overall Study||2
444386|NCT01357720|1088794|P2|COMPLETED|Overall Study||195
444387|NCT01357720|1088795|P1|COMPLETED|Overall Study||198
444388|NCT01357720|1088794|P2|STARTED|Overall Study||200
444389|NCT01357720|1088795|P1|STARTED|Overall Study||200
444390|NCT01357655|1088811|P2|NOT COMPLETED|Overall Study||0
444391|NCT01357655|1088812|P1|NOT COMPLETED|Overall Study||66
444392|NCT01357655|1088811|P2|COMPLETED|Overall Study||0
444393|NCT01357655|1088812|P1|COMPLETED|Overall Study||0
444394|NCT01357655|1088811|P2|STARTED|Overall Study||0
444395|NCT01357655|1088812|P1|STARTED|Overall Study||66
444396|NCT01357616|1088829|P2|NOT COMPLETED|Overall Study||9
444397|NCT01357616|1088830|P1|NOT COMPLETED|Overall Study||10
444398|NCT01357616|1088829|P2|COMPLETED|Overall Study||153
444399|NCT01357616|1088830|P1|COMPLETED|Overall Study||156
444400|NCT01357616|1088829|P2|STARTED|Overall Study||162
444401|NCT01357616|1088830|P1|STARTED|Overall Study||166
444402|NCT01357551|1088844|P2|NOT COMPLETED|Overall Study||11
444403|NCT01357551|1088845|P1|NOT COMPLETED|Overall Study||22
444404|NCT01357551|1088844|P2|COMPLETED|Overall Study||101
444405|NCT01357551|1088845|P1|COMPLETED|Overall Study||88
444406|NCT01357551|1088844|P2|STARTED|Overall Study||112
444407|NCT01357551|1088845|P1|STARTED|Overall Study||110
444408|NCT01357512|1088859|P2|NOT COMPLETED|Overall Study||5
444409|NCT01357512|1088860|P1|NOT COMPLETED|Overall Study||12
444410|NCT01357512|1088859|P2|COMPLETED|Overall Study||60
444411|NCT01357512|1088860|P1|COMPLETED|Overall Study||53
444412|NCT01357512|1088859|P2|STARTED|Overall Study||65
444413|NCT01357512|1088860|P1|STARTED|Overall Study||65
444414|NCT01357239|1088872|P4|NOT COMPLETED|Stratum II: Partially-Methylated||2
444415|NCT01357239|1088873|P3|NOT COMPLETED|Stratum II: Partially-Methylated||1
444416|NCT01357239|1088874|P2|NOT COMPLETED|Stratum II: Partially-Methylated||0
444417|NCT01357239|1088875|P1|NOT COMPLETED|Stratum II: Partially-Methylated||0
444418|NCT01357239|1088872|P4|COMPLETED|Stratum II: Partially-Methylated||18
444419|NCT01357239|1088873|P3|COMPLETED|Stratum II: Partially-Methylated||21
444420|NCT01357239|1088874|P2|COMPLETED|Stratum II: Partially-Methylated||21
444421|NCT01357239|1088875|P1|COMPLETED|Stratum II: Partially-Methylated||23
444422|NCT01357239|1088872|P4|STARTED|Stratum II: Partially-Methylated||20
444423|NCT01357239|1088873|P3|STARTED|Stratum II: Partially-Methylated||22
444424|NCT01357239|1088874|P2|STARTED|Stratum II: Partially-Methylated||21
444425|NCT01357239|1088875|P1|STARTED|Stratum II: Partially-Methylated||23
444426|NCT01357239|1088872|P4|NOT COMPLETED|Stratum I: Fully-Methylated||0
444427|NCT01357239|1088873|P3|NOT COMPLETED|Stratum I: Fully-Methylated||1
444428|NCT01357239|1088874|P2|NOT COMPLETED|Stratum I: Fully-Methylated||0
444429|NCT01357239|1088875|P1|NOT COMPLETED|Stratum I: Fully-Methylated||0
444430|NCT01357239|1088872|P4|COMPLETED|Stratum I: Fully-Methylated||22
444431|NCT01357239|1088873|P3|COMPLETED|Stratum I: Fully-Methylated||16
444432|NCT01357239|1088874|P2|COMPLETED|Stratum I: Fully-Methylated||6
444433|NCT01357239|1088875|P1|COMPLETED|Stratum I: Fully-Methylated||8
444434|NCT01357239|1088872|P4|STARTED|Stratum I: Fully-Methylated||22
444435|NCT01357239|1088873|P3|STARTED|Stratum I: Fully-Methylated||17
444436|NCT01357239|1088874|P2|STARTED|Stratum I: Fully-Methylated||6
444437|NCT01357239|1088875|P1|STARTED|Stratum I: Fully-Methylated||8
444438|NCT01357239|1088872|P4|NOT COMPLETED|Stratum: All Patients||2
444439|NCT01357239|1088873|P3|NOT COMPLETED|Stratum: All Patients||2
444440|NCT01357239|1088874|P2|NOT COMPLETED|Stratum: All Patients||0
444441|NCT01357239|1088875|P1|NOT COMPLETED|Stratum: All Patients||0
444442|NCT01357239|1088872|P4|COMPLETED|Stratum: All Patients||40
444443|NCT01357239|1088873|P3|COMPLETED|Stratum: All Patients||37
444444|NCT01357239|1088874|P2|COMPLETED|Stratum: All Patients||27
444445|NCT01357239|1088875|P1|COMPLETED|Stratum: All Patients||31
444446|NCT01357239|1088872|P4|STARTED|Stratum: All Patients||42
444447|NCT01357239|1088873|P3|STARTED|Stratum: All Patients||39
444448|NCT01357239|1088874|P2|STARTED|Stratum: All Patients||27
444449|NCT01357239|1088875|P1|STARTED|Stratum: All Patients||31
444450|NCT01357161|1088933|P3|NOT COMPLETED|Part 2 (Double-Blind Comparison)||62
444451|NCT01357161|1088934|P2|NOT COMPLETED|Part 2 (Double-Blind Comparison)||59
444452|NCT01357161|1088935|P1|NOT COMPLETED|Part 2 (Double-Blind Comparison)||0
444453|NCT01357161|1088933|P3|COMPLETED|Part 2 (Double-Blind Comparison)||0
444454|NCT01357161|1088934|P2|COMPLETED|Part 2 (Double-Blind Comparison)||0
444455|NCT01357161|1088935|P1|COMPLETED|Part 2 (Double-Blind Comparison)||0
444456|NCT01357161|1088933|P3|Treated|Part 2 (Double-Blind Comparison)||60
444457|NCT01357161|1088934|P2|Treated|Part 2 (Double-Blind Comparison)||59
444458|NCT01357161|1088935|P1|Treated|Part 2 (Double-Blind Comparison)||0
444459|NCT01357161|1088933|P3|STARTED|Part 2 (Double-Blind Comparison)|New participants enrolled in Part 2.|62
444460|NCT01357161|1088934|P2|STARTED|Part 2 (Double-Blind Comparison)|New participants enrolled in Part 2.|59
444461|NCT01357161|1088935|P1|STARTED|Part 2 (Double-Blind Comparison)||0
444462|NCT01357161|1088933|P3|NOT COMPLETED|Part 1 (Open Label Run-in)||0
444463|NCT01357161|1088934|P2|NOT COMPLETED|Part 1 (Open Label Run-in)||0
444464|NCT01357161|1088935|P1|NOT COMPLETED|Part 1 (Open Label Run-in)||15
444465|NCT01357161|1088933|P3|COMPLETED|Part 1 (Open Label Run-in)||0
444466|NCT01357161|1088934|P2|COMPLETED|Part 1 (Open Label Run-in)||0
444467|NCT01357161|1088935|P1|COMPLETED|Part 1 (Open Label Run-in)||0
444468|NCT01357161|1088933|P3|STARTED|Part 1 (Open Label Run-in)||0
444469|NCT01357161|1088934|P2|STARTED|Part 1 (Open Label Run-in)||0
444470|NCT01357161|1088935|P1|STARTED|Part 1 (Open Label Run-in)||15
444471|NCT01357148|1088964|P1|NOT COMPLETED|Overall Study||0
444472|NCT01357148|1088964|P1|COMPLETED|Overall Study||143
444473|NCT01357148|1088964|P1|STARTED|Overall Study||143
444474|NCT01357135|1088974|P3|NOT COMPLETED|Overall Study||263
444475|NCT01357135|1088975|P2|NOT COMPLETED|Overall Study||223
444476|NCT01357135|1088976|P1|NOT COMPLETED|Overall Study||598
444477|NCT01357135|1088974|P3|COMPLETED|Overall Study||583
444478|NCT01357135|1088975|P2|COMPLETED|Overall Study||510
444479|NCT01357135|1088976|P1|COMPLETED|Overall Study||1276
444480|NCT01357135|1088974|P3|STARTED|Overall Study||846
444481|NCT01357135|1088975|P2|STARTED|Overall Study||733
444482|NCT01357135|1088976|P1|STARTED|Overall Study||1874
444483|NCT01356966|1088987|P2|NOT COMPLETED|Overall Study||2
444484|NCT01356966|1088988|P1|NOT COMPLETED|Overall Study||2
444485|NCT01356966|1088987|P2|COMPLETED|Overall Study||12
444486|NCT01356966|1088988|P1|COMPLETED|Overall Study||16
444487|NCT01356966|1088987|P2|STARTED|Overall Study||14
444488|NCT01356966|1088988|P1|STARTED|Overall Study||18
444489|NCT01356940|1089000|P2|NOT COMPLETED|Second Intervention (28 Days)||0
444490|NCT01356940|1089001|P1|NOT COMPLETED|Second Intervention (28 Days)||1
444491|NCT01356940|1089000|P2|COMPLETED|Second Intervention (28 Days)||21
444492|NCT01356940|1089001|P1|COMPLETED|Second Intervention (28 Days)||20
444493|NCT01356940|1089000|P2|STARTED|Second Intervention (28 Days)||21
444494|NCT01356940|1089001|P1|STARTED|Second Intervention (28 Days)||21
444495|NCT01356940|1089000|P2|NOT COMPLETED|Washout (14 Days)||0
444496|NCT01356940|1089001|P1|NOT COMPLETED|Washout (14 Days)||0
444497|NCT01356940|1089000|P2|COMPLETED|Washout (14 Days)||21
444498|NCT01356940|1089001|P1|COMPLETED|Washout (14 Days)||21
444499|NCT01356940|1089000|P2|STARTED|Washout (14 Days)||21
444500|NCT01356940|1089001|P1|STARTED|Washout (14 Days)||21
444501|NCT01356940|1089000|P2|NOT COMPLETED|First Intervention (28 Days)||0
444502|NCT01356940|1089001|P1|NOT COMPLETED|First Intervention (28 Days)||1
444503|NCT01356940|1089000|P2|COMPLETED|First Intervention (28 Days)||21
444504|NCT01356940|1089001|P1|COMPLETED|First Intervention (28 Days)||21
444505|NCT01356940|1089000|P2|STARTED|First Intervention (28 Days)||21
444506|NCT01356940|1089001|P1|STARTED|First Intervention (28 Days)||22
444507|NCT01356667|1089009|P2|NOT COMPLETED|Overall Study||6
444508|NCT01356667|1089010|P1|NOT COMPLETED|Overall Study||4
444509|NCT01356667|1089009|P2|COMPLETED|Overall Study||0
444510|NCT01356667|1089010|P1|COMPLETED|Overall Study||0
444511|NCT01356667|1089009|P2|STARTED|Overall Study||6
444512|NCT01356667|1089010|P1|STARTED|Overall Study||4
444513|NCT01356628|1089020|P1|NOT COMPLETED|Overall Study||0
444514|NCT01356628|1089020|P1|COMPLETED|Overall Study||23
444515|NCT01356628|1089020|P1|STARTED|Overall Study||23
444516|NCT01356602|1089028|P3|NOT COMPLETED|Overall Study||24
444517|NCT01356602|1089029|P2|NOT COMPLETED|Overall Study||15
444518|NCT01356602|1089030|P1|NOT COMPLETED|Overall Study||9
444519|NCT01356602|1089028|P3|COMPLETED|Overall Study||108
444520|NCT01356602|1089029|P2|COMPLETED|Overall Study||117
444521|NCT01356602|1089030|P1|COMPLETED|Overall Study||124
444522|NCT01356602|1089028|P3|Full Analysis Set|Overall Study||129
444523|NCT01356602|1089029|P2|Full Analysis Set|Overall Study||129
444524|NCT01356602|1089030|P1|Full Analysis Set|Overall Study||131
444525|NCT01356602|1089028|P3|Safety Set|Overall Study|In this arm, 3 patients also took other active drug.|133
444526|NCT01356602|1089029|P2|Safety Set|Overall Study|In this arm, 3 patients also took other active drug.|133
444527|NCT01356602|1089030|P1|Safety Set|Overall Study|In this arm, 1 patient had only 3 placebo injections and 3 patients also took other active drug.|133
444528|NCT01356602|1089028|P3|STARTED|Overall Study||132
444529|NCT01356602|1089029|P2|STARTED|Overall Study||132
444530|NCT01356602|1089030|P1|STARTED|Overall Study||133
444531|NCT01356589|1089089|P1|NOT COMPLETED|Overall Study||5
444532|NCT01356589|1089089|P1|COMPLETED|Overall Study||1283
444533|NCT01356589|1089089|P1|Treated|Overall Study||1285
444534|NCT01356589|1089089|P1|STARTED|Overall Study||1288
444535|NCT01356498|1089101|P6|NOT COMPLETED|Overall Study||14
444536|NCT01356498|1089102|P5|NOT COMPLETED|Overall Study||20
444537|NCT01356498|1089103|P4|NOT COMPLETED|Overall Study||14
444538|NCT01356498|1089104|P3|NOT COMPLETED|Overall Study||12
444539|NCT01356498|1089105|P2|NOT COMPLETED|Overall Study||8
444540|NCT01356498|1089106|P1|NOT COMPLETED|Overall Study||11
444541|NCT01356498|1089101|P6|COMPLETED|Overall Study||2
444542|NCT01356498|1089102|P5|COMPLETED|Overall Study||8
444543|NCT01356498|1089103|P4|COMPLETED|Overall Study||8
444544|NCT01356498|1089104|P3|COMPLETED|Overall Study||11
444545|NCT01356498|1089105|P2|COMPLETED|Overall Study||17
444546|NCT01356498|1089106|P1|COMPLETED|Overall Study||24
444547|NCT01356498|1089101|P6|STARTED|Overall Study||16
444548|NCT01356498|1089102|P5|STARTED|Overall Study||28
444549|NCT01356498|1089103|P4|STARTED|Overall Study||22
444550|NCT01356498|1089104|P3|STARTED|Overall Study||23
444551|NCT01356498|1089105|P2|STARTED|Overall Study|2 other patients received no investigational drug in C0407 but elected to be followed in Observation|25
444552|NCT01356498|1089106|P1|STARTED|Overall Study||35
444553|NCT01356407|1089146|P2|NOT COMPLETED|Overall Study||4
444554|NCT01356407|1089147|P1|NOT COMPLETED|Overall Study||6
444555|NCT01356407|1089146|P2|COMPLETED|Overall Study||146
444556|NCT01356407|1089147|P1|COMPLETED|Overall Study||144
444557|NCT01356407|1089146|P2|STARTED|Overall Study||150
444558|NCT01356407|1089147|P1|STARTED|Overall Study||150
444559|NCT01356147|1089165|P2|NOT COMPLETED|Overall Study||0
444560|NCT01356147|1089166|P1|NOT COMPLETED|Overall Study||0
444561|NCT01356147|1089165|P2|COMPLETED|Overall Study||6
444562|NCT01356147|1089166|P1|COMPLETED|Overall Study||5
444563|NCT01356147|1089165|P2|STARTED|Overall Study||6
444564|NCT01356147|1089166|P1|STARTED|Overall Study||5
444565|NCT01355978|1089172|P1|NOT COMPLETED|Overall Study||4
444566|NCT01355978|1089172|P1|COMPLETED|Overall Study||18
444567|NCT01355978|1089172|P1|STARTED|Overall Study||22
444568|NCT01355705|1089178|P1|NOT COMPLETED|Overall Study||0
444569|NCT01355705|1089178|P1|COMPLETED|Overall Study||14
444570|NCT01355705|1089178|P1|STARTED|Overall Study||14
444571|NCT01355679|1089185|P1|NOT COMPLETED|Overall Study||2
444572|NCT01355679|1089185|P1|COMPLETED|Overall Study||14
444573|NCT01355679|1089185|P1|STARTED|Overall Study||16
444574|NCT01355627|1089194|P2|NOT COMPLETED|Overall Study||38
444575|NCT01355627|1089195|P1|NOT COMPLETED|Overall Study||33
444576|NCT01355627|1089194|P2|COMPLETED|Overall Study||326
444577|NCT01355627|1089195|P1|COMPLETED|Overall Study||329
444660|NCT01355588|1089207|P4|COMPLETED|First Intervention (Day 1)||4
444578|NCT01355627|1089194|P2|Full Analysis Set|Overall Study|One participant randomized to Current Practice actually received TachoSil®.|365
444579|NCT01355627|1089195|P1|Full Analysis Set|Overall Study|One participant's data for final follow-up is missing, completion status could not be confirmed.|361
444580|NCT01355627|1089194|P2|Safety Analysis Set|Overall Study||364
444581|NCT01355627|1089195|P1|Safety Analysis Set|Overall Study||362
444582|NCT01355627|1089194|P2|STARTED|Overall Study||364
444583|NCT01355627|1089195|P1|STARTED|Overall Study||362
444584|NCT01355588|1089207|P4|NOT COMPLETED|Fourth Intervention (After Washout)||0
444585|NCT01355588|1089208|P3|NOT COMPLETED|Fourth Intervention (After Washout)||0
444586|NCT01355588|1089209|P2|NOT COMPLETED|Fourth Intervention (After Washout)||0
444587|NCT01355588|1089210|P1|NOT COMPLETED|Fourth Intervention (After Washout)||0
444588|NCT01355588|1089207|P4|COMPLETED|Fourth Intervention (After Washout)||4
444589|NCT01355588|1089208|P3|COMPLETED|Fourth Intervention (After Washout)||4
444590|NCT01355588|1089209|P2|COMPLETED|Fourth Intervention (After Washout)||4
444591|NCT01355588|1089210|P1|COMPLETED|Fourth Intervention (After Washout)||4
444592|NCT01355588|1089207|P4|STARTED|Fourth Intervention (After Washout)||4
444593|NCT01355588|1089208|P3|STARTED|Fourth Intervention (After Washout)||4
444594|NCT01355588|1089209|P2|STARTED|Fourth Intervention (After Washout)||4
444595|NCT01355588|1089210|P1|STARTED|Fourth Intervention (After Washout)||4
444596|NCT01355588|1089207|P4|NOT COMPLETED|Washout (3-7 Days)||0
444597|NCT01355588|1089208|P3|NOT COMPLETED|Washout (3-7 Days)||0
444598|NCT01355588|1089209|P2|NOT COMPLETED|Washout (3-7 Days)||0
444599|NCT01355588|1089210|P1|NOT COMPLETED|Washout (3-7 Days)||0
444600|NCT01355588|1089207|P4|COMPLETED|Washout (3-7 Days)||4
444601|NCT01355588|1089208|P3|COMPLETED|Washout (3-7 Days)||4
444602|NCT01355588|1089209|P2|COMPLETED|Washout (3-7 Days)||4
444603|NCT01355588|1089210|P1|COMPLETED|Washout (3-7 Days)||4
444604|NCT01355588|1089207|P4|STARTED|Washout (3-7 Days)||4
444605|NCT01355588|1089208|P3|STARTED|Washout (3-7 Days)||4
444606|NCT01355588|1089209|P2|STARTED|Washout (3-7 Days)||4
444607|NCT01355588|1089210|P1|STARTED|Washout (3-7 Days)||4
444608|NCT01355588|1089207|P4|NOT COMPLETED|Third Intervention (After Washout)||0
444609|NCT01355588|1089208|P3|NOT COMPLETED|Third Intervention (After Washout)||0
444610|NCT01355588|1089209|P2|NOT COMPLETED|Third Intervention (After Washout)||0
444611|NCT01355588|1089210|P1|NOT COMPLETED|Third Intervention (After Washout)||0
444612|NCT01355588|1089207|P4|COMPLETED|Third Intervention (After Washout)||4
444613|NCT01355588|1089208|P3|COMPLETED|Third Intervention (After Washout)||4
444614|NCT01355588|1089209|P2|COMPLETED|Third Intervention (After Washout)||4
444615|NCT01355588|1089210|P1|COMPLETED|Third Intervention (After Washout)||4
444616|NCT01355588|1089207|P4|STARTED|Third Intervention (After Washout)||4
444617|NCT01355588|1089208|P3|STARTED|Third Intervention (After Washout)||4
444618|NCT01355588|1089209|P2|STARTED|Third Intervention (After Washout)||4
444619|NCT01355588|1089210|P1|STARTED|Third Intervention (After Washout)||4
444620|NCT01355588|1089207|P4|NOT COMPLETED|Washout (3-7 Days)||0
444621|NCT01355588|1089208|P3|NOT COMPLETED|Washout (3-7 Days)||0
444622|NCT01355588|1089209|P2|NOT COMPLETED|Washout (3-7 Days)||0
444623|NCT01355588|1089210|P1|NOT COMPLETED|Washout (3-7 Days)||0
444624|NCT01355588|1089207|P4|COMPLETED|Washout (3-7 Days)||4
444625|NCT01355588|1089208|P3|COMPLETED|Washout (3-7 Days)||4
444626|NCT01355588|1089209|P2|COMPLETED|Washout (3-7 Days)||4
444627|NCT01355588|1089210|P1|COMPLETED|Washout (3-7 Days)||4
444628|NCT01355588|1089207|P4|STARTED|Washout (3-7 Days)||4
444629|NCT01355588|1089208|P3|STARTED|Washout (3-7 Days)||4
444630|NCT01355588|1089209|P2|STARTED|Washout (3-7 Days)||4
444631|NCT01355588|1089210|P1|STARTED|Washout (3-7 Days)||4
444632|NCT01355588|1089207|P4|NOT COMPLETED|Second Intervention (After Washout)||0
444633|NCT01355588|1089208|P3|NOT COMPLETED|Second Intervention (After Washout)||0
444634|NCT01355588|1089209|P2|NOT COMPLETED|Second Intervention (After Washout)||0
444635|NCT01355588|1089210|P1|NOT COMPLETED|Second Intervention (After Washout)||0
444636|NCT01355588|1089207|P4|COMPLETED|Second Intervention (After Washout)||4
444637|NCT01355588|1089208|P3|COMPLETED|Second Intervention (After Washout)||4
444638|NCT01355588|1089209|P2|COMPLETED|Second Intervention (After Washout)||4
444639|NCT01355588|1089210|P1|COMPLETED|Second Intervention (After Washout)||4
444640|NCT01355588|1089207|P4|STARTED|Second Intervention (After Washout)||4
444641|NCT01355588|1089208|P3|STARTED|Second Intervention (After Washout)||4
444642|NCT01355588|1089209|P2|STARTED|Second Intervention (After Washout)||4
444643|NCT01355588|1089210|P1|STARTED|Second Intervention (After Washout)||4
444644|NCT01355588|1089207|P4|NOT COMPLETED|Washout (3-7 Days)||0
444645|NCT01355588|1089208|P3|NOT COMPLETED|Washout (3-7 Days)||0
444646|NCT01355588|1089209|P2|NOT COMPLETED|Washout (3-7 Days)||0
444647|NCT01355588|1089210|P1|NOT COMPLETED|Washout (3-7 Days)||0
444648|NCT01355588|1089207|P4|COMPLETED|Washout (3-7 Days)||4
444649|NCT01355588|1089208|P3|COMPLETED|Washout (3-7 Days)||4
444650|NCT01355588|1089209|P2|COMPLETED|Washout (3-7 Days)||4
444651|NCT01355588|1089210|P1|COMPLETED|Washout (3-7 Days)||4
444652|NCT01355588|1089207|P4|STARTED|Washout (3-7 Days)||4
444653|NCT01355588|1089208|P3|STARTED|Washout (3-7 Days)||4
444654|NCT01355588|1089209|P2|STARTED|Washout (3-7 Days)||4
444655|NCT01355588|1089210|P1|STARTED|Washout (3-7 Days)||4
444656|NCT01355588|1089207|P4|NOT COMPLETED|First Intervention (Day 1)||0
444657|NCT01355588|1089208|P3|NOT COMPLETED|First Intervention (Day 1)||0
444658|NCT01355588|1089209|P2|NOT COMPLETED|First Intervention (Day 1)||0
444659|NCT01355588|1089210|P1|NOT COMPLETED|First Intervention (Day 1)||0
444661|NCT01355588|1089208|P3|COMPLETED|First Intervention (Day 1)||4
444662|NCT01355588|1089209|P2|COMPLETED|First Intervention (Day 1)||4
444663|NCT01355588|1089210|P1|COMPLETED|First Intervention (Day 1)||4
444664|NCT01355588|1089207|P4|STARTED|First Intervention (Day 1)||4
444665|NCT01355588|1089208|P3|STARTED|First Intervention (Day 1)||4
444666|NCT01355588|1089209|P2|STARTED|First Intervention (Day 1)||4
444667|NCT01355588|1089210|P1|STARTED|First Intervention (Day 1)||4
444668|NCT01355523|1089234|P2|NOT COMPLETED|Overall Study||10
444669|NCT01355523|1089235|P1|NOT COMPLETED|Overall Study||1
444670|NCT01355523|1089234|P2|COMPLETED|Overall Study||16
444671|NCT01355523|1089235|P1|COMPLETED|Overall Study||27
444672|NCT01355523|1089234|P2|STARTED|Overall Study||26
444673|NCT01355523|1089235|P1|STARTED|Overall Study||28
444674|NCT01355484|1089279|P2|NOT COMPLETED|Overall Study||54
444675|NCT01355484|1089280|P1|NOT COMPLETED|Overall Study||51
444676|NCT01355484|1089279|P2|COMPLETED|Overall Study||107
444677|NCT01355484|1089280|P1|COMPLETED|Overall Study||109
444678|NCT01355484|1089279|P2|STARTED|Overall Study||161
444679|NCT01355484|1089280|P1|STARTED|Overall Study||160
444680|NCT01355471|1089290|P2|NOT COMPLETED|Overall Study||3
444681|NCT01355471|1089291|P1|NOT COMPLETED|Overall Study||7
444682|NCT01355471|1089290|P2|COMPLETED|Overall Study||142
444683|NCT01355471|1089291|P1|COMPLETED|Overall Study||141
444684|NCT01355471|1089290|P2|STARTED|Overall Study||145
444685|NCT01355471|1089291|P1|STARTED|Overall Study||148
444686|NCT01355458|1089299|P2|NOT COMPLETED|Overall Study||4
444687|NCT01355458|1089300|P1|NOT COMPLETED|Overall Study||2
444688|NCT01355458|1089299|P2|COMPLETED|Overall Study||127
444689|NCT01355458|1089300|P1|COMPLETED|Overall Study||127
444690|NCT01355458|1089299|P2|STARTED|Overall Study||131
444691|NCT01355458|1089300|P1|STARTED|Overall Study||129
444692|NCT01355419|1089306|P1|NOT COMPLETED|Overall Study||8
444693|NCT01355419|1089306|P1|COMPLETED|Overall Study||142
444694|NCT01355419|1089306|P1|STARTED|Overall Study||150
444695|NCT01355302|1089311|P3|NOT COMPLETED|Phase 2||0
444696|NCT01355302|1089312|P2|NOT COMPLETED|Phase 2||0
444697|NCT01355302|1089313|P1|NOT COMPLETED|Phase 2||0
444698|NCT01355302|1089311|P3|COMPLETED|Phase 2||0
444699|NCT01355302|1089312|P2|COMPLETED|Phase 2||0
444700|NCT01355302|1089313|P1|COMPLETED|Phase 2||0
444701|NCT01355302|1089311|P3|STARTED|Phase 2|The study was terminated prior to enrollment|0
444702|NCT01355302|1089312|P2|STARTED|Phase 2|The study was terminated prior to enrollment|0
444703|NCT01355302|1089313|P1|STARTED|Phase 2|Treatment arm not designated for phase 2.|0
444704|NCT01355302|1089311|P3|NOT COMPLETED|Phase 1b||0
444705|NCT01355302|1089312|P2|NOT COMPLETED|Phase 1b||0
444706|NCT01355302|1089313|P1|NOT COMPLETED|Phase 1b||6
444707|NCT01355302|1089311|P3|COMPLETED|Phase 1b||0
444708|NCT01355302|1089312|P2|COMPLETED|Phase 1b||0
444709|NCT01355302|1089313|P1|COMPLETED|Phase 1b|The subject who completed 6 cycles was withdrawn by sponsor request.|1
444710|NCT01355302|1089311|P3|STARTED|Phase 1b||0
444711|NCT01355302|1089312|P2|STARTED|Phase 1b||0
444712|NCT01355302|1089313|P1|STARTED|Phase 1b|Replaced 1 subject; who discontinued study drug in first cycle|7
444713|NCT01355289|1089328|P5|NOT COMPLETED|Open Label Extension||34
444714|NCT01355289|1089329|P4|NOT COMPLETED|Open Label Extension||0
444715|NCT01355289|1089330|P3|NOT COMPLETED|Open Label Extension||0
444716|NCT01355289|1089331|P2|NOT COMPLETED|Open Label Extension||0
444717|NCT01355289|1089332|P1|NOT COMPLETED|Open Label Extension||0
444718|NCT01355289|1089328|P5|COMPLETED|Open Label Extension||28
444719|NCT01355289|1089329|P4|COMPLETED|Open Label Extension||0
444720|NCT01355289|1089330|P3|COMPLETED|Open Label Extension||0
444721|NCT01355289|1089331|P2|COMPLETED|Open Label Extension||0
444722|NCT01355289|1089332|P1|COMPLETED|Open Label Extension||0
444723|NCT01355289|1089328|P5|STARTED|Open Label Extension||62
444724|NCT01355289|1089329|P4|STARTED|Open Label Extension||0
444725|NCT01355289|1089330|P3|STARTED|Open Label Extension||0
444726|NCT01355289|1089331|P2|STARTED|Open Label Extension||0
444727|NCT01355289|1089332|P1|STARTED|Open Label Extension||0
444728|NCT01355289|1089328|P5|NOT COMPLETED|Core Study||0
444729|NCT01355289|1089329|P4|NOT COMPLETED|Core Study||2
444730|NCT01355289|1089330|P3|NOT COMPLETED|Core Study||0
444731|NCT01355289|1089331|P2|NOT COMPLETED|Core Study||0
444732|NCT01355289|1089332|P1|NOT COMPLETED|Core Study||1
444733|NCT01355289|1089328|P5|COMPLETED|Core Study||0
444734|NCT01355289|1089329|P4|COMPLETED|Core Study||12
444735|NCT01355289|1089330|P3|COMPLETED|Core Study||18
444736|NCT01355289|1089331|P2|COMPLETED|Core Study||16
444737|NCT01355289|1089332|P1|COMPLETED|Core Study||16
444738|NCT01355289|1089328|P5|STARTED|Core Study||0
444739|NCT01355289|1089329|P4|STARTED|Core Study||14
444740|NCT01355289|1089330|P3|STARTED|Core Study||18
444741|NCT01355289|1089331|P2|STARTED|Core Study||16
444742|NCT01355289|1089332|P1|STARTED|Core Study||17
444743|NCT01355224|1089359|P4|NOT COMPLETED|Overall Study||29
444744|NCT01355224|1089360|P3|NOT COMPLETED|Overall Study||19
444745|NCT01355224|1089361|P2|NOT COMPLETED|Overall Study||23
444746|NCT01355224|1089362|P1|NOT COMPLETED|Overall Study||31
444747|NCT01355224|1089359|P4|COMPLETED|Overall Study||172
444748|NCT01355224|1089360|P3|COMPLETED|Overall Study||177
444749|NCT01355224|1089361|P2|COMPLETED|Overall Study||180
444750|NCT01355224|1089362|P1|COMPLETED|Overall Study||167
444751|NCT01355224|1089359|P4|Competed Baseline|Overall Study||193
444752|NCT01355224|1089360|P3|Competed Baseline|Overall Study||193
444753|NCT01355224|1089361|P2|Competed Baseline|Overall Study||200
444754|NCT01355224|1089362|P1|Competed Baseline|Overall Study||191
444755|NCT01355224|1089359|P4|STARTED|Overall Study||201
444756|NCT01355224|1089360|P3|STARTED|Overall Study||196
444757|NCT01355224|1089361|P2|STARTED|Overall Study||203
444758|NCT01355224|1089362|P1|STARTED|Overall Study||198
444759|NCT01355081|1089385|P3|NOT COMPLETED|Overall Study||11
444760|NCT01355081|1089386|P2|NOT COMPLETED|Overall Study||10
444761|NCT01355081|1089387|P1|NOT COMPLETED|Overall Study||7
444762|NCT01355081|1089385|P3|COMPLETED|Overall Study||113
444763|NCT01355081|1089386|P2|COMPLETED|Overall Study||113
444764|NCT01355081|1089387|P1|COMPLETED|Overall Study||112
444765|NCT01355081|1089385|P3|STARTED|Overall Study||124
444766|NCT01355081|1089386|P2|STARTED|Overall Study||123
444767|NCT01355081|1089387|P1|STARTED|Overall Study||119
444768|NCT01355068|1089410|P2|NOT COMPLETED|Second Intervention Period||0
444769|NCT01355068|1089411|P1|NOT COMPLETED|Second Intervention Period||0
444770|NCT01355068|1089410|P2|COMPLETED|Second Intervention Period||11
444771|NCT01355068|1089411|P1|COMPLETED|Second Intervention Period||13
444772|NCT01355068|1089410|P2|STARTED|Second Intervention Period||11
444773|NCT01355068|1089411|P1|STARTED|Second Intervention Period||13
444774|NCT01355068|1089410|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
444775|NCT01355068|1089411|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
444776|NCT01355068|1089410|P2|COMPLETED|Washout Period (at Least 7 Days)||11
444777|NCT01355068|1089411|P1|COMPLETED|Washout Period (at Least 7 Days)||13
444778|NCT01355068|1089410|P2|STARTED|Washout Period (at Least 7 Days)||11
444779|NCT01355068|1089411|P1|STARTED|Washout Period (at Least 7 Days)||13
444780|NCT01355068|1089410|P2|NOT COMPLETED|First Intervention Period||2
444781|NCT01355068|1089411|P1|NOT COMPLETED|First Intervention Period||0
444782|NCT01355068|1089410|P2|COMPLETED|First Intervention Period||11
444783|NCT01355068|1089411|P1|COMPLETED|First Intervention Period||13
444784|NCT01355068|1089410|P2|STARTED|First Intervention Period||13
444785|NCT01355068|1089411|P1|STARTED|First Intervention Period||13
444786|NCT01354990|1089427|P1|NOT COMPLETED|Overall Study||0
444787|NCT01354990|1089427|P1|COMPLETED|Overall Study||2974
444788|NCT01354990|1089427|P1|STARTED|Overall Study||2974
444789|NCT01354938|1089434|P1|NOT COMPLETED|Overall Study||1
444790|NCT01354938|1089434|P1|COMPLETED|Overall Study||219
444791|NCT01354938|1089434|P1|STARTED|Overall Study||220
444792|NCT01354899|1089440|P1|NOT COMPLETED|Overall Study||3
444793|NCT01354899|1089440|P1|COMPLETED|Overall Study||21
444794|NCT01354899|1089440|P1|STARTED|Overall Study||24
444795|NCT01354652|1089448|P3|NOT COMPLETED|Overall Study||0
444796|NCT01354652|1089449|P2|NOT COMPLETED|Overall Study||2
444797|NCT01354652|1089450|P1|NOT COMPLETED|Overall Study||3
444798|NCT01354652|1089448|P3|COMPLETED|Overall Study||0
444799|NCT01354652|1089449|P2|COMPLETED|Overall Study||0
444800|NCT01354652|1089450|P1|COMPLETED|Overall Study||0
444801|NCT01354652|1089448|P3|STARTED|Overall Study||0
444802|NCT01354652|1089449|P2|STARTED|Overall Study||2
444803|NCT01354652|1089450|P1|STARTED|Overall Study||3
444804|NCT01354444|1089475|P2|NOT COMPLETED|Overall Study||4
444805|NCT01354444|1089476|P1|NOT COMPLETED|Overall Study||8
444806|NCT01354444|1089475|P2|COMPLETED|Overall Study||11
444807|NCT01354444|1089476|P1|COMPLETED|Overall Study||6
444808|NCT01354444|1089475|P2|STARTED|Overall Study||15
444809|NCT01354444|1089476|P1|STARTED|Overall Study||14
444810|NCT01354431|1089489|P3|NOT COMPLETED|Participants Treated||54
444811|NCT01354431|1089490|P2|NOT COMPLETED|Participants Treated||54
444812|NCT01354431|1089491|P1|NOT COMPLETED|Participants Treated||59
444813|NCT01354431|1089489|P3|COMPLETED|Participants Treated||0
444814|NCT01354431|1089490|P2|COMPLETED|Participants Treated||0
444815|NCT01354431|1089491|P1|COMPLETED|Participants Treated||0
444816|NCT01354431|1089489|P3|STARTED|Participants Treated||54
444817|NCT01354431|1089490|P2|STARTED|Participants Treated||54
444818|NCT01354431|1089491|P1|STARTED|Participants Treated||59
444819|NCT01354431|1089489|P3|NOT COMPLETED|Randomized to Enter Treatment Period||0
444820|NCT01354431|1089490|P2|NOT COMPLETED|Randomized to Enter Treatment Period||0
444821|NCT01354431|1089491|P1|NOT COMPLETED|Randomized to Enter Treatment Period||1
444822|NCT01354431|1089489|P3|COMPLETED|Randomized to Enter Treatment Period||54
444823|NCT01354431|1089490|P2|COMPLETED|Randomized to Enter Treatment Period||54
444824|NCT01354431|1089491|P1|COMPLETED|Randomized to Enter Treatment Period||59
444825|NCT01354431|1089489|P3|STARTED|Randomized to Enter Treatment Period||54
444826|NCT01354431|1089490|P2|STARTED|Randomized to Enter Treatment Period||54
444827|NCT01354431|1089491|P1|STARTED|Randomized to Enter Treatment Period||60
444828|NCT01354314|1089515|P4|NOT COMPLETED|Overall Study||6
444829|NCT01354314|1089516|P3|NOT COMPLETED|Overall Study||8
444830|NCT01354314|1089517|P2|NOT COMPLETED|Overall Study||3
444831|NCT01354314|1089518|P1|NOT COMPLETED|Overall Study||6
444832|NCT01354314|1089515|P4|COMPLETED|Overall Study||5
444833|NCT01354314|1089516|P3|COMPLETED|Overall Study||3
444834|NCT01354314|1089517|P2|COMPLETED|Overall Study||8
444835|NCT01354314|1089518|P1|COMPLETED|Overall Study||6
444836|NCT01354314|1089515|P4|Completed (ITT)|Overall Study||10
444837|NCT01354314|1089516|P3|Completed (ITT)|Overall Study||9
444838|NCT01354314|1089517|P2|Completed (ITT)|Overall Study||11
444839|NCT01354314|1089518|P1|Completed (ITT)|Overall Study||11
444840|NCT01354314|1089515|P4|STARTED|Overall Study||11
444841|NCT01354314|1089516|P3|STARTED|Overall Study||11
444842|NCT01354314|1089517|P2|STARTED|Overall Study||11
444843|NCT01354314|1089518|P1|STARTED|Overall Study||12
444844|NCT01354223|1089654|P2|NOT COMPLETED|Overall Study||1
444845|NCT01354223|1089655|P1|NOT COMPLETED|Overall Study||3
444846|NCT01354223|1089654|P2|COMPLETED|Overall Study||29
444847|NCT01354223|1089655|P1|COMPLETED|Overall Study||57
444848|NCT01354223|1089654|P2|STARTED|Overall Study||30
444849|NCT01354223|1089655|P1|STARTED|Overall Study||60
444850|NCT01354197|1089671|P1|NOT COMPLETED|Overall Study||0
444851|NCT01354197|1089671|P1|COMPLETED|Overall Study||4652
444852|NCT01354197|1089671|P1|STARTED|Overall Study||4652
444853|NCT01354145|1089679|P2|NOT COMPLETED|Overall Study||34
444854|NCT01354145|1089680|P1|NOT COMPLETED|Overall Study||39
444855|NCT01354145|1089679|P2|COMPLETED|Overall Study||63
444856|NCT01354145|1089680|P1|COMPLETED|Overall Study||58
444857|NCT01354145|1089679|P2|STARTED|Overall Study||97
444858|NCT01354145|1089680|P1|STARTED|Overall Study||97
444859|NCT01354132|1089714|P2|NOT COMPLETED|1 Month Post Study Medication||3
444860|NCT01354132|1089715|P1|NOT COMPLETED|1 Month Post Study Medication||1
444861|NCT01354132|1089714|P2|COMPLETED|1 Month Post Study Medication||16
444862|NCT01354132|1089715|P1|COMPLETED|1 Month Post Study Medication||21
444863|NCT01354132|1089714|P2|1 Follow-up Visit (Visit 8)|1 Month Post Study Medication||16
444864|NCT01354132|1089715|P1|1 Follow-up Visit (Visit 8)|1 Month Post Study Medication||21
444865|NCT01354132|1089714|P2|STARTED|1 Month Post Study Medication||19
444866|NCT01354132|1089715|P1|STARTED|1 Month Post Study Medication||22
444867|NCT01354132|1089714|P2|NOT COMPLETED|Double Blind (Visits 1-7)||11
444868|NCT01354132|1089715|P1|NOT COMPLETED|Double Blind (Visits 1-7)||9
444869|NCT01354132|1089714|P2|COMPLETED|Double Blind (Visits 1-7)||19
444870|NCT01354132|1089715|P1|COMPLETED|Double Blind (Visits 1-7)||22
444871|NCT01354132|1089714|P2|Didn't Complete at Least 1 Visit|Double Blind (Visits 1-7)||4
444872|NCT01354132|1089715|P1|Didn't Complete at Least 1 Visit|Double Blind (Visits 1-7)||2
444873|NCT01354132|1089714|P2|Stopped After First Visit|Double Blind (Visits 1-7)||2
444874|NCT01354132|1089715|P1|Stopped After First Visit|Double Blind (Visits 1-7)||3
444875|NCT01354132|1089714|P2|Completed More Than 1 Visit|Double Blind (Visits 1-7)||5
444876|NCT01354132|1089715|P1|Completed More Than 1 Visit|Double Blind (Visits 1-7)||4
444877|NCT01354132|1089714|P2|STARTED|Double Blind (Visits 1-7)|11 did not compete 7 study visits|30
444878|NCT01354132|1089715|P1|STARTED|Double Blind (Visits 1-7)|9 did not compete 7 study visits|31
444879|NCT01354132|1089714|P2|NOT COMPLETED|Randomization||1
444880|NCT01354132|1089715|P1|NOT COMPLETED|Randomization||1
444881|NCT01354132|1089714|P2|COMPLETED|Randomization||30
444882|NCT01354132|1089715|P1|COMPLETED|Randomization||31
444883|NCT01354132|1089714|P2|STARTED|Randomization|1 never took study medication due to subject withdrawal|31
444884|NCT01354132|1089715|P1|STARTED|Randomization|1 never took study medication dropped by physician decision (White matter lesion on MRI)|32
444885|NCT01354106|1089753|P1|NOT COMPLETED|Overall Study||2
444886|NCT01354106|1089753|P1|COMPLETED|Overall Study||24
444887|NCT01354106|1089753|P1|STARTED|Overall Study||26
444888|NCT01354028|1089759|P2|NOT COMPLETED|Overall Study||5
444889|NCT01354028|1089760|P1|NOT COMPLETED|Overall Study||2
444890|NCT01354028|1089759|P2|COMPLETED|Overall Study||10
444891|NCT01354028|1089760|P1|COMPLETED|Overall Study||13
444892|NCT01354028|1089759|P2|STARTED|Overall Study||15
444893|NCT01354028|1089760|P1|STARTED|Overall Study||15
444894|NCT01354015|1089774|P2|NOT COMPLETED|Overall Study||5
444895|NCT01354015|1089775|P1|NOT COMPLETED|Overall Study||6
444896|NCT01354015|1089774|P2|COMPLETED|Overall Study||43
444897|NCT01354015|1089775|P1|COMPLETED|Overall Study||44
444898|NCT01354015|1089774|P2|STARTED|Overall Study||48
444899|NCT01354015|1089775|P1|STARTED|Overall Study||50
444900|NCT01353976|1089785|P2|NOT COMPLETED|Overall Study||51
444901|NCT01353976|1089786|P1|NOT COMPLETED|Overall Study||48
444902|NCT01353976|1089785|P2|COMPLETED|Overall Study||83
444903|NCT01353976|1089786|P1|COMPLETED|Overall Study||82
444904|NCT01353976|1089785|P2|STARTED|Overall Study||134
444905|NCT01353976|1089786|P1|STARTED|Overall Study||130
444906|NCT01353963|1089796|P1|NOT COMPLETED|Overall Study||2
444907|NCT01353963|1089796|P1|COMPLETED|Overall Study||11
444908|NCT01353963|1089796|P1|STARTED|Overall Study||13
444909|NCT01353911|1089814|P8|NOT COMPLETED|Overall Study||15
444910|NCT01353911|1089815|P7|NOT COMPLETED|Overall Study||6
444911|NCT01353911|1089816|P6|NOT COMPLETED|Overall Study||7
444912|NCT01353911|1089817|P5|NOT COMPLETED|Overall Study||6
444913|NCT01353911|1089818|P4|NOT COMPLETED|Overall Study||2
444914|NCT01353911|1089819|P3|NOT COMPLETED|Overall Study||9
444915|NCT01353911|1089820|P2|NOT COMPLETED|Overall Study||9
444916|NCT01353911|1089821|P1|NOT COMPLETED|Overall Study||8
444917|NCT01353911|1089814|P8|COMPLETED|Overall Study||51
444918|NCT01353911|1089815|P7|COMPLETED|Overall Study||30
444919|NCT01353911|1089816|P6|COMPLETED|Overall Study||36
444920|NCT01353911|1089817|P5|COMPLETED|Overall Study||23
444921|NCT01353911|1089818|P4|COMPLETED|Overall Study||22
444922|NCT01353911|1089819|P3|COMPLETED|Overall Study||59
444923|NCT01353911|1089820|P2|COMPLETED|Overall Study||57
444924|NCT01353911|1089821|P1|COMPLETED|Overall Study||28
444925|NCT01353911|1089814|P8|STARTED|Overall Study||66
444926|NCT01353911|1089815|P7|STARTED|Overall Study||36
444927|NCT01353911|1089816|P6|STARTED|Overall Study||43
444928|NCT01353911|1089817|P5|STARTED|Overall Study||29
444929|NCT01353911|1089818|P4|STARTED|Overall Study||24
444930|NCT01353911|1089819|P3|STARTED|Overall Study||68
444931|NCT01353911|1089820|P2|STARTED|Overall Study||66
444932|NCT01353911|1089821|P1|STARTED|Overall Study||36
444933|NCT01353898|1089901|P6|NOT COMPLETED|Overall Study||1
444934|NCT01353898|1089902|P5|NOT COMPLETED|Overall Study||0
444935|NCT01353898|1089903|P4|NOT COMPLETED|Overall Study||0
444936|NCT01353898|1089904|P3|NOT COMPLETED|Overall Study||0
444937|NCT01353898|1089905|P2|NOT COMPLETED|Overall Study||0
444938|NCT01353898|1089906|P1|NOT COMPLETED|Overall Study||0
444939|NCT01353898|1089901|P6|COMPLETED|Overall Study||1
444940|NCT01353898|1089902|P5|COMPLETED|Overall Study||2
444941|NCT01353898|1089903|P4|COMPLETED|Overall Study||2
444942|NCT01353898|1089904|P3|COMPLETED|Overall Study||2
444943|NCT01353898|1089905|P2|COMPLETED|Overall Study||2
444944|NCT01353898|1089906|P1|COMPLETED|Overall Study||2
444945|NCT01353898|1089901|P6|STARTED|Overall Study||2
444946|NCT01353898|1089902|P5|STARTED|Overall Study||2
444947|NCT01353898|1089903|P4|STARTED|Overall Study||2
444948|NCT01353898|1089904|P3|STARTED|Overall Study||2
444949|NCT01353898|1089905|P2|STARTED|Overall Study||2
444950|NCT01353898|1089906|P1|STARTED|Overall Study||2
444951|NCT01353859|1089932|P1|NOT COMPLETED|Overall Study||4
444952|NCT01353859|1089932|P1|COMPLETED|Overall Study||35
444953|NCT01353859|1089932|P1|STARTED|Overall Study||39
444954|NCT01353664|1089945|P1|NOT COMPLETED|Overall Study||19
444955|NCT01353664|1089945|P1|COMPLETED|Overall Study|Completed = Number of participants who continued on Romidepsin treatment|0
444956|NCT01353664|1089945|P1|STARTED|Overall Study|Participants who received at least 1 dose of study drug.|19
444957|NCT01353586|1089951|P2|NOT COMPLETED|Overall Study||2
444958|NCT01353586|1089952|P1|NOT COMPLETED|Overall Study||7
444959|NCT01353586|1089951|P2|COMPLETED|Overall Study||17
444960|NCT01353586|1089952|P1|COMPLETED|Overall Study||160
444961|NCT01353586|1089951|P2|Participated in SNA Substudy|Overall Study||19
444962|NCT01353586|1089952|P1|Participated in SNA Substudy|Overall Study||19
444963|NCT01353586|1089951|P2|Participated in Roll-in Phase|Overall Study||0
444964|NCT01353586|1089952|P1|Participated in Roll-in Phase|Overall Study||22
444965|NCT01353586|1089951|P2|Participated in Workflow Phase|Overall Study||0
444966|NCT01353586|1089952|P1|Participated in Workflow Phase|Overall Study||20
444967|NCT01353586|1089951|P2|STARTED|Overall Study||19
444968|NCT01353586|1089952|P1|STARTED|Overall Study||167
444969|NCT01353508|1089970|P4|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
444970|NCT01353508|1089971|P3|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
444971|NCT01353508|1089972|P2|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
444972|NCT01353508|1089973|P1|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||1
444973|NCT01353508|1089970|P4|COMPLETED|Period 2 - Second Intervention (7 Days)||7
444974|NCT01353508|1089971|P3|COMPLETED|Period 2 - Second Intervention (7 Days)||8
444975|NCT01353508|1089972|P2|COMPLETED|Period 2 - Second Intervention (7 Days)||8
444976|NCT01353508|1089973|P1|COMPLETED|Period 2 - Second Intervention (7 Days)||7
444977|NCT01353508|1089970|P4|STARTED|Period 2 - Second Intervention (7 Days)||7
444978|NCT01353508|1089971|P3|STARTED|Period 2 - Second Intervention (7 Days)||8
444979|NCT01353508|1089972|P2|STARTED|Period 2 - Second Intervention (7 Days)||8
444980|NCT01353508|1089973|P1|STARTED|Period 2 - Second Intervention (7 Days)||8
444981|NCT01353508|1089970|P4|NOT COMPLETED|Period 1 - First Intervention (7 Days)||1
444982|NCT01353508|1089971|P3|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
444983|NCT01353508|1089972|P2|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
444984|NCT01353508|1089973|P1|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
444985|NCT01353508|1089970|P4|COMPLETED|Period 1 - First Intervention (7 Days)||7
444986|NCT01353508|1089971|P3|COMPLETED|Period 1 - First Intervention (7 Days)||8
444987|NCT01353508|1089972|P2|COMPLETED|Period 1 - First Intervention (7 Days)||8
444988|NCT01353508|1089973|P1|COMPLETED|Period 1 - First Intervention (7 Days)||8
444989|NCT01353508|1089970|P4|STARTED|Period 1 - First Intervention (7 Days)||8
444990|NCT01353508|1089971|P3|STARTED|Period 1 - First Intervention (7 Days)||8
444991|NCT01353508|1089972|P2|STARTED|Period 1 - First Intervention (7 Days)||8
444992|NCT01353508|1089973|P1|STARTED|Period 1 - First Intervention (7 Days)||8
444993|NCT01353274|1090051|P1|NOT COMPLETED|Overall Study||28
444994|NCT01353274|1090051|P1|COMPLETED|Overall Study||1129
444995|NCT01353274|1090051|P1|STARTED|Overall Study||1157
444996|NCT01353222|1090061|P2|NOT COMPLETED|Overall Study||72
444997|NCT01353222|1090062|P1|NOT COMPLETED|Overall Study||70
444998|NCT01353222|1090061|P2|COMPLETED|Overall Study||0
444999|NCT01353222|1090062|P1|COMPLETED|Overall Study||0
445000|NCT01353222|1090061|P2|Standard Care Arm ≥1 Post-baseline Visit|Overall Study||72
445001|NCT01353222|1090062|P1|Standard Care Arm ≥1 Post-baseline Visit|Overall Study||0
445002|NCT01353222|1090061|P2|DN24-02 Arm ≥1 Leukapheresis|Overall Study||0
445003|NCT01353222|1090062|P1|DN24-02 Arm ≥1 Leukapheresis|Overall Study||67
445004|NCT01353222|1090061|P2|STARTED|Overall Study||72
445005|NCT01353222|1090062|P1|STARTED|Overall Study||70
445006|NCT01353144|1090070|P2|NOT COMPLETED|Overall Study||8
445007|NCT01353144|1090071|P1|NOT COMPLETED|Overall Study||9
445008|NCT01353144|1090070|P2|COMPLETED|Overall Study||81
445009|NCT01353144|1090071|P1|COMPLETED|Overall Study||80
445010|NCT01353144|1090070|P2|STARTED|Overall Study||89
445011|NCT01353144|1090071|P1|STARTED|Overall Study||89
445012|NCT01353079|1090081|P2|NOT COMPLETED|Overall Study||21
445013|NCT01353079|1090082|P1|NOT COMPLETED|Overall Study||27
445014|NCT01353079|1090081|P2|COMPLETED|Overall Study||190
445015|NCT01353079|1090082|P1|COMPLETED|Overall Study||191
445016|NCT01353079|1090081|P2|STARTED|Overall Study||211
445017|NCT01353079|1090082|P1|STARTED|Overall Study||218
445018|NCT01352845|1090096|P2|NOT COMPLETED|Overall Study||203
445019|NCT01352845|1090097|P1|NOT COMPLETED|Overall Study||671
445020|NCT01352845|1090096|P2|COMPLETED|Overall Study||619
445021|NCT01352845|1090097|P1|COMPLETED|Overall Study||1800
445022|NCT01352845|1090096|P2|STARTED|Overall Study||822
445023|NCT01352845|1090097|P1|STARTED|Overall Study||2471
445024|NCT01352793|1090186|P2|NOT COMPLETED|Overall Study||245
445025|NCT01352793|1090187|P1|NOT COMPLETED|Overall Study||585
445026|NCT01352793|1090186|P2|COMPLETED|Overall Study||1663
445027|NCT01352793|1090187|P1|COMPLETED|Overall Study||3219
445028|NCT01352793|1090186|P2|Vaccination 3|Overall Study||1710
445029|NCT01352793|1090187|P1|Vaccination 3|Overall Study||3314
445030|NCT01352793|1090186|P2|Vaccination 2|Overall Study||1806
445031|NCT01352793|1090187|P1|Vaccination 2|Overall Study||3530
445032|NCT01352793|1090186|P2|Vaccination 1|Overall Study||1908
445033|NCT01352793|1090187|P1|Vaccination 1|Overall Study||3796
445034|NCT01352793|1090186|P2|STARTED|Overall Study||1908
445035|NCT01352793|1090187|P1|STARTED|Overall Study||3804
445036|NCT01352741|1090211|P2|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
445037|NCT01352741|1090212|P1|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
445038|NCT01352741|1090211|P2|COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
445039|NCT01352741|1090212|P1|COMPLETED|Open-Label Tapentadol Pick-Up Arm||37
445040|NCT01352741|1090211|P2|STARTED|Open-Label Tapentadol Pick-Up Arm|Participants did not continue treatment. They were switched to tapentadol PR or discontinued.|0
445041|NCT01352741|1090212|P1|STARTED|Open-Label Tapentadol Pick-Up Arm|19 from tapentadol in the comparative phase and 18 from tapentadol & pregabalin entered this arm.|37
445042|NCT01352741|1090211|P2|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||0
445043|NCT01352741|1090212|P1|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||8
445044|NCT01352741|1090211|P2|COMPLETED|Open-Label Tapentadol Continuation Arm||0
445045|NCT01352741|1090212|P1|COMPLETED|Open-Label Tapentadol Continuation Arm||51
445046|NCT01352741|1090211|P2|Full Analysis Set|Open-Label Tapentadol Continuation Arm||0
445047|NCT01352741|1090212|P1|Full Analysis Set|Open-Label Tapentadol Continuation Arm||57
445048|NCT01352741|1090211|P2|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||0
445049|NCT01352741|1090212|P1|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||2
445050|NCT01352741|1090211|P2|STARTED|Open-Label Tapentadol Continuation Arm|In this period no tapentadol PR and pregabalin treatment was planned by the protocol.|0
445051|NCT01352741|1090212|P1|STARTED|Open-Label Tapentadol Continuation Arm|59 of the 73 participants that did not qualify for the comparative period entered this arm.|59
445052|NCT01352741|1090211|P2|NOT COMPLETED|Double-blind Comparative Period||26
445053|NCT01352741|1090212|P1|NOT COMPLETED|Double-blind Comparative Period||28
445054|NCT01352741|1090211|P2|COMPLETED|Double-blind Comparative Period||133
445055|NCT01352741|1090212|P1|COMPLETED|Double-blind Comparative Period||126
445056|NCT01352741|1090211|P2|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||137
445057|NCT01352741|1090212|P1|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||123
445058|NCT01352741|1090211|P2|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||137
445059|NCT01352741|1090212|P1|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||123
445060|NCT01352741|1090211|P2|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||137
445061|NCT01352741|1090212|P1|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||123
445062|NCT01352741|1090211|P2|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||137
445063|NCT01352741|1090212|P1|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||123
445064|NCT01352741|1090211|P2|EQ-5D Per Protocol Set|Double-blind Comparative Period||143
445065|NCT01352741|1090212|P1|EQ-5D Per Protocol Set|Double-blind Comparative Period||131
445066|NCT01352741|1090211|P2|SF-12 Per Protocol Set|Double-blind Comparative Period||143
445067|NCT01352741|1090212|P1|SF-12 Per Protocol Set|Double-blind Comparative Period||131
445068|NCT01352741|1090211|P2|painDetect Per Protocol Set|Double-blind Comparative Period||127
445069|NCT01352741|1090212|P1|painDetect Per Protocol Set|Double-blind Comparative Period||109
445070|NCT01352741|1090211|P2|Per Protocol Set|Double-blind Comparative Period||149
445071|NCT01352741|1090212|P1|Per Protocol Set|Double-blind Comparative Period||139
445072|NCT01352741|1090211|P2|Major Protocol Deviations|Double-blind Comparative Period||8
445073|NCT01352741|1090212|P1|Major Protocol Deviations|Double-blind Comparative Period||13
445074|NCT01352741|1090211|P2|Full Analysis Set|Double-blind Comparative Period||157
445075|NCT01352741|1090212|P1|Full Analysis Set|Double-blind Comparative Period||152
445076|NCT01352741|1090211|P2|No Pain Assessments Available|Double-blind Comparative Period||2
445077|NCT01352741|1090212|P1|No Pain Assessments Available|Double-blind Comparative Period||2
445078|NCT01352741|1090211|P2|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||18
445079|NCT01352741|1090212|P1|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||19
445080|NCT01352741|1090211|P2|STARTED|Double-blind Comparative Period|159 of the 313 participants that qualified were randomized to tapentadol and pregabalin treatment.|159
445081|NCT01352741|1090212|P1|STARTED|Double-blind Comparative Period|Of the 313 participants that qualified for randomization 154 were randomized to tapentadol.|154
445082|NCT01352741|1090211|P2|NOT COMPLETED|Open-label Tapentadol Titration Period||0
445083|NCT01352741|1090212|P1|NOT COMPLETED|Open-label Tapentadol Titration Period||73
445084|NCT01352741|1090211|P2|COMPLETED|Open-label Tapentadol Titration Period||0
445085|NCT01352741|1090212|P1|COMPLETED|Open-label Tapentadol Titration Period|59 of 73 participants not completing the titration period entered the open-label continuation arm.|372
445086|NCT01352741|1090211|P2|Full Analysis Set|Open-label Tapentadol Titration Period||0
445087|NCT01352741|1090212|P1|Full Analysis Set|Open-label Tapentadol Titration Period||436
445088|NCT01352741|1090211|P2|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||0
445089|NCT01352741|1090212|P1|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||59
445090|NCT01352741|1090211|P2|STARTED|Open-label Tapentadol Titration Period||0
445091|NCT01352741|1090212|P1|STARTED|Open-label Tapentadol Titration Period|All participants started with 2 x 50 mg tapentadol PR and titrated upwards in steps of 100 mg/day.|445
445092|NCT01352715|1090306|P2|NOT COMPLETED|Overall Study||46
445093|NCT01352715|1090307|P1|NOT COMPLETED|Overall Study||45
445094|NCT01352715|1090306|P2|COMPLETED|Overall Study||209
445095|NCT01352715|1090307|P1|COMPLETED|Overall Study||215
445096|NCT01352715|1090306|P2|STARTED|Overall Study||255
445097|NCT01352715|1090307|P1|STARTED|Overall Study||260
445098|NCT01352585|1090329|P1|NOT COMPLETED|Overall Study||11
445099|NCT01352585|1090329|P1|COMPLETED|Overall Study||36
445100|NCT01352585|1090329|P1|STARTED|Overall Study||47
445101|NCT01352546|1090340|P1|NOT COMPLETED|Overall Study||0
445102|NCT01352546|1090340|P1|COMPLETED|Overall Study||31
445103|NCT01352546|1090340|P1|STARTED|Overall Study||31
445104|NCT01352507|1090346|P2|NOT COMPLETED|Extension Phase||0
445105|NCT01352507|1090347|P1|NOT COMPLETED|Extension Phase||0
445106|NCT01352507|1090346|P2|COMPLETED|Extension Phase||173
445107|NCT01352507|1090347|P1|COMPLETED|Extension Phase||164
445108|NCT01352507|1090346|P2|STARTED|Extension Phase||173
445109|NCT01352507|1090347|P1|STARTED|Extension Phase||164
445110|NCT01352507|1090346|P2|NOT COMPLETED|Treatment Period 2||3
445111|NCT01352507|1090347|P1|NOT COMPLETED|Treatment Period 2||6
445112|NCT01352507|1090346|P2|COMPLETED|Treatment Period 2|Seven participants who completed Treatment Period 2 chose not to enter the Extension Phase.|180
445113|NCT01352507|1090347|P1|COMPLETED|Treatment Period 2|Six participants who completed Treatment Period 2 chose not to enter the Extension Phase.|170
445114|NCT01352507|1090346|P2|Received Treatment|Treatment Period 2||181
445115|NCT01352507|1090347|P1|Received Treatment|Treatment Period 2||173
445116|NCT01352507|1090346|P2|STARTED|Treatment Period 2||183
445117|NCT01352507|1090347|P1|STARTED|Treatment Period 2||176
445118|NCT01352507|1090346|P2|NOT COMPLETED|Washout Period||1
445119|NCT01352507|1090347|P1|NOT COMPLETED|Washout Period||0
445120|NCT01352507|1090346|P2|COMPLETED|Washout Period||183
445121|NCT01352507|1090347|P1|COMPLETED|Washout Period||176
445122|NCT01352507|1090346|P2|STARTED|Washout Period||184
445123|NCT01352507|1090347|P1|STARTED|Washout Period||176
445124|NCT01352507|1090346|P2|NOT COMPLETED|Treatment Period 1||9
445125|NCT01352507|1090347|P1|NOT COMPLETED|Treatment Period 1||14
445126|NCT01352507|1090346|P2|COMPLETED|Treatment Period 1||184
445127|NCT01352507|1090347|P1|COMPLETED|Treatment Period 1||176
445128|NCT01352507|1090346|P2|Received Treatment|Treatment Period 1||188
445129|NCT01352507|1090347|P1|Received Treatment|Treatment Period 1||182
445130|NCT01352507|1090346|P2|STARTED|Treatment Period 1||193
445131|NCT01352507|1090347|P1|STARTED|Treatment Period 1||190
445132|NCT01352468|1090380|P2|NOT COMPLETED|Overall Study||4
445133|NCT01352468|1090381|P1|NOT COMPLETED|Overall Study||5
445134|NCT01352468|1090380|P2|COMPLETED|Overall Study||18
445135|NCT01352468|1090381|P1|COMPLETED|Overall Study||17
445136|NCT01352468|1090380|P2|STARTED|Overall Study||22
445137|NCT01352468|1090381|P1|STARTED|Overall Study||22
445138|NCT01352442|1090391|P1|NOT COMPLETED|Overall Study||12
445139|NCT01352442|1090391|P1|COMPLETED|Overall Study||139
445140|NCT01352442|1090391|P1|STARTED|Overall Study||151
445141|NCT01352416|1090400|P4|NOT COMPLETED|Overall Study||1
445142|NCT01352416|1090401|P3|NOT COMPLETED|Overall Study||2
445143|NCT01352416|1090402|P2|NOT COMPLETED|Overall Study||2
445144|NCT01352416|1090403|P1|NOT COMPLETED|Overall Study||1
445145|NCT01352416|1090400|P4|COMPLETED|Overall Study||1
445146|NCT01352416|1090401|P3|COMPLETED|Overall Study||0
445147|NCT01352416|1090402|P2|COMPLETED|Overall Study||5
445148|NCT01352416|1090403|P1|COMPLETED|Overall Study||3
445149|NCT01352416|1090400|P4|STARTED|Overall Study||2
445150|NCT01352416|1090401|P3|STARTED|Overall Study||2
445151|NCT01352416|1090402|P2|STARTED|Overall Study||7
445152|NCT01352416|1090403|P1|STARTED|Overall Study||4
445153|NCT01352221|1090415|P4|NOT COMPLETED|Open-label Phase||11
445154|NCT01352221|1090416|P3|NOT COMPLETED|Open-label Phase||13
445155|NCT01352221|1090417|P2|NOT COMPLETED|Open-label Phase||0
445156|NCT01352221|1090418|P1|NOT COMPLETED|Open-label Phase||0
445157|NCT01352221|1090415|P4|COMPLETED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|36
445158|NCT01352221|1090416|P3|COMPLETED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|37
445159|NCT01352221|1090417|P2|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
445160|NCT01352221|1090418|P1|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
445161|NCT01352221|1090415|P4|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|47
445162|NCT01352221|1090416|P3|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|50
445163|NCT01352221|1090417|P2|STARTED|Open-label Phase|Not Applicable to open-label phase|0
445164|NCT01352221|1090418|P1|STARTED|Open-label Phase|Not Applicable to open-label phase|0
445165|NCT01352221|1090415|P4|NOT COMPLETED|Double-blind Phase||0
445166|NCT01352221|1090416|P3|NOT COMPLETED|Double-blind Phase||0
445167|NCT01352221|1090417|P2|NOT COMPLETED|Double-blind Phase||11
445168|NCT01352221|1090418|P1|NOT COMPLETED|Double-blind Phase||9
445169|NCT01352221|1090415|P4|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
445170|NCT01352221|1090416|P3|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
445171|NCT01352221|1090417|P2|COMPLETED|Double-blind Phase||53
445172|NCT01352221|1090418|P1|COMPLETED|Double-blind Phase||55
445173|NCT01352221|1090415|P4|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
445174|NCT01352221|1090416|P3|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
445175|NCT01352221|1090417|P2|STARTED|Double-blind Phase||64
445176|NCT01352221|1090418|P1|STARTED|Double-blind Phase||64
445177|NCT01352117|1090478|P2|NOT COMPLETED|Overall Study||96
445178|NCT01352117|1090479|P1|NOT COMPLETED|Overall Study||68
445179|NCT01352117|1090478|P2|COMPLETED|Overall Study||0
445180|NCT01352117|1090479|P1|COMPLETED|Overall Study||28
445181|NCT01352117|1090478|P2|Study Week 96 Data Potential|Overall Study||61
445182|NCT01352117|1090479|P1|Study Week 96 Data Potential|Overall Study||58
445183|NCT01352117|1090478|P2|Study Week 48 Data Potential|Overall Study||83
445184|NCT01352117|1090479|P1|Study Week 48 Data Potential|Overall Study||80
445185|NCT01352117|1090478|P2|Entered Step 2 to Initiate Delayed ET|Overall Study|Only Arm A participants could enter Step 2 to receive delayed ET.|0
445186|NCT01352117|1090479|P1|Entered Step 2 to Initiate Delayed ET|Overall Study||32
445187|NCT01352117|1090478|P2|STARTED|Overall Study||96
445188|NCT01352117|1090479|P1|STARTED|Overall Study||96
445189|NCT01351623|1090531|P1|NOT COMPLETED|Overall Study||9
445190|NCT01351623|1090531|P1|COMPLETED|Overall Study||35
445191|NCT01351623|1090531|P1|STARTED|Overall Study||44
445192|NCT01351506|1090537|P1|NOT COMPLETED|Overall Study||137
445193|NCT01351506|1090537|P1|COMPLETED|Overall Study||465
445194|NCT01351506|1090537|P1|STARTED|Overall Study||602
445195|NCT01351480|1090547|P1|NOT COMPLETED|Overall Study||8
445196|NCT01351480|1090547|P1|COMPLETED|Overall Study||26
445197|NCT01351480|1090547|P1|STARTED|Overall Study||34
445198|NCT01351415|1090557|P2|NOT COMPLETED|Overall Study||240
445199|NCT01351415|1090558|P1|NOT COMPLETED|Overall Study||245
445200|NCT01351415|1090557|P2|COMPLETED|Overall Study||0
445201|NCT01351415|1090558|P1|COMPLETED|Overall Study||0
445202|NCT01351415|1090557|P2|Treated Participants|Overall Study||232
445203|NCT01351415|1090558|P1|Treated Participants|Overall Study||243
445204|NCT01351415|1090557|P2|STARTED|Overall Study||240
445205|NCT01351415|1090558|P1|STARTED|Overall Study||245
445206|NCT01351337|1090578|P1|NOT COMPLETED|Overall Study||0
445207|NCT01351337|1090578|P1|COMPLETED|Overall Study||58
445208|NCT01351337|1090578|P1|STARTED|Overall Study||58
445209|NCT01351090|1090587|P3|NOT COMPLETED|Overall Study||6
445210|NCT01351090|1090588|P2|NOT COMPLETED|Overall Study||11
445211|NCT01351090|1090589|P1|NOT COMPLETED|Overall Study||11
445212|NCT01351090|1090587|P3|COMPLETED|Overall Study||36
445213|NCT01351090|1090588|P2|COMPLETED|Overall Study||31
445214|NCT01351090|1090589|P1|COMPLETED|Overall Study||32
445215|NCT01351090|1090587|P3|STARTED|Overall Study||42
445216|NCT01351090|1090588|P2|STARTED|Overall Study||42
445217|NCT01351090|1090589|P1|STARTED|Overall Study||43
445218|NCT01351077|1090608|P2|NOT COMPLETED|Overall Study||0
445219|NCT01351077|1090609|P1|NOT COMPLETED|Overall Study||0
445220|NCT01351077|1090608|P2|COMPLETED|Overall Study||180
445221|NCT01351077|1090609|P1|COMPLETED|Overall Study||180
445222|NCT01351077|1090608|P2|STARTED|Overall Study||180
445223|NCT01351077|1090609|P1|STARTED|Overall Study||180
445224|NCT01351064|1090625|P2|NOT COMPLETED|Overall Study||0
445225|NCT01351064|1090626|P1|NOT COMPLETED|Overall Study||0
445226|NCT01351064|1090625|P2|COMPLETED|Overall Study||42
445227|NCT01351064|1090626|P1|COMPLETED|Overall Study||42
445228|NCT01351064|1090625|P2|STARTED|Overall Study||42
445229|NCT01351064|1090626|P1|STARTED|Overall Study||42
445230|NCT01351025|1090636|P2|NOT COMPLETED|Week 44 - 48||0
445231|NCT01351025|1090637|P1|NOT COMPLETED|Week 44 - 48||0
445232|NCT01351025|1090636|P2|COMPLETED|Week 44 - 48||43
445233|NCT01351025|1090637|P1|COMPLETED|Week 44 - 48||42
445234|NCT01351025|1090636|P2|STARTED|Week 44 - 48||43
445235|NCT01351025|1090637|P1|STARTED|Week 44 - 48||42
445236|NCT01351025|1090636|P2|NOT COMPLETED|Week 24 - 44||4
445237|NCT01351025|1090637|P1|NOT COMPLETED|Week 24 - 44||1
445238|NCT01351025|1090636|P2|COMPLETED|Week 24 - 44||43
445239|NCT01351025|1090637|P1|COMPLETED|Week 24 - 44||42
445240|NCT01351025|1090636|P2|STARTED|Week 24 - 44||47
445241|NCT01351025|1090637|P1|STARTED|Week 24 - 44||43
445242|NCT01351025|1090636|P2|NOT COMPLETED|Week 20 - 24||0
445243|NCT01351025|1090637|P1|NOT COMPLETED|Week 20 - 24||0
445244|NCT01351025|1090636|P2|COMPLETED|Week 20 - 24||47
445245|NCT01351025|1090637|P1|COMPLETED|Week 20 - 24||43
445246|NCT01351025|1090636|P2|STARTED|Week 20 - 24||47
445247|NCT01351025|1090637|P1|STARTED|Week 20 - 24||43
445248|NCT01351025|1090636|P2|NOT COMPLETED|Week 0 - 20||1
445249|NCT01351025|1090637|P1|NOT COMPLETED|Week 0 - 20||3
445250|NCT01351025|1090636|P2|COMPLETED|Week 0 - 20||47
445251|NCT01351025|1090637|P1|COMPLETED|Week 0 - 20||43
445252|NCT01351025|1090636|P2|STARTED|Week 0 - 20||48
445253|NCT01351025|1090637|P1|STARTED|Week 0 - 20||46
445254|NCT01350999|1090670|P3|NOT COMPLETED|Overall Study||21
445255|NCT01350999|1090671|P2|NOT COMPLETED|Overall Study||14
445256|NCT01350999|1090672|P1|NOT COMPLETED|Overall Study||8
445257|NCT01350999|1090670|P3|COMPLETED|Overall Study||146
445258|NCT01350999|1090671|P2|COMPLETED|Overall Study||157
445259|NCT01350999|1090672|P1|COMPLETED|Overall Study||157
445260|NCT01350999|1090670|P3|Treated|Overall Study||167
445261|NCT01350999|1090671|P2|Treated|Overall Study||171
445262|NCT01350999|1090672|P1|Treated|Overall Study||165
445263|NCT01350999|1090670|P3|STARTED|Overall Study||167
445264|NCT01350999|1090671|P2|STARTED|Overall Study||171
445265|NCT01350999|1090672|P1|STARTED|Overall Study||165
445266|NCT01350973|1090710|P3|NOT COMPLETED|Overall Study||8
445267|NCT01350973|1090711|P2|NOT COMPLETED|Overall Study||8
445268|NCT01350973|1090712|P1|NOT COMPLETED|Overall Study||6
445269|NCT01350973|1090710|P3|COMPLETED|Overall Study||187
445270|NCT01350973|1090711|P2|COMPLETED|Overall Study||202
445271|NCT01350973|1090712|P1|COMPLETED|Overall Study||200
445272|NCT01350973|1090710|P3|Received Treatment|Overall Study||195
445273|NCT01350973|1090711|P2|Received Treatment|Overall Study||210
445274|NCT01350973|1090712|P1|Received Treatment|Overall Study||205
445275|NCT01350973|1090710|P3|STARTED|Overall Study||195
445276|NCT01350973|1090711|P2|STARTED|Overall Study||210
445277|NCT01350973|1090712|P1|STARTED|Overall Study||206
445278|NCT01350947|1090747|P1|NOT COMPLETED|Overall Study||0
445279|NCT01350947|1090747|P1|COMPLETED|Overall Study||11
445280|NCT01350947|1090747|P1|STARTED|Overall Study||11
445281|NCT01350934|1090753|P2|NOT COMPLETED|Extension Study||4
445282|NCT01350934|1090754|P1|NOT COMPLETED|Extension Study||5
445283|NCT01350934|1090753|P2|COMPLETED|Extension Study||101
445284|NCT01350934|1090754|P1|COMPLETED|Extension Study||95
445285|NCT01350934|1090753|P2|STARTED|Extension Study||105
445286|NCT01350934|1090754|P1|STARTED|Extension Study||100
445287|NCT01350934|1090753|P2|NOT COMPLETED|Base Study||3
445288|NCT01350934|1090754|P1|NOT COMPLETED|Base Study||11
445289|NCT01350934|1090753|P2|COMPLETED|Base Study||105
445290|NCT01350934|1090754|P1|COMPLETED|Base Study||100
445291|NCT01350934|1090753|P2|STARTED|Base Study||108
445292|NCT01350934|1090754|P1|STARTED|Base Study||111
445293|NCT01350804|1090776|P4|NOT COMPLETED|Extension Study, Weeks 52 - 260||23
445294|NCT01350804|1090777|P3|NOT COMPLETED|Extension Study, Weeks 52 - 260||72
445295|NCT01350804|1090778|P2|NOT COMPLETED|Extension Study, Weeks 52 - 260||79
445296|NCT01350804|1090779|P1|NOT COMPLETED|Extension Study, Weeks 52 - 260||80
445297|NCT01350804|1090776|P4|COMPLETED|Extension Study, Weeks 52 - 260||0
445298|NCT01350804|1090777|P3|COMPLETED|Extension Study, Weeks 52 - 260||0
445299|NCT01350804|1090778|P2|COMPLETED|Extension Study, Weeks 52 - 260||0
445300|NCT01350804|1090779|P1|COMPLETED|Extension Study, Weeks 52 - 260||0
445301|NCT01350804|1090776|P4|STARTED|Extension Study, Weeks 52 - 260|During the extension, these participants received AIN457.|23
445302|NCT01350804|1090777|P3|STARTED|Extension Study, Weeks 52 - 260|During the extension, these participants received AIN457.|72
445303|NCT01350804|1090778|P2|STARTED|Extension Study, Weeks 52 - 260||79
445304|NCT01350804|1090779|P1|STARTED|Extension Study, Weeks 52 - 260||80
445305|NCT01350804|1090776|P4|NOT COMPLETED|Core Study||26
445306|NCT01350804|1090777|P3|NOT COMPLETED|Core Study||47
445307|NCT01350804|1090778|P2|NOT COMPLETED|Core Study||47
445308|NCT01350804|1090779|P1|NOT COMPLETED|Core Study||41
445309|NCT01350804|1090776|P4|COMPLETED|Core Study||112
445310|NCT01350804|1090777|P3|COMPLETED|Core Study||91
445311|NCT01350804|1090778|P2|COMPLETED|Core Study||90
445312|NCT01350804|1090779|P1|COMPLETED|Core Study||97
445313|NCT01350804|1090776|P4|Full Analysis Set|Core Study||138
445314|NCT01350804|1090777|P3|Full Analysis Set|Core Study||138
445315|NCT01350804|1090778|P2|Full Analysis Set|Core Study||137
445316|NCT01350804|1090779|P1|Full Analysis Set|Core Study||138
445317|NCT01350804|1090776|P4|Treatment Switch to AIN457 at Week 24|Core Study||37
445318|NCT01350804|1090777|P3|Treatment Switch to AIN457 at Week 24|Core Study||45
445319|NCT01350804|1090778|P2|Treatment Switch to AIN457 at Week 24|Core Study||0
445320|NCT01350804|1090779|P1|Treatment Switch to AIN457 at Week 24|Core Study||0
445321|NCT01350804|1090776|P4|Tratment Switch to AIN457 at Week 16|Core Study||0
445322|NCT01350804|1090777|P3|Tratment Switch to AIN457 at Week 16|Core Study|15 participantsdiscontinued prior to the treatment switch|78
445323|NCT01350804|1090778|P2|Tratment Switch to AIN457 at Week 16|Core Study||0
445324|NCT01350804|1090779|P1|Tratment Switch to AIN457 at Week 16|Core Study||0
445325|NCT01350804|1090776|P4|Safety Set|Core Study|1 participant did not receive treatment; therefore participant was not counted in safety analysis.|137
445326|NCT01350804|1090777|P3|Safety Set|Core Study|1 participant actually received placebo; participant was reassigned to placebo for safety analysis.|139
445327|NCT01350804|1090778|P2|Safety Set|Core Study|1 participant did not receive treatment; therefore participant was not counted in safety analysis.|136
445328|NCT01350804|1090779|P1|Safety Set|Core Study|1 participant actually received placebo; participant was reassigned to placebo for safety analysis.|137
445329|NCT01350804|1090776|P4|STARTED|Core Study||138
445330|NCT01350804|1090777|P3|STARTED|Core Study||138
445331|NCT01350804|1090778|P2|STARTED|Core Study||137
445332|NCT01350804|1090779|P1|STARTED|Core Study||138
445333|NCT01350583|1090868|P1|NOT COMPLETED|Overall Study||0
445334|NCT01350583|1090868|P1|COMPLETED|Overall Study||2
445335|NCT01350583|1090868|P1|STARTED|Overall Study||2
445336|NCT01350544|1090876|P2|NOT COMPLETED|Overall Study||22
445337|NCT01350544|1090877|P1|NOT COMPLETED|Overall Study||23
445338|NCT01350544|1090876|P2|COMPLETED|Overall Study||86
445339|NCT01350544|1090877|P1|COMPLETED|Overall Study||85
445340|NCT01350544|1090876|P2|STARTED|Overall Study||108
445341|NCT01350544|1090877|P1|STARTED|Overall Study||108
445342|NCT01350479|1090885|P2|NOT COMPLETED|Overall Study||0
445343|NCT01350479|1090886|P1|NOT COMPLETED|Overall Study||0
445344|NCT01350479|1090885|P2|COMPLETED|Overall Study||106
445345|NCT01350479|1090886|P1|COMPLETED|Overall Study||94
445346|NCT01350479|1090885|P2|STARTED|Overall Study||106
445347|NCT01350479|1090886|P1|STARTED|Overall Study||94
445348|NCT01350414|1090892|P1|NOT COMPLETED|Overall Study||19
445349|NCT01350414|1090892|P1|COMPLETED|Overall Study||162
445350|NCT01350414|1090892|P1|Year 5|Overall Study||162
445351|NCT01350414|1090892|P1|Year 4|Overall Study||159
445352|NCT01350414|1090892|P1|Year 3|Overall Study||162
445353|NCT01350414|1090892|P1|Year 2|Overall Study||165
445354|NCT01350414|1090892|P1|STARTED|Overall Study||181
445355|NCT01350401|1090909|P1|NOT COMPLETED|Overall Study||0
445356|NCT01350401|1090909|P1|COMPLETED|Overall Study||4
445357|NCT01350401|1090909|P1|STARTED|Overall Study||4
445358|NCT01350388|1090921|P2|NOT COMPLETED|Overall Study||1
445359|NCT01350388|1090922|P1|NOT COMPLETED|Overall Study||3
445360|NCT01350388|1090921|P2|COMPLETED|Overall Study||39
445361|NCT01350388|1090922|P1|COMPLETED|Overall Study||37
445362|NCT01350388|1090921|P2|STARTED|Overall Study||40
445363|NCT01350388|1090922|P1|STARTED|Overall Study||40
445364|NCT01350271|1090941|P3|NOT COMPLETED|Overall Study||26
445365|NCT01350271|1090942|P2|NOT COMPLETED|Overall Study||17
445366|NCT01350271|1090943|P1|NOT COMPLETED|Overall Study||21
445367|NCT01350271|1090941|P3|COMPLETED|Overall Study||48
445368|NCT01350271|1090942|P2|COMPLETED|Overall Study||53
445369|NCT01350271|1090943|P1|COMPLETED|Overall Study||49
445370|NCT01350271|1090941|P3|STARTED|Overall Study||74
445371|NCT01350271|1090942|P2|STARTED|Overall Study||70
445372|NCT01350271|1090943|P1|STARTED|Overall Study||70
445373|NCT01350258|1090957|P1|NOT COMPLETED|Overall Study||0
445374|NCT01350258|1090957|P1|COMPLETED|Overall Study||8
445375|NCT01350258|1090957|P1|STARTED|Overall Study||8
445376|NCT01350245|1090966|P1|NOT COMPLETED|Overall Study||0
445377|NCT01350245|1090966|P1|COMPLETED|Overall Study||28
445378|NCT01350245|1090966|P1|STARTED|Overall Study||28
445379|NCT01350232|1090971|P1|NOT COMPLETED|Overall Study||0
445380|NCT01350232|1090971|P1|COMPLETED|Overall Study||2
445381|NCT01350232|1090971|P1|STARTED|Overall Study||2
445382|NCT01350141|1090985|P3|NOT COMPLETED|Overall Study||1
445383|NCT01350141|1090986|P2|NOT COMPLETED|Overall Study||0
445384|NCT01350141|1090987|P1|NOT COMPLETED|Overall Study||3
445385|NCT01350141|1090985|P3|COMPLETED|Overall Study||15
445386|NCT01350141|1090986|P2|COMPLETED|Overall Study||15
445387|NCT01350141|1090987|P1|COMPLETED|Overall Study||12
445388|NCT01350141|1090985|P3|Treated|Overall Study||16
445389|NCT01350141|1090986|P2|Treated|Overall Study||15
445390|NCT01350141|1090987|P1|Treated|Overall Study||14
445391|NCT01350141|1090985|P3|STARTED|Overall Study||16
445392|NCT01350141|1090986|P2|STARTED|Overall Study||15
445393|NCT01350141|1090987|P1|STARTED|Overall Study||15
445394|NCT01350128|1091021|P1|NOT COMPLETED|Overall Study||14
445395|NCT01350128|1091021|P1|COMPLETED|Overall Study||89
445396|NCT01350128|1091021|P1|Atrovent HFA 34 µg BID|Overall Study||48
445397|NCT01350128|1091021|P1|Placebo MDI BID|Overall Study||48
445398|NCT01350128|1091021|P1|GP MDI 4.6 µg BID|Overall Study||45
445399|NCT01350128|1091021|P1|GP MDI 9 µg BID|Overall Study||49
445400|NCT01350128|1091021|P1|GP MDI 18 µg BID|Overall Study||49
445401|NCT01350128|1091021|P1|GP MDI 36 µg BID|Overall Study|Glycopyrronium Metered Dose Inhaler|49
445402|NCT01350128|1091021|P1|STARTED|Overall Study||103
445403|NCT01350115|1091085|P2|NOT COMPLETED|Long Term Follow-Up (All Patients)||2
445404|NCT01350115|1091086|P1|NOT COMPLETED|Long Term Follow-Up (All Patients)||1
445405|NCT01350115|1091085|P2|COMPLETED|Long Term Follow-Up (All Patients)||0
445406|NCT01350115|1091086|P1|COMPLETED|Long Term Follow-Up (All Patients)||7
445407|NCT01350115|1091085|P2|STARTED|Long Term Follow-Up (All Patients)||2
445408|NCT01350115|1091086|P1|STARTED|Long Term Follow-Up (All Patients)||8
445409|NCT01350115|1091085|P2|NOT COMPLETED|Core Study (All Patients)||0
445410|NCT01350115|1091086|P1|NOT COMPLETED|Core Study (All Patients)||0
445411|NCT01350115|1091085|P2|COMPLETED|Core Study (All Patients)||2
445412|NCT01350115|1091086|P1|COMPLETED|Core Study (All Patients)||8
445413|NCT01350115|1091085|P2|Pharmacodynamic Set|Core Study (All Patients)||2
445414|NCT01350115|1091086|P1|Pharmacodynamic Set|Core Study (All Patients)||7
445415|NCT01350115|1091085|P2|Safety Anlysis Set|Core Study (All Patients)||2
445416|NCT01350115|1091086|P1|Safety Anlysis Set|Core Study (All Patients)||8
445417|NCT01350115|1091085|P2|STARTED|Core Study (All Patients)||2
445418|NCT01350115|1091086|P1|STARTED|Core Study (All Patients)||8
445419|NCT01350102|1091102|P4|NOT COMPLETED|Overall Study||0
445420|NCT01350102|1091103|P3|NOT COMPLETED|Overall Study||1
445421|NCT01350102|1091104|P2|NOT COMPLETED|Overall Study||0
445422|NCT01350102|1091105|P1|NOT COMPLETED|Overall Study||0
445423|NCT01350102|1091102|P4|COMPLETED|Overall Study||0
445424|NCT01350102|1091103|P3|COMPLETED|Overall Study||0
445425|NCT01350102|1091104|P2|COMPLETED|Overall Study||1
445426|NCT01350102|1091105|P1|COMPLETED|Overall Study||0
445427|NCT01350102|1091102|P4|STARTED|Overall Study||0
445428|NCT01350102|1091103|P3|STARTED|Overall Study||1
445429|NCT01350102|1091104|P2|STARTED|Overall Study||1
445430|NCT01350102|1091105|P1|STARTED|Overall Study||0
445431|NCT01349972|1091125|P2|NOT COMPLETED|Overall Study||2
445432|NCT01349972|1091126|P1|NOT COMPLETED|Overall Study||5
445433|NCT01349972|1091125|P2|COMPLETED|Overall Study||56
445434|NCT01349972|1091126|P1|COMPLETED|Overall Study||109
445435|NCT01349972|1091125|P2|STARTED|Overall Study||58
445436|NCT01349972|1091126|P1|STARTED|Overall Study||114
445437|NCT01349959|1091142|P1|NOT COMPLETED|Overall Study||7
445438|NCT01349959|1091142|P1|COMPLETED|Overall Study||33
445439|NCT01349959|1091142|P1|STARTED|Overall Study|58 consented, 18 failed screening and did not receive study treatment|40
445440|NCT01349933|1091148|P1|NOT COMPLETED|Overall Study||0
445441|NCT01349933|1091148|P1|COMPLETED|Overall Study||21
445442|NCT01349933|1091148|P1|STARTED|Overall Study||21
445443|NCT01349920|1091158|P1|NOT COMPLETED|Overall Study||0
445444|NCT01349920|1091158|P1|COMPLETED|Overall Study||15
445445|NCT01349920|1091158|P1|STARTED|Overall Study||15
445446|NCT01349907|1091178|P2|NOT COMPLETED|Overall Study||43
445447|NCT01349907|1091179|P1|NOT COMPLETED|Overall Study||139
445448|NCT01349907|1091178|P2|COMPLETED|Overall Study||38
445449|NCT01349907|1091179|P1|COMPLETED|Overall Study||102
445450|NCT01349907|1091178|P2|STARTED|Overall Study|Enrolled and Treated|81
445451|NCT01349907|1091179|P1|STARTED|Overall Study|Enrolled and Treated|241
445452|NCT01349829|1091217|P2|NOT COMPLETED|Overall Study||23
445453|NCT01349829|1091218|P1|NOT COMPLETED|Overall Study||9
445454|NCT01349829|1091217|P2|COMPLETED|Overall Study||102
445455|NCT01349829|1091218|P1|COMPLETED|Overall Study||117
445456|NCT01349829|1091217|P2|STARTED|Overall Study||125
445457|NCT01349829|1091218|P1|STARTED|Overall Study||126
445458|NCT01349816|1091236|P1|NOT COMPLETED|Overall Study||30
445459|NCT01349816|1091236|P1|COMPLETED|Overall Study||155
445460|NCT01349816|1091236|P1|FF MDI 9.6 µg|Overall Study||61
445461|NCT01349816|1091236|P1|GFF MDI 9/9.6 µg|Overall Study||57
445462|NCT01349816|1091236|P1|GFF MDI 18/9.6 µg|Overall Study||57
445463|NCT01349816|1091236|P1|GFF MDI 36/9.6 µg|Overall Study||56
445464|NCT01349816|1091236|P1|GFF MDI 36/7.2 µg|Overall Study||58
445465|NCT01349816|1091236|P1|GP MDI 36 µg|Overall Study||61
445466|NCT01349816|1091236|P1|STARTED|Overall Study||185
445467|NCT01349803|1091302|P4|NOT COMPLETED|Overall Study||2
445468|NCT01349803|1091303|P3|NOT COMPLETED|Overall Study||3
445469|NCT01349803|1091304|P2|NOT COMPLETED|Overall Study||1
445470|NCT01349803|1091305|P1|NOT COMPLETED|Overall Study||1
445471|NCT01349803|1091302|P4|COMPLETED|Overall Study||57
445472|NCT01349803|1091303|P3|COMPLETED|Overall Study||57
445473|NCT01349803|1091304|P2|COMPLETED|Overall Study||57
445474|NCT01349803|1091305|P1|COMPLETED|Overall Study||59
445475|NCT01349803|1091302|P4|STARTED|Overall Study||59
445476|NCT01349803|1091303|P3|STARTED|Overall Study||60
445477|NCT01349803|1091304|P2|STARTED|Overall Study||58
445478|NCT01349803|1091305|P1|STARTED|Overall Study||60
445479|NCT01349790|1091375|P1|NOT COMPLETED|Overall Study||9
445480|NCT01349790|1091375|P1|COMPLETED|Overall Study||31
445481|NCT01349790|1091375|P1|STARTED|Overall Study||40
445482|NCT01349660|1091397|P3|NOT COMPLETED|Overall Study||76
445483|NCT01349660|1091398|P2|NOT COMPLETED|Overall Study||6
445484|NCT01349660|1091399|P1|NOT COMPLETED|Overall Study||6
445485|NCT01349660|1091397|P3|COMPLETED|Overall Study||0
445486|NCT01349660|1091398|P2|COMPLETED|Overall Study||0
445487|NCT01349660|1091399|P1|COMPLETED|Overall Study||0
445488|NCT01349660|1091397|P3|STARTED|Overall Study||76
445489|NCT01349660|1091398|P2|STARTED|Overall Study||6
445490|NCT01349660|1091399|P1|STARTED|Overall Study||6
445491|NCT01349595|1091417|P2|NOT COMPLETED|Overall Study||2
445492|NCT01349595|1091418|P1|NOT COMPLETED|Overall Study||2
445493|NCT01349595|1091417|P2|COMPLETED|Overall Study||0
445494|NCT01349595|1091418|P1|COMPLETED|Overall Study||0
445495|NCT01349595|1091417|P2|STARTED|Overall Study||2
445496|NCT01349595|1091418|P1|STARTED|Overall Study||2
445497|NCT01349491|1091426|P2|NOT COMPLETED|Overall Study||0
445498|NCT01349491|1091427|P1|NOT COMPLETED|Overall Study||0
445499|NCT01349491|1091426|P2|COMPLETED|Overall Study||5
445500|NCT01349491|1091427|P1|COMPLETED|Overall Study||5
445501|NCT01349491|1091426|P2|STARTED|Overall Study||5
445502|NCT01349491|1091427|P1|STARTED|Overall Study||5
445503|NCT01349465|1091435|P2|NOT COMPLETED|Overall Study||22
445504|NCT01349465|1091436|P1|NOT COMPLETED|Overall Study||18
445505|NCT01349465|1091435|P2|COMPLETED|Overall Study||27
445506|NCT01349465|1091436|P1|COMPLETED|Overall Study||182
445507|NCT01349465|1091435|P2|STARTED|Overall Study||49
445508|NCT01349465|1091436|P1|STARTED|Overall Study||200
445509|NCT01349231|1091448|P1|NOT COMPLETED|Overall Study||0
445510|NCT01349231|1091448|P1|COMPLETED|Overall Study||10
445511|NCT01349231|1091448|P1|STARTED|Overall Study||10
445512|NCT01349192|1091457|P2|NOT COMPLETED|Overall Study||6
445513|NCT01349192|1091458|P1|NOT COMPLETED|Overall Study||3
445514|NCT01349192|1091457|P2|COMPLETED|Overall Study||17
445515|NCT01349192|1091458|P1|COMPLETED|Overall Study||21
445516|NCT01349192|1091457|P2|Withdrawals|Overall Study||6
445517|NCT01349192|1091458|P1|Withdrawals|Overall Study||3
445518|NCT01349192|1091457|P2|Evaluable for Primary Endpoint|Overall Study||19
445519|NCT01349192|1091458|P1|Evaluable for Primary Endpoint|Overall Study||22
445520|NCT01349192|1091457|P2|STARTED|Overall Study||23
445521|NCT01349192|1091458|P1|STARTED|Overall Study||24
445522|NCT01349114|1091472|P2|NOT COMPLETED|Overall Study||0
445523|NCT01349114|1091473|P1|NOT COMPLETED|Overall Study||0
445524|NCT01349114|1091472|P2|COMPLETED|Overall Study||11
445525|NCT01349114|1091473|P1|COMPLETED|Overall Study||10
445526|NCT01349114|1091472|P2|STARTED|Overall Study||11
445527|NCT01349114|1091473|P1|STARTED|Overall Study||10
445528|NCT01348854|1091483|P2|NOT COMPLETED|Overall Study||1
445529|NCT01348854|1091484|P1|NOT COMPLETED|Overall Study||3
445530|NCT01348854|1091483|P2|COMPLETED|Overall Study|9 eyes of 5 participants|5
445531|NCT01348854|1091484|P1|COMPLETED|Overall Study|47 eyes of 31 participants|31
445532|NCT01348854|1091483|P2|STARTED|Overall Study|10 eyes of 6 participants|6
445533|NCT01348854|1091484|P1|STARTED|Overall Study|53 eyes of 34 participants|34
445534|NCT01348789|1091492|P1|NOT COMPLETED|Overall Study||4
445535|NCT01348789|1091492|P1|COMPLETED|Overall Study|4 subjects did not complete all 3 treatments but were evaluated for primary and secondary endpoints.|33
445536|NCT01348789|1091492|P1|STARTED|Overall Study||37
445537|NCT01348776|1091503|P1|NOT COMPLETED|Overall Study||3
445538|NCT01348776|1091503|P1|COMPLETED|Overall Study||84
445539|NCT01348776|1091503|P1|STARTED|Overall Study|3 subjects were lost to follow-up: 2 after the 1-month follow-up, 1 after performing 4 treatments|87
445540|NCT01348607|1091519|P3|NOT COMPLETED|Overall Study||0
445541|NCT01348607|1091520|P2|NOT COMPLETED|Overall Study||0
445542|NCT01348607|1091521|P1|NOT COMPLETED|Overall Study||0
445543|NCT01348607|1091519|P3|COMPLETED|Overall Study||0
445544|NCT01348607|1091520|P2|COMPLETED|Overall Study||0
445545|NCT01348607|1091521|P1|COMPLETED|Overall Study||1
445546|NCT01348607|1091519|P3|STARTED|Overall Study||0
445547|NCT01348607|1091520|P2|STARTED|Overall Study||0
445548|NCT01348607|1091521|P1|STARTED|Overall Study||1
445549|NCT01348425|1091534|P2|NOT COMPLETED|Overall Study||1
445550|NCT01348425|1091535|P1|NOT COMPLETED|Overall Study||1
445551|NCT01348425|1091534|P2|COMPLETED|Overall Study||13
445552|NCT01348425|1091535|P1|COMPLETED|Overall Study||30
445553|NCT01348425|1091534|P2|STARTED|Overall Study||14
445554|NCT01348425|1091535|P1|STARTED|Overall Study||31
445555|NCT01348165|1091547|P7|NOT COMPLETED|Overall Study||1
445556|NCT01348165|1091548|P6|NOT COMPLETED|Overall Study||0
445557|NCT01348165|1091549|P5|NOT COMPLETED|Overall Study||0
445558|NCT01348165|1091550|P4|NOT COMPLETED|Overall Study||0
445559|NCT01348165|1091551|P3|NOT COMPLETED|Overall Study||0
445560|NCT01348165|1091552|P2|NOT COMPLETED|Overall Study||0
445561|NCT01348165|1091553|P1|NOT COMPLETED|Overall Study||0
445562|NCT01348165|1091547|P7|COMPLETED|Overall Study||5
445563|NCT01348165|1091548|P6|COMPLETED|Overall Study||1
445564|NCT01348165|1091549|P5|COMPLETED|Overall Study||6
445565|NCT01348165|1091550|P4|COMPLETED|Overall Study||6
445566|NCT01348165|1091551|P3|COMPLETED|Overall Study||6
445567|NCT01348165|1091552|P2|COMPLETED|Overall Study||5
445568|NCT01348165|1091553|P1|COMPLETED|Overall Study||10
445569|NCT01348165|1091547|P7|STARTED|Overall Study||6
445570|NCT01348165|1091548|P6|STARTED|Overall Study||1
445571|NCT01348165|1091549|P5|STARTED|Overall Study||6
445572|NCT01348165|1091550|P4|STARTED|Overall Study||6
445573|NCT01348165|1091551|P3|STARTED|Overall Study||6
445574|NCT01348165|1091552|P2|STARTED|Overall Study||5
445575|NCT01348165|1091553|P1|STARTED|Overall Study||10
445576|NCT01348139|1091682|P6|NOT COMPLETED|Period 6||0
445577|NCT01348139|1091683|P5|NOT COMPLETED|Period 6||0
445578|NCT01348139|1091684|P4|NOT COMPLETED|Period 6||0
445579|NCT01348139|1091685|P3|NOT COMPLETED|Period 6||0
445580|NCT01348139|1091686|P2|NOT COMPLETED|Period 6||0
445581|NCT01348139|1091687|P1|NOT COMPLETED|Period 6||0
445582|NCT01348139|1091682|P6|COMPLETED|Period 6||4
445583|NCT01348139|1091683|P5|COMPLETED|Period 6||5
445584|NCT01348139|1091684|P4|COMPLETED|Period 6||4
445585|NCT01348139|1091685|P3|COMPLETED|Period 6||4
445586|NCT01348139|1091686|P2|COMPLETED|Period 6||4
445587|NCT01348139|1091687|P1|COMPLETED|Period 6||4
445588|NCT01348139|1091682|P6|STARTED|Period 6||4
445589|NCT01348139|1091683|P5|STARTED|Period 6||5
445590|NCT01348139|1091684|P4|STARTED|Period 6||4
445591|NCT01348139|1091685|P3|STARTED|Period 6||4
445592|NCT01348139|1091686|P2|STARTED|Period 6||4
445593|NCT01348139|1091687|P1|STARTED|Period 6||4
445594|NCT01348139|1091682|P6|NOT COMPLETED|Period 5||0
445595|NCT01348139|1091683|P5|NOT COMPLETED|Period 5||0
445596|NCT01348139|1091684|P4|NOT COMPLETED|Period 5||0
445597|NCT01348139|1091685|P3|NOT COMPLETED|Period 5||0
445598|NCT01348139|1091686|P2|NOT COMPLETED|Period 5||0
445599|NCT01348139|1091687|P1|NOT COMPLETED|Period 5||0
445600|NCT01348139|1091682|P6|COMPLETED|Period 5||4
445601|NCT01348139|1091683|P5|COMPLETED|Period 5||5
445602|NCT01348139|1091684|P4|COMPLETED|Period 5||4
445603|NCT01348139|1091685|P3|COMPLETED|Period 5||4
445604|NCT01348139|1091686|P2|COMPLETED|Period 5||4
445605|NCT01348139|1091687|P1|COMPLETED|Period 5||4
445606|NCT01348139|1091682|P6|STARTED|Period 5||4
445607|NCT01348139|1091683|P5|STARTED|Period 5||5
445608|NCT01348139|1091684|P4|STARTED|Period 5||4
445609|NCT01348139|1091685|P3|STARTED|Period 5||4
445610|NCT01348139|1091686|P2|STARTED|Period 5||4
445611|NCT01348139|1091687|P1|STARTED|Period 5||4
445612|NCT01348139|1091682|P6|NOT COMPLETED|Period 4||0
445613|NCT01348139|1091683|P5|NOT COMPLETED|Period 4||0
445614|NCT01348139|1091684|P4|NOT COMPLETED|Period 4||0
445615|NCT01348139|1091685|P3|NOT COMPLETED|Period 4||0
445616|NCT01348139|1091686|P2|NOT COMPLETED|Period 4||0
445617|NCT01348139|1091687|P1|NOT COMPLETED|Period 4||0
445618|NCT01348139|1091682|P6|COMPLETED|Period 4||4
445619|NCT01348139|1091683|P5|COMPLETED|Period 4||5
445620|NCT01348139|1091684|P4|COMPLETED|Period 4||4
445621|NCT01348139|1091685|P3|COMPLETED|Period 4||4
445622|NCT01348139|1091686|P2|COMPLETED|Period 4||4
445623|NCT01348139|1091687|P1|COMPLETED|Period 4||4
445624|NCT01348139|1091682|P6|STARTED|Period 4||4
445625|NCT01348139|1091683|P5|STARTED|Period 4||5
445626|NCT01348139|1091684|P4|STARTED|Period 4||4
445627|NCT01348139|1091685|P3|STARTED|Period 4||4
445628|NCT01348139|1091686|P2|STARTED|Period 4||4
445629|NCT01348139|1091687|P1|STARTED|Period 4||4
445630|NCT01348139|1091682|P6|NOT COMPLETED|Period 3||0
445631|NCT01348139|1091683|P5|NOT COMPLETED|Period 3||0
445632|NCT01348139|1091684|P4|NOT COMPLETED|Period 3||0
445633|NCT01348139|1091685|P3|NOT COMPLETED|Period 3||0
445634|NCT01348139|1091686|P2|NOT COMPLETED|Period 3||0
445635|NCT01348139|1091687|P1|NOT COMPLETED|Period 3||0
445636|NCT01348139|1091682|P6|COMPLETED|Period 3||4
445637|NCT01348139|1091683|P5|COMPLETED|Period 3||5
445638|NCT01348139|1091684|P4|COMPLETED|Period 3||4
445639|NCT01348139|1091685|P3|COMPLETED|Period 3||4
445640|NCT01348139|1091686|P2|COMPLETED|Period 3||4
445641|NCT01348139|1091687|P1|COMPLETED|Period 3||4
445642|NCT01348139|1091682|P6|STARTED|Period 3||4
445643|NCT01348139|1091683|P5|STARTED|Period 3||5
445644|NCT01348139|1091684|P4|STARTED|Period 3||4
445645|NCT01348139|1091685|P3|STARTED|Period 3||4
445646|NCT01348139|1091686|P2|STARTED|Period 3||4
445647|NCT01348139|1091687|P1|STARTED|Period 3||4
445648|NCT01348139|1091682|P6|NOT COMPLETED|Period 2||0
445649|NCT01348139|1091683|P5|NOT COMPLETED|Period 2||0
445650|NCT01348139|1091684|P4|NOT COMPLETED|Period 2||0
445651|NCT01348139|1091685|P3|NOT COMPLETED|Period 2||0
445652|NCT01348139|1091686|P2|NOT COMPLETED|Period 2||0
445653|NCT01348139|1091687|P1|NOT COMPLETED|Period 2||0
445654|NCT01348139|1091682|P6|COMPLETED|Period 2||4
445655|NCT01348139|1091683|P5|COMPLETED|Period 2||5
445656|NCT01348139|1091684|P4|COMPLETED|Period 2||4
445657|NCT01348139|1091685|P3|COMPLETED|Period 2||4
445658|NCT01348139|1091686|P2|COMPLETED|Period 2||4
445659|NCT01348139|1091687|P1|COMPLETED|Period 2||4
445660|NCT01348139|1091682|P6|STARTED|Period 2||4
445661|NCT01348139|1091683|P5|STARTED|Period 2||5
445662|NCT01348139|1091684|P4|STARTED|Period 2||4
445663|NCT01348139|1091685|P3|STARTED|Period 2||4
445664|NCT01348139|1091686|P2|STARTED|Period 2||4
445665|NCT01348139|1091687|P1|STARTED|Period 2||4
445666|NCT01348139|1091682|P6|NOT COMPLETED|Period 1||0
445667|NCT01348139|1091683|P5|NOT COMPLETED|Period 1||0
445668|NCT01348139|1091684|P4|NOT COMPLETED|Period 1||0
445669|NCT01348139|1091685|P3|NOT COMPLETED|Period 1||0
445670|NCT01348139|1091686|P2|NOT COMPLETED|Period 1||0
445671|NCT01348139|1091687|P1|NOT COMPLETED|Period 1||1
445672|NCT01348139|1091682|P6|COMPLETED|Period 1||4
445673|NCT01348139|1091683|P5|COMPLETED|Period 1||5
445674|NCT01348139|1091684|P4|COMPLETED|Period 1||4
445675|NCT01348139|1091685|P3|COMPLETED|Period 1||4
445676|NCT01348139|1091686|P2|COMPLETED|Period 1||4
445677|NCT01348139|1091687|P1|COMPLETED|Period 1||4
445678|NCT01348139|1091682|P6|STARTED|Period 1||4
445679|NCT01348139|1091683|P5|STARTED|Period 1||5
445680|NCT01348139|1091684|P4|STARTED|Period 1||4
445681|NCT01348139|1091685|P3|STARTED|Period 1||4
445682|NCT01348139|1091686|P2|STARTED|Period 1||4
445683|NCT01348139|1091687|P1|STARTED|Period 1||5
445684|NCT01348100|1091768|P7|NOT COMPLETED|Overall Study||3
445685|NCT01348100|1091769|P6|NOT COMPLETED|Overall Study||2
445686|NCT01348100|1091770|P5|NOT COMPLETED|Overall Study||1
445687|NCT01348100|1091771|P4|NOT COMPLETED|Overall Study||1
445688|NCT01348100|1091772|P3|NOT COMPLETED|Overall Study||2
445689|NCT01348100|1091773|P2|NOT COMPLETED|Overall Study||0
445690|NCT01348100|1091774|P1|NOT COMPLETED|Overall Study||0
445691|NCT01348100|1091768|P7|COMPLETED|Overall Study||13
445692|NCT01348100|1091769|P6|COMPLETED|Overall Study||14
445693|NCT01348100|1091770|P5|COMPLETED|Overall Study||14
445694|NCT01348100|1091771|P4|COMPLETED|Overall Study||14
445695|NCT01348100|1091772|P3|COMPLETED|Overall Study||13
445696|NCT01348100|1091773|P2|COMPLETED|Overall Study||2
445697|NCT01348100|1091774|P1|COMPLETED|Overall Study||2
445698|NCT01348100|1091768|P7|STARTED|Overall Study||16
445699|NCT01348100|1091769|P6|STARTED|Overall Study||16
445700|NCT01348100|1091770|P5|STARTED|Overall Study||15
445701|NCT01348100|1091771|P4|STARTED|Overall Study||15
445702|NCT01348100|1091772|P3|STARTED|Overall Study||15
445703|NCT01348100|1091773|P2|STARTED|Overall Study||2
445704|NCT01348100|1091774|P1|STARTED|Overall Study||2
445705|NCT01348087|1091819|P1|NOT COMPLETED|Overall Study||148
445706|NCT01348087|1091819|P1|COMPLETED|Overall Study||0
445707|NCT01348087|1091819|P1|STARTED|Overall Study||148
445708|NCT01347931|1091833|P1|NOT COMPLETED|NIOV System||0
445709|NCT01347931|1091833|P1|COMPLETED|NIOV System||29
445710|NCT01347931|1091833|P1|STARTED|NIOV System||29
445711|NCT01347931|1091833|P1|NOT COMPLETED|Standard Oxygen Therapy||1
445712|NCT01347931|1091833|P1|COMPLETED|Standard Oxygen Therapy||29
445713|NCT01347931|1091833|P1|STARTED|Standard Oxygen Therapy||30
445714|NCT01347879|1091845|P2|NOT COMPLETED|Overall Study||17
445715|NCT01347879|1091846|P1|NOT COMPLETED|Overall Study||7
445716|NCT01347879|1091845|P2|COMPLETED|Overall Study||83
445717|NCT01347879|1091846|P1|COMPLETED|Overall Study||46
445718|NCT01347879|1091845|P2|STARTED|Overall Study||100
445719|NCT01347879|1091846|P1|STARTED|Overall Study||53
445720|NCT01347840|1091878|P1|NOT COMPLETED|Overall Study||1
445721|NCT01347840|1091878|P1|COMPLETED|Overall Study||0
445722|NCT01347840|1091878|P1|STARTED|Overall Study|1 subject enrolled but withdrew consent|1
445723|NCT01347788|1091891|P3|NOT COMPLETED|Overall Study||0
445724|NCT01347788|1091892|P2|NOT COMPLETED|Overall Study||0
445725|NCT01347788|1091893|P1|NOT COMPLETED|Overall Study||0
445726|NCT01347788|1091891|P3|COMPLETED|Overall Study||13
445727|NCT01347788|1091892|P2|COMPLETED|Overall Study||10
445728|NCT01347788|1091893|P1|COMPLETED|Overall Study||11
445729|NCT01347788|1091891|P3|STARTED|Overall Study||13
445730|NCT01347788|1091892|P2|STARTED|Overall Study||10
445731|NCT01347788|1091893|P1|STARTED|Overall Study||11
445732|NCT01347762|1091905|P4|NOT COMPLETED|Overall Study||8
445733|NCT01347762|1091906|P3|NOT COMPLETED|Overall Study||9
445734|NCT01347762|1091907|P2|NOT COMPLETED|Overall Study||2
445735|NCT01347762|1091908|P1|NOT COMPLETED|Overall Study||4
445736|NCT01347762|1091905|P4|COMPLETED|Overall Study||10
445737|NCT01347762|1091906|P3|COMPLETED|Overall Study||7
445738|NCT01347762|1091907|P2|COMPLETED|Overall Study||6
445739|NCT01347762|1091908|P1|COMPLETED|Overall Study||6
445740|NCT01347762|1091905|P4|STARTED|Overall Study||18
445741|NCT01347762|1091906|P3|STARTED|Overall Study||16
445742|NCT01347762|1091907|P2|STARTED|Overall Study||8
445743|NCT01347762|1091908|P1|STARTED|Overall Study||10
445744|NCT01347710|1091934|P1|NOT COMPLETED|Overall Study||31
445745|NCT01347710|1091934|P1|COMPLETED|Overall Study||764
445746|NCT01347710|1091934|P1|STARTED|Overall Study||795
445747|NCT01347632|1091949|P1|NOT COMPLETED|Overall Study||2
445748|NCT01347632|1091949|P1|COMPLETED|Overall Study||33
445749|NCT01347632|1091949|P1|STARTED|Overall Study||35
445750|NCT01347580|1091956|P2|NOT COMPLETED|Overall Study||56
445751|NCT01347580|1091957|P1|NOT COMPLETED|Overall Study||65
445752|NCT01347580|1091956|P2|COMPLETED|Overall Study|based on randomized treatment|897
445753|NCT01347580|1091957|P1|COMPLETED|Overall Study|based on randomized treatment|844
445754|NCT01347580|1091956|P2|Safety Population|Overall Study|based on actual treatment|950
445755|NCT01347580|1091957|P1|Safety Population|Overall Study|based on actual treatment|908
445756|NCT01347580|1091956|P2|Modified Intent to Treat Population|Overall Study|based on randomized treatment|952
445757|NCT01347580|1091957|P1|Modified Intent to Treat Population|Overall Study|based on randomized treatment|906
445758|NCT01347580|1091956|P2|STARTED|Overall Study|based on randomized treatment|953
445759|NCT01347580|1091957|P1|STARTED|Overall Study|based on randomized treatment|909
445760|NCT01347554|1091987|P2|NOT COMPLETED|Overall Study||11
445761|NCT01347554|1091988|P1|NOT COMPLETED|Overall Study||7
445762|NCT01347554|1091987|P2|COMPLETED|Overall Study|Final TIMI flow grade 0 or 1 patients or failed PCI cases (N=11) were excluded.|231
445763|NCT01347554|1091988|P1|COMPLETED|Overall Study|Final TIMI flow grade 0 or 1 patients or failed PCI cases (N=7) were excluded.|230
445764|NCT01347554|1091987|P2|STARTED|Overall Study||242
445765|NCT01347554|1091988|P1|STARTED|Overall Study||237
445766|NCT01347255|1092000|P1|NOT COMPLETED|Overall Study||0
445767|NCT01347255|1092000|P1|COMPLETED|Overall Study||24
445768|NCT01347255|1092000|P1|STARTED|Overall Study||24
445769|NCT01347112|1092025|P2|NOT COMPLETED|Overall Study||12
445770|NCT01347112|1092026|P1|NOT COMPLETED|Overall Study||4
445771|NCT01347112|1092025|P2|COMPLETED|Overall Study||5
445772|NCT01347112|1092026|P1|COMPLETED|Overall Study||12
445773|NCT01347112|1092025|P2|STARTED|Overall Study||17
445774|NCT01347112|1092026|P1|STARTED|Overall Study||16
445775|NCT01347086|1092046|P10|NOT COMPLETED|Overall Study||1
445776|NCT01347086|1092047|P9|NOT COMPLETED|Overall Study||0
445777|NCT01347086|1092048|P8|NOT COMPLETED|Overall Study||1
445778|NCT01347086|1092049|P7|NOT COMPLETED|Overall Study||1
445779|NCT01347086|1092050|P6|NOT COMPLETED|Overall Study||0
445780|NCT01347086|1092051|P5|NOT COMPLETED|Overall Study||0
445781|NCT01347086|1092052|P4|NOT COMPLETED|Overall Study||0
445782|NCT01347086|1092053|P3|NOT COMPLETED|Overall Study||1
445783|NCT01347086|1092054|P2|NOT COMPLETED|Overall Study||0
445784|NCT01347086|1092055|P1|NOT COMPLETED|Overall Study||0
445785|NCT01347086|1092046|P10|COMPLETED|Overall Study||6
445786|NCT01347086|1092047|P9|COMPLETED|Overall Study||6
445787|NCT01347086|1092048|P8|COMPLETED|Overall Study||6
445788|NCT01347086|1092049|P7|COMPLETED|Overall Study||6
445789|NCT01347086|1092050|P6|COMPLETED|Overall Study||6
445790|NCT01347086|1092051|P5|COMPLETED|Overall Study||6
445791|NCT01347086|1092052|P4|COMPLETED|Overall Study||6
445792|NCT01347086|1092053|P3|COMPLETED|Overall Study||6
445793|NCT01347086|1092054|P2|COMPLETED|Overall Study||6
445794|NCT01347086|1092055|P1|COMPLETED|Overall Study||2
445795|NCT01347086|1092046|P10|STARTED|Overall Study|One subject was not treated.|7
445796|NCT01347086|1092047|P9|STARTED|Overall Study||6
445797|NCT01347086|1092048|P8|STARTED|Overall Study|One subject was not treated.|7
445798|NCT01347086|1092049|P7|STARTED|Overall Study|"2 participants treated together with each dose level of Deleobuvir.~1 subject was not treated."|7
445799|NCT01347086|1092050|P6|STARTED|Overall Study||6
445800|NCT01347086|1092051|P5|STARTED|Overall Study||6
445801|NCT01347086|1092052|P4|STARTED|Overall Study||6
445802|NCT01347086|1092053|P3|STARTED|Overall Study|"2 participants were treated together with each dose level of Deleobuvir.~1 subject was not treated."|7
445803|NCT01347086|1092054|P2|STARTED|Overall Study||6
445804|NCT01347086|1092055|P1|STARTED|Overall Study||2
445805|NCT01347073|1092154|P1|NOT COMPLETED|Overall Study||2
445806|NCT01347073|1092154|P1|COMPLETED|Overall Study||21
445807|NCT01347073|1092154|P1|STARTED|Overall Study||23
445808|NCT01347060|1092168|P2|NOT COMPLETED|Overall Study||0
445809|NCT01347060|1092169|P1|NOT COMPLETED|Overall Study||0
445810|NCT01347060|1092168|P2|COMPLETED|Overall Study||7580
445811|NCT01347060|1092169|P1|COMPLETED|Overall Study||9868
445812|NCT01347060|1092168|P2|STARTED|Overall Study||7580
445813|NCT01347060|1092169|P1|STARTED|Overall Study||9868
445814|NCT01347034|1092181|P2|NOT COMPLETED|Overall Study||0
445815|NCT01347034|1092182|P1|NOT COMPLETED|Overall Study||0
445816|NCT01347034|1092181|P2|COMPLETED|Overall Study||14
445817|NCT01347034|1092182|P1|COMPLETED|Overall Study||6
445818|NCT01347034|1092181|P2|STARTED|Overall Study||14
445819|NCT01347034|1092182|P1|STARTED|Overall Study||6
445820|NCT01347008|1092192|P2|NOT COMPLETED|Overall Study||0
445821|NCT01347008|1092193|P1|NOT COMPLETED|Overall Study||0
445822|NCT01347008|1092192|P2|COMPLETED|Overall Study||20
445823|NCT01347008|1092193|P1|COMPLETED|Overall Study||21
445824|NCT01347008|1092192|P2|STARTED|Overall Study||20
445825|NCT01347008|1092193|P1|STARTED|Overall Study||21
445826|NCT01346852|1092205|P2|NOT COMPLETED|Overall Study||0
445827|NCT01346852|1092206|P1|NOT COMPLETED|Overall Study||0
445828|NCT01346852|1092205|P2|COMPLETED|Overall Study||59684
445829|NCT01346852|1092206|P1|COMPLETED|Overall Study||41753
445830|NCT01346852|1092205|P2|STARTED|Overall Study||59684
445831|NCT01346852|1092206|P1|STARTED|Overall Study||41753
445832|NCT01346839|1092216|P2|NOT COMPLETED|Overall Study||209
445833|NCT01346839|1092217|P1|NOT COMPLETED|Overall Study||314
445834|NCT01346839|1092216|P2|COMPLETED|Overall Study|All triggers were applied retrospectively on 7/19/2012.|364
445835|NCT01346839|1092217|P1|COMPLETED|Overall Study||369
445836|NCT01346839|1092216|P2|STARTED|Overall Study||573
445837|NCT01346839|1092217|P1|STARTED|Overall Study||683
445838|NCT01346774|1092233|P2|NOT COMPLETED|Overall Study||17
445839|NCT01346774|1092234|P1|NOT COMPLETED|Overall Study||13
445840|NCT01346774|1092233|P2|COMPLETED|Overall Study||63
445841|NCT01346774|1092234|P1|COMPLETED|Overall Study||67
445842|NCT01346774|1092233|P2|STARTED|Overall Study||80
445843|NCT01346774|1092234|P1|STARTED|Overall Study||80
445844|NCT01346592|1092243|P3|NOT COMPLETED|Overall Study||78
445845|NCT01346592|1092244|P2|NOT COMPLETED|Overall Study||89
445846|NCT01346592|1092245|P1|NOT COMPLETED|Overall Study||153
445847|NCT01346592|1092243|P3|COMPLETED|Overall Study||1408
445848|NCT01346592|1092244|P2|COMPLETED|Overall Study||1389
445849|NCT01346592|1092245|P1|COMPLETED|Overall Study||2983
445850|NCT01346592|1092243|P3|STARTED|Overall Study||1486
445851|NCT01346592|1092244|P2|STARTED|Overall Study||1478
445852|NCT01346592|1092245|P1|STARTED|Overall Study||3136
445853|NCT01346514|1092337|P2|NOT COMPLETED|Overall Study||37
445854|NCT01346514|1092338|P1|NOT COMPLETED|Overall Study||29
445855|NCT01346514|1092337|P2|COMPLETED|Overall Study|Number of patients completing BL-12 months.|53
445856|NCT01346514|1092338|P1|COMPLETED|Overall Study|Number of patients completing BL-12 months|62
445857|NCT01346514|1092337|P2|12 Month Assessment|Overall Study||53
445858|NCT01346514|1092338|P1|12 Month Assessment|Overall Study||62
445859|NCT01346514|1092337|P2|9 Month Assessment|Overall Study||59
445860|NCT01346514|1092338|P1|9 Month Assessment|Overall Study||67
445861|NCT01346514|1092337|P2|6 Month Assessment|Overall Study||61
445862|NCT01346514|1092338|P1|6 Month Assessment|Overall Study||74
445863|NCT01346514|1092337|P2|3 Month Assessment|Overall Study||68
445864|NCT01346514|1092338|P1|3 Month Assessment|Overall Study||83
445865|NCT01346514|1092337|P2|STARTED|Overall Study||90
445866|NCT01346514|1092338|P1|STARTED|Overall Study||91
445867|NCT01346501|1092358|P2|NOT COMPLETED|Overall Study||13
445868|NCT01346501|1092359|P1|NOT COMPLETED|Overall Study||11
445869|NCT01346501|1092358|P2|COMPLETED|Overall Study||80
445870|NCT01346501|1092359|P1|COMPLETED|Overall Study||68
445871|NCT01346501|1092358|P2|STARTED|Overall Study||93
445872|NCT01346501|1092359|P1|STARTED|Overall Study||79
445873|NCT01346488|1092372|P1|NOT COMPLETED|Overall Study||706
445874|NCT01346488|1092372|P1|COMPLETED|Overall Study||1262
445875|NCT01346488|1092372|P1|STARTED|Overall Study||1968
445876|NCT01346475|1092392|P2|NOT COMPLETED|Second Intervention||0
445877|NCT01346475|1092393|P1|NOT COMPLETED|Second Intervention||0
445878|NCT01346475|1092392|P2|COMPLETED|Second Intervention||25
445879|NCT01346475|1092393|P1|COMPLETED|Second Intervention||18
445880|NCT01346475|1092392|P2|STARTED|Second Intervention||25
445881|NCT01346475|1092393|P1|STARTED|Second Intervention||18
445882|NCT01346475|1092392|P2|NOT COMPLETED|First Intervention||3
445883|NCT01346475|1092393|P1|NOT COMPLETED|First Intervention||4
445884|NCT01346475|1092392|P2|COMPLETED|First Intervention||25
445885|NCT01346475|1092393|P1|COMPLETED|First Intervention||18
445886|NCT01346475|1092392|P2|STARTED|First Intervention||28
445887|NCT01346475|1092393|P1|STARTED|First Intervention||22
445888|NCT01346410|1092405|P1|NOT COMPLETED|Overall Study||1
445889|NCT01346410|1092405|P1|COMPLETED|Overall Study||0
445890|NCT01346410|1092405|P1|STARTED|Overall Study||1
445891|NCT01346397|1092411|P2|NOT COMPLETED|Overall Study||0
445892|NCT01346397|1092412|P1|NOT COMPLETED|Overall Study||0
445893|NCT01346397|1092411|P2|COMPLETED|Overall Study||85
445894|NCT01346397|1092412|P1|COMPLETED|Overall Study||85
445895|NCT01346397|1092411|P2|STARTED|Overall Study||85
445896|NCT01346397|1092412|P1|STARTED|Overall Study||85
445897|NCT01346293|1092422|P2|NOT COMPLETED|Overall Study||21
445898|NCT01346293|1092423|P1|NOT COMPLETED|Overall Study||67
445899|NCT01346293|1092422|P2|COMPLETED|Overall Study||608
445900|NCT01346293|1092423|P1|COMPLETED|Overall Study||2676
445901|NCT01346293|1092422|P2|STARTED|Overall Study||629
445902|NCT01346293|1092423|P1|STARTED|Overall Study||2743
445903|NCT01346189|1092453|P4|NOT COMPLETED|Overall Study||11
445904|NCT01346189|1092454|P3|NOT COMPLETED|Overall Study||14
445905|NCT01346189|1092455|P2|NOT COMPLETED|Overall Study||17
445906|NCT01346189|1092456|P1|NOT COMPLETED|Overall Study||16
445907|NCT01346189|1092453|P4|COMPLETED|Overall Study|366 patients (58 primary care physicians) included in analysis|355
445908|NCT01346189|1092454|P3|COMPLETED|Overall Study|346 patients (58 primary care physicians) included in analysis|332
445909|NCT01346189|1092455|P2|COMPLETED|Overall Study|358 Patients (58 primary care physicians) included in analysis|341
445910|NCT01346189|1092456|P1|COMPLETED|Overall Study|433 patients (64 primary care physicians) included in analysis|417
445911|NCT01346189|1092453|P4|STARTED|Overall Study||366
445912|NCT01346189|1092454|P3|STARTED|Overall Study||346
445913|NCT01346189|1092455|P2|STARTED|Overall Study||358
445914|NCT01346189|1092456|P1|STARTED|Overall Study||433
445915|NCT01346176|1092473|P3|NOT COMPLETED|Completed Satisfaction Survey||6
445916|NCT01346176|1092474|P2|NOT COMPLETED|Completed Satisfaction Survey||4
445917|NCT01346176|1092475|P1|NOT COMPLETED|Completed Satisfaction Survey||6
445918|NCT01346176|1092473|P3|COMPLETED|Completed Satisfaction Survey||27
445919|NCT01346176|1092474|P2|COMPLETED|Completed Satisfaction Survey||22
445920|NCT01346176|1092475|P1|COMPLETED|Completed Satisfaction Survey||29
445921|NCT01346176|1092473|P3|STARTED|Completed Satisfaction Survey||33
445922|NCT01346176|1092474|P2|STARTED|Completed Satisfaction Survey||26
445923|NCT01346176|1092475|P1|STARTED|Completed Satisfaction Survey||35
445924|NCT01346176|1092473|P3|NOT COMPLETED|Completed Advance Directive||10
445925|NCT01346176|1092474|P2|NOT COMPLETED|Completed Advance Directive||14
445926|NCT01346176|1092475|P1|NOT COMPLETED|Completed Advance Directive||13
445927|NCT01346176|1092473|P3|COMPLETED|Completed Advance Directive||33
445928|NCT01346176|1092474|P2|COMPLETED|Completed Advance Directive||26
445929|NCT01346176|1092475|P1|COMPLETED|Completed Advance Directive||35
445930|NCT01346176|1092473|P3|STARTED|Completed Advance Directive||43
445931|NCT01346176|1092474|P2|STARTED|Completed Advance Directive||40
445932|NCT01346176|1092475|P1|STARTED|Completed Advance Directive||48
445933|NCT01346176|1092473|P3|NOT COMPLETED|Recruited||0
445934|NCT01346176|1092474|P2|NOT COMPLETED|Recruited||0
445935|NCT01346176|1092475|P1|NOT COMPLETED|Recruited||1
445936|NCT01346176|1092473|P3|COMPLETED|Recruited||43
445937|NCT01346176|1092474|P2|COMPLETED|Recruited||40
445938|NCT01346176|1092475|P1|COMPLETED|Recruited||48
445939|NCT01346176|1092473|P3|STARTED|Recruited||43
445940|NCT01346176|1092474|P2|STARTED|Recruited||40
445941|NCT01346176|1092475|P1|STARTED|Recruited||49
445942|NCT01346085|1092486|P1|NOT COMPLETED|Overall Study||0
445943|NCT01346085|1092486|P1|COMPLETED|Overall Study||10
445944|NCT01346085|1092486|P1|STARTED|Overall Study||10
445945|NCT01346072|1092493|P2|NOT COMPLETED|Overall Study||0
445946|NCT01346072|1092494|P1|NOT COMPLETED|Overall Study||0
445947|NCT01346072|1092493|P2|COMPLETED|Overall Study||10
445948|NCT01346072|1092494|P1|COMPLETED|Overall Study||11
445949|NCT01346072|1092493|P2|STARTED|Overall Study||10
445950|NCT01346072|1092494|P1|STARTED|Overall Study||11
445951|NCT01346059|1092504|P2|NOT COMPLETED|Overall Study||0
445952|NCT01346059|1092505|P1|NOT COMPLETED|Overall Study||1
445953|NCT01346059|1092504|P2|COMPLETED|Overall Study||1
445954|NCT01346059|1092505|P1|COMPLETED|Overall Study||0
445955|NCT01346059|1092504|P2|STARTED|Overall Study||1
445956|NCT01346059|1092505|P1|STARTED|Overall Study||1
445957|NCT01345929|1092517|P2|NOT COMPLETED|Overall Study||19
445958|NCT01345929|1092518|P1|NOT COMPLETED|Overall Study||21
445959|NCT01345929|1092517|P2|COMPLETED|Overall Study||516
445960|NCT01345929|1092518|P1|COMPLETED|Overall Study||512
445961|NCT01345929|1092517|P2|STARTED|Overall Study||535
445962|NCT01345929|1092518|P1|STARTED|Overall Study||533
445963|NCT01345786|1092530|P4|NOT COMPLETED|Overall Study||3
445964|NCT01345786|1092531|P3|NOT COMPLETED|Overall Study||5
445965|NCT01345786|1092532|P2|NOT COMPLETED|Overall Study||8
445966|NCT01345786|1092533|P1|NOT COMPLETED|Overall Study||6
445967|NCT01345786|1092530|P4|COMPLETED|Overall Study||35
445968|NCT01345786|1092531|P3|COMPLETED|Overall Study||33
445969|NCT01345786|1092532|P2|COMPLETED|Overall Study||33
445970|NCT01345786|1092533|P1|COMPLETED|Overall Study||35
445971|NCT01345786|1092530|P4|Treated|Overall Study||37
445972|NCT01345786|1092531|P3|Treated|Overall Study||37
445973|NCT01345786|1092532|P2|Treated|Overall Study||41
445974|NCT01345786|1092533|P1|Treated|Overall Study||41
445975|NCT01345786|1092530|P4|STARTED|Overall Study|Number randomized|38
445976|NCT01345786|1092531|P3|STARTED|Overall Study|Number randomized|38
445977|NCT01345786|1092532|P2|STARTED|Overall Study|Number randomized|41
445978|NCT01345786|1092533|P1|STARTED|Overall Study|Number randomized|41
445979|NCT01345721|1092582|P3|NOT COMPLETED|Overall Study||0
445980|NCT01345721|1092583|P2|NOT COMPLETED|Overall Study||0
445981|NCT01345721|1092584|P1|NOT COMPLETED|Overall Study||0
445982|NCT01345721|1092582|P3|COMPLETED|Overall Study||65
445983|NCT01345721|1092583|P2|COMPLETED|Overall Study||66
445984|NCT01345721|1092584|P1|COMPLETED|Overall Study||74
445985|NCT01345721|1092582|P3|STARTED|Overall Study||65
445986|NCT01345721|1092583|P2|STARTED|Overall Study||66
445987|NCT01345721|1092584|P1|STARTED|Overall Study||74
445988|NCT01345682|1092613|P2|NOT COMPLETED|Overall Study||161
445989|NCT01345682|1092614|P1|NOT COMPLETED|Overall Study||322
445990|NCT01345682|1092613|P2|COMPLETED|Overall Study||0
445991|NCT01345682|1092614|P1|COMPLETED|Overall Study||0
445992|NCT01345682|1092613|P2|STARTED|Overall Study|Randomised|161
445993|NCT01345682|1092614|P1|STARTED|Overall Study|Randomised|322
445994|NCT01345669|1092648|P2|NOT COMPLETED|Overall Study||119
445995|NCT01345669|1092649|P1|NOT COMPLETED|Overall Study||287
445996|NCT01345669|1092648|P2|COMPLETED|Overall Study||87
445997|NCT01345669|1092649|P1|COMPLETED|Overall Study||124
445998|NCT01345669|1092648|P2|STARTED|Overall Study||206
445999|NCT01345669|1092649|P1|STARTED|Overall Study||411
446000|NCT01345630|1092667|P2|NOT COMPLETED|Overall Study||359
446001|NCT01345630|1092668|P1|NOT COMPLETED|Overall Study||361
446002|NCT01345630|1092667|P2|COMPLETED|Overall Study||42
446003|NCT01345630|1092668|P1|COMPLETED|Overall Study||35
446004|NCT01345630|1092667|P2|STARTED|Overall Study||401
446005|NCT01345630|1092668|P1|STARTED|Overall Study||396
446006|NCT01345591|1092724|P1|NOT COMPLETED|Overall Study||1
446007|NCT01345591|1092724|P1|COMPLETED|Overall Study||19
446008|NCT01345591|1092724|P1|STARTED|Overall Study||20
446009|NCT01345318|1092733|P1|NOT COMPLETED|Overall Study||80
446010|NCT01345318|1092733|P1|COMPLETED|Overall Study||111
446011|NCT01345318|1092733|P1|STARTED|Overall Study||191
446012|NCT01345292|1092741|P3|NOT COMPLETED|Overall Study||1
446013|NCT01345292|1092742|P2|NOT COMPLETED|Overall Study||0
446014|NCT01345292|1092743|P1|NOT COMPLETED|Overall Study||2
446015|NCT01345292|1092741|P3|COMPLETED|Overall Study||74
446016|NCT01345292|1092742|P2|COMPLETED|Overall Study||76
446017|NCT01345292|1092743|P1|COMPLETED|Overall Study||73
446018|NCT01345292|1092741|P3|STARTED|Overall Study||75
446019|NCT01345292|1092742|P2|STARTED|Overall Study||76
446020|NCT01345292|1092743|P1|STARTED|Overall Study||75
446021|NCT01345253|1092774|P2|NOT COMPLETED|Overall Study||79
446022|NCT01345253|1092775|P1|NOT COMPLETED|Overall Study||56
446023|NCT01345253|1092774|P2|COMPLETED|Overall Study||372
446024|NCT01345253|1092775|P1|COMPLETED|Overall Study||170
446025|NCT01345253|1092774|P2|STARTED|Overall Study||451
446026|NCT01345253|1092775|P1|STARTED|Overall Study||226
446027|NCT01345240|1092794|P5|NOT COMPLETED|Overall Study||7
446028|NCT01345240|1092795|P4|NOT COMPLETED|Overall Study||10
446029|NCT01345240|1092796|P3|NOT COMPLETED|Overall Study||10
446030|NCT01345240|1092797|P2|NOT COMPLETED|Overall Study||14
446031|NCT01345240|1092798|P1|NOT COMPLETED|Overall Study||2
446032|NCT01345240|1092794|P5|COMPLETED|Overall Study||132
446033|NCT01345240|1092795|P4|COMPLETED|Overall Study||131
446034|NCT01345240|1092796|P3|COMPLETED|Overall Study||131
446035|NCT01345240|1092797|P2|COMPLETED|Overall Study||128
446036|NCT01345240|1092798|P1|COMPLETED|Overall Study||140
446037|NCT01345240|1092794|P5|STARTED|Overall Study||139
446038|NCT01345240|1092795|P4|STARTED|Overall Study||141
446039|NCT01345240|1092796|P3|STARTED|Overall Study||141
446040|NCT01345240|1092797|P2|STARTED|Overall Study||142
446041|NCT01345240|1092798|P1|STARTED|Overall Study||142
446042|NCT01345162|1092893|P2|NOT COMPLETED|Overall Study||4
446043|NCT01345162|1092894|P1|NOT COMPLETED|Overall Study||2
446044|NCT01345162|1092893|P2|COMPLETED|Overall Study||96
446045|NCT01345162|1092894|P1|COMPLETED|Overall Study||98
446046|NCT01345162|1092893|P2|STARTED|Overall Study||100
446047|NCT01345162|1092894|P1|STARTED|Overall Study||100
446048|NCT01345123|1092903|P3|NOT COMPLETED|Overall Study||88
446049|NCT01345123|1092904|P2|NOT COMPLETED|Overall Study||85
446050|NCT01345123|1092905|P1|NOT COMPLETED|Overall Study||79
446051|NCT01345123|1092903|P3|COMPLETED|Overall Study|3291 - 88 study participants who were no longer health plan eligible members (zero eligible months)|3203
446052|NCT01345123|1092904|P2|COMPLETED|Overall Study|3311 - 85 study participants who were no longer health plan eligible members (zero eligible months)|3226
446053|NCT01345123|1092905|P1|COMPLETED|Overall Study|3323 - 79 study participants who were no longer health plan eligible members (zero eligible months)|3244
446054|NCT01345123|1092903|P3|STARTED|Overall Study||3291
446055|NCT01345123|1092904|P2|STARTED|Overall Study||3311
446056|NCT01345123|1092905|P1|STARTED|Overall Study||3323
446057|NCT01345058|1092927|P2|NOT COMPLETED|Overall Study||0
446058|NCT01345058|1092928|P1|NOT COMPLETED|Overall Study||5
446059|NCT01345058|1092927|P2|COMPLETED|Overall Study||36
446060|NCT01345058|1092928|P1|COMPLETED|Overall Study||15
446061|NCT01345058|1092927|P2|Received Lacosamide|Overall Study||0
446062|NCT01345058|1092928|P1|Received Lacosamide|Overall Study||19
446063|NCT01345058|1092927|P2|STARTED|Overall Study||36
446064|NCT01345058|1092928|P1|STARTED|Overall Study||20
446065|NCT01345019|1092944|P2|NOT COMPLETED|Overall Study||272
446066|NCT01345019|1092945|P1|NOT COMPLETED|Overall Study||263
446067|NCT01345019|1092944|P2|COMPLETED|Overall Study|Still on study as of the data cut-off date|587
446068|NCT01345019|1092945|P1|COMPLETED|Overall Study|Still on study as of the data cut-off date|596
446069|NCT01345019|1092944|P2|Received Treatment|Overall Study||850
446070|NCT01345019|1092945|P1|Received Treatment|Overall Study||852
446071|NCT01345019|1092944|P2|STARTED|Overall Study||859
446072|NCT01345019|1092945|P1|STARTED|Overall Study||859
446073|NCT01344876|1092965|P5|NOT COMPLETED|Overall Study||1
446074|NCT01344876|1092966|P4|NOT COMPLETED|Overall Study||3
446075|NCT01344876|1092967|P3|NOT COMPLETED|Overall Study||1
446076|NCT01344876|1092968|P2|NOT COMPLETED|Overall Study||0
446077|NCT01344876|1092969|P1|NOT COMPLETED|Overall Study||1
446078|NCT01344876|1092965|P5|COMPLETED|Overall Study||2
446079|NCT01344876|1092966|P4|COMPLETED|Overall Study||3
446080|NCT01344876|1092967|P3|COMPLETED|Overall Study||3
446081|NCT01344876|1092968|P2|COMPLETED|Overall Study||3
446082|NCT01344876|1092969|P1|COMPLETED|Overall Study||3
446083|NCT01344876|1092965|P5|STARTED|Overall Study||3
446084|NCT01344876|1092966|P4|STARTED|Overall Study||6
446085|NCT01344876|1092967|P3|STARTED|Overall Study||4
446086|NCT01344876|1092968|P2|STARTED|Overall Study||3
446087|NCT01344876|1092969|P1|STARTED|Overall Study||4
446088|NCT01344824|1092983|P1|NOT COMPLETED|Overall Study||37
446089|NCT01344824|1092983|P1|COMPLETED|Overall Study||1
446090|NCT01344824|1092983|P1|STARTED|Overall Study||38
446091|NCT01344759|1092991|P2|NOT COMPLETED|Overall Study||2
446092|NCT01344759|1092992|P1|NOT COMPLETED|Overall Study||0
446093|NCT01344759|1092991|P2|COMPLETED|Overall Study|Two of the original DEX group subjects were removed, due to receiving dexmedetomidine and propofol.|28
446094|NCT01344759|1092992|P1|COMPLETED|Overall Study||30
446095|NCT01344759|1092991|P2|STARTED|Overall Study||30
446096|NCT01344759|1092992|P1|STARTED|Overall Study||30
446097|NCT01344629|1093024|P2|NOT COMPLETED|Crossover Period 4||0
446098|NCT01344629|1093025|P1|NOT COMPLETED|Crossover Period 4||0
446099|NCT01344629|1093024|P2|COMPLETED|Crossover Period 4||31
446100|NCT01344629|1093025|P1|COMPLETED|Crossover Period 4||32
446101|NCT01344629|1093024|P2|STARTED|Crossover Period 4||31
446102|NCT01344629|1093025|P1|STARTED|Crossover Period 4||32
446103|NCT01344629|1093024|P2|NOT COMPLETED|Crossover Period 3||0
446104|NCT01344629|1093025|P1|NOT COMPLETED|Crossover Period 3||0
446105|NCT01344629|1093024|P2|COMPLETED|Crossover Period 3||31
446106|NCT01344629|1093025|P1|COMPLETED|Crossover Period 3||32
446107|NCT01344629|1093024|P2|STARTED|Crossover Period 3||31
446108|NCT01344629|1093025|P1|STARTED|Crossover Period 3||32
446109|NCT01344629|1093024|P2|NOT COMPLETED|Crossover Period 2||1
446110|NCT01344629|1093025|P1|NOT COMPLETED|Crossover Period 2||0
446111|NCT01344629|1093024|P2|COMPLETED|Crossover Period 2||31
446112|NCT01344629|1093025|P1|COMPLETED|Crossover Period 2||32
446113|NCT01344629|1093024|P2|STARTED|Crossover Period 2||32
446114|NCT01344629|1093025|P1|STARTED|Crossover Period 2||32
446115|NCT01344629|1093024|P2|NOT COMPLETED|Crossover Period 1||0
446116|NCT01344629|1093025|P1|NOT COMPLETED|Crossover Period 1||0
446117|NCT01344629|1093024|P2|COMPLETED|Crossover Period 1||32
446118|NCT01344629|1093025|P1|COMPLETED|Crossover Period 1||32
446119|NCT01344629|1093024|P2|STARTED|Crossover Period 1||32
446120|NCT01344629|1093025|P1|STARTED|Crossover Period 1||32
446121|NCT01344616|1093045|P2|NOT COMPLETED|Overall Study||44
446122|NCT01344616|1093046|P1|NOT COMPLETED|Overall Study||35
446123|NCT01344616|1093045|P2|COMPLETED|Overall Study||194
446124|NCT01344616|1093046|P1|COMPLETED|Overall Study||209
446125|NCT01344616|1093045|P2|STARTED|Overall Study||238
446126|NCT01344616|1093046|P1|STARTED|Overall Study||244
446127|NCT01344538|1093054|P2|NOT COMPLETED|Overall Study||1
446128|NCT01344538|1093055|P1|NOT COMPLETED|Overall Study||2
446129|NCT01344538|1093054|P2|COMPLETED|Overall Study||16
446130|NCT01344538|1093055|P1|COMPLETED|Overall Study||14
446131|NCT01344538|1093054|P2|STARTED|Overall Study||17
446132|NCT01344538|1093055|P1|STARTED|Overall Study||16
446133|NCT01344460|1093061|P1|NOT COMPLETED|Overall Study||3
446134|NCT01344460|1093061|P1|COMPLETED|Overall Study||312
446135|NCT01344460|1093061|P1|Fulfilled Requirements of FAS Population|Overall Study|Full analysis set (FAS)|292
446136|NCT01344460|1093061|P1|STARTED|Overall Study|Participants received study drug; Safety analysis set|315
446137|NCT01344447|1093106|P1|NOT COMPLETED|Overall Study||8
446138|NCT01344447|1093106|P1|COMPLETED|Overall Study||471
446139|NCT01344447|1093106|P1|Fulfilled Requirement of FAS Population|Overall Study|Full Analysis Set (FAS)|457
446140|NCT01344447|1093106|P1|STARTED|Overall Study|Participant received study drug; Safety analysis set|479
446141|NCT01344369|1093150|P2|NOT COMPLETED|Second Intervention||1
446142|NCT01344369|1093151|P1|NOT COMPLETED|Second Intervention||0
446143|NCT01344369|1093150|P2|COMPLETED|Second Intervention||16
446144|NCT01344369|1093151|P1|COMPLETED|Second Intervention||17
446145|NCT01344369|1093150|P2|STARTED|Second Intervention||17
446146|NCT01344369|1093151|P1|STARTED|Second Intervention||17
446147|NCT01344369|1093150|P2|NOT COMPLETED|Washout of 28 Days||1
446148|NCT01344369|1093151|P1|NOT COMPLETED|Washout of 28 Days||1
446149|NCT01344369|1093150|P2|COMPLETED|Washout of 28 Days||17
446150|NCT01344369|1093151|P1|COMPLETED|Washout of 28 Days||17
446151|NCT01344369|1093150|P2|STARTED|Washout of 28 Days||18
446152|NCT01344369|1093151|P1|STARTED|Washout of 28 Days||18
446153|NCT01344369|1093150|P2|NOT COMPLETED|First Intervention||0
446154|NCT01344369|1093151|P1|NOT COMPLETED|First Intervention||0
446155|NCT01344369|1093150|P2|COMPLETED|First Intervention||18
446156|NCT01344369|1093151|P1|COMPLETED|First Intervention||18
446157|NCT01344369|1093150|P2|STARTED|First Intervention||18
446158|NCT01344369|1093151|P1|STARTED|First Intervention||18
446159|NCT01344161|1093169|P2|NOT COMPLETED|Overall Study||3
446160|NCT01344161|1093170|P1|NOT COMPLETED|Overall Study||5
446161|NCT01344161|1093169|P2|COMPLETED|Overall Study||39
446162|NCT01344161|1093170|P1|COMPLETED|Overall Study||38
446163|NCT01344161|1093169|P2|STARTED|Overall Study||42
446164|NCT01344161|1093170|P1|STARTED|Overall Study||43
446165|NCT01344057|1093182|P1|NOT COMPLETED|Overall Study||1
446166|NCT01344057|1093182|P1|COMPLETED|Overall Study||62
446167|NCT01344057|1093182|P1|STARTED|Overall Study||63
446168|NCT01343901|1093189|P1|NOT COMPLETED|Overall Study||113
446169|NCT01343901|1093189|P1|COMPLETED|Overall Study||97
446170|NCT01343901|1093189|P1|Efficacy Population|Overall Study||205
446171|NCT01343901|1093189|P1|STARTED|Overall Study||210
446172|NCT01343888|1093213|P3|NOT COMPLETED|Overall Study||22
446173|NCT01343888|1093214|P2|NOT COMPLETED|Overall Study||39
446174|NCT01343888|1093215|P1|NOT COMPLETED|Overall Study||25
446175|NCT01343888|1093213|P3|COMPLETED|Overall Study||110
446176|NCT01343888|1093214|P2|COMPLETED|Overall Study||222
446177|NCT01343888|1093215|P1|COMPLETED|Overall Study||234
446178|NCT01343888|1093213|P3|STARTED|Overall Study|133 subject randomized; 132 subjects treated with at least one dose; 1 subject was not treated|132
446179|NCT01343888|1093214|P2|STARTED|Overall Study|262 subject randomized; 261 subjects treated with at least one dose; 1 subject was not treated|261
446180|NCT01343888|1093215|P1|STARTED|Overall Study|261 subject randomized; 259 subjects treated with at least one dose; 2 subjects were not treated|259
446181|NCT01343823|1093257|P4|NOT COMPLETED|Overall Study||1
446182|NCT01343823|1093258|P3|NOT COMPLETED|Overall Study||0
446183|NCT01343823|1093259|P2|NOT COMPLETED|Overall Study||0
446184|NCT01343823|1093260|P1|NOT COMPLETED|Overall Study||2
446185|NCT01343823|1093257|P4|COMPLETED|Overall Study||19
446186|NCT01343823|1093258|P3|COMPLETED|Overall Study||19
446187|NCT01343823|1093259|P2|COMPLETED|Overall Study||20
446188|NCT01343823|1093260|P1|COMPLETED|Overall Study||18
446189|NCT01343823|1093257|P4|STARTED|Overall Study||20
446190|NCT01343823|1093258|P3|STARTED|Overall Study||19
446191|NCT01343823|1093259|P2|STARTED|Overall Study||20
446192|NCT01343823|1093260|P1|STARTED|Overall Study||20
446193|NCT01343667|1093276|P2|NOT COMPLETED|Overall Study||56
446194|NCT01343667|1093277|P1|NOT COMPLETED|Overall Study||12
446195|NCT01343667|1093276|P2|COMPLETED|Overall Study||916
446196|NCT01343667|1093277|P1|COMPLETED|Overall Study||413
446197|NCT01343667|1093276|P2|STARTED|Overall Study||972
446198|NCT01343667|1093277|P1|STARTED|Overall Study||425
446199|NCT01343485|1093285|P2|NOT COMPLETED|Overall Study||134
446200|NCT01343485|1093286|P1|NOT COMPLETED|Overall Study||149
446201|NCT01343485|1093285|P2|COMPLETED|Overall Study||46
446202|NCT01343485|1093286|P1|COMPLETED|Overall Study||36
446203|NCT01343485|1093285|P2|STARTED|Overall Study||180
446204|NCT01343485|1093286|P1|STARTED|Overall Study||185
446205|NCT01343368|1093294|P2|NOT COMPLETED|Overall Study||0
446206|NCT01343368|1093295|P1|NOT COMPLETED|Overall Study||2
446207|NCT01343368|1093294|P2|COMPLETED|Overall Study||10
446208|NCT01343368|1093295|P1|COMPLETED|Overall Study||7
446209|NCT01343368|1093294|P2|STARTED|Overall Study||10
446210|NCT01343368|1093295|P1|STARTED|Overall Study||9
446211|NCT01343277|1093331|P2|NOT COMPLETED|Overall Study||193
446212|NCT01343277|1093332|P1|NOT COMPLETED|Overall Study||384
446213|NCT01343277|1093331|P2|COMPLETED|Overall Study||0
446214|NCT01343277|1093332|P1|COMPLETED|Overall Study||0
446215|NCT01343277|1093331|P2|Treated|Overall Study||172
446216|NCT01343277|1093332|P1|Treated|Overall Study||378
446217|NCT01343277|1093331|P2|STARTED|Overall Study||193
446218|NCT01343277|1093332|P1|STARTED|Overall Study||384
446219|NCT01343251|1093350|P2|NOT COMPLETED|Overall Study||0
446220|NCT01343251|1093351|P1|NOT COMPLETED|Overall Study||0
446221|NCT01343251|1093350|P2|COMPLETED|Overall Study||17
446222|NCT01343251|1093351|P1|COMPLETED|Overall Study||16
446223|NCT01343251|1093350|P2|STARTED|Overall Study||17
446224|NCT01343251|1093351|P1|STARTED|Overall Study||16
446225|NCT01343095|1093368|P3|NOT COMPLETED|Overall Study||0
446226|NCT01343095|1093369|P2|NOT COMPLETED|Overall Study||0
446227|NCT01343095|1093370|P1|NOT COMPLETED|Overall Study||0
446228|NCT01343095|1093368|P3|COMPLETED|Overall Study||3
446229|NCT01343095|1093369|P2|COMPLETED|Overall Study||3
446230|NCT01343095|1093370|P1|COMPLETED|Overall Study||2
446231|NCT01343095|1093368|P3|STARTED|Overall Study||3
446232|NCT01343095|1093369|P2|STARTED|Overall Study||3
446233|NCT01343095|1093370|P1|STARTED|Overall Study||2
446234|NCT01343082|1093393|P3|NOT COMPLETED|Treatment Period , Switched to DE-111||12
446235|NCT01343082|1093394|P2|NOT COMPLETED|Treatment Period , Switched to DE-111||9
446236|NCT01343082|1093395|P1|NOT COMPLETED|Treatment Period , Switched to DE-111||5
446237|NCT01343082|1093393|P3|COMPLETED|Treatment Period , Switched to DE-111||31
446238|NCT01343082|1093394|P2|COMPLETED|Treatment Period , Switched to DE-111||36
446239|NCT01343082|1093395|P1|COMPLETED|Treatment Period , Switched to DE-111||43
446240|NCT01343082|1093393|P3|STARTED|Treatment Period , Switched to DE-111||43
446241|NCT01343082|1093394|P2|STARTED|Treatment Period , Switched to DE-111||45
446242|NCT01343082|1093395|P1|STARTED|Treatment Period , Switched to DE-111||48
446243|NCT01343082|1093393|P3|NOT COMPLETED|The run-in Period||5
446244|NCT01343082|1093394|P2|NOT COMPLETED|The run-in Period||4
446245|NCT01343082|1093395|P1|NOT COMPLETED|The run-in Period||3
446246|NCT01343082|1093393|P3|COMPLETED|The run-in Period||43
446247|NCT01343082|1093394|P2|COMPLETED|The run-in Period||45
446248|NCT01343082|1093395|P1|COMPLETED|The run-in Period||48
446249|NCT01343082|1093393|P3|STARTED|The run-in Period||48
446250|NCT01343082|1093394|P2|STARTED|The run-in Period||49
446251|NCT01343082|1093395|P1|STARTED|The run-in Period||51
446252|NCT01343056|1093403|P4|NOT COMPLETED|Overall Study||9
446253|NCT01343056|1093404|P3|NOT COMPLETED|Overall Study||3
446254|NCT01343056|1093405|P2|NOT COMPLETED|Overall Study||5
446255|NCT01343056|1093406|P1|NOT COMPLETED|Overall Study||7
446256|NCT01343056|1093403|P4|COMPLETED|Overall Study||29
446257|NCT01343056|1093404|P3|COMPLETED|Overall Study||29
446258|NCT01343056|1093405|P2|COMPLETED|Overall Study||31
446259|NCT01343056|1093406|P1|COMPLETED|Overall Study||28
446260|NCT01343056|1093403|P4|STARTED|Overall Study||38
446261|NCT01343056|1093404|P3|STARTED|Overall Study||32
446262|NCT01343056|1093405|P2|STARTED|Overall Study||36
446263|NCT01343056|1093406|P1|STARTED|Overall Study||35
446264|NCT01343004|1093447|P3|NOT COMPLETED|Overall Study||160
446265|NCT01343004|1093448|P2|NOT COMPLETED|Overall Study||218
446266|NCT01343004|1093449|P1|NOT COMPLETED|Overall Study||184
446267|NCT01343004|1093447|P3|COMPLETED|Overall Study||658
446268|NCT01343004|1093448|P2|COMPLETED|Overall Study||606
446269|NCT01343004|1093449|P1|COMPLETED|Overall Study||637
446270|NCT01343004|1093447|P3|STARTED|Overall Study||818
446271|NCT01343004|1093448|P2|STARTED|Overall Study||824
446272|NCT01343004|1093449|P1|STARTED|Overall Study||821
446273|NCT01342965|1093474|P2|NOT COMPLETED|Overall Study||107
446274|NCT01342965|1093475|P1|NOT COMPLETED|Overall Study||109
446275|NCT01342965|1093474|P2|COMPLETED|Overall Study||0
446276|NCT01342965|1093475|P1|COMPLETED|Overall Study||1
446277|NCT01342965|1093474|P2|Received Treatment|Overall Study||104
446278|NCT01342965|1093475|P1|Received Treatment|Overall Study||110
446279|NCT01342965|1093474|P2|STARTED|Overall Study||107
446280|NCT01342965|1093475|P1|STARTED|Overall Study||110
446281|NCT01342926|1093493|P4|NOT COMPLETED|Overall Study||12
446282|NCT01342926|1093494|P3|NOT COMPLETED|Overall Study||14
446283|NCT01342926|1093495|P2|NOT COMPLETED|Overall Study||15
446284|NCT01342926|1093496|P1|NOT COMPLETED|Overall Study||9
446285|NCT01342926|1093493|P4|COMPLETED|Overall Study||39
446286|NCT01342926|1093494|P3|COMPLETED|Overall Study||34
446287|NCT01342926|1093495|P2|COMPLETED|Overall Study||31
446288|NCT01342926|1093496|P1|COMPLETED|Overall Study||37
446289|NCT01342926|1093493|P4|STARTED|Overall Study||51
446290|NCT01342926|1093494|P3|STARTED|Overall Study||48
446291|NCT01342926|1093495|P2|STARTED|Overall Study||46
446292|NCT01342926|1093496|P1|STARTED|Overall Study||46
446293|NCT01342913|1093576|P3|NOT COMPLETED|Double-Blind Treatment Period||23
446294|NCT01342913|1093577|P2|NOT COMPLETED|Double-Blind Treatment Period||16
446295|NCT01342913|1093578|P1|NOT COMPLETED|Double-Blind Treatment Period||0
446296|NCT01342913|1093576|P3|COMPLETED|Double-Blind Treatment Period||243
446297|NCT01342913|1093577|P2|COMPLETED|Double-Blind Treatment Period||246
446298|NCT01342913|1093578|P1|COMPLETED|Double-Blind Treatment Period||0
446299|NCT01342913|1093576|P3|STARTED|Double-Blind Treatment Period||266
446300|NCT01342913|1093577|P2|STARTED|Double-Blind Treatment Period||262
446301|NCT01342913|1093578|P1|STARTED|Double-Blind Treatment Period||0
446302|NCT01342913|1093576|P3|NOT COMPLETED|2-week Run-in Period||0
446303|NCT01342913|1093577|P2|NOT COMPLETED|2-week Run-in Period||0
446304|NCT01342913|1093578|P1|NOT COMPLETED|2-week Run-in Period||174
446305|NCT01342913|1093576|P3|COMPLETED|2-week Run-in Period||0
446306|NCT01342913|1093577|P2|COMPLETED|2-week Run-in Period||0
446307|NCT01342913|1093578|P1|COMPLETED|2-week Run-in Period||528
446308|NCT01342913|1093576|P3|STARTED|2-week Run-in Period||0
446309|NCT01342913|1093577|P2|STARTED|2-week Run-in Period||0
446310|NCT01342913|1093578|P1|STARTED|2-week Run-in Period||702
446311|NCT01342887|1093588|P1|NOT COMPLETED|Overall Study||2
446312|NCT01342887|1093588|P1|COMPLETED|Overall Study||4
446313|NCT01342887|1093588|P1|STARTED|Overall Study||6
446314|NCT01342770|1093595|P1|NOT COMPLETED|Overall Study||0
446315|NCT01342770|1093595|P1|COMPLETED|Overall Study||6
446316|NCT01342770|1093595|P1|STARTED|Overall Study||6
446317|NCT01342757|1093613|P1|NOT COMPLETED|Overall Study||0
446318|NCT01342757|1093613|P1|COMPLETED|Overall Study||12
446319|NCT01342757|1093613|P1|STARTED|Overall Study||12
446320|NCT01342666|1093622|P2|NOT COMPLETED|Overall Study||0
446321|NCT01342666|1093623|P1|NOT COMPLETED|Overall Study||0
446322|NCT01342666|1093622|P2|COMPLETED|Overall Study||24
446323|NCT01342666|1093623|P1|COMPLETED|Overall Study||26
446324|NCT01342666|1093622|P2|STARTED|Overall Study||24
446325|NCT01342666|1093623|P1|STARTED|Overall Study||26
446326|NCT01342640|1093629|P1|NOT COMPLETED|Overall Study||41
446327|NCT01342640|1093629|P1|COMPLETED|Overall Study||29
446328|NCT01342640|1093629|P1|STARTED|Overall Study||70
446329|NCT01342549|1093637|P2|NOT COMPLETED|Overall Study||0
446330|NCT01342549|1093638|P1|NOT COMPLETED|Overall Study||0
446331|NCT01342549|1093637|P2|COMPLETED|Overall Study||31
446332|NCT01342549|1093638|P1|COMPLETED|Overall Study||31
446333|NCT01342549|1093637|P2|STARTED|Overall Study||31
446334|NCT01342549|1093638|P1|STARTED|Overall Study||31
446335|NCT01342523|1093676|P32|NOT COMPLETED|Overall Study||1
446336|NCT01342523|1093677|P31|NOT COMPLETED|Overall Study||1
446337|NCT01342523|1093678|P30|NOT COMPLETED|Overall Study||1
446338|NCT01342523|1093679|P29|NOT COMPLETED|Overall Study||1
446339|NCT01342523|1093680|P28|NOT COMPLETED|Overall Study||1
446340|NCT01342523|1093681|P27|NOT COMPLETED|Overall Study||1
446341|NCT01342523|1093682|P26|NOT COMPLETED|Overall Study||2
446342|NCT01342523|1093683|P25|NOT COMPLETED|Overall Study||1
446343|NCT01342523|1093684|P24|NOT COMPLETED|Overall Study||1
446344|NCT01342523|1093685|P23|NOT COMPLETED|Overall Study||0
446345|NCT01342523|1093686|P22|NOT COMPLETED|Overall Study||0
446346|NCT01342523|1093687|P21|NOT COMPLETED|Overall Study||0
446347|NCT01342523|1093688|P20|NOT COMPLETED|Overall Study||0
446348|NCT01342523|1093689|P19|NOT COMPLETED|Overall Study||0
446349|NCT01342523|1093690|P18|NOT COMPLETED|Overall Study||0
446350|NCT01342523|1093691|P17|NOT COMPLETED|Overall Study||1
446351|NCT01342523|1093692|P16|NOT COMPLETED|Overall Study||0
446352|NCT01342523|1093693|P15|NOT COMPLETED|Overall Study||1
446353|NCT01342523|1093694|P14|NOT COMPLETED|Overall Study||2
446354|NCT01342523|1093695|P13|NOT COMPLETED|Overall Study||0
446355|NCT01342523|1093696|P12|NOT COMPLETED|Overall Study||2
446356|NCT01342523|1093697|P11|NOT COMPLETED|Overall Study||0
446357|NCT01342523|1093698|P10|NOT COMPLETED|Overall Study||0
446358|NCT01342523|1093699|P9|NOT COMPLETED|Overall Study||0
446359|NCT01342523|1093700|P8|NOT COMPLETED|Overall Study||0
446360|NCT01342523|1093701|P7|NOT COMPLETED|Overall Study||0
446361|NCT01342523|1093702|P6|NOT COMPLETED|Overall Study||0
446362|NCT01342523|1093703|P5|NOT COMPLETED|Overall Study||0
446363|NCT01342523|1093704|P4|NOT COMPLETED|Overall Study||1
446364|NCT01342523|1093705|P3|NOT COMPLETED|Overall Study||0
446365|NCT01342523|1093706|P2|NOT COMPLETED|Overall Study||0
446366|NCT01342523|1093707|P1|NOT COMPLETED|Overall Study||1
446367|NCT01342523|1093676|P32|COMPLETED|Overall Study||27
446368|NCT01342523|1093677|P31|COMPLETED|Overall Study||30
446369|NCT01342523|1093678|P30|COMPLETED|Overall Study||28
446370|NCT01342523|1093679|P29|COMPLETED|Overall Study||34
446371|NCT01342523|1093680|P28|COMPLETED|Overall Study||30
446372|NCT01342523|1093681|P27|COMPLETED|Overall Study||33
446373|NCT01342523|1093682|P26|COMPLETED|Overall Study||36
446374|NCT01342523|1093683|P25|COMPLETED|Overall Study||36
446375|NCT01342523|1093684|P24|COMPLETED|Overall Study||35
446376|NCT01342523|1093685|P23|COMPLETED|Overall Study||36
446377|NCT01342523|1093686|P22|COMPLETED|Overall Study||30
446378|NCT01342523|1093687|P21|COMPLETED|Overall Study||29
446379|NCT01342523|1093688|P20|COMPLETED|Overall Study||27
446380|NCT01342523|1093689|P19|COMPLETED|Overall Study||21
446381|NCT01342523|1093690|P18|COMPLETED|Overall Study||27
446382|NCT01342523|1093691|P17|COMPLETED|Overall Study||28
446383|NCT01342523|1093692|P16|COMPLETED|Overall Study||32
446384|NCT01342523|1093693|P15|COMPLETED|Overall Study||37
446385|NCT01342523|1093694|P14|COMPLETED|Overall Study||36
446386|NCT01342523|1093695|P13|COMPLETED|Overall Study||39
446387|NCT01342523|1093696|P12|COMPLETED|Overall Study||36
446388|NCT01342523|1093697|P11|COMPLETED|Overall Study||38
446389|NCT01342523|1093698|P10|COMPLETED|Overall Study||28
446390|NCT01342523|1093699|P9|COMPLETED|Overall Study||28
446391|NCT01342523|1093700|P8|COMPLETED|Overall Study||27
446392|NCT01342523|1093701|P7|COMPLETED|Overall Study||22
446393|NCT01342523|1093702|P6|COMPLETED|Overall Study||36
446394|NCT01342523|1093703|P5|COMPLETED|Overall Study||36
446395|NCT01342523|1093704|P4|COMPLETED|Overall Study||32
446396|NCT01342523|1093705|P3|COMPLETED|Overall Study||36
446397|NCT01342523|1093706|P2|COMPLETED|Overall Study||32
446398|NCT01342523|1093707|P1|COMPLETED|Overall Study||34
446399|NCT01342523|1093676|P32|STARTED|Overall Study||28
446400|NCT01342523|1093677|P31|STARTED|Overall Study||31
446401|NCT01342523|1093678|P30|STARTED|Overall Study||29
446402|NCT01342523|1093679|P29|STARTED|Overall Study||35
446403|NCT01342523|1093680|P28|STARTED|Overall Study||31
446404|NCT01342523|1093681|P27|STARTED|Overall Study||34
446405|NCT01342523|1093682|P26|STARTED|Overall Study||38
446406|NCT01342523|1093683|P25|STARTED|Overall Study||37
446407|NCT01342523|1093684|P24|STARTED|Overall Study||36
446408|NCT01342523|1093685|P23|STARTED|Overall Study||36
446409|NCT01342523|1093686|P22|STARTED|Overall Study||30
446410|NCT01342523|1093687|P21|STARTED|Overall Study||29
446411|NCT01342523|1093688|P20|STARTED|Overall Study||27
446412|NCT01342523|1093689|P19|STARTED|Overall Study||21
446413|NCT01342523|1093690|P18|STARTED|Overall Study||27
446414|NCT01342523|1093691|P17|STARTED|Overall Study||29
446415|NCT01342523|1093692|P16|STARTED|Overall Study||32
446416|NCT01342523|1093693|P15|STARTED|Overall Study||38
446417|NCT01342523|1093694|P14|STARTED|Overall Study||38
446418|NCT01342523|1093695|P13|STARTED|Overall Study||39
446419|NCT01342523|1093696|P12|STARTED|Overall Study||38
446420|NCT01342523|1093697|P11|STARTED|Overall Study||38
446421|NCT01342523|1093698|P10|STARTED|Overall Study||28
446422|NCT01342523|1093699|P9|STARTED|Overall Study||28
446423|NCT01342523|1093700|P8|STARTED|Overall Study||27
446424|NCT01342523|1093701|P7|STARTED|Overall Study||22
446425|NCT01342523|1093702|P6|STARTED|Overall Study||36
446426|NCT01342523|1093703|P5|STARTED|Overall Study||36
446427|NCT01342523|1093704|P4|STARTED|Overall Study||33
446428|NCT01342523|1093705|P3|STARTED|Overall Study||36
446429|NCT01342523|1093706|P2|STARTED|Overall Study||32
446430|NCT01342523|1093707|P1|STARTED|Overall Study||35
446431|NCT01342510|1093724|P4|NOT COMPLETED|Overall Study||11
446432|NCT01342510|1093725|P3|NOT COMPLETED|Overall Study||13
446433|NCT01342510|1093726|P2|NOT COMPLETED|Overall Study||6
446434|NCT01342510|1093727|P1|NOT COMPLETED|Overall Study||12
446435|NCT01342510|1093724|P4|COMPLETED|Overall Study||39
446436|NCT01342510|1093725|P3|COMPLETED|Overall Study||37
446437|NCT01342510|1093726|P2|COMPLETED|Overall Study||44
446438|NCT01342510|1093727|P1|COMPLETED|Overall Study||38
446439|NCT01342510|1093724|P4|STARTED|Overall Study||50
446440|NCT01342510|1093725|P3|STARTED|Overall Study||50
446441|NCT01342510|1093726|P2|STARTED|Overall Study||50
446442|NCT01342510|1093727|P1|STARTED|Overall Study||50
446443|NCT01342484|1093740|P3|NOT COMPLETED|Overall Study||1
446444|NCT01342484|1093741|P2|NOT COMPLETED|Overall Study||0
446445|NCT01342484|1093742|P1|NOT COMPLETED|Overall Study||2
446446|NCT01342484|1093740|P3|COMPLETED|Overall Study||13
446447|NCT01342484|1093741|P2|COMPLETED|Overall Study||10
446448|NCT01342484|1093742|P1|COMPLETED|Overall Study||13
446449|NCT01342484|1093740|P3|STARTED|Overall Study||14
446450|NCT01342484|1093741|P2|STARTED|Overall Study||10
446451|NCT01342484|1093742|P1|STARTED|Overall Study||15
446452|NCT01342471|1093758|P2|NOT COMPLETED|Overall Study||6
446453|NCT01342471|1093759|P1|NOT COMPLETED|Overall Study||5
446454|NCT01342471|1093758|P2|COMPLETED|Overall Study||23
446455|NCT01342471|1093759|P1|COMPLETED|Overall Study||24
446456|NCT01342471|1093758|P2|STARTED|Overall Study||29
446457|NCT01342471|1093759|P1|STARTED|Overall Study||29
446458|NCT01342458|1093775|P2|NOT COMPLETED|Overall Study||4
446459|NCT01342458|1093776|P1|NOT COMPLETED|Overall Study||2
446460|NCT01342458|1093775|P2|COMPLETED|Overall Study||24
446461|NCT01342458|1093776|P1|COMPLETED|Overall Study||26
446462|NCT01342458|1093775|P2|STARTED|Overall Study||28
446463|NCT01342458|1093776|P1|STARTED|Overall Study||28
446464|NCT01342445|1093798|P2|NOT COMPLETED|Overall Study||2
446465|NCT01342445|1093799|P1|NOT COMPLETED|Overall Study||0
446466|NCT01342445|1093798|P2|COMPLETED|Overall Study||22
446467|NCT01342445|1093799|P1|COMPLETED|Overall Study||26
446468|NCT01342445|1093798|P2|STARTED|Overall Study||24
446469|NCT01342445|1093799|P1|STARTED|Overall Study||26
446470|NCT01342341|1093815|P2|NOT COMPLETED|Overall Study||4
446471|NCT01342341|1093816|P1|NOT COMPLETED|Overall Study||4
446472|NCT01342341|1093815|P2|COMPLETED|Overall Study||20
446473|NCT01342341|1093816|P1|COMPLETED|Overall Study||20
446474|NCT01342341|1093815|P2|STARTED|Overall Study||24
446475|NCT01342341|1093816|P1|STARTED|Overall Study||24
446476|NCT01342211|1093827|P5|NOT COMPLETED|Overall Study||2
446477|NCT01342211|1093828|P4|NOT COMPLETED|Overall Study||2
446478|NCT01342211|1093829|P3|NOT COMPLETED|Overall Study||0
446479|NCT01342211|1093830|P2|NOT COMPLETED|Overall Study||2
446480|NCT01342211|1093831|P1|NOT COMPLETED|Overall Study||0
446481|NCT01342211|1093827|P5|COMPLETED|Overall Study||16
446482|NCT01342211|1093828|P4|COMPLETED|Overall Study||17
446483|NCT01342211|1093829|P3|COMPLETED|Overall Study||18
446484|NCT01342211|1093830|P2|COMPLETED|Overall Study||17
446485|NCT01342211|1093831|P1|COMPLETED|Overall Study||19
446486|NCT01342211|1093827|P5|Treated|Overall Study||17
446487|NCT01342211|1093828|P4|Treated|Overall Study||19
446488|NCT01342211|1093829|P3|Treated|Overall Study||18
446489|NCT01342211|1093830|P2|Treated|Overall Study||17
446490|NCT01342211|1093831|P1|Treated|Overall Study||19
446491|NCT01342211|1093827|P5|STARTED|Overall Study||18
446492|NCT01342211|1093828|P4|STARTED|Overall Study||19
446493|NCT01342211|1093829|P3|STARTED|Overall Study||18
446494|NCT01342211|1093830|P2|STARTED|Overall Study||19
446495|NCT01342211|1093831|P1|STARTED|Overall Study||19
446496|NCT01342172|1093897|P1|NOT COMPLETED|Overall Study||0
446497|NCT01342172|1093897|P1|COMPLETED|Overall Study||9
446498|NCT01342172|1093897|P1|STARTED|Overall Study||9
446499|NCT01342107|1093903|P2|NOT COMPLETED|Overall Study||0
446500|NCT01342107|1093904|P1|NOT COMPLETED|Overall Study||0
446501|NCT01342107|1093903|P2|COMPLETED|Overall Study||32
446502|NCT01342107|1093904|P1|COMPLETED|Overall Study||34
446503|NCT01342107|1093903|P2|STARTED|Overall Study||32
446504|NCT01342107|1093904|P1|STARTED|Overall Study||34
446505|NCT01342094|1093912|P2|NOT COMPLETED|Overall Study||3
446506|NCT01342094|1093913|P1|NOT COMPLETED|Overall Study||5
446507|NCT01342094|1093912|P2|COMPLETED|Overall Study||81
446508|NCT01342094|1093913|P1|COMPLETED|Overall Study||77
446509|NCT01342094|1093912|P2|STARTED|Overall Study||84
446510|NCT01342094|1093913|P1|STARTED|Overall Study||82
446511|NCT01342081|1093922|P3|NOT COMPLETED|Overall Study||1
446512|NCT01342081|1093923|P2|NOT COMPLETED|Overall Study||2
446513|NCT01342081|1093924|P1|NOT COMPLETED|Overall Study||2
446514|NCT01342081|1093922|P3|COMPLETED|Overall Study||163
446515|NCT01342081|1093923|P2|COMPLETED|Overall Study||162
446516|NCT01342081|1093924|P1|COMPLETED|Overall Study||159
446517|NCT01342081|1093922|P3|STARTED|Overall Study||164
446518|NCT01342081|1093923|P2|STARTED|Overall Study||164
446519|NCT01342081|1093924|P1|STARTED|Overall Study||161
446520|NCT01342029|1093932|P2|NOT COMPLETED|Period 2||0
446521|NCT01342029|1093933|P1|NOT COMPLETED|Period 2||2
446522|NCT01342029|1093932|P2|COMPLETED|Period 2||67
446523|NCT01342029|1093933|P1|COMPLETED|Period 2||65
446524|NCT01342029|1093932|P2|Dropout|Period 2||0
446525|NCT01342029|1093933|P1|Dropout|Period 2||2
446526|NCT01342029|1093932|P2|STARTED|Period 2||67
446527|NCT01342029|1093933|P1|STARTED|Period 2||67
446528|NCT01342029|1093932|P2|NOT COMPLETED|Washout||4
446529|NCT01342029|1093933|P1|NOT COMPLETED|Washout||0
446530|NCT01342029|1093932|P2|COMPLETED|Washout||67
446531|NCT01342029|1093933|P1|COMPLETED|Washout||67
446532|NCT01342029|1093932|P2|STARTED|Washout||71
446533|NCT01342029|1093933|P1|STARTED|Washout||67
446534|NCT01342029|1093932|P2|NOT COMPLETED|Period 1||1
446535|NCT01342029|1093933|P1|NOT COMPLETED|Period 1||3
446536|NCT01342029|1093932|P2|COMPLETED|Period 1||71
446537|NCT01342029|1093933|P1|COMPLETED|Period 1||67
446538|NCT01342029|1093932|P2|Dropout|Period 1||1
446539|NCT01342029|1093933|P1|Dropout|Period 1||3
446540|NCT01342029|1093932|P2|STARTED|Period 1||72
446541|NCT01342029|1093933|P1|STARTED|Period 1||70
446542|NCT01341990|1093943|P2|NOT COMPLETED|Overall Study||1
446543|NCT01341990|1093944|P1|NOT COMPLETED|Overall Study||3
446544|NCT01341990|1093943|P2|COMPLETED|Overall Study||32
446545|NCT01341990|1093944|P1|COMPLETED|Overall Study||32
446546|NCT01341990|1093943|P2|STARTED|Overall Study||33
446547|NCT01341990|1093944|P1|STARTED|Overall Study||35
446548|NCT01341977|1093954|P2|NOT COMPLETED|Overall Study||15
446549|NCT01341977|1093955|P1|NOT COMPLETED|Overall Study||14
446550|NCT01341977|1093954|P2|COMPLETED|Overall Study||270
446551|NCT01341977|1093955|P1|COMPLETED|Overall Study||274
446552|NCT01341977|1093954|P2|STARTED|Overall Study||285
446553|NCT01341977|1093955|P1|STARTED|Overall Study||288
446554|NCT01341912|1093961|P1|NOT COMPLETED|Overall Study||0
446555|NCT01341912|1093961|P1|COMPLETED|Overall Study||3
446556|NCT01341912|1093961|P1|STARTED|Overall Study||3
446557|NCT01341782|1093968|P2|NOT COMPLETED|Overall Study||14
446558|NCT01341782|1093969|P1|NOT COMPLETED|Overall Study||15
446559|NCT01341782|1093968|P2|COMPLETED|Overall Study||114
446560|NCT01341782|1093969|P1|COMPLETED|Overall Study||112
446561|NCT01341782|1093968|P2|STARTED|Overall Study||128
446562|NCT01341782|1093969|P1|STARTED|Overall Study||127
446563|NCT01341600|1093988|P3|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
446564|NCT01341600|1093989|P2|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
446565|NCT01341600|1093990|P1|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
446566|NCT01341600|1093988|P3|COMPLETED|Clopidogrel Plus Omeprazole||4
446567|NCT01341600|1093989|P2|COMPLETED|Clopidogrel Plus Omeprazole||5
446568|NCT01341600|1093990|P1|COMPLETED|Clopidogrel Plus Omeprazole||5
446569|NCT01341600|1093988|P3|STARTED|Clopidogrel Plus Omeprazole||4
446570|NCT01341600|1093989|P2|STARTED|Clopidogrel Plus Omeprazole||5
446571|NCT01341600|1093990|P1|STARTED|Clopidogrel Plus Omeprazole||5
446572|NCT01341600|1093988|P3|NOT COMPLETED|Clopidogrel 225 mg||0
446573|NCT01341600|1093989|P2|NOT COMPLETED|Clopidogrel 225 mg||0
446574|NCT01341600|1093990|P1|NOT COMPLETED|Clopidogrel 225 mg||0
446575|NCT01341600|1093988|P3|COMPLETED|Clopidogrel 225 mg||6
446576|NCT01341600|1093989|P2|COMPLETED|Clopidogrel 225 mg||6
446577|NCT01341600|1093990|P1|COMPLETED|Clopidogrel 225 mg||6
446578|NCT01341600|1093988|P3|STARTED|Clopidogrel 225 mg||6
446579|NCT01341600|1093989|P2|STARTED|Clopidogrel 225 mg||6
446580|NCT01341600|1093990|P1|STARTED|Clopidogrel 225 mg||6
446581|NCT01341600|1093988|P3|NOT COMPLETED|Clopidogrel 150 mg||0
446582|NCT01341600|1093989|P2|NOT COMPLETED|Clopidogrel 150 mg||0
446583|NCT01341600|1093990|P1|NOT COMPLETED|Clopidogrel 150 mg||0
446584|NCT01341600|1093988|P3|COMPLETED|Clopidogrel 150 mg||6
446585|NCT01341600|1093989|P2|COMPLETED|Clopidogrel 150 mg||6
446586|NCT01341600|1093990|P1|COMPLETED|Clopidogrel 150 mg||6
446587|NCT01341600|1093988|P3|STARTED|Clopidogrel 150 mg||6
446588|NCT01341600|1093989|P2|STARTED|Clopidogrel 150 mg||6
446589|NCT01341600|1093990|P1|STARTED|Clopidogrel 150 mg||6
446590|NCT01341600|1093988|P3|NOT COMPLETED|Clopidogrel 75 mg||0
446591|NCT01341600|1093989|P2|NOT COMPLETED|Clopidogrel 75 mg||0
446592|NCT01341600|1093990|P1|NOT COMPLETED|Clopidogrel 75 mg||0
446593|NCT01341600|1093988|P3|COMPLETED|Clopidogrel 75 mg||6
446594|NCT01341600|1093989|P2|COMPLETED|Clopidogrel 75 mg||6
446595|NCT01341600|1093990|P1|COMPLETED|Clopidogrel 75 mg||6
446596|NCT01341600|1093988|P3|STARTED|Clopidogrel 75 mg||6
446597|NCT01341600|1093989|P2|STARTED|Clopidogrel 75 mg||6
446598|NCT01341600|1093990|P1|STARTED|Clopidogrel 75 mg||6
446599|NCT01341587|1094009|P2|NOT COMPLETED|Overall Study||10
446600|NCT01341587|1094010|P1|NOT COMPLETED|Overall Study||4
446601|NCT01341587|1094009|P2|COMPLETED|Overall Study||0
446602|NCT01341587|1094010|P1|COMPLETED|Overall Study||0
446603|NCT01341587|1094009|P2|STARTED|Overall Study||10
446604|NCT01341587|1094010|P1|STARTED|Overall Study||4
446605|NCT01341444|1094018|P2|NOT COMPLETED|Overall Study||3
446606|NCT01341444|1094019|P1|NOT COMPLETED|Overall Study||5
446607|NCT01341444|1094018|P2|COMPLETED|Overall Study||29
446608|NCT01341444|1094019|P1|COMPLETED|Overall Study||26
446609|NCT01341444|1094018|P2|STARTED|Overall Study||32
446610|NCT01341444|1094019|P1|STARTED|Overall Study||31
446611|NCT01341301|1094025|P1|NOT COMPLETED|Overall Study||0
446612|NCT01341301|1094025|P1|COMPLETED|Overall Study||25
446613|NCT01341301|1094025|P1|STARTED|Overall Study||25
446614|NCT01341067|1094032|P1|NOT COMPLETED|Overall Study||4
446615|NCT01341067|1094032|P1|COMPLETED|Overall Study||26
446616|NCT01341067|1094032|P1|STARTED|Overall Study||30
446617|NCT01340937|1094043|P4|NOT COMPLETED|Period 3: Toddler Vaccinations||10
446618|NCT01340937|1094044|P3|NOT COMPLETED|Period 3: Toddler Vaccinations||9
446619|NCT01340937|1094045|P2|NOT COMPLETED|Period 3: Toddler Vaccinations||17
446620|NCT01340937|1094046|P1|NOT COMPLETED|Period 3: Toddler Vaccinations||9
446621|NCT01340937|1094043|P4|COMPLETED|Period 3: Toddler Vaccinations||319
446622|NCT01340937|1094044|P3|COMPLETED|Period 3: Toddler Vaccinations||660
446623|NCT01340937|1094045|P2|COMPLETED|Period 3: Toddler Vaccinations||641
446624|NCT01340937|1094046|P1|COMPLETED|Period 3: Toddler Vaccinations||666
446625|NCT01340937|1094043|P4|STARTED|Period 3: Toddler Vaccinations||329
446626|NCT01340937|1094044|P3|STARTED|Period 3: Toddler Vaccinations||669
446627|NCT01340937|1094045|P2|STARTED|Period 3: Toddler Vaccinations||658
446628|NCT01340937|1094046|P1|STARTED|Period 3: Toddler Vaccinations||675
446629|NCT01340937|1094043|P4|NOT COMPLETED|Period 2: Interim Period||41
446630|NCT01340937|1094044|P3|NOT COMPLETED|Period 2: Interim Period||84
446631|NCT01340937|1094045|P2|NOT COMPLETED|Period 2: Interim Period||79
446632|NCT01340937|1094046|P1|NOT COMPLETED|Period 2: Interim Period||67
446633|NCT01340937|1094043|P4|COMPLETED|Period 2: Interim Period||329
446634|NCT01340937|1094044|P3|COMPLETED|Period 2: Interim Period||669
446635|NCT01340937|1094045|P2|COMPLETED|Period 2: Interim Period||658
446636|NCT01340937|1094046|P1|COMPLETED|Period 2: Interim Period||675
446637|NCT01340937|1094043|P4|STARTED|Period 2: Interim Period||370
446638|NCT01340937|1094044|P3|STARTED|Period 2: Interim Period||753
446639|NCT01340937|1094045|P2|STARTED|Period 2: Interim Period||737
446640|NCT01340937|1094046|P1|STARTED|Period 2: Interim Period||742
446641|NCT01340937|1094043|P4|NOT COMPLETED|Period 1: Infant Series||32
446642|NCT01340937|1094044|P3|NOT COMPLETED|Period 1: Infant Series||56
446643|NCT01340937|1094045|P2|NOT COMPLETED|Period 1: Infant Series||60
446644|NCT01340937|1094046|P1|NOT COMPLETED|Period 1: Infant Series||58
446645|NCT01340937|1094043|P4|COMPLETED|Period 1: Infant Series||370
446646|NCT01340937|1094044|P3|COMPLETED|Period 1: Infant Series||753
446647|NCT01340937|1094045|P2|COMPLETED|Period 1: Infant Series||737
446648|NCT01340937|1094046|P1|COMPLETED|Period 1: Infant Series||742
446649|NCT01340937|1094043|P4|STARTED|Period 1: Infant Series||402
446650|NCT01340937|1094044|P3|STARTED|Period 1: Infant Series||809
446651|NCT01340937|1094045|P2|STARTED|Period 1: Infant Series||797
446652|NCT01340937|1094046|P1|STARTED|Period 1: Infant Series||800
446653|NCT01340794|1094205|P2|NOT COMPLETED|Overall Study||1
446654|NCT01340794|1094206|P1|NOT COMPLETED|Overall Study||0
446655|NCT01340794|1094205|P2|COMPLETED|Overall Study||4
446656|NCT01340794|1094206|P1|COMPLETED|Overall Study||2
446657|NCT01340794|1094205|P2|STARTED|Overall Study||5
446658|NCT01340794|1094206|P1|STARTED|Overall Study||2
446659|NCT01340768|1094222|P2|NOT COMPLETED|Overall Study||5
446660|NCT01340768|1094223|P1|NOT COMPLETED|Overall Study||17
446661|NCT01340768|1094222|P2|COMPLETED|Overall Study||429
446662|NCT01340768|1094223|P1|COMPLETED|Overall Study||419
446663|NCT01340768|1094222|P2|STARTED|Overall Study||434
446664|NCT01340768|1094223|P1|STARTED|Overall Study||436
446665|NCT01340664|1094234|P3|NOT COMPLETED|Overall Study||13
446666|NCT01340664|1094235|P2|NOT COMPLETED|Overall Study||8
446667|NCT01340664|1094236|P1|NOT COMPLETED|Overall Study||7
446668|NCT01340664|1094234|P3|COMPLETED|Overall Study||80
446669|NCT01340664|1094235|P2|COMPLETED|Overall Study||85
446670|NCT01340664|1094236|P1|COMPLETED|Overall Study||86
446671|NCT01340664|1094234|P3|STARTED|Overall Study||93
446672|NCT01340664|1094235|P2|STARTED|Overall Study||93
446673|NCT01340664|1094236|P1|STARTED|Overall Study||93
446674|NCT01340651|1094253|P1|NOT COMPLETED|Overall Study||17
446675|NCT01340651|1094253|P1|COMPLETED|Overall Study||24
446676|NCT01340651|1094253|P1|STARTED|Overall Study||41
446677|NCT01340625|1094269|P2|NOT COMPLETED|Second Intervention||0
446678|NCT01340625|1094270|P1|NOT COMPLETED|Second Intervention||0
446679|NCT01340625|1094269|P2|COMPLETED|Second Intervention||18
446680|NCT01340625|1094270|P1|COMPLETED|Second Intervention||16
446681|NCT01340625|1094269|P2|STARTED|Second Intervention||18
446682|NCT01340625|1094270|P1|STARTED|Second Intervention||16
446683|NCT01340625|1094269|P2|NOT COMPLETED|Washout Period of 28 Days||0
446684|NCT01340625|1094270|P1|NOT COMPLETED|Washout Period of 28 Days||1
446685|NCT01340625|1094269|P2|COMPLETED|Washout Period of 28 Days||18
446686|NCT01340625|1094270|P1|COMPLETED|Washout Period of 28 Days||16
446687|NCT01340625|1094269|P2|STARTED|Washout Period of 28 Days||18
446688|NCT01340625|1094270|P1|STARTED|Washout Period of 28 Days||17
446689|NCT01340625|1094269|P2|NOT COMPLETED|First Intervention||0
446690|NCT01340625|1094270|P1|NOT COMPLETED|First Intervention||1
446691|NCT01340625|1094269|P2|COMPLETED|First Intervention||18
446692|NCT01340625|1094270|P1|COMPLETED|First Intervention||17
446693|NCT01340625|1094269|P2|STARTED|First Intervention||18
446694|NCT01340625|1094270|P1|STARTED|First Intervention||18
446695|NCT01340586|1094288|P2|NOT COMPLETED|Overall Study||0
446696|NCT01340586|1094289|P1|NOT COMPLETED|Overall Study||0
446697|NCT01340586|1094288|P2|COMPLETED|Overall Study||8
446698|NCT01340586|1094289|P1|COMPLETED|Overall Study||8
446699|NCT01340586|1094288|P2|STARTED|Overall Study||8
446700|NCT01340586|1094289|P1|STARTED|Overall Study||8
446701|NCT01340573|1094354|P1|NOT COMPLETED|Overall Study||3
446702|NCT01340573|1094354|P1|COMPLETED|Overall Study||0
446703|NCT01340573|1094354|P1|STARTED|Overall Study||3
446704|NCT01340495|1094375|P1|NOT COMPLETED|Overall Study||1
446705|NCT01340495|1094375|P1|COMPLETED|Overall Study||69
446706|NCT01340495|1094375|P1|STARTED|Overall Study||70
446707|NCT01340300|1094385|P4|NOT COMPLETED|Overall Study||14
446708|NCT01340300|1094386|P3|NOT COMPLETED|Overall Study||15
446709|NCT01340300|1094387|P2|NOT COMPLETED|Overall Study||9
446710|NCT01340300|1094388|P1|NOT COMPLETED|Overall Study||9
446711|NCT01340300|1094385|P4|COMPLETED|Overall Study||20
446712|NCT01340300|1094386|P3|COMPLETED|Overall Study||20
446713|NCT01340300|1094387|P2|COMPLETED|Overall Study||26
446714|NCT01340300|1094388|P1|COMPLETED|Overall Study||26
446715|NCT01340300|1094385|P4|Follow-up Blood Sample|Overall Study||18
446716|NCT01340300|1094386|P3|Follow-up Blood Sample|Overall Study||19
446717|NCT01340300|1094387|P2|Follow-up Blood Sample|Overall Study||26
446718|NCT01340300|1094388|P1|Follow-up Blood Sample|Overall Study||25
446719|NCT01340300|1094385|P4|Baseline Blood Sample|Overall Study||29
446720|NCT01340300|1094386|P3|Baseline Blood Sample|Overall Study||32
446721|NCT01340300|1094387|P2|Baseline Blood Sample|Overall Study||34
446722|NCT01340300|1094388|P1|Baseline Blood Sample|Overall Study||33
446723|NCT01340300|1094385|P4|STARTED|Overall Study||34
446724|NCT01340300|1094386|P3|STARTED|Overall Study||35
446725|NCT01340300|1094387|P2|STARTED|Overall Study||35
446726|NCT01340300|1094388|P1|STARTED|Overall Study||35
446727|NCT01340209|1094421|P3|NOT COMPLETED|Overall Study||8
446728|NCT01340209|1094422|P2|NOT COMPLETED|Overall Study||8
446729|NCT01340209|1094423|P1|NOT COMPLETED|Overall Study||5
446730|NCT01340209|1094421|P3|COMPLETED|Overall Study||106
446731|NCT01340209|1094422|P2|COMPLETED|Overall Study||106
446732|NCT01340209|1094423|P1|COMPLETED|Overall Study||52
446733|NCT01340209|1094421|P3|STARTED|Overall Study||114
446734|NCT01340209|1094422|P2|STARTED|Overall Study||114
446735|NCT01340209|1094423|P1|STARTED|Overall Study||57
446736|NCT01340196|1094458|P1|NOT COMPLETED|Treat. Period 3 (Faldaprevir)||2
446737|NCT01340196|1094458|P1|COMPLETED|Treat. Period 3 (Faldaprevir)||14
446738|NCT01340196|1094458|P1|STARTED|Treat. Period 3 (Faldaprevir)||16
446739|NCT01340196|1094458|P1|NOT COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||0
446740|NCT01340196|1094458|P1|COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||16
446741|NCT01340196|1094458|P1|STARTED|Treat. Period 2 (Tenofovir/Faldaprevir)||16
446742|NCT01340196|1094458|P1|NOT COMPLETED|Treat. Period 1 (Tenofovir)||0
446743|NCT01340196|1094458|P1|COMPLETED|Treat. Period 1 (Tenofovir)||16
446744|NCT01340196|1094458|P1|STARTED|Treat. Period 1 (Tenofovir)||16
446745|NCT01340144|1094489|P2|NOT COMPLETED|Overall Study||58
446746|NCT01340144|1094490|P1|NOT COMPLETED|Overall Study||72
446747|NCT01340144|1094489|P2|COMPLETED|Overall Study||567
446748|NCT01340144|1094490|P1|COMPLETED|Overall Study||553
446749|NCT01340144|1094489|P2|STARTED|Overall Study||625
446750|NCT01340144|1094490|P1|STARTED|Overall Study||625
446751|NCT01340066|1094498|P3|NOT COMPLETED|5 Week Double Blind Randomization Period||3
446752|NCT01340066|1094499|P2|NOT COMPLETED|5 Week Double Blind Randomization Period||5
446753|NCT01340066|1094500|P1|NOT COMPLETED|5 Week Double Blind Randomization Period||0
446754|NCT01340066|1094498|P3|COMPLETED|5 Week Double Blind Randomization Period||31
446755|NCT01340066|1094499|P2|COMPLETED|5 Week Double Blind Randomization Period||28
446756|NCT01340066|1094500|P1|COMPLETED|5 Week Double Blind Randomization Period||0
446757|NCT01340066|1094498|P3|STARTED|5 Week Double Blind Randomization Period||34
446758|NCT01340066|1094499|P2|STARTED|5 Week Double Blind Randomization Period||33
446759|NCT01340066|1094500|P1|STARTED|5 Week Double Blind Randomization Period||0
446760|NCT01340066|1094498|P3|NOT COMPLETED|Placebo Run in Period||0
446761|NCT01340066|1094499|P2|NOT COMPLETED|Placebo Run in Period||0
446762|NCT01340066|1094500|P1|NOT COMPLETED|Placebo Run in Period||27
446763|NCT01340066|1094498|P3|COMPLETED|Placebo Run in Period||0
446764|NCT01340066|1094499|P2|COMPLETED|Placebo Run in Period||0
446765|NCT01340066|1094500|P1|COMPLETED|Placebo Run in Period|Completed run in period and were eligible for randomization|67
446766|NCT01340066|1094498|P3|STARTED|Placebo Run in Period||0
446767|NCT01340066|1094499|P2|STARTED|Placebo Run in Period||0
446768|NCT01340066|1094500|P1|STARTED|Placebo Run in Period||94
446769|NCT01340027|1094519|P12|NOT COMPLETED|Overall Study||4
446770|NCT01340027|1094520|P11|NOT COMPLETED|Overall Study||2
446771|NCT01340027|1094521|P10|NOT COMPLETED|Overall Study||6
446772|NCT01340027|1094522|P9|NOT COMPLETED|Overall Study||8
446773|NCT01340027|1094523|P8|NOT COMPLETED|Overall Study||7
446774|NCT01340027|1094524|P7|NOT COMPLETED|Overall Study||7
446775|NCT01340027|1094525|P6|NOT COMPLETED|Overall Study||4
446776|NCT01340027|1094526|P5|NOT COMPLETED|Overall Study||10
446777|NCT01340027|1094527|P4|NOT COMPLETED|Overall Study||4
446778|NCT01340027|1094528|P3|NOT COMPLETED|Overall Study||4
446779|NCT01340027|1094529|P2|NOT COMPLETED|Overall Study||7
446780|NCT01340027|1094530|P1|NOT COMPLETED|Overall Study||5
446781|NCT01340027|1094519|P12|COMPLETED|Overall Study||77
446782|NCT01340027|1094520|P11|COMPLETED|Overall Study||79
446783|NCT01340027|1094521|P10|COMPLETED|Overall Study||146
446784|NCT01340027|1094522|P9|COMPLETED|Overall Study||136
446785|NCT01340027|1094523|P8|COMPLETED|Overall Study||142
446786|NCT01340027|1094524|P7|COMPLETED|Overall Study||142
446787|NCT01340027|1094525|P6|COMPLETED|Overall Study||74
446788|NCT01340027|1094526|P5|COMPLETED|Overall Study||146
446789|NCT01340027|1094527|P4|COMPLETED|Overall Study||75
446790|NCT01340027|1094528|P3|COMPLETED|Overall Study||75
446791|NCT01340027|1094529|P2|COMPLETED|Overall Study||71
446792|NCT01340027|1094530|P1|COMPLETED|Overall Study||76
446793|NCT01340027|1094519|P12|Received Treatment|Overall Study||81
446794|NCT01340027|1094520|P11|Received Treatment|Overall Study||81
446795|NCT01340027|1094521|P10|Received Treatment|Overall Study||152
446796|NCT01340027|1094522|P9|Received Treatment|Overall Study||144
446797|NCT01340027|1094523|P8|Received Treatment|Overall Study||149
446798|NCT01340027|1094524|P7|Received Treatment|Overall Study||149
446799|NCT01340027|1094525|P6|Received Treatment|Overall Study||78
446800|NCT01340027|1094526|P5|Received Treatment|Overall Study||156
446801|NCT01340027|1094527|P4|Received Treatment|Overall Study||79
446802|NCT01340027|1094528|P3|Received Treatment|Overall Study||78
446803|NCT01340027|1094529|P2|Received Treatment|Overall Study||78
446804|NCT01340027|1094530|P1|Received Treatment|Overall Study||81
446805|NCT01340027|1094519|P12|STARTED|Overall Study||81
446806|NCT01340027|1094520|P11|STARTED|Overall Study||81
446807|NCT01340027|1094521|P10|STARTED|Overall Study||152
446808|NCT01340027|1094522|P9|STARTED|Overall Study||144
446809|NCT01340027|1094523|P8|STARTED|Overall Study||149
446810|NCT01340027|1094524|P7|STARTED|Overall Study||149
446811|NCT01340027|1094525|P6|STARTED|Overall Study||78
446812|NCT01340027|1094526|P5|STARTED|Overall Study||156
446813|NCT01340027|1094527|P4|STARTED|Overall Study||79
446814|NCT01340027|1094528|P3|STARTED|Overall Study||79
446815|NCT01340027|1094529|P2|STARTED|Overall Study||78
446816|NCT01340027|1094530|P1|STARTED|Overall Study||81
446817|NCT01340014|1094906|P2|NOT COMPLETED|Period 2, Second 7 Days||1
446818|NCT01340014|1094907|P1|NOT COMPLETED|Period 2, Second 7 Days||0
446819|NCT01340014|1094906|P2|COMPLETED|Period 2, Second 7 Days||56
446820|NCT01340014|1094907|P1|COMPLETED|Period 2, Second 7 Days||53
446821|NCT01340014|1094906|P2|STARTED|Period 2, Second 7 Days||57
446822|NCT01340014|1094907|P1|STARTED|Period 2, Second 7 Days||53
446823|NCT01340014|1094906|P2|NOT COMPLETED|Period 1, First 7 Days||0
446824|NCT01340014|1094907|P1|NOT COMPLETED|Period 1, First 7 Days||2
446825|NCT01340014|1094906|P2|COMPLETED|Period 1, First 7 Days||57
446826|NCT01340014|1094907|P1|COMPLETED|Period 1, First 7 Days||53
446827|NCT01340014|1094906|P2|STARTED|Period 1, First 7 Days||57
446828|NCT01340014|1094907|P1|STARTED|Period 1, First 7 Days||55
446829|NCT01339936|1094915|P1|NOT COMPLETED|Overall Study||2
446830|NCT01339936|1094915|P1|COMPLETED|Overall Study|plus 1 excluded from analysis set|36
446831|NCT01339936|1094915|P1|STARTED|Overall Study|plus 2 screen failures|38
446832|NCT01339923|1094928|P7|NOT COMPLETED|Overall Study||14
446833|NCT01339923|1094929|P6|NOT COMPLETED|Overall Study||9
446834|NCT01339923|1094930|P5|NOT COMPLETED|Overall Study||5
446835|NCT01339923|1094931|P4|NOT COMPLETED|Overall Study||4
446836|NCT01339923|1094932|P3|NOT COMPLETED|Overall Study||8
446837|NCT01339923|1094933|P2|NOT COMPLETED|Overall Study||16
446838|NCT01339923|1094934|P1|NOT COMPLETED|Overall Study||14
446839|NCT01339923|1094928|P7|COMPLETED|Overall Study||111
446840|NCT01339923|1094929|P6|COMPLETED|Overall Study||117
446841|NCT01339923|1094930|P5|COMPLETED|Overall Study||295
446842|NCT01339923|1094931|P4|COMPLETED|Overall Study||100
446843|NCT01339923|1094932|P3|COMPLETED|Overall Study||243
446844|NCT01339923|1094933|P2|COMPLETED|Overall Study||234
446845|NCT01339923|1094934|P1|COMPLETED|Overall Study||239
446846|NCT01339923|1094928|P7|STARTED|Overall Study||125
446847|NCT01339923|1094929|P6|STARTED|Overall Study||126
446848|NCT01339923|1094930|P5|STARTED|Overall Study||300
446849|NCT01339923|1094931|P4|STARTED|Overall Study||104
446850|NCT01339923|1094932|P3|STARTED|Overall Study||251
446851|NCT01339923|1094933|P2|STARTED|Overall Study||250
446852|NCT01339923|1094934|P1|STARTED|Overall Study||253
446853|NCT01339910|1095005|P2|NOT COMPLETED|Overall Study||4
446854|NCT01339910|1095006|P1|NOT COMPLETED|Overall Study||3
446855|NCT01339910|1095005|P2|COMPLETED|Overall Study||133
446856|NCT01339910|1095006|P1|COMPLETED|Overall Study||132
446857|NCT01339910|1095005|P2|STARTED|Overall Study||137
446858|NCT01339910|1095006|P1|STARTED|Overall Study||135
446859|NCT01339897|1095044|P4|NOT COMPLETED|Overall Study||1
446860|NCT01339897|1095045|P3|NOT COMPLETED|Overall Study||0
446861|NCT01339897|1095046|P2|NOT COMPLETED|Overall Study||0
446862|NCT01339897|1095047|P1|NOT COMPLETED|Overall Study||1
446863|NCT01339897|1095044|P4|COMPLETED|Overall Study||5
446864|NCT01339897|1095045|P3|COMPLETED|Overall Study||6
446865|NCT01339897|1095046|P2|COMPLETED|Overall Study||6
446866|NCT01339897|1095047|P1|COMPLETED|Overall Study||6
446867|NCT01339897|1095044|P4|STARTED|Overall Study||6
446868|NCT01339897|1095045|P3|STARTED|Overall Study||6
446869|NCT01339897|1095046|P2|STARTED|Overall Study||6
446870|NCT01339897|1095047|P1|STARTED|Overall Study||7
446871|NCT01339832|1095073|P1|NOT COMPLETED|Overall Study||14
446872|NCT01339832|1095073|P1|COMPLETED|Overall Study||37
446873|NCT01339832|1095073|P1|STARTED|Overall Study||51
446874|NCT01339429|1095084|P1|NOT COMPLETED|Overall Study||4
446875|NCT01339429|1095084|P1|COMPLETED|Overall Study||37
446876|NCT01339429|1095084|P1|STARTED|Overall Study||41
446877|NCT01339416|1095089|P1|NOT COMPLETED|Overall Study||0
446878|NCT01339416|1095089|P1|COMPLETED|Overall Study||8202
446879|NCT01339416|1095089|P1|STARTED|Overall Study||8202
446880|NCT01339403|1095101|P2|NOT COMPLETED|Overall Study||0
446881|NCT01339403|1095102|P1|NOT COMPLETED|Overall Study||0
446882|NCT01339403|1095101|P2|COMPLETED|Overall Study||257600
446883|NCT01339403|1095102|P1|COMPLETED|Overall Study||24768
446884|NCT01339403|1095101|P2|STARTED|Overall Study||257600
446885|NCT01339403|1095102|P1|STARTED|Overall Study||24768
446886|NCT01339390|1095124|P2|NOT COMPLETED|Overall Study||156
446887|NCT01339390|1095125|P1|NOT COMPLETED|Overall Study||157
446888|NCT01339390|1095124|P2|COMPLETED|Overall Study||1442
446889|NCT01339390|1095125|P1|COMPLETED|Overall Study||1414
446890|NCT01339390|1095124|P2|STARTED|Overall Study||1598
446891|NCT01339390|1095125|P1|STARTED|Overall Study||1571
446892|NCT01339299|1095133|P2|NOT COMPLETED|Overall Study||0
446893|NCT01339299|1095134|P1|NOT COMPLETED|Overall Study||0
446894|NCT01339299|1095133|P2|COMPLETED|Overall Study||50
446895|NCT01339299|1095134|P1|COMPLETED|Overall Study||50
446896|NCT01339299|1095133|P2|STARTED|Overall Study||50
446897|NCT01339299|1095134|P1|STARTED|Overall Study||50
446898|NCT01339260|1095142|P2|NOT COMPLETED|Multi-cycle Extension||193
446899|NCT01339260|1095143|P1|NOT COMPLETED|Multi-cycle Extension||186
446900|NCT01339260|1095142|P2|COMPLETED|Multi-cycle Extension|Patients completing at least number of cycles they were scheduled to|458
446901|NCT01339260|1095143|P1|COMPLETED|Multi-cycle Extension|Patients completing at least number of cycles they were scheduled to|449
446902|NCT01339260|1095142|P2|Safety Population|Multi-cycle Extension|Patients receiving palonosetron|651
446903|NCT01339260|1095143|P1|Safety Population|Multi-cycle Extension|Patients receiving netupitant/palonosetron combination|635
446904|NCT01339260|1095142|P2|STARTED|Multi-cycle Extension|Patients scheduled to palonosetron|651
446905|NCT01339260|1095143|P1|STARTED|Multi-cycle Extension|Patients scheduled to netupitant/palonosetron combination|635
446906|NCT01339260|1095142|P2|NOT COMPLETED|Cycle 1||10
446907|NCT01339260|1095143|P1|NOT COMPLETED|Cycle 1||7
446908|NCT01339260|1095142|P2|COMPLETED|Cycle 1||719
446909|NCT01339260|1095143|P1|COMPLETED|Cycle 1||719
446910|NCT01339260|1095142|P2|Full Analysis Set|Cycle 1|Patients receiving chemotherapy and randomized to palonosetron|725
446911|NCT01339260|1095143|P1|Full Analysis Set|Cycle 1|Patients receiving chemotherapy and randomized to netupitant/palonosetron combination|724
446912|NCT01339260|1095142|P2|Safety Population|Cycle 1|Patients receiving palonosetron|725
446913|NCT01339260|1095143|P1|Safety Population|Cycle 1|Patients receiving netupitant/palonosetron combination|725
446914|NCT01339260|1095142|P2|STARTED|Cycle 1|Intent-To-Treat: randomized patients|729
446915|NCT01339260|1095143|P1|STARTED|Cycle 1|Intent-To-Treat: randomized patients|726
446916|NCT01339247|1095155|P2|NOT COMPLETED|Period 2||0
446917|NCT01339247|1095156|P1|NOT COMPLETED|Period 2||0
446918|NCT01339247|1095155|P2|COMPLETED|Period 2||30
446919|NCT01339247|1095156|P1|COMPLETED|Period 2||30
446920|NCT01339247|1095155|P2|STARTED|Period 2||30
446921|NCT01339247|1095156|P1|STARTED|Period 2||30
446922|NCT01339247|1095155|P2|NOT COMPLETED|Period 1||0
446923|NCT01339247|1095156|P1|NOT COMPLETED|Period 1||0
446924|NCT01339247|1095155|P2|COMPLETED|Period 1||30
446925|NCT01339247|1095156|P1|COMPLETED|Period 1||30
446926|NCT01339247|1095155|P2|STARTED|Period 1||30
446927|NCT01339247|1095156|P1|STARTED|Period 1||30
446928|NCT01339091|1095168|P2|NOT COMPLETED|Overall Study||28
446929|NCT01339091|1095169|P1|NOT COMPLETED|Overall Study||27
446930|NCT01339091|1095168|P2|COMPLETED|Overall Study||257
446931|NCT01339091|1095169|P1|COMPLETED|Overall Study||261
446932|NCT01339091|1095168|P2|Safety Population|Overall Study||284
446933|NCT01339091|1095169|P1|Safety Population|Overall Study||284
446934|NCT01339091|1095168|P2|STARTED|Overall Study||285
446935|NCT01339091|1095169|P1|STARTED|Overall Study||288
446936|NCT01339052|1095183|P2|NOT COMPLETED|Overall Study||50
446937|NCT01339052|1095184|P1|NOT COMPLETED|Overall Study||15
446938|NCT01339052|1095183|P2|COMPLETED|Overall Study||0
446939|NCT01339052|1095184|P1|COMPLETED|Overall Study||0
446940|NCT01339052|1095183|P2|Evaluable Plasma Sample at Surgery|Overall Study|Milestone is not relevant for non-surgical cohort.|0
446941|NCT01339052|1095184|P1|Evaluable Plasma Sample at Surgery|Overall Study||13
446942|NCT01339052|1095183|P2|Evaluable Tumor Sample at Surgery|Overall Study|Milestone is not relevant for non-surgical cohort.|0
446943|NCT01339052|1095184|P1|Evaluable Tumor Sample at Surgery|Overall Study||14
446944|NCT01339052|1095183|P2|Measurable Disease|Overall Study|Radiographic response evaluated on participants with measurable disease only.|40
446945|NCT01339052|1095184|P1|Measurable Disease|Overall Study||11
446946|NCT01339052|1095183|P2|STARTED|Overall Study||50
446947|NCT01339052|1095184|P1|STARTED|Overall Study||15
446948|NCT01339013|1095204|P1|NOT COMPLETED|Overall Study||0
446949|NCT01339013|1095204|P1|COMPLETED|Overall Study||6
446950|NCT01339013|1095204|P1|STARTED|Overall Study||6
446951|NCT01339000|1095210|P2|NOT COMPLETED|Overall Study||0
446952|NCT01339000|1095211|P1|NOT COMPLETED|Overall Study||1
446953|NCT01339000|1095210|P2|COMPLETED|Overall Study||0
446954|NCT01339000|1095211|P1|COMPLETED|Overall Study||0
446955|NCT01339000|1095210|P2|STARTED|Overall Study||0
446956|NCT01339000|1095211|P1|STARTED|Overall Study|The patient received day 1, 29, 36, 43, 50, and 57 vaccines but did not receive interleukin-7 (IL-7)|1
446957|NCT01338870|1095231|P6|NOT COMPLETED|Overall Study||6
446958|NCT01338870|1095232|P5|NOT COMPLETED|Overall Study||6
446959|NCT01338870|1095233|P4|NOT COMPLETED|Overall Study||9
446960|NCT01338870|1095234|P3|NOT COMPLETED|Overall Study||11
446961|NCT01338870|1095235|P2|NOT COMPLETED|Overall Study||12
446962|NCT01338870|1095236|P1|NOT COMPLETED|Overall Study||9
446963|NCT01338870|1095231|P6|COMPLETED|Overall Study||44
446964|NCT01338870|1095232|P5|COMPLETED|Overall Study||46
446965|NCT01338870|1095233|P4|COMPLETED|Overall Study||41
446966|NCT01338870|1095234|P3|COMPLETED|Overall Study||39
446967|NCT01338870|1095235|P2|COMPLETED|Overall Study||37
446968|NCT01338870|1095236|P1|COMPLETED|Overall Study||41
446969|NCT01338870|1095231|P6|STARTED|Overall Study||50
446970|NCT01338870|1095232|P5|STARTED|Overall Study||52
446971|NCT01338870|1095233|P4|STARTED|Overall Study||50
446972|NCT01338870|1095234|P3|STARTED|Overall Study||50
446973|NCT01338870|1095235|P2|STARTED|Overall Study||49
446974|NCT01338870|1095236|P1|STARTED|Overall Study||50
446975|NCT01338857|1095286|P1|NOT COMPLETED|Overall Study||11
446976|NCT01338857|1095286|P1|COMPLETED|Overall Study||1
446977|NCT01338857|1095286|P1|STARTED|Overall Study||12
446978|NCT01338818|1095291|P1|NOT COMPLETED|Overall Study||36
446979|NCT01338818|1095291|P1|COMPLETED|Overall Study||262
446980|NCT01338818|1095291|P1|STARTED|Overall Study||298
446981|NCT01338792|1095297|P1|NOT COMPLETED|Overall Study||4
446982|NCT01338792|1095297|P1|COMPLETED|Overall Study||43
446983|NCT01338792|1095297|P1|STARTED|Overall Study||47
446984|NCT01338649|1095305|P2|NOT COMPLETED|Overall Study||0
446985|NCT01338649|1095306|P1|NOT COMPLETED|Overall Study||0
446986|NCT01338649|1095305|P2|COMPLETED|Overall Study||14
446987|NCT01338649|1095306|P1|COMPLETED|Overall Study||13
446988|NCT01338649|1095305|P2|STARTED|Overall Study||14
446989|NCT01338649|1095306|P1|STARTED|Overall Study||13
446990|NCT01338636|1095312|P1|NOT COMPLETED|Overall Study||8
446991|NCT01338636|1095312|P1|COMPLETED|Overall Study||22
446992|NCT01338636|1095312|P1|STARTED|Overall Study||30
446993|NCT01338610|1095326|P3|NOT COMPLETED|Overall Study||1
446994|NCT01338610|1095327|P2|NOT COMPLETED|Overall Study||1
446995|NCT01338610|1095328|P1|NOT COMPLETED|Overall Study||5
446996|NCT01338610|1095326|P3|COMPLETED|Overall Study||28
446997|NCT01338610|1095327|P2|COMPLETED|Overall Study||55
446998|NCT01338610|1095328|P1|COMPLETED|Overall Study||34
446999|NCT01338610|1095326|P3|STARTED|Overall Study||29
447000|NCT01338610|1095327|P2|STARTED|Overall Study||56
447001|NCT01338610|1095328|P1|STARTED|Overall Study||39
447002|NCT01338493|1095335|P1|NOT COMPLETED|24 Months Follow up||0
447003|NCT01338493|1095335|P1|COMPLETED|24 Months Follow up||104
447004|NCT01338493|1095335|P1|STARTED|24 Months Follow up||104
447005|NCT01338493|1095335|P1|NOT COMPLETED|12 Months Follow up||9
447006|NCT01338493|1095335|P1|COMPLETED|12 Months Follow up||104
447007|NCT01338493|1095335|P1|STARTED|12 Months Follow up||113
447008|NCT01338493|1095335|P1|NOT COMPLETED|6 Months Follow up||19
447009|NCT01338493|1095335|P1|COMPLETED|6 Months Follow up||113
447010|NCT01338493|1095335|P1|STARTED|6 Months Follow up||132
447011|NCT01338493|1095335|P1|NOT COMPLETED|Discharge||2
447012|NCT01338493|1095335|P1|COMPLETED|Discharge||132
447013|NCT01338493|1095335|P1|STARTED|Discharge||134
447014|NCT01338493|1095335|P1|NOT COMPLETED|Implant||0
447015|NCT01338493|1095335|P1|COMPLETED|Implant||134
447016|NCT01338493|1095335|P1|STARTED|Implant||134
447017|NCT01338493|1095335|P1|NOT COMPLETED|Enrolled||5
447018|NCT01338493|1095335|P1|COMPLETED|Enrolled||134
447019|NCT01338493|1095335|P1|STARTED|Enrolled||139
447020|NCT01338415|1095342|P2|NOT COMPLETED|Overall Study||9
447021|NCT01338415|1095343|P1|NOT COMPLETED|Overall Study||10
447022|NCT01338415|1095342|P2|COMPLETED|Overall Study||22
447023|NCT01338415|1095343|P1|COMPLETED|Overall Study||23
447024|NCT01338415|1095342|P2|Enrolled in FUTURE 3 Extension|Overall Study||27
447025|NCT01338415|1095343|P1|Enrolled in FUTURE 3 Extension|Overall Study||31
447026|NCT01338415|1095342|P2|STARTED|Overall Study||31
447027|NCT01338415|1095343|P1|STARTED|Overall Study||33
447028|NCT01338298|1095365|P2|NOT COMPLETED|Overall Study||3
447029|NCT01338298|1095366|P1|NOT COMPLETED|Overall Study||4
447030|NCT01338298|1095365|P2|COMPLETED|Overall Study||15
447031|NCT01338298|1095366|P1|COMPLETED|Overall Study||20
447032|NCT01338298|1095365|P2|STARTED|Overall Study||18
447033|NCT01338298|1095366|P1|STARTED|Overall Study||24
447034|NCT01338025|1095376|P2|NOT COMPLETED|Overall Study||11
447035|NCT01338025|1095377|P1|NOT COMPLETED|Overall Study||11
447036|NCT01338025|1095376|P2|COMPLETED|Overall Study||6
447037|NCT01338025|1095377|P1|COMPLETED|Overall Study||5
447038|NCT01338025|1095376|P2|STARTED|Overall Study||17
447039|NCT01338025|1095377|P1|STARTED|Overall Study||16
447040|NCT01338012|1095389|P1|NOT COMPLETED|Overall Study||8
447041|NCT01338012|1095389|P1|COMPLETED|Overall Study||0
447042|NCT01338012|1095389|P1|STARTED|Overall Study||8
447043|NCT01337960|1095396|P3|NOT COMPLETED|Overall Study||0
447044|NCT01337960|1095397|P2|NOT COMPLETED|Overall Study||0
447045|NCT01337960|1095398|P1|NOT COMPLETED|Overall Study||2
447046|NCT01337960|1095396|P3|COMPLETED|Overall Study||6
447047|NCT01337960|1095397|P2|COMPLETED|Overall Study||14
447048|NCT01337960|1095398|P1|COMPLETED|Overall Study||12
447049|NCT01337960|1095396|P3|STARTED|Overall Study||6
447050|NCT01337960|1095397|P2|STARTED|Overall Study||14
447051|NCT01337960|1095398|P1|STARTED|Overall Study||14
447052|NCT01337739|1095420|P2|NOT COMPLETED|Overall Study||0
447053|NCT01337739|1095421|P1|NOT COMPLETED|Overall Study||0
447054|NCT01337739|1095420|P2|COMPLETED|Overall Study||4
447055|NCT01337739|1095421|P1|COMPLETED|Overall Study||6
447056|NCT01337739|1095420|P2|STARTED|Overall Study||4
447057|NCT01337739|1095421|P1|STARTED|Overall Study||6
447058|NCT01337674|1095431|P4|NOT COMPLETED|Treatment Period 2||0
447059|NCT01337674|1095432|P3|NOT COMPLETED|Treatment Period 2||1
447060|NCT01337674|1095433|P2|NOT COMPLETED|Treatment Period 2||0
447061|NCT01337674|1095434|P1|NOT COMPLETED|Treatment Period 2||0
447062|NCT01337674|1095431|P4|COMPLETED|Treatment Period 2||6
447063|NCT01337674|1095432|P3|COMPLETED|Treatment Period 2||5
447064|NCT01337674|1095433|P2|COMPLETED|Treatment Period 2||6
447065|NCT01337674|1095434|P1|COMPLETED|Treatment Period 2||6
447066|NCT01337674|1095431|P4|STARTED|Treatment Period 2||6
447067|NCT01337674|1095432|P3|STARTED|Treatment Period 2||6
447068|NCT01337674|1095433|P2|STARTED|Treatment Period 2||6
447069|NCT01337674|1095434|P1|STARTED|Treatment Period 2||6
447070|NCT01337674|1095431|P4|NOT COMPLETED|Two-week Washout Period||0
447071|NCT01337674|1095432|P3|NOT COMPLETED|Two-week Washout Period||0
447072|NCT01337674|1095433|P2|NOT COMPLETED|Two-week Washout Period||0
447073|NCT01337674|1095434|P1|NOT COMPLETED|Two-week Washout Period||0
447074|NCT01337674|1095431|P4|COMPLETED|Two-week Washout Period||6
447075|NCT01337674|1095432|P3|COMPLETED|Two-week Washout Period||6
447076|NCT01337674|1095433|P2|COMPLETED|Two-week Washout Period||6
447077|NCT01337674|1095434|P1|COMPLETED|Two-week Washout Period||6
447078|NCT01337674|1095431|P4|STARTED|Two-week Washout Period||6
447079|NCT01337674|1095432|P3|STARTED|Two-week Washout Period||6
447080|NCT01337674|1095433|P2|STARTED|Two-week Washout Period||6
447081|NCT01337674|1095434|P1|STARTED|Two-week Washout Period||6
447082|NCT01337674|1095431|P4|NOT COMPLETED|Treatment Period 1||1
447083|NCT01337674|1095432|P3|NOT COMPLETED|Treatment Period 1||0
447084|NCT01337674|1095433|P2|NOT COMPLETED|Treatment Period 1||1
447085|NCT01337674|1095434|P1|NOT COMPLETED|Treatment Period 1||0
447086|NCT01337674|1095431|P4|COMPLETED|Treatment Period 1||6
447087|NCT01337674|1095432|P3|COMPLETED|Treatment Period 1||6
447088|NCT01337674|1095433|P2|COMPLETED|Treatment Period 1||6
447089|NCT01337674|1095434|P1|COMPLETED|Treatment Period 1||6
447090|NCT01337674|1095431|P4|STARTED|Treatment Period 1|The discontinued participant was replaced|7
447091|NCT01337674|1095432|P3|STARTED|Treatment Period 1||6
447092|NCT01337674|1095433|P2|STARTED|Treatment Period 1|The discontinued participant was replaced|7
447093|NCT01337674|1095434|P1|STARTED|Treatment Period 1||6
447094|NCT01337635|1095452|P2|NOT COMPLETED|Overall Study||1
447095|NCT01337635|1095453|P1|NOT COMPLETED|Overall Study||0
447096|NCT01337635|1095452|P2|COMPLETED|Overall Study||2
447097|NCT01337635|1095453|P1|COMPLETED|Overall Study||4
447098|NCT01337635|1095452|P2|STARTED|Overall Study||3
447099|NCT01337635|1095453|P1|STARTED|Overall Study||4
447100|NCT01337609|1095462|P3|NOT COMPLETED|Overall Study||0
447101|NCT01337609|1095463|P2|NOT COMPLETED|Overall Study||0
447102|NCT01337609|1095464|P1|NOT COMPLETED|Overall Study||1
447103|NCT01337609|1095462|P3|COMPLETED|Overall Study||2
447104|NCT01337609|1095463|P2|COMPLETED|Overall Study||2
447105|NCT01337609|1095464|P1|COMPLETED|Overall Study||0
447106|NCT01337609|1095462|P3|STARTED|Overall Study||2
447107|NCT01337609|1095463|P2|STARTED|Overall Study||2
447108|NCT01337609|1095464|P1|STARTED|Overall Study||1
447109|NCT01337336|1095486|P2|NOT COMPLETED|Overall Study||0
447110|NCT01337336|1095487|P1|NOT COMPLETED|Overall Study||0
447111|NCT01337336|1095486|P2|COMPLETED|Overall Study||2923
447112|NCT01337336|1095487|P1|COMPLETED|Overall Study||1078
447113|NCT01337336|1095486|P2|STARTED|Overall Study||2923
447114|NCT01337336|1095487|P1|STARTED|Overall Study||1078
447115|NCT01337297|1095501|P2|NOT COMPLETED|Overall Study||6
447116|NCT01337297|1095502|P1|NOT COMPLETED|Overall Study||5
447117|NCT01337297|1095501|P2|COMPLETED|Overall Study||3
447118|NCT01337297|1095502|P1|COMPLETED|Overall Study||6
447119|NCT01337297|1095501|P2|STARTED|Overall Study||9
447120|NCT01337297|1095502|P1|STARTED|Overall Study||11
447121|NCT01337167|1095510|P2|NOT COMPLETED|Toddler Vaccinations||13
447122|NCT01337167|1095511|P1|NOT COMPLETED|Toddler Vaccinations||14
447123|NCT01337167|1095510|P2|COMPLETED|Toddler Vaccinations||407
447124|NCT01337167|1095511|P1|COMPLETED|Toddler Vaccinations||829
447125|NCT01337167|1095510|P2|STARTED|Toddler Vaccinations||420
447126|NCT01337167|1095511|P1|STARTED|Toddler Vaccinations||843
447127|NCT01337167|1095510|P2|NOT COMPLETED|Interim Period||40
447128|NCT01337167|1095511|P1|NOT COMPLETED|Interim Period||81
447129|NCT01337167|1095510|P2|COMPLETED|Interim Period||420
447130|NCT01337167|1095511|P1|COMPLETED|Interim Period||843
447131|NCT01337167|1095510|P2|STARTED|Interim Period||460
447132|NCT01337167|1095511|P1|STARTED|Interim Period||924
447133|NCT01337167|1095510|P2|NOT COMPLETED|Infant Series||27
447134|NCT01337167|1095511|P1|NOT COMPLETED|Infant Series||62
447135|NCT01337167|1095510|P2|COMPLETED|Infant Series||460
447136|NCT01337167|1095511|P1|COMPLETED|Infant Series||924
447137|NCT01337167|1095510|P2|STARTED|Infant Series||487
447138|NCT01337167|1095511|P1|STARTED|Infant Series||986
447139|NCT01337115|1095579|P2|NOT COMPLETED|Overall Study||0
447140|NCT01337115|1095580|P1|NOT COMPLETED|Overall Study||2
447141|NCT01337115|1095579|P2|COMPLETED|Overall Study||25
447142|NCT01337115|1095580|P1|COMPLETED|Overall Study|2 patients could not be assessed after 12h because of catheter dislocation|23
447143|NCT01337115|1095579|P2|STARTED|Overall Study||25
447144|NCT01337115|1095580|P1|STARTED|Overall Study||25
447145|NCT01337089|1095592|P1|NOT COMPLETED|Overall Study||404
447146|NCT01337089|1095592|P1|COMPLETED|Overall Study||256
447147|NCT01337089|1095592|P1|Efficacy Dataset|Overall Study|One participant withdrew after administering nabiximols, but no efficacy data were collected.|659
447148|NCT01337089|1095592|P1|Safety Population|Overall Study||660
447149|NCT01337089|1095592|P1|Received at Least 1 Dose of Study Drug|Overall Study||660
447150|NCT01337089|1095592|P1|STARTED|Overall Study||660
447151|NCT01337076|1095600|P1|NOT COMPLETED|Overall Study||2
447152|NCT01337076|1095600|P1|COMPLETED|Overall Study|subjects met the primary endpoint of 6 months postimplant activation|19
447153|NCT01337076|1095600|P1|STARTED|Overall Study|subjects implanted|21
447154|NCT01337050|1095607|P3|NOT COMPLETED|Overall Study||19
447155|NCT01337050|1095608|P2|NOT COMPLETED|Overall Study||13
447156|NCT01337050|1095609|P1|NOT COMPLETED|Overall Study||4
447157|NCT01337050|1095607|P3|COMPLETED|Overall Study||0
447158|NCT01337050|1095608|P2|COMPLETED|Overall Study||0
447159|NCT01337050|1095609|P1|COMPLETED|Overall Study||0
447160|NCT01337050|1095607|P3|STARTED|Overall Study||19
447161|NCT01337050|1095608|P2|STARTED|Overall Study||13
447162|NCT01337050|1095609|P1|STARTED|Overall Study||4
447163|NCT01336972|1095670|P3|NOT COMPLETED|Overall Study||0
447164|NCT01336972|1095671|P2|NOT COMPLETED|Overall Study||1
447165|NCT01336972|1095672|P1|NOT COMPLETED|Overall Study||1
447166|NCT01336972|1095670|P3|COMPLETED|Overall Study||9
447167|NCT01336972|1095671|P2|COMPLETED|Overall Study||9
447168|NCT01336972|1095672|P1|COMPLETED|Overall Study||9
447169|NCT01336972|1095670|P3|STARTED|Overall Study||9
447170|NCT01336972|1095671|P2|STARTED|Overall Study||10
447171|NCT01336972|1095672|P1|STARTED|Overall Study||10
447172|NCT01336933|1095707|P1|NOT COMPLETED|Overall Study||1
447173|NCT01336933|1095707|P1|COMPLETED|Overall Study||33
447174|NCT01336933|1095707|P1|STARTED|Overall Study||34
447175|NCT01336894|1095718|P2|NOT COMPLETED|Follow-up||7
447176|NCT01336894|1095719|P1|NOT COMPLETED|Follow-up||2
447177|NCT01336894|1095718|P2|COMPLETED|Follow-up||0
447178|NCT01336894|1095719|P1|COMPLETED|Follow-up||2
447179|NCT01336894|1095718|P2|STARTED|Follow-up||7
447180|NCT01336894|1095719|P1|STARTED|Follow-up||4
447181|NCT01336894|1095718|P2|NOT COMPLETED|Protocol Interventions||0
447182|NCT01336894|1095719|P1|NOT COMPLETED|Protocol Interventions||0
447183|NCT01336894|1095718|P2|COMPLETED|Protocol Interventions||7
447184|NCT01336894|1095719|P1|COMPLETED|Protocol Interventions||4
447185|NCT01336894|1095718|P2|STARTED|Protocol Interventions||7
447186|NCT01336894|1095719|P1|STARTED|Protocol Interventions||4
447187|NCT01336764|1095739|P2|NOT COMPLETED|Overall Study||5
447188|NCT01336764|1095740|P1|NOT COMPLETED|Overall Study||5
447189|NCT01336764|1095739|P2|COMPLETED|Overall Study||5
447190|NCT01336764|1095740|P1|COMPLETED|Overall Study||7
447191|NCT01336764|1095739|P2|STARTED|Overall Study||10
447192|NCT01336764|1095740|P1|STARTED|Overall Study||12
447193|NCT01336738|1095751|P5|NOT COMPLETED|Overall Study||10
447194|NCT01336738|1095752|P4|NOT COMPLETED|Overall Study||7
447195|NCT01336738|1095753|P3|NOT COMPLETED|Overall Study||8
447196|NCT01336738|1095754|P2|NOT COMPLETED|Overall Study||9
447197|NCT01336738|1095755|P1|NOT COMPLETED|Overall Study||7
447198|NCT01336738|1095751|P5|COMPLETED|Overall Study||43
447199|NCT01336738|1095752|P4|COMPLETED|Overall Study||47
447200|NCT01336738|1095753|P3|COMPLETED|Overall Study||45
447201|NCT01336738|1095754|P2|COMPLETED|Overall Study||45
447202|NCT01336738|1095755|P1|COMPLETED|Overall Study||45
447203|NCT01336738|1095751|P5|STARTED|Overall Study||53
447204|NCT01336738|1095752|P4|STARTED|Overall Study||54
447205|NCT01336738|1095753|P3|STARTED|Overall Study||53
447206|NCT01336738|1095754|P2|STARTED|Overall Study||54
447207|NCT01336738|1095755|P1|STARTED|Overall Study||52
447208|NCT01336712|1095797|P1|NOT COMPLETED|Overall Study||3
447209|NCT01336712|1095797|P1|COMPLETED|Overall Study||27
447210|NCT01336712|1095797|P1|STARTED|Overall Study||30
447211|NCT01336647|1095810|P3|NOT COMPLETED|Overall Study||3
447212|NCT01336647|1095811|P2|NOT COMPLETED|Overall Study||1
447213|NCT01336647|1095812|P1|NOT COMPLETED|Overall Study||4
447214|NCT01336647|1095810|P3|COMPLETED|Overall Study||44
447215|NCT01336647|1095811|P2|COMPLETED|Overall Study||48
447216|NCT01336647|1095812|P1|COMPLETED|Overall Study||42
447217|NCT01336647|1095810|P3|STARTED|Overall Study||47
447218|NCT01336647|1095811|P2|STARTED|Overall Study||49
447219|NCT01336647|1095812|P1|STARTED|Overall Study||46
447220|NCT01336634|1095826|P3|NOT COMPLETED|Overall Study||36
447221|NCT01336634|1095827|P2|NOT COMPLETED|Overall Study||57
447222|NCT01336634|1095828|P1|NOT COMPLETED|Overall Study||84
447223|NCT01336634|1095826|P3|COMPLETED|Overall Study||0
447224|NCT01336634|1095827|P2|COMPLETED|Overall Study||0
447225|NCT01336634|1095828|P1|COMPLETED|Overall Study||0
447226|NCT01336634|1095826|P3|STARTED|Overall Study||36
447227|NCT01336634|1095827|P2|STARTED|Overall Study||57
447228|NCT01336634|1095828|P1|STARTED|Overall Study||84
447229|NCT01336621|1095869|P1|NOT COMPLETED|Overall Study||98
447230|NCT01336621|1095869|P1|COMPLETED|Overall Study||0
447231|NCT01336621|1095869|P1|STARTED|Overall Study||98
447232|NCT01336608|1095913|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||24
447233|NCT01336608|1095914|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||30
447234|NCT01336608|1095915|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||44
447235|NCT01336608|1095916|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
447236|NCT01336608|1095913|P4|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|111
447237|NCT01336608|1095914|P3|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|124
447238|NCT01336608|1095915|P2|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|97
447239|NCT01336608|1095916|P1|COMPLETED|24-week, Double-blind Treatment Period||0
447240|NCT01336608|1095913|P4|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|110
447241|NCT01336608|1095914|P3|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|124
447242|NCT01336608|1095915|P2|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|96
447243|NCT01336608|1095916|P1|Completed the Treatment Period|24-week, Double-blind Treatment Period||0
447244|NCT01336608|1095913|P4|STARTED|24-week, Double-blind Treatment Period||135
447245|NCT01336608|1095914|P3|STARTED|24-week, Double-blind Treatment Period||154
447246|NCT01336608|1095915|P2|STARTED|24-week, Double-blind Treatment Period||141
447247|NCT01336608|1095916|P1|STARTED|24-week, Double-blind Treatment Period||0
447248|NCT01336608|1095913|P4|NOT COMPLETED|2-week, Single-blind Run-In Period||0
447249|NCT01336608|1095914|P3|NOT COMPLETED|2-week, Single-blind Run-In Period||0
447250|NCT01336608|1095915|P2|NOT COMPLETED|2-week, Single-blind Run-In Period||0
447251|NCT01336608|1095916|P1|NOT COMPLETED|2-week, Single-blind Run-In Period||115
447252|NCT01336608|1095913|P4|COMPLETED|2-week, Single-blind Run-In Period||0
447253|NCT01336608|1095914|P3|COMPLETED|2-week, Single-blind Run-In Period||0
447254|NCT01336608|1095915|P2|COMPLETED|2-week, Single-blind Run-In Period||0
447255|NCT01336608|1095916|P1|COMPLETED|2-week, Single-blind Run-In Period||444
447256|NCT01336608|1095913|P4|STARTED|2-week, Single-blind Run-In Period||0
447257|NCT01336608|1095914|P3|STARTED|2-week, Single-blind Run-In Period||0
447258|NCT01336608|1095915|P2|STARTED|2-week, Single-blind Run-In Period||0
447259|NCT01336608|1095916|P1|STARTED|2-week, Single-blind Run-In Period||559
447260|NCT01336569|1095930|P1|NOT COMPLETED|Overall Study||4
447261|NCT01336569|1095930|P1|COMPLETED|Overall Study||45
447262|NCT01336569|1095930|P1|STARTED|Overall Study||49
447263|NCT01336413|1095936|P2|NOT COMPLETED|Overall Study||8
447264|NCT01336413|1095937|P1|NOT COMPLETED|Overall Study||1
447265|NCT01336413|1095936|P2|COMPLETED|Overall Study||18
447266|NCT01336413|1095937|P1|COMPLETED|Overall Study||26
447267|NCT01336413|1095936|P2|STARTED|Overall Study||26
447268|NCT01336413|1095937|P1|STARTED|Overall Study||27
447269|NCT01336296|1095955|P2|NOT COMPLETED|Overall Study||4
447270|NCT01336296|1095956|P1|NOT COMPLETED|Overall Study||5
447271|NCT01336296|1095955|P2|COMPLETED|Overall Study||17
447272|NCT01336296|1095956|P1|COMPLETED|Overall Study||35
447273|NCT01336296|1095955|P2|STARTED|Overall Study||21
447274|NCT01336296|1095956|P1|STARTED|Overall Study||40
447275|NCT01336205|1095972|P2|NOT COMPLETED|Overall Study||89
447276|NCT01336205|1095973|P1|NOT COMPLETED|Overall Study||233
447277|NCT01336205|1095972|P2|COMPLETED|Overall Study||192
447278|NCT01336205|1095973|P1|COMPLETED|Overall Study||330
447279|NCT01336205|1095972|P2|STARTED|Overall Study||281
447280|NCT01336205|1095973|P1|STARTED|Overall Study||563
447281|NCT01336140|1095985|P2|NOT COMPLETED|Overall Study||0
447282|NCT01336140|1095986|P1|NOT COMPLETED|Overall Study||0
447283|NCT01336140|1095985|P2|COMPLETED|Overall Study||150
447284|NCT01336140|1095986|P1|COMPLETED|Overall Study||150
447285|NCT01336140|1095985|P2|STARTED|Overall Study||150
447286|NCT01336140|1095986|P1|STARTED|Overall Study||150
447287|NCT01336023|1096001|P3|NOT COMPLETED|Week 27 to 52||28
447288|NCT01336023|1096002|P2|NOT COMPLETED|Week 27 to 52||44
447289|NCT01336023|1096003|P1|NOT COMPLETED|Week 27 to 52||28
447290|NCT01336023|1096001|P3|COMPLETED|Week 27 to 52||285
447291|NCT01336023|1096002|P2|COMPLETED|Week 27 to 52||621
447292|NCT01336023|1096003|P1|COMPLETED|Week 27 to 52||305
447293|NCT01336023|1096001|P3|STARTED|Week 27 to 52|From the main trial, 29 subjects were not enrolled in the extension (week 27-52).|313
447294|NCT01336023|1096002|P2|STARTED|Week 27 to 52|From the main trial, 71 subjects were not enrolled in the extension (week 27-52).|665
447295|NCT01336023|1096003|P1|STARTED|Week 27 to 52|From the main trial, 33 subjects were not enrolled in the extension (week 27-52).|333
447296|NCT01336023|1096001|P3|NOT COMPLETED|Week 0 to Week 26||73
447297|NCT01336023|1096002|P2|NOT COMPLETED|Week 0 to Week 26||98
447298|NCT01336023|1096003|P1|NOT COMPLETED|Week 0 to Week 26||48
447299|NCT01336023|1096001|P3|COMPLETED|Week 0 to Week 26||342
447300|NCT01336023|1096002|P2|COMPLETED|Week 0 to Week 26||736
447301|NCT01336023|1096003|P1|COMPLETED|Week 0 to Week 26||366
447302|NCT01336023|1096001|P3|Exposed|Week 0 to Week 26|2 subjects withdrew before exposure to trial drug and were not included in the analysis|413
447303|NCT01336023|1096002|P2|Exposed|Week 0 to Week 26|8 subjects withdrew before exposure to trial drug and were not included in the analysis|826
447304|NCT01336023|1096003|P1|Exposed|Week 0 to Week 26|1 subject withdrew before exposure to trial drug and was not included in the analysis|413
447305|NCT01336023|1096001|P3|STARTED|Week 0 to Week 26||415
447306|NCT01336023|1096002|P2|STARTED|Week 0 to Week 26||834
447307|NCT01336023|1096003|P1|STARTED|Week 0 to Week 26||414
447308|NCT01335997|1096024|P2|NOT COMPLETED|Period III||79
447309|NCT01335997|1096025|P1|NOT COMPLETED|Period III||78
447310|NCT01335997|1096024|P2|COMPLETED|Period III||4
447311|NCT01335997|1096025|P1|COMPLETED|Period III||6
447312|NCT01335997|1096024|P2|STARTED|Period III||83
447313|NCT01335997|1096025|P1|STARTED|Period III||84
447314|NCT01335997|1096024|P2|NOT COMPLETED|Period I and II||479
447315|NCT01335997|1096025|P1|NOT COMPLETED|Period I and II||493
447316|NCT01335997|1096024|P2|COMPLETED|Period I and II||83
447317|NCT01335997|1096025|P1|COMPLETED|Period I and II||84
447318|NCT01335997|1096024|P2|STARTED|Period I and II||562
447319|NCT01335997|1096025|P1|STARTED|Period I and II||577
447320|NCT01335971|1096038|P3|NOT COMPLETED|Overall Study||1
447321|NCT01335971|1096039|P2|NOT COMPLETED|Overall Study||1
447322|NCT01335971|1096040|P1|NOT COMPLETED|Overall Study||2
447323|NCT01335971|1096038|P3|COMPLETED|Overall Study||28
447324|NCT01335971|1096039|P2|COMPLETED|Overall Study||28
447325|NCT01335971|1096040|P1|COMPLETED|Overall Study||29
447326|NCT01335971|1096038|P3|STARTED|Overall Study||29
447327|NCT01335971|1096039|P2|STARTED|Overall Study||29
447328|NCT01335971|1096040|P1|STARTED|Overall Study||31
447329|NCT01335932|1096077|P2|NOT COMPLETED|Overall Study||4
447330|NCT01335932|1096078|P1|NOT COMPLETED|Overall Study||0
447331|NCT01335932|1096077|P2|COMPLETED|Overall Study||72
447332|NCT01335932|1096078|P1|COMPLETED|Overall Study||84
447333|NCT01335932|1096077|P2|STARTED|Overall Study||76
447334|NCT01335932|1096078|P1|STARTED|Overall Study||84
447335|NCT01335867|1096086|P2|NOT COMPLETED|Overall Study||4
447336|NCT01335867|1096087|P1|NOT COMPLETED|Overall Study||7
447337|NCT01335867|1096086|P2|COMPLETED|Overall Study||12
447338|NCT01335867|1096087|P1|COMPLETED|Overall Study||9
447339|NCT01335867|1096086|P2|STARTED|Overall Study||16
447340|NCT01335867|1096087|P1|STARTED|Overall Study||16
447341|NCT01335789|1096097|P2|NOT COMPLETED|Overall Study||0
447342|NCT01335789|1096098|P1|NOT COMPLETED|Overall Study||0
447343|NCT01335789|1096097|P2|COMPLETED|Overall Study||8
447344|NCT01335789|1096098|P1|COMPLETED|Overall Study||8
447345|NCT01335789|1096097|P2|STARTED|Overall Study||8
447346|NCT01335789|1096098|P1|STARTED|Overall Study||8
447347|NCT01335750|1096108|P1|NOT COMPLETED|Overall Study||0
447348|NCT01335750|1096108|P1|COMPLETED|Overall Study||32
447349|NCT01335750|1096108|P1|STARTED|Overall Study||32
447350|NCT01335724|1096129|P2|NOT COMPLETED|Overall Study||0
447351|NCT01335724|1096130|P1|NOT COMPLETED|Overall Study||0
447352|NCT01335724|1096129|P2|COMPLETED|Overall Study||36
447353|NCT01335724|1096130|P1|COMPLETED|Overall Study||36
447354|NCT01335724|1096129|P2|STARTED|Overall Study||36
447355|NCT01335724|1096130|P1|STARTED|Overall Study||36
447356|NCT01335698|1096145|P5|NOT COMPLETED|Treatment Stage 2||6
447357|NCT01335698|1096146|P4|NOT COMPLETED|Treatment Stage 2||24
447358|NCT01335698|1096147|P3|NOT COMPLETED|Treatment Stage 2||16
447359|NCT01335698|1096148|P2|NOT COMPLETED|Treatment Stage 2||4
447360|NCT01335698|1096149|P1|NOT COMPLETED|Treatment Stage 2||15
447361|NCT01335698|1096145|P5|COMPLETED|Treatment Stage 2||0
447362|NCT01335698|1096146|P4|COMPLETED|Treatment Stage 2||2
447363|NCT01335698|1096147|P3|COMPLETED|Treatment Stage 2||0
447364|NCT01335698|1096148|P2|COMPLETED|Treatment Stage 2||0
447365|NCT01335698|1096149|P1|COMPLETED|Treatment Stage 2||0
447366|NCT01335698|1096145|P5|STARTED|Treatment Stage 2||6
447367|NCT01335698|1096146|P4|STARTED|Treatment Stage 2||26
447368|NCT01335698|1096147|P3|STARTED|Treatment Stage 2||16
447369|NCT01335698|1096148|P2|STARTED|Treatment Stage 2||4
447370|NCT01335698|1096149|P1|STARTED|Treatment Stage 2||15
447371|NCT01335698|1096145|P5|NOT COMPLETED|Treatment Stage 1||2
447372|NCT01335698|1096146|P4|NOT COMPLETED|Treatment Stage 1||9
447373|NCT01335698|1096147|P3|NOT COMPLETED|Treatment Stage 1||5
447374|NCT01335698|1096148|P2|NOT COMPLETED|Treatment Stage 1||8
447375|NCT01335698|1096149|P1|NOT COMPLETED|Treatment Stage 1||8
447376|NCT01335698|1096145|P5|COMPLETED|Treatment Stage 1||6
447377|NCT01335698|1096146|P4|COMPLETED|Treatment Stage 1||26
447378|NCT01335698|1096147|P3|COMPLETED|Treatment Stage 1||16
447379|NCT01335698|1096148|P2|COMPLETED|Treatment Stage 1||4
447380|NCT01335698|1096149|P1|COMPLETED|Treatment Stage 1||15
447381|NCT01335698|1096145|P5|STARTED|Treatment Stage 1||8
447382|NCT01335698|1096146|P4|STARTED|Treatment Stage 1||35
447383|NCT01335698|1096147|P3|STARTED|Treatment Stage 1||21
447384|NCT01335698|1096148|P2|STARTED|Treatment Stage 1||12
447385|NCT01335698|1096149|P1|STARTED|Treatment Stage 1||23
447386|NCT01335685|1096200|P8|NOT COMPLETED|Overall Study||3
447387|NCT01335685|1096201|P7|NOT COMPLETED|Overall Study||2
447388|NCT01335685|1096202|P6|NOT COMPLETED|Overall Study||5
447389|NCT01335685|1096203|P5|NOT COMPLETED|Overall Study||0
447390|NCT01335685|1096204|P4|NOT COMPLETED|Overall Study||11
447391|NCT01335685|1096205|P3|NOT COMPLETED|Overall Study||2
447392|NCT01335685|1096206|P2|NOT COMPLETED|Overall Study||1
447393|NCT01335685|1096207|P1|NOT COMPLETED|Overall Study||3
447394|NCT01335685|1096200|P8|COMPLETED|Overall Study||3
447395|NCT01335685|1096201|P7|COMPLETED|Overall Study||2
447396|NCT01335685|1096202|P6|COMPLETED|Overall Study||1
447397|NCT01335685|1096203|P5|COMPLETED|Overall Study||5
447398|NCT01335685|1096204|P4|COMPLETED|Overall Study||15
447399|NCT01335685|1096205|P3|COMPLETED|Overall Study||1
447400|NCT01335685|1096206|P2|COMPLETED|Overall Study||3
447401|NCT01335685|1096207|P1|COMPLETED|Overall Study||4
447402|NCT01335685|1096200|P8|STARTED|Overall Study||6
447403|NCT01335685|1096201|P7|STARTED|Overall Study||4
447404|NCT01335685|1096202|P6|STARTED|Overall Study||6
447405|NCT01335685|1096203|P5|STARTED|Overall Study||5
447406|NCT01335685|1096204|P4|STARTED|Overall Study||26
447407|NCT01335685|1096205|P3|STARTED|Overall Study||3
447408|NCT01335685|1096206|P2|STARTED|Overall Study||4
447409|NCT01335685|1096207|P1|STARTED|Overall Study||7
447410|NCT01335542|1096311|P2|NOT COMPLETED|Overall Study||0
447411|NCT01335542|1096312|P1|NOT COMPLETED|Overall Study||0
447412|NCT01335542|1096311|P2|COMPLETED|Overall Study||45
447413|NCT01335542|1096312|P1|COMPLETED|Overall Study||45
447414|NCT01335542|1096311|P2|STARTED|Overall Study||45
447415|NCT01335542|1096312|P1|STARTED|Overall Study||45
447416|NCT01335477|1096320|P2|NOT COMPLETED|Overall Study||59
447417|NCT01335477|1096321|P1|NOT COMPLETED|Overall Study||41
447418|NCT01335477|1096320|P2|COMPLETED|Overall Study||272
447419|NCT01335477|1096321|P1|COMPLETED|Overall Study||179
447420|NCT01335477|1096320|P2|STARTED|Overall Study||331
447421|NCT01335477|1096321|P1|STARTED|Overall Study||220
447422|NCT01335464|1096385|P2|NOT COMPLETED|Overall Study||49
447423|NCT01335464|1096386|P1|NOT COMPLETED|Overall Study||32
447424|NCT01335464|1096385|P2|COMPLETED|Overall Study||260
447425|NCT01335464|1096386|P1|COMPLETED|Overall Study||174
447426|NCT01335464|1096385|P2|STARTED|Overall Study||309
447427|NCT01335464|1096386|P1|STARTED|Overall Study||206
447428|NCT01335308|1096451|P3|NOT COMPLETED|Overall Study||81
447429|NCT01335308|1096452|P2|NOT COMPLETED|Overall Study||67
447430|NCT01335308|1096453|P1|NOT COMPLETED|Overall Study||40
447431|NCT01335308|1096451|P3|COMPLETED|Overall Study||154
447432|NCT01335308|1096452|P2|COMPLETED|Overall Study||145
447433|NCT01335308|1096453|P1|COMPLETED|Overall Study||158
447434|NCT01335308|1096451|P3|STARTED|Overall Study||235
447435|NCT01335308|1096452|P2|STARTED|Overall Study||212
447436|NCT01335308|1096453|P1|STARTED|Overall Study||198
447437|NCT01335230|1096474|P4|NOT COMPLETED|Overall Study||0
447438|NCT01335230|1096475|P3|NOT COMPLETED|Overall Study||0
447439|NCT01335230|1096476|P2|NOT COMPLETED|Overall Study||0
447440|NCT01335230|1096477|P1|NOT COMPLETED|Overall Study||0
447441|NCT01335230|1096474|P4|COMPLETED|Overall Study|subjects|10
447442|NCT01335230|1096475|P3|COMPLETED|Overall Study|subjects|10
447443|NCT01335230|1096476|P2|COMPLETED|Overall Study|subjects|10
447444|NCT01335230|1096477|P1|COMPLETED|Overall Study|subjects|10
447445|NCT01335230|1096474|P4|STARTED|Overall Study|subjects|10
447446|NCT01335230|1096475|P3|STARTED|Overall Study|subjects|10
447447|NCT01335230|1096476|P2|STARTED|Overall Study|subjects|10
447448|NCT01335230|1096477|P1|STARTED|Overall Study|subjects|10
447449|NCT01335191|1096489|P2|NOT COMPLETED|Overall Study||0
447450|NCT01335191|1096490|P1|NOT COMPLETED|Overall Study||0
447451|NCT01335191|1096489|P2|COMPLETED|Overall Study||11
447452|NCT01335191|1096490|P1|COMPLETED|Overall Study||16
447453|NCT01335191|1096489|P2|STARTED|Overall Study||11
447454|NCT01335191|1096490|P1|STARTED|Overall Study||16
447455|NCT01335061|1096496|P1|NOT COMPLETED|Overall Study||0
447456|NCT01335061|1096496|P1|COMPLETED|Overall Study||25
447457|NCT01335061|1096496|P1|STARTED|Overall Study||25
447458|NCT01334957|1096511|P1|NOT COMPLETED|Overall Study||0
447459|NCT01334957|1096511|P1|COMPLETED|Overall Study||300
447460|NCT01334957|1096511|P1|Received Multiple Doses|Overall Study||48
447461|NCT01334957|1096511|P1|Received Single Dose|Overall Study||252
447462|NCT01334957|1096511|P1|STARTED|Overall Study||300
447463|NCT01334944|1096519|P2|NOT COMPLETED|Overall Study||0
447464|NCT01334944|1096520|P1|NOT COMPLETED|Overall Study||0
447465|NCT01334944|1096519|P2|COMPLETED|Overall Study||139
447466|NCT01334944|1096520|P1|COMPLETED|Overall Study||11
447467|NCT01334944|1096519|P2|Received Multiple Doses|Overall Study||43
447468|NCT01334944|1096520|P1|Received Multiple Doses|Overall Study||10
447469|NCT01334944|1096519|P2|Received Singel Dose|Overall Study||96
447470|NCT01334944|1096520|P1|Received Singel Dose|Overall Study||1
447471|NCT01334944|1096519|P2|STARTED|Overall Study||139
447472|NCT01334944|1096520|P1|STARTED|Overall Study||11
447473|NCT01334918|1096546|P2|NOT COMPLETED|Overall Study||1
447474|NCT01334918|1096547|P1|NOT COMPLETED|Overall Study||8
447475|NCT01334918|1096546|P2|COMPLETED|Overall Study||60
447476|NCT01334918|1096547|P1|COMPLETED|Overall Study||55
447477|NCT01334918|1096546|P2|Randomized + 1 Stress Scan|Overall Study|Equates to Safety Analysis Set (SAF)|61
447478|NCT01334918|1096547|P1|Randomized + 1 Stress Scan|Overall Study|Equates to Safety Analysis Set (SAF)|57
447479|NCT01334918|1096546|P2|STARTED|Overall Study||61
447480|NCT01334918|1096547|P1|STARTED|Overall Study||63
447481|NCT01334866|1096573|P1|NOT COMPLETED|Overall Study||19
447482|NCT01334866|1096573|P1|COMPLETED|Overall Study||72
447483|NCT01334866|1096573|P1|STARTED|Overall Study|91 subjects were enrolled in the study; with 89 subjects receiving the study treatment.|91
447484|NCT01334723|1096583|P2|NOT COMPLETED|Overall Study||0
447485|NCT01334723|1096584|P1|NOT COMPLETED|Overall Study||0
447486|NCT01334723|1096583|P2|COMPLETED|Overall Study||17739
447487|NCT01334723|1096584|P1|COMPLETED|Overall Study||17293
447488|NCT01334723|1096583|P2|STARTED|Overall Study||17739
447489|NCT01334723|1096584|P1|STARTED|Overall Study||17293
447490|NCT01334710|1096610|P1|NOT COMPLETED|Overall Study||3
447491|NCT01334710|1096610|P1|COMPLETED|Overall Study|Due to safety signals in a parallel trial ON OSI906 in hepatocellular cancer the trial was stopped.|0
447492|NCT01334710|1096610|P1|STARTED|Overall Study||3
447493|NCT01334606|1096615|P1|NOT COMPLETED|Overall Study||18
447494|NCT01334606|1096615|P1|COMPLETED|Overall Study||3
447495|NCT01334606|1096615|P1|STARTED|Overall Study||21
447496|NCT01334554|1096623|P2|NOT COMPLETED|Overall Study||2
447497|NCT01334554|1096624|P1|NOT COMPLETED|Overall Study||4
447498|NCT01334554|1096623|P2|COMPLETED|Overall Study||21
447499|NCT01334554|1096624|P1|COMPLETED|Overall Study||19
447500|NCT01334554|1096623|P2|STARTED|Overall Study||23
447501|NCT01334554|1096624|P1|STARTED|Overall Study||23
447502|NCT01334515|1096634|P2|NOT COMPLETED|Overall Study||29
447503|NCT01334515|1096635|P1|NOT COMPLETED|Overall Study||12
447504|NCT01334515|1096634|P2|COMPLETED|Overall Study||7
447505|NCT01334515|1096635|P1|COMPLETED|Overall Study||4
447506|NCT01334515|1096634|P2|STARTED|Overall Study||36
447507|NCT01334515|1096635|P1|STARTED|Overall Study||16
447508|NCT01334229|1096645|P2|NOT COMPLETED|Overall Study||0
447509|NCT01334229|1096646|P1|NOT COMPLETED|Overall Study||0
447510|NCT01334229|1096645|P2|COMPLETED|Overall Study||11
447511|NCT01334229|1096646|P1|COMPLETED|Overall Study||11
447512|NCT01334229|1096645|P2|STARTED|Overall Study||11
447513|NCT01334229|1096646|P1|STARTED|Overall Study||11
447514|NCT01334216|1096664|P2|NOT COMPLETED|Overall Study||0
447515|NCT01334216|1096665|P1|NOT COMPLETED|Overall Study||0
447516|NCT01334216|1096664|P2|COMPLETED|Overall Study||194
447517|NCT01334216|1096665|P1|COMPLETED|Overall Study||168
447518|NCT01334216|1096664|P2|STARTED|Overall Study||194
447519|NCT01334216|1096665|P1|STARTED|Overall Study||168
447520|NCT01334125|1096673|P2|NOT COMPLETED|Overall Study||3
447521|NCT01334125|1096674|P1|NOT COMPLETED|Overall Study||3
447522|NCT01334125|1096673|P2|COMPLETED|Overall Study|3 subjects left for college and moved out of the area|10
447523|NCT01334125|1096674|P1|COMPLETED|Overall Study|3 subjects move to another city|12
447524|NCT01334125|1096673|P2|STARTED|Overall Study||13
447525|NCT01334125|1096674|P1|STARTED|Overall Study||15
447526|NCT01333956|1096690|P4|NOT COMPLETED|Overall Study||2
447527|NCT01333956|1096691|P3|NOT COMPLETED|Overall Study||1
447528|NCT01333956|1096692|P2|NOT COMPLETED|Overall Study||4
447529|NCT01333956|1096693|P1|NOT COMPLETED|Overall Study||2
447530|NCT01333956|1096690|P4|COMPLETED|Overall Study||28
447531|NCT01333956|1096691|P3|COMPLETED|Overall Study||29
447532|NCT01333956|1096692|P2|COMPLETED|Overall Study||26
447533|NCT01333956|1096693|P1|COMPLETED|Overall Study||28
447534|NCT01333956|1096690|P4|STARTED|Overall Study||30
447535|NCT01333956|1096691|P3|STARTED|Overall Study||30
447536|NCT01333956|1096692|P2|STARTED|Overall Study||30
447537|NCT01333956|1096693|P1|STARTED|Overall Study||30
447538|NCT01333943|1096729|P2|NOT COMPLETED|Overall Study||0
447539|NCT01333943|1096730|P1|NOT COMPLETED|Overall Study||1
447540|NCT01333943|1096729|P2|COMPLETED|Overall Study||47
447541|NCT01333943|1096730|P1|COMPLETED|Overall Study||46
447542|NCT01333943|1096729|P2|STARTED|Overall Study||47
447543|NCT01333943|1096730|P1|STARTED|Overall Study||47
447544|NCT01333865|1096746|P1|NOT COMPLETED|Overall Study||2
447545|NCT01333865|1096746|P1|COMPLETED|Overall Study|2 participants were withdrawn. One was still analyzed, but one was withdrawn too early for analysis|17
447546|NCT01333865|1096746|P1|STARTED|Overall Study|25 participants signed consent, but only 19 completed screening and were analyzed at baseline.|19
447547|NCT01333813|1096751|P1|NOT COMPLETED|Overall Study||0
447548|NCT01333813|1096751|P1|COMPLETED|Overall Study||297
447549|NCT01333813|1096751|P1|STARTED|Overall Study||297
447550|NCT01333722|1096766|P2|NOT COMPLETED|Overall Study||3
447551|NCT01333722|1096767|P1|NOT COMPLETED|Overall Study||0
447552|NCT01333722|1096766|P2|COMPLETED|Overall Study||46
447553|NCT01333722|1096767|P1|COMPLETED|Overall Study||51
447554|NCT01333722|1096766|P2|STARTED|Overall Study||49
447555|NCT01333722|1096767|P1|STARTED|Overall Study||51
447556|NCT01333592|1096781|P2|NOT COMPLETED|Overall Study||17
447557|NCT01333592|1096782|P1|NOT COMPLETED|Overall Study||9
447558|NCT01333592|1096781|P2|COMPLETED|Overall Study||52
447559|NCT01333592|1096782|P1|COMPLETED|Overall Study||58
447560|NCT01333592|1096781|P2|STARTED|Overall Study||69
447561|NCT01333592|1096782|P1|STARTED|Overall Study||67
447562|NCT01333501|1096792|P2|NOT COMPLETED|Overall Study||21
447563|NCT01333501|1096793|P1|NOT COMPLETED|Overall Study||9
447564|NCT01333501|1096792|P2|COMPLETED|Overall Study||30
447565|NCT01333501|1096793|P1|COMPLETED|Overall Study||97
447566|NCT01333501|1096792|P2|Safety Population|Overall Study||47
447567|NCT01333501|1096793|P1|Safety Population|Overall Study||104
447568|NCT01333501|1096792|P2|Full Analysis Set (FAS)|Overall Study||28
447569|NCT01333501|1096793|P1|Full Analysis Set (FAS)|Overall Study||80
447570|NCT01333501|1096792|P2|STARTED|Overall Study||51
447571|NCT01333501|1096793|P1|STARTED|Overall Study||106
447572|NCT01333488|1096842|P3|NOT COMPLETED|Overall Study||0
447573|NCT01333488|1096843|P2|NOT COMPLETED|Overall Study||0
447574|NCT01333488|1096844|P1|NOT COMPLETED|Overall Study||0
447575|NCT01333488|1096842|P3|COMPLETED|Overall Study||3
447576|NCT01333488|1096843|P2|COMPLETED|Overall Study||1
447577|NCT01333488|1096844|P1|COMPLETED|Overall Study||2
447578|NCT01333488|1096842|P3|STARTED|Overall Study||3
447579|NCT01333488|1096843|P2|STARTED|Overall Study||1
447580|NCT01333488|1096844|P1|STARTED|Overall Study||2
447581|NCT01333475|1096860|P2|NOT COMPLETED|Overall Study||3
447582|NCT01333475|1096861|P1|NOT COMPLETED|Overall Study||2
447583|NCT01333475|1096860|P2|COMPLETED|Overall Study||6
447584|NCT01333475|1096861|P1|COMPLETED|Overall Study||10
447585|NCT01333475|1096860|P2|STARTED|Overall Study||9
447586|NCT01333475|1096861|P1|STARTED|Overall Study||12
447587|NCT01333436|1096871|P2|NOT COMPLETED|Overall Study||0
447588|NCT01333436|1096872|P1|NOT COMPLETED|Overall Study||0
447589|NCT01333436|1096871|P2|COMPLETED|Overall Study||50
447590|NCT01333436|1096872|P1|COMPLETED|Overall Study||43
447591|NCT01333436|1096871|P2|STARTED|Overall Study||50
447592|NCT01333436|1096872|P1|STARTED|Overall Study||43
447593|NCT01333397|1096887|P5|NOT COMPLETED|Overall Study||0
447594|NCT01333397|1096888|P4|NOT COMPLETED|Overall Study||1
447595|NCT01333397|1096889|P3|NOT COMPLETED|Overall Study||0
447596|NCT01333397|1096890|P2|NOT COMPLETED|Overall Study||0
447597|NCT01333397|1096891|P1|NOT COMPLETED|Overall Study||1
447598|NCT01333397|1096887|P5|COMPLETED|Overall Study||35
447599|NCT01333397|1096888|P4|COMPLETED|Overall Study||34
447600|NCT01333397|1096889|P3|COMPLETED|Overall Study||35
447601|NCT01333397|1096890|P2|COMPLETED|Overall Study||36
447602|NCT01333397|1096891|P1|COMPLETED|Overall Study||34
447603|NCT01333397|1096887|P5|STARTED|Overall Study||35
447604|NCT01333397|1096888|P4|STARTED|Overall Study||35
447605|NCT01333397|1096889|P3|STARTED|Overall Study||35
447606|NCT01333397|1096890|P2|STARTED|Overall Study||36
447607|NCT01333397|1096891|P1|STARTED|Overall Study||35
447608|NCT01333189|1096965|P2|NOT COMPLETED|Overall Study||2
447609|NCT01333189|1096966|P1|NOT COMPLETED|Overall Study||2
447610|NCT01333189|1096965|P2|COMPLETED|Overall Study||11
447611|NCT01333189|1096966|P1|COMPLETED|Overall Study||11
447612|NCT01333189|1096965|P2|STARTED|Overall Study||13
447613|NCT01333189|1096966|P1|STARTED|Overall Study||13
447614|NCT01333111|1096997|P3|NOT COMPLETED|Overall Study||2
447615|NCT01333111|1096998|P2|NOT COMPLETED|Overall Study||3
447616|NCT01333111|1096999|P1|NOT COMPLETED|Overall Study||2
447617|NCT01333111|1096997|P3|COMPLETED|Overall Study||13
447618|NCT01333111|1096998|P2|COMPLETED|Overall Study||26
447619|NCT01333111|1096999|P1|COMPLETED|Overall Study||28
447620|NCT01333111|1096997|P3|STARTED|Overall Study||15
447621|NCT01333111|1096998|P2|STARTED|Overall Study||29
447622|NCT01333111|1096999|P1|STARTED|Overall Study||30
447623|NCT01332994|1097023|P1|NOT COMPLETED|Overall Study||71
447624|NCT01332994|1097023|P1|COMPLETED|Overall Study||448
447625|NCT01332994|1097023|P1|Completed Week 66 (TCZ/RTX)|Overall Study||25
447626|NCT01332994|1097023|P1|Completed Week 32 (TCZ/RTX)|Overall Study||26
447627|NCT01332994|1097023|P1|Completed Week 32 (TCZ/TCZ)|Overall Study||200
447628|NCT01332994|1097023|P1|Completed Week 16|Overall Study||463
447629|NCT01332994|1097023|P1|STARTED|Overall Study||519
447630|NCT01332981|1097079|P1|NOT COMPLETED|Overall Study||0
447631|NCT01332981|1097079|P1|COMPLETED|Overall Study||220
447632|NCT01332981|1097079|P1|STARTED|Overall Study||220
447633|NCT01332968|1097092|P8|NOT COMPLETED|Follow-Up Period||531
447634|NCT01332968|1097093|P7|NOT COMPLETED|Follow-Up Period||542
447635|NCT01332968|1097094|P6|NOT COMPLETED|Follow-Up Period||0
447636|NCT01332968|1097095|P5|NOT COMPLETED|Follow-Up Period||0
447637|NCT01332968|1097096|P4|NOT COMPLETED|Follow-Up Period||0
447638|NCT01332968|1097097|P3|NOT COMPLETED|Follow-Up Period||0
447639|NCT01332968|1097098|P2|NOT COMPLETED|Follow-Up Period||0
447640|NCT01332968|1097099|P1|NOT COMPLETED|Follow-Up Period||0
447641|NCT01332968|1097092|P8|COMPLETED|Follow-Up Period||0
447642|NCT01332968|1097093|P7|COMPLETED|Follow-Up Period||0
447643|NCT01332968|1097094|P6|COMPLETED|Follow-Up Period||0
447644|NCT01332968|1097095|P5|COMPLETED|Follow-Up Period||0
447645|NCT01332968|1097096|P4|COMPLETED|Follow-Up Period||0
447646|NCT01332968|1097097|P3|COMPLETED|Follow-Up Period||0
447647|NCT01332968|1097098|P2|COMPLETED|Follow-Up Period||0
447648|NCT01332968|1097099|P1|COMPLETED|Follow-Up Period||0
447649|NCT01332968|1097092|P8|STARTED|Follow-Up Period||531
447650|NCT01332968|1097093|P7|STARTED|Follow-Up Period||542
447651|NCT01332968|1097094|P6|STARTED|Follow-Up Period||0
447652|NCT01332968|1097095|P5|STARTED|Follow-Up Period||0
447653|NCT01332968|1097096|P4|STARTED|Follow-Up Period||0
447654|NCT01332968|1097097|P3|STARTED|Follow-Up Period||0
447655|NCT01332968|1097098|P2|STARTED|Follow-Up Period||0
447656|NCT01332968|1097099|P1|STARTED|Follow-Up Period||0
447657|NCT01332968|1097092|P8|NOT COMPLETED|Maintenance/Observation Period||0
447658|NCT01332968|1097093|P7|NOT COMPLETED|Maintenance/Observation Period||0
447659|NCT01332968|1097094|P6|NOT COMPLETED|Maintenance/Observation Period||9
447660|NCT01332968|1097095|P5|NOT COMPLETED|Maintenance/Observation Period||10
447661|NCT01332968|1097096|P4|NOT COMPLETED|Maintenance/Observation Period||207
447662|NCT01332968|1097097|P3|NOT COMPLETED|Maintenance/Observation Period||213
447663|NCT01332968|1097098|P2|NOT COMPLETED|Maintenance/Observation Period||0
447664|NCT01332968|1097099|P1|NOT COMPLETED|Maintenance/Observation Period||0
447665|NCT01332968|1097092|P8|COMPLETED|Maintenance/Observation Period||0
447666|NCT01332968|1097093|P7|COMPLETED|Maintenance/Observation Period||0
447667|NCT01332968|1097094|P6|COMPLETED|Maintenance/Observation Period||2
447668|NCT01332968|1097095|P5|COMPLETED|Maintenance/Observation Period||2
447669|NCT01332968|1097096|P4|COMPLETED|Maintenance/Observation Period||417
447670|NCT01332968|1097097|P3|COMPLETED|Maintenance/Observation Period||399
447671|NCT01332968|1097098|P2|COMPLETED|Maintenance/Observation Period||0
447672|NCT01332968|1097099|P1|COMPLETED|Maintenance/Observation Period||0
447673|NCT01332968|1097092|P8|STARTED|Maintenance/Observation Period||0
447674|NCT01332968|1097093|P7|STARTED|Maintenance/Observation Period||0
447675|NCT01332968|1097094|P6|STARTED|Maintenance/Observation Period||11
447676|NCT01332968|1097095|P5|STARTED|Maintenance/Observation Period||12
447677|NCT01332968|1097096|P4|STARTED|Maintenance/Observation Period||624
447678|NCT01332968|1097097|P3|STARTED|Maintenance/Observation Period||612
447679|NCT01332968|1097098|P2|STARTED|Maintenance/Observation Period||0
447680|NCT01332968|1097099|P1|STARTED|Maintenance/Observation Period||0
447681|NCT01332968|1097092|P8|NOT COMPLETED|Induction Period||0
447682|NCT01332968|1097093|P7|NOT COMPLETED|Induction Period||0
447683|NCT01332968|1097094|P6|NOT COMPLETED|Induction Period||0
447684|NCT01332968|1097095|P5|NOT COMPLETED|Induction Period||0
447685|NCT01332968|1097096|P4|NOT COMPLETED|Induction Period||0
447686|NCT01332968|1097097|P3|NOT COMPLETED|Induction Period||0
447687|NCT01332968|1097098|P2|NOT COMPLETED|Induction Period||56
447688|NCT01332968|1097099|P1|NOT COMPLETED|Induction Period||58
447689|NCT01332968|1097092|P8|COMPLETED|Induction Period||0
447690|NCT01332968|1097093|P7|COMPLETED|Induction Period||0
447691|NCT01332968|1097094|P6|COMPLETED|Induction Period||0
447692|NCT01332968|1097095|P5|COMPLETED|Induction Period||0
447693|NCT01332968|1097096|P4|COMPLETED|Induction Period||0
447694|NCT01332968|1097097|P3|COMPLETED|Induction Period||0
447695|NCT01332968|1097098|P2|COMPLETED|Induction Period||646
447696|NCT01332968|1097099|P1|COMPLETED|Induction Period||641
447697|NCT01332968|1097092|P8|STARTED|Induction Period||0
447698|NCT01332968|1097093|P7|STARTED|Induction Period||0
447699|NCT01332968|1097094|P6|STARTED|Induction Period||0
447700|NCT01332968|1097095|P5|STARTED|Induction Period||0
447701|NCT01332968|1097096|P4|STARTED|Induction Period||0
447702|NCT01332968|1097097|P3|STARTED|Induction Period||0
447703|NCT01332968|1097098|P2|STARTED|Induction Period||702
447704|NCT01332968|1097099|P1|STARTED|Induction Period||699
447705|NCT01332851|1097165|P2|NOT COMPLETED|Overall Study||13
447706|NCT01332851|1097166|P1|NOT COMPLETED|Overall Study||11
447707|NCT01332851|1097165|P2|COMPLETED|Overall Study||110
447708|NCT01332851|1097166|P1|COMPLETED|Overall Study||113
447709|NCT01332851|1097165|P2|Completed Follow up 3|Overall Study|Includes 3 new caregivers enrolled due to initial parent no longer parenting|110
447710|NCT01332851|1097166|P1|Completed Follow up 3|Overall Study|Includes 3 new caregivers enrolled due to initial parent no longer parenting|113
447711|NCT01332851|1097165|P2|Completed Follow up 2|Overall Study|Includes 4 new caregivers enrolled due to initial parent no longer parenting|111
447712|NCT01332851|1097166|P1|Completed Follow up 2|Overall Study|Includes 1 new caregiver enrolled due to initial parent no longer parenting|111
447713|NCT01332851|1097165|P2|Completed Follow up 1|Overall Study|Includes 1 new caregiver enrolled due to initial parent no longer parenting|112
447714|NCT01332851|1097166|P1|Completed Follow up 1|Overall Study||116
447715|NCT01332851|1097165|P2|Completed Intervention|Overall Study|4 no intervention, 9 <full dose, 110 full dose; 4 new caregivers enrolled-initial parent dropped out|110
447716|NCT01332851|1097166|P1|Completed Intervention|Overall Study|9 no intervention, 8 <full dose, 107 full dose; 3 new caregivers enrolled-initial parent dropped out|107
447717|NCT01332851|1097165|P2|STARTED|Overall Study||123
447718|NCT01332851|1097166|P1|STARTED|Overall Study||124
447719|NCT01332721|1097198|P1|NOT COMPLETED|Overall Study||0
447720|NCT01332721|1097198|P1|COMPLETED|Overall Study||38
447721|NCT01332721|1097198|P1|STARTED|Overall Study||38
447722|NCT01332578|1097204|P2|NOT COMPLETED|Period II||0
447723|NCT01332578|1097205|P1|NOT COMPLETED|Period II||0
447724|NCT01332578|1097204|P2|COMPLETED|Period II||13
447725|NCT01332578|1097205|P1|COMPLETED|Period II||12
447726|NCT01332578|1097204|P2|STARTED|Period II||13
447727|NCT01332578|1097205|P1|STARTED|Period II||12
447728|NCT01332578|1097204|P2|NOT COMPLETED|Washout Period||0
447729|NCT01332578|1097205|P1|NOT COMPLETED|Washout Period||0
447730|NCT01332578|1097204|P2|COMPLETED|Washout Period||13
447731|NCT01332578|1097205|P1|COMPLETED|Washout Period||12
447732|NCT01332578|1097204|P2|STARTED|Washout Period||13
447733|NCT01332578|1097205|P1|STARTED|Washout Period||12
447734|NCT01332578|1097204|P2|NOT COMPLETED|Period I||0
447735|NCT01332578|1097205|P1|NOT COMPLETED|Period I||0
447736|NCT01332578|1097204|P2|COMPLETED|Period I||13
447737|NCT01332578|1097205|P1|COMPLETED|Period I||12
447738|NCT01332578|1097204|P2|STARTED|Period I||13
447739|NCT01332578|1097205|P1|STARTED|Period I||12
447740|NCT01332500|1097228|P4|NOT COMPLETED|Overall Study||0
447741|NCT01332500|1097229|P3|NOT COMPLETED|Overall Study||0
447742|NCT01332500|1097230|P2|NOT COMPLETED|Overall Study||0
447743|NCT01332500|1097231|P1|NOT COMPLETED|Overall Study||0
447744|NCT01332500|1097228|P4|COMPLETED|Overall Study||5806
447745|NCT01332500|1097229|P3|COMPLETED|Overall Study||2903
447746|NCT01332500|1097230|P2|COMPLETED|Overall Study||39771
447747|NCT01332500|1097231|P1|COMPLETED|Overall Study||13257
447748|NCT01332500|1097228|P4|STARTED|Overall Study||5806
447749|NCT01332500|1097229|P3|STARTED|Overall Study||2903
447750|NCT01332500|1097230|P2|STARTED|Overall Study||39771
447751|NCT01332500|1097231|P1|STARTED|Overall Study||13257
447752|NCT01332487|1097251|P2|NOT COMPLETED|Overall Study||0
447753|NCT01332487|1097252|P1|NOT COMPLETED|Overall Study||0
447754|NCT01332487|1097251|P2|COMPLETED|Overall Study||3063
447755|NCT01332487|1097252|P1|COMPLETED|Overall Study||5554
447756|NCT01332487|1097251|P2|STARTED|Overall Study||3063
447757|NCT01332487|1097252|P1|STARTED|Overall Study||5554
447758|NCT01332461|1097262|P2|NOT COMPLETED|Overall Study||0
447759|NCT01332461|1097263|P1|NOT COMPLETED|Overall Study||0
447760|NCT01332461|1097262|P2|COMPLETED|Overall Study||4386
447761|NCT01332461|1097263|P1|COMPLETED|Overall Study||1291
447762|NCT01332461|1097262|P2|STARTED|Overall Study||4386
447763|NCT01332461|1097263|P1|STARTED|Overall Study||1291
447764|NCT01332435|1097277|P4|NOT COMPLETED|Overall Study||0
447765|NCT01332435|1097278|P3|NOT COMPLETED|Overall Study||0
447766|NCT01332435|1097279|P2|NOT COMPLETED|Overall Study||0
447767|NCT01332435|1097280|P1|NOT COMPLETED|Overall Study||0
447768|NCT01332435|1097277|P4|COMPLETED|Overall Study||1656
447769|NCT01332435|1097278|P3|COMPLETED|Overall Study||2604
447770|NCT01332435|1097279|P2|COMPLETED|Overall Study||1064
447771|NCT01332435|1097280|P1|COMPLETED|Overall Study||1572
447772|NCT01332435|1097277|P4|STARTED|Overall Study||1656
447773|NCT01332435|1097278|P3|STARTED|Overall Study||2604
447774|NCT01332435|1097279|P2|STARTED|Overall Study||1064
447775|NCT01332435|1097280|P1|STARTED|Overall Study||1572
447776|NCT01332357|1097310|P1|NOT COMPLETED|Overall Study||0
447777|NCT01332357|1097310|P1|COMPLETED|Overall Study||6139
447778|NCT01332357|1097310|P1|STARTED|Overall Study||6139
447779|NCT01332318|1097318|P4|NOT COMPLETED|Overall Study||2
447780|NCT01332318|1097319|P3|NOT COMPLETED|Overall Study||1
447781|NCT01332318|1097320|P2|NOT COMPLETED|Overall Study||4
447782|NCT01332318|1097321|P1|NOT COMPLETED|Overall Study||2
447783|NCT01332318|1097318|P4|COMPLETED|Overall Study||28
447784|NCT01332318|1097319|P3|COMPLETED|Overall Study||33
447785|NCT01332318|1097320|P2|COMPLETED|Overall Study||28
447786|NCT01332318|1097321|P1|COMPLETED|Overall Study||32
447787|NCT01332318|1097318|P4|STARTED|Overall Study||30
447788|NCT01332318|1097319|P3|STARTED|Overall Study||34
447789|NCT01332318|1097320|P2|STARTED|Overall Study||32
447790|NCT01332318|1097321|P1|STARTED|Overall Study||34
447791|NCT01332305|1097432|P5|NOT COMPLETED|Overall Study||12
447792|NCT01332305|1097433|P4|NOT COMPLETED|Overall Study||8
447793|NCT01332305|1097434|P3|NOT COMPLETED|Overall Study||14
447794|NCT01332305|1097435|P2|NOT COMPLETED|Overall Study||14
447795|NCT01332305|1097436|P1|NOT COMPLETED|Overall Study||10
447796|NCT01332305|1097432|P5|COMPLETED|Overall Study||33
447797|NCT01332305|1097433|P4|COMPLETED|Overall Study||30
447798|NCT01332305|1097434|P3|COMPLETED|Overall Study||31
447799|NCT01332305|1097435|P2|COMPLETED|Overall Study||34
447800|NCT01332305|1097436|P1|COMPLETED|Overall Study||31
447801|NCT01332305|1097432|P5|STARTED|Overall Study||45
447802|NCT01332305|1097433|P4|STARTED|Overall Study||38
447803|NCT01332305|1097434|P3|STARTED|Overall Study||45
447804|NCT01332305|1097435|P2|STARTED|Overall Study||48
447805|NCT01332305|1097436|P1|STARTED|Overall Study||41
447806|NCT01332292|1097458|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||1
447807|NCT01332292|1097459|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||1
447808|NCT01332292|1097458|P2|COMPLETED|Treatment Period 2 (14 Days)||11
447809|NCT01332292|1097459|P1|COMPLETED|Treatment Period 2 (14 Days)||11
447810|NCT01332292|1097458|P2|STARTED|Treatment Period 2 (14 Days)||12
447811|NCT01332292|1097459|P1|STARTED|Treatment Period 2 (14 Days)||12
447812|NCT01332292|1097458|P2|NOT COMPLETED|Washout Period (>=7 Days)||0
447813|NCT01332292|1097459|P1|NOT COMPLETED|Washout Period (>=7 Days)||0
447814|NCT01332292|1097458|P2|COMPLETED|Washout Period (>=7 Days)||12
447815|NCT01332292|1097459|P1|COMPLETED|Washout Period (>=7 Days)||12
447816|NCT01332292|1097458|P2|STARTED|Washout Period (>=7 Days)||12
447817|NCT01332292|1097459|P1|STARTED|Washout Period (>=7 Days)||12
447818|NCT01332292|1097458|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
447819|NCT01332292|1097459|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||2
447820|NCT01332292|1097458|P2|COMPLETED|Treatment Period 1 (14 Days)||12
447821|NCT01332292|1097459|P1|COMPLETED|Treatment Period 1 (14 Days)||12
447822|NCT01332292|1097458|P2|STARTED|Treatment Period 1 (14 Days)||13
447823|NCT01332292|1097459|P1|STARTED|Treatment Period 1 (14 Days)||14
447824|NCT01332253|1097521|P2|NOT COMPLETED|Overall Study||0
447825|NCT01332253|1097522|P1|NOT COMPLETED|Overall Study||0
447826|NCT01332253|1097521|P2|COMPLETED|Overall Study||79
447827|NCT01332253|1097522|P1|COMPLETED|Overall Study||82
447828|NCT01332253|1097521|P2|STARTED|Overall Study||79
447829|NCT01332253|1097522|P1|STARTED|Overall Study||82
447830|NCT01332227|1097550|P2|NOT COMPLETED|Overall Study||5
447831|NCT01332227|1097551|P1|NOT COMPLETED|Overall Study||16
447832|NCT01332227|1097550|P2|COMPLETED|Overall Study||32
447833|NCT01332227|1097551|P1|COMPLETED|Overall Study||56
447834|NCT01332227|1097550|P2|STARTED|Overall Study|Participants who received treatment|37
447835|NCT01332227|1097551|P1|STARTED|Overall Study|Participants who received treatment|72
447836|NCT01332188|1097573|P4|NOT COMPLETED|Overall Study||0
447837|NCT01332188|1097574|P3|NOT COMPLETED|Overall Study||4
447838|NCT01332188|1097575|P2|NOT COMPLETED|Overall Study||1
447839|NCT01332188|1097576|P1|NOT COMPLETED|Overall Study||2
447840|NCT01332188|1097573|P4|COMPLETED|Overall Study||25
447841|NCT01332188|1097574|P3|COMPLETED|Overall Study||21
447842|NCT01332188|1097575|P2|COMPLETED|Overall Study||25
447843|NCT01332188|1097576|P1|COMPLETED|Overall Study||23
447844|NCT01332188|1097573|P4|STARTED|Overall Study||25
447845|NCT01332188|1097574|P3|STARTED|Overall Study||25
447846|NCT01332188|1097575|P2|STARTED|Overall Study||26
447847|NCT01332188|1097576|P1|STARTED|Overall Study||25
447848|NCT01332149|1097732|P2|NOT COMPLETED|Overall Study||38
447849|NCT01332149|1097733|P1|NOT COMPLETED|Overall Study||30
447850|NCT01332149|1097732|P2|COMPLETED|Overall Study||271
447851|NCT01332149|1097733|P1|COMPLETED|Overall Study||284
447852|NCT01332149|1097732|P2|Treated|Overall Study||307
447853|NCT01332149|1097733|P1|Treated|Overall Study||313
447854|NCT01332149|1097732|P2|STARTED|Overall Study|Assigned to study treatment.|309
447855|NCT01332149|1097733|P1|STARTED|Overall Study|Assigned to study treatment.|314
447856|NCT01332123|1097787|P1|NOT COMPLETED|Overall Study||0
447857|NCT01332123|1097787|P1|COMPLETED|Overall Study||10
447858|NCT01332123|1097787|P1|STARTED|Overall Study||10
447859|NCT01332071|1097792|P2|NOT COMPLETED|Period 2||0
447860|NCT01332071|1097793|P1|NOT COMPLETED|Period 2||0
447861|NCT01332071|1097792|P2|COMPLETED|Period 2||13
447862|NCT01332071|1097793|P1|COMPLETED|Period 2||13
447863|NCT01332071|1097792|P2|STARTED|Period 2||13
447864|NCT01332071|1097793|P1|STARTED|Period 2||13
447865|NCT01332071|1097792|P2|NOT COMPLETED|7-Day Washout Period||0
447866|NCT01332071|1097793|P1|NOT COMPLETED|7-Day Washout Period||0
447867|NCT01332071|1097792|P2|COMPLETED|7-Day Washout Period||13
447868|NCT01332071|1097793|P1|COMPLETED|7-Day Washout Period||13
447869|NCT01332071|1097792|P2|STARTED|7-Day Washout Period||13
447870|NCT01332071|1097793|P1|STARTED|7-Day Washout Period||13
447871|NCT01332071|1097792|P2|NOT COMPLETED|Period 1||0
447872|NCT01332071|1097793|P1|NOT COMPLETED|Period 1||0
447873|NCT01332071|1097792|P2|COMPLETED|Period 1||13
447874|NCT01332071|1097793|P1|COMPLETED|Period 1||13
447875|NCT01332071|1097792|P2|STARTED|Period 1||13
447876|NCT01332071|1097793|P1|STARTED|Period 1||13
447877|NCT01332019|1097811|P2|NOT COMPLETED|Overall Study||122
447878|NCT01332019|1097812|P1|NOT COMPLETED|Overall Study||113
447879|NCT01332019|1097811|P2|COMPLETED|Overall Study||425
447880|NCT01332019|1097812|P1|COMPLETED|Overall Study||417
447881|NCT01332019|1097811|P2|STARTED|Overall Study||547
447882|NCT01332019|1097812|P1|STARTED|Overall Study||530
447883|NCT01331837|1097896|P2|NOT COMPLETED|Overall Study||67
447884|NCT01331837|1097897|P1|NOT COMPLETED|Overall Study||56
447885|NCT01331837|1097896|P2|COMPLETED|Overall Study||1475
447886|NCT01331837|1097897|P1|COMPLETED|Overall Study||1482
447887|NCT01331837|1097896|P2|STARTED|Overall Study||1542
447888|NCT01331837|1097897|P1|STARTED|Overall Study||1538
447889|NCT01331824|1097937|P1|NOT COMPLETED|Overall Study||13
447890|NCT01331824|1097937|P1|COMPLETED|Overall Study||9
447891|NCT01331824|1097937|P1|STARTED|Overall Study||22
447892|NCT01331694|1097950|P6|NOT COMPLETED|Overall Study||0
447893|NCT01331694|1097951|P5|NOT COMPLETED|Overall Study||0
447894|NCT01331694|1097952|P4|NOT COMPLETED|Overall Study||0
447895|NCT01331694|1097953|P3|NOT COMPLETED|Overall Study||0
447896|NCT01331694|1097954|P2|NOT COMPLETED|Overall Study||0
447897|NCT01331694|1097955|P1|NOT COMPLETED|Overall Study||0
447898|NCT01331694|1097950|P6|COMPLETED|Overall Study||9126
447899|NCT01331694|1097951|P5|COMPLETED|Overall Study||10617
447900|NCT01331694|1097952|P4|COMPLETED|Overall Study||12595
447901|NCT01331694|1097953|P3|COMPLETED|Overall Study||12659
447902|NCT01331694|1097954|P2|COMPLETED|Overall Study||14449
447903|NCT01331694|1097955|P1|COMPLETED|Overall Study||16684
447904|NCT01331694|1097950|P6|STARTED|Overall Study||9126
447905|NCT01331694|1097951|P5|STARTED|Overall Study||10617
447906|NCT01331694|1097952|P4|STARTED|Overall Study||12595
447907|NCT01331694|1097953|P3|STARTED|Overall Study||12659
447908|NCT01331694|1097954|P2|STARTED|Overall Study||14449
447909|NCT01331694|1097955|P1|STARTED|Overall Study||16684
447910|NCT01331681|1097972|P3|NOT COMPLETED|Overall Study||35
447911|NCT01331681|1097973|P2|NOT COMPLETED|Overall Study||34
447912|NCT01331681|1097974|P1|NOT COMPLETED|Overall Study||35
447913|NCT01331681|1097972|P3|COMPLETED|Overall Study|Completed Week 148|100
447914|NCT01331681|1097973|P2|COMPLETED|Overall Study|Completed Week 148|101
447915|NCT01331681|1097974|P1|COMPLETED|Overall Study|Completed Week 148|101
447916|NCT01331681|1097972|P3|Completed Week 148|Overall Study||100
447917|NCT01331681|1097973|P2|Completed Week 148|Overall Study||101
447918|NCT01331681|1097974|P1|Completed Week 148|Overall Study||101
447919|NCT01331681|1097972|P3|Completed Week 100|Overall Study||105
447920|NCT01331681|1097973|P2|Completed Week 100|Overall Study||110
447921|NCT01331681|1097974|P1|Completed Week 100|Overall Study||115
447922|NCT01331681|1097972|P3|Completed Week 52|Overall Study||115
447923|NCT01331681|1097973|P2|Completed Week 52|Overall Study||121
447924|NCT01331681|1097974|P1|Completed Week 52|Overall Study||125
447925|NCT01331681|1097972|P3|Participants Received Treatment|Overall Study|safety population|133
447926|NCT01331681|1097973|P2|Participants Received Treatment|Overall Study|safety population|135
447927|NCT01331681|1097974|P1|Participants Received Treatment|Overall Study|safety population|136
447928|NCT01331681|1097972|P3|STARTED|Overall Study|randomized|135
447929|NCT01331681|1097973|P2|STARTED|Overall Study|randomized|135
447930|NCT01331681|1097974|P1|STARTED|Overall Study|randomized|136
447931|NCT01331304|1098002|P2|NOT COMPLETED|Overall Study||60
447932|NCT01331304|1098003|P1|NOT COMPLETED|Overall Study||58
447933|NCT01331304|1098002|P2|COMPLETED|Overall Study||182
447934|NCT01331304|1098003|P1|COMPLETED|Overall Study||182
447935|NCT01331304|1098002|P2|STARTED|Overall Study||242
447936|NCT01331304|1098003|P1|STARTED|Overall Study||240
447937|NCT01331291|1098017|P2|NOT COMPLETED|Overall Study||9
447938|NCT01331291|1098018|P1|NOT COMPLETED|Overall Study||2
447939|NCT01331291|1098017|P2|COMPLETED|Overall Study||0
447940|NCT01331291|1098018|P1|COMPLETED|Overall Study||0
447941|NCT01331291|1098017|P2|STARTED|Overall Study||9
447942|NCT01331291|1098018|P1|STARTED|Overall Study||2
447943|NCT01331213|1098031|P2|NOT COMPLETED|Overall Study||0
447944|NCT01331213|1098032|P1|NOT COMPLETED|Overall Study||0
447945|NCT01331213|1098031|P2|COMPLETED|Overall Study||10
447946|NCT01331213|1098032|P1|COMPLETED|Overall Study||8
447947|NCT01331213|1098031|P2|STARTED|Overall Study||10
447948|NCT01331213|1098032|P1|STARTED|Overall Study||8
447949|NCT01331161|1098052|P2|NOT COMPLETED|Overall Study||2
447950|NCT01331161|1098053|P1|NOT COMPLETED|Overall Study||1
447951|NCT01331161|1098052|P2|COMPLETED|Overall Study||31
447952|NCT01331161|1098053|P1|COMPLETED|Overall Study||43
447953|NCT01331161|1098052|P2|STARTED|Overall Study||33
447954|NCT01331161|1098053|P1|STARTED|Overall Study||44
447955|NCT01331109|1098061|P1|NOT COMPLETED|Overall Study||57
447956|NCT01331109|1098061|P1|COMPLETED|Overall Study||0
447957|NCT01331109|1098061|P1|STARTED|Overall Study||57
447958|NCT01331005|1098073|P2|NOT COMPLETED|Overall Study||4
447959|NCT01331005|1098074|P1|NOT COMPLETED|Overall Study||4
447960|NCT01331005|1098073|P2|COMPLETED|Overall Study||57
447961|NCT01331005|1098074|P1|COMPLETED|Overall Study||60
447962|NCT01331005|1098073|P2|STARTED|Overall Study||61
447963|NCT01331005|1098074|P1|STARTED|Overall Study||64
447964|NCT01330914|1098080|P1|NOT COMPLETED|Overall Study||7
447965|NCT01330914|1098080|P1|COMPLETED|Overall Study||48
447966|NCT01330914|1098080|P1|STARTED|Overall Study||55
447967|NCT01330628|1098086|P2|NOT COMPLETED|Overall Study||40
447968|NCT01330628|1098087|P1|NOT COMPLETED|Overall Study||70
447969|NCT01330628|1098086|P2|COMPLETED|Overall Study||42
447970|NCT01330628|1098087|P1|COMPLETED|Overall Study||100
447971|NCT01330628|1098086|P2|6 Month Follow-up|Overall Study||60
447972|NCT01330628|1098087|P1|6 Month Follow-up|Overall Study||135
447973|NCT01330628|1098086|P2|30 Day Follow-up|Overall Study||73
447974|NCT01330628|1098087|P1|30 Day Follow-up|Overall Study||165
447975|NCT01330628|1098086|P2|STARTED|Overall Study||82
447976|NCT01330628|1098087|P1|STARTED|Overall Study||170
447977|NCT01330433|1098097|P2|NOT COMPLETED|Overall Study||3
447978|NCT01330433|1098098|P1|NOT COMPLETED|Overall Study||2
447979|NCT01330433|1098097|P2|COMPLETED|Overall Study||16
447980|NCT01330433|1098098|P1|COMPLETED|Overall Study||14
447981|NCT01330433|1098097|P2|STARTED|Overall Study||19
447982|NCT01330433|1098098|P1|STARTED|Overall Study||16
447983|NCT01330420|1098118|P1|NOT COMPLETED|Overall Study||4
447984|NCT01330420|1098118|P1|COMPLETED|Overall Study||24
447985|NCT01330420|1098118|P1|STARTED|Overall Study||28
447986|NCT01330394|1098128|P2|NOT COMPLETED|Overall Study||0
447987|NCT01330394|1098129|P1|NOT COMPLETED|Overall Study||0
447988|NCT01330394|1098128|P2|COMPLETED|Overall Study||16
447989|NCT01330394|1098129|P1|COMPLETED|Overall Study||17
447990|NCT01330394|1098128|P2|STARTED|Overall Study||16
447991|NCT01330394|1098129|P1|STARTED|Overall Study||17
447992|NCT01330381|1098137|P3|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||18
447993|NCT01330381|1098138|P2|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||0
447994|NCT01330381|1098139|P1|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||10
447995|NCT01330381|1098137|P3|COMPLETED|Open-label Treatment Period (16 Weeks)||81
447996|NCT01330381|1098138|P2|COMPLETED|Open-label Treatment Period (16 Weeks)||0
447997|NCT01330381|1098139|P1|COMPLETED|Open-label Treatment Period (16 Weeks)||88
447998|NCT01330381|1098137|P3|STARTED|Open-label Treatment Period (16 Weeks)||99
447999|NCT01330381|1098138|P2|STARTED|Open-label Treatment Period (16 Weeks)||0
448000|NCT01330381|1098139|P1|STARTED|Open-label Treatment Period (16 Weeks)||98
448001|NCT01330381|1098137|P3|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||0
448002|NCT01330381|1098138|P2|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||7
448003|NCT01330381|1098139|P1|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||11
448004|NCT01330381|1098137|P3|COMPLETED|Double-blind Treatment Period (8 Weeks)||0
448005|NCT01330381|1098138|P2|COMPLETED|Double-blind Treatment Period (8 Weeks)||101
448006|NCT01330381|1098139|P1|COMPLETED|Double-blind Treatment Period (8 Weeks)||96
448007|NCT01330381|1098137|P3|Received Treatment|Double-blind Treatment Period (8 Weeks)||0
448008|NCT01330381|1098138|P2|Received Treatment|Double-blind Treatment Period (8 Weeks)||107
448009|NCT01330381|1098139|P1|Received Treatment|Double-blind Treatment Period (8 Weeks)||106
448010|NCT01330381|1098137|P3|STARTED|Double-blind Treatment Period (8 Weeks)||0
448011|NCT01330381|1098138|P2|STARTED|Double-blind Treatment Period (8 Weeks)||108
448012|NCT01330381|1098139|P1|STARTED|Double-blind Treatment Period (8 Weeks)||107
448013|NCT01330355|1098185|P2|NOT COMPLETED|Overall Study||0
448014|NCT01330355|1098186|P1|NOT COMPLETED|Overall Study||0
448015|NCT01330355|1098185|P2|COMPLETED|Overall Study||17
448016|NCT01330355|1098186|P1|COMPLETED|Overall Study||16
448017|NCT01330355|1098185|P2|STARTED|Overall Study||17
448018|NCT01330355|1098186|P1|STARTED|Overall Study||16
448019|NCT01330316|1098200|P2|NOT COMPLETED|Overall Study||15
448020|NCT01330316|1098201|P1|NOT COMPLETED|Overall Study||2
448021|NCT01330316|1098200|P2|COMPLETED|Overall Study||60
448022|NCT01330316|1098201|P1|COMPLETED|Overall Study||41
448023|NCT01330316|1098200|P2|STARTED|Overall Study||75
448024|NCT01330316|1098201|P1|STARTED|Overall Study||43
448025|NCT01330303|1098237|P2|NOT COMPLETED|Period 2||0
448026|NCT01330303|1098238|P1|NOT COMPLETED|Period 2||0
448027|NCT01330303|1098237|P2|COMPLETED|Period 2||18
448028|NCT01330303|1098238|P1|COMPLETED|Period 2||19
448029|NCT01330303|1098237|P2|STARTED|Period 2||18
448030|NCT01330303|1098238|P1|STARTED|Period 2||19
448031|NCT01330303|1098237|P2|NOT COMPLETED|7-Day Washout Period||0
448032|NCT01330303|1098238|P1|NOT COMPLETED|7-Day Washout Period||0
448033|NCT01330303|1098237|P2|COMPLETED|7-Day Washout Period||18
448034|NCT01330303|1098238|P1|COMPLETED|7-Day Washout Period||19
448035|NCT01330303|1098237|P2|STARTED|7-Day Washout Period||18
448036|NCT01330303|1098238|P1|STARTED|7-Day Washout Period||19
448037|NCT01330303|1098237|P2|NOT COMPLETED|Period 1||2
448038|NCT01330303|1098238|P1|NOT COMPLETED|Period 1||1
448039|NCT01330303|1098237|P2|COMPLETED|Period 1||18
448040|NCT01330303|1098238|P1|COMPLETED|Period 1||19
448041|NCT01330303|1098237|P2|STARTED|Period 1||20
448042|NCT01330303|1098238|P1|STARTED|Period 1||20
448043|NCT01330290|1098248|P1|NOT COMPLETED|Overall Study||0
448044|NCT01330290|1098248|P1|COMPLETED|Overall Study|As this is a cross-sectional study, the terms completed/not completed are not applicable.|148
448045|NCT01330290|1098248|P1|STARTED|Overall Study||148
448046|NCT01330134|1098274|P2|NOT COMPLETED|Overall Study||0
448047|NCT01330134|1098275|P1|NOT COMPLETED|Overall Study||0
448048|NCT01330134|1098274|P2|COMPLETED|Overall Study||237
448049|NCT01330134|1098275|P1|COMPLETED|Overall Study||244
448050|NCT01330134|1098274|P2|STARTED|Overall Study||237
448051|NCT01330134|1098275|P1|STARTED|Overall Study||244
448052|NCT01330108|1098285|P1|NOT COMPLETED|Overall Study||4
448053|NCT01330108|1098285|P1|COMPLETED|Overall Study||28
448054|NCT01330108|1098285|P1|STARTED|Overall Study||32
448055|NCT01330043|1098292|P2|NOT COMPLETED|Overall Study||4
448056|NCT01330043|1098293|P1|NOT COMPLETED|Overall Study||0
448057|NCT01330043|1098292|P2|COMPLETED|Overall Study||108
448058|NCT01330043|1098293|P1|COMPLETED|Overall Study||111
448059|NCT01330043|1098292|P2|STARTED|Overall Study||112
448060|NCT01330043|1098293|P1|STARTED|Overall Study||111
448061|NCT01330030|1098303|P2|NOT COMPLETED|Overall Study||17
448062|NCT01330030|1098304|P1|NOT COMPLETED|Overall Study||16
448063|NCT01330030|1098303|P2|COMPLETED|Overall Study|number assessed at week 52 follow-up|105
448064|NCT01330030|1098304|P1|COMPLETED|Overall Study|number assessed at week 52 follow-up|105
448065|NCT01330030|1098303|P2|STARTED|Overall Study||122
448066|NCT01330030|1098304|P1|STARTED|Overall Study||121
448067|NCT01330017|1098315|P5|NOT COMPLETED|Overall Study||3
448068|NCT01330017|1098316|P4|NOT COMPLETED|Overall Study||12
448069|NCT01330017|1098317|P3|NOT COMPLETED|Overall Study||8
448070|NCT01330017|1098318|P2|NOT COMPLETED|Overall Study||4
448071|NCT01330017|1098319|P1|NOT COMPLETED|Overall Study||5
448072|NCT01330017|1098315|P5|COMPLETED|Overall Study||100
448073|NCT01330017|1098316|P4|COMPLETED|Overall Study||100
448074|NCT01330017|1098317|P3|COMPLETED|Overall Study||99
448075|NCT01330017|1098318|P2|COMPLETED|Overall Study||104
448076|NCT01330017|1098319|P1|COMPLETED|Overall Study||104
448077|NCT01330017|1098315|P5|STARTED|Overall Study||103
448078|NCT01330017|1098316|P4|STARTED|Overall Study||112
448079|NCT01330017|1098317|P3|STARTED|Overall Study||107
448080|NCT01330017|1098318|P2|STARTED|Overall Study||108
448081|NCT01330017|1098319|P1|STARTED|Overall Study||109
448082|NCT01329978|1098368|P5|NOT COMPLETED|Rerandomization Treatment Period||4
448083|NCT01329978|1098369|P4|NOT COMPLETED|Rerandomization Treatment Period||5
448084|NCT01329978|1098370|P3|NOT COMPLETED|Rerandomization Treatment Period||0
448085|NCT01329978|1098371|P2|NOT COMPLETED|Rerandomization Treatment Period||0
448086|NCT01329978|1098372|P1|NOT COMPLETED|Rerandomization Treatment Period||0
448087|NCT01329978|1098368|P5|COMPLETED|Rerandomization Treatment Period||71
448088|NCT01329978|1098369|P4|COMPLETED|Rerandomization Treatment Period||70
448089|NCT01329978|1098370|P3|COMPLETED|Rerandomization Treatment Period||0
448090|NCT01329978|1098371|P2|COMPLETED|Rerandomization Treatment Period||0
448091|NCT01329978|1098372|P1|COMPLETED|Rerandomization Treatment Period||0
448092|NCT01329978|1098368|P5|STARTED|Rerandomization Treatment Period|This group includes participants rerandomized from the SOF+PEG+RBV 12 week/Rerandomization Group.|75
448093|NCT01329978|1098369|P4|STARTED|Rerandomization Treatment Period|This group includes participants rerandomized from the SOF+PEG+RBV 12 week/Rerandomization Group.|75
448094|NCT01329978|1098370|P3|STARTED|Rerandomization Treatment Period||0
448095|NCT01329978|1098371|P2|STARTED|Rerandomization Treatment Period||0
448096|NCT01329978|1098372|P1|STARTED|Rerandomization Treatment Period||0
448097|NCT01329978|1098368|P5|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
448098|NCT01329978|1098369|P4|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
448099|NCT01329978|1098370|P3|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||5
448100|NCT01329978|1098371|P2|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||13
448101|NCT01329978|1098372|P1|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||4
448102|NCT01329978|1098368|P5|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
448103|NCT01329978|1098369|P4|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
448104|NCT01329978|1098370|P3|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|150 participants were re-randomized after 12 weeks of treatment.|150
448105|NCT01329978|1098371|P2|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|Participants in this group were not re-randomized for further treatment|112
448106|NCT01329978|1098372|P1|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|Participants in this group were not re-randomized for further treatment|48
448107|NCT01329978|1098368|P5|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0
448108|NCT01329978|1098369|P4|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0
448109|NCT01329978|1098370|P3|STARTED|Sofosbuvir+PEG+RBV Treatment Period||155
448110|NCT01329978|1098371|P2|STARTED|Sofosbuvir+PEG+RBV Treatment Period||125
448111|NCT01329978|1098372|P1|STARTED|Sofosbuvir+PEG+RBV Treatment Period||52
448112|NCT01329939|1098446|P4|NOT COMPLETED|Overall Study||5
448113|NCT01329939|1098447|P3|NOT COMPLETED|Overall Study||1
448114|NCT01329939|1098448|P2|NOT COMPLETED|Overall Study||1
448115|NCT01329939|1098449|P1|NOT COMPLETED|Overall Study||3
448116|NCT01329939|1098446|P4|COMPLETED|Overall Study||4
448117|NCT01329939|1098447|P3|COMPLETED|Overall Study||4
448118|NCT01329939|1098448|P2|COMPLETED|Overall Study||4
448119|NCT01329939|1098449|P1|COMPLETED|Overall Study||4
448120|NCT01329939|1098446|P4|STARTED|Overall Study||9
448121|NCT01329939|1098447|P3|STARTED|Overall Study||5
448122|NCT01329939|1098448|P2|STARTED|Overall Study||5
448123|NCT01329939|1098449|P1|STARTED|Overall Study||7
448124|NCT01329848|1098487|P1|NOT COMPLETED|Overall Study||29
448125|NCT01329848|1098487|P1|COMPLETED|Overall Study||54
448126|NCT01329848|1098487|P1|STARTED|Overall Study||83
448127|NCT01329679|1098492|P2|NOT COMPLETED|Overall Study||0
448128|NCT01329679|1098493|P1|NOT COMPLETED|Overall Study||0
448129|NCT01329679|1098492|P2|COMPLETED|Overall Study||13
448130|NCT01329679|1098493|P1|COMPLETED|Overall Study||13
448131|NCT01329679|1098492|P2|STARTED|Overall Study||13
448132|NCT01329679|1098493|P1|STARTED|Overall Study||13
448133|NCT01329562|1098513|P2|NOT COMPLETED|Overall Study||7
448134|NCT01329562|1098514|P1|NOT COMPLETED|Overall Study||9
448135|NCT01329562|1098513|P2|COMPLETED|Overall Study||14
448136|NCT01329562|1098514|P1|COMPLETED|Overall Study||11
448137|NCT01329562|1098513|P2|STARTED|Overall Study||21
448138|NCT01329562|1098514|P1|STARTED|Overall Study||20
448139|NCT01329549|1098563|P1|NOT COMPLETED|Overall Study||2
448140|NCT01329549|1098563|P1|COMPLETED|Overall Study||0
448141|NCT01329549|1098563|P1|STARTED|Overall Study||2
448142|NCT01329419|1098574|P1|NOT COMPLETED|Overall Study||235
448143|NCT01329419|1098574|P1|COMPLETED|Overall Study||4158
448144|NCT01329419|1098574|P1|STARTED|Overall Study||4393
448145|NCT01329263|1098582|P2|NOT COMPLETED|Overall Study||23
448146|NCT01329263|1098583|P1|NOT COMPLETED|Overall Study||5
448147|NCT01329263|1098582|P2|COMPLETED|Overall Study||22
448148|NCT01329263|1098583|P1|COMPLETED|Overall Study||10
448149|NCT01329263|1098582|P2|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||22
448150|NCT01329263|1098583|P1|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||10
448151|NCT01329263|1098582|P2|Completed Period 2 Own or CCrush Menthol|Overall Study||30
448152|NCT01329263|1098583|P1|Completed Period 2 Own or CCrush Menthol|Overall Study||10
448153|NCT01329263|1098582|P2|Completed Period 1 Own Menthol|Overall Study||45
448154|NCT01329263|1098583|P1|Completed Period 1 Own Menthol|Overall Study||15
448155|NCT01329263|1098582|P2|STARTED|Overall Study||45
448156|NCT01329263|1098583|P1|STARTED|Overall Study||15
448157|NCT01329198|1098597|P2|NOT COMPLETED|Overall Study||0
448158|NCT01329198|1098598|P1|NOT COMPLETED|Overall Study||0
448159|NCT01329198|1098597|P2|COMPLETED|Overall Study||2
448160|NCT01329198|1098598|P1|COMPLETED|Overall Study||3
448161|NCT01329198|1098597|P2|STARTED|Overall Study||2
448162|NCT01329198|1098598|P1|STARTED|Overall Study||3
448163|NCT01329185|1098611|P2|NOT COMPLETED|Overall Study||0
448164|NCT01329185|1098612|P1|NOT COMPLETED|Overall Study||0
448165|NCT01329185|1098611|P2|COMPLETED|Overall Study||7
448166|NCT01329185|1098612|P1|COMPLETED|Overall Study||10
448167|NCT01329185|1098611|P2|PTLD|Overall Study||0
448168|NCT01329185|1098612|P1|PTLD|Overall Study||1
448169|NCT01329185|1098611|P2|CMV Disease|Overall Study||0
448170|NCT01329185|1098612|P1|CMV Disease|Overall Study||1
448171|NCT01329185|1098611|P2|STARTED|Overall Study||7
448172|NCT01329185|1098612|P1|STARTED|Overall Study||10
448173|NCT01329029|1098620|P2|NOT COMPLETED|Overall Study||192
448174|NCT01329029|1098621|P1|NOT COMPLETED|Overall Study||269
448175|NCT01329029|1098620|P2|COMPLETED|Overall Study||780
448176|NCT01329029|1098621|P1|COMPLETED|Overall Study||704
448177|NCT01329029|1098620|P2|Safety Population|Overall Study||967
448178|NCT01329029|1098621|P1|Safety Population|Overall Study||968
448179|NCT01329029|1098620|P2|Full Analysis Set (FAS)|Overall Study||966
448180|NCT01329029|1098621|P1|Full Analysis Set (FAS)|Overall Study||969
448181|NCT01329029|1098620|P2|STARTED|Overall Study||972
448182|NCT01329029|1098621|P1|STARTED|Overall Study||973
448183|NCT01328964|1098694|P3|NOT COMPLETED|Overall Study||0
448184|NCT01328964|1098695|P2|NOT COMPLETED|Overall Study||0
448185|NCT01328964|1098696|P1|NOT COMPLETED|Overall Study||0
448186|NCT01328964|1098694|P3|COMPLETED|Overall Study||4424
448187|NCT01328964|1098695|P2|COMPLETED|Overall Study||3270
448188|NCT01328964|1098696|P1|COMPLETED|Overall Study||2212
448189|NCT01328964|1098694|P3|STARTED|Overall Study||4424
448190|NCT01328964|1098695|P2|STARTED|Overall Study||3270
448191|NCT01328964|1098696|P1|STARTED|Overall Study||2212
448192|NCT01328951|1098711|P2|NOT COMPLETED|Overall Study||322
448193|NCT01328951|1098712|P1|NOT COMPLETED|Overall Study||321
448194|NCT01328951|1098711|P2|COMPLETED|Overall Study||0
448195|NCT01328951|1098712|P1|COMPLETED|Overall Study||0
448196|NCT01328951|1098711|P2|STARTED|Overall Study||322
448197|NCT01328951|1098712|P1|STARTED|Overall Study||321
448198|NCT01328873|1098736|P1|NOT COMPLETED|Overall Study||0
448199|NCT01328873|1098736|P1|COMPLETED|Overall Study||49
448200|NCT01328873|1098736|P1|STARTED|Overall Study||49
448201|NCT01328782|1098748|P3|NOT COMPLETED|Overall Study||0
448202|NCT01328782|1098749|P2|NOT COMPLETED|Overall Study||0
448203|NCT01328782|1098750|P1|NOT COMPLETED|Overall Study||0
448204|NCT01328782|1098748|P3|COMPLETED|Overall Study||39
448205|NCT01328782|1098749|P2|COMPLETED|Overall Study||42
448206|NCT01328782|1098750|P1|COMPLETED|Overall Study||43
448207|NCT01328782|1098748|P3|STARTED|Overall Study||39
448208|NCT01328782|1098749|P2|STARTED|Overall Study||42
448209|NCT01328782|1098750|P1|STARTED|Overall Study||43
448210|NCT01328769|1098772|P2|NOT COMPLETED|Overall Study||1
448211|NCT01328769|1098773|P1|NOT COMPLETED|Overall Study||0
448212|NCT01328769|1098772|P2|COMPLETED|Overall Study||23
448213|NCT01328769|1098773|P1|COMPLETED|Overall Study||25
448214|NCT01328769|1098772|P2|STARTED|Overall Study||24
448215|NCT01328769|1098773|P1|STARTED|Overall Study||25
448216|NCT01328756|1098781|P1|NOT COMPLETED|Overall Study||123
448217|NCT01328756|1098781|P1|COMPLETED|Overall Study||191
448218|NCT01328756|1098781|P1|STARTED|Overall Study||314
448219|NCT01328717|1098798|P1|NOT COMPLETED|Overall Study||1
448220|NCT01328717|1098798|P1|COMPLETED|Overall Study||77
448221|NCT01328717|1098798|P1|STARTED|Overall Study||78
448222|NCT01328574|1098803|P1|NOT COMPLETED|Overall Study||1
448223|NCT01328574|1098803|P1|COMPLETED|Overall Study||12
448224|NCT01328574|1098803|P1|STARTED|Overall Study||13
448225|NCT01328548|1098817|P2|NOT COMPLETED|Overall Study||0
448226|NCT01328548|1098818|P1|NOT COMPLETED|Overall Study||4
448227|NCT01328548|1098817|P2|COMPLETED|Overall Study||50
448228|NCT01328548|1098818|P1|COMPLETED|Overall Study||187
448229|NCT01328548|1098817|P2|STARTED|Overall Study||50
448230|NCT01328548|1098818|P1|STARTED|Overall Study||191
448231|NCT01328496|1098838|P2|NOT COMPLETED|Overall Study||0
448232|NCT01328496|1098839|P1|NOT COMPLETED|Overall Study||1
448233|NCT01328496|1098838|P2|COMPLETED|Overall Study||4
448234|NCT01328496|1098839|P1|COMPLETED|Overall Study||9
448235|NCT01328496|1098838|P2|STARTED|Overall Study||4
448236|NCT01328496|1098839|P1|STARTED|Overall Study||10
448237|NCT01328444|1098857|P6|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7
448238|NCT01328444|1098858|P5|NOT COMPLETED|Treatment Period 2 (12 Weeks)||8
448239|NCT01328444|1098859|P4|NOT COMPLETED|Treatment Period 2 (12 Weeks)||5
448240|NCT01328444|1098860|P3|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
448241|NCT01328444|1098861|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1
448242|NCT01328444|1098862|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||11
448243|NCT01328444|1098857|P6|COMPLETED|Treatment Period 2 (12 Weeks)||59
448244|NCT01328444|1098858|P5|COMPLETED|Treatment Period 2 (12 Weeks)||63
448245|NCT01328444|1098859|P4|COMPLETED|Treatment Period 2 (12 Weeks)||30
448246|NCT01328444|1098860|P3|COMPLETED|Treatment Period 2 (12 Weeks)||19
448247|NCT01328444|1098861|P2|COMPLETED|Treatment Period 2 (12 Weeks)||22
448248|NCT01328444|1098862|P1|COMPLETED|Treatment Period 2 (12 Weeks)||65
448249|NCT01328444|1098857|P6|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|66
448250|NCT01328444|1098858|P5|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|71
448251|NCT01328444|1098859|P4|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|35
448252|NCT01328444|1098860|P3|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|22
448253|NCT01328444|1098861|P2|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|23
448254|NCT01328444|1098862|P1|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|76
448255|NCT01328444|1098857|P6|NOT COMPLETED|Washout Period (14 Days)||4
448256|NCT01328444|1098858|P5|NOT COMPLETED|Washout Period (14 Days)||1
448257|NCT01328444|1098859|P4|NOT COMPLETED|Washout Period (14 Days)||1
448258|NCT01328444|1098860|P3|NOT COMPLETED|Washout Period (14 Days)||0
448259|NCT01328444|1098861|P2|NOT COMPLETED|Washout Period (14 Days)||1
448260|NCT01328444|1098862|P1|NOT COMPLETED|Washout Period (14 Days)||1
448261|NCT01328444|1098857|P6|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|68
448262|NCT01328444|1098858|P5|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|66
448263|NCT01328444|1098859|P4|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|32
448264|NCT01328444|1098860|P3|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|25
448265|NCT01328444|1098861|P2|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
448266|NCT01328444|1098862|P1|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|82
448267|NCT01328444|1098857|P6|STARTED|Washout Period (14 Days)||72
448268|NCT01328444|1098858|P5|STARTED|Washout Period (14 Days)||67
448269|NCT01328444|1098859|P4|STARTED|Washout Period (14 Days)||33
448270|NCT01328444|1098860|P3|STARTED|Washout Period (14 Days)||25
448271|NCT01328444|1098861|P2|STARTED|Washout Period (14 Days)||21
448272|NCT01328444|1098862|P1|STARTED|Washout Period (14 Days)||83
448273|NCT01328444|1098857|P6|NOT COMPLETED|Treatment Period 1 (12 Weeks)||6
448274|NCT01328444|1098858|P5|NOT COMPLETED|Treatment Period 1 (12 Weeks)||14
448275|NCT01328444|1098859|P4|NOT COMPLETED|Treatment Period 1 (12 Weeks)||8
448276|NCT01328444|1098860|P3|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3
448277|NCT01328444|1098861|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
448278|NCT01328444|1098862|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||11
448279|NCT01328444|1098857|P6|COMPLETED|Treatment Period 1 (12 Weeks)||72
448280|NCT01328444|1098858|P5|COMPLETED|Treatment Period 1 (12 Weeks)||67
448281|NCT01328444|1098859|P4|COMPLETED|Treatment Period 1 (12 Weeks)||33
448282|NCT01328444|1098860|P3|COMPLETED|Treatment Period 1 (12 Weeks)||25
448283|NCT01328444|1098861|P2|COMPLETED|Treatment Period 1 (12 Weeks)||21
448284|NCT01328444|1098862|P1|COMPLETED|Treatment Period 1 (12 Weeks)||83
448285|NCT01328444|1098857|P6|STARTED|Treatment Period 1 (12 Weeks)||78
448286|NCT01328444|1098858|P5|STARTED|Treatment Period 1 (12 Weeks)||81
448287|NCT01328444|1098859|P4|STARTED|Treatment Period 1 (12 Weeks)||41
448288|NCT01328444|1098860|P3|STARTED|Treatment Period 1 (12 Weeks)||28
448289|NCT01328444|1098861|P2|STARTED|Treatment Period 1 (12 Weeks)||26
448290|NCT01328444|1098862|P1|STARTED|Treatment Period 1 (12 Weeks)||94
448291|NCT01328431|1098908|P2|NOT COMPLETED|12 Month (12M)||97
448292|NCT01328431|1098909|P1|NOT COMPLETED|12 Month (12M)||84
448293|NCT01328431|1098908|P2|COMPLETED|12 Month (12M)||289
448294|NCT01328431|1098909|P1|COMPLETED|12 Month (12M)||304
448295|NCT01328431|1098908|P2|STARTED|12 Month (12M)|Attempted to contact all subjects at 12M follow-up. Deceased subjects excluded.|386
448296|NCT01328431|1098909|P1|STARTED|12 Month (12M)|Attempted to contact all subjects at 12M follow-up. Deceased subjects excluded.|388
448297|NCT01328431|1098908|P2|NOT COMPLETED|3 Month (3M)||72
448298|NCT01328431|1098909|P1|NOT COMPLETED|3 Month (3M)||77
448299|NCT01328431|1098908|P2|COMPLETED|3 Month (3M)||316
448300|NCT01328431|1098909|P1|COMPLETED|3 Month (3M)||313
448301|NCT01328431|1098908|P2|STARTED|3 Month (3M)|Attempted to contact all subjects for 3M follow-up, regardless of whether they completed 1M.|388
448302|NCT01328431|1098909|P1|STARTED|3 Month (3M)|Attempted to contact all subjects for 3M follow-up, regardless of whether they completed 1M.|390
448303|NCT01328431|1098908|P2|NOT COMPLETED|1 Month (1M)||58
448304|NCT01328431|1098909|P1|NOT COMPLETED|1 Month (1M)||55
448305|NCT01328431|1098908|P2|COMPLETED|1 Month (1M)||330
448306|NCT01328431|1098909|P1|COMPLETED|1 Month (1M)||335
448307|NCT01328431|1098908|P2|STARTED|1 Month (1M)||388
448308|NCT01328431|1098909|P1|STARTED|1 Month (1M)||390
448309|NCT01328431|1098908|P2|NOT COMPLETED|Baseline||2
448310|NCT01328431|1098909|P1|NOT COMPLETED|Baseline||0
448311|NCT01328431|1098908|P2|COMPLETED|Baseline|Two subjects enrolled in study twice. Protocol violation.|388
448312|NCT01328431|1098909|P1|COMPLETED|Baseline||390
448313|NCT01328431|1098908|P2|STARTED|Baseline||390
448314|NCT01328431|1098909|P1|STARTED|Baseline||390
448315|NCT01328405|1098919|P2|NOT COMPLETED|Overall Study||0
448316|NCT01328405|1098920|P1|NOT COMPLETED|Overall Study||0
448317|NCT01328405|1098919|P2|COMPLETED|Overall Study||48
448318|NCT01328405|1098920|P1|COMPLETED|Overall Study||52
448319|NCT01328405|1098919|P2|STARTED|Overall Study||48
448320|NCT01328405|1098920|P1|STARTED|Overall Study||52
448321|NCT01328379|1098937|P3|NOT COMPLETED|Overall Study||0
448322|NCT01328379|1098938|P2|NOT COMPLETED|Overall Study||0
448323|NCT01328379|1098939|P1|NOT COMPLETED|Overall Study||1
448324|NCT01328379|1098937|P3|COMPLETED|Overall Study||143
448325|NCT01328379|1098938|P2|COMPLETED|Overall Study||144
448326|NCT01328379|1098939|P1|COMPLETED|Overall Study||142
448327|NCT01328379|1098937|P3|STARTED|Overall Study||143
448328|NCT01328379|1098938|P2|STARTED|Overall Study||144
448329|NCT01328379|1098939|P1|STARTED|Overall Study||143
448330|NCT01328366|1098965|P1|NOT COMPLETED|Overall Study||10
448331|NCT01328366|1098965|P1|COMPLETED|Overall Study||143
448332|NCT01328366|1098965|P1|STARTED|Overall Study||153
448333|NCT01328184|1098983|P1|NOT COMPLETED|Overall Study||0
448334|NCT01328184|1098983|P1|COMPLETED|Overall Study||18
448335|NCT01328184|1098983|P1|STARTED|Overall Study||18
448336|NCT01328158|1099023|P1|NOT COMPLETED|Overall Study||0
448337|NCT01328158|1099023|P1|COMPLETED|Overall Study||220
448338|NCT01328158|1099023|P1|STARTED|Overall Study||220
448339|NCT01328080|1099061|P1|NOT COMPLETED|Overall Study||5
448340|NCT01328080|1099061|P1|COMPLETED|Overall Study||6
448341|NCT01328080|1099061|P1|STARTED|Overall Study|11 subjects consented; 1 withdrew consent before first UVB treatment|11
448342|NCT01328054|1099065|P2|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||5
448343|NCT01328054|1099066|P1|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0
448344|NCT01328054|1099065|P2|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||53
448345|NCT01328054|1099066|P1|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0
448346|NCT01328054|1099065|P2|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)|One par. was double dosed with lapatinib due to a dosing error - reason for difference in # Started.|58
448347|NCT01328054|1099066|P1|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)||0
448348|NCT01328054|1099065|P2|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
448349|NCT01328054|1099066|P1|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
448350|NCT01328054|1099065|P2|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
448351|NCT01328054|1099066|P1|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||57
448352|NCT01328054|1099065|P2|STARTED|Placebo on Day 1 and Day 2 (2 Days)||0
448353|NCT01328054|1099066|P1|STARTED|Placebo on Day 1 and Day 2 (2 Days)||57
448354|NCT01328041|1099091|P1|NOT COMPLETED|Overall Study||57
448355|NCT01328041|1099091|P1|COMPLETED|Overall Study||126
448356|NCT01328041|1099091|P1|STARTED|Overall Study||183
448357|NCT01327989|1099113|P1|NOT COMPLETED|Overall Study||14
448358|NCT01327989|1099113|P1|COMPLETED|Overall Study||188
448359|NCT01327989|1099113|P1|STARTED|Overall Study||202
448360|NCT01327976|1099127|P2|NOT COMPLETED|Overall Study||7
448361|NCT01327976|1099128|P1|NOT COMPLETED|Overall Study||8
448362|NCT01327976|1099127|P2|COMPLETED|Overall Study||70
448363|NCT01327976|1099128|P1|COMPLETED|Overall Study||154
448364|NCT01327976|1099127|P2|STARTED|Overall Study||77
448365|NCT01327976|1099128|P1|STARTED|Overall Study||162
448366|NCT01327885|1099140|P2|NOT COMPLETED|Overall Study||224
448367|NCT01327885|1099141|P1|NOT COMPLETED|Overall Study||228
448368|NCT01327885|1099140|P2|COMPLETED|Overall Study||0
448369|NCT01327885|1099141|P1|COMPLETED|Overall Study||0
448370|NCT01327885|1099140|P2|STARTED|Overall Study||224
448371|NCT01327885|1099141|P1|STARTED|Overall Study||228
448372|NCT01327703|1099153|P2|NOT COMPLETED|Second Treatment Period||2
448373|NCT01327703|1099154|P1|NOT COMPLETED|Second Treatment Period||1
448374|NCT01327703|1099153|P2|COMPLETED|Second Treatment Period||42
448375|NCT01327703|1099154|P1|COMPLETED|Second Treatment Period||39
448376|NCT01327703|1099153|P2|STARTED|Second Treatment Period|One participant discontinued between first and second treatment periods due to adverse event.|44
448377|NCT01327703|1099154|P1|STARTED|Second Treatment Period|Two participants discontinued between first and second treatment periods due to adverse event.|40
448378|NCT01327703|1099153|P2|NOT COMPLETED|First Treatment Period||0
448379|NCT01327703|1099154|P1|NOT COMPLETED|First Treatment Period||0
448380|NCT01327703|1099153|P2|COMPLETED|First Treatment Period||45
448381|NCT01327703|1099154|P1|COMPLETED|First Treatment Period||42
448382|NCT01327703|1099153|P2|STARTED|First Treatment Period||45
448383|NCT01327703|1099154|P1|STARTED|First Treatment Period||42
448384|NCT01327677|1099188|P2|NOT COMPLETED|Overall Study||13
448385|NCT01327677|1099189|P1|NOT COMPLETED|Overall Study||20
448386|NCT01327677|1099188|P2|COMPLETED|Overall Study||56
448387|NCT01327677|1099189|P1|COMPLETED|Overall Study||48
448388|NCT01327677|1099188|P2|STARTED|Overall Study||69
448389|NCT01327677|1099189|P1|STARTED|Overall Study||68
448390|NCT01327651|1099210|P9|NOT COMPLETED|Post Study Follow-up||2
448391|NCT01327651|1099211|P8|NOT COMPLETED|Post Study Follow-up||1
448392|NCT01327651|1099212|P7|NOT COMPLETED|Post Study Follow-up||4
448393|NCT01327651|1099213|P6|NOT COMPLETED|Post Study Follow-up||0
448394|NCT01327651|1099214|P5|NOT COMPLETED|Post Study Follow-up||0
448395|NCT01327651|1099215|P4|NOT COMPLETED|Post Study Follow-up||0
448396|NCT01327651|1099216|P3|NOT COMPLETED|Post Study Follow-up||1
448397|NCT01327651|1099217|P2|NOT COMPLETED|Post Study Follow-up||1
448398|NCT01327651|1099218|P1|NOT COMPLETED|Post Study Follow-up||0
448399|NCT01327651|1099210|P9|COMPLETED|Post Study Follow-up||47
448400|NCT01327651|1099211|P8|COMPLETED|Post Study Follow-up||49
448401|NCT01327651|1099212|P7|COMPLETED|Post Study Follow-up||45
448402|NCT01327651|1099213|P6|COMPLETED|Post Study Follow-up||59
448403|NCT01327651|1099214|P5|COMPLETED|Post Study Follow-up||56
448404|NCT01327651|1099215|P4|COMPLETED|Post Study Follow-up||57
448405|NCT01327651|1099216|P3|COMPLETED|Post Study Follow-up||55
448406|NCT01327651|1099217|P2|COMPLETED|Post Study Follow-up||55
448407|NCT01327651|1099218|P1|COMPLETED|Post Study Follow-up||56
448408|NCT01327651|1099210|P9|STARTED|Post Study Follow-up||49
448409|NCT01327651|1099211|P8|STARTED|Post Study Follow-up||50
448410|NCT01327651|1099212|P7|STARTED|Post Study Follow-up||49
448411|NCT01327651|1099213|P6|STARTED|Post Study Follow-up||59
448412|NCT01327651|1099214|P5|STARTED|Post Study Follow-up||56
448413|NCT01327651|1099215|P4|STARTED|Post Study Follow-up||57
448414|NCT01327651|1099216|P3|STARTED|Post Study Follow-up||56
448415|NCT01327651|1099217|P2|STARTED|Post Study Follow-up||56
448416|NCT01327651|1099218|P1|STARTED|Post Study Follow-up||56
448417|NCT01327651|1099210|P9|NOT COMPLETED|Self-administered Dosing Period||11
448418|NCT01327651|1099211|P8|NOT COMPLETED|Self-administered Dosing Period||10
448419|NCT01327651|1099212|P7|NOT COMPLETED|Self-administered Dosing Period||10
448420|NCT01327651|1099213|P6|NOT COMPLETED|Self-administered Dosing Period||0
448421|NCT01327651|1099214|P5|NOT COMPLETED|Self-administered Dosing Period||3
448422|NCT01327651|1099215|P4|NOT COMPLETED|Self-administered Dosing Period||3
448423|NCT01327651|1099216|P3|NOT COMPLETED|Self-administered Dosing Period||4
448424|NCT01327651|1099217|P2|NOT COMPLETED|Self-administered Dosing Period||3
448425|NCT01327651|1099218|P1|NOT COMPLETED|Self-administered Dosing Period||4
448426|NCT01327651|1099210|P9|COMPLETED|Self-administered Dosing Period||49
448427|NCT01327651|1099211|P8|COMPLETED|Self-administered Dosing Period||50
448428|NCT01327651|1099212|P7|COMPLETED|Self-administered Dosing Period||49
448429|NCT01327651|1099213|P6|COMPLETED|Self-administered Dosing Period||59
448430|NCT01327651|1099214|P5|COMPLETED|Self-administered Dosing Period||56
448431|NCT01327651|1099215|P4|COMPLETED|Self-administered Dosing Period||57
448432|NCT01327651|1099216|P3|COMPLETED|Self-administered Dosing Period||56
448433|NCT01327651|1099217|P2|COMPLETED|Self-administered Dosing Period||56
448434|NCT01327651|1099218|P1|COMPLETED|Self-administered Dosing Period||56
448435|NCT01327651|1099210|P9|Week 26|Self-administered Dosing Period||49
448436|NCT01327651|1099211|P8|Week 26|Self-administered Dosing Period||51
448437|NCT01327651|1099212|P7|Week 26|Self-administered Dosing Period||50
448438|NCT01327651|1099213|P6|Week 26|Self-administered Dosing Period||58
448439|NCT01327651|1099214|P5|Week 26|Self-administered Dosing Period||56
448440|NCT01327651|1099215|P4|Week 26|Self-administered Dosing Period||57
448441|NCT01327651|1099216|P3|Week 26|Self-administered Dosing Period||53
448442|NCT01327651|1099217|P2|Week 26|Self-administered Dosing Period||56
448443|NCT01327651|1099218|P1|Week 26|Self-administered Dosing Period||58
448444|NCT01327651|1099210|P9|Week 22|Self-administered Dosing Period||51
448445|NCT01327651|1099211|P8|Week 22|Self-administered Dosing Period||50
448446|NCT01327651|1099212|P7|Week 22|Self-administered Dosing Period||50
448447|NCT01327651|1099213|P6|Week 22|Self-administered Dosing Period||59
448448|NCT01327651|1099214|P5|Week 22|Self-administered Dosing Period||56
448449|NCT01327651|1099215|P4|Week 22|Self-administered Dosing Period||58
448450|NCT01327651|1099216|P3|Week 22|Self-administered Dosing Period||55
448451|NCT01327651|1099217|P2|Week 22|Self-administered Dosing Period||56
448452|NCT01327651|1099218|P1|Week 22|Self-administered Dosing Period||59
448453|NCT01327651|1099210|P9|Week 18|Self-administered Dosing Period||53
448454|NCT01327651|1099211|P8|Week 18|Self-administered Dosing Period||49
448455|NCT01327651|1099212|P7|Week 18|Self-administered Dosing Period||53
448456|NCT01327651|1099213|P6|Week 18|Self-administered Dosing Period||59
448457|NCT01327651|1099214|P5|Week 18|Self-administered Dosing Period||57
448458|NCT01327651|1099215|P4|Week 18|Self-administered Dosing Period||60
448459|NCT01327651|1099216|P3|Week 18|Self-administered Dosing Period||56
448460|NCT01327651|1099217|P2|Week 18|Self-administered Dosing Period||56
448461|NCT01327651|1099218|P1|Week 18|Self-administered Dosing Period||57
448462|NCT01327651|1099210|P9|Week 14|Self-administered Dosing Period||54
448463|NCT01327651|1099211|P8|Week 14|Self-administered Dosing Period||51
448464|NCT01327651|1099212|P7|Week 14|Self-administered Dosing Period||54
448465|NCT01327651|1099213|P6|Week 14|Self-administered Dosing Period||59
448466|NCT01327651|1099214|P5|Week 14|Self-administered Dosing Period||58
448467|NCT01327651|1099215|P4|Week 14|Self-administered Dosing Period||60
448468|NCT01327651|1099216|P3|Week 14|Self-administered Dosing Period||57
448469|NCT01327651|1099217|P2|Week 14|Self-administered Dosing Period||55
448470|NCT01327651|1099218|P1|Week 14|Self-administered Dosing Period||59
448471|NCT01327651|1099210|P9|Week 10|Self-administered Dosing Period||56
448472|NCT01327651|1099211|P8|Week 10|Self-administered Dosing Period||57
448473|NCT01327651|1099212|P7|Week 10|Self-administered Dosing Period||57
448474|NCT01327651|1099213|P6|Week 10|Self-administered Dosing Period||59
448475|NCT01327651|1099214|P5|Week 10|Self-administered Dosing Period||59
448476|NCT01327651|1099215|P4|Week 10|Self-administered Dosing Period||60
448477|NCT01327651|1099216|P3|Week 10|Self-administered Dosing Period||60
448478|NCT01327651|1099217|P2|Week 10|Self-administered Dosing Period||58
448479|NCT01327651|1099218|P1|Week 10|Self-administered Dosing Period||59
448480|NCT01327651|1099210|P9|STARTED|Self-administered Dosing Period||60
448481|NCT01327651|1099211|P8|STARTED|Self-administered Dosing Period||60
448482|NCT01327651|1099212|P7|STARTED|Self-administered Dosing Period||59
448483|NCT01327651|1099213|P6|STARTED|Self-administered Dosing Period||59
448484|NCT01327651|1099214|P5|STARTED|Self-administered Dosing Period||59
448485|NCT01327651|1099215|P4|STARTED|Self-administered Dosing Period||60
448486|NCT01327651|1099216|P3|STARTED|Self-administered Dosing Period||60
448487|NCT01327651|1099217|P2|STARTED|Self-administered Dosing Period||59
448488|NCT01327651|1099218|P1|STARTED|Self-administered Dosing Period||60
448489|NCT01327599|1099337|P1|NOT COMPLETED|Overall Study||3
448490|NCT01327599|1099337|P1|COMPLETED|Overall Study||57
448491|NCT01327599|1099337|P1|STARTED|Overall Study||60
448492|NCT01327547|1099347|P2|NOT COMPLETED|Overall Study||22
448493|NCT01327547|1099348|P1|NOT COMPLETED|Overall Study||20
448494|NCT01327547|1099347|P2|COMPLETED|Overall Study||45
448495|NCT01327547|1099348|P1|COMPLETED|Overall Study||50
448496|NCT01327547|1099347|P2|Randomized and Not Treated|Overall Study|Randomized but was withdrawn prior to receiving treatment due to poor venous access.|1
448497|NCT01327547|1099348|P1|Randomized and Not Treated|Overall Study||0
448498|NCT01327547|1099347|P2|STARTED|Overall Study||67
448499|NCT01327547|1099348|P1|STARTED|Overall Study||70
448500|NCT01327508|1099401|P2|NOT COMPLETED|Overall Study||0
448501|NCT01327508|1099402|P1|NOT COMPLETED|Overall Study||0
448502|NCT01327508|1099401|P2|COMPLETED|Overall Study||30
448503|NCT01327508|1099402|P1|COMPLETED|Overall Study||30
448504|NCT01327508|1099401|P2|STARTED|Overall Study||30
448505|NCT01327508|1099402|P1|STARTED|Overall Study||30
448506|NCT01327495|1099416|P6|NOT COMPLETED|Overall Study||2
448507|NCT01327495|1099417|P5|NOT COMPLETED|Overall Study||3
448508|NCT01327495|1099418|P4|NOT COMPLETED|Overall Study||0
448509|NCT01327495|1099419|P3|NOT COMPLETED|Overall Study||2
448510|NCT01327495|1099420|P2|NOT COMPLETED|Overall Study||2
448511|NCT01327495|1099421|P1|NOT COMPLETED|Overall Study||2
448512|NCT01327495|1099416|P6|COMPLETED|Overall Study|1 subject withdrawn d/t elevated LFTs, 1 dropped out d/t ski accident|9
448513|NCT01327495|1099417|P5|COMPLETED|Overall Study|1 dropped out pre drug finish, 2 non-compliant subjects dropped|8
448514|NCT01327495|1099418|P4|COMPLETED|Overall Study||9
448515|NCT01327495|1099419|P3|COMPLETED|Overall Study|1 withdrawn due to injection AE. 1 drop-out (declined prostate biopsy and final visit).|8
448516|NCT01327495|1099420|P2|COMPLETED|Overall Study|1 subject declined prostate biopsy & no-showed to final visit, 1 subject dropped d/t elevated LFTs.|9
448517|NCT01327495|1099421|P1|COMPLETED|Overall Study|1 dropped due to decreased libido & energy, 1 dropped due to too much pain with acyline injections|8
448518|NCT01327495|1099416|P6|STARTED|Overall Study||11
448519|NCT01327495|1099417|P5|STARTED|Overall Study||11
448520|NCT01327495|1099418|P4|STARTED|Overall Study||9
448521|NCT01327495|1099419|P3|STARTED|Overall Study||10
448522|NCT01327495|1099420|P2|STARTED|Overall Study||11
448523|NCT01327495|1099421|P1|STARTED|Overall Study||10
448524|NCT01327482|1099513|P1|NOT COMPLETED|Overall Study||1
448525|NCT01327482|1099513|P1|COMPLETED|Overall Study|The 10th participant completed 2/3 visits|9
448526|NCT01327482|1099513|P1|STARTED|Overall Study||10
448527|NCT01327339|1099518|P1|NOT COMPLETED|Overall Study||8
448528|NCT01327339|1099518|P1|COMPLETED|Overall Study||747
448529|NCT01327339|1099518|P1|STARTED|Overall Study||755
448530|NCT01327313|1099528|P4|NOT COMPLETED|Overall Study||0
448531|NCT01327313|1099529|P3|NOT COMPLETED|Overall Study||0
448532|NCT01327313|1099530|P2|NOT COMPLETED|Overall Study||0
448533|NCT01327313|1099531|P1|NOT COMPLETED|Overall Study||0
448534|NCT01327313|1099528|P4|COMPLETED|Overall Study||7
448535|NCT01327313|1099529|P3|COMPLETED|Overall Study||6
448536|NCT01327313|1099530|P2|COMPLETED|Overall Study||6
448537|NCT01327313|1099531|P1|COMPLETED|Overall Study||8
448538|NCT01327313|1099528|P4|STARTED|Overall Study||7
448539|NCT01327313|1099529|P3|STARTED|Overall Study||6
448540|NCT01327313|1099530|P2|STARTED|Overall Study||6
448541|NCT01327313|1099531|P1|STARTED|Overall Study||8
448542|NCT01327300|1099653|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
448543|NCT01327300|1099654|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
448544|NCT01327300|1099653|P2|COMPLETED|Second Intervention (12 Weeks)||2
448545|NCT01327300|1099654|P1|COMPLETED|Second Intervention (12 Weeks)||4
448546|NCT01327300|1099653|P2|STARTED|Second Intervention (12 Weeks)||2
448547|NCT01327300|1099654|P1|STARTED|Second Intervention (12 Weeks)||4
448548|NCT01327300|1099653|P2|NOT COMPLETED|Washout (3 Weeks)||0
448549|NCT01327300|1099654|P1|NOT COMPLETED|Washout (3 Weeks)||1
448550|NCT01327300|1099653|P2|COMPLETED|Washout (3 Weeks)||2
448551|NCT01327300|1099654|P1|COMPLETED|Washout (3 Weeks)||4
448552|NCT01327300|1099653|P2|STARTED|Washout (3 Weeks)||2
448553|NCT01327300|1099654|P1|STARTED|Washout (3 Weeks)||5
448554|NCT01327300|1099653|P2|NOT COMPLETED|First Intervention (12 Weeks)||0
448555|NCT01327300|1099654|P1|NOT COMPLETED|First Intervention (12 Weeks)||0
448556|NCT01327300|1099653|P2|COMPLETED|First Intervention (12 Weeks)||2
448557|NCT01327300|1099654|P1|COMPLETED|First Intervention (12 Weeks)||5
448558|NCT01327300|1099653|P2|STARTED|First Intervention (12 Weeks)||2
448559|NCT01327300|1099654|P1|STARTED|First Intervention (12 Weeks)||5
448560|NCT01327274|1099670|P1|NOT COMPLETED|Overall Study||0
448561|NCT01327274|1099670|P1|COMPLETED|Overall Study||15
448562|NCT01327274|1099670|P1|STARTED|Overall Study||15
448563|NCT01327053|1099679|P2|NOT COMPLETED|Overall Study||105
448564|NCT01327053|1099680|P1|NOT COMPLETED|Overall Study||40
448565|NCT01327053|1099679|P2|COMPLETED|Overall Study|Completed = patients ongoing at time of cut-off date (28-Jun-2013)|46
448566|NCT01327053|1099680|P1|COMPLETED|Overall Study|Completed = patients ongoing at time of cut-off date (28-Jun-2013)|39
448567|NCT01327053|1099679|P2|STARTED|Overall Study||151
448568|NCT01327053|1099680|P1|STARTED|Overall Study||79
448569|NCT01326962|1099708|P1|NOT COMPLETED|Overall Study||7
448570|NCT01326962|1099708|P1|COMPLETED|Overall Study||21
448571|NCT01326962|1099708|P1|STARTED|Overall Study||28
448572|NCT01326910|1099726|P2|NOT COMPLETED|Overall Study||3
448573|NCT01326910|1099727|P1|NOT COMPLETED|Overall Study||4
448574|NCT01326910|1099726|P2|COMPLETED|Overall Study||42
448575|NCT01326910|1099727|P1|COMPLETED|Overall Study||41
448576|NCT01326910|1099726|P2|STARTED|Overall Study||45
448577|NCT01326910|1099727|P1|STARTED|Overall Study||45
448578|NCT01326845|1099741|P2|NOT COMPLETED|Overall Study||5
448579|NCT01326845|1099742|P1|NOT COMPLETED|Overall Study||7
448580|NCT01326845|1099741|P2|COMPLETED|Overall Study|Study terminated early|0
448581|NCT01326845|1099742|P1|COMPLETED|Overall Study|Study terminated early|0
448582|NCT01326845|1099741|P2|STARTED|Overall Study||5
448583|NCT01326845|1099742|P1|STARTED|Overall Study||7
448584|NCT01326728|1099766|P2|NOT COMPLETED|Overall Study||9
448585|NCT01326728|1099767|P1|NOT COMPLETED|Overall Study||47
448586|NCT01326728|1099766|P2|COMPLETED|Overall Study||0
448587|NCT01326728|1099767|P1|COMPLETED|Overall Study||0
448588|NCT01326728|1099766|P2|STARTED|Overall Study||9
448589|NCT01326728|1099767|P1|STARTED|Overall Study||47
448590|NCT01326533|1099786|P2|NOT COMPLETED|Overall Study||0
448591|NCT01326533|1099787|P1|NOT COMPLETED|Overall Study||4
448592|NCT01326533|1099786|P2|COMPLETED|Overall Study||15
448593|NCT01326533|1099787|P1|COMPLETED|Overall Study||13
448594|NCT01326533|1099786|P2|STARTED|Overall Study||15
448595|NCT01326533|1099787|P1|STARTED|Overall Study||17
448596|NCT01326026|1099797|P2|NOT COMPLETED|Overall Study||13
448597|NCT01326026|1099798|P1|NOT COMPLETED|Overall Study||12
448598|NCT01326026|1099797|P2|COMPLETED|Overall Study||98
448599|NCT01326026|1099798|P1|COMPLETED|Overall Study||99
448600|NCT01326026|1099797|P2|Exposed|Overall Study||111
448601|NCT01326026|1099798|P1|Exposed|Overall Study|One subject withdrew before exposure to trial drug|110
448602|NCT01326026|1099797|P2|STARTED|Overall Study||111
448603|NCT01326026|1099798|P1|STARTED|Overall Study||111
448604|NCT01325870|1099815|P3|NOT COMPLETED|Overall Study||8
448605|NCT01325870|1099816|P2|NOT COMPLETED|Overall Study||13
448606|NCT01325870|1099817|P1|NOT COMPLETED|Overall Study||11
448607|NCT01325870|1099815|P3|COMPLETED|Overall Study||6
448608|NCT01325870|1099816|P2|COMPLETED|Overall Study||3
448609|NCT01325870|1099817|P1|COMPLETED|Overall Study||7
448610|NCT01325870|1099815|P3|STARTED|Overall Study||14
448611|NCT01325870|1099816|P2|STARTED|Overall Study||16
448612|NCT01325870|1099817|P1|STARTED|Overall Study||18
448613|NCT01325792|1099831|P1|NOT COMPLETED|Overall Study||17
448614|NCT01325792|1099831|P1|COMPLETED|Overall Study||87
448615|NCT01325792|1099831|P1|STARTED|Overall Study||104
448616|NCT01325714|1099838|P2|NOT COMPLETED|Overall Study||31
448617|NCT01325714|1099839|P1|NOT COMPLETED|Overall Study||34
448618|NCT01325714|1099838|P2|COMPLETED|Overall Study||71
448619|NCT01325714|1099839|P1|COMPLETED|Overall Study||67
448620|NCT01325714|1099838|P2|12 Month Assessment|Overall Study||71
448621|NCT01325714|1099839|P1|12 Month Assessment|Overall Study||67
448622|NCT01325714|1099838|P2|6 Month Asessment|Overall Study||82
448623|NCT01325714|1099839|P1|6 Month Asessment|Overall Study||75
448624|NCT01325714|1099838|P2|3 Month Assessment|Overall Study||86
448625|NCT01325714|1099839|P1|3 Month Assessment|Overall Study||82
448626|NCT01325714|1099838|P2|STARTED|Overall Study||102
448627|NCT01325714|1099839|P1|STARTED|Overall Study||101
448628|NCT01325701|1099863|P2|NOT COMPLETED|Overall Study||3
448629|NCT01325701|1099864|P1|NOT COMPLETED|Overall Study||21
448630|NCT01325701|1099863|P2|COMPLETED|Overall Study||5
448631|NCT01325701|1099864|P1|COMPLETED|Overall Study||49
448632|NCT01325701|1099863|P2|STARTED|Overall Study||8
448633|NCT01325701|1099864|P1|STARTED|Overall Study||70
448634|NCT01325623|1099874|P1|NOT COMPLETED|Overall Study||3
448635|NCT01325623|1099874|P1|COMPLETED|Overall Study||28
448636|NCT01325623|1099874|P1|STARTED|Overall Study||31
448637|NCT01325584|1099916|P1|NOT COMPLETED|Overall Study||1
448638|NCT01325584|1099916|P1|COMPLETED|Overall Study||11
448639|NCT01325584|1099916|P1|STARTED|Overall Study||12
448640|NCT01325532|1099926|P2|NOT COMPLETED|Overall Study||0
448641|NCT01325532|1099927|P1|NOT COMPLETED|Overall Study||2
448642|NCT01325532|1099926|P2|COMPLETED|Overall Study||13
448643|NCT01325532|1099927|P1|COMPLETED|Overall Study||15
448644|NCT01325532|1099926|P2|STARTED|Overall Study||13
448645|NCT01325532|1099927|P1|STARTED|Overall Study||17
448646|NCT01325493|1099939|P2|NOT COMPLETED|Overall Study||3
448647|NCT01325493|1099940|P1|NOT COMPLETED|Overall Study||1
448648|NCT01325493|1099939|P2|COMPLETED|Overall Study||21
448649|NCT01325493|1099940|P1|COMPLETED|Overall Study||29
448650|NCT01325493|1099939|P2|STARTED|Overall Study||24
448651|NCT01325493|1099940|P1|STARTED|Overall Study||30
448652|NCT01325428|1099952|P1|NOT COMPLETED|Part B||3
448653|NCT01325428|1099952|P1|COMPLETED|Part B||7
448654|NCT01325428|1099952|P1|STARTED|Part B||10
448655|NCT01325428|1099952|P1|NOT COMPLETED|Part A||16
448656|NCT01325428|1099952|P1|COMPLETED|Part A||10
448657|NCT01325428|1099952|P1|STARTED|Part A||26
448658|NCT01325350|1099972|P5|NOT COMPLETED|Overall Study||12
448659|NCT01325350|1099973|P4|NOT COMPLETED|Overall Study||9
448660|NCT01325350|1099974|P3|NOT COMPLETED|Overall Study||17
448661|NCT01325350|1099975|P2|NOT COMPLETED|Overall Study||5
448662|NCT01325350|1099976|P1|NOT COMPLETED|Overall Study||6
448663|NCT01325350|1099972|P5|COMPLETED|Overall Study||50
448664|NCT01325350|1099973|P4|COMPLETED|Overall Study||52
448665|NCT01325350|1099974|P3|COMPLETED|Overall Study||44
448666|NCT01325350|1099975|P2|COMPLETED|Overall Study||56
448667|NCT01325350|1099976|P1|COMPLETED|Overall Study||55
448668|NCT01325350|1099972|P5|STARTED|Overall Study||62
448669|NCT01325350|1099973|P4|STARTED|Overall Study||61
448670|NCT01325350|1099974|P3|STARTED|Overall Study||61
448671|NCT01325350|1099975|P2|STARTED|Overall Study||61
448672|NCT01325350|1099976|P1|STARTED|Overall Study||61
448673|NCT01325337|1100018|P5|NOT COMPLETED|Overall Study||8
448674|NCT01325337|1100019|P4|NOT COMPLETED|Overall Study||10
448675|NCT01325337|1100020|P3|NOT COMPLETED|Overall Study||9
448676|NCT01325337|1100021|P2|NOT COMPLETED|Overall Study||9
448677|NCT01325337|1100022|P1|NOT COMPLETED|Overall Study||5
448678|NCT01325337|1100018|P5|COMPLETED|Overall Study||53
448679|NCT01325337|1100019|P4|COMPLETED|Overall Study||52
448680|NCT01325337|1100020|P3|COMPLETED|Overall Study||53
448681|NCT01325337|1100021|P2|COMPLETED|Overall Study||52
448682|NCT01325337|1100022|P1|COMPLETED|Overall Study||56
448683|NCT01325337|1100018|P5|STARTED|Overall Study||61
448684|NCT01325337|1100019|P4|STARTED|Overall Study||62
448685|NCT01325337|1100020|P3|STARTED|Overall Study||62
448686|NCT01325337|1100021|P2|STARTED|Overall Study||61
448687|NCT01325337|1100022|P1|STARTED|Overall Study||61
448688|NCT01325311|1100061|P2|NOT COMPLETED|Overall Study||0
448689|NCT01325311|1100062|P1|NOT COMPLETED|Overall Study||0
448690|NCT01325311|1100061|P2|COMPLETED|Overall Study||7
448691|NCT01325311|1100062|P1|COMPLETED|Overall Study||8
448692|NCT01325311|1100061|P2|STARTED|Overall Study||7
448693|NCT01325311|1100062|P1|STARTED|Overall Study||8
448694|NCT01325181|1100098|P2|NOT COMPLETED|Overall Study||2
448695|NCT01325181|1100099|P1|NOT COMPLETED|Overall Study||0
448696|NCT01325181|1100098|P2|COMPLETED|Overall Study||14
448697|NCT01325181|1100099|P1|COMPLETED|Overall Study||18
448698|NCT01325181|1100098|P2|STARTED|Overall Study||16
448699|NCT01325181|1100099|P1|STARTED|Overall Study||18
448700|NCT01324999|1100105|P1|NOT COMPLETED|Overall Study||5
448701|NCT01324999|1100105|P1|COMPLETED|Overall Study||7
448702|NCT01324999|1100105|P1|STARTED|Overall Study||12
448703|NCT01324947|1100116|P1|NOT COMPLETED|Overall Study||74
448704|NCT01324947|1100116|P1|COMPLETED|Overall Study||0
448705|NCT01324947|1100116|P1|Efficacy Evaluable Population (EEP)|Overall Study|Participants who received ≥ 1 dose of study drug and had at least 1 postbaseline efficacy assessment|64
448706|NCT01324947|1100116|P1|Safety Population|Overall Study|Safety Population includes those who were enrolled and received at least one dose of study drug|73
448707|NCT01324947|1100116|P1|STARTED|Overall Study||74
448708|NCT01324882|1100129|P2|NOT COMPLETED|Overall Study||0
448709|NCT01324882|1100130|P1|NOT COMPLETED|Overall Study||0
448710|NCT01324882|1100129|P2|COMPLETED|Overall Study|30 patients had the colonoscopy|30
448711|NCT01324882|1100130|P1|COMPLETED|Overall Study|27 patients had the colonoscopy|27
448712|NCT01324882|1100129|P2|STARTED|Overall Study|30 patients were randomized to this arm|30
448713|NCT01324882|1100130|P1|STARTED|Overall Study|27 patients were randomized to this arm.|27
448714|NCT01324700|1100142|P4|NOT COMPLETED|Overall Study||11
448715|NCT01324700|1100143|P3|NOT COMPLETED|Overall Study||16
448716|NCT01324700|1100144|P2|NOT COMPLETED|Overall Study||4
448717|NCT01324700|1100145|P1|NOT COMPLETED|Overall Study||9
448718|NCT01324700|1100142|P4|COMPLETED|Overall Study||37
448719|NCT01324700|1100143|P3|COMPLETED|Overall Study||33
448720|NCT01324700|1100144|P2|COMPLETED|Overall Study||16
448721|NCT01324700|1100145|P1|COMPLETED|Overall Study||13
448722|NCT01324700|1100142|P4|STARTED|Overall Study||48
448723|NCT01324700|1100143|P3|STARTED|Overall Study||49
448724|NCT01324700|1100144|P2|STARTED|Overall Study||20
448725|NCT01324700|1100145|P1|STARTED|Overall Study||22
448726|NCT01324687|1100161|P2|NOT COMPLETED|Overall Study||15
448727|NCT01324687|1100162|P1|NOT COMPLETED|Overall Study||0
448728|NCT01324687|1100161|P2|COMPLETED|Overall Study||479
448729|NCT01324687|1100162|P1|COMPLETED|Overall Study||1058
448730|NCT01324687|1100161|P2|STARTED|Overall Study||494
448731|NCT01324687|1100162|P1|STARTED|Overall Study||1058
448732|NCT01324622|1100172|P2|NOT COMPLETED|Overall Study||7
448733|NCT01324622|1100173|P1|NOT COMPLETED|Overall Study||9
448734|NCT01324622|1100172|P2|COMPLETED|Overall Study||4
448735|NCT01324622|1100173|P1|COMPLETED|Overall Study||4
448736|NCT01324622|1100172|P2|STARTED|Overall Study||11
448737|NCT01324622|1100173|P1|STARTED|Overall Study||13
448738|NCT01324570|1100203|P2|NOT COMPLETED|Overall Study||14
448739|NCT01324570|1100204|P1|NOT COMPLETED|Overall Study||4
448740|NCT01324570|1100203|P2|COMPLETED|Overall Study||21
448741|NCT01324570|1100204|P1|COMPLETED|Overall Study||2
448742|NCT01324570|1100203|P2|STARTED|Overall Study||35
448743|NCT01324570|1100204|P1|STARTED|Overall Study||6
448744|NCT01324453|1100218|P2|NOT COMPLETED|Overall Study||0
448745|NCT01324453|1100219|P1|NOT COMPLETED|Overall Study||0
448746|NCT01324453|1100218|P2|COMPLETED|Overall Study||49
448747|NCT01324453|1100219|P1|COMPLETED|Overall Study||54
448748|NCT01324453|1100218|P2|STARTED|Overall Study||49
448749|NCT01324453|1100219|P1|STARTED|Overall Study||54
448750|NCT01324440|1100241|P2|NOT COMPLETED|Overall Study||1
448751|NCT01324440|1100242|P1|NOT COMPLETED|Overall Study||0
448752|NCT01324440|1100241|P2|COMPLETED|Overall Study||31
448753|NCT01324440|1100242|P1|COMPLETED|Overall Study||32
448754|NCT01324440|1100241|P2|STARTED|Overall Study||32
448755|NCT01324440|1100242|P1|STARTED|Overall Study||32
448756|NCT01324401|1100256|P2|NOT COMPLETED|Overall Study||6
448757|NCT01324401|1100257|P1|NOT COMPLETED|Overall Study||1
448758|NCT01324401|1100256|P2|COMPLETED|Overall Study|three (3) unable to complete due to adverse events|20
448759|NCT01324401|1100257|P1|COMPLETED|Overall Study|one (1) could not tolerate minimum starting dose|3
448760|NCT01324401|1100256|P2|STARTED|Overall Study|3 excluded from ITT analysis: 1 screen fail, 2 voluntary withdrawal pre-treatment|26
448761|NCT01324401|1100257|P1|STARTED|Overall Study||4
448762|NCT01324388|1100268|P4|NOT COMPLETED|Part 2 of Study: Second Intervention||0
448763|NCT01324388|1100269|P3|NOT COMPLETED|Part 2 of Study: Second Intervention||1
448764|NCT01324388|1100270|P2|NOT COMPLETED|Part 2 of Study: Second Intervention||0
448765|NCT01324388|1100271|P1|NOT COMPLETED|Part 2 of Study: Second Intervention||0
448766|NCT01324388|1100268|P4|COMPLETED|Part 2 of Study: Second Intervention||9
448767|NCT01324388|1100269|P3|COMPLETED|Part 2 of Study: Second Intervention||9
448768|NCT01324388|1100270|P2|COMPLETED|Part 2 of Study: Second Intervention||0
448769|NCT01324388|1100271|P1|COMPLETED|Part 2 of Study: Second Intervention||0
448770|NCT01324388|1100268|P4|STARTED|Part 2 of Study: Second Intervention||9
448771|NCT01324388|1100269|P3|STARTED|Part 2 of Study: Second Intervention||10
448772|NCT01324388|1100270|P2|STARTED|Part 2 of Study: Second Intervention||0
448773|NCT01324388|1100271|P1|STARTED|Part 2 of Study: Second Intervention||0
448774|NCT01324388|1100268|P4|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
448775|NCT01324388|1100269|P3|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
448776|NCT01324388|1100270|P2|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
448777|NCT01324388|1100271|P1|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
448778|NCT01324388|1100268|P4|COMPLETED|Part 2: Washout of at Least 21 Days||9
448779|NCT01324388|1100269|P3|COMPLETED|Part 2: Washout of at Least 21 Days||10
448780|NCT01324388|1100270|P2|COMPLETED|Part 2: Washout of at Least 21 Days||0
448781|NCT01324388|1100271|P1|COMPLETED|Part 2: Washout of at Least 21 Days||0
448782|NCT01324388|1100268|P4|STARTED|Part 2: Washout of at Least 21 Days||9
448783|NCT01324388|1100269|P3|STARTED|Part 2: Washout of at Least 21 Days||10
448784|NCT01324388|1100270|P2|STARTED|Part 2: Washout of at Least 21 Days||0
448785|NCT01324388|1100271|P1|STARTED|Part 2: Washout of at Least 21 Days||0
448786|NCT01324388|1100268|P4|NOT COMPLETED|Part 2 of Study: First Intervention||1
448787|NCT01324388|1100269|P3|NOT COMPLETED|Part 2 of Study: First Intervention||0
448788|NCT01324388|1100270|P2|NOT COMPLETED|Part 2 of Study: First Intervention||0
448789|NCT01324388|1100271|P1|NOT COMPLETED|Part 2 of Study: First Intervention||0
448790|NCT01324388|1100268|P4|COMPLETED|Part 2 of Study: First Intervention||9
448791|NCT01324388|1100269|P3|COMPLETED|Part 2 of Study: First Intervention||10
448792|NCT01324388|1100270|P2|COMPLETED|Part 2 of Study: First Intervention||0
448793|NCT01324388|1100271|P1|COMPLETED|Part 2 of Study: First Intervention||0
448794|NCT01324388|1100268|P4|STARTED|Part 2 of Study: First Intervention||10
448795|NCT01324388|1100269|P3|STARTED|Part 2 of Study: First Intervention||10
448796|NCT01324388|1100270|P2|STARTED|Part 2 of Study: First Intervention||0
448797|NCT01324388|1100271|P1|STARTED|Part 2 of Study: First Intervention||0
448798|NCT01324388|1100268|P4|NOT COMPLETED|Part 1 of Study||0
448799|NCT01324388|1100269|P3|NOT COMPLETED|Part 1 of Study||0
448800|NCT01324388|1100270|P2|NOT COMPLETED|Part 1 of Study||2
448801|NCT01324388|1100271|P1|NOT COMPLETED|Part 1 of Study||4
448802|NCT01324388|1100268|P4|COMPLETED|Part 1 of Study||0
448803|NCT01324388|1100269|P3|COMPLETED|Part 1 of Study||0
448804|NCT01324388|1100270|P2|COMPLETED|Part 1 of Study||6
448805|NCT01324388|1100271|P1|COMPLETED|Part 1 of Study||19
448806|NCT01324388|1100268|P4|Received at Least 1 Dose|Part 1 of Study||0
448807|NCT01324388|1100269|P3|Received at Least 1 Dose|Part 1 of Study||0
448808|NCT01324388|1100270|P2|Received at Least 1 Dose|Part 1 of Study||8
448809|NCT01324388|1100271|P1|Received at Least 1 Dose|Part 1 of Study||23
448810|NCT01324388|1100268|P4|STARTED|Part 1 of Study||0
448811|NCT01324388|1100269|P3|STARTED|Part 1 of Study||0
448812|NCT01324388|1100270|P2|STARTED|Part 1 of Study||8
448813|NCT01324388|1100271|P1|STARTED|Part 1 of Study||23
448814|NCT01324349|1100292|P2|NOT COMPLETED|Overall Study||2
448815|NCT01324349|1100293|P1|NOT COMPLETED|Overall Study||1
448816|NCT01324349|1100292|P2|COMPLETED|Overall Study||16
448817|NCT01324349|1100293|P1|COMPLETED|Overall Study||31
448818|NCT01324349|1100292|P2|STARTED|Overall Study||18
448819|NCT01324349|1100293|P1|STARTED|Overall Study||32
448820|NCT01324323|1100303|P1|NOT COMPLETED|Overall Study||1
448821|NCT01324323|1100303|P1|COMPLETED|Overall Study||13
448822|NCT01324323|1100303|P1|STARTED|Overall Study||14
448823|NCT01324310|1100323|P1|NOT COMPLETED|Overall Study||2
448824|NCT01324310|1100323|P1|COMPLETED|Overall Study||13
448825|NCT01324310|1100323|P1|STARTED|Overall Study||15
448826|NCT01324271|1100343|P2|NOT COMPLETED|Overall Study||0
448827|NCT01324271|1100344|P1|NOT COMPLETED|Overall Study||4
448828|NCT01324271|1100343|P2|COMPLETED|Overall Study||28
448829|NCT01324271|1100344|P1|COMPLETED|Overall Study||53
448830|NCT01324271|1100343|P2|STARTED|Overall Study||28
448831|NCT01324271|1100344|P1|STARTED|Overall Study||57
448832|NCT01324128|1100352|P4|NOT COMPLETED|Stage 2||3
448833|NCT01324128|1100353|P3|NOT COMPLETED|Stage 2||8
448834|NCT01324128|1100354|P2|NOT COMPLETED|Stage 2||0
448835|NCT01324128|1100355|P1|NOT COMPLETED|Stage 2||0
448836|NCT01324128|1100352|P4|COMPLETED|Stage 2||46
448837|NCT01324128|1100353|P3|COMPLETED|Stage 2||42
448838|NCT01324128|1100354|P2|COMPLETED|Stage 2||0
448839|NCT01324128|1100355|P1|COMPLETED|Stage 2||0
448840|NCT01324128|1100352|P4|STARTED|Stage 2||49
448841|NCT01324128|1100353|P3|STARTED|Stage 2||50
448842|NCT01324128|1100354|P2|STARTED|Stage 2||0
448843|NCT01324128|1100355|P1|STARTED|Stage 2||0
448844|NCT01324128|1100352|P4|NOT COMPLETED|Stage 1||0
448845|NCT01324128|1100353|P3|NOT COMPLETED|Stage 1||0
448846|NCT01324128|1100354|P2|NOT COMPLETED|Stage 1||56
448847|NCT01324128|1100355|P1|NOT COMPLETED|Stage 1||195
448848|NCT01324128|1100352|P4|COMPLETED|Stage 1||0
448849|NCT01324128|1100353|P3|COMPLETED|Stage 1||0
448850|NCT01324128|1100354|P2|COMPLETED|Stage 1||293
448851|NCT01324128|1100355|P1|COMPLETED|Stage 1||515
448852|NCT01324128|1100352|P4|STARTED|Stage 1||0
448853|NCT01324128|1100353|P3|STARTED|Stage 1||0
448854|NCT01324128|1100354|P2|STARTED|Stage 1||349
448855|NCT01324128|1100355|P1|STARTED|Stage 1||710
448856|NCT01324102|1100367|P2|NOT COMPLETED|Overall Study||6
448857|NCT01324102|1100368|P1|NOT COMPLETED|Overall Study||1
448858|NCT01324102|1100367|P2|COMPLETED|Overall Study||6
448859|NCT01324102|1100368|P1|COMPLETED|Overall Study||10
448860|NCT01324102|1100367|P2|STARTED|Overall Study|Yoga group 4 and 6|12
448861|NCT01324102|1100368|P1|STARTED|Overall Study|Yoga groups 3 and 5 (not including pre-randomization group)|11
448862|NCT01324024|1100375|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
448863|NCT01324024|1100376|P1|NOT COMPLETED|Second Intervention (4 Weeks)||2
448864|NCT01324024|1100375|P2|COMPLETED|Second Intervention (4 Weeks)||16
448865|NCT01324024|1100376|P1|COMPLETED|Second Intervention (4 Weeks)||16
448866|NCT01324024|1100375|P2|STARTED|Second Intervention (4 Weeks)||17
448867|NCT01324024|1100376|P1|STARTED|Second Intervention (4 Weeks)||18
448868|NCT01324024|1100375|P2|NOT COMPLETED|Washout (2 Weeks)||0
448869|NCT01324024|1100376|P1|NOT COMPLETED|Washout (2 Weeks)||0
448870|NCT01324024|1100375|P2|COMPLETED|Washout (2 Weeks)||17
448871|NCT01324024|1100376|P1|COMPLETED|Washout (2 Weeks)||18
448872|NCT01324024|1100375|P2|STARTED|Washout (2 Weeks)||17
448873|NCT01324024|1100376|P1|STARTED|Washout (2 Weeks)||18
448874|NCT01324024|1100375|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
448875|NCT01324024|1100376|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
448876|NCT01324024|1100375|P2|COMPLETED|First Intervention (4 Weeks)||17
448877|NCT01324024|1100376|P1|COMPLETED|First Intervention (4 Weeks)||18
448878|NCT01324024|1100375|P2|STARTED|First Intervention (4 Weeks)||17
448879|NCT01324024|1100376|P1|STARTED|First Intervention (4 Weeks)||18
448880|NCT01323998|1100394|P5|NOT COMPLETED|Overall Study||0
448881|NCT01323998|1100395|P4|NOT COMPLETED|Overall Study||0
448882|NCT01323998|1100396|P3|NOT COMPLETED|Overall Study||0
448883|NCT01323998|1100397|P2|NOT COMPLETED|Overall Study||0
448884|NCT01323998|1100398|P1|NOT COMPLETED|Overall Study||0
448885|NCT01323998|1100394|P5|COMPLETED|Overall Study||6735
448886|NCT01323998|1100395|P4|COMPLETED|Overall Study||12052
448887|NCT01323998|1100396|P3|COMPLETED|Overall Study||10294
448888|NCT01323998|1100397|P2|COMPLETED|Overall Study||18681
448889|NCT01323998|1100398|P1|COMPLETED|Overall Study||200631
448890|NCT01323998|1100394|P5|STARTED|Overall Study||6735
448891|NCT01323998|1100395|P4|STARTED|Overall Study||12052
448892|NCT01323998|1100396|P3|STARTED|Overall Study||10294
448893|NCT01323998|1100397|P2|STARTED|Overall Study||18681
448894|NCT01323998|1100398|P1|STARTED|Overall Study||200631
448895|NCT01323972|1100414|P4|NOT COMPLETED|Overall Study||1
448896|NCT01323972|1100415|P3|NOT COMPLETED|Overall Study||2
448897|NCT01323972|1100416|P2|NOT COMPLETED|Overall Study||3
448898|NCT01323972|1100417|P1|NOT COMPLETED|Overall Study||2
448899|NCT01323972|1100414|P4|COMPLETED|Overall Study||79
448900|NCT01323972|1100415|P3|COMPLETED|Overall Study||78
448901|NCT01323972|1100416|P2|COMPLETED|Overall Study||76
448902|NCT01323972|1100417|P1|COMPLETED|Overall Study||79
448903|NCT01323972|1100414|P4|STARTED|Overall Study||80
448904|NCT01323972|1100415|P3|STARTED|Overall Study||80
448905|NCT01323972|1100416|P2|STARTED|Overall Study||79
448906|NCT01323972|1100417|P1|STARTED|Overall Study||81
448907|NCT01323959|1100452|P3|NOT COMPLETED|Overall Study||0
448908|NCT01323959|1100453|P2|NOT COMPLETED|Overall Study||0
448909|NCT01323959|1100454|P1|NOT COMPLETED|Overall Study||0
448910|NCT01323959|1100452|P3|COMPLETED|Overall Study||72
448911|NCT01323959|1100453|P2|COMPLETED|Overall Study||72
448912|NCT01323959|1100454|P1|COMPLETED|Overall Study||67
448913|NCT01323959|1100452|P3|STARTED|Overall Study||72
448914|NCT01323959|1100453|P2|STARTED|Overall Study||72
448915|NCT01323959|1100454|P1|STARTED|Overall Study||67
448916|NCT01323920|1100510|P1|NOT COMPLETED|Overall Study||6
448917|NCT01323920|1100510|P1|COMPLETED|Overall Study||29
448918|NCT01323920|1100510|P1|STARTED|Overall Study||35
448919|NCT01323855|1100522|P5|NOT COMPLETED|Overall Study||0
448920|NCT01323855|1100523|P4|NOT COMPLETED|Overall Study||0
448921|NCT01323855|1100524|P3|NOT COMPLETED|Overall Study||0
448922|NCT01323855|1100525|P2|NOT COMPLETED|Overall Study||0
448923|NCT01323855|1100526|P1|NOT COMPLETED|Overall Study||0
448924|NCT01323855|1100522|P5|COMPLETED|Overall Study||11
448925|NCT01323855|1100523|P4|COMPLETED|Overall Study||9
448926|NCT01323855|1100524|P3|COMPLETED|Overall Study||8
448927|NCT01323855|1100525|P2|COMPLETED|Overall Study||9
448928|NCT01323855|1100526|P1|COMPLETED|Overall Study||9
448929|NCT01323855|1100522|P5|STARTED|Overall Study||11
448930|NCT01323855|1100523|P4|STARTED|Overall Study||9
448931|NCT01323855|1100524|P3|STARTED|Overall Study||8
448932|NCT01323855|1100525|P2|STARTED|Overall Study||9
448933|NCT01323855|1100526|P1|STARTED|Overall Study||9
448934|NCT01323790|1100551|P3|NOT COMPLETED|Overall Study||45
448935|NCT01323790|1100552|P2|NOT COMPLETED|Overall Study||60
448936|NCT01323790|1100553|P1|NOT COMPLETED|Overall Study||55
448937|NCT01323790|1100551|P3|COMPLETED|Overall Study||188
448938|NCT01323790|1100552|P2|COMPLETED|Overall Study||174
448939|NCT01323790|1100553|P1|COMPLETED|Overall Study||178
448940|NCT01323790|1100551|P3|STARTED|Overall Study||233
448941|NCT01323790|1100552|P2|STARTED|Overall Study||234
448942|NCT01323790|1100553|P1|STARTED|Overall Study||233
448943|NCT01323777|1100591|P1|NOT COMPLETED|Overall Study||0
448944|NCT01323777|1100591|P1|COMPLETED|Overall Study||65
448945|NCT01323777|1100591|P1|STARTED|Overall Study||65
448946|NCT01323673|1100604|P2|NOT COMPLETED|Overall Study||5
448947|NCT01323673|1100605|P1|NOT COMPLETED|Overall Study||3
448948|NCT01323673|1100604|P2|COMPLETED|Overall Study||58
448949|NCT01323673|1100605|P1|COMPLETED|Overall Study||59
448950|NCT01323673|1100604|P2|STARTED|Overall Study||63
448951|NCT01323673|1100605|P1|STARTED|Overall Study||62
448952|NCT01323660|1100625|P6|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7
448953|NCT01323660|1100626|P5|NOT COMPLETED|Treatment Period 2 (12 Weeks)||4
448954|NCT01323660|1100627|P4|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
448955|NCT01323660|1100628|P3|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
448956|NCT01323660|1100629|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1
448957|NCT01323660|1100630|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||12
448958|NCT01323660|1100625|P6|COMPLETED|Treatment Period 2 (12 Weeks)||51
448959|NCT01323660|1100626|P5|COMPLETED|Treatment Period 2 (12 Weeks)||55
448960|NCT01323660|1100627|P4|COMPLETED|Treatment Period 2 (12 Weeks)||25
448961|NCT01323660|1100628|P3|COMPLETED|Treatment Period 2 (12 Weeks)||14
448962|NCT01323660|1100629|P2|COMPLETED|Treatment Period 2 (12 Weeks)||17
448963|NCT01323660|1100630|P1|COMPLETED|Treatment Period 2 (12 Weeks)||55
448964|NCT01323660|1100625|P6|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|58
448965|NCT01323660|1100626|P5|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|59
448966|NCT01323660|1100627|P4|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|28
448967|NCT01323660|1100628|P3|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|17
448968|NCT01323660|1100629|P2|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|18
448969|NCT01323660|1100630|P1|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|67
448970|NCT01323660|1100625|P6|NOT COMPLETED|Washout Period (14 Days)||2
448971|NCT01323660|1100626|P5|NOT COMPLETED|Washout Period (14 Days)||3
448972|NCT01323660|1100627|P4|NOT COMPLETED|Washout Period (14 Days)||3
448973|NCT01323660|1100628|P3|NOT COMPLETED|Washout Period (14 Days)||1
448974|NCT01323660|1100629|P2|NOT COMPLETED|Washout Period (14 Days)||0
448975|NCT01323660|1100630|P1|NOT COMPLETED|Washout Period (14 Days)||0
448976|NCT01323660|1100625|P6|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|59
448977|NCT01323660|1100626|P5|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|58
448978|NCT01323660|1100627|P4|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|28
448979|NCT01323660|1100628|P3|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
448980|NCT01323660|1100629|P2|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
448981|NCT01323660|1100630|P1|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|65
448982|NCT01323660|1100625|P6|STARTED|Washout Period (14 Days)||61
448983|NCT01323660|1100626|P5|STARTED|Washout Period (14 Days)||61
448984|NCT01323660|1100627|P4|STARTED|Washout Period (14 Days)||31
448985|NCT01323660|1100628|P3|STARTED|Washout Period (14 Days)||19
448986|NCT01323660|1100629|P2|STARTED|Washout Period (14 Days)||21
448987|NCT01323660|1100630|P1|STARTED|Washout Period (14 Days)||65
448988|NCT01323660|1100625|P6|NOT COMPLETED|Treatment Period 1 (12 Weeks)||9
448989|NCT01323660|1100626|P5|NOT COMPLETED|Treatment Period 1 (12 Weeks)||10
448990|NCT01323660|1100627|P4|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
448991|NCT01323660|1100628|P3|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
448992|NCT01323660|1100629|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||1
448993|NCT01323660|1100630|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||19
448994|NCT01323660|1100625|P6|COMPLETED|Treatment Period 1 (12 Weeks)||61
448995|NCT01323660|1100626|P5|COMPLETED|Treatment Period 1 (12 Weeks)||61
448996|NCT01323660|1100627|P4|COMPLETED|Treatment Period 1 (12 Weeks)||31
448997|NCT01323660|1100628|P3|COMPLETED|Treatment Period 1 (12 Weeks)||19
448998|NCT01323660|1100629|P2|COMPLETED|Treatment Period 1 (12 Weeks)||21
448999|NCT01323660|1100630|P1|COMPLETED|Treatment Period 1 (12 Weeks)||65
449000|NCT01323660|1100625|P6|STARTED|Treatment Period 1 (12 Weeks)||70
449001|NCT01323660|1100626|P5|STARTED|Treatment Period 1 (12 Weeks)||71
449002|NCT01323660|1100627|P4|STARTED|Treatment Period 1 (12 Weeks)||36
449003|NCT01323660|1100628|P3|STARTED|Treatment Period 1 (12 Weeks)||24
449004|NCT01323660|1100629|P2|STARTED|Treatment Period 1 (12 Weeks)||22
449005|NCT01323660|1100630|P1|STARTED|Treatment Period 1 (12 Weeks)||84
449006|NCT01323647|1100676|P2|NOT COMPLETED|Overall Study||0
449007|NCT01323647|1100677|P1|NOT COMPLETED|Overall Study||9
449008|NCT01323647|1100676|P2|COMPLETED|Overall Study||487
449009|NCT01323647|1100677|P1|COMPLETED|Overall Study||461
449010|NCT01323647|1100676|P2|STARTED|Overall Study||487
449011|NCT01323647|1100677|P1|STARTED|Overall Study||470
449012|NCT01323634|1100694|P3|NOT COMPLETED|Double-Blind (DB) Treatment Period||22
449013|NCT01323634|1100695|P2|NOT COMPLETED|Double-Blind (DB) Treatment Period||25
449014|NCT01323634|1100696|P1|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
449015|NCT01323634|1100694|P3|COMPLETED|Double-Blind (DB) Treatment Period||239
449016|NCT01323634|1100695|P2|COMPLETED|Double-Blind (DB) Treatment Period||235
449017|NCT01323634|1100696|P1|COMPLETED|Double-Blind (DB) Treatment Period||0
449018|NCT01323634|1100694|P3|STARTED|Double-Blind (DB) Treatment Period||261
449019|NCT01323634|1100695|P2|STARTED|Double-Blind (DB) Treatment Period||260
449020|NCT01323634|1100696|P1|STARTED|Double-Blind (DB) Treatment Period||0
449021|NCT01323634|1100694|P3|NOT COMPLETED|2-week Run-in Period||0
449022|NCT01323634|1100695|P2|NOT COMPLETED|2-week Run-in Period||0
449023|NCT01323634|1100696|P1|NOT COMPLETED|2-week Run-in Period||212
449024|NCT01323634|1100694|P3|COMPLETED|2-week Run-in Period||0
449025|NCT01323634|1100695|P2|COMPLETED|2-week Run-in Period||0
449026|NCT01323634|1100696|P1|COMPLETED|2-week Run-in Period||521
449027|NCT01323634|1100694|P3|STARTED|2-week Run-in Period||0
449028|NCT01323634|1100695|P2|STARTED|2-week Run-in Period||0
449029|NCT01323634|1100696|P1|STARTED|2-week Run-in Period||733
449030|NCT01323621|1100706|P3|NOT COMPLETED|12-week, Double-blind Treatment Period||20
449031|NCT01323621|1100707|P2|NOT COMPLETED|12-week, Double-blind Treatment Period||15
449032|NCT01323621|1100708|P1|NOT COMPLETED|12-week, Double-blind Treatment Period||0
449033|NCT01323621|1100706|P3|COMPLETED|12-week, Double-blind Treatment Period||239
449034|NCT01323621|1100707|P2|COMPLETED|12-week, Double-blind Treatment Period||237
449035|NCT01323621|1100708|P1|COMPLETED|12-week, Double-blind Treatment Period||0
449036|NCT01323621|1100706|P3|STARTED|12-week, Double-blind Treatment Period||259
449037|NCT01323621|1100707|P2|STARTED|12-week, Double-blind Treatment Period||252
449038|NCT01323621|1100708|P1|STARTED|12-week, Double-blind Treatment Period||0
449039|NCT01323621|1100706|P3|NOT COMPLETED|2-week, Single-blind Run In Period||0
449040|NCT01323621|1100707|P2|NOT COMPLETED|2-week, Single-blind Run In Period||0
449041|NCT01323621|1100708|P1|NOT COMPLETED|2-week, Single-blind Run In Period||228
449042|NCT01323621|1100706|P3|COMPLETED|2-week, Single-blind Run In Period||0
449043|NCT01323621|1100707|P2|COMPLETED|2-week, Single-blind Run In Period||0
449044|NCT01323621|1100708|P1|COMPLETED|2-week, Single-blind Run In Period||511
449045|NCT01323621|1100706|P3|STARTED|2-week, Single-blind Run In Period||0
449046|NCT01323621|1100707|P2|STARTED|2-week, Single-blind Run In Period||0
449047|NCT01323621|1100708|P1|STARTED|2-week, Single-blind Run In Period||739
449048|NCT01323595|1100718|P2|NOT COMPLETED|Overall Study||21
449049|NCT01323595|1100719|P1|NOT COMPLETED|Overall Study||23
449050|NCT01323595|1100718|P2|COMPLETED|Overall Study|Remaining subjects did not return questionaire|18
449051|NCT01323595|1100719|P1|COMPLETED|Overall Study|Remaining subjects did not return questionnaire|16
449052|NCT01323595|1100718|P2|STARTED|Overall Study||39
449053|NCT01323595|1100719|P1|STARTED|Overall Study||39
449054|NCT01323582|1100727|P2|NOT COMPLETED|Weeks 8-11 (Period 2)||1
449055|NCT01323582|1100728|P1|NOT COMPLETED|Weeks 8-11 (Period 2)||0
449056|NCT01323582|1100727|P2|COMPLETED|Weeks 8-11 (Period 2)||10
449057|NCT01323582|1100728|P1|COMPLETED|Weeks 8-11 (Period 2)||10
449058|NCT01323582|1100727|P2|STARTED|Weeks 8-11 (Period 2)||11
449059|NCT01323582|1100728|P1|STARTED|Weeks 8-11 (Period 2)||10
449060|NCT01323582|1100727|P2|NOT COMPLETED|Weeks 5-7 (Washout)||1
449061|NCT01323582|1100728|P1|NOT COMPLETED|Weeks 5-7 (Washout)||0
449062|NCT01323582|1100727|P2|COMPLETED|Weeks 5-7 (Washout)||11
449063|NCT01323582|1100728|P1|COMPLETED|Weeks 5-7 (Washout)||10
449064|NCT01323582|1100727|P2|STARTED|Weeks 5-7 (Washout)||12
449065|NCT01323582|1100728|P1|STARTED|Weeks 5-7 (Washout)||10
449066|NCT01323582|1100727|P2|NOT COMPLETED|Weeks 1-4 (First Period)||2
449067|NCT01323582|1100728|P1|NOT COMPLETED|Weeks 1-4 (First Period)||2
449068|NCT01323582|1100727|P2|COMPLETED|Weeks 1-4 (First Period)||12
449069|NCT01323582|1100728|P1|COMPLETED|Weeks 1-4 (First Period)||10
449070|NCT01323582|1100727|P2|STARTED|Weeks 1-4 (First Period)||14
449071|NCT01323582|1100728|P1|STARTED|Weeks 1-4 (First Period)||12
449072|NCT01323517|1100744|P1|NOT COMPLETED|Overall Study||0
449073|NCT01323517|1100744|P1|COMPLETED|Overall Study||26
449074|NCT01323517|1100744|P1|STARTED|Overall Study||26
449075|NCT01323478|1100751|P1|NOT COMPLETED|Overall Study||24
449076|NCT01323478|1100751|P1|COMPLETED|Overall Study||47
449077|NCT01323478|1100751|P1|STARTED|Overall Study||71
449078|NCT01323387|1100764|P1|NOT COMPLETED|Overall Study||84
449079|NCT01323387|1100764|P1|COMPLETED|Overall Study||94
449080|NCT01323387|1100764|P1|STARTED|Overall Study||178
449081|NCT01323270|1100777|P2|NOT COMPLETED|Overall Study||29
449082|NCT01323270|1100778|P1|NOT COMPLETED|Overall Study||43
449083|NCT01323270|1100777|P2|COMPLETED|Overall Study||347
449084|NCT01323270|1100778|P1|COMPLETED|Overall Study||330
449085|NCT01323270|1100777|P2|STARTED|Overall Study||376
449086|NCT01323270|1100778|P1|STARTED|Overall Study||373
449087|NCT01323192|1100800|P2|NOT COMPLETED|Overall Study||6
449088|NCT01323192|1100801|P1|NOT COMPLETED|Overall Study||9
449089|NCT01323192|1100800|P2|COMPLETED|Overall Study||135
449090|NCT01323192|1100801|P1|COMPLETED|Overall Study||134
449091|NCT01323192|1100800|P2|STARTED|Overall Study||141
449092|NCT01323192|1100801|P1|STARTED|Overall Study||143
449093|NCT01323140|1100817|P1|NOT COMPLETED|Overall Study||2
449094|NCT01323140|1100817|P1|COMPLETED|Overall Study||38
449095|NCT01323140|1100817|P1|STARTED|Overall Study||40
449096|NCT01323010|1100823|P2|NOT COMPLETED|Overall Study||0
449097|NCT01323010|1100824|P1|NOT COMPLETED|Overall Study||0
449098|NCT01323010|1100823|P2|COMPLETED|Overall Study||59
449099|NCT01323010|1100824|P1|COMPLETED|Overall Study||60
449100|NCT01323010|1100823|P2|STARTED|Overall Study||59
449101|NCT01323010|1100824|P1|STARTED|Overall Study||60
449102|NCT01322971|1100875|P2|NOT COMPLETED|Overall Study||1
449103|NCT01322971|1100876|P1|NOT COMPLETED|Overall Study||1
449104|NCT01322971|1100875|P2|COMPLETED|Overall Study||0
449105|NCT01322971|1100876|P1|COMPLETED|Overall Study||0
449106|NCT01322971|1100875|P2|STARTED|Overall Study||1
449107|NCT01322971|1100876|P1|STARTED|Overall Study||1
449108|NCT01322945|1100890|P2|NOT COMPLETED|Overall Study||0
449109|NCT01322945|1100891|P1|NOT COMPLETED|Overall Study||0
449110|NCT01322945|1100890|P2|COMPLETED|Overall Study||42
449111|NCT01322945|1100891|P1|COMPLETED|Overall Study||52
449112|NCT01322945|1100890|P2|STARTED|Overall Study||42
449113|NCT01322945|1100891|P1|STARTED|Overall Study||52
449114|NCT01322841|1100901|P2|NOT COMPLETED|Overall Study||0
449115|NCT01322841|1100902|P1|NOT COMPLETED|Overall Study||0
449116|NCT01322841|1100901|P2|COMPLETED|Overall Study||1123
449117|NCT01322841|1100902|P1|COMPLETED|Overall Study||1116
449118|NCT01322841|1100901|P2|STARTED|Overall Study||1123
449119|NCT01322841|1100902|P1|STARTED|Overall Study||1116
449120|NCT01322815|1100912|P2|NOT COMPLETED|Overall Study||0
449121|NCT01322815|1100913|P1|NOT COMPLETED|Overall Study||0
449122|NCT01322815|1100912|P2|COMPLETED|Overall Study||4
449123|NCT01322815|1100913|P1|COMPLETED|Overall Study||7
449124|NCT01322815|1100912|P2|STARTED|Overall Study||4
449125|NCT01322815|1100913|P1|STARTED|Overall Study||7
449126|NCT01322633|1100921|P2|NOT COMPLETED|Overall Study||0
449127|NCT01322633|1100922|P1|NOT COMPLETED|Overall Study||0
449128|NCT01322633|1100921|P2|COMPLETED|Overall Study||27686
449129|NCT01322633|1100922|P1|COMPLETED|Overall Study||34178
449130|NCT01322633|1100921|P2|STARTED|Overall Study||27686
449131|NCT01322633|1100922|P1|STARTED|Overall Study||34178
449132|NCT01322607|1100934|P2|NOT COMPLETED|Overall Study||0
449133|NCT01322607|1100935|P1|NOT COMPLETED|Overall Study||1
449134|NCT01322607|1100934|P2|COMPLETED|Overall Study||9
449135|NCT01322607|1100935|P1|COMPLETED|Overall Study||10
449136|NCT01322607|1100934|P2|STARTED|Overall Study||9
449137|NCT01322607|1100935|P1|STARTED|Overall Study||11
449138|NCT01322594|1100953|P6|NOT COMPLETED|Overall Study||0
449139|NCT01322594|1100954|P5|NOT COMPLETED|Overall Study||0
449140|NCT01322594|1100955|P4|NOT COMPLETED|Overall Study||0
449141|NCT01322594|1100956|P3|NOT COMPLETED|Overall Study||0
449142|NCT01322594|1100957|P2|NOT COMPLETED|Overall Study||0
449143|NCT01322594|1100958|P1|NOT COMPLETED|Overall Study||0
449144|NCT01322594|1100953|P6|COMPLETED|Overall Study||6
449145|NCT01322594|1100954|P5|COMPLETED|Overall Study||7
449146|NCT01322594|1100955|P4|COMPLETED|Overall Study||6
449147|NCT01322594|1100956|P3|COMPLETED|Overall Study||3
449148|NCT01322594|1100957|P2|COMPLETED|Overall Study||3
449149|NCT01322594|1100958|P1|COMPLETED|Overall Study||6
449150|NCT01322594|1100953|P6|STARTED|Overall Study||6
449151|NCT01322594|1100954|P5|STARTED|Overall Study||7
449152|NCT01322594|1100955|P4|STARTED|Overall Study||6
449153|NCT01322594|1100956|P3|STARTED|Overall Study||3
449154|NCT01322594|1100957|P2|STARTED|Overall Study||3
449155|NCT01322594|1100958|P1|STARTED|Overall Study|RANDOMIZED SUBJECTS THROUGH STUDY DAY 240-300|6
449156|NCT01322386|1101040|P2|NOT COMPLETED|Overall Study||2
449157|NCT01322386|1101041|P1|NOT COMPLETED|Overall Study||0
449158|NCT01322386|1101040|P2|COMPLETED|Overall Study||9
449159|NCT01322386|1101041|P1|COMPLETED|Overall Study||10
449160|NCT01322386|1101040|P2|STARTED|Overall Study||11
449161|NCT01322386|1101041|P1|STARTED|Overall Study||10
449162|NCT01322360|1101049|P1|NOT COMPLETED|Overall Study||0
449163|NCT01322360|1101049|P1|COMPLETED|Overall Study||50
449164|NCT01322360|1101049|P1|STARTED|Overall Study||50
449165|NCT01322347|1101056|P2|NOT COMPLETED|Overall Study||35
449166|NCT01322347|1101057|P1|NOT COMPLETED|Overall Study||51
449167|NCT01322347|1101056|P2|COMPLETED|Overall Study||112
449168|NCT01322347|1101057|P1|COMPLETED|Overall Study||96
449169|NCT01322347|1101056|P2|Completed St 3|Overall Study||86
449170|NCT01322347|1101057|P1|Completed St 3|Overall Study||82
449171|NCT01322347|1101056|P2|Enrolled in St 3|Overall Study||113
449172|NCT01322347|1101057|P1|Enrolled in St 3|Overall Study||101
449173|NCT01322347|1101056|P2|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||90
449174|NCT01322347|1101057|P1|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||68
449175|NCT01322347|1101056|P2|Completed 48 Wks in St 2|Overall Study||22
449176|NCT01322347|1101057|P1|Completed 48 Wks in St 2|Overall Study||28
449177|NCT01322347|1101056|P2|STARTED|Overall Study||147
449178|NCT01322347|1101057|P1|STARTED|Overall Study||147
449179|NCT01322048|1101094|P2|NOT COMPLETED|Overall Study||0
449180|NCT01322048|1101095|P1|NOT COMPLETED|Overall Study||0
449181|NCT01322048|1101094|P2|COMPLETED|Overall Study||26
449182|NCT01322048|1101095|P1|COMPLETED|Overall Study||21
449183|NCT01322048|1101094|P2|STARTED|Overall Study||26
449184|NCT01322048|1101095|P1|STARTED|Overall Study||21
449185|NCT01322022|1101105|P2|NOT COMPLETED|Overall Study||2
449186|NCT01322022|1101106|P1|NOT COMPLETED|Overall Study||5
449187|NCT01322022|1101105|P2|COMPLETED|Overall Study||18
449188|NCT01322022|1101106|P1|COMPLETED|Overall Study||15
449189|NCT01322022|1101105|P2|Week 4|Overall Study||18
449190|NCT01322022|1101106|P1|Week 4|Overall Study||15
449191|NCT01322022|1101105|P2|STARTED|Overall Study||20
449192|NCT01322022|1101106|P1|STARTED|Overall Study||20
449193|NCT01322009|1101120|P2|NOT COMPLETED|Overall Study||3
449194|NCT01322009|1101121|P1|NOT COMPLETED|Overall Study||0
449195|NCT01322009|1101120|P2|COMPLETED|Overall Study||4
449196|NCT01322009|1101121|P1|COMPLETED|Overall Study||7
449197|NCT01322009|1101120|P2|STARTED|Overall Study||7
449198|NCT01322009|1101121|P1|STARTED|Overall Study||7
449199|NCT01321749|1101131|P2|NOT COMPLETED|Overall Study||22
449200|NCT01321749|1101132|P1|NOT COMPLETED|Overall Study||13
449201|NCT01321749|1101131|P2|COMPLETED|Overall Study||30
449202|NCT01321749|1101132|P1|COMPLETED|Overall Study||38
449203|NCT01321749|1101131|P2|STARTED|Overall Study||52
449204|NCT01321749|1101132|P1|STARTED|Overall Study||51
449205|NCT01321723|1101141|P3|NOT COMPLETED|Overall Study||4
449206|NCT01321723|1101142|P2|NOT COMPLETED|Overall Study||5
449207|NCT01321723|1101143|P1|NOT COMPLETED|Overall Study||5
449208|NCT01321723|1101141|P3|COMPLETED|Overall Study||28
449209|NCT01321723|1101142|P2|COMPLETED|Overall Study||28
449210|NCT01321723|1101143|P1|COMPLETED|Overall Study||27
449211|NCT01321723|1101141|P3|STARTED|Overall Study||32
449212|NCT01321723|1101142|P2|STARTED|Overall Study||33
449213|NCT01321723|1101143|P1|STARTED|Overall Study||32
449214|NCT01321710|1101165|P3|NOT COMPLETED|Overall Study||0
449215|NCT01321710|1101166|P2|NOT COMPLETED|Overall Study||5
449216|NCT01321710|1101167|P1|NOT COMPLETED|Overall Study||4
449217|NCT01321710|1101165|P3|COMPLETED|Overall Study||44
449218|NCT01321710|1101166|P2|COMPLETED|Overall Study||53
449219|NCT01321710|1101167|P1|COMPLETED|Overall Study||46
449220|NCT01321710|1101165|P3|STARTED|Overall Study||44
449221|NCT01321710|1101166|P2|STARTED|Overall Study||58
449222|NCT01321710|1101167|P1|STARTED|Overall Study||50
449223|NCT01321697|1101182|P1|NOT COMPLETED|Overall Study||7
449224|NCT01321697|1101182|P1|COMPLETED|Overall Study||0
449225|NCT01321697|1101182|P1|STARTED|Overall Study||7
449226|NCT01321554|1101188|P4|NOT COMPLETED|OOL Lenvatinib Treatment Period||2
449227|NCT01321554|1101189|P3|NOT COMPLETED|OOL Lenvatinib Treatment Period||28
449228|NCT01321554|1101190|P2|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
449229|NCT01321554|1101191|P1|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
449230|NCT01321554|1101188|P4|COMPLETED|OOL Lenvatinib Treatment Period|Discontinued due to disease progression or treatment ongoing at data cut off (15 Nov 2013)|25
449231|NCT01321554|1101189|P3|COMPLETED|OOL Lenvatinib Treatment Period|Discontinued due to disease progression or treatment ongoing at data cut off (15 Nov 2013)|54
449232|NCT01321554|1101190|P2|COMPLETED|OOL Lenvatinib Treatment Period||0
449233|NCT01321554|1101191|P1|COMPLETED|OOL Lenvatinib Treatment Period||0
449234|NCT01321554|1101188|P4|Discontinued Due to Disease Progression|OOL Lenvatinib Treatment Period||3
449235|NCT01321554|1101189|P3|Discontinued Due to Disease Progression|OOL Lenvatinib Treatment Period||18
449236|NCT01321554|1101190|P2|Discontinued Due to Disease Progression|OOL Lenvatinib Treatment Period||0
449237|NCT01321554|1101191|P1|Discontinued Due to Disease Progression|OOL Lenvatinib Treatment Period||0
449238|NCT01321554|1101188|P4|Treatment Ongoing at Data Cutoff|OOL Lenvatinib Treatment Period||22
449239|NCT01321554|1101189|P3|Treatment Ongoing at Data Cutoff|OOL Lenvatinib Treatment Period||36
449240|NCT01321554|1101190|P2|Treatment Ongoing at Data Cutoff|OOL Lenvatinib Treatment Period||0
449241|NCT01321554|1101191|P1|Treatment Ongoing at Data Cutoff|OOL Lenvatinib Treatment Period||0
449242|NCT01321554|1101188|P4|STARTED|OOL Lenvatinib Treatment Period||27
449243|NCT01321554|1101189|P3|STARTED|OOL Lenvatinib Treatment Period||82
449244|NCT01321554|1101190|P2|STARTED|OOL Lenvatinib Treatment Period||0
449245|NCT01321554|1101191|P1|STARTED|OOL Lenvatinib Treatment Period||0
449246|NCT01321554|1101188|P4|NOT COMPLETED|Randomization Phase||0
449247|NCT01321554|1101189|P3|NOT COMPLETED|Randomization Phase||0
449248|NCT01321554|1101190|P2|NOT COMPLETED|Randomization Phase||4
449249|NCT01321554|1101191|P1|NOT COMPLETED|Randomization Phase||45
449250|NCT01321554|1101188|P4|COMPLETED|Randomization Phase||0
449251|NCT01321554|1101189|P3|COMPLETED|Randomization Phase||0
449252|NCT01321554|1101190|P2|COMPLETED|Randomization Phase|Discontinued due to disease progression or treatment ongoing at data cut off (15 Nov 2013)|127
449253|NCT01321554|1101191|P1|COMPLETED|Randomization Phase|Discontinued due to disease progression or treatment ongoing at data cut off (15 Nov 2013)|216
449254|NCT01321554|1101188|P4|Discontinued Due to Disease Progression|Randomization Phase||0
449255|NCT01321554|1101189|P3|Discontinued Due to Disease Progression|Randomization Phase||0
449256|NCT01321554|1101190|P2|Discontinued Due to Disease Progression|Randomization Phase||119
449257|NCT01321554|1101191|P1|Discontinued Due to Disease Progression|Randomization Phase||94
449258|NCT01321554|1101188|P4|Treatment Ongoing at Data Cutoff|Randomization Phase||0
449259|NCT01321554|1101189|P3|Treatment Ongoing at Data Cutoff|Randomization Phase||0
449260|NCT01321554|1101190|P2|Treatment Ongoing at Data Cutoff|Randomization Phase||8
449261|NCT01321554|1101191|P1|Treatment Ongoing at Data Cutoff|Randomization Phase||122
449262|NCT01321554|1101188|P4|STARTED|Randomization Phase||0
449263|NCT01321554|1101189|P3|STARTED|Randomization Phase||0
449264|NCT01321554|1101190|P2|STARTED|Randomization Phase||131
449265|NCT01321554|1101191|P1|STARTED|Randomization Phase||261
449266|NCT01321073|1101204|P1|NOT COMPLETED|Overall Study||7
449267|NCT01321073|1101204|P1|COMPLETED|Overall Study||57
449268|NCT01321073|1101204|P1|STARTED|Overall Study||64
449269|NCT01321008|1101208|P1|NOT COMPLETED|Overall Study||1
449270|NCT01321008|1101208|P1|COMPLETED|Overall Study||0
449271|NCT01321008|1101208|P1|STARTED|Overall Study||1
449272|NCT01320943|1101214|P2|NOT COMPLETED|Overall Study||2
449273|NCT01320943|1101215|P1|NOT COMPLETED|Overall Study||1
449274|NCT01320943|1101214|P2|COMPLETED|Overall Study||20
449275|NCT01320943|1101215|P1|COMPLETED|Overall Study||20
449276|NCT01320943|1101214|P2|STARTED|Overall Study||22
449277|NCT01320943|1101215|P1|STARTED|Overall Study|13 participants did not restart TDF; 8 participants restarted TDF during the study.|21
449278|NCT01320826|1101234|P1|NOT COMPLETED|Overall Study||0
449279|NCT01320826|1101234|P1|COMPLETED|Overall Study||577
449280|NCT01320826|1101234|P1|STARTED|Overall Study||577
449281|NCT01320735|1101249|P1|NOT COMPLETED|Overall Study||106
449282|NCT01320735|1101249|P1|COMPLETED|Overall Study||194
449283|NCT01320735|1101249|P1|STARTED|Overall Study||300
449284|NCT01320722|1101271|P5|NOT COMPLETED|Overall Study||8
449285|NCT01320722|1101272|P4|NOT COMPLETED|Overall Study||14
449286|NCT01320722|1101273|P3|NOT COMPLETED|Overall Study||7
449287|NCT01320722|1101274|P2|NOT COMPLETED|Overall Study||6
449288|NCT01320722|1101275|P1|NOT COMPLETED|Overall Study||3
449289|NCT01320722|1101271|P5|COMPLETED|Overall Study||45
449290|NCT01320722|1101272|P4|COMPLETED|Overall Study||35
449291|NCT01320722|1101273|P3|COMPLETED|Overall Study||40
449292|NCT01320722|1101274|P2|COMPLETED|Overall Study||41
449293|NCT01320722|1101275|P1|COMPLETED|Overall Study||43
449294|NCT01320722|1101271|P5|Received Intervention|Overall Study||51
449295|NCT01320722|1101272|P4|Received Intervention|Overall Study||48
449296|NCT01320722|1101273|P3|Received Intervention|Overall Study||46
449297|NCT01320722|1101274|P2|Received Intervention|Overall Study||45
449298|NCT01320722|1101275|P1|Received Intervention|Overall Study||43
449299|NCT01320722|1101271|P5|STARTED|Overall Study||53
449300|NCT01320722|1101272|P4|STARTED|Overall Study||49
449301|NCT01320722|1101273|P3|STARTED|Overall Study||47
449302|NCT01320722|1101274|P2|STARTED|Overall Study||47
449303|NCT01320722|1101275|P1|STARTED|Overall Study||46
449304|NCT01320683|1101312|P1|NOT COMPLETED|Overall Study||1
449305|NCT01320683|1101312|P1|COMPLETED|Overall Study||0
449306|NCT01320683|1101312|P1|STARTED|Overall Study||1
449307|NCT01320553|1101321|P4|NOT COMPLETED|Overall Study||1
449308|NCT01320553|1101322|P3|NOT COMPLETED|Overall Study||2
449309|NCT01320553|1101323|P2|NOT COMPLETED|Overall Study||4
449310|NCT01320553|1101324|P1|NOT COMPLETED|Overall Study||1
449311|NCT01320553|1101321|P4|COMPLETED|Overall Study||29
449312|NCT01320553|1101322|P3|COMPLETED|Overall Study||29
449313|NCT01320553|1101323|P2|COMPLETED|Overall Study||26
449314|NCT01320553|1101324|P1|COMPLETED|Overall Study||30
449315|NCT01320553|1101321|P4|STARTED|Overall Study||30
449316|NCT01320553|1101322|P3|STARTED|Overall Study||31
449317|NCT01320553|1101323|P2|STARTED|Overall Study||30
449318|NCT01320553|1101324|P1|STARTED|Overall Study||31
449319|NCT01320293|1101338|P1|NOT COMPLETED|Overall Study||2
449320|NCT01320293|1101338|P1|COMPLETED|Overall Study||16
449321|NCT01320293|1101338|P1|STARTED|Overall Study||18
449322|NCT01320202|1101346|P2|NOT COMPLETED|Overall Study||44
449323|NCT01320202|1101347|P1|NOT COMPLETED|Overall Study||56
449324|NCT01320202|1101346|P2|COMPLETED|Overall Study||109
449325|NCT01320202|1101347|P1|COMPLETED|Overall Study||96
449326|NCT01320202|1101346|P2|Completed St 3|Overall Study||82
449327|NCT01320202|1101347|P1|Completed St 3|Overall Study||79
449328|NCT01320202|1101346|P2|Enrolled in St 3|Overall Study||109
449329|NCT01320202|1101347|P1|Enrolled in St 3|Overall Study||98
449330|NCT01320202|1101346|P2|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||82
449331|NCT01320202|1101347|P1|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||69
449332|NCT01320202|1101346|P2|Comp 48 Wks in St 2|Overall Study||27
449333|NCT01320202|1101347|P1|Comp 48 Wks in St 2|Overall Study||27
449334|NCT01320202|1101346|P2|STARTED|Overall Study||153
449335|NCT01320202|1101347|P1|STARTED|Overall Study||152
449336|NCT01320137|1101384|P2|NOT COMPLETED|Overall Study||0
449337|NCT01320137|1101385|P1|NOT COMPLETED|Overall Study||0
449338|NCT01320137|1101384|P2|COMPLETED|Overall Study||40
449339|NCT01320137|1101385|P1|COMPLETED|Overall Study||40
449340|NCT01320137|1101384|P2|STARTED|Overall Study||40
449341|NCT01320137|1101385|P1|STARTED|Overall Study||40
449342|NCT01320072|1101399|P2|NOT COMPLETED|Overall Study||0
449343|NCT01320072|1101400|P1|NOT COMPLETED|Overall Study||0
449344|NCT01320072|1101399|P2|COMPLETED|Overall Study||13
449345|NCT01320072|1101400|P1|COMPLETED|Overall Study||16
449346|NCT01320072|1101399|P2|STARTED|Overall Study||13
449347|NCT01320072|1101400|P1|STARTED|Overall Study||16
449348|NCT01319877|1101411|P2|NOT COMPLETED|Overall Study||45
449349|NCT01319877|1101412|P1|NOT COMPLETED|Overall Study||108
449350|NCT01319877|1101411|P2|COMPLETED|Overall Study||108
449351|NCT01319877|1101412|P1|COMPLETED|Overall Study||345
449352|NCT01319877|1101411|P2|STARTED|Overall Study||153
449353|NCT01319877|1101412|P1|STARTED|Overall Study||453
449354|NCT01319851|1101447|P1|NOT COMPLETED|Overall Study||0
449355|NCT01319851|1101447|P1|COMPLETED|Overall Study||3
449356|NCT01319851|1101447|P1|STARTED|Overall Study||3
449357|NCT01319812|1101459|P2|NOT COMPLETED|Overall Study||22
449358|NCT01319812|1101460|P1|NOT COMPLETED|Overall Study||16
449359|NCT01319812|1101459|P2|COMPLETED|Overall Study||280
449360|NCT01319812|1101460|P1|COMPLETED|Overall Study||145
449361|NCT01319812|1101459|P2|STARTED|Overall Study||302
449362|NCT01319812|1101460|P1|STARTED|Overall Study||161
449363|NCT01319799|1101532|P1|NOT COMPLETED|Overall Study||0
449364|NCT01319799|1101532|P1|COMPLETED|Overall Study||10
449365|NCT01319799|1101532|P1|STARTED|Overall Study||10
449366|NCT01319773|1101542|P5|NOT COMPLETED|Overall Study||0
449367|NCT01319773|1101543|P4|NOT COMPLETED|Overall Study||0
449368|NCT01319773|1101544|P3|NOT COMPLETED|Overall Study||0
449369|NCT01319773|1101545|P2|NOT COMPLETED|Overall Study||0
449370|NCT01319773|1101546|P1|NOT COMPLETED|Overall Study||0
449371|NCT01319773|1101542|P5|COMPLETED|Overall Study||8
449372|NCT01319773|1101543|P4|COMPLETED|Overall Study||8
449373|NCT01319773|1101544|P3|COMPLETED|Overall Study||8
449374|NCT01319773|1101545|P2|COMPLETED|Overall Study||10
449375|NCT01319773|1101546|P1|COMPLETED|Overall Study||10
449376|NCT01319773|1101542|P5|STARTED|Overall Study||8
449377|NCT01319773|1101543|P4|STARTED|Overall Study||8
449378|NCT01319773|1101544|P3|STARTED|Overall Study||8
449379|NCT01319773|1101545|P2|STARTED|Overall Study||10
449380|NCT01319773|1101546|P1|STARTED|Overall Study||10
449381|NCT01319721|1101562|P2|NOT COMPLETED|Overall Study||6
449382|NCT01319721|1101563|P1|NOT COMPLETED|Overall Study||1
449383|NCT01319721|1101562|P2|COMPLETED|Overall Study|The unit of measure is eyes.|42
449384|NCT01319721|1101563|P1|COMPLETED|Overall Study|The unit of measure is eyes.|47
449385|NCT01319721|1101562|P2|STARTED|Overall Study|The unit of measure is eyes.|48
449386|NCT01319721|1101563|P1|STARTED|Overall Study|The unit of measure is eyes.|48
449387|NCT01319617|1101577|P1|NOT COMPLETED|Overall Study||1
449388|NCT01319617|1101577|P1|COMPLETED|Overall Study||40
449389|NCT01319617|1101577|P1|STARTED|Overall Study||41
449390|NCT01319552|1101581|P1|NOT COMPLETED|Overall Study||0
449391|NCT01319552|1101581|P1|COMPLETED|Overall Study||14
449392|NCT01319552|1101581|P1|STARTED|Overall Study||14
449393|NCT01319539|1101586|P1|NOT COMPLETED|Overall Study||0
449394|NCT01319539|1101586|P1|COMPLETED|Overall Study||12
449395|NCT01319539|1101586|P1|STARTED|Overall Study||12
449396|NCT01319500|1101596|P2|NOT COMPLETED|Overall Study||0
449397|NCT01319500|1101597|P1|NOT COMPLETED|Overall Study||0
449398|NCT01319500|1101596|P2|COMPLETED|Overall Study||2589
449399|NCT01319500|1101597|P1|COMPLETED|Overall Study||1187
449400|NCT01319500|1101596|P2|STARTED|Overall Study||2589
449401|NCT01319500|1101597|P1|STARTED|Overall Study||1187
449402|NCT01319422|1101616|P2|NOT COMPLETED|Overall Study||0
449403|NCT01319422|1101617|P1|NOT COMPLETED|Overall Study||1
449404|NCT01319422|1101616|P2|COMPLETED|Overall Study||20
449405|NCT01319422|1101617|P1|COMPLETED|Overall Study||19
449406|NCT01319422|1101616|P2|STARTED|Overall Study||20
449407|NCT01319422|1101617|P1|STARTED|Overall Study||20
449408|NCT01319396|1101631|P1|NOT COMPLETED|Overall Study||0
449409|NCT01319396|1101631|P1|COMPLETED|Overall Study||24
449410|NCT01319396|1101631|P1|STARTED|Overall Study||24
449411|NCT01319383|1101635|P2|NOT COMPLETED|Overall Study||10
449412|NCT01319383|1101636|P1|NOT COMPLETED|Overall Study||12
449413|NCT01319383|1101635|P2|COMPLETED|Overall Study||3
449414|NCT01319383|1101636|P1|COMPLETED|Overall Study||0
449415|NCT01319383|1101635|P2|Step 4|Overall Study|Only 3/6 completed the study.|3
449416|NCT01319383|1101636|P1|Step 4|Overall Study|Arm 1 did not have a Step 4|0
449417|NCT01319383|1101635|P2|Step 3|Overall Study|3 Arm 1 participants enrolled here; 6/7 had in vivo response to 2 VOR doses given 72 hours apart.|6
449418|NCT01319383|1101636|P1|Step 3|Overall Study|None who qualified for the 2 series of 11 doses of VOR (taken M-T-W & off for 4 days for 4 wks).|0
449419|NCT01319383|1101635|P2|Step 2|Overall Study||0
449420|NCT01319383|1101636|P1|Step 2|Overall Study|The 4 without ex vivo response (Step 1) took a single dose to see if in vivo response would occur|4
449421|NCT01319383|1101635|P2|Step 2|Overall Study|The 7 participants without an in vivo response to single dose of VOR 400 mg PO were terminated.|4
449422|NCT01319383|1101636|P1|Step 2|Overall Study|These participants demonstrated an ex vivo response in Step 1|8
449423|NCT01319383|1101635|P2|Step 1|Overall Study|The 2 participants without an ex vivo response were terminated from the study.|11
449424|NCT01319383|1101636|P1|Step 1|Overall Study||8
449425|NCT01319383|1101635|P2|STARTED|Overall Study||13
449426|NCT01319383|1101636|P1|STARTED|Overall Study||12
449427|NCT01319318|1101653|P1|NOT COMPLETED|Overall Study||0
449428|NCT01319318|1101653|P1|COMPLETED|Overall Study||25
449429|NCT01319318|1101653|P1|STARTED|Overall Study||25
449430|NCT01319110|1101659|P2|NOT COMPLETED|Overall Study||0
449431|NCT01319110|1101660|P1|NOT COMPLETED|Overall Study||0
449432|NCT01319110|1101659|P2|COMPLETED|Overall Study||5
449433|NCT01319110|1101660|P1|COMPLETED|Overall Study||5
449434|NCT01319110|1101659|P2|STARTED|Overall Study||5
449435|NCT01319110|1101660|P1|STARTED|Overall Study||5
449436|NCT01319045|1101668|P1|NOT COMPLETED|Overall Study||2
449437|NCT01319045|1101668|P1|COMPLETED|Overall Study|Study was discontinued due to low enrollment|3
449438|NCT01319045|1101668|P1|STARTED|Overall Study||5
449439|NCT01318993|1101675|P1|NOT COMPLETED|Overall Study||398
449440|NCT01318993|1101675|P1|COMPLETED|Overall Study||0
449441|NCT01318993|1101675|P1|STARTED|Overall Study||398
449442|NCT01318967|1101691|P1|NOT COMPLETED|Overall Study||0
449443|NCT01318967|1101691|P1|COMPLETED|Overall Study||10
449444|NCT01318967|1101691|P1|STARTED|Overall Study||10
449445|NCT01318915|1101696|P1|NOT COMPLETED|Overall Study||8
449446|NCT01318915|1101696|P1|COMPLETED|Overall Study||2
449447|NCT01318915|1101696|P1|STARTED|Overall Study||10
449448|NCT01318876|1101700|P1|NOT COMPLETED|Day 29 Survey||1825
449449|NCT01318876|1101700|P1|COMPLETED|Day 29 Survey||5724
449450|NCT01318876|1101700|P1|STARTED|Day 29 Survey|All participants with a valid e-mail, have received the second survey|7549
449451|NCT01318876|1101700|P1|NOT COMPLETED|Day 8 Survey||1820
449452|NCT01318876|1101700|P1|COMPLETED|Day 8 Survey||5825
449453|NCT01318876|1101700|P1|STARTED|Day 8 Survey||7645
449454|NCT01318733|1101705|P1|NOT COMPLETED|Overall Study||170
449455|NCT01318733|1101705|P1|COMPLETED|Overall Study||279
449456|NCT01318733|1101705|P1|STARTED|Overall Study||449
449457|NCT01318694|1101713|P4|NOT COMPLETED|Overall Study||68
449458|NCT01318694|1101714|P3|NOT COMPLETED|Overall Study||43
449459|NCT01318694|1101715|P2|NOT COMPLETED|Overall Study||58
449460|NCT01318694|1101716|P1|NOT COMPLETED|Overall Study||52
449461|NCT01318694|1101713|P4|COMPLETED|Overall Study||200
449462|NCT01318694|1101714|P3|COMPLETED|Overall Study||225
449463|NCT01318694|1101715|P2|COMPLETED|Overall Study||212
449464|NCT01318694|1101716|P1|COMPLETED|Overall Study||223
449465|NCT01318694|1101713|P4|Safety Set|Overall Study||265
449466|NCT01318694|1101714|P3|Safety Set|Overall Study||265
449467|NCT01318694|1101715|P2|Safety Set|Overall Study||268
449468|NCT01318694|1101716|P1|Safety Set|Overall Study||273
449469|NCT01318694|1101713|P4|Full Analysis Set|Overall Study||268
449470|NCT01318694|1101714|P3|Full Analysis Set|Overall Study||265
449471|NCT01318694|1101715|P2|Full Analysis Set|Overall Study||270
449472|NCT01318694|1101716|P1|Full Analysis Set|Overall Study||274
449473|NCT01318694|1101713|P4|STARTED|Overall Study||268
449474|NCT01318694|1101714|P3|STARTED|Overall Study||268
449475|NCT01318694|1101715|P2|STARTED|Overall Study||270
449476|NCT01318694|1101716|P1|STARTED|Overall Study||275
449477|NCT01318538|1101772|P3|NOT COMPLETED|Overall Study||0
449478|NCT01318538|1101773|P2|NOT COMPLETED|Overall Study||0
449479|NCT01318538|1101774|P1|NOT COMPLETED|Overall Study||0
449480|NCT01318538|1101772|P3|COMPLETED|Overall Study||8
449481|NCT01318538|1101773|P2|COMPLETED|Overall Study||106
449482|NCT01318538|1101774|P1|COMPLETED|Overall Study||52
449483|NCT01318538|1101772|P3|STARTED|Overall Study||8
449484|NCT01318538|1101773|P2|STARTED|Overall Study||106
449485|NCT01318538|1101774|P1|STARTED|Overall Study||52
449486|NCT01318512|1101798|P1|NOT COMPLETED|Maintenance Period (6 Months)||11
449487|NCT01318512|1101798|P1|COMPLETED|Maintenance Period (6 Months)||329
449488|NCT01318512|1101798|P1|STARTED|Maintenance Period (6 Months)||340
449489|NCT01318512|1101798|P1|NOT COMPLETED|Titration Period (4 Months)||0
449490|NCT01318512|1101798|P1|COMPLETED|Titration Period (4 Months)||340
449491|NCT01318512|1101798|P1|STARTED|Titration Period (4 Months)||340
449492|NCT01318499|1101817|P3|NOT COMPLETED|Overall Study||147
449493|NCT01318499|1101818|P2|NOT COMPLETED|Overall Study||76
449494|NCT01318499|1101819|P1|NOT COMPLETED|Overall Study||65
449495|NCT01318499|1101817|P3|COMPLETED|Overall Study||121
449496|NCT01318499|1101818|P2|COMPLETED|Overall Study||458
449497|NCT01318499|1101819|P1|COMPLETED|Overall Study||475
449498|NCT01318499|1101817|P3|STARTED|Overall Study||268
449499|NCT01318499|1101818|P2|STARTED|Overall Study||534
449500|NCT01318499|1101819|P1|STARTED|Overall Study||540
449501|NCT01318408|1101837|P1|NOT COMPLETED|Overall Study||8
449502|NCT01318408|1101837|P1|COMPLETED|Overall Study||16
449503|NCT01318408|1101837|P1|STARTED|Overall Study||24
449504|NCT01318382|1101842|P1|NOT COMPLETED|Overall Study||13
449505|NCT01318382|1101842|P1|COMPLETED|Overall Study||289
449506|NCT01318382|1101842|P1|STARTED|Overall Study||302
449507|NCT01318278|1101852|P3|NOT COMPLETED|Overall Study||0
449508|NCT01318278|1101853|P2|NOT COMPLETED|Overall Study||0
449509|NCT01318278|1101854|P1|NOT COMPLETED|Overall Study||0
449510|NCT01318278|1101852|P3|COMPLETED|Overall Study||50
449511|NCT01318278|1101853|P2|COMPLETED|Overall Study||10
449512|NCT01318278|1101854|P1|COMPLETED|Overall Study||10
449513|NCT01318278|1101852|P3|STARTED|Overall Study||50
449514|NCT01318278|1101853|P2|STARTED|Overall Study||10
449515|NCT01318278|1101854|P1|STARTED|Overall Study||10
449516|NCT01318135|1101900|P8|NOT COMPLETED|Entered - Long-Term Extension Study||3
449517|NCT01318135|1101901|P7|NOT COMPLETED|Entered - Long-Term Extension Study||1
449518|NCT01318135|1101902|P6|NOT COMPLETED|Entered - Long-Term Extension Study||4
449519|NCT01318135|1101903|P5|NOT COMPLETED|Entered - Long-Term Extension Study||9
449520|NCT01318135|1101904|P4|NOT COMPLETED|Entered - Long-Term Extension Study||7
449521|NCT01318135|1101905|P3|NOT COMPLETED|Entered - Long-Term Extension Study||8
449522|NCT01318135|1101906|P2|NOT COMPLETED|Entered - Long-Term Extension Study||13
449523|NCT01318135|1101907|P1|NOT COMPLETED|Entered - Long-Term Extension Study||17
449524|NCT01318135|1101900|P8|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|46
449525|NCT01318135|1101901|P7|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|49
449526|NCT01318135|1101902|P6|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|83
449527|NCT01318135|1101903|P5|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|81
449528|NCT01318135|1101904|P4|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|42
449529|NCT01318135|1101905|P3|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|38
449530|NCT01318135|1101906|P2|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|89
449531|NCT01318135|1101907|P1|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|80
449532|NCT01318135|1101900|P8|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|49
449533|NCT01318135|1101901|P7|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|50
449534|NCT01318135|1101902|P6|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|87
449535|NCT01318135|1101903|P5|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|90
449536|NCT01318135|1101904|P4|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|49
449537|NCT01318135|1101905|P3|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|46
449538|NCT01318135|1101906|P2|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|102
449539|NCT01318135|1101907|P1|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|97
449540|NCT01318135|1101900|P8|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
449541|NCT01318135|1101901|P7|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
449542|NCT01318135|1101902|P6|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
449543|NCT01318135|1101903|P5|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
449544|NCT01318135|1101904|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
449545|NCT01318135|1101905|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
449546|NCT01318135|1101906|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
449547|NCT01318135|1101907|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
449548|NCT01318135|1101900|P8|COMPLETED|Enrolled - Long-Term Extension Study||49
449549|NCT01318135|1101901|P7|COMPLETED|Enrolled - Long-Term Extension Study||50
449550|NCT01318135|1101902|P6|COMPLETED|Enrolled - Long-Term Extension Study||90
449551|NCT01318135|1101903|P5|COMPLETED|Enrolled - Long-Term Extension Study||91
449552|NCT01318135|1101904|P4|COMPLETED|Enrolled - Long-Term Extension Study||49
449553|NCT01318135|1101905|P3|COMPLETED|Enrolled - Long-Term Extension Study||46
449554|NCT01318135|1101906|P2|COMPLETED|Enrolled - Long-Term Extension Study||102
449555|NCT01318135|1101907|P1|COMPLETED|Enrolled - Long-Term Extension Study||97
449556|NCT01318135|1101900|P8|STARTED|Enrolled - Long-Term Extension Study||49
449557|NCT01318135|1101901|P7|STARTED|Enrolled - Long-Term Extension Study||50
449558|NCT01318135|1101902|P6|STARTED|Enrolled - Long-Term Extension Study||90
449559|NCT01318135|1101903|P5|STARTED|Enrolled - Long-Term Extension Study||91
449560|NCT01318135|1101904|P4|STARTED|Enrolled - Long-Term Extension Study||49
449561|NCT01318135|1101905|P3|STARTED|Enrolled - Long-Term Extension Study||46
449562|NCT01318135|1101906|P2|STARTED|Enrolled - Long-Term Extension Study||102
449563|NCT01318135|1101907|P1|STARTED|Enrolled - Long-Term Extension Study||99
449564|NCT01318122|1102039|P4|NOT COMPLETED|Entered - Long-Term Extension Study||4
449565|NCT01318122|1102040|P3|NOT COMPLETED|Entered - Long-Term Extension Study||6
449566|NCT01318122|1102041|P2|NOT COMPLETED|Entered - Long-Term Extension Study||11
449567|NCT01318122|1102042|P1|NOT COMPLETED|Entered - Long-Term Extension Study||9
449568|NCT01318122|1102039|P4|COMPLETED|Entered - Long-Term Extension Study||48
449569|NCT01318122|1102040|P3|COMPLETED|Entered - Long-Term Extension Study||49
449570|NCT01318122|1102041|P2|COMPLETED|Entered - Long-Term Extension Study||99
449571|NCT01318122|1102042|P1|COMPLETED|Entered - Long-Term Extension Study||96
449572|NCT01318122|1102039|P4|STARTED|Entered - Long-Term Extension Study||52
449573|NCT01318122|1102040|P3|STARTED|Entered - Long-Term Extension Study||55
449574|NCT01318122|1102041|P2|STARTED|Entered - Long-Term Extension Study||110
449575|NCT01318122|1102042|P1|STARTED|Entered - Long-Term Extension Study||105
449576|NCT01318122|1102039|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
449577|NCT01318122|1102040|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
449578|NCT01318122|1102041|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
449579|NCT01318122|1102042|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
449580|NCT01318122|1102039|P4|COMPLETED|Enrolled - Long-Term Extension Study||52
449581|NCT01318122|1102040|P3|COMPLETED|Enrolled - Long-Term Extension Study||55
449582|NCT01318122|1102041|P2|COMPLETED|Enrolled - Long-Term Extension Study||110
449583|NCT01318122|1102042|P1|COMPLETED|Enrolled - Long-Term Extension Study||105
449584|NCT01318122|1102039|P4|STARTED|Enrolled - Long-Term Extension Study||53
449585|NCT01318122|1102040|P3|STARTED|Enrolled - Long-Term Extension Study||57
449586|NCT01318122|1102041|P2|STARTED|Enrolled - Long-Term Extension Study|5 randomized participants from alogliptin 12.5 & 25 mg group CCT-004 study did not enter this study|110
449587|NCT01318122|1102042|P1|STARTED|Enrolled - Long-Term Extension Study|5 randomized participants from alogliptin 12.5 & 25 mg group CCT-004 study did not enter this study|106
449588|NCT01318109|1102111|P3|NOT COMPLETED|Overall Study||0
449589|NCT01318109|1102112|P2|NOT COMPLETED|Overall Study||3
449590|NCT01318109|1102113|P1|NOT COMPLETED|Overall Study||1
449591|NCT01318109|1102111|P3|COMPLETED|Overall Study||100
449592|NCT01318109|1102112|P2|COMPLETED|Overall Study||93
449593|NCT01318109|1102113|P1|COMPLETED|Overall Study||91
449594|NCT01318109|1102111|P3|STARTED|Overall Study||100
449595|NCT01318109|1102112|P2|STARTED|Overall Study||96
449596|NCT01318109|1102113|P1|STARTED|Overall Study||92
449597|NCT01318083|1102148|P3|NOT COMPLETED|Overall Study||5
449598|NCT01318083|1102149|P2|NOT COMPLETED|Overall Study||2
449599|NCT01318083|1102150|P1|NOT COMPLETED|Overall Study||6
449600|NCT01318083|1102148|P3|COMPLETED|Overall Study||98
449601|NCT01318083|1102149|P2|COMPLETED|Overall Study||102
449602|NCT01318083|1102150|P1|COMPLETED|Overall Study||99
449603|NCT01318083|1102148|P3|STARTED|Overall Study||103
449604|NCT01318083|1102149|P2|STARTED|Overall Study||104
449605|NCT01318083|1102150|P1|STARTED|Overall Study||105
449606|NCT01318070|1102185|P3|NOT COMPLETED|Overall Study||7
449607|NCT01318070|1102186|P2|NOT COMPLETED|Overall Study||2
449608|NCT01318070|1102187|P1|NOT COMPLETED|Overall Study||2
449609|NCT01318070|1102185|P3|COMPLETED|Overall Study||108
449610|NCT01318070|1102186|P2|COMPLETED|Overall Study||111
449611|NCT01318070|1102187|P1|COMPLETED|Overall Study||109
449612|NCT01318070|1102185|P3|STARTED|Overall Study||115
449613|NCT01318070|1102186|P2|STARTED|Overall Study||113
449614|NCT01318070|1102187|P1|STARTED|Overall Study||111
449615|NCT01317901|1102221|P2|NOT COMPLETED|Overall Study||0
449616|NCT01317901|1102222|P1|NOT COMPLETED|Overall Study||0
449617|NCT01317901|1102221|P2|COMPLETED|Overall Study||6
449618|NCT01317901|1102222|P1|COMPLETED|Overall Study||6
449619|NCT01317901|1102221|P2|STARTED|Overall Study||6
449620|NCT01317901|1102222|P1|STARTED|Overall Study||6
449621|NCT01317797|1102231|P3|NOT COMPLETED|Overall Study||1
449622|NCT01317797|1102232|P2|NOT COMPLETED|Overall Study||1
449623|NCT01317797|1102233|P1|NOT COMPLETED|Overall Study||0
449624|NCT01317797|1102231|P3|COMPLETED|Overall Study||8
449625|NCT01317797|1102232|P2|COMPLETED|Overall Study||6
449626|NCT01317797|1102233|P1|COMPLETED|Overall Study||8
449627|NCT01317797|1102231|P3|STARTED|Overall Study||9
449628|NCT01317797|1102232|P2|STARTED|Overall Study||7
449629|NCT01317797|1102233|P1|STARTED|Overall Study||8
449630|NCT01317667|1102288|P3|NOT COMPLETED|Overall Study||0
449631|NCT01317667|1102289|P2|NOT COMPLETED|Overall Study||0
449632|NCT01317667|1102290|P1|NOT COMPLETED|Overall Study||0
449633|NCT01317667|1102288|P3|COMPLETED|Overall Study|The original trial design was modified to limit the number of vaccinations in Group 3 to 1 dose.|10
449634|NCT01317667|1102289|P2|COMPLETED|Overall Study||10
449635|NCT01317667|1102290|P1|COMPLETED|Overall Study||10
449636|NCT01317667|1102288|P3|STARTED|Overall Study||10
449637|NCT01317667|1102289|P2|STARTED|Overall Study||10
449638|NCT01317667|1102290|P1|STARTED|Overall Study||10
449639|NCT01317641|1102310|P9|NOT COMPLETED|Overall Study||5
449640|NCT01317641|1102311|P8|NOT COMPLETED|Overall Study||5
449641|NCT01317641|1102312|P7|NOT COMPLETED|Overall Study||3
449642|NCT01317641|1102313|P6|NOT COMPLETED|Overall Study||0
449643|NCT01317641|1102314|P5|NOT COMPLETED|Overall Study||0
449644|NCT01317641|1102315|P4|NOT COMPLETED|Overall Study||1
449645|NCT01317641|1102316|P3|NOT COMPLETED|Overall Study||0
449646|NCT01317641|1102317|P2|NOT COMPLETED|Overall Study||1
449647|NCT01317641|1102318|P1|NOT COMPLETED|Overall Study||1
449648|NCT01317641|1102310|P9|COMPLETED|Overall Study||31
449649|NCT01317641|1102311|P8|COMPLETED|Overall Study||33
449650|NCT01317641|1102312|P7|COMPLETED|Overall Study||35
449651|NCT01317641|1102313|P6|COMPLETED|Overall Study||3
449652|NCT01317641|1102314|P5|COMPLETED|Overall Study||3
449653|NCT01317641|1102315|P4|COMPLETED|Overall Study||3
449654|NCT01317641|1102316|P3|COMPLETED|Overall Study||3
449655|NCT01317641|1102317|P2|COMPLETED|Overall Study||6
449656|NCT01317641|1102318|P1|COMPLETED|Overall Study||3
449657|NCT01317641|1102310|P9|STARTED|Overall Study||36
449658|NCT01317641|1102311|P8|STARTED|Overall Study||38
449659|NCT01317641|1102312|P7|STARTED|Overall Study||38
449660|NCT01317641|1102313|P6|STARTED|Overall Study||3
449661|NCT01317641|1102314|P5|STARTED|Overall Study||3
449662|NCT01317641|1102315|P4|STARTED|Overall Study||4
449663|NCT01317641|1102316|P3|STARTED|Overall Study||3
449664|NCT01317641|1102317|P2|STARTED|Overall Study||7
449665|NCT01317641|1102318|P1|STARTED|Overall Study||4
449666|NCT01317615|1102420|P1|NOT COMPLETED|Overall Study||49
449667|NCT01317615|1102420|P1|COMPLETED|Overall Study||0
449668|NCT01317615|1102420|P1|STARTED|Overall Study||49
449669|NCT01317160|1102431|P2|NOT COMPLETED|Overall Study||6
449670|NCT01317160|1102432|P1|NOT COMPLETED|Overall Study||4
449671|NCT01317160|1102431|P2|COMPLETED|Overall Study||69
449672|NCT01317160|1102432|P1|COMPLETED|Overall Study||71
449673|NCT01317160|1102431|P2|Allocation to Treatment|Overall Study|1 patient was incorrect included|74
449674|NCT01317160|1102432|P1|Allocation to Treatment|Overall Study|1 patient was incorrect included|74
449675|NCT01317160|1102431|P2|STARTED|Overall Study||75
449676|NCT01317160|1102432|P1|STARTED|Overall Study||75
449677|NCT01317095|1102442|P2|NOT COMPLETED|Overall Study||0
449678|NCT01317095|1102443|P1|NOT COMPLETED|Overall Study||0
449679|NCT01317095|1102442|P2|COMPLETED|Overall Study||41
449680|NCT01317095|1102443|P1|COMPLETED|Overall Study||39
449681|NCT01317095|1102442|P2|STARTED|Overall Study||41
449682|NCT01317095|1102443|P1|STARTED|Overall Study||39
449683|NCT01317004|1102457|P2|NOT COMPLETED|Overall Study||9
449684|NCT01317004|1102458|P1|NOT COMPLETED|Overall Study||4
449685|NCT01317004|1102457|P2|COMPLETED|Overall Study||5
449686|NCT01317004|1102458|P1|COMPLETED|Overall Study||47
449687|NCT01317004|1102457|P2|Safety Set|Overall Study||11
449688|NCT01317004|1102458|P1|Safety Set|Overall Study||50
449689|NCT01317004|1102457|P2|STARTED|Overall Study||14
449690|NCT01317004|1102458|P1|STARTED|Overall Study||51
449691|NCT01316939|1102479|P3|NOT COMPLETED|Overall Study||69
449692|NCT01316939|1102480|P2|NOT COMPLETED|Overall Study||68
449693|NCT01316939|1102481|P1|NOT COMPLETED|Overall Study||63
449694|NCT01316939|1102479|P3|COMPLETED|Overall Study||7
449695|NCT01316939|1102480|P2|COMPLETED|Overall Study||9
449696|NCT01316939|1102481|P1|COMPLETED|Overall Study||13
449697|NCT01316939|1102479|P3|STARTED|Overall Study||76
449698|NCT01316939|1102480|P2|STARTED|Overall Study||77
449699|NCT01316939|1102481|P1|STARTED|Overall Study||76
449700|NCT01316926|1102561|P2|NOT COMPLETED|Period 2||0
449701|NCT01316926|1102562|P1|NOT COMPLETED|Period 2||0
449702|NCT01316926|1102561|P2|COMPLETED|Period 2||30
449703|NCT01316926|1102562|P1|COMPLETED|Period 2||29
449704|NCT01316926|1102561|P2|STARTED|Period 2||30
449705|NCT01316926|1102562|P1|STARTED|Period 2|One participant completed Period 1, but did not appear in Period 2|29
449706|NCT01316926|1102561|P2|NOT COMPLETED|Period 1||0
449707|NCT01316926|1102562|P1|NOT COMPLETED|Period 1||0
449708|NCT01316926|1102561|P2|COMPLETED|Period 1||30
449709|NCT01316926|1102562|P1|COMPLETED|Period 1||30
449710|NCT01316926|1102561|P2|STARTED|Period 1||30
449711|NCT01316926|1102562|P1|STARTED|Period 1||30
449712|NCT01316913|1102576|P4|NOT COMPLETED|Overall Study||39
449713|NCT01316913|1102577|P3|NOT COMPLETED|Overall Study||49
449714|NCT01316913|1102578|P2|NOT COMPLETED|Overall Study||54
449715|NCT01316913|1102579|P1|NOT COMPLETED|Overall Study||57
449716|NCT01316913|1102576|P4|COMPLETED|Overall Study||176
449717|NCT01316913|1102577|P3|COMPLETED|Overall Study||166
449718|NCT01316913|1102578|P2|COMPLETED|Overall Study||163
449719|NCT01316913|1102579|P1|COMPLETED|Overall Study||165
449720|NCT01316913|1102576|P4|STARTED|Overall Study||215
449721|NCT01316913|1102577|P3|STARTED|Overall Study||215
449722|NCT01316913|1102578|P2|STARTED|Overall Study||217
449723|NCT01316913|1102579|P1|STARTED|Overall Study||222
449724|NCT01316900|1102601|P4|NOT COMPLETED|Overall Study||31
449725|NCT01316900|1102602|P3|NOT COMPLETED|Overall Study||41
449726|NCT01316900|1102603|P2|NOT COMPLETED|Overall Study||31
449727|NCT01316900|1102604|P1|NOT COMPLETED|Overall Study||44
449728|NCT01316900|1102601|P4|COMPLETED|Overall Study||177
449729|NCT01316900|1102602|P3|COMPLETED|Overall Study||173
449730|NCT01316900|1102603|P2|COMPLETED|Overall Study||181
449731|NCT01316900|1102604|P1|COMPLETED|Overall Study||165
449732|NCT01316900|1102601|P4|STARTED|Overall Study||208
449733|NCT01316900|1102602|P3|STARTED|Overall Study||214
449734|NCT01316900|1102603|P2|STARTED|Overall Study||212
449735|NCT01316900|1102604|P1|STARTED|Overall Study||209
449736|NCT01316887|1102625|P3|NOT COMPLETED|Overall Study||83
449737|NCT01316887|1102626|P2|NOT COMPLETED|Overall Study||94
449738|NCT01316887|1102627|P1|NOT COMPLETED|Overall Study||43
449739|NCT01316887|1102625|P3|COMPLETED|Overall Study||143
449740|NCT01316887|1102626|P2|COMPLETED|Overall Study||133
449741|NCT01316887|1102627|P1|COMPLETED|Overall Study||66
449742|NCT01316887|1102625|P3|STARTED|Overall Study||226
449743|NCT01316887|1102626|P2|STARTED|Overall Study||227
449744|NCT01316887|1102627|P1|STARTED|Overall Study||109
449745|NCT01316692|1102689|P1|NOT COMPLETED|Overall Study||12
449746|NCT01316692|1102689|P1|COMPLETED|Overall Study||0
449747|NCT01316692|1102689|P1|STARTED|Overall Study||12
449748|NCT01316614|1102698|P1|NOT COMPLETED|Overall Study||37
449749|NCT01316614|1102698|P1|COMPLETED|Overall Study||100
449750|NCT01316614|1102698|P1|STARTED|Overall Study||137
449751|NCT01316575|1102715|P2|NOT COMPLETED|Overall Study||1
449752|NCT01316575|1102716|P1|NOT COMPLETED|Overall Study||2
449753|NCT01316575|1102715|P2|COMPLETED|Overall Study||19
449754|NCT01316575|1102716|P1|COMPLETED|Overall Study||18
449755|NCT01316575|1102715|P2|STARTED|Overall Study||20
449756|NCT01316575|1102716|P1|STARTED|Overall Study||20
449757|NCT01316419|1102728|P1|NOT COMPLETED|Overall Study||265
449758|NCT01316419|1102728|P1|COMPLETED|Overall Study||1824
449759|NCT01316419|1102728|P1|STARTED|Overall Study||2089
449760|NCT01316380|1102754|P3|NOT COMPLETED|Overall Study||3
449761|NCT01316380|1102755|P2|NOT COMPLETED|Overall Study||5
449762|NCT01316380|1102756|P1|NOT COMPLETED|Overall Study||2
449763|NCT01316380|1102754|P3|COMPLETED|Overall Study||152
449764|NCT01316380|1102755|P2|COMPLETED|Overall Study||149
449765|NCT01316380|1102756|P1|COMPLETED|Overall Study||154
449766|NCT01316380|1102754|P3|STARTED|Overall Study||155
449767|NCT01316380|1102755|P2|STARTED|Overall Study||154
449768|NCT01316380|1102756|P1|STARTED|Overall Study||156
449769|NCT01316341|1102797|P3|NOT COMPLETED|Overall Study||0
449770|NCT01316341|1102798|P2|NOT COMPLETED|Overall Study||0
449771|NCT01316341|1102799|P1|NOT COMPLETED|Overall Study||0
449772|NCT01316341|1102797|P3|COMPLETED|Overall Study||9
449773|NCT01316341|1102798|P2|COMPLETED|Overall Study||9
449774|NCT01316341|1102799|P1|COMPLETED|Overall Study||6
449775|NCT01316341|1102797|P3|STARTED|Overall Study||9
449776|NCT01316341|1102798|P2|STARTED|Overall Study||9
449777|NCT01316341|1102799|P1|STARTED|Overall Study||6
449778|NCT01316315|1102867|P2|NOT COMPLETED|Sequence 2||0
449779|NCT01316315|1102868|P1|NOT COMPLETED|Sequence 2||0
449780|NCT01316315|1102867|P2|COMPLETED|Sequence 2||7
449781|NCT01316315|1102868|P1|COMPLETED|Sequence 2||7
449782|NCT01316315|1102867|P2|STARTED|Sequence 2||7
449783|NCT01316315|1102868|P1|STARTED|Sequence 2||7
449784|NCT01316315|1102867|P2|NOT COMPLETED|Sequence 1||0
449785|NCT01316315|1102868|P1|NOT COMPLETED|Sequence 1||0
449786|NCT01316315|1102867|P2|COMPLETED|Sequence 1||7
449787|NCT01316315|1102868|P1|COMPLETED|Sequence 1||7
449788|NCT01316315|1102867|P2|STARTED|Sequence 1||7
449789|NCT01316315|1102868|P1|STARTED|Sequence 1||7
449790|NCT01316302|1102882|P2|NOT COMPLETED|Overall Study||11
449791|NCT01316302|1102883|P1|NOT COMPLETED|Overall Study||10
449792|NCT01316302|1102882|P2|COMPLETED|Overall Study||22
449793|NCT01316302|1102883|P1|COMPLETED|Overall Study||20
449794|NCT01316302|1102882|P2|STARTED|Overall Study||33
449795|NCT01316302|1102883|P1|STARTED|Overall Study||30
449796|NCT01316263|1102895|P2|NOT COMPLETED|Overall Study||0
449797|NCT01316263|1102896|P1|NOT COMPLETED|Overall Study||0
449798|NCT01316263|1102895|P2|COMPLETED|Overall Study||14
449799|NCT01316263|1102896|P1|COMPLETED|Overall Study||7
449800|NCT01316263|1102895|P2|Received Any Study Drug|Overall Study||14
449801|NCT01316263|1102896|P1|Received Any Study Drug|Overall Study||7
449802|NCT01316263|1102895|P2|STARTED|Overall Study||14
449803|NCT01316263|1102896|P1|STARTED|Overall Study||7
449804|NCT01316224|1102922|P1|NOT COMPLETED|Overall Study||10
449805|NCT01316224|1102922|P1|COMPLETED|Overall Study||42
449806|NCT01316224|1102922|P1|Completed Visit 4 to Rheumatologist|Overall Study||28
449807|NCT01316224|1102922|P1|Completed Visit 4 to Dermatologist|Overall Study||42
449808|NCT01316224|1102922|P1|Completed Visit 3 to Rheumatologist|Overall Study||39
449809|NCT01316224|1102922|P1|Completed Visit 3 to Dermatologist|Overall Study||48
449810|NCT01316224|1102922|P1|Completed Visit 2 to Dermatologist|Overall Study||51
449811|NCT01316224|1102922|P1|Completed Visit 1 to Rheumatologist|Overall Study||49
449812|NCT01316224|1102922|P1|Completed Visit 1 to Dermatologist|Overall Study||52
449813|NCT01316224|1102922|P1|STARTED|Overall Study||52
449814|NCT01316055|1102939|P3|NOT COMPLETED|Overall Study||0
449815|NCT01316055|1102940|P2|NOT COMPLETED|Overall Study||0
449816|NCT01316055|1102941|P1|NOT COMPLETED|Overall Study||1
449817|NCT01316055|1102939|P3|COMPLETED|Overall Study||12
449818|NCT01316055|1102940|P2|COMPLETED|Overall Study||17
449819|NCT01316055|1102941|P1|COMPLETED|Overall Study||12
449820|NCT01316055|1102939|P3|STARTED|Overall Study||12
449821|NCT01316055|1102940|P2|STARTED|Overall Study||17
449822|NCT01316055|1102941|P1|STARTED|Overall Study||13
449823|NCT01316042|1102957|P2|NOT COMPLETED|Overall Study||1
449824|NCT01316042|1102958|P1|NOT COMPLETED|Overall Study||0
449825|NCT01316042|1102957|P2|COMPLETED|Overall Study||1
449826|NCT01316042|1102958|P1|COMPLETED|Overall Study||2
449827|NCT01316042|1102957|P2|STARTED|Overall Study||2
449828|NCT01316042|1102958|P1|STARTED|Overall Study||2
449829|NCT01315873|1102964|P1|NOT COMPLETED|Overall Study||0
449830|NCT01315873|1102964|P1|COMPLETED|Overall Study||24
449831|NCT01315873|1102964|P1|STARTED|Overall Study||24
449832|NCT01315847|1102972|P2|NOT COMPLETED|Part III, Period 2||0
449833|NCT01315847|1102973|P1|NOT COMPLETED|Part III, Period 2||0
449834|NCT01315847|1102972|P2|COMPLETED|Part III, Period 2||3
449835|NCT01315847|1102973|P1|COMPLETED|Part III, Period 2||0
449836|NCT01315847|1102972|P2|Received [11C]MK-4232|Part III, Period 2||3
449837|NCT01315847|1102973|P1|Received [11C]MK-4232|Part III, Period 2||0
449838|NCT01315847|1102972|P2|Received Telcagepant|Part III, Period 2||3
449839|NCT01315847|1102973|P1|Received Telcagepant|Part III, Period 2||0
449840|NCT01315847|1102972|P2|STARTED|Part III, Period 2||3
449841|NCT01315847|1102973|P1|STARTED|Part III, Period 2||0
449842|NCT01315847|1102972|P2|NOT COMPLETED|Part III, Period 1||1
449843|NCT01315847|1102973|P1|NOT COMPLETED|Part III, Period 1||0
449844|NCT01315847|1102972|P2|COMPLETED|Part III, Period 1||3
449845|NCT01315847|1102973|P1|COMPLETED|Part III, Period 1||0
449846|NCT01315847|1102972|P2|Received [11C]MK-4232|Part III, Period 1|One of these participants received [11C]MK-4232 only at baseline.|4
449847|NCT01315847|1102973|P1|Received [11C]MK-4232|Part III, Period 1||0
449848|NCT01315847|1102972|P2|Received Telcagepant|Part III, Period 1||4
449849|NCT01315847|1102973|P1|Received Telcagepant|Part III, Period 1||0
449850|NCT01315847|1102972|P2|STARTED|Part III, Period 1|Subjects who participated in Part III did not participate in Part I.|4
449851|NCT01315847|1102973|P1|STARTED|Part III, Period 1||0
449852|NCT01315847|1102972|P2|NOT COMPLETED|Part I, Period 2||0
449853|NCT01315847|1102973|P1|NOT COMPLETED|Part I, Period 2||0
449854|NCT01315847|1102972|P2|COMPLETED|Part I, Period 2||0
449855|NCT01315847|1102973|P1|COMPLETED|Part I, Period 2||3
449856|NCT01315847|1102972|P2|Received [11C]MK-4232|Part I, Period 2||0
449857|NCT01315847|1102973|P1|Received [11C]MK-4232|Part I, Period 2||3
449858|NCT01315847|1102972|P2|Received Telcagepant|Part I, Period 2||0
449859|NCT01315847|1102973|P1|Received Telcagepant|Part I, Period 2||3
449860|NCT01315847|1102972|P2|STARTED|Part I, Period 2||0
449861|NCT01315847|1102973|P1|STARTED|Part I, Period 2|One of these subjects did not participate in Part I, Period 1.|3
449862|NCT01315847|1102972|P2|NOT COMPLETED|Part I, Period 1||0
449863|NCT01315847|1102973|P1|NOT COMPLETED|Part I, Period 1||3
449864|NCT01315847|1102972|P2|COMPLETED|Part I, Period 1||0
449865|NCT01315847|1102973|P1|COMPLETED|Part I, Period 1||2
449866|NCT01315847|1102972|P2|Received [11C]MK-4232|Part I, Period 1||0
449867|NCT01315847|1102973|P1|Received [11C]MK-4232|Part I, Period 1|One of these participants received [11C]MK-4232 only at baseline.|5
449868|NCT01315847|1102972|P2|Received Telcagepant|Part I, Period 1||0
449869|NCT01315847|1102973|P1|Received Telcagepant|Part I, Period 1||5
449870|NCT01315847|1102972|P2|STARTED|Part I, Period 1||0
449871|NCT01315847|1102973|P1|STARTED|Part I, Period 1|Subjects who participated in Part I did not participate in Part III.|5
449872|NCT01315665|1102987|P2|NOT COMPLETED|Overall Study||0
449873|NCT01315665|1102988|P1|NOT COMPLETED|Overall Study||0
449874|NCT01315665|1102987|P2|COMPLETED|Overall Study||5
449875|NCT01315665|1102988|P1|COMPLETED|Overall Study||10
449876|NCT01315665|1102987|P2|STARTED|Overall Study||5
449877|NCT01315665|1102988|P1|STARTED|Overall Study||10
449878|NCT01315574|1103004|P2|NOT COMPLETED|Overall Study||0
449879|NCT01315574|1103005|P1|NOT COMPLETED|Overall Study||0
449880|NCT01315574|1103004|P2|COMPLETED|Overall Study||7
449881|NCT01315574|1103005|P1|COMPLETED|Overall Study||7
449882|NCT01315574|1103004|P2|STARTED|Overall Study||7
449883|NCT01315574|1103005|P1|STARTED|Overall Study||7
449884|NCT01315353|1103018|P3|NOT COMPLETED|Overall Study||13
449885|NCT01315353|1103019|P2|NOT COMPLETED|Overall Study||23
449886|NCT01315353|1103020|P1|NOT COMPLETED|Overall Study||29
449887|NCT01315353|1103018|P3|COMPLETED|Overall Study||166
449888|NCT01315353|1103019|P2|COMPLETED|Overall Study||120
449889|NCT01315353|1103020|P1|COMPLETED|Overall Study||116
449890|NCT01315353|1103018|P3|STARTED|Overall Study||179
449891|NCT01315353|1103019|P2|STARTED|Overall Study||143
449892|NCT01315353|1103020|P1|STARTED|Overall Study||145
449893|NCT01315249|1103047|P2|NOT COMPLETED|Overall Study||47
449894|NCT01315249|1103048|P1|NOT COMPLETED|Overall Study||44
449895|NCT01315249|1103047|P2|COMPLETED|Overall Study||217
449896|NCT01315249|1103048|P1|COMPLETED|Overall Study||215
449897|NCT01315249|1103047|P2|STARTED|Overall Study||264
449898|NCT01315249|1103048|P1|STARTED|Overall Study||259
449899|NCT01315158|1103076|P2|NOT COMPLETED|Overall Study||0
449900|NCT01315158|1103077|P1|NOT COMPLETED|Overall Study||0
449901|NCT01315158|1103076|P2|COMPLETED|Overall Study||19
449902|NCT01315158|1103077|P1|COMPLETED|Overall Study||17
449903|NCT01315158|1103076|P2|STARTED|Overall Study||19
449904|NCT01315158|1103077|P1|STARTED|Overall Study||17
449905|NCT01315145|1103101|P2|NOT COMPLETED|Overall Study||5
449906|NCT01315145|1103102|P1|NOT COMPLETED|Overall Study||17
449907|NCT01315145|1103101|P2|COMPLETED|Overall Study||11
449908|NCT01315145|1103102|P1|COMPLETED|Overall Study||105
449909|NCT01315145|1103101|P2|STARTED|Overall Study||16
449910|NCT01315145|1103102|P1|STARTED|Overall Study||122
449911|NCT01315028|1103110|P2|NOT COMPLETED|Overall Study||1
449912|NCT01315028|1103111|P1|NOT COMPLETED|Overall Study||1
449913|NCT01315028|1103110|P2|COMPLETED|Overall Study||9
449914|NCT01315028|1103111|P1|COMPLETED|Overall Study||9
449915|NCT01315028|1103110|P2|STARTED|Overall Study||10
449916|NCT01315028|1103111|P1|STARTED|Overall Study||10
449917|NCT01315002|1103123|P2|NOT COMPLETED|Overall Study||5
449918|NCT01315002|1103124|P1|NOT COMPLETED|Overall Study||5
449919|NCT01315002|1103123|P2|COMPLETED|Overall Study||55
449920|NCT01315002|1103124|P1|COMPLETED|Overall Study||56
449921|NCT01315002|1103123|P2|STARTED|Overall Study||60
449922|NCT01315002|1103124|P1|STARTED|Overall Study||61
449923|NCT01314963|1103130|P1|NOT COMPLETED|Overall Study||0
449924|NCT01314963|1103130|P1|COMPLETED|Overall Study||50
449925|NCT01314963|1103130|P1|STARTED|Overall Study||50
449926|NCT01314872|1103147|P15|NOT COMPLETED|Period 2||24
449927|NCT01314872|1103148|P14|NOT COMPLETED|Period 2||53
449928|NCT01314872|1103149|P13|NOT COMPLETED|Period 2||60
449929|NCT01314872|1103150|P12|NOT COMPLETED|Period 2||48
449930|NCT01314872|1103151|P11|NOT COMPLETED|Period 2||0
449931|NCT01314872|1103152|P10|NOT COMPLETED|Period 2||0
449932|NCT01314872|1103153|P9|NOT COMPLETED|Period 2||0
449933|NCT01314872|1103154|P8|NOT COMPLETED|Period 2||0
449934|NCT01314872|1103155|P7|NOT COMPLETED|Period 2||0
449935|NCT01314872|1103156|P6|NOT COMPLETED|Period 2||0
449936|NCT01314872|1103157|P5|NOT COMPLETED|Period 2||0
449937|NCT01314872|1103158|P4|NOT COMPLETED|Period 2||0
449938|NCT01314872|1103159|P3|NOT COMPLETED|Period 2||0
449939|NCT01314872|1103160|P2|NOT COMPLETED|Period 2||0
449940|NCT01314872|1103161|P1|NOT COMPLETED|Period 2||0
449941|NCT01314872|1103147|P15|COMPLETED|Period 2||110
449942|NCT01314872|1103148|P14|COMPLETED|Period 2||187
449943|NCT01314872|1103149|P13|COMPLETED|Period 2||188
449944|NCT01314872|1103150|P12|COMPLETED|Period 2||175
449945|NCT01314872|1103151|P11|COMPLETED|Period 2||0
449946|NCT01314872|1103152|P10|COMPLETED|Period 2||0
449947|NCT01314872|1103153|P9|COMPLETED|Period 2||0
449948|NCT01314872|1103154|P8|COMPLETED|Period 2||0
449949|NCT01314872|1103155|P7|COMPLETED|Period 2||0
449950|NCT01314872|1103156|P6|COMPLETED|Period 2||0
449951|NCT01314872|1103157|P5|COMPLETED|Period 2||0
449952|NCT01314872|1103158|P4|COMPLETED|Period 2||0
449953|NCT01314872|1103159|P3|COMPLETED|Period 2||0
449954|NCT01314872|1103160|P2|COMPLETED|Period 2||0
449955|NCT01314872|1103161|P1|COMPLETED|Period 2||0
449956|NCT01314872|1103147|P15|STARTED|Period 2||134
449957|NCT01314872|1103148|P14|STARTED|Period 2||240
449958|NCT01314872|1103149|P13|STARTED|Period 2||248
449959|NCT01314872|1103150|P12|STARTED|Period 2||223
449960|NCT01314872|1103151|P11|STARTED|Period 2||0
449961|NCT01314872|1103152|P10|STARTED|Period 2||0
449962|NCT01314872|1103153|P9|STARTED|Period 2||0
449963|NCT01314872|1103154|P8|STARTED|Period 2||0
449964|NCT01314872|1103155|P7|STARTED|Period 2||0
449965|NCT01314872|1103156|P6|STARTED|Period 2||0
449966|NCT01314872|1103157|P5|STARTED|Period 2||0
449967|NCT01314872|1103158|P4|STARTED|Period 2||0
449968|NCT01314872|1103159|P3|STARTED|Period 2||0
449969|NCT01314872|1103160|P2|STARTED|Period 2||0
449970|NCT01314872|1103161|P1|STARTED|Period 2||0
449971|NCT01314872|1103147|P15|NOT COMPLETED|Treatment Period 1||0
449972|NCT01314872|1103148|P14|NOT COMPLETED|Treatment Period 1||0
449973|NCT01314872|1103149|P13|NOT COMPLETED|Treatment Period 1||0
449974|NCT01314872|1103150|P12|NOT COMPLETED|Treatment Period 1||0
449975|NCT01314872|1103151|P11|NOT COMPLETED|Treatment Period 1||3
449976|NCT01314872|1103152|P10|NOT COMPLETED|Treatment Period 1||4
449977|NCT01314872|1103153|P9|NOT COMPLETED|Treatment Period 1||6
449978|NCT01314872|1103154|P8|NOT COMPLETED|Treatment Period 1||7
449979|NCT01314872|1103155|P7|NOT COMPLETED|Treatment Period 1||8
449980|NCT01314872|1103156|P6|NOT COMPLETED|Treatment Period 1||7
449981|NCT01314872|1103157|P5|NOT COMPLETED|Treatment Period 1||7
449982|NCT01314872|1103158|P4|NOT COMPLETED|Treatment Period 1||7
449983|NCT01314872|1103159|P3|NOT COMPLETED|Treatment Period 1||6
449984|NCT01314872|1103160|P2|NOT COMPLETED|Treatment Period 1||6
449985|NCT01314872|1103161|P1|NOT COMPLETED|Treatment Period 1||10
449986|NCT01314872|1103147|P15|COMPLETED|Treatment Period 1||0
449987|NCT01314872|1103148|P14|COMPLETED|Treatment Period 1||0
449988|NCT01314872|1103149|P13|COMPLETED|Treatment Period 1||0
449989|NCT01314872|1103150|P12|COMPLETED|Treatment Period 1||0
449990|NCT01314872|1103151|P11|COMPLETED|Treatment Period 1||107
449991|NCT01314872|1103152|P10|COMPLETED|Treatment Period 1||118
449992|NCT01314872|1103153|P9|COMPLETED|Treatment Period 1||106
449993|NCT01314872|1103154|P8|COMPLETED|Treatment Period 1||57
449994|NCT01314872|1103155|P7|COMPLETED|Treatment Period 1||126
449995|NCT01314872|1103156|P6|COMPLETED|Treatment Period 1||128
449996|NCT01314872|1103157|P5|COMPLETED|Treatment Period 1||142
449997|NCT01314872|1103158|P4|COMPLETED|Treatment Period 1||143
449998|NCT01314872|1103159|P3|COMPLETED|Treatment Period 1||128
449999|NCT01314872|1103160|P2|COMPLETED|Treatment Period 1||138
450000|NCT01314872|1103161|P1|COMPLETED|Treatment Period 1||131
450001|NCT01314872|1103147|P15|STARTED|Treatment Period 1||0
450002|NCT01314872|1103148|P14|STARTED|Treatment Period 1||0
450003|NCT01314872|1103149|P13|STARTED|Treatment Period 1||0
450004|NCT01314872|1103150|P12|STARTED|Treatment Period 1||0
450005|NCT01314872|1103151|P11|STARTED|Treatment Period 1||110
450006|NCT01314872|1103152|P10|STARTED|Treatment Period 1||122
450007|NCT01314872|1103153|P9|STARTED|Treatment Period 1||112
450008|NCT01314872|1103154|P8|STARTED|Treatment Period 1||64
450009|NCT01314872|1103155|P7|STARTED|Treatment Period 1||134
450010|NCT01314872|1103156|P6|STARTED|Treatment Period 1||135
450011|NCT01314872|1103157|P5|STARTED|Treatment Period 1||149
450012|NCT01314872|1103158|P4|STARTED|Treatment Period 1||150
450013|NCT01314872|1103159|P3|STARTED|Treatment Period 1||134
450014|NCT01314872|1103160|P2|STARTED|Treatment Period 1||144
450015|NCT01314872|1103161|P1|STARTED|Treatment Period 1||141
450016|NCT01314742|1103254|P2|NOT COMPLETED|Overall Study||0
450017|NCT01314742|1103255|P1|NOT COMPLETED|Overall Study||0
450018|NCT01314742|1103254|P2|COMPLETED|Overall Study||21
450019|NCT01314742|1103255|P1|COMPLETED|Overall Study||20
450020|NCT01314742|1103254|P2|STARTED|Overall Study||21
450021|NCT01314742|1103255|P1|STARTED|Overall Study||20
450022|NCT01314716|1103265|P2|NOT COMPLETED|Open-Label Phase||12
450023|NCT01314716|1103266|P1|NOT COMPLETED|Open-Label Phase||10
450024|NCT01314716|1103265|P2|COMPLETED|Open-Label Phase||98
450025|NCT01314716|1103266|P1|COMPLETED|Open-Label Phase||102
450026|NCT01314716|1103265|P2|STARTED|Open-Label Phase|13 participants in this group did not continue from the randomized to the open-label phase.|110
450027|NCT01314716|1103266|P1|STARTED|Open-Label Phase|7 participants in this group did not continue from the randomized to the open-label phase.|112
450028|NCT01314716|1103265|P2|NOT COMPLETED|Double-Blind Phase||15
450029|NCT01314716|1103266|P1|NOT COMPLETED|Double-Blind Phase||17
450030|NCT01314716|1103265|P2|COMPLETED|Double-Blind Phase||123
450031|NCT01314716|1103266|P1|COMPLETED|Double-Blind Phase||119
450032|NCT01314716|1103265|P2|Randomized and Treated|Double-Blind Phase||137
450033|NCT01314716|1103266|P1|Randomized and Treated|Double-Blind Phase||135
450034|NCT01314716|1103265|P2|STARTED|Double-Blind Phase||138
450035|NCT01314716|1103266|P1|STARTED|Double-Blind Phase||136
450036|NCT01314703|1103278|P1|NOT COMPLETED|Overall Study||8
450037|NCT01314703|1103278|P1|COMPLETED|Overall Study||27
450038|NCT01314703|1103278|P1|Discontinued When Enrollment Completed|Overall Study||3
450039|NCT01314703|1103278|P1|Non Qualified Bacterial Screening Counts|Overall Study||3
450040|NCT01314703|1103278|P1|Excluded Prior to Screening Baseline|Overall Study||2
450041|NCT01314703|1103278|P1|Completed Study|Overall Study||27
450042|NCT01314703|1103278|P1|Completed Treatment Visit|Overall Study||27
450043|NCT01314703|1103278|P1|Completed Screen Visit|Overall Study||33
450044|NCT01314703|1103278|P1|Signed Informed Consent|Overall Study||35
450045|NCT01314703|1103278|P1|STARTED|Overall Study||35
450046|NCT01314443|1103287|P4|NOT COMPLETED|Overall Study||2
450047|NCT01314443|1103288|P3|NOT COMPLETED|Overall Study||2
450048|NCT01314443|1103289|P2|NOT COMPLETED|Overall Study||3
450049|NCT01314443|1103290|P1|NOT COMPLETED|Overall Study||4
450050|NCT01314443|1103287|P4|COMPLETED|Overall Study||13
450051|NCT01314443|1103288|P3|COMPLETED|Overall Study||13
450052|NCT01314443|1103289|P2|COMPLETED|Overall Study||16
450053|NCT01314443|1103290|P1|COMPLETED|Overall Study||14
450054|NCT01314443|1103287|P4|STARTED|Overall Study||15
450055|NCT01314443|1103288|P3|STARTED|Overall Study||15
450056|NCT01314443|1103289|P2|STARTED|Overall Study||19
450057|NCT01314443|1103290|P1|STARTED|Overall Study||18
450058|NCT01314417|1103308|P1|NOT COMPLETED|Overall Study||0
450059|NCT01314417|1103308|P1|COMPLETED|Overall Study||2
450060|NCT01314417|1103308|P1|STARTED|Overall Study||2
450061|NCT01314261|1103339|P4|NOT COMPLETED|Overall Study||3
450062|NCT01314261|1103340|P3|NOT COMPLETED|Overall Study||3
450063|NCT01314261|1103341|P2|NOT COMPLETED|Overall Study||4
450064|NCT01314261|1103342|P1|NOT COMPLETED|Overall Study||2
450065|NCT01314261|1103339|P4|COMPLETED|Overall Study||6
450066|NCT01314261|1103340|P3|COMPLETED|Overall Study||7
450067|NCT01314261|1103341|P2|COMPLETED|Overall Study||5
450068|NCT01314261|1103342|P1|COMPLETED|Overall Study||7
450069|NCT01314261|1103339|P4|Discontinued pegIFN/RBV|Overall Study||1
450070|NCT01314261|1103340|P3|Discontinued pegIFN/RBV|Overall Study||5
450071|NCT01314261|1103341|P2|Discontinued pegIFN/RBV|Overall Study||4
450072|NCT01314261|1103342|P1|Discontinued pegIFN/RBV|Overall Study||1
450073|NCT01314261|1103339|P4|Discontinued ABT-267 or Placebo|Overall Study||0
450074|NCT01314261|1103340|P3|Discontinued ABT-267 or Placebo|Overall Study||1
450075|NCT01314261|1103341|P2|Discontinued ABT-267 or Placebo|Overall Study||0
450076|NCT01314261|1103342|P1|Discontinued ABT-267 or Placebo|Overall Study||1
450077|NCT01314261|1103339|P4|STARTED|Overall Study||9
450078|NCT01314261|1103340|P3|STARTED|Overall Study||10
450079|NCT01314261|1103341|P2|STARTED|Overall Study||9
450080|NCT01314261|1103342|P1|STARTED|Overall Study||9
450081|NCT01314118|1103393|P1|NOT COMPLETED|Overall Study||131
450082|NCT01314118|1103393|P1|COMPLETED|Overall Study||0
450083|NCT01314118|1103393|P1|STARTED|Overall Study||131
450084|NCT01314105|1103402|P2|NOT COMPLETED|Overall Study||12
450085|NCT01314105|1103403|P1|NOT COMPLETED|Overall Study||7
450086|NCT01314105|1103402|P2|COMPLETED|Overall Study||0
450087|NCT01314105|1103403|P1|COMPLETED|Overall Study||0
450088|NCT01314105|1103402|P2|STARTED|Overall Study||12
450089|NCT01314105|1103403|P1|STARTED|Overall Study||7
450090|NCT01314014|1103445|P1|NOT COMPLETED|Overall Study||0
450091|NCT01314014|1103445|P1|COMPLETED|Overall Study|Treatment continued for as long as the subject derived benefit.|22
450092|NCT01314014|1103445|P1|STARTED|Overall Study||22
450093|NCT01314001|1103456|P6|NOT COMPLETED|Overall Study||71
450094|NCT01314001|1103457|P5|NOT COMPLETED|Overall Study||72
450095|NCT01314001|1103458|P4|NOT COMPLETED|Overall Study||69
450096|NCT01314001|1103459|P3|NOT COMPLETED|Overall Study||69
450097|NCT01314001|1103460|P2|NOT COMPLETED|Overall Study||69
450098|NCT01314001|1103461|P1|NOT COMPLETED|Overall Study||75
450099|NCT01314001|1103456|P6|COMPLETED|Overall Study||129
450100|NCT01314001|1103457|P5|COMPLETED|Overall Study||148
450101|NCT01314001|1103458|P4|COMPLETED|Overall Study||122
450102|NCT01314001|1103459|P3|COMPLETED|Overall Study||158
450103|NCT01314001|1103460|P2|COMPLETED|Overall Study||124
450104|NCT01314001|1103461|P1|COMPLETED|Overall Study||140
450105|NCT01314001|1103456|P6|6-Month Follow Up Survey|Overall Study||139
450106|NCT01314001|1103457|P5|6-Month Follow Up Survey|Overall Study||157
450107|NCT01314001|1103458|P4|6-Month Follow Up Survey|Overall Study||135
450108|NCT01314001|1103459|P3|6-Month Follow Up Survey|Overall Study||165
450109|NCT01314001|1103460|P2|6-Month Follow Up Survey|Overall Study||137
450110|NCT01314001|1103461|P1|6-Month Follow Up Survey|Overall Study||146
450111|NCT01314001|1103456|P6|End-of-Treatment Visit|Overall Study||160
450112|NCT01314001|1103457|P5|End-of-Treatment Visit|Overall Study||174
450113|NCT01314001|1103458|P4|End-of-Treatment Visit|Overall Study||146
450114|NCT01314001|1103459|P3|End-of-Treatment Visit|Overall Study||179
450115|NCT01314001|1103460|P2|End-of-Treatment Visit|Overall Study||141
450116|NCT01314001|1103461|P1|End-of-Treatment Visit|Overall Study||156
450117|NCT01314001|1103456|P6|STARTED|Overall Study||200
450118|NCT01314001|1103457|P5|STARTED|Overall Study||220
450119|NCT01314001|1103458|P4|STARTED|Overall Study||191
450120|NCT01314001|1103459|P3|STARTED|Overall Study||227
450121|NCT01314001|1103460|P2|STARTED|Overall Study||193
450122|NCT01314001|1103461|P1|STARTED|Overall Study||215
450123|NCT01313936|1103507|P2|NOT COMPLETED|Overall Study||0
450124|NCT01313936|1103508|P1|NOT COMPLETED|Overall Study||0
450125|NCT01313936|1103507|P2|COMPLETED|Overall Study||26
450126|NCT01313936|1103508|P1|COMPLETED|Overall Study||6
450127|NCT01313936|1103507|P2|STARTED|Overall Study||26
450128|NCT01313936|1103508|P1|STARTED|Overall Study||6
450129|NCT01313923|1103516|P1|NOT COMPLETED|Overall Study||3
450130|NCT01313923|1103516|P1|COMPLETED|Overall Study||0
450131|NCT01313923|1103516|P1|STARTED|Overall Study||3
450132|NCT01313910|1103520|P1|NOT COMPLETED|Overall Study||0
450133|NCT01313910|1103520|P1|COMPLETED|Overall Study||8
450134|NCT01313910|1103520|P1|STARTED|Overall Study||8
450135|NCT01313897|1103528|P1|NOT COMPLETED|Overall Study||2
450136|NCT01313897|1103528|P1|COMPLETED|Overall Study||8
450137|NCT01313897|1103528|P1|STARTED|Overall Study||10
450138|NCT01313884|1103532|P1|NOT COMPLETED|Overall Study||1
450139|NCT01313884|1103532|P1|COMPLETED|Overall Study||2
450140|NCT01313884|1103532|P1|STARTED|Overall Study||3
450141|NCT01313858|1103540|P3|NOT COMPLETED|Overall Study||238
450142|NCT01313858|1103541|P2|NOT COMPLETED|Overall Study||270
450143|NCT01313858|1103542|P1|NOT COMPLETED|Overall Study||286
450144|NCT01313858|1103540|P3|COMPLETED|Overall Study||305
450145|NCT01313858|1103541|P2|COMPLETED|Overall Study||276
450146|NCT01313858|1103542|P1|COMPLETED|Overall Study||238
450147|NCT01313858|1103540|P3|STARTED|Overall Study||543
450148|NCT01313858|1103541|P2|STARTED|Overall Study||546
450149|NCT01313858|1103542|P1|STARTED|Overall Study||524
450150|NCT01313780|1103565|P2|NOT COMPLETED|Overall Study||28
450151|NCT01313780|1103566|P1|NOT COMPLETED|Overall Study||25
450152|NCT01313780|1103565|P2|COMPLETED|Overall Study|PPS|31
450153|NCT01313780|1103566|P1|COMPLETED|Overall Study|PPS|33
450154|NCT01313780|1103565|P2|STARTED|Overall Study|FAS|59
450155|NCT01313780|1103566|P1|STARTED|Overall Study|FAS|58
450156|NCT01313728|1103574|P1|NOT COMPLETED|Baseline to Completion||0
450157|NCT01313728|1103574|P1|COMPLETED|Baseline to Completion||25
450158|NCT01313728|1103574|P1|STARTED|Baseline to Completion||25
450159|NCT01313728|1103574|P1|NOT COMPLETED|Informed Consent to Baseline||1
450160|NCT01313728|1103574|P1|COMPLETED|Informed Consent to Baseline|One subject withdrew after signing informed consent, but prior to Baseline measurements being taken.|25
450161|NCT01313728|1103574|P1|STARTED|Informed Consent to Baseline||26
450162|NCT01313689|1103594|P5|NOT COMPLETED|24-Week Randomization 2||15
450163|NCT01313689|1103595|P4|NOT COMPLETED|24-Week Randomization 2||1
450164|NCT01313689|1103596|P3|NOT COMPLETED|24-Week Randomization 2||3
450165|NCT01313689|1103597|P2|NOT COMPLETED|24-Week Randomization 2||0
450166|NCT01313689|1103598|P1|NOT COMPLETED|24-Week Randomization 2||0
450167|NCT01313689|1103594|P5|COMPLETED|24-Week Randomization 2||27
450168|NCT01313689|1103595|P4|COMPLETED|24-Week Randomization 2||12
450169|NCT01313689|1103596|P3|COMPLETED|24-Week Randomization 2||21
450170|NCT01313689|1103597|P2|COMPLETED|24-Week Randomization 2||0
450171|NCT01313689|1103598|P1|COMPLETED|24-Week Randomization 2||0
450172|NCT01313689|1103594|P5|STARTED|24-Week Randomization 2|OFA Participants who did not enter Randomization 2.|42
450173|NCT01313689|1103595|P4|STARTED|24-Week Randomization 2|Not all participants from Randomization 1 continued to Randomization 2.|13
450174|NCT01313689|1103596|P3|STARTED|24-Week Randomization 2|Not all participants from Randomization 1 continued to Randomization 2.|24
450175|NCT01313689|1103597|P2|STARTED|24-Week Randomization 2||0
450176|NCT01313689|1103598|P1|STARTED|24-Week Randomization 2||0
450177|NCT01313689|1103594|P5|NOT COMPLETED|24-Week Randomization 1||0
450178|NCT01313689|1103595|P4|NOT COMPLETED|24-Week Randomization 1||0
450179|NCT01313689|1103596|P3|NOT COMPLETED|24-Week Randomization 1||0
450180|NCT01313689|1103597|P2|NOT COMPLETED|24-Week Randomization 1||10
450181|NCT01313689|1103598|P1|NOT COMPLETED|24-Week Randomization 1||19
450182|NCT01313689|1103594|P5|COMPLETED|24-Week Randomization 1||0
450183|NCT01313689|1103595|P4|COMPLETED|24-Week Randomization 1||0
450184|NCT01313689|1103596|P3|COMPLETED|24-Week Randomization 1||0
450185|NCT01313689|1103597|P2|COMPLETED|24-Week Randomization 1|Par. that did not receive OFA salvage continued visits for Follow-up and overall survival assessment|33
450186|NCT01313689|1103598|P1|COMPLETED|24-Week Randomization 1|Par. not entering Randomization 2 continued visits for Follow-up and overall survival assessment|60
450187|NCT01313689|1103594|P5|STARTED|24-Week Randomization 1||0
450188|NCT01313689|1103595|P4|STARTED|24-Week Randomization 1||0
450189|NCT01313689|1103596|P3|STARTED|24-Week Randomization 1||0
450190|NCT01313689|1103597|P2|STARTED|24-Week Randomization 1|Of the 43 participants in the PC arm, 22 entered the OFA Salvage arm.|43
450191|NCT01313689|1103598|P1|STARTED|24-Week Randomization 1||79
450192|NCT01313676|1103677|P4|NOT COMPLETED|Overall Study||994
450193|NCT01313676|1103678|P3|NOT COMPLETED|Overall Study||1088
450194|NCT01313676|1103679|P2|NOT COMPLETED|Overall Study||1113
450195|NCT01313676|1103680|P1|NOT COMPLETED|Overall Study||1250
450196|NCT01313676|1103677|P4|COMPLETED|Overall Study||3146
450197|NCT01313676|1103678|P3|COMPLETED|Overall Study||3052
450198|NCT01313676|1103679|P2|COMPLETED|Overall Study||3044
450199|NCT01313676|1103680|P1|COMPLETED|Overall Study||2881
450200|NCT01313676|1103677|P4|STARTED|Overall Study||4140
450201|NCT01313676|1103678|P3|STARTED|Overall Study||4140
450202|NCT01313676|1103679|P2|STARTED|Overall Study||4157
450203|NCT01313676|1103680|P1|STARTED|Overall Study||4131
450204|NCT01313663|1103700|P2|NOT COMPLETED|Overall Study||8
450205|NCT01313663|1103701|P1|NOT COMPLETED|Overall Study||4
450206|NCT01313663|1103700|P2|COMPLETED|Overall Study||3
450207|NCT01313663|1103701|P1|COMPLETED|Overall Study||5
450208|NCT01313663|1103700|P2|STARTED|Overall Study||11
450209|NCT01313663|1103701|P1|STARTED|Overall Study||9
450210|NCT01313650|1103739|P4|NOT COMPLETED|Overall Study||81
450211|NCT01313650|1103740|P3|NOT COMPLETED|Overall Study||103
450212|NCT01313650|1103741|P2|NOT COMPLETED|Overall Study||94
450213|NCT01313650|1103742|P1|NOT COMPLETED|Overall Study||76
450214|NCT01313650|1103739|P4|COMPLETED|Overall Study||332
450215|NCT01313650|1103740|P3|COMPLETED|Overall Study||318
450216|NCT01313650|1103741|P2|COMPLETED|Overall Study||324
450217|NCT01313650|1103742|P1|COMPLETED|Overall Study||204
450218|NCT01313650|1103739|P4|STARTED|Overall Study||413
450219|NCT01313650|1103740|P3|STARTED|Overall Study||421
450220|NCT01313650|1103741|P2|STARTED|Overall Study||418
450221|NCT01313650|1103742|P1|STARTED|Overall Study||280
450222|NCT01313637|1103768|P4|NOT COMPLETED|Overall Study||78
450223|NCT01313637|1103769|P3|NOT COMPLETED|Overall Study||106
450224|NCT01313637|1103770|P2|NOT COMPLETED|Overall Study||95
450225|NCT01313637|1103771|P1|NOT COMPLETED|Overall Study||92
450226|NCT01313637|1103768|P4|COMPLETED|Overall Study||325
450227|NCT01313637|1103769|P3|COMPLETED|Overall Study||298
450228|NCT01313637|1103770|P2|COMPLETED|Overall Study||312
450229|NCT01313637|1103771|P1|COMPLETED|Overall Study||183
450230|NCT01313637|1103768|P4|STARTED|Overall Study||403
450231|NCT01313637|1103769|P3|STARTED|Overall Study||404
450232|NCT01313637|1103770|P2|STARTED|Overall Study||407
450233|NCT01313637|1103771|P1|STARTED|Overall Study||275
450234|NCT01313624|1103795|P2|NOT COMPLETED|Open-Label Phase||13
450235|NCT01313624|1103796|P1|NOT COMPLETED|Open-Label Phase||4
450236|NCT01313624|1103795|P2|COMPLETED|Open-Label Phase||109
450237|NCT01313624|1103796|P1|COMPLETED|Open-Label Phase||92
450238|NCT01313624|1103795|P2|STARTED|Open-Label Phase||122
450239|NCT01313624|1103796|P1|STARTED|Open-Label Phase||96
450240|NCT01313624|1103795|P2|NOT COMPLETED|Double-Blind Phase||10
450241|NCT01313624|1103796|P1|NOT COMPLETED|Double-Blind Phase||38
450242|NCT01313624|1103795|P2|COMPLETED|Double-Blind Phase||122
450243|NCT01313624|1103796|P1|COMPLETED|Double-Blind Phase||96
450244|NCT01313624|1103795|P2|STARTED|Double-Blind Phase||132
450245|NCT01313624|1103796|P1|STARTED|Double-Blind Phase||134
450246|NCT01313559|1103810|P2|NOT COMPLETED|Overall Study||2
450247|NCT01313559|1103811|P1|NOT COMPLETED|Overall Study||4
450248|NCT01313559|1103810|P2|COMPLETED|Overall Study||0
450249|NCT01313559|1103811|P1|COMPLETED|Overall Study||0
450250|NCT01313559|1103810|P2|STARTED|Overall Study||2
450251|NCT01313559|1103811|P1|STARTED|Overall Study||4
450252|NCT01313520|1103825|P2|NOT COMPLETED|Overall Study||0
450253|NCT01313520|1103826|P1|NOT COMPLETED|Overall Study||0
450254|NCT01313520|1103825|P2|COMPLETED|Overall Study||31
450255|NCT01313520|1103826|P1|COMPLETED|Overall Study||30
450256|NCT01313520|1103825|P2|STARTED|Overall Study||31
450257|NCT01313520|1103826|P1|STARTED|Overall Study||30
450258|NCT01313507|1103846|P1|NOT COMPLETED|Overall Study||0
450259|NCT01313507|1103846|P1|COMPLETED|Overall Study||21
450260|NCT01313507|1103846|P1|STARTED|Overall Study||21
450261|NCT01313494|1103854|P2|NOT COMPLETED|Overall Study||50
450262|NCT01313494|1103855|P1|NOT COMPLETED|Overall Study||67
450263|NCT01313494|1103854|P2|COMPLETED|Overall Study||263
450264|NCT01313494|1103855|P1|COMPLETED|Overall Study||246
450265|NCT01313494|1103854|P2|Safety Set|Overall Study|2 patients in the placebo arm were misallocated and may have received roflumilast in error.|311
450266|NCT01313494|1103855|P1|Safety Set|Overall Study|2 patients in the placebo arm were misallocated and may have received roflumilast in error.|315
450267|NCT01313494|1103854|P2|STARTED|Overall Study||313
450268|NCT01313494|1103855|P1|STARTED|Overall Study||313
450269|NCT01313312|1103907|P1|NOT COMPLETED|Overall Study||36
450270|NCT01313312|1103907|P1|COMPLETED|Overall Study||222
450271|NCT01313312|1103907|P1|Cycle 5|Overall Study||11
450272|NCT01313312|1103907|P1|Cycle 4|Overall Study||81
450273|NCT01313312|1103907|P1|Cycle 3|Overall Study||175
450274|NCT01313312|1103907|P1|Cycle 2|Overall Study||229
450275|NCT01313312|1103907|P1|Cycle 1|Overall Study||254
450276|NCT01313312|1103907|P1|STARTED|Overall Study||258
450277|NCT01313299|1103954|P3|NOT COMPLETED|Overall Study||4
450278|NCT01313299|1103955|P2|NOT COMPLETED|Overall Study||3
450279|NCT01313299|1103956|P1|NOT COMPLETED|Overall Study||7
450280|NCT01313299|1103954|P3|COMPLETED|Overall Study||77
450281|NCT01313299|1103955|P2|COMPLETED|Overall Study||78
450282|NCT01313299|1103956|P1|COMPLETED|Overall Study||74
450283|NCT01313299|1103954|P3|STARTED|Overall Study||81
450284|NCT01313299|1103955|P2|STARTED|Overall Study||81
450285|NCT01313299|1103956|P1|STARTED|Overall Study||81
450286|NCT01313273|1103972|P2|NOT COMPLETED|Overall Study||1
450287|NCT01313273|1103973|P1|NOT COMPLETED|Overall Study||2
450288|NCT01313273|1103972|P2|COMPLETED|Overall Study||0
450289|NCT01313273|1103973|P1|COMPLETED|Overall Study||0
450290|NCT01313273|1103972|P2|STARTED|Overall Study||1
450291|NCT01313273|1103973|P1|STARTED|Overall Study||2
450292|NCT01313221|1103988|P3|NOT COMPLETED|Overall Study||23
450293|NCT01313221|1103989|P2|NOT COMPLETED|Overall Study||8
450294|NCT01313221|1103990|P1|NOT COMPLETED|Overall Study||12
450295|NCT01313221|1103988|P3|COMPLETED|Overall Study||0
450296|NCT01313221|1103989|P2|COMPLETED|Overall Study||135
450297|NCT01313221|1103990|P1|COMPLETED|Overall Study||132
450298|NCT01313221|1103988|P3|Randomized|Overall Study||0
450299|NCT01313221|1103989|P2|Randomized|Overall Study||143
450300|NCT01313221|1103990|P1|Randomized|Overall Study||144
450301|NCT01313221|1103988|P3|STARTED|Overall Study||23
450302|NCT01313221|1103989|P2|STARTED|Overall Study||143
450303|NCT01313221|1103990|P1|STARTED|Overall Study||144
450304|NCT01313208|1104042|P2|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||3
450305|NCT01313208|1104043|P1|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||6
450306|NCT01313208|1104042|P2|COMPLETED|Open-label Phase (Weeks 13 - 24)||98
450307|NCT01313208|1104043|P1|COMPLETED|Open-label Phase (Weeks 13 - 24)||92
450308|NCT01313208|1104042|P2|STARTED|Open-label Phase (Weeks 13 - 24)||101
450309|NCT01313208|1104043|P1|STARTED|Open-label Phase (Weeks 13 - 24)||98
450310|NCT01313208|1104042|P2|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||5
450311|NCT01313208|1104043|P1|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||6
450312|NCT01313208|1104042|P2|COMPLETED|Double-blind Phase (Weeks 1 - 12)||101
450313|NCT01313208|1104043|P1|COMPLETED|Double-blind Phase (Weeks 1 - 12)||98
450314|NCT01313208|1104042|P2|STARTED|Double-blind Phase (Weeks 1 - 12)||106
450315|NCT01313208|1104043|P1|STARTED|Double-blind Phase (Weeks 1 - 12)||104
450316|NCT01313182|1104133|P2|NOT COMPLETED|Overall Study||92
450317|NCT01313182|1104134|P1|NOT COMPLETED|Overall Study||66
450318|NCT01313182|1104133|P2|COMPLETED|Overall Study||763
450319|NCT01313182|1104134|P1|COMPLETED|Overall Study||776
450320|NCT01313182|1104133|P2|STARTED|Overall Study||855
450321|NCT01313182|1104134|P1|STARTED|Overall Study||842
450322|NCT01313117|1104140|P1|NOT COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1
450323|NCT01313117|1104140|P1|COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||0
450324|NCT01313117|1104140|P1|STARTED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1
450325|NCT01313117|1104140|P1|NOT COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||0
450326|NCT01313117|1104140|P1|COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2
450327|NCT01313117|1104140|P1|STARTED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2
450328|NCT01313117|1104140|P1|NOT COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||0
450329|NCT01313117|1104140|P1|COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2
450330|NCT01313117|1104140|P1|STARTED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2
450331|NCT01313117|1104140|P1|NOT COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1
450332|NCT01313117|1104140|P1|COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1
450333|NCT01313117|1104140|P1|STARTED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||2
450334|NCT01313117|1104140|P1|NOT COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||0
450335|NCT01313117|1104140|P1|COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2
450336|NCT01313117|1104140|P1|STARTED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2
450337|NCT01313078|1104147|P1|NOT COMPLETED|Overall Study||3
450338|NCT01313078|1104147|P1|COMPLETED|Overall Study||1
450339|NCT01313078|1104147|P1|STARTED|Overall Study||4
450340|NCT01313039|1104152|P1|NOT COMPLETED|Overall Study||2
450341|NCT01313039|1104152|P1|COMPLETED|Overall Study||2
450342|NCT01313039|1104152|P1|STARTED|Overall Study||4
450343|NCT01312961|1104158|P2|NOT COMPLETED|Overall Study||7
450344|NCT01312961|1104159|P1|NOT COMPLETED|Overall Study||17
450345|NCT01312961|1104158|P2|COMPLETED|Overall Study||45
450346|NCT01312961|1104159|P1|COMPLETED|Overall Study||35
450347|NCT01312961|1104158|P2|Treated|Overall Study||52
450348|NCT01312961|1104159|P1|Treated|Overall Study||52
450349|NCT01312961|1104158|P2|STARTED|Overall Study||52
450350|NCT01312961|1104159|P1|STARTED|Overall Study||52
450351|NCT01312948|1104185|P1|NOT COMPLETED|Overall Study||0
450352|NCT01312948|1104185|P1|COMPLETED|Overall Study||6
450353|NCT01312948|1104185|P1|STARTED|Overall Study||6
450354|NCT01312909|1104195|P3|NOT COMPLETED|Overall Study||47
450355|NCT01312909|1104196|P2|NOT COMPLETED|Overall Study||36
450356|NCT01312909|1104197|P1|NOT COMPLETED|Overall Study||42
450357|NCT01312909|1104195|P3|COMPLETED|Overall Study||53
450358|NCT01312909|1104196|P2|COMPLETED|Overall Study||67
450359|NCT01312909|1104197|P1|COMPLETED|Overall Study||67
450360|NCT01312909|1104195|P3|Treated|Overall Study||99
450361|NCT01312909|1104196|P2|Treated|Overall Study||100
450362|NCT01312909|1104197|P1|Treated|Overall Study||108
450363|NCT01312909|1104195|P3|STARTED|Overall Study||100
450364|NCT01312909|1104196|P2|STARTED|Overall Study||103
450365|NCT01312909|1104197|P1|STARTED|Overall Study||109
450366|NCT01312844|1104246|P2|NOT COMPLETED|Overall Study||0
450367|NCT01312844|1104247|P1|NOT COMPLETED|Overall Study||0
450368|NCT01312844|1104246|P2|COMPLETED|Overall Study||3
450369|NCT01312844|1104247|P1|COMPLETED|Overall Study||4
450370|NCT01312844|1104246|P2|STARTED|Overall Study||3
450371|NCT01312844|1104247|P1|STARTED|Overall Study||4
450372|NCT01312818|1104269|P1|NOT COMPLETED|Overall Study||0
450373|NCT01312818|1104269|P1|COMPLETED|Overall Study||2
450374|NCT01312818|1104269|P1|STARTED|Overall Study||2
450375|NCT01312805|1104277|P2|NOT COMPLETED|Overall Study||0
450376|NCT01312805|1104278|P1|NOT COMPLETED|Overall Study||0
450377|NCT01312805|1104277|P2|COMPLETED|Overall Study||1082
450378|NCT01312805|1104278|P1|COMPLETED|Overall Study||1016
450379|NCT01312805|1104277|P2|STARTED|Overall Study||1082
450380|NCT01312805|1104278|P1|STARTED|Overall Study||1016
450381|NCT01312766|1104286|P2|NOT COMPLETED|Overall Study||5
450382|NCT01312766|1104287|P1|NOT COMPLETED|Overall Study||6
450383|NCT01312766|1104286|P2|COMPLETED|Overall Study||130
450384|NCT01312766|1104287|P1|COMPLETED|Overall Study||129
450385|NCT01312766|1104286|P2|STARTED|Overall Study||135
450386|NCT01312766|1104287|P1|STARTED|Overall Study||135
450387|NCT01312519|1104319|P2|NOT COMPLETED|Overall Study||0
450388|NCT01312519|1104320|P1|NOT COMPLETED|Overall Study||0
450389|NCT01312519|1104319|P2|COMPLETED|Overall Study||24
450390|NCT01312519|1104320|P1|COMPLETED|Overall Study||26
450391|NCT01312519|1104319|P2|STARTED|Overall Study||24
450392|NCT01312519|1104320|P1|STARTED|Overall Study||26
450393|NCT01312467|1104328|P1|NOT COMPLETED|Overall Study||13
450394|NCT01312467|1104328|P1|COMPLETED|Overall Study||32
450395|NCT01312467|1104328|P1|STARTED|Overall Study||45
450396|NCT01312428|1104337|P2|NOT COMPLETED|Overall Study||4
450397|NCT01312428|1104338|P1|NOT COMPLETED|Overall Study||3
450398|NCT01312428|1104337|P2|COMPLETED|Overall Study||0
450399|NCT01312428|1104338|P1|COMPLETED|Overall Study||0
450400|NCT01312428|1104337|P2|STARTED|Overall Study||4
450401|NCT01312428|1104338|P1|STARTED|Overall Study||3
450402|NCT01312272|1104348|P2|NOT COMPLETED|Overall Study||1
450403|NCT01312272|1104349|P1|NOT COMPLETED|Overall Study||0
450404|NCT01312272|1104348|P2|COMPLETED|Overall Study||11
450405|NCT01312272|1104349|P1|COMPLETED|Overall Study||12
450406|NCT01312272|1104348|P2|STARTED|Overall Study||12
450407|NCT01312272|1104349|P1|STARTED|Overall Study||12
450408|NCT01312181|1104368|P3|NOT COMPLETED|Overall Study||8
450409|NCT01312181|1104369|P2|NOT COMPLETED|Overall Study||6
450410|NCT01312181|1104370|P1|NOT COMPLETED|Overall Study||2
450411|NCT01312181|1104368|P3|COMPLETED|Overall Study||75
450412|NCT01312181|1104369|P2|COMPLETED|Overall Study||71
450413|NCT01312181|1104370|P1|COMPLETED|Overall Study||78
450414|NCT01312181|1104368|P3|STARTED|Overall Study||83
450415|NCT01312181|1104369|P2|STARTED|Overall Study||77
450416|NCT01312181|1104370|P1|STARTED|Overall Study||80
450417|NCT01312129|1104383|P2|NOT COMPLETED|Second Intervention (24 Hours)||1
450418|NCT01312129|1104384|P1|NOT COMPLETED|Second Intervention (24 Hours)||0
450419|NCT01312129|1104383|P2|COMPLETED|Second Intervention (24 Hours)||6
450420|NCT01312129|1104384|P1|COMPLETED|Second Intervention (24 Hours)||6
450421|NCT01312129|1104383|P2|Alcohol Cue|Second Intervention (24 Hours)||6
450422|NCT01312129|1104384|P1|Alcohol Cue|Second Intervention (24 Hours)||6
450423|NCT01312129|1104383|P2|Control Cue|Second Intervention (24 Hours)||6
450424|NCT01312129|1104384|P1|Control Cue|Second Intervention (24 Hours)||6
450425|NCT01312129|1104383|P2|STARTED|Second Intervention (24 Hours)||7
450426|NCT01312129|1104384|P1|STARTED|Second Intervention (24 Hours)||6
450427|NCT01312129|1104383|P2|NOT COMPLETED|Washout (1 Week)||0
450428|NCT01312129|1104384|P1|NOT COMPLETED|Washout (1 Week)||0
450429|NCT01312129|1104383|P2|COMPLETED|Washout (1 Week)||7
450430|NCT01312129|1104384|P1|COMPLETED|Washout (1 Week)||6
450431|NCT01312129|1104383|P2|STARTED|Washout (1 Week)||7
450432|NCT01312129|1104384|P1|STARTED|Washout (1 Week)||6
450433|NCT01312129|1104383|P2|NOT COMPLETED|First Intervention (24 Hours)||0
450434|NCT01312129|1104384|P1|NOT COMPLETED|First Intervention (24 Hours)||0
450435|NCT01312129|1104383|P2|COMPLETED|First Intervention (24 Hours)||7
450436|NCT01312129|1104384|P1|COMPLETED|First Intervention (24 Hours)||6
450437|NCT01312129|1104383|P2|Alcohol Cue|First Intervention (24 Hours)||7
450438|NCT01312129|1104384|P1|Alcohol Cue|First Intervention (24 Hours)||6
450439|NCT01312129|1104383|P2|Control Cue|First Intervention (24 Hours)||7
450440|NCT01312129|1104384|P1|Control Cue|First Intervention (24 Hours)||6
450441|NCT01312129|1104383|P2|STARTED|First Intervention (24 Hours)||7
450442|NCT01312129|1104384|P1|STARTED|First Intervention (24 Hours)||6
450443|NCT01312038|1104392|P2|NOT COMPLETED|Overall Study||0
450444|NCT01312038|1104393|P1|NOT COMPLETED|Overall Study||0
450445|NCT01312038|1104392|P2|COMPLETED|Overall Study||12
450446|NCT01312038|1104393|P1|COMPLETED|Overall Study||13
450447|NCT01312038|1104392|P2|STARTED|Overall Study||12
450448|NCT01312038|1104393|P1|STARTED|Overall Study||13
450449|NCT01311895|1104401|P2|NOT COMPLETED|Overall Study||0
450450|NCT01311895|1104402|P1|NOT COMPLETED|Overall Study||0
450451|NCT01311895|1104401|P2|COMPLETED|Overall Study||175
450452|NCT01311895|1104402|P1|COMPLETED|Overall Study||175
450453|NCT01311895|1104401|P2|STARTED|Overall Study||175
450454|NCT01311895|1104402|P1|STARTED|Overall Study||175
450455|NCT01311687|1104414|P2|NOT COMPLETED|PFS Follow-up Phase||1
450456|NCT01311687|1104415|P1|NOT COMPLETED|PFS Follow-up Phase||3
450457|NCT01311687|1104414|P2|COMPLETED|PFS Follow-up Phase||7
450458|NCT01311687|1104415|P1|COMPLETED|PFS Follow-up Phase||5
450459|NCT01311687|1104414|P2|STARTED|PFS Follow-up Phase||8
450460|NCT01311687|1104415|P1|STARTED|PFS Follow-up Phase||8
450461|NCT01311687|1104414|P2|NOT COMPLETED|Treatment Phase||11
450462|NCT01311687|1104415|P1|NOT COMPLETED|Treatment Phase||60
450463|NCT01311687|1104414|P2|COMPLETED|Treatment Phase|Completed represents participants who discontinued from study treatment|142
450464|NCT01311687|1104415|P1|COMPLETED|Treatment Phase|Completed represents participants who discontinued from study treatment|242
450465|NCT01311687|1104414|P2|Received Study Treatment|Treatment Phase||150
450466|NCT01311687|1104415|P1|Received Study Treatment|Treatment Phase||300
450467|NCT01311687|1104414|P2|STARTED|Treatment Phase||153
450468|NCT01311687|1104415|P1|STARTED|Treatment Phase||302
450469|NCT01311661|1104465|P1|NOT COMPLETED|Overall Study||7
450470|NCT01311661|1104465|P1|COMPLETED|Overall Study||199
450471|NCT01311661|1104465|P1|Received Olo 10 mcg qd|Overall Study||102
450472|NCT01311661|1104465|P1|Received Olo 5 mcg Bid|Overall Study||101
450473|NCT01311661|1104465|P1|Received Olo 5 mcg qd|Overall Study||101
450474|NCT01311661|1104465|P1|Received Olo 2.5 mcg Bid|Overall Study||101
450475|NCT01311661|1104465|P1|Received Placebo|Overall Study||201
450476|NCT01311661|1104465|P1|STARTED|Overall Study|Entered and treated|206
450477|NCT01311557|1104609|P2|NOT COMPLETED|Overall Study||6
450478|NCT01311557|1104610|P1|NOT COMPLETED|Overall Study||5
450479|NCT01311557|1104609|P2|COMPLETED|Overall Study||645
450480|NCT01311557|1104610|P1|COMPLETED|Overall Study||646
450481|NCT01311557|1104609|P2|STARTED|Overall Study||651
450482|NCT01311557|1104610|P1|STARTED|Overall Study||651
450483|NCT01311505|1104626|P2|NOT COMPLETED|Second Intervention Period||0
450484|NCT01311505|1104627|P1|NOT COMPLETED|Second Intervention Period||0
450485|NCT01311505|1104626|P2|COMPLETED|Second Intervention Period||10
450486|NCT01311505|1104627|P1|COMPLETED|Second Intervention Period||10
450487|NCT01311505|1104626|P2|STARTED|Second Intervention Period||10
450488|NCT01311505|1104627|P1|STARTED|Second Intervention Period||10
450489|NCT01311505|1104626|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
450490|NCT01311505|1104627|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
450491|NCT01311505|1104626|P2|COMPLETED|Washout Period (at Least 7 Days)||10
450492|NCT01311505|1104627|P1|COMPLETED|Washout Period (at Least 7 Days)||10
450493|NCT01311505|1104626|P2|STARTED|Washout Period (at Least 7 Days)||10
450494|NCT01311505|1104627|P1|STARTED|Washout Period (at Least 7 Days)||10
450495|NCT01311505|1104626|P2|NOT COMPLETED|First Intervention Period||1
450496|NCT01311505|1104627|P1|NOT COMPLETED|First Intervention Period||0
450497|NCT01311505|1104626|P2|COMPLETED|First Intervention Period||10
450498|NCT01311505|1104627|P1|COMPLETED|First Intervention Period||10
450499|NCT01311505|1104626|P2|STARTED|First Intervention Period||11
450500|NCT01311505|1104627|P1|STARTED|First Intervention Period||10
450501|NCT01311362|1104655|P1|NOT COMPLETED|Ambrisentan and SJW||0
450502|NCT01311362|1104655|P1|COMPLETED|Ambrisentan and SJW||20
450503|NCT01311362|1104655|P1|STARTED|Ambrisentan and SJW||20
450504|NCT01311362|1104655|P1|NOT COMPLETED|Ambrisentan Steady-state||0
450505|NCT01311362|1104655|P1|COMPLETED|Ambrisentan Steady-state||20
450506|NCT01311362|1104655|P1|STARTED|Ambrisentan Steady-state||20
450507|NCT01311362|1104655|P1|NOT COMPLETED|Ambrisentan Single Dose||0
450508|NCT01311362|1104655|P1|COMPLETED|Ambrisentan Single Dose||20
450509|NCT01311362|1104655|P1|STARTED|Ambrisentan Single Dose|All 20 study participants completed each study period. Total number of study participants: 20|20
450510|NCT01311102|1104668|P2|NOT COMPLETED|Overall Study||0
450511|NCT01311102|1104669|P1|NOT COMPLETED|Overall Study||0
450512|NCT01311102|1104668|P2|COMPLETED|Overall Study||20
450513|NCT01311102|1104669|P1|COMPLETED|Overall Study||20
450514|NCT01311102|1104668|P2|STARTED|Overall Study||20
450515|NCT01311102|1104669|P1|STARTED|Overall Study||20
450516|NCT01311024|1104683|P2|NOT COMPLETED|Overall Study||22
450517|NCT01311024|1104684|P1|NOT COMPLETED|Overall Study||35
450518|NCT01311024|1104683|P2|COMPLETED|Overall Study||789
450519|NCT01311024|1104684|P1|COMPLETED|Overall Study||1495
450520|NCT01311024|1104683|P2|STARTED|Overall Study||811
450521|NCT01311024|1104684|P1|STARTED|Overall Study||1530
450522|NCT01310868|1104690|P1|NOT COMPLETED|Overall Study||13
450523|NCT01310868|1104690|P1|COMPLETED|Overall Study||59
450524|NCT01310868|1104690|P1|STARTED|Overall Study||72
450525|NCT01310855|1104698|P2|NOT COMPLETED|Overall Study||0
450526|NCT01310855|1104699|P1|NOT COMPLETED|Overall Study||0
450527|NCT01310855|1104698|P2|COMPLETED|Overall Study||19
450528|NCT01310855|1104699|P1|COMPLETED|Overall Study||19
450529|NCT01310855|1104698|P2|STARTED|Overall Study||19
450530|NCT01310855|1104699|P1|STARTED|Overall Study||19
450531|NCT01310803|1104707|P2|NOT COMPLETED|Overall Study||0
450532|NCT01310803|1104708|P1|NOT COMPLETED|Overall Study||1
450533|NCT01310803|1104707|P2|COMPLETED|Overall Study||0
450534|NCT01310803|1104708|P1|COMPLETED|Overall Study||0
450535|NCT01310803|1104707|P2|STARTED|Overall Study||0
450536|NCT01310803|1104708|P1|STARTED|Overall Study||1
450537|NCT01310777|1104719|P3|NOT COMPLETED|Overall Study||30
450538|NCT01310777|1104720|P2|NOT COMPLETED|Overall Study||14
450539|NCT01310777|1104721|P1|NOT COMPLETED|Overall Study||33
450540|NCT01310777|1104719|P3|COMPLETED|Overall Study||145
450541|NCT01310777|1104720|P2|COMPLETED|Overall Study||178
450542|NCT01310777|1104721|P1|COMPLETED|Overall Study||160
450543|NCT01310777|1104719|P3|STARTED|Overall Study||175
450544|NCT01310777|1104720|P2|STARTED|Overall Study||192
450545|NCT01310777|1104721|P1|STARTED|Overall Study||193
450546|NCT01310699|1104731|P2|NOT COMPLETED|Overall Study||6
450547|NCT01310699|1104732|P1|NOT COMPLETED|Overall Study||4
450548|NCT01310699|1104731|P2|COMPLETED|Overall Study||143
450549|NCT01310699|1104732|P1|COMPLETED|Overall Study||128
450550|NCT01310699|1104731|P2|STARTED|Overall Study||149
450551|NCT01310699|1104732|P1|STARTED|Overall Study||132
450552|NCT01310582|1104744|P2|NOT COMPLETED|Overall Study||0
450553|NCT01310582|1104745|P1|NOT COMPLETED|Overall Study||0
450554|NCT01310582|1104744|P2|COMPLETED|Overall Study||26
450555|NCT01310582|1104745|P1|COMPLETED|Overall Study||31
450556|NCT01310582|1104744|P2|STARTED|Overall Study||26
450557|NCT01310582|1104745|P1|STARTED|Overall Study||31
450558|NCT01310413|1104759|P7|NOT COMPLETED|From Day U0 to Day U385||3
450559|NCT01310413|1104760|P6|NOT COMPLETED|From Day U0 to Day U385||0
450560|NCT01310413|1104761|P5|NOT COMPLETED|From Day U0 to Day U385||0
450561|NCT01310413|1104762|P4|NOT COMPLETED|From Day U0 to Day U385||0
450562|NCT01310413|1104763|P3|NOT COMPLETED|From Day U0 to Day U385||0
450563|NCT01310413|1104764|P2|NOT COMPLETED|From Day U0 to Day U385||0
450564|NCT01310413|1104765|P1|NOT COMPLETED|From Day U0 to Day U385||0
450565|NCT01310413|1104759|P7|COMPLETED|From Day U0 to Day U385|Upto Day U42|152
450566|NCT01310413|1104760|P6|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
450567|NCT01310413|1104761|P5|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
450568|NCT01310413|1104762|P4|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
450569|NCT01310413|1104763|P3|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
450570|NCT01310413|1104764|P2|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
450571|NCT01310413|1104765|P1|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
450572|NCT01310413|1104759|P7|STARTED|From Day U0 to Day U385|Upto Day U42|155
450573|NCT01310413|1104760|P6|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
450574|NCT01310413|1104761|P5|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
450575|NCT01310413|1104762|P4|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
450576|NCT01310413|1104763|P3|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
450577|NCT01310413|1104764|P2|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
450578|NCT01310413|1104765|P1|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
450579|NCT01310413|1104759|P7|NOT COMPLETED|Day 0 to Day 385||0
450580|NCT01310413|1104760|P6|NOT COMPLETED|Day 0 to Day 385||3
450581|NCT01310413|1104761|P5|NOT COMPLETED|Day 0 to Day 385||3
450582|NCT01310413|1104762|P4|NOT COMPLETED|Day 0 to Day 385||8
450583|NCT01310413|1104763|P3|NOT COMPLETED|Day 0 to Day 385||7
450584|NCT01310413|1104764|P2|NOT COMPLETED|Day 0 to Day 385||8
450585|NCT01310413|1104765|P1|NOT COMPLETED|Day 0 to Day 385||27
450586|NCT01310413|1104759|P7|COMPLETED|Day 0 to Day 385|This group is only followed during the Unblinded Phase of the study, from Days U0 to U385.|0
450587|NCT01310413|1104760|P6|COMPLETED|Day 0 to Day 385||77
450588|NCT01310413|1104761|P5|COMPLETED|Day 0 to Day 385||73
450589|NCT01310413|1104762|P4|COMPLETED|Day 0 to Day 385||67
450590|NCT01310413|1104763|P3|COMPLETED|Day 0 to Day 385||203
450591|NCT01310413|1104764|P2|COMPLETED|Day 0 to Day 385||190
450592|NCT01310413|1104765|P1|COMPLETED|Day 0 to Day 385||172
450593|NCT01310413|1104759|P7|STARTED|Day 0 to Day 385|This group is only followed during the Unblinded Phase of the study, from Days U0 to U385.|0
450594|NCT01310413|1104760|P6|STARTED|Day 0 to Day 385||80
450595|NCT01310413|1104761|P5|STARTED|Day 0 to Day 385||76
450596|NCT01310413|1104762|P4|STARTED|Day 0 to Day 385||75
450597|NCT01310413|1104763|P3|STARTED|Day 0 to Day 385||210
450598|NCT01310413|1104764|P2|STARTED|Day 0 to Day 385||198
450599|NCT01310413|1104765|P1|STARTED|Day 0 to Day 385||199
450600|NCT01310400|1104921|P3|NOT COMPLETED|Overall Study||30
450601|NCT01310400|1104922|P2|NOT COMPLETED|Overall Study||32
450602|NCT01310400|1104923|P1|NOT COMPLETED|Overall Study||28
450603|NCT01310400|1104921|P3|COMPLETED|Overall Study||422
450604|NCT01310400|1104922|P2|COMPLETED|Overall Study||420
450605|NCT01310400|1104923|P1|COMPLETED|Overall Study||424
450606|NCT01310400|1104921|P3|STARTED|Overall Study||452
450607|NCT01310400|1104922|P2|STARTED|Overall Study||452
450608|NCT01310400|1104923|P1|STARTED|Overall Study||452
450609|NCT01310179|1104940|P1|NOT COMPLETED|Overall Study||0
450610|NCT01310179|1104940|P1|COMPLETED|Overall Study||12
450611|NCT01310179|1104940|P1|STARTED|Overall Study||12
450612|NCT01310127|1104947|P2|NOT COMPLETED|Overall Study||1
450613|NCT01310127|1104948|P1|NOT COMPLETED|Overall Study||2
450614|NCT01310127|1104947|P2|COMPLETED|Overall Study||10
450615|NCT01310127|1104948|P1|COMPLETED|Overall Study||10
450616|NCT01310127|1104947|P2|STARTED|Overall Study||11
450617|NCT01310127|1104948|P1|STARTED|Overall Study||12
450618|NCT01309997|1104962|P2|NOT COMPLETED|Overall Study||6
450619|NCT01309997|1104963|P1|NOT COMPLETED|Overall Study||5
450620|NCT01309997|1104962|P2|COMPLETED|Overall Study||31
450621|NCT01309997|1104963|P1|COMPLETED|Overall Study||30
450622|NCT01309997|1104962|P2|Crossed Over to Second Arm|Overall Study||23
450623|NCT01309997|1104963|P1|Crossed Over to Second Arm|Overall Study||19
450624|NCT01309997|1104962|P2|Remained on First Arm Only|Overall Study||14
450625|NCT01309997|1104963|P1|Remained on First Arm Only|Overall Study||16
450626|NCT01309997|1104962|P2|STARTED|Overall Study||37
450627|NCT01309997|1104963|P1|STARTED|Overall Study||35
450628|NCT01309919|1104987|P2|NOT COMPLETED|Overall Study||48
450629|NCT01309919|1104988|P1|NOT COMPLETED|Overall Study||17
450630|NCT01309919|1104987|P2|COMPLETED|Overall Study||27
450631|NCT01309919|1104988|P1|COMPLETED|Overall Study||58
450632|NCT01309919|1104987|P2|STARTED|Overall Study||75
450633|NCT01309919|1104988|P1|STARTED|Overall Study||75
450634|NCT01309893|1105000|P2|NOT COMPLETED|Week 2 - Crossover Intervention||1
450635|NCT01309893|1105001|P1|NOT COMPLETED|Week 2 - Crossover Intervention||1
450636|NCT01309893|1105000|P2|COMPLETED|Week 2 - Crossover Intervention||32
450637|NCT01309893|1105001|P1|COMPLETED|Week 2 - Crossover Intervention||32
450638|NCT01309893|1105000|P2|STARTED|Week 2 - Crossover Intervention||33
450639|NCT01309893|1105001|P1|STARTED|Week 2 - Crossover Intervention||33
450640|NCT01309893|1105000|P2|NOT COMPLETED|Week 1 - First Intervention||0
450641|NCT01309893|1105001|P1|NOT COMPLETED|Week 1 - First Intervention||0
450642|NCT01309893|1105000|P2|COMPLETED|Week 1 - First Intervention||33
450643|NCT01309893|1105001|P1|COMPLETED|Week 1 - First Intervention||33
450644|NCT01309893|1105000|P2|STARTED|Week 1 - First Intervention||33
450645|NCT01309893|1105001|P1|STARTED|Week 1 - First Intervention||33
450646|NCT01309880|1105011|P2|NOT COMPLETED|Overall Study||0
450647|NCT01309880|1105012|P1|NOT COMPLETED|Overall Study||0
450648|NCT01309880|1105011|P2|COMPLETED|Overall Study||33
450649|NCT01309880|1105012|P1|COMPLETED|Overall Study||33
450650|NCT01309880|1105011|P2|STARTED|Overall Study||33
450651|NCT01309880|1105012|P1|STARTED|Overall Study||33
450652|NCT01309841|1105025|P3|NOT COMPLETED|Overall Study||37
450653|NCT01309841|1105026|P2|NOT COMPLETED|Overall Study||41
450654|NCT01309841|1105027|P1|NOT COMPLETED|Overall Study||39
450655|NCT01309841|1105025|P3|COMPLETED|Overall Study||180
450656|NCT01309841|1105026|P2|COMPLETED|Overall Study||177
450657|NCT01309841|1105027|P1|COMPLETED|Overall Study||178
450658|NCT01309841|1105025|P3|STARTED|Overall Study||217
450659|NCT01309841|1105026|P2|STARTED|Overall Study||218
450660|NCT01309841|1105027|P1|STARTED|Overall Study||217
450661|NCT01309828|1105067|P2|NOT COMPLETED|Overall Study||16
450662|NCT01309828|1105068|P1|NOT COMPLETED|Overall Study||16
450663|NCT01309828|1105067|P2|COMPLETED|Overall Study||60
450664|NCT01309828|1105068|P1|COMPLETED|Overall Study||61
450665|NCT01309828|1105067|P2|STARTED|Overall Study||76
450666|NCT01309828|1105068|P1|STARTED|Overall Study||77
450667|NCT01309802|1105082|P2|NOT COMPLETED|Overall Study||9
450668|NCT01309802|1105083|P1|NOT COMPLETED|Overall Study||12
450669|NCT01309802|1105082|P2|COMPLETED|Overall Study||14
450670|NCT01309802|1105083|P1|COMPLETED|Overall Study||13
450671|NCT01309802|1105082|P2|STARTED|Overall Study||23
450672|NCT01309802|1105083|P1|STARTED|Overall Study||25
450673|NCT01309737|1105102|P5|NOT COMPLETED|Week 16 to 52||33
450674|NCT01309737|1105103|P4|NOT COMPLETED|Week 16 to 52||34
450675|NCT01309737|1105104|P3|NOT COMPLETED|Week 16 to 52||0
450676|NCT01309737|1105105|P2|NOT COMPLETED|Week 16 to 52||103
450677|NCT01309737|1105106|P1|NOT COMPLETED|Week 16 to 52||133
450678|NCT01309737|1105102|P5|COMPLETED|Week 16 to 52||44
450679|NCT01309737|1105103|P4|COMPLETED|Week 16 to 52||41
450680|NCT01309737|1105104|P3|COMPLETED|Week 16 to 52||0
450681|NCT01309737|1105105|P2|COMPLETED|Week 16 to 52||238
450682|NCT01309737|1105106|P1|COMPLETED|Week 16 to 52||198
450683|NCT01309737|1105102|P5|STARTED|Week 16 to 52||77
450684|NCT01309737|1105103|P4|STARTED|Week 16 to 52||75
450685|NCT01309737|1105104|P3|STARTED|Week 16 to 52||0
450686|NCT01309737|1105105|P2|STARTED|Week 16 to 52||341
450687|NCT01309737|1105106|P1|STARTED|Week 16 to 52||331
450688|NCT01309737|1105102|P5|NOT COMPLETED|Week 0 to 16||0
450689|NCT01309737|1105103|P4|NOT COMPLETED|Week 0 to 16||0
450690|NCT01309737|1105104|P3|NOT COMPLETED|Week 0 to 16||44
450691|NCT01309737|1105105|P2|NOT COMPLETED|Week 0 to 16||40
450692|NCT01309737|1105106|P1|NOT COMPLETED|Week 0 to 16||52
450693|NCT01309737|1105102|P5|COMPLETED|Week 0 to 16||0
450694|NCT01309737|1105103|P4|COMPLETED|Week 0 to 16||0
450695|NCT01309737|1105104|P3|COMPLETED|Week 0 to 16||152
450696|NCT01309737|1105105|P2|COMPLETED|Week 0 to 16||341
450697|NCT01309737|1105106|P1|COMPLETED|Week 0 to 16||331
450698|NCT01309737|1105102|P5|Treated|Week 0 to 16||0
450699|NCT01309737|1105103|P4|Treated|Week 0 to 16||0
450700|NCT01309737|1105104|P3|Treated|Week 0 to 16||196
450701|NCT01309737|1105105|P2|Treated|Week 0 to 16||381
450702|NCT01309737|1105106|P1|Treated|Week 0 to 16||382
450703|NCT01309737|1105102|P5|STARTED|Week 0 to 16||0
450704|NCT01309737|1105103|P4|STARTED|Week 0 to 16||0
450705|NCT01309737|1105104|P3|STARTED|Week 0 to 16||196
450706|NCT01309737|1105105|P2|STARTED|Week 0 to 16||381
450707|NCT01309737|1105106|P1|STARTED|Week 0 to 16||383
450708|NCT01309672|1105301|P1|NOT COMPLETED|Overall Study||37
450709|NCT01309672|1105301|P1|COMPLETED|Overall Study||4
450710|NCT01309672|1105301|P1|Received Protocol Treatment|Overall Study||40
450711|NCT01309672|1105301|P1|STARTED|Overall Study||41
450712|NCT01309659|1105311|P2|NOT COMPLETED|Overall Study||1
450713|NCT01309659|1105312|P1|NOT COMPLETED|Overall Study||0
450714|NCT01309659|1105311|P2|COMPLETED|Overall Study||9
450715|NCT01309659|1105312|P1|COMPLETED|Overall Study||9
450716|NCT01309659|1105311|P2|STARTED|Overall Study||10
450717|NCT01309659|1105312|P1|STARTED|Overall Study||9
450718|NCT01309646|1105354|P2|NOT COMPLETED|Overall Study||0
450719|NCT01309646|1105355|P1|NOT COMPLETED|Overall Study||0
450720|NCT01309646|1105354|P2|COMPLETED|Overall Study||227
450721|NCT01309646|1105355|P1|COMPLETED|Overall Study||224
450722|NCT01309646|1105354|P2|STARTED|Overall Study||227
450723|NCT01309646|1105355|P1|STARTED|Overall Study||224
450724|NCT01309581|1105395|P2|NOT COMPLETED|Overall Study||0
450725|NCT01309581|1105396|P1|NOT COMPLETED|Overall Study||0
450726|NCT01309581|1105395|P2|COMPLETED|Overall Study||1
450727|NCT01309581|1105396|P1|COMPLETED|Overall Study||2
450728|NCT01309581|1105395|P2|STARTED|Overall Study||1
450729|NCT01309581|1105396|P1|STARTED|Overall Study||2
450730|NCT01309451|1105406|P2|NOT COMPLETED|Overall Study||3
450731|NCT01309451|1105407|P1|NOT COMPLETED|Overall Study||2
450732|NCT01309451|1105406|P2|COMPLETED|Overall Study|unit of measure is number of eyes|18
450733|NCT01309451|1105407|P1|COMPLETED|Overall Study|unit of measure is number of eyes|17
450734|NCT01309451|1105406|P2|STARTED|Overall Study|unit of measure is number of eyes|21
450735|NCT01309451|1105407|P1|STARTED|Overall Study|unit of measure is number of eyes|19
450736|NCT01309386|1105417|P2|NOT COMPLETED|Overall Study||21
450737|NCT01309386|1105418|P1|NOT COMPLETED|Overall Study||22
450738|NCT01309386|1105417|P2|COMPLETED|Overall Study||29
450739|NCT01309386|1105418|P1|COMPLETED|Overall Study||28
450740|NCT01309386|1105417|P2|STARTED|Overall Study||50
450741|NCT01309386|1105418|P1|STARTED|Overall Study||50
450742|NCT01309360|1105439|P3|NOT COMPLETED|Overall Study||0
450743|NCT01309360|1105440|P2|NOT COMPLETED|Overall Study||0
450744|NCT01309360|1105441|P1|NOT COMPLETED|Overall Study||0
450745|NCT01309360|1105439|P3|COMPLETED|Overall Study||40
450746|NCT01309360|1105440|P2|COMPLETED|Overall Study||40
450747|NCT01309360|1105441|P1|COMPLETED|Overall Study||40
450748|NCT01309360|1105439|P3|STARTED|Overall Study||40
450749|NCT01309360|1105440|P2|STARTED|Overall Study||40
450750|NCT01309360|1105441|P1|STARTED|Overall Study||40
450751|NCT01309308|1105466|P2|NOT COMPLETED|Overall Study||4
450752|NCT01309308|1105467|P1|NOT COMPLETED|Overall Study||6
450753|NCT01309308|1105466|P2|COMPLETED|Overall Study||71
450754|NCT01309308|1105467|P1|COMPLETED|Overall Study||69
450755|NCT01309308|1105466|P2|STARTED|Overall Study||75
450756|NCT01309308|1105467|P1|STARTED|Overall Study||75
450757|NCT01309282|1105475|P1|NOT COMPLETED|Overall Study||1
450758|NCT01309282|1105475|P1|COMPLETED|Overall Study||8
450759|NCT01309282|1105475|P1|STARTED|Overall Study||9
450760|NCT01309269|1105492|P1|NOT COMPLETED|Overall Study||840
450761|NCT01309269|1105492|P1|COMPLETED|Overall Study||245
450762|NCT01309269|1105492|P1|Treated|Overall Study||978
450763|NCT01309269|1105492|P1|STARTED|Overall Study||1085
450764|NCT01309243|1105500|P2|NOT COMPLETED|Extension Phase||0
450765|NCT01309243|1105501|P1|NOT COMPLETED|Extension Phase||6
450766|NCT01309243|1105500|P2|COMPLETED|Extension Phase||117
450767|NCT01309243|1105501|P1|COMPLETED|Extension Phase||34
450768|NCT01309243|1105500|P2|STARTED|Extension Phase|117 participants from the Randomized Phase continued the study in the Extension Phase.|117
450769|NCT01309243|1105501|P1|STARTED|Extension Phase|40 participants from the Randomized Phase continued the study in the Extension Phase.|40
450770|NCT01309243|1105500|P2|NOT COMPLETED|Randomized Phase Through Week 96||109
450771|NCT01309243|1105501|P1|NOT COMPLETED|Randomized Phase Through Week 96||84
450772|NCT01309243|1105500|P2|COMPLETED|Randomized Phase Through Week 96||290
450773|NCT01309243|1105501|P1|COMPLETED|Randomized Phase Through Week 96||316
450774|NCT01309243|1105500|P2|Randomized and Treated|Randomized Phase Through Week 96||392
450775|NCT01309243|1105501|P1|Randomized and Treated|Randomized Phase Through Week 96||394
450776|NCT01309243|1105500|P2|STARTED|Randomized Phase Through Week 96||399
450777|NCT01309243|1105501|P1|STARTED|Randomized Phase Through Week 96||400
450778|NCT01309204|1105527|P2|NOT COMPLETED|Overall Study||75
450779|NCT01309204|1105528|P1|NOT COMPLETED|Overall Study||67
450780|NCT01309204|1105527|P2|COMPLETED|Overall Study||361
450781|NCT01309204|1105528|P1|COMPLETED|Overall Study||385
450782|NCT01309204|1105527|P2|STARTED|Overall Study||436
450783|NCT01309204|1105528|P1|STARTED|Overall Study||452
450784|NCT01309100|1105534|P1|NOT COMPLETED|Overall Study||2
450785|NCT01309100|1105534|P1|COMPLETED|Overall Study||142
450786|NCT01309100|1105534|P1|STARTED|Overall Study||144
450787|NCT01308918|1105545|P1|NOT COMPLETED|Overall Study||0
450788|NCT01308918|1105545|P1|COMPLETED|Overall Study||50
450789|NCT01308918|1105545|P1|STARTED|Overall Study||50
450790|NCT01308840|1105552|P1|NOT COMPLETED|Overall Study||0
450791|NCT01308840|1105552|P1|COMPLETED|Overall Study||31
450792|NCT01308840|1105552|P1|STARTED|Overall Study||31
450793|NCT01308814|1105561|P2|NOT COMPLETED|Overall Study||23
450794|NCT01308814|1105562|P1|NOT COMPLETED|Overall Study||17
450795|NCT01308814|1105561|P2|COMPLETED|Overall Study||63
450796|NCT01308814|1105562|P1|COMPLETED|Overall Study||69
450797|NCT01308814|1105561|P2|STARTED|Overall Study||86
450798|NCT01308814|1105562|P1|STARTED|Overall Study||86
450799|NCT01308788|1105582|P2|NOT COMPLETED|2-year Treatment||11
450800|NCT01308788|1105583|P1|NOT COMPLETED|2-year Treatment||4
450801|NCT01308788|1105582|P2|COMPLETED|2-year Treatment||10
450802|NCT01308788|1105583|P1|COMPLETED|2-year Treatment||10
450803|NCT01308788|1105582|P2|STARTED|2-year Treatment||21
450804|NCT01308788|1105583|P1|STARTED|2-year Treatment||14
450805|NCT01308788|1105582|P2|NOT COMPLETED|6-month Treatment||0
450806|NCT01308788|1105583|P1|NOT COMPLETED|6-month Treatment||0
450807|NCT01308788|1105582|P2|COMPLETED|6-month Treatment||21
450808|NCT01308788|1105583|P1|COMPLETED|6-month Treatment||14
450809|NCT01308788|1105582|P2|STARTED|6-month Treatment||21
450810|NCT01308788|1105583|P1|STARTED|6-month Treatment||14
450811|NCT01308762|1105618|P3|NOT COMPLETED|Overall Study||0
450812|NCT01308762|1105619|P2|NOT COMPLETED|Overall Study||1
450813|NCT01308762|1105620|P1|NOT COMPLETED|Overall Study||0
450814|NCT01308762|1105618|P3|COMPLETED|Overall Study||6
450815|NCT01308762|1105619|P2|COMPLETED|Overall Study|One patient was withdrawn as they were retrospecively found to have been ineligible at study entry|6
450816|NCT01308762|1105620|P1|COMPLETED|Overall Study||6
450817|NCT01308762|1105618|P3|STARTED|Overall Study||6
450818|NCT01308762|1105619|P2|STARTED|Overall Study||7
450819|NCT01308762|1105620|P1|STARTED|Overall Study||6
450820|NCT01308749|1105633|P2|NOT COMPLETED|Period 2: Open Label Treatment||2
450821|NCT01308749|1105634|P1|NOT COMPLETED|Period 2: Open Label Treatment||0
450822|NCT01308749|1105633|P2|COMPLETED|Period 2: Open Label Treatment||11
450823|NCT01308749|1105634|P1|COMPLETED|Period 2: Open Label Treatment||11
450824|NCT01308749|1105633|P2|STARTED|Period 2: Open Label Treatment||13
450825|NCT01308749|1105634|P1|STARTED|Period 2: Open Label Treatment||11
450826|NCT01308749|1105633|P2|NOT COMPLETED|Period 1: Double Blind Treatment||0
450827|NCT01308749|1105634|P1|NOT COMPLETED|Period 1: Double Blind Treatment||1
450828|NCT01308749|1105633|P2|COMPLETED|Period 1: Double Blind Treatment||13
450829|NCT01308749|1105634|P1|COMPLETED|Period 1: Double Blind Treatment||11
450830|NCT01308749|1105633|P2|STARTED|Period 1: Double Blind Treatment||13
450831|NCT01308749|1105634|P1|STARTED|Period 1: Double Blind Treatment||12
450832|NCT01308736|1105664|P2|NOT COMPLETED|Overall Study||5
450833|NCT01308736|1105665|P1|NOT COMPLETED|Overall Study||6
450834|NCT01308736|1105664|P2|COMPLETED|Overall Study||27
450835|NCT01308736|1105665|P1|COMPLETED|Overall Study||25
450836|NCT01308736|1105664|P2|STARTED|Overall Study||32
450837|NCT01308736|1105665|P1|STARTED|Overall Study||31
450838|NCT01308619|1105673|P2|NOT COMPLETED|Overall Study||3
450839|NCT01308619|1105674|P1|NOT COMPLETED|Overall Study||7
450840|NCT01308619|1105673|P2|COMPLETED|Overall Study||83
450841|NCT01308619|1105674|P1|COMPLETED|Overall Study||77
450842|NCT01308619|1105673|P2|STARTED|Overall Study||86
450843|NCT01308619|1105674|P1|STARTED|Overall Study||84
450844|NCT01308580|1105688|P2|NOT COMPLETED|Overall Study||7
450845|NCT01308580|1105689|P1|NOT COMPLETED|Overall Study||12
450846|NCT01308580|1105688|P2|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival|595
450847|NCT01308580|1105689|P1|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival|586
450848|NCT01308580|1105688|P2|Treated|Overall Study|Random assignment, was not actual treatment in some cases|588
450849|NCT01308580|1105689|P1|Treated|Overall Study|Random assignment, was not actual treatment in some cases|587
450850|NCT01308580|1105688|P2|STARTED|Overall Study||602
450851|NCT01308580|1105689|P1|STARTED|Overall Study||598
450852|NCT01308567|1105732|P3|NOT COMPLETED|Overall Study||4
450853|NCT01308567|1105733|P2|NOT COMPLETED|Overall Study||4
450854|NCT01308567|1105734|P1|NOT COMPLETED|Overall Study||2
450855|NCT01308567|1105732|P3|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|384
450856|NCT01308567|1105733|P2|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|385
450857|NCT01308567|1105734|P1|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|389
450858|NCT01308567|1105732|P3|Ongoing Treatment at Data Cut-off|Overall Study||3
450859|NCT01308567|1105733|P2|Ongoing Treatment at Data Cut-off|Overall Study||6
450860|NCT01308567|1105734|P1|Ongoing Treatment at Data Cut-off|Overall Study||4
450861|NCT01308567|1105732|P3|Treated|Overall Study|For 2 participants, actual treatment received was Cabazitaxel 20 mg/m^2.|377
450862|NCT01308567|1105733|P2|Treated|Overall Study|For 15 participants, actual treatment received was Cabazitaxel 25 mg/m^2.|382
450863|NCT01308567|1105734|P1|Treated|Overall Study|For 1 participant, actual treatment received was Cabazitaxel 25 mg/m^2.|388
450864|NCT01308567|1105732|P3|STARTED|Overall Study|Randomized|388
450865|NCT01308567|1105733|P2|STARTED|Overall Study|Randomized|389
450866|NCT01308567|1105734|P1|STARTED|Overall Study|Randomized|391
450867|NCT01308476|1105774|P2|NOT COMPLETED|Overall Study||2
450868|NCT01308476|1105775|P1|NOT COMPLETED|Overall Study||3
450869|NCT01308476|1105774|P2|COMPLETED|Overall Study||45
450870|NCT01308476|1105775|P1|COMPLETED|Overall Study||45
450871|NCT01308476|1105774|P2|STARTED|Overall Study|Entered and treated.|47
450872|NCT01308476|1105775|P1|STARTED|Overall Study|Entered and treated.|48
450873|NCT01308463|1105795|P1|NOT COMPLETED|Overall Study||29
450874|NCT01308463|1105795|P1|COMPLETED|Overall Study||0
450875|NCT01308463|1105795|P1|12 Years|Overall Study||2
450876|NCT01308463|1105795|P1|11 Years|Overall Study||8
450877|NCT01308463|1105795|P1|10 Years|Overall Study||8
450878|NCT01308463|1105795|P1|9 Years|Overall Study||11
450879|NCT01308463|1105795|P1|8 Years|Overall Study||14
450880|NCT01308463|1105795|P1|7 Years|Overall Study||12
450881|NCT01308463|1105795|P1|6 Years|Overall Study||11
450882|NCT01308463|1105795|P1|5 Years|Overall Study||20
450883|NCT01308463|1105795|P1|4 Years|Overall Study||20
450884|NCT01308463|1105795|P1|3 Years|Overall Study||17
450885|NCT01308463|1105795|P1|2 Years|Overall Study||18
450886|NCT01308463|1105795|P1|1 Year|Overall Study||21
450887|NCT01308463|1105795|P1|6 Months|Overall Study||23
450888|NCT01308463|1105795|P1|STARTED|Overall Study||29
450889|NCT01308450|1105802|P1|NOT COMPLETED|Overall Study||2
450890|NCT01308450|1105802|P1|COMPLETED|Overall Study|Last subject was enrolled 06/28/2011|300
450891|NCT01308450|1105802|P1|STARTED|Overall Study|302 subjects were screen. 300 subjects were enrolled in this one site, one visit study.|302
450892|NCT01308424|1105808|P3|NOT COMPLETED|Randomization||2
450893|NCT01308424|1105809|P2|NOT COMPLETED|Randomization||3
450894|NCT01308424|1105810|P1|NOT COMPLETED|Randomization||0
450895|NCT01308424|1105808|P3|COMPLETED|Randomization||82
450896|NCT01308424|1105809|P2|COMPLETED|Randomization||84
450897|NCT01308424|1105810|P1|COMPLETED|Randomization||0
450898|NCT01308424|1105808|P3|STARTED|Randomization||84
450899|NCT01308424|1105809|P2|STARTED|Randomization||87
450900|NCT01308424|1105810|P1|STARTED|Randomization||0
450901|NCT01308424|1105808|P3|NOT COMPLETED|Baseline Eligibility||0
450902|NCT01308424|1105809|P2|NOT COMPLETED|Baseline Eligibility||0
450903|NCT01308424|1105810|P1|NOT COMPLETED|Baseline Eligibility||71
450904|NCT01308424|1105808|P3|COMPLETED|Baseline Eligibility||0
450905|NCT01308424|1105809|P2|COMPLETED|Baseline Eligibility||0
450906|NCT01308424|1105810|P1|COMPLETED|Baseline Eligibility|Completed baseline run in and were eligible for randomization|171
450907|NCT01308424|1105808|P3|STARTED|Baseline Eligibility||0
450908|NCT01308424|1105809|P2|STARTED|Baseline Eligibility||0
450909|NCT01308424|1105810|P1|STARTED|Baseline Eligibility||242
450910|NCT01307956|1105817|P1|NOT COMPLETED|Overall Study||0
450911|NCT01307956|1105817|P1|COMPLETED|Overall Study||11
450912|NCT01307956|1105817|P1|STARTED|Overall Study||11
450913|NCT01307891|1105823|P2|NOT COMPLETED|Overall Study||1
450914|NCT01307891|1105824|P1|NOT COMPLETED|Overall Study||3
450915|NCT01307891|1105823|P2|COMPLETED|Overall Study||21
450916|NCT01307891|1105824|P1|COMPLETED|Overall Study||39
450917|NCT01307891|1105823|P2|STARTED|Overall Study||22
450918|NCT01307891|1105824|P1|STARTED|Overall Study||42
450919|NCT01307787|1105836|P2|NOT COMPLETED|Overall Study||0
450920|NCT01307787|1105837|P1|NOT COMPLETED|Overall Study||2
450921|NCT01307787|1105836|P2|COMPLETED|Overall Study||15
450922|NCT01307787|1105837|P1|COMPLETED|Overall Study||17
450923|NCT01307787|1105836|P2|T2= After 22 Weeks at Follow-up|Overall Study||15
450924|NCT01307787|1105837|P1|T2= After 22 Weeks at Follow-up|Overall Study||17
450925|NCT01307787|1105836|P2|T1= After 9 Weeks Post Intervention|Overall Study||15
450926|NCT01307787|1105837|P1|T1= After 9 Weeks Post Intervention|Overall Study||18
450927|NCT01307787|1105836|P2|STARTED|Overall Study||15
450928|NCT01307787|1105837|P1|STARTED|Overall Study||19
450929|NCT01307631|1105857|P2|NOT COMPLETED|Overall Study||0
450930|NCT01307631|1105858|P1|NOT COMPLETED|Overall Study||0
450931|NCT01307631|1105857|P2|COMPLETED|Overall Study||28
450932|NCT01307631|1105858|P1|COMPLETED|Overall Study||9
450933|NCT01307631|1105857|P2|STARTED|Overall Study||28
450934|NCT01307631|1105858|P1|STARTED|Overall Study||9
450935|NCT01307618|1105868|P2|NOT COMPLETED|Overall Study||0
450936|NCT01307618|1105869|P1|NOT COMPLETED|Overall Study||0
450937|NCT01307618|1105868|P2|COMPLETED|Overall Study||5
450938|NCT01307618|1105869|P1|COMPLETED|Overall Study||5
450939|NCT01307618|1105868|P2|STARTED|Overall Study||5
450940|NCT01307618|1105869|P1|STARTED|Overall Study||5
450941|NCT01307462|1105885|P1|NOT COMPLETED|Overall Study||1
450942|NCT01307462|1105885|P1|COMPLETED|Overall Study||35
450943|NCT01307462|1105885|P1|STARTED|Overall Study||36
450944|NCT01307423|1105901|P7|NOT COMPLETED|Active Treatment Phase (Week 25-52)||1
450945|NCT01307423|1105902|P6|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3
450946|NCT01307423|1105903|P5|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3
450947|NCT01307423|1105904|P4|NOT COMPLETED|Active Treatment Phase (Week 25-52)||8
450948|NCT01307423|1105905|P3|NOT COMPLETED|Active Treatment Phase (Week 25-52)||9
450949|NCT01307423|1105906|P2|NOT COMPLETED|Active Treatment Phase (Week 25-52)||19
450950|NCT01307423|1105907|P1|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
450951|NCT01307423|1105901|P7|COMPLETED|Active Treatment Phase (Week 25-52)||25
450952|NCT01307423|1105902|P6|COMPLETED|Active Treatment Phase (Week 25-52)||43
450953|NCT01307423|1105903|P5|COMPLETED|Active Treatment Phase (Week 25-52)||23
450954|NCT01307423|1105904|P4|COMPLETED|Active Treatment Phase (Week 25-52)||38
450955|NCT01307423|1105905|P3|COMPLETED|Active Treatment Phase (Week 25-52)||141
450956|NCT01307423|1105906|P2|COMPLETED|Active Treatment Phase (Week 25-52)||132
450957|NCT01307423|1105907|P1|COMPLETED|Active Treatment Phase (Week 25-52)||0
450958|NCT01307423|1105901|P7|STARTED|Active Treatment Phase (Week 25-52)||26
450959|NCT01307423|1105902|P6|STARTED|Active Treatment Phase (Week 25-52)|Six participants who escaped early and completed Week 24 did not enter the active treatment phase|46
450960|NCT01307423|1105903|P5|STARTED|Active Treatment Phase (Week 25-52)||26
450961|NCT01307423|1105904|P4|STARTED|Active Treatment Phase (Week 25-52)|Four participants who escaped early and completed Week 24 did not enter the active treatment phase.|46
450962|NCT01307423|1105905|P3|STARTED|Active Treatment Phase (Week 25-52)|Five participants who completed Week 24 did not enter active treatment phase|150
450963|NCT01307423|1105906|P2|STARTED|Active Treatment Phase (Week 25-52)|Nine participants who completed Week 24 did not enter active treatment phase|151
450964|NCT01307423|1105907|P1|STARTED|Active Treatment Phase (Week 25-52)||0
450965|NCT01307423|1105901|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
450966|NCT01307423|1105902|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
450967|NCT01307423|1105903|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
450968|NCT01307423|1105904|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
450969|NCT01307423|1105905|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
450970|NCT01307423|1105906|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||15
450971|NCT01307423|1105907|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
450972|NCT01307423|1105901|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
450973|NCT01307423|1105902|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
450974|NCT01307423|1105903|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
450975|NCT01307423|1105904|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
450976|NCT01307423|1105905|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||155
450977|NCT01307423|1105906|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||160
450978|NCT01307423|1105907|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|Two participants did not escape early and finished Week 24 did not enter the active treatment phase|156
450979|NCT01307423|1105901|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
450980|NCT01307423|1105902|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
450981|NCT01307423|1105903|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
450982|NCT01307423|1105904|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
450983|NCT01307423|1105905|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||79
450984|NCT01307423|1105906|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||73
450985|NCT01307423|1105907|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|One participant who escaped early did not complete Week 24|103
450986|NCT01307423|1105901|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
450987|NCT01307423|1105902|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
450988|NCT01307423|1105903|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
450989|NCT01307423|1105904|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
450990|NCT01307423|1105905|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166
450991|NCT01307423|1105906|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||168
450992|NCT01307423|1105907|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166
450993|NCT01307423|1105901|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
450994|NCT01307423|1105902|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
450995|NCT01307423|1105903|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
450996|NCT01307423|1105904|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
450997|NCT01307423|1105905|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175
450998|NCT01307423|1105906|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175
450999|NCT01307423|1105907|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||176
451000|NCT01307423|1105901|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
451001|NCT01307423|1105902|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
451002|NCT01307423|1105903|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
451003|NCT01307423|1105904|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
451004|NCT01307423|1105905|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||177
451005|NCT01307423|1105906|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||175
451006|NCT01307423|1105907|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||176
451007|NCT01307397|1106016|P1|NOT COMPLETED|Overall Study||0
451008|NCT01307397|1106016|P1|COMPLETED|Overall Study|A participant completed study in case of progressive disease, adverse events or consent withdrawn|3219
451009|NCT01307397|1106016|P1|STARTED|Overall Study||3219
451010|NCT01307319|1106038|P3|NOT COMPLETED|Overall Study||7
451011|NCT01307319|1106039|P2|NOT COMPLETED|Overall Study||8
451012|NCT01307319|1106040|P1|NOT COMPLETED|Overall Study||4
451013|NCT01307319|1106038|P3|COMPLETED|Overall Study||227
451014|NCT01307319|1106039|P2|COMPLETED|Overall Study||234
451015|NCT01307319|1106040|P1|COMPLETED|Overall Study||235
451016|NCT01307319|1106038|P3|ITT Population|Overall Study||234
451017|NCT01307319|1106039|P2|ITT Population|Overall Study||241
451018|NCT01307319|1106040|P1|ITT Population|Overall Study|One participant provided no post-baseline assessment.|238
451019|NCT01307319|1106038|P3|Safety Population|Overall Study||234
451020|NCT01307319|1106039|P2|Safety Population|Overall Study|One participant was randomized in error and did not receive study medication.|241
451021|NCT01307319|1106040|P1|Safety Population|Overall Study||239
451022|NCT01307319|1106038|P3|STARTED|Overall Study|Randomized|234
451023|NCT01307319|1106039|P2|STARTED|Overall Study|Randomized|242
451024|NCT01307319|1106040|P1|STARTED|Overall Study|Randomized|239
451025|NCT01307111|1106054|P2|NOT COMPLETED|1-2 Week IUD Check up||2
451026|NCT01307111|1106055|P1|NOT COMPLETED|1-2 Week IUD Check up||2
451027|NCT01307111|1106054|P2|COMPLETED|1-2 Week IUD Check up||38
451028|NCT01307111|1106055|P1|COMPLETED|1-2 Week IUD Check up||38
451029|NCT01307111|1106054|P2|STARTED|1-2 Week IUD Check up||40
451030|NCT01307111|1106055|P1|STARTED|1-2 Week IUD Check up||40
451031|NCT01307111|1106054|P2|NOT COMPLETED|IUD Insertion||0
451032|NCT01307111|1106055|P1|NOT COMPLETED|IUD Insertion||2
451033|NCT01307111|1106054|P2|COMPLETED|IUD Insertion||40
451034|NCT01307111|1106055|P1|COMPLETED|IUD Insertion||40
451035|NCT01307111|1106054|P2|STARTED|IUD Insertion||40
451036|NCT01307111|1106055|P1|STARTED|IUD Insertion||42
451037|NCT01307046|1106065|P2|NOT COMPLETED|Overall Study||11
451038|NCT01307046|1106066|P1|NOT COMPLETED|Overall Study||12
451039|NCT01307046|1106065|P2|COMPLETED|Overall Study||159
451040|NCT01307046|1106066|P1|COMPLETED|Overall Study||154
451041|NCT01307046|1106065|P2|STARTED|Overall Study||170
451042|NCT01307046|1106066|P1|STARTED|Overall Study||166
451043|NCT01307033|1106078|P4|NOT COMPLETED|44-week Open-label Extension||12
451044|NCT01307033|1106079|P3|NOT COMPLETED|44-week Open-label Extension||11
451045|NCT01307033|1106080|P2|NOT COMPLETED|44-week Open-label Extension||0
451046|NCT01307033|1106081|P1|NOT COMPLETED|44-week Open-label Extension||0
451047|NCT01307033|1106078|P4|COMPLETED|44-week Open-label Extension||115
451048|NCT01307033|1106079|P3|COMPLETED|44-week Open-label Extension||120
451049|NCT01307033|1106080|P2|COMPLETED|44-week Open-label Extension||0
451050|NCT01307033|1106081|P1|COMPLETED|44-week Open-label Extension||0
451051|NCT01307033|1106078|P4|STARTED|44-week Open-label Extension||127
451052|NCT01307033|1106079|P3|STARTED|44-week Open-label Extension||131
451053|NCT01307033|1106080|P2|STARTED|44-week Open-label Extension||0
451054|NCT01307033|1106081|P1|STARTED|44-week Open-label Extension||0
451055|NCT01307033|1106078|P4|NOT COMPLETED|8-week Double-blind Period||0
451056|NCT01307033|1106079|P3|NOT COMPLETED|8-week Double-blind Period||0
451057|NCT01307033|1106080|P2|NOT COMPLETED|8-week Double-blind Period||7
451058|NCT01307033|1106081|P1|NOT COMPLETED|8-week Double-blind Period||13
451059|NCT01307033|1106078|P4|COMPLETED|8-week Double-blind Period||0
451060|NCT01307033|1106079|P3|COMPLETED|8-week Double-blind Period||0
451061|NCT01307033|1106080|P2|COMPLETED|8-week Double-blind Period||127
451062|NCT01307033|1106081|P1|COMPLETED|8-week Double-blind Period||131
451063|NCT01307033|1106078|P4|STARTED|8-week Double-blind Period||0
451064|NCT01307033|1106079|P3|STARTED|8-week Double-blind Period||0
451065|NCT01307033|1106080|P2|STARTED|8-week Double-blind Period||134
451066|NCT01307033|1106081|P1|STARTED|8-week Double-blind Period||144
451067|NCT01307020|1106103|P10|NOT COMPLETED|Overall Study||0
451068|NCT01307020|1106104|P9|NOT COMPLETED|Overall Study||0
451069|NCT01307020|1106105|P8|NOT COMPLETED|Overall Study||0
451070|NCT01307020|1106106|P7|NOT COMPLETED|Overall Study||1
451071|NCT01307020|1106107|P6|NOT COMPLETED|Overall Study||0
451072|NCT01307020|1106108|P5|NOT COMPLETED|Overall Study||0
451073|NCT01307020|1106109|P4|NOT COMPLETED|Overall Study||1
451074|NCT01307020|1106110|P3|NOT COMPLETED|Overall Study||1
451075|NCT01307020|1106111|P2|NOT COMPLETED|Overall Study||1
451076|NCT01307020|1106112|P1|NOT COMPLETED|Overall Study||0
451077|NCT01307020|1106103|P10|COMPLETED|Overall Study||62
451078|NCT01307020|1106104|P9|COMPLETED|Overall Study||61
451079|NCT01307020|1106105|P8|COMPLETED|Overall Study||60
451080|NCT01307020|1106106|P7|COMPLETED|Overall Study||58
451081|NCT01307020|1106107|P6|COMPLETED|Overall Study||61
451082|NCT01307020|1106108|P5|COMPLETED|Overall Study||60
451083|NCT01307020|1106109|P4|COMPLETED|Overall Study||60
451084|NCT01307020|1106110|P3|COMPLETED|Overall Study||62
451085|NCT01307020|1106111|P2|COMPLETED|Overall Study||62
451086|NCT01307020|1106112|P1|COMPLETED|Overall Study||61
451087|NCT01307020|1106103|P10|ITT (>= 1 Assessment Post Randomization)|Overall Study||62
451088|NCT01307020|1106104|P9|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
451089|NCT01307020|1106105|P8|ITT (>= 1 Assessment Post Randomization)|Overall Study||59
451090|NCT01307020|1106106|P7|ITT (>= 1 Assessment Post Randomization)|Overall Study||59
451091|NCT01307020|1106107|P6|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
451092|NCT01307020|1106108|P5|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
451093|NCT01307020|1106109|P4|ITT (>= 1 Assessment Post Randomization)|Overall Study||61
451094|NCT01307020|1106110|P3|ITT (>= 1 Assessment Post Randomization)|Overall Study||63
451095|NCT01307020|1106111|P2|ITT (>= 1 Assessment Post Randomization)|Overall Study||62
451096|NCT01307020|1106112|P1|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
451097|NCT01307020|1106103|P10|Safety Population|Overall Study||62
451098|NCT01307020|1106104|P9|Safety Population|Overall Study||61
451099|NCT01307020|1106105|P8|Safety Population|Overall Study||60
451100|NCT01307020|1106106|P7|Safety Population|Overall Study||59
451101|NCT01307020|1106107|P6|Safety Population|Overall Study||61
451102|NCT01307020|1106108|P5|Safety Population|Overall Study||60
451103|NCT01307020|1106109|P4|Safety Population|Overall Study||61
451104|NCT01307020|1106110|P3|Safety Population|Overall Study||63
451105|NCT01307020|1106111|P2|Safety Population|Overall Study||63
451106|NCT01307020|1106112|P1|Safety Population|Overall Study||61
451107|NCT01307020|1106103|P10|STARTED|Overall Study||62
451108|NCT01307020|1106104|P9|STARTED|Overall Study||61
451109|NCT01307020|1106105|P8|STARTED|Overall Study||60
451110|NCT01307020|1106106|P7|STARTED|Overall Study||59
451111|NCT01307020|1106107|P6|STARTED|Overall Study||61
451112|NCT01307020|1106108|P5|STARTED|Overall Study||60
451113|NCT01307020|1106109|P4|STARTED|Overall Study||61
451114|NCT01307020|1106110|P3|STARTED|Overall Study||63
451115|NCT01307020|1106111|P2|STARTED|Overall Study||63
451116|NCT01307020|1106112|P1|STARTED|Overall Study||61
451117|NCT01307007|1106156|P2|NOT COMPLETED|Overall Study||0
451118|NCT01307007|1106157|P1|NOT COMPLETED|Overall Study||0
451119|NCT01307007|1106156|P2|COMPLETED|Overall Study||30
451120|NCT01307007|1106157|P1|COMPLETED|Overall Study||25
451121|NCT01307007|1106156|P2|STARTED|Overall Study||30
451122|NCT01307007|1106157|P1|STARTED|Overall Study||25
451123|NCT01306968|1106167|P4|NOT COMPLETED|Overall Study||4
451124|NCT01306968|1106168|P3|NOT COMPLETED|Overall Study||1
451125|NCT01306968|1106169|P2|NOT COMPLETED|Overall Study||3
451126|NCT01306968|1106170|P1|NOT COMPLETED|Overall Study||1
451127|NCT01306968|1106167|P4|COMPLETED|Overall Study||21
451128|NCT01306968|1106168|P3|COMPLETED|Overall Study||23
451129|NCT01306968|1106169|P2|COMPLETED|Overall Study||20
451130|NCT01306968|1106170|P1|COMPLETED|Overall Study||6
451131|NCT01306968|1106167|P4|STARTED|Overall Study|2 participants withdrew before chamber sessions were initiated|25
451132|NCT01306968|1106168|P3|STARTED|Overall Study||24
451133|NCT01306968|1106169|P2|STARTED|Overall Study||23
451134|NCT01306968|1106170|P1|STARTED|Overall Study||7
451135|NCT01306877|1106194|P2|NOT COMPLETED|Overall Study||4
451136|NCT01306877|1106195|P1|NOT COMPLETED|Overall Study||3
451137|NCT01306877|1106194|P2|COMPLETED|Overall Study||67
451138|NCT01306877|1106195|P1|COMPLETED|Overall Study||75
451139|NCT01306877|1106194|P2|STARTED|Overall Study||71
451140|NCT01306877|1106195|P1|STARTED|Overall Study||78
451141|NCT01306643|1106213|P1|NOT COMPLETED|Overall Study||13
451142|NCT01306643|1106213|P1|COMPLETED|Overall Study|Completed Study was defined as participants who completed through Cycle 12 (Week 48) per protocol.|5
451143|NCT01306643|1106213|P1|STARTED|Overall Study||18
451144|NCT01306617|1106225|P3|NOT COMPLETED|Overall Study||5
451145|NCT01306617|1106226|P2|NOT COMPLETED|Overall Study||1
451146|NCT01306617|1106227|P1|NOT COMPLETED|Overall Study||1
451147|NCT01306617|1106225|P3|COMPLETED|Overall Study|The number of participants who completed study drug|12
451148|NCT01306617|1106226|P2|COMPLETED|Overall Study|The number of participants who completed study drug|13
451149|NCT01306617|1106227|P1|COMPLETED|Overall Study|The number of participants who completed study drug|18
451150|NCT01306617|1106225|P3|STARTED|Overall Study||17
451151|NCT01306617|1106226|P2|STARTED|Overall Study||14
451152|NCT01306617|1106227|P1|STARTED|Overall Study||19
451153|NCT01306305|1106270|P2|NOT COMPLETED|Overall Study||0
451154|NCT01306305|1106271|P1|NOT COMPLETED|Overall Study||2
451155|NCT01306305|1106270|P2|COMPLETED|Overall Study||55
451156|NCT01306305|1106271|P1|COMPLETED|Overall Study||53
451157|NCT01306305|1106270|P2|STARTED|Overall Study||55
451158|NCT01306305|1106271|P1|STARTED|Overall Study||55
451159|NCT01306292|1106287|P4|NOT COMPLETED|Second Injection||0
451160|NCT01306292|1106288|P3|NOT COMPLETED|Second Injection||1
451161|NCT01306292|1106289|P2|NOT COMPLETED|Second Injection||0
451162|NCT01306292|1106290|P1|NOT COMPLETED|Second Injection||0
451163|NCT01306292|1106287|P4|COMPLETED|Second Injection||10
451164|NCT01306292|1106288|P3|COMPLETED|Second Injection|1 subject completed both injections but not 24-hour follow-up; all other values were recorded.|7
451165|NCT01306292|1106289|P2|COMPLETED|Second Injection||8
451166|NCT01306292|1106290|P1|COMPLETED|Second Injection||10
451167|NCT01306292|1106287|P4|STARTED|Second Injection||10
451168|NCT01306292|1106288|P3|STARTED|Second Injection||8
451169|NCT01306292|1106289|P2|STARTED|Second Injection||8
451170|NCT01306292|1106290|P1|STARTED|Second Injection||10
451171|NCT01306292|1106287|P4|NOT COMPLETED|Washout (at Least 10 Minutes)||0
451172|NCT01306292|1106288|P3|NOT COMPLETED|Washout (at Least 10 Minutes)||0
451173|NCT01306292|1106289|P2|NOT COMPLETED|Washout (at Least 10 Minutes)||0
451174|NCT01306292|1106290|P1|NOT COMPLETED|Washout (at Least 10 Minutes)||0
451175|NCT01306292|1106287|P4|COMPLETED|Washout (at Least 10 Minutes)||10
451176|NCT01306292|1106288|P3|COMPLETED|Washout (at Least 10 Minutes)||8
451177|NCT01306292|1106289|P2|COMPLETED|Washout (at Least 10 Minutes)||8
451178|NCT01306292|1106290|P1|COMPLETED|Washout (at Least 10 Minutes)||10
451179|NCT01306292|1106287|P4|STARTED|Washout (at Least 10 Minutes)||10
451180|NCT01306292|1106288|P3|STARTED|Washout (at Least 10 Minutes)||8
451181|NCT01306292|1106289|P2|STARTED|Washout (at Least 10 Minutes)||8
451182|NCT01306292|1106290|P1|STARTED|Washout (at Least 10 Minutes)||10
451183|NCT01306292|1106287|P4|NOT COMPLETED|First Injection||0
451184|NCT01306292|1106288|P3|NOT COMPLETED|First Injection||0
451185|NCT01306292|1106289|P2|NOT COMPLETED|First Injection||0
451186|NCT01306292|1106290|P1|NOT COMPLETED|First Injection||0
451187|NCT01306292|1106287|P4|COMPLETED|First Injection||10
451188|NCT01306292|1106288|P3|COMPLETED|First Injection||8
451189|NCT01306292|1106289|P2|COMPLETED|First Injection||8
451190|NCT01306292|1106290|P1|COMPLETED|First Injection||10
451191|NCT01306292|1106287|P4|STARTED|First Injection||10
451192|NCT01306292|1106288|P3|STARTED|First Injection||8
451193|NCT01306292|1106289|P2|STARTED|First Injection||8
451194|NCT01306292|1106290|P1|STARTED|First Injection||10
451195|NCT01306253|1106308|P2|NOT COMPLETED|Overall Study||1
451196|NCT01306253|1106309|P1|NOT COMPLETED|Overall Study||1
451197|NCT01306253|1106308|P2|COMPLETED|Overall Study||56
451198|NCT01306253|1106309|P1|COMPLETED|Overall Study||56
451199|NCT01306253|1106308|P2|STARTED|Overall Study||57
451200|NCT01306253|1106309|P1|STARTED|Overall Study||57
451201|NCT01306214|1106326|P3|NOT COMPLETED|Overall Study||22
451202|NCT01306214|1106327|P2|NOT COMPLETED|Overall Study||28
451203|NCT01306214|1106328|P1|NOT COMPLETED|Overall Study||28
451204|NCT01306214|1106326|P3|COMPLETED|Overall Study||168
451205|NCT01306214|1106327|P2|COMPLETED|Overall Study||159
451206|NCT01306214|1106328|P1|COMPLETED|Overall Study||161
451207|NCT01306214|1106326|P3|STARTED|Overall Study||190
451208|NCT01306214|1106327|P2|STARTED|Overall Study||187
451209|NCT01306214|1106328|P1|STARTED|Overall Study||189
451210|NCT01306201|1106345|P1|NOT COMPLETED|Overall Study||10
451211|NCT01306201|1106345|P1|COMPLETED|Overall Study|Total of 10 subjects were excluded from analysis|53
451212|NCT01306201|1106345|P1|STARTED|Overall Study||63
451213|NCT01306175|1106353|P1|NOT COMPLETED|Second Intervention||0
451214|NCT01306175|1106353|P1|COMPLETED|Second Intervention||20
451215|NCT01306175|1106353|P1|STARTED|Second Intervention||20
451216|NCT01306175|1106353|P1|NOT COMPLETED|Washout Period of at Least 14 Days||0
451217|NCT01306175|1106353|P1|COMPLETED|Washout Period of at Least 14 Days||20
451218|NCT01306175|1106353|P1|STARTED|Washout Period of at Least 14 Days||20
451219|NCT01306175|1106353|P1|NOT COMPLETED|First Intervention||0
451220|NCT01306175|1106353|P1|COMPLETED|First Intervention||20
451221|NCT01306175|1106353|P1|STARTED|First Intervention||20
451222|NCT01306162|1106367|P4|NOT COMPLETED|Period 4||0
451223|NCT01306162|1106368|P3|NOT COMPLETED|Period 4||0
451224|NCT01306162|1106369|P2|NOT COMPLETED|Period 4||0
451225|NCT01306162|1106370|P1|NOT COMPLETED|Period 4||0
451226|NCT01306162|1106367|P4|COMPLETED|Period 4||8
451227|NCT01306162|1106368|P3|COMPLETED|Period 4||9
451228|NCT01306162|1106369|P2|COMPLETED|Period 4||8
451229|NCT01306162|1106370|P1|COMPLETED|Period 4||9
451230|NCT01306162|1106367|P4|STARTED|Period 4||8
451231|NCT01306162|1106368|P3|STARTED|Period 4||9
451232|NCT01306162|1106369|P2|STARTED|Period 4||8
451233|NCT01306162|1106370|P1|STARTED|Period 4||9
451234|NCT01306162|1106367|P4|NOT COMPLETED|Washout 2||0
451235|NCT01306162|1106368|P3|NOT COMPLETED|Washout 2||0
451236|NCT01306162|1106369|P2|NOT COMPLETED|Washout 2||0
451237|NCT01306162|1106370|P1|NOT COMPLETED|Washout 2||0
451238|NCT01306162|1106367|P4|COMPLETED|Washout 2||8
451239|NCT01306162|1106368|P3|COMPLETED|Washout 2||9
451240|NCT01306162|1106369|P2|COMPLETED|Washout 2||8
451241|NCT01306162|1106370|P1|COMPLETED|Washout 2||9
451242|NCT01306162|1106367|P4|STARTED|Washout 2|The last dose of Dronedarone was followed by a washout period of at least 10 days.|8
451243|NCT01306162|1106368|P3|STARTED|Washout 2|The last dose of Dronedarone was followed by a washout period of at least 10 days.|9
451244|NCT01306162|1106369|P2|STARTED|Washout 2|No washout period. Treatment D followed directly after treatment E.|8
451245|NCT01306162|1106370|P1|STARTED|Washout 2|No washout period. Treatment E followed directly after treatment D.|9
451246|NCT01306162|1106367|P4|NOT COMPLETED|Period 3||0
451247|NCT01306162|1106368|P3|NOT COMPLETED|Period 3||0
451248|NCT01306162|1106369|P2|NOT COMPLETED|Period 3||0
451249|NCT01306162|1106370|P1|NOT COMPLETED|Period 3||0
451250|NCT01306162|1106367|P4|COMPLETED|Period 3||8
451251|NCT01306162|1106368|P3|COMPLETED|Period 3||9
451252|NCT01306162|1106369|P2|COMPLETED|Period 3||8
451253|NCT01306162|1106370|P1|COMPLETED|Period 3||9
451254|NCT01306162|1106367|P4|STARTED|Period 3||8
451255|NCT01306162|1106368|P3|STARTED|Period 3||9
451256|NCT01306162|1106369|P2|STARTED|Period 3||8
451257|NCT01306162|1106370|P1|STARTED|Period 3||9
451258|NCT01306162|1106367|P4|NOT COMPLETED|Period 2||0
451259|NCT01306162|1106368|P3|NOT COMPLETED|Period 2||0
451260|NCT01306162|1106369|P2|NOT COMPLETED|Period 2||0
451261|NCT01306162|1106370|P1|NOT COMPLETED|Period 2||0
451262|NCT01306162|1106367|P4|COMPLETED|Period 2||8
451263|NCT01306162|1106368|P3|COMPLETED|Period 2||9
451264|NCT01306162|1106369|P2|COMPLETED|Period 2||8
451265|NCT01306162|1106370|P1|COMPLETED|Period 2||9
451266|NCT01306162|1106367|P4|STARTED|Period 2|No washout phase after Period 2.|8
451267|NCT01306162|1106368|P3|STARTED|Period 2|No washout phase after Period 2.|9
451268|NCT01306162|1106369|P2|STARTED|Period 2|No washout phase after Period 2.|8
451269|NCT01306162|1106370|P1|STARTED|Period 2|No washout phase after Period 2.|9
451270|NCT01306162|1106367|P4|NOT COMPLETED|Washout 1||0
451271|NCT01306162|1106368|P3|NOT COMPLETED|Washout 1||0
451272|NCT01306162|1106369|P2|NOT COMPLETED|Washout 1||1
451273|NCT01306162|1106370|P1|NOT COMPLETED|Washout 1||0
451274|NCT01306162|1106367|P4|COMPLETED|Washout 1||8
451275|NCT01306162|1106368|P3|COMPLETED|Washout 1||9
451276|NCT01306162|1106369|P2|COMPLETED|Washout 1||8
451277|NCT01306162|1106370|P1|COMPLETED|Washout 1||9
451278|NCT01306162|1106367|P4|STARTED|Washout 1|No washout period.Treatment E followed directly after treatment C.|8
451279|NCT01306162|1106368|P3|STARTED|Washout 1|No washout period. Treatment D followed directly after treatment B.|9
451280|NCT01306162|1106369|P2|STARTED|Washout 1|Treatment A was followed by a washout period of at least 96 hours.|9
451281|NCT01306162|1106370|P1|STARTED|Washout 1|Treatment A was followed by a washout period of at least 96 hours.|9
451282|NCT01306162|1106367|P4|NOT COMPLETED|Period 1||1
451283|NCT01306162|1106368|P3|NOT COMPLETED|Period 1||0
451284|NCT01306162|1106369|P2|NOT COMPLETED|Period 1||0
451285|NCT01306162|1106370|P1|NOT COMPLETED|Period 1||0
451286|NCT01306162|1106367|P4|COMPLETED|Period 1||8
451287|NCT01306162|1106368|P3|COMPLETED|Period 1||9
451288|NCT01306162|1106369|P2|COMPLETED|Period 1||9
451289|NCT01306162|1106370|P1|COMPLETED|Period 1||9
451290|NCT01306162|1106367|P4|STARTED|Period 1||9
451291|NCT01306162|1106368|P3|STARTED|Period 1||9
451292|NCT01306162|1106369|P2|STARTED|Period 1||9
451293|NCT01306162|1106370|P1|STARTED|Period 1||9
451294|NCT01306058|1106398|P1|NOT COMPLETED|Overall Study||2
451295|NCT01306058|1106398|P1|COMPLETED|Overall Study||25
451296|NCT01306058|1106398|P1|STARTED|Overall Study||27
451297|NCT01306032|1106424|P6|NOT COMPLETED|Disease Progression/Crossover||0
451298|NCT01306032|1106425|P5|NOT COMPLETED|Disease Progression/Crossover||0
451299|NCT01306032|1106426|P4|NOT COMPLETED|Disease Progression/Crossover||3
451300|NCT01306032|1106427|P3|NOT COMPLETED|Disease Progression/Crossover||0
451301|NCT01306032|1106428|P2|NOT COMPLETED|Disease Progression/Crossover||2
451302|NCT01306032|1106429|P1|NOT COMPLETED|Disease Progression/Crossover||0
451303|NCT01306032|1106424|P6|COMPLETED|Disease Progression/Crossover||0
451304|NCT01306032|1106425|P5|COMPLETED|Disease Progression/Crossover||0
451305|NCT01306032|1106426|P4|COMPLETED|Disease Progression/Crossover||26
451306|NCT01306032|1106427|P3|COMPLETED|Disease Progression/Crossover||0
451307|NCT01306032|1106428|P2|COMPLETED|Disease Progression/Crossover||14
451308|NCT01306032|1106429|P1|COMPLETED|Disease Progression/Crossover||0
451309|NCT01306032|1106424|P6|STARTED|Disease Progression/Crossover||0
451310|NCT01306032|1106425|P5|STARTED|Disease Progression/Crossover||0
451311|NCT01306032|1106426|P4|STARTED|Disease Progression/Crossover||29
451312|NCT01306032|1106427|P3|STARTED|Disease Progression/Crossover||0
451313|NCT01306032|1106428|P2|STARTED|Disease Progression/Crossover||16
451314|NCT01306032|1106429|P1|STARTED|Disease Progression/Crossover||0
451315|NCT01306032|1106424|P6|NOT COMPLETED|First Intervention||2
451316|NCT01306032|1106425|P5|NOT COMPLETED|First Intervention||2
451317|NCT01306032|1106426|P4|NOT COMPLETED|First Intervention||1
451318|NCT01306032|1106427|P3|NOT COMPLETED|First Intervention||2
451319|NCT01306032|1106428|P2|NOT COMPLETED|First Intervention||2
451320|NCT01306032|1106429|P1|NOT COMPLETED|First Intervention||1
451321|NCT01306032|1106424|P6|COMPLETED|First Intervention||0
451322|NCT01306032|1106425|P5|COMPLETED|First Intervention||0
451323|NCT01306032|1106426|P4|COMPLETED|First Intervention||37
451324|NCT01306032|1106427|P3|COMPLETED|First Intervention||35
451325|NCT01306032|1106428|P2|COMPLETED|First Intervention||18
451326|NCT01306032|1106429|P1|COMPLETED|First Intervention||21
451327|NCT01306032|1106424|P6|STARTED|First Intervention||2
451328|NCT01306032|1106425|P5|STARTED|First Intervention||2
451329|NCT01306032|1106426|P4|STARTED|First Intervention|Not all participants on the Cyclophosphamide Alone Arm met eligibility criteria to crossover.|38
451330|NCT01306032|1106427|P3|STARTED|First Intervention||37
451331|NCT01306032|1106428|P2|STARTED|First Intervention|Not all participants on the Cyclophosphamide Alone Arm met eligibility criteria to crossover.|20
451332|NCT01306032|1106429|P1|STARTED|First Intervention||22
451333|NCT01305941|1106481|P1|NOT COMPLETED|Overall Study||10
451334|NCT01305941|1106481|P1|COMPLETED|Overall Study||22
451335|NCT01305941|1106481|P1|STARTED|Overall Study||32
451336|NCT01305811|1106495|P2|NOT COMPLETED|Overall Study||11
451337|NCT01305811|1106496|P1|NOT COMPLETED|Overall Study||8
451338|NCT01305811|1106495|P2|COMPLETED|Overall Study||41
451339|NCT01305811|1106496|P1|COMPLETED|Overall Study||44
451340|NCT01305811|1106495|P2|STARTED|Overall Study||52
451341|NCT01305811|1106496|P1|STARTED|Overall Study||52
451342|NCT01305772|1106506|P2|NOT COMPLETED|Overall Study||0
451343|NCT01305772|1106507|P1|NOT COMPLETED|Overall Study||0
451344|NCT01305772|1106506|P2|COMPLETED|Overall Study||1
451345|NCT01305772|1106507|P1|COMPLETED|Overall Study||5
451346|NCT01305772|1106506|P2|RT + Panitumumab Dose #2 / #3|Overall Study||1
451347|NCT01305772|1106507|P1|RT + Panitumumab Dose #2 / #3|Overall Study|RT and doses #2 and #3 of panitumumab administered to patients regardless of 2nd biopsy status.|5
451348|NCT01305772|1106506|P2|Surgery/Biopsy #2|Overall Study||1
451349|NCT01305772|1106507|P1|Surgery/Biopsy #2|Overall Study|2nd research tissue sample not collected for 4 patients due to safety risk to subject.|1
451350|NCT01305772|1106506|P2|Research PET/CT #2|Overall Study||1
451351|NCT01305772|1106507|P1|Research PET/CT #2|Overall Study||5
451352|NCT01305772|1106506|P2|Panitumumab Dose #1|Overall Study||1
451353|NCT01305772|1106507|P1|Panitumumab Dose #1|Overall Study||5
451354|NCT01305772|1106506|P2|Research PET/CT #1|Overall Study||1
451355|NCT01305772|1106507|P1|Research PET/CT #1|Overall Study||5
451356|NCT01305772|1106506|P2|Genomic Screening + Biopsy #1|Overall Study||1
451357|NCT01305772|1106507|P1|Genomic Screening + Biopsy #1|Overall Study||5
451358|NCT01305772|1106506|P2|STARTED|Overall Study||1
451359|NCT01305772|1106507|P1|STARTED|Overall Study||5
451360|NCT01305655|1106514|P1|NOT COMPLETED|Overall Study||0
451361|NCT01305655|1106514|P1|COMPLETED|Overall Study|December 31, 2014|47
451362|NCT01305655|1106514|P1|STARTED|Overall Study|July 2008|47
451363|NCT01305577|1106521|P3|NOT COMPLETED|Overall Study||10
451364|NCT01305577|1106522|P2|NOT COMPLETED|Overall Study||11
451365|NCT01305577|1106523|P1|NOT COMPLETED|Overall Study||13
451366|NCT01305577|1106521|P3|COMPLETED|Overall Study||112
451367|NCT01305577|1106522|P2|COMPLETED|Overall Study||110
451368|NCT01305577|1106523|P1|COMPLETED|Overall Study||107
451369|NCT01305577|1106521|P3|Received Treatment|Overall Study||122
451370|NCT01305577|1106522|P2|Received Treatment|Overall Study||121
451371|NCT01305577|1106523|P1|Received Treatment|Overall Study||119
451372|NCT01305577|1106521|P3|STARTED|Overall Study||122
451373|NCT01305577|1106522|P2|STARTED|Overall Study||121
451374|NCT01305577|1106523|P1|STARTED|Overall Study||120
451375|NCT01305564|1106552|P1|NOT COMPLETED|Overall Study||37
451376|NCT01305564|1106552|P1|COMPLETED|Overall Study||163
451377|NCT01305564|1106552|P1|STARTED|Overall Study||200
451378|NCT01305473|1106567|P1|NOT COMPLETED|Overall Study||0
451379|NCT01305473|1106567|P1|COMPLETED|Overall Study||90
451380|NCT01305473|1106567|P1|STARTED|Overall Study||90
451381|NCT01305408|1106579|P2|NOT COMPLETED|Overall Study||31
451382|NCT01305408|1106580|P1|NOT COMPLETED|Overall Study||32
451383|NCT01305408|1106579|P2|COMPLETED|Overall Study||169
451384|NCT01305408|1106580|P1|COMPLETED|Overall Study||167
451385|NCT01305408|1106579|P2|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|197
451386|NCT01305408|1106580|P1|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|196
451387|NCT01305408|1106579|P2|Safety Population|Overall Study|Treated participants.|200
451388|NCT01305408|1106580|P1|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|198
451389|NCT01305408|1106579|P2|STARTED|Overall Study||200
451390|NCT01305408|1106580|P1|STARTED|Overall Study||199
451391|NCT01305265|1106632|P2|NOT COMPLETED|Overall Study||6
451392|NCT01305265|1106633|P1|NOT COMPLETED|Overall Study||2
451393|NCT01305265|1106632|P2|COMPLETED|Overall Study||64
451394|NCT01305265|1106633|P1|COMPLETED|Overall Study||69
451395|NCT01305265|1106632|P2|STARTED|Overall Study||70
451396|NCT01305265|1106633|P1|STARTED|Overall Study||71
451397|NCT01305252|1106641|P2|NOT COMPLETED|Overall Study||0
451398|NCT01305252|1106642|P1|NOT COMPLETED|Overall Study||1
451399|NCT01305252|1106641|P2|COMPLETED|Overall Study||11
451400|NCT01305252|1106642|P1|COMPLETED|Overall Study||9
451401|NCT01305252|1106641|P2|STARTED|Overall Study||11
451402|NCT01305252|1106642|P1|STARTED|Overall Study||10
451403|NCT01305239|1106656|P1|NOT COMPLETED|Overall Study||23
451404|NCT01305239|1106656|P1|COMPLETED|Overall Study||375
451405|NCT01305239|1106656|P1|Intent to Treat Population|Overall Study||287
451406|NCT01305239|1106656|P1|Safety Set|Overall Study||397
451407|NCT01305239|1106656|P1|STARTED|Overall Study||398
451408|NCT01305213|1106666|P2|NOT COMPLETED|Overall Study||0
451409|NCT01305213|1106667|P1|NOT COMPLETED|Overall Study||0
451410|NCT01305213|1106666|P2|COMPLETED|Overall Study||54
451411|NCT01305213|1106667|P1|COMPLETED|Overall Study||53
451412|NCT01305213|1106666|P2|STARTED|Overall Study||54
451413|NCT01305213|1106667|P1|STARTED|Overall Study||53
451414|NCT01305200|1106686|P3|NOT COMPLETED|Overall Study||3
451415|NCT01305200|1106687|P2|NOT COMPLETED|Overall Study||31
451416|NCT01305200|1106688|P1|NOT COMPLETED|Overall Study||29
451417|NCT01305200|1106686|P3|COMPLETED|Overall Study||0
451418|NCT01305200|1106687|P2|COMPLETED|Overall Study||81
451419|NCT01305200|1106688|P1|COMPLETED|Overall Study||82
451420|NCT01305200|1106686|P3|STARTED|Overall Study||3
451421|NCT01305200|1106687|P2|STARTED|Overall Study||112
451422|NCT01305200|1106688|P1|STARTED|Overall Study||111
451423|NCT01305044|1106718|P2|NOT COMPLETED|Overall Study||6
451424|NCT01305044|1106719|P1|NOT COMPLETED|Overall Study||3
451425|NCT01305044|1106718|P2|COMPLETED|Overall Study||25
451426|NCT01305044|1106719|P1|COMPLETED|Overall Study||29
451427|NCT01305044|1106718|P2|STARTED|Overall Study||31
451428|NCT01305044|1106719|P1|STARTED|Overall Study||32
451429|NCT01304966|1106743|P1|NOT COMPLETED|Overall Study||0
451430|NCT01304966|1106743|P1|COMPLETED|Overall Study||15
451431|NCT01304966|1106743|P1|STARTED|Overall Study||15
451432|NCT01304706|1106749|P1|NOT COMPLETED|Overall Study||17
451433|NCT01304706|1106749|P1|COMPLETED|Overall Study||104
451434|NCT01304706|1106749|P1|STARTED|Overall Study||121
451435|NCT01304693|1106758|P5|NOT COMPLETED|Overall Study||1
451436|NCT01304693|1106759|P4|NOT COMPLETED|Overall Study||1
451437|NCT01304693|1106760|P3|NOT COMPLETED|Overall Study||1
451438|NCT01304693|1106761|P2|NOT COMPLETED|Overall Study||0
451439|NCT01304693|1106762|P1|NOT COMPLETED|Overall Study||0
451440|NCT01304693|1106758|P5|COMPLETED|Overall Study||60
451441|NCT01304693|1106759|P4|COMPLETED|Overall Study||39
451442|NCT01304693|1106760|P3|COMPLETED|Overall Study||47
451443|NCT01304693|1106761|P2|COMPLETED|Overall Study||35
451444|NCT01304693|1106762|P1|COMPLETED|Overall Study||10
451445|NCT01304693|1106758|P5|STARTED|Overall Study||61
451446|NCT01304693|1106759|P4|STARTED|Overall Study||40
451447|NCT01304693|1106760|P3|STARTED|Overall Study||48
451448|NCT01304693|1106761|P2|STARTED|Overall Study||35
451449|NCT01304693|1106762|P1|STARTED|Overall Study||10
451450|NCT01304641|1106781|P2|NOT COMPLETED|Overall Study||0
451451|NCT01304641|1106782|P1|NOT COMPLETED|Overall Study||0
451452|NCT01304641|1106781|P2|COMPLETED|Overall Study||20132
451453|NCT01304641|1106782|P1|COMPLETED|Overall Study||11470
451454|NCT01304641|1106781|P2|STARTED|Overall Study||20132
451455|NCT01304641|1106782|P1|STARTED|Overall Study||11470
451456|NCT01304589|1106800|P1|NOT COMPLETED|Overall Study||13
451457|NCT01304589|1106800|P1|COMPLETED|Overall Study||18
451458|NCT01304589|1106800|P1|STARTED|Overall Study||31
451459|NCT01304498|1106809|P2|NOT COMPLETED|Overall Study||5
451460|NCT01304498|1106810|P1|NOT COMPLETED|Overall Study||6
451461|NCT01304498|1106809|P2|COMPLETED|Overall Study||295
451462|NCT01304498|1106810|P1|COMPLETED|Overall Study||294
451463|NCT01304498|1106809|P2|Received ≥1 Dose|Overall Study||300
451464|NCT01304498|1106810|P1|Received ≥1 Dose|Overall Study||300
451465|NCT01304498|1106809|P2|STARTED|Overall Study||300
451466|NCT01304498|1106810|P1|STARTED|Overall Study||300
451467|NCT01304329|1106830|P6|NOT COMPLETED|Third Intervention (3 Days)||0
451468|NCT01304329|1106831|P5|NOT COMPLETED|Third Intervention (3 Days)||0
451469|NCT01304329|1106832|P4|NOT COMPLETED|Third Intervention (3 Days)||0
451470|NCT01304329|1106833|P3|NOT COMPLETED|Third Intervention (3 Days)||0
451471|NCT01304329|1106834|P2|NOT COMPLETED|Third Intervention (3 Days)||1
451472|NCT01304329|1106835|P1|NOT COMPLETED|Third Intervention (3 Days)||0
451473|NCT01304329|1106830|P6|COMPLETED|Third Intervention (3 Days)||3
451474|NCT01304329|1106831|P5|COMPLETED|Third Intervention (3 Days)||3
451475|NCT01304329|1106832|P4|COMPLETED|Third Intervention (3 Days)||3
451476|NCT01304329|1106833|P3|COMPLETED|Third Intervention (3 Days)||3
451477|NCT01304329|1106834|P2|COMPLETED|Third Intervention (3 Days)||2
451478|NCT01304329|1106835|P1|COMPLETED|Third Intervention (3 Days)||3
451479|NCT01304329|1106830|P6|STARTED|Third Intervention (3 Days)||3
451480|NCT01304329|1106831|P5|STARTED|Third Intervention (3 Days)||3
451481|NCT01304329|1106832|P4|STARTED|Third Intervention (3 Days)||3
451482|NCT01304329|1106833|P3|STARTED|Third Intervention (3 Days)||3
451483|NCT01304329|1106834|P2|STARTED|Third Intervention (3 Days)||3
451484|NCT01304329|1106835|P1|STARTED|Third Intervention (3 Days)||3
451485|NCT01304329|1106830|P6|NOT COMPLETED|Second Intervention (3 Days)||0
451486|NCT01304329|1106831|P5|NOT COMPLETED|Second Intervention (3 Days)||0
451487|NCT01304329|1106832|P4|NOT COMPLETED|Second Intervention (3 Days)||0
451488|NCT01304329|1106833|P3|NOT COMPLETED|Second Intervention (3 Days)||0
451489|NCT01304329|1106834|P2|NOT COMPLETED|Second Intervention (3 Days)||0
451490|NCT01304329|1106835|P1|NOT COMPLETED|Second Intervention (3 Days)||0
451491|NCT01304329|1106830|P6|COMPLETED|Second Intervention (3 Days)||3
451492|NCT01304329|1106831|P5|COMPLETED|Second Intervention (3 Days)||3
451493|NCT01304329|1106832|P4|COMPLETED|Second Intervention (3 Days)||3
451494|NCT01304329|1106833|P3|COMPLETED|Second Intervention (3 Days)||3
451495|NCT01304329|1106834|P2|COMPLETED|Second Intervention (3 Days)||3
451496|NCT01304329|1106835|P1|COMPLETED|Second Intervention (3 Days)||3
451497|NCT01304329|1106830|P6|STARTED|Second Intervention (3 Days)||3
451498|NCT01304329|1106831|P5|STARTED|Second Intervention (3 Days)||3
451499|NCT01304329|1106832|P4|STARTED|Second Intervention (3 Days)||3
451500|NCT01304329|1106833|P3|STARTED|Second Intervention (3 Days)||3
451501|NCT01304329|1106834|P2|STARTED|Second Intervention (3 Days)||3
451502|NCT01304329|1106835|P1|STARTED|Second Intervention (3 Days)||3
451503|NCT01304329|1106830|P6|NOT COMPLETED|First Intervention (3 Days)||0
451504|NCT01304329|1106831|P5|NOT COMPLETED|First Intervention (3 Days)||0
451505|NCT01304329|1106832|P4|NOT COMPLETED|First Intervention (3 Days)||0
451506|NCT01304329|1106833|P3|NOT COMPLETED|First Intervention (3 Days)||0
451507|NCT01304329|1106834|P2|NOT COMPLETED|First Intervention (3 Days)||0
451508|NCT01304329|1106835|P1|NOT COMPLETED|First Intervention (3 Days)||0
451509|NCT01304329|1106830|P6|COMPLETED|First Intervention (3 Days)||3
451510|NCT01304329|1106831|P5|COMPLETED|First Intervention (3 Days)||3
451511|NCT01304329|1106832|P4|COMPLETED|First Intervention (3 Days)||3
451512|NCT01304329|1106833|P3|COMPLETED|First Intervention (3 Days)||3
451513|NCT01304329|1106834|P2|COMPLETED|First Intervention (3 Days)||3
451514|NCT01304329|1106835|P1|COMPLETED|First Intervention (3 Days)||3
451515|NCT01304329|1106830|P6|STARTED|First Intervention (3 Days)||3
451516|NCT01304329|1106831|P5|STARTED|First Intervention (3 Days)||3
451517|NCT01304329|1106832|P4|STARTED|First Intervention (3 Days)||3
451518|NCT01304329|1106833|P3|STARTED|First Intervention (3 Days)||3
451519|NCT01304329|1106834|P2|STARTED|First Intervention (3 Days)||3
451520|NCT01304329|1106835|P1|STARTED|First Intervention (3 Days)||3
451521|NCT01304316|1106852|P1|NOT COMPLETED|Overall Study||0
451522|NCT01304316|1106852|P1|COMPLETED|Overall Study||12
451523|NCT01304316|1106852|P1|STARTED|Overall Study||12
451524|NCT01304277|1106866|P1|NOT COMPLETED|Treatment (Replagal AF, Week 2- EOS)||0
451525|NCT01304277|1106866|P1|COMPLETED|Treatment (Replagal AF, Week 2- EOS)||17
451526|NCT01304277|1106866|P1|STARTED|Treatment (Replagal AF, Week 2- EOS)||17
451527|NCT01304277|1106866|P1|NOT COMPLETED|Screening (Replagal RB, Week 0- Week 2)||0
451528|NCT01304277|1106866|P1|COMPLETED|Screening (Replagal RB, Week 0- Week 2)||17
451529|NCT01304277|1106866|P1|STARTED|Screening (Replagal RB, Week 0- Week 2)||17
451530|NCT01304238|1106888|P10|NOT COMPLETED|Overall Study||0
451531|NCT01304238|1106889|P9|NOT COMPLETED|Overall Study||0
451532|NCT01304238|1106890|P8|NOT COMPLETED|Overall Study||0
451533|NCT01304238|1106891|P7|NOT COMPLETED|Overall Study||0
451534|NCT01304238|1106892|P6|NOT COMPLETED|Overall Study||0
451535|NCT01304238|1106893|P5|NOT COMPLETED|Overall Study||0
451536|NCT01304238|1106894|P4|NOT COMPLETED|Overall Study||0
451537|NCT01304238|1106895|P3|NOT COMPLETED|Overall Study||0
451538|NCT01304238|1106896|P2|NOT COMPLETED|Overall Study||0
451539|NCT01304238|1106897|P1|NOT COMPLETED|Overall Study||0
451540|NCT01304238|1106888|P10|COMPLETED|Overall Study||3
451541|NCT01304238|1106889|P9|COMPLETED|Overall Study||1
451542|NCT01304238|1106890|P8|COMPLETED|Overall Study||4
451543|NCT01304238|1106891|P7|COMPLETED|Overall Study||5
451544|NCT01304238|1106892|P6|COMPLETED|Overall Study||11
451545|NCT01304238|1106893|P5|COMPLETED|Overall Study||11
451546|NCT01304238|1106894|P4|COMPLETED|Overall Study||78
451547|NCT01304238|1106895|P3|COMPLETED|Overall Study||46
451548|NCT01304238|1106896|P2|COMPLETED|Overall Study||4
451549|NCT01304238|1106897|P1|COMPLETED|Overall Study||32
451550|NCT01304238|1106888|P10|STARTED|Overall Study||3
451551|NCT01304238|1106889|P9|STARTED|Overall Study||1
451552|NCT01304238|1106890|P8|STARTED|Overall Study||4
451553|NCT01304238|1106891|P7|STARTED|Overall Study||5
451554|NCT01304238|1106892|P6|STARTED|Overall Study||11
451555|NCT01304238|1106893|P5|STARTED|Overall Study||11
451556|NCT01304238|1106894|P4|STARTED|Overall Study||78
451557|NCT01304238|1106895|P3|STARTED|Overall Study||46
451558|NCT01304238|1106896|P2|STARTED|Overall Study||4
451559|NCT01304238|1106897|P1|STARTED|Overall Study||32
451560|NCT01304147|1106969|P2|NOT COMPLETED|Second Intervention (7days)||1
451561|NCT01304147|1106970|P1|NOT COMPLETED|Second Intervention (7days)||1
451562|NCT01304147|1106969|P2|COMPLETED|Second Intervention (7days)||9
451563|NCT01304147|1106970|P1|COMPLETED|Second Intervention (7days)||9
451564|NCT01304147|1106969|P2|STARTED|Second Intervention (7days)||10
451565|NCT01304147|1106970|P1|STARTED|Second Intervention (7days)||10
451566|NCT01304147|1106969|P2|NOT COMPLETED|Washout (1 Day)||0
451567|NCT01304147|1106970|P1|NOT COMPLETED|Washout (1 Day)||0
451568|NCT01304147|1106969|P2|COMPLETED|Washout (1 Day)||10
451569|NCT01304147|1106970|P1|COMPLETED|Washout (1 Day)||10
451570|NCT01304147|1106969|P2|STARTED|Washout (1 Day)||10
451571|NCT01304147|1106970|P1|STARTED|Washout (1 Day)||10
451572|NCT01304147|1106969|P2|NOT COMPLETED|First Intervention (7days)||0
451573|NCT01304147|1106970|P1|NOT COMPLETED|First Intervention (7days)||0
451574|NCT01304147|1106969|P2|COMPLETED|First Intervention (7days)||10
451575|NCT01304147|1106970|P1|COMPLETED|First Intervention (7days)||10
451576|NCT01304147|1106969|P2|STARTED|First Intervention (7days)||10
451577|NCT01304147|1106970|P1|STARTED|First Intervention (7days)||10
451578|NCT01304082|1106978|P5|NOT COMPLETED|Overall Study||0
451579|NCT01304082|1106979|P4|NOT COMPLETED|Overall Study||0
451580|NCT01304082|1106980|P3|NOT COMPLETED|Overall Study||0
451581|NCT01304082|1106981|P2|NOT COMPLETED|Overall Study||0
451582|NCT01304082|1106982|P1|NOT COMPLETED|Overall Study||0
451583|NCT01304082|1106978|P5|COMPLETED|Overall Study||5
451584|NCT01304082|1106979|P4|COMPLETED|Overall Study||8
451585|NCT01304082|1106980|P3|COMPLETED|Overall Study||11
451586|NCT01304082|1106981|P2|COMPLETED|Overall Study||2
451587|NCT01304082|1106982|P1|COMPLETED|Overall Study||3
451588|NCT01304082|1106978|P5|Third Intervention|Overall Study||5
451589|NCT01304082|1106979|P4|Third Intervention|Overall Study||8
451590|NCT01304082|1106980|P3|Third Intervention|Overall Study||11
451591|NCT01304082|1106981|P2|Third Intervention|Overall Study||2
451592|NCT01304082|1106982|P1|Third Intervention|Overall Study||3
451593|NCT01304082|1106978|P5|Second Intervention|Overall Study||5
451594|NCT01304082|1106979|P4|Second Intervention|Overall Study||8
451595|NCT01304082|1106980|P3|Second Intervention|Overall Study||11
451596|NCT01304082|1106981|P2|Second Intervention|Overall Study||2
451597|NCT01304082|1106982|P1|Second Intervention|Overall Study||3
451598|NCT01304082|1106978|P5|First Intervention|Overall Study||5
451599|NCT01304082|1106979|P4|First Intervention|Overall Study||8
451600|NCT01304082|1106980|P3|First Intervention|Overall Study||11
451601|NCT01304082|1106981|P2|First Intervention|Overall Study||2
451602|NCT01304082|1106982|P1|First Intervention|Overall Study||3
451603|NCT01304082|1106978|P5|STARTED|Overall Study||5
451604|NCT01304082|1106979|P4|STARTED|Overall Study||8
451605|NCT01304082|1106980|P3|STARTED|Overall Study||11
451606|NCT01304082|1106981|P2|STARTED|Overall Study||2
451607|NCT01304082|1106982|P1|STARTED|Overall Study||3
451608|NCT01303861|1107004|P4|NOT COMPLETED|Overall Study||59
451609|NCT01303861|1107005|P3|NOT COMPLETED|Overall Study||36
451610|NCT01303861|1107006|P2|NOT COMPLETED|Overall Study||25
451611|NCT01303861|1107007|P1|NOT COMPLETED|Overall Study||58
451612|NCT01303861|1107004|P4|COMPLETED|Overall Study||54
451613|NCT01303861|1107005|P3|COMPLETED|Overall Study||19
451614|NCT01303861|1107006|P2|COMPLETED|Overall Study||25
451615|NCT01303861|1107007|P1|COMPLETED|Overall Study||51
451616|NCT01303861|1107004|P4|Finished Treatment Phase|Overall Study||72
451617|NCT01303861|1107005|P3|Finished Treatment Phase|Overall Study||39
451618|NCT01303861|1107006|P2|Finished Treatment Phase|Overall Study||34
451619|NCT01303861|1107007|P1|Finished Treatment Phase|Overall Study||71
451620|NCT01303861|1107004|P4|STARTED|Overall Study||113
451621|NCT01303861|1107005|P3|STARTED|Overall Study||55
451622|NCT01303861|1107006|P2|STARTED|Overall Study||50
451623|NCT01303861|1107007|P1|STARTED|Overall Study||109
451624|NCT01303835|1107028|P2|NOT COMPLETED|Overall Study||25
451625|NCT01303835|1107029|P1|NOT COMPLETED|Overall Study||19
451626|NCT01303835|1107028|P2|COMPLETED|Overall Study||31
451627|NCT01303835|1107029|P1|COMPLETED|Overall Study||35
451628|NCT01303835|1107028|P2|STARTED|Overall Study||56
451629|NCT01303835|1107029|P1|STARTED|Overall Study||54
451630|NCT01303744|1107043|P4|NOT COMPLETED|Overall Study||0
451631|NCT01303744|1107044|P3|NOT COMPLETED|Overall Study||0
451632|NCT01303744|1107045|P2|NOT COMPLETED|Overall Study||0
451633|NCT01303744|1107046|P1|NOT COMPLETED|Overall Study||0
451634|NCT01303744|1107043|P4|COMPLETED|Overall Study||24
451635|NCT01303744|1107044|P3|COMPLETED|Overall Study||24
451636|NCT01303744|1107045|P2|COMPLETED|Overall Study||24
451637|NCT01303744|1107046|P1|COMPLETED|Overall Study||24
451638|NCT01303744|1107043|P4|STARTED|Overall Study||24
451639|NCT01303744|1107044|P3|STARTED|Overall Study||24
451640|NCT01303744|1107045|P2|STARTED|Overall Study||24
451641|NCT01303744|1107046|P1|STARTED|Overall Study||24
451642|NCT01303627|1107066|P2|NOT COMPLETED|Overall Study||1
451643|NCT01303627|1107067|P1|NOT COMPLETED|Overall Study||0
451644|NCT01303627|1107066|P2|COMPLETED|Overall Study|One patient excluded from the study because of the failure while performing uretero-renoscopy|20
451645|NCT01303627|1107067|P1|COMPLETED|Overall Study||21
451646|NCT01303627|1107066|P2|STARTED|Overall Study||21
451647|NCT01303627|1107067|P1|STARTED|Overall Study||21
451648|NCT01303510|1107075|P2|NOT COMPLETED|Overall Study||0
451649|NCT01303510|1107076|P1|NOT COMPLETED|Overall Study||1
451650|NCT01303510|1107075|P2|COMPLETED|Overall Study||56
451651|NCT01303510|1107076|P1|COMPLETED|Overall Study||54
451652|NCT01303510|1107075|P2|STARTED|Overall Study||56
451653|NCT01303510|1107076|P1|STARTED|Overall Study||55
451654|NCT01303445|1107090|P2|NOT COMPLETED|Follow-up Period (14 Days)||1
451655|NCT01303445|1107091|P1|NOT COMPLETED|Follow-up Period (14 Days)||0
451656|NCT01303445|1107090|P2|COMPLETED|Follow-up Period (14 Days)||25
451657|NCT01303445|1107091|P1|COMPLETED|Follow-up Period (14 Days)||26
451658|NCT01303445|1107090|P2|STARTED|Follow-up Period (14 Days)||26
451659|NCT01303445|1107091|P1|STARTED|Follow-up Period (14 Days)||26
451660|NCT01303445|1107090|P2|NOT COMPLETED|Fourth Intervention (7 Days)||0
451661|NCT01303445|1107091|P1|NOT COMPLETED|Fourth Intervention (7 Days)||1
451662|NCT01303445|1107090|P2|COMPLETED|Fourth Intervention (7 Days)||26
451663|NCT01303445|1107091|P1|COMPLETED|Fourth Intervention (7 Days)||26
451664|NCT01303445|1107090|P2|STARTED|Fourth Intervention (7 Days)||26
451665|NCT01303445|1107091|P1|STARTED|Fourth Intervention (7 Days)||27
451666|NCT01303445|1107090|P2|NOT COMPLETED|Third Intervention (7 Days)||0
451667|NCT01303445|1107091|P1|NOT COMPLETED|Third Intervention (7 Days)||0
451668|NCT01303445|1107090|P2|COMPLETED|Third Intervention (7 Days)||26
451669|NCT01303445|1107091|P1|COMPLETED|Third Intervention (7 Days)||27
451670|NCT01303445|1107090|P2|STARTED|Third Intervention (7 Days)||26
451671|NCT01303445|1107091|P1|STARTED|Third Intervention (7 Days)||27
451672|NCT01303445|1107090|P2|NOT COMPLETED|Washout (14 Days)||2
451673|NCT01303445|1107091|P1|NOT COMPLETED|Washout (14 Days)||1
451674|NCT01303445|1107090|P2|COMPLETED|Washout (14 Days)||26
451675|NCT01303445|1107091|P1|COMPLETED|Washout (14 Days)||27
451676|NCT01303445|1107090|P2|STARTED|Washout (14 Days)||28
451677|NCT01303445|1107091|P1|STARTED|Washout (14 Days)||28
451678|NCT01303445|1107090|P2|NOT COMPLETED|Second Intervention (7 Days)||2
451679|NCT01303445|1107091|P1|NOT COMPLETED|Second Intervention (7 Days)||1
451680|NCT01303445|1107090|P2|COMPLETED|Second Intervention (7 Days)||28
451681|NCT01303445|1107091|P1|COMPLETED|Second Intervention (7 Days)||28
451682|NCT01303445|1107090|P2|STARTED|Second Intervention (7 Days)||30
451683|NCT01303445|1107091|P1|STARTED|Second Intervention (7 Days)||29
451684|NCT01303445|1107090|P2|NOT COMPLETED|First Intervention (7 Days)||0
451685|NCT01303445|1107091|P1|NOT COMPLETED|First Intervention (7 Days)||1
451686|NCT01303445|1107090|P2|COMPLETED|First Intervention (7 Days)||30
451687|NCT01303445|1107091|P1|COMPLETED|First Intervention (7 Days)||29
451688|NCT01303445|1107090|P2|STARTED|First Intervention (7 Days)||30
451689|NCT01303445|1107091|P1|STARTED|First Intervention (7 Days)||30
451690|NCT01303406|1107123|P2|NOT COMPLETED|Overall Study||1
451691|NCT01303406|1107124|P1|NOT COMPLETED|Overall Study||0
451692|NCT01303406|1107123|P2|COMPLETED|Overall Study||15
451693|NCT01303406|1107124|P1|COMPLETED|Overall Study||13
451694|NCT01303406|1107123|P2|STARTED|Overall Study||16
451695|NCT01303406|1107124|P1|STARTED|Overall Study||13
451696|NCT01303380|1107132|P1|NOT COMPLETED|Overall Study||1
451697|NCT01303380|1107132|P1|COMPLETED|Overall Study||8
451698|NCT01303380|1107132|P1|STARTED|Overall Study||9
451699|NCT01303224|1107162|P4|NOT COMPLETED|Overall Study||10
451700|NCT01303224|1107163|P3|NOT COMPLETED|Overall Study||6
451701|NCT01303224|1107164|P2|NOT COMPLETED|Overall Study||11
451702|NCT01303224|1107165|P1|NOT COMPLETED|Overall Study||11
451703|NCT01303224|1107162|P4|COMPLETED|Overall Study||133
451704|NCT01303224|1107163|P3|COMPLETED|Overall Study||133
451705|NCT01303224|1107164|P2|COMPLETED|Overall Study||131
451706|NCT01303224|1107165|P1|COMPLETED|Overall Study||130
451707|NCT01303224|1107162|P4|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|142
451708|NCT01303224|1107163|P3|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|139
451709|NCT01303224|1107164|P2|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|138
451710|NCT01303224|1107165|P1|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|140
451711|NCT01303224|1107162|P4|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|143
451712|NCT01303224|1107163|P3|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|139
451713|NCT01303224|1107164|P2|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|142
451714|NCT01303224|1107165|P1|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|141
451715|NCT01303159|1107191|P1|NOT COMPLETED|Overall Study||23
451716|NCT01303159|1107191|P1|COMPLETED|Overall Study||6
451717|NCT01303159|1107191|P1|STARTED|Overall Study||29
451718|NCT01302938|1107198|P2|NOT COMPLETED|Overall Study||0
451719|NCT01302938|1107199|P1|NOT COMPLETED|Overall Study||2
451720|NCT01302938|1107198|P2|COMPLETED|Overall Study||6
451721|NCT01302938|1107199|P1|COMPLETED|Overall Study||10
451722|NCT01302938|1107198|P2|STARTED|Overall Study||6
451723|NCT01302938|1107199|P1|STARTED|Overall Study||12
451724|NCT01302899|1107244|P2|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0
451725|NCT01302899|1107245|P1|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0
451726|NCT01302899|1107244|P2|COMPLETED|Period 4 (Weeks 19 to 26)||3
451727|NCT01302899|1107245|P1|COMPLETED|Period 4 (Weeks 19 to 26)||3
451728|NCT01302899|1107244|P2|STARTED|Period 4 (Weeks 19 to 26)||3
451729|NCT01302899|1107245|P1|STARTED|Period 4 (Weeks 19 to 26)||3
451730|NCT01302899|1107244|P2|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0
451731|NCT01302899|1107245|P1|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0
451732|NCT01302899|1107244|P2|COMPLETED|Period 3 (Weeks 13 to 18)||3
451733|NCT01302899|1107245|P1|COMPLETED|Period 3 (Weeks 13 to 18)||3
451734|NCT01302899|1107244|P2|STARTED|Period 3 (Weeks 13 to 18)||3
451735|NCT01302899|1107245|P1|STARTED|Period 3 (Weeks 13 to 18)||3
451736|NCT01302899|1107244|P2|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1
451737|NCT01302899|1107245|P1|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1
451738|NCT01302899|1107244|P2|COMPLETED|Period 2 (Weeks 7 to 12)||3
451739|NCT01302899|1107245|P1|COMPLETED|Period 2 (Weeks 7 to 12)||3
451740|NCT01302899|1107244|P2|STARTED|Period 2 (Weeks 7 to 12)||4
451741|NCT01302899|1107245|P1|STARTED|Period 2 (Weeks 7 to 12)||4
451742|NCT01302899|1107244|P2|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0
451743|NCT01302899|1107245|P1|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0
451744|NCT01302899|1107244|P2|COMPLETED|Period 1 (Day 1 to End of Week 6)||4
451745|NCT01302899|1107245|P1|COMPLETED|Period 1 (Day 1 to End of Week 6)||4
451746|NCT01302899|1107244|P2|STARTED|Period 1 (Day 1 to End of Week 6)||4
451747|NCT01302899|1107245|P1|STARTED|Period 1 (Day 1 to End of Week 6)||4
451748|NCT01302860|1107295|P1|NOT COMPLETED|Overall Study||0
451749|NCT01302860|1107295|P1|COMPLETED|Overall Study||17
451750|NCT01302860|1107295|P1|STARTED|Overall Study||17
451751|NCT01302743|1107310|P3|NOT COMPLETED|Overall Study||2
451752|NCT01302743|1107311|P2|NOT COMPLETED|Overall Study||1
451753|NCT01302743|1107312|P1|NOT COMPLETED|Overall Study||1
451754|NCT01302743|1107310|P3|COMPLETED|Overall Study||8
451755|NCT01302743|1107311|P2|COMPLETED|Overall Study||7
451756|NCT01302743|1107312|P1|COMPLETED|Overall Study||6
451757|NCT01302743|1107310|P3|STARTED|Overall Study||10
451758|NCT01302743|1107311|P2|STARTED|Overall Study||8
451759|NCT01302743|1107312|P1|STARTED|Overall Study||7
451760|NCT01302691|1107325|P2|NOT COMPLETED|Overall Study||6
451761|NCT01302691|1107326|P1|NOT COMPLETED|Overall Study||10
451762|NCT01302691|1107325|P2|COMPLETED|Overall Study||157
451763|NCT01302691|1107326|P1|COMPLETED|Overall Study||154
451764|NCT01302691|1107325|P2|STARTED|Overall Study||163
451765|NCT01302691|1107326|P1|STARTED|Overall Study||164
451766|NCT01302548|1107346|P2|NOT COMPLETED|Overall Study||1
451767|NCT01302548|1107347|P1|NOT COMPLETED|Overall Study||2
451768|NCT01302548|1107346|P2|COMPLETED|Overall Study||18
451769|NCT01302548|1107347|P1|COMPLETED|Overall Study||12
451770|NCT01302548|1107346|P2|STARTED|Overall Study||19
451771|NCT01302548|1107347|P1|STARTED|Overall Study||14
451772|NCT01302483|1107359|P2|NOT COMPLETED|Overall Study||0
451773|NCT01302483|1107360|P1|NOT COMPLETED|Overall Study||0
451774|NCT01302483|1107359|P2|COMPLETED|Overall Study||15
451775|NCT01302483|1107360|P1|COMPLETED|Overall Study||30
451776|NCT01302483|1107359|P2|STARTED|Overall Study||15
451777|NCT01302483|1107360|P1|STARTED|Overall Study||30
451778|NCT01302444|1107376|P2|NOT COMPLETED|Overall Study||0
451779|NCT01302444|1107377|P1|NOT COMPLETED|Overall Study||0
451780|NCT01302444|1107376|P2|COMPLETED|Overall Study||0
451781|NCT01302444|1107377|P1|COMPLETED|Overall Study||1
451782|NCT01302444|1107376|P2|STARTED|Overall Study||0
451783|NCT01302444|1107377|P1|STARTED|Overall Study||1
451784|NCT01302418|1107397|P1|NOT COMPLETED|Overall Study||18
451785|NCT01302418|1107397|P1|COMPLETED|Overall Study||254
451786|NCT01302418|1107397|P1|STARTED|Overall Study||272
451787|NCT01302392|1107403|P2|NOT COMPLETED|Overall Study||1
451788|NCT01302392|1107404|P1|NOT COMPLETED|Overall Study||7
451789|NCT01302392|1107403|P2|COMPLETED|Overall Study||156
451790|NCT01302392|1107404|P1|COMPLETED|Overall Study||151
451791|NCT01302392|1107403|P2|Treated|Overall Study||157
451792|NCT01302392|1107404|P1|Treated|Overall Study||153
451793|NCT01302392|1107403|P2|STARTED|Overall Study||157
451794|NCT01302392|1107404|P1|STARTED|Overall Study||158
451795|NCT01302366|1107424|P1|NOT COMPLETED|Overall Study||5
451796|NCT01302366|1107424|P1|COMPLETED|Overall Study||15
451797|NCT01302366|1107424|P1|STARTED|Overall Study||20
451798|NCT01302119|1107432|P2|NOT COMPLETED|Overall Study||28
451799|NCT01302119|1107433|P1|NOT COMPLETED|Overall Study||50
451800|NCT01302119|1107432|P2|COMPLETED|Overall Study||177
451801|NCT01302119|1107433|P1|COMPLETED|Overall Study||349
451802|NCT01302119|1107432|P2|STARTED|Overall Study||205
451803|NCT01302119|1107433|P1|STARTED|Overall Study||399
451804|NCT01302067|1107448|P3|NOT COMPLETED|Overall Study||98
451805|NCT01302067|1107449|P2|NOT COMPLETED|Overall Study||34
451806|NCT01302067|1107450|P1|NOT COMPLETED|Overall Study||78
451807|NCT01302067|1107448|P3|COMPLETED|Overall Study||681
451808|NCT01302067|1107449|P2|COMPLETED|Overall Study||352
451809|NCT01302067|1107450|P1|COMPLETED|Overall Study||712
451810|NCT01302067|1107448|P3|STARTED|Overall Study||779
451811|NCT01302067|1107449|P2|STARTED|Overall Study||386
451812|NCT01302067|1107450|P1|STARTED|Overall Study||790
451813|NCT01302054|1107521|P3|NOT COMPLETED|Double-Blind Treatment Phase||46
451814|NCT01302054|1107522|P2|NOT COMPLETED|Double-Blind Treatment Phase||27
451815|NCT01302054|1107523|P1|NOT COMPLETED|Double-Blind Treatment Phase||0
451816|NCT01302054|1107521|P3|COMPLETED|Double-Blind Treatment Phase||255
451817|NCT01302054|1107522|P2|COMPLETED|Double-Blind Treatment Phase||281
451818|NCT01302054|1107523|P1|COMPLETED|Double-Blind Treatment Phase||0
451819|NCT01302054|1107521|P3|STARTED|Double-Blind Treatment Phase||301
451820|NCT01302054|1107522|P2|STARTED|Double-Blind Treatment Phase||308
451821|NCT01302054|1107523|P1|STARTED|Double-Blind Treatment Phase||0
451822|NCT01302054|1107521|P3|NOT COMPLETED|Between Open-Label and Double Blind||0
451823|NCT01302054|1107522|P2|NOT COMPLETED|Between Open-Label and Double Blind||0
451824|NCT01302054|1107523|P1|NOT COMPLETED|Between Open-Label and Double Blind||2
451825|NCT01302054|1107521|P3|COMPLETED|Between Open-Label and Double Blind||0
451826|NCT01302054|1107522|P2|COMPLETED|Between Open-Label and Double Blind||0
451827|NCT01302054|1107523|P1|COMPLETED|Between Open-Label and Double Blind||609
451828|NCT01302054|1107521|P3|STARTED|Between Open-Label and Double Blind||0
451829|NCT01302054|1107522|P2|STARTED|Between Open-Label and Double Blind||0
451830|NCT01302054|1107523|P1|STARTED|Between Open-Label and Double Blind||611
451831|NCT01302054|1107521|P3|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0
451832|NCT01302054|1107522|P2|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0
451833|NCT01302054|1107523|P1|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||379
451834|NCT01302054|1107521|P3|COMPLETED|Tolterodine Open-Label Run-In Phase||0
451835|NCT01302054|1107522|P2|COMPLETED|Tolterodine Open-Label Run-In Phase||0
451836|NCT01302054|1107523|P1|COMPLETED|Tolterodine Open-Label Run-In Phase||611
451837|NCT01302054|1107521|P3|STARTED|Tolterodine Open-Label Run-In Phase||0
451838|NCT01302054|1107522|P2|STARTED|Tolterodine Open-Label Run-In Phase||0
451839|NCT01302054|1107523|P1|STARTED|Tolterodine Open-Label Run-In Phase||990
451840|NCT01302041|1107550|P1|NOT COMPLETED|Overall Study||40
451841|NCT01302041|1107550|P1|COMPLETED|Overall Study|Participants who discontinued treatment and completed the 30-day follow-up visit|27
451842|NCT01302041|1107550|P1|Treatment Received|Overall Study||67
451843|NCT01302041|1107550|P1|STARTED|Overall Study||67
451844|NCT01301963|1107581|P2|NOT COMPLETED|Overall Study||0
451845|NCT01301963|1107582|P1|NOT COMPLETED|Overall Study||0
451846|NCT01301963|1107581|P2|COMPLETED|Overall Study||4
451847|NCT01301963|1107582|P1|COMPLETED|Overall Study||5
451848|NCT01301963|1107581|P2|STARTED|Overall Study||4
451849|NCT01301963|1107582|P1|STARTED|Overall Study||5
451850|NCT01301950|1107592|P2|NOT COMPLETED|Overall Study||1
451851|NCT01301950|1107593|P1|NOT COMPLETED|Overall Study||0
451852|NCT01301950|1107592|P2|COMPLETED|Overall Study||14
451853|NCT01301950|1107593|P1|COMPLETED|Overall Study||15
451854|NCT01301950|1107592|P2|STARTED|Overall Study||15
451855|NCT01301950|1107593|P1|STARTED|Overall Study||15
451856|NCT01301833|1107611|P4|NOT COMPLETED|Overall Study||7
451857|NCT01301833|1107612|P3|NOT COMPLETED|Overall Study||7
451858|NCT01301833|1107613|P2|NOT COMPLETED|Overall Study||8
451859|NCT01301833|1107614|P1|NOT COMPLETED|Overall Study||15
451860|NCT01301833|1107611|P4|COMPLETED|Overall Study||68
451861|NCT01301833|1107612|P3|COMPLETED|Overall Study||88
451862|NCT01301833|1107613|P2|COMPLETED|Overall Study||72
451863|NCT01301833|1107614|P1|COMPLETED|Overall Study||197
451864|NCT01301833|1107611|P4|STARTED|Overall Study||75
451865|NCT01301833|1107612|P3|STARTED|Overall Study||95
451866|NCT01301833|1107613|P2|STARTED|Overall Study||80
451867|NCT01301833|1107614|P1|STARTED|Overall Study||212
451868|NCT01301742|1107640|P2|NOT COMPLETED|Second Intervention||0
451869|NCT01301742|1107641|P1|NOT COMPLETED|Second Intervention||0
451870|NCT01301742|1107640|P2|COMPLETED|Second Intervention||9
451871|NCT01301742|1107641|P1|COMPLETED|Second Intervention||9
451872|NCT01301742|1107640|P2|STARTED|Second Intervention||9
451873|NCT01301742|1107641|P1|STARTED|Second Intervention||9
451874|NCT01301742|1107640|P2|NOT COMPLETED|Washout Period of at Least 7 Days||0
451875|NCT01301742|1107641|P1|NOT COMPLETED|Washout Period of at Least 7 Days||0
451876|NCT01301742|1107640|P2|COMPLETED|Washout Period of at Least 7 Days||9
451877|NCT01301742|1107641|P1|COMPLETED|Washout Period of at Least 7 Days||9
451878|NCT01301742|1107640|P2|STARTED|Washout Period of at Least 7 Days||9
451879|NCT01301742|1107641|P1|STARTED|Washout Period of at Least 7 Days||9
451880|NCT01301742|1107640|P2|NOT COMPLETED|First Intervention||0
451881|NCT01301742|1107641|P1|NOT COMPLETED|First Intervention||0
451882|NCT01301742|1107640|P2|COMPLETED|First Intervention||9
451883|NCT01301742|1107641|P1|COMPLETED|First Intervention||9
451884|NCT01301742|1107640|P2|STARTED|First Intervention||9
451885|NCT01301742|1107641|P1|STARTED|First Intervention||9
451886|NCT01301729|1107652|P1|NOT COMPLETED|Overall Study||4
451887|NCT01301729|1107652|P1|COMPLETED|Overall Study||28
451888|NCT01301729|1107652|P1|STARTED|Overall Study||32
451889|NCT01301508|1107665|P2|NOT COMPLETED|Overall Study||3
451890|NCT01301508|1107666|P1|NOT COMPLETED|Overall Study||1
451891|NCT01301508|1107665|P2|COMPLETED|Overall Study||22
451892|NCT01301508|1107666|P1|COMPLETED|Overall Study||20
451893|NCT01301508|1107665|P2|STARTED|Overall Study||25
451894|NCT01301508|1107666|P1|STARTED|Overall Study||21
451895|NCT01301456|1107696|P12|NOT COMPLETED|Stage 2||0
451896|NCT01301456|1107697|P11|NOT COMPLETED|Stage 2||1
451897|NCT01301456|1107698|P10|NOT COMPLETED|Stage 2||0
451898|NCT01301456|1107699|P9|NOT COMPLETED|Stage 2||0
451899|NCT01301456|1107700|P8|NOT COMPLETED|Stage 2||0
451900|NCT01301456|1107701|P7|NOT COMPLETED|Stage 2||0
451901|NCT01301456|1107702|P6|NOT COMPLETED|Stage 2||0
451902|NCT01301456|1107703|P5|NOT COMPLETED|Stage 2||0
451903|NCT01301456|1107704|P4|NOT COMPLETED|Stage 2||0
451904|NCT01301456|1107705|P3|NOT COMPLETED|Stage 2||0
451905|NCT01301456|1107706|P2|NOT COMPLETED|Stage 2||0
451906|NCT01301456|1107707|P1|NOT COMPLETED|Stage 2||0
451907|NCT01301456|1107696|P12|COMPLETED|Stage 2||6
451908|NCT01301456|1107697|P11|COMPLETED|Stage 2||6
451909|NCT01301456|1107698|P10|COMPLETED|Stage 2||7
451910|NCT01301456|1107699|P9|COMPLETED|Stage 2||5
451911|NCT01301456|1107700|P8|COMPLETED|Stage 2||7
451912|NCT01301456|1107701|P7|COMPLETED|Stage 2||0
451913|NCT01301456|1107702|P6|COMPLETED|Stage 2||0
451914|NCT01301456|1107703|P5|COMPLETED|Stage 2||0
451915|NCT01301456|1107704|P4|COMPLETED|Stage 2||0
451916|NCT01301456|1107705|P3|COMPLETED|Stage 2||0
451917|NCT01301456|1107706|P2|COMPLETED|Stage 2||0
451918|NCT01301456|1107707|P1|COMPLETED|Stage 2||0
451919|NCT01301456|1107696|P12|Received Treatment|Stage 2||6
451920|NCT01301456|1107697|P11|Received Treatment|Stage 2||7
451921|NCT01301456|1107698|P10|Received Treatment|Stage 2||7
451922|NCT01301456|1107699|P9|Received Treatment|Stage 2||5
451923|NCT01301456|1107700|P8|Received Treatment|Stage 2||7
451924|NCT01301456|1107701|P7|Received Treatment|Stage 2||0
451925|NCT01301456|1107702|P6|Received Treatment|Stage 2||0
451926|NCT01301456|1107703|P5|Received Treatment|Stage 2||0
451927|NCT01301456|1107704|P4|Received Treatment|Stage 2||0
451928|NCT01301456|1107705|P3|Received Treatment|Stage 2||0
451929|NCT01301456|1107706|P2|Received Treatment|Stage 2||0
451930|NCT01301456|1107707|P1|Received Treatment|Stage 2||0
451931|NCT01301456|1107696|P12|STARTED|Stage 2||6
451932|NCT01301456|1107697|P11|STARTED|Stage 2||7
451933|NCT01301456|1107698|P10|STARTED|Stage 2||7
451934|NCT01301456|1107699|P9|STARTED|Stage 2||5
451935|NCT01301456|1107700|P8|STARTED|Stage 2||7
451936|NCT01301456|1107701|P7|STARTED|Stage 2||0
451937|NCT01301456|1107702|P6|STARTED|Stage 2||0
451938|NCT01301456|1107703|P5|STARTED|Stage 2||0
451939|NCT01301456|1107704|P4|STARTED|Stage 2||0
451940|NCT01301456|1107705|P3|STARTED|Stage 2||0
451941|NCT01301456|1107706|P2|STARTED|Stage 2||0
451942|NCT01301456|1107707|P1|STARTED|Stage 2||0
451943|NCT01301456|1107696|P12|NOT COMPLETED|Stage 1||0
451944|NCT01301456|1107697|P11|NOT COMPLETED|Stage 1||0
451945|NCT01301456|1107698|P10|NOT COMPLETED|Stage 1||0
451946|NCT01301456|1107699|P9|NOT COMPLETED|Stage 1||0
451947|NCT01301456|1107700|P8|NOT COMPLETED|Stage 1||0
451948|NCT01301456|1107701|P7|NOT COMPLETED|Stage 1||1
451949|NCT01301456|1107702|P6|NOT COMPLETED|Stage 1||0
451950|NCT01301456|1107703|P5|NOT COMPLETED|Stage 1||1
451951|NCT01301456|1107704|P4|NOT COMPLETED|Stage 1||0
451952|NCT01301456|1107705|P3|NOT COMPLETED|Stage 1||1
451953|NCT01301456|1107706|P2|NOT COMPLETED|Stage 1||0
451954|NCT01301456|1107707|P1|NOT COMPLETED|Stage 1||0
451955|NCT01301456|1107696|P12|COMPLETED|Stage 1||0
451956|NCT01301456|1107697|P11|COMPLETED|Stage 1||0
451957|NCT01301456|1107698|P10|COMPLETED|Stage 1||0
451958|NCT01301456|1107699|P9|COMPLETED|Stage 1||0
451959|NCT01301456|1107700|P8|COMPLETED|Stage 1||0
451960|NCT01301456|1107701|P7|COMPLETED|Stage 1||7
451961|NCT01301456|1107702|P6|COMPLETED|Stage 1||5
451962|NCT01301456|1107703|P5|COMPLETED|Stage 1||6
451963|NCT01301456|1107704|P4|COMPLETED|Stage 1||6
451964|NCT01301456|1107705|P3|COMPLETED|Stage 1||5
451965|NCT01301456|1107706|P2|COMPLETED|Stage 1||5
451966|NCT01301456|1107707|P1|COMPLETED|Stage 1||15
451967|NCT01301456|1107696|P12|Received Treatment|Stage 1||0
451968|NCT01301456|1107697|P11|Received Treatment|Stage 1||0
451969|NCT01301456|1107698|P10|Received Treatment|Stage 1||0
451970|NCT01301456|1107699|P9|Received Treatment|Stage 1||0
451971|NCT01301456|1107700|P8|Received Treatment|Stage 1||0
451972|NCT01301456|1107701|P7|Received Treatment|Stage 1||7
451973|NCT01301456|1107702|P6|Received Treatment|Stage 1||5
451974|NCT01301456|1107703|P5|Received Treatment|Stage 1||7
451975|NCT01301456|1107704|P4|Received Treatment|Stage 1||6
451976|NCT01301456|1107705|P3|Received Treatment|Stage 1||6
451977|NCT01301456|1107706|P2|Received Treatment|Stage 1||5
451978|NCT01301456|1107707|P1|Received Treatment|Stage 1||15
451979|NCT01301456|1107696|P12|STARTED|Stage 1||0
451980|NCT01301456|1107697|P11|STARTED|Stage 1||0
451981|NCT01301456|1107698|P10|STARTED|Stage 1||0
451982|NCT01301456|1107699|P9|STARTED|Stage 1||0
451983|NCT01301456|1107700|P8|STARTED|Stage 1||0
451984|NCT01301456|1107701|P7|STARTED|Stage 1||8
451985|NCT01301456|1107702|P6|STARTED|Stage 1||5
451986|NCT01301456|1107703|P5|STARTED|Stage 1||7
451987|NCT01301456|1107704|P4|STARTED|Stage 1||6
451988|NCT01301456|1107705|P3|STARTED|Stage 1||6
451989|NCT01301456|1107706|P2|STARTED|Stage 1||5
451990|NCT01301456|1107707|P1|STARTED|Stage 1||15
451991|NCT01301274|1107935|P2|NOT COMPLETED|Overall Study||1
451992|NCT01301274|1107936|P1|NOT COMPLETED|Overall Study||2
451993|NCT01301274|1107935|P2|COMPLETED|Overall Study||31
451994|NCT01301274|1107936|P1|COMPLETED|Overall Study||32
451995|NCT01301274|1107935|P2|STARTED|Overall Study||32
451996|NCT01301274|1107936|P1|STARTED|Overall Study||34
451997|NCT01301092|1107951|P3|NOT COMPLETED|Overall Study||1
451998|NCT01301092|1107952|P2|NOT COMPLETED|Overall Study||0
451999|NCT01301092|1107953|P1|NOT COMPLETED|Overall Study||0
452000|NCT01301092|1107951|P3|COMPLETED|Overall Study||7
452001|NCT01301092|1107952|P2|COMPLETED|Overall Study||16
452002|NCT01301092|1107953|P1|COMPLETED|Overall Study||6
452003|NCT01301092|1107951|P3|STARTED|Overall Study||8
452004|NCT01301092|1107952|P2|STARTED|Overall Study||16
452005|NCT01301092|1107953|P1|STARTED|Overall Study||6
452006|NCT01301079|1107970|P2|NOT COMPLETED|Overall Study||2
452007|NCT01301079|1107971|P1|NOT COMPLETED|Overall Study||2
452008|NCT01301079|1107970|P2|COMPLETED|Overall Study||28
452009|NCT01301079|1107971|P1|COMPLETED|Overall Study||28
452010|NCT01301079|1107970|P2|STARTED|Overall Study||30
452011|NCT01301079|1107971|P1|STARTED|Overall Study||30
452012|NCT01301066|1108049|P2|NOT COMPLETED|Overall Study||35
452013|NCT01301066|1108050|P1|NOT COMPLETED|Overall Study||27
452014|NCT01301066|1108049|P2|COMPLETED|Overall Study||91
452015|NCT01301066|1108050|P1|COMPLETED|Overall Study||99
452016|NCT01301066|1108049|P2|STARTED|Overall Study||126
452017|NCT01301066|1108050|P1|STARTED|Overall Study||126
452018|NCT01301027|1108058|P2|NOT COMPLETED|Overall Study||10
452019|NCT01301027|1108059|P1|NOT COMPLETED|Overall Study||8
452020|NCT01301027|1108058|P2|COMPLETED|Overall Study||37
452021|NCT01301027|1108059|P1|COMPLETED|Overall Study||40
452022|NCT01301027|1108058|P2|STARTED|Overall Study||47
452023|NCT01301027|1108059|P1|STARTED|Overall Study||48
452024|NCT01301001|1108071|P2|NOT COMPLETED|Second Intervention||0
452025|NCT01301001|1108072|P1|NOT COMPLETED|Second Intervention||4
452026|NCT01301001|1108071|P2|COMPLETED|Second Intervention||36
452027|NCT01301001|1108072|P1|COMPLETED|Second Intervention||30
452028|NCT01301001|1108071|P2|STARTED|Second Intervention||36
452029|NCT01301001|1108072|P1|STARTED|Second Intervention||34
452030|NCT01301001|1108071|P2|NOT COMPLETED|Washout (2 Weeks)||0
452031|NCT01301001|1108072|P1|NOT COMPLETED|Washout (2 Weeks)||0
452032|NCT01301001|1108071|P2|COMPLETED|Washout (2 Weeks)||36
452033|NCT01301001|1108072|P1|COMPLETED|Washout (2 Weeks)||34
452034|NCT01301001|1108071|P2|STARTED|Washout (2 Weeks)||36
452035|NCT01301001|1108072|P1|STARTED|Washout (2 Weeks)||34
452036|NCT01301001|1108071|P2|NOT COMPLETED|First Intervention||9
452037|NCT01301001|1108072|P1|NOT COMPLETED|First Intervention||10
452038|NCT01301001|1108071|P2|COMPLETED|First Intervention||36
452039|NCT01301001|1108072|P1|COMPLETED|First Intervention||34
452040|NCT01301001|1108071|P2|STARTED|First Intervention||45
452041|NCT01301001|1108072|P1|STARTED|First Intervention||44
452042|NCT01300923|1108082|P2|NOT COMPLETED|Overall Study||2
452043|NCT01300923|1108083|P1|NOT COMPLETED|Overall Study||0
452044|NCT01300923|1108082|P2|COMPLETED|Overall Study||0
452045|NCT01300923|1108083|P1|COMPLETED|Overall Study||12
452046|NCT01300923|1108082|P2|STARTED|Overall Study||2
452047|NCT01300923|1108083|P1|STARTED|Overall Study||12
452048|NCT01300819|1108096|P2|NOT COMPLETED|Overall Study||44
452049|NCT01300819|1108097|P1|NOT COMPLETED|Overall Study||22
452050|NCT01300819|1108096|P2|COMPLETED|Overall Study||180
452051|NCT01300819|1108097|P1|COMPLETED|Overall Study||103
452052|NCT01300819|1108096|P2|STARTED|Overall Study||224
452053|NCT01300819|1108097|P1|STARTED|Overall Study||125
452054|NCT01300767|1108125|P1|NOT COMPLETED|Overall Study||4
452055|NCT01300767|1108125|P1|COMPLETED|Overall Study||70
452056|NCT01300767|1108125|P1|STARTED|Overall Study||74
452057|NCT01300741|1108153|P1|NOT COMPLETED|Overall Study||3
452058|NCT01300741|1108153|P1|COMPLETED|Overall Study||72
452059|NCT01300741|1108153|P1|STARTED|Overall Study||75
452060|NCT01300728|1108183|P2|NOT COMPLETED|Overall Study||1
452061|NCT01300728|1108184|P1|NOT COMPLETED|Overall Study||2
452062|NCT01300728|1108183|P2|COMPLETED|Overall Study||25
452063|NCT01300728|1108184|P1|COMPLETED|Overall Study||24
452064|NCT01300728|1108183|P2|STARTED|Overall Study||26
452065|NCT01300728|1108184|P1|STARTED|Overall Study||26
452066|NCT01300650|1108198|P1|NOT COMPLETED|Overall Study||1
452067|NCT01300650|1108198|P1|COMPLETED|Overall Study||7
452068|NCT01300650|1108198|P1|STARTED|Overall Study||8
452069|NCT01300624|1108204|P1|NOT COMPLETED|Overall Study||0
452070|NCT01300624|1108204|P1|COMPLETED|Overall Study||11
452071|NCT01300624|1108204|P1|STARTED|Overall Study||11
452072|NCT01300559|1108216|P2|NOT COMPLETED|Overall Study||0
452073|NCT01300559|1108217|P1|NOT COMPLETED|Overall Study||0
452074|NCT01300559|1108216|P2|COMPLETED|Overall Study||30
452075|NCT01300559|1108217|P1|COMPLETED|Overall Study||30
452076|NCT01300559|1108216|P2|STARTED|Overall Study||30
452077|NCT01300559|1108217|P1|STARTED|Overall Study||30
452078|NCT01300546|1108225|P2|NOT COMPLETED|Overall Study||6
452079|NCT01300546|1108226|P1|NOT COMPLETED|Overall Study||1
452080|NCT01300546|1108225|P2|COMPLETED|Overall Study||14
452081|NCT01300546|1108226|P1|COMPLETED|Overall Study||18
452082|NCT01300546|1108225|P2|STARTED|Overall Study||20
452083|NCT01300546|1108226|P1|STARTED|Overall Study||19
452084|NCT01300455|1108256|P2|NOT COMPLETED|Period 2||0
452085|NCT01300455|1108257|P1|NOT COMPLETED|Period 2||0
452086|NCT01300455|1108256|P2|COMPLETED|Period 2||13
452087|NCT01300455|1108257|P1|COMPLETED|Period 2||12
452088|NCT01300455|1108256|P2|STARTED|Period 2||13
452089|NCT01300455|1108257|P1|STARTED|Period 2||12
452090|NCT01300455|1108256|P2|NOT COMPLETED|Washout||0
452091|NCT01300455|1108257|P1|NOT COMPLETED|Washout||1
452092|NCT01300455|1108256|P2|COMPLETED|Washout||13
452093|NCT01300455|1108257|P1|COMPLETED|Washout||12
452094|NCT01300455|1108256|P2|STARTED|Washout||13
452095|NCT01300455|1108257|P1|STARTED|Washout||13
452096|NCT01300455|1108256|P2|NOT COMPLETED|Period 1||0
452097|NCT01300455|1108257|P1|NOT COMPLETED|Period 1||0
452098|NCT01300455|1108256|P2|COMPLETED|Period 1||13
452099|NCT01300455|1108257|P1|COMPLETED|Period 1||13
452100|NCT01300455|1108256|P2|STARTED|Period 1||13
452101|NCT01300455|1108257|P1|STARTED|Period 1||13
452102|NCT01300351|1108277|P2|NOT COMPLETED|Overall Study||38
452103|NCT01300351|1108278|P1|NOT COMPLETED|Overall Study||36
452104|NCT01300351|1108277|P2|COMPLETED|Overall Study||72
452105|NCT01300351|1108278|P1|COMPLETED|Overall Study||75
452106|NCT01300351|1108277|P2|Received Study Treatment|Overall Study||110
452107|NCT01300351|1108278|P1|Received Study Treatment|Overall Study||109
452108|NCT01300351|1108277|P2|STARTED|Overall Study||110
452109|NCT01300351|1108278|P1|STARTED|Overall Study||111
452110|NCT01300338|1108294|P2|NOT COMPLETED|Overall Study||0
452111|NCT01300338|1108295|P1|NOT COMPLETED|Overall Study||5
452112|NCT01300338|1108294|P2|COMPLETED|Overall Study||25
452113|NCT01300338|1108295|P1|COMPLETED|Overall Study||20
452114|NCT01300338|1108294|P2|STARTED|Overall Study||25
452115|NCT01300338|1108295|P1|STARTED|Overall Study||25
452116|NCT01300286|1108303|P1|NOT COMPLETED|Overall Study||1
452117|NCT01300286|1108303|P1|COMPLETED|Overall Study||22
452118|NCT01300286|1108303|P1|STARTED|Overall Study||23
452119|NCT01300260|1108313|P2|NOT COMPLETED|Period 2 of Study: Second Intervention||1
452120|NCT01300260|1108314|P1|NOT COMPLETED|Period 2 of Study: Second Intervention||0
452121|NCT01300260|1108313|P2|COMPLETED|Period 2 of Study: Second Intervention||15
452122|NCT01300260|1108314|P1|COMPLETED|Period 2 of Study: Second Intervention||14
452123|NCT01300260|1108313|P2|STARTED|Period 2 of Study: Second Intervention||16
452124|NCT01300260|1108314|P1|STARTED|Period 2 of Study: Second Intervention||14
452125|NCT01300260|1108313|P2|NOT COMPLETED|Washout Period of at Least 28 Days||0
452126|NCT01300260|1108314|P1|NOT COMPLETED|Washout Period of at Least 28 Days||0
452127|NCT01300260|1108313|P2|COMPLETED|Washout Period of at Least 28 Days||16
452128|NCT01300260|1108314|P1|COMPLETED|Washout Period of at Least 28 Days||14
452129|NCT01300260|1108313|P2|STARTED|Washout Period of at Least 28 Days||16
452130|NCT01300260|1108314|P1|STARTED|Washout Period of at Least 28 Days||14
452131|NCT01300260|1108313|P2|NOT COMPLETED|Period 1 of Study: First Intervention||1
452132|NCT01300260|1108314|P1|NOT COMPLETED|Period 1 of Study: First Intervention||1
452133|NCT01300260|1108313|P2|COMPLETED|Period 1 of Study: First Intervention||16
452134|NCT01300260|1108314|P1|COMPLETED|Period 1 of Study: First Intervention||14
452135|NCT01300260|1108313|P2|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||17
452136|NCT01300260|1108314|P1|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||15
452137|NCT01300260|1108313|P2|STARTED|Period 1 of Study: First Intervention||17
452138|NCT01300260|1108314|P1|STARTED|Period 1 of Study: First Intervention||15
452139|NCT01300247|1108346|P2|NOT COMPLETED|Overall Study||2
452140|NCT01300247|1108347|P1|NOT COMPLETED|Overall Study||4
452141|NCT01300247|1108346|P2|COMPLETED|Overall Study||18
452142|NCT01300247|1108347|P1|COMPLETED|Overall Study||17
452143|NCT01300247|1108346|P2|STARTED|Overall Study||20
452144|NCT01300247|1108347|P1|STARTED|Overall Study||21
452145|NCT01300234|1108379|P2|NOT COMPLETED|Overall Study||10
452146|NCT01300234|1108380|P1|NOT COMPLETED|Overall Study||4
452147|NCT01300234|1108379|P2|COMPLETED|Overall Study||245
452148|NCT01300234|1108380|P1|COMPLETED|Overall Study||253
452149|NCT01300234|1108379|P2|STARTED|Overall Study||255
452150|NCT01300234|1108380|P1|STARTED|Overall Study||257
452151|NCT01300052|1108412|P2|NOT COMPLETED|Overall Study||3
452152|NCT01300052|1108413|P1|NOT COMPLETED|Overall Study||6
452153|NCT01300052|1108412|P2|COMPLETED|Overall Study||19
452154|NCT01300052|1108413|P1|COMPLETED|Overall Study||40
452155|NCT01300052|1108412|P2|STARTED|Overall Study||22
452156|NCT01300052|1108413|P1|STARTED|Overall Study||46
452157|NCT01299961|1108431|P1|NOT COMPLETED|Overall Study||6
452158|NCT01299961|1108431|P1|COMPLETED|Overall Study||19
452159|NCT01299961|1108431|P1|STARTED|Overall Study||25
452160|NCT01299909|1108440|P3|NOT COMPLETED|Overall Study||17
452161|NCT01299909|1108441|P2|NOT COMPLETED|Overall Study||18
452162|NCT01299909|1108442|P1|NOT COMPLETED|Overall Study||22
452163|NCT01299909|1108440|P3|COMPLETED|Overall Study||23
452164|NCT01299909|1108441|P2|COMPLETED|Overall Study||49
452165|NCT01299909|1108442|P1|COMPLETED|Overall Study||46
452166|NCT01299909|1108440|P3|STARTED|Overall Study||40
452167|NCT01299909|1108441|P2|STARTED|Overall Study||67
452168|NCT01299909|1108442|P1|STARTED|Overall Study||68
452169|NCT01299896|1108457|P2|NOT COMPLETED|Overall Study||18
452170|NCT01299896|1108458|P1|NOT COMPLETED|Overall Study||1
452171|NCT01299896|1108457|P2|COMPLETED|Overall Study||296
452172|NCT01299896|1108458|P1|COMPLETED|Overall Study||318
452173|NCT01299896|1108457|P2|STARTED|Overall Study||314
452174|NCT01299896|1108458|P1|STARTED|Overall Study||319
452175|NCT01299805|1108466|P2|NOT COMPLETED|Overall Study||0
452176|NCT01299805|1108467|P1|NOT COMPLETED|Overall Study||2
452177|NCT01299805|1108466|P2|COMPLETED|Overall Study||5
452178|NCT01299805|1108467|P1|COMPLETED|Overall Study||10
452179|NCT01299805|1108466|P2|STARTED|Overall Study||5
452180|NCT01299805|1108467|P1|STARTED|Overall Study||12
452181|NCT01299610|1108498|P3|NOT COMPLETED|Overall Study||0
452182|NCT01299610|1108499|P2|NOT COMPLETED|Overall Study||0
452183|NCT01299610|1108500|P1|NOT COMPLETED|Overall Study||0
452184|NCT01299610|1108498|P3|COMPLETED|Overall Study||10
452185|NCT01299610|1108499|P2|COMPLETED|Overall Study||5
452186|NCT01299610|1108500|P1|COMPLETED|Overall Study||10
452187|NCT01299610|1108498|P3|STARTED|Overall Study||10
452188|NCT01299610|1108499|P2|STARTED|Overall Study||5
452189|NCT01299610|1108500|P1|STARTED|Overall Study||10
452190|NCT01299584|1108545|P1|NOT COMPLETED|Overall Study||9
452191|NCT01299584|1108545|P1|COMPLETED|Overall Study||766
452192|NCT01299584|1108545|P1|STARTED|Overall Study||775
452193|NCT01299571|1108552|P1|NOT COMPLETED|Overall Study||107
452194|NCT01299571|1108552|P1|COMPLETED|Overall Study||3870
452195|NCT01299571|1108552|P1|STARTED|Overall Study||3977
452196|NCT01299480|1108563|P5|NOT COMPLETED|Overall Study||20
452197|NCT01299480|1108564|P4|NOT COMPLETED|Overall Study||25
452198|NCT01299480|1108565|P3|NOT COMPLETED|Overall Study||41
452199|NCT01299480|1108566|P2|NOT COMPLETED|Overall Study||35
452200|NCT01299480|1108567|P1|NOT COMPLETED|Overall Study||42
452201|NCT01299480|1108563|P5|COMPLETED|Overall Study||123
452202|NCT01299480|1108564|P4|COMPLETED|Overall Study||261
452203|NCT01299480|1108565|P3|COMPLETED|Overall Study||386
452204|NCT01299480|1108566|P2|COMPLETED|Overall Study||395
452205|NCT01299480|1108567|P1|COMPLETED|Overall Study||385
452206|NCT01299480|1108563|P5|STARTED|Overall Study||143
452207|NCT01299480|1108564|P4|STARTED|Overall Study||286
452208|NCT01299480|1108565|P3|STARTED|Overall Study||427
452209|NCT01299480|1108566|P2|STARTED|Overall Study||430
452210|NCT01299480|1108567|P1|STARTED|Overall Study||427
452211|NCT01299454|1108606|P4|NOT COMPLETED|Overall Study||0
452212|NCT01299454|1108607|P3|NOT COMPLETED|Overall Study||0
452213|NCT01299454|1108608|P2|NOT COMPLETED|Overall Study||0
452214|NCT01299454|1108609|P1|NOT COMPLETED|Overall Study||0
452215|NCT01299454|1108606|P4|COMPLETED|Overall Study||23
452216|NCT01299454|1108607|P3|COMPLETED|Overall Study||6
452217|NCT01299454|1108608|P2|COMPLETED|Overall Study||8
452218|NCT01299454|1108609|P1|COMPLETED|Overall Study||8
452219|NCT01299454|1108606|P4|STARTED|Overall Study||23
452220|NCT01299454|1108607|P3|STARTED|Overall Study||6
452221|NCT01299454|1108608|P2|STARTED|Overall Study||8
452222|NCT01299454|1108609|P1|STARTED|Overall Study||8
452223|NCT01299389|1108769|P4|NOT COMPLETED|Post-observational||6
452224|NCT01299389|1108770|P3|NOT COMPLETED|Post-observational||12
452225|NCT01299389|1108771|P2|NOT COMPLETED|Post-observational||0
452226|NCT01299389|1108772|P1|NOT COMPLETED|Post-observational||0
452227|NCT01299389|1108769|P4|COMPLETED|Post-observational||149
452228|NCT01299389|1108770|P3|COMPLETED|Post-observational||144
452229|NCT01299389|1108771|P2|COMPLETED|Post-observational||0
452230|NCT01299389|1108772|P1|COMPLETED|Post-observational||0
452231|NCT01299389|1108769|P4|STARTED|Post-observational||155
452232|NCT01299389|1108770|P3|STARTED|Post-observational||156
452233|NCT01299389|1108771|P2|STARTED|Post-observational||0
452234|NCT01299389|1108772|P1|STARTED|Post-observational||0
452235|NCT01299389|1108769|P4|NOT COMPLETED|Double-blind||0
452236|NCT01299389|1108770|P3|NOT COMPLETED|Double-blind||0
452237|NCT01299389|1108771|P2|NOT COMPLETED|Double-blind||64
452238|NCT01299389|1108772|P1|NOT COMPLETED|Double-blind||109
452239|NCT01299389|1108769|P4|COMPLETED|Double-blind||0
452240|NCT01299389|1108770|P3|COMPLETED|Double-blind||0
452241|NCT01299389|1108771|P2|COMPLETED|Double-blind||95
452242|NCT01299389|1108772|P1|COMPLETED|Double-blind||55
452243|NCT01299389|1108769|P4|STARTED|Double-blind||0
452244|NCT01299389|1108770|P3|STARTED|Double-blind||0
452245|NCT01299389|1108771|P2|STARTED|Double-blind||159
452246|NCT01299389|1108772|P1|STARTED|Double-blind||164
452247|NCT01299376|1108794|P2|NOT COMPLETED|Extension (Weeks 9 to 52)||15
452248|NCT01299376|1108795|P1|NOT COMPLETED|Extension (Weeks 9 to 52)||10
452249|NCT01299376|1108794|P2|COMPLETED|Extension (Weeks 9 to 52)||118
452250|NCT01299376|1108795|P1|COMPLETED|Extension (Weeks 9 to 52)||124
452251|NCT01299376|1108794|P2|STARTED|Extension (Weeks 9 to 52)||133
452252|NCT01299376|1108795|P1|STARTED|Extension (Weeks 9 to 52)||134
452253|NCT01299376|1108794|P2|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||12
452254|NCT01299376|1108795|P1|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||7
452255|NCT01299376|1108794|P2|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||133
452256|NCT01299376|1108795|P1|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||134
452257|NCT01299376|1108794|P2|STARTED|Double-blind Treatment (Weeks 1 to 8)||145
452258|NCT01299376|1108795|P1|STARTED|Double-blind Treatment (Weeks 1 to 8)||141
452259|NCT01299285|1108825|P1|NOT COMPLETED|Overall Study||0
452260|NCT01299285|1108825|P1|COMPLETED|Overall Study||6
452261|NCT01299285|1108825|P1|STARTED|Overall Study||6
452262|NCT01299272|1108838|P4|NOT COMPLETED|Double-blind (DB) Randomized Period||58
452263|NCT01299272|1108839|P3|NOT COMPLETED|Double-blind (DB) Randomized Period||70
452264|NCT01299272|1108840|P2|NOT COMPLETED|Double-blind (DB) Randomized Period||0
452265|NCT01299272|1108841|P1|NOT COMPLETED|Double-blind (DB) Randomized Period||0
452266|NCT01299272|1108838|P4|COMPLETED|Double-blind (DB) Randomized Period||234
452267|NCT01299272|1108839|P3|COMPLETED|Double-blind (DB) Randomized Period||224
452268|NCT01299272|1108840|P2|COMPLETED|Double-blind (DB) Randomized Period||0
452269|NCT01299272|1108841|P1|COMPLETED|Double-blind (DB) Randomized Period||0
452270|NCT01299272|1108838|P4|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period entered the DC Period.|268
452271|NCT01299272|1108839|P3|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period were randomized to the abrupt DC Period.|132
452272|NCT01299272|1108840|P2|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period||0
452273|NCT01299272|1108841|P1|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period||0
452274|NCT01299272|1108838|P4|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
452275|NCT01299272|1108839|P3|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period were randomized to the taper DC Period.|129
452276|NCT01299272|1108840|P2|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
452277|NCT01299272|1108841|P1|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
452278|NCT01299272|1108838|P4|STARTED|Double-blind (DB) Randomized Period||292
452279|NCT01299272|1108839|P3|STARTED|Double-blind (DB) Randomized Period||294
452280|NCT01299272|1108840|P2|STARTED|Double-blind (DB) Randomized Period||0
452281|NCT01299272|1108841|P1|STARTED|Double-blind (DB) Randomized Period||0
452282|NCT01299272|1108838|P4|NOT COMPLETED|Stabilization Open-label (OL) Period||0
452283|NCT01299272|1108839|P3|NOT COMPLETED|Stabilization Open-label (OL) Period||0
452284|NCT01299272|1108840|P2|NOT COMPLETED|Stabilization Open-label (OL) Period||249
452285|NCT01299272|1108841|P1|NOT COMPLETED|Stabilization Open-label (OL) Period||0
452286|NCT01299272|1108838|P4|COMPLETED|Stabilization Open-label (OL) Period||0
452287|NCT01299272|1108839|P3|COMPLETED|Stabilization Open-label (OL) Period||0
452288|NCT01299272|1108840|P2|COMPLETED|Stabilization Open-label (OL) Period|Participants who completed the Stabilization OL Period were randomized to the DB Period.|586
452289|NCT01299272|1108841|P1|COMPLETED|Stabilization Open-label (OL) Period||0
452290|NCT01299272|1108838|P4|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
452291|NCT01299272|1108839|P3|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
452292|NCT01299272|1108840|P2|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period|Participants who discontinued the Stabilization OL Period had the option to enter the DC Period.|164
452293|NCT01299272|1108841|P1|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
452294|NCT01299272|1108838|P4|STARTED|Stabilization Open-label (OL) Period||0
452295|NCT01299272|1108839|P3|STARTED|Stabilization Open-label (OL) Period||0
452296|NCT01299272|1108840|P2|STARTED|Stabilization Open-label (OL) Period||835
452297|NCT01299272|1108841|P1|STARTED|Stabilization Open-label (OL) Period||0
452298|NCT01299272|1108838|P4|NOT COMPLETED|Acute Open-label (OL) Period||0
452299|NCT01299272|1108839|P3|NOT COMPLETED|Acute Open-label (OL) Period||0
452300|NCT01299272|1108840|P2|NOT COMPLETED|Acute Open-label (OL) Period||0
452301|NCT01299272|1108841|P1|NOT COMPLETED|Acute Open-label (OL) Period||414
452302|NCT01299272|1108838|P4|COMPLETED|Acute Open-label (OL) Period||0
452303|NCT01299272|1108839|P3|COMPLETED|Acute Open-label (OL) Period||0
452304|NCT01299272|1108840|P2|COMPLETED|Acute Open-label (OL) Period||0
452305|NCT01299272|1108841|P1|COMPLETED|Acute Open-label (OL) Period|Participants who completed the Acute OL Period entered the Stabilization OL Period.|835
452306|NCT01299272|1108838|P4|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
452307|NCT01299272|1108839|P3|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
452308|NCT01299272|1108840|P2|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
452309|NCT01299272|1108841|P1|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period|Participants who discontinued the Acute OL Period had the option to enter the DC Period.|271
452310|NCT01299272|1108838|P4|STARTED|Acute Open-label (OL) Period||0
452311|NCT01299272|1108839|P3|STARTED|Acute Open-label (OL) Period||0
452312|NCT01299272|1108840|P2|STARTED|Acute Open-label (OL) Period||0
452313|NCT01299272|1108841|P1|STARTED|Acute Open-label (OL) Period||1249
452314|NCT01299116|1108896|P3|NOT COMPLETED|Overall Study||11
452315|NCT01299116|1108897|P2|NOT COMPLETED|Overall Study||9
452316|NCT01299116|1108898|P1|NOT COMPLETED|Overall Study||65
452317|NCT01299116|1108896|P3|COMPLETED|Overall Study||184
452318|NCT01299116|1108897|P2|COMPLETED|Overall Study||168
452319|NCT01299116|1108898|P1|COMPLETED|Overall Study||457
452320|NCT01299116|1108896|P3|STARTED|Overall Study||195
452321|NCT01299116|1108897|P2|STARTED|Overall Study||177
452322|NCT01299116|1108898|P1|STARTED|Overall Study||522
452323|NCT01299103|1108915|P3|NOT COMPLETED|Overall Study||2
452324|NCT01299103|1108916|P2|NOT COMPLETED|Overall Study||2
452325|NCT01299103|1108917|P1|NOT COMPLETED|Overall Study||0
452326|NCT01299103|1108915|P3|COMPLETED|Overall Study||8
452327|NCT01299103|1108916|P2|COMPLETED|Overall Study||13
452328|NCT01299103|1108917|P1|COMPLETED|Overall Study||15
452329|NCT01299103|1108915|P3|STARTED|Overall Study||10
452330|NCT01299103|1108916|P2|STARTED|Overall Study||15
452331|NCT01299103|1108917|P1|STARTED|Overall Study||15
452332|NCT01299090|1108928|P1|NOT COMPLETED|Overall Study||0
452333|NCT01299090|1108928|P1|COMPLETED|Overall Study||49
452334|NCT01299090|1108928|P1|STARTED|Overall Study||49
452335|NCT01299077|1108933|P1|NOT COMPLETED|Overall Study||0
452336|NCT01299077|1108933|P1|COMPLETED|Overall Study||478
452337|NCT01299077|1108933|P1|STARTED|Overall Study||478
452338|NCT01299025|1108943|P2|NOT COMPLETED|Overall Study||1
452339|NCT01299025|1108944|P1|NOT COMPLETED|Overall Study||3
452340|NCT01299025|1108943|P2|COMPLETED|Overall Study||41
452341|NCT01299025|1108944|P1|COMPLETED|Overall Study||39
452342|NCT01299025|1108943|P2|STARTED|Overall Study||42
452343|NCT01299025|1108944|P1|STARTED|Overall Study||42
452344|NCT01298778|1108958|P2|NOT COMPLETED|Overall Study||6
452345|NCT01298778|1108959|P1|NOT COMPLETED|Overall Study||3
452346|NCT01298778|1108958|P2|COMPLETED|Overall Study||30
452347|NCT01298778|1108959|P1|COMPLETED|Overall Study||30
452348|NCT01298778|1108958|P2|STARTED|Overall Study||36
452349|NCT01298778|1108959|P1|STARTED|Overall Study||33
452350|NCT01298661|1108982|P3|NOT COMPLETED|Overall Study||2
452351|NCT01298661|1108983|P2|NOT COMPLETED|Overall Study||0
452352|NCT01298661|1108984|P1|NOT COMPLETED|Overall Study||2
452353|NCT01298661|1108982|P3|COMPLETED|Overall Study||32
452354|NCT01298661|1108983|P2|COMPLETED|Overall Study||24
452355|NCT01298661|1108984|P1|COMPLETED|Overall Study||31
452356|NCT01298661|1108982|P3|STARTED|Overall Study||34
452357|NCT01298661|1108983|P2|STARTED|Overall Study||24
452358|NCT01298661|1108984|P1|STARTED|Overall Study||33
452359|NCT01298648|1109062|P1|NOT COMPLETED|Overall Study||23
452360|NCT01298648|1109062|P1|COMPLETED|Overall Study||1693
452361|NCT01298648|1109062|P1|STARTED|Overall Study||1716
452362|NCT01298570|1109073|P2|NOT COMPLETED|Overall Study||61
452363|NCT01298570|1109074|P1|NOT COMPLETED|Overall Study||120
452364|NCT01298570|1109073|P2|COMPLETED|Overall Study||0
452365|NCT01298570|1109074|P1|COMPLETED|Overall Study||0
452366|NCT01298570|1109073|P2|STARTED|Overall Study||61
452367|NCT01298570|1109074|P1|STARTED|Overall Study||120
452368|NCT01298544|1109090|P1|NOT COMPLETED|Overall Study||0
452369|NCT01298544|1109090|P1|COMPLETED|Overall Study||335
452370|NCT01298544|1109090|P1|STARTED|Overall Study||335
452371|NCT01298531|1109101|P2|NOT COMPLETED|Overall Study||7
452372|NCT01298531|1109102|P1|NOT COMPLETED|Overall Study||9
452373|NCT01298531|1109101|P2|COMPLETED|Overall Study||41
452374|NCT01298531|1109102|P1|COMPLETED|Overall Study||33
452375|NCT01298531|1109101|P2|STARTED|Overall Study||48
452376|NCT01298531|1109102|P1|STARTED|Overall Study||42
452377|NCT01298518|1109231|P3|NOT COMPLETED|Overall Study||1
452378|NCT01298518|1109232|P2|NOT COMPLETED|Overall Study||0
452379|NCT01298518|1109233|P1|NOT COMPLETED|Overall Study||0
452380|NCT01298518|1109231|P3|COMPLETED|Overall Study||15
452381|NCT01298518|1109232|P2|COMPLETED|Overall Study||16
452382|NCT01298518|1109233|P1|COMPLETED|Overall Study||16
452383|NCT01298518|1109231|P3|STARTED|Overall Study||16
452384|NCT01298518|1109232|P2|STARTED|Overall Study||16
452385|NCT01298518|1109233|P1|STARTED|Overall Study||16
452386|NCT01298492|1109285|P1|NOT COMPLETED|Overall Study||119
452387|NCT01298492|1109285|P1|COMPLETED|Overall Study||149
452388|NCT01298492|1109285|P1|STARTED|Overall Study||268
452389|NCT01298362|1109293|P2|NOT COMPLETED|Overall Study||43
452390|NCT01298362|1109294|P1|NOT COMPLETED|Overall Study||38
452391|NCT01298362|1109293|P2|COMPLETED|Overall Study||123
452392|NCT01298362|1109294|P1|COMPLETED|Overall Study||86
452393|NCT01298362|1109293|P2|STARTED|Overall Study||166
452394|NCT01298362|1109294|P1|STARTED|Overall Study||124
452395|NCT01298323|1109314|P2|NOT COMPLETED|Overall Study||88
452396|NCT01298323|1109315|P1|NOT COMPLETED|Overall Study||86
452397|NCT01298323|1109314|P2|COMPLETED|Overall Study||15
452398|NCT01298323|1109315|P1|COMPLETED|Overall Study||16
452399|NCT01298323|1109314|P2|Ongoing|Overall Study||55
452400|NCT01298323|1109315|P1|Ongoing|Overall Study||55
452401|NCT01298323|1109314|P2|STARTED|Overall Study||103
452402|NCT01298323|1109315|P1|STARTED|Overall Study||102
452403|NCT01298167|1109323|P2|NOT COMPLETED|Overall Study||0
452404|NCT01298167|1109324|P1|NOT COMPLETED|Overall Study||1
452405|NCT01298167|1109323|P2|COMPLETED|Overall Study||8
452406|NCT01298167|1109324|P1|COMPLETED|Overall Study||5
452407|NCT01298167|1109323|P2|STARTED|Overall Study||8
452408|NCT01298167|1109324|P1|STARTED|Overall Study||6
452409|NCT01298128|1109332|P2|NOT COMPLETED|Overall Study||8
452410|NCT01298128|1109333|P1|NOT COMPLETED|Overall Study||9
452411|NCT01298128|1109332|P2|COMPLETED|Overall Study||27
452412|NCT01298128|1109333|P1|COMPLETED|Overall Study||26
452413|NCT01298128|1109332|P2|STARTED|Overall Study||35
452414|NCT01298128|1109333|P1|STARTED|Overall Study||35
452415|NCT01298063|1109344|P5|NOT COMPLETED|Overall Study||0
452416|NCT01298063|1109345|P4|NOT COMPLETED|Overall Study||0
452417|NCT01298063|1109346|P3|NOT COMPLETED|Overall Study||0
452418|NCT01298063|1109347|P2|NOT COMPLETED|Overall Study||0
452419|NCT01298063|1109348|P1|NOT COMPLETED|Overall Study||0
452420|NCT01298063|1109344|P5|COMPLETED|Overall Study||8
452421|NCT01298063|1109345|P4|COMPLETED|Overall Study||8
452422|NCT01298063|1109346|P3|COMPLETED|Overall Study||8
452423|NCT01298063|1109347|P2|COMPLETED|Overall Study||3
452424|NCT01298063|1109348|P1|COMPLETED|Overall Study||8
452425|NCT01298063|1109344|P5|STARTED|Overall Study||8
452426|NCT01298063|1109345|P4|STARTED|Overall Study||8
452427|NCT01298063|1109346|P3|STARTED|Overall Study||8
452428|NCT01298063|1109347|P2|STARTED|Overall Study||3
452429|NCT01298063|1109348|P1|STARTED|Overall Study||8
452430|NCT01297920|1109378|P3|NOT COMPLETED|Overall Study||57
452431|NCT01297920|1109379|P2|NOT COMPLETED|Overall Study||27
452432|NCT01297920|1109380|P1|NOT COMPLETED|Overall Study||58
452433|NCT01297920|1109378|P3|COMPLETED|Overall Study||178
452434|NCT01297920|1109379|P2|COMPLETED|Overall Study||207
452435|NCT01297920|1109380|P1|COMPLETED|Overall Study||163
452436|NCT01297920|1109378|P3|STARTED|Overall Study||235
452437|NCT01297920|1109379|P2|STARTED|Overall Study||234
452438|NCT01297920|1109380|P1|STARTED|Overall Study||221
452439|NCT01297595|1109388|P2|NOT COMPLETED|Second Intervention Period||0
452440|NCT01297595|1109389|P1|NOT COMPLETED|Second Intervention Period||0
452441|NCT01297595|1109388|P2|COMPLETED|Second Intervention Period||11
452442|NCT01297595|1109389|P1|COMPLETED|Second Intervention Period||11
452443|NCT01297595|1109388|P2|STARTED|Second Intervention Period||11
452444|NCT01297595|1109389|P1|STARTED|Second Intervention Period||11
452445|NCT01297595|1109388|P2|NOT COMPLETED|Washout Period (At Least 14 Days)||0
452446|NCT01297595|1109389|P1|NOT COMPLETED|Washout Period (At Least 14 Days)||0
452447|NCT01297595|1109388|P2|COMPLETED|Washout Period (At Least 14 Days)||11
452448|NCT01297595|1109389|P1|COMPLETED|Washout Period (At Least 14 Days)||11
452449|NCT01297595|1109388|P2|STARTED|Washout Period (At Least 14 Days)||11
452450|NCT01297595|1109389|P1|STARTED|Washout Period (At Least 14 Days)||11
452451|NCT01297595|1109388|P2|NOT COMPLETED|First Intervention Period||0
452452|NCT01297595|1109389|P1|NOT COMPLETED|First Intervention Period||0
452453|NCT01297595|1109388|P2|COMPLETED|First Intervention Period||11
452454|NCT01297595|1109389|P1|COMPLETED|First Intervention Period||11
452455|NCT01297595|1109388|P2|STARTED|First Intervention Period||11
452456|NCT01297595|1109389|P1|STARTED|First Intervention Period||11
452457|NCT01297517|1109424|P3|NOT COMPLETED|Overall Study||27
452458|NCT01297517|1109425|P2|NOT COMPLETED|Overall Study||12
452459|NCT01297517|1109426|P1|NOT COMPLETED|Overall Study||27
452460|NCT01297517|1109424|P3|COMPLETED|Overall Study||193
452461|NCT01297517|1109425|P2|COMPLETED|Overall Study||214
452462|NCT01297517|1109426|P1|COMPLETED|Overall Study||187
452463|NCT01297517|1109424|P3|STARTED|Overall Study||220
452464|NCT01297517|1109425|P2|STARTED|Overall Study||226
452465|NCT01297517|1109426|P1|STARTED|Overall Study||214
452466|NCT01297504|1109434|P1|NOT COMPLETED|Overall Study||67
452467|NCT01297504|1109434|P1|COMPLETED|Overall Study||397
452468|NCT01297504|1109434|P1|Participants Studied|Overall Study|Six participants were eliminated due to invalid consent, previous palivizumab or no study visits|458
452469|NCT01297504|1109434|P1|STARTED|Overall Study||464
452470|NCT01297491|1109448|P2|NOT COMPLETED|Overall Study||33
452471|NCT01297491|1109449|P1|NOT COMPLETED|Overall Study||30
452472|NCT01297491|1109448|P2|COMPLETED|Overall Study||0
452473|NCT01297491|1109449|P1|COMPLETED|Overall Study||0
452474|NCT01297491|1109448|P2|STARTED|Overall Study||33
452475|NCT01297491|1109449|P1|STARTED|Overall Study||30
452476|NCT01297465|1109467|P2|NOT COMPLETED|Overall Study||10
452477|NCT01297465|1109468|P1|NOT COMPLETED|Overall Study||8
452478|NCT01297465|1109467|P2|COMPLETED|Overall Study||93
452479|NCT01297465|1109468|P1|COMPLETED|Overall Study||91
452480|NCT01297465|1109467|P2|STARTED|Overall Study||103
452481|NCT01297465|1109468|P1|STARTED|Overall Study||99
452482|NCT01297348|1109502|P2|NOT COMPLETED|Overall Study||0
452483|NCT01297348|1109503|P1|NOT COMPLETED|Overall Study||0
452484|NCT01297348|1109502|P2|COMPLETED|Overall Study||586401
452485|NCT01297348|1109503|P1|COMPLETED|Overall Study||12281
452486|NCT01297348|1109502|P2|STARTED|Overall Study||586401
452487|NCT01297348|1109503|P1|STARTED|Overall Study||12281
452488|NCT01297335|1109513|P1|NOT COMPLETED|Overall Study||0
452489|NCT01297335|1109513|P1|COMPLETED|Overall Study||10
452490|NCT01297335|1109513|P1|STARTED|Overall Study||10
452491|NCT01297322|1109521|P2|NOT COMPLETED|Overall Study||1
452492|NCT01297322|1109522|P1|NOT COMPLETED|Overall Study||1
452493|NCT01297322|1109521|P2|COMPLETED|Overall Study||274
452494|NCT01297322|1109522|P1|COMPLETED|Overall Study||141
452495|NCT01297322|1109521|P2|STARTED|Overall Study||275
452496|NCT01297322|1109522|P1|STARTED|Overall Study||142
452497|NCT01297283|1109542|P1|NOT COMPLETED|Overall Study||19
452498|NCT01297283|1109542|P1|COMPLETED|Overall Study||176
452499|NCT01297283|1109542|P1|STARTED|Overall Study||195
452500|NCT01297270|1109550|P3|NOT COMPLETED|Overall Study||29
452501|NCT01297270|1109551|P2|NOT COMPLETED|Overall Study||72
452502|NCT01297270|1109552|P1|NOT COMPLETED|Overall Study||45
452503|NCT01297270|1109550|P3|COMPLETED|Overall Study||103
452504|NCT01297270|1109551|P2|COMPLETED|Overall Study||192
452505|NCT01297270|1109552|P1|COMPLETED|Overall Study||217
452506|NCT01297270|1109550|P3|STARTED|Overall Study||132
452507|NCT01297270|1109551|P2|STARTED|Overall Study||264
452508|NCT01297270|1109552|P1|STARTED|Overall Study||262
452509|NCT01297257|1109590|P1|NOT COMPLETED|Overall Study||0
452510|NCT01297257|1109590|P1|COMPLETED|Overall Study||7740
452511|NCT01297257|1109590|P1|STARTED|Overall Study||7740
452512|NCT01297062|1109601|P7|NOT COMPLETED|Overall Study||8
452513|NCT01297062|1109602|P6|NOT COMPLETED|Overall Study||1
452514|NCT01297062|1109603|P5|NOT COMPLETED|Overall Study||2
452515|NCT01297062|1109604|P4|NOT COMPLETED|Overall Study||1
452516|NCT01297062|1109605|P3|NOT COMPLETED|Overall Study||2
452517|NCT01297062|1109606|P2|NOT COMPLETED|Overall Study||1
452518|NCT01297062|1109607|P1|NOT COMPLETED|Overall Study||4
452519|NCT01297062|1109601|P7|COMPLETED|Overall Study||0
452520|NCT01297062|1109602|P6|COMPLETED|Overall Study||13
452521|NCT01297062|1109603|P5|COMPLETED|Overall Study||13
452522|NCT01297062|1109604|P4|COMPLETED|Overall Study||13
452523|NCT01297062|1109605|P3|COMPLETED|Overall Study||12
452524|NCT01297062|1109606|P2|COMPLETED|Overall Study||13
452525|NCT01297062|1109607|P1|COMPLETED|Overall Study||11
452526|NCT01297062|1109601|P7|Evaluable Population|Overall Study||0
452527|NCT01297062|1109602|P6|Evaluable Population|Overall Study||13
452528|NCT01297062|1109603|P5|Evaluable Population|Overall Study||13
452529|NCT01297062|1109604|P4|Evaluable Population|Overall Study||13
452530|NCT01297062|1109605|P3|Evaluable Population|Overall Study||12
452531|NCT01297062|1109606|P2|Evaluable Population|Overall Study||12
452532|NCT01297062|1109607|P1|Evaluable Population|Overall Study||11
452533|NCT01297062|1109601|P7|Intent to Treat (ITT)|Overall Study||0
452534|NCT01297062|1109602|P6|Intent to Treat (ITT)|Overall Study||14
452535|NCT01297062|1109603|P5|Intent to Treat (ITT)|Overall Study||15
452536|NCT01297062|1109604|P4|Intent to Treat (ITT)|Overall Study||14
452537|NCT01297062|1109605|P3|Intent to Treat (ITT)|Overall Study||14
452538|NCT01297062|1109606|P2|Intent to Treat (ITT)|Overall Study||14
452539|NCT01297062|1109607|P1|Intent to Treat (ITT)|Overall Study||15
452540|NCT01297062|1109601|P7|STARTED|Overall Study||8
452541|NCT01297062|1109602|P6|STARTED|Overall Study||14
452542|NCT01297062|1109603|P5|STARTED|Overall Study||15
452543|NCT01297062|1109604|P4|STARTED|Overall Study||14
452544|NCT01297062|1109605|P3|STARTED|Overall Study||14
452545|NCT01297062|1109606|P2|STARTED|Overall Study||14
452546|NCT01297062|1109607|P1|STARTED|Overall Study||15
452547|NCT01296841|1109631|P2|NOT COMPLETED|Overall Study||0
452548|NCT01296841|1109632|P1|NOT COMPLETED|Overall Study||0
452549|NCT01296841|1109631|P2|COMPLETED|Overall Study||15
452550|NCT01296841|1109632|P1|COMPLETED|Overall Study||19
452551|NCT01296841|1109631|P2|STARTED|Overall Study||15
452552|NCT01296841|1109632|P1|STARTED|Overall Study||19
452553|NCT01296815|1109644|P2|NOT COMPLETED|Overall Study||0
452554|NCT01296815|1109645|P1|NOT COMPLETED|Overall Study||0
452555|NCT01296815|1109644|P2|COMPLETED|Overall Study||7
452556|NCT01296815|1109645|P1|COMPLETED|Overall Study||7
452557|NCT01296815|1109644|P2|STARTED|Overall Study||7
452558|NCT01296815|1109645|P1|STARTED|Overall Study||7
452559|NCT01296763|1109654|P3|NOT COMPLETED|Overall Study||0
452560|NCT01296763|1109655|P2|NOT COMPLETED|Overall Study||0
452561|NCT01296763|1109656|P1|NOT COMPLETED|Overall Study||0
452562|NCT01296763|1109654|P3|COMPLETED|Overall Study||6
452563|NCT01296763|1109655|P2|COMPLETED|Overall Study||5
452564|NCT01296763|1109656|P1|COMPLETED|Overall Study||7
452565|NCT01296763|1109654|P3|STARTED|Overall Study||6
452566|NCT01296763|1109655|P2|STARTED|Overall Study||5
452567|NCT01296763|1109656|P1|STARTED|Overall Study||7
452568|NCT01296698|1109669|P2|NOT COMPLETED|Overall Study||13
452569|NCT01296698|1109670|P1|NOT COMPLETED|Overall Study||244
452570|NCT01296698|1109669|P2|COMPLETED|Overall Study||0
452571|NCT01296698|1109670|P1|COMPLETED|Overall Study||0
452572|NCT01296698|1109669|P2|STARTED|Overall Study||13
452573|NCT01296698|1109670|P1|STARTED|Overall Study||244
452574|NCT01296672|1109724|P2|NOT COMPLETED|Overall Study||18
452575|NCT01296672|1109725|P1|NOT COMPLETED|Overall Study||73
452576|NCT01296672|1109724|P2|COMPLETED|Overall Study||59
452577|NCT01296672|1109725|P1|COMPLETED|Overall Study||233
452578|NCT01296672|1109724|P2|STARTED|Overall Study||77
452579|NCT01296672|1109725|P1|STARTED|Overall Study||306
452580|NCT01296646|1109737|P2|NOT COMPLETED|Overall Study||11
452581|NCT01296646|1109738|P1|NOT COMPLETED|Overall Study||11
452582|NCT01296646|1109737|P2|COMPLETED|Overall Study||29
452583|NCT01296646|1109738|P1|COMPLETED|Overall Study||29
452584|NCT01296646|1109737|P2|STARTED|Overall Study||40
452585|NCT01296646|1109738|P1|STARTED|Overall Study||40
452586|NCT01296412|1109748|P2|NOT COMPLETED|Overall Study||70
452587|NCT01296412|1109749|P1|NOT COMPLETED|Overall Study||51
452588|NCT01296412|1109748|P2|COMPLETED|Overall Study||257
452589|NCT01296412|1109749|P1|COMPLETED|Overall Study||275
452590|NCT01296412|1109748|P2|STARTED|Overall Study||327
452591|NCT01296412|1109749|P1|STARTED|Overall Study||326
452592|NCT01296360|1109763|P2|NOT COMPLETED|Overall Study||8
452593|NCT01296360|1109764|P1|NOT COMPLETED|Overall Study||6
452594|NCT01296360|1109763|P2|COMPLETED|Overall Study||142
452595|NCT01296360|1109764|P1|COMPLETED|Overall Study||144
452596|NCT01296360|1109763|P2|Visit 2a (Month 13)|Overall Study||0
452597|NCT01296360|1109764|P1|Visit 2a (Month 13)|Overall Study|visit in Booster Group only: ~13 months after immunization in IC51-323 (i.e., 1 month post booster)|148
452598|NCT01296360|1109763|P2|Visit 2 (Month 12)|Overall Study||149
452599|NCT01296360|1109764|P1|Visit 2 (Month 12)|Overall Study|booster was administered|148
452600|NCT01296360|1109763|P2|STARTED|Overall Study||150
452601|NCT01296360|1109764|P1|STARTED|Overall Study||150
452602|NCT01296347|1109772|P2|NOT COMPLETED|Overall Study||5
452603|NCT01296347|1109773|P1|NOT COMPLETED|Overall Study||0
452604|NCT01296347|1109772|P2|COMPLETED|Overall Study||47
452605|NCT01296347|1109773|P1|COMPLETED|Overall Study||52
452606|NCT01296347|1109772|P2|6 Weeks Afer Surgery|Overall Study||47
452607|NCT01296347|1109773|P1|6 Weeks Afer Surgery|Overall Study||52
452608|NCT01296347|1109772|P2|STARTED|Overall Study||52
452609|NCT01296347|1109773|P1|STARTED|Overall Study||52
452610|NCT01296152|1109779|P1|NOT COMPLETED|Overall Study||1
452611|NCT01296152|1109779|P1|COMPLETED|Overall Study||24
452612|NCT01296152|1109779|P1|STARTED|Overall Study||25
452613|NCT01296035|1109806|P1|NOT COMPLETED|Overall Study||1
452614|NCT01296035|1109806|P1|COMPLETED|Overall Study||7
452615|NCT01296035|1109806|P1|STARTED|Overall Study||8
452616|NCT01295905|1109813|P2|NOT COMPLETED|Overall Study||0
452617|NCT01295905|1109814|P1|NOT COMPLETED|Overall Study||2
452618|NCT01295905|1109813|P2|COMPLETED|Overall Study||30
452619|NCT01295905|1109814|P1|COMPLETED|Overall Study||58
452620|NCT01295905|1109813|P2|STARTED|Overall Study||30
452621|NCT01295905|1109814|P1|STARTED|Overall Study||60
452622|NCT01295879|1109826|P1|NOT COMPLETED|Overall Study||0
452623|NCT01295879|1109826|P1|COMPLETED|Overall Study||29
452624|NCT01295879|1109826|P1|STARTED|Overall Study||29
452625|NCT01295840|1109832|P1|NOT COMPLETED|Overall Study||1
452626|NCT01295840|1109832|P1|COMPLETED|Overall Study||50
452627|NCT01295840|1109832|P1|STARTED|Overall Study||51
452628|NCT01295814|1109848|P2|NOT COMPLETED|Overall Study||2
452629|NCT01295814|1109849|P1|NOT COMPLETED|Overall Study||2
452630|NCT01295814|1109848|P2|COMPLETED|Overall Study||19
452631|NCT01295814|1109849|P1|COMPLETED|Overall Study||20
452632|NCT01295814|1109848|P2|STARTED|Overall Study||21
452633|NCT01295814|1109849|P1|STARTED|Overall Study||22
452634|NCT01295671|1109866|P3|NOT COMPLETED|Overall Study||3
452635|NCT01295671|1109867|P2|NOT COMPLETED|Overall Study||7
452636|NCT01295671|1109868|P1|NOT COMPLETED|Overall Study||7
452637|NCT01295671|1109866|P3|COMPLETED|Overall Study||66
452638|NCT01295671|1109867|P2|COMPLETED|Overall Study||60
452639|NCT01295671|1109868|P1|COMPLETED|Overall Study||60
452640|NCT01295671|1109866|P3|STARTED|Overall Study||69
452641|NCT01295671|1109867|P2|STARTED|Overall Study||67
452642|NCT01295671|1109868|P1|STARTED|Overall Study||67
452643|NCT01295320|1109906|P1|NOT COMPLETED|Overall Study||10
452644|NCT01295320|1109906|P1|COMPLETED|Overall Study||119
452645|NCT01295320|1109906|P1|STARTED|Overall Study||129
452646|NCT01295281|1109923|P2|NOT COMPLETED|Second Intervention (7days)||0
452647|NCT01295281|1109924|P1|NOT COMPLETED|Second Intervention (7days)||0
452648|NCT01295281|1109923|P2|COMPLETED|Second Intervention (7days)||51
452649|NCT01295281|1109924|P1|COMPLETED|Second Intervention (7days)||53
452650|NCT01295281|1109923|P2|STARTED|Second Intervention (7days)||51
452651|NCT01295281|1109924|P1|STARTED|Second Intervention (7days)||53
452652|NCT01295281|1109923|P2|NOT COMPLETED|First Intervention (7 Days)||1
452653|NCT01295281|1109924|P1|NOT COMPLETED|First Intervention (7 Days)||0
452654|NCT01295281|1109923|P2|COMPLETED|First Intervention (7 Days)||51
452655|NCT01295281|1109924|P1|COMPLETED|First Intervention (7 Days)||53
452656|NCT01295281|1109923|P2|STARTED|First Intervention (7 Days)||52
452657|NCT01295281|1109924|P1|STARTED|First Intervention (7 Days)||53
452658|NCT01295216|1109932|P2|NOT COMPLETED|Overall Study||34
452659|NCT01295216|1109933|P1|NOT COMPLETED|Overall Study||50
452660|NCT01295216|1109932|P2|COMPLETED|Overall Study||287
452661|NCT01295216|1109933|P1|COMPLETED|Overall Study||266
452662|NCT01295216|1109932|P2|STARTED|Overall Study||321
452663|NCT01295216|1109933|P1|STARTED|Overall Study||316
452664|NCT01295112|1109951|P2|NOT COMPLETED|Overall Study||0
452665|NCT01295112|1109952|P1|NOT COMPLETED|Overall Study||0
452666|NCT01295112|1109951|P2|COMPLETED|Overall Study||33
452667|NCT01295112|1109952|P1|COMPLETED|Overall Study||35
452668|NCT01295112|1109951|P2|STARTED|Overall Study||33
452669|NCT01295112|1109952|P1|STARTED|Overall Study||35
452670|NCT01295034|1109962|P2|NOT COMPLETED|Overall Study||5
452671|NCT01295034|1109963|P1|NOT COMPLETED|Overall Study||5
452672|NCT01295034|1109962|P2|COMPLETED|Overall Study||25
452673|NCT01295034|1109963|P1|COMPLETED|Overall Study||27
452674|NCT01295034|1109962|P2|STARTED|Overall Study||30
452675|NCT01295034|1109963|P1|STARTED|Overall Study||32
452676|NCT01294917|1109971|P1|NOT COMPLETED|Overall Study||6
452677|NCT01294917|1109971|P1|COMPLETED|Overall Study||36
452678|NCT01294917|1109971|P1|Received OptiFree RepleniSH MPS|Overall Study||36
452679|NCT01294917|1109971|P1|Received Clear Care|Overall Study||36
452680|NCT01294917|1109971|P1|Received Investigational MPS|Overall Study||36
452681|NCT01294917|1109971|P1|STARTED|Overall Study||42
452682|NCT01294800|1109981|P4|NOT COMPLETED|Overall Study||16
452683|NCT01294800|1109982|P3|NOT COMPLETED|Overall Study||17
452684|NCT01294800|1109983|P2|NOT COMPLETED|Overall Study||10
452685|NCT01294800|1109984|P1|NOT COMPLETED|Overall Study||11
452686|NCT01294800|1109981|P4|COMPLETED|Overall Study||97
452687|NCT01294800|1109982|P3|COMPLETED|Overall Study||96
452688|NCT01294800|1109983|P2|COMPLETED|Overall Study||103
452689|NCT01294800|1109984|P1|COMPLETED|Overall Study||100
452690|NCT01294800|1109981|P4|STARTED|Overall Study||113
452691|NCT01294800|1109982|P3|STARTED|Overall Study||113
452692|NCT01294800|1109983|P2|STARTED|Overall Study||113
452693|NCT01294800|1109984|P1|STARTED|Overall Study||111
452694|NCT01294787|1110010|P6|NOT COMPLETED|Period 3||0
452695|NCT01294787|1110011|P5|NOT COMPLETED|Period 3||1
452696|NCT01294787|1110012|P4|NOT COMPLETED|Period 3||0
452697|NCT01294787|1110013|P3|NOT COMPLETED|Period 3||0
452698|NCT01294787|1110014|P2|NOT COMPLETED|Period 3||0
452699|NCT01294787|1110015|P1|NOT COMPLETED|Period 3||0
452700|NCT01294787|1110010|P6|COMPLETED|Period 3||13
452701|NCT01294787|1110011|P5|COMPLETED|Period 3||13
452702|NCT01294787|1110012|P4|COMPLETED|Period 3||9
452703|NCT01294787|1110013|P3|COMPLETED|Period 3||13
452704|NCT01294787|1110014|P2|COMPLETED|Period 3||13
452705|NCT01294787|1110015|P1|COMPLETED|Period 3||12
452706|NCT01294787|1110010|P6|STARTED|Period 3||13
452707|NCT01294787|1110011|P5|STARTED|Period 3||14
452708|NCT01294787|1110012|P4|STARTED|Period 3||9
452709|NCT01294787|1110013|P3|STARTED|Period 3||13
452710|NCT01294787|1110014|P2|STARTED|Period 3||13
452711|NCT01294787|1110015|P1|STARTED|Period 3||12
452712|NCT01294787|1110010|P6|NOT COMPLETED|Period 2||0
452713|NCT01294787|1110011|P5|NOT COMPLETED|Period 2||0
452714|NCT01294787|1110012|P4|NOT COMPLETED|Period 2||2
452715|NCT01294787|1110013|P3|NOT COMPLETED|Period 2||0
452716|NCT01294787|1110014|P2|NOT COMPLETED|Period 2||3
452717|NCT01294787|1110015|P1|NOT COMPLETED|Period 2||0
452718|NCT01294787|1110010|P6|COMPLETED|Period 2||13
452719|NCT01294787|1110011|P5|COMPLETED|Period 2||14
452720|NCT01294787|1110012|P4|COMPLETED|Period 2||9
452721|NCT01294787|1110013|P3|COMPLETED|Period 2||13
452722|NCT01294787|1110014|P2|COMPLETED|Period 2||13
452723|NCT01294787|1110015|P1|COMPLETED|Period 2||12
452724|NCT01294787|1110010|P6|STARTED|Period 2||13
452725|NCT01294787|1110011|P5|STARTED|Period 2||14
452726|NCT01294787|1110012|P4|STARTED|Period 2||11
452727|NCT01294787|1110013|P3|STARTED|Period 2||13
452728|NCT01294787|1110014|P2|STARTED|Period 2||16
452729|NCT01294787|1110015|P1|STARTED|Period 2||12
452730|NCT01294787|1110010|P6|NOT COMPLETED|Period 1||2
452731|NCT01294787|1110011|P5|NOT COMPLETED|Period 1||2
452732|NCT01294787|1110012|P4|NOT COMPLETED|Period 1||1
452733|NCT01294787|1110013|P3|NOT COMPLETED|Period 1||1
452734|NCT01294787|1110014|P2|NOT COMPLETED|Period 1||0
452735|NCT01294787|1110015|P1|NOT COMPLETED|Period 1||0
452736|NCT01294787|1110010|P6|COMPLETED|Period 1||13
452737|NCT01294787|1110011|P5|COMPLETED|Period 1||14
452738|NCT01294787|1110012|P4|COMPLETED|Period 1||11
452739|NCT01294787|1110013|P3|COMPLETED|Period 1||13
452740|NCT01294787|1110014|P2|COMPLETED|Period 1||16
452741|NCT01294787|1110015|P1|COMPLETED|Period 1||12
452742|NCT01294787|1110010|P6|STARTED|Period 1|One randomized participant did not receive study drug|15
452743|NCT01294787|1110011|P5|STARTED|Period 1||16
452744|NCT01294787|1110012|P4|STARTED|Period 1||12
452745|NCT01294787|1110013|P3|STARTED|Period 1||14
452746|NCT01294787|1110014|P2|STARTED|Period 1||16
452747|NCT01294787|1110015|P1|STARTED|Period 1||12
452748|NCT01294748|1110059|P2|NOT COMPLETED|Overall Study||2
452749|NCT01294748|1110060|P1|NOT COMPLETED|Overall Study||5
452750|NCT01294748|1110059|P2|COMPLETED|Overall Study|At 270 days|59
452751|NCT01294748|1110060|P1|COMPLETED|Overall Study|At 270 days|118
452752|NCT01294748|1110059|P2|STARTED|Overall Study||61
452753|NCT01294748|1110060|P1|STARTED|Overall Study||123
452754|NCT01294709|1110086|P2|NOT COMPLETED|Period 2||0
452755|NCT01294709|1110087|P1|NOT COMPLETED|Period 2||1
452756|NCT01294709|1110086|P2|COMPLETED|Period 2||31
452757|NCT01294709|1110087|P1|COMPLETED|Period 2||28
452758|NCT01294709|1110086|P2|STARTED|Period 2||31
452759|NCT01294709|1110087|P1|STARTED|Period 2||29
452760|NCT01294709|1110086|P2|NOT COMPLETED|Washout Period||1
452761|NCT01294709|1110087|P1|NOT COMPLETED|Washout Period||1
452762|NCT01294709|1110086|P2|COMPLETED|Washout Period||31
452763|NCT01294709|1110087|P1|COMPLETED|Washout Period||29
452764|NCT01294709|1110086|P2|STARTED|Washout Period||32
452765|NCT01294709|1110087|P1|STARTED|Washout Period||30
452766|NCT01294709|1110086|P2|NOT COMPLETED|Period 1||1
452767|NCT01294709|1110087|P1|NOT COMPLETED|Period 1||1
452768|NCT01294709|1110086|P2|COMPLETED|Period 1||32
452769|NCT01294709|1110087|P1|COMPLETED|Period 1||30
452770|NCT01294709|1110086|P2|STARTED|Period 1||33
452771|NCT01294709|1110087|P1|STARTED|Period 1||31
452772|NCT01294696|1110106|P1|NOT COMPLETED|Overall Study||74
452773|NCT01294696|1110106|P1|COMPLETED|Overall Study||1187
452774|NCT01294696|1110106|P1|STARTED|Overall Study||1261
452775|NCT01294683|1110120|P2|NOT COMPLETED|Post Crossover (Period III)||32
452776|NCT01294683|1110121|P1|NOT COMPLETED|Post Crossover (Period III)||33
452777|NCT01294683|1110120|P2|COMPLETED|Post Crossover (Period III)||190
452778|NCT01294683|1110121|P1|COMPLETED|Post Crossover (Period III)||199
452779|NCT01294683|1110120|P2|STARTED|Post Crossover (Period III)||222
452780|NCT01294683|1110121|P1|STARTED|Post Crossover (Period III)||232
452781|NCT01294683|1110120|P2|NOT COMPLETED|Precrossover (Periods I/II)||266
452782|NCT01294683|1110121|P1|NOT COMPLETED|Precrossover (Periods I/II)||257
452783|NCT01294683|1110120|P2|COMPLETED|Precrossover (Periods I/II)||222
452784|NCT01294683|1110121|P1|COMPLETED|Precrossover (Periods I/II)||232
452785|NCT01294683|1110120|P2|Treated|Precrossover (Periods I/II)||486
452786|NCT01294683|1110121|P1|Treated|Precrossover (Periods I/II)||486
452787|NCT01294683|1110120|P2|STARTED|Precrossover (Periods I/II)||488
452788|NCT01294683|1110121|P1|STARTED|Precrossover (Periods I/II)||489
452789|NCT01294644|1110174|P3|NOT COMPLETED|Overall Study||14
452790|NCT01294644|1110175|P2|NOT COMPLETED|Overall Study||10
452791|NCT01294644|1110176|P1|NOT COMPLETED|Overall Study||10
452792|NCT01294644|1110174|P3|COMPLETED|Overall Study||103
452793|NCT01294644|1110175|P2|COMPLETED|Overall Study||112
452794|NCT01294644|1110176|P1|COMPLETED|Overall Study||111
452795|NCT01294644|1110174|P3|Received Treatment|Overall Study||114
452796|NCT01294644|1110175|P2|Received Treatment|Overall Study||122
452797|NCT01294644|1110176|P1|Received Treatment|Overall Study||118
452798|NCT01294644|1110174|P3|STARTED|Overall Study||117
452799|NCT01294644|1110175|P2|STARTED|Overall Study||122
452800|NCT01294644|1110176|P1|STARTED|Overall Study||121
452801|NCT01294592|1110207|P2|NOT COMPLETED|Overall Study||73
452802|NCT01294592|1110208|P1|NOT COMPLETED|Overall Study||77
452803|NCT01294592|1110207|P2|COMPLETED|Overall Study||300
452804|NCT01294592|1110208|P1|COMPLETED|Overall Study||292
452805|NCT01294592|1110207|P2|STARTED|Overall Study||373
452806|NCT01294592|1110208|P1|STARTED|Overall Study||369
452807|NCT01294553|1110236|P1|NOT COMPLETED|Overall Study||269
452808|NCT01294553|1110236|P1|COMPLETED|Overall Study||713
452809|NCT01294553|1110236|P1|STARTED|Overall Study||982
452810|NCT01294514|1110242|P1|NOT COMPLETED|Overall Study||1
452811|NCT01294514|1110242|P1|COMPLETED|Overall Study||26
452812|NCT01294514|1110242|P1|STARTED|Overall Study||27
452813|NCT01294462|1110252|P2|NOT COMPLETED|Overall Study||63
452814|NCT01294462|1110253|P1|NOT COMPLETED|Overall Study||66
452815|NCT01294462|1110252|P2|COMPLETED|Overall Study||337
452816|NCT01294462|1110253|P1|COMPLETED|Overall Study||335
452817|NCT01294462|1110252|P2|Received Randomized Treatment|Overall Study||380
452818|NCT01294462|1110253|P1|Received Randomized Treatment|Overall Study||387
452819|NCT01294462|1110252|P2|STARTED|Overall Study||400
452820|NCT01294462|1110253|P1|STARTED|Overall Study||401
452821|NCT01294449|1110267|P2|NOT COMPLETED|Overall Study||15
452822|NCT01294449|1110268|P1|NOT COMPLETED|Overall Study||12
452823|NCT01294449|1110267|P2|COMPLETED|Overall Study||237
452824|NCT01294449|1110268|P1|COMPLETED|Overall Study||144
452825|NCT01294449|1110267|P2|Consent to Registry|Overall Study||245
452826|NCT01294449|1110268|P1|Consent to Registry|Overall Study||149
452827|NCT01294449|1110267|P2|STARTED|Overall Study||252
452828|NCT01294449|1110268|P1|STARTED|Overall Study||156
452829|NCT01294436|1110276|P2|NOT COMPLETED|Overall Study||70
452830|NCT01294436|1110277|P1|NOT COMPLETED|Overall Study||28
452831|NCT01294436|1110276|P2|COMPLETED|Overall Study||409
452832|NCT01294436|1110277|P1|COMPLETED|Overall Study||221
452833|NCT01294436|1110276|P2|STARTED|Overall Study||479
452834|NCT01294436|1110277|P1|STARTED|Overall Study||249
452835|NCT01294423|1110312|P3|NOT COMPLETED|Overall Study||8
452836|NCT01294423|1110313|P2|NOT COMPLETED|Overall Study||9
452837|NCT01294423|1110314|P1|NOT COMPLETED|Overall Study||5
452838|NCT01294423|1110312|P3|COMPLETED|Overall Study||79
452839|NCT01294423|1110313|P2|COMPLETED|Overall Study||79
452840|NCT01294423|1110314|P1|COMPLETED|Overall Study||81
452841|NCT01294423|1110312|P3|STARTED|Overall Study||87
452842|NCT01294423|1110313|P2|STARTED|Overall Study||88
452843|NCT01294423|1110314|P1|STARTED|Overall Study||86
452844|NCT01294397|1110328|P1|NOT COMPLETED|Overall Study||2
452845|NCT01294397|1110328|P1|COMPLETED|Overall Study||17
452846|NCT01294397|1110328|P1|STARTED|Overall Study||19
452847|NCT01294384|1110341|P3|NOT COMPLETED|Overall Study||9
452848|NCT01294384|1110342|P2|NOT COMPLETED|Overall Study||6
452849|NCT01294384|1110343|P1|NOT COMPLETED|Overall Study||4
452850|NCT01294384|1110341|P3|COMPLETED|Overall Study||95
452851|NCT01294384|1110342|P2|COMPLETED|Overall Study||94
452852|NCT01294384|1110343|P1|COMPLETED|Overall Study||97
452853|NCT01294384|1110341|P3|STARTED|Overall Study||104
452854|NCT01294384|1110342|P2|STARTED|Overall Study||100
452855|NCT01294384|1110343|P1|STARTED|Overall Study||101
452856|NCT01294371|1110372|P1|NOT COMPLETED|Overall Study||34
452857|NCT01294371|1110372|P1|COMPLETED|Overall Study||357
452858|NCT01294371|1110372|P1|Treated|Overall Study||390
452859|NCT01294371|1110372|P1|STARTED|Overall Study||391
452860|NCT01294319|1110388|P8|NOT COMPLETED|Overall Study||0
452861|NCT01294319|1110389|P7|NOT COMPLETED|Overall Study||0
452862|NCT01294319|1110390|P6|NOT COMPLETED|Overall Study||0
452863|NCT01294319|1110391|P5|NOT COMPLETED|Overall Study||0
452864|NCT01294319|1110392|P4|NOT COMPLETED|Overall Study||0
452865|NCT01294319|1110393|P3|NOT COMPLETED|Overall Study||0
452866|NCT01294319|1110394|P2|NOT COMPLETED|Overall Study||0
452867|NCT01294319|1110395|P1|NOT COMPLETED|Overall Study||0
452868|NCT01294319|1110388|P8|COMPLETED|Overall Study||5
452869|NCT01294319|1110389|P7|COMPLETED|Overall Study||5
452870|NCT01294319|1110390|P6|COMPLETED|Overall Study||4
452871|NCT01294319|1110391|P5|COMPLETED|Overall Study||5
452872|NCT01294319|1110392|P4|COMPLETED|Overall Study||5
452873|NCT01294319|1110393|P3|COMPLETED|Overall Study||5
452874|NCT01294319|1110394|P2|COMPLETED|Overall Study||6
452875|NCT01294319|1110395|P1|COMPLETED|Overall Study||4
452876|NCT01294319|1110388|P8|STARTED|Overall Study||5
452877|NCT01294319|1110389|P7|STARTED|Overall Study||5
452878|NCT01294319|1110390|P6|STARTED|Overall Study||4
452879|NCT01294319|1110391|P5|STARTED|Overall Study||5
452880|NCT01294319|1110392|P4|STARTED|Overall Study||5
452881|NCT01294319|1110393|P3|STARTED|Overall Study||5
452882|NCT01294319|1110394|P2|STARTED|Overall Study||6
452883|NCT01294319|1110395|P1|STARTED|Overall Study||4
452884|NCT01294306|1110405|P2|NOT COMPLETED|Overall Study||0
452885|NCT01294306|1110406|P1|NOT COMPLETED|Overall Study||0
452886|NCT01294306|1110405|P2|COMPLETED|Overall Study||35
452887|NCT01294306|1110406|P1|COMPLETED|Overall Study||45
452888|NCT01294306|1110405|P2|STARTED|Overall Study||35
452889|NCT01294306|1110406|P1|STARTED|Overall Study||45
452890|NCT01294267|1110420|P1|NOT COMPLETED|Overall Study||0
452891|NCT01294267|1110420|P1|COMPLETED|Overall Study||20
452892|NCT01294267|1110420|P1|STARTED|Overall Study||20
452893|NCT01294241|1110426|P1|NOT COMPLETED|Overall Study||0
452894|NCT01294241|1110426|P1|COMPLETED|Overall Study||10
452895|NCT01294241|1110426|P1|STARTED|Overall Study||10
452896|NCT01294228|1110434|P1|NOT COMPLETED|Overall Study||0
452897|NCT01294228|1110434|P1|COMPLETED|Overall Study||1001
452898|NCT01294228|1110434|P1|STARTED|Overall Study||1001
452899|NCT01294163|1110441|P3|NOT COMPLETED|Overall Study||3
452900|NCT01294163|1110442|P2|NOT COMPLETED|Overall Study||0
452901|NCT01294163|1110443|P1|NOT COMPLETED|Overall Study||1
452902|NCT01294163|1110441|P3|COMPLETED|Overall Study||163
452903|NCT01294163|1110442|P2|COMPLETED|Overall Study||165
452904|NCT01294163|1110443|P1|COMPLETED|Overall Study||177
452905|NCT01294163|1110441|P3|STARTED|Overall Study||166
452906|NCT01294163|1110442|P2|STARTED|Overall Study||165
452907|NCT01294163|1110443|P1|STARTED|Overall Study||178
452908|NCT01294150|1110454|P2|NOT COMPLETED|Overall Study||2
452909|NCT01294150|1110455|P1|NOT COMPLETED|Overall Study||2
452910|NCT01294150|1110454|P2|COMPLETED|Overall Study||64
452911|NCT01294150|1110455|P1|COMPLETED|Overall Study||138
452912|NCT01294150|1110454|P2|STARTED|Overall Study||66
452913|NCT01294150|1110455|P1|STARTED|Overall Study||140
452914|NCT01294098|1110468|P3|NOT COMPLETED|Overall Study||1
452915|NCT01294098|1110469|P2|NOT COMPLETED|Overall Study||1
452916|NCT01294098|1110470|P1|NOT COMPLETED|Overall Study||0
452917|NCT01294098|1110468|P3|COMPLETED|Overall Study||0
452918|NCT01294098|1110469|P2|COMPLETED|Overall Study||0
452919|NCT01294098|1110470|P1|COMPLETED|Overall Study||0
452920|NCT01294098|1110468|P3|STARTED|Overall Study||1
452921|NCT01294098|1110469|P2|STARTED|Overall Study||1
452922|NCT01294098|1110470|P1|STARTED|Overall Study||0
452923|NCT01294046|1110484|P1|NOT COMPLETED|Overall Study||3
452924|NCT01294046|1110484|P1|COMPLETED|Overall Study||0
452925|NCT01294046|1110484|P1|STARTED|Overall Study||3
452926|NCT01293968|1110499|P2|NOT COMPLETED|Overall Study||3
452927|NCT01293968|1110500|P1|NOT COMPLETED|Overall Study||3
452928|NCT01293968|1110499|P2|COMPLETED|Overall Study||14
452929|NCT01293968|1110500|P1|COMPLETED|Overall Study||17
452930|NCT01293968|1110499|P2|STARTED|Overall Study||17
452931|NCT01293968|1110500|P1|STARTED|Overall Study||20
452932|NCT01293825|1110506|P1|NOT COMPLETED|Overall Study||10
452933|NCT01293825|1110506|P1|COMPLETED|Overall Study||20
452934|NCT01293825|1110506|P1|STARTED|Overall Study||30
452935|NCT01293695|1110520|P2|NOT COMPLETED|Overall Study||7
452936|NCT01293695|1110521|P1|NOT COMPLETED|Overall Study||15
452937|NCT01293695|1110520|P2|COMPLETED|Overall Study||87
452938|NCT01293695|1110521|P1|COMPLETED|Overall Study||78
452939|NCT01293695|1110520|P2|STARTED|Overall Study||94
452940|NCT01293695|1110521|P1|STARTED|Overall Study||93
452941|NCT01293539|1110535|P1|NOT COMPLETED|Overall Study||1
452942|NCT01293539|1110535|P1|COMPLETED|Overall Study||9
452943|NCT01293539|1110535|P1|STARTED|Overall Study||10
452944|NCT01293240|1110539|P1|NOT COMPLETED|Overall Study||2
452945|NCT01293240|1110539|P1|COMPLETED|Overall Study||115
452946|NCT01293240|1110539|P1|STARTED|Overall Study||117
452947|NCT01293084|1110554|P1|NOT COMPLETED|Overall Study||5
452948|NCT01293084|1110554|P1|COMPLETED|Overall Study||12
452949|NCT01293084|1110554|P1|STARTED|Overall Study||17
452950|NCT01293032|1110566|P4|NOT COMPLETED|Treatment||1
452951|NCT01293032|1110567|P3|NOT COMPLETED|Treatment||1
452952|NCT01293032|1110568|P2|NOT COMPLETED|Treatment||5
452953|NCT01293032|1110569|P1|NOT COMPLETED|Treatment||2
452954|NCT01293032|1110566|P4|COMPLETED|Treatment||13
452955|NCT01293032|1110567|P3|COMPLETED|Treatment||10
452956|NCT01293032|1110568|P2|COMPLETED|Treatment||14
452957|NCT01293032|1110569|P1|COMPLETED|Treatment||10
452958|NCT01293032|1110566|P4|STARTED|Treatment||14
452959|NCT01293032|1110567|P3|STARTED|Treatment||11
452960|NCT01293032|1110568|P2|STARTED|Treatment|2/5 subjects who refused Arm 2(chemo) were treated with Arm 1(hormonal) and evaluable for response.|19
452961|NCT01293032|1110569|P1|STARTED|Treatment||12
452962|NCT01293032|1110566|P4|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
452963|NCT01293032|1110567|P3|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||5
452964|NCT01293032|1110568|P2|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
452965|NCT01293032|1110569|P1|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
452966|NCT01293032|1110566|P4|COMPLETED|Recurrence Score(RS)Assigned/Randomized||14
452967|NCT01293032|1110567|P3|COMPLETED|Recurrence Score(RS)Assigned/Randomized|2/5 subjects who refused Arm 2(chemo) were treated with Arm 1(hormonal) and evaluable for response.|11
452968|NCT01293032|1110568|P2|COMPLETED|Recurrence Score(RS)Assigned/Randomized||17
452969|NCT01293032|1110569|P1|COMPLETED|Recurrence Score(RS)Assigned/Randomized||12
452970|NCT01293032|1110566|P4|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||14
452971|NCT01293032|1110567|P3|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||16
452972|NCT01293032|1110568|P2|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||17
452973|NCT01293032|1110569|P1|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||12
452974|NCT01293032|1110566|P4|STARTED|Recurrence Score(RS)Assigned/Randomized||14
452975|NCT01293032|1110567|P3|STARTED|Recurrence Score(RS)Assigned/Randomized||16
452976|NCT01293032|1110568|P2|STARTED|Recurrence Score(RS)Assigned/Randomized||17
452977|NCT01293032|1110569|P1|STARTED|Recurrence Score(RS)Assigned/Randomized||12
452978|NCT01293006|1110580|P4|NOT COMPLETED|Period 2||0
452979|NCT01293006|1110581|P3|NOT COMPLETED|Period 2||0
452980|NCT01293006|1110582|P2|NOT COMPLETED|Period 2||0
452981|NCT01293006|1110583|P1|NOT COMPLETED|Period 2||1
452982|NCT01293006|1110580|P4|COMPLETED|Period 2||3
452983|NCT01293006|1110581|P3|COMPLETED|Period 2||9
452984|NCT01293006|1110582|P2|COMPLETED|Period 2||2
452985|NCT01293006|1110583|P1|COMPLETED|Period 2||10
452986|NCT01293006|1110580|P4|STARTED|Period 2||3
452987|NCT01293006|1110581|P3|STARTED|Period 2||9
452988|NCT01293006|1110582|P2|STARTED|Period 2||2
452989|NCT01293006|1110583|P1|STARTED|Period 2||11
452990|NCT01293006|1110580|P4|NOT COMPLETED|Washout||0
452991|NCT01293006|1110581|P3|NOT COMPLETED|Washout||0
452992|NCT01293006|1110582|P2|NOT COMPLETED|Washout||0
452993|NCT01293006|1110583|P1|NOT COMPLETED|Washout||0
452994|NCT01293006|1110580|P4|COMPLETED|Washout||3
452995|NCT01293006|1110581|P3|COMPLETED|Washout||9
452996|NCT01293006|1110582|P2|COMPLETED|Washout||2
452997|NCT01293006|1110583|P1|COMPLETED|Washout||11
452998|NCT01293006|1110580|P4|STARTED|Washout||3
452999|NCT01293006|1110581|P3|STARTED|Washout||9
453000|NCT01293006|1110582|P2|STARTED|Washout||2
453001|NCT01293006|1110583|P1|STARTED|Washout||11
453002|NCT01293006|1110580|P4|NOT COMPLETED|Period 1||0
453003|NCT01293006|1110581|P3|NOT COMPLETED|Period 1||0
453004|NCT01293006|1110582|P2|NOT COMPLETED|Period 1||0
453005|NCT01293006|1110583|P1|NOT COMPLETED|Period 1||0
453006|NCT01293006|1110580|P4|COMPLETED|Period 1||3
453007|NCT01293006|1110581|P3|COMPLETED|Period 1||9
453008|NCT01293006|1110582|P2|COMPLETED|Period 1||2
453009|NCT01293006|1110583|P1|COMPLETED|Period 1||11
453010|NCT01293006|1110580|P4|STARTED|Period 1||3
453011|NCT01293006|1110581|P3|STARTED|Period 1||9
453012|NCT01293006|1110582|P2|STARTED|Period 1||2
453013|NCT01293006|1110583|P1|STARTED|Period 1||11
453014|NCT01292928|1110604|P1|NOT COMPLETED|Overall Study||24
453015|NCT01292928|1110604|P1|COMPLETED|Overall Study||275
453016|NCT01292928|1110604|P1|Completed 12-Month Clinical Follow-up|Overall Study||266
453017|NCT01292928|1110604|P1|STARTED|Overall Study||299
453018|NCT01292876|1110621|P1|NOT COMPLETED|Overall Study||4
453019|NCT01292876|1110621|P1|COMPLETED|Overall Study||13
453020|NCT01292876|1110621|P1|STARTED|Overall Study||17
453021|NCT01292837|1110627|P1|NOT COMPLETED|Overall Study||2
453022|NCT01292837|1110627|P1|COMPLETED|Overall Study||11
453023|NCT01292837|1110627|P1|STARTED|Overall Study||13
453024|NCT01292798|1110636|P1|NOT COMPLETED|Overall Study||0
453025|NCT01292798|1110636|P1|COMPLETED|Overall Study||43
453026|NCT01292798|1110636|P1|Persistent DME After 3 Months|Overall Study|Subjects with persistent DME after 3 monthly injections of 0.5 mg of ranibizumab|29
453027|NCT01292798|1110636|P1|STARTED|Overall Study||43
453028|NCT01292746|1110642|P1|NOT COMPLETED|Overall Study||0
453029|NCT01292746|1110642|P1|COMPLETED|Overall Study||14
453030|NCT01292746|1110642|P1|STARTED|Overall Study||14
453031|NCT01292642|1110646|P1|NOT COMPLETED|Overall Study||5
453032|NCT01292642|1110646|P1|COMPLETED|Overall Study||7
453033|NCT01292642|1110646|P1|STARTED|Overall Study||12
453034|NCT01292629|1110654|P1|NOT COMPLETED|Overall Study||0
453035|NCT01292629|1110654|P1|COMPLETED|Overall Study||125
453036|NCT01292629|1110654|P1|STARTED|Overall Study||125
453037|NCT01292603|1110664|P6|NOT COMPLETED|Part 2: Survival Follow-UP||13
453038|NCT01292603|1110665|P5|NOT COMPLETED|Part 2: Survival Follow-UP||11
453039|NCT01292603|1110666|P4|NOT COMPLETED|Part 2: Survival Follow-UP||0
453040|NCT01292603|1110667|P3|NOT COMPLETED|Part 2: Survival Follow-UP||0
453041|NCT01292603|1110668|P2|NOT COMPLETED|Part 2: Survival Follow-UP||0
453042|NCT01292603|1110669|P1|NOT COMPLETED|Part 2: Survival Follow-UP||0
453043|NCT01292603|1110664|P6|COMPLETED|Part 2: Survival Follow-UP||0
453044|NCT01292603|1110665|P5|COMPLETED|Part 2: Survival Follow-UP||0
453045|NCT01292603|1110666|P4|COMPLETED|Part 2: Survival Follow-UP||0
453046|NCT01292603|1110667|P3|COMPLETED|Part 2: Survival Follow-UP||0
453047|NCT01292603|1110668|P2|COMPLETED|Part 2: Survival Follow-UP||0
453048|NCT01292603|1110669|P1|COMPLETED|Part 2: Survival Follow-UP||0
453049|NCT01292603|1110664|P6|STARTED|Part 2: Survival Follow-UP||13
453050|NCT01292603|1110665|P5|STARTED|Part 2: Survival Follow-UP||11
453051|NCT01292603|1110666|P4|STARTED|Part 2: Survival Follow-UP||0
453052|NCT01292603|1110667|P3|STARTED|Part 2: Survival Follow-UP||0
453053|NCT01292603|1110668|P2|STARTED|Part 2: Survival Follow-UP||0
453054|NCT01292603|1110669|P1|STARTED|Part 2: Survival Follow-UP||0
453055|NCT01292603|1110664|P6|NOT COMPLETED|Part 2: Regular Follow-Up||78
453056|NCT01292603|1110665|P5|NOT COMPLETED|Part 2: Regular Follow-Up||78
453057|NCT01292603|1110666|P4|NOT COMPLETED|Part 2: Regular Follow-Up||0
453058|NCT01292603|1110667|P3|NOT COMPLETED|Part 2: Regular Follow-Up||0
453059|NCT01292603|1110668|P2|NOT COMPLETED|Part 2: Regular Follow-Up||0
453060|NCT01292603|1110669|P1|NOT COMPLETED|Part 2: Regular Follow-Up||0
453061|NCT01292603|1110664|P6|COMPLETED|Part 2: Regular Follow-Up||0
453062|NCT01292603|1110665|P5|COMPLETED|Part 2: Regular Follow-Up||0
453063|NCT01292603|1110666|P4|COMPLETED|Part 2: Regular Follow-Up||0
453064|NCT01292603|1110667|P3|COMPLETED|Part 2: Regular Follow-Up||0
453065|NCT01292603|1110668|P2|COMPLETED|Part 2: Regular Follow-Up||0
453066|NCT01292603|1110669|P1|COMPLETED|Part 2: Regular Follow-Up||0
453067|NCT01292603|1110664|P6|STARTED|Part 2: Regular Follow-Up||78
453068|NCT01292603|1110665|P5|STARTED|Part 2: Regular Follow-Up||78
453069|NCT01292603|1110666|P4|STARTED|Part 2: Regular Follow-Up||0
453070|NCT01292603|1110667|P3|STARTED|Part 2: Regular Follow-Up||0
453071|NCT01292603|1110668|P2|STARTED|Part 2: Regular Follow-Up||0
453072|NCT01292603|1110669|P1|STARTED|Part 2: Regular Follow-Up||0
453073|NCT01292603|1110664|P6|NOT COMPLETED|Part 2: Dose Confirmation Period||15
453074|NCT01292603|1110665|P5|NOT COMPLETED|Part 2: Dose Confirmation Period||16
453075|NCT01292603|1110666|P4|NOT COMPLETED|Part 2: Dose Confirmation Period||0
453076|NCT01292603|1110667|P3|NOT COMPLETED|Part 2: Dose Confirmation Period||0
453077|NCT01292603|1110668|P2|NOT COMPLETED|Part 2: Dose Confirmation Period||0
453078|NCT01292603|1110669|P1|NOT COMPLETED|Part 2: Dose Confirmation Period||0
453079|NCT01292603|1110664|P6|COMPLETED|Part 2: Dose Confirmation Period||73
453080|NCT01292603|1110665|P5|COMPLETED|Part 2: Dose Confirmation Period||72
453081|NCT01292603|1110666|P4|COMPLETED|Part 2: Dose Confirmation Period||0
453082|NCT01292603|1110667|P3|COMPLETED|Part 2: Dose Confirmation Period||0
453083|NCT01292603|1110668|P2|COMPLETED|Part 2: Dose Confirmation Period||0
453084|NCT01292603|1110669|P1|COMPLETED|Part 2: Dose Confirmation Period||0
453085|NCT01292603|1110664|P6|STARTED|Part 2: Dose Confirmation Period||88
453086|NCT01292603|1110665|P5|STARTED|Part 2: Dose Confirmation Period||88
453087|NCT01292603|1110666|P4|STARTED|Part 2: Dose Confirmation Period||0
453088|NCT01292603|1110667|P3|STARTED|Part 2: Dose Confirmation Period||0
453089|NCT01292603|1110668|P2|STARTED|Part 2: Dose Confirmation Period||0
453090|NCT01292603|1110669|P1|STARTED|Part 2: Dose Confirmation Period||0
453091|NCT01292603|1110664|P6|NOT COMPLETED|Part 1: Survival Follow-Up||0
453092|NCT01292603|1110665|P5|NOT COMPLETED|Part 1: Survival Follow-Up||0
453093|NCT01292603|1110666|P4|NOT COMPLETED|Part 1: Survival Follow-Up||0
453094|NCT01292603|1110667|P3|NOT COMPLETED|Part 1: Survival Follow-Up||2
453095|NCT01292603|1110668|P2|NOT COMPLETED|Part 1: Survival Follow-Up||2
453096|NCT01292603|1110669|P1|NOT COMPLETED|Part 1: Survival Follow-Up||4
453097|NCT01292603|1110664|P6|COMPLETED|Part 1: Survival Follow-Up||0
453098|NCT01292603|1110665|P5|COMPLETED|Part 1: Survival Follow-Up||0
453099|NCT01292603|1110666|P4|COMPLETED|Part 1: Survival Follow-Up||0
453100|NCT01292603|1110667|P3|COMPLETED|Part 1: Survival Follow-Up||0
453101|NCT01292603|1110668|P2|COMPLETED|Part 1: Survival Follow-Up||0
453102|NCT01292603|1110669|P1|COMPLETED|Part 1: Survival Follow-Up||0
453103|NCT01292603|1110664|P6|STARTED|Part 1: Survival Follow-Up||0
453104|NCT01292603|1110665|P5|STARTED|Part 1: Survival Follow-Up||0
453105|NCT01292603|1110666|P4|STARTED|Part 1: Survival Follow-Up||0
453106|NCT01292603|1110667|P3|STARTED|Part 1: Survival Follow-Up||2
453107|NCT01292603|1110668|P2|STARTED|Part 1: Survival Follow-Up||2
453108|NCT01292603|1110669|P1|STARTED|Part 1: Survival Follow-Up||4
453109|NCT01292603|1110664|P6|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
453110|NCT01292603|1110665|P5|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
453111|NCT01292603|1110666|P4|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
453112|NCT01292603|1110667|P3|NOT COMPLETED|Part 1: Regular Follow-Up Period||23
453113|NCT01292603|1110668|P2|NOT COMPLETED|Part 1: Regular Follow-Up Period||17
453114|NCT01292603|1110669|P1|NOT COMPLETED|Part 1: Regular Follow-Up Period||16
453115|NCT01292603|1110664|P6|COMPLETED|Part 1: Regular Follow-Up Period||0
453116|NCT01292603|1110665|P5|COMPLETED|Part 1: Regular Follow-Up Period||0
453117|NCT01292603|1110666|P4|COMPLETED|Part 1: Regular Follow-Up Period||0
453118|NCT01292603|1110667|P3|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|0
453119|NCT01292603|1110668|P2|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|0
453120|NCT01292603|1110669|P1|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|0
453121|NCT01292603|1110664|P6|STARTED|Part 1: Regular Follow-Up Period||0
453122|NCT01292603|1110665|P5|STARTED|Part 1: Regular Follow-Up Period||0
453123|NCT01292603|1110666|P4|STARTED|Part 1: Regular Follow-Up Period||0
453124|NCT01292603|1110667|P3|STARTED|Part 1: Regular Follow-Up Period||23
453125|NCT01292603|1110668|P2|STARTED|Part 1: Regular Follow-Up Period||17
453126|NCT01292603|1110669|P1|STARTED|Part 1: Regular Follow-Up Period||16
453127|NCT01292603|1110664|P6|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
453128|NCT01292603|1110665|P5|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
453129|NCT01292603|1110666|P4|NOT COMPLETED|Part 1: Pilot Dose Selection Period||8
453130|NCT01292603|1110667|P3|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
453131|NCT01292603|1110668|P2|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
453132|NCT01292603|1110669|P1|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
453133|NCT01292603|1110664|P6|COMPLETED|Part 1: Pilot Dose Selection Period||0
453134|NCT01292603|1110665|P5|COMPLETED|Part 1: Pilot Dose Selection Period||0
453135|NCT01292603|1110666|P4|COMPLETED|Part 1: Pilot Dose Selection Period||0
453136|NCT01292603|1110667|P3|COMPLETED|Part 1: Pilot Dose Selection Period||23
453137|NCT01292603|1110668|P2|COMPLETED|Part 1: Pilot Dose Selection Period||17
453138|NCT01292603|1110669|P1|COMPLETED|Part 1: Pilot Dose Selection Period||16
453139|NCT01292603|1110664|P6|STARTED|Part 1: Pilot Dose Selection Period||0
453140|NCT01292603|1110665|P5|STARTED|Part 1: Pilot Dose Selection Period||0
453141|NCT01292603|1110666|P4|STARTED|Part 1: Pilot Dose Selection Period|These participants were withdrawn prior to SC treatment.|8
453142|NCT01292603|1110667|P3|STARTED|Part 1: Pilot Dose Selection Period|1 participant received a dose of 1000mg of rituximab by oversight.|23
453143|NCT01292603|1110668|P2|STARTED|Part 1: Pilot Dose Selection Period||17
453144|NCT01292603|1110669|P1|STARTED|Part 1: Pilot Dose Selection Period||16
453145|NCT01292538|1110715|P2|NOT COMPLETED|Overall Study||0
453146|NCT01292538|1110716|P1|NOT COMPLETED|Overall Study||0
453147|NCT01292538|1110715|P2|COMPLETED|Overall Study||32
453148|NCT01292538|1110716|P1|COMPLETED|Overall Study||35
453149|NCT01292538|1110715|P2|STARTED|Overall Study||32
453150|NCT01292538|1110716|P1|STARTED|Overall Study||35
453151|NCT01292486|1110722|P1|NOT COMPLETED|Overall Study||6
453152|NCT01292486|1110722|P1|COMPLETED|Overall Study||26
453153|NCT01292486|1110722|P1|STARTED|Overall Study||32
453154|NCT01292473|1110736|P4|NOT COMPLETED|Overall Study||12
453155|NCT01292473|1110737|P3|NOT COMPLETED|Overall Study||9
453156|NCT01292473|1110738|P2|NOT COMPLETED|Overall Study||7
453157|NCT01292473|1110739|P1|NOT COMPLETED|Overall Study||5
453158|NCT01292473|1110736|P4|COMPLETED|Overall Study||67
453159|NCT01292473|1110737|P3|COMPLETED|Overall Study||74
453160|NCT01292473|1110738|P2|COMPLETED|Overall Study||75
453161|NCT01292473|1110739|P1|COMPLETED|Overall Study||74
453162|NCT01292473|1110736|P4|STARTED|Overall Study||79
453163|NCT01292473|1110737|P3|STARTED|Overall Study||83
453164|NCT01292473|1110738|P2|STARTED|Overall Study||82
453165|NCT01292473|1110739|P1|STARTED|Overall Study||79
453166|NCT01292304|1110781|P1|NOT COMPLETED|Overall Study||0
453167|NCT01292304|1110781|P1|COMPLETED|Overall Study||10
453168|NCT01292304|1110781|P1|STARTED|Overall Study||10
453169|NCT01292265|1110789|P1|NOT COMPLETED|Overall Study||0
453170|NCT01292265|1110789|P1|COMPLETED|Overall Study||3
453171|NCT01292265|1110789|P1|STARTED|Overall Study||3
453172|NCT01292239|1110798|P2|NOT COMPLETED|Overall Study||7
453173|NCT01292239|1110799|P1|NOT COMPLETED|Overall Study||4
453174|NCT01292239|1110798|P2|COMPLETED|Overall Study||53
453175|NCT01292239|1110799|P1|COMPLETED|Overall Study||119
453176|NCT01292239|1110798|P2|STARTED|Overall Study||60
453177|NCT01292239|1110799|P1|STARTED|Overall Study||123
453178|NCT01292226|1110820|P1|NOT COMPLETED|Overall Study||13
453179|NCT01292226|1110820|P1|COMPLETED|Overall Study||32
453180|NCT01292226|1110820|P1|STARTED|Overall Study||45
453181|NCT01292187|1110853|P2|NOT COMPLETED|Overall Study||13
453182|NCT01292187|1110854|P1|NOT COMPLETED|Overall Study||17
453183|NCT01292187|1110853|P2|COMPLETED|Overall Study||30
453184|NCT01292187|1110854|P1|COMPLETED|Overall Study||69
453185|NCT01292187|1110853|P2|STARTED|Overall Study||43
453186|NCT01292187|1110854|P1|STARTED|Overall Study||86
453187|NCT01292135|1110864|P2|NOT COMPLETED|Overall Study||9
453188|NCT01292135|1110865|P1|NOT COMPLETED|Overall Study||0
453189|NCT01292135|1110864|P2|COMPLETED|Overall Study||21
453190|NCT01292135|1110865|P1|COMPLETED|Overall Study||3
453191|NCT01292135|1110864|P2|STARTED|Overall Study||30
453192|NCT01292135|1110865|P1|STARTED|Overall Study||3
453193|NCT01292070|1110883|P1|NOT COMPLETED|Overall Study||0
453194|NCT01292070|1110883|P1|COMPLETED|Overall Study||4
453195|NCT01292070|1110883|P1|STARTED|Overall Study||4
453196|NCT01292057|1110889|P2|NOT COMPLETED|Overall Study||2
453197|NCT01292057|1110890|P1|NOT COMPLETED|Overall Study||2
453198|NCT01292057|1110889|P2|COMPLETED|Overall Study||48
453199|NCT01292057|1110890|P1|COMPLETED|Overall Study||47
453200|NCT01292057|1110889|P2|STARTED|Overall Study||50
453201|NCT01292057|1110890|P1|STARTED|Overall Study||49
453202|NCT01292005|1110900|P2|NOT COMPLETED|Overall Study||0
453203|NCT01292005|1110901|P1|NOT COMPLETED|Overall Study||0
453204|NCT01292005|1110900|P2|COMPLETED|Overall Study||14
453205|NCT01292005|1110901|P1|COMPLETED|Overall Study||14
453206|NCT01292005|1110900|P2|STARTED|Overall Study||14
453207|NCT01292005|1110901|P1|STARTED|Overall Study||14
453208|NCT01291836|1110925|P2|NOT COMPLETED|Overall Study||0
453209|NCT01291836|1110926|P1|NOT COMPLETED|Overall Study||0
453210|NCT01291836|1110925|P2|COMPLETED|Overall Study||71
453211|NCT01291836|1110926|P1|COMPLETED|Overall Study||930
453212|NCT01291836|1110925|P2|STARTED|Overall Study||71
453213|NCT01291836|1110926|P1|STARTED|Overall Study||930
453214|NCT01291784|1110932|P3|NOT COMPLETED|Overall Study||0
453215|NCT01291784|1110933|P2|NOT COMPLETED|Overall Study||1
453216|NCT01291784|1110934|P1|NOT COMPLETED|Overall Study||0
453217|NCT01291784|1110932|P3|COMPLETED|Overall Study||1
453218|NCT01291784|1110933|P2|COMPLETED|Overall Study||0
453219|NCT01291784|1110934|P1|COMPLETED|Overall Study||1
453220|NCT01291784|1110932|P3|STARTED|Overall Study||1
453221|NCT01291784|1110933|P2|STARTED|Overall Study||1
453222|NCT01291784|1110934|P1|STARTED|Overall Study||1
453223|NCT01291498|1110954|P1|NOT COMPLETED|Overall Study||1
453224|NCT01291498|1110954|P1|COMPLETED|Overall Study||0
453225|NCT01291498|1110954|P1|STARTED|Overall Study||1
453226|NCT01291277|1110962|P2|NOT COMPLETED|Overall Study||3
453227|NCT01291277|1110963|P1|NOT COMPLETED|Overall Study||5
453228|NCT01291277|1110962|P2|COMPLETED|Overall Study||42
453229|NCT01291277|1110963|P1|COMPLETED|Overall Study||40
453230|NCT01291277|1110962|P2|STARTED|Overall Study||45
453231|NCT01291277|1110963|P1|STARTED|Overall Study||45
453232|NCT01291264|1110969|P1|NOT COMPLETED|Overall Study||0
453233|NCT01291264|1110969|P1|COMPLETED|Overall Study||260
453234|NCT01291264|1110969|P1|STARTED|Overall Study||260
453235|NCT01291225|1110975|P2|NOT COMPLETED|Overall Study||39
453236|NCT01291225|1110976|P1|NOT COMPLETED|Overall Study||85
453237|NCT01291225|1110975|P2|COMPLETED|Overall Study||121
453238|NCT01291225|1110976|P1|COMPLETED|Overall Study||66
453239|NCT01291225|1110975|P2|STARTED|Overall Study||160
453240|NCT01291225|1110976|P1|STARTED|Overall Study||151
453241|NCT01291173|1110990|P4|NOT COMPLETED|Overall Study||13
453242|NCT01291173|1110991|P3|NOT COMPLETED|Overall Study||13
453243|NCT01291173|1110992|P2|NOT COMPLETED|Overall Study||15
453244|NCT01291173|1110993|P1|NOT COMPLETED|Overall Study||17
453245|NCT01291173|1110990|P4|COMPLETED|Overall Study||52
453246|NCT01291173|1110991|P3|COMPLETED|Overall Study||52
453247|NCT01291173|1110992|P2|COMPLETED|Overall Study||51
453248|NCT01291173|1110993|P1|COMPLETED|Overall Study||47
453249|NCT01291173|1110990|P4|STARTED|Overall Study||65
453250|NCT01291173|1110991|P3|STARTED|Overall Study||65
453251|NCT01291173|1110992|P2|STARTED|Overall Study||66
453252|NCT01291173|1110993|P1|STARTED|Overall Study||64
453253|NCT01291160|1111057|P2|NOT COMPLETED|Overall Study||16
453254|NCT01291160|1111058|P1|NOT COMPLETED|Overall Study||18
453255|NCT01291160|1111057|P2|COMPLETED|Overall Study||48
453256|NCT01291160|1111058|P1|COMPLETED|Overall Study||48
453257|NCT01291160|1111057|P2|STARTED|Overall Study||64
453258|NCT01291160|1111058|P1|STARTED|Overall Study||66
453259|NCT01291108|1111068|P6|NOT COMPLETED|Month 2 (Adjunctive Therapy)||1
453260|NCT01291108|1111069|P5|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
453261|NCT01291108|1111070|P4|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
453262|NCT01291108|1111071|P3|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
453263|NCT01291108|1111072|P2|NOT COMPLETED|Month 2 (Adjunctive Therapy)||2
453264|NCT01291108|1111073|P1|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
453265|NCT01291108|1111068|P6|COMPLETED|Month 2 (Adjunctive Therapy)||25
453266|NCT01291108|1111069|P5|COMPLETED|Month 2 (Adjunctive Therapy)||34
453267|NCT01291108|1111070|P4|COMPLETED|Month 2 (Adjunctive Therapy)||0
453268|NCT01291108|1111071|P3|COMPLETED|Month 2 (Adjunctive Therapy)||24
453269|NCT01291108|1111072|P2|COMPLETED|Month 2 (Adjunctive Therapy)||38
453270|NCT01291108|1111073|P1|COMPLETED|Month 2 (Adjunctive Therapy)||0
453271|NCT01291108|1111068|P6|STARTED|Month 2 (Adjunctive Therapy)||26
453272|NCT01291108|1111069|P5|STARTED|Month 2 (Adjunctive Therapy)||34
453273|NCT01291108|1111070|P4|STARTED|Month 2 (Adjunctive Therapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|0
453274|NCT01291108|1111071|P3|STARTED|Month 2 (Adjunctive Therapy)||24
453275|NCT01291108|1111072|P2|STARTED|Month 2 (Adjunctive Therapy)||40
453276|NCT01291108|1111073|P1|STARTED|Month 2 (Adjunctive Therapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|0
453277|NCT01291108|1111068|P6|NOT COMPLETED|Month 1 (Monotherapy)||0
453278|NCT01291108|1111069|P5|NOT COMPLETED|Month 1 (Monotherapy)||0
453279|NCT01291108|1111070|P4|NOT COMPLETED|Month 1 (Monotherapy)||0
453280|NCT01291108|1111071|P3|NOT COMPLETED|Month 1 (Monotherapy)||0
453281|NCT01291108|1111072|P2|NOT COMPLETED|Month 1 (Monotherapy)||0
453282|NCT01291108|1111073|P1|NOT COMPLETED|Month 1 (Monotherapy)||1
453283|NCT01291108|1111068|P6|COMPLETED|Month 1 (Monotherapy)||0
453284|NCT01291108|1111069|P5|COMPLETED|Month 1 (Monotherapy)||0
453285|NCT01291108|1111070|P4|COMPLETED|Month 1 (Monotherapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|60
453286|NCT01291108|1111071|P3|COMPLETED|Month 1 (Monotherapy)||0
453287|NCT01291108|1111072|P2|COMPLETED|Month 1 (Monotherapy)||0
453288|NCT01291108|1111073|P1|COMPLETED|Month 1 (Monotherapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|64
453289|NCT01291108|1111068|P6|STARTED|Month 1 (Monotherapy)||0
453290|NCT01291108|1111069|P5|STARTED|Month 1 (Monotherapy)||0
453291|NCT01291108|1111070|P4|STARTED|Month 1 (Monotherapy)||60
453292|NCT01291108|1111071|P3|STARTED|Month 1 (Monotherapy)||0
453293|NCT01291108|1111072|P2|STARTED|Month 1 (Monotherapy)||0
453294|NCT01291108|1111073|P1|STARTED|Month 1 (Monotherapy)||65
453295|NCT01291056|1111089|P2|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0
453296|NCT01291056|1111090|P1|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0
453297|NCT01291056|1111089|P2|COMPLETED|Intervention Two (Menstration Days 3-7)||10
453298|NCT01291056|1111090|P1|COMPLETED|Intervention Two (Menstration Days 3-7)||10
453299|NCT01291056|1111089|P2|STARTED|Intervention Two (Menstration Days 3-7)||10
453300|NCT01291056|1111090|P1|STARTED|Intervention Two (Menstration Days 3-7)||10
453301|NCT01291056|1111089|P2|NOT COMPLETED|Washout||0
453302|NCT01291056|1111090|P1|NOT COMPLETED|Washout||0
453303|NCT01291056|1111089|P2|COMPLETED|Washout||10
453304|NCT01291056|1111090|P1|COMPLETED|Washout||10
453305|NCT01291056|1111089|P2|STARTED|Washout||10
453306|NCT01291056|1111090|P1|STARTED|Washout||10
453307|NCT01291056|1111089|P2|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0
453308|NCT01291056|1111090|P1|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0
453309|NCT01291056|1111089|P2|COMPLETED|Intervention One (Menstraution Day 3-7)||10
453310|NCT01291056|1111090|P1|COMPLETED|Intervention One (Menstraution Day 3-7)||10
453311|NCT01291056|1111089|P2|STARTED|Intervention One (Menstraution Day 3-7)||10
453312|NCT01291056|1111090|P1|STARTED|Intervention One (Menstraution Day 3-7)||10
453313|NCT01291017|1111102|P1|NOT COMPLETED|Overall Study||5
453314|NCT01291017|1111102|P1|COMPLETED|Overall Study||14
453315|NCT01291017|1111102|P1|STARTED|Overall Study||19
453316|NCT01290978|1111110|P1|NOT COMPLETED|Overall Study||0
453317|NCT01290978|1111110|P1|COMPLETED|Overall Study||22
453318|NCT01290978|1111110|P1|STARTED|Overall Study||22
453319|NCT01290952|1111119|P2|NOT COMPLETED|Overall Study||14
453320|NCT01290952|1111120|P1|NOT COMPLETED|Overall Study||12
453321|NCT01290952|1111119|P2|COMPLETED|Overall Study||193
453322|NCT01290952|1111120|P1|COMPLETED|Overall Study||192
453323|NCT01290952|1111119|P2|STARTED|Overall Study||207
453324|NCT01290952|1111120|P1|STARTED|Overall Study||204
453325|NCT01290913|1111128|P1|NOT COMPLETED|Overall Study||1
453326|NCT01290913|1111128|P1|COMPLETED|Overall Study||12
453327|NCT01290913|1111128|P1|STARTED|Overall Study||13
453328|NCT01290887|1111135|P2|NOT COMPLETED|Overall Study||536
453329|NCT01290887|1111136|P1|NOT COMPLETED|Overall Study||466
453330|NCT01290887|1111135|P2|COMPLETED|Overall Study|Completed study includes completion of the 104 week treatment phase and the 90-day follow-up.|35
453331|NCT01290887|1111136|P1|COMPLETED|Overall Study|Completed study includes completion of the 104 week treatment phase and the 90-day follow-up.|15
453332|NCT01290887|1111135|P2|Safety Analysis Set|Overall Study||571
453333|NCT01290887|1111136|P1|Safety Analysis Set|Overall Study|One patient was enrolled but not treated.|480
453334|NCT01290887|1111135|P2|STARTED|Overall Study||571
453335|NCT01290887|1111136|P1|STARTED|Overall Study||481
453336|NCT01290874|1111176|P2|NOT COMPLETED|Overall Study||404
453337|NCT01290874|1111177|P1|NOT COMPLETED|Overall Study||410
453338|NCT01290874|1111176|P2|COMPLETED|Overall Study||134
453339|NCT01290874|1111177|P1|COMPLETED|Overall Study||122
453340|NCT01290874|1111176|P2|STARTED|Overall Study||538
453341|NCT01290874|1111177|P1|STARTED|Overall Study||532
453342|NCT01290822|1111197|P1|NOT COMPLETED|Overall Study||11
453343|NCT01290822|1111197|P1|COMPLETED|Overall Study||1
453344|NCT01290822|1111197|P1|STARTED|Overall Study||12
453345|NCT01290796|1111206|P1|NOT COMPLETED|Overall Study||30
453346|NCT01290796|1111206|P1|COMPLETED|Overall Study||123
453347|NCT01290796|1111206|P1|STARTED|Overall Study||153
453348|NCT01290757|1111222|P2|NOT COMPLETED|Overall Study||2
453349|NCT01290757|1111223|P1|NOT COMPLETED|Overall Study||2
453350|NCT01290757|1111222|P2|COMPLETED|Overall Study||88
453351|NCT01290757|1111223|P1|COMPLETED|Overall Study||88
453352|NCT01290757|1111222|P2|STARTED|Overall Study||90
453353|NCT01290757|1111223|P1|STARTED|Overall Study||90
453354|NCT01290731|1111239|P1|NOT COMPLETED|Overall Study||1
453355|NCT01290731|1111239|P1|COMPLETED|Overall Study||48
453356|NCT01290731|1111239|P1|STARTED|Overall Study||49
453357|NCT01290718|1111251|P1|NOT COMPLETED|Overall Study||4
453358|NCT01290718|1111251|P1|COMPLETED|Overall Study||0
453359|NCT01290718|1111251|P1|STARTED|Overall Study||4
453360|NCT01290679|1111260|P2|NOT COMPLETED|Overall Study||21
453361|NCT01290679|1111261|P1|NOT COMPLETED|Overall Study||16
453362|NCT01290679|1111260|P2|COMPLETED|Overall Study||113
453363|NCT01290679|1111261|P1|COMPLETED|Overall Study||241
453364|NCT01290679|1111260|P2|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|134
453365|NCT01290679|1111261|P1|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|257
453366|NCT01290666|1111330|P1|NOT COMPLETED|Overall Study||38
453367|NCT01290666|1111330|P1|COMPLETED|Overall Study||55
453368|NCT01290666|1111330|P1|STARTED|Overall Study||93
453369|NCT01290640|1111336|P2|NOT COMPLETED|Overall Study||0
453370|NCT01290640|1111337|P1|NOT COMPLETED|Overall Study||0
453371|NCT01290640|1111336|P2|COMPLETED|Overall Study||10
453372|NCT01290640|1111337|P1|COMPLETED|Overall Study||12
453373|NCT01290640|1111336|P2|STARTED|Overall Study||10
453374|NCT01290640|1111337|P1|STARTED|Overall Study||12
453375|NCT01290627|1111348|P3|NOT COMPLETED|Overall Study||0
453376|NCT01290627|1111349|P2|NOT COMPLETED|Overall Study||0
453377|NCT01290627|1111350|P1|NOT COMPLETED|Overall Study||0
453378|NCT01290627|1111348|P3|COMPLETED|Overall Study||10
453379|NCT01290627|1111349|P2|COMPLETED|Overall Study||10
453380|NCT01290627|1111350|P1|COMPLETED|Overall Study||10
453381|NCT01290627|1111348|P3|STARTED|Overall Study||10
453382|NCT01290627|1111349|P2|STARTED|Overall Study||10
453383|NCT01290627|1111350|P1|STARTED|Overall Study||10
453384|NCT01290614|1111372|P2|NOT COMPLETED|Overall Study||0
453385|NCT01290614|1111373|P1|NOT COMPLETED|Overall Study||552
453386|NCT01290614|1111372|P2|COMPLETED|Overall Study||1129
453387|NCT01290614|1111373|P1|COMPLETED|Overall Study||518
453388|NCT01290614|1111372|P2|STARTED|Overall Study||1129
453389|NCT01290614|1111373|P1|STARTED|Overall Study||1070
453390|NCT01290601|1111383|P4|NOT COMPLETED|Overall Study||0
453391|NCT01290601|1111384|P3|NOT COMPLETED|Overall Study||0
453392|NCT01290601|1111385|P2|NOT COMPLETED|Overall Study||5
453393|NCT01290601|1111386|P1|NOT COMPLETED|Overall Study||11
453394|NCT01290601|1111383|P4|COMPLETED|Overall Study||0
453395|NCT01290601|1111384|P3|COMPLETED|Overall Study||0
453396|NCT01290601|1111385|P2|COMPLETED|Overall Study||19
453397|NCT01290601|1111386|P1|COMPLETED|Overall Study||35
453398|NCT01290601|1111383|P4|STARTED|Overall Study||0
453399|NCT01290601|1111384|P3|STARTED|Overall Study||0
453400|NCT01290601|1111385|P2|STARTED|Overall Study||24
453401|NCT01290601|1111386|P1|STARTED|Overall Study||46
453402|NCT01290536|1111400|P1|NOT COMPLETED|Overall Study||0
453403|NCT01290536|1111400|P1|COMPLETED|Overall Study||42
453404|NCT01290536|1111400|P1|STARTED|Overall Study||42
453405|NCT01290523|1111407|P1|NOT COMPLETED|Overall Study||0
453406|NCT01290523|1111407|P1|COMPLETED|Overall Study||14
453407|NCT01290523|1111407|P1|STARTED|Overall Study||14
453408|NCT01290484|1111412|P1|NOT COMPLETED|Overall Study||0
453409|NCT01290484|1111412|P1|COMPLETED|Overall Study||7
453410|NCT01290484|1111412|P1|STARTED|Overall Study||7
453411|NCT01290341|1111418|P2|NOT COMPLETED|Overall Study||29
453412|NCT01290341|1111419|P1|NOT COMPLETED|Overall Study||92
453413|NCT01290341|1111418|P2|COMPLETED|Overall Study||258
453414|NCT01290341|1111419|P1|COMPLETED|Overall Study||481
453415|NCT01290341|1111418|P2|STARTED|Overall Study||287
453416|NCT01290341|1111419|P1|STARTED|Overall Study||573
453417|NCT01290315|1111431|P4|NOT COMPLETED|Overall Study||5
453418|NCT01290315|1111432|P3|NOT COMPLETED|Overall Study||0
453419|NCT01290315|1111433|P2|NOT COMPLETED|Overall Study||3
453420|NCT01290315|1111434|P1|NOT COMPLETED|Overall Study||3
453421|NCT01290315|1111431|P4|COMPLETED|Overall Study||8
453422|NCT01290315|1111432|P3|COMPLETED|Overall Study||10
453423|NCT01290315|1111433|P2|COMPLETED|Overall Study||9
453424|NCT01290315|1111434|P1|COMPLETED|Overall Study||11
453425|NCT01290315|1111431|P4|STARTED|Overall Study||13
453426|NCT01290315|1111432|P3|STARTED|Overall Study||10
453427|NCT01290315|1111433|P2|STARTED|Overall Study||12
453428|NCT01290315|1111434|P1|STARTED|Overall Study||14
453429|NCT01290263|1111456|P5|NOT COMPLETED|Overall Study||37
453430|NCT01290263|1111457|P4|NOT COMPLETED|Overall Study||27
453431|NCT01290263|1111458|P3|NOT COMPLETED|Overall Study||7
453432|NCT01290263|1111459|P2|NOT COMPLETED|Overall Study||3
453433|NCT01290263|1111460|P1|NOT COMPLETED|Overall Study||11
453434|NCT01290263|1111456|P5|COMPLETED|Overall Study||0
453435|NCT01290263|1111457|P4|COMPLETED|Overall Study||0
453436|NCT01290263|1111458|P3|COMPLETED|Overall Study||0
453437|NCT01290263|1111459|P2|COMPLETED|Overall Study||0
453438|NCT01290263|1111460|P1|COMPLETED|Overall Study||0
453439|NCT01290263|1111456|P5|STARTED|Overall Study||37
453440|NCT01290263|1111457|P4|STARTED|Overall Study||27
453441|NCT01290263|1111458|P3|STARTED|Overall Study||7
453442|NCT01290263|1111459|P2|STARTED|Overall Study||3
453443|NCT01290263|1111460|P1|STARTED|Overall Study||11
453444|NCT01290237|1111478|P2|NOT COMPLETED|Overall Study||2
453445|NCT01290237|1111479|P1|NOT COMPLETED|Overall Study||11
453446|NCT01290237|1111478|P2|COMPLETED|Overall Study||27
453447|NCT01290237|1111479|P1|COMPLETED|Overall Study||19
453448|NCT01290237|1111478|P2|STARTED|Overall Study||29
453449|NCT01290237|1111479|P1|STARTED|Overall Study||30
453450|NCT01290224|1111487|P1|NOT COMPLETED|Overall Study||5
453451|NCT01290224|1111487|P1|COMPLETED|Overall Study||5
453452|NCT01290224|1111487|P1|STARTED|Overall Study||10
453453|NCT01290094|1111498|P1|NOT COMPLETED|Overall Study||6
453454|NCT01290094|1111498|P1|COMPLETED|Overall Study||35
453455|NCT01290094|1111498|P1|STARTED|Overall Study||41
453456|NCT01290068|1111511|P2|NOT COMPLETED|Overall Study||6
453457|NCT01290068|1111512|P1|NOT COMPLETED|Overall Study||7
453458|NCT01290068|1111511|P2|COMPLETED|Overall Study||94
453459|NCT01290068|1111512|P1|COMPLETED|Overall Study||101
453460|NCT01290068|1111511|P2|Implanted|Overall Study||98
453461|NCT01290068|1111512|P1|Implanted|Overall Study||108
453462|NCT01290068|1111511|P2|STARTED|Overall Study||100
453463|NCT01290068|1111512|P1|STARTED|Overall Study||108
453464|NCT01290029|1111524|P1|NOT COMPLETED|Overall Study||2
453465|NCT01290029|1111524|P1|COMPLETED|Overall Study||12
453466|NCT01290029|1111524|P1|Received Study Treatment|Overall Study||12
453467|NCT01290029|1111524|P1|STARTED|Overall Study||14
453468|NCT01289990|1111550|P13|NOT COMPLETED|Overall Study||98
453469|NCT01289990|1111551|P12|NOT COMPLETED|Overall Study||68
453470|NCT01289990|1111552|P11|NOT COMPLETED|Overall Study||76
453471|NCT01289990|1111553|P10|NOT COMPLETED|Overall Study||86
453472|NCT01289990|1111554|P9|NOT COMPLETED|Overall Study||75
453473|NCT01289990|1111555|P8|NOT COMPLETED|Overall Study||55
453474|NCT01289990|1111556|P7|NOT COMPLETED|Overall Study||88
453475|NCT01289990|1111557|P6|NOT COMPLETED|Overall Study||74
453476|NCT01289990|1111558|P5|NOT COMPLETED|Overall Study||72
453477|NCT01289990|1111559|P4|NOT COMPLETED|Overall Study||87
453478|NCT01289990|1111560|P3|NOT COMPLETED|Overall Study||109
453479|NCT01289990|1111561|P2|NOT COMPLETED|Overall Study||81
453480|NCT01289990|1111562|P1|NOT COMPLETED|Overall Study||77
453481|NCT01289990|1111550|P13|COMPLETED|Overall Study||127
453482|NCT01289990|1111551|P12|COMPLETED|Overall Study||150
453483|NCT01289990|1111552|P11|COMPLETED|Overall Study||150
453484|NCT01289990|1111553|P10|COMPLETED|Overall Study||121
453485|NCT01289990|1111554|P9|COMPLETED|Overall Study||139
453486|NCT01289990|1111555|P8|COMPLETED|Overall Study||162
453487|NCT01289990|1111556|P7|COMPLETED|Overall Study||78
453488|NCT01289990|1111557|P6|COMPLETED|Overall Study||94
453489|NCT01289990|1111558|P5|COMPLETED|Overall Study||93
453490|NCT01289990|1111559|P4|COMPLETED|Overall Study||136
453491|NCT01289990|1111560|P3|COMPLETED|Overall Study||119
453492|NCT01289990|1111561|P2|COMPLETED|Overall Study||143
453493|NCT01289990|1111562|P1|COMPLETED|Overall Study||147
453494|NCT01289990|1111550|P13|STARTED|Overall Study||225
453495|NCT01289990|1111551|P12|STARTED|Overall Study||218
453496|NCT01289990|1111552|P11|STARTED|Overall Study||226
453497|NCT01289990|1111553|P10|STARTED|Overall Study||207
453498|NCT01289990|1111554|P9|STARTED|Overall Study||214
453499|NCT01289990|1111555|P8|STARTED|Overall Study||217
453500|NCT01289990|1111556|P7|STARTED|Overall Study||166
453501|NCT01289990|1111557|P6|STARTED|Overall Study||168
453502|NCT01289990|1111558|P5|STARTED|Overall Study||165
453503|NCT01289990|1111559|P4|STARTED|Overall Study||223
453504|NCT01289990|1111560|P3|STARTED|Overall Study||228
453505|NCT01289990|1111561|P2|STARTED|Overall Study||224
453506|NCT01289990|1111562|P1|STARTED|Overall Study||224
453507|NCT01289912|1111748|P2|NOT COMPLETED|Overall Study||2
453508|NCT01289912|1111749|P1|NOT COMPLETED|Overall Study||3
453509|NCT01289912|1111748|P2|COMPLETED|Overall Study||13
453510|NCT01289912|1111749|P1|COMPLETED|Overall Study||29
453511|NCT01289912|1111748|P2|STARTED|Overall Study||15
453512|NCT01289912|1111749|P1|STARTED|Overall Study||32
453513|NCT01289847|1111779|P1|NOT COMPLETED|Overall Study||1
453514|NCT01289847|1111779|P1|COMPLETED|Overall Study||24
453515|NCT01289847|1111779|P1|STARTED|Overall Study||25
453516|NCT01289821|1111788|P1|NOT COMPLETED|Survival Follow-up Period||18
453517|NCT01289821|1111788|P1|COMPLETED|Survival Follow-up Period|34 participants died and completed survival follow-up period.|34
453518|NCT01289821|1111788|P1|STARTED|Survival Follow-up Period||52
453519|NCT01289821|1111788|P1|NOT COMPLETED|Safety Follow-up Period||5
453520|NCT01289821|1111788|P1|COMPLETED|Safety Follow-up Period||49
453521|NCT01289821|1111788|P1|STARTED|Safety Follow-up Period||54
453522|NCT01289821|1111788|P1|NOT COMPLETED|Treatment Period||54
453523|NCT01289821|1111788|P1|COMPLETED|Treatment Period||0
453524|NCT01289821|1111788|P1|Participants Received Regorafenib|Treatment Period||54
453525|NCT01289821|1111788|P1|STARTED|Treatment Period||54
453526|NCT01289782|1111799|P2|NOT COMPLETED|Overall Study||12
453527|NCT01289782|1111800|P1|NOT COMPLETED|Overall Study||25
453528|NCT01289782|1111799|P2|COMPLETED|Overall Study||118
453529|NCT01289782|1111800|P1|COMPLETED|Overall Study||239
453530|NCT01289782|1111799|P2|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|130
453531|NCT01289782|1111800|P1|STARTED|Overall Study||264
453532|NCT01289639|1111872|P3|NOT COMPLETED|Overall Study||0
453533|NCT01289639|1111873|P2|NOT COMPLETED|Overall Study||0
453534|NCT01289639|1111874|P1|NOT COMPLETED|Overall Study||1
453535|NCT01289639|1111872|P3|COMPLETED|Overall Study||0
453536|NCT01289639|1111873|P2|COMPLETED|Overall Study||6
453537|NCT01289639|1111874|P1|COMPLETED|Overall Study||4
453538|NCT01289639|1111872|P3|STARTED|Overall Study||0
453539|NCT01289639|1111873|P2|STARTED|Overall Study||6
453540|NCT01289639|1111874|P1|STARTED|Overall Study||5
453541|NCT01289574|1111900|P3|NOT COMPLETED|Overall Study||3
453542|NCT01289574|1111901|P2|NOT COMPLETED|Overall Study||3
453543|NCT01289574|1111902|P1|NOT COMPLETED|Overall Study||7
453544|NCT01289574|1111900|P3|COMPLETED|Overall Study||60
453545|NCT01289574|1111901|P2|COMPLETED|Overall Study||57
453546|NCT01289574|1111902|P1|COMPLETED|Overall Study||51
453547|NCT01289574|1111900|P3|STARTED|Overall Study||63
453548|NCT01289574|1111901|P2|STARTED|Overall Study||60
453549|NCT01289574|1111902|P1|STARTED|Overall Study||58
453550|NCT01289548|1111919|P3|NOT COMPLETED|Overall Study||0
453551|NCT01289548|1111920|P2|NOT COMPLETED|Overall Study||0
453552|NCT01289548|1111921|P1|NOT COMPLETED|Overall Study||0
453553|NCT01289548|1111919|P3|COMPLETED|Overall Study||40
453554|NCT01289548|1111920|P2|COMPLETED|Overall Study||40
453555|NCT01289548|1111921|P1|COMPLETED|Overall Study||40
453556|NCT01289548|1111919|P3|Recipients|Overall Study||20
453557|NCT01289548|1111920|P2|Recipients|Overall Study||20
453558|NCT01289548|1111921|P1|Recipients|Overall Study||20
453559|NCT01289548|1111919|P3|Donors|Overall Study||20
453560|NCT01289548|1111920|P2|Donors|Overall Study||20
453561|NCT01289548|1111921|P1|Donors|Overall Study||20
453562|NCT01289548|1111919|P3|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
453563|NCT01289548|1111920|P2|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
453564|NCT01289548|1111921|P1|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
453565|NCT01289522|1111965|P1|NOT COMPLETED|Overall Study||11
453566|NCT01289522|1111965|P1|COMPLETED|Overall Study||43
453567|NCT01289522|1111965|P1|STARTED|Overall Study||54
453568|NCT01289418|1111974|P1|NOT COMPLETED|Day 29 Survey||2468
453569|NCT01289418|1111974|P1|COMPLETED|Day 29 Survey||4057
453570|NCT01289418|1111974|P1|STARTED|Day 29 Survey||6525
453571|NCT01289418|1111974|P1|NOT COMPLETED|Day 8 Survey||2218
453572|NCT01289418|1111974|P1|COMPLETED|Day 8 Survey||4307
453573|NCT01289418|1111974|P1|STARTED|Day 8 Survey||6525
453574|NCT01289392|1111983|P3|NOT COMPLETED|Overall Study||0
453575|NCT01289392|1111984|P2|NOT COMPLETED|Overall Study||0
453576|NCT01289392|1111985|P1|NOT COMPLETED|Overall Study||0
453577|NCT01289392|1111983|P3|COMPLETED|Overall Study||7
453578|NCT01289392|1111984|P2|COMPLETED|Overall Study||9
453579|NCT01289392|1111985|P1|COMPLETED|Overall Study||9
453580|NCT01289392|1111983|P3|STARTED|Overall Study||7
453581|NCT01289392|1111984|P2|STARTED|Overall Study||9
453582|NCT01289392|1111985|P1|STARTED|Overall Study||9
453583|NCT01289275|1111997|P4|NOT COMPLETED|Overall Study||0
453584|NCT01289275|1111998|P3|NOT COMPLETED|Overall Study||0
453585|NCT01289275|1111999|P2|NOT COMPLETED|Overall Study||0
453586|NCT01289275|1112000|P1|NOT COMPLETED|Overall Study||0
453587|NCT01289275|1111997|P4|COMPLETED|Overall Study||316
453588|NCT01289275|1111998|P3|COMPLETED|Overall Study||317
453589|NCT01289275|1111999|P2|COMPLETED|Overall Study||320
453590|NCT01289275|1112000|P1|COMPLETED|Overall Study||317
453591|NCT01289275|1111997|P4|STARTED|Overall Study||316
453592|NCT01289275|1111998|P3|STARTED|Overall Study||317
453593|NCT01289275|1111999|P2|STARTED|Overall Study||320
453594|NCT01289275|1112000|P1|STARTED|Overall Study||317
453595|NCT01289210|1112010|P1|NOT COMPLETED|Overall Study||1
453596|NCT01289210|1112010|P1|COMPLETED|Overall Study||1
453597|NCT01289210|1112010|P1|STARTED|Overall Study||2
453598|NCT01289119|1112020|P6|NOT COMPLETED|Overall Study||4
453599|NCT01289119|1112021|P5|NOT COMPLETED|Overall Study||5
453600|NCT01289119|1112022|P4|NOT COMPLETED|Overall Study||6
453601|NCT01289119|1112023|P3|NOT COMPLETED|Overall Study||9
453602|NCT01289119|1112024|P2|NOT COMPLETED|Overall Study||9
453603|NCT01289119|1112025|P1|NOT COMPLETED|Overall Study||9
453604|NCT01289119|1112020|P6|COMPLETED|Overall Study||57
453605|NCT01289119|1112021|P5|COMPLETED|Overall Study||58
453606|NCT01289119|1112022|P4|COMPLETED|Overall Study||93
453607|NCT01289119|1112023|P3|COMPLETED|Overall Study||89
453608|NCT01289119|1112024|P2|COMPLETED|Overall Study||83
453609|NCT01289119|1112025|P1|COMPLETED|Overall Study||84
453610|NCT01289119|1112020|P6|Treated|Overall Study||61
453611|NCT01289119|1112021|P5|Treated|Overall Study||63
453612|NCT01289119|1112022|P4|Treated|Overall Study||99
453613|NCT01289119|1112023|P3|Treated|Overall Study||98
453614|NCT01289119|1112024|P2|Treated|Overall Study||92
453615|NCT01289119|1112025|P1|Treated|Overall Study|Patients who took at least one dose of double-blind study drug.|92
453616|NCT01289119|1112020|P6|STARTED|Overall Study||61
453617|NCT01289119|1112021|P5|STARTED|Overall Study||63
453618|NCT01289119|1112022|P4|STARTED|Overall Study||99
453619|NCT01289119|1112023|P3|STARTED|Overall Study||98
453620|NCT01289119|1112024|P2|STARTED|Overall Study||92
453621|NCT01289119|1112025|P1|STARTED|Overall Study||93
453622|NCT01289080|1112107|P2|NOT COMPLETED|Overall Study||0
453623|NCT01289080|1112108|P1|NOT COMPLETED|Overall Study||0
453624|NCT01289080|1112107|P2|COMPLETED|Overall Study||10
453625|NCT01289080|1112108|P1|COMPLETED|Overall Study||9
453626|NCT01289080|1112107|P2|STARTED|Overall Study||10
453627|NCT01289080|1112108|P1|STARTED|Overall Study||9
453628|NCT01289067|1112139|P1|NOT COMPLETED|Overall Study||0
453629|NCT01289067|1112139|P1|COMPLETED|Overall Study||13
453630|NCT01289067|1112139|P1|STARTED|Overall Study||13
453631|NCT01289041|1112146|P1|NOT COMPLETED|Overall Study||70
453632|NCT01289041|1112146|P1|COMPLETED|Overall Study||0
453633|NCT01289041|1112146|P1|STARTED|Overall Study||70
453634|NCT01289028|1112158|P1|NOT COMPLETED|Overall Study||83
453635|NCT01289028|1112158|P1|COMPLETED|Overall Study||42
453636|NCT01289028|1112158|P1|STARTED|Overall Study||125
453637|NCT01289015|1112172|P2|NOT COMPLETED|Overall Study||54
453638|NCT01289015|1112173|P1|NOT COMPLETED|Overall Study||99
453639|NCT01289015|1112172|P2|COMPLETED|Overall Study||230
453640|NCT01289015|1112173|P1|COMPLETED|Overall Study||472
453641|NCT01289015|1112172|P2|STARTED|Overall Study||284
453642|NCT01289015|1112173|P1|STARTED|Overall Study||571
453643|NCT01288976|1112184|P3|NOT COMPLETED|Overall Study||20
453644|NCT01288976|1112185|P2|NOT COMPLETED|Overall Study||27
453645|NCT01288976|1112186|P1|NOT COMPLETED|Overall Study||178
453646|NCT01288976|1112184|P3|COMPLETED|Overall Study||85
453647|NCT01288976|1112185|P2|COMPLETED|Overall Study||22
453648|NCT01288976|1112186|P1|COMPLETED|Overall Study||389
453649|NCT01288976|1112184|P3|STARTED|Overall Study||105
453650|NCT01288976|1112185|P2|STARTED|Overall Study||49
453651|NCT01288976|1112186|P1|STARTED|Overall Study||567
453652|NCT01288911|1112215|P2|NOT COMPLETED|Overall Study||170
453653|NCT01288911|1112216|P1|NOT COMPLETED|Overall Study||125
453654|NCT01288911|1112215|P2|COMPLETED|Overall Study|Indicates participants still receiving treatment as of 19 October 2014|21
453655|NCT01288911|1112216|P1|COMPLETED|Overall Study|Indicates participants still receiving treatment as of 19 October 2014|59
453656|NCT01288911|1112215|P2|Received Treatment|Overall Study||189
453657|NCT01288911|1112216|P1|Received Treatment|Overall Study||183
453658|NCT01288911|1112215|P2|STARTED|Overall Study||191
453659|NCT01288911|1112216|P1|STARTED|Overall Study||184
453660|NCT01288859|1112244|P6|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
453661|NCT01288859|1112245|P5|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
453662|NCT01288859|1112246|P4|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
453663|NCT01288859|1112247|P3|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
453664|NCT01288859|1112248|P2|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
453665|NCT01288859|1112249|P1|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
453666|NCT01288859|1112244|P6|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
453667|NCT01288859|1112245|P5|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5
453668|NCT01288859|1112246|P4|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5
453669|NCT01288859|1112247|P3|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
453670|NCT01288859|1112248|P2|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
453671|NCT01288859|1112249|P1|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
453672|NCT01288859|1112244|P6|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
453673|NCT01288859|1112245|P5|STARTED|Control Cream Then Enc Polyph. (1 Day)||5
453674|NCT01288859|1112246|P4|STARTED|Control Cream Then Enc Polyph. (1 Day)||5
453675|NCT01288859|1112247|P3|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
453676|NCT01288859|1112248|P2|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
453677|NCT01288859|1112249|P1|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
453678|NCT01288859|1112244|P6|NOT COMPLETED|Washout Period of 1 Week||0
453679|NCT01288859|1112245|P5|NOT COMPLETED|Washout Period of 1 Week||0
453680|NCT01288859|1112246|P4|NOT COMPLETED|Washout Period of 1 Week||0
453681|NCT01288859|1112247|P3|NOT COMPLETED|Washout Period of 1 Week||0
453682|NCT01288859|1112248|P2|NOT COMPLETED|Washout Period of 1 Week||0
453683|NCT01288859|1112249|P1|NOT COMPLETED|Washout Period of 1 Week||0
453684|NCT01288859|1112244|P6|COMPLETED|Washout Period of 1 Week||0
453685|NCT01288859|1112245|P5|COMPLETED|Washout Period of 1 Week||5
453686|NCT01288859|1112246|P4|COMPLETED|Washout Period of 1 Week||5
453687|NCT01288859|1112247|P3|COMPLETED|Washout Period of 1 Week||0
453688|NCT01288859|1112248|P2|COMPLETED|Washout Period of 1 Week||0
453689|NCT01288859|1112249|P1|COMPLETED|Washout Period of 1 Week||0
453690|NCT01288859|1112244|P6|STARTED|Washout Period of 1 Week||0
453691|NCT01288859|1112245|P5|STARTED|Washout Period of 1 Week||5
453692|NCT01288859|1112246|P4|STARTED|Washout Period of 1 Week||5
453693|NCT01288859|1112247|P3|STARTED|Washout Period of 1 Week||0
453694|NCT01288859|1112248|P2|STARTED|Washout Period of 1 Week||0
453695|NCT01288859|1112249|P1|STARTED|Washout Period of 1 Week||0
453696|NCT01288859|1112244|P6|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
453697|NCT01288859|1112245|P5|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
453698|NCT01288859|1112246|P4|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
453699|NCT01288859|1112247|P3|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
453700|NCT01288859|1112248|P2|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
453701|NCT01288859|1112249|P1|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
453702|NCT01288859|1112244|P6|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
453703|NCT01288859|1112245|P5|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5
453704|NCT01288859|1112246|P4|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5
453705|NCT01288859|1112247|P3|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
453706|NCT01288859|1112248|P2|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
453707|NCT01288859|1112249|P1|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
453708|NCT01288859|1112244|P6|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
453709|NCT01288859|1112245|P5|STARTED|Enc Polyph. Then Control Cream (1 Day)||5
453710|NCT01288859|1112246|P4|STARTED|Enc Polyph. Then Control Cream (1 Day)||5
453711|NCT01288859|1112247|P3|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
453712|NCT01288859|1112248|P2|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
453713|NCT01288859|1112249|P1|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
453714|NCT01288859|1112244|P6|NOT COMPLETED|Washout Period of 1 Week||0
453715|NCT01288859|1112245|P5|NOT COMPLETED|Washout Period of 1 Week||0
453716|NCT01288859|1112246|P4|NOT COMPLETED|Washout Period of 1 Week||0
453717|NCT01288859|1112247|P3|NOT COMPLETED|Washout Period of 1 Week||0
453718|NCT01288859|1112248|P2|NOT COMPLETED|Washout Period of 1 Week||0
453719|NCT01288859|1112249|P1|NOT COMPLETED|Washout Period of 1 Week||0
453720|NCT01288859|1112244|P6|COMPLETED|Washout Period of 1 Week||0
453721|NCT01288859|1112245|P5|COMPLETED|Washout Period of 1 Week||5
453722|NCT01288859|1112246|P4|COMPLETED|Washout Period of 1 Week||5
453723|NCT01288859|1112247|P3|COMPLETED|Washout Period of 1 Week||0
453724|NCT01288859|1112248|P2|COMPLETED|Washout Period of 1 Week||0
453725|NCT01288859|1112249|P1|COMPLETED|Washout Period of 1 Week||0
453726|NCT01288859|1112244|P6|STARTED|Washout Period of 1 Week||0
453727|NCT01288859|1112245|P5|STARTED|Washout Period of 1 Week||5
453728|NCT01288859|1112246|P4|STARTED|Washout Period of 1 Week||5
453729|NCT01288859|1112247|P3|STARTED|Washout Period of 1 Week||0
453730|NCT01288859|1112248|P2|STARTED|Washout Period of 1 Week||0
453731|NCT01288859|1112249|P1|STARTED|Washout Period of 1 Week||0
453732|NCT01288859|1112244|P6|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
453733|NCT01288859|1112245|P5|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
453734|NCT01288859|1112246|P4|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
453735|NCT01288859|1112247|P3|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
453736|NCT01288859|1112248|P2|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
453737|NCT01288859|1112249|P1|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
453738|NCT01288859|1112244|P6|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
453739|NCT01288859|1112245|P5|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
453740|NCT01288859|1112246|P4|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
453741|NCT01288859|1112247|P3|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
453742|NCT01288859|1112248|P2|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
453743|NCT01288859|1112249|P1|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
453744|NCT01288859|1112244|P6|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
453745|NCT01288859|1112245|P5|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
453746|NCT01288859|1112246|P4|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
453747|NCT01288859|1112247|P3|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
453748|NCT01288859|1112248|P2|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
453749|NCT01288859|1112249|P1|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
453750|NCT01288859|1112244|P6|NOT COMPLETED|Washout Period of 1 Week||0
453751|NCT01288859|1112245|P5|NOT COMPLETED|Washout Period of 1 Week||0
453752|NCT01288859|1112246|P4|NOT COMPLETED|Washout Period of 1 Week||0
453753|NCT01288859|1112247|P3|NOT COMPLETED|Washout Period of 1 Week||0
453754|NCT01288859|1112248|P2|NOT COMPLETED|Washout Period of 1 Week||0
453755|NCT01288859|1112249|P1|NOT COMPLETED|Washout Period of 1 Week||0
453756|NCT01288859|1112244|P6|COMPLETED|Washout Period of 1 Week||0
453757|NCT01288859|1112245|P5|COMPLETED|Washout Period of 1 Week||0
453758|NCT01288859|1112246|P4|COMPLETED|Washout Period of 1 Week||0
453759|NCT01288859|1112247|P3|COMPLETED|Washout Period of 1 Week||5
453760|NCT01288859|1112248|P2|COMPLETED|Washout Period of 1 Week||5
453761|NCT01288859|1112249|P1|COMPLETED|Washout Period of 1 Week||0
453762|NCT01288859|1112244|P6|STARTED|Washout Period of 1 Week||0
453763|NCT01288859|1112245|P5|STARTED|Washout Period of 1 Week||0
453764|NCT01288859|1112246|P4|STARTED|Washout Period of 1 Week||0
453765|NCT01288859|1112247|P3|STARTED|Washout Period of 1 Week||5
453766|NCT01288859|1112248|P2|STARTED|Washout Period of 1 Week||5
453767|NCT01288859|1112249|P1|STARTED|Washout Period of 1 Week||0
453768|NCT01288859|1112244|P6|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
453769|NCT01288859|1112245|P5|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
453770|NCT01288859|1112246|P4|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
453771|NCT01288859|1112247|P3|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
453772|NCT01288859|1112248|P2|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
453773|NCT01288859|1112249|P1|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
453774|NCT01288859|1112244|P6|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
453775|NCT01288859|1112245|P5|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
453776|NCT01288859|1112246|P4|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
453777|NCT01288859|1112247|P3|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
453778|NCT01288859|1112248|P2|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
453779|NCT01288859|1112249|P1|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
453780|NCT01288859|1112244|P6|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
453781|NCT01288859|1112245|P5|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
453782|NCT01288859|1112246|P4|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
453783|NCT01288859|1112247|P3|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
453784|NCT01288859|1112248|P2|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
453785|NCT01288859|1112249|P1|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
453786|NCT01288859|1112244|P6|NOT COMPLETED|Washout Period of 1 Week||0
453787|NCT01288859|1112245|P5|NOT COMPLETED|Washout Period of 1 Week||0
453788|NCT01288859|1112246|P4|NOT COMPLETED|Washout Period of 1 Week||0
453789|NCT01288859|1112247|P3|NOT COMPLETED|Washout Period of 1 Week||0
453790|NCT01288859|1112248|P2|NOT COMPLETED|Washout Period of 1 Week||0
453791|NCT01288859|1112249|P1|NOT COMPLETED|Washout Period of 1 Week||0
453792|NCT01288859|1112244|P6|COMPLETED|Washout Period of 1 Week||5
453793|NCT01288859|1112245|P5|COMPLETED|Washout Period of 1 Week||0
453794|NCT01288859|1112246|P4|COMPLETED|Washout Period of 1 Week||0
453795|NCT01288859|1112247|P3|COMPLETED|Washout Period of 1 Week||0
453796|NCT01288859|1112248|P2|COMPLETED|Washout Period of 1 Week||0
453797|NCT01288859|1112249|P1|COMPLETED|Washout Period of 1 Week||5
453798|NCT01288859|1112244|P6|STARTED|Washout Period of 1 Week||5
453799|NCT01288859|1112245|P5|STARTED|Washout Period of 1 Week||0
453800|NCT01288859|1112246|P4|STARTED|Washout Period of 1 Week||0
453801|NCT01288859|1112247|P3|STARTED|Washout Period of 1 Week||0
453802|NCT01288859|1112248|P2|STARTED|Washout Period of 1 Week||0
453803|NCT01288859|1112249|P1|STARTED|Washout Period of 1 Week||5
453804|NCT01288859|1112244|P6|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
453805|NCT01288859|1112245|P5|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
453806|NCT01288859|1112246|P4|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
453807|NCT01288859|1112247|P3|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
453808|NCT01288859|1112248|P2|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
453809|NCT01288859|1112249|P1|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
453810|NCT01288859|1112244|P6|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5
453811|NCT01288859|1112245|P5|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
453812|NCT01288859|1112246|P4|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
453813|NCT01288859|1112247|P3|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
453814|NCT01288859|1112248|P2|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
453815|NCT01288859|1112249|P1|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5
453816|NCT01288859|1112244|P6|STARTED|Encapsulated Then Free Curcumin (1 Day)||5
453817|NCT01288859|1112245|P5|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
453818|NCT01288859|1112246|P4|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
453819|NCT01288859|1112247|P3|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
453820|NCT01288859|1112248|P2|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
453821|NCT01288859|1112249|P1|STARTED|Encapsulated Then Free Curcumin (1 Day)||5
453822|NCT01288859|1112244|P6|NOT COMPLETED|Washout Period of 1 Week||0
453823|NCT01288859|1112245|P5|NOT COMPLETED|Washout Period of 1 Week||0
453824|NCT01288859|1112246|P4|NOT COMPLETED|Washout Period of 1 Week||0
453825|NCT01288859|1112247|P3|NOT COMPLETED|Washout Period of 1 Week||0
453826|NCT01288859|1112248|P2|NOT COMPLETED|Washout Period of 1 Week||0
453827|NCT01288859|1112249|P1|NOT COMPLETED|Washout Period of 1 Week||0
453828|NCT01288859|1112244|P6|COMPLETED|Washout Period of 1 Week||5
453829|NCT01288859|1112245|P5|COMPLETED|Washout Period of 1 Week||0
453830|NCT01288859|1112246|P4|COMPLETED|Washout Period of 1 Week||0
453831|NCT01288859|1112247|P3|COMPLETED|Washout Period of 1 Week||0
453832|NCT01288859|1112248|P2|COMPLETED|Washout Period of 1 Week||0
453833|NCT01288859|1112249|P1|COMPLETED|Washout Period of 1 Week||5
453834|NCT01288859|1112244|P6|STARTED|Washout Period of 1 Week||5
453835|NCT01288859|1112245|P5|STARTED|Washout Period of 1 Week||0
453836|NCT01288859|1112246|P4|STARTED|Washout Period of 1 Week||0
453837|NCT01288859|1112247|P3|STARTED|Washout Period of 1 Week||0
453838|NCT01288859|1112248|P2|STARTED|Washout Period of 1 Week||0
453839|NCT01288859|1112249|P1|STARTED|Washout Period of 1 Week||5
453840|NCT01288859|1112244|P6|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
453841|NCT01288859|1112245|P5|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
453842|NCT01288859|1112246|P4|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
453843|NCT01288859|1112247|P3|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
453844|NCT01288859|1112248|P2|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
453845|NCT01288859|1112249|P1|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
453846|NCT01288859|1112244|P6|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5
453847|NCT01288859|1112245|P5|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
453848|NCT01288859|1112246|P4|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
453849|NCT01288859|1112247|P3|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
453850|NCT01288859|1112248|P2|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
453851|NCT01288859|1112249|P1|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5
453852|NCT01288859|1112244|P6|STARTED|Free Then Encapsulated Curcumin (1 Day)||5
453853|NCT01288859|1112245|P5|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
453854|NCT01288859|1112246|P4|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
453855|NCT01288859|1112247|P3|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
453856|NCT01288859|1112248|P2|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
453857|NCT01288859|1112249|P1|STARTED|Free Then Encapsulated Curcumin (1 Day)||5
453858|NCT01288833|1112277|P2|NOT COMPLETED|Overall Study||0
453859|NCT01288833|1112278|P1|NOT COMPLETED|Overall Study||0
453860|NCT01288833|1112277|P2|COMPLETED|Overall Study||281
453861|NCT01288833|1112278|P1|COMPLETED|Overall Study||277
453862|NCT01288833|1112277|P2|STARTED|Overall Study||281
453863|NCT01288833|1112278|P1|STARTED|Overall Study||277
453864|NCT01288781|1112294|P2|NOT COMPLETED|Overall Study||0
453865|NCT01288781|1112295|P1|NOT COMPLETED|Overall Study||0
453866|NCT01288781|1112294|P2|COMPLETED|Overall Study||12
453867|NCT01288781|1112295|P1|COMPLETED|Overall Study||11
453868|NCT01288781|1112294|P2|STARTED|Overall Study||12
453869|NCT01288781|1112295|P1|STARTED|Overall Study||11
453870|NCT01288729|1112315|P2|NOT COMPLETED|Overall Study||0
453871|NCT01288729|1112316|P1|NOT COMPLETED|Overall Study||1
453872|NCT01288729|1112315|P2|COMPLETED|Overall Study||10
453873|NCT01288729|1112316|P1|COMPLETED|Overall Study||9
453874|NCT01288729|1112315|P2|STARTED|Overall Study||10
453875|NCT01288729|1112316|P1|STARTED|Overall Study||10
453876|NCT01288612|1112325|P3|NOT COMPLETED|Overall Study||82
453877|NCT01288612|1112326|P2|NOT COMPLETED|Overall Study||82
453878|NCT01288612|1112327|P1|NOT COMPLETED|Overall Study||89
453879|NCT01288612|1112325|P3|COMPLETED|Overall Study||76
453880|NCT01288612|1112326|P2|COMPLETED|Overall Study||69
453881|NCT01288612|1112327|P1|COMPLETED|Overall Study||61
453882|NCT01288612|1112325|P3|Agreed to Take Part|Overall Study||76
453883|NCT01288612|1112326|P2|Agreed to Take Part|Overall Study||72
453884|NCT01288612|1112327|P1|Agreed to Take Part|Overall Study||61
453885|NCT01288612|1112325|P3|Contacted|Overall Study||138
453886|NCT01288612|1112326|P2|Contacted|Overall Study||135
453887|NCT01288612|1112327|P1|Contacted|Overall Study||139
453888|NCT01288612|1112325|P3|STARTED|Overall Study||158
453889|NCT01288612|1112326|P2|STARTED|Overall Study||151
453890|NCT01288612|1112327|P1|STARTED|Overall Study||150
453891|NCT01288534|1112356|P1|NOT COMPLETED|Overall Study||0
453892|NCT01288534|1112356|P1|COMPLETED|Overall Study||68
453893|NCT01288534|1112356|P1|STARTED|Overall Study||68
453894|NCT01288521|1112366|P2|NOT COMPLETED|Overall Study||0
453895|NCT01288521|1112367|P1|NOT COMPLETED|Overall Study||0
453896|NCT01288521|1112366|P2|COMPLETED|Overall Study||5
453897|NCT01288521|1112367|P1|COMPLETED|Overall Study||3
453898|NCT01288521|1112366|P2|STARTED|Overall Study||5
453899|NCT01288521|1112367|P1|STARTED|Overall Study||3
453900|NCT01288469|1112376|P3|NOT COMPLETED|Overall Study||2
453901|NCT01288469|1112377|P2|NOT COMPLETED|Overall Study||3
453902|NCT01288469|1112378|P1|NOT COMPLETED|Overall Study||7
453903|NCT01288469|1112376|P3|COMPLETED|Overall Study||28
453904|NCT01288469|1112377|P2|COMPLETED|Overall Study||28
453905|NCT01288469|1112378|P1|COMPLETED|Overall Study||24
453906|NCT01288469|1112376|P3|Treated|Overall Study||30
453907|NCT01288469|1112377|P2|Treated|Overall Study||31
453908|NCT01288469|1112378|P1|Treated|Overall Study||31
453909|NCT01288469|1112376|P3|STARTED|Overall Study|Randomized|30
453910|NCT01288469|1112377|P2|STARTED|Overall Study|Randomized|31
453911|NCT01288469|1112378|P1|STARTED|Overall Study|Randomized|31
453912|NCT01288443|1112410|P6|NOT COMPLETED|Overall Study||5
453913|NCT01288443|1112411|P5|NOT COMPLETED|Overall Study||7
453914|NCT01288443|1112412|P4|NOT COMPLETED|Overall Study||4
453915|NCT01288443|1112413|P3|NOT COMPLETED|Overall Study||1
453916|NCT01288443|1112414|P2|NOT COMPLETED|Overall Study||1
453917|NCT01288443|1112415|P1|NOT COMPLETED|Overall Study||0
453918|NCT01288443|1112410|P6|COMPLETED|Overall Study||25
453919|NCT01288443|1112411|P5|COMPLETED|Overall Study||23
453920|NCT01288443|1112412|P4|COMPLETED|Overall Study||27
453921|NCT01288443|1112413|P3|COMPLETED|Overall Study||30
453922|NCT01288443|1112414|P2|COMPLETED|Overall Study||29
453923|NCT01288443|1112415|P1|COMPLETED|Overall Study||31
453924|NCT01288443|1112410|P6|Treated|Overall Study||30
453925|NCT01288443|1112411|P5|Treated|Overall Study||29
453926|NCT01288443|1112412|P4|Treated|Overall Study||31
453927|NCT01288443|1112413|P3|Treated|Overall Study||31
453928|NCT01288443|1112414|P2|Treated|Overall Study||30
453929|NCT01288443|1112415|P1|Treated|Overall Study||31
453930|NCT01288443|1112410|P6|STARTED|Overall Study|Randomized|30
453931|NCT01288443|1112411|P5|STARTED|Overall Study|Randomized|30
453932|NCT01288443|1112412|P4|STARTED|Overall Study|Randomized|31
453933|NCT01288443|1112413|P3|STARTED|Overall Study|Randomized|31
453934|NCT01288443|1112414|P2|STARTED|Overall Study|Randomized|30
453935|NCT01288443|1112415|P1|STARTED|Overall Study|Randomized|31
453936|NCT01288287|1112465|P1|NOT COMPLETED|Overall Study||46
453937|NCT01288287|1112465|P1|COMPLETED|Overall Study||103
453938|NCT01288287|1112465|P1|Full Analysis Set|Overall Study||111
453939|NCT01288287|1112465|P1|Safety Set|Overall Study||147
453940|NCT01288287|1112465|P1|STARTED|Overall Study||149
453941|NCT01288209|1112480|P2|NOT COMPLETED|Overall Study||3
453942|NCT01288209|1112481|P1|NOT COMPLETED|Overall Study||2
453943|NCT01288209|1112480|P2|COMPLETED|Overall Study||50
453944|NCT01288209|1112481|P1|COMPLETED|Overall Study||51
453945|NCT01288209|1112480|P2|STARTED|Overall Study||53
453946|NCT01288209|1112481|P1|STARTED|Overall Study||53
453947|NCT01288079|1112511|P4|NOT COMPLETED|Overall Study||17
453948|NCT01288079|1112512|P3|NOT COMPLETED|Overall Study||19
453949|NCT01288079|1112513|P2|NOT COMPLETED|Overall Study||27
453950|NCT01288079|1112514|P1|NOT COMPLETED|Overall Study||20
453951|NCT01288079|1112511|P4|COMPLETED|Overall Study||18
453952|NCT01288079|1112512|P3|COMPLETED|Overall Study||18
453953|NCT01288079|1112513|P2|COMPLETED|Overall Study||9
453954|NCT01288079|1112514|P1|COMPLETED|Overall Study||17
453955|NCT01288079|1112511|P4|STARTED|Overall Study||35
453956|NCT01288079|1112512|P3|STARTED|Overall Study||37
453957|NCT01288079|1112513|P2|STARTED|Overall Study||36
453958|NCT01288079|1112514|P1|STARTED|Overall Study||37
453959|NCT01288027|1112524|P1|NOT COMPLETED|Overall Study||0
453960|NCT01288027|1112524|P1|COMPLETED|Overall Study||16
453961|NCT01288027|1112524|P1|Full Analysis Set (FAS)|Overall Study|All participants who received at least 1 complete infusion of alglucosidase alfa.|16
453962|NCT01288027|1112524|P1|STARTED|Overall Study||16
453963|NCT01287897|1112538|P4|NOT COMPLETED|Overall Study||7
453964|NCT01287897|1112539|P3|NOT COMPLETED|Overall Study||12
453965|NCT01287897|1112540|P2|NOT COMPLETED|Overall Study||11
453966|NCT01287897|1112541|P1|NOT COMPLETED|Overall Study||11
453967|NCT01287897|1112538|P4|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|33
453968|NCT01287897|1112539|P3|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|59
453969|NCT01287897|1112540|P2|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|58
453970|NCT01287897|1112541|P1|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|59
453971|NCT01287897|1112538|P4|Enrolled in NCT01345318|Overall Study||29
453972|NCT01287897|1112539|P3|Enrolled in NCT01345318|Overall Study||56
453973|NCT01287897|1112540|P2|Enrolled in NCT01345318|Overall Study||50
453974|NCT01287897|1112541|P1|Enrolled in NCT01345318|Overall Study||56
453975|NCT01287897|1112538|P4|Completed Follow-up Period|Overall Study||4
453976|NCT01287897|1112539|P3|Completed Follow-up Period|Overall Study||3
453977|NCT01287897|1112540|P2|Completed Follow-up Period|Overall Study||8
453978|NCT01287897|1112541|P1|Completed Follow-up Period|Overall Study||3
453979|NCT01287897|1112538|P4|Completed Treatment Period|Overall Study||29
453980|NCT01287897|1112539|P3|Completed Treatment Period|Overall Study||58
453981|NCT01287897|1112540|P2|Completed Treatment Period|Overall Study||52
453982|NCT01287897|1112541|P1|Completed Treatment Period|Overall Study||58
453983|NCT01287897|1112538|P4|Treated|Overall Study||40
453984|NCT01287897|1112539|P3|Treated|Overall Study||71
453985|NCT01287897|1112540|P2|Treated|Overall Study||67
453986|NCT01287897|1112541|P1|Treated|Overall Study||69
453987|NCT01287897|1112538|P4|STARTED|Overall Study|Enrollment was halted before reaching the planned sample size due to safety findings in NCT01405196.|40
453988|NCT01287897|1112539|P3|STARTED|Overall Study||71
453989|NCT01287897|1112540|P2|STARTED|Overall Study||69
453990|NCT01287897|1112541|P1|STARTED|Overall Study||70
453991|NCT01287832|1112592|P2|NOT COMPLETED|Overall Study||1
453992|NCT01287832|1112593|P1|NOT COMPLETED|Overall Study||1
453993|NCT01287832|1112592|P2|COMPLETED|Overall Study||4
453994|NCT01287832|1112593|P1|COMPLETED|Overall Study||5
453995|NCT01287832|1112592|P2|STARTED|Overall Study||5
453996|NCT01287832|1112593|P1|STARTED|Overall Study||6
453997|NCT01287754|1112601|P2|NOT COMPLETED|Overall Study||21
453998|NCT01287754|1112602|P1|NOT COMPLETED|Overall Study||3
453999|NCT01287754|1112601|P2|COMPLETED|Overall Study||0
454000|NCT01287754|1112602|P1|COMPLETED|Overall Study||0
454001|NCT01287754|1112601|P2|STARTED|Overall Study||21
454002|NCT01287754|1112602|P1|STARTED|Overall Study||3
454003|NCT01287741|1112614|P2|NOT COMPLETED|Overall Study||706
454004|NCT01287741|1112615|P1|NOT COMPLETED|Overall Study||712
454005|NCT01287741|1112614|P2|COMPLETED|Overall Study||0
454006|NCT01287741|1112615|P1|COMPLETED|Overall Study||0
454007|NCT01287741|1112614|P2|STARTED|Overall Study||706
454008|NCT01287741|1112615|P1|STARTED|Overall Study||712
454009|NCT01287611|1112651|P2|NOT COMPLETED|Overall Study||19
454010|NCT01287611|1112652|P1|NOT COMPLETED|Overall Study||33
454011|NCT01287611|1112651|P2|COMPLETED|Overall Study||65
454012|NCT01287611|1112652|P1|COMPLETED|Overall Study||51
454095|NCT01287208|1112759|P2|NOT COMPLETED|Phase 1: Randomized Phase||3
454013|NCT01287611|1112651|P2|The Number of Patients Who Underwent C/S|Overall Study||84
454014|NCT01287611|1112652|P1|The Number of Patients Who Underwent C/S|Overall Study||84
454015|NCT01287611|1112651|P2|STARTED|Overall Study||84
454016|NCT01287611|1112652|P1|STARTED|Overall Study||84
454017|NCT01287416|1112662|P2|NOT COMPLETED|6 Month Follow-up||2
454018|NCT01287416|1112663|P1|NOT COMPLETED|6 Month Follow-up||3
454019|NCT01287416|1112662|P2|COMPLETED|6 Month Follow-up||22
454020|NCT01287416|1112663|P1|COMPLETED|6 Month Follow-up||28
454021|NCT01287416|1112662|P2|STARTED|6 Month Follow-up|all participants that had completed the baseline measure were invited to do the follow-up|24
454022|NCT01287416|1112663|P1|STARTED|6 Month Follow-up|all participants that had completed the baseline measure were invited to do the follow-up|31
454023|NCT01287416|1112662|P2|NOT COMPLETED|Pre-post Training||25
454024|NCT01287416|1112663|P1|NOT COMPLETED|Pre-post Training||22
454025|NCT01287416|1112662|P2|COMPLETED|Pre-post Training||23
454026|NCT01287416|1112663|P1|COMPLETED|Pre-post Training||26
454027|NCT01287416|1112662|P2|Post Training Questionnaire|Pre-post Training||23
454028|NCT01287416|1112663|P1|Post Training Questionnaire|Pre-post Training||26
454029|NCT01287416|1112662|P2|Training Workshop|Pre-post Training|number of people that showed up for the training session|24
454030|NCT01287416|1112663|P1|Training Workshop|Pre-post Training|number of people that showed up for the training session|31
454031|NCT01287416|1112662|P2|STARTED|Pre-post Training|number of people that were invited to participate based on eligibility and consent received|48
454032|NCT01287416|1112663|P1|STARTED|Pre-post Training|number of people that were invited to participate based on eligibility and consent received|48
454033|NCT01287403|1112699|P1|NOT COMPLETED|6th and Last Intervention (1 Day)||0
454034|NCT01287403|1112699|P1|COMPLETED|6th and Last Intervention (1 Day)||13
454035|NCT01287403|1112699|P1|STARTED|6th and Last Intervention (1 Day)||13
454036|NCT01287403|1112699|P1|NOT COMPLETED|Washout (7 Days)||0
454037|NCT01287403|1112699|P1|COMPLETED|Washout (7 Days)||13
454038|NCT01287403|1112699|P1|STARTED|Washout (7 Days)||13
454039|NCT01287403|1112699|P1|NOT COMPLETED|5th Intervention (1 Day)||0
454040|NCT01287403|1112699|P1|COMPLETED|5th Intervention (1 Day)||13
454041|NCT01287403|1112699|P1|STARTED|5th Intervention (1 Day)||13
454042|NCT01287403|1112699|P1|NOT COMPLETED|Washout (7 Days)||0
454043|NCT01287403|1112699|P1|COMPLETED|Washout (7 Days)||13
454044|NCT01287403|1112699|P1|STARTED|Washout (7 Days)||13
454045|NCT01287403|1112699|P1|NOT COMPLETED|4th Intervention (1 Day)||0
454046|NCT01287403|1112699|P1|COMPLETED|4th Intervention (1 Day)||13
454047|NCT01287403|1112699|P1|STARTED|4th Intervention (1 Day)||13
454048|NCT01287403|1112699|P1|NOT COMPLETED|Washout (7 Days)||0
454049|NCT01287403|1112699|P1|COMPLETED|Washout (7 Days)||13
454050|NCT01287403|1112699|P1|STARTED|Washout (7 Days)||13
454051|NCT01287403|1112699|P1|NOT COMPLETED|3rd Intervention (1 Day)||0
454052|NCT01287403|1112699|P1|COMPLETED|3rd Intervention (1 Day)||13
454053|NCT01287403|1112699|P1|STARTED|3rd Intervention (1 Day)||13
454054|NCT01287403|1112699|P1|NOT COMPLETED|Washout (7 Days)||0
454055|NCT01287403|1112699|P1|COMPLETED|Washout (7 Days)||13
454056|NCT01287403|1112699|P1|STARTED|Washout (7 Days)||13
454057|NCT01287403|1112699|P1|NOT COMPLETED|2nd Intervention (1 Day)||0
454058|NCT01287403|1112699|P1|COMPLETED|2nd Intervention (1 Day)||13
454059|NCT01287403|1112699|P1|STARTED|2nd Intervention (1 Day)||13
454060|NCT01287403|1112699|P1|NOT COMPLETED|Washout 7 Days||0
454061|NCT01287403|1112699|P1|COMPLETED|Washout 7 Days||13
454062|NCT01287403|1112699|P1|STARTED|Washout 7 Days||13
454063|NCT01287403|1112699|P1|NOT COMPLETED|1st Intervention (1 Day)||1
454064|NCT01287403|1112699|P1|COMPLETED|1st Intervention (1 Day)|"The adverse event was linked to the intake of refined wheat flour"|13
454065|NCT01287403|1112699|P1|STARTED|1st Intervention (1 Day)||14
454066|NCT01287403|1112699|P1|NOT COMPLETED|Diet Restriction (7 Days)||0
454067|NCT01287403|1112699|P1|COMPLETED|Diet Restriction (7 Days)||14
454068|NCT01287403|1112699|P1|STARTED|Diet Restriction (7 Days)||14
454069|NCT01287364|1112715|P2|NOT COMPLETED|Overall Study||10
454070|NCT01287364|1112716|P1|NOT COMPLETED|Overall Study||9
454071|NCT01287364|1112715|P2|COMPLETED|Overall Study||81
454072|NCT01287364|1112716|P1|COMPLETED|Overall Study||85
454073|NCT01287364|1112715|P2|STARTED|Overall Study||91
454074|NCT01287364|1112716|P1|STARTED|Overall Study||94
454075|NCT01287221|1112738|P2|NOT COMPLETED|Overall Study||5
454076|NCT01287221|1112739|P1|NOT COMPLETED|Overall Study||4
454077|NCT01287221|1112738|P2|COMPLETED|Overall Study||45
454078|NCT01287221|1112739|P1|COMPLETED|Overall Study||46
454079|NCT01287221|1112738|P2|Completed 12 Months Follow-up|Overall Study||39
454080|NCT01287221|1112739|P1|Completed 12 Months Follow-up|Overall Study||40
454081|NCT01287221|1112738|P2|Completed 9 Months Follow-up|Overall Study||40
454082|NCT01287221|1112739|P1|Completed 9 Months Follow-up|Overall Study||42
454083|NCT01287221|1112738|P2|Completed 6 Months Follow-up|Overall Study||43
454084|NCT01287221|1112739|P1|Completed 6 Months Follow-up|Overall Study||47
454085|NCT01287221|1112738|P2|Completed 3 Months Follow-up|Overall Study||50
454086|NCT01287221|1112739|P1|Completed 3 Months Follow-up|Overall Study||49
454087|NCT01287221|1112738|P2|STARTED|Overall Study||50
454088|NCT01287221|1112739|P1|STARTED|Overall Study||50
454089|NCT01287208|1112759|P2|NOT COMPLETED|Phase 2: Team Competition||0
454090|NCT01287208|1112760|P1|NOT COMPLETED|Phase 2: Team Competition||0
454091|NCT01287208|1112759|P2|COMPLETED|Phase 2: Team Competition||49
454092|NCT01287208|1112760|P1|COMPLETED|Phase 2: Team Competition||50
454093|NCT01287208|1112759|P2|STARTED|Phase 2: Team Competition||49
454094|NCT01287208|1112760|P1|STARTED|Phase 2: Team Competition||50
454096|NCT01287208|1112760|P1|NOT COMPLETED|Phase 1: Randomized Phase||2
454097|NCT01287208|1112759|P2|COMPLETED|Phase 1: Randomized Phase||49
454098|NCT01287208|1112760|P1|COMPLETED|Phase 1: Randomized Phase||50
454099|NCT01287208|1112759|P2|STARTED|Phase 1: Randomized Phase||52
454100|NCT01287208|1112760|P1|STARTED|Phase 1: Randomized Phase||52
454101|NCT01287195|1112774|P1|NOT COMPLETED|Overall Study||2
454102|NCT01287195|1112774|P1|COMPLETED|Overall Study||4
454103|NCT01287195|1112774|P1|STARTED|Overall Study||6
454104|NCT01287117|1112789|P4|NOT COMPLETED|Overall Study||12
454105|NCT01287117|1112790|P3|NOT COMPLETED|Overall Study||16
454106|NCT01287117|1112791|P2|NOT COMPLETED|Overall Study||14
454107|NCT01287117|1112792|P1|NOT COMPLETED|Overall Study||15
454108|NCT01287117|1112789|P4|COMPLETED|Overall Study||69
454109|NCT01287117|1112790|P3|COMPLETED|Overall Study||64
454110|NCT01287117|1112791|P2|COMPLETED|Overall Study||64
454111|NCT01287117|1112792|P1|COMPLETED|Overall Study||65
454112|NCT01287117|1112789|P4|Received Treatment|Overall Study||81
454113|NCT01287117|1112790|P3|Received Treatment|Overall Study||80
454114|NCT01287117|1112791|P2|Received Treatment|Overall Study||77
454115|NCT01287117|1112792|P1|Received Treatment|Overall Study||80
454116|NCT01287117|1112789|P4|STARTED|Overall Study||81
454117|NCT01287117|1112790|P3|STARTED|Overall Study||80
454118|NCT01287117|1112791|P2|STARTED|Overall Study||78
454119|NCT01287117|1112792|P1|STARTED|Overall Study||80
454120|NCT01287065|1112838|P6|NOT COMPLETED|Treatment Period 3||0
454121|NCT01287065|1112839|P5|NOT COMPLETED|Treatment Period 3||0
454122|NCT01287065|1112840|P4|NOT COMPLETED|Treatment Period 3||0
454123|NCT01287065|1112841|P3|NOT COMPLETED|Treatment Period 3||0
454124|NCT01287065|1112842|P2|NOT COMPLETED|Treatment Period 3||0
454125|NCT01287065|1112843|P1|NOT COMPLETED|Treatment Period 3||0
454126|NCT01287065|1112838|P6|COMPLETED|Treatment Period 3||4
454127|NCT01287065|1112839|P5|COMPLETED|Treatment Period 3||4
454128|NCT01287065|1112840|P4|COMPLETED|Treatment Period 3||4
454129|NCT01287065|1112841|P3|COMPLETED|Treatment Period 3||4
454130|NCT01287065|1112842|P2|COMPLETED|Treatment Period 3||4
454131|NCT01287065|1112843|P1|COMPLETED|Treatment Period 3||4
454132|NCT01287065|1112838|P6|STARTED|Treatment Period 3||4
454133|NCT01287065|1112839|P5|STARTED|Treatment Period 3||4
454134|NCT01287065|1112840|P4|STARTED|Treatment Period 3||4
454135|NCT01287065|1112841|P3|STARTED|Treatment Period 3||4
454136|NCT01287065|1112842|P2|STARTED|Treatment Period 3||4
454137|NCT01287065|1112843|P1|STARTED|Treatment Period 3||4
454138|NCT01287065|1112838|P6|NOT COMPLETED|Washout Period 2||0
454139|NCT01287065|1112839|P5|NOT COMPLETED|Washout Period 2||0
454140|NCT01287065|1112840|P4|NOT COMPLETED|Washout Period 2||0
454141|NCT01287065|1112841|P3|NOT COMPLETED|Washout Period 2||0
454142|NCT01287065|1112842|P2|NOT COMPLETED|Washout Period 2||0
454143|NCT01287065|1112843|P1|NOT COMPLETED|Washout Period 2||0
454144|NCT01287065|1112838|P6|COMPLETED|Washout Period 2||4
454145|NCT01287065|1112839|P5|COMPLETED|Washout Period 2||4
454146|NCT01287065|1112840|P4|COMPLETED|Washout Period 2||4
454147|NCT01287065|1112841|P3|COMPLETED|Washout Period 2||4
454148|NCT01287065|1112842|P2|COMPLETED|Washout Period 2||4
454149|NCT01287065|1112843|P1|COMPLETED|Washout Period 2||4
454150|NCT01287065|1112838|P6|STARTED|Washout Period 2||4
454151|NCT01287065|1112839|P5|STARTED|Washout Period 2||4
454152|NCT01287065|1112840|P4|STARTED|Washout Period 2||4
454153|NCT01287065|1112841|P3|STARTED|Washout Period 2||4
454154|NCT01287065|1112842|P2|STARTED|Washout Period 2||4
454155|NCT01287065|1112843|P1|STARTED|Washout Period 2||4
454156|NCT01287065|1112838|P6|NOT COMPLETED|Treatment Period 2||0
454157|NCT01287065|1112839|P5|NOT COMPLETED|Treatment Period 2||0
454158|NCT01287065|1112840|P4|NOT COMPLETED|Treatment Period 2||0
454159|NCT01287065|1112841|P3|NOT COMPLETED|Treatment Period 2||0
454160|NCT01287065|1112842|P2|NOT COMPLETED|Treatment Period 2||0
454161|NCT01287065|1112843|P1|NOT COMPLETED|Treatment Period 2||0
454162|NCT01287065|1112838|P6|COMPLETED|Treatment Period 2||4
454163|NCT01287065|1112839|P5|COMPLETED|Treatment Period 2||4
454164|NCT01287065|1112840|P4|COMPLETED|Treatment Period 2||4
454165|NCT01287065|1112841|P3|COMPLETED|Treatment Period 2||4
454166|NCT01287065|1112842|P2|COMPLETED|Treatment Period 2||4
454167|NCT01287065|1112843|P1|COMPLETED|Treatment Period 2||4
454168|NCT01287065|1112838|P6|STARTED|Treatment Period 2||4
454169|NCT01287065|1112839|P5|STARTED|Treatment Period 2||4
454170|NCT01287065|1112840|P4|STARTED|Treatment Period 2||4
454171|NCT01287065|1112841|P3|STARTED|Treatment Period 2||4
454172|NCT01287065|1112842|P2|STARTED|Treatment Period 2||4
454173|NCT01287065|1112843|P1|STARTED|Treatment Period 2||4
454174|NCT01287065|1112838|P6|NOT COMPLETED|Washout Period 1||0
454175|NCT01287065|1112839|P5|NOT COMPLETED|Washout Period 1||0
454176|NCT01287065|1112840|P4|NOT COMPLETED|Washout Period 1||0
454177|NCT01287065|1112841|P3|NOT COMPLETED|Washout Period 1||0
454178|NCT01287065|1112842|P2|NOT COMPLETED|Washout Period 1||0
454179|NCT01287065|1112843|P1|NOT COMPLETED|Washout Period 1||0
454180|NCT01287065|1112838|P6|COMPLETED|Washout Period 1||4
454181|NCT01287065|1112839|P5|COMPLETED|Washout Period 1||4
454182|NCT01287065|1112840|P4|COMPLETED|Washout Period 1||4
454183|NCT01287065|1112841|P3|COMPLETED|Washout Period 1||4
454184|NCT01287065|1112842|P2|COMPLETED|Washout Period 1||4
454185|NCT01287065|1112843|P1|COMPLETED|Washout Period 1||4
454186|NCT01287065|1112838|P6|STARTED|Washout Period 1||4
454187|NCT01287065|1112839|P5|STARTED|Washout Period 1||4
454188|NCT01287065|1112840|P4|STARTED|Washout Period 1||4
454189|NCT01287065|1112841|P3|STARTED|Washout Period 1||4
454190|NCT01287065|1112842|P2|STARTED|Washout Period 1||4
454191|NCT01287065|1112843|P1|STARTED|Washout Period 1||4
454192|NCT01287065|1112838|P6|NOT COMPLETED|Treatment Period 1||1
454193|NCT01287065|1112839|P5|NOT COMPLETED|Treatment Period 1||1
454194|NCT01287065|1112840|P4|NOT COMPLETED|Treatment Period 1||0
454195|NCT01287065|1112841|P3|NOT COMPLETED|Treatment Period 1||0
454196|NCT01287065|1112842|P2|NOT COMPLETED|Treatment Period 1||0
454197|NCT01287065|1112843|P1|NOT COMPLETED|Treatment Period 1||0
454198|NCT01287065|1112838|P6|COMPLETED|Treatment Period 1||4
454199|NCT01287065|1112839|P5|COMPLETED|Treatment Period 1||4
454200|NCT01287065|1112840|P4|COMPLETED|Treatment Period 1||4
454201|NCT01287065|1112841|P3|COMPLETED|Treatment Period 1||4
454202|NCT01287065|1112842|P2|COMPLETED|Treatment Period 1||4
454203|NCT01287065|1112843|P1|COMPLETED|Treatment Period 1||4
454204|NCT01287065|1112838|P6|STARTED|Treatment Period 1||5
454205|NCT01287065|1112839|P5|STARTED|Treatment Period 1||5
454206|NCT01287065|1112840|P4|STARTED|Treatment Period 1||4
454207|NCT01287065|1112841|P3|STARTED|Treatment Period 1||4
454208|NCT01287065|1112842|P2|STARTED|Treatment Period 1||4
454209|NCT01287065|1112843|P1|STARTED|Treatment Period 1||4
454210|NCT01287039|1112862|P2|NOT COMPLETED|Overall Study||27
454211|NCT01287039|1112863|P1|NOT COMPLETED|Overall Study||29
454212|NCT01287039|1112862|P2|COMPLETED|Overall Study||218
454213|NCT01287039|1112863|P1|COMPLETED|Overall Study||215
454214|NCT01287039|1112862|P2|STARTED|Overall Study||245
454215|NCT01287039|1112863|P1|STARTED|Overall Study||244
454216|NCT01287013|1112896|P3|NOT COMPLETED|Overall Study||21
454217|NCT01287013|1112897|P2|NOT COMPLETED|Overall Study||5
454218|NCT01287013|1112898|P1|NOT COMPLETED|Overall Study||3
454219|NCT01287013|1112896|P3|COMPLETED|Overall Study||0
454220|NCT01287013|1112897|P2|COMPLETED|Overall Study||29
454221|NCT01287013|1112898|P1|COMPLETED|Overall Study||29
454222|NCT01287013|1112896|P3|STARTED|Overall Study||21
454223|NCT01287013|1112897|P2|STARTED|Overall Study||34
454224|NCT01287013|1112898|P1|STARTED|Overall Study||32
454225|NCT01286818|1112913|P1|NOT COMPLETED|Overall Study||0
454226|NCT01286818|1112913|P1|COMPLETED|Overall Study||6
454227|NCT01286818|1112913|P1|Completed DLT Assessment Period|Overall Study||5
454228|NCT01286818|1112913|P1|STARTED|Overall Study||6
454229|NCT01286805|1112927|P2|NOT COMPLETED|Overall Study||1
454230|NCT01286805|1112928|P1|NOT COMPLETED|Overall Study||0
454231|NCT01286805|1112927|P2|COMPLETED|Overall Study||41
454232|NCT01286805|1112928|P1|COMPLETED|Overall Study||41
454233|NCT01286805|1112927|P2|STARTED|Overall Study||42
454234|NCT01286805|1112928|P1|STARTED|Overall Study||41
454235|NCT01286753|1112950|P2|NOT COMPLETED|Overall Study||25
454236|NCT01286753|1112951|P1|NOT COMPLETED|Overall Study||26
454237|NCT01286753|1112950|P2|COMPLETED|Overall Study||0
454238|NCT01286753|1112951|P1|COMPLETED|Overall Study||0
454239|NCT01286753|1112950|P2|STARTED|Overall Study||25
454240|NCT01286753|1112951|P1|STARTED|Overall Study||26
454241|NCT01286740|1112969|P1|NOT COMPLETED|Overall Study||2
454242|NCT01286740|1112969|P1|COMPLETED|Overall Study||48
454243|NCT01286740|1112969|P1|Week 12 (Primary Endpoint)|Overall Study||49
454244|NCT01286740|1112969|P1|Enrolled and Treated|Overall Study||49
454245|NCT01286740|1112969|P1|STARTED|Overall Study||50
454246|NCT01286558|1112987|P2|NOT COMPLETED|Overall Study||2
454247|NCT01286558|1112988|P1|NOT COMPLETED|Overall Study||1
454248|NCT01286558|1112987|P2|COMPLETED|Overall Study||111
454249|NCT01286558|1112988|P1|COMPLETED|Overall Study||111
454250|NCT01286558|1112987|P2|STARTED|Overall Study||113
454251|NCT01286558|1112988|P1|STARTED|Overall Study||112
454252|NCT01286493|1113018|P1|NOT COMPLETED|Overall Study||3
454253|NCT01286493|1113018|P1|COMPLETED|Overall Study||30
454254|NCT01286493|1113018|P1|STARTED|Overall Study||33
454255|NCT01286480|1113024|P2|NOT COMPLETED|Overall Study||3
454256|NCT01286480|1113025|P1|NOT COMPLETED|Overall Study||5
454257|NCT01286480|1113024|P2|COMPLETED|Overall Study||31
454258|NCT01286480|1113025|P1|COMPLETED|Overall Study||27
454259|NCT01286480|1113024|P2|STARTED|Overall Study||34
454260|NCT01286480|1113025|P1|STARTED|Overall Study||32
454261|NCT01286454|1113033|P11|NOT COMPLETED|Part II- Sixth Intervention Period||0
454262|NCT01286454|1113034|P10|NOT COMPLETED|Part II- Sixth Intervention Period||0
454263|NCT01286454|1113035|P9|NOT COMPLETED|Part II- Sixth Intervention Period||0
454264|NCT01286454|1113036|P8|NOT COMPLETED|Part II- Sixth Intervention Period||0
454265|NCT01286454|1113037|P7|NOT COMPLETED|Part II- Sixth Intervention Period||0
454266|NCT01286454|1113038|P6|NOT COMPLETED|Part II- Sixth Intervention Period||0
454267|NCT01286454|1113039|P5|NOT COMPLETED|Part II- Sixth Intervention Period||0
454268|NCT01286454|1113040|P4|NOT COMPLETED|Part II- Sixth Intervention Period||0
454269|NCT01286454|1113041|P3|NOT COMPLETED|Part II- Sixth Intervention Period||0
454270|NCT01286454|1113042|P2|NOT COMPLETED|Part II- Sixth Intervention Period||0
454271|NCT01286454|1113043|P1|NOT COMPLETED|Part II- Sixth Intervention Period||0
454272|NCT01286454|1113033|P11|COMPLETED|Part II- Sixth Intervention Period||20
454273|NCT01286454|1113034|P10|COMPLETED|Part II- Sixth Intervention Period||0
454274|NCT01286454|1113035|P9|COMPLETED|Part II- Sixth Intervention Period||0
454275|NCT01286454|1113036|P8|COMPLETED|Part II- Sixth Intervention Period||0
454276|NCT01286454|1113037|P7|COMPLETED|Part II- Sixth Intervention Period||0
454277|NCT01286454|1113038|P6|COMPLETED|Part II- Sixth Intervention Period||0
454278|NCT01286454|1113039|P5|COMPLETED|Part II- Sixth Intervention Period||0
454279|NCT01286454|1113040|P4|COMPLETED|Part II- Sixth Intervention Period||0
454280|NCT01286454|1113041|P3|COMPLETED|Part II- Sixth Intervention Period||0
454281|NCT01286454|1113042|P2|COMPLETED|Part II- Sixth Intervention Period||0
454282|NCT01286454|1113043|P1|COMPLETED|Part II- Sixth Intervention Period||0
454283|NCT01286454|1113033|P11|STARTED|Part II- Sixth Intervention Period||20
454284|NCT01286454|1113034|P10|STARTED|Part II- Sixth Intervention Period||0
454285|NCT01286454|1113035|P9|STARTED|Part II- Sixth Intervention Period||0
454286|NCT01286454|1113036|P8|STARTED|Part II- Sixth Intervention Period||0
454287|NCT01286454|1113037|P7|STARTED|Part II- Sixth Intervention Period||0
454288|NCT01286454|1113038|P6|STARTED|Part II- Sixth Intervention Period||0
454289|NCT01286454|1113039|P5|STARTED|Part II- Sixth Intervention Period||0
454290|NCT01286454|1113040|P4|STARTED|Part II- Sixth Intervention Period||0
454291|NCT01286454|1113041|P3|STARTED|Part II- Sixth Intervention Period||0
454292|NCT01286454|1113042|P2|STARTED|Part II- Sixth Intervention Period||0
454293|NCT01286454|1113043|P1|STARTED|Part II- Sixth Intervention Period||0
454294|NCT01286454|1113033|P11|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
454295|NCT01286454|1113034|P10|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
454296|NCT01286454|1113035|P9|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
454297|NCT01286454|1113036|P8|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
454298|NCT01286454|1113037|P7|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
454299|NCT01286454|1113038|P6|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
454300|NCT01286454|1113039|P5|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
454301|NCT01286454|1113040|P4|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
454302|NCT01286454|1113041|P3|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
454303|NCT01286454|1113042|P2|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
454304|NCT01286454|1113043|P1|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
454305|NCT01286454|1113033|P11|COMPLETED|Washout Period (Approximately 2 Weeks)||0
454306|NCT01286454|1113034|P10|COMPLETED|Washout Period (Approximately 2 Weeks)||2
454307|NCT01286454|1113035|P9|COMPLETED|Washout Period (Approximately 2 Weeks)||2
454308|NCT01286454|1113036|P8|COMPLETED|Washout Period (Approximately 2 Weeks)||2
454309|NCT01286454|1113037|P7|COMPLETED|Washout Period (Approximately 2 Weeks)||2
454310|NCT01286454|1113038|P6|COMPLETED|Washout Period (Approximately 2 Weeks)||2
454311|NCT01286454|1113039|P5|COMPLETED|Washout Period (Approximately 2 Weeks)||2
454312|NCT01286454|1113040|P4|COMPLETED|Washout Period (Approximately 2 Weeks)||2
454313|NCT01286454|1113041|P3|COMPLETED|Washout Period (Approximately 2 Weeks)||2
454314|NCT01286454|1113042|P2|COMPLETED|Washout Period (Approximately 2 Weeks)||2
454315|NCT01286454|1113043|P1|COMPLETED|Washout Period (Approximately 2 Weeks)||2
454316|NCT01286454|1113033|P11|STARTED|Washout Period (Approximately 2 Weeks)||0
454317|NCT01286454|1113034|P10|STARTED|Washout Period (Approximately 2 Weeks)||2
454318|NCT01286454|1113035|P9|STARTED|Washout Period (Approximately 2 Weeks)||2
454319|NCT01286454|1113036|P8|STARTED|Washout Period (Approximately 2 Weeks)||2
454320|NCT01286454|1113037|P7|STARTED|Washout Period (Approximately 2 Weeks)||2
454321|NCT01286454|1113038|P6|STARTED|Washout Period (Approximately 2 Weeks)||2
454322|NCT01286454|1113039|P5|STARTED|Washout Period (Approximately 2 Weeks)||2
454323|NCT01286454|1113040|P4|STARTED|Washout Period (Approximately 2 Weeks)||2
454324|NCT01286454|1113041|P3|STARTED|Washout Period (Approximately 2 Weeks)||2
454325|NCT01286454|1113042|P2|STARTED|Washout Period (Approximately 2 Weeks)||2
454326|NCT01286454|1113043|P1|STARTED|Washout Period (Approximately 2 Weeks)||2
454327|NCT01286454|1113033|P11|NOT COMPLETED|Fifth Intervention Period||0
454328|NCT01286454|1113034|P10|NOT COMPLETED|Fifth Intervention Period||0
454329|NCT01286454|1113035|P9|NOT COMPLETED|Fifth Intervention Period||0
454330|NCT01286454|1113036|P8|NOT COMPLETED|Fifth Intervention Period||0
454331|NCT01286454|1113037|P7|NOT COMPLETED|Fifth Intervention Period||0
454332|NCT01286454|1113038|P6|NOT COMPLETED|Fifth Intervention Period||0
454333|NCT01286454|1113039|P5|NOT COMPLETED|Fifth Intervention Period||0
454334|NCT01286454|1113040|P4|NOT COMPLETED|Fifth Intervention Period||0
454335|NCT01286454|1113041|P3|NOT COMPLETED|Fifth Intervention Period||0
454336|NCT01286454|1113042|P2|NOT COMPLETED|Fifth Intervention Period||0
454337|NCT01286454|1113043|P1|NOT COMPLETED|Fifth Intervention Period||0
454338|NCT01286454|1113033|P11|COMPLETED|Fifth Intervention Period||0
454339|NCT01286454|1113034|P10|COMPLETED|Fifth Intervention Period||2
454340|NCT01286454|1113035|P9|COMPLETED|Fifth Intervention Period||2
454341|NCT01286454|1113036|P8|COMPLETED|Fifth Intervention Period||2
454342|NCT01286454|1113037|P7|COMPLETED|Fifth Intervention Period||2
454343|NCT01286454|1113038|P6|COMPLETED|Fifth Intervention Period||2
454344|NCT01286454|1113039|P5|COMPLETED|Fifth Intervention Period||2
454345|NCT01286454|1113040|P4|COMPLETED|Fifth Intervention Period||2
454346|NCT01286454|1113041|P3|COMPLETED|Fifth Intervention Period||2
454347|NCT01286454|1113042|P2|COMPLETED|Fifth Intervention Period||2
454348|NCT01286454|1113043|P1|COMPLETED|Fifth Intervention Period||2
454349|NCT01286454|1113033|P11|STARTED|Fifth Intervention Period||0
454350|NCT01286454|1113034|P10|STARTED|Fifth Intervention Period||2
454351|NCT01286454|1113035|P9|STARTED|Fifth Intervention Period||2
454352|NCT01286454|1113036|P8|STARTED|Fifth Intervention Period||2
454353|NCT01286454|1113037|P7|STARTED|Fifth Intervention Period||2
454354|NCT01286454|1113038|P6|STARTED|Fifth Intervention Period||2
454355|NCT01286454|1113039|P5|STARTED|Fifth Intervention Period||2
454356|NCT01286454|1113040|P4|STARTED|Fifth Intervention Period||2
454357|NCT01286454|1113041|P3|STARTED|Fifth Intervention Period||2
454358|NCT01286454|1113042|P2|STARTED|Fifth Intervention Period||2
454359|NCT01286454|1113043|P1|STARTED|Fifth Intervention Period||2
454360|NCT01286454|1113033|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
454361|NCT01286454|1113034|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
454362|NCT01286454|1113035|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
454363|NCT01286454|1113036|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
454364|NCT01286454|1113037|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
454365|NCT01286454|1113038|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
454366|NCT01286454|1113039|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
454367|NCT01286454|1113040|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
454368|NCT01286454|1113041|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
454369|NCT01286454|1113042|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
454370|NCT01286454|1113043|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
454371|NCT01286454|1113033|P11|COMPLETED|Washout Period (At Least 3 Days)||0
454372|NCT01286454|1113034|P10|COMPLETED|Washout Period (At Least 3 Days)||2
454373|NCT01286454|1113035|P9|COMPLETED|Washout Period (At Least 3 Days)||2
454374|NCT01286454|1113036|P8|COMPLETED|Washout Period (At Least 3 Days)||2
454375|NCT01286454|1113037|P7|COMPLETED|Washout Period (At Least 3 Days)||2
454376|NCT01286454|1113038|P6|COMPLETED|Washout Period (At Least 3 Days)||2
454377|NCT01286454|1113039|P5|COMPLETED|Washout Period (At Least 3 Days)||2
454378|NCT01286454|1113040|P4|COMPLETED|Washout Period (At Least 3 Days)||2
454379|NCT01286454|1113041|P3|COMPLETED|Washout Period (At Least 3 Days)||2
454380|NCT01286454|1113042|P2|COMPLETED|Washout Period (At Least 3 Days)||2
454381|NCT01286454|1113043|P1|COMPLETED|Washout Period (At Least 3 Days)||2
454382|NCT01286454|1113033|P11|STARTED|Washout Period (At Least 3 Days)||0
454383|NCT01286454|1113034|P10|STARTED|Washout Period (At Least 3 Days)||2
454384|NCT01286454|1113035|P9|STARTED|Washout Period (At Least 3 Days)||2
454385|NCT01286454|1113036|P8|STARTED|Washout Period (At Least 3 Days)||2
454386|NCT01286454|1113037|P7|STARTED|Washout Period (At Least 3 Days)||2
454387|NCT01286454|1113038|P6|STARTED|Washout Period (At Least 3 Days)||2
454388|NCT01286454|1113039|P5|STARTED|Washout Period (At Least 3 Days)||2
454389|NCT01286454|1113040|P4|STARTED|Washout Period (At Least 3 Days)||2
454390|NCT01286454|1113041|P3|STARTED|Washout Period (At Least 3 Days)||2
454391|NCT01286454|1113042|P2|STARTED|Washout Period (At Least 3 Days)||2
454392|NCT01286454|1113043|P1|STARTED|Washout Period (At Least 3 Days)||2
454393|NCT01286454|1113033|P11|NOT COMPLETED|Fourth Intervention Period||0
454394|NCT01286454|1113034|P10|NOT COMPLETED|Fourth Intervention Period||0
454395|NCT01286454|1113035|P9|NOT COMPLETED|Fourth Intervention Period||0
454396|NCT01286454|1113036|P8|NOT COMPLETED|Fourth Intervention Period||0
454397|NCT01286454|1113037|P7|NOT COMPLETED|Fourth Intervention Period||0
454398|NCT01286454|1113038|P6|NOT COMPLETED|Fourth Intervention Period||0
454399|NCT01286454|1113039|P5|NOT COMPLETED|Fourth Intervention Period||0
454400|NCT01286454|1113040|P4|NOT COMPLETED|Fourth Intervention Period||0
454401|NCT01286454|1113041|P3|NOT COMPLETED|Fourth Intervention Period||0
454402|NCT01286454|1113042|P2|NOT COMPLETED|Fourth Intervention Period||0
454403|NCT01286454|1113043|P1|NOT COMPLETED|Fourth Intervention Period||0
454404|NCT01286454|1113033|P11|COMPLETED|Fourth Intervention Period||0
454405|NCT01286454|1113034|P10|COMPLETED|Fourth Intervention Period||2
454406|NCT01286454|1113035|P9|COMPLETED|Fourth Intervention Period||2
454407|NCT01286454|1113036|P8|COMPLETED|Fourth Intervention Period||2
454408|NCT01286454|1113037|P7|COMPLETED|Fourth Intervention Period||2
454409|NCT01286454|1113038|P6|COMPLETED|Fourth Intervention Period||2
454410|NCT01286454|1113039|P5|COMPLETED|Fourth Intervention Period||2
454411|NCT01286454|1113040|P4|COMPLETED|Fourth Intervention Period||2
454412|NCT01286454|1113041|P3|COMPLETED|Fourth Intervention Period||2
454413|NCT01286454|1113042|P2|COMPLETED|Fourth Intervention Period||2
454414|NCT01286454|1113043|P1|COMPLETED|Fourth Intervention Period||2
454415|NCT01286454|1113033|P11|STARTED|Fourth Intervention Period||0
454416|NCT01286454|1113034|P10|STARTED|Fourth Intervention Period||2
454417|NCT01286454|1113035|P9|STARTED|Fourth Intervention Period||2
454418|NCT01286454|1113036|P8|STARTED|Fourth Intervention Period||2
454419|NCT01286454|1113037|P7|STARTED|Fourth Intervention Period||2
454420|NCT01286454|1113038|P6|STARTED|Fourth Intervention Period||2
454421|NCT01286454|1113039|P5|STARTED|Fourth Intervention Period||2
454422|NCT01286454|1113040|P4|STARTED|Fourth Intervention Period||2
454423|NCT01286454|1113041|P3|STARTED|Fourth Intervention Period||2
454424|NCT01286454|1113042|P2|STARTED|Fourth Intervention Period||2
454425|NCT01286454|1113043|P1|STARTED|Fourth Intervention Period||2
454426|NCT01286454|1113033|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
454427|NCT01286454|1113034|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
454428|NCT01286454|1113035|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
454429|NCT01286454|1113036|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
454430|NCT01286454|1113037|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
454431|NCT01286454|1113038|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
454432|NCT01286454|1113039|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
454433|NCT01286454|1113040|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
454434|NCT01286454|1113041|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
454435|NCT01286454|1113042|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
454436|NCT01286454|1113043|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
454437|NCT01286454|1113033|P11|COMPLETED|Washout Period (At Least 3 Days)||0
454438|NCT01286454|1113034|P10|COMPLETED|Washout Period (At Least 3 Days)||2
454439|NCT01286454|1113035|P9|COMPLETED|Washout Period (At Least 3 Days)||2
454440|NCT01286454|1113036|P8|COMPLETED|Washout Period (At Least 3 Days)||2
454441|NCT01286454|1113037|P7|COMPLETED|Washout Period (At Least 3 Days)||2
454442|NCT01286454|1113038|P6|COMPLETED|Washout Period (At Least 3 Days)||2
454443|NCT01286454|1113039|P5|COMPLETED|Washout Period (At Least 3 Days)||2
454444|NCT01286454|1113040|P4|COMPLETED|Washout Period (At Least 3 Days)||2
454445|NCT01286454|1113041|P3|COMPLETED|Washout Period (At Least 3 Days)||2
454446|NCT01286454|1113042|P2|COMPLETED|Washout Period (At Least 3 Days)||2
454447|NCT01286454|1113043|P1|COMPLETED|Washout Period (At Least 3 Days)||2
454448|NCT01286454|1113033|P11|STARTED|Washout Period (At Least 3 Days)||0
454449|NCT01286454|1113034|P10|STARTED|Washout Period (At Least 3 Days)||2
454450|NCT01286454|1113035|P9|STARTED|Washout Period (At Least 3 Days)||2
454451|NCT01286454|1113036|P8|STARTED|Washout Period (At Least 3 Days)||2
454452|NCT01286454|1113037|P7|STARTED|Washout Period (At Least 3 Days)||2
454453|NCT01286454|1113038|P6|STARTED|Washout Period (At Least 3 Days)||2
454454|NCT01286454|1113039|P5|STARTED|Washout Period (At Least 3 Days)||2
454455|NCT01286454|1113040|P4|STARTED|Washout Period (At Least 3 Days)||2
454456|NCT01286454|1113041|P3|STARTED|Washout Period (At Least 3 Days)||2
454457|NCT01286454|1113042|P2|STARTED|Washout Period (At Least 3 Days)||2
454458|NCT01286454|1113043|P1|STARTED|Washout Period (At Least 3 Days)||2
454459|NCT01286454|1113033|P11|NOT COMPLETED|Third Intervention Period||0
454460|NCT01286454|1113034|P10|NOT COMPLETED|Third Intervention Period||0
454461|NCT01286454|1113035|P9|NOT COMPLETED|Third Intervention Period||0
454462|NCT01286454|1113036|P8|NOT COMPLETED|Third Intervention Period||0
454463|NCT01286454|1113037|P7|NOT COMPLETED|Third Intervention Period||0
454464|NCT01286454|1113038|P6|NOT COMPLETED|Third Intervention Period||0
454465|NCT01286454|1113039|P5|NOT COMPLETED|Third Intervention Period||0
454466|NCT01286454|1113040|P4|NOT COMPLETED|Third Intervention Period||0
454467|NCT01286454|1113041|P3|NOT COMPLETED|Third Intervention Period||0
454468|NCT01286454|1113042|P2|NOT COMPLETED|Third Intervention Period||0
454469|NCT01286454|1113043|P1|NOT COMPLETED|Third Intervention Period||0
454470|NCT01286454|1113033|P11|COMPLETED|Third Intervention Period||0
454471|NCT01286454|1113034|P10|COMPLETED|Third Intervention Period||2
454472|NCT01286454|1113035|P9|COMPLETED|Third Intervention Period||2
454473|NCT01286454|1113036|P8|COMPLETED|Third Intervention Period||2
454474|NCT01286454|1113037|P7|COMPLETED|Third Intervention Period||2
454475|NCT01286454|1113038|P6|COMPLETED|Third Intervention Period||2
454476|NCT01286454|1113039|P5|COMPLETED|Third Intervention Period||2
454477|NCT01286454|1113040|P4|COMPLETED|Third Intervention Period||2
454478|NCT01286454|1113041|P3|COMPLETED|Third Intervention Period||2
454479|NCT01286454|1113042|P2|COMPLETED|Third Intervention Period||2
454480|NCT01286454|1113043|P1|COMPLETED|Third Intervention Period||2
454481|NCT01286454|1113033|P11|STARTED|Third Intervention Period||0
454482|NCT01286454|1113034|P10|STARTED|Third Intervention Period||2
454483|NCT01286454|1113035|P9|STARTED|Third Intervention Period||2
454484|NCT01286454|1113036|P8|STARTED|Third Intervention Period||2
454485|NCT01286454|1113037|P7|STARTED|Third Intervention Period||2
454486|NCT01286454|1113038|P6|STARTED|Third Intervention Period||2
454487|NCT01286454|1113039|P5|STARTED|Third Intervention Period||2
454488|NCT01286454|1113040|P4|STARTED|Third Intervention Period||2
454489|NCT01286454|1113041|P3|STARTED|Third Intervention Period||2
454490|NCT01286454|1113042|P2|STARTED|Third Intervention Period||2
454491|NCT01286454|1113043|P1|STARTED|Third Intervention Period||2
454492|NCT01286454|1113033|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
454493|NCT01286454|1113034|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
454494|NCT01286454|1113035|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
454495|NCT01286454|1113036|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
454496|NCT01286454|1113037|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
454497|NCT01286454|1113038|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
454498|NCT01286454|1113039|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
454499|NCT01286454|1113040|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
454500|NCT01286454|1113041|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
454501|NCT01286454|1113042|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
454502|NCT01286454|1113043|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
454503|NCT01286454|1113033|P11|COMPLETED|Washout Period (At Least 3 Days)||0
454504|NCT01286454|1113034|P10|COMPLETED|Washout Period (At Least 3 Days)||2
454505|NCT01286454|1113035|P9|COMPLETED|Washout Period (At Least 3 Days)||2
454506|NCT01286454|1113036|P8|COMPLETED|Washout Period (At Least 3 Days)||2
454507|NCT01286454|1113037|P7|COMPLETED|Washout Period (At Least 3 Days)||2
454508|NCT01286454|1113038|P6|COMPLETED|Washout Period (At Least 3 Days)||2
454509|NCT01286454|1113039|P5|COMPLETED|Washout Period (At Least 3 Days)||2
454510|NCT01286454|1113040|P4|COMPLETED|Washout Period (At Least 3 Days)||2
454511|NCT01286454|1113041|P3|COMPLETED|Washout Period (At Least 3 Days)||2
454512|NCT01286454|1113042|P2|COMPLETED|Washout Period (At Least 3 Days)||2
454513|NCT01286454|1113043|P1|COMPLETED|Washout Period (At Least 3 Days)||2
454514|NCT01286454|1113033|P11|STARTED|Washout Period (At Least 3 Days)||0
454515|NCT01286454|1113034|P10|STARTED|Washout Period (At Least 3 Days)||2
454516|NCT01286454|1113035|P9|STARTED|Washout Period (At Least 3 Days)||2
454517|NCT01286454|1113036|P8|STARTED|Washout Period (At Least 3 Days)||2
454518|NCT01286454|1113037|P7|STARTED|Washout Period (At Least 3 Days)||2
454519|NCT01286454|1113038|P6|STARTED|Washout Period (At Least 3 Days)||2
454520|NCT01286454|1113039|P5|STARTED|Washout Period (At Least 3 Days)||2
454521|NCT01286454|1113040|P4|STARTED|Washout Period (At Least 3 Days)||2
454522|NCT01286454|1113041|P3|STARTED|Washout Period (At Least 3 Days)||2
454523|NCT01286454|1113042|P2|STARTED|Washout Period (At Least 3 Days)||2
454524|NCT01286454|1113043|P1|STARTED|Washout Period (At Least 3 Days)||2
454525|NCT01286454|1113033|P11|NOT COMPLETED|Second Intervention Period||0
454526|NCT01286454|1113034|P10|NOT COMPLETED|Second Intervention Period||0
454527|NCT01286454|1113035|P9|NOT COMPLETED|Second Intervention Period||0
454528|NCT01286454|1113036|P8|NOT COMPLETED|Second Intervention Period||0
454529|NCT01286454|1113037|P7|NOT COMPLETED|Second Intervention Period||0
454530|NCT01286454|1113038|P6|NOT COMPLETED|Second Intervention Period||0
454531|NCT01286454|1113039|P5|NOT COMPLETED|Second Intervention Period||0
454532|NCT01286454|1113040|P4|NOT COMPLETED|Second Intervention Period||0
454533|NCT01286454|1113041|P3|NOT COMPLETED|Second Intervention Period||0
454534|NCT01286454|1113042|P2|NOT COMPLETED|Second Intervention Period||0
454535|NCT01286454|1113043|P1|NOT COMPLETED|Second Intervention Period||0
454536|NCT01286454|1113033|P11|COMPLETED|Second Intervention Period||0
454537|NCT01286454|1113034|P10|COMPLETED|Second Intervention Period||2
454538|NCT01286454|1113035|P9|COMPLETED|Second Intervention Period||2
454539|NCT01286454|1113036|P8|COMPLETED|Second Intervention Period||2
454540|NCT01286454|1113037|P7|COMPLETED|Second Intervention Period||2
454541|NCT01286454|1113038|P6|COMPLETED|Second Intervention Period||2
454542|NCT01286454|1113039|P5|COMPLETED|Second Intervention Period||2
454543|NCT01286454|1113040|P4|COMPLETED|Second Intervention Period||2
454544|NCT01286454|1113041|P3|COMPLETED|Second Intervention Period||2
454545|NCT01286454|1113042|P2|COMPLETED|Second Intervention Period||2
454546|NCT01286454|1113043|P1|COMPLETED|Second Intervention Period||2
454547|NCT01286454|1113033|P11|STARTED|Second Intervention Period||0
454548|NCT01286454|1113034|P10|STARTED|Second Intervention Period||2
454549|NCT01286454|1113035|P9|STARTED|Second Intervention Period||2
454550|NCT01286454|1113036|P8|STARTED|Second Intervention Period||2
454551|NCT01286454|1113037|P7|STARTED|Second Intervention Period||2
454552|NCT01286454|1113038|P6|STARTED|Second Intervention Period||2
454553|NCT01286454|1113039|P5|STARTED|Second Intervention Period||2
454554|NCT01286454|1113040|P4|STARTED|Second Intervention Period||2
454555|NCT01286454|1113041|P3|STARTED|Second Intervention Period||2
454556|NCT01286454|1113042|P2|STARTED|Second Intervention Period||2
454557|NCT01286454|1113043|P1|STARTED|Second Intervention Period||2
454558|NCT01286454|1113033|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
454559|NCT01286454|1113034|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
454560|NCT01286454|1113035|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
454561|NCT01286454|1113036|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
454562|NCT01286454|1113037|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
454563|NCT01286454|1113038|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
454564|NCT01286454|1113039|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
454565|NCT01286454|1113040|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
454566|NCT01286454|1113041|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
454567|NCT01286454|1113042|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
454568|NCT01286454|1113043|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
454569|NCT01286454|1113033|P11|COMPLETED|Washout Period (At Least 3 Days)||0
454570|NCT01286454|1113034|P10|COMPLETED|Washout Period (At Least 3 Days)||2
454571|NCT01286454|1113035|P9|COMPLETED|Washout Period (At Least 3 Days)||2
454572|NCT01286454|1113036|P8|COMPLETED|Washout Period (At Least 3 Days)||2
454573|NCT01286454|1113037|P7|COMPLETED|Washout Period (At Least 3 Days)||2
454574|NCT01286454|1113038|P6|COMPLETED|Washout Period (At Least 3 Days)||2
454575|NCT01286454|1113039|P5|COMPLETED|Washout Period (At Least 3 Days)||2
454576|NCT01286454|1113040|P4|COMPLETED|Washout Period (At Least 3 Days)||2
454577|NCT01286454|1113041|P3|COMPLETED|Washout Period (At Least 3 Days)||2
454578|NCT01286454|1113042|P2|COMPLETED|Washout Period (At Least 3 Days)||2
454579|NCT01286454|1113043|P1|COMPLETED|Washout Period (At Least 3 Days)||2
454580|NCT01286454|1113033|P11|STARTED|Washout Period (At Least 3 Days)||0
454581|NCT01286454|1113034|P10|STARTED|Washout Period (At Least 3 Days)||2
454582|NCT01286454|1113035|P9|STARTED|Washout Period (At Least 3 Days)||2
454583|NCT01286454|1113036|P8|STARTED|Washout Period (At Least 3 Days)||2
454584|NCT01286454|1113037|P7|STARTED|Washout Period (At Least 3 Days)||2
454585|NCT01286454|1113038|P6|STARTED|Washout Period (At Least 3 Days)||2
454586|NCT01286454|1113039|P5|STARTED|Washout Period (At Least 3 Days)||2
454587|NCT01286454|1113040|P4|STARTED|Washout Period (At Least 3 Days)||2
454588|NCT01286454|1113041|P3|STARTED|Washout Period (At Least 3 Days)||2
454589|NCT01286454|1113042|P2|STARTED|Washout Period (At Least 3 Days)||2
454590|NCT01286454|1113043|P1|STARTED|Washout Period (At Least 3 Days)||2
454591|NCT01286454|1113033|P11|NOT COMPLETED|Part I- First Intervention Period||0
454592|NCT01286454|1113034|P10|NOT COMPLETED|Part I- First Intervention Period||0
454593|NCT01286454|1113035|P9|NOT COMPLETED|Part I- First Intervention Period||0
454594|NCT01286454|1113036|P8|NOT COMPLETED|Part I- First Intervention Period||0
454595|NCT01286454|1113037|P7|NOT COMPLETED|Part I- First Intervention Period||0
454596|NCT01286454|1113038|P6|NOT COMPLETED|Part I- First Intervention Period||0
454597|NCT01286454|1113039|P5|NOT COMPLETED|Part I- First Intervention Period||0
454598|NCT01286454|1113040|P4|NOT COMPLETED|Part I- First Intervention Period||0
454599|NCT01286454|1113041|P3|NOT COMPLETED|Part I- First Intervention Period||0
454600|NCT01286454|1113042|P2|NOT COMPLETED|Part I- First Intervention Period||0
454601|NCT01286454|1113043|P1|NOT COMPLETED|Part I- First Intervention Period||0
454602|NCT01286454|1113033|P11|COMPLETED|Part I- First Intervention Period||0
454603|NCT01286454|1113034|P10|COMPLETED|Part I- First Intervention Period||2
454604|NCT01286454|1113035|P9|COMPLETED|Part I- First Intervention Period||2
454605|NCT01286454|1113036|P8|COMPLETED|Part I- First Intervention Period||2
454606|NCT01286454|1113037|P7|COMPLETED|Part I- First Intervention Period||2
454607|NCT01286454|1113038|P6|COMPLETED|Part I- First Intervention Period||2
454608|NCT01286454|1113039|P5|COMPLETED|Part I- First Intervention Period||2
454609|NCT01286454|1113040|P4|COMPLETED|Part I- First Intervention Period||2
454610|NCT01286454|1113041|P3|COMPLETED|Part I- First Intervention Period||2
454611|NCT01286454|1113042|P2|COMPLETED|Part I- First Intervention Period||2
454612|NCT01286454|1113043|P1|COMPLETED|Part I- First Intervention Period||2
454613|NCT01286454|1113033|P11|STARTED|Part I- First Intervention Period||0
454614|NCT01286454|1113034|P10|STARTED|Part I- First Intervention Period||2
454615|NCT01286454|1113035|P9|STARTED|Part I- First Intervention Period||2
454616|NCT01286454|1113036|P8|STARTED|Part I- First Intervention Period||2
454617|NCT01286454|1113037|P7|STARTED|Part I- First Intervention Period||2
454618|NCT01286454|1113038|P6|STARTED|Part I- First Intervention Period||2
454619|NCT01286454|1113039|P5|STARTED|Part I- First Intervention Period||2
454620|NCT01286454|1113040|P4|STARTED|Part I- First Intervention Period||2
454621|NCT01286454|1113041|P3|STARTED|Part I- First Intervention Period||2
454622|NCT01286454|1113042|P2|STARTED|Part I- First Intervention Period||2
454623|NCT01286454|1113043|P1|STARTED|Part I- First Intervention Period||2
454624|NCT01286402|1113083|P2|NOT COMPLETED|Overall Study||0
454625|NCT01286402|1113084|P1|NOT COMPLETED|Overall Study||0
454626|NCT01286402|1113083|P2|COMPLETED|Overall Study||6
454627|NCT01286402|1113084|P1|COMPLETED|Overall Study||5
454628|NCT01286402|1113083|P2|STARTED|Overall Study||6
454629|NCT01286402|1113084|P1|STARTED|Overall Study||5
454630|NCT01286324|1113092|P2|NOT COMPLETED|Overall Study||0
454631|NCT01286324|1113093|P1|NOT COMPLETED|Overall Study||0
454632|NCT01286324|1113092|P2|COMPLETED|Overall Study||17
454633|NCT01286324|1113093|P1|COMPLETED|Overall Study||17
454634|NCT01286324|1113092|P2|STARTED|Overall Study||17
454635|NCT01286324|1113093|P1|STARTED|Overall Study||17
454636|NCT01286311|1113111|P2|NOT COMPLETED|Overall Study||0
454637|NCT01286311|1113112|P1|NOT COMPLETED|Overall Study||14
454638|NCT01286311|1113111|P2|COMPLETED|Overall Study|217 patients (of the 15 physician randomized to the intervention) completed the study.|232
454639|NCT01286311|1113112|P1|COMPLETED|Overall Study|204 patients (of the 14 physician randomized to the intervention) completed the study.|218
454640|NCT01286311|1113111|P2|STARTED|Overall Study|217 patients (of the 15 physician randomized to the intervention) started the study.|232
454641|NCT01286311|1113112|P1|STARTED|Overall Study|218 patients (of the 14 physician randomized to the intervention) started the study.|232
454642|NCT01286207|1113129|P3|NOT COMPLETED|Overall Study||90
454643|NCT01286207|1113130|P2|NOT COMPLETED|Overall Study||248
454644|NCT01286207|1113131|P1|NOT COMPLETED|Overall Study||298
454645|NCT01286207|1113129|P3|COMPLETED|Overall Study||261
454646|NCT01286207|1113130|P2|COMPLETED|Overall Study||609
454647|NCT01286207|1113131|P1|COMPLETED|Overall Study||453
454648|NCT01286207|1113129|P3|STARTED|Overall Study||351
454649|NCT01286207|1113130|P2|STARTED|Overall Study||857
454650|NCT01286207|1113131|P1|STARTED|Overall Study||751
454651|NCT01286168|1113151|P1|NOT COMPLETED|Overall Study||3
454652|NCT01286168|1113151|P1|COMPLETED|Overall Study||101
454653|NCT01286168|1113151|P1|STARTED|Overall Study||104
454654|NCT01286129|1113165|P2|NOT COMPLETED|Overall Study||5
454655|NCT01286129|1113166|P1|NOT COMPLETED|Overall Study||8
454656|NCT01286129|1113165|P2|COMPLETED|Overall Study||13
454657|NCT01286129|1113166|P1|COMPLETED|Overall Study||19
454658|NCT01286129|1113165|P2|STARTED|Overall Study||18
454659|NCT01286129|1113166|P1|STARTED|Overall Study||27
454660|NCT01286077|1113176|P2|NOT COMPLETED|Overall Study||7
454661|NCT01286077|1113177|P1|NOT COMPLETED|Overall Study||10
454662|NCT01286077|1113176|P2|COMPLETED|Overall Study||46
454663|NCT01286077|1113177|P1|COMPLETED|Overall Study||41
454664|NCT01286077|1113176|P2|STARTED|Overall Study|One patient did not have any post-baseline assessment and was excluded from the ITT population.|53
454665|NCT01286077|1113177|P1|STARTED|Overall Study|One patient did not start treatment and was excluded from the Intent to Treat (ITT) population.|51
454666|NCT01286012|1113213|P2|NOT COMPLETED|Overall Study||14
454667|NCT01286012|1113214|P1|NOT COMPLETED|Overall Study||13
454668|NCT01286012|1113213|P2|COMPLETED|Overall Study||40
454669|NCT01286012|1113214|P1|COMPLETED|Overall Study||41
454670|NCT01286012|1113213|P2|STARTED|Overall Study|3 patients randomized to placebo did not receive study drug.|54
454671|NCT01286012|1113214|P1|STARTED|Overall Study|2 patients randomized to SFP did not receive study drug.|54
454672|NCT01285947|1113224|P2|NOT COMPLETED|Overall Study||0
454673|NCT01285947|1113225|P1|NOT COMPLETED|Overall Study||0
454674|NCT01285947|1113224|P2|COMPLETED|Overall Study||10
454675|NCT01285947|1113225|P1|COMPLETED|Overall Study||10
454676|NCT01285947|1113224|P2|STARTED|Overall Study||10
454677|NCT01285947|1113225|P1|STARTED|Overall Study||10
454678|NCT01285908|1113231|P3|NOT COMPLETED|Treatment Crossover||0
454679|NCT01285908|1113232|P2|NOT COMPLETED|Treatment Crossover||0
454680|NCT01285908|1113233|P1|NOT COMPLETED|Treatment Crossover||0
454681|NCT01285908|1113231|P3|COMPLETED|Treatment Crossover||2
454682|NCT01285908|1113232|P2|COMPLETED|Treatment Crossover||2
454683|NCT01285908|1113233|P1|COMPLETED|Treatment Crossover||0
454684|NCT01285908|1113231|P3|STARTED|Treatment Crossover||2
454685|NCT01285908|1113232|P2|STARTED|Treatment Crossover|One subject in treatment crossover did not complete baseline testing as unable to complete tasks|2
454686|NCT01285908|1113233|P1|STARTED|Treatment Crossover||0
454687|NCT01285908|1113231|P3|NOT COMPLETED|Baseline Measurement||0
454688|NCT01285908|1113232|P2|NOT COMPLETED|Baseline Measurement||0
454689|NCT01285908|1113233|P1|NOT COMPLETED|Baseline Measurement||3
454690|NCT01285908|1113231|P3|COMPLETED|Baseline Measurement||0
454691|NCT01285908|1113232|P2|COMPLETED|Baseline Measurement||0
454692|NCT01285908|1113233|P1|COMPLETED|Baseline Measurement||3
454693|NCT01285908|1113231|P3|STARTED|Baseline Measurement||0
454694|NCT01285908|1113232|P2|STARTED|Baseline Measurement||0
454695|NCT01285908|1113233|P1|STARTED|Baseline Measurement||6
454696|NCT01285843|1113267|P2|NOT COMPLETED|Overall Study||2
454697|NCT01285843|1113268|P1|NOT COMPLETED|Overall Study||2
454698|NCT01285843|1113267|P2|COMPLETED|Overall Study||18
454699|NCT01285843|1113268|P1|COMPLETED|Overall Study||18
454700|NCT01285843|1113267|P2|STARTED|Overall Study||20
454701|NCT01285843|1113268|P1|STARTED|Overall Study||20
454702|NCT01285791|1113283|P3|NOT COMPLETED|Overall Study||0
454703|NCT01285791|1113284|P2|NOT COMPLETED|Overall Study||0
454704|NCT01285791|1113285|P1|NOT COMPLETED|Overall Study||0
454705|NCT01285791|1113283|P3|COMPLETED|Overall Study||13
454706|NCT01285791|1113284|P2|COMPLETED|Overall Study||15
454707|NCT01285791|1113285|P1|COMPLETED|Overall Study||11
454708|NCT01285791|1113283|P3|STARTED|Overall Study||13
454709|NCT01285791|1113284|P2|STARTED|Overall Study||15
454710|NCT01285791|1113285|P1|STARTED|Overall Study||11
454711|NCT01285713|1113295|P2|NOT COMPLETED|Overall Study||0
454712|NCT01285713|1113296|P1|NOT COMPLETED|Overall Study||0
454713|NCT01285713|1113295|P2|COMPLETED|Overall Study||41
454714|NCT01285713|1113296|P1|COMPLETED|Overall Study||42
454715|NCT01285713|1113295|P2|STARTED|Overall Study||41
454716|NCT01285713|1113296|P1|STARTED|Overall Study||42
454717|NCT01285635|1113305|P3|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
454718|NCT01285635|1113306|P2|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
454719|NCT01285635|1113307|P1|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
454720|NCT01285635|1113305|P3|COMPLETED|Second Intervention (10, 3 Week Cycles)||11
454721|NCT01285635|1113306|P2|COMPLETED|Second Intervention (10, 3 Week Cycles)||11
454722|NCT01285635|1113307|P1|COMPLETED|Second Intervention (10, 3 Week Cycles)||13
454723|NCT01285635|1113305|P3|STARTED|Second Intervention (10, 3 Week Cycles)||11
454724|NCT01285635|1113306|P2|STARTED|Second Intervention (10, 3 Week Cycles)||11
454725|NCT01285635|1113307|P1|STARTED|Second Intervention (10, 3 Week Cycles)||13
454726|NCT01285635|1113305|P3|NOT COMPLETED|First Intervention (2 Weeks)||0
454727|NCT01285635|1113306|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
454728|NCT01285635|1113307|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
454729|NCT01285635|1113305|P3|COMPLETED|First Intervention (2 Weeks)||11
454730|NCT01285635|1113306|P2|COMPLETED|First Intervention (2 Weeks)||11
454731|NCT01285635|1113307|P1|COMPLETED|First Intervention (2 Weeks)||13
454732|NCT01285635|1113305|P3|STARTED|First Intervention (2 Weeks)||11
454733|NCT01285635|1113306|P2|STARTED|First Intervention (2 Weeks)||11
454734|NCT01285635|1113307|P1|STARTED|First Intervention (2 Weeks)||13
454735|NCT01285609|1113327|P2|NOT COMPLETED|Treated With Blinded Therapy||353
454736|NCT01285609|1113328|P1|NOT COMPLETED|Treated With Blinded Therapy||379
454737|NCT01285609|1113327|P2|COMPLETED|Treated With Blinded Therapy|Completed = Still on Treatment|8
454738|NCT01285609|1113328|P1|COMPLETED|Treated With Blinded Therapy|Completed = Still on Treatment|9
454739|NCT01285609|1113327|P2|STARTED|Treated With Blinded Therapy||361
454740|NCT01285609|1113328|P1|STARTED|Treated With Blinded Therapy||388
454741|NCT01285609|1113327|P2|NOT COMPLETED|Randomized||116
454742|NCT01285609|1113328|P1|NOT COMPLETED|Randomized||91
454743|NCT01285609|1113327|P2|COMPLETED|Randomized||361
454744|NCT01285609|1113328|P1|COMPLETED|Randomized||388
454745|NCT01285609|1113327|P2|Treated With Chemotherapy (1st Dose)|Randomized||473
454746|NCT01285609|1113328|P1|Treated With Chemotherapy (1st Dose)|Randomized||475
454747|NCT01285609|1113327|P2|STARTED|Randomized|Represents participants randomized to this arm prior to 1st dose of chemotherapy treatment|477
454748|NCT01285609|1113328|P1|STARTED|Randomized|Represents participants randomized to this arm prior to 1st dose of chemotherapy treatment|479
454749|NCT01285518|1113346|P8|NOT COMPLETED|Overall Study||0
454750|NCT01285518|1113347|P7|NOT COMPLETED|Overall Study||0
454751|NCT01285518|1113348|P6|NOT COMPLETED|Overall Study||1
454752|NCT01285518|1113349|P5|NOT COMPLETED|Overall Study||0
454753|NCT01285518|1113350|P4|NOT COMPLETED|Overall Study||0
454754|NCT01285518|1113351|P3|NOT COMPLETED|Overall Study||0
454755|NCT01285518|1113352|P2|NOT COMPLETED|Overall Study||0
454756|NCT01285518|1113353|P1|NOT COMPLETED|Overall Study||0
454757|NCT01285518|1113346|P8|COMPLETED|Overall Study||14
454758|NCT01285518|1113347|P7|COMPLETED|Overall Study||10
454759|NCT01285518|1113348|P6|COMPLETED|Overall Study||9
454760|NCT01285518|1113349|P5|COMPLETED|Overall Study||10
454761|NCT01285518|1113350|P4|COMPLETED|Overall Study||10
454762|NCT01285518|1113351|P3|COMPLETED|Overall Study||10
454763|NCT01285518|1113352|P2|COMPLETED|Overall Study||10
454764|NCT01285518|1113353|P1|COMPLETED|Overall Study||10
454765|NCT01285518|1113346|P8|STARTED|Overall Study||14
454766|NCT01285518|1113347|P7|STARTED|Overall Study||10
454767|NCT01285518|1113348|P6|STARTED|Overall Study||10
454768|NCT01285518|1113349|P5|STARTED|Overall Study||10
454769|NCT01285518|1113350|P4|STARTED|Overall Study||10
454770|NCT01285518|1113351|P3|STARTED|Overall Study||10
454771|NCT01285518|1113352|P2|STARTED|Overall Study||10
454772|NCT01285518|1113353|P1|STARTED|Overall Study||10
454773|NCT01285492|1113613|P2|NOT COMPLETED|Overall Study||1
454774|NCT01285492|1113614|P1|NOT COMPLETED|Overall Study||17
454775|NCT01285492|1113613|P2|COMPLETED|Overall Study||38
454776|NCT01285492|1113614|P1|COMPLETED|Overall Study||104
454777|NCT01285492|1113613|P2|Safety Set (for Demographics)|Overall Study|All patients who took study drug|39
454778|NCT01285492|1113614|P1|Safety Set (for Demographics)|Overall Study|All patients who took study drug; 2 patients did not|119
454779|NCT01285492|1113613|P2|STARTED|Overall Study|All patients randomized to this group|39
454780|NCT01285492|1113614|P1|STARTED|Overall Study|All patients randomized to this group|121
454781|NCT01285427|1113632|P1|NOT COMPLETED|Overall Study||1
454782|NCT01285427|1113632|P1|COMPLETED|Overall Study|One sample be discarded per FDA, sample drawn with heparin tube, not specified in protocol.|299
454783|NCT01285427|1113632|P1|STARTED|Overall Study||300
454784|NCT01285401|1113646|P2|NOT COMPLETED|Overall Study||29
454785|NCT01285401|1113647|P1|NOT COMPLETED|Overall Study||17
454786|NCT01285401|1113646|P2|COMPLETED|Overall Study||88
454787|NCT01285401|1113647|P1|COMPLETED|Overall Study||98
454788|NCT01285401|1113646|P2|Treated|Overall Study||116
454789|NCT01285401|1113647|P1|Treated|Overall Study||113
454790|NCT01285401|1113646|P2|STARTED|Overall Study||117
454791|NCT01285401|1113647|P1|STARTED|Overall Study||115
454792|NCT01285323|1113687|P2|NOT COMPLETED|Overall Study||30
454793|NCT01285323|1113688|P1|NOT COMPLETED|Overall Study||33
454794|NCT01285323|1113687|P2|COMPLETED|Overall Study||202
454795|NCT01285323|1113688|P1|COMPLETED|Overall Study||199
454796|NCT01285323|1113687|P2|Safety Analysis Set|Overall Study||232
454797|NCT01285323|1113688|P1|Safety Analysis Set|Overall Study|Participants who received at least 1 dose of study drug|232
454798|NCT01285323|1113687|P2|Full Analysis Set|Overall Study||232
454799|NCT01285323|1113688|P1|Full Analysis Set|Overall Study|Randomized participants who received at least 1 dose of study drug|232
454800|NCT01285323|1113687|P2|STARTED|Overall Study||232
454801|NCT01285323|1113688|P1|STARTED|Overall Study||232
454802|NCT01285310|1113723|P5|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||19
454803|NCT01285310|1113724|P4|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||10
454804|NCT01285310|1113725|P3|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||26
454805|NCT01285310|1113726|P2|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||32
454806|NCT01285310|1113727|P1|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||0
454807|NCT01285310|1113723|P5|COMPLETED|Active Treatment Phase: Weeks 25-52||23
454808|NCT01285310|1113724|P4|COMPLETED|Active Treatment Phase: Weeks 25-52||17
454809|NCT01285310|1113725|P3|COMPLETED|Active Treatment Phase: Weeks 25-52||34
454810|NCT01285310|1113726|P2|COMPLETED|Active Treatment Phase: Weeks 25-52||31
454811|NCT01285310|1113727|P1|COMPLETED|Active Treatment Phase: Weeks 25-52||0
454812|NCT01285310|1113723|P5|STARTED|Active Treatment Phase: Weeks 25-52||42
454813|NCT01285310|1113724|P4|STARTED|Active Treatment Phase: Weeks 25-52||27
454814|NCT01285310|1113725|P3|STARTED|Active Treatment Phase: Weeks 25-52||60
454815|NCT01285310|1113726|P2|STARTED|Active Treatment Phase: Weeks 25-52||63
454816|NCT01285310|1113727|P1|STARTED|Active Treatment Phase: Weeks 25-52||0
454817|NCT01285310|1113723|P5|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
454818|NCT01285310|1113724|P4|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
454819|NCT01285310|1113725|P3|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15
454820|NCT01285310|1113726|P2|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15
454821|NCT01285310|1113727|P1|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||9
454822|NCT01285310|1113723|P5|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
454823|NCT01285310|1113724|P4|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
454824|NCT01285310|1113725|P3|COMPLETED|Placebo Controlled Phase: Weeks 0-24|1 participant chose not to enter active treatment phase|61
454825|NCT01285310|1113726|P2|COMPLETED|Placebo Controlled Phase: Weeks 0-24|Four participants chose not to enter the active treatment phase|67
454826|NCT01285310|1113727|P1|COMPLETED|Placebo Controlled Phase: Weeks 0-24|1 participant chose not to enter the active treatment phase|70
454827|NCT01285310|1113723|P5|STARTED|Placebo Controlled Phase: Weeks 0-24||0
454828|NCT01285310|1113724|P4|STARTED|Placebo Controlled Phase: Weeks 0-24||0
454829|NCT01285310|1113725|P3|STARTED|Placebo Controlled Phase: Weeks 0-24||76
454830|NCT01285310|1113726|P2|STARTED|Placebo Controlled Phase: Weeks 0-24||82
454831|NCT01285310|1113727|P1|STARTED|Placebo Controlled Phase: Weeks 0-24||79
454832|NCT01285076|1113960|P1|NOT COMPLETED|Overall Study||0
454833|NCT01285076|1113960|P1|COMPLETED|Overall Study||834
454834|NCT01285076|1113960|P1|STARTED|Overall Study||834
454835|NCT01285050|1113973|P1|NOT COMPLETED|Overall Study||1
454836|NCT01285050|1113973|P1|COMPLETED|Overall Study||19
454837|NCT01285050|1113973|P1|STARTED|Overall Study||20
454838|NCT01285024|1113980|P2|NOT COMPLETED|Overall Study||0
454839|NCT01285024|1113981|P1|NOT COMPLETED|Overall Study||0
454840|NCT01285024|1113980|P2|COMPLETED|Overall Study||60
454841|NCT01285024|1113981|P1|COMPLETED|Overall Study||49
454842|NCT01285024|1113980|P2|STARTED|Overall Study||60
454843|NCT01285024|1113981|P1|STARTED|Overall Study||49
454844|NCT01284959|1113992|P3|NOT COMPLETED|Overall Study||1
454845|NCT01284959|1113993|P2|NOT COMPLETED|Overall Study||0
454846|NCT01284959|1113994|P1|NOT COMPLETED|Overall Study||1
454847|NCT01284959|1113992|P3|COMPLETED|Overall Study||10
454848|NCT01284959|1113993|P2|COMPLETED|Overall Study||12
454849|NCT01284959|1113994|P1|COMPLETED|Overall Study||10
454850|NCT01284959|1113992|P3|STARTED|Overall Study||11
454851|NCT01284959|1113993|P2|STARTED|Overall Study||12
454852|NCT01284959|1113994|P1|STARTED|Overall Study||11
454853|NCT01284634|1114024|P4|NOT COMPLETED|Overall Study||1
454854|NCT01284634|1114025|P3|NOT COMPLETED|Overall Study||2
454855|NCT01284634|1114026|P2|NOT COMPLETED|Overall Study||0
454856|NCT01284634|1114027|P1|NOT COMPLETED|Overall Study||1
454857|NCT01284634|1114024|P4|COMPLETED|Overall Study||4
454858|NCT01284634|1114025|P3|COMPLETED|Overall Study||5
454859|NCT01284634|1114026|P2|COMPLETED|Overall Study||6
454860|NCT01284634|1114027|P1|COMPLETED|Overall Study||6
454861|NCT01284634|1114024|P4|STARTED|Overall Study||5
454862|NCT01284634|1114025|P3|STARTED|Overall Study||7
454863|NCT01284634|1114026|P2|STARTED|Overall Study||6
454864|NCT01284634|1114027|P1|STARTED|Overall Study||7
454865|NCT01284621|1114169|P6|NOT COMPLETED|Third Intervention (8 Days)||0
454866|NCT01284621|1114170|P5|NOT COMPLETED|Third Intervention (8 Days)||0
454867|NCT01284621|1114171|P4|NOT COMPLETED|Third Intervention (8 Days)||0
454868|NCT01284621|1114172|P3|NOT COMPLETED|Third Intervention (8 Days)||0
454869|NCT01284621|1114173|P2|NOT COMPLETED|Third Intervention (8 Days)||0
454870|NCT01284621|1114174|P1|NOT COMPLETED|Third Intervention (8 Days)||0
454871|NCT01284621|1114169|P6|COMPLETED|Third Intervention (8 Days)||4
454872|NCT01284621|1114170|P5|COMPLETED|Third Intervention (8 Days)||3
454873|NCT01284621|1114171|P4|COMPLETED|Third Intervention (8 Days)||4
454874|NCT01284621|1114172|P3|COMPLETED|Third Intervention (8 Days)||4
454875|NCT01284621|1114173|P2|COMPLETED|Third Intervention (8 Days)||4
454876|NCT01284621|1114174|P1|COMPLETED|Third Intervention (8 Days)||3
454877|NCT01284621|1114169|P6|STARTED|Third Intervention (8 Days)||4
454878|NCT01284621|1114170|P5|STARTED|Third Intervention (8 Days)||3
454879|NCT01284621|1114171|P4|STARTED|Third Intervention (8 Days)||4
454880|NCT01284621|1114172|P3|STARTED|Third Intervention (8 Days)||4
454881|NCT01284621|1114173|P2|STARTED|Third Intervention (8 Days)||4
454882|NCT01284621|1114174|P1|STARTED|Third Intervention (8 Days)||3
454883|NCT01284621|1114169|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
454884|NCT01284621|1114170|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
454885|NCT01284621|1114171|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
454886|NCT01284621|1114172|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
454887|NCT01284621|1114173|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
454888|NCT01284621|1114174|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
454889|NCT01284621|1114169|P6|COMPLETED|Washout Period 2 (7 Days)||4
454890|NCT01284621|1114170|P5|COMPLETED|Washout Period 2 (7 Days)||3
454891|NCT01284621|1114171|P4|COMPLETED|Washout Period 2 (7 Days)||4
454892|NCT01284621|1114172|P3|COMPLETED|Washout Period 2 (7 Days)||4
454893|NCT01284621|1114173|P2|COMPLETED|Washout Period 2 (7 Days)||4
454894|NCT01284621|1114174|P1|COMPLETED|Washout Period 2 (7 Days)||3
454895|NCT01284621|1114169|P6|STARTED|Washout Period 2 (7 Days)||4
454896|NCT01284621|1114170|P5|STARTED|Washout Period 2 (7 Days)||3
454897|NCT01284621|1114171|P4|STARTED|Washout Period 2 (7 Days)||4
454898|NCT01284621|1114172|P3|STARTED|Washout Period 2 (7 Days)||4
454899|NCT01284621|1114173|P2|STARTED|Washout Period 2 (7 Days)||4
454900|NCT01284621|1114174|P1|STARTED|Washout Period 2 (7 Days)||3
454901|NCT01284621|1114169|P6|NOT COMPLETED|Second Intervention (8 Days)||0
454902|NCT01284621|1114170|P5|NOT COMPLETED|Second Intervention (8 Days)||0
454903|NCT01284621|1114171|P4|NOT COMPLETED|Second Intervention (8 Days)||0
454904|NCT01284621|1114172|P3|NOT COMPLETED|Second Intervention (8 Days)||0
454905|NCT01284621|1114173|P2|NOT COMPLETED|Second Intervention (8 Days)||0
454906|NCT01284621|1114174|P1|NOT COMPLETED|Second Intervention (8 Days)||0
454907|NCT01284621|1114169|P6|COMPLETED|Second Intervention (8 Days)||4
454908|NCT01284621|1114170|P5|COMPLETED|Second Intervention (8 Days)||3
454909|NCT01284621|1114171|P4|COMPLETED|Second Intervention (8 Days)||4
454910|NCT01284621|1114172|P3|COMPLETED|Second Intervention (8 Days)||4
454911|NCT01284621|1114173|P2|COMPLETED|Second Intervention (8 Days)||4
454912|NCT01284621|1114174|P1|COMPLETED|Second Intervention (8 Days)||3
454913|NCT01284621|1114169|P6|STARTED|Second Intervention (8 Days)||4
454914|NCT01284621|1114170|P5|STARTED|Second Intervention (8 Days)||3
454915|NCT01284621|1114171|P4|STARTED|Second Intervention (8 Days)||4
454916|NCT01284621|1114172|P3|STARTED|Second Intervention (8 Days)||4
454917|NCT01284621|1114173|P2|STARTED|Second Intervention (8 Days)||4
454918|NCT01284621|1114174|P1|STARTED|Second Intervention (8 Days)||3
454919|NCT01284621|1114169|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
454920|NCT01284621|1114170|P5|NOT COMPLETED|Washout Period 1 (7 Days)||1
454921|NCT01284621|1114171|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
454922|NCT01284621|1114172|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
454923|NCT01284621|1114173|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
454924|NCT01284621|1114174|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
454925|NCT01284621|1114169|P6|COMPLETED|Washout Period 1 (7 Days)||4
454926|NCT01284621|1114170|P5|COMPLETED|Washout Period 1 (7 Days)||3
454927|NCT01284621|1114171|P4|COMPLETED|Washout Period 1 (7 Days)||4
454928|NCT01284621|1114172|P3|COMPLETED|Washout Period 1 (7 Days)||4
454929|NCT01284621|1114173|P2|COMPLETED|Washout Period 1 (7 Days)||4
454930|NCT01284621|1114174|P1|COMPLETED|Washout Period 1 (7 Days)||3
454931|NCT01284621|1114169|P6|STARTED|Washout Period 1 (7 Days)||4
454932|NCT01284621|1114170|P5|STARTED|Washout Period 1 (7 Days)||4
454933|NCT01284621|1114171|P4|STARTED|Washout Period 1 (7 Days)||4
454934|NCT01284621|1114172|P3|STARTED|Washout Period 1 (7 Days)||4
454935|NCT01284621|1114173|P2|STARTED|Washout Period 1 (7 Days)||4
454936|NCT01284621|1114174|P1|STARTED|Washout Period 1 (7 Days)||3
454937|NCT01284621|1114169|P6|NOT COMPLETED|First Intervention (8 Days)||0
454938|NCT01284621|1114170|P5|NOT COMPLETED|First Intervention (8 Days)||0
454939|NCT01284621|1114171|P4|NOT COMPLETED|First Intervention (8 Days)||0
454940|NCT01284621|1114172|P3|NOT COMPLETED|First Intervention (8 Days)||0
454941|NCT01284621|1114173|P2|NOT COMPLETED|First Intervention (8 Days)||0
454942|NCT01284621|1114174|P1|NOT COMPLETED|First Intervention (8 Days)||0
454943|NCT01284621|1114169|P6|COMPLETED|First Intervention (8 Days)||4
454944|NCT01284621|1114170|P5|COMPLETED|First Intervention (8 Days)||4
454945|NCT01284621|1114171|P4|COMPLETED|First Intervention (8 Days)||4
454946|NCT01284621|1114172|P3|COMPLETED|First Intervention (8 Days)||4
454947|NCT01284621|1114173|P2|COMPLETED|First Intervention (8 Days)||4
454948|NCT01284621|1114174|P1|COMPLETED|First Intervention (8 Days)||3
454949|NCT01284621|1114169|P6|STARTED|First Intervention (8 Days)||4
454950|NCT01284621|1114170|P5|STARTED|First Intervention (8 Days)||4
454951|NCT01284621|1114171|P4|STARTED|First Intervention (8 Days)||4
454952|NCT01284621|1114172|P3|STARTED|First Intervention (8 Days)||4
454953|NCT01284621|1114173|P2|STARTED|First Intervention (8 Days)||4
454954|NCT01284621|1114174|P1|STARTED|First Intervention (8 Days)||3
454955|NCT01284517|1114218|P2|NOT COMPLETED|Overall Study||36
454956|NCT01284517|1114219|P1|NOT COMPLETED|Overall Study||32
454957|NCT01284517|1114218|P2|COMPLETED|Overall Study||140
454958|NCT01284517|1114219|P1|COMPLETED|Overall Study||148
454959|NCT01284517|1114218|P2|STARTED|Overall Study||176
454960|NCT01284517|1114219|P1|STARTED|Overall Study||180
454961|NCT01284504|1114231|P2|NOT COMPLETED|Overall Study||0
454962|NCT01284504|1114232|P1|NOT COMPLETED|Overall Study||0
454963|NCT01284504|1114231|P2|COMPLETED|Overall Study||0
454964|NCT01284504|1114232|P1|COMPLETED|Overall Study||0
454965|NCT01284504|1114231|P2|STARTED|Overall Study||0
454966|NCT01284504|1114232|P1|STARTED|Overall Study||0
454967|NCT01284491|1114242|P1|NOT COMPLETED|Overall Study||13
454968|NCT01284491|1114242|P1|COMPLETED|Overall Study||0
454969|NCT01284491|1114242|P1|STARTED|Overall Study||13
454970|NCT01284426|1114248|P1|NOT COMPLETED|Overall Study||2
454971|NCT01284426|1114248|P1|COMPLETED|Overall Study||92
454972|NCT01284426|1114248|P1|STARTED|Overall Study||94
454973|NCT01284361|1114252|P1|NOT COMPLETED|Overall Study||9
454974|NCT01284361|1114252|P1|COMPLETED|Overall Study||82
454975|NCT01284361|1114252|P1|STARTED|Overall Study||91
454976|NCT01284296|1114259|P1|NOT COMPLETED|Overall Study||0
454977|NCT01284296|1114259|P1|COMPLETED|Overall Study||20
454978|NCT01284296|1114259|P1|STARTED|Overall Study||20
454979|NCT01284244|1114266|P2|NOT COMPLETED|Overall Study||0
454980|NCT01284244|1114267|P1|NOT COMPLETED|Overall Study||0
454981|NCT01284244|1114266|P2|COMPLETED|Overall Study||18
454982|NCT01284244|1114267|P1|COMPLETED|Overall Study||18
454983|NCT01284244|1114266|P2|STARTED|Overall Study||18
454984|NCT01284244|1114267|P1|STARTED|Overall Study||18
454985|NCT01284140|1114275|P2|NOT COMPLETED|Subjects With Paired 24hr Collections||6
454986|NCT01284140|1114276|P1|NOT COMPLETED|Subjects With Paired 24hr Collections||5
454987|NCT01284140|1114275|P2|COMPLETED|Subjects With Paired 24hr Collections||5
454988|NCT01284140|1114276|P1|COMPLETED|Subjects With Paired 24hr Collections||6
454989|NCT01284140|1114275|P2|STARTED|Subjects With Paired 24hr Collections||11
454990|NCT01284140|1114276|P1|STARTED|Subjects With Paired 24hr Collections||11
454991|NCT01284140|1114275|P2|NOT COMPLETED|Randomization and Intervention||0
454992|NCT01284140|1114276|P1|NOT COMPLETED|Randomization and Intervention||0
454993|NCT01284140|1114275|P2|COMPLETED|Randomization and Intervention||11
454994|NCT01284140|1114276|P1|COMPLETED|Randomization and Intervention||11
454995|NCT01284140|1114275|P2|STARTED|Randomization and Intervention||11
454996|NCT01284140|1114276|P1|STARTED|Randomization and Intervention||11
454997|NCT01284114|1114290|P1|NOT COMPLETED|Overall Study||4
454998|NCT01284114|1114290|P1|COMPLETED|Overall Study||19
454999|NCT01284114|1114290|P1|STARTED|Overall Study||23
455000|NCT01284062|1114302|P4|NOT COMPLETED|Overall Study||14
455001|NCT01284062|1114303|P3|NOT COMPLETED|Overall Study||6
455002|NCT01284062|1114304|P2|NOT COMPLETED|Overall Study||8
455003|NCT01284062|1114305|P1|NOT COMPLETED|Overall Study||11
455004|NCT01284062|1114302|P4|COMPLETED|Overall Study||7
455005|NCT01284062|1114303|P3|COMPLETED|Overall Study||15
455006|NCT01284062|1114304|P2|COMPLETED|Overall Study||13
455007|NCT01284062|1114305|P1|COMPLETED|Overall Study||10
455008|NCT01284062|1114302|P4|STARTED|Overall Study||21
455009|NCT01284062|1114303|P3|STARTED|Overall Study||21
455010|NCT01284062|1114304|P2|STARTED|Overall Study||21
455011|NCT01284062|1114305|P1|STARTED|Overall Study||21
455012|NCT01283971|1114379|P2|NOT COMPLETED|Overall Study||12
455013|NCT01283971|1114380|P1|NOT COMPLETED|Overall Study||15
455014|NCT01283971|1114379|P2|COMPLETED|Overall Study||36
455015|NCT01283971|1114380|P1|COMPLETED|Overall Study||33
455016|NCT01283971|1114379|P2|Intent to Treat Population|Overall Study||48
455017|NCT01283971|1114380|P1|Intent to Treat Population|Overall Study||46
455018|NCT01283971|1114379|P2|STARTED|Overall Study||48
455019|NCT01283971|1114380|P1|STARTED|Overall Study||48
455020|NCT01283581|1114427|P3|NOT COMPLETED|Overall Study||20
455021|NCT01283581|1114428|P2|NOT COMPLETED|Overall Study||14
455022|NCT01283581|1114429|P1|NOT COMPLETED|Overall Study||12
455023|NCT01283581|1114427|P3|COMPLETED|Overall Study||78
455024|NCT01283581|1114428|P2|COMPLETED|Overall Study||63
455025|NCT01283581|1114429|P1|COMPLETED|Overall Study||69
455026|NCT01283581|1114427|P3|STARTED|Overall Study||98
455027|NCT01283581|1114428|P2|STARTED|Overall Study||77
455028|NCT01283581|1114429|P1|STARTED|Overall Study||81
455029|NCT01283555|1114440|P2|NOT COMPLETED|Second Intervention||0
455030|NCT01283555|1114441|P1|NOT COMPLETED|Second Intervention||0
455031|NCT01283555|1114440|P2|COMPLETED|Second Intervention||12
455032|NCT01283555|1114441|P1|COMPLETED|Second Intervention||13
455033|NCT01283555|1114440|P2|STARTED|Second Intervention||12
455034|NCT01283555|1114441|P1|STARTED|Second Intervention||13
455035|NCT01283555|1114440|P2|NOT COMPLETED|Washout Period of at Least 21 Days||0
455036|NCT01283555|1114441|P1|NOT COMPLETED|Washout Period of at Least 21 Days||0
455037|NCT01283555|1114440|P2|COMPLETED|Washout Period of at Least 21 Days||12
455038|NCT01283555|1114441|P1|COMPLETED|Washout Period of at Least 21 Days||13
455039|NCT01283555|1114440|P2|STARTED|Washout Period of at Least 21 Days||12
455040|NCT01283555|1114441|P1|STARTED|Washout Period of at Least 21 Days||13
455041|NCT01283555|1114440|P2|NOT COMPLETED|First Intervention||0
455042|NCT01283555|1114441|P1|NOT COMPLETED|First Intervention||0
455043|NCT01283555|1114440|P2|COMPLETED|First Intervention||12
455044|NCT01283555|1114441|P1|COMPLETED|First Intervention||13
455045|NCT01283555|1114440|P2|STARTED|First Intervention||12
455046|NCT01283555|1114441|P1|STARTED|First Intervention||13
455047|NCT01283516|1114493|P9|NOT COMPLETED|Overall Study||122
455048|NCT01283516|1114494|P8|NOT COMPLETED|Overall Study||3
455049|NCT01283516|1114495|P7|NOT COMPLETED|Overall Study||8
455050|NCT01283516|1114496|P6|NOT COMPLETED|Overall Study||8
455051|NCT01283516|1114497|P5|NOT COMPLETED|Overall Study||13
455052|NCT01283516|1114498|P4|NOT COMPLETED|Overall Study||3
455053|NCT01283516|1114499|P3|NOT COMPLETED|Overall Study||2
455054|NCT01283516|1114500|P2|NOT COMPLETED|Overall Study||2
455055|NCT01283516|1114501|P1|NOT COMPLETED|Overall Study||2
455056|NCT01283516|1114493|P9|COMPLETED|Overall Study||133
455057|NCT01283516|1114494|P8|COMPLETED|Overall Study||2
455058|NCT01283516|1114495|P7|COMPLETED|Overall Study||2
455059|NCT01283516|1114496|P6|COMPLETED|Overall Study||2
455060|NCT01283516|1114497|P5|COMPLETED|Overall Study||1
455061|NCT01283516|1114498|P4|COMPLETED|Overall Study||0
455062|NCT01283516|1114499|P3|COMPLETED|Overall Study||1
455063|NCT01283516|1114500|P2|COMPLETED|Overall Study||0
455064|NCT01283516|1114501|P1|COMPLETED|Overall Study|Completed = Treatment Ongoing|0
455065|NCT01283516|1114493|P9|Dose-Determining Set (DDS)|Overall Study||8
455066|NCT01283516|1114494|P8|Dose-Determining Set (DDS)|Overall Study||5
455067|NCT01283516|1114495|P7|Dose-Determining Set (DDS)|Overall Study||10
455068|NCT01283516|1114496|P6|Dose-Determining Set (DDS)|Overall Study||8
455069|NCT01283516|1114497|P5|Dose-Determining Set (DDS)|Overall Study||14
455070|NCT01283516|1114498|P4|Dose-Determining Set (DDS)|Overall Study||3
455071|NCT01283516|1114499|P3|Dose-Determining Set (DDS)|Overall Study||3
455072|NCT01283516|1114500|P2|Dose-Determining Set (DDS)|Overall Study||1
455073|NCT01283516|1114501|P1|Dose-Determining Set (DDS)|Overall Study||2
455074|NCT01283516|1114493|P9|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||246
455075|NCT01283516|1114494|P8|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||5
455076|NCT01283516|1114495|P7|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||9
455077|NCT01283516|1114496|P6|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||10
455078|NCT01283516|1114497|P5|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||12
455079|NCT01283516|1114498|P4|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||3
455080|NCT01283516|1114499|P3|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2
455081|NCT01283516|1114500|P2|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||1
455082|NCT01283516|1114501|P1|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2
455083|NCT01283516|1114493|P9|STARTED|Overall Study||255
455084|NCT01283516|1114494|P8|STARTED|Overall Study||5
455085|NCT01283516|1114495|P7|STARTED|Overall Study||10
455086|NCT01283516|1114496|P6|STARTED|Overall Study||10
455087|NCT01283516|1114497|P5|STARTED|Overall Study||14
455088|NCT01283516|1114498|P4|STARTED|Overall Study||3
455089|NCT01283516|1114499|P3|STARTED|Overall Study||3
455090|NCT01283516|1114500|P2|STARTED|Overall Study||2
455091|NCT01283516|1114501|P1|STARTED|Overall Study|Started = Full Analysis Set and Safety Set|2
455092|NCT01283464|1114525|P2|NOT COMPLETED|Overall Study||1
455093|NCT01283464|1114526|P1|NOT COMPLETED|Overall Study||2
455094|NCT01283464|1114525|P2|COMPLETED|Overall Study||11
455095|NCT01283464|1114526|P1|COMPLETED|Overall Study||10
455096|NCT01283464|1114525|P2|STARTED|Overall Study||12
455097|NCT01283464|1114526|P1|STARTED|Overall Study||12
455098|NCT01283334|1114532|P1|NOT COMPLETED|Overall Study||7
455099|NCT01283334|1114532|P1|COMPLETED|Overall Study||13
455100|NCT01283334|1114532|P1|STARTED|Overall Study||20
455101|NCT01283321|1114540|P2|NOT COMPLETED|Overall Study||0
455102|NCT01283321|1114541|P1|NOT COMPLETED|Overall Study||0
455103|NCT01283321|1114540|P2|COMPLETED|Overall Study||10
455104|NCT01283321|1114541|P1|COMPLETED|Overall Study||10
455105|NCT01283321|1114540|P2|STARTED|Overall Study||10
455106|NCT01283321|1114541|P1|STARTED|Overall Study||10
455107|NCT01283282|1114555|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
455108|NCT01283282|1114556|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
455109|NCT01283282|1114555|P2|COMPLETED|Second Intervention (6 Weeks)||19
455110|NCT01283282|1114556|P1|COMPLETED|Second Intervention (6 Weeks)||22
455111|NCT01283282|1114555|P2|STARTED|Second Intervention (6 Weeks)||19
455112|NCT01283282|1114556|P1|STARTED|Second Intervention (6 Weeks)||22
455113|NCT01283282|1114555|P2|NOT COMPLETED|First Intervention (6 Weeks)||4
455114|NCT01283282|1114556|P1|NOT COMPLETED|First Intervention (6 Weeks)||3
455115|NCT01283282|1114555|P2|COMPLETED|First Intervention (6 Weeks)||19
455116|NCT01283282|1114556|P1|COMPLETED|First Intervention (6 Weeks)||22
455117|NCT01283282|1114555|P2|STARTED|First Intervention (6 Weeks)||23
455118|NCT01283282|1114556|P1|STARTED|First Intervention (6 Weeks)||25
455119|NCT01283152|1114576|P2|NOT COMPLETED|Overall Study||0
455120|NCT01283152|1114577|P1|NOT COMPLETED|Overall Study||2
455121|NCT01283152|1114576|P2|COMPLETED|Overall Study||25
455122|NCT01283152|1114577|P1|COMPLETED|Overall Study||23
455123|NCT01283152|1114576|P2|24-hr HESA Attempted|Overall Study||25
455124|NCT01283152|1114577|P1|24-hr HESA Attempted|Overall Study||25
455125|NCT01283152|1114576|P2|Study Treatment Received|Overall Study||25
455126|NCT01283152|1114577|P1|Study Treatment Received|Overall Study||25
455127|NCT01283152|1114576|P2|ITT Population|Overall Study||25
455128|NCT01283152|1114577|P1|ITT Population|Overall Study||25
455129|NCT01283152|1114576|P2|STARTED|Overall Study||25
455130|NCT01283152|1114577|P1|STARTED|Overall Study||25
455131|NCT01283139|1114591|P4|NOT COMPLETED|Overall Study||15
455132|NCT01283139|1114592|P3|NOT COMPLETED|Overall Study||18
455133|NCT01283139|1114593|P2|NOT COMPLETED|Overall Study||18
455134|NCT01283139|1114594|P1|NOT COMPLETED|Overall Study||17
455135|NCT01283139|1114591|P4|COMPLETED|Overall Study||92
455136|NCT01283139|1114592|P3|COMPLETED|Overall Study||91
455137|NCT01283139|1114593|P2|COMPLETED|Overall Study||90
455138|NCT01283139|1114594|P1|COMPLETED|Overall Study||91
455139|NCT01283139|1114591|P4|STARTED|Overall Study||107
455140|NCT01283139|1114592|P3|STARTED|Overall Study||109
455141|NCT01283139|1114593|P2|STARTED|Overall Study||108
455142|NCT01283139|1114594|P1|STARTED|Overall Study||108
455143|NCT01283035|1114636|P1|NOT COMPLETED|Overall Study||1
455144|NCT01283035|1114636|P1|COMPLETED|Overall Study||5
455145|NCT01283035|1114636|P1|STARTED|Overall Study||6
455146|NCT01283022|1114645|P1|NOT COMPLETED|Overall Study||0
455147|NCT01283022|1114645|P1|COMPLETED|Overall Study||24
455148|NCT01283022|1114645|P1|STARTED|Overall Study||24
455149|NCT01282866|1114651|P1|NOT COMPLETED|Overall Study||1
455150|NCT01282866|1114651|P1|COMPLETED|Overall Study||34
455151|NCT01282866|1114651|P1|STARTED|Overall Study||35
455152|NCT01282814|1114659|P2|NOT COMPLETED|Second Intervention||0
455153|NCT01282814|1114660|P1|NOT COMPLETED|Second Intervention||0
455154|NCT01282814|1114659|P2|COMPLETED|Second Intervention||9
455155|NCT01282814|1114660|P1|COMPLETED|Second Intervention||10
455156|NCT01282814|1114659|P2|STARTED|Second Intervention||9
455157|NCT01282814|1114660|P1|STARTED|Second Intervention||10
455158|NCT01282814|1114659|P2|NOT COMPLETED|Washout of 7 Days||0
455159|NCT01282814|1114660|P1|NOT COMPLETED|Washout of 7 Days||2
455160|NCT01282814|1114659|P2|COMPLETED|Washout of 7 Days||9
455161|NCT01282814|1114660|P1|COMPLETED|Washout of 7 Days||10
455162|NCT01282814|1114659|P2|STARTED|Washout of 7 Days||9
455163|NCT01282814|1114660|P1|STARTED|Washout of 7 Days||12
455164|NCT01282814|1114659|P2|NOT COMPLETED|First Intervention||3
455165|NCT01282814|1114660|P1|NOT COMPLETED|First Intervention||0
455166|NCT01282814|1114659|P2|COMPLETED|First Intervention||9
455167|NCT01282814|1114660|P1|COMPLETED|First Intervention||12
455168|NCT01282814|1114659|P2|STARTED|First Intervention||12
455169|NCT01282814|1114660|P1|STARTED|First Intervention||12
455170|NCT01282801|1114672|P2|NOT COMPLETED|Second Intervention||1
455171|NCT01282801|1114673|P1|NOT COMPLETED|Second Intervention||0
455172|NCT01282801|1114672|P2|COMPLETED|Second Intervention||8
455173|NCT01282801|1114673|P1|COMPLETED|Second Intervention||9
455174|NCT01282801|1114672|P2|STARTED|Second Intervention||9
455175|NCT01282801|1114673|P1|STARTED|Second Intervention||9
455176|NCT01282801|1114672|P2|NOT COMPLETED|Washout of 7 Days||0
455177|NCT01282801|1114673|P1|NOT COMPLETED|Washout of 7 Days||0
455178|NCT01282801|1114672|P2|COMPLETED|Washout of 7 Days||9
455179|NCT01282801|1114673|P1|COMPLETED|Washout of 7 Days||9
455180|NCT01282801|1114672|P2|STARTED|Washout of 7 Days||9
455181|NCT01282801|1114673|P1|STARTED|Washout of 7 Days||9
455182|NCT01282801|1114672|P2|NOT COMPLETED|First Intervention||0
455183|NCT01282801|1114673|P1|NOT COMPLETED|First Intervention||0
455184|NCT01282801|1114672|P2|COMPLETED|First Intervention||9
455185|NCT01282801|1114673|P1|COMPLETED|First Intervention||9
455186|NCT01282801|1114672|P2|STARTED|First Intervention||9
455187|NCT01282801|1114673|P1|STARTED|First Intervention||9
455188|NCT01282723|1114689|P1|NOT COMPLETED|Overall Study||0
455189|NCT01282723|1114689|P1|COMPLETED|Overall Study||20
455190|NCT01282723|1114689|P1|STARTED|Overall Study||20
455191|NCT01282710|1114693|P1|NOT COMPLETED|Overall Study||0
455192|NCT01282710|1114693|P1|COMPLETED|Overall Study||20
455193|NCT01282710|1114693|P1|STARTED|Overall Study||20
455194|NCT01282476|1114697|P1|NOT COMPLETED|Overall Study||11
455195|NCT01282476|1114697|P1|COMPLETED|Overall Study||7
455196|NCT01282476|1114697|P1|STARTED|Overall Study||18
455197|NCT01282424|1114703|P1|NOT COMPLETED|Overall Study||76
455198|NCT01282424|1114703|P1|COMPLETED|Overall Study||49
455199|NCT01282424|1114703|P1|Completed: Death|Overall Study||8
455200|NCT01282424|1114703|P1|Completed: Disease Progression|Overall Study||41
455201|NCT01282424|1114703|P1|STARTED|Overall Study||125
455202|NCT01282372|1114720|P1|NOT COMPLETED|Overall Study||79
455203|NCT01282372|1114720|P1|COMPLETED|Overall Study||421
455204|NCT01282372|1114720|P1|STARTED|Overall Study||500
455205|NCT01282294|1114748|P1|NOT COMPLETED|Overall Study||19
455206|NCT01282294|1114748|P1|COMPLETED|Overall Study||81
455207|NCT01282294|1114748|P1|12 Months|Overall Study||86
455208|NCT01282294|1114748|P1|6 Months|Overall Study||94
455209|NCT01282294|1114748|P1|3 Months|Overall Study||95
455210|NCT01282294|1114748|P1|6 Weeks|Overall Study||95
455211|NCT01282294|1114748|P1|Post-operative|Overall Study||99
455212|NCT01282294|1114748|P1|Intra-operative|Overall Study||99
455213|NCT01282294|1114748|P1|STARTED|Overall Study||100
455214|NCT01282242|1114768|P2|NOT COMPLETED|Overall Study||0
455215|NCT01282242|1114769|P1|NOT COMPLETED|Overall Study||0
455216|NCT01282242|1114768|P2|COMPLETED|Overall Study||8
455217|NCT01282242|1114769|P1|COMPLETED|Overall Study||80
455218|NCT01282242|1114768|P2|STARTED|Overall Study||8
455219|NCT01282242|1114769|P1|STARTED|Overall Study||80
455220|NCT01282229|1114777|P1|NOT COMPLETED|Overall Study||2
455221|NCT01282229|1114777|P1|COMPLETED|Overall Study|57 Participants contributed 228 quadrants (57*4)|57
455222|NCT01282229|1114777|P1|STARTED|Overall Study|59 Participants contributed 236 quadrants (59*4)|59
455223|NCT01282203|1114807|P1|NOT COMPLETED|Overall Study||1
455224|NCT01282203|1114807|P1|COMPLETED|Overall Study||1121
455225|NCT01282203|1114807|P1|STARTED|Overall Study||1122
455226|NCT01282164|1114829|P2|NOT COMPLETED|Overall Study||0
455227|NCT01282164|1114830|P1|NOT COMPLETED|Overall Study||1
455228|NCT01282164|1114829|P2|COMPLETED|Overall Study||14
455229|NCT01282164|1114830|P1|COMPLETED|Overall Study||28
455230|NCT01282164|1114829|P2|STARTED|Overall Study||14
455231|NCT01282164|1114830|P1|STARTED|Overall Study||29
455232|NCT01282138|1114855|P2|NOT COMPLETED|CAPT||0
455233|NCT01282138|1114856|P1|NOT COMPLETED|CAPT||0
455234|NCT01282138|1114855|P2|COMPLETED|CAPT||7
455235|NCT01282138|1114856|P1|COMPLETED|CAPT||6
455236|NCT01282138|1114855|P2|STARTED|CAPT||7
455237|NCT01282138|1114856|P1|STARTED|CAPT||6
455238|NCT01282138|1114855|P2|NOT COMPLETED|EEC||0
455239|NCT01282138|1114856|P1|NOT COMPLETED|EEC||0
455240|NCT01282138|1114855|P2|COMPLETED|EEC||7
455241|NCT01282138|1114856|P1|COMPLETED|EEC||6
455242|NCT01282138|1114855|P2|STARTED|EEC||7
455243|NCT01282138|1114856|P1|STARTED|EEC||6
455244|NCT01282086|1114864|P1|NOT COMPLETED|Overall Study||0
455245|NCT01282086|1114864|P1|COMPLETED|Overall Study||1365
455246|NCT01282086|1114864|P1|STARTED|Overall Study||1365
455247|NCT01281917|1114881|P1|NOT COMPLETED|Overall Study||1
455248|NCT01281917|1114881|P1|COMPLETED|Overall Study||39
455249|NCT01281917|1114881|P1|STARTED|Overall Study||40
455250|NCT01281865|1114893|P2|NOT COMPLETED|Overall Study||1
455251|NCT01281865|1114894|P1|NOT COMPLETED|Overall Study||3
455252|NCT01281865|1114893|P2|COMPLETED|Overall Study||1
455253|NCT01281865|1114894|P1|COMPLETED|Overall Study||9
455254|NCT01281865|1114893|P2|STARTED|Overall Study||2
455255|NCT01281865|1114894|P1|STARTED|Overall Study||12
455256|NCT01281839|1114902|P2|NOT COMPLETED|Overall Study||14
455257|NCT01281839|1114903|P1|NOT COMPLETED|Overall Study||10
455258|NCT01281839|1114902|P2|COMPLETED|Overall Study||119
455259|NCT01281839|1114903|P1|COMPLETED|Overall Study||250
455260|NCT01281839|1114902|P2|STARTED|Overall Study||133
455261|NCT01281839|1114903|P1|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|260
455262|NCT01281644|1114964|P1|NOT COMPLETED|Overall Study||5
455263|NCT01281644|1114964|P1|COMPLETED|Overall Study||18
455264|NCT01281644|1114964|P1|STARTED|Overall Study||23
455265|NCT01281501|1114974|P2|NOT COMPLETED|Overall Study||0
455266|NCT01281501|1114975|P1|NOT COMPLETED|Overall Study||0
455267|NCT01281501|1114974|P2|COMPLETED|Overall Study||43
455268|NCT01281501|1114975|P1|COMPLETED|Overall Study||44
455269|NCT01281501|1114974|P2|STARTED|Overall Study||43
455270|NCT01281501|1114975|P1|STARTED|Overall Study||44
455271|NCT01281475|1114989|P2|NOT COMPLETED|Overall Study||8
455272|NCT01281475|1114990|P1|NOT COMPLETED|Overall Study||4
455273|NCT01281475|1114989|P2|COMPLETED|Overall Study||26
455274|NCT01281475|1114990|P1|COMPLETED|Overall Study||29
455275|NCT01281475|1114989|P2|STARTED|Overall Study||34
455276|NCT01281475|1114990|P1|STARTED|Overall Study||33
455277|NCT01281306|1115005|P7|NOT COMPLETED|Overall Study||7
455278|NCT01281306|1115006|P6|NOT COMPLETED|Overall Study||7
455279|NCT01281306|1115007|P5|NOT COMPLETED|Overall Study||9
455280|NCT01281306|1115008|P4|NOT COMPLETED|Overall Study||11
455281|NCT01281306|1115009|P3|NOT COMPLETED|Overall Study||8
455282|NCT01281306|1115010|P2|NOT COMPLETED|Overall Study||4
455283|NCT01281306|1115011|P1|NOT COMPLETED|Overall Study||8
455284|NCT01281306|1115005|P7|COMPLETED|Overall Study||51
455285|NCT01281306|1115006|P6|COMPLETED|Overall Study||135
455286|NCT01281306|1115007|P5|COMPLETED|Overall Study||134
455287|NCT01281306|1115008|P4|COMPLETED|Overall Study||123
455288|NCT01281306|1115009|P3|COMPLETED|Overall Study||133
455289|NCT01281306|1115010|P2|COMPLETED|Overall Study||141
455290|NCT01281306|1115011|P1|COMPLETED|Overall Study||136
455291|NCT01281306|1115005|P7|Ambulatory Blood Pressure Monitoring Set|Overall Study||35
455292|NCT01281306|1115006|P6|Ambulatory Blood Pressure Monitoring Set|Overall Study||91
455293|NCT01281306|1115007|P5|Ambulatory Blood Pressure Monitoring Set|Overall Study||93
455294|NCT01281306|1115008|P4|Ambulatory Blood Pressure Monitoring Set|Overall Study||95
455295|NCT01281306|1115009|P3|Ambulatory Blood Pressure Monitoring Set|Overall Study||92
455296|NCT01281306|1115010|P2|Ambulatory Blood Pressure Monitoring Set|Overall Study||99
455297|NCT01281306|1115011|P1|Ambulatory Blood Pressure Monitoring Set|Overall Study||95
455298|NCT01281306|1115005|P7|Safety Set|Overall Study||58
455299|NCT01281306|1115006|P6|Safety Set|Overall Study||142
455300|NCT01281306|1115007|P5|Safety Set|Overall Study||143
455301|NCT01281306|1115008|P4|Safety Set|Overall Study||133
455302|NCT01281306|1115009|P3|Safety Set|Overall Study||141
455303|NCT01281306|1115010|P2|Safety Set|Overall Study||145
455304|NCT01281306|1115011|P1|Safety Set|Overall Study||143
455305|NCT01281306|1115005|P7|Full Analysis Set|Overall Study||58
455306|NCT01281306|1115006|P6|Full Analysis Set|Overall Study||142
455307|NCT01281306|1115007|P5|Full Analysis Set|Overall Study||143
455308|NCT01281306|1115008|P4|Full Analysis Set|Overall Study||133
455309|NCT01281306|1115009|P3|Full Analysis Set|Overall Study||141
455310|NCT01281306|1115010|P2|Full Analysis Set|Overall Study||145
455311|NCT01281306|1115011|P1|Full Analysis Set|Overall Study||143
455312|NCT01281306|1115005|P7|STARTED|Overall Study||58
455313|NCT01281306|1115006|P6|STARTED|Overall Study||142
455314|NCT01281306|1115007|P5|STARTED|Overall Study||143
455315|NCT01281306|1115008|P4|STARTED|Overall Study||134
455316|NCT01281306|1115009|P3|STARTED|Overall Study||141
455317|NCT01281306|1115010|P2|STARTED|Overall Study||145
455318|NCT01281306|1115011|P1|STARTED|Overall Study||144
455319|NCT01281202|1115127|P2|NOT COMPLETED|Overall Study||36
455320|NCT01281202|1115128|P1|NOT COMPLETED|Overall Study||28
455321|NCT01281202|1115127|P2|COMPLETED|Overall Study||68
455322|NCT01281202|1115128|P1|COMPLETED|Overall Study||75
455323|NCT01281202|1115127|P2|STARTED|Overall Study||104
455324|NCT01281202|1115128|P1|STARTED|Overall Study||103
455325|NCT01281124|1115136|P1|NOT COMPLETED|Overall Study||1
455326|NCT01281124|1115136|P1|COMPLETED|Overall Study||0
455327|NCT01281124|1115136|P1|STARTED|Overall Study||1
455328|NCT01281007|1115144|P2|NOT COMPLETED|Overall Study||8
455329|NCT01281007|1115145|P1|NOT COMPLETED|Overall Study||4
455330|NCT01281007|1115144|P2|COMPLETED|Overall Study||67
455331|NCT01281007|1115145|P1|COMPLETED|Overall Study||71
455332|NCT01281007|1115144|P2|STARTED|Overall Study||75
455333|NCT01281007|1115145|P1|STARTED|Overall Study||75
455334|NCT01280981|1115151|P1|NOT COMPLETED|Overall Study||92
455335|NCT01280981|1115151|P1|COMPLETED|Overall Study||196
455336|NCT01280981|1115151|P1|Intent to Treat (ITT) Population|Overall Study|Participants who took drug during at least one menstrual cycle|260
455337|NCT01280981|1115151|P1|STARTED|Overall Study||288
455338|NCT01280968|1115162|P2|NOT COMPLETED|Overall Study||3
455339|NCT01280968|1115163|P1|NOT COMPLETED|Overall Study||18
455340|NCT01280968|1115162|P2|COMPLETED|Overall Study||4
455341|NCT01280968|1115163|P1|COMPLETED|Overall Study||27
455342|NCT01280968|1115162|P2|STARTED|Overall Study||7
455343|NCT01280968|1115163|P1|STARTED|Overall Study||45
455344|NCT01280955|1115179|P1|NOT COMPLETED|Overall Study||3
455345|NCT01280955|1115179|P1|COMPLETED|Overall Study||27
455346|NCT01280955|1115179|P1|STARTED|Overall Study||30
455347|NCT01280942|1115212|P2|NOT COMPLETED|Overall Study||0
455348|NCT01280942|1115213|P1|NOT COMPLETED|Overall Study||0
455349|NCT01280942|1115212|P2|COMPLETED|Overall Study||9911
455350|NCT01280942|1115213|P1|COMPLETED|Overall Study||10120
455351|NCT01280942|1115212|P2|STARTED|Overall Study||9911
455352|NCT01280942|1115213|P1|STARTED|Overall Study||10120
455353|NCT01280903|1115223|P2|NOT COMPLETED|Overall Study||16
455354|NCT01280903|1115224|P1|NOT COMPLETED|Overall Study||23
455355|NCT01280903|1115223|P2|COMPLETED|Overall Study|91 participants analyzed per intention-to-treat|75
455356|NCT01280903|1115224|P1|COMPLETED|Overall Study|91 participants analyzed per intention-to-treat|68
455357|NCT01280903|1115223|P2|STARTED|Overall Study||91
455358|NCT01280903|1115224|P1|STARTED|Overall Study||91
455359|NCT01280695|1115293|P5|NOT COMPLETED|Overall Study||2
455360|NCT01280695|1115294|P4|NOT COMPLETED|Overall Study||4
455361|NCT01280695|1115295|P3|NOT COMPLETED|Overall Study||5
455362|NCT01280695|1115296|P2|NOT COMPLETED|Overall Study||1
455363|NCT01280695|1115297|P1|NOT COMPLETED|Overall Study||0
455364|NCT01280695|1115293|P5|COMPLETED|Overall Study||24
455365|NCT01280695|1115294|P4|COMPLETED|Overall Study||22
455366|NCT01280695|1115295|P3|COMPLETED|Overall Study||21
455367|NCT01280695|1115296|P2|COMPLETED|Overall Study||24
455368|NCT01280695|1115297|P1|COMPLETED|Overall Study||26
455369|NCT01280695|1115293|P5|STARTED|Overall Study||26
455370|NCT01280695|1115294|P4|STARTED|Overall Study||26
455371|NCT01280695|1115295|P3|STARTED|Overall Study||26
455372|NCT01280695|1115296|P2|STARTED|Overall Study||25
455373|NCT01280695|1115297|P1|STARTED|Overall Study||26
455374|NCT01280656|1115337|P3|NOT COMPLETED|Overall Study||63
455375|NCT01280656|1115338|P2|NOT COMPLETED|Overall Study||47
455376|NCT01280656|1115339|P1|NOT COMPLETED|Overall Study||3
455377|NCT01280656|1115337|P3|COMPLETED|Overall Study||223
455378|NCT01280656|1115338|P2|COMPLETED|Overall Study||265
455379|NCT01280656|1115339|P1|COMPLETED|Overall Study||59
455380|NCT01280656|1115337|P3|STARTED|Overall Study||286
455381|NCT01280656|1115338|P2|STARTED|Overall Study||312
455382|NCT01280656|1115339|P1|STARTED|Overall Study||62
455383|NCT01280604|1115385|P2|NOT COMPLETED|Overall Study||5
455384|NCT01280604|1115386|P1|NOT COMPLETED|Overall Study||9
455385|NCT01280604|1115385|P2|COMPLETED|Overall Study||28
455386|NCT01280604|1115386|P1|COMPLETED|Overall Study||24
455387|NCT01280604|1115385|P2|Subjects Meeting All Inclusion Criteria|Overall Study||29
455388|NCT01280604|1115386|P1|Subjects Meeting All Inclusion Criteria|Overall Study||25
455389|NCT01280604|1115385|P2|STARTED|Overall Study||33
455390|NCT01280604|1115386|P1|STARTED|Overall Study||33
455391|NCT01280591|1115406|P4|NOT COMPLETED|Overall Study||3
455392|NCT01280591|1115407|P3|NOT COMPLETED|Overall Study||0
455393|NCT01280591|1115408|P2|NOT COMPLETED|Overall Study||0
455394|NCT01280591|1115409|P1|NOT COMPLETED|Overall Study||0
455395|NCT01280591|1115406|P4|COMPLETED|Overall Study||99
455396|NCT01280591|1115407|P3|COMPLETED|Overall Study||203
455397|NCT01280591|1115408|P2|COMPLETED|Overall Study||204
455398|NCT01280591|1115409|P1|COMPLETED|Overall Study||203
455399|NCT01280591|1115406|P4|STARTED|Overall Study||102
455400|NCT01280591|1115407|P3|STARTED|Overall Study||203
455401|NCT01280591|1115408|P2|STARTED|Overall Study||204
455402|NCT01280591|1115409|P1|STARTED|Overall Study||203
455403|NCT01280552|1115501|P2|NOT COMPLETED|Overall Study||1
455404|NCT01280552|1115502|P1|NOT COMPLETED|Overall Study||6
455405|NCT01280552|1115501|P2|COMPLETED|Overall Study||42
455406|NCT01280552|1115502|P1|COMPLETED|Overall Study|Survival is still being assessed|75
455407|NCT01280552|1115501|P2|STARTED|Overall Study||43
455408|NCT01280552|1115502|P1|STARTED|Overall Study||81
455409|NCT01280357|1115514|P1|NOT COMPLETED|Overall Study||26
455410|NCT01280357|1115514|P1|COMPLETED|Overall Study||34
455411|NCT01280357|1115514|P1|STARTED|Overall Study||60
455412|NCT01280266|1115523|P2|NOT COMPLETED|Second Intervention (Week 5-9)||0
455413|NCT01280266|1115524|P1|NOT COMPLETED|Second Intervention (Week 5-9)||0
455414|NCT01280266|1115523|P2|COMPLETED|Second Intervention (Week 5-9)||12
455415|NCT01280266|1115524|P1|COMPLETED|Second Intervention (Week 5-9)||14
455416|NCT01280266|1115523|P2|STARTED|Second Intervention (Week 5-9)||12
455417|NCT01280266|1115524|P1|STARTED|Second Intervention (Week 5-9)||14
455418|NCT01280266|1115523|P2|NOT COMPLETED|Washout Period (Week 4-5)||0
455419|NCT01280266|1115524|P1|NOT COMPLETED|Washout Period (Week 4-5)||0
455420|NCT01280266|1115523|P2|COMPLETED|Washout Period (Week 4-5)||12
455421|NCT01280266|1115524|P1|COMPLETED|Washout Period (Week 4-5)||14
455422|NCT01280266|1115523|P2|STARTED|Washout Period (Week 4-5)||12
455423|NCT01280266|1115524|P1|STARTED|Washout Period (Week 4-5)||14
455424|NCT01280266|1115523|P2|NOT COMPLETED|First Intervention (Week 1-4)||2
455425|NCT01280266|1115524|P1|NOT COMPLETED|First Intervention (Week 1-4)||1
455426|NCT01280266|1115523|P2|COMPLETED|First Intervention (Week 1-4)||12
455427|NCT01280266|1115524|P1|COMPLETED|First Intervention (Week 1-4)||14
455428|NCT01280266|1115523|P2|STARTED|First Intervention (Week 1-4)||14
455429|NCT01280266|1115524|P1|STARTED|First Intervention (Week 1-4)||15
455430|NCT01280123|1115549|P3|NOT COMPLETED|Overall Study||1
455431|NCT01280123|1115550|P2|NOT COMPLETED|Overall Study||4
455432|NCT01280123|1115551|P1|NOT COMPLETED|Overall Study||1
455433|NCT01280123|1115549|P3|COMPLETED|Overall Study||70
455434|NCT01280123|1115550|P2|COMPLETED|Overall Study||63
455435|NCT01280123|1115551|P1|COMPLETED|Overall Study||71
455436|NCT01280123|1115549|P3|STARTED|Overall Study||71
455437|NCT01280123|1115550|P2|STARTED|Overall Study||67
455438|NCT01280123|1115551|P1|STARTED|Overall Study||72
455439|NCT01280110|1115576|P2|NOT COMPLETED|Overall Study||0
455440|NCT01280110|1115577|P1|NOT COMPLETED|Overall Study||0
455441|NCT01280110|1115576|P2|COMPLETED|Overall Study||22
455442|NCT01280110|1115577|P1|COMPLETED|Overall Study||22
455443|NCT01280110|1115576|P2|STARTED|Overall Study||22
455444|NCT01280110|1115577|P1|STARTED|Overall Study||22
455445|NCT01280058|1115587|P2|NOT COMPLETED|Overall Study||0
455446|NCT01280058|1115588|P1|NOT COMPLETED|Overall Study||0
455447|NCT01280058|1115587|P2|COMPLETED|Overall Study||37
455448|NCT01280058|1115588|P1|COMPLETED|Overall Study||36
455449|NCT01280058|1115587|P2|STARTED|Overall Study||37
455450|NCT01280058|1115588|P1|STARTED|Overall Study||36
455451|NCT01279681|1115606|P2|NOT COMPLETED|Overall Study||17
455452|NCT01279681|1115607|P1|NOT COMPLETED|Overall Study||15
455453|NCT01279681|1115606|P2|COMPLETED|Overall Study||0
455454|NCT01279681|1115607|P1|COMPLETED|Overall Study||0
455455|NCT01279681|1115606|P2|STARTED|Overall Study||17
455456|NCT01279681|1115607|P1|STARTED|Overall Study||15
455457|NCT01279564|1115621|P2|NOT COMPLETED|Overall Study||0
455458|NCT01279564|1115622|P1|NOT COMPLETED|Overall Study||0
455459|NCT01279564|1115621|P2|COMPLETED|Overall Study||32
455460|NCT01279564|1115622|P1|COMPLETED|Overall Study||40
455461|NCT01279564|1115621|P2|STARTED|Overall Study||32
455462|NCT01279564|1115622|P1|STARTED|Overall Study||40
455463|NCT01279447|1115630|P2|NOT COMPLETED|Overall Study||1
455464|NCT01279447|1115631|P1|NOT COMPLETED|Overall Study||3
455465|NCT01279447|1115630|P2|COMPLETED|Overall Study||33
455466|NCT01279447|1115631|P1|COMPLETED|Overall Study||31
455467|NCT01279447|1115630|P2|STARTED|Overall Study||34
455468|NCT01279447|1115631|P1|STARTED|Overall Study||34
455469|NCT01279317|1115637|P2|NOT COMPLETED|Period 2||0
455470|NCT01279317|1115638|P1|NOT COMPLETED|Period 2||0
455471|NCT01279317|1115637|P2|COMPLETED|Period 2||6
455472|NCT01279317|1115638|P1|COMPLETED|Period 2||6
455473|NCT01279317|1115637|P2|STARTED|Period 2||6
455474|NCT01279317|1115638|P1|STARTED|Period 2||6
455475|NCT01279317|1115637|P2|NOT COMPLETED|Washout||0
455476|NCT01279317|1115638|P1|NOT COMPLETED|Washout||0
455477|NCT01279317|1115637|P2|COMPLETED|Washout||6
455478|NCT01279317|1115638|P1|COMPLETED|Washout||6
455479|NCT01279317|1115637|P2|STARTED|Washout||6
455480|NCT01279317|1115638|P1|STARTED|Washout||6
455481|NCT01279317|1115637|P2|NOT COMPLETED|Period 1||0
455482|NCT01279317|1115638|P1|NOT COMPLETED|Period 1||0
455483|NCT01279317|1115637|P2|COMPLETED|Period 1||6
455484|NCT01279317|1115638|P1|COMPLETED|Period 1||6
455485|NCT01279317|1115637|P2|STARTED|Period 1||6
455486|NCT01279317|1115638|P1|STARTED|Period 1||6
455487|NCT01279265|1115645|P2|NOT COMPLETED|Overall Study||6
455488|NCT01279265|1115646|P1|NOT COMPLETED|Overall Study||4
455489|NCT01279265|1115645|P2|COMPLETED|Overall Study||11
455490|NCT01279265|1115646|P1|COMPLETED|Overall Study||9
455491|NCT01279265|1115645|P2|STARTED|Overall Study||17
455492|NCT01279265|1115646|P1|STARTED|Overall Study||13
455493|NCT01279200|1115658|P2|NOT COMPLETED|Overall Study||7
455494|NCT01279200|1115659|P1|NOT COMPLETED|Overall Study||2
455495|NCT01279200|1115658|P2|COMPLETED|Overall Study||4
455496|NCT01279200|1115659|P1|COMPLETED|Overall Study||8
455497|NCT01279200|1115658|P2|STARTED|Overall Study||11
455498|NCT01279200|1115659|P1|STARTED|Overall Study||10
455499|NCT01279187|1115669|P2|NOT COMPLETED|Overall Study||0
455500|NCT01279187|1115670|P1|NOT COMPLETED|Overall Study||0
455501|NCT01279187|1115669|P2|COMPLETED|Overall Study||13
455502|NCT01279187|1115670|P1|COMPLETED|Overall Study||14
455503|NCT01279187|1115669|P2|STARTED|Overall Study||13
455504|NCT01279187|1115670|P1|STARTED|Overall Study||14
455505|NCT01279109|1115686|P2|NOT COMPLETED|Overall Study||12
455506|NCT01279109|1115687|P1|NOT COMPLETED|Overall Study||13
455507|NCT01279109|1115686|P2|COMPLETED|Overall Study||55
455508|NCT01279109|1115687|P1|COMPLETED|Overall Study||55
455509|NCT01279109|1115686|P2|STARTED|Overall Study||67
455510|NCT01279109|1115687|P1|STARTED|Overall Study||68
455511|NCT01279070|1115697|P2|NOT COMPLETED|Overall Study||4
455512|NCT01279070|1115698|P1|NOT COMPLETED|Overall Study||5
455513|NCT01279070|1115697|P2|COMPLETED|Overall Study|4 outpatients left the leisure group up to 2 months after starting Leisure group.|24
455514|NCT01279070|1115698|P1|COMPLETED|Overall Study|5 outpatients left the treatment up to 2 months after starting REPYFLEC.|29
455515|NCT01279070|1115697|P2|STARTED|Overall Study|28 outpatients were randomly assigned to 32 sessions of leisure group.|28
455516|NCT01279070|1115698|P1|STARTED|Overall Study|34 outpatients were randomly assigned to 32 sessions of REPYFLEC.|34
455517|NCT01279044|1115717|P3|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||3
455518|NCT01279044|1115718|P2|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||11
455519|NCT01279044|1115719|P1|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||0
455520|NCT01279044|1115717|P3|COMPLETED|PHASE 2 - Randmonized Controlled Trial||161
455521|NCT01279044|1115718|P2|COMPLETED|PHASE 2 - Randmonized Controlled Trial||151
455522|NCT01279044|1115719|P1|COMPLETED|PHASE 2 - Randmonized Controlled Trial|Participants who participated in the RCT did not participate in the formative phase.|0
455523|NCT01279044|1115717|P3|STARTED|PHASE 2 - Randmonized Controlled Trial||164
455524|NCT01279044|1115718|P2|STARTED|PHASE 2 - Randmonized Controlled Trial||162
455525|NCT01279044|1115719|P1|STARTED|PHASE 2 - Randmonized Controlled Trial|Participants who participated in the RCT did not participate in the formative phase.|0
455526|NCT01279044|1115717|P3|NOT COMPLETED|PHASE 1 - Formative||0
455527|NCT01279044|1115718|P2|NOT COMPLETED|PHASE 1 - Formative||0
455528|NCT01279044|1115719|P1|NOT COMPLETED|PHASE 1 - Formative||0
455529|NCT01279044|1115717|P3|COMPLETED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
455530|NCT01279044|1115718|P2|COMPLETED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
455531|NCT01279044|1115719|P1|COMPLETED|PHASE 1 - Formative||59
455532|NCT01279044|1115717|P3|STARTED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
455533|NCT01279044|1115718|P2|STARTED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
455534|NCT01279044|1115719|P1|STARTED|PHASE 1 - Formative||59
455535|NCT01278953|1115739|P2|NOT COMPLETED|Overall Study||11
455536|NCT01278953|1115740|P1|NOT COMPLETED|Overall Study||9
455537|NCT01278953|1115739|P2|COMPLETED|Overall Study||134
455538|NCT01278953|1115740|P1|COMPLETED|Overall Study||146
455539|NCT01278953|1115739|P2|STARTED|Overall Study||145
455540|NCT01278953|1115740|P1|STARTED|Overall Study||155
455541|NCT01278927|1115752|P4|NOT COMPLETED|Overall Study||0
455542|NCT01278927|1115753|P3|NOT COMPLETED|Overall Study||0
455543|NCT01278927|1115754|P2|NOT COMPLETED|Overall Study||0
455544|NCT01278927|1115755|P1|NOT COMPLETED|Overall Study||0
455545|NCT01278927|1115752|P4|COMPLETED|Overall Study||175
455546|NCT01278927|1115753|P3|COMPLETED|Overall Study||178
455547|NCT01278927|1115754|P2|COMPLETED|Overall Study||178
455548|NCT01278927|1115755|P1|COMPLETED|Overall Study||180
455549|NCT01278927|1115752|P4|STARTED|Overall Study||175
455550|NCT01278927|1115753|P3|STARTED|Overall Study||178
455551|NCT01278927|1115754|P2|STARTED|Overall Study||178
455552|NCT01278927|1115755|P1|STARTED|Overall Study||180
455553|NCT01278797|1115793|P2|NOT COMPLETED|Period 2||0
455554|NCT01278797|1115794|P1|NOT COMPLETED|Period 2||0
455555|NCT01278797|1115793|P2|COMPLETED|Period 2||13
455556|NCT01278797|1115794|P1|COMPLETED|Period 2||13
455557|NCT01278797|1115793|P2|STARTED|Period 2||13
455558|NCT01278797|1115794|P1|STARTED|Period 2||13
455559|NCT01278797|1115793|P2|NOT COMPLETED|Washout Period of 21 Days||0
455560|NCT01278797|1115794|P1|NOT COMPLETED|Washout Period of 21 Days||0
455561|NCT01278797|1115793|P2|COMPLETED|Washout Period of 21 Days||13
455562|NCT01278797|1115794|P1|COMPLETED|Washout Period of 21 Days||13
455563|NCT01278797|1115793|P2|STARTED|Washout Period of 21 Days||13
455564|NCT01278797|1115794|P1|STARTED|Washout Period of 21 Days||13
455565|NCT01278797|1115793|P2|NOT COMPLETED|Period 1||1
455566|NCT01278797|1115794|P1|NOT COMPLETED|Period 1||1
455567|NCT01278797|1115793|P2|COMPLETED|Period 1||13
455568|NCT01278797|1115794|P1|COMPLETED|Period 1||13
455569|NCT01278797|1115793|P2|STARTED|Period 1||14
455570|NCT01278797|1115794|P1|STARTED|Period 1||14
455571|NCT01278745|1115806|P4|NOT COMPLETED|Overall Study||78
455572|NCT01278745|1115807|P3|NOT COMPLETED|Overall Study||121
455573|NCT01278745|1115808|P2|NOT COMPLETED|Overall Study||6
455574|NCT01278745|1115809|P1|NOT COMPLETED|Overall Study||5
455575|NCT01278745|1115806|P4|COMPLETED|Overall Study||0
455576|NCT01278745|1115807|P3|COMPLETED|Overall Study||0
455577|NCT01278745|1115808|P2|COMPLETED|Overall Study||68
455578|NCT01278745|1115809|P1|COMPLETED|Overall Study||84
455579|NCT01278745|1115806|P4|STARTED|Overall Study||78
455580|NCT01278745|1115807|P3|STARTED|Overall Study||121
455581|NCT01278745|1115808|P2|STARTED|Overall Study||74
455582|NCT01278745|1115809|P1|STARTED|Overall Study||89
455583|NCT01278615|1115841|P1|NOT COMPLETED|Overall Study||2
455584|NCT01278615|1115841|P1|COMPLETED|Overall Study||14
455585|NCT01278615|1115841|P1|STARTED|Overall Study||16
455586|NCT01278485|1115851|P1|NOT COMPLETED|Overall Study||0
455587|NCT01278485|1115851|P1|COMPLETED|Overall Study||719
455588|NCT01278485|1115851|P1|STARTED|Overall Study||719
455589|NCT01278407|1115867|P5|NOT COMPLETED|Extension Phase||30
455590|NCT01278407|1115868|P4|NOT COMPLETED|Extension Phase||12
455591|NCT01278407|1115869|P3|NOT COMPLETED|Extension Phase||0
455592|NCT01278407|1115870|P2|NOT COMPLETED|Extension Phase||0
455593|NCT01278407|1115871|P1|NOT COMPLETED|Extension Phase||0
455594|NCT01278407|1115867|P5|COMPLETED|Extension Phase||66
455595|NCT01278407|1115868|P4|COMPLETED|Extension Phase||34
455596|NCT01278407|1115869|P3|COMPLETED|Extension Phase||0
455597|NCT01278407|1115870|P2|COMPLETED|Extension Phase||0
455598|NCT01278407|1115871|P1|COMPLETED|Extension Phase||0
455599|NCT01278407|1115867|P5|STARTED|Extension Phase||96
455600|NCT01278407|1115868|P4|STARTED|Extension Phase||46
455601|NCT01278407|1115869|P3|STARTED|Extension Phase||0
455602|NCT01278407|1115870|P2|STARTED|Extension Phase||0
455603|NCT01278407|1115871|P1|STARTED|Extension Phase||0
455604|NCT01278407|1115867|P5|NOT COMPLETED|Confirmatory Phase||0
455605|NCT01278407|1115868|P4|NOT COMPLETED|Confirmatory Phase||0
455606|NCT01278407|1115869|P3|NOT COMPLETED|Confirmatory Phase||6
455607|NCT01278407|1115870|P2|NOT COMPLETED|Confirmatory Phase||16
455608|NCT01278407|1115871|P1|NOT COMPLETED|Confirmatory Phase||9
455609|NCT01278407|1115867|P5|COMPLETED|Confirmatory Phase||0
455610|NCT01278407|1115868|P4|COMPLETED|Confirmatory Phase||0
455611|NCT01278407|1115869|P3|COMPLETED|Confirmatory Phase||43
455612|NCT01278407|1115870|P2|COMPLETED|Confirmatory Phase||31
455613|NCT01278407|1115871|P1|COMPLETED|Confirmatory Phase||37
455614|NCT01278407|1115867|P5|STARTED|Confirmatory Phase||0
455615|NCT01278407|1115868|P4|STARTED|Confirmatory Phase||0
455616|NCT01278407|1115869|P3|STARTED|Confirmatory Phase||49
455617|NCT01278407|1115870|P2|STARTED|Confirmatory Phase||47
455618|NCT01278407|1115871|P1|STARTED|Confirmatory Phase||46
455619|NCT01278394|1115884|P1|NOT COMPLETED|Overall Study||1
455620|NCT01278394|1115884|P1|COMPLETED|Overall Study||28
455621|NCT01278394|1115884|P1|STARTED|Overall Study||29
455622|NCT01278342|1115897|P3|NOT COMPLETED|Overall Study||0
455623|NCT01278342|1115898|P2|NOT COMPLETED|Overall Study||1
455624|NCT01278342|1115899|P1|NOT COMPLETED|Overall Study||4
455625|NCT01278342|1115897|P3|COMPLETED|Overall Study||32
455626|NCT01278342|1115898|P2|COMPLETED|Overall Study||30
455627|NCT01278342|1115899|P1|COMPLETED|Overall Study||3
455628|NCT01278342|1115897|P3|STARTED|Overall Study||32
455629|NCT01278342|1115898|P2|STARTED|Overall Study||31
455630|NCT01278342|1115899|P1|STARTED|Overall Study||7
455631|NCT01278303|1115913|P1|NOT COMPLETED|Overall Study||0
455632|NCT01278303|1115913|P1|COMPLETED|Overall Study||82
455633|NCT01278303|1115913|P1|STARTED|Overall Study||82
455634|NCT01278173|1115919|P1|NOT COMPLETED|Overall Study||27
455635|NCT01278173|1115919|P1|COMPLETED|Overall Study||38
455636|NCT01278173|1115919|P1|STARTED|Overall Study||65
455637|NCT01278160|1115926|P2|NOT COMPLETED|Overall Study||6
455638|NCT01278160|1115927|P1|NOT COMPLETED|Overall Study||5
455639|NCT01278160|1115926|P2|COMPLETED|Overall Study||84
455640|NCT01278160|1115927|P1|COMPLETED|Overall Study||84
455641|NCT01278160|1115926|P2|STARTED|Overall Study||90
455642|NCT01278160|1115927|P1|STARTED|Overall Study||89
455643|NCT01278030|1115943|P2|NOT COMPLETED|Overall Study||4
455644|NCT01278030|1115944|P1|NOT COMPLETED|Overall Study||8
455645|NCT01278030|1115943|P2|COMPLETED|Overall Study||31
455646|NCT01278030|1115944|P1|COMPLETED|Overall Study||35
455647|NCT01278030|1115943|P2|STARTED|Overall Study||35
455648|NCT01278030|1115944|P1|STARTED|Overall Study||43
455649|NCT01277887|1115952|P2|NOT COMPLETED|Post-Quit Treatment Phase||5
455650|NCT01277887|1115953|P1|NOT COMPLETED|Post-Quit Treatment Phase||3
455651|NCT01277887|1115952|P2|COMPLETED|Post-Quit Treatment Phase||5
455652|NCT01277887|1115953|P1|COMPLETED|Post-Quit Treatment Phase||3
455653|NCT01277887|1115952|P2|STARTED|Post-Quit Treatment Phase||10
455654|NCT01277887|1115953|P1|STARTED|Post-Quit Treatment Phase||6
455655|NCT01277887|1115952|P2|NOT COMPLETED|Pre-Quit Treatment Phase||0
455656|NCT01277887|1115953|P1|NOT COMPLETED|Pre-Quit Treatment Phase||3
455657|NCT01277887|1115952|P2|COMPLETED|Pre-Quit Treatment Phase||10
455658|NCT01277887|1115953|P1|COMPLETED|Pre-Quit Treatment Phase||6
455659|NCT01277887|1115952|P2|Entered Study|Pre-Quit Treatment Phase||10
455660|NCT01277887|1115953|P1|Entered Study|Pre-Quit Treatment Phase||7
455661|NCT01277887|1115952|P2|STARTED|Pre-Quit Treatment Phase||10
455662|NCT01277887|1115953|P1|STARTED|Pre-Quit Treatment Phase||9
455663|NCT01277861|1115965|P2|NOT COMPLETED|Overall Study||2
455664|NCT01277861|1115966|P1|NOT COMPLETED|Overall Study||2
455665|NCT01277861|1115965|P2|COMPLETED|Overall Study||47
455666|NCT01277861|1115966|P1|COMPLETED|Overall Study||49
455667|NCT01277861|1115965|P2|STARTED|Overall Study||49
455668|NCT01277861|1115966|P1|STARTED|Overall Study||51
455669|NCT01277822|1115978|P2|NOT COMPLETED|Overall Study||11
455670|NCT01277822|1115979|P1|NOT COMPLETED|Overall Study||15
455671|NCT01277822|1115978|P2|COMPLETED|Overall Study||155
455672|NCT01277822|1115979|P1|COMPLETED|Overall Study||153
455673|NCT01277822|1115978|P2|STARTED|Overall Study||166
455674|NCT01277822|1115979|P1|STARTED|Overall Study||168
455675|NCT01277757|1115999|P1|NOT COMPLETED|Overall Study||2
455676|NCT01277757|1115999|P1|COMPLETED|Overall Study||28
455677|NCT01277757|1115999|P1|STARTED|Overall Study||30
455678|NCT01277718|1116006|P2|NOT COMPLETED|Period 3 - Third Intervention||0
455679|NCT01277718|1116007|P1|NOT COMPLETED|Period 3 - Third Intervention||0
455680|NCT01277718|1116006|P2|COMPLETED|Period 3 - Third Intervention||7
455681|NCT01277718|1116007|P1|COMPLETED|Period 3 - Third Intervention||10
455682|NCT01277718|1116006|P2|STARTED|Period 3 - Third Intervention||7
455683|NCT01277718|1116007|P1|STARTED|Period 3 - Third Intervention||10
455684|NCT01277718|1116006|P2|NOT COMPLETED|Washout Period of 13 Days||0
455685|NCT01277718|1116007|P1|NOT COMPLETED|Washout Period of 13 Days||0
455686|NCT01277718|1116006|P2|COMPLETED|Washout Period of 13 Days||7
455687|NCT01277718|1116007|P1|COMPLETED|Washout Period of 13 Days||10
455688|NCT01277718|1116006|P2|STARTED|Washout Period of 13 Days||7
455689|NCT01277718|1116007|P1|STARTED|Washout Period of 13 Days||10
455690|NCT01277718|1116006|P2|NOT COMPLETED|Period 2 - Second Intervention||3
455691|NCT01277718|1116007|P1|NOT COMPLETED|Period 2 - Second Intervention||0
455692|NCT01277718|1116006|P2|COMPLETED|Period 2 - Second Intervention||7
455693|NCT01277718|1116007|P1|COMPLETED|Period 2 - Second Intervention||10
455694|NCT01277718|1116006|P2|STARTED|Period 2 - Second Intervention||10
455695|NCT01277718|1116007|P1|STARTED|Period 2 - Second Intervention||10
455696|NCT01277718|1116006|P2|NOT COMPLETED|Washout Period of 13 Days||0
455697|NCT01277718|1116007|P1|NOT COMPLETED|Washout Period of 13 Days||0
455698|NCT01277718|1116006|P2|COMPLETED|Washout Period of 13 Days||10
455699|NCT01277718|1116007|P1|COMPLETED|Washout Period of 13 Days||10
455700|NCT01277718|1116006|P2|STARTED|Washout Period of 13 Days||10
455701|NCT01277718|1116007|P1|STARTED|Washout Period of 13 Days||10
455702|NCT01277718|1116006|P2|NOT COMPLETED|Period 1 - First Intervention||0
455703|NCT01277718|1116007|P1|NOT COMPLETED|Period 1 - First Intervention||0
455704|NCT01277718|1116006|P2|COMPLETED|Period 1 - First Intervention||10
455705|NCT01277718|1116007|P1|COMPLETED|Period 1 - First Intervention||10
455706|NCT01277718|1116006|P2|STARTED|Period 1 - First Intervention||10
455707|NCT01277718|1116007|P1|STARTED|Period 1 - First Intervention||10
455708|NCT01277666|1116021|P3|NOT COMPLETED|Overall Study||49
455709|NCT01277666|1116022|P2|NOT COMPLETED|Overall Study||59
455710|NCT01277666|1116023|P1|NOT COMPLETED|Overall Study||45
455711|NCT01277666|1116021|P3|COMPLETED|Overall Study||153
455712|NCT01277666|1116022|P2|COMPLETED|Overall Study||144
455713|NCT01277666|1116023|P1|COMPLETED|Overall Study||158
455714|NCT01277666|1116021|P3|STARTED|Overall Study||202
455715|NCT01277666|1116022|P2|STARTED|Overall Study||203
455716|NCT01277666|1116023|P1|STARTED|Overall Study||203
455717|NCT01277601|1116056|P4|NOT COMPLETED|Overall Study||36
455718|NCT01277601|1116057|P3|NOT COMPLETED|Overall Study||27
455719|NCT01277601|1116058|P2|NOT COMPLETED|Overall Study||48
455720|NCT01277601|1116059|P1|NOT COMPLETED|Overall Study||37
455721|NCT01277601|1116056|P4|COMPLETED|Overall Study||150
455722|NCT01277601|1116057|P3|COMPLETED|Overall Study||163
455723|NCT01277601|1116058|P2|COMPLETED|Overall Study||139
455724|NCT01277601|1116059|P1|COMPLETED|Overall Study||151
455725|NCT01277601|1116056|P4|STARTED|Overall Study||186
455726|NCT01277601|1116057|P3|STARTED|Overall Study||190
455727|NCT01277601|1116058|P2|STARTED|Overall Study||187
455728|NCT01277601|1116059|P1|STARTED|Overall Study||188
455729|NCT01277549|1116150|P2|NOT COMPLETED|Overall Study||14
455730|NCT01277549|1116151|P1|NOT COMPLETED|Overall Study||26
455731|NCT01277549|1116150|P2|COMPLETED|Overall Study||15
455732|NCT01277549|1116151|P1|COMPLETED|Overall Study||15
455733|NCT01277549|1116150|P2|STARTED|Overall Study||29
455734|NCT01277549|1116151|P1|STARTED|Overall Study||41
455735|NCT01277523|1116168|P3|NOT COMPLETED|Overall Study||0
455736|NCT01277523|1116169|P2|NOT COMPLETED|Overall Study||1
455737|NCT01277523|1116170|P1|NOT COMPLETED|Overall Study||3
455738|NCT01277523|1116168|P3|COMPLETED|Overall Study||130
455739|NCT01277523|1116169|P2|COMPLETED|Overall Study||126
455740|NCT01277523|1116170|P1|COMPLETED|Overall Study||132
455741|NCT01277523|1116168|P3|STARTED|Overall Study||130
455742|NCT01277523|1116169|P2|STARTED|Overall Study||127
455743|NCT01277523|1116170|P1|STARTED|Overall Study||135
455744|NCT01277510|1116222|P2|NOT COMPLETED|Open-label Phase||3
455745|NCT01277510|1116223|P1|NOT COMPLETED|Open-label Phase||7
455746|NCT01277510|1116222|P2|COMPLETED|Open-label Phase|Completed investigational product|1
455747|NCT01277510|1116223|P1|COMPLETED|Open-label Phase|Completed investigational product|1
455748|NCT01277510|1116222|P2|Received Investigational Product|Open-label Phase||4
455749|NCT01277510|1116223|P1|Received Investigational Product|Open-label Phase||6
455750|NCT01277510|1116222|P2|STARTED|Open-label Phase||4
455751|NCT01277510|1116223|P1|STARTED|Open-label Phase||8
455752|NCT01277510|1116222|P2|NOT COMPLETED|Double-blind Phase||18
455753|NCT01277510|1116223|P1|NOT COMPLETED|Double-blind Phase||13
455754|NCT01277510|1116222|P2|COMPLETED|Double-blind Phase|Completed investigational product|4
455755|NCT01277510|1116223|P1|COMPLETED|Double-blind Phase|Completed investigational product|8
455756|NCT01277510|1116222|P2|Received Investigational Product|Double-blind Phase||22
455757|NCT01277510|1116223|P1|Received Investigational Product|Double-blind Phase||21
455758|NCT01277510|1116222|P2|STARTED|Double-blind Phase||22
455759|NCT01277510|1116223|P1|STARTED|Double-blind Phase||21
455760|NCT01277354|1116247|P2|NOT COMPLETED|Overall Study||0
455761|NCT01277354|1116248|P1|NOT COMPLETED|Overall Study||0
455762|NCT01277354|1116247|P2|COMPLETED|Overall Study||1
455763|NCT01277354|1116248|P1|COMPLETED|Overall Study||1
455764|NCT01277354|1116247|P2|STARTED|Overall Study||1
455765|NCT01277354|1116248|P1|STARTED|Overall Study||1
455766|NCT01277302|1116257|P3|NOT COMPLETED|8-Month Alternate Dose Regimen Period||6
455767|NCT01277302|1116258|P2|NOT COMPLETED|8-Month Alternate Dose Regimen Period||4
455768|NCT01277302|1116259|P1|NOT COMPLETED|8-Month Alternate Dose Regimen Period||5
455769|NCT01277302|1116257|P3|COMPLETED|8-Month Alternate Dose Regimen Period||13
455770|NCT01277302|1116258|P2|COMPLETED|8-Month Alternate Dose Regimen Period||82
455771|NCT01277302|1116259|P1|COMPLETED|8-Month Alternate Dose Regimen Period||80
455772|NCT01277302|1116257|P3|STARTED|8-Month Alternate Dose Regimen Period||19
455773|NCT01277302|1116258|P2|STARTED|8-Month Alternate Dose Regimen Period||86
455774|NCT01277302|1116259|P1|STARTED|8-Month Alternate Dose Regimen Period||85
455775|NCT01277302|1116257|P3|NOT COMPLETED|7-Month Fixed Treatment Period||12
455776|NCT01277302|1116258|P2|NOT COMPLETED|7-Month Fixed Treatment Period||0
455777|NCT01277302|1116259|P1|NOT COMPLETED|7-Month Fixed Treatment Period||0
455778|NCT01277302|1116257|P3|COMPLETED|7-Month Fixed Treatment Period||19
455779|NCT01277302|1116258|P2|COMPLETED|7-Month Fixed Treatment Period||86
455780|NCT01277302|1116259|P1|COMPLETED|7-Month Fixed Treatment Period||85
455781|NCT01277302|1116257|P3|STARTED|7-Month Fixed Treatment Period||31
455782|NCT01277302|1116258|P2|STARTED|7-Month Fixed Treatment Period||86
455783|NCT01277302|1116259|P1|STARTED|7-Month Fixed Treatment Period||85
455784|NCT01277211|1116291|P2|NOT COMPLETED|Overall Study||63
455785|NCT01277211|1116292|P1|NOT COMPLETED|Overall Study||150
455786|NCT01277211|1116291|P2|COMPLETED|Overall Study||182
455787|NCT01277211|1116292|P1|COMPLETED|Overall Study||588
455788|NCT01277211|1116291|P2|Treated|Overall Study||232
455789|NCT01277211|1116292|P1|Treated|Overall Study||714
455790|NCT01277211|1116291|P2|STARTED|Overall Study||245
455791|NCT01277211|1116292|P1|STARTED|Overall Study||738
455792|NCT01277159|1116307|P5|NOT COMPLETED|Overall Study||5
455793|NCT01277159|1116308|P4|NOT COMPLETED|Overall Study||3
455794|NCT01277159|1116309|P3|NOT COMPLETED|Overall Study||3
455795|NCT01277159|1116310|P2|NOT COMPLETED|Overall Study||1
455796|NCT01277159|1116311|P1|NOT COMPLETED|Overall Study||4
455797|NCT01277159|1116307|P5|COMPLETED|Overall Study||16
455798|NCT01277159|1116308|P4|COMPLETED|Overall Study||19
455799|NCT01277159|1116309|P3|COMPLETED|Overall Study||19
455800|NCT01277159|1116310|P2|COMPLETED|Overall Study||21
455801|NCT01277159|1116311|P1|COMPLETED|Overall Study||17
455802|NCT01277159|1116307|P5|STARTED|Overall Study||21
455803|NCT01277159|1116308|P4|STARTED|Overall Study||22
455804|NCT01277159|1116309|P3|STARTED|Overall Study||22
455805|NCT01277159|1116310|P2|STARTED|Overall Study||22
455806|NCT01277159|1116311|P1|STARTED|Overall Study||21
455807|NCT01277081|1116325|P2|NOT COMPLETED|Overall Study||0
455808|NCT01277081|1116326|P1|NOT COMPLETED|Overall Study||0
455809|NCT01277081|1116325|P2|COMPLETED|Overall Study||100
455810|NCT01277081|1116326|P1|COMPLETED|Overall Study||100
455811|NCT01277081|1116325|P2|STARTED|Overall Study||100
455812|NCT01277081|1116326|P1|STARTED|Overall Study||100
455813|NCT01277042|1116344|P2|NOT COMPLETED|Overall Study||5
455814|NCT01277042|1116345|P1|NOT COMPLETED|Overall Study||8
455815|NCT01277042|1116344|P2|COMPLETED|Overall Study||601
455816|NCT01277042|1116345|P1|COMPLETED|Overall Study||598
455817|NCT01277042|1116344|P2|STARTED|Overall Study||606
455818|NCT01277042|1116345|P1|STARTED|Overall Study||606
455819|NCT01276847|1116370|P3|NOT COMPLETED|Overall Study||0
455820|NCT01276847|1116371|P2|NOT COMPLETED|Overall Study||0
455821|NCT01276847|1116372|P1|NOT COMPLETED|Overall Study||1
455822|NCT01276847|1116370|P3|COMPLETED|Overall Study||20
455823|NCT01276847|1116371|P2|COMPLETED|Overall Study||10
455824|NCT01276847|1116372|P1|COMPLETED|Overall Study||9
455825|NCT01276847|1116370|P3|STARTED|Overall Study||20
455826|NCT01276847|1116371|P2|STARTED|Overall Study||10
455827|NCT01276847|1116372|P1|STARTED|Overall Study||10
455828|NCT01276821|1116382|P2|NOT COMPLETED|Overall Study||1
455829|NCT01276821|1116383|P1|NOT COMPLETED|Overall Study||0
455830|NCT01276821|1116382|P2|COMPLETED|Overall Study||49
455831|NCT01276821|1116383|P1|COMPLETED|Overall Study||50
455832|NCT01276821|1116382|P2|STARTED|Overall Study||50
455833|NCT01276821|1116383|P1|STARTED|Overall Study||50
455834|NCT01276756|1116403|P2|NOT COMPLETED|Overall Study||2
455835|NCT01276756|1116404|P1|NOT COMPLETED|Overall Study||5
455836|NCT01276756|1116403|P2|COMPLETED|Overall Study||48
455837|NCT01276756|1116404|P1|COMPLETED|Overall Study||45
455838|NCT01276756|1116403|P2|STARTED|Overall Study||50
455839|NCT01276756|1116404|P1|STARTED|Overall Study||50
455840|NCT01276652|1116421|P3|NOT COMPLETED|Period 2: Observational||0
455841|NCT01276652|1116422|P2|NOT COMPLETED|Period 2: Observational||0
455842|NCT01276652|1116423|P1|NOT COMPLETED|Period 2: Observational||0
455843|NCT01276652|1116421|P3|COMPLETED|Period 2: Observational||5
455844|NCT01276652|1116422|P2|COMPLETED|Period 2: Observational||8
455845|NCT01276652|1116423|P1|COMPLETED|Period 2: Observational||9
455846|NCT01276652|1116421|P3|STARTED|Period 2: Observational|Subjects were only enrolled in the Observational arm during Period 2.|5
455847|NCT01276652|1116422|P2|STARTED|Period 2: Observational||8
455848|NCT01276652|1116423|P1|STARTED|Period 2: Observational||9
455849|NCT01276652|1116421|P3|NOT COMPLETED|Period 1: Randomization||0
455850|NCT01276652|1116422|P2|NOT COMPLETED|Period 1: Randomization||0
455851|NCT01276652|1116423|P1|NOT COMPLETED|Period 1: Randomization||0
455852|NCT01276652|1116421|P3|COMPLETED|Period 1: Randomization||0
455853|NCT01276652|1116422|P2|COMPLETED|Period 1: Randomization||8
455854|NCT01276652|1116423|P1|COMPLETED|Period 1: Randomization||9
455855|NCT01276652|1116421|P3|STARTED|Period 1: Randomization|No subjects were enrolled in this arm during Period 1.|0
455856|NCT01276652|1116422|P2|STARTED|Period 1: Randomization||8
455857|NCT01276652|1116423|P1|STARTED|Period 1: Randomization||9
455858|NCT01276639|1116449|P5|NOT COMPLETED|Week 16 to 52||21
455859|NCT01276639|1116450|P4|NOT COMPLETED|Week 16 to 52||16
455860|NCT01276639|1116451|P3|NOT COMPLETED|Week 16 to 52||0
455861|NCT01276639|1116452|P2|NOT COMPLETED|Week 16 to 52||101
455862|NCT01276639|1116453|P1|NOT COMPLETED|Week 16 to 52||127
455863|NCT01276639|1116449|P5|COMPLETED|Week 16 to 52||45
455864|NCT01276639|1116450|P4|COMPLETED|Week 16 to 52||50
455865|NCT01276639|1116451|P3|COMPLETED|Week 16 to 52||0
455866|NCT01276639|1116452|P2|COMPLETED|Week 16 to 52||219
455867|NCT01276639|1116453|P1|COMPLETED|Week 16 to 52||186
455868|NCT01276639|1116449|P5|STARTED|Week 16 to 52||66
455869|NCT01276639|1116450|P4|STARTED|Week 16 to 52||66
455870|NCT01276639|1116451|P3|STARTED|Week 16 to 52||0
455871|NCT01276639|1116452|P2|STARTED|Week 16 to 52||320
455872|NCT01276639|1116453|P1|STARTED|Week 16 to 52||313
455873|NCT01276639|1116449|P5|NOT COMPLETED|Week 0 to 16||0
455874|NCT01276639|1116450|P4|NOT COMPLETED|Week 0 to 16||0
455875|NCT01276639|1116451|P3|NOT COMPLETED|Week 0 to 16||45
455876|NCT01276639|1116452|P2|NOT COMPLETED|Week 0 to 16||41
455877|NCT01276639|1116453|P1|NOT COMPLETED|Week 0 to 16||50
455878|NCT01276639|1116449|P5|COMPLETED|Week 0 to 16||0
455879|NCT01276639|1116450|P4|COMPLETED|Week 0 to 16||0
455880|NCT01276639|1116451|P3|COMPLETED|Week 0 to 16||132
455881|NCT01276639|1116452|P2|COMPLETED|Week 0 to 16||320
455882|NCT01276639|1116453|P1|COMPLETED|Week 0 to 16||313
455883|NCT01276639|1116449|P5|Treated|Week 0 to 16||0
455884|NCT01276639|1116450|P4|Treated|Week 0 to 16||0
455885|NCT01276639|1116451|P3|Treated|Week 0 to 16||177
455886|NCT01276639|1116452|P2|Treated|Week 0 to 16||360
455887|NCT01276639|1116453|P1|Treated|Week 0 to 16||363
455888|NCT01276639|1116449|P5|STARTED|Week 0 to 16||0
455889|NCT01276639|1116450|P4|STARTED|Week 0 to 16||0
455890|NCT01276639|1116451|P3|STARTED|Week 0 to 16||177
455891|NCT01276639|1116452|P2|STARTED|Week 0 to 16||361
455892|NCT01276639|1116453|P1|STARTED|Week 0 to 16||363
455893|NCT01276535|1116648|P1|NOT COMPLETED|Overall Study||0
455894|NCT01276535|1116648|P1|COMPLETED|Overall Study||12
455895|NCT01276535|1116648|P1|STARTED|Overall Study||12
455896|NCT01276509|1116658|P4|NOT COMPLETED|Overall Study||5
455897|NCT01276509|1116659|P3|NOT COMPLETED|Overall Study||5
455898|NCT01276509|1116660|P2|NOT COMPLETED|Overall Study||12
455899|NCT01276509|1116661|P1|NOT COMPLETED|Overall Study||13
455900|NCT01276509|1116658|P4|COMPLETED|Overall Study||58
455901|NCT01276509|1116659|P3|COMPLETED|Overall Study||63
455902|NCT01276509|1116660|P2|COMPLETED|Overall Study||53
455903|NCT01276509|1116661|P1|COMPLETED|Overall Study||53
455904|NCT01276509|1116658|P4|STARTED|Overall Study||63
455905|NCT01276509|1116659|P3|STARTED|Overall Study||68
455906|NCT01276509|1116660|P2|STARTED|Overall Study||65
455907|NCT01276509|1116661|P1|STARTED|Overall Study||66
455908|NCT01276457|1116714|P2|NOT COMPLETED|Extension Study||2
455909|NCT01276457|1116715|P1|NOT COMPLETED|Extension Study||6
455910|NCT01276457|1116714|P2|COMPLETED|Extension Study||110
455911|NCT01276457|1116715|P1|COMPLETED|Extension Study||105
455912|NCT01276457|1116714|P2|STARTED|Extension Study||112
455913|NCT01276457|1116715|P1|STARTED|Extension Study||111
455914|NCT01276457|1116714|P2|NOT COMPLETED|Core Study||20
455915|NCT01276457|1116715|P1|NOT COMPLETED|Core Study||13
455916|NCT01276457|1116714|P2|COMPLETED|Core Study||123
455917|NCT01276457|1116715|P1|COMPLETED|Core Study||129
455918|NCT01276457|1116714|P2|STARTED|Core Study||143
455919|NCT01276457|1116715|P1|STARTED|Core Study||142
455920|NCT01276353|1116729|P2|NOT COMPLETED|Extension||9
455921|NCT01276353|1116730|P1|NOT COMPLETED|Extension||7
455922|NCT01276353|1116729|P2|COMPLETED|Extension||14
455923|NCT01276353|1116730|P1|COMPLETED|Extension||12
455924|NCT01276353|1116729|P2|STARTED|Extension||23
455925|NCT01276353|1116730|P1|STARTED|Extension||19
455926|NCT01276353|1116729|P2|NOT COMPLETED|Double-blind||0
455927|NCT01276353|1116730|P1|NOT COMPLETED|Double-blind||3
455928|NCT01276353|1116729|P2|COMPLETED|Double-blind||23
455929|NCT01276353|1116730|P1|COMPLETED|Double-blind||19
455930|NCT01276353|1116729|P2|STARTED|Double-blind||23
455931|NCT01276353|1116730|P1|STARTED|Double-blind||22
455932|NCT01276327|1116742|P2|NOT COMPLETED|Overall Study||3
455933|NCT01276327|1116743|P1|NOT COMPLETED|Overall Study||2
455934|NCT01276327|1116742|P2|COMPLETED|Overall Study||29
455935|NCT01276327|1116743|P1|COMPLETED|Overall Study||30
455936|NCT01276327|1116742|P2|STARTED|Overall Study||32
455937|NCT01276327|1116743|P1|STARTED|Overall Study||32
455938|NCT01276314|1116769|P4|NOT COMPLETED|Overall Study||5
455939|NCT01276314|1116770|P3|NOT COMPLETED|Overall Study||4
455940|NCT01276314|1116771|P2|NOT COMPLETED|Overall Study||10
455941|NCT01276314|1116772|P1|NOT COMPLETED|Overall Study||10
455942|NCT01276314|1116769|P4|COMPLETED|Overall Study||17
455943|NCT01276314|1116770|P3|COMPLETED|Overall Study||18
455944|NCT01276314|1116771|P2|COMPLETED|Overall Study||33
455945|NCT01276314|1116772|P1|COMPLETED|Overall Study||38
455946|NCT01276314|1116769|P4|STARTED|Overall Study||22
455947|NCT01276314|1116770|P3|STARTED|Overall Study||22
455948|NCT01276314|1116771|P2|STARTED|Overall Study||43
455949|NCT01276314|1116772|P1|STARTED|Overall Study||48
455950|NCT01276301|1116782|P2|NOT COMPLETED|Second Intervention||0
455951|NCT01276301|1116783|P1|NOT COMPLETED|Second Intervention||0
455952|NCT01276301|1116782|P2|COMPLETED|Second Intervention||8
455953|NCT01276301|1116783|P1|COMPLETED|Second Intervention||8
455954|NCT01276301|1116782|P2|STARTED|Second Intervention||8
455955|NCT01276301|1116783|P1|STARTED|Second Intervention||8
455956|NCT01276301|1116782|P2|NOT COMPLETED|Washout Period of 7 Days||0
455957|NCT01276301|1116783|P1|NOT COMPLETED|Washout Period of 7 Days||0
455958|NCT01276301|1116782|P2|COMPLETED|Washout Period of 7 Days||8
455959|NCT01276301|1116783|P1|COMPLETED|Washout Period of 7 Days||8
455960|NCT01276301|1116782|P2|STARTED|Washout Period of 7 Days||8
455961|NCT01276301|1116783|P1|STARTED|Washout Period of 7 Days||8
455962|NCT01276301|1116782|P2|NOT COMPLETED|First Intervention||0
455963|NCT01276301|1116783|P1|NOT COMPLETED|First Intervention||0
455964|NCT01276301|1116782|P2|COMPLETED|First Intervention||8
455965|NCT01276301|1116783|P1|COMPLETED|First Intervention||8
455966|NCT01276301|1116782|P2|STARTED|First Intervention||8
455967|NCT01276301|1116783|P1|STARTED|First Intervention||8
455968|NCT01276288|1116810|P4|NOT COMPLETED|Overall Study||0
455969|NCT01276288|1116811|P3|NOT COMPLETED|Overall Study||0
455970|NCT01276288|1116812|P2|NOT COMPLETED|Overall Study||1
455971|NCT01276288|1116813|P1|NOT COMPLETED|Overall Study||2
455972|NCT01276288|1116810|P4|COMPLETED|Overall Study||5
455973|NCT01276288|1116811|P3|COMPLETED|Overall Study||5
455974|NCT01276288|1116812|P2|COMPLETED|Overall Study||5
455975|NCT01276288|1116813|P1|COMPLETED|Overall Study||5
455976|NCT01276288|1116810|P4|Received EMPA+TOR|Overall Study||5
455977|NCT01276288|1116811|P3|Received EMPA+TOR|Overall Study||5
455978|NCT01276288|1116812|P2|Received EMPA+TOR|Overall Study||0
455979|NCT01276288|1116813|P1|Received EMPA+TOR|Overall Study||0
455980|NCT01276288|1116810|P4|Received EMPA+HCT|Overall Study||0
455981|NCT01276288|1116811|P3|Received EMPA+HCT|Overall Study||0
455982|NCT01276288|1116812|P2|Received EMPA+HCT|Overall Study||5
455983|NCT01276288|1116813|P1|Received EMPA+HCT|Overall Study||5
455984|NCT01276288|1116810|P4|Received EMPA|Overall Study||5
455985|NCT01276288|1116811|P3|Received EMPA|Overall Study||5
455986|NCT01276288|1116812|P2|Received EMPA|Overall Study||5
455987|NCT01276288|1116813|P1|Received EMPA|Overall Study||6
455988|NCT01276288|1116810|P4|STARTED|Overall Study||5
455989|NCT01276288|1116811|P3|STARTED|Overall Study||5
455990|NCT01276288|1116812|P2|STARTED|Overall Study||6
455991|NCT01276288|1116813|P1|STARTED|Overall Study||7
455992|NCT01276223|1116940|P3|NOT COMPLETED|Overall Study||3
455993|NCT01276223|1116941|P2|NOT COMPLETED|Overall Study||4
455994|NCT01276223|1116942|P1|NOT COMPLETED|Overall Study||11
455995|NCT01276223|1116940|P3|COMPLETED|Overall Study||101
455996|NCT01276223|1116941|P2|COMPLETED|Overall Study||103
455997|NCT01276223|1116942|P1|COMPLETED|Overall Study||67
455998|NCT01276223|1116940|P3|STARTED|Overall Study||104
455999|NCT01276223|1116941|P2|STARTED|Overall Study||107
456000|NCT01276223|1116942|P1|STARTED|Overall Study||78
456001|NCT01276197|1116951|P2|NOT COMPLETED|Overall Study||110
456002|NCT01276197|1116952|P1|NOT COMPLETED|Overall Study||108
456003|NCT01276197|1116951|P2|COMPLETED|Overall Study||200
456004|NCT01276197|1116952|P1|COMPLETED|Overall Study||200
456005|NCT01276197|1116951|P2|STARTED|Overall Study||310
456006|NCT01276197|1116952|P1|STARTED|Overall Study||308
456007|NCT01276171|1116963|P3|NOT COMPLETED|Overall Study||0
456008|NCT01276171|1116964|P2|NOT COMPLETED|Overall Study||0
456009|NCT01276171|1116965|P1|NOT COMPLETED|Overall Study||0
456010|NCT01276171|1116963|P3|COMPLETED|Overall Study||256
456011|NCT01276171|1116964|P2|COMPLETED|Overall Study||244
456012|NCT01276171|1116965|P1|COMPLETED|Overall Study||249
456013|NCT01276171|1116963|P3|STARTED|Overall Study||256
456014|NCT01276171|1116964|P2|STARTED|Overall Study||244
456015|NCT01276171|1116965|P1|STARTED|Overall Study||249
456016|NCT01276106|1116983|P4|NOT COMPLETED|Overall Study||13
456017|NCT01276106|1116984|P3|NOT COMPLETED|Overall Study||16
456018|NCT01276106|1116985|P2|NOT COMPLETED|Overall Study||9
456019|NCT01276106|1116986|P1|NOT COMPLETED|Overall Study||12
456020|NCT01276106|1116983|P4|COMPLETED|Overall Study||52
456021|NCT01276106|1116984|P3|COMPLETED|Overall Study||49
456022|NCT01276106|1116985|P2|COMPLETED|Overall Study||55
456023|NCT01276106|1116986|P1|COMPLETED|Overall Study||53
456024|NCT01276106|1116983|P4|STARTED|Overall Study||65
456025|NCT01276106|1116984|P3|STARTED|Overall Study||65
456026|NCT01276106|1116985|P2|STARTED|Overall Study||64
456027|NCT01276106|1116986|P1|STARTED|Overall Study||65
456028|NCT01276054|1116998|P2|NOT COMPLETED|Overall Study||2
456029|NCT01276054|1116999|P1|NOT COMPLETED|Overall Study||2
456030|NCT01276054|1116998|P2|COMPLETED|Overall Study||0
456031|NCT01276054|1116999|P1|COMPLETED|Overall Study||0
456032|NCT01276054|1116998|P2|STARTED|Overall Study||2
456033|NCT01276054|1116999|P1|STARTED|Overall Study||2
456034|NCT01275833|1117007|P2|NOT COMPLETED|Overall Study||1
456035|NCT01275833|1117008|P1|NOT COMPLETED|Overall Study||1
456036|NCT01275833|1117007|P2|COMPLETED|Overall Study||0
456037|NCT01275833|1117008|P1|COMPLETED|Overall Study||0
456038|NCT01275833|1117007|P2|STARTED|Overall Study||1
456039|NCT01275833|1117008|P1|STARTED|Overall Study||1
456040|NCT01275755|1117016|P2|NOT COMPLETED|Run-out Placebo Period||0
456041|NCT01275755|1117017|P1|NOT COMPLETED|Run-out Placebo Period||1
456042|NCT01275755|1117016|P2|COMPLETED|Run-out Placebo Period||37
456043|NCT01275755|1117017|P1|COMPLETED|Run-out Placebo Period||38
456044|NCT01275755|1117016|P2|STARTED|Run-out Placebo Period||37
456045|NCT01275755|1117017|P1|STARTED|Run-out Placebo Period||39
456046|NCT01275755|1117016|P2|NOT COMPLETED|Double-blind Treatment Period||3
456047|NCT01275755|1117017|P1|NOT COMPLETED|Double-blind Treatment Period||2
456048|NCT01275755|1117016|P2|COMPLETED|Double-blind Treatment Period||37
456049|NCT01275755|1117017|P1|COMPLETED|Double-blind Treatment Period||39
456050|NCT01275755|1117016|P2|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||40
456051|NCT01275755|1117017|P1|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||41
456052|NCT01275755|1117016|P2|STARTED|Double-blind Treatment Period||40
456053|NCT01275755|1117017|P1|STARTED|Double-blind Treatment Period||41
456054|NCT01275755|1117016|P2|NOT COMPLETED|Run-in Placebo Period||0
456055|NCT01275755|1117017|P1|NOT COMPLETED|Run-in Placebo Period||0
456056|NCT01275755|1117016|P2|COMPLETED|Run-in Placebo Period||40
456057|NCT01275755|1117017|P1|COMPLETED|Run-in Placebo Period||41
456058|NCT01275755|1117016|P2|STARTED|Run-in Placebo Period||40
456059|NCT01275755|1117017|P1|STARTED|Run-in Placebo Period||41
456060|NCT01275664|1117023|P1|NOT COMPLETED|Overall Study||0
456061|NCT01275664|1117023|P1|COMPLETED|Overall Study||4
456062|NCT01275664|1117023|P1|STARTED|Overall Study||4
456063|NCT01275625|1117031|P1|NOT COMPLETED|Overall Study||13
456064|NCT01275625|1117031|P1|COMPLETED|Overall Study||64
456065|NCT01275625|1117031|P1|Treated|Overall Study||77
456066|NCT01275625|1117031|P1|STARTED|Overall Study||77
456067|NCT01275586|1117045|P1|NOT COMPLETED|Overall Study||3
456068|NCT01275586|1117045|P1|COMPLETED|Overall Study||3
456069|NCT01275586|1117045|P1|STARTED|Overall Study||6
456070|NCT01275430|1117049|P1|NOT COMPLETED|Overall Study||9
456071|NCT01275430|1117049|P1|COMPLETED|Overall Study||18
456072|NCT01275430|1117049|P1|STARTED|Overall Study||27
456073|NCT01275365|1117061|P4|NOT COMPLETED|Overall Study||3
456074|NCT01275365|1117062|P3|NOT COMPLETED|Overall Study||5
456075|NCT01275365|1117063|P2|NOT COMPLETED|Overall Study||3
456076|NCT01275365|1117064|P1|NOT COMPLETED|Overall Study||3
456077|NCT01275365|1117061|P4|COMPLETED|Overall Study||19
456078|NCT01275365|1117062|P3|COMPLETED|Overall Study||17
456079|NCT01275365|1117063|P2|COMPLETED|Overall Study||21
456080|NCT01275365|1117064|P1|COMPLETED|Overall Study||21
456081|NCT01275365|1117061|P4|STARTED|Overall Study||22
456082|NCT01275365|1117062|P3|STARTED|Overall Study||22
456083|NCT01275365|1117063|P2|STARTED|Overall Study||24
456084|NCT01275365|1117064|P1|STARTED|Overall Study||24
456085|NCT01275313|1117112|P2|NOT COMPLETED|Overall Study||52
456086|NCT01275313|1117113|P1|NOT COMPLETED|Overall Study||25
456087|NCT01275313|1117112|P2|COMPLETED|Overall Study||79
456088|NCT01275313|1117113|P1|COMPLETED|Overall Study||102
456089|NCT01275313|1117112|P2|STARTED|Overall Study||131
456090|NCT01275313|1117113|P1|STARTED|Overall Study||127
456091|NCT01275196|1117121|P2|NOT COMPLETED|Overall Study||21
456092|NCT01275196|1117122|P1|NOT COMPLETED|Overall Study||20
456093|NCT01275196|1117121|P2|COMPLETED|Overall Study||113
456094|NCT01275196|1117122|P1|COMPLETED|Overall Study||113
456095|NCT01275196|1117121|P2|Intended to Continue Into Extension|Overall Study||113
456096|NCT01275196|1117122|P1|Intended to Continue Into Extension|Overall Study||112
456097|NCT01275196|1117121|P2|STARTED|Overall Study||134
456098|NCT01275196|1117122|P1|STARTED|Overall Study||133
456099|NCT01275131|1117165|P4|NOT COMPLETED|Period 2 (Crossover)||2
456100|NCT01275131|1117166|P3|NOT COMPLETED|Period 2 (Crossover)||1
456101|NCT01275131|1117167|P2|NOT COMPLETED|Period 2 (Crossover)||1
456102|NCT01275131|1117168|P1|NOT COMPLETED|Period 2 (Crossover)||1
456103|NCT01275131|1117165|P4|COMPLETED|Period 2 (Crossover)||8
456104|NCT01275131|1117166|P3|COMPLETED|Period 2 (Crossover)||9
456105|NCT01275131|1117167|P2|COMPLETED|Period 2 (Crossover)||8
456106|NCT01275131|1117168|P1|COMPLETED|Period 2 (Crossover)||8
456107|NCT01275131|1117165|P4|STARTED|Period 2 (Crossover)||10
456108|NCT01275131|1117166|P3|STARTED|Period 2 (Crossover)||10
456109|NCT01275131|1117167|P2|STARTED|Period 2 (Crossover)||9
456110|NCT01275131|1117168|P1|STARTED|Period 2 (Crossover)||9
456111|NCT01275131|1117165|P4|NOT COMPLETED|5- to 14-Day Washout Period||0
456112|NCT01275131|1117166|P3|NOT COMPLETED|5- to 14-Day Washout Period||0
456113|NCT01275131|1117167|P2|NOT COMPLETED|5- to 14-Day Washout Period||0
456114|NCT01275131|1117168|P1|NOT COMPLETED|5- to 14-Day Washout Period||0
456115|NCT01275131|1117165|P4|COMPLETED|5- to 14-Day Washout Period||10
456116|NCT01275131|1117166|P3|COMPLETED|5- to 14-Day Washout Period||10
456117|NCT01275131|1117167|P2|COMPLETED|5- to 14-Day Washout Period||9
456118|NCT01275131|1117168|P1|COMPLETED|5- to 14-Day Washout Period||9
456119|NCT01275131|1117165|P4|STARTED|5- to 14-Day Washout Period||10
456120|NCT01275131|1117166|P3|STARTED|5- to 14-Day Washout Period||10
456121|NCT01275131|1117167|P2|STARTED|5- to 14-Day Washout Period||9
456122|NCT01275131|1117168|P1|STARTED|5- to 14-Day Washout Period||9
456123|NCT01275131|1117165|P4|NOT COMPLETED|Period 1||2
456124|NCT01275131|1117166|P3|NOT COMPLETED|Period 1||3
456125|NCT01275131|1117167|P2|NOT COMPLETED|Period 1||0
456126|NCT01275131|1117168|P1|NOT COMPLETED|Period 1||2
456127|NCT01275131|1117165|P4|COMPLETED|Period 1||10
456128|NCT01275131|1117166|P3|COMPLETED|Period 1||10
456129|NCT01275131|1117167|P2|COMPLETED|Period 1||9
456130|NCT01275131|1117168|P1|COMPLETED|Period 1||9
456131|NCT01275131|1117165|P4|Received at Least One Dose of Study Drug|Period 1||12
456132|NCT01275131|1117166|P3|Received at Least One Dose of Study Drug|Period 1||13
456133|NCT01275131|1117167|P2|Received at Least One Dose of Study Drug|Period 1||9
456134|NCT01275131|1117168|P1|Received at Least One Dose of Study Drug|Period 1||11
456135|NCT01275131|1117165|P4|STARTED|Period 1||12
456136|NCT01275131|1117166|P3|STARTED|Period 1||13
456137|NCT01275131|1117167|P2|STARTED|Period 1||9
456138|NCT01275131|1117168|P1|STARTED|Period 1||11
456139|NCT01275092|1117202|P1|NOT COMPLETED|Overall Study||0
456140|NCT01275092|1117202|P1|COMPLETED|Overall Study||164
456141|NCT01275092|1117202|P1|STARTED|Overall Study||164
456142|NCT01275066|1117211|P3|NOT COMPLETED|Overall Study||1
456143|NCT01275066|1117212|P2|NOT COMPLETED|Overall Study||0
456144|NCT01275066|1117213|P1|NOT COMPLETED|Overall Study||1
456145|NCT01275066|1117211|P3|COMPLETED|Overall Study||57
456146|NCT01275066|1117212|P2|COMPLETED|Overall Study||59
456147|NCT01275066|1117213|P1|COMPLETED|Overall Study||59
456148|NCT01275066|1117211|P3|Treated|Overall Study||58
456149|NCT01275066|1117212|P2|Treated|Overall Study||59
456150|NCT01275066|1117213|P1|Treated|Overall Study||59
456151|NCT01275066|1117211|P3|STARTED|Overall Study||58
456152|NCT01275066|1117212|P2|STARTED|Overall Study||59
456153|NCT01275066|1117213|P1|STARTED|Overall Study||60
456154|NCT01275053|1117227|P1|NOT COMPLETED|Overall Study||0
456155|NCT01275053|1117227|P1|COMPLETED|Overall Study||12
456156|NCT01275053|1117227|P1|STARTED|Overall Study||12
456157|NCT01274897|1117233|P2|NOT COMPLETED|Overall Study||0
456158|NCT01274897|1117234|P1|NOT COMPLETED|Overall Study||0
456159|NCT01274897|1117233|P2|COMPLETED|Overall Study||153
456160|NCT01274897|1117234|P1|COMPLETED|Overall Study||297
456161|NCT01274897|1117233|P2|STARTED|Overall Study||153
456162|NCT01274897|1117234|P1|STARTED|Overall Study||297
456163|NCT01274715|1117246|P1|NOT COMPLETED|Overall Study||4
456164|NCT01274715|1117246|P1|COMPLETED|Overall Study||8
456165|NCT01274715|1117246|P1|Screened Out at Baseline|Overall Study||3
456166|NCT01274715|1117246|P1|STARTED|Overall Study||12
456167|NCT01274637|1117253|P2|NOT COMPLETED|Overall Study||2
456168|NCT01274637|1117254|P1|NOT COMPLETED|Overall Study||0
456169|NCT01274637|1117253|P2|COMPLETED|Overall Study||30
456170|NCT01274637|1117254|P1|COMPLETED|Overall Study||30
456171|NCT01274637|1117253|P2|STARTED|Overall Study||32
456172|NCT01274637|1117254|P1|STARTED|Overall Study||30
456173|NCT01274611|1117270|P1|NOT COMPLETED|Overall Study||0
456174|NCT01274611|1117270|P1|COMPLETED|Overall Study||20
456175|NCT01274611|1117270|P1|STARTED|Overall Study||20
456176|NCT01274585|1117280|P2|NOT COMPLETED|Overall Study||0
456177|NCT01274585|1117281|P1|NOT COMPLETED|Overall Study||0
456178|NCT01274585|1117280|P2|COMPLETED|Overall Study||3
456179|NCT01274585|1117281|P1|COMPLETED|Overall Study||2
456180|NCT01274585|1117280|P2|STARTED|Overall Study||3
456181|NCT01274585|1117281|P1|STARTED|Overall Study||2
456182|NCT01274559|1117293|P2|NOT COMPLETED|Overall Study||145
456183|NCT01274559|1117294|P1|NOT COMPLETED|Overall Study||197
456184|NCT01274559|1117293|P2|COMPLETED|Overall Study||441
456185|NCT01274559|1117294|P1|COMPLETED|Overall Study||390
456186|NCT01274559|1117293|P2|Treated|Overall Study||572
456187|NCT01274559|1117294|P1|Treated|Overall Study||572
456188|NCT01274559|1117293|P2|STARTED|Overall Study||586
456189|NCT01274559|1117294|P1|STARTED|Overall Study||587
456190|NCT01274533|1117344|P1|NOT COMPLETED|Overall Study||4
456191|NCT01274533|1117344|P1|COMPLETED|Overall Study||0
456192|NCT01274533|1117344|P1|STARTED|Overall Study||4
456193|NCT01274429|1117349|P1|NOT COMPLETED|Overall Study||5
456194|NCT01274429|1117349|P1|COMPLETED|Overall Study||0
456195|NCT01274429|1117349|P1|STARTED|Overall Study||5
456196|NCT01274182|1117357|P3|NOT COMPLETED|Overall Study||12
456197|NCT01274182|1117358|P2|NOT COMPLETED|Overall Study||18
456198|NCT01274182|1117359|P1|NOT COMPLETED|Overall Study||21
456199|NCT01274182|1117357|P3|COMPLETED|Overall Study||80
456200|NCT01274182|1117358|P2|COMPLETED|Overall Study||69
456201|NCT01274182|1117359|P1|COMPLETED|Overall Study||112
456202|NCT01274182|1117357|P3|24 Weeks|Overall Study||84
456203|NCT01274182|1117358|P2|24 Weeks|Overall Study||83
456204|NCT01274182|1117359|P1|24 Weeks|Overall Study||123
456205|NCT01274182|1117357|P3|STARTED|Overall Study||92
456206|NCT01274182|1117358|P2|STARTED|Overall Study||87
456207|NCT01274182|1117359|P1|STARTED|Overall Study||133
456208|NCT01273896|1117396|P1|NOT COMPLETED|Overall Study||0
456209|NCT01273896|1117396|P1|COMPLETED|Overall Study||22
456210|NCT01273896|1117396|P1|STARTED|Overall Study||22
456211|NCT01273883|1117400|P2|NOT COMPLETED|Second Intervention||1
456212|NCT01273883|1117401|P1|NOT COMPLETED|Second Intervention||2
456213|NCT01273883|1117400|P2|COMPLETED|Second Intervention||17
456214|NCT01273883|1117401|P1|COMPLETED|Second Intervention||15
456215|NCT01273883|1117400|P2|STARTED|Second Intervention||18
456216|NCT01273883|1117401|P1|STARTED|Second Intervention||17
456217|NCT01273883|1117400|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
456218|NCT01273883|1117401|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
456219|NCT01273883|1117400|P2|COMPLETED|Washout Period of 2 Weeks||18
456220|NCT01273883|1117401|P1|COMPLETED|Washout Period of 2 Weeks||17
456221|NCT01273883|1117400|P2|STARTED|Washout Period of 2 Weeks||18
456222|NCT01273883|1117401|P1|STARTED|Washout Period of 2 Weeks||17
456223|NCT01273883|1117400|P2|NOT COMPLETED|First Intervention||1
456224|NCT01273883|1117401|P1|NOT COMPLETED|First Intervention||2
456225|NCT01273883|1117400|P2|COMPLETED|First Intervention||18
456226|NCT01273883|1117401|P1|COMPLETED|First Intervention||17
456227|NCT01273883|1117400|P2|STARTED|First Intervention|Received at least 1 dose of study drug.|19
456228|NCT01273883|1117401|P1|STARTED|First Intervention|Received at least 1 dose of study drug.|19
456229|NCT01273857|1117415|P2|NOT COMPLETED|Overall Study||0
456230|NCT01273857|1117416|P1|NOT COMPLETED|Overall Study||0
456231|NCT01273857|1117415|P2|COMPLETED|Overall Study||7
456232|NCT01273857|1117416|P1|COMPLETED|Overall Study||7
456233|NCT01273857|1117415|P2|STARTED|Overall Study||7
456234|NCT01273857|1117416|P1|STARTED|Overall Study||7
456235|NCT01273818|1117427|P3|NOT COMPLETED|Overall Study||9
456236|NCT01273818|1117428|P2|NOT COMPLETED|Overall Study||2
456237|NCT01273818|1117429|P1|NOT COMPLETED|Overall Study||13
456238|NCT01273818|1117427|P3|COMPLETED|Overall Study||91
456239|NCT01273818|1117428|P2|COMPLETED|Overall Study||98
456240|NCT01273818|1117429|P1|COMPLETED|Overall Study||87
456241|NCT01273818|1117427|P3|STARTED|Overall Study||100
456242|NCT01273818|1117428|P2|STARTED|Overall Study||100
456243|NCT01273818|1117429|P1|STARTED|Overall Study||100
456244|NCT01273805|1117439|P2|NOT COMPLETED|Overall Study||10
456245|NCT01273805|1117440|P1|NOT COMPLETED|Overall Study||10
456246|NCT01273805|1117439|P2|COMPLETED|Overall Study||0
456247|NCT01273805|1117440|P1|COMPLETED|Overall Study||0
456248|NCT01273805|1117439|P2|STARTED|Overall Study||10
456249|NCT01273805|1117440|P1|STARTED|Overall Study||10
456250|NCT01273766|1117459|P3|NOT COMPLETED|Overall Study||0
456251|NCT01273766|1117460|P2|NOT COMPLETED|Overall Study||0
456252|NCT01273766|1117461|P1|NOT COMPLETED|Overall Study||0
456253|NCT01273766|1117459|P3|COMPLETED|Overall Study||5
456254|NCT01273766|1117460|P2|COMPLETED|Overall Study||7
456255|NCT01273766|1117461|P1|COMPLETED|Overall Study||4
456256|NCT01273766|1117459|P3|STARTED|Overall Study||5
456257|NCT01273766|1117460|P2|STARTED|Overall Study||7
456258|NCT01273766|1117461|P1|STARTED|Overall Study||4
456259|NCT01273623|1117471|P1|NOT COMPLETED|Overall Study||29
456260|NCT01273623|1117471|P1|COMPLETED|Overall Study|met IVUS criteria|26
456261|NCT01273623|1117471|P1|STARTED|Overall Study|met angiographic criteria|55
456262|NCT01273597|1117478|P1|NOT COMPLETED|Overall Study||8
456263|NCT01273597|1117478|P1|COMPLETED|Overall Study||52
456264|NCT01273597|1117478|P1|STARTED|Overall Study||60
456265|NCT01273519|1117493|P3|NOT COMPLETED|Overall Study||8
456266|NCT01273519|1117494|P2|NOT COMPLETED|Overall Study||5
456267|NCT01273519|1117495|P1|NOT COMPLETED|Overall Study||19
456268|NCT01273519|1117493|P3|COMPLETED|Overall Study||39
456269|NCT01273519|1117494|P2|COMPLETED|Overall Study||25
456270|NCT01273519|1117495|P1|COMPLETED|Overall Study||59
456271|NCT01273519|1117493|P3|STARTED|Overall Study||47
456272|NCT01273519|1117494|P2|STARTED|Overall Study||30
456273|NCT01273519|1117495|P1|STARTED|Overall Study||78
456274|NCT01273181|1117532|P4|NOT COMPLETED|Phase 2, Dose 2||1
456275|NCT01273181|1117533|P3|NOT COMPLETED|Phase 2, Dose 2||0
456276|NCT01273181|1117534|P2|NOT COMPLETED|Phase 2, Dose 2||0
456277|NCT01273181|1117535|P1|NOT COMPLETED|Phase 2, Dose 2||0
456278|NCT01273181|1117532|P4|COMPLETED|Phase 2, Dose 2||0
456279|NCT01273181|1117533|P3|COMPLETED|Phase 2, Dose 2||0
456280|NCT01273181|1117534|P2|COMPLETED|Phase 2, Dose 2||0
456281|NCT01273181|1117535|P1|COMPLETED|Phase 2, Dose 2||0
456282|NCT01273181|1117532|P4|STARTED|Phase 2, Dose 2||1
456283|NCT01273181|1117533|P3|STARTED|Phase 2, Dose 2||0
456284|NCT01273181|1117534|P2|STARTED|Phase 2, Dose 2||0
456285|NCT01273181|1117535|P1|STARTED|Phase 2, Dose 2||0
456286|NCT01273181|1117532|P4|NOT COMPLETED|Phase 2, Dose 1||0
456287|NCT01273181|1117533|P3|NOT COMPLETED|Phase 2, Dose 1||1
456288|NCT01273181|1117534|P2|NOT COMPLETED|Phase 2, Dose 1||0
456289|NCT01273181|1117535|P1|NOT COMPLETED|Phase 2, Dose 1||0
456290|NCT01273181|1117532|P4|COMPLETED|Phase 2, Dose 1||0
456291|NCT01273181|1117533|P3|COMPLETED|Phase 2, Dose 1||1
456292|NCT01273181|1117534|P2|COMPLETED|Phase 2, Dose 1||0
456293|NCT01273181|1117535|P1|COMPLETED|Phase 2, Dose 1||0
456294|NCT01273181|1117532|P4|STARTED|Phase 2, Dose 1||0
456295|NCT01273181|1117533|P3|STARTED|Phase 2, Dose 1||2
456296|NCT01273181|1117534|P2|STARTED|Phase 2, Dose 1||0
456297|NCT01273181|1117535|P1|STARTED|Phase 2, Dose 1||0
456298|NCT01273181|1117532|P4|NOT COMPLETED|Phase I, Dose 2||0
456299|NCT01273181|1117533|P3|NOT COMPLETED|Phase I, Dose 2||0
456300|NCT01273181|1117534|P2|NOT COMPLETED|Phase I, Dose 2||1
456301|NCT01273181|1117535|P1|NOT COMPLETED|Phase I, Dose 2||0
456302|NCT01273181|1117532|P4|COMPLETED|Phase I, Dose 2||0
456303|NCT01273181|1117533|P3|COMPLETED|Phase I, Dose 2||0
456304|NCT01273181|1117534|P2|COMPLETED|Phase I, Dose 2||2
456305|NCT01273181|1117535|P1|COMPLETED|Phase I, Dose 2||0
456306|NCT01273181|1117532|P4|STARTED|Phase I, Dose 2||0
456307|NCT01273181|1117533|P3|STARTED|Phase I, Dose 2||0
456308|NCT01273181|1117534|P2|STARTED|Phase I, Dose 2||3
456309|NCT01273181|1117535|P1|STARTED|Phase I, Dose 2||0
456310|NCT01273181|1117532|P4|NOT COMPLETED|Phase I, Dose 1||0
456311|NCT01273181|1117533|P3|NOT COMPLETED|Phase I, Dose 1||0
456312|NCT01273181|1117534|P2|NOT COMPLETED|Phase I, Dose 1||0
456313|NCT01273181|1117535|P1|NOT COMPLETED|Phase I, Dose 1||1
456314|NCT01273181|1117532|P4|COMPLETED|Phase I, Dose 1||0
456315|NCT01273181|1117533|P3|COMPLETED|Phase I, Dose 1||0
456316|NCT01273181|1117534|P2|COMPLETED|Phase I, Dose 1||0
456317|NCT01273181|1117535|P1|COMPLETED|Phase I, Dose 1||2
456318|NCT01273181|1117532|P4|STARTED|Phase I, Dose 1||0
456319|NCT01273181|1117533|P3|STARTED|Phase I, Dose 1||0
456320|NCT01273181|1117534|P2|STARTED|Phase I, Dose 1||0
456321|NCT01273181|1117535|P1|STARTED|Phase I, Dose 1||3
456322|NCT01273064|1117554|P5|NOT COMPLETED|Overall Study||10
456323|NCT01273064|1117555|P4|NOT COMPLETED|Overall Study||20
456324|NCT01273064|1117556|P3|NOT COMPLETED|Overall Study||31
456325|NCT01273064|1117557|P2|NOT COMPLETED|Overall Study||30
456326|NCT01273064|1117558|P1|NOT COMPLETED|Overall Study||23
456327|NCT01273064|1117554|P5|COMPLETED|Overall Study||0
456328|NCT01273064|1117555|P4|COMPLETED|Overall Study||0
456329|NCT01273064|1117556|P3|COMPLETED|Overall Study||0
456330|NCT01273064|1117557|P2|COMPLETED|Overall Study||0
456331|NCT01273064|1117558|P1|COMPLETED|Overall Study||0
456332|NCT01273064|1117554|P5|STARTED|Overall Study|Began study on the placebo arm, and crossed over to CTS-1027 15 mg at Wk 12 due to lack of response|10
456333|NCT01273064|1117555|P4|STARTED|Overall Study||20
456334|NCT01273064|1117556|P3|STARTED|Overall Study||31
456335|NCT01273064|1117557|P2|STARTED|Overall Study||30
456336|NCT01273064|1117558|P1|STARTED|Overall Study||23
456337|NCT01273038|1117577|P2|NOT COMPLETED|Second Intervention (14 Days)||2
456338|NCT01273038|1117578|P1|NOT COMPLETED|Second Intervention (14 Days)||0
456339|NCT01273038|1117577|P2|COMPLETED|Second Intervention (14 Days)||8
456340|NCT01273038|1117578|P1|COMPLETED|Second Intervention (14 Days)||10
456341|NCT01273038|1117577|P2|STARTED|Second Intervention (14 Days)||10
456342|NCT01273038|1117578|P1|STARTED|Second Intervention (14 Days)||10
456343|NCT01273038|1117577|P2|NOT COMPLETED|First Intervention (14 Days)||0
456344|NCT01273038|1117578|P1|NOT COMPLETED|First Intervention (14 Days)||0
456345|NCT01273038|1117577|P2|COMPLETED|First Intervention (14 Days)||10
456346|NCT01273038|1117578|P1|COMPLETED|First Intervention (14 Days)||10
456347|NCT01273038|1117577|P2|STARTED|First Intervention (14 Days)||10
456348|NCT01273038|1117578|P1|STARTED|First Intervention (14 Days)||10
456349|NCT01272960|1117586|P2|NOT COMPLETED|Overall Study||0
456350|NCT01272960|1117587|P1|NOT COMPLETED|Overall Study||0
456351|NCT01272960|1117586|P2|COMPLETED|Overall Study||15
456352|NCT01272960|1117587|P1|COMPLETED|Overall Study||14
456353|NCT01272960|1117586|P2|STARTED|Overall Study||15
456354|NCT01272960|1117587|P1|STARTED|Overall Study||14
456355|NCT01272947|1117601|P2|NOT COMPLETED|Overall Study||2
456356|NCT01272947|1117602|P1|NOT COMPLETED|Overall Study||2
456357|NCT01272947|1117601|P2|COMPLETED|Overall Study||98
456358|NCT01272947|1117602|P1|COMPLETED|Overall Study||102
456359|NCT01272947|1117601|P2|STARTED|Overall Study||100
456360|NCT01272947|1117602|P1|STARTED|Overall Study||104
456361|NCT01272934|1117612|P2|NOT COMPLETED|Overall Study||2
456362|NCT01272934|1117613|P1|NOT COMPLETED|Overall Study||0
456363|NCT01272934|1117612|P2|COMPLETED|Overall Study||101
456364|NCT01272934|1117613|P1|COMPLETED|Overall Study||102
456365|NCT01272934|1117612|P2|STARTED|Overall Study||103
456366|NCT01272934|1117613|P1|STARTED|Overall Study||102
456367|NCT01272921|1117623|P2|NOT COMPLETED|Overall Study||1
456368|NCT01272921|1117624|P1|NOT COMPLETED|Overall Study||2
456369|NCT01272921|1117623|P2|COMPLETED|Overall Study||70
456370|NCT01272921|1117624|P1|COMPLETED|Overall Study||69
456371|NCT01272921|1117623|P2|STARTED|Overall Study||71
456372|NCT01272921|1117624|P1|STARTED|Overall Study||71
456373|NCT01272908|1117632|P1|NOT COMPLETED|Re-Treatment Period||6
456374|NCT01272908|1117632|P1|COMPLETED|Re-Treatment Period||71
456375|NCT01272908|1117632|P1|STARTED|Re-Treatment Period|Only participants with active disease as characterized by DAS-28 score ≥2.6 were included.|77
456376|NCT01272908|1117632|P1|NOT COMPLETED|Initial Treatment Period||8
456377|NCT01272908|1117632|P1|COMPLETED|Initial Treatment Period||112
456378|NCT01272908|1117632|P1|STARTED|Initial Treatment Period||120
456379|NCT01272882|1117666|P1|NOT COMPLETED|Overall Study||0
456380|NCT01272882|1117666|P1|COMPLETED|Overall Study||13
456381|NCT01272882|1117666|P1|STARTED|Overall Study||13
456382|NCT01272869|1117672|P2|NOT COMPLETED|Period 2 (14 Days)||0
456383|NCT01272869|1117673|P1|NOT COMPLETED|Period 2 (14 Days)||1
456384|NCT01272869|1117672|P2|COMPLETED|Period 2 (14 Days)||10
456385|NCT01272869|1117673|P1|COMPLETED|Period 2 (14 Days)||9
456386|NCT01272869|1117672|P2|STARTED|Period 2 (14 Days)||10
456387|NCT01272869|1117673|P1|STARTED|Period 2 (14 Days)||10
456388|NCT01272869|1117672|P2|NOT COMPLETED|Period 1 (14 Days)||0
456389|NCT01272869|1117673|P1|NOT COMPLETED|Period 1 (14 Days)||0
456390|NCT01272869|1117672|P2|COMPLETED|Period 1 (14 Days)||10
456391|NCT01272869|1117673|P1|COMPLETED|Period 1 (14 Days)||10
456392|NCT01272869|1117672|P2|STARTED|Period 1 (14 Days)||10
456393|NCT01272869|1117673|P1|STARTED|Period 1 (14 Days)||10
456394|NCT01272830|1117681|P2|NOT COMPLETED|Overall Study||5
456395|NCT01272830|1117682|P1|NOT COMPLETED|Overall Study||8
456396|NCT01272830|1117681|P2|COMPLETED|Overall Study||21
456397|NCT01272830|1117682|P1|COMPLETED|Overall Study||17
456398|NCT01272830|1117681|P2|STARTED|Overall Study||26
456399|NCT01272830|1117682|P1|STARTED|Overall Study||25
456400|NCT01272804|1117700|P6|NOT COMPLETED|Overall Study||1
456401|NCT01272804|1117701|P5|NOT COMPLETED|Overall Study||2
456402|NCT01272804|1117702|P4|NOT COMPLETED|Overall Study||0
456403|NCT01272804|1117703|P3|NOT COMPLETED|Overall Study||0
456404|NCT01272804|1117704|P2|NOT COMPLETED|Overall Study||0
456405|NCT01272804|1117705|P1|NOT COMPLETED|Overall Study||1
456406|NCT01272804|1117700|P6|COMPLETED|Overall Study||15
456407|NCT01272804|1117701|P5|COMPLETED|Overall Study||7
456408|NCT01272804|1117702|P4|COMPLETED|Overall Study||9
456409|NCT01272804|1117703|P3|COMPLETED|Overall Study||9
456410|NCT01272804|1117704|P2|COMPLETED|Overall Study||9
456411|NCT01272804|1117705|P1|COMPLETED|Overall Study||8
456412|NCT01272804|1117700|P6|STARTED|Overall Study||16
456413|NCT01272804|1117701|P5|STARTED|Overall Study||9
456414|NCT01272804|1117702|P4|STARTED|Overall Study||9
456415|NCT01272804|1117703|P3|STARTED|Overall Study||9
456416|NCT01272804|1117704|P2|STARTED|Overall Study||9
456417|NCT01272804|1117705|P1|STARTED|Overall Study||9
456418|NCT01272661|1117863|P3|NOT COMPLETED|Overall Study||72
456419|NCT01272661|1117864|P2|NOT COMPLETED|Overall Study||209
456420|NCT01272661|1117865|P1|NOT COMPLETED|Overall Study||126
456421|NCT01272661|1117863|P3|COMPLETED|Overall Study||314
456422|NCT01272661|1117864|P2|COMPLETED|Overall Study||288
456423|NCT01272661|1117865|P1|COMPLETED|Overall Study||287
456424|NCT01272661|1117863|P3|STARTED|Overall Study||386
456425|NCT01272661|1117864|P2|STARTED|Overall Study||497
456426|NCT01272661|1117865|P1|STARTED|Overall Study||413
456427|NCT01272635|1117890|P4|NOT COMPLETED|Overall Study||23
456428|NCT01272635|1117891|P3|NOT COMPLETED|Overall Study||31
456429|NCT01272635|1117892|P2|NOT COMPLETED|Overall Study||20
456430|NCT01272635|1117893|P1|NOT COMPLETED|Overall Study||31
456431|NCT01272635|1117890|P4|COMPLETED|Overall Study||129
456432|NCT01272635|1117891|P3|COMPLETED|Overall Study||117
456433|NCT01272635|1117892|P2|COMPLETED|Overall Study||134
456434|NCT01272635|1117893|P1|COMPLETED|Overall Study||122
456435|NCT01272635|1117890|P4|STARTED|Overall Study||152
456436|NCT01272635|1117891|P3|STARTED|Overall Study||148
456437|NCT01272635|1117892|P2|STARTED|Overall Study||154
456438|NCT01272635|1117893|P1|STARTED|Overall Study||153
456439|NCT01272583|1117911|P2|NOT COMPLETED|Overall Study||0
456440|NCT01272583|1117912|P1|NOT COMPLETED|Overall Study||0
456441|NCT01272583|1117911|P2|COMPLETED|Overall Study||8
456442|NCT01272583|1117912|P1|COMPLETED|Overall Study||8
456443|NCT01272583|1117911|P2|STARTED|Overall Study||8
456444|NCT01272583|1117912|P1|STARTED|Overall Study||8
456445|NCT01272284|1117941|P1|NOT COMPLETED|12-month Follow-up Visit||4
456446|NCT01272284|1117941|P1|COMPLETED|12-month Follow-up Visit||105
456447|NCT01272284|1117941|P1|STARTED|12-month Follow-up Visit||109
456448|NCT01272284|1117941|P1|NOT COMPLETED|6-month Follow-up Visit||3
456449|NCT01272284|1117941|P1|COMPLETED|6-month Follow-up Visit||109
456450|NCT01272284|1117941|P1|STARTED|6-month Follow-up Visit||112
456451|NCT01272284|1117941|P1|NOT COMPLETED|3-month Follow-up Visit||1
456452|NCT01272284|1117941|P1|COMPLETED|3-month Follow-up Visit||112
456453|NCT01272284|1117941|P1|STARTED|3-month Follow-up Visit||113
456454|NCT01272245|1117955|P1|NOT COMPLETED|Overall Study||0
456455|NCT01272245|1117955|P1|COMPLETED|Overall Study||36
456456|NCT01272245|1117955|P1|STARTED|Overall Study||36
456457|NCT01272232|1117966|P3|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||5
456458|NCT01272232|1117967|P2|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||10
456459|NCT01272232|1117968|P1|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||14
456460|NCT01272232|1117966|P3|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||135
456461|NCT01272232|1117967|P2|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||154
456462|NCT01272232|1117968|P1|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||310
456463|NCT01272232|1117966|P3|STARTED|Off Drug Follow-up Period (Weeks 56-68)||140
456464|NCT01272232|1117967|P2|STARTED|Off Drug Follow-up Period (Weeks 56-68)||164
456465|NCT01272232|1117968|P1|STARTED|Off Drug Follow-up Period (Weeks 56-68)||324
456466|NCT01272232|1117966|P3|NOT COMPLETED|Weeks 0-56||72
456467|NCT01272232|1117967|P2|NOT COMPLETED|Weeks 0-56||47
456468|NCT01272232|1117968|P1|NOT COMPLETED|Weeks 0-56||99
456469|NCT01272232|1117966|P3|COMPLETED|Weeks 0-56||140
456470|NCT01272232|1117967|P2|COMPLETED|Weeks 0-56||164
456471|NCT01272232|1117968|P1|COMPLETED|Weeks 0-56||324
456472|NCT01272232|1117966|P3|Exposed|Weeks 0-56||212
456473|NCT01272232|1117967|P2|Exposed|Weeks 0-56|1 subject dropped out after randomisation and before exposure to trial drug.|210
456474|NCT01272232|1117968|P1|Exposed|Weeks 0-56|1 subject dropped out after randomisation and before exposure to trial drug.|422
456475|NCT01272232|1117966|P3|STARTED|Weeks 0-56||212
456476|NCT01272232|1117967|P2|STARTED|Weeks 0-56||211
456477|NCT01272232|1117968|P1|STARTED|Weeks 0-56||423
456478|NCT01272219|1118013|P6|NOT COMPLETED|Main + Extension Period: Week 0-172||422
456479|NCT01272219|1118014|P5|NOT COMPLETED|Main + Extension Period: Week 0-172||722
456480|NCT01272219|1118015|P4|NOT COMPLETED|Main + Extension Period: Week 0-172||0
456481|NCT01272219|1118016|P3|NOT COMPLETED|Main + Extension Period: Week 0-172||0
456482|NCT01272219|1118017|P2|NOT COMPLETED|Main + Extension Period: Week 0-172||0
456483|NCT01272219|1118018|P1|NOT COMPLETED|Main + Extension Period: Week 0-172||0
456484|NCT01272219|1118013|P6|COMPLETED|Main + Extension Period: Week 0-172||327
456485|NCT01272219|1118014|P5|COMPLETED|Main + Extension Period: Week 0-172||783
456486|NCT01272219|1118015|P4|COMPLETED|Main + Extension Period: Week 0-172||0
456487|NCT01272219|1118016|P3|COMPLETED|Main + Extension Period: Week 0-172||0
456488|NCT01272219|1118017|P2|COMPLETED|Main + Extension Period: Week 0-172||0
456489|NCT01272219|1118018|P1|COMPLETED|Main + Extension Period: Week 0-172||0
456490|NCT01272219|1118013|P6|Exposed|Main + Extension Period: Week 0-172||747
456491|NCT01272219|1118014|P5|Exposed|Main + Extension Period: Week 0-172||1501
456492|NCT01272219|1118015|P4|Exposed|Main + Extension Period: Week 0-172||0
456493|NCT01272219|1118016|P3|Exposed|Main + Extension Period: Week 0-172||0
456494|NCT01272219|1118017|P2|Exposed|Main + Extension Period: Week 0-172||0
456495|NCT01272219|1118018|P1|Exposed|Main + Extension Period: Week 0-172||0
456496|NCT01272219|1118013|P6|STARTED|Main + Extension Period: Week 0-172|Incorrect stratification: In this period, overall 6 subjects with no pre-diabetes included by error.|749
456497|NCT01272219|1118014|P5|STARTED|Main + Extension Period: Week 0-172|Incorrect stratification: In this period, overall 6 subjects with no pre-diabetes included by error.|1505
456498|NCT01272219|1118015|P4|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to main and re-randomised period|0
456499|NCT01272219|1118016|P3|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to re-randomised period|0
456500|NCT01272219|1118017|P2|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to re-randomised period|0
456501|NCT01272219|1118018|P1|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to main period|0
456502|NCT01272219|1118013|P6|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
456503|NCT01272219|1118014|P5|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
456504|NCT01272219|1118015|P4|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||15
456505|NCT01272219|1118016|P3|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||7
456506|NCT01272219|1118017|P2|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||9
456507|NCT01272219|1118018|P1|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
456508|NCT01272219|1118013|P6|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
456509|NCT01272219|1118014|P5|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
456510|NCT01272219|1118015|P4|COMPLETED|Re-randomised Period: Week 56 to Week 68||289
456511|NCT01272219|1118016|P3|COMPLETED|Re-randomised Period: Week 56 to Week 68||343
456512|NCT01272219|1118017|P2|COMPLETED|Re-randomised Period: Week 56 to Week 68||342
456513|NCT01272219|1118018|P1|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
456514|NCT01272219|1118013|P6|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
456515|NCT01272219|1118014|P5|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
456516|NCT01272219|1118015|P4|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|304
456517|NCT01272219|1118016|P3|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|350
456518|NCT01272219|1118017|P2|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|351
456519|NCT01272219|1118018|P1|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
456520|NCT01272219|1118013|P6|NOT COMPLETED|Main Period: Week 0 to Week 56||252
456521|NCT01272219|1118014|P5|NOT COMPLETED|Main Period: Week 0 to Week 56||418
456522|NCT01272219|1118015|P4|NOT COMPLETED|Main Period: Week 0 to Week 56||191
456523|NCT01272219|1118016|P3|NOT COMPLETED|Main Period: Week 0 to Week 56||0
456524|NCT01272219|1118017|P2|NOT COMPLETED|Main Period: Week 0 to Week 56||0
456525|NCT01272219|1118018|P1|NOT COMPLETED|Main Period: Week 0 to Week 56||280
456526|NCT01272219|1118013|P6|COMPLETED|Main Period: Week 0 to Week 56||505
456527|NCT01272219|1118014|P5|COMPLETED|Main Period: Week 0 to Week 56||1110
456528|NCT01272219|1118015|P4|COMPLETED|Main Period: Week 0 to Week 56||296
456529|NCT01272219|1118016|P3|COMPLETED|Main Period: Week 0 to Week 56||0
456530|NCT01272219|1118017|P2|COMPLETED|Main Period: Week 0 to Week 56||0
456531|NCT01272219|1118018|P1|COMPLETED|Main Period: Week 0 to Week 56||679
456532|NCT01272219|1118013|P6|Exposed|Main Period: Week 0 to Week 56||755
456533|NCT01272219|1118014|P5|Exposed|Main Period: Week 0 to Week 56||1524
456534|NCT01272219|1118015|P4|Exposed|Main Period: Week 0 to Week 56||487
456535|NCT01272219|1118016|P3|Exposed|Main Period: Week 0 to Week 56||0
456536|NCT01272219|1118017|P2|Exposed|Main Period: Week 0 to Week 56||0
456537|NCT01272219|1118018|P1|Exposed|Main Period: Week 0 to Week 56||957
456538|NCT01272219|1118013|P6|STARTED|Main Period: Week 0 to Week 56||757
456539|NCT01272219|1118014|P5|STARTED|Main Period: Week 0 to Week 56||1528
456540|NCT01272219|1118015|P4|STARTED|Main Period: Week 0 to Week 56||487
456541|NCT01272219|1118016|P3|STARTED|Main Period: Week 0 to Week 56|This arm is not considered for main period as these subjects belong to re-randomised period|0
456542|NCT01272219|1118017|P2|STARTED|Main Period: Week 0 to Week 56|This arm is not considered for main period as these subjects belong to re-randomised period|0
456543|NCT01272219|1118018|P1|STARTED|Main Period: Week 0 to Week 56||959
456544|NCT01272193|1118052|P2|NOT COMPLETED|Overall Study||12
456545|NCT01272193|1118053|P1|NOT COMPLETED|Overall Study||10
456546|NCT01272193|1118052|P2|COMPLETED|Overall Study||137
456547|NCT01272193|1118053|P1|COMPLETED|Overall Study||137
456548|NCT01272193|1118052|P2|STARTED|Overall Study||149
456549|NCT01272193|1118053|P1|STARTED|Overall Study||147
456550|NCT01272180|1118073|P4|NOT COMPLETED|Overall Study||14
456551|NCT01272180|1118074|P3|NOT COMPLETED|Overall Study||13
456552|NCT01272180|1118075|P2|NOT COMPLETED|Overall Study||21
456553|NCT01272180|1118076|P1|NOT COMPLETED|Overall Study||17
456554|NCT01272180|1118073|P4|COMPLETED|Overall Study||107
456555|NCT01272180|1118074|P3|COMPLETED|Overall Study||109
456556|NCT01272180|1118075|P2|COMPLETED|Overall Study||100
456557|NCT01272180|1118076|P1|COMPLETED|Overall Study||103
456558|NCT01272180|1118073|P4|STARTED|Overall Study||121
456559|NCT01272180|1118074|P3|STARTED|Overall Study||122
456560|NCT01272180|1118075|P2|STARTED|Overall Study||121
456561|NCT01272180|1118076|P1|STARTED|Overall Study||120
456562|NCT01272141|1118113|P1|NOT COMPLETED|Overall Study||0
456563|NCT01272141|1118113|P1|COMPLETED|Overall Study||5
456564|NCT01272141|1118113|P1|STARTED|Overall Study||5
456565|NCT01272076|1118118|P1|NOT COMPLETED|Overall Study||0
456566|NCT01272076|1118118|P1|COMPLETED|Overall Study||52
456567|NCT01272076|1118118|P1|STARTED|Overall Study||52
456568|NCT01272011|1118125|P3|NOT COMPLETED|Overall Study||0
456569|NCT01272011|1118126|P2|NOT COMPLETED|Overall Study||2
456570|NCT01272011|1118127|P1|NOT COMPLETED|Overall Study||0
456571|NCT01272011|1118125|P3|COMPLETED|Overall Study||3
456572|NCT01272011|1118126|P2|COMPLETED|Overall Study||8
456573|NCT01272011|1118127|P1|COMPLETED|Overall Study||3
456574|NCT01272011|1118125|P3|STARTED|Overall Study||3
456575|NCT01272011|1118126|P2|STARTED|Overall Study||10
456576|NCT01272011|1118127|P1|STARTED|Overall Study||3
456577|NCT01271946|1118140|P2|NOT COMPLETED|Overall Study||0
456578|NCT01271946|1118141|P1|NOT COMPLETED|Overall Study||0
456579|NCT01271946|1118140|P2|COMPLETED|Overall Study||5
456580|NCT01271946|1118141|P1|COMPLETED|Overall Study||346
456581|NCT01271946|1118140|P2|STARTED|Overall Study||5
456582|NCT01271946|1118141|P1|STARTED|Overall Study||346
456583|NCT01271907|1118166|P3|NOT COMPLETED|Overall Study||0
456584|NCT01271907|1118167|P2|NOT COMPLETED|Overall Study||0
456585|NCT01271907|1118168|P1|NOT COMPLETED|Overall Study||0
456586|NCT01271907|1118166|P3|COMPLETED|Overall Study||0
456587|NCT01271907|1118167|P2|COMPLETED|Overall Study||0
456588|NCT01271907|1118168|P1|COMPLETED|Overall Study||3
456589|NCT01271907|1118166|P3|STARTED|Overall Study||0
456590|NCT01271907|1118167|P2|STARTED|Overall Study||0
456591|NCT01271907|1118168|P1|STARTED|Overall Study||3
456592|NCT01271855|1118184|P2|NOT COMPLETED|Overall Study||0
456593|NCT01271855|1118185|P1|NOT COMPLETED|Overall Study||0
456594|NCT01271855|1118184|P2|COMPLETED|Overall Study||52
456595|NCT01271855|1118185|P1|COMPLETED|Overall Study||48
456596|NCT01271855|1118184|P2|STARTED|Overall Study||52
456597|NCT01271855|1118185|P1|STARTED|Overall Study||48
456670|NCT01271712|1118391|P2|NOT COMPLETED|Survival Follow-up||6
456671|NCT01271712|1118392|P1|NOT COMPLETED|Survival Follow-up||15
456672|NCT01271712|1118391|P2|COMPLETED|Survival Follow-up|33 participants died and completed survival follow-up.|33
456673|NCT01271712|1118392|P1|COMPLETED|Survival Follow-up|85 participants died and completed survival follow-up.|85
456674|NCT01271712|1118391|P2|STARTED|Survival Follow-up|All participants entered Survival Follow-up immediately after safety follow-up|39
456675|NCT01271712|1118392|P1|STARTED|Survival Follow-up|All participants entered Survival Follow-up immediately after safety follow-up|100
456676|NCT01271712|1118391|P2|NOT COMPLETED|Safety Follow-up||15
456677|NCT01271712|1118392|P1|NOT COMPLETED|Safety Follow-up||21
456678|NCT01271712|1118391|P2|COMPLETED|Safety Follow-up||37
456679|NCT01271712|1118392|P1|COMPLETED|Safety Follow-up||97
456680|NCT01271712|1118391|P2|STARTED|Safety Follow-up|All participants who discontinued study drug entered 30-day Safety Follow-up|52
456681|NCT01271712|1118392|P1|STARTED|Safety Follow-up|All participants who discontinued study drug entered 30-day Safety Follow-up|118
456682|NCT01271712|1118391|P2|NOT COMPLETED|Open Label Treatment||58
456683|NCT01271712|1118392|P1|NOT COMPLETED|Open Label Treatment||91
456684|NCT01271712|1118391|P2|COMPLETED|Open Label Treatment||0
456685|NCT01271712|1118392|P1|COMPLETED|Open Label Treatment||0
456686|NCT01271712|1118391|P2|STARTED|Open Label Treatment||58
456687|NCT01271712|1118392|P1|STARTED|Open Label Treatment||91
456688|NCT01271712|1118391|P2|NOT COMPLETED|Double Blind Treatment||8
456689|NCT01271712|1118392|P1|NOT COMPLETED|Double Blind Treatment||42
456690|NCT01271712|1118391|P2|COMPLETED|Double Blind Treatment|58 participants started open-label treatment with regorafenib|58
456691|NCT01271712|1118392|P1|COMPLETED|Double Blind Treatment|91 participants started open-label treatment with regorafenib|91
456692|NCT01271712|1118391|P2|Participants Received Treatment|Double Blind Treatment||66
456693|NCT01271712|1118392|P1|Participants Received Treatment|Double Blind Treatment||132
456694|NCT01271712|1118391|P2|STARTED|Double Blind Treatment||66
456695|NCT01271712|1118392|P1|STARTED|Double Blind Treatment||133
456696|NCT01271686|1118413|P1|NOT COMPLETED|Overall Study||0
456697|NCT01271686|1118413|P1|COMPLETED|Overall Study||16
456698|NCT01271686|1118413|P1|STARTED|Overall Study||16
456699|NCT01271543|1118419|P2|NOT COMPLETED|Overall Study||1
456700|NCT01271543|1118420|P1|NOT COMPLETED|Overall Study||1
456701|NCT01271543|1118419|P2|COMPLETED|Overall Study||29
456702|NCT01271543|1118420|P1|COMPLETED|Overall Study||29
456703|NCT01271543|1118419|P2|STARTED|Overall Study||30
456704|NCT01271543|1118420|P1|STARTED|Overall Study||30
456705|NCT01271452|1118430|P2|NOT COMPLETED|Overall Study||8
456706|NCT01271452|1118431|P1|NOT COMPLETED|Overall Study||7
456707|NCT01271452|1118430|P2|COMPLETED|Overall Study||104
456708|NCT01271452|1118431|P1|COMPLETED|Overall Study||105
456709|NCT01271452|1118430|P2|STARTED|Overall Study||112
456710|NCT01271452|1118431|P1|STARTED|Overall Study||112
456711|NCT01271413|1118453|P2|NOT COMPLETED|Overall Study||8
456712|NCT01271413|1118454|P1|NOT COMPLETED|Overall Study||9
456713|NCT01271413|1118453|P2|COMPLETED|Overall Study||28
456714|NCT01271413|1118454|P1|COMPLETED|Overall Study||28
456715|NCT01271413|1118453|P2|STARTED|Overall Study||36
456716|NCT01271413|1118454|P1|STARTED|Overall Study||37
456717|NCT01271244|1118462|P2|NOT COMPLETED|Overall Study||3
456718|NCT01271244|1118463|P1|NOT COMPLETED|Overall Study||7
456719|NCT01271244|1118462|P2|COMPLETED|Overall Study||5
456720|NCT01271244|1118463|P1|COMPLETED|Overall Study||11
456721|NCT01271244|1118462|P2|STARTED|Overall Study||8
456722|NCT01271244|1118463|P1|STARTED|Overall Study||18
456723|NCT01271036|1118471|P2|NOT COMPLETED|Overall Study||0
456724|NCT01271036|1118472|P1|NOT COMPLETED|Overall Study||0
456725|NCT01271036|1118471|P2|COMPLETED|Overall Study||62
456726|NCT01271036|1118472|P1|COMPLETED|Overall Study||62
456727|NCT01271036|1118471|P2|STARTED|Overall Study||62
456728|NCT01271036|1118472|P1|STARTED|Overall Study||62
456729|NCT01271010|1118486|P1|NOT COMPLETED|Overall Study||61
456730|NCT01271010|1118486|P1|COMPLETED|Overall Study||28
456731|NCT01271010|1118486|P1|STARTED|Overall Study||89
456732|NCT01270971|1118501|P2|NOT COMPLETED|Overall Study||23
456733|NCT01270971|1118502|P1|NOT COMPLETED|Overall Study||52
456734|NCT01270971|1118501|P2|COMPLETED|Overall Study||171
456735|NCT01270971|1118502|P1|COMPLETED|Overall Study||348
456736|NCT01270971|1118501|P2|STARTED|Overall Study||194
456737|NCT01270971|1118502|P1|STARTED|Overall Study||400
456738|NCT01270958|1118514|P1|NOT COMPLETED|Overall Study||4
456739|NCT01270958|1118514|P1|COMPLETED|Overall Study||56
456740|NCT01270958|1118514|P1|STARTED|Overall Study||60
456741|NCT01270919|1118538|P1|NOT COMPLETED|Overall Study||0
456742|NCT01270919|1118538|P1|COMPLETED|Overall Study||0
456743|NCT01270919|1118538|P1|STARTED|Overall Study|One participant was enrolled but was censored.|0
456744|NCT01270880|1118543|P1|NOT COMPLETED|Overall Study||1
456745|NCT01270880|1118543|P1|COMPLETED|Overall Study||17
456746|NCT01270880|1118543|P1|STARTED|Overall Study||18
456747|NCT01270867|1118549|P2|NOT COMPLETED|Overall Study||0
456748|NCT01270867|1118550|P1|NOT COMPLETED|Overall Study||1
456749|NCT01270867|1118549|P2|COMPLETED|Overall Study||88
456750|NCT01270867|1118550|P1|COMPLETED|Overall Study||89
456751|NCT01270867|1118549|P2|STARTED|Overall Study||88
456752|NCT01270867|1118550|P1|STARTED|Overall Study||90
456753|NCT01270841|1118568|P4|NOT COMPLETED|Overall Study||13
456754|NCT01270841|1118569|P3|NOT COMPLETED|Overall Study||11
456755|NCT01270841|1118570|P2|NOT COMPLETED|Overall Study||14
456756|NCT01270841|1118571|P1|NOT COMPLETED|Overall Study||13
456757|NCT01270841|1118568|P4|COMPLETED|Overall Study||20
456758|NCT01270841|1118569|P3|COMPLETED|Overall Study||18
456759|NCT01270841|1118570|P2|COMPLETED|Overall Study||19
456760|NCT01270841|1118571|P1|COMPLETED|Overall Study||16
456761|NCT01270841|1118568|P4|STARTED|Overall Study||33
456762|NCT01270841|1118569|P3|STARTED|Overall Study||29
456763|NCT01270841|1118570|P2|STARTED|Overall Study||33
456764|NCT01270841|1118571|P1|STARTED|Overall Study||29
456765|NCT01270828|1118595|P3|NOT COMPLETED|Double Blind Phase||0
456766|NCT01270828|1118596|P2|NOT COMPLETED|Double Blind Phase||45
456767|NCT01270828|1118597|P1|NOT COMPLETED|Double Blind Phase||26
456768|NCT01270828|1118595|P3|COMPLETED|Double Blind Phase||0
456769|NCT01270828|1118596|P2|COMPLETED|Double Blind Phase||160
456770|NCT01270828|1118597|P1|COMPLETED|Double Blind Phase||182
456771|NCT01270828|1118595|P3|STARTED|Double Blind Phase||0
456772|NCT01270828|1118596|P2|STARTED|Double Blind Phase||205
456773|NCT01270828|1118597|P1|STARTED|Double Blind Phase||208
456774|NCT01270828|1118595|P3|NOT COMPLETED|Pregabalin CR SB||146
456775|NCT01270828|1118596|P2|NOT COMPLETED|Pregabalin CR SB||0
456776|NCT01270828|1118597|P1|NOT COMPLETED|Pregabalin CR SB||0
456777|NCT01270828|1118595|P3|COMPLETED|Pregabalin CR SB||660
456778|NCT01270828|1118596|P2|COMPLETED|Pregabalin CR SB||0
456779|NCT01270828|1118597|P1|COMPLETED|Pregabalin CR SB||0
456780|NCT01270828|1118595|P3|STARTED|Pregabalin CR SB||806
456781|NCT01270828|1118596|P2|STARTED|Pregabalin CR SB||0
456782|NCT01270828|1118597|P1|STARTED|Pregabalin CR SB||0
456783|NCT01270802|1118639|P2|NOT COMPLETED|Overall Study||1
456784|NCT01270802|1118640|P1|NOT COMPLETED|Overall Study||2
456785|NCT01270802|1118639|P2|COMPLETED|Overall Study||14
456786|NCT01270802|1118640|P1|COMPLETED|Overall Study||13
456787|NCT01270802|1118639|P2|STARTED|Overall Study||15
456788|NCT01270802|1118640|P1|STARTED|Overall Study||15
456789|NCT01270711|1118656|P8|NOT COMPLETED|Part 2: Effectiveness||0
456790|NCT01270711|1118657|P7|NOT COMPLETED|Part 2: Effectiveness||0
456791|NCT01270711|1118658|P6|NOT COMPLETED|Part 2: Effectiveness||0
456792|NCT01270711|1118659|P5|NOT COMPLETED|Part 2: Effectiveness||0
456793|NCT01270711|1118660|P4|NOT COMPLETED|Part 2: Effectiveness||0
456794|NCT01270711|1118661|P3|NOT COMPLETED|Part 2: Effectiveness||0
456795|NCT01270711|1118662|P2|NOT COMPLETED|Part 2: Effectiveness||0
456796|NCT01270711|1118663|P1|NOT COMPLETED|Part 2: Effectiveness||0
456797|NCT01270711|1118656|P8|COMPLETED|Part 2: Effectiveness||48
456798|NCT01270711|1118657|P7|COMPLETED|Part 2: Effectiveness||2
456799|NCT01270711|1118658|P6|COMPLETED|Part 2: Effectiveness||11
456800|NCT01270711|1118659|P5|COMPLETED|Part 2: Effectiveness||0
456801|NCT01270711|1118660|P4|COMPLETED|Part 2: Effectiveness||0
456802|NCT01270711|1118661|P3|COMPLETED|Part 2: Effectiveness||0
456803|NCT01270711|1118662|P2|COMPLETED|Part 2: Effectiveness||0
456804|NCT01270711|1118663|P1|COMPLETED|Part 2: Effectiveness||0
456805|NCT01270711|1118656|P8|STARTED|Part 2: Effectiveness||48
456806|NCT01270711|1118657|P7|STARTED|Part 2: Effectiveness||2
456807|NCT01270711|1118658|P6|STARTED|Part 2: Effectiveness||11
456808|NCT01270711|1118659|P5|STARTED|Part 2: Effectiveness||0
456809|NCT01270711|1118660|P4|STARTED|Part 2: Effectiveness||0
456810|NCT01270711|1118661|P3|STARTED|Part 2: Effectiveness||0
456811|NCT01270711|1118662|P2|STARTED|Part 2: Effectiveness||0
456812|NCT01270711|1118663|P1|STARTED|Part 2: Effectiveness||0
456813|NCT01270711|1118656|P8|NOT COMPLETED|Part 1: Compliance||0
456814|NCT01270711|1118657|P7|NOT COMPLETED|Part 1: Compliance||0
456815|NCT01270711|1118658|P6|NOT COMPLETED|Part 1: Compliance||0
456816|NCT01270711|1118659|P5|NOT COMPLETED|Part 1: Compliance||0
456817|NCT01270711|1118660|P4|NOT COMPLETED|Part 1: Compliance||0
456818|NCT01270711|1118661|P3|NOT COMPLETED|Part 1: Compliance||0
456819|NCT01270711|1118662|P2|NOT COMPLETED|Part 1: Compliance||0
456820|NCT01270711|1118663|P1|NOT COMPLETED|Part 1: Compliance||0
456821|NCT01270711|1118656|P8|COMPLETED|Part 1: Compliance||0
456822|NCT01270711|1118657|P7|COMPLETED|Part 1: Compliance||0
456823|NCT01270711|1118658|P6|COMPLETED|Part 1: Compliance||0
456824|NCT01270711|1118659|P5|COMPLETED|Part 1: Compliance||2024
456825|NCT01270711|1118660|P4|COMPLETED|Part 1: Compliance||5486
456826|NCT01270711|1118661|P3|COMPLETED|Part 1: Compliance||326
456827|NCT01270711|1118662|P2|COMPLETED|Part 1: Compliance||6580
456828|NCT01270711|1118663|P1|COMPLETED|Part 1: Compliance||7537
456829|NCT01270711|1118656|P8|STARTED|Part 1: Compliance||0
456830|NCT01270711|1118657|P7|STARTED|Part 1: Compliance||0
456831|NCT01270711|1118658|P6|STARTED|Part 1: Compliance||0
456832|NCT01270711|1118659|P5|STARTED|Part 1: Compliance||2024
456833|NCT01270711|1118660|P4|STARTED|Part 1: Compliance||5486
456834|NCT01270711|1118661|P3|STARTED|Part 1: Compliance||326
456835|NCT01270711|1118662|P2|STARTED|Part 1: Compliance||6580
456836|NCT01270711|1118663|P1|STARTED|Part 1: Compliance||7537
456837|NCT01270659|1118764|P4|NOT COMPLETED|Overall Study||0
456838|NCT01270659|1118765|P3|NOT COMPLETED|Overall Study||0
456839|NCT01270659|1118766|P2|NOT COMPLETED|Overall Study||0
456840|NCT01270659|1118767|P1|NOT COMPLETED|Overall Study||0
456841|NCT01270659|1118764|P4|COMPLETED|Overall Study||25
456842|NCT01270659|1118765|P3|COMPLETED|Overall Study||4
456843|NCT01270659|1118766|P2|COMPLETED|Overall Study||25
456844|NCT01270659|1118767|P1|COMPLETED|Overall Study||6
456845|NCT01270659|1118764|P4|STARTED|Overall Study||25
456846|NCT01270659|1118765|P3|STARTED|Overall Study||4
456847|NCT01270659|1118766|P2|STARTED|Overall Study||25
456848|NCT01270659|1118767|P1|STARTED|Overall Study||6
456849|NCT01270620|1118787|P2|NOT COMPLETED|Overall Study||3
456850|NCT01270620|1118788|P1|NOT COMPLETED|Overall Study||1
456851|NCT01270620|1118787|P2|COMPLETED|Overall Study||47
456852|NCT01270620|1118788|P1|COMPLETED|Overall Study||49
456853|NCT01270620|1118787|P2|STARTED|Overall Study||50
456854|NCT01270620|1118788|P1|STARTED|Overall Study||50
456855|NCT01270581|1118840|P2|NOT COMPLETED|Overall Study||0
456856|NCT01270581|1118841|P1|NOT COMPLETED|Overall Study||1
456857|NCT01270581|1118840|P2|COMPLETED|Overall Study||3
456858|NCT01270581|1118841|P1|COMPLETED|Overall Study||3
456859|NCT01270581|1118840|P2|STARTED|Overall Study||3
456860|NCT01270581|1118841|P1|STARTED|Overall Study||4
456861|NCT01270555|1118847|P1|NOT COMPLETED|Overall Study||13
456862|NCT01270555|1118847|P1|COMPLETED|Overall Study||19
456863|NCT01270555|1118847|P1|STARTED|Overall Study||32
456864|NCT01270542|1118859|P2|NOT COMPLETED|Overall Study||1
456865|NCT01270542|1118860|P1|NOT COMPLETED|Overall Study||1
456866|NCT01270542|1118859|P2|COMPLETED|Overall Study||8
456867|NCT01270542|1118860|P1|COMPLETED|Overall Study||9
456868|NCT01270542|1118859|P2|STARTED|Overall Study||9
456869|NCT01270542|1118860|P1|STARTED|Overall Study||10
456870|NCT01270529|1118873|P3|NOT COMPLETED|Overall Study||0
456871|NCT01270529|1118874|P2|NOT COMPLETED|Overall Study||0
456872|NCT01270529|1118875|P1|NOT COMPLETED|Overall Study||0
456873|NCT01270529|1118873|P3|COMPLETED|Overall Study||25
456874|NCT01270529|1118874|P2|COMPLETED|Overall Study||7
456875|NCT01270529|1118875|P1|COMPLETED|Overall Study||12
456876|NCT01270529|1118873|P3|STARTED|Overall Study||25
456877|NCT01270529|1118874|P2|STARTED|Overall Study||7
456878|NCT01270529|1118875|P1|STARTED|Overall Study||12
456879|NCT01270503|1118883|P1|NOT COMPLETED|Overall Study||1
456880|NCT01270503|1118883|P1|COMPLETED|Overall Study||537
456881|NCT01270503|1118883|P1|STARTED|Overall Study||538
456882|NCT01270464|1118891|P3|NOT COMPLETED|Overall Study||18
456883|NCT01270464|1118892|P2|NOT COMPLETED|Overall Study||12
456884|NCT01270464|1118893|P1|NOT COMPLETED|Overall Study||20
456885|NCT01270464|1118891|P3|COMPLETED|Overall Study||88
456886|NCT01270464|1118892|P2|COMPLETED|Overall Study||92
456887|NCT01270464|1118893|P1|COMPLETED|Overall Study||85
456888|NCT01270464|1118891|P3|Pharmacokinetic Analysis Set|Overall Study||103
456889|NCT01270464|1118892|P2|Pharmacokinetic Analysis Set|Overall Study||103
456890|NCT01270464|1118893|P1|Pharmacokinetic Analysis Set|Overall Study||105
456891|NCT01270464|1118891|P3|Full Analysis Set|Overall Study||103
456892|NCT01270464|1118892|P2|Full Analysis Set|Overall Study||103
456893|NCT01270464|1118893|P1|Full Analysis Set|Overall Study||105
456894|NCT01270464|1118891|P3|Safety Analysis Set|Overall Study||103
456895|NCT01270464|1118892|P2|Safety Analysis Set|Overall Study||103
456896|NCT01270464|1118893|P1|Safety Analysis Set|Overall Study||105
456897|NCT01270464|1118891|P3|STARTED|Overall Study||106
456898|NCT01270464|1118892|P2|STARTED|Overall Study||104
456899|NCT01270464|1118893|P1|STARTED|Overall Study||105
456900|NCT01270256|1118942|P2|NOT COMPLETED|Overall Study||0
456901|NCT01270256|1118943|P1|NOT COMPLETED|Overall Study||1
456902|NCT01270256|1118942|P2|COMPLETED|Overall Study||20
456903|NCT01270256|1118943|P1|COMPLETED|Overall Study||20
456904|NCT01270256|1118942|P2|STARTED|Overall Study||20
456905|NCT01270256|1118943|P1|STARTED|Overall Study||21
456906|NCT01270139|1118952|P3|NOT COMPLETED|Overall Study||20
456907|NCT01270139|1118953|P2|NOT COMPLETED|Overall Study||26
456908|NCT01270139|1118954|P1|NOT COMPLETED|Overall Study||18
456909|NCT01270139|1118952|P3|COMPLETED|Overall Study|Pre-treatment evaluable population|40
456910|NCT01270139|1118953|P2|COMPLETED|Overall Study|Pre-treatment evaluable population|34
456911|NCT01270139|1118954|P1|COMPLETED|Overall Study|Pre-treatment evaluable population|42
456912|NCT01270139|1118952|P3|STARTED|Overall Study|Intention-to-treat population|60
456913|NCT01270139|1118953|P2|STARTED|Overall Study|Intention-to-treat population|60
456914|NCT01270139|1118954|P1|STARTED|Overall Study|Intention-to-treat population|60
456915|NCT01270126|1119014|P2|NOT COMPLETED|Overall Study||0
456916|NCT01270126|1119015|P1|NOT COMPLETED|Overall Study||0
456917|NCT01270126|1119014|P2|COMPLETED|Overall Study||10
456918|NCT01270126|1119015|P1|COMPLETED|Overall Study||12
456919|NCT01270126|1119014|P2|STARTED|Overall Study||10
456920|NCT01270126|1119015|P1|STARTED|Overall Study||12
456921|NCT01269918|1119023|P2|NOT COMPLETED|Overall Study||3
456922|NCT01269918|1119024|P1|NOT COMPLETED|Overall Study||0
456923|NCT01269918|1119023|P2|COMPLETED|Overall Study||68
456924|NCT01269918|1119024|P1|COMPLETED|Overall Study||71
456925|NCT01269918|1119023|P2|STARTED|Overall Study||71
456926|NCT01269918|1119024|P1|STARTED|Overall Study||71
456927|NCT01269801|1119058|P2|NOT COMPLETED|Overall Study||3
456928|NCT01269801|1119059|P1|NOT COMPLETED|Overall Study||0
456929|NCT01269801|1119058|P2|COMPLETED|Overall Study||77
456930|NCT01269801|1119059|P1|COMPLETED|Overall Study||74
456931|NCT01269801|1119058|P2|STARTED|Overall Study||80
456932|NCT01269801|1119059|P1|STARTED|Overall Study||74
456933|NCT01269749|1119067|P2|NOT COMPLETED|Overall Study||0
456934|NCT01269749|1119068|P1|NOT COMPLETED|Overall Study||0
456935|NCT01269749|1119067|P2|COMPLETED|Overall Study||3
456936|NCT01269749|1119068|P1|COMPLETED|Overall Study||16
456937|NCT01269749|1119067|P2|STARTED|Overall Study||3
456938|NCT01269749|1119068|P1|STARTED|Overall Study||16
456939|NCT01269736|1119078|P2|NOT COMPLETED|Patient Outcomes (Hospital Admissions)||0
456940|NCT01269736|1119079|P1|NOT COMPLETED|Patient Outcomes (Hospital Admissions)||0
456941|NCT01269736|1119078|P2|COMPLETED|Patient Outcomes (Hospital Admissions)|43799 unique patients assessed overall (at any time point) by end of study.|43799
456942|NCT01269736|1119079|P1|COMPLETED|Patient Outcomes (Hospital Admissions)|52085 unique patients assessed overall (at any time point) by end of study.|52085
456943|NCT01269736|1119078|P2|30 Months Assessment|Patient Outcomes (Hospital Admissions)|13265 unique patients, assessed at 6 hospitals.|13265
456944|NCT01269736|1119079|P1|30 Months Assessment|Patient Outcomes (Hospital Admissions)|16702 unique patients, assessed at 7 hospitals.|16702
456945|NCT01269736|1119078|P2|15 Months Assessment|Patient Outcomes (Hospital Admissions)|14075 unique patients, assessed at 6 hospitals.|14075
456946|NCT01269736|1119079|P1|15 Months Assessment|Patient Outcomes (Hospital Admissions)|18031 unique patients, assessed at 7 hospitals.|18031
456947|NCT01269736|1119078|P2|Baseline Assessment|Patient Outcomes (Hospital Admissions)|16549 unique patients, assessed at 6 hospitals.|16549
456948|NCT01269736|1119079|P1|Baseline Assessment|Patient Outcomes (Hospital Admissions)|17352 unique patients, assessed at 7 hospitals.|17352
456949|NCT01269736|1119078|P2|STARTED|Patient Outcomes (Hospital Admissions)|16459 unique patients were assessed at 6 hospitals at the initiation of the study.|43799
456950|NCT01269736|1119079|P1|STARTED|Patient Outcomes (Hospital Admissions)|17352 unique patients were assessed at 7 hospitals at the initiation of the study.|52085
456951|NCT01269736|1119078|P2|NOT COMPLETED|Patient Quality of Care Assessments||0
456952|NCT01269736|1119079|P1|NOT COMPLETED|Patient Quality of Care Assessments||0
456953|NCT01269736|1119078|P2|COMPLETED|Patient Quality of Care Assessments|2288 unique patients assessed overall (at any time point) by end of study.|2288
456954|NCT01269736|1119079|P1|COMPLETED|Patient Quality of Care Assessments|2299 unique patients assessed overall (at any time point) by end of study.|2299
456955|NCT01269736|1119078|P2|30 Months Assessment|Patient Quality of Care Assessments|626 unique patients, assessed at 7 hospitals.|626
456956|NCT01269736|1119079|P1|30 Months Assessment|Patient Quality of Care Assessments|697 unique patients, assessed at 8 hospitals.|697
456957|NCT01269736|1119078|P2|15 Months Assessment|Patient Quality of Care Assessments|773 unique patients, assessed at 8 hospitals.|773
456958|NCT01269736|1119079|P1|15 Months Assessment|Patient Quality of Care Assessments|687 unique patients, assessed at 8 hospitals.|687
456959|NCT01269736|1119078|P2|Baseline Assessment|Patient Quality of Care Assessments|889 unique patients, assessed at 8 hospitals.|889
456960|NCT01269736|1119079|P1|Baseline Assessment|Patient Quality of Care Assessments|915 unique patients, assessed at 9 hospitals.|915
456961|NCT01269736|1119078|P2|STARTED|Patient Quality of Care Assessments|889 unique patients were assessed at 8 hospitals at the initiation of the study.|2288
456962|NCT01269736|1119079|P1|STARTED|Patient Quality of Care Assessments|915 unique patients were assessed at 9 hospitals at the initiation of the study.|2299
456963|NCT01269736|1119078|P2|NOT COMPLETED|Nurses' Knowledge Assessments||0
456964|NCT01269736|1119079|P1|NOT COMPLETED|Nurses' Knowledge Assessments||0
456965|NCT01269736|1119078|P2|COMPLETED|Nurses' Knowledge Assessments|1428 unique nurses assessed overall (at any time point) by end of study.|1428
456966|NCT01269736|1119079|P1|COMPLETED|Nurses' Knowledge Assessments|1585 unique nurses assessed overall (at any time point) by end of study.|1585
456967|NCT01269736|1119078|P2|30 Months Assessment|Nurses' Knowledge Assessments|926 unique nurses, assessed at 8 hospitals.|926
456968|NCT01269736|1119079|P1|30 Months Assessment|Nurses' Knowledge Assessments|741 unique nurses, assessed at 8 hospitals.|741
456969|NCT01269736|1119078|P2|15 Months Assessment|Nurses' Knowledge Assessments|866 unique nurses, assessed at 8 hospitals.|782
456970|NCT01269736|1119079|P1|15 Months Assessment|Nurses' Knowledge Assessments|1108 unique nurses, assessed at 9 hospitals.|1108
456971|NCT01269736|1119078|P2|Baseline Assessment|Nurses' Knowledge Assessments|866 unique nurses, assessed at 8 hospitals.|866
456972|NCT01269736|1119079|P1|Baseline Assessment|Nurses' Knowledge Assessments|873 unique nurses, assessed at 9 hospitals.|873
456973|NCT01269736|1119078|P2|STARTED|Nurses' Knowledge Assessments|866 unique nurses were assessed at 8 hospitals at the initiation of the study.|1428
456974|NCT01269736|1119079|P1|STARTED|Nurses' Knowledge Assessments|873 unique nurses were assessed at 9 hospitals at the initiation of the study.|1585
456975|NCT01269710|1119091|P1|NOT COMPLETED|Overall Study||3
456976|NCT01269710|1119091|P1|COMPLETED|Overall Study|This refers to Week 52.|1
456977|NCT01269710|1119091|P1|Week 36|Overall Study||2
456978|NCT01269710|1119091|P1|Week 12|Overall Study||3
456979|NCT01269710|1119091|P1|STARTED|Overall Study||4
456980|NCT01269346|1119099|P1|NOT COMPLETED|Extension Phase||43
456981|NCT01269346|1119099|P1|COMPLETED|Extension Phase||0
456982|NCT01269346|1119099|P1|STARTED|Extension Phase|Out of 52 participants randomized, only 43 continued into the Extension Phase of the study.|43
456983|NCT01269346|1119099|P1|NOT COMPLETED|Treatment Phase||9
456984|NCT01269346|1119099|P1|COMPLETED|Treatment Phase||43
456985|NCT01269346|1119099|P1|Completed 6 Cycles|Treatment Phase||45
456986|NCT01269346|1119099|P1|STARTED|Treatment Phase||52
456987|NCT01269125|1119110|P3|NOT COMPLETED|Overall Study||0
456988|NCT01269125|1119111|P2|NOT COMPLETED|Overall Study||5
456989|NCT01269125|1119112|P1|NOT COMPLETED|Overall Study||7
456990|NCT01269125|1119110|P3|COMPLETED|Overall Study||60
456991|NCT01269125|1119111|P2|COMPLETED|Overall Study|OHSS:4; premature luteinization: 1|55
456992|NCT01269125|1119112|P1|COMPLETED|Overall Study|lost to follow up:4; OHSS: 2; premature luteinization: 1|53
456993|NCT01269125|1119110|P3|STARTED|Overall Study||60
456994|NCT01269125|1119111|P2|STARTED|Overall Study||60
456995|NCT01269125|1119112|P1|STARTED|Overall Study||60
456996|NCT01269047|1119135|P3|NOT COMPLETED|Overall Study||1
456997|NCT01269047|1119136|P2|NOT COMPLETED|Overall Study||2
456998|NCT01269047|1119137|P1|NOT COMPLETED|Overall Study||1
456999|NCT01269047|1119135|P3|COMPLETED|Overall Study||10
457000|NCT01269047|1119136|P2|COMPLETED|Overall Study||11
457001|NCT01269047|1119137|P1|COMPLETED|Overall Study||12
457002|NCT01269047|1119135|P3|STARTED|Overall Study||11
457003|NCT01269047|1119136|P2|STARTED|Overall Study||13
457004|NCT01269047|1119137|P1|STARTED|Overall Study||13
457005|NCT01268943|1119156|P4|NOT COMPLETED|Overall Study||0
457006|NCT01268943|1119157|P3|NOT COMPLETED|Overall Study||0
457007|NCT01268943|1119158|P2|NOT COMPLETED|Overall Study||0
457008|NCT01268943|1119159|P1|NOT COMPLETED|Overall Study||0
457009|NCT01268943|1119156|P4|COMPLETED|Overall Study||6
457010|NCT01268943|1119157|P3|COMPLETED|Overall Study||3
457011|NCT01268943|1119158|P2|COMPLETED|Overall Study||3
457012|NCT01268943|1119159|P1|COMPLETED|Overall Study||6
457013|NCT01268943|1119156|P4|STARTED|Overall Study||6
457014|NCT01268943|1119157|P3|STARTED|Overall Study||3
457015|NCT01268943|1119158|P2|STARTED|Overall Study||3
457016|NCT01268943|1119159|P1|STARTED|Overall Study||6
457017|NCT01268891|1119171|P2|NOT COMPLETED|Overall Study||8
457018|NCT01268891|1119172|P1|NOT COMPLETED|Overall Study||8
457019|NCT01268891|1119171|P2|COMPLETED|Overall Study||58
457020|NCT01268891|1119172|P1|COMPLETED|Overall Study||58
457021|NCT01268891|1119171|P2|STARTED|Overall Study||66
457022|NCT01268891|1119172|P1|STARTED|Overall Study||66
457023|NCT01268683|1119184|P1|NOT COMPLETED|Overall Study||0
457024|NCT01268683|1119184|P1|COMPLETED|Overall Study||10
457025|NCT01268683|1119184|P1|STARTED|Overall Study||10
457026|NCT01268566|1119191|P1|NOT COMPLETED|Overall Study||43
457027|NCT01268566|1119191|P1|COMPLETED|Overall Study||13
457028|NCT01268566|1119191|P1|STARTED|Overall Study||56
457029|NCT01268553|1119209|P1|NOT COMPLETED|Overall Study||0
457030|NCT01268553|1119209|P1|COMPLETED|Overall Study||6
457031|NCT01268553|1119209|P1|STARTED|Overall Study||6
457032|NCT01268501|1119218|P1|NOT COMPLETED|Overall Study||9
457033|NCT01268501|1119218|P1|COMPLETED|Overall Study||87
457034|NCT01268501|1119218|P1|STARTED|Overall Study||96
457035|NCT01268488|1119222|P1|NOT COMPLETED|Overall Study||5
457036|NCT01268488|1119222|P1|COMPLETED|Overall Study||93
457037|NCT01268488|1119222|P1|STARTED|Overall Study||98
457038|NCT01268306|1119229|P1|NOT COMPLETED|Overall Study||1
457039|NCT01268306|1119229|P1|COMPLETED|Overall Study||7
457040|NCT01268306|1119229|P1|STARTED|Overall Study||8
457041|NCT01268293|1119233|P1|NOT COMPLETED|Overall Study||9
457042|NCT01268293|1119233|P1|COMPLETED|Overall Study||0
457043|NCT01268293|1119233|P1|Completed Cycle 1|Overall Study||9
457044|NCT01268293|1119233|P1|STARTED|Overall Study||9
457045|NCT01268267|1119238|P1|NOT COMPLETED|Overall Study||1
457046|NCT01268267|1119238|P1|COMPLETED|Overall Study||93
457047|NCT01268267|1119238|P1|STARTED|Overall Study||94
457048|NCT01268189|1119245|P1|NOT COMPLETED|Overall Study||3
457049|NCT01268189|1119245|P1|COMPLETED|Overall Study||17
457050|NCT01268189|1119245|P1|STARTED|Overall Study||20
457051|NCT01268150|1119259|P1|NOT COMPLETED|Extension Phase||27
457052|NCT01268150|1119259|P1|COMPLETED|Extension Phase||1
457053|NCT01268150|1119259|P1|Treatment Ongoing at Data Cutoff Date|Extension Phase||1
457054|NCT01268150|1119259|P1|STARTED|Extension Phase|28 participants discontinued study drug in Treatment Phase so did not enter the Extension Phase|28
457055|NCT01268150|1119259|P1|NOT COMPLETED|Treatment Phase||28
457056|NCT01268150|1119259|P1|COMPLETED|Treatment Phase||28
457057|NCT01268150|1119259|P1|STARTED|Treatment Phase||56
457058|NCT01268111|1119269|P2|NOT COMPLETED|Overall Study||0
457059|NCT01268111|1119270|P1|NOT COMPLETED|Overall Study||0
457060|NCT01268111|1119269|P2|COMPLETED|Overall Study||6
457061|NCT01268111|1119270|P1|COMPLETED|Overall Study||6
457062|NCT01268111|1119269|P2|STARTED|Overall Study||6
457063|NCT01268111|1119270|P1|STARTED|Overall Study||6
457064|NCT01268098|1119278|P2|NOT COMPLETED|Overall Study||0
457065|NCT01268098|1119279|P1|NOT COMPLETED|Overall Study||1
457066|NCT01268098|1119278|P2|COMPLETED|Overall Study||23
457067|NCT01268098|1119279|P1|COMPLETED|Overall Study||18
457068|NCT01268098|1119278|P2|STARTED|Overall Study||23
457069|NCT01268098|1119279|P1|STARTED|Overall Study||19
457070|NCT01267994|1119287|P1|NOT COMPLETED|Overall Study||2
457071|NCT01267994|1119287|P1|COMPLETED|Overall Study|Excluded from analysis, could not reach first milestone (day 28) for efficacy assessment, n=2|10
457072|NCT01267994|1119287|P1|STARTED|Overall Study|Declined to participate. n=1 Did not receive intervention due to infeciton, n=1|12
457073|NCT01267929|1119294|P2|NOT COMPLETED|Overall Study||0
457074|NCT01267929|1119295|P1|NOT COMPLETED|Overall Study||0
457075|NCT01267929|1119294|P2|COMPLETED|Overall Study||15
457076|NCT01267929|1119295|P1|COMPLETED|Overall Study||15
457077|NCT01267929|1119294|P2|STARTED|Overall Study||15
457078|NCT01267929|1119295|P1|STARTED|Overall Study||15
457079|NCT01267864|1119304|P3|NOT COMPLETED|Overall Study||0
457080|NCT01267864|1119305|P2|NOT COMPLETED|Overall Study||0
457081|NCT01267864|1119306|P1|NOT COMPLETED|Overall Study||0
457082|NCT01267864|1119304|P3|COMPLETED|Overall Study||110
457083|NCT01267864|1119305|P2|COMPLETED|Overall Study||110
457084|NCT01267864|1119306|P1|COMPLETED|Overall Study||110
457085|NCT01267864|1119304|P3|STARTED|Overall Study||110
457086|NCT01267864|1119305|P2|STARTED|Overall Study||110
457087|NCT01267864|1119306|P1|STARTED|Overall Study||110
457088|NCT01267825|1119325|P2|NOT COMPLETED|Overall Study||0
457089|NCT01267825|1119326|P1|NOT COMPLETED|Overall Study||0
457090|NCT01267825|1119325|P2|COMPLETED|Overall Study||0
457091|NCT01267825|1119326|P1|COMPLETED|Overall Study||0
457092|NCT01267825|1119325|P2|STARTED|Overall Study||0
457093|NCT01267825|1119326|P1|STARTED|Overall Study||0
457094|NCT01267422|1119336|P2|NOT COMPLETED|Safety and Efficacy Study||0
457095|NCT01267422|1119337|P1|NOT COMPLETED|Safety and Efficacy Study||0
457096|NCT01267422|1119336|P2|COMPLETED|Safety and Efficacy Study||4
457097|NCT01267422|1119337|P1|COMPLETED|Safety and Efficacy Study||5
457098|NCT01267422|1119336|P2|STARTED|Safety and Efficacy Study||4
457099|NCT01267422|1119337|P1|STARTED|Safety and Efficacy Study||5
457100|NCT01267422|1119336|P2|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0
457101|NCT01267422|1119337|P1|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0
457102|NCT01267422|1119336|P2|COMPLETED|Intravitreal rAAV2-ND4 Injection||4
457103|NCT01267422|1119337|P1|COMPLETED|Intravitreal rAAV2-ND4 Injection||5
457104|NCT01267422|1119336|P2|STARTED|Intravitreal rAAV2-ND4 Injection||4
457105|NCT01267422|1119337|P1|STARTED|Intravitreal rAAV2-ND4 Injection||5
457106|NCT01267292|1119357|P2|NOT COMPLETED|Overall Study||6
457107|NCT01267292|1119358|P1|NOT COMPLETED|Overall Study||4
457108|NCT01267292|1119357|P2|COMPLETED|Overall Study||20
457109|NCT01267292|1119358|P1|COMPLETED|Overall Study||20
457110|NCT01267292|1119357|P2|STARTED|Overall Study||26
457111|NCT01267292|1119358|P1|STARTED|Overall Study||24
457112|NCT01267266|1119392|P2|NOT COMPLETED|Randomized Phase||0
457113|NCT01267266|1119393|P1|NOT COMPLETED|Randomized Phase||0
457114|NCT01267266|1119392|P2|COMPLETED|Randomized Phase||5
457115|NCT01267266|1119393|P1|COMPLETED|Randomized Phase||3
457116|NCT01267266|1119392|P2|STARTED|Randomized Phase|5 of 8 patients randomized to placebo.|5
457117|NCT01267266|1119393|P1|STARTED|Randomized Phase|3 of 8 patients randomized to saracatinib.|3
457118|NCT01267266|1119392|P2|NOT COMPLETED|Lead-in Phase||0
457119|NCT01267266|1119393|P1|NOT COMPLETED|Lead-in Phase||23
457120|NCT01267266|1119392|P2|COMPLETED|Lead-in Phase||0
457121|NCT01267266|1119393|P1|COMPLETED|Lead-in Phase|12 patients had radiographic progression, 8 clinical progression, 2 toxicity, 1 withdrawal.|8
457122|NCT01267266|1119392|P2|STARTED|Lead-in Phase||0
457123|NCT01267266|1119393|P1|STARTED|Lead-in Phase||31
457124|NCT01267266|1119392|P2|NOT COMPLETED|Enrollment Phase||0
457125|NCT01267266|1119393|P1|NOT COMPLETED|Enrollment Phase||2
457126|NCT01267266|1119392|P2|COMPLETED|Enrollment Phase||0
457127|NCT01267266|1119393|P1|COMPLETED|Enrollment Phase|Two patients signed consent but did not proceed to treatment.|31
457128|NCT01267266|1119392|P2|STARTED|Enrollment Phase||0
457129|NCT01267266|1119393|P1|STARTED|Enrollment Phase||33
457130|NCT01267253|1119406|P1|NOT COMPLETED|Overall Study||3
457131|NCT01267253|1119406|P1|COMPLETED|Overall Study|Eligible and treated patients|28
457132|NCT01267253|1119406|P1|STARTED|Overall Study||31
457133|NCT01267240|1119414|P1|NOT COMPLETED|Overall Study||0
457134|NCT01267240|1119414|P1|COMPLETED|Overall Study||25
457135|NCT01267240|1119414|P1|STARTED|Overall Study||25
457136|NCT01267227|1119424|P4|NOT COMPLETED|Overall Study||3
457137|NCT01267227|1119425|P3|NOT COMPLETED|Overall Study||2
457138|NCT01267227|1119426|P2|NOT COMPLETED|Overall Study||1
457139|NCT01267227|1119427|P1|NOT COMPLETED|Overall Study||1
457140|NCT01267227|1119424|P4|COMPLETED|Overall Study||17
457141|NCT01267227|1119425|P3|COMPLETED|Overall Study||18
457142|NCT01267227|1119426|P2|COMPLETED|Overall Study||19
457143|NCT01267227|1119427|P1|COMPLETED|Overall Study||19
457144|NCT01267227|1119424|P4|STARTED|Overall Study||20
457145|NCT01267227|1119425|P3|STARTED|Overall Study||20
457146|NCT01267227|1119426|P2|STARTED|Overall Study||20
457147|NCT01267227|1119427|P1|STARTED|Overall Study||20
457148|NCT01267201|1119445|P6|NOT COMPLETED|Third Intervention Period||0
457149|NCT01267201|1119446|P5|NOT COMPLETED|Third Intervention Period||0
457150|NCT01267201|1119447|P4|NOT COMPLETED|Third Intervention Period||0
457151|NCT01267201|1119448|P3|NOT COMPLETED|Third Intervention Period||0
457152|NCT01267201|1119449|P2|NOT COMPLETED|Third Intervention Period||0
457153|NCT01267201|1119450|P1|NOT COMPLETED|Third Intervention Period||0
457154|NCT01267201|1119445|P6|COMPLETED|Third Intervention Period||4
457155|NCT01267201|1119446|P5|COMPLETED|Third Intervention Period||4
457156|NCT01267201|1119447|P4|COMPLETED|Third Intervention Period||4
457157|NCT01267201|1119448|P3|COMPLETED|Third Intervention Period||4
457158|NCT01267201|1119449|P2|COMPLETED|Third Intervention Period||3
457159|NCT01267201|1119450|P1|COMPLETED|Third Intervention Period||3
457160|NCT01267201|1119445|P6|STARTED|Third Intervention Period||4
457161|NCT01267201|1119446|P5|STARTED|Third Intervention Period||4
457162|NCT01267201|1119447|P4|STARTED|Third Intervention Period||4
457163|NCT01267201|1119448|P3|STARTED|Third Intervention Period||4
457164|NCT01267201|1119449|P2|STARTED|Third Intervention Period||3
457165|NCT01267201|1119450|P1|STARTED|Third Intervention Period||3
457166|NCT01267201|1119445|P6|NOT COMPLETED|Washout Period (At Least 2 Days)||0
457167|NCT01267201|1119446|P5|NOT COMPLETED|Washout Period (At Least 2 Days)||0
457168|NCT01267201|1119447|P4|NOT COMPLETED|Washout Period (At Least 2 Days)||0
457169|NCT01267201|1119448|P3|NOT COMPLETED|Washout Period (At Least 2 Days)||0
457170|NCT01267201|1119449|P2|NOT COMPLETED|Washout Period (At Least 2 Days)||0
457171|NCT01267201|1119450|P1|NOT COMPLETED|Washout Period (At Least 2 Days)||0
457172|NCT01267201|1119445|P6|COMPLETED|Washout Period (At Least 2 Days)||4
457173|NCT01267201|1119446|P5|COMPLETED|Washout Period (At Least 2 Days)||4
457174|NCT01267201|1119447|P4|COMPLETED|Washout Period (At Least 2 Days)||4
457175|NCT01267201|1119448|P3|COMPLETED|Washout Period (At Least 2 Days)||4
457176|NCT01267201|1119449|P2|COMPLETED|Washout Period (At Least 2 Days)||3
457177|NCT01267201|1119450|P1|COMPLETED|Washout Period (At Least 2 Days)||3
457178|NCT01267201|1119445|P6|STARTED|Washout Period (At Least 2 Days)||4
457179|NCT01267201|1119446|P5|STARTED|Washout Period (At Least 2 Days)||4
457180|NCT01267201|1119447|P4|STARTED|Washout Period (At Least 2 Days)||4
457181|NCT01267201|1119448|P3|STARTED|Washout Period (At Least 2 Days)||4
457182|NCT01267201|1119449|P2|STARTED|Washout Period (At Least 2 Days)||3
457183|NCT01267201|1119450|P1|STARTED|Washout Period (At Least 2 Days)||3
457184|NCT01267201|1119445|P6|NOT COMPLETED|Second Intervention Period||0
457185|NCT01267201|1119446|P5|NOT COMPLETED|Second Intervention Period||0
457186|NCT01267201|1119447|P4|NOT COMPLETED|Second Intervention Period||0
457187|NCT01267201|1119448|P3|NOT COMPLETED|Second Intervention Period||0
457188|NCT01267201|1119449|P2|NOT COMPLETED|Second Intervention Period||1
457189|NCT01267201|1119450|P1|NOT COMPLETED|Second Intervention Period||0
457190|NCT01267201|1119445|P6|COMPLETED|Second Intervention Period||4
457191|NCT01267201|1119446|P5|COMPLETED|Second Intervention Period||4
457192|NCT01267201|1119447|P4|COMPLETED|Second Intervention Period||4
457193|NCT01267201|1119448|P3|COMPLETED|Second Intervention Period||4
457194|NCT01267201|1119449|P2|COMPLETED|Second Intervention Period||3
457195|NCT01267201|1119450|P1|COMPLETED|Second Intervention Period||3
457196|NCT01267201|1119445|P6|STARTED|Second Intervention Period||4
457197|NCT01267201|1119446|P5|STARTED|Second Intervention Period||4
457198|NCT01267201|1119447|P4|STARTED|Second Intervention Period||4
457199|NCT01267201|1119448|P3|STARTED|Second Intervention Period||4
457200|NCT01267201|1119449|P2|STARTED|Second Intervention Period||4
457201|NCT01267201|1119450|P1|STARTED|Second Intervention Period||3
457202|NCT01267201|1119445|P6|NOT COMPLETED|Washout Period (At Least 2 Days)||0
457203|NCT01267201|1119446|P5|NOT COMPLETED|Washout Period (At Least 2 Days)||0
457204|NCT01267201|1119447|P4|NOT COMPLETED|Washout Period (At Least 2 Days)||0
457205|NCT01267201|1119448|P3|NOT COMPLETED|Washout Period (At Least 2 Days)||0
457206|NCT01267201|1119449|P2|NOT COMPLETED|Washout Period (At Least 2 Days)||0
457207|NCT01267201|1119450|P1|NOT COMPLETED|Washout Period (At Least 2 Days)||0
457208|NCT01267201|1119445|P6|COMPLETED|Washout Period (At Least 2 Days)||4
457209|NCT01267201|1119446|P5|COMPLETED|Washout Period (At Least 2 Days)||4
457210|NCT01267201|1119447|P4|COMPLETED|Washout Period (At Least 2 Days)||4
457211|NCT01267201|1119448|P3|COMPLETED|Washout Period (At Least 2 Days)||4
457212|NCT01267201|1119449|P2|COMPLETED|Washout Period (At Least 2 Days)||4
457213|NCT01267201|1119450|P1|COMPLETED|Washout Period (At Least 2 Days)||3
457214|NCT01267201|1119445|P6|STARTED|Washout Period (At Least 2 Days)||4
457215|NCT01267201|1119446|P5|STARTED|Washout Period (At Least 2 Days)||4
457216|NCT01267201|1119447|P4|STARTED|Washout Period (At Least 2 Days)||4
457217|NCT01267201|1119448|P3|STARTED|Washout Period (At Least 2 Days)||4
457218|NCT01267201|1119449|P2|STARTED|Washout Period (At Least 2 Days)||4
457219|NCT01267201|1119450|P1|STARTED|Washout Period (At Least 2 Days)||3
457220|NCT01267201|1119445|P6|NOT COMPLETED|First Intervention Period||0
457221|NCT01267201|1119446|P5|NOT COMPLETED|First Intervention Period||0
457222|NCT01267201|1119447|P4|NOT COMPLETED|First Intervention Period||0
457223|NCT01267201|1119448|P3|NOT COMPLETED|First Intervention Period||0
457224|NCT01267201|1119449|P2|NOT COMPLETED|First Intervention Period||0
457225|NCT01267201|1119450|P1|NOT COMPLETED|First Intervention Period||1
457226|NCT01267201|1119445|P6|COMPLETED|First Intervention Period||4
457227|NCT01267201|1119446|P5|COMPLETED|First Intervention Period||4
457228|NCT01267201|1119447|P4|COMPLETED|First Intervention Period||4
457229|NCT01267201|1119448|P3|COMPLETED|First Intervention Period||4
457230|NCT01267201|1119449|P2|COMPLETED|First Intervention Period||4
457231|NCT01267201|1119450|P1|COMPLETED|First Intervention Period||3
457232|NCT01267201|1119445|P6|STARTED|First Intervention Period||4
457233|NCT01267201|1119446|P5|STARTED|First Intervention Period||4
457234|NCT01267201|1119447|P4|STARTED|First Intervention Period||4
457235|NCT01267201|1119448|P3|STARTED|First Intervention Period||4
457236|NCT01267201|1119449|P2|STARTED|First Intervention Period||4
457237|NCT01267201|1119450|P1|STARTED|First Intervention Period||4
457238|NCT01267175|1119467|P1|NOT COMPLETED|Overall Study||2
457239|NCT01267175|1119467|P1|COMPLETED|Overall Study||29
457240|NCT01267175|1119467|P1|STARTED|Overall Study||31
457241|NCT01267136|1119474|P2|NOT COMPLETED|Overall Study||6
457242|NCT01267136|1119475|P1|NOT COMPLETED|Overall Study||4
457243|NCT01267136|1119474|P2|COMPLETED|Overall Study||36
457244|NCT01267136|1119475|P1|COMPLETED|Overall Study||38
457245|NCT01267136|1119474|P2|STARTED|Overall Study||42
457246|NCT01267136|1119475|P1|STARTED|Overall Study||42
457247|NCT01267045|1119485|P2|NOT COMPLETED|6-month Outcome||3
457248|NCT01267045|1119486|P1|NOT COMPLETED|6-month Outcome||0
457249|NCT01267045|1119485|P2|COMPLETED|6-month Outcome||23
457250|NCT01267045|1119486|P1|COMPLETED|6-month Outcome||22
457251|NCT01267045|1119485|P2|STARTED|6-month Outcome||26
457252|NCT01267045|1119486|P1|STARTED|6-month Outcome||22
457253|NCT01267045|1119485|P2|NOT COMPLETED|2-month Outcomes||3
457254|NCT01267045|1119486|P1|NOT COMPLETED|2-month Outcomes||4
457255|NCT01267045|1119485|P2|COMPLETED|2-month Outcomes||26
457256|NCT01267045|1119486|P1|COMPLETED|2-month Outcomes||22
457257|NCT01267045|1119485|P2|STARTED|2-month Outcomes||29
457258|NCT01267045|1119486|P1|STARTED|2-month Outcomes||26
457259|NCT01267019|1119521|P3|NOT COMPLETED|Overall Study||6
457260|NCT01267019|1119522|P2|NOT COMPLETED|Overall Study||6
457261|NCT01267019|1119523|P1|NOT COMPLETED|Overall Study||6
457262|NCT01267019|1119521|P3|COMPLETED|Overall Study||47
457263|NCT01267019|1119522|P2|COMPLETED|Overall Study||47
457264|NCT01267019|1119523|P1|COMPLETED|Overall Study||41
457265|NCT01267019|1119521|P3|STARTED|Overall Study||53
457266|NCT01267019|1119522|P2|STARTED|Overall Study||53
457267|NCT01267019|1119523|P1|STARTED|Overall Study||47
457268|NCT01266967|1119539|P2|NOT COMPLETED|Overall Study||83
457269|NCT01266967|1119540|P1|NOT COMPLETED|Overall Study||89
457270|NCT01266967|1119539|P2|COMPLETED|Overall Study||0
457271|NCT01266967|1119540|P1|COMPLETED|Overall Study||0
457272|NCT01266967|1119539|P2|STARTED|Overall Study||83
457273|NCT01266967|1119540|P1|STARTED|Overall Study||89
457274|NCT01266876|1119592|P5|NOT COMPLETED|Overall Study||0
457275|NCT01266876|1119593|P4|NOT COMPLETED|Overall Study||1
457276|NCT01266876|1119594|P3|NOT COMPLETED|Overall Study||0
457277|NCT01266876|1119595|P2|NOT COMPLETED|Overall Study||0
457278|NCT01266876|1119596|P1|NOT COMPLETED|Overall Study||0
457279|NCT01266876|1119592|P5|COMPLETED|Overall Study||16
457280|NCT01266876|1119593|P4|COMPLETED|Overall Study||14
457281|NCT01266876|1119594|P3|COMPLETED|Overall Study||16
457282|NCT01266876|1119595|P2|COMPLETED|Overall Study||15
457283|NCT01266876|1119596|P1|COMPLETED|Overall Study||15
457284|NCT01266876|1119592|P5|STARTED|Overall Study||16
457285|NCT01266876|1119593|P4|STARTED|Overall Study||15
457286|NCT01266876|1119594|P3|STARTED|Overall Study||16
457287|NCT01266876|1119595|P2|STARTED|Overall Study||15
457288|NCT01266876|1119596|P1|STARTED|Overall Study||15
457289|NCT01266850|1119703|P5|NOT COMPLETED|Overall Study||30
457290|NCT01266850|1119704|P4|NOT COMPLETED|Overall Study||28
457291|NCT01266850|1119705|P3|NOT COMPLETED|Overall Study||24
457292|NCT01266850|1119706|P2|NOT COMPLETED|Overall Study||36
457293|NCT01266850|1119707|P1|NOT COMPLETED|Overall Study||30
457294|NCT01266850|1119703|P5|COMPLETED|Overall Study||297
457295|NCT01266850|1119704|P4|COMPLETED|Overall Study||301
457296|NCT01266850|1119705|P3|COMPLETED|Overall Study||214
457297|NCT01266850|1119706|P2|COMPLETED|Overall Study||212
457298|NCT01266850|1119707|P1|COMPLETED|Overall Study||212
457299|NCT01266850|1119703|P5|Received Third Vaccine|Overall Study||299
457300|NCT01266850|1119704|P4|Received Third Vaccine|Overall Study||0
457301|NCT01266850|1119705|P3|Received Third Vaccine|Overall Study||217
457302|NCT01266850|1119706|P2|Received Third Vaccine|Overall Study||221
457303|NCT01266850|1119707|P1|Received Third Vaccine|Overall Study||221
457304|NCT01266850|1119703|P5|Received Second Vaccine|Overall Study||307
457305|NCT01266850|1119704|P4|Received Second Vaccine|Overall Study||311
457306|NCT01266850|1119705|P3|Received Second Vaccine|Overall Study||227
457307|NCT01266850|1119706|P2|Received Second Vaccine|Overall Study||233
457308|NCT01266850|1119707|P1|Received Second Vaccine|Overall Study||231
457309|NCT01266850|1119703|P5|STARTED|Overall Study||327
457310|NCT01266850|1119704|P4|STARTED|Overall Study||329
457311|NCT01266850|1119705|P3|STARTED|Overall Study||238
457312|NCT01266850|1119706|P2|STARTED|Overall Study||248
457313|NCT01266850|1119707|P1|STARTED|Overall Study||242
457314|NCT01266824|1119761|P2|NOT COMPLETED|Overall Study||3
457315|NCT01266824|1119762|P1|NOT COMPLETED|Overall Study||2
457316|NCT01266824|1119761|P2|COMPLETED|Overall Study||0
457317|NCT01266824|1119762|P1|COMPLETED|Overall Study||0
457318|NCT01266824|1119761|P2|STARTED|Overall Study||3
457319|NCT01266824|1119762|P1|STARTED|Overall Study||2
457320|NCT01266447|1119774|P1|NOT COMPLETED|Overall Study||0
457321|NCT01266447|1119774|P1|COMPLETED|Overall Study|Eligible and treated patients|27
457322|NCT01266447|1119774|P1|STARTED|Overall Study||27
457323|NCT01266317|1119783|P1|NOT COMPLETED|Overall Study||2
457324|NCT01266317|1119783|P1|COMPLETED|Overall Study||7
457325|NCT01266317|1119783|P1|STARTED|Overall Study|One additional patient was a protocol violation post consent when autoantibodies returned positive|9
457326|NCT01266291|1119788|P1|NOT COMPLETED|Overall Study||1
457327|NCT01266291|1119788|P1|COMPLETED|Overall Study||0
457328|NCT01266291|1119788|P1|STARTED|Overall Study||1
457329|NCT01266265|1119795|P2|NOT COMPLETED|Overall Study||190
457330|NCT01266265|1119796|P1|NOT COMPLETED|Overall Study||205
457331|NCT01266265|1119795|P2|COMPLETED|Overall Study||477
457332|NCT01266265|1119796|P1|COMPLETED|Overall Study||461
457333|NCT01266265|1119795|P2|STARTED|Overall Study||667
457334|NCT01266265|1119796|P1|STARTED|Overall Study||666
457335|NCT01266148|1119804|P2|NOT COMPLETED|Overall Study||3
457336|NCT01266148|1119805|P1|NOT COMPLETED|Overall Study||7
457337|NCT01266148|1119804|P2|COMPLETED|Overall Study||56
457338|NCT01266148|1119805|P1|COMPLETED|Overall Study||49
457339|NCT01266148|1119804|P2|STARTED|Overall Study||59
457340|NCT01266148|1119805|P1|STARTED|Overall Study||56
457341|NCT01266122|1119833|P2|NOT COMPLETED|Overall Study||6
457342|NCT01266122|1119834|P1|NOT COMPLETED|Overall Study||6
457343|NCT01266122|1119833|P2|COMPLETED|Overall Study||42
457344|NCT01266122|1119834|P1|COMPLETED|Overall Study||42
457345|NCT01266122|1119833|P2|STARTED|Overall Study||48
457346|NCT01266122|1119834|P1|STARTED|Overall Study||48
457347|NCT01266070|1119842|P1|NOT COMPLETED|Overall Study||4
457348|NCT01266070|1119842|P1|COMPLETED|Overall Study||2
457349|NCT01266070|1119842|P1|STARTED|Overall Study||6
457350|NCT01266031|1119850|P3|NOT COMPLETED|Overall Study||3
457351|NCT01266031|1119851|P2|NOT COMPLETED|Overall Study||3
457352|NCT01266031|1119852|P1|NOT COMPLETED|Overall Study||0
457353|NCT01266031|1119850|P3|COMPLETED|Overall Study||46
457354|NCT01266031|1119851|P2|COMPLETED|Overall Study||38
457355|NCT01266031|1119852|P1|COMPLETED|Overall Study||6
457356|NCT01266031|1119850|P3|STARTED|Overall Study||49
457357|NCT01266031|1119851|P2|STARTED|Overall Study||41
457358|NCT01266031|1119852|P1|STARTED|Overall Study||6
457359|NCT01266018|1119860|P2|NOT COMPLETED|Overall Study||1
457360|NCT01266018|1119861|P1|NOT COMPLETED|Overall Study||1
457361|NCT01266018|1119860|P2|COMPLETED|Overall Study||12
457362|NCT01266018|1119861|P1|COMPLETED|Overall Study|Defined as evaluable for the primary endpoint|8
457363|NCT01266018|1119860|P2|STARTED|Overall Study||13
457364|NCT01266018|1119861|P1|STARTED|Overall Study||9
457365|NCT01265992|1119872|P1|NOT COMPLETED|Overall Study||9
457366|NCT01265992|1119872|P1|COMPLETED|Overall Study||41
457367|NCT01265992|1119872|P1|Received Treatment|Overall Study||49
457368|NCT01265992|1119872|P1|STARTED|Overall Study||50
457369|NCT01265966|1119888|P3|NOT COMPLETED|Overall Study||2
457370|NCT01265966|1119889|P2|NOT COMPLETED|Overall Study||2
457371|NCT01265966|1119890|P1|NOT COMPLETED|Overall Study||3
457372|NCT01265966|1119888|P3|COMPLETED|Overall Study||27
457373|NCT01265966|1119889|P2|COMPLETED|Overall Study||39
457374|NCT01265966|1119890|P1|COMPLETED|Overall Study||44
457375|NCT01265966|1119888|P3|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|2
457376|NCT01265966|1119889|P2|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|2
457377|NCT01265966|1119890|P1|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|3
457378|NCT01265966|1119888|P3|STARTED|Overall Study||29
457379|NCT01265966|1119889|P2|STARTED|Overall Study||41
457380|NCT01265966|1119890|P1|STARTED|Overall Study||47
457381|NCT01265953|1119900|P2|NOT COMPLETED|Overall Study||3
457382|NCT01265953|1119901|P1|NOT COMPLETED|Overall Study||5
457383|NCT01265953|1119900|P2|COMPLETED|Overall Study||45
457384|NCT01265953|1119901|P1|COMPLETED|Overall Study||45
457385|NCT01265953|1119900|P2|STARTED|Overall Study||48
457386|NCT01265953|1119901|P1|STARTED|Overall Study||50
457387|NCT01265875|1119913|P1|NOT COMPLETED|Overall Study||1
457388|NCT01265875|1119913|P1|COMPLETED|Overall Study||11
457389|NCT01265875|1119913|P1|STARTED|Overall Study||12
457390|NCT01265823|1119921|P1|NOT COMPLETED|Overall Study||7
457391|NCT01265823|1119921|P1|COMPLETED|Overall Study||143
457392|NCT01265823|1119921|P1|STARTED|Overall Study||150
457393|NCT01265797|1119950|P2|NOT COMPLETED|Open Label Month||1
457394|NCT01265797|1119951|P1|NOT COMPLETED|Open Label Month||0
457395|NCT01265797|1119950|P2|COMPLETED|Open Label Month||26
457396|NCT01265797|1119951|P1|COMPLETED|Open Label Month||24
457397|NCT01265797|1119950|P2|STARTED|Open Label Month||27
457398|NCT01265797|1119951|P1|STARTED|Open Label Month||24
457399|NCT01265797|1119950|P2|NOT COMPLETED|Blinded Month||2
457400|NCT01265797|1119951|P1|NOT COMPLETED|Blinded Month||10
457401|NCT01265797|1119950|P2|COMPLETED|Blinded Month||27
457402|NCT01265797|1119951|P1|COMPLETED|Blinded Month||24
457403|NCT01265797|1119950|P2|STARTED|Blinded Month||29
457404|NCT01265797|1119951|P1|STARTED|Blinded Month||34
457405|NCT01265797|1119950|P2|NOT COMPLETED|Run-in Month||5
457406|NCT01265797|1119951|P1|NOT COMPLETED|Run-in Month||0
457407|NCT01265797|1119950|P2|COMPLETED|Run-in Month||29
457408|NCT01265797|1119951|P1|COMPLETED|Run-in Month||34
457409|NCT01265797|1119950|P2|STARTED|Run-in Month||34
457410|NCT01265797|1119951|P1|STARTED|Run-in Month||34
457411|NCT01265784|1119982|P3|NOT COMPLETED|Overall Study||4
457412|NCT01265784|1119983|P2|NOT COMPLETED|Overall Study||8
457413|NCT01265784|1119984|P1|NOT COMPLETED|Overall Study||12
457414|NCT01265784|1119982|P3|COMPLETED|Overall Study||26
457415|NCT01265784|1119983|P2|COMPLETED|Overall Study||49
457416|NCT01265784|1119984|P1|COMPLETED|Overall Study||44
457417|NCT01265784|1119982|P3|Received at Least 1 Dose of Study Drug|Overall Study||29
457418|NCT01265784|1119983|P2|Received at Least 1 Dose of Study Drug|Overall Study||56
457419|NCT01265784|1119984|P1|Received at Least 1 Dose of Study Drug|Overall Study|1 participant randomized to TP-434 1.5 mg/kg took ertapenem. Results are included in ertapenem arm.|54
457420|NCT01265784|1119982|P3|STARTED|Overall Study||30
457421|NCT01265784|1119983|P2|STARTED|Overall Study||57
457422|NCT01265784|1119984|P1|STARTED|Overall Study||56
457423|NCT01265667|1120052|P2|NOT COMPLETED|Overall Study||13
457424|NCT01265667|1120053|P1|NOT COMPLETED|Overall Study||20
457425|NCT01265667|1120052|P2|COMPLETED|Overall Study||135
457426|NCT01265667|1120053|P1|COMPLETED|Overall Study||125
457427|NCT01265667|1120052|P2|STARTED|Overall Study||148
457428|NCT01265667|1120053|P1|STARTED|Overall Study||145
457429|NCT01265615|1120069|P4|NOT COMPLETED|Overall Study||3
457430|NCT01265615|1120070|P3|NOT COMPLETED|Overall Study||4
457431|NCT01265615|1120071|P2|NOT COMPLETED|Overall Study||2
457432|NCT01265615|1120072|P1|NOT COMPLETED|Overall Study||2
457433|NCT01265615|1120069|P4|COMPLETED|Overall Study||27
457434|NCT01265615|1120070|P3|COMPLETED|Overall Study||26
457435|NCT01265615|1120071|P2|COMPLETED|Overall Study||28
457436|NCT01265615|1120072|P1|COMPLETED|Overall Study||28
457437|NCT01265615|1120069|P4|STARTED|Overall Study||30
457438|NCT01265615|1120070|P3|STARTED|Overall Study||30
457439|NCT01265615|1120071|P2|STARTED|Overall Study||30
457440|NCT01265615|1120072|P1|STARTED|Overall Study||30
457441|NCT01265563|1120123|P5|NOT COMPLETED|Overall Study||2
457442|NCT01265563|1120124|P4|NOT COMPLETED|Overall Study||0
457443|NCT01265563|1120125|P3|NOT COMPLETED|Overall Study||1
457444|NCT01265563|1120126|P2|NOT COMPLETED|Overall Study||1
457445|NCT01265563|1120127|P1|NOT COMPLETED|Overall Study||0
457446|NCT01265563|1120123|P5|COMPLETED|Overall Study||14
457447|NCT01265563|1120124|P4|COMPLETED|Overall Study||16
457448|NCT01265563|1120125|P3|COMPLETED|Overall Study||16
457449|NCT01265563|1120126|P2|COMPLETED|Overall Study||12
457450|NCT01265563|1120127|P1|COMPLETED|Overall Study||16
457451|NCT01265563|1120123|P5|STARTED|Overall Study||16
457452|NCT01265563|1120124|P4|STARTED|Overall Study||16
457453|NCT01265563|1120125|P3|STARTED|Overall Study||17
457454|NCT01265563|1120126|P2|STARTED|Overall Study||13
457455|NCT01265563|1120127|P1|STARTED|Overall Study||16
457456|NCT01265550|1120147|P3|NOT COMPLETED|Overall Study||20
457457|NCT01265550|1120148|P2|NOT COMPLETED|Overall Study||8
457458|NCT01265550|1120149|P1|NOT COMPLETED|Overall Study||15
457459|NCT01265550|1120147|P3|COMPLETED|Overall Study||6
457460|NCT01265550|1120148|P2|COMPLETED|Overall Study||19
457461|NCT01265550|1120149|P1|COMPLETED|Overall Study||10
457462|NCT01265550|1120147|P3|STARTED|Overall Study||26
457463|NCT01265550|1120148|P2|STARTED|Overall Study||27
457464|NCT01265550|1120149|P1|STARTED|Overall Study||25
457465|NCT01265524|1120201|P2|NOT COMPLETED|Overall Study||6
457466|NCT01265524|1120202|P1|NOT COMPLETED|Overall Study||18
457467|NCT01265524|1120201|P2|COMPLETED|Overall Study||46
457468|NCT01265524|1120202|P1|COMPLETED|Overall Study||41
457469|NCT01265524|1120201|P2|STARTED|Overall Study||52
457470|NCT01265524|1120202|P1|STARTED|Overall Study||59
457471|NCT01265511|1120222|P2|NOT COMPLETED|Overall Study||3
457472|NCT01265511|1120223|P1|NOT COMPLETED|Overall Study||2
457473|NCT01265511|1120222|P2|COMPLETED|Overall Study||5
457474|NCT01265511|1120223|P1|COMPLETED|Overall Study||0
457475|NCT01265511|1120222|P2|STARTED|Overall Study||8
457476|NCT01265511|1120223|P1|STARTED|Overall Study||2
457477|NCT01265498|1120237|P2|NOT COMPLETED|Overall Study||33
457478|NCT01265498|1120238|P1|NOT COMPLETED|Overall Study||31
457479|NCT01265498|1120237|P2|COMPLETED|Overall Study||109
457480|NCT01265498|1120238|P1|COMPLETED|Overall Study||110
457481|NCT01265498|1120237|P2|Both Baseline and Week 72 Biopsy|Overall Study||98
457482|NCT01265498|1120238|P1|Both Baseline and Week 72 Biopsy|Overall Study||102
457483|NCT01265498|1120237|P2|STARTED|Overall Study||142
457484|NCT01265498|1120238|P1|STARTED|Overall Study||141
457485|NCT01265459|1120341|P3|NOT COMPLETED|Overall Study||2
457486|NCT01265459|1120342|P2|NOT COMPLETED|Overall Study||0
457487|NCT01265459|1120343|P1|NOT COMPLETED|Overall Study||0
457488|NCT01265459|1120341|P3|COMPLETED|Overall Study||20
457489|NCT01265459|1120342|P2|COMPLETED|Overall Study||23
457490|NCT01265459|1120343|P1|COMPLETED|Overall Study||23
457491|NCT01265459|1120341|P3|STARTED|Overall Study||22
457492|NCT01265459|1120342|P2|STARTED|Overall Study||23
457493|NCT01265459|1120343|P1|STARTED|Overall Study||23
457494|NCT01265446|1120365|P2|NOT COMPLETED|Overall Study||0
457495|NCT01265446|1120366|P1|NOT COMPLETED|Overall Study||1
457496|NCT01265446|1120365|P2|COMPLETED|Overall Study||125
457497|NCT01265446|1120366|P1|COMPLETED|Overall Study||124
457498|NCT01265446|1120365|P2|STARTED|Overall Study||125
457499|NCT01265446|1120366|P1|STARTED|Overall Study||125
457500|NCT01265420|1120374|P1|NOT COMPLETED|Overall Study||1
457501|NCT01265420|1120374|P1|COMPLETED|Overall Study|One patient was seen at Day 10 but did not return for Day 30 evaluation|6
457502|NCT01265420|1120374|P1|STARTED|Overall Study||7
457503|NCT01265394|1120378|P1|NOT COMPLETED|Overall Study||37
457504|NCT01265394|1120378|P1|COMPLETED|Overall Study||181
457505|NCT01265394|1120378|P1|STARTED|Overall Study||218
457506|NCT01265056|1120385|P2|NOT COMPLETED|Follow up||3
457507|NCT01265056|1120386|P1|NOT COMPLETED|Follow up||7
457508|NCT01265056|1120385|P2|COMPLETED|Follow up||24
457509|NCT01265056|1120386|P1|COMPLETED|Follow up||19
457510|NCT01265056|1120385|P2|STARTED|Follow up||27
457511|NCT01265056|1120386|P1|STARTED|Follow up||26
457512|NCT01265056|1120385|P2|NOT COMPLETED|Initial Study Period||2
457513|NCT01265056|1120386|P1|NOT COMPLETED|Initial Study Period||2
457514|NCT01265056|1120385|P2|COMPLETED|Initial Study Period||25
457515|NCT01265056|1120386|P1|COMPLETED|Initial Study Period||24
457516|NCT01265056|1120385|P2|STARTED|Initial Study Period||27
457517|NCT01265056|1120386|P1|STARTED|Initial Study Period||26
457518|NCT01264952|1120399|P3|NOT COMPLETED|Overall Study||0
457519|NCT01264952|1120400|P2|NOT COMPLETED|Overall Study||0
457520|NCT01264952|1120401|P1|NOT COMPLETED|Overall Study||0
457521|NCT01264952|1120399|P3|COMPLETED|Overall Study||8
457522|NCT01264952|1120400|P2|COMPLETED|Overall Study||2
457523|NCT01264952|1120401|P1|COMPLETED|Overall Study||6
457524|NCT01264952|1120399|P3|STARTED|Overall Study||8
457525|NCT01264952|1120400|P2|STARTED|Overall Study||2
457526|NCT01264952|1120401|P1|STARTED|Overall Study||6
457527|NCT01264939|1120417|P2|NOT COMPLETED|Overall Study||28
457528|NCT01264939|1120418|P1|NOT COMPLETED|Overall Study||18
457529|NCT01264939|1120417|P2|COMPLETED|Overall Study||224
457530|NCT01264939|1120418|P1|COMPLETED|Overall Study||66
457531|NCT01264939|1120417|P2|STARTED|Overall Study||252
457532|NCT01264939|1120418|P1|STARTED|Overall Study||84
457533|NCT01264887|1120444|P1|NOT COMPLETED|Overall Study||31
457534|NCT01264887|1120444|P1|COMPLETED|Overall Study||0
457535|NCT01264887|1120444|P1|STARTED|Overall Study||31
457536|NCT01264835|1120455|P1|NOT COMPLETED|Overall Study||1
457537|NCT01264835|1120455|P1|COMPLETED|Overall Study||1
457538|NCT01264835|1120455|P1|STARTED|Overall Study||2
457539|NCT01264770|1120465|P6|NOT COMPLETED|Overall Study||6
457540|NCT01264770|1120466|P5|NOT COMPLETED|Overall Study||8
457541|NCT01264770|1120467|P4|NOT COMPLETED|Overall Study||6
457542|NCT01264770|1120468|P3|NOT COMPLETED|Overall Study||16
457543|NCT01264770|1120469|P2|NOT COMPLETED|Overall Study||10
457544|NCT01264770|1120470|P1|NOT COMPLETED|Overall Study||18
457545|NCT01264770|1120465|P6|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|19
457546|NCT01264770|1120466|P5|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|19
457547|NCT01264770|1120467|P4|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|48
457548|NCT01264770|1120468|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|41
457549|NCT01264770|1120469|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|38
457550|NCT01264770|1120470|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|36
457551|NCT01264770|1120465|P6|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|0
457552|NCT01264770|1120466|P5|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
457553|NCT01264770|1120467|P4|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|3
457554|NCT01264770|1120468|P3|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
457555|NCT01264770|1120469|P2|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|5
457556|NCT01264770|1120470|P1|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
457557|NCT01264770|1120465|P6|STARTED|Overall Study|Patients who received treatment|25
457558|NCT01264770|1120466|P5|STARTED|Overall Study|Patients who received treatment|27
457559|NCT01264770|1120467|P4|STARTED|Overall Study|Patients who received treatment|54
457560|NCT01264770|1120468|P3|STARTED|Overall Study|Patients who received treatment|57
457561|NCT01264770|1120469|P2|STARTED|Overall Study|Patients who received treatment|48
457562|NCT01264770|1120470|P1|STARTED|Overall Study|Patients who received treatment|54
457563|NCT01264679|1120554|P1|NOT COMPLETED|Overall Study||5
457564|NCT01264679|1120554|P1|COMPLETED|Overall Study||3
457565|NCT01264679|1120554|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
457566|NCT01264679|1120554|P1|STARTED|Overall Study||8
457567|NCT01264614|1120562|P2|NOT COMPLETED|Overall Study||2
457568|NCT01264614|1120563|P1|NOT COMPLETED|Overall Study||1
457569|NCT01264614|1120562|P2|COMPLETED|Overall Study||7
457570|NCT01264614|1120563|P1|COMPLETED|Overall Study||12
457571|NCT01264614|1120562|P2|STARTED|Overall Study||9
457572|NCT01264614|1120563|P1|STARTED|Overall Study||13
457573|NCT01264601|1120579|P2|NOT COMPLETED|Overall Study||0
457574|NCT01264601|1120580|P1|NOT COMPLETED|Overall Study||0
457575|NCT01264601|1120579|P2|COMPLETED|Overall Study||14
457576|NCT01264601|1120580|P1|COMPLETED|Overall Study||17
457577|NCT01264601|1120579|P2|STARTED|Overall Study||14
457578|NCT01264601|1120580|P1|STARTED|Overall Study||17
457579|NCT01264380|1120588|P3|NOT COMPLETED|Period C||14
457580|NCT01264380|1120589|P2|NOT COMPLETED|Period C||0
457581|NCT01264380|1120590|P1|NOT COMPLETED|Period C||0
457582|NCT01264380|1120588|P3|COMPLETED|Period C||2
457583|NCT01264380|1120589|P2|COMPLETED|Period C||0
457584|NCT01264380|1120590|P1|COMPLETED|Period C||0
457585|NCT01264380|1120588|P3|STARTED|Period C||16
457586|NCT01264380|1120589|P2|STARTED|Period C||0
457587|NCT01264380|1120590|P1|STARTED|Period C||0
457588|NCT01264380|1120588|P3|NOT COMPLETED|Period B||0
457589|NCT01264380|1120589|P2|NOT COMPLETED|Period B||0
457590|NCT01264380|1120590|P1|NOT COMPLETED|Period B||0
457591|NCT01264380|1120588|P3|COMPLETED|Period B||0
457592|NCT01264380|1120589|P2|COMPLETED|Period B||8
457593|NCT01264380|1120590|P1|COMPLETED|Period B||8
457594|NCT01264380|1120588|P3|STARTED|Period B||0
457595|NCT01264380|1120589|P2|STARTED|Period B||8
457596|NCT01264380|1120590|P1|STARTED|Period B||8
457597|NCT01264380|1120588|P3|NOT COMPLETED|Period A||0
457598|NCT01264380|1120589|P2|NOT COMPLETED|Period A||0
457599|NCT01264380|1120590|P1|NOT COMPLETED|Period A||0
457600|NCT01264380|1120588|P3|COMPLETED|Period A||0
457601|NCT01264380|1120589|P2|COMPLETED|Period A||8
457602|NCT01264380|1120590|P1|COMPLETED|Period A||8
457603|NCT01264380|1120588|P3|STARTED|Period A||0
457604|NCT01264380|1120589|P2|STARTED|Period A||8
457605|NCT01264380|1120590|P1|STARTED|Period A||8
457606|NCT01264081|1120611|P1|NOT COMPLETED|Analysis||0
457607|NCT01264081|1120611|P1|COMPLETED|Analysis||2
457608|NCT01264081|1120611|P1|STARTED|Analysis||2
457609|NCT01264081|1120611|P1|NOT COMPLETED|Started Treatment||2
457610|NCT01264081|1120611|P1|COMPLETED|Started Treatment||2
457611|NCT01264081|1120611|P1|STARTED|Started Treatment||4
457612|NCT01264081|1120611|P1|NOT COMPLETED|Participants Screened||30
457613|NCT01264081|1120611|P1|COMPLETED|Participants Screened||4
457614|NCT01264081|1120611|P1|STARTED|Participants Screened||34
457615|NCT01264016|1120616|P1|NOT COMPLETED|Overall Study||2
457616|NCT01264016|1120616|P1|COMPLETED|Overall Study||94
457617|NCT01264016|1120616|P1|STARTED|Overall Study||96
457618|NCT01263925|1120624|P2|NOT COMPLETED|Overall Study||52
457619|NCT01263925|1120625|P1|NOT COMPLETED|Overall Study||51
457620|NCT01263925|1120624|P2|COMPLETED|Overall Study||233
457621|NCT01263925|1120625|P1|COMPLETED|Overall Study||225
457622|NCT01263925|1120624|P2|Full Analysis Set|Overall Study||272
457623|NCT01263925|1120625|P1|Full Analysis Set|Overall Study||269
457624|NCT01263925|1120624|P2|STARTED|Overall Study||285
457625|NCT01263925|1120625|P1|STARTED|Overall Study||276
457626|NCT01263873|1120659|P2|NOT COMPLETED|Overall Study||1
457627|NCT01263873|1120660|P1|NOT COMPLETED|Overall Study||1
457628|NCT01263873|1120659|P2|COMPLETED|Overall Study||29
457629|NCT01263873|1120660|P1|COMPLETED|Overall Study||29
457630|NCT01263873|1120659|P2|STARTED|Overall Study||30
457631|NCT01263873|1120660|P1|STARTED|Overall Study||30
457632|NCT01263717|1120672|P2|NOT COMPLETED|Overall Study||6
457633|NCT01263717|1120673|P1|NOT COMPLETED|Overall Study||5
457634|NCT01263717|1120672|P2|COMPLETED|Overall Study||20
457635|NCT01263717|1120673|P1|COMPLETED|Overall Study||23
457636|NCT01263717|1120672|P2|Baseline Visit|Overall Study||22
457637|NCT01263717|1120673|P1|Baseline Visit|Overall Study||28
457638|NCT01263717|1120672|P2|STARTED|Overall Study||26
457639|NCT01263717|1120673|P1|STARTED|Overall Study||28
457640|NCT01263704|1120701|P1|NOT COMPLETED|Overall Study||29
457641|NCT01263704|1120701|P1|COMPLETED|Overall Study||13
457642|NCT01263704|1120701|P1|STARTED|Overall Study||42
457643|NCT01263691|1120716|P6|NOT COMPLETED|Overall Study||0
457644|NCT01263691|1120717|P5|NOT COMPLETED|Overall Study||0
457645|NCT01263691|1120718|P4|NOT COMPLETED|Overall Study||1
457646|NCT01263691|1120719|P3|NOT COMPLETED|Overall Study||1
457647|NCT01263691|1120720|P2|NOT COMPLETED|Overall Study||0
457648|NCT01263691|1120721|P1|NOT COMPLETED|Overall Study||3
457649|NCT01263691|1120716|P6|COMPLETED|Overall Study||15
457650|NCT01263691|1120717|P5|COMPLETED|Overall Study||18
457651|NCT01263691|1120718|P4|COMPLETED|Overall Study||18
457652|NCT01263691|1120719|P3|COMPLETED|Overall Study||16
457653|NCT01263691|1120720|P2|COMPLETED|Overall Study||18
457654|NCT01263691|1120721|P1|COMPLETED|Overall Study||15
457655|NCT01263691|1120716|P6|STARTED|Overall Study||15
457656|NCT01263691|1120717|P5|STARTED|Overall Study||18
457657|NCT01263691|1120718|P4|STARTED|Overall Study||19
457658|NCT01263691|1120719|P3|STARTED|Overall Study||17
457659|NCT01263691|1120720|P2|STARTED|Overall Study||18
457660|NCT01263691|1120721|P1|STARTED|Overall Study||18
457661|NCT01263665|1120831|P1|NOT COMPLETED|Overall Study||9
457662|NCT01263665|1120831|P1|COMPLETED|Overall Study||62
457663|NCT01263665|1120831|P1|STARTED|Overall Study||71
457664|NCT01263639|1120838|P2|NOT COMPLETED|Overall Study||79
457665|NCT01263639|1120839|P1|NOT COMPLETED|Overall Study||73
457666|NCT01263639|1120838|P2|COMPLETED|Overall Study||42
457667|NCT01263639|1120839|P1|COMPLETED|Overall Study||34
457668|NCT01263639|1120838|P2|STARTED|Overall Study||121
457669|NCT01263639|1120839|P1|STARTED|Overall Study||107
457670|NCT01263561|1120847|P2|NOT COMPLETED|Overall Study||2
457671|NCT01263561|1120848|P1|NOT COMPLETED|Overall Study||1
457672|NCT01263561|1120847|P2|COMPLETED|Overall Study||31
457673|NCT01263561|1120848|P1|COMPLETED|Overall Study||30
457674|NCT01263561|1120847|P2|STARTED|Overall Study||33
457675|NCT01263561|1120848|P1|STARTED|Overall Study||31
457676|NCT01263509|1120860|P4|NOT COMPLETED|Entered - Long-Term Extension Study||2
457677|NCT01263509|1120861|P3|NOT COMPLETED|Entered - Long-Term Extension Study||5
457678|NCT01263509|1120862|P2|NOT COMPLETED|Entered - Long-Term Extension Study||12
457679|NCT01263509|1120863|P1|NOT COMPLETED|Entered - Long-Term Extension Study||8
457680|NCT01263509|1120860|P4|COMPLETED|Entered - Long-Term Extension Study||24
457681|NCT01263509|1120861|P3|COMPLETED|Entered - Long-Term Extension Study||27
457682|NCT01263509|1120862|P2|COMPLETED|Entered - Long-Term Extension Study||48
457683|NCT01263509|1120863|P1|COMPLETED|Entered - Long-Term Extension Study||53
457684|NCT01263509|1120860|P4|STARTED|Entered - Long-Term Extension Study||26
457685|NCT01263509|1120861|P3|STARTED|Entered - Long-Term Extension Study||32
457686|NCT01263509|1120862|P2|STARTED|Entered - Long-Term Extension Study||60
457687|NCT01263509|1120863|P1|STARTED|Entered - Long-Term Extension Study||61
457688|NCT01263509|1120860|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
457689|NCT01263509|1120861|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
457690|NCT01263509|1120862|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
457691|NCT01263509|1120863|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
457692|NCT01263509|1120860|P4|COMPLETED|Enrolled - Long-Term Extension Study||26
457693|NCT01263509|1120861|P3|COMPLETED|Enrolled - Long-Term Extension Study||32
457694|NCT01263509|1120862|P2|COMPLETED|Enrolled - Long-Term Extension Study||60
457695|NCT01263509|1120863|P1|COMPLETED|Enrolled - Long-Term Extension Study||61
457696|NCT01263509|1120860|P4|STARTED|Enrolled - Long-Term Extension Study||26
457697|NCT01263509|1120861|P3|STARTED|Enrolled - Long-Term Extension Study||32
457698|NCT01263509|1120862|P2|STARTED|Enrolled - Long-Term Extension Study||60
457699|NCT01263509|1120863|P1|STARTED|Enrolled - Long-Term Extension Study||61
457700|NCT01263496|1120992|P9|NOT COMPLETED|Entered - Long-Term Extension Study||3
457701|NCT01263496|1120993|P8|NOT COMPLETED|Entered - Long-Term Extension Study||1
457702|NCT01263496|1120994|P7|NOT COMPLETED|Entered - Long-Term Extension Study||1
457703|NCT01263496|1120995|P6|NOT COMPLETED|Entered - Long-Term Extension Study||1
457704|NCT01263496|1120996|P5|NOT COMPLETED|Entered - Long-Term Extension Study||10
457705|NCT01263496|1120997|P4|NOT COMPLETED|Entered - Long-Term Extension Study||6
457706|NCT01263496|1120998|P3|NOT COMPLETED|Entered - Long-Term Extension Study||10
457707|NCT01263496|1120999|P2|NOT COMPLETED|Entered - Long-Term Extension Study||13
457708|NCT01263496|1121000|P1|NOT COMPLETED|Entered - Long-Term Extension Study||9
457709|NCT01263496|1120992|P9|COMPLETED|Entered - Long-Term Extension Study||15
457710|NCT01263496|1120993|P8|COMPLETED|Entered - Long-Term Extension Study||16
457711|NCT01263496|1120994|P7|COMPLETED|Entered - Long-Term Extension Study||16
457712|NCT01263496|1120995|P6|COMPLETED|Entered - Long-Term Extension Study||16
457713|NCT01263496|1120996|P5|COMPLETED|Entered - Long-Term Extension Study||61
457714|NCT01263496|1120997|P4|COMPLETED|Entered - Long-Term Extension Study||68
457715|NCT01263496|1120998|P3|COMPLETED|Entered - Long-Term Extension Study||62
457716|NCT01263496|1120999|P2|COMPLETED|Entered - Long-Term Extension Study||59
457717|NCT01263496|1121000|P1|COMPLETED|Entered - Long-Term Extension Study||62
457718|NCT01263496|1120992|P9|STARTED|Entered - Long-Term Extension Study||18
457719|NCT01263496|1120993|P8|STARTED|Entered - Long-Term Extension Study|1 participant did not enter from previous period (voluntary withdraw).|17
457720|NCT01263496|1120994|P7|STARTED|Entered - Long-Term Extension Study||17
457721|NCT01263496|1120995|P6|STARTED|Entered - Long-Term Extension Study||17
457722|NCT01263496|1120996|P5|STARTED|Entered - Long-Term Extension Study|1 participant did not enter from previous period (voluntary withdraw).|71
457723|NCT01263496|1120997|P4|STARTED|Entered - Long-Term Extension Study||74
457724|NCT01263496|1120998|P3|STARTED|Entered - Long-Term Extension Study||72
457725|NCT01263496|1120999|P2|STARTED|Entered - Long-Term Extension Study|3 participants did not enter from previous period (1 voluntary withdraw; 2 did not meet criteria).|72
457726|NCT01263496|1121000|P1|STARTED|Entered - Long-Term Extension Study||71
457727|NCT01263496|1120992|P9|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
457728|NCT01263496|1120993|P8|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
457729|NCT01263496|1120994|P7|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
457730|NCT01263496|1120995|P6|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
457731|NCT01263496|1120996|P5|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
457732|NCT01263496|1120997|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
457733|NCT01263496|1120998|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
457734|NCT01263496|1120999|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
457735|NCT01263496|1121000|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
457736|NCT01263496|1120992|P9|COMPLETED|Enrolled - Long-Term Extension Study||18
457737|NCT01263496|1120993|P8|COMPLETED|Enrolled - Long-Term Extension Study||18
457738|NCT01263496|1120994|P7|COMPLETED|Enrolled - Long-Term Extension Study||17
457739|NCT01263496|1120995|P6|COMPLETED|Enrolled - Long-Term Extension Study||17
457740|NCT01263496|1120996|P5|COMPLETED|Enrolled - Long-Term Extension Study||72
457741|NCT01263496|1120997|P4|COMPLETED|Enrolled - Long-Term Extension Study||74
457742|NCT01263496|1120998|P3|COMPLETED|Enrolled - Long-Term Extension Study||72
457743|NCT01263496|1120999|P2|COMPLETED|Enrolled - Long-Term Extension Study||75
457744|NCT01263496|1121000|P1|COMPLETED|Enrolled - Long-Term Extension Study||71
457745|NCT01263496|1120992|P9|STARTED|Enrolled - Long-Term Extension Study||18
457746|NCT01263496|1120993|P8|STARTED|Enrolled - Long-Term Extension Study||18
457747|NCT01263496|1120994|P7|STARTED|Enrolled - Long-Term Extension Study||17
457748|NCT01263496|1120995|P6|STARTED|Enrolled - Long-Term Extension Study||17
457749|NCT01263496|1120996|P5|STARTED|Enrolled - Long-Term Extension Study||74
457750|NCT01263496|1120997|P4|STARTED|Enrolled - Long-Term Extension Study||75
457751|NCT01263496|1120998|P3|STARTED|Enrolled - Long-Term Extension Study||72
457752|NCT01263496|1120999|P2|STARTED|Enrolled - Long-Term Extension Study||75
457753|NCT01263496|1121000|P1|STARTED|Enrolled - Long-Term Extension Study||72
457754|NCT01263483|1121295|P3|NOT COMPLETED|Overall Study||5
457755|NCT01263483|1121296|P2|NOT COMPLETED|Overall Study||2
457756|NCT01263483|1121297|P1|NOT COMPLETED|Overall Study||7
457757|NCT01263483|1121295|P3|COMPLETED|Overall Study||74
457758|NCT01263483|1121296|P2|COMPLETED|Overall Study||74
457759|NCT01263483|1121297|P1|COMPLETED|Overall Study||68
457760|NCT01263483|1121295|P3|STARTED|Overall Study||79
457761|NCT01263483|1121296|P2|STARTED|Overall Study||76
457762|NCT01263483|1121297|P1|STARTED|Overall Study||75
457763|NCT01263470|1121359|P6|NOT COMPLETED|Overall Study||5
457764|NCT01263470|1121360|P5|NOT COMPLETED|Overall Study||3
457765|NCT01263470|1121361|P4|NOT COMPLETED|Overall Study||3
457766|NCT01263470|1121362|P3|NOT COMPLETED|Overall Study||4
457767|NCT01263470|1121363|P2|NOT COMPLETED|Overall Study||5
457768|NCT01263470|1121364|P1|NOT COMPLETED|Overall Study||2
457769|NCT01263470|1121359|P6|COMPLETED|Overall Study||78
457770|NCT01263470|1121360|P5|COMPLETED|Overall Study||76
457771|NCT01263470|1121361|P4|COMPLETED|Overall Study||77
457772|NCT01263470|1121362|P3|COMPLETED|Overall Study||80
457773|NCT01263470|1121363|P2|COMPLETED|Overall Study||74
457774|NCT01263470|1121364|P1|COMPLETED|Overall Study||73
457775|NCT01263470|1121359|P6|STARTED|Overall Study||83
457776|NCT01263470|1121360|P5|STARTED|Overall Study||79
457777|NCT01263470|1121361|P4|STARTED|Overall Study||80
457778|NCT01263470|1121362|P3|STARTED|Overall Study||84
457779|NCT01263470|1121363|P2|STARTED|Overall Study||79
457780|NCT01263470|1121364|P1|STARTED|Overall Study||75
457781|NCT01263444|1121474|P1|NOT COMPLETED|Overall Study||10
457782|NCT01263444|1121474|P1|COMPLETED|Overall Study||37
457783|NCT01263444|1121474|P1|STARTED|Overall Study||47
457784|NCT01263301|1121483|P2|NOT COMPLETED|Overall Study||0
457785|NCT01263301|1121484|P1|NOT COMPLETED|Overall Study||0
457786|NCT01263301|1121483|P2|COMPLETED|Overall Study||11
457787|NCT01263301|1121484|P1|COMPLETED|Overall Study||5
457788|NCT01263301|1121483|P2|STARTED|Overall Study||11
457789|NCT01263301|1121484|P1|STARTED|Overall Study||5
457790|NCT01263132|1121498|P2|NOT COMPLETED|Overall Study||0
457791|NCT01263132|1121499|P1|NOT COMPLETED|Overall Study||0
457792|NCT01263132|1121498|P2|COMPLETED|Overall Study||37
457793|NCT01263132|1121499|P1|COMPLETED|Overall Study||38
457794|NCT01263132|1121498|P2|STARTED|Overall Study||37
457795|NCT01263132|1121499|P1|STARTED|Overall Study||38
457796|NCT01263054|1121515|P2|NOT COMPLETED|Overall Study||6
457797|NCT01263054|1121516|P1|NOT COMPLETED|Overall Study||5
457798|NCT01263054|1121515|P2|COMPLETED|Overall Study||28
457799|NCT01263054|1121516|P1|COMPLETED|Overall Study||24
457800|NCT01263054|1121515|P2|STARTED|Overall Study||34
457801|NCT01263054|1121516|P1|STARTED|Overall Study||29
457802|NCT01263028|1121534|P1|NOT COMPLETED|Overall Study||6
457803|NCT01263028|1121534|P1|COMPLETED|Overall Study||0
457804|NCT01263028|1121534|P1|STARTED|Overall Study||6
457805|NCT01263015|1121544|P2|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||31
457806|NCT01263015|1121545|P1|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||24
457807|NCT01263015|1121544|P2|COMPLETED|Open-label Phase: 48 Weeks Duration||278
457808|NCT01263015|1121545|P1|COMPLETED|Open-label Phase: 48 Weeks Duration||317
457809|NCT01263015|1121544|P2|STARTED|Open-label Phase: 48 Weeks Duration||309
457810|NCT01263015|1121545|P1|STARTED|Open-label Phase: 48 Weeks Duration||341
457811|NCT01263015|1121544|P2|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||109
457812|NCT01263015|1121545|P1|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||72
457813|NCT01263015|1121544|P2|COMPLETED|Double-blind Phase: 96 Weeks Duration||310
457814|NCT01263015|1121545|P1|COMPLETED|Double-blind Phase: 96 Weeks Duration||342
457815|NCT01263015|1121544|P2|STARTED|Double-blind Phase: 96 Weeks Duration||419
457816|NCT01263015|1121545|P1|STARTED|Double-blind Phase: 96 Weeks Duration||414
457817|NCT01262989|1121571|P2|NOT COMPLETED|Period 2||1
457818|NCT01262989|1121572|P1|NOT COMPLETED|Period 2||0
457819|NCT01262989|1121571|P2|COMPLETED|Period 2||16
457820|NCT01262989|1121572|P1|COMPLETED|Period 2||19
457821|NCT01262989|1121571|P2|STARTED|Period 2||17
457822|NCT01262989|1121572|P1|STARTED|Period 2||19
457823|NCT01262989|1121571|P2|NOT COMPLETED|7-Day Washout Period||0
457824|NCT01262989|1121572|P1|NOT COMPLETED|7-Day Washout Period||0
457825|NCT01262989|1121571|P2|COMPLETED|7-Day Washout Period||17
457826|NCT01262989|1121572|P1|COMPLETED|7-Day Washout Period||19
457827|NCT01262989|1121571|P2|STARTED|7-Day Washout Period||17
457828|NCT01262989|1121572|P1|STARTED|7-Day Washout Period||19
457829|NCT01262989|1121571|P2|NOT COMPLETED|Period 1||3
457830|NCT01262989|1121572|P1|NOT COMPLETED|Period 1||1
457831|NCT01262989|1121571|P2|COMPLETED|Period 1||17
457832|NCT01262989|1121572|P1|COMPLETED|Period 1||19
457833|NCT01262989|1121571|P2|STARTED|Period 1||20
457834|NCT01262989|1121572|P1|STARTED|Period 1||20
457835|NCT01262898|1121586|P4|NOT COMPLETED|Overall Study||0
457836|NCT01262898|1121587|P3|NOT COMPLETED|Overall Study||0
457837|NCT01262898|1121588|P2|NOT COMPLETED|Overall Study||2
457838|NCT01262898|1121589|P1|NOT COMPLETED|Overall Study||3
457839|NCT01262898|1121586|P4|COMPLETED|Overall Study||22
457840|NCT01262898|1121587|P3|COMPLETED|Overall Study||18
457841|NCT01262898|1121588|P2|COMPLETED|Overall Study||16
457842|NCT01262898|1121589|P1|COMPLETED|Overall Study||18
457843|NCT01262898|1121586|P4|STARTED|Overall Study||22
457844|NCT01262898|1121587|P3|STARTED|Overall Study||18
457845|NCT01262898|1121588|P2|STARTED|Overall Study||18
457846|NCT01262898|1121589|P1|STARTED|Overall Study||21
457847|NCT01262872|1121717|P8|NOT COMPLETED|Step 2||6
457848|NCT01262872|1121718|P7|NOT COMPLETED|Step 2||9
457849|NCT01262872|1121719|P6|NOT COMPLETED|Step 2||9
457850|NCT01262872|1121720|P5|NOT COMPLETED|Step 2||5
457851|NCT01262872|1121721|P4|NOT COMPLETED|Step 2||10
457852|NCT01262872|1121722|P3|NOT COMPLETED|Step 2||9
457853|NCT01262872|1121723|P2|NOT COMPLETED|Step 2||0
457854|NCT01262872|1121724|P1|NOT COMPLETED|Step 2||0
457855|NCT01262872|1121717|P8|COMPLETED|Step 2||194
457856|NCT01262872|1121718|P7|COMPLETED|Step 2||191
457857|NCT01262872|1121719|P6|COMPLETED|Step 2||191
457858|NCT01262872|1121720|P5|COMPLETED|Step 2||195
457859|NCT01262872|1121721|P4|COMPLETED|Step 2||190
457860|NCT01262872|1121722|P3|COMPLETED|Step 2||191
457861|NCT01262872|1121723|P2|COMPLETED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
457862|NCT01262872|1121724|P1|COMPLETED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
457863|NCT01262872|1121717|P8|STARTED|Step 2||200
457864|NCT01262872|1121718|P7|STARTED|Step 2||200
457865|NCT01262872|1121719|P6|STARTED|Step 2||200
457866|NCT01262872|1121720|P5|STARTED|Step 2||200
457867|NCT01262872|1121721|P4|STARTED|Step 2||200
457868|NCT01262872|1121722|P3|STARTED|Step 2||200
457869|NCT01262872|1121723|P2|STARTED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
457870|NCT01262872|1121724|P1|STARTED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
457871|NCT01262872|1121717|P8|NOT COMPLETED|Step 1||0
457872|NCT01262872|1121718|P7|NOT COMPLETED|Step 1||0
457873|NCT01262872|1121719|P6|NOT COMPLETED|Step 1||0
457874|NCT01262872|1121720|P5|NOT COMPLETED|Step 1||0
457875|NCT01262872|1121721|P4|NOT COMPLETED|Step 1||0
457876|NCT01262872|1121722|P3|NOT COMPLETED|Step 1||0
457877|NCT01262872|1121723|P2|NOT COMPLETED|Step 1||0
457878|NCT01262872|1121724|P1|NOT COMPLETED|Step 1||0
458038|NCT01262118|1122312|P2|STARTED|Baseline Assessment Period (3 Days)||33
457879|NCT01262872|1121717|P8|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
457880|NCT01262872|1121718|P7|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
457881|NCT01262872|1121719|P6|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
457882|NCT01262872|1121720|P5|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
457883|NCT01262872|1121721|P4|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone|0
457884|NCT01262872|1121722|P3|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
457885|NCT01262872|1121723|P2|COMPLETED|Step 1||60
457886|NCT01262872|1121724|P1|COMPLETED|Step 1||60
457887|NCT01262872|1121717|P8|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
457888|NCT01262872|1121718|P7|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
457889|NCT01262872|1121719|P6|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
457890|NCT01262872|1121720|P5|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
457891|NCT01262872|1121721|P4|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
457892|NCT01262872|1121722|P3|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
457893|NCT01262872|1121723|P2|STARTED|Step 1||60
457894|NCT01262872|1121724|P1|STARTED|Step 1||60
457895|NCT01262846|1121979|P2|NOT COMPLETED|Overall Study||3
457896|NCT01262846|1121980|P1|NOT COMPLETED|Overall Study||2
457897|NCT01262846|1121979|P2|COMPLETED|Overall Study||97
457898|NCT01262846|1121980|P1|COMPLETED|Overall Study||93
457899|NCT01262846|1121979|P2|STARTED|Overall Study||100
457900|NCT01262846|1121980|P1|STARTED|Overall Study||95
457901|NCT01262820|1121986|P1|NOT COMPLETED|Overall Study||15
457902|NCT01262820|1121986|P1|COMPLETED|Overall Study||0
457903|NCT01262820|1121986|P1|STARTED|Overall Study||15
457904|NCT01262755|1121993|P1|NOT COMPLETED|Overall Study||0
457905|NCT01262755|1121993|P1|COMPLETED|Overall Study||450
457906|NCT01262755|1121993|P1|STARTED|Overall Study||450
457907|NCT01262677|1122000|P3|NOT COMPLETED|Overall Study||12
457908|NCT01262677|1122001|P2|NOT COMPLETED|Overall Study||15
457909|NCT01262677|1122002|P1|NOT COMPLETED|Overall Study||9
457910|NCT01262677|1122000|P3|COMPLETED|Overall Study||98
457911|NCT01262677|1122001|P2|COMPLETED|Overall Study||98
457912|NCT01262677|1122002|P1|COMPLETED|Overall Study||91
457913|NCT01262677|1122000|P3|STARTED|Overall Study||110
457914|NCT01262677|1122001|P2|STARTED|Overall Study||113
457915|NCT01262677|1122002|P1|STARTED|Overall Study||100
457916|NCT01262651|1122093|P2|NOT COMPLETED|Overall Study||48
457917|NCT01262651|1122094|P1|NOT COMPLETED|Overall Study||58
457918|NCT01262651|1122093|P2|COMPLETED|Overall Study||150
457919|NCT01262651|1122094|P1|COMPLETED|Overall Study||141
457920|NCT01262651|1122093|P2|ITT Population|Overall Study||198
457921|NCT01262651|1122094|P1|ITT Population|Overall Study||199
457922|NCT01262651|1122093|P2|Safety Population|Overall Study||198
457923|NCT01262651|1122094|P1|Safety Population|Overall Study||199
457924|NCT01262651|1122093|P2|Received at Least 1 Dose of Study Drug|Overall Study||198
457925|NCT01262651|1122094|P1|Received at Least 1 Dose of Study Drug|Overall Study||199
457926|NCT01262651|1122093|P2|STARTED|Overall Study||198
457927|NCT01262651|1122094|P1|STARTED|Overall Study||199
457928|NCT01262599|1122122|P2|NOT COMPLETED|Overall Study||0
457929|NCT01262599|1122123|P1|NOT COMPLETED|Overall Study||0
457930|NCT01262599|1122122|P2|COMPLETED|Overall Study||16
457931|NCT01262599|1122123|P1|COMPLETED|Overall Study||16
457932|NCT01262599|1122122|P2|STARTED|Overall Study||16
457933|NCT01262599|1122123|P1|STARTED|Overall Study||16
457934|NCT01262573|1122131|P2|NOT COMPLETED|Overall Study||1
457935|NCT01262573|1122132|P1|NOT COMPLETED|Overall Study||0
457936|NCT01262573|1122131|P2|COMPLETED|Overall Study||31
457937|NCT01262573|1122132|P1|COMPLETED|Overall Study||32
457938|NCT01262573|1122131|P2|STARTED|Overall Study||32
457939|NCT01262573|1122132|P1|STARTED|Overall Study||32
457940|NCT01262560|1122143|P3|NOT COMPLETED|Overall Study||2
457941|NCT01262560|1122144|P2|NOT COMPLETED|Overall Study||1
457942|NCT01262560|1122145|P1|NOT COMPLETED|Overall Study||0
457943|NCT01262560|1122143|P3|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|54
457944|NCT01262560|1122144|P2|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|53
457945|NCT01262560|1122145|P1|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|53
457946|NCT01262560|1122143|P3|STARTED|Overall Study||56
457947|NCT01262560|1122144|P2|STARTED|Overall Study||54
457948|NCT01262560|1122145|P1|STARTED|Overall Study||53
457949|NCT01262547|1122180|P1|NOT COMPLETED|Overall Study||0
457950|NCT01262547|1122180|P1|COMPLETED|Overall Study||3
457951|NCT01262547|1122180|P1|STARTED|Overall Study||3
457952|NCT01262456|1122194|P3|NOT COMPLETED|1-Month Open-Label Extension Period||5
457953|NCT01262456|1122195|P2|NOT COMPLETED|1-Month Open-Label Extension Period||3
457954|NCT01262456|1122196|P1|NOT COMPLETED|1-Month Open-Label Extension Period||4
457955|NCT01262456|1122194|P3|COMPLETED|1-Month Open-Label Extension Period||98
457956|NCT01262456|1122195|P2|COMPLETED|1-Month Open-Label Extension Period||97
457957|NCT01262456|1122196|P1|COMPLETED|1-Month Open-Label Extension Period||120
457958|NCT01262456|1122194|P3|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period|1 subject was randomized to Desmopressin 75 μg but received 50 μg. Also true in Double-Blind Period|102
457959|NCT01262456|1122195|P2|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||101
457960|NCT01262456|1122196|P1|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||124
457961|NCT01262456|1122194|P3|STARTED|1-Month Open-Label Extension Period||103
457962|NCT01262456|1122195|P2|STARTED|1-Month Open-Label Extension Period||100
457963|NCT01262456|1122196|P1|STARTED|1-Month Open-Label Extension Period||124
457964|NCT01262456|1122194|P3|NOT COMPLETED|3-Month Double-Blind Period||26
457965|NCT01262456|1122195|P2|NOT COMPLETED|3-Month Double-Blind Period||23
457966|NCT01262456|1122196|P1|NOT COMPLETED|3-Month Double-Blind Period||19
457967|NCT01262456|1122194|P3|COMPLETED|3-Month Double-Blind Period||103
457968|NCT01262456|1122195|P2|COMPLETED|3-Month Double-Blind Period||100
457969|NCT01262456|1122196|P1|COMPLETED|3-Month Double-Blind Period||124
457970|NCT01262456|1122194|P3|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|122
457971|NCT01262456|1122195|P2|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|119
457972|NCT01262456|1122196|P1|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|143
457973|NCT01262456|1122194|P3|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|124
457974|NCT01262456|1122195|P2|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|119
457975|NCT01262456|1122196|P1|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|142
457976|NCT01262456|1122194|P3|STARTED|3-Month Double-Blind Period|ITT population: randomized participants regardless of exposure to treatment|129
457977|NCT01262456|1122195|P2|STARTED|3-Month Double-Blind Period|ITT population: randomized participants regardless of exposure to treatment|123
457978|NCT01262456|1122196|P1|STARTED|3-Month Double-Blind Period|Intent-to-Treat (ITT) population: randomized participants regardless of exposure to treatment|143
457988|NCT01262352|1122267|P2|NOT COMPLETED|Period 2||0
457989|NCT01262352|1122268|P1|NOT COMPLETED|Period 2||0
457990|NCT01262352|1122267|P2|COMPLETED|Period 2||8
457991|NCT01262352|1122268|P1|COMPLETED|Period 2||9
457992|NCT01262352|1122267|P2|Dosed|Period 2||8
457993|NCT01262352|1122268|P1|Dosed|Period 2||9
457994|NCT01262352|1122267|P2|STARTED|Period 2||8
457995|NCT01262352|1122268|P1|STARTED|Period 2||9
457996|NCT01262352|1122267|P2|NOT COMPLETED|Washout||2
457997|NCT01262352|1122268|P1|NOT COMPLETED|Washout||1
457998|NCT01262352|1122267|P2|COMPLETED|Washout||8
457999|NCT01262352|1122268|P1|COMPLETED|Washout||9
458000|NCT01262352|1122267|P2|STARTED|Washout||10
458001|NCT01262352|1122268|P1|STARTED|Washout||10
458002|NCT01262352|1122267|P2|NOT COMPLETED|Period 1||0
458003|NCT01262352|1122268|P1|NOT COMPLETED|Period 1||1
458004|NCT01262352|1122267|P2|COMPLETED|Period 1||10
458005|NCT01262352|1122268|P1|COMPLETED|Period 1||10
458006|NCT01262352|1122267|P2|Dosed|Period 1||10
458007|NCT01262352|1122268|P1|Dosed|Period 1||10
458008|NCT01262352|1122267|P2|STARTED|Period 1||10
458009|NCT01262352|1122268|P1|STARTED|Period 1||11
458010|NCT01262339|1122280|P1|NOT COMPLETED|Overall Study||0
458011|NCT01262339|1122280|P1|COMPLETED|Overall Study||2
458012|NCT01262339|1122280|P1|STARTED|Overall Study||2
458013|NCT01262287|1122286|P2|NOT COMPLETED|Overall Study||1
458014|NCT01262287|1122287|P1|NOT COMPLETED|Overall Study||2
458015|NCT01262287|1122286|P2|COMPLETED|Overall Study||18
458016|NCT01262287|1122287|P1|COMPLETED|Overall Study||18
458017|NCT01262287|1122286|P2|STARTED|Overall Study||19
458018|NCT01262287|1122287|P1|STARTED|Overall Study||20
458019|NCT01262131|1122300|P3|NOT COMPLETED|Overall Study||0
458020|NCT01262131|1122301|P2|NOT COMPLETED|Overall Study||0
458021|NCT01262131|1122302|P1|NOT COMPLETED|Overall Study||0
458022|NCT01262131|1122300|P3|COMPLETED|Overall Study||4
458023|NCT01262131|1122301|P2|COMPLETED|Overall Study||4
458024|NCT01262131|1122302|P1|COMPLETED|Overall Study||5
458025|NCT01262131|1122300|P3|STARTED|Overall Study||4
458026|NCT01262131|1122301|P2|STARTED|Overall Study||4
458027|NCT01262131|1122302|P1|STARTED|Overall Study||5
458028|NCT01262118|1122312|P2|NOT COMPLETED|Treatment Period (6 Weeks)||0
458029|NCT01262118|1122313|P1|NOT COMPLETED|Treatment Period (6 Weeks)||0
458030|NCT01262118|1122312|P2|COMPLETED|Treatment Period (6 Weeks)||0
458031|NCT01262118|1122313|P1|COMPLETED|Treatment Period (6 Weeks)||36
458032|NCT01262118|1122312|P2|STARTED|Treatment Period (6 Weeks)||0
458033|NCT01262118|1122313|P1|STARTED|Treatment Period (6 Weeks)||36
458034|NCT01262118|1122312|P2|NOT COMPLETED|Baseline Assessment Period (3 Days)||0
458035|NCT01262118|1122313|P1|NOT COMPLETED|Baseline Assessment Period (3 Days)||0
458036|NCT01262118|1122312|P2|COMPLETED|Baseline Assessment Period (3 Days)||33
458037|NCT01262118|1122313|P1|COMPLETED|Baseline Assessment Period (3 Days)||36
458039|NCT01262118|1122313|P1|STARTED|Baseline Assessment Period (3 Days)||36
458040|NCT01262105|1122339|P2|NOT COMPLETED|Overall Study||0
458041|NCT01262105|1122340|P1|NOT COMPLETED|Overall Study||0
458042|NCT01262105|1122339|P2|COMPLETED|Overall Study||10
458043|NCT01262105|1122340|P1|COMPLETED|Overall Study||13
458044|NCT01262105|1122339|P2|STARTED|Overall Study||10
458045|NCT01262105|1122340|P1|STARTED|Overall Study||13
458046|NCT01262092|1122348|P2|NOT COMPLETED|Gabapentin Taper||0
458047|NCT01262092|1122349|P1|NOT COMPLETED|Gabapentin Taper||1
458048|NCT01262092|1122348|P2|COMPLETED|Gabapentin Taper||11
458049|NCT01262092|1122349|P1|COMPLETED|Gabapentin Taper||9
458050|NCT01262092|1122348|P2|STARTED|Gabapentin Taper|One participant dropped out after the buprenorphine taper but prior to the gabapentin taper|11
458051|NCT01262092|1122349|P1|STARTED|Gabapentin Taper|One participant dropped out after the buprenorphine taper but prior to the gabapentin taper|10
458052|NCT01262092|1122348|P2|NOT COMPLETED|Buprenorphine Taper||1
458053|NCT01262092|1122349|P1|NOT COMPLETED|Buprenorphine Taper||1
458054|NCT01262092|1122348|P2|COMPLETED|Buprenorphine Taper||12
458055|NCT01262092|1122349|P1|COMPLETED|Buprenorphine Taper||11
458056|NCT01262092|1122348|P2|STARTED|Buprenorphine Taper||13
458057|NCT01262092|1122349|P1|STARTED|Buprenorphine Taper|One left the study prior to starting the taper due to pharmacy error (started taper in wk 2)|12
458058|NCT01262092|1122348|P2|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||1
458059|NCT01262092|1122349|P1|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||3
458060|NCT01262092|1122348|P2|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13
458061|NCT01262092|1122349|P1|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13
458062|NCT01262092|1122348|P2|STARTED|Buprenorphine+Gabapentin/Plac Induction||14
458063|NCT01262092|1122349|P1|STARTED|Buprenorphine+Gabapentin/Plac Induction||16
458064|NCT01262027|1122355|P1|NOT COMPLETED|Overall Study||5
458065|NCT01262027|1122355|P1|COMPLETED|Overall Study||17
458066|NCT01262027|1122355|P1|STARTED|Overall Study||22
458067|NCT01261975|1122360|P1|NOT COMPLETED|Overall Study||1
458068|NCT01261975|1122360|P1|COMPLETED|Overall Study|35 Participants 70 eyes completed|35
458069|NCT01261975|1122360|P1|STARTED|Overall Study|36 Participants 72 eyes started|36
458079|NCT01261780|1122409|P2|NOT COMPLETED|Overall Study||2
458080|NCT01261780|1122410|P1|NOT COMPLETED|Overall Study||2
458081|NCT01261780|1122409|P2|COMPLETED|Overall Study||5
458082|NCT01261780|1122410|P1|COMPLETED|Overall Study||5
458083|NCT01261780|1122409|P2|STARTED|Overall Study||7
458084|NCT01261780|1122410|P1|STARTED|Overall Study||7
458085|NCT01261624|1122420|P2|NOT COMPLETED|Week 13 to Week 24||1
458086|NCT01261624|1122421|P1|NOT COMPLETED|Week 13 to Week 24||0
458087|NCT01261624|1122420|P2|COMPLETED|Week 13 to Week 24||10
458088|NCT01261624|1122421|P1|COMPLETED|Week 13 to Week 24||1
458089|NCT01261624|1122420|P2|STARTED|Week 13 to Week 24|Of 6 pts of HDTC: 3 non-responders went out of study, 3 continued. 8 swithched from LDTC to HDTC|11
458090|NCT01261624|1122421|P1|STARTED|Week 13 to Week 24|Of 9 pts from LDTC: 5 non-responders switched to HDTC; 4 pts responded, but 3 switched to HDTC|1
458091|NCT01261624|1122420|P2|NOT COMPLETED|Week 0 to Week 12||3
458092|NCT01261624|1122421|P1|NOT COMPLETED|Week 0 to Week 12||1
458093|NCT01261624|1122420|P2|COMPLETED|Week 0 to Week 12||3
458094|NCT01261624|1122421|P1|COMPLETED|Week 0 to Week 12||9
458095|NCT01261624|1122420|P2|STARTED|Week 0 to Week 12||6
458096|NCT01261624|1122421|P1|STARTED|Week 0 to Week 12||10
458097|NCT01261559|1122440|P2|NOT COMPLETED|Overall Study||0
458098|NCT01261559|1122441|P1|NOT COMPLETED|Overall Study||0
458099|NCT01261559|1122440|P2|COMPLETED|Overall Study||36
458100|NCT01261559|1122441|P1|COMPLETED|Overall Study||36
458101|NCT01261559|1122440|P2|STARTED|Overall Study||36
458102|NCT01261559|1122441|P1|STARTED|Overall Study||36
458103|NCT01261507|1122449|P1|NOT COMPLETED|Overall Study||0
458104|NCT01261507|1122449|P1|COMPLETED|Overall Study||15
458105|NCT01261507|1122449|P1|STARTED|Overall Study||15
458106|NCT01261390|1122462|P4|NOT COMPLETED|Overall Study||8
458107|NCT01261390|1122463|P3|NOT COMPLETED|Overall Study||7
458108|NCT01261390|1122464|P2|NOT COMPLETED|Overall Study||9
458109|NCT01261390|1122465|P1|NOT COMPLETED|Overall Study||7
458110|NCT01261390|1122462|P4|COMPLETED|Overall Study|14 of the 33 participants that completed the study in this arm were under the 6-Month protocol.|33
458111|NCT01261390|1122463|P3|COMPLETED|Overall Study|16 of the 35 participants that completed the study in this arm were under the 6-Month protocol.|35
458112|NCT01261390|1122464|P2|COMPLETED|Overall Study|12 of the 33 participants that completed the study in this arm were under the 6-Month protocol.|33
458113|NCT01261390|1122465|P1|COMPLETED|Overall Study|14 of the 37 participants that completed the study in this arm were under the 6-Month protocol.|37
458114|NCT01261390|1122462|P4|12-Month Visit|Overall Study||19
458115|NCT01261390|1122463|P3|12-Month Visit|Overall Study||19
458116|NCT01261390|1122464|P2|12-Month Visit|Overall Study||21
458117|NCT01261390|1122465|P1|12-Month Visit|Overall Study||23
458118|NCT01261390|1122462|P4|6-Month Visit|Overall Study|For 14 of the 32 participants in this arm, this was their final visit.|32
458119|NCT01261390|1122463|P3|6-Month Visit|Overall Study|For 16 of the 34 participants in this arm, this was their final visit.|34
458120|NCT01261390|1122464|P2|6-Month Visit|Overall Study|For 12 of the 34 participants in this arm, this was their final visit.|34
458121|NCT01261390|1122465|P1|6-Month Visit|Overall Study|For 14 of the 30 participants in this arm, this was their final visit.|37
458122|NCT01261390|1122462|P4|STARTED|Overall Study|15 of the 41 participants only had to complete a 6-month follow-up assessment.|41
458123|NCT01261390|1122463|P3|STARTED|Overall Study|16 of the 42 participants only had to complete a 6-month follow-up assessment.|42
458124|NCT01261390|1122464|P2|STARTED|Overall Study|15 of the 42 participants only had to complete a 6-month follow-up assessment.|42
458125|NCT01261390|1122465|P1|STARTED|Overall Study|15 of the 44 participants only had to complete a 6-month follow-up assessment.|44
458126|NCT01261325|1122630|P3|NOT COMPLETED|Overall Study||26
458127|NCT01261325|1122631|P2|NOT COMPLETED|Overall Study||29
458128|NCT01261325|1122632|P1|NOT COMPLETED|Overall Study||17
458129|NCT01261325|1122630|P3|COMPLETED|Overall Study||225
458130|NCT01261325|1122631|P2|COMPLETED|Overall Study||225
458131|NCT01261325|1122632|P1|COMPLETED|Overall Study||246
458132|NCT01261325|1122630|P3|STARTED|Overall Study||251
458133|NCT01261325|1122631|P2|STARTED|Overall Study||254
458134|NCT01261325|1122632|P1|STARTED|Overall Study||263
458135|NCT01261247|1122664|P1|NOT COMPLETED|Overall Study||2
458136|NCT01261247|1122664|P1|COMPLETED|Overall Study||39
458137|NCT01261247|1122664|P1|STARTED|Overall Study||41
458138|NCT01261052|1122671|P1|NOT COMPLETED|APD Only Intervention (33 Hours)||0
458139|NCT01261052|1122671|P1|COMPLETED|APD Only Intervention (33 Hours)||14
458140|NCT01261052|1122671|P1|STARTED|APD Only Intervention (33 Hours)||14
458141|NCT01261052|1122671|P1|NOT COMPLETED|FMPD/APD Intervention (33 Hours)||0
458142|NCT01261052|1122671|P1|COMPLETED|FMPD/APD Intervention (33 Hours)||14
458143|NCT01261052|1122671|P1|STARTED|FMPD/APD Intervention (33 Hours)||14
458144|NCT01261000|1122677|P1|NOT COMPLETED|Overall Study||1
458145|NCT01261000|1122677|P1|COMPLETED|Overall Study||7
458146|NCT01261000|1122677|P1|STARTED|Overall Study||8
458147|NCT01260948|1122683|P2|NOT COMPLETED|Second Intervention||1
458148|NCT01260948|1122684|P1|NOT COMPLETED|Second Intervention||0
458149|NCT01260948|1122683|P2|COMPLETED|Second Intervention||9
458150|NCT01260948|1122684|P1|COMPLETED|Second Intervention||12
458151|NCT01260948|1122683|P2|STARTED|Second Intervention||10
458152|NCT01260948|1122684|P1|STARTED|Second Intervention||12
458153|NCT01260948|1122683|P2|NOT COMPLETED|Washout of 28 Days||3
458154|NCT01260948|1122684|P1|NOT COMPLETED|Washout of 28 Days||1
458155|NCT01260948|1122683|P2|COMPLETED|Washout of 28 Days||10
458156|NCT01260948|1122684|P1|COMPLETED|Washout of 28 Days||12
458157|NCT01260948|1122683|P2|STARTED|Washout of 28 Days||13
458158|NCT01260948|1122684|P1|STARTED|Washout of 28 Days||13
458159|NCT01260948|1122683|P2|NOT COMPLETED|First Intervention||0
458160|NCT01260948|1122684|P1|NOT COMPLETED|First Intervention||0
458161|NCT01260948|1122683|P2|COMPLETED|First Intervention||13
458162|NCT01260948|1122684|P1|COMPLETED|First Intervention||13
458163|NCT01260948|1122683|P2|STARTED|First Intervention||13
458164|NCT01260948|1122684|P1|STARTED|First Intervention||13
458165|NCT01260922|1122694|P2|NOT COMPLETED|Second Intervention||2
458166|NCT01260922|1122695|P1|NOT COMPLETED|Second Intervention||0
458167|NCT01260922|1122694|P2|COMPLETED|Second Intervention||8
458168|NCT01260922|1122695|P1|COMPLETED|Second Intervention||9
458169|NCT01260922|1122694|P2|STARTED|Second Intervention||10
458170|NCT01260922|1122695|P1|STARTED|Second Intervention||9
458171|NCT01260922|1122694|P2|NOT COMPLETED|Washout of 28 Days||2
458172|NCT01260922|1122695|P1|NOT COMPLETED|Washout of 28 Days||4
458173|NCT01260922|1122694|P2|COMPLETED|Washout of 28 Days||10
458174|NCT01260922|1122695|P1|COMPLETED|Washout of 28 Days||9
458175|NCT01260922|1122694|P2|STARTED|Washout of 28 Days||12
458176|NCT01260922|1122695|P1|STARTED|Washout of 28 Days||13
458177|NCT01260922|1122694|P2|NOT COMPLETED|First Intervention||1
458178|NCT01260922|1122695|P1|NOT COMPLETED|First Intervention||0
458179|NCT01260922|1122694|P2|COMPLETED|First Intervention||12
458180|NCT01260922|1122695|P1|COMPLETED|First Intervention||13
458181|NCT01260922|1122694|P2|STARTED|First Intervention||13
458182|NCT01260922|1122695|P1|STARTED|First Intervention||13
458183|NCT01260896|1122705|P2|NOT COMPLETED|Second Intervention||0
458184|NCT01260896|1122706|P1|NOT COMPLETED|Second Intervention||0
458185|NCT01260896|1122705|P2|COMPLETED|Second Intervention||12
458186|NCT01260896|1122706|P1|COMPLETED|Second Intervention||10
458187|NCT01260896|1122705|P2|STARTED|Second Intervention||12
458188|NCT01260896|1122706|P1|STARTED|Second Intervention||10
458189|NCT01260896|1122705|P2|NOT COMPLETED|Washout of 7 Days||0
458190|NCT01260896|1122706|P1|NOT COMPLETED|Washout of 7 Days||0
458191|NCT01260896|1122705|P2|COMPLETED|Washout of 7 Days||12
458192|NCT01260896|1122706|P1|COMPLETED|Washout of 7 Days||10
458193|NCT01260896|1122705|P2|STARTED|Washout of 7 Days||12
458194|NCT01260896|1122706|P1|STARTED|Washout of 7 Days||10
458195|NCT01260896|1122705|P2|NOT COMPLETED|First Intervention||0
458196|NCT01260896|1122706|P1|NOT COMPLETED|First Intervention||2
458197|NCT01260896|1122705|P2|COMPLETED|First Intervention||12
458198|NCT01260896|1122706|P1|COMPLETED|First Intervention||10
458199|NCT01260896|1122705|P2|STARTED|First Intervention||12
458200|NCT01260896|1122706|P1|STARTED|First Intervention||12
458201|NCT01260883|1122725|P3|NOT COMPLETED|Overall Study||0
458202|NCT01260883|1122726|P2|NOT COMPLETED|Overall Study||0
458203|NCT01260883|1122727|P1|NOT COMPLETED|Overall Study||0
458204|NCT01260883|1122725|P3|COMPLETED|Overall Study||18
458205|NCT01260883|1122726|P2|COMPLETED|Overall Study||11
458206|NCT01260883|1122727|P1|COMPLETED|Overall Study||22
458207|NCT01260883|1122725|P3|STARTED|Overall Study||18
458208|NCT01260883|1122726|P2|STARTED|Overall Study||11
458209|NCT01260883|1122727|P1|STARTED|Overall Study||22
458210|NCT01260701|1122764|P1|NOT COMPLETED|Overall Study||75
458211|NCT01260701|1122764|P1|COMPLETED|Overall Study||0
458212|NCT01260701|1122764|P1|Eligible and Began Protocol Therapy|Overall Study||70
458213|NCT01260701|1122764|P1|Eligible|Overall Study||71
458214|NCT01260701|1122764|P1|STARTED|Overall Study||75
458215|NCT01260688|1122773|P2|NOT COMPLETED|Overall Study||0
458216|NCT01260688|1122774|P1|NOT COMPLETED|Overall Study||0
458217|NCT01260688|1122773|P2|COMPLETED|Overall Study||11
458218|NCT01260688|1122774|P1|COMPLETED|Overall Study||11
458219|NCT01260688|1122773|P2|STARTED|Overall Study||11
458220|NCT01260688|1122774|P1|STARTED|Overall Study||11
458221|NCT01260662|1122811|P3|NOT COMPLETED|Overall Study||0
458222|NCT01260662|1122812|P2|NOT COMPLETED|Overall Study||0
458223|NCT01260662|1122813|P1|NOT COMPLETED|Overall Study||0
458224|NCT01260662|1122811|P3|COMPLETED|Overall Study||96
458225|NCT01260662|1122812|P2|COMPLETED|Overall Study||85
458226|NCT01260662|1122813|P1|COMPLETED|Overall Study||90
458227|NCT01260662|1122811|P3|STARTED|Overall Study||96
458228|NCT01260662|1122812|P2|STARTED|Overall Study||85
458229|NCT01260662|1122813|P1|STARTED|Overall Study||90
458230|NCT01260649|1122832|P2|NOT COMPLETED|Overall Study||1
458231|NCT01260649|1122833|P1|NOT COMPLETED|Overall Study||2
458232|NCT01260649|1122832|P2|COMPLETED|Overall Study||8
458233|NCT01260649|1122833|P1|COMPLETED|Overall Study||6
458234|NCT01260649|1122832|P2|STARTED|Overall Study||9
458235|NCT01260649|1122833|P1|STARTED|Overall Study||8
458236|NCT01260584|1122845|P4|NOT COMPLETED|Period 2||1
458237|NCT01260584|1122846|P3|NOT COMPLETED|Period 2||5
458238|NCT01260584|1122847|P2|NOT COMPLETED|Period 2||3
458239|NCT01260584|1122848|P1|NOT COMPLETED|Period 2||1
458240|NCT01260584|1122845|P4|COMPLETED|Period 2||26
458241|NCT01260584|1122846|P3|COMPLETED|Period 2||20
458242|NCT01260584|1122847|P2|COMPLETED|Period 2||25
458243|NCT01260584|1122848|P1|COMPLETED|Period 2||26
458244|NCT01260584|1122845|P4|STARTED|Period 2||27
458245|NCT01260584|1122846|P3|STARTED|Period 2||25
458246|NCT01260584|1122847|P2|STARTED|Period 2||28
458247|NCT01260584|1122848|P1|STARTED|Period 2||27
458248|NCT01260584|1122845|P4|NOT COMPLETED|Period 1||1
458249|NCT01260584|1122846|P3|NOT COMPLETED|Period 1||2
458250|NCT01260584|1122847|P2|NOT COMPLETED|Period 1||0
458251|NCT01260584|1122848|P1|NOT COMPLETED|Period 1||0
458252|NCT01260584|1122845|P4|COMPLETED|Period 1||27
458253|NCT01260584|1122846|P3|COMPLETED|Period 1||25
458254|NCT01260584|1122847|P2|COMPLETED|Period 1||28
458255|NCT01260584|1122848|P1|COMPLETED|Period 1||27
458256|NCT01260584|1122845|P4|STARTED|Period 1||28
458257|NCT01260584|1122846|P3|STARTED|Period 1||27
458258|NCT01260584|1122847|P2|STARTED|Period 1||28
458259|NCT01260584|1122848|P1|STARTED|Period 1||27
458260|NCT01260493|1122884|P2|NOT COMPLETED|Overall Study||4
458261|NCT01260493|1122885|P1|NOT COMPLETED|Overall Study||16
458262|NCT01260493|1122884|P2|COMPLETED|Overall Study||85
458263|NCT01260493|1122885|P1|COMPLETED|Overall Study||76
458264|NCT01260493|1122884|P2|STARTED|Overall Study||89
458265|NCT01260493|1122885|P1|STARTED|Overall Study||92
458266|NCT01260467|1122891|P1|NOT COMPLETED|Overall Study||2
458267|NCT01260467|1122891|P1|COMPLETED|Overall Study||2
458268|NCT01260467|1122891|P1|STARTED|Overall Study||4
458269|NCT01260454|1122897|P1|NOT COMPLETED|Overall Study||0
458270|NCT01260454|1122897|P1|COMPLETED|Overall Study||6
458271|NCT01260454|1122897|P1|STARTED|Overall Study||6
458272|NCT01260350|1122923|P22|NOT COMPLETED|Overall Study||0
458273|NCT01260350|1122924|P21|NOT COMPLETED|Overall Study||3
458274|NCT01260350|1122925|P20|NOT COMPLETED|Overall Study||0
458275|NCT01260350|1122926|P19|NOT COMPLETED|Overall Study||0
458276|NCT01260350|1122927|P18|NOT COMPLETED|Overall Study||1
458277|NCT01260350|1122928|P17|NOT COMPLETED|Overall Study||0
458278|NCT01260350|1122929|P16|NOT COMPLETED|Overall Study||0
458279|NCT01260350|1122930|P15|NOT COMPLETED|Overall Study||0
458280|NCT01260350|1122931|P14|NOT COMPLETED|Overall Study||0
458281|NCT01260350|1122932|P13|NOT COMPLETED|Overall Study||0
458282|NCT01260350|1122933|P12|NOT COMPLETED|Overall Study||0
458283|NCT01260350|1122934|P11|NOT COMPLETED|Overall Study||0
458284|NCT01260350|1122935|P10|NOT COMPLETED|Overall Study||0
458285|NCT01260350|1122936|P9|NOT COMPLETED|Overall Study||1
458286|NCT01260350|1122937|P8|NOT COMPLETED|Overall Study||0
458287|NCT01260350|1122938|P7|NOT COMPLETED|Overall Study||0
458288|NCT01260350|1122939|P6|NOT COMPLETED|Overall Study||0
458289|NCT01260350|1122940|P5|NOT COMPLETED|Overall Study||0
458290|NCT01260350|1122941|P4|NOT COMPLETED|Overall Study||0
458291|NCT01260350|1122942|P3|NOT COMPLETED|Overall Study||0
458292|NCT01260350|1122943|P2|NOT COMPLETED|Overall Study||0
458293|NCT01260350|1122944|P1|NOT COMPLETED|Overall Study||0
458294|NCT01260350|1122923|P22|COMPLETED|Overall Study||0
458295|NCT01260350|1122924|P21|COMPLETED|Overall Study||22
458296|NCT01260350|1122925|P20|COMPLETED|Overall Study||14
458297|NCT01260350|1122926|P19|COMPLETED|Overall Study||0
458298|NCT01260350|1122927|P18|COMPLETED|Overall Study||9
458299|NCT01260350|1122928|P17|COMPLETED|Overall Study||9
458300|NCT01260350|1122929|P16|COMPLETED|Overall Study||10
458301|NCT01260350|1122930|P15|COMPLETED|Overall Study||25
458302|NCT01260350|1122931|P14|COMPLETED|Overall Study||10
458303|NCT01260350|1122932|P13|COMPLETED|Overall Study||25
458304|NCT01260350|1122933|P12|COMPLETED|Overall Study||9
458305|NCT01260350|1122934|P11|COMPLETED|Overall Study||10
458306|NCT01260350|1122935|P10|COMPLETED|Overall Study||25
458307|NCT01260350|1122936|P9|COMPLETED|Overall Study||24
458308|NCT01260350|1122937|P8|COMPLETED|Overall Study||25
458309|NCT01260350|1122938|P7|COMPLETED|Overall Study||10
458310|NCT01260350|1122939|P6|COMPLETED|Overall Study||10
458311|NCT01260350|1122940|P5|COMPLETED|Overall Study||10
458312|NCT01260350|1122941|P4|COMPLETED|Overall Study||11
458313|NCT01260350|1122942|P3|COMPLETED|Overall Study||10
458314|NCT01260350|1122943|P2|COMPLETED|Overall Study||9
458315|NCT01260350|1122944|P1|COMPLETED|Overall Study||10
458316|NCT01260350|1122923|P22|STARTED|Overall Study||0
458317|NCT01260350|1122924|P21|STARTED|Overall Study||25
458318|NCT01260350|1122925|P20|STARTED|Overall Study||14
458319|NCT01260350|1122926|P19|STARTED|Overall Study||0
458320|NCT01260350|1122927|P18|STARTED|Overall Study||10
458321|NCT01260350|1122928|P17|STARTED|Overall Study||9
458322|NCT01260350|1122929|P16|STARTED|Overall Study||10
458323|NCT01260350|1122930|P15|STARTED|Overall Study||25
458324|NCT01260350|1122931|P14|STARTED|Overall Study||10
458325|NCT01260350|1122932|P13|STARTED|Overall Study||25
458326|NCT01260350|1122933|P12|STARTED|Overall Study||9
458327|NCT01260350|1122934|P11|STARTED|Overall Study||10
458328|NCT01260350|1122935|P10|STARTED|Overall Study||25
458329|NCT01260350|1122936|P9|STARTED|Overall Study||25
458330|NCT01260350|1122937|P8|STARTED|Overall Study||25
458331|NCT01260350|1122938|P7|STARTED|Overall Study||10
458332|NCT01260350|1122939|P6|STARTED|Overall Study||10
458333|NCT01260350|1122940|P5|STARTED|Overall Study||10
458334|NCT01260350|1122941|P4|STARTED|Overall Study||11
458335|NCT01260350|1122942|P3|STARTED|Overall Study||10
458336|NCT01260350|1122943|P2|STARTED|Overall Study||9
458337|NCT01260350|1122944|P1|STARTED|Overall Study||10
458338|NCT01260324|1123136|P2|NOT COMPLETED|Overall Study||0
458339|NCT01260324|1123137|P1|NOT COMPLETED|Overall Study||0
458340|NCT01260324|1123136|P2|COMPLETED|Overall Study||20000
458341|NCT01260324|1123137|P1|COMPLETED|Overall Study||1283
458342|NCT01260324|1123136|P2|STARTED|Overall Study||20000
458343|NCT01260324|1123137|P1|STARTED|Overall Study||1283
458344|NCT01260311|1123151|P1|NOT COMPLETED|Overall Study||127
458345|NCT01260311|1123151|P1|COMPLETED|Overall Study||381
458346|NCT01260311|1123151|P1|STARTED|Overall Study||508
458347|NCT01260272|1123161|P2|NOT COMPLETED|Overall Study||2
458348|NCT01260272|1123162|P1|NOT COMPLETED|Overall Study||2
458349|NCT01260272|1123161|P2|COMPLETED|Overall Study||30
458350|NCT01260272|1123162|P1|COMPLETED|Overall Study||15
458351|NCT01260272|1123161|P2|STARTED|Overall Study||32
458352|NCT01260272|1123162|P1|STARTED|Overall Study||17
458353|NCT01260194|1123182|P1|NOT COMPLETED|Overall Study||1
458354|NCT01260194|1123182|P1|COMPLETED|Overall Study||3
458355|NCT01260194|1123182|P1|STARTED|Overall Study||4
458356|NCT01260142|1123200|P6|NOT COMPLETED|Treatment Period 2||0
458357|NCT01260142|1123201|P5|NOT COMPLETED|Treatment Period 2||0
458358|NCT01260142|1123202|P4|NOT COMPLETED|Treatment Period 2||0
458359|NCT01260142|1123203|P3|NOT COMPLETED|Treatment Period 2||0
458360|NCT01260142|1123204|P2|NOT COMPLETED|Treatment Period 2||0
458361|NCT01260142|1123205|P1|NOT COMPLETED|Treatment Period 2||0
458362|NCT01260142|1123200|P6|COMPLETED|Treatment Period 2||3
458363|NCT01260142|1123201|P5|COMPLETED|Treatment Period 2||4
458364|NCT01260142|1123202|P4|COMPLETED|Treatment Period 2||6
458365|NCT01260142|1123203|P3|COMPLETED|Treatment Period 2||6
458366|NCT01260142|1123204|P2|COMPLETED|Treatment Period 2||5
458367|NCT01260142|1123205|P1|COMPLETED|Treatment Period 2||5
458368|NCT01260142|1123200|P6|STARTED|Treatment Period 2||3
458369|NCT01260142|1123201|P5|STARTED|Treatment Period 2||4
458370|NCT01260142|1123202|P4|STARTED|Treatment Period 2||6
458371|NCT01260142|1123203|P3|STARTED|Treatment Period 2||6
458372|NCT01260142|1123204|P2|STARTED|Treatment Period 2||5
458373|NCT01260142|1123205|P1|STARTED|Treatment Period 2||5
458374|NCT01260142|1123200|P6|NOT COMPLETED|Treatment Period 1||3
458375|NCT01260142|1123201|P5|NOT COMPLETED|Treatment Period 1||2
458376|NCT01260142|1123202|P4|NOT COMPLETED|Treatment Period 1||0
458377|NCT01260142|1123203|P3|NOT COMPLETED|Treatment Period 1||0
458378|NCT01260142|1123204|P2|NOT COMPLETED|Treatment Period 1||1
458379|NCT01260142|1123205|P1|NOT COMPLETED|Treatment Period 1||1
458380|NCT01260142|1123200|P6|COMPLETED|Treatment Period 1||3
458381|NCT01260142|1123201|P5|COMPLETED|Treatment Period 1||4
458382|NCT01260142|1123202|P4|COMPLETED|Treatment Period 1||6
458383|NCT01260142|1123203|P3|COMPLETED|Treatment Period 1||6
458384|NCT01260142|1123204|P2|COMPLETED|Treatment Period 1||5
458385|NCT01260142|1123205|P1|COMPLETED|Treatment Period 1||5
458386|NCT01260142|1123200|P6|STARTED|Treatment Period 1||6
458387|NCT01260142|1123201|P5|STARTED|Treatment Period 1||6
458388|NCT01260142|1123202|P4|STARTED|Treatment Period 1||6
458389|NCT01260142|1123203|P3|STARTED|Treatment Period 1||6
458390|NCT01260142|1123204|P2|STARTED|Treatment Period 1||6
458391|NCT01260142|1123205|P1|STARTED|Treatment Period 1||6
458392|NCT01259726|1123259|P4|NOT COMPLETED|Overall Study||5
458393|NCT01259726|1123260|P3|NOT COMPLETED|Overall Study||4
458394|NCT01259726|1123261|P2|NOT COMPLETED|Overall Study||4
458395|NCT01259726|1123262|P1|NOT COMPLETED|Overall Study||5
458396|NCT01259726|1123259|P4|COMPLETED|Overall Study||36
458397|NCT01259726|1123260|P3|COMPLETED|Overall Study||39
458398|NCT01259726|1123261|P2|COMPLETED|Overall Study||37
458399|NCT01259726|1123262|P1|COMPLETED|Overall Study||38
458400|NCT01259726|1123259|P4|Treated|Overall Study||39
458401|NCT01259726|1123260|P3|Treated|Overall Study||41
458402|NCT01259726|1123261|P2|Treated|Overall Study||37
458403|NCT01259726|1123262|P1|Treated|Overall Study||40
458404|NCT01259726|1123259|P4|STARTED|Overall Study||41
458405|NCT01259726|1123260|P3|STARTED|Overall Study||43
458406|NCT01259726|1123261|P2|STARTED|Overall Study||41
458407|NCT01259726|1123262|P1|STARTED|Overall Study||43
458408|NCT01259713|1123294|P2|NOT COMPLETED|Overall Study||41
458409|NCT01259713|1123295|P1|NOT COMPLETED|Overall Study||95
458410|NCT01259713|1123294|P2|COMPLETED|Overall Study||77
458411|NCT01259713|1123295|P1|COMPLETED|Overall Study||142
458412|NCT01259713|1123294|P2|STARTED|Overall Study||118
458413|NCT01259713|1123295|P1|STARTED|Overall Study||237
458414|NCT01259596|1123319|P2|NOT COMPLETED|Overall Study||6
458415|NCT01259596|1123320|P1|NOT COMPLETED|Overall Study||4
458416|NCT01259596|1123319|P2|COMPLETED|Overall Study||65
458417|NCT01259596|1123320|P1|COMPLETED|Overall Study||66
458418|NCT01259596|1123319|P2|STARTED|Overall Study||71
458419|NCT01259596|1123320|P1|STARTED|Overall Study||70
458420|NCT01259492|1123342|P4|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||81
458421|NCT01259492|1123343|P3|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||50
458422|NCT01259492|1123344|P2|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||69
458423|NCT01259492|1123345|P1|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||54
458424|NCT01259492|1123342|P4|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|42
458425|NCT01259492|1123343|P3|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|70
458426|NCT01259492|1123344|P2|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|63
458427|NCT01259492|1123345|P1|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|60
458428|NCT01259492|1123342|P4|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||115
458429|NCT01259492|1123343|P3|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||114
458430|NCT01259492|1123344|P2|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||128
458431|NCT01259492|1123345|P1|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||110
458432|NCT01259492|1123342|P4|STARTED|Period 3 (Week 15 to End of Week 40)||123
458433|NCT01259492|1123343|P3|STARTED|Period 3 (Week 15 to End of Week 40)||120
458434|NCT01259492|1123344|P2|STARTED|Period 3 (Week 15 to End of Week 40)||132
458435|NCT01259492|1123345|P1|STARTED|Period 3 (Week 15 to End of Week 40)|In period 3, all 489 patients who completed period 2 were re-randomized to 4 arms.|114
458436|NCT01259492|1123342|P4|NOT COMPLETED|Period 2 (Week 10 to Week 14)||28
458437|NCT01259492|1123343|P3|NOT COMPLETED|Period 2 (Week 10 to Week 14)||24
458438|NCT01259492|1123344|P2|NOT COMPLETED|Period 2 (Week 10 to Week 14)||18
458439|NCT01259492|1123345|P1|NOT COMPLETED|Period 2 (Week 10 to Week 14)||25
458440|NCT01259492|1123342|P4|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|125
458441|NCT01259492|1123343|P3|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|114
458442|NCT01259492|1123344|P2|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|123
458443|NCT01259492|1123345|P1|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|127
458444|NCT01259492|1123342|P4|STARTED|Period 2 (Week 10 to Week 14)||153
458445|NCT01259492|1123343|P3|STARTED|Period 2 (Week 10 to Week 14)||138
458446|NCT01259492|1123344|P2|STARTED|Period 2 (Week 10 to Week 14)||141
458447|NCT01259492|1123345|P1|STARTED|Period 2 (Week 10 to Week 14)|Treatment arms including Placebo indicate patients belong to respective treatment arms in Period 1|152
458448|NCT01259492|1123342|P4|NOT COMPLETED|Period 1 (9 Weeks)||28
458449|NCT01259492|1123343|P3|NOT COMPLETED|Period 1 (9 Weeks)||43
458450|NCT01259492|1123344|P2|NOT COMPLETED|Period 1 (9 Weeks)||41
458451|NCT01259492|1123345|P1|NOT COMPLETED|Period 1 (9 Weeks)||29
458452|NCT01259492|1123342|P4|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|153
458453|NCT01259492|1123343|P3|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|138
458454|NCT01259492|1123344|P2|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|141
458455|NCT01259492|1123345|P1|COMPLETED|Period 1 (9 Weeks)|"Completed indicates patients entered Period 2."|152
458456|NCT01259492|1123342|P4|Full Analysis Set|Period 1 (9 Weeks)||172
458457|NCT01259492|1123343|P3|Full Analysis Set|Period 1 (9 Weeks)||179
458458|NCT01259492|1123344|P2|Full Analysis Set|Period 1 (9 Weeks)||175
458459|NCT01259492|1123345|P1|Full Analysis Set|Period 1 (9 Weeks)||174
458460|NCT01259492|1123342|P4|STARTED|Period 1 (9 Weeks)||181
458461|NCT01259492|1123343|P3|STARTED|Period 1 (9 Weeks)||181
458462|NCT01259492|1123344|P2|STARTED|Period 1 (9 Weeks)||182
458463|NCT01259492|1123345|P1|STARTED|Period 1 (9 Weeks)||181
458464|NCT01259466|1123394|P2|NOT COMPLETED|Overall Study||9
458465|NCT01259466|1123395|P1|NOT COMPLETED|Overall Study||1
458466|NCT01259466|1123394|P2|COMPLETED|Overall Study||18
458467|NCT01259466|1123395|P1|COMPLETED|Overall Study||26
458468|NCT01259466|1123394|P2|STARTED|Overall Study||27
458469|NCT01259466|1123395|P1|STARTED|Overall Study||27
458470|NCT01259440|1123405|P2|NOT COMPLETED|Overall Study||0
458471|NCT01259440|1123406|P1|NOT COMPLETED|Overall Study||0
458472|NCT01259440|1123405|P2|COMPLETED|Overall Study||10
458473|NCT01259440|1123406|P1|COMPLETED|Overall Study||13
458474|NCT01259440|1123405|P2|STARTED|Overall Study||10
458475|NCT01259440|1123406|P1|STARTED|Overall Study||13
458476|NCT01259427|1123414|P2|NOT COMPLETED|Overall Study||14
458477|NCT01259427|1123415|P1|NOT COMPLETED|Overall Study||18
458478|NCT01259427|1123414|P2|COMPLETED|Overall Study||110
458479|NCT01259427|1123415|P1|COMPLETED|Overall Study||106
458480|NCT01259427|1123414|P2|STARTED|Overall Study||124
458481|NCT01259427|1123415|P1|STARTED|Overall Study||124
458482|NCT01259401|1123433|P2|NOT COMPLETED|4-month Follow-up||2
458483|NCT01259401|1123434|P1|NOT COMPLETED|4-month Follow-up||0
458484|NCT01259401|1123433|P2|COMPLETED|4-month Follow-up||19
458485|NCT01259401|1123434|P1|COMPLETED|4-month Follow-up||21
458486|NCT01259401|1123433|P2|STARTED|4-month Follow-up||21
458487|NCT01259401|1123434|P1|STARTED|4-month Follow-up||21
458488|NCT01259401|1123433|P2|NOT COMPLETED|End of 4-week Intervention||0
458489|NCT01259401|1123434|P1|NOT COMPLETED|End of 4-week Intervention||0
458490|NCT01259401|1123433|P2|COMPLETED|End of 4-week Intervention||21
458491|NCT01259401|1123434|P1|COMPLETED|End of 4-week Intervention||21
458492|NCT01259401|1123433|P2|STARTED|End of 4-week Intervention||21
458493|NCT01259401|1123434|P1|STARTED|End of 4-week Intervention||21
458494|NCT01259375|1123442|P1|NOT COMPLETED|Overall Study||1
458495|NCT01259375|1123442|P1|COMPLETED|Overall Study||23
458496|NCT01259375|1123442|P1|STARTED|Overall Study||24
458497|NCT01259297|1123459|P8|NOT COMPLETED|Double Blind Randomized Period||3
458498|NCT01259297|1123460|P7|NOT COMPLETED|Double Blind Randomized Period||6
458499|NCT01259297|1123461|P6|NOT COMPLETED|Double Blind Randomized Period||8
458500|NCT01259297|1123462|P5|NOT COMPLETED|Double Blind Randomized Period||4
458501|NCT01259297|1123463|P4|NOT COMPLETED|Double Blind Randomized Period||4
458502|NCT01259297|1123464|P3|NOT COMPLETED|Double Blind Randomized Period||1
458503|NCT01259297|1123465|P2|NOT COMPLETED|Double Blind Randomized Period||3
458504|NCT01259297|1123466|P1|NOT COMPLETED|Double Blind Randomized Period||2
458505|NCT01259297|1123459|P8|COMPLETED|Double Blind Randomized Period||196
458506|NCT01259297|1123460|P7|COMPLETED|Double Blind Randomized Period||190
458507|NCT01259297|1123461|P6|COMPLETED|Double Blind Randomized Period||245
458508|NCT01259297|1123462|P5|COMPLETED|Double Blind Randomized Period||247
458509|NCT01259297|1123463|P4|COMPLETED|Double Blind Randomized Period||191
458510|NCT01259297|1123464|P3|COMPLETED|Double Blind Randomized Period||188
458511|NCT01259297|1123465|P2|COMPLETED|Double Blind Randomized Period||229
458512|NCT01259297|1123466|P1|COMPLETED|Double Blind Randomized Period||242
458513|NCT01259297|1123459|P8|STARTED|Double Blind Randomized Period||199
458514|NCT01259297|1123460|P7|STARTED|Double Blind Randomized Period||196
458515|NCT01259297|1123461|P6|STARTED|Double Blind Randomized Period||253
458516|NCT01259297|1123462|P5|STARTED|Double Blind Randomized Period||251
458517|NCT01259297|1123463|P4|STARTED|Double Blind Randomized Period||195
458518|NCT01259297|1123464|P3|STARTED|Double Blind Randomized Period||189
458519|NCT01259297|1123465|P2|STARTED|Double Blind Randomized Period||232
458520|NCT01259297|1123466|P1|STARTED|Double Blind Randomized Period||244
458521|NCT01259297|1123459|P8|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
458522|NCT01259297|1123460|P7|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
458523|NCT01259297|1123461|P6|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
458524|NCT01259297|1123462|P5|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
458525|NCT01259297|1123463|P4|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
458526|NCT01259297|1123464|P3|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||222
458527|NCT01259297|1123465|P2|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
458528|NCT01259297|1123466|P1|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||355
458529|NCT01259297|1123459|P8|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
458530|NCT01259297|1123460|P7|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
458531|NCT01259297|1123461|P6|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
458532|NCT01259297|1123462|P5|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
458533|NCT01259297|1123463|P4|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
458534|NCT01259297|1123464|P3|COMPLETED|Run-in Open Label Period (4-5 Weeks)||779
458535|NCT01259297|1123465|P2|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
458536|NCT01259297|1123466|P1|COMPLETED|Run-in Open Label Period (4-5 Weeks)||980
458537|NCT01259297|1123459|P8|STARTED|Run-in Open Label Period (4-5 Weeks)||0
458538|NCT01259297|1123460|P7|STARTED|Run-in Open Label Period (4-5 Weeks)||0
458539|NCT01259297|1123461|P6|STARTED|Run-in Open Label Period (4-5 Weeks)||0
458540|NCT01259297|1123462|P5|STARTED|Run-in Open Label Period (4-5 Weeks)||0
458541|NCT01259297|1123463|P4|STARTED|Run-in Open Label Period (4-5 Weeks)||0
458542|NCT01259297|1123464|P3|STARTED|Run-in Open Label Period (4-5 Weeks)||1001
458543|NCT01259297|1123465|P2|STARTED|Run-in Open Label Period (4-5 Weeks)||0
458544|NCT01259297|1123466|P1|STARTED|Run-in Open Label Period (4-5 Weeks)||1335
458545|NCT01259284|1123497|P3|NOT COMPLETED|Overall Study||0
458546|NCT01259284|1123498|P2|NOT COMPLETED|Overall Study||0
458547|NCT01259284|1123499|P1|NOT COMPLETED|Overall Study||2
458548|NCT01259284|1123497|P3|COMPLETED|Overall Study||0
458549|NCT01259284|1123498|P2|COMPLETED|Overall Study||0
458550|NCT01259284|1123499|P1|COMPLETED|Overall Study||0
458551|NCT01259284|1123497|P3|STARTED|Overall Study||0
458552|NCT01259284|1123498|P2|STARTED|Overall Study||0
458553|NCT01259284|1123499|P1|STARTED|Overall Study||2
458554|NCT01259245|1123509|P2|NOT COMPLETED|Overall Study||26
458555|NCT01259245|1123510|P1|NOT COMPLETED|Overall Study||28
458556|NCT01259245|1123509|P2|COMPLETED|Overall Study|24 discontinued intervention and 2 deceased|68
458557|NCT01259245|1123510|P1|COMPLETED|Overall Study|27 were lost to follow-up and 1 deceased|70
458558|NCT01259245|1123509|P2|STARTED|Overall Study||94
458559|NCT01259245|1123510|P1|STARTED|Overall Study||98
458560|NCT01259115|1123534|P2|NOT COMPLETED|Period 2||0
458561|NCT01259115|1123535|P1|NOT COMPLETED|Period 2||1
458562|NCT01259115|1123534|P2|COMPLETED|Period 2||9
458563|NCT01259115|1123535|P1|COMPLETED|Period 2||6
458564|NCT01259115|1123534|P2|STARTED|Period 2||9
458565|NCT01259115|1123535|P1|STARTED|Period 2||7
458566|NCT01259115|1123534|P2|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0
458567|NCT01259115|1123535|P1|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0
458568|NCT01259115|1123534|P2|COMPLETED|Period: Washout Period of 4 to 18 Days||9
458569|NCT01259115|1123535|P1|COMPLETED|Period: Washout Period of 4 to 18 Days||7
458570|NCT01259115|1123534|P2|STARTED|Period: Washout Period of 4 to 18 Days||9
458571|NCT01259115|1123535|P1|STARTED|Period: Washout Period of 4 to 18 Days||7
458572|NCT01259115|1123534|P2|NOT COMPLETED|Period 1||1
458573|NCT01259115|1123535|P1|NOT COMPLETED|Period 1||3
458574|NCT01259115|1123534|P2|COMPLETED|Period 1||9
458575|NCT01259115|1123535|P1|COMPLETED|Period 1||7
458576|NCT01259115|1123534|P2|STARTED|Period 1||10
458577|NCT01259115|1123535|P1|STARTED|Period 1||10
458578|NCT01259102|1123571|P5|NOT COMPLETED|Overall Study||1
458579|NCT01259102|1123572|P4|NOT COMPLETED|Overall Study||2
458580|NCT01259102|1123573|P3|NOT COMPLETED|Overall Study||2
458581|NCT01259102|1123574|P2|NOT COMPLETED|Overall Study||0
458582|NCT01259102|1123575|P1|NOT COMPLETED|Overall Study||1
458583|NCT01259102|1123571|P5|COMPLETED|Overall Study||13
458584|NCT01259102|1123572|P4|COMPLETED|Overall Study||12
458585|NCT01259102|1123573|P3|COMPLETED|Overall Study||13
458586|NCT01259102|1123574|P2|COMPLETED|Overall Study||14
458587|NCT01259102|1123575|P1|COMPLETED|Overall Study||12
458588|NCT01259102|1123571|P5|STARTED|Overall Study||14
458589|NCT01259102|1123572|P4|STARTED|Overall Study||14
458590|NCT01259102|1123573|P3|STARTED|Overall Study||15
458591|NCT01259102|1123574|P2|STARTED|Overall Study||14
458592|NCT01259102|1123575|P1|STARTED|Overall Study||13
458593|NCT01259063|1123632|P1|NOT COMPLETED|Overall Study||0
458594|NCT01259063|1123632|P1|COMPLETED|Overall Study||33
458595|NCT01259063|1123632|P1|STARTED|Overall Study||33
458596|NCT01259024|1123641|P1|NOT COMPLETED|Overall Study||1
458597|NCT01259024|1123641|P1|COMPLETED|Overall Study||0
458598|NCT01259024|1123641|P1|STARTED|Overall Study||1
458599|NCT01259011|1123650|P2|NOT COMPLETED|After Patient Death||0
458600|NCT01259011|1123651|P1|NOT COMPLETED|After Patient Death||0
458601|NCT01259011|1123650|P2|COMPLETED|After Patient Death||28
458602|NCT01259011|1123651|P1|COMPLETED|After Patient Death||17
458603|NCT01259011|1123650|P2|STARTED|After Patient Death|of 109 patient-surrogate dyads/pairs randomized, 28 surrogates of patients who died|28
458604|NCT01259011|1123651|P1|STARTED|After Patient Death|of 101 patient-surrogate dyads/pairs randomized, 17 surrogates of patients who died|17
458605|NCT01259011|1123650|P2|NOT COMPLETED|Main Study Period||0
458606|NCT01259011|1123651|P1|NOT COMPLETED|Main Study Period||0
458607|NCT01259011|1123650|P2|COMPLETED|Main Study Period||109
458608|NCT01259011|1123651|P1|COMPLETED|Main Study Period||101
458609|NCT01259011|1123650|P2|STARTED|Main Study Period|109 dyads (=218 individuals)|109
458610|NCT01259011|1123651|P1|STARTED|Main Study Period|101 dyads (=202 individuals)|101
458611|NCT01258998|1123661|P1|NOT COMPLETED|Overall Study||1
458612|NCT01258998|1123661|P1|COMPLETED|Overall Study||59
458613|NCT01258998|1123661|P1|STARTED|Overall Study||60
458614|NCT01258985|1123667|P2|NOT COMPLETED|Overall Study||0
458615|NCT01258985|1123668|P1|NOT COMPLETED|Overall Study||0
458616|NCT01258985|1123667|P2|COMPLETED|Overall Study||98
458617|NCT01258985|1123668|P1|COMPLETED|Overall Study||106
458618|NCT01258985|1123667|P2|STARTED|Overall Study||98
458619|NCT01258985|1123668|P1|STARTED|Overall Study||106
458620|NCT01258803|1123694|P6|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
458621|NCT01258803|1123695|P5|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
458622|NCT01258803|1123696|P4|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
458623|NCT01258803|1123697|P3|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
458624|NCT01258803|1123698|P2|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
458625|NCT01258803|1123699|P1|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
458626|NCT01258803|1123694|P6|COMPLETED|Treatment Period 4 (1 Dose)||15
458627|NCT01258803|1123695|P5|COMPLETED|Treatment Period 4 (1 Dose)||15
458628|NCT01258803|1123696|P4|COMPLETED|Treatment Period 4 (1 Dose)||15
458629|NCT01258803|1123697|P3|COMPLETED|Treatment Period 4 (1 Dose)||14
458630|NCT01258803|1123698|P2|COMPLETED|Treatment Period 4 (1 Dose)||14
458631|NCT01258803|1123699|P1|COMPLETED|Treatment Period 4 (1 Dose)||14
458632|NCT01258803|1123694|P6|STARTED|Treatment Period 4 (1 Dose)||15
458633|NCT01258803|1123695|P5|STARTED|Treatment Period 4 (1 Dose)||15
458634|NCT01258803|1123696|P4|STARTED|Treatment Period 4 (1 Dose)||15
458635|NCT01258803|1123697|P3|STARTED|Treatment Period 4 (1 Dose)||14
458636|NCT01258803|1123698|P2|STARTED|Treatment Period 4 (1 Dose)||14
458637|NCT01258803|1123699|P1|STARTED|Treatment Period 4 (1 Dose)||14
458638|NCT01258803|1123694|P6|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
458639|NCT01258803|1123695|P5|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
458640|NCT01258803|1123696|P4|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
458641|NCT01258803|1123697|P3|NOT COMPLETED|Treatment Period 3 (1 Dose)||1
458642|NCT01258803|1123698|P2|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
458643|NCT01258803|1123699|P1|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
458644|NCT01258803|1123694|P6|COMPLETED|Treatment Period 3 (1 Dose)||15
458645|NCT01258803|1123695|P5|COMPLETED|Treatment Period 3 (1 Dose)||15
458646|NCT01258803|1123696|P4|COMPLETED|Treatment Period 3 (1 Dose)||15
458647|NCT01258803|1123697|P3|COMPLETED|Treatment Period 3 (1 Dose)||14
458648|NCT01258803|1123698|P2|COMPLETED|Treatment Period 3 (1 Dose)||14
458649|NCT01258803|1123699|P1|COMPLETED|Treatment Period 3 (1 Dose)||14
458650|NCT01258803|1123694|P6|STARTED|Treatment Period 3 (1 Dose)||15
458651|NCT01258803|1123695|P5|STARTED|Treatment Period 3 (1 Dose)||15
458652|NCT01258803|1123696|P4|STARTED|Treatment Period 3 (1 Dose)||15
458653|NCT01258803|1123697|P3|STARTED|Treatment Period 3 (1 Dose)||15
458654|NCT01258803|1123698|P2|STARTED|Treatment Period 3 (1 Dose)||14
458655|NCT01258803|1123699|P1|STARTED|Treatment Period 3 (1 Dose)||14
458656|NCT01258803|1123694|P6|NOT COMPLETED|Treatment Period 2 (1 Dose)||1
458657|NCT01258803|1123695|P5|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
458658|NCT01258803|1123696|P4|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
458659|NCT01258803|1123697|P3|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
458660|NCT01258803|1123698|P2|NOT COMPLETED|Treatment Period 2 (1 Dose)||2
458661|NCT01258803|1123699|P1|NOT COMPLETED|Treatment Period 2 (1 Dose)||1
458662|NCT01258803|1123694|P6|COMPLETED|Treatment Period 2 (1 Dose)||15
458663|NCT01258803|1123695|P5|COMPLETED|Treatment Period 2 (1 Dose)||15
458664|NCT01258803|1123696|P4|COMPLETED|Treatment Period 2 (1 Dose)||15
458665|NCT01258803|1123697|P3|COMPLETED|Treatment Period 2 (1 Dose)||15
458666|NCT01258803|1123698|P2|COMPLETED|Treatment Period 2 (1 Dose)||14
458667|NCT01258803|1123699|P1|COMPLETED|Treatment Period 2 (1 Dose)||14
458668|NCT01258803|1123694|P6|STARTED|Treatment Period 2 (1 Dose)||16
458669|NCT01258803|1123695|P5|STARTED|Treatment Period 2 (1 Dose)||15
458670|NCT01258803|1123696|P4|STARTED|Treatment Period 2 (1 Dose)||15
458671|NCT01258803|1123697|P3|STARTED|Treatment Period 2 (1 Dose)||15
458672|NCT01258803|1123698|P2|STARTED|Treatment Period 2 (1 Dose)||16
458673|NCT01258803|1123699|P1|STARTED|Treatment Period 2 (1 Dose)||15
458674|NCT01258803|1123694|P6|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
458675|NCT01258803|1123695|P5|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
458676|NCT01258803|1123696|P4|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
458677|NCT01258803|1123697|P3|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
458678|NCT01258803|1123698|P2|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
458679|NCT01258803|1123699|P1|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
458680|NCT01258803|1123694|P6|COMPLETED|Treatment Period 1 (1 Dose)||16
458681|NCT01258803|1123695|P5|COMPLETED|Treatment Period 1 (1 Dose)||15
458682|NCT01258803|1123696|P4|COMPLETED|Treatment Period 1 (1 Dose)||15
458683|NCT01258803|1123697|P3|COMPLETED|Treatment Period 1 (1 Dose)||15
458684|NCT01258803|1123698|P2|COMPLETED|Treatment Period 1 (1 Dose)||16
458685|NCT01258803|1123699|P1|COMPLETED|Treatment Period 1 (1 Dose)||15
458686|NCT01258803|1123694|P6|STARTED|Treatment Period 1 (1 Dose)||16
458687|NCT01258803|1123695|P5|STARTED|Treatment Period 1 (1 Dose)||15
458688|NCT01258803|1123696|P4|STARTED|Treatment Period 1 (1 Dose)||15
458689|NCT01258803|1123697|P3|STARTED|Treatment Period 1 (1 Dose)||15
458690|NCT01258803|1123698|P2|STARTED|Treatment Period 1 (1 Dose)||16
458691|NCT01258803|1123699|P1|STARTED|Treatment Period 1 (1 Dose)||15
458692|NCT01258790|1123727|P2|NOT COMPLETED|Overall Study||0
458693|NCT01258790|1123728|P1|NOT COMPLETED|Overall Study||0
458694|NCT01258790|1123727|P2|COMPLETED|Overall Study||6
458695|NCT01258790|1123728|P1|COMPLETED|Overall Study||6
458696|NCT01258790|1123727|P2|STARTED|Overall Study||6
458697|NCT01258790|1123728|P1|STARTED|Overall Study||6
458698|NCT01258738|1123736|P2|NOT COMPLETED|Open-label Period||21
458699|NCT01258738|1123737|P1|NOT COMPLETED|Open-label Period||17
458700|NCT01258738|1123736|P2|COMPLETED|Open-label Period||85
458701|NCT01258738|1123737|P1|COMPLETED|Open-label Period||85
458702|NCT01258738|1123736|P2|STARTED|Open-label Period||106
458703|NCT01258738|1123737|P1|STARTED|Open-label Period||102
458704|NCT01258738|1123736|P2|NOT COMPLETED|Double-blind Period||7
458705|NCT01258738|1123737|P1|NOT COMPLETED|Double-blind Period||9
458706|NCT01258738|1123736|P2|COMPLETED|Double-blind Period|Only 106 participants entered the open label period.|107
458707|NCT01258738|1123737|P1|COMPLETED|Double-blind Period||102
458708|NCT01258738|1123736|P2|Treated|Double-blind Period||113
458709|NCT01258738|1123737|P1|Treated|Double-blind Period||111
458710|NCT01258738|1123736|P2|STARTED|Double-blind Period||114
458711|NCT01258738|1123737|P1|STARTED|Double-blind Period||111
458712|NCT01258660|1123875|P2|NOT COMPLETED|Overall Study||11
458713|NCT01258660|1123876|P1|NOT COMPLETED|Overall Study||11
458714|NCT01258660|1123875|P2|COMPLETED|Overall Study|completed and valid for primary analysis data set|75
458715|NCT01258660|1123876|P1|COMPLETED|Overall Study|completed and valid for primary analysis data set|75
458716|NCT01258660|1123875|P2|Completed Treatment|Overall Study||81
458717|NCT01258660|1123876|P1|Completed Treatment|Overall Study||79
458718|NCT01258660|1123875|P2|Received Treatment|Overall Study||82
458719|NCT01258660|1123876|P1|Received Treatment|Overall Study||79
458720|NCT01258660|1123875|P2|STARTED|Overall Study|randomized and received at least one dose of treatment|86
458721|NCT01258660|1123876|P1|STARTED|Overall Study|randomized and received at least one dose of treatment|86
458722|NCT01258595|1123895|P2|NOT COMPLETED|Overall Study||1
458723|NCT01258595|1123896|P1|NOT COMPLETED|Overall Study||1
458724|NCT01258595|1123895|P2|COMPLETED|Overall Study||151
458725|NCT01258595|1123896|P1|COMPLETED|Overall Study||147
458726|NCT01258595|1123895|P2|STARTED|Overall Study||152
458727|NCT01258595|1123896|P1|STARTED|Overall Study||148
458728|NCT01258582|1123912|P2|NOT COMPLETED|Overall Study||258
458729|NCT01258582|1123913|P1|NOT COMPLETED|Overall Study||282
458730|NCT01258582|1123912|P2|COMPLETED|Overall Study||563
458731|NCT01258582|1123913|P1|COMPLETED|Overall Study||548
458732|NCT01258582|1123912|P2|STARTED|Overall Study||821
458733|NCT01258582|1123913|P1|STARTED|Overall Study||830
458734|NCT01258504|1123919|P1|NOT COMPLETED|Bosentan and SJW||0
458735|NCT01258504|1123919|P1|COMPLETED|Bosentan and SJW||13
458736|NCT01258504|1123919|P1|STARTED|Bosentan and SJW||13
458737|NCT01258504|1123919|P1|NOT COMPLETED|Bosentan Steady-state||0
458738|NCT01258504|1123919|P1|COMPLETED|Bosentan Steady-state||13
458739|NCT01258504|1123919|P1|STARTED|Bosentan Steady-state||13
458740|NCT01258504|1123919|P1|NOT COMPLETED|Bosentan Single Dose||0
458741|NCT01258504|1123919|P1|COMPLETED|Bosentan Single Dose||13
458742|NCT01258504|1123919|P1|STARTED|Bosentan Single Dose||13
458743|NCT01258387|1123938|P7|NOT COMPLETED|Overall Study||0
458744|NCT01258387|1123939|P6|NOT COMPLETED|Overall Study||0
458745|NCT01258387|1123940|P5|NOT COMPLETED|Overall Study||0
458746|NCT01258387|1123941|P4|NOT COMPLETED|Overall Study||0
458747|NCT01258387|1123942|P3|NOT COMPLETED|Overall Study||0
458748|NCT01258387|1123943|P2|NOT COMPLETED|Overall Study||0
458749|NCT01258387|1123944|P1|NOT COMPLETED|Overall Study||0
458750|NCT01258387|1123938|P7|COMPLETED|Overall Study||4
458751|NCT01258387|1123939|P6|COMPLETED|Overall Study||6
458752|NCT01258387|1123940|P5|COMPLETED|Overall Study||6
458753|NCT01258387|1123941|P4|COMPLETED|Overall Study||6
458754|NCT01258387|1123942|P3|COMPLETED|Overall Study||6
458755|NCT01258387|1123943|P2|COMPLETED|Overall Study||6
458756|NCT01258387|1123944|P1|COMPLETED|Overall Study||6
458757|NCT01258387|1123938|P7|Patients Randomized to Placebo|Overall Study||1
458758|NCT01258387|1123939|P6|Patients Randomized to Placebo|Overall Study||2
458759|NCT01258387|1123940|P5|Patients Randomized to Placebo|Overall Study||2
458760|NCT01258387|1123941|P4|Patients Randomized to Placebo|Overall Study||2
458761|NCT01258387|1123942|P3|Patients Randomized to Placebo|Overall Study||2
458762|NCT01258387|1123943|P2|Patients Randomized to Placebo|Overall Study||2
458763|NCT01258387|1123944|P1|Patients Randomized to Placebo|Overall Study||2
458764|NCT01258387|1123938|P7|Patients Randomized to GGF2|Overall Study||3
458765|NCT01258387|1123939|P6|Patients Randomized to GGF2|Overall Study||4
458766|NCT01258387|1123940|P5|Patients Randomized to GGF2|Overall Study||4
458767|NCT01258387|1123941|P4|Patients Randomized to GGF2|Overall Study||4
458768|NCT01258387|1123942|P3|Patients Randomized to GGF2|Overall Study||4
458769|NCT01258387|1123943|P2|Patients Randomized to GGF2|Overall Study||4
458770|NCT01258387|1123944|P1|Patients Randomized to GGF2|Overall Study||4
458771|NCT01258387|1123938|P7|STARTED|Overall Study||4
458772|NCT01258387|1123939|P6|STARTED|Overall Study||6
458773|NCT01258387|1123940|P5|STARTED|Overall Study||6
458774|NCT01258387|1123941|P4|STARTED|Overall Study||6
458775|NCT01258387|1123942|P3|STARTED|Overall Study||6
458776|NCT01258387|1123943|P2|STARTED|Overall Study||6
458777|NCT01258387|1123944|P1|STARTED|Overall Study||6
458778|NCT01258153|1123989|P3|NOT COMPLETED|Overall Study||1
458779|NCT01258153|1123990|P2|NOT COMPLETED|Overall Study||1
458780|NCT01258153|1123991|P1|NOT COMPLETED|Overall Study||1
458781|NCT01258153|1123989|P3|COMPLETED|Overall Study||36
458782|NCT01258153|1123990|P2|COMPLETED|Overall Study||37
458783|NCT01258153|1123991|P1|COMPLETED|Overall Study||39
458784|NCT01258153|1123989|P3|STARTED|Overall Study||37
458785|NCT01258153|1123990|P2|STARTED|Overall Study||38
458786|NCT01258153|1123991|P1|STARTED|Overall Study||40
458787|NCT01258101|1124018|P4|NOT COMPLETED|Overall Study||25
458788|NCT01258101|1124019|P3|NOT COMPLETED|Overall Study||11
458789|NCT01258101|1124020|P2|NOT COMPLETED|Overall Study||34
458790|NCT01258101|1124021|P1|NOT COMPLETED|Overall Study||33
458791|NCT01258101|1124018|P4|COMPLETED|Overall Study||27
458792|NCT01258101|1124019|P3|COMPLETED|Overall Study||22
458793|NCT01258101|1124020|P2|COMPLETED|Overall Study||110
458794|NCT01258101|1124021|P1|COMPLETED|Overall Study||118
458795|NCT01258101|1124018|P4|Standard Analysis Population|Overall Study||26
458796|NCT01258101|1124019|P3|Standard Analysis Population|Overall Study||21
458797|NCT01258101|1124020|P2|Standard Analysis Population|Overall Study||110
458798|NCT01258101|1124021|P1|Standard Analysis Population|Overall Study||115
458799|NCT01258101|1124018|P4|Safety Analysis Population|Overall Study||48
458800|NCT01258101|1124019|P3|Safety Analysis Population|Overall Study||30
458801|NCT01258101|1124020|P2|Safety Analysis Population|Overall Study||141
458802|NCT01258101|1124021|P1|Safety Analysis Population|Overall Study||144
458803|NCT01258101|1124018|P4|STARTED|Overall Study||52
458804|NCT01258101|1124019|P3|STARTED|Overall Study||33
458805|NCT01258101|1124020|P2|STARTED|Overall Study||144
458806|NCT01258101|1124021|P1|STARTED|Overall Study||151
458807|NCT01258049|1124073|P2|NOT COMPLETED|Overall Study||2
458808|NCT01258049|1124074|P1|NOT COMPLETED|Overall Study||2
458809|NCT01258049|1124073|P2|COMPLETED|Overall Study||72
458810|NCT01258049|1124074|P1|COMPLETED|Overall Study||75
458811|NCT01258049|1124073|P2|STARTED|Overall Study||74
458812|NCT01258049|1124074|P1|STARTED|Overall Study||77
458813|NCT01257880|1124112|P2|NOT COMPLETED|Overall Study||0
458814|NCT01257880|1124113|P1|NOT COMPLETED|Overall Study||0
458815|NCT01257880|1124112|P2|COMPLETED|Overall Study||19
458816|NCT01257880|1124113|P1|COMPLETED|Overall Study||12
458817|NCT01257880|1124112|P2|STARTED|Overall Study||19
458818|NCT01257880|1124113|P1|STARTED|Overall Study||12
458819|NCT01257802|1124123|P2|NOT COMPLETED|Overall Study||6
458820|NCT01257802|1124124|P1|NOT COMPLETED|Overall Study||1
458821|NCT01257802|1124123|P2|COMPLETED|Overall Study||2
458822|NCT01257802|1124124|P1|COMPLETED|Overall Study||5
458823|NCT01257802|1124123|P2|6 Month / 24 Week Visit|Overall Study||2
458824|NCT01257802|1124124|P1|6 Month / 24 Week Visit|Overall Study||5
458825|NCT01257802|1124123|P2|STARTED|Overall Study||8
458826|NCT01257802|1124124|P1|STARTED|Overall Study||6
458827|NCT01257750|1124138|P1|NOT COMPLETED|Overall Study||0
458828|NCT01257750|1124138|P1|COMPLETED|Overall Study||20
458829|NCT01257750|1124138|P1|STARTED|Overall Study||20
458830|NCT01257737|1124151|P2|NOT COMPLETED|Overall Study||4
458831|NCT01257737|1124152|P1|NOT COMPLETED|Overall Study||2
458832|NCT01257737|1124151|P2|COMPLETED|Overall Study||39
458833|NCT01257737|1124152|P1|COMPLETED|Overall Study||43
458834|NCT01257737|1124151|P2|STARTED|Overall Study||43
458835|NCT01257737|1124152|P1|STARTED|Overall Study||45
458836|NCT01257581|1124173|P3|NOT COMPLETED|Overall Study||6
458837|NCT01257581|1124174|P2|NOT COMPLETED|Overall Study||3
458838|NCT01257581|1124175|P1|NOT COMPLETED|Overall Study||5
458839|NCT01257581|1124173|P3|COMPLETED|Overall Study||11
458840|NCT01257581|1124174|P2|COMPLETED|Overall Study||18
458841|NCT01257581|1124175|P1|COMPLETED|Overall Study||17
458842|NCT01257581|1124173|P3|STARTED|Overall Study||17
458843|NCT01257581|1124174|P2|STARTED|Overall Study||21
458844|NCT01257581|1124175|P1|STARTED|Overall Study||22
458845|NCT01257542|1124215|P2|NOT COMPLETED|Overall Study||7
458846|NCT01257542|1124216|P1|NOT COMPLETED|Overall Study||3
458847|NCT01257542|1124215|P2|COMPLETED|Overall Study||45
458848|NCT01257542|1124216|P1|COMPLETED|Overall Study||52
458849|NCT01257542|1124215|P2|STARTED|Overall Study||52
458850|NCT01257542|1124216|P1|STARTED|Overall Study||55
458851|NCT01257503|1124236|P2|NOT COMPLETED|Overall Study||11
458852|NCT01257503|1124237|P1|NOT COMPLETED|Overall Study||8
458853|NCT01257503|1124236|P2|COMPLETED|Overall Study|Completed defined as participants who completed telephone follow-up at end of study period|119
458854|NCT01257503|1124237|P1|COMPLETED|Overall Study|Completed defined as participants who completed telephone follow-up at end of study period|125
458855|NCT01257503|1124236|P2|Returned Dosage Logbooks|Overall Study||80
458856|NCT01257503|1124237|P1|Returned Dosage Logbooks|Overall Study||75
458857|NCT01257503|1124236|P2|Returned Symptom Diaries|Overall Study||83
458858|NCT01257503|1124237|P1|Returned Symptom Diaries|Overall Study||80
458859|NCT01257503|1124236|P2|STARTED|Overall Study||130
458860|NCT01257503|1124237|P1|STARTED|Overall Study||133
458861|NCT01257438|1124253|P2|NOT COMPLETED|Overall Study||46
458862|NCT01257438|1124254|P1|NOT COMPLETED|Overall Study||30
458863|NCT01257438|1124253|P2|COMPLETED|Overall Study||97
458864|NCT01257438|1124254|P1|COMPLETED|Overall Study||102
458865|NCT01257438|1124253|P2|STARTED|Overall Study||143
458866|NCT01257438|1124254|P1|STARTED|Overall Study||132
458867|NCT01257425|1124266|P2|NOT COMPLETED|Overall Study||6
458868|NCT01257425|1124267|P1|NOT COMPLETED|Overall Study||6
458869|NCT01257425|1124266|P2|COMPLETED|Overall Study||45
458870|NCT01257425|1124267|P1|COMPLETED|Overall Study||46
458871|NCT01257425|1124266|P2|STARTED|Overall Study||51
458872|NCT01257425|1124267|P1|STARTED|Overall Study||52
458873|NCT01257347|1124289|P4|NOT COMPLETED|Overall Study||0
458874|NCT01257347|1124290|P3|NOT COMPLETED|Overall Study||0
458875|NCT01257347|1124291|P2|NOT COMPLETED|Overall Study||0
458876|NCT01257347|1124292|P1|NOT COMPLETED|Overall Study||0
458877|NCT01257347|1124289|P4|COMPLETED|Overall Study||65
458878|NCT01257347|1124290|P3|COMPLETED|Overall Study||35
458879|NCT01257347|1124291|P2|COMPLETED|Overall Study||12
458880|NCT01257347|1124292|P1|COMPLETED|Overall Study||12
458881|NCT01257347|1124289|P4|STARTED|Overall Study||65
458882|NCT01257347|1124290|P3|STARTED|Overall Study||35
458883|NCT01257347|1124291|P2|STARTED|Overall Study|Median patients per provider = 4; range 1-13 (65 patients)|12
458884|NCT01257347|1124292|P1|STARTED|Overall Study|Median patients per provider = 3; range 1-10 (35 patients)|12
458885|NCT01257230|1124309|P3|NOT COMPLETED|Overall Study||6
458886|NCT01257230|1124310|P2|NOT COMPLETED|Overall Study||10
458887|NCT01257230|1124311|P1|NOT COMPLETED|Overall Study||6
458888|NCT01257230|1124309|P3|COMPLETED|Overall Study||129
458889|NCT01257230|1124310|P2|COMPLETED|Overall Study||115
458890|NCT01257230|1124311|P1|COMPLETED|Overall Study||132
458891|NCT01257230|1124309|P3|STARTED|Overall Study||135
458892|NCT01257230|1124310|P2|STARTED|Overall Study||125
458893|NCT01257230|1124311|P1|STARTED|Overall Study||138
458894|NCT01257217|1124366|P2|NOT COMPLETED|Overall Study||0
458895|NCT01257217|1124367|P1|NOT COMPLETED|Overall Study||2
458896|NCT01257217|1124366|P2|COMPLETED|Overall Study||10
458897|NCT01257217|1124367|P1|COMPLETED|Overall Study||13
458898|NCT01257217|1124366|P2|STARTED|Overall Study||10
458899|NCT01257217|1124367|P1|STARTED|Overall Study||15
458900|NCT01257204|1124388|P3|NOT COMPLETED|Follow-up Period (up to Week 48)||10
458901|NCT01257204|1124389|P2|NOT COMPLETED|Follow-up Period (up to Week 48)||6
458902|NCT01257204|1124390|P1|NOT COMPLETED|Follow-up Period (up to Week 48)||1
458903|NCT01257204|1124388|P3|COMPLETED|Follow-up Period (up to Week 48)||39
458904|NCT01257204|1124389|P2|COMPLETED|Follow-up Period (up to Week 48)||41
458905|NCT01257204|1124390|P1|COMPLETED|Follow-up Period (up to Week 48)||48
458906|NCT01257204|1124388|P3|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|49
458907|NCT01257204|1124389|P2|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|47
458908|NCT01257204|1124390|P1|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|49
458909|NCT01257204|1124388|P3|NOT COMPLETED|Treatment Period (up to Week 24)||9
458910|NCT01257204|1124389|P2|NOT COMPLETED|Treatment Period (up to Week 24)||6
458911|NCT01257204|1124390|P1|NOT COMPLETED|Treatment Period (up to Week 24)||5
458912|NCT01257204|1124388|P3|COMPLETED|Treatment Period (up to Week 24)||42
458913|NCT01257204|1124389|P2|COMPLETED|Treatment Period (up to Week 24)||44
458914|NCT01257204|1124390|P1|COMPLETED|Treatment Period (up to Week 24)||45
458915|NCT01257204|1124388|P3|STARTED|Treatment Period (up to Week 24)||51
458916|NCT01257204|1124389|P2|STARTED|Treatment Period (up to Week 24)||50
458917|NCT01257204|1124390|P1|STARTED|Treatment Period (up to Week 24)||50
458918|NCT01256983|1124436|P2|NOT COMPLETED|Overall Study||3
458919|NCT01256983|1124437|P1|NOT COMPLETED|Overall Study||1
458920|NCT01256983|1124436|P2|COMPLETED|Overall Study||12
458921|NCT01256983|1124437|P1|COMPLETED|Overall Study||14
458922|NCT01256983|1124436|P2|STARTED|Overall Study||15
458923|NCT01256983|1124437|P1|STARTED|Overall Study||15
458924|NCT01256944|1124445|P2|NOT COMPLETED|Overall Study||0
458925|NCT01256944|1124446|P1|NOT COMPLETED|Overall Study||0
458926|NCT01256944|1124445|P2|COMPLETED|Overall Study||220
458927|NCT01256944|1124446|P1|COMPLETED|Overall Study||70
458928|NCT01256944|1124445|P2|STARTED|Overall Study||220
458929|NCT01256944|1124446|P1|STARTED|Overall Study||70
458930|NCT01256918|1124474|P1|NOT COMPLETED|Overall Study||0
458931|NCT01256918|1124474|P1|COMPLETED|Overall Study||200
458932|NCT01256918|1124474|P1|Full Thickness Nuclear Crack Achieved|Overall Study||200
458933|NCT01256918|1124474|P1|STARTED|Overall Study||200
458934|NCT01256840|1124488|P3|NOT COMPLETED|Overall Study||0
458935|NCT01256840|1124489|P2|NOT COMPLETED|Overall Study||0
458936|NCT01256840|1124490|P1|NOT COMPLETED|Overall Study||0
458937|NCT01256840|1124488|P3|COMPLETED|Overall Study||25
458938|NCT01256840|1124489|P2|COMPLETED|Overall Study||16
458939|NCT01256840|1124490|P1|COMPLETED|Overall Study||30
458940|NCT01256840|1124488|P3|STARTED|Overall Study||25
458941|NCT01256840|1124489|P2|STARTED|Overall Study||16
458942|NCT01256840|1124490|P1|STARTED|Overall Study||30
458943|NCT01256684|1124501|P3|NOT COMPLETED|Overall Study||11
458944|NCT01256684|1124502|P2|NOT COMPLETED|Overall Study||13
458945|NCT01256684|1124503|P1|NOT COMPLETED|Overall Study||9
458946|NCT01256684|1124501|P3|COMPLETED|Overall Study||76
458947|NCT01256684|1124502|P2|COMPLETED|Overall Study||74
458948|NCT01256684|1124503|P1|COMPLETED|Overall Study||72
458949|NCT01256684|1124501|P3|ITT Population|Overall Study||81
458950|NCT01256684|1124502|P2|ITT Population|Overall Study||79
458951|NCT01256684|1124503|P1|ITT Population|Overall Study||77
458952|NCT01256684|1124501|P3|Safety Population|Overall Study||87
458953|NCT01256684|1124502|P2|Safety Population|Overall Study||86
458954|NCT01256684|1124503|P1|Safety Population|Overall Study||80
458955|NCT01256684|1124501|P3|STARTED|Overall Study||87
458956|NCT01256684|1124502|P2|STARTED|Overall Study||87
458957|NCT01256684|1124503|P1|STARTED|Overall Study||81
458958|NCT01256671|1124535|P1|NOT COMPLETED|Overall Study||95
458959|NCT01256671|1124535|P1|COMPLETED|Overall Study||435
458960|NCT01256671|1124535|P1|Safety Population|Overall Study||521
458961|NCT01256671|1124535|P1|STARTED|Overall Study||530
458962|NCT01256658|1124548|P2|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||6372
458963|NCT01256658|1124549|P1|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||5854
458964|NCT01256658|1124548|P2|COMPLETED|Period 2 - Follow up Only - No Treatment||0
458965|NCT01256658|1124549|P1|COMPLETED|Period 2 - Follow up Only - No Treatment||0
458966|NCT01256658|1124548|P2|Study Termination|Period 2 - Follow up Only - No Treatment|138 participants who completed period 1 did not enroll to continue on period 2|6287
458967|NCT01256658|1124549|P1|Study Termination|Period 2 - Follow up Only - No Treatment|43 participants who completed period 1 did not enroll to continue on period 2|5777
458968|NCT01256658|1124548|P2|Death|Period 2 - Follow up Only - No Treatment||8
458969|NCT01256658|1124549|P1|Death|Period 2 - Follow up Only - No Treatment||6
458970|NCT01256658|1124548|P2|Lost to Follow up|Period 2 - Follow up Only - No Treatment||77
458971|NCT01256658|1124549|P1|Lost to Follow up|Period 2 - Follow up Only - No Treatment||71
458972|NCT01256658|1124548|P2|STARTED|Period 2 - Follow up Only - No Treatment|138 participants who completed period 1 did not enroll to continue on period 2|6372
458973|NCT01256658|1124549|P1|STARTED|Period 2 - Follow up Only - No Treatment|43 participants who completed period 1 did not enroll to continue on period 2|5854
458974|NCT01256658|1124548|P2|NOT COMPLETED|Period 1||748
458975|NCT01256658|1124549|P1|NOT COMPLETED|Period 1||920
458976|NCT01256658|1124548|P2|COMPLETED|Period 1||6510
458977|NCT01256658|1124549|P1|COMPLETED|Period 1||5897
458978|NCT01256658|1124548|P2|STARTED|Period 1||7258
458979|NCT01256658|1124549|P1|STARTED|Period 1||6817
458980|NCT01256567|1124599|P1|NOT COMPLETED|Overall Study||1
458981|NCT01256567|1124599|P1|COMPLETED|Overall Study||6
458982|NCT01256567|1124599|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
458983|NCT01256567|1124599|P1|STARTED|Overall Study||7
458984|NCT01256502|1124609|P1|NOT COMPLETED|Overall Study||10
458985|NCT01256502|1124609|P1|COMPLETED|Overall Study||129
458986|NCT01256502|1124609|P1|STARTED|Overall Study|Implanted with SERI during Stage I breast reconstruction surgery|139
458987|NCT01256476|1124621|P2|NOT COMPLETED|Overall Study||7
458988|NCT01256476|1124622|P1|NOT COMPLETED|Overall Study||6
458989|NCT01256476|1124621|P2|COMPLETED|Overall Study||157
458990|NCT01256476|1124622|P1|COMPLETED|Overall Study||158
458991|NCT01256476|1124621|P2|STARTED|Overall Study||164
458992|NCT01256476|1124622|P1|STARTED|Overall Study||164
458993|NCT01256450|1124630|P3|NOT COMPLETED|Double-blind Treatment||37
458994|NCT01256450|1124631|P2|NOT COMPLETED|Double-blind Treatment||28
458995|NCT01256450|1124632|P1|NOT COMPLETED|Double-blind Treatment||0
458996|NCT01256450|1124630|P3|COMPLETED|Double-blind Treatment||81
458997|NCT01256450|1124631|P2|COMPLETED|Double-blind Treatment||89
458998|NCT01256450|1124632|P1|COMPLETED|Double-blind Treatment||0
458999|NCT01256450|1124630|P3|STARTED|Double-blind Treatment|Subjects were randomized to DB treatment after completing OL titration in the previous period.|118
459000|NCT01256450|1124631|P2|STARTED|Double-blind Treatment|Subjects were randomized to DB treatment after completing OL titration in the previous period.|117
459001|NCT01256450|1124632|P1|STARTED|Double-blind Treatment|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
459002|NCT01256450|1124630|P3|NOT COMPLETED|Open-label Titration||0
459003|NCT01256450|1124631|P2|NOT COMPLETED|Open-label Titration||0
459004|NCT01256450|1124632|P1|NOT COMPLETED|Open-label Titration||99
459005|NCT01256450|1124630|P3|COMPLETED|Open-label Titration||0
459006|NCT01256450|1124631|P2|COMPLETED|Open-label Titration||0
459007|NCT01256450|1124632|P1|COMPLETED|Open-label Titration||235
459008|NCT01256450|1124630|P3|STARTED|Open-label Titration||0
459009|NCT01256450|1124631|P2|STARTED|Open-label Titration||0
459010|NCT01256450|1124632|P1|STARTED|Open-label Titration||334
459011|NCT01256424|1124661|P4|NOT COMPLETED|Overall Study||7
459012|NCT01256424|1124662|P3|NOT COMPLETED|Overall Study||7
459013|NCT01256424|1124663|P2|NOT COMPLETED|Overall Study||8
459014|NCT01256424|1124664|P1|NOT COMPLETED|Overall Study||9
459015|NCT01256424|1124661|P4|COMPLETED|Overall Study||61
459016|NCT01256424|1124662|P3|COMPLETED|Overall Study||55
459017|NCT01256424|1124663|P2|COMPLETED|Overall Study||59
459018|NCT01256424|1124664|P1|COMPLETED|Overall Study||56
459019|NCT01256424|1124661|P4|STARTED|Overall Study||68
459020|NCT01256424|1124662|P3|STARTED|Overall Study||62
459021|NCT01256424|1124663|P2|STARTED|Overall Study||67
459022|NCT01256424|1124664|P1|STARTED|Overall Study||65
459023|NCT01256411|1124690|P6|NOT COMPLETED|Extension by Mono or Combination Therapy||4
459024|NCT01256411|1124691|P5|NOT COMPLETED|Extension by Mono or Combination Therapy||17
459025|NCT01256411|1124692|P4|NOT COMPLETED|Extension by Mono or Combination Therapy||0
459026|NCT01256411|1124693|P3|NOT COMPLETED|Extension by Mono or Combination Therapy||0
459027|NCT01256411|1124694|P2|NOT COMPLETED|Extension by Mono or Combination Therapy||0
459028|NCT01256411|1124695|P1|NOT COMPLETED|Extension by Mono or Combination Therapy||0
459029|NCT01256411|1124690|P6|COMPLETED|Extension by Mono or Combination Therapy||109
459030|NCT01256411|1124691|P5|COMPLETED|Extension by Mono or Combination Therapy||211
459031|NCT01256411|1124692|P4|COMPLETED|Extension by Mono or Combination Therapy||0
459032|NCT01256411|1124693|P3|COMPLETED|Extension by Mono or Combination Therapy||0
459033|NCT01256411|1124694|P2|COMPLETED|Extension by Mono or Combination Therapy||0
459034|NCT01256411|1124695|P1|COMPLETED|Extension by Mono or Combination Therapy||0
459035|NCT01256411|1124690|P6|STARTED|Extension by Mono or Combination Therapy||113
459036|NCT01256411|1124691|P5|STARTED|Extension by Mono or Combination Therapy||228
459037|NCT01256411|1124692|P4|STARTED|Extension by Mono or Combination Therapy||0
459038|NCT01256411|1124693|P3|STARTED|Extension by Mono or Combination Therapy||0
459039|NCT01256411|1124694|P2|STARTED|Extension by Mono or Combination Therapy||0
459040|NCT01256411|1124695|P1|STARTED|Extension by Mono or Combination Therapy||0
459041|NCT01256411|1124690|P6|NOT COMPLETED|Extension by Maximum Treatment||0
459042|NCT01256411|1124691|P5|NOT COMPLETED|Extension by Maximum Treatment||0
459043|NCT01256411|1124692|P4|NOT COMPLETED|Extension by Maximum Treatment||0
459044|NCT01256411|1124693|P3|NOT COMPLETED|Extension by Maximum Treatment||4
459045|NCT01256411|1124694|P2|NOT COMPLETED|Extension by Maximum Treatment||10
459046|NCT01256411|1124695|P1|NOT COMPLETED|Extension by Maximum Treatment||7
459047|NCT01256411|1124690|P6|COMPLETED|Extension by Maximum Treatment||0
459048|NCT01256411|1124691|P5|COMPLETED|Extension by Maximum Treatment||0
459049|NCT01256411|1124692|P4|COMPLETED|Extension by Maximum Treatment||4
459050|NCT01256411|1124693|P3|COMPLETED|Extension by Maximum Treatment||105
459051|NCT01256411|1124694|P2|COMPLETED|Extension by Maximum Treatment||79
459052|NCT01256411|1124695|P1|COMPLETED|Extension by Maximum Treatment||132
459053|NCT01256411|1124690|P6|Down Titrated to 100 mg|Extension by Maximum Treatment||0
459054|NCT01256411|1124691|P5|Down Titrated to 100 mg|Extension by Maximum Treatment||0
459055|NCT01256411|1124692|P4|Down Titrated to 100 mg|Extension by Maximum Treatment||0
459056|NCT01256411|1124693|P3|Down Titrated to 100 mg|Extension by Maximum Treatment||0
459057|NCT01256411|1124694|P2|Down Titrated to 100 mg|Extension by Maximum Treatment||0
459058|NCT01256411|1124695|P1|Down Titrated to 100 mg|Extension by Maximum Treatment||12
459059|NCT01256411|1124690|P6|STARTED|Extension by Maximum Treatment||0
459060|NCT01256411|1124691|P5|STARTED|Extension by Maximum Treatment||0
459061|NCT01256411|1124692|P4|STARTED|Extension by Maximum Treatment||4
459062|NCT01256411|1124693|P3|STARTED|Extension by Maximum Treatment||109
459063|NCT01256411|1124694|P2|STARTED|Extension by Maximum Treatment||89
459064|NCT01256411|1124695|P1|STARTED|Extension by Maximum Treatment||139
459065|NCT01256385|1124721|P2|NOT COMPLETED|Overall Study||3
459066|NCT01256385|1124722|P1|NOT COMPLETED|Overall Study||3
459067|NCT01256385|1124721|P2|COMPLETED|Overall Study||40
459068|NCT01256385|1124722|P1|COMPLETED|Overall Study||40
459069|NCT01256385|1124721|P2|Crossover From Arm B to Arm A|Overall Study||15
459070|NCT01256385|1124722|P1|Crossover From Arm B to Arm A|Overall Study||0
459071|NCT01256385|1124721|P2|STARTED|Overall Study||43
459072|NCT01256385|1124722|P1|STARTED|Overall Study||43
459073|NCT01256294|1124742|P2|NOT COMPLETED|Overall Study||2
459074|NCT01256294|1124743|P1|NOT COMPLETED|Overall Study||4
459075|NCT01256294|1124742|P2|COMPLETED|Overall Study||33
459076|NCT01256294|1124743|P1|COMPLETED|Overall Study||32
459077|NCT01256294|1124742|P2|STARTED|Overall Study||35
459078|NCT01256294|1124743|P1|STARTED|Overall Study||36
459079|NCT01256281|1124759|P1|NOT COMPLETED|Overall Study||0
459080|NCT01256281|1124759|P1|COMPLETED|Overall Study||2
459081|NCT01256281|1124759|P1|STARTED|Overall Study||2
459082|NCT01256190|1124765|P2|NOT COMPLETED|Overall Study||0
459083|NCT01256190|1124766|P1|NOT COMPLETED|Overall Study||2
459084|NCT01256190|1124765|P2|COMPLETED|Overall Study||17
459085|NCT01256190|1124766|P1|COMPLETED|Overall Study||37
459086|NCT01256190|1124765|P2|STARTED|Overall Study||17
459087|NCT01256190|1124766|P1|STARTED|Overall Study||39
459088|NCT01256177|1124782|P2|NOT COMPLETED|Overall Study||37
459089|NCT01256177|1124783|P1|NOT COMPLETED|Overall Study||50
459090|NCT01256177|1124782|P2|COMPLETED|Overall Study||111
459091|NCT01256177|1124783|P1|COMPLETED|Overall Study||98
459092|NCT01256177|1124782|P2|STARTED|Overall Study||148
459093|NCT01256177|1124783|P1|STARTED|Overall Study||148
459094|NCT01256164|1124807|P2|NOT COMPLETED|Overall Study||0
459095|NCT01256164|1124808|P1|NOT COMPLETED|Overall Study||0
459096|NCT01256164|1124807|P2|COMPLETED|Overall Study||23
459097|NCT01256164|1124808|P1|COMPLETED|Overall Study||47
459098|NCT01256164|1124807|P2|STARTED|Overall Study||23
459099|NCT01256164|1124808|P1|STARTED|Overall Study||47
459100|NCT01256086|1124826|P4|NOT COMPLETED|Treatment Day 4||0
459101|NCT01256086|1124827|P3|NOT COMPLETED|Treatment Day 4||0
459102|NCT01256086|1124828|P2|NOT COMPLETED|Treatment Day 4||0
459103|NCT01256086|1124829|P1|NOT COMPLETED|Treatment Day 4||0
459104|NCT01256086|1124826|P4|COMPLETED|Treatment Day 4||11
459105|NCT01256086|1124827|P3|COMPLETED|Treatment Day 4||9
459106|NCT01256086|1124828|P2|COMPLETED|Treatment Day 4||10
459107|NCT01256086|1124829|P1|COMPLETED|Treatment Day 4||11
459108|NCT01256086|1124826|P4|STARTED|Treatment Day 4||11
459109|NCT01256086|1124827|P3|STARTED|Treatment Day 4||9
459110|NCT01256086|1124828|P2|STARTED|Treatment Day 4||10
459111|NCT01256086|1124829|P1|STARTED|Treatment Day 4||11
459112|NCT01256086|1124826|P4|NOT COMPLETED|Treatment Day 3||0
459113|NCT01256086|1124827|P3|NOT COMPLETED|Treatment Day 3||0
459114|NCT01256086|1124828|P2|NOT COMPLETED|Treatment Day 3||0
459115|NCT01256086|1124829|P1|NOT COMPLETED|Treatment Day 3||0
459116|NCT01256086|1124826|P4|COMPLETED|Treatment Day 3||11
459117|NCT01256086|1124827|P3|COMPLETED|Treatment Day 3||9
459118|NCT01256086|1124828|P2|COMPLETED|Treatment Day 3||10
459119|NCT01256086|1124829|P1|COMPLETED|Treatment Day 3||11
459120|NCT01256086|1124826|P4|STARTED|Treatment Day 3||11
459121|NCT01256086|1124827|P3|STARTED|Treatment Day 3||9
459122|NCT01256086|1124828|P2|STARTED|Treatment Day 3||10
459123|NCT01256086|1124829|P1|STARTED|Treatment Day 3||11
459124|NCT01256086|1124826|P4|NOT COMPLETED|Treatment Day 2||0
459125|NCT01256086|1124827|P3|NOT COMPLETED|Treatment Day 2||0
459126|NCT01256086|1124828|P2|NOT COMPLETED|Treatment Day 2||0
459127|NCT01256086|1124829|P1|NOT COMPLETED|Treatment Day 2||0
459128|NCT01256086|1124826|P4|COMPLETED|Treatment Day 2||11
459129|NCT01256086|1124827|P3|COMPLETED|Treatment Day 2||9
459130|NCT01256086|1124828|P2|COMPLETED|Treatment Day 2||10
459131|NCT01256086|1124829|P1|COMPLETED|Treatment Day 2||11
459132|NCT01256086|1124826|P4|STARTED|Treatment Day 2||11
459133|NCT01256086|1124827|P3|STARTED|Treatment Day 2||9
459134|NCT01256086|1124828|P2|STARTED|Treatment Day 2||10
459135|NCT01256086|1124829|P1|STARTED|Treatment Day 2||11
459136|NCT01256086|1124826|P4|NOT COMPLETED|Treatment Day 1||0
459137|NCT01256086|1124827|P3|NOT COMPLETED|Treatment Day 1||0
459138|NCT01256086|1124828|P2|NOT COMPLETED|Treatment Day 1||0
459139|NCT01256086|1124829|P1|NOT COMPLETED|Treatment Day 1||0
459140|NCT01256086|1124826|P4|COMPLETED|Treatment Day 1||11
459141|NCT01256086|1124827|P3|COMPLETED|Treatment Day 1||11
459142|NCT01256086|1124828|P2|COMPLETED|Treatment Day 1||11
459143|NCT01256086|1124829|P1|COMPLETED|Treatment Day 1||11
459144|NCT01256086|1124826|P4|STARTED|Treatment Day 1||11
459145|NCT01256086|1124827|P3|STARTED|Treatment Day 1||11
459146|NCT01256086|1124828|P2|STARTED|Treatment Day 1||11
459147|NCT01256086|1124829|P1|STARTED|Treatment Day 1||11
459148|NCT01256060|1124839|P4|NOT COMPLETED|Overall Study||0
459149|NCT01256060|1124840|P3|NOT COMPLETED|Overall Study||0
459150|NCT01256060|1124841|P2|NOT COMPLETED|Overall Study||1
459151|NCT01256060|1124842|P1|NOT COMPLETED|Overall Study||0
459152|NCT01256060|1124839|P4|COMPLETED|Overall Study||6
459153|NCT01256060|1124840|P3|COMPLETED|Overall Study||3
459154|NCT01256060|1124841|P2|COMPLETED|Overall Study||2
459155|NCT01256060|1124842|P1|COMPLETED|Overall Study||3
459156|NCT01256060|1124839|P4|STARTED|Overall Study||6
459157|NCT01256060|1124840|P3|STARTED|Overall Study||3
459158|NCT01256060|1124841|P2|STARTED|Overall Study||3
459159|NCT01256060|1124842|P1|STARTED|Overall Study||3
459160|NCT01256034|1124851|P2|NOT COMPLETED|Overall Study||25
459161|NCT01256034|1124852|P1|NOT COMPLETED|Overall Study||25
459162|NCT01256034|1124851|P2|COMPLETED|Overall Study||0
459163|NCT01256034|1124852|P1|COMPLETED|Overall Study||0
459164|NCT01256034|1124851|P2|STARTED|Overall Study||25
459165|NCT01256034|1124852|P1|STARTED|Overall Study||25
459166|NCT01256008|1124861|P3|NOT COMPLETED|Overall Study||21
459167|NCT01256008|1124862|P2|NOT COMPLETED|Overall Study||7
459168|NCT01256008|1124863|P1|NOT COMPLETED|Overall Study||8
459169|NCT01256008|1124861|P3|COMPLETED|Overall Study||175
459170|NCT01256008|1124862|P2|COMPLETED|Overall Study||91
459171|NCT01256008|1124863|P1|COMPLETED|Overall Study||90
459172|NCT01256008|1124861|P3|STARTED|Overall Study||196
459173|NCT01256008|1124862|P2|STARTED|Overall Study||98
459174|NCT01256008|1124863|P1|STARTED|Overall Study||98
459175|NCT01255904|1124885|P2|NOT COMPLETED|Overall Study||4
459176|NCT01255904|1124886|P1|NOT COMPLETED|Overall Study||1
459177|NCT01255904|1124885|P2|COMPLETED|Overall Study||41
459178|NCT01255904|1124886|P1|COMPLETED|Overall Study||44
459179|NCT01255904|1124885|P2|STARTED|Overall Study||45
459180|NCT01255904|1124886|P1|STARTED|Overall Study||45
459181|NCT01255787|1124896|P4|NOT COMPLETED|Overall Study||22
459182|NCT01255787|1124897|P3|NOT COMPLETED|Overall Study||18
459183|NCT01255787|1124898|P2|NOT COMPLETED|Overall Study||17
459184|NCT01255787|1124899|P1|NOT COMPLETED|Overall Study||16
459185|NCT01255787|1124896|P4|COMPLETED|Overall Study||132
459186|NCT01255787|1124897|P3|COMPLETED|Overall Study||132
459187|NCT01255787|1124898|P2|COMPLETED|Overall Study||127
459188|NCT01255787|1124899|P1|COMPLETED|Overall Study||136
459189|NCT01255787|1124896|P4|Treated|Overall Study||150
459190|NCT01255787|1124897|P3|Treated|Overall Study||148
459191|NCT01255787|1124898|P2|Treated|Overall Study||144
459192|NCT01255787|1124899|P1|Treated|Overall Study||152
459193|NCT01255787|1124896|P4|STARTED|Overall Study||154
459194|NCT01255787|1124897|P3|STARTED|Overall Study||150
459195|NCT01255787|1124898|P2|STARTED|Overall Study||144
459196|NCT01255787|1124899|P1|STARTED|Overall Study||152
459197|NCT01255761|1124927|P2|NOT COMPLETED|Overall Study||175
459198|NCT01255761|1124928|P1|NOT COMPLETED|Overall Study||182
459199|NCT01255761|1124927|P2|COMPLETED|Overall Study||192
459200|NCT01255761|1124928|P1|COMPLETED|Overall Study||187
459201|NCT01255761|1124927|P2|STARTED|Overall Study||367
459202|NCT01255761|1124928|P1|STARTED|Overall Study||369
459203|NCT01255722|1125013|P3|NOT COMPLETED|Overall Study||1
459204|NCT01255722|1125014|P2|NOT COMPLETED|Overall Study||1
459205|NCT01255722|1125015|P1|NOT COMPLETED|Overall Study||3
459206|NCT01255722|1125013|P3|COMPLETED|Overall Study||152
459207|NCT01255722|1125014|P2|COMPLETED|Overall Study||159
459208|NCT01255722|1125015|P1|COMPLETED|Overall Study||152
459209|NCT01255722|1125013|P3|STARTED|Overall Study||153
459210|NCT01255722|1125014|P2|STARTED|Overall Study||160
459211|NCT01255722|1125015|P1|STARTED|Overall Study||155
459212|NCT01255631|1125040|P2|NOT COMPLETED|Overall Study||6
459213|NCT01255631|1125041|P1|NOT COMPLETED|Overall Study||9
459214|NCT01255631|1125040|P2|COMPLETED|Overall Study|study terminated due to poor enrollment|3
459215|NCT01255631|1125041|P1|COMPLETED|Overall Study|study terminated due to poor enrollment|4
459216|NCT01255631|1125040|P2|STARTED|Overall Study||9
459217|NCT01255631|1125041|P1|STARTED|Overall Study||13
459218|NCT01255592|1125059|P2|NOT COMPLETED|Overall Study||1
459219|NCT01255592|1125060|P1|NOT COMPLETED|Overall Study||6
459220|NCT01255592|1125059|P2|COMPLETED|Overall Study||25
459221|NCT01255592|1125060|P1|COMPLETED|Overall Study||20
459222|NCT01255592|1125059|P2|STARTED|Overall Study||26
459223|NCT01255592|1125060|P1|STARTED|Overall Study||26
459224|NCT01255449|1125116|P1|NOT COMPLETED|Overall Study||0
459225|NCT01255449|1125116|P1|COMPLETED|Overall Study||26
459226|NCT01255449|1125116|P1|STARTED|Overall Study||26
459227|NCT01255436|1125123|P2|NOT COMPLETED|Overall Study||194
459228|NCT01255436|1125124|P1|NOT COMPLETED|Overall Study||182
459229|NCT01255436|1125123|P2|COMPLETED|Overall Study||135
459230|NCT01255436|1125124|P1|COMPLETED|Overall Study||151
459231|NCT01255436|1125123|P2|STARTED|Overall Study|350 patients enrolled but 21 excluded because of missing baseline data|329
459232|NCT01255436|1125124|P1|STARTED|Overall Study|350 patients enrolled but 17 excluded because of missing baseline data.|333
459233|NCT01255423|1125138|P2|NOT COMPLETED|Overall Study||3
459234|NCT01255423|1125139|P1|NOT COMPLETED|Overall Study||3
459235|NCT01255423|1125138|P2|COMPLETED|Overall Study||99
459236|NCT01255423|1125139|P1|COMPLETED|Overall Study||101
459237|NCT01255423|1125138|P2|STARTED|Overall Study||102
459238|NCT01255423|1125139|P1|STARTED|Overall Study||104
459239|NCT01255306|1125155|P2|NOT COMPLETED|Overall Study||1
459240|NCT01255306|1125156|P1|NOT COMPLETED|Overall Study||1
459241|NCT01255306|1125155|P2|COMPLETED|Overall Study||32
459242|NCT01255306|1125156|P1|COMPLETED|Overall Study||25
459243|NCT01255306|1125155|P2|STARTED|Overall Study||33
459244|NCT01255306|1125156|P1|STARTED|Overall Study||26
459245|NCT01255163|1125167|P2|NOT COMPLETED|Overall Study||5
459246|NCT01255163|1125168|P1|NOT COMPLETED|Overall Study||4
459247|NCT01255163|1125167|P2|COMPLETED|Overall Study||9
459248|NCT01255163|1125168|P1|COMPLETED|Overall Study||9
459249|NCT01255163|1125167|P2|STARTED|Overall Study||14
459250|NCT01255163|1125168|P1|STARTED|Overall Study||13
459251|NCT01255137|1125190|P1|NOT COMPLETED|Overall Study||0
459252|NCT01255137|1125190|P1|COMPLETED|Overall Study||13
459253|NCT01255137|1125190|P1|STARTED|Overall Study||13
459254|NCT01254890|1125197|P2|NOT COMPLETED|Overall Study||10
459255|NCT01254890|1125198|P1|NOT COMPLETED|Overall Study||1
459256|NCT01254890|1125197|P2|COMPLETED|Overall Study||47
459257|NCT01254890|1125198|P1|COMPLETED|Overall Study||2
459258|NCT01254890|1125197|P2|STARTED|Overall Study||57
459259|NCT01254890|1125198|P1|STARTED|Overall Study||3
459260|NCT01254877|1125207|P3|NOT COMPLETED|Overall Study||5
459261|NCT01254877|1125208|P2|NOT COMPLETED|Overall Study||11
459262|NCT01254877|1125209|P1|NOT COMPLETED|Overall Study||10
459263|NCT01254877|1125207|P3|COMPLETED|Overall Study||64
459264|NCT01254877|1125208|P2|COMPLETED|Overall Study||58
459265|NCT01254877|1125209|P1|COMPLETED|Overall Study||57
459266|NCT01254877|1125207|P3|STARTED|Overall Study||69
459267|NCT01254877|1125208|P2|STARTED|Overall Study||69
459268|NCT01254877|1125209|P1|STARTED|Overall Study||67
459269|NCT01254851|1125234|P2|NOT COMPLETED|Overall Study||9
459270|NCT01254851|1125235|P1|NOT COMPLETED|Overall Study||8
459271|NCT01254851|1125234|P2|COMPLETED|Overall Study||68
459272|NCT01254851|1125235|P1|COMPLETED|Overall Study||61
459273|NCT01254851|1125234|P2|STARTED|Overall Study||77
459274|NCT01254851|1125235|P1|STARTED|Overall Study||69
459275|NCT01254760|1125241|P2|NOT COMPLETED|Second Period, 5 Days of Wear||0
459276|NCT01254760|1125242|P1|NOT COMPLETED|Second Period, 5 Days of Wear||0
459277|NCT01254760|1125241|P2|COMPLETED|Second Period, 5 Days of Wear||38
459278|NCT01254760|1125242|P1|COMPLETED|Second Period, 5 Days of Wear||34
459279|NCT01254760|1125241|P2|STARTED|Second Period, 5 Days of Wear||38
459280|NCT01254760|1125242|P1|STARTED|Second Period, 5 Days of Wear||34
459281|NCT01254760|1125241|P2|NOT COMPLETED|First Period, 5 Days of Wear||0
459282|NCT01254760|1125242|P1|NOT COMPLETED|First Period, 5 Days of Wear||0
459283|NCT01254760|1125241|P2|COMPLETED|First Period, 5 Days of Wear||38
459284|NCT01254760|1125242|P1|COMPLETED|First Period, 5 Days of Wear||34
459285|NCT01254760|1125241|P2|STARTED|First Period, 5 Days of Wear||38
459286|NCT01254760|1125242|P1|STARTED|First Period, 5 Days of Wear||34
459287|NCT01254747|1125260|P4|NOT COMPLETED|Overall Study||2
459288|NCT01254747|1125261|P3|NOT COMPLETED|Overall Study||4
459289|NCT01254747|1125262|P2|NOT COMPLETED|Overall Study||6
459290|NCT01254747|1125263|P1|NOT COMPLETED|Overall Study||0
459291|NCT01254747|1125260|P4|COMPLETED|Overall Study||28
459292|NCT01254747|1125261|P3|COMPLETED|Overall Study||26
459293|NCT01254747|1125262|P2|COMPLETED|Overall Study||23
459294|NCT01254747|1125263|P1|COMPLETED|Overall Study||40
459295|NCT01254747|1125260|P4|STARTED|Overall Study||30
459296|NCT01254747|1125261|P3|STARTED|Overall Study||30
459297|NCT01254747|1125262|P2|STARTED|Overall Study||29
459298|NCT01254747|1125263|P1|STARTED|Overall Study||40
459299|NCT01254721|1125303|P2|NOT COMPLETED|Overall Study||22
459300|NCT01254721|1125304|P1|NOT COMPLETED|Overall Study||15
459301|NCT01254721|1125303|P2|COMPLETED|Overall Study||42
459302|NCT01254721|1125304|P1|COMPLETED|Overall Study||52
459303|NCT01254721|1125303|P2|STARTED|Overall Study|Seroquel XR: 300mg Lithium: 900mg|64
459304|NCT01254721|1125304|P1|STARTED|Overall Study|Seroquel XR: 300mg|67
459305|NCT01254669|1125314|P2|NOT COMPLETED|Overall Study||4
459306|NCT01254669|1125315|P1|NOT COMPLETED|Overall Study||3
459307|NCT01254669|1125314|P2|COMPLETED|Overall Study||96
459308|NCT01254669|1125315|P1|COMPLETED|Overall Study||97
459309|NCT01254669|1125314|P2|STARTED|Overall Study||100
459310|NCT01254669|1125315|P1|STARTED|Overall Study||100
459311|NCT01254656|1125326|P3|NOT COMPLETED|Overall Study||18
459312|NCT01254656|1125327|P2|NOT COMPLETED|Overall Study||43
459313|NCT01254656|1125328|P1|NOT COMPLETED|Overall Study||47
459314|NCT01254656|1125326|P3|COMPLETED|Overall Study||0
459315|NCT01254656|1125327|P2|COMPLETED|Overall Study||0
459316|NCT01254656|1125328|P1|COMPLETED|Overall Study||0
459317|NCT01254656|1125326|P3|Treated|Overall Study||18
459318|NCT01254656|1125327|P2|Treated|Overall Study||43
459319|NCT01254656|1125328|P1|Treated|Overall Study||47
459320|NCT01254656|1125326|P3|STARTED|Overall Study||18
459321|NCT01254656|1125327|P2|STARTED|Overall Study||43
459322|NCT01254656|1125328|P1|STARTED|Overall Study||47
459323|NCT01254643|1125354|P1|NOT COMPLETED|Overall Study||1
459324|NCT01254643|1125354|P1|COMPLETED|Overall Study||99
459325|NCT01254643|1125354|P1|Vaccination 3|Overall Study||99
459326|NCT01254643|1125354|P1|Vaccination 2|Overall Study||99
459327|NCT01254643|1125354|P1|Vaccination 1|Overall Study||100
459328|NCT01254643|1125354|P1|STARTED|Overall Study||100
459329|NCT01254630|1125366|P4|NOT COMPLETED|Overall Study||1285
459330|NCT01254630|1125367|P3|NOT COMPLETED|Overall Study||812
459331|NCT01254630|1125368|P2|NOT COMPLETED|Overall Study||1288
459332|NCT01254630|1125369|P1|NOT COMPLETED|Overall Study||802
459333|NCT01254630|1125366|P4|COMPLETED|Overall Study||0
459334|NCT01254630|1125367|P3|COMPLETED|Overall Study||552
459335|NCT01254630|1125368|P2|COMPLETED|Overall Study||0
459336|NCT01254630|1125369|P1|COMPLETED|Overall Study||546
459337|NCT01254630|1125366|P4|Received Vaccination 4|Overall Study||1160
459338|NCT01254630|1125367|P3|Received Vaccination 4|Overall Study||1212
459339|NCT01254630|1125368|P2|Received Vaccination 4|Overall Study||1145
459340|NCT01254630|1125369|P1|Received Vaccination 4|Overall Study||1155
459341|NCT01254630|1125366|P4|Received Vaccination 3|Overall Study||1194
459342|NCT01254630|1125367|P3|Received Vaccination 3|Overall Study||1247
459343|NCT01254630|1125368|P2|Received Vaccination 3|Overall Study||1178
459344|NCT01254630|1125369|P1|Received Vaccination 3|Overall Study||1198
459345|NCT01254630|1125366|P4|Received Vaccination 2|Overall Study||1226
459346|NCT01254630|1125367|P3|Received Vaccination 2|Overall Study||1286
459347|NCT01254630|1125368|P2|Received Vaccination 2|Overall Study||1217
459348|NCT01254630|1125369|P1|Received Vaccination 2|Overall Study||1255
459349|NCT01254630|1125366|P4|Received Vaccination 1|Overall Study||1275
459350|NCT01254630|1125367|P3|Received Vaccination 1|Overall Study||1350
459351|NCT01254630|1125368|P2|Received Vaccination 1|Overall Study||1277
459352|NCT01254630|1125369|P1|Received Vaccination 1|Overall Study||1328
459353|NCT01254630|1125366|P4|STARTED|Overall Study||1285
459354|NCT01254630|1125367|P3|STARTED|Overall Study||1364
459355|NCT01254630|1125368|P2|STARTED|Overall Study||1288
459356|NCT01254630|1125369|P1|STARTED|Overall Study||1348
459357|NCT01254604|1125389|P2|NOT COMPLETED|Overall Study||9
459358|NCT01254604|1125390|P1|NOT COMPLETED|Overall Study||8
459359|NCT01254604|1125389|P2|COMPLETED|Overall Study||86
459360|NCT01254604|1125390|P1|COMPLETED|Overall Study||87
459361|NCT01254604|1125389|P2|Treated|Overall Study|"The 1 out of 95 started who did not take study drug discontinued due to Withdrawal by Subject"|94
459362|NCT01254604|1125390|P1|Treated|Overall Study|"The 2 out of 95 started who did not take study drug discontinued due to Withdrawal by Subject"|93
459363|NCT01254604|1125389|P2|STARTED|Overall Study||95
459364|NCT01254604|1125390|P1|STARTED|Overall Study||95
459365|NCT01254565|1125408|P6|NOT COMPLETED|Overall Study||4
459366|NCT01254565|1125409|P5|NOT COMPLETED|Overall Study||4
459367|NCT01254565|1125410|P4|NOT COMPLETED|Overall Study||1
459368|NCT01254565|1125411|P3|NOT COMPLETED|Overall Study||0
459369|NCT01254565|1125412|P2|NOT COMPLETED|Overall Study||1
459370|NCT01254565|1125413|P1|NOT COMPLETED|Overall Study||1
459371|NCT01254565|1125408|P6|COMPLETED|Overall Study||13
459372|NCT01254565|1125409|P5|COMPLETED|Overall Study||12
459373|NCT01254565|1125410|P4|COMPLETED|Overall Study||20
459374|NCT01254565|1125411|P3|COMPLETED|Overall Study||21
459375|NCT01254565|1125412|P2|COMPLETED|Overall Study||6
459376|NCT01254565|1125413|P1|COMPLETED|Overall Study||4
459377|NCT01254565|1125408|P6|Received Treatment|Overall Study||13
459378|NCT01254565|1125409|P5|Received Treatment|Overall Study||13
459379|NCT01254565|1125410|P4|Received Treatment|Overall Study||21
459380|NCT01254565|1125411|P3|Received Treatment|Overall Study||21
459381|NCT01254565|1125412|P2|Received Treatment|Overall Study||6
459382|NCT01254565|1125413|P1|Received Treatment|Overall Study||4
459383|NCT01254565|1125408|P6|STARTED|Overall Study||17
459384|NCT01254565|1125409|P5|STARTED|Overall Study||16
459385|NCT01254565|1125410|P4|STARTED|Overall Study||21
459386|NCT01254565|1125411|P3|STARTED|Overall Study||21
459387|NCT01254565|1125412|P2|STARTED|Overall Study||7
459388|NCT01254565|1125413|P1|STARTED|Overall Study||5
459389|NCT01254409|1125467|P4|NOT COMPLETED|Overall Study||0
459390|NCT01254409|1125468|P3|NOT COMPLETED|Overall Study||0
459391|NCT01254409|1125469|P2|NOT COMPLETED|Overall Study||1
459392|NCT01254409|1125470|P1|NOT COMPLETED|Overall Study||0
459393|NCT01254409|1125467|P4|COMPLETED|Overall Study||4
459394|NCT01254409|1125468|P3|COMPLETED|Overall Study||5
459395|NCT01254409|1125469|P2|COMPLETED|Overall Study||5
459396|NCT01254409|1125470|P1|COMPLETED|Overall Study||6
459397|NCT01254409|1125467|P4|STARTED|Overall Study||4
459398|NCT01254409|1125468|P3|STARTED|Overall Study||5
459399|NCT01254409|1125469|P2|STARTED|Overall Study||6
459400|NCT01254409|1125470|P1|STARTED|Overall Study||6
459401|NCT01254396|1125522|P2|NOT COMPLETED|Second Intervention Period||0
459402|NCT01254396|1125523|P1|NOT COMPLETED|Second Intervention Period||0
459403|NCT01254396|1125522|P2|COMPLETED|Second Intervention Period||6
459404|NCT01254396|1125523|P1|COMPLETED|Second Intervention Period||6
459405|NCT01254396|1125522|P2|STARTED|Second Intervention Period||6
459406|NCT01254396|1125523|P1|STARTED|Second Intervention Period||6
459407|NCT01254396|1125522|P2|NOT COMPLETED|Washout Period (at Least 1 Day)||0
459408|NCT01254396|1125523|P1|NOT COMPLETED|Washout Period (at Least 1 Day)||0
459409|NCT01254396|1125522|P2|COMPLETED|Washout Period (at Least 1 Day)||6
459410|NCT01254396|1125523|P1|COMPLETED|Washout Period (at Least 1 Day)||6
459411|NCT01254396|1125522|P2|STARTED|Washout Period (at Least 1 Day)||6
459412|NCT01254396|1125523|P1|STARTED|Washout Period (at Least 1 Day)||6
459413|NCT01254396|1125522|P2|NOT COMPLETED|First Intervention Period||0
459414|NCT01254396|1125523|P1|NOT COMPLETED|First Intervention Period||0
459415|NCT01254396|1125522|P2|COMPLETED|First Intervention Period||6
459416|NCT01254396|1125523|P1|COMPLETED|First Intervention Period||6
459417|NCT01254396|1125522|P2|STARTED|First Intervention Period||6
459418|NCT01254396|1125523|P1|STARTED|First Intervention Period||6
459419|NCT01254344|1125539|P2|NOT COMPLETED|Overall Study||19
459420|NCT01254344|1125540|P1|NOT COMPLETED|Overall Study||13
459421|NCT01254344|1125539|P2|COMPLETED|Overall Study||281
459422|NCT01254344|1125540|P1|COMPLETED|Overall Study||286
459423|NCT01254344|1125539|P2|Treated|Overall Study||297
459424|NCT01254344|1125540|P1|Treated|Overall Study||290
459425|NCT01254344|1125539|P2|STARTED|Overall Study||300
459426|NCT01254344|1125540|P1|STARTED|Overall Study||299
459427|NCT01254331|1125548|P1|NOT COMPLETED|Extension Phase||4
459428|NCT01254331|1125548|P1|COMPLETED|Extension Phase||41
459429|NCT01254331|1125548|P1|STARTED|Extension Phase|1 participant withdrew consent after completing initial phase and did not enter the extension phase|45
459430|NCT01254331|1125548|P1|NOT COMPLETED|Initial Phase||5
459431|NCT01254331|1125548|P1|COMPLETED|Initial Phase||46
459432|NCT01254331|1125548|P1|STARTED|Initial Phase||51
459433|NCT01254318|1125566|P1|NOT COMPLETED|Overall Study||52
459434|NCT01254318|1125566|P1|COMPLETED|Overall Study|Alive at end of study|78
459435|NCT01254318|1125566|P1|STARTED|Overall Study|Alive at start of study|130
459436|NCT01254305|1125575|P3|NOT COMPLETED|Overall Study||17
459437|NCT01254305|1125576|P2|NOT COMPLETED|Overall Study||18
459438|NCT01254305|1125577|P1|NOT COMPLETED|Overall Study||22
459439|NCT01254305|1125575|P3|COMPLETED|Overall Study||62
459440|NCT01254305|1125576|P2|COMPLETED|Overall Study||72
459441|NCT01254305|1125577|P1|COMPLETED|Overall Study||71
459442|NCT01254305|1125575|P3|Safety Population|Overall Study||77
459443|NCT01254305|1125576|P2|Safety Population|Overall Study||85
459444|NCT01254305|1125577|P1|Safety Population|Overall Study||89
459445|NCT01254305|1125575|P3|STARTED|Overall Study||79
459446|NCT01254305|1125576|P2|STARTED|Overall Study||90
459447|NCT01254305|1125577|P1|STARTED|Overall Study||93
459448|NCT01254292|1125593|P2|NOT COMPLETED|LCS12 Extension Phase||0
459449|NCT01254292|1125594|P1|NOT COMPLETED|LCS12 Extension Phase||37
459450|NCT01254292|1125593|P2|COMPLETED|LCS12 Extension Phase||0
459451|NCT01254292|1125594|P1|COMPLETED|LCS12 Extension Phase||163
459452|NCT01254292|1125593|P2|STARTED|LCS12 Extension Phase|Optional Extension Phase was for LCS12 group only.|0
459453|NCT01254292|1125594|P1|STARTED|LCS12 Extension Phase|A total of 200 participants elected to enter this optional Extension Phase.|200
459454|NCT01254292|1125593|P2|NOT COMPLETED|Comparative Phase||81
459455|NCT01254292|1125594|P1|NOT COMPLETED|Comparative Phase||55
459456|NCT01254292|1125593|P2|COMPLETED|Comparative Phase||204
459457|NCT01254292|1125594|P1|COMPLETED|Comparative Phase||227
459458|NCT01254292|1125593|P2|Participants Received Treatment|Comparative Phase|safety population|281
459459|NCT01254292|1125594|P1|Participants Received Treatment|Comparative Phase|safety population|279
459460|NCT01254292|1125593|P2|STARTED|Comparative Phase||285
459461|NCT01254292|1125594|P1|STARTED|Comparative Phase||282
459462|NCT01254214|1125656|P2|NOT COMPLETED|Overall Study||1
459463|NCT01254214|1125657|P1|NOT COMPLETED|Overall Study||3
459464|NCT01254214|1125656|P2|COMPLETED|Overall Study||27
459465|NCT01254214|1125657|P1|COMPLETED|Overall Study||24
459466|NCT01254214|1125656|P2|STARTED|Overall Study||28
459467|NCT01254214|1125657|P1|STARTED|Overall Study||27
459468|NCT01254188|1125671|P1|NOT COMPLETED|Overall Study||93
459469|NCT01254188|1125671|P1|COMPLETED|Overall Study||328
459470|NCT01254188|1125671|P1|STARTED|Overall Study||421
459471|NCT01254045|1125682|P6|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
459472|NCT01254045|1125683|P5|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
459473|NCT01254045|1125684|P4|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
459474|NCT01254045|1125685|P3|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
459475|NCT01254045|1125686|P2|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
459476|NCT01254045|1125687|P1|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
459477|NCT01254045|1125682|P6|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
459478|NCT01254045|1125683|P5|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
459479|NCT01254045|1125684|P4|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
459480|NCT01254045|1125685|P3|COMPLETED|Third/Time 3 (1 Day at Week 3)||2
459481|NCT01254045|1125686|P2|COMPLETED|Third/Time 3 (1 Day at Week 3)||2
459482|NCT01254045|1125687|P1|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
459483|NCT01254045|1125682|P6|STARTED|Third/Time 3 (1 Day at Week 3)||1
459484|NCT01254045|1125683|P5|STARTED|Third/Time 3 (1 Day at Week 3)||1
459485|NCT01254045|1125684|P4|STARTED|Third/Time 3 (1 Day at Week 3)||1
459486|NCT01254045|1125685|P3|STARTED|Third/Time 3 (1 Day at Week 3)||2
459487|NCT01254045|1125686|P2|STARTED|Third/Time 3 (1 Day at Week 3)||2
459488|NCT01254045|1125687|P1|STARTED|Third/Time 3 (1 Day at Week 3)||1
459489|NCT01254045|1125682|P6|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
459490|NCT01254045|1125683|P5|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
459491|NCT01254045|1125684|P4|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
459492|NCT01254045|1125685|P3|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
459493|NCT01254045|1125686|P2|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
459494|NCT01254045|1125687|P1|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
459495|NCT01254045|1125682|P6|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
459496|NCT01254045|1125683|P5|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
459497|NCT01254045|1125684|P4|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
459498|NCT01254045|1125685|P3|COMPLETED|Second/Time 2 (1 Day at Week 2)||2
459499|NCT01254045|1125686|P2|COMPLETED|Second/Time 2 (1 Day at Week 2)||2
459500|NCT01254045|1125687|P1|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
459501|NCT01254045|1125682|P6|STARTED|Second/Time 2 (1 Day at Week 2)||1
459502|NCT01254045|1125683|P5|STARTED|Second/Time 2 (1 Day at Week 2)||1
459503|NCT01254045|1125684|P4|STARTED|Second/Time 2 (1 Day at Week 2)||1
459504|NCT01254045|1125685|P3|STARTED|Second/Time 2 (1 Day at Week 2)||2
459505|NCT01254045|1125686|P2|STARTED|Second/Time 2 (1 Day at Week 2)||2
459506|NCT01254045|1125687|P1|STARTED|Second/Time 2 (1 Day at Week 2)||1
459507|NCT01254045|1125682|P6|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
459508|NCT01254045|1125683|P5|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
459509|NCT01254045|1125684|P4|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
459510|NCT01254045|1125685|P3|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
459511|NCT01254045|1125686|P2|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
459512|NCT01254045|1125687|P1|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||1
459513|NCT01254045|1125682|P6|COMPLETED|First/Baseline (1 Day at Week 1 )||1
459514|NCT01254045|1125683|P5|COMPLETED|First/Baseline (1 Day at Week 1 )||1
459515|NCT01254045|1125684|P4|COMPLETED|First/Baseline (1 Day at Week 1 )||1
459516|NCT01254045|1125685|P3|COMPLETED|First/Baseline (1 Day at Week 1 )||2
459517|NCT01254045|1125686|P2|COMPLETED|First/Baseline (1 Day at Week 1 )||2
459518|NCT01254045|1125687|P1|COMPLETED|First/Baseline (1 Day at Week 1 )||1
459519|NCT01254045|1125682|P6|STARTED|First/Baseline (1 Day at Week 1 )||1
459520|NCT01254045|1125683|P5|STARTED|First/Baseline (1 Day at Week 1 )||1
459521|NCT01254045|1125684|P4|STARTED|First/Baseline (1 Day at Week 1 )||1
459522|NCT01254045|1125685|P3|STARTED|First/Baseline (1 Day at Week 1 )||2
459523|NCT01254045|1125686|P2|STARTED|First/Baseline (1 Day at Week 1 )||2
459524|NCT01254045|1125687|P1|STARTED|First/Baseline (1 Day at Week 1 )|One completed all baseline measures including administration of placebo, but then lost to follow-up.|2
459525|NCT01253980|1125700|P2|NOT COMPLETED|Overall Study||0
459526|NCT01253980|1125701|P1|NOT COMPLETED|Overall Study||0
459527|NCT01253980|1125700|P2|COMPLETED|Overall Study||39
459528|NCT01253980|1125701|P1|COMPLETED|Overall Study||35
459529|NCT01253980|1125700|P2|STARTED|Overall Study||39
459530|NCT01253980|1125701|P1|STARTED|Overall Study||35
459531|NCT01253902|1125710|P3|NOT COMPLETED|Overall Study||4
459532|NCT01253902|1125711|P2|NOT COMPLETED|Overall Study||2
459533|NCT01253902|1125712|P1|NOT COMPLETED|Overall Study||5
459534|NCT01253902|1125710|P3|COMPLETED|Overall Study||51
459535|NCT01253902|1125711|P2|COMPLETED|Overall Study||51
459536|NCT01253902|1125712|P1|COMPLETED|Overall Study||51
459537|NCT01253902|1125710|P3|STARTED|Overall Study||55
459538|NCT01253902|1125711|P2|STARTED|Overall Study||53
459539|NCT01253902|1125712|P1|STARTED|Overall Study||56
459540|NCT01253824|1125728|P2|NOT COMPLETED|Overall Study||0
459541|NCT01253824|1125729|P1|NOT COMPLETED|Overall Study||0
459542|NCT01253824|1125728|P2|COMPLETED|Overall Study||7
459543|NCT01253824|1125729|P1|COMPLETED|Overall Study||7
459544|NCT01253824|1125728|P2|STARTED|Overall Study||7
459545|NCT01253824|1125729|P1|STARTED|Overall Study||7
459546|NCT01253811|1125741|P1|NOT COMPLETED|Overall Study||1
459547|NCT01253811|1125741|P1|COMPLETED|Overall Study||5
459548|NCT01253811|1125741|P1|Exposed|Overall Study||6
459549|NCT01253811|1125741|P1|STARTED|Overall Study||6
459550|NCT01253642|1125760|P1|NOT COMPLETED|Overall Study||5
459551|NCT01253642|1125760|P1|COMPLETED|Overall Study||6
459552|NCT01253642|1125760|P1|STARTED|Overall Study||11
459553|NCT01253577|1125772|P1|NOT COMPLETED|Overall Study||3
459554|NCT01253577|1125772|P1|COMPLETED|Overall Study||102
459555|NCT01253577|1125772|P1|STARTED|Overall Study||105
459556|NCT01253564|1125780|P1|NOT COMPLETED|Overall Study||24
459557|NCT01253564|1125780|P1|COMPLETED|Overall Study||0
459558|NCT01253564|1125780|P1|STARTED|Overall Study||24
459559|NCT01253525|1125797|P1|NOT COMPLETED|Overall Study||0
459560|NCT01253525|1125797|P1|COMPLETED|Overall Study||6
459561|NCT01253525|1125797|P1|Received Any Quantity of Study Drug|Overall Study||6
459562|NCT01253525|1125797|P1|STARTED|Overall Study||6
459563|NCT01253447|1125824|P1|NOT COMPLETED|Overall Study||2
459564|NCT01253447|1125824|P1|COMPLETED|Overall Study||17
459565|NCT01253447|1125824|P1|STARTED|Overall Study||19
459566|NCT01253421|1125832|P5|NOT COMPLETED|Drug+Scanning Visit||1
459567|NCT01253421|1125833|P4|NOT COMPLETED|Drug+Scanning Visit||0
459568|NCT01253421|1125834|P3|NOT COMPLETED|Drug+Scanning Visit||0
459569|NCT01253421|1125835|P2|NOT COMPLETED|Drug+Scanning Visit||0
459570|NCT01253421|1125836|P1|NOT COMPLETED|Drug+Scanning Visit||0
459571|NCT01253421|1125832|P5|COMPLETED|Drug+Scanning Visit||14
459572|NCT01253421|1125833|P4|COMPLETED|Drug+Scanning Visit||16
459573|NCT01253421|1125834|P3|COMPLETED|Drug+Scanning Visit||14
459574|NCT01253421|1125835|P2|COMPLETED|Drug+Scanning Visit||15
459575|NCT01253421|1125836|P1|COMPLETED|Drug+Scanning Visit||0
459576|NCT01253421|1125832|P5|Received Drug Challenge|Drug+Scanning Visit||15
459577|NCT01253421|1125833|P4|Received Drug Challenge|Drug+Scanning Visit||16
459578|NCT01253421|1125834|P3|Received Drug Challenge|Drug+Scanning Visit||14
459579|NCT01253421|1125835|P2|Received Drug Challenge|Drug+Scanning Visit||15
459580|NCT01253421|1125836|P1|Received Drug Challenge|Drug+Scanning Visit||0
459581|NCT01253421|1125832|P5|STARTED|Drug+Scanning Visit||15
459582|NCT01253421|1125833|P4|STARTED|Drug+Scanning Visit||16
459583|NCT01253421|1125834|P3|STARTED|Drug+Scanning Visit||14
459584|NCT01253421|1125835|P2|STARTED|Drug+Scanning Visit||15
459585|NCT01253421|1125836|P1|STARTED|Drug+Scanning Visit|Arm has no participants once randomization has occurred.|0
459586|NCT01253421|1125832|P5|NOT COMPLETED|Assessment and Scheduling||0
459587|NCT01253421|1125833|P4|NOT COMPLETED|Assessment and Scheduling||0
459588|NCT01253421|1125834|P3|NOT COMPLETED|Assessment and Scheduling||0
459589|NCT01253421|1125835|P2|NOT COMPLETED|Assessment and Scheduling||0
459590|NCT01253421|1125836|P1|NOT COMPLETED|Assessment and Scheduling||99
459591|NCT01253421|1125832|P5|COMPLETED|Assessment and Scheduling||0
459592|NCT01253421|1125833|P4|COMPLETED|Assessment and Scheduling||0
459593|NCT01253421|1125834|P3|COMPLETED|Assessment and Scheduling||0
459594|NCT01253421|1125835|P2|COMPLETED|Assessment and Scheduling||0
459595|NCT01253421|1125836|P1|COMPLETED|Assessment and Scheduling||60
459596|NCT01253421|1125832|P5|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
459597|NCT01253421|1125833|P4|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
459598|NCT01253421|1125834|P3|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
459599|NCT01253421|1125835|P2|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
459600|NCT01253421|1125836|P1|Returned for Drug+Scanning Visit|Assessment and Scheduling||60
459601|NCT01253421|1125832|P5|Eligible After Screening Visit|Assessment and Scheduling||0
459602|NCT01253421|1125833|P4|Eligible After Screening Visit|Assessment and Scheduling||0
459603|NCT01253421|1125834|P3|Eligible After Screening Visit|Assessment and Scheduling||0
459604|NCT01253421|1125835|P2|Eligible After Screening Visit|Assessment and Scheduling||0
459605|NCT01253421|1125836|P1|Eligible After Screening Visit|Assessment and Scheduling||85
459606|NCT01253421|1125832|P5|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
459607|NCT01253421|1125833|P4|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
459608|NCT01253421|1125834|P3|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
459609|NCT01253421|1125835|P2|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
459610|NCT01253421|1125836|P1|STARTED|Assessment and Scheduling||159
459611|NCT01253408|1125885|P3|NOT COMPLETED|Overall Study||0
459612|NCT01253408|1125886|P2|NOT COMPLETED|Overall Study||1
459613|NCT01253408|1125887|P1|NOT COMPLETED|Overall Study||0
459614|NCT01253408|1125885|P3|COMPLETED|Overall Study||13
459615|NCT01253408|1125886|P2|COMPLETED|Overall Study||12
459616|NCT01253408|1125887|P1|COMPLETED|Overall Study||10
459617|NCT01253408|1125885|P3|STARTED|Overall Study||13
459618|NCT01253408|1125886|P2|STARTED|Overall Study||13
459619|NCT01253408|1125887|P1|STARTED|Overall Study||10
459620|NCT01253369|1125910|P1|NOT COMPLETED|Overall Study||33
459621|NCT01253369|1125910|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
459622|NCT01253369|1125910|P1|Evaluable|Overall Study|Evaluable pts were w/ measurable disease, min 1 cycle of trt rcvd and 1 on-trt disease assessment.|30
459623|NCT01253369|1125910|P1|STARTED|Overall Study||33
459624|NCT01253343|1125917|P2|NOT COMPLETED|Overall Study||0
459625|NCT01253343|1125918|P1|NOT COMPLETED|Overall Study||0
459626|NCT01253343|1125917|P2|COMPLETED|Overall Study||8
459627|NCT01253343|1125918|P1|COMPLETED|Overall Study||9
459628|NCT01253343|1125917|P2|STARTED|Overall Study||8
459629|NCT01253343|1125918|P1|STARTED|Overall Study||9
459630|NCT01253317|1125940|P1|NOT COMPLETED|Overall Study||2
459631|NCT01253317|1125940|P1|COMPLETED|Overall Study||10
459632|NCT01253317|1125940|P1|STARTED|Overall Study||12
459633|NCT01253304|1125952|P4|NOT COMPLETED|Overall Study||1
459634|NCT01253304|1125953|P3|NOT COMPLETED|Overall Study||0
459635|NCT01253304|1125954|P2|NOT COMPLETED|Overall Study||0
459636|NCT01253304|1125955|P1|NOT COMPLETED|Overall Study||0
459637|NCT01253304|1125952|P4|COMPLETED|Overall Study||2
459638|NCT01253304|1125953|P3|COMPLETED|Overall Study||6
459639|NCT01253304|1125954|P2|COMPLETED|Overall Study||6
459640|NCT01253304|1125955|P1|COMPLETED|Overall Study||11
459641|NCT01253304|1125952|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
459642|NCT01253304|1125953|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
459643|NCT01253304|1125954|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
459644|NCT01253304|1125955|P1|Received at Least 1 Dose of Study Drug|Overall Study||11
459645|NCT01253304|1125952|P4|STARTED|Overall Study||3
459646|NCT01253304|1125953|P3|STARTED|Overall Study||6
459647|NCT01253304|1125954|P2|STARTED|Overall Study||6
459648|NCT01253304|1125955|P1|STARTED|Overall Study||11
459649|NCT01253265|1125994|P5|NOT COMPLETED|Overall Study||1
459650|NCT01253265|1125995|P4|NOT COMPLETED|Overall Study||0
459651|NCT01253265|1125996|P3|NOT COMPLETED|Overall Study||0
459652|NCT01253265|1125997|P2|NOT COMPLETED|Overall Study||0
459653|NCT01253265|1125998|P1|NOT COMPLETED|Overall Study||1
459654|NCT01253265|1125994|P5|COMPLETED|Overall Study||7
459655|NCT01253265|1125995|P4|COMPLETED|Overall Study||6
459656|NCT01253265|1125996|P3|COMPLETED|Overall Study||6
459657|NCT01253265|1125997|P2|COMPLETED|Overall Study||6
459658|NCT01253265|1125998|P1|COMPLETED|Overall Study||5
459659|NCT01253265|1125994|P5|STARTED|Overall Study||8
459660|NCT01253265|1125995|P4|STARTED|Overall Study||6
459661|NCT01253265|1125996|P3|STARTED|Overall Study||6
459662|NCT01253265|1125997|P2|STARTED|Overall Study||6
459663|NCT01253265|1125998|P1|STARTED|Overall Study||6
459664|NCT01253200|1126047|P5|NOT COMPLETED|Overall Study||5
459665|NCT01253200|1126048|P4|NOT COMPLETED|Overall Study||5
459666|NCT01253200|1126049|P3|NOT COMPLETED|Overall Study||2
459667|NCT01253200|1126050|P2|NOT COMPLETED|Overall Study||19
459668|NCT01253200|1126051|P1|NOT COMPLETED|Overall Study||21
459669|NCT01253200|1126047|P5|COMPLETED|Overall Study||0
459670|NCT01253200|1126048|P4|COMPLETED|Overall Study||12
459671|NCT01253200|1126049|P3|COMPLETED|Overall Study||28
459672|NCT01253200|1126050|P2|COMPLETED|Overall Study||106
459673|NCT01253200|1126051|P1|COMPLETED|Overall Study||104
459674|NCT01253200|1126047|P5|3 Month Follow-up|Overall Study||0
459675|NCT01253200|1126048|P4|3 Month Follow-up|Overall Study||12
459676|NCT01253200|1126049|P3|3 Month Follow-up|Overall Study||28
459677|NCT01253200|1126050|P2|3 Month Follow-up|Overall Study||106
459678|NCT01253200|1126051|P1|3 Month Follow-up|Overall Study||104
459679|NCT01253200|1126047|P5|10 Day Follow-up|Overall Study||0
459680|NCT01253200|1126048|P4|10 Day Follow-up|Overall Study||12
459681|NCT01253200|1126049|P3|10 Day Follow-up|Overall Study||28
459682|NCT01253200|1126050|P2|10 Day Follow-up|Overall Study||111
459683|NCT01253200|1126051|P1|10 Day Follow-up|Overall Study||106
459684|NCT01253200|1126047|P5|Procedure|Overall Study||0
459685|NCT01253200|1126048|P4|Procedure|Overall Study||12
459686|NCT01253200|1126049|P3|Procedure|Overall Study||28
459687|NCT01253200|1126050|P2|Procedure|Overall Study||111
459688|NCT01253200|1126051|P1|Procedure|Overall Study||109
459689|NCT01253200|1126047|P5|STARTED|Overall Study||5
459690|NCT01253200|1126048|P4|STARTED|Overall Study||17
459691|NCT01253200|1126049|P3|STARTED|Overall Study||30
459692|NCT01253200|1126050|P2|STARTED|Overall Study||125
459693|NCT01253200|1126051|P1|STARTED|Overall Study||125
459694|NCT01253187|1126066|P6|NOT COMPLETED|Period 3||0
459695|NCT01253187|1126067|P5|NOT COMPLETED|Period 3||1
459696|NCT01253187|1126068|P4|NOT COMPLETED|Period 3||0
459697|NCT01253187|1126069|P3|NOT COMPLETED|Period 3||0
459698|NCT01253187|1126070|P2|NOT COMPLETED|Period 3||1
459699|NCT01253187|1126071|P1|NOT COMPLETED|Period 3||1
459700|NCT01253187|1126066|P6|COMPLETED|Period 3||6
459701|NCT01253187|1126067|P5|COMPLETED|Period 3||7
459702|NCT01253187|1126068|P4|COMPLETED|Period 3||7
459703|NCT01253187|1126069|P3|COMPLETED|Period 3||7
459704|NCT01253187|1126070|P2|COMPLETED|Period 3||7
459705|NCT01253187|1126071|P1|COMPLETED|Period 3||6
459706|NCT01253187|1126066|P6|STARTED|Period 3||6
459707|NCT01253187|1126067|P5|STARTED|Period 3||8
459708|NCT01253187|1126068|P4|STARTED|Period 3||7
459709|NCT01253187|1126069|P3|STARTED|Period 3||7
459710|NCT01253187|1126070|P2|STARTED|Period 3||8
459711|NCT01253187|1126071|P1|STARTED|Period 3||7
459712|NCT01253187|1126066|P6|NOT COMPLETED|Period 2||0
459713|NCT01253187|1126067|P5|NOT COMPLETED|Period 2||1
459714|NCT01253187|1126068|P4|NOT COMPLETED|Period 2||0
459715|NCT01253187|1126069|P3|NOT COMPLETED|Period 2||0
459716|NCT01253187|1126070|P2|NOT COMPLETED|Period 2||0
459717|NCT01253187|1126071|P1|NOT COMPLETED|Period 2||0
459718|NCT01253187|1126066|P6|COMPLETED|Period 2||6
459719|NCT01253187|1126067|P5|COMPLETED|Period 2||8
459720|NCT01253187|1126068|P4|COMPLETED|Period 2||7
459721|NCT01253187|1126069|P3|COMPLETED|Period 2||7
459722|NCT01253187|1126070|P2|COMPLETED|Period 2||8
459723|NCT01253187|1126071|P1|COMPLETED|Period 2||7
459724|NCT01253187|1126066|P6|STARTED|Period 2||6
459725|NCT01253187|1126067|P5|STARTED|Period 2||9
459726|NCT01253187|1126068|P4|STARTED|Period 2||7
459727|NCT01253187|1126069|P3|STARTED|Period 2||7
459728|NCT01253187|1126070|P2|STARTED|Period 2||8
459729|NCT01253187|1126071|P1|STARTED|Period 2||7
459730|NCT01253187|1126066|P6|NOT COMPLETED|Period 1||0
459731|NCT01253187|1126067|P5|NOT COMPLETED|Period 1||0
459732|NCT01253187|1126068|P4|NOT COMPLETED|Period 1||0
459733|NCT01253187|1126069|P3|NOT COMPLETED|Period 1||0
459734|NCT01253187|1126070|P2|NOT COMPLETED|Period 1||0
459735|NCT01253187|1126071|P1|NOT COMPLETED|Period 1||0
459736|NCT01253187|1126066|P6|COMPLETED|Period 1||6
459737|NCT01253187|1126067|P5|COMPLETED|Period 1||9
459738|NCT01253187|1126068|P4|COMPLETED|Period 1||7
459739|NCT01253187|1126069|P3|COMPLETED|Period 1||7
459740|NCT01253187|1126070|P2|COMPLETED|Period 1||8
459741|NCT01253187|1126071|P1|COMPLETED|Period 1||7
459742|NCT01253187|1126066|P6|STARTED|Period 1||6
459743|NCT01253187|1126067|P5|STARTED|Period 1||9
459744|NCT01253187|1126068|P4|STARTED|Period 1||7
459745|NCT01253187|1126069|P3|STARTED|Period 1||7
459746|NCT01253187|1126070|P2|STARTED|Period 1||8
459747|NCT01253187|1126071|P1|STARTED|Period 1||7
459748|NCT01253174|1126100|P6|NOT COMPLETED|Period 3||0
459749|NCT01253174|1126101|P5|NOT COMPLETED|Period 3||1
459750|NCT01253174|1126102|P4|NOT COMPLETED|Period 3||0
459751|NCT01253174|1126103|P3|NOT COMPLETED|Period 3||1
459752|NCT01253174|1126104|P2|NOT COMPLETED|Period 3||1
459753|NCT01253174|1126105|P1|NOT COMPLETED|Period 3||0
459754|NCT01253174|1126100|P6|COMPLETED|Period 3||7
459755|NCT01253174|1126101|P5|COMPLETED|Period 3||7
459756|NCT01253174|1126102|P4|COMPLETED|Period 3||7
459757|NCT01253174|1126103|P3|COMPLETED|Period 3||6
459758|NCT01253174|1126104|P2|COMPLETED|Period 3||8
459759|NCT01253174|1126105|P1|COMPLETED|Period 3||6
459760|NCT01253174|1126100|P6|STARTED|Period 3||7
459761|NCT01253174|1126101|P5|STARTED|Period 3||8
459762|NCT01253174|1126102|P4|STARTED|Period 3||7
459763|NCT01253174|1126103|P3|STARTED|Period 3||7
459764|NCT01253174|1126104|P2|STARTED|Period 3||9
459765|NCT01253174|1126105|P1|STARTED|Period 3||6
459766|NCT01253174|1126100|P6|NOT COMPLETED|Period 2||0
459767|NCT01253174|1126101|P5|NOT COMPLETED|Period 2||0
459768|NCT01253174|1126102|P4|NOT COMPLETED|Period 2||0
459769|NCT01253174|1126103|P3|NOT COMPLETED|Period 2||1
459770|NCT01253174|1126104|P2|NOT COMPLETED|Period 2||0
459771|NCT01253174|1126105|P1|NOT COMPLETED|Period 2||0
459772|NCT01253174|1126100|P6|COMPLETED|Period 2||7
459773|NCT01253174|1126101|P5|COMPLETED|Period 2||8
459774|NCT01253174|1126102|P4|COMPLETED|Period 2||7
459775|NCT01253174|1126103|P3|COMPLETED|Period 2||7
459776|NCT01253174|1126104|P2|COMPLETED|Period 2||9
459777|NCT01253174|1126105|P1|COMPLETED|Period 2||6
459778|NCT01253174|1126100|P6|STARTED|Period 2||7
459779|NCT01253174|1126101|P5|STARTED|Period 2||8
459780|NCT01253174|1126102|P4|STARTED|Period 2||7
459781|NCT01253174|1126103|P3|STARTED|Period 2||8
459782|NCT01253174|1126104|P2|STARTED|Period 2||9
459783|NCT01253174|1126105|P1|STARTED|Period 2||6
459784|NCT01253174|1126100|P6|NOT COMPLETED|Period 1||0
459785|NCT01253174|1126101|P5|NOT COMPLETED|Period 1||1
459786|NCT01253174|1126102|P4|NOT COMPLETED|Period 1||0
459787|NCT01253174|1126103|P3|NOT COMPLETED|Period 1||1
459788|NCT01253174|1126104|P2|NOT COMPLETED|Period 1||1
459789|NCT01253174|1126105|P1|NOT COMPLETED|Period 1||0
459790|NCT01253174|1126100|P6|COMPLETED|Period 1||7
459791|NCT01253174|1126101|P5|COMPLETED|Period 1||8
459792|NCT01253174|1126102|P4|COMPLETED|Period 1||7
459793|NCT01253174|1126103|P3|COMPLETED|Period 1||8
459794|NCT01253174|1126104|P2|COMPLETED|Period 1||9
459795|NCT01253174|1126105|P1|COMPLETED|Period 1||6
459796|NCT01253174|1126100|P6|STARTED|Period 1||7
459797|NCT01253174|1126101|P5|STARTED|Period 1||9
459798|NCT01253174|1126102|P4|STARTED|Period 1||7
459799|NCT01253174|1126103|P3|STARTED|Period 1||9
459800|NCT01253174|1126104|P2|STARTED|Period 1||10
459801|NCT01253174|1126105|P1|STARTED|Period 1||6
459802|NCT01253148|1126134|P1|NOT COMPLETED|Overall Study||0
459803|NCT01253148|1126134|P1|COMPLETED|Overall Study||25
459804|NCT01253148|1126134|P1|STARTED|Overall Study||25
459805|NCT01253135|1126140|P1|NOT COMPLETED|Amended Protocol||1
459806|NCT01253135|1126140|P1|COMPLETED|Amended Protocol||24
459807|NCT01253135|1126140|P1|STARTED|Amended Protocol||25
459808|NCT01253135|1126140|P1|NOT COMPLETED|Original Protocol||15
459809|NCT01253135|1126140|P1|COMPLETED|Original Protocol||0
459810|NCT01253135|1126140|P1|STARTED|Original Protocol||15
459811|NCT01253070|1126148|P1|NOT COMPLETED|Overall Study||0
459812|NCT01253070|1126148|P1|COMPLETED|Overall Study||54
459813|NCT01253070|1126148|P1|STARTED|Overall Study||54
459814|NCT01253044|1126159|P2|NOT COMPLETED|Overall Study||29
459815|NCT01253044|1126160|P1|NOT COMPLETED|Overall Study||38
459816|NCT01253044|1126159|P2|COMPLETED|Overall Study||51
459817|NCT01253044|1126160|P1|COMPLETED|Overall Study||42
459818|NCT01253044|1126159|P2|STARTED|Overall Study||80
459819|NCT01253044|1126160|P1|STARTED|Overall Study||80
459820|NCT01253018|1126170|P2|NOT COMPLETED|Overall Study||2
459821|NCT01253018|1126171|P1|NOT COMPLETED|Overall Study||4
459822|NCT01253018|1126170|P2|COMPLETED|Overall Study||21
459823|NCT01253018|1126171|P1|COMPLETED|Overall Study||18
459824|NCT01253018|1126170|P2|STARTED|Overall Study||23
459825|NCT01253018|1126171|P1|STARTED|Overall Study||22
459826|NCT01252966|1126185|P2|NOT COMPLETED|Overall Study||13
459827|NCT01252966|1126186|P1|NOT COMPLETED|Overall Study||23
459828|NCT01252966|1126185|P2|COMPLETED|Overall Study||92
459829|NCT01252966|1126186|P1|COMPLETED|Overall Study||85
459830|NCT01252966|1126185|P2|STARTED|Overall Study||105
459831|NCT01252966|1126186|P1|STARTED|Overall Study||108
459832|NCT01252953|1126202|P2|NOT COMPLETED|Overall Study||38
459833|NCT01252953|1126203|P1|NOT COMPLETED|Overall Study||38
459834|NCT01252953|1126202|P2|COMPLETED|Overall Study||15186
459835|NCT01252953|1126203|P1|COMPLETED|Overall Study||15187
459836|NCT01252953|1126202|P2|STARTED|Overall Study||15224
459837|NCT01252953|1126203|P1|STARTED|Overall Study||15225
459838|NCT01252940|1126217|P2|NOT COMPLETED|Extension Phase||3
459839|NCT01252940|1126218|P1|NOT COMPLETED|Extension Phase||10
459840|NCT01252940|1126217|P2|COMPLETED|Extension Phase||46
459841|NCT01252940|1126218|P1|COMPLETED|Extension Phase||100
459842|NCT01252940|1126217|P2|STARTED|Extension Phase|SBR/Delayed Switch Group: 49 participants completing the main study continued in extension phase.|49
459843|NCT01252940|1126218|P1|STARTED|Extension Phase|FTC/RPV/TDF group: 110 participants completing the main study continued in extension phase.|110
459844|NCT01252940|1126217|P2|NOT COMPLETED|Main Study Phase||12
459845|NCT01252940|1126218|P1|NOT COMPLETED|Main Study Phase||26
459846|NCT01252940|1126217|P2|COMPLETED|Main Study Phase|Discontinuations after switch: withdrawal by subject, 2; adverse event, 1; protocol violation, 1.|149
459847|NCT01252940|1126218|P1|COMPLETED|Main Study Phase||295
459848|NCT01252940|1126217|P2|Completed 24 Weeks|Main Study Phase|152 participants switched regimens at Week 24.|153
459849|NCT01252940|1126218|P1|Completed 24 Weeks|Main Study Phase||0
459850|NCT01252940|1126217|P2|STARTED|Main Study Phase||161
459851|NCT01252940|1126218|P1|STARTED|Main Study Phase||321
459852|NCT01252810|1126249|P2|NOT COMPLETED|Overall Study||3
459853|NCT01252810|1126250|P1|NOT COMPLETED|Overall Study||14
459854|NCT01252810|1126249|P2|COMPLETED|Overall Study||139
459855|NCT01252810|1126250|P1|COMPLETED|Overall Study||128
459856|NCT01252810|1126249|P2|STARTED|Overall Study||142
459857|NCT01252810|1126250|P1|STARTED|Overall Study||142
459858|NCT01252745|1126263|P3|NOT COMPLETED|Overall Study||0
459859|NCT01252745|1126264|P2|NOT COMPLETED|Overall Study||0
459860|NCT01252745|1126265|P1|NOT COMPLETED|Overall Study||0
459861|NCT01252745|1126263|P3|COMPLETED|Overall Study||7
459862|NCT01252745|1126264|P2|COMPLETED|Overall Study||7
459863|NCT01252745|1126265|P1|COMPLETED|Overall Study||8
459864|NCT01252745|1126263|P3|STARTED|Overall Study||7
459865|NCT01252745|1126264|P2|STARTED|Overall Study||7
459866|NCT01252745|1126265|P1|STARTED|Overall Study||8
459867|NCT01252355|1126282|P3|NOT COMPLETED|Overall Study||179
459868|NCT01252355|1126283|P2|NOT COMPLETED|Overall Study||178
459869|NCT01252355|1126284|P1|NOT COMPLETED|Overall Study||177
459870|NCT01252355|1126282|P3|COMPLETED|Overall Study||0
459871|NCT01252355|1126283|P2|COMPLETED|Overall Study||0
459872|NCT01252355|1126284|P1|COMPLETED|Overall Study||0
459873|NCT01252355|1126282|P3|Treated|Overall Study|One participant received teriflunomide 7 mg.|179
459874|NCT01252355|1126283|P2|Treated|Overall Study||178
459875|NCT01252355|1126284|P1|Treated|Overall Study||175
459876|NCT01252355|1126282|P3|STARTED|Overall Study|Randomized.|179
459877|NCT01252355|1126283|P2|STARTED|Overall Study|Randomized.|178
459878|NCT01252355|1126284|P1|STARTED|Overall Study|Randomized.|177
459879|NCT01252290|1126322|P1|NOT COMPLETED|Overall Study||1
459880|NCT01252290|1126322|P1|COMPLETED|Overall Study||34
459881|NCT01252290|1126322|P1|STARTED|Overall Study||35
459882|NCT01252277|1126330|P1|NOT COMPLETED|Overall Study||2
459883|NCT01252277|1126330|P1|COMPLETED|Overall Study||34
459884|NCT01252277|1126330|P1|STARTED|Overall Study||36
459885|NCT01252251|1126338|P1|NOT COMPLETED|Overall Study||1
459886|NCT01252251|1126338|P1|COMPLETED|Overall Study||13
459887|NCT01252251|1126338|P1|STARTED|Overall Study||14
459888|NCT01252238|1126350|P3|NOT COMPLETED|Overall Study||4
459889|NCT01252238|1126351|P2|NOT COMPLETED|Overall Study||4
459890|NCT01252238|1126352|P1|NOT COMPLETED|Overall Study||4
459891|NCT01252238|1126350|P3|COMPLETED|Overall Study|sponsor terminated study|4
459892|NCT01252238|1126351|P2|COMPLETED|Overall Study|sponsor terminated study|4
459893|NCT01252238|1126352|P1|COMPLETED|Overall Study|sponsor terminated study|4
459894|NCT01252238|1126350|P3|STARTED|Overall Study||8
459895|NCT01252238|1126351|P2|STARTED|Overall Study||8
459896|NCT01252238|1126352|P1|STARTED|Overall Study||8
459897|NCT01252186|1126369|P3|NOT COMPLETED|Overall Study||34
459898|NCT01252186|1126370|P2|NOT COMPLETED|Overall Study||32
459899|NCT01252186|1126371|P1|NOT COMPLETED|Overall Study||30
459900|NCT01252186|1126369|P3|COMPLETED|Overall Study||53
459901|NCT01252186|1126370|P2|COMPLETED|Overall Study||59
459902|NCT01252186|1126371|P1|COMPLETED|Overall Study||57
459903|NCT01252186|1126369|P3|Received Study Drug|Overall Study||80
459904|NCT01252186|1126370|P2|Received Study Drug|Overall Study||89
459905|NCT01252186|1126371|P1|Received Study Drug|Overall Study||83
459906|NCT01252186|1126369|P3|STARTED|Overall Study||87
459907|NCT01252186|1126370|P2|STARTED|Overall Study||91
459908|NCT01252186|1126371|P1|STARTED|Overall Study||87
459909|NCT01252147|1126439|P1|NOT COMPLETED|Overall Study||0
459910|NCT01252147|1126439|P1|COMPLETED|Overall Study||68
459911|NCT01252147|1126439|P1|STARTED|Overall Study||68
459912|NCT01252134|1126444|P6|NOT COMPLETED|Period 3, 8 Hours||0
459913|NCT01252134|1126445|P5|NOT COMPLETED|Period 3, 8 Hours||0
459914|NCT01252134|1126446|P4|NOT COMPLETED|Period 3, 8 Hours||0
459915|NCT01252134|1126447|P3|NOT COMPLETED|Period 3, 8 Hours||0
459916|NCT01252134|1126448|P2|NOT COMPLETED|Period 3, 8 Hours||0
459917|NCT01252134|1126449|P1|NOT COMPLETED|Period 3, 8 Hours||0
459918|NCT01252134|1126444|P6|COMPLETED|Period 3, 8 Hours||4
459919|NCT01252134|1126445|P5|COMPLETED|Period 3, 8 Hours||3
459920|NCT01252134|1126446|P4|COMPLETED|Period 3, 8 Hours||5
459921|NCT01252134|1126447|P3|COMPLETED|Period 3, 8 Hours||2
459922|NCT01252134|1126448|P2|COMPLETED|Period 3, 8 Hours||3
459923|NCT01252134|1126449|P1|COMPLETED|Period 3, 8 Hours||3
459924|NCT01252134|1126444|P6|STARTED|Period 3, 8 Hours||4
459925|NCT01252134|1126445|P5|STARTED|Period 3, 8 Hours||3
459926|NCT01252134|1126446|P4|STARTED|Period 3, 8 Hours||5
459927|NCT01252134|1126447|P3|STARTED|Period 3, 8 Hours||2
459928|NCT01252134|1126448|P2|STARTED|Period 3, 8 Hours||3
459929|NCT01252134|1126449|P1|STARTED|Period 3, 8 Hours||3
459930|NCT01252134|1126444|P6|NOT COMPLETED|Period 2, 8 Hours||0
459931|NCT01252134|1126445|P5|NOT COMPLETED|Period 2, 8 Hours||0
459932|NCT01252134|1126446|P4|NOT COMPLETED|Period 2, 8 Hours||0
459933|NCT01252134|1126447|P3|NOT COMPLETED|Period 2, 8 Hours||0
459934|NCT01252134|1126448|P2|NOT COMPLETED|Period 2, 8 Hours||0
459935|NCT01252134|1126449|P1|NOT COMPLETED|Period 2, 8 Hours||0
459936|NCT01252134|1126444|P6|COMPLETED|Period 2, 8 Hours||4
459937|NCT01252134|1126445|P5|COMPLETED|Period 2, 8 Hours||3
459938|NCT01252134|1126446|P4|COMPLETED|Period 2, 8 Hours||5
459939|NCT01252134|1126447|P3|COMPLETED|Period 2, 8 Hours||2
459940|NCT01252134|1126448|P2|COMPLETED|Period 2, 8 Hours||3
459941|NCT01252134|1126449|P1|COMPLETED|Period 2, 8 Hours||3
459942|NCT01252134|1126444|P6|STARTED|Period 2, 8 Hours||4
459943|NCT01252134|1126445|P5|STARTED|Period 2, 8 Hours||3
459944|NCT01252134|1126446|P4|STARTED|Period 2, 8 Hours||5
459945|NCT01252134|1126447|P3|STARTED|Period 2, 8 Hours||2
459946|NCT01252134|1126448|P2|STARTED|Period 2, 8 Hours||3
459947|NCT01252134|1126449|P1|STARTED|Period 2, 8 Hours||3
459948|NCT01252134|1126444|P6|NOT COMPLETED|Period 1, 8 Hours||0
459949|NCT01252134|1126445|P5|NOT COMPLETED|Period 1, 8 Hours||0
459950|NCT01252134|1126446|P4|NOT COMPLETED|Period 1, 8 Hours||0
459951|NCT01252134|1126447|P3|NOT COMPLETED|Period 1, 8 Hours||1
459952|NCT01252134|1126448|P2|NOT COMPLETED|Period 1, 8 Hours||1
459953|NCT01252134|1126449|P1|NOT COMPLETED|Period 1, 8 Hours||0
459954|NCT01252134|1126444|P6|COMPLETED|Period 1, 8 Hours||4
459955|NCT01252134|1126445|P5|COMPLETED|Period 1, 8 Hours||3
459956|NCT01252134|1126446|P4|COMPLETED|Period 1, 8 Hours||5
459957|NCT01252134|1126447|P3|COMPLETED|Period 1, 8 Hours||2
459958|NCT01252134|1126448|P2|COMPLETED|Period 1, 8 Hours||3
459959|NCT01252134|1126449|P1|COMPLETED|Period 1, 8 Hours||3
459960|NCT01252134|1126444|P6|STARTED|Period 1, 8 Hours||4
459961|NCT01252134|1126445|P5|STARTED|Period 1, 8 Hours||3
459962|NCT01252134|1126446|P4|STARTED|Period 1, 8 Hours||5
459963|NCT01252134|1126447|P3|STARTED|Period 1, 8 Hours||3
459964|NCT01252134|1126448|P2|STARTED|Period 1, 8 Hours||4
459965|NCT01252134|1126449|P1|STARTED|Period 1, 8 Hours||3
459966|NCT01252095|1126468|P2|NOT COMPLETED|Overall Study||0
459967|NCT01252095|1126469|P1|NOT COMPLETED|Overall Study||1
459968|NCT01252095|1126468|P2|COMPLETED|Overall Study||1
459969|NCT01252095|1126469|P1|COMPLETED|Overall Study||2
459970|NCT01252095|1126468|P2|STARTED|Overall Study||1
459971|NCT01252095|1126469|P1|STARTED|Overall Study||3
459972|NCT01251978|1126477|P2|NOT COMPLETED|Overall Study||0
459973|NCT01251978|1126478|P1|NOT COMPLETED|Overall Study||0
459974|NCT01251978|1126477|P2|COMPLETED|Overall Study||3
459975|NCT01251978|1126478|P1|COMPLETED|Overall Study||5
459976|NCT01251978|1126477|P2|STARTED|Overall Study||3
459977|NCT01251978|1126478|P1|STARTED|Overall Study||5
459978|NCT01251952|1126487|P1|NOT COMPLETED|Overall Study||1
459979|NCT01251952|1126487|P1|COMPLETED|Overall Study||1
459980|NCT01251952|1126487|P1|STARTED|Overall Study||2
459981|NCT01251770|1126493|P2|NOT COMPLETED|Overall Study||7
459982|NCT01251770|1126494|P1|NOT COMPLETED|Overall Study||13
459983|NCT01251770|1126493|P2|COMPLETED|Overall Study||29
459984|NCT01251770|1126494|P1|COMPLETED|Overall Study||29
459985|NCT01251770|1126493|P2|STARTED|Overall Study||36
459986|NCT01251770|1126494|P1|STARTED|Overall Study||42
459987|NCT01251757|1126505|P3|NOT COMPLETED|Overall Study||0
459988|NCT01251757|1126506|P2|NOT COMPLETED|Overall Study||0
459989|NCT01251757|1126507|P1|NOT COMPLETED|Overall Study||0
459990|NCT01251757|1126505|P3|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.6 (2.5) mos, but we computed an adherence score for everyone.|7250
459991|NCT01251757|1126506|P2|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.6 (2.4) mos, but we computed an adherence score for everyone.|7247
459992|NCT01251757|1126507|P1|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.7 (2.3) mos, but we computed an adherence score for everyone.|7255
460078|NCT01251315|1126867|P4|STARTED|Overall Study||4
459993|NCT01251757|1126505|P3|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7250
459994|NCT01251757|1126506|P2|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7247
459995|NCT01251757|1126507|P1|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7255
459996|NCT01251653|1126545|P9|NOT COMPLETED|Overall Study||6
459997|NCT01251653|1126546|P8|NOT COMPLETED|Overall Study||12
459998|NCT01251653|1126547|P7|NOT COMPLETED|Overall Study||18
459999|NCT01251653|1126548|P6|NOT COMPLETED|Overall Study||18
460000|NCT01251653|1126549|P5|NOT COMPLETED|Overall Study||2
460001|NCT01251653|1126550|P4|NOT COMPLETED|Overall Study||6
460002|NCT01251653|1126551|P3|NOT COMPLETED|Overall Study||20
460003|NCT01251653|1126552|P2|NOT COMPLETED|Overall Study||8
460004|NCT01251653|1126553|P1|NOT COMPLETED|Overall Study||3
460005|NCT01251653|1126545|P9|COMPLETED|Overall Study||0
460006|NCT01251653|1126546|P8|COMPLETED|Overall Study||0
460007|NCT01251653|1126547|P7|COMPLETED|Overall Study||0
460008|NCT01251653|1126548|P6|COMPLETED|Overall Study||0
460009|NCT01251653|1126549|P5|COMPLETED|Overall Study||0
460010|NCT01251653|1126550|P4|COMPLETED|Overall Study||0
460011|NCT01251653|1126551|P3|COMPLETED|Overall Study||0
460012|NCT01251653|1126552|P2|COMPLETED|Overall Study||0
460013|NCT01251653|1126553|P1|COMPLETED|Overall Study||0
460014|NCT01251653|1126545|P9|STARTED|Overall Study||6
460015|NCT01251653|1126546|P8|STARTED|Overall Study||12
460016|NCT01251653|1126547|P7|STARTED|Overall Study||18
460017|NCT01251653|1126548|P6|STARTED|Overall Study||18
460018|NCT01251653|1126549|P5|STARTED|Overall Study||2
460019|NCT01251653|1126550|P4|STARTED|Overall Study||6
460020|NCT01251653|1126551|P3|STARTED|Overall Study||20
460021|NCT01251653|1126552|P2|STARTED|Overall Study||8
460022|NCT01251653|1126553|P1|STARTED|Overall Study||3
460023|NCT01251614|1126681|P3|NOT COMPLETED|Overall Study||8
460024|NCT01251614|1126682|P2|NOT COMPLETED|Overall Study||13
460025|NCT01251614|1126683|P1|NOT COMPLETED|Overall Study||3
460026|NCT01251614|1126681|P3|COMPLETED|Overall Study||30
460027|NCT01251614|1126682|P2|COMPLETED|Overall Study||26
460028|NCT01251614|1126683|P1|COMPLETED|Overall Study||34
460029|NCT01251614|1126681|P3|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
460030|NCT01251614|1126682|P2|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
460031|NCT01251614|1126683|P1|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
460032|NCT01251614|1126681|P3|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|19
460033|NCT01251614|1126682|P2|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|11
460034|NCT01251614|1126683|P1|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|8
460035|NCT01251614|1126681|P3|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|23
460036|NCT01251614|1126682|P2|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|18
460037|NCT01251614|1126683|P1|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|13
460038|NCT01251614|1126681|P3|STARTED|Overall Study||38
460039|NCT01251614|1126682|P2|STARTED|Overall Study||39
460040|NCT01251614|1126683|P1|STARTED|Overall Study||37
460041|NCT01251588|1126757|P2|NOT COMPLETED|Overall Study||4
460042|NCT01251588|1126758|P1|NOT COMPLETED|Overall Study||0
460043|NCT01251588|1126757|P2|COMPLETED|Overall Study||59
460044|NCT01251588|1126758|P1|COMPLETED|Overall Study||65
460045|NCT01251588|1126757|P2|STARTED|Overall Study||63
460046|NCT01251588|1126758|P1|STARTED|Overall Study||65
460047|NCT01251380|1126790|P1|NOT COMPLETED|Overall Study||22
460048|NCT01251380|1126790|P1|COMPLETED|Overall Study||194
460049|NCT01251380|1126790|P1|Cycle 4|Overall Study||11
460050|NCT01251380|1126790|P1|Cycle 3|Overall Study||86
460051|NCT01251380|1126790|P1|Cycle 2|Overall Study||175
460052|NCT01251380|1126790|P1|Cycle 1|Overall Study||207
460053|NCT01251380|1126790|P1|STARTED|Overall Study|Safety population.|216
460054|NCT01251367|1126814|P1|NOT COMPLETED|Overall Study||76
460055|NCT01251367|1126814|P1|COMPLETED|Overall Study||269
460056|NCT01251367|1126814|P1|Cycle 4|Overall Study||139
460057|NCT01251367|1126814|P1|Cycle 3|Overall Study||224
460058|NCT01251367|1126814|P1|Cycle 2|Overall Study||297
460059|NCT01251367|1126814|P1|Cycle 1|Overall Study||345
460060|NCT01251367|1126814|P1|STARTED|Overall Study||345
460061|NCT01251354|1126849|P1|NOT COMPLETED|Overall Study||6
460062|NCT01251354|1126849|P1|COMPLETED|Overall Study||0
460063|NCT01251354|1126849|P1|STARTED|Overall Study||6
460064|NCT01251315|1126865|P6|NOT COMPLETED|Overall Study||0
460065|NCT01251315|1126866|P5|NOT COMPLETED|Overall Study||0
460066|NCT01251315|1126867|P4|NOT COMPLETED|Overall Study||0
460067|NCT01251315|1126868|P3|NOT COMPLETED|Overall Study||0
460068|NCT01251315|1126869|P2|NOT COMPLETED|Overall Study||0
460069|NCT01251315|1126870|P1|NOT COMPLETED|Overall Study||0
460070|NCT01251315|1126865|P6|COMPLETED|Overall Study||4
460071|NCT01251315|1126866|P5|COMPLETED|Overall Study||4
460072|NCT01251315|1126867|P4|COMPLETED|Overall Study||4
460073|NCT01251315|1126868|P3|COMPLETED|Overall Study||4
460074|NCT01251315|1126869|P2|COMPLETED|Overall Study||4
460075|NCT01251315|1126870|P1|COMPLETED|Overall Study||4
460076|NCT01251315|1126865|P6|STARTED|Overall Study||4
460077|NCT01251315|1126866|P5|STARTED|Overall Study||4
460079|NCT01251315|1126868|P3|STARTED|Overall Study||4
460080|NCT01251315|1126869|P2|STARTED|Overall Study||4
460081|NCT01251315|1126870|P1|STARTED|Overall Study||4
460082|NCT01251276|1126892|P2|NOT COMPLETED|Overall Study||1
460083|NCT01251276|1126893|P1|NOT COMPLETED|Overall Study||1
460084|NCT01251276|1126892|P2|COMPLETED|Overall Study||107
460085|NCT01251276|1126893|P1|COMPLETED|Overall Study||95
460086|NCT01251276|1126892|P2|Vaccinated|Overall Study||108
460087|NCT01251276|1126893|P1|Vaccinated|Overall Study||96
460088|NCT01251276|1126892|P2|STARTED|Overall Study|Not all Base Study completers enrolled in the Challenge Dose Study|108
460089|NCT01251276|1126893|P1|STARTED|Overall Study|Not all Base Study completers enrolled in the Challenge Dose Study|96
460090|NCT01251146|1126911|P2|NOT COMPLETED|Overall Study||10
460091|NCT01251146|1126912|P1|NOT COMPLETED|Overall Study||3
460092|NCT01251146|1126911|P2|COMPLETED|Overall Study||81
460093|NCT01251146|1126912|P1|COMPLETED|Overall Study||83
460094|NCT01251146|1126911|P2|STARTED|Overall Study||91
460095|NCT01251146|1126912|P1|STARTED|Overall Study||86
460096|NCT01251120|1126934|P2|NOT COMPLETED|Overall Study||1
460097|NCT01251120|1126935|P1|NOT COMPLETED|Overall Study||0
460098|NCT01251120|1126934|P2|COMPLETED|Overall Study||0
460099|NCT01251120|1126935|P1|COMPLETED|Overall Study||1
460100|NCT01251120|1126934|P2|STARTED|Overall Study||1
460101|NCT01251120|1126935|P1|STARTED|Overall Study||1
460102|NCT01251042|1126957|P2|NOT COMPLETED|Overall Study||0
460103|NCT01251042|1126958|P1|NOT COMPLETED|Overall Study||0
460104|NCT01251042|1126957|P2|COMPLETED|Overall Study||23
460105|NCT01251042|1126958|P1|COMPLETED|Overall Study||26
460106|NCT01251042|1126957|P2|STARTED|Overall Study||23
460107|NCT01251042|1126958|P1|STARTED|Overall Study||26
460108|NCT01250990|1126990|P2|NOT COMPLETED|Overall Study||2
460109|NCT01250990|1126991|P1|NOT COMPLETED|Overall Study||4
460110|NCT01250990|1126990|P2|COMPLETED|Overall Study||9
460111|NCT01250990|1126991|P1|COMPLETED|Overall Study||7
460112|NCT01250990|1126990|P2|STARTED|Overall Study||11
460113|NCT01250990|1126991|P1|STARTED|Overall Study||11
460114|NCT01250925|1127000|P3|NOT COMPLETED|Overall Study||2
460115|NCT01250925|1127001|P2|NOT COMPLETED|Overall Study||3
460116|NCT01250925|1127002|P1|NOT COMPLETED|Overall Study||5
460117|NCT01250925|1127000|P3|COMPLETED|Overall Study||30
460118|NCT01250925|1127001|P2|COMPLETED|Overall Study||28
460119|NCT01250925|1127002|P1|COMPLETED|Overall Study||26
460120|NCT01250925|1127000|P3|STARTED|Overall Study||32
460121|NCT01250925|1127001|P2|STARTED|Overall Study||31
460122|NCT01250925|1127002|P1|STARTED|Overall Study||31
460123|NCT01250899|1127042|P2|NOT COMPLETED|Overall Study||0
460124|NCT01250899|1127043|P1|NOT COMPLETED|Overall Study||0
460125|NCT01250899|1127042|P2|COMPLETED|Overall Study||82
460126|NCT01250899|1127043|P1|COMPLETED|Overall Study||40
460127|NCT01250899|1127042|P2|STARTED|Overall Study||82
460128|NCT01250899|1127043|P1|STARTED|Overall Study||40
460129|NCT01250834|1127047|P1|NOT COMPLETED|Overall Study||0
460130|NCT01250834|1127047|P1|COMPLETED|Overall Study||27
460131|NCT01250834|1127047|P1|STARTED|Overall Study||27
460132|NCT01250769|1127068|P4|NOT COMPLETED|Overall Study||0
460133|NCT01250769|1127069|P3|NOT COMPLETED|Overall Study||2
460134|NCT01250769|1127070|P2|NOT COMPLETED|Overall Study||1
460135|NCT01250769|1127071|P1|NOT COMPLETED|Overall Study||0
460136|NCT01250769|1127068|P4|COMPLETED|Overall Study||11
460137|NCT01250769|1127069|P3|COMPLETED|Overall Study||73
460138|NCT01250769|1127070|P2|COMPLETED|Overall Study||72
460139|NCT01250769|1127071|P1|COMPLETED|Overall Study||11
460140|NCT01250769|1127068|P4|Day 14|Overall Study||11
460141|NCT01250769|1127069|P3|Day 14|Overall Study||74
460142|NCT01250769|1127070|P2|Day 14|Overall Study||72
460143|NCT01250769|1127071|P1|Day 14|Overall Study||11
460144|NCT01250769|1127068|P4|STARTED|Overall Study||11
460145|NCT01250769|1127069|P3|STARTED|Overall Study||75
460146|NCT01250769|1127070|P2|STARTED|Overall Study||73
460147|NCT01250769|1127071|P1|STARTED|Overall Study||11
460148|NCT01250756|1127103|P2|NOT COMPLETED|After Toddler Dose||1
460149|NCT01250756|1127104|P1|NOT COMPLETED|After Toddler Dose||0
460150|NCT01250756|1127103|P2|COMPLETED|After Toddler Dose||147
460151|NCT01250756|1127104|P1|COMPLETED|After Toddler Dose||0
460152|NCT01250756|1127103|P2|STARTED|After Toddler Dose||148
460153|NCT01250756|1127104|P1|STARTED|After Toddler Dose||0
460154|NCT01250756|1127103|P2|NOT COMPLETED|Toddler Dose||1
460155|NCT01250756|1127104|P1|NOT COMPLETED|Toddler Dose||0
460156|NCT01250756|1127103|P2|COMPLETED|Toddler Dose||148
460157|NCT01250756|1127104|P1|COMPLETED|Toddler Dose||122
460158|NCT01250756|1127103|P2|STARTED|Toddler Dose||149
460159|NCT01250756|1127104|P1|STARTED|Toddler Dose||122
460160|NCT01250756|1127103|P2|NOT COMPLETED|After Infant Series||4
460161|NCT01250756|1127104|P1|NOT COMPLETED|After Infant Series||11
460162|NCT01250756|1127103|P2|COMPLETED|After Infant Series||149
460163|NCT01250756|1127104|P1|COMPLETED|After Infant Series||122
460164|NCT01250756|1127103|P2|STARTED|After Infant Series||153
460165|NCT01250756|1127104|P1|STARTED|After Infant Series||133
460166|NCT01250756|1127103|P2|NOT COMPLETED|Infant Series||7
460167|NCT01250756|1127104|P1|NOT COMPLETED|Infant Series||28
460168|NCT01250756|1127103|P2|COMPLETED|Infant Series||153
460169|NCT01250756|1127104|P1|COMPLETED|Infant Series||133
460170|NCT01250756|1127103|P2|Vaccinated Dose 3|Infant Series||155
460171|NCT01250756|1127104|P1|Vaccinated Dose 3|Infant Series||133
460172|NCT01250756|1127103|P2|Vaccinated Dose 2|Infant Series||157
460173|NCT01250756|1127104|P1|Vaccinated Dose 2|Infant Series||147
460174|NCT01250756|1127103|P2|Vaccinated Dose 1|Infant Series||158
460175|NCT01250756|1127104|P1|Vaccinated Dose 1|Infant Series||159
460176|NCT01250756|1127103|P2|STARTED|Infant Series||160
460177|NCT01250756|1127104|P1|STARTED|Infant Series||161
460178|NCT01250730|1127157|P3|NOT COMPLETED|Overall Study||0
460179|NCT01250730|1127158|P2|NOT COMPLETED|Overall Study||0
460180|NCT01250730|1127159|P1|NOT COMPLETED|Overall Study||0
460181|NCT01250730|1127157|P3|COMPLETED|Overall Study||6
460182|NCT01250730|1127158|P2|COMPLETED|Overall Study||6
460183|NCT01250730|1127159|P1|COMPLETED|Overall Study||6
460184|NCT01250730|1127157|P3|STARTED|Overall Study||6
460185|NCT01250730|1127158|P2|STARTED|Overall Study||6
460186|NCT01250730|1127159|P1|STARTED|Overall Study||6
460187|NCT01250717|1127215|P1|NOT COMPLETED|Overall Study||0
460188|NCT01250717|1127215|P1|COMPLETED|Overall Study||28
460189|NCT01250717|1127215|P1|STARTED|Overall Study||28
460190|NCT01250509|1127221|P2|NOT COMPLETED|Overall Study||2
460191|NCT01250509|1127222|P1|NOT COMPLETED|Overall Study||5
460192|NCT01250509|1127221|P2|COMPLETED|Overall Study||21
460193|NCT01250509|1127222|P1|COMPLETED|Overall Study||19
460194|NCT01250509|1127221|P2|STARTED|Overall Study||23
460195|NCT01250509|1127222|P1|STARTED|Overall Study||24
460196|NCT01250418|1127236|P2|NOT COMPLETED|Overall Study||1
460197|NCT01250418|1127237|P1|NOT COMPLETED|Overall Study||1
460198|NCT01250418|1127236|P2|COMPLETED|Overall Study||15
460199|NCT01250418|1127237|P1|COMPLETED|Overall Study||8
460200|NCT01250418|1127236|P2|STARTED|Overall Study||16
460201|NCT01250418|1127237|P1|STARTED|Overall Study||9
460202|NCT01250379|1127245|P2|NOT COMPLETED|Overall Study||193
460203|NCT01250379|1127246|P1|NOT COMPLETED|Overall Study||202
460204|NCT01250379|1127245|P2|COMPLETED|Overall Study|Participants under study follow-up as of Data Cutoff 30 April 2015 were considered as completers.|54
460205|NCT01250379|1127246|P1|COMPLETED|Overall Study|Participants under study follow-up as of Data Cutoff 30 April 2015 were considered as completers.|45
460206|NCT01250379|1127245|P2|STARTED|Overall Study||247
460207|NCT01250379|1127246|P1|STARTED|Overall Study||247
460208|NCT01250184|1127307|P3|NOT COMPLETED|Overall Study||0
460209|NCT01250184|1127308|P2|NOT COMPLETED|Overall Study||0
460210|NCT01250184|1127309|P1|NOT COMPLETED|Overall Study||0
460211|NCT01250184|1127307|P3|COMPLETED|Overall Study||43
460212|NCT01250184|1127308|P2|COMPLETED|Overall Study||41
460213|NCT01250184|1127309|P1|COMPLETED|Overall Study||43
460214|NCT01250184|1127307|P3|STARTED|Overall Study||43
460215|NCT01250184|1127308|P2|STARTED|Overall Study||41
460216|NCT01250184|1127309|P1|STARTED|Overall Study||43
460217|NCT01250171|1127335|P3|NOT COMPLETED|Overall Study||0
460218|NCT01250171|1127336|P2|NOT COMPLETED|Overall Study||0
460219|NCT01250171|1127337|P1|NOT COMPLETED|Overall Study||1
460220|NCT01250171|1127335|P3|COMPLETED|Overall Study||24
460221|NCT01250171|1127336|P2|COMPLETED|Overall Study||22
460222|NCT01250171|1127337|P1|COMPLETED|Overall Study||25
460223|NCT01250171|1127335|P3|STARTED|Overall Study||24
460224|NCT01250171|1127336|P2|STARTED|Overall Study||22
460225|NCT01250171|1127337|P1|STARTED|Overall Study||26
460226|NCT01250145|1127368|P2|NOT COMPLETED|Overall Study||5
460227|NCT01250145|1127369|P1|NOT COMPLETED|Overall Study||2
460228|NCT01250145|1127368|P2|COMPLETED|Overall Study||205
460229|NCT01250145|1127369|P1|COMPLETED|Overall Study||39
460230|NCT01250145|1127368|P2|STARTED|Overall Study||210
460231|NCT01250145|1127369|P1|STARTED|Overall Study||41
460232|NCT01250119|1127389|P2|NOT COMPLETED|Treatment Phase||41
460233|NCT01250119|1127390|P1|NOT COMPLETED|Treatment Phase||0
460234|NCT01250119|1127389|P2|COMPLETED|Treatment Phase||0
460235|NCT01250119|1127390|P1|COMPLETED|Treatment Phase||0
460236|NCT01250119|1127389|P2|STARTED|Treatment Phase|Out of 52 participants with positive EGFR mutation test result, only 41 participants were treated.|41
460237|NCT01250119|1127390|P1|STARTED|Treatment Phase||0
460238|NCT01250119|1127389|P2|NOT COMPLETED|Diagnostic Phase||0
460239|NCT01250119|1127390|P1|NOT COMPLETED|Diagnostic Phase||113
460240|NCT01250119|1127389|P2|COMPLETED|Diagnostic Phase||0
460241|NCT01250119|1127390|P1|COMPLETED|Diagnostic Phase|Completed refers to participants with both positive and negative EGFR mutation test result.|575
460242|NCT01250119|1127389|P2|STARTED|Diagnostic Phase||0
460243|NCT01250119|1127390|P1|STARTED|Diagnostic Phase||688
460244|NCT01250054|1127405|P2|NOT COMPLETED|Period 2, One Week of Wear||0
460245|NCT01250054|1127406|P1|NOT COMPLETED|Period 2, One Week of Wear||1
460246|NCT01250054|1127405|P2|COMPLETED|Period 2, One Week of Wear||8
460247|NCT01250054|1127406|P1|COMPLETED|Period 2, One Week of Wear||6
460248|NCT01250054|1127405|P2|STARTED|Period 2, One Week of Wear||8
460249|NCT01250054|1127406|P1|STARTED|Period 2, One Week of Wear||7
460250|NCT01250054|1127405|P2|NOT COMPLETED|Period 1, One Week of Wear||0
460251|NCT01250054|1127406|P1|NOT COMPLETED|Period 1, One Week of Wear||0
460252|NCT01250054|1127405|P2|COMPLETED|Period 1, One Week of Wear|One subject discontinued between Period 1 and Period 2 due to noncompliance.|8
460253|NCT01250054|1127406|P1|COMPLETED|Period 1, One Week of Wear|One subject discontinued between Period 1 and Period 2 due to power availability.|8
460254|NCT01250054|1127405|P2|STARTED|Period 1, One Week of Wear|One subject did not wear Period 1 lenses due to power availability and proceeded to Period 2 lenses.|8
460255|NCT01250054|1127406|P1|STARTED|Period 1, One Week of Wear||8
460256|NCT01250002|1127414|P2|NOT COMPLETED|Overall Study||3
460257|NCT01250002|1127415|P1|NOT COMPLETED|Overall Study||4
460258|NCT01250002|1127414|P2|COMPLETED|Overall Study||32
460259|NCT01250002|1127415|P1|COMPLETED|Overall Study||31
460260|NCT01250002|1127414|P2|STARTED|Overall Study||35
460261|NCT01250002|1127415|P1|STARTED|Overall Study||35
460262|NCT01249872|1127429|P6|NOT COMPLETED|Overall Study||0
460263|NCT01249872|1127430|P5|NOT COMPLETED|Overall Study||0
460264|NCT01249872|1127431|P4|NOT COMPLETED|Overall Study||0
460265|NCT01249872|1127432|P3|NOT COMPLETED|Overall Study||0
460266|NCT01249872|1127433|P2|NOT COMPLETED|Overall Study||0
460267|NCT01249872|1127434|P1|NOT COMPLETED|Overall Study||0
460268|NCT01249872|1127429|P6|COMPLETED|Overall Study||16
460269|NCT01249872|1127430|P5|COMPLETED|Overall Study||16
460270|NCT01249872|1127431|P4|COMPLETED|Overall Study||16
460271|NCT01249872|1127432|P3|COMPLETED|Overall Study||16
460272|NCT01249872|1127433|P2|COMPLETED|Overall Study||16
460273|NCT01249872|1127434|P1|COMPLETED|Overall Study||16
460274|NCT01249872|1127429|P6|STARTED|Overall Study||16
460275|NCT01249872|1127430|P5|STARTED|Overall Study||16
460276|NCT01249872|1127431|P4|STARTED|Overall Study||16
460277|NCT01249872|1127432|P3|STARTED|Overall Study||16
460278|NCT01249872|1127433|P2|STARTED|Overall Study||16
460279|NCT01249872|1127434|P1|STARTED|Overall Study||16
460280|NCT01249833|1127480|P2|NOT COMPLETED|Overall Study||1
460281|NCT01249833|1127481|P1|NOT COMPLETED|Overall Study||0
460282|NCT01249833|1127480|P2|COMPLETED|Overall Study||62
460283|NCT01249833|1127481|P1|COMPLETED|Overall Study||59
460284|NCT01249833|1127480|P2|STARTED|Overall Study||63
460285|NCT01249833|1127481|P1|STARTED|Overall Study||59
460286|NCT01249664|1127495|P2|NOT COMPLETED|Overall Study||0
460287|NCT01249664|1127496|P1|NOT COMPLETED|Overall Study||6
460288|NCT01249664|1127495|P2|COMPLETED|Overall Study|Completers of study visits up to week 48|31
460289|NCT01249664|1127496|P1|COMPLETED|Overall Study|Completers of study visits up to week 48|85
460290|NCT01249664|1127495|P2|Completed 48 Weeks Treatment|Overall Study||24
460291|NCT01249664|1127496|P1|Completed 48 Weeks Treatment|Overall Study||78
460292|NCT01249664|1127495|P2|Completed 24 Weeks Treatment|Overall Study|Withdrawal from treatment does not equal to withdrawal from study.|25
460293|NCT01249664|1127496|P1|Completed 24 Weeks Treatment|Overall Study|Withdrawal from treatment does not equal to withdrawal from study.|83
460294|NCT01249664|1127495|P2|Fulfilled Requirements of FAS Population|Overall Study|FAS population: Basis of efficacy evaluation|31
460295|NCT01249664|1127496|P1|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) population: Basis of efficacy evaluation|90
460296|NCT01249664|1127495|P2|Participants Received Treatment|Overall Study|Safety population|31
460297|NCT01249664|1127496|P1|Participants Received Treatment|Overall Study|Safety population|91
460298|NCT01249664|1127495|P2|STARTED|Overall Study||31
460299|NCT01249664|1127496|P1|STARTED|Overall Study||91
460300|NCT01249651|1127546|P1|NOT COMPLETED|Overall Study||7
460301|NCT01249651|1127546|P1|COMPLETED|Overall Study|Completed the 8-week treatment period|94
460302|NCT01249651|1127546|P1|STARTED|Overall Study|Enrolled|101
460303|NCT01249417|1127556|P3|NOT COMPLETED|Treatment Phase - ITT Population||4
460304|NCT01249417|1127557|P2|NOT COMPLETED|Treatment Phase - ITT Population||4
460305|NCT01249417|1127558|P1|NOT COMPLETED|Treatment Phase - ITT Population||1
460306|NCT01249417|1127556|P3|COMPLETED|Treatment Phase - ITT Population||73
460307|NCT01249417|1127557|P2|COMPLETED|Treatment Phase - ITT Population||75
460308|NCT01249417|1127558|P1|COMPLETED|Treatment Phase - ITT Population||78
460309|NCT01249417|1127556|P3|STARTED|Treatment Phase - ITT Population||77
460310|NCT01249417|1127557|P2|STARTED|Treatment Phase - ITT Population||79
460311|NCT01249417|1127558|P1|STARTED|Treatment Phase - ITT Population||79
460312|NCT01249417|1127556|P3|NOT COMPLETED|Randomised Population||4
460313|NCT01249417|1127557|P2|NOT COMPLETED|Randomised Population||1
460314|NCT01249417|1127558|P1|NOT COMPLETED|Randomised Population||1
460315|NCT01249417|1127556|P3|COMPLETED|Randomised Population||77
460316|NCT01249417|1127557|P2|COMPLETED|Randomised Population||79
460317|NCT01249417|1127558|P1|COMPLETED|Randomised Population||79
460318|NCT01249417|1127556|P3|Treated|Randomised Population||79
460319|NCT01249417|1127557|P2|Treated|Randomised Population||80
460320|NCT01249417|1127558|P1|Treated|Randomised Population||80
460321|NCT01249417|1127556|P3|STARTED|Randomised Population||81
460322|NCT01249417|1127557|P2|STARTED|Randomised Population||80
460323|NCT01249417|1127558|P1|STARTED|Randomised Population||80
460324|NCT01249404|1127575|P3|NOT COMPLETED|Overall Study||7
460325|NCT01249404|1127576|P2|NOT COMPLETED|Overall Study||8
460326|NCT01249404|1127577|P1|NOT COMPLETED|Overall Study||7
460327|NCT01249404|1127575|P3|COMPLETED|Overall Study||125
460328|NCT01249404|1127576|P2|COMPLETED|Overall Study||121
460329|NCT01249404|1127577|P1|COMPLETED|Overall Study||120
460330|NCT01249404|1127575|P3|STARTED|Overall Study||132
460331|NCT01249404|1127576|P2|STARTED|Overall Study||129
460332|NCT01249404|1127577|P1|STARTED|Overall Study||127
460333|NCT01249274|1127656|P2|NOT COMPLETED|Overall Study||6
460334|NCT01249274|1127657|P1|NOT COMPLETED|Overall Study||4
460335|NCT01249274|1127656|P2|COMPLETED|Overall Study||19
460336|NCT01249274|1127657|P1|COMPLETED|Overall Study||21
460337|NCT01249274|1127656|P2|Completed Post Trial Visit But Not tx|Overall Study||2
460338|NCT01249274|1127657|P1|Completed Post Trial Visit But Not tx|Overall Study||1
460339|NCT01249274|1127656|P2|Completed Treatment & Post Trial Visit|Overall Study||17
460340|NCT01249274|1127657|P1|Completed Treatment & Post Trial Visit|Overall Study||20
460341|NCT01249274|1127656|P2|Completed Treatment|Overall Study||19
460342|NCT01249274|1127657|P1|Completed Treatment|Overall Study||21
460343|NCT01249274|1127656|P2|STARTED|Overall Study|all 25 were included in intention-to-treat and safety analyses|25
460344|NCT01249274|1127657|P1|STARTED|Overall Study|all 25 were included in intention-to-treat and safety analyses|25
460345|NCT01249261|1127683|P2|NOT COMPLETED|Overall Study||0
460346|NCT01249261|1127684|P1|NOT COMPLETED|Overall Study||1
460347|NCT01249261|1127683|P2|COMPLETED|Overall Study||31
460348|NCT01249261|1127684|P1|COMPLETED|Overall Study||29
460349|NCT01249261|1127683|P2|STARTED|Overall Study||31
460350|NCT01249261|1127684|P1|STARTED|Overall Study||30
460351|NCT01249157|1127712|P1|NOT COMPLETED|Overall Study||1
460352|NCT01249157|1127712|P1|COMPLETED|Overall Study|No data displayed because Outcome Measure has zero total participants analyzed.|0
460353|NCT01249157|1127712|P1|STARTED|Overall Study||1
460354|NCT01249131|1127716|P6|NOT COMPLETED|Third Intervention||0
460355|NCT01249131|1127717|P5|NOT COMPLETED|Third Intervention||0
460356|NCT01249131|1127718|P4|NOT COMPLETED|Third Intervention||0
460357|NCT01249131|1127719|P3|NOT COMPLETED|Third Intervention||0
460358|NCT01249131|1127720|P2|NOT COMPLETED|Third Intervention||0
460359|NCT01249131|1127721|P1|NOT COMPLETED|Third Intervention||0
460360|NCT01249131|1127716|P6|COMPLETED|Third Intervention||4
460361|NCT01249131|1127717|P5|COMPLETED|Third Intervention||2
460362|NCT01249131|1127718|P4|COMPLETED|Third Intervention||3
460363|NCT01249131|1127719|P3|COMPLETED|Third Intervention||4
460364|NCT01249131|1127720|P2|COMPLETED|Third Intervention||3
460365|NCT01249131|1127721|P1|COMPLETED|Third Intervention||3
460366|NCT01249131|1127716|P6|STARTED|Third Intervention||4
460367|NCT01249131|1127717|P5|STARTED|Third Intervention||2
460368|NCT01249131|1127718|P4|STARTED|Third Intervention||3
460369|NCT01249131|1127719|P3|STARTED|Third Intervention||4
460370|NCT01249131|1127720|P2|STARTED|Third Intervention||3
460371|NCT01249131|1127721|P1|STARTED|Third Intervention||3
460372|NCT01249131|1127716|P6|NOT COMPLETED|Washout Period of 10 Days||0
460373|NCT01249131|1127717|P5|NOT COMPLETED|Washout Period of 10 Days||0
460374|NCT01249131|1127718|P4|NOT COMPLETED|Washout Period of 10 Days||0
460375|NCT01249131|1127719|P3|NOT COMPLETED|Washout Period of 10 Days||0
460376|NCT01249131|1127720|P2|NOT COMPLETED|Washout Period of 10 Days||0
460377|NCT01249131|1127721|P1|NOT COMPLETED|Washout Period of 10 Days||0
460378|NCT01249131|1127716|P6|COMPLETED|Washout Period of 10 Days||4
460379|NCT01249131|1127717|P5|COMPLETED|Washout Period of 10 Days||2
460380|NCT01249131|1127718|P4|COMPLETED|Washout Period of 10 Days||3
460381|NCT01249131|1127719|P3|COMPLETED|Washout Period of 10 Days||4
460382|NCT01249131|1127720|P2|COMPLETED|Washout Period of 10 Days||3
460383|NCT01249131|1127721|P1|COMPLETED|Washout Period of 10 Days||3
460384|NCT01249131|1127716|P6|STARTED|Washout Period of 10 Days||4
460385|NCT01249131|1127717|P5|STARTED|Washout Period of 10 Days||2
460386|NCT01249131|1127718|P4|STARTED|Washout Period of 10 Days||3
460387|NCT01249131|1127719|P3|STARTED|Washout Period of 10 Days||4
460388|NCT01249131|1127720|P2|STARTED|Washout Period of 10 Days||3
460389|NCT01249131|1127721|P1|STARTED|Washout Period of 10 Days||3
460390|NCT01249131|1127716|P6|NOT COMPLETED|Second Intervention||0
460391|NCT01249131|1127717|P5|NOT COMPLETED|Second Intervention||0
460392|NCT01249131|1127718|P4|NOT COMPLETED|Second Intervention||0
460393|NCT01249131|1127719|P3|NOT COMPLETED|Second Intervention||0
460394|NCT01249131|1127720|P2|NOT COMPLETED|Second Intervention||0
460395|NCT01249131|1127721|P1|NOT COMPLETED|Second Intervention||0
460396|NCT01249131|1127716|P6|COMPLETED|Second Intervention||4
460397|NCT01249131|1127717|P5|COMPLETED|Second Intervention||2
460398|NCT01249131|1127718|P4|COMPLETED|Second Intervention||3
460399|NCT01249131|1127719|P3|COMPLETED|Second Intervention||4
460400|NCT01249131|1127720|P2|COMPLETED|Second Intervention||3
460401|NCT01249131|1127721|P1|COMPLETED|Second Intervention||3
460402|NCT01249131|1127716|P6|STARTED|Second Intervention||4
460403|NCT01249131|1127717|P5|STARTED|Second Intervention||2
460404|NCT01249131|1127718|P4|STARTED|Second Intervention||3
460405|NCT01249131|1127719|P3|STARTED|Second Intervention||4
460406|NCT01249131|1127720|P2|STARTED|Second Intervention||3
460407|NCT01249131|1127721|P1|STARTED|Second Intervention||3
460408|NCT01249131|1127716|P6|NOT COMPLETED|Washout Period of 10 Days||0
460409|NCT01249131|1127717|P5|NOT COMPLETED|Washout Period of 10 Days||1
460410|NCT01249131|1127718|P4|NOT COMPLETED|Washout Period of 10 Days||0
460411|NCT01249131|1127719|P3|NOT COMPLETED|Washout Period of 10 Days||0
460412|NCT01249131|1127720|P2|NOT COMPLETED|Washout Period of 10 Days||0
460413|NCT01249131|1127721|P1|NOT COMPLETED|Washout Period of 10 Days||0
460414|NCT01249131|1127716|P6|COMPLETED|Washout Period of 10 Days||4
460415|NCT01249131|1127717|P5|COMPLETED|Washout Period of 10 Days||2
460416|NCT01249131|1127718|P4|COMPLETED|Washout Period of 10 Days||3
460417|NCT01249131|1127719|P3|COMPLETED|Washout Period of 10 Days||4
460418|NCT01249131|1127720|P2|COMPLETED|Washout Period of 10 Days||3
460419|NCT01249131|1127721|P1|COMPLETED|Washout Period of 10 Days||3
460420|NCT01249131|1127716|P6|STARTED|Washout Period of 10 Days||4
460421|NCT01249131|1127717|P5|STARTED|Washout Period of 10 Days||3
460422|NCT01249131|1127718|P4|STARTED|Washout Period of 10 Days||3
460423|NCT01249131|1127719|P3|STARTED|Washout Period of 10 Days||4
460424|NCT01249131|1127720|P2|STARTED|Washout Period of 10 Days||3
460425|NCT01249131|1127721|P1|STARTED|Washout Period of 10 Days||3
460426|NCT01249131|1127716|P6|NOT COMPLETED|First Intervention||0
460427|NCT01249131|1127717|P5|NOT COMPLETED|First Intervention||0
460428|NCT01249131|1127718|P4|NOT COMPLETED|First Intervention||0
460429|NCT01249131|1127719|P3|NOT COMPLETED|First Intervention||0
460430|NCT01249131|1127720|P2|NOT COMPLETED|First Intervention||0
460431|NCT01249131|1127721|P1|NOT COMPLETED|First Intervention||0
460432|NCT01249131|1127716|P6|COMPLETED|First Intervention||4
460433|NCT01249131|1127717|P5|COMPLETED|First Intervention||3
460434|NCT01249131|1127718|P4|COMPLETED|First Intervention||3
460435|NCT01249131|1127719|P3|COMPLETED|First Intervention||4
460436|NCT01249131|1127720|P2|COMPLETED|First Intervention||3
460437|NCT01249131|1127721|P1|COMPLETED|First Intervention||3
460438|NCT01249131|1127716|P6|STARTED|First Intervention||4
460439|NCT01249131|1127717|P5|STARTED|First Intervention||3
460440|NCT01249131|1127718|P4|STARTED|First Intervention||3
460441|NCT01249131|1127719|P3|STARTED|First Intervention||4
460442|NCT01249131|1127720|P2|STARTED|First Intervention||3
460443|NCT01249131|1127721|P1|STARTED|First Intervention||3
460444|NCT01249118|1127741|P3|NOT COMPLETED|Second Washout Period||0
460445|NCT01249118|1127742|P2|NOT COMPLETED|Second Washout Period||0
460446|NCT01249118|1127743|P1|NOT COMPLETED|Second Washout Period||0
460447|NCT01249118|1127741|P3|COMPLETED|Second Washout Period||5
460448|NCT01249118|1127742|P2|COMPLETED|Second Washout Period||5
460449|NCT01249118|1127743|P1|COMPLETED|Second Washout Period||2
460450|NCT01249118|1127741|P3|STARTED|Second Washout Period||5
460451|NCT01249118|1127742|P2|STARTED|Second Washout Period||5
460452|NCT01249118|1127743|P1|STARTED|Second Washout Period||2
460453|NCT01249118|1127741|P3|NOT COMPLETED|Second Intervention Period||0
460454|NCT01249118|1127742|P2|NOT COMPLETED|Second Intervention Period||0
460455|NCT01249118|1127743|P1|NOT COMPLETED|Second Intervention Period||0
460456|NCT01249118|1127741|P3|COMPLETED|Second Intervention Period||5
460457|NCT01249118|1127742|P2|COMPLETED|Second Intervention Period||5
460458|NCT01249118|1127743|P1|COMPLETED|Second Intervention Period||2
460459|NCT01249118|1127741|P3|STARTED|Second Intervention Period||5
460460|NCT01249118|1127742|P2|STARTED|Second Intervention Period||5
460461|NCT01249118|1127743|P1|STARTED|Second Intervention Period||2
460462|NCT01249118|1127741|P3|NOT COMPLETED|First Washout Period||0
460463|NCT01249118|1127742|P2|NOT COMPLETED|First Washout Period||1
460464|NCT01249118|1127743|P1|NOT COMPLETED|First Washout Period||0
460465|NCT01249118|1127741|P3|COMPLETED|First Washout Period||5
460466|NCT01249118|1127742|P2|COMPLETED|First Washout Period||5
460467|NCT01249118|1127743|P1|COMPLETED|First Washout Period||2
460468|NCT01249118|1127741|P3|STARTED|First Washout Period||5
460469|NCT01249118|1127742|P2|STARTED|First Washout Period||6
460470|NCT01249118|1127743|P1|STARTED|First Washout Period||2
460471|NCT01249118|1127741|P3|NOT COMPLETED|First Intervention Period||0
460472|NCT01249118|1127742|P2|NOT COMPLETED|First Intervention Period||0
460473|NCT01249118|1127743|P1|NOT COMPLETED|First Intervention Period||0
460474|NCT01249118|1127741|P3|COMPLETED|First Intervention Period||5
460475|NCT01249118|1127742|P2|COMPLETED|First Intervention Period||6
460476|NCT01249118|1127743|P1|COMPLETED|First Intervention Period||2
460477|NCT01249118|1127741|P3|STARTED|First Intervention Period||5
460478|NCT01249118|1127742|P2|STARTED|First Intervention Period||6
460479|NCT01249118|1127743|P1|STARTED|First Intervention Period||2
460480|NCT01249092|1127777|P1|NOT COMPLETED|Overall Study||2
460481|NCT01249092|1127777|P1|COMPLETED|Overall Study||18
460482|NCT01249092|1127777|P1|STARTED|Overall Study||20
460483|NCT01248949|1127788|P5|NOT COMPLETED|Overall Study||4
460484|NCT01248949|1127789|P4|NOT COMPLETED|Overall Study||10
460485|NCT01248949|1127790|P3|NOT COMPLETED|Overall Study||37
460486|NCT01248949|1127791|P2|NOT COMPLETED|Overall Study||13
460487|NCT01248949|1127792|P1|NOT COMPLETED|Overall Study||33
460488|NCT01248949|1127788|P5|COMPLETED|Overall Study||3
460489|NCT01248949|1127789|P4|COMPLETED|Overall Study||3
460490|NCT01248949|1127790|P3|COMPLETED|Overall Study||1
460491|NCT01248949|1127791|P2|COMPLETED|Overall Study||3
460492|NCT01248949|1127792|P1|COMPLETED|Overall Study||9
460493|NCT01248949|1127788|P5|STARTED|Overall Study||7
460494|NCT01248949|1127789|P4|STARTED|Overall Study||13
460495|NCT01248949|1127790|P3|STARTED|Overall Study||38
460496|NCT01248949|1127791|P2|STARTED|Overall Study||16
460497|NCT01248949|1127792|P1|STARTED|Overall Study||42
460498|NCT01248936|1127904|P1|NOT COMPLETED|Overall Study||374
460499|NCT01248936|1127904|P1|COMPLETED|Overall Study||0
460500|NCT01248936|1127904|P1|STARTED|Overall Study||374
460501|NCT01248884|1127917|P3|NOT COMPLETED|Overall Study||1
460502|NCT01248884|1127918|P2|NOT COMPLETED|Overall Study||3
460503|NCT01248884|1127919|P1|NOT COMPLETED|Overall Study||2
460504|NCT01248884|1127917|P3|COMPLETED|Overall Study||238
460505|NCT01248884|1127918|P2|COMPLETED|Overall Study||239
460506|NCT01248884|1127919|P1|COMPLETED|Overall Study||238
460507|NCT01248884|1127917|P3|STARTED|Overall Study||239
460508|NCT01248884|1127918|P2|STARTED|Overall Study||242
460509|NCT01248884|1127919|P1|STARTED|Overall Study||240
460510|NCT01248793|1127971|P2|NOT COMPLETED|Overall Study||6
460511|NCT01248793|1127972|P1|NOT COMPLETED|Overall Study||4
460512|NCT01248793|1127971|P2|COMPLETED|Overall Study||102
460513|NCT01248793|1127972|P1|COMPLETED|Overall Study||101
460514|NCT01248793|1127971|P2|STARTED|Overall Study||108
460515|NCT01248793|1127972|P1|STARTED|Overall Study||105
460516|NCT01248780|1127986|P2|NOT COMPLETED|Overall Study||15
460517|NCT01248780|1127987|P1|NOT COMPLETED|Overall Study||9
460518|NCT01248780|1127986|P2|COMPLETED|Overall Study||117
460519|NCT01248780|1127987|P1|COMPLETED|Overall Study||123
460520|NCT01248780|1127986|P2|STARTED|Overall Study||132
460521|NCT01248780|1127987|P1|STARTED|Overall Study||132
460522|NCT01248728|1128001|P2|NOT COMPLETED|Overall Study||2
460523|NCT01248728|1128002|P1|NOT COMPLETED|Overall Study||4
460524|NCT01248728|1128001|P2|COMPLETED|Overall Study||17
460525|NCT01248728|1128002|P1|COMPLETED|Overall Study||15
460526|NCT01248728|1128001|P2|STARTED|Overall Study||19
460527|NCT01248728|1128002|P1|STARTED|Overall Study||19
460528|NCT01248715|1128018|P2|NOT COMPLETED|Overall Study||510
460529|NCT01248715|1128019|P1|NOT COMPLETED|Overall Study||501
460530|NCT01248715|1128018|P2|COMPLETED|Overall Study||41
460531|NCT01248715|1128019|P1|COMPLETED|Overall Study||55
460532|NCT01248715|1128018|P2|STARTED|Overall Study||551
460533|NCT01248715|1128019|P1|STARTED|Overall Study||556
460534|NCT01248468|1128040|P3|NOT COMPLETED|Overall Study||4
460535|NCT01248468|1128041|P2|NOT COMPLETED|Overall Study||14
460536|NCT01248468|1128042|P1|NOT COMPLETED|Overall Study||15
460537|NCT01248468|1128040|P3|COMPLETED|Overall Study||145
460538|NCT01248468|1128041|P2|COMPLETED|Overall Study||290
460539|NCT01248468|1128042|P1|COMPLETED|Overall Study||284
460540|NCT01248468|1128040|P3|ITT Population|Overall Study||125
460541|NCT01248468|1128041|P2|ITT Population|Overall Study||261
460542|NCT01248468|1128042|P1|ITT Population|Overall Study||256
460543|NCT01248468|1128040|P3|Safety Population|Overall Study||133
460544|NCT01248468|1128041|P2|Safety Population|Overall Study||271
460545|NCT01248468|1128042|P1|Safety Population|Overall Study||266
460546|NCT01248468|1128040|P3|STARTED|Overall Study||149
460547|NCT01248468|1128041|P2|STARTED|Overall Study||304
460548|NCT01248468|1128042|P1|STARTED|Overall Study||299
460549|NCT01248455|1128059|P1|NOT COMPLETED|Overall Study||1
460550|NCT01248455|1128059|P1|COMPLETED|Overall Study||8
460551|NCT01248455|1128059|P1|STARTED|Overall Study||9
460552|NCT01248416|1128067|P3|NOT COMPLETED|Overall Study||1
460553|NCT01248416|1128068|P2|NOT COMPLETED|Overall Study||0
460554|NCT01248416|1128069|P1|NOT COMPLETED|Overall Study||4
460555|NCT01248416|1128067|P3|COMPLETED|Overall Study||25
460556|NCT01248416|1128068|P2|COMPLETED|Overall Study||25
460557|NCT01248416|1128069|P1|COMPLETED|Overall Study||21
460558|NCT01248416|1128067|P3|STARTED|Overall Study||26
460559|NCT01248416|1128068|P2|STARTED|Overall Study||25
460560|NCT01248416|1128069|P1|STARTED|Overall Study||25
460561|NCT01248364|1128104|P4|NOT COMPLETED|Overall Study||0
460562|NCT01248364|1128105|P3|NOT COMPLETED|Overall Study||0
460563|NCT01248364|1128106|P2|NOT COMPLETED|Overall Study||1
460564|NCT01248364|1128107|P1|NOT COMPLETED|Overall Study||0
460565|NCT01248364|1128104|P4|COMPLETED|Overall Study||12
460566|NCT01248364|1128105|P3|COMPLETED|Overall Study||13
460567|NCT01248364|1128106|P2|COMPLETED|Overall Study||33
460568|NCT01248364|1128107|P1|COMPLETED|Overall Study||32
460569|NCT01248364|1128104|P4|Completed Chronic Phase:28-day Treatment|Overall Study||0
460570|NCT01248364|1128105|P3|Completed Chronic Phase:28-day Treatment|Overall Study||13
460571|NCT01248364|1128106|P2|Completed Chronic Phase:28-day Treatment|Overall Study||33
460572|NCT01248364|1128107|P1|Completed Chronic Phase:28-day Treatment|Overall Study||32
460573|NCT01248364|1128104|P4|Completed Acute Phase:Single Dose, Day 1|Overall Study||12
460574|NCT01248364|1128105|P3|Completed Acute Phase:Single Dose, Day 1|Overall Study||13
460575|NCT01248364|1128106|P2|Completed Acute Phase:Single Dose, Day 1|Overall Study||34
460576|NCT01248364|1128107|P1|Completed Acute Phase:Single Dose, Day 1|Overall Study||32
460577|NCT01248364|1128104|P4|STARTED|Overall Study||12
460578|NCT01248364|1128105|P3|STARTED|Overall Study||13
460579|NCT01248364|1128106|P2|STARTED|Overall Study||34
460580|NCT01248364|1128107|P1|STARTED|Overall Study||32
460581|NCT01248221|1128155|P2|NOT COMPLETED|Overall Study||0
460582|NCT01248221|1128156|P1|NOT COMPLETED|Overall Study||0
460583|NCT01248221|1128155|P2|COMPLETED|Overall Study||15
460584|NCT01248221|1128156|P1|COMPLETED|Overall Study||15
460585|NCT01248221|1128155|P2|STARTED|Overall Study||15
460586|NCT01248221|1128156|P1|STARTED|Overall Study||15
460587|NCT01248130|1128170|P2|NOT COMPLETED|Overall Study||0
460588|NCT01248130|1128171|P1|NOT COMPLETED|Overall Study||2
460589|NCT01248130|1128170|P2|COMPLETED|Overall Study||4
460590|NCT01248130|1128171|P1|COMPLETED|Overall Study||1
460591|NCT01248130|1128170|P2|STARTED|Overall Study||4
460592|NCT01248130|1128171|P1|STARTED|Overall Study||3
460593|NCT01248065|1128181|P2|NOT COMPLETED|Overall Study||22
460594|NCT01248065|1128182|P1|NOT COMPLETED|Overall Study||26
460595|NCT01248065|1128181|P2|COMPLETED|Overall Study|All 201 participants were included in the primary time-to-event analysis.|179
460596|NCT01248065|1128182|P1|COMPLETED|Overall Study|All 207 participants were included in the primary time-to-event analysis.|181
460597|NCT01248065|1128181|P2|STARTED|Overall Study||201
460598|NCT01248065|1128182|P1|STARTED|Overall Study||207
460599|NCT01248013|1128192|P1|NOT COMPLETED|Overall Study||14
460600|NCT01248013|1128192|P1|COMPLETED|Overall Study||75
460601|NCT01248013|1128192|P1|Irritable Bowel Syndrome Hypnotherapy|Overall Study||75
460602|NCT01248013|1128192|P1|STARTED|Overall Study||89
460603|NCT01247974|1128198|P2|NOT COMPLETED|Overall Study||19
460604|NCT01247974|1128199|P1|NOT COMPLETED|Overall Study||26
460605|NCT01247974|1128198|P2|COMPLETED|Overall Study||203
460606|NCT01247974|1128199|P1|COMPLETED|Overall Study||191
460607|NCT01247974|1128198|P2|STARTED|Overall Study||222
460608|NCT01247974|1128199|P1|STARTED|Overall Study||217
460609|NCT01247922|1128207|P1|NOT COMPLETED|Overall Study||4
460610|NCT01247922|1128207|P1|COMPLETED|Overall Study||0
460611|NCT01247922|1128207|P1|Treated|Overall Study||4
460612|NCT01247922|1128207|P1|STARTED|Overall Study||4
460613|NCT01247675|1128217|P4|NOT COMPLETED|Overall Study||0
460614|NCT01247675|1128218|P3|NOT COMPLETED|Overall Study||0
460615|NCT01247675|1128219|P2|NOT COMPLETED|Overall Study||2
460616|NCT01247675|1128220|P1|NOT COMPLETED|Overall Study||2
460617|NCT01247675|1128217|P4|COMPLETED|Overall Study||8
460618|NCT01247675|1128218|P3|COMPLETED|Overall Study||9
460619|NCT01247675|1128219|P2|COMPLETED|Overall Study||8
460620|NCT01247675|1128220|P1|COMPLETED|Overall Study||8
460621|NCT01247675|1128217|P4|STARTED|Overall Study||8
460622|NCT01247675|1128218|P3|STARTED|Overall Study||9
460623|NCT01247675|1128219|P2|STARTED|Overall Study||10
460624|NCT01247675|1128220|P1|STARTED|Overall Study||10
460625|NCT01247571|1128242|P1|NOT COMPLETED|Overall Study||3
460626|NCT01247571|1128242|P1|COMPLETED|Overall Study||19
460627|NCT01247571|1128242|P1|STARTED|Overall Study||22
460628|NCT01247428|1128250|P1|NOT COMPLETED|Overall Study||0
460629|NCT01247428|1128250|P1|COMPLETED|Overall Study||30
460630|NCT01247428|1128250|P1|STARTED|Overall Study||30
460631|NCT01247350|1128276|P5|NOT COMPLETED|Overall Study||1
460632|NCT01247350|1128277|P4|NOT COMPLETED|Overall Study||1
460633|NCT01247350|1128278|P3|NOT COMPLETED|Overall Study||1
460634|NCT01247350|1128279|P2|NOT COMPLETED|Overall Study||0
460635|NCT01247350|1128280|P1|NOT COMPLETED|Overall Study||0
460636|NCT01247350|1128276|P5|COMPLETED|Overall Study||8
460637|NCT01247350|1128277|P4|COMPLETED|Overall Study||6
460638|NCT01247350|1128278|P3|COMPLETED|Overall Study||5
460639|NCT01247350|1128279|P2|COMPLETED|Overall Study||6
460640|NCT01247350|1128280|P1|COMPLETED|Overall Study||6
460641|NCT01247350|1128276|P5|Received Multiple Doses of Study Drug|Overall Study||5
460642|NCT01247350|1128277|P4|Received Multiple Doses of Study Drug|Overall Study||6
460643|NCT01247350|1128278|P3|Received Multiple Doses of Study Drug|Overall Study||6
460644|NCT01247350|1128279|P2|Received Multiple Doses of Study Drug|Overall Study||0
460645|NCT01247350|1128280|P1|Received Multiple Doses of Study Drug|Overall Study||0
460646|NCT01247350|1128276|P5|STARTED|Overall Study||9
460647|NCT01247350|1128277|P4|STARTED|Overall Study||7
460648|NCT01247350|1128278|P3|STARTED|Overall Study||6
460649|NCT01247350|1128279|P2|STARTED|Overall Study||6
460650|NCT01247350|1128280|P1|STARTED|Overall Study||6
460651|NCT01247324|1128338|P2|NOT COMPLETED|Overall Study||44
460652|NCT01247324|1128339|P1|NOT COMPLETED|Overall Study||71
460653|NCT01247324|1128338|P2|COMPLETED|Overall Study||366
460654|NCT01247324|1128339|P1|COMPLETED|Overall Study||340
460655|NCT01247324|1128338|P2|STARTED|Overall Study||410
460656|NCT01247324|1128339|P1|STARTED|Overall Study||411
460657|NCT01247298|1128370|P1|NOT COMPLETED|Overall Study||0
460658|NCT01247298|1128370|P1|COMPLETED|Overall Study||17
460659|NCT01247298|1128370|P1|STARTED|Overall Study||17
460660|NCT01247285|1128380|P2|NOT COMPLETED|Second Intervention||0
460661|NCT01247285|1128381|P1|NOT COMPLETED|Second Intervention||0
460662|NCT01247285|1128380|P2|COMPLETED|Second Intervention||13
460663|NCT01247285|1128381|P1|COMPLETED|Second Intervention||13
460664|NCT01247285|1128380|P2|STARTED|Second Intervention||13
460665|NCT01247285|1128381|P1|STARTED|Second Intervention||13
460666|NCT01247285|1128380|P2|NOT COMPLETED|Washout of 28 Days||0
460667|NCT01247285|1128381|P1|NOT COMPLETED|Washout of 28 Days||0
460668|NCT01247285|1128380|P2|COMPLETED|Washout of 28 Days||13
460669|NCT01247285|1128381|P1|COMPLETED|Washout of 28 Days||13
460670|NCT01247285|1128380|P2|STARTED|Washout of 28 Days||13
460671|NCT01247285|1128381|P1|STARTED|Washout of 28 Days||13
460672|NCT01247285|1128380|P2|NOT COMPLETED|First Intervention||0
460673|NCT01247285|1128381|P1|NOT COMPLETED|First Intervention||0
460674|NCT01247285|1128380|P2|COMPLETED|First Intervention||13
460675|NCT01247285|1128381|P1|COMPLETED|First Intervention||13
460676|NCT01247285|1128380|P2|STARTED|First Intervention||13
460677|NCT01247285|1128381|P1|STARTED|First Intervention||13
460678|NCT01247272|1128399|P2|NOT COMPLETED|Second Intervention||0
460679|NCT01247272|1128400|P1|NOT COMPLETED|Second Intervention||0
460680|NCT01247272|1128399|P2|COMPLETED|Second Intervention||13
460681|NCT01247272|1128400|P1|COMPLETED|Second Intervention||13
460682|NCT01247272|1128399|P2|STARTED|Second Intervention||13
460683|NCT01247272|1128400|P1|STARTED|Second Intervention||13
460684|NCT01247272|1128399|P2|NOT COMPLETED|Washout of 28 Days||0
460685|NCT01247272|1128400|P1|NOT COMPLETED|Washout of 28 Days||0
460686|NCT01247272|1128399|P2|COMPLETED|Washout of 28 Days||13
460687|NCT01247272|1128400|P1|COMPLETED|Washout of 28 Days||13
460688|NCT01247272|1128399|P2|STARTED|Washout of 28 Days||13
460689|NCT01247272|1128400|P1|STARTED|Washout of 28 Days||13
460690|NCT01247272|1128399|P2|NOT COMPLETED|First Intervention||0
460691|NCT01247272|1128400|P1|NOT COMPLETED|First Intervention||0
460692|NCT01247272|1128399|P2|COMPLETED|First Intervention||13
460693|NCT01247272|1128400|P1|COMPLETED|First Intervention||13
460694|NCT01247272|1128399|P2|STARTED|First Intervention||13
460695|NCT01247272|1128400|P1|STARTED|First Intervention||13
460696|NCT01247220|1128418|P2|NOT COMPLETED|Overall Study||0
460697|NCT01247220|1128419|P1|NOT COMPLETED|Overall Study||0
460698|NCT01247220|1128418|P2|COMPLETED|Overall Study||6
460699|NCT01247220|1128419|P1|COMPLETED|Overall Study||6
460700|NCT01247220|1128418|P2|STARTED|Overall Study||6
460701|NCT01247220|1128419|P1|STARTED|Overall Study||6
460702|NCT01247090|1128432|P3|NOT COMPLETED|Overall Study||0
460703|NCT01247090|1128433|P2|NOT COMPLETED|Overall Study||1
460704|NCT01247090|1128434|P1|NOT COMPLETED|Overall Study||1
460705|NCT01247090|1128432|P3|COMPLETED|Overall Study||4
460706|NCT01247090|1128433|P2|COMPLETED|Overall Study||3
460707|NCT01247090|1128434|P1|COMPLETED|Overall Study||3
460708|NCT01247090|1128432|P3|STARTED|Overall Study||4
460709|NCT01247090|1128433|P2|STARTED|Overall Study||4
460710|NCT01247090|1128434|P1|STARTED|Overall Study||4
460711|NCT01247064|1128444|P2|NOT COMPLETED|Overall Study||0
460712|NCT01247064|1128445|P1|NOT COMPLETED|Overall Study||0
460713|NCT01247064|1128444|P2|COMPLETED|Overall Study||31
460714|NCT01247064|1128445|P1|COMPLETED|Overall Study||31
460715|NCT01247064|1128444|P2|STARTED|Overall Study||31
460716|NCT01247064|1128445|P1|STARTED|Overall Study||31
460717|NCT01246999|1128463|P4|NOT COMPLETED|Overall Study||2
460718|NCT01246999|1128464|P3|NOT COMPLETED|Overall Study||0
460719|NCT01246999|1128465|P2|NOT COMPLETED|Overall Study||1
460720|NCT01246999|1128466|P1|NOT COMPLETED|Overall Study||0
460721|NCT01246999|1128463|P4|COMPLETED|Overall Study||15
460722|NCT01246999|1128464|P3|COMPLETED|Overall Study||2
460723|NCT01246999|1128465|P2|COMPLETED|Overall Study||3
460724|NCT01246999|1128466|P1|COMPLETED|Overall Study||11
460725|NCT01246999|1128463|P4|STARTED|Overall Study||17
460726|NCT01246999|1128464|P3|STARTED|Overall Study||2
460727|NCT01246999|1128465|P2|STARTED|Overall Study||4
460728|NCT01246999|1128466|P1|STARTED|Overall Study||11
460729|NCT01246973|1128501|P2|NOT COMPLETED|Overall Study||47
460730|NCT01246973|1128502|P1|NOT COMPLETED|Overall Study||61
460731|NCT01246973|1128501|P2|COMPLETED|Overall Study||295
460732|NCT01246973|1128502|P1|COMPLETED|Overall Study||283
460733|NCT01246973|1128501|P2|STARTED|Overall Study||342
460734|NCT01246973|1128502|P1|STARTED|Overall Study||344
460735|NCT01246960|1128512|P2|NOT COMPLETED|Overall Study||4
460736|NCT01246960|1128513|P1|NOT COMPLETED|Overall Study||6
460737|NCT01246960|1128512|P2|COMPLETED|Overall Study||80
460738|NCT01246960|1128513|P1|COMPLETED|Overall Study||78
460739|NCT01246960|1128512|P2|Received Any Quantity of Study Drug|Overall Study||80
460740|NCT01246960|1128513|P1|Received Any Quantity of Study Drug|Overall Study||82
460741|NCT01246960|1128512|P2|STARTED|Overall Study||84
460742|NCT01246960|1128513|P1|STARTED|Overall Study||84
460743|NCT01246895|1128533|P2|NOT COMPLETED|Overall Study||4
460744|NCT01246895|1128534|P1|NOT COMPLETED|Overall Study||3
460745|NCT01246895|1128533|P2|COMPLETED|Overall Study||26
460746|NCT01246895|1128534|P1|COMPLETED|Overall Study||34
460747|NCT01246895|1128533|P2|STARTED|Overall Study||30
460748|NCT01246895|1128534|P1|STARTED|Overall Study||37
460749|NCT01246791|1128548|P1|NOT COMPLETED|Overall Study||0
460750|NCT01246791|1128548|P1|COMPLETED|Overall Study||12
460751|NCT01246791|1128548|P1|STARTED|Overall Study||12
460752|NCT01246713|1128563|P2|NOT COMPLETED|Second Acetaminophen Dosing (1 Day)||0
460753|NCT01246713|1128564|P1|NOT COMPLETED|Second Acetaminophen Dosing (1 Day)||0
460754|NCT01246713|1128563|P2|COMPLETED|Second Acetaminophen Dosing (1 Day)||9
460755|NCT01246713|1128564|P1|COMPLETED|Second Acetaminophen Dosing (1 Day)||6
460756|NCT01246713|1128563|P2|STARTED|Second Acetaminophen Dosing (1 Day)||9
460757|NCT01246713|1128564|P1|STARTED|Second Acetaminophen Dosing (1 Day)||6
460758|NCT01246713|1128563|P2|NOT COMPLETED|Washout (at Least 14 Days)||0
460759|NCT01246713|1128564|P1|NOT COMPLETED|Washout (at Least 14 Days)||0
460760|NCT01246713|1128563|P2|COMPLETED|Washout (at Least 14 Days)||9
460761|NCT01246713|1128564|P1|COMPLETED|Washout (at Least 14 Days)||6
460762|NCT01246713|1128563|P2|STARTED|Washout (at Least 14 Days)||9
460763|NCT01246713|1128564|P1|STARTED|Washout (at Least 14 Days)||6
460764|NCT01246713|1128563|P2|NOT COMPLETED|First Acetaminophen Dosing (1 Day)||0
460765|NCT01246713|1128564|P1|NOT COMPLETED|First Acetaminophen Dosing (1 Day)||0
460766|NCT01246713|1128563|P2|COMPLETED|First Acetaminophen Dosing (1 Day)||9
460767|NCT01246713|1128564|P1|COMPLETED|First Acetaminophen Dosing (1 Day)||6
460768|NCT01246713|1128563|P2|STARTED|First Acetaminophen Dosing (1 Day)||9
460769|NCT01246713|1128564|P1|STARTED|First Acetaminophen Dosing (1 Day)||6
460770|NCT01246479|1128570|P1|NOT COMPLETED|Overall Study||5
460771|NCT01246479|1128570|P1|COMPLETED|Overall Study|primary endpoint at Month 12|18
460772|NCT01246479|1128570|P1|STARTED|Overall Study||23
460773|NCT01246401|1128576|P2|NOT COMPLETED|Overall Study||0
460774|NCT01246401|1128577|P1|NOT COMPLETED|Overall Study||0
460775|NCT01246401|1128576|P2|COMPLETED|Overall Study||27
460776|NCT01246401|1128577|P1|COMPLETED|Overall Study||66
460777|NCT01246401|1128576|P2|STARTED|Overall Study||27
460778|NCT01246401|1128577|P1|STARTED|Overall Study||66
460779|NCT01246349|1128603|P2|NOT COMPLETED|Overall Study||0
460780|NCT01246349|1128604|P1|NOT COMPLETED|Overall Study||0
460781|NCT01246349|1128603|P2|COMPLETED|Overall Study||20
460782|NCT01246349|1128604|P1|COMPLETED|Overall Study||20
460783|NCT01246349|1128603|P2|STARTED|Overall Study||20
460784|NCT01246349|1128604|P1|STARTED|Overall Study||20
460785|NCT01246258|1128616|P1|NOT COMPLETED|Overall Study||0
460786|NCT01246258|1128616|P1|COMPLETED|Overall Study||5
460787|NCT01246258|1128616|P1|STARTED|Overall Study||5
460788|NCT01246206|1128621|P1|NOT COMPLETED|Overall Study||1
460789|NCT01246206|1128621|P1|COMPLETED|Overall Study||20
460790|NCT01246206|1128621|P1|STARTED|Overall Study||21
460791|NCT01246076|1128632|P1|NOT COMPLETED|Overall Study||0
460792|NCT01246076|1128632|P1|COMPLETED|Overall Study||24
460793|NCT01246076|1128632|P1|STARTED|Overall Study||24
460794|NCT01246011|1128644|P3|NOT COMPLETED|Overall Study||4
460795|NCT01246011|1128645|P2|NOT COMPLETED|Overall Study||0
460796|NCT01246011|1128646|P1|NOT COMPLETED|Overall Study||0
460797|NCT01246011|1128644|P3|COMPLETED|Overall Study||5
460798|NCT01246011|1128645|P2|COMPLETED|Overall Study||0
460799|NCT01246011|1128646|P1|COMPLETED|Overall Study||0
460800|NCT01246011|1128644|P3|STARTED|Overall Study||9
460801|NCT01246011|1128645|P2|STARTED|Overall Study||0
460802|NCT01246011|1128646|P1|STARTED|Overall Study||0
460803|NCT01245764|1128661|P4|NOT COMPLETED|Study Phase B||0
460804|NCT01245764|1128662|P3|NOT COMPLETED|Study Phase B||0
460805|NCT01245764|1128663|P2|NOT COMPLETED|Study Phase B||0
460806|NCT01245764|1128664|P1|NOT COMPLETED|Study Phase B||0
460807|NCT01245764|1128661|P4|COMPLETED|Study Phase B||17
460808|NCT01245764|1128662|P3|COMPLETED|Study Phase B||0
460809|NCT01245764|1128663|P2|COMPLETED|Study Phase B||0
460810|NCT01245764|1128664|P1|COMPLETED|Study Phase B||0
460811|NCT01245764|1128661|P4|Completed Vaccinations in Study Phase B|Study Phase B||17
460812|NCT01245764|1128662|P3|Completed Vaccinations in Study Phase B|Study Phase B||0
460813|NCT01245764|1128663|P2|Completed Vaccinations in Study Phase B|Study Phase B||0
460814|NCT01245764|1128664|P1|Completed Vaccinations in Study Phase B|Study Phase B||0
460815|NCT01245764|1128661|P4|STARTED|Study Phase B||17
460816|NCT01245764|1128662|P3|STARTED|Study Phase B||0
460817|NCT01245764|1128663|P2|STARTED|Study Phase B||0
460818|NCT01245764|1128664|P1|STARTED|Study Phase B||0
460819|NCT01245764|1128661|P4|NOT COMPLETED|Study Phase A||3
460820|NCT01245764|1128662|P3|NOT COMPLETED|Study Phase A||10
460821|NCT01245764|1128663|P2|NOT COMPLETED|Study Phase A||5
460822|NCT01245764|1128664|P1|NOT COMPLETED|Study Phase A||9
460823|NCT01245764|1128661|P4|COMPLETED|Study Phase A||17
460824|NCT01245764|1128662|P3|COMPLETED|Study Phase A||110
460825|NCT01245764|1128663|P2|COMPLETED|Study Phase A||25
460826|NCT01245764|1128664|P1|COMPLETED|Study Phase A||71
460827|NCT01245764|1128661|P4|Completed Vaccinations in Study Phase A|Study Phase A||19
460828|NCT01245764|1128662|P3|Completed Vaccinations in Study Phase A|Study Phase A||117
460829|NCT01245764|1128663|P2|Completed Vaccinations in Study Phase A|Study Phase A||28
460830|NCT01245764|1128664|P1|Completed Vaccinations in Study Phase A|Study Phase A||77
460831|NCT01245764|1128661|P4|STARTED|Study Phase A||20
460832|NCT01245764|1128662|P3|STARTED|Study Phase A||120
460833|NCT01245764|1128663|P2|STARTED|Study Phase A||30
460834|NCT01245764|1128664|P1|STARTED|Study Phase A||80
460835|NCT01245751|1128702|P4|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
460836|NCT01245751|1128703|P3|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
460837|NCT01245751|1128704|P2|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
460838|NCT01245751|1128705|P1|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
460839|NCT01245751|1128702|P4|COMPLETED|Part 2: Week 156 (3 Year) Visit||0
460840|NCT01245751|1128703|P3|COMPLETED|Part 2: Week 156 (3 Year) Visit||0
460841|NCT01245751|1128704|P2|COMPLETED|Part 2: Week 156 (3 Year) Visit||139
460842|NCT01245751|1128705|P1|COMPLETED|Part 2: Week 156 (3 Year) Visit||161
460843|NCT01245751|1128702|P4|STARTED|Part 2: Week 156 (3 Year) Visit|Part 2 was planned for Groups 1 and 2 only|0
460844|NCT01245751|1128703|P3|STARTED|Part 2: Week 156 (3 Year) Visit|Part 2 was planned for Groups 1 and 2 only|0
460845|NCT01245751|1128704|P2|STARTED|Part 2: Week 156 (3 Year) Visit|Enrollment in Part 2 was voluntary|139
460846|NCT01245751|1128705|P1|STARTED|Part 2: Week 156 (3 Year) Visit|Enrollment in Part 2 was voluntary|161
460847|NCT01245751|1128702|P4|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2
460848|NCT01245751|1128703|P3|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||0
460849|NCT01245751|1128704|P2|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||5
460850|NCT01245751|1128705|P1|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2
460851|NCT01245751|1128702|P4|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||98
460852|NCT01245751|1128703|P3|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||100
460853|NCT01245751|1128704|P2|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||194
460854|NCT01245751|1128705|P1|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||199
460855|NCT01245751|1128702|P4|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100
460856|NCT01245751|1128703|P3|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100
460857|NCT01245751|1128704|P2|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||199
460858|NCT01245751|1128705|P1|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||201
460859|NCT01245751|1128702|P4|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100
460860|NCT01245751|1128703|P3|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100
460861|NCT01245751|1128704|P2|STARTED|Part 1: Day 1 to Week 52 (1 Year)||199
460862|NCT01245751|1128705|P1|STARTED|Part 1: Day 1 to Week 52 (1 Year)||201
460863|NCT01245738|1128718|P1|NOT COMPLETED|Overall Study||40
460864|NCT01245738|1128718|P1|COMPLETED|Overall Study||474
460865|NCT01245738|1128718|P1|STARTED|Overall Study||514
460866|NCT01245647|1128737|P2|NOT COMPLETED|Overall Study||4
460867|NCT01245647|1128738|P1|NOT COMPLETED|Overall Study||0
460868|NCT01245647|1128737|P2|COMPLETED|Overall Study||8
460869|NCT01245647|1128738|P1|COMPLETED|Overall Study||7
460870|NCT01245647|1128737|P2|STARTED|Overall Study||12
460871|NCT01245647|1128738|P1|STARTED|Overall Study||7
460872|NCT01245595|1128754|P2|NOT COMPLETED|Overall Study||0
460873|NCT01245595|1128755|P1|NOT COMPLETED|Overall Study||0
460874|NCT01245595|1128754|P2|COMPLETED|Overall Study||72
460875|NCT01245595|1128755|P1|COMPLETED|Overall Study||72
460876|NCT01245595|1128754|P2|Completed Full Course of Study Drug|Overall Study||61
460877|NCT01245595|1128755|P1|Completed Full Course of Study Drug|Overall Study||57
460878|NCT01245595|1128754|P2|STARTED|Overall Study||72
460879|NCT01245595|1128755|P1|STARTED|Overall Study||72
460880|NCT01245439|1128761|P1|NOT COMPLETED|Overall Study||0
460881|NCT01245439|1128761|P1|COMPLETED|Overall Study||65
460882|NCT01245439|1128761|P1|STARTED|Overall Study||65
460883|NCT01245413|1128792|P2|NOT COMPLETED|Athena First,||0
460884|NCT01245413|1128793|P1|NOT COMPLETED|Athena First,||0
460885|NCT01245413|1128792|P2|COMPLETED|Athena First,||16
460886|NCT01245413|1128793|P1|COMPLETED|Athena First,||16
460887|NCT01245413|1128792|P2|STARTED|Athena First,||16
460888|NCT01245413|1128793|P1|STARTED|Athena First,||16
460889|NCT01245413|1128792|P2|NOT COMPLETED|Sensura First,||0
460890|NCT01245413|1128793|P1|NOT COMPLETED|Sensura First,||0
460891|NCT01245413|1128792|P2|COMPLETED|Sensura First,||16
460892|NCT01245413|1128793|P1|COMPLETED|Sensura First,||16
460893|NCT01245413|1128792|P2|STARTED|Sensura First,||16
460894|NCT01245413|1128793|P1|STARTED|Sensura First,||16
460895|NCT01245387|1128799|P1|NOT COMPLETED|Overall Study||813
460896|NCT01245387|1128799|P1|COMPLETED|Overall Study||188
460897|NCT01245387|1128799|P1|STARTED|Overall Study||1001
460898|NCT01245374|1128848|P1|NOT COMPLETED|Overall Study||4
460899|NCT01245374|1128848|P1|COMPLETED|Overall Study||99
460900|NCT01245374|1128848|P1|STARTED|Overall Study||103
460901|NCT01245283|1128871|P3|NOT COMPLETED|Overall Study||11
460902|NCT01245283|1128872|P2|NOT COMPLETED|Overall Study||11
460903|NCT01245283|1128873|P1|NOT COMPLETED|Overall Study||14
460904|NCT01245283|1128871|P3|COMPLETED|Overall Study||19
460905|NCT01245283|1128872|P2|COMPLETED|Overall Study||17
460906|NCT01245283|1128873|P1|COMPLETED|Overall Study||18
460907|NCT01245283|1128871|P3|STARTED|Overall Study||30
460908|NCT01245283|1128872|P2|STARTED|Overall Study||28
460909|NCT01245283|1128873|P1|STARTED|Overall Study||32
460910|NCT01245270|1128907|P2|NOT COMPLETED|Overall Study||0
460911|NCT01245270|1128908|P1|NOT COMPLETED|Overall Study||0
460912|NCT01245270|1128907|P2|COMPLETED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
460913|NCT01245270|1128908|P1|COMPLETED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
460914|NCT01245270|1128907|P2|STARTED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
460915|NCT01245270|1128908|P1|STARTED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
460916|NCT01245140|1128918|P2|NOT COMPLETED|Overall Study||10
460917|NCT01245140|1128919|P1|NOT COMPLETED|Overall Study||3
460918|NCT01245140|1128918|P2|COMPLETED|Overall Study||14
460919|NCT01245140|1128919|P1|COMPLETED|Overall Study||6
460920|NCT01245140|1128918|P2|STARTED|Overall Study||24
460921|NCT01245140|1128919|P1|STARTED|Overall Study||9
460922|NCT01245101|1128975|P2|NOT COMPLETED|Period 3 (Treatment)||0
460923|NCT01245101|1128976|P1|NOT COMPLETED|Period 3 (Treatment)||1
460924|NCT01245101|1128975|P2|COMPLETED|Period 3 (Treatment)||0
460925|NCT01245101|1128976|P1|COMPLETED|Period 3 (Treatment)||11
460926|NCT01245101|1128975|P2|STARTED|Period 3 (Treatment)||0
460927|NCT01245101|1128976|P1|STARTED|Period 3 (Treatment)||12
460928|NCT01245101|1128975|P2|NOT COMPLETED|Period 2 (Washout)||0
460929|NCT01245101|1128976|P1|NOT COMPLETED|Period 2 (Washout)||1
460930|NCT01245101|1128975|P2|COMPLETED|Period 2 (Washout)||0
460931|NCT01245101|1128976|P1|COMPLETED|Period 2 (Washout)||12
460932|NCT01245101|1128975|P2|STARTED|Period 2 (Washout)||0
460933|NCT01245101|1128976|P1|STARTED|Period 2 (Washout)||13
460934|NCT01245101|1128975|P2|NOT COMPLETED|Period 1 (Treatment)||0
460935|NCT01245101|1128976|P1|NOT COMPLETED|Period 1 (Treatment)||2
460936|NCT01245101|1128975|P2|COMPLETED|Period 1 (Treatment)||0
460937|NCT01245101|1128976|P1|COMPLETED|Period 1 (Treatment)||13
460938|NCT01245101|1128975|P2|STARTED|Period 1 (Treatment)||0
460939|NCT01245101|1128976|P1|STARTED|Period 1 (Treatment)||15
460940|NCT01245062|1128986|P3|NOT COMPLETED|Cross-over Phase||17
460941|NCT01245062|1128987|P2|NOT COMPLETED|Cross-over Phase||0
460942|NCT01245062|1128988|P1|NOT COMPLETED|Cross-over Phase||0
460943|NCT01245062|1128986|P3|COMPLETED|Cross-over Phase||53
460944|NCT01245062|1128987|P2|COMPLETED|Cross-over Phase||0
460945|NCT01245062|1128988|P1|COMPLETED|Cross-over Phase||0
460946|NCT01245062|1128986|P3|STARTED|Cross-over Phase|As of the data cut on December 16, 2016, 70 of 108 participants crossed over from CT to trametinib.|70
460947|NCT01245062|1128987|P2|STARTED|Cross-over Phase||0
460948|NCT01245062|1128988|P1|STARTED|Cross-over Phase||0
460949|NCT01245062|1128986|P3|NOT COMPLETED|Randomization and Crossover Phase||0
460950|NCT01245062|1128987|P2|NOT COMPLETED|Randomization and Crossover Phase||31
460951|NCT01245062|1128988|P1|NOT COMPLETED|Randomization and Crossover Phase||41
460952|NCT01245062|1128986|P3|COMPLETED|Randomization and Crossover Phase||0
460953|NCT01245062|1128987|P2|COMPLETED|Randomization and Crossover Phase||77
460954|NCT01245062|1128988|P1|COMPLETED|Randomization and Crossover Phase||173
460955|NCT01245062|1128986|P3|STARTED|Randomization and Crossover Phase||0
460956|NCT01245062|1128987|P2|STARTED|Randomization and Crossover Phase||108
460957|NCT01245062|1128988|P1|STARTED|Randomization and Crossover Phase||214
460958|NCT01245049|1129026|P2|NOT COMPLETED|Overall Study||4
460959|NCT01245049|1129027|P1|NOT COMPLETED|Overall Study||1
460960|NCT01245049|1129026|P2|COMPLETED|Overall Study||126
460961|NCT01245049|1129027|P1|COMPLETED|Overall Study||254
460962|NCT01245049|1129026|P2|STARTED|Overall Study||130
460963|NCT01245049|1129027|P1|STARTED|Overall Study||255
460964|NCT01244984|1129080|P3|NOT COMPLETED|Overall Study||4
460965|NCT01244984|1129081|P2|NOT COMPLETED|Overall Study||14
460966|NCT01244984|1129082|P1|NOT COMPLETED|Overall Study||5
460967|NCT01244984|1129080|P3|COMPLETED|Overall Study||86
460968|NCT01244984|1129081|P2|COMPLETED|Overall Study||79
460969|NCT01244984|1129082|P1|COMPLETED|Overall Study||55
460970|NCT01244984|1129080|P3|STARTED|Overall Study||90
460971|NCT01244984|1129081|P2|STARTED|Overall Study||93
460972|NCT01244984|1129082|P1|STARTED|Overall Study||60
460973|NCT01244906|1129156|P1|NOT COMPLETED|Overall Study||8
460974|NCT01244906|1129156|P1|COMPLETED|Overall Study||18
460975|NCT01244906|1129156|P1|STARTED|Overall Study||26
460976|NCT01244893|1129165|P2|NOT COMPLETED|Final Visit||0
460977|NCT01244893|1129166|P1|NOT COMPLETED|Final Visit||0
460978|NCT01244893|1129165|P2|COMPLETED|Final Visit||21
460979|NCT01244893|1129166|P1|COMPLETED|Final Visit||21
460980|NCT01244893|1129165|P2|STARTED|Final Visit||21
460981|NCT01244893|1129166|P1|STARTED|Final Visit||21
460982|NCT01244893|1129165|P2|NOT COMPLETED|1-Week Follow Up||0
460983|NCT01244893|1129166|P1|NOT COMPLETED|1-Week Follow Up||1
460984|NCT01244893|1129165|P2|COMPLETED|1-Week Follow Up||21
460985|NCT01244893|1129166|P1|COMPLETED|1-Week Follow Up||21
460986|NCT01244893|1129165|P2|STARTED|1-Week Follow Up||21
460987|NCT01244893|1129166|P1|STARTED|1-Week Follow Up||22
460988|NCT01244893|1129165|P2|NOT COMPLETED|Baseline||1
460989|NCT01244893|1129166|P1|NOT COMPLETED|Baseline||0
460990|NCT01244893|1129165|P2|COMPLETED|Baseline||21
460991|NCT01244893|1129166|P1|COMPLETED|Baseline||22
460992|NCT01244893|1129165|P2|STARTED|Baseline||22
460993|NCT01244893|1129166|P1|STARTED|Baseline||22
460994|NCT01244828|1129178|P1|NOT COMPLETED|Overall Study||78
460995|NCT01244828|1129178|P1|COMPLETED|Overall Study||79
460996|NCT01244828|1129178|P1|STARTED|Overall Study|Received study drug|157
460997|NCT01244815|1129194|P4|NOT COMPLETED|Overall Study||12
460998|NCT01244815|1129195|P3|NOT COMPLETED|Overall Study||11
460999|NCT01244815|1129196|P2|NOT COMPLETED|Overall Study||17
461000|NCT01244815|1129197|P1|NOT COMPLETED|Overall Study||14
461001|NCT01244815|1129194|P4|COMPLETED|Overall Study||87
461002|NCT01244815|1129195|P3|COMPLETED|Overall Study||88
461003|NCT01244815|1129196|P2|COMPLETED|Overall Study||88
461004|NCT01244815|1129197|P1|COMPLETED|Overall Study||87
461005|NCT01244815|1129194|P4|Treated|Overall Study||99
461006|NCT01244815|1129195|P3|Treated|Overall Study||99
461007|NCT01244815|1129196|P2|Treated|Overall Study||104
461008|NCT01244815|1129197|P1|Treated|Overall Study||101
461009|NCT01244815|1129194|P4|STARTED|Overall Study|Randomized|99
461010|NCT01244815|1129195|P3|STARTED|Overall Study|Randomized|99
461011|NCT01244815|1129196|P2|STARTED|Overall Study|Randomized|105
461012|NCT01244815|1129197|P1|STARTED|Overall Study|Randomized|101
461013|NCT01244724|1129271|P1|NOT COMPLETED|Overall Study||8
461014|NCT01244724|1129271|P1|COMPLETED|Overall Study||9
461015|NCT01244724|1129271|P1|Week 2 Visit|Overall Study||15
461016|NCT01244724|1129271|P1|STARTED|Overall Study|Of these 15 returned for a week 2 visit and are included in the efficacy analysis.|17
461017|NCT01244711|1129275|P1|NOT COMPLETED|Overall Study||0
461018|NCT01244711|1129275|P1|COMPLETED|Overall Study||1
461019|NCT01244711|1129275|P1|STARTED|Overall Study||1
461020|NCT01244633|1129279|P1|NOT COMPLETED|Overall Study||3
461021|NCT01244633|1129279|P1|COMPLETED|Overall Study||15
461022|NCT01244633|1129279|P1|STARTED|Overall Study||18
461023|NCT01244620|1129283|P4|NOT COMPLETED|Overall Study||4
461024|NCT01244620|1129284|P3|NOT COMPLETED|Overall Study||4
461025|NCT01244620|1129285|P2|NOT COMPLETED|Overall Study||4
461026|NCT01244620|1129286|P1|NOT COMPLETED|Overall Study||4
461027|NCT01244620|1129283|P4|COMPLETED|Overall Study||0
461028|NCT01244620|1129284|P3|COMPLETED|Overall Study||0
461029|NCT01244620|1129285|P2|COMPLETED|Overall Study||0
461030|NCT01244620|1129286|P1|COMPLETED|Overall Study||0
461031|NCT01244620|1129283|P4|STARTED|Overall Study||4
461032|NCT01244620|1129284|P3|STARTED|Overall Study||4
461033|NCT01244620|1129285|P2|STARTED|Overall Study||4
461034|NCT01244620|1129286|P1|STARTED|Overall Study||4
461035|NCT01244529|1129320|P1|NOT COMPLETED|Overall Study||0
461036|NCT01244529|1129320|P1|COMPLETED|Overall Study||41
461037|NCT01244529|1129320|P1|STARTED|Overall Study||41
461038|NCT01244516|1129345|P3|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||2
461039|NCT01244516|1129346|P2|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||1
461040|NCT01244516|1129347|P1|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||3
461041|NCT01244516|1129345|P3|COMPLETED|Period 2 (1-week to 2-week Visit)||168
461042|NCT01244516|1129346|P2|COMPLETED|Period 2 (1-week to 2-week Visit)||170
461043|NCT01244516|1129347|P1|COMPLETED|Period 2 (1-week to 2-week Visit)||163
461044|NCT01244516|1129345|P3|STARTED|Period 2 (1-week to 2-week Visit)||170
461045|NCT01244516|1129346|P2|STARTED|Period 2 (1-week to 2-week Visit)||171
461046|NCT01244516|1129347|P1|STARTED|Period 2 (1-week to 2-week Visit)||166
461047|NCT01244516|1129345|P3|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||3
461048|NCT01244516|1129346|P2|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||6
461049|NCT01244516|1129347|P1|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||4
461050|NCT01244516|1129345|P3|COMPLETED|Period 1 (Baseline to 1-week Visit)||170
461051|NCT01244516|1129346|P2|COMPLETED|Period 1 (Baseline to 1-week Visit)||171
461052|NCT01244516|1129347|P1|COMPLETED|Period 1 (Baseline to 1-week Visit)||166
461053|NCT01244516|1129345|P3|STARTED|Period 1 (Baseline to 1-week Visit)||173
461054|NCT01244516|1129346|P2|STARTED|Period 1 (Baseline to 1-week Visit)||177
461055|NCT01244516|1129347|P1|STARTED|Period 1 (Baseline to 1-week Visit)||170
461056|NCT01244503|1129360|P1|NOT COMPLETED|Overall Study||0
461057|NCT01244503|1129360|P1|COMPLETED|Overall Study||61
461058|NCT01244503|1129360|P1|STARTED|Overall Study||61
461059|NCT01244490|1129368|P3|NOT COMPLETED|Overall Study||23
461060|NCT01244490|1129369|P2|NOT COMPLETED|Overall Study||24
461061|NCT01244490|1129370|P1|NOT COMPLETED|Overall Study||19
461062|NCT01244490|1129368|P3|COMPLETED|Overall Study||89
461063|NCT01244490|1129369|P2|COMPLETED|Overall Study||91
461064|NCT01244490|1129370|P1|COMPLETED|Overall Study||92
461065|NCT01244490|1129368|P3|STARTED|Overall Study||112
461066|NCT01244490|1129369|P2|STARTED|Overall Study||115
461067|NCT01244490|1129370|P1|STARTED|Overall Study||111
461068|NCT01244477|1129425|P2|NOT COMPLETED|Overall Study||3
461069|NCT01244477|1129426|P1|NOT COMPLETED|Overall Study||20
461070|NCT01244477|1129425|P2|COMPLETED|Overall Study||20
461071|NCT01244477|1129426|P1|COMPLETED|Overall Study||18
461072|NCT01244477|1129425|P2|STARTED|Overall Study||23
461073|NCT01244477|1129426|P1|STARTED|Overall Study||38
461074|NCT01244425|1129438|P2|NOT COMPLETED|Overall Study||3
461075|NCT01244425|1129439|P1|NOT COMPLETED|Overall Study||3
461076|NCT01244425|1129438|P2|COMPLETED|Overall Study|Adverse Event: septic shock with multi-organ failure due to liver abscess (death)|32
461077|NCT01244425|1129439|P1|COMPLETED|Overall Study|Adverse Event: multi-organ failure (death)|32
461078|NCT01244425|1129438|P2|STARTED|Overall Study||35
461079|NCT01244425|1129439|P1|STARTED|Overall Study||35
461080|NCT01244412|1129459|P1|NOT COMPLETED|Overall Study||0
461081|NCT01244412|1129459|P1|COMPLETED|Overall Study||1
461082|NCT01244412|1129459|P1|STARTED|Overall Study||1
461083|NCT01244243|1129463|P1|NOT COMPLETED|Overall Study||0
461084|NCT01244243|1129463|P1|COMPLETED|Overall Study||41
461085|NCT01244243|1129463|P1|STARTED|Overall Study||41
461086|NCT01244126|1129471|P3|NOT COMPLETED|Overall Study||9
461087|NCT01244126|1129472|P2|NOT COMPLETED|Overall Study||3
461088|NCT01244126|1129473|P1|NOT COMPLETED|Overall Study||3
461089|NCT01244126|1129471|P3|COMPLETED|Overall Study||48
461090|NCT01244126|1129472|P2|COMPLETED|Overall Study||52
461091|NCT01244126|1129473|P1|COMPLETED|Overall Study||56
461092|NCT01244126|1129471|P3|STARTED|Overall Study||57
461093|NCT01244126|1129472|P2|STARTED|Overall Study||55
461094|NCT01244126|1129473|P1|STARTED|Overall Study||59
461095|NCT01244061|1129486|P2|NOT COMPLETED|Overall Study||103
461096|NCT01244061|1129487|P1|NOT COMPLETED|Overall Study||82
461097|NCT01244061|1129486|P2|COMPLETED|Overall Study||144
461098|NCT01244061|1129487|P1|COMPLETED|Overall Study||169
461099|NCT01244061|1129486|P2|STARTED|Overall Study||247
461100|NCT01244061|1129487|P1|STARTED|Overall Study||251
461101|NCT01243944|1129501|P2|NOT COMPLETED|Overall Study||108
461102|NCT01243944|1129502|P1|NOT COMPLETED|Overall Study||17
461103|NCT01243944|1129501|P2|COMPLETED|Overall Study|These are the numbers of subjects who completed 48 weeks of treatment.|3
461104|NCT01243944|1129502|P1|COMPLETED|Overall Study|These are the numbers of subjects who completed 48 weeks of treatment.|93
461105|NCT01243944|1129501|P2|STARTED|Overall Study|One subject withdrew consent 5 days after randomization to BAT arm and wasn't treated while on study|111
461106|NCT01243944|1129502|P1|STARTED|Overall Study||110
461107|NCT01243892|1129526|P2|NOT COMPLETED|Overall Study||0
461108|NCT01243892|1129527|P1|NOT COMPLETED|Overall Study||2
461109|NCT01243892|1129526|P2|COMPLETED|Overall Study||3
461110|NCT01243892|1129527|P1|COMPLETED|Overall Study||13
461111|NCT01243892|1129526|P2|STARTED|Overall Study||3
461112|NCT01243892|1129527|P1|STARTED|Overall Study||15
461113|NCT01243775|1129537|P1|NOT COMPLETED|Overall Study||2
461114|NCT01243775|1129537|P1|COMPLETED|Overall Study||31
461115|NCT01243775|1129537|P1|STARTED|Overall Study||33
461116|NCT01243762|1129551|P7|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||6
461117|NCT01243762|1129552|P6|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
461118|NCT01243762|1129553|P5|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||4
461119|NCT01243762|1129554|P4|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||2
461120|NCT01243762|1129555|P3|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
461121|NCT01243762|1129556|P2|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||5
461122|NCT01243762|1129557|P1|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||1
461123|NCT01243762|1129551|P7|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
461124|NCT01243762|1129552|P6|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
461125|NCT01243762|1129553|P5|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
461126|NCT01243762|1129554|P4|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
461127|NCT01243762|1129555|P3|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
461128|NCT01243762|1129556|P2|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
461129|NCT01243762|1129557|P1|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
461130|NCT01243762|1129551|P7|STARTED|Part 2 (Dose Confirmation/Efficacy)|New participants were enrolled in Part 2 of the study that did not participate in Part 1|6
461131|NCT01243762|1129552|P6|STARTED|Part 2 (Dose Confirmation/Efficacy)||0
461132|NCT01243762|1129553|P5|STARTED|Part 2 (Dose Confirmation/Efficacy)||4
461133|NCT01243762|1129554|P4|STARTED|Part 2 (Dose Confirmation/Efficacy)||2
461134|NCT01243762|1129555|P3|STARTED|Part 2 (Dose Confirmation/Efficacy)||0
461135|NCT01243762|1129556|P2|STARTED|Part 2 (Dose Confirmation/Efficacy)||5
461136|NCT01243762|1129557|P1|STARTED|Part 2 (Dose Confirmation/Efficacy)||1
461137|NCT01243762|1129551|P7|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||0
461138|NCT01243762|1129552|P6|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
461139|NCT01243762|1129553|P5|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||6
461140|NCT01243762|1129554|P4|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||6
461141|NCT01243762|1129555|P3|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
461142|NCT01243762|1129556|P2|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||8
461143|NCT01243762|1129557|P1|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
461144|NCT01243762|1129551|P7|COMPLETED|Part 1 (Dose Escalation/MTD)||0
461145|NCT01243762|1129552|P6|COMPLETED|Part 1 (Dose Escalation/MTD)||0
461146|NCT01243762|1129553|P5|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|4
461147|NCT01243762|1129554|P4|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|2
461148|NCT01243762|1129555|P3|COMPLETED|Part 1 (Dose Escalation/MTD)||0
461149|NCT01243762|1129556|P2|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|5
461150|NCT01243762|1129557|P1|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|1
461151|NCT01243762|1129551|P7|STARTED|Part 1 (Dose Escalation/MTD)||0
461152|NCT01243762|1129552|P6|STARTED|Part 1 (Dose Escalation/MTD)||3
461153|NCT01243762|1129553|P5|STARTED|Part 1 (Dose Escalation/MTD)||10
461154|NCT01243762|1129554|P4|STARTED|Part 1 (Dose Escalation/MTD)||8
461155|NCT01243762|1129555|P3|STARTED|Part 1 (Dose Escalation/MTD)||3
461156|NCT01243762|1129556|P2|STARTED|Part 1 (Dose Escalation/MTD)||13
461157|NCT01243762|1129557|P1|STARTED|Part 1 (Dose Escalation/MTD)||4
461158|NCT01243671|1129576|P1|NOT COMPLETED|Overall Study||5
461159|NCT01243671|1129576|P1|COMPLETED|Overall Study|Completed 136 weeks of treatment.|15
461160|NCT01243671|1129576|P1|Completed 52 Weeks of Treatment|Overall Study||17
461161|NCT01243671|1129576|P1|Completed 24 Weeks of Treatment|Overall Study||18
461162|NCT01243671|1129576|P1|STARTED|Overall Study||20
461163|NCT01243619|1129589|P1|NOT COMPLETED|Overall Study||0
461164|NCT01243619|1129589|P1|COMPLETED|Overall Study|Patient enrollment is complete, data analysis is ongoing|5
461165|NCT01243619|1129589|P1|STARTED|Overall Study||5
461166|NCT01243580|1129595|P2|NOT COMPLETED|Overall Study||2
461167|NCT01243580|1129596|P1|NOT COMPLETED|Overall Study||0
461168|NCT01243580|1129595|P2|COMPLETED|Overall Study||16
461169|NCT01243580|1129596|P1|COMPLETED|Overall Study||18
461170|NCT01243580|1129595|P2|STARTED|Overall Study||18
461171|NCT01243580|1129596|P1|STARTED|Overall Study||18
461172|NCT01243567|1129625|P2|NOT COMPLETED|Overall Study||0
461173|NCT01243567|1129626|P1|NOT COMPLETED|Overall Study||1
461174|NCT01243567|1129625|P2|COMPLETED|Overall Study||38
461175|NCT01243567|1129626|P1|COMPLETED|Overall Study||42
461176|NCT01243567|1129625|P2|STARTED|Overall Study||38
461177|NCT01243567|1129626|P1|STARTED|Overall Study||43
461178|NCT01243450|1129643|P3|NOT COMPLETED|Overall Study||67
461179|NCT01243450|1129644|P2|NOT COMPLETED|Overall Study||25
461180|NCT01243450|1129645|P1|NOT COMPLETED|Overall Study||83
461181|NCT01243450|1129643|P3|COMPLETED|Overall Study||337
461182|NCT01243450|1129644|P2|COMPLETED|Overall Study||110
461183|NCT01243450|1129645|P1|COMPLETED|Overall Study||318
461184|NCT01243450|1129643|P3|STARTED|Overall Study||404
461185|NCT01243450|1129644|P2|STARTED|Overall Study||135
461186|NCT01243450|1129645|P1|STARTED|Overall Study||401
461187|NCT01243411|1129653|P1|NOT COMPLETED|Overall Study||41
461188|NCT01243411|1129653|P1|COMPLETED|Overall Study||306
461189|NCT01243411|1129653|P1|STARTED|Overall Study||347
461190|NCT01243320|1129665|P1|NOT COMPLETED|32ppm Oral Silver (14 Days)||0
461191|NCT01243320|1129665|P1|COMPLETED|32ppm Oral Silver (14 Days)||24
461192|NCT01243320|1129665|P1|STARTED|32ppm Oral Silver (14 Days)||24
461193|NCT01243320|1129665|P1|NOT COMPLETED|Washout (3 Days)||0
461194|NCT01243320|1129665|P1|COMPLETED|Washout (3 Days)||36
461195|NCT01243320|1129665|P1|STARTED|Washout (3 Days)||36
461196|NCT01243320|1129665|P1|NOT COMPLETED|10ppm Oral Silver (14 Days)||0
461197|NCT01243320|1129665|P1|COMPLETED|10ppm Oral Silver (14 Days)||36
461198|NCT01243320|1129665|P1|STARTED|10ppm Oral Silver (14 Days)||36
461199|NCT01243320|1129665|P1|NOT COMPLETED|10ppm Oral Silver (7 Days)||0
461200|NCT01243320|1129665|P1|COMPLETED|10ppm Oral Silver (7 Days)||36
461201|NCT01243320|1129665|P1|STARTED|10ppm Oral Silver (7 Days)||36
461202|NCT01243320|1129665|P1|NOT COMPLETED|10ppm Oral Silver (3 Days)||0
461203|NCT01243320|1129665|P1|COMPLETED|10ppm Oral Silver (3 Days)||36
461204|NCT01243320|1129665|P1|STARTED|10ppm Oral Silver (3 Days)||36
461205|NCT01243294|1129741|P2|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0
461206|NCT01243294|1129742|P1|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0
461207|NCT01243294|1129741|P2|COMPLETED|Second Intervention (10 Days +/- 2 Days)||26
461208|NCT01243294|1129742|P1|COMPLETED|Second Intervention (10 Days +/- 2 Days)||28
461209|NCT01243294|1129741|P2|STARTED|Second Intervention (10 Days +/- 2 Days)||26
461210|NCT01243294|1129742|P1|STARTED|Second Intervention (10 Days +/- 2 Days)||28
461211|NCT01243294|1129741|P2|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0
461212|NCT01243294|1129742|P1|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0
461213|NCT01243294|1129741|P2|COMPLETED|First Intervention (10 Days +/- 2 Days)||26
461214|NCT01243294|1129742|P1|COMPLETED|First Intervention (10 Days +/- 2 Days)||28
461215|NCT01243294|1129741|P2|STARTED|First Intervention (10 Days +/- 2 Days)||26
461216|NCT01243294|1129742|P1|STARTED|First Intervention (10 Days +/- 2 Days)||28
461217|NCT01243242|1129760|P2|NOT COMPLETED|Overall Study||4
461218|NCT01243242|1129761|P1|NOT COMPLETED|Overall Study||3
461219|NCT01243242|1129760|P2|COMPLETED|Overall Study||56
461220|NCT01243242|1129761|P1|COMPLETED|Overall Study||57
461221|NCT01243242|1129760|P2|STARTED|Overall Study||60
461222|NCT01243242|1129761|P1|STARTED|Overall Study||60
461223|NCT01243177|1129775|P2|NOT COMPLETED|Overall Study||178
461224|NCT01243177|1129776|P1|NOT COMPLETED|Overall Study||178
461225|NCT01243177|1129775|P2|COMPLETED|Overall Study||264
461226|NCT01243177|1129776|P1|COMPLETED|Overall Study||266
461227|NCT01243177|1129775|P2|STARTED|Overall Study||442
461228|NCT01243177|1129776|P1|STARTED|Overall Study||444
461229|NCT01243112|1129792|P1|NOT COMPLETED|Overall Study||0
461230|NCT01243112|1129792|P1|COMPLETED|Overall Study||25
461231|NCT01243112|1129792|P1|STARTED|Overall Study||25
461232|NCT01242813|1129797|P1|NOT COMPLETED|Overall Study||2
461233|NCT01242813|1129797|P1|COMPLETED|Overall Study||18
461234|NCT01242813|1129797|P1|STARTED|Overall Study||20
461235|NCT01242748|1129819|P2|NOT COMPLETED|Overall Study||14
461236|NCT01242748|1129820|P1|NOT COMPLETED|Overall Study||38
461237|NCT01242748|1129819|P2|COMPLETED|Overall Study||80
461238|NCT01242748|1129820|P1|COMPLETED|Overall Study|These participants were ongoing when the trial was closed by the Sponsor.|156
461239|NCT01242748|1129819|P2|CS35/CS35A Full Analysis Set (FAS)|Overall Study||282
461240|NCT01242748|1129820|P1|CS35/CS35A Full Analysis Set (FAS)|Overall Study|Received at least 1 dose of trial drug during CS35+had at least 1 efficacy assessment after dosing.|565
461241|NCT01242748|1129819|P2|CS35/CS35A Safety Analysis Set|Overall Study||283
461242|NCT01242748|1129820|P1|CS35/CS35A Safety Analysis Set|Overall Study|Received at least 1 dose of trial drug during the main CS35 trial.|565
461243|NCT01242748|1129819|P2|STARTED|Overall Study||94
461244|NCT01242748|1129820|P1|STARTED|Overall Study|Enrolled in CS35A, CS35A Full Analysis Set.|194
461245|NCT01242527|1129844|P4|NOT COMPLETED|Overall Study||9
461246|NCT01242527|1129845|P3|NOT COMPLETED|Overall Study||14
461247|NCT01242527|1129846|P2|NOT COMPLETED|Overall Study||7
461248|NCT01242527|1129847|P1|NOT COMPLETED|Overall Study||5
461249|NCT01242527|1129844|P4|COMPLETED|Overall Study||90
461250|NCT01242527|1129845|P3|COMPLETED|Overall Study||87
461251|NCT01242527|1129846|P2|COMPLETED|Overall Study||93
461252|NCT01242527|1129847|P1|COMPLETED|Overall Study||94
461253|NCT01242527|1129844|P4|STARTED|Overall Study||99
461254|NCT01242527|1129845|P3|STARTED|Overall Study||101
461255|NCT01242527|1129846|P2|STARTED|Overall Study||100
461256|NCT01242527|1129847|P1|STARTED|Overall Study||99
461257|NCT01242514|1129860|P3|NOT COMPLETED|Overall Study||212
461258|NCT01242514|1129861|P2|NOT COMPLETED|Overall Study||357
461259|NCT01242514|1129862|P1|NOT COMPLETED|Overall Study||1343
461260|NCT01242514|1129860|P3|COMPLETED|Overall Study|Due to project closure.|0
461261|NCT01242514|1129861|P2|COMPLETED|Overall Study|Due to project closure.|0
461262|NCT01242514|1129862|P1|COMPLETED|Overall Study|Due to project closure.|0
461263|NCT01242514|1129860|P3|Enrolled But Did Not Receive Treatment|Overall Study|Adverse event/other|2
461264|NCT01242514|1129861|P2|Enrolled But Did Not Receive Treatment|Overall Study||0
461265|NCT01242514|1129862|P1|Enrolled But Did Not Receive Treatment|Overall Study|Other|3
461266|NCT01242514|1129860|P3|STARTED|Overall Study|Patients who received treatment|212
461267|NCT01242514|1129861|P2|STARTED|Overall Study|Patients who received treatment|357
461268|NCT01242514|1129862|P1|STARTED|Overall Study|Patients who received treatment|1343
461269|NCT01242371|1129881|P2|NOT COMPLETED|Overall Study||5
461270|NCT01242371|1129882|P1|NOT COMPLETED|Overall Study||2
461271|NCT01242371|1129881|P2|COMPLETED|Overall Study||27
461272|NCT01242371|1129882|P1|COMPLETED|Overall Study||31
461273|NCT01242371|1129881|P2|STARTED|Overall Study||32
461274|NCT01242371|1129882|P1|STARTED|Overall Study||33
461275|NCT01242176|1129888|P2|NOT COMPLETED|Second Intervention||0
461276|NCT01242176|1129889|P1|NOT COMPLETED|Second Intervention||0
461277|NCT01242176|1129888|P2|COMPLETED|Second Intervention||10
461278|NCT01242176|1129889|P1|COMPLETED|Second Intervention||11
461279|NCT01242176|1129888|P2|STARTED|Second Intervention||10
461280|NCT01242176|1129889|P1|STARTED|Second Intervention||11
461281|NCT01242176|1129888|P2|NOT COMPLETED|Washout Period of 7 Days||2
461282|NCT01242176|1129889|P1|NOT COMPLETED|Washout Period of 7 Days||1
461283|NCT01242176|1129888|P2|COMPLETED|Washout Period of 7 Days||10
461284|NCT01242176|1129889|P1|COMPLETED|Washout Period of 7 Days||11
461285|NCT01242176|1129888|P2|STARTED|Washout Period of 7 Days||12
461286|NCT01242176|1129889|P1|STARTED|Washout Period of 7 Days||12
461287|NCT01242176|1129888|P2|NOT COMPLETED|First Intervention||0
461288|NCT01242176|1129889|P1|NOT COMPLETED|First Intervention||0
461289|NCT01242176|1129888|P2|COMPLETED|First Intervention||12
461290|NCT01242176|1129889|P1|COMPLETED|First Intervention||12
461291|NCT01242176|1129888|P2|STARTED|First Intervention||12
461292|NCT01242176|1129889|P1|STARTED|First Intervention||12
461293|NCT01242111|1129899|P1|NOT COMPLETED|Overall Study||3
461294|NCT01242111|1129899|P1|COMPLETED|Overall Study||17
461295|NCT01242111|1129899|P1|STARTED|Overall Study||20
461296|NCT01242085|1129911|P3|NOT COMPLETED|Overall Study||0
461297|NCT01242085|1129912|P2|NOT COMPLETED|Overall Study||7
461298|NCT01242085|1129913|P1|NOT COMPLETED|Overall Study||8
461299|NCT01242085|1129911|P3|COMPLETED|Overall Study||1
461300|NCT01242085|1129912|P2|COMPLETED|Overall Study|7 patients did not receive allocated intervention since 5 had medical problems and 2 withdrew|26
461301|NCT01242085|1129913|P1|COMPLETED|Overall Study|8 patients did not undergo intervention since 4 had medical problems and 4 withdrew|22
461302|NCT01242085|1129911|P3|STARTED|Overall Study||1
461303|NCT01242085|1129912|P2|STARTED|Overall Study||33
461304|NCT01242085|1129913|P1|STARTED|Overall Study||30
461305|NCT01242020|1129923|P2|NOT COMPLETED|Overall Study||0
461306|NCT01242020|1129924|P1|NOT COMPLETED|Overall Study||3
461307|NCT01242020|1129923|P2|COMPLETED|Overall Study||0
461308|NCT01242020|1129924|P1|COMPLETED|Overall Study||3
461309|NCT01242020|1129923|P2|STARTED|Overall Study||0
461310|NCT01242020|1129924|P1|STARTED|Overall Study||6
461311|NCT01241916|1129934|P2|NOT COMPLETED|Overall Study||10
461312|NCT01241916|1129935|P1|NOT COMPLETED|Overall Study||7
461313|NCT01241916|1129934|P2|COMPLETED|Overall Study||21
461314|NCT01241916|1129935|P1|COMPLETED|Overall Study||28
461315|NCT01241916|1129934|P2|STARTED|Overall Study||31
461316|NCT01241916|1129935|P1|STARTED|Overall Study||35
461317|NCT01241903|1129945|P2|NOT COMPLETED|Overall Study||0
461318|NCT01241903|1129946|P1|NOT COMPLETED|Overall Study||1
461319|NCT01241903|1129945|P2|COMPLETED|Overall Study||27
461320|NCT01241903|1129946|P1|COMPLETED|Overall Study||26
461321|NCT01241903|1129945|P2|STARTED|Overall Study||27
461322|NCT01241903|1129946|P1|STARTED|Overall Study||27
461323|NCT01241760|1129954|P2|NOT COMPLETED|Overall Study||40
461324|NCT01241760|1129955|P1|NOT COMPLETED|Overall Study||34
461325|NCT01241760|1129954|P2|COMPLETED|Overall Study||329
461326|NCT01241760|1129955|P1|COMPLETED|Overall Study||337
461327|NCT01241760|1129954|P2|STARTED|Overall Study||369
461328|NCT01241760|1129955|P1|STARTED|Overall Study||371
461329|NCT01241591|1129978|P4|NOT COMPLETED|Overall Study||12
461330|NCT01241591|1129979|P3|NOT COMPLETED|Overall Study||22
461331|NCT01241591|1129980|P2|NOT COMPLETED|Overall Study||24
461332|NCT01241591|1129981|P1|NOT COMPLETED|Overall Study||23
461333|NCT01241591|1129978|P4|COMPLETED|Overall Study||95
461334|NCT01241591|1129979|P3|COMPLETED|Overall Study||313
461335|NCT01241591|1129980|P2|COMPLETED|Overall Study||306
461336|NCT01241591|1129981|P1|COMPLETED|Overall Study||306
461337|NCT01241591|1129978|P4|STARTED|Overall Study||107
461338|NCT01241591|1129979|P3|STARTED|Overall Study||335
461339|NCT01241591|1129980|P2|STARTED|Overall Study||330
461340|NCT01241591|1129981|P1|STARTED|Overall Study||329
461341|NCT01241565|1130171|P1|NOT COMPLETED|Overall Study||0
461342|NCT01241565|1130171|P1|COMPLETED|Overall Study||50
461343|NCT01241565|1130171|P1|STARTED|Overall Study||50
461344|NCT01241552|1130184|P4|NOT COMPLETED|Overall Study||64
461345|NCT01241552|1130185|P3|NOT COMPLETED|Overall Study||60
461346|NCT01241552|1130186|P2|NOT COMPLETED|Overall Study||63
461347|NCT01241552|1130187|P1|NOT COMPLETED|Overall Study||41
461348|NCT01241552|1130184|P4|COMPLETED|Overall Study||340
461349|NCT01241552|1130185|P3|COMPLETED|Overall Study||343
461350|NCT01241552|1130186|P2|COMPLETED|Overall Study||340
461351|NCT01241552|1130187|P1|COMPLETED|Overall Study||201
461352|NCT01241552|1130184|P4|Treated|Overall Study||397
461353|NCT01241552|1130185|P3|Treated|Overall Study||388
461354|NCT01241552|1130186|P2|Treated|Overall Study||392
461355|NCT01241552|1130187|P1|Treated|Overall Study||235
461356|NCT01241552|1130184|P4|STARTED|Overall Study||404
461357|NCT01241552|1130185|P3|STARTED|Overall Study||403
461358|NCT01241552|1130186|P2|STARTED|Overall Study||403
461359|NCT01241552|1130187|P1|STARTED|Overall Study||242
461360|NCT01241539|1130253|P1|NOT COMPLETED|Period 2||0
461361|NCT01241539|1130253|P1|COMPLETED|Period 2||7
461362|NCT01241539|1130253|P1|STARTED|Period 2|After a wash-out phase of at least 6 weeks.|7
461363|NCT01241539|1130253|P1|NOT COMPLETED|Period 1||0
461364|NCT01241539|1130253|P1|COMPLETED|Period 1||7
461365|NCT01241539|1130253|P1|STARTED|Period 1||7
461366|NCT01241513|1130274|P2|NOT COMPLETED|Overall Study||0
461367|NCT01241513|1130275|P1|NOT COMPLETED|Overall Study||0
461368|NCT01241513|1130274|P2|COMPLETED|Overall Study||9
461369|NCT01241513|1130275|P1|COMPLETED|Overall Study|Study has been completed|10
461370|NCT01241513|1130274|P2|STARTED|Overall Study||9
461371|NCT01241513|1130275|P1|STARTED|Overall Study||10
461372|NCT01241448|1130284|P4|NOT COMPLETED|Overall Study||23
461373|NCT01241448|1130285|P3|NOT COMPLETED|Overall Study||23
461374|NCT01241448|1130286|P2|NOT COMPLETED|Overall Study||29
461375|NCT01241448|1130287|P1|NOT COMPLETED|Overall Study||37
461376|NCT01241448|1130284|P4|COMPLETED|Overall Study||43
461377|NCT01241448|1130285|P3|COMPLETED|Overall Study||43
461378|NCT01241448|1130286|P2|COMPLETED|Overall Study||36
461379|NCT01241448|1130287|P1|COMPLETED|Overall Study||29
461380|NCT01241448|1130284|P4|ITT With ≥1 Post-Baseline Measure|Overall Study||62
461381|NCT01241448|1130285|P3|ITT With ≥1 Post-Baseline Measure|Overall Study||64
461382|NCT01241448|1130286|P2|ITT With ≥1 Post-Baseline Measure|Overall Study||61
461383|NCT01241448|1130287|P1|ITT With ≥1 Post-Baseline Measure|Overall Study||61
461384|NCT01241448|1130284|P4|Intent-to-Treat Population (ITT)|Overall Study||64
461385|NCT01241448|1130285|P3|Intent-to-Treat Population (ITT)|Overall Study||64
461386|NCT01241448|1130286|P2|Intent-to-Treat Population (ITT)|Overall Study||63
461387|NCT01241448|1130287|P1|Intent-to-Treat Population (ITT)|Overall Study||63
461388|NCT01241448|1130284|P4|STARTED|Overall Study||66
461389|NCT01241448|1130285|P3|STARTED|Overall Study||66
461390|NCT01241448|1130286|P2|STARTED|Overall Study||65
461391|NCT01241448|1130287|P1|STARTED|Overall Study||66
461392|NCT01241292|1130353|P2|NOT COMPLETED|Overall Study||3
461393|NCT01241292|1130354|P1|NOT COMPLETED|Overall Study||3
461394|NCT01241292|1130353|P2|COMPLETED|Overall Study|completed=treatment on-going|0
461395|NCT01241292|1130354|P1|COMPLETED|Overall Study|completed=treatment on-going|0
461396|NCT01241292|1130353|P2|Entered Treatment Period|Overall Study||3
461397|NCT01241292|1130354|P1|Entered Treatment Period|Overall Study||3
461398|NCT01241292|1130353|P2|STARTED|Overall Study||3
461399|NCT01241292|1130354|P1|STARTED|Overall Study||3
461400|NCT01241279|1130378|P2|NOT COMPLETED|Overall Study||1
461401|NCT01241279|1130379|P1|NOT COMPLETED|Overall Study||0
461402|NCT01241279|1130378|P2|COMPLETED|Overall Study||1
461403|NCT01241279|1130379|P1|COMPLETED|Overall Study||4
461404|NCT01241279|1130378|P2|STARTED|Overall Study||2
461405|NCT01241279|1130379|P1|STARTED|Overall Study||4
461406|NCT01241240|1130389|P2|NOT COMPLETED|Overall Study||9
461407|NCT01241240|1130390|P1|NOT COMPLETED|Overall Study||8
461408|NCT01241240|1130389|P2|COMPLETED|Overall Study||89
461409|NCT01241240|1130390|P1|COMPLETED|Overall Study||86
461410|NCT01241240|1130389|P2|STARTED|Overall Study||98
461411|NCT01241240|1130390|P1|STARTED|Overall Study||94
461412|NCT01240915|1130408|P9|NOT COMPLETED|Overall Study||8
461413|NCT01240915|1130409|P8|NOT COMPLETED|Overall Study||4
461414|NCT01240915|1130410|P7|NOT COMPLETED|Overall Study||8
461415|NCT01240915|1130411|P6|NOT COMPLETED|Overall Study||10
461416|NCT01240915|1130412|P5|NOT COMPLETED|Overall Study||4
461417|NCT01240915|1130413|P4|NOT COMPLETED|Overall Study||3
461418|NCT01240915|1130414|P3|NOT COMPLETED|Overall Study||0
461419|NCT01240915|1130415|P2|NOT COMPLETED|Overall Study||1
461420|NCT01240915|1130416|P1|NOT COMPLETED|Overall Study||2
461421|NCT01240915|1130408|P9|COMPLETED|Overall Study||13
461422|NCT01240915|1130409|P8|COMPLETED|Overall Study||15
461423|NCT01240915|1130410|P7|COMPLETED|Overall Study||17
461424|NCT01240915|1130411|P6|COMPLETED|Overall Study||13
461425|NCT01240915|1130412|P5|COMPLETED|Overall Study||2
461426|NCT01240915|1130413|P4|COMPLETED|Overall Study||1
461427|NCT01240915|1130414|P3|COMPLETED|Overall Study||2
461428|NCT01240915|1130415|P2|COMPLETED|Overall Study||2
461429|NCT01240915|1130416|P1|COMPLETED|Overall Study||0
461430|NCT01240915|1130408|P9|STARTED|Overall Study||21
461431|NCT01240915|1130409|P8|STARTED|Overall Study||19
461432|NCT01240915|1130410|P7|STARTED|Overall Study||25
461433|NCT01240915|1130411|P6|STARTED|Overall Study||23
461434|NCT01240915|1130412|P5|STARTED|Overall Study||6
461435|NCT01240915|1130413|P4|STARTED|Overall Study||4
461436|NCT01240915|1130414|P3|STARTED|Overall Study||2
461437|NCT01240915|1130415|P2|STARTED|Overall Study||3
461438|NCT01240915|1130416|P1|STARTED|Overall Study||2
461439|NCT01240902|1130599|P4|NOT COMPLETED|Overall Study||165
461440|NCT01240902|1130600|P3|NOT COMPLETED|Overall Study||100
461441|NCT01240902|1130601|P2|NOT COMPLETED|Overall Study||79
461442|NCT01240902|1130602|P1|NOT COMPLETED|Overall Study||211
461443|NCT01240902|1130599|P4|COMPLETED|Overall Study||237
461444|NCT01240902|1130600|P3|COMPLETED|Overall Study||295
461445|NCT01240902|1130601|P2|COMPLETED|Overall Study||77
461446|NCT01240902|1130602|P1|COMPLETED|Overall Study||289
461447|NCT01240902|1130599|P4|STARTED|Overall Study||402
461448|NCT01240902|1130600|P3|STARTED|Overall Study||395
461449|NCT01240902|1130601|P2|STARTED|Overall Study||156
461450|NCT01240902|1130602|P1|STARTED|Overall Study||500
461451|NCT01240863|1130690|P3|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||52
461452|NCT01240863|1130691|P2|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||46
461453|NCT01240863|1130692|P1|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||0
461454|NCT01240863|1130690|P3|COMPLETED|Double-blind Treatment Period (12 Weeks)||94
461455|NCT01240863|1130691|P2|COMPLETED|Double-blind Treatment Period (12 Weeks)||102
461456|NCT01240863|1130692|P1|COMPLETED|Double-blind Treatment Period (12 Weeks)||0
461457|NCT01240863|1130690|P3|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||146
461458|NCT01240863|1130691|P2|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||147
461459|NCT01240863|1130692|P1|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||0
461460|NCT01240863|1130690|P3|STARTED|Double-blind Treatment Period (12 Weeks)||146
461461|NCT01240863|1130691|P2|STARTED|Double-blind Treatment Period (12 Weeks)||148
461462|NCT01240863|1130692|P1|STARTED|Double-blind Treatment Period (12 Weeks)||0
461463|NCT01240863|1130690|P3|NOT COMPLETED|Open-label Titration Period||0
461464|NCT01240863|1130691|P2|NOT COMPLETED|Open-label Titration Period||0
461465|NCT01240863|1130692|P1|NOT COMPLETED|Open-label Titration Period||97
461466|NCT01240863|1130690|P3|COMPLETED|Open-label Titration Period||0
461467|NCT01240863|1130691|P2|COMPLETED|Open-label Titration Period||0
461468|NCT01240863|1130692|P1|COMPLETED|Open-label Titration Period||294
461469|NCT01240863|1130690|P3|Safety Analysis Set|Open-label Titration Period||0
461470|NCT01240863|1130691|P2|Safety Analysis Set|Open-label Titration Period||0
461471|NCT01240863|1130692|P1|Safety Analysis Set|Open-label Titration Period||389
461472|NCT01240863|1130690|P3|STARTED|Open-label Titration Period||0
461473|NCT01240863|1130691|P2|STARTED|Open-label Titration Period||0
461474|NCT01240863|1130692|P1|STARTED|Open-label Titration Period||391
461475|NCT01240811|1130754|P3|NOT COMPLETED|Overall Study||1
461476|NCT01240811|1130755|P2|NOT COMPLETED|Overall Study||1
461477|NCT01240811|1130756|P1|NOT COMPLETED|Overall Study||0
461478|NCT01240811|1130754|P3|COMPLETED|Overall Study||16
461479|NCT01240811|1130755|P2|COMPLETED|Overall Study||16
461480|NCT01240811|1130756|P1|COMPLETED|Overall Study||8
461481|NCT01240811|1130754|P3|STARTED|Overall Study||17
461482|NCT01240811|1130755|P2|STARTED|Overall Study||17
461483|NCT01240811|1130756|P1|STARTED|Overall Study||8
461484|NCT01240785|1130772|P2|NOT COMPLETED|Overall Study||3
461485|NCT01240785|1130773|P1|NOT COMPLETED|Overall Study||1
461486|NCT01240785|1130772|P2|COMPLETED|Overall Study||107
461487|NCT01240785|1130773|P1|COMPLETED|Overall Study|110 women completed in the metformin arm and 107 women completed in the insulin arm.|110
461488|NCT01240785|1130772|P2|STARTED|Overall Study||110
461489|NCT01240785|1130773|P1|STARTED|Overall Study||111
461490|NCT01240746|1130804|P3|NOT COMPLETED|Overall Study||243
461491|NCT01240746|1130805|P2|NOT COMPLETED|Overall Study||48
461492|NCT01240746|1130806|P1|NOT COMPLETED|Overall Study||59
461493|NCT01240746|1130804|P3|COMPLETED|Overall Study||2659
461494|NCT01240746|1130805|P2|COMPLETED|Overall Study||677
461495|NCT01240746|1130806|P1|COMPLETED|Overall Study||677
461496|NCT01240746|1130804|P3|STARTED|Overall Study||2902
461497|NCT01240746|1130805|P2|STARTED|Overall Study||725
461498|NCT01240746|1130806|P1|STARTED|Overall Study||736
461499|NCT01240590|1130861|P5|NOT COMPLETED|Phase II||1
461500|NCT01240590|1130862|P4|NOT COMPLETED|Phase II||2
461501|NCT01240590|1130863|P3|NOT COMPLETED|Phase II||0
461502|NCT01240590|1130864|P2|NOT COMPLETED|Phase II||0
461503|NCT01240590|1130865|P1|NOT COMPLETED|Phase II||0
461504|NCT01240590|1130861|P5|COMPLETED|Phase II||0
461505|NCT01240590|1130862|P4|COMPLETED|Phase II||15
461506|NCT01240590|1130863|P3|COMPLETED|Phase II||0
461507|NCT01240590|1130864|P2|COMPLETED|Phase II||0
461508|NCT01240590|1130865|P1|COMPLETED|Phase II||0
461509|NCT01240590|1130861|P5|STARTED|Phase II||1
461510|NCT01240590|1130862|P4|STARTED|Phase II||17
461511|NCT01240590|1130863|P3|STARTED|Phase II||0
461512|NCT01240590|1130864|P2|STARTED|Phase II||0
461513|NCT01240590|1130865|P1|STARTED|Phase II||0
461514|NCT01240590|1130861|P5|NOT COMPLETED|Phase I||0
461515|NCT01240590|1130862|P4|NOT COMPLETED|Phase I||0
461516|NCT01240590|1130863|P3|NOT COMPLETED|Phase I||3
461517|NCT01240590|1130864|P2|NOT COMPLETED|Phase I||0
461518|NCT01240590|1130865|P1|NOT COMPLETED|Phase I||0
461519|NCT01240590|1130861|P5|COMPLETED|Phase I||0
461520|NCT01240590|1130862|P4|COMPLETED|Phase I||0
461521|NCT01240590|1130863|P3|COMPLETED|Phase I||0
461522|NCT01240590|1130864|P2|COMPLETED|Phase I||6
461523|NCT01240590|1130865|P1|COMPLETED|Phase I||0
461524|NCT01240590|1130861|P5|STARTED|Phase I||0
461525|NCT01240590|1130862|P4|STARTED|Phase I||0
461526|NCT01240590|1130863|P3|STARTED|Phase I||3
461527|NCT01240590|1130864|P2|STARTED|Phase I||6
461528|NCT01240590|1130865|P1|STARTED|Phase I||0
461529|NCT01240551|1130893|P2|NOT COMPLETED|Overall Study||3
461530|NCT01240551|1130894|P1|NOT COMPLETED|Overall Study||4
461531|NCT01240551|1130893|P2|COMPLETED|Overall Study||27
461532|NCT01240551|1130894|P1|COMPLETED|Overall Study||26
461533|NCT01240551|1130893|P2|STARTED|Overall Study||30
461534|NCT01240551|1130894|P1|STARTED|Overall Study||30
461535|NCT01240382|1130904|P2|NOT COMPLETED|Overall Study||4
461536|NCT01240382|1130905|P1|NOT COMPLETED|Overall Study||2
461537|NCT01240382|1130904|P2|COMPLETED|Overall Study||139
461538|NCT01240382|1130905|P1|COMPLETED|Overall Study||142
461539|NCT01240382|1130904|P2|STARTED|Overall Study||143
461540|NCT01240382|1130905|P1|STARTED|Overall Study||144
461541|NCT01240356|1130915|P2|NOT COMPLETED|Overall Study||0
461542|NCT01240356|1130916|P1|NOT COMPLETED|Overall Study||3
461543|NCT01240356|1130915|P2|COMPLETED|Overall Study||20
461544|NCT01240356|1130916|P1|COMPLETED|Overall Study||15
461545|NCT01240356|1130915|P2|STARTED|Overall Study||20
461546|NCT01240356|1130916|P1|STARTED|Overall Study||18
461547|NCT01240330|1130927|P1|NOT COMPLETED|Overall Study||0
461548|NCT01240330|1130927|P1|COMPLETED|Overall Study||33
461549|NCT01240330|1130927|P1|STARTED|Overall Study||33
461550|NCT01240200|1130935|P2|NOT COMPLETED|12-week Crossover Phase - Period 2||0
461551|NCT01240200|1130936|P1|NOT COMPLETED|12-week Crossover Phase - Period 2||0
461552|NCT01240200|1130935|P2|COMPLETED|12-week Crossover Phase - Period 2||23
461553|NCT01240200|1130936|P1|COMPLETED|12-week Crossover Phase - Period 2||23
461554|NCT01240200|1130935|P2|STARTED|12-week Crossover Phase - Period 2||23
461555|NCT01240200|1130936|P1|STARTED|12-week Crossover Phase - Period 2||23
461556|NCT01240200|1130935|P2|NOT COMPLETED|12-week Crossover Phase - Period 1||1
461557|NCT01240200|1130936|P1|NOT COMPLETED|12-week Crossover Phase - Period 1||2
461558|NCT01240200|1130935|P2|COMPLETED|12-week Crossover Phase - Period 1||23
461559|NCT01240200|1130936|P1|COMPLETED|12-week Crossover Phase - Period 1||23
461560|NCT01240200|1130935|P2|STARTED|12-week Crossover Phase - Period 1||24
461561|NCT01240200|1130936|P1|STARTED|12-week Crossover Phase - Period 1||25
461562|NCT01240135|1130944|P2|NOT COMPLETED|Period Two, 14 Days of Wear||2
461563|NCT01240135|1130945|P1|NOT COMPLETED|Period Two, 14 Days of Wear||1
461564|NCT01240135|1130944|P2|COMPLETED|Period Two, 14 Days of Wear||43
461565|NCT01240135|1130945|P1|COMPLETED|Period Two, 14 Days of Wear||43
461566|NCT01240135|1130944|P2|STARTED|Period Two, 14 Days of Wear||45
461567|NCT01240135|1130945|P1|STARTED|Period Two, 14 Days of Wear||44
461568|NCT01240135|1130944|P2|NOT COMPLETED|Period One, 14 Days of Wear||0
461569|NCT01240135|1130945|P1|NOT COMPLETED|Period One, 14 Days of Wear||0
461570|NCT01240135|1130944|P2|COMPLETED|Period One, 14 Days of Wear||45
461571|NCT01240135|1130945|P1|COMPLETED|Period One, 14 Days of Wear||44
461572|NCT01240135|1130944|P2|STARTED|Period One, 14 Days of Wear||45
461573|NCT01240135|1130945|P1|STARTED|Period One, 14 Days of Wear||44
461574|NCT01240122|1130953|P1|NOT COMPLETED|Overall Study||0
461575|NCT01240122|1130953|P1|COMPLETED|Overall Study||29
461576|NCT01240122|1130953|P1|STARTED|Overall Study||29
461577|NCT01239992|1130962|P1|NOT COMPLETED|Overall Study||2
461578|NCT01239992|1130962|P1|COMPLETED|Overall Study||10
461579|NCT01239992|1130962|P1|STARTED|Overall Study||12
461580|NCT01239797|1130971|P2|NOT COMPLETED|Treated Participants||274
461581|NCT01239797|1130972|P1|NOT COMPLETED|Treated Participants||235
461582|NCT01239797|1130971|P2|COMPLETED|Treated Participants|Completed = Still on Treatment|43
461583|NCT01239797|1130972|P1|COMPLETED|Treated Participants|Completed = Still on Treatment|83
461584|NCT01239797|1130971|P2|STARTED|Treated Participants|1 participant was randomized to treatment E-Ld but received treatment Ld|317
461585|NCT01239797|1130972|P1|STARTED|Treated Participants|1 participant was randomized to treatment E-Ld but received treatment Ld|318
461586|NCT01239797|1130971|P2|NOT COMPLETED|Randomized Participants||9
461587|NCT01239797|1130972|P1|NOT COMPLETED|Randomized Participants||2
461588|NCT01239797|1130971|P2|COMPLETED|Randomized Participants||316
461589|NCT01239797|1130972|P1|COMPLETED|Randomized Participants||319
461590|NCT01239797|1130971|P2|STARTED|Randomized Participants||325
461591|NCT01239797|1130972|P1|STARTED|Randomized Participants||321
461592|NCT01239745|1130980|P1|NOT COMPLETED|Overall Study||46
461593|NCT01239745|1130980|P1|COMPLETED|Overall Study||0
461594|NCT01239745|1130980|P1|STARTED|Overall Study||46
461595|NCT01239732|1130991|P1|NOT COMPLETED|Overall Study||1021
461596|NCT01239732|1130991|P1|COMPLETED|Overall Study||0
461597|NCT01239732|1130991|P1|STARTED|Overall Study||1021
461598|NCT01239680|1131004|P2|NOT COMPLETED|Overall Study||0
461599|NCT01239680|1131005|P1|NOT COMPLETED|Overall Study||2
461600|NCT01239680|1131004|P2|COMPLETED|Overall Study||2
461601|NCT01239680|1131005|P1|COMPLETED|Overall Study||1
461602|NCT01239680|1131004|P2|STARTED|Overall Study||2
461603|NCT01239680|1131005|P1|STARTED|Overall Study||3
461604|NCT01239511|1131015|P4|NOT COMPLETED|Overall Study||9
461605|NCT01239511|1131016|P3|NOT COMPLETED|Overall Study||4
461606|NCT01239511|1131017|P2|NOT COMPLETED|Overall Study||5
461607|NCT01239511|1131018|P1|NOT COMPLETED|Overall Study||1
461608|NCT01239511|1131015|P4|COMPLETED|Overall Study||38
461609|NCT01239511|1131016|P3|COMPLETED|Overall Study||43
461610|NCT01239511|1131017|P2|COMPLETED|Overall Study||40
461611|NCT01239511|1131018|P1|COMPLETED|Overall Study||46
461612|NCT01239511|1131015|P4|STARTED|Overall Study||47
461613|NCT01239511|1131016|P3|STARTED|Overall Study||47
461614|NCT01239511|1131017|P2|STARTED|Overall Study||45
461615|NCT01239511|1131018|P1|STARTED|Overall Study||47
461616|NCT01239394|1131028|P1|NOT COMPLETED|Overall Study||1
461617|NCT01239394|1131028|P1|COMPLETED|Overall Study||41
461618|NCT01239394|1131028|P1|STARTED|Overall Study||42
461619|NCT01239381|1131035|P1|NOT COMPLETED|Overall Study||2
461620|NCT01239381|1131035|P1|COMPLETED|Overall Study||90
461621|NCT01239381|1131035|P1|STARTED|Overall Study||92
461622|NCT01239355|1131045|P1|NOT COMPLETED|Overall Study||0
461623|NCT01239355|1131045|P1|COMPLETED|Overall Study||15
461624|NCT01239355|1131045|P1|STARTED|Overall Study||15
461625|NCT01239342|1131053|P2|NOT COMPLETED|Overall Study||6
461626|NCT01239342|1131054|P1|NOT COMPLETED|Overall Study||3
461627|NCT01239342|1131053|P2|COMPLETED|Overall Study||8
461628|NCT01239342|1131054|P1|COMPLETED|Overall Study||26
461629|NCT01239342|1131053|P2|STARTED|Overall Study||14
461630|NCT01239342|1131054|P1|STARTED|Overall Study||29
461631|NCT01239316|1131070|P1|NOT COMPLETED|Overall Study||12
461632|NCT01239316|1131070|P1|COMPLETED|Overall Study||0
461633|NCT01239316|1131070|P1|STARTED|Overall Study||12
461634|NCT01239212|1131078|P1|NOT COMPLETED|Overall Study||0
461635|NCT01239212|1131078|P1|COMPLETED|Overall Study||7
461636|NCT01239212|1131078|P1|STARTED|Overall Study||7
461637|NCT01239121|1131085|P3|NOT COMPLETED|Overall Study||0
461638|NCT01239121|1131086|P2|NOT COMPLETED|Overall Study||4
461639|NCT01239121|1131087|P1|NOT COMPLETED|Overall Study||2
461640|NCT01239121|1131085|P3|COMPLETED|Overall Study||15
461641|NCT01239121|1131086|P2|COMPLETED|Overall Study||195
461642|NCT01239121|1131087|P1|COMPLETED|Overall Study||186
461643|NCT01239121|1131085|P3|STARTED|Overall Study||15
461644|NCT01239121|1131086|P2|STARTED|Overall Study||199
461645|NCT01239121|1131087|P1|STARTED|Overall Study||188
461646|NCT01239056|1131101|P1|NOT COMPLETED|Overall Study||0
461647|NCT01239056|1131101|P1|COMPLETED|Overall Study||20
461648|NCT01239056|1131101|P1|STARTED|Overall Study||20
461649|NCT01239043|1131109|P2|NOT COMPLETED|Overall Study||1
461650|NCT01239043|1131110|P1|NOT COMPLETED|Overall Study||2
461651|NCT01239043|1131109|P2|COMPLETED|Overall Study||102
461652|NCT01239043|1131110|P1|COMPLETED|Overall Study||34
461653|NCT01239043|1131109|P2|STARTED|Overall Study||103
461654|NCT01239043|1131110|P1|STARTED|Overall Study|For safety analysis number includes 1 participant randomized to Menactra who received Menomune.|36
461655|NCT01238991|1131138|P10|NOT COMPLETED|Overall Study||2
461656|NCT01238991|1131139|P9|NOT COMPLETED|Overall Study||4
461657|NCT01238991|1131140|P8|NOT COMPLETED|Overall Study||5
461658|NCT01238991|1131141|P7|NOT COMPLETED|Overall Study||8
461659|NCT01238991|1131142|P6|NOT COMPLETED|Overall Study||0
461660|NCT01238991|1131143|P5|NOT COMPLETED|Overall Study||2
461661|NCT01238991|1131144|P4|NOT COMPLETED|Overall Study||2
461662|NCT01238991|1131145|P3|NOT COMPLETED|Overall Study||6
461663|NCT01238991|1131146|P2|NOT COMPLETED|Overall Study||0
461664|NCT01238991|1131147|P1|NOT COMPLETED|Overall Study||2
461665|NCT01238991|1131138|P10|COMPLETED|Overall Study||0
461666|NCT01238991|1131139|P9|COMPLETED|Overall Study||0
461667|NCT01238991|1131140|P8|COMPLETED|Overall Study||0
461668|NCT01238991|1131141|P7|COMPLETED|Overall Study||0
461669|NCT01238991|1131142|P6|COMPLETED|Overall Study||2
461670|NCT01238991|1131143|P5|COMPLETED|Overall Study||3
461671|NCT01238991|1131144|P4|COMPLETED|Overall Study||4
461672|NCT01238991|1131145|P3|COMPLETED|Overall Study||5
461673|NCT01238991|1131146|P2|COMPLETED|Overall Study||3
461674|NCT01238991|1131147|P1|COMPLETED|Overall Study||5
461675|NCT01238991|1131138|P10|Received Treatment|Overall Study||2
461676|NCT01238991|1131139|P9|Received Treatment|Overall Study||4
461677|NCT01238991|1131140|P8|Received Treatment|Overall Study||5
461678|NCT01238991|1131141|P7|Received Treatment|Overall Study||8
461679|NCT01238991|1131142|P6|Received Treatment|Overall Study||2
461680|NCT01238991|1131143|P5|Received Treatment|Overall Study||5
461681|NCT01238991|1131144|P4|Received Treatment|Overall Study||6
461682|NCT01238991|1131145|P3|Received Treatment|Overall Study||11
461683|NCT01238991|1131146|P2|Received Treatment|Overall Study||3
461684|NCT01238991|1131147|P1|Received Treatment|Overall Study||7
461685|NCT01238991|1131138|P10|STARTED|Overall Study||2
461686|NCT01238991|1131139|P9|STARTED|Overall Study||4
461687|NCT01238991|1131140|P8|STARTED|Overall Study||5
461688|NCT01238991|1131141|P7|STARTED|Overall Study||8
461689|NCT01238991|1131142|P6|STARTED|Overall Study||2
461690|NCT01238991|1131143|P5|STARTED|Overall Study||5
461691|NCT01238991|1131144|P4|STARTED|Overall Study||6
461692|NCT01238991|1131145|P3|STARTED|Overall Study||11
461693|NCT01238991|1131146|P2|STARTED|Overall Study||3
461694|NCT01238991|1131147|P1|STARTED|Overall Study||7
461695|NCT01238900|1131234|P1|NOT COMPLETED|<12 Months Post Stent Removal||5
461696|NCT01238900|1131234|P1|COMPLETED|<12 Months Post Stent Removal||18
461697|NCT01238900|1131234|P1|STARTED|<12 Months Post Stent Removal||23
461698|NCT01238900|1131234|P1|NOT COMPLETED|6 Months Post Stent Placement||0
461699|NCT01238900|1131234|P1|COMPLETED|6 Months Post Stent Placement||23
461700|NCT01238900|1131234|P1|STARTED|6 Months Post Stent Placement||23
461701|NCT01238861|1131248|P6|NOT COMPLETED|Overall Study||15
461702|NCT01238861|1131249|P5|NOT COMPLETED|Overall Study||13
461703|NCT01238861|1131250|P4|NOT COMPLETED|Overall Study||13
461704|NCT01238861|1131251|P3|NOT COMPLETED|Overall Study||11
461705|NCT01238861|1131252|P2|NOT COMPLETED|Overall Study||8
461706|NCT01238861|1131253|P1|NOT COMPLETED|Overall Study||11
461707|NCT01238861|1131248|P6|COMPLETED|Overall Study||125
461708|NCT01238861|1131249|P5|COMPLETED|Overall Study||129
461709|NCT01238861|1131250|P4|COMPLETED|Overall Study||69
461710|NCT01238861|1131251|P3|COMPLETED|Overall Study||70
461711|NCT01238861|1131252|P2|COMPLETED|Overall Study||73
461712|NCT01238861|1131253|P1|COMPLETED|Overall Study||69
461713|NCT01238861|1131248|P6|STARTED|Overall Study||140
461714|NCT01238861|1131249|P5|STARTED|Overall Study||142
461715|NCT01238861|1131250|P4|STARTED|Overall Study||82
461716|NCT01238861|1131251|P3|STARTED|Overall Study||81
461717|NCT01238861|1131252|P2|STARTED|Overall Study||81
461718|NCT01238861|1131253|P1|STARTED|Overall Study||80
461719|NCT01238848|1131333|P2|NOT COMPLETED|Overall Study||5
461720|NCT01238848|1131334|P1|NOT COMPLETED|Overall Study||13
461721|NCT01238848|1131333|P2|COMPLETED|Overall Study||45
461722|NCT01238848|1131334|P1|COMPLETED|Overall Study||37
461723|NCT01238848|1131333|P2|STARTED|Overall Study||50
461724|NCT01238848|1131334|P1|STARTED|Overall Study||50
461725|NCT01238822|1131342|P1|NOT COMPLETED|Overall Study||3
461726|NCT01238822|1131342|P1|COMPLETED|Overall Study||93
461727|NCT01238822|1131342|P1|Received High Dosage|Overall Study||93
461728|NCT01238822|1131342|P1|Received Medium Dosage|Overall Study||93
461729|NCT01238822|1131342|P1|Received Low Dosage|Overall Study||93
461730|NCT01238822|1131342|P1|Received Placebo|Overall Study||93
461731|NCT01238822|1131342|P1|STARTED|Overall Study||96
461732|NCT01238640|1131352|P1|NOT COMPLETED|Overall Study||0
461733|NCT01238640|1131352|P1|COMPLETED|Overall Study||84
461734|NCT01238640|1131352|P1|STARTED|Overall Study||84
461735|NCT01238588|1131369|P1|NOT COMPLETED|Overall Study||3
461736|NCT01238588|1131369|P1|COMPLETED|Overall Study||9
461737|NCT01238588|1131369|P1|STARTED|Overall Study||12
461738|NCT01238575|1131382|P2|NOT COMPLETED|Overall Study||4
461739|NCT01238575|1131383|P1|NOT COMPLETED|Overall Study||4
461740|NCT01238575|1131382|P2|COMPLETED|Overall Study||28
461741|NCT01238575|1131383|P1|COMPLETED|Overall Study||26
461742|NCT01238575|1131382|P2|STARTED|Overall Study||32
461743|NCT01238575|1131383|P1|STARTED|Overall Study||30
461744|NCT01238536|1131421|P2|NOT COMPLETED|Overall Study||50
461745|NCT01238536|1131422|P1|NOT COMPLETED|Overall Study||47
461746|NCT01238536|1131421|P2|COMPLETED|Overall Study||150
461747|NCT01238536|1131422|P1|COMPLETED|Overall Study||153
461748|NCT01238536|1131421|P2|STARTED|Overall Study||200
461749|NCT01238536|1131422|P1|STARTED|Overall Study||200
461750|NCT01238471|1131436|P2|NOT COMPLETED|Overall Study||0
461751|NCT01238471|1131437|P1|NOT COMPLETED|Overall Study||0
461752|NCT01238471|1131436|P2|COMPLETED|Overall Study||10
461753|NCT01238471|1131437|P1|COMPLETED|Overall Study||10
461754|NCT01238471|1131436|P2|STARTED|Overall Study||10
461755|NCT01238471|1131437|P1|STARTED|Overall Study||10
461756|NCT01238341|1131443|P1|NOT COMPLETED|Overall Study||0
461757|NCT01238341|1131443|P1|COMPLETED|Overall Study||7
461758|NCT01238341|1131443|P1|STARTED|Overall Study||7
461759|NCT01238211|1131450|P1|NOT COMPLETED|Overall Study||58
461760|NCT01238211|1131450|P1|COMPLETED|Overall Study||3
461761|NCT01238211|1131450|P1|STARTED|Overall Study||61
461762|NCT01237678|1131457|P3|NOT COMPLETED|Phase II||50
461763|NCT01237678|1131458|P2|NOT COMPLETED|Phase II||98
461764|NCT01237678|1131459|P1|NOT COMPLETED|Phase II||0
461765|NCT01237678|1131457|P3|COMPLETED|Phase II||0
461766|NCT01237678|1131458|P2|COMPLETED|Phase II||0
461767|NCT01237678|1131459|P1|COMPLETED|Phase II||0
461768|NCT01237678|1131457|P3|Received Intervention|Phase II||47
461769|NCT01237678|1131458|P2|Received Intervention|Phase II||94
461770|NCT01237678|1131459|P1|Received Intervention|Phase II||0
461771|NCT01237678|1131457|P3|STARTED|Phase II|50 subjects were randomized, 47 subjects treated|50
461772|NCT01237678|1131458|P2|STARTED|Phase II|98 subjects were randomized, 94 subjects treated|98
461773|NCT01237678|1131459|P1|STARTED|Phase II||0
461774|NCT01237678|1131457|P3|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
461775|NCT01237678|1131458|P2|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
461776|NCT01237678|1131459|P1|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||33
461777|NCT01237678|1131457|P3|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
461778|NCT01237678|1131458|P2|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
461779|NCT01237678|1131459|P1|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
461780|NCT01237678|1131457|P3|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||0
461781|NCT01237678|1131458|P2|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||0
461782|NCT01237678|1131459|P1|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||33
461783|NCT01237678|1131457|P3|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||0
461784|NCT01237678|1131458|P2|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||0
461785|NCT01237678|1131459|P1|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||33
461786|NCT01237613|1131478|P1|NOT COMPLETED|Overall Study||0
461787|NCT01237613|1131478|P1|COMPLETED|Overall Study||4
461788|NCT01237613|1131478|P1|STARTED|Overall Study||4
461789|NCT01237353|1131502|P1|NOT COMPLETED|Overall Study||0
461790|NCT01237353|1131502|P1|COMPLETED|Overall Study||6
461791|NCT01237353|1131502|P1|STARTED|Overall Study||6
461792|NCT01237340|1131507|P1|NOT COMPLETED|Overall Study||40
461793|NCT01237340|1131507|P1|COMPLETED|Overall Study||19
461794|NCT01237340|1131507|P1|STARTED|Overall Study||59
461795|NCT01237327|1131521|P2|NOT COMPLETED|Overall Study||40
461796|NCT01237327|1131522|P1|NOT COMPLETED|Overall Study||42
461797|NCT01237327|1131521|P2|COMPLETED|Overall Study|On treatment at Extension Study cut-off date.|1
461798|NCT01237327|1131522|P1|COMPLETED|Overall Study|On treatment at Extension Study cut-off date.|1
461799|NCT01237327|1131521|P2|Continued Treatment in Extension Study|Overall Study||17
461800|NCT01237327|1131522|P1|Continued Treatment in Extension Study|Overall Study||21
461801|NCT01237327|1131521|P2|Completed Treatment in Core Study|Overall Study|Completed 26 weeks of treatment in Core Study; continued in Extension Study for follow-up only.|2
461802|NCT01237327|1131522|P1|Completed Treatment in Core Study|Overall Study|Completed 26 weeks of treatment in Core Study; continued in Extension Study for follow-up only.|3
461803|NCT01237327|1131521|P2|Stopped Treatment in Core Study (D/C)|Overall Study|Continued in Extension Study for follow-up only; not treated with study medication.|24
461804|NCT01237327|1131522|P1|Stopped Treatment in Core Study (D/C)|Overall Study|Continued in Extension Study for follow-up only; not treated with study medication.|22
461805|NCT01237327|1131521|P2|STARTED|Overall Study||41
461806|NCT01237327|1131522|P1|STARTED|Overall Study||43
461807|NCT01237301|1131538|P2|NOT COMPLETED|Overall Study||4
461808|NCT01237301|1131539|P1|NOT COMPLETED|Overall Study||5
461809|NCT01237301|1131538|P2|COMPLETED|Overall Study||55
461810|NCT01237301|1131539|P1|COMPLETED|Overall Study||60
461811|NCT01237301|1131538|P2|STARTED|Overall Study||59
461812|NCT01237301|1131539|P1|STARTED|Overall Study||65
461813|NCT01237223|1131551|P6|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5
461814|NCT01237223|1131552|P5|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||4
461815|NCT01237223|1131553|P4|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5
461816|NCT01237223|1131554|P3|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15
461817|NCT01237223|1131555|P2|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15
461818|NCT01237223|1131556|P1|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||33
461819|NCT01237223|1131551|P6|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||154
461820|NCT01237223|1131552|P5|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||155
461821|NCT01237223|1131553|P4|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||153
461822|NCT01237223|1131554|P3|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||143
461823|NCT01237223|1131555|P2|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||142
461824|NCT01237223|1131556|P1|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||120
461825|NCT01237223|1131551|P6|STARTED|Double Blind (Treatment Period, 8 Weeks)||159
461826|NCT01237223|1131552|P5|STARTED|Double Blind (Treatment Period, 8 Weeks)||159
461827|NCT01237223|1131553|P4|STARTED|Double Blind (Treatment Period, 8 Weeks)||158
461828|NCT01237223|1131554|P3|STARTED|Double Blind (Treatment Period, 8 Weeks)||158
461829|NCT01237223|1131555|P2|STARTED|Double Blind (Treatment Period, 8 Weeks)||157
461830|NCT01237223|1131556|P1|STARTED|Double Blind (Treatment Period, 8 Weeks)||153
461831|NCT01237223|1131551|P6|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
461832|NCT01237223|1131552|P5|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
461833|NCT01237223|1131553|P4|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
461834|NCT01237223|1131554|P3|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
461835|NCT01237223|1131555|P2|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
461836|NCT01237223|1131556|P1|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||398
461837|NCT01237223|1131551|P6|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
461838|NCT01237223|1131552|P5|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
461839|NCT01237223|1131553|P4|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
461840|NCT01237223|1131554|P3|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
461841|NCT01237223|1131555|P2|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
461842|NCT01237223|1131556|P1|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||944
461843|NCT01237223|1131551|P6|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
461844|NCT01237223|1131552|P5|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
461845|NCT01237223|1131553|P4|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
461846|NCT01237223|1131554|P3|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
461847|NCT01237223|1131555|P2|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
461848|NCT01237223|1131556|P1|STARTED|Single Blind(Run-in Period, 4 Weeks)|All the patients enrolled to single blind period received only placebo treatment.|1342
461849|NCT01237197|1131597|P2|NOT COMPLETED|Open Label Period||0
461850|NCT01237197|1131598|P1|NOT COMPLETED|Open Label Period||0
461851|NCT01237197|1131597|P2|COMPLETED|Open Label Period||10
461852|NCT01237197|1131598|P1|COMPLETED|Open Label Period||12
461853|NCT01237197|1131597|P2|STARTED|Open Label Period||10
461854|NCT01237197|1131598|P1|STARTED|Open Label Period||12
461855|NCT01237197|1131597|P2|NOT COMPLETED|Randomization Period||3
461856|NCT01237197|1131598|P1|NOT COMPLETED|Randomization Period||1
461857|NCT01237197|1131597|P2|COMPLETED|Randomization Period||10
461858|NCT01237197|1131598|P1|COMPLETED|Randomization Period||12
461859|NCT01237197|1131597|P2|STARTED|Randomization Period||13
461860|NCT01237197|1131598|P1|STARTED|Randomization Period||13
461861|NCT01237080|1131606|P2|NOT COMPLETED|Overall Study||0
461862|NCT01237080|1131607|P1|NOT COMPLETED|Overall Study||0
461863|NCT01237080|1131606|P2|COMPLETED|Overall Study||50
461864|NCT01237080|1131607|P1|COMPLETED|Overall Study||50
461865|NCT01237080|1131606|P2|STARTED|Overall Study||50
461866|NCT01237080|1131607|P1|STARTED|Overall Study||50
461867|NCT01237054|1131615|P1|NOT COMPLETED|Overall Study||1
461868|NCT01237054|1131615|P1|COMPLETED|Overall Study||30
461869|NCT01237054|1131615|P1|STARTED|Overall Study||31
461870|NCT01236768|1131638|P2|NOT COMPLETED|Overall Study||61
461871|NCT01236768|1131639|P1|NOT COMPLETED|Overall Study||89
461872|NCT01236768|1131638|P2|COMPLETED|Overall Study||145
461873|NCT01236768|1131639|P1|COMPLETED|Overall Study||112
461874|NCT01236768|1131638|P2|STARTED|Overall Study||206
461875|NCT01236768|1131639|P1|STARTED|Overall Study||201
461876|NCT01236742|1131656|P3|NOT COMPLETED|Overall Study||3
461877|NCT01236742|1131657|P2|NOT COMPLETED|Overall Study||3
461878|NCT01236742|1131658|P1|NOT COMPLETED|Overall Study||3
461879|NCT01236742|1131656|P3|COMPLETED|Overall Study||13
461880|NCT01236742|1131657|P2|COMPLETED|Overall Study||16
461881|NCT01236742|1131658|P1|COMPLETED|Overall Study||15
461882|NCT01236742|1131656|P3|STARTED|Overall Study||16
461883|NCT01236742|1131657|P2|STARTED|Overall Study||19
461884|NCT01236742|1131658|P1|STARTED|Overall Study||18
461885|NCT01236573|1131680|P11|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||1
461886|NCT01236573|1131681|P10|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
461887|NCT01236573|1131682|P9|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
461888|NCT01236573|1131683|P8|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
461889|NCT01236573|1131684|P7|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
461890|NCT01236573|1131685|P6|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
461891|NCT01236573|1131686|P5|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
461892|NCT01236573|1131687|P4|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
461893|NCT01236573|1131688|P3|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
461894|NCT01236573|1131689|P2|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
461895|NCT01236573|1131690|P1|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
461896|NCT01236573|1131680|P11|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||5
461897|NCT01236573|1131681|P10|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
461898|NCT01236573|1131682|P9|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
461899|NCT01236573|1131683|P8|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
461900|NCT01236573|1131684|P7|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
461901|NCT01236573|1131685|P6|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
461902|NCT01236573|1131686|P5|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
461903|NCT01236573|1131687|P4|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
461904|NCT01236573|1131688|P3|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
461905|NCT01236573|1131689|P2|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
461906|NCT01236573|1131690|P1|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
461907|NCT01236573|1131680|P11|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||6
461908|NCT01236573|1131681|P10|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
461909|NCT01236573|1131682|P9|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
461910|NCT01236573|1131683|P8|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
461911|NCT01236573|1131684|P7|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
461912|NCT01236573|1131685|P6|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
461913|NCT01236573|1131686|P5|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
461914|NCT01236573|1131687|P4|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
461915|NCT01236573|1131688|P3|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
461916|NCT01236573|1131689|P2|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
461917|NCT01236573|1131690|P1|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
461918|NCT01236573|1131680|P11|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
461919|NCT01236573|1131681|P10|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
461920|NCT01236573|1131682|P9|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
461921|NCT01236573|1131683|P8|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
461922|NCT01236573|1131684|P7|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
461923|NCT01236573|1131685|P6|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
461924|NCT01236573|1131686|P5|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
461925|NCT01236573|1131687|P4|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
461926|NCT01236573|1131688|P3|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
461927|NCT01236573|1131689|P2|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
461928|NCT01236573|1131690|P1|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
461929|NCT01236573|1131680|P11|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
461930|NCT01236573|1131681|P10|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3
461931|NCT01236573|1131682|P9|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
461932|NCT01236573|1131683|P8|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3
461933|NCT01236573|1131684|P7|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
461934|NCT01236573|1131685|P6|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||4
461935|NCT01236573|1131686|P5|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
461936|NCT01236573|1131687|P4|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
461937|NCT01236573|1131688|P3|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
461938|NCT01236573|1131689|P2|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
461939|NCT01236573|1131690|P1|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
461940|NCT01236573|1131680|P11|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
461941|NCT01236573|1131681|P10|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
461942|NCT01236573|1131682|P9|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
461943|NCT01236573|1131683|P8|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3
461944|NCT01236573|1131684|P7|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3
461945|NCT01236573|1131685|P6|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
461946|NCT01236573|1131686|P5|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||1
461947|NCT01236573|1131687|P4|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
461948|NCT01236573|1131688|P3|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
461949|NCT01236573|1131689|P2|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
461950|NCT01236573|1131690|P1|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
461951|NCT01236573|1131680|P11|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
461952|NCT01236573|1131681|P10|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
461953|NCT01236573|1131682|P9|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
461954|NCT01236573|1131683|P8|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
461955|NCT01236573|1131684|P7|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
461956|NCT01236573|1131685|P6|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
461957|NCT01236573|1131686|P5|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
461958|NCT01236573|1131687|P4|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
461959|NCT01236573|1131688|P3|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
461960|NCT01236573|1131689|P2|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
461961|NCT01236573|1131690|P1|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
461962|NCT01236573|1131680|P11|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
461963|NCT01236573|1131681|P10|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
461964|NCT01236573|1131682|P9|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
461965|NCT01236573|1131683|P8|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
461966|NCT01236573|1131684|P7|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
461967|NCT01236573|1131685|P6|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
461968|NCT01236573|1131686|P5|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
461969|NCT01236573|1131687|P4|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
461970|NCT01236573|1131688|P3|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||6
461971|NCT01236573|1131689|P2|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
461972|NCT01236573|1131690|P1|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
461973|NCT01236573|1131680|P11|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
461974|NCT01236573|1131681|P10|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
461975|NCT01236573|1131682|P9|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
461976|NCT01236573|1131683|P8|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
461977|NCT01236573|1131684|P7|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
461978|NCT01236573|1131685|P6|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
461979|NCT01236573|1131686|P5|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
461980|NCT01236573|1131687|P4|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
461981|NCT01236573|1131688|P3|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||6
461982|NCT01236573|1131689|P2|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
461983|NCT01236573|1131690|P1|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
461984|NCT01236534|1131728|P2|NOT COMPLETED|Overall Study||0
461985|NCT01236534|1131729|P1|NOT COMPLETED|Overall Study||3
461986|NCT01236534|1131728|P2|COMPLETED|Overall Study||10
461987|NCT01236534|1131729|P1|COMPLETED|Overall Study|2 subjects stopped treatment due to diarrhea, and 1 stopped treatment due to constipation.|8
461988|NCT01236534|1131728|P2|STARTED|Overall Study||10
461989|NCT01236534|1131729|P1|STARTED|Overall Study||11
461990|NCT01236521|1131739|P2|NOT COMPLETED|Overall Study||25
461991|NCT01236521|1131740|P1|NOT COMPLETED|Overall Study||21
461992|NCT01236521|1131739|P2|COMPLETED|Overall Study||105
461993|NCT01236521|1131740|P1|COMPLETED|Overall Study||110
461994|NCT01236521|1131739|P2|12-moth Completed|Overall Study||105
461995|NCT01236521|1131740|P1|12-moth Completed|Overall Study||110
461996|NCT01236521|1131739|P2|9-month Completed|Overall Study||101
461997|NCT01236521|1131740|P1|9-month Completed|Overall Study||115
461998|NCT01236521|1131739|P2|6-month Completed|Overall Study||116
461999|NCT01236521|1131740|P1|6-month Completed|Overall Study||122
462000|NCT01236521|1131739|P2|3-month Completed|Overall Study||119
462001|NCT01236521|1131740|P1|3-month Completed|Overall Study||122
462002|NCT01236521|1131739|P2|STARTED|Overall Study||130
462003|NCT01236521|1131740|P1|STARTED|Overall Study||131
462004|NCT01236391|1131768|P1|NOT COMPLETED|Overall Study||16
462005|NCT01236391|1131768|P1|COMPLETED|Overall Study|Participants who were on treatment or discontinued treatment due to disease progression or death|95
462006|NCT01236391|1131768|P1|STARTED|Overall Study|Participants who received study treatment|111
462007|NCT01236378|1131776|P1|NOT COMPLETED|Overall Study||0
462008|NCT01236378|1131776|P1|COMPLETED|Overall Study||24
462009|NCT01236378|1131776|P1|STARTED|Overall Study||24
462010|NCT01236365|1131790|P2|NOT COMPLETED|Overall Study||2
462011|NCT01236365|1131791|P1|NOT COMPLETED|Overall Study||2
462012|NCT01236365|1131790|P2|COMPLETED|Overall Study||19
462013|NCT01236365|1131791|P1|COMPLETED|Overall Study||19
462014|NCT01236365|1131790|P2|STARTED|Overall Study||21
462015|NCT01236365|1131791|P1|STARTED|Overall Study||21
462016|NCT01236339|1131805|P2|NOT COMPLETED|Overall Study||13
462017|NCT01236339|1131806|P1|NOT COMPLETED|Overall Study||11
462018|NCT01236339|1131805|P2|COMPLETED|Overall Study||0
462019|NCT01236339|1131806|P1|COMPLETED|Overall Study||2
462020|NCT01236339|1131805|P2|LVP Crossover to TIPS|Overall Study|ONLY patients failing LVP and meeting crossover according to protocol definition|4
462021|NCT01236339|1131806|P1|LVP Crossover to TIPS|Overall Study||0
462022|NCT01236339|1131805|P2|STARTED|Overall Study||13
462023|NCT01236339|1131806|P1|STARTED|Overall Study||13
462024|NCT01236326|1131826|P2|NOT COMPLETED|Overall Study||4
462025|NCT01236326|1131827|P1|NOT COMPLETED|Overall Study||1
462026|NCT01236326|1131826|P2|COMPLETED|Overall Study||51
462027|NCT01236326|1131827|P1|COMPLETED|Overall Study||49
462028|NCT01236326|1131826|P2|STARTED|Overall Study||55
462029|NCT01236326|1131827|P1|STARTED|Overall Study||50
462030|NCT01236300|1131841|P1|NOT COMPLETED|Overall Study||0
462031|NCT01236300|1131841|P1|COMPLETED|Overall Study||66
462032|NCT01236300|1131841|P1|STARTED|Overall Study||66
462033|NCT01236196|1131851|P2|NOT COMPLETED|Overall Study||8
462034|NCT01236196|1131852|P1|NOT COMPLETED|Overall Study||1
462035|NCT01236196|1131851|P2|COMPLETED|Overall Study||13
462036|NCT01236196|1131852|P1|COMPLETED|Overall Study||17
462037|NCT01236196|1131851|P2|STARTED|Overall Study||21
462038|NCT01236196|1131852|P1|STARTED|Overall Study||18
462039|NCT01236170|1131864|P1|NOT COMPLETED|Overall Study||15
462040|NCT01236170|1131864|P1|COMPLETED|Overall Study||482
462041|NCT01236170|1131864|P1|STARTED|Overall Study||497
462042|NCT01236118|1131874|P3|NOT COMPLETED|Overall Study||3
462043|NCT01236118|1131875|P2|NOT COMPLETED|Overall Study||1
462044|NCT01236118|1131876|P1|NOT COMPLETED|Overall Study||2
462045|NCT01236118|1131874|P3|COMPLETED|Overall Study||14
462046|NCT01236118|1131875|P2|COMPLETED|Overall Study||4
462047|NCT01236118|1131876|P1|COMPLETED|Overall Study||4
462048|NCT01236118|1131874|P3|STARTED|Overall Study||17
462049|NCT01236118|1131875|P2|STARTED|Overall Study||5
462050|NCT01236118|1131876|P1|STARTED|Overall Study||6
462051|NCT01236105|1131884|P1|NOT COMPLETED|Overall Study||0
462052|NCT01236105|1131884|P1|COMPLETED|Overall Study||21
462053|NCT01236105|1131884|P1|STARTED|Overall Study||21
462054|NCT01236053|1131920|P22|NOT COMPLETED|Overall Study||0
462055|NCT01236053|1131921|P21|NOT COMPLETED|Overall Study||0
462056|NCT01236053|1131922|P20|NOT COMPLETED|Overall Study||0
462057|NCT01236053|1131923|P19|NOT COMPLETED|Overall Study||0
462058|NCT01236053|1131924|P18|NOT COMPLETED|Overall Study||0
462059|NCT01236053|1131925|P17|NOT COMPLETED|Overall Study||0
462060|NCT01236053|1131926|P16|NOT COMPLETED|Overall Study||0
462061|NCT01236053|1131927|P15|NOT COMPLETED|Overall Study||0
462062|NCT01236053|1131928|P14|NOT COMPLETED|Overall Study||0
462063|NCT01236053|1131929|P13|NOT COMPLETED|Overall Study||0
462064|NCT01236053|1131930|P12|NOT COMPLETED|Overall Study||0
462065|NCT01236053|1131931|P11|NOT COMPLETED|Overall Study||0
462066|NCT01236053|1131932|P10|NOT COMPLETED|Overall Study||0
462067|NCT01236053|1131933|P9|NOT COMPLETED|Overall Study||0
462068|NCT01236053|1131934|P8|NOT COMPLETED|Overall Study||0
462069|NCT01236053|1131935|P7|NOT COMPLETED|Overall Study||0
462070|NCT01236053|1131936|P6|NOT COMPLETED|Overall Study||0
462071|NCT01236053|1131937|P5|NOT COMPLETED|Overall Study||0
462072|NCT01236053|1131938|P4|NOT COMPLETED|Overall Study||0
462073|NCT01236053|1131939|P3|NOT COMPLETED|Overall Study||0
462074|NCT01236053|1131940|P2|NOT COMPLETED|Overall Study||0
462075|NCT01236053|1131941|P1|NOT COMPLETED|Overall Study||0
462076|NCT01236053|1131920|P22|COMPLETED|Overall Study||12167
462077|NCT01236053|1131921|P21|COMPLETED|Overall Study||1272
462078|NCT01236053|1131922|P20|COMPLETED|Overall Study||20382
462079|NCT01236053|1131923|P19|COMPLETED|Overall Study||2155
462080|NCT01236053|1131924|P18|COMPLETED|Overall Study||380
462081|NCT01236053|1131925|P17|COMPLETED|Overall Study||38
462082|NCT01236053|1131926|P16|COMPLETED|Overall Study||43559
462083|NCT01236053|1131927|P15|COMPLETED|Overall Study||4600
462084|NCT01236053|1131928|P14|COMPLETED|Overall Study||1396
462085|NCT01236053|1131929|P13|COMPLETED|Overall Study||148
462086|NCT01236053|1131930|P12|COMPLETED|Overall Study||188924
462087|NCT01236053|1131931|P11|COMPLETED|Overall Study||19564
462088|NCT01236053|1131932|P10|COMPLETED|Overall Study||2935
462089|NCT01236053|1131933|P9|COMPLETED|Overall Study||300
462090|NCT01236053|1131934|P8|COMPLETED|Overall Study||102836
462091|NCT01236053|1131935|P7|COMPLETED|Overall Study||10855
462092|NCT01236053|1131936|P6|COMPLETED|Overall Study||2067
462093|NCT01236053|1131937|P5|COMPLETED|Overall Study||212
462094|NCT01236053|1131938|P4|COMPLETED|Overall Study||17853
462095|NCT01236053|1131939|P3|COMPLETED|Overall Study||1877
462096|NCT01236053|1131940|P2|COMPLETED|Overall Study||1710950
462097|NCT01236053|1131941|P1|COMPLETED|Overall Study||179138
462098|NCT01236053|1131920|P22|STARTED|Overall Study||12167
462099|NCT01236053|1131921|P21|STARTED|Overall Study||1272
462100|NCT01236053|1131922|P20|STARTED|Overall Study||20382
462101|NCT01236053|1131923|P19|STARTED|Overall Study||2155
462102|NCT01236053|1131924|P18|STARTED|Overall Study||380
462103|NCT01236053|1131925|P17|STARTED|Overall Study||38
462104|NCT01236053|1131926|P16|STARTED|Overall Study||43559
462105|NCT01236053|1131927|P15|STARTED|Overall Study||4600
462106|NCT01236053|1131928|P14|STARTED|Overall Study||1396
462107|NCT01236053|1131929|P13|STARTED|Overall Study||148
462108|NCT01236053|1131930|P12|STARTED|Overall Study||188924
462109|NCT01236053|1131931|P11|STARTED|Overall Study||19564
462110|NCT01236053|1131932|P10|STARTED|Overall Study||2935
462111|NCT01236053|1131933|P9|STARTED|Overall Study||300
462112|NCT01236053|1131934|P8|STARTED|Overall Study||102836
462113|NCT01236053|1131935|P7|STARTED|Overall Study||10855
462114|NCT01236053|1131936|P6|STARTED|Overall Study||2067
462115|NCT01236053|1131937|P5|STARTED|Overall Study||212
462116|NCT01236053|1131938|P4|STARTED|Overall Study||17853
462117|NCT01236053|1131939|P3|STARTED|Overall Study||1877
462118|NCT01236053|1131940|P2|STARTED|Overall Study||1710950
462119|NCT01236053|1131941|P1|STARTED|Overall Study||179138
462120|NCT01236001|1132077|P2|NOT COMPLETED|Overall Study||22
462121|NCT01236001|1132078|P1|NOT COMPLETED|Overall Study||18
462122|NCT01236001|1132077|P2|COMPLETED|Overall Study||65
462123|NCT01236001|1132078|P1|COMPLETED|Overall Study||87
462124|NCT01236001|1132077|P2|STARTED|Overall Study||87
462125|NCT01236001|1132078|P1|STARTED|Overall Study||105
462126|NCT01235975|1132110|P2|NOT COMPLETED|Overall Study||7
462127|NCT01235975|1132111|P1|NOT COMPLETED|Overall Study||17
462128|NCT01235975|1132110|P2|COMPLETED|Overall Study||88
462129|NCT01235975|1132111|P1|COMPLETED|Overall Study||257
462130|NCT01235975|1132110|P2|STARTED|Overall Study||95
462131|NCT01235975|1132111|P1|STARTED|Overall Study||274
462132|NCT01235923|1132145|P2|NOT COMPLETED|Overall Study||0
462133|NCT01235923|1132146|P1|NOT COMPLETED|Overall Study||0
462134|NCT01235923|1132145|P2|COMPLETED|Overall Study||10
462135|NCT01235923|1132146|P1|COMPLETED|Overall Study||10
462136|NCT01235923|1132145|P2|STARTED|Overall Study||10
462137|NCT01235923|1132146|P1|STARTED|Overall Study||10
462141|NCT01235897|1132160|P1|NOT COMPLETED|Overall Study||0
462142|NCT01235897|1132160|P1|COMPLETED|Overall Study||16
462143|NCT01235897|1132160|P1|STARTED|Overall Study||16
462144|NCT01235741|1132168|P3|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||7
462145|NCT01235741|1132169|P2|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||9
462146|NCT01235741|1132170|P1|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||0
462147|NCT01235741|1132168|P3|COMPLETED|Follow-Up Post Treatment up to Month 6|7 participants did not complete the 6 month follow up period|29
462148|NCT01235741|1132169|P2|COMPLETED|Follow-Up Post Treatment up to Month 6|9 participants did not complete the 6 month follow up period|27
462149|NCT01235741|1132170|P1|COMPLETED|Follow-Up Post Treatment up to Month 6||0
462150|NCT01235741|1132168|P3|STARTED|Follow-Up Post Treatment up to Month 6|No treatment; those who had been treated with drug (36) were followed up 6 months post treatment.|36
462151|NCT01235741|1132169|P2|STARTED|Follow-Up Post Treatment up to Month 6|No treatment; those who had been treated with placebo (36) were followed up 6 Months post treatment.|36
462152|NCT01235741|1132170|P1|STARTED|Follow-Up Post Treatment up to Month 6||0
462153|NCT01235741|1132168|P3|NOT COMPLETED|Randomized to Treatment||36
462154|NCT01235741|1132169|P2|NOT COMPLETED|Randomized to Treatment||36
462155|NCT01235741|1132170|P1|NOT COMPLETED|Randomized to Treatment||0
462156|NCT01235741|1132168|P3|COMPLETED|Randomized to Treatment|Study terminated by Sponsor. Maximum exposure to study drug was 30 days.|0
462157|NCT01235741|1132169|P2|COMPLETED|Randomized to Treatment|Study terminated by Sponsor. Maximum exposure to study drug was 30 days.|0
462158|NCT01235741|1132170|P1|COMPLETED|Randomized to Treatment||0
462159|NCT01235741|1132168|P3|STARTED|Randomized to Treatment||36
462160|NCT01235741|1132169|P2|STARTED|Randomized to Treatment||36
462161|NCT01235741|1132170|P1|STARTED|Randomized to Treatment||0
462162|NCT01235741|1132168|P3|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
462163|NCT01235741|1132169|P2|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
462164|NCT01235741|1132170|P1|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||141
462165|NCT01235741|1132168|P3|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
462166|NCT01235741|1132169|P2|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
462167|NCT01235741|1132170|P1|COMPLETED|Non-Randomized Low Calorie Diet Lead-In|Study terminated by Sponsor. 72 randomized to treatment at time study halted.|72
462168|NCT01235741|1132168|P3|STARTED|Non-Randomized Low Calorie Diet Lead-In||0
462169|NCT01235741|1132169|P2|STARTED|Non-Randomized Low Calorie Diet Lead-In||0
462170|NCT01235741|1132170|P1|STARTED|Non-Randomized Low Calorie Diet Lead-In|6 Week LCD period. Those who lost >=2% of body weight were randomized to treatment.|213
462171|NCT01235728|1132197|P8|NOT COMPLETED|Overall Study||0
462172|NCT01235728|1132198|P7|NOT COMPLETED|Overall Study||0
462173|NCT01235728|1132199|P6|NOT COMPLETED|Overall Study||0
462174|NCT01235728|1132200|P5|NOT COMPLETED|Overall Study||0
462175|NCT01235728|1132201|P4|NOT COMPLETED|Overall Study||1
462176|NCT01235728|1132202|P3|NOT COMPLETED|Overall Study||0
462177|NCT01235728|1132203|P2|NOT COMPLETED|Overall Study||0
462178|NCT01235728|1132204|P1|NOT COMPLETED|Overall Study||0
462179|NCT01235728|1132197|P8|COMPLETED|Overall Study||3
462180|NCT01235728|1132198|P7|COMPLETED|Overall Study||3
462181|NCT01235728|1132199|P6|COMPLETED|Overall Study||3
462182|NCT01235728|1132200|P5|COMPLETED|Overall Study||3
462183|NCT01235728|1132201|P4|COMPLETED|Overall Study||2
462184|NCT01235728|1132202|P3|COMPLETED|Overall Study||3
462185|NCT01235728|1132203|P2|COMPLETED|Overall Study||3
462186|NCT01235728|1132204|P1|COMPLETED|Overall Study||3
462187|NCT01235728|1132197|P8|STARTED|Overall Study||3
462188|NCT01235728|1132198|P7|STARTED|Overall Study||3
462189|NCT01235728|1132199|P6|STARTED|Overall Study||3
462190|NCT01235728|1132200|P5|STARTED|Overall Study||3
462191|NCT01235728|1132201|P4|STARTED|Overall Study||3
462192|NCT01235728|1132202|P3|STARTED|Overall Study||3
462193|NCT01235728|1132203|P2|STARTED|Overall Study||3
462194|NCT01235728|1132204|P1|STARTED|Overall Study||3
462195|NCT01235715|1132214|P2|NOT COMPLETED|Overall Study||2
462196|NCT01235715|1132215|P1|NOT COMPLETED|Overall Study||0
462197|NCT01235715|1132214|P2|COMPLETED|Overall Study||100
462198|NCT01235715|1132215|P1|COMPLETED|Overall Study||98
462199|NCT01235715|1132214|P2|STARTED|Overall Study||102
462200|NCT01235715|1132215|P1|STARTED|Overall Study||98
462201|NCT01235689|1132255|P2|NOT COMPLETED|Overall Study||32
462202|NCT01235689|1132256|P1|NOT COMPLETED|Overall Study||29
462203|NCT01235689|1132255|P2|COMPLETED|Overall Study||90
462204|NCT01235689|1132256|P1|COMPLETED|Overall Study||93
462205|NCT01235689|1132255|P2|Randomized at Week 9|Overall Study||53
462206|NCT01235689|1132256|P1|Randomized at Week 9|Overall Study||59
462207|NCT01235689|1132255|P2|Early Randomized (Baseline to Week 9)|Overall Study||69
462208|NCT01235689|1132256|P1|Early Randomized (Baseline to Week 9)|Overall Study||63
462209|NCT01235689|1132255|P2|STARTED|Overall Study|Total randomized includes participants who randomized at Week 9 and earlier.|122
462210|NCT01235689|1132256|P1|STARTED|Overall Study|Total randomized includes participants who randomized at Week 9 and earlier.|122
462211|NCT01235598|1132328|P2|NOT COMPLETED|Overall Study||4
462212|NCT01235598|1132329|P1|NOT COMPLETED|Overall Study||1
462213|NCT01235598|1132328|P2|COMPLETED|Overall Study||24
462214|NCT01235598|1132329|P1|COMPLETED|Overall Study||12
462215|NCT01235598|1132328|P2|STARTED|Overall Study|One subject was randomized to the CZP Arm but never received an injection (due to pre-treatment AE)|28
462216|NCT01235598|1132329|P1|STARTED|Overall Study||13
462217|NCT01235546|1132374|P2|NOT COMPLETED|Overall Study||1
462218|NCT01235546|1132375|P1|NOT COMPLETED|Overall Study||2
462219|NCT01235546|1132374|P2|COMPLETED|Overall Study||1018
462220|NCT01235546|1132375|P1|COMPLETED|Overall Study||992
462221|NCT01235546|1132374|P2|STARTED|Overall Study||1019
462222|NCT01235546|1132375|P1|STARTED|Overall Study||994
462223|NCT01235507|1132399|P1|NOT COMPLETED|Overall Study||2
462224|NCT01235507|1132399|P1|COMPLETED|Overall Study||69
462225|NCT01235507|1132399|P1|STARTED|Overall Study||71
462226|NCT01235442|1132413|P2|NOT COMPLETED|Overall Study||44
462227|NCT01235442|1132414|P1|NOT COMPLETED|Overall Study||44
462228|NCT01235442|1132413|P2|COMPLETED|Overall Study||251
462229|NCT01235442|1132414|P1|COMPLETED|Overall Study||253
462230|NCT01235442|1132413|P2|STARTED|Overall Study||295
462231|NCT01235442|1132414|P1|STARTED|Overall Study||297
462232|NCT01235403|1132432|P1|NOT COMPLETED|Overall Study||26
462233|NCT01235403|1132432|P1|COMPLETED|Overall Study||74
462234|NCT01235403|1132432|P1|STARTED|Overall Study||100
462235|NCT01235377|1132440|P2|NOT COMPLETED|Overall Study||1
462236|NCT01235377|1132441|P1|NOT COMPLETED|Overall Study||1
462237|NCT01235377|1132440|P2|COMPLETED|Overall Study||8
462238|NCT01235377|1132441|P1|COMPLETED|Overall Study||10
462239|NCT01235377|1132440|P2|STARTED|Overall Study||9
462240|NCT01235377|1132441|P1|STARTED|Overall Study||11
462241|NCT01235338|1132449|P2|NOT COMPLETED|Overall Study||5
462242|NCT01235338|1132450|P1|NOT COMPLETED|Overall Study||11
462243|NCT01235338|1132449|P2|COMPLETED|Overall Study||33
462244|NCT01235338|1132450|P1|COMPLETED|Overall Study||31
462245|NCT01235338|1132449|P2|STARTED|Overall Study||38
462246|NCT01235338|1132450|P1|STARTED|Overall Study||42
462247|NCT01235234|1132495|P3|NOT COMPLETED|Overall Study||1
462248|NCT01235234|1132496|P2|NOT COMPLETED|Overall Study||2
462249|NCT01235234|1132497|P1|NOT COMPLETED|Overall Study||2
462250|NCT01235234|1132495|P3|COMPLETED|Overall Study||80
462251|NCT01235234|1132496|P2|COMPLETED|Overall Study||76
462252|NCT01235234|1132497|P1|COMPLETED|Overall Study||75
462253|NCT01235234|1132495|P3|STARTED|Overall Study||81
462254|NCT01235234|1132496|P2|STARTED|Overall Study||78
462255|NCT01235234|1132497|P1|STARTED|Overall Study||77
462256|NCT01235195|1132505|P2|NOT COMPLETED|Second Intervention||0
462257|NCT01235195|1132506|P1|NOT COMPLETED|Second Intervention||0
462258|NCT01235195|1132505|P2|COMPLETED|Second Intervention||15
462259|NCT01235195|1132506|P1|COMPLETED|Second Intervention||15
462260|NCT01235195|1132505|P2|STARTED|Second Intervention||15
462261|NCT01235195|1132506|P1|STARTED|Second Intervention||15
462262|NCT01235195|1132505|P2|NOT COMPLETED|Washout Period of At Least 8 Days||0
462263|NCT01235195|1132506|P1|NOT COMPLETED|Washout Period of At Least 8 Days||0
462264|NCT01235195|1132505|P2|COMPLETED|Washout Period of At Least 8 Days||15
462265|NCT01235195|1132506|P1|COMPLETED|Washout Period of At Least 8 Days||15
462266|NCT01235195|1132505|P2|STARTED|Washout Period of At Least 8 Days||15
462267|NCT01235195|1132506|P1|STARTED|Washout Period of At Least 8 Days||15
462268|NCT01235195|1132505|P2|NOT COMPLETED|First Intervention||0
462269|NCT01235195|1132506|P1|NOT COMPLETED|First Intervention||0
462270|NCT01235195|1132505|P2|COMPLETED|First Intervention||15
462271|NCT01235195|1132506|P1|COMPLETED|First Intervention||15
462272|NCT01235195|1132505|P2|STARTED|First Intervention||15
462273|NCT01235195|1132506|P1|STARTED|First Intervention||15
462274|NCT01234922|1132526|P4|NOT COMPLETED|Overall Study||0
462275|NCT01234922|1132527|P3|NOT COMPLETED|Overall Study||0
462276|NCT01234922|1132528|P2|NOT COMPLETED|Overall Study||0
462277|NCT01234922|1132529|P1|NOT COMPLETED|Overall Study||0
462278|NCT01234922|1132526|P4|COMPLETED|Overall Study||2
462279|NCT01234922|1132527|P3|COMPLETED|Overall Study||2
462280|NCT01234922|1132528|P2|COMPLETED|Overall Study||1
462281|NCT01234922|1132529|P1|COMPLETED|Overall Study||1
462282|NCT01234922|1132526|P4|STARTED|Overall Study||2
462283|NCT01234922|1132527|P3|STARTED|Overall Study||2
462284|NCT01234922|1132528|P2|STARTED|Overall Study||1
462285|NCT01234922|1132529|P1|STARTED|Overall Study||1
462286|NCT01234883|1132545|P2|NOT COMPLETED|Overall Study||13
462287|NCT01234883|1132546|P1|NOT COMPLETED|Overall Study||10
462288|NCT01234883|1132545|P2|COMPLETED|Overall Study||36
462289|NCT01234883|1132546|P1|COMPLETED|Overall Study||41
462290|NCT01234883|1132545|P2|STARTED|Overall Study||49
462291|NCT01234883|1132546|P1|STARTED|Overall Study||51
462292|NCT01234870|1132552|P1|NOT COMPLETED|Overall Study||0
462293|NCT01234870|1132552|P1|COMPLETED|Overall Study||40
462294|NCT01234870|1132552|P1|STARTED|Overall Study||40
462295|NCT01234831|1132559|P2|NOT COMPLETED|Overall Study||4
462296|NCT01234831|1132560|P1|NOT COMPLETED|Overall Study||2
462297|NCT01234831|1132559|P2|COMPLETED|Overall Study||198
462298|NCT01234831|1132560|P1|COMPLETED|Overall Study||259
462299|NCT01234831|1132559|P2|STARTED|Overall Study||202
462300|NCT01234831|1132560|P1|STARTED|Overall Study||261
462301|NCT01234766|1132572|P1|NOT COMPLETED|Overall Study||4
462302|NCT01234766|1132572|P1|COMPLETED|Overall Study||35
462303|NCT01234766|1132572|P1|STARTED|Overall Study||39
462304|NCT01234714|1132576|P1|NOT COMPLETED|Overall Study||0
462305|NCT01234714|1132576|P1|COMPLETED|Overall Study||84
462306|NCT01234714|1132576|P1|STARTED|Overall Study||84
462307|NCT01234675|1132593|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
462308|NCT01234675|1132594|P1|NOT COMPLETED|Second Intervention (6 Weeks)||2
462309|NCT01234675|1132593|P2|COMPLETED|Second Intervention (6 Weeks)||8
462310|NCT01234675|1132594|P1|COMPLETED|Second Intervention (6 Weeks)||7
462311|NCT01234675|1132593|P2|STARTED|Second Intervention (6 Weeks)||8
462312|NCT01234675|1132594|P1|STARTED|Second Intervention (6 Weeks)||9
462313|NCT01234675|1132593|P2|NOT COMPLETED|First Intervention (6 Weeks)||1
462314|NCT01234675|1132594|P1|NOT COMPLETED|First Intervention (6 Weeks)||1
462315|NCT01234675|1132593|P2|COMPLETED|First Intervention (6 Weeks)||8
462316|NCT01234675|1132594|P1|COMPLETED|First Intervention (6 Weeks)||9
462317|NCT01234675|1132593|P2|STARTED|First Intervention (6 Weeks)||9
462318|NCT01234675|1132594|P1|STARTED|First Intervention (6 Weeks)||10
462319|NCT01234467|1132608|P1|NOT COMPLETED|Overall Study||12
462320|NCT01234467|1132608|P1|COMPLETED|Overall Study||11
462321|NCT01234467|1132608|P1|STARTED|Overall Study||23
462322|NCT01234337|1132619|P2|NOT COMPLETED|Overall Study||64
462323|NCT01234337|1132620|P1|NOT COMPLETED|Overall Study||97
462324|NCT01234337|1132619|P2|COMPLETED|Overall Study||207
462325|NCT01234337|1132620|P1|COMPLETED|Overall Study||169
462326|NCT01234337|1132619|P2|Participants Received Treatment|Overall Study||267
462327|NCT01234337|1132620|P1|Participants Received Treatment|Overall Study||260
462328|NCT01234337|1132619|P2|STARTED|Overall Study||271
462329|NCT01234337|1132620|P1|STARTED|Overall Study||266
462330|NCT01234207|1132648|P2|NOT COMPLETED|Second Intervention||0
462331|NCT01234207|1132649|P1|NOT COMPLETED|Second Intervention||0
462332|NCT01234207|1132648|P2|COMPLETED|Second Intervention||48
462333|NCT01234207|1132649|P1|COMPLETED|Second Intervention||47
462334|NCT01234207|1132648|P2|STARTED|Second Intervention||48
462335|NCT01234207|1132649|P1|STARTED|Second Intervention||47
462336|NCT01234207|1132648|P2|NOT COMPLETED|1-Week Washout Period||0
462337|NCT01234207|1132649|P1|NOT COMPLETED|1-Week Washout Period||0
462338|NCT01234207|1132648|P2|COMPLETED|1-Week Washout Period||48
462339|NCT01234207|1132649|P1|COMPLETED|1-Week Washout Period||47
462340|NCT01234207|1132648|P2|STARTED|1-Week Washout Period||48
462341|NCT01234207|1132649|P1|STARTED|1-Week Washout Period||47
462342|NCT01234207|1132648|P2|NOT COMPLETED|First Intervention||0
462343|NCT01234207|1132649|P1|NOT COMPLETED|First Intervention||0
462344|NCT01234207|1132648|P2|COMPLETED|First Intervention||48
462345|NCT01234207|1132649|P1|COMPLETED|First Intervention||47
462346|NCT01234207|1132648|P2|STARTED|First Intervention||48
462347|NCT01234207|1132649|P1|STARTED|First Intervention||47
462348|NCT01234103|1132671|P2|NOT COMPLETED|Overall Study||0
462349|NCT01234103|1132672|P1|NOT COMPLETED|Overall Study||0
462350|NCT01234103|1132671|P2|COMPLETED|Overall Study||391
462351|NCT01234103|1132672|P1|COMPLETED|Overall Study||542
462352|NCT01234103|1132671|P2|STARTED|Overall Study||391
462353|NCT01234103|1132672|P1|STARTED|Overall Study||542
462354|NCT01233999|1132680|P1|NOT COMPLETED|Overall Study||2
462355|NCT01233999|1132680|P1|COMPLETED|Overall Study||8
462356|NCT01233999|1132680|P1|STARTED|Overall Study||10
462357|NCT01233921|1132686|P2|NOT COMPLETED|Overall Study||0
462358|NCT01233921|1132687|P1|NOT COMPLETED|Overall Study||0
462359|NCT01233921|1132686|P2|COMPLETED|Overall Study||3
462360|NCT01233921|1132687|P1|COMPLETED|Overall Study||3
462361|NCT01233921|1132686|P2|STARTED|Overall Study||3
462362|NCT01233921|1132687|P1|STARTED|Overall Study||3
462363|NCT01233869|1132699|P4|NOT COMPLETED|Extended Treatment Period (46 Months)||16
462364|NCT01233869|1132700|P3|NOT COMPLETED|Extended Treatment Period (46 Months)||5
462365|NCT01233869|1132701|P2|NOT COMPLETED|Extended Treatment Period (46 Months)||3
462366|NCT01233869|1132702|P1|NOT COMPLETED|Extended Treatment Period (46 Months)||14
462367|NCT01233869|1132699|P4|COMPLETED|Extended Treatment Period (46 Months)||18
462368|NCT01233869|1132700|P3|COMPLETED|Extended Treatment Period (46 Months)||17
462369|NCT01233869|1132701|P2|COMPLETED|Extended Treatment Period (46 Months)||0
462370|NCT01233869|1132702|P1|COMPLETED|Extended Treatment Period (46 Months)||20
462371|NCT01233869|1132699|P4|STARTED|Extended Treatment Period (46 Months)||34
462372|NCT01233869|1132700|P3|STARTED|Extended Treatment Period (46 Months)||22
462373|NCT01233869|1132701|P2|STARTED|Extended Treatment Period (46 Months)||3
462374|NCT01233869|1132702|P1|STARTED|Extended Treatment Period (46 Months)||34
462375|NCT01233869|1132699|P4|NOT COMPLETED|Washout Period 30 Days||0
462376|NCT01233869|1132700|P3|NOT COMPLETED|Washout Period 30 Days||0
462377|NCT01233869|1132701|P2|NOT COMPLETED|Washout Period 30 Days||0
462378|NCT01233869|1132702|P1|NOT COMPLETED|Washout Period 30 Days||0
462379|NCT01233869|1132699|P4|COMPLETED|Washout Period 30 Days||34
462380|NCT01233869|1132700|P3|COMPLETED|Washout Period 30 Days||22
462381|NCT01233869|1132701|P2|COMPLETED|Washout Period 30 Days||3
462382|NCT01233869|1132702|P1|COMPLETED|Washout Period 30 Days||34
462383|NCT01233869|1132699|P4|STARTED|Washout Period 30 Days||34
462384|NCT01233869|1132700|P3|STARTED|Washout Period 30 Days||22
462385|NCT01233869|1132701|P2|STARTED|Washout Period 30 Days||3
462386|NCT01233869|1132702|P1|STARTED|Washout Period 30 Days||34
462387|NCT01233869|1132699|P4|NOT COMPLETED|Initial Treatment Period (24 Months)||22
462388|NCT01233869|1132700|P3|NOT COMPLETED|Initial Treatment Period (24 Months)||2
462389|NCT01233869|1132701|P2|NOT COMPLETED|Initial Treatment Period (24 Months)||28
462390|NCT01233869|1132702|P1|NOT COMPLETED|Initial Treatment Period (24 Months)||24
462391|NCT01233869|1132699|P4|COMPLETED|Initial Treatment Period (24 Months)||34
462392|NCT01233869|1132700|P3|COMPLETED|Initial Treatment Period (24 Months)||22
462393|NCT01233869|1132701|P2|COMPLETED|Initial Treatment Period (24 Months)||3
462394|NCT01233869|1132702|P1|COMPLETED|Initial Treatment Period (24 Months)||34
462395|NCT01233869|1132699|P4|STARTED|Initial Treatment Period (24 Months)||56
462396|NCT01233869|1132700|P3|STARTED|Initial Treatment Period (24 Months)||24
462397|NCT01233869|1132701|P2|STARTED|Initial Treatment Period (24 Months)||31
462398|NCT01233869|1132702|P1|STARTED|Initial Treatment Period (24 Months)||58
462399|NCT01233817|1132788|P1|NOT COMPLETED|Overall Study||3
462400|NCT01233817|1132788|P1|COMPLETED|Overall Study||9
462401|NCT01233817|1132788|P1|STARTED|Overall Study||12
462402|NCT01233726|1132795|P3|NOT COMPLETED|Overall Study||1
462403|NCT01233726|1132796|P2|NOT COMPLETED|Overall Study||0
462404|NCT01233726|1132797|P1|NOT COMPLETED|Overall Study||1
462405|NCT01233726|1132795|P3|COMPLETED|Overall Study||52
462406|NCT01233726|1132796|P2|COMPLETED|Overall Study||53
462407|NCT01233726|1132797|P1|COMPLETED|Overall Study||52
462408|NCT01233726|1132795|P3|STARTED|Overall Study||53
462409|NCT01233726|1132796|P2|STARTED|Overall Study||53
462410|NCT01233726|1132797|P1|STARTED|Overall Study||53
462411|NCT01233687|1132835|P1|NOT COMPLETED|Phase II AMG 102 + Erlotinib||4
462412|NCT01233687|1132835|P1|COMPLETED|Phase II AMG 102 + Erlotinib||45
462413|NCT01233687|1132835|P1|Response-Evaluable|Phase II AMG 102 + Erlotinib||45
462414|NCT01233687|1132835|P1|STARTED|Phase II AMG 102 + Erlotinib|Includes 7 participants from Phase 1 part of study.|49
462415|NCT01233687|1132835|P1|NOT COMPLETED|Phase I RP2D AMG 102 + Erlotinib||0
462416|NCT01233687|1132835|P1|COMPLETED|Phase I RP2D AMG 102 + Erlotinib||7
462417|NCT01233687|1132835|P1|STARTED|Phase I RP2D AMG 102 + Erlotinib||7
462418|NCT01233609|1132845|P2|NOT COMPLETED|Overall Study||2
462419|NCT01233609|1132846|P1|NOT COMPLETED|Overall Study||9
462420|NCT01233609|1132845|P2|COMPLETED|Overall Study||42
462421|NCT01233609|1132846|P1|COMPLETED|Overall Study||37
462422|NCT01233609|1132845|P2|STARTED|Overall Study||44
462423|NCT01233609|1132846|P1|STARTED|Overall Study||46
462424|NCT01233284|1132870|P5|NOT COMPLETED|Period 4 (4 Weeks)||0
462425|NCT01233284|1132871|P4|NOT COMPLETED|Period 4 (4 Weeks)||1
462426|NCT01233284|1132872|P3|NOT COMPLETED|Period 4 (4 Weeks)||0
462427|NCT01233284|1132873|P2|NOT COMPLETED|Period 4 (4 Weeks)||1
462428|NCT01233284|1132874|P1|NOT COMPLETED|Period 4 (4 Weeks)||0
462429|NCT01233284|1132870|P5|COMPLETED|Period 4 (4 Weeks)||1
462430|NCT01233284|1132871|P4|COMPLETED|Period 4 (4 Weeks)||33
462431|NCT01233284|1132872|P3|COMPLETED|Period 4 (4 Weeks)||35
462432|NCT01233284|1132873|P2|COMPLETED|Period 4 (4 Weeks)||36
462433|NCT01233284|1132874|P1|COMPLETED|Period 4 (4 Weeks)||36
462434|NCT01233284|1132870|P5|STARTED|Period 4 (4 Weeks)||1
462435|NCT01233284|1132871|P4|STARTED|Period 4 (4 Weeks)||34
462436|NCT01233284|1132872|P3|STARTED|Period 4 (4 Weeks)||35
462437|NCT01233284|1132873|P2|STARTED|Period 4 (4 Weeks)||37
462438|NCT01233284|1132874|P1|STARTED|Period 4 (4 Weeks)||36
462439|NCT01233284|1132870|P5|NOT COMPLETED|Period 3 (4 Weeks)||0
462440|NCT01233284|1132871|P4|NOT COMPLETED|Period 3 (4 Weeks)||1
462441|NCT01233284|1132872|P3|NOT COMPLETED|Period 3 (4 Weeks)||1
462442|NCT01233284|1132873|P2|NOT COMPLETED|Period 3 (4 Weeks)||0
462443|NCT01233284|1132874|P1|NOT COMPLETED|Period 3 (4 Weeks)||0
462444|NCT01233284|1132870|P5|COMPLETED|Period 3 (4 Weeks)||1
462445|NCT01233284|1132871|P4|COMPLETED|Period 3 (4 Weeks)||34
462446|NCT01233284|1132872|P3|COMPLETED|Period 3 (4 Weeks)||35
462447|NCT01233284|1132873|P2|COMPLETED|Period 3 (4 Weeks)||37
462448|NCT01233284|1132874|P1|COMPLETED|Period 3 (4 Weeks)||36
462449|NCT01233284|1132870|P5|STARTED|Period 3 (4 Weeks)||1
462450|NCT01233284|1132871|P4|STARTED|Period 3 (4 Weeks)||35
462451|NCT01233284|1132872|P3|STARTED|Period 3 (4 Weeks)||36
462452|NCT01233284|1132873|P2|STARTED|Period 3 (4 Weeks)||37
462453|NCT01233284|1132874|P1|STARTED|Period 3 (4 Weeks)||36
462454|NCT01233284|1132870|P5|NOT COMPLETED|Period 2 (4 Weeks)||0
462455|NCT01233284|1132871|P4|NOT COMPLETED|Period 2 (4 Weeks)||0
462456|NCT01233284|1132872|P3|NOT COMPLETED|Period 2 (4 Weeks)||1
462457|NCT01233284|1132873|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
462458|NCT01233284|1132874|P1|NOT COMPLETED|Period 2 (4 Weeks)||0
462459|NCT01233284|1132870|P5|COMPLETED|Period 2 (4 Weeks)||1
462460|NCT01233284|1132871|P4|COMPLETED|Period 2 (4 Weeks)||35
462461|NCT01233284|1132872|P3|COMPLETED|Period 2 (4 Weeks)||36
462462|NCT01233284|1132873|P2|COMPLETED|Period 2 (4 Weeks)||37
462463|NCT01233284|1132874|P1|COMPLETED|Period 2 (4 Weeks)||36
462464|NCT01233284|1132870|P5|STARTED|Period 2 (4 Weeks)||1
462465|NCT01233284|1132871|P4|STARTED|Period 2 (4 Weeks)||35
462466|NCT01233284|1132872|P3|STARTED|Period 2 (4 Weeks)||37
462467|NCT01233284|1132873|P2|STARTED|Period 2 (4 Weeks)||37
462468|NCT01233284|1132874|P1|STARTED|Period 2 (4 Weeks)||36
462469|NCT01233284|1132870|P5|NOT COMPLETED|Period 1 (4 Weeks)||0
462470|NCT01233284|1132871|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
462471|NCT01233284|1132872|P3|NOT COMPLETED|Period 1 (4 Weeks)||1
462472|NCT01233284|1132873|P2|NOT COMPLETED|Period 1 (4 Weeks)||1
462473|NCT01233284|1132874|P1|NOT COMPLETED|Period 1 (4 Weeks)||1
462474|NCT01233284|1132870|P5|COMPLETED|Period 1 (4 Weeks)||1
462475|NCT01233284|1132871|P4|COMPLETED|Period 1 (4 Weeks)||35
462476|NCT01233284|1132872|P3|COMPLETED|Period 1 (4 Weeks)||37
462477|NCT01233284|1132873|P2|COMPLETED|Period 1 (4 Weeks)||37
462478|NCT01233284|1132874|P1|COMPLETED|Period 1 (4 Weeks)||36
462479|NCT01233284|1132870|P5|STARTED|Period 1 (4 Weeks)||1
462480|NCT01233284|1132871|P4|STARTED|Period 1 (4 Weeks)||35
462481|NCT01233284|1132872|P3|STARTED|Period 1 (4 Weeks)||38
462482|NCT01233284|1132873|P2|STARTED|Period 1 (4 Weeks)||38
462483|NCT01233284|1132874|P1|STARTED|Period 1 (4 Weeks)||37
462484|NCT01233258|1132955|P6|NOT COMPLETED|Second Intervention (6 Months)||0
462485|NCT01233258|1132956|P5|NOT COMPLETED|Second Intervention (6 Months)||0
462486|NCT01233258|1132957|P4|NOT COMPLETED|Second Intervention (6 Months)||0
462487|NCT01233258|1132958|P3|NOT COMPLETED|Second Intervention (6 Months)||0
462488|NCT01233258|1132959|P2|NOT COMPLETED|Second Intervention (6 Months)||0
462489|NCT01233258|1132960|P1|NOT COMPLETED|Second Intervention (6 Months)||0
462490|NCT01233258|1132955|P6|COMPLETED|Second Intervention (6 Months)||15
462491|NCT01233258|1132956|P5|COMPLETED|Second Intervention (6 Months)||16
462492|NCT01233258|1132957|P4|COMPLETED|Second Intervention (6 Months)||15
462493|NCT01233258|1132958|P3|COMPLETED|Second Intervention (6 Months)||13
462494|NCT01233258|1132959|P2|COMPLETED|Second Intervention (6 Months)||10
462495|NCT01233258|1132960|P1|COMPLETED|Second Intervention (6 Months)||10
462496|NCT01233258|1132955|P6|STARTED|Second Intervention (6 Months)||15
462497|NCT01233258|1132956|P5|STARTED|Second Intervention (6 Months)||16
462498|NCT01233258|1132957|P4|STARTED|Second Intervention (6 Months)||15
462499|NCT01233258|1132958|P3|STARTED|Second Intervention (6 Months)||13
462500|NCT01233258|1132959|P2|STARTED|Second Intervention (6 Months)||10
462501|NCT01233258|1132960|P1|STARTED|Second Intervention (6 Months)||10
462502|NCT01233258|1132955|P6|NOT COMPLETED|Washout (2-3 Days)||0
462503|NCT01233258|1132956|P5|NOT COMPLETED|Washout (2-3 Days)||0
462504|NCT01233258|1132957|P4|NOT COMPLETED|Washout (2-3 Days)||0
462505|NCT01233258|1132958|P3|NOT COMPLETED|Washout (2-3 Days)||0
462506|NCT01233258|1132959|P2|NOT COMPLETED|Washout (2-3 Days)||0
462507|NCT01233258|1132960|P1|NOT COMPLETED|Washout (2-3 Days)||0
462508|NCT01233258|1132955|P6|COMPLETED|Washout (2-3 Days)||15
462509|NCT01233258|1132956|P5|COMPLETED|Washout (2-3 Days)||16
462510|NCT01233258|1132957|P4|COMPLETED|Washout (2-3 Days)||15
462511|NCT01233258|1132958|P3|COMPLETED|Washout (2-3 Days)||13
462512|NCT01233258|1132959|P2|COMPLETED|Washout (2-3 Days)||10
462513|NCT01233258|1132960|P1|COMPLETED|Washout (2-3 Days)||10
462514|NCT01233258|1132955|P6|STARTED|Washout (2-3 Days)||15
462515|NCT01233258|1132956|P5|STARTED|Washout (2-3 Days)||16
462516|NCT01233258|1132957|P4|STARTED|Washout (2-3 Days)||15
462517|NCT01233258|1132958|P3|STARTED|Washout (2-3 Days)||13
462518|NCT01233258|1132959|P2|STARTED|Washout (2-3 Days)||10
462519|NCT01233258|1132960|P1|STARTED|Washout (2-3 Days)||10
462520|NCT01233258|1132955|P6|NOT COMPLETED|First Intervention (6 Months)||1
462521|NCT01233258|1132956|P5|NOT COMPLETED|First Intervention (6 Months)||0
462522|NCT01233258|1132957|P4|NOT COMPLETED|First Intervention (6 Months)||1
462523|NCT01233258|1132958|P3|NOT COMPLETED|First Intervention (6 Months)||1
462524|NCT01233258|1132959|P2|NOT COMPLETED|First Intervention (6 Months)||0
462525|NCT01233258|1132960|P1|NOT COMPLETED|First Intervention (6 Months)||1
462526|NCT01233258|1132955|P6|COMPLETED|First Intervention (6 Months)||15
462527|NCT01233258|1132956|P5|COMPLETED|First Intervention (6 Months)||16
462528|NCT01233258|1132957|P4|COMPLETED|First Intervention (6 Months)||15
462529|NCT01233258|1132958|P3|COMPLETED|First Intervention (6 Months)||13
462530|NCT01233258|1132959|P2|COMPLETED|First Intervention (6 Months)||10
462531|NCT01233258|1132960|P1|COMPLETED|First Intervention (6 Months)||10
462532|NCT01233258|1132955|P6|Participants Received Treatment|First Intervention (6 Months)||15
462533|NCT01233258|1132956|P5|Participants Received Treatment|First Intervention (6 Months)||16
462534|NCT01233258|1132957|P4|Participants Received Treatment|First Intervention (6 Months)||15
462535|NCT01233258|1132958|P3|Participants Received Treatment|First Intervention (6 Months)||13
462536|NCT01233258|1132959|P2|Participants Received Treatment|First Intervention (6 Months)||10
462537|NCT01233258|1132960|P1|Participants Received Treatment|First Intervention (6 Months)||11
462538|NCT01233258|1132955|P6|STARTED|First Intervention (6 Months)||16
462539|NCT01233258|1132956|P5|STARTED|First Intervention (6 Months)||16
462540|NCT01233258|1132957|P4|STARTED|First Intervention (6 Months)||16
462541|NCT01233258|1132958|P3|STARTED|First Intervention (6 Months)||14
462542|NCT01233258|1132959|P2|STARTED|First Intervention (6 Months)||10
462543|NCT01233258|1132960|P1|STARTED|First Intervention (6 Months)||11
462544|NCT01233232|1132980|P3|NOT COMPLETED|Overall Study||0
462545|NCT01233232|1132981|P2|NOT COMPLETED|Overall Study||0
462546|NCT01233232|1132982|P1|NOT COMPLETED|Overall Study||1
462547|NCT01233232|1132980|P3|COMPLETED|Overall Study||28
462548|NCT01233232|1132981|P2|COMPLETED|Overall Study||30
462549|NCT01233232|1132982|P1|COMPLETED|Overall Study||28
462550|NCT01233232|1132980|P3|STARTED|Overall Study||28
462551|NCT01233232|1132981|P2|STARTED|Overall Study||30
462552|NCT01233232|1132982|P1|STARTED|Overall Study||29
462553|NCT01233076|1133035|P2|NOT COMPLETED|Period 2, One Week||0
462554|NCT01233076|1133036|P1|NOT COMPLETED|Period 2, One Week||1
462555|NCT01233076|1133035|P2|COMPLETED|Period 2, One Week||30
462556|NCT01233076|1133036|P1|COMPLETED|Period 2, One Week||29
462557|NCT01233076|1133035|P2|STARTED|Period 2, One Week||30
462558|NCT01233076|1133036|P1|STARTED|Period 2, One Week||30
462559|NCT01233076|1133035|P2|NOT COMPLETED|Period 1, One Week||0
462560|NCT01233076|1133036|P1|NOT COMPLETED|Period 1, One Week||0
462561|NCT01233076|1133035|P2|COMPLETED|Period 1, One Week||30
462562|NCT01233076|1133036|P1|COMPLETED|Period 1, One Week||30
462563|NCT01233076|1133035|P2|STARTED|Period 1, One Week||30
462564|NCT01233076|1133036|P1|STARTED|Period 1, One Week||30
462565|NCT01233050|1133044|P2|NOT COMPLETED|Overall Study||6
462566|NCT01233050|1133045|P1|NOT COMPLETED|Overall Study||8
462567|NCT01233050|1133044|P2|COMPLETED|Overall Study|6 participants were excluded after treatment administered due to inclusion/exclusion criteria|396
462568|NCT01233050|1133045|P1|COMPLETED|Overall Study|8 participants were excluded after treatment administered due to inclusion/exclusion criteria|392
462569|NCT01233050|1133044|P2|STARTED|Overall Study||402
462570|NCT01233050|1133045|P1|STARTED|Overall Study||400
462571|NCT01232920|1133063|P2|NOT COMPLETED|Overall Study||7
462572|NCT01232920|1133064|P1|NOT COMPLETED|Overall Study||6
462573|NCT01232920|1133063|P2|COMPLETED|Overall Study||32
462574|NCT01232920|1133064|P1|COMPLETED|Overall Study||35
462575|NCT01232920|1133063|P2|STARTED|Overall Study||39
462576|NCT01232920|1133064|P1|STARTED|Overall Study||41
462577|NCT01232894|1133078|P2|NOT COMPLETED|Overall Study||8
462578|NCT01232894|1133079|P1|NOT COMPLETED|Overall Study||12
462579|NCT01232894|1133078|P2|COMPLETED|Overall Study||22
462580|NCT01232894|1133079|P1|COMPLETED|Overall Study||48
462581|NCT01232894|1133078|P2|Received Study Drug|Overall Study||28
462582|NCT01232894|1133079|P1|Received Study Drug|Overall Study||59
462583|NCT01232894|1133078|P2|STARTED|Overall Study||30
462584|NCT01232894|1133079|P1|STARTED|Overall Study||60
462585|NCT01232868|1133087|P2|NOT COMPLETED|Overall Study||4
462586|NCT01232868|1133088|P1|NOT COMPLETED|Overall Study||2
462587|NCT01232868|1133087|P2|COMPLETED|Overall Study||40
462588|NCT01232868|1133088|P1|COMPLETED|Overall Study||20
462589|NCT01232868|1133087|P2|STARTED|Overall Study||44
462590|NCT01232868|1133088|P1|STARTED|Overall Study||22
462591|NCT01232829|1133096|P1|NOT COMPLETED|Overall Study||0
462592|NCT01232829|1133096|P1|COMPLETED|Overall Study||18
462593|NCT01232829|1133096|P1|STARTED|Overall Study||18
462594|NCT01232790|1133102|P2|NOT COMPLETED|Second Crossover||2
462595|NCT01232790|1133103|P1|NOT COMPLETED|Second Crossover||1
462596|NCT01232790|1133102|P2|COMPLETED|Second Crossover||9
462597|NCT01232790|1133103|P1|COMPLETED|Second Crossover||10
462598|NCT01232790|1133102|P2|STARTED|Second Crossover||11
462599|NCT01232790|1133103|P1|STARTED|Second Crossover||11
462600|NCT01232790|1133102|P2|NOT COMPLETED|First Crossover||0
462601|NCT01232790|1133103|P1|NOT COMPLETED|First Crossover||1
462602|NCT01232790|1133102|P2|COMPLETED|First Crossover||11
462603|NCT01232790|1133103|P1|COMPLETED|First Crossover||11
462604|NCT01232790|1133102|P2|STARTED|First Crossover||11
462605|NCT01232790|1133103|P1|STARTED|First Crossover||12
462606|NCT01232790|1133102|P2|NOT COMPLETED|Initial Assessment||1
462607|NCT01232790|1133103|P1|NOT COMPLETED|Initial Assessment||0
462608|NCT01232790|1133102|P2|COMPLETED|Initial Assessment||11
462609|NCT01232790|1133103|P1|COMPLETED|Initial Assessment||12
462610|NCT01232790|1133102|P2|STARTED|Initial Assessment||12
462611|NCT01232790|1133103|P1|STARTED|Initial Assessment||12
462612|NCT01232790|1133102|P2|NOT COMPLETED|Randomization||2
462613|NCT01232790|1133103|P1|NOT COMPLETED|Randomization||2
462614|NCT01232790|1133102|P2|COMPLETED|Randomization||12
462615|NCT01232790|1133103|P1|COMPLETED|Randomization||12
462616|NCT01232790|1133102|P2|STARTED|Randomization||14
462617|NCT01232790|1133103|P1|STARTED|Randomization||14
462618|NCT01232738|1133157|P1|NOT COMPLETED|Overall Study||13
462619|NCT01232738|1133157|P1|COMPLETED|Overall Study||23
462620|NCT01232738|1133157|P1|STARTED|Overall Study||36
462621|NCT01232569|1133173|P4|NOT COMPLETED|Open-label Extension Period||27
462622|NCT01232569|1133174|P3|NOT COMPLETED|Open-label Extension Period||27
462623|NCT01232569|1133175|P2|NOT COMPLETED|Open-label Extension Period||0
462624|NCT01232569|1133176|P1|NOT COMPLETED|Open-label Extension Period||0
462625|NCT01232569|1133173|P4|COMPLETED|Open-label Extension Period||200
462626|NCT01232569|1133174|P3|COMPLETED|Open-label Extension Period||203
462627|NCT01232569|1133175|P2|COMPLETED|Open-label Extension Period||0
462628|NCT01232569|1133176|P1|COMPLETED|Open-label Extension Period||0
462629|NCT01232569|1133173|P4|STARTED|Open-label Extension Period|Some participants who completed the double-blind period did not enter the open-label period.|227
462630|NCT01232569|1133174|P3|STARTED|Open-label Extension Period|Some participants who completed the double-blind period did not enter the open-label period.|230
462631|NCT01232569|1133175|P2|STARTED|Open-label Extension Period|There were no participants in this reporting group in this period.|0
462632|NCT01232569|1133176|P1|STARTED|Open-label Extension Period|There were no participants in this reporting group in this period.|0
462633|NCT01232569|1133173|P4|NOT COMPLETED|Double-blind Treatment Period||0
462634|NCT01232569|1133174|P3|NOT COMPLETED|Double-blind Treatment Period||0
462635|NCT01232569|1133175|P2|NOT COMPLETED|Double-blind Treatment Period||9
462636|NCT01232569|1133176|P1|NOT COMPLETED|Double-blind Treatment Period||28
462637|NCT01232569|1133173|P4|COMPLETED|Double-blind Treatment Period||0
462638|NCT01232569|1133174|P3|COMPLETED|Double-blind Treatment Period||0
462639|NCT01232569|1133175|P2|COMPLETED|Double-blind Treatment Period||209
462640|NCT01232569|1133176|P1|COMPLETED|Double-blind Treatment Period||410
462641|NCT01232569|1133173|P4|STARTED|Double-blind Treatment Period|There were no participants in this reporting group in this period.|0
462642|NCT01232569|1133174|P3|STARTED|Double-blind Treatment Period|There were no participants in this reporting group in this period.|0
462643|NCT01232569|1133175|P2|STARTED|Double-blind Treatment Period||218
462644|NCT01232569|1133176|P1|STARTED|Double-blind Treatment Period||438
462645|NCT01232504|1133220|P3|NOT COMPLETED|Overall Study||8
462646|NCT01232504|1133221|P2|NOT COMPLETED|Overall Study||2
462647|NCT01232504|1133222|P1|NOT COMPLETED|Overall Study||9
462648|NCT01232504|1133220|P3|COMPLETED|Overall Study||61
462649|NCT01232504|1133221|P2|COMPLETED|Overall Study||67
462650|NCT01232504|1133222|P1|COMPLETED|Overall Study||59
462651|NCT01232504|1133220|P3|STARTED|Overall Study||69
462652|NCT01232504|1133221|P2|STARTED|Overall Study||69
462653|NCT01232504|1133222|P1|STARTED|Overall Study||68
462654|NCT01232491|1133256|P2|NOT COMPLETED|Overall Study||63
462655|NCT01232491|1133257|P1|NOT COMPLETED|Overall Study||60
462656|NCT01232491|1133256|P2|COMPLETED|Overall Study||242
462657|NCT01232491|1133257|P1|COMPLETED|Overall Study||246
462658|NCT01232491|1133256|P2|Exposed (Safety Analysis Set)|Overall Study|Four subjects withdrew prior to exposure to trial drug.|301
462659|NCT01232491|1133257|P1|Exposed (Safety Analysis Set)|Overall Study|One subject withdrew prior to exposure to trial drug.|305
462660|NCT01232491|1133256|P2|STARTED|Overall Study||305
462661|NCT01232491|1133257|P1|STARTED|Overall Study||306
462662|NCT01232465|1133277|P2|NOT COMPLETED|Overall Study||0
462663|NCT01232465|1133278|P1|NOT COMPLETED|Overall Study||0
462664|NCT01232465|1133277|P2|COMPLETED|Overall Study||402
462665|NCT01232465|1133278|P1|COMPLETED|Overall Study||337
462666|NCT01232465|1133277|P2|STARTED|Overall Study||402
462667|NCT01232465|1133278|P1|STARTED|Overall Study||337
462668|NCT01232452|1133286|P2|NOT COMPLETED|Overall Study||39
462669|NCT01232452|1133287|P1|NOT COMPLETED|Overall Study||39
462670|NCT01232452|1133286|P2|COMPLETED|Overall Study||46
462671|NCT01232452|1133287|P1|COMPLETED|Overall Study||48
462672|NCT01232452|1133286|P2|Received at Least One Dose of Study Drug|Overall Study||81
462673|NCT01232452|1133287|P1|Received at Least One Dose of Study Drug|Overall Study||85
462674|NCT01232452|1133286|P2|STARTED|Overall Study||85
462675|NCT01232452|1133287|P1|STARTED|Overall Study||87
462676|NCT01232296|1133313|P2|NOT COMPLETED|Overall Study||83
462677|NCT01232296|1133314|P1|NOT COMPLETED|Overall Study||82
462678|NCT01232296|1133313|P2|COMPLETED|Overall Study||0
462679|NCT01232296|1133314|P1|COMPLETED|Overall Study||0
462680|NCT01232296|1133313|P2|Safety Set|Overall Study||83
462681|NCT01232296|1133314|P1|Safety Set|Overall Study|The Safety Set includes all patients who received at least one dose of study medication|79
462682|NCT01232296|1133313|P2|Full Analysis Set|Overall Study||83
462683|NCT01232296|1133314|P1|Full Analysis Set|Overall Study||82
462684|NCT01232296|1133313|P2|STARTED|Overall Study||83
462685|NCT01232296|1133314|P1|STARTED|Overall Study||82
462686|NCT01232283|1133331|P10|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||61
462687|NCT01232283|1133332|P9|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||108
462688|NCT01232283|1133333|P8|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
462689|NCT01232283|1133334|P7|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
462690|NCT01232283|1133335|P6|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
462691|NCT01232283|1133336|P5|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
462692|NCT01232283|1133337|P4|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
462693|NCT01232283|1133338|P3|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
462694|NCT01232283|1133339|P2|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
462695|NCT01232283|1133340|P1|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
462696|NCT01232283|1133331|P10|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||19
462697|NCT01232283|1133332|P9|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||29
462698|NCT01232283|1133333|P8|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
462699|NCT01232283|1133334|P7|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
462700|NCT01232283|1133335|P6|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
462701|NCT01232283|1133336|P5|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
462702|NCT01232283|1133337|P4|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
462703|NCT01232283|1133338|P3|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
462704|NCT01232283|1133339|P2|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
462705|NCT01232283|1133340|P1|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
462706|NCT01232283|1133331|P10|STARTED|Long-Term Extension Phase (Weeks 52-260)||80
462707|NCT01232283|1133332|P9|STARTED|Long-Term Extension Phase (Weeks 52-260)||137
462708|NCT01232283|1133333|P8|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
462709|NCT01232283|1133334|P7|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
462710|NCT01232283|1133335|P6|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
462711|NCT01232283|1133336|P5|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
462712|NCT01232283|1133337|P4|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
462713|NCT01232283|1133338|P3|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
462714|NCT01232283|1133339|P2|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
462715|NCT01232283|1133340|P1|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
462716|NCT01232283|1133331|P10|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
462717|NCT01232283|1133332|P9|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
462718|NCT01232283|1133333|P8|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12
462719|NCT01232283|1133334|P7|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||17
462720|NCT01232283|1133335|P6|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||5
462721|NCT01232283|1133336|P5|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12
462722|NCT01232283|1133337|P4|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
462723|NCT01232283|1133338|P3|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
462724|NCT01232283|1133339|P2|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
462725|NCT01232283|1133340|P1|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
462726|NCT01232283|1133331|P10|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
462727|NCT01232283|1133332|P9|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
462728|NCT01232283|1133333|P8|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||84
462729|NCT01232283|1133334|P7|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||41
462730|NCT01232283|1133335|P6|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||56
462731|NCT01232283|1133336|P5|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||50
462732|NCT01232283|1133337|P4|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
462733|NCT01232283|1133338|P3|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
462734|NCT01232283|1133339|P2|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
462735|NCT01232283|1133340|P1|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
462736|NCT01232283|1133331|P10|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
462737|NCT01232283|1133332|P9|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
462738|NCT01232283|1133333|P8|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||17
462739|NCT01232283|1133334|P7|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||28
462740|NCT01232283|1133335|P6|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
462741|NCT01232283|1133336|P5|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
462742|NCT01232283|1133337|P4|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
462743|NCT01232283|1133338|P3|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
462744|NCT01232283|1133339|P2|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
462745|NCT01232283|1133340|P1|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
462746|NCT01232283|1133331|P10|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
462747|NCT01232283|1133332|P9|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
462748|NCT01232283|1133333|P8|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||96
462749|NCT01232283|1133334|P7|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||58
462750|NCT01232283|1133335|P6|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|13 participants discontinued after Week 32 but prior to entry into the Randomized Withdrawal Phase|61
462751|NCT01232283|1133336|P5|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|4 participants discontinued after Week 32 but prior to entry into the Randomized Withdrawal Phase|62
462752|NCT01232283|1133337|P4|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
462753|NCT01232283|1133338|P3|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
462754|NCT01232283|1133339|P2|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
462755|NCT01232283|1133340|P1|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
462756|NCT01232283|1133331|P10|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
462757|NCT01232283|1133332|P9|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
462758|NCT01232283|1133333|P8|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
462759|NCT01232283|1133334|P7|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
462760|NCT01232283|1133335|P6|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
462761|NCT01232283|1133336|P5|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
462762|NCT01232283|1133337|P4|NOT COMPLETED|Maintenance Phase (Weeks16-32)||8
462763|NCT01232283|1133338|P3|NOT COMPLETED|Maintenance Phase (Weeks16-32)||40
462764|NCT01232283|1133339|P2|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
462765|NCT01232283|1133340|P1|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
462766|NCT01232283|1133331|P10|COMPLETED|Maintenance Phase (Weeks16-32)||0
462767|NCT01232283|1133332|P9|COMPLETED|Maintenance Phase (Weeks16-32)||0
462768|NCT01232283|1133333|P8|COMPLETED|Maintenance Phase (Weeks16-32)||0
462769|NCT01232283|1133334|P7|COMPLETED|Maintenance Phase (Weeks16-32)||0
462770|NCT01232283|1133335|P6|COMPLETED|Maintenance Phase (Weeks16-32)||0
462771|NCT01232283|1133336|P5|COMPLETED|Maintenance Phase (Weeks16-32)||0
462772|NCT01232283|1133337|P4|COMPLETED|Maintenance Phase (Weeks16-32)||100
462773|NCT01232283|1133338|P3|COMPLETED|Maintenance Phase (Weeks16-32)||194
462774|NCT01232283|1133339|P2|COMPLETED|Maintenance Phase (Weeks16-32)||0
462775|NCT01232283|1133340|P1|COMPLETED|Maintenance Phase (Weeks16-32)||0
462776|NCT01232283|1133331|P10|STARTED|Maintenance Phase (Weeks16-32)||0
462777|NCT01232283|1133332|P9|STARTED|Maintenance Phase (Weeks16-32)||0
462778|NCT01232283|1133333|P8|STARTED|Maintenance Phase (Weeks16-32)||0
462779|NCT01232283|1133334|P7|STARTED|Maintenance Phase (Weeks16-32)||0
462780|NCT01232283|1133335|P6|STARTED|Maintenance Phase (Weeks16-32)||0
462781|NCT01232283|1133336|P5|STARTED|Maintenance Phase (Weeks16-32)||0
462782|NCT01232283|1133337|P4|STARTED|Maintenance Phase (Weeks16-32)|4 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|108
462783|NCT01232283|1133338|P3|STARTED|Maintenance Phase (Weeks16-32)|5 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|234
462784|NCT01232283|1133339|P2|STARTED|Maintenance Phase (Weeks16-32)||0
462785|NCT01232283|1133340|P1|STARTED|Maintenance Phase (Weeks16-32)||0
462786|NCT01232283|1133331|P10|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
462787|NCT01232283|1133332|P9|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
462788|NCT01232283|1133333|P8|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
462789|NCT01232283|1133334|P7|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
462790|NCT01232283|1133335|P6|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
462791|NCT01232283|1133336|P5|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
462792|NCT01232283|1133337|P4|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
462793|NCT01232283|1133338|P3|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
462794|NCT01232283|1133339|P2|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||26
462795|NCT01232283|1133340|P1|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||36
462796|NCT01232283|1133331|P10|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
462797|NCT01232283|1133332|P9|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
462798|NCT01232283|1133333|P8|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
462799|NCT01232283|1133334|P7|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
462800|NCT01232283|1133335|P6|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
462801|NCT01232283|1133336|P5|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
462802|NCT01232283|1133337|P4|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
462803|NCT01232283|1133338|P3|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
462804|NCT01232283|1133339|P2|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||112
462805|NCT01232283|1133340|P1|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||239
462806|NCT01232283|1133331|P10|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
462807|NCT01232283|1133332|P9|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
462808|NCT01232283|1133333|P8|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
462809|NCT01232283|1133334|P7|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
462810|NCT01232283|1133335|P6|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
462811|NCT01232283|1133336|P5|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
462812|NCT01232283|1133337|P4|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
462813|NCT01232283|1133338|P3|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
462814|NCT01232283|1133339|P2|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)|1 protocol violation occurred|136
462815|NCT01232283|1133340|P1|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)|1 protocol violation occurred|272
462816|NCT01232283|1133331|P10|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
462817|NCT01232283|1133332|P9|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
462818|NCT01232283|1133333|P8|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
462819|NCT01232283|1133334|P7|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
462820|NCT01232283|1133335|P6|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
462821|NCT01232283|1133336|P5|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
462822|NCT01232283|1133337|P4|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
462823|NCT01232283|1133338|P3|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
462824|NCT01232283|1133339|P2|STARTED|Placebo Controlled Phase (Weeks 0-16)||138
462825|NCT01232283|1133340|P1|STARTED|Placebo Controlled Phase (Weeks 0-16)||275
462826|NCT01232205|1133374|P2|NOT COMPLETED|Overall Study||3
462827|NCT01232205|1133375|P1|NOT COMPLETED|Overall Study||3
462828|NCT01232205|1133374|P2|COMPLETED|Overall Study||55
462829|NCT01232205|1133375|P1|COMPLETED|Overall Study||49
462830|NCT01232205|1133374|P2|STARTED|Overall Study||58
462831|NCT01232205|1133375|P1|STARTED|Overall Study||52
462832|NCT01232127|1133381|P3|NOT COMPLETED|Period 3: Days 18-24||0
462833|NCT01232127|1133382|P2|NOT COMPLETED|Period 3: Days 18-24||0
462834|NCT01232127|1133383|P1|NOT COMPLETED|Period 3: Days 18-24||0
462835|NCT01232127|1133381|P3|COMPLETED|Period 3: Days 18-24||24
462836|NCT01232127|1133382|P2|COMPLETED|Period 3: Days 18-24||0
462837|NCT01232127|1133383|P1|COMPLETED|Period 3: Days 18-24||0
462838|NCT01232127|1133381|P3|STARTED|Period 3: Days 18-24|Participants who received treatment.|24
462839|NCT01232127|1133382|P2|STARTED|Period 3: Days 18-24||0
462840|NCT01232127|1133383|P1|STARTED|Period 3: Days 18-24||0
462841|NCT01232127|1133381|P3|NOT COMPLETED|Period 2: Days 11-17||0
462842|NCT01232127|1133382|P2|NOT COMPLETED|Period 2: Days 11-17||0
462843|NCT01232127|1133383|P1|NOT COMPLETED|Period 2: Days 11-17||0
462844|NCT01232127|1133381|P3|COMPLETED|Period 2: Days 11-17||0
462845|NCT01232127|1133382|P2|COMPLETED|Period 2: Days 11-17||24
462846|NCT01232127|1133383|P1|COMPLETED|Period 2: Days 11-17||0
462847|NCT01232127|1133381|P3|STARTED|Period 2: Days 11-17||0
462848|NCT01232127|1133382|P2|STARTED|Period 2: Days 11-17|Participants who received treatment.|24
462849|NCT01232127|1133383|P1|STARTED|Period 2: Days 11-17||0
462850|NCT01232127|1133381|P3|NOT COMPLETED|Period 1: Days 1-10||0
462851|NCT01232127|1133382|P2|NOT COMPLETED|Period 1: Days 1-10||0
462852|NCT01232127|1133383|P1|NOT COMPLETED|Period 1: Days 1-10||1
462853|NCT01232127|1133381|P3|COMPLETED|Period 1: Days 1-10||0
462854|NCT01232127|1133382|P2|COMPLETED|Period 1: Days 1-10||0
462855|NCT01232127|1133383|P1|COMPLETED|Period 1: Days 1-10||24
462856|NCT01232127|1133381|P3|STARTED|Period 1: Days 1-10||0
462857|NCT01232127|1133382|P2|STARTED|Period 1: Days 1-10||0
462858|NCT01232127|1133383|P1|STARTED|Period 1: Days 1-10|Participants who received treatment.|25
462859|NCT01231984|1133407|P4|NOT COMPLETED|Study Period 2||4
462860|NCT01231984|1133408|P3|NOT COMPLETED|Study Period 2||0
462861|NCT01231984|1133409|P2|NOT COMPLETED|Study Period 2||2
462862|NCT01231984|1133410|P1|NOT COMPLETED|Study Period 2||3
462863|NCT01231984|1133407|P4|COMPLETED|Study Period 2||56
462864|NCT01231984|1133408|P3|COMPLETED|Study Period 2||59
462865|NCT01231984|1133409|P2|COMPLETED|Study Period 2||61
462866|NCT01231984|1133410|P1|COMPLETED|Study Period 2||54
462867|NCT01231984|1133407|P4|STARTED|Study Period 2||60
462868|NCT01231984|1133408|P3|STARTED|Study Period 2||59
462869|NCT01231984|1133409|P2|STARTED|Study Period 2||63
462870|NCT01231984|1133410|P1|STARTED|Study Period 2||57
462871|NCT01231984|1133407|P4|NOT COMPLETED|Study Period 1||9
462872|NCT01231984|1133408|P3|NOT COMPLETED|Study Period 1||7
462873|NCT01231984|1133409|P2|NOT COMPLETED|Study Period 1||7
462874|NCT01231984|1133410|P1|NOT COMPLETED|Study Period 1||12
462875|NCT01231984|1133407|P4|COMPLETED|Study Period 1||60
462876|NCT01231984|1133408|P3|COMPLETED|Study Period 1||59
462877|NCT01231984|1133409|P2|COMPLETED|Study Period 1||63
462878|NCT01231984|1133410|P1|COMPLETED|Study Period 1||57
462879|NCT01231984|1133407|P4|STARTED|Study Period 1||69
462880|NCT01231984|1133408|P3|STARTED|Study Period 1||66
462881|NCT01231984|1133409|P2|STARTED|Study Period 1||70
462882|NCT01231984|1133410|P1|STARTED|Study Period 1||69
462883|NCT01231841|1133431|P1|NOT COMPLETED|Overall Study||0
462884|NCT01231841|1133431|P1|COMPLETED|Overall Study||20
462885|NCT01231841|1133431|P1|STARTED|Overall Study||20
462886|NCT01231750|1133437|P2|NOT COMPLETED|Overall Study||0
462887|NCT01231750|1133438|P1|NOT COMPLETED|Overall Study||0
462888|NCT01231750|1133437|P2|COMPLETED|Overall Study||4
462889|NCT01231750|1133438|P1|COMPLETED|Overall Study||3
462890|NCT01231750|1133437|P2|STARTED|Overall Study||4
462891|NCT01231750|1133438|P1|STARTED|Overall Study||3
462892|NCT01231646|1133456|P2|NOT COMPLETED|Overall Study||0
462893|NCT01231646|1133457|P1|NOT COMPLETED|Overall Study||0
462894|NCT01231646|1133456|P2|COMPLETED|Overall Study||10
462895|NCT01231646|1133457|P1|COMPLETED|Overall Study||28
462896|NCT01231646|1133456|P2|STARTED|Overall Study||10
462897|NCT01231646|1133457|P1|STARTED|Overall Study||28
462898|NCT01231633|1133465|P2|NOT COMPLETED|Overall Study||0
462899|NCT01231633|1133466|P1|NOT COMPLETED|Overall Study||0
462900|NCT01231633|1133465|P2|COMPLETED|Overall Study||13
462901|NCT01231633|1133466|P1|COMPLETED|Overall Study||14
462902|NCT01231633|1133465|P2|STARTED|Overall Study||13
462903|NCT01231633|1133466|P1|STARTED|Overall Study||14
462904|NCT01231620|1133479|P3|NOT COMPLETED|Overall Study||39
462905|NCT01231620|1133480|P2|NOT COMPLETED|Overall Study||31
462906|NCT01231620|1133481|P1|NOT COMPLETED|Overall Study||26
462907|NCT01231620|1133479|P3|COMPLETED|Overall Study||166
462908|NCT01231620|1133480|P2|COMPLETED|Overall Study||178
462909|NCT01231620|1133481|P1|COMPLETED|Overall Study||175
462910|NCT01231620|1133479|P3|STARTED|Overall Study||205
462911|NCT01231620|1133480|P2|STARTED|Overall Study||209
462912|NCT01231620|1133481|P1|STARTED|Overall Study||201
462913|NCT01231607|1133587|P5|NOT COMPLETED|Overall Study||24
462914|NCT01231607|1133588|P4|NOT COMPLETED|Overall Study||38
462915|NCT01231607|1133589|P3|NOT COMPLETED|Overall Study||31
462916|NCT01231607|1133590|P2|NOT COMPLETED|Overall Study||34
462917|NCT01231607|1133591|P1|NOT COMPLETED|Overall Study||29
462918|NCT01231607|1133587|P5|COMPLETED|Overall Study||157
462919|NCT01231607|1133588|P4|COMPLETED|Overall Study||141
462920|NCT01231607|1133589|P3|COMPLETED|Overall Study||153
462921|NCT01231607|1133590|P2|COMPLETED|Overall Study||154
462922|NCT01231607|1133591|P1|COMPLETED|Overall Study||156
462923|NCT01231607|1133587|P5|STARTED|Overall Study||181
462924|NCT01231607|1133588|P4|STARTED|Overall Study||179
462925|NCT01231607|1133589|P3|STARTED|Overall Study||184
462926|NCT01231607|1133590|P2|STARTED|Overall Study||188
462927|NCT01231607|1133591|P1|STARTED|Overall Study||185
462928|NCT01231581|1133683|P2|NOT COMPLETED|Overall Study||80
462929|NCT01231581|1133684|P1|NOT COMPLETED|Overall Study||80
462930|NCT01231581|1133683|P2|COMPLETED|Overall Study||0
462931|NCT01231581|1133684|P1|COMPLETED|Overall Study||0
462932|NCT01231581|1133683|P2|Ongoing|Overall Study||0
462933|NCT01231581|1133684|P1|Ongoing|Overall Study|Participant is continuing treatment with trametinib and gemcitabine under roll over study MEK114375.|1
462934|NCT01231581|1133683|P2|STARTED|Overall Study||80
462935|NCT01231581|1133684|P1|STARTED|Overall Study||80
462936|NCT01231555|1133705|P3|NOT COMPLETED|Overall Study||8
462937|NCT01231555|1133706|P2|NOT COMPLETED|Overall Study||7
462938|NCT01231555|1133707|P1|NOT COMPLETED|Overall Study||8
462939|NCT01231555|1133705|P3|COMPLETED|Overall Study||0
462940|NCT01231555|1133706|P2|COMPLETED|Overall Study||0
462941|NCT01231555|1133707|P1|COMPLETED|Overall Study||0
462942|NCT01231555|1133705|P3|STARTED|Overall Study||8
462943|NCT01231555|1133706|P2|STARTED|Overall Study||7
462944|NCT01231555|1133707|P1|STARTED|Overall Study||8
462945|NCT01231516|1133738|P2|NOT COMPLETED|Open-label Phase||26
462946|NCT01231516|1133739|P1|NOT COMPLETED|Open-label Phase||295
462947|NCT01231516|1133738|P2|COMPLETED|Open-label Phase||1
462948|NCT01231516|1133739|P1|COMPLETED|Open-label Phase||0
462949|NCT01231516|1133738|P2|Ongoing at the Time of Analysis|Open-label Phase||23
462950|NCT01231516|1133739|P1|Ongoing at the Time of Analysis|Open-label Phase||282
462951|NCT01231516|1133738|P2|STARTED|Open-label Phase|256 participants completed the Double-blind Phase but did not enter the Open-label Phase.|27
462952|NCT01231516|1133739|P1|STARTED|Open-label Phase|4 participants completed the Double-blind Phase but did not enter the Open-label Phase.|295
462953|NCT01231516|1133738|P2|NOT COMPLETED|48 Week Double-blind Phase||79
462954|NCT01231516|1133739|P1|NOT COMPLETED|48 Week Double-blind Phase||58
462955|NCT01231516|1133738|P2|COMPLETED|48 Week Double-blind Phase||283
462956|NCT01231516|1133739|P1|COMPLETED|48 Week Double-blind Phase||299
462957|NCT01231516|1133738|P2|STARTED|48 Week Double-blind Phase||362
462958|NCT01231516|1133739|P1|STARTED|48 Week Double-blind Phase||357
462959|NCT01231503|1133769|P8|NOT COMPLETED|Overall Study||8
462960|NCT01231503|1133770|P7|NOT COMPLETED|Overall Study||7
462961|NCT01231503|1133771|P6|NOT COMPLETED|Overall Study||16
462962|NCT01231503|1133772|P5|NOT COMPLETED|Overall Study||10
462963|NCT01231503|1133773|P4|NOT COMPLETED|Overall Study||8
462964|NCT01231503|1133774|P3|NOT COMPLETED|Overall Study||12
462965|NCT01231503|1133775|P2|NOT COMPLETED|Overall Study||13
462966|NCT01231503|1133776|P1|NOT COMPLETED|Overall Study||14
462967|NCT01231503|1133769|P8|COMPLETED|Overall Study||52
462968|NCT01231503|1133770|P7|COMPLETED|Overall Study||53
462969|NCT01231503|1133771|P6|COMPLETED|Overall Study||44
462970|NCT01231503|1133772|P5|COMPLETED|Overall Study||50
462971|NCT01231503|1133773|P4|COMPLETED|Overall Study||52
462972|NCT01231503|1133774|P3|COMPLETED|Overall Study||48
462973|NCT01231503|1133775|P2|COMPLETED|Overall Study||46
462974|NCT01231503|1133776|P1|COMPLETED|Overall Study||46
462975|NCT01231503|1133769|P8|STARTED|Overall Study||60
462976|NCT01231503|1133770|P7|STARTED|Overall Study||60
462977|NCT01231503|1133771|P6|STARTED|Overall Study||60
462978|NCT01231503|1133772|P5|STARTED|Overall Study||60
462979|NCT01231503|1133773|P4|STARTED|Overall Study||60
462980|NCT01231503|1133774|P3|STARTED|Overall Study||60
462981|NCT01231503|1133775|P2|STARTED|Overall Study||59
462982|NCT01231503|1133776|P1|STARTED|Overall Study||60
462983|NCT01231464|1134000|P2|NOT COMPLETED|Overall Study||7
462984|NCT01231464|1134001|P1|NOT COMPLETED|Overall Study||5
462985|NCT01231464|1134000|P2|COMPLETED|Overall Study||176
462986|NCT01231464|1134001|P1|COMPLETED|Overall Study||177
462987|NCT01231464|1134000|P2|STARTED|Overall Study||183
462988|NCT01231464|1134001|P1|STARTED|Overall Study||182
462989|NCT01231412|1134014|P3|NOT COMPLETED|Overall Study||0
462990|NCT01231412|1134015|P2|NOT COMPLETED|Overall Study||1
462991|NCT01231412|1134016|P1|NOT COMPLETED|Overall Study||0
462992|NCT01231412|1134014|P3|COMPLETED|Overall Study||6
462993|NCT01231412|1134015|P2|COMPLETED|Overall Study||90
462994|NCT01231412|1134016|P1|COMPLETED|Overall Study||77
462995|NCT01231412|1134014|P3|STARTED|Overall Study||6
462996|NCT01231412|1134015|P2|STARTED|Overall Study||91
462997|NCT01231412|1134016|P1|STARTED|Overall Study||77
462998|NCT01231399|1134039|P1|NOT COMPLETED|Overall Study||0
462999|NCT01231399|1134039|P1|COMPLETED|Overall Study||6
463000|NCT01231399|1134039|P1|STARTED|Overall Study||6
463001|NCT01231373|1134050|P4|NOT COMPLETED|Overall Study||1
463002|NCT01231373|1134051|P3|NOT COMPLETED|Overall Study||0
463003|NCT01231373|1134052|P2|NOT COMPLETED|Overall Study||1
463004|NCT01231373|1134053|P1|NOT COMPLETED|Overall Study||3
463005|NCT01231373|1134050|P4|COMPLETED|Overall Study||57
463006|NCT01231373|1134051|P3|COMPLETED|Overall Study||60
463007|NCT01231373|1134052|P2|COMPLETED|Overall Study||57
463008|NCT01231373|1134053|P1|COMPLETED|Overall Study||56
463009|NCT01231373|1134050|P4|Patients Receiving Blinded Treatment|Overall Study||58
463010|NCT01231373|1134051|P3|Patients Receiving Blinded Treatment|Overall Study||60
463011|NCT01231373|1134052|P2|Patients Receiving Blinded Treatment|Overall Study||57
463012|NCT01231373|1134053|P1|Patients Receiving Blinded Treatment|Overall Study||57
463013|NCT01231373|1134050|P4|STARTED|Overall Study||58
463014|NCT01231373|1134051|P3|STARTED|Overall Study||60
463015|NCT01231373|1134052|P2|STARTED|Overall Study||58
463016|NCT01231373|1134053|P1|STARTED|Overall Study||59
463017|NCT01231334|1134073|P2|NOT COMPLETED|Overall Study||21
463018|NCT01231334|1134074|P1|NOT COMPLETED|Overall Study||19
463019|NCT01231334|1134073|P2|COMPLETED|Overall Study||120
463020|NCT01231334|1134074|P1|COMPLETED|Overall Study||126
463021|NCT01231334|1134073|P2|STARTED|Overall Study||141
463022|NCT01231334|1134074|P1|STARTED|Overall Study||145
463023|NCT01231321|1134092|P1|NOT COMPLETED|Overall Study||5
463024|NCT01231321|1134092|P1|COMPLETED|Overall Study||95
463025|NCT01231321|1134092|P1|STARTED|Overall Study||100
463026|NCT01231230|1134103|P1|NOT COMPLETED|Overall Study||0
463027|NCT01231230|1134103|P1|COMPLETED|Overall Study||14
463028|NCT01231230|1134103|P1|Placebo|Overall Study||14
463029|NCT01231230|1134103|P1|Fluticasone/Salmeterol|Overall Study||14
463030|NCT01231230|1134103|P1|Salmeterol|Overall Study||14
463031|NCT01231230|1134103|P1|Fluticasone|Overall Study||14
463032|NCT01231230|1134103|P1|STARTED|Overall Study||14
463033|NCT01230892|1134115|P2|NOT COMPLETED|Overall Study||1
463034|NCT01230892|1134116|P1|NOT COMPLETED|Overall Study||3
463035|NCT01230892|1134115|P2|COMPLETED|Overall Study||13
463036|NCT01230892|1134116|P1|COMPLETED|Overall Study||12
463037|NCT01230892|1134115|P2|STARTED|Overall Study||14
463038|NCT01230892|1134116|P1|STARTED|Overall Study||15
463039|NCT01230827|1134126|P4|NOT COMPLETED|Overall Study||78
463040|NCT01230827|1134127|P3|NOT COMPLETED|Overall Study||65
463041|NCT01230827|1134128|P2|NOT COMPLETED|Overall Study||11
463042|NCT01230827|1134129|P1|NOT COMPLETED|Overall Study||19
463043|NCT01230827|1134126|P4|COMPLETED|Overall Study||0
463044|NCT01230827|1134127|P3|COMPLETED|Overall Study||0
463045|NCT01230827|1134128|P2|COMPLETED|Overall Study||0
463046|NCT01230827|1134129|P1|COMPLETED|Overall Study||0
463047|NCT01230827|1134126|P4|STARTED|Overall Study||78
463048|NCT01230827|1134127|P3|STARTED|Overall Study||65
463049|NCT01230827|1134128|P2|STARTED|Overall Study||11
463050|NCT01230827|1134129|P1|STARTED|Overall Study||19
463051|NCT01230814|1134145|P2|NOT COMPLETED|Overall Study||4
463052|NCT01230814|1134146|P1|NOT COMPLETED|Overall Study||13
463053|NCT01230814|1134145|P2|COMPLETED|Overall Study||112
463054|NCT01230814|1134146|P1|COMPLETED|Overall Study||105
463055|NCT01230814|1134145|P2|STARTED|Overall Study||116
463056|NCT01230814|1134146|P1|STARTED|Overall Study||118
463057|NCT01230801|1134161|P3|NOT COMPLETED|Overall Study||1
463058|NCT01230801|1134162|P2|NOT COMPLETED|Overall Study||0
463059|NCT01230801|1134163|P1|NOT COMPLETED|Overall Study||0
463060|NCT01230801|1134161|P3|COMPLETED|Overall Study||15
463061|NCT01230801|1134162|P2|COMPLETED|Overall Study||3
463062|NCT01230801|1134163|P1|COMPLETED|Overall Study||3
463063|NCT01230801|1134161|P3|STARTED|Overall Study||16
463064|NCT01230801|1134162|P2|STARTED|Overall Study||3
463065|NCT01230801|1134163|P1|STARTED|Overall Study||3
463066|NCT01230788|1134196|P1|NOT COMPLETED|Overall Study||1
463067|NCT01230788|1134196|P1|COMPLETED|Overall Study||0
463068|NCT01230788|1134196|P1|STARTED|Overall Study||1
463069|NCT01230749|1134208|P4|NOT COMPLETED|Overall Study||2
463070|NCT01230749|1134209|P3|NOT COMPLETED|Overall Study||2
463071|NCT01230749|1134210|P2|NOT COMPLETED|Overall Study||2
463072|NCT01230749|1134211|P1|NOT COMPLETED|Overall Study||0
463073|NCT01230749|1134208|P4|COMPLETED|Overall Study||20
463074|NCT01230749|1134209|P3|COMPLETED|Overall Study||21
463075|NCT01230749|1134210|P2|COMPLETED|Overall Study||20
463076|NCT01230749|1134211|P1|COMPLETED|Overall Study||22
463077|NCT01230749|1134208|P4|STARTED|Overall Study||22
463078|NCT01230749|1134209|P3|STARTED|Overall Study||23
463079|NCT01230749|1134210|P2|STARTED|Overall Study||22
463080|NCT01230749|1134211|P1|STARTED|Overall Study||22
463081|NCT01230710|1134246|P1|NOT COMPLETED|Overall Study||49
463082|NCT01230710|1134246|P1|COMPLETED|Overall Study||2
463083|NCT01230710|1134246|P1|STARTED|Overall Study||51
463084|NCT01230593|1134257|P3|NOT COMPLETED|Overall Study||12
463085|NCT01230593|1134258|P2|NOT COMPLETED|Overall Study||18
463086|NCT01230593|1134259|P1|NOT COMPLETED|Overall Study||15
463087|NCT01230593|1134257|P3|COMPLETED|Overall Study||38
463088|NCT01230593|1134258|P2|COMPLETED|Overall Study||32
463089|NCT01230593|1134259|P1|COMPLETED|Overall Study||35
463090|NCT01230593|1134257|P3|STARTED|Overall Study||50
463091|NCT01230593|1134258|P2|STARTED|Overall Study||50
463092|NCT01230593|1134259|P1|STARTED|Overall Study||50
463093|NCT01230502|1134273|P3|NOT COMPLETED|Overall Study||0
463094|NCT01230502|1134274|P2|NOT COMPLETED|Overall Study||0
463095|NCT01230502|1134275|P1|NOT COMPLETED|Overall Study||0
463096|NCT01230502|1134273|P3|COMPLETED|Overall Study||0
463097|NCT01230502|1134274|P2|COMPLETED|Overall Study||0
463098|NCT01230502|1134275|P1|COMPLETED|Overall Study||9
463099|NCT01230502|1134273|P3|STARTED|Overall Study||0
463100|NCT01230502|1134274|P2|STARTED|Overall Study||0
463101|NCT01230502|1134275|P1|STARTED|Overall Study||9
463102|NCT01230424|1134288|P2|NOT COMPLETED|Overall Study||0
463103|NCT01230424|1134289|P1|NOT COMPLETED|Overall Study||0
463104|NCT01230424|1134288|P2|COMPLETED|Overall Study||70
463105|NCT01230424|1134289|P1|COMPLETED|Overall Study||70
463106|NCT01230424|1134288|P2|STARTED|Overall Study||70
463107|NCT01230424|1134289|P1|STARTED|Overall Study||70
463108|NCT01230307|1134317|P2|NOT COMPLETED|Overall Study||2
463109|NCT01230307|1134318|P1|NOT COMPLETED|Overall Study||0
463110|NCT01230307|1134317|P2|COMPLETED|Overall Study||4
463111|NCT01230307|1134318|P1|COMPLETED|Overall Study||6
463112|NCT01230307|1134317|P2|STARTED|Overall Study||6
463113|NCT01230307|1134318|P1|STARTED|Overall Study||6
463114|NCT01230177|1134330|P1|NOT COMPLETED|Overall Study||0
463115|NCT01230177|1134330|P1|COMPLETED|Overall Study||3
463116|NCT01230177|1134330|P1|STARTED|Overall Study||3
463117|NCT01230060|1134338|P1|NOT COMPLETED|Overall Study||1
463118|NCT01230060|1134338|P1|COMPLETED|Overall Study||121
463119|NCT01230060|1134338|P1|STARTED|Overall Study||122
463120|NCT01230021|1134342|P1|NOT COMPLETED|Overall Study||0
463121|NCT01230021|1134342|P1|COMPLETED|Overall Study||6
463122|NCT01230021|1134342|P1|STARTED|Overall Study||6
463123|NCT01229943|1134364|P2|NOT COMPLETED|Overall Study||17
463124|NCT01229943|1134365|P1|NOT COMPLETED|Overall Study||18
463125|NCT01229943|1134364|P2|COMPLETED|Overall Study||58
463126|NCT01229943|1134365|P1|COMPLETED|Overall Study||57
463127|NCT01229943|1134364|P2|STARTED|Overall Study||75
463128|NCT01229943|1134365|P1|STARTED|Overall Study||75
463129|NCT01229891|1134378|P3|NOT COMPLETED|Overall Study||0
463130|NCT01229891|1134379|P2|NOT COMPLETED|Overall Study||0
463131|NCT01229891|1134380|P1|NOT COMPLETED|Overall Study||0
463132|NCT01229891|1134378|P3|COMPLETED|Overall Study||30
463133|NCT01229891|1134379|P2|COMPLETED|Overall Study||30
463134|NCT01229891|1134380|P1|COMPLETED|Overall Study||30
463135|NCT01229891|1134378|P3|STARTED|Overall Study||30
463136|NCT01229891|1134379|P2|STARTED|Overall Study||30
463137|NCT01229891|1134380|P1|STARTED|Overall Study||30
463138|NCT01229735|1134411|P2|NOT COMPLETED|Overall Study||66
463139|NCT01229735|1134412|P1|NOT COMPLETED|Overall Study||66
463140|NCT01229735|1134411|P2|COMPLETED|Overall Study||100
463141|NCT01229735|1134412|P1|COMPLETED|Overall Study||111
463142|NCT01229735|1134411|P2|STARTED|Overall Study||166
463143|NCT01229735|1134412|P1|STARTED|Overall Study||177
463144|NCT01229722|1134428|P2|NOT COMPLETED|Overall Study||0
463145|NCT01229722|1134429|P1|NOT COMPLETED|Overall Study||4
463146|NCT01229722|1134428|P2|COMPLETED|Overall Study||36
463147|NCT01229722|1134429|P1|COMPLETED|Overall Study||30
463148|NCT01229722|1134428|P2|STARTED|Overall Study||36
463149|NCT01229722|1134429|P1|STARTED|Overall Study||34
463150|NCT01229527|1134438|P3|NOT COMPLETED|Overall Study||0
463151|NCT01229527|1134439|P2|NOT COMPLETED|Overall Study||0
463152|NCT01229527|1134440|P1|NOT COMPLETED|Overall Study||0
463153|NCT01229527|1134438|P3|COMPLETED|Overall Study||30
463154|NCT01229527|1134439|P2|COMPLETED|Overall Study||30
463155|NCT01229527|1134440|P1|COMPLETED|Overall Study||30
463156|NCT01229527|1134438|P3|STARTED|Overall Study||30
463157|NCT01229527|1134439|P2|STARTED|Overall Study||30
463158|NCT01229527|1134440|P1|STARTED|Overall Study||30
463159|NCT01229462|1134453|P2|NOT COMPLETED|Overall Study||9
463160|NCT01229462|1134454|P1|NOT COMPLETED|Overall Study||5
463161|NCT01229462|1134453|P2|COMPLETED|Overall Study||109
463162|NCT01229462|1134454|P1|COMPLETED|Overall Study||115
463163|NCT01229462|1134453|P2|STARTED|Overall Study||118
463164|NCT01229462|1134454|P1|STARTED|Overall Study||120
463165|NCT01229436|1134460|P1|NOT COMPLETED|Overall Study||5
463166|NCT01229436|1134460|P1|COMPLETED|Overall Study||249
463167|NCT01229436|1134460|P1|STARTED|Overall Study||254
463168|NCT01229423|1134498|P1|NOT COMPLETED|Overall Study||15
463169|NCT01229423|1134498|P1|COMPLETED|Overall Study||47
463170|NCT01229423|1134498|P1|STARTED|Overall Study||62
463171|NCT01229410|1134509|P2|NOT COMPLETED|Overall Study||3
463172|NCT01229410|1134510|P1|NOT COMPLETED|Overall Study||5
463173|NCT01229410|1134509|P2|COMPLETED|Overall Study||9
463174|NCT01229410|1134510|P1|COMPLETED|Overall Study||7
463175|NCT01229410|1134509|P2|STARTED|Overall Study||12
463176|NCT01229410|1134510|P1|STARTED|Overall Study||12
463177|NCT01229397|1134522|P2|NOT COMPLETED|Overall Study||9
463178|NCT01229397|1134523|P1|NOT COMPLETED|Overall Study||11
463179|NCT01229397|1134522|P2|COMPLETED|Overall Study||93
463180|NCT01229397|1134523|P1|COMPLETED|Overall Study||92
463181|NCT01229397|1134522|P2|STARTED|Overall Study||102
463182|NCT01229397|1134523|P1|STARTED|Overall Study||103
463183|NCT01229371|1134541|P4|NOT COMPLETED|Overall Study||0
463184|NCT01229371|1134542|P3|NOT COMPLETED|Overall Study||0
463185|NCT01229371|1134543|P2|NOT COMPLETED|Overall Study||1
463186|NCT01229371|1134544|P1|NOT COMPLETED|Overall Study||0
463187|NCT01229371|1134541|P4|COMPLETED|Overall Study||110
463188|NCT01229371|1134542|P3|COMPLETED|Overall Study||110
463189|NCT01229371|1134543|P2|COMPLETED|Overall Study||110
463190|NCT01229371|1134544|P1|COMPLETED|Overall Study||109
463191|NCT01229371|1134541|P4|STARTED|Overall Study||110
463192|NCT01229371|1134542|P3|STARTED|Overall Study||110
463193|NCT01229371|1134543|P2|STARTED|Overall Study||111
463194|NCT01229371|1134544|P1|STARTED|Overall Study||109
463195|NCT01229254|1134569|P3|NOT COMPLETED|Overall Study||12
463196|NCT01229254|1134570|P2|NOT COMPLETED|Overall Study||16
463197|NCT01229254|1134571|P1|NOT COMPLETED|Overall Study||15
463198|NCT01229254|1134569|P3|COMPLETED|Overall Study||61
463199|NCT01229254|1134570|P2|COMPLETED|Overall Study||58
463200|NCT01229254|1134571|P1|COMPLETED|Overall Study||27
463201|NCT01229254|1134569|P3|STARTED|Overall Study||73
463202|NCT01229254|1134570|P2|STARTED|Overall Study||74
463203|NCT01229254|1134571|P1|STARTED|Overall Study||42
463204|NCT01229228|1134585|P5|NOT COMPLETED|Overall Study||1
463205|NCT01229228|1134586|P4|NOT COMPLETED|Overall Study||0
463206|NCT01229228|1134587|P3|NOT COMPLETED|Overall Study||1
463207|NCT01229228|1134588|P2|NOT COMPLETED|Overall Study||0
463208|NCT01229228|1134589|P1|NOT COMPLETED|Overall Study||1
463209|NCT01229228|1134585|P5|COMPLETED|Overall Study||50
463210|NCT01229228|1134586|P4|COMPLETED|Overall Study||51
463211|NCT01229228|1134587|P3|COMPLETED|Overall Study||49
463212|NCT01229228|1134588|P2|COMPLETED|Overall Study||51
463213|NCT01229228|1134589|P1|COMPLETED|Overall Study||50
463214|NCT01229228|1134585|P5|STARTED|Overall Study||51
463215|NCT01229228|1134586|P4|STARTED|Overall Study||51
463216|NCT01229228|1134587|P3|STARTED|Overall Study||50
463217|NCT01229228|1134588|P2|STARTED|Overall Study||51
463218|NCT01229228|1134589|P1|STARTED|Overall Study||51
463219|NCT01229176|1134609|P8|NOT COMPLETED|Overall Study||3
463220|NCT01229176|1134610|P7|NOT COMPLETED|Overall Study||0
463221|NCT01229176|1134611|P6|NOT COMPLETED|Overall Study||2
463222|NCT01229176|1134612|P5|NOT COMPLETED|Overall Study||2
463223|NCT01229176|1134613|P4|NOT COMPLETED|Overall Study||1
463224|NCT01229176|1134614|P3|NOT COMPLETED|Overall Study||0
463225|NCT01229176|1134615|P2|NOT COMPLETED|Overall Study||3
463226|NCT01229176|1134616|P1|NOT COMPLETED|Overall Study||0
463227|NCT01229176|1134609|P8|COMPLETED|Overall Study||17
463228|NCT01229176|1134610|P7|COMPLETED|Overall Study||20
463229|NCT01229176|1134611|P6|COMPLETED|Overall Study||18
463230|NCT01229176|1134612|P5|COMPLETED|Overall Study||18
463231|NCT01229176|1134613|P4|COMPLETED|Overall Study||19
463232|NCT01229176|1134614|P3|COMPLETED|Overall Study||20
463233|NCT01229176|1134615|P2|COMPLETED|Overall Study||37
463234|NCT01229176|1134616|P1|COMPLETED|Overall Study||40
463235|NCT01229176|1134609|P8|STARTED|Overall Study||20
463236|NCT01229176|1134610|P7|STARTED|Overall Study||20
463237|NCT01229176|1134611|P6|STARTED|Overall Study||20
463238|NCT01229176|1134612|P5|STARTED|Overall Study||20
463239|NCT01229176|1134613|P4|STARTED|Overall Study||20
463240|NCT01229176|1134614|P3|STARTED|Overall Study||20
463241|NCT01229176|1134615|P2|STARTED|Overall Study||40
463242|NCT01229176|1134616|P1|STARTED|Overall Study||40
463243|NCT01229150|1134670|P4|NOT COMPLETED|Overall Study||0
463244|NCT01229150|1134671|P3|NOT COMPLETED|Overall Study||0
463245|NCT01229150|1134672|P2|NOT COMPLETED|Overall Study||2
463246|NCT01229150|1134673|P1|NOT COMPLETED|Overall Study||2
463247|NCT01229150|1134670|P4|COMPLETED|Overall Study||19
463248|NCT01229150|1134671|P3|COMPLETED|Overall Study||19
463249|NCT01229150|1134672|P2|COMPLETED|Overall Study||9
463250|NCT01229150|1134673|P1|COMPLETED|Overall Study||28
463251|NCT01229150|1134670|P4|STARTED|Overall Study||19
463252|NCT01229150|1134671|P3|STARTED|Overall Study||19
463253|NCT01229150|1134672|P2|STARTED|Overall Study||11
463254|NCT01229150|1134673|P1|STARTED|Overall Study||30
463255|NCT01229111|1134730|P1|NOT COMPLETED|Overall Study||1
463256|NCT01229111|1134730|P1|COMPLETED|Overall Study||13
463257|NCT01229111|1134730|P1|STARTED|Overall Study||14
463258|NCT01228968|1134738|P1|NOT COMPLETED|Overall Study||0
463259|NCT01228968|1134738|P1|COMPLETED|Overall Study||9
463260|NCT01228968|1134738|P1|STARTED|Overall Study||9
463261|NCT01228929|1134748|P3|NOT COMPLETED|High Temperature Condition||0
463262|NCT01228929|1134749|P2|NOT COMPLETED|High Temperature Condition||0
463263|NCT01228929|1134750|P1|NOT COMPLETED|High Temperature Condition||0
463264|NCT01228929|1134748|P3|COMPLETED|High Temperature Condition||6
463265|NCT01228929|1134749|P2|COMPLETED|High Temperature Condition||6
463266|NCT01228929|1134750|P1|COMPLETED|High Temperature Condition||6
463267|NCT01228929|1134748|P3|STARTED|High Temperature Condition||6
463268|NCT01228929|1134749|P2|STARTED|High Temperature Condition||6
463269|NCT01228929|1134750|P1|STARTED|High Temperature Condition||6
463270|NCT01228929|1134748|P3|NOT COMPLETED|Low Humidity Condition||0
463271|NCT01228929|1134749|P2|NOT COMPLETED|Low Humidity Condition||0
463272|NCT01228929|1134750|P1|NOT COMPLETED|Low Humidity Condition||0
463273|NCT01228929|1134748|P3|COMPLETED|Low Humidity Condition||6
463274|NCT01228929|1134749|P2|COMPLETED|Low Humidity Condition||6
463275|NCT01228929|1134750|P1|COMPLETED|Low Humidity Condition||6
463276|NCT01228929|1134748|P3|STARTED|Low Humidity Condition||6
463277|NCT01228929|1134749|P2|STARTED|Low Humidity Condition||6
463278|NCT01228929|1134750|P1|STARTED|Low Humidity Condition||6
463279|NCT01228929|1134748|P3|NOT COMPLETED|Nominal Condition||0
463280|NCT01228929|1134749|P2|NOT COMPLETED|Nominal Condition||0
463281|NCT01228929|1134750|P1|NOT COMPLETED|Nominal Condition||0
463282|NCT01228929|1134748|P3|COMPLETED|Nominal Condition||6
463283|NCT01228929|1134749|P2|COMPLETED|Nominal Condition||6
463284|NCT01228929|1134750|P1|COMPLETED|Nominal Condition||6
463285|NCT01228929|1134748|P3|STARTED|Nominal Condition||6
463286|NCT01228929|1134749|P2|STARTED|Nominal Condition||6
463287|NCT01228929|1134750|P1|STARTED|Nominal Condition||6
463288|NCT01228903|1134760|P2|NOT COMPLETED|Overall Study||5
463289|NCT01228903|1134761|P1|NOT COMPLETED|Overall Study||5
463290|NCT01228903|1134760|P2|COMPLETED|Overall Study||34
463291|NCT01228903|1134761|P1|COMPLETED|Overall Study||36
463292|NCT01228903|1134760|P2|STARTED|Overall Study||39
463293|NCT01228903|1134761|P1|STARTED|Overall Study||41
463294|NCT01228747|1134779|P2|NOT COMPLETED|Overall Study||45
463295|NCT01228747|1134780|P1|NOT COMPLETED|Overall Study||65
463296|NCT01228747|1134779|P2|COMPLETED|Overall Study||81
463297|NCT01228747|1134780|P1|COMPLETED|Overall Study||60
463298|NCT01228747|1134779|P2|STARTED|Overall Study||126
463299|NCT01228747|1134780|P1|STARTED|Overall Study||125
463310|NCT01228591|1134811|P2|NOT COMPLETED|Final Visit||0
463311|NCT01228591|1134812|P1|NOT COMPLETED|Final Visit||0
463312|NCT01228591|1134811|P2|COMPLETED|Final Visit||16
463313|NCT01228591|1134812|P1|COMPLETED|Final Visit||17
463314|NCT01228591|1134811|P2|STARTED|Final Visit||16
463315|NCT01228591|1134812|P1|STARTED|Final Visit||17
463316|NCT01228591|1134811|P2|NOT COMPLETED|1-Week Follow-Up||0
463317|NCT01228591|1134812|P1|NOT COMPLETED|1-Week Follow-Up||0
463318|NCT01228591|1134811|P2|COMPLETED|1-Week Follow-Up||16
463319|NCT01228591|1134812|P1|COMPLETED|1-Week Follow-Up||17
463320|NCT01228591|1134811|P2|STARTED|1-Week Follow-Up||16
463321|NCT01228591|1134812|P1|STARTED|1-Week Follow-Up||17
463322|NCT01228591|1134811|P2|NOT COMPLETED|Baseline||2
463323|NCT01228591|1134812|P1|NOT COMPLETED|Baseline||1
463324|NCT01228591|1134811|P2|COMPLETED|Baseline||16
463325|NCT01228591|1134812|P1|COMPLETED|Baseline||17
463326|NCT01228591|1134811|P2|STARTED|Baseline||18
463327|NCT01228591|1134812|P1|STARTED|Baseline||18
463328|NCT01228435|1134830|P2|NOT COMPLETED|Overall Study||0
463329|NCT01228435|1134831|P1|NOT COMPLETED|Overall Study||0
463330|NCT01228435|1134830|P2|COMPLETED|Overall Study||2
463331|NCT01228435|1134831|P1|COMPLETED|Overall Study||1
463332|NCT01228435|1134830|P2|STARTED|Overall Study||2
463333|NCT01228435|1134831|P1|STARTED|Overall Study||1
463334|NCT01228318|1134841|P2|NOT COMPLETED|Overall Study||7
463335|NCT01228318|1134842|P1|NOT COMPLETED|Overall Study||4
463336|NCT01228318|1134841|P2|COMPLETED|Overall Study||22
463337|NCT01228318|1134842|P1|COMPLETED|Overall Study||30
463338|NCT01228318|1134841|P2|STARTED|Overall Study||29
463339|NCT01228318|1134842|P1|STARTED|Overall Study||34
463340|NCT01228175|1134858|P2|NOT COMPLETED|Overall Study||53
463341|NCT01228175|1134859|P1|NOT COMPLETED|Overall Study||66
463342|NCT01228175|1134858|P2|COMPLETED|Overall Study||46
463343|NCT01228175|1134859|P1|COMPLETED|Overall Study||53
463344|NCT01228175|1134858|P2|STARTED|Overall Study||99
463345|NCT01228175|1134859|P1|STARTED|Overall Study||119
463346|NCT01228149|1134867|P2|NOT COMPLETED|Overall Study||4
463347|NCT01228149|1134868|P1|NOT COMPLETED|Overall Study||5
463348|NCT01228149|1134867|P2|COMPLETED|Overall Study||26
463349|NCT01228149|1134868|P1|COMPLETED|Overall Study||27
463350|NCT01228149|1134867|P2|STARTED|Overall Study||30
463351|NCT01228149|1134868|P1|STARTED|Overall Study||32
463352|NCT01228084|1134890|P1|NOT COMPLETED|Overall Study||4
463353|NCT01228084|1134890|P1|COMPLETED|Overall Study||16
463354|NCT01228084|1134890|P1|STARTED|Overall Study||20
463355|NCT01228071|1134901|P1|NOT COMPLETED|Overall Study||2
463356|NCT01228071|1134901|P1|COMPLETED|Overall Study||32
463357|NCT01228071|1134901|P1|STARTED|Overall Study||34
463358|NCT01228019|1134907|P1|NOT COMPLETED|Overall Study||304
463359|NCT01228019|1134907|P1|COMPLETED|Overall Study||862
463360|NCT01228019|1134907|P1|STARTED|Overall Study||1166
463361|NCT01227993|1134922|P1|NOT COMPLETED|Overall Study||0
463362|NCT01227993|1134922|P1|COMPLETED|Overall Study||3
463363|NCT01227993|1134922|P1|STARTED|Overall Study||3
463364|NCT01227980|1134934|P2|NOT COMPLETED|Overall Study||5
463365|NCT01227980|1134935|P1|NOT COMPLETED|Overall Study||2
463366|NCT01227980|1134934|P2|COMPLETED|Overall Study||25
463367|NCT01227980|1134935|P1|COMPLETED|Overall Study|Two subjects did not complete the scripts sessions but completed the remainder of the protocol|38
463368|NCT01227980|1134934|P2|Measure Drug Level Concentration|Overall Study|No placebo subjects completed this milestone which measured active drug levels|0
463369|NCT01227980|1134935|P1|Measure Drug Level Concentration|Overall Study||10
463370|NCT01227980|1134934|P2|Scripts Challenge Sessions|Overall Study||25
463371|NCT01227980|1134935|P1|Scripts Challenge Sessions|Overall Study||26
463372|NCT01227980|1134934|P2|STARTED|Overall Study||30
463373|NCT01227980|1134935|P1|STARTED|Overall Study||40
463374|NCT01227967|1134973|P2|NOT COMPLETED|Overall Study||13
463375|NCT01227967|1134974|P1|NOT COMPLETED|Overall Study||16
463376|NCT01227967|1134973|P2|COMPLETED|Overall Study||303
463377|NCT01227967|1134974|P1|COMPLETED|Overall Study||298
463378|NCT01227967|1134973|P2|STARTED|Overall Study||316
463379|NCT01227967|1134974|P1|STARTED|Overall Study||314
463380|NCT01227954|1135008|P1|NOT COMPLETED|Overall Study||13
463381|NCT01227954|1135008|P1|COMPLETED|Overall Study|Eligible subjects available for analysis|100
463382|NCT01227954|1135008|P1|STARTED|Overall Study||113
463383|NCT01227928|1135022|P2|NOT COMPLETED|Overall Study||17
463384|NCT01227928|1135023|P1|NOT COMPLETED|Overall Study||22
463385|NCT01227928|1135022|P2|COMPLETED|Overall Study||56
463386|NCT01227928|1135023|P1|COMPLETED|Overall Study||50
463387|NCT01227928|1135022|P2|STARTED|Overall Study||73
463388|NCT01227928|1135023|P1|STARTED|Overall Study||72
463389|NCT01227902|1135061|P4|NOT COMPLETED|Overall Study||10
463390|NCT01227902|1135062|P3|NOT COMPLETED|Overall Study||19
463391|NCT01227902|1135063|P2|NOT COMPLETED|Overall Study||13
463392|NCT01227902|1135064|P1|NOT COMPLETED|Overall Study||18
463393|NCT01227902|1135061|P4|COMPLETED|Overall Study||42
463394|NCT01227902|1135062|P3|COMPLETED|Overall Study||25
463395|NCT01227902|1135063|P2|COMPLETED|Overall Study||38
463396|NCT01227902|1135064|P1|COMPLETED|Overall Study||38
463397|NCT01227902|1135061|P4|STARTED|Overall Study||52
463398|NCT01227902|1135062|P3|STARTED|Overall Study||44
463399|NCT01227902|1135063|P2|STARTED|Overall Study||51
463400|NCT01227902|1135064|P1|STARTED|Overall Study||56
463401|NCT01227889|1135157|P2|NOT COMPLETED|Crossover Phase||37
463402|NCT01227889|1135158|P1|NOT COMPLETED|Crossover Phase||0
463403|NCT01227889|1135157|P2|COMPLETED|Crossover Phase||0
463404|NCT01227889|1135158|P1|COMPLETED|Crossover Phase||0
463405|NCT01227889|1135157|P2|STARTED|Crossover Phase|As of the data cut on December 18, 2012, 36 of 63 participants crossed over from DTIC to GSK2118436.|37
463406|NCT01227889|1135158|P1|STARTED|Crossover Phase||0
463407|NCT01227889|1135157|P2|NOT COMPLETED|Randomized Phase (RP)||63
463408|NCT01227889|1135158|P1|NOT COMPLETED|Randomized Phase (RP)||187
463409|NCT01227889|1135157|P2|COMPLETED|Randomized Phase (RP)||0
463410|NCT01227889|1135158|P1|COMPLETED|Randomized Phase (RP)||0
463411|NCT01227889|1135157|P2|STARTED|Randomized Phase (RP)||63
463412|NCT01227889|1135158|P1|STARTED|Randomized Phase (RP)||187
463413|NCT01227824|1135185|P3|NOT COMPLETED|Open-label Phase: Median of 1267 Days||44
463414|NCT01227824|1135186|P2|NOT COMPLETED|Open-label Phase: Median of 1267 Days||0
463415|NCT01227824|1135187|P1|NOT COMPLETED|Open-label Phase: Median of 1267 Days||0
463416|NCT01227824|1135185|P3|COMPLETED|Open-label Phase: Median of 1267 Days||294
463417|NCT01227824|1135186|P2|COMPLETED|Open-label Phase: Median of 1267 Days||0
463418|NCT01227824|1135187|P1|COMPLETED|Open-label Phase: Median of 1267 Days||0
463419|NCT01227824|1135185|P3|STARTED|Open-label Phase: Median of 1267 Days|338 participants continued into the Open-label phase on completing the Double-blind Phase|338
463420|NCT01227824|1135186|P2|STARTED|Open-label Phase: Median of 1267 Days||0
463421|NCT01227824|1135187|P1|STARTED|Open-label Phase: Median of 1267 Days||0
463422|NCT01227824|1135185|P3|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||0
463423|NCT01227824|1135186|P2|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||79
463424|NCT01227824|1135187|P1|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||107
463425|NCT01227824|1135185|P3|COMPLETED|Double-blind Phase: 96 Weeks Duration||0
463426|NCT01227824|1135186|P2|COMPLETED|Double-blind Phase: 96 Weeks Duration||332
463427|NCT01227824|1135187|P1|COMPLETED|Double-blind Phase: 96 Weeks Duration||304
463428|NCT01227824|1135185|P3|STARTED|Double-blind Phase: 96 Weeks Duration||0
463429|NCT01227824|1135186|P2|STARTED|Double-blind Phase: 96 Weeks Duration||411
463430|NCT01227824|1135187|P1|STARTED|Double-blind Phase: 96 Weeks Duration||411
463431|NCT01227785|1135216|P1|NOT COMPLETED|Overall Study||12
463432|NCT01227785|1135216|P1|COMPLETED|Overall Study||108
463433|NCT01227785|1135216|P1|STARTED|Overall Study||120
463434|NCT01227707|1135282|P1|NOT COMPLETED|Overall Study||24
463435|NCT01227707|1135282|P1|COMPLETED|Overall Study||19
463436|NCT01227707|1135282|P1|STARTED|Overall Study||43
463437|NCT01227681|1135301|P3|NOT COMPLETED|Overall Study||0
463438|NCT01227681|1135302|P2|NOT COMPLETED|Overall Study||0
463439|NCT01227681|1135303|P1|NOT COMPLETED|Overall Study||0
463440|NCT01227681|1135301|P3|COMPLETED|Overall Study||0
463441|NCT01227681|1135302|P2|COMPLETED|Overall Study||0
463442|NCT01227681|1135303|P1|COMPLETED|Overall Study||4
463443|NCT01227681|1135301|P3|STARTED|Overall Study||0
463444|NCT01227681|1135302|P2|STARTED|Overall Study||0
463445|NCT01227681|1135303|P1|STARTED|Overall Study||4
463446|NCT01227668|1135309|P2|NOT COMPLETED|Phase 2 (Randomization Phase)||25
463447|NCT01227668|1135310|P1|NOT COMPLETED|Phase 2 (Randomization Phase)||19
463448|NCT01227668|1135309|P2|COMPLETED|Phase 2 (Randomization Phase)||19
463449|NCT01227668|1135310|P1|COMPLETED|Phase 2 (Randomization Phase)||22
463450|NCT01227668|1135309|P2|Received Treatment|Phase 2 (Randomization Phase)||43
463451|NCT01227668|1135310|P1|Received Treatment|Phase 2 (Randomization Phase)||39
463452|NCT01227668|1135309|P2|STARTED|Phase 2 (Randomization Phase)|Randomized|44
463453|NCT01227668|1135310|P1|STARTED|Phase 2 (Randomization Phase)|Randomized|41
463454|NCT01227668|1135309|P2|NOT COMPLETED|Phase 1 (Stabilization Phase)||0
463455|NCT01227668|1135310|P1|NOT COMPLETED|Phase 1 (Stabilization Phase)||72
463456|NCT01227668|1135309|P2|COMPLETED|Phase 1 (Stabilization Phase)||0
463457|NCT01227668|1135310|P1|COMPLETED|Phase 1 (Stabilization Phase)||85
463458|NCT01227668|1135309|P2|Received Treatment|Phase 1 (Stabilization Phase)||0
463459|NCT01227668|1135310|P1|Received Treatment|Phase 1 (Stabilization Phase)||155
463460|NCT01227668|1135309|P2|STARTED|Phase 1 (Stabilization Phase)||0
463461|NCT01227668|1135310|P1|STARTED|Phase 1 (Stabilization Phase)|Randomized|157
463462|NCT01227655|1135327|P3|NOT COMPLETED|Overall Study||14
463463|NCT01227655|1135328|P2|NOT COMPLETED|Overall Study||26
463464|NCT01227655|1135329|P1|NOT COMPLETED|Overall Study||11
463465|NCT01227655|1135327|P3|COMPLETED|Overall Study||130
463466|NCT01227655|1135328|P2|COMPLETED|Overall Study||128
463467|NCT01227655|1135329|P1|COMPLETED|Overall Study||118
463468|NCT01227655|1135327|P3|Full Analysis Set|Overall Study||135
463469|NCT01227655|1135328|P2|Full Analysis Set|Overall Study||147
463470|NCT01227655|1135329|P1|Full Analysis Set|Overall Study||125
463471|NCT01227655|1135327|P3|Safety Set|Overall Study||136
463472|NCT01227655|1135328|P2|Safety Set|Overall Study||150
463473|NCT01227655|1135329|P1|Safety Set|Overall Study||125
463474|NCT01227655|1135327|P3|STARTED|Overall Study||144
463475|NCT01227655|1135328|P2|STARTED|Overall Study||154
463476|NCT01227655|1135329|P1|STARTED|Overall Study||129
463477|NCT01227629|1135356|P10|NOT COMPLETED|Overall Study||2
463478|NCT01227629|1135357|P9|NOT COMPLETED|Overall Study||6
463479|NCT01227629|1135358|P8|NOT COMPLETED|Overall Study||6
463480|NCT01227629|1135359|P7|NOT COMPLETED|Overall Study||8
463481|NCT01227629|1135360|P6|NOT COMPLETED|Overall Study||1
463482|NCT01227629|1135361|P5|NOT COMPLETED|Overall Study||2
463483|NCT01227629|1135362|P4|NOT COMPLETED|Overall Study||8
463484|NCT01227629|1135363|P3|NOT COMPLETED|Overall Study||1
463485|NCT01227629|1135364|P2|NOT COMPLETED|Overall Study||2
463486|NCT01227629|1135365|P1|NOT COMPLETED|Overall Study||2
463487|NCT01227629|1135356|P10|COMPLETED|Overall Study||68
463488|NCT01227629|1135357|P9|COMPLETED|Overall Study||24
463489|NCT01227629|1135358|P8|COMPLETED|Overall Study||27
463490|NCT01227629|1135359|P7|COMPLETED|Overall Study||90
463491|NCT01227629|1135360|P6|COMPLETED|Overall Study||32
463492|NCT01227629|1135361|P5|COMPLETED|Overall Study||32
463493|NCT01227629|1135362|P4|COMPLETED|Overall Study||91
463494|NCT01227629|1135363|P3|COMPLETED|Overall Study||26
463495|NCT01227629|1135364|P2|COMPLETED|Overall Study||18
463496|NCT01227629|1135365|P1|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|56
463497|NCT01227629|1135356|P10|STARTED|Overall Study||70
463498|NCT01227629|1135357|P9|STARTED|Overall Study||30
463499|NCT01227629|1135358|P8|STARTED|Overall Study||33
463500|NCT01227629|1135359|P7|STARTED|Overall Study||98
463501|NCT01227629|1135360|P6|STARTED|Overall Study||33
463502|NCT01227629|1135361|P5|STARTED|Overall Study||34
463503|NCT01227629|1135362|P4|STARTED|Overall Study||99
463504|NCT01227629|1135363|P3|STARTED|Overall Study||27
463505|NCT01227629|1135364|P2|STARTED|Overall Study||20
463506|NCT01227629|1135365|P1|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|58
463507|NCT01227577|1135601|P1|NOT COMPLETED|Overall Study||35
463508|NCT01227577|1135601|P1|COMPLETED|Overall Study||93
463509|NCT01227577|1135601|P1|STARTED|Overall Study||128
463510|NCT01227564|1135616|P3|NOT COMPLETED|Overall Study||6
463511|NCT01227564|1135617|P2|NOT COMPLETED|Overall Study||2
463512|NCT01227564|1135618|P1|NOT COMPLETED|Overall Study||4
463513|NCT01227564|1135616|P3|COMPLETED|Overall Study|Completed study|15
463514|NCT01227564|1135617|P2|COMPLETED|Overall Study|Completed study|18
463515|NCT01227564|1135618|P1|COMPLETED|Overall Study|Completed study|18
463516|NCT01227564|1135616|P3|Completed Treatment|Overall Study|1 participant stopped treatment due to lack of efficacy, 3 due to no longer willing to participate.|17
463517|NCT01227564|1135617|P2|Completed Treatment|Overall Study|2 participants discontinued treatment due to no longer willing to participate in study.|18
463518|NCT01227564|1135618|P1|Completed Treatment|Overall Study|1 participant discontinued treatment due to an adverse event (AE).|21
463519|NCT01227564|1135616|P3|Treated|Overall Study||21
463520|NCT01227564|1135617|P2|Treated|Overall Study||20
463521|NCT01227564|1135618|P1|Treated|Overall Study||22
463522|NCT01227564|1135616|P3|STARTED|Overall Study||21
463523|NCT01227564|1135617|P2|STARTED|Overall Study||20
463524|NCT01227564|1135618|P1|STARTED|Overall Study||22
463525|NCT01227551|1135749|P1|NOT COMPLETED|Overall Study||34
463526|NCT01227551|1135749|P1|COMPLETED|Overall Study||23
463527|NCT01227551|1135749|P1|STARTED|Overall Study||57
463528|NCT01227512|1135756|P2|NOT COMPLETED|Overall Study||10
463529|NCT01227512|1135757|P1|NOT COMPLETED|Overall Study||13
463530|NCT01227512|1135756|P2|COMPLETED|Overall Study||48
463531|NCT01227512|1135757|P1|COMPLETED|Overall Study||53
463532|NCT01227512|1135756|P2|STARTED|Overall Study||58
463533|NCT01227512|1135757|P1|STARTED|Overall Study||66
463534|NCT01227434|1135779|P2|NOT COMPLETED|Overall Study||0
463535|NCT01227434|1135780|P1|NOT COMPLETED|Overall Study||0
463536|NCT01227434|1135779|P2|COMPLETED|Overall Study||16
463537|NCT01227434|1135780|P1|COMPLETED|Overall Study||6
463538|NCT01227434|1135779|P2|STARTED|Overall Study||16
463539|NCT01227434|1135780|P1|STARTED|Overall Study||6
463540|NCT01227421|1135791|P3|NOT COMPLETED|Overall Study||10
463541|NCT01227421|1135792|P2|NOT COMPLETED|Overall Study||18
463542|NCT01227421|1135793|P1|NOT COMPLETED|Overall Study||11
463543|NCT01227421|1135791|P3|COMPLETED|Overall Study||201
463544|NCT01227421|1135792|P2|COMPLETED|Overall Study||194
463545|NCT01227421|1135793|P1|COMPLETED|Overall Study||190
463546|NCT01227421|1135791|P3|STARTED|Overall Study||211
463547|NCT01227421|1135792|P2|STARTED|Overall Study||212
463548|NCT01227421|1135793|P1|STARTED|Overall Study||201
463549|NCT01227395|1135845|P2|NOT COMPLETED|Overall Study||1
463550|NCT01227395|1135846|P1|NOT COMPLETED|Overall Study||0
463551|NCT01227395|1135845|P2|COMPLETED|Overall Study||84
463552|NCT01227395|1135846|P1|COMPLETED|Overall Study||391
463553|NCT01227395|1135845|P2|STARTED|Overall Study||85
463554|NCT01227395|1135846|P1|STARTED|Overall Study||391
463555|NCT01227382|1135874|P1|NOT COMPLETED|Overall Study||0
463556|NCT01227382|1135874|P1|COMPLETED|Overall Study||26
463557|NCT01227382|1135874|P1|STARTED|Overall Study||26
463558|NCT01227278|1135886|P2|NOT COMPLETED|Overall Study||8
463559|NCT01227278|1135887|P1|NOT COMPLETED|Overall Study||5
463560|NCT01227278|1135886|P2|COMPLETED|Overall Study||43
463561|NCT01227278|1135887|P1|COMPLETED|Overall Study||45
463562|NCT01227278|1135886|P2|STARTED|Overall Study||51
463563|NCT01227278|1135887|P1|STARTED|Overall Study||50
463564|NCT01227265|1135914|P3|NOT COMPLETED|Overall Study||14
463565|NCT01227265|1135915|P2|NOT COMPLETED|Overall Study||20
463566|NCT01227265|1135916|P1|NOT COMPLETED|Overall Study||19
463567|NCT01227265|1135914|P3|COMPLETED|Overall Study||145
463568|NCT01227265|1135915|P2|COMPLETED|Overall Study||139
463569|NCT01227265|1135916|P1|COMPLETED|Overall Study||139
463570|NCT01227265|1135914|P3|Treated|Overall Study||159
463571|NCT01227265|1135915|P2|Treated|Overall Study||157
463572|NCT01227265|1135916|P1|Treated|Overall Study||157
463573|NCT01227265|1135914|P3|STARTED|Overall Study||159
463574|NCT01227265|1135915|P2|STARTED|Overall Study||159
463575|NCT01227265|1135916|P1|STARTED|Overall Study||158
463576|NCT01227057|1135944|P2|NOT COMPLETED|Overall Study||8
463577|NCT01227057|1135945|P1|NOT COMPLETED|Overall Study||6
463578|NCT01227057|1135944|P2|COMPLETED|Overall Study||19
463579|NCT01227057|1135945|P1|COMPLETED|Overall Study||25
463580|NCT01227057|1135944|P2|STARTED|Overall Study||27
463581|NCT01227057|1135945|P1|STARTED|Overall Study||31
463582|NCT01227018|1135953|P1|NOT COMPLETED|Overall Study||15
463583|NCT01227018|1135953|P1|COMPLETED|Overall Study||0
463584|NCT01227018|1135953|P1|STARTED|Overall Study||15
463585|NCT01227005|1135963|P2|NOT COMPLETED|Overall Study||1
463586|NCT01227005|1135964|P1|NOT COMPLETED|Overall Study||5
463587|NCT01227005|1135963|P2|COMPLETED|Overall Study||51
463588|NCT01227005|1135964|P1|COMPLETED|Overall Study||50
463589|NCT01227005|1135963|P2|STARTED|Overall Study||52
463590|NCT01227005|1135964|P1|STARTED|Overall Study||55
463591|NCT01226745|1135980|P6|NOT COMPLETED|Overall Study||5
463592|NCT01226745|1135981|P5|NOT COMPLETED|Overall Study||4
463593|NCT01226745|1135982|P4|NOT COMPLETED|Overall Study||5
463594|NCT01226745|1135983|P3|NOT COMPLETED|Overall Study||20
463595|NCT01226745|1135984|P2|NOT COMPLETED|Overall Study||16
463596|NCT01226745|1135985|P1|NOT COMPLETED|Overall Study||17
463597|NCT01226745|1135980|P6|COMPLETED|Overall Study||24
463598|NCT01226745|1135981|P5|COMPLETED|Overall Study||22
463599|NCT01226745|1135982|P4|COMPLETED|Overall Study||24
463600|NCT01226745|1135983|P3|COMPLETED|Overall Study||69
463601|NCT01226745|1135984|P2|COMPLETED|Overall Study||71
463602|NCT01226745|1135985|P1|COMPLETED|Overall Study||63
463603|NCT01226745|1135980|P6|STARTED|Overall Study||29
463604|NCT01226745|1135981|P5|STARTED|Overall Study||26
463605|NCT01226745|1135982|P4|STARTED|Overall Study||29
463606|NCT01226745|1135983|P3|STARTED|Overall Study||89
463607|NCT01226745|1135984|P2|STARTED|Overall Study||87
463608|NCT01226745|1135985|P1|STARTED|Overall Study||80
463609|NCT01226732|1136065|P6|NOT COMPLETED|Overall Study||6
463610|NCT01226732|1136066|P5|NOT COMPLETED|Overall Study||3
463611|NCT01226732|1136067|P4|NOT COMPLETED|Overall Study||5
463612|NCT01226732|1136068|P3|NOT COMPLETED|Overall Study||3
463613|NCT01226732|1136069|P2|NOT COMPLETED|Overall Study||3
463614|NCT01226732|1136070|P1|NOT COMPLETED|Overall Study||3
463615|NCT01226732|1136065|P6|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
463616|NCT01226732|1136066|P5|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
463617|NCT01226732|1136067|P4|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
463618|NCT01226732|1136068|P3|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
463619|NCT01226732|1136069|P2|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
463620|NCT01226732|1136070|P1|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
463621|NCT01226732|1136065|P6|STARTED|Overall Study||6
463622|NCT01226732|1136066|P5|STARTED|Overall Study||3
463623|NCT01226732|1136067|P4|STARTED|Overall Study||5
463624|NCT01226732|1136068|P3|STARTED|Overall Study||3
463625|NCT01226732|1136069|P2|STARTED|Overall Study||3
463626|NCT01226732|1136070|P1|STARTED|Overall Study||3
463627|NCT01226719|1136086|P1|NOT COMPLETED|Overall Study||13
463628|NCT01226719|1136086|P1|COMPLETED|Overall Study|Completed = patient is surgical candidate, underwent resection, received treatment to week 24.|2
463629|NCT01226719|1136086|P1|STARTED|Overall Study||15
463630|NCT01226706|1136096|P2|NOT COMPLETED|Overall Study||0
463631|NCT01226706|1136097|P1|NOT COMPLETED|Overall Study||0
463632|NCT01226706|1136096|P2|COMPLETED|Overall Study||11
463633|NCT01226706|1136097|P1|COMPLETED|Overall Study||10
463634|NCT01226706|1136096|P2|STARTED|Overall Study||11
463635|NCT01226706|1136097|P1|STARTED|Overall Study||10
463636|NCT01226511|1136181|P2|NOT COMPLETED|Taper Period||3
463637|NCT01226511|1136182|P1|NOT COMPLETED|Taper Period||5
463638|NCT01226511|1136181|P2|COMPLETED|Taper Period||54
463639|NCT01226511|1136182|P1|COMPLETED|Taper Period||46
463640|NCT01226511|1136181|P2|STARTED|Taper Period||57
463641|NCT01226511|1136182|P1|STARTED|Taper Period||51
463642|NCT01226511|1136181|P2|NOT COMPLETED|Extension Treatment Period||27
463643|NCT01226511|1136182|P1|NOT COMPLETED|Extension Treatment Period||27
463644|NCT01226511|1136181|P2|COMPLETED|Extension Treatment Period|Thirty-five (35) participants who completed extension treatment did not enter the taper period.|83
463645|NCT01226511|1136182|P1|COMPLETED|Extension Treatment Period|Thirty-nine (39) participants who completed extension treatment did not enter the taper period.|81
463646|NCT01226511|1136181|P2|STARTED|Extension Treatment Period|Twenty-three (23) participants who discontinued extension treatment did not enter the taper period.|110
463647|NCT01226511|1136182|P1|STARTED|Extension Treatment Period|Nineteen (19) participants who discontinued extension treatment did not enter the taper period.|108
463648|NCT01226511|1136181|P2|NOT COMPLETED|Acute Treatment Period||31
463649|NCT01226511|1136182|P1|NOT COMPLETED|Acute Treatment Period||32
463650|NCT01226511|1136181|P2|COMPLETED|Acute Treatment Period||110
463651|NCT01226511|1136182|P1|COMPLETED|Acute Treatment Period||108
463652|NCT01226511|1136181|P2|STARTED|Acute Treatment Period|Twenty-six (26) participants who discontinued acute treatment did not enter the taper period.|141
463653|NCT01226511|1136182|P1|STARTED|Acute Treatment Period|Thirty-one (31) participants who discontinued acute treatment did not enter the taper period.|140
463654|NCT01226459|1136220|P2|NOT COMPLETED|Overall Study||32
463655|NCT01226459|1136221|P1|NOT COMPLETED|Overall Study||21
463656|NCT01226459|1136220|P2|COMPLETED|Overall Study||171
463657|NCT01226459|1136221|P1|COMPLETED|Overall Study||180
463658|NCT01226459|1136220|P2|STARTED|Overall Study||203
463659|NCT01226459|1136221|P1|STARTED|Overall Study||201
463660|NCT01226420|1136231|P1|NOT COMPLETED|Overall Study||0
463661|NCT01226420|1136231|P1|COMPLETED|Overall Study||6
463662|NCT01226420|1136231|P1|STARTED|Overall Study||6
463663|NCT01226121|1136239|P3|NOT COMPLETED|Overall Study||1
463664|NCT01226121|1136240|P2|NOT COMPLETED|Overall Study||0
463665|NCT01226121|1136241|P1|NOT COMPLETED|Overall Study||2
463666|NCT01226121|1136239|P3|COMPLETED|Overall Study||12
463667|NCT01226121|1136240|P2|COMPLETED|Overall Study||11
463668|NCT01226121|1136241|P1|COMPLETED|Overall Study||11
463669|NCT01226121|1136239|P3|30 Day Evaluation|Overall Study||13
463670|NCT01226121|1136240|P2|30 Day Evaluation|Overall Study||11
463671|NCT01226121|1136241|P1|30 Day Evaluation|Overall Study||12
463672|NCT01226121|1136239|P3|STARTED|Overall Study||13
463673|NCT01226121|1136240|P2|STARTED|Overall Study||11
463674|NCT01226121|1136241|P1|STARTED|Overall Study||13
463675|NCT01226095|1136252|P1|NOT COMPLETED|Overall Study||1
463676|NCT01226095|1136252|P1|COMPLETED|Overall Study||518
463677|NCT01226095|1136252|P1|STARTED|Overall Study||519
463678|NCT01226043|1136277|P4|NOT COMPLETED|30-week Observational Phase||13
463679|NCT01226043|1136278|P3|NOT COMPLETED|30-week Observational Phase||6
463680|NCT01226043|1136279|P2|NOT COMPLETED|30-week Observational Phase||0
463681|NCT01226043|1136280|P1|NOT COMPLETED|30-week Observational Phase||0
463682|NCT01226043|1136277|P4|COMPLETED|30-week Observational Phase||140
463683|NCT01226043|1136278|P3|COMPLETED|30-week Observational Phase||153
463684|NCT01226043|1136279|P2|COMPLETED|30-week Observational Phase||0
463685|NCT01226043|1136280|P1|COMPLETED|30-week Observational Phase||0
463686|NCT01226043|1136277|P4|TREATED|30-week Observational Phase||153
463687|NCT01226043|1136278|P3|TREATED|30-week Observational Phase||159
463688|NCT01226043|1136279|P2|TREATED|30-week Observational Phase||0
463689|NCT01226043|1136280|P1|TREATED|30-week Observational Phase||0
463690|NCT01226043|1136277|P4|STARTED|30-week Observational Phase||153
463691|NCT01226043|1136278|P3|STARTED|30-week Observational Phase||159
463692|NCT01226043|1136279|P2|STARTED|30-week Observational Phase||0
463693|NCT01226043|1136280|P1|STARTED|30-week Observational Phase||0
463694|NCT01226043|1136277|P4|NOT COMPLETED|6-week Re-randomization Phase||11
463695|NCT01226043|1136278|P3|NOT COMPLETED|6-week Re-randomization Phase||7
463696|NCT01226043|1136279|P2|NOT COMPLETED|6-week Re-randomization Phase||0
463697|NCT01226043|1136280|P1|NOT COMPLETED|6-week Re-randomization Phase||0
463698|NCT01226043|1136277|P4|COMPLETED|6-week Re-randomization Phase|3 patients did not enter the observational phase of the study|156
463699|NCT01226043|1136278|P3|COMPLETED|6-week Re-randomization Phase||159
463700|NCT01226043|1136279|P2|COMPLETED|6-week Re-randomization Phase||0
463701|NCT01226043|1136280|P1|COMPLETED|6-week Re-randomization Phase||0
463702|NCT01226043|1136277|P4|TREATED|6-week Re-randomization Phase||165
463703|NCT01226043|1136278|P3|TREATED|6-week Re-randomization Phase||165
463704|NCT01226043|1136279|P2|TREATED|6-week Re-randomization Phase||0
463705|NCT01226043|1136280|P1|TREATED|6-week Re-randomization Phase||0
463706|NCT01226043|1136277|P4|STARTED|6-week Re-randomization Phase||167
463707|NCT01226043|1136278|P3|STARTED|6-week Re-randomization Phase||166
463708|NCT01226043|1136279|P2|STARTED|6-week Re-randomization Phase||0
463709|NCT01226043|1136280|P1|STARTED|6-week Re-randomization Phase||0
463710|NCT01226043|1136277|P4|NOT COMPLETED|4-week Crossover Phase - Period 2||0
463711|NCT01226043|1136278|P3|NOT COMPLETED|4-week Crossover Phase - Period 2||0
463712|NCT01226043|1136279|P2|NOT COMPLETED|4-week Crossover Phase - Period 2||6
463713|NCT01226043|1136280|P1|NOT COMPLETED|4-week Crossover Phase - Period 2||4
463714|NCT01226043|1136277|P4|COMPLETED|4-week Crossover Phase - Period 2||0
463715|NCT01226043|1136278|P3|COMPLETED|4-week Crossover Phase - Period 2||0
463716|NCT01226043|1136279|P2|COMPLETED|4-week Crossover Phase - Period 2|22 patients were not re-randomized to the second phase of the study|188
463717|NCT01226043|1136280|P1|COMPLETED|4-week Crossover Phase - Period 2|28 patients were not re-randomized to the second phase of the study|195
463718|NCT01226043|1136277|P4|TREATED|4-week Crossover Phase - Period 2||0
463719|NCT01226043|1136278|P3|TREATED|4-week Crossover Phase - Period 2||0
463720|NCT01226043|1136279|P2|TREATED|4-week Crossover Phase - Period 2||194
463721|NCT01226043|1136280|P1|TREATED|4-week Crossover Phase - Period 2||199
463722|NCT01226043|1136277|P4|STARTED|4-week Crossover Phase - Period 2||0
463723|NCT01226043|1136278|P3|STARTED|4-week Crossover Phase - Period 2||0
463724|NCT01226043|1136279|P2|STARTED|4-week Crossover Phase - Period 2||194
463725|NCT01226043|1136280|P1|STARTED|4-week Crossover Phase - Period 2||199
463726|NCT01226043|1136277|P4|NOT COMPLETED|4-week Crossover Phase - Period 1||0
463727|NCT01226043|1136278|P3|NOT COMPLETED|4-week Crossover Phase - Period 1||0
463728|NCT01226043|1136279|P2|NOT COMPLETED|4-week Crossover Phase - Period 1||9
463729|NCT01226043|1136280|P1|NOT COMPLETED|4-week Crossover Phase - Period 1||3
463730|NCT01226043|1136277|P4|COMPLETED|4-week Crossover Phase - Period 1||0
463731|NCT01226043|1136278|P3|COMPLETED|4-week Crossover Phase - Period 1||0
463732|NCT01226043|1136279|P2|COMPLETED|4-week Crossover Phase - Period 1||194
463733|NCT01226043|1136280|P1|COMPLETED|4-week Crossover Phase - Period 1||199
463734|NCT01226043|1136277|P4|TREATED|4-week Crossover Phase - Period 1||0
463735|NCT01226043|1136278|P3|TREATED|4-week Crossover Phase - Period 1||0
463736|NCT01226043|1136279|P2|TREATED|4-week Crossover Phase - Period 1||200
463737|NCT01226043|1136280|P1|TREATED|4-week Crossover Phase - Period 1||202
463738|NCT01226043|1136277|P4|STARTED|4-week Crossover Phase - Period 1||0
463739|NCT01226043|1136278|P3|STARTED|4-week Crossover Phase - Period 1||0
463740|NCT01226043|1136279|P2|STARTED|4-week Crossover Phase - Period 1||203
463741|NCT01226043|1136280|P1|STARTED|4-week Crossover Phase - Period 1||202
463742|NCT01225991|1136318|P1|NOT COMPLETED|Overall Study||6
463743|NCT01225991|1136318|P1|COMPLETED|Overall Study||12
463744|NCT01225991|1136318|P1|STARTED|Overall Study||18
463745|NCT01225952|1136329|P3|NOT COMPLETED|Overall Study||6
463746|NCT01225952|1136330|P2|NOT COMPLETED|Overall Study||4
463747|NCT01225952|1136331|P1|NOT COMPLETED|Overall Study||6
463748|NCT01225952|1136329|P3|COMPLETED|Overall Study||25
463749|NCT01225952|1136330|P2|COMPLETED|Overall Study||27
463750|NCT01225952|1136331|P1|COMPLETED|Overall Study||25
463751|NCT01225952|1136329|P3|STARTED|Overall Study||31
463752|NCT01225952|1136330|P2|STARTED|Overall Study||31
463753|NCT01225952|1136331|P1|STARTED|Overall Study||31
463754|NCT01225926|1136416|P2|NOT COMPLETED|Overall Study||0
463755|NCT01225926|1136417|P1|NOT COMPLETED|Overall Study||0
463756|NCT01225926|1136416|P2|COMPLETED|Overall Study||12
463757|NCT01225926|1136417|P1|COMPLETED|Overall Study||12
463758|NCT01225926|1136416|P2|STARTED|Overall Study||12
463759|NCT01225926|1136417|P1|STARTED|Overall Study||12
463760|NCT01225887|1136423|P1|NOT COMPLETED|Overall Study||5
463761|NCT01225887|1136423|P1|COMPLETED|Overall Study||32
463762|NCT01225887|1136423|P1|STARTED|Overall Study||37
463763|NCT01225835|1136433|P2|NOT COMPLETED|Overall Study||3
463764|NCT01225835|1136434|P1|NOT COMPLETED|Overall Study||7
463765|NCT01225835|1136433|P2|COMPLETED|Overall Study|hCG criterion met|59
463766|NCT01225835|1136434|P1|COMPLETED|Overall Study|hCG criterion met|55
463767|NCT01225835|1136433|P2|Per Protocol Population|Overall Study||58
463768|NCT01225835|1136434|P1|Per Protocol Population|Overall Study||48
463769|NCT01225835|1136433|P2|STARTED|Overall Study||62
463770|NCT01225835|1136434|P1|STARTED|Overall Study||62
463771|NCT01225822|1136482|P5|NOT COMPLETED|Overall Study||31
463772|NCT01225822|1136483|P4|NOT COMPLETED|Overall Study||52
463773|NCT01225822|1136484|P3|NOT COMPLETED|Overall Study||38
463774|NCT01225822|1136485|P2|NOT COMPLETED|Overall Study||56
463775|NCT01225822|1136486|P1|NOT COMPLETED|Overall Study||38
463776|NCT01225822|1136482|P5|COMPLETED|Overall Study||361
463777|NCT01225822|1136483|P4|COMPLETED|Overall Study||333
463778|NCT01225822|1136484|P3|COMPLETED|Overall Study||355
463779|NCT01225822|1136485|P2|COMPLETED|Overall Study||334
463780|NCT01225822|1136486|P1|COMPLETED|Overall Study||351
463781|NCT01225822|1136482|P5|STARTED|Overall Study||392
463782|NCT01225822|1136483|P4|STARTED|Overall Study||385
463783|NCT01225822|1136484|P3|STARTED|Overall Study||393
463784|NCT01225822|1136485|P2|STARTED|Overall Study||390
463785|NCT01225822|1136486|P1|STARTED|Overall Study||389
463786|NCT01225731|1136553|P13|NOT COMPLETED|Part 3||7
463787|NCT01225731|1136554|P12|NOT COMPLETED|Part 3||10
463788|NCT01225731|1136555|P11|NOT COMPLETED|Part 3||6
463789|NCT01225731|1136556|P10|NOT COMPLETED|Part 3||0
463790|NCT01225731|1136557|P9|NOT COMPLETED|Part 3||0
463791|NCT01225731|1136558|P8|NOT COMPLETED|Part 3||0
463792|NCT01225731|1136559|P7|NOT COMPLETED|Part 3||0
463793|NCT01225731|1136560|P6|NOT COMPLETED|Part 3||0
463794|NCT01225731|1136561|P5|NOT COMPLETED|Part 3||0
463795|NCT01225731|1136562|P4|NOT COMPLETED|Part 3||0
463796|NCT01225731|1136563|P3|NOT COMPLETED|Part 3||0
463797|NCT01225731|1136564|P2|NOT COMPLETED|Part 3||0
463798|NCT01225731|1136565|P1|NOT COMPLETED|Part 3||0
463799|NCT01225731|1136553|P13|COMPLETED|Part 3||60
463800|NCT01225731|1136554|P12|COMPLETED|Part 3||116
463801|NCT01225731|1136555|P11|COMPLETED|Part 3||80
463802|NCT01225731|1136556|P10|COMPLETED|Part 3||10
463803|NCT01225731|1136557|P9|COMPLETED|Part 3||0
463804|NCT01225731|1136558|P8|COMPLETED|Part 3||0
463805|NCT01225731|1136559|P7|COMPLETED|Part 3||0
463806|NCT01225731|1136560|P6|COMPLETED|Part 3||0
463807|NCT01225731|1136561|P5|COMPLETED|Part 3||0
463808|NCT01225731|1136562|P4|COMPLETED|Part 3||0
463809|NCT01225731|1136563|P3|COMPLETED|Part 3||0
463810|NCT01225731|1136564|P2|COMPLETED|Part 3||0
463811|NCT01225731|1136565|P1|COMPLETED|Part 3||0
463812|NCT01225731|1136553|P13|STARTED|Part 3|Not all participants entered follow-up|67
463813|NCT01225731|1136554|P12|STARTED|Part 3|Not all participants entered follow-up|126
463814|NCT01225731|1136555|P11|STARTED|Part 3|Not all participants entered follow-up|86
463815|NCT01225731|1136556|P10|STARTED|Part 3|Not all participants entered follow-up|10
463816|NCT01225731|1136557|P9|STARTED|Part 3|Participants could enter the follow-up period|0
463817|NCT01225731|1136558|P8|STARTED|Part 3|Participants could enter the follow-up period|0
463818|NCT01225731|1136559|P7|STARTED|Part 3|Participants could enter the follow-up period|0
463819|NCT01225731|1136560|P6|STARTED|Part 3|Participants could enter the follow-up period|0
463820|NCT01225731|1136561|P5|STARTED|Part 3||0
463821|NCT01225731|1136562|P4|STARTED|Part 3||0
463822|NCT01225731|1136563|P3|STARTED|Part 3||0
463823|NCT01225731|1136564|P2|STARTED|Part 3||0
463824|NCT01225731|1136565|P1|STARTED|Part 3||0
463825|NCT01225731|1136553|P13|NOT COMPLETED|Part 2||0
463826|NCT01225731|1136554|P12|NOT COMPLETED|Part 2||0
463827|NCT01225731|1136555|P11|NOT COMPLETED|Part 2||0
463828|NCT01225731|1136556|P10|NOT COMPLETED|Part 2||0
463829|NCT01225731|1136557|P9|NOT COMPLETED|Part 2||11
463830|NCT01225731|1136558|P8|NOT COMPLETED|Part 2||25
463831|NCT01225731|1136559|P7|NOT COMPLETED|Part 2||8
463832|NCT01225731|1136560|P6|NOT COMPLETED|Part 2||3
463833|NCT01225731|1136561|P5|NOT COMPLETED|Part 2||0
463834|NCT01225731|1136562|P4|NOT COMPLETED|Part 2||0
463835|NCT01225731|1136563|P3|NOT COMPLETED|Part 2||0
463836|NCT01225731|1136564|P2|NOT COMPLETED|Part 2||0
463837|NCT01225731|1136565|P1|NOT COMPLETED|Part 2||0
463838|NCT01225731|1136553|P13|COMPLETED|Part 2||0
463839|NCT01225731|1136554|P12|COMPLETED|Part 2||0
463840|NCT01225731|1136555|P11|COMPLETED|Part 2||0
463841|NCT01225731|1136556|P10|COMPLETED|Part 2||0
463842|NCT01225731|1136557|P9|COMPLETED|Part 2||68
463843|NCT01225731|1136558|P8|COMPLETED|Part 2||128
463844|NCT01225731|1136559|P7|COMPLETED|Part 2||86
463845|NCT01225731|1136560|P6|COMPLETED|Part 2||10
463846|NCT01225731|1136561|P5|COMPLETED|Part 2||0
463847|NCT01225731|1136562|P4|COMPLETED|Part 2||0
463848|NCT01225731|1136563|P3|COMPLETED|Part 2||0
463849|NCT01225731|1136564|P2|COMPLETED|Part 2||0
463850|NCT01225731|1136565|P1|COMPLETED|Part 2||0
463851|NCT01225731|1136553|P13|STARTED|Part 2||0
463852|NCT01225731|1136554|P12|STARTED|Part 2||0
463853|NCT01225731|1136555|P11|STARTED|Part 2||0
463854|NCT01225731|1136556|P10|STARTED|Part 2||0
463855|NCT01225731|1136557|P9|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|79
463856|NCT01225731|1136558|P8|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|153
463857|NCT01225731|1136559|P7|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|94
463858|NCT01225731|1136560|P6|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|13
463859|NCT01225731|1136561|P5|STARTED|Part 2|Participants could progress into Part 2; no placebo was given in Part 2|0
463860|NCT01225731|1136562|P4|STARTED|Part 2|Participants could progress into Part 2|0
463861|NCT01225731|1136563|P3|STARTED|Part 2|Participants could progress into Part 2|0
463862|NCT01225731|1136564|P2|STARTED|Part 2|Participants could progress into Part 2|0
463863|NCT01225731|1136565|P1|STARTED|Part 2|Participants could progress into Part 2|0
463864|NCT01225731|1136553|P13|NOT COMPLETED|Part 1||0
463865|NCT01225731|1136554|P12|NOT COMPLETED|Part 1||0
463866|NCT01225731|1136555|P11|NOT COMPLETED|Part 1||0
463867|NCT01225731|1136556|P10|NOT COMPLETED|Part 1||0
463868|NCT01225731|1136557|P9|NOT COMPLETED|Part 1||0
463869|NCT01225731|1136558|P8|NOT COMPLETED|Part 1||0
463870|NCT01225731|1136559|P7|NOT COMPLETED|Part 1||0
463871|NCT01225731|1136560|P6|NOT COMPLETED|Part 1||0
463872|NCT01225731|1136561|P5|NOT COMPLETED|Part 1||6
463873|NCT01225731|1136562|P4|NOT COMPLETED|Part 1||2
463874|NCT01225731|1136563|P3|NOT COMPLETED|Part 1||1
463875|NCT01225731|1136564|P2|NOT COMPLETED|Part 1||5
463876|NCT01225731|1136565|P1|NOT COMPLETED|Part 1||2
463877|NCT01225731|1136553|P13|COMPLETED|Part 1||0
463878|NCT01225731|1136554|P12|COMPLETED|Part 1||0
463879|NCT01225731|1136555|P11|COMPLETED|Part 1||0
463880|NCT01225731|1136556|P10|COMPLETED|Part 1||0
463881|NCT01225731|1136557|P9|COMPLETED|Part 1||0
463882|NCT01225731|1136558|P8|COMPLETED|Part 1||0
463883|NCT01225731|1136559|P7|COMPLETED|Part 1||0
463884|NCT01225731|1136560|P6|COMPLETED|Part 1||0
463885|NCT01225731|1136561|P5|COMPLETED|Part 1||40
463886|NCT01225731|1136562|P4|COMPLETED|Part 1||84
463887|NCT01225731|1136563|P3|COMPLETED|Part 1||88
463888|NCT01225731|1136564|P2|COMPLETED|Part 1||87
463889|NCT01225731|1136565|P1|COMPLETED|Part 1||40
463890|NCT01225731|1136553|P13|STARTED|Part 1||0
463891|NCT01225731|1136554|P12|STARTED|Part 1||0
463892|NCT01225731|1136555|P11|STARTED|Part 1||0
463893|NCT01225731|1136556|P10|STARTED|Part 1||0
463894|NCT01225731|1136557|P9|STARTED|Part 1||0
463895|NCT01225731|1136558|P8|STARTED|Part 1||0
463896|NCT01225731|1136559|P7|STARTED|Part 1||0
463897|NCT01225731|1136560|P6|STARTED|Part 1||0
463898|NCT01225731|1136561|P5|STARTED|Part 1||46
463899|NCT01225731|1136562|P4|STARTED|Part 1||86
463900|NCT01225731|1136563|P3|STARTED|Part 1||89
463901|NCT01225731|1136564|P2|STARTED|Part 1||92
463902|NCT01225731|1136565|P1|STARTED|Part 1||42
463903|NCT01225562|1136660|P3|NOT COMPLETED|Overall Study||53
463904|NCT01225562|1136661|P2|NOT COMPLETED|Overall Study||56
463905|NCT01225562|1136662|P1|NOT COMPLETED|Overall Study||55
463906|NCT01225562|1136660|P3|COMPLETED|Overall Study||7014
463907|NCT01225562|1136661|P2|COMPLETED|Overall Study||6989
463908|NCT01225562|1136662|P1|COMPLETED|Overall Study||6995
463909|NCT01225562|1136660|P3|STARTED|Overall Study||7067
463910|NCT01225562|1136661|P2|STARTED|Overall Study||7045
463911|NCT01225562|1136662|P1|STARTED|Overall Study||7050
463912|NCT01225549|1136679|P10|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
463913|NCT01225549|1136680|P9|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
463914|NCT01225549|1136681|P8|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
463915|NCT01225549|1136682|P7|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
463916|NCT01225549|1136683|P6|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
463917|NCT01225549|1136684|P5|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
463918|NCT01225549|1136685|P4|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
463919|NCT01225549|1136686|P3|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
463920|NCT01225549|1136687|P2|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
463921|NCT01225549|1136688|P1|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
463922|NCT01225549|1136679|P10|COMPLETED|Period 7 - Fourth Treatment Period||1
463923|NCT01225549|1136680|P9|COMPLETED|Period 7 - Fourth Treatment Period||4
463924|NCT01225549|1136681|P8|COMPLETED|Period 7 - Fourth Treatment Period||1
463925|NCT01225549|1136682|P7|COMPLETED|Period 7 - Fourth Treatment Period||3
463926|NCT01225549|1136683|P6|COMPLETED|Period 7 - Fourth Treatment Period||1
463927|NCT01225549|1136684|P5|COMPLETED|Period 7 - Fourth Treatment Period||1
463928|NCT01225549|1136685|P4|COMPLETED|Period 7 - Fourth Treatment Period||0
463929|NCT01225549|1136686|P3|COMPLETED|Period 7 - Fourth Treatment Period||3
463930|NCT01225549|1136687|P2|COMPLETED|Period 7 - Fourth Treatment Period||3
463931|NCT01225549|1136688|P1|COMPLETED|Period 7 - Fourth Treatment Period||1
463932|NCT01225549|1136679|P10|STARTED|Period 7 - Fourth Treatment Period||1
463933|NCT01225549|1136680|P9|STARTED|Period 7 - Fourth Treatment Period||4
463934|NCT01225549|1136681|P8|STARTED|Period 7 - Fourth Treatment Period||1
463935|NCT01225549|1136682|P7|STARTED|Period 7 - Fourth Treatment Period||3
463936|NCT01225549|1136683|P6|STARTED|Period 7 - Fourth Treatment Period||1
463937|NCT01225549|1136684|P5|STARTED|Period 7 - Fourth Treatment Period||1
463938|NCT01225549|1136685|P4|STARTED|Period 7 - Fourth Treatment Period||0
463939|NCT01225549|1136686|P3|STARTED|Period 7 - Fourth Treatment Period||3
463940|NCT01225549|1136687|P2|STARTED|Period 7 - Fourth Treatment Period||3
463941|NCT01225549|1136688|P1|STARTED|Period 7 - Fourth Treatment Period||1
463942|NCT01225549|1136679|P10|NOT COMPLETED|Period 6 - Washout||0
463943|NCT01225549|1136680|P9|NOT COMPLETED|Period 6 - Washout||0
463944|NCT01225549|1136681|P8|NOT COMPLETED|Period 6 - Washout||0
463945|NCT01225549|1136682|P7|NOT COMPLETED|Period 6 - Washout||0
463946|NCT01225549|1136683|P6|NOT COMPLETED|Period 6 - Washout||0
463947|NCT01225549|1136684|P5|NOT COMPLETED|Period 6 - Washout||0
463948|NCT01225549|1136685|P4|NOT COMPLETED|Period 6 - Washout||1
463949|NCT01225549|1136686|P3|NOT COMPLETED|Period 6 - Washout||0
463950|NCT01225549|1136687|P2|NOT COMPLETED|Period 6 - Washout||0
463951|NCT01225549|1136688|P1|NOT COMPLETED|Period 6 - Washout||0
463952|NCT01225549|1136679|P10|COMPLETED|Period 6 - Washout||1
463953|NCT01225549|1136680|P9|COMPLETED|Period 6 - Washout||4
463954|NCT01225549|1136681|P8|COMPLETED|Period 6 - Washout||1
463955|NCT01225549|1136682|P7|COMPLETED|Period 6 - Washout||3
463956|NCT01225549|1136683|P6|COMPLETED|Period 6 - Washout||1
463957|NCT01225549|1136684|P5|COMPLETED|Period 6 - Washout||1
463958|NCT01225549|1136685|P4|COMPLETED|Period 6 - Washout||0
463959|NCT01225549|1136686|P3|COMPLETED|Period 6 - Washout||3
463960|NCT01225549|1136687|P2|COMPLETED|Period 6 - Washout||3
463961|NCT01225549|1136688|P1|COMPLETED|Period 6 - Washout||1
463962|NCT01225549|1136679|P10|STARTED|Period 6 - Washout||1
463963|NCT01225549|1136680|P9|STARTED|Period 6 - Washout||4
463964|NCT01225549|1136681|P8|STARTED|Period 6 - Washout||1
463965|NCT01225549|1136682|P7|STARTED|Period 6 - Washout||3
463966|NCT01225549|1136683|P6|STARTED|Period 6 - Washout||1
463967|NCT01225549|1136684|P5|STARTED|Period 6 - Washout||1
463968|NCT01225549|1136685|P4|STARTED|Period 6 - Washout||1
463969|NCT01225549|1136686|P3|STARTED|Period 6 - Washout||3
463970|NCT01225549|1136687|P2|STARTED|Period 6 - Washout||3
463971|NCT01225549|1136688|P1|STARTED|Period 6 - Washout||1
463972|NCT01225549|1136679|P10|NOT COMPLETED|Period 5 - Third Treatment Period||0
463973|NCT01225549|1136680|P9|NOT COMPLETED|Period 5 - Third Treatment Period||0
463974|NCT01225549|1136681|P8|NOT COMPLETED|Period 5 - Third Treatment Period||0
463975|NCT01225549|1136682|P7|NOT COMPLETED|Period 5 - Third Treatment Period||0
463976|NCT01225549|1136683|P6|NOT COMPLETED|Period 5 - Third Treatment Period||0
463977|NCT01225549|1136684|P5|NOT COMPLETED|Period 5 - Third Treatment Period||0
463978|NCT01225549|1136685|P4|NOT COMPLETED|Period 5 - Third Treatment Period||0
463979|NCT01225549|1136686|P3|NOT COMPLETED|Period 5 - Third Treatment Period||0
463980|NCT01225549|1136687|P2|NOT COMPLETED|Period 5 - Third Treatment Period||0
463981|NCT01225549|1136688|P1|NOT COMPLETED|Period 5 - Third Treatment Period||0
463982|NCT01225549|1136679|P10|COMPLETED|Period 5 - Third Treatment Period||1
463983|NCT01225549|1136680|P9|COMPLETED|Period 5 - Third Treatment Period||4
463984|NCT01225549|1136681|P8|COMPLETED|Period 5 - Third Treatment Period||1
463985|NCT01225549|1136682|P7|COMPLETED|Period 5 - Third Treatment Period||3
463986|NCT01225549|1136683|P6|COMPLETED|Period 5 - Third Treatment Period||1
463987|NCT01225549|1136684|P5|COMPLETED|Period 5 - Third Treatment Period||1
463988|NCT01225549|1136685|P4|COMPLETED|Period 5 - Third Treatment Period||1
463989|NCT01225549|1136686|P3|COMPLETED|Period 5 - Third Treatment Period||3
463990|NCT01225549|1136687|P2|COMPLETED|Period 5 - Third Treatment Period||3
463991|NCT01225549|1136688|P1|COMPLETED|Period 5 - Third Treatment Period||1
463992|NCT01225549|1136679|P10|STARTED|Period 5 - Third Treatment Period||1
463993|NCT01225549|1136680|P9|STARTED|Period 5 - Third Treatment Period||4
463994|NCT01225549|1136681|P8|STARTED|Period 5 - Third Treatment Period||1
463995|NCT01225549|1136682|P7|STARTED|Period 5 - Third Treatment Period||3
463996|NCT01225549|1136683|P6|STARTED|Period 5 - Third Treatment Period||1
463997|NCT01225549|1136684|P5|STARTED|Period 5 - Third Treatment Period||1
463998|NCT01225549|1136685|P4|STARTED|Period 5 - Third Treatment Period||1
463999|NCT01225549|1136686|P3|STARTED|Period 5 - Third Treatment Period||3
464000|NCT01225549|1136687|P2|STARTED|Period 5 - Third Treatment Period||3
464001|NCT01225549|1136688|P1|STARTED|Period 5 - Third Treatment Period||1
464002|NCT01225549|1136679|P10|NOT COMPLETED|Period 4 - Washout||0
464003|NCT01225549|1136680|P9|NOT COMPLETED|Period 4 - Washout||0
464004|NCT01225549|1136681|P8|NOT COMPLETED|Period 4 - Washout||0
464005|NCT01225549|1136682|P7|NOT COMPLETED|Period 4 - Washout||0
464006|NCT01225549|1136683|P6|NOT COMPLETED|Period 4 - Washout||0
464007|NCT01225549|1136684|P5|NOT COMPLETED|Period 4 - Washout||0
464008|NCT01225549|1136685|P4|NOT COMPLETED|Period 4 - Washout||0
464009|NCT01225549|1136686|P3|NOT COMPLETED|Period 4 - Washout||0
464010|NCT01225549|1136687|P2|NOT COMPLETED|Period 4 - Washout||1
464011|NCT01225549|1136688|P1|NOT COMPLETED|Period 4 - Washout||0
464012|NCT01225549|1136679|P10|COMPLETED|Period 4 - Washout||1
464013|NCT01225549|1136680|P9|COMPLETED|Period 4 - Washout||4
464014|NCT01225549|1136681|P8|COMPLETED|Period 4 - Washout||1
464015|NCT01225549|1136682|P7|COMPLETED|Period 4 - Washout||3
464016|NCT01225549|1136683|P6|COMPLETED|Period 4 - Washout||1
464017|NCT01225549|1136684|P5|COMPLETED|Period 4 - Washout||1
464018|NCT01225549|1136685|P4|COMPLETED|Period 4 - Washout||1
464019|NCT01225549|1136686|P3|COMPLETED|Period 4 - Washout||3
464020|NCT01225549|1136687|P2|COMPLETED|Period 4 - Washout||3
464021|NCT01225549|1136688|P1|COMPLETED|Period 4 - Washout||1
464022|NCT01225549|1136679|P10|STARTED|Period 4 - Washout||1
464023|NCT01225549|1136680|P9|STARTED|Period 4 - Washout||4
464024|NCT01225549|1136681|P8|STARTED|Period 4 - Washout||1
464025|NCT01225549|1136682|P7|STARTED|Period 4 - Washout||3
464026|NCT01225549|1136683|P6|STARTED|Period 4 - Washout||1
464027|NCT01225549|1136684|P5|STARTED|Period 4 - Washout||1
464028|NCT01225549|1136685|P4|STARTED|Period 4 - Washout||1
464029|NCT01225549|1136686|P3|STARTED|Period 4 - Washout||3
464030|NCT01225549|1136687|P2|STARTED|Period 4 - Washout||4
464031|NCT01225549|1136688|P1|STARTED|Period 4 - Washout||1
464032|NCT01225549|1136679|P10|NOT COMPLETED|Period 3 - Second Treatment Period||0
464033|NCT01225549|1136680|P9|NOT COMPLETED|Period 3 - Second Treatment Period||0
464034|NCT01225549|1136681|P8|NOT COMPLETED|Period 3 - Second Treatment Period||0
464035|NCT01225549|1136682|P7|NOT COMPLETED|Period 3 - Second Treatment Period||0
464036|NCT01225549|1136683|P6|NOT COMPLETED|Period 3 - Second Treatment Period||0
464037|NCT01225549|1136684|P5|NOT COMPLETED|Period 3 - Second Treatment Period||0
464038|NCT01225549|1136685|P4|NOT COMPLETED|Period 3 - Second Treatment Period||0
464039|NCT01225549|1136686|P3|NOT COMPLETED|Period 3 - Second Treatment Period||0
464040|NCT01225549|1136687|P2|NOT COMPLETED|Period 3 - Second Treatment Period||0
464041|NCT01225549|1136688|P1|NOT COMPLETED|Period 3 - Second Treatment Period||0
464042|NCT01225549|1136679|P10|COMPLETED|Period 3 - Second Treatment Period||1
464043|NCT01225549|1136680|P9|COMPLETED|Period 3 - Second Treatment Period||4
464044|NCT01225549|1136681|P8|COMPLETED|Period 3 - Second Treatment Period||1
464045|NCT01225549|1136682|P7|COMPLETED|Period 3 - Second Treatment Period||3
464046|NCT01225549|1136683|P6|COMPLETED|Period 3 - Second Treatment Period||1
464047|NCT01225549|1136684|P5|COMPLETED|Period 3 - Second Treatment Period||1
464048|NCT01225549|1136685|P4|COMPLETED|Period 3 - Second Treatment Period||1
464049|NCT01225549|1136686|P3|COMPLETED|Period 3 - Second Treatment Period||3
464050|NCT01225549|1136687|P2|COMPLETED|Period 3 - Second Treatment Period||4
464051|NCT01225549|1136688|P1|COMPLETED|Period 3 - Second Treatment Period||1
464052|NCT01225549|1136679|P10|STARTED|Period 3 - Second Treatment Period||1
464053|NCT01225549|1136680|P9|STARTED|Period 3 - Second Treatment Period||4
464054|NCT01225549|1136681|P8|STARTED|Period 3 - Second Treatment Period||1
464055|NCT01225549|1136682|P7|STARTED|Period 3 - Second Treatment Period||3
464056|NCT01225549|1136683|P6|STARTED|Period 3 - Second Treatment Period||1
464057|NCT01225549|1136684|P5|STARTED|Period 3 - Second Treatment Period||1
464058|NCT01225549|1136685|P4|STARTED|Period 3 - Second Treatment Period||1
464059|NCT01225549|1136686|P3|STARTED|Period 3 - Second Treatment Period||3
464060|NCT01225549|1136687|P2|STARTED|Period 3 - Second Treatment Period||4
464061|NCT01225549|1136688|P1|STARTED|Period 3 - Second Treatment Period||1
464062|NCT01225549|1136679|P10|NOT COMPLETED|Period 2 - Washout||0
464063|NCT01225549|1136680|P9|NOT COMPLETED|Period 2 - Washout||0
464064|NCT01225549|1136681|P8|NOT COMPLETED|Period 2 - Washout||0
464065|NCT01225549|1136682|P7|NOT COMPLETED|Period 2 - Washout||0
464066|NCT01225549|1136683|P6|NOT COMPLETED|Period 2 - Washout||0
464067|NCT01225549|1136684|P5|NOT COMPLETED|Period 2 - Washout||0
464068|NCT01225549|1136685|P4|NOT COMPLETED|Period 2 - Washout||0
464069|NCT01225549|1136686|P3|NOT COMPLETED|Period 2 - Washout||0
464070|NCT01225549|1136687|P2|NOT COMPLETED|Period 2 - Washout||0
464071|NCT01225549|1136688|P1|NOT COMPLETED|Period 2 - Washout||0
464072|NCT01225549|1136679|P10|COMPLETED|Period 2 - Washout||1
464073|NCT01225549|1136680|P9|COMPLETED|Period 2 - Washout||4
464074|NCT01225549|1136681|P8|COMPLETED|Period 2 - Washout||1
464075|NCT01225549|1136682|P7|COMPLETED|Period 2 - Washout||3
464076|NCT01225549|1136683|P6|COMPLETED|Period 2 - Washout||1
464077|NCT01225549|1136684|P5|COMPLETED|Period 2 - Washout||1
464078|NCT01225549|1136685|P4|COMPLETED|Period 2 - Washout||1
464079|NCT01225549|1136686|P3|COMPLETED|Period 2 - Washout||3
464080|NCT01225549|1136687|P2|COMPLETED|Period 2 - Washout||4
464081|NCT01225549|1136688|P1|COMPLETED|Period 2 - Washout||1
464082|NCT01225549|1136679|P10|STARTED|Period 2 - Washout||1
464083|NCT01225549|1136680|P9|STARTED|Period 2 - Washout||4
464084|NCT01225549|1136681|P8|STARTED|Period 2 - Washout||1
464085|NCT01225549|1136682|P7|STARTED|Period 2 - Washout||3
464086|NCT01225549|1136683|P6|STARTED|Period 2 - Washout||1
464087|NCT01225549|1136684|P5|STARTED|Period 2 - Washout||1
464088|NCT01225549|1136685|P4|STARTED|Period 2 - Washout||1
464089|NCT01225549|1136686|P3|STARTED|Period 2 - Washout||3
464090|NCT01225549|1136687|P2|STARTED|Period 2 - Washout||4
464091|NCT01225549|1136688|P1|STARTED|Period 2 - Washout||1
464092|NCT01225549|1136679|P10|NOT COMPLETED|Period 1 - First Treatment Period||0
464093|NCT01225549|1136680|P9|NOT COMPLETED|Period 1 - First Treatment Period||0
464094|NCT01225549|1136681|P8|NOT COMPLETED|Period 1 - First Treatment Period||0
464095|NCT01225549|1136682|P7|NOT COMPLETED|Period 1 - First Treatment Period||0
464096|NCT01225549|1136683|P6|NOT COMPLETED|Period 1 - First Treatment Period||0
464097|NCT01225549|1136684|P5|NOT COMPLETED|Period 1 - First Treatment Period||0
464098|NCT01225549|1136685|P4|NOT COMPLETED|Period 1 - First Treatment Period||0
464099|NCT01225549|1136686|P3|NOT COMPLETED|Period 1 - First Treatment Period||0
464100|NCT01225549|1136687|P2|NOT COMPLETED|Period 1 - First Treatment Period||0
464101|NCT01225549|1136688|P1|NOT COMPLETED|Period 1 - First Treatment Period||0
464102|NCT01225549|1136679|P10|COMPLETED|Period 1 - First Treatment Period||1
464103|NCT01225549|1136680|P9|COMPLETED|Period 1 - First Treatment Period||4
464104|NCT01225549|1136681|P8|COMPLETED|Period 1 - First Treatment Period||1
464105|NCT01225549|1136682|P7|COMPLETED|Period 1 - First Treatment Period||3
464106|NCT01225549|1136683|P6|COMPLETED|Period 1 - First Treatment Period||1
464107|NCT01225549|1136684|P5|COMPLETED|Period 1 - First Treatment Period||1
464108|NCT01225549|1136685|P4|COMPLETED|Period 1 - First Treatment Period||1
464109|NCT01225549|1136686|P3|COMPLETED|Period 1 - First Treatment Period||3
464110|NCT01225549|1136687|P2|COMPLETED|Period 1 - First Treatment Period||4
464111|NCT01225549|1136688|P1|COMPLETED|Period 1 - First Treatment Period||1
464112|NCT01225549|1136679|P10|STARTED|Period 1 - First Treatment Period||1
464113|NCT01225549|1136680|P9|STARTED|Period 1 - First Treatment Period||4
464114|NCT01225549|1136681|P8|STARTED|Period 1 - First Treatment Period||1
464115|NCT01225549|1136682|P7|STARTED|Period 1 - First Treatment Period||3
464116|NCT01225549|1136683|P6|STARTED|Period 1 - First Treatment Period||1
464117|NCT01225549|1136684|P5|STARTED|Period 1 - First Treatment Period||1
464118|NCT01225549|1136685|P4|STARTED|Period 1 - First Treatment Period||1
464119|NCT01225549|1136686|P3|STARTED|Period 1 - First Treatment Period||3
464120|NCT01225549|1136687|P2|STARTED|Period 1 - First Treatment Period||4
464121|NCT01225549|1136688|P1|STARTED|Period 1 - First Treatment Period||1
464122|NCT01225354|1136730|P1|NOT COMPLETED|Overall Study||1
464123|NCT01225354|1136730|P1|COMPLETED|Overall Study||19
464124|NCT01225354|1136730|P1|STARTED|Overall Study||20
464125|NCT01225289|1136737|P2|NOT COMPLETED|Overall Study||1
464126|NCT01225289|1136738|P1|NOT COMPLETED|Overall Study||0
464127|NCT01225289|1136737|P2|COMPLETED|Overall Study||17
464128|NCT01225289|1136738|P1|COMPLETED|Overall Study||18
464129|NCT01225289|1136737|P2|STARTED|Overall Study||18
464130|NCT01225289|1136738|P1|STARTED|Overall Study||18
464131|NCT01225263|1136752|P2|NOT COMPLETED|Weeks 13 to 24||1
464132|NCT01225263|1136753|P1|NOT COMPLETED|Weeks 13 to 24||4
464133|NCT01225263|1136752|P2|COMPLETED|Weeks 13 to 24||28
464134|NCT01225263|1136753|P1|COMPLETED|Weeks 13 to 24||24
464135|NCT01225263|1136752|P2|STARTED|Weeks 13 to 24||29
464136|NCT01225263|1136753|P1|STARTED|Weeks 13 to 24||28
464137|NCT01225263|1136752|P2|NOT COMPLETED|Weeks 1 to 12||0
464138|NCT01225263|1136753|P1|NOT COMPLETED|Weeks 1 to 12||0
464139|NCT01225263|1136752|P2|COMPLETED|Weeks 1 to 12||29
464140|NCT01225263|1136753|P1|COMPLETED|Weeks 1 to 12||28
464141|NCT01225263|1136752|P2|STARTED|Weeks 1 to 12||29
464142|NCT01225263|1136753|P1|STARTED|Weeks 1 to 12||28
464143|NCT01225211|1136771|P10|NOT COMPLETED|Overall Study||5
464144|NCT01225211|1136772|P9|NOT COMPLETED|Overall Study||1
464145|NCT01225211|1136773|P8|NOT COMPLETED|Overall Study||0
464146|NCT01225211|1136774|P7|NOT COMPLETED|Overall Study||1
464147|NCT01225211|1136775|P6|NOT COMPLETED|Overall Study||0
464148|NCT01225211|1136776|P5|NOT COMPLETED|Overall Study||0
464149|NCT01225211|1136777|P4|NOT COMPLETED|Overall Study||0
464150|NCT01225211|1136778|P3|NOT COMPLETED|Overall Study||1
464151|NCT01225211|1136779|P2|NOT COMPLETED|Overall Study||0
464152|NCT01225211|1136780|P1|NOT COMPLETED|Overall Study||0
464153|NCT01225211|1136771|P10|COMPLETED|Overall Study||57
464154|NCT01225211|1136772|P9|COMPLETED|Overall Study||62
464155|NCT01225211|1136773|P8|COMPLETED|Overall Study||11
464156|NCT01225211|1136774|P7|COMPLETED|Overall Study||41
464157|NCT01225211|1136775|P6|COMPLETED|Overall Study||21
464158|NCT01225211|1136776|P5|COMPLETED|Overall Study||23
464159|NCT01225211|1136777|P4|COMPLETED|Overall Study||27
464160|NCT01225211|1136778|P3|COMPLETED|Overall Study||20
464161|NCT01225211|1136779|P2|COMPLETED|Overall Study||20
464162|NCT01225211|1136780|P1|COMPLETED|Overall Study||21
464163|NCT01225211|1136771|P10|STARTED|Overall Study||62
464164|NCT01225211|1136772|P9|STARTED|Overall Study||63
464165|NCT01225211|1136773|P8|STARTED|Overall Study||11
464166|NCT01225211|1136774|P7|STARTED|Overall Study||42
464167|NCT01225211|1136775|P6|STARTED|Overall Study||21
464168|NCT01225211|1136776|P5|STARTED|Overall Study||23
464169|NCT01225211|1136777|P4|STARTED|Overall Study||27
464170|NCT01225211|1136778|P3|STARTED|Overall Study||21
464171|NCT01225211|1136779|P2|STARTED|Overall Study||20
464172|NCT01225211|1136780|P1|STARTED|Overall Study||21
464173|NCT01225159|1136883|P2|NOT COMPLETED|Overall Study||0
464174|NCT01225159|1136884|P1|NOT COMPLETED|Overall Study||1
464175|NCT01225159|1136883|P2|COMPLETED|Overall Study||100
464176|NCT01225159|1136884|P1|COMPLETED|Overall Study||99
464177|NCT01225159|1136883|P2|STARTED|Overall Study||100
464178|NCT01225159|1136884|P1|STARTED|Overall Study||100
464179|NCT01225146|1136894|P2|NOT COMPLETED|Overall Study||2
464180|NCT01225146|1136895|P1|NOT COMPLETED|Overall Study||0
464181|NCT01225146|1136894|P2|COMPLETED|Overall Study||0
464182|NCT01225146|1136895|P1|COMPLETED|Overall Study||6
464183|NCT01225146|1136894|P2|STARTED|Overall Study||2
464184|NCT01225146|1136895|P1|STARTED|Overall Study||6
464185|NCT01225068|1136913|P2|NOT COMPLETED|Overall Study||1
464186|NCT01225068|1136914|P1|NOT COMPLETED|Overall Study||4
464187|NCT01225068|1136913|P2|COMPLETED|Overall Study||19
464188|NCT01225068|1136914|P1|COMPLETED|Overall Study||16
464189|NCT01225068|1136913|P2|STARTED|Overall Study||20
464190|NCT01225068|1136914|P1|STARTED|Overall Study||20
464200|NCT01225029|1136950|P2|NOT COMPLETED|Overall Study||0
464201|NCT01225029|1136951|P1|NOT COMPLETED|Overall Study||0
464202|NCT01225029|1136950|P2|COMPLETED|Overall Study||32
464203|NCT01225029|1136951|P1|COMPLETED|Overall Study||32
464204|NCT01225029|1136950|P2|STARTED|Overall Study||32
464205|NCT01225029|1136951|P1|STARTED|Overall Study||32
464206|NCT01224821|1136961|P1|NOT COMPLETED|Long-Term Follow-Up||11
464207|NCT01224821|1136961|P1|COMPLETED|Long-Term Follow-Up||0
464208|NCT01224821|1136961|P1|STARTED|Long-Term Follow-Up|11/47 participants withdrawing from this study enrolled in the LTFU study for continued evaluation.|11
464209|NCT01224821|1136961|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||46
464210|NCT01224821|1136961|P1|COMPLETED|Dosimetric and Therapeutic Treatment|This participant completed the study per Protocol Amendment 2.|1
464211|NCT01224821|1136961|P1|STARTED|Dosimetric and Therapeutic Treatment||47
464212|NCT01224782|1136980|P1|NOT COMPLETED|Overall Study||264
464213|NCT01224782|1136980|P1|COMPLETED|Overall Study||730
464214|NCT01224782|1136980|P1|STARTED|Overall Study||994
464215|NCT01224678|1136991|P2|NOT COMPLETED|Overall Study||0
464216|NCT01224678|1136992|P1|NOT COMPLETED|Overall Study||0
464217|NCT01224678|1136991|P2|COMPLETED|Overall Study||150
464218|NCT01224678|1136992|P1|COMPLETED|Overall Study||150
464219|NCT01224678|1136991|P2|STARTED|Overall Study||150
464220|NCT01224678|1136992|P1|STARTED|Overall Study||150
464221|NCT01224639|1137006|P8|NOT COMPLETED|Overall Study||2
464222|NCT01224639|1137007|P7|NOT COMPLETED|Overall Study||1
464223|NCT01224639|1137008|P6|NOT COMPLETED|Overall Study||0
464224|NCT01224639|1137009|P5|NOT COMPLETED|Overall Study||2
464225|NCT01224639|1137010|P4|NOT COMPLETED|Overall Study||0
464226|NCT01224639|1137011|P3|NOT COMPLETED|Overall Study||0
464227|NCT01224639|1137012|P2|NOT COMPLETED|Overall Study||0
464228|NCT01224639|1137013|P1|NOT COMPLETED|Overall Study||0
464229|NCT01224639|1137006|P8|COMPLETED|Overall Study||3
464230|NCT01224639|1137007|P7|COMPLETED|Overall Study||17
464231|NCT01224639|1137008|P6|COMPLETED|Overall Study||4
464232|NCT01224639|1137009|P5|COMPLETED|Overall Study||19
464233|NCT01224639|1137010|P4|COMPLETED|Overall Study||3
464234|NCT01224639|1137011|P3|COMPLETED|Overall Study||21
464235|NCT01224639|1137012|P2|COMPLETED|Overall Study||5
464236|NCT01224639|1137013|P1|COMPLETED|Overall Study||19
464237|NCT01224639|1137006|P8|STARTED|Overall Study||5
464238|NCT01224639|1137007|P7|STARTED|Overall Study||18
464239|NCT01224639|1137008|P6|STARTED|Overall Study||4
464240|NCT01224639|1137009|P5|STARTED|Overall Study||21
464241|NCT01224639|1137010|P4|STARTED|Overall Study||3
464242|NCT01224639|1137011|P3|STARTED|Overall Study||21
464243|NCT01224639|1137012|P2|STARTED|Overall Study||5
464244|NCT01224639|1137013|P1|STARTED|Overall Study||19
464245|NCT01224626|1137119|P1|NOT COMPLETED|Overall Study||1
464246|NCT01224626|1137119|P1|COMPLETED|Overall Study||41
464247|NCT01224626|1137119|P1|STARTED|Overall Study||42
464248|NCT01224444|1137125|P1|NOT COMPLETED|Overall Study||0
464249|NCT01224444|1137125|P1|COMPLETED|Overall Study||269
464250|NCT01224444|1137125|P1|STARTED|Overall Study||269
464251|NCT01224431|1137131|P2|NOT COMPLETED|Overall Study||5
464252|NCT01224431|1137132|P1|NOT COMPLETED|Overall Study||0
464253|NCT01224431|1137131|P2|COMPLETED|Overall Study||25
464254|NCT01224431|1137132|P1|COMPLETED|Overall Study||30
464255|NCT01224431|1137131|P2|STARTED|Overall Study||30
464256|NCT01224431|1137132|P1|STARTED|Overall Study||30
464257|NCT01224236|1137140|P2|NOT COMPLETED|Overall Study||1
464258|NCT01224236|1137141|P1|NOT COMPLETED|Overall Study||1
464259|NCT01224236|1137140|P2|COMPLETED|Overall Study||73
464260|NCT01224236|1137141|P1|COMPLETED|Overall Study||75
464261|NCT01224236|1137140|P2|STARTED|Overall Study||74
464262|NCT01224236|1137141|P1|STARTED|Overall Study||76
464263|NCT01224171|1137151|P2|NOT COMPLETED|Overall Study||13
464264|NCT01224171|1137152|P1|NOT COMPLETED|Overall Study||15
464265|NCT01224171|1137151|P2|COMPLETED|Overall Study|Completed study is defined as patients who completed the Week 10 assessments.|196
464266|NCT01224171|1137152|P1|COMPLETED|Overall Study|Completed study is defined as patients who completed the Week 10 assessments.|192
464267|NCT01224171|1137151|P2|TNFα Antagonist Failure Population|Overall Study|Previously failed (inadequate response, loss of response, or intolerance) TNFα antagonist therapy|158
464268|NCT01224171|1137152|P1|TNFα Antagonist Failure Population|Overall Study|Previously failed (inadequate response, loss of response, or intolerance) TNFα antagonist therapy|157
464269|NCT01224171|1137151|P2|STARTED|Overall Study||209
464270|NCT01224171|1137152|P1|STARTED|Overall Study||207
464271|NCT01224015|1137175|P3|NOT COMPLETED|Overall Study||13
464272|NCT01224015|1137176|P2|NOT COMPLETED|Overall Study||16
464273|NCT01224015|1137177|P1|NOT COMPLETED|Overall Study||14
464274|NCT01224015|1137175|P3|COMPLETED|Overall Study||83
464275|NCT01224015|1137176|P2|COMPLETED|Overall Study||211
464276|NCT01224015|1137177|P1|COMPLETED|Overall Study||347
464277|NCT01224015|1137175|P3|STARTED|Overall Study||96
464278|NCT01224015|1137176|P2|STARTED|Overall Study||227
464279|NCT01224015|1137177|P1|STARTED|Overall Study||361
464280|NCT01223963|1137185|P1|NOT COMPLETED|Overall Study||0
464281|NCT01223963|1137185|P1|COMPLETED|Overall Study||93
464282|NCT01223963|1137185|P1|STARTED|Overall Study|All subjects treated between May 1 2008 and Dec 31 2009 in selected clinics were to be asked.|93
464283|NCT01223937|1137192|P2|NOT COMPLETED|Overall Study||18
464284|NCT01223937|1137193|P1|NOT COMPLETED|Overall Study||17
464285|NCT01223937|1137192|P2|COMPLETED|Overall Study||119
464286|NCT01223937|1137193|P1|COMPLETED|Overall Study||114
464287|NCT01223937|1137192|P2|Safety Analysis Set (SAS)|Overall Study|SAS: participants with at least one post-treatment safety assessment|135
464288|NCT01223937|1137193|P1|Safety Analysis Set (SAS)|Overall Study|SAS: participants with at least one post-treatment safety assessment|126
464289|NCT01223937|1137192|P2|Full Analysis Set (FAS)|Overall Study|FAS: participants with at least one post-treatment efficacy assessment|133
464290|NCT01223937|1137193|P1|Full Analysis Set (FAS)|Overall Study|FAS: participants with at least one post-treatment efficacy assessment|128
464291|NCT01223937|1137192|P2|STARTED|Overall Study|Intent to treat population: randomized participants regardless if they were exposed to treatment.|137
464292|NCT01223937|1137193|P1|STARTED|Overall Study|Intent to treat population: randomized participants regardless if they were exposed to treatment.|131
464293|NCT01223703|1137217|P2|NOT COMPLETED|Overall Study||0
464294|NCT01223703|1137218|P1|NOT COMPLETED|Overall Study||0
464295|NCT01223703|1137217|P2|COMPLETED|Overall Study||66
464296|NCT01223703|1137218|P1|COMPLETED|Overall Study||67
464297|NCT01223703|1137217|P2|STARTED|Overall Study||66
464298|NCT01223703|1137218|P1|STARTED|Overall Study||67
464299|NCT01223469|1137232|P2|NOT COMPLETED|Overall Study||0
464300|NCT01223469|1137233|P1|NOT COMPLETED|Overall Study||0
464301|NCT01223469|1137232|P2|COMPLETED|Overall Study||43
464302|NCT01223469|1137233|P1|COMPLETED|Overall Study||34
464303|NCT01223469|1137232|P2|STARTED|Overall Study||43
464304|NCT01223469|1137233|P1|STARTED|Overall Study||34
464305|NCT01223404|1137239|P6|NOT COMPLETED|Third Intervention (1 Day)||0
464306|NCT01223404|1137240|P5|NOT COMPLETED|Third Intervention (1 Day)||0
464307|NCT01223404|1137241|P4|NOT COMPLETED|Third Intervention (1 Day)||1
464308|NCT01223404|1137242|P3|NOT COMPLETED|Third Intervention (1 Day)||0
464309|NCT01223404|1137243|P2|NOT COMPLETED|Third Intervention (1 Day)||0
464310|NCT01223404|1137244|P1|NOT COMPLETED|Third Intervention (1 Day)||0
464311|NCT01223404|1137239|P6|COMPLETED|Third Intervention (1 Day)||3
464312|NCT01223404|1137240|P5|COMPLETED|Third Intervention (1 Day)||2
464313|NCT01223404|1137241|P4|COMPLETED|Third Intervention (1 Day)||3
464314|NCT01223404|1137242|P3|COMPLETED|Third Intervention (1 Day)||4
464315|NCT01223404|1137243|P2|COMPLETED|Third Intervention (1 Day)||3
464316|NCT01223404|1137244|P1|COMPLETED|Third Intervention (1 Day)||3
464317|NCT01223404|1137239|P6|STARTED|Third Intervention (1 Day)||3
464318|NCT01223404|1137240|P5|STARTED|Third Intervention (1 Day)||2
464319|NCT01223404|1137241|P4|STARTED|Third Intervention (1 Day)||4
464320|NCT01223404|1137242|P3|STARTED|Third Intervention (1 Day)||4
464321|NCT01223404|1137243|P2|STARTED|Third Intervention (1 Day)||3
464322|NCT01223404|1137244|P1|STARTED|Third Intervention (1 Day)||3
464323|NCT01223404|1137239|P6|NOT COMPLETED|Second Intervention (1 Day)||0
464324|NCT01223404|1137240|P5|NOT COMPLETED|Second Intervention (1 Day)||0
464325|NCT01223404|1137241|P4|NOT COMPLETED|Second Intervention (1 Day)||0
464326|NCT01223404|1137242|P3|NOT COMPLETED|Second Intervention (1 Day)||0
464327|NCT01223404|1137243|P2|NOT COMPLETED|Second Intervention (1 Day)||0
464328|NCT01223404|1137244|P1|NOT COMPLETED|Second Intervention (1 Day)||1
464329|NCT01223404|1137239|P6|COMPLETED|Second Intervention (1 Day)||3
464330|NCT01223404|1137240|P5|COMPLETED|Second Intervention (1 Day)||2
464331|NCT01223404|1137241|P4|COMPLETED|Second Intervention (1 Day)||4
464332|NCT01223404|1137242|P3|COMPLETED|Second Intervention (1 Day)||4
464333|NCT01223404|1137243|P2|COMPLETED|Second Intervention (1 Day)||3
464334|NCT01223404|1137244|P1|COMPLETED|Second Intervention (1 Day)||3
464335|NCT01223404|1137239|P6|STARTED|Second Intervention (1 Day)||3
464336|NCT01223404|1137240|P5|STARTED|Second Intervention (1 Day)||2
464337|NCT01223404|1137241|P4|STARTED|Second Intervention (1 Day)||4
464338|NCT01223404|1137242|P3|STARTED|Second Intervention (1 Day)||4
464339|NCT01223404|1137243|P2|STARTED|Second Intervention (1 Day)||3
464340|NCT01223404|1137244|P1|STARTED|Second Intervention (1 Day)||4
464341|NCT01223404|1137239|P6|NOT COMPLETED|First Intervention (1 Day)||0
464342|NCT01223404|1137240|P5|NOT COMPLETED|First Intervention (1 Day)||0
464343|NCT01223404|1137241|P4|NOT COMPLETED|First Intervention (1 Day)||1
464344|NCT01223404|1137242|P3|NOT COMPLETED|First Intervention (1 Day)||0
464345|NCT01223404|1137243|P2|NOT COMPLETED|First Intervention (1 Day)||0
464346|NCT01223404|1137244|P1|NOT COMPLETED|First Intervention (1 Day)||0
464347|NCT01223404|1137239|P6|COMPLETED|First Intervention (1 Day)||3
464348|NCT01223404|1137240|P5|COMPLETED|First Intervention (1 Day)||2
464349|NCT01223404|1137241|P4|COMPLETED|First Intervention (1 Day)||4
464350|NCT01223404|1137242|P3|COMPLETED|First Intervention (1 Day)||4
464351|NCT01223404|1137243|P2|COMPLETED|First Intervention (1 Day)||3
464352|NCT01223404|1137244|P1|COMPLETED|First Intervention (1 Day)||4
464353|NCT01223404|1137239|P6|STARTED|First Intervention (1 Day)||3
464354|NCT01223404|1137240|P5|STARTED|First Intervention (1 Day)||2
464355|NCT01223404|1137241|P4|STARTED|First Intervention (1 Day)||5
464356|NCT01223404|1137242|P3|STARTED|First Intervention (1 Day)||4
464357|NCT01223404|1137243|P2|STARTED|First Intervention (1 Day)||3
464358|NCT01223404|1137244|P1|STARTED|First Intervention (1 Day)||4
464359|NCT01223365|1137267|P1|NOT COMPLETED|Open-label Treatment Period||102
464360|NCT01223365|1137267|P1|COMPLETED|Open-label Treatment Period||189
464361|NCT01223365|1137267|P1|STARTED|Open-label Treatment Period||291
464362|NCT01223365|1137267|P1|NOT COMPLETED|Open-label Titration Period||39
464363|NCT01223365|1137267|P1|COMPLETED|Open-label Titration Period||291
464364|NCT01223365|1137267|P1|Achieved Stable Pain Relief|Open-label Titration Period||294
464365|NCT01223365|1137267|P1|Safety Analysis Set|Open-label Titration Period||329
464366|NCT01223365|1137267|P1|STARTED|Open-label Titration Period||330
464367|NCT01223352|1137310|P2|NOT COMPLETED|Overall Study||0
464368|NCT01223352|1137311|P1|NOT COMPLETED|Overall Study||0
464369|NCT01223352|1137310|P2|COMPLETED|Overall Study||33
464370|NCT01223352|1137311|P1|COMPLETED|Overall Study||31
464371|NCT01223352|1137310|P2|STARTED|Overall Study||33
464372|NCT01223352|1137311|P1|STARTED|Overall Study||31
464373|NCT01223235|1137331|P1|NOT COMPLETED|Overall Study||1
464374|NCT01223235|1137331|P1|COMPLETED|Overall Study||21
464375|NCT01223235|1137331|P1|STARTED|Overall Study||22
464376|NCT01223196|1137339|P2|NOT COMPLETED|Overall Study||0
464377|NCT01223196|1137340|P1|NOT COMPLETED|Overall Study||4
464378|NCT01223196|1137339|P2|COMPLETED|Overall Study||11
464379|NCT01223196|1137340|P1|COMPLETED|Overall Study||9
464380|NCT01223196|1137339|P2|STARTED|Overall Study||11
464381|NCT01223196|1137340|P1|STARTED|Overall Study||13
464382|NCT01223183|1137352|P2|NOT COMPLETED|Imaging Day 2||0
464383|NCT01223183|1137353|P1|NOT COMPLETED|Imaging Day 2||0
464384|NCT01223183|1137352|P2|COMPLETED|Imaging Day 2||9
464385|NCT01223183|1137353|P1|COMPLETED|Imaging Day 2||8
464386|NCT01223183|1137352|P2|STARTED|Imaging Day 2||9
464387|NCT01223183|1137353|P1|STARTED|Imaging Day 2||8
464388|NCT01223183|1137352|P2|NOT COMPLETED|Washout Period (5-24 Days)||0
464389|NCT01223183|1137353|P1|NOT COMPLETED|Washout Period (5-24 Days)||2
464390|NCT01223183|1137352|P2|COMPLETED|Washout Period (5-24 Days)||9
464391|NCT01223183|1137353|P1|COMPLETED|Washout Period (5-24 Days)||8
464392|NCT01223183|1137352|P2|STARTED|Washout Period (5-24 Days)||9
464393|NCT01223183|1137353|P1|STARTED|Washout Period (5-24 Days)||10
464394|NCT01223183|1137352|P2|NOT COMPLETED|Imaging Day 1||1
464395|NCT01223183|1137353|P1|NOT COMPLETED|Imaging Day 1||0
464396|NCT01223183|1137352|P2|COMPLETED|Imaging Day 1||9
464397|NCT01223183|1137353|P1|COMPLETED|Imaging Day 1||10
464398|NCT01223183|1137352|P2|STARTED|Imaging Day 1||10
464399|NCT01223183|1137353|P1|STARTED|Imaging Day 1||10
464400|NCT01223027|1137363|P2|NOT COMPLETED|Overall Study||277
464401|NCT01223027|1137364|P1|NOT COMPLETED|Overall Study||274
464402|NCT01223027|1137363|P2|COMPLETED|Overall Study|Completed = Ongoing at data cut-off of 25-Jan-2013|9
464403|NCT01223027|1137364|P1|COMPLETED|Overall Study|Completed = Ongoing at data cut-off of 25-Jan-2013|10
464404|NCT01223027|1137363|P2|STARTED|Overall Study||286
464405|NCT01223027|1137364|P1|STARTED|Overall Study||284
464406|NCT01223001|1137387|P2|NOT COMPLETED|Overall Study||4
464407|NCT01223001|1137388|P1|NOT COMPLETED|Overall Study||4
464408|NCT01223001|1137387|P2|COMPLETED|Overall Study||0
464409|NCT01223001|1137388|P1|COMPLETED|Overall Study||0
464410|NCT01223001|1137387|P2|STARTED|Overall Study||4
464411|NCT01223001|1137388|P1|STARTED|Overall Study||4
464412|NCT01222884|1137396|P2|NOT COMPLETED|Overall Study||4
464413|NCT01222884|1137397|P1|NOT COMPLETED|Overall Study||24
464414|NCT01222884|1137396|P2|COMPLETED|Overall Study||113
464415|NCT01222884|1137397|P1|COMPLETED|Overall Study||210
464416|NCT01222884|1137396|P2|STARTED|Overall Study||117
464417|NCT01222884|1137397|P1|STARTED|Overall Study||234
464418|NCT01222871|1137407|P2|NOT COMPLETED|Overall Study||0
464419|NCT01222871|1137408|P1|NOT COMPLETED|Overall Study||0
464420|NCT01222871|1137407|P2|COMPLETED|Overall Study||0
464421|NCT01222871|1137408|P1|COMPLETED|Overall Study||0
464422|NCT01222871|1137407|P2|STARTED|Overall Study||0
464423|NCT01222871|1137408|P1|STARTED|Overall Study||0
464424|NCT01222832|1137417|P2|NOT COMPLETED|Overall Study||1
464425|NCT01222832|1137418|P1|NOT COMPLETED|Overall Study||0
464426|NCT01222832|1137417|P2|COMPLETED|Overall Study||112
464427|NCT01222832|1137418|P1|COMPLETED|Overall Study||113
464428|NCT01222832|1137417|P2|STARTED|Overall Study||113
464429|NCT01222832|1137418|P1|STARTED|Overall Study||113
464430|NCT01222715|1137426|P2|NOT COMPLETED|Overall Study||27
464431|NCT01222715|1137427|P1|NOT COMPLETED|Overall Study||36
464432|NCT01222715|1137426|P2|COMPLETED|Overall Study||16
464433|NCT01222715|1137427|P1|COMPLETED|Overall Study||8
464434|NCT01222715|1137426|P2|STARTED|Overall Study||43
464435|NCT01222715|1137427|P1|STARTED|Overall Study||44
464436|NCT01222689|1137437|P1|NOT COMPLETED|Overall Study||0
464437|NCT01222689|1137437|P1|COMPLETED|Overall Study||46
464438|NCT01222689|1137437|P1|STARTED|Overall Study||46
464439|NCT01222585|1137450|P1|NOT COMPLETED|Overall Study||0
464440|NCT01222585|1137450|P1|COMPLETED|Overall Study||24
464441|NCT01222585|1137450|P1|STARTED|Overall Study||24
464442|NCT01222572|1137460|P3|NOT COMPLETED|Overall Study||0
464443|NCT01222572|1137461|P2|NOT COMPLETED|Overall Study||0
464444|NCT01222572|1137462|P1|NOT COMPLETED|Overall Study||0
464445|NCT01222572|1137460|P3|COMPLETED|Overall Study||0
464446|NCT01222572|1137461|P2|COMPLETED|Overall Study||0
464447|NCT01222572|1137462|P1|COMPLETED|Overall Study||1
464448|NCT01222572|1137460|P3|STARTED|Overall Study||0
464449|NCT01222572|1137461|P2|STARTED|Overall Study||0
464450|NCT01222572|1137462|P1|STARTED|Overall Study||1
464451|NCT01222533|1137466|P1|NOT COMPLETED|Overall Study||14
464452|NCT01222533|1137466|P1|COMPLETED|Overall Study|Completed planned observation time (week 21)|140
464453|NCT01222533|1137466|P1|Received Tio HH18|Overall Study||146
464454|NCT01222533|1137466|P1|Received Tio R5|Overall Study||150
464455|NCT01222533|1137466|P1|Received Tio R2.5|Overall Study||145
464456|NCT01222533|1137466|P1|Received Tio R1.25|Overall Study||147
464457|NCT01222533|1137466|P1|Received Placebo|Overall Study||147
464458|NCT01222533|1137466|P1|STARTED|Overall Study|Entered and treated.|154
464459|NCT01222520|1137605|P2|NOT COMPLETED|Double-blind Period||2
464460|NCT01222520|1137606|P1|NOT COMPLETED|Double-blind Period||1
464461|NCT01222520|1137605|P2|COMPLETED|Double-blind Period||85
464462|NCT01222520|1137606|P1|COMPLETED|Double-blind Period||86
464463|NCT01222520|1137605|P2|STARTED|Double-blind Period||87
464464|NCT01222520|1137606|P1|STARTED|Double-blind Period||87
464465|NCT01222520|1137605|P2|NOT COMPLETED|Open-label run-in Period||23
464466|NCT01222520|1137606|P1|NOT COMPLETED|Open-label run-in Period||0
464467|NCT01222520|1137605|P2|COMPLETED|Open-label run-in Period||174
464468|NCT01222520|1137606|P1|COMPLETED|Open-label run-in Period||0
464469|NCT01222520|1137605|P2|STARTED|Open-label run-in Period||197
464470|NCT01222520|1137606|P1|STARTED|Open-label run-in Period||0
464471|NCT01222507|1137624|P1|NOT COMPLETED|Overall Study||2
464472|NCT01222507|1137624|P1|COMPLETED|Overall Study||60
464473|NCT01222507|1137624|P1|STARTED|Overall Study||62
464474|NCT01222416|1137630|P2|NOT COMPLETED|Overall Study||0
464475|NCT01222416|1137631|P1|NOT COMPLETED|Overall Study||20
464476|NCT01222416|1137630|P2|COMPLETED|Overall Study||0
464477|NCT01222416|1137631|P1|COMPLETED|Overall Study||30
464478|NCT01222416|1137630|P2|STARTED|Overall Study||0
464479|NCT01222416|1137631|P1|STARTED|Overall Study||50
464480|NCT01222403|1137641|P2|NOT COMPLETED|Overall Study||2
464481|NCT01222403|1137642|P1|NOT COMPLETED|Overall Study||0
464482|NCT01222403|1137641|P2|COMPLETED|Overall Study||379
464483|NCT01222403|1137642|P1|COMPLETED|Overall Study||386
464484|NCT01222403|1137641|P2|STARTED|Overall Study||381
464485|NCT01222403|1137642|P1|STARTED|Overall Study||386
464486|NCT01222390|1137652|P1|NOT COMPLETED|Overall Study||0
464487|NCT01222390|1137652|P1|COMPLETED|Overall Study||12
464488|NCT01222390|1137652|P1|STARTED|Overall Study||12
464489|NCT01222286|1137658|P2|NOT COMPLETED|Overall Study||0
464490|NCT01222286|1137659|P1|NOT COMPLETED|Overall Study||0
464491|NCT01222286|1137658|P2|COMPLETED|Overall Study||14
464492|NCT01222286|1137659|P1|COMPLETED|Overall Study||16
464493|NCT01222286|1137658|P2|STARTED|Overall Study||14
464494|NCT01222286|1137659|P1|STARTED|Overall Study||16
464495|NCT01222273|1137671|P1|NOT COMPLETED|Overall Study||0
464496|NCT01222273|1137671|P1|COMPLETED|Overall Study||7
464497|NCT01222273|1137671|P1|STARTED|Overall Study||7
464498|NCT01222234|1137680|P3|NOT COMPLETED|Overall Study||2
464499|NCT01222234|1137681|P2|NOT COMPLETED|Overall Study||2
464500|NCT01222234|1137682|P1|NOT COMPLETED|Overall Study||0
464501|NCT01222234|1137680|P3|COMPLETED|Overall Study||22
464502|NCT01222234|1137681|P2|COMPLETED|Overall Study||15
464503|NCT01222234|1137682|P1|COMPLETED|Overall Study||15
464504|NCT01222234|1137680|P3|STARTED|Overall Study||24
464505|NCT01222234|1137681|P2|STARTED|Overall Study||17
464506|NCT01222234|1137682|P1|STARTED|Overall Study||15
464507|NCT01222195|1137691|P1|NOT COMPLETED|Overall Study||0
464508|NCT01222195|1137691|P1|COMPLETED|Overall Study||1
464509|NCT01222195|1137691|P1|STARTED|Overall Study||1
464510|NCT01222117|1137706|P11|NOT COMPLETED|Overall Study||0
464511|NCT01222117|1137707|P10|NOT COMPLETED|Overall Study||2
464512|NCT01222117|1137708|P9|NOT COMPLETED|Overall Study||3
464513|NCT01222117|1137709|P8|NOT COMPLETED|Overall Study||0
464514|NCT01222117|1137710|P7|NOT COMPLETED|Overall Study||0
464515|NCT01222117|1137711|P6|NOT COMPLETED|Overall Study||1
464516|NCT01222117|1137712|P5|NOT COMPLETED|Overall Study||1
464517|NCT01222117|1137713|P4|NOT COMPLETED|Overall Study||1
464518|NCT01222117|1137714|P3|NOT COMPLETED|Overall Study||0
464519|NCT01222117|1137715|P2|NOT COMPLETED|Overall Study||1
464520|NCT01222117|1137716|P1|NOT COMPLETED|Overall Study||3
464521|NCT01222117|1137706|P11|COMPLETED|Overall Study||6
464522|NCT01222117|1137707|P10|COMPLETED|Overall Study||17
464523|NCT01222117|1137708|P9|COMPLETED|Overall Study||20
464524|NCT01222117|1137709|P8|COMPLETED|Overall Study||12
464525|NCT01222117|1137710|P7|COMPLETED|Overall Study||13
464526|NCT01222117|1137711|P6|COMPLETED|Overall Study||9
464527|NCT01222117|1137712|P5|COMPLETED|Overall Study||8
464528|NCT01222117|1137713|P4|COMPLETED|Overall Study||19
464529|NCT01222117|1137714|P3|COMPLETED|Overall Study||22
464530|NCT01222117|1137715|P2|COMPLETED|Overall Study||19
464531|NCT01222117|1137716|P1|COMPLETED|Overall Study||17
464532|NCT01222117|1137706|P11|STARTED|Overall Study||6
464533|NCT01222117|1137707|P10|STARTED|Overall Study||19
464534|NCT01222117|1137708|P9|STARTED|Overall Study||23
464535|NCT01222117|1137709|P8|STARTED|Overall Study||12
464536|NCT01222117|1137710|P7|STARTED|Overall Study||13
464537|NCT01222117|1137711|P6|STARTED|Overall Study||10
464538|NCT01222117|1137712|P5|STARTED|Overall Study||9
464539|NCT01222117|1137713|P4|STARTED|Overall Study||20
464540|NCT01222117|1137714|P3|STARTED|Overall Study||22
464541|NCT01222117|1137715|P2|STARTED|Overall Study||20
464542|NCT01222117|1137716|P1|STARTED|Overall Study||20
464543|NCT01222104|1137751|P1|NOT COMPLETED|Overall Study||47
464544|NCT01222104|1137751|P1|COMPLETED|Overall Study||587
464545|NCT01222104|1137751|P1|Completed 30-day Visit-No Angio-Seal|Overall Study||90
464546|NCT01222104|1137751|P1|Completed 30-day Visit-Angio-Seal|Overall Study||497
464547|NCT01222104|1137751|P1|Successful Deployment and Hemostasis|Overall Study||524
464548|NCT01222104|1137751|P1|Successful Deployment|Overall Study||529
464549|NCT01222104|1137751|P1|Angio-Seal Deployment Attempted|Overall Study||534
464550|NCT01222104|1137751|P1|STARTED|Overall Study||634
464551|NCT01222091|1137765|P2|NOT COMPLETED|Overall Study||0
464552|NCT01222091|1137766|P1|NOT COMPLETED|Overall Study||0
464553|NCT01222091|1137765|P2|COMPLETED|Overall Study||5
464554|NCT01222091|1137766|P1|COMPLETED|Overall Study||5
464555|NCT01222091|1137765|P2|STARTED|Overall Study||5
464556|NCT01222091|1137766|P1|STARTED|Overall Study||5
464557|NCT01222078|1137774|P1|NOT COMPLETED|Overall Study||1
464558|NCT01222078|1137774|P1|COMPLETED|Overall Study||0
464559|NCT01222078|1137774|P1|STARTED|Overall Study||1
464560|NCT01221948|1137808|P1|NOT COMPLETED|Overall Study||14
464561|NCT01221948|1137808|P1|COMPLETED|Overall Study||39
464562|NCT01221948|1137808|P1|STARTED|Overall Study||53
464563|NCT01221753|1137819|P1|NOT COMPLETED|Overall Study||1
464564|NCT01221753|1137819|P1|COMPLETED|Overall Study||6
464565|NCT01221753|1137819|P1|STARTED|Overall Study||7
464566|NCT01221727|1137826|P2|NOT COMPLETED|Overall Study||1
464567|NCT01221727|1137827|P1|NOT COMPLETED|Overall Study||3
464568|NCT01221727|1137826|P2|COMPLETED|Overall Study||8
464569|NCT01221727|1137827|P1|COMPLETED|Overall Study||18
464570|NCT01221727|1137826|P2|Treated|Overall Study|Number of subjects received investigational product|8
464571|NCT01221727|1137827|P1|Treated|Overall Study|Number of subjects received investigational product|19
464572|NCT01221727|1137826|P2|STARTED|Overall Study|Number of subjects randomized into the study|9
464573|NCT01221727|1137827|P1|STARTED|Overall Study|Number of subjects randomized into the study|21
464574|NCT01221623|1137848|P2|NOT COMPLETED|Overall Study||14
464575|NCT01221623|1137849|P1|NOT COMPLETED|Overall Study||38
464576|NCT01221623|1137848|P2|COMPLETED|Overall Study||127
464577|NCT01221623|1137849|P1|COMPLETED|Overall Study||236
464578|NCT01221623|1137848|P2|STARTED|Overall Study||141
464579|NCT01221623|1137849|P1|STARTED|Overall Study||274
464580|NCT01221597|1137873|P2|NOT COMPLETED|Overall Study||16
464581|NCT01221597|1137874|P1|NOT COMPLETED|Overall Study||36
464582|NCT01221597|1137873|P2|COMPLETED|Overall Study||124
464583|NCT01221597|1137874|P1|COMPLETED|Overall Study||241
464584|NCT01221597|1137873|P2|STARTED|Overall Study||140
464585|NCT01221597|1137874|P1|STARTED|Overall Study||277
464586|NCT01221441|1137898|P2|NOT COMPLETED|Overall Study||12
464587|NCT01221441|1137899|P1|NOT COMPLETED|Overall Study||22
464588|NCT01221441|1137898|P2|COMPLETED|Overall Study||23
464589|NCT01221441|1137899|P1|COMPLETED|Overall Study||45
464590|NCT01221441|1137898|P2|STARTED|Overall Study||35
464591|NCT01221441|1137899|P1|STARTED|Overall Study||67
464592|NCT01221363|1137931|P2|NOT COMPLETED|Overall Study||5
464593|NCT01221363|1137932|P1|NOT COMPLETED|Overall Study||12
464594|NCT01221363|1137931|P2|COMPLETED|Overall Study||68
464595|NCT01221363|1137932|P1|COMPLETED|Overall Study||81
464596|NCT01221363|1137931|P2|STARTED|Overall Study||73
464597|NCT01221363|1137932|P1|STARTED|Overall Study||93
464598|NCT01221350|1137942|P2|NOT COMPLETED|Overall Study||3
464599|NCT01221350|1137943|P1|NOT COMPLETED|Overall Study||5
464600|NCT01221350|1137942|P2|COMPLETED|Overall Study||24
464601|NCT01221350|1137943|P1|COMPLETED|Overall Study||23
464602|NCT01221350|1137942|P2|Analysis Population|Overall Study||24
464603|NCT01221350|1137943|P1|Analysis Population|Overall Study||23
464604|NCT01221350|1137942|P2|Received Intervention|Overall Study||27
464605|NCT01221350|1137943|P1|Received Intervention|Overall Study||28
464606|NCT01221350|1137942|P2|STARTED|Overall Study||27
464607|NCT01221350|1137943|P1|STARTED|Overall Study||28
464608|NCT01221311|1137985|P2|NOT COMPLETED|Overall Study||0
464609|NCT01221311|1137986|P1|NOT COMPLETED|Overall Study||0
464610|NCT01221311|1137985|P2|COMPLETED|Overall Study||55
464611|NCT01221311|1137986|P1|COMPLETED|Overall Study||57
464612|NCT01221311|1137985|P2|STARTED|Overall Study||55
464613|NCT01221311|1137986|P1|STARTED|Overall Study||57
464614|NCT01221298|1137992|P1|NOT COMPLETED|Overall Study||0
464615|NCT01221298|1137992|P1|COMPLETED|Overall Study|The number of participants who completed study drug|11
464616|NCT01221298|1137992|P1|STARTED|Overall Study||11
464617|NCT01221285|1138002|P1|NOT COMPLETED|Overall Study||1
464618|NCT01221285|1138002|P1|COMPLETED|Overall Study||10
464619|NCT01221285|1138002|P1|STARTED|Overall Study||11
464620|NCT01221272|1138011|P2|NOT COMPLETED|Period 2||2
464621|NCT01221272|1138012|P1|NOT COMPLETED|Period 2||0
464622|NCT01221272|1138011|P2|COMPLETED|Period 2||37
464623|NCT01221272|1138012|P1|COMPLETED|Period 2||39
464624|NCT01221272|1138011|P2|STARTED|Period 2|1 participant did not complete Period 1, but started and completed Period 2.|39
464625|NCT01221272|1138012|P1|STARTED|Period 2||39
464626|NCT01221272|1138011|P2|NOT COMPLETED|Period 1||2
464627|NCT01221272|1138012|P1|NOT COMPLETED|Period 1||2
464628|NCT01221272|1138011|P2|COMPLETED|Period 1||38
464629|NCT01221272|1138012|P1|COMPLETED|Period 1||39
464630|NCT01221272|1138011|P2|STARTED|Period 1||40
464631|NCT01221272|1138012|P1|STARTED|Period 1||41
464632|NCT01221090|1138031|P4|NOT COMPLETED|Overall Study||22
464633|NCT01221090|1138032|P3|NOT COMPLETED|Overall Study||42
464634|NCT01221090|1138033|P2|NOT COMPLETED|Overall Study||34
464635|NCT01221090|1138034|P1|NOT COMPLETED|Overall Study||15
464636|NCT01221090|1138031|P4|COMPLETED|Overall Study||73
464637|NCT01221090|1138032|P3|COMPLETED|Overall Study||57
464638|NCT01221090|1138033|P2|COMPLETED|Overall Study||47
464639|NCT01221090|1138034|P1|COMPLETED|Overall Study||86
464640|NCT01221090|1138031|P4|STARTED|Overall Study||95
464641|NCT01221090|1138032|P3|STARTED|Overall Study||99
464642|NCT01221090|1138033|P2|STARTED|Overall Study||81
464643|NCT01221090|1138034|P1|STARTED|Overall Study||101
464644|NCT01220973|1138060|P1|NOT COMPLETED|Overall Study||4
464645|NCT01220973|1138060|P1|COMPLETED|Overall Study||23
464646|NCT01220973|1138060|P1|STARTED|Overall Study||27
464647|NCT01220869|1138064|P1|NOT COMPLETED|Overall Study||6
464648|NCT01220869|1138064|P1|COMPLETED|Overall Study||104
464649|NCT01220869|1138064|P1|STARTED|Overall Study||110
464650|NCT01220739|1138074|P2|NOT COMPLETED|Overall Study||0
464651|NCT01220739|1138075|P1|NOT COMPLETED|Overall Study||0
464652|NCT01220739|1138074|P2|COMPLETED|Overall Study||5
464653|NCT01220739|1138075|P1|COMPLETED|Overall Study||7
464654|NCT01220739|1138074|P2|STARTED|Overall Study||5
464655|NCT01220739|1138075|P1|STARTED|Overall Study||7
464656|NCT01220609|1138083|P1|NOT COMPLETED|Overall Study||3
464657|NCT01220609|1138083|P1|COMPLETED|Overall Study|Eligible and treated patients|23
464658|NCT01220609|1138083|P1|STARTED|Overall Study||26
464659|NCT01220557|1138097|P2|NOT COMPLETED|Overall Study||5
464660|NCT01220557|1138098|P1|NOT COMPLETED|Overall Study||6
464661|NCT01220557|1138097|P2|COMPLETED|Overall Study|per protocol analysis including patients which participated in at least 6 out of 12 lessons.|74
464662|NCT01220557|1138098|P1|COMPLETED|Overall Study|per protocol analysis including patients which participated in at least 6 out of 12 lessons.|75
464663|NCT01220557|1138097|P2|STARTED|Overall Study||79
464664|NCT01220557|1138098|P1|STARTED|Overall Study||81
464665|NCT01220466|1138107|P3|NOT COMPLETED|Overall Study||0
464666|NCT01220466|1138108|P2|NOT COMPLETED|Overall Study||0
464667|NCT01220466|1138109|P1|NOT COMPLETED|Overall Study||0
464668|NCT01220466|1138107|P3|COMPLETED|Overall Study|16 eyes|10
464669|NCT01220466|1138108|P2|COMPLETED|Overall Study|108 eyes|56
464670|NCT01220466|1138109|P1|COMPLETED|Overall Study|19 eyes|11
464671|NCT01220466|1138107|P3|STARTED|Overall Study|16 eyes|10
464672|NCT01220466|1138108|P2|STARTED|Overall Study|108 eyes|56
464673|NCT01220466|1138109|P1|STARTED|Overall Study|19 eyes|11
464674|NCT01220414|1138131|P4|NOT COMPLETED|Overall Study||1
464675|NCT01220414|1138132|P3|NOT COMPLETED|Overall Study||0
464676|NCT01220414|1138133|P2|NOT COMPLETED|Overall Study||0
464677|NCT01220414|1138134|P1|NOT COMPLETED|Overall Study||1
464678|NCT01220414|1138131|P4|COMPLETED|Overall Study||14
464679|NCT01220414|1138132|P3|COMPLETED|Overall Study||14
464680|NCT01220414|1138133|P2|COMPLETED|Overall Study||14
464681|NCT01220414|1138134|P1|COMPLETED|Overall Study||14
464682|NCT01220414|1138131|P4|STARTED|Overall Study||15
464683|NCT01220414|1138132|P3|STARTED|Overall Study||14
464684|NCT01220414|1138133|P2|STARTED|Overall Study||14
464685|NCT01220414|1138134|P1|STARTED|Overall Study||15
464686|NCT01220401|1138141|P1|NOT COMPLETED|Overall Study||3
464687|NCT01220401|1138141|P1|COMPLETED|Overall Study||18
464688|NCT01220401|1138141|P1|STARTED|Overall Study||21
464689|NCT01220297|1138150|P1|NOT COMPLETED|Overall Study||3
464690|NCT01220297|1138150|P1|COMPLETED|Overall Study||0
464691|NCT01220297|1138150|P1|STARTED|Overall Study||3
464692|NCT01220180|1138167|P1|NOT COMPLETED|Overall Study||207
464693|NCT01220180|1138167|P1|COMPLETED|Overall Study||3968
464694|NCT01220180|1138167|P1|Treated|Overall Study||4174
464695|NCT01220180|1138167|P1|STARTED|Overall Study||4175
464696|NCT01220128|1138197|P7|NOT COMPLETED|Overall Study||5
464697|NCT01220128|1138198|P6|NOT COMPLETED|Overall Study||0
464698|NCT01220128|1138199|P5|NOT COMPLETED|Overall Study||0
464699|NCT01220128|1138200|P4|NOT COMPLETED|Overall Study||0
464700|NCT01220128|1138201|P3|NOT COMPLETED|Overall Study||3
464701|NCT01220128|1138202|P2|NOT COMPLETED|Overall Study||1
464702|NCT01220128|1138203|P1|NOT COMPLETED|Overall Study||4
464703|NCT01220128|1138197|P7|COMPLETED|Overall Study||3
464704|NCT01220128|1138198|P6|COMPLETED|Overall Study||4
464705|NCT01220128|1138199|P5|COMPLETED|Overall Study||11
464706|NCT01220128|1138200|P4|COMPLETED|Overall Study||6
464707|NCT01220128|1138201|P3|COMPLETED|Overall Study||6
464708|NCT01220128|1138202|P2|COMPLETED|Overall Study||6
464709|NCT01220128|1138203|P1|COMPLETED|Overall Study||11
464710|NCT01220128|1138197|P7|STARTED|Overall Study||8
464711|NCT01220128|1138198|P6|STARTED|Overall Study||4
464712|NCT01220128|1138199|P5|STARTED|Overall Study||11
464713|NCT01220128|1138200|P4|STARTED|Overall Study||6
464714|NCT01220128|1138201|P3|STARTED|Overall Study||9
464715|NCT01220128|1138202|P2|STARTED|Overall Study||7
464716|NCT01220128|1138203|P1|STARTED|Overall Study||15
464717|NCT01219985|1138408|P1|NOT COMPLETED|Overall Study||20
464718|NCT01219985|1138408|P1|COMPLETED|Overall Study||30
464719|NCT01219985|1138408|P1|STARTED|Overall Study||50
464720|NCT01219933|1138414|P1|NOT COMPLETED|Overall Study||38
464721|NCT01219933|1138414|P1|COMPLETED|Overall Study||30
464722|NCT01219933|1138414|P1|STARTED|Overall Study||68
464723|NCT01219881|1138453|P2|NOT COMPLETED|Overall Study||5
464724|NCT01219881|1138454|P1|NOT COMPLETED|Overall Study||4
464725|NCT01219881|1138453|P2|COMPLETED|Overall Study||32
464726|NCT01219881|1138454|P1|COMPLETED|Overall Study||34
464727|NCT01219881|1138453|P2|STARTED|Overall Study||37
464728|NCT01219881|1138454|P1|STARTED|Overall Study||38
464729|NCT01219855|1138471|P5|NOT COMPLETED|Overall Study||1
464730|NCT01219855|1138472|P4|NOT COMPLETED|Overall Study||1
464731|NCT01219855|1138473|P3|NOT COMPLETED|Overall Study||1
464732|NCT01219855|1138474|P2|NOT COMPLETED|Overall Study||5
464733|NCT01219855|1138475|P1|NOT COMPLETED|Overall Study||1
464734|NCT01219855|1138471|P5|COMPLETED|Overall Study||13
464735|NCT01219855|1138472|P4|COMPLETED|Overall Study||12
464736|NCT01219855|1138473|P3|COMPLETED|Overall Study||16
464737|NCT01219855|1138474|P2|COMPLETED|Overall Study||12
464738|NCT01219855|1138475|P1|COMPLETED|Overall Study||16
464739|NCT01219855|1138471|P5|STARTED|Overall Study||14
464740|NCT01219855|1138472|P4|STARTED|Overall Study||13
464741|NCT01219855|1138473|P3|STARTED|Overall Study||17
464742|NCT01219855|1138474|P2|STARTED|Overall Study||17
464743|NCT01219855|1138475|P1|STARTED|Overall Study||17
464744|NCT01219777|1138511|P1|NOT COMPLETED|Overall Study||0
464745|NCT01219777|1138511|P1|COMPLETED|Overall Study||9
464746|NCT01219777|1138511|P1|STARTED|Overall Study||9
464747|NCT01219738|1138516|P1|NOT COMPLETED|Overall Study||0
464748|NCT01219738|1138516|P1|COMPLETED|Overall Study||20
464749|NCT01219738|1138516|P1|Budesonide 720- 4 Times|Overall Study||20
464750|NCT01219738|1138516|P1|Budesonide 1440|Overall Study||20
464751|NCT01219738|1138516|P1|Budesonide 720|Overall Study||20
464752|NCT01219738|1138516|P1|Budesonide 360|Overall Study||20
464753|NCT01219738|1138516|P1|STARTED|Overall Study||20
464754|NCT01219673|1138537|P8|NOT COMPLETED|Overall Study||0
464755|NCT01219673|1138538|P7|NOT COMPLETED|Overall Study||0
464756|NCT01219673|1138539|P6|NOT COMPLETED|Overall Study||0
464757|NCT01219673|1138540|P5|NOT COMPLETED|Overall Study||0
464758|NCT01219673|1138541|P4|NOT COMPLETED|Overall Study||0
464759|NCT01219673|1138542|P3|NOT COMPLETED|Overall Study||0
464760|NCT01219673|1138543|P2|NOT COMPLETED|Overall Study||0
464761|NCT01219673|1138544|P1|NOT COMPLETED|Overall Study||0
464762|NCT01219673|1138537|P8|COMPLETED|Overall Study||0
464763|NCT01219673|1138538|P7|COMPLETED|Overall Study||0
464764|NCT01219673|1138539|P6|COMPLETED|Overall Study||0
464765|NCT01219673|1138540|P5|COMPLETED|Overall Study||0
464766|NCT01219673|1138541|P4|COMPLETED|Overall Study||0
464767|NCT01219673|1138542|P3|COMPLETED|Overall Study||1
464768|NCT01219673|1138543|P2|COMPLETED|Overall Study||0
464769|NCT01219673|1138544|P1|COMPLETED|Overall Study||0
464770|NCT01219673|1138537|P8|STARTED|Overall Study||0
464771|NCT01219673|1138538|P7|STARTED|Overall Study||0
464772|NCT01219673|1138539|P6|STARTED|Overall Study||0
464773|NCT01219673|1138540|P5|STARTED|Overall Study||0
464774|NCT01219673|1138541|P4|STARTED|Overall Study||0
464775|NCT01219673|1138542|P3|STARTED|Overall Study||1
464776|NCT01219673|1138543|P2|STARTED|Overall Study||0
464777|NCT01219673|1138544|P1|STARTED|Overall Study||0
464778|NCT01218997|1138564|P2|NOT COMPLETED|Overall Study||41
464779|NCT01218997|1138565|P1|NOT COMPLETED|Overall Study||245
464780|NCT01218997|1138564|P2|COMPLETED|Overall Study||24
464781|NCT01218997|1138565|P1|COMPLETED|Overall Study||126
464782|NCT01218997|1138564|P2|STARTED|Overall Study||65
464783|NCT01218997|1138565|P1|STARTED|Overall Study||371
464784|NCT01218984|1138574|P3|NOT COMPLETED|Overall Study||3
464785|NCT01218984|1138575|P2|NOT COMPLETED|Overall Study||2
464786|NCT01218984|1138576|P1|NOT COMPLETED|Overall Study||1
464787|NCT01218984|1138574|P3|COMPLETED|Overall Study||7
464788|NCT01218984|1138575|P2|COMPLETED|Overall Study||6
464789|NCT01218984|1138576|P1|COMPLETED|Overall Study||8
464790|NCT01218984|1138574|P3|STARTED|Overall Study||10
464791|NCT01218984|1138575|P2|STARTED|Overall Study||8
464792|NCT01218984|1138576|P1|STARTED|Overall Study||9
464793|NCT01218971|1138586|P2|NOT COMPLETED|Overall Study||80
464794|NCT01218971|1138587|P1|NOT COMPLETED|Overall Study||104
464795|NCT01218971|1138586|P2|COMPLETED|Overall Study||77
464796|NCT01218971|1138587|P1|COMPLETED|Overall Study||71
464797|NCT01218971|1138586|P2|STARTED|Overall Study||157
464798|NCT01218971|1138587|P1|STARTED|Overall Study||175
464799|NCT01218958|1138600|P3|NOT COMPLETED|Overall Study||81
464800|NCT01218958|1138601|P2|NOT COMPLETED|Overall Study||81
464801|NCT01218958|1138602|P1|NOT COMPLETED|Overall Study||84
464802|NCT01218958|1138600|P3|COMPLETED|Overall Study||128
464803|NCT01218958|1138601|P2|COMPLETED|Overall Study||124
464804|NCT01218958|1138602|P1|COMPLETED|Overall Study||126
464805|NCT01218958|1138600|P3|STARTED|Overall Study||209
464806|NCT01218958|1138601|P2|STARTED|Overall Study||205
464807|NCT01218958|1138602|P1|STARTED|Overall Study||210
464808|NCT01218867|1138624|P11|NOT COMPLETED|Overall Study||0
464809|NCT01218867|1138625|P10|NOT COMPLETED|Overall Study||0
464810|NCT01218867|1138626|P9|NOT COMPLETED|Overall Study||0
464811|NCT01218867|1138627|P8|NOT COMPLETED|Overall Study||0
464812|NCT01218867|1138628|P7|NOT COMPLETED|Overall Study||1
464813|NCT01218867|1138629|P6|NOT COMPLETED|Overall Study||0
464814|NCT01218867|1138630|P5|NOT COMPLETED|Overall Study||0
464815|NCT01218867|1138631|P4|NOT COMPLETED|Overall Study||0
464816|NCT01218867|1138632|P3|NOT COMPLETED|Overall Study||0
464817|NCT01218867|1138633|P2|NOT COMPLETED|Overall Study||0
464818|NCT01218867|1138634|P1|NOT COMPLETED|Overall Study||0
464819|NCT01218867|1138624|P11|COMPLETED|Overall Study||2
464820|NCT01218867|1138625|P10|COMPLETED|Overall Study||4
464821|NCT01218867|1138626|P9|COMPLETED|Overall Study||3
464822|NCT01218867|1138627|P8|COMPLETED|Overall Study||3
464823|NCT01218867|1138628|P7|COMPLETED|Overall Study||3
464824|NCT01218867|1138629|P6|COMPLETED|Overall Study||1
464825|NCT01218867|1138630|P5|COMPLETED|Overall Study||1
464826|NCT01218867|1138631|P4|COMPLETED|Overall Study||1
464827|NCT01218867|1138632|P3|COMPLETED|Overall Study||3
464828|NCT01218867|1138633|P2|COMPLETED|Overall Study||1
464829|NCT01218867|1138634|P1|COMPLETED|Overall Study||1
464830|NCT01218867|1138624|P11|STARTED|Overall Study||2
464831|NCT01218867|1138625|P10|STARTED|Overall Study||4
464832|NCT01218867|1138626|P9|STARTED|Overall Study||3
464833|NCT01218867|1138627|P8|STARTED|Overall Study||3
464834|NCT01218867|1138628|P7|STARTED|Overall Study||4
464835|NCT01218867|1138629|P6|STARTED|Overall Study||1
464836|NCT01218867|1138630|P5|STARTED|Overall Study||1
464837|NCT01218867|1138631|P4|STARTED|Overall Study||1
464838|NCT01218867|1138632|P3|STARTED|Overall Study||3
464839|NCT01218867|1138633|P2|STARTED|Overall Study||1
464840|NCT01218867|1138634|P1|STARTED|Overall Study||1
464841|NCT01218802|1138682|P2|NOT COMPLETED|Overall Study||18
464842|NCT01218802|1138683|P1|NOT COMPLETED|Overall Study||10
464843|NCT01218802|1138682|P2|COMPLETED|Overall Study||57
464844|NCT01218802|1138683|P1|COMPLETED|Overall Study||62
464845|NCT01218802|1138682|P2|STARTED|Overall Study||75
464846|NCT01218802|1138683|P1|STARTED|Overall Study||72
464847|NCT01218646|1138695|P4|NOT COMPLETED|Overall Study||1
464848|NCT01218646|1138696|P3|NOT COMPLETED|Overall Study||2
464849|NCT01218646|1138697|P2|NOT COMPLETED|Overall Study||0
464850|NCT01218646|1138698|P1|NOT COMPLETED|Overall Study||1
464851|NCT01218646|1138695|P4|COMPLETED|Overall Study||63
464852|NCT01218646|1138696|P3|COMPLETED|Overall Study||223
464853|NCT01218646|1138697|P2|COMPLETED|Overall Study||225
464854|NCT01218646|1138698|P1|COMPLETED|Overall Study||224
464855|NCT01218646|1138695|P4|STARTED|Overall Study||64
464856|NCT01218646|1138696|P3|STARTED|Overall Study||225
464857|NCT01218646|1138697|P2|STARTED|Overall Study||225
464858|NCT01218646|1138698|P1|STARTED|Overall Study||225
464859|NCT01218594|1138736|P1|NOT COMPLETED|Overall Study||12
464860|NCT01218594|1138736|P1|COMPLETED|Overall Study||36
464861|NCT01218594|1138736|P1|STARTED|Overall Study||48
464862|NCT01218477|1138744|P4|NOT COMPLETED|Overall Study||2
464863|NCT01218477|1138745|P3|NOT COMPLETED|Overall Study||14
464864|NCT01218477|1138746|P2|NOT COMPLETED|Overall Study||8
464865|NCT01218477|1138747|P1|NOT COMPLETED|Overall Study||3
464866|NCT01218477|1138744|P4|COMPLETED|Overall Study|Still receiving study drug|0
464867|NCT01218477|1138745|P3|COMPLETED|Overall Study|Still receiving study drug|0
464868|NCT01218477|1138746|P2|COMPLETED|Overall Study|Still receiving study drug|0
464869|NCT01218477|1138747|P1|COMPLETED|Overall Study|Still receiving study drug|0
464870|NCT01218477|1138744|P4|STARTED|Overall Study|Participants who received treatment|2
464871|NCT01218477|1138745|P3|STARTED|Overall Study|Participants who received treatment|14
464872|NCT01218477|1138746|P2|STARTED|Overall Study|Participants who received treatment|8
464873|NCT01218477|1138747|P1|STARTED|Overall Study|Participants who received treatment|3
464874|NCT01218438|1138764|P1|NOT COMPLETED|Epoch 4||3
464875|NCT01218438|1138764|P1|COMPLETED|Epoch 4||67
464876|NCT01218438|1138764|P1|STARTED|Epoch 4||70
464877|NCT01218438|1138764|P1|NOT COMPLETED|Epoch 3||4
464878|NCT01218438|1138764|P1|COMPLETED|Epoch 3||70
464879|NCT01218438|1138764|P1|STARTED|Epoch 3||74
464880|NCT01218438|1138764|P1|NOT COMPLETED|Epoch 2||0
464881|NCT01218438|1138764|P1|COMPLETED|Epoch 2||45
464882|NCT01218438|1138764|P1|STARTED|Epoch 2||45
464883|NCT01218438|1138764|P1|NOT COMPLETED|Epoch 1||3
464884|NCT01218438|1138764|P1|COMPLETED|Epoch 1||74
464885|NCT01218438|1138764|P1|STARTED|Epoch 1||77
464886|NCT01218399|1138919|P2|NOT COMPLETED|Overall Study||0
464887|NCT01218399|1138920|P1|NOT COMPLETED|Overall Study||0
464888|NCT01218399|1138919|P2|COMPLETED|Overall Study||5
464889|NCT01218399|1138920|P1|COMPLETED|Overall Study||5
464890|NCT01218399|1138919|P2|STARTED|Overall Study||5
464891|NCT01218399|1138920|P1|STARTED|Overall Study||5
464892|NCT01218308|1138930|P2|NOT COMPLETED|Overall Study||120
464893|NCT01218308|1138931|P1|NOT COMPLETED|Overall Study||103
464894|NCT01218308|1138930|P2|COMPLETED|Overall Study||2464
464895|NCT01218308|1138931|P1|COMPLETED|Overall Study||2481
464896|NCT01218308|1138930|P2|STARTED|Overall Study||2584
464897|NCT01218308|1138931|P1|STARTED|Overall Study||2584
464898|NCT01218243|1138975|P2|NOT COMPLETED|Overall Study||14
464899|NCT01218243|1138976|P1|NOT COMPLETED|Overall Study||9
464900|NCT01218243|1138975|P2|COMPLETED|Overall Study||36
464901|NCT01218243|1138976|P1|COMPLETED|Overall Study||41
464902|NCT01218243|1138975|P2|Treatment Completed|Overall Study||42
464903|NCT01218243|1138976|P1|Treatment Completed|Overall Study||45
464904|NCT01218243|1138975|P2|STARTED|Overall Study||50
464905|NCT01218243|1138976|P1|STARTED|Overall Study||50
464906|NCT01218204|1138992|P4|NOT COMPLETED|Part B Pooled Treatment Arm||3
464907|NCT01218204|1138993|P3|NOT COMPLETED|Part B Pooled Treatment Arm||0
464908|NCT01218204|1138994|P2|NOT COMPLETED|Part B Pooled Treatment Arm||0
464909|NCT01218204|1138995|P1|NOT COMPLETED|Part B Pooled Treatment Arm||0
464910|NCT01218204|1138992|P4|COMPLETED|Part B Pooled Treatment Arm||127
464911|NCT01218204|1138993|P3|COMPLETED|Part B Pooled Treatment Arm||0
464912|NCT01218204|1138994|P2|COMPLETED|Part B Pooled Treatment Arm||0
464913|NCT01218204|1138995|P1|COMPLETED|Part B Pooled Treatment Arm||0
464914|NCT01218204|1138992|P4|STARTED|Part B Pooled Treatment Arm||130
464915|NCT01218204|1138993|P3|STARTED|Part B Pooled Treatment Arm||0
464916|NCT01218204|1138994|P2|STARTED|Part B Pooled Treatment Arm||0
464917|NCT01218204|1138995|P1|STARTED|Part B Pooled Treatment Arm||0
464918|NCT01218204|1138992|P4|NOT COMPLETED|Part B Run-in||0
464919|NCT01218204|1138993|P3|NOT COMPLETED|Part B Run-in||6
464920|NCT01218204|1138994|P2|NOT COMPLETED|Part B Run-in||0
464921|NCT01218204|1138995|P1|NOT COMPLETED|Part B Run-in||0
464922|NCT01218204|1138992|P4|COMPLETED|Part B Run-in||0
464923|NCT01218204|1138993|P3|COMPLETED|Part B Run-in||83
464924|NCT01218204|1138994|P2|COMPLETED|Part B Run-in||0
464925|NCT01218204|1138995|P1|COMPLETED|Part B Run-in||0
464926|NCT01218204|1138992|P4|STARTED|Part B Run-in||0
464927|NCT01218204|1138993|P3|STARTED|Part B Run-in||89
464928|NCT01218204|1138994|P2|STARTED|Part B Run-in||0
464929|NCT01218204|1138995|P1|STARTED|Part B Run-in||0
464930|NCT01218204|1138992|P4|NOT COMPLETED|Part B Washout||0
464931|NCT01218204|1138993|P3|NOT COMPLETED|Part B Washout||0
464932|NCT01218204|1138994|P2|NOT COMPLETED|Part B Washout||145
464933|NCT01218204|1138995|P1|NOT COMPLETED|Part B Washout||0
464934|NCT01218204|1138992|P4|COMPLETED|Part B Washout||0
464935|NCT01218204|1138993|P3|COMPLETED|Part B Washout||0
464936|NCT01218204|1138994|P2|COMPLETED|Part B Washout||136
464937|NCT01218204|1138995|P1|COMPLETED|Part B Washout||0
464938|NCT01218204|1138992|P4|STARTED|Part B Washout||0
464939|NCT01218204|1138993|P3|STARTED|Part B Washout||0
464940|NCT01218204|1138994|P2|STARTED|Part B Washout||281
464941|NCT01218204|1138995|P1|STARTED|Part B Washout||0
464942|NCT01218204|1138992|P4|NOT COMPLETED|Part A||0
464943|NCT01218204|1138993|P3|NOT COMPLETED|Part A||0
464944|NCT01218204|1138994|P2|NOT COMPLETED|Part A||0
464945|NCT01218204|1138995|P1|NOT COMPLETED|Part A||0
464946|NCT01218204|1138992|P4|COMPLETED|Part A||0
464947|NCT01218204|1138993|P3|COMPLETED|Part A||0
464948|NCT01218204|1138994|P2|COMPLETED|Part A||0
464949|NCT01218204|1138995|P1|COMPLETED|Part A||6
464950|NCT01218204|1138992|P4|STARTED|Part A||0
464951|NCT01218204|1138993|P3|STARTED|Part A||0
464952|NCT01218204|1138994|P2|STARTED|Part A||0
464953|NCT01218204|1138995|P1|STARTED|Part A||6
464954|NCT01218126|1139259|P4|NOT COMPLETED|Overall Study||35
464955|NCT01218126|1139260|P3|NOT COMPLETED|Overall Study||24
464956|NCT01218126|1139261|P2|NOT COMPLETED|Overall Study||22
464957|NCT01218126|1139262|P1|NOT COMPLETED|Overall Study||24
464958|NCT01218126|1139259|P4|COMPLETED|Overall Study||114
464959|NCT01218126|1139260|P3|COMPLETED|Overall Study||127
464960|NCT01218126|1139261|P2|COMPLETED|Overall Study||127
464961|NCT01218126|1139262|P1|COMPLETED|Overall Study||129
464962|NCT01218126|1139259|P4|STARTED|Overall Study||149
464963|NCT01218126|1139260|P3|STARTED|Overall Study||151
464964|NCT01218126|1139261|P2|STARTED|Overall Study||149
464965|NCT01218126|1139262|P1|STARTED|Overall Study||153
464966|NCT01218113|1139303|P3|NOT COMPLETED|Overall Study||6
464967|NCT01218113|1139304|P2|NOT COMPLETED|Overall Study||1
464968|NCT01218113|1139305|P1|NOT COMPLETED|Overall Study||5
464969|NCT01218113|1139303|P3|COMPLETED|Overall Study||58
464970|NCT01218113|1139304|P2|COMPLETED|Overall Study||63
464971|NCT01218113|1139305|P1|COMPLETED|Overall Study||57
464972|NCT01218113|1139303|P3|STARTED|Overall Study||64
464973|NCT01218113|1139304|P2|STARTED|Overall Study||64
464974|NCT01218113|1139305|P1|STARTED|Overall Study||62
464975|NCT01218100|1139486|P4|NOT COMPLETED|Overall Study||34
464976|NCT01218100|1139487|P3|NOT COMPLETED|Overall Study||27
464977|NCT01218100|1139488|P2|NOT COMPLETED|Overall Study||25
464978|NCT01218100|1139489|P1|NOT COMPLETED|Overall Study||24
464979|NCT01218100|1139486|P4|COMPLETED|Overall Study||156
464980|NCT01218100|1139487|P3|COMPLETED|Overall Study||162
464981|NCT01218100|1139488|P2|COMPLETED|Overall Study||165
464982|NCT01218100|1139489|P1|COMPLETED|Overall Study||71
464983|NCT01218100|1139486|P4|STARTED|Overall Study||190
464984|NCT01218100|1139487|P3|STARTED|Overall Study||189
464985|NCT01218100|1139488|P2|STARTED|Overall Study||190
464986|NCT01218100|1139489|P1|STARTED|Overall Study||95
464987|NCT01218087|1139505|P2|NOT COMPLETED|Overall Study||6
464988|NCT01218087|1139506|P1|NOT COMPLETED|Overall Study||15
464989|NCT01218087|1139505|P2|COMPLETED|Overall Study||35
464990|NCT01218087|1139506|P1|COMPLETED|Overall Study||27
464991|NCT01218087|1139505|P2|STARTED|Overall Study||41
464992|NCT01218087|1139506|P1|STARTED|Overall Study||42
464993|NCT01218009|1139516|P2|NOT COMPLETED|Overall Study||165
464994|NCT01218009|1139517|P1|NOT COMPLETED|Overall Study||166
464995|NCT01218009|1139516|P2|COMPLETED|Overall Study||0
464996|NCT01218009|1139517|P1|COMPLETED|Overall Study||0
464997|NCT01218009|1139516|P2|STARTED|Overall Study||165
464998|NCT01218009|1139517|P1|STARTED|Overall Study||166
464999|NCT01217957|1139540|P5|NOT COMPLETED|Phase 2||1
465000|NCT01217957|1139541|P4|NOT COMPLETED|Phase 2||0
465001|NCT01217957|1139542|P3|NOT COMPLETED|Phase 2||0
465002|NCT01217957|1139543|P2|NOT COMPLETED|Phase 2||0
465003|NCT01217957|1139544|P1|NOT COMPLETED|Phase 2||0
465004|NCT01217957|1139540|P5|COMPLETED|Phase 2|Completed=Participants who are ongoing or who have died on study.|49
465005|NCT01217957|1139541|P4|COMPLETED|Phase 2||0
465006|NCT01217957|1139542|P3|COMPLETED|Phase 2||0
465007|NCT01217957|1139543|P2|COMPLETED|Phase 2||0
465008|NCT01217957|1139544|P1|COMPLETED|Phase 2||0
465009|NCT01217957|1139540|P5|STARTED|Phase 2||50
465010|NCT01217957|1139541|P4|STARTED|Phase 2||0
465011|NCT01217957|1139542|P3|STARTED|Phase 2||0
465012|NCT01217957|1139543|P2|STARTED|Phase 2||0
465013|NCT01217957|1139544|P1|STARTED|Phase 2||0
465014|NCT01217957|1139540|P5|NOT COMPLETED|Phase 1||0
465015|NCT01217957|1139541|P4|NOT COMPLETED|Phase 1||1
465016|NCT01217957|1139542|P3|NOT COMPLETED|Phase 1||1
465017|NCT01217957|1139543|P2|NOT COMPLETED|Phase 1||0
465018|NCT01217957|1139544|P1|NOT COMPLETED|Phase 1||1
465019|NCT01217957|1139540|P5|COMPLETED|Phase 1||0
465020|NCT01217957|1139541|P4|COMPLETED|Phase 1||2
465021|NCT01217957|1139542|P3|COMPLETED|Phase 1||5
465022|NCT01217957|1139543|P2|COMPLETED|Phase 1||3
465023|NCT01217957|1139544|P1|COMPLETED|Phase 1||2
465024|NCT01217957|1139540|P5|STARTED|Phase 1||0
465025|NCT01217957|1139541|P4|STARTED|Phase 1||3
465026|NCT01217957|1139542|P3|STARTED|Phase 1||6
465027|NCT01217957|1139543|P2|STARTED|Phase 1||3
465028|NCT01217957|1139544|P1|STARTED|Phase 1||3
465029|NCT01217944|1139603|P3|NOT COMPLETED|Overall Study||0
465030|NCT01217944|1139604|P2|NOT COMPLETED|Overall Study||4
465031|NCT01217944|1139605|P1|NOT COMPLETED|Overall Study||6
465032|NCT01217944|1139603|P3|COMPLETED|Overall Study||55
465033|NCT01217944|1139604|P2|COMPLETED|Overall Study||112
465034|NCT01217944|1139605|P1|COMPLETED|Overall Study||100
465035|NCT01217944|1139603|P3|Completed 6 Months|Overall Study||55
465036|NCT01217944|1139604|P2|Completed 6 Months|Overall Study||116
465037|NCT01217944|1139605|P1|Completed 6 Months|Overall Study||103
465038|NCT01217944|1139603|P3|Completed 3 Months|Overall Study||55
465039|NCT01217944|1139604|P2|Completed 3 Months|Overall Study||116
465040|NCT01217944|1139605|P1|Completed 3 Months|Overall Study||105
465041|NCT01217944|1139603|P3|STARTED|Overall Study||55
465042|NCT01217944|1139604|P2|STARTED|Overall Study||116
465043|NCT01217944|1139605|P1|STARTED|Overall Study||106
465044|NCT01217892|1139648|P4|NOT COMPLETED|Overall Study||8
465045|NCT01217892|1139649|P3|NOT COMPLETED|Overall Study||9
465046|NCT01217892|1139650|P2|NOT COMPLETED|Overall Study||6
465047|NCT01217892|1139651|P1|NOT COMPLETED|Overall Study||7
465048|NCT01217892|1139648|P4|COMPLETED|Overall Study||93
465049|NCT01217892|1139649|P3|COMPLETED|Overall Study||90
465050|NCT01217892|1139650|P2|COMPLETED|Overall Study||94
465051|NCT01217892|1139651|P1|COMPLETED|Overall Study||93
465052|NCT01217892|1139648|P4|STARTED|Overall Study||101
465053|NCT01217892|1139649|P3|STARTED|Overall Study||99
465054|NCT01217892|1139650|P2|STARTED|Overall Study||100
465055|NCT01217892|1139651|P1|STARTED|Overall Study||100
465056|NCT01217840|1139679|P2|NOT COMPLETED|Overall Study||3
465057|NCT01217840|1139680|P1|NOT COMPLETED|Overall Study||6
465058|NCT01217840|1139679|P2|COMPLETED|Overall Study||17
465059|NCT01217840|1139680|P1|COMPLETED|Overall Study||14
465060|NCT01217840|1139679|P2|STARTED|Overall Study||20
465061|NCT01217840|1139680|P1|STARTED|Overall Study||20
465062|NCT01217827|1139704|P2|NOT COMPLETED|Overall Study||0
465063|NCT01217827|1139705|P1|NOT COMPLETED|Overall Study||0
465064|NCT01217827|1139704|P2|COMPLETED|Overall Study||43
465065|NCT01217827|1139705|P1|COMPLETED|Overall Study||46
465066|NCT01217827|1139704|P2|STARTED|Overall Study||43
465067|NCT01217827|1139705|P1|STARTED|Overall Study||46
465068|NCT01217814|1139714|P3|NOT COMPLETED|Overall Study||1
465069|NCT01217814|1139715|P2|NOT COMPLETED|Overall Study||1
465070|NCT01217814|1139716|P1|NOT COMPLETED|Overall Study||1
465071|NCT01217814|1139714|P3|COMPLETED|Overall Study||6
465072|NCT01217814|1139715|P2|COMPLETED|Overall Study||4
465073|NCT01217814|1139716|P1|COMPLETED|Overall Study||3
465074|NCT01217814|1139714|P3|STARTED|Overall Study||7
465075|NCT01217814|1139715|P2|STARTED|Overall Study||5
465076|NCT01217814|1139716|P1|STARTED|Overall Study||4
465077|NCT01217801|1139742|P2|NOT COMPLETED|Period 2||0
465078|NCT01217801|1139743|P1|NOT COMPLETED|Period 2||0
465079|NCT01217801|1139742|P2|COMPLETED|Period 2||22
465080|NCT01217801|1139743|P1|COMPLETED|Period 2||23
465081|NCT01217801|1139742|P2|STARTED|Period 2||22
465082|NCT01217801|1139743|P1|STARTED|Period 2||23
465083|NCT01217801|1139742|P2|NOT COMPLETED|Period 1||2
465084|NCT01217801|1139743|P1|NOT COMPLETED|Period 1||1
465085|NCT01217801|1139742|P2|COMPLETED|Period 1||22
465086|NCT01217801|1139743|P1|COMPLETED|Period 1||23
465087|NCT01217801|1139742|P2|STARTED|Period 1||24
465088|NCT01217801|1139743|P1|STARTED|Period 1||24
465089|NCT01217749|1139752|P3|NOT COMPLETED|Overall Study||2
465090|NCT01217749|1139753|P2|NOT COMPLETED|Overall Study||3
465091|NCT01217749|1139754|P1|NOT COMPLETED|Overall Study||3
465092|NCT01217749|1139752|P3|COMPLETED|Overall Study||22
465093|NCT01217749|1139753|P2|COMPLETED|Overall Study||17
465094|NCT01217749|1139754|P1|COMPLETED|Overall Study||24
465095|NCT01217749|1139752|P3|STARTED|Overall Study||24
465096|NCT01217749|1139753|P2|STARTED|Overall Study||20
465097|NCT01217749|1139754|P1|STARTED|Overall Study||27
465098|NCT01217606|1139772|P2|NOT COMPLETED|9-Month Masked Extension||11
465099|NCT01217606|1139773|P1|NOT COMPLETED|9-Month Masked Extension||13
465100|NCT01217606|1139772|P2|COMPLETED|9-Month Masked Extension||62
465101|NCT01217606|1139773|P1|COMPLETED|9-Month Masked Extension||54
465102|NCT01217606|1139772|P2|Not Enrolled in Masked Extension|9-Month Masked Extension||10
465103|NCT01217606|1139773|P1|Not Enrolled in Masked Extension|9-Month Masked Extension||9
465104|NCT01217606|1139772|P2|STARTED|9-Month Masked Extension||73
465105|NCT01217606|1139773|P1|STARTED|9-Month Masked Extension||67
465106|NCT01217606|1139772|P2|NOT COMPLETED|Initial Treatment Phase||12
465107|NCT01217606|1139773|P1|NOT COMPLETED|Initial Treatment Phase||14
465108|NCT01217606|1139772|P2|COMPLETED|Initial Treatment Phase||83
465109|NCT01217606|1139773|P1|COMPLETED|Initial Treatment Phase||76
465110|NCT01217606|1139772|P2|STARTED|Initial Treatment Phase||95
465111|NCT01217606|1139773|P1|STARTED|Initial Treatment Phase||90
465112|NCT01217515|1139786|P3|NOT COMPLETED|Overall Study||10
465113|NCT01217515|1139787|P2|NOT COMPLETED|Overall Study||8
465114|NCT01217515|1139788|P1|NOT COMPLETED|Overall Study||7
465115|NCT01217515|1139786|P3|COMPLETED|Overall Study||145
465116|NCT01217515|1139787|P2|COMPLETED|Overall Study||148
465117|NCT01217515|1139788|P1|COMPLETED|Overall Study||147
465118|NCT01217515|1139786|P3|STARTED|Overall Study||155
465119|NCT01217515|1139787|P2|STARTED|Overall Study||156
465120|NCT01217515|1139788|P1|STARTED|Overall Study||154
465121|NCT01217476|1139804|P2|NOT COMPLETED|Overall Study||7
465122|NCT01217476|1139805|P1|NOT COMPLETED|Overall Study||12
465123|NCT01217476|1139804|P2|COMPLETED|Overall Study||95
465124|NCT01217476|1139805|P1|COMPLETED|Overall Study||93
465125|NCT01217476|1139804|P2|STARTED|Overall Study||102
465126|NCT01217476|1139805|P1|STARTED|Overall Study||105
465127|NCT01217463|1139815|P2|NOT COMPLETED|Overall Study||8
465128|NCT01217463|1139816|P1|NOT COMPLETED|Overall Study||13
465129|NCT01217463|1139815|P2|COMPLETED|Overall Study||94
465130|NCT01217463|1139816|P1|COMPLETED|Overall Study||86
465131|NCT01217463|1139815|P2|STARTED|Overall Study||102
465132|NCT01217463|1139816|P1|STARTED|Overall Study||99
465133|NCT01217411|1139827|P3|NOT COMPLETED|Overall Study||0
465134|NCT01217411|1139828|P2|NOT COMPLETED|Overall Study||0
465135|NCT01217411|1139829|P1|NOT COMPLETED|Overall Study||0
465136|NCT01217411|1139827|P3|COMPLETED|Overall Study||0
465137|NCT01217411|1139828|P2|COMPLETED|Overall Study||0
465138|NCT01217411|1139829|P1|COMPLETED|Overall Study||5
465139|NCT01217411|1139827|P3|STARTED|Overall Study||0
465140|NCT01217411|1139828|P2|STARTED|Overall Study||0
465141|NCT01217411|1139829|P1|STARTED|Overall Study||5
465142|NCT01217307|1139836|P2|NOT COMPLETED|Overall Study||1
465143|NCT01217307|1139837|P1|NOT COMPLETED|Overall Study||0
465144|NCT01217307|1139836|P2|COMPLETED|Overall Study||188
465145|NCT01217307|1139837|P1|COMPLETED|Overall Study||191
465146|NCT01217307|1139836|P2|STARTED|Overall Study||189
465147|NCT01217307|1139837|P1|STARTED|Overall Study||191
465148|NCT01217229|1139843|P1|NOT COMPLETED|Overall Study||0
465149|NCT01217229|1139843|P1|COMPLETED|Overall Study||20
465150|NCT01217229|1139843|P1|STARTED|Overall Study||20
465151|NCT01217112|1139852|P5|NOT COMPLETED|Overall Study||1
465152|NCT01217112|1139853|P4|NOT COMPLETED|Overall Study||2
465153|NCT01217112|1139854|P3|NOT COMPLETED|Overall Study||1
465154|NCT01217112|1139855|P2|NOT COMPLETED|Overall Study||2
465155|NCT01217112|1139856|P1|NOT COMPLETED|Overall Study||0
465156|NCT01217112|1139852|P5|COMPLETED|Overall Study||13
465157|NCT01217112|1139853|P4|COMPLETED|Overall Study||10
465158|NCT01217112|1139854|P3|COMPLETED|Overall Study||12
465159|NCT01217112|1139855|P2|COMPLETED|Overall Study||10
465160|NCT01217112|1139856|P1|COMPLETED|Overall Study||11
465161|NCT01217112|1139852|P5|STARTED|Overall Study||14
465162|NCT01217112|1139853|P4|STARTED|Overall Study||12
465163|NCT01217112|1139854|P3|STARTED|Overall Study||13
465164|NCT01217112|1139855|P2|STARTED|Overall Study||12
465165|NCT01217112|1139856|P1|STARTED|Overall Study||11
465166|NCT01217073|1140089|P8|NOT COMPLETED|Extension Period||20
465167|NCT01217073|1140090|P7|NOT COMPLETED|Extension Period||91
465168|NCT01217073|1140091|P6|NOT COMPLETED|Extension Period||0
465169|NCT01217073|1140092|P5|NOT COMPLETED|Extension Period||0
465170|NCT01217073|1140093|P4|NOT COMPLETED|Extension Period||0
465171|NCT01217073|1140094|P3|NOT COMPLETED|Extension Period||0
465172|NCT01217073|1140095|P2|NOT COMPLETED|Extension Period||0
465173|NCT01217073|1140096|P1|NOT COMPLETED|Extension Period||0
465174|NCT01217073|1140089|P8|COMPLETED|Extension Period||60
465175|NCT01217073|1140090|P7|COMPLETED|Extension Period||314
465176|NCT01217073|1140091|P6|COMPLETED|Extension Period||0
465177|NCT01217073|1140092|P5|COMPLETED|Extension Period||0
465178|NCT01217073|1140093|P4|COMPLETED|Extension Period||0
465179|NCT01217073|1140094|P3|COMPLETED|Extension Period||0
465180|NCT01217073|1140095|P2|COMPLETED|Extension Period||0
465181|NCT01217073|1140096|P1|COMPLETED|Extension Period||0
465182|NCT01217073|1140089|P8|STARTED|Extension Period||80
465183|NCT01217073|1140090|P7|STARTED|Extension Period||405
465184|NCT01217073|1140091|P6|STARTED|Extension Period||0
465185|NCT01217073|1140092|P5|STARTED|Extension Period||0
465186|NCT01217073|1140093|P4|STARTED|Extension Period||0
465187|NCT01217073|1140094|P3|STARTED|Extension Period||0
465188|NCT01217073|1140095|P2|STARTED|Extension Period||0
465189|NCT01217073|1140096|P1|STARTED|Extension Period||0
465190|NCT01217073|1140089|P8|NOT COMPLETED|Base Period||0
465191|NCT01217073|1140090|P7|NOT COMPLETED|Base Period||0
465192|NCT01217073|1140091|P6|NOT COMPLETED|Base Period||9
465193|NCT01217073|1140092|P5|NOT COMPLETED|Base Period||15
465194|NCT01217073|1140093|P4|NOT COMPLETED|Base Period||2
465195|NCT01217073|1140094|P3|NOT COMPLETED|Base Period||7
465196|NCT01217073|1140095|P2|NOT COMPLETED|Base Period||5
465197|NCT01217073|1140096|P1|NOT COMPLETED|Base Period||7
465198|NCT01217073|1140089|P8|COMPLETED|Base Period||0
465199|NCT01217073|1140090|P7|COMPLETED|Base Period||0
465200|NCT01217073|1140091|P6|COMPLETED|Base Period||105
465201|NCT01217073|1140092|P5|COMPLETED|Base Period||99
465202|NCT01217073|1140093|P4|COMPLETED|Base Period||113
465203|NCT01217073|1140094|P3|COMPLETED|Base Period||107
465204|NCT01217073|1140095|P2|COMPLETED|Base Period||110
465205|NCT01217073|1140096|P1|COMPLETED|Base Period||106
465206|NCT01217073|1140089|P8|STARTED|Base Period||0
465207|NCT01217073|1140090|P7|STARTED|Base Period||0
465208|NCT01217073|1140091|P6|STARTED|Base Period||114
465209|NCT01217073|1140092|P5|STARTED|Base Period||114
465210|NCT01217073|1140093|P4|STARTED|Base Period||115
465211|NCT01217073|1140094|P3|STARTED|Base Period||114
465212|NCT01217073|1140095|P2|STARTED|Base Period||115
465213|NCT01217073|1140096|P1|STARTED|Base Period||113
465214|NCT01216943|1140164|P1|NOT COMPLETED|Overall Study||13
465215|NCT01216943|1140164|P1|COMPLETED|Overall Study||113
465216|NCT01216943|1140164|P1|STARTED|Overall Study||126
465217|NCT01216761|1140168|P3|NOT COMPLETED|Overall Study||0
465218|NCT01216761|1140169|P2|NOT COMPLETED|Overall Study||0
465219|NCT01216761|1140170|P1|NOT COMPLETED|Overall Study||0
465220|NCT01216761|1140168|P3|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1379
465221|NCT01216761|1140169|P2|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1410
465222|NCT01216761|1140170|P1|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1421
465223|NCT01216761|1140168|P3|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1379
465224|NCT01216761|1140169|P2|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1410
465225|NCT01216761|1140170|P1|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1421
465226|NCT01216748|1140178|P1|NOT COMPLETED|Overall Study||0
465227|NCT01216748|1140178|P1|COMPLETED|Overall Study||10
465228|NCT01216748|1140178|P1|Eucapnic Hyperventilation|Overall Study||10
465229|NCT01216748|1140178|P1|Hypercapnic Hyperventilation|Overall Study||10
465230|NCT01216748|1140178|P1|Hypocapnic Hyperventilation|Overall Study||10
465231|NCT01216748|1140178|P1|Quiet Breathing|Overall Study||10
465232|NCT01216748|1140178|P1|STARTED|Overall Study||10
465233|NCT01216735|1140185|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
465234|NCT01216735|1140186|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
465235|NCT01216735|1140185|P2|COMPLETED|Second Intervention (3 Weeks)||7
465236|NCT01216735|1140186|P1|COMPLETED|Second Intervention (3 Weeks)||8
465237|NCT01216735|1140185|P2|STARTED|Second Intervention (3 Weeks)||7
465238|NCT01216735|1140186|P1|STARTED|Second Intervention (3 Weeks)||8
465239|NCT01216735|1140185|P2|NOT COMPLETED|Washout (3 Weeks)||0
465240|NCT01216735|1140186|P1|NOT COMPLETED|Washout (3 Weeks)||0
465241|NCT01216735|1140185|P2|COMPLETED|Washout (3 Weeks)||7
465242|NCT01216735|1140186|P1|COMPLETED|Washout (3 Weeks)||8
465243|NCT01216735|1140185|P2|STARTED|Washout (3 Weeks)||7
465244|NCT01216735|1140186|P1|STARTED|Washout (3 Weeks)||8
465245|NCT01216735|1140185|P2|NOT COMPLETED|First Intervention (3 Weeks)||0
465246|NCT01216735|1140186|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
465247|NCT01216735|1140185|P2|COMPLETED|First Intervention (3 Weeks)||7
465248|NCT01216735|1140186|P1|COMPLETED|First Intervention (3 Weeks)||8
465249|NCT01216735|1140185|P2|STARTED|First Intervention (3 Weeks)||7
465250|NCT01216735|1140186|P1|STARTED|First Intervention (3 Weeks)||8
465251|NCT01216631|1140197|P3|NOT COMPLETED|Overall Study||0
465252|NCT01216631|1140198|P2|NOT COMPLETED|Overall Study||0
465253|NCT01216631|1140199|P1|NOT COMPLETED|Overall Study||0
465254|NCT01216631|1140197|P3|COMPLETED|Overall Study||1
465255|NCT01216631|1140198|P2|COMPLETED|Overall Study||0
465256|NCT01216631|1140199|P1|COMPLETED|Overall Study||0
465257|NCT01216631|1140197|P3|STARTED|Overall Study||1
465258|NCT01216631|1140198|P2|STARTED|Overall Study||0
465259|NCT01216631|1140199|P1|STARTED|Overall Study||0
465260|NCT01216410|1140210|P3|NOT COMPLETED|Overall Study||3
465261|NCT01216410|1140211|P2|NOT COMPLETED|Overall Study||1
465262|NCT01216410|1140212|P1|NOT COMPLETED|Overall Study||2
465263|NCT01216410|1140210|P3|COMPLETED|Overall Study||100
465264|NCT01216410|1140211|P2|COMPLETED|Overall Study||99
465265|NCT01216410|1140212|P1|COMPLETED|Overall Study||101
465266|NCT01216410|1140210|P3|STARTED|Overall Study||103
465267|NCT01216410|1140211|P2|STARTED|Overall Study||100
465268|NCT01216410|1140212|P1|STARTED|Overall Study||103
465269|NCT01216397|1140232|P2|NOT COMPLETED|Period 2||0
465270|NCT01216397|1140233|P1|NOT COMPLETED|Period 2||0
465271|NCT01216397|1140232|P2|COMPLETED|Period 2||20
465272|NCT01216397|1140233|P1|COMPLETED|Period 2||20
465273|NCT01216397|1140232|P2|STARTED|Period 2||20
465274|NCT01216397|1140233|P1|STARTED|Period 2||20
465275|NCT01216397|1140232|P2|NOT COMPLETED|Washout (35 Days)||0
465276|NCT01216397|1140233|P1|NOT COMPLETED|Washout (35 Days)||0
465277|NCT01216397|1140232|P2|COMPLETED|Washout (35 Days)||20
465278|NCT01216397|1140233|P1|COMPLETED|Washout (35 Days)||20
465279|NCT01216397|1140232|P2|STARTED|Washout (35 Days)||20
465280|NCT01216397|1140233|P1|STARTED|Washout (35 Days)||20
465281|NCT01216397|1140232|P2|NOT COMPLETED|Period 1||0
465282|NCT01216397|1140233|P1|NOT COMPLETED|Period 1||0
465283|NCT01216397|1140232|P2|COMPLETED|Period 1||20
465284|NCT01216397|1140233|P1|COMPLETED|Period 1||20
465285|NCT01216397|1140232|P2|STARTED|Period 1||20
465286|NCT01216397|1140233|P1|STARTED|Period 1||20
465287|NCT01216319|1140285|P1|NOT COMPLETED|Overall Study||4
465288|NCT01216319|1140285|P1|COMPLETED|Overall Study||46
465289|NCT01216319|1140285|P1|STARTED|Overall Study||50
465290|NCT01216241|1140292|P2|NOT COMPLETED|Overall Study||0
465291|NCT01216241|1140293|P1|NOT COMPLETED|Overall Study||0
465292|NCT01216241|1140292|P2|COMPLETED|Overall Study|Reporter remains blinded so the 4 completed could have been either study drug or placebo.|18
465293|NCT01216241|1140293|P1|COMPLETED|Overall Study|Reporter remains blinded so the 4 completed could have been either study drug or placebo.|18
465294|NCT01216241|1140292|P2|STARTED|Overall Study|18 subjects randomized. All didn't receive study drug/placebo if they didn't have neutropenic fever|18
465295|NCT01216241|1140293|P1|STARTED|Overall Study|18 subjects randomized. All didn't receive study drug/placebo if they didn't have neutropenic fever|18
465296|NCT01216163|1140302|P3|NOT COMPLETED|Overall Study||0
465297|NCT01216163|1140303|P2|NOT COMPLETED|Overall Study||1
465298|NCT01216163|1140304|P1|NOT COMPLETED|Overall Study||1
465299|NCT01216163|1140302|P3|COMPLETED|Overall Study||85
465300|NCT01216163|1140303|P2|COMPLETED|Overall Study||87
465301|NCT01216163|1140304|P1|COMPLETED|Overall Study||44
465302|NCT01216163|1140302|P3|STARTED|Overall Study||85
465303|NCT01216163|1140303|P2|STARTED|Overall Study||88
465304|NCT01216163|1140304|P1|STARTED|Overall Study||45
465305|NCT01216072|1140356|P2|NOT COMPLETED|Open-Label Extension Period (3 Months)||14
465306|NCT01216072|1140357|P1|NOT COMPLETED|Open-Label Extension Period (3 Months)||0
465307|NCT01216072|1140356|P2|COMPLETED|Open-Label Extension Period (3 Months)||181
465308|NCT01216072|1140357|P1|COMPLETED|Open-Label Extension Period (3 Months)||0
465309|NCT01216072|1140356|P2|Safety Set|Open-Label Extension Period (3 Months)||193
465310|NCT01216072|1140357|P1|Safety Set|Open-Label Extension Period (3 Months)||0
465311|NCT01216072|1140356|P2|STARTED|Open-Label Extension Period (3 Months)|Only DMT patients, who completed the core study, were eligible for fingolimod.|195
465312|NCT01216072|1140357|P1|STARTED|Open-Label Extension Period (3 Months)||0
465313|NCT01216072|1140356|P2|NOT COMPLETED|Open-Label Core Period ( 6 Months)||34
465314|NCT01216072|1140357|P1|NOT COMPLETED|Open-Label Core Period ( 6 Months)||76
465315|NCT01216072|1140356|P2|COMPLETED|Open-Label Core Period ( 6 Months)||229
465316|NCT01216072|1140357|P1|COMPLETED|Open-Label Core Period ( 6 Months)||714
465317|NCT01216072|1140356|P2|Safety Set|Open-Label Core Period ( 6 Months)||245
465318|NCT01216072|1140357|P1|Safety Set|Open-Label Core Period ( 6 Months)||783
465319|NCT01216072|1140356|P2|Full Analysis Set|Open-Label Core Period ( 6 Months)||263
465320|NCT01216072|1140357|P1|Full Analysis Set|Open-Label Core Period ( 6 Months)|One patient was randomized in error and was not included in FAS.|789
465321|NCT01216072|1140356|P2|STARTED|Open-Label Core Period ( 6 Months)||263
465322|NCT01216072|1140357|P1|STARTED|Open-Label Core Period ( 6 Months)||790
465323|NCT01215981|1140385|P2|NOT COMPLETED|Overall Study||1
465324|NCT01215981|1140386|P1|NOT COMPLETED|Overall Study||2
465325|NCT01215981|1140385|P2|COMPLETED|Overall Study||32
465326|NCT01215981|1140386|P1|COMPLETED|Overall Study||33
465327|NCT01215981|1140385|P2|STARTED|Overall Study||33
465328|NCT01215981|1140386|P1|STARTED|Overall Study||35
465329|NCT01215968|1140396|P2|NOT COMPLETED|Overall Study||7
465330|NCT01215968|1140397|P1|NOT COMPLETED|Overall Study||2
465331|NCT01215968|1140396|P2|COMPLETED|Overall Study||18
465332|NCT01215968|1140397|P1|COMPLETED|Overall Study||11
465333|NCT01215968|1140396|P2|Received at Least 1 Dose of Study Drug|Overall Study|25 participants received placebo during Week 1.|24
465334|NCT01215968|1140397|P1|Received at Least 1 Dose of Study Drug|Overall Study||13
465335|NCT01215968|1140396|P2|STARTED|Overall Study||25
465336|NCT01215968|1140397|P1|STARTED|Overall Study||13
465337|NCT01215955|1140417|P4|NOT COMPLETED|Overall Study||53
465338|NCT01215955|1140418|P3|NOT COMPLETED|Overall Study||48
465339|NCT01215955|1140419|P2|NOT COMPLETED|Overall Study||53
465340|NCT01215955|1140420|P1|NOT COMPLETED|Overall Study||45
465341|NCT01215955|1140417|P4|COMPLETED|Overall Study||241
465342|NCT01215955|1140418|P3|COMPLETED|Overall Study||244
465343|NCT01215955|1140419|P2|COMPLETED|Overall Study||210
465344|NCT01215955|1140420|P1|COMPLETED|Overall Study||223
465345|NCT01215955|1140417|P4|Received at Least 1 Dose of Study Drug|Overall Study||290
465346|NCT01215955|1140418|P3|Received at Least 1 Dose of Study Drug|Overall Study||288
465347|NCT01215955|1140419|P2|Received at Least 1 Dose of Study Drug|Overall Study||261
465348|NCT01215955|1140420|P1|Received at Least 1 Dose of Study Drug|Overall Study||267
465349|NCT01215955|1140417|P4|STARTED|Overall Study|Two (2) participants from 1 site were excluded due to quality issues and validity of the data.|294
465350|NCT01215955|1140418|P3|STARTED|Overall Study|Three (3) participants from 1 site were excluded due to quality issues and validity of data.|292
465351|NCT01215955|1140419|P2|STARTED|Overall Study||263
465352|NCT01215955|1140420|P1|STARTED|Overall Study||268
465353|NCT01215942|1140488|P2|NOT COMPLETED|Post-Treatment Follow-Up Period||146
465354|NCT01215942|1140489|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||85
465355|NCT01215942|1140488|P2|COMPLETED|Post-Treatment Follow-Up Period||445
465356|NCT01215942|1140489|P1|COMPLETED|Post-Treatment Follow-Up Period||283
465357|NCT01215942|1140488|P2|STARTED|Post-Treatment Follow-Up Period|Not all participants who discontinued treatment entered post-treatment follow-up period.|591
465358|NCT01215942|1140489|P1|STARTED|Post-Treatment Follow-Up Period|Not all participants who discontinued treatment entered post-treatment follow-up period.|368
465359|NCT01215942|1140488|P2|NOT COMPLETED|Treatment Period||672
465360|NCT01215942|1140489|P1|NOT COMPLETED|Treatment Period||414
465361|NCT01215942|1140488|P2|COMPLETED|Treatment Period||0
465362|NCT01215942|1140489|P1|COMPLETED|Treatment Period||0
465363|NCT01215942|1140488|P2|STARTED|Treatment Period|Participants who discontinued treatment were followed in post-treatment follow-up.|672
465364|NCT01215942|1140489|P1|STARTED|Treatment Period|Participants who discontinued treatment were followed in post-treatment follow-up.|414
465365|NCT01215929|1140606|P2|NOT COMPLETED|Overall Study||5
465366|NCT01215929|1140607|P1|NOT COMPLETED|Overall Study||6
465367|NCT01215929|1140606|P2|COMPLETED|Overall Study||12
465368|NCT01215929|1140607|P1|COMPLETED|Overall Study||12
465369|NCT01215929|1140606|P2|STARTED|Overall Study||17
465370|NCT01215929|1140607|P1|STARTED|Overall Study||18
465371|NCT01215851|1140619|P6|NOT COMPLETED|Follow up Period||1
465372|NCT01215851|1140620|P5|NOT COMPLETED|Follow up Period||0
465373|NCT01215851|1140621|P4|NOT COMPLETED|Follow up Period||0
465374|NCT01215851|1140622|P3|NOT COMPLETED|Follow up Period||0
465375|NCT01215851|1140623|P2|NOT COMPLETED|Follow up Period||0
465376|NCT01215851|1140624|P1|NOT COMPLETED|Follow up Period||0
465377|NCT01215851|1140619|P6|COMPLETED|Follow up Period||13
465378|NCT01215851|1140620|P5|COMPLETED|Follow up Period||10
465379|NCT01215851|1140621|P4|COMPLETED|Follow up Period||12
465380|NCT01215851|1140622|P3|COMPLETED|Follow up Period||14
465381|NCT01215851|1140623|P2|COMPLETED|Follow up Period||14
465382|NCT01215851|1140624|P1|COMPLETED|Follow up Period||14
465383|NCT01215851|1140619|P6|STARTED|Follow up Period||14
465384|NCT01215851|1140620|P5|STARTED|Follow up Period||10
465385|NCT01215851|1140621|P4|STARTED|Follow up Period||12
465386|NCT01215851|1140622|P3|STARTED|Follow up Period||14
465387|NCT01215851|1140623|P2|STARTED|Follow up Period||14
465388|NCT01215851|1140624|P1|STARTED|Follow up Period||14
465389|NCT01215851|1140619|P6|NOT COMPLETED|Treatment Period||1
465390|NCT01215851|1140620|P5|NOT COMPLETED|Treatment Period||0
465391|NCT01215851|1140621|P4|NOT COMPLETED|Treatment Period||3
465392|NCT01215851|1140622|P3|NOT COMPLETED|Treatment Period||1
465393|NCT01215851|1140623|P2|NOT COMPLETED|Treatment Period||1
465394|NCT01215851|1140624|P1|NOT COMPLETED|Treatment Period||1
465395|NCT01215851|1140619|P6|COMPLETED|Treatment Period||14
465396|NCT01215851|1140620|P5|COMPLETED|Treatment Period||10
465397|NCT01215851|1140621|P4|COMPLETED|Treatment Period||12
465398|NCT01215851|1140622|P3|COMPLETED|Treatment Period||14
465399|NCT01215851|1140623|P2|COMPLETED|Treatment Period||14
465400|NCT01215851|1140624|P1|COMPLETED|Treatment Period||14
465401|NCT01215851|1140619|P6|STARTED|Treatment Period||15
465402|NCT01215851|1140620|P5|STARTED|Treatment Period||10
465403|NCT01215851|1140621|P4|STARTED|Treatment Period||15
465404|NCT01215851|1140622|P3|STARTED|Treatment Period||15
465405|NCT01215851|1140623|P2|STARTED|Treatment Period||15
465406|NCT01215851|1140624|P1|STARTED|Treatment Period||15
465407|NCT01215786|1140665|P3|NOT COMPLETED|Overall Study||0
465408|NCT01215786|1140666|P2|NOT COMPLETED|Overall Study||0
465409|NCT01215786|1140667|P1|NOT COMPLETED|Overall Study||0
465410|NCT01215786|1140665|P3|COMPLETED|Overall Study||10
465411|NCT01215786|1140666|P2|COMPLETED|Overall Study||19
465412|NCT01215786|1140667|P1|COMPLETED|Overall Study||21
465413|NCT01215786|1140665|P3|STARTED|Overall Study||10
465414|NCT01215786|1140666|P2|STARTED|Overall Study||19
465415|NCT01215786|1140667|P1|STARTED|Overall Study||21
465416|NCT01215734|1140683|P2|NOT COMPLETED|Overall Study||1
465417|NCT01215734|1140684|P1|NOT COMPLETED|Overall Study||0
465418|NCT01215734|1140683|P2|COMPLETED|Overall Study||14
465419|NCT01215734|1140684|P1|COMPLETED|Overall Study||29
465420|NCT01215734|1140683|P2|STARTED|Overall Study||15
465421|NCT01215734|1140684|P1|STARTED|Overall Study||29
465422|NCT01215721|1140692|P1|NOT COMPLETED|Overall Study||2
465423|NCT01215721|1140692|P1|COMPLETED|Overall Study||38
465424|NCT01215721|1140692|P1|STARTED|Overall Study||40
465425|NCT01215695|1140698|P2|NOT COMPLETED|Overall Study||0
465426|NCT01215695|1140699|P1|NOT COMPLETED|Overall Study||0
465427|NCT01215695|1140698|P2|COMPLETED|Overall Study||70
465428|NCT01215695|1140699|P1|COMPLETED|Overall Study||70
465429|NCT01215695|1140698|P2|STARTED|Overall Study||70
465430|NCT01215695|1140699|P1|STARTED|Overall Study||70
465431|NCT01215643|1140718|P5|NOT COMPLETED|Overall Study||11
465432|NCT01215643|1140719|P4|NOT COMPLETED|Overall Study||4
465433|NCT01215643|1140720|P3|NOT COMPLETED|Overall Study||12
465434|NCT01215643|1140721|P2|NOT COMPLETED|Overall Study||4
465435|NCT01215643|1140722|P1|NOT COMPLETED|Overall Study||9
465436|NCT01215643|1140718|P5|COMPLETED|Overall Study||29
465437|NCT01215643|1140719|P4|COMPLETED|Overall Study||35
465438|NCT01215643|1140720|P3|COMPLETED|Overall Study||82
465439|NCT01215643|1140721|P2|COMPLETED|Overall Study||80
465440|NCT01215643|1140722|P1|COMPLETED|Overall Study||74
465441|NCT01215643|1140718|P5|STARTED|Overall Study||40
465442|NCT01215643|1140719|P4|STARTED|Overall Study||39
465443|NCT01215643|1140720|P3|STARTED|Overall Study||94
465444|NCT01215643|1140721|P2|STARTED|Overall Study||84
465445|NCT01215643|1140722|P1|STARTED|Overall Study||83
465446|NCT01215513|1140824|P1|NOT COMPLETED|Overall Study||45
465447|NCT01215513|1140824|P1|COMPLETED|Overall Study||112
465448|NCT01215513|1140824|P1|CS42A Safety Analysis Set|Overall Study|127 participants were enrolled in the extension study CS42A|127
465449|NCT01215513|1140824|P1|CS42 and CS42A Full Analysis Set|Overall Study|155 participants received at least 1 dose of degarelix and had at least 1 efficacy assessment|155
465450|NCT01215513|1140824|P1|CS42 and CS42A Safety Analysis Set|Overall Study|156 participants received at least 1 dose of degarelix|156
465451|NCT01215513|1140824|P1|STARTED|Overall Study|157 participants were allocated to treatment in CS42 main study (Intent-to-treat analysis set)|157
465452|NCT01215435|1140833|P2|NOT COMPLETED|Overall Study||16
465453|NCT01215435|1140834|P1|NOT COMPLETED|Overall Study||19
465454|NCT01215435|1140833|P2|COMPLETED|Overall Study||107
465455|NCT01215435|1140834|P1|COMPLETED|Overall Study||103
465456|NCT01215435|1140833|P2|STARTED|Overall Study||123
465457|NCT01215435|1140834|P1|STARTED|Overall Study||122
465458|NCT01215422|1140848|P4|NOT COMPLETED|Overall Study||8
465459|NCT01215422|1140849|P3|NOT COMPLETED|Overall Study||3
465460|NCT01215422|1140850|P2|NOT COMPLETED|Overall Study||0
465461|NCT01215422|1140851|P1|NOT COMPLETED|Overall Study||8
465462|NCT01215422|1140848|P4|COMPLETED|Overall Study||193
465463|NCT01215422|1140849|P3|COMPLETED|Overall Study||193
465464|NCT01215422|1140850|P2|COMPLETED|Overall Study||249
465465|NCT01215422|1140851|P1|COMPLETED|Overall Study||6
465466|NCT01215422|1140848|P4|STARTED|Overall Study||201
465467|NCT01215422|1140849|P3|STARTED|Overall Study||196
465468|NCT01215422|1140850|P2|STARTED|Overall Study||249
465469|NCT01215422|1140851|P1|STARTED|Overall Study||14
465470|NCT01215357|1140873|P1|NOT COMPLETED|Overall Study||12
465471|NCT01215357|1140873|P1|COMPLETED|Overall Study||22
465472|NCT01215357|1140873|P1|STARTED|Overall Study||34
465473|NCT01215344|1140879|P2|NOT COMPLETED|Overall Study||0
465474|NCT01215344|1140880|P1|NOT COMPLETED|Overall Study||10
465475|NCT01215344|1140879|P2|COMPLETED|Overall Study||3
465476|NCT01215344|1140880|P1|COMPLETED|Overall Study||23
465477|NCT01215344|1140879|P2|STARTED|Overall Study||3
465478|NCT01215344|1140880|P1|STARTED|Overall Study||33
465479|NCT01215292|1140893|P5|NOT COMPLETED|Overall Study||0
465480|NCT01215292|1140894|P4|NOT COMPLETED|Overall Study||0
465481|NCT01215292|1140895|P3|NOT COMPLETED|Overall Study||0
465482|NCT01215292|1140896|P2|NOT COMPLETED|Overall Study||0
465483|NCT01215292|1140897|P1|NOT COMPLETED|Overall Study||0
465484|NCT01215292|1140893|P5|COMPLETED|Overall Study||8
465485|NCT01215292|1140894|P4|COMPLETED|Overall Study||8
465486|NCT01215292|1140895|P3|COMPLETED|Overall Study||8
465487|NCT01215292|1140896|P2|COMPLETED|Overall Study||8
465488|NCT01215292|1140897|P1|COMPLETED|Overall Study||8
465489|NCT01215292|1140893|P5|STARTED|Overall Study||8
465490|NCT01215292|1140894|P4|STARTED|Overall Study||8
465491|NCT01215292|1140895|P3|STARTED|Overall Study||8
465492|NCT01215292|1140896|P2|STARTED|Overall Study||8
465493|NCT01215292|1140897|P1|STARTED|Overall Study||8
465494|NCT01215279|1140921|P2|NOT COMPLETED|Overall Study||0
465495|NCT01215279|1140922|P1|NOT COMPLETED|Overall Study||0
465496|NCT01215279|1140921|P2|COMPLETED|Overall Study||32
465497|NCT01215279|1140922|P1|COMPLETED|Overall Study||31
465498|NCT01215279|1140921|P2|STARTED|Overall Study||32
465499|NCT01215279|1140922|P1|STARTED|Overall Study||31
465500|NCT01215253|1140988|P2|NOT COMPLETED|Overall Study||63
465501|NCT01215253|1140989|P1|NOT COMPLETED|Overall Study||86
465502|NCT01215253|1140988|P2|COMPLETED|Overall Study||439
465503|NCT01215253|1140989|P1|COMPLETED|Overall Study||424
465504|NCT01215253|1140988|P2|STARTED|Overall Study||502
465505|NCT01215253|1140989|P1|STARTED|Overall Study||510
465506|NCT01215227|1141023|P6|NOT COMPLETED|Overall Study||58
465507|NCT01215227|1141024|P5|NOT COMPLETED|Overall Study||48
465508|NCT01215227|1141025|P4|NOT COMPLETED|Overall Study||49
465509|NCT01215227|1141026|P3|NOT COMPLETED|Overall Study||57
465510|NCT01215227|1141027|P2|NOT COMPLETED|Overall Study||119
465511|NCT01215227|1141028|P1|NOT COMPLETED|Overall Study||121
465512|NCT01215227|1141023|P6|COMPLETED|Overall Study||51
465513|NCT01215227|1141024|P5|COMPLETED|Overall Study||45
465514|NCT01215227|1141025|P4|COMPLETED|Overall Study||48
465515|NCT01215227|1141026|P3|COMPLETED|Overall Study||50
465516|NCT01215227|1141027|P2|COMPLETED|Overall Study||96
465517|NCT01215227|1141028|P1|COMPLETED|Overall Study||97
465518|NCT01215227|1141023|P6|Treated|Overall Study||108
465519|NCT01215227|1141024|P5|Treated|Overall Study||93
465520|NCT01215227|1141025|P4|Treated|Overall Study||96
465521|NCT01215227|1141026|P3|Treated|Overall Study||106
465522|NCT01215227|1141027|P2|Treated|Overall Study||215
465523|NCT01215227|1141028|P1|Treated|Overall Study||218
465524|NCT01215227|1141023|P6|STARTED|Overall Study||109
465525|NCT01215227|1141024|P5|STARTED|Overall Study||93
465526|NCT01215227|1141025|P4|STARTED|Overall Study||97
465527|NCT01215227|1141026|P3|STARTED|Overall Study||107
465528|NCT01215227|1141027|P2|STARTED|Overall Study||215
465529|NCT01215227|1141028|P1|STARTED|Overall Study||218
465530|NCT01215123|1141072|P1|NOT COMPLETED|Overall Study||0
465531|NCT01215123|1141072|P1|COMPLETED|Overall Study||28
465532|NCT01215123|1141072|P1|STARTED|Overall Study||28
465533|NCT01215110|1141082|P5|NOT COMPLETED|Overall Study||0
465534|NCT01215110|1141083|P4|NOT COMPLETED|Overall Study||1
465535|NCT01215110|1141084|P3|NOT COMPLETED|Overall Study||2
465536|NCT01215110|1141085|P2|NOT COMPLETED|Overall Study||0
465537|NCT01215110|1141086|P1|NOT COMPLETED|Overall Study||0
465538|NCT01215110|1141082|P5|COMPLETED|Overall Study||8
465539|NCT01215110|1141083|P4|COMPLETED|Overall Study||14
465540|NCT01215110|1141084|P3|COMPLETED|Overall Study||13
465541|NCT01215110|1141085|P2|COMPLETED|Overall Study||15
465542|NCT01215110|1141086|P1|COMPLETED|Overall Study||15
465543|NCT01215110|1141082|P5|STARTED|Overall Study||8
465544|NCT01215110|1141083|P4|STARTED|Overall Study||15
465545|NCT01215110|1141084|P3|STARTED|Overall Study||15
465546|NCT01215110|1141085|P2|STARTED|Overall Study||15
465547|NCT01215110|1141086|P1|STARTED|Overall Study||15
465548|NCT01215097|1141147|P2|NOT COMPLETED|Overall Study||14
465549|NCT01215097|1141148|P1|NOT COMPLETED|Overall Study||12
465550|NCT01215097|1141147|P2|COMPLETED|Overall Study||191
465551|NCT01215097|1141148|P1|COMPLETED|Overall Study||88
465552|NCT01215097|1141147|P2|STARTED|Overall Study|Patients who are randomised and treated with linagliptin.|205
465553|NCT01215097|1141148|P1|STARTED|Overall Study|Patients who are randomised and treated with placebo. 1 patient was not treated then not included.|100
465554|NCT01215032|1141180|P1|NOT COMPLETED|Overall Study||20
465555|NCT01215032|1141180|P1|COMPLETED|Overall Study||1
465556|NCT01215032|1141180|P1|STARTED|Overall Study||21
465557|NCT01214980|1141190|P2|NOT COMPLETED|Overall Study||2
465558|NCT01214980|1141191|P1|NOT COMPLETED|Overall Study||3
465559|NCT01214980|1141190|P2|COMPLETED|Overall Study||14
465560|NCT01214980|1141191|P1|COMPLETED|Overall Study||13
465561|NCT01214980|1141190|P2|STARTED|Overall Study||16
465562|NCT01214980|1141191|P1|STARTED|Overall Study||16
465563|NCT01214915|1141205|P1|NOT COMPLETED|Overall Study||11
465564|NCT01214915|1141205|P1|COMPLETED|Overall Study||42
465565|NCT01214915|1141205|P1|STARTED|Overall Study||53
465566|NCT01214850|1141216|P3|NOT COMPLETED|Overall Study||161
465567|NCT01214850|1141217|P2|NOT COMPLETED|Overall Study||144
465568|NCT01214850|1141218|P1|NOT COMPLETED|Overall Study||183
465569|NCT01214850|1141216|P3|COMPLETED|Overall Study||826
465570|NCT01214850|1141217|P2|COMPLETED|Overall Study||844
465571|NCT01214850|1141218|P1|COMPLETED|Overall Study||796
465572|NCT01214850|1141216|P3|STARTED|Overall Study||987
465573|NCT01214850|1141217|P2|STARTED|Overall Study||988
465574|NCT01214850|1141218|P1|STARTED|Overall Study||979
465575|NCT01214837|1141302|P3|NOT COMPLETED|Overall Study||62
465576|NCT01214837|1141303|P2|NOT COMPLETED|Overall Study||64
465577|NCT01214837|1141304|P1|NOT COMPLETED|Overall Study||54
465578|NCT01214837|1141302|P3|COMPLETED|Overall Study||184
465579|NCT01214837|1141303|P2|COMPLETED|Overall Study||192
465580|NCT01214837|1141304|P1|COMPLETED|Overall Study||195
465581|NCT01214837|1141302|P3|STARTED|Overall Study||246
465582|NCT01214837|1141303|P2|STARTED|Overall Study||256
465583|NCT01214837|1141304|P1|STARTED|Overall Study||249
465584|NCT01214824|1141341|P1|NOT COMPLETED|Overall Study||3
465585|NCT01214824|1141341|P1|COMPLETED|Overall Study||29
465586|NCT01214824|1141341|P1|STARTED|Overall Study||32
465587|NCT01214811|1141348|P1|NOT COMPLETED|Overall Study||3
465588|NCT01214811|1141348|P1|COMPLETED|Overall Study||24
465589|NCT01214811|1141348|P1|STARTED|Overall Study||27
465590|NCT01214759|1141352|P1|NOT COMPLETED|Overall Study||48
465591|NCT01214759|1141352|P1|COMPLETED|Overall Study||55
465592|NCT01214759|1141352|P1|28 Days nPEP Completion|Overall Study||85
465593|NCT01214759|1141352|P1|STARTED|Overall Study||103
465594|NCT01214720|1141360|P2|NOT COMPLETED|Overall Study||68
465595|NCT01214720|1141361|P1|NOT COMPLETED|Overall Study||85
465596|NCT01214720|1141360|P2|COMPLETED|Overall Study|Indicates patients who had died at the time of the data cut-off|233
465597|NCT01214720|1141361|P1|COMPLETED|Overall Study|Indicates patients who had died at the time of the data cut-off|221
465598|NCT01214720|1141360|P2|STARTED|Overall Study||301
465599|NCT01214720|1141361|P1|STARTED|Overall Study||306
465600|NCT01214616|1141382|P4|NOT COMPLETED|Overall Study||6
465601|NCT01214616|1141383|P3|NOT COMPLETED|Overall Study||3
465602|NCT01214616|1141384|P2|NOT COMPLETED|Overall Study||5
465603|NCT01214616|1141385|P1|NOT COMPLETED|Overall Study||3
465604|NCT01214616|1141382|P4|COMPLETED|Overall Study||0
465605|NCT01214616|1141383|P3|COMPLETED|Overall Study||0
465606|NCT01214616|1141384|P2|COMPLETED|Overall Study||0
465607|NCT01214616|1141385|P1|COMPLETED|Overall Study||0
465608|NCT01214616|1141382|P4|STARTED|Overall Study|Cohort 3 with afatinib/vinorelbine modification. Skipping vinorelbine allowed and not considered DLT|6
465609|NCT01214616|1141383|P3|STARTED|Overall Study||3
465610|NCT01214616|1141384|P2|STARTED|Overall Study||5
465611|NCT01214616|1141385|P1|STARTED|Overall Study||3
465612|NCT01214434|1141421|P2|NOT COMPLETED|Overall Study||2
465613|NCT01214434|1141422|P1|NOT COMPLETED|Overall Study||4
465614|NCT01214434|1141421|P2|COMPLETED|Overall Study||25
465615|NCT01214434|1141422|P1|COMPLETED|Overall Study||11
465616|NCT01214434|1141421|P2|STARTED|Overall Study||27
465617|NCT01214434|1141422|P1|STARTED|Overall Study||15
465618|NCT01214395|1141438|P1|NOT COMPLETED|Overall Study||5
465619|NCT01214395|1141438|P1|COMPLETED|Overall Study||0
465620|NCT01214395|1141438|P1|STARTED|Overall Study||5
465621|NCT01214330|1141443|P1|NOT COMPLETED|Overall Study||48
465622|NCT01214330|1141443|P1|COMPLETED|Overall Study||102
465623|NCT01214330|1141443|P1|STARTED|Overall Study||150
465624|NCT01214252|1141447|P1|NOT COMPLETED|Overall Study||82
465625|NCT01214252|1141447|P1|COMPLETED|Overall Study||343
465626|NCT01214252|1141447|P1|STARTED|Overall Study||425
465627|NCT01214239|1141455|P2|NOT COMPLETED|Overall Study||18
465628|NCT01214239|1141456|P1|NOT COMPLETED|Overall Study||12
465629|NCT01214239|1141455|P2|COMPLETED|Overall Study||182
465630|NCT01214239|1141456|P1|COMPLETED|Overall Study||87
465631|NCT01214239|1141455|P2|STARTED|Overall Study|patients who were randomised and treated with placebo. 1 patient was not treated then not included|200
465632|NCT01214239|1141456|P1|STARTED|Overall Study|patients who were randomised and treated with placebo|99
465633|NCT01214187|1141490|P2|NOT COMPLETED|Overall Study||6
465634|NCT01214187|1141491|P1|NOT COMPLETED|Overall Study||7
465635|NCT01214187|1141490|P2|COMPLETED|Overall Study||23
465636|NCT01214187|1141491|P1|COMPLETED|Overall Study||22
465637|NCT01214187|1141490|P2|STARTED|Overall Study||29
465638|NCT01214187|1141491|P1|STARTED|Overall Study||29
465639|NCT01214174|1141508|P3|NOT COMPLETED|Overall Study||1
465640|NCT01214174|1141509|P2|NOT COMPLETED|Overall Study||0
465641|NCT01214174|1141510|P1|NOT COMPLETED|Overall Study||0
465642|NCT01214174|1141508|P3|COMPLETED|Overall Study||13
465643|NCT01214174|1141509|P2|COMPLETED|Overall Study||16
465644|NCT01214174|1141510|P1|COMPLETED|Overall Study||13
465645|NCT01214174|1141508|P3|STARTED|Overall Study||14
465646|NCT01214174|1141509|P2|STARTED|Overall Study||16
465647|NCT01214174|1141510|P1|STARTED|Overall Study||13
465648|NCT01214161|1141520|P2|NOT COMPLETED|Overall Study||0
465649|NCT01214161|1141521|P1|NOT COMPLETED|Overall Study||0
465650|NCT01214161|1141520|P2|COMPLETED|Overall Study||100
465651|NCT01214161|1141521|P1|COMPLETED|Overall Study||100
465652|NCT01214161|1141520|P2|STARTED|Overall Study||100
465653|NCT01214161|1141521|P1|STARTED|Overall Study||100
465654|NCT01214109|1141531|P4|NOT COMPLETED|Overall Study||0
465655|NCT01214109|1141532|P3|NOT COMPLETED|Overall Study||0
465656|NCT01214109|1141533|P2|NOT COMPLETED|Overall Study||0
465657|NCT01214109|1141534|P1|NOT COMPLETED|Overall Study||0
465658|NCT01214109|1141531|P4|COMPLETED|Overall Study||24
465659|NCT01214109|1141532|P3|COMPLETED|Overall Study||24
465660|NCT01214109|1141533|P2|COMPLETED|Overall Study||24
465661|NCT01214109|1141534|P1|COMPLETED|Overall Study||24
465662|NCT01214109|1141531|P4|STARTED|Overall Study||24
465663|NCT01214109|1141532|P3|STARTED|Overall Study||24
465664|NCT01214109|1141533|P2|STARTED|Overall Study||24
465665|NCT01214109|1141534|P1|STARTED|Overall Study||24
465666|NCT01214083|1141626|P3|NOT COMPLETED|Overall Study||10
465667|NCT01214083|1141627|P2|NOT COMPLETED|Overall Study||10
465668|NCT01214083|1141628|P1|NOT COMPLETED|Overall Study||12
465669|NCT01214083|1141626|P3|COMPLETED|Overall Study||21
465670|NCT01214083|1141627|P2|COMPLETED|Overall Study||23
465671|NCT01214083|1141628|P1|COMPLETED|Overall Study||19
465672|NCT01214083|1141626|P3|STARTED|Overall Study||31
465673|NCT01214083|1141627|P2|STARTED|Overall Study||33
465674|NCT01214083|1141628|P1|STARTED|Overall Study||31
465675|NCT01213966|1141664|P4|NOT COMPLETED|Overall Study||1
465676|NCT01213966|1141665|P3|NOT COMPLETED|Overall Study||3
465677|NCT01213966|1141666|P2|NOT COMPLETED|Overall Study||0
465678|NCT01213966|1141667|P1|NOT COMPLETED|Overall Study||1
465679|NCT01213966|1141664|P4|COMPLETED|Overall Study||20
465680|NCT01213966|1141665|P3|COMPLETED|Overall Study||17
465681|NCT01213966|1141666|P2|COMPLETED|Overall Study||20
465682|NCT01213966|1141667|P1|COMPLETED|Overall Study||19
465683|NCT01213966|1141664|P4|STARTED|Overall Study||21
465684|NCT01213966|1141665|P3|STARTED|Overall Study||20
465685|NCT01213966|1141666|P2|STARTED|Overall Study||20
465686|NCT01213966|1141667|P1|STARTED|Overall Study||20
465687|NCT01213836|1141679|P2|NOT COMPLETED|Period 2, Second Intervention||0
465688|NCT01213836|1141680|P1|NOT COMPLETED|Period 2, Second Intervention||0
465689|NCT01213836|1141679|P2|COMPLETED|Period 2, Second Intervention||29
465690|NCT01213836|1141680|P1|COMPLETED|Period 2, Second Intervention||31
465691|NCT01213836|1141679|P2|STARTED|Period 2, Second Intervention||29
465692|NCT01213836|1141680|P1|STARTED|Period 2, Second Intervention||31
465693|NCT01213836|1141679|P2|NOT COMPLETED|Period 1, First Intervention||3
465694|NCT01213836|1141680|P1|NOT COMPLETED|Period 1, First Intervention||3
465695|NCT01213836|1141679|P2|COMPLETED|Period 1, First Intervention||29
465696|NCT01213836|1141680|P1|COMPLETED|Period 1, First Intervention||31
465697|NCT01213836|1141679|P2|STARTED|Period 1, First Intervention||32
465698|NCT01213836|1141680|P1|STARTED|Period 1, First Intervention||34
465699|NCT01213823|1141700|P2|NOT COMPLETED|Overall Study||0
465700|NCT01213823|1141701|P1|NOT COMPLETED|Overall Study||0
465701|NCT01213823|1141700|P2|COMPLETED|Overall Study||467
465702|NCT01213823|1141701|P1|COMPLETED|Overall Study||69
465703|NCT01213823|1141700|P2|STARTED|Overall Study||467
465704|NCT01213823|1141701|P1|STARTED|Overall Study||69
465705|NCT01213706|1141707|P1|NOT COMPLETED|WBPA||0
465706|NCT01213706|1141707|P1|COMPLETED|WBPA||45
465707|NCT01213706|1141707|P1|STARTED|WBPA||45
465708|NCT01213706|1141707|P1|NOT COMPLETED|Washout (1 Hour)||0
465709|NCT01213706|1141707|P1|COMPLETED|Washout (1 Hour)||45
465710|NCT01213706|1141707|P1|STARTED|Washout (1 Hour)||45
465711|NCT01213706|1141707|P1|NOT COMPLETED|Sham WBPA||0
465712|NCT01213706|1141707|P1|COMPLETED|Sham WBPA||45
465713|NCT01213706|1141707|P1|STARTED|Sham WBPA||45
465714|NCT01213589|1141716|P3|NOT COMPLETED|Overall Study||8
465715|NCT01213589|1141717|P2|NOT COMPLETED|Overall Study||5
465716|NCT01213589|1141718|P1|NOT COMPLETED|Overall Study||13
465717|NCT01213589|1141716|P3|COMPLETED|Overall Study||18
465718|NCT01213589|1141717|P2|COMPLETED|Overall Study||19
465719|NCT01213589|1141718|P1|COMPLETED|Overall Study||37
465720|NCT01213589|1141716|P3|STARTED|Overall Study||26
465721|NCT01213589|1141717|P2|STARTED|Overall Study||24
465722|NCT01213589|1141718|P1|STARTED|Overall Study||50
465723|NCT01213576|1141748|P4|NOT COMPLETED|Overall Study||4
465724|NCT01213576|1141749|P3|NOT COMPLETED|Overall Study||5
465725|NCT01213576|1141750|P2|NOT COMPLETED|Overall Study||4
465726|NCT01213576|1141751|P1|NOT COMPLETED|Overall Study||3
465727|NCT01213576|1141748|P4|COMPLETED|Overall Study||13
465728|NCT01213576|1141749|P3|COMPLETED|Overall Study||13
465729|NCT01213576|1141750|P2|COMPLETED|Overall Study||13
465730|NCT01213576|1141751|P1|COMPLETED|Overall Study||15
465731|NCT01213576|1141748|P4|STARTED|Overall Study||17
465732|NCT01213576|1141749|P3|STARTED|Overall Study||18
465733|NCT01213576|1141750|P2|STARTED|Overall Study||17
465734|NCT01213576|1141751|P1|STARTED|Overall Study||18
465735|NCT01213329|1141767|P2|NOT COMPLETED|Phase 2||0
465736|NCT01213329|1141768|P1|NOT COMPLETED|Phase 2||0
465737|NCT01213329|1141767|P2|COMPLETED|Phase 2||0
465738|NCT01213329|1141768|P1|COMPLETED|Phase 2||0
465739|NCT01213329|1141767|P2|STARTED|Phase 2||0
465740|NCT01213329|1141768|P1|STARTED|Phase 2||0
465741|NCT01213329|1141767|P2|NOT COMPLETED|Screening||0
465742|NCT01213329|1141768|P1|NOT COMPLETED|Screening||0
465743|NCT01213329|1141767|P2|COMPLETED|Screening||25
465744|NCT01213329|1141768|P1|COMPLETED|Screening||25
465745|NCT01213329|1141767|P2|STARTED|Screening||25
465746|NCT01213329|1141768|P1|STARTED|Screening||25
465747|NCT01213316|1141774|P1|NOT COMPLETED|Overall Study||0
465748|NCT01213316|1141774|P1|COMPLETED|Overall Study||451
465749|NCT01213316|1141774|P1|Initial Cohort|Overall Study|Participants >=18 years of age in the initial cohort|272
465750|NCT01213316|1141774|P1|Discontinued Treatment Before 48 Weeks|Overall Study||67
465751|NCT01213316|1141774|P1|Amendment Cohort: Newly Enrolled|Overall Study|Participants >=50 years of age newly enrolled|179
465752|NCT01213316|1141774|P1|Amendment Cohort: Prolonged Participants|Overall Study|Participants >=50 years of age in the initial cohort who accept an additional 48-week observation|48
465753|NCT01213316|1141774|P1|STARTED|Overall Study|Participants in the initial and amendment cohorts|451
465754|NCT01213264|1141793|P3|NOT COMPLETED|Overall Study||6
465755|NCT01213264|1141794|P2|NOT COMPLETED|Overall Study||2
465756|NCT01213264|1141795|P1|NOT COMPLETED|Overall Study||2
465757|NCT01213264|1141793|P3|COMPLETED|Overall Study||321
465758|NCT01213264|1141794|P2|COMPLETED|Overall Study||175
465759|NCT01213264|1141795|P1|COMPLETED|Overall Study||153
465760|NCT01213264|1141793|P3|STARTED|Overall Study||327
465761|NCT01213264|1141794|P2|STARTED|Overall Study||177
465762|NCT01213264|1141795|P1|STARTED|Overall Study||155
465763|NCT01213251|1141815|P3|NOT COMPLETED|Overall Study||11
465764|NCT01213251|1141816|P2|NOT COMPLETED|Overall Study||4
465765|NCT01213251|1141817|P1|NOT COMPLETED|Overall Study||6
465766|NCT01213251|1141815|P3|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|34
465767|NCT01213251|1141816|P2|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|37
465768|NCT01213251|1141817|P1|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|34
465769|NCT01213251|1141815|P3|STARTED|Overall Study||45
465770|NCT01213251|1141816|P2|STARTED|Overall Study||41
465771|NCT01213251|1141817|P1|STARTED|Overall Study||40
465772|NCT01213199|1141838|P1|NOT COMPLETED|Overall Study||4
465773|NCT01213199|1141838|P1|COMPLETED|Overall Study||16
465774|NCT01213199|1141838|P1|STARTED|Overall Study||20
465775|NCT01213173|1141844|P2|NOT COMPLETED|Overall Study||16
465776|NCT01213173|1141845|P1|NOT COMPLETED|Overall Study||12
465777|NCT01213173|1141844|P2|COMPLETED|Overall Study|Patients who completed the study|110
465778|NCT01213173|1141845|P1|COMPLETED|Overall Study|Patients who completed the study|113
465779|NCT01213173|1141844|P2|Patients Included in PP Population|Overall Study||89
465780|NCT01213173|1141845|P1|Patients Included in PP Population|Overall Study||102
465781|NCT01213173|1141844|P2|Patients Included in ITT Population|Overall Study||115
465782|NCT01213173|1141845|P1|Patients Included in ITT Population|Overall Study||116
465783|NCT01213173|1141844|P2|Patients Included in Safety Population|Overall Study||112
465784|NCT01213173|1141845|P1|Patients Included in Safety Population|Overall Study||139
465785|NCT01213173|1141844|P2|STARTED|Overall Study|Patients who were randomized and received treatment|126
465786|NCT01213173|1141845|P1|STARTED|Overall Study|Patients who were randomized and received treatment|125
465787|NCT01213043|1141877|P2|NOT COMPLETED|Follow-up||0
465788|NCT01213043|1141878|P1|NOT COMPLETED|Follow-up||0
465789|NCT01213043|1141877|P2|COMPLETED|Follow-up||15
465790|NCT01213043|1141878|P1|COMPLETED|Follow-up||15
465791|NCT01213043|1141877|P2|STARTED|Follow-up||15
465792|NCT01213043|1141878|P1|STARTED|Follow-up||15
465793|NCT01213043|1141877|P2|NOT COMPLETED|Treatment Period 2||0
465794|NCT01213043|1141878|P1|NOT COMPLETED|Treatment Period 2||0
465795|NCT01213043|1141877|P2|COMPLETED|Treatment Period 2||15
465796|NCT01213043|1141878|P1|COMPLETED|Treatment Period 2||15
465797|NCT01213043|1141877|P2|STARTED|Treatment Period 2||15
465798|NCT01213043|1141878|P1|STARTED|Treatment Period 2||15
465799|NCT01213043|1141877|P2|NOT COMPLETED|Washout Period||0
465800|NCT01213043|1141878|P1|NOT COMPLETED|Washout Period||0
465801|NCT01213043|1141877|P2|COMPLETED|Washout Period||15
465802|NCT01213043|1141878|P1|COMPLETED|Washout Period||15
465803|NCT01213043|1141877|P2|STARTED|Washout Period||15
465804|NCT01213043|1141878|P1|STARTED|Washout Period||15
465805|NCT01213043|1141877|P2|NOT COMPLETED|Treatment Period 1||0
465806|NCT01213043|1141878|P1|NOT COMPLETED|Treatment Period 1||0
465807|NCT01213043|1141877|P2|COMPLETED|Treatment Period 1||15
465808|NCT01213043|1141878|P1|COMPLETED|Treatment Period 1||15
465809|NCT01213043|1141877|P2|STARTED|Treatment Period 1||15
465810|NCT01213043|1141878|P1|STARTED|Treatment Period 1||15
465811|NCT01212991|1141906|P2|NOT COMPLETED|Overall Study||374
465812|NCT01212991|1141907|P1|NOT COMPLETED|Overall Study||613
465813|NCT01212991|1141906|P2|COMPLETED|Overall Study|Indicates participants continuing in long-term follow-up as of 16SEP2013.|471
465814|NCT01212991|1141907|P1|COMPLETED|Overall Study|Indicates participants continuing in long-term follow-up as of 16SEP2013.|259
465815|NCT01212991|1141906|P2|STARTED|Overall Study||845
465816|NCT01212991|1141907|P1|STARTED|Overall Study||872
465817|NCT01212874|1141927|P2|NOT COMPLETED|Overall Study||23
465818|NCT01212874|1141928|P1|NOT COMPLETED|Overall Study||22
465819|NCT01212874|1141927|P2|COMPLETED|Overall Study||12
465820|NCT01212874|1141928|P1|COMPLETED|Overall Study||13
465821|NCT01212874|1141927|P2|Received Allocated Intervention|Overall Study||12
465822|NCT01212874|1141928|P1|Received Allocated Intervention|Overall Study||13
465823|NCT01212874|1141927|P2|STARTED|Overall Study||35
465824|NCT01212874|1141928|P1|STARTED|Overall Study||35
465825|NCT01212770|1141939|P9|NOT COMPLETED|Long-term Safety Phase (Year 5)||1
465826|NCT01212770|1141940|P8|NOT COMPLETED|Long-term Safety Phase (Year 5)||2
465827|NCT01212770|1141941|P7|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
465828|NCT01212770|1141942|P6|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
465829|NCT01212770|1141943|P5|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
465830|NCT01212770|1141944|P4|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
465831|NCT01212770|1141945|P3|NOT COMPLETED|Long-term Safety Phase (Year 5)||11
465832|NCT01212770|1141946|P2|NOT COMPLETED|Long-term Safety Phase (Year 5)||2
465833|NCT01212770|1141947|P1|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
465834|NCT01212770|1141939|P9|COMPLETED|Long-term Safety Phase (Year 5)||41
465835|NCT01212770|1141940|P8|COMPLETED|Long-term Safety Phase (Year 5)||30
465836|NCT01212770|1141941|P7|COMPLETED|Long-term Safety Phase (Year 5)||0
465837|NCT01212770|1141942|P6|COMPLETED|Long-term Safety Phase (Year 5)||0
465838|NCT01212770|1141943|P5|COMPLETED|Long-term Safety Phase (Year 5)||0
465839|NCT01212770|1141944|P4|COMPLETED|Long-term Safety Phase (Year 5)||0
465840|NCT01212770|1141945|P3|COMPLETED|Long-term Safety Phase (Year 5)||72
465841|NCT01212770|1141946|P2|COMPLETED|Long-term Safety Phase (Year 5)||68
465842|NCT01212770|1141947|P1|COMPLETED|Long-term Safety Phase (Year 5)||0
465843|NCT01212770|1141939|P9|STARTED|Long-term Safety Phase (Year 5)||42
465844|NCT01212770|1141940|P8|STARTED|Long-term Safety Phase (Year 5)||32
465845|NCT01212770|1141941|P7|STARTED|Long-term Safety Phase (Year 5)||0
465846|NCT01212770|1141942|P6|STARTED|Long-term Safety Phase (Year 5)||0
465847|NCT01212770|1141943|P5|STARTED|Long-term Safety Phase (Year 5)||0
465848|NCT01212770|1141944|P4|STARTED|Long-term Safety Phase (Year 5)||0
465849|NCT01212770|1141945|P3|STARTED|Long-term Safety Phase (Year 5)||83
465850|NCT01212770|1141946|P2|STARTED|Long-term Safety Phase (Year 5)|1 participant who completed Year 4 did not continue treatment in Year 5|70
465851|NCT01212770|1141947|P1|STARTED|Long-term Safety Phase (Year 5)||0
465852|NCT01212770|1141939|P9|NOT COMPLETED|Long-term Safety Phase (Year 4)||2
465853|NCT01212770|1141940|P8|NOT COMPLETED|Long-term Safety Phase (Year 4)||3
465854|NCT01212770|1141941|P7|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
465855|NCT01212770|1141942|P6|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
465856|NCT01212770|1141943|P5|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
465857|NCT01212770|1141944|P4|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
465858|NCT01212770|1141945|P3|NOT COMPLETED|Long-term Safety Phase (Year 4)||11
465859|NCT01212770|1141946|P2|NOT COMPLETED|Long-term Safety Phase (Year 4)||6
465860|NCT01212770|1141947|P1|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
465861|NCT01212770|1141939|P9|COMPLETED|Long-term Safety Phase (Year 4)||42
465862|NCT01212770|1141940|P8|COMPLETED|Long-term Safety Phase (Year 4)||32
465863|NCT01212770|1141941|P7|COMPLETED|Long-term Safety Phase (Year 4)||0
465864|NCT01212770|1141942|P6|COMPLETED|Long-term Safety Phase (Year 4)||0
465865|NCT01212770|1141943|P5|COMPLETED|Long-term Safety Phase (Year 4)||0
465866|NCT01212770|1141944|P4|COMPLETED|Long-term Safety Phase (Year 4)||0
465867|NCT01212770|1141945|P3|COMPLETED|Long-term Safety Phase (Year 4)||83
465868|NCT01212770|1141946|P2|COMPLETED|Long-term Safety Phase (Year 4)||71
465869|NCT01212770|1141947|P1|COMPLETED|Long-term Safety Phase (Year 4)||0
465870|NCT01212770|1141939|P9|STARTED|Long-term Safety Phase (Year 4)||44
465871|NCT01212770|1141940|P8|STARTED|Long-term Safety Phase (Year 4)||35
465872|NCT01212770|1141941|P7|STARTED|Long-term Safety Phase (Year 4)||0
465873|NCT01212770|1141942|P6|STARTED|Long-term Safety Phase (Year 4)||0
465874|NCT01212770|1141943|P5|STARTED|Long-term Safety Phase (Year 4)||0
465875|NCT01212770|1141944|P4|STARTED|Long-term Safety Phase (Year 4)||0
465876|NCT01212770|1141945|P3|STARTED|Long-term Safety Phase (Year 4)||94
465877|NCT01212770|1141946|P2|STARTED|Long-term Safety Phase (Year 4)|1 participant was counted in Year 4 but not in year 3 due to late APR dispensing|77
465878|NCT01212770|1141947|P1|STARTED|Long-term Safety Phase (Year 4)||0
465879|NCT01212770|1141939|P9|NOT COMPLETED|Long-term Safety Phase (Year 3)||5
465880|NCT01212770|1141940|P8|NOT COMPLETED|Long-term Safety Phase (Year 3)||7
465881|NCT01212770|1141941|P7|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
465882|NCT01212770|1141942|P6|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
465883|NCT01212770|1141943|P5|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
465884|NCT01212770|1141944|P4|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
465885|NCT01212770|1141945|P3|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
465886|NCT01212770|1141946|P2|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
465887|NCT01212770|1141947|P1|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
465888|NCT01212770|1141939|P9|COMPLETED|Long-term Safety Phase (Year 3)||44
465889|NCT01212770|1141940|P8|COMPLETED|Long-term Safety Phase (Year 3)||35
465890|NCT01212770|1141941|P7|COMPLETED|Long-term Safety Phase (Year 3)||0
465891|NCT01212770|1141942|P6|COMPLETED|Long-term Safety Phase (Year 3)||0
465892|NCT01212770|1141943|P5|COMPLETED|Long-term Safety Phase (Year 3)||0
465893|NCT01212770|1141944|P4|COMPLETED|Long-term Safety Phase (Year 3)||0
465894|NCT01212770|1141945|P3|COMPLETED|Long-term Safety Phase (Year 3)||94
465895|NCT01212770|1141946|P2|COMPLETED|Long-term Safety Phase (Year 3)|1 participant missed due to APR dispensed late|76
465896|NCT01212770|1141947|P1|COMPLETED|Long-term Safety Phase (Year 3)||0
465897|NCT01212770|1141939|P9|STARTED|Long-term Safety Phase (Year 3)|Patients from the PBO/APR 30 mg EE and XO are combined;1 patient finished Wk 52;no entry into LTSP|49
465898|NCT01212770|1141940|P8|STARTED|Long-term Safety Phase (Year 3)|The PBO/APR 20 mg EE and XO participants from week 24-52 are combined within the LTSP.|42
465899|NCT01212770|1141941|P7|STARTED|Long-term Safety Phase (Year 3)||0
465900|NCT01212770|1141942|P6|STARTED|Long-term Safety Phase (Year 3)||0
465901|NCT01212770|1141943|P5|STARTED|Long-term Safety Phase (Year 3)||0
465902|NCT01212770|1141944|P4|STARTED|Long-term Safety Phase (Year 3)||0
465903|NCT01212770|1141945|P3|STARTED|Long-term Safety Phase (Year 3)|1 participant who completed Year 2 did not continue treatment in Year 3|105
465904|NCT01212770|1141946|P2|STARTED|Long-term Safety Phase (Year 3)|1 participant who completed Year 2 did not continue treatment in Year 3|87
465905|NCT01212770|1141947|P1|STARTED|Long-term Safety Phase (Year 3)||0
465906|NCT01212770|1141939|P9|NOT COMPLETED|Long-term Safety Phase (Year 2)||14
465907|NCT01212770|1141940|P8|NOT COMPLETED|Long-term Safety Phase (Year 2)||9
465908|NCT01212770|1141941|P7|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
465909|NCT01212770|1141942|P6|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
465910|NCT01212770|1141943|P5|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
465911|NCT01212770|1141944|P4|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
465912|NCT01212770|1141945|P3|NOT COMPLETED|Long-term Safety Phase (Year 2)||15
465913|NCT01212770|1141946|P2|NOT COMPLETED|Long-term Safety Phase (Year 2)||23
465914|NCT01212770|1141947|P1|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
465915|NCT01212770|1141939|P9|COMPLETED|Long-term Safety Phase (Year 2)||50
465916|NCT01212770|1141940|P8|COMPLETED|Long-term Safety Phase (Year 2)||42
465917|NCT01212770|1141941|P7|COMPLETED|Long-term Safety Phase (Year 2)||0
465918|NCT01212770|1141942|P6|COMPLETED|Long-term Safety Phase (Year 2)||0
465919|NCT01212770|1141943|P5|COMPLETED|Long-term Safety Phase (Year 2)||0
465920|NCT01212770|1141944|P4|COMPLETED|Long-term Safety Phase (Year 2)||0
465921|NCT01212770|1141945|P3|COMPLETED|Long-term Safety Phase (Year 2)||106
465922|NCT01212770|1141946|P2|COMPLETED|Long-term Safety Phase (Year 2)||88
465923|NCT01212770|1141947|P1|COMPLETED|Long-term Safety Phase (Year 2)||0
465924|NCT01212770|1141939|P9|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 30 mg EE and XO are combined;3 patients finished Wk 52;no entry into LTSP|64
465925|NCT01212770|1141940|P8|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 20 mg EE and XO are combined;5 patients finished Wk 52;no entry into LTSP|51
465926|NCT01212770|1141941|P7|STARTED|Long-term Safety Phase (Year 2)||0
465927|NCT01212770|1141942|P6|STARTED|Long-term Safety Phase (Year 2)||0
465928|NCT01212770|1141943|P5|STARTED|Long-term Safety Phase (Year 2)||0
465929|NCT01212770|1141944|P4|STARTED|Long-term Safety Phase (Year 2)||0
465930|NCT01212770|1141945|P3|STARTED|Long-term Safety Phase (Year 2)|5 participants who completed Week 52 did not enter the long-term safety phase|121
465931|NCT01212770|1141946|P2|STARTED|Long-term Safety Phase (Year 2)|9 participants who completed Week 52 did not enter the long-term safety phase (LTSP)|111
465932|NCT01212770|1141947|P1|STARTED|Long-term Safety Phase (Year 2)||0
465933|NCT01212770|1141939|P9|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
465934|NCT01212770|1141940|P8|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
465935|NCT01212770|1141941|P7|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
465936|NCT01212770|1141942|P6|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||3
465937|NCT01212770|1141943|P5|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
465938|NCT01212770|1141944|P4|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||11
465939|NCT01212770|1141945|P3|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||12
465940|NCT01212770|1141946|P2|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||19
465941|NCT01212770|1141947|P1|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
465942|NCT01212770|1141939|P9|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
465943|NCT01212770|1141940|P8|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
465944|NCT01212770|1141941|P7|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23
465945|NCT01212770|1141942|P6|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||44
465946|NCT01212770|1141943|P5|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23
465947|NCT01212770|1141944|P4|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||32
465948|NCT01212770|1141945|P3|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||126
465949|NCT01212770|1141946|P2|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||120
465950|NCT01212770|1141947|P1|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
465951|NCT01212770|1141939|P9|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
465952|NCT01212770|1141940|P8|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
465953|NCT01212770|1141941|P7|STARTED|Active Treatment Phase (Weeks 25 - 52)||25
465954|NCT01212770|1141942|P6|STARTED|Active Treatment Phase (Weeks 25 - 52)|3 participants who EE completed Week 24 did not enter the Week 24-52 active treatment phase|47
465955|NCT01212770|1141943|P5|STARTED|Active Treatment Phase (Weeks 25 - 52)||25
465956|NCT01212770|1141944|P4|STARTED|Active Treatment Phase (Weeks 25 - 52)|3 participants who EE completed Week 24 did not enter the Week 24-52 active treatment phase|43
465957|NCT01212770|1141945|P3|STARTED|Active Treatment Phase (Weeks 25 - 52)|7 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|138
465958|NCT01212770|1141946|P2|STARTED|Active Treatment Phase (Weeks 25 - 52)|8 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|139
465959|NCT01212770|1141947|P1|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
465960|NCT01212770|1141939|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
465961|NCT01212770|1141940|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
465962|NCT01212770|1141941|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
465963|NCT01212770|1141942|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
465964|NCT01212770|1141943|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
465965|NCT01212770|1141944|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
465966|NCT01212770|1141945|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
465967|NCT01212770|1141946|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
465968|NCT01212770|1141947|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||23
465969|NCT01212770|1141939|P9|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
465970|NCT01212770|1141940|P8|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
465971|NCT01212770|1141941|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
465972|NCT01212770|1141942|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
465973|NCT01212770|1141943|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
465974|NCT01212770|1141944|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
465975|NCT01212770|1141945|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||145
465976|NCT01212770|1141946|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||147
465977|NCT01212770|1141947|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||146
465978|NCT01212770|1141939|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
465979|NCT01212770|1141940|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
465980|NCT01212770|1141941|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
465981|NCT01212770|1141942|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
465982|NCT01212770|1141943|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
465983|NCT01212770|1141944|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
465984|NCT01212770|1141945|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|1 participant who escaped early did not complete Week 24|53
465985|NCT01212770|1141946|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||76
465986|NCT01212770|1141947|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|1 participant who escaped early did not complete Week (Wk) 24|97
465987|NCT01212770|1141939|P9|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
465988|NCT01212770|1141940|P8|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
465989|NCT01212770|1141941|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
465990|NCT01212770|1141942|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
465991|NCT01212770|1141943|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
465992|NCT01212770|1141944|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
465993|NCT01212770|1141945|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156
465994|NCT01212770|1141946|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||157
465995|NCT01212770|1141947|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156
465996|NCT01212770|1141939|P9|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
465997|NCT01212770|1141940|P8|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
465998|NCT01212770|1141941|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
465999|NCT01212770|1141942|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
466000|NCT01212770|1141943|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
466001|NCT01212770|1141944|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
466002|NCT01212770|1141945|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||167
466003|NCT01212770|1141946|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169
466004|NCT01212770|1141947|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169
466005|NCT01212770|1141939|P9|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
466006|NCT01212770|1141940|P8|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
466007|NCT01212770|1141941|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
466008|NCT01212770|1141942|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
466009|NCT01212770|1141943|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
466010|NCT01212770|1141944|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
466011|NCT01212770|1141945|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||167
466012|NCT01212770|1141946|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||169
466013|NCT01212770|1141947|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||169
466014|NCT01212757|1142144|P9|NOT COMPLETED|Long-Term Safety Phase (Year 5)||2
466015|NCT01212757|1142145|P8|NOT COMPLETED|Long-Term Safety Phase (Year 5)||5
466016|NCT01212757|1142146|P7|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
466017|NCT01212757|1142147|P6|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
466018|NCT01212757|1142148|P5|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
466019|NCT01212757|1142149|P4|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
466020|NCT01212757|1142150|P3|NOT COMPLETED|Long-Term Safety Phase (Year 5)||8
466021|NCT01212757|1142151|P2|NOT COMPLETED|Long-Term Safety Phase (Year 5)||8
466022|NCT01212757|1142152|P1|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
466023|NCT01212757|1142144|P9|COMPLETED|Long-Term Safety Phase (Year 5)||37
466024|NCT01212757|1142145|P8|COMPLETED|Long-Term Safety Phase (Year 5)||33
466025|NCT01212757|1142146|P7|COMPLETED|Long-Term Safety Phase (Year 5)||0
466026|NCT01212757|1142147|P6|COMPLETED|Long-Term Safety Phase (Year 5)||0
466027|NCT01212757|1142148|P5|COMPLETED|Long-Term Safety Phase (Year 5)||0
466028|NCT01212757|1142149|P4|COMPLETED|Long-Term Safety Phase (Year 5)||0
466029|NCT01212757|1142150|P3|COMPLETED|Long-Term Safety Phase (Year 5)||69
466030|NCT01212757|1142151|P2|COMPLETED|Long-Term Safety Phase (Year 5)||72
466031|NCT01212757|1142152|P1|COMPLETED|Long-Term Safety Phase (Year 5)||0
466032|NCT01212757|1142144|P9|STARTED|Long-Term Safety Phase (Year 5)||39
466033|NCT01212757|1142145|P8|STARTED|Long-Term Safety Phase (Year 5)|1 participant was only counted in year 5 but not in 4 year due to late APR dispensing|38
466034|NCT01212757|1142146|P7|STARTED|Long-Term Safety Phase (Year 5)||0
466035|NCT01212757|1142147|P6|STARTED|Long-Term Safety Phase (Year 5)||0
466036|NCT01212757|1142148|P5|STARTED|Long-Term Safety Phase (Year 5)||0
466037|NCT01212757|1142149|P4|STARTED|Long-Term Safety Phase (Year 5)||0
466038|NCT01212757|1142150|P3|STARTED|Long-Term Safety Phase (Year 5)||77
466039|NCT01212757|1142151|P2|STARTED|Long-Term Safety Phase (Year 5)||80
466040|NCT01212757|1142152|P1|STARTED|Long-Term Safety Phase (Year 5)||0
466041|NCT01212757|1142144|P9|NOT COMPLETED|Long-Term Safety Phase (Year 4)||7
466042|NCT01212757|1142145|P8|NOT COMPLETED|Long-Term Safety Phase (Year 4)||4
466043|NCT01212757|1142146|P7|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
466044|NCT01212757|1142147|P6|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
466045|NCT01212757|1142148|P5|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
466046|NCT01212757|1142149|P4|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
466047|NCT01212757|1142150|P3|NOT COMPLETED|Long-Term Safety Phase (Year 4)||7
466048|NCT01212757|1142151|P2|NOT COMPLETED|Long-Term Safety Phase (Year 4)||9
466049|NCT01212757|1142152|P1|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
466050|NCT01212757|1142144|P9|COMPLETED|Long-Term Safety Phase (Year 4)||39
466051|NCT01212757|1142145|P8|COMPLETED|Long-Term Safety Phase (Year 4)||37
466052|NCT01212757|1142146|P7|COMPLETED|Long-Term Safety Phase (Year 4)||0
466053|NCT01212757|1142147|P6|COMPLETED|Long-Term Safety Phase (Year 4)||0
466054|NCT01212757|1142148|P5|COMPLETED|Long-Term Safety Phase (Year 4)||0
466055|NCT01212757|1142149|P4|COMPLETED|Long-Term Safety Phase (Year 4)||0
466056|NCT01212757|1142150|P3|COMPLETED|Long-Term Safety Phase (Year 4)||77
466057|NCT01212757|1142151|P2|COMPLETED|Long-Term Safety Phase (Year 4)||80
466058|NCT01212757|1142152|P1|COMPLETED|Long-Term Safety Phase (Year 4)||0
466059|NCT01212757|1142144|P9|STARTED|Long-Term Safety Phase (Year 4)||46
466060|NCT01212757|1142145|P8|STARTED|Long-Term Safety Phase (Year 4)|1 participant who completed Year 3 did not continue treatment in Year 4|41
466061|NCT01212757|1142146|P7|STARTED|Long-Term Safety Phase (Year 4)||0
466062|NCT01212757|1142147|P6|STARTED|Long-Term Safety Phase (Year 4)||0
466063|NCT01212757|1142148|P5|STARTED|Long-Term Safety Phase (Year 4)||0
466064|NCT01212757|1142149|P4|STARTED|Long-Term Safety Phase (Year 4)||0
466065|NCT01212757|1142150|P3|STARTED|Long-Term Safety Phase (Year 4)||84
466066|NCT01212757|1142151|P2|STARTED|Long-Term Safety Phase (Year 4)||89
466067|NCT01212757|1142152|P1|STARTED|Long-Term Safety Phase (Year 4)||0
466068|NCT01212757|1142144|P9|NOT COMPLETED|Long-Term Safety Phase (Year 3)||5
466069|NCT01212757|1142145|P8|NOT COMPLETED|Long-Term Safety Phase (Year 3)||6
466070|NCT01212757|1142146|P7|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
466071|NCT01212757|1142147|P6|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
466072|NCT01212757|1142148|P5|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
466073|NCT01212757|1142149|P4|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
466074|NCT01212757|1142150|P3|NOT COMPLETED|Long-Term Safety Phase (Year 3)||11
466075|NCT01212757|1142151|P2|NOT COMPLETED|Long-Term Safety Phase (Year 3)||18
466076|NCT01212757|1142152|P1|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
466077|NCT01212757|1142144|P9|COMPLETED|Long-Term Safety Phase (Year 3)||46
466078|NCT01212757|1142145|P8|COMPLETED|Long-Term Safety Phase (Year 3)||42
466079|NCT01212757|1142146|P7|COMPLETED|Long-Term Safety Phase (Year 3)||0
466080|NCT01212757|1142147|P6|COMPLETED|Long-Term Safety Phase (Year 3)||0
466081|NCT01212757|1142148|P5|COMPLETED|Long-Term Safety Phase (Year 3)||0
466082|NCT01212757|1142149|P4|COMPLETED|Long-Term Safety Phase (Year 3)||0
466083|NCT01212757|1142150|P3|COMPLETED|Long-Term Safety Phase (Year 3)||84
466084|NCT01212757|1142151|P2|COMPLETED|Long-Term Safety Phase (Year 3)||89
466085|NCT01212757|1142152|P1|COMPLETED|Long-Term Safety Phase (Year 3)||0
466086|NCT01212757|1142144|P9|STARTED|Long-Term Safety Phase (Year 3)||51
466087|NCT01212757|1142145|P8|STARTED|Long-Term Safety Phase (Year 3)||48
466088|NCT01212757|1142146|P7|STARTED|Long-Term Safety Phase (Year 3)||0
466089|NCT01212757|1142147|P6|STARTED|Long-Term Safety Phase (Year 3)||0
466090|NCT01212757|1142148|P5|STARTED|Long-Term Safety Phase (Year 3)||0
466091|NCT01212757|1142149|P4|STARTED|Long-Term Safety Phase (Year 3)||0
466092|NCT01212757|1142150|P3|STARTED|Long-Term Safety Phase (Year 3)||95
466093|NCT01212757|1142151|P2|STARTED|Long-Term Safety Phase (Year 3)||107
466094|NCT01212757|1142152|P1|STARTED|Long-Term Safety Phase (Year 3)||0
466095|NCT01212757|1142144|P9|NOT COMPLETED|Long-Term Safety Phase (Year 2)||9
466096|NCT01212757|1142145|P8|NOT COMPLETED|Long-Term Safety Phase (Year 2)||10
466097|NCT01212757|1142146|P7|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
466098|NCT01212757|1142147|P6|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
466099|NCT01212757|1142148|P5|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
466100|NCT01212757|1142149|P4|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
466101|NCT01212757|1142150|P3|NOT COMPLETED|Long-Term Safety Phase (Year 2)||14
466102|NCT01212757|1142151|P2|NOT COMPLETED|Long-Term Safety Phase (Year 2)||12
466103|NCT01212757|1142152|P1|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
466104|NCT01212757|1142144|P9|COMPLETED|Long-Term Safety Phase (Year 2)||51
466105|NCT01212757|1142145|P8|COMPLETED|Long-Term Safety Phase (Year 2)||48
466106|NCT01212757|1142146|P7|COMPLETED|Long-Term Safety Phase (Year 2)||0
466107|NCT01212757|1142147|P6|COMPLETED|Long-Term Safety Phase (Year 2)||0
466108|NCT01212757|1142148|P5|COMPLETED|Long-Term Safety Phase (Year 2)||0
466109|NCT01212757|1142149|P4|COMPLETED|Long-Term Safety Phase (Year 2)||0
466110|NCT01212757|1142150|P3|COMPLETED|Long-Term Safety Phase (Year 2)||95
466111|NCT01212757|1142151|P2|COMPLETED|Long-Term Safety Phase (Year 2)||107
466112|NCT01212757|1142152|P1|COMPLETED|Long-Term Safety Phase (Year 2)||0
466113|NCT01212757|1142144|P9|STARTED|Long-Term Safety Phase (Year 2)|Combined PBO-APR 30EE+XO;2 participants who completed Week 52 did not enter long-term safety phase|60
466114|NCT01212757|1142145|P8|STARTED|Long-Term Safety Phase (Year 2)|Combined PBO-APR 20EE+XO;2 participants who completed Week 52 did not enter long-term safety phase|58
466115|NCT01212757|1142146|P7|STARTED|Long-Term Safety Phase (Year 2)||0
466116|NCT01212757|1142147|P6|STARTED|Long-Term Safety Phase (Year 2)||0
466117|NCT01212757|1142148|P5|STARTED|Long-Term Safety Phase (Year 2)||0
466118|NCT01212757|1142149|P4|STARTED|Long-Term Safety Phase (Year 2)||0
466119|NCT01212757|1142150|P3|STARTED|Long-Term Safety Phase (Year 2)|5 participants who completed Week 52 did not enter the long-term safety phase|109
466120|NCT01212757|1142151|P2|STARTED|Long-Term Safety Phase (Year 2)|6 participants who completed Week 52 did not enter the long-term safety phase|119
466121|NCT01212757|1142152|P1|STARTED|Long-Term Safety Phase (Year 2)||0
466122|NCT01212757|1142144|P9|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
466123|NCT01212757|1142145|P8|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
466124|NCT01212757|1142146|P7|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
466125|NCT01212757|1142147|P6|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||7
466126|NCT01212757|1142148|P5|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||2
466127|NCT01212757|1142149|P4|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||8
466128|NCT01212757|1142150|P3|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||20
466129|NCT01212757|1142151|P2|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||12
466130|NCT01212757|1142152|P1|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
466131|NCT01212757|1142144|P9|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
466132|NCT01212757|1142145|P8|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
466133|NCT01212757|1142146|P7|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||28
466134|NCT01212757|1142147|P6|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||34
466135|NCT01212757|1142148|P5|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||25
466136|NCT01212757|1142149|P4|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||35
466137|NCT01212757|1142150|P3|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||114
466138|NCT01212757|1142151|P2|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||125
466139|NCT01212757|1142152|P1|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
466140|NCT01212757|1142144|P9|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
466141|NCT01212757|1142145|P8|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
466142|NCT01212757|1142146|P7|STARTED|Active Treatment Phase (Weeks 24 - 52)||28
466143|NCT01212757|1142147|P6|STARTED|Active Treatment Phase (Weeks 24 - 52)|2 participants who EE and completed Week 24 did not enter the Week 24-52 active treatment phase|41
466144|NCT01212757|1142148|P5|STARTED|Active Treatment Phase (Weeks 24 - 52)||27
466145|NCT01212757|1142149|P4|STARTED|Active Treatment Phase (Weeks 24 - 52)||43
466146|NCT01212757|1142150|P3|STARTED|Active Treatment Phase (Weeks 24 - 52)|8 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|134
466147|NCT01212757|1142151|P2|STARTED|Active Treatment Phase (Weeks 24 - 52)|6 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|137
466148|NCT01212757|1142152|P1|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
466149|NCT01212757|1142144|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
466150|NCT01212757|1142145|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
466151|NCT01212757|1142146|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
466152|NCT01212757|1142147|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
466153|NCT01212757|1142148|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
466154|NCT01212757|1142149|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
466155|NCT01212757|1142150|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||21
466156|NCT01212757|1142151|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
466157|NCT01212757|1142152|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||19
466158|NCT01212757|1142144|P9|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
466159|NCT01212757|1142145|P8|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
466160|NCT01212757|1142146|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
466161|NCT01212757|1142147|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
466162|NCT01212757|1142148|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
466163|NCT01212757|1142149|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
466164|NCT01212757|1142150|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||142
466165|NCT01212757|1142151|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||143
466166|NCT01212757|1142152|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|Two participants who completed Week 24 did not enter the active treatment phase|143
466167|NCT01212757|1142144|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
466168|NCT01212757|1142145|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
466169|NCT01212757|1142146|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
466170|NCT01212757|1142147|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
466171|NCT01212757|1142148|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
466172|NCT01212757|1142149|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
466173|NCT01212757|1142150|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||64
466174|NCT01212757|1142151|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Three participants who escaped early did not complete Week 24|59
466175|NCT01212757|1142152|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Two participants who escaped early did not complete Week 24|88
466176|NCT01212757|1142144|P9|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
466177|NCT01212757|1142145|P8|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
466178|NCT01212757|1142146|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
466179|NCT01212757|1142147|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
466180|NCT01212757|1142148|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
466181|NCT01212757|1142149|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
466182|NCT01212757|1142150|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||149
466183|NCT01212757|1142151|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||151
466184|NCT01212757|1142152|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||148
466185|NCT01212757|1142144|P9|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
466186|NCT01212757|1142145|P8|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
466187|NCT01212757|1142146|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
466188|NCT01212757|1142147|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
466189|NCT01212757|1142148|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
466190|NCT01212757|1142149|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
466191|NCT01212757|1142150|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||162
466192|NCT01212757|1142151|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||163
466193|NCT01212757|1142152|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||159
466194|NCT01212757|1142144|P9|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
466195|NCT01212757|1142145|P8|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
466196|NCT01212757|1142146|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
466197|NCT01212757|1142147|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
466198|NCT01212757|1142148|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
466199|NCT01212757|1142149|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
466200|NCT01212757|1142150|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||163
466201|NCT01212757|1142151|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||163
466202|NCT01212757|1142152|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||162
466203|NCT01212627|1142336|P1|NOT COMPLETED|Overall Study||0
466204|NCT01212627|1142336|P1|COMPLETED|Overall Study||12
466205|NCT01212627|1142336|P1|STARTED|Overall Study||12
466206|NCT01212484|1142340|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
466207|NCT01212484|1142341|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
466208|NCT01212484|1142340|P2|COMPLETED|Second Intervention (4 Weeks)||3
466209|NCT01212484|1142341|P1|COMPLETED|Second Intervention (4 Weeks)||5
466210|NCT01212484|1142340|P2|STARTED|Second Intervention (4 Weeks)||4
466211|NCT01212484|1142341|P1|STARTED|Second Intervention (4 Weeks)||5
466212|NCT01212484|1142340|P2|NOT COMPLETED|First Intervention (4 Weeks)||2
466213|NCT01212484|1142341|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
466214|NCT01212484|1142340|P2|COMPLETED|First Intervention (4 Weeks)||4
466215|NCT01212484|1142341|P1|COMPLETED|First Intervention (4 Weeks)||5
466216|NCT01212484|1142340|P2|STARTED|First Intervention (4 Weeks)||6
466217|NCT01212484|1142341|P1|STARTED|First Intervention (4 Weeks)||5
466218|NCT01212484|1142340|P2|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||0
466219|NCT01212484|1142341|P1|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||1
466220|NCT01212484|1142340|P2|COMPLETED|Carbidopa Titration Period (4 Weeks)||6
466221|NCT01212484|1142341|P1|COMPLETED|Carbidopa Titration Period (4 Weeks)||5
466222|NCT01212484|1142340|P2|STARTED|Carbidopa Titration Period (4 Weeks)||6
466223|NCT01212484|1142341|P1|STARTED|Carbidopa Titration Period (4 Weeks)||6
466224|NCT01212445|1142354|P3|NOT COMPLETED|Overall Study||0
466225|NCT01212445|1142355|P2|NOT COMPLETED|Overall Study||0
466226|NCT01212445|1142356|P1|NOT COMPLETED|Overall Study||0
466227|NCT01212445|1142354|P3|COMPLETED|Overall Study||51
466228|NCT01212445|1142355|P2|COMPLETED|Overall Study||51
466229|NCT01212445|1142356|P1|COMPLETED|Overall Study||52
466230|NCT01212445|1142354|P3|STARTED|Overall Study||51
466231|NCT01212445|1142355|P2|STARTED|Overall Study||51
466232|NCT01212445|1142356|P1|STARTED|Overall Study||52
466233|NCT01212302|1142385|P1|NOT COMPLETED|Overall Study||0
466234|NCT01212302|1142385|P1|COMPLETED|Overall Study||504
466235|NCT01212302|1142385|P1|STARTED|Overall Study||504
466236|NCT01212185|1142391|P2|NOT COMPLETED|Overall Study||1
466237|NCT01212185|1142392|P1|NOT COMPLETED|Overall Study||2
466238|NCT01212185|1142391|P2|COMPLETED|Overall Study||7
466239|NCT01212185|1142392|P1|COMPLETED|Overall Study||4
466240|NCT01212185|1142391|P2|STARTED|Overall Study||8
466241|NCT01212185|1142392|P1|STARTED|Overall Study||6
466242|NCT01212172|1142400|P2|NOT COMPLETED|Overall Study||1
466243|NCT01212172|1142401|P1|NOT COMPLETED|Overall Study||1
466244|NCT01212172|1142400|P2|COMPLETED|Overall Study||9
466245|NCT01212172|1142401|P1|COMPLETED|Overall Study||9
466246|NCT01212172|1142400|P2|STARTED|Overall Study||10
466247|NCT01212172|1142401|P1|STARTED|Overall Study||10
466248|NCT01212159|1142411|P2|NOT COMPLETED|Overall Study||12
466249|NCT01212159|1142412|P1|NOT COMPLETED|Overall Study||12
466250|NCT01212159|1142411|P2|COMPLETED|Overall Study||32
466251|NCT01212159|1142412|P1|COMPLETED|Overall Study||14
466252|NCT01212159|1142411|P2|STARTED|Overall Study||44
466253|NCT01212159|1142412|P1|STARTED|Overall Study||26
466254|NCT01212094|1142425|P3|NOT COMPLETED|Years 2 & 3: Treatment Randomization||11
466255|NCT01212094|1142426|P2|NOT COMPLETED|Years 2 & 3: Treatment Randomization||4
466256|NCT01212094|1142427|P1|NOT COMPLETED|Years 2 & 3: Treatment Randomization||0
466257|NCT01212094|1142425|P3|COMPLETED|Years 2 & 3: Treatment Randomization||7
466258|NCT01212094|1142426|P2|COMPLETED|Years 2 & 3: Treatment Randomization||5
466259|NCT01212094|1142427|P1|COMPLETED|Years 2 & 3: Treatment Randomization||0
466260|NCT01212094|1142425|P3|STARTED|Years 2 & 3: Treatment Randomization||18
466261|NCT01212094|1142426|P2|STARTED|Years 2 & 3: Treatment Randomization||9
466262|NCT01212094|1142427|P1|STARTED|Years 2 & 3: Treatment Randomization||0
466263|NCT01212094|1142425|P3|NOT COMPLETED|Year 1: Baseline Monitoring||0
466264|NCT01212094|1142426|P2|NOT COMPLETED|Year 1: Baseline Monitoring||0
466265|NCT01212094|1142427|P1|NOT COMPLETED|Year 1: Baseline Monitoring||16
466266|NCT01212094|1142425|P3|COMPLETED|Year 1: Baseline Monitoring||0
466267|NCT01212094|1142426|P2|COMPLETED|Year 1: Baseline Monitoring||0
466268|NCT01212094|1142427|P1|COMPLETED|Year 1: Baseline Monitoring||27
466269|NCT01212094|1142425|P3|STARTED|Year 1: Baseline Monitoring||0
466270|NCT01212094|1142426|P2|STARTED|Year 1: Baseline Monitoring||0
466271|NCT01212094|1142427|P1|STARTED|Year 1: Baseline Monitoring||43
466272|NCT01211873|1142461|P3|NOT COMPLETED|Overall Study||2
466273|NCT01211873|1142462|P2|NOT COMPLETED|Overall Study||2
466274|NCT01211873|1142463|P1|NOT COMPLETED|Overall Study||5
466275|NCT01211873|1142461|P3|COMPLETED|Overall Study||36
466276|NCT01211873|1142462|P2|COMPLETED|Overall Study||117
466277|NCT01211873|1142463|P1|COMPLETED|Overall Study||240
466278|NCT01211873|1142461|P3|STARTED|Overall Study||38
466279|NCT01211873|1142462|P2|STARTED|Overall Study||119
466280|NCT01211873|1142463|P1|STARTED|Overall Study||245
466281|NCT01211769|1142474|P4|NOT COMPLETED|Overall Study||11
466282|NCT01211769|1142475|P3|NOT COMPLETED|Overall Study||8
466283|NCT01211769|1142476|P2|NOT COMPLETED|Overall Study||10
466284|NCT01211769|1142477|P1|NOT COMPLETED|Overall Study||9
466285|NCT01211769|1142474|P4|COMPLETED|Overall Study||9
466286|NCT01211769|1142475|P3|COMPLETED|Overall Study||12
466287|NCT01211769|1142476|P2|COMPLETED|Overall Study||10
466288|NCT01211769|1142477|P1|COMPLETED|Overall Study||11
466289|NCT01211769|1142474|P4|Participants/Group|Overall Study||20
466290|NCT01211769|1142475|P3|Participants/Group|Overall Study||20
466291|NCT01211769|1142476|P2|Participants/Group|Overall Study||20
466292|NCT01211769|1142477|P1|Participants/Group|Overall Study||20
466293|NCT01211769|1142474|P4|STARTED|Overall Study||20
466294|NCT01211769|1142475|P3|STARTED|Overall Study||20
466295|NCT01211769|1142476|P2|STARTED|Overall Study||20
466296|NCT01211769|1142477|P1|STARTED|Overall Study||20
466297|NCT01211730|1142497|P2|NOT COMPLETED|Overall Study||0
466298|NCT01211730|1142498|P1|NOT COMPLETED|Overall Study||0
466299|NCT01211730|1142497|P2|COMPLETED|Overall Study||82
466300|NCT01211730|1142498|P1|COMPLETED|Overall Study||82
466301|NCT01211730|1142497|P2|STARTED|Overall Study||82
466302|NCT01211730|1142498|P1|STARTED|Overall Study||82
466303|NCT01211665|1142516|P2|NOT COMPLETED|Overall Study||0
466304|NCT01211665|1142517|P1|NOT COMPLETED|Overall Study||2
466305|NCT01211665|1142516|P2|COMPLETED|Overall Study|completed treatment with study drug|1
466306|NCT01211665|1142517|P1|COMPLETED|Overall Study||0
466307|NCT01211665|1142516|P2|STARTED|Overall Study||1
466308|NCT01211665|1142517|P1|STARTED|Overall Study||2
466309|NCT01211613|1142544|P3|NOT COMPLETED|Overall Study||2
466310|NCT01211613|1142545|P2|NOT COMPLETED|Overall Study||2
466311|NCT01211613|1142546|P1|NOT COMPLETED|Overall Study||3
466312|NCT01211613|1142544|P3|COMPLETED|Overall Study||33
466313|NCT01211613|1142545|P2|COMPLETED|Overall Study||33
466314|NCT01211613|1142546|P1|COMPLETED|Overall Study||34
466315|NCT01211613|1142544|P3|STARTED|Overall Study||35
466316|NCT01211613|1142545|P2|STARTED|Overall Study||35
466317|NCT01211613|1142546|P1|STARTED|Overall Study||37
466318|NCT01211535|1142559|P2|NOT COMPLETED|Overall Study||1
466319|NCT01211535|1142560|P1|NOT COMPLETED|Overall Study||0
466320|NCT01211535|1142559|P2|COMPLETED|Overall Study||51
466321|NCT01211535|1142560|P1|COMPLETED|Overall Study||52
466322|NCT01211535|1142559|P2|STARTED|Overall Study||52
466323|NCT01211535|1142560|P1|STARTED|Overall Study||52
466324|NCT01211340|1142568|P2|NOT COMPLETED|Overall Study||0
466325|NCT01211340|1142569|P1|NOT COMPLETED|Overall Study||0
466326|NCT01211340|1142568|P2|COMPLETED|Overall Study||223
466327|NCT01211340|1142569|P1|COMPLETED|Overall Study||223
466328|NCT01211340|1142568|P2|STARTED|Overall Study||223
466329|NCT01211340|1142569|P1|STARTED|Overall Study||223
466330|NCT01211197|1142579|P6|NOT COMPLETED|Treatment Period 3 (1 Day)||0
466331|NCT01211197|1142580|P5|NOT COMPLETED|Treatment Period 3 (1 Day)||0
466332|NCT01211197|1142581|P4|NOT COMPLETED|Treatment Period 3 (1 Day)||0
466333|NCT01211197|1142582|P3|NOT COMPLETED|Treatment Period 3 (1 Day)||0
466334|NCT01211197|1142583|P2|NOT COMPLETED|Treatment Period 3 (1 Day)||0
466335|NCT01211197|1142584|P1|NOT COMPLETED|Treatment Period 3 (1 Day)||0
466336|NCT01211197|1142579|P6|COMPLETED|Treatment Period 3 (1 Day)||2
466337|NCT01211197|1142580|P5|COMPLETED|Treatment Period 3 (1 Day)||2
466338|NCT01211197|1142581|P4|COMPLETED|Treatment Period 3 (1 Day)||3
466339|NCT01211197|1142582|P3|COMPLETED|Treatment Period 3 (1 Day)||2
466340|NCT01211197|1142583|P2|COMPLETED|Treatment Period 3 (1 Day)||3
466341|NCT01211197|1142584|P1|COMPLETED|Treatment Period 3 (1 Day)||2
466342|NCT01211197|1142579|P6|STARTED|Treatment Period 3 (1 Day)||2
466343|NCT01211197|1142580|P5|STARTED|Treatment Period 3 (1 Day)||2
466344|NCT01211197|1142581|P4|STARTED|Treatment Period 3 (1 Day)||3
466345|NCT01211197|1142582|P3|STARTED|Treatment Period 3 (1 Day)||2
466346|NCT01211197|1142583|P2|STARTED|Treatment Period 3 (1 Day)||3
466347|NCT01211197|1142584|P1|STARTED|Treatment Period 3 (1 Day)||2
466348|NCT01211197|1142579|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
466349|NCT01211197|1142580|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
466350|NCT01211197|1142581|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
466351|NCT01211197|1142582|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
466352|NCT01211197|1142583|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
466353|NCT01211197|1142584|P1|NOT COMPLETED|Washout Period 2 (7 Days)||1
466354|NCT01211197|1142579|P6|COMPLETED|Washout Period 2 (7 Days)||2
466355|NCT01211197|1142580|P5|COMPLETED|Washout Period 2 (7 Days)||2
466356|NCT01211197|1142581|P4|COMPLETED|Washout Period 2 (7 Days)||3
466357|NCT01211197|1142582|P3|COMPLETED|Washout Period 2 (7 Days)||2
466358|NCT01211197|1142583|P2|COMPLETED|Washout Period 2 (7 Days)||3
466359|NCT01211197|1142584|P1|COMPLETED|Washout Period 2 (7 Days)||2
466360|NCT01211197|1142579|P6|STARTED|Washout Period 2 (7 Days)||2
466361|NCT01211197|1142580|P5|STARTED|Washout Period 2 (7 Days)||2
466362|NCT01211197|1142581|P4|STARTED|Washout Period 2 (7 Days)||3
466363|NCT01211197|1142582|P3|STARTED|Washout Period 2 (7 Days)||2
466364|NCT01211197|1142583|P2|STARTED|Washout Period 2 (7 Days)||3
466365|NCT01211197|1142584|P1|STARTED|Washout Period 2 (7 Days)||3
466366|NCT01211197|1142579|P6|NOT COMPLETED|Treatment Period 2 (1 Day)||0
466367|NCT01211197|1142580|P5|NOT COMPLETED|Treatment Period 2 (1 Day)||0
466368|NCT01211197|1142581|P4|NOT COMPLETED|Treatment Period 2 (1 Day)||0
466369|NCT01211197|1142582|P3|NOT COMPLETED|Treatment Period 2 (1 Day)||0
466370|NCT01211197|1142583|P2|NOT COMPLETED|Treatment Period 2 (1 Day)||0
466371|NCT01211197|1142584|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
466372|NCT01211197|1142579|P6|COMPLETED|Treatment Period 2 (1 Day)||2
466373|NCT01211197|1142580|P5|COMPLETED|Treatment Period 2 (1 Day)||2
466374|NCT01211197|1142581|P4|COMPLETED|Treatment Period 2 (1 Day)||3
466375|NCT01211197|1142582|P3|COMPLETED|Treatment Period 2 (1 Day)||2
466376|NCT01211197|1142583|P2|COMPLETED|Treatment Period 2 (1 Day)||3
466377|NCT01211197|1142584|P1|COMPLETED|Treatment Period 2 (1 Day)||3
466378|NCT01211197|1142579|P6|STARTED|Treatment Period 2 (1 Day)||2
466379|NCT01211197|1142580|P5|STARTED|Treatment Period 2 (1 Day)||2
466380|NCT01211197|1142581|P4|STARTED|Treatment Period 2 (1 Day)||3
466381|NCT01211197|1142582|P3|STARTED|Treatment Period 2 (1 Day)||2
466382|NCT01211197|1142583|P2|STARTED|Treatment Period 2 (1 Day)||3
466383|NCT01211197|1142584|P1|STARTED|Treatment Period 2 (1 Day)||3
466384|NCT01211197|1142579|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
466385|NCT01211197|1142580|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
466386|NCT01211197|1142581|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
466387|NCT01211197|1142582|P3|NOT COMPLETED|Washout Period 1 (7 Days)||1
466388|NCT01211197|1142583|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
466389|NCT01211197|1142584|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
466390|NCT01211197|1142579|P6|COMPLETED|Washout Period 1 (7 Days)||2
466391|NCT01211197|1142580|P5|COMPLETED|Washout Period 1 (7 Days)||2
466392|NCT01211197|1142581|P4|COMPLETED|Washout Period 1 (7 Days)||3
466393|NCT01211197|1142582|P3|COMPLETED|Washout Period 1 (7 Days)||2
466394|NCT01211197|1142583|P2|COMPLETED|Washout Period 1 (7 Days)||3
466395|NCT01211197|1142584|P1|COMPLETED|Washout Period 1 (7 Days)||3
466396|NCT01211197|1142579|P6|STARTED|Washout Period 1 (7 Days)||2
466397|NCT01211197|1142580|P5|STARTED|Washout Period 1 (7 Days)||2
466398|NCT01211197|1142581|P4|STARTED|Washout Period 1 (7 Days)||3
466399|NCT01211197|1142582|P3|STARTED|Washout Period 1 (7 Days)||3
466400|NCT01211197|1142583|P2|STARTED|Washout Period 1 (7 Days)||3
466401|NCT01211197|1142584|P1|STARTED|Washout Period 1 (7 Days)||3
466402|NCT01211197|1142579|P6|NOT COMPLETED|Treatment Period 1 (1 Day)||0
466403|NCT01211197|1142580|P5|NOT COMPLETED|Treatment Period 1 (1 Day)||0
466404|NCT01211197|1142581|P4|NOT COMPLETED|Treatment Period 1 (1 Day)||0
466405|NCT01211197|1142582|P3|NOT COMPLETED|Treatment Period 1 (1 Day)||0
466406|NCT01211197|1142583|P2|NOT COMPLETED|Treatment Period 1 (1 Day)||0
466407|NCT01211197|1142584|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
466408|NCT01211197|1142579|P6|COMPLETED|Treatment Period 1 (1 Day)||2
466409|NCT01211197|1142580|P5|COMPLETED|Treatment Period 1 (1 Day)||2
466410|NCT01211197|1142581|P4|COMPLETED|Treatment Period 1 (1 Day)||3
466411|NCT01211197|1142582|P3|COMPLETED|Treatment Period 1 (1 Day)||3
466412|NCT01211197|1142583|P2|COMPLETED|Treatment Period 1 (1 Day)||3
466413|NCT01211197|1142584|P1|COMPLETED|Treatment Period 1 (1 Day)||3
466414|NCT01211197|1142579|P6|STARTED|Treatment Period 1 (1 Day)||2
466415|NCT01211197|1142580|P5|STARTED|Treatment Period 1 (1 Day)||2
466416|NCT01211197|1142581|P4|STARTED|Treatment Period 1 (1 Day)||3
466417|NCT01211197|1142582|P3|STARTED|Treatment Period 1 (1 Day)||3
466418|NCT01211197|1142583|P2|STARTED|Treatment Period 1 (1 Day)||3
466419|NCT01211197|1142584|P1|STARTED|Treatment Period 1 (1 Day)||3
466420|NCT01211184|1142631|P3|NOT COMPLETED|Overall Study||1
466421|NCT01211184|1142632|P2|NOT COMPLETED|Overall Study||2
466422|NCT01211184|1142633|P1|NOT COMPLETED|Overall Study||0
466423|NCT01211184|1142631|P3|COMPLETED|Overall Study||19
466424|NCT01211184|1142632|P2|COMPLETED|Overall Study||18
466425|NCT01211184|1142633|P1|COMPLETED|Overall Study||20
466426|NCT01211184|1142631|P3|STARTED|Overall Study||20
466427|NCT01211184|1142632|P2|STARTED|Overall Study||20
466428|NCT01211184|1142633|P1|STARTED|Overall Study||20
466429|NCT01211145|1142648|P4|NOT COMPLETED|Overall Study||20
466430|NCT01211145|1142649|P3|NOT COMPLETED|Overall Study||13
466431|NCT01211145|1142650|P2|NOT COMPLETED|Overall Study||17
466432|NCT01211145|1142651|P1|NOT COMPLETED|Overall Study||26
466433|NCT01211145|1142648|P4|COMPLETED|Overall Study||268
466434|NCT01211145|1142649|P3|COMPLETED|Overall Study||86
466435|NCT01211145|1142650|P2|COMPLETED|Overall Study||98
466436|NCT01211145|1142651|P1|COMPLETED|Overall Study|1 patient was not counted as completed or discontinued due to incomplete information (N=270-1=269).|270
466437|NCT01211145|1142648|P4|STARTED|Overall Study||288
466438|NCT01211145|1142649|P3|STARTED|Overall Study||99
466439|NCT01211145|1142650|P2|STARTED|Overall Study||115
466440|NCT01211145|1142651|P1|STARTED|Overall Study||296
466441|NCT01211106|1142683|P2|NOT COMPLETED|Overall Study||11
466442|NCT01211106|1142684|P1|NOT COMPLETED|Overall Study||13
466443|NCT01211106|1142683|P2|COMPLETED|Overall Study||77
466444|NCT01211106|1142684|P1|COMPLETED|Overall Study||82
466445|NCT01211106|1142683|P2|STARTED|Overall Study||88
466446|NCT01211106|1142684|P1|STARTED|Overall Study||95
466447|NCT01210820|1142694|P2|NOT COMPLETED|Overall Study||0
466448|NCT01210820|1142695|P1|NOT COMPLETED|Overall Study||0
466449|NCT01210820|1142694|P2|COMPLETED|Overall Study||4
466450|NCT01210820|1142695|P1|COMPLETED|Overall Study||17
466451|NCT01210820|1142694|P2|STARTED|Overall Study||4
466452|NCT01210820|1142695|P1|STARTED|Overall Study||17
466453|NCT01210807|1142705|P2|NOT COMPLETED|Overall Study||3
466454|NCT01210807|1142706|P1|NOT COMPLETED|Overall Study||3
466455|NCT01210807|1142705|P2|COMPLETED|Overall Study||31
466456|NCT01210807|1142706|P1|COMPLETED|Overall Study||33
466457|NCT01210807|1142705|P2|STARTED|Overall Study||34
466458|NCT01210807|1142706|P1|STARTED|Overall Study||36
466459|NCT01210716|1142714|P2|NOT COMPLETED|Second TPE Procedure||0
466460|NCT01210716|1142715|P1|NOT COMPLETED|Second TPE Procedure||3
466461|NCT01210716|1142714|P2|COMPLETED|Second TPE Procedure||15
466462|NCT01210716|1142715|P1|COMPLETED|Second TPE Procedure||15
466463|NCT01210716|1142714|P2|STARTED|Second TPE Procedure||15
466464|NCT01210716|1142715|P1|STARTED|Second TPE Procedure||18
466465|NCT01210716|1142714|P2|NOT COMPLETED|First TPE Procedure||2
466466|NCT01210716|1142715|P1|NOT COMPLETED|First TPE Procedure||2
466467|NCT01210716|1142714|P2|COMPLETED|First TPE Procedure||15
466468|NCT01210716|1142715|P1|COMPLETED|First TPE Procedure||18
466469|NCT01210716|1142714|P2|STARTED|First TPE Procedure||17
466470|NCT01210716|1142715|P1|STARTED|First TPE Procedure||20
466471|NCT01210690|1142721|P1|NOT COMPLETED|Overall Study||26
466472|NCT01210690|1142721|P1|COMPLETED|Overall Study||75
466473|NCT01210690|1142721|P1|STARTED|Overall Study||101
466474|NCT01210651|1142736|P2|NOT COMPLETED|Overall Study||8
466475|NCT01210651|1142737|P1|NOT COMPLETED|Overall Study||5
466476|NCT01210651|1142736|P2|COMPLETED|Overall Study||10
466477|NCT01210651|1142737|P1|COMPLETED|Overall Study||15
466478|NCT01210651|1142736|P2|Number Attending 1st Assigned Session|Overall Study||12
466479|NCT01210651|1142737|P1|Number Attending 1st Assigned Session|Overall Study||18
466480|NCT01210651|1142736|P2|STARTED|Overall Study|Number randomized to intervention, but not number who started intervention by attending 1st session.|18
466481|NCT01210651|1142737|P1|STARTED|Overall Study|Number randomized to intervention, but not number who started intervention by attending 1st session.|20
466482|NCT01210560|1142753|P9|NOT COMPLETED|Intervention 3 (7 Days)||0
466483|NCT01210560|1142754|P8|NOT COMPLETED|Intervention 3 (7 Days)||0
466484|NCT01210560|1142755|P7|NOT COMPLETED|Intervention 3 (7 Days)||0
466485|NCT01210560|1142756|P6|NOT COMPLETED|Intervention 3 (7 Days)||0
466486|NCT01210560|1142757|P5|NOT COMPLETED|Intervention 3 (7 Days)||0
466487|NCT01210560|1142758|P4|NOT COMPLETED|Intervention 3 (7 Days)||0
466488|NCT01210560|1142759|P3|NOT COMPLETED|Intervention 3 (7 Days)||0
466489|NCT01210560|1142760|P2|NOT COMPLETED|Intervention 3 (7 Days)||0
466490|NCT01210560|1142761|P1|NOT COMPLETED|Intervention 3 (7 Days)||0
466491|NCT01210560|1142753|P9|COMPLETED|Intervention 3 (7 Days)||5
466492|NCT01210560|1142754|P8|COMPLETED|Intervention 3 (7 Days)||4
466493|NCT01210560|1142755|P7|COMPLETED|Intervention 3 (7 Days)||4
466494|NCT01210560|1142756|P6|COMPLETED|Intervention 3 (7 Days)||2
466495|NCT01210560|1142757|P5|COMPLETED|Intervention 3 (7 Days)||2
466496|NCT01210560|1142758|P4|COMPLETED|Intervention 3 (7 Days)||2
466497|NCT01210560|1142759|P3|COMPLETED|Intervention 3 (7 Days)||2
466498|NCT01210560|1142760|P2|COMPLETED|Intervention 3 (7 Days)||2
466499|NCT01210560|1142761|P1|COMPLETED|Intervention 3 (7 Days)||2
466500|NCT01210560|1142753|P9|STARTED|Intervention 3 (7 Days)||5
466501|NCT01210560|1142754|P8|STARTED|Intervention 3 (7 Days)||4
466502|NCT01210560|1142755|P7|STARTED|Intervention 3 (7 Days)||4
466503|NCT01210560|1142756|P6|STARTED|Intervention 3 (7 Days)||2
466504|NCT01210560|1142757|P5|STARTED|Intervention 3 (7 Days)||2
466505|NCT01210560|1142758|P4|STARTED|Intervention 3 (7 Days)||2
466506|NCT01210560|1142759|P3|STARTED|Intervention 3 (7 Days)||2
466507|NCT01210560|1142760|P2|STARTED|Intervention 3 (7 Days)||2
466508|NCT01210560|1142761|P1|STARTED|Intervention 3 (7 Days)||2
466509|NCT01210560|1142753|P9|NOT COMPLETED|Intervention 2 (7 Days)||0
466510|NCT01210560|1142754|P8|NOT COMPLETED|Intervention 2 (7 Days)||0
466511|NCT01210560|1142755|P7|NOT COMPLETED|Intervention 2 (7 Days)||0
466512|NCT01210560|1142756|P6|NOT COMPLETED|Intervention 2 (7 Days)||0
466513|NCT01210560|1142757|P5|NOT COMPLETED|Intervention 2 (7 Days)||0
466514|NCT01210560|1142758|P4|NOT COMPLETED|Intervention 2 (7 Days)||0
466515|NCT01210560|1142759|P3|NOT COMPLETED|Intervention 2 (7 Days)||0
466516|NCT01210560|1142760|P2|NOT COMPLETED|Intervention 2 (7 Days)||0
466517|NCT01210560|1142761|P1|NOT COMPLETED|Intervention 2 (7 Days)||0
466518|NCT01210560|1142753|P9|COMPLETED|Intervention 2 (7 Days)||5
466519|NCT01210560|1142754|P8|COMPLETED|Intervention 2 (7 Days)||4
466520|NCT01210560|1142755|P7|COMPLETED|Intervention 2 (7 Days)||4
466521|NCT01210560|1142756|P6|COMPLETED|Intervention 2 (7 Days)||2
466522|NCT01210560|1142757|P5|COMPLETED|Intervention 2 (7 Days)||2
466523|NCT01210560|1142758|P4|COMPLETED|Intervention 2 (7 Days)||2
466524|NCT01210560|1142759|P3|COMPLETED|Intervention 2 (7 Days)||2
466525|NCT01210560|1142760|P2|COMPLETED|Intervention 2 (7 Days)||2
466526|NCT01210560|1142761|P1|COMPLETED|Intervention 2 (7 Days)||2
466527|NCT01210560|1142753|P9|STARTED|Intervention 2 (7 Days)||5
466528|NCT01210560|1142754|P8|STARTED|Intervention 2 (7 Days)||4
466529|NCT01210560|1142755|P7|STARTED|Intervention 2 (7 Days)||4
466530|NCT01210560|1142756|P6|STARTED|Intervention 2 (7 Days)||2
466531|NCT01210560|1142757|P5|STARTED|Intervention 2 (7 Days)||2
466532|NCT01210560|1142758|P4|STARTED|Intervention 2 (7 Days)||2
466533|NCT01210560|1142759|P3|STARTED|Intervention 2 (7 Days)||2
466534|NCT01210560|1142760|P2|STARTED|Intervention 2 (7 Days)||2
466535|NCT01210560|1142761|P1|STARTED|Intervention 2 (7 Days)||2
466536|NCT01210560|1142753|P9|NOT COMPLETED|Intervention 1 (7 Days)||0
466537|NCT01210560|1142754|P8|NOT COMPLETED|Intervention 1 (7 Days)||0
466538|NCT01210560|1142755|P7|NOT COMPLETED|Intervention 1 (7 Days)||0
466539|NCT01210560|1142756|P6|NOT COMPLETED|Intervention 1 (7 Days)||0
466540|NCT01210560|1142757|P5|NOT COMPLETED|Intervention 1 (7 Days)||0
466541|NCT01210560|1142758|P4|NOT COMPLETED|Intervention 1 (7 Days)||0
466542|NCT01210560|1142759|P3|NOT COMPLETED|Intervention 1 (7 Days)||0
466543|NCT01210560|1142760|P2|NOT COMPLETED|Intervention 1 (7 Days)||0
466544|NCT01210560|1142761|P1|NOT COMPLETED|Intervention 1 (7 Days)||0
466545|NCT01210560|1142753|P9|COMPLETED|Intervention 1 (7 Days)||5
466546|NCT01210560|1142754|P8|COMPLETED|Intervention 1 (7 Days)||4
466547|NCT01210560|1142755|P7|COMPLETED|Intervention 1 (7 Days)||4
466548|NCT01210560|1142756|P6|COMPLETED|Intervention 1 (7 Days)||2
466549|NCT01210560|1142757|P5|COMPLETED|Intervention 1 (7 Days)||2
466550|NCT01210560|1142758|P4|COMPLETED|Intervention 1 (7 Days)||2
466551|NCT01210560|1142759|P3|COMPLETED|Intervention 1 (7 Days)||2
466552|NCT01210560|1142760|P2|COMPLETED|Intervention 1 (7 Days)||2
466553|NCT01210560|1142761|P1|COMPLETED|Intervention 1 (7 Days)||2
466554|NCT01210560|1142753|P9|STARTED|Intervention 1 (7 Days)||5
466555|NCT01210560|1142754|P8|STARTED|Intervention 1 (7 Days)||4
466556|NCT01210560|1142755|P7|STARTED|Intervention 1 (7 Days)||4
466557|NCT01210560|1142756|P6|STARTED|Intervention 1 (7 Days)||2
466558|NCT01210560|1142757|P5|STARTED|Intervention 1 (7 Days)||2
466559|NCT01210560|1142758|P4|STARTED|Intervention 1 (7 Days)||2
466560|NCT01210560|1142759|P3|STARTED|Intervention 1 (7 Days)||2
466561|NCT01210560|1142760|P2|STARTED|Intervention 1 (7 Days)||2
466562|NCT01210560|1142761|P1|STARTED|Intervention 1 (7 Days)||2
466563|NCT01210495|1142857|P4|NOT COMPLETED|Overall Study||68
466564|NCT01210495|1142858|P3|NOT COMPLETED|Overall Study||134
466565|NCT01210495|1142859|P2|NOT COMPLETED|Overall Study||7
466566|NCT01210495|1142860|P1|NOT COMPLETED|Overall Study||15
466567|NCT01210495|1142857|P4|COMPLETED|Overall Study||0
466568|NCT01210495|1142858|P3|COMPLETED|Overall Study||0
466569|NCT01210495|1142859|P2|COMPLETED|Overall Study||0
466570|NCT01210495|1142860|P1|COMPLETED|Overall Study||0
466571|NCT01210495|1142857|P4|STARTED|Overall Study||68
466572|NCT01210495|1142858|P3|STARTED|Overall Study||134
466573|NCT01210495|1142859|P2|STARTED|Overall Study||7
466574|NCT01210495|1142860|P1|STARTED|Overall Study||15
466575|NCT01210443|1142922|P1|NOT COMPLETED|Overall Study||2
466576|NCT01210443|1142922|P1|COMPLETED|Overall Study||0
466577|NCT01210443|1142922|P1|STARTED|Overall Study||2
466578|NCT01210222|1142930|P1|NOT COMPLETED|Overall Study||3
466579|NCT01210222|1142930|P1|COMPLETED|Overall Study||32
466580|NCT01210222|1142930|P1|STARTED|Overall Study||35
466581|NCT01210170|1142943|P1|NOT COMPLETED|Overall Study||7
466582|NCT01210170|1142943|P1|COMPLETED|Overall Study||15
466583|NCT01210170|1142943|P1|STARTED|Overall Study||22
466584|NCT01210144|1142966|P2|NOT COMPLETED|Overall Study||0
466585|NCT01210144|1142967|P1|NOT COMPLETED|Overall Study||3
466586|NCT01210144|1142966|P2|COMPLETED|Overall Study||11
466587|NCT01210144|1142967|P1|COMPLETED|Overall Study||10
466588|NCT01210144|1142966|P2|STARTED|Overall Study||11
466589|NCT01210144|1142967|P1|STARTED|Overall Study||13
466590|NCT01210118|1142989|P2|NOT COMPLETED|Overall Study||5
466591|NCT01210118|1142990|P1|NOT COMPLETED|Overall Study||3
466592|NCT01210118|1142989|P2|COMPLETED|Overall Study||42
466593|NCT01210118|1142990|P1|COMPLETED|Overall Study||42
466594|NCT01210118|1142989|P2|STARTED|Overall Study||47
466595|NCT01210118|1142990|P1|STARTED|Overall Study||45
466596|NCT01210079|1143004|P2|NOT COMPLETED|Overall Study||0
466597|NCT01210079|1143005|P1|NOT COMPLETED|Overall Study||0
466598|NCT01210079|1143004|P2|COMPLETED|Overall Study||16
466599|NCT01210079|1143005|P1|COMPLETED|Overall Study||10
466600|NCT01210079|1143004|P2|STARTED|Overall Study||16
466601|NCT01210079|1143005|P1|STARTED|Overall Study||10
466602|NCT01210001|1143014|P3|NOT COMPLETED|Overall Study||12
466603|NCT01210001|1143015|P2|NOT COMPLETED|Overall Study||11
466604|NCT01210001|1143016|P1|NOT COMPLETED|Overall Study||19
466605|NCT01210001|1143014|P3|COMPLETED|Overall Study||156
466606|NCT01210001|1143015|P2|COMPLETED|Overall Study||154
466607|NCT01210001|1143016|P1|COMPLETED|Overall Study||147
466608|NCT01210001|1143014|P3|STARTED|Overall Study||168
466609|NCT01210001|1143015|P2|STARTED|Overall Study||165
466610|NCT01210001|1143016|P1|STARTED|Overall Study||166
466611|NCT01209949|1143036|P1|NOT COMPLETED|Overall Study||3
466612|NCT01209949|1143036|P1|COMPLETED|Overall Study||27
466613|NCT01209949|1143036|P1|STARTED|Overall Study||30
466614|NCT01209780|1143046|P5|NOT COMPLETED|Overall Study||5
466615|NCT01209780|1143047|P4|NOT COMPLETED|Overall Study||10
466616|NCT01209780|1143048|P3|NOT COMPLETED|Overall Study||4
466617|NCT01209780|1143049|P2|NOT COMPLETED|Overall Study||18
466618|NCT01209780|1143050|P1|NOT COMPLETED|Overall Study||26
466619|NCT01209780|1143046|P5|COMPLETED|Overall Study||407
466620|NCT01209780|1143047|P4|COMPLETED|Overall Study||807
466621|NCT01209780|1143048|P3|COMPLETED|Overall Study||44
466622|NCT01209780|1143049|P2|COMPLETED|Overall Study||467
466623|NCT01209780|1143050|P1|COMPLETED|Overall Study||1016
466624|NCT01209780|1143046|P5|STARTED|Overall Study||412
466625|NCT01209780|1143047|P4|STARTED|Overall Study||817
466626|NCT01209780|1143048|P3|STARTED|Overall Study||48
466627|NCT01209780|1143049|P2|STARTED|Overall Study||485
466628|NCT01209780|1143050|P1|STARTED|Overall Study||1042
466629|NCT01209767|1143076|P1|NOT COMPLETED|Overall Study||4
466630|NCT01209767|1143076|P1|COMPLETED|Overall Study||18
466631|NCT01209767|1143076|P1|STARTED|Overall Study||22
466632|NCT01209702|1143086|P4|NOT COMPLETED|Overall Study||153
466633|NCT01209702|1143087|P3|NOT COMPLETED|Overall Study||51
466634|NCT01209702|1143088|P2|NOT COMPLETED|Overall Study||51
466635|NCT01209702|1143089|P1|NOT COMPLETED|Overall Study||51
466636|NCT01209702|1143086|P4|COMPLETED|Overall Study||0
466637|NCT01209702|1143087|P3|COMPLETED|Overall Study||0
466638|NCT01209702|1143088|P2|COMPLETED|Overall Study||0
466639|NCT01209702|1143089|P1|COMPLETED|Overall Study||0
466640|NCT01209702|1143086|P4|Completed 24 Weeks Treatment|Overall Study||10
466641|NCT01209702|1143087|P3|Completed 24 Weeks Treatment|Overall Study||3
466642|NCT01209702|1143088|P2|Completed 24 Weeks Treatment|Overall Study||28
466643|NCT01209702|1143089|P1|Completed 24 Weeks Treatment|Overall Study||19
466644|NCT01209702|1143086|P4|Completed 12 Weeks Treatment|Overall Study||59
466645|NCT01209702|1143087|P3|Completed 12 Weeks Treatment|Overall Study||12
466646|NCT01209702|1143088|P2|Completed 12 Weeks Treatment|Overall Study||48
466647|NCT01209702|1143089|P1|Completed 12 Weeks Treatment|Overall Study||50
466648|NCT01209702|1143086|P4|Escape or Switched to Tocilizumab|Overall Study||0
466649|NCT01209702|1143087|P3|Escape or Switched to Tocilizumab|Overall Study||6
466650|NCT01209702|1143088|P2|Escape or Switched to Tocilizumab|Overall Study||0
466651|NCT01209702|1143089|P1|Escape or Switched to Tocilizumab|Overall Study||51
466652|NCT01209702|1143086|P4|Treated|Overall Study||152
466653|NCT01209702|1143087|P3|Treated|Overall Study||51
466654|NCT01209702|1143088|P2|Treated|Overall Study||51
466655|NCT01209702|1143089|P1|Treated|Overall Study||51
466656|NCT01209702|1143086|P4|STARTED|Overall Study||153
466657|NCT01209702|1143087|P3|STARTED|Overall Study||51
466658|NCT01209702|1143088|P2|STARTED|Overall Study||51
466659|NCT01209702|1143089|P1|STARTED|Overall Study||51
466660|NCT01209689|1143145|P2|NOT COMPLETED|Overall Study||22
466661|NCT01209689|1143146|P1|NOT COMPLETED|Overall Study||91
466662|NCT01209689|1143145|P2|COMPLETED|Overall Study||0
466663|NCT01209689|1143146|P1|COMPLETED|Overall Study||0
466664|NCT01209689|1143145|P2|STARTED|Overall Study||22
466665|NCT01209689|1143146|P1|STARTED|Overall Study||91
466666|NCT01209624|1143152|P1|NOT COMPLETED|Overall Study||326
466667|NCT01209624|1143152|P1|COMPLETED|Overall Study||576
466668|NCT01209624|1143152|P1|Per Protocol Population|Overall Study||469
466669|NCT01209624|1143152|P1|STARTED|Overall Study||902
466670|NCT01209598|1143185|P2|NOT COMPLETED|Overall Study||0
466671|NCT01209598|1143186|P1|NOT COMPLETED|Overall Study||1
466672|NCT01209598|1143185|P2|COMPLETED|Overall Study||60
466673|NCT01209598|1143186|P1|COMPLETED|Overall Study||29
466674|NCT01209598|1143185|P2|STARTED|Overall Study||60
466675|NCT01209598|1143186|P1|STARTED|Overall Study||30
466676|NCT01209520|1143194|P1|NOT COMPLETED|Overall Study||3
466677|NCT01209520|1143194|P1|COMPLETED|Overall Study||3
466678|NCT01209520|1143194|P1|STARTED|Overall Study||6
466679|NCT01209286|1143202|P3|NOT COMPLETED|Overall Study||3
466680|NCT01209286|1143203|P2|NOT COMPLETED|Overall Study||10
466681|NCT01209286|1143204|P1|NOT COMPLETED|Overall Study||5
466682|NCT01209286|1143202|P3|COMPLETED|Overall Study||3
466683|NCT01209286|1143203|P2|COMPLETED|Overall Study||13
466684|NCT01209286|1143204|P1|COMPLETED|Overall Study||2
466685|NCT01209286|1143202|P3|STARTED|Overall Study||6
466686|NCT01209286|1143203|P2|STARTED|Overall Study||23
466687|NCT01209286|1143204|P1|STARTED|Overall Study||7
466688|NCT01209260|1143257|P2|NOT COMPLETED|Overall Study||0
466689|NCT01209260|1143258|P1|NOT COMPLETED|Overall Study||0
466690|NCT01209260|1143257|P2|COMPLETED|Overall Study||36
466691|NCT01209260|1143258|P1|COMPLETED|Overall Study||36
466692|NCT01209260|1143257|P2|STARTED|Overall Study||36
466693|NCT01209260|1143258|P1|STARTED|Overall Study||36
466694|NCT01209195|1143272|P6|NOT COMPLETED|Overall Study||0
466695|NCT01209195|1143273|P5|NOT COMPLETED|Overall Study||0
466696|NCT01209195|1143274|P4|NOT COMPLETED|Overall Study||0
466697|NCT01209195|1143275|P3|NOT COMPLETED|Overall Study||0
466698|NCT01209195|1143276|P2|NOT COMPLETED|Overall Study||0
466699|NCT01209195|1143277|P1|NOT COMPLETED|Overall Study||0
466700|NCT01209195|1143272|P6|COMPLETED|Overall Study||13
466701|NCT01209195|1143273|P5|COMPLETED|Overall Study||6
466702|NCT01209195|1143274|P4|COMPLETED|Overall Study||6
466703|NCT01209195|1143275|P3|COMPLETED|Overall Study||6
466704|NCT01209195|1143276|P2|COMPLETED|Overall Study||3
466705|NCT01209195|1143277|P1|COMPLETED|Overall Study||7
466706|NCT01209195|1143272|P6|STARTED|Overall Study||13
466707|NCT01209195|1143273|P5|STARTED|Overall Study||6
466708|NCT01209195|1143274|P4|STARTED|Overall Study||6
466709|NCT01209195|1143275|P3|STARTED|Overall Study||6
466710|NCT01209195|1143276|P2|STARTED|Overall Study||3
466711|NCT01209195|1143277|P1|STARTED|Overall Study||7
466712|NCT01209143|1143313|P2|NOT COMPLETED|Overall Study||20
466713|NCT01209143|1143314|P1|NOT COMPLETED|Overall Study||19
466714|NCT01209143|1143313|P2|COMPLETED|Overall Study||8
466715|NCT01209143|1143314|P1|COMPLETED|Overall Study||5
466716|NCT01209143|1143313|P2|STARTED|Overall Study||28
466717|NCT01209143|1143314|P1|STARTED|Overall Study||24
466718|NCT01209078|1143324|P2|NOT COMPLETED|Overall Study||3
466719|NCT01209078|1143325|P1|NOT COMPLETED|Overall Study||16
466720|NCT01209078|1143324|P2|COMPLETED|Overall Study||24
466721|NCT01209078|1143325|P1|COMPLETED|Overall Study||41
466722|NCT01209078|1143324|P2|STARTED|Overall Study||27
466723|NCT01209078|1143325|P1|STARTED|Overall Study||57
466724|NCT01208961|1143400|P2|NOT COMPLETED|High-Fat Period IV||0
466725|NCT01208961|1143401|P1|NOT COMPLETED|High-Fat Period IV||0
466726|NCT01208961|1143400|P2|COMPLETED|High-Fat Period IV||26
466727|NCT01208961|1143401|P1|COMPLETED|High-Fat Period IV||25
466728|NCT01208961|1143400|P2|STARTED|High-Fat Period IV||26
466729|NCT01208961|1143401|P1|STARTED|High-Fat Period IV||25
466730|NCT01208961|1143400|P2|NOT COMPLETED|High-Fat Period III||0
466731|NCT01208961|1143401|P1|NOT COMPLETED|High-Fat Period III||1
466732|NCT01208961|1143400|P2|COMPLETED|High-Fat Period III||26
466733|NCT01208961|1143401|P1|COMPLETED|High-Fat Period III||25
466734|NCT01208961|1143400|P2|STARTED|High-Fat Period III||26
466735|NCT01208961|1143401|P1|STARTED|High-Fat Period III||26
466736|NCT01208961|1143400|P2|NOT COMPLETED|Low-Fat Period II||0
466737|NCT01208961|1143401|P1|NOT COMPLETED|Low-Fat Period II||0
466738|NCT01208961|1143400|P2|COMPLETED|Low-Fat Period II||27
466739|NCT01208961|1143401|P1|COMPLETED|Low-Fat Period II||26
466740|NCT01208961|1143400|P2|STARTED|Low-Fat Period II||27
466741|NCT01208961|1143401|P1|STARTED|Low-Fat Period II||26
466742|NCT01208961|1143400|P2|NOT COMPLETED|Low-Fat Period I||0
466743|NCT01208961|1143401|P1|NOT COMPLETED|Low-Fat Period I||0
466744|NCT01208961|1143400|P2|COMPLETED|Low-Fat Period I||27
466745|NCT01208961|1143401|P1|COMPLETED|Low-Fat Period I||27
466746|NCT01208961|1143400|P2|STARTED|Low-Fat Period I||27
466747|NCT01208961|1143401|P1|STARTED|Low-Fat Period I||27
466748|NCT01208870|1143412|P2|NOT COMPLETED|Overall Study||8
466749|NCT01208870|1143413|P1|NOT COMPLETED|Overall Study||2
466750|NCT01208870|1143412|P2|COMPLETED|Overall Study||36
466751|NCT01208870|1143413|P1|COMPLETED|Overall Study||44
466752|NCT01208870|1143412|P2|Pilot 2|Overall Study||22
466753|NCT01208870|1143413|P1|Pilot 2|Overall Study||26
466754|NCT01208870|1143412|P2|Pilot 1|Overall Study||22
466755|NCT01208870|1143413|P1|Pilot 1|Overall Study||20
466756|NCT01208870|1143412|P2|STARTED|Overall Study|The same group was run as Pilot 1 Spring 2012 and Pilot 2 Summer 2013.|44
466757|NCT01208870|1143413|P1|STARTED|Overall Study|The same group was run as Pilot 1 Spring 2012 and Pilot 2 Summer 2013|46
466758|NCT01208415|1143429|P1|NOT COMPLETED|Overall Study||40
466759|NCT01208415|1143429|P1|COMPLETED|Overall Study||0
466760|NCT01208415|1143429|P1|6 Months|Overall Study||37
466761|NCT01208415|1143429|P1|STARTED|Overall Study||40
466762|NCT01208402|1143435|P2|NOT COMPLETED|Overall Study||0
466763|NCT01208402|1143436|P1|NOT COMPLETED|Overall Study||1
466764|NCT01208402|1143435|P2|COMPLETED|Overall Study||28
466765|NCT01208402|1143436|P1|COMPLETED|Overall Study||30
466766|NCT01208402|1143435|P2|STARTED|Overall Study||28
466767|NCT01208402|1143436|P1|STARTED|Overall Study||31
466768|NCT01208337|1143452|P1|NOT COMPLETED|Overall Study||3
466769|NCT01208337|1143452|P1|COMPLETED|Overall Study||20
466770|NCT01208337|1143452|P1|Five-year Follow-up|Overall Study||20
466771|NCT01208337|1143452|P1|One-year Follow-up|Overall Study||23
466772|NCT01208337|1143452|P1|STARTED|Overall Study||23
466773|NCT01208233|1143466|P6|NOT COMPLETED|Overall Study||21
466774|NCT01208233|1143467|P5|NOT COMPLETED|Overall Study||24
466775|NCT01208233|1143468|P4|NOT COMPLETED|Overall Study||1
466776|NCT01208233|1143469|P3|NOT COMPLETED|Overall Study||4
466777|NCT01208233|1143470|P2|NOT COMPLETED|Overall Study||3
466778|NCT01208233|1143471|P1|NOT COMPLETED|Overall Study||5
466779|NCT01208233|1143466|P6|COMPLETED|Overall Study||46
466780|NCT01208233|1143467|P5|COMPLETED|Overall Study||46
466781|NCT01208233|1143468|P4|COMPLETED|Overall Study||9
466782|NCT01208233|1143469|P3|COMPLETED|Overall Study||7
466783|NCT01208233|1143470|P2|COMPLETED|Overall Study||6
466784|NCT01208233|1143471|P1|COMPLETED|Overall Study||6
466785|NCT01208233|1143466|P6|STARTED|Overall Study||67
466786|NCT01208233|1143467|P5|STARTED|Overall Study||70
466787|NCT01208233|1143468|P4|STARTED|Overall Study||10
466788|NCT01208233|1143469|P3|STARTED|Overall Study||11
466789|NCT01208233|1143470|P2|STARTED|Overall Study||9
466790|NCT01208233|1143471|P1|STARTED|Overall Study||11
466791|NCT01208220|1143584|P2|NOT COMPLETED|Overall Study||0
466792|NCT01208220|1143585|P1|NOT COMPLETED|Overall Study||0
466793|NCT01208220|1143584|P2|COMPLETED|Overall Study||1
466794|NCT01208220|1143585|P1|COMPLETED|Overall Study||1
466795|NCT01208220|1143584|P2|STARTED|Overall Study||1
466796|NCT01208220|1143585|P1|STARTED|Overall Study||1
466797|NCT01208207|1143596|P7|NOT COMPLETED|Part II||11
466798|NCT01208207|1143597|P6|NOT COMPLETED|Part II||16
466799|NCT01208207|1143598|P5|NOT COMPLETED|Part II||23
466800|NCT01208207|1143599|P4|NOT COMPLETED|Part II||32
466801|NCT01208207|1143600|P3|NOT COMPLETED|Part II||0
466802|NCT01208207|1143601|P2|NOT COMPLETED|Part II||0
466803|NCT01208207|1143602|P1|NOT COMPLETED|Part II||0
466804|NCT01208207|1143596|P7|COMPLETED|Part II||131
466805|NCT01208207|1143597|P6|COMPLETED|Part II||129
466806|NCT01208207|1143598|P5|COMPLETED|Part II||295
466807|NCT01208207|1143599|P4|COMPLETED|Part II||282
466808|NCT01208207|1143600|P3|COMPLETED|Part II||0
466809|NCT01208207|1143601|P2|COMPLETED|Part II||0
466810|NCT01208207|1143602|P1|COMPLETED|Part II||0
466811|NCT01208207|1143596|P7|STARTED|Part II||142
466812|NCT01208207|1143597|P6|STARTED|Part II||145
466813|NCT01208207|1143598|P5|STARTED|Part II||318
466814|NCT01208207|1143599|P4|STARTED|Part II||314
466815|NCT01208207|1143600|P3|STARTED|Part II||0
466816|NCT01208207|1143601|P2|STARTED|Part II||0
466817|NCT01208207|1143602|P1|STARTED|Part II||0
466818|NCT01208207|1143596|P7|NOT COMPLETED|Part I||0
466819|NCT01208207|1143597|P6|NOT COMPLETED|Part I||0
466820|NCT01208207|1143598|P5|NOT COMPLETED|Part I||0
466821|NCT01208207|1143599|P4|NOT COMPLETED|Part I||0
466822|NCT01208207|1143600|P3|NOT COMPLETED|Part I||15
466823|NCT01208207|1143601|P2|NOT COMPLETED|Part I||11
466824|NCT01208207|1143602|P1|NOT COMPLETED|Part I||70
466825|NCT01208207|1143596|P7|COMPLETED|Part I||0
466826|NCT01208207|1143597|P6|COMPLETED|Part I||0
466827|NCT01208207|1143598|P5|COMPLETED|Part I||0
466828|NCT01208207|1143599|P4|COMPLETED|Part I||0
466829|NCT01208207|1143600|P3|COMPLETED|Part I||142
466830|NCT01208207|1143601|P2|COMPLETED|Part I||145
466831|NCT01208207|1143602|P1|COMPLETED|Part I||632
466832|NCT01208207|1143596|P7|STARTED|Part I||0
466833|NCT01208207|1143597|P6|STARTED|Part I||0
466834|NCT01208207|1143598|P5|STARTED|Part I||0
466835|NCT01208207|1143599|P4|STARTED|Part I||0
466836|NCT01208207|1143600|P3|STARTED|Part I||157
466837|NCT01208207|1143601|P2|STARTED|Part I||156
466838|NCT01208207|1143602|P1|STARTED|Part I||702
466839|NCT01208181|1143629|P5|NOT COMPLETED|Part 2||0
466840|NCT01208181|1143630|P4|NOT COMPLETED|Part 2||20
466841|NCT01208181|1143631|P3|NOT COMPLETED|Part 2||16
466842|NCT01208181|1143632|P2|NOT COMPLETED|Part 2||0
466843|NCT01208181|1143633|P1|NOT COMPLETED|Part 2||0
466844|NCT01208181|1143629|P5|COMPLETED|Part 2||0
466845|NCT01208181|1143630|P4|COMPLETED|Part 2||343
466846|NCT01208181|1143631|P3|COMPLETED|Part 2||334
466847|NCT01208181|1143632|P2|COMPLETED|Part 2||0
466848|NCT01208181|1143633|P1|COMPLETED|Part 2||0
466849|NCT01208181|1143629|P5|STARTED|Part 2|Per protocol, participants did not receive placebo during Part II of the study|0
466850|NCT01208181|1143630|P4|STARTED|Part 2|Participants receiving etoricoxib 60 mg in Part I received etoricoxib 90 mg in Part II of the study|363
466851|NCT01208181|1143631|P3|STARTED|Part 2|Participants receiving etoricoxib 60 mg in Part I received etoricoxib 60 mg in Part II of the study|350
466852|NCT01208181|1143632|P2|STARTED|Part 2|Per protocol, there were no participants in this arm during Part II of the study|0
466853|NCT01208181|1143633|P1|STARTED|Part 2|Per protocol, there were no participants in this arm during Part II of the study|0
466854|NCT01208181|1143629|P5|NOT COMPLETED|Part 1||22
466855|NCT01208181|1143630|P4|NOT COMPLETED|Part 1||0
466856|NCT01208181|1143631|P3|NOT COMPLETED|Part 1||0
466857|NCT01208181|1143632|P2|NOT COMPLETED|Part 1||55
466858|NCT01208181|1143633|P1|NOT COMPLETED|Part 1||99
466859|NCT01208181|1143629|P5|COMPLETED|Part 1|Per protocol, participants in this arm did not continue into Part II of the study|96
466860|NCT01208181|1143630|P4|COMPLETED|Part 1||0
466861|NCT01208181|1143631|P3|COMPLETED|Part 1||0
466862|NCT01208181|1143632|P2|COMPLETED|Part 1|Per protocol, participants in this arm did not continue into Part II of the study|413
466863|NCT01208181|1143633|P1|COMPLETED|Part 1|Six participants from this arm did not continue into Part II of the study|719
466864|NCT01208181|1143629|P5|STARTED|Part 1||118
466865|NCT01208181|1143630|P4|STARTED|Part 1||0
466866|NCT01208181|1143631|P3|STARTED|Part 1||0
466867|NCT01208181|1143632|P2|STARTED|Part 1||468
466868|NCT01208181|1143633|P1|STARTED|Part 1||818
466869|NCT01207934|1143665|P3|NOT COMPLETED|Overall Study||0
466870|NCT01207934|1143666|P2|NOT COMPLETED|Overall Study||0
466871|NCT01207934|1143667|P1|NOT COMPLETED|Overall Study||0
466872|NCT01207934|1143665|P3|COMPLETED|Overall Study||6
466873|NCT01207934|1143666|P2|COMPLETED|Overall Study||6
466874|NCT01207934|1143667|P1|COMPLETED|Overall Study||6
466875|NCT01207934|1143665|P3|STARTED|Overall Study||6
466876|NCT01207934|1143666|P2|STARTED|Overall Study||6
466877|NCT01207934|1143667|P1|STARTED|Overall Study||6
466878|NCT01207765|1143684|P1|NOT COMPLETED|Overall Study||0
466879|NCT01207765|1143684|P1|COMPLETED|Overall Study||8
466880|NCT01207765|1143684|P1|STARTED|Overall Study||8
466881|NCT01207687|1143690|P1|NOT COMPLETED|Overall Study||2
466882|NCT01207687|1143690|P1|COMPLETED|Overall Study||12
466883|NCT01207687|1143690|P1|STARTED|Overall Study||14
466884|NCT01207648|1143716|P1|NOT COMPLETED|Overall Study||0
466885|NCT01207648|1143716|P1|COMPLETED|Overall Study||307
466886|NCT01207648|1143716|P1|STARTED|Overall Study||307
466887|NCT01207596|1143724|P1|NOT COMPLETED|Overall Study||9
466888|NCT01207596|1143724|P1|COMPLETED|Overall Study||21
466889|NCT01207596|1143724|P1|STARTED|Overall Study||30
466890|NCT01207583|1143737|P3|NOT COMPLETED|Overall Study||1
466891|NCT01207583|1143738|P2|NOT COMPLETED|Overall Study||5
466892|NCT01207583|1143739|P1|NOT COMPLETED|Overall Study||1
466893|NCT01207583|1143737|P3|COMPLETED|Overall Study||54
466894|NCT01207583|1143738|P2|COMPLETED|Overall Study||26
466895|NCT01207583|1143739|P1|COMPLETED|Overall Study||13
466896|NCT01207583|1143737|P3|Dose 4|Overall Study||0
466897|NCT01207583|1143738|P2|Dose 4|Overall Study||0
466898|NCT01207583|1143739|P1|Dose 4|Overall Study||7
466899|NCT01207583|1143737|P3|Dose 3|Overall Study||0
466900|NCT01207583|1143738|P2|Dose 3|Overall Study||27
466901|NCT01207583|1143739|P1|Dose 3|Overall Study||13
466902|NCT01207583|1143737|P3|Dose 2|Overall Study||54
466903|NCT01207583|1143738|P2|Dose 2|Overall Study||29
466904|NCT01207583|1143739|P1|Dose 2|Overall Study||13
466905|NCT01207583|1143737|P3|Dose 1|Overall Study||55
466906|NCT01207583|1143738|P2|Dose 1|Overall Study||31
466907|NCT01207583|1143739|P1|Dose 1|Overall Study||14
466908|NCT01207583|1143737|P3|STARTED|Overall Study||55
466909|NCT01207583|1143738|P2|STARTED|Overall Study||31
466910|NCT01207583|1143739|P1|STARTED|Overall Study||14
466911|NCT01207570|1143779|P2|NOT COMPLETED|The Second Stage (After Crossover)||0
466912|NCT01207570|1143780|P1|NOT COMPLETED|The Second Stage (After Crossover)||0
466913|NCT01207570|1143779|P2|COMPLETED|The Second Stage (After Crossover)||23
466914|NCT01207570|1143780|P1|COMPLETED|The Second Stage (After Crossover)||31
466915|NCT01207570|1143779|P2|STARTED|The Second Stage (After Crossover)||23
466916|NCT01207570|1143780|P1|STARTED|The Second Stage (After Crossover)||31
466917|NCT01207570|1143779|P2|NOT COMPLETED|The First Stage (Before Crossover)||0
466918|NCT01207570|1143780|P1|NOT COMPLETED|The First Stage (Before Crossover)||0
466919|NCT01207570|1143779|P2|COMPLETED|The First Stage (Before Crossover)||31
466920|NCT01207570|1143780|P1|COMPLETED|The First Stage (Before Crossover)||23
466921|NCT01207570|1143779|P2|STARTED|The First Stage (Before Crossover)||31
466922|NCT01207570|1143780|P1|STARTED|The First Stage (Before Crossover)||23
466923|NCT01207492|1143792|P1|NOT COMPLETED|Overall Study||15
466924|NCT01207492|1143792|P1|COMPLETED|Overall Study||2
466925|NCT01207492|1143792|P1|STARTED|Overall Study||17
466926|NCT01207466|1143798|P2|NOT COMPLETED|Period 2, One Week of Wear||0
466927|NCT01207466|1143799|P1|NOT COMPLETED|Period 2, One Week of Wear||0
466928|NCT01207466|1143798|P2|COMPLETED|Period 2, One Week of Wear||48
466929|NCT01207466|1143799|P1|COMPLETED|Period 2, One Week of Wear||45
466930|NCT01207466|1143798|P2|STARTED|Period 2, One Week of Wear||48
466931|NCT01207466|1143799|P1|STARTED|Period 2, One Week of Wear||45
466932|NCT01207466|1143798|P2|NOT COMPLETED|Period 1, One Week of Wear||0
466933|NCT01207466|1143799|P1|NOT COMPLETED|Period 1, One Week of Wear||0
466934|NCT01207466|1143798|P2|COMPLETED|Period 1, One Week of Wear||48
466935|NCT01207466|1143799|P1|COMPLETED|Period 1, One Week of Wear|One participant discontinued between Period 1 and Period 2 due to inclusion/exclusion criteria.|46
466936|NCT01207466|1143798|P2|STARTED|Period 1, One Week of Wear||48
466937|NCT01207466|1143799|P1|STARTED|Period 1, One Week of Wear||46
466938|NCT01207453|1143807|P2|NOT COMPLETED|2nd Intervention||2
466939|NCT01207453|1143808|P1|NOT COMPLETED|2nd Intervention||2
466940|NCT01207453|1143807|P2|COMPLETED|2nd Intervention||15
466941|NCT01207453|1143808|P1|COMPLETED|2nd Intervention||17
466942|NCT01207453|1143807|P2|STARTED|2nd Intervention||17
466943|NCT01207453|1143808|P1|STARTED|2nd Intervention||19
466944|NCT01207453|1143807|P2|NOT COMPLETED|Washout||0
466945|NCT01207453|1143808|P1|NOT COMPLETED|Washout||2
466946|NCT01207453|1143807|P2|COMPLETED|Washout||17
466947|NCT01207453|1143808|P1|COMPLETED|Washout||19
466948|NCT01207453|1143807|P2|STARTED|Washout||17
466949|NCT01207453|1143808|P1|STARTED|Washout||21
466950|NCT01207453|1143807|P2|NOT COMPLETED|First Intervention||1
466951|NCT01207453|1143808|P1|NOT COMPLETED|First Intervention||2
466952|NCT01207453|1143807|P2|COMPLETED|First Intervention||17
466953|NCT01207453|1143808|P1|COMPLETED|First Intervention||21
466954|NCT01207453|1143807|P2|STARTED|First Intervention||18
466955|NCT01207453|1143808|P1|STARTED|First Intervention||23
466956|NCT01207427|1143830|P3|NOT COMPLETED|Run-out Placebo Period||0
466957|NCT01207427|1143831|P2|NOT COMPLETED|Run-out Placebo Period||0
466958|NCT01207427|1143832|P1|NOT COMPLETED|Run-out Placebo Period||0
466959|NCT01207427|1143830|P3|COMPLETED|Run-out Placebo Period||41
466960|NCT01207427|1143831|P2|COMPLETED|Run-out Placebo Period||43
466961|NCT01207427|1143832|P1|COMPLETED|Run-out Placebo Period||40
466962|NCT01207427|1143830|P3|STARTED|Run-out Placebo Period||41
466963|NCT01207427|1143831|P2|STARTED|Run-out Placebo Period||43
466964|NCT01207427|1143832|P1|STARTED|Run-out Placebo Period||40
466965|NCT01207427|1143830|P3|NOT COMPLETED|Double-blind Treatment Period||2
466966|NCT01207427|1143831|P2|NOT COMPLETED|Double-blind Treatment Period||2
466967|NCT01207427|1143832|P1|NOT COMPLETED|Double-blind Treatment Period||3
466968|NCT01207427|1143830|P3|COMPLETED|Double-blind Treatment Period||41
466969|NCT01207427|1143831|P2|COMPLETED|Double-blind Treatment Period||43
466970|NCT01207427|1143832|P1|COMPLETED|Double-blind Treatment Period||40
466971|NCT01207427|1143830|P3|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43
466972|NCT01207427|1143831|P2|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||45
466973|NCT01207427|1143832|P1|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43
466974|NCT01207427|1143830|P3|STARTED|Double-blind Treatment Period||43
466975|NCT01207427|1143831|P2|STARTED|Double-blind Treatment Period||45
466976|NCT01207427|1143832|P1|STARTED|Double-blind Treatment Period||43
466977|NCT01207427|1143830|P3|NOT COMPLETED|Run-in Placebo Period||0
466978|NCT01207427|1143831|P2|NOT COMPLETED|Run-in Placebo Period||0
466979|NCT01207427|1143832|P1|NOT COMPLETED|Run-in Placebo Period||0
466980|NCT01207427|1143830|P3|COMPLETED|Run-in Placebo Period||43
466981|NCT01207427|1143831|P2|COMPLETED|Run-in Placebo Period||45
466982|NCT01207427|1143832|P1|COMPLETED|Run-in Placebo Period||43
466983|NCT01207427|1143830|P3|STARTED|Run-in Placebo Period||43
466984|NCT01207427|1143831|P2|STARTED|Run-in Placebo Period||45
466985|NCT01207427|1143832|P1|STARTED|Run-in Placebo Period||43
466986|NCT01207414|1143842|P2|NOT COMPLETED|Overall Study||82
466987|NCT01207414|1143843|P1|NOT COMPLETED|Overall Study||73
466988|NCT01207414|1143842|P2|COMPLETED|Overall Study||178
466989|NCT01207414|1143843|P1|COMPLETED|Overall Study||168
466990|NCT01207414|1143842|P2|Safety Population: Received Study Drug|Overall Study||260
466991|NCT01207414|1143843|P1|Safety Population: Received Study Drug|Overall Study||240
466992|NCT01207414|1143842|P2|STARTED|Overall Study||260
466993|NCT01207414|1143843|P1|STARTED|Overall Study|Includes 1 patient randomized in error.|241
466994|NCT01207401|1143861|P2|NOT COMPLETED|Overall Study||0
466995|NCT01207401|1143862|P1|NOT COMPLETED|Overall Study||0
466996|NCT01207401|1143861|P2|COMPLETED|Overall Study||24
466997|NCT01207401|1143862|P1|COMPLETED|Overall Study||26
466998|NCT01207401|1143861|P2|STARTED|Overall Study||24
466999|NCT01207401|1143862|P1|STARTED|Overall Study||26
467000|NCT01207388|1143868|P1|NOT COMPLETED|Overall Study||33
467001|NCT01207388|1143868|P1|COMPLETED|Overall Study|Completed the core study|83
467002|NCT01207388|1143868|P1|STARTED|Overall Study||116
467003|NCT01207219|1143891|P3|NOT COMPLETED|Overall Study||7
467004|NCT01207219|1143892|P2|NOT COMPLETED|Overall Study||11
467005|NCT01207219|1143893|P1|NOT COMPLETED|Overall Study||11
467006|NCT01207219|1143891|P3|COMPLETED|Overall Study||32
467007|NCT01207219|1143892|P2|COMPLETED|Overall Study||29
467008|NCT01207219|1143893|P1|COMPLETED|Overall Study||34
467009|NCT01207219|1143891|P3|Included in ITT Analysis|Overall Study||38
467010|NCT01207219|1143892|P2|Included in ITT Analysis|Overall Study||37
467011|NCT01207219|1143893|P1|Included in ITT Analysis|Overall Study||40
467012|NCT01207219|1143891|P3|STARTED|Overall Study||39
467013|NCT01207219|1143892|P2|STARTED|Overall Study||40
467014|NCT01207219|1143893|P1|STARTED|Overall Study||45
467015|NCT01207102|1143913|P1|NOT COMPLETED|Overall Study||10
467016|NCT01207102|1143913|P1|COMPLETED|Overall Study||0
467017|NCT01207102|1143913|P1|STARTED|Overall Study||10
467018|NCT01206777|1143918|P1|NOT COMPLETED|Overall Study||2
467019|NCT01206777|1143918|P1|COMPLETED|Overall Study||50
467020|NCT01206777|1143918|P1|Discontinued Trial and Deemed Ineligible|Overall Study||2
467021|NCT01206777|1143918|P1|STARTED|Overall Study||52
467022|NCT01206738|1143927|P3|NOT COMPLETED|Overall Study||19
467023|NCT01206738|1143928|P2|NOT COMPLETED|Overall Study||25
467024|NCT01206738|1143929|P1|NOT COMPLETED|Overall Study||23
467025|NCT01206738|1143927|P3|COMPLETED|Overall Study||42
467026|NCT01206738|1143928|P2|COMPLETED|Overall Study||49
467027|NCT01206738|1143929|P1|COMPLETED|Overall Study||40
467028|NCT01206738|1143927|P3|STARTED|Overall Study||61
467029|NCT01206738|1143928|P2|STARTED|Overall Study||74
467030|NCT01206738|1143929|P1|STARTED|Overall Study||63
467031|NCT01206660|1143941|P2|NOT COMPLETED|Overall Study||0
467032|NCT01206660|1143942|P1|NOT COMPLETED|Overall Study||0
467033|NCT01206660|1143941|P2|COMPLETED|Overall Study||60
467034|NCT01206660|1143942|P1|COMPLETED|Overall Study||60
467035|NCT01206660|1143941|P2|STARTED|Overall Study||60
467036|NCT01206660|1143942|P1|STARTED|Overall Study||60
467037|NCT01206608|1143954|P2|NOT COMPLETED|Overall Study||0
467038|NCT01206608|1143955|P1|NOT COMPLETED|Overall Study||0
467039|NCT01206608|1143954|P2|COMPLETED|Overall Study||20
467040|NCT01206608|1143955|P1|COMPLETED|Overall Study||20
467041|NCT01206608|1143954|P2|STARTED|Overall Study||20
467042|NCT01206608|1143955|P1|STARTED|Overall Study||20
467043|NCT01206595|1143963|P2|NOT COMPLETED|Overall Study||0
467044|NCT01206595|1143964|P1|NOT COMPLETED|Overall Study||0
467045|NCT01206595|1143963|P2|COMPLETED|Overall Study||20
467046|NCT01206595|1143964|P1|COMPLETED|Overall Study||38
467047|NCT01206595|1143963|P2|STARTED|Overall Study||20
467048|NCT01206595|1143964|P1|STARTED|Overall Study||38
467049|NCT01206582|1143974|P2|NOT COMPLETED|Overall Study||2
467050|NCT01206582|1143975|P1|NOT COMPLETED|Overall Study||2
467051|NCT01206582|1143974|P2|COMPLETED|Overall Study||7
467052|NCT01206582|1143975|P1|COMPLETED|Overall Study||9
467053|NCT01206582|1143974|P2|STARTED|Overall Study||9
467054|NCT01206582|1143975|P1|STARTED|Overall Study||11
467055|NCT01206517|1144007|P6|NOT COMPLETED|Overall Study||0
467056|NCT01206517|1144008|P5|NOT COMPLETED|Overall Study||1
467057|NCT01206517|1144009|P4|NOT COMPLETED|Overall Study||0
467058|NCT01206517|1144010|P3|NOT COMPLETED|Overall Study||2
467059|NCT01206517|1144011|P2|NOT COMPLETED|Overall Study||0
467060|NCT01206517|1144012|P1|NOT COMPLETED|Overall Study||0
467061|NCT01206517|1144007|P6|COMPLETED|Overall Study||4
467062|NCT01206517|1144008|P5|COMPLETED|Overall Study||3
467063|NCT01206517|1144009|P4|COMPLETED|Overall Study||4
467064|NCT01206517|1144010|P3|COMPLETED|Overall Study||4
467065|NCT01206517|1144011|P2|COMPLETED|Overall Study||6
467066|NCT01206517|1144012|P1|COMPLETED|Overall Study||6
467067|NCT01206517|1144007|P6|STARTED|Overall Study||4
467068|NCT01206517|1144008|P5|STARTED|Overall Study||4
467069|NCT01206517|1144009|P4|STARTED|Overall Study||4
467070|NCT01206517|1144010|P3|STARTED|Overall Study||6
467071|NCT01206517|1144011|P2|STARTED|Overall Study||6
467072|NCT01206517|1144012|P1|STARTED|Overall Study||6
467073|NCT01206478|1144043|P2|NOT COMPLETED|Overall Study||5
467074|NCT01206478|1144044|P1|NOT COMPLETED|Overall Study||2
467075|NCT01206478|1144043|P2|COMPLETED|Overall Study||7
467076|NCT01206478|1144044|P1|COMPLETED|Overall Study||7
467077|NCT01206478|1144043|P2|STARTED|Overall Study||12
467078|NCT01206478|1144044|P1|STARTED|Overall Study||9
467079|NCT01206452|1144054|P2|NOT COMPLETED|Overall Study||0
467080|NCT01206452|1144055|P1|NOT COMPLETED|Overall Study||0
467081|NCT01206452|1144054|P2|COMPLETED|Overall Study||30
467082|NCT01206452|1144055|P1|COMPLETED|Overall Study||30
467083|NCT01206452|1144054|P2|STARTED|Overall Study||30
467084|NCT01206452|1144055|P1|STARTED|Overall Study||30
467085|NCT01206439|1144069|P1|NOT COMPLETED|Overall Study||1
467086|NCT01206439|1144069|P1|COMPLETED|Overall Study||1
467087|NCT01206439|1144069|P1|STARTED|Overall Study||2
467088|NCT01206387|1144075|P2|NOT COMPLETED|Overall Study||0
467089|NCT01206387|1144076|P1|NOT COMPLETED|Overall Study||1
467090|NCT01206387|1144075|P2|COMPLETED|Overall Study||60
467091|NCT01206387|1144076|P1|COMPLETED|Overall Study||59
467092|NCT01206387|1144075|P2|STARTED|Overall Study||60
467093|NCT01206387|1144076|P1|STARTED|Overall Study||60
467094|NCT01206322|1144092|P4|NOT COMPLETED|Overall Study||1
467095|NCT01206322|1144093|P3|NOT COMPLETED|Overall Study||0
467096|NCT01206322|1144094|P2|NOT COMPLETED|Overall Study||0
467097|NCT01206322|1144095|P1|NOT COMPLETED|Overall Study||0
467098|NCT01206322|1144092|P4|COMPLETED|Overall Study||5
467099|NCT01206322|1144093|P3|COMPLETED|Overall Study||9
467100|NCT01206322|1144094|P2|COMPLETED|Overall Study||11
467101|NCT01206322|1144095|P1|COMPLETED|Overall Study||4
467102|NCT01206322|1144092|P4|STARTED|Overall Study||6
467103|NCT01206322|1144093|P3|STARTED|Overall Study||9
467104|NCT01206322|1144094|P2|STARTED|Overall Study||11
467105|NCT01206322|1144095|P1|STARTED|Overall Study||4
467106|NCT01206140|1144111|P2|NOT COMPLETED|Overall Study||0
467107|NCT01206140|1144112|P1|NOT COMPLETED|Overall Study||1
467108|NCT01206140|1144111|P2|COMPLETED|Overall Study||35
467109|NCT01206140|1144112|P1|COMPLETED|Overall Study||34
467110|NCT01206140|1144111|P2|STARTED|Overall Study||35
467111|NCT01206140|1144112|P1|STARTED|Overall Study||35
467112|NCT01206101|1144124|P2|NOT COMPLETED|Overall Study||1
467113|NCT01206101|1144125|P1|NOT COMPLETED|Overall Study||2
467114|NCT01206101|1144124|P2|COMPLETED|Overall Study||0
467115|NCT01206101|1144125|P1|COMPLETED|Overall Study||0
467116|NCT01206101|1144124|P2|STARTED|Overall Study||1
467117|NCT01206101|1144125|P1|STARTED|Overall Study||2
467118|NCT01206062|1144143|P2|NOT COMPLETED|Overall Study||0
467119|NCT01206062|1144144|P1|NOT COMPLETED|Overall Study||0
467120|NCT01206062|1144143|P2|COMPLETED|Overall Study||4683
467121|NCT01206062|1144144|P1|COMPLETED|Overall Study||4678
467122|NCT01206062|1144143|P2|STARTED|Overall Study||4683
467123|NCT01206062|1144144|P1|STARTED|Overall Study||4678
467124|NCT01205828|1144156|P1|NOT COMPLETED|Overall Study||0
467125|NCT01205828|1144156|P1|COMPLETED|Overall Study|Completed the first stage of the study, terminated as pre-planned due to lack of efficacy|16
467126|NCT01205828|1144156|P1|STARTED|Overall Study||16
467127|NCT01205776|1144166|P2|NOT COMPLETED|3 Years Follow-up||24
467128|NCT01205776|1144167|P1|NOT COMPLETED|3 Years Follow-up||16
467129|NCT01205776|1144166|P2|COMPLETED|3 Years Follow-up||889
467130|NCT01205776|1144167|P1|COMPLETED|3 Years Follow-up||911
467131|NCT01205776|1144166|P2|STARTED|3 Years Follow-up||913
467132|NCT01205776|1144167|P1|STARTED|3 Years Follow-up||927
467133|NCT01205776|1144166|P2|NOT COMPLETED|2 Years Follow-up||32
467134|NCT01205776|1144167|P1|NOT COMPLETED|2 Years Follow-up||16
467135|NCT01205776|1144166|P2|COMPLETED|2 Years Follow-up||913
467136|NCT01205776|1144167|P1|COMPLETED|2 Years Follow-up||927
467137|NCT01205776|1144166|P2|STARTED|2 Years Follow-up||945
467138|NCT01205776|1144167|P1|STARTED|2 Years Follow-up||943
467139|NCT01205776|1144166|P2|NOT COMPLETED|1 Month Follow-up||12
467140|NCT01205776|1144167|P1|NOT COMPLETED|1 Month Follow-up||5
467141|NCT01205776|1144166|P2|COMPLETED|1 Month Follow-up||945
467142|NCT01205776|1144167|P1|COMPLETED|1 Month Follow-up||943
467143|NCT01205776|1144166|P2|STARTED|1 Month Follow-up||957
467144|NCT01205776|1144167|P1|STARTED|1 Month Follow-up||948
467145|NCT01205685|1144307|P1|NOT COMPLETED|Overall Study||11
467146|NCT01205685|1144307|P1|COMPLETED|Overall Study||0
467147|NCT01205685|1144307|P1|STARTED|Overall Study||11
467148|NCT01205646|1144314|P1|NOT COMPLETED|Overall Study||0
467149|NCT01205646|1144314|P1|COMPLETED|Overall Study||11
467150|NCT01205646|1144314|P1|STARTED|Overall Study||11
467151|NCT01205581|1144327|P6|NOT COMPLETED|Overall Study||0
467152|NCT01205581|1144328|P5|NOT COMPLETED|Overall Study||0
467153|NCT01205581|1144329|P4|NOT COMPLETED|Overall Study||0
467154|NCT01205581|1144330|P3|NOT COMPLETED|Overall Study||0
467155|NCT01205581|1144331|P2|NOT COMPLETED|Overall Study||0
467156|NCT01205581|1144332|P1|NOT COMPLETED|Overall Study||1
467157|NCT01205581|1144327|P6|COMPLETED|Overall Study||20
467158|NCT01205581|1144328|P5|COMPLETED|Overall Study||20
467159|NCT01205581|1144329|P4|COMPLETED|Overall Study||9
467160|NCT01205581|1144330|P3|COMPLETED|Overall Study||8
467161|NCT01205581|1144331|P2|COMPLETED|Overall Study||13
467162|NCT01205581|1144332|P1|COMPLETED|Overall Study||13
467163|NCT01205581|1144327|P6|STARTED|Overall Study||20
467164|NCT01205581|1144328|P5|STARTED|Overall Study||20
467165|NCT01205581|1144329|P4|STARTED|Overall Study||9
467166|NCT01205581|1144330|P3|STARTED|Overall Study||8
467167|NCT01205581|1144331|P2|STARTED|Overall Study||13
467168|NCT01205581|1144332|P1|STARTED|Overall Study||14
467169|NCT01205568|1144396|P2|NOT COMPLETED|Overall Study||0
467170|NCT01205568|1144397|P1|NOT COMPLETED|Overall Study||0
467171|NCT01205568|1144396|P2|COMPLETED|Overall Study||47
467172|NCT01205568|1144397|P1|COMPLETED|Overall Study||65
467173|NCT01205568|1144396|P2|STARTED|Overall Study|8 patients received only HPB therapy, 39 patients received both CB and HPB therapy.|47
467174|NCT01205568|1144397|P1|STARTED|Overall Study|26 patients received only CB therapy, 39 patients received both CB and HPB therapy.|65
467175|NCT01205529|1144402|P1|NOT COMPLETED|Overall Study||55
467176|NCT01205529|1144402|P1|COMPLETED|Overall Study||106
467177|NCT01205529|1144402|P1|STARTED|Overall Study||161
467178|NCT01205503|1144408|P2|NOT COMPLETED|Second Intervention (2nd Cycle)||0
467179|NCT01205503|1144409|P1|NOT COMPLETED|Second Intervention (2nd Cycle)||0
467180|NCT01205503|1144408|P2|COMPLETED|Second Intervention (2nd Cycle)||16
467181|NCT01205503|1144409|P1|COMPLETED|Second Intervention (2nd Cycle)||16
467182|NCT01205503|1144408|P2|STARTED|Second Intervention (2nd Cycle)||16
467183|NCT01205503|1144409|P1|STARTED|Second Intervention (2nd Cycle)||16
467184|NCT01205503|1144408|P2|NOT COMPLETED|First Intervention (1st Cycle)||0
467185|NCT01205503|1144409|P1|NOT COMPLETED|First Intervention (1st Cycle)||0
467186|NCT01205503|1144408|P2|COMPLETED|First Intervention (1st Cycle)||16
467187|NCT01205503|1144409|P1|COMPLETED|First Intervention (1st Cycle)||16
467188|NCT01205503|1144408|P2|STARTED|First Intervention (1st Cycle)||16
467189|NCT01205503|1144409|P1|STARTED|First Intervention (1st Cycle)||16
467190|NCT01205451|1144425|P2|NOT COMPLETED|Overall Study||10
467191|NCT01205451|1144426|P1|NOT COMPLETED|Overall Study||6
467192|NCT01205451|1144425|P2|COMPLETED|Overall Study||46
467193|NCT01205451|1144426|P1|COMPLETED|Overall Study||47
467194|NCT01205451|1144425|P2|STARTED|Overall Study||56
467195|NCT01205451|1144426|P1|STARTED|Overall Study||53
467196|NCT01205438|1144471|P3|NOT COMPLETED|Overall Study||88
467197|NCT01205438|1144472|P2|NOT COMPLETED|Overall Study||87
467198|NCT01205438|1144473|P1|NOT COMPLETED|Overall Study||77
467199|NCT01205438|1144471|P3|COMPLETED|Overall Study||288
467200|NCT01205438|1144472|P2|COMPLETED|Overall Study||289
467201|NCT01205438|1144473|P1|COMPLETED|Overall Study||295
467202|NCT01205438|1144471|P3|Participated in Follow Up|Overall Study||66
467203|NCT01205438|1144472|P2|Participated in Follow Up|Overall Study||78
467204|NCT01205438|1144473|P1|Participated in Follow Up|Overall Study||72
467205|NCT01205438|1144471|P3|Received At Least One Dose of Study Drug|Overall Study||376
467206|NCT01205438|1144472|P2|Received At Least One Dose of Study Drug|Overall Study||374
467207|NCT01205438|1144473|P1|Received At Least One Dose of Study Drug|Overall Study||371
467208|NCT01205438|1144471|P3|STARTED|Overall Study||376
467209|NCT01205438|1144472|P2|STARTED|Overall Study||376
467210|NCT01205438|1144473|P1|STARTED|Overall Study||372
467211|NCT01205399|1144523|P1|NOT COMPLETED|Overall Study||0
467212|NCT01205399|1144523|P1|COMPLETED|Overall Study||78
467213|NCT01205399|1144523|P1|STARTED|Overall Study||78
467214|NCT01205269|1144529|P6|NOT COMPLETED|Period 5 - Third Intervention||0
467215|NCT01205269|1144530|P5|NOT COMPLETED|Period 5 - Third Intervention||0
467216|NCT01205269|1144531|P4|NOT COMPLETED|Period 5 - Third Intervention||0
467217|NCT01205269|1144532|P3|NOT COMPLETED|Period 5 - Third Intervention||0
467218|NCT01205269|1144533|P2|NOT COMPLETED|Period 5 - Third Intervention||0
467219|NCT01205269|1144534|P1|NOT COMPLETED|Period 5 - Third Intervention||0
467220|NCT01205269|1144529|P6|COMPLETED|Period 5 - Third Intervention||5
467221|NCT01205269|1144530|P5|COMPLETED|Period 5 - Third Intervention||5
467222|NCT01205269|1144531|P4|COMPLETED|Period 5 - Third Intervention||5
467223|NCT01205269|1144532|P3|COMPLETED|Period 5 - Third Intervention||4
467224|NCT01205269|1144533|P2|COMPLETED|Period 5 - Third Intervention||4
467225|NCT01205269|1144534|P1|COMPLETED|Period 5 - Third Intervention||4
467226|NCT01205269|1144529|P6|STARTED|Period 5 - Third Intervention||5
467227|NCT01205269|1144530|P5|STARTED|Period 5 - Third Intervention||5
467228|NCT01205269|1144531|P4|STARTED|Period 5 - Third Intervention||5
467229|NCT01205269|1144532|P3|STARTED|Period 5 - Third Intervention||4
467230|NCT01205269|1144533|P2|STARTED|Period 5 - Third Intervention||4
467231|NCT01205269|1144534|P1|STARTED|Period 5 - Third Intervention||4
467232|NCT01205269|1144529|P6|NOT COMPLETED|Period 4 - Washout||0
467233|NCT01205269|1144530|P5|NOT COMPLETED|Period 4 - Washout||0
467234|NCT01205269|1144531|P4|NOT COMPLETED|Period 4 - Washout||1
467235|NCT01205269|1144532|P3|NOT COMPLETED|Period 4 - Washout||0
467236|NCT01205269|1144533|P2|NOT COMPLETED|Period 4 - Washout||0
467237|NCT01205269|1144534|P1|NOT COMPLETED|Period 4 - Washout||0
467238|NCT01205269|1144529|P6|COMPLETED|Period 4 - Washout||5
467239|NCT01205269|1144530|P5|COMPLETED|Period 4 - Washout||5
467240|NCT01205269|1144531|P4|COMPLETED|Period 4 - Washout||5
467241|NCT01205269|1144532|P3|COMPLETED|Period 4 - Washout||4
467242|NCT01205269|1144533|P2|COMPLETED|Period 4 - Washout||4
467243|NCT01205269|1144534|P1|COMPLETED|Period 4 - Washout||4
467244|NCT01205269|1144529|P6|STARTED|Period 4 - Washout||5
467245|NCT01205269|1144530|P5|STARTED|Period 4 - Washout||5
467246|NCT01205269|1144531|P4|STARTED|Period 4 - Washout||6
467247|NCT01205269|1144532|P3|STARTED|Period 4 - Washout||4
467248|NCT01205269|1144533|P2|STARTED|Period 4 - Washout||4
467249|NCT01205269|1144534|P1|STARTED|Period 4 - Washout||4
467250|NCT01205269|1144529|P6|NOT COMPLETED|Period 3 - Second Intervention||0
467251|NCT01205269|1144530|P5|NOT COMPLETED|Period 3 - Second Intervention||0
467252|NCT01205269|1144531|P4|NOT COMPLETED|Period 3 - Second Intervention||0
467253|NCT01205269|1144532|P3|NOT COMPLETED|Period 3 - Second Intervention||0
467254|NCT01205269|1144533|P2|NOT COMPLETED|Period 3 - Second Intervention||0
467255|NCT01205269|1144534|P1|NOT COMPLETED|Period 3 - Second Intervention||0
467256|NCT01205269|1144529|P6|COMPLETED|Period 3 - Second Intervention||5
467257|NCT01205269|1144530|P5|COMPLETED|Period 3 - Second Intervention||5
467258|NCT01205269|1144531|P4|COMPLETED|Period 3 - Second Intervention||6
467259|NCT01205269|1144532|P3|COMPLETED|Period 3 - Second Intervention||4
467260|NCT01205269|1144533|P2|COMPLETED|Period 3 - Second Intervention||4
467261|NCT01205269|1144534|P1|COMPLETED|Period 3 - Second Intervention||4
467262|NCT01205269|1144529|P6|STARTED|Period 3 - Second Intervention||5
467263|NCT01205269|1144530|P5|STARTED|Period 3 - Second Intervention||5
467264|NCT01205269|1144531|P4|STARTED|Period 3 - Second Intervention||6
467265|NCT01205269|1144532|P3|STARTED|Period 3 - Second Intervention||4
467266|NCT01205269|1144533|P2|STARTED|Period 3 - Second Intervention||4
467267|NCT01205269|1144534|P1|STARTED|Period 3 - Second Intervention||4
467268|NCT01205269|1144529|P6|NOT COMPLETED|Period 2 - Washout||0
467269|NCT01205269|1144530|P5|NOT COMPLETED|Period 2 - Washout||0
467270|NCT01205269|1144531|P4|NOT COMPLETED|Period 2 - Washout||0
467271|NCT01205269|1144532|P3|NOT COMPLETED|Period 2 - Washout||0
467272|NCT01205269|1144533|P2|NOT COMPLETED|Period 2 - Washout||0
467273|NCT01205269|1144534|P1|NOT COMPLETED|Period 2 - Washout||0
467274|NCT01205269|1144529|P6|COMPLETED|Period 2 - Washout||5
467275|NCT01205269|1144530|P5|COMPLETED|Period 2 - Washout||5
467276|NCT01205269|1144531|P4|COMPLETED|Period 2 - Washout||6
467277|NCT01205269|1144532|P3|COMPLETED|Period 2 - Washout||4
467278|NCT01205269|1144533|P2|COMPLETED|Period 2 - Washout||4
467279|NCT01205269|1144534|P1|COMPLETED|Period 2 - Washout||4
467280|NCT01205269|1144529|P6|STARTED|Period 2 - Washout||5
467281|NCT01205269|1144530|P5|STARTED|Period 2 - Washout||5
467282|NCT01205269|1144531|P4|STARTED|Period 2 - Washout||6
467283|NCT01205269|1144532|P3|STARTED|Period 2 - Washout||4
467284|NCT01205269|1144533|P2|STARTED|Period 2 - Washout||4
467285|NCT01205269|1144534|P1|STARTED|Period 2 - Washout||4
467286|NCT01205269|1144529|P6|NOT COMPLETED|Period 1 - First Intervention||0
467287|NCT01205269|1144530|P5|NOT COMPLETED|Period 1 - First Intervention||0
467288|NCT01205269|1144531|P4|NOT COMPLETED|Period 1 - First Intervention||0
467289|NCT01205269|1144532|P3|NOT COMPLETED|Period 1 - First Intervention||0
467290|NCT01205269|1144533|P2|NOT COMPLETED|Period 1 - First Intervention||0
467291|NCT01205269|1144534|P1|NOT COMPLETED|Period 1 - First Intervention||0
467292|NCT01205269|1144529|P6|COMPLETED|Period 1 - First Intervention||5
467293|NCT01205269|1144530|P5|COMPLETED|Period 1 - First Intervention||5
467294|NCT01205269|1144531|P4|COMPLETED|Period 1 - First Intervention||6
467295|NCT01205269|1144532|P3|COMPLETED|Period 1 - First Intervention||4
467296|NCT01205269|1144533|P2|COMPLETED|Period 1 - First Intervention||4
467297|NCT01205269|1144534|P1|COMPLETED|Period 1 - First Intervention||4
467298|NCT01205269|1144529|P6|STARTED|Period 1 - First Intervention||5
467299|NCT01205269|1144530|P5|STARTED|Period 1 - First Intervention||5
467300|NCT01205269|1144531|P4|STARTED|Period 1 - First Intervention||6
467301|NCT01205269|1144532|P3|STARTED|Period 1 - First Intervention||4
467302|NCT01205269|1144533|P2|STARTED|Period 1 - First Intervention||4
467303|NCT01205269|1144534|P1|STARTED|Period 1 - First Intervention||4
467304|NCT01205230|1144574|P2|NOT COMPLETED|Overall Study||0
467305|NCT01205230|1144575|P1|NOT COMPLETED|Overall Study||5
467306|NCT01205230|1144574|P2|COMPLETED|Overall Study||13
467307|NCT01205230|1144575|P1|COMPLETED|Overall Study||16
467308|NCT01205230|1144574|P2|Combination Therapy|Overall Study||13
467309|NCT01205230|1144575|P1|Combination Therapy|Overall Study||21
467310|NCT01205230|1144574|P2|STARTED|Overall Study||13
467311|NCT01205230|1144575|P1|STARTED|Overall Study||21
467312|NCT01205165|1144618|P1|NOT COMPLETED|Overall Study||2
467313|NCT01205165|1144618|P1|COMPLETED|Overall Study||102
467314|NCT01205165|1144618|P1|STARTED|Overall Study||104
467315|NCT01205152|1144631|P1|NOT COMPLETED|Overall Study||1
467316|NCT01205152|1144631|P1|COMPLETED|Overall Study||9
467317|NCT01205152|1144631|P1|STARTED|Overall Study||10
467318|NCT01205126|1144644|P2|NOT COMPLETED|Maintenance Phase||40
467319|NCT01205126|1144645|P1|NOT COMPLETED|Maintenance Phase||37
467320|NCT01205126|1144644|P2|COMPLETED|Maintenance Phase||67
467321|NCT01205126|1144645|P1|COMPLETED|Maintenance Phase||70
467322|NCT01205126|1144644|P2|STARTED|Maintenance Phase||107
467323|NCT01205126|1144645|P1|STARTED|Maintenance Phase||107
467324|NCT01205126|1144644|P2|NOT COMPLETED|Between Titration & Maintenance Phase||4
467325|NCT01205126|1144645|P1|NOT COMPLETED|Between Titration & Maintenance Phase||0
467326|NCT01205126|1144644|P2|COMPLETED|Between Titration & Maintenance Phase||107
467327|NCT01205126|1144645|P1|COMPLETED|Between Titration & Maintenance Phase||107
467328|NCT01205126|1144644|P2|STARTED|Between Titration & Maintenance Phase||111
467329|NCT01205126|1144645|P1|STARTED|Between Titration & Maintenance Phase||107
467330|NCT01205126|1144644|P2|NOT COMPLETED|Titration Phase||19
467331|NCT01205126|1144645|P1|NOT COMPLETED|Titration Phase||23
467332|NCT01205126|1144644|P2|COMPLETED|Titration Phase||111
467333|NCT01205126|1144645|P1|COMPLETED|Titration Phase||107
467334|NCT01205126|1144644|P2|STARTED|Titration Phase||130
467335|NCT01205126|1144645|P1|STARTED|Titration Phase||130
467336|NCT01205035|1144663|P2|NOT COMPLETED|Overall Study||0
467337|NCT01205035|1144664|P1|NOT COMPLETED|Overall Study||2
467338|NCT01205035|1144663|P2|COMPLETED|Overall Study||3
467339|NCT01205035|1144664|P1|COMPLETED|Overall Study||1
467340|NCT01205035|1144663|P2|STARTED|Overall Study||3
467341|NCT01205035|1144664|P1|STARTED|Overall Study||3
467342|NCT01204918|1144681|P3|NOT COMPLETED|Overall Study||5
467343|NCT01204918|1144682|P2|NOT COMPLETED|Overall Study||10
467344|NCT01204918|1144683|P1|NOT COMPLETED|Overall Study||4
467345|NCT01204918|1144681|P3|COMPLETED|Overall Study||35
467346|NCT01204918|1144682|P2|COMPLETED|Overall Study||29
467347|NCT01204918|1144683|P1|COMPLETED|Overall Study||21
467348|NCT01204918|1144681|P3|Stage 2 End|Overall Study||35
467349|NCT01204918|1144682|P2|Stage 2 End|Overall Study||29
467350|NCT01204918|1144683|P1|Stage 2 End|Overall Study||21
467351|NCT01204918|1144681|P3|Stage 2 Begin|Overall Study||36
467352|NCT01204918|1144682|P2|Stage 2 Begin|Overall Study||35
467353|NCT01204918|1144683|P1|Stage 2 Begin|Overall Study||22
467354|NCT01204918|1144681|P3|Stage 1 End|Overall Study||36
467355|NCT01204918|1144682|P2|Stage 1 End|Overall Study||35
467356|NCT01204918|1144683|P1|Stage 1 End|Overall Study||22
467357|NCT01204918|1144681|P3|Stage 1 Begin|Overall Study||40
467358|NCT01204918|1144682|P2|Stage 1 Begin|Overall Study||39
467359|NCT01204918|1144683|P1|Stage 1 Begin|Overall Study||25
467360|NCT01204918|1144681|P3|STARTED|Overall Study||40
467361|NCT01204918|1144682|P2|STARTED|Overall Study||39
467362|NCT01204918|1144683|P1|STARTED|Overall Study||25
467363|NCT01204853|1144700|P1|NOT COMPLETED|Overall Study||0
467364|NCT01204853|1144700|P1|COMPLETED|Overall Study||2
467365|NCT01204853|1144700|P1|STARTED|Overall Study||2
467366|NCT01204788|1144712|P2|NOT COMPLETED|Overall Study||3
467367|NCT01204788|1144713|P1|NOT COMPLETED|Overall Study||1
467368|NCT01204788|1144712|P2|COMPLETED|Overall Study||0
467369|NCT01204788|1144713|P1|COMPLETED|Overall Study||0
467370|NCT01204788|1144712|P2|STARTED|Overall Study||3
467371|NCT01204788|1144713|P1|STARTED|Overall Study||1
467372|NCT01204775|1144721|P2|NOT COMPLETED|Overall Study||1
467373|NCT01204775|1144722|P1|NOT COMPLETED|Overall Study||1
467374|NCT01204775|1144721|P2|COMPLETED|Overall Study||3
467375|NCT01204775|1144722|P1|COMPLETED|Overall Study||3
467376|NCT01204775|1144721|P2|Double-blind Treatment Period|Overall Study||4
467377|NCT01204775|1144722|P1|Double-blind Treatment Period|Overall Study||4
467378|NCT01204775|1144721|P2|STARTED|Overall Study||4
467379|NCT01204775|1144722|P1|STARTED|Overall Study||4
467380|NCT01204736|1144732|P4|NOT COMPLETED|Overall Study||0
467381|NCT01204736|1144733|P3|NOT COMPLETED|Overall Study||0
467382|NCT01204736|1144734|P2|NOT COMPLETED|Overall Study||0
467383|NCT01204736|1144735|P1|NOT COMPLETED|Overall Study||0
467384|NCT01204736|1144732|P4|COMPLETED|Overall Study||2
467385|NCT01204736|1144733|P3|COMPLETED|Overall Study||3
467386|NCT01204736|1144734|P2|COMPLETED|Overall Study||5
467387|NCT01204736|1144735|P1|COMPLETED|Overall Study||4
467388|NCT01204736|1144732|P4|STARTED|Overall Study||2
467389|NCT01204736|1144733|P3|STARTED|Overall Study||3
467390|NCT01204736|1144734|P2|STARTED|Overall Study||5
467391|NCT01204736|1144735|P1|STARTED|Overall Study||4
467392|NCT01204697|1144747|P2|NOT COMPLETED|Overall Study||36
467393|NCT01204697|1144748|P1|NOT COMPLETED|Overall Study||31
467394|NCT01204697|1144747|P2|COMPLETED|Overall Study||2
467395|NCT01204697|1144748|P1|COMPLETED|Overall Study||5
467396|NCT01204697|1144747|P2|Treated|Overall Study||37
467397|NCT01204697|1144748|P1|Treated|Overall Study||36
467398|NCT01204697|1144747|P2|STARTED|Overall Study||38
467399|NCT01204697|1144748|P1|STARTED|Overall Study||36
467400|NCT01204671|1144769|P5|NOT COMPLETED|Overall Study||4
467401|NCT01204671|1144770|P4|NOT COMPLETED|Overall Study||13
467402|NCT01204671|1144771|P3|NOT COMPLETED|Overall Study||13
467403|NCT01204671|1144772|P2|NOT COMPLETED|Overall Study||15
467404|NCT01204671|1144773|P1|NOT COMPLETED|Overall Study||14
467405|NCT01204671|1144769|P5|COMPLETED|Overall Study||606
467406|NCT01204671|1144770|P4|COMPLETED|Overall Study||997
467407|NCT01204671|1144771|P3|COMPLETED|Overall Study||998
467408|NCT01204671|1144772|P2|COMPLETED|Overall Study||998
467409|NCT01204671|1144773|P1|COMPLETED|Overall Study||998
467410|NCT01204671|1144769|P5|STARTED|Overall Study||610
467411|NCT01204671|1144770|P4|STARTED|Overall Study||1010
467412|NCT01204671|1144771|P3|STARTED|Overall Study||1011
467413|NCT01204671|1144772|P2|STARTED|Overall Study||1013
467414|NCT01204671|1144773|P1|STARTED|Overall Study||1012
467415|NCT01204658|1144835|P4|NOT COMPLETED|Booster Phase||0
467416|NCT01204658|1144836|P3|NOT COMPLETED|Booster Phase||0
467417|NCT01204658|1144837|P2|NOT COMPLETED|Booster Phase||0
467418|NCT01204658|1144838|P1|NOT COMPLETED|Booster Phase||0
467419|NCT01204658|1144835|P4|COMPLETED|Booster Phase||140
467420|NCT01204658|1144836|P3|COMPLETED|Booster Phase||140
467421|NCT01204658|1144837|P2|COMPLETED|Booster Phase||140
467422|NCT01204658|1144838|P1|COMPLETED|Booster Phase||144
467423|NCT01204658|1144835|P4|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
467424|NCT01204658|1144836|P3|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
467425|NCT01204658|1144837|P2|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
467426|NCT01204658|1144838|P1|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|144
467427|NCT01204658|1144835|P4|NOT COMPLETED|Primary Phase||0
467428|NCT01204658|1144836|P3|NOT COMPLETED|Primary Phase||1
467429|NCT01204658|1144837|P2|NOT COMPLETED|Primary Phase||0
467430|NCT01204658|1144838|P1|NOT COMPLETED|Primary Phase||0
467431|NCT01204658|1144835|P4|COMPLETED|Primary Phase||142
467432|NCT01204658|1144836|P3|COMPLETED|Primary Phase||144
467433|NCT01204658|1144837|P2|COMPLETED|Primary Phase||142
467434|NCT01204658|1144838|P1|COMPLETED|Primary Phase||146
467435|NCT01204658|1144835|P4|STARTED|Primary Phase||142
467436|NCT01204658|1144836|P3|STARTED|Primary Phase||145
467437|NCT01204658|1144837|P2|STARTED|Primary Phase||142
467438|NCT01204658|1144838|P1|STARTED|Primary Phase||146
467439|NCT01204398|1144948|P1|NOT COMPLETED|Overall Study||1
467440|NCT01204398|1144948|P1|COMPLETED|Overall Study|Completed trial medication.|26
467441|NCT01204398|1144948|P1|STARTED|Overall Study|Entered and treated.|27
467442|NCT01204294|1144965|P7|NOT COMPLETED|Overall Study||2
467443|NCT01204294|1144966|P6|NOT COMPLETED|Overall Study||5
467444|NCT01204294|1144967|P5|NOT COMPLETED|Overall Study||2
467445|NCT01204294|1144968|P4|NOT COMPLETED|Overall Study||11
467446|NCT01204294|1144969|P3|NOT COMPLETED|Overall Study||5
467447|NCT01204294|1144970|P2|NOT COMPLETED|Overall Study||8
467448|NCT01204294|1144971|P1|NOT COMPLETED|Overall Study||3
467449|NCT01204294|1144965|P7|COMPLETED|Overall Study||59
467450|NCT01204294|1144966|P6|COMPLETED|Overall Study||58
467451|NCT01204294|1144967|P5|COMPLETED|Overall Study||83
467452|NCT01204294|1144968|P4|COMPLETED|Overall Study||132
467453|NCT01204294|1144969|P3|COMPLETED|Overall Study||69
467454|NCT01204294|1144970|P2|COMPLETED|Overall Study||58
467455|NCT01204294|1144971|P1|COMPLETED|Overall Study||79
467456|NCT01204294|1144965|P7|STARTED|Overall Study||61
467457|NCT01204294|1144966|P6|STARTED|Overall Study||63
467458|NCT01204294|1144967|P5|STARTED|Overall Study||85
467459|NCT01204294|1144968|P4|STARTED|Overall Study||143
467460|NCT01204294|1144969|P3|STARTED|Overall Study||74
467461|NCT01204294|1144970|P2|STARTED|Overall Study||66
467462|NCT01204294|1144971|P1|STARTED|Overall Study||82
467463|NCT01204255|1144994|P1|NOT COMPLETED|Overall Study||1
467464|NCT01204255|1144994|P1|COMPLETED|Overall Study||10
467465|NCT01204255|1144994|P1|STARTED|Overall Study||11
467466|NCT01204203|1144999|P1|NOT COMPLETED|Overall Study||0
467467|NCT01204203|1144999|P1|COMPLETED|Overall Study||8
467468|NCT01204203|1144999|P1|STARTED|Overall Study||8
467469|NCT01203956|1145005|P2|NOT COMPLETED|Second Two-week Period||6
467470|NCT01203956|1145006|P1|NOT COMPLETED|Second Two-week Period||5
467471|NCT01203956|1145005|P2|COMPLETED|Second Two-week Period|Completed with evaluable results, as assessed over both two-week study periods.|7
467472|NCT01203956|1145006|P1|COMPLETED|Second Two-week Period|Completed with evaluable results, as assessed over both two-week study periods.|10
467473|NCT01203956|1145005|P2|Attended Sleep Studies for 14 Nights|Second Two-week Period||13
467474|NCT01203956|1145006|P1|Attended Sleep Studies for 14 Nights|Second Two-week Period||15
467475|NCT01203956|1145005|P2|STARTED|Second Two-week Period||13
467476|NCT01203956|1145006|P1|STARTED|Second Two-week Period||15
467477|NCT01203956|1145005|P2|NOT COMPLETED|First Two-week Period||0
467478|NCT01203956|1145006|P1|NOT COMPLETED|First Two-week Period||0
467479|NCT01203956|1145005|P2|COMPLETED|First Two-week Period|All participants continued to the second two-week period, whether or not they had evaluable results.|13
467480|NCT01203956|1145006|P1|COMPLETED|First Two-week Period|All participants continued to the second two-week period, whether or not they had evaluable results.|15
467481|NCT01203956|1145005|P2|STARTED|First Two-week Period||13
467482|NCT01203956|1145006|P1|STARTED|First Two-week Period||15
467483|NCT01203930|1145015|P2|NOT COMPLETED|Overall Study||41
467484|NCT01203930|1145016|P1|NOT COMPLETED|Overall Study||21
467485|NCT01203930|1145015|P2|COMPLETED|Overall Study||0
467486|NCT01203930|1145016|P1|COMPLETED|Overall Study|43 participants completed 12 cycles and were then eligible to enroll in the extension study (101-99)|43
467487|NCT01203930|1145015|P2|STARTED|Overall Study||41
467488|NCT01203930|1145016|P1|STARTED|Overall Study||64
467489|NCT01203917|1145038|P1|NOT COMPLETED|Overall Study||36
467490|NCT01203917|1145038|P1|COMPLETED|Overall Study|Patients on-going study at data cut-off(of which 49 were still on study treatment).|71
467491|NCT01203917|1145038|P1|STARTED|Overall Study|106 patients were EGFR M+ patients and 1 patient was EGFR M+I|107
467492|NCT01203878|1145051|P3|NOT COMPLETED|Overall Study||3
467493|NCT01203878|1145052|P2|NOT COMPLETED|Overall Study||0
467494|NCT01203878|1145053|P1|NOT COMPLETED|Overall Study||0
467495|NCT01203878|1145051|P3|COMPLETED|Overall Study||0
467496|NCT01203878|1145052|P2|COMPLETED|Overall Study||9
467497|NCT01203878|1145053|P1|COMPLETED|Overall Study||9
467498|NCT01203878|1145051|P3|STARTED|Overall Study||3
467499|NCT01203878|1145052|P2|STARTED|Overall Study||9
467500|NCT01203878|1145053|P1|STARTED|Overall Study||9
467501|NCT01203852|1145064|P1|NOT COMPLETED|Chlorthalidone 8 Weeks||0
467502|NCT01203852|1145064|P1|COMPLETED|Chlorthalidone 8 Weeks||328
467503|NCT01203852|1145064|P1|Continued From Metoprolol|Chlorthalidone 8 Weeks||282
467504|NCT01203852|1145064|P1|STARTED|Chlorthalidone 8 Weeks|Subjects were allowed to enter the study at Chlorthalidone without completing Metoprolol.|328
467505|NCT01203852|1145064|P1|NOT COMPLETED|Washout 2 Weeks||46
467506|NCT01203852|1145064|P1|COMPLETED|Washout 2 Weeks||282
467507|NCT01203852|1145064|P1|STARTED|Washout 2 Weeks|Some study subjects did not proceed to the washout phase after the first intervention.|328
467508|NCT01203852|1145064|P1|NOT COMPLETED|Metoprolol 8 Weeks||470
467509|NCT01203852|1145064|P1|COMPLETED|Metoprolol 8 Weeks||369
467510|NCT01203852|1145064|P1|STARTED|Metoprolol 8 Weeks|This is the total number of subjects for both groups.|839
467511|NCT01203826|1145073|P2|NOT COMPLETED|Overall Study||0
467512|NCT01203826|1145074|P1|NOT COMPLETED|Overall Study||0
467513|NCT01203826|1145073|P2|COMPLETED|Overall Study||6
467514|NCT01203826|1145074|P1|COMPLETED|Overall Study||6
467515|NCT01203826|1145073|P2|STARTED|Overall Study|Dose cohorts are per assigned dose in ENB-006-09. Results presented are for Study ENB-008-10 only.|6
467516|NCT01203826|1145074|P1|STARTED|Overall Study|Dose cohorts are per assigned dose in ENB-006-09. Results presented are for Study ENB-008-10 only.|6
467517|NCT01203787|1145082|P2|NOT COMPLETED|Overall Study||27
467518|NCT01203787|1145083|P1|NOT COMPLETED|Overall Study||31
467519|NCT01203787|1145082|P2|COMPLETED|Overall Study||30
467520|NCT01203787|1145083|P1|COMPLETED|Overall Study||32
467521|NCT01203787|1145082|P2|STARTED|Overall Study||57
467522|NCT01203787|1145083|P1|STARTED|Overall Study||63
467523|NCT01203644|1145103|P2|NOT COMPLETED|Overall Study||0
467524|NCT01203644|1145104|P1|NOT COMPLETED|Overall Study||0
467525|NCT01203644|1145103|P2|COMPLETED|Overall Study||50
467526|NCT01203644|1145104|P1|COMPLETED|Overall Study||26
467527|NCT01203644|1145103|P2|STARTED|Overall Study||50
467528|NCT01203644|1145104|P1|STARTED|Overall Study||26
467529|NCT01203319|1145116|P3|NOT COMPLETED|Overall Study||5
467530|NCT01203319|1145117|P2|NOT COMPLETED|Overall Study||9
467531|NCT01203319|1145118|P1|NOT COMPLETED|Overall Study||6
467532|NCT01203319|1145116|P3|COMPLETED|Overall Study||217
467533|NCT01203319|1145117|P2|COMPLETED|Overall Study||426
467534|NCT01203319|1145118|P1|COMPLETED|Overall Study||428
467535|NCT01203319|1145116|P3|STARTED|Overall Study||222
467536|NCT01203319|1145117|P2|STARTED|Overall Study||435
467537|NCT01203319|1145118|P1|STARTED|Overall Study||434
467538|NCT01203189|1145135|P3|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
467539|NCT01203189|1145136|P2|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
467540|NCT01203189|1145137|P1|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
467541|NCT01203189|1145135|P3|COMPLETED|Cross Over Period 4 Weeks Treatment||3
467542|NCT01203189|1145136|P2|COMPLETED|Cross Over Period 4 Weeks Treatment||0
467543|NCT01203189|1145137|P1|COMPLETED|Cross Over Period 4 Weeks Treatment||0
467544|NCT01203189|1145135|P3|STARTED|Cross Over Period 4 Weeks Treatment||3
467545|NCT01203189|1145136|P2|STARTED|Cross Over Period 4 Weeks Treatment||0
467546|NCT01203189|1145137|P1|STARTED|Cross Over Period 4 Weeks Treatment||0
467547|NCT01203189|1145135|P3|NOT COMPLETED|First 4 Weeks Treatment||0
467548|NCT01203189|1145136|P2|NOT COMPLETED|First 4 Weeks Treatment||2
467549|NCT01203189|1145137|P1|NOT COMPLETED|First 4 Weeks Treatment||2
467550|NCT01203189|1145135|P3|COMPLETED|First 4 Weeks Treatment||3
467551|NCT01203189|1145136|P2|COMPLETED|First 4 Weeks Treatment||8
467552|NCT01203189|1145137|P1|COMPLETED|First 4 Weeks Treatment||8
467553|NCT01203189|1145135|P3|STARTED|First 4 Weeks Treatment||3
467554|NCT01203189|1145136|P2|STARTED|First 4 Weeks Treatment||10
467555|NCT01203189|1145137|P1|STARTED|First 4 Weeks Treatment||10
467556|NCT01203098|1145154|P3|NOT COMPLETED|Overall Study||11
467557|NCT01203098|1145155|P2|NOT COMPLETED|Overall Study||4
467558|NCT01203098|1145156|P1|NOT COMPLETED|Overall Study||6
467559|NCT01203098|1145154|P3|COMPLETED|Overall Study||78
467560|NCT01203098|1145155|P2|COMPLETED|Overall Study||82
467561|NCT01203098|1145156|P1|COMPLETED|Overall Study||83
467562|NCT01203098|1145154|P3|Safety Analysis Dataset|Overall Study||87
467563|NCT01203098|1145155|P2|Safety Analysis Dataset|Overall Study||85
467564|NCT01203098|1145156|P1|Safety Analysis Dataset|Overall Study||89
467565|NCT01203098|1145154|P3|STARTED|Overall Study||89
467566|NCT01203098|1145155|P2|STARTED|Overall Study||86
467567|NCT01203098|1145156|P1|STARTED|Overall Study||89
467568|NCT01203072|1145172|P5|NOT COMPLETED|Overall Study||6
467569|NCT01203072|1145173|P4|NOT COMPLETED|Overall Study||6
467570|NCT01203072|1145174|P3|NOT COMPLETED|Overall Study||3
467571|NCT01203072|1145175|P2|NOT COMPLETED|Overall Study||6
467572|NCT01203072|1145176|P1|NOT COMPLETED|Overall Study||10
467573|NCT01203072|1145172|P5|COMPLETED|Overall Study||96
467574|NCT01203072|1145173|P4|COMPLETED|Overall Study||100
467575|NCT01203072|1145174|P3|COMPLETED|Overall Study||101
467576|NCT01203072|1145175|P2|COMPLETED|Overall Study||100
467577|NCT01203072|1145176|P1|COMPLETED|Overall Study||95
467578|NCT01203072|1145172|P5|STARTED|Overall Study||102
467579|NCT01203072|1145173|P4|STARTED|Overall Study||106
467580|NCT01203072|1145174|P3|STARTED|Overall Study||104
467581|NCT01203072|1145175|P2|STARTED|Overall Study||106
467582|NCT01203072|1145176|P1|STARTED|Overall Study||105
467583|NCT01203046|1145195|P2|NOT COMPLETED|Overall Study||0
467584|NCT01203046|1145196|P1|NOT COMPLETED|Overall Study||0
467585|NCT01203046|1145195|P2|COMPLETED|Overall Study||28
467586|NCT01203046|1145196|P1|COMPLETED|Overall Study||28
467587|NCT01203046|1145195|P2|STARTED|Overall Study||28
467588|NCT01203046|1145196|P1|STARTED|Overall Study||28
467589|NCT01202994|1145204|P1|NOT COMPLETED|Overall Study||0
467590|NCT01202994|1145204|P1|COMPLETED|Overall Study||27
467591|NCT01202994|1145204|P1|STARTED|Overall Study||27
467592|NCT01202955|1145211|P2|NOT COMPLETED|Period 3: 10 Days||0
467593|NCT01202955|1145212|P1|NOT COMPLETED|Period 3: 10 Days||0
467594|NCT01202955|1145211|P2|COMPLETED|Period 3: 10 Days||8
467595|NCT01202955|1145212|P1|COMPLETED|Period 3: 10 Days||9
467596|NCT01202955|1145211|P2|STARTED|Period 3: 10 Days||8
467597|NCT01202955|1145212|P1|STARTED|Period 3: 10 Days||9
467598|NCT01202955|1145211|P2|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0
467599|NCT01202955|1145212|P1|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0
467600|NCT01202955|1145211|P2|COMPLETED|Period 2: 7 Days (Wash-Out)||8
467601|NCT01202955|1145212|P1|COMPLETED|Period 2: 7 Days (Wash-Out)||9
467602|NCT01202955|1145211|P2|STARTED|Period 2: 7 Days (Wash-Out)||8
467603|NCT01202955|1145212|P1|STARTED|Period 2: 7 Days (Wash-Out)||9
467604|NCT01202955|1145211|P2|NOT COMPLETED|Period 1: 10 Days||2
467605|NCT01202955|1145212|P1|NOT COMPLETED|Period 1: 10 Days||0
467606|NCT01202955|1145211|P2|COMPLETED|Period 1: 10 Days||8
467607|NCT01202955|1145212|P1|COMPLETED|Period 1: 10 Days||9
467608|NCT01202955|1145211|P2|STARTED|Period 1: 10 Days||10
467609|NCT01202955|1145212|P1|STARTED|Period 1: 10 Days||9
467610|NCT01202903|1145224|P2|NOT COMPLETED|Overall Study||16
467611|NCT01202903|1145225|P1|NOT COMPLETED|Overall Study||11
467612|NCT01202903|1145224|P2|COMPLETED|Overall Study||292
467613|NCT01202903|1145225|P1|COMPLETED|Overall Study||297
467614|NCT01202903|1145224|P2|Safety Set*|Overall Study||299
467615|NCT01202903|1145225|P1|Safety Set*|Overall Study||310
467616|NCT01202903|1145224|P2|Full Analysis Set|Overall Study||302
467617|NCT01202903|1145225|P1|Full Analysis Set|Overall Study||306
467618|NCT01202903|1145224|P2|STARTED|Overall Study||308
467619|NCT01202903|1145225|P1|STARTED|Overall Study||308
467620|NCT01202877|1145252|P3|NOT COMPLETED|Overall Study||6
467621|NCT01202877|1145253|P2|NOT COMPLETED|Overall Study||1
467622|NCT01202877|1145254|P1|NOT COMPLETED|Overall Study||0
467623|NCT01202877|1145252|P3|COMPLETED|Overall Study||34
467624|NCT01202877|1145253|P2|COMPLETED|Overall Study||7
467625|NCT01202877|1145254|P1|COMPLETED|Overall Study||6
467626|NCT01202877|1145252|P3|STARTED|Overall Study||40
467627|NCT01202877|1145253|P2|STARTED|Overall Study||8
467628|NCT01202877|1145254|P1|STARTED|Overall Study||6
467629|NCT01202773|1145266|P3|NOT COMPLETED|Overall Study||55
467630|NCT01202773|1145267|P2|NOT COMPLETED|Overall Study||43
467631|NCT01202773|1145268|P1|NOT COMPLETED|Overall Study||57
467632|NCT01202773|1145266|P3|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|100
467633|NCT01202773|1145267|P2|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|105
467634|NCT01202773|1145268|P1|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|96
467635|NCT01202773|1145266|P3|Post-Treatment Follow-Up Population|Overall Study||51
467636|NCT01202773|1145267|P2|Post-Treatment Follow-Up Population|Overall Study||36
467637|NCT01202773|1145268|P1|Post-Treatment Follow-Up Population|Overall Study||46
467638|NCT01202773|1145266|P3|Week 16 NR|Overall Study||37
467639|NCT01202773|1145267|P2|Week 16 NR|Overall Study||33
467640|NCT01202773|1145268|P1|Week 16 NR|Overall Study||23
467641|NCT01202773|1145266|P3|Received at Least 1 Dose of Study Drug|Overall Study||154
467642|NCT01202773|1145267|P2|Received at Least 1 Dose of Study Drug|Overall Study||147
467643|NCT01202773|1145268|P1|Received at Least 1 Dose of Study Drug|Overall Study||153
467644|NCT01202773|1145266|P3|STARTED|Overall Study||155
467645|NCT01202773|1145267|P2|STARTED|Overall Study||148
467646|NCT01202773|1145268|P1|STARTED|Overall Study||153
467647|NCT01202760|1145345|P3|NOT COMPLETED|Overall Study||35
467648|NCT01202760|1145346|P2|NOT COMPLETED|Overall Study||52
467649|NCT01202760|1145347|P1|NOT COMPLETED|Overall Study||47
467650|NCT01202760|1145345|P3|COMPLETED|Overall Study||216
467651|NCT01202760|1145346|P2|COMPLETED|Overall Study||322
467652|NCT01202760|1145347|P1|COMPLETED|Overall Study||332
467653|NCT01202760|1145345|P3|Received at Least One Dose of Study Drug|Overall Study||250
467654|NCT01202760|1145346|P2|Received at Least One Dose of Study Drug|Overall Study||371
467655|NCT01202760|1145347|P1|Received at Least One Dose of Study Drug|Overall Study||379
467656|NCT01202760|1145345|P3|STARTED|Overall Study||251
467657|NCT01202760|1145346|P2|STARTED|Overall Study||374
467658|NCT01202760|1145347|P1|STARTED|Overall Study||379
467659|NCT01202747|1145415|P1|NOT COMPLETED|Overall Study||1
467660|NCT01202747|1145415|P1|COMPLETED|Overall Study|One subject did not return for the 4 Week visit due to inconvenience.|49
467661|NCT01202747|1145415|P1|STARTED|Overall Study||50
467662|NCT01202656|1145421|P2|NOT COMPLETED|CrossoverCycle||0
467663|NCT01202656|1145422|P1|NOT COMPLETED|CrossoverCycle||0
467664|NCT01202656|1145421|P2|COMPLETED|CrossoverCycle||14
467665|NCT01202656|1145422|P1|COMPLETED|CrossoverCycle||18
467666|NCT01202656|1145421|P2|STARTED|CrossoverCycle|14 ongoing pregnancies were not eligible for crossover, others chose to not have another IVF cycle|14
467667|NCT01202656|1145422|P1|STARTED|CrossoverCycle|16 ongoing pregnancies were not eligible for crossover, others chose to not have another IVF cycle|18
467668|NCT01202656|1145421|P2|NOT COMPLETED|Cycle 1||0
467669|NCT01202656|1145422|P1|NOT COMPLETED|Cycle 1||0
467670|NCT01202656|1145421|P2|COMPLETED|Cycle 1||62
467671|NCT01202656|1145422|P1|COMPLETED|Cycle 1||67
467672|NCT01202656|1145421|P2|STARTED|Cycle 1|Results reported In Barad et al 2014 are combined from both G-CSF studies|62
467673|NCT01202656|1145422|P1|STARTED|Cycle 1|Results reported In Barad et al 2014 are combined from both G-CSF studies|67
467674|NCT01202643|1145432|P2|NOT COMPLETED|Crossover Cycle||0
467675|NCT01202643|1145433|P1|NOT COMPLETED|Crossover Cycle||0
467676|NCT01202643|1145432|P2|COMPLETED|Crossover Cycle||2
467677|NCT01202643|1145433|P1|COMPLETED|Crossover Cycle||1
467678|NCT01202643|1145432|P2|STARTED|Crossover Cycle|Three patients became pregnant after Period 1, 1 patient chose not to cycle again|2
467679|NCT01202643|1145433|P1|STARTED|Crossover Cycle|On patient became pregnant following Period 1, Only one non-pregnant chose to cycle again|1
467680|NCT01202643|1145432|P2|NOT COMPLETED|Period 1||0
467681|NCT01202643|1145433|P1|NOT COMPLETED|Period 1||0
467682|NCT01202643|1145432|P2|COMPLETED|Period 1||6
467683|NCT01202643|1145433|P1|COMPLETED|Period 1||6
467684|NCT01202643|1145432|P2|STARTED|Period 1||6
467685|NCT01202643|1145433|P1|STARTED|Period 1||6
467686|NCT01202591|1145447|P6|NOT COMPLETED|Overall Study||4
467687|NCT01202591|1145448|P5|NOT COMPLETED|Overall Study||5
467688|NCT01202591|1145449|P4|NOT COMPLETED|Overall Study||7
467689|NCT01202591|1145450|P3|NOT COMPLETED|Overall Study||11
467690|NCT01202591|1145451|P2|NOT COMPLETED|Overall Study||5
467691|NCT01202591|1145452|P1|NOT COMPLETED|Overall Study||5
467692|NCT01202591|1145447|P6|COMPLETED|Overall Study||0
467693|NCT01202591|1145448|P5|COMPLETED|Overall Study||0
467694|NCT01202591|1145449|P4|COMPLETED|Overall Study||2
467695|NCT01202591|1145450|P3|COMPLETED|Overall Study||1
467696|NCT01202591|1145451|P2|COMPLETED|Overall Study||0
467697|NCT01202591|1145452|P1|COMPLETED|Overall Study||0
467698|NCT01202591|1145447|P6|STARTED|Overall Study||4
467699|NCT01202591|1145448|P5|STARTED|Overall Study||5
467700|NCT01202591|1145449|P4|STARTED|Overall Study||9
467701|NCT01202591|1145450|P3|STARTED|Overall Study||12
467702|NCT01202591|1145451|P2|STARTED|Overall Study||5
467703|NCT01202591|1145452|P1|STARTED|Overall Study||5
467704|NCT01202578|1145466|P1|NOT COMPLETED|Overall Study||0
467705|NCT01202578|1145466|P1|COMPLETED|Overall Study||53
467706|NCT01202578|1145466|P1|STARTED|Overall Study||53
467707|NCT01202565|1145473|P1|NOT COMPLETED|Overall Study||67
467708|NCT01202565|1145473|P1|COMPLETED|Overall Study|Indicates participants who completed the Month 12 visit|439
467709|NCT01202565|1145473|P1|Full Analysis Set|Overall Study|Participants with a signed informed consent and any available data regarding adalimumab treatment.|501
467710|NCT01202565|1145473|P1|STARTED|Overall Study||506
467711|NCT01202279|1145498|P2|NOT COMPLETED|Overall Study||27
467712|NCT01202279|1145499|P1|NOT COMPLETED|Overall Study||37
467713|NCT01202279|1145498|P2|COMPLETED|Overall Study||561
467714|NCT01202279|1145499|P1|COMPLETED|Overall Study||554
467715|NCT01202279|1145498|P2|STARTED|Overall Study||588
467716|NCT01202279|1145499|P1|STARTED|Overall Study||591
467717|NCT01202253|1145507|P1|NOT COMPLETED|Overall Study||0
467718|NCT01202253|1145507|P1|COMPLETED|Overall Study||50
467719|NCT01202253|1145507|P1|STARTED|Overall Study||50
467720|NCT01202227|1145551|P1|NOT COMPLETED|Overall Study||19
467721|NCT01202227|1145551|P1|COMPLETED|Overall Study||84
467722|NCT01202227|1145551|P1|STARTED|Overall Study|Treated|103
467723|NCT01202188|1145575|P5|NOT COMPLETED|Overall Study||45
467724|NCT01202188|1145576|P4|NOT COMPLETED|Overall Study||42
467725|NCT01202188|1145577|P3|NOT COMPLETED|Overall Study||53
467726|NCT01202188|1145578|P2|NOT COMPLETED|Overall Study||56
467727|NCT01202188|1145579|P1|NOT COMPLETED|Overall Study||38
467728|NCT01202188|1145575|P5|COMPLETED|Overall Study||189
467729|NCT01202188|1145576|P4|COMPLETED|Overall Study||441
467730|NCT01202188|1145577|P3|COMPLETED|Overall Study||422
467731|NCT01202188|1145578|P2|COMPLETED|Overall Study||421
467732|NCT01202188|1145579|P1|COMPLETED|Overall Study||437
467733|NCT01202188|1145575|P5|Safety Set; Received Study Drug|Overall Study||232
467734|NCT01202188|1145576|P4|Safety Set; Received Study Drug|Overall Study||480
467735|NCT01202188|1145577|P3|Safety Set; Received Study Drug|Overall Study||473
467736|NCT01202188|1145578|P2|Safety Set; Received Study Drug|Overall Study||476
467737|NCT01202188|1145579|P1|Safety Set; Received Study Drug|Overall Study||474
467738|NCT01202188|1145575|P5|STARTED|Overall Study||234
467739|NCT01202188|1145576|P4|STARTED|Overall Study||483
467740|NCT01202188|1145577|P3|STARTED|Overall Study||475
467741|NCT01202188|1145578|P2|STARTED|Overall Study||477
467742|NCT01202188|1145579|P1|STARTED|Overall Study||475
467743|NCT01202162|1145687|P2|NOT COMPLETED|Overall Study||2
467744|NCT01202162|1145688|P1|NOT COMPLETED|Overall Study||3
467745|NCT01202162|1145687|P2|COMPLETED|Overall Study|40 completed the intraoperative through discharge phase of the study.|40
467746|NCT01202162|1145688|P1|COMPLETED|Overall Study|40 completed the intraoperative through discharge phase of the study.|40
467747|NCT01202162|1145687|P2|STARTED|Overall Study||42
467748|NCT01202162|1145688|P1|STARTED|Overall Study||43
467749|NCT01202110|1145698|P2|NOT COMPLETED|Overall Study||0
467750|NCT01202110|1145699|P1|NOT COMPLETED|Overall Study||0
467751|NCT01202110|1145698|P2|COMPLETED|Overall Study||0
467752|NCT01202110|1145699|P1|COMPLETED|Overall Study||10
467753|NCT01202110|1145698|P2|STARTED|Overall Study||0
467754|NCT01202110|1145699|P1|STARTED|Overall Study||10
467755|NCT01202071|1145703|P4|NOT COMPLETED|Overall Study||0
467756|NCT01202071|1145704|P3|NOT COMPLETED|Overall Study||0
467757|NCT01202071|1145705|P2|NOT COMPLETED|Overall Study||0
467758|NCT01202071|1145706|P1|NOT COMPLETED|Overall Study||0
467759|NCT01202071|1145703|P4|COMPLETED|Overall Study||6
467760|NCT01202071|1145704|P3|COMPLETED|Overall Study||6
467761|NCT01202071|1145705|P2|COMPLETED|Overall Study||6
467762|NCT01202071|1145706|P1|COMPLETED|Overall Study||6
467763|NCT01202071|1145703|P4|STARTED|Overall Study||6
467764|NCT01202071|1145704|P3|STARTED|Overall Study||6
467765|NCT01202071|1145705|P2|STARTED|Overall Study||6
467766|NCT01202071|1145706|P1|STARTED|Overall Study||6
467767|NCT01201967|1145726|P2|NOT COMPLETED|Overall Study||5
467768|NCT01201967|1145727|P1|NOT COMPLETED|Overall Study||6
467769|NCT01201967|1145726|P2|COMPLETED|Overall Study||86
467770|NCT01201967|1145727|P1|COMPLETED|Overall Study||86
467771|NCT01201967|1145726|P2|STARTED|Overall Study||91
467772|NCT01201967|1145727|P1|STARTED|Overall Study||92
467773|NCT01201915|1145752|P3|NOT COMPLETED|Overall Study||6
467774|NCT01201915|1145753|P2|NOT COMPLETED|Overall Study||11
467775|NCT01201915|1145754|P1|NOT COMPLETED|Overall Study||8
467776|NCT01201915|1145752|P3|COMPLETED|Overall Study||19
467777|NCT01201915|1145753|P2|COMPLETED|Overall Study||14
467778|NCT01201915|1145754|P1|COMPLETED|Overall Study||16
467779|NCT01201915|1145752|P3|STARTED|Overall Study||25
467780|NCT01201915|1145753|P2|STARTED|Overall Study||25
467781|NCT01201915|1145754|P1|STARTED|Overall Study||24
467782|NCT01201811|1145765|P1|NOT COMPLETED|Overall Study||19
467783|NCT01201811|1145765|P1|COMPLETED|Overall Study||25
467784|NCT01201811|1145765|P1|STARTED|Overall Study||44
467785|NCT01201798|1145787|P2|NOT COMPLETED|Overall Study||15
467786|NCT01201798|1145788|P1|NOT COMPLETED|Overall Study||9
467787|NCT01201798|1145787|P2|COMPLETED|Overall Study||39
467788|NCT01201798|1145788|P1|COMPLETED|Overall Study||47
467789|NCT01201798|1145787|P2|STARTED|Overall Study||54
467790|NCT01201798|1145788|P1|STARTED|Overall Study||56
467791|NCT01201785|1145812|P1|NOT COMPLETED|Overall Study||16
467792|NCT01201785|1145812|P1|COMPLETED|Overall Study||20
467793|NCT01201785|1145812|P1|STARTED|Overall Study||36
467794|NCT01201772|1145819|P3|NOT COMPLETED|Overall Study||0
467795|NCT01201772|1145820|P2|NOT COMPLETED|Overall Study||0
467796|NCT01201772|1145821|P1|NOT COMPLETED|Overall Study||1
467797|NCT01201772|1145819|P3|COMPLETED|Overall Study||21
467798|NCT01201772|1145820|P2|COMPLETED|Overall Study||21
467799|NCT01201772|1145821|P1|COMPLETED|Overall Study||22
467800|NCT01201772|1145819|P3|STARTED|Overall Study||21
467801|NCT01201772|1145820|P2|STARTED|Overall Study||21
467802|NCT01201772|1145821|P1|STARTED|Overall Study||23
467803|NCT01201759|1145829|P2|NOT COMPLETED|Visit 5||0
467804|NCT01201759|1145830|P1|NOT COMPLETED|Visit 5||0
467805|NCT01201759|1145829|P2|COMPLETED|Visit 5||3
467806|NCT01201759|1145830|P1|COMPLETED|Visit 5||7
467807|NCT01201759|1145829|P2|STARTED|Visit 5||3
467808|NCT01201759|1145830|P1|STARTED|Visit 5||7
467809|NCT01201759|1145829|P2|NOT COMPLETED|Visit 4 Crossover||1
467810|NCT01201759|1145830|P1|NOT COMPLETED|Visit 4 Crossover||0
467811|NCT01201759|1145829|P2|COMPLETED|Visit 4 Crossover||3
467812|NCT01201759|1145830|P1|COMPLETED|Visit 4 Crossover||7
467813|NCT01201759|1145829|P2|STARTED|Visit 4 Crossover||4
467814|NCT01201759|1145830|P1|STARTED|Visit 4 Crossover||7
467815|NCT01201759|1145829|P2|NOT COMPLETED|Visit 3 - Washout||3
467816|NCT01201759|1145830|P1|NOT COMPLETED|Visit 3 - Washout||1
467817|NCT01201759|1145829|P2|COMPLETED|Visit 3 - Washout||4
467818|NCT01201759|1145830|P1|COMPLETED|Visit 3 - Washout||7
467819|NCT01201759|1145829|P2|STARTED|Visit 3 - Washout||7
467820|NCT01201759|1145830|P1|STARTED|Visit 3 - Washout||8
467821|NCT01201759|1145829|P2|NOT COMPLETED|Visit 2||0
467822|NCT01201759|1145830|P1|NOT COMPLETED|Visit 2||0
467823|NCT01201759|1145829|P2|COMPLETED|Visit 2||7
467824|NCT01201759|1145830|P1|COMPLETED|Visit 2||8
467825|NCT01201759|1145829|P2|STARTED|Visit 2||7
467826|NCT01201759|1145830|P1|STARTED|Visit 2||8
467827|NCT01201759|1145829|P2|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||1
467828|NCT01201759|1145830|P1|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||2
467829|NCT01201759|1145829|P2|COMPLETED|Visit 1 Wash-in ( Untreated)||7
467830|NCT01201759|1145830|P1|COMPLETED|Visit 1 Wash-in ( Untreated)||8
467831|NCT01201759|1145829|P2|STARTED|Visit 1 Wash-in ( Untreated)||8
467832|NCT01201759|1145830|P1|STARTED|Visit 1 Wash-in ( Untreated)||10
467833|NCT01201629|1145844|P2|NOT COMPLETED|Overall Study||0
467834|NCT01201629|1145845|P1|NOT COMPLETED|Overall Study||0
467835|NCT01201629|1145844|P2|COMPLETED|Overall Study||8
467836|NCT01201629|1145845|P1|COMPLETED|Overall Study||8
467837|NCT01201629|1145844|P2|STARTED|Overall Study||8
467838|NCT01201629|1145845|P1|STARTED|Overall Study||8
467839|NCT01201486|1145855|P1|NOT COMPLETED|Overall Study||0
467840|NCT01201486|1145855|P1|COMPLETED|Overall Study||6781
467841|NCT01201486|1145855|P1|STARTED|Overall Study||6781
467842|NCT01201343|1145859|P1|NOT COMPLETED|Overall Study||19
467843|NCT01201343|1145859|P1|COMPLETED|Overall Study||60
467844|NCT01201343|1145859|P1|Treated|Overall Study||76
467845|NCT01201343|1145859|P1|STARTED|Overall Study||79
467846|NCT01201317|1145873|P3|NOT COMPLETED|Overall Study||8
467847|NCT01201317|1145874|P2|NOT COMPLETED|Overall Study||7
467848|NCT01201317|1145875|P1|NOT COMPLETED|Overall Study||9
467849|NCT01201317|1145873|P3|COMPLETED|Overall Study||33
467850|NCT01201317|1145874|P2|COMPLETED|Overall Study||38
467851|NCT01201317|1145875|P1|COMPLETED|Overall Study||39
467852|NCT01201317|1145873|P3|STARTED|Overall Study||41
467853|NCT01201317|1145874|P2|STARTED|Overall Study||45
467854|NCT01201317|1145875|P1|STARTED|Overall Study||48
467855|NCT01201265|1145895|P1|NOT COMPLETED|Overall Study||38
467856|NCT01201265|1145895|P1|COMPLETED|Overall Study||2
467857|NCT01201265|1145895|P1|STARTED|Overall Study||40
467858|NCT01200992|1145909|P2|NOT COMPLETED|Overall Study||41
467859|NCT01200992|1145910|P1|NOT COMPLETED|Overall Study||37
467860|NCT01200992|1145909|P2|COMPLETED|Overall Study||4
467861|NCT01200992|1145910|P1|COMPLETED|Overall Study||2
467862|NCT01200992|1145909|P2|STARTED|Overall Study||45
467863|NCT01200992|1145910|P1|STARTED|Overall Study||39
467864|NCT01200875|1145918|P1|NOT COMPLETED|Overall Study||0
467865|NCT01200875|1145918|P1|COMPLETED|Overall Study||25
467866|NCT01200875|1145918|P1|STARTED|Overall Study||25
467867|NCT01200810|1145924|P2|NOT COMPLETED|Overall Study||5
467868|NCT01200810|1145925|P1|NOT COMPLETED|Overall Study||5
467869|NCT01200810|1145924|P2|COMPLETED|Overall Study||0
467870|NCT01200810|1145925|P1|COMPLETED|Overall Study||0
467871|NCT01200810|1145924|P2|STARTED|Overall Study||5
467872|NCT01200810|1145925|P1|STARTED|Overall Study||5
467873|NCT01200797|1145945|P1|NOT COMPLETED|Overall Study||19
467874|NCT01200797|1145945|P1|COMPLETED|Overall Study||0
467875|NCT01200797|1145945|P1|STARTED|Overall Study||19
467876|NCT01200758|1145955|P4|NOT COMPLETED|Stage 2||50
467877|NCT01200758|1145956|P3|NOT COMPLETED|Stage 2||41
467878|NCT01200758|1145957|P2|NOT COMPLETED|Stage 2||0
467879|NCT01200758|1145958|P1|NOT COMPLETED|Stage 2||0
467880|NCT01200758|1145955|P4|COMPLETED|Stage 2|Participants completed treatment period.|92
467881|NCT01200758|1145956|P3|COMPLETED|Stage 2|Participants completed treatment period.|100
467882|NCT01200758|1145957|P2|COMPLETED|Stage 2||0
467883|NCT01200758|1145958|P1|COMPLETED|Stage 2||0
467884|NCT01200758|1145955|P4|STARTED|Stage 2||142
467885|NCT01200758|1145956|P3|STARTED|Stage 2||141
467886|NCT01200758|1145957|P2|STARTED|Stage 2|Different participants were randomized into different stages of the study.|0
467887|NCT01200758|1145958|P1|STARTED|Stage 2|Different participants were randomized into different stages of the study.|0
467888|NCT01200758|1145955|P4|NOT COMPLETED|Stage I||0
467889|NCT01200758|1145956|P3|NOT COMPLETED|Stage I||0
467890|NCT01200758|1145957|P2|NOT COMPLETED|Stage I||17
467891|NCT01200758|1145958|P1|NOT COMPLETED|Stage I||18
467892|NCT01200758|1145955|P4|COMPLETED|Stage I||0
467893|NCT01200758|1145956|P3|COMPLETED|Stage I||0
467894|NCT01200758|1145957|P2|COMPLETED|Stage I|Participants completed treatment period.|46
467895|NCT01200758|1145958|P1|COMPLETED|Stage I|Participants completed treatment period.|46
467896|NCT01200758|1145955|P4|STARTED|Stage I|Different participants were randomized into different stages of the study.|0
467897|NCT01200758|1145956|P3|STARTED|Stage I|Different participants were randomized into different stages of the study.|0
467898|NCT01200758|1145957|P2|STARTED|Stage I||63
467899|NCT01200758|1145958|P1|STARTED|Stage I||64
467900|NCT01200602|1146014|P2|NOT COMPLETED|Overall Study||0
467901|NCT01200602|1146015|P1|NOT COMPLETED|Overall Study||0
467902|NCT01200602|1146014|P2|COMPLETED|Overall Study||0
467903|NCT01200602|1146015|P1|COMPLETED|Overall Study||0
467904|NCT01200602|1146014|P2|STARTED|Overall Study||0
467905|NCT01200602|1146015|P1|STARTED|Overall Study||0
467906|NCT01200589|1146031|P2|NOT COMPLETED|Overall Study||189
467907|NCT01200589|1146032|P1|NOT COMPLETED|Overall Study||190
467908|NCT01200589|1146031|P2|COMPLETED|Overall Study||30
467909|NCT01200589|1146032|P1|COMPLETED|Overall Study||29
467910|NCT01200589|1146031|P2|Safety Set|Overall Study||218
467911|NCT01200589|1146032|P1|Safety Set|Overall Study||217
467912|NCT01200589|1146031|P2|Intent-to-treat (ITT) Analysis Set|Overall Study||219
467913|NCT01200589|1146032|P1|Intent-to-treat (ITT) Analysis Set|Overall Study||219
467914|NCT01200589|1146031|P2|STARTED|Overall Study||219
467915|NCT01200589|1146032|P1|STARTED|Overall Study||219
467916|NCT01200524|1146059|P3|NOT COMPLETED|Overall Study||4
467917|NCT01200524|1146060|P2|NOT COMPLETED|Overall Study||1
467918|NCT01200524|1146061|P1|NOT COMPLETED|Overall Study||2
467919|NCT01200524|1146059|P3|COMPLETED|Overall Study||40
467920|NCT01200524|1146060|P2|COMPLETED|Overall Study||47
467921|NCT01200524|1146061|P1|COMPLETED|Overall Study||39
467922|NCT01200524|1146059|P3|STARTED|Overall Study||44
467923|NCT01200524|1146060|P2|STARTED|Overall Study||48
467924|NCT01200524|1146061|P1|STARTED|Overall Study||41
467925|NCT01200511|1146081|P1|NOT COMPLETED|Overall Study||5
467926|NCT01200511|1146081|P1|COMPLETED|Overall Study||44
467927|NCT01200511|1146081|P1|STARTED|Overall Study||49
467928|NCT01200498|1146089|P1|NOT COMPLETED|Overall Study||0
467929|NCT01200498|1146089|P1|COMPLETED|Overall Study||22
467930|NCT01200498|1146089|P1|STARTED|Overall Study||22
467931|NCT01200433|1146095|P2|NOT COMPLETED|Overall Study||0
467932|NCT01200433|1146096|P1|NOT COMPLETED|Overall Study||0
467933|NCT01200433|1146095|P2|COMPLETED|Overall Study||23
467934|NCT01200433|1146096|P1|COMPLETED|Overall Study||21
467935|NCT01200433|1146095|P2|STARTED|Overall Study||23
467936|NCT01200433|1146096|P1|STARTED|Overall Study||21
467937|NCT01200368|1146119|P3|NOT COMPLETED|Toddler Dose||1
467938|NCT01200368|1146120|P2|NOT COMPLETED|Toddler Dose||3
467939|NCT01200368|1146121|P1|NOT COMPLETED|Toddler Dose||0
467940|NCT01200368|1146119|P3|COMPLETED|Toddler Dose||168
467941|NCT01200368|1146120|P2|COMPLETED|Toddler Dose||159
467942|NCT01200368|1146121|P1|COMPLETED|Toddler Dose||162
467943|NCT01200368|1146119|P3|STARTED|Toddler Dose||169
467944|NCT01200368|1146120|P2|STARTED|Toddler Dose||162
467945|NCT01200368|1146121|P1|STARTED|Toddler Dose||162
467946|NCT01200368|1146119|P3|NOT COMPLETED|After Infant Series||9
467947|NCT01200368|1146120|P2|NOT COMPLETED|After Infant Series||16
467948|NCT01200368|1146121|P1|NOT COMPLETED|After Infant Series||18
467949|NCT01200368|1146119|P3|COMPLETED|After Infant Series||169
467950|NCT01200368|1146120|P2|COMPLETED|After Infant Series||162
467951|NCT01200368|1146121|P1|COMPLETED|After Infant Series||162
467952|NCT01200368|1146119|P3|STARTED|After Infant Series||178
467953|NCT01200368|1146120|P2|STARTED|After Infant Series||178
467954|NCT01200368|1146121|P1|STARTED|After Infant Series||180
467955|NCT01200368|1146119|P3|NOT COMPLETED|Infant Series||6
467956|NCT01200368|1146120|P2|NOT COMPLETED|Infant Series||6
467957|NCT01200368|1146121|P1|NOT COMPLETED|Infant Series||3
467958|NCT01200368|1146119|P3|COMPLETED|Infant Series||178
467959|NCT01200368|1146120|P2|COMPLETED|Infant Series||178
467960|NCT01200368|1146121|P1|COMPLETED|Infant Series||180
467961|NCT01200368|1146119|P3|Vaccinated Dose 3|Infant Series||182
467962|NCT01200368|1146120|P2|Vaccinated Dose 3|Infant Series||178
467963|NCT01200368|1146121|P1|Vaccinated Dose 3|Infant Series||181
467964|NCT01200368|1146119|P3|Vaccinated Dose 2|Infant Series||183
467965|NCT01200368|1146120|P2|Vaccinated Dose 2|Infant Series||182
467966|NCT01200368|1146121|P1|Vaccinated Dose 2|Infant Series||183
467967|NCT01200368|1146119|P3|Vaccinated Dose 1|Infant Series||183
467968|NCT01200368|1146120|P2|Vaccinated Dose 1|Infant Series||183
467969|NCT01200368|1146121|P1|Vaccinated Dose 1|Infant Series||183
467970|NCT01200368|1146119|P3|STARTED|Infant Series||184
467971|NCT01200368|1146120|P2|STARTED|Infant Series||184
467972|NCT01200368|1146121|P1|STARTED|Infant Series||183
467973|NCT01200355|1146187|P2|NOT COMPLETED|Overall Study||2
467974|NCT01200355|1146188|P1|NOT COMPLETED|Overall Study||7
467975|NCT01200355|1146187|P2|COMPLETED|Overall Study||53
467976|NCT01200355|1146188|P1|COMPLETED|Overall Study||51
467977|NCT01200355|1146187|P2|STARTED|Overall Study||55
467978|NCT01200355|1146188|P1|STARTED|Overall Study||58
467979|NCT01200342|1146202|P1|NOT COMPLETED|Overall Study||1
467980|NCT01200342|1146202|P1|COMPLETED|Overall Study||6
467981|NCT01200342|1146202|P1|STARTED|Overall Study||7
467982|NCT01200290|1146207|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||2
467983|NCT01200290|1146207|P1|COMPLETED|Post-Treatment Follow-Up Period||16
467984|NCT01200290|1146207|P1|STARTED|Post-Treatment Follow-Up Period|Participant who discontinued treatment was included in the post-treatment follow-up period.|18
467985|NCT01200290|1146207|P1|NOT COMPLETED|Treatment Period||1
467986|NCT01200290|1146207|P1|COMPLETED|Treatment Period||17
467987|NCT01200290|1146207|P1|Received at Least 1 Dose of Study Drug|Treatment Period||18
467988|NCT01200290|1146207|P1|STARTED|Treatment Period||18
467989|NCT01200238|1146220|P2|NOT COMPLETED|Overall Study||10
467990|NCT01200238|1146221|P1|NOT COMPLETED|Overall Study||7
467991|NCT01200238|1146220|P2|COMPLETED|Overall Study||0
467992|NCT01200238|1146221|P1|COMPLETED|Overall Study||0
467993|NCT01200238|1146220|P2|STARTED|Overall Study||10
467994|NCT01200238|1146221|P1|STARTED|Overall Study||7
467995|NCT01200160|1146239|P1|NOT COMPLETED|Overall Study||62
467996|NCT01200160|1146239|P1|COMPLETED|Overall Study||66
467997|NCT01200160|1146239|P1|STARTED|Overall Study||128
467998|NCT01200069|1146245|P2|NOT COMPLETED|Overall Study||1
467999|NCT01200069|1146246|P1|NOT COMPLETED|Overall Study||0
468000|NCT01200069|1146245|P2|COMPLETED|Overall Study||5
468001|NCT01200069|1146246|P1|COMPLETED|Overall Study||8
468002|NCT01200069|1146245|P2|STARTED|Overall Study||6
468003|NCT01200069|1146246|P1|STARTED|Overall Study||8
468004|NCT01199965|1146300|P2|NOT COMPLETED|Overall Study||0
468005|NCT01199965|1146301|P1|NOT COMPLETED|Overall Study||1
468006|NCT01199965|1146300|P2|COMPLETED|Overall Study||24
468007|NCT01199965|1146301|P1|COMPLETED|Overall Study||22
468008|NCT01199965|1146300|P2|STARTED|Overall Study||24
468009|NCT01199965|1146301|P1|STARTED|Overall Study||23
468010|NCT01199939|1146315|P1|NOT COMPLETED|Overall Study||13
468011|NCT01199939|1146315|P1|COMPLETED|Overall Study||41
468012|NCT01199939|1146315|P1|STARTED|Overall Study|Number of enrolled participants|54
468013|NCT01199926|1146334|P2|NOT COMPLETED|Overall Study||4
468014|NCT01199926|1146335|P1|NOT COMPLETED|Overall Study||7
468015|NCT01199926|1146334|P2|COMPLETED|Overall Study||13
468016|NCT01199926|1146335|P1|COMPLETED|Overall Study||10
468017|NCT01199926|1146334|P2|STARTED|Overall Study||17
468018|NCT01199926|1146335|P1|STARTED|Overall Study||17
468019|NCT01199861|1146347|P2|NOT COMPLETED|Overall Study||0
468020|NCT01199861|1146348|P1|NOT COMPLETED|Overall Study||2
468021|NCT01199861|1146347|P2|COMPLETED|Overall Study||43
468022|NCT01199861|1146348|P1|COMPLETED|Overall Study||93
468023|NCT01199861|1146347|P2|STARTED|Overall Study||43
468024|NCT01199861|1146348|P1|STARTED|Overall Study||95
468025|NCT01199822|1146369|P3|NOT COMPLETED|Overall Study||0
468026|NCT01199822|1146370|P2|NOT COMPLETED|Overall Study||1
468027|NCT01199822|1146371|P1|NOT COMPLETED|Overall Study||0
468028|NCT01199822|1146369|P3|COMPLETED|Overall Study||6
468029|NCT01199822|1146370|P2|COMPLETED|Overall Study||6
468030|NCT01199822|1146371|P1|COMPLETED|Overall Study||3
468031|NCT01199822|1146369|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
468032|NCT01199822|1146370|P2|Received at Least 1 Dose of Study Drug|Overall Study||7
468033|NCT01199822|1146371|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
468034|NCT01199822|1146369|P3|STARTED|Overall Study||6
468035|NCT01199822|1146370|P2|STARTED|Overall Study||7
468036|NCT01199822|1146371|P1|STARTED|Overall Study||3
468037|NCT01199744|1146404|P1|NOT COMPLETED|Overall Study||0
468038|NCT01199744|1146404|P1|COMPLETED|Overall Study||1575
468039|NCT01199744|1146404|P1|STARTED|Overall Study||1575
468040|NCT01199731|1146420|P3|NOT COMPLETED|Overall Study||10
468041|NCT01199731|1146421|P2|NOT COMPLETED|Overall Study||11
468042|NCT01199731|1146422|P1|NOT COMPLETED|Overall Study||9
468043|NCT01199731|1146420|P3|COMPLETED|Overall Study||0
468044|NCT01199731|1146421|P2|COMPLETED|Overall Study||0
468045|NCT01199731|1146422|P1|COMPLETED|Overall Study||0
468046|NCT01199731|1146420|P3|STARTED|Overall Study||10
468047|NCT01199731|1146421|P2|STARTED|Overall Study||11
468048|NCT01199731|1146422|P1|STARTED|Overall Study||9
468049|NCT01199705|1146460|P1|NOT COMPLETED|SCIG Treatment (Efficacy)||0
468050|NCT01199705|1146460|P1|COMPLETED|SCIG Treatment (Efficacy)||24
468051|NCT01199705|1146460|P1|STARTED|SCIG Treatment (Efficacy)||24
468052|NCT01199705|1146460|P1|NOT COMPLETED|SCIG Treatment (Wash-in/Wash-out)||1
468053|NCT01199705|1146460|P1|COMPLETED|SCIG Treatment (Wash-in/Wash-out)||24
468054|NCT01199705|1146460|P1|STARTED|SCIG Treatment (Wash-in/Wash-out)||25
468055|NCT01199705|1146460|P1|NOT COMPLETED|IVIG Treatment||0
468056|NCT01199705|1146460|P1|COMPLETED|IVIG Treatment||25
468057|NCT01199705|1146460|P1|STARTED|IVIG Treatment||25
468058|NCT01199601|1146492|P2|NOT COMPLETED|Overall Study||78
468059|NCT01199601|1146493|P1|NOT COMPLETED|Overall Study||69
468060|NCT01199601|1146492|P2|COMPLETED|Overall Study||344
468061|NCT01199601|1146493|P1|COMPLETED|Overall Study||353
468062|NCT01199601|1146492|P2|STARTED|Overall Study|Intervention Group|422
468063|NCT01199601|1146493|P1|STARTED|Overall Study|Control Group|422
468064|NCT01199471|1146503|P1|NOT COMPLETED|Overall Study||6
468065|NCT01199471|1146503|P1|COMPLETED|Overall Study||3994
468066|NCT01199471|1146503|P1|STARTED|Overall Study|3 patients who did not meet ASA Physical Status Class 1 - 3 were excluded from all analyses.|4000
468067|NCT01199237|1146514|P2|NOT COMPLETED|Overall Study||0
468068|NCT01199237|1146515|P1|NOT COMPLETED|Overall Study||0
468069|NCT01199237|1146514|P2|COMPLETED|Overall Study||40
468070|NCT01199237|1146515|P1|COMPLETED|Overall Study||41
468071|NCT01199237|1146514|P2|STARTED|Overall Study||40
468072|NCT01199237|1146515|P1|STARTED|Overall Study||41
468073|NCT01199146|1146529|P1|NOT COMPLETED|Overall Study||3
468074|NCT01199146|1146529|P1|COMPLETED|Overall Study||39
468075|NCT01199146|1146529|P1|STARTED|Overall Study||42
468076|NCT01199042|1146535|P1|NOT COMPLETED|At Home (3 Months)||1
468077|NCT01199042|1146535|P1|COMPLETED|At Home (3 Months)||26
468078|NCT01199042|1146535|P1|STARTED|At Home (3 Months)||27
468079|NCT01199042|1146535|P1|NOT COMPLETED|Sleep Laboratory (3 Nights)||2
468080|NCT01199042|1146535|P1|COMPLETED|Sleep Laboratory (3 Nights)||27
468081|NCT01199042|1146535|P1|STARTED|Sleep Laboratory (3 Nights)||29
468082|NCT01199016|1146544|P1|NOT COMPLETED|Overall Study||77
468083|NCT01199016|1146544|P1|COMPLETED|Overall Study||162
468084|NCT01199016|1146544|P1|Treated|Overall Study||236
468085|NCT01199016|1146544|P1|STARTED|Overall Study||239
468086|NCT01198977|1146553|P2|NOT COMPLETED|Overall Study||0
468087|NCT01198977|1146554|P1|NOT COMPLETED|Overall Study||1
468088|NCT01198977|1146553|P2|COMPLETED|Overall Study||33
468089|NCT01198977|1146554|P1|COMPLETED|Overall Study||30
468090|NCT01198977|1146553|P2|STARTED|Overall Study||33
468091|NCT01198977|1146554|P1|STARTED|Overall Study||31
468092|NCT01198873|1146566|P2|NOT COMPLETED|Overall Study||32
468093|NCT01198873|1146567|P1|NOT COMPLETED|Overall Study||37
468094|NCT01198873|1146566|P2|COMPLETED|Overall Study||3
468095|NCT01198873|1146567|P1|COMPLETED|Overall Study||4
468096|NCT01198873|1146566|P2|Evaluable for Efficacy|Overall Study|9 participants discontinued before completing 3-month treatment and were not assessed post-baseline|26
468097|NCT01198873|1146567|P1|Evaluable for Efficacy|Overall Study|8 participants discontinued before completing 3-month treatment and were not assessed post-baseline|33
468098|NCT01198873|1146566|P2|Treated|Overall Study||35
468099|NCT01198873|1146567|P1|Treated|Overall Study||41
468100|NCT01198873|1146566|P2|STARTED|Overall Study||35
468101|NCT01198873|1146567|P1|STARTED|Overall Study||41
468102|NCT01198795|1146581|P1|NOT COMPLETED|Overall Study||82
468103|NCT01198795|1146581|P1|COMPLETED|Overall Study||80
468104|NCT01198795|1146581|P1|STARTED|Overall Study||162
468105|NCT01198769|1146585|P1|NOT COMPLETED|Overall Study||0
468106|NCT01198769|1146585|P1|COMPLETED|Overall Study||15
468107|NCT01198769|1146585|P1|STARTED|Overall Study||15
468108|NCT01198756|1146598|P4|NOT COMPLETED|Overall Study||26
468109|NCT01198756|1146599|P3|NOT COMPLETED|Overall Study||30
468110|NCT01198756|1146600|P2|NOT COMPLETED|Overall Study||40
468111|NCT01198756|1146601|P1|NOT COMPLETED|Overall Study||38
468112|NCT01198756|1146598|P4|COMPLETED|Overall Study||275
468113|NCT01198756|1146599|P3|COMPLETED|Overall Study||902
468114|NCT01198756|1146600|P2|COMPLETED|Overall Study||889
468115|NCT01198756|1146601|P1|COMPLETED|Overall Study||894
468116|NCT01198756|1146598|P4|STARTED|Overall Study||301
468117|NCT01198756|1146599|P3|STARTED|Overall Study||932
468118|NCT01198756|1146600|P2|STARTED|Overall Study||929
468119|NCT01198756|1146601|P1|STARTED|Overall Study||932
468120|NCT01198691|1146699|P2|NOT COMPLETED|6 Week Post-partum Survey||24
468121|NCT01198691|1146700|P1|NOT COMPLETED|6 Week Post-partum Survey||29
468122|NCT01198691|1146699|P2|COMPLETED|6 Week Post-partum Survey||26
468123|NCT01198691|1146700|P1|COMPLETED|6 Week Post-partum Survey||21
468124|NCT01198691|1146699|P2|STARTED|6 Week Post-partum Survey|Survey was sent to all participants even if they were missing data from the previous two periods.|50
468125|NCT01198691|1146700|P1|STARTED|6 Week Post-partum Survey|Survey was sent to all participants even if they were missing data from the previous two periods.|50
468126|NCT01198691|1146699|P2|NOT COMPLETED|Survey Prior to Discharge||33
468127|NCT01198691|1146700|P1|NOT COMPLETED|Survey Prior to Discharge||32
468128|NCT01198691|1146699|P2|COMPLETED|Survey Prior to Discharge||17
468129|NCT01198691|1146700|P1|COMPLETED|Survey Prior to Discharge||18
468130|NCT01198691|1146699|P2|STARTED|Survey Prior to Discharge|Survey was given to all participants even if they were missing data from previous periods.|50
468131|NCT01198691|1146700|P1|STARTED|Survey Prior to Discharge|Survey was given to all participants even if they were missing data from previous periods.|50
468132|NCT01198691|1146699|P2|NOT COMPLETED|Completed VAS Score at Discharge||6
468133|NCT01198691|1146700|P1|NOT COMPLETED|Completed VAS Score at Discharge||5
468134|NCT01198691|1146699|P2|COMPLETED|Completed VAS Score at Discharge||44
468135|NCT01198691|1146700|P1|COMPLETED|Completed VAS Score at Discharge||45
468136|NCT01198691|1146699|P2|STARTED|Completed VAS Score at Discharge|Missing a VAS score on postop day one did not exclude participants from having a score at discharge.|50
468137|NCT01198691|1146700|P1|STARTED|Completed VAS Score at Discharge|Missing a VAS score on postop day one did not exclude participants from having a score at discharge.|50
468138|NCT01198691|1146699|P2|NOT COMPLETED|Completed VAS Score Postop Day 1||4
468139|NCT01198691|1146700|P1|NOT COMPLETED|Completed VAS Score Postop Day 1||3
468140|NCT01198691|1146699|P2|COMPLETED|Completed VAS Score Postop Day 1||46
468141|NCT01198691|1146700|P1|COMPLETED|Completed VAS Score Postop Day 1||47
468142|NCT01198691|1146699|P2|STARTED|Completed VAS Score Postop Day 1||50
468143|NCT01198691|1146700|P1|STARTED|Completed VAS Score Postop Day 1||50
468144|NCT01198691|1146699|P2|NOT COMPLETED|Completed Surgery -Received Intervention||0
468145|NCT01198691|1146700|P1|NOT COMPLETED|Completed Surgery -Received Intervention||0
468146|NCT01198691|1146699|P2|COMPLETED|Completed Surgery -Received Intervention||50
468147|NCT01198691|1146700|P1|COMPLETED|Completed Surgery -Received Intervention||50
468148|NCT01198691|1146699|P2|STARTED|Completed Surgery -Received Intervention||50
468149|NCT01198691|1146700|P1|STARTED|Completed Surgery -Received Intervention||50
468150|NCT01198600|1146712|P4|NOT COMPLETED|Phase 3: 43 Days of Wear||0
468151|NCT01198600|1146713|P3|NOT COMPLETED|Phase 3: 43 Days of Wear||0
468152|NCT01198600|1146714|P2|NOT COMPLETED|Phase 3: 43 Days of Wear||0
468153|NCT01198600|1146715|P1|NOT COMPLETED|Phase 3: 43 Days of Wear||0
468154|NCT01198600|1146712|P4|COMPLETED|Phase 3: 43 Days of Wear||38
468155|NCT01198600|1146713|P3|COMPLETED|Phase 3: 43 Days of Wear||0
468156|NCT01198600|1146714|P2|COMPLETED|Phase 3: 43 Days of Wear||0
468157|NCT01198600|1146715|P1|COMPLETED|Phase 3: 43 Days of Wear||0
468158|NCT01198600|1146712|P4|STARTED|Phase 3: 43 Days of Wear||38
468159|NCT01198600|1146713|P3|STARTED|Phase 3: 43 Days of Wear||0
468160|NCT01198600|1146714|P2|STARTED|Phase 3: 43 Days of Wear||0
468161|NCT01198600|1146715|P1|STARTED|Phase 3: 43 Days of Wear||0
468162|NCT01198600|1146712|P4|NOT COMPLETED|Phase 2: 56 Days of Wear||0
468163|NCT01198600|1146713|P3|NOT COMPLETED|Phase 2: 56 Days of Wear||5
468164|NCT01198600|1146714|P2|NOT COMPLETED|Phase 2: 56 Days of Wear||0
468165|NCT01198600|1146715|P1|NOT COMPLETED|Phase 2: 56 Days of Wear||0
468166|NCT01198600|1146712|P4|COMPLETED|Phase 2: 56 Days of Wear||0
468167|NCT01198600|1146713|P3|COMPLETED|Phase 2: 56 Days of Wear||62
468168|NCT01198600|1146714|P2|COMPLETED|Phase 2: 56 Days of Wear||0
468169|NCT01198600|1146715|P1|COMPLETED|Phase 2: 56 Days of Wear||0
468170|NCT01198600|1146712|P4|STARTED|Phase 2: 56 Days of Wear||0
468171|NCT01198600|1146713|P3|STARTED|Phase 2: 56 Days of Wear||67
468172|NCT01198600|1146714|P2|STARTED|Phase 2: 56 Days of Wear||0
468173|NCT01198600|1146715|P1|STARTED|Phase 2: 56 Days of Wear||0
468174|NCT01198600|1146712|P4|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
468175|NCT01198600|1146713|P3|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
468176|NCT01198600|1146714|P2|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||1
468177|NCT01198600|1146715|P1|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
468178|NCT01198600|1146712|P4|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
468179|NCT01198600|1146713|P3|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
468180|NCT01198600|1146714|P2|COMPLETED|Phase 1: Period Two, 30 Days of Wear||35
468181|NCT01198600|1146715|P1|COMPLETED|Phase 1: Period Two, 30 Days of Wear||32
468182|NCT01198600|1146712|P4|STARTED|Phase 1: Period Two, 30 Days of Wear||0
468183|NCT01198600|1146713|P3|STARTED|Phase 1: Period Two, 30 Days of Wear||0
468184|NCT01198600|1146714|P2|STARTED|Phase 1: Period Two, 30 Days of Wear||36
468185|NCT01198600|1146715|P1|STARTED|Phase 1: Period Two, 30 Days of Wear|One participant discontinued between Period One and Period Two due to unconvenience.|32
468186|NCT01198600|1146712|P4|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0
468187|NCT01198600|1146713|P3|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0
468188|NCT01198600|1146714|P2|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||1
468189|NCT01198600|1146715|P1|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||2
468190|NCT01198600|1146712|P4|COMPLETED|Phase 1: Period One, 30 Days of Wear||0
468191|NCT01198600|1146713|P3|COMPLETED|Phase 1: Period One, 30 Days of Wear||0
468192|NCT01198600|1146714|P2|COMPLETED|Phase 1: Period One, 30 Days of Wear||36
468193|NCT01198600|1146715|P1|COMPLETED|Phase 1: Period One, 30 Days of Wear||33
468194|NCT01198600|1146712|P4|STARTED|Phase 1: Period One, 30 Days of Wear||0
468195|NCT01198600|1146713|P3|STARTED|Phase 1: Period One, 30 Days of Wear||0
468196|NCT01198600|1146714|P2|STARTED|Phase 1: Period One, 30 Days of Wear||37
468197|NCT01198600|1146715|P1|STARTED|Phase 1: Period One, 30 Days of Wear||35
468198|NCT01198574|1146741|P4|NOT COMPLETED|Overall Study||4
468199|NCT01198574|1146742|P3|NOT COMPLETED|Overall Study||1
468200|NCT01198574|1146743|P2|NOT COMPLETED|Overall Study||1
468201|NCT01198574|1146744|P1|NOT COMPLETED|Overall Study||4
468202|NCT01198574|1146741|P4|COMPLETED|Overall Study||98
468203|NCT01198574|1146742|P3|COMPLETED|Overall Study||99
468204|NCT01198574|1146743|P2|COMPLETED|Overall Study||101
468205|NCT01198574|1146744|P1|COMPLETED|Overall Study||94
468206|NCT01198574|1146741|P4|STARTED|Overall Study||102
468207|NCT01198574|1146742|P3|STARTED|Overall Study||100
468208|NCT01198574|1146743|P2|STARTED|Overall Study||102
468209|NCT01198574|1146744|P1|STARTED|Overall Study||98
468210|NCT01198548|1146762|P1|NOT COMPLETED|Overall Study||10
468211|NCT01198548|1146762|P1|COMPLETED|Overall Study||0
468212|NCT01198548|1146762|P1|STARTED|Overall Study||10
468213|NCT01198509|1146777|P6|NOT COMPLETED|Overall Study||0
468214|NCT01198509|1146778|P5|NOT COMPLETED|Overall Study||0
468215|NCT01198509|1146779|P4|NOT COMPLETED|Overall Study||0
468216|NCT01198509|1146780|P3|NOT COMPLETED|Overall Study||0
468217|NCT01198509|1146781|P2|NOT COMPLETED|Overall Study||0
468218|NCT01198509|1146782|P1|NOT COMPLETED|Overall Study||1
468219|NCT01198509|1146777|P6|COMPLETED|Overall Study||58
468220|NCT01198509|1146778|P5|COMPLETED|Overall Study||20
468221|NCT01198509|1146779|P4|COMPLETED|Overall Study||66
468222|NCT01198509|1146780|P3|COMPLETED|Overall Study||19
468223|NCT01198509|1146781|P2|COMPLETED|Overall Study||10
468224|NCT01198509|1146782|P1|COMPLETED|Overall Study|Patient declined further participation after enrollment and allocation to treatment group|4
468225|NCT01198509|1146777|P6|STARTED|Overall Study||58
468226|NCT01198509|1146778|P5|STARTED|Overall Study||20
468227|NCT01198509|1146779|P4|STARTED|Overall Study||66
468228|NCT01198509|1146780|P3|STARTED|Overall Study||19
468229|NCT01198509|1146781|P2|STARTED|Overall Study||10
468230|NCT01198509|1146782|P1|STARTED|Overall Study||5
468231|NCT01198366|1146805|P6|NOT COMPLETED|Overall Study||13
468232|NCT01198366|1146806|P5|NOT COMPLETED|Overall Study||15
468233|NCT01198366|1146807|P4|NOT COMPLETED|Overall Study||5
468234|NCT01198366|1146808|P3|NOT COMPLETED|Overall Study||8
468235|NCT01198366|1146809|P2|NOT COMPLETED|Overall Study||7
468236|NCT01198366|1146810|P1|NOT COMPLETED|Overall Study||12
468237|NCT01198366|1146805|P6|COMPLETED|Overall Study||128
468238|NCT01198366|1146806|P5|COMPLETED|Overall Study||125
468239|NCT01198366|1146807|P4|COMPLETED|Overall Study||47
468240|NCT01198366|1146808|P3|COMPLETED|Overall Study||43
468241|NCT01198366|1146809|P2|COMPLETED|Overall Study||44
468242|NCT01198366|1146810|P1|COMPLETED|Overall Study||40
468243|NCT01198366|1146805|P6|STARTED|Overall Study||141
468244|NCT01198366|1146806|P5|STARTED|Overall Study||140
468245|NCT01198366|1146807|P4|STARTED|Overall Study||52
468246|NCT01198366|1146808|P3|STARTED|Overall Study||51
468247|NCT01198366|1146809|P2|STARTED|Overall Study||51
468248|NCT01198366|1146810|P1|STARTED|Overall Study||52
468249|NCT01198327|1146848|P1|NOT COMPLETED|Overall Study||10
468250|NCT01198327|1146848|P1|COMPLETED|Overall Study||56
468251|NCT01198327|1146848|P1|STARTED|Overall Study||66
468252|NCT01198275|1146858|P2|NOT COMPLETED|Overall Study||5
468253|NCT01198275|1146859|P1|NOT COMPLETED|Overall Study||6
468254|NCT01198275|1146858|P2|COMPLETED|Overall Study||94
468255|NCT01198275|1146859|P1|COMPLETED|Overall Study||94
468256|NCT01198275|1146858|P2|STARTED|Overall Study||99
468257|NCT01198275|1146859|P1|STARTED|Overall Study||100
468258|NCT01198145|1146867|P2|NOT COMPLETED|Overall Study||1
468259|NCT01198145|1146868|P1|NOT COMPLETED|Overall Study||1
468260|NCT01198145|1146867|P2|COMPLETED|Overall Study||42
468261|NCT01198145|1146868|P1|COMPLETED|Overall Study||43
468262|NCT01198145|1146867|P2|STARTED|Overall Study||43
468263|NCT01198145|1146868|P1|STARTED|Overall Study||44
468264|NCT01198132|1146890|P2|NOT COMPLETED|Overall Study||21
468265|NCT01198132|1146891|P1|NOT COMPLETED|Overall Study||18
468266|NCT01198132|1146890|P2|COMPLETED|Overall Study||45
468267|NCT01198132|1146891|P1|COMPLETED|Overall Study||45
468268|NCT01198132|1146890|P2|STARTED|Overall Study||66
468269|NCT01198132|1146891|P1|STARTED|Overall Study||63
468270|NCT01198002|1146918|P3|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||78
468271|NCT01198002|1146919|P2|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||73
468272|NCT01198002|1146920|P1|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||69
468273|NCT01198002|1146918|P3|COMPLETED|Treatment Period 2 (Weeks 52-100)||2
468274|NCT01198002|1146919|P2|COMPLETED|Treatment Period 2 (Weeks 52-100)||0
468275|NCT01198002|1146920|P1|COMPLETED|Treatment Period 2 (Weeks 52-100)||1
468276|NCT01198002|1146918|P3|STARTED|Treatment Period 2 (Weeks 52-100)||80
468277|NCT01198002|1146919|P2|STARTED|Treatment Period 2 (Weeks 52-100)||73
468278|NCT01198002|1146920|P1|STARTED|Treatment Period 2 (Weeks 52-100)||70
468279|NCT01198002|1146918|P3|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||269
468280|NCT01198002|1146919|P2|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||274
468281|NCT01198002|1146920|P1|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||275
468282|NCT01198002|1146918|P3|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|80
468283|NCT01198002|1146919|P2|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|73
468284|NCT01198002|1146920|P1|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|70
468285|NCT01198002|1146918|P3|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||307
468286|NCT01198002|1146919|P2|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||303
468287|NCT01198002|1146920|P1|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||293
468288|NCT01198002|1146918|P3|Week 16 NR|Treatment Period 1 (Weeks 0-52)||90
468289|NCT01198002|1146919|P2|Week 16 NR|Treatment Period 1 (Weeks 0-52)||62
468290|NCT01198002|1146920|P1|Week 16 NR|Treatment Period 1 (Weeks 0-52)||58
468291|NCT01198002|1146918|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||348
468292|NCT01198002|1146919|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||345
468293|NCT01198002|1146920|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||345
468294|NCT01198002|1146918|P3|STARTED|Treatment Period 1 (Weeks 0-52)||349
468295|NCT01198002|1146919|P2|STARTED|Treatment Period 1 (Weeks 0-52)||347
468296|NCT01198002|1146920|P1|STARTED|Treatment Period 1 (Weeks 0-52)||345
468297|NCT01197911|1147035|P3|NOT COMPLETED|Overall Study||1
468298|NCT01197911|1147036|P2|NOT COMPLETED|Overall Study||0
468299|NCT01197911|1147037|P1|NOT COMPLETED|Overall Study||0
468300|NCT01197911|1147035|P3|COMPLETED|Overall Study||9
468301|NCT01197911|1147036|P2|COMPLETED|Overall Study||10
468302|NCT01197911|1147037|P1|COMPLETED|Overall Study||18
468303|NCT01197911|1147035|P3|STARTED|Overall Study||10
468304|NCT01197911|1147036|P2|STARTED|Overall Study||10
468305|NCT01197911|1147037|P1|STARTED|Overall Study||18
468306|NCT01197898|1147122|P2|NOT COMPLETED|Overall Study||0
468307|NCT01197898|1147123|P1|NOT COMPLETED|Overall Study||0
468308|NCT01197898|1147122|P2|COMPLETED|Overall Study||5
468309|NCT01197898|1147123|P1|COMPLETED|Overall Study||5
468310|NCT01197898|1147122|P2|STARTED|Overall Study||5
468311|NCT01197898|1147123|P1|STARTED|Overall Study||5
468312|NCT01197833|1147132|P3|NOT COMPLETED|Overall Study||0
468313|NCT01197833|1147133|P2|NOT COMPLETED|Overall Study||0
468314|NCT01197833|1147134|P1|NOT COMPLETED|Overall Study||0
468315|NCT01197833|1147132|P3|COMPLETED|Overall Study||40
468316|NCT01197833|1147133|P2|COMPLETED|Overall Study||39
468317|NCT01197833|1147134|P1|COMPLETED|Overall Study||38
468318|NCT01197833|1147132|P3|STARTED|Overall Study||40
468319|NCT01197833|1147133|P2|STARTED|Overall Study||39
468320|NCT01197833|1147134|P1|STARTED|Overall Study||38
468321|NCT01197794|1147152|P7|NOT COMPLETED|Overall Study||21
468322|NCT01197794|1147153|P6|NOT COMPLETED|Overall Study||19
468323|NCT01197794|1147154|P5|NOT COMPLETED|Overall Study||14
468324|NCT01197794|1147155|P4|NOT COMPLETED|Overall Study||12
468325|NCT01197794|1147156|P3|NOT COMPLETED|Overall Study||13
468326|NCT01197794|1147157|P2|NOT COMPLETED|Overall Study||15
468327|NCT01197794|1147158|P1|NOT COMPLETED|Overall Study||16
468328|NCT01197794|1147152|P7|COMPLETED|Overall Study||142
468329|NCT01197794|1147153|P6|COMPLETED|Overall Study||144
468330|NCT01197794|1147154|P5|COMPLETED|Overall Study||149
468331|NCT01197794|1147155|P4|COMPLETED|Overall Study||152
468332|NCT01197794|1147156|P3|COMPLETED|Overall Study||153
468333|NCT01197794|1147157|P2|COMPLETED|Overall Study||146
468334|NCT01197794|1147158|P1|COMPLETED|Overall Study||148
468335|NCT01197794|1147152|P7|STARTED|Overall Study|Two participants excluded due to Good Clinical Practice (GCP) violation at centre 4323|163
468336|NCT01197794|1147153|P6|STARTED|Overall Study||163
468337|NCT01197794|1147154|P5|STARTED|Overall Study|One participant excluded due to Good Clinical Practice (GCP) violation at centre 4323|163
468338|NCT01197794|1147155|P4|STARTED|Overall Study||164
468339|NCT01197794|1147156|P3|STARTED|Overall Study|Two participants did not receive study treatment|166
468340|NCT01197794|1147157|P2|STARTED|Overall Study|Two participants did not receive study treatment|161
468341|NCT01197794|1147158|P1|STARTED|Overall Study||164
468342|NCT01197755|1147240|P3|NOT COMPLETED|Overall Study||54
468343|NCT01197755|1147241|P2|NOT COMPLETED|Overall Study||43
468344|NCT01197755|1147242|P1|NOT COMPLETED|Overall Study||38
468345|NCT01197755|1147240|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|55
468346|NCT01197755|1147241|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|65
468347|NCT01197755|1147242|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|67
468348|NCT01197755|1147240|P3|Randomised But Did Not Receive Treatment|Overall Study|Severe non-compliance to the protocol|1
468349|NCT01197755|1147241|P2|Randomised But Did Not Receive Treatment|Overall Study||0
468350|NCT01197755|1147242|P1|Randomised But Did Not Receive Treatment|Overall Study||0
468351|NCT01197755|1147240|P3|STARTED|Overall Study|Patients who received treatment|109
468352|NCT01197755|1147241|P2|STARTED|Overall Study|Patients who received treatment|108
468353|NCT01197755|1147242|P1|STARTED|Overall Study|Patients who received treatment|105
468354|NCT01197612|1147282|P1|NOT COMPLETED|Overall Study||12
468355|NCT01197612|1147282|P1|COMPLETED|Overall Study||6
468356|NCT01197612|1147282|P1|Returned for Week 24|Overall Study||6
468357|NCT01197612|1147282|P1|Week 3|Overall Study||16
468358|NCT01197612|1147282|P1|STARTED|Overall Study||18
468359|NCT01197560|1147295|P2|NOT COMPLETED|Overall Study||53
468360|NCT01197560|1147296|P1|NOT COMPLETED|Overall Study||46
468361|NCT01197560|1147295|P2|COMPLETED|Overall Study|Completed = those completed and ongoing on treatment at the time of the data cut-off of 04 July 2013|4
468362|NCT01197560|1147296|P1|COMPLETED|Overall Study|Completed equals participants ongoing on treatment at the time of the data cut-off of 04 July 2013|8
468363|NCT01197560|1147295|P2|Discontinued Treatment After ≥ 6 Cycles|Overall Study||3
468364|NCT01197560|1147296|P1|Discontinued Treatment After ≥ 6 Cycles|Overall Study||7
468365|NCT01197560|1147295|P2|Lenalidomide Crossover|Overall Study||29
468366|NCT01197560|1147296|P1|Lenalidomide Crossover|Overall Study||0
468367|NCT01197560|1147295|P2|Received ≥ One Dose Study Drug|Overall Study||55
468368|NCT01197560|1147296|P1|Received ≥ One Dose Study Drug|Overall Study||54
468369|NCT01197560|1147295|P2|STARTED|Overall Study|This is the intent to treat population|57
468370|NCT01197560|1147296|P1|STARTED|Overall Study|This is the intent to treat population|54
468371|NCT01197547|1147320|P1|NOT COMPLETED|Overall Study||22
468372|NCT01197547|1147320|P1|COMPLETED|Overall Study|992 Intent-To-Treat (ITT) 931 evaluable subjects|992
468373|NCT01197547|1147320|P1|STARTED|Overall Study||1014
468374|NCT01197534|1147329|P3|NOT COMPLETED|Overall Study||173
468375|NCT01197534|1147330|P2|NOT COMPLETED|Overall Study||130
468376|NCT01197534|1147331|P1|NOT COMPLETED|Overall Study||134
468377|NCT01197534|1147329|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|129
468378|NCT01197534|1147330|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|168
468379|NCT01197534|1147331|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|174
468380|NCT01197534|1147329|P3|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled / Severe non-compliance to protocol|3
468381|NCT01197534|1147330|P2|Randomised But Did Not Receive Treatment|Overall Study|Adverse event / Other|2
468382|NCT01197534|1147331|P1|Randomised But Did Not Receive Treatment|Overall Study||0
468383|NCT01197534|1147329|P3|STARTED|Overall Study|Patients who received treatment|302
468384|NCT01197534|1147330|P2|STARTED|Overall Study|Patients who received treatment|298
468385|NCT01197534|1147331|P1|STARTED|Overall Study|Patients who received treatment|308
468386|NCT01197521|1147375|P3|NOT COMPLETED|Overall Study||143
468387|NCT01197521|1147376|P2|NOT COMPLETED|Overall Study||113
468388|NCT01197521|1147377|P1|NOT COMPLETED|Overall Study||103
468389|NCT01197521|1147375|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|161
468390|NCT01197521|1147376|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|191
468391|NCT01197521|1147377|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|207
468392|NCT01197521|1147375|P3|Randomised But Did Not Receive Treatment|Overall Study|Adverse event/eligibility criteria not fulfilled|2
468393|NCT01197521|1147376|P2|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/other|2
468394|NCT01197521|1147377|P1|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled|1
468395|NCT01197521|1147375|P3|STARTED|Overall Study|Patients who received treatment|304
468396|NCT01197521|1147376|P2|STARTED|Overall Study|Patients who received treatment|304
468397|NCT01197521|1147377|P1|STARTED|Overall Study|Patients who received treatment|310
468398|NCT01197508|1147422|P4|NOT COMPLETED|Overall Study||16
468399|NCT01197508|1147423|P3|NOT COMPLETED|Overall Study||49
468400|NCT01197508|1147424|P2|NOT COMPLETED|Overall Study||30
468401|NCT01197508|1147425|P1|NOT COMPLETED|Overall Study||23
468402|NCT01197508|1147422|P4|COMPLETED|Overall Study||158
468403|NCT01197508|1147423|P3|COMPLETED|Overall Study||125
468404|NCT01197508|1147424|P2|COMPLETED|Overall Study||144
468405|NCT01197508|1147425|P1|COMPLETED|Overall Study||151
468406|NCT01197508|1147422|P4|Received Treatment|Overall Study||174
468407|NCT01197508|1147423|P3|Received Treatment|Overall Study||171
468408|NCT01197508|1147424|P2|Received Treatment|Overall Study||174
468409|NCT01197508|1147425|P1|Received Treatment|Overall Study||174
468410|NCT01197508|1147422|P4|STARTED|Overall Study||174
468411|NCT01197508|1147423|P3|STARTED|Overall Study||174
468412|NCT01197508|1147424|P2|STARTED|Overall Study||174
468413|NCT01197508|1147425|P1|STARTED|Overall Study||174
468414|NCT01197495|1147521|P2|NOT COMPLETED|Overall Study||7
468415|NCT01197495|1147522|P1|NOT COMPLETED|Overall Study||13
468416|NCT01197495|1147521|P2|COMPLETED|Overall Study||49
468417|NCT01197495|1147522|P1|COMPLETED|Overall Study||144
468418|NCT01197495|1147521|P2|STARTED|Overall Study||56
468419|NCT01197495|1147522|P1|STARTED|Overall Study||157
468420|NCT01197417|1147535|P2|NOT COMPLETED|Overall Study||18
468421|NCT01197417|1147536|P1|NOT COMPLETED|Overall Study||8
468422|NCT01197417|1147535|P2|COMPLETED|Overall Study||86
468423|NCT01197417|1147536|P1|COMPLETED|Overall Study||96
468424|NCT01197417|1147535|P2|Received Study Drug|Overall Study||103
468425|NCT01197417|1147536|P1|Received Study Drug|Overall Study||101
468426|NCT01197417|1147535|P2|STARTED|Overall Study||104
468427|NCT01197417|1147536|P1|STARTED|Overall Study||104
468428|NCT01197326|1147556|P2|NOT COMPLETED|Overall Study||0
468429|NCT01197326|1147557|P1|NOT COMPLETED|Overall Study||0
468430|NCT01197326|1147556|P2|COMPLETED|Overall Study||209
468431|NCT01197326|1147557|P1|COMPLETED|Overall Study||205
468432|NCT01197326|1147556|P2|STARTED|Overall Study||209
468433|NCT01197326|1147557|P1|STARTED|Overall Study||205
468434|NCT01196988|1147569|P4|NOT COMPLETED|Overall Study||1
468435|NCT01196988|1147570|P3|NOT COMPLETED|Overall Study||25
468436|NCT01196988|1147571|P2|NOT COMPLETED|Overall Study||32
468437|NCT01196988|1147572|P1|NOT COMPLETED|Overall Study||24
468438|NCT01196988|1147569|P4|COMPLETED|Overall Study||276
468439|NCT01196988|1147570|P3|COMPLETED|Overall Study||886
468440|NCT01196988|1147571|P2|COMPLETED|Overall Study||880
468441|NCT01196988|1147572|P1|COMPLETED|Overall Study||891
468442|NCT01196988|1147569|P4|STARTED|Overall Study||277
468443|NCT01196988|1147570|P3|STARTED|Overall Study||911
468444|NCT01196988|1147571|P2|STARTED|Overall Study||912
468445|NCT01196988|1147572|P1|STARTED|Overall Study||915
468446|NCT01196975|1147666|P5|NOT COMPLETED|Overall Study||13
468447|NCT01196975|1147667|P4|NOT COMPLETED|Overall Study||6
468448|NCT01196975|1147668|P3|NOT COMPLETED|Overall Study||5
468449|NCT01196975|1147669|P2|NOT COMPLETED|Overall Study||9
468450|NCT01196975|1147670|P1|NOT COMPLETED|Overall Study||15
468451|NCT01196975|1147666|P5|COMPLETED|Overall Study||205
468452|NCT01196975|1147667|P4|COMPLETED|Overall Study||207
468453|NCT01196975|1147668|P3|COMPLETED|Overall Study||420
468454|NCT01196975|1147669|P2|COMPLETED|Overall Study||415
468455|NCT01196975|1147670|P1|COMPLETED|Overall Study||408
468456|NCT01196975|1147666|P5|STARTED|Overall Study||218
468457|NCT01196975|1147667|P4|STARTED|Overall Study||213
468458|NCT01196975|1147668|P3|STARTED|Overall Study||425
468459|NCT01196975|1147669|P2|STARTED|Overall Study||424
468460|NCT01196975|1147670|P1|STARTED|Overall Study||423
468461|NCT01196923|1147802|P1|NOT COMPLETED|Overall Study||0
468462|NCT01196923|1147802|P1|COMPLETED|Overall Study||20
468463|NCT01196923|1147802|P1|STARTED|Overall Study||20
468464|NCT01196819|1147808|P2|NOT COMPLETED|Overall Study||28
468465|NCT01196819|1147809|P1|NOT COMPLETED|Overall Study||28
468466|NCT01196819|1147808|P2|COMPLETED|Overall Study||199
468467|NCT01196819|1147809|P1|COMPLETED|Overall Study||203
468468|NCT01196819|1147808|P2|STARTED|Overall Study||227
468469|NCT01196819|1147809|P1|STARTED|Overall Study||231
468470|NCT01196741|1147831|P2|NOT COMPLETED|Overall Study||28
468471|NCT01196741|1147832|P1|NOT COMPLETED|Overall Study||60
468472|NCT01196741|1147831|P2|COMPLETED|Overall Study||8
468473|NCT01196741|1147832|P1|COMPLETED|Overall Study||11
468474|NCT01196741|1147831|P2|STARTED|Overall Study||36
468475|NCT01196741|1147832|P1|STARTED|Overall Study||71
468476|NCT01196442|1147846|P1|NOT COMPLETED|Overall Study||0
468477|NCT01196442|1147846|P1|COMPLETED|Overall Study||39
468478|NCT01196442|1147846|P1|STARTED|Overall Study||39
468479|NCT01196429|1147858|P2|NOT COMPLETED|Overall Study||0
468480|NCT01196429|1147859|P1|NOT COMPLETED|Overall Study||3
468481|NCT01196429|1147858|P2|COMPLETED|Overall Study||45
468482|NCT01196429|1147859|P1|COMPLETED|Overall Study||42
468483|NCT01196429|1147858|P2|STARTED|Overall Study||45
468484|NCT01196429|1147859|P1|STARTED|Overall Study||45
468485|NCT01196416|1147875|P1|NOT COMPLETED|Overall Study||2
468486|NCT01196416|1147875|P1|COMPLETED|Overall Study||12
468487|NCT01196416|1147875|P1|STARTED|Overall Study||14
468488|NCT01196377|1147886|P4|NOT COMPLETED|Overall Study||0
468489|NCT01196377|1147887|P3|NOT COMPLETED|Overall Study||0
468490|NCT01196377|1147888|P2|NOT COMPLETED|Overall Study||0
468491|NCT01196377|1147889|P1|NOT COMPLETED|Overall Study||0
468492|NCT01196377|1147886|P4|COMPLETED|Overall Study||4
468493|NCT01196377|1147887|P3|COMPLETED|Overall Study||4
468494|NCT01196377|1147888|P2|COMPLETED|Overall Study||4
468495|NCT01196377|1147889|P1|COMPLETED|Overall Study||4
468496|NCT01196377|1147886|P4|STARTED|Overall Study||4
468497|NCT01196377|1147887|P3|STARTED|Overall Study||4
468498|NCT01196377|1147888|P2|STARTED|Overall Study||4
468499|NCT01196377|1147889|P1|STARTED|Overall Study||4
468500|NCT01196104|1147901|P2|NOT COMPLETED|Overall Study||5
468501|NCT01196104|1147902|P1|NOT COMPLETED|Overall Study||4
468502|NCT01196104|1147901|P2|COMPLETED|Overall Study||15
468503|NCT01196104|1147902|P1|COMPLETED|Overall Study||15
468504|NCT01196104|1147901|P2|STARTED|Overall Study||20
468505|NCT01196104|1147902|P1|STARTED|Overall Study||19
468506|NCT01196091|1147945|P3|NOT COMPLETED|Overall Study||104
468507|NCT01196091|1147946|P2|NOT COMPLETED|Overall Study||98
468508|NCT01196091|1147947|P1|NOT COMPLETED|Overall Study||88
468509|NCT01196091|1147945|P3|COMPLETED|Overall Study||284
468510|NCT01196091|1147946|P2|COMPLETED|Overall Study||291
468511|NCT01196091|1147947|P1|COMPLETED|Overall Study||299
468512|NCT01196091|1147945|P3|Follow-Up|Overall Study||128
468513|NCT01196091|1147946|P2|Follow-Up|Overall Study||105
468514|NCT01196091|1147947|P1|Follow-Up|Overall Study||103
468515|NCT01196091|1147945|P3|ITT-Received Drug and Excluded Sites|Overall Study||379
468516|NCT01196091|1147946|P2|ITT-Received Drug and Excluded Sites|Overall Study||378
468517|NCT01196091|1147947|P1|ITT-Received Drug and Excluded Sites|Overall Study||381
468518|NCT01196091|1147945|P3|Received at Least 1 Dose of Study Drug|Overall Study||387
468519|NCT01196091|1147946|P2|Received at Least 1 Dose of Study Drug|Overall Study||389
468520|NCT01196091|1147947|P1|Received at Least 1 Dose of Study Drug|Overall Study||386
468521|NCT01196091|1147945|P3|STARTED|Overall Study||388
468522|NCT01196091|1147946|P2|STARTED|Overall Study||389
468523|NCT01196091|1147947|P1|STARTED|Overall Study||387
468524|NCT01196078|1147999|P2|NOT COMPLETED|Overall Study||37
468525|NCT01196078|1148000|P1|NOT COMPLETED|Overall Study||33
468526|NCT01196078|1147999|P2|COMPLETED|Overall Study||20
468527|NCT01196078|1148000|P1|COMPLETED|Overall Study||24
468528|NCT01196078|1147999|P2|STARTED|Overall Study||57
468529|NCT01196078|1148000|P1|STARTED|Overall Study||57
468530|NCT01196052|1148028|P1|NOT COMPLETED|Overall Study||23
468531|NCT01196052|1148028|P1|COMPLETED|Overall Study||130
468532|NCT01196052|1148028|P1|Received Trastuzumab Emtansine|Overall Study||148
468533|NCT01196052|1148028|P1|STARTED|Overall Study||153
468534|NCT01196026|1148045|P6|NOT COMPLETED|Overall Study||0
468535|NCT01196026|1148046|P5|NOT COMPLETED|Overall Study||1
468536|NCT01196026|1148047|P4|NOT COMPLETED|Overall Study||0
468537|NCT01196026|1148048|P3|NOT COMPLETED|Overall Study||0
468538|NCT01196026|1148049|P2|NOT COMPLETED|Overall Study||8
468539|NCT01196026|1148050|P1|NOT COMPLETED|Overall Study||1
468540|NCT01196026|1148045|P6|COMPLETED|Overall Study||24
468541|NCT01196026|1148046|P5|COMPLETED|Overall Study||42
468542|NCT01196026|1148047|P4|COMPLETED|Overall Study||10
468543|NCT01196026|1148048|P3|COMPLETED|Overall Study||23
468544|NCT01196026|1148049|P2|COMPLETED|Overall Study||36
468545|NCT01196026|1148050|P1|COMPLETED|Overall Study||9
468546|NCT01196026|1148045|P6|Completed at Day 28|Overall Study||24
468547|NCT01196026|1148046|P5|Completed at Day 28|Overall Study||42
468548|NCT01196026|1148047|P4|Completed at Day 28|Overall Study||10
468549|NCT01196026|1148048|P3|Completed at Day 28|Overall Study||23
468550|NCT01196026|1148049|P2|Completed at Day 28|Overall Study||41
468551|NCT01196026|1148050|P1|Completed at Day 28|Overall Study||9
468552|NCT01196026|1148045|P6|STARTED|Overall Study||24
468553|NCT01196026|1148046|P5|STARTED|Overall Study||43
468554|NCT01196026|1148047|P4|STARTED|Overall Study||10
468555|NCT01196026|1148048|P3|STARTED|Overall Study||23
468556|NCT01196026|1148049|P2|STARTED|Overall Study||44
468557|NCT01196026|1148050|P1|STARTED|Overall Study||10
468558|NCT01195948|1148286|P3|NOT COMPLETED|Overall Study||2
468559|NCT01195948|1148287|P2|NOT COMPLETED|Overall Study||1
468560|NCT01195948|1148288|P1|NOT COMPLETED|Overall Study||0
468561|NCT01195948|1148286|P3|COMPLETED|Overall Study||9
468562|NCT01195948|1148287|P2|COMPLETED|Overall Study||9
468563|NCT01195948|1148288|P1|COMPLETED|Overall Study||10
468564|NCT01195948|1148286|P3|Week 24|Overall Study||10
468565|NCT01195948|1148287|P2|Week 24|Overall Study||10
468566|NCT01195948|1148288|P1|Week 24|Overall Study||10
468567|NCT01195948|1148286|P3|STARTED|Overall Study||11
468568|NCT01195948|1148287|P2|STARTED|Overall Study||10
468569|NCT01195948|1148288|P1|STARTED|Overall Study||10
468570|NCT01195922|1148314|P1|NOT COMPLETED|Overall Study||0
468571|NCT01195922|1148314|P1|COMPLETED|Overall Study||16
468572|NCT01195922|1148314|P1|STARTED|Overall Study||16
468573|NCT01195844|1148320|P1|NOT COMPLETED|Overall Study||40
468574|NCT01195844|1148320|P1|COMPLETED|Overall Study||190
468575|NCT01195844|1148320|P1|STARTED|Overall Study||230
468576|NCT01195831|1148337|P2|NOT COMPLETED|Overall Study||10
468577|NCT01195831|1148338|P1|NOT COMPLETED|Overall Study||8
468578|NCT01195831|1148337|P2|COMPLETED|Overall Study||114
468579|NCT01195831|1148338|P1|COMPLETED|Overall Study||112
468580|NCT01195831|1148337|P2|STARTED|Overall Study||124
468581|NCT01195831|1148338|P1|STARTED|Overall Study||120
468582|NCT01195779|1148366|P14|NOT COMPLETED|Overall Study||0
468583|NCT01195779|1148367|P13|NOT COMPLETED|Overall Study||0
468584|NCT01195779|1148368|P12|NOT COMPLETED|Overall Study||0
468585|NCT01195779|1148369|P11|NOT COMPLETED|Overall Study||0
468586|NCT01195779|1148370|P10|NOT COMPLETED|Overall Study||0
468587|NCT01195779|1148371|P9|NOT COMPLETED|Overall Study||0
468588|NCT01195779|1148372|P8|NOT COMPLETED|Overall Study||0
468589|NCT01195779|1148373|P7|NOT COMPLETED|Overall Study||0
468590|NCT01195779|1148374|P6|NOT COMPLETED|Overall Study||0
468591|NCT01195779|1148375|P5|NOT COMPLETED|Overall Study||0
468592|NCT01195779|1148376|P4|NOT COMPLETED|Overall Study||0
468593|NCT01195779|1148377|P3|NOT COMPLETED|Overall Study||0
468594|NCT01195779|1148378|P2|NOT COMPLETED|Overall Study||0
468595|NCT01195779|1148379|P1|NOT COMPLETED|Overall Study||0
468596|NCT01195779|1148366|P14|COMPLETED|Overall Study||1
468597|NCT01195779|1148367|P13|COMPLETED|Overall Study||0
468598|NCT01195779|1148368|P12|COMPLETED|Overall Study||1
468599|NCT01195779|1148369|P11|COMPLETED|Overall Study||0
468600|NCT01195779|1148370|P10|COMPLETED|Overall Study||0
468601|NCT01195779|1148371|P9|COMPLETED|Overall Study||0
468602|NCT01195779|1148372|P8|COMPLETED|Overall Study||1
468603|NCT01195779|1148373|P7|COMPLETED|Overall Study||0
468604|NCT01195779|1148374|P6|COMPLETED|Overall Study||0
468605|NCT01195779|1148375|P5|COMPLETED|Overall Study||1
468606|NCT01195779|1148376|P4|COMPLETED|Overall Study||0
468607|NCT01195779|1148377|P3|COMPLETED|Overall Study||0
468608|NCT01195779|1148378|P2|COMPLETED|Overall Study||0
468609|NCT01195779|1148379|P1|COMPLETED|Overall Study||0
468610|NCT01195779|1148366|P14|STARTED|Overall Study||1
468611|NCT01195779|1148367|P13|STARTED|Overall Study||0
468612|NCT01195779|1148368|P12|STARTED|Overall Study||1
468613|NCT01195779|1148369|P11|STARTED|Overall Study||0
468614|NCT01195779|1148370|P10|STARTED|Overall Study||0
468615|NCT01195779|1148371|P9|STARTED|Overall Study||0
468616|NCT01195779|1148372|P8|STARTED|Overall Study||1
468617|NCT01195779|1148373|P7|STARTED|Overall Study||0
468618|NCT01195779|1148374|P6|STARTED|Overall Study||0
468619|NCT01195779|1148375|P5|STARTED|Overall Study||1
468620|NCT01195779|1148376|P4|STARTED|Overall Study||0
468621|NCT01195779|1148377|P3|STARTED|Overall Study||0
468622|NCT01195779|1148378|P2|STARTED|Overall Study||0
468623|NCT01195779|1148379|P1|STARTED|Overall Study||0
468624|NCT01195701|1148551|P2|NOT COMPLETED|Overall Study||5
468625|NCT01195701|1148552|P1|NOT COMPLETED|Overall Study||0
468626|NCT01195701|1148551|P2|COMPLETED|Overall Study||20
468627|NCT01195701|1148552|P1|COMPLETED|Overall Study||10
468628|NCT01195701|1148551|P2|STARTED|Overall Study||25
468629|NCT01195701|1148552|P1|STARTED|Overall Study||10
468630|NCT01195675|1148578|P1|NOT COMPLETED|Overall Study||3
468631|NCT01195675|1148578|P1|COMPLETED|Overall Study||27
468632|NCT01195675|1148578|P1|Received Placebo 2|Overall Study||28
468633|NCT01195675|1148578|P1|Received Placebo 1|Overall Study||29
468634|NCT01195675|1148578|P1|Received Moxifloxacin|Overall Study||29
468635|NCT01195675|1148578|P1|Received Empa 200mg|Overall Study||30
468636|NCT01195675|1148578|P1|Received Empa 25mg|Overall Study||28
468637|NCT01195675|1148578|P1|STARTED|Overall Study||30
468638|NCT01195662|1148611|P3|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||1
468639|NCT01195662|1148612|P2|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||0
468640|NCT01195662|1148613|P1|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||3
468641|NCT01195662|1148611|P3|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||119
468642|NCT01195662|1148612|P2|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||209
468643|NCT01195662|1148613|P1|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||200
468644|NCT01195662|1148611|P3|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|1 participant discontinued drug but remained in the study and entered the follow up period.|120
468645|NCT01195662|1148612|P2|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|2 participants completed treatment period but chose not to enter follow up period.|209
468646|NCT01195662|1148613|P1|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|1 participant discontinued drug but remained in study and entered Follow-Up.|203
468647|NCT01195662|1148611|P3|NOT COMPLETED|Double Blind Treatment Period||14
468648|NCT01195662|1148612|P2|NOT COMPLETED|Double Blind Treatment Period||14
468649|NCT01195662|1148613|P1|NOT COMPLETED|Double Blind Treatment Period||22
468650|NCT01195662|1148611|P3|COMPLETED|Double Blind Treatment Period||119
468651|NCT01195662|1148612|P2|COMPLETED|Double Blind Treatment Period||211
468652|NCT01195662|1148613|P1|COMPLETED|Double Blind Treatment Period||202
468653|NCT01195662|1148611|P3|STARTED|Double Blind Treatment Period||133
468654|NCT01195662|1148612|P2|STARTED|Double Blind Treatment Period||225
468655|NCT01195662|1148613|P1|STARTED|Double Blind Treatment Period||224
468656|NCT01195636|1148643|P2|NOT COMPLETED|Second Intervention (3 Weeks)||2
468657|NCT01195636|1148644|P1|NOT COMPLETED|Second Intervention (3 Weeks)||1
468658|NCT01195636|1148643|P2|COMPLETED|Second Intervention (3 Weeks)||27
468659|NCT01195636|1148644|P1|COMPLETED|Second Intervention (3 Weeks)||27
468660|NCT01195636|1148643|P2|STARTED|Second Intervention (3 Weeks)||29
468661|NCT01195636|1148644|P1|STARTED|Second Intervention (3 Weeks)||28
468662|NCT01195636|1148643|P2|NOT COMPLETED|Washout Period (2 Weeks)||3
468663|NCT01195636|1148644|P1|NOT COMPLETED|Washout Period (2 Weeks)||2
468664|NCT01195636|1148643|P2|COMPLETED|Washout Period (2 Weeks)||29
468665|NCT01195636|1148644|P1|COMPLETED|Washout Period (2 Weeks)||28
468666|NCT01195636|1148643|P2|STARTED|Washout Period (2 Weeks)||32
468667|NCT01195636|1148644|P1|STARTED|Washout Period (2 Weeks)||30
468668|NCT01195636|1148643|P2|NOT COMPLETED|First Intervention (3 Weeks)||3
468669|NCT01195636|1148644|P1|NOT COMPLETED|First Intervention (3 Weeks)||5
468670|NCT01195636|1148643|P2|COMPLETED|First Intervention (3 Weeks)||32
468671|NCT01195636|1148644|P1|COMPLETED|First Intervention (3 Weeks)||30
468672|NCT01195636|1148643|P2|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||35
468673|NCT01195636|1148644|P1|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||33
468674|NCT01195636|1148643|P2|STARTED|First Intervention (3 Weeks)||35
468675|NCT01195636|1148644|P1|STARTED|First Intervention (3 Weeks)||35
468676|NCT01195623|1148670|P2|NOT COMPLETED|Overall Study||37
468677|NCT01195623|1148671|P1|NOT COMPLETED|Overall Study||35
468678|NCT01195623|1148670|P2|COMPLETED|Overall Study|129 legs|108
468679|NCT01195623|1148671|P1|COMPLETED|Overall Study|127 legs|113
468680|NCT01195623|1148670|P2|STARTED|Overall Study|177 legs total operated|145
468681|NCT01195623|1148671|P1|STARTED|Overall Study|166 legs total operated|148
468682|NCT01195597|1148679|P1|NOT COMPLETED|Overall Study||13
468683|NCT01195597|1148679|P1|COMPLETED|Overall Study||27
468684|NCT01195597|1148679|P1|STARTED|Overall Study||40
468685|NCT01195584|1148687|P3|NOT COMPLETED|Overall Study||0
468686|NCT01195584|1148688|P2|NOT COMPLETED|Overall Study||0
468687|NCT01195584|1148689|P1|NOT COMPLETED|Overall Study||0
468688|NCT01195584|1148687|P3|COMPLETED|Overall Study||27
468689|NCT01195584|1148688|P2|COMPLETED|Overall Study||25
468690|NCT01195584|1148689|P1|COMPLETED|Overall Study||20
468691|NCT01195584|1148687|P3|STARTED|Overall Study||27
468692|NCT01195584|1148688|P2|STARTED|Overall Study||25
468693|NCT01195584|1148689|P1|STARTED|Overall Study||20
468694|NCT01195467|1148700|P1|NOT COMPLETED|Overall Study||10
468695|NCT01195467|1148700|P1|COMPLETED|Overall Study||30
468696|NCT01195467|1148700|P1|STARTED|Overall Study||40
468697|NCT01195415|1148705|P1|NOT COMPLETED|Overall Study||2
468698|NCT01195415|1148705|P1|COMPLETED|Overall Study||23
468699|NCT01195415|1148705|P1|STARTED|Overall Study||25
468700|NCT01195363|1148714|P2|NOT COMPLETED|Overall Study||9
468701|NCT01195363|1148715|P1|NOT COMPLETED|Overall Study||11
468702|NCT01195363|1148714|P2|COMPLETED|Overall Study||4
468703|NCT01195363|1148715|P1|COMPLETED|Overall Study||4
468704|NCT01195363|1148714|P2|STARTED|Overall Study||13
468705|NCT01195363|1148715|P1|STARTED|Overall Study||15
468706|NCT01195272|1148721|P1|NOT COMPLETED|Overall Study||4
468707|NCT01195272|1148721|P1|COMPLETED|Overall Study||17
468708|NCT01195272|1148721|P1|STARTED|Overall Study||21
468709|NCT01195116|1148740|P2|NOT COMPLETED|Overall Study||0
468710|NCT01195116|1148741|P1|NOT COMPLETED|Overall Study||0
468711|NCT01195116|1148740|P2|COMPLETED|Overall Study||20
468712|NCT01195116|1148741|P1|COMPLETED|Overall Study||21
468713|NCT01195116|1148740|P2|STARTED|Overall Study||20
468714|NCT01195116|1148741|P1|STARTED|Overall Study||21
468715|NCT01195103|1148750|P3|NOT COMPLETED|Overall Study||0
468716|NCT01195103|1148751|P2|NOT COMPLETED|Overall Study||0
468717|NCT01195103|1148752|P1|NOT COMPLETED|Overall Study||1
468718|NCT01195103|1148750|P3|COMPLETED|Overall Study||5
468719|NCT01195103|1148751|P2|COMPLETED|Overall Study||2
468720|NCT01195103|1148752|P1|COMPLETED|Overall Study|One patient withdrew after randomization but before received study drug.|5
468721|NCT01195103|1148750|P3|STARTED|Overall Study||5
468722|NCT01195103|1148751|P2|STARTED|Overall Study||2
468723|NCT01195103|1148752|P1|STARTED|Overall Study||6
468724|NCT01195090|1148762|P2|NOT COMPLETED|Overall Study||8
468725|NCT01195090|1148763|P1|NOT COMPLETED|Overall Study||6
468726|NCT01195090|1148762|P2|COMPLETED|Overall Study||52
468727|NCT01195090|1148763|P1|COMPLETED|Overall Study||54
468728|NCT01195090|1148762|P2|STARTED|Overall Study||60
468729|NCT01195090|1148763|P1|STARTED|Overall Study||60
468730|NCT01195025|1148821|P5|NOT COMPLETED|Third Intervention C||0
468731|NCT01195025|1148822|P4|NOT COMPLETED|Third Intervention C||0
468732|NCT01195025|1148823|P3|NOT COMPLETED|Third Intervention C||0
468733|NCT01195025|1148824|P2|NOT COMPLETED|Third Intervention C||0
468734|NCT01195025|1148825|P1|NOT COMPLETED|Third Intervention C||0
468735|NCT01195025|1148821|P5|COMPLETED|Third Intervention C||1
468736|NCT01195025|1148822|P4|COMPLETED|Third Intervention C||2
468737|NCT01195025|1148823|P3|COMPLETED|Third Intervention C||2
468738|NCT01195025|1148824|P2|COMPLETED|Third Intervention C||3
468739|NCT01195025|1148825|P1|COMPLETED|Third Intervention C||2
468740|NCT01195025|1148821|P5|STARTED|Third Intervention C||1
468741|NCT01195025|1148822|P4|STARTED|Third Intervention C||2
468742|NCT01195025|1148823|P3|STARTED|Third Intervention C||2
468743|NCT01195025|1148824|P2|STARTED|Third Intervention C||3
468744|NCT01195025|1148825|P1|STARTED|Third Intervention C||2
468745|NCT01195025|1148821|P5|NOT COMPLETED|Second Intervention B||0
468746|NCT01195025|1148822|P4|NOT COMPLETED|Second Intervention B||0
468747|NCT01195025|1148823|P3|NOT COMPLETED|Second Intervention B||0
468748|NCT01195025|1148824|P2|NOT COMPLETED|Second Intervention B||0
468749|NCT01195025|1148825|P1|NOT COMPLETED|Second Intervention B||0
468750|NCT01195025|1148821|P5|COMPLETED|Second Intervention B||1
468751|NCT01195025|1148822|P4|COMPLETED|Second Intervention B||2
468752|NCT01195025|1148823|P3|COMPLETED|Second Intervention B||2
468753|NCT01195025|1148824|P2|COMPLETED|Second Intervention B||3
468754|NCT01195025|1148825|P1|COMPLETED|Second Intervention B||2
468755|NCT01195025|1148821|P5|STARTED|Second Intervention B||1
468756|NCT01195025|1148822|P4|STARTED|Second Intervention B||2
468757|NCT01195025|1148823|P3|STARTED|Second Intervention B||2
468758|NCT01195025|1148824|P2|STARTED|Second Intervention B||3
468759|NCT01195025|1148825|P1|STARTED|Second Intervention B||2
468760|NCT01195025|1148821|P5|NOT COMPLETED|First Intervention A||0
468761|NCT01195025|1148822|P4|NOT COMPLETED|First Intervention A||0
468762|NCT01195025|1148823|P3|NOT COMPLETED|First Intervention A||0
468763|NCT01195025|1148824|P2|NOT COMPLETED|First Intervention A||0
468764|NCT01195025|1148825|P1|NOT COMPLETED|First Intervention A||0
468765|NCT01195025|1148821|P5|COMPLETED|First Intervention A||1
468766|NCT01195025|1148822|P4|COMPLETED|First Intervention A||2
468767|NCT01195025|1148823|P3|COMPLETED|First Intervention A||2
468768|NCT01195025|1148824|P2|COMPLETED|First Intervention A||3
468769|NCT01195025|1148825|P1|COMPLETED|First Intervention A||2
468770|NCT01195025|1148821|P5|STARTED|First Intervention A||1
468771|NCT01195025|1148822|P4|STARTED|First Intervention A||2
468772|NCT01195025|1148823|P3|STARTED|First Intervention A||2
468773|NCT01195025|1148824|P2|STARTED|First Intervention A||3
468774|NCT01195025|1148825|P1|STARTED|First Intervention A||2
468775|NCT01194999|1148832|P1|NOT COMPLETED|Overall Study||17
468776|NCT01194999|1148832|P1|COMPLETED|Overall Study||115
468777|NCT01194999|1148832|P1|STARTED|Overall Study||132
468778|NCT01194973|1148836|P1|NOT COMPLETED|26 Week Treatment Period||3
468779|NCT01194973|1148836|P1|COMPLETED|26 Week Treatment Period||38
468780|NCT01194973|1148836|P1|STARTED|26 Week Treatment Period||41
468781|NCT01194973|1148836|P1|NOT COMPLETED|Screening Period||3
468782|NCT01194973|1148836|P1|COMPLETED|Screening Period||41
468783|NCT01194973|1148836|P1|STARTED|Screening Period||44
468784|NCT01194908|1148851|P1|NOT COMPLETED|Overall Study||0
468785|NCT01194908|1148851|P1|COMPLETED|Overall Study||5
468786|NCT01194908|1148851|P1|STARTED|Overall Study||5
468787|NCT01194869|1148856|P1|NOT COMPLETED|Overall Study||4
468788|NCT01194869|1148856|P1|COMPLETED|Overall Study||21
468789|NCT01194869|1148856|P1|STARTED|Overall Study||25
468790|NCT01194856|1148864|P2|NOT COMPLETED|Overall Study||0
468791|NCT01194856|1148865|P1|NOT COMPLETED|Overall Study||1
468792|NCT01194856|1148864|P2|COMPLETED|Overall Study||0
468793|NCT01194856|1148865|P1|COMPLETED|Overall Study||0
468794|NCT01194856|1148864|P2|STARTED|Overall Study||0
468795|NCT01194856|1148865|P1|STARTED|Overall Study||1
468796|NCT01194830|1148887|P2|NOT COMPLETED|Overall Study||27
468797|NCT01194830|1148888|P1|NOT COMPLETED|Overall Study||36
468798|NCT01194830|1148887|P2|COMPLETED|Overall Study||83
468799|NCT01194830|1148888|P1|COMPLETED|Overall Study||88
468800|NCT01194830|1148887|P2|STARTED|Overall Study||110
468801|NCT01194830|1148888|P1|STARTED|Overall Study||124
468802|NCT01194674|1148910|P1|NOT COMPLETED|Overall Study||0
468803|NCT01194674|1148910|P1|COMPLETED|Overall Study||2
468804|NCT01194674|1148910|P1|STARTED|Overall Study||2
468805|NCT01194570|1148919|P2|NOT COMPLETED|Overall Study||488
468806|NCT01194570|1148920|P1|NOT COMPLETED|Overall Study||244
468807|NCT01194570|1148919|P2|COMPLETED|Overall Study||0
468808|NCT01194570|1148920|P1|COMPLETED|Overall Study|"Reason for discontinuation were provided for Core Treatment Completion."|0
468809|NCT01194570|1148919|P2|STARTED|Overall Study||488
468810|NCT01194570|1148920|P1|STARTED|Overall Study||244
468811|NCT01194531|1148940|P2|NOT COMPLETED|Overall Study||3
468812|NCT01194531|1148941|P1|NOT COMPLETED|Overall Study||5
468813|NCT01194531|1148940|P2|COMPLETED|Overall Study||27
468814|NCT01194531|1148941|P1|COMPLETED|Overall Study||24
468815|NCT01194531|1148940|P2|STARTED|Overall Study||30
468816|NCT01194531|1148941|P1|STARTED|Overall Study||29
468817|NCT01194479|1148949|P4|NOT COMPLETED|Overall Study||0
468818|NCT01194479|1148950|P3|NOT COMPLETED|Overall Study||0
468819|NCT01194479|1148951|P2|NOT COMPLETED|Overall Study||0
468820|NCT01194479|1148952|P1|NOT COMPLETED|Overall Study||0
468821|NCT01194479|1148949|P4|COMPLETED|Overall Study||5
468822|NCT01194479|1148950|P3|COMPLETED|Overall Study||2
468823|NCT01194479|1148951|P2|COMPLETED|Overall Study||4
468824|NCT01194479|1148952|P1|COMPLETED|Overall Study||3
468825|NCT01194479|1148949|P4|Cross-over at Second Visit|Overall Study||5
468826|NCT01194479|1148950|P3|Cross-over at Second Visit|Overall Study||2
468827|NCT01194479|1148951|P2|Cross-over at Second Visit|Overall Study||4
468828|NCT01194479|1148952|P1|Cross-over at Second Visit|Overall Study||3
468829|NCT01194479|1148949|P4|STARTED|Overall Study||5
468830|NCT01194479|1148950|P3|STARTED|Overall Study||2
468831|NCT01194479|1148951|P2|STARTED|Overall Study||4
468832|NCT01194479|1148952|P1|STARTED|Overall Study||3
468833|NCT01194453|1148976|P2|NOT COMPLETED|Overall Study||17
468834|NCT01194453|1148977|P1|NOT COMPLETED|Overall Study||17
468835|NCT01194453|1148976|P2|COMPLETED|Overall Study||127
468836|NCT01194453|1148977|P1|COMPLETED|Overall Study||127
468837|NCT01194453|1148976|P2|STARTED|Overall Study||144
468838|NCT01194453|1148977|P1|STARTED|Overall Study||144
468839|NCT01194440|1148985|P1|NOT COMPLETED|Overall Study||12
468840|NCT01194440|1148985|P1|COMPLETED|Overall Study||47
468841|NCT01194440|1148985|P1|STARTED|Overall Study||59
468842|NCT01194427|1148989|P1|NOT COMPLETED|Overall Study||0
468843|NCT01194427|1148989|P1|COMPLETED|Overall Study||2
468844|NCT01194427|1148989|P1|STARTED|Overall Study||2
468845|NCT01194414|1148995|P4|NOT COMPLETED|72 Weeks Open Label Extension||26
468846|NCT01194414|1148996|P3|NOT COMPLETED|72 Weeks Open Label Extension||8
468847|NCT01194414|1148997|P2|NOT COMPLETED|72 Weeks Open Label Extension||66
468848|NCT01194414|1148998|P1|NOT COMPLETED|72 Weeks Open Label Extension||79
468849|NCT01194414|1148995|P4|COMPLETED|72 Weeks Open Label Extension||160
468850|NCT01194414|1148996|P3|COMPLETED|72 Weeks Open Label Extension||40
468851|NCT01194414|1148997|P2|COMPLETED|72 Weeks Open Label Extension||311
468852|NCT01194414|1148998|P1|COMPLETED|72 Weeks Open Label Extension||445
468853|NCT01194414|1148995|P4|STARTED|72 Weeks Open Label Extension||186
468854|NCT01194414|1148996|P3|STARTED|72 Weeks Open Label Extension||48
468855|NCT01194414|1148997|P2|STARTED|72 Weeks Open Label Extension||377
468856|NCT01194414|1148998|P1|STARTED|72 Weeks Open Label Extension||524
468857|NCT01194414|1148995|P4|NOT COMPLETED|24 Weeks Double Blind Period||0
468858|NCT01194414|1148996|P3|NOT COMPLETED|24 Weeks Double Blind Period||0
468859|NCT01194414|1148997|P2|NOT COMPLETED|24 Weeks Double Blind Period||67
468860|NCT01194414|1148998|P1|NOT COMPLETED|24 Weeks Double Blind Period||59
468861|NCT01194414|1148995|P4|COMPLETED|24 Weeks Double Blind Period||0
468862|NCT01194414|1148996|P3|COMPLETED|24 Weeks Double Blind Period||0
468863|NCT01194414|1148997|P2|COMPLETED|24 Weeks Double Blind Period||564
468864|NCT01194414|1148998|P1|COMPLETED|24 Weeks Double Blind Period||572
468865|NCT01194414|1148995|P4|Per Protocol Population|24 Weeks Double Blind Period||0
468866|NCT01194414|1148996|P3|Per Protocol Population|24 Weeks Double Blind Period||0
468867|NCT01194414|1148997|P2|Per Protocol Population|24 Weeks Double Blind Period||537
468868|NCT01194414|1148998|P1|Per Protocol Population|24 Weeks Double Blind Period||558
468869|NCT01194414|1148995|P4|STARTED|24 Weeks Double Blind Period||0
468870|NCT01194414|1148996|P3|STARTED|24 Weeks Double Blind Period||0
468871|NCT01194414|1148997|P2|STARTED|24 Weeks Double Blind Period||631
468872|NCT01194414|1148998|P1|STARTED|24 Weeks Double Blind Period||631
468873|NCT01194297|1149060|P2|NOT COMPLETED|Overall Study||0
468874|NCT01194297|1149061|P1|NOT COMPLETED|Overall Study||0
468875|NCT01194297|1149060|P2|COMPLETED|Overall Study||1
468876|NCT01194297|1149061|P1|COMPLETED|Overall Study||2
468877|NCT01194297|1149060|P2|STARTED|Overall Study||1
468878|NCT01194297|1149061|P1|STARTED|Overall Study||2
468879|NCT01194258|1149069|P5|NOT COMPLETED|Period 2 (12 Weeks)||2
468880|NCT01194258|1149070|P4|NOT COMPLETED|Period 2 (12 Weeks)||0
468881|NCT01194258|1149071|P3|NOT COMPLETED|Period 2 (12 Weeks)||1
468882|NCT01194258|1149072|P2|NOT COMPLETED|Period 2 (12 Weeks)||2
468883|NCT01194258|1149073|P1|NOT COMPLETED|Period 2 (12 Weeks)||0
468884|NCT01194258|1149069|P5|COMPLETED|Period 2 (12 Weeks)||30
468885|NCT01194258|1149070|P4|COMPLETED|Period 2 (12 Weeks)||29
468886|NCT01194258|1149071|P3|COMPLETED|Period 2 (12 Weeks)||29
468887|NCT01194258|1149072|P2|COMPLETED|Period 2 (12 Weeks)||27
468888|NCT01194258|1149073|P1|COMPLETED|Period 2 (12 Weeks)||0
468889|NCT01194258|1149069|P5|STARTED|Period 2 (12 Weeks)||32
468890|NCT01194258|1149070|P4|STARTED|Period 2 (12 Weeks)||29
468891|NCT01194258|1149071|P3|STARTED|Period 2 (12 Weeks)||30
468892|NCT01194258|1149072|P2|STARTED|Period 2 (12 Weeks)||29
468893|NCT01194258|1149073|P1|STARTED|Period 2 (12 Weeks)||0
468894|NCT01194258|1149069|P5|NOT COMPLETED|Period 1 (12 Weeks)||1
468895|NCT01194258|1149070|P4|NOT COMPLETED|Period 1 (12 Weeks)||0
468896|NCT01194258|1149071|P3|NOT COMPLETED|Period 1 (12 Weeks)||0
468897|NCT01194258|1149072|P2|NOT COMPLETED|Period 1 (12 Weeks)||0
468898|NCT01194258|1149073|P1|NOT COMPLETED|Period 1 (12 Weeks)||0
468899|NCT01194258|1149069|P5|COMPLETED|Period 1 (12 Weeks)||32
468900|NCT01194258|1149070|P4|COMPLETED|Period 1 (12 Weeks)||29
468901|NCT01194258|1149071|P3|COMPLETED|Period 1 (12 Weeks)||30
468902|NCT01194258|1149072|P2|COMPLETED|Period 1 (12 Weeks)||29
468903|NCT01194258|1149073|P1|COMPLETED|Period 1 (12 Weeks)||0
468904|NCT01194258|1149069|P5|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||33
468905|NCT01194258|1149070|P4|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29
468906|NCT01194258|1149071|P3|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||30
468907|NCT01194258|1149072|P2|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29
468908|NCT01194258|1149073|P1|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||0
468909|NCT01194258|1149069|P5|STARTED|Period 1 (12 Weeks)|After the titration phase, 33 participants were randomized to the Aspart-PH20/Insulin lispro group.|33
468910|NCT01194258|1149070|P4|STARTED|Period 1 (12 Weeks)|After the titration phase, 29 participants were randomized to the Insulin lispro/Aspart-PH20 group.|29
468911|NCT01194258|1149071|P3|STARTED|Period 1 (12 Weeks)|After the titration phase, 30 participants were randomized to the Lispro-PH20/Insulin lispro group.|30
468912|NCT01194258|1149072|P2|STARTED|Period 1 (12 Weeks)|After the titration phase, 29 participants were randomized to the Insulin lispro/Lispro-PH20 group.|29
468913|NCT01194258|1149073|P1|STARTED|Period 1 (12 Weeks)|Participants were randomized to the Insulin lispro or an Analog-PH20 group after titration.|0
468914|NCT01194258|1149069|P5|NOT COMPLETED|Titration Period||0
468915|NCT01194258|1149070|P4|NOT COMPLETED|Titration Period||0
468916|NCT01194258|1149071|P3|NOT COMPLETED|Titration Period||0
468917|NCT01194258|1149072|P2|NOT COMPLETED|Titration Period||0
468918|NCT01194258|1149073|P1|NOT COMPLETED|Titration Period||11
468919|NCT01194258|1149069|P5|COMPLETED|Titration Period||0
468920|NCT01194258|1149070|P4|COMPLETED|Titration Period||0
468921|NCT01194258|1149071|P3|COMPLETED|Titration Period||0
468922|NCT01194258|1149072|P2|COMPLETED|Titration Period||0
468923|NCT01194258|1149073|P1|COMPLETED|Titration Period||121
468924|NCT01194258|1149069|P5|STARTED|Titration Period||0
468925|NCT01194258|1149070|P4|STARTED|Titration Period||0
468926|NCT01194258|1149071|P3|STARTED|Titration Period||0
468927|NCT01194258|1149072|P2|STARTED|Titration Period||0
468928|NCT01194258|1149073|P1|STARTED|Titration Period||132
468929|NCT01194245|1149097|P5|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
468930|NCT01194245|1149098|P4|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
468931|NCT01194245|1149099|P3|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
468932|NCT01194245|1149100|P2|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
468933|NCT01194245|1149101|P1|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
468934|NCT01194245|1149097|P5|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||28
468935|NCT01194245|1149098|P4|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29
468936|NCT01194245|1149099|P3|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||27
468937|NCT01194245|1149100|P2|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29
468938|NCT01194245|1149101|P1|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
468939|NCT01194245|1149097|P5|STARTED|Treatment Period 2 (Weeks 12 to 24)||28
468940|NCT01194245|1149098|P4|STARTED|Treatment Period 2 (Weeks 12 to 24)||29
468941|NCT01194245|1149099|P3|STARTED|Treatment Period 2 (Weeks 12 to 24)||27
468942|NCT01194245|1149100|P2|STARTED|Treatment Period 2 (Weeks 12 to 24)||29
468943|NCT01194245|1149101|P1|STARTED|Treatment Period 2 (Weeks 12 to 24)||0
468944|NCT01194245|1149097|P5|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||2
468945|NCT01194245|1149098|P4|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1
468946|NCT01194245|1149099|P3|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1
468947|NCT01194245|1149100|P2|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
468948|NCT01194245|1149101|P1|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
468949|NCT01194245|1149097|P5|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||28
468950|NCT01194245|1149098|P4|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29
468951|NCT01194245|1149099|P3|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||27
468952|NCT01194245|1149100|P2|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29
468953|NCT01194245|1149101|P1|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
468954|NCT01194245|1149097|P5|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30
468955|NCT01194245|1149098|P4|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30
468956|NCT01194245|1149099|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||28
468957|NCT01194245|1149100|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||29
468958|NCT01194245|1149101|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||0
468959|NCT01194245|1149097|P5|STARTED|Treatment Period 1 (Weeks 0 to 12)||30
468960|NCT01194245|1149098|P4|STARTED|Treatment Period 1 (Weeks 0 to 12)||30
468961|NCT01194245|1149099|P3|STARTED|Treatment Period 1 (Weeks 0 to 12)||28
468962|NCT01194245|1149100|P2|STARTED|Treatment Period 1 (Weeks 0 to 12)||29
468963|NCT01194245|1149101|P1|STARTED|Treatment Period 1 (Weeks 0 to 12)||0
468964|NCT01194245|1149097|P5|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
468965|NCT01194245|1149098|P4|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
468966|NCT01194245|1149099|P3|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
468967|NCT01194245|1149100|P2|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
468968|NCT01194245|1149101|P1|NOT COMPLETED|Titration Period (4 to 6 Weeks)||18
468969|NCT01194245|1149097|P5|COMPLETED|Titration Period (4 to 6 Weeks)||0
468970|NCT01194245|1149098|P4|COMPLETED|Titration Period (4 to 6 Weeks)||0
468971|NCT01194245|1149099|P3|COMPLETED|Titration Period (4 to 6 Weeks)||0
468972|NCT01194245|1149100|P2|COMPLETED|Titration Period (4 to 6 Weeks)||0
468973|NCT01194245|1149101|P1|COMPLETED|Titration Period (4 to 6 Weeks)|Participants that completed the Titration Period were randomized to Treatment Period 1.|117
468974|NCT01194245|1149097|P5|STARTED|Titration Period (4 to 6 Weeks)||0
468975|NCT01194245|1149098|P4|STARTED|Titration Period (4 to 6 Weeks)||0
468976|NCT01194245|1149099|P3|STARTED|Titration Period (4 to 6 Weeks)||0
468977|NCT01194245|1149100|P2|STARTED|Titration Period (4 to 6 Weeks)||0
468978|NCT01194245|1149101|P1|STARTED|Titration Period (4 to 6 Weeks)||135
468979|NCT01194219|1149122|P10|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||112
468980|NCT01194219|1149123|P9|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||220
468981|NCT01194219|1149124|P8|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
468982|NCT01194219|1149125|P7|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
468983|NCT01194219|1149126|P6|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
468984|NCT01194219|1149127|P5|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
468985|NCT01194219|1149128|P4|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
468986|NCT01194219|1149129|P3|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
468987|NCT01194219|1149130|P2|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
468988|NCT01194219|1149131|P1|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
468989|NCT01194219|1149122|P10|COMPLETED|Long-Term Extension Weeks 52 to 260||41
468990|NCT01194219|1149123|P9|COMPLETED|Long-Term Extension Weeks 52 to 260||86
468991|NCT01194219|1149124|P8|COMPLETED|Long-Term Extension Weeks 52 to 260||0
468992|NCT01194219|1149125|P7|COMPLETED|Long-Term Extension Weeks 52 to 260||0
468993|NCT01194219|1149126|P6|COMPLETED|Long-Term Extension Weeks 52 to 260||0
468994|NCT01194219|1149127|P5|COMPLETED|Long-Term Extension Weeks 52 to 260||0
468995|NCT01194219|1149128|P4|COMPLETED|Long-Term Extension Weeks 52 to 260||0
468996|NCT01194219|1149129|P3|COMPLETED|Long-Term Extension Weeks 52 to 260||0
468997|NCT01194219|1149130|P2|COMPLETED|Long-Term Extension Weeks 52 to 260||0
468998|NCT01194219|1149131|P1|COMPLETED|Long-Term Extension Weeks 52 to 260||0
468999|NCT01194219|1149122|P10|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||153
469000|NCT01194219|1149123|P9|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||304
469001|NCT01194219|1149124|P8|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
469002|NCT01194219|1149125|P7|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
469003|NCT01194219|1149126|P6|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
469004|NCT01194219|1149127|P5|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
469005|NCT01194219|1149128|P4|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
469006|NCT01194219|1149129|P3|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
469007|NCT01194219|1149130|P2|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
469008|NCT01194219|1149131|P1|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
469009|NCT01194219|1149122|P10|STARTED|Long-Term Extension Weeks 52 to 260||153
469010|NCT01194219|1149123|P9|STARTED|Long-Term Extension Weeks 52 to 260||306
469011|NCT01194219|1149124|P8|STARTED|Long-Term Extension Weeks 52 to 260||0
469012|NCT01194219|1149125|P7|STARTED|Long-Term Extension Weeks 52 to 260||0
469013|NCT01194219|1149126|P6|STARTED|Long-Term Extension Weeks 52 to 260||0
469014|NCT01194219|1149127|P5|STARTED|Long-Term Extension Weeks 52 to 260||0
469015|NCT01194219|1149128|P4|STARTED|Long-Term Extension Weeks 52 to 260||0
469016|NCT01194219|1149129|P3|STARTED|Long-Term Extension Weeks 52 to 260||0
469017|NCT01194219|1149130|P2|STARTED|Long-Term Extension Weeks 52 to 260||0
469018|NCT01194219|1149131|P1|STARTED|Long-Term Extension Weeks 52 to 260||0
469019|NCT01194219|1149122|P10|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
469020|NCT01194219|1149123|P9|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
469021|NCT01194219|1149124|P8|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||45
469022|NCT01194219|1149125|P7|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||61
469023|NCT01194219|1149126|P6|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||4
469024|NCT01194219|1149127|P5|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||4
469025|NCT01194219|1149128|P4|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
469026|NCT01194219|1149129|P3|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
469027|NCT01194219|1149130|P2|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
469028|NCT01194219|1149131|P1|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
469029|NCT01194219|1149122|P10|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
469030|NCT01194219|1149123|P9|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
469031|NCT01194219|1149124|P8|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|10 participants discontinued after Week 52 but prior to entry into the long term extension study|163
469032|NCT01194219|1149125|P7|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|18 participants discontinued after Week 52 but prior to entry into the long term extension study|184
469033|NCT01194219|1149126|P6|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|5 participants discontinued after Week 52 but prior to entry into the long term extension study|73
469034|NCT01194219|1149127|P5|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|1 participant discontinued after Week 52 but prior to entry into the long term extension study|73
469035|NCT01194219|1149128|P4|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
469036|NCT01194219|1149129|P3|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
469037|NCT01194219|1149130|P2|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
469038|NCT01194219|1149131|P1|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
469039|NCT01194219|1149122|P10|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
469040|NCT01194219|1149123|P9|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
469041|NCT01194219|1149124|P8|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||91
469042|NCT01194219|1149125|P7|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||126
469043|NCT01194219|1149126|P6|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
469044|NCT01194219|1149127|P5|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
469045|NCT01194219|1149128|P4|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
469046|NCT01194219|1149129|P3|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
469047|NCT01194219|1149130|P2|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
469048|NCT01194219|1149131|P1|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
469049|NCT01194219|1149122|P10|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
469050|NCT01194219|1149123|P9|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
469051|NCT01194219|1149124|P8|STARTED|Randomized Withdrawal Phase-Weeks 32-52||208
469052|NCT01194219|1149125|P7|STARTED|Randomized Withdrawal Phase-Weeks 32-52||245
469053|NCT01194219|1149126|P6|STARTED|Randomized Withdrawal Phase-Weeks 32-52|25 participants discontinued after week 32 but prior to entry into the Randomized withdrawal Phase|77
469054|NCT01194219|1149127|P5|STARTED|Randomized Withdrawal Phase-Weeks 32-52|7 participants discontinued after week 32 but prior to entry into the Randomized withdrawal Phase|77
469055|NCT01194219|1149128|P4|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
469056|NCT01194219|1149129|P3|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
469057|NCT01194219|1149130|P2|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
469058|NCT01194219|1149131|P1|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
469059|NCT01194219|1149122|P10|NOT COMPLETED|Maintenance Phase Weeks16-32||0
469060|NCT01194219|1149123|P9|NOT COMPLETED|Maintenance Phase Weeks16-32||0
469061|NCT01194219|1149124|P8|NOT COMPLETED|Maintenance Phase Weeks16-32||0
469062|NCT01194219|1149125|P7|NOT COMPLETED|Maintenance Phase Weeks16-32||0
469063|NCT01194219|1149126|P6|NOT COMPLETED|Maintenance Phase Weeks16-32||0
469064|NCT01194219|1149127|P5|NOT COMPLETED|Maintenance Phase Weeks16-32||0
469065|NCT01194219|1149128|P4|NOT COMPLETED|Maintenance Phase Weeks16-32||30
469066|NCT01194219|1149129|P3|NOT COMPLETED|Maintenance Phase Weeks16-32||70
469067|NCT01194219|1149130|P2|NOT COMPLETED|Maintenance Phase Weeks16-32||0
469068|NCT01194219|1149131|P1|NOT COMPLETED|Maintenance Phase Weeks16-32||0
469069|NCT01194219|1149122|P10|COMPLETED|Maintenance Phase Weeks16-32||0
469070|NCT01194219|1149123|P9|COMPLETED|Maintenance Phase Weeks16-32||0
469071|NCT01194219|1149124|P8|COMPLETED|Maintenance Phase Weeks16-32||0
469072|NCT01194219|1149125|P7|COMPLETED|Maintenance Phase Weeks16-32||0
469073|NCT01194219|1149126|P6|COMPLETED|Maintenance Phase Weeks16-32||0
469074|NCT01194219|1149127|P5|COMPLETED|Maintenance Phase Weeks16-32||0
469075|NCT01194219|1149128|P4|COMPLETED|Maintenance Phase Weeks16-32||215
469076|NCT01194219|1149129|P3|COMPLETED|Maintenance Phase Weeks16-32||424
469077|NCT01194219|1149130|P2|COMPLETED|Maintenance Phase Weeks16-32||0
469078|NCT01194219|1149131|P1|COMPLETED|Maintenance Phase Weeks16-32||0
469079|NCT01194219|1149122|P10|Received Apremilast|Maintenance Phase Weeks16-32||0
469080|NCT01194219|1149123|P9|Received Apremilast|Maintenance Phase Weeks16-32||0
469081|NCT01194219|1149124|P8|Received Apremilast|Maintenance Phase Weeks16-32||0
469082|NCT01194219|1149125|P7|Received Apremilast|Maintenance Phase Weeks16-32||0
469083|NCT01194219|1149126|P6|Received Apremilast|Maintenance Phase Weeks16-32||0
469084|NCT01194219|1149127|P5|Received Apremilast|Maintenance Phase Weeks16-32||0
469085|NCT01194219|1149128|P4|Received Apremilast|Maintenance Phase Weeks16-32|1 participant elected not to participate at the time the first dose was dispensed.|244
469086|NCT01194219|1149129|P3|Received Apremilast|Maintenance Phase Weeks16-32|1 participant elected not to participate at the time the first dose was dispensed.|493
469087|NCT01194219|1149130|P2|Received Apremilast|Maintenance Phase Weeks16-32||0
469088|NCT01194219|1149131|P1|Received Apremilast|Maintenance Phase Weeks16-32||0
469089|NCT01194219|1149122|P10|STARTED|Maintenance Phase Weeks16-32||0
469090|NCT01194219|1149123|P9|STARTED|Maintenance Phase Weeks16-32||0
469091|NCT01194219|1149124|P8|STARTED|Maintenance Phase Weeks16-32||0
469092|NCT01194219|1149125|P7|STARTED|Maintenance Phase Weeks16-32||0
469093|NCT01194219|1149126|P6|STARTED|Maintenance Phase Weeks16-32||0
469094|NCT01194219|1149127|P5|STARTED|Maintenance Phase Weeks16-32||0
469095|NCT01194219|1149128|P4|STARTED|Maintenance Phase Weeks16-32|4 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|245
469096|NCT01194219|1149129|P3|STARTED|Maintenance Phase Weeks16-32|9 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|494
469097|NCT01194219|1149130|P2|STARTED|Maintenance Phase Weeks16-32||0
469098|NCT01194219|1149131|P1|STARTED|Maintenance Phase Weeks16-32||0
469099|NCT01194219|1149122|P10|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
469100|NCT01194219|1149123|P9|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
469101|NCT01194219|1149124|P8|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
469102|NCT01194219|1149125|P7|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
469103|NCT01194219|1149126|P6|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
469104|NCT01194219|1149127|P5|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
469105|NCT01194219|1149128|P4|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
469106|NCT01194219|1149129|P3|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
469107|NCT01194219|1149130|P2|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||33
469108|NCT01194219|1149131|P1|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||59
469109|NCT01194219|1149122|P10|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
469110|NCT01194219|1149123|P9|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
469111|NCT01194219|1149124|P8|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
469112|NCT01194219|1149125|P7|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
469113|NCT01194219|1149126|P6|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
469114|NCT01194219|1149127|P5|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
469115|NCT01194219|1149128|P4|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
469116|NCT01194219|1149129|P3|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
469117|NCT01194219|1149130|P2|COMPLETED|Placebo-Controlled Phase Weeks 0-16||249
469118|NCT01194219|1149131|P1|COMPLETED|Placebo-Controlled Phase Weeks 0-16||503
469119|NCT01194219|1149122|P10|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
469120|NCT01194219|1149123|P9|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
469121|NCT01194219|1149124|P8|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
469122|NCT01194219|1149125|P7|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
469123|NCT01194219|1149126|P6|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
469124|NCT01194219|1149127|P5|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
469125|NCT01194219|1149128|P4|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
469126|NCT01194219|1149129|P3|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
469127|NCT01194219|1149130|P2|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||282
469128|NCT01194219|1149131|P1|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||560
469129|NCT01194219|1149122|P10|STARTED|Placebo-Controlled Phase Weeks 0-16||0
469130|NCT01194219|1149123|P9|STARTED|Placebo-Controlled Phase Weeks 0-16||0
469131|NCT01194219|1149124|P8|STARTED|Placebo-Controlled Phase Weeks 0-16||0
469132|NCT01194219|1149125|P7|STARTED|Placebo-Controlled Phase Weeks 0-16||0
469133|NCT01194219|1149126|P6|STARTED|Placebo-Controlled Phase Weeks 0-16||0
469134|NCT01194219|1149127|P5|STARTED|Placebo-Controlled Phase Weeks 0-16||0
469135|NCT01194219|1149128|P4|STARTED|Placebo-Controlled Phase Weeks 0-16||0
469136|NCT01194219|1149129|P3|STARTED|Placebo-Controlled Phase Weeks 0-16||0
469137|NCT01194219|1149130|P2|STARTED|Placebo-Controlled Phase Weeks 0-16||282
469138|NCT01194219|1149131|P1|STARTED|Placebo-Controlled Phase Weeks 0-16||562
469139|NCT01194154|1149165|P2|NOT COMPLETED|Overall Study||33
469140|NCT01194154|1149166|P1|NOT COMPLETED|Overall Study||49
469141|NCT01194154|1149165|P2|COMPLETED|Overall Study||91
469142|NCT01194154|1149166|P1|COMPLETED|Overall Study||68
469143|NCT01194154|1149165|P2|Safety Analysis Set|Overall Study|3 participants randomized to placebo but received MIRCERA and included in MIRCERA arm (as treated).|117
469144|NCT01194154|1149166|P1|Safety Analysis Set|Overall Study|3 participants randomized to placebo but received MIRCERA and included in MIRCERA arm (as treated).|118
469145|NCT01194154|1149165|P2|Full Analysis Set|Overall Study||120
469146|NCT01194154|1149166|P1|Full Analysis Set|Overall Study||115
469147|NCT01194154|1149165|P2|STARTED|Overall Study||124
469148|NCT01194154|1149166|P1|STARTED|Overall Study||117
469149|NCT01194089|1149186|P2|NOT COMPLETED|Overall Study||0
469150|NCT01194089|1149187|P1|NOT COMPLETED|Overall Study||0
469151|NCT01194089|1149186|P2|COMPLETED|Overall Study||47
469152|NCT01194089|1149187|P1|COMPLETED|Overall Study||42
469153|NCT01194089|1149186|P2|STARTED|Overall Study||47
469154|NCT01194089|1149187|P1|STARTED|Overall Study||42
469155|NCT01193920|1149207|P10|NOT COMPLETED|Overall Study||7
469156|NCT01193920|1149208|P9|NOT COMPLETED|Overall Study||5
469157|NCT01193920|1149209|P8|NOT COMPLETED|Overall Study||4
469158|NCT01193920|1149210|P7|NOT COMPLETED|Overall Study||6
469159|NCT01193920|1149211|P6|NOT COMPLETED|Overall Study||4
469160|NCT01193920|1149212|P5|NOT COMPLETED|Overall Study||6
469161|NCT01193920|1149213|P4|NOT COMPLETED|Overall Study||4
469162|NCT01193920|1149214|P3|NOT COMPLETED|Overall Study||6
469163|NCT01193920|1149215|P2|NOT COMPLETED|Overall Study||0
469164|NCT01193920|1149216|P1|NOT COMPLETED|Overall Study||3
469165|NCT01193920|1149207|P10|COMPLETED|Overall Study||74
469166|NCT01193920|1149208|P9|COMPLETED|Overall Study||71
469167|NCT01193920|1149209|P8|COMPLETED|Overall Study||76
469168|NCT01193920|1149210|P7|COMPLETED|Overall Study||74
469169|NCT01193920|1149211|P6|COMPLETED|Overall Study||76
469170|NCT01193920|1149212|P5|COMPLETED|Overall Study||74
469171|NCT01193920|1149213|P4|COMPLETED|Overall Study||76
469172|NCT01193920|1149214|P3|COMPLETED|Overall Study||74
469173|NCT01193920|1149215|P2|COMPLETED|Overall Study||20
469174|NCT01193920|1149216|P1|COMPLETED|Overall Study||37
469175|NCT01193920|1149207|P10|STARTED|Overall Study||81
469176|NCT01193920|1149208|P9|STARTED|Overall Study||76
469177|NCT01193920|1149209|P8|STARTED|Overall Study||80
469178|NCT01193920|1149210|P7|STARTED|Overall Study||80
469179|NCT01193920|1149211|P6|STARTED|Overall Study||80
469180|NCT01193920|1149212|P5|STARTED|Overall Study||80
469181|NCT01193920|1149213|P4|STARTED|Overall Study||80
469182|NCT01193920|1149214|P3|STARTED|Overall Study||80
469183|NCT01193920|1149215|P2|STARTED|Overall Study||20
469184|NCT01193920|1149216|P1|STARTED|Overall Study||40
469185|NCT01193907|1149270|P4|NOT COMPLETED|Overall Study||1
469186|NCT01193907|1149271|P3|NOT COMPLETED|Overall Study||0
469187|NCT01193907|1149272|P2|NOT COMPLETED|Overall Study||0
469188|NCT01193907|1149273|P1|NOT COMPLETED|Overall Study||1
469189|NCT01193907|1149270|P4|COMPLETED|Overall Study||21
469190|NCT01193907|1149271|P3|COMPLETED|Overall Study||22
469191|NCT01193907|1149272|P2|COMPLETED|Overall Study||22
469192|NCT01193907|1149273|P1|COMPLETED|Overall Study||21
469193|NCT01193907|1149270|P4|STARTED|Overall Study||22
469194|NCT01193907|1149271|P3|STARTED|Overall Study||22
469195|NCT01193907|1149272|P2|STARTED|Overall Study||22
469196|NCT01193907|1149273|P1|STARTED|Overall Study||22
469197|NCT01193868|1149295|P1|NOT COMPLETED|Overall Study||0
469198|NCT01193868|1149295|P1|COMPLETED|Overall Study||6
469199|NCT01193868|1149295|P1|STARTED|Overall Study||6
469200|NCT01193842|1149312|P5|NOT COMPLETED|Phase II: Randomized Groups||10
469201|NCT01193842|1149313|P4|NOT COMPLETED|Phase II: Randomized Groups||12
469202|NCT01193842|1149314|P3|NOT COMPLETED|Phase II: Randomized Groups||0
469203|NCT01193842|1149315|P2|NOT COMPLETED|Phase II: Randomized Groups||0
469204|NCT01193842|1149316|P1|NOT COMPLETED|Phase II: Randomized Groups||0
469205|NCT01193842|1149312|P5|COMPLETED|Phase II: Randomized Groups||36
469206|NCT01193842|1149313|P4|COMPLETED|Phase II: Randomized Groups||33
469207|NCT01193842|1149314|P3|COMPLETED|Phase II: Randomized Groups||0
469208|NCT01193842|1149315|P2|COMPLETED|Phase II: Randomized Groups||0
469209|NCT01193842|1149316|P1|COMPLETED|Phase II: Randomized Groups||0
469210|NCT01193842|1149312|P5|STARTED|Phase II: Randomized Groups||46
469211|NCT01193842|1149313|P4|STARTED|Phase II: Randomized Groups||45
469212|NCT01193842|1149314|P3|STARTED|Phase II: Randomized Groups||0
469213|NCT01193842|1149315|P2|STARTED|Phase II: Randomized Groups||0
469214|NCT01193842|1149316|P1|STARTED|Phase II: Randomized Groups||0
469215|NCT01193842|1149312|P5|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
469216|NCT01193842|1149313|P4|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
469217|NCT01193842|1149314|P3|NOT COMPLETED|Phase I: VR-CHOP, DL 1||1
469218|NCT01193842|1149315|P2|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
469219|NCT01193842|1149316|P1|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
469220|NCT01193842|1149312|P5|COMPLETED|Phase I: VR-CHOP, DL 1||0
469221|NCT01193842|1149313|P4|COMPLETED|Phase I: VR-CHOP, DL 1||0
469222|NCT01193842|1149314|P3|COMPLETED|Phase I: VR-CHOP, DL 1||1
469223|NCT01193842|1149315|P2|COMPLETED|Phase I: VR-CHOP, DL 1||0
469224|NCT01193842|1149316|P1|COMPLETED|Phase I: VR-CHOP, DL 1||0
469225|NCT01193842|1149312|P5|STARTED|Phase I: VR-CHOP, DL 1||0
469226|NCT01193842|1149313|P4|STARTED|Phase I: VR-CHOP, DL 1||0
469227|NCT01193842|1149314|P3|STARTED|Phase I: VR-CHOP, DL 1||2
469228|NCT01193842|1149315|P2|STARTED|Phase I: VR-CHOP, DL 1||0
469229|NCT01193842|1149316|P1|STARTED|Phase I: VR-CHOP, DL 1||0
469230|NCT01193842|1149312|P5|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
469231|NCT01193842|1149313|P4|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
469232|NCT01193842|1149314|P3|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
469233|NCT01193842|1149315|P2|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
469234|NCT01193842|1149316|P1|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||1
469235|NCT01193842|1149312|P5|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
469236|NCT01193842|1149313|P4|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
469237|NCT01193842|1149314|P3|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
469238|NCT01193842|1149315|P2|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
469239|NCT01193842|1149316|P1|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||3
469240|NCT01193842|1149312|P5|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
469241|NCT01193842|1149313|P4|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
469242|NCT01193842|1149314|P3|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
469243|NCT01193842|1149315|P2|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
469244|NCT01193842|1149316|P1|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||4
469245|NCT01193842|1149312|P5|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
469246|NCT01193842|1149313|P4|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
469247|NCT01193842|1149314|P3|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
469248|NCT01193842|1149315|P2|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||1
469249|NCT01193842|1149316|P1|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
469250|NCT01193842|1149312|P5|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
469251|NCT01193842|1149313|P4|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
469252|NCT01193842|1149314|P3|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
469253|NCT01193842|1149315|P2|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||6
469254|NCT01193842|1149316|P1|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
469255|NCT01193842|1149312|P5|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
469256|NCT01193842|1149313|P4|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
469257|NCT01193842|1149314|P3|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
469258|NCT01193842|1149315|P2|STARTED|Phase I: VR-DA-EPOCH, DL 2||7
469259|NCT01193842|1149316|P1|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
469260|NCT01193842|1149312|P5|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
469261|NCT01193842|1149313|P4|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
469262|NCT01193842|1149314|P3|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
469263|NCT01193842|1149315|P2|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
469264|NCT01193842|1149316|P1|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
469265|NCT01193842|1149312|P5|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
469266|NCT01193842|1149313|P4|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
469267|NCT01193842|1149314|P3|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
469268|NCT01193842|1149315|P2|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
469269|NCT01193842|1149316|P1|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||3
469270|NCT01193842|1149312|P5|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
469271|NCT01193842|1149313|P4|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
469272|NCT01193842|1149314|P3|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
469273|NCT01193842|1149315|P2|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
469274|NCT01193842|1149316|P1|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||3
469275|NCT01193686|1149351|P2|NOT COMPLETED|Overall Study||1
469276|NCT01193686|1149352|P1|NOT COMPLETED|Overall Study||7
469277|NCT01193686|1149351|P2|COMPLETED|Overall Study||8
469278|NCT01193686|1149352|P1|COMPLETED|Overall Study||8
469279|NCT01193686|1149351|P2|Completed Visits and Final Assessment|Overall Study||8
469280|NCT01193686|1149352|P1|Completed Visits and Final Assessment|Overall Study||8
469281|NCT01193686|1149351|P2|Completed Mentor Training|Overall Study|Not applicable. Recipients were not required to complete training.|0
469282|NCT01193686|1149352|P1|Completed Mentor Training|Overall Study||9
469283|NCT01193686|1149351|P2|Completed Baseline Assessment|Overall Study||9
469284|NCT01193686|1149352|P1|Completed Baseline Assessment|Overall Study||15
469285|NCT01193686|1149351|P2|STARTED|Overall Study||9
469286|NCT01193686|1149352|P1|STARTED|Overall Study||15
469287|NCT01193660|1149369|P3|NOT COMPLETED|Overall Study||2
469288|NCT01193660|1149370|P2|NOT COMPLETED|Overall Study||3
469289|NCT01193660|1149371|P1|NOT COMPLETED|Overall Study||4
469290|NCT01193660|1149369|P3|COMPLETED|Overall Study||32
469291|NCT01193660|1149370|P2|COMPLETED|Overall Study||33
469292|NCT01193660|1149371|P1|COMPLETED|Overall Study||31
469293|NCT01193660|1149369|P3|STARTED|Overall Study||34
469294|NCT01193660|1149370|P2|STARTED|Overall Study||36
469295|NCT01193660|1149371|P1|STARTED|Overall Study||35
469296|NCT01193608|1149415|P6|NOT COMPLETED|Overall Study||2
469297|NCT01193608|1149416|P5|NOT COMPLETED|Overall Study||5
469298|NCT01193608|1149417|P4|NOT COMPLETED|Overall Study||3
469299|NCT01193608|1149418|P3|NOT COMPLETED|Overall Study||2
469300|NCT01193608|1149419|P2|NOT COMPLETED|Overall Study||2
469301|NCT01193608|1149420|P1|NOT COMPLETED|Overall Study||0
469302|NCT01193608|1149415|P6|COMPLETED|Overall Study||17
469303|NCT01193608|1149416|P5|COMPLETED|Overall Study||19
469304|NCT01193608|1149417|P4|COMPLETED|Overall Study||14
469305|NCT01193608|1149418|P3|COMPLETED|Overall Study||14
469306|NCT01193608|1149419|P2|COMPLETED|Overall Study||4
469307|NCT01193608|1149420|P1|COMPLETED|Overall Study||6
469308|NCT01193608|1149415|P6|STARTED|Overall Study||19
469309|NCT01193608|1149416|P5|STARTED|Overall Study||24
469310|NCT01193608|1149417|P4|STARTED|Overall Study||17
469311|NCT01193608|1149418|P3|STARTED|Overall Study||16
469312|NCT01193608|1149419|P2|STARTED|Overall Study||6
469313|NCT01193608|1149420|P1|STARTED|Overall Study||6
469314|NCT01193582|1149657|P4|NOT COMPLETED|12 Month Follow-up||11
469315|NCT01193582|1149658|P3|NOT COMPLETED|12 Month Follow-up||4
469316|NCT01193582|1149659|P2|NOT COMPLETED|12 Month Follow-up||0
469317|NCT01193582|1149660|P1|NOT COMPLETED|12 Month Follow-up||6
469318|NCT01193582|1149657|P4|COMPLETED|12 Month Follow-up||166
469319|NCT01193582|1149658|P3|COMPLETED|12 Month Follow-up||113
469320|NCT01193582|1149659|P2|COMPLETED|12 Month Follow-up||88
469321|NCT01193582|1149660|P1|COMPLETED|12 Month Follow-up||83
469322|NCT01193582|1149657|P4|STARTED|12 Month Follow-up||177
469323|NCT01193582|1149658|P3|STARTED|12 Month Follow-up||117
469324|NCT01193582|1149659|P2|STARTED|12 Month Follow-up||88
469325|NCT01193582|1149660|P1|STARTED|12 Month Follow-up||89
469326|NCT01193582|1149657|P4|NOT COMPLETED|Vaccination Series||3
469327|NCT01193582|1149658|P3|NOT COMPLETED|Vaccination Series||8
469328|NCT01193582|1149659|P2|NOT COMPLETED|Vaccination Series||13
469329|NCT01193582|1149660|P1|NOT COMPLETED|Vaccination Series||11
469330|NCT01193582|1149657|P4|COMPLETED|Vaccination Series||177
469331|NCT01193582|1149658|P3|COMPLETED|Vaccination Series||117
469332|NCT01193582|1149659|P2|COMPLETED|Vaccination Series||88
469333|NCT01193582|1149660|P1|COMPLETED|Vaccination Series||89
469334|NCT01193582|1149657|P4|Vaccinated Dose 4|Vaccination Series||0
469335|NCT01193582|1149658|P3|Vaccinated Dose 4|Vaccination Series||0
469336|NCT01193582|1149659|P2|Vaccinated Dose 4|Vaccination Series||0
469337|NCT01193582|1149660|P1|Vaccinated Dose 4|Vaccination Series||90
469338|NCT01193582|1149657|P4|Vaccinated Dose 3|Vaccination Series||0
469339|NCT01193582|1149658|P3|Vaccinated Dose 3|Vaccination Series||0
469340|NCT01193582|1149659|P2|Vaccinated Dose 3|Vaccination Series||89
469341|NCT01193582|1149660|P1|Vaccinated Dose 3|Vaccination Series||90
469342|NCT01193582|1149657|P4|Vaccinated Dose 2|Vaccination Series||0
469343|NCT01193582|1149658|P3|Vaccinated Dose 2|Vaccination Series||118
469344|NCT01193582|1149659|P2|Vaccinated Dose 2|Vaccination Series||91
469345|NCT01193582|1149660|P1|Vaccinated Dose 2|Vaccination Series||92
469346|NCT01193582|1149657|P4|Vaccinated Dose 1|Vaccination Series||180
469347|NCT01193582|1149658|P3|Vaccinated Dose 1|Vaccination Series||125
469348|NCT01193582|1149659|P2|Vaccinated Dose 1|Vaccination Series||100
469349|NCT01193582|1149660|P1|Vaccinated Dose 1|Vaccination Series||100
469350|NCT01193582|1149657|P4|STARTED|Vaccination Series||180
469351|NCT01193582|1149658|P3|STARTED|Vaccination Series||125
469352|NCT01193582|1149659|P2|STARTED|Vaccination Series||101
469353|NCT01193582|1149660|P1|STARTED|Vaccination Series||100
469354|NCT01193556|1149690|P2|NOT COMPLETED|Overall Study||25
469355|NCT01193556|1149691|P1|NOT COMPLETED|Overall Study||26
469356|NCT01193556|1149690|P2|COMPLETED|Overall Study||0
469357|NCT01193556|1149691|P1|COMPLETED|Overall Study||0
469358|NCT01193556|1149690|P2|STARTED|Overall Study||25
469359|NCT01193556|1149691|P1|STARTED|Overall Study||26
469360|NCT01193348|1149699|P1|NOT COMPLETED|Post Treatment Period (Patients Who Disc||2
469361|NCT01193348|1149699|P1|COMPLETED|Post Treatment Period (Patients Who Disc||8
469362|NCT01193348|1149699|P1|STARTED|Post Treatment Period (Patients Who Disc||10
469363|NCT01193348|1149699|P1|NOT COMPLETED|Extension Treatment Period||1
469364|NCT01193348|1149699|P1|COMPLETED|Extension Treatment Period||16
469365|NCT01193348|1149699|P1|STARTED|Extension Treatment Period||17
469366|NCT01193348|1149699|P1|NOT COMPLETED|Treatment Period (26 Weeks)||3
469367|NCT01193348|1149699|P1|COMPLETED|Treatment Period (26 Weeks)||19
469368|NCT01193348|1149699|P1|STARTED|Treatment Period (26 Weeks)||22
469369|NCT01193348|1149699|P1|NOT COMPLETED|Screening Period||5
469370|NCT01193348|1149699|P1|COMPLETED|Screening Period||22
469371|NCT01193348|1149699|P1|STARTED|Screening Period||27
469372|NCT01193335|1149719|P2|NOT COMPLETED|2-Year Follow-up||8
469373|NCT01193335|1149720|P1|NOT COMPLETED|2-Year Follow-up||7
469374|NCT01193335|1149719|P2|COMPLETED|2-Year Follow-up||80
469375|NCT01193335|1149720|P1|COMPLETED|2-Year Follow-up||81
469376|NCT01193335|1149719|P2|STARTED|2-Year Follow-up||88
469377|NCT01193335|1149720|P1|STARTED|2-Year Follow-up||88
469378|NCT01193335|1149719|P2|NOT COMPLETED|1-Year Follow-up||9
469379|NCT01193335|1149720|P1|NOT COMPLETED|1-Year Follow-up||11
469380|NCT01193335|1149719|P2|COMPLETED|1-Year Follow-up||88
469381|NCT01193335|1149720|P1|COMPLETED|1-Year Follow-up||88
469382|NCT01193335|1149719|P2|STARTED|1-Year Follow-up||97
469383|NCT01193335|1149720|P1|STARTED|1-Year Follow-up||99
469384|NCT01193335|1149719|P2|NOT COMPLETED|Toddler Dose||0
469385|NCT01193335|1149720|P1|NOT COMPLETED|Toddler Dose||0
469386|NCT01193335|1149719|P2|COMPLETED|Toddler Dose||97
469387|NCT01193335|1149720|P1|COMPLETED|Toddler Dose||99
469388|NCT01193335|1149719|P2|STARTED|Toddler Dose||97
469389|NCT01193335|1149720|P1|STARTED|Toddler Dose||99
469390|NCT01193335|1149719|P2|NOT COMPLETED|After Infant Series||3
469391|NCT01193335|1149720|P1|NOT COMPLETED|After Infant Series||1
469392|NCT01193335|1149719|P2|COMPLETED|After Infant Series||97
469393|NCT01193335|1149720|P1|COMPLETED|After Infant Series||99
469394|NCT01193335|1149719|P2|STARTED|After Infant Series||100
469395|NCT01193335|1149720|P1|STARTED|After Infant Series||100
469396|NCT01193335|1149719|P2|NOT COMPLETED|Infant Series||0
469397|NCT01193335|1149720|P1|NOT COMPLETED|Infant Series||0
469398|NCT01193335|1149719|P2|COMPLETED|Infant Series||100
469399|NCT01193335|1149720|P1|COMPLETED|Infant Series||100
469400|NCT01193335|1149719|P2|STARTED|Infant Series||100
469401|NCT01193335|1149720|P1|STARTED|Infant Series||100
469402|NCT01193283|1149815|P1|NOT COMPLETED|Overall Study||1
469403|NCT01193283|1149815|P1|COMPLETED|Overall Study||21
469404|NCT01193283|1149815|P1|STARTED|Overall Study||22
469405|NCT01193244|1149821|P2|NOT COMPLETED|Overall Study||390
469406|NCT01193244|1149822|P1|NOT COMPLETED|Overall Study||388
469407|NCT01193244|1149821|P2|COMPLETED|Overall Study||391
469408|NCT01193244|1149822|P1|COMPLETED|Overall Study||391
469409|NCT01193244|1149821|P2|Treated|Overall Study|Participants randomized to receive Placebo but crossed-over to receive Orteronel after unblinding.|784
469410|NCT01193244|1149822|P1|Treated|Overall Study|Participants who continued to receive Placebo after unblinding.|770
469411|NCT01193244|1149821|P2|STARTED|Overall Study||781
469412|NCT01193244|1149822|P1|STARTED|Overall Study||779
469413|NCT01193218|1149877|P8|NOT COMPLETED|12-52 Weeks||4
469414|NCT01193218|1149878|P7|NOT COMPLETED|12-52 Weeks||3
469415|NCT01193218|1149879|P6|NOT COMPLETED|12-52 Weeks||5
469416|NCT01193218|1149880|P5|NOT COMPLETED|12-52 Weeks||4
469417|NCT01193218|1149881|P4|NOT COMPLETED|12-52 Weeks||3
469418|NCT01193218|1149882|P3|NOT COMPLETED|12-52 Weeks||4
469419|NCT01193218|1149883|P2|NOT COMPLETED|12-52 Weeks||0
469420|NCT01193218|1149884|P1|NOT COMPLETED|12-52 Weeks||5
469421|NCT01193218|1149877|P8|COMPLETED|12-52 Weeks||49
469422|NCT01193218|1149878|P7|COMPLETED|12-52 Weeks||51
469423|NCT01193218|1149879|P6|COMPLETED|12-52 Weeks||101
469424|NCT01193218|1149880|P5|COMPLETED|12-52 Weeks||104
469425|NCT01193218|1149881|P4|COMPLETED|12-52 Weeks||50
469426|NCT01193218|1149882|P3|COMPLETED|12-52 Weeks||50
469427|NCT01193218|1149883|P2|COMPLETED|12-52 Weeks||50
469428|NCT01193218|1149884|P1|COMPLETED|12-52 Weeks||45
469429|NCT01193218|1149877|P8|STARTED|12-52 Weeks||53
469430|NCT01193218|1149878|P7|STARTED|12-52 Weeks||54
469431|NCT01193218|1149879|P6|STARTED|12-52 Weeks||106
469432|NCT01193218|1149880|P5|STARTED|12-52 Weeks||108
469433|NCT01193218|1149881|P4|STARTED|12-52 Weeks||53
469434|NCT01193218|1149882|P3|STARTED|12-52 Weeks||54
469435|NCT01193218|1149883|P2|STARTED|12-52 Weeks||50
469436|NCT01193218|1149884|P1|STARTED|12-52 Weeks||50
469437|NCT01193218|1149877|P8|NOT COMPLETED|0-12 Weeks||0
469438|NCT01193218|1149878|P7|NOT COMPLETED|0-12 Weeks||3
469439|NCT01193218|1149879|P6|NOT COMPLETED|0-12 Weeks||3
469440|NCT01193218|1149880|P5|NOT COMPLETED|0-12 Weeks||1
469441|NCT01193218|1149881|P4|NOT COMPLETED|0-12 Weeks||0
469442|NCT01193218|1149882|P3|NOT COMPLETED|0-12 Weeks||3
469443|NCT01193218|1149883|P2|NOT COMPLETED|0-12 Weeks||0
469444|NCT01193218|1149884|P1|NOT COMPLETED|0-12 Weeks||9
469445|NCT01193218|1149877|P8|COMPLETED|0-12 Weeks||0
469446|NCT01193218|1149878|P7|COMPLETED|0-12 Weeks||107
469447|NCT01193218|1149879|P6|COMPLETED|0-12 Weeks||106
469448|NCT01193218|1149880|P5|COMPLETED|0-12 Weeks||108
469449|NCT01193218|1149881|P4|COMPLETED|0-12 Weeks||0
469450|NCT01193218|1149882|P3|COMPLETED|0-12 Weeks||107
469451|NCT01193218|1149883|P2|COMPLETED|0-12 Weeks||0
469452|NCT01193218|1149884|P1|COMPLETED|0-12 Weeks||100
469453|NCT01193218|1149877|P8|STARTED|0-12 Weeks|It is actually N/A|0
469454|NCT01193218|1149878|P7|STARTED|0-12 Weeks|It is actually empa 50mg group|110
469455|NCT01193218|1149879|P6|STARTED|0-12 Weeks||109
469456|NCT01193218|1149880|P5|STARTED|0-12 Weeks||109
469457|NCT01193218|1149881|P4|STARTED|0-12 Weeks|It is actually N/A|0
469458|NCT01193218|1149882|P3|STARTED|0-12 Weeks|It is actually empa 5mg group|110
469459|NCT01193218|1149883|P2|STARTED|0-12 Weeks|It is actually N/A|0
469460|NCT01193218|1149884|P1|STARTED|0-12 Weeks|It is actually placebo group|109
469461|NCT01193153|1149915|P2|NOT COMPLETED|Double Blind Relapse Prevention Period||105
469462|NCT01193153|1149916|P1|NOT COMPLETED|Double Blind Relapse Prevention Period||64
469463|NCT01193153|1149915|P2|COMPLETED|Double Blind Relapse Prevention Period||65
469464|NCT01193153|1149916|P1|COMPLETED|Double Blind Relapse Prevention Period||100
469465|NCT01193153|1149915|P2|STARTED|Double Blind Relapse Prevention Period||170
469466|NCT01193153|1149916|P1|STARTED|Double Blind Relapse Prevention Period||164
469467|NCT01193153|1149915|P2|NOT COMPLETED|Open-label Stabilization Period||0
469468|NCT01193153|1149916|P1|NOT COMPLETED|Open-label Stabilization Period||98
469469|NCT01193153|1149915|P2|COMPLETED|Open-label Stabilization Period||0
469470|NCT01193153|1149916|P1|COMPLETED|Open-label Stabilization Period||334
469471|NCT01193153|1149915|P2|STARTED|Open-label Stabilization Period||0
469472|NCT01193153|1149916|P1|STARTED|Open-label Stabilization Period||432
469473|NCT01193153|1149915|P2|NOT COMPLETED|Open-label Lead in Period||0
469474|NCT01193153|1149916|P1|NOT COMPLETED|Open-label Lead in Period||235
469475|NCT01193153|1149915|P2|COMPLETED|Open-label Lead in Period||0
469476|NCT01193153|1149916|P1|COMPLETED|Open-label Lead in Period||432
469477|NCT01193153|1149915|P2|STARTED|Open-label Lead in Period||0
469478|NCT01193153|1149916|P1|STARTED|Open-label Lead in Period||667
469479|NCT01193127|1149951|P4|NOT COMPLETED|Treated||1
469480|NCT01193127|1149952|P3|NOT COMPLETED|Treated||0
469481|NCT01193127|1149953|P2|NOT COMPLETED|Treated||0
469482|NCT01193127|1149954|P1|NOT COMPLETED|Treated||0
469483|NCT01193127|1149951|P4|COMPLETED|Treated||55
469484|NCT01193127|1149952|P3|COMPLETED|Treated||55
469485|NCT01193127|1149953|P2|COMPLETED|Treated||54
469486|NCT01193127|1149954|P1|COMPLETED|Treated||57
469487|NCT01193127|1149951|P4|STARTED|Treated||56
469488|NCT01193127|1149952|P3|STARTED|Treated||55
469489|NCT01193127|1149953|P2|STARTED|Treated||54
469490|NCT01193127|1149954|P1|STARTED|Treated||57
469491|NCT01193127|1149951|P4|NOT COMPLETED|Randomized||1
469492|NCT01193127|1149952|P3|NOT COMPLETED|Randomized||0
469493|NCT01193127|1149953|P2|NOT COMPLETED|Randomized||0
469494|NCT01193127|1149954|P1|NOT COMPLETED|Randomized||0
469495|NCT01193127|1149951|P4|COMPLETED|Randomized||56
469496|NCT01193127|1149952|P3|COMPLETED|Randomized||55
469497|NCT01193127|1149953|P2|COMPLETED|Randomized||54
469498|NCT01193127|1149954|P1|COMPLETED|Randomized||57
469499|NCT01193127|1149951|P4|STARTED|Randomized||57
469500|NCT01193127|1149952|P3|STARTED|Randomized||55
469501|NCT01193127|1149953|P2|STARTED|Randomized||54
469502|NCT01193127|1149954|P1|STARTED|Randomized||57
469503|NCT01193114|1150258|P2|NOT COMPLETED|Overall Study||0
469504|NCT01193114|1150259|P1|NOT COMPLETED|Overall Study||0
469505|NCT01193114|1150258|P2|COMPLETED|Overall Study||30
469506|NCT01193114|1150259|P1|COMPLETED|Overall Study||30
469507|NCT01193114|1150258|P2|STARTED|Overall Study||30
469508|NCT01193114|1150259|P1|STARTED|Overall Study||30
469509|NCT01193101|1150279|P4|NOT COMPLETED|Overall Study||12
469510|NCT01193101|1150280|P3|NOT COMPLETED|Overall Study||3
469511|NCT01193101|1150281|P2|NOT COMPLETED|Overall Study||7
469512|NCT01193101|1150282|P1|NOT COMPLETED|Overall Study||5
469513|NCT01193101|1150279|P4|COMPLETED|Overall Study||80
469514|NCT01193101|1150280|P3|COMPLETED|Overall Study||93
469515|NCT01193101|1150281|P2|COMPLETED|Overall Study||94
469516|NCT01193101|1150282|P1|COMPLETED|Overall Study||95
469517|NCT01193101|1150279|P4|Placebo Withdrawal Set|Overall Study||80
469518|NCT01193101|1150280|P3|Placebo Withdrawal Set|Overall Study||93
469519|NCT01193101|1150281|P2|Placebo Withdrawal Set|Overall Study||94
469520|NCT01193101|1150282|P1|Placebo Withdrawal Set|Overall Study||95
469521|NCT01193101|1150279|P4|Full Analysis Set|Overall Study||92
469522|NCT01193101|1150280|P3|Full Analysis Set|Overall Study||96
469523|NCT01193101|1150281|P2|Full Analysis Set|Overall Study||101
469524|NCT01193101|1150282|P1|Full Analysis Set|Overall Study||100
469525|NCT01193101|1150279|P4|STARTED|Overall Study||92
469526|NCT01193101|1150280|P3|STARTED|Overall Study||96
469527|NCT01193101|1150281|P2|STARTED|Overall Study||101
469528|NCT01193101|1150282|P1|STARTED|Overall Study||100
469529|NCT01193049|1150338|P2|NOT COMPLETED|Period 3 : Double Blind Crossover||0
469530|NCT01193049|1150339|P1|NOT COMPLETED|Period 3 : Double Blind Crossover||0
469531|NCT01193049|1150338|P2|COMPLETED|Period 3 : Double Blind Crossover||6
469532|NCT01193049|1150339|P1|COMPLETED|Period 3 : Double Blind Crossover||5
469533|NCT01193049|1150338|P2|STARTED|Period 3 : Double Blind Crossover||6
469534|NCT01193049|1150339|P1|STARTED|Period 3 : Double Blind Crossover||5
469535|NCT01193049|1150338|P2|NOT COMPLETED|Washout 2 : 21 Day Washout||0
469536|NCT01193049|1150339|P1|NOT COMPLETED|Washout 2 : 21 Day Washout||0
469537|NCT01193049|1150338|P2|COMPLETED|Washout 2 : 21 Day Washout||6
469538|NCT01193049|1150339|P1|COMPLETED|Washout 2 : 21 Day Washout||5
469539|NCT01193049|1150338|P2|STARTED|Washout 2 : 21 Day Washout||6
469540|NCT01193049|1150339|P1|STARTED|Washout 2 : 21 Day Washout||5
469541|NCT01193049|1150338|P2|NOT COMPLETED|Period 2 : Double Blind Crossover||0
469542|NCT01193049|1150339|P1|NOT COMPLETED|Period 2 : Double Blind Crossover||0
469543|NCT01193049|1150338|P2|COMPLETED|Period 2 : Double Blind Crossover||6
469544|NCT01193049|1150339|P1|COMPLETED|Period 2 : Double Blind Crossover||5
469545|NCT01193049|1150338|P2|STARTED|Period 2 : Double Blind Crossover||6
469546|NCT01193049|1150339|P1|STARTED|Period 2 : Double Blind Crossover||5
469547|NCT01193049|1150338|P2|NOT COMPLETED|Washout 1 : 21 Day Washout||0
469548|NCT01193049|1150339|P1|NOT COMPLETED|Washout 1 : 21 Day Washout||0
469549|NCT01193049|1150338|P2|COMPLETED|Washout 1 : 21 Day Washout||6
469550|NCT01193049|1150339|P1|COMPLETED|Washout 1 : 21 Day Washout||5
469551|NCT01193049|1150338|P2|STARTED|Washout 1 : 21 Day Washout||6
469552|NCT01193049|1150339|P1|STARTED|Washout 1 : 21 Day Washout||5
469553|NCT01193049|1150338|P2|NOT COMPLETED|Period 1: Placebo Run-In||0
469554|NCT01193049|1150339|P1|NOT COMPLETED|Period 1: Placebo Run-In||0
469555|NCT01193049|1150338|P2|COMPLETED|Period 1: Placebo Run-In||6
469556|NCT01193049|1150339|P1|COMPLETED|Period 1: Placebo Run-In||5
469557|NCT01193049|1150338|P2|STARTED|Period 1: Placebo Run-In||6
469558|NCT01193049|1150339|P1|STARTED|Period 1: Placebo Run-In||5
469559|NCT01192776|1150373|P4|NOT COMPLETED|Overall Study||20
469560|NCT01192776|1150374|P3|NOT COMPLETED|Overall Study||21
469561|NCT01192776|1150375|P2|NOT COMPLETED|Overall Study||21
469562|NCT01192776|1150376|P1|NOT COMPLETED|Overall Study||11
469563|NCT01192776|1150373|P4|COMPLETED|Overall Study||63
469564|NCT01192776|1150374|P3|COMPLETED|Overall Study||75
469565|NCT01192776|1150375|P2|COMPLETED|Overall Study||69
469566|NCT01192776|1150376|P1|COMPLETED|Overall Study||84
469567|NCT01192776|1150373|P4|Died After Discharge|Overall Study||1
469568|NCT01192776|1150374|P3|Died After Discharge|Overall Study||3
469569|NCT01192776|1150375|P2|Died After Discharge|Overall Study||2
469570|NCT01192776|1150376|P1|Died After Discharge|Overall Study||1
469571|NCT01192776|1150373|P4|Died Prior to Discharge|Overall Study||14
469572|NCT01192776|1150374|P3|Died Prior to Discharge|Overall Study||15
469573|NCT01192776|1150375|P2|Died Prior to Discharge|Overall Study||13
469574|NCT01192776|1150376|P1|Died Prior to Discharge|Overall Study||7
469575|NCT01192776|1150373|P4|STARTED|Overall Study||83
469576|NCT01192776|1150374|P3|STARTED|Overall Study||96
469577|NCT01192776|1150375|P2|STARTED|Overall Study||90
469578|NCT01192776|1150376|P1|STARTED|Overall Study||95
469579|NCT01192698|1150428|P2|NOT COMPLETED|Overall Study||0
469580|NCT01192698|1150429|P1|NOT COMPLETED|Overall Study||0
469581|NCT01192698|1150428|P2|COMPLETED|Overall Study||5
469582|NCT01192698|1150429|P1|COMPLETED|Overall Study||10
469583|NCT01192698|1150428|P2|STARTED|Overall Study||5
469584|NCT01192698|1150429|P1|STARTED|Overall Study||10
469585|NCT01192542|1150435|P2|NOT COMPLETED|Period 2||0
469586|NCT01192542|1150436|P1|NOT COMPLETED|Period 2||0
469587|NCT01192542|1150435|P2|COMPLETED|Period 2||20
469588|NCT01192542|1150436|P1|COMPLETED|Period 2||18
469589|NCT01192542|1150435|P2|STARTED|Period 2||20
469590|NCT01192542|1150436|P1|STARTED|Period 2||18
469591|NCT01192542|1150435|P2|NOT COMPLETED|Period 1||0
469592|NCT01192542|1150436|P1|NOT COMPLETED|Period 1||0
469593|NCT01192542|1150435|P2|COMPLETED|Period 1||20
469594|NCT01192542|1150436|P1|COMPLETED|Period 1||18
469595|NCT01192542|1150435|P2|STARTED|Period 1||20
469596|NCT01192542|1150436|P1|STARTED|Period 1||18
469597|NCT01192516|1150450|P3|NOT COMPLETED|Overall Study||8
469598|NCT01192516|1150451|P2|NOT COMPLETED|Overall Study||17
469599|NCT01192516|1150452|P1|NOT COMPLETED|Overall Study||20
469600|NCT01192516|1150450|P3|COMPLETED|Overall Study||55
469601|NCT01192516|1150451|P2|COMPLETED|Overall Study||49
469602|NCT01192516|1150452|P1|COMPLETED|Overall Study||46
469603|NCT01192516|1150450|P3|STARTED|Overall Study|Indicates number of people initially randomized to group|63
469604|NCT01192516|1150451|P2|STARTED|Overall Study|Indicates number of people initially randomized to group|66
469605|NCT01192516|1150452|P1|STARTED|Overall Study|Indicates number of people initially randomized to group|66
469606|NCT01192412|1150486|P2|NOT COMPLETED|Overall Study||2
469607|NCT01192412|1150487|P1|NOT COMPLETED|Overall Study||4
469608|NCT01192412|1150486|P2|COMPLETED|Overall Study||488
469609|NCT01192412|1150487|P1|COMPLETED|Overall Study||493
469610|NCT01192412|1150486|P2|STARTED|Overall Study||490
469611|NCT01192412|1150487|P1|STARTED|Overall Study||497
469612|NCT01192399|1150495|P1|NOT COMPLETED|Overall Study||2
469613|NCT01192399|1150495|P1|COMPLETED|Overall Study||27
469614|NCT01192399|1150495|P1|STARTED|Overall Study||29
469615|NCT01192347|1150505|P1|NOT COMPLETED|Overall Study||12
469616|NCT01192347|1150505|P1|COMPLETED|Overall Study||163
469617|NCT01192347|1150505|P1|STARTED|Overall Study||175
469618|NCT01192295|1150528|P2|NOT COMPLETED|Overall Study||23
469619|NCT01192295|1150529|P1|NOT COMPLETED|Overall Study||10
469620|NCT01192295|1150528|P2|COMPLETED|Overall Study||105
469621|NCT01192295|1150529|P1|COMPLETED|Overall Study||17
469622|NCT01192295|1150528|P2|STARTED|Overall Study||128
469623|NCT01192295|1150529|P1|STARTED|Overall Study||27
469624|NCT01192282|1150546|P1|NOT COMPLETED|Overall Study||0
469625|NCT01192282|1150546|P1|COMPLETED|Overall Study||156
469626|NCT01192282|1150546|P1|STARTED|Overall Study||156
469627|NCT01192204|1150563|P2|NOT COMPLETED|Overall Study||0
469628|NCT01192204|1150564|P1|NOT COMPLETED|Overall Study||1
469629|NCT01192204|1150563|P2|COMPLETED|Overall Study||18
469630|NCT01192204|1150564|P1|COMPLETED|Overall Study||22
469631|NCT01192204|1150563|P2|STARTED|Overall Study||18
469632|NCT01192204|1150564|P1|STARTED|Overall Study||23
469633|NCT01192191|1150576|P2|NOT COMPLETED|Overall Study||21
469634|NCT01192191|1150577|P1|NOT COMPLETED|Overall Study||11
469635|NCT01192191|1150576|P2|COMPLETED|Overall Study||106
469636|NCT01192191|1150577|P1|COMPLETED|Overall Study||49
469637|NCT01192191|1150576|P2|STARTED|Overall Study||127
469638|NCT01192191|1150577|P1|STARTED|Overall Study||60
469639|NCT01192178|1150603|P2|NOT COMPLETED|Overall Study||23
469640|NCT01192178|1150604|P1|NOT COMPLETED|Overall Study||24
469641|NCT01192178|1150603|P2|COMPLETED|Overall Study||145
469642|NCT01192178|1150604|P1|COMPLETED|Overall Study||147
469643|NCT01192178|1150603|P2|STARTED|Overall Study||168
469644|NCT01192178|1150604|P1|STARTED|Overall Study||171
469645|NCT01192152|1150624|P2|NOT COMPLETED|Period 3||0
469646|NCT01192152|1150625|P1|NOT COMPLETED|Period 3||1
469647|NCT01192152|1150624|P2|COMPLETED|Period 3||0
469648|NCT01192152|1150625|P1|COMPLETED|Period 3||14
469649|NCT01192152|1150624|P2|STARTED|Period 3||0
469650|NCT01192152|1150625|P1|STARTED|Period 3||15
469651|NCT01192152|1150624|P2|NOT COMPLETED|Period 2||0
469652|NCT01192152|1150625|P1|NOT COMPLETED|Period 2||0
469653|NCT01192152|1150624|P2|COMPLETED|Period 2||14
469654|NCT01192152|1150625|P1|COMPLETED|Period 2||15
469655|NCT01192152|1150624|P2|STARTED|Period 2||14
469656|NCT01192152|1150625|P1|STARTED|Period 2||15
469657|NCT01192152|1150624|P2|NOT COMPLETED|Period 1||1
469658|NCT01192152|1150625|P1|NOT COMPLETED|Period 1||0
469659|NCT01192152|1150624|P2|COMPLETED|Period 1||14
469660|NCT01192152|1150625|P1|COMPLETED|Period 1||15
469661|NCT01192152|1150624|P2|STARTED|Period 1||15
469662|NCT01192152|1150625|P1|STARTED|Period 1||15
469663|NCT01192139|1150726|P6|NOT COMPLETED|Period 3||0
469664|NCT01192139|1150727|P5|NOT COMPLETED|Period 3||0
469665|NCT01192139|1150728|P4|NOT COMPLETED|Period 3||0
469666|NCT01192139|1150729|P3|NOT COMPLETED|Period 3||0
469667|NCT01192139|1150730|P2|NOT COMPLETED|Period 3||0
469668|NCT01192139|1150731|P1|NOT COMPLETED|Period 3||0
469669|NCT01192139|1150726|P6|COMPLETED|Period 3||5
469670|NCT01192139|1150727|P5|COMPLETED|Period 3||5
469671|NCT01192139|1150728|P4|COMPLETED|Period 3||5
469672|NCT01192139|1150729|P3|COMPLETED|Period 3||5
469673|NCT01192139|1150730|P2|COMPLETED|Period 3||5
469674|NCT01192139|1150731|P1|COMPLETED|Period 3||5
469675|NCT01192139|1150726|P6|STARTED|Period 3||5
469676|NCT01192139|1150727|P5|STARTED|Period 3||5
469677|NCT01192139|1150728|P4|STARTED|Period 3||5
469678|NCT01192139|1150729|P3|STARTED|Period 3||5
469679|NCT01192139|1150730|P2|STARTED|Period 3||5
469680|NCT01192139|1150731|P1|STARTED|Period 3||5
469681|NCT01192139|1150726|P6|NOT COMPLETED|Period 2||0
469682|NCT01192139|1150727|P5|NOT COMPLETED|Period 2||0
469683|NCT01192139|1150728|P4|NOT COMPLETED|Period 2||0
469684|NCT01192139|1150729|P3|NOT COMPLETED|Period 2||0
469685|NCT01192139|1150730|P2|NOT COMPLETED|Period 2||0
469686|NCT01192139|1150731|P1|NOT COMPLETED|Period 2||0
469687|NCT01192139|1150726|P6|COMPLETED|Period 2||5
469688|NCT01192139|1150727|P5|COMPLETED|Period 2||5
469689|NCT01192139|1150728|P4|COMPLETED|Period 2||5
469690|NCT01192139|1150729|P3|COMPLETED|Period 2||5
469691|NCT01192139|1150730|P2|COMPLETED|Period 2||5
469692|NCT01192139|1150731|P1|COMPLETED|Period 2||5
469693|NCT01192139|1150726|P6|STARTED|Period 2||5
469694|NCT01192139|1150727|P5|STARTED|Period 2||5
469695|NCT01192139|1150728|P4|STARTED|Period 2||5
469696|NCT01192139|1150729|P3|STARTED|Period 2||5
469697|NCT01192139|1150730|P2|STARTED|Period 2||5
469698|NCT01192139|1150731|P1|STARTED|Period 2||5
469699|NCT01192139|1150726|P6|NOT COMPLETED|Period 1||0
469700|NCT01192139|1150727|P5|NOT COMPLETED|Period 1||0
469701|NCT01192139|1150728|P4|NOT COMPLETED|Period 1||0
469702|NCT01192139|1150729|P3|NOT COMPLETED|Period 1||0
469703|NCT01192139|1150730|P2|NOT COMPLETED|Period 1||0
469704|NCT01192139|1150731|P1|NOT COMPLETED|Period 1||0
469705|NCT01192139|1150726|P6|COMPLETED|Period 1||5
469706|NCT01192139|1150727|P5|COMPLETED|Period 1||5
469707|NCT01192139|1150728|P4|COMPLETED|Period 1||5
469708|NCT01192139|1150729|P3|COMPLETED|Period 1||5
469709|NCT01192139|1150730|P2|COMPLETED|Period 1||5
469710|NCT01192139|1150731|P1|COMPLETED|Period 1||5
469711|NCT01192139|1150726|P6|STARTED|Period 1||5
469712|NCT01192139|1150727|P5|STARTED|Period 1||5
469713|NCT01192139|1150728|P4|STARTED|Period 1||5
469714|NCT01192139|1150729|P3|STARTED|Period 1||5
469715|NCT01192139|1150730|P2|STARTED|Period 1||5
469716|NCT01192139|1150731|P1|STARTED|Period 1||5
469717|NCT01192126|1150796|P2|NOT COMPLETED|Second Intervention (1 Week)||0
469718|NCT01192126|1150797|P1|NOT COMPLETED|Second Intervention (1 Week)||0
469719|NCT01192126|1150796|P2|COMPLETED|Second Intervention (1 Week)||50
469720|NCT01192126|1150797|P1|COMPLETED|Second Intervention (1 Week)||49
469721|NCT01192126|1150796|P2|STARTED|Second Intervention (1 Week)||50
469722|NCT01192126|1150797|P1|STARTED|Second Intervention (1 Week)||49
469723|NCT01192126|1150796|P2|NOT COMPLETED|First Intervention (1 Week)||1
469724|NCT01192126|1150797|P1|NOT COMPLETED|First Intervention (1 Week)||2
469725|NCT01192126|1150796|P2|COMPLETED|First Intervention (1 Week)||50
469726|NCT01192126|1150797|P1|COMPLETED|First Intervention (1 Week)||49
469727|NCT01192126|1150796|P2|STARTED|First Intervention (1 Week)||51
469728|NCT01192126|1150797|P1|STARTED|First Intervention (1 Week)||51
469729|NCT01192022|1150809|P5|NOT COMPLETED|Overall Study||1
469730|NCT01192022|1150810|P4|NOT COMPLETED|Overall Study||2
469731|NCT01192022|1150811|P3|NOT COMPLETED|Overall Study||1
469732|NCT01192022|1150812|P2|NOT COMPLETED|Overall Study||11
469733|NCT01192022|1150813|P1|NOT COMPLETED|Overall Study||13
469734|NCT01192022|1150809|P5|COMPLETED|Overall Study||11
469735|NCT01192022|1150810|P4|COMPLETED|Overall Study||7
469736|NCT01192022|1150811|P3|COMPLETED|Overall Study||7
469737|NCT01192022|1150812|P2|COMPLETED|Overall Study||99
469738|NCT01192022|1150813|P1|COMPLETED|Overall Study||101
469739|NCT01192022|1150809|P5|Safety Population-Received Treatment|Overall Study||12
469740|NCT01192022|1150810|P4|Safety Population-Received Treatment|Overall Study||9
469741|NCT01192022|1150811|P3|Safety Population-Received Treatment|Overall Study||8
469742|NCT01192022|1150812|P2|Safety Population-Received Treatment|Overall Study||109
469743|NCT01192022|1150813|P1|Safety Population-Received Treatment|Overall Study||114
469744|NCT01192022|1150809|P5|STARTED|Overall Study||12
469745|NCT01192022|1150810|P4|STARTED|Overall Study||9
469746|NCT01192022|1150811|P3|STARTED|Overall Study||8
469747|NCT01192022|1150812|P2|STARTED|Overall Study||110
469748|NCT01192022|1150813|P1|STARTED|Overall Study||114
469749|NCT01191944|1150836|P2|NOT COMPLETED|Overall Study||19
469750|NCT01191944|1150837|P1|NOT COMPLETED|Overall Study||17
469751|NCT01191944|1150836|P2|COMPLETED|Overall Study|Completed titration/maintenance|220
469752|NCT01191944|1150837|P1|COMPLETED|Overall Study|Completed titration/maintenance|217
469753|NCT01191944|1150836|P2|STARTED|Overall Study|Treated titration/maintenance|239
469754|NCT01191944|1150837|P1|STARTED|Overall Study|Treated titration/maintenance|234
469755|NCT01191840|1150883|P2|NOT COMPLETED|Overall Study||15
469756|NCT01191840|1150884|P1|NOT COMPLETED|Overall Study||14
469757|NCT01191840|1150883|P2|COMPLETED|Overall Study||240
469758|NCT01191840|1150884|P1|COMPLETED|Overall Study||240
469759|NCT01191840|1150883|P2|STARTED|Overall Study||255
469760|NCT01191840|1150884|P1|STARTED|Overall Study||254
469761|NCT01191827|1150900|P2|NOT COMPLETED|Overall Study||0
469762|NCT01191827|1150901|P1|NOT COMPLETED|Overall Study||0
469763|NCT01191827|1150900|P2|COMPLETED|Overall Study||20
469764|NCT01191827|1150901|P1|COMPLETED|Overall Study||20
469765|NCT01191827|1150900|P2|STARTED|Overall Study||20
469766|NCT01191827|1150901|P1|STARTED|Overall Study||20
469767|NCT01191801|1150909|P2|NOT COMPLETED|Overall Study||337
469768|NCT01191801|1150910|P1|NOT COMPLETED|Overall Study||316
469769|NCT01191801|1150909|P2|COMPLETED|Overall Study||18
469770|NCT01191801|1150910|P1|COMPLETED|Overall Study||40
469771|NCT01191801|1150909|P2|STARTED|Overall Study||355
469772|NCT01191801|1150910|P1|STARTED|Overall Study||356
469773|NCT01191788|1150930|P2|NOT COMPLETED|Overall Study||22
469774|NCT01191788|1150931|P1|NOT COMPLETED|Overall Study||21
469775|NCT01191788|1150930|P2|COMPLETED|Overall Study|Completed 3-month followup|137
469776|NCT01191788|1150931|P1|COMPLETED|Overall Study|Completed 3-month followup|119
469777|NCT01191788|1150930|P2|STARTED|Overall Study||159
469778|NCT01191788|1150931|P1|STARTED|Overall Study||140
469779|NCT01191762|1150941|P2|NOT COMPLETED|Overall Study||0
469780|NCT01191762|1150942|P1|NOT COMPLETED|Overall Study||1
469781|NCT01191762|1150941|P2|COMPLETED|Overall Study||15
469782|NCT01191762|1150942|P1|COMPLETED|Overall Study|One subject dropped out on the 3rd treatment day because of gastrointestinal complaints.|14
469783|NCT01191762|1150941|P2|STARTED|Overall Study||15
469784|NCT01191762|1150942|P1|STARTED|Overall Study||15
469785|NCT01191749|1150948|P1|NOT COMPLETED|Overall Study||0
469786|NCT01191749|1150948|P1|COMPLETED|Overall Study||7
469787|NCT01191749|1150948|P1|STARTED|Overall Study||7
469788|NCT01191736|1150959|P7|NOT COMPLETED|Overall Study||0
469789|NCT01191736|1150960|P6|NOT COMPLETED|Overall Study||0
469790|NCT01191736|1150961|P5|NOT COMPLETED|Overall Study||0
469791|NCT01191736|1150962|P4|NOT COMPLETED|Overall Study||0
469792|NCT01191736|1150963|P3|NOT COMPLETED|Overall Study||0
469793|NCT01191736|1150964|P2|NOT COMPLETED|Overall Study||0
469794|NCT01191736|1150965|P1|NOT COMPLETED|Overall Study||0
469795|NCT01191736|1150959|P7|COMPLETED|Overall Study||45
469796|NCT01191736|1150960|P6|COMPLETED|Overall Study||50
469797|NCT01191736|1150961|P5|COMPLETED|Overall Study||48
469798|NCT01191736|1150962|P4|COMPLETED|Overall Study||46
469799|NCT01191736|1150963|P3|COMPLETED|Overall Study||49
469800|NCT01191736|1150964|P2|COMPLETED|Overall Study||47
469801|NCT01191736|1150965|P1|COMPLETED|Overall Study||51
469802|NCT01191736|1150959|P7|STARTED|Overall Study||45
469803|NCT01191736|1150960|P6|STARTED|Overall Study||50
469804|NCT01191736|1150961|P5|STARTED|Overall Study||48
469805|NCT01191736|1150962|P4|STARTED|Overall Study||46
469806|NCT01191736|1150963|P3|STARTED|Overall Study||49
469807|NCT01191736|1150964|P2|STARTED|Overall Study||47
469808|NCT01191736|1150965|P1|STARTED|Overall Study||51
469809|NCT01191723|1150988|P6|NOT COMPLETED|Overall Study||0
469810|NCT01191723|1150989|P5|NOT COMPLETED|Overall Study||0
469811|NCT01191723|1150990|P4|NOT COMPLETED|Overall Study||0
469812|NCT01191723|1150991|P3|NOT COMPLETED|Overall Study||0
469813|NCT01191723|1150992|P2|NOT COMPLETED|Overall Study||0
469814|NCT01191723|1150993|P1|NOT COMPLETED|Overall Study||0
469815|NCT01191723|1150988|P6|COMPLETED|Overall Study||9
469816|NCT01191723|1150989|P5|COMPLETED|Overall Study||9
469817|NCT01191723|1150990|P4|COMPLETED|Overall Study||9
469818|NCT01191723|1150991|P3|COMPLETED|Overall Study||9
469819|NCT01191723|1150992|P2|COMPLETED|Overall Study||9
469820|NCT01191723|1150993|P1|COMPLETED|Overall Study||9
469821|NCT01191723|1150988|P6|STARTED|Overall Study||9
469822|NCT01191723|1150989|P5|STARTED|Overall Study||9
469823|NCT01191723|1150990|P4|STARTED|Overall Study||9
469824|NCT01191723|1150991|P3|STARTED|Overall Study||9
469825|NCT01191723|1150992|P2|STARTED|Overall Study||9
469826|NCT01191723|1150993|P1|STARTED|Overall Study||9
469827|NCT01191476|1151014|P3|NOT COMPLETED|Overall Study||0
469828|NCT01191476|1151015|P2|NOT COMPLETED|Overall Study||4
469829|NCT01191476|1151016|P1|NOT COMPLETED|Overall Study||3
469830|NCT01191476|1151014|P3|COMPLETED|Overall Study||111
469831|NCT01191476|1151015|P2|COMPLETED|Overall Study||107
469832|NCT01191476|1151016|P1|COMPLETED|Overall Study||109
469833|NCT01191476|1151014|P3|STARTED|Overall Study|Data was not collected for 1 subject for baseline characteristics or the full analysis set.|111
469834|NCT01191476|1151015|P2|STARTED|Overall Study|Data was not collected for 1 subject for baseline characteristics or the full analysis set.|111
469835|NCT01191476|1151016|P1|STARTED|Overall Study||112
469836|NCT01191411|1151039|P3|NOT COMPLETED|Overall Study||3427
469837|NCT01191411|1151040|P2|NOT COMPLETED|Overall Study||361
469838|NCT01191411|1151041|P1|NOT COMPLETED|Overall Study||945
469839|NCT01191411|1151039|P3|COMPLETED|Overall Study||471
469840|NCT01191411|1151040|P2|COMPLETED|Overall Study||118
469841|NCT01191411|1151041|P1|COMPLETED|Overall Study||648
469842|NCT01191411|1151039|P3|STARTED|Overall Study||3898
469843|NCT01191411|1151040|P2|STARTED|Overall Study||479
469844|NCT01191411|1151041|P1|STARTED|Overall Study||1593
469845|NCT01191398|1151052|P3|NOT COMPLETED|Overall Study||0
469846|NCT01191398|1151053|P2|NOT COMPLETED|Overall Study||0
469847|NCT01191398|1151054|P1|NOT COMPLETED|Overall Study||0
469848|NCT01191398|1151052|P3|COMPLETED|Overall Study||18
469849|NCT01191398|1151053|P2|COMPLETED|Overall Study||17
469850|NCT01191398|1151054|P1|COMPLETED|Overall Study||17
469851|NCT01191398|1151052|P3|STARTED|Overall Study||18
469852|NCT01191398|1151053|P2|STARTED|Overall Study||17
469853|NCT01191398|1151054|P1|STARTED|Overall Study||17
469854|NCT01191333|1151067|P2|NOT COMPLETED|Overall Study||18
469855|NCT01191333|1151068|P1|NOT COMPLETED|Overall Study||21
469856|NCT01191333|1151067|P2|COMPLETED|Overall Study||65
469857|NCT01191333|1151068|P1|COMPLETED|Overall Study||60
469858|NCT01191333|1151067|P2|STARTED|Overall Study||83
469859|NCT01191333|1151068|P1|STARTED|Overall Study||81
469860|NCT01191320|1151087|P3|NOT COMPLETED|Overall Study||7
469861|NCT01191320|1151088|P2|NOT COMPLETED|Overall Study||6
469862|NCT01191320|1151089|P1|NOT COMPLETED|Overall Study||7
469863|NCT01191320|1151087|P3|COMPLETED|Overall Study||31
469864|NCT01191320|1151088|P2|COMPLETED|Overall Study||32
469865|NCT01191320|1151089|P1|COMPLETED|Overall Study||36
469866|NCT01191320|1151087|P3|STARTED|Overall Study||38
469867|NCT01191320|1151088|P2|STARTED|Overall Study||38
469868|NCT01191320|1151089|P1|STARTED|Overall Study||43
469869|NCT01191268|1151100|P3|NOT COMPLETED|Overall Study||52
469870|NCT01191268|1151101|P2|NOT COMPLETED|Overall Study||55
469871|NCT01191268|1151102|P1|NOT COMPLETED|Overall Study||58
469872|NCT01191268|1151100|P3|COMPLETED|Overall Study||244
469873|NCT01191268|1151101|P2|COMPLETED|Overall Study||238
469874|NCT01191268|1151102|P1|COMPLETED|Overall Study||237
469875|NCT01191268|1151100|P3|Received at Least One Dose of Study Drug|Overall Study||296
469876|NCT01191268|1151101|P2|Received at Least One Dose of Study Drug|Overall Study||293
469877|NCT01191268|1151102|P1|Received at Least One Dose of Study Drug|Overall Study||295
469878|NCT01191268|1151100|P3|STARTED|Overall Study||296
469879|NCT01191268|1151101|P2|STARTED|Overall Study||293
469880|NCT01191268|1151102|P1|STARTED|Overall Study||295
469881|NCT01191255|1151199|P4|NOT COMPLETED|Efficacy Assessment Period||6
469882|NCT01191255|1151200|P3|NOT COMPLETED|Efficacy Assessment Period||26
469883|NCT01191255|1151201|P2|NOT COMPLETED|Efficacy Assessment Period||0
469884|NCT01191255|1151202|P1|NOT COMPLETED|Efficacy Assessment Period||0
469885|NCT01191255|1151199|P4|COMPLETED|Efficacy Assessment Period||90
469886|NCT01191255|1151200|P3|COMPLETED|Efficacy Assessment Period||70
469887|NCT01191255|1151201|P2|COMPLETED|Efficacy Assessment Period||0
469888|NCT01191255|1151202|P1|COMPLETED|Efficacy Assessment Period||0
469889|NCT01191255|1151199|P4|STARTED|Efficacy Assessment Period||96
469890|NCT01191255|1151200|P3|STARTED|Efficacy Assessment Period||96
469891|NCT01191255|1151201|P2|STARTED|Efficacy Assessment Period||0
469892|NCT01191255|1151202|P1|STARTED|Efficacy Assessment Period||0
469893|NCT01191255|1151199|P4|NOT COMPLETED|Safety Assessment Period||0
469894|NCT01191255|1151200|P3|NOT COMPLETED|Safety Assessment Period||0
469895|NCT01191255|1151201|P2|NOT COMPLETED|Safety Assessment Period||99
469896|NCT01191255|1151202|P1|NOT COMPLETED|Safety Assessment Period||38
469897|NCT01191255|1151199|P4|COMPLETED|Safety Assessment Period||0
469898|NCT01191255|1151200|P3|COMPLETED|Safety Assessment Period||0
469899|NCT01191255|1151201|P2|COMPLETED|Safety Assessment Period||193
469900|NCT01191255|1151202|P1|COMPLETED|Safety Assessment Period||111
469901|NCT01191255|1151199|P4|Safety Population|Safety Assessment Period||0
469902|NCT01191255|1151200|P3|Safety Population|Safety Assessment Period||0
469903|NCT01191255|1151201|P2|Safety Population|Safety Assessment Period||289
469904|NCT01191255|1151202|P1|Safety Population|Safety Assessment Period||149
469905|NCT01191255|1151199|P4|STARTED|Safety Assessment Period||0
469906|NCT01191255|1151200|P3|STARTED|Safety Assessment Period||0
469907|NCT01191255|1151201|P2|STARTED|Safety Assessment Period||292
469908|NCT01191255|1151202|P1|STARTED|Safety Assessment Period|3 subjects were assigned to receive KRX-0502 but didn't receive a single dose|149
469909|NCT01191242|1151228|P1|NOT COMPLETED|Overall Study||0
469910|NCT01191242|1151228|P1|COMPLETED|Overall Study||31
469911|NCT01191242|1151228|P1|STARTED|Overall Study||31
469912|NCT01191190|1151243|P1|NOT COMPLETED|Overall Study||1
469913|NCT01191190|1151243|P1|COMPLETED|Overall Study||20
469914|NCT01191190|1151243|P1|STARTED|Overall Study||21
469915|NCT01191086|1151256|P1|NOT COMPLETED|Overall Study||62
469916|NCT01191086|1151256|P1|COMPLETED|Overall Study||148
469917|NCT01191086|1151256|P1|STARTED|Overall Study||210
469918|NCT01191008|1151260|P1|NOT COMPLETED|Overall Study||15
469919|NCT01191008|1151260|P1|COMPLETED|Overall Study||618
469920|NCT01191008|1151260|P1|STARTED|Overall Study||633
469921|NCT01190891|1151268|P2|NOT COMPLETED|Overall Study||0
469922|NCT01190891|1151269|P1|NOT COMPLETED|Overall Study||6
469923|NCT01190891|1151268|P2|COMPLETED|Overall Study||52
469924|NCT01190891|1151269|P1|COMPLETED|Overall Study||46
469925|NCT01190891|1151268|P2|STARTED|Overall Study||52
469926|NCT01190891|1151269|P1|STARTED|Overall Study||52
469927|NCT01190878|1151281|P4|NOT COMPLETED|Overall Study||20
469928|NCT01190878|1151282|P3|NOT COMPLETED|Overall Study||5
469929|NCT01190878|1151283|P2|NOT COMPLETED|Overall Study||3
469930|NCT01190878|1151284|P1|NOT COMPLETED|Overall Study||3
469931|NCT01190878|1151281|P4|COMPLETED|Overall Study||22
469932|NCT01190878|1151282|P3|COMPLETED|Overall Study||37
469933|NCT01190878|1151283|P2|COMPLETED|Overall Study||42
469934|NCT01190878|1151284|P1|COMPLETED|Overall Study||37
469935|NCT01190878|1151281|P4|STARTED|Overall Study||42
469936|NCT01190878|1151282|P3|STARTED|Overall Study||42
469937|NCT01190878|1151283|P2|STARTED|Overall Study||45
469938|NCT01190878|1151284|P1|STARTED|Overall Study||40
469939|NCT01190865|1151294|P1|NOT COMPLETED|Overall Study||3
469940|NCT01190865|1151294|P1|COMPLETED|Overall Study||25
469941|NCT01190865|1151294|P1|STARTED|Overall Study||28
469942|NCT01190839|1151301|P2|NOT COMPLETED|Overall Study||147
469943|NCT01190839|1151302|P1|NOT COMPLETED|Overall Study||150
469944|NCT01190839|1151301|P2|COMPLETED|Overall Study||0
469945|NCT01190839|1151302|P1|COMPLETED|Overall Study||0
469946|NCT01190839|1151301|P2|Treated|Overall Study||143
469947|NCT01190839|1151302|P1|Treated|Overall Study||148
469948|NCT01190839|1151301|P2|STARTED|Overall Study||147
469949|NCT01190839|1151302|P1|STARTED|Overall Study||150
469950|NCT01190813|1151316|P2|NOT COMPLETED|Overall Study||4
469951|NCT01190813|1151317|P1|NOT COMPLETED|Overall Study||4
469952|NCT01190813|1151316|P2|COMPLETED|Overall Study||45
469953|NCT01190813|1151317|P1|COMPLETED|Overall Study||86
469954|NCT01190813|1151316|P2|26-week Visit|Overall Study|0 missed, 0 dropped|45
469955|NCT01190813|1151317|P1|26-week Visit|Overall Study|0 missed, 0 dropped|86
469956|NCT01190813|1151316|P2|23-week Phone Call|Overall Study|4 missed, 0 dropped|41
469957|NCT01190813|1151317|P1|23-week Phone Call|Overall Study|4 missed, 1 dropped|82
469958|NCT01190813|1151316|P2|18-week Visit (Masked Primary)|Overall Study|1 dropped|45
469959|NCT01190813|1151317|P1|18-week Visit (Masked Primary)|Overall Study|0 dropped|87
469960|NCT01190813|1151316|P2|16-week Visit|Overall Study|2 dropped|46
469961|NCT01190813|1151317|P1|16-week Visit|Overall Study|1 dropped|87
469962|NCT01190813|1151316|P2|13-week Phone Call|Overall Study|0 dropped, 0 missed|48
469963|NCT01190813|1151317|P1|13-week Phone Call|Overall Study|6 missed, 0 dropped|82
469964|NCT01190813|1151316|P2|10-week Visit|Overall Study|0 dropped, 0 missed|48
469965|NCT01190813|1151317|P1|10-week Visit|Overall Study|0 missed, 0 dropped|88
469966|NCT01190813|1151316|P2|7-week Phone Call|Overall Study|2 missed, 0 dropped|46
469967|NCT01190813|1151317|P1|7-week Phone Call|Overall Study|3 missed, 0 dropped|85
469968|NCT01190813|1151316|P2|4-week Visit|Overall Study|1 missed, 1 dropped|47
469969|NCT01190813|1151317|P1|4-week Visit|Overall Study|0 missed, 1 dropped|88
469970|NCT01190813|1151316|P2|2-week Phone Call|Overall Study|1 missed, 0 dropped|48
469971|NCT01190813|1151317|P1|2-week Phone Call|Overall Study|2 missed, 1 dropped|87
469972|NCT01190813|1151316|P2|STARTED|Overall Study||49
469973|NCT01190813|1151317|P1|STARTED|Overall Study||90
469974|NCT01190566|1151409|P2|NOT COMPLETED|Overall Study||0
469975|NCT01190566|1151410|P1|NOT COMPLETED|Overall Study||0
469976|NCT01190566|1151409|P2|COMPLETED|Overall Study||42
469977|NCT01190566|1151410|P1|COMPLETED|Overall Study||6
469978|NCT01190566|1151409|P2|STARTED|Overall Study||42
469979|NCT01190566|1151410|P1|STARTED|Overall Study||6
469980|NCT01190527|1151431|P1|NOT COMPLETED|Overall Study||0
469981|NCT01190527|1151431|P1|COMPLETED|Overall Study||42
469982|NCT01190527|1151431|P1|STARTED|Overall Study||42
469983|NCT01190514|1151438|P4|NOT COMPLETED|Fourth Intervention (Period 4)||0
469984|NCT01190514|1151439|P3|NOT COMPLETED|Fourth Intervention (Period 4)||0
469985|NCT01190514|1151440|P2|NOT COMPLETED|Fourth Intervention (Period 4)||0
469986|NCT01190514|1151441|P1|NOT COMPLETED|Fourth Intervention (Period 4)||0
469987|NCT01190514|1151438|P4|COMPLETED|Fourth Intervention (Period 4)||10
469988|NCT01190514|1151439|P3|COMPLETED|Fourth Intervention (Period 4)||10
469989|NCT01190514|1151440|P2|COMPLETED|Fourth Intervention (Period 4)||10
469990|NCT01190514|1151441|P1|COMPLETED|Fourth Intervention (Period 4)||9
469991|NCT01190514|1151438|P4|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment A|10
469992|NCT01190514|1151439|P3|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment B|10
469993|NCT01190514|1151440|P2|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment C|10
469994|NCT01190514|1151441|P1|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment D|9
469995|NCT01190514|1151438|P4|NOT COMPLETED|Third Intervention (Period 3)||0
469996|NCT01190514|1151439|P3|NOT COMPLETED|Third Intervention (Period 3)||0
469997|NCT01190514|1151440|P2|NOT COMPLETED|Third Intervention (Period 3)||0
469998|NCT01190514|1151441|P1|NOT COMPLETED|Third Intervention (Period 3)||1
469999|NCT01190514|1151438|P4|COMPLETED|Third Intervention (Period 3)||10
470000|NCT01190514|1151439|P3|COMPLETED|Third Intervention (Period 3)||10
470001|NCT01190514|1151440|P2|COMPLETED|Third Intervention (Period 3)||10
470002|NCT01190514|1151441|P1|COMPLETED|Third Intervention (Period 3)|Discontinued participant received treatments ABC of sequence ABCD.|9
470003|NCT01190514|1151438|P4|STARTED|Third Intervention (Period 3)|Period 3 received treatment B|10
470004|NCT01190514|1151439|P3|STARTED|Third Intervention (Period 3)|Period 3 received treatment A|10
470005|NCT01190514|1151440|P2|STARTED|Third Intervention (Period 3)|Period 3 received treatment D|10
470006|NCT01190514|1151441|P1|STARTED|Third Intervention (Period 3)|Period 3 received treatment C|10
470007|NCT01190514|1151438|P4|NOT COMPLETED|Second Intervention (Period 2)||0
470008|NCT01190514|1151439|P3|NOT COMPLETED|Second Intervention (Period 2)||0
470009|NCT01190514|1151440|P2|NOT COMPLETED|Second Intervention (Period 2)||0
470010|NCT01190514|1151441|P1|NOT COMPLETED|Second Intervention (Period 2)||0
470011|NCT01190514|1151438|P4|COMPLETED|Second Intervention (Period 2)||10
470012|NCT01190514|1151439|P3|COMPLETED|Second Intervention (Period 2)||10
470013|NCT01190514|1151440|P2|COMPLETED|Second Intervention (Period 2)||10
470014|NCT01190514|1151441|P1|COMPLETED|Second Intervention (Period 2)||10
470015|NCT01190514|1151438|P4|STARTED|Second Intervention (Period 2)|Period 2 received treatment C|10
470016|NCT01190514|1151439|P3|STARTED|Second Intervention (Period 2)|Period 2 received treatment D|10
470017|NCT01190514|1151440|P2|STARTED|Second Intervention (Period 2)|Period 2 received treatment A|10
470018|NCT01190514|1151441|P1|STARTED|Second Intervention (Period 2)|Period 2 received treatment B|10
470019|NCT01190514|1151438|P4|NOT COMPLETED|First Intervention (Period 1)||0
470020|NCT01190514|1151439|P3|NOT COMPLETED|First Intervention (Period 1)||0
470021|NCT01190514|1151440|P2|NOT COMPLETED|First Intervention (Period 1)||0
470022|NCT01190514|1151441|P1|NOT COMPLETED|First Intervention (Period 1)||1
470023|NCT01190514|1151438|P4|COMPLETED|First Intervention (Period 1)||10
470024|NCT01190514|1151439|P3|COMPLETED|First Intervention (Period 1)||10
470025|NCT01190514|1151440|P2|COMPLETED|First Intervention (Period 1)||10
470026|NCT01190514|1151441|P1|COMPLETED|First Intervention (Period 1)|Discontinued participant received treatment A of sequence ABCD.|10
470027|NCT01190514|1151438|P4|STARTED|First Intervention (Period 1)||10
470028|NCT01190514|1151439|P3|STARTED|First Intervention (Period 1)||10
470029|NCT01190514|1151440|P2|STARTED|First Intervention (Period 1)||10
470030|NCT01190514|1151441|P1|STARTED|First Intervention (Period 1)||11
470031|NCT01190475|1151474|P3|NOT COMPLETED|Overall Study||1
470032|NCT01190475|1151475|P2|NOT COMPLETED|Overall Study||0
470033|NCT01190475|1151476|P1|NOT COMPLETED|Overall Study||0
470034|NCT01190475|1151474|P3|COMPLETED|Overall Study||1
470035|NCT01190475|1151475|P2|COMPLETED|Overall Study||2
470036|NCT01190475|1151476|P1|COMPLETED|Overall Study||2
470037|NCT01190475|1151474|P3|STARTED|Overall Study||2
470038|NCT01190475|1151475|P2|STARTED|Overall Study||2
470039|NCT01190475|1151476|P1|STARTED|Overall Study||2
470040|NCT01190436|1151484|P1|NOT COMPLETED|Overall Study||39
470041|NCT01190436|1151484|P1|COMPLETED|Overall Study||86
470042|NCT01190436|1151484|P1|STARTED|Overall Study||125
470043|NCT01190306|1151500|P2|NOT COMPLETED|Overall Study||0
470044|NCT01190306|1151501|P1|NOT COMPLETED|Overall Study||0
470045|NCT01190306|1151500|P2|COMPLETED|Overall Study||66
470046|NCT01190306|1151501|P1|COMPLETED|Overall Study||61
470047|NCT01190306|1151500|P2|STARTED|Overall Study||66
470048|NCT01190306|1151501|P1|STARTED|Overall Study||61
470049|NCT01190267|1151509|P2|NOT COMPLETED|Overall Study||4
470050|NCT01190267|1151510|P1|NOT COMPLETED|Overall Study||41
470051|NCT01190267|1151509|P2|COMPLETED|Overall Study||4
470052|NCT01190267|1151510|P1|COMPLETED|Overall Study||155
470053|NCT01190267|1151509|P2|STARTED|Overall Study||8
470054|NCT01190267|1151510|P1|STARTED|Overall Study||196
470055|NCT01190254|1151521|P3|NOT COMPLETED|Overall Study||22
470056|NCT01190254|1151522|P2|NOT COMPLETED|Overall Study||17
470057|NCT01190254|1151523|P1|NOT COMPLETED|Overall Study||21
470058|NCT01190254|1151521|P3|COMPLETED|Overall Study||84
470059|NCT01190254|1151522|P2|COMPLETED|Overall Study||81
470060|NCT01190254|1151523|P1|COMPLETED|Overall Study||81
470061|NCT01190254|1151521|P3|Treated|Overall Study||106
470062|NCT01190254|1151522|P2|Treated|Overall Study||98
470063|NCT01190254|1151523|P1|Treated|Overall Study||102
470064|NCT01190254|1151521|P3|STARTED|Overall Study||106
470065|NCT01190254|1151522|P2|STARTED|Overall Study||98
470066|NCT01190254|1151523|P1|STARTED|Overall Study||102
470067|NCT01190228|1151588|P3|NOT COMPLETED|Overall Study||0
470068|NCT01190228|1151589|P2|NOT COMPLETED|Overall Study||0
470069|NCT01190228|1151590|P1|NOT COMPLETED|Overall Study||5
470070|NCT01190228|1151588|P3|COMPLETED|Overall Study||59
470071|NCT01190228|1151589|P2|COMPLETED|Overall Study||46
470072|NCT01190228|1151590|P1|COMPLETED|Overall Study||344
470073|NCT01190228|1151588|P3|STARTED|Overall Study||59
470074|NCT01190228|1151589|P2|STARTED|Overall Study||46
470075|NCT01190228|1151590|P1|STARTED|Overall Study||349
470076|NCT01190215|1151613|P2|NOT COMPLETED|Up to Month 6||0
470077|NCT01190215|1151614|P1|NOT COMPLETED|Up to Month 6||2
470078|NCT01190215|1151613|P2|COMPLETED|Up to Month 6||39
470079|NCT01190215|1151614|P1|COMPLETED|Up to Month 6||36
470080|NCT01190215|1151613|P2|STARTED|Up to Month 6||39
470081|NCT01190215|1151614|P1|STARTED|Up to Month 6||38
470082|NCT01190215|1151613|P2|NOT COMPLETED|Up to Day 28||0
470083|NCT01190215|1151614|P1|NOT COMPLETED|Up to Day 28||0
470084|NCT01190215|1151613|P2|COMPLETED|Up to Day 28||39
470085|NCT01190215|1151614|P1|COMPLETED|Up to Day 28||38
470086|NCT01190215|1151613|P2|STARTED|Up to Day 28||39
470087|NCT01190215|1151614|P1|STARTED|Up to Day 28||38
470088|NCT01190150|1151684|P2|NOT COMPLETED|Second Treatment||0
470089|NCT01190150|1151685|P1|NOT COMPLETED|Second Treatment||0
470090|NCT01190150|1151684|P2|COMPLETED|Second Treatment||7
470091|NCT01190150|1151685|P1|COMPLETED|Second Treatment||10
470092|NCT01190150|1151684|P2|STARTED|Second Treatment||7
470093|NCT01190150|1151685|P1|STARTED|Second Treatment||10
470094|NCT01190150|1151684|P2|NOT COMPLETED|Washout||2
470095|NCT01190150|1151685|P1|NOT COMPLETED|Washout||0
470096|NCT01190150|1151684|P2|COMPLETED|Washout||7
470097|NCT01190150|1151685|P1|COMPLETED|Washout||10
470098|NCT01190150|1151684|P2|STARTED|Washout||9
470099|NCT01190150|1151685|P1|STARTED|Washout||10
470100|NCT01190150|1151684|P2|NOT COMPLETED|First Treatment||0
470101|NCT01190150|1151685|P1|NOT COMPLETED|First Treatment||1
470102|NCT01190150|1151684|P2|COMPLETED|First Treatment||9
470103|NCT01190150|1151685|P1|COMPLETED|First Treatment||10
470104|NCT01190150|1151684|P2|STARTED|First Treatment|Randomized, as well as Safety and PK populations|9
470105|NCT01190150|1151685|P1|STARTED|First Treatment|Randomized, as well as Safety and PK populations|11
470106|NCT01190124|1151712|P3|NOT COMPLETED|Overall Study||1
470107|NCT01190124|1151713|P2|NOT COMPLETED|Overall Study||0
470108|NCT01190124|1151714|P1|NOT COMPLETED|Overall Study||17
470109|NCT01190124|1151712|P3|COMPLETED|Overall Study||19
470110|NCT01190124|1151713|P2|COMPLETED|Overall Study||24
470111|NCT01190124|1151714|P1|COMPLETED|Overall Study||90
470112|NCT01190124|1151712|P3|STARTED|Overall Study||20
470113|NCT01190124|1151713|P2|STARTED|Overall Study||24
470114|NCT01190124|1151714|P1|STARTED|Overall Study||107
470115|NCT01190098|1151752|P2|NOT COMPLETED|Overall Study||2
470116|NCT01190098|1151753|P1|NOT COMPLETED|Overall Study||3
470117|NCT01190098|1151752|P2|COMPLETED|Overall Study||8
470118|NCT01190098|1151753|P1|COMPLETED|Overall Study||39
470119|NCT01190098|1151752|P2|STARTED|Overall Study||10
470120|NCT01190098|1151753|P1|STARTED|Overall Study||42
470121|NCT01190085|1151776|P3|NOT COMPLETED|Overall Study||0
470122|NCT01190085|1151777|P2|NOT COMPLETED|Overall Study||0
470123|NCT01190085|1151778|P1|NOT COMPLETED|Overall Study||0
470124|NCT01190085|1151776|P3|COMPLETED|Overall Study||18
470125|NCT01190085|1151777|P2|COMPLETED|Overall Study||14
470126|NCT01190085|1151778|P1|COMPLETED|Overall Study||13
470127|NCT01190085|1151776|P3|STARTED|Overall Study||18
470128|NCT01190085|1151777|P2|STARTED|Overall Study||14
470129|NCT01190085|1151778|P1|STARTED|Overall Study||13
470130|NCT01190007|1151792|P1|NOT COMPLETED|Overall Study||14
470131|NCT01190007|1151792|P1|COMPLETED|Overall Study||145
470132|NCT01190007|1151792|P1|STARTED|Overall Study|Treated|159
470133|NCT01189890|1151809|P2|NOT COMPLETED|Overall Study||39
470134|NCT01189890|1151810|P1|NOT COMPLETED|Overall Study||37
470135|NCT01189890|1151809|P2|COMPLETED|Overall Study||200
470136|NCT01189890|1151810|P1|COMPLETED|Overall Study||204
470137|NCT01189890|1151809|P2|STARTED|Overall Study|3 randomized glimepiride participants did not receive study drug.|239
470138|NCT01189890|1151810|P1|STARTED|Overall Study||241
470139|NCT01189812|1151832|P2|NOT COMPLETED|Overall Study||8
470140|NCT01189812|1151833|P1|NOT COMPLETED|Overall Study||8
470141|NCT01189812|1151832|P2|COMPLETED|Overall Study||32
470142|NCT01189812|1151833|P1|COMPLETED|Overall Study||32
470143|NCT01189812|1151832|P2|STARTED|Overall Study||40
470144|NCT01189812|1151833|P1|STARTED|Overall Study||40
470145|NCT01189760|1151842|P3|NOT COMPLETED|Overall Study||51
470146|NCT01189760|1151843|P2|NOT COMPLETED|Overall Study||23
470147|NCT01189760|1151844|P1|NOT COMPLETED|Overall Study||14
470148|NCT01189760|1151842|P3|COMPLETED|Overall Study||255
470149|NCT01189760|1151843|P2|COMPLETED|Overall Study||283
470150|NCT01189760|1151844|P1|COMPLETED|Overall Study||291
470151|NCT01189760|1151842|P3|STARTED|Overall Study||306
470152|NCT01189760|1151843|P2|STARTED|Overall Study||306
470153|NCT01189760|1151844|P1|STARTED|Overall Study||305
470154|NCT01189747|1151878|P2|NOT COMPLETED|Overall Study||18
470155|NCT01189747|1151879|P1|NOT COMPLETED|Overall Study||12
470156|NCT01189747|1151878|P2|COMPLETED|Overall Study||206
470157|NCT01189747|1151879|P1|COMPLETED|Overall Study||210
470158|NCT01189747|1151878|P2|STARTED|Overall Study||224
470159|NCT01189747|1151879|P1|STARTED|Overall Study||222
470160|NCT01189617|1151903|P2|NOT COMPLETED|Overall Study||0
470161|NCT01189617|1151904|P1|NOT COMPLETED|Overall Study||0
470162|NCT01189617|1151903|P2|COMPLETED|Overall Study||35
470163|NCT01189617|1151904|P1|COMPLETED|Overall Study||35
470164|NCT01189617|1151903|P2|STARTED|Overall Study||35
470165|NCT01189617|1151904|P1|STARTED|Overall Study||35
470166|NCT01189604|1151917|P7|NOT COMPLETED|Overall Study||1
470167|NCT01189604|1151918|P6|NOT COMPLETED|Overall Study||1
470168|NCT01189604|1151919|P5|NOT COMPLETED|Overall Study||2
470169|NCT01189604|1151920|P4|NOT COMPLETED|Overall Study||0
470170|NCT01189604|1151921|P3|NOT COMPLETED|Overall Study||0
470171|NCT01189604|1151922|P2|NOT COMPLETED|Overall Study||1
470172|NCT01189604|1151923|P1|NOT COMPLETED|Overall Study||1
470173|NCT01189604|1151917|P7|COMPLETED|Overall Study||9
470174|NCT01189604|1151918|P6|COMPLETED|Overall Study||10
470175|NCT01189604|1151919|P5|COMPLETED|Overall Study||18
470176|NCT01189604|1151920|P4|COMPLETED|Overall Study||20
470177|NCT01189604|1151921|P3|COMPLETED|Overall Study||20
470178|NCT01189604|1151922|P2|COMPLETED|Overall Study||20
470179|NCT01189604|1151923|P1|COMPLETED|Overall Study||20
470180|NCT01189604|1151917|P7|Administered Study Drug|Overall Study||10
470181|NCT01189604|1151918|P6|Administered Study Drug|Overall Study||10
470182|NCT01189604|1151919|P5|Administered Study Drug|Overall Study||20
470183|NCT01189604|1151920|P4|Administered Study Drug|Overall Study||20
470184|NCT01189604|1151921|P3|Administered Study Drug|Overall Study||20
470185|NCT01189604|1151922|P2|Administered Study Drug|Overall Study||20
470186|NCT01189604|1151923|P1|Administered Study Drug|Overall Study||20
470187|NCT01189604|1151917|P7|STARTED|Overall Study||10
470188|NCT01189604|1151918|P6|STARTED|Overall Study||11
470189|NCT01189604|1151919|P5|STARTED|Overall Study||20
470190|NCT01189604|1151920|P4|STARTED|Overall Study||20
470191|NCT01189604|1151921|P3|STARTED|Overall Study||20
470192|NCT01189604|1151922|P2|STARTED|Overall Study||21
470193|NCT01189604|1151923|P1|STARTED|Overall Study||21
470194|NCT01189500|1151967|P1|NOT COMPLETED|Period 2: Coadministration TAMOX+DVS SR||1
470195|NCT01189500|1151967|P1|COMPLETED|Period 2: Coadministration TAMOX+DVS SR||28
470196|NCT01189500|1151967|P1|STARTED|Period 2: Coadministration TAMOX+DVS SR||29
470197|NCT01189500|1151967|P1|NOT COMPLETED|Period 1: TAMOX Alone||1
470198|NCT01189500|1151967|P1|COMPLETED|Period 1: TAMOX Alone||29
470199|NCT01189500|1151967|P1|STARTED|Period 1: TAMOX Alone||30
470200|NCT01189487|1152028|P1|NOT COMPLETED|Overall Study||3
470201|NCT01189487|1152028|P1|COMPLETED|Overall Study||44
470202|NCT01189487|1152028|P1|STARTED|Overall Study|Treated participants|47
470203|NCT01189461|1152036|P1|NOT COMPLETED|Overall Study||34
470204|NCT01189461|1152036|P1|COMPLETED|Overall Study||12
470205|NCT01189461|1152036|P1|STARTED|Overall Study||46
470206|NCT01189435|1152043|P1|NOT COMPLETED|Overall Study||2
470207|NCT01189435|1152043|P1|COMPLETED|Overall Study||0
470208|NCT01189435|1152043|P1|STARTED|Overall Study||2
470209|NCT01189370|1152047|P3|NOT COMPLETED|Dose Level 3||6
470210|NCT01189370|1152048|P2|NOT COMPLETED|Dose Level 3||0
470211|NCT01189370|1152049|P1|NOT COMPLETED|Dose Level 3||0
470212|NCT01189370|1152047|P3|COMPLETED|Dose Level 3||6
470213|NCT01189370|1152048|P2|COMPLETED|Dose Level 3||0
470214|NCT01189370|1152049|P1|COMPLETED|Dose Level 3||0
470215|NCT01189370|1152047|P3|STARTED|Dose Level 3||12
470216|NCT01189370|1152048|P2|STARTED|Dose Level 3||0
470217|NCT01189370|1152049|P1|STARTED|Dose Level 3||0
470218|NCT01189370|1152047|P3|NOT COMPLETED|Dose Level 2||0
470219|NCT01189370|1152048|P2|NOT COMPLETED|Dose Level 2||4
470220|NCT01189370|1152049|P1|NOT COMPLETED|Dose Level 2||0
470221|NCT01189370|1152047|P3|COMPLETED|Dose Level 2||0
470222|NCT01189370|1152048|P2|COMPLETED|Dose Level 2||12
470223|NCT01189370|1152049|P1|COMPLETED|Dose Level 2||0
470224|NCT01189370|1152047|P3|STARTED|Dose Level 2||0
470225|NCT01189370|1152048|P2|STARTED|Dose Level 2||16
470226|NCT01189370|1152049|P1|STARTED|Dose Level 2||0
470227|NCT01189370|1152047|P3|NOT COMPLETED|Dose Level 1||0
470228|NCT01189370|1152048|P2|NOT COMPLETED|Dose Level 1||0
470229|NCT01189370|1152049|P1|NOT COMPLETED|Dose Level 1||9
470230|NCT01189370|1152047|P3|COMPLETED|Dose Level 1||0
470231|NCT01189370|1152048|P2|COMPLETED|Dose Level 1||0
470232|NCT01189370|1152049|P1|COMPLETED|Dose Level 1||16
470233|NCT01189370|1152047|P3|STARTED|Dose Level 1||0
470234|NCT01189370|1152048|P2|STARTED|Dose Level 1||0
470235|NCT01189370|1152049|P1|STARTED|Dose Level 1||25
470236|NCT01189292|1152058|P2|NOT COMPLETED|Per Protocol Analysis||16
470237|NCT01189292|1152059|P1|NOT COMPLETED|Per Protocol Analysis||11
470238|NCT01189292|1152058|P2|COMPLETED|Per Protocol Analysis||60
470239|NCT01189292|1152059|P1|COMPLETED|Per Protocol Analysis||65
470240|NCT01189292|1152058|P2|STARTED|Per Protocol Analysis||76
470241|NCT01189292|1152059|P1|STARTED|Per Protocol Analysis||76
470242|NCT01189292|1152058|P2|NOT COMPLETED|Intention to Treat Analysis||0
470243|NCT01189292|1152059|P1|NOT COMPLETED|Intention to Treat Analysis||0
470244|NCT01189292|1152058|P2|COMPLETED|Intention to Treat Analysis||76
470245|NCT01189292|1152059|P1|COMPLETED|Intention to Treat Analysis||76
470246|NCT01189292|1152058|P2|STARTED|Intention to Treat Analysis||76
470247|NCT01189292|1152059|P1|STARTED|Intention to Treat Analysis||76
470248|NCT01189279|1152080|P3|NOT COMPLETED|Overall Study||1
470249|NCT01189279|1152081|P2|NOT COMPLETED|Overall Study||0
470250|NCT01189279|1152082|P1|NOT COMPLETED|Overall Study||1
470251|NCT01189279|1152080|P3|COMPLETED|Overall Study||13
470252|NCT01189279|1152081|P2|COMPLETED|Overall Study||14
470253|NCT01189279|1152082|P1|COMPLETED|Overall Study||13
470254|NCT01189279|1152080|P3|STARTED|Overall Study||14
470255|NCT01189279|1152081|P2|STARTED|Overall Study||14
470256|NCT01189279|1152082|P1|STARTED|Overall Study||14
470257|NCT01189240|1152102|P3|NOT COMPLETED|Overall Study||0
470258|NCT01189240|1152103|P2|NOT COMPLETED|Overall Study||0
470259|NCT01189240|1152104|P1|NOT COMPLETED|Overall Study||0
470260|NCT01189240|1152102|P3|COMPLETED|Overall Study||3
470261|NCT01189240|1152103|P2|COMPLETED|Overall Study||6
470262|NCT01189240|1152104|P1|COMPLETED|Overall Study||4
470263|NCT01189240|1152102|P3|STARTED|Overall Study||3
470264|NCT01189240|1152103|P2|STARTED|Overall Study||6
470265|NCT01189240|1152104|P1|STARTED|Overall Study||4
470266|NCT01189227|1152125|P2|NOT COMPLETED|Overall Study||3
470267|NCT01189227|1152126|P1|NOT COMPLETED|Overall Study||6
470268|NCT01189227|1152125|P2|COMPLETED|Overall Study||0
470269|NCT01189227|1152126|P1|COMPLETED|Overall Study||0
470270|NCT01189227|1152125|P2|STARTED|Overall Study||3
470271|NCT01189227|1152126|P1|STARTED|Overall Study||6
470272|NCT01189201|1152132|P1|NOT COMPLETED|Overall Study||1
470273|NCT01189201|1152132|P1|COMPLETED|Overall Study||41
470274|NCT01189201|1152132|P1|Received Empa/Linagliptin FDC A3(Fasted)|Overall Study||24
470275|NCT01189201|1152132|P1|Received Empa/Linagliptin FDC A1 (Fed)|Overall Study||18
470276|NCT01189201|1152132|P1|Rec. Empa/Linagliptin Ind.Tablet(Fasted)|Overall Study||41
470277|NCT01189201|1152132|P1|Received Empa/Linagliptin FDC A1(Fasted)|Overall Study||42
470278|NCT01189201|1152132|P1|STARTED|Overall Study||42
470279|NCT01189136|1152188|P2|NOT COMPLETED|Overall Study||0
470280|NCT01189136|1152189|P1|NOT COMPLETED|Overall Study||0
470281|NCT01189136|1152188|P2|COMPLETED|Overall Study||42
470282|NCT01189136|1152189|P1|COMPLETED|Overall Study||42
470283|NCT01189136|1152188|P2|STARTED|Overall Study||42
470284|NCT01189136|1152189|P1|STARTED|Overall Study||42
470285|NCT01189123|1152203|P2|NOT COMPLETED|Overall Study||6
470286|NCT01189123|1152204|P1|NOT COMPLETED|Overall Study||2
470287|NCT01189123|1152203|P2|COMPLETED|Overall Study||47
470288|NCT01189123|1152204|P1|COMPLETED|Overall Study||50
470289|NCT01189123|1152203|P2|STARTED|Overall Study||53
470290|NCT01189123|1152204|P1|STARTED|Overall Study||52
470291|NCT01189110|1152214|P2|NOT COMPLETED|Overall Study||0
470292|NCT01189110|1152215|P1|NOT COMPLETED|Overall Study||0
470293|NCT01189110|1152214|P2|COMPLETED|Overall Study||61
470294|NCT01189110|1152215|P1|COMPLETED|Overall Study|February, 2011|64
470295|NCT01189110|1152214|P2|STARTED|Overall Study||61
470296|NCT01189110|1152215|P1|STARTED|Overall Study|September, 2010|64
470297|NCT01189071|1152223|P2|NOT COMPLETED|Overall Study||0
470298|NCT01189071|1152224|P1|NOT COMPLETED|Overall Study||0
470299|NCT01189071|1152223|P2|COMPLETED|Overall Study||0
470300|NCT01189071|1152224|P1|COMPLETED|Overall Study||0
470301|NCT01189071|1152223|P2|STARTED|Overall Study||0
470302|NCT01189071|1152224|P1|STARTED|Overall Study||0
470303|NCT01189032|1152235|P3|NOT COMPLETED|Overall Study||6
470304|NCT01189032|1152236|P2|NOT COMPLETED|Overall Study||7
470305|NCT01189032|1152237|P1|NOT COMPLETED|Overall Study||5
470306|NCT01189032|1152235|P3|COMPLETED|Overall Study||90
470307|NCT01189032|1152236|P2|COMPLETED|Overall Study||89
470308|NCT01189032|1152237|P1|COMPLETED|Overall Study||89
470309|NCT01189032|1152235|P3|STARTED|Overall Study||96
470310|NCT01189032|1152236|P2|STARTED|Overall Study||96
470311|NCT01189032|1152237|P1|STARTED|Overall Study||94
470312|NCT01188967|1152247|P2|NOT COMPLETED|Overall Study||4
470313|NCT01188967|1152248|P1|NOT COMPLETED|Overall Study||5
470314|NCT01188967|1152247|P2|COMPLETED|Overall Study||4
470315|NCT01188967|1152248|P1|COMPLETED|Overall Study||5
470316|NCT01188967|1152247|P2|STARTED|Overall Study||8
470317|NCT01188967|1152248|P1|STARTED|Overall Study||10
470318|NCT01188928|1152264|P4|NOT COMPLETED|Overall Study||18
470319|NCT01188928|1152265|P3|NOT COMPLETED|Overall Study||14
470320|NCT01188928|1152266|P2|NOT COMPLETED|Overall Study||62
470321|NCT01188928|1152267|P1|NOT COMPLETED|Overall Study||38
470322|NCT01188928|1152264|P4|COMPLETED|Overall Study||77
470323|NCT01188928|1152265|P3|COMPLETED|Overall Study||82
470324|NCT01188928|1152266|P2|COMPLETED|Overall Study||417
470325|NCT01188928|1152267|P1|COMPLETED|Overall Study||444
470326|NCT01188928|1152264|P4|STARTED|Overall Study||95
470327|NCT01188928|1152265|P3|STARTED|Overall Study||96
470328|NCT01188928|1152266|P2|STARTED|Overall Study||479
470329|NCT01188928|1152267|P1|STARTED|Overall Study||482
470330|NCT01188876|1152289|P1|NOT COMPLETED|Overall Study||0
470331|NCT01188876|1152289|P1|COMPLETED|Overall Study||50
470332|NCT01188876|1152289|P1|STARTED|Overall Study||50
470333|NCT01188811|1152301|P2|NOT COMPLETED|Overall Study||2
470334|NCT01188811|1152302|P1|NOT COMPLETED|Overall Study||6
470335|NCT01188811|1152301|P2|COMPLETED|Overall Study||24
470336|NCT01188811|1152302|P1|COMPLETED|Overall Study||22
470337|NCT01188811|1152301|P2|STARTED|Overall Study||26
470338|NCT01188811|1152302|P1|STARTED|Overall Study||28
470339|NCT01188798|1152314|P2|NOT COMPLETED|Overall Study||3
470340|NCT01188798|1152315|P1|NOT COMPLETED|Overall Study||2
470341|NCT01188798|1152314|P2|COMPLETED|Overall Study||1
470342|NCT01188798|1152315|P1|COMPLETED|Overall Study||0
470343|NCT01188798|1152314|P2|STARTED|Overall Study||4
470344|NCT01188798|1152315|P1|STARTED|Overall Study||2
470345|NCT01188772|1152327|P4|NOT COMPLETED|Overall Study||1
470346|NCT01188772|1152328|P3|NOT COMPLETED|Overall Study||11
470347|NCT01188772|1152329|P2|NOT COMPLETED|Overall Study||3
470348|NCT01188772|1152330|P1|NOT COMPLETED|Overall Study||5
470349|NCT01188772|1152327|P4|COMPLETED|Overall Study||24
470350|NCT01188772|1152328|P3|COMPLETED|Overall Study||15
470351|NCT01188772|1152329|P2|COMPLETED|Overall Study||45
470352|NCT01188772|1152330|P1|COMPLETED|Overall Study||43
470353|NCT01188772|1152327|P4|Randomized and Treated|Overall Study||25
470354|NCT01188772|1152328|P3|Randomized and Treated|Overall Study||26
470355|NCT01188772|1152329|P2|Randomized and Treated|Overall Study||47
470356|NCT01188772|1152330|P1|Randomized and Treated|Overall Study||48
470357|NCT01188772|1152327|P4|STARTED|Overall Study||25
470358|NCT01188772|1152328|P3|STARTED|Overall Study||26
470359|NCT01188772|1152329|P2|STARTED|Overall Study||48
470360|NCT01188772|1152330|P1|STARTED|Overall Study||48
470361|NCT01188694|1152388|P3|NOT COMPLETED|Overall Study||1
470362|NCT01188694|1152389|P2|NOT COMPLETED|Overall Study||1
470363|NCT01188694|1152390|P1|NOT COMPLETED|Overall Study||5
470364|NCT01188694|1152388|P3|COMPLETED|Overall Study||10
470365|NCT01188694|1152389|P2|COMPLETED|Overall Study||15
470366|NCT01188694|1152390|P1|COMPLETED|Overall Study||10
470367|NCT01188694|1152388|P3|STARTED|Overall Study||11
470368|NCT01188694|1152389|P2|STARTED|Overall Study||16
470369|NCT01188694|1152390|P1|STARTED|Overall Study||15
470370|NCT01188681|1152402|P4|NOT COMPLETED|Overall Study||1
470371|NCT01188681|1152403|P3|NOT COMPLETED|Overall Study||1
470372|NCT01188681|1152404|P2|NOT COMPLETED|Overall Study||0
470373|NCT01188681|1152405|P1|NOT COMPLETED|Overall Study||0
470374|NCT01188681|1152402|P4|COMPLETED|Overall Study||33
470375|NCT01188681|1152403|P3|COMPLETED|Overall Study||32
470376|NCT01188681|1152404|P2|COMPLETED|Overall Study||6
470377|NCT01188681|1152405|P1|COMPLETED|Overall Study||6
470378|NCT01188681|1152402|P4|STARTED|Overall Study|34 patients enrolled, 33 patients treated. One patient withdrew consent and was not treated.|34
470379|NCT01188681|1152403|P3|STARTED|Overall Study|33 patients enrolled, 32 patients treated. One patient had bladder cancer and was not treated.|33
470380|NCT01188681|1152404|P2|STARTED|Overall Study||6
470381|NCT01188681|1152405|P1|STARTED|Overall Study||6
470382|NCT01188668|1152419|P1|NOT COMPLETED|Period 2: Coadministration ARIP + DVS SR||3
470383|NCT01188668|1152419|P1|COMPLETED|Period 2: Coadministration ARIP + DVS SR||33
470384|NCT01188668|1152419|P1|STARTED|Period 2: Coadministration ARIP + DVS SR||36
470385|NCT01188668|1152419|P1|NOT COMPLETED|Period 1: ARIP Alone||2
470386|NCT01188668|1152419|P1|COMPLETED|Period 1: ARIP Alone||36
470387|NCT01188668|1152419|P1|STARTED|Period 1: ARIP Alone||38
470388|NCT01188655|1152452|P1|NOT COMPLETED|Overall Study||13
470389|NCT01188655|1152452|P1|COMPLETED|Overall Study||76
470390|NCT01188655|1152452|P1|STARTED|Overall Study||89
470391|NCT01188603|1152467|P1|NOT COMPLETED|Overall Study||0
470392|NCT01188603|1152467|P1|COMPLETED|Overall Study||24
470393|NCT01188603|1152467|P1|STARTED|Overall Study||24
470394|NCT01188577|1152477|P2|NOT COMPLETED|Visit 2||0
470395|NCT01188577|1152478|P1|NOT COMPLETED|Visit 2||0
470396|NCT01188577|1152477|P2|COMPLETED|Visit 2||12
470397|NCT01188577|1152478|P1|COMPLETED|Visit 2||11
470398|NCT01188577|1152477|P2|STARTED|Visit 2||12
470399|NCT01188577|1152478|P1|STARTED|Visit 2||11
470400|NCT01188577|1152477|P2|NOT COMPLETED|3-14 Day Washout||0
470401|NCT01188577|1152478|P1|NOT COMPLETED|3-14 Day Washout||0
470402|NCT01188577|1152477|P2|COMPLETED|3-14 Day Washout||12
470403|NCT01188577|1152478|P1|COMPLETED|3-14 Day Washout||11
470404|NCT01188577|1152477|P2|STARTED|3-14 Day Washout||12
470405|NCT01188577|1152478|P1|STARTED|3-14 Day Washout||11
470406|NCT01188577|1152477|P2|NOT COMPLETED|Visit 1||0
470407|NCT01188577|1152478|P1|NOT COMPLETED|Visit 1||0
470408|NCT01188577|1152477|P2|COMPLETED|Visit 1||12
470409|NCT01188577|1152478|P1|COMPLETED|Visit 1||11
470410|NCT01188577|1152477|P2|STARTED|Visit 1||12
470411|NCT01188577|1152478|P1|STARTED|Visit 1||11
470412|NCT01188564|1152496|P2|NOT COMPLETED|Open Label Phase||0
470413|NCT01188564|1152497|P1|NOT COMPLETED|Open Label Phase||0
470414|NCT01188564|1152496|P2|COMPLETED|Open Label Phase||20
470415|NCT01188564|1152497|P1|COMPLETED|Open Label Phase||24
470416|NCT01188564|1152496|P2|STARTED|Open Label Phase|Not all Double Blind Phase participants went on to Open Label Phase|20
470417|NCT01188564|1152497|P1|STARTED|Open Label Phase|Not all Double-Blind Phase participants went on to Open Label Phase|24
470418|NCT01188564|1152496|P2|NOT COMPLETED|Double-blind Phase||0
470419|NCT01188564|1152497|P1|NOT COMPLETED|Double-blind Phase||1
470420|NCT01188564|1152496|P2|COMPLETED|Double-blind Phase||31
470421|NCT01188564|1152497|P1|COMPLETED|Double-blind Phase||43
470422|NCT01188564|1152496|P2|STARTED|Double-blind Phase||31
470423|NCT01188564|1152497|P1|STARTED|Double-blind Phase||44
470424|NCT01188551|1152509|P4|NOT COMPLETED|Overall Study||0
470425|NCT01188551|1152510|P3|NOT COMPLETED|Overall Study||0
470426|NCT01188551|1152511|P2|NOT COMPLETED|Overall Study||0
470427|NCT01188551|1152512|P1|NOT COMPLETED|Overall Study||1
470428|NCT01188551|1152509|P4|COMPLETED|Overall Study||25
470429|NCT01188551|1152510|P3|COMPLETED|Overall Study||25
470430|NCT01188551|1152511|P2|COMPLETED|Overall Study||25
470431|NCT01188551|1152512|P1|COMPLETED|Overall Study||24
470432|NCT01188551|1152509|P4|STARTED|Overall Study||25
470433|NCT01188551|1152510|P3|STARTED|Overall Study||25
470434|NCT01188551|1152511|P2|STARTED|Overall Study||25
470435|NCT01188551|1152512|P1|STARTED|Overall Study||25
470436|NCT01188538|1152528|P2|NOT COMPLETED|Overall Study||1
470437|NCT01188538|1152529|P1|NOT COMPLETED|Overall Study||0
470438|NCT01188538|1152528|P2|COMPLETED|Overall Study||19
470439|NCT01188538|1152529|P1|COMPLETED|Overall Study||20
470440|NCT01188538|1152528|P2|STARTED|Overall Study||20
470441|NCT01188538|1152529|P1|STARTED|Overall Study||20
470442|NCT01188499|1152542|P5|NOT COMPLETED|Overall Study||0
470443|NCT01188499|1152543|P4|NOT COMPLETED|Overall Study||0
470444|NCT01188499|1152544|P3|NOT COMPLETED|Overall Study||0
470445|NCT01188499|1152545|P2|NOT COMPLETED|Overall Study||0
470446|NCT01188499|1152546|P1|NOT COMPLETED|Overall Study||0
470447|NCT01188499|1152542|P5|COMPLETED|Overall Study||18
470448|NCT01188499|1152543|P4|COMPLETED|Overall Study||18
470449|NCT01188499|1152544|P3|COMPLETED|Overall Study||33
470450|NCT01188499|1152545|P2|COMPLETED|Overall Study||83
470451|NCT01188499|1152546|P1|COMPLETED|Overall Study||24
470452|NCT01188499|1152542|P5|STARTED|Overall Study||18
470453|NCT01188499|1152543|P4|STARTED|Overall Study||18
470454|NCT01188499|1152544|P3|STARTED|Overall Study||33
470455|NCT01188499|1152545|P2|STARTED|Overall Study||83
470456|NCT01188499|1152546|P1|STARTED|Overall Study||24
470457|NCT01188460|1152565|P2|NOT COMPLETED|Overall Study||0
470458|NCT01188460|1152566|P1|NOT COMPLETED|Overall Study||0
470459|NCT01188460|1152565|P2|COMPLETED|Overall Study||23
470460|NCT01188460|1152566|P1|COMPLETED|Overall Study||25
470461|NCT01188460|1152565|P2|STARTED|Overall Study||23
470462|NCT01188460|1152566|P1|STARTED|Overall Study||25
470463|NCT01188447|1152592|P1|NOT COMPLETED|Overall Study||0
470464|NCT01188447|1152592|P1|COMPLETED|Overall Study||4034
470465|NCT01188447|1152592|P1|STARTED|Overall Study||4034
470466|NCT01188421|1152603|P3|NOT COMPLETED|Overall Study||14
470467|NCT01188421|1152604|P2|NOT COMPLETED|Overall Study||10
470468|NCT01188421|1152605|P1|NOT COMPLETED|Overall Study||3
470469|NCT01188421|1152603|P3|COMPLETED|Overall Study||22
470470|NCT01188421|1152604|P2|COMPLETED|Overall Study||26
470471|NCT01188421|1152605|P1|COMPLETED|Overall Study||28
470472|NCT01188421|1152603|P3|STARTED|Overall Study||36
470473|NCT01188421|1152604|P2|STARTED|Overall Study||36
470474|NCT01188421|1152605|P1|STARTED|Overall Study||31
470475|NCT01188343|1152616|P3|NOT COMPLETED|Overall Study||1
470476|NCT01188343|1152617|P2|NOT COMPLETED|Overall Study||26
470477|NCT01188343|1152618|P1|NOT COMPLETED|Overall Study||1
470478|NCT01188343|1152616|P3|COMPLETED|Overall Study||220
470479|NCT01188343|1152617|P2|COMPLETED|Overall Study||193
470480|NCT01188343|1152618|P1|COMPLETED|Overall Study||101
470481|NCT01188343|1152616|P3|STARTED|Overall Study||221
470482|NCT01188343|1152617|P2|STARTED|Overall Study||219
470483|NCT01188343|1152618|P1|STARTED|Overall Study||102
470484|NCT01188226|1152644|P1|NOT COMPLETED|Overall Study||4
470485|NCT01188226|1152644|P1|COMPLETED|Overall Study||6
470486|NCT01188226|1152644|P1|STARTED|Overall Study||10
470487|NCT01188109|1152683|P1|NOT COMPLETED|Overall Study||0
470488|NCT01188109|1152683|P1|COMPLETED|Overall Study||22
470489|NCT01188109|1152683|P1|STARTED|Overall Study||22
470490|NCT01187953|1152690|P2|NOT COMPLETED|Overall Study||21
470491|NCT01187953|1152691|P1|NOT COMPLETED|Overall Study||15
470492|NCT01187953|1152690|P2|COMPLETED|Overall Study||254
470493|NCT01187953|1152691|P1|COMPLETED|Overall Study||253
470494|NCT01187953|1152690|P2|Dosed|Overall Study||271
470495|NCT01187953|1152691|P1|Dosed|Overall Study||266
470496|NCT01187953|1152690|P2|STARTED|Overall Study||275
470497|NCT01187953|1152691|P1|STARTED|Overall Study||268
470498|NCT01187914|1152699|P1|NOT COMPLETED|Overall Study||0
470499|NCT01187914|1152699|P1|COMPLETED|Overall Study||40
470500|NCT01187914|1152699|P1|STARTED|Overall Study||40
470501|NCT01187901|1152705|P2|NOT COMPLETED|Overall Study||10
470502|NCT01187901|1152706|P1|NOT COMPLETED|Overall Study||9
470503|NCT01187901|1152705|P2|COMPLETED|Overall Study||36
470504|NCT01187901|1152706|P1|COMPLETED|Overall Study||37
470505|NCT01187901|1152705|P2|STARTED|Overall Study||46
470506|NCT01187901|1152706|P1|STARTED|Overall Study||46
470507|NCT01187771|1152724|P2|NOT COMPLETED|Overall Study||3
470508|NCT01187771|1152725|P1|NOT COMPLETED|Overall Study||3
470509|NCT01187771|1152724|P2|COMPLETED|Overall Study||18
470510|NCT01187771|1152725|P1|COMPLETED|Overall Study||25
470511|NCT01187771|1152724|P2|STARTED|Overall Study||21
470512|NCT01187771|1152725|P1|STARTED|Overall Study||28
470513|NCT01187550|1152747|P2|NOT COMPLETED|Overall Study||1
470514|NCT01187550|1152748|P1|NOT COMPLETED|Overall Study||14
470515|NCT01187550|1152747|P2|COMPLETED|Overall Study||29
470516|NCT01187550|1152748|P1|COMPLETED|Overall Study||169
470517|NCT01187550|1152747|P2|Treated|Overall Study||30
470518|NCT01187550|1152748|P1|Treated|Overall Study||175
470519|NCT01187550|1152747|P2|STARTED|Overall Study||30
470520|NCT01187550|1152748|P1|STARTED|Overall Study||183
470521|NCT01187511|1152766|P2|NOT COMPLETED|Overall Study||1
470522|NCT01187511|1152767|P1|NOT COMPLETED|Overall Study||8
470523|NCT01187511|1152766|P2|COMPLETED|Overall Study||21
470524|NCT01187511|1152767|P1|COMPLETED|Overall Study||14
470525|NCT01187511|1152766|P2|STARTED|Overall Study||22
470526|NCT01187511|1152767|P1|STARTED|Overall Study||22
470527|NCT01187498|1152875|P2|NOT COMPLETED|Overall Study||10
470528|NCT01187498|1152876|P1|NOT COMPLETED|Overall Study||9
470529|NCT01187498|1152875|P2|COMPLETED|Overall Study||60
470530|NCT01187498|1152876|P1|COMPLETED|Overall Study||64
470531|NCT01187498|1152875|P2|STARTED|Overall Study||70
470532|NCT01187498|1152876|P1|STARTED|Overall Study||73
470533|NCT01187446|1152904|P2|NOT COMPLETED|Overall Study||1
470534|NCT01187446|1152905|P1|NOT COMPLETED|Overall Study||0
470535|NCT01187446|1152904|P2|COMPLETED|Overall Study||13
470536|NCT01187446|1152905|P1|COMPLETED|Overall Study||14
470537|NCT01187446|1152904|P2|STARTED|Overall Study||14
470538|NCT01187446|1152905|P1|STARTED|Overall Study||14
470539|NCT01187433|1152921|P2|NOT COMPLETED|Overall Study||4
470540|NCT01187433|1152922|P1|NOT COMPLETED|Overall Study||11
470541|NCT01187433|1152921|P2|COMPLETED|Overall Study||46
470542|NCT01187433|1152922|P1|COMPLETED|Overall Study||89
470543|NCT01187433|1152921|P2|STARTED|Overall Study||50
470544|NCT01187433|1152922|P1|STARTED|Overall Study||100
470545|NCT01187407|1152952|P5|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||75
470546|NCT01187407|1152953|P4|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||29
470547|NCT01187407|1152954|P3|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
470548|NCT01187407|1152955|P2|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||36
470549|NCT01187407|1152956|P1|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
470550|NCT01187407|1152952|P5|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||626
470551|NCT01187407|1152953|P4|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||202
470552|NCT01187407|1152954|P3|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||191
470553|NCT01187407|1152955|P2|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||196
470554|NCT01187407|1152956|P1|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
470555|NCT01187407|1152952|P5|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|660
470556|NCT01187407|1152953|P4|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|220
470557|NCT01187407|1152954|P3|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|215
470558|NCT01187407|1152955|P2|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|212
470559|NCT01187407|1152956|P1|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
470560|NCT01187407|1152952|P5|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||701
470561|NCT01187407|1152953|P4|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||231
470562|NCT01187407|1152954|P3|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||226
470563|NCT01187407|1152955|P2|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||232
470564|NCT01187407|1152956|P1|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
470565|NCT01187407|1152952|P5|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
470566|NCT01187407|1152953|P4|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
470567|NCT01187407|1152954|P3|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
470568|NCT01187407|1152955|P2|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
470569|NCT01187407|1152956|P1|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||90
470570|NCT01187407|1152952|P5|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
470571|NCT01187407|1152953|P4|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
470572|NCT01187407|1152954|P3|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
470573|NCT01187407|1152955|P2|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
470574|NCT01187407|1152956|P1|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the Adjunctive Treatment (AT) Phase.|1390
470575|NCT01187407|1152952|P5|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
470576|NCT01187407|1152953|P4|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
470577|NCT01187407|1152954|P3|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
470578|NCT01187407|1152955|P2|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
470579|NCT01187407|1152956|P1|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase early had the option to enter the DC Phase.|25
470580|NCT01187407|1152952|P5|STARTED|Confirmation (CF) Phase, 3 Weeks||0
470581|NCT01187407|1152953|P4|STARTED|Confirmation (CF) Phase, 3 Weeks||0
470582|NCT01187407|1152954|P3|STARTED|Confirmation (CF) Phase, 3 Weeks||0
470583|NCT01187407|1152955|P2|STARTED|Confirmation (CF) Phase, 3 Weeks||0
470584|NCT01187407|1152956|P1|STARTED|Confirmation (CF) Phase, 3 Weeks||1480
470585|NCT01187381|1153026|P1|NOT COMPLETED|Overall Study||0
470586|NCT01187381|1153026|P1|COMPLETED|Overall Study|A participant completed study when the trastuzumab treatment was discontinued.|250
470587|NCT01187381|1153026|P1|STARTED|Overall Study||250
470588|NCT01187355|1153038|P2|NOT COMPLETED|Overall Study||20
470589|NCT01187355|1153039|P1|NOT COMPLETED|Overall Study||18
470590|NCT01187355|1153038|P2|COMPLETED|Overall Study||277
470591|NCT01187355|1153039|P1|COMPLETED|Overall Study||276
470592|NCT01187355|1153038|P2|STARTED|Overall Study||297
470593|NCT01187355|1153039|P1|STARTED|Overall Study||294
470594|NCT01187043|1153054|P5|NOT COMPLETED|Overall Study||2
470595|NCT01187043|1153055|P4|NOT COMPLETED|Overall Study||0
470596|NCT01187043|1153056|P3|NOT COMPLETED|Overall Study||4
470597|NCT01187043|1153057|P2|NOT COMPLETED|Overall Study||0
470598|NCT01187043|1153058|P1|NOT COMPLETED|Overall Study||1
470599|NCT01187043|1153054|P5|COMPLETED|Overall Study||10
470600|NCT01187043|1153055|P4|COMPLETED|Overall Study||12
470601|NCT01187043|1153056|P3|COMPLETED|Overall Study||8
470602|NCT01187043|1153057|P2|COMPLETED|Overall Study||10
470603|NCT01187043|1153058|P1|COMPLETED|Overall Study||11
470604|NCT01187043|1153054|P5|STARTED|Overall Study||12
470605|NCT01187043|1153055|P4|STARTED|Overall Study||12
470606|NCT01187043|1153056|P3|STARTED|Overall Study||12
470607|NCT01187043|1153057|P2|STARTED|Overall Study||10
470608|NCT01187043|1153058|P1|STARTED|Overall Study||12
470609|NCT01187017|1153070|P1|NOT COMPLETED|Overall Study||0
470610|NCT01187017|1153070|P1|COMPLETED|Overall Study||1
470611|NCT01187017|1153070|P1|STARTED|Overall Study||1
470612|NCT01187004|1153076|P2|NOT COMPLETED|Overall Study||0
470613|NCT01187004|1153077|P1|NOT COMPLETED|Overall Study||0
470614|NCT01187004|1153076|P2|COMPLETED|Overall Study||144
470615|NCT01187004|1153077|P1|COMPLETED|Overall Study||20
470616|NCT01187004|1153076|P2|STARTED|Overall Study||144
470617|NCT01187004|1153077|P1|STARTED|Overall Study||20
470618|NCT01186939|1153084|P1|NOT COMPLETED|Overall Study||40
470619|NCT01186939|1153084|P1|COMPLETED|Overall Study||0
470620|NCT01186939|1153084|P1|STARTED|Overall Study||40
470621|NCT01186848|1153088|P1|NOT COMPLETED|Overall Study||8
470622|NCT01186848|1153088|P1|COMPLETED|Overall Study||22
470623|NCT01186848|1153088|P1|STARTED|Overall Study||30
470624|NCT01186796|1153096|P2|NOT COMPLETED|Overall Study||2
470625|NCT01186796|1153097|P1|NOT COMPLETED|Overall Study||4
470626|NCT01186796|1153096|P2|COMPLETED|Overall Study||14
470627|NCT01186796|1153097|P1|COMPLETED|Overall Study||10
470628|NCT01186796|1153096|P2|STARTED|Overall Study|1 subject was randomized but withdrew before study interventions.|16
470629|NCT01186796|1153097|P1|STARTED|Overall Study||14
470630|NCT01186744|1153117|P6|NOT COMPLETED|Overall Study||26
470631|NCT01186744|1153118|P5|NOT COMPLETED|Overall Study||6
470632|NCT01186744|1153119|P4|NOT COMPLETED|Overall Study||12
470633|NCT01186744|1153120|P3|NOT COMPLETED|Overall Study||6
470634|NCT01186744|1153121|P2|NOT COMPLETED|Overall Study||152
470635|NCT01186744|1153122|P1|NOT COMPLETED|Overall Study||208
470636|NCT01186744|1153117|P6|COMPLETED|Overall Study||107
470637|NCT01186744|1153118|P5|COMPLETED|Overall Study||39
470638|NCT01186744|1153119|P4|COMPLETED|Overall Study||70
470639|NCT01186744|1153120|P3|COMPLETED|Overall Study||25
470640|NCT01186744|1153121|P2|COMPLETED|Overall Study||5
470641|NCT01186744|1153122|P1|COMPLETED|Overall Study||10
470642|NCT01186744|1153117|P6|STARTED|Overall Study||133
470643|NCT01186744|1153118|P5|STARTED|Overall Study||45
470644|NCT01186744|1153119|P4|STARTED|Overall Study||82
470645|NCT01186744|1153120|P3|STARTED|Overall Study||31
470646|NCT01186744|1153121|P2|STARTED|Overall Study||157
470647|NCT01186744|1153122|P1|STARTED|Overall Study||218
470648|NCT01186705|1153538|P1|NOT COMPLETED|Overall Study||0
470649|NCT01186705|1153538|P1|COMPLETED|Overall Study||1
470650|NCT01186705|1153538|P1|STARTED|Overall Study||1
470651|NCT01186692|1153542|P1|NOT COMPLETED|Overall Study||32
470652|NCT01186692|1153542|P1|COMPLETED|Overall Study||99
470653|NCT01186692|1153542|P1|STARTED|Overall Study||131
470654|NCT01186562|1153552|P2|NOT COMPLETED|Overall Study||2
470655|NCT01186562|1153553|P1|NOT COMPLETED|Overall Study||4
470656|NCT01186562|1153552|P2|COMPLETED|Overall Study||27
470657|NCT01186562|1153553|P1|COMPLETED|Overall Study||50
470658|NCT01186562|1153552|P2|STARTED|Overall Study||29
470659|NCT01186562|1153553|P1|STARTED|Overall Study||54
470660|NCT01186458|1153569|P1|NOT COMPLETED|Overall Study||1
470661|NCT01186458|1153569|P1|COMPLETED|Overall Study||3
470662|NCT01186458|1153569|P1|STARTED|Overall Study||4
470663|NCT01186419|1153578|P2|NOT COMPLETED|Overall Study||9
470664|NCT01186419|1153579|P1|NOT COMPLETED|Overall Study||7
470665|NCT01186419|1153578|P2|COMPLETED|Overall Study||18
470666|NCT01186419|1153579|P1|COMPLETED|Overall Study||17
470667|NCT01186419|1153578|P2|STARTED|Overall Study||27
470668|NCT01186419|1153579|P1|STARTED|Overall Study||24
470669|NCT01186406|1153586|P1|NOT COMPLETED|Overall Study||0
470670|NCT01186406|1153586|P1|COMPLETED|Overall Study||41
470671|NCT01186406|1153586|P1|STARTED|Overall Study||41
470672|NCT01186250|1153595|P2|NOT COMPLETED|Overall Study||0
470673|NCT01186250|1153596|P1|NOT COMPLETED|Overall Study||1
470674|NCT01186250|1153595|P2|COMPLETED|Overall Study||9
470675|NCT01186250|1153596|P1|COMPLETED|Overall Study||8
470676|NCT01186250|1153595|P2|STARTED|Overall Study||9
470677|NCT01186250|1153596|P1|STARTED|Overall Study||9
470678|NCT01185964|1153617|P4|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||5
470679|NCT01185964|1153618|P3|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
470680|NCT01185964|1153619|P2|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
470681|NCT01185964|1153620|P1|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
470682|NCT01185964|1153617|P4|COMPLETED|Optional Olaratumab Monotherapy on Dox||25
470683|NCT01185964|1153618|P3|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
470684|NCT01185964|1153619|P2|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
470685|NCT01185964|1153620|P1|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
470686|NCT01185964|1153617|P4|STARTED|Optional Olaratumab Monotherapy on Dox|Participants with disease progression after treatment received olaratumab.|30
470687|NCT01185964|1153618|P3|STARTED|Optional Olaratumab Monotherapy on Dox||0
470688|NCT01185964|1153619|P2|STARTED|Optional Olaratumab Monotherapy on Dox||0
470689|NCT01185964|1153620|P1|STARTED|Optional Olaratumab Monotherapy on Dox||0
470690|NCT01185964|1153617|P4|NOT COMPLETED|Phase 1b and Phase 2||0
470691|NCT01185964|1153618|P3|NOT COMPLETED|Phase 1b and Phase 2||9
470692|NCT01185964|1153619|P2|NOT COMPLETED|Phase 1b and Phase 2||10
470693|NCT01185964|1153620|P1|NOT COMPLETED|Phase 1b and Phase 2||2
470694|NCT01185964|1153617|P4|COMPLETED|Phase 1b and Phase 2||0
470695|NCT01185964|1153618|P3|COMPLETED|Phase 1b and Phase 2||58
470696|NCT01185964|1153619|P2|COMPLETED|Phase 1b and Phase 2||56
470697|NCT01185964|1153620|P1|COMPLETED|Phase 1b and Phase 2||13
470698|NCT01185964|1153617|P4|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||0
470699|NCT01185964|1153618|P3|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||65
470700|NCT01185964|1153619|P2|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||64
470701|NCT01185964|1153620|P1|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||15
470702|NCT01185964|1153617|P4|STARTED|Phase 1b and Phase 2||0
470703|NCT01185964|1153618|P3|STARTED|Phase 1b and Phase 2||67
470704|NCT01185964|1153619|P2|STARTED|Phase 1b and Phase 2||66
470705|NCT01185964|1153620|P1|STARTED|Phase 1b and Phase 2||15
470706|NCT01185834|1153646|P1|NOT COMPLETED|Overall Study||14
470707|NCT01185834|1153646|P1|COMPLETED|Overall Study||104
470708|NCT01185834|1153646|P1|STARTED|Overall Study||118
470709|NCT01185821|1153656|P5|NOT COMPLETED|Overall Study||24
470710|NCT01185821|1153657|P4|NOT COMPLETED|Overall Study||6
470711|NCT01185821|1153658|P3|NOT COMPLETED|Overall Study||10
470712|NCT01185821|1153659|P2|NOT COMPLETED|Overall Study||9
470713|NCT01185821|1153660|P1|NOT COMPLETED|Overall Study||7
470714|NCT01185821|1153656|P5|COMPLETED|Overall Study||26
470715|NCT01185821|1153657|P4|COMPLETED|Overall Study||23
470716|NCT01185821|1153658|P3|COMPLETED|Overall Study||33
470717|NCT01185821|1153659|P2|COMPLETED|Overall Study||20
470718|NCT01185821|1153660|P1|COMPLETED|Overall Study||26
470719|NCT01185821|1153656|P5|Patients on Placebo in Core|Overall Study||2
470720|NCT01185821|1153657|P4|Patients on Placebo in Core|Overall Study||8
470721|NCT01185821|1153658|P3|Patients on Placebo in Core|Overall Study||9
470722|NCT01185821|1153659|P2|Patients on Placebo in Core|Overall Study||7
470723|NCT01185821|1153660|P1|Patients on Placebo in Core|Overall Study||8
470724|NCT01185821|1153656|P5|Patients Without Washout|Overall Study||17
470725|NCT01185821|1153657|P4|Patients Without Washout|Overall Study||0
470726|NCT01185821|1153658|P3|Patients Without Washout|Overall Study||4
470727|NCT01185821|1153659|P2|Patients Without Washout|Overall Study||0
470728|NCT01185821|1153660|P1|Patients Without Washout|Overall Study||0
470729|NCT01185821|1153656|P5|Patients With Washout|Overall Study||33
470730|NCT01185821|1153657|P4|Patients With Washout|Overall Study||29
470731|NCT01185821|1153658|P3|Patients With Washout|Overall Study||39
470732|NCT01185821|1153659|P2|Patients With Washout|Overall Study||29
470733|NCT01185821|1153660|P1|Patients With Washout|Overall Study||33
470734|NCT01185821|1153656|P5|STARTED|Overall Study||50
470735|NCT01185821|1153657|P4|STARTED|Overall Study||29
470736|NCT01185821|1153658|P3|STARTED|Overall Study||43
470737|NCT01185821|1153659|P2|STARTED|Overall Study||29
470738|NCT01185821|1153660|P1|STARTED|Overall Study||33
470739|NCT01185782|1153711|P2|NOT COMPLETED|Overall Study||11
470740|NCT01185782|1153712|P1|NOT COMPLETED|Overall Study||6
470741|NCT01185782|1153711|P2|COMPLETED|Overall Study||125
470742|NCT01185782|1153712|P1|COMPLETED|Overall Study||123
470743|NCT01185782|1153711|P2|Treated|Overall Study||132
470744|NCT01185782|1153712|P1|Treated|Overall Study||129
470745|NCT01185782|1153711|P2|STARTED|Overall Study||136
470746|NCT01185782|1153712|P1|STARTED|Overall Study||129
470747|NCT01185704|1153740|P2|NOT COMPLETED|Overall Study||8
470748|NCT01185704|1153741|P1|NOT COMPLETED|Overall Study||13
470749|NCT01185704|1153740|P2|COMPLETED|Overall Study||60
470750|NCT01185704|1153741|P1|COMPLETED|Overall Study||55
470751|NCT01185704|1153740|P2|Treated|Overall Study||65
470752|NCT01185704|1153741|P1|Treated|Overall Study||65
470753|NCT01185704|1153740|P2|STARTED|Overall Study||68
470754|NCT01185704|1153741|P1|STARTED|Overall Study||68
470755|NCT01185600|1153777|P2|NOT COMPLETED|Overall Study||45
470756|NCT01185600|1153778|P1|NOT COMPLETED|Overall Study||32
470757|NCT01185600|1153777|P2|COMPLETED|Overall Study||59
470758|NCT01185600|1153778|P1|COMPLETED|Overall Study||41
470759|NCT01185600|1153777|P2|STARTED|Overall Study||104
470760|NCT01185600|1153778|P1|STARTED|Overall Study||73
470761|NCT01185561|1153800|P2|NOT COMPLETED|Overall Study||12
470762|NCT01185561|1153801|P1|NOT COMPLETED|Overall Study||2
470763|NCT01185561|1153800|P2|COMPLETED|Overall Study||26
470764|NCT01185561|1153801|P1|COMPLETED|Overall Study||34
470765|NCT01185561|1153800|P2|STARTED|Overall Study||38
470766|NCT01185561|1153801|P1|STARTED|Overall Study||36
470767|NCT01185522|1153813|P1|NOT COMPLETED|Overall Study||108
470768|NCT01185522|1153813|P1|COMPLETED|Overall Study||585
470769|NCT01185522|1153813|P1|STARTED|Overall Study||693
470770|NCT01185509|1153839|P2|NOT COMPLETED|Overall Study||20
470771|NCT01185509|1153840|P1|NOT COMPLETED|Overall Study||11
470772|NCT01185509|1153839|P2|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
470773|NCT01185509|1153840|P1|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
470774|NCT01185509|1153839|P2|STARTED|Overall Study||20
470775|NCT01185509|1153840|P1|STARTED|Overall Study||11
470776|NCT01185353|1153855|P10|NOT COMPLETED|Part D (Weeks 76 Through 128)||1
470777|NCT01185353|1153856|P9|NOT COMPLETED|Part D (Weeks 76 Through 128)||7
470778|NCT01185353|1153857|P8|NOT COMPLETED|Part D (Weeks 76 Through 128)||3
470779|NCT01185353|1153858|P7|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
470780|NCT01185353|1153859|P6|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
470781|NCT01185353|1153860|P5|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
470782|NCT01185353|1153861|P4|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
470783|NCT01185353|1153862|P3|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
470784|NCT01185353|1153863|P2|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
470785|NCT01185353|1153864|P1|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
470786|NCT01185353|1153855|P10|COMPLETED|Part D (Weeks 76 Through 128)||17
470787|NCT01185353|1153856|P9|COMPLETED|Part D (Weeks 76 Through 128)||40
470788|NCT01185353|1153857|P8|COMPLETED|Part D (Weeks 76 Through 128)||76
470789|NCT01185353|1153858|P7|COMPLETED|Part D (Weeks 76 Through 128)||0
470790|NCT01185353|1153859|P6|COMPLETED|Part D (Weeks 76 Through 128)||0
470791|NCT01185353|1153860|P5|COMPLETED|Part D (Weeks 76 Through 128)||0
470792|NCT01185353|1153861|P4|COMPLETED|Part D (Weeks 76 Through 128)||0
470793|NCT01185353|1153862|P3|COMPLETED|Part D (Weeks 76 Through 128)||0
470794|NCT01185353|1153863|P2|COMPLETED|Part D (Weeks 76 Through 128)||0
470795|NCT01185353|1153864|P1|COMPLETED|Part D (Weeks 76 Through 128)||0
470796|NCT01185353|1153855|P10|STARTED|Part D (Weeks 76 Through 128)||18
470797|NCT01185353|1153856|P9|STARTED|Part D (Weeks 76 Through 128)||47
470798|NCT01185353|1153857|P8|STARTED|Part D (Weeks 76 Through 128)||79
470799|NCT01185353|1153858|P7|STARTED|Part D (Weeks 76 Through 128)||0
470800|NCT01185353|1153859|P6|STARTED|Part D (Weeks 76 Through 128)||0
470801|NCT01185353|1153860|P5|STARTED|Part D (Weeks 76 Through 128)||0
470802|NCT01185353|1153861|P4|STARTED|Part D (Weeks 76 Through 128)||0
470803|NCT01185353|1153862|P3|STARTED|Part D (Weeks 76 Through 128)||0
470804|NCT01185353|1153863|P2|STARTED|Part D (Weeks 76 Through 128)||0
470805|NCT01185353|1153864|P1|STARTED|Part D (Weeks 76 Through 128)||0
470806|NCT01185353|1153855|P10|NOT COMPLETED|Part C (Weeks 24 Through 76)||8
470807|NCT01185353|1153856|P9|NOT COMPLETED|Part C (Weeks 24 Through 76)||8
470808|NCT01185353|1153857|P8|NOT COMPLETED|Part C (Weeks 24 Through 76)||16
470809|NCT01185353|1153858|P7|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
470810|NCT01185353|1153859|P6|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
470811|NCT01185353|1153860|P5|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
470812|NCT01185353|1153861|P4|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
470813|NCT01185353|1153862|P3|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
470814|NCT01185353|1153863|P2|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
470815|NCT01185353|1153864|P1|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
470816|NCT01185353|1153855|P10|COMPLETED|Part C (Weeks 24 Through 76)||24
470817|NCT01185353|1153856|P9|COMPLETED|Part C (Weeks 24 Through 76)||53
470818|NCT01185353|1153857|P8|COMPLETED|Part C (Weeks 24 Through 76)||92
470819|NCT01185353|1153858|P7|COMPLETED|Part C (Weeks 24 Through 76)||0
470820|NCT01185353|1153859|P6|COMPLETED|Part C (Weeks 24 Through 76)||0
470821|NCT01185353|1153860|P5|COMPLETED|Part C (Weeks 24 Through 76)||0
470822|NCT01185353|1153861|P4|COMPLETED|Part C (Weeks 24 Through 76)||0
470823|NCT01185353|1153862|P3|COMPLETED|Part C (Weeks 24 Through 76)||0
470824|NCT01185353|1153863|P2|COMPLETED|Part C (Weeks 24 Through 76)||0
470825|NCT01185353|1153864|P1|COMPLETED|Part C (Weeks 24 Through 76)||0
470826|NCT01185353|1153855|P10|STARTED|Part C (Weeks 24 Through 76)||32
470827|NCT01185353|1153856|P9|STARTED|Part C (Weeks 24 Through 76)||61
470828|NCT01185353|1153857|P8|STARTED|Part C (Weeks 24 Through 76)||108
470829|NCT01185353|1153858|P7|STARTED|Part C (Weeks 24 Through 76)||0
470830|NCT01185353|1153859|P6|STARTED|Part C (Weeks 24 Through 76)||0
470831|NCT01185353|1153860|P5|STARTED|Part C (Weeks 24 Through 76)||0
470832|NCT01185353|1153861|P4|STARTED|Part C (Weeks 24 Through 76)||0
470833|NCT01185353|1153862|P3|STARTED|Part C (Weeks 24 Through 76)||0
470834|NCT01185353|1153863|P2|STARTED|Part C (Weeks 24 Through 76)||0
470835|NCT01185353|1153864|P1|STARTED|Part C (Weeks 24 Through 76)||0
470836|NCT01185353|1153855|P10|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
470837|NCT01185353|1153856|P9|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
470838|NCT01185353|1153857|P8|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
470839|NCT01185353|1153858|P7|NOT COMPLETED|Part B (Weeks 12 Through 24)||6
470840|NCT01185353|1153859|P6|NOT COMPLETED|Part B (Weeks 12 Through 24)||4
470841|NCT01185353|1153860|P5|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
470842|NCT01185353|1153861|P4|NOT COMPLETED|Part B (Weeks 12 Through 24)||4
470843|NCT01185353|1153862|P3|NOT COMPLETED|Part B (Weeks 12 Through 24)||2
470844|NCT01185353|1153863|P2|NOT COMPLETED|Part B (Weeks 12 Through 24)||1
470845|NCT01185353|1153864|P1|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
470846|NCT01185353|1153855|P10|COMPLETED|Part B (Weeks 12 Through 24)||0
470847|NCT01185353|1153856|P9|COMPLETED|Part B (Weeks 12 Through 24)||0
470848|NCT01185353|1153857|P8|COMPLETED|Part B (Weeks 12 Through 24)||0
470849|NCT01185353|1153858|P7|COMPLETED|Part B (Weeks 12 Through 24)||57
470850|NCT01185353|1153859|P6|COMPLETED|Part B (Weeks 12 Through 24)||59
470851|NCT01185353|1153860|P5|COMPLETED|Part B (Weeks 12 Through 24)||0
470852|NCT01185353|1153861|P4|COMPLETED|Part B (Weeks 12 Through 24)||45
470853|NCT01185353|1153862|P3|COMPLETED|Part B (Weeks 12 Through 24)||48
470854|NCT01185353|1153863|P2|COMPLETED|Part B (Weeks 12 Through 24)||50
470855|NCT01185353|1153864|P1|COMPLETED|Part B (Weeks 12 Through 24)||0
470856|NCT01185353|1153855|P10|STARTED|Part B (Weeks 12 Through 24)||0
470857|NCT01185353|1153856|P9|STARTED|Part B (Weeks 12 Through 24)||0
470858|NCT01185353|1153857|P8|STARTED|Part B (Weeks 12 Through 24)||0
470859|NCT01185353|1153858|P7|STARTED|Part B (Weeks 12 Through 24)||63
470860|NCT01185353|1153859|P6|STARTED|Part B (Weeks 12 Through 24)||63
470861|NCT01185353|1153860|P5|STARTED|Part B (Weeks 12 Through 24)||0
470862|NCT01185353|1153861|P4|STARTED|Part B (Weeks 12 Through 24)||49
470863|NCT01185353|1153862|P3|STARTED|Part B (Weeks 12 Through 24)||50
470864|NCT01185353|1153863|P2|STARTED|Part B (Weeks 12 Through 24)||51
470865|NCT01185353|1153864|P1|STARTED|Part B (Weeks 12 Through 24)||0
470866|NCT01185353|1153855|P10|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
470867|NCT01185353|1153856|P9|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
470868|NCT01185353|1153857|P8|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
470869|NCT01185353|1153858|P7|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
470870|NCT01185353|1153859|P6|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
470871|NCT01185353|1153860|P5|NOT COMPLETED|Part A (Weeks 0 Through 12)||16
470872|NCT01185353|1153861|P4|NOT COMPLETED|Part A (Weeks 0 Through 12)||1
470873|NCT01185353|1153862|P3|NOT COMPLETED|Part A (Weeks 0 Through 12)||2
470874|NCT01185353|1153863|P2|NOT COMPLETED|Part A (Weeks 0 Through 12)||1
470875|NCT01185353|1153864|P1|NOT COMPLETED|Part A (Weeks 0 Through 12)||5
470876|NCT01185353|1153855|P10|COMPLETED|Part A (Weeks 0 Through 12)||0
470877|NCT01185353|1153856|P9|COMPLETED|Part A (Weeks 0 Through 12)||0
470878|NCT01185353|1153857|P8|COMPLETED|Part A (Weeks 0 Through 12)||0
470879|NCT01185353|1153858|P7|COMPLETED|Part A (Weeks 0 Through 12)||0
470880|NCT01185353|1153859|P6|COMPLETED|Part A (Weeks 0 Through 12)||0
470881|NCT01185353|1153860|P5|COMPLETED|Part A (Weeks 0 Through 12)||82
470882|NCT01185353|1153861|P4|COMPLETED|Part A (Weeks 0 Through 12)||49
470883|NCT01185353|1153862|P3|COMPLETED|Part A (Weeks 0 Through 12)||50
470884|NCT01185353|1153863|P2|COMPLETED|Part A (Weeks 0 Through 12)||51
470885|NCT01185353|1153864|P1|COMPLETED|Part A (Weeks 0 Through 12)||44
470886|NCT01185353|1153855|P10|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
470887|NCT01185353|1153856|P9|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
470888|NCT01185353|1153857|P8|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
470889|NCT01185353|1153858|P7|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
470890|NCT01185353|1153859|P6|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
470891|NCT01185353|1153860|P5|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||98
470892|NCT01185353|1153861|P4|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||50
470893|NCT01185353|1153862|P3|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||52
470894|NCT01185353|1153863|P2|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||52
470895|NCT01185353|1153864|P1|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||49
470896|NCT01185353|1153855|P10|STARTED|Part A (Weeks 0 Through 12)||0
470897|NCT01185353|1153856|P9|STARTED|Part A (Weeks 0 Through 12)||0
470898|NCT01185353|1153857|P8|STARTED|Part A (Weeks 0 Through 12)||0
470899|NCT01185353|1153858|P7|STARTED|Part A (Weeks 0 Through 12)||0
470900|NCT01185353|1153859|P6|STARTED|Part A (Weeks 0 Through 12)||0
470901|NCT01185353|1153860|P5|STARTED|Part A (Weeks 0 Through 12)||98
470902|NCT01185353|1153861|P4|STARTED|Part A (Weeks 0 Through 12)||50
470903|NCT01185353|1153862|P3|STARTED|Part A (Weeks 0 Through 12)||52
470904|NCT01185353|1153863|P2|STARTED|Part A (Weeks 0 Through 12)||52
470905|NCT01185353|1153864|P1|STARTED|Part A (Weeks 0 Through 12)||49
470906|NCT01185340|1154025|P4|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||61
470907|NCT01185340|1154026|P3|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||33
470908|NCT01185340|1154027|P2|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
470909|NCT01185340|1154028|P1|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
470910|NCT01185340|1154025|P4|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||458
470911|NCT01185340|1154026|P3|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||186
470912|NCT01185340|1154027|P2|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||195
470913|NCT01185340|1154028|P1|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
470914|NCT01185340|1154025|P4|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|483
470915|NCT01185340|1154026|P3|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|204
470916|NCT01185340|1154027|P2|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|206
470917|NCT01185340|1154028|P1|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
470918|NCT01185340|1154025|P4|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||519
470919|NCT01185340|1154026|P3|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||219
470920|NCT01185340|1154027|P2|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||230
470921|NCT01185340|1154028|P1|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
470922|NCT01185340|1154025|P4|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
470923|NCT01185340|1154026|P3|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
470924|NCT01185340|1154027|P2|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
470925|NCT01185340|1154028|P1|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||88
470926|NCT01185340|1154025|P4|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
470927|NCT01185340|1154026|P3|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
470928|NCT01185340|1154027|P2|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
470929|NCT01185340|1154028|P1|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the Adjunctive Treatment (AT) Phase.|968
470930|NCT01185340|1154025|P4|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
470931|NCT01185340|1154026|P3|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
470932|NCT01185340|1154027|P2|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
470933|NCT01185340|1154028|P1|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase early had the option to enter the DC Phase.|18
470934|NCT01185340|1154025|P4|STARTED|Confirmation (CF) Phase, 3 Weeks||0
470935|NCT01185340|1154026|P3|STARTED|Confirmation (CF) Phase, 3 Weeks||0
470936|NCT01185340|1154027|P2|STARTED|Confirmation (CF) Phase, 3 Weeks||0
470937|NCT01185340|1154028|P1|STARTED|Confirmation (CF) Phase, 3 Weeks||1056
470938|NCT01185301|1154080|P4|NOT COMPLETED|Overall Study||9
470939|NCT01185301|1154081|P3|NOT COMPLETED|Overall Study||6
470940|NCT01185301|1154082|P2|NOT COMPLETED|Overall Study||7
470941|NCT01185301|1154083|P1|NOT COMPLETED|Overall Study||15
470942|NCT01185301|1154080|P4|COMPLETED|Overall Study||89
470943|NCT01185301|1154081|P3|COMPLETED|Overall Study||93
470944|NCT01185301|1154082|P2|COMPLETED|Overall Study||93
470945|NCT01185301|1154083|P1|COMPLETED|Overall Study||83
470946|NCT01185301|1154080|P4|STARTED|Overall Study||98
470947|NCT01185301|1154081|P3|STARTED|Overall Study||99
470948|NCT01185301|1154082|P2|STARTED|Overall Study||100
470949|NCT01185301|1154083|P1|STARTED|Overall Study||98
470950|NCT01185288|1154143|P2|NOT COMPLETED|Overall Study||16
470951|NCT01185288|1154144|P1|NOT COMPLETED|Overall Study||19
470952|NCT01185288|1154143|P2|COMPLETED|Overall Study||139
470953|NCT01185288|1154144|P1|COMPLETED|Overall Study||135
470954|NCT01185288|1154143|P2|STARTED|Overall Study||155
470955|NCT01185288|1154144|P1|STARTED|Overall Study||154
470956|NCT01185249|1154162|P1|NOT COMPLETED|Overall Study||42
470957|NCT01185249|1154162|P1|COMPLETED|Overall Study|Data was analyzed for patients with three consecutive days of data.|24
470958|NCT01185249|1154162|P1|STARTED|Overall Study|Total number of patients consented to participate.|66
470959|NCT01185080|1154170|P3|NOT COMPLETED|Overall Study||1
470960|NCT01185080|1154171|P2|NOT COMPLETED|Overall Study||1
470961|NCT01185080|1154172|P1|NOT COMPLETED|Overall Study||1
470962|NCT01185080|1154170|P3|COMPLETED|Overall Study||16
470963|NCT01185080|1154171|P2|COMPLETED|Overall Study||15
470964|NCT01185080|1154172|P1|COMPLETED|Overall Study||49
470965|NCT01185080|1154170|P3|STARTED|Overall Study||17
470966|NCT01185080|1154171|P2|STARTED|Overall Study||16
470967|NCT01185080|1154172|P1|STARTED|Overall Study||50
470968|NCT01185028|1154219|P1|NOT COMPLETED|Overall Study||4
470969|NCT01185028|1154219|P1|COMPLETED|Overall Study||4
470970|NCT01185028|1154219|P1|STARTED|Overall Study||8
470971|NCT01184989|1154224|P1|NOT COMPLETED|Overall Study||12
470972|NCT01184989|1154224|P1|COMPLETED|Overall Study||100
470973|NCT01184989|1154224|P1|STARTED|Overall Study|Treated Patients|112
470974|NCT01184898|1154230|P1|NOT COMPLETED|Overall Study||0
470975|NCT01184898|1154230|P1|COMPLETED|Overall Study||36
470976|NCT01184898|1154230|P1|STARTED|Overall Study||36
470977|NCT01184885|1154237|P1|NOT COMPLETED|Overall Study||0
470978|NCT01184885|1154237|P1|COMPLETED|Overall Study||7
470979|NCT01184885|1154237|P1|STARTED|Overall Study||7
470980|NCT01184872|1154244|P2|NOT COMPLETED|Overall Study||8
470981|NCT01184872|1154245|P1|NOT COMPLETED|Overall Study||10
470982|NCT01184872|1154244|P2|COMPLETED|Overall Study||31
470983|NCT01184872|1154245|P1|COMPLETED|Overall Study||71
470984|NCT01184872|1154244|P2|Microbiologically Evaluable Set (MES)|Overall Study||27
470985|NCT01184872|1154245|P1|Microbiologically Evaluable Set (MES)|Overall Study||65
470986|NCT01184872|1154244|P2|Clinical Evaluable Set (CES)|Overall Study||30
470987|NCT01184872|1154245|P1|Clinical Evaluable Set (CES)|Overall Study||73
470988|NCT01184872|1154244|P2|Safety Set|Overall Study||40
470989|NCT01184872|1154245|P1|Safety Set|Overall Study|One patient randomized to Daptomycin received Vancomycin.|80
470990|NCT01184872|1154244|P2|STARTED|Overall Study||39
470991|NCT01184872|1154245|P1|STARTED|Overall Study|"Started indicates randomized and full analysis set."|81
470992|NCT01184859|1154264|P5|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1
470993|NCT01184859|1154265|P4|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
470994|NCT01184859|1154266|P3|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
470995|NCT01184859|1154267|P2|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
470996|NCT01184859|1154268|P1|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1
470997|NCT01184859|1154264|P5|COMPLETED|Period 2: Daily Dose for 28 Days||22
470998|NCT01184859|1154265|P4|COMPLETED|Period 2: Daily Dose for 28 Days||22
470999|NCT01184859|1154266|P3|COMPLETED|Period 2: Daily Dose for 28 Days||22
471000|NCT01184859|1154267|P2|COMPLETED|Period 2: Daily Dose for 28 Days||23
471001|NCT01184859|1154268|P1|COMPLETED|Period 2: Daily Dose for 28 Days||22
471002|NCT01184859|1154264|P5|STARTED|Period 2: Daily Dose for 28 Days||23
471003|NCT01184859|1154265|P4|STARTED|Period 2: Daily Dose for 28 Days||22
471004|NCT01184859|1154266|P3|STARTED|Period 2: Daily Dose for 28 Days||22
471005|NCT01184859|1154267|P2|STARTED|Period 2: Daily Dose for 28 Days||23
471006|NCT01184859|1154268|P1|STARTED|Period 2: Daily Dose for 28 Days||23
471007|NCT01184859|1154264|P5|NOT COMPLETED|Washout Period||0
471008|NCT01184859|1154265|P4|NOT COMPLETED|Washout Period||0
471009|NCT01184859|1154266|P3|NOT COMPLETED|Washout Period||0
471010|NCT01184859|1154267|P2|NOT COMPLETED|Washout Period||0
471011|NCT01184859|1154268|P1|NOT COMPLETED|Washout Period||0
471012|NCT01184859|1154264|P5|COMPLETED|Washout Period||23
471013|NCT01184859|1154265|P4|COMPLETED|Washout Period||22
471014|NCT01184859|1154266|P3|COMPLETED|Washout Period||22
471015|NCT01184859|1154267|P2|COMPLETED|Washout Period||23
471016|NCT01184859|1154268|P1|COMPLETED|Washout Period||23
471017|NCT01184859|1154264|P5|STARTED|Washout Period||23
471018|NCT01184859|1154265|P4|STARTED|Washout Period||22
471019|NCT01184859|1154266|P3|STARTED|Washout Period||22
471020|NCT01184859|1154267|P2|STARTED|Washout Period||23
471021|NCT01184859|1154268|P1|STARTED|Washout Period||23
471022|NCT01184859|1154264|P5|NOT COMPLETED|Period 1: Single Dose||1
471023|NCT01184859|1154265|P4|NOT COMPLETED|Period 1: Single Dose||0
471024|NCT01184859|1154266|P3|NOT COMPLETED|Period 1: Single Dose||0
471025|NCT01184859|1154267|P2|NOT COMPLETED|Period 1: Single Dose||2
471026|NCT01184859|1154268|P1|NOT COMPLETED|Period 1: Single Dose||0
471027|NCT01184859|1154264|P5|COMPLETED|Period 1: Single Dose||23
471028|NCT01184859|1154265|P4|COMPLETED|Period 1: Single Dose||22
471029|NCT01184859|1154266|P3|COMPLETED|Period 1: Single Dose||22
471030|NCT01184859|1154267|P2|COMPLETED|Period 1: Single Dose||23
471031|NCT01184859|1154268|P1|COMPLETED|Period 1: Single Dose||23
471032|NCT01184859|1154264|P5|Per Protocol (PP)|Period 1: Single Dose|1 additional participant disqualified due to 'other'.|23
471033|NCT01184859|1154265|P4|Per Protocol (PP)|Period 1: Single Dose||21
471034|NCT01184859|1154266|P3|Per Protocol (PP)|Period 1: Single Dose||22
471035|NCT01184859|1154267|P2|Per Protocol (PP)|Period 1: Single Dose||23
471036|NCT01184859|1154268|P1|Per Protocol (PP)|Period 1: Single Dose||23
471037|NCT01184859|1154264|P5|Full Analysis Set (FAS)|Period 1: Single Dose||24
471038|NCT01184859|1154265|P4|Full Analysis Set (FAS)|Period 1: Single Dose|1 participant disqualified due to major entry criteria violation|21
471039|NCT01184859|1154266|P3|Full Analysis Set (FAS)|Period 1: Single Dose||22
471040|NCT01184859|1154267|P2|Full Analysis Set (FAS)|Period 1: Single Dose|2 participants disqualified due to no post-baseline primary efficacy data, and/or 'other'.|23
471041|NCT01184859|1154268|P1|Full Analysis Set (FAS)|Period 1: Single Dose||23
471042|NCT01184859|1154264|P5|STARTED|Period 1: Single Dose||24
471043|NCT01184859|1154265|P4|STARTED|Period 1: Single Dose||22
471044|NCT01184859|1154266|P3|STARTED|Period 1: Single Dose||22
471045|NCT01184859|1154267|P2|STARTED|Period 1: Single Dose||25
471046|NCT01184859|1154268|P1|STARTED|Period 1: Single Dose||23
471047|NCT01184846|1154360|P1|NOT COMPLETED|Overall Study||3
471048|NCT01184846|1154360|P1|COMPLETED|Overall Study||25
471049|NCT01184846|1154360|P1|STARTED|Overall Study||28
471050|NCT01184755|1154381|P3|NOT COMPLETED|Overall Study||6
471051|NCT01184755|1154382|P2|NOT COMPLETED|Overall Study||11
471052|NCT01184755|1154383|P1|NOT COMPLETED|Overall Study||25
471053|NCT01184755|1154381|P3|COMPLETED|Overall Study||56
471054|NCT01184755|1154382|P2|COMPLETED|Overall Study||54
471055|NCT01184755|1154383|P1|COMPLETED|Overall Study||101
471056|NCT01184755|1154381|P3|STARTED|Overall Study||62
471057|NCT01184755|1154382|P2|STARTED|Overall Study||65
471058|NCT01184755|1154383|P1|STARTED|Overall Study||126
471059|NCT01184417|1154393|P2|NOT COMPLETED|Overall Study||0
471060|NCT01184417|1154394|P1|NOT COMPLETED|Overall Study||0
471061|NCT01184417|1154393|P2|COMPLETED|Overall Study||51
471062|NCT01184417|1154394|P1|COMPLETED|Overall Study||51
471063|NCT01184417|1154393|P2|STARTED|Overall Study||51
471064|NCT01184417|1154394|P1|STARTED|Overall Study||51
471065|NCT01184118|1154414|P1|NOT COMPLETED|Overall Study||18
471066|NCT01184118|1154414|P1|COMPLETED|Overall Study||18
471067|NCT01184118|1154414|P1|FP MDI as Indicated (2 Weeks)|Overall Study||18
471068|NCT01184118|1154414|P1|FP MDI 880 mcg/Day (2 Weeks)|Overall Study||18
471069|NCT01184118|1154414|P1|FP MDI 1,760 mcg/Day (16 Weeks)|Overall Study||18
471070|NCT01184118|1154414|P1|STARTED|Overall Study||36
471071|NCT01184079|1154422|P2|NOT COMPLETED|Overall Study||2
471072|NCT01184079|1154423|P1|NOT COMPLETED|Overall Study||14
471073|NCT01184079|1154422|P2|COMPLETED|Overall Study||107
471074|NCT01184079|1154423|P1|COMPLETED|Overall Study||97
471075|NCT01184079|1154422|P2|Final Blood Draw|Overall Study||107
471076|NCT01184079|1154423|P1|Final Blood Draw|Overall Study||97
471077|NCT01184079|1154422|P2|Dose 3|Overall Study||107
471078|NCT01184079|1154423|P1|Dose 3|Overall Study||101
471079|NCT01184079|1154422|P2|Dose 2|Overall Study||108
471080|NCT01184079|1154423|P1|Dose 2|Overall Study||110
471081|NCT01184079|1154422|P2|STARTED|Overall Study||109
471082|NCT01184079|1154423|P1|STARTED|Overall Study||111
471083|NCT01184053|1154433|P1|NOT COMPLETED|Overall Study||3
471084|NCT01184053|1154433|P1|COMPLETED|Overall Study||0
471085|NCT01184053|1154433|P1|STARTED|Overall Study||3
471086|NCT01184014|1154442|P2|NOT COMPLETED|Overall Study||6
471087|NCT01184014|1154443|P1|NOT COMPLETED|Overall Study||5
471088|NCT01184014|1154442|P2|COMPLETED|Overall Study||31
471089|NCT01184014|1154443|P1|COMPLETED|Overall Study||30
471090|NCT01184014|1154442|P2|STARTED|Overall Study||37
471091|NCT01184014|1154443|P1|STARTED|Overall Study||35
471092|NCT01183975|1154449|P1|NOT COMPLETED|Overall Study||73
471093|NCT01183975|1154449|P1|COMPLETED|Overall Study||444
471094|NCT01183975|1154449|P1|STARTED|Overall Study||517
471095|NCT01183858|1154456|P2|NOT COMPLETED|Overall Study||156
471096|NCT01183858|1154457|P1|NOT COMPLETED|Overall Study||153
471097|NCT01183858|1154456|P2|COMPLETED|Overall Study||3
471098|NCT01183858|1154457|P1|COMPLETED|Overall Study||1
471099|NCT01183858|1154456|P2|Safety Population|Overall Study||158
471100|NCT01183858|1154457|P1|Safety Population|Overall Study||154
471101|NCT01183858|1154456|P2|STARTED|Overall Study||159
471102|NCT01183858|1154457|P1|STARTED|Overall Study||154
471103|NCT01183780|1154479|P2|NOT COMPLETED|Overall Study||25
471104|NCT01183780|1154480|P1|NOT COMPLETED|Overall Study||31
471105|NCT01183780|1154479|P2|COMPLETED|Overall Study||511
471106|NCT01183780|1154480|P1|COMPLETED|Overall Study||505
471107|NCT01183780|1154479|P2|Received at Least 1 Dose of Study Drug|Overall Study||529
471108|NCT01183780|1154480|P1|Received at Least 1 Dose of Study Drug|Overall Study||528
471109|NCT01183780|1154479|P2|STARTED|Overall Study||536
471110|NCT01183780|1154480|P1|STARTED|Overall Study||536
471111|NCT01183728|1154497|P1|NOT COMPLETED|Overall Study||0
471112|NCT01183728|1154497|P1|COMPLETED|Overall Study||12
471113|NCT01183728|1154497|P1|STARTED|Overall Study||12
471114|NCT01183689|1154505|P3|NOT COMPLETED|Overall Study||0
471115|NCT01183689|1154506|P2|NOT COMPLETED|Overall Study||0
471116|NCT01183689|1154507|P1|NOT COMPLETED|Overall Study||0
471117|NCT01183689|1154505|P3|COMPLETED|Overall Study||197
471118|NCT01183689|1154506|P2|COMPLETED|Overall Study||200
471119|NCT01183689|1154507|P1|COMPLETED|Overall Study||202
471120|NCT01183689|1154505|P3|Year 4 Visit|Overall Study||30
471121|NCT01183689|1154506|P2|Year 4 Visit|Overall Study||33
471122|NCT01183689|1154507|P1|Year 4 Visit|Overall Study||38
471123|NCT01183689|1154505|P3|Year 3 Visit|Overall Study||126
471124|NCT01183689|1154506|P2|Year 3 Visit|Overall Study||125
471125|NCT01183689|1154507|P1|Year 3 Visit|Overall Study||139
471126|NCT01183689|1154505|P3|Year 2 Visit|Overall Study||174
471127|NCT01183689|1154506|P2|Year 2 Visit|Overall Study||172
471128|NCT01183689|1154507|P1|Year 2 Visit|Overall Study||178
471129|NCT01183689|1154505|P3|Year 1 Visit|Overall Study||183
471130|NCT01183689|1154506|P2|Year 1 Visit|Overall Study||172
471131|NCT01183689|1154507|P1|Year 1 Visit|Overall Study||187
471132|NCT01183689|1154505|P3|Month 4 Visit|Overall Study||187
471133|NCT01183689|1154506|P2|Month 4 Visit|Overall Study||192
471134|NCT01183689|1154507|P1|Month 4 Visit|Overall Study||197
471135|NCT01183689|1154505|P3|STARTED|Overall Study||197
471136|NCT01183689|1154506|P2|STARTED|Overall Study||200
471137|NCT01183689|1154507|P1|STARTED|Overall Study||202
471138|NCT01183650|1154577|P2|NOT COMPLETED|Overall Study||0
471139|NCT01183650|1154578|P1|NOT COMPLETED|Overall Study||0
471140|NCT01183650|1154577|P2|COMPLETED|Overall Study||12
471141|NCT01183650|1154578|P1|COMPLETED|Overall Study||12
471142|NCT01183650|1154577|P2|STARTED|Overall Study||12
471143|NCT01183650|1154578|P1|STARTED|Overall Study||12
471144|NCT01183546|1154588|P1|NOT COMPLETED|Overall Study||0
471145|NCT01183546|1154588|P1|COMPLETED|Overall Study||53
471146|NCT01183546|1154588|P1|STARTED|Overall Study||53
471147|NCT01183533|1154595|P1|NOT COMPLETED|Overall Study||0
471148|NCT01183533|1154595|P1|COMPLETED|Overall Study|- all pre-planned 40 patients received the study medication.|40
471149|NCT01183533|1154595|P1|STARTED|Overall Study|Between Oct 2010 and Oct 2013.|40
471150|NCT01183481|1154601|P1|NOT COMPLETED|Overall Study||0
471151|NCT01183481|1154601|P1|COMPLETED|Overall Study||19
471152|NCT01183481|1154601|P1|STARTED|Overall Study||19
471153|NCT01183468|1154613|P4|NOT COMPLETED|Overall Study||0
471154|NCT01183468|1154614|P3|NOT COMPLETED|Overall Study||0
471155|NCT01183468|1154615|P2|NOT COMPLETED|Overall Study||2
471156|NCT01183468|1154616|P1|NOT COMPLETED|Overall Study||3
471157|NCT01183468|1154613|P4|COMPLETED|Overall Study||0
471158|NCT01183468|1154614|P3|COMPLETED|Overall Study||0
471159|NCT01183468|1154615|P2|COMPLETED|Overall Study||7
471160|NCT01183468|1154616|P1|COMPLETED|Overall Study||5
471161|NCT01183468|1154613|P4|STARTED|Overall Study||0
471162|NCT01183468|1154614|P3|STARTED|Overall Study||0
471163|NCT01183468|1154615|P2|STARTED|Overall Study||9
471164|NCT01183468|1154616|P1|STARTED|Overall Study||8
471165|NCT01183390|1154626|P2|NOT COMPLETED|Second Intervention||0
471166|NCT01183390|1154627|P1|NOT COMPLETED|Second Intervention||0
471167|NCT01183390|1154626|P2|COMPLETED|Second Intervention||10
471168|NCT01183390|1154627|P1|COMPLETED|Second Intervention||11
471169|NCT01183390|1154626|P2|STARTED|Second Intervention||10
471170|NCT01183390|1154627|P1|STARTED|Second Intervention||11
471171|NCT01183390|1154626|P2|NOT COMPLETED|Washout of 21 Days||0
471172|NCT01183390|1154627|P1|NOT COMPLETED|Washout of 21 Days||0
471173|NCT01183390|1154626|P2|COMPLETED|Washout of 21 Days||10
471174|NCT01183390|1154627|P1|COMPLETED|Washout of 21 Days||11
471175|NCT01183390|1154626|P2|STARTED|Washout of 21 Days||10
471176|NCT01183390|1154627|P1|STARTED|Washout of 21 Days||11
471177|NCT01183390|1154626|P2|NOT COMPLETED|First Intervention||1
471178|NCT01183390|1154627|P1|NOT COMPLETED|First Intervention||0
471179|NCT01183390|1154626|P2|COMPLETED|First Intervention||10
471180|NCT01183390|1154627|P1|COMPLETED|First Intervention||11
471181|NCT01183390|1154626|P2|STARTED|First Intervention||11
471182|NCT01183390|1154627|P1|STARTED|First Intervention||11
471183|NCT01183312|1154637|P2|NOT COMPLETED|Second Intervention Day||0
471184|NCT01183312|1154638|P1|NOT COMPLETED|Second Intervention Day||0
471185|NCT01183312|1154637|P2|COMPLETED|Second Intervention Day||5
471186|NCT01183312|1154638|P1|COMPLETED|Second Intervention Day||5
471187|NCT01183312|1154637|P2|STARTED|Second Intervention Day||5
471188|NCT01183312|1154638|P1|STARTED|Second Intervention Day||5
471189|NCT01183312|1154637|P2|NOT COMPLETED|Washout Period of at Least 1 Week||0
471190|NCT01183312|1154638|P1|NOT COMPLETED|Washout Period of at Least 1 Week||0
471191|NCT01183312|1154637|P2|COMPLETED|Washout Period of at Least 1 Week||5
471192|NCT01183312|1154638|P1|COMPLETED|Washout Period of at Least 1 Week||5
471193|NCT01183312|1154637|P2|STARTED|Washout Period of at Least 1 Week||5
471194|NCT01183312|1154638|P1|STARTED|Washout Period of at Least 1 Week||5
471195|NCT01183312|1154637|P2|NOT COMPLETED|First Intervention Day||0
471196|NCT01183312|1154638|P1|NOT COMPLETED|First Intervention Day||0
471197|NCT01183312|1154637|P2|COMPLETED|First Intervention Day||5
471198|NCT01183312|1154638|P1|COMPLETED|First Intervention Day||5
471199|NCT01183312|1154637|P2|STARTED|First Intervention Day||5
471200|NCT01183312|1154638|P1|STARTED|First Intervention Day||5
471201|NCT01183260|1154660|P2|NOT COMPLETED|Overall Study||2
471202|NCT01183260|1154661|P1|NOT COMPLETED|Overall Study||4
471203|NCT01183260|1154660|P2|COMPLETED|Overall Study||9
471204|NCT01183260|1154661|P1|COMPLETED|Overall Study||10
471205|NCT01183260|1154660|P2|STARTED|Overall Study||11
471206|NCT01183260|1154661|P1|STARTED|Overall Study||14
471207|NCT01183234|1154671|P2|NOT COMPLETED|Second Intervention||0
471208|NCT01183234|1154672|P1|NOT COMPLETED|Second Intervention||0
471209|NCT01183234|1154671|P2|COMPLETED|Second Intervention||14
471210|NCT01183234|1154672|P1|COMPLETED|Second Intervention||13
471211|NCT01183234|1154671|P2|STARTED|Second Intervention||14
471212|NCT01183234|1154672|P1|STARTED|Second Intervention||13
471213|NCT01183234|1154671|P2|NOT COMPLETED|Washout||0
471214|NCT01183234|1154672|P1|NOT COMPLETED|Washout||0
471215|NCT01183234|1154671|P2|COMPLETED|Washout||14
471216|NCT01183234|1154672|P1|COMPLETED|Washout||13
471217|NCT01183234|1154671|P2|STARTED|Washout||14
471218|NCT01183234|1154672|P1|STARTED|Washout||13
471219|NCT01183234|1154671|P2|NOT COMPLETED|First Intervention||0
471220|NCT01183234|1154672|P1|NOT COMPLETED|First Intervention||1
471221|NCT01183234|1154671|P2|COMPLETED|First Intervention||14
471222|NCT01183234|1154672|P1|COMPLETED|First Intervention||13
471223|NCT01183234|1154671|P2|STARTED|First Intervention||14
471224|NCT01183234|1154672|P1|STARTED|First Intervention||14
471225|NCT01183169|1154686|P7|NOT COMPLETED|Post-switch Phase||9
471226|NCT01183169|1154687|P6|NOT COMPLETED|Post-switch Phase||14
471227|NCT01183169|1154688|P5|NOT COMPLETED|Post-switch Phase||0
471228|NCT01183169|1154689|P4|NOT COMPLETED|Post-switch Phase||0
471229|NCT01183169|1154690|P3|NOT COMPLETED|Post-switch Phase||0
471230|NCT01183169|1154691|P2|NOT COMPLETED|Post-switch Phase||0
471231|NCT01183169|1154692|P1|NOT COMPLETED|Post-switch Phase||0
471232|NCT01183169|1154686|P7|COMPLETED|Post-switch Phase||21
471233|NCT01183169|1154687|P6|COMPLETED|Post-switch Phase||21
471234|NCT01183169|1154688|P5|COMPLETED|Post-switch Phase||0
471235|NCT01183169|1154689|P4|COMPLETED|Post-switch Phase||0
471236|NCT01183169|1154690|P3|COMPLETED|Post-switch Phase||0
471237|NCT01183169|1154691|P2|COMPLETED|Post-switch Phase||0
471238|NCT01183169|1154692|P1|COMPLETED|Post-switch Phase||0
471239|NCT01183169|1154686|P7|Completed Treatment|Post-switch Phase||13
471240|NCT01183169|1154687|P6|Completed Treatment|Post-switch Phase||12
471241|NCT01183169|1154688|P5|Completed Treatment|Post-switch Phase||0
471242|NCT01183169|1154689|P4|Completed Treatment|Post-switch Phase||0
471243|NCT01183169|1154690|P3|Completed Treatment|Post-switch Phase||0
471244|NCT01183169|1154691|P2|Completed Treatment|Post-switch Phase||0
471245|NCT01183169|1154692|P1|Completed Treatment|Post-switch Phase||0
471246|NCT01183169|1154686|P7|STARTED|Post-switch Phase|Participants in Treatment C2 who switched to active ALV|30
471247|NCT01183169|1154687|P6|STARTED|Post-switch Phase|Participants in Treatment C1 who switched to active ALV|35
471248|NCT01183169|1154688|P5|STARTED|Post-switch Phase|Not a post-switch group|0
471249|NCT01183169|1154689|P4|STARTED|Post-switch Phase|Not a post-switch group|0
471250|NCT01183169|1154690|P3|STARTED|Post-switch Phase|Not a post-switch group|0
471251|NCT01183169|1154691|P2|STARTED|Post-switch Phase|Not a post-switch group|0
471252|NCT01183169|1154692|P1|STARTED|Post-switch Phase|Not a post-switch group|0
471253|NCT01183169|1154686|P7|NOT COMPLETED|Main Phase||0
471254|NCT01183169|1154687|P6|NOT COMPLETED|Main Phase||0
471255|NCT01183169|1154688|P5|NOT COMPLETED|Main Phase||26
471256|NCT01183169|1154689|P4|NOT COMPLETED|Main Phase||37
471257|NCT01183169|1154690|P3|NOT COMPLETED|Main Phase||41
471258|NCT01183169|1154691|P2|NOT COMPLETED|Main Phase||22
471259|NCT01183169|1154692|P1|NOT COMPLETED|Main Phase||27
471260|NCT01183169|1154686|P7|COMPLETED|Main Phase||0
471261|NCT01183169|1154687|P6|COMPLETED|Main Phase||0
471262|NCT01183169|1154688|P5|COMPLETED|Main Phase||83
471263|NCT01183169|1154689|P4|COMPLETED|Main Phase||18
471264|NCT01183169|1154690|P3|COMPLETED|Main Phase||18
471265|NCT01183169|1154691|P2|COMPLETED|Main Phase||93
471266|NCT01183169|1154692|P1|COMPLETED|Main Phase||94
471267|NCT01183169|1154686|P7|Switched to ALV|Main Phase||0
471268|NCT01183169|1154687|P6|Switched to ALV|Main Phase||0
471269|NCT01183169|1154688|P5|Switched to ALV|Main Phase||0
471270|NCT01183169|1154689|P4|Switched to ALV|Main Phase||30
471271|NCT01183169|1154690|P3|Switched to ALV|Main Phase||35
471272|NCT01183169|1154691|P2|Switched to ALV|Main Phase||0
471273|NCT01183169|1154692|P1|Switched to ALV|Main Phase||0
471274|NCT01183169|1154686|P7|Completed Treatment|Main Phase||0
471275|NCT01183169|1154687|P6|Completed Treatment|Main Phase||0
471276|NCT01183169|1154688|P5|Completed Treatment|Main Phase||77
471277|NCT01183169|1154689|P4|Completed Treatment|Main Phase||17
471278|NCT01183169|1154690|P3|Completed Treatment|Main Phase||17
471279|NCT01183169|1154691|P2|Completed Treatment|Main Phase||78
471280|NCT01183169|1154692|P1|Completed Treatment|Main Phase||72
471281|NCT01183169|1154686|P7|STARTED|Main Phase||0
471282|NCT01183169|1154687|P6|STARTED|Main Phase||0
471283|NCT01183169|1154688|P5|STARTED|Main Phase||109
471284|NCT01183169|1154689|P4|STARTED|Main Phase||55
471285|NCT01183169|1154690|P3|STARTED|Main Phase||59
471286|NCT01183169|1154691|P2|STARTED|Main Phase||115
471287|NCT01183169|1154692|P1|STARTED|Main Phase||121
471288|NCT01183143|1154764|P1|NOT COMPLETED|Overall Study||150
471289|NCT01183143|1154764|P1|COMPLETED|Overall Study||65
471290|NCT01183143|1154764|P1|Intention to Treat (ITT) Population|Overall Study|ITT=Subjects who received at least 1 dose of the investigational medicinal product (IMP).|204
471291|NCT01183143|1154764|P1|STARTED|Overall Study||215
471292|NCT01183104|1154780|P2|NOT COMPLETED|Overall Study||92
471293|NCT01183104|1154781|P1|NOT COMPLETED|Overall Study||77
471294|NCT01183104|1154780|P2|COMPLETED|Overall Study||60
471295|NCT01183104|1154781|P1|COMPLETED|Overall Study||76
471296|NCT01183104|1154780|P2|Enrolled in Extension Study|Overall Study||61
471297|NCT01183104|1154781|P1|Enrolled in Extension Study|Overall Study||80
471298|NCT01183104|1154780|P2|Completed 52-week Treatment|Overall Study||111
471299|NCT01183104|1154781|P1|Completed 52-week Treatment|Overall Study||119
471300|NCT01183104|1154780|P2|Continued Treatment for 12 Weeks|Overall Study||129
471301|NCT01183104|1154781|P1|Continued Treatment for 12 Weeks|Overall Study||143
471302|NCT01183104|1154780|P2|Received Study Drug|Overall Study||143
471303|NCT01183104|1154781|P1|Received Study Drug|Overall Study||148
471304|NCT01183104|1154780|P2|STARTED|Overall Study||152
471305|NCT01183104|1154781|P1|STARTED|Overall Study||153
471306|NCT01183065|1154797|P1|NOT COMPLETED|Overall Study||1
471307|NCT01183065|1154797|P1|COMPLETED|Overall Study||12
471308|NCT01183065|1154797|P1|STARTED|Overall Study||13
471309|NCT01183013|1154808|P7|NOT COMPLETED|Overall Study||37
471310|NCT01183013|1154809|P6|NOT COMPLETED|Overall Study||45
471311|NCT01183013|1154810|P5|NOT COMPLETED|Overall Study||36
471312|NCT01183013|1154811|P4|NOT COMPLETED|Overall Study||30
471313|NCT01183013|1154812|P3|NOT COMPLETED|Overall Study||41
471314|NCT01183013|1154813|P2|NOT COMPLETED|Overall Study||39
471315|NCT01183013|1154814|P1|NOT COMPLETED|Overall Study||45
471316|NCT01183013|1154808|P7|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|96
471317|NCT01183013|1154809|P6|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|88
471318|NCT01183013|1154810|P5|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|90
471319|NCT01183013|1154811|P4|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|105
471320|NCT01183013|1154812|P3|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|97
471321|NCT01183013|1154813|P2|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|101
471322|NCT01183013|1154814|P1|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|86
471323|NCT01183013|1154808|P7|STARTED|Overall Study||133
471324|NCT01183013|1154809|P6|STARTED|Overall Study||133
471325|NCT01183013|1154810|P5|STARTED|Overall Study||126
471326|NCT01183013|1154811|P4|STARTED|Overall Study||135
471327|NCT01183013|1154812|P3|STARTED|Overall Study||138
471328|NCT01183013|1154813|P2|STARTED|Overall Study||140
471329|NCT01183013|1154814|P1|STARTED|Overall Study||131
471330|NCT01182805|1154893|P1|NOT COMPLETED|Overall Study||0
471331|NCT01182805|1154893|P1|COMPLETED|Overall Study||50
471332|NCT01182805|1154893|P1|STARTED|Overall Study||50
471333|NCT01182727|1154902|P1|NOT COMPLETED|Overall Study||0
471334|NCT01182727|1154902|P1|COMPLETED|Overall Study||10
471335|NCT01182727|1154902|P1|STARTED|Overall Study||10
471336|NCT01182675|1154908|P2|NOT COMPLETED|Overall Study||0
471337|NCT01182675|1154909|P1|NOT COMPLETED|Overall Study||0
471338|NCT01182675|1154908|P2|COMPLETED|Overall Study||0
471339|NCT01182675|1154909|P1|COMPLETED|Overall Study||7
471340|NCT01182675|1154908|P2|STARTED|Overall Study||0
471341|NCT01182675|1154909|P1|STARTED|Overall Study||7
471342|NCT01182610|1154915|P1|NOT COMPLETED|Overall Study||0
471343|NCT01182610|1154915|P1|COMPLETED|Overall Study||1
471344|NCT01182610|1154915|P1|STARTED|Overall Study||1
471345|NCT01182493|1154925|P2|NOT COMPLETED|Overall Study||7
471346|NCT01182493|1154926|P1|NOT COMPLETED|Overall Study||16
471347|NCT01182493|1154925|P2|COMPLETED|Overall Study||156
471348|NCT01182493|1154926|P1|COMPLETED|Overall Study||152
471349|NCT01182493|1154925|P2|STARTED|Overall Study||163
471350|NCT01182493|1154926|P1|STARTED|Overall Study||168
471351|NCT01182480|1154944|P1|NOT COMPLETED|Overall Study||0
471352|NCT01182480|1154944|P1|COMPLETED|Overall Study||47
471353|NCT01182480|1154944|P1|STARTED|Overall Study||47
471354|NCT01182428|1154950|P2|NOT COMPLETED|Overall Study||1
471355|NCT01182428|1154951|P1|NOT COMPLETED|Overall Study||11
471356|NCT01182428|1154950|P2|COMPLETED|Overall Study||150
471357|NCT01182428|1154951|P1|COMPLETED|Overall Study||293
471358|NCT01182428|1154950|P2|STARTED|Overall Study||151
471359|NCT01182428|1154951|P1|STARTED|Overall Study||304
471360|NCT01182415|1155015|P1|NOT COMPLETED|Overall Study||1
471361|NCT01182415|1155015|P1|COMPLETED|Overall Study||29
471362|NCT01182415|1155015|P1|STARTED|Overall Study||30
471363|NCT01182376|1155024|P2|NOT COMPLETED|Overall Study||5
471364|NCT01182376|1155025|P1|NOT COMPLETED|Overall Study||11
471365|NCT01182376|1155024|P2|COMPLETED|Overall Study||13
471366|NCT01182376|1155025|P1|COMPLETED|Overall Study||4
471367|NCT01182376|1155024|P2|STARTED|Overall Study||18
471368|NCT01182376|1155025|P1|STARTED|Overall Study||15
471369|NCT01182337|1155033|P2|NOT COMPLETED|Overall Study||2
471370|NCT01182337|1155034|P1|NOT COMPLETED|Overall Study||3
471371|NCT01182337|1155033|P2|COMPLETED|Overall Study||7
471372|NCT01182337|1155034|P1|COMPLETED|Overall Study||19
471373|NCT01182337|1155033|P2|STARTED|Overall Study||9
471374|NCT01182337|1155034|P1|STARTED|Overall Study||22
471375|NCT01182298|1155052|P1|NOT COMPLETED|Overall Study||6
471376|NCT01182298|1155052|P1|COMPLETED|Overall Study||4
471377|NCT01182298|1155052|P1|STARTED|Overall Study||10
471378|NCT01182285|1155056|P3|NOT COMPLETED|Third Intervention Week 11-52||8
471379|NCT01182285|1155057|P2|NOT COMPLETED|Third Intervention Week 11-52||0
471380|NCT01182285|1155058|P1|NOT COMPLETED|Third Intervention Week 11-52||0
471381|NCT01182285|1155056|P3|COMPLETED|Third Intervention Week 11-52||0
471382|NCT01182285|1155057|P2|COMPLETED|Third Intervention Week 11-52||0
471383|NCT01182285|1155058|P1|COMPLETED|Third Intervention Week 11-52||0
471384|NCT01182285|1155056|P3|STARTED|Third Intervention Week 11-52|2 subj. taken off study after completing ph 1: 1 due to a negative uptake scan & one off due to PD.|8
471385|NCT01182285|1155057|P2|STARTED|Third Intervention Week 11-52||0
471386|NCT01182285|1155058|P1|STARTED|Third Intervention Week 11-52||0
471387|NCT01182285|1155056|P3|NOT COMPLETED|Second Intervention Week 11-17||0
471388|NCT01182285|1155057|P2|NOT COMPLETED|Second Intervention Week 11-17||0
471389|NCT01182285|1155058|P1|NOT COMPLETED|Second Intervention Week 11-17||0
471390|NCT01182285|1155056|P3|COMPLETED|Second Intervention Week 11-17||0
471391|NCT01182285|1155057|P2|COMPLETED|Second Intervention Week 11-17||0
471392|NCT01182285|1155058|P1|COMPLETED|Second Intervention Week 11-17||0
471393|NCT01182285|1155056|P3|STARTED|Second Intervention Week 11-17||0
471394|NCT01182285|1155057|P2|STARTED|Second Intervention Week 11-17||0
471395|NCT01182285|1155058|P1|STARTED|Second Intervention Week 11-17||0
471396|NCT01182285|1155056|P3|NOT COMPLETED|First Intervention Week 1-10||0
471397|NCT01182285|1155057|P2|NOT COMPLETED|First Intervention Week 1-10||0
471398|NCT01182285|1155058|P1|NOT COMPLETED|First Intervention Week 1-10||3
471399|NCT01182285|1155056|P3|COMPLETED|First Intervention Week 1-10||0
471400|NCT01182285|1155057|P2|COMPLETED|First Intervention Week 1-10||0
471401|NCT01182285|1155058|P1|COMPLETED|First Intervention Week 1-10||10
471402|NCT01182285|1155056|P3|STARTED|First Intervention Week 1-10||0
471403|NCT01182285|1155057|P2|STARTED|First Intervention Week 1-10||0
471404|NCT01182285|1155058|P1|STARTED|First Intervention Week 1-10||13
471405|NCT01182207|1155068|P2|NOT COMPLETED|Second Intervention||0
471406|NCT01182207|1155069|P1|NOT COMPLETED|Second Intervention||1
471407|NCT01182207|1155068|P2|COMPLETED|Second Intervention||14
471408|NCT01182207|1155069|P1|COMPLETED|Second Intervention||17
471409|NCT01182207|1155068|P2|STARTED|Second Intervention||14
471410|NCT01182207|1155069|P1|STARTED|Second Intervention||18
471411|NCT01182207|1155068|P2|NOT COMPLETED|Washout of 28 Days||0
471412|NCT01182207|1155069|P1|NOT COMPLETED|Washout of 28 Days||0
471413|NCT01182207|1155068|P2|COMPLETED|Washout of 28 Days||14
471414|NCT01182207|1155069|P1|COMPLETED|Washout of 28 Days||18
471415|NCT01182207|1155068|P2|STARTED|Washout of 28 Days||14
471416|NCT01182207|1155069|P1|STARTED|Washout of 28 Days||18
471417|NCT01182207|1155068|P2|NOT COMPLETED|First Intervention||1
471418|NCT01182207|1155069|P1|NOT COMPLETED|First Intervention||0
471419|NCT01182207|1155068|P2|COMPLETED|First Intervention||14
471420|NCT01182207|1155069|P1|COMPLETED|First Intervention||18
471421|NCT01182207|1155068|P2|STARTED|First Intervention||15
471422|NCT01182207|1155069|P1|STARTED|First Intervention||18
471423|NCT01182194|1155087|P2|NOT COMPLETED|Second Intervention||0
471424|NCT01182194|1155088|P1|NOT COMPLETED|Second Intervention||0
471425|NCT01182194|1155087|P2|COMPLETED|Second Intervention||16
471426|NCT01182194|1155088|P1|COMPLETED|Second Intervention||15
471427|NCT01182194|1155087|P2|STARTED|Second Intervention||16
471428|NCT01182194|1155088|P1|STARTED|Second Intervention||15
471429|NCT01182194|1155087|P2|NOT COMPLETED|Washout of 28 Days||0
471430|NCT01182194|1155088|P1|NOT COMPLETED|Washout of 28 Days||1
471431|NCT01182194|1155087|P2|COMPLETED|Washout of 28 Days||16
471432|NCT01182194|1155088|P1|COMPLETED|Washout of 28 Days||15
471433|NCT01182194|1155087|P2|STARTED|Washout of 28 Days||16
471434|NCT01182194|1155088|P1|STARTED|Washout of 28 Days||16
471435|NCT01182194|1155087|P2|NOT COMPLETED|First Intervention||0
471436|NCT01182194|1155088|P1|NOT COMPLETED|First Intervention||0
471437|NCT01182194|1155087|P2|COMPLETED|First Intervention||16
471438|NCT01182194|1155088|P1|COMPLETED|First Intervention||16
471439|NCT01182194|1155087|P2|STARTED|First Intervention||16
471440|NCT01182194|1155088|P1|STARTED|First Intervention||16
471441|NCT01182181|1155106|P2|NOT COMPLETED|Second Intervention||0
471442|NCT01182181|1155107|P1|NOT COMPLETED|Second Intervention||0
471443|NCT01182181|1155106|P2|COMPLETED|Second Intervention||10
471444|NCT01182181|1155107|P1|COMPLETED|Second Intervention||10
471445|NCT01182181|1155106|P2|STARTED|Second Intervention||10
471446|NCT01182181|1155107|P1|STARTED|Second Intervention||10
471447|NCT01182181|1155106|P2|NOT COMPLETED|Washout of 21 Days||1
471448|NCT01182181|1155107|P1|NOT COMPLETED|Washout of 21 Days||0
471449|NCT01182181|1155106|P2|COMPLETED|Washout of 21 Days||10
471450|NCT01182181|1155107|P1|COMPLETED|Washout of 21 Days||10
471451|NCT01182181|1155106|P2|STARTED|Washout of 21 Days||11
471452|NCT01182181|1155107|P1|STARTED|Washout of 21 Days||10
471453|NCT01182181|1155106|P2|NOT COMPLETED|First Intervention||0
471454|NCT01182181|1155107|P1|NOT COMPLETED|First Intervention||1
471455|NCT01182181|1155106|P2|COMPLETED|First Intervention||11
471456|NCT01182181|1155107|P1|COMPLETED|First Intervention||10
471457|NCT01182181|1155106|P2|STARTED|First Intervention||11
471458|NCT01182181|1155107|P1|STARTED|First Intervention||11
471459|NCT01182103|1155117|P2|NOT COMPLETED|Overall Study||0
471460|NCT01182103|1155118|P1|NOT COMPLETED|Overall Study||0
471461|NCT01182103|1155117|P2|COMPLETED|Overall Study||62
471462|NCT01182103|1155118|P1|COMPLETED|Overall Study||48
471463|NCT01182103|1155117|P2|STARTED|Overall Study||62
471464|NCT01182103|1155118|P1|STARTED|Overall Study||48
471465|NCT01181986|1155132|P3|NOT COMPLETED|Phase 2||0
471466|NCT01181986|1155133|P2|NOT COMPLETED|Phase 2||4
471467|NCT01181986|1155134|P1|NOT COMPLETED|Phase 2||0
471468|NCT01181986|1155132|P3|COMPLETED|Phase 2||0
471469|NCT01181986|1155133|P2|COMPLETED|Phase 2||18
471470|NCT01181986|1155134|P1|COMPLETED|Phase 2||18
471471|NCT01181986|1155132|P3|STARTED|Phase 2|N/A for Sub-study 2|0
471472|NCT01181986|1155133|P2|STARTED|Phase 2||22
471473|NCT01181986|1155134|P1|STARTED|Phase 2||18
471474|NCT01181986|1155132|P3|NOT COMPLETED|Phase 1||2
471475|NCT01181986|1155133|P2|NOT COMPLETED|Phase 1||1
471476|NCT01181986|1155134|P1|NOT COMPLETED|Phase 1||1
471477|NCT01181986|1155132|P3|COMPLETED|Phase 1||32
471478|NCT01181986|1155133|P2|COMPLETED|Phase 1||22
471479|NCT01181986|1155134|P1|COMPLETED|Phase 1||18
471480|NCT01181986|1155132|P3|Exendin-9+Exenatide|Phase 1||33
471481|NCT01181986|1155133|P2|Exendin-9+Exenatide|Phase 1|N/A for this arm|0
471482|NCT01181986|1155134|P1|Exendin-9+Exenatide|Phase 1|N/A for this arm|0
471483|NCT01181986|1155132|P3|Saline+Placebo|Phase 1||33
471484|NCT01181986|1155133|P2|Saline+Placebo|Phase 1|N/A for this arm|0
471485|NCT01181986|1155134|P1|Saline+Placebo|Phase 1|N/A for this arm|0
471486|NCT01181986|1155132|P3|Saline+Exenatide|Phase 1||32
471487|NCT01181986|1155133|P2|Saline+Exenatide|Phase 1|N/A for this arm|0
471488|NCT01181986|1155134|P1|Saline+Exenatide|Phase 1|N/A for this arm|0
471489|NCT01181986|1155132|P3|STARTED|Phase 1||34
471490|NCT01181986|1155133|P2|STARTED|Phase 1||23
471491|NCT01181986|1155134|P1|STARTED|Phase 1||19
471492|NCT01181947|1155150|P1|NOT COMPLETED|Overall Study||0
471493|NCT01181947|1155150|P1|COMPLETED|Overall Study||100
471494|NCT01181947|1155150|P1|STARTED|Overall Study||100
471495|NCT01181921|1155155|P1|NOT COMPLETED|Overall Study||1
471496|NCT01181921|1155155|P1|COMPLETED|Overall Study||0
471497|NCT01181921|1155155|P1|STARTED|Overall Study||1
471498|NCT01181895|1155162|P3|NOT COMPLETED|Overall Study||18
471499|NCT01181895|1155163|P2|NOT COMPLETED|Overall Study||14
471500|NCT01181895|1155164|P1|NOT COMPLETED|Overall Study||17
471501|NCT01181895|1155162|P3|COMPLETED|Overall Study||98
471502|NCT01181895|1155163|P2|COMPLETED|Overall Study||101
471503|NCT01181895|1155164|P1|COMPLETED|Overall Study||99
471504|NCT01181895|1155162|P3|STARTED|Overall Study||116
471505|NCT01181895|1155163|P2|STARTED|Overall Study||115
471506|NCT01181895|1155164|P1|STARTED|Overall Study||116
471507|NCT01181804|1155197|P4|NOT COMPLETED|Period 4, Fasted (Part 2)||0
471508|NCT01181804|1155198|P3|NOT COMPLETED|Period 4, Fasted (Part 2)||1
471509|NCT01181804|1155199|P2|NOT COMPLETED|Period 4, Fasted (Part 2)||0
471510|NCT01181804|1155200|P1|NOT COMPLETED|Period 4, Fasted (Part 2)||0
471511|NCT01181804|1155197|P4|COMPLETED|Period 4, Fasted (Part 2)||58
471512|NCT01181804|1155198|P3|COMPLETED|Period 4, Fasted (Part 2)||58
471513|NCT01181804|1155199|P2|COMPLETED|Period 4, Fasted (Part 2)||0
471514|NCT01181804|1155200|P1|COMPLETED|Period 4, Fasted (Part 2)||0
471515|NCT01181804|1155197|P4|STARTED|Period 4, Fasted (Part 2)||58
471516|NCT01181804|1155198|P3|STARTED|Period 4, Fasted (Part 2)||59
471517|NCT01181804|1155199|P2|STARTED|Period 4, Fasted (Part 2)||0
471518|NCT01181804|1155200|P1|STARTED|Period 4, Fasted (Part 2)||0
471519|NCT01181804|1155197|P4|NOT COMPLETED|Period 3, Fasted (Part 2)||0
471520|NCT01181804|1155198|P3|NOT COMPLETED|Period 3, Fasted (Part 2)||0
471521|NCT01181804|1155199|P2|NOT COMPLETED|Period 3, Fasted (Part 2)||0
471522|NCT01181804|1155200|P1|NOT COMPLETED|Period 3, Fasted (Part 2)||0
471523|NCT01181804|1155197|P4|COMPLETED|Period 3, Fasted (Part 2)||58
471524|NCT01181804|1155198|P3|COMPLETED|Period 3, Fasted (Part 2)||59
471525|NCT01181804|1155199|P2|COMPLETED|Period 3, Fasted (Part 2)||0
471526|NCT01181804|1155200|P1|COMPLETED|Period 3, Fasted (Part 2)||0
471527|NCT01181804|1155197|P4|STARTED|Period 3, Fasted (Part 2)||58
471528|NCT01181804|1155198|P3|STARTED|Period 3, Fasted (Part 2)||59
471529|NCT01181804|1155199|P2|STARTED|Period 3, Fasted (Part 2)||0
471530|NCT01181804|1155200|P1|STARTED|Period 3, Fasted (Part 2)||0
471531|NCT01181804|1155197|P4|NOT COMPLETED|Period 2, Fed (Part 1)||0
471532|NCT01181804|1155198|P3|NOT COMPLETED|Period 2, Fed (Part 1)||0
471533|NCT01181804|1155199|P2|NOT COMPLETED|Period 2, Fed (Part 1)||0
471534|NCT01181804|1155200|P1|NOT COMPLETED|Period 2, Fed (Part 1)||0
471535|NCT01181804|1155197|P4|COMPLETED|Period 2, Fed (Part 1)||0
471536|NCT01181804|1155198|P3|COMPLETED|Period 2, Fed (Part 1)||0
471537|NCT01181804|1155199|P2|COMPLETED|Period 2, Fed (Part 1)||30
471538|NCT01181804|1155200|P1|COMPLETED|Period 2, Fed (Part 1)||30
471539|NCT01181804|1155197|P4|STARTED|Period 2, Fed (Part 1)||0
471540|NCT01181804|1155198|P3|STARTED|Period 2, Fed (Part 1)||0
471541|NCT01181804|1155199|P2|STARTED|Period 2, Fed (Part 1)||30
471542|NCT01181804|1155200|P1|STARTED|Period 2, Fed (Part 1)||30
471543|NCT01181804|1155197|P4|NOT COMPLETED|Period 1, Fed (Part 1)||0
471544|NCT01181804|1155198|P3|NOT COMPLETED|Period 1, Fed (Part 1)||0
471545|NCT01181804|1155199|P2|NOT COMPLETED|Period 1, Fed (Part 1)||0
471546|NCT01181804|1155200|P1|NOT COMPLETED|Period 1, Fed (Part 1)||0
471547|NCT01181804|1155197|P4|COMPLETED|Period 1, Fed (Part 1)||0
471548|NCT01181804|1155198|P3|COMPLETED|Period 1, Fed (Part 1)||0
471549|NCT01181804|1155199|P2|COMPLETED|Period 1, Fed (Part 1)||30
471550|NCT01181804|1155200|P1|COMPLETED|Period 1, Fed (Part 1)||30
471551|NCT01181804|1155197|P4|STARTED|Period 1, Fed (Part 1)||0
471552|NCT01181804|1155198|P3|STARTED|Period 1, Fed (Part 1)||0
471553|NCT01181804|1155199|P2|STARTED|Period 1, Fed (Part 1)||30
471554|NCT01181804|1155200|P1|STARTED|Period 1, Fed (Part 1)||30
471555|NCT01181778|1155222|P1|NOT COMPLETED|Overall Study||48
471556|NCT01181778|1155222|P1|COMPLETED|Overall Study||1871
471557|NCT01181778|1155222|P1|STARTED|Overall Study||1919
471558|NCT01181726|1155230|P2|NOT COMPLETED|Second Intervention||0
471559|NCT01181726|1155231|P1|NOT COMPLETED|Second Intervention||0
471560|NCT01181726|1155230|P2|COMPLETED|Second Intervention||20
471561|NCT01181726|1155231|P1|COMPLETED|Second Intervention||19
471562|NCT01181726|1155230|P2|STARTED|Second Intervention||20
471563|NCT01181726|1155231|P1|STARTED|Second Intervention||19
471564|NCT01181726|1155230|P2|NOT COMPLETED|Washout of 28 Days||0
471565|NCT01181726|1155231|P1|NOT COMPLETED|Washout of 28 Days||0
471566|NCT01181726|1155230|P2|COMPLETED|Washout of 28 Days||20
471567|NCT01181726|1155231|P1|COMPLETED|Washout of 28 Days||19
471568|NCT01181726|1155230|P2|STARTED|Washout of 28 Days||20
471569|NCT01181726|1155231|P1|STARTED|Washout of 28 Days||19
471570|NCT01181726|1155230|P2|NOT COMPLETED|First Intervention||0
471571|NCT01181726|1155231|P1|NOT COMPLETED|First Intervention||1
471572|NCT01181726|1155230|P2|COMPLETED|First Intervention||20
471573|NCT01181726|1155231|P1|COMPLETED|First Intervention||19
471574|NCT01181726|1155230|P2|STARTED|First Intervention||20
471575|NCT01181726|1155231|P1|STARTED|First Intervention||20
471576|NCT01181609|1155277|P1|NOT COMPLETED|Overall Study||53
471577|NCT01181609|1155277|P1|COMPLETED|Overall Study||1
471578|NCT01181609|1155277|P1|STARTED|Overall Study||54
471579|NCT01181531|1155290|P2|NOT COMPLETED|Overall Study||53
471580|NCT01181531|1155291|P1|NOT COMPLETED|Overall Study||61
471581|NCT01181531|1155290|P2|COMPLETED|Overall Study||102
471582|NCT01181531|1155291|P1|COMPLETED|Overall Study||96
471583|NCT01181531|1155290|P2|Received Investigational Product|Overall Study||153
471584|NCT01181531|1155291|P1|Received Investigational Product|Overall Study||155
471585|NCT01181531|1155290|P2|STARTED|Overall Study|Subjects are randomized after washout.|155
471586|NCT01181531|1155291|P1|STARTED|Overall Study|Subjects are randomized after washout.|157
471587|NCT01181492|1155304|P3|NOT COMPLETED|Overall Study||0
471588|NCT01181492|1155305|P2|NOT COMPLETED|Overall Study||0
471589|NCT01181492|1155306|P1|NOT COMPLETED|Overall Study||0
471590|NCT01181492|1155304|P3|COMPLETED|Overall Study||7
471591|NCT01181492|1155305|P2|COMPLETED|Overall Study||66
471592|NCT01181492|1155306|P1|COMPLETED|Overall Study||103
471593|NCT01181492|1155304|P3|STARTED|Overall Study||7
471594|NCT01181492|1155305|P2|STARTED|Overall Study||66
471595|NCT01181492|1155306|P1|STARTED|Overall Study||103
471596|NCT01181349|1155320|P1|NOT COMPLETED|Overall Study||0
471597|NCT01181349|1155320|P1|COMPLETED|Overall Study||350
471598|NCT01181349|1155320|P1|STARTED|Overall Study||350
471599|NCT01181323|1155336|P4|NOT COMPLETED|Overall Study||3
471600|NCT01181323|1155337|P3|NOT COMPLETED|Overall Study||1
471601|NCT01181323|1155338|P2|NOT COMPLETED|Overall Study||3
471602|NCT01181323|1155339|P1|NOT COMPLETED|Overall Study||1
471603|NCT01181323|1155336|P4|COMPLETED|Overall Study||122
471604|NCT01181323|1155337|P3|COMPLETED|Overall Study||123
471605|NCT01181323|1155338|P2|COMPLETED|Overall Study||121
471606|NCT01181323|1155339|P1|COMPLETED|Overall Study||123
471607|NCT01181323|1155336|P4|STARTED|Overall Study||125
471608|NCT01181323|1155337|P3|STARTED|Overall Study||124
471609|NCT01181323|1155338|P2|STARTED|Overall Study||124
471610|NCT01181323|1155339|P1|STARTED|Overall Study||124
471611|NCT01181271|1155414|P1|NOT COMPLETED|Allogeneic Transplant||0
471612|NCT01181271|1155414|P1|COMPLETED|Allogeneic Transplant||29
471613|NCT01181271|1155414|P1|STARTED|Allogeneic Transplant||29
471614|NCT01181271|1155414|P1|NOT COMPLETED|Evaluation for Allogeneic Transplant||13
471615|NCT01181271|1155414|P1|COMPLETED|Evaluation for Allogeneic Transplant||29
471616|NCT01181271|1155414|P1|STARTED|Evaluation for Allogeneic Transplant||42
471617|NCT01181271|1155414|P1|NOT COMPLETED|Autologous Transplant||0
471618|NCT01181271|1155414|P1|COMPLETED|Autologous Transplant||42
471619|NCT01181271|1155414|P1|STARTED|Autologous Transplant||42
471620|NCT01181258|1155429|P1|NOT COMPLETED|Overall Study||0
471621|NCT01181258|1155429|P1|COMPLETED|Overall Study||16
471622|NCT01181258|1155429|P1|STARTED|Overall Study||16
471623|NCT01181167|1155438|P2|NOT COMPLETED|Overall Study||32
471624|NCT01181167|1155439|P1|NOT COMPLETED|Overall Study||23
471625|NCT01181167|1155438|P2|COMPLETED|Overall Study||271
471626|NCT01181167|1155439|P1|COMPLETED|Overall Study||284
471627|NCT01181167|1155438|P2|Efficacy Analysis Population|Overall Study||248
471628|NCT01181167|1155439|P1|Efficacy Analysis Population|Overall Study||255
471629|NCT01181167|1155438|P2|STARTED|Overall Study||303
471630|NCT01181167|1155439|P1|STARTED|Overall Study||307
471631|NCT01181141|1155449|P2|NOT COMPLETED|Overall Study||4
471632|NCT01181141|1155450|P1|NOT COMPLETED|Overall Study||12
471633|NCT01181141|1155449|P2|COMPLETED|Overall Study||26
471634|NCT01181141|1155450|P1|COMPLETED|Overall Study||50
471635|NCT01181141|1155449|P2|Safety Analysis Population|Overall Study||29
471636|NCT01181141|1155450|P1|Safety Analysis Population|Overall Study||59
471637|NCT01181141|1155449|P2|STARTED|Overall Study||30
471638|NCT01181141|1155450|P1|STARTED|Overall Study||62
471639|NCT01181128|1155459|P3|NOT COMPLETED|Overall Study||1
471640|NCT01181128|1155460|P2|NOT COMPLETED|Overall Study||5
471641|NCT01181128|1155461|P1|NOT COMPLETED|Overall Study||6
471642|NCT01181128|1155459|P3|COMPLETED|Overall Study||22
471643|NCT01181128|1155460|P2|COMPLETED|Overall Study||19
471644|NCT01181128|1155461|P1|COMPLETED|Overall Study||112
471645|NCT01181128|1155459|P3|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|0
471646|NCT01181128|1155460|P2|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|1
471647|NCT01181128|1155461|P1|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|8
471648|NCT01181128|1155459|P3|Pharmacokinetic (PK) Subgroup|Overall Study||0
471649|NCT01181128|1155460|P2|Pharmacokinetic (PK) Subgroup|Overall Study||0
471650|NCT01181128|1155461|P1|Pharmacokinetic (PK) Subgroup|Overall Study||30
471651|NCT01181128|1155459|P3|STARTED|Overall Study||23
471652|NCT01181128|1155460|P2|STARTED|Overall Study||24
471653|NCT01181128|1155461|P1|STARTED|Overall Study||118
471654|NCT01181102|1155549|P2|NOT COMPLETED|Overall Study||46
471655|NCT01181102|1155550|P1|NOT COMPLETED|Overall Study||51
471656|NCT01181102|1155549|P2|COMPLETED|Overall Study||310
471657|NCT01181102|1155550|P1|COMPLETED|Overall Study||309
471658|NCT01181102|1155549|P2|Efficacy Analysis Population|Overall Study||295
471659|NCT01181102|1155550|P1|Efficacy Analysis Population|Overall Study||299
471660|NCT01181102|1155549|P2|Safety Analysis Set|Overall Study||349
471661|NCT01181102|1155550|P1|Safety Analysis Set|Overall Study||354
471662|NCT01181102|1155549|P2|STARTED|Overall Study||356
471663|NCT01181102|1155550|P1|STARTED|Overall Study||360
471664|NCT01181050|1155560|P2|NOT COMPLETED|Overall Study||0
471665|NCT01181050|1155561|P1|NOT COMPLETED|Overall Study||0
471666|NCT01181050|1155560|P2|COMPLETED|Overall Study||22
471667|NCT01181050|1155561|P1|COMPLETED|Overall Study||41
471668|NCT01181050|1155560|P2|STARTED|Overall Study||22
471669|NCT01181050|1155561|P1|STARTED|Overall Study||41
471670|NCT01181011|1155571|P1|NOT COMPLETED|Overall Study||3
471671|NCT01181011|1155571|P1|COMPLETED|Overall Study||25
471672|NCT01181011|1155571|P1|Received Amlodipine 5mg|Overall Study||26
471673|NCT01181011|1155571|P1|Received Telmisartan 80mg,Amlodipine 5mg|Overall Study||27
471674|NCT01181011|1155571|P1|Received Telmisartan 80mg|Overall Study||27
471675|NCT01181011|1155571|P1|STARTED|Overall Study||28
471676|NCT01180998|1155621|P3|NOT COMPLETED|Overall Study||10
471677|NCT01180998|1155622|P2|NOT COMPLETED|Overall Study||4
471678|NCT01180998|1155623|P1|NOT COMPLETED|Overall Study||4
471679|NCT01180998|1155621|P3|COMPLETED|Overall Study||51
471680|NCT01180998|1155622|P2|COMPLETED|Overall Study||68
471681|NCT01180998|1155623|P1|COMPLETED|Overall Study||63
471682|NCT01180998|1155621|P3|STARTED|Overall Study||61
471683|NCT01180998|1155622|P2|STARTED|Overall Study||72
471684|NCT01180998|1155623|P1|STARTED|Overall Study||67
471685|NCT01180985|1155637|P2|NOT COMPLETED|Period 2 (7 +/- 1 Days)||0
471686|NCT01180985|1155638|P1|NOT COMPLETED|Period 2 (7 +/- 1 Days)||1
471687|NCT01180985|1155637|P2|COMPLETED|Period 2 (7 +/- 1 Days)||26
471688|NCT01180985|1155638|P1|COMPLETED|Period 2 (7 +/- 1 Days)||26
471689|NCT01180985|1155637|P2|STARTED|Period 2 (7 +/- 1 Days)||26
471690|NCT01180985|1155638|P1|STARTED|Period 2 (7 +/- 1 Days)||27
471691|NCT01180985|1155637|P2|NOT COMPLETED|Period 1 (7 +/- Days)||0
471692|NCT01180985|1155638|P1|NOT COMPLETED|Period 1 (7 +/- Days)||0
471693|NCT01180985|1155637|P2|COMPLETED|Period 1 (7 +/- Days)||26
471694|NCT01180985|1155638|P1|COMPLETED|Period 1 (7 +/- Days)||27
471695|NCT01180985|1155637|P2|STARTED|Period 1 (7 +/- Days)||26
471696|NCT01180985|1155638|P1|STARTED|Period 1 (7 +/- Days)||27
471697|NCT01180894|1155657|P2|NOT COMPLETED|Overall Study||0
471698|NCT01180894|1155658|P1|NOT COMPLETED|Overall Study||0
471699|NCT01180894|1155657|P2|COMPLETED|Overall Study||75
471700|NCT01180894|1155658|P1|COMPLETED|Overall Study||75
471701|NCT01180894|1155657|P2|STARTED|Overall Study||75
471702|NCT01180894|1155658|P1|STARTED|Overall Study||75
471703|NCT01180790|1155677|P7|NOT COMPLETED|Overall Study||1
471704|NCT01180790|1155678|P6|NOT COMPLETED|Overall Study||7
471705|NCT01180790|1155679|P5|NOT COMPLETED|Overall Study||5
471706|NCT01180790|1155680|P4|NOT COMPLETED|Overall Study||9
471707|NCT01180790|1155681|P3|NOT COMPLETED|Overall Study||13
471708|NCT01180790|1155682|P2|NOT COMPLETED|Overall Study||5
471709|NCT01180790|1155683|P1|NOT COMPLETED|Overall Study||9
471710|NCT01180790|1155677|P7|COMPLETED|Overall Study||18
471711|NCT01180790|1155678|P6|COMPLETED|Overall Study||13
471712|NCT01180790|1155679|P5|COMPLETED|Overall Study||14
471713|NCT01180790|1155680|P4|COMPLETED|Overall Study||6
471714|NCT01180790|1155681|P3|COMPLETED|Overall Study||4
471715|NCT01180790|1155682|P2|COMPLETED|Overall Study||11
471716|NCT01180790|1155683|P1|COMPLETED|Overall Study||7
471717|NCT01180790|1155677|P7|STARTED|Overall Study||19
471718|NCT01180790|1155678|P6|STARTED|Overall Study||20
471719|NCT01180790|1155679|P5|STARTED|Overall Study||19
471720|NCT01180790|1155680|P4|STARTED|Overall Study||15
471721|NCT01180790|1155681|P3|STARTED|Overall Study||17
471722|NCT01180790|1155682|P2|STARTED|Overall Study||16
471723|NCT01180790|1155683|P1|STARTED|Overall Study||16
471724|NCT01180777|1155748|P1|NOT COMPLETED|Overall Study||12
471725|NCT01180777|1155748|P1|COMPLETED|Overall Study||80
471726|NCT01180777|1155748|P1|STARTED|Overall Study||92
471727|NCT01180660|1155762|P2|NOT COMPLETED|Overall Study||0
471728|NCT01180660|1155763|P1|NOT COMPLETED|Overall Study||1
471729|NCT01180660|1155762|P2|COMPLETED|Overall Study||26
471730|NCT01180660|1155763|P1|COMPLETED|Overall Study||24
471731|NCT01180660|1155762|P2|STARTED|Overall Study||26
471732|NCT01180660|1155763|P1|STARTED|Overall Study||25
471733|NCT01180647|1155773|P2|NOT COMPLETED|Overall Study||6
471734|NCT01180647|1155774|P1|NOT COMPLETED|Overall Study||5
471735|NCT01180647|1155773|P2|COMPLETED|Overall Study||11
471736|NCT01180647|1155774|P1|COMPLETED|Overall Study||12
471737|NCT01180647|1155773|P2|STARTED|Overall Study||17
471738|NCT01180647|1155774|P1|STARTED|Overall Study||17
471739|NCT01180478|1155792|P2|NOT COMPLETED|Overall Study||188
471740|NCT01180478|1155793|P1|NOT COMPLETED|Overall Study||181
471741|NCT01180478|1155792|P2|COMPLETED|Overall Study||293
471742|NCT01180478|1155793|P1|COMPLETED|Overall Study||303
471743|NCT01180478|1155792|P2|STARTED|Overall Study||481
471744|NCT01180478|1155793|P1|STARTED|Overall Study||484
471745|NCT01180400|1155809|P2|NOT COMPLETED|Overall Study||27
471746|NCT01180400|1155810|P1|NOT COMPLETED|Overall Study||25
471747|NCT01180400|1155809|P2|COMPLETED|Overall Study||121
471748|NCT01180400|1155810|P1|COMPLETED|Overall Study||122
471749|NCT01180400|1155809|P2|Received Treatment|Overall Study||146
471750|NCT01180400|1155810|P1|Received Treatment|Overall Study||147
471751|NCT01180400|1155809|P2|STARTED|Overall Study||148
471752|NCT01180400|1155810|P1|STARTED|Overall Study||147
471753|NCT01180296|1155858|P2|NOT COMPLETED|Overall Study||2
471754|NCT01180296|1155859|P1|NOT COMPLETED|Overall Study||1
471755|NCT01180296|1155858|P2|COMPLETED|Overall Study||14
471756|NCT01180296|1155859|P1|COMPLETED|Overall Study||19
471757|NCT01180296|1155858|P2|STARTED|Overall Study||16
471758|NCT01180296|1155859|P1|STARTED|Overall Study||20
471759|NCT01180244|1155867|P2|NOT COMPLETED|Overall Study||8
471760|NCT01180244|1155868|P1|NOT COMPLETED|Overall Study||6
471761|NCT01180244|1155867|P2|COMPLETED|Overall Study|Number of placebo group patients who completed all study visits and are evaluable|38
471762|NCT01180244|1155868|P1|COMPLETED|Overall Study|Number of active treatment patients who completed all study visits and are evaluable|39
471763|NCT01180244|1155867|P2|Received Treatment|Overall Study|Number of patients in the placebo group that received at least one sham treatment|45
471764|NCT01180244|1155868|P1|Received Treatment|Overall Study|Number of patients in the active treatment group that received at least one study treatment|40
471765|NCT01180244|1155867|P2|STARTED|Overall Study|Number of enrolled patients initially randomized to placebo group|46
471766|NCT01180244|1155868|P1|STARTED|Overall Study|Number of enrolled patients initially randomized to active treatment group|45
471767|NCT01180127|1155886|P4|NOT COMPLETED|Overall Study||1
471768|NCT01180127|1155887|P3|NOT COMPLETED|Overall Study||1
471769|NCT01180127|1155888|P2|NOT COMPLETED|Overall Study||0
471770|NCT01180127|1155889|P1|NOT COMPLETED|Overall Study||2
471771|NCT01180127|1155886|P4|COMPLETED|Overall Study||9
471772|NCT01180127|1155887|P3|COMPLETED|Overall Study||9
471773|NCT01180127|1155888|P2|COMPLETED|Overall Study||11
471774|NCT01180127|1155889|P1|COMPLETED|Overall Study||8
471775|NCT01180127|1155886|P4|STARTED|Overall Study||10
471776|NCT01180127|1155887|P3|STARTED|Overall Study||10
471777|NCT01180127|1155888|P2|STARTED|Overall Study||11
471778|NCT01180127|1155889|P1|STARTED|Overall Study||10
471779|NCT01180049|1155913|P2|NOT COMPLETED|Overall Study||43
471780|NCT01180049|1155914|P1|NOT COMPLETED|Overall Study||47
471781|NCT01180049|1155913|P2|COMPLETED|Overall Study|This is an ongoing study. Date for data cut-off is 12 November 2015.|0
471782|NCT01180049|1155914|P1|COMPLETED|Overall Study|This is an ongoing study. Date for data cut-off is 12 November 2015.|0
471783|NCT01180049|1155913|P2|Treated|Overall Study||42
471784|NCT01180049|1155914|P1|Treated|Overall Study||47
471785|NCT01180049|1155913|P2|STARTED|Overall Study||43
471786|NCT01180049|1155914|P1|STARTED|Overall Study||47
471787|NCT01179984|1155934|P1|NOT COMPLETED|Overall Study||18
471788|NCT01179984|1155934|P1|COMPLETED|Overall Study||58
471789|NCT01179984|1155934|P1|STARTED|Overall Study||76
471790|NCT01179919|1155940|P1|NOT COMPLETED|Overall Study||2
471791|NCT01179919|1155940|P1|COMPLETED|Overall Study||19
471792|NCT01179919|1155940|P1|STARTED|Overall Study||21
471793|NCT01179737|1155949|P4|NOT COMPLETED|Extension||0
471794|NCT01179737|1155950|P3|NOT COMPLETED|Extension||0
471795|NCT01179737|1155951|P2|NOT COMPLETED|Extension||0
471796|NCT01179737|1155952|P1|NOT COMPLETED|Extension||3
471797|NCT01179737|1155949|P4|COMPLETED|Extension||0
471798|NCT01179737|1155950|P3|COMPLETED|Extension||0
471799|NCT01179737|1155951|P2|COMPLETED|Extension||0
471800|NCT01179737|1155952|P1|COMPLETED|Extension||0
471801|NCT01179737|1155949|P4|STARTED|Extension||0
471802|NCT01179737|1155950|P3|STARTED|Extension||0
471803|NCT01179737|1155951|P2|STARTED|Extension|One patient did not enrol in the extension|0
471804|NCT01179737|1155952|P1|STARTED|Extension|Two patients did not enrol in the extension|3
471805|NCT01179737|1155949|P4|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
471806|NCT01179737|1155950|P3|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
471807|NCT01179737|1155951|P2|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
471808|NCT01179737|1155952|P1|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||1
471809|NCT01179737|1155949|P4|COMPLETED|Cohort 1 & Cohort 2 Expansion||0
471810|NCT01179737|1155950|P3|COMPLETED|Cohort 1 & Cohort 2 Expansion||0
471811|NCT01179737|1155951|P2|COMPLETED|Cohort 1 & Cohort 2 Expansion||1
471812|NCT01179737|1155952|P1|COMPLETED|Cohort 1 & Cohort 2 Expansion||4
471813|NCT01179737|1155949|P4|STARTED|Cohort 1 & Cohort 2 Expansion||0
471814|NCT01179737|1155950|P3|STARTED|Cohort 1 & Cohort 2 Expansion||0
471815|NCT01179737|1155951|P2|STARTED|Cohort 1 & Cohort 2 Expansion||1
471816|NCT01179737|1155952|P1|STARTED|Cohort 1 & Cohort 2 Expansion|2 participants did not enroll in extension|5
471817|NCT01179737|1155949|P4|NOT COMPLETED|Cohort 1 & Cohort 2||4
471818|NCT01179737|1155950|P3|NOT COMPLETED|Cohort 1 & Cohort 2||4
471819|NCT01179737|1155951|P2|NOT COMPLETED|Cohort 1 & Cohort 2||2
471820|NCT01179737|1155952|P1|NOT COMPLETED|Cohort 1 & Cohort 2||5
471821|NCT01179737|1155949|P4|COMPLETED|Cohort 1 & Cohort 2||0
471822|NCT01179737|1155950|P3|COMPLETED|Cohort 1 & Cohort 2||0
471823|NCT01179737|1155951|P2|COMPLETED|Cohort 1 & Cohort 2||1
471824|NCT01179737|1155952|P1|COMPLETED|Cohort 1 & Cohort 2||7
471825|NCT01179737|1155949|P4|STARTED|Cohort 1 & Cohort 2||4
471826|NCT01179737|1155950|P3|STARTED|Cohort 1 & Cohort 2||4
471827|NCT01179737|1155951|P2|STARTED|Cohort 1 & Cohort 2|One patient was missing the end of study evaluation|3
471828|NCT01179737|1155952|P1|STARTED|Cohort 1 & Cohort 2||12
471829|NCT01179672|1155963|P2|NOT COMPLETED|Overall Study||26
471830|NCT01179672|1155964|P1|NOT COMPLETED|Overall Study||30
471831|NCT01179672|1155963|P2|COMPLETED|Overall Study||176
471832|NCT01179672|1155964|P1|COMPLETED|Overall Study||173
471833|NCT01179672|1155963|P2|Entered Taper|Overall Study||177
471834|NCT01179672|1155964|P1|Entered Taper|Overall Study||181
471835|NCT01179672|1155963|P2|Received at Least 1 Dose of Study Drug|Overall Study||202
471836|NCT01179672|1155964|P1|Received at Least 1 Dose of Study Drug|Overall Study||202
471837|NCT01179672|1155963|P2|STARTED|Overall Study||202
471838|NCT01179672|1155964|P1|STARTED|Overall Study||203
471839|NCT01179568|1155994|P4|NOT COMPLETED|Overall Study||20
471840|NCT01179568|1155995|P3|NOT COMPLETED|Overall Study||23
471841|NCT01179568|1155996|P2|NOT COMPLETED|Overall Study||38
471842|NCT01179568|1155997|P1|NOT COMPLETED|Overall Study||28
471843|NCT01179568|1155994|P4|COMPLETED|Overall Study||76
471844|NCT01179568|1155995|P3|COMPLETED|Overall Study||76
471845|NCT01179568|1155996|P2|COMPLETED|Overall Study||61
471846|NCT01179568|1155997|P1|COMPLETED|Overall Study||73
471847|NCT01179568|1155994|P4|Completed Week 12 Assessment|Overall Study||75
471848|NCT01179568|1155995|P3|Completed Week 12 Assessment|Overall Study||76
471849|NCT01179568|1155996|P2|Completed Week 12 Assessment|Overall Study||69
471850|NCT01179568|1155997|P1|Completed Week 12 Assessment|Overall Study||69
471851|NCT01179568|1155994|P4|STARTED|Overall Study||96
471852|NCT01179568|1155995|P3|STARTED|Overall Study||99
471853|NCT01179568|1155996|P2|STARTED|Overall Study||99
471854|NCT01179568|1155997|P1|STARTED|Overall Study||101
471855|NCT01179516|1156020|P3|NOT COMPLETED|Overall Study||31
471856|NCT01179516|1156021|P2|NOT COMPLETED|Overall Study||26
471857|NCT01179516|1156022|P1|NOT COMPLETED|Overall Study||27
471858|NCT01179516|1156020|P3|COMPLETED|Overall Study||121
471859|NCT01179516|1156021|P2|COMPLETED|Overall Study||131
471860|NCT01179516|1156022|P1|COMPLETED|Overall Study||133
471861|NCT01179516|1156020|P3|Treated|Overall Study||151
471862|NCT01179516|1156021|P2|Treated|Overall Study||154
471863|NCT01179516|1156022|P1|Treated|Overall Study||160
471864|NCT01179516|1156020|P3|STARTED|Overall Study||152
471865|NCT01179516|1156021|P2|STARTED|Overall Study||157
471866|NCT01179516|1156022|P1|STARTED|Overall Study||160
471867|NCT01179490|1156045|P1|NOT COMPLETED|Overall Study||0
471868|NCT01179490|1156045|P1|COMPLETED|Overall Study||5
471869|NCT01179490|1156045|P1|STARTED|Overall Study||5
471870|NCT01179399|1156066|P1|NOT COMPLETED|Overall Study||32
471871|NCT01179399|1156066|P1|COMPLETED|Overall Study||0
471872|NCT01179399|1156066|P1|STARTED|Overall Study||32
471873|NCT01179347|1156072|P2|NOT COMPLETED|Open-label Period (12 Weeks)||16
471874|NCT01179347|1156073|P1|NOT COMPLETED|Open-label Period (12 Weeks)||15
471875|NCT01179347|1156072|P2|COMPLETED|Open-label Period (12 Weeks)|Completed open-label period.|278
471876|NCT01179347|1156073|P1|COMPLETED|Open-label Period (12 Weeks)|Completed open-label period.|132
471877|NCT01179347|1156072|P2|STARTED|Open-label Period (12 Weeks)|Treated in open-label period.|294
471878|NCT01179347|1156073|P1|STARTED|Open-label Period (12 Weeks)|Treated in open-label period.|147
471879|NCT01179347|1156072|P2|NOT COMPLETED|Double-blind Period (12 Weeks)||14
471880|NCT01179347|1156073|P1|NOT COMPLETED|Double-blind Period (12 Weeks)||8
471881|NCT01179347|1156072|P2|COMPLETED|Double-blind Period (12 Weeks)|Completed double-blind period.|294
471882|NCT01179347|1156073|P1|COMPLETED|Double-blind Period (12 Weeks)|Completed double-blind period.|147
471883|NCT01179347|1156072|P2|STARTED|Double-blind Period (12 Weeks)|Entered and treated in double-blind period.|308
471884|NCT01179347|1156073|P1|STARTED|Double-blind Period (12 Weeks)|Entered and treated in double-blind period.|155
471885|NCT01179334|1156095|P2|NOT COMPLETED|Long-term Extension (LTE) Period||6
471886|NCT01179334|1156096|P1|NOT COMPLETED|Long-term Extension (LTE) Period||11
471887|NCT01179334|1156095|P2|COMPLETED|Long-term Extension (LTE) Period|LTE phase was terminated by sponsor|0
471888|NCT01179334|1156096|P1|COMPLETED|Long-term Extension (LTE) Period|LTE phase was terminated by sponsor|0
471889|NCT01179334|1156095|P2|STARTED|Long-term Extension (LTE) Period||6
471890|NCT01179334|1156096|P1|STARTED|Long-term Extension (LTE) Period||11
471891|NCT01179334|1156095|P2|NOT COMPLETED|Treatment Period||0
471892|NCT01179334|1156096|P1|NOT COMPLETED|Treatment Period||1
471893|NCT01179334|1156095|P2|COMPLETED|Treatment Period||6
471894|NCT01179334|1156096|P1|COMPLETED|Treatment Period||11
471895|NCT01179334|1156095|P2|Participants Received Treatment|Treatment Period||6
471896|NCT01179334|1156096|P1|Participants Received Treatment|Treatment Period||12
471897|NCT01179334|1156095|P2|STARTED|Treatment Period||6
471898|NCT01179334|1156096|P1|STARTED|Treatment Period||12
471899|NCT01179217|1156126|P2|NOT COMPLETED|Overall Study||19
471900|NCT01179217|1156127|P1|NOT COMPLETED|Overall Study||55
471901|NCT01179217|1156126|P2|COMPLETED|Overall Study||59
471902|NCT01179217|1156127|P1|COMPLETED|Overall Study||97
471903|NCT01179217|1156126|P2|STARTED|Overall Study||78
471904|NCT01179217|1156127|P1|STARTED|Overall Study||152
471905|NCT01179191|1156151|P1|NOT COMPLETED|Maintenance Phase (8 Weeks)||117
471906|NCT01179191|1156151|P1|COMPLETED|Maintenance Phase (8 Weeks)||234
471907|NCT01179191|1156151|P1|STARTED|Maintenance Phase (8 Weeks)||351
471908|NCT01179191|1156151|P1|NOT COMPLETED|Titration Phase (up to 6 Weeks)||333
471909|NCT01179191|1156151|P1|COMPLETED|Titration Phase (up to 6 Weeks)||351
471910|NCT01179191|1156151|P1|STARTED|Titration Phase (up to 6 Weeks)||684
471911|NCT01179113|1156170|P2|NOT COMPLETED|Overall Study||0
471912|NCT01179113|1156171|P1|NOT COMPLETED|Overall Study||0
471913|NCT01179113|1156170|P2|COMPLETED|Overall Study||16
471914|NCT01179113|1156171|P1|COMPLETED|Overall Study||17
471915|NCT01179113|1156170|P2|STARTED|Overall Study||16
471916|NCT01179113|1156171|P1|STARTED|Overall Study||17
471917|NCT01179048|1156183|P2|NOT COMPLETED|Overall Study||159
471918|NCT01179048|1156184|P1|NOT COMPLETED|Overall Study||139
471919|NCT01179048|1156183|P2|COMPLETED|Overall Study||4513
471920|NCT01179048|1156184|P1|COMPLETED|Overall Study||4529
471921|NCT01179048|1156183|P2|STARTED|Overall Study||4672
471922|NCT01179048|1156184|P1|STARTED|Overall Study||4668
471923|NCT01178944|1156200|P1|NOT COMPLETED|Overall Study||0
471924|NCT01178944|1156200|P1|COMPLETED|Overall Study||35
471925|NCT01178944|1156200|P1|STARTED|Overall Study||35
471926|NCT01178853|1156211|P2|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||3
471927|NCT01178853|1156212|P1|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||0
471928|NCT01178853|1156211|P2|COMPLETED|Period 4 (Warfarin + Study Drug)||19
471929|NCT01178853|1156212|P1|COMPLETED|Period 4 (Warfarin + Study Drug)||21
471930|NCT01178853|1156211|P2|STARTED|Period 4 (Warfarin + Study Drug)||22
471931|NCT01178853|1156212|P1|STARTED|Period 4 (Warfarin + Study Drug)||21
471932|NCT01178853|1156211|P2|NOT COMPLETED|Period 3 (Warfarin Titration)||0
471933|NCT01178853|1156212|P1|NOT COMPLETED|Period 3 (Warfarin Titration)||1
471934|NCT01178853|1156211|P2|COMPLETED|Period 3 (Warfarin Titration)||22
471935|NCT01178853|1156212|P1|COMPLETED|Period 3 (Warfarin Titration)||21
471936|NCT01178853|1156211|P2|STARTED|Period 3 (Warfarin Titration)||22
471937|NCT01178853|1156212|P1|STARTED|Period 3 (Warfarin Titration)||22
471938|NCT01178853|1156211|P2|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||0
471939|NCT01178853|1156212|P1|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||1
471940|NCT01178853|1156211|P2|COMPLETED|Period 2 (Warfarin + Study Drug)||22
471941|NCT01178853|1156212|P1|COMPLETED|Period 2 (Warfarin + Study Drug)||22
471942|NCT01178853|1156211|P2|STARTED|Period 2 (Warfarin + Study Drug)||22
471943|NCT01178853|1156212|P1|STARTED|Period 2 (Warfarin + Study Drug)||23
471944|NCT01178853|1156211|P2|NOT COMPLETED|Period 1 (Warfarin Titration)||2
471945|NCT01178853|1156212|P1|NOT COMPLETED|Period 1 (Warfarin Titration)||1
471946|NCT01178853|1156211|P2|COMPLETED|Period 1 (Warfarin Titration)||22
471947|NCT01178853|1156212|P1|COMPLETED|Period 1 (Warfarin Titration)||23
471948|NCT01178853|1156211|P2|STARTED|Period 1 (Warfarin Titration)||24
471949|NCT01178853|1156212|P1|STARTED|Period 1 (Warfarin Titration)||24
471950|NCT01178827|1156221|P3|NOT COMPLETED|Overall Study||0
471951|NCT01178827|1156222|P2|NOT COMPLETED|Overall Study||0
471952|NCT01178827|1156223|P1|NOT COMPLETED|Overall Study||0
471953|NCT01178827|1156221|P3|COMPLETED|Overall Study||4
471954|NCT01178827|1156222|P2|COMPLETED|Overall Study||10
471955|NCT01178827|1156223|P1|COMPLETED|Overall Study||6
471956|NCT01178827|1156221|P3|STARTED|Overall Study||4
471957|NCT01178827|1156222|P2|STARTED|Overall Study||10
471958|NCT01178827|1156223|P1|STARTED|Overall Study||6
471959|NCT01178762|1156252|P1|NOT COMPLETED|Overall Study||15
471960|NCT01178762|1156252|P1|COMPLETED|Overall Study||27
471961|NCT01178762|1156252|P1|STARTED|Overall Study||42
471962|NCT01178671|1156258|P2|NOT COMPLETED|Overall Study||15
471963|NCT01178671|1156259|P1|NOT COMPLETED|Overall Study||12
471964|NCT01178671|1156258|P2|COMPLETED|Overall Study||3
471965|NCT01178671|1156259|P1|COMPLETED|Overall Study||6
471966|NCT01178671|1156258|P2|STARTED|Overall Study||18
471967|NCT01178671|1156259|P1|STARTED|Overall Study||18
471968|NCT01178528|1156286|P3|NOT COMPLETED|Overall Study||0
471969|NCT01178528|1156287|P2|NOT COMPLETED|Overall Study||0
471970|NCT01178528|1156288|P1|NOT COMPLETED|Overall Study||0
471971|NCT01178528|1156286|P3|COMPLETED|Overall Study||42
471972|NCT01178528|1156287|P2|COMPLETED|Overall Study||38
471973|NCT01178528|1156288|P1|COMPLETED|Overall Study||41
471974|NCT01178528|1156286|P3|STARTED|Overall Study||42
471975|NCT01178528|1156287|P2|STARTED|Overall Study||38
471976|NCT01178528|1156288|P1|STARTED|Overall Study||41
471977|NCT01178385|1156307|P2|NOT COMPLETED|Overall Study||0
471978|NCT01178385|1156308|P1|NOT COMPLETED|Overall Study||2
471979|NCT01178385|1156307|P2|COMPLETED|Overall Study||21
471980|NCT01178385|1156308|P1|COMPLETED|Overall Study||22
471981|NCT01178385|1156307|P2|STARTED|Overall Study||21
471982|NCT01178385|1156308|P1|STARTED|Overall Study||24
471983|NCT01178333|1156321|P3|NOT COMPLETED|Overall Study||0
471984|NCT01178333|1156322|P2|NOT COMPLETED|Overall Study||0
471985|NCT01178333|1156323|P1|NOT COMPLETED|Overall Study||0
471986|NCT01178333|1156321|P3|COMPLETED|Overall Study||87
471987|NCT01178333|1156322|P2|COMPLETED|Overall Study||284
471988|NCT01178333|1156323|P1|COMPLETED|Overall Study||71
471989|NCT01178333|1156321|P3|STARTED|Overall Study||87
471990|NCT01178333|1156322|P2|STARTED|Overall Study||284
471991|NCT01178333|1156323|P1|STARTED|Overall Study||71
471992|NCT01178294|1156377|P1|NOT COMPLETED|Overall Study||11
471993|NCT01178294|1156377|P1|COMPLETED|Overall Study||18
471994|NCT01178294|1156377|P1|STARTED|Overall Study|25 subjects enrolled under OBI-1-301 + 4 subjects enrolled under expanded access OBI-1-301a.|29
471995|NCT01178281|1156400|P2|NOT COMPLETED|Overall Study||77
471996|NCT01178281|1156401|P1|NOT COMPLETED|Overall Study||149
471997|NCT01178281|1156400|P2|COMPLETED|Overall Study|Participants remain on treatment|7
471998|NCT01178281|1156401|P1|COMPLETED|Overall Study|Participants remain on treatment|19
471999|NCT01178281|1156400|P2|STARTED|Overall Study|Intent to Treat Population (ITT)|84
472000|NCT01178281|1156401|P1|STARTED|Overall Study|Intent to Treat Population (ITT)|168
472001|NCT01178268|1156409|P2|NOT COMPLETED|Overall Study||1
472002|NCT01178268|1156410|P1|NOT COMPLETED|Overall Study||7
472003|NCT01178268|1156409|P2|COMPLETED|Overall Study||120
472004|NCT01178268|1156410|P1|COMPLETED|Overall Study||360
472005|NCT01178268|1156409|P2|STARTED|Overall Study||121
472006|NCT01178268|1156410|P1|STARTED|Overall Study||367
472007|NCT01178138|1156627|P1|NOT COMPLETED|Overall Study||23
472008|NCT01178138|1156627|P1|COMPLETED|Overall Study||1
472009|NCT01178138|1156627|P1|Completed 3 Sessions|Overall Study||1
472010|NCT01178138|1156627|P1|Completed 5 Sessions|Overall Study||1
472011|NCT01178138|1156627|P1|Completed 6 Sessions|Overall Study||1
472012|NCT01178138|1156627|P1|STARTED|Overall Study||24
472013|NCT01178125|1156648|P1|NOT COMPLETED|Overall Study||1178
472014|NCT01178125|1156648|P1|COMPLETED|Overall Study||1680
472015|NCT01178125|1156648|P1|Pregnancy ITT (PITT) Population|Overall Study|Participants in the ITT population between the ages of 18 and 35, inclusive.|2401
472016|NCT01178125|1156648|P1|Intent to Treat (ITT) Population|Overall Study|Completed at least one 28-day cycle of investigational product.|2607
472017|NCT01178125|1156648|P1|Safety Population|Overall Study|Received at least 1 dose of DR-102.|2765
472018|NCT01178125|1156648|P1|STARTED|Overall Study|Number enrolled.|2858
472019|NCT01178099|1156679|P2|NOT COMPLETED|Overall Study||1
472020|NCT01178099|1156680|P1|NOT COMPLETED|Overall Study||0
472021|NCT01178099|1156679|P2|COMPLETED|Overall Study||12
472022|NCT01178099|1156680|P1|COMPLETED|Overall Study||13
472023|NCT01178099|1156679|P2|STARTED|Overall Study||13
472024|NCT01178099|1156680|P1|STARTED|Overall Study||13
472025|NCT01178073|1156721|P3|NOT COMPLETED|Overall Study||46
472026|NCT01178073|1156722|P2|NOT COMPLETED|Overall Study||44
472027|NCT01178073|1156723|P1|NOT COMPLETED|Overall Study||62
472028|NCT01178073|1156721|P3|COMPLETED|Overall Study||105
472029|NCT01178073|1156722|P2|COMPLETED|Overall Study||108
472030|NCT01178073|1156723|P1|COMPLETED|Overall Study||240
472031|NCT01178073|1156721|P3|STARTED|Overall Study||151
472032|NCT01178073|1156722|P2|STARTED|Overall Study||152
472033|NCT01178073|1156723|P1|STARTED|Overall Study||302
472034|NCT01177969|1156754|P2|NOT COMPLETED|Overall Study||3
472035|NCT01177969|1156755|P1|NOT COMPLETED|Overall Study||3
472036|NCT01177969|1156754|P2|COMPLETED|Overall Study||11
472037|NCT01177969|1156755|P1|COMPLETED|Overall Study||16
472038|NCT01177969|1156754|P2|STARTED|Overall Study||14
472039|NCT01177969|1156755|P1|STARTED|Overall Study||19
472040|NCT01177956|1156763|P1|NOT COMPLETED|Overall Study||0
472041|NCT01177956|1156763|P1|COMPLETED|Overall Study||68
472042|NCT01177956|1156763|P1|STARTED|Overall Study||68
472043|NCT01177943|1156778|P2|NOT COMPLETED|Second Intervention||0
472044|NCT01177943|1156779|P1|NOT COMPLETED|Second Intervention||0
472045|NCT01177943|1156778|P2|COMPLETED|Second Intervention||21
472046|NCT01177943|1156779|P1|COMPLETED|Second Intervention||19
472047|NCT01177943|1156778|P2|STARTED|Second Intervention||21
472048|NCT01177943|1156779|P1|STARTED|Second Intervention||19
472049|NCT01177943|1156778|P2|NOT COMPLETED|First Intervention||0
472050|NCT01177943|1156779|P1|NOT COMPLETED|First Intervention||2
472051|NCT01177943|1156778|P2|COMPLETED|First Intervention||21
472052|NCT01177943|1156779|P1|COMPLETED|First Intervention||19
472053|NCT01177943|1156778|P2|STARTED|First Intervention||21
472054|NCT01177943|1156779|P1|STARTED|First Intervention||21
472055|NCT01177813|1156792|P5|NOT COMPLETED|Overall Study||9
472056|NCT01177813|1156793|P4|NOT COMPLETED|Overall Study||17
472057|NCT01177813|1156794|P3|NOT COMPLETED|Overall Study||20
472058|NCT01177813|1156795|P2|NOT COMPLETED|Overall Study||18
472059|NCT01177813|1156796|P1|NOT COMPLETED|Overall Study||41
472060|NCT01177813|1156792|P5|COMPLETED|Overall Study||78
472061|NCT01177813|1156793|P4|COMPLETED|Overall Study||206
472062|NCT01177813|1156794|P3|COMPLETED|Overall Study||204
472063|NCT01177813|1156795|P2|COMPLETED|Overall Study||206
472064|NCT01177813|1156796|P1|COMPLETED|Overall Study||187
472065|NCT01177813|1156792|P5|STARTED|Overall Study||87
472066|NCT01177813|1156793|P4|STARTED|Overall Study||223
472067|NCT01177813|1156794|P3|STARTED|Overall Study||224
472068|NCT01177813|1156795|P2|STARTED|Overall Study||224
472069|NCT01177813|1156796|P1|STARTED|Overall Study||228
472070|NCT01177800|1156825|P2|NOT COMPLETED|Overall Study||5
472071|NCT01177800|1156826|P1|NOT COMPLETED|Overall Study||10
472072|NCT01177800|1156825|P2|COMPLETED|Overall Study||40
472073|NCT01177800|1156826|P1|COMPLETED|Overall Study||74
472074|NCT01177800|1156825|P2|STARTED|Overall Study||45
472075|NCT01177800|1156826|P1|STARTED|Overall Study||84
472076|NCT01177735|1156840|P1|NOT COMPLETED|Overall Study||71
472077|NCT01177735|1156840|P1|COMPLETED|Overall Study||0
472078|NCT01177735|1156840|P1|STARTED|Overall Study||71
472079|NCT01177722|1156848|P4|NOT COMPLETED|Overall Study||7
472080|NCT01177722|1156849|P3|NOT COMPLETED|Overall Study||9
472081|NCT01177722|1156850|P2|NOT COMPLETED|Overall Study||10
472082|NCT01177722|1156851|P1|NOT COMPLETED|Overall Study||13
472083|NCT01177722|1156848|P4|COMPLETED|Overall Study||338
472084|NCT01177722|1156849|P3|COMPLETED|Overall Study||333
472085|NCT01177722|1156850|P2|COMPLETED|Overall Study||334
472086|NCT01177722|1156851|P1|COMPLETED|Overall Study||331
472087|NCT01177722|1156848|P4|STARTED|Overall Study||345
472088|NCT01177722|1156849|P3|STARTED|Overall Study||342
472089|NCT01177722|1156850|P2|STARTED|Overall Study|A randomized participant got Batch A vaccine, analyses was according to actual vaccine administered.|344
472090|NCT01177722|1156851|P1|STARTED|Overall Study|A Batch B participant got Batch A vaccine data analyses was according to actual vaccine administered|344
472091|NCT01177709|1156877|P1|NOT COMPLETED|Overall Study||0
472092|NCT01177709|1156877|P1|COMPLETED|Overall Study||12
472093|NCT01177709|1156877|P1|STARTED|Overall Study||12
472094|NCT01177670|1156883|P1|NOT COMPLETED|Overall Study||169
472095|NCT01177670|1156883|P1|COMPLETED|Overall Study||0
472096|NCT01177670|1156883|P1|STARTED|Overall Study||169
472097|NCT01177553|1156890|P2|NOT COMPLETED|Overall Study||0
472098|NCT01177553|1156891|P1|NOT COMPLETED|Overall Study||1
472099|NCT01177553|1156890|P2|COMPLETED|Overall Study|data as of March 2009|2
472100|NCT01177553|1156891|P1|COMPLETED|Overall Study|data as of March 2009|2
472101|NCT01177553|1156890|P2|STARTED|Overall Study||2
472102|NCT01177553|1156891|P1|STARTED|Overall Study||3
472103|NCT01177410|1156900|P3|NOT COMPLETED|Overall Study||5
472104|NCT01177410|1156901|P2|NOT COMPLETED|Overall Study||7
472105|NCT01177410|1156902|P1|NOT COMPLETED|Overall Study||1
472106|NCT01177410|1156900|P3|COMPLETED|Overall Study||45
472107|NCT01177410|1156901|P2|COMPLETED|Overall Study||40
472108|NCT01177410|1156902|P1|COMPLETED|Overall Study||50
472109|NCT01177410|1156900|P3|STARTED|Overall Study||50
472110|NCT01177410|1156901|P2|STARTED|Overall Study||47
472111|NCT01177410|1156902|P1|STARTED|Overall Study||51
472112|NCT01177384|1156915|P2|NOT COMPLETED|Overall Study||26
472113|NCT01177384|1156916|P1|NOT COMPLETED|Overall Study||14
472114|NCT01177384|1156915|P2|COMPLETED|Overall Study||164
472115|NCT01177384|1156916|P1|COMPLETED|Overall Study||177
472116|NCT01177384|1156915|P2|STARTED|Overall Study|Includes the second randomization of a participant|190
472117|NCT01177384|1156916|P1|STARTED|Overall Study||191
472118|NCT01177293|1156928|P2|NOT COMPLETED|Second Intervention Period||0
472119|NCT01177293|1156929|P1|NOT COMPLETED|Second Intervention Period||0
472120|NCT01177293|1156928|P2|COMPLETED|Second Intervention Period||6
472121|NCT01177293|1156929|P1|COMPLETED|Second Intervention Period||7
472122|NCT01177293|1156928|P2|STARTED|Second Intervention Period||6
472123|NCT01177293|1156929|P1|STARTED|Second Intervention Period||7
472124|NCT01177293|1156928|P2|NOT COMPLETED|Washout Period (of 14 Days)||1
472125|NCT01177293|1156929|P1|NOT COMPLETED|Washout Period (of 14 Days)||0
472126|NCT01177293|1156928|P2|COMPLETED|Washout Period (of 14 Days)||6
472127|NCT01177293|1156929|P1|COMPLETED|Washout Period (of 14 Days)||7
472128|NCT01177293|1156928|P2|STARTED|Washout Period (of 14 Days)||7
472129|NCT01177293|1156929|P1|STARTED|Washout Period (of 14 Days)||7
472130|NCT01177293|1156928|P2|NOT COMPLETED|First Intervention Period||0
472131|NCT01177293|1156929|P1|NOT COMPLETED|First Intervention Period||0
472132|NCT01177293|1156928|P2|COMPLETED|First Intervention Period||7
472133|NCT01177293|1156929|P1|COMPLETED|First Intervention Period||7
472134|NCT01177293|1156928|P2|STARTED|First Intervention Period||7
472135|NCT01177293|1156929|P1|STARTED|First Intervention Period||7
472136|NCT01177228|1156947|P4|NOT COMPLETED|Overall Study||0
472137|NCT01177228|1156948|P3|NOT COMPLETED|Overall Study||0
472138|NCT01177228|1156949|P2|NOT COMPLETED|Overall Study||2
472139|NCT01177228|1156950|P1|NOT COMPLETED|Overall Study||1
472140|NCT01177228|1156947|P4|COMPLETED|Overall Study||11
472141|NCT01177228|1156948|P3|COMPLETED|Overall Study||14
472142|NCT01177228|1156949|P2|COMPLETED|Overall Study||11
472143|NCT01177228|1156950|P1|COMPLETED|Overall Study||8
472144|NCT01177228|1156947|P4|Received Treatment|Overall Study||11
472145|NCT01177228|1156948|P3|Received Treatment|Overall Study||14
472146|NCT01177228|1156949|P2|Received Treatment|Overall Study||12
472147|NCT01177228|1156950|P1|Received Treatment|Overall Study||9
472148|NCT01177228|1156947|P4|STARTED|Overall Study||11
472149|NCT01177228|1156948|P3|STARTED|Overall Study||14
472150|NCT01177228|1156949|P2|STARTED|Overall Study||13
472151|NCT01177228|1156950|P1|STARTED|Overall Study||9
472152|NCT01177098|1156990|P2|NOT COMPLETED|Overall Study||12
472153|NCT01177098|1156991|P1|NOT COMPLETED|Overall Study||9
472154|NCT01177098|1156990|P2|COMPLETED|Overall Study||271
472155|NCT01177098|1156991|P1|COMPLETED|Overall Study||269
472156|NCT01177098|1156990|P2|STARTED|Overall Study||283
472157|NCT01177098|1156991|P1|STARTED|Overall Study||278
472158|NCT01177007|1157007|P1|NOT COMPLETED|Overall Study||38
472159|NCT01177007|1157007|P1|COMPLETED|Overall Study||12
472160|NCT01177007|1157007|P1|Completed First Clinical and Imaging|Overall Study||43
472161|NCT01177007|1157007|P1|Completed First Y90 Treatment|Overall Study||50
472162|NCT01177007|1157007|P1|STARTED|Overall Study||50
472163|NCT01176968|1157021|P2|NOT COMPLETED|Overall Study||82
472164|NCT01176968|1157022|P1|NOT COMPLETED|Overall Study||84
472165|NCT01176968|1157021|P2|COMPLETED|Overall Study||424
472166|NCT01176968|1157022|P1|COMPLETED|Overall Study||422
472167|NCT01176968|1157021|P2|Treated|Overall Study||505
472168|NCT01176968|1157022|P1|Treated|Overall Study||505
472169|NCT01176968|1157021|P2|STARTED|Overall Study||506
472170|NCT01176968|1157022|P1|STARTED|Overall Study||506
472171|NCT01176955|1157056|P2|NOT COMPLETED|Overall Study||2
472172|NCT01176955|1157057|P1|NOT COMPLETED|Overall Study||3
472173|NCT01176955|1157056|P2|COMPLETED|Overall Study||8
472174|NCT01176955|1157057|P1|COMPLETED|Overall Study||7
472175|NCT01176955|1157056|P2|STARTED|Overall Study||10
472176|NCT01176955|1157057|P1|STARTED|Overall Study||10
472177|NCT01176877|1157068|P1|NOT COMPLETED|Overall Study||9
472178|NCT01176877|1157068|P1|COMPLETED|Overall Study||31
472179|NCT01176877|1157068|P1|STARTED|Overall Study||40
472180|NCT01176773|1157073|P1|NOT COMPLETED|Overall Study||3
472181|NCT01176773|1157073|P1|COMPLETED|Overall Study||59
472182|NCT01176773|1157073|P1|STARTED|Overall Study||62
472183|NCT01176617|1157084|P3|NOT COMPLETED|6 - 12 Months (Randomized)||0
472184|NCT01176617|1157085|P2|NOT COMPLETED|6 - 12 Months (Randomized)||0
472185|NCT01176617|1157086|P1|NOT COMPLETED|6 - 12 Months (Randomized)||5
472186|NCT01176617|1157084|P3|COMPLETED|6 - 12 Months (Randomized)||0
472187|NCT01176617|1157085|P2|COMPLETED|6 - 12 Months (Randomized)||20
472188|NCT01176617|1157086|P1|COMPLETED|6 - 12 Months (Randomized)||13
472189|NCT01176617|1157084|P3|STARTED|6 - 12 Months (Randomized)||0
472190|NCT01176617|1157085|P2|STARTED|6 - 12 Months (Randomized)||20
472191|NCT01176617|1157086|P1|STARTED|6 - 12 Months (Randomized)||18
472192|NCT01176617|1157084|P3|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
472193|NCT01176617|1157085|P2|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
472194|NCT01176617|1157086|P1|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
472195|NCT01176617|1157084|P3|COMPLETED|1 - 6 Months (Ron-randomized)||38
472196|NCT01176617|1157085|P2|COMPLETED|1 - 6 Months (Ron-randomized)||0
472197|NCT01176617|1157086|P1|COMPLETED|1 - 6 Months (Ron-randomized)||0
472198|NCT01176617|1157084|P3|STARTED|1 - 6 Months (Ron-randomized)||38
472199|NCT01176617|1157085|P2|STARTED|1 - 6 Months (Ron-randomized)||0
472200|NCT01176617|1157086|P1|STARTED|1 - 6 Months (Ron-randomized)||0
472201|NCT01176565|1157097|P2|NOT COMPLETED|Overall Study||19
472202|NCT01176565|1157098|P1|NOT COMPLETED|Overall Study||20
472203|NCT01176565|1157097|P2|COMPLETED|Overall Study||481
472204|NCT01176565|1157098|P1|COMPLETED|Overall Study||480
472205|NCT01176565|1157097|P2|STARTED|Overall Study||500
472206|NCT01176565|1157098|P1|STARTED|Overall Study||500
472207|NCT01176513|1157116|P1|NOT COMPLETED|Overall Study||3
472208|NCT01176513|1157116|P1|COMPLETED|Overall Study||22
472209|NCT01176513|1157116|P1|STARTED|Overall Study||25
472210|NCT01176448|1157121|P1|NOT COMPLETED|Overall Study||0
472211|NCT01176448|1157121|P1|COMPLETED|Overall Study||6
472212|NCT01176448|1157121|P1|STARTED|Overall Study||6
472213|NCT01176435|1157132|P3|NOT COMPLETED|Overall Study||0
472214|NCT01176435|1157133|P2|NOT COMPLETED|Overall Study||0
472215|NCT01176435|1157134|P1|NOT COMPLETED|Overall Study||0
472216|NCT01176435|1157132|P3|COMPLETED|Overall Study||15
472217|NCT01176435|1157133|P2|COMPLETED|Overall Study||15
472218|NCT01176435|1157134|P1|COMPLETED|Overall Study||15
472219|NCT01176435|1157132|P3|STARTED|Overall Study||15
472220|NCT01176435|1157133|P2|STARTED|Overall Study||15
472221|NCT01176435|1157134|P1|STARTED|Overall Study||15
472222|NCT01176292|1157144|P2|NOT COMPLETED|Overall Study||9
472223|NCT01176292|1157145|P1|NOT COMPLETED|Overall Study||5
472224|NCT01176292|1157144|P2|COMPLETED|Overall Study||62
472225|NCT01176292|1157145|P1|COMPLETED|Overall Study||66
472226|NCT01176292|1157144|P2|STARTED|Overall Study||71
472227|NCT01176292|1157145|P1|STARTED|Overall Study||71
472228|NCT01176266|1157163|P1|NOT COMPLETED|Overall Study||9
472229|NCT01176266|1157163|P1|COMPLETED|Overall Study||60
472230|NCT01176266|1157163|P1|STARTED|Overall Study||69
472231|NCT01176240|1157187|P2|NOT COMPLETED|Study 306B||17
472232|NCT01176240|1157188|P1|NOT COMPLETED|Study 306B||26
472233|NCT01176240|1157187|P2|COMPLETED|Study 306B||68
472234|NCT01176240|1157188|P1|COMPLETED|Study 306B||63
472235|NCT01176240|1157187|P2|4 wk of Stable Dosing and Visit 6|Study 306B||73
472236|NCT01176240|1157188|P1|4 wk of Stable Dosing and Visit 6|Study 306B||67
472237|NCT01176240|1157187|P2|2 wk of Stable Dosing and Visit 5|Study 306B||75
472238|NCT01176240|1157188|P1|2 wk of Stable Dosing and Visit 5|Study 306B||68
472239|NCT01176240|1157187|P2|1 wk of Stable Dosing and Visit 4|Study 306B||78
472240|NCT01176240|1157188|P1|1 wk of Stable Dosing and Visit 4|Study 306B||69
472241|NCT01176240|1157187|P2|Took at Least 1 Dose of Study Drug|Study 306B|One randomized patient discontinued before receiving study drug.|84
472242|NCT01176240|1157188|P1|Took at Least 1 Dose of Study Drug|Study 306B|Two randomized patients discontinued before receiving study drug.|87
472243|NCT01176240|1157187|P2|STARTED|Study 306B||85
472244|NCT01176240|1157188|P1|STARTED|Study 306B||89
472245|NCT01176240|1157187|P2|NOT COMPLETED|Study 306A||3
472246|NCT01176240|1157188|P1|NOT COMPLETED|Study 306A||3
472247|NCT01176240|1157187|P2|COMPLETED|Study 306A||24
472248|NCT01176240|1157188|P1|COMPLETED|Study 306A||21
472249|NCT01176240|1157187|P2|STARTED|Study 306A||27
472250|NCT01176240|1157188|P1|STARTED|Study 306A||24
472251|NCT01176058|1157214|P2|NOT COMPLETED|Overall Study||3
472252|NCT01176058|1157215|P1|NOT COMPLETED|Overall Study||4
472253|NCT01176058|1157214|P2|COMPLETED|Overall Study||5
472254|NCT01176058|1157215|P1|COMPLETED|Overall Study||5
472255|NCT01176058|1157214|P2|STARTED|Overall Study||8
472256|NCT01176058|1157215|P1|STARTED|Overall Study||9
472257|NCT01176032|1157239|P2|NOT COMPLETED|Overall Study||1
472258|NCT01176032|1157240|P1|NOT COMPLETED|Overall Study||6
472259|NCT01176032|1157239|P2|COMPLETED|Overall Study||36
472260|NCT01176032|1157240|P1|COMPLETED|Overall Study||31
472261|NCT01176032|1157239|P2|Intention-to-treat (ITT) Population|Overall Study||37
472262|NCT01176032|1157240|P1|Intention-to-treat (ITT) Population|Overall Study||32
472263|NCT01176032|1157239|P2|STARTED|Overall Study||37
472264|NCT01176032|1157240|P1|STARTED|Overall Study|"Started indicates randomized and safety population"|37
472265|NCT01175902|1157300|P2|NOT COMPLETED|Overall Study||0
472266|NCT01175902|1157301|P1|NOT COMPLETED|Overall Study||0
472267|NCT01175902|1157300|P2|COMPLETED|Overall Study||22
472268|NCT01175902|1157301|P1|COMPLETED|Overall Study||22
472269|NCT01175902|1157300|P2|STARTED|Overall Study||22
472270|NCT01175902|1157301|P1|STARTED|Overall Study||22
472271|NCT01175850|1157319|P2|NOT COMPLETED|IN.PACT SFA II Phase||5
472272|NCT01175850|1157320|P1|NOT COMPLETED|IN.PACT SFA II Phase||12
472273|NCT01175850|1157319|P2|COMPLETED|IN.PACT SFA II Phase||55
472274|NCT01175850|1157320|P1|COMPLETED|IN.PACT SFA II Phase||109
472275|NCT01175850|1157319|P2|STARTED|IN.PACT SFA II Phase||60
472276|NCT01175850|1157320|P1|STARTED|IN.PACT SFA II Phase||121
472277|NCT01175850|1157319|P2|NOT COMPLETED|IN.PACT SFA I Phase||2
472278|NCT01175850|1157320|P1|NOT COMPLETED|IN.PACT SFA I Phase||11
472279|NCT01175850|1157319|P2|COMPLETED|IN.PACT SFA I Phase||49
472280|NCT01175850|1157320|P1|COMPLETED|IN.PACT SFA I Phase||88
472281|NCT01175850|1157319|P2|STARTED|IN.PACT SFA I Phase||51
472282|NCT01175850|1157320|P1|STARTED|IN.PACT SFA I Phase||99
472283|NCT01175824|1157364|P2|NOT COMPLETED|Overall Study||22
472284|NCT01175824|1157365|P1|NOT COMPLETED|Overall Study||16
472285|NCT01175824|1157364|P2|COMPLETED|Overall Study||220
472286|NCT01175824|1157365|P1|COMPLETED|Overall Study||220
472287|NCT01175824|1157364|P2|Received at Least 1 Dose of Study Drug|Overall Study||240
472288|NCT01175824|1157365|P1|Received at Least 1 Dose of Study Drug|Overall Study||236
472289|NCT01175824|1157364|P2|STARTED|Overall Study||242
472290|NCT01175824|1157365|P1|STARTED|Overall Study||236
472291|NCT01175811|1157399|P2|NOT COMPLETED|Overall Study||14
472292|NCT01175811|1157400|P1|NOT COMPLETED|Overall Study||16
472293|NCT01175811|1157399|P2|COMPLETED|Overall Study||189
472294|NCT01175811|1157400|P1|COMPLETED|Overall Study||183
472295|NCT01175811|1157399|P2|Received at Least 1 Dose of Study Drug|Overall Study||202
472296|NCT01175811|1157400|P1|Received at Least 1 Dose of Study Drug|Overall Study||197
472297|NCT01175811|1157399|P2|STARTED|Overall Study||203
472298|NCT01175811|1157400|P1|STARTED|Overall Study||199
472299|NCT01175798|1157426|P2|NOT COMPLETED|Overall Study||21
472300|NCT01175798|1157427|P1|NOT COMPLETED|Overall Study||7
472301|NCT01175798|1157426|P2|COMPLETED|Overall Study||41
472302|NCT01175798|1157427|P1|COMPLETED|Overall Study||27
472303|NCT01175798|1157426|P2|STARTED|Overall Study||62
472304|NCT01175798|1157427|P1|STARTED|Overall Study||34
472305|NCT01175707|1157435|P2|NOT COMPLETED|Overall Study||6
472306|NCT01175707|1157436|P1|NOT COMPLETED|Overall Study||4
472307|NCT01175707|1157435|P2|COMPLETED|Overall Study||34
472308|NCT01175707|1157436|P1|COMPLETED|Overall Study||36
472309|NCT01175707|1157435|P2|STARTED|Overall Study||40
472310|NCT01175707|1157436|P1|STARTED|Overall Study||40
472311|NCT01175668|1157472|P2|NOT COMPLETED|Overall Study||0
472312|NCT01175668|1157473|P1|NOT COMPLETED|Overall Study||2
472313|NCT01175668|1157472|P2|COMPLETED|Overall Study||34
472314|NCT01175668|1157473|P1|COMPLETED|Overall Study||32
472315|NCT01175668|1157472|P2|STARTED|Overall Study||34
472316|NCT01175668|1157473|P1|STARTED|Overall Study||34
472317|NCT01175590|1157483|P2|NOT COMPLETED|Overall Study||10
472318|NCT01175590|1157484|P1|NOT COMPLETED|Overall Study||12
472319|NCT01175590|1157483|P2|COMPLETED|Overall Study||161
472320|NCT01175590|1157484|P1|COMPLETED|Overall Study||335
472321|NCT01175590|1157483|P2|Safety Population|Overall Study||170
472322|NCT01175590|1157484|P1|Safety Population|Overall Study||344
472323|NCT01175590|1157483|P2|Modified Intent to Treat Population|Overall Study||87
472324|NCT01175590|1157484|P1|Modified Intent to Treat Population|Overall Study||212
472325|NCT01175590|1157483|P2|STARTED|Overall Study||171
472326|NCT01175590|1157484|P1|STARTED|Overall Study||347
472327|NCT01175473|1157518|P2|NOT COMPLETED|Overall Study||2
472328|NCT01175473|1157519|P1|NOT COMPLETED|Overall Study||2
472329|NCT01175473|1157518|P2|COMPLETED|Overall Study||69
472330|NCT01175473|1157519|P1|COMPLETED|Overall Study||75
472331|NCT01175473|1157518|P2|Pharmacodynamic (PD) Population|Overall Study||68
472332|NCT01175473|1157519|P1|Pharmacodynamic (PD) Population|Overall Study|All patients who received at least 1 dose; had baseline and at least 1 post-baseline PD assessment.|75
472333|NCT01175473|1157518|P2|Safety Population|Overall Study||71
472334|NCT01175473|1157519|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|77
472335|NCT01175473|1157518|P2|STARTED|Overall Study||71
472336|NCT01175473|1157519|P1|STARTED|Overall Study|Randomized and treated.|77
472337|NCT01175434|1157545|P2|NOT COMPLETED|Overall Study||0
472338|NCT01175434|1157546|P1|NOT COMPLETED|Overall Study||0
472339|NCT01175434|1157545|P2|COMPLETED|Overall Study||51
472340|NCT01175434|1157546|P1|COMPLETED|Overall Study||48
472341|NCT01175434|1157545|P2|STARTED|Overall Study||51
472342|NCT01175434|1157546|P1|STARTED|Overall Study||48
472343|NCT01175395|1157552|P1|NOT COMPLETED|Overall Study||0
472344|NCT01175395|1157552|P1|COMPLETED|Overall Study||10
472345|NCT01175395|1157552|P1|STARTED|Overall Study||10
472346|NCT01175382|1157560|P3|NOT COMPLETED|Overall Study||6
472347|NCT01175382|1157561|P2|NOT COMPLETED|Overall Study||7
472348|NCT01175382|1157562|P1|NOT COMPLETED|Overall Study||8
472349|NCT01175382|1157560|P3|COMPLETED|Overall Study||59
472350|NCT01175382|1157561|P2|COMPLETED|Overall Study||61
472351|NCT01175382|1157562|P1|COMPLETED|Overall Study||63
472352|NCT01175382|1157560|P3|STARTED|Overall Study||65
472353|NCT01175382|1157561|P2|STARTED|Overall Study||68
472354|NCT01175382|1157562|P1|STARTED|Overall Study||71
472355|NCT01175369|1157641|P2|NOT COMPLETED|Overall Study||5
472356|NCT01175369|1157642|P1|NOT COMPLETED|Overall Study||2
472357|NCT01175369|1157641|P2|COMPLETED|Overall Study||260
472358|NCT01175369|1157642|P1|COMPLETED|Overall Study||263
472359|NCT01175369|1157641|P2|STARTED|Overall Study||265
472360|NCT01175369|1157642|P1|STARTED|Overall Study||265
472361|NCT01175356|1157648|P1|NOT COMPLETED|Overall Study||81
472362|NCT01175356|1157648|P1|COMPLETED|Overall Study||18
472363|NCT01175356|1157648|P1|STARTED|Overall Study||99
472364|NCT01175343|1157654|P1|NOT COMPLETED|Overall Study||0
472365|NCT01175343|1157654|P1|COMPLETED|Overall Study||44
472366|NCT01175343|1157654|P1|STARTED|Overall Study||44
472367|NCT01175317|1157666|P2|NOT COMPLETED|Overall Study||0
472368|NCT01175317|1157667|P1|NOT COMPLETED|Overall Study||0
472369|NCT01175317|1157666|P2|COMPLETED|Overall Study||31
472370|NCT01175317|1157667|P1|COMPLETED|Overall Study||27
472371|NCT01175317|1157666|P2|STARTED|Overall Study||31
472372|NCT01175317|1157667|P1|STARTED|Overall Study||27
472373|NCT01175226|1157677|P2|NOT COMPLETED|Overall Study||5
472374|NCT01175226|1157678|P1|NOT COMPLETED|Overall Study||11
472375|NCT01175226|1157677|P2|COMPLETED|Overall Study||140
472376|NCT01175226|1157678|P1|COMPLETED|Overall Study||144
472377|NCT01175226|1157677|P2|STARTED|Overall Study||145
472378|NCT01175226|1157678|P1|STARTED|Overall Study||155
472379|NCT01175213|1157688|P2|NOT COMPLETED|Safety Follow-up||0
472380|NCT01175213|1157689|P1|NOT COMPLETED|Safety Follow-up||1
472381|NCT01175213|1157688|P2|COMPLETED|Safety Follow-up||3
472382|NCT01175213|1157689|P1|COMPLETED|Safety Follow-up||47
472383|NCT01175213|1157688|P2|STARTED|Safety Follow-up||3
472384|NCT01175213|1157689|P1|STARTED|Safety Follow-up||48
472385|NCT01175213|1157688|P2|NOT COMPLETED|IGSC, 10%/rHuPH20||0
472386|NCT01175213|1157689|P1|NOT COMPLETED|IGSC, 10%/rHuPH20||15
472387|NCT01175213|1157688|P2|COMPLETED|IGSC, 10%/rHuPH20||3
472388|NCT01175213|1157689|P1|COMPLETED|IGSC, 10%/rHuPH20||48
472389|NCT01175213|1157688|P2|STARTED|IGSC, 10%/rHuPH20|3 participants treated IV with IGIV,10% without rHuPH20 throughout the study.|3
472390|NCT01175213|1157689|P1|STARTED|IGSC, 10%/rHuPH20||63
472391|NCT01175148|1157736|P2|NOT COMPLETED|Overall Study||0
472392|NCT01175148|1157737|P1|NOT COMPLETED|Overall Study||0
472393|NCT01175148|1157736|P2|COMPLETED|Overall Study||30
472394|NCT01175148|1157737|P1|COMPLETED|Overall Study||30
472395|NCT01175148|1157736|P2|STARTED|Overall Study||30
472396|NCT01175148|1157737|P1|STARTED|Overall Study||30
472397|NCT01175135|1157746|P4|NOT COMPLETED|Overall Study||14
472398|NCT01175135|1157747|P3|NOT COMPLETED|Overall Study||12
472399|NCT01175135|1157748|P2|NOT COMPLETED|Overall Study||22
472400|NCT01175135|1157749|P1|NOT COMPLETED|Overall Study||16
472401|NCT01175135|1157746|P4|COMPLETED|Overall Study||60
472402|NCT01175135|1157747|P3|COMPLETED|Overall Study||25
472403|NCT01175135|1157748|P2|COMPLETED|Overall Study||52
472404|NCT01175135|1157749|P1|COMPLETED|Overall Study||58
472405|NCT01175135|1157746|P4|Analyzed for Efficacy|Overall Study||73
472406|NCT01175135|1157747|P3|Analyzed for Efficacy|Overall Study||34
472407|NCT01175135|1157748|P2|Analyzed for Efficacy|Overall Study||73
472408|NCT01175135|1157749|P1|Analyzed for Efficacy|Overall Study||74
472409|NCT01175135|1157746|P4|Treated|Overall Study||74
472410|NCT01175135|1157747|P3|Treated|Overall Study||36
472411|NCT01175135|1157748|P2|Treated|Overall Study||74
472412|NCT01175135|1157749|P1|Treated|Overall Study||74
472413|NCT01175135|1157746|P4|STARTED|Overall Study||74
472414|NCT01175135|1157747|P3|STARTED|Overall Study||37
472415|NCT01175135|1157748|P2|STARTED|Overall Study||74
472416|NCT01175135|1157749|P1|STARTED|Overall Study||74
472417|NCT01175031|1157831|P1|NOT COMPLETED|Overall Study||0
472418|NCT01175031|1157831|P1|COMPLETED|Overall Study||45
472419|NCT01175031|1157831|P1|STARTED|Overall Study||45
472420|NCT01175018|1157841|P2|NOT COMPLETED|Overall Study||1
472421|NCT01175018|1157842|P1|NOT COMPLETED|Overall Study||3
472422|NCT01175018|1157841|P2|COMPLETED|Overall Study||14
472423|NCT01175018|1157842|P1|COMPLETED|Overall Study||12
472424|NCT01175018|1157841|P2|STARTED|Overall Study||15
472425|NCT01175018|1157842|P1|STARTED|Overall Study||15
472426|NCT01175005|1157878|P1|NOT COMPLETED|Overall Study||0
472427|NCT01175005|1157878|P1|COMPLETED|Overall Study||62
472428|NCT01175005|1157878|P1|STARTED|Overall Study||62
472429|NCT01174784|1157883|P1|NOT COMPLETED|Overall Study||0
472430|NCT01174784|1157883|P1|COMPLETED|Overall Study||88
472431|NCT01174784|1157883|P1|STARTED|Overall Study||88
472432|NCT01174576|1157888|P1|NOT COMPLETED|Overall Study||0
472433|NCT01174576|1157888|P1|COMPLETED|Overall Study||16
472434|NCT01174576|1157888|P1|STARTED|Overall Study|All participants received all interventions without exception.|16
472435|NCT01174550|1157931|P2|NOT COMPLETED|Overall Study||873
472436|NCT01174550|1157932|P1|NOT COMPLETED|Overall Study||1270
472437|NCT01174550|1157931|P2|COMPLETED|Overall Study||4123
472438|NCT01174550|1157932|P1|COMPLETED|Overall Study||3737
472439|NCT01174550|1157931|P2|STARTED|Overall Study||4996
472440|NCT01174550|1157932|P1|STARTED|Overall Study||5007
472441|NCT01174459|1157960|P1|NOT COMPLETED|Overall Study||5
472442|NCT01174459|1157960|P1|COMPLETED|Overall Study|Case report form (CRF) collected|566
472443|NCT01174459|1157960|P1|STARTED|Overall Study|Registered patients|571
472444|NCT01174446|1157965|P4|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
472445|NCT01174446|1157966|P3|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
472446|NCT01174446|1157967|P2|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1
472447|NCT01174446|1157968|P1|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1
472448|NCT01174446|1157965|P4|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
472449|NCT01174446|1157966|P3|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
472450|NCT01174446|1157967|P2|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13
472451|NCT01174446|1157968|P1|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13
472452|NCT01174446|1157965|P4|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0
472453|NCT01174446|1157966|P3|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0
472454|NCT01174446|1157967|P2|STARTED|Part 3 -Pharmacokinetic BAX326 Only|Includes all participants who completed Part 1|14
472455|NCT01174446|1157968|P1|STARTED|Part 3 -Pharmacokinetic BAX326 Only|Includes all participants who completed Part 1|14
472456|NCT01174446|1157965|P4|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
472457|NCT01174446|1157966|P3|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||2
472458|NCT01174446|1157967|P2|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
472459|NCT01174446|1157968|P1|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
472460|NCT01174446|1157965|P4|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
472461|NCT01174446|1157966|P3|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||29
472462|NCT01174446|1157967|P2|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
472463|NCT01174446|1157968|P1|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
472464|NCT01174446|1157965|P4|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|This group only participated in Study Part 2|14
472465|NCT01174446|1157966|P3|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|This group only participated in Study Part 2|31
472466|NCT01174446|1157967|P2|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|In Study Part 2 all 14 participants received Prophylaxis|14
472467|NCT01174446|1157968|P1|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|In Study Part 2 all 14 participants received Prophylaxis|14
472468|NCT01174446|1157965|P4|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
472469|NCT01174446|1157966|P3|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
472470|NCT01174446|1157967|P2|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
472471|NCT01174446|1157968|P1|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
472472|NCT01174446|1157965|P4|COMPLETED|Part 1 -Pharmacokinetic Crossover||0
472473|NCT01174446|1157966|P3|COMPLETED|Part 1 -Pharmacokinetic Crossover||0
472474|NCT01174446|1157967|P2|COMPLETED|Part 1 -Pharmacokinetic Crossover||14
472475|NCT01174446|1157968|P1|COMPLETED|Part 1 -Pharmacokinetic Crossover|BAX326 was mistakenly infused for second PK infusion (ie should have been BeneFIX) for 1 participant|14
472476|NCT01174446|1157965|P4|STARTED|Part 1 -Pharmacokinetic Crossover||0
472477|NCT01174446|1157966|P3|STARTED|Part 1 -Pharmacokinetic Crossover||0
472478|NCT01174446|1157967|P2|STARTED|Part 1 -Pharmacokinetic Crossover||14
472479|NCT01174446|1157968|P1|STARTED|Part 1 -Pharmacokinetic Crossover||14
472480|NCT01174342|1158155|P1|NOT COMPLETED|Overall Study||4
472481|NCT01174342|1158155|P1|COMPLETED|Overall Study||26
472482|NCT01174342|1158155|P1|STARTED|Overall Study||30
472483|NCT01174264|1158162|P3|NOT COMPLETED|Steady-state Pharmacokinetics||2
472484|NCT01174264|1158163|P2|NOT COMPLETED|Steady-state Pharmacokinetics||0
472485|NCT01174264|1158164|P1|NOT COMPLETED|Steady-state Pharmacokinetics||6
472486|NCT01174264|1158162|P3|COMPLETED|Steady-state Pharmacokinetics||27
472487|NCT01174264|1158163|P2|COMPLETED|Steady-state Pharmacokinetics||0
472488|NCT01174264|1158164|P1|COMPLETED|Steady-state Pharmacokinetics||25
472489|NCT01174264|1158162|P3|STARTED|Steady-state Pharmacokinetics|Includes 11 patients from period 1 high-fat arm and 18 patients from period 1 low-fat arm|29
472490|NCT01174264|1158163|P2|STARTED|Steady-state Pharmacokinetics|Patients in period 2 were randomized to fasting vs. fed state only.|0
472491|NCT01174264|1158164|P1|STARTED|Steady-state Pharmacokinetics|Includes 22 patients from period 1 fasting arm and 9 patients from period 1 high-fat arm|31
472492|NCT01174264|1158162|P3|NOT COMPLETED|Single Dose Pharmacokinetics||2
472493|NCT01174264|1158163|P2|NOT COMPLETED|Single Dose Pharmacokinetics||0
472494|NCT01174264|1158164|P1|NOT COMPLETED|Single Dose Pharmacokinetics||1
472495|NCT01174264|1158162|P3|COMPLETED|Single Dose Pharmacokinetics||18
472496|NCT01174264|1158163|P2|COMPLETED|Single Dose Pharmacokinetics||20
472497|NCT01174264|1158164|P1|COMPLETED|Single Dose Pharmacokinetics||22
472498|NCT01174264|1158162|P3|STARTED|Single Dose Pharmacokinetics||20
472499|NCT01174264|1158163|P2|STARTED|Single Dose Pharmacokinetics||20
472500|NCT01174264|1158164|P1|STARTED|Single Dose Pharmacokinetics||23
472501|NCT01174238|1158196|P1|NOT COMPLETED|Overall Study||2
472502|NCT01174238|1158196|P1|COMPLETED|Overall Study||36
472503|NCT01174238|1158196|P1|Participants That Underwent FLT-PET Scan|Overall Study||6
472504|NCT01174238|1158196|P1|STARTED|Overall Study||38
472505|NCT01174186|1158207|P2|NOT COMPLETED|Overall Study||3
472506|NCT01174186|1158208|P1|NOT COMPLETED|Overall Study||0
472507|NCT01174186|1158207|P2|COMPLETED|Overall Study||12
472508|NCT01174186|1158208|P1|COMPLETED|Overall Study||15
472509|NCT01174186|1158207|P2|STARTED|Overall Study||15
472510|NCT01174186|1158208|P1|STARTED|Overall Study|Patients were included over three years|15
472511|NCT01174173|1158215|P1|NOT COMPLETED|Overall Study||1
472512|NCT01174173|1158215|P1|COMPLETED|Overall Study||10
472513|NCT01174173|1158215|P1|STARTED|Overall Study||11
472514|NCT01174160|1158226|P2|NOT COMPLETED|Overall Study||6
472515|NCT01174160|1158227|P1|NOT COMPLETED|Overall Study||8
472516|NCT01174160|1158226|P2|COMPLETED|Overall Study||56
472517|NCT01174160|1158227|P1|COMPLETED|Overall Study||53
472518|NCT01174160|1158226|P2|Discontinued Post Dose|Overall Study||0
472519|NCT01174160|1158227|P1|Discontinued Post Dose|Overall Study||2
472520|NCT01174160|1158226|P2|Dosed|Overall Study||56
472521|NCT01174160|1158227|P1|Dosed|Overall Study||55
472522|NCT01174160|1158226|P2|Discontinued Pre Dose|Overall Study||6
472523|NCT01174160|1158227|P1|Discontinued Pre Dose|Overall Study||6
472524|NCT01174160|1158226|P2|STARTED|Overall Study||62
472525|NCT01174160|1158227|P1|STARTED|Overall Study||61
472526|NCT01174082|1158235|P2|NOT COMPLETED|Overall Study||0
472527|NCT01174082|1158236|P1|NOT COMPLETED|Overall Study||0
472528|NCT01174082|1158235|P2|COMPLETED|Overall Study||1
472529|NCT01174082|1158236|P1|COMPLETED|Overall Study||1
472530|NCT01174082|1158235|P2|STARTED|Overall Study||1
472531|NCT01174082|1158236|P1|STARTED|Overall Study||1
472532|NCT01174043|1158242|P1|NOT COMPLETED|Overall Study||11
472533|NCT01174043|1158242|P1|COMPLETED|Overall Study||0
472534|NCT01174043|1158242|P1|STARTED|Overall Study||11
472535|NCT01174030|1158253|P5|NOT COMPLETED|Overall Study||1
472536|NCT01174030|1158254|P4|NOT COMPLETED|Overall Study||2
472537|NCT01174030|1158255|P3|NOT COMPLETED|Overall Study||2
472538|NCT01174030|1158256|P2|NOT COMPLETED|Overall Study||2
472539|NCT01174030|1158257|P1|NOT COMPLETED|Overall Study||2
472540|NCT01174030|1158253|P5|COMPLETED|Overall Study||52
472541|NCT01174030|1158254|P4|COMPLETED|Overall Study||53
472542|NCT01174030|1158255|P3|COMPLETED|Overall Study||52
472543|NCT01174030|1158256|P2|COMPLETED|Overall Study||52
472544|NCT01174030|1158257|P1|COMPLETED|Overall Study||51
472545|NCT01174030|1158253|P5|STARTED|Overall Study||53
472546|NCT01174030|1158254|P4|STARTED|Overall Study||55
472547|NCT01174030|1158255|P3|STARTED|Overall Study||54
472548|NCT01174030|1158256|P2|STARTED|Overall Study||54
472549|NCT01174030|1158257|P1|STARTED|Overall Study||53
472550|NCT01174004|1158281|P2|NOT COMPLETED|Overall Study||16
472551|NCT01174004|1158282|P1|NOT COMPLETED|Overall Study||7
472552|NCT01174004|1158281|P2|COMPLETED|Overall Study||89
472553|NCT01174004|1158282|P1|COMPLETED|Overall Study||87
472554|NCT01174004|1158281|P2|STARTED|Overall Study||105
472555|NCT01174004|1158282|P1|STARTED|Overall Study||94
472556|NCT01173874|1158292|P2|NOT COMPLETED|Overall Study||23
472557|NCT01173874|1158293|P1|NOT COMPLETED|Overall Study||23
472558|NCT01173874|1158292|P2|COMPLETED|Overall Study||41
472559|NCT01173874|1158293|P1|COMPLETED|Overall Study||33
472560|NCT01173874|1158292|P2|STARTED|Overall Study||64
472561|NCT01173874|1158293|P1|STARTED|Overall Study||56
472562|NCT01173848|1158307|P2|NOT COMPLETED|Overall Study||8
472563|NCT01173848|1158308|P1|NOT COMPLETED|Overall Study||4
472564|NCT01173848|1158307|P2|COMPLETED|Overall Study||3
472565|NCT01173848|1158308|P1|COMPLETED|Overall Study||4
472566|NCT01173848|1158307|P2|STARTED|Overall Study||11
472567|NCT01173848|1158308|P1|STARTED|Overall Study||8
472568|NCT01173718|1158313|P1|NOT COMPLETED|Overall Study||44
472569|NCT01173718|1158313|P1|COMPLETED|Overall Study||94
472570|NCT01173718|1158313|P1|STARTED|Overall Study||138
472571|NCT01173679|1158322|P1|NOT COMPLETED|Overall Study||1
472572|NCT01173679|1158322|P1|COMPLETED|Overall Study||9
472573|NCT01173679|1158322|P1|STARTED|Overall Study||10
472574|NCT01173653|1158330|P2|NOT COMPLETED|Overall Study||41
472575|NCT01173653|1158331|P1|NOT COMPLETED|Overall Study||53
472576|NCT01173653|1158330|P2|COMPLETED|Overall Study||49
472577|NCT01173653|1158331|P1|COMPLETED|Overall Study||56
472578|NCT01173653|1158330|P2|STARTED|Overall Study||90
472579|NCT01173653|1158331|P1|STARTED|Overall Study||109
472580|NCT01173601|1158341|P5|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||68
472581|NCT01173601|1158342|P4|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||30
472582|NCT01173601|1158343|P3|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||33
472583|NCT01173601|1158344|P2|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
472584|NCT01173601|1158345|P1|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
472585|NCT01173601|1158341|P5|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||559
472586|NCT01173601|1158342|P4|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||210
472587|NCT01173601|1158343|P3|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||197
472588|NCT01173601|1158344|P2|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||196
472589|NCT01173601|1158345|P1|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
472590|NCT01173601|1158341|P5|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|586
472591|NCT01173601|1158342|P4|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|221
472592|NCT01173601|1158343|P3|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|108
472593|NCT01173601|1158344|P2|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|100
472594|NCT01173601|1158345|P1|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
472595|NCT01173601|1158341|P5|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
472596|NCT01173601|1158342|P4|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
472597|NCT01173601|1158343|P3|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the taper DC Phase.|107
472598|NCT01173601|1158344|P2|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the taper DC Phase.|100
472599|NCT01173601|1158345|P1|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
472600|NCT01173601|1158341|P5|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||627
472601|NCT01173601|1158342|P4|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||240
472602|NCT01173601|1158343|P3|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||230
472603|NCT01173601|1158344|P2|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||231
472604|NCT01173601|1158345|P1|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
472605|NCT01173601|1158341|P5|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
472606|NCT01173601|1158342|P4|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
472607|NCT01173601|1158343|P3|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
472608|NCT01173601|1158344|P2|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
472609|NCT01173601|1158345|P1|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||88
472610|NCT01173601|1158341|P5|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
472611|NCT01173601|1158342|P4|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
472612|NCT01173601|1158343|P3|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
472613|NCT01173601|1158344|P2|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
472614|NCT01173601|1158345|P1|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the AT Phase.|1328
472615|NCT01173601|1158341|P5|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
472616|NCT01173601|1158342|P4|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
472617|NCT01173601|1158343|P3|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
472618|NCT01173601|1158344|P2|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
472619|NCT01173601|1158345|P1|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase had the option to enter the DC phase.|21
472620|NCT01173601|1158341|P5|STARTED|Confirmation (CF) Phase, 3 Weeks||0
472621|NCT01173601|1158342|P4|STARTED|Confirmation (CF) Phase, 3 Weeks||0
472622|NCT01173601|1158343|P3|STARTED|Confirmation (CF) Phase, 3 Weeks||0
472623|NCT01173601|1158344|P2|STARTED|Confirmation (CF) Phase, 3 Weeks||0
472624|NCT01173601|1158345|P1|STARTED|Confirmation (CF) Phase, 3 Weeks||1416
472625|NCT01173523|1158422|P2|NOT COMPLETED|Overall Study||12
472626|NCT01173523|1158423|P1|NOT COMPLETED|Overall Study||13
472627|NCT01173523|1158422|P2|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
472628|NCT01173523|1158423|P1|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
472629|NCT01173523|1158422|P2|STARTED|Overall Study||12
472630|NCT01173523|1158423|P1|STARTED|Overall Study||13
472631|NCT01173471|1158439|P4|NOT COMPLETED|Overall Study||1
472632|NCT01173471|1158440|P3|NOT COMPLETED|Overall Study||3
472633|NCT01173471|1158441|P2|NOT COMPLETED|Overall Study||0
472634|NCT01173471|1158442|P1|NOT COMPLETED|Overall Study||2
472635|NCT01173471|1158439|P4|COMPLETED|Overall Study|Completed study|18
472636|NCT01173471|1158440|P3|COMPLETED|Overall Study|Completed study|15
472637|NCT01173471|1158441|P2|COMPLETED|Overall Study|Completed study|7
472638|NCT01173471|1158442|P1|COMPLETED|Overall Study|Completed study|4
472639|NCT01173471|1158439|P4|Completed Treatment|Overall Study||18
472640|NCT01173471|1158440|P3|Completed Treatment|Overall Study||15
472641|NCT01173471|1158441|P2|Completed Treatment|Overall Study||7
472642|NCT01173471|1158442|P1|Completed Treatment|Overall Study||4
472643|NCT01173471|1158439|P4|Received Treatment|Overall Study||19
472644|NCT01173471|1158440|P3|Received Treatment|Overall Study||18
472645|NCT01173471|1158441|P2|Received Treatment|Overall Study||7
472646|NCT01173471|1158442|P1|Received Treatment|Overall Study||6
472647|NCT01173471|1158439|P4|STARTED|Overall Study|Randomized|19
472648|NCT01173471|1158440|P3|STARTED|Overall Study|Randomized|18
472649|NCT01173471|1158441|P2|STARTED|Overall Study|Randomized|7
472650|NCT01173471|1158442|P1|STARTED|Overall Study|Randomized|6
472651|NCT01173211|1158466|P6|NOT COMPLETED|Overall Study||0
472652|NCT01173211|1158467|P5|NOT COMPLETED|Overall Study||0
472653|NCT01173211|1158468|P4|NOT COMPLETED|Overall Study||0
472654|NCT01173211|1158469|P3|NOT COMPLETED|Overall Study||2
472655|NCT01173211|1158470|P2|NOT COMPLETED|Overall Study||1
472656|NCT01173211|1158471|P1|NOT COMPLETED|Overall Study||2
472657|NCT01173211|1158466|P6|COMPLETED|Overall Study||13
472658|NCT01173211|1158467|P5|COMPLETED|Overall Study||16
472659|NCT01173211|1158468|P4|COMPLETED|Overall Study||15
472660|NCT01173211|1158469|P3|COMPLETED|Overall Study||44
472661|NCT01173211|1158470|P2|COMPLETED|Overall Study||44
472662|NCT01173211|1158471|P1|COMPLETED|Overall Study||46
472663|NCT01173211|1158466|P6|STARTED|Overall Study||13
472664|NCT01173211|1158467|P5|STARTED|Overall Study||16
472665|NCT01173211|1158468|P4|STARTED|Overall Study||15
472666|NCT01173211|1158469|P3|STARTED|Overall Study||46
472667|NCT01173211|1158470|P2|STARTED|Overall Study||45
472668|NCT01173211|1158471|P1|STARTED|Overall Study||48
472669|NCT01173120|1158572|P1|NOT COMPLETED|Overall Study||62
472670|NCT01173120|1158572|P1|COMPLETED|Overall Study||0
472671|NCT01173120|1158572|P1|Discontinued ACP Substudy and Main Study|Overall Study||5
472672|NCT01173120|1158572|P1|Switched Back to Main Study|Overall Study||57
472673|NCT01173120|1158572|P1|STARTED|Overall Study||62
472674|NCT01173055|1158590|P2|NOT COMPLETED|Period 2 - Day 64 to 112||1
472675|NCT01173055|1158591|P1|NOT COMPLETED|Period 2 - Day 64 to 112||0
472676|NCT01173055|1158590|P2|COMPLETED|Period 2 - Day 64 to 112||9
472677|NCT01173055|1158591|P1|COMPLETED|Period 2 - Day 64 to 112||8
472678|NCT01173055|1158590|P2|STARTED|Period 2 - Day 64 to 112||10
472679|NCT01173055|1158591|P1|STARTED|Period 2 - Day 64 to 112||8
472680|NCT01173055|1158590|P2|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0
472681|NCT01173055|1158591|P1|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0
472682|NCT01173055|1158590|P2|COMPLETED|Placebo Washout Period - Day 50 to 63||10
472683|NCT01173055|1158591|P1|COMPLETED|Placebo Washout Period - Day 50 to 63||8
472684|NCT01173055|1158590|P2|STARTED|Placebo Washout Period - Day 50 to 63||10
472685|NCT01173055|1158591|P1|STARTED|Placebo Washout Period - Day 50 to 63||8
472686|NCT01173055|1158590|P2|NOT COMPLETED|Period 1 - Day 1 to 49||2
472687|NCT01173055|1158591|P1|NOT COMPLETED|Period 1 - Day 1 to 49||2
472688|NCT01173055|1158590|P2|COMPLETED|Period 1 - Day 1 to 49||10
472689|NCT01173055|1158591|P1|COMPLETED|Period 1 - Day 1 to 49||8
472690|NCT01173055|1158590|P2|STARTED|Period 1 - Day 1 to 49||12
472691|NCT01173055|1158591|P1|STARTED|Period 1 - Day 1 to 49||10
472692|NCT01173029|1158609|P2|NOT COMPLETED|Overall Study||0
472693|NCT01173029|1158610|P1|NOT COMPLETED|Overall Study||0
472694|NCT01173029|1158609|P2|COMPLETED|Overall Study||31
472695|NCT01173029|1158610|P1|COMPLETED|Overall Study||61
472696|NCT01173029|1158609|P2|STARTED|Overall Study||31
472697|NCT01173029|1158610|P1|STARTED|Overall Study||61
472698|NCT01172938|1158630|P9|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||2
472699|NCT01172938|1158631|P8|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||3
472700|NCT01172938|1158632|P7|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
472701|NCT01172938|1158633|P6|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
472702|NCT01172938|1158634|P5|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
472703|NCT01172938|1158635|P4|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
472704|NCT01172938|1158636|P3|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||8
472705|NCT01172938|1158637|P2|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||3
472706|NCT01172938|1158638|P1|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
472707|NCT01172938|1158630|P9|COMPLETED|Active-Treatment Phase (Weeks 208-260)||32
472708|NCT01172938|1158631|P8|COMPLETED|Active-Treatment Phase (Weeks 208-260)||29
472709|NCT01172938|1158632|P7|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
472710|NCT01172938|1158633|P6|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
472711|NCT01172938|1158634|P5|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
472712|NCT01172938|1158635|P4|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
472713|NCT01172938|1158636|P3|COMPLETED|Active-Treatment Phase (Weeks 208-260)||80
472714|NCT01172938|1158637|P2|COMPLETED|Active-Treatment Phase (Weeks 208-260)||72
472715|NCT01172938|1158638|P1|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
472716|NCT01172938|1158630|P9|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
472717|NCT01172938|1158631|P8|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||25
472718|NCT01172938|1158632|P7|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
472719|NCT01172938|1158633|P6|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
472720|NCT01172938|1158634|P5|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
472721|NCT01172938|1158635|P4|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
472722|NCT01172938|1158636|P3|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
472723|NCT01172938|1158637|P2|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
472724|NCT01172938|1158638|P1|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
472725|NCT01172938|1158630|P9|STARTED|Active-Treatment Phase (Weeks 208-260)||34
472726|NCT01172938|1158631|P8|STARTED|Active-Treatment Phase (Weeks 208-260)||32
472727|NCT01172938|1158632|P7|STARTED|Active-Treatment Phase (Weeks 208-260)||0
472728|NCT01172938|1158633|P6|STARTED|Active-Treatment Phase (Weeks 208-260)||0
472729|NCT01172938|1158634|P5|STARTED|Active-Treatment Phase (Weeks 208-260)||0
472730|NCT01172938|1158635|P4|STARTED|Active-Treatment Phase (Weeks 208-260)||0
472731|NCT01172938|1158636|P3|STARTED|Active-Treatment Phase (Weeks 208-260)||88
472732|NCT01172938|1158637|P2|STARTED|Active-Treatment Phase (Weeks 208-260)||75
472733|NCT01172938|1158638|P1|STARTED|Active-Treatment Phase (Weeks 208-260)||0
472734|NCT01172938|1158630|P9|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||7
472735|NCT01172938|1158631|P8|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||9
472736|NCT01172938|1158632|P7|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
472737|NCT01172938|1158633|P6|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
472738|NCT01172938|1158634|P5|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
472739|NCT01172938|1158635|P4|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
472740|NCT01172938|1158636|P3|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||5
472741|NCT01172938|1158637|P2|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||9
472742|NCT01172938|1158638|P1|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
472743|NCT01172938|1158630|P9|COMPLETED|Active-Treatment Phase (Weeks 156-208)||34
472744|NCT01172938|1158631|P8|COMPLETED|Active-Treatment Phase (Weeks 156-208)||32
472745|NCT01172938|1158632|P7|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
472746|NCT01172938|1158633|P6|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
472747|NCT01172938|1158634|P5|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
472748|NCT01172938|1158635|P4|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
472749|NCT01172938|1158636|P3|COMPLETED|Active-Treatment Phase (Weeks 156-208)||88
472750|NCT01172938|1158637|P2|COMPLETED|Active-Treatment Phase (Weeks 156-208)||75
472751|NCT01172938|1158638|P1|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
472752|NCT01172938|1158630|P9|STARTED|Active-Treatment Phase (Weeks 156-208)||41
472753|NCT01172938|1158631|P8|STARTED|Active-Treatment Phase (Weeks 156-208)||41
472754|NCT01172938|1158632|P7|STARTED|Active-Treatment Phase (Weeks 156-208)||0
472755|NCT01172938|1158633|P6|STARTED|Active-Treatment Phase (Weeks 156-208)||0
472756|NCT01172938|1158634|P5|STARTED|Active-Treatment Phase (Weeks 156-208)||0
472757|NCT01172938|1158635|P4|STARTED|Active-Treatment Phase (Weeks 156-208)||0
472758|NCT01172938|1158636|P3|STARTED|Active-Treatment Phase (Weeks 156-208)||93
472759|NCT01172938|1158637|P2|STARTED|Active-Treatment Phase (Weeks 156-208)||84
472760|NCT01172938|1158638|P1|STARTED|Active-Treatment Phase (Weeks 156-208)||0
472761|NCT01172938|1158630|P9|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||4
472762|NCT01172938|1158631|P8|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||5
472763|NCT01172938|1158632|P7|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
472764|NCT01172938|1158633|P6|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
472765|NCT01172938|1158634|P5|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
472766|NCT01172938|1158635|P4|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
472767|NCT01172938|1158636|P3|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||7
472768|NCT01172938|1158637|P2|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||11
472769|NCT01172938|1158638|P1|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
472770|NCT01172938|1158630|P9|COMPLETED|Active-Treatment Phase Weeks (104-156)||41
472771|NCT01172938|1158631|P8|COMPLETED|Active-Treatment Phase Weeks (104-156)||41
472772|NCT01172938|1158632|P7|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
472773|NCT01172938|1158633|P6|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
472774|NCT01172938|1158634|P5|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
472775|NCT01172938|1158635|P4|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
472776|NCT01172938|1158636|P3|COMPLETED|Active-Treatment Phase Weeks (104-156)||93
472777|NCT01172938|1158637|P2|COMPLETED|Active-Treatment Phase Weeks (104-156)||84
472778|NCT01172938|1158638|P1|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
472779|NCT01172938|1158630|P9|STARTED|Active-Treatment Phase Weeks (104-156)||45
472780|NCT01172938|1158631|P8|STARTED|Active-Treatment Phase Weeks (104-156)||46
472781|NCT01172938|1158632|P7|STARTED|Active-Treatment Phase Weeks (104-156)||0
472782|NCT01172938|1158633|P6|STARTED|Active-Treatment Phase Weeks (104-156)||0
472783|NCT01172938|1158634|P5|STARTED|Active-Treatment Phase Weeks (104-156)||0
472784|NCT01172938|1158635|P4|STARTED|Active-Treatment Phase Weeks (104-156)||0
472785|NCT01172938|1158636|P3|STARTED|Active-Treatment Phase Weeks (104-156)||100
472786|NCT01172938|1158637|P2|STARTED|Active-Treatment Phase Weeks (104-156)||95
472787|NCT01172938|1158638|P1|STARTED|Active-Treatment Phase Weeks (104-156)||0
472788|NCT01172938|1158630|P9|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||4
472789|NCT01172938|1158631|P8|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||15
472790|NCT01172938|1158632|P7|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
472791|NCT01172938|1158633|P6|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
472792|NCT01172938|1158634|P5|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
472793|NCT01172938|1158635|P4|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
472794|NCT01172938|1158636|P3|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||21
472795|NCT01172938|1158637|P2|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||23
472796|NCT01172938|1158638|P1|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
472797|NCT01172938|1158630|P9|COMPLETED|Active-Treatment Phase (Weeks 52-104)||45
472798|NCT01172938|1158631|P8|COMPLETED|Active-Treatment Phase (Weeks 52-104)||46
472799|NCT01172938|1158632|P7|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
472800|NCT01172938|1158633|P6|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
472801|NCT01172938|1158634|P5|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
472802|NCT01172938|1158635|P4|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
472803|NCT01172938|1158636|P3|COMPLETED|Active-Treatment Phase (Weeks 52-104)||100
472804|NCT01172938|1158637|P2|COMPLETED|Active-Treatment Phase (Weeks 52-104)||95
472805|NCT01172938|1158638|P1|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
472806|NCT01172938|1158630|P9|STARTED|Active-Treatment Phase (Weeks 52-104)||49
472807|NCT01172938|1158631|P8|STARTED|Active-Treatment Phase (Weeks 52-104)||61
472808|NCT01172938|1158632|P7|STARTED|Active-Treatment Phase (Weeks 52-104)||0
472809|NCT01172938|1158633|P6|STARTED|Active-Treatment Phase (Weeks 52-104)||0
472810|NCT01172938|1158634|P5|STARTED|Active-Treatment Phase (Weeks 52-104)||0
472811|NCT01172938|1158635|P4|STARTED|Active-Treatment Phase (Weeks 52-104)||0
472812|NCT01172938|1158636|P3|STARTED|Active-Treatment Phase (Weeks 52-104)|Nine participants who completed Week 52 did not enter the next year of active treatment phase|121
472813|NCT01172938|1158637|P2|STARTED|Active-Treatment Phase (Weeks 52-104)|Six participants who completed Week 52 did not enter the next year of active treatment phase|118
472814|NCT01172938|1158638|P1|STARTED|Active-Treatment Phase (Weeks 52-104)||0
472815|NCT01172938|1158630|P9|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
472816|NCT01172938|1158631|P8|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
472817|NCT01172938|1158632|P7|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||2
472818|NCT01172938|1158633|P6|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||15
472819|NCT01172938|1158634|P5|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||4
472820|NCT01172938|1158635|P4|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||7
472821|NCT01172938|1158636|P3|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||15
472822|NCT01172938|1158637|P2|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||12
472823|NCT01172938|1158638|P1|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
472824|NCT01172938|1158630|P9|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
472825|NCT01172938|1158631|P8|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
472826|NCT01172938|1158632|P7|COMPLETED|Active Treatment Phase (Weeks 25-52)||22
472827|NCT01172938|1158633|P6|COMPLETED|Active Treatment Phase (Weeks 25-52)||34
472828|NCT01172938|1158634|P5|COMPLETED|Active Treatment Phase (Weeks 25-52)||19
472829|NCT01172938|1158635|P4|COMPLETED|Active Treatment Phase (Weeks 25-52)||44
472830|NCT01172938|1158636|P3|COMPLETED|Active Treatment Phase (Weeks 25-52)||130
472831|NCT01172938|1158637|P2|COMPLETED|Active Treatment Phase (Weeks 25-52)||124
472832|NCT01172938|1158638|P1|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
472833|NCT01172938|1158630|P9|STARTED|Active Treatment Phase (Weeks 25-52)||0
472834|NCT01172938|1158631|P8|STARTED|Active Treatment Phase (Weeks 25-52)||0
472835|NCT01172938|1158632|P7|STARTED|Active Treatment Phase (Weeks 25-52)||24
472836|NCT01172938|1158633|P6|STARTED|Active Treatment Phase (Weeks 25-52)|One participant who escaped early and completed Week 24 did not enter the active treatment phase|49
472837|NCT01172938|1158634|P5|STARTED|Active Treatment Phase (Weeks 25-52)||23
472838|NCT01172938|1158635|P4|STARTED|Active Treatment Phase (Weeks 25-52)|One participant who escaped early and completed Week 24 did not enter the active treatment phase|51
472839|NCT01172938|1158636|P3|STARTED|Active Treatment Phase (Weeks 25-52)|Three participants who completed Week 24 did not enter the active treatment phase|145
472914|NCT01172821|1158866|P2|COMPLETED|Overall Study||245
472840|NCT01172938|1158637|P2|STARTED|Active Treatment Phase (Weeks 25-52)|Ten participants who completed Week 24 did not enter the active treatment phase|136
472841|NCT01172938|1158638|P1|STARTED|Active Treatment Phase (Weeks 25-52)||0
472842|NCT01172938|1158630|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
472843|NCT01172938|1158631|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
472844|NCT01172938|1158632|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
472845|NCT01172938|1158633|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
472846|NCT01172938|1158634|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
472847|NCT01172938|1158635|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
472848|NCT01172938|1158636|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||20
472849|NCT01172938|1158637|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||22
472850|NCT01172938|1158638|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||18
472851|NCT01172938|1158630|P9|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
472852|NCT01172938|1158631|P8|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
472853|NCT01172938|1158632|P7|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
472854|NCT01172938|1158633|P6|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
472855|NCT01172938|1158634|P5|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
472856|NCT01172938|1158635|P4|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
472857|NCT01172938|1158636|P3|COMPLETED|Placebo-controlled Phase (Week 0-24)||148
472858|NCT01172938|1158637|P2|COMPLETED|Placebo-controlled Phase (Week 0-24)||146
472859|NCT01172938|1158638|P1|COMPLETED|Placebo-controlled Phase (Week 0-24)|One participant who completed Week 24 did not enter the active treatment phase|150
472860|NCT01172938|1158630|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
472861|NCT01172938|1158631|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
472862|NCT01172938|1158632|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
472863|NCT01172938|1158633|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
472864|NCT01172938|1158634|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
472865|NCT01172938|1158635|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
472866|NCT01172938|1158636|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||58
472867|NCT01172938|1158637|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|Six participants who escaped early did not complete Week 24|78
472868|NCT01172938|1158638|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|Five participants who escaped early did not complete Week 24|107
472869|NCT01172938|1158630|P9|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
472870|NCT01172938|1158631|P8|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
472871|NCT01172938|1158632|P7|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
472872|NCT01172938|1158633|P6|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
472873|NCT01172938|1158634|P5|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
472874|NCT01172938|1158635|P4|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
472875|NCT01172938|1158636|P3|Completed Week 16|Placebo-controlled Phase (Week 0-24)||154
472876|NCT01172938|1158637|P2|Completed Week 16|Placebo-controlled Phase (Week 0-24)||158
472877|NCT01172938|1158638|P1|Completed Week 16|Placebo-controlled Phase (Week 0-24)||158
472878|NCT01172938|1158630|P9|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
472879|NCT01172938|1158631|P8|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
472880|NCT01172938|1158632|P7|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
472881|NCT01172938|1158633|P6|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
472882|NCT01172938|1158634|P5|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
472883|NCT01172938|1158635|P4|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
472884|NCT01172938|1158636|P3|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
472885|NCT01172938|1158637|P2|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
472886|NCT01172938|1158638|P1|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
472887|NCT01172938|1158630|P9|STARTED|Placebo-controlled Phase (Week 0-24)||0
472888|NCT01172938|1158631|P8|STARTED|Placebo-controlled Phase (Week 0-24)||0
472889|NCT01172938|1158632|P7|STARTED|Placebo-controlled Phase (Week 0-24)||0
472890|NCT01172938|1158633|P6|STARTED|Placebo-controlled Phase (Week 0-24)||0
472891|NCT01172938|1158634|P5|STARTED|Placebo-controlled Phase (Week 0-24)||0
472892|NCT01172938|1158635|P4|STARTED|Placebo-controlled Phase (Week 0-24)||0
472893|NCT01172938|1158636|P3|STARTED|Placebo-controlled Phase (Week 0-24)||168
472894|NCT01172938|1158637|P2|STARTED|Placebo-controlled Phase (Week 0-24)||168
472895|NCT01172938|1158638|P1|STARTED|Placebo-controlled Phase (Week 0-24)||168
472896|NCT01172873|1158824|P2|NOT COMPLETED|Overall Study||2
472897|NCT01172873|1158825|P1|NOT COMPLETED|Overall Study||3
472898|NCT01172873|1158824|P2|COMPLETED|Overall Study||3
472899|NCT01172873|1158825|P1|COMPLETED|Overall Study||8
472900|NCT01172873|1158824|P2|STARTED|Overall Study||5
472901|NCT01172873|1158825|P1|STARTED|Overall Study||11
472902|NCT01172847|1158835|P1|NOT COMPLETED|Overall Study||3
472903|NCT01172847|1158835|P1|COMPLETED|Overall Study||21
472904|NCT01172847|1158835|P1|Oseltamivir + Rimantadine|Overall Study||21
472905|NCT01172847|1158835|P1|Rimantadine|Overall Study||22
472906|NCT01172847|1158835|P1|Oseltamivir|Overall Study||24
472907|NCT01172847|1158835|P1|STARTED|Overall Study||24
472908|NCT01172821|1158864|P4|NOT COMPLETED|Overall Study||17
472909|NCT01172821|1158865|P3|NOT COMPLETED|Overall Study||13
472910|NCT01172821|1158866|P2|NOT COMPLETED|Overall Study||12
472911|NCT01172821|1158867|P1|NOT COMPLETED|Overall Study||14
472912|NCT01172821|1158864|P4|COMPLETED|Overall Study||249
472913|NCT01172821|1158865|P3|COMPLETED|Overall Study||240
472915|NCT01172821|1158867|P1|COMPLETED|Overall Study||240
472916|NCT01172821|1158864|P4|STARTED|Overall Study|Entered and Treated|266
472917|NCT01172821|1158865|P3|STARTED|Overall Study|Entered and Treated|253
472918|NCT01172821|1158866|P2|STARTED|Overall Study|Entered and Treated|257
472919|NCT01172821|1158867|P1|STARTED|Overall Study|Entered and Treated|254
472920|NCT01172808|1158957|P4|NOT COMPLETED|Overall Study||15
472921|NCT01172808|1158958|P3|NOT COMPLETED|Overall Study||23
472922|NCT01172808|1158959|P2|NOT COMPLETED|Overall Study||13
472923|NCT01172808|1158960|P1|NOT COMPLETED|Overall Study||21
472924|NCT01172808|1158957|P4|COMPLETED|Overall Study||260
472925|NCT01172808|1158958|P3|COMPLETED|Overall Study||241
472926|NCT01172808|1158959|P2|COMPLETED|Overall Study||249
472927|NCT01172808|1158960|P1|COMPLETED|Overall Study||248
472928|NCT01172808|1158957|P4|STARTED|Overall Study|Entered and Treated|275
472929|NCT01172808|1158958|P3|STARTED|Overall Study|Entered and Treated|264
472930|NCT01172808|1158959|P2|STARTED|Overall Study|Entered and Treated|262
472931|NCT01172808|1158960|P1|STARTED|Overall Study|Entered and Treated|269
472932|NCT01172600|1159048|P2|NOT COMPLETED|Overall Study||0
472933|NCT01172600|1159049|P1|NOT COMPLETED|Overall Study||0
472934|NCT01172600|1159048|P2|COMPLETED|Overall Study||39
472935|NCT01172600|1159049|P1|COMPLETED|Overall Study||39
472936|NCT01172600|1159048|P2|STARTED|Overall Study||39
472937|NCT01172600|1159049|P1|STARTED|Overall Study||39
472938|NCT01172535|1159079|P1|NOT COMPLETED|Overall Study||8
472939|NCT01172535|1159079|P1|COMPLETED|Overall Study||89
472940|NCT01172535|1159079|P1|STARTED|Overall Study||97
472941|NCT01172522|1159096|P2|NOT COMPLETED|Overall Study||0
472942|NCT01172522|1159097|P1|NOT COMPLETED|Overall Study||0
472943|NCT01172522|1159096|P2|COMPLETED|Overall Study||15
472944|NCT01172522|1159097|P1|COMPLETED|Overall Study||15
472945|NCT01172522|1159096|P2|STARTED|Overall Study||15
472946|NCT01172522|1159097|P1|STARTED|Overall Study||15
472947|NCT01172418|1159104|P2|NOT COMPLETED|Overall Study||0
472948|NCT01172418|1159105|P1|NOT COMPLETED|Overall Study||0
472949|NCT01172418|1159104|P2|COMPLETED|Overall Study||100
472950|NCT01172418|1159105|P1|COMPLETED|Overall Study||100
472951|NCT01172418|1159104|P2|STARTED|Overall Study||100
472952|NCT01172418|1159105|P1|STARTED|Overall Study||100
472953|NCT01172353|1159121|P2|NOT COMPLETED|Overall Study||0
472954|NCT01172353|1159122|P1|NOT COMPLETED|Overall Study||0
472955|NCT01172353|1159121|P2|COMPLETED|Overall Study||151
472956|NCT01172353|1159122|P1|COMPLETED|Overall Study||150
472957|NCT01172353|1159121|P2|STARTED|Overall Study||151
472958|NCT01172353|1159122|P1|STARTED|Overall Study||150
472959|NCT01172288|1159132|P2|NOT COMPLETED|Overall Study||1
472960|NCT01172288|1159133|P1|NOT COMPLETED|Overall Study||1
472961|NCT01172288|1159132|P2|COMPLETED|Overall Study||13
472962|NCT01172288|1159133|P1|COMPLETED|Overall Study||16
472963|NCT01172288|1159132|P2|STARTED|Overall Study||14
472964|NCT01172288|1159133|P1|STARTED|Overall Study||17
472965|NCT01172197|1159149|P2|NOT COMPLETED|Overall Study||0
472966|NCT01172197|1159150|P1|NOT COMPLETED|Overall Study||0
472967|NCT01172197|1159149|P2|COMPLETED|Overall Study||7
472968|NCT01172197|1159150|P1|COMPLETED|Overall Study||7
472969|NCT01172197|1159149|P2|STARTED|Overall Study||7
472970|NCT01172197|1159150|P1|STARTED|Overall Study||7
472971|NCT01172184|1159156|P1|NOT COMPLETED|Overall Study||0
472972|NCT01172184|1159156|P1|COMPLETED|Overall Study||111
472973|NCT01172184|1159156|P1|STARTED|Overall Study||111
472974|NCT01172145|1159164|P2|NOT COMPLETED|Overall Study||0
472975|NCT01172145|1159165|P1|NOT COMPLETED|Overall Study||0
472976|NCT01172145|1159164|P2|COMPLETED|Overall Study||11
472977|NCT01172145|1159165|P1|COMPLETED|Overall Study||11
472978|NCT01172145|1159164|P2|STARTED|Overall Study||11
472979|NCT01172145|1159165|P1|STARTED|Overall Study||11
472980|NCT01171989|1159188|P3|NOT COMPLETED|Overall Study||1
472981|NCT01171989|1159189|P2|NOT COMPLETED|Overall Study||0
472982|NCT01171989|1159190|P1|NOT COMPLETED|Overall Study||0
472983|NCT01171989|1159188|P3|COMPLETED|Overall Study||120
472984|NCT01171989|1159189|P2|COMPLETED|Overall Study||133
472985|NCT01171989|1159190|P1|COMPLETED|Overall Study||137
472986|NCT01171989|1159188|P3|STARTED|Overall Study||121
472987|NCT01171989|1159189|P2|STARTED|Overall Study||133
472988|NCT01171989|1159190|P1|STARTED|Overall Study||137
472989|NCT01171976|1159264|P3|NOT COMPLETED|Overall Study||15
472990|NCT01171976|1159265|P2|NOT COMPLETED|Overall Study||11
472991|NCT01171976|1159266|P1|NOT COMPLETED|Overall Study||14
472992|NCT01171976|1159264|P3|COMPLETED|Overall Study||108
472993|NCT01171976|1159265|P2|COMPLETED|Overall Study||117
472994|NCT01171976|1159266|P1|COMPLETED|Overall Study||107
472995|NCT01171976|1159264|P3|Safety Set|Overall Study|Exclude 1 who did not get drug and 4 got laser treatment|118
472996|NCT01171976|1159265|P2|Safety Set|Overall Study|Exclude 1 who did not get drug and 3 got laser treatment, include 2 from 1st arm with no laser|126
472997|NCT01171976|1159266|P1|Safety Set|Overall Study|Include 4 from PRN and 3 from TE alone who got laser treatment, exclude 2 with no laser treatment.|126
472998|NCT01171976|1159264|P3|STARTED|Overall Study||123
472999|NCT01171976|1159265|P2|STARTED|Overall Study||128
473000|NCT01171976|1159266|P1|STARTED|Overall Study||121
473001|NCT01171963|1159303|P2|NOT COMPLETED|Overall Study||168
473002|NCT01171963|1159304|P1|NOT COMPLETED|Overall Study||148
473003|NCT01171963|1159303|P2|COMPLETED|Overall Study||1499
473004|NCT01171963|1159304|P1|COMPLETED|Overall Study||1518
473005|NCT01171963|1159303|P2|STARTED|Overall Study||1667
473006|NCT01171963|1159304|P1|STARTED|Overall Study||1666
473007|NCT01171924|1159362|P2|NOT COMPLETED|Overall Study||23
473008|NCT01171924|1159363|P1|NOT COMPLETED|Overall Study||23
473009|NCT01171924|1159362|P2|COMPLETED|Overall Study||0
473010|NCT01171924|1159363|P1|COMPLETED|Overall Study||0
473011|NCT01171924|1159362|P2|STARTED|Overall Study||23
473012|NCT01171924|1159363|P1|STARTED|Overall Study||23
473013|NCT01171820|1159371|P2|NOT COMPLETED|Overall Study||6
473014|NCT01171820|1159372|P1|NOT COMPLETED|Overall Study||6
473015|NCT01171820|1159371|P2|COMPLETED|Overall Study||212
473016|NCT01171820|1159372|P1|COMPLETED|Overall Study||100
473017|NCT01171820|1159371|P2|STARTED|Overall Study||218
473018|NCT01171820|1159372|P1|STARTED|Overall Study||106
473019|NCT01171794|1159428|P2|NOT COMPLETED|Overall Study||0
473020|NCT01171794|1159429|P1|NOT COMPLETED|Overall Study||3
473021|NCT01171794|1159428|P2|COMPLETED|Overall Study||42
473022|NCT01171794|1159429|P1|COMPLETED|Overall Study||44
473023|NCT01171794|1159428|P2|STARTED|Overall Study||42
473024|NCT01171794|1159429|P1|STARTED|Overall Study||47
473025|NCT01171690|1159439|P2|NOT COMPLETED|Overall Study||0
473026|NCT01171690|1159440|P1|NOT COMPLETED|Overall Study||0
473027|NCT01171690|1159439|P2|COMPLETED|Overall Study||5
473028|NCT01171690|1159440|P1|COMPLETED|Overall Study||5
473029|NCT01171690|1159439|P2|STARTED|Overall Study||5
473030|NCT01171690|1159440|P1|STARTED|Overall Study||5
473031|NCT01171677|1159450|P2|NOT COMPLETED|Overall Study||3
473032|NCT01171677|1159451|P1|NOT COMPLETED|Overall Study||6
473033|NCT01171677|1159450|P2|COMPLETED|Overall Study||12
473034|NCT01171677|1159451|P1|COMPLETED|Overall Study||11
473035|NCT01171677|1159450|P2|STARTED|Overall Study||15
473036|NCT01171677|1159451|P1|STARTED|Overall Study||17
473037|NCT01171612|1159483|P1|NOT COMPLETED|Overall Study||51
473038|NCT01171612|1159483|P1|COMPLETED|Overall Study||432
473039|NCT01171612|1159483|P1|STARTED|Overall Study||483
473040|NCT01171534|1159493|P2|NOT COMPLETED|Overall Study||3
473041|NCT01171534|1159494|P1|NOT COMPLETED|Overall Study||0
473042|NCT01171534|1159493|P2|COMPLETED|Overall Study||4
473043|NCT01171534|1159494|P1|COMPLETED|Overall Study||0
473044|NCT01171534|1159493|P2|STARTED|Overall Study||7
473045|NCT01171534|1159494|P1|STARTED|Overall Study|retrospective arm never performed on study|0
473046|NCT01171521|1159506|P1|NOT COMPLETED|Overall Study||6
473047|NCT01171521|1159506|P1|COMPLETED|Overall Study||0
473048|NCT01171521|1159506|P1|STARTED|Overall Study||6
473049|NCT01171183|1159513|P2|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||5
473050|NCT01171183|1159514|P1|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||10
473051|NCT01171183|1159513|P2|COMPLETED|Outpatient Participation (Weeks 3-10)||4
473052|NCT01171183|1159514|P1|COMPLETED|Outpatient Participation (Weeks 3-10)||2
473053|NCT01171183|1159513|P2|STARTED|Outpatient Participation (Weeks 3-10)|One subject completed the residential stay but was discharged due to protocol noncompliance.|9
473054|NCT01171183|1159514|P1|STARTED|Outpatient Participation (Weeks 3-10)|One subject completed the residential stay but withdrew prior to starting the outpatient phase.|12
473055|NCT01171183|1159513|P2|NOT COMPLETED|Residential Facility (Weeks 1-2)||6
473056|NCT01171183|1159514|P1|NOT COMPLETED|Residential Facility (Weeks 1-2)||2
473057|NCT01171183|1159513|P2|COMPLETED|Residential Facility (Weeks 1-2)||10
473058|NCT01171183|1159514|P1|COMPLETED|Residential Facility (Weeks 1-2)||13
473059|NCT01171183|1159513|P2|STARTED|Residential Facility (Weeks 1-2)|Subjects receiving at least one dose of study med. One did not due to BP outside study parameters.|16
473060|NCT01171183|1159514|P1|STARTED|Residential Facility (Weeks 1-2)|Those who were admitted to the residential facility and received at least one dose of study med.|15
473061|NCT01171118|1159522|P1|NOT COMPLETED|Overall Study||0
473062|NCT01171118|1159522|P1|COMPLETED|Overall Study||10
473063|NCT01171118|1159522|P1|STARTED|Overall Study||10
473064|NCT01170962|1159535|P3|NOT COMPLETED|Follow up Period||6
473065|NCT01170962|1159536|P2|NOT COMPLETED|Follow up Period||27
473066|NCT01170962|1159537|P1|NOT COMPLETED|Follow up Period||39
473067|NCT01170962|1159535|P3|COMPLETED|Follow up Period||9
473068|NCT01170962|1159536|P2|COMPLETED|Follow up Period||165
473069|NCT01170962|1159537|P1|COMPLETED|Follow up Period||159
473070|NCT01170962|1159535|P3|STARTED|Follow up Period|Out of 17 participants who entered the treatment period, 15 continued in the follow-up period.|15
473071|NCT01170962|1159536|P2|STARTED|Follow up Period|Out of 199 participants who entered the treatment period, 192 continued in the follow-up period.|192
473072|NCT01170962|1159537|P1|STARTED|Follow up Period|Out of 203 participants who entered the treatment period, 198 continued in the follow-up period.|198
473073|NCT01170962|1159535|P3|NOT COMPLETED|Treatment Period||12
473074|NCT01170962|1159536|P2|NOT COMPLETED|Treatment Period||111
473075|NCT01170962|1159537|P1|NOT COMPLETED|Treatment Period||127
473076|NCT01170962|1159535|P3|COMPLETED|Treatment Period||5
473077|NCT01170962|1159536|P2|COMPLETED|Treatment Period||88
473078|NCT01170962|1159537|P1|COMPLETED|Treatment Period||76
473079|NCT01170962|1159535|P3|PDR ­Randomized to 48 Weeks Follow­-up|Treatment Period||0
473080|NCT01170962|1159536|P2|PDR ­Randomized to 48 Weeks Follow­-up|Treatment Period||36
473081|NCT01170962|1159537|P1|PDR ­Randomized to 48 Weeks Follow­-up|Treatment Period||28
473082|NCT01170962|1159535|P3|PDR ­Randomized to 24 Weeks pegIFNα­-2a|Treatment Period||0
473083|NCT01170962|1159536|P2|PDR ­Randomized to 24 Weeks pegIFNα­-2a|Treatment Period||36
473084|NCT01170962|1159537|P1|PDR ­Randomized to 24 Weeks pegIFNα­-2a|Treatment Period||30
473085|NCT01170962|1159535|P3|No PDR|Treatment Period||17
473086|NCT01170962|1159536|P2|No PDR|Treatment Period||127
473087|NCT01170962|1159537|P1|No PDR|Treatment Period||145
473088|NCT01170962|1159535|P3|STARTED|Treatment Period||17
473089|NCT01170962|1159536|P2|STARTED|Treatment Period||199
473090|NCT01170962|1159537|P1|STARTED|Treatment Period||203
473091|NCT01170949|1159583|P2|NOT COMPLETED|Overall Study||4
473092|NCT01170949|1159584|P1|NOT COMPLETED|Overall Study||7
473093|NCT01170949|1159583|P2|COMPLETED|Overall Study||22
473094|NCT01170949|1159584|P1|COMPLETED|Overall Study||43
473095|NCT01170949|1159583|P2|STARTED|Overall Study||26
473096|NCT01170949|1159584|P1|STARTED|Overall Study||50
473097|NCT01170884|1159592|P2|NOT COMPLETED|Overall Study||2
473098|NCT01170884|1159593|P1|NOT COMPLETED|Overall Study||5
473099|NCT01170884|1159592|P2|COMPLETED|Overall Study||60
473100|NCT01170884|1159593|P1|COMPLETED|Overall Study||54
473101|NCT01170884|1159592|P2|STARTED|Overall Study||62
473102|NCT01170884|1159593|P1|STARTED|Overall Study||59
473103|NCT01170754|1159601|P2|NOT COMPLETED|Overall Study||0
473104|NCT01170754|1159602|P1|NOT COMPLETED|Overall Study||0
473105|NCT01170754|1159601|P2|COMPLETED|Overall Study||70
473106|NCT01170754|1159602|P1|COMPLETED|Overall Study||66
473107|NCT01170754|1159601|P2|STARTED|Overall Study||70
473108|NCT01170754|1159602|P1|STARTED|Overall Study||66
473109|NCT01170663|1159632|P2|NOT COMPLETED|Overall Study||20
473110|NCT01170663|1159633|P1|NOT COMPLETED|Overall Study||14
473111|NCT01170663|1159632|P2|COMPLETED|Overall Study||315
473112|NCT01170663|1159633|P1|COMPLETED|Overall Study||316
473113|NCT01170663|1159632|P2|Received Any Treatment (Safety Pop)|Overall Study||329
473114|NCT01170663|1159633|P1|Received Any Treatment (Safety Pop)|Overall Study||327
473115|NCT01170663|1159632|P2|STARTED|Overall Study|Participant was included in the placebo/paclitaxel treatment arm (intent-to-treat (ITT) population).|335
473116|NCT01170663|1159633|P1|STARTED|Overall Study|Participant was included in ramucirumab (IMC-1121B)/paclitaxel treatment arm (safety population).|330
473117|NCT01170598|1159661|P1|NOT COMPLETED|Overall Study||6
473118|NCT01170598|1159661|P1|COMPLETED|Overall Study||29
473119|NCT01170598|1159661|P1|STARTED|Overall Study||35
473120|NCT01170546|1159680|P4|NOT COMPLETED|Overall Study||0
473121|NCT01170546|1159681|P3|NOT COMPLETED|Overall Study||0
473122|NCT01170546|1159682|P2|NOT COMPLETED|Overall Study||0
473123|NCT01170546|1159683|P1|NOT COMPLETED|Overall Study||0
473124|NCT01170546|1159680|P4|COMPLETED|Overall Study||8
473125|NCT01170546|1159681|P3|COMPLETED|Overall Study||6
473126|NCT01170546|1159682|P2|COMPLETED|Overall Study||7
473127|NCT01170546|1159683|P1|COMPLETED|Overall Study||7
473128|NCT01170546|1159680|P4|STARTED|Overall Study||8
473129|NCT01170546|1159681|P3|STARTED|Overall Study||6
473130|NCT01170546|1159682|P2|STARTED|Overall Study||7
473131|NCT01170546|1159683|P1|STARTED|Overall Study||7
473132|NCT01170533|1159693|P2|NOT COMPLETED|Pantoprazole Cross-over||0
473133|NCT01170533|1159694|P1|NOT COMPLETED|Pantoprazole Cross-over||0
473134|NCT01170533|1159693|P2|COMPLETED|Pantoprazole Cross-over||20
473135|NCT01170533|1159694|P1|COMPLETED|Pantoprazole Cross-over||0
473136|NCT01170533|1159693|P2|STARTED|Pantoprazole Cross-over|15 participants continued from omeprazole cross-over; the remaining 5 were new participants|20
473137|NCT01170533|1159694|P1|STARTED|Pantoprazole Cross-over||0
473138|NCT01170533|1159693|P2|NOT COMPLETED|Omeprazole Cross-over||0
473139|NCT01170533|1159694|P1|NOT COMPLETED|Omeprazole Cross-over||0
473140|NCT01170533|1159693|P2|COMPLETED|Omeprazole Cross-over||0
473141|NCT01170533|1159694|P1|COMPLETED|Omeprazole Cross-over||20
473142|NCT01170533|1159693|P2|STARTED|Omeprazole Cross-over||0
473143|NCT01170533|1159694|P1|STARTED|Omeprazole Cross-over||20
473144|NCT01170390|1159706|P3|NOT COMPLETED|Randomized Treatment||0
473145|NCT01170390|1159707|P2|NOT COMPLETED|Randomized Treatment||1
473146|NCT01170390|1159708|P1|NOT COMPLETED|Randomized Treatment||0
473147|NCT01170390|1159706|P3|COMPLETED|Randomized Treatment||15
473148|NCT01170390|1159707|P2|COMPLETED|Randomized Treatment||16
473149|NCT01170390|1159708|P1|COMPLETED|Randomized Treatment||0
473150|NCT01170390|1159706|P3|STARTED|Randomized Treatment||15
473151|NCT01170390|1159707|P2|STARTED|Randomized Treatment||17
473152|NCT01170390|1159708|P1|STARTED|Randomized Treatment||0
473153|NCT01170390|1159706|P3|NOT COMPLETED|Oral Contraceptives||0
473154|NCT01170390|1159707|P2|NOT COMPLETED|Oral Contraceptives||0
473155|NCT01170390|1159708|P1|NOT COMPLETED|Oral Contraceptives||1
473156|NCT01170390|1159706|P3|COMPLETED|Oral Contraceptives||0
473157|NCT01170390|1159707|P2|COMPLETED|Oral Contraceptives||0
473158|NCT01170390|1159708|P1|COMPLETED|Oral Contraceptives||31
473159|NCT01170390|1159706|P3|STARTED|Oral Contraceptives||0
473160|NCT01170390|1159707|P2|STARTED|Oral Contraceptives||0
473161|NCT01170390|1159708|P1|STARTED|Oral Contraceptives||32
473162|NCT01170364|1159724|P2|NOT COMPLETED|Overall Study||1
473163|NCT01170364|1159725|P1|NOT COMPLETED|Overall Study||4
473164|NCT01170364|1159724|P2|COMPLETED|Overall Study|One participant was unable to begin the second testing period due to scheduling conflicts.|5
473165|NCT01170364|1159725|P1|COMPLETED|Overall Study||4
473166|NCT01170364|1159724|P2|STARTED|Overall Study||6
473167|NCT01170364|1159725|P1|STARTED|Overall Study||8
473168|NCT01170273|1159733|P2|NOT COMPLETED|Overall Study||9
473169|NCT01170273|1159734|P1|NOT COMPLETED|Overall Study||8
473170|NCT01170273|1159733|P2|COMPLETED|Overall Study||57
473171|NCT01170273|1159734|P1|COMPLETED|Overall Study||56
473172|NCT01170273|1159733|P2|STARTED|Overall Study||66
473173|NCT01170273|1159734|P1|STARTED|Overall Study||64
473174|NCT01170247|1159742|P2|NOT COMPLETED|Overall Study||0
473175|NCT01170247|1159743|P1|NOT COMPLETED|Overall Study||0
473176|NCT01170247|1159742|P2|COMPLETED|Overall Study||1
473177|NCT01170247|1159743|P1|COMPLETED|Overall Study||2
473178|NCT01170247|1159742|P2|STARTED|Overall Study||1
473179|NCT01170247|1159743|P1|STARTED|Overall Study||2
473180|NCT01170221|1159751|P2|NOT COMPLETED|Overall Study||28
473181|NCT01170221|1159752|P1|NOT COMPLETED|Overall Study||33
473182|NCT01170221|1159751|P2|COMPLETED|Overall Study||307
473183|NCT01170221|1159752|P1|COMPLETED|Overall Study||299
473184|NCT01170221|1159751|P2|STARTED|Overall Study||335
473185|NCT01170221|1159752|P1|STARTED|Overall Study||332
473186|NCT01170208|1159775|P3|NOT COMPLETED|Overall Study||2
473187|NCT01170208|1159776|P2|NOT COMPLETED|Overall Study||0
473188|NCT01170208|1159777|P1|NOT COMPLETED|Overall Study||6
473189|NCT01170208|1159775|P3|COMPLETED|Overall Study||4
473190|NCT01170208|1159776|P2|COMPLETED|Overall Study||20
473191|NCT01170208|1159777|P1|COMPLETED|Overall Study||14
473192|NCT01170208|1159775|P3|STARTED|Overall Study||6
473193|NCT01170208|1159776|P2|STARTED|Overall Study||20
473194|NCT01170208|1159777|P1|STARTED|Overall Study||20
473201|NCT01170091|1159796|P1|NOT COMPLETED|Overall Study||24
473202|NCT01170091|1159796|P1|COMPLETED|Overall Study||627
473203|NCT01170091|1159796|P1|STARTED|Overall Study||651
473204|NCT01170039|1159805|P2|NOT COMPLETED|Overall Study||6
473205|NCT01170039|1159806|P1|NOT COMPLETED|Overall Study||8
473206|NCT01170039|1159805|P2|COMPLETED|Overall Study||33
473207|NCT01170039|1159806|P1|COMPLETED|Overall Study||29
473208|NCT01170039|1159805|P2|STARTED|Overall Study||39
473209|NCT01170039|1159806|P1|STARTED|Overall Study||37
473210|NCT01169987|1159818|P1|NOT COMPLETED|Overall Study||31
473211|NCT01169987|1159818|P1|COMPLETED|Overall Study||160
473212|NCT01169987|1159818|P1|STARTED|Overall Study||191
473213|NCT01169779|1159884|P2|NOT COMPLETED|Overall Study||17
473214|NCT01169779|1159885|P1|NOT COMPLETED|Overall Study||11
473215|NCT01169779|1159884|P2|COMPLETED|Overall Study||179
473216|NCT01169779|1159885|P1|COMPLETED|Overall Study||184
473217|NCT01169779|1159884|P2|Subgroup for Standardized Meal Test|Overall Study||121
473218|NCT01169779|1159885|P1|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal test was performed.|130
473219|NCT01169779|1159884|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||195
473220|NCT01169779|1159885|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|193
473221|NCT01169779|1159884|P2|Treated/Safety Population|Overall Study||196
473222|NCT01169779|1159885|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|194
473223|NCT01169779|1159884|P2|STARTED|Overall Study||196
473224|NCT01169779|1159885|P1|STARTED|Overall Study|Randomized.|195
473225|NCT01169753|1159911|P2|NOT COMPLETED|Overall Study||1
473226|NCT01169753|1159912|P1|NOT COMPLETED|Overall Study||0
473227|NCT01169753|1159911|P2|COMPLETED|Overall Study||0
473228|NCT01169753|1159912|P1|COMPLETED|Overall Study||0
473229|NCT01169753|1159911|P2|STARTED|Overall Study||1
473230|NCT01169753|1159912|P1|STARTED|Overall Study||0
473231|NCT01169701|1159920|P2|NOT COMPLETED|Overall Study||10
473232|NCT01169701|1159921|P1|NOT COMPLETED|Overall Study||5
473233|NCT01169701|1159920|P2|COMPLETED|Overall Study||25
473234|NCT01169701|1159921|P1|COMPLETED|Overall Study||31
473235|NCT01169701|1159920|P2|Intent to Treat (ITT) Set|Overall Study||28
473236|NCT01169701|1159921|P1|Intent to Treat (ITT) Set|Overall Study||32
473237|NCT01169701|1159920|P2|Safety Set|Overall Study||35
473238|NCT01169701|1159921|P1|Safety Set|Overall Study||36
473239|NCT01169701|1159920|P2|STARTED|Overall Study||35
473240|NCT01169701|1159921|P1|STARTED|Overall Study||36
473241|NCT01169675|1159958|P5|NOT COMPLETED|Overall Study||6
473242|NCT01169675|1159959|P4|NOT COMPLETED|Overall Study||17
473243|NCT01169675|1159960|P3|NOT COMPLETED|Overall Study||7
473244|NCT01169675|1159961|P2|NOT COMPLETED|Overall Study||3
473245|NCT01169675|1159962|P1|NOT COMPLETED|Overall Study||20
473246|NCT01169675|1159958|P5|COMPLETED|Overall Study||0
473247|NCT01169675|1159959|P4|COMPLETED|Overall Study||0
473248|NCT01169675|1159960|P3|COMPLETED|Overall Study||0
473249|NCT01169675|1159961|P2|COMPLETED|Overall Study||0
473250|NCT01169675|1159962|P1|COMPLETED|Overall Study||0
473251|NCT01169675|1159958|P5|STARTED|Overall Study||6
473252|NCT01169675|1159959|P4|STARTED|Overall Study||17
473253|NCT01169675|1159960|P3|STARTED|Overall Study||7
473254|NCT01169675|1159961|P2|STARTED|Overall Study||3
473255|NCT01169675|1159962|P1|STARTED|Overall Study||20
473256|NCT01169649|1159999|P1|NOT COMPLETED|Overall Study||3
473257|NCT01169649|1159999|P1|COMPLETED|Overall Study||8
473258|NCT01169649|1159999|P1|STARTED|Overall Study||11
473259|NCT01169610|1160003|P1|NOT COMPLETED|Overall Study||0
473260|NCT01169610|1160003|P1|COMPLETED|Overall Study||1
473261|NCT01169610|1160003|P1|STARTED|Overall Study||1
473262|NCT01169558|1160011|P1|NOT COMPLETED|Overall Study||156
473263|NCT01169558|1160011|P1|COMPLETED|Overall Study||6
473264|NCT01169558|1160011|P1|STARTED|Overall Study||162
473265|NCT01169519|1160018|P1|NOT COMPLETED|Overall Study||0
473266|NCT01169519|1160018|P1|COMPLETED|Overall Study||21
473267|NCT01169519|1160018|P1|STARTED|Overall Study|This was a pre-post study, All patients receiving a baseline assessment, also received sildenafil.|21
473268|NCT01169493|1160036|P6|NOT COMPLETED|Period 3 (6 Months)||0
473269|NCT01169493|1160037|P5|NOT COMPLETED|Period 3 (6 Months)||0
473270|NCT01169493|1160038|P4|NOT COMPLETED|Period 3 (6 Months)||0
473271|NCT01169493|1160039|P3|NOT COMPLETED|Period 3 (6 Months)||1
473272|NCT01169493|1160040|P2|NOT COMPLETED|Period 3 (6 Months)||2
473273|NCT01169493|1160041|P1|NOT COMPLETED|Period 3 (6 Months)||0
473274|NCT01169493|1160036|P6|COMPLETED|Period 3 (6 Months)||2
473275|NCT01169493|1160037|P5|COMPLETED|Period 3 (6 Months)||0
473276|NCT01169493|1160038|P4|COMPLETED|Period 3 (6 Months)||0
473277|NCT01169493|1160039|P3|COMPLETED|Period 3 (6 Months)||2
473278|NCT01169493|1160040|P2|COMPLETED|Period 3 (6 Months)||1
473279|NCT01169493|1160041|P1|COMPLETED|Period 3 (6 Months)||2
473280|NCT01169493|1160036|P6|STARTED|Period 3 (6 Months)||2
473281|NCT01169493|1160037|P5|STARTED|Period 3 (6 Months)||0
473282|NCT01169493|1160038|P4|STARTED|Period 3 (6 Months)||0
473283|NCT01169493|1160039|P3|STARTED|Period 3 (6 Months)||3
473284|NCT01169493|1160040|P2|STARTED|Period 3 (6 Months)||3
473285|NCT01169493|1160041|P1|STARTED|Period 3 (6 Months)||2
473286|NCT01169493|1160036|P6|NOT COMPLETED|Period 2 (6 Months)||0
473287|NCT01169493|1160037|P5|NOT COMPLETED|Period 2 (6 Months)||0
473288|NCT01169493|1160038|P4|NOT COMPLETED|Period 2 (6 Months)||0
473289|NCT01169493|1160039|P3|NOT COMPLETED|Period 2 (6 Months)||0
473290|NCT01169493|1160040|P2|NOT COMPLETED|Period 2 (6 Months)||0
473291|NCT01169493|1160041|P1|NOT COMPLETED|Period 2 (6 Months)||0
473292|NCT01169493|1160036|P6|COMPLETED|Period 2 (6 Months)||2
473293|NCT01169493|1160037|P5|COMPLETED|Period 2 (6 Months)||0
473294|NCT01169493|1160038|P4|COMPLETED|Period 2 (6 Months)||0
473295|NCT01169493|1160039|P3|COMPLETED|Period 2 (6 Months)||3
473296|NCT01169493|1160040|P2|COMPLETED|Period 2 (6 Months)||3
473297|NCT01169493|1160041|P1|COMPLETED|Period 2 (6 Months)||2
473298|NCT01169493|1160036|P6|STARTED|Period 2 (6 Months)||2
473299|NCT01169493|1160037|P5|STARTED|Period 2 (6 Months)||0
473300|NCT01169493|1160038|P4|STARTED|Period 2 (6 Months)||0
473301|NCT01169493|1160039|P3|STARTED|Period 2 (6 Months)||3
473302|NCT01169493|1160040|P2|STARTED|Period 2 (6 Months)||3
473303|NCT01169493|1160041|P1|STARTED|Period 2 (6 Months)||2
473304|NCT01169493|1160036|P6|NOT COMPLETED|Period 1 (6 Months)||3
473305|NCT01169493|1160037|P5|NOT COMPLETED|Period 1 (6 Months)||0
473306|NCT01169493|1160038|P4|NOT COMPLETED|Period 1 (6 Months)||0
473307|NCT01169493|1160039|P3|NOT COMPLETED|Period 1 (6 Months)||2
473308|NCT01169493|1160040|P2|NOT COMPLETED|Period 1 (6 Months)||1
473309|NCT01169493|1160041|P1|NOT COMPLETED|Period 1 (6 Months)||0
473310|NCT01169493|1160036|P6|COMPLETED|Period 1 (6 Months)||2
473311|NCT01169493|1160037|P5|COMPLETED|Period 1 (6 Months)||0
473312|NCT01169493|1160038|P4|COMPLETED|Period 1 (6 Months)||0
473313|NCT01169493|1160039|P3|COMPLETED|Period 1 (6 Months)||3
473314|NCT01169493|1160040|P2|COMPLETED|Period 1 (6 Months)||3
473315|NCT01169493|1160041|P1|COMPLETED|Period 1 (6 Months)||2
473316|NCT01169493|1160036|P6|STARTED|Period 1 (6 Months)||5
473317|NCT01169493|1160037|P5|STARTED|Period 1 (6 Months)||0
473318|NCT01169493|1160038|P4|STARTED|Period 1 (6 Months)||0
473319|NCT01169493|1160039|P3|STARTED|Period 1 (6 Months)||5
473320|NCT01169493|1160040|P2|STARTED|Period 1 (6 Months)||4
473321|NCT01169493|1160041|P1|STARTED|Period 1 (6 Months)||2
473322|NCT01169467|1160072|P2|NOT COMPLETED|Overall Study||4
473323|NCT01169467|1160073|P1|NOT COMPLETED|Overall Study||7
473324|NCT01169467|1160072|P2|COMPLETED|Overall Study||36
473325|NCT01169467|1160073|P1|COMPLETED|Overall Study||37
473326|NCT01169467|1160072|P2|STARTED|Overall Study||40
473327|NCT01169467|1160073|P1|STARTED|Overall Study||44
473328|NCT01169350|1160087|P1|NOT COMPLETED|Overall Study||5
473329|NCT01169350|1160087|P1|COMPLETED|Overall Study||3
473330|NCT01169350|1160087|P1|STARTED|Overall Study||8
473331|NCT01169311|1160094|P1|NOT COMPLETED|Overall Study||0
473332|NCT01169311|1160094|P1|COMPLETED|Overall Study||27
473333|NCT01169311|1160094|P1|STARTED|Overall Study||27
473334|NCT01169103|1160108|P2|NOT COMPLETED|Overall Study||4
473335|NCT01169103|1160109|P1|NOT COMPLETED|Overall Study||6
473336|NCT01169103|1160108|P2|COMPLETED|Overall Study||7
473337|NCT01169103|1160109|P1|COMPLETED|Overall Study||5
473338|NCT01169103|1160108|P2|STARTED|Overall Study||11
473339|NCT01169103|1160109|P1|STARTED|Overall Study||11
473340|NCT01169064|1160125|P2|NOT COMPLETED|Overall Study||0
473341|NCT01169064|1160126|P1|NOT COMPLETED|Overall Study||0
473342|NCT01169064|1160125|P2|COMPLETED|Overall Study||236
473343|NCT01169064|1160126|P1|COMPLETED|Overall Study||239
473344|NCT01169064|1160125|P2|STARTED|Overall Study||236
473345|NCT01169064|1160126|P1|STARTED|Overall Study||239
473346|NCT01169038|1160136|P1|NOT COMPLETED|Overall Study||7
473347|NCT01169038|1160136|P1|COMPLETED|Overall Study||8
473348|NCT01169038|1160136|P1|STARTED|Overall Study||15
473349|NCT01168999|1160144|P4|NOT COMPLETED|Overall Study||0
473350|NCT01168999|1160145|P3|NOT COMPLETED|Overall Study||0
473351|NCT01168999|1160146|P2|NOT COMPLETED|Overall Study||1
473352|NCT01168999|1160147|P1|NOT COMPLETED|Overall Study||2
473353|NCT01168999|1160144|P4|COMPLETED|Overall Study||28
473354|NCT01168999|1160145|P3|COMPLETED|Overall Study||27
473355|NCT01168999|1160146|P2|COMPLETED|Overall Study||26
473356|NCT01168999|1160147|P1|COMPLETED|Overall Study||26
473357|NCT01168999|1160144|P4|STARTED|Overall Study||28
473358|NCT01168999|1160145|P3|STARTED|Overall Study||27
473359|NCT01168999|1160146|P2|STARTED|Overall Study||27
473360|NCT01168999|1160147|P1|STARTED|Overall Study||28
473361|NCT01168986|1160192|P3|NOT COMPLETED|Overall Study||0
473362|NCT01168986|1160193|P2|NOT COMPLETED|Overall Study||1
473363|NCT01168986|1160194|P1|NOT COMPLETED|Overall Study||2
473364|NCT01168986|1160192|P3|COMPLETED|Overall Study||21
473365|NCT01168986|1160193|P2|COMPLETED|Overall Study||20
473366|NCT01168986|1160194|P1|COMPLETED|Overall Study||18
473367|NCT01168986|1160192|P3|STARTED|Overall Study||21
473368|NCT01168986|1160193|P2|STARTED|Overall Study||21
473369|NCT01168986|1160194|P1|STARTED|Overall Study||20
473370|NCT01168973|1160213|P2|NOT COMPLETED|Overall Study||611
473371|NCT01168973|1160214|P1|NOT COMPLETED|Overall Study||613
473372|NCT01168973|1160213|P2|COMPLETED|Overall Study||14
473373|NCT01168973|1160214|P1|COMPLETED|Overall Study||15
473374|NCT01168973|1160213|P2|Received Any Quantity of Any Study Drug|Overall Study|Three participants randomized to placebo and docetaxel received 1 dose of ramucirumab in error.|621
473375|NCT01168973|1160214|P1|Received Any Quantity of Any Study Drug|Overall Study||624
473376|NCT01168973|1160213|P2|STARTED|Overall Study||625
473377|NCT01168973|1160214|P1|STARTED|Overall Study||628
473378|NCT01168934|1160235|P2|NOT COMPLETED|Second Intervention Period||0
473379|NCT01168934|1160236|P1|NOT COMPLETED|Second Intervention Period||0
473380|NCT01168934|1160235|P2|COMPLETED|Second Intervention Period||7
473381|NCT01168934|1160236|P1|COMPLETED|Second Intervention Period||7
473382|NCT01168934|1160235|P2|STARTED|Second Intervention Period||7
473383|NCT01168934|1160236|P1|STARTED|Second Intervention Period||7
473384|NCT01168934|1160235|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
473385|NCT01168934|1160236|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
473386|NCT01168934|1160235|P2|COMPLETED|Washout Period (at Least 14 Days)||7
473387|NCT01168934|1160236|P1|COMPLETED|Washout Period (at Least 14 Days)||7
473388|NCT01168934|1160235|P2|STARTED|Washout Period (at Least 14 Days)||7
473389|NCT01168934|1160236|P1|STARTED|Washout Period (at Least 14 Days)||7
473390|NCT01168934|1160235|P2|NOT COMPLETED|First Intervention Period||0
473391|NCT01168934|1160236|P1|NOT COMPLETED|First Intervention Period||0
473392|NCT01168934|1160235|P2|COMPLETED|First Intervention Period||7
473393|NCT01168934|1160236|P1|COMPLETED|First Intervention Period||7
473394|NCT01168934|1160235|P2|STARTED|First Intervention Period||7
473395|NCT01168934|1160236|P1|STARTED|First Intervention Period||7
473396|NCT01168908|1160270|P2|NOT COMPLETED|Open Label||1
473397|NCT01168908|1160271|P1|NOT COMPLETED|Open Label||1
473398|NCT01168908|1160270|P2|COMPLETED|Open Label||7
473399|NCT01168908|1160271|P1|COMPLETED|Open Label||6
473400|NCT01168908|1160270|P2|STARTED|Open Label||8
473401|NCT01168908|1160271|P1|STARTED|Open Label||7
473402|NCT01168908|1160270|P2|NOT COMPLETED|Double Blind, Placebo Controlled||2
473403|NCT01168908|1160271|P1|NOT COMPLETED|Double Blind, Placebo Controlled||3
473404|NCT01168908|1160270|P2|COMPLETED|Double Blind, Placebo Controlled||8
473405|NCT01168908|1160271|P1|COMPLETED|Double Blind, Placebo Controlled||7
473406|NCT01168908|1160270|P2|STARTED|Double Blind, Placebo Controlled||10
473407|NCT01168908|1160271|P1|STARTED|Double Blind, Placebo Controlled||10
473408|NCT01168856|1160287|P2|NOT COMPLETED|Overall Study||343
473409|NCT01168856|1160288|P1|NOT COMPLETED|Overall Study||18
473410|NCT01168856|1160287|P2|COMPLETED|Overall Study||215
473411|NCT01168856|1160288|P1|COMPLETED|Overall Study||158
473412|NCT01168856|1160287|P2|STARTED|Overall Study||558
473413|NCT01168856|1160288|P1|STARTED|Overall Study||176
473414|NCT01168726|1160348|P3|NOT COMPLETED|Overall Study||5
473415|NCT01168726|1160349|P2|NOT COMPLETED|Overall Study||9
473416|NCT01168726|1160350|P1|NOT COMPLETED|Overall Study||8
473417|NCT01168726|1160348|P3|COMPLETED|Overall Study||128
473418|NCT01168726|1160349|P2|COMPLETED|Overall Study||112
473419|NCT01168726|1160350|P1|COMPLETED|Overall Study||103
473420|NCT01168726|1160348|P3|STARTED|Overall Study||133
473421|NCT01168726|1160349|P2|STARTED|Overall Study||121
473422|NCT01168726|1160350|P1|STARTED|Overall Study||111
473423|NCT01168687|1160369|P2|NOT COMPLETED|Overall Study||0
473424|NCT01168687|1160370|P1|NOT COMPLETED|Overall Study||0
473425|NCT01168687|1160369|P2|COMPLETED|Overall Study||23
473426|NCT01168687|1160370|P1|COMPLETED|Overall Study||23
473427|NCT01168687|1160369|P2|STARTED|Overall Study||23
473428|NCT01168687|1160370|P1|STARTED|Overall Study||23
473429|NCT01168674|1160376|P2|NOT COMPLETED|Overall Study||0
473430|NCT01168674|1160377|P1|NOT COMPLETED|Overall Study||0
473431|NCT01168674|1160376|P2|COMPLETED|Overall Study||24
473432|NCT01168674|1160377|P1|COMPLETED|Overall Study||25
473433|NCT01168674|1160376|P2|STARTED|Overall Study||24
473434|NCT01168674|1160377|P1|STARTED|Overall Study||25
473435|NCT01168596|1160386|P2|NOT COMPLETED|Overall Study||1
473436|NCT01168596|1160387|P1|NOT COMPLETED|Overall Study||3
473437|NCT01168596|1160386|P2|COMPLETED|Overall Study||13
473438|NCT01168596|1160387|P1|COMPLETED|Overall Study||13
473439|NCT01168596|1160386|P2|STARTED|Overall Study||14
473440|NCT01168596|1160387|P1|STARTED|Overall Study||16
473441|NCT01168427|1160431|P1|NOT COMPLETED|Overall Study||1
473442|NCT01168427|1160431|P1|COMPLETED|Overall Study||65
473443|NCT01168427|1160431|P1|STARTED|Overall Study||66
473444|NCT01168349|1160436|P1|NOT COMPLETED|Overall Study||301
473445|NCT01168349|1160436|P1|COMPLETED|Overall Study||754
473446|NCT01168349|1160436|P1|STARTED|Overall Study||1055
473447|NCT01168232|1160542|P1|NOT COMPLETED|Overall Study||8
473448|NCT01168232|1160542|P1|COMPLETED|Overall Study|Eligible and treated patients|34
473449|NCT01168232|1160542|P1|STARTED|Overall Study||42
473450|NCT01168219|1160549|P1|NOT COMPLETED|Overall Study||0
473451|NCT01168219|1160549|P1|COMPLETED|Overall Study||68
473452|NCT01168219|1160549|P1|STARTED|Overall Study||68
473453|NCT01168024|1160555|P2|NOT COMPLETED|Overall Study||0
473454|NCT01168024|1160556|P1|NOT COMPLETED|Overall Study||0
473455|NCT01168024|1160555|P2|COMPLETED|Overall Study||3
473456|NCT01168024|1160556|P1|COMPLETED|Overall Study||13
473457|NCT01168024|1160555|P2|STARTED|Overall Study||3
473458|NCT01168024|1160556|P1|STARTED|Overall Study|13 tx/3 controls. Roll-ins occurred for product training, several more treatment cases than control.|13
473459|NCT01167907|1160570|P2|NOT COMPLETED|Overall Study||1
473460|NCT01167907|1160571|P1|NOT COMPLETED|Overall Study||2
473461|NCT01167907|1160570|P2|COMPLETED|Overall Study||14
473462|NCT01167907|1160571|P1|COMPLETED|Overall Study||15
473463|NCT01167907|1160570|P2|STARTED|Overall Study||15
473464|NCT01167907|1160571|P1|STARTED|Overall Study||17
473465|NCT01167881|1160589|P2|NOT COMPLETED|Overall Study||191
473466|NCT01167881|1160590|P1|NOT COMPLETED|Overall Study||159
473467|NCT01167881|1160589|P2|COMPLETED|Overall Study||589
473468|NCT01167881|1160590|P1|COMPLETED|Overall Study||610
473469|NCT01167881|1160589|P2|Completed After 4 Years Treatment|Overall Study||462
473470|NCT01167881|1160590|P1|Completed After 4 Years Treatment|Overall Study||515
473471|NCT01167881|1160589|P2|Completed After 2 Years Treatment|Overall Study||127
473472|NCT01167881|1160590|P1|Completed After 2 Years Treatment|Overall Study||95
473473|NCT01167881|1160589|P2|STARTED|Overall Study||780
473474|NCT01167881|1160590|P1|STARTED|Overall Study||769
473475|NCT01167829|1160614|P1|NOT COMPLETED|Overall Study||0
473476|NCT01167829|1160614|P1|COMPLETED|Overall Study||12
473477|NCT01167829|1160614|P1|STARTED|Overall Study||12
473478|NCT01167712|1160629|P2|NOT COMPLETED|Overall Study||0
473479|NCT01167712|1160630|P1|NOT COMPLETED|Overall Study||0
473480|NCT01167712|1160629|P2|COMPLETED|Overall Study||346
473481|NCT01167712|1160630|P1|COMPLETED|Overall Study||346
473482|NCT01167712|1160629|P2|STARTED|Overall Study||346
473483|NCT01167712|1160630|P1|STARTED|Overall Study||346
473484|NCT01167634|1160644|P4|NOT COMPLETED|Overall Study||4
473485|NCT01167634|1160645|P3|NOT COMPLETED|Overall Study||3
473486|NCT01167634|1160646|P2|NOT COMPLETED|Overall Study||4
473487|NCT01167634|1160647|P1|NOT COMPLETED|Overall Study||2
473488|NCT01167634|1160644|P4|COMPLETED|Overall Study||29
473489|NCT01167634|1160645|P3|COMPLETED|Overall Study||30
473490|NCT01167634|1160646|P2|COMPLETED|Overall Study||29
473491|NCT01167634|1160647|P1|COMPLETED|Overall Study||31
473492|NCT01167634|1160644|P4|STARTED|Overall Study||33
473493|NCT01167634|1160645|P3|STARTED|Overall Study||33
473494|NCT01167634|1160646|P2|STARTED|Overall Study||33
473495|NCT01167634|1160647|P1|STARTED|Overall Study||33
473496|NCT01167608|1160657|P1|NOT COMPLETED|Overall Study||114
473497|NCT01167608|1160657|P1|COMPLETED|Overall Study||769
473498|NCT01167608|1160657|P1|STARTED|Overall Study||883
473499|NCT01167582|1160668|P2|NOT COMPLETED|Overall Study||1
473500|NCT01167582|1160669|P1|NOT COMPLETED|Overall Study||0
473501|NCT01167582|1160668|P2|COMPLETED|Overall Study||54
473502|NCT01167582|1160669|P1|COMPLETED|Overall Study||55
473503|NCT01167582|1160668|P2|STARTED|Overall Study||55
473504|NCT01167582|1160669|P1|STARTED|Overall Study||55
473505|NCT01167504|1160681|P1|NOT COMPLETED|Overall Study||3
473506|NCT01167504|1160681|P1|COMPLETED|Overall Study||12
473507|NCT01167504|1160681|P1|STARTED|Overall Study||15
473508|NCT01167452|1160686|P1|NOT COMPLETED|Overall Study||0
473509|NCT01167452|1160686|P1|COMPLETED|Overall Study||36
473510|NCT01167452|1160686|P1|STARTED|Overall Study||36
473511|NCT01167426|1160691|P1|NOT COMPLETED|Overall Study||10
473512|NCT01167426|1160691|P1|COMPLETED|Overall Study||138
473513|NCT01167426|1160691|P1|STARTED|Overall Study||148
473514|NCT01167257|1160699|P2|NOT COMPLETED|Overall Study||3
473515|NCT01167257|1160700|P1|NOT COMPLETED|Overall Study||3
473516|NCT01167257|1160699|P2|COMPLETED|Overall Study||28
473517|NCT01167257|1160700|P1|COMPLETED|Overall Study||28
473518|NCT01167257|1160699|P2|STARTED|Overall Study||31
473519|NCT01167257|1160700|P1|STARTED|Overall Study||31
473520|NCT01167192|1160722|P1|NOT COMPLETED|Overall Study||4
473521|NCT01167192|1160722|P1|COMPLETED|Overall Study||6
473522|NCT01167192|1160722|P1|STARTED|Overall Study||10
473523|NCT01167179|1160739|P2|NOT COMPLETED|Overall Study||21
473524|NCT01167179|1160740|P1|NOT COMPLETED|Overall Study||15
473525|NCT01167179|1160739|P2|COMPLETED|Overall Study||59
473526|NCT01167179|1160740|P1|COMPLETED|Overall Study||65
473527|NCT01167179|1160739|P2|STARTED|Overall Study||80
473528|NCT01167179|1160740|P1|STARTED|Overall Study||80
473529|NCT01167153|1160750|P2|NOT COMPLETED|Overall Study||33
473530|NCT01167153|1160751|P1|NOT COMPLETED|Overall Study||18
473531|NCT01167153|1160750|P2|COMPLETED|Overall Study||249
473532|NCT01167153|1160751|P1|COMPLETED|Overall Study||264
473533|NCT01167153|1160750|P2|Intention to Treat (ITT)|Overall Study||268
473534|NCT01167153|1160751|P1|Intention to Treat (ITT)|Overall Study||272
473535|NCT01167153|1160750|P2|STARTED|Overall Study||282
473536|NCT01167153|1160751|P1|STARTED|Overall Study||282
473537|NCT01167140|1160769|P1|NOT COMPLETED|Overall Study||1
473538|NCT01167140|1160769|P1|COMPLETED|Overall Study||41
473539|NCT01167140|1160769|P1|STARTED|Overall Study||42
473540|NCT01167023|1160777|P3|NOT COMPLETED|Overall Study||2
473541|NCT01167023|1160778|P2|NOT COMPLETED|Overall Study||3
473542|NCT01167023|1160779|P1|NOT COMPLETED|Overall Study||0
473543|NCT01167023|1160777|P3|COMPLETED|Overall Study||39
473544|NCT01167023|1160778|P2|COMPLETED|Overall Study||18
473545|NCT01167023|1160779|P1|COMPLETED|Overall Study||0
473546|NCT01167023|1160777|P3|Received at Least 1 Dose of Study Drug|Overall Study||41
473547|NCT01167023|1160778|P2|Received at Least 1 Dose of Study Drug|Overall Study||19
473548|NCT01167023|1160779|P1|Received at Least 1 Dose of Study Drug|Overall Study||0
473549|NCT01167023|1160777|P3|STARTED|Overall Study||41
473550|NCT01167023|1160778|P2|STARTED|Overall Study||21
473551|NCT01167023|1160779|P1|STARTED|Overall Study||0
473552|NCT01166997|1160799|P2|NOT COMPLETED|Overall Study||0
473553|NCT01166997|1160800|P1|NOT COMPLETED|Overall Study||2
473554|NCT01166997|1160799|P2|COMPLETED|Overall Study||30
473555|NCT01166997|1160800|P1|COMPLETED|Overall Study||27
473556|NCT01166997|1160799|P2|STARTED|Overall Study||30
473557|NCT01166997|1160800|P1|STARTED|Overall Study||29
473558|NCT01166971|1160810|P2|NOT COMPLETED|Overall Study||1
473559|NCT01166971|1160811|P1|NOT COMPLETED|Overall Study||1
473560|NCT01166971|1160810|P2|COMPLETED|Overall Study||30
473561|NCT01166971|1160811|P1|COMPLETED|Overall Study||32
473562|NCT01166971|1160810|P2|STARTED|Overall Study||31
473563|NCT01166971|1160811|P1|STARTED|Overall Study||33
473564|NCT01166958|1160819|P2|NOT COMPLETED|Overall Study||0
473565|NCT01166958|1160820|P1|NOT COMPLETED|Overall Study||1
473566|NCT01166958|1160819|P2|COMPLETED|Overall Study||13
473567|NCT01166958|1160820|P1|COMPLETED|Overall Study||12
473568|NCT01166958|1160819|P2|STARTED|Overall Study||13
473569|NCT01166958|1160820|P1|STARTED|Overall Study||13
473570|NCT01166763|1160834|P1|NOT COMPLETED|Overall Study||3
473571|NCT01166763|1160834|P1|COMPLETED|Overall Study||27
473572|NCT01166763|1160834|P1|STARTED|Overall Study||30
473573|NCT01166750|1160842|P2|NOT COMPLETED|Overall Study||0
473574|NCT01166750|1160843|P1|NOT COMPLETED|Overall Study||1
473575|NCT01166750|1160842|P2|COMPLETED|Overall Study||13
473576|NCT01166750|1160843|P1|COMPLETED|Overall Study||9
473577|NCT01166750|1160842|P2|STARTED|Overall Study||13
473578|NCT01166750|1160843|P1|STARTED|Overall Study||10
473579|NCT01166724|1160851|P2|NOT COMPLETED|Overall Study||5
473580|NCT01166724|1160852|P1|NOT COMPLETED|Overall Study||7
473581|NCT01166724|1160851|P2|COMPLETED|Overall Study||0
473582|NCT01166724|1160852|P1|COMPLETED|Overall Study||0
473583|NCT01166724|1160851|P2|STARTED|Overall Study||5
473584|NCT01166724|1160852|P1|STARTED|Overall Study||7
473585|NCT01166659|1160860|P1|NOT COMPLETED|Overall Study||13
473586|NCT01166659|1160860|P1|COMPLETED|Overall Study||35
473587|NCT01166659|1160860|P1|STARTED|Overall Study||48
473588|NCT01166646|1160869|P2|NOT COMPLETED|Overall Study||1
473589|NCT01166646|1160870|P1|NOT COMPLETED|Overall Study||1
473590|NCT01166646|1160869|P2|COMPLETED|Overall Study||21
473591|NCT01166646|1160870|P1|COMPLETED|Overall Study||20
473592|NCT01166646|1160869|P2|STARTED|Overall Study||22
473593|NCT01166646|1160870|P1|STARTED|Overall Study||21
473594|NCT01166438|1160888|P2|NOT COMPLETED|Off Treatment Follow-up Phase||56
473595|NCT01166438|1160889|P1|NOT COMPLETED|Off Treatment Follow-up Phase||34
473596|NCT01166438|1160888|P2|COMPLETED|Off Treatment Follow-up Phase||33
473597|NCT01166438|1160889|P1|COMPLETED|Off Treatment Follow-up Phase||51
473598|NCT01166438|1160888|P2|STARTED|Off Treatment Follow-up Phase||89
473599|NCT01166438|1160889|P1|STARTED|Off Treatment Follow-up Phase||85
473600|NCT01166438|1160888|P2|NOT COMPLETED|Double-blind Phase: 1st 6 Months||9
473601|NCT01166438|1160889|P1|NOT COMPLETED|Double-blind Phase: 1st 6 Months||9
473602|NCT01166438|1160888|P2|COMPLETED|Double-blind Phase: 1st 6 Months|Completion of 12 month follow-up visit|118
473603|NCT01166438|1160889|P1|COMPLETED|Double-blind Phase: 1st 6 Months|Completion of 12 month follow-up visit|113
473604|NCT01166438|1160888|P2|Treated|Double-blind Phase: 1st 6 Months||126
473605|NCT01166438|1160889|P1|Treated|Double-blind Phase: 1st 6 Months||121
473606|NCT01166438|1160888|P2|STARTED|Double-blind Phase: 1st 6 Months||127
473607|NCT01166438|1160889|P1|STARTED|Double-blind Phase: 1st 6 Months||122
473608|NCT01166347|1160905|P2|NOT COMPLETED|Overall Study||1
473609|NCT01166347|1160906|P1|NOT COMPLETED|Overall Study||2
473610|NCT01166347|1160905|P2|COMPLETED|Overall Study||148
473611|NCT01166347|1160906|P1|COMPLETED|Overall Study||295
473612|NCT01166347|1160905|P2|STARTED|Overall Study||149
473613|NCT01166347|1160906|P1|STARTED|Overall Study||297
473614|NCT01166282|1160938|P3|NOT COMPLETED|Open-label Period||17
473615|NCT01166282|1160939|P2|NOT COMPLETED|Open-label Period||0
473616|NCT01166282|1160940|P1|NOT COMPLETED|Open-label Period||0
473617|NCT01166282|1160938|P3|COMPLETED|Open-label Period||29
473618|NCT01166282|1160939|P2|COMPLETED|Open-label Period||0
473619|NCT01166282|1160940|P1|COMPLETED|Open-label Period||0
473620|NCT01166282|1160938|P3|STARTED|Open-label Period||46
473621|NCT01166282|1160939|P2|STARTED|Open-label Period||0
473622|NCT01166282|1160940|P1|STARTED|Open-label Period||0
473623|NCT01166282|1160938|P3|NOT COMPLETED|Double-blind Period||0
473624|NCT01166282|1160939|P2|NOT COMPLETED|Double-blind Period||0
473625|NCT01166282|1160940|P1|NOT COMPLETED|Double-blind Period||0
473626|NCT01166282|1160938|P3|COMPLETED|Double-blind Period||0
473627|NCT01166282|1160939|P2|COMPLETED|Double-blind Period||31
473628|NCT01166282|1160940|P1|COMPLETED|Double-blind Period||15
473629|NCT01166282|1160938|P3|STARTED|Double-blind Period||0
473630|NCT01166282|1160939|P2|STARTED|Double-blind Period||31
473631|NCT01166282|1160940|P1|STARTED|Double-blind Period||15
473632|NCT01166230|1160964|P2|NOT COMPLETED|Overall Study||16
473633|NCT01166230|1160965|P1|NOT COMPLETED|Overall Study||19
473634|NCT01166230|1160964|P2|COMPLETED|Overall Study||255
473635|NCT01166230|1160965|P1|COMPLETED|Overall Study||261
473636|NCT01166230|1160964|P2|STARTED|Overall Study||271
473637|NCT01166230|1160965|P1|STARTED|Overall Study||280
473638|NCT01166178|1160979|P2|NOT COMPLETED|Overall Study||8
473639|NCT01166178|1160980|P1|NOT COMPLETED|Overall Study||21
473640|NCT01166178|1160979|P2|COMPLETED|Overall Study||0
473641|NCT01166178|1160980|P1|COMPLETED|Overall Study||0
473642|NCT01166178|1160979|P2|STARTED|Overall Study||8
473643|NCT01166178|1160980|P1|STARTED|Overall Study||21
473644|NCT01166139|1161006|P1|NOT COMPLETED|Overall Study||3
473645|NCT01166139|1161006|P1|COMPLETED|Overall Study||7
473646|NCT01166139|1161006|P1|STARTED|Overall Study||10
473647|NCT01166126|1161012|P1|NOT COMPLETED|Overall Study||0
473648|NCT01166126|1161012|P1|COMPLETED|Overall Study||4
473649|NCT01166126|1161012|P1|STARTED|Overall Study||4
473650|NCT01165996|1161019|P1|NOT COMPLETED|Overall Study||2
473651|NCT01165996|1161019|P1|COMPLETED|Overall Study||23
473652|NCT01165996|1161019|P1|Maintenance Phase|Overall Study||23
473653|NCT01165996|1161019|P1|Induction Phase|Overall Study||25
473654|NCT01165996|1161019|P1|STARTED|Overall Study||25
473655|NCT01165983|1161027|P2|NOT COMPLETED|Overall Study||7
473656|NCT01165983|1161028|P1|NOT COMPLETED|Overall Study||5
473657|NCT01165983|1161027|P2|COMPLETED|Overall Study||42
473658|NCT01165983|1161028|P1|COMPLETED|Overall Study||46
473659|NCT01165983|1161027|P2|STARTED|Overall Study||49
473660|NCT01165983|1161028|P1|STARTED|Overall Study||51
473661|NCT01165840|1161072|P1|NOT COMPLETED|Overall Study||0
473662|NCT01165840|1161072|P1|COMPLETED|Overall Study||36
473663|NCT01165840|1161072|P1|STARTED|Overall Study||36
473664|NCT01165775|1161076|P1|NOT COMPLETED|Overall Study||2
473665|NCT01165775|1161076|P1|COMPLETED|Overall Study||15
473666|NCT01165775|1161076|P1|STARTED|Overall Study||17
473667|NCT01165684|1161086|P2|NOT COMPLETED|Overall Study||52
473668|NCT01165684|1161087|P1|NOT COMPLETED|Overall Study||28
473669|NCT01165684|1161086|P2|COMPLETED|Overall Study||148
473670|NCT01165684|1161087|P1|COMPLETED|Overall Study||173
473671|NCT01165684|1161086|P2|Exposed|Overall Study|1 subject withdrew prior to exposure to trial drug|199
473672|NCT01165684|1161087|P1|Exposed|Overall Study|3 subjects withdrew prior to exposure to trial drug|198
473673|NCT01165684|1161086|P2|STARTED|Overall Study||200
473674|NCT01165684|1161087|P1|STARTED|Overall Study||201
473675|NCT01165554|1161121|P1|NOT COMPLETED|Overall Study||23
473676|NCT01165554|1161121|P1|COMPLETED|Overall Study||180
473677|NCT01165554|1161121|P1|STARTED|Overall Study|This was the number of subjects that started the study.|203
473678|NCT01165541|1161128|P1|NOT COMPLETED|Quetiapine XR and Mirtazepine||5
473679|NCT01165541|1161128|P1|COMPLETED|Quetiapine XR and Mirtazepine||11
473680|NCT01165541|1161128|P1|STARTED|Quetiapine XR and Mirtazepine||16
473681|NCT01165541|1161128|P1|NOT COMPLETED|Quetiapine XR Monotherapy||4
473682|NCT01165541|1161128|P1|COMPLETED|Quetiapine XR Monotherapy||16
473683|NCT01165541|1161128|P1|STARTED|Quetiapine XR Monotherapy||20
473684|NCT01165450|1161134|P1|NOT COMPLETED|Overall Study||0
473685|NCT01165450|1161134|P1|COMPLETED|Overall Study||2
473686|NCT01165450|1161134|P1|STARTED|Overall Study||2
473687|NCT01165424|1161144|P1|NOT COMPLETED|Overall Study||4
473688|NCT01165424|1161144|P1|COMPLETED|Overall Study||76
473689|NCT01165424|1161144|P1|STARTED|Overall Study||80
473690|NCT01165320|1161151|P3|NOT COMPLETED|Overall Study||0
473691|NCT01165320|1161152|P2|NOT COMPLETED|Overall Study||4
473692|NCT01165320|1161153|P1|NOT COMPLETED|Overall Study||3
473693|NCT01165320|1161151|P3|COMPLETED|Overall Study||0
473694|NCT01165320|1161152|P2|COMPLETED|Overall Study||4
473695|NCT01165320|1161153|P1|COMPLETED|Overall Study||9
473696|NCT01165320|1161151|P3|STARTED|Overall Study|No participants with esophageal candidiasis were identified for inclusion in the study|0
473697|NCT01165320|1161152|P2|STARTED|Overall Study||8
473698|NCT01165320|1161153|P1|STARTED|Overall Study||12
473699|NCT01165307|1161163|P2|NOT COMPLETED|Overall Study||3
473700|NCT01165307|1161164|P1|NOT COMPLETED|Overall Study||14
473701|NCT01165307|1161163|P2|COMPLETED|Overall Study||31
473702|NCT01165307|1161164|P1|COMPLETED|Overall Study||19
473703|NCT01165307|1161163|P2|STARTED|Overall Study||34
473704|NCT01165307|1161164|P1|STARTED|Overall Study||33
473705|NCT01165281|1161194|P2|NOT COMPLETED|Overall Study||51
473706|NCT01165281|1161195|P1|NOT COMPLETED|Overall Study||58
473707|NCT01165281|1161194|P2|COMPLETED|Overall Study||121
473708|NCT01165281|1161195|P1|COMPLETED|Overall Study||110
473709|NCT01165281|1161194|P2|STARTED|Overall Study||172
473710|NCT01165281|1161195|P1|STARTED|Overall Study||168
473711|NCT01165242|1161216|P3|NOT COMPLETED|Overall Study||14
473712|NCT01165242|1161217|P2|NOT COMPLETED|Overall Study||10
473713|NCT01165242|1161218|P1|NOT COMPLETED|Overall Study||10
473714|NCT01165242|1161216|P3|COMPLETED|Overall Study||324
473715|NCT01165242|1161217|P2|COMPLETED|Overall Study||326
473716|NCT01165242|1161218|P1|COMPLETED|Overall Study||327
473717|NCT01165242|1161216|P3|STARTED|Overall Study||338
473718|NCT01165242|1161217|P2|STARTED|Overall Study||336
473719|NCT01165242|1161218|P1|STARTED|Overall Study||337
473720|NCT01165229|1161252|P2|NOT COMPLETED|Overall Study||1189
473721|NCT01165229|1161253|P1|NOT COMPLETED|Overall Study||1180
473722|NCT01165229|1161252|P2|COMPLETED|Overall Study||5761
473723|NCT01165229|1161253|P1|COMPLETED|Overall Study||5770
473724|NCT01165229|1161252|P2|STARTED|Overall Study||6950
473725|NCT01165229|1161253|P1|STARTED|Overall Study||6950
473726|NCT01165216|1161381|P2|NOT COMPLETED|Overall Study||7
473727|NCT01165216|1161382|P1|NOT COMPLETED|Overall Study||8
473820|NCT01164475|1161866|P1|STARTED|Overall Study||30
473728|NCT01165216|1161381|P2|COMPLETED|Overall Study|Completed=still on study drug|0
473729|NCT01165216|1161382|P1|COMPLETED|Overall Study|Completed=still on study drug|0
473730|NCT01165216|1161381|P2|Received at Least 1 Dose of Ipilimumab|Overall Study||6
473731|NCT01165216|1161382|P1|Received at Least 1 Dose of Ipilimumab|Overall Study||6
473732|NCT01165216|1161381|P2|STARTED|Overall Study|Participants who received any study drug|7
473733|NCT01165216|1161382|P1|STARTED|Overall Study|Participants who received any study drug|8
473734|NCT01165203|1161404|P2|NOT COMPLETED|Extended Safety Follow-up Phase||4
473735|NCT01165203|1161405|P1|NOT COMPLETED|Extended Safety Follow-up Phase||7
473736|NCT01165203|1161404|P2|COMPLETED|Extended Safety Follow-up Phase||45
473737|NCT01165203|1161405|P1|COMPLETED|Extended Safety Follow-up Phase||67
473738|NCT01165203|1161404|P2|STARTED|Extended Safety Follow-up Phase||49
473739|NCT01165203|1161405|P1|STARTED|Extended Safety Follow-up Phase||74
473740|NCT01165203|1161404|P2|NOT COMPLETED|Active Phase||2
473741|NCT01165203|1161405|P1|NOT COMPLETED|Active Phase||5
473742|NCT01165203|1161404|P2|COMPLETED|Active Phase||47
473743|NCT01165203|1161405|P1|COMPLETED|Active Phase||69
473744|NCT01165203|1161404|P2|STARTED|Active Phase||49
473745|NCT01165203|1161405|P1|STARTED|Active Phase||74
473746|NCT01165177|1161495|P2|NOT COMPLETED|Overall Study||902
473747|NCT01165177|1161496|P1|NOT COMPLETED|Overall Study||922
473748|NCT01165177|1161495|P2|COMPLETED|Overall Study||6808
473749|NCT01165177|1161496|P1|COMPLETED|Overall Study||6773
473750|NCT01165177|1161495|P2|STARTED|Overall Study||7710
473751|NCT01165177|1161496|P1|STARTED|Overall Study||7695
473752|NCT01165138|1161621|P4|NOT COMPLETED|Overall Study||22
473753|NCT01165138|1161622|P3|NOT COMPLETED|Overall Study||20
473754|NCT01165138|1161623|P2|NOT COMPLETED|Overall Study||52
473755|NCT01165138|1161624|P1|NOT COMPLETED|Overall Study||0
473756|NCT01165138|1161621|P4|COMPLETED|Overall Study||179
473757|NCT01165138|1161622|P3|COMPLETED|Overall Study||185
473758|NCT01165138|1161623|P2|COMPLETED|Overall Study||151
473759|NCT01165138|1161624|P1|COMPLETED|Overall Study||0
473760|NCT01165138|1161621|P4|STARTED|Overall Study||201
473761|NCT01165138|1161622|P3|STARTED|Overall Study||205
473762|NCT01165138|1161623|P2|STARTED|Overall Study||203
473763|NCT01165138|1161624|P1|STARTED|Overall Study||0
473764|NCT01165112|1161683|P1|NOT COMPLETED|Overall Study||0
473765|NCT01165112|1161683|P1|COMPLETED|Overall Study||48
473766|NCT01165112|1161683|P1|STARTED|Overall Study||48
473767|NCT01165047|1161690|P1|NOT COMPLETED|Overall Study||0
473768|NCT01165047|1161690|P1|COMPLETED|Overall Study||10
473769|NCT01165047|1161690|P1|STARTED|Overall Study||10
473770|NCT01165021|1161694|P1|NOT COMPLETED|Overall Study||1
473771|NCT01165021|1161694|P1|COMPLETED|Overall Study||18
473772|NCT01165021|1161694|P1|3 Cycles of Chemo, Then Surgery|Overall Study||15
473773|NCT01165021|1161694|P1|≥1 Dose Chemo, Baseline, Cy 3 Assessment|Overall Study||17
473774|NCT01165021|1161694|P1|≥1 Dose Chemo|Overall Study||19
473775|NCT01165021|1161694|P1|STARTED|Overall Study||19
473776|NCT01164891|1161702|P1|NOT COMPLETED|Overall Study||6
473777|NCT01164891|1161702|P1|COMPLETED|Overall Study||1
473778|NCT01164891|1161702|P1|STARTED|Overall Study||7
473779|NCT01164865|1161722|P2|NOT COMPLETED|Overall Study||1
473780|NCT01164865|1161723|P1|NOT COMPLETED|Overall Study||2
473781|NCT01164865|1161722|P2|COMPLETED|Overall Study||38
473782|NCT01164865|1161723|P1|COMPLETED|Overall Study||37
473783|NCT01164865|1161722|P2|STARTED|Overall Study||39
473784|NCT01164865|1161723|P1|STARTED|Overall Study||39
473785|NCT01164722|1161733|P2|NOT COMPLETED|Overall Study||15
473786|NCT01164722|1161734|P1|NOT COMPLETED|Overall Study||18
473787|NCT01164722|1161733|P2|COMPLETED|Overall Study||45
473788|NCT01164722|1161734|P1|COMPLETED|Overall Study||42
473789|NCT01164722|1161733|P2|STARTED|Overall Study||60
473790|NCT01164722|1161734|P1|STARTED|Overall Study||60
473791|NCT01164644|1161750|P2|NOT COMPLETED|Overall Study||1
473792|NCT01164644|1161751|P1|NOT COMPLETED|Overall Study||3
473793|NCT01164644|1161750|P2|COMPLETED|Overall Study||13
473794|NCT01164644|1161751|P1|COMPLETED|Overall Study||9
473795|NCT01164644|1161750|P2|STARTED|Overall Study||14
473796|NCT01164644|1161751|P1|STARTED|Overall Study||12
473797|NCT01164579|1161764|P3|NOT COMPLETED|Overall Study||16
473798|NCT01164579|1161765|P2|NOT COMPLETED|Overall Study||9
473799|NCT01164579|1161766|P1|NOT COMPLETED|Overall Study||8
473800|NCT01164579|1161764|P3|COMPLETED|Overall Study||21
473801|NCT01164579|1161765|P2|COMPLETED|Overall Study||27
473802|NCT01164579|1161766|P1|COMPLETED|Overall Study||28
473803|NCT01164579|1161764|P3|STARTED|Overall Study||37
473804|NCT01164579|1161765|P2|STARTED|Overall Study||36
473805|NCT01164579|1161766|P1|STARTED|Overall Study||36
473806|NCT01164501|1161846|P3|NOT COMPLETED|Overall Study||42
473807|NCT01164501|1161847|P2|NOT COMPLETED|Overall Study||10
473808|NCT01164501|1161848|P1|NOT COMPLETED|Overall Study||43
473809|NCT01164501|1161846|P3|COMPLETED|Overall Study||280
473810|NCT01164501|1161847|P2|COMPLETED|Overall Study||88
473811|NCT01164501|1161848|P1|COMPLETED|Overall Study||278
473812|NCT01164501|1161846|P3|STARTED|Overall Study||322
473813|NCT01164501|1161847|P2|STARTED|Overall Study||98
473814|NCT01164501|1161848|P1|STARTED|Overall Study||321
473815|NCT01164475|1161865|P2|NOT COMPLETED|Overall Study||2
473816|NCT01164475|1161866|P1|NOT COMPLETED|Overall Study||2
473817|NCT01164475|1161865|P2|COMPLETED|Overall Study||29
473818|NCT01164475|1161866|P1|COMPLETED|Overall Study||28
473819|NCT01164475|1161865|P2|STARTED|Overall Study||31
473821|NCT01164137|1161892|P2|NOT COMPLETED|Overall Study||0
473822|NCT01164137|1161893|P1|NOT COMPLETED|Overall Study||3
473823|NCT01164137|1161892|P2|COMPLETED|Overall Study||76
473824|NCT01164137|1161893|P1|COMPLETED|Overall Study||77
473825|NCT01164137|1161892|P2|STARTED|Overall Study||76
473826|NCT01164137|1161893|P1|STARTED|Overall Study||80
473827|NCT01164007|1161907|P1|NOT COMPLETED|Overall Study||40
473828|NCT01164007|1161907|P1|COMPLETED|Overall Study||0
473829|NCT01164007|1161907|P1|Treated|Overall Study||37
473830|NCT01164007|1161907|P1|STARTED|Overall Study||40
473831|NCT01163955|1161923|P2|NOT COMPLETED|Overall Study||4
473832|NCT01163955|1161924|P1|NOT COMPLETED|Overall Study||0
473833|NCT01163955|1161923|P2|COMPLETED|Overall Study||26
473834|NCT01163955|1161924|P1|COMPLETED|Overall Study||26
473835|NCT01163955|1161923|P2|STARTED|Overall Study||30
473836|NCT01163955|1161924|P1|STARTED|Overall Study||26
473837|NCT01163916|1161933|P3|NOT COMPLETED|Overall Study||20
473838|NCT01163916|1161934|P2|NOT COMPLETED|Overall Study||4
473839|NCT01163916|1161935|P1|NOT COMPLETED|Overall Study||30
473840|NCT01163916|1161933|P3|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|71
473841|NCT01163916|1161934|P2|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|31
473842|NCT01163916|1161935|P1|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|96
473843|NCT01163916|1161933|P3|Safety Population|Overall Study||91
473844|NCT01163916|1161934|P2|Safety Population|Overall Study||35
473845|NCT01163916|1161935|P1|Safety Population|Overall Study|One patient discontinued prior to receiving treatment with adalimumab due to absence of medication.|125
473846|NCT01163916|1161933|P3|STARTED|Overall Study||91
473847|NCT01163916|1161934|P2|STARTED|Overall Study||35
473848|NCT01163916|1161935|P1|STARTED|Overall Study||126
473849|NCT01163851|1161973|P2|NOT COMPLETED|Overall Study||1
473850|NCT01163851|1161974|P1|NOT COMPLETED|Overall Study||1
473851|NCT01163851|1161973|P2|COMPLETED|Overall Study||11
473852|NCT01163851|1161974|P1|COMPLETED|Overall Study||12
473853|NCT01163851|1161973|P2|Treated|Overall Study||12
473854|NCT01163851|1161974|P1|Treated|Overall Study||12
473855|NCT01163851|1161973|P2|STARTED|Overall Study||12
473856|NCT01163851|1161974|P1|STARTED|Overall Study||13
473857|NCT01163760|1162052|P4|NOT COMPLETED|Period 4 (Follow-up)||0
473858|NCT01163760|1162053|P3|NOT COMPLETED|Period 4 (Follow-up)||0
473859|NCT01163760|1162054|P2|NOT COMPLETED|Period 4 (Follow-up)||0
473860|NCT01163760|1162055|P1|NOT COMPLETED|Period 4 (Follow-up)||0
473861|NCT01163760|1162052|P4|COMPLETED|Period 4 (Follow-up)||12
473862|NCT01163760|1162053|P3|COMPLETED|Period 4 (Follow-up)||13
473863|NCT01163760|1162054|P2|COMPLETED|Period 4 (Follow-up)||13
473864|NCT01163760|1162055|P1|COMPLETED|Period 4 (Follow-up)||12
473865|NCT01163760|1162052|P4|STARTED|Period 4 (Follow-up)||12
473866|NCT01163760|1162053|P3|STARTED|Period 4 (Follow-up)||13
473867|NCT01163760|1162054|P2|STARTED|Period 4 (Follow-up)||13
473868|NCT01163760|1162055|P1|STARTED|Period 4 (Follow-up)||12
473869|NCT01163760|1162052|P4|NOT COMPLETED|Period 3 (Fit)||0
473870|NCT01163760|1162053|P3|NOT COMPLETED|Period 3 (Fit)||0
473871|NCT01163760|1162054|P2|NOT COMPLETED|Period 3 (Fit)||0
473872|NCT01163760|1162055|P1|NOT COMPLETED|Period 3 (Fit)||0
473873|NCT01163760|1162052|P4|COMPLETED|Period 3 (Fit)||12
473874|NCT01163760|1162053|P3|COMPLETED|Period 3 (Fit)||13
473875|NCT01163760|1162054|P2|COMPLETED|Period 3 (Fit)||13
473876|NCT01163760|1162055|P1|COMPLETED|Period 3 (Fit)||12
473877|NCT01163760|1162052|P4|STARTED|Period 3 (Fit)||12
473878|NCT01163760|1162053|P3|STARTED|Period 3 (Fit)||13
473879|NCT01163760|1162054|P2|STARTED|Period 3 (Fit)||13
473880|NCT01163760|1162055|P1|STARTED|Period 3 (Fit)||12
473881|NCT01163760|1162052|P4|NOT COMPLETED|Period 2 (Follow-up)||0
473882|NCT01163760|1162053|P3|NOT COMPLETED|Period 2 (Follow-up)||0
473883|NCT01163760|1162054|P2|NOT COMPLETED|Period 2 (Follow-up)||0
473884|NCT01163760|1162055|P1|NOT COMPLETED|Period 2 (Follow-up)||0
473885|NCT01163760|1162052|P4|COMPLETED|Period 2 (Follow-up)||12
473886|NCT01163760|1162053|P3|COMPLETED|Period 2 (Follow-up)||13
473887|NCT01163760|1162054|P2|COMPLETED|Period 2 (Follow-up)||13
473888|NCT01163760|1162055|P1|COMPLETED|Period 2 (Follow-up)||12
473889|NCT01163760|1162052|P4|STARTED|Period 2 (Follow-up)||12
473890|NCT01163760|1162053|P3|STARTED|Period 2 (Follow-up)||13
473891|NCT01163760|1162054|P2|STARTED|Period 2 (Follow-up)||13
473892|NCT01163760|1162055|P1|STARTED|Period 2 (Follow-up)||12
473893|NCT01163760|1162052|P4|NOT COMPLETED|Period 1 (Fit)||0
473894|NCT01163760|1162053|P3|NOT COMPLETED|Period 1 (Fit)||0
473895|NCT01163760|1162054|P2|NOT COMPLETED|Period 1 (Fit)||0
473896|NCT01163760|1162055|P1|NOT COMPLETED|Period 1 (Fit)||0
473897|NCT01163760|1162052|P4|COMPLETED|Period 1 (Fit)||12
473898|NCT01163760|1162053|P3|COMPLETED|Period 1 (Fit)||13
473899|NCT01163760|1162054|P2|COMPLETED|Period 1 (Fit)||13
473900|NCT01163760|1162055|P1|COMPLETED|Period 1 (Fit)||12
473901|NCT01163760|1162052|P4|STARTED|Period 1 (Fit)||12
473902|NCT01163760|1162053|P3|STARTED|Period 1 (Fit)||13
473903|NCT01163760|1162054|P2|STARTED|Period 1 (Fit)||13
473904|NCT01163760|1162055|P1|STARTED|Period 1 (Fit)||12
473905|NCT01163747|1162069|P2|NOT COMPLETED|Overall Study||11
473906|NCT01163747|1162070|P1|NOT COMPLETED|Overall Study||6
473907|NCT01163747|1162069|P2|COMPLETED|Overall Study||49
473908|NCT01163747|1162070|P1|COMPLETED|Overall Study||25
473909|NCT01163747|1162069|P2|Per Protocol Population|Overall Study|Participants who received at least 1 dose of study treatment excluding major protocol violators.|54
473910|NCT01163747|1162070|P1|Per Protocol Population|Overall Study|Participants who received at least 1 dose of study treatment excluding major protocol violators.|27
473911|NCT01163747|1162069|P2|STARTED|Overall Study||60
473912|NCT01163747|1162070|P1|STARTED|Overall Study||31
473913|NCT01163721|1162090|P2|NOT COMPLETED|Overall Study||12
473914|NCT01163721|1162091|P1|NOT COMPLETED|Overall Study||8
473915|NCT01163721|1162090|P2|COMPLETED|Overall Study||29
473916|NCT01163721|1162091|P1|COMPLETED|Overall Study||31
473917|NCT01163721|1162090|P2|STARTED|Overall Study||41
473918|NCT01163721|1162091|P1|STARTED|Overall Study||39
473919|NCT01163656|1162103|P2|NOT COMPLETED|Overall Study||3
473920|NCT01163656|1162104|P1|NOT COMPLETED|Overall Study||3
473921|NCT01163656|1162103|P2|COMPLETED|Overall Study||30
473922|NCT01163656|1162104|P1|COMPLETED|Overall Study||30
473923|NCT01163656|1162103|P2|STARTED|Overall Study||33
473924|NCT01163656|1162104|P1|STARTED|Overall Study||33
473925|NCT01163617|1162110|P8|NOT COMPLETED|Phase B (Injection Time), Week 4||0
473926|NCT01163617|1162111|P7|NOT COMPLETED|Phase B (Injection Time), Week 4||0
473927|NCT01163617|1162112|P6|NOT COMPLETED|Phase B (Injection Time), Week 4||0
473928|NCT01163617|1162113|P5|NOT COMPLETED|Phase B (Injection Time), Week 4||0
473929|NCT01163617|1162114|P4|NOT COMPLETED|Phase B (Injection Time), Week 4||0
473930|NCT01163617|1162115|P3|NOT COMPLETED|Phase B (Injection Time), Week 4||0
473931|NCT01163617|1162116|P2|NOT COMPLETED|Phase B (Injection Time), Week 4||0
473932|NCT01163617|1162117|P1|NOT COMPLETED|Phase B (Injection Time), Week 4||0
473933|NCT01163617|1162110|P8|COMPLETED|Phase B (Injection Time), Week 4||20
473934|NCT01163617|1162111|P7|COMPLETED|Phase B (Injection Time), Week 4||16
473935|NCT01163617|1162112|P6|COMPLETED|Phase B (Injection Time), Week 4||27
473936|NCT01163617|1162113|P5|COMPLETED|Phase B (Injection Time), Week 4||18
473937|NCT01163617|1162114|P4|COMPLETED|Phase B (Injection Time), Week 4||0
473938|NCT01163617|1162115|P3|COMPLETED|Phase B (Injection Time), Week 4||0
473939|NCT01163617|1162116|P2|COMPLETED|Phase B (Injection Time), Week 4||0
473940|NCT01163617|1162117|P1|COMPLETED|Phase B (Injection Time), Week 4||0
473941|NCT01163617|1162110|P8|STARTED|Phase B (Injection Time), Week 4||20
473942|NCT01163617|1162111|P7|STARTED|Phase B (Injection Time), Week 4||16
473943|NCT01163617|1162112|P6|STARTED|Phase B (Injection Time), Week 4||27
473944|NCT01163617|1162113|P5|STARTED|Phase B (Injection Time), Week 4||18
473945|NCT01163617|1162114|P4|STARTED|Phase B (Injection Time), Week 4||0
473946|NCT01163617|1162115|P3|STARTED|Phase B (Injection Time), Week 4||0
473947|NCT01163617|1162116|P2|STARTED|Phase B (Injection Time), Week 4||0
473948|NCT01163617|1162117|P1|STARTED|Phase B (Injection Time), Week 4||0
473949|NCT01163617|1162110|P8|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
473950|NCT01163617|1162111|P7|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
473951|NCT01163617|1162112|P6|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
473952|NCT01163617|1162113|P5|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
473953|NCT01163617|1162114|P4|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
473954|NCT01163617|1162115|P3|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||1
473955|NCT01163617|1162116|P2|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||2
473956|NCT01163617|1162117|P1|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
473957|NCT01163617|1162110|P8|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
473958|NCT01163617|1162111|P7|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
473959|NCT01163617|1162112|P6|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
473960|NCT01163617|1162113|P5|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
473961|NCT01163617|1162114|P4|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21
473962|NCT01163617|1162115|P3|COMPLETED|Phase A (User Experience), Weeks 0 and 2||20
473963|NCT01163617|1162116|P2|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21
473964|NCT01163617|1162117|P1|COMPLETED|Phase A (User Experience), Weeks 0 and 2||19
473965|NCT01163617|1162110|P8|STARTED|Phase A (User Experience), Weeks 0 and 2||0
473966|NCT01163617|1162111|P7|STARTED|Phase A (User Experience), Weeks 0 and 2||0
473967|NCT01163617|1162112|P6|STARTED|Phase A (User Experience), Weeks 0 and 2||0
473968|NCT01163617|1162113|P5|STARTED|Phase A (User Experience), Weeks 0 and 2||0
473969|NCT01163617|1162114|P4|STARTED|Phase A (User Experience), Weeks 0 and 2||21
473970|NCT01163617|1162115|P3|STARTED|Phase A (User Experience), Weeks 0 and 2||21
473971|NCT01163617|1162116|P2|STARTED|Phase A (User Experience), Weeks 0 and 2||23
473972|NCT01163617|1162117|P1|STARTED|Phase A (User Experience), Weeks 0 and 2||19
473973|NCT01163604|1162139|P2|NOT COMPLETED|Overall Study||0
473974|NCT01163604|1162140|P1|NOT COMPLETED|Overall Study||0
473975|NCT01163604|1162139|P2|COMPLETED|Overall Study|August 2011|56
473976|NCT01163604|1162140|P1|COMPLETED|Overall Study|August 2011|58
473977|NCT01163604|1162139|P2|STARTED|Overall Study|August 2010|56
473978|NCT01163604|1162140|P1|STARTED|Overall Study|August 2010|58
473979|NCT01163474|1162146|P1|NOT COMPLETED|Overall Study||16
473980|NCT01163474|1162146|P1|COMPLETED|Overall Study||24
473981|NCT01163474|1162146|P1|STARTED|Overall Study||40
473982|NCT01163461|1162152|P2|NOT COMPLETED|Overall Study||0
473983|NCT01163461|1162153|P1|NOT COMPLETED|Overall Study||0
473984|NCT01163461|1162152|P2|COMPLETED|Overall Study||14
473985|NCT01163461|1162153|P1|COMPLETED|Overall Study||14
473986|NCT01163461|1162152|P2|STARTED|Overall Study||14
473987|NCT01163461|1162153|P1|STARTED|Overall Study||14
473988|NCT01163318|1162157|P1|NOT COMPLETED|Overall Study||268
473989|NCT01163318|1162157|P1|COMPLETED|Overall Study||284
473990|NCT01163318|1162157|P1|STARTED|Overall Study||552
473991|NCT01163292|1162166|P2|NOT COMPLETED|Overall Study||22
473992|NCT01163292|1162167|P1|NOT COMPLETED|Overall Study||41
473993|NCT01163292|1162166|P2|COMPLETED|Overall Study||92
473994|NCT01163292|1162167|P1|COMPLETED|Overall Study||65
473995|NCT01163292|1162166|P2|STARTED|Overall Study||114
473996|NCT01163292|1162167|P1|STARTED|Overall Study||106
473997|NCT01163279|1162183|P2|NOT COMPLETED|Overall Study||0
473998|NCT01163279|1162184|P1|NOT COMPLETED|Overall Study||2
473999|NCT01163279|1162183|P2|COMPLETED|Overall Study||9
474000|NCT01163279|1162184|P1|COMPLETED|Overall Study||8
474001|NCT01163279|1162183|P2|STARTED|Overall Study||9
474002|NCT01163279|1162184|P1|STARTED|Overall Study||10
474003|NCT01163266|1162213|P3|NOT COMPLETED|Overall Study||28
474004|NCT01163266|1162214|P2|NOT COMPLETED|Overall Study||31
474005|NCT01163266|1162215|P1|NOT COMPLETED|Overall Study||18
474006|NCT01163266|1162213|P3|COMPLETED|Overall Study||122
474007|NCT01163266|1162214|P2|COMPLETED|Overall Study||124
474008|NCT01163266|1162215|P1|COMPLETED|Overall Study||139
474009|NCT01163266|1162213|P3|Treated|Overall Study||150
474010|NCT01163266|1162214|P2|Treated|Overall Study||155
474011|NCT01163266|1162215|P1|Treated|Overall Study||157
474012|NCT01163266|1162213|P3|STARTED|Overall Study||150
474013|NCT01163266|1162214|P2|STARTED|Overall Study||155
474014|NCT01163266|1162215|P1|STARTED|Overall Study||157
474015|NCT01163253|1162240|P2|NOT COMPLETED|Overall Study||586
474016|NCT01163253|1162241|P1|NOT COMPLETED|Overall Study||2281
474017|NCT01163253|1162240|P2|COMPLETED|Overall Study||0
474018|NCT01163253|1162241|P1|COMPLETED|Overall Study||0
474019|NCT01163253|1162240|P2|STARTED|Overall Study||586
474020|NCT01163253|1162241|P1|STARTED|Overall Study||2281
474021|NCT01163214|1162403|P2|NOT COMPLETED|Overall Study||0
474022|NCT01163214|1162404|P1|NOT COMPLETED|Overall Study||0
474023|NCT01163214|1162403|P2|COMPLETED|Overall Study||81
474024|NCT01163214|1162404|P1|COMPLETED|Overall Study||79
474025|NCT01163214|1162403|P2|STARTED|Overall Study||81
474026|NCT01163214|1162404|P1|STARTED|Overall Study||79
474027|NCT01163162|1162420|P1|NOT COMPLETED|Overall Study||0
474028|NCT01163162|1162420|P1|COMPLETED|Overall Study||16
474029|NCT01163162|1162420|P1|STARTED|Overall Study||16
474030|NCT01163149|1162429|P3|NOT COMPLETED|Extension Treatment Period||2
474031|NCT01163149|1162430|P2|NOT COMPLETED|Extension Treatment Period||1
474032|NCT01163149|1162431|P1|NOT COMPLETED|Extension Treatment Period||2
474033|NCT01163149|1162429|P3|COMPLETED|Extension Treatment Period||4
474034|NCT01163149|1162430|P2|COMPLETED|Extension Treatment Period||5
474035|NCT01163149|1162431|P1|COMPLETED|Extension Treatment Period||5
474036|NCT01163149|1162429|P3|STARTED|Extension Treatment Period||6
474037|NCT01163149|1162430|P2|STARTED|Extension Treatment Period||6
474038|NCT01163149|1162431|P1|STARTED|Extension Treatment Period||7
474039|NCT01163149|1162429|P3|NOT COMPLETED|Primary Treatment Period||0
474040|NCT01163149|1162430|P2|NOT COMPLETED|Primary Treatment Period||0
474041|NCT01163149|1162431|P1|NOT COMPLETED|Primary Treatment Period||0
474042|NCT01163149|1162429|P3|COMPLETED|Primary Treatment Period||6
474043|NCT01163149|1162430|P2|COMPLETED|Primary Treatment Period||6
474044|NCT01163149|1162431|P1|COMPLETED|Primary Treatment Period||7
474045|NCT01163149|1162429|P3|STARTED|Primary Treatment Period||6
474046|NCT01163149|1162430|P2|STARTED|Primary Treatment Period||6
474047|NCT01163149|1162431|P1|STARTED|Primary Treatment Period||7
474048|NCT01163097|1162476|P3|NOT COMPLETED|Overall Study||0
474049|NCT01163097|1162477|P2|NOT COMPLETED|Overall Study||0
474050|NCT01163097|1162478|P1|NOT COMPLETED|Overall Study||6
474051|NCT01163097|1162476|P3|COMPLETED|Overall Study||8
474052|NCT01163097|1162477|P2|COMPLETED|Overall Study||16
474053|NCT01163097|1162478|P1|COMPLETED|Overall Study||14
474054|NCT01163097|1162476|P3|STARTED|Overall Study||8
474055|NCT01163097|1162477|P2|STARTED|Overall Study||16
474056|NCT01163097|1162478|P1|STARTED|Overall Study|15 subjects were successfully titrated and entered the palifermin treatment|20
474057|NCT01163032|1162531|P3|NOT COMPLETED|Open Label Extension Phase||16
474058|NCT01163032|1162532|P2|NOT COMPLETED|Open Label Extension Phase||0
474059|NCT01163032|1162533|P1|NOT COMPLETED|Open Label Extension Phase||0
474060|NCT01163032|1162531|P3|COMPLETED|Open Label Extension Phase||39
474061|NCT01163032|1162532|P2|COMPLETED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
474062|NCT01163032|1162533|P1|COMPLETED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
474063|NCT01163032|1162531|P3|STARTED|Open Label Extension Phase|3 randomized patients rolled into extension (2 randomized to tasimelteon and one to placebo)|55
474064|NCT01163032|1162532|P2|STARTED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
474065|NCT01163032|1162533|P1|STARTED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
474066|NCT01163032|1162531|P3|NOT COMPLETED|Randomization Phase||0
474067|NCT01163032|1162532|P2|NOT COMPLETED|Randomization Phase||12
474068|NCT01163032|1162533|P1|NOT COMPLETED|Randomization Phase||10
474069|NCT01163032|1162531|P3|COMPLETED|Randomization Phase|Not applicable for Randomized Phase|0
474070|NCT01163032|1162532|P2|COMPLETED|Randomization Phase||30
474071|NCT01163032|1162533|P1|COMPLETED|Randomization Phase||32
474072|NCT01163032|1162531|P3|STARTED|Randomization Phase|Not applicable for Randomized Phase|0
474073|NCT01163032|1162532|P2|STARTED|Randomization Phase||42
474074|NCT01163032|1162533|P1|STARTED|Randomization Phase||42
474075|NCT01162863|1162566|P3|NOT COMPLETED|Overall Study||0
474076|NCT01162863|1162567|P2|NOT COMPLETED|Overall Study||1
474077|NCT01162863|1162568|P1|NOT COMPLETED|Overall Study||1
474078|NCT01162863|1162566|P3|COMPLETED|Overall Study||17
474079|NCT01162863|1162567|P2|COMPLETED|Overall Study||16
474080|NCT01162863|1162568|P1|COMPLETED|Overall Study||17
474081|NCT01162863|1162566|P3|STARTED|Overall Study||17
474082|NCT01162863|1162567|P2|STARTED|Overall Study||17
474083|NCT01162863|1162568|P1|STARTED|Overall Study||18
474084|NCT01162733|1162584|P2|NOT COMPLETED|Overall Study||25
474085|NCT01162733|1162585|P1|NOT COMPLETED|Overall Study||27
474086|NCT01162733|1162584|P2|COMPLETED|Overall Study||25
474087|NCT01162733|1162585|P1|COMPLETED|Overall Study||22
474088|NCT01162733|1162584|P2|STARTED|Overall Study||50
474089|NCT01162733|1162585|P1|STARTED|Overall Study||49
474090|NCT01162499|1162593|P2|NOT COMPLETED|Intervention 2 (4 Hours)||0
474091|NCT01162499|1162594|P1|NOT COMPLETED|Intervention 2 (4 Hours)||0
474092|NCT01162499|1162593|P2|COMPLETED|Intervention 2 (4 Hours)||3
474093|NCT01162499|1162594|P1|COMPLETED|Intervention 2 (4 Hours)||3
474094|NCT01162499|1162593|P2|STARTED|Intervention 2 (4 Hours)||3
474095|NCT01162499|1162594|P1|STARTED|Intervention 2 (4 Hours)||3
474096|NCT01162499|1162593|P2|NOT COMPLETED|Intervention 1 (4 Hours)||1
474097|NCT01162499|1162594|P1|NOT COMPLETED|Intervention 1 (4 Hours)||0
474098|NCT01162499|1162593|P2|COMPLETED|Intervention 1 (4 Hours)||3
474099|NCT01162499|1162594|P1|COMPLETED|Intervention 1 (4 Hours)||3
474100|NCT01162499|1162593|P2|Received Intervention|Intervention 1 (4 Hours)||3
474101|NCT01162499|1162594|P1|Received Intervention|Intervention 1 (4 Hours)||3
474102|NCT01162499|1162593|P2|STARTED|Intervention 1 (4 Hours)||4
474103|NCT01162499|1162594|P1|STARTED|Intervention 1 (4 Hours)||3
474104|NCT01162473|1162616|P2|NOT COMPLETED|Overall Study||5
474105|NCT01162473|1162617|P1|NOT COMPLETED|Overall Study||2
474106|NCT01162473|1162616|P2|COMPLETED|Overall Study||12
474107|NCT01162473|1162617|P1|COMPLETED|Overall Study||6
474108|NCT01162473|1162616|P2|STARTED|Overall Study||17
474109|NCT01162473|1162617|P1|STARTED|Overall Study||8
474110|NCT01162421|1162625|P2|NOT COMPLETED|Overall Study||13
474111|NCT01162421|1162626|P1|NOT COMPLETED|Overall Study||8
474112|NCT01162421|1162625|P2|COMPLETED|Overall Study||27
474113|NCT01162421|1162626|P1|COMPLETED|Overall Study||29
474114|NCT01162421|1162625|P2|STARTED|Overall Study||40
474115|NCT01162421|1162626|P1|STARTED|Overall Study||37
474116|NCT01162343|1162704|P1|NOT COMPLETED|Overall Study||92
474117|NCT01162343|1162704|P1|COMPLETED|Overall Study||406
474118|NCT01162343|1162704|P1|STARTED|Overall Study||498
474119|NCT01162317|1162710|P2|NOT COMPLETED|Overall Study||2
474120|NCT01162317|1162711|P1|NOT COMPLETED|Overall Study||3
474121|NCT01162317|1162710|P2|COMPLETED|Overall Study||28
474122|NCT01162317|1162711|P1|COMPLETED|Overall Study||27
474123|NCT01162317|1162710|P2|STARTED|Overall Study||30
474124|NCT01162317|1162711|P1|STARTED|Overall Study||30
474125|NCT01162304|1162719|P1|NOT COMPLETED|Overall Study||11
474126|NCT01162304|1162719|P1|COMPLETED|Overall Study||7
474127|NCT01162304|1162719|P1|STARTED|Overall Study||18
474128|NCT01162135|1162733|P1|NOT COMPLETED|Overall Study||3
474129|NCT01162135|1162733|P1|COMPLETED|Overall Study||13
474130|NCT01162135|1162733|P1|STARTED|Overall Study||16
474131|NCT01162122|1162739|P2|NOT COMPLETED|Overall Study||196
474132|NCT01162122|1162740|P1|NOT COMPLETED|Overall Study||191
474133|NCT01162122|1162739|P2|COMPLETED|Overall Study||3356
474134|NCT01162122|1162740|P1|COMPLETED|Overall Study||3361
474135|NCT01162122|1162739|P2|Vaccinated|Overall Study||3541
474136|NCT01162122|1162740|P1|Vaccinated|Overall Study||3541
474137|NCT01162122|1162739|P2|STARTED|Overall Study||3552
474138|NCT01162122|1162740|P1|STARTED|Overall Study||3552
474139|NCT01162096|1162797|P1|NOT COMPLETED|Overall Study||0
474140|NCT01162096|1162797|P1|COMPLETED|Overall Study||34
474141|NCT01162096|1162797|P1|STARTED|Overall Study||34
474142|NCT01161862|1162805|P2|NOT COMPLETED|Overall Study||0
474143|NCT01161862|1162806|P1|NOT COMPLETED|Overall Study||0
474144|NCT01161862|1162805|P2|COMPLETED|Overall Study||12
474145|NCT01161862|1162806|P1|COMPLETED|Overall Study||12
474146|NCT01161862|1162805|P2|STARTED|Overall Study||12
474147|NCT01161862|1162806|P1|STARTED|Overall Study||12
474148|NCT01161771|1162826|P1|NOT COMPLETED|Overall Study||0
474149|NCT01161771|1162826|P1|COMPLETED|Overall Study||32
474150|NCT01161771|1162826|P1|STARTED|Overall Study||32
474151|NCT01161628|1162835|P1|NOT COMPLETED|Overall Study||8
474152|NCT01161628|1162835|P1|COMPLETED|Overall Study||17
474153|NCT01161628|1162835|P1|STARTED|Overall Study||25
474154|NCT01161563|1162849|P2|NOT COMPLETED|Overall Study||6
474155|NCT01161563|1162850|P1|NOT COMPLETED|Overall Study||5
474156|NCT01161563|1162849|P2|COMPLETED|Overall Study||49
474157|NCT01161563|1162850|P1|COMPLETED|Overall Study||58
474158|NCT01161563|1162849|P2|STARTED|Overall Study||55
474159|NCT01161563|1162850|P1|STARTED|Overall Study||63
474160|NCT01161537|1162858|P1|NOT COMPLETED|Part B||2
474161|NCT01161537|1162858|P1|COMPLETED|Part B||7
474162|NCT01161537|1162858|P1|STARTED|Part B|4 subjects from Part A continued in Part B of the study.|9
474163|NCT01161537|1162858|P1|NOT COMPLETED|Part A||0
474164|NCT01161537|1162858|P1|COMPLETED|Part A||8
474165|NCT01161537|1162858|P1|STARTED|Part A||8
474166|NCT01161498|1162876|P2|NOT COMPLETED|Overall Study||1
474167|NCT01161498|1162877|P1|NOT COMPLETED|Overall Study||0
474168|NCT01161498|1162876|P2|COMPLETED|Overall Study||1
474169|NCT01161498|1162877|P1|COMPLETED|Overall Study||3
474170|NCT01161498|1162876|P2|STARTED|Overall Study||2
474171|NCT01161498|1162877|P1|STARTED|Overall Study||3
474172|NCT01161472|1162901|P4|NOT COMPLETED|Fourth Intervention Period||0
474173|NCT01161472|1162902|P3|NOT COMPLETED|Fourth Intervention Period||0
474174|NCT01161472|1162903|P2|NOT COMPLETED|Fourth Intervention Period||0
474175|NCT01161472|1162904|P1|NOT COMPLETED|Fourth Intervention Period||0
474176|NCT01161472|1162901|P4|COMPLETED|Fourth Intervention Period||5
474177|NCT01161472|1162902|P3|COMPLETED|Fourth Intervention Period||5
474178|NCT01161472|1162903|P2|COMPLETED|Fourth Intervention Period||5
474179|NCT01161472|1162904|P1|COMPLETED|Fourth Intervention Period||4
474180|NCT01161472|1162901|P4|STARTED|Fourth Intervention Period||5
474181|NCT01161472|1162902|P3|STARTED|Fourth Intervention Period||5
474182|NCT01161472|1162903|P2|STARTED|Fourth Intervention Period||5
474183|NCT01161472|1162904|P1|STARTED|Fourth Intervention Period||4
474184|NCT01161472|1162901|P4|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
474185|NCT01161472|1162902|P3|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
474186|NCT01161472|1162903|P2|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
474187|NCT01161472|1162904|P1|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
474188|NCT01161472|1162901|P4|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
474189|NCT01161472|1162902|P3|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
474190|NCT01161472|1162903|P2|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
474191|NCT01161472|1162904|P1|COMPLETED|Washout Period (At Least 3 to 6 Days)||4
474192|NCT01161472|1162901|P4|STARTED|Washout Period (At Least 3 to 6 Days)||5
474193|NCT01161472|1162902|P3|STARTED|Washout Period (At Least 3 to 6 Days)||5
474194|NCT01161472|1162903|P2|STARTED|Washout Period (At Least 3 to 6 Days)||5
474195|NCT01161472|1162904|P1|STARTED|Washout Period (At Least 3 to 6 Days)||4
474196|NCT01161472|1162901|P4|NOT COMPLETED|Third Intervention Period||0
474197|NCT01161472|1162902|P3|NOT COMPLETED|Third Intervention Period||0
474198|NCT01161472|1162903|P2|NOT COMPLETED|Third Intervention Period||0
474199|NCT01161472|1162904|P1|NOT COMPLETED|Third Intervention Period||0
474200|NCT01161472|1162901|P4|COMPLETED|Third Intervention Period||5
474201|NCT01161472|1162902|P3|COMPLETED|Third Intervention Period||5
474202|NCT01161472|1162903|P2|COMPLETED|Third Intervention Period||5
474203|NCT01161472|1162904|P1|COMPLETED|Third Intervention Period||4
474204|NCT01161472|1162901|P4|STARTED|Third Intervention Period||5
474205|NCT01161472|1162902|P3|STARTED|Third Intervention Period||5
474206|NCT01161472|1162903|P2|STARTED|Third Intervention Period||5
474207|NCT01161472|1162904|P1|STARTED|Third Intervention Period||4
474208|NCT01161472|1162901|P4|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
474209|NCT01161472|1162902|P3|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
474210|NCT01161472|1162903|P2|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
474211|NCT01161472|1162904|P1|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||1
474212|NCT01161472|1162901|P4|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
474213|NCT01161472|1162902|P3|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
474214|NCT01161472|1162903|P2|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
474215|NCT01161472|1162904|P1|COMPLETED|Washout Period (At Least 3 to 6 Days)||4
474216|NCT01161472|1162901|P4|STARTED|Washout Period (At Least 3 to 6 Days)||5
474217|NCT01161472|1162902|P3|STARTED|Washout Period (At Least 3 to 6 Days)||5
474218|NCT01161472|1162903|P2|STARTED|Washout Period (At Least 3 to 6 Days)||5
474219|NCT01161472|1162904|P1|STARTED|Washout Period (At Least 3 to 6 Days)||5
474220|NCT01161472|1162901|P4|NOT COMPLETED|Second Intervention Period||0
474221|NCT01161472|1162902|P3|NOT COMPLETED|Second Intervention Period||0
474222|NCT01161472|1162903|P2|NOT COMPLETED|Second Intervention Period||0
474223|NCT01161472|1162904|P1|NOT COMPLETED|Second Intervention Period||0
474224|NCT01161472|1162901|P4|COMPLETED|Second Intervention Period||5
474225|NCT01161472|1162902|P3|COMPLETED|Second Intervention Period||5
474226|NCT01161472|1162903|P2|COMPLETED|Second Intervention Period||5
474227|NCT01161472|1162904|P1|COMPLETED|Second Intervention Period||5
474228|NCT01161472|1162901|P4|STARTED|Second Intervention Period||5
474229|NCT01161472|1162902|P3|STARTED|Second Intervention Period||5
474230|NCT01161472|1162903|P2|STARTED|Second Intervention Period||5
474231|NCT01161472|1162904|P1|STARTED|Second Intervention Period||5
474232|NCT01161472|1162901|P4|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
474233|NCT01161472|1162902|P3|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
474234|NCT01161472|1162903|P2|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
474235|NCT01161472|1162904|P1|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
474236|NCT01161472|1162901|P4|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
474237|NCT01161472|1162902|P3|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
474238|NCT01161472|1162903|P2|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
474239|NCT01161472|1162904|P1|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
474240|NCT01161472|1162901|P4|STARTED|Washout Period (At Least 3 to 6 Days)||5
474241|NCT01161472|1162902|P3|STARTED|Washout Period (At Least 3 to 6 Days)||5
474242|NCT01161472|1162903|P2|STARTED|Washout Period (At Least 3 to 6 Days)||5
474243|NCT01161472|1162904|P1|STARTED|Washout Period (At Least 3 to 6 Days)||5
474244|NCT01161472|1162901|P4|NOT COMPLETED|First Intervention Period||0
474245|NCT01161472|1162902|P3|NOT COMPLETED|First Intervention Period||0
474246|NCT01161472|1162903|P2|NOT COMPLETED|First Intervention Period||0
474247|NCT01161472|1162904|P1|NOT COMPLETED|First Intervention Period||0
474248|NCT01161472|1162901|P4|COMPLETED|First Intervention Period||5
474249|NCT01161472|1162902|P3|COMPLETED|First Intervention Period||5
474250|NCT01161472|1162903|P2|COMPLETED|First Intervention Period||5
474251|NCT01161472|1162904|P1|COMPLETED|First Intervention Period||5
474252|NCT01161472|1162901|P4|Treated|First Intervention Period||5
474253|NCT01161472|1162902|P3|Treated|First Intervention Period||5
474254|NCT01161472|1162903|P2|Treated|First Intervention Period||5
474255|NCT01161472|1162904|P1|Treated|First Intervention Period||5
474256|NCT01161472|1162901|P4|STARTED|First Intervention Period||5
474257|NCT01161472|1162902|P3|STARTED|First Intervention Period||5
474258|NCT01161472|1162903|P2|STARTED|First Intervention Period||5
474259|NCT01161472|1162904|P1|STARTED|First Intervention Period||5
474260|NCT01161446|1162960|P2|NOT COMPLETED|Overall Study||15
474261|NCT01161446|1162961|P1|NOT COMPLETED|Overall Study||18
474262|NCT01161446|1162960|P2|COMPLETED|Overall Study||99
474263|NCT01161446|1162961|P1|COMPLETED|Overall Study||98
474264|NCT01161446|1162960|P2|STARTED|Overall Study||114
474265|NCT01161446|1162961|P1|STARTED|Overall Study||116
474266|NCT01161420|1162973|P1|NOT COMPLETED|Withdrawal Study - Withdrawal||0
474267|NCT01161420|1162973|P1|COMPLETED|Withdrawal Study - Withdrawal||23
474268|NCT01161420|1162973|P1|STARTED|Withdrawal Study - Withdrawal||23
474269|NCT01161420|1162973|P1|NOT COMPLETED|Withdrawal Study - Maintenance||0
474270|NCT01161420|1162973|P1|COMPLETED|Withdrawal Study - Maintenance||23
474271|NCT01161420|1162973|P1|STARTED|Withdrawal Study - Maintenance||23
474272|NCT01161420|1162973|P1|NOT COMPLETED|Inspire Therapy||2
474273|NCT01161420|1162973|P1|COMPLETED|Inspire Therapy||124
474274|NCT01161420|1162973|P1|STARTED|Inspire Therapy||126
474275|NCT01161407|1162987|P2|NOT COMPLETED|Overall Study||1
474276|NCT01161407|1162988|P1|NOT COMPLETED|Overall Study||3
474277|NCT01161407|1162987|P2|COMPLETED|Overall Study||5
474278|NCT01161407|1162988|P1|COMPLETED|Overall Study||3
474279|NCT01161407|1162987|P2|STARTED|Overall Study||6
474280|NCT01161407|1162988|P1|STARTED|Overall Study||6
474281|NCT01161329|1163000|P2|NOT COMPLETED|Overall Study||10
474282|NCT01161329|1163001|P1|NOT COMPLETED|Overall Study||4
474283|NCT01161329|1163000|P2|COMPLETED|Overall Study||24
474284|NCT01161329|1163001|P1|COMPLETED|Overall Study||29
474285|NCT01161329|1163000|P2|STARTED|Overall Study||34
474286|NCT01161329|1163001|P1|STARTED|Overall Study||33
474287|NCT01161225|1163012|P3|NOT COMPLETED|Overall Study||2
474288|NCT01161225|1163013|P2|NOT COMPLETED|Overall Study||9
474289|NCT01161225|1163014|P1|NOT COMPLETED|Overall Study||14
474290|NCT01161225|1163012|P3|COMPLETED|Overall Study||12
474291|NCT01161225|1163013|P2|COMPLETED|Overall Study||44
474292|NCT01161225|1163014|P1|COMPLETED|Overall Study||45
474293|NCT01161225|1163012|P3|STARTED|Overall Study||14
474294|NCT01161225|1163013|P2|STARTED|Overall Study||53
474295|NCT01161225|1163014|P1|STARTED|Overall Study||59
474296|NCT01161173|1163043|P1|NOT COMPLETED|Overall Study||347
474297|NCT01161173|1163043|P1|COMPLETED|Overall Study||0
474298|NCT01161173|1163043|P1|STARTED|Overall Study||347
474299|NCT01161160|1163055|P3|NOT COMPLETED|Overall Study||0
474300|NCT01161160|1163056|P2|NOT COMPLETED|Overall Study||0
474301|NCT01161160|1163057|P1|NOT COMPLETED|Overall Study||0
474302|NCT01161160|1163055|P3|COMPLETED|Overall Study||58
474303|NCT01161160|1163056|P2|COMPLETED|Overall Study||75
474304|NCT01161160|1163057|P1|COMPLETED|Overall Study||76
474305|NCT01161160|1163055|P3|STARTED|Overall Study||58
474306|NCT01161160|1163056|P2|STARTED|Overall Study||75
474307|NCT01161160|1163057|P1|STARTED|Overall Study||76
474308|NCT01161121|1163128|P1|NOT COMPLETED|Overall Study||0
474309|NCT01161121|1163128|P1|COMPLETED|Overall Study||46
474310|NCT01161121|1163128|P1|STARTED|Overall Study||46
474311|NCT01160848|1163140|P2|NOT COMPLETED|Overall Study||0
474312|NCT01160848|1163141|P1|NOT COMPLETED|Overall Study||0
474313|NCT01160848|1163140|P2|COMPLETED|Overall Study||8
474314|NCT01160848|1163141|P1|COMPLETED|Overall Study||12
474315|NCT01160848|1163140|P2|STARTED|Overall Study||8
474316|NCT01160848|1163141|P1|STARTED|Overall Study||12
474317|NCT01160822|1163170|P7|NOT COMPLETED|Overall Study||9
474318|NCT01160822|1163171|P6|NOT COMPLETED|Overall Study||7
474319|NCT01160822|1163172|P5|NOT COMPLETED|Overall Study||9
474320|NCT01160822|1163173|P4|NOT COMPLETED|Overall Study||0
474321|NCT01160822|1163174|P3|NOT COMPLETED|Overall Study||0
474322|NCT01160822|1163175|P2|NOT COMPLETED|Overall Study||0
474323|NCT01160822|1163176|P1|NOT COMPLETED|Overall Study||0
474324|NCT01160822|1163170|P7|COMPLETED|Overall Study||44
474325|NCT01160822|1163171|P6|COMPLETED|Overall Study||40
474326|NCT01160822|1163172|P5|COMPLETED|Overall Study||36
474327|NCT01160822|1163173|P4|COMPLETED|Overall Study||5
474328|NCT01160822|1163174|P3|COMPLETED|Overall Study||6
474329|NCT01160822|1163175|P2|COMPLETED|Overall Study||7
474330|NCT01160822|1163176|P1|COMPLETED|Overall Study||6
474331|NCT01160822|1163170|P7|STARTED|Overall Study||53
474332|NCT01160822|1163171|P6|STARTED|Overall Study||47
474333|NCT01160822|1163172|P5|STARTED|Overall Study||45
474334|NCT01160822|1163173|P4|STARTED|Overall Study||5
474335|NCT01160822|1163174|P3|STARTED|Overall Study||6
474336|NCT01160822|1163175|P2|STARTED|Overall Study||7
474337|NCT01160822|1163176|P1|STARTED|Overall Study||6
474338|NCT01160770|1163265|P1|NOT COMPLETED|Overall Study||79
474339|NCT01160770|1163265|P1|COMPLETED|Overall Study||188
474340|NCT01160770|1163265|P1|STARTED|Overall Study||267
474341|NCT01160744|1163278|P4|NOT COMPLETED|Overall Study||22
474342|NCT01160744|1163279|P3|NOT COMPLETED|Overall Study||20
474343|NCT01160744|1163280|P2|NOT COMPLETED|Overall Study||25
474344|NCT01160744|1163281|P1|NOT COMPLETED|Overall Study||20
474345|NCT01160744|1163278|P4|COMPLETED|Overall Study||49
474346|NCT01160744|1163279|P3|COMPLETED|Overall Study||49
474347|NCT01160744|1163280|P2|COMPLETED|Overall Study||44
474348|NCT01160744|1163281|P1|COMPLETED|Overall Study||51
474349|NCT01160744|1163278|P4|Received Study Drug|Overall Study||71
474350|NCT01160744|1163279|P3|Received Study Drug|Overall Study||63
474351|NCT01160744|1163280|P2|Received Study Drug|Overall Study||67
474352|NCT01160744|1163281|P1|Received Study Drug|Overall Study||69
474353|NCT01160744|1163278|P4|STARTED|Overall Study||71
474354|NCT01160744|1163279|P3|STARTED|Overall Study||69
474355|NCT01160744|1163280|P2|STARTED|Overall Study||69
474356|NCT01160744|1163281|P1|STARTED|Overall Study||71
474357|NCT01160640|1163317|P2|NOT COMPLETED|Overall Study||6
474358|NCT01160640|1163318|P1|NOT COMPLETED|Overall Study||4
474359|NCT01160640|1163317|P2|COMPLETED|Overall Study||110
474360|NCT01160640|1163318|P1|COMPLETED|Overall Study||113
474361|NCT01160640|1163317|P2|STARTED|Overall Study||116
474362|NCT01160640|1163318|P1|STARTED|Overall Study||117
474363|NCT01160614|1163334|P2|NOT COMPLETED|Overall Study||2
474364|NCT01160614|1163335|P1|NOT COMPLETED|Overall Study||0
474365|NCT01160614|1163334|P2|COMPLETED|Overall Study||23
474366|NCT01160614|1163335|P1|COMPLETED|Overall Study||5
474367|NCT01160614|1163334|P2|STARTED|Overall Study||25
474368|NCT01160614|1163335|P1|STARTED|Overall Study||5
474369|NCT01160484|1163383|P1|NOT COMPLETED|Overall Study||18
474370|NCT01160484|1163383|P1|COMPLETED|Overall Study||22
474371|NCT01160484|1163383|P1|STARTED|Overall Study||40
474372|NCT01160458|1163393|P1|NOT COMPLETED|Overall Study||0
474373|NCT01160458|1163393|P1|COMPLETED|Overall Study||20
474374|NCT01160458|1163393|P1|STARTED|Overall Study||20
474375|NCT01160445|1163403|P2|NOT COMPLETED|Overall Study||0
474376|NCT01160445|1163404|P1|NOT COMPLETED|Overall Study||0
474377|NCT01160445|1163403|P2|COMPLETED|Overall Study||2
474378|NCT01160445|1163404|P1|COMPLETED|Overall Study||7
474379|NCT01160445|1163403|P2|STARTED|Overall Study||2
474380|NCT01160445|1163404|P1|STARTED|Overall Study||7
474381|NCT01160380|1163414|P2|NOT COMPLETED|Overall Study||5
474382|NCT01160380|1163415|P1|NOT COMPLETED|Overall Study||8
474383|NCT01160380|1163414|P2|COMPLETED|Overall Study||20
474384|NCT01160380|1163415|P1|COMPLETED|Overall Study||17
474385|NCT01160380|1163414|P2|STARTED|Overall Study||25
474386|NCT01160380|1163415|P1|STARTED|Overall Study||25
474387|NCT01160237|1163436|P3|NOT COMPLETED|Overall Study||0
474388|NCT01160237|1163437|P2|NOT COMPLETED|Overall Study||0
474389|NCT01160237|1163438|P1|NOT COMPLETED|Overall Study||0
474390|NCT01160237|1163436|P3|COMPLETED|Overall Study||0
474391|NCT01160237|1163437|P2|COMPLETED|Overall Study||3
474392|NCT01160237|1163438|P1|COMPLETED|Overall Study||4
474393|NCT01160237|1163436|P3|STARTED|Overall Study||0
474394|NCT01160237|1163437|P2|STARTED|Overall Study||3
474395|NCT01160237|1163438|P1|STARTED|Overall Study||4
474396|NCT01160198|1163464|P3|NOT COMPLETED|Overall Study||1
474397|NCT01160198|1163465|P2|NOT COMPLETED|Overall Study||3
474398|NCT01160198|1163466|P1|NOT COMPLETED|Overall Study||2
474399|NCT01160198|1163464|P3|COMPLETED|Overall Study||89
474400|NCT01160198|1163465|P2|COMPLETED|Overall Study||88
474401|NCT01160198|1163466|P1|COMPLETED|Overall Study||87
474402|NCT01160198|1163464|P3|STARTED|Overall Study||90
474403|NCT01160198|1163465|P2|STARTED|Overall Study||91
474404|NCT01160198|1163466|P1|STARTED|Overall Study||89
474405|NCT01159938|1163488|P5|NOT COMPLETED|Second Study Period||0
474406|NCT01159938|1163489|P4|NOT COMPLETED|Second Study Period||0
474407|NCT01159938|1163490|P3|NOT COMPLETED|Second Study Period||0
474408|NCT01159938|1163491|P2|NOT COMPLETED|Second Study Period||0
474409|NCT01159938|1163492|P1|NOT COMPLETED|Second Study Period||0
474410|NCT01159938|1163488|P5|COMPLETED|Second Study Period||12
474411|NCT01159938|1163489|P4|COMPLETED|Second Study Period||12
474412|NCT01159938|1163490|P3|COMPLETED|Second Study Period||10
474413|NCT01159938|1163491|P2|COMPLETED|Second Study Period||11
474414|NCT01159938|1163492|P1|COMPLETED|Second Study Period||0
474415|NCT01159938|1163488|P5|STARTED|Second Study Period||12
474416|NCT01159938|1163489|P4|STARTED|Second Study Period||12
474417|NCT01159938|1163490|P3|STARTED|Second Study Period||10
474418|NCT01159938|1163491|P2|STARTED|Second Study Period||11
474419|NCT01159938|1163492|P1|STARTED|Second Study Period||0
474420|NCT01159938|1163488|P5|NOT COMPLETED|First Study Period||0
474421|NCT01159938|1163489|P4|NOT COMPLETED|First Study Period||0
474422|NCT01159938|1163490|P3|NOT COMPLETED|First Study Period||1
474423|NCT01159938|1163491|P2|NOT COMPLETED|First Study Period||0
474424|NCT01159938|1163492|P1|NOT COMPLETED|First Study Period||0
474425|NCT01159938|1163488|P5|COMPLETED|First Study Period||12
474426|NCT01159938|1163489|P4|COMPLETED|First Study Period||12
474427|NCT01159938|1163490|P3|COMPLETED|First Study Period||10
474428|NCT01159938|1163491|P2|COMPLETED|First Study Period||11
474429|NCT01159938|1163492|P1|COMPLETED|First Study Period||26
474430|NCT01159938|1163488|P5|Safety and Efficacy Analysis Population|First Study Period||12
474431|NCT01159938|1163489|P4|Safety and Efficacy Analysis Population|First Study Period||12
474432|NCT01159938|1163490|P3|Safety and Efficacy Analysis Population|First Study Period|Microalbuminuria relaxed with protocol amendment. T2DM albuminuria participant included in analyses.|11
474433|NCT01159938|1163491|P2|Safety and Efficacy Analysis Population|First Study Period||11
474434|NCT01159938|1163492|P1|Safety and Efficacy Analysis Population|First Study Period|One healthy participant completed study but was excluded from analyses (major protocol violation).|25
474435|NCT01159938|1163488|P5|Received at Least 1 Dose of Study Drug|First Study Period||12
474436|NCT01159938|1163489|P4|Received at Least 1 Dose of Study Drug|First Study Period||12
474437|NCT01159938|1163490|P3|Received at Least 1 Dose of Study Drug|First Study Period||11
474438|NCT01159938|1163491|P2|Received at Least 1 Dose of Study Drug|First Study Period||11
474439|NCT01159938|1163492|P1|Received at Least 1 Dose of Study Drug|First Study Period||0
474440|NCT01159938|1163488|P5|STARTED|First Study Period||12
474441|NCT01159938|1163489|P4|STARTED|First Study Period||12
474442|NCT01159938|1163490|P3|STARTED|First Study Period||11
474443|NCT01159938|1163491|P2|STARTED|First Study Period||11
474444|NCT01159938|1163492|P1|STARTED|First Study Period||26
474445|NCT01159912|1163555|P3|NOT COMPLETED|Overall Study||26
474446|NCT01159912|1163556|P2|NOT COMPLETED|Overall Study||22
474447|NCT01159912|1163557|P1|NOT COMPLETED|Overall Study||40
474448|NCT01159912|1163555|P3|COMPLETED|Overall Study||88
474449|NCT01159912|1163556|P2|COMPLETED|Overall Study||92
474450|NCT01159912|1163557|P1|COMPLETED|Overall Study||75
474451|NCT01159912|1163555|P3|STARTED|Overall Study||114
474452|NCT01159912|1163556|P2|STARTED|Overall Study||114
474453|NCT01159912|1163557|P1|STARTED|Overall Study||115
474454|NCT01159769|1163580|P1|NOT COMPLETED|Overall Study||1
474455|NCT01159769|1163580|P1|COMPLETED|Overall Study||214
474456|NCT01159769|1163580|P1|STARTED|Overall Study||215
474457|NCT01159743|1163587|P2|NOT COMPLETED|Overall Study||0
474458|NCT01159743|1163588|P1|NOT COMPLETED|Overall Study||0
474459|NCT01159743|1163587|P2|COMPLETED|Overall Study||109
474460|NCT01159743|1163588|P1|COMPLETED|Overall Study||237
474461|NCT01159743|1163587|P2|STARTED|Overall Study||109
474462|NCT01159743|1163588|P1|STARTED|Overall Study||237
474463|NCT01159691|1163600|P1|NOT COMPLETED|Overall Study||22
474464|NCT01159691|1163600|P1|COMPLETED|Overall Study|Multiple discontinuation reasons were possible.|54
474465|NCT01159691|1163600|P1|STARTED|Overall Study||76
474466|NCT01159665|1163613|P6|NOT COMPLETED|Overall Study||0
474467|NCT01159665|1163614|P5|NOT COMPLETED|Overall Study||0
474468|NCT01159665|1163615|P4|NOT COMPLETED|Overall Study||0
474469|NCT01159665|1163616|P3|NOT COMPLETED|Overall Study||0
474470|NCT01159665|1163617|P2|NOT COMPLETED|Overall Study||1
474471|NCT01159665|1163618|P1|NOT COMPLETED|Overall Study||0
474472|NCT01159665|1163613|P6|COMPLETED|Overall Study||4
474473|NCT01159665|1163614|P5|COMPLETED|Overall Study||4
474474|NCT01159665|1163615|P4|COMPLETED|Overall Study||4
474475|NCT01159665|1163616|P3|COMPLETED|Overall Study||8
474476|NCT01159665|1163617|P2|COMPLETED|Overall Study||8
474477|NCT01159665|1163618|P1|COMPLETED|Overall Study||9
474478|NCT01159665|1163613|P6|STARTED|Overall Study||4
474479|NCT01159665|1163614|P5|STARTED|Overall Study||4
474480|NCT01159665|1163615|P4|STARTED|Overall Study||4
474481|NCT01159665|1163616|P3|STARTED|Overall Study||8
474482|NCT01159665|1163617|P2|STARTED|Overall Study||9
474483|NCT01159665|1163618|P1|STARTED|Overall Study||9
474484|NCT01159600|1163646|P8|NOT COMPLETED|Overall Study||18
474485|NCT01159600|1163647|P7|NOT COMPLETED|Overall Study||19
474486|NCT01159600|1163648|P6|NOT COMPLETED|Overall Study||18
474487|NCT01159600|1163649|P5|NOT COMPLETED|Overall Study||24
474488|NCT01159600|1163650|P4|NOT COMPLETED|Overall Study||11
474489|NCT01159600|1163651|P3|NOT COMPLETED|Overall Study||18
474490|NCT01159600|1163652|P2|NOT COMPLETED|Overall Study||8
474491|NCT01159600|1163653|P1|NOT COMPLETED|Overall Study||21
474492|NCT01159600|1163646|P8|COMPLETED|Overall Study||85
474493|NCT01159600|1163647|P7|COMPLETED|Overall Study||199
474494|NCT01159600|1163648|P6|COMPLETED|Overall Study||208
474495|NCT01159600|1163649|P5|COMPLETED|Overall Study||201
474496|NCT01159600|1163650|P4|COMPLETED|Overall Study||58
474497|NCT01159600|1163651|P3|COMPLETED|Overall Study||196
474498|NCT01159600|1163652|P2|COMPLETED|Overall Study||209
474499|NCT01159600|1163653|P1|COMPLETED|Overall Study||186
474500|NCT01159600|1163646|P8|STARTED|Overall Study||103
474501|NCT01159600|1163647|P7|STARTED|Overall Study||218
474502|NCT01159600|1163648|P6|STARTED|Overall Study||226
474503|NCT01159600|1163649|P5|STARTED|Overall Study||225
474504|NCT01159600|1163650|P4|STARTED|Overall Study||69
474505|NCT01159600|1163651|P3|STARTED|Overall Study||214
474506|NCT01159600|1163652|P2|STARTED|Overall Study||217
474507|NCT01159600|1163653|P1|STARTED|Overall Study||207
474508|NCT01159574|1163695|P1|NOT COMPLETED|Follow Up Phase||20
474509|NCT01159574|1163695|P1|COMPLETED|Follow Up Phase|Completion defined as those that are no longer in long term follow up due to death.|92
474510|NCT01159574|1163695|P1|STARTED|Follow Up Phase||112
474511|NCT01159574|1163695|P1|NOT COMPLETED|Treatment Phase||21
474512|NCT01159574|1163695|P1|COMPLETED|Treatment Phase||100
474513|NCT01159574|1163695|P1|STARTED|Treatment Phase||121
474514|NCT01159535|1163704|P3|NOT COMPLETED|Overall Study||31
474515|NCT01159535|1163705|P2|NOT COMPLETED|Overall Study||24
474516|NCT01159535|1163706|P1|NOT COMPLETED|Overall Study||24
474517|NCT01159535|1163704|P3|COMPLETED|Overall Study||64
474518|NCT01159535|1163705|P2|COMPLETED|Overall Study||64
474519|NCT01159535|1163706|P1|COMPLETED|Overall Study||79
474520|NCT01159535|1163704|P3|STARTED|Overall Study||95
474521|NCT01159535|1163705|P2|STARTED|Overall Study||88
474522|NCT01159535|1163706|P1|STARTED|Overall Study||103
474523|NCT01159431|1163716|P2|NOT COMPLETED|Overall Study||6
474524|NCT01159431|1163717|P1|NOT COMPLETED|Overall Study||2
474525|NCT01159431|1163716|P2|COMPLETED|Overall Study||19
474526|NCT01159431|1163717|P1|COMPLETED|Overall Study||23
474527|NCT01159431|1163716|P2|STARTED|Overall Study||25
474528|NCT01159431|1163717|P1|STARTED|Overall Study||25
474529|NCT01159262|1163736|P3|NOT COMPLETED|Overall Study||0
474530|NCT01159262|1163737|P2|NOT COMPLETED|Overall Study||0
474531|NCT01159262|1163738|P1|NOT COMPLETED|Overall Study||0
474532|NCT01159262|1163736|P3|COMPLETED|Overall Study||8
474533|NCT01159262|1163737|P2|COMPLETED|Overall Study||14
474534|NCT01159262|1163738|P1|COMPLETED|Overall Study||14
474535|NCT01159262|1163736|P3|STARTED|Overall Study||8
474536|NCT01159262|1163737|P2|STARTED|Overall Study||14
474537|NCT01159262|1163738|P1|STARTED|Overall Study||14
474538|NCT01159171|1163770|P1|NOT COMPLETED|Overall Study||50
474539|NCT01159171|1163770|P1|COMPLETED|Overall Study||0
474540|NCT01159171|1163770|P1|STARTED|Overall Study||50
474541|NCT01159054|1163785|P1|NOT COMPLETED|Overall Study||20
474542|NCT01159054|1163785|P1|COMPLETED|Overall Study||2
474543|NCT01159054|1163785|P1|STARTED|Overall Study||22
474544|NCT01158976|1163799|P2|NOT COMPLETED|Overall Study||4
474545|NCT01158976|1163800|P1|NOT COMPLETED|Overall Study||9
474546|NCT01158976|1163799|P2|COMPLETED|Overall Study||17
474547|NCT01158976|1163800|P1|COMPLETED|Overall Study||34
474548|NCT01158976|1163799|P2|STARTED|Overall Study||21
474549|NCT01158976|1163800|P1|STARTED|Overall Study||43
474550|NCT01158924|1163844|P2|NOT COMPLETED|Overall Study||3
474551|NCT01158924|1163845|P1|NOT COMPLETED|Overall Study||1
474552|NCT01158924|1163844|P2|COMPLETED|Overall Study||23
474553|NCT01158924|1163845|P1|COMPLETED|Overall Study||13
474554|NCT01158924|1163844|P2|STARTED|Overall Study||26
474555|NCT01158924|1163845|P1|STARTED|Overall Study||14
474556|NCT01158716|1163861|P2|NOT COMPLETED|Overall Study||1
474557|NCT01158716|1163862|P1|NOT COMPLETED|Overall Study||1
474558|NCT01158716|1163861|P2|COMPLETED|Overall Study||47
474559|NCT01158716|1163862|P1|COMPLETED|Overall Study||47
474560|NCT01158716|1163861|P2|STARTED|Overall Study||48
474561|NCT01158716|1163862|P1|STARTED|Overall Study||48
474562|NCT01158703|1163870|P2|NOT COMPLETED|Overall Study||0
474563|NCT01158703|1163871|P1|NOT COMPLETED|Overall Study||0
474564|NCT01158703|1163870|P2|COMPLETED|Overall Study||8
474565|NCT01158703|1163871|P1|COMPLETED|Overall Study||12
474566|NCT01158703|1163870|P2|STARTED|Overall Study||8
474567|NCT01158703|1163871|P1|STARTED|Overall Study||12
474568|NCT01158573|1163891|P4|NOT COMPLETED|Overall Study||0
474569|NCT01158573|1163892|P3|NOT COMPLETED|Overall Study||0
474570|NCT01158573|1163893|P2|NOT COMPLETED|Overall Study||0
474571|NCT01158573|1163894|P1|NOT COMPLETED|Overall Study||0
474572|NCT01158573|1163891|P4|COMPLETED|Overall Study||28
474573|NCT01158573|1163892|P3|COMPLETED|Overall Study||29
474574|NCT01158573|1163893|P2|COMPLETED|Overall Study||30
474575|NCT01158573|1163894|P1|COMPLETED|Overall Study|Study completed at 117 subjects.|30
474576|NCT01158573|1163891|P4|STARTED|Overall Study||28
474577|NCT01158573|1163892|P3|STARTED|Overall Study||29
474578|NCT01158573|1163893|P2|STARTED|Overall Study||30
474579|NCT01158573|1163894|P1|STARTED|Overall Study|Aimed to recruit 160 from July 2010 to May 2013. Each subject studied on one time point only|30
474580|NCT01158534|1163916|P1|NOT COMPLETED|Overall Study||3
474581|NCT01158534|1163916|P1|COMPLETED|Overall Study|All three pts that did not complete study had some treatment|14
474582|NCT01158534|1163916|P1|STARTED|Overall Study||17
474583|NCT01158378|1163926|P2|NOT COMPLETED|Overall Study||9
474584|NCT01158378|1163927|P1|NOT COMPLETED|Overall Study||10
474585|NCT01158378|1163926|P2|COMPLETED|Overall Study||117
474586|NCT01158378|1163927|P1|COMPLETED|Overall Study||114
474587|NCT01158378|1163926|P2|STARTED|Overall Study||126
474588|NCT01158378|1163927|P1|STARTED|Overall Study||124
474589|NCT01158261|1163939|P1|NOT COMPLETED|Overall Study||17
474590|NCT01158261|1163939|P1|COMPLETED|Overall Study||283
474591|NCT01158261|1163939|P1|STARTED|Overall Study||300
474592|NCT01158118|1163945|P2|NOT COMPLETED|Overall Study||3
474593|NCT01158118|1163946|P1|NOT COMPLETED|Overall Study||1
474594|NCT01158118|1163945|P2|COMPLETED|Overall Study||21
474595|NCT01158118|1163946|P1|COMPLETED|Overall Study||23
474596|NCT01158118|1163945|P2|STARTED|Overall Study||24
474597|NCT01158118|1163946|P1|STARTED|Overall Study||24
474598|NCT01157845|1163962|P1|NOT COMPLETED|Overall Study||35
474599|NCT01157845|1163962|P1|COMPLETED|Overall Study||130
474600|NCT01157845|1163962|P1|STARTED|Overall Study||165
474601|NCT01157533|1163967|P1|NOT COMPLETED|Overall Study||0
474602|NCT01157533|1163967|P1|COMPLETED|Overall Study||1
474603|NCT01157533|1163967|P1|STARTED|Overall Study||1
474604|NCT01157429|1163973|P2|NOT COMPLETED|Overall Study||4
474605|NCT01157429|1163974|P1|NOT COMPLETED|Overall Study||4
474606|NCT01157429|1163973|P2|COMPLETED|Overall Study||8
474607|NCT01157429|1163974|P1|COMPLETED|Overall Study||8
474608|NCT01157429|1163973|P2|STARTED|Overall Study||12
474609|NCT01157429|1163974|P1|STARTED|Overall Study||12
474610|NCT01157416|1163982|P2|NOT COMPLETED|Overall Study||0
474611|NCT01157416|1163983|P1|NOT COMPLETED|Overall Study||2
474612|NCT01157416|1163982|P2|COMPLETED|Overall Study||16
474613|NCT01157416|1163983|P1|COMPLETED|Overall Study||15
474614|NCT01157416|1163982|P2|STARTED|Overall Study||16
474615|NCT01157416|1163983|P1|STARTED|Overall Study||17
474616|NCT01157377|1163996|P7|NOT COMPLETED|Overall Study||2
474617|NCT01157377|1163997|P6|NOT COMPLETED|Overall Study||3
474618|NCT01157377|1163998|P5|NOT COMPLETED|Overall Study||2
474619|NCT01157377|1163999|P4|NOT COMPLETED|Overall Study||1
474620|NCT01157377|1164000|P3|NOT COMPLETED|Overall Study||1
474621|NCT01157377|1164001|P2|NOT COMPLETED|Overall Study||3
474622|NCT01157377|1164002|P1|NOT COMPLETED|Overall Study||2
474623|NCT01157377|1163996|P7|COMPLETED|Overall Study||27
474624|NCT01157377|1163997|P6|COMPLETED|Overall Study||16
474625|NCT01157377|1163998|P5|COMPLETED|Overall Study||18
474626|NCT01157377|1163999|P4|COMPLETED|Overall Study||14
474627|NCT01157377|1164000|P3|COMPLETED|Overall Study||26
474628|NCT01157377|1164001|P2|COMPLETED|Overall Study||20
474629|NCT01157377|1164002|P1|COMPLETED|Overall Study||21
474630|NCT01157377|1163996|P7|STARTED|Overall Study||29
474631|NCT01157377|1163997|P6|STARTED|Overall Study||19
474632|NCT01157377|1163998|P5|STARTED|Overall Study||20
474633|NCT01157377|1163999|P4|STARTED|Overall Study||15
474634|NCT01157377|1164000|P3|STARTED|Overall Study||27
474635|NCT01157377|1164001|P2|STARTED|Overall Study||23
474636|NCT01157377|1164002|P1|STARTED|Overall Study||23
474637|NCT01157351|1164020|P2|NOT COMPLETED|Overall Study||132
474638|NCT01157351|1164021|P1|NOT COMPLETED|Overall Study||137
474639|NCT01157351|1164020|P2|COMPLETED|Overall Study||88
474640|NCT01157351|1164021|P1|COMPLETED|Overall Study||93
474641|NCT01157351|1164020|P2|Treated|Overall Study||218
474642|NCT01157351|1164021|P1|Treated|Overall Study||226
474643|NCT01157351|1164020|P2|STARTED|Overall Study||220
474644|NCT01157351|1164021|P1|STARTED|Overall Study||230
474645|NCT01157234|1164039|P2|NOT COMPLETED|Overall Study||0
474646|NCT01157234|1164040|P1|NOT COMPLETED|Overall Study||1
474647|NCT01157234|1164039|P2|COMPLETED|Overall Study||15
474648|NCT01157234|1164040|P1|COMPLETED|Overall Study||14
474649|NCT01157234|1164039|P2|STARTED|Overall Study||15
474650|NCT01157234|1164040|P1|STARTED|Overall Study||15
474651|NCT01157182|1164072|P2|NOT COMPLETED|Second Intervention||0
474652|NCT01157182|1164073|P1|NOT COMPLETED|Second Intervention||0
474653|NCT01157182|1164072|P2|COMPLETED|Second Intervention||18
474654|NCT01157182|1164073|P1|COMPLETED|Second Intervention||16
474655|NCT01157182|1164072|P2|STARTED|Second Intervention||18
474656|NCT01157182|1164073|P1|STARTED|Second Intervention||16
474657|NCT01157182|1164072|P2|NOT COMPLETED|Washout of 28 Days||0
474658|NCT01157182|1164073|P1|NOT COMPLETED|Washout of 28 Days||2
474659|NCT01157182|1164072|P2|COMPLETED|Washout of 28 Days||18
474660|NCT01157182|1164073|P1|COMPLETED|Washout of 28 Days||16
474661|NCT01157182|1164072|P2|STARTED|Washout of 28 Days||18
474662|NCT01157182|1164073|P1|STARTED|Washout of 28 Days||18
474663|NCT01157182|1164072|P2|NOT COMPLETED|First Intervention||0
474664|NCT01157182|1164073|P1|NOT COMPLETED|First Intervention||0
474665|NCT01157182|1164072|P2|COMPLETED|First Intervention||18
474666|NCT01157182|1164073|P1|COMPLETED|First Intervention||18
474667|NCT01157182|1164072|P2|STARTED|First Intervention||18
474668|NCT01157182|1164073|P1|STARTED|First Intervention||18
474669|NCT01157169|1164121|P2|NOT COMPLETED|Second Intervention||1
474670|NCT01157169|1164122|P1|NOT COMPLETED|Second Intervention||0
474671|NCT01157169|1164121|P2|COMPLETED|Second Intervention||17
474672|NCT01157169|1164122|P1|COMPLETED|Second Intervention||16
474673|NCT01157169|1164121|P2|STARTED|Second Intervention||18
474674|NCT01157169|1164122|P1|STARTED|Second Intervention||16
474675|NCT01157169|1164121|P2|NOT COMPLETED|Washout of 10 Days||0
474676|NCT01157169|1164122|P1|NOT COMPLETED|Washout of 10 Days||0
474677|NCT01157169|1164121|P2|COMPLETED|Washout of 10 Days||18
474678|NCT01157169|1164122|P1|COMPLETED|Washout of 10 Days||16
474679|NCT01157169|1164121|P2|STARTED|Washout of 10 Days||18
474680|NCT01157169|1164122|P1|STARTED|Washout of 10 Days||16
474681|NCT01157169|1164121|P2|NOT COMPLETED|First Intervention||2
474682|NCT01157169|1164122|P1|NOT COMPLETED|First Intervention||4
474683|NCT01157169|1164121|P2|COMPLETED|First Intervention||18
474684|NCT01157169|1164122|P1|COMPLETED|First Intervention||16
474685|NCT01157169|1164121|P2|STARTED|First Intervention||20
474686|NCT01157169|1164122|P1|STARTED|First Intervention||20
474687|NCT01157117|1164141|P3|NOT COMPLETED|Overall Study||15
474688|NCT01157117|1164142|P2|NOT COMPLETED|Overall Study||11
474689|NCT01157117|1164143|P1|NOT COMPLETED|Overall Study||9
474690|NCT01157117|1164141|P3|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|5
474691|NCT01157117|1164142|P2|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|18
474692|NCT01157117|1164143|P1|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|19
474693|NCT01157117|1164141|P3|Completed Final Month 38 Study Visit|Overall Study||3
474694|NCT01157117|1164142|P2|Completed Final Month 38 Study Visit|Overall Study||18
474695|NCT01157117|1164143|P1|Completed Final Month 38 Study Visit|Overall Study||19
474696|NCT01157117|1164141|P3|Completed Month 32 Tolerance OFC|Overall Study||0
474697|NCT01157117|1164142|P2|Completed Month 32 Tolerance OFC|Overall Study||20
474698|NCT01157117|1164143|P1|Completed Month 32 Tolerance OFC|Overall Study||24
474699|NCT01157117|1164141|P3|Discontinued Milk OIT at Month 30|Overall Study||0
474700|NCT01157117|1164142|P2|Discontinued Milk OIT at Month 30|Overall Study||20
474701|NCT01157117|1164143|P1|Discontinued Milk OIT at Month 30|Overall Study||24
474702|NCT01157117|1164141|P3|Completed Month 28 Desensitization OFC|Overall Study||0
474703|NCT01157117|1164142|P2|Completed Month 28 Desensitization OFC|Overall Study||24
474704|NCT01157117|1164143|P1|Completed Month 28 Desensitization OFC|Overall Study||26
474705|NCT01157117|1164141|P3|Unblinded at Month 16|Overall Study||0
474706|NCT01157117|1164142|P2|Unblinded at Month 16|Overall Study||26
474707|NCT01157117|1164143|P1|Unblinded at Month 16|Overall Study||26
474708|NCT01157117|1164141|P3|Reached Milk OIT Maintenance Dosing|Overall Study||0
474709|NCT01157117|1164142|P2|Reached Milk OIT Maintenance Dosing|Overall Study||26
474710|NCT01157117|1164143|P1|Reached Milk OIT Maintenance Dosing|Overall Study||26
474711|NCT01157117|1164141|P3|Began Milk OIT Dosing at Month 4|Overall Study||0
474802|NCT01156376|1164469|P2|NOT COMPLETED|Overall Study||0
474712|NCT01157117|1164142|P2|Began Milk OIT Dosing at Month 4|Overall Study||28
474713|NCT01157117|1164143|P1|Began Milk OIT Dosing at Month 4|Overall Study||27
474714|NCT01157117|1164141|P3|Began Omalizumab or Placebo Dosing|Overall Study||0
474715|NCT01157117|1164142|P2|Began Omalizumab or Placebo Dosing|Overall Study||28
474716|NCT01157117|1164143|P1|Began Omalizumab or Placebo Dosing|Overall Study||27
474717|NCT01157117|1164141|P3|STARTED|Overall Study||20
474718|NCT01157117|1164142|P2|STARTED|Overall Study||29
474719|NCT01157117|1164143|P1|STARTED|Overall Study||28
474720|NCT01157078|1164184|P2|NOT COMPLETED|Overall Study||36
474721|NCT01157078|1164185|P1|NOT COMPLETED|Overall Study||35
474722|NCT01157078|1164184|P2|COMPLETED|Overall Study||124
474723|NCT01157078|1164185|P1|COMPLETED|Overall Study||124
474724|NCT01157078|1164184|P2|Received Treatment|Overall Study||159
474725|NCT01157078|1164185|P1|Received Treatment|Overall Study||157
474726|NCT01157078|1164184|P2|STARTED|Overall Study||160
474727|NCT01157078|1164185|P1|STARTED|Overall Study||159
474728|NCT01157065|1164235|P2|NOT COMPLETED|Overall Study||1
474729|NCT01157065|1164236|P1|NOT COMPLETED|Overall Study||0
474730|NCT01157065|1164235|P2|COMPLETED|Overall Study||10
474731|NCT01157065|1164236|P1|COMPLETED|Overall Study||38
474732|NCT01157065|1164235|P2|STARTED|Overall Study||11
474733|NCT01157065|1164236|P1|STARTED|Overall Study||38
474734|NCT01156987|1164246|P2|NOT COMPLETED|Overall Study||11
474735|NCT01156987|1164247|P1|NOT COMPLETED|Overall Study||0
474736|NCT01156987|1164246|P2|COMPLETED|Overall Study||12
474737|NCT01156987|1164247|P1|COMPLETED|Overall Study||8
474738|NCT01156987|1164246|P2|STARTED|Overall Study||23
474739|NCT01156987|1164247|P1|STARTED|Overall Study||8
474740|NCT01156844|1164257|P4|NOT COMPLETED|Overall Study||6
474741|NCT01156844|1164258|P3|NOT COMPLETED|Overall Study||6
474742|NCT01156844|1164259|P2|NOT COMPLETED|Overall Study||2
474743|NCT01156844|1164260|P1|NOT COMPLETED|Overall Study||2
474744|NCT01156844|1164257|P4|COMPLETED|Overall Study||41
474745|NCT01156844|1164258|P3|COMPLETED|Overall Study||42
474746|NCT01156844|1164259|P2|COMPLETED|Overall Study||46
474747|NCT01156844|1164260|P1|COMPLETED|Overall Study||46
474748|NCT01156844|1164257|P4|PD & Safety Sets: Received Study Drug|Overall Study||46
474749|NCT01156844|1164258|P3|PD & Safety Sets: Received Study Drug|Overall Study||48
474750|NCT01156844|1164259|P2|PD & Safety Sets: Received Study Drug|Overall Study||47
474751|NCT01156844|1164260|P1|PD & Safety Sets: Received Study Drug|Overall Study|PD=Pharmacodynamic|48
474752|NCT01156844|1164257|P4|STARTED|Overall Study||47
474753|NCT01156844|1164258|P3|STARTED|Overall Study||48
474754|NCT01156844|1164259|P2|STARTED|Overall Study||48
474755|NCT01156844|1164260|P1|STARTED|Overall Study|Randomized participants.|48
474756|NCT01156792|1164279|P1|NOT COMPLETED|Overall Study||69
474757|NCT01156792|1164279|P1|COMPLETED|Overall Study||93
474758|NCT01156792|1164279|P1|STARTED|Overall Study||162
474759|NCT01156701|1164344|P4|NOT COMPLETED|Overall Study||0
474760|NCT01156701|1164345|P3|NOT COMPLETED|Overall Study||0
474761|NCT01156701|1164346|P2|NOT COMPLETED|Overall Study||0
474762|NCT01156701|1164347|P1|NOT COMPLETED|Overall Study||0
474763|NCT01156701|1164344|P4|COMPLETED|Overall Study||6725
474764|NCT01156701|1164345|P3|COMPLETED|Overall Study||163716
474765|NCT01156701|1164346|P2|COMPLETED|Overall Study||1007
474766|NCT01156701|1164347|P1|COMPLETED|Overall Study||257
474767|NCT01156701|1164344|P4|STARTED|Overall Study||6725
474768|NCT01156701|1164345|P3|STARTED|Overall Study||163716
474769|NCT01156701|1164346|P2|STARTED|Overall Study||1007
474770|NCT01156701|1164347|P1|STARTED|Overall Study||257
474771|NCT01156675|1164384|P3|NOT COMPLETED|Overall Study||2
474772|NCT01156675|1164385|P2|NOT COMPLETED|Overall Study||25
474773|NCT01156675|1164386|P1|NOT COMPLETED|Overall Study||34
474774|NCT01156675|1164384|P3|COMPLETED|Overall Study||0
474775|NCT01156675|1164385|P2|COMPLETED|Overall Study||81
474776|NCT01156675|1164386|P1|COMPLETED|Overall Study||73
474777|NCT01156675|1164384|P3|STARTED|Overall Study||2
474778|NCT01156675|1164385|P2|STARTED|Overall Study||106
474779|NCT01156675|1164386|P1|STARTED|Overall Study||107
474780|NCT01156597|1164420|P2|NOT COMPLETED|Overall Study||1
474781|NCT01156597|1164421|P1|NOT COMPLETED|Overall Study||3
474782|NCT01156597|1164420|P2|COMPLETED|Overall Study||13
474783|NCT01156597|1164421|P1|COMPLETED|Overall Study||13
474784|NCT01156597|1164420|P2|STARTED|Overall Study||14
474785|NCT01156597|1164421|P1|STARTED|Overall Study||16
474786|NCT01156571|1164433|P2|NOT COMPLETED|Overall Study||19
474787|NCT01156571|1164434|P1|NOT COMPLETED|Overall Study||17
474788|NCT01156571|1164433|P2|COMPLETED|Overall Study|Completed = ITT patients who completed scheduled visits or developed a primary endpoint event|5545
474789|NCT01156571|1164434|P1|COMPLETED|Overall Study|Completed = ITT patients who completed scheduled visits or developed a primary endpoint event|5564
474790|NCT01156571|1164433|P2|STARTED|Overall Study|ITT: defined as all patients randomized.|5564
474791|NCT01156571|1164434|P1|STARTED|Overall Study|ITT: defined as all patients randomized.|5581
474792|NCT01156532|1164444|P1|NOT COMPLETED|Overall Study||2
474793|NCT01156532|1164444|P1|COMPLETED|Overall Study||28
474794|NCT01156532|1164444|P1|STARTED|Overall Study||30
474795|NCT01156480|1164456|P2|NOT COMPLETED|Overall Study||1
474796|NCT01156480|1164457|P1|NOT COMPLETED|Overall Study||0
474797|NCT01156480|1164456|P2|COMPLETED|Overall Study||1
474798|NCT01156480|1164457|P1|COMPLETED|Overall Study||0
474799|NCT01156480|1164456|P2|STARTED|Overall Study||2
474800|NCT01156480|1164457|P1|STARTED|Overall Study||0
474801|NCT01156376|1164468|P3|NOT COMPLETED|Overall Study||4
474803|NCT01156376|1164470|P1|NOT COMPLETED|Overall Study||1
474804|NCT01156376|1164468|P3|COMPLETED|Overall Study||23
474805|NCT01156376|1164469|P2|COMPLETED|Overall Study||26
474806|NCT01156376|1164470|P1|COMPLETED|Overall Study||26
474807|NCT01156376|1164468|P3|STARTED|Overall Study||27
474808|NCT01156376|1164469|P2|STARTED|Overall Study||26
474809|NCT01156376|1164470|P1|STARTED|Overall Study||27
474810|NCT01156363|1164691|P1|NOT COMPLETED|Overall Study||22
474811|NCT01156363|1164691|P1|COMPLETED|Overall Study||64
474812|NCT01156363|1164691|P1|STARTED|Overall Study||86
474813|NCT01156311|1164713|P4|NOT COMPLETED|6-month Add-on Therapy Period||10
474814|NCT01156311|1164714|P3|NOT COMPLETED|6-month Add-on Therapy Period||12
474815|NCT01156311|1164715|P2|NOT COMPLETED|6-month Add-on Therapy Period||0
474816|NCT01156311|1164716|P1|NOT COMPLETED|6-month Add-on Therapy Period||0
474817|NCT01156311|1164713|P4|COMPLETED|6-month Add-on Therapy Period||37
474818|NCT01156311|1164714|P3|COMPLETED|6-month Add-on Therapy Period||45
474819|NCT01156311|1164715|P2|COMPLETED|6-month Add-on Therapy Period||0
474820|NCT01156311|1164716|P1|COMPLETED|6-month Add-on Therapy Period||0
474821|NCT01156311|1164713|P4|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||38
474822|NCT01156311|1164714|P3|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||45
474823|NCT01156311|1164715|P2|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0
474824|NCT01156311|1164716|P1|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0
474825|NCT01156311|1164713|P4|STARTED|6-month Add-on Therapy Period||47
474826|NCT01156311|1164714|P3|STARTED|6-month Add-on Therapy Period||57
474827|NCT01156311|1164715|P2|STARTED|6-month Add-on Therapy Period||0
474828|NCT01156311|1164716|P1|STARTED|6-month Add-on Therapy Period||0
474829|NCT01156311|1164713|P4|NOT COMPLETED|2-Month Monotherapy Period||0
474830|NCT01156311|1164714|P3|NOT COMPLETED|2-Month Monotherapy Period||0
474831|NCT01156311|1164715|P2|NOT COMPLETED|2-Month Monotherapy Period||2
474832|NCT01156311|1164716|P1|NOT COMPLETED|2-Month Monotherapy Period||2
474833|NCT01156311|1164713|P4|COMPLETED|2-Month Monotherapy Period||0
474834|NCT01156311|1164714|P3|COMPLETED|2-Month Monotherapy Period||0
474835|NCT01156311|1164715|P2|COMPLETED|2-Month Monotherapy Period||47
474836|NCT01156311|1164716|P1|COMPLETED|2-Month Monotherapy Period||57
474837|NCT01156311|1164713|P4|STARTED|2-Month Monotherapy Period||0
474838|NCT01156311|1164714|P3|STARTED|2-Month Monotherapy Period||0
474839|NCT01156311|1164715|P2|STARTED|2-Month Monotherapy Period||49
474840|NCT01156311|1164716|P1|STARTED|2-Month Monotherapy Period||59
474841|NCT01156142|1164740|P2|NOT COMPLETED|Overall Study||7
474842|NCT01156142|1164741|P1|NOT COMPLETED|Overall Study||8
474843|NCT01156142|1164740|P2|COMPLETED|Overall Study||71
474844|NCT01156142|1164741|P1|COMPLETED|Overall Study||69
474845|NCT01156142|1164740|P2|STARTED|Overall Study||78
474846|NCT01156142|1164741|P1|STARTED|Overall Study||77
474847|NCT01156116|1164759|P2|NOT COMPLETED|Overall Study||1
474848|NCT01156116|1164760|P1|NOT COMPLETED|Overall Study||5
474849|NCT01156116|1164759|P2|COMPLETED|Overall Study||12
474850|NCT01156116|1164760|P1|COMPLETED|Overall Study||21
474851|NCT01156116|1164759|P2|STARTED|Overall Study||13
474852|NCT01156116|1164760|P1|STARTED|Overall Study||26
474853|NCT01156051|1164774|P2|NOT COMPLETED|Overall Study||1
474854|NCT01156051|1164775|P1|NOT COMPLETED|Overall Study||1
474855|NCT01156051|1164774|P2|COMPLETED|Overall Study||16
474856|NCT01156051|1164775|P1|COMPLETED|Overall Study||11
474857|NCT01156051|1164774|P2|STARTED|Overall Study||17
474858|NCT01156051|1164775|P1|STARTED|Overall Study||12
474859|NCT01156012|1164789|P2|NOT COMPLETED|Overall Study||3
474860|NCT01156012|1164790|P1|NOT COMPLETED|Overall Study||7
474861|NCT01156012|1164789|P2|COMPLETED|Overall Study||186
474862|NCT01156012|1164790|P1|COMPLETED|Overall Study||206
474863|NCT01156012|1164789|P2|STARTED|Overall Study||189
474864|NCT01156012|1164790|P1|STARTED|Overall Study||213
474865|NCT01155999|1164798|P2|NOT COMPLETED|Overall Study||4
474866|NCT01155999|1164799|P1|NOT COMPLETED|Overall Study||7
474867|NCT01155999|1164798|P2|COMPLETED|Overall Study||136
474868|NCT01155999|1164799|P1|COMPLETED|Overall Study||139
474869|NCT01155999|1164798|P2|STARTED|Overall Study||140
474870|NCT01155999|1164799|P1|STARTED|Overall Study||146
474871|NCT01155869|1164807|P2|NOT COMPLETED|Overall Study||1
474872|NCT01155869|1164808|P1|NOT COMPLETED|Overall Study||3
474873|NCT01155869|1164807|P2|COMPLETED|Overall Study||3
474874|NCT01155869|1164808|P1|COMPLETED|Overall Study||0
474875|NCT01155869|1164807|P2|STARTED|Overall Study||4
474876|NCT01155869|1164808|P1|STARTED|Overall Study||3
474877|NCT01155830|1164819|P3|NOT COMPLETED|Overall Study||0
474878|NCT01155830|1164820|P2|NOT COMPLETED|Overall Study||0
474879|NCT01155830|1164821|P1|NOT COMPLETED|Overall Study||0
474880|NCT01155830|1164819|P3|COMPLETED|Overall Study||21
474881|NCT01155830|1164820|P2|COMPLETED|Overall Study||0
474882|NCT01155830|1164821|P1|COMPLETED|Overall Study||0
474883|NCT01155830|1164819|P3|STARTED|Overall Study||21
474884|NCT01155830|1164820|P2|STARTED|Overall Study||0
474885|NCT01155830|1164821|P1|STARTED|Overall Study||0
474886|NCT01155726|1164832|P4|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
474887|NCT01155726|1164833|P3|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
474888|NCT01155726|1164834|P2|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
474889|NCT01155726|1164835|P1|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
474890|NCT01155726|1164832|P4|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||25
474891|NCT01155726|1164833|P3|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||28
474892|NCT01155726|1164834|P2|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||20
474893|NCT01155726|1164835|P1|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||23
474894|NCT01155726|1164832|P4|STARTED|Period 2, 3 Days (Unmask) or (Partial)||25
474895|NCT01155726|1164833|P3|STARTED|Period 2, 3 Days (Unmask) or (Partial)||28
474896|NCT01155726|1164834|P2|STARTED|Period 2, 3 Days (Unmask) or (Partial)||20
474897|NCT01155726|1164835|P1|STARTED|Period 2, 3 Days (Unmask) or (Partial)||23
474898|NCT01155726|1164832|P4|NOT COMPLETED|Period 1, 3 Days (Masked)||0
474899|NCT01155726|1164833|P3|NOT COMPLETED|Period 1, 3 Days (Masked)||2
474900|NCT01155726|1164834|P2|NOT COMPLETED|Period 1, 3 Days (Masked)||0
474901|NCT01155726|1164835|P1|NOT COMPLETED|Period 1, 3 Days (Masked)||1
474902|NCT01155726|1164832|P4|COMPLETED|Period 1, 3 Days (Masked)||25
474903|NCT01155726|1164833|P3|COMPLETED|Period 1, 3 Days (Masked)||28
474904|NCT01155726|1164834|P2|COMPLETED|Period 1, 3 Days (Masked)||20
474905|NCT01155726|1164835|P1|COMPLETED|Period 1, 3 Days (Masked)||23
474906|NCT01155726|1164832|P4|STARTED|Period 1, 3 Days (Masked)||25
474907|NCT01155726|1164833|P3|STARTED|Period 1, 3 Days (Masked)||30
474908|NCT01155726|1164834|P2|STARTED|Period 1, 3 Days (Masked)||20
474909|NCT01155726|1164835|P1|STARTED|Period 1, 3 Days (Masked)||24
474910|NCT01155661|1164857|P1|NOT COMPLETED|Overall Study||280
474911|NCT01155661|1164857|P1|COMPLETED|Overall Study||328
474912|NCT01155661|1164857|P1|STARTED|Overall Study||608
474913|NCT01155570|1164883|P1|NOT COMPLETED|Overall Study||142
474914|NCT01155570|1164883|P1|COMPLETED|Overall Study||592
474915|NCT01155570|1164883|P1|Efficacy Analysis Population|Overall Study|5 received Humira off-label, 21 did not receive Humira after the first administration|708
474916|NCT01155570|1164883|P1|STARTED|Overall Study|Safety Analysis Population|734
474917|NCT01155531|1164917|P4|NOT COMPLETED|Overall Study||1
474918|NCT01155531|1164918|P3|NOT COMPLETED|Overall Study||2
474919|NCT01155531|1164919|P2|NOT COMPLETED|Overall Study||0
474920|NCT01155531|1164920|P1|NOT COMPLETED|Overall Study||1
474921|NCT01155531|1164917|P4|COMPLETED|Overall Study||9
474922|NCT01155531|1164918|P3|COMPLETED|Overall Study||8
474923|NCT01155531|1164919|P2|COMPLETED|Overall Study||10
474924|NCT01155531|1164920|P1|COMPLETED|Overall Study||9
474925|NCT01155531|1164917|P4|STARTED|Overall Study||10
474926|NCT01155531|1164918|P3|STARTED|Overall Study||10
474927|NCT01155531|1164919|P2|STARTED|Overall Study||10
474928|NCT01155531|1164920|P1|STARTED|Overall Study||10
474929|NCT01155479|1164943|P5|NOT COMPLETED|Part II||55
474930|NCT01155479|1164944|P4|NOT COMPLETED|Part II||50
474931|NCT01155479|1164945|P3|NOT COMPLETED|Part II||58
474932|NCT01155479|1164946|P2|NOT COMPLETED|Part II||61
474933|NCT01155479|1164947|P1|NOT COMPLETED|Part II||59
474934|NCT01155479|1164943|P5|COMPLETED|Part II||126
474935|NCT01155479|1164944|P4|COMPLETED|Part II||127
474936|NCT01155479|1164945|P3|COMPLETED|Part II||109
474937|NCT01155479|1164946|P2|COMPLETED|Part II||116
474938|NCT01155479|1164947|P1|COMPLETED|Part II||107
474939|NCT01155479|1164943|P5|STARTED|Part II||181
474940|NCT01155479|1164944|P4|STARTED|Part II||177
474941|NCT01155479|1164945|P3|STARTED|Part II||167
474942|NCT01155479|1164946|P2|STARTED|Part II||177
474943|NCT01155479|1164947|P1|STARTED|Part II||166
474944|NCT01155479|1164943|P5|NOT COMPLETED|Part I||23
474945|NCT01155479|1164944|P4|NOT COMPLETED|Part I||27
474946|NCT01155479|1164945|P3|NOT COMPLETED|Part I||39
474947|NCT01155479|1164946|P2|NOT COMPLETED|Part I||27
474948|NCT01155479|1164947|P1|NOT COMPLETED|Part I||38
474949|NCT01155479|1164943|P5|COMPLETED|Part I||181
474950|NCT01155479|1164944|P4|COMPLETED|Part I||177
474951|NCT01155479|1164945|P3|COMPLETED|Part I||167
474952|NCT01155479|1164946|P2|COMPLETED|Part I||177
474953|NCT01155479|1164947|P1|COMPLETED|Part I||166
474954|NCT01155479|1164943|P5|Treated|Part I||203
474955|NCT01155479|1164944|P4|Treated|Part I||198
474956|NCT01155479|1164945|P3|Treated|Part I||204
474957|NCT01155479|1164946|P2|Treated|Part I||202
474958|NCT01155479|1164947|P1|Treated|Part I||200
474959|NCT01155479|1164943|P5|STARTED|Part I||204
474960|NCT01155479|1164944|P4|STARTED|Part I||204
474961|NCT01155479|1164945|P3|STARTED|Part I||206
474962|NCT01155479|1164946|P2|STARTED|Part I||204
474963|NCT01155479|1164947|P1|STARTED|Part I||204
474964|NCT01155466|1164999|P5|NOT COMPLETED|Overall Study||27
474965|NCT01155466|1165000|P4|NOT COMPLETED|Overall Study||21
474966|NCT01155466|1165001|P3|NOT COMPLETED|Overall Study||20
474967|NCT01155466|1165002|P2|NOT COMPLETED|Overall Study||25
474968|NCT01155466|1165003|P1|NOT COMPLETED|Overall Study||22
474969|NCT01155466|1164999|P5|COMPLETED|Overall Study|Completed treatment phase|129
474970|NCT01155466|1165000|P4|COMPLETED|Overall Study|Completed treatment phase|134
474971|NCT01155466|1165001|P3|COMPLETED|Overall Study|Completed treatment phase|136
474972|NCT01155466|1165002|P2|COMPLETED|Overall Study|Completed treatment phase|130
474973|NCT01155466|1165003|P1|COMPLETED|Overall Study|Completed treatment phase|134
474974|NCT01155466|1164999|P5|Treated|Overall Study||154
474975|NCT01155466|1165000|P4|Treated|Overall Study||155
474976|NCT01155466|1165001|P3|Treated|Overall Study||153
474977|NCT01155466|1165002|P2|Treated|Overall Study||153
474978|NCT01155466|1165003|P1|Treated|Overall Study||154
474979|NCT01155466|1164999|P5|STARTED|Overall Study||156
474980|NCT01155466|1165000|P4|STARTED|Overall Study||155
474981|NCT01155466|1165001|P3|STARTED|Overall Study||156
474982|NCT01155466|1165002|P2|STARTED|Overall Study||155
474983|NCT01155466|1165003|P1|STARTED|Overall Study||156
474984|NCT01155388|1165057|P2|NOT COMPLETED|Overall Study||0
474985|NCT01155388|1165058|P1|NOT COMPLETED|Overall Study||1
474986|NCT01155388|1165057|P2|COMPLETED|Overall Study||6
474987|NCT01155388|1165058|P1|COMPLETED|Overall Study||7
474988|NCT01155388|1165057|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
474989|NCT01155388|1165058|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
474990|NCT01155388|1165057|P2|STARTED|Overall Study||6
474991|NCT01155388|1165058|P1|STARTED|Overall Study||8
474992|NCT01155375|1165068|P2|NOT COMPLETED|Overall Study||0
474993|NCT01155375|1165069|P1|NOT COMPLETED|Overall Study||1
474994|NCT01155375|1165068|P2|COMPLETED|Overall Study||6
474995|NCT01155375|1165069|P1|COMPLETED|Overall Study||7
474996|NCT01155375|1165068|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
474997|NCT01155375|1165069|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
474998|NCT01155375|1165068|P2|STARTED|Overall Study||6
474999|NCT01155375|1165069|P1|STARTED|Overall Study||8
475000|NCT01155336|1165079|P2|NOT COMPLETED|Overall Study||0
475001|NCT01155336|1165080|P1|NOT COMPLETED|Overall Study||0
475002|NCT01155336|1165079|P2|COMPLETED|Overall Study|We did not complete the study.|4
475003|NCT01155336|1165080|P1|COMPLETED|Overall Study|We did not complete the study.|0
475004|NCT01155336|1165079|P2|STARTED|Overall Study|We did not complete the study.|4
475005|NCT01155336|1165080|P1|STARTED|Overall Study|We did not complete the study.|0
475006|NCT01155323|1165088|P2|NOT COMPLETED|Second Intervention||1
475007|NCT01155323|1165089|P1|NOT COMPLETED|Second Intervention||1
475008|NCT01155323|1165088|P2|COMPLETED|Second Intervention||56
475009|NCT01155323|1165089|P1|COMPLETED|Second Intervention||58
475010|NCT01155323|1165088|P2|STARTED|Second Intervention||57
475011|NCT01155323|1165089|P1|STARTED|Second Intervention||59
475012|NCT01155323|1165088|P2|NOT COMPLETED|First Intervention||1
475013|NCT01155323|1165089|P1|NOT COMPLETED|First Intervention||1
475014|NCT01155323|1165088|P2|COMPLETED|First Intervention||57
475015|NCT01155323|1165089|P1|COMPLETED|First Intervention||59
475016|NCT01155323|1165088|P2|STARTED|First Intervention||58
475017|NCT01155323|1165089|P1|STARTED|First Intervention||60
475018|NCT01155284|1165107|P2|NOT COMPLETED|Overall Study||5
475019|NCT01155284|1165108|P1|NOT COMPLETED|Overall Study||7
475020|NCT01155284|1165107|P2|COMPLETED|Overall Study||18
475021|NCT01155284|1165108|P1|COMPLETED|Overall Study||40
475022|NCT01155284|1165107|P2|STARTED|Overall Study||23
475023|NCT01155284|1165108|P1|STARTED|Overall Study||47
475024|NCT01155219|1165118|P2|NOT COMPLETED|Overall Study||3
475025|NCT01155219|1165119|P1|NOT COMPLETED|Overall Study||4
475026|NCT01155219|1165118|P2|COMPLETED|Overall Study||70
475027|NCT01155219|1165119|P1|COMPLETED|Overall Study||73
475028|NCT01155219|1165118|P2|STARTED|Overall Study||73
475029|NCT01155219|1165119|P1|STARTED|Overall Study||77
475030|NCT01155180|1165127|P2|NOT COMPLETED|Overall Study||0
475031|NCT01155180|1165128|P1|NOT COMPLETED|Overall Study||0
475032|NCT01155180|1165127|P2|COMPLETED|Overall Study||6
475033|NCT01155180|1165128|P1|COMPLETED|Overall Study||18
475034|NCT01155180|1165127|P2|STARTED|Overall Study||6
475035|NCT01155180|1165128|P1|STARTED|Overall Study||18
475036|NCT01155167|1165136|P2|NOT COMPLETED|Overall Study||0
475037|NCT01155167|1165137|P1|NOT COMPLETED|Overall Study||3
475038|NCT01155167|1165136|P2|COMPLETED|Overall Study||43
475039|NCT01155167|1165137|P1|COMPLETED|Overall Study||40
475040|NCT01155167|1165136|P2|STARTED|Overall Study||43
475041|NCT01155167|1165137|P1|STARTED|Overall Study||43
475042|NCT01155154|1165150|P3|NOT COMPLETED|Overall Study||0
475043|NCT01155154|1165151|P2|NOT COMPLETED|Overall Study||0
475044|NCT01155154|1165152|P1|NOT COMPLETED|Overall Study||0
475045|NCT01155154|1165150|P3|COMPLETED|Overall Study||24
475046|NCT01155154|1165151|P2|COMPLETED|Overall Study||24
475047|NCT01155154|1165152|P1|COMPLETED|Overall Study||25
475048|NCT01155154|1165150|P3|STARTED|Overall Study||24
475049|NCT01155154|1165151|P2|STARTED|Overall Study||24
475050|NCT01155154|1165152|P1|STARTED|Overall Study||25
475051|NCT01155141|1165160|P1|NOT COMPLETED|Overall Study||2
475052|NCT01155141|1165160|P1|COMPLETED|Overall Study||14
475053|NCT01155141|1165160|P1|STARTED|Overall Study||16
475054|NCT01155063|1165172|P1|NOT COMPLETED|Overall Study||89
475055|NCT01155063|1165172|P1|COMPLETED|Overall Study||0
475056|NCT01155063|1165172|P1|STARTED|Overall Study||89
475057|NCT01155024|1165182|P2|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||6
475058|NCT01155024|1165183|P1|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||0
475059|NCT01155024|1165182|P2|COMPLETED|Direct Manufactured Socket 3 Month Trial||4
475060|NCT01155024|1165183|P1|COMPLETED|Direct Manufactured Socket 3 Month Trial||0
475061|NCT01155024|1165182|P2|STARTED|Direct Manufactured Socket 3 Month Trial||10
475062|NCT01155024|1165183|P1|STARTED|Direct Manufactured Socket 3 Month Trial||0
475063|NCT01155024|1165182|P2|NOT COMPLETED|Second Socket Intervention Fitting||0
475064|NCT01155024|1165183|P1|NOT COMPLETED|Second Socket Intervention Fitting||0
475065|NCT01155024|1165182|P2|COMPLETED|Second Socket Intervention Fitting||5
475066|NCT01155024|1165183|P1|COMPLETED|Second Socket Intervention Fitting||5
475067|NCT01155024|1165182|P2|STARTED|Second Socket Intervention Fitting||5
475068|NCT01155024|1165183|P1|STARTED|Second Socket Intervention Fitting||5
475069|NCT01155024|1165182|P2|NOT COMPLETED|First Socket Intervention Fitting||0
475070|NCT01155024|1165183|P1|NOT COMPLETED|First Socket Intervention Fitting||0
475071|NCT01155024|1165182|P2|COMPLETED|First Socket Intervention Fitting||5
475072|NCT01155024|1165183|P1|COMPLETED|First Socket Intervention Fitting||5
475073|NCT01155024|1165182|P2|STARTED|First Socket Intervention Fitting||5
475074|NCT01155024|1165183|P1|STARTED|First Socket Intervention Fitting||5
475075|NCT01155011|1165193|P2|NOT COMPLETED|6 to 12 Months||10
475076|NCT01155011|1165194|P1|NOT COMPLETED|6 to 12 Months||9
475077|NCT01155011|1165193|P2|COMPLETED|6 to 12 Months||121
475078|NCT01155011|1165194|P1|COMPLETED|6 to 12 Months||120
475079|NCT01155011|1165193|P2|STARTED|6 to 12 Months||131
475080|NCT01155011|1165194|P1|STARTED|6 to 12 Months||129
475081|NCT01155011|1165193|P2|NOT COMPLETED|Baseline to 6 Months||25
475082|NCT01155011|1165194|P1|NOT COMPLETED|Baseline to 6 Months||22
475083|NCT01155011|1165193|P2|COMPLETED|Baseline to 6 Months||131
475084|NCT01155011|1165194|P1|COMPLETED|Baseline to 6 Months||129
475085|NCT01155011|1165193|P2|STARTED|Baseline to 6 Months||156
475086|NCT01155011|1165194|P1|STARTED|Baseline to 6 Months||151
475087|NCT01154985|1165207|P3|NOT COMPLETED|Overall Study||18
475088|NCT01154985|1165208|P2|NOT COMPLETED|Overall Study||27
475089|NCT01154985|1165209|P1|NOT COMPLETED|Overall Study||17
475090|NCT01154985|1165207|P3|COMPLETED|Overall Study||68
475091|NCT01154985|1165208|P2|COMPLETED|Overall Study||55
475092|NCT01154985|1165209|P1|COMPLETED|Overall Study||58
475093|NCT01154985|1165207|P3|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|64
475094|NCT01154985|1165208|P2|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|55
475095|NCT01154985|1165209|P1|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|55
475096|NCT01154985|1165207|P3|Valid Biopsy -Baseline and Month 12.5|Overall Study||68
475097|NCT01154985|1165208|P2|Valid Biopsy -Baseline and Month 12.5|Overall Study||62
475098|NCT01154985|1165209|P1|Valid Biopsy -Baseline and Month 12.5|Overall Study||60
475099|NCT01154985|1165207|P3|Full Analysis Set|Overall Study|Received at least one dose of study medication|86
475100|NCT01154985|1165208|P2|Full Analysis Set|Overall Study|Received at least one dose of study medication|82
475101|NCT01154985|1165209|P1|Full Analysis Set|Overall Study|Received at least one dose of study medication|75
475102|NCT01154985|1165207|P3|STARTED|Overall Study|Randomized|86
475103|NCT01154985|1165208|P2|STARTED|Overall Study|Randomized|82
475104|NCT01154985|1165209|P1|STARTED|Overall Study|Randomized|75
475105|NCT01154816|1165235|P12|NOT COMPLETED|Overall Study||4
475106|NCT01154816|1165236|P11|NOT COMPLETED|Overall Study||11
475107|NCT01154816|1165237|P10|NOT COMPLETED|Overall Study||10
475108|NCT01154816|1165238|P9|NOT COMPLETED|Overall Study||9
475109|NCT01154816|1165239|P8|NOT COMPLETED|Overall Study||7
475110|NCT01154816|1165240|P7|NOT COMPLETED|Overall Study||6
475111|NCT01154816|1165241|P6|NOT COMPLETED|Overall Study||8
475112|NCT01154816|1165242|P5|NOT COMPLETED|Overall Study||10
475113|NCT01154816|1165243|P4|NOT COMPLETED|Overall Study||10
475114|NCT01154816|1165244|P3|NOT COMPLETED|Overall Study||10
475115|NCT01154816|1165245|P2|NOT COMPLETED|Overall Study||10
475116|NCT01154816|1165246|P1|NOT COMPLETED|Overall Study||20
475117|NCT01154816|1165235|P12|COMPLETED|Overall Study||0
475118|NCT01154816|1165236|P11|COMPLETED|Overall Study||0
475119|NCT01154816|1165237|P10|COMPLETED|Overall Study||0
475120|NCT01154816|1165238|P9|COMPLETED|Overall Study||1
475121|NCT01154816|1165239|P8|COMPLETED|Overall Study||0
475122|NCT01154816|1165240|P7|COMPLETED|Overall Study||0
475123|NCT01154816|1165241|P6|COMPLETED|Overall Study||0
475124|NCT01154816|1165242|P5|COMPLETED|Overall Study||0
475125|NCT01154816|1165243|P4|COMPLETED|Overall Study||0
475126|NCT01154816|1165244|P3|COMPLETED|Overall Study||0
475127|NCT01154816|1165245|P2|COMPLETED|Overall Study||2
475128|NCT01154816|1165246|P1|COMPLETED|Overall Study||0
475129|NCT01154816|1165235|P12|STARTED|Overall Study||4
475130|NCT01154816|1165236|P11|STARTED|Overall Study||11
475131|NCT01154816|1165237|P10|STARTED|Overall Study||10
475132|NCT01154816|1165238|P9|STARTED|Overall Study||10
475133|NCT01154816|1165239|P8|STARTED|Overall Study||7
475134|NCT01154816|1165240|P7|STARTED|Overall Study||6
475135|NCT01154816|1165241|P6|STARTED|Overall Study||8
475136|NCT01154816|1165242|P5|STARTED|Overall Study||10
475137|NCT01154816|1165243|P4|STARTED|Overall Study||10
475138|NCT01154816|1165244|P3|STARTED|Overall Study||10
475139|NCT01154816|1165245|P2|STARTED|Overall Study||12
475140|NCT01154816|1165246|P1|STARTED|Overall Study||20
475141|NCT01154751|1165279|P1|NOT COMPLETED|3-year Follow-up||49
475142|NCT01154751|1165279|P1|COMPLETED|3-year Follow-up||34
475143|NCT01154751|1165279|P1|STARTED|3-year Follow-up||83
475144|NCT01154751|1165279|P1|NOT COMPLETED|2-year Follow-up||10
475145|NCT01154751|1165279|P1|COMPLETED|2-year Follow-up||83
475146|NCT01154751|1165279|P1|STARTED|2-year Follow-up||93
475147|NCT01154751|1165279|P1|NOT COMPLETED|1-year Follow-up||5
475148|NCT01154751|1165279|P1|COMPLETED|1-year Follow-up||93
475149|NCT01154751|1165279|P1|STARTED|1-year Follow-up||98
475150|NCT01154751|1165279|P1|NOT COMPLETED|6-month Follow-up||11
475151|NCT01154751|1165279|P1|COMPLETED|6-month Follow-up||98
475152|NCT01154751|1165279|P1|STARTED|6-month Follow-up||109
475153|NCT01154699|1165304|P2|NOT COMPLETED|Second Intervention||0
475154|NCT01154699|1165305|P1|NOT COMPLETED|Second Intervention||0
475155|NCT01154699|1165304|P2|COMPLETED|Second Intervention||8
475156|NCT01154699|1165305|P1|COMPLETED|Second Intervention||13
475157|NCT01154699|1165304|P2|Subjects With Asthma + OSA|Second Intervention||2
475158|NCT01154699|1165305|P1|Subjects With Asthma + OSA|Second Intervention||6
475159|NCT01154699|1165304|P2|Subjects With Asthma Only|Second Intervention||6
475244|NCT01154634|1165337|P1|COMPLETED|Period 3- Second Intervention||4
475160|NCT01154699|1165305|P1|Subjects With Asthma Only|Second Intervention||7
475161|NCT01154699|1165304|P2|STARTED|Second Intervention||8
475162|NCT01154699|1165305|P1|STARTED|Second Intervention||13
475163|NCT01154699|1165304|P2|NOT COMPLETED|Washout Period (4 Weeks)||0
475164|NCT01154699|1165305|P1|NOT COMPLETED|Washout Period (4 Weeks)||0
475165|NCT01154699|1165304|P2|COMPLETED|Washout Period (4 Weeks)||8
475166|NCT01154699|1165305|P1|COMPLETED|Washout Period (4 Weeks)||13
475167|NCT01154699|1165304|P2|Subjects With Asthma + OSA|Washout Period (4 Weeks)||2
475168|NCT01154699|1165305|P1|Subjects With Asthma + OSA|Washout Period (4 Weeks)||6
475169|NCT01154699|1165304|P2|Subjects With Asthma Only|Washout Period (4 Weeks)||6
475170|NCT01154699|1165305|P1|Subjects With Asthma Only|Washout Period (4 Weeks)||7
475171|NCT01154699|1165304|P2|STARTED|Washout Period (4 Weeks)||8
475172|NCT01154699|1165305|P1|STARTED|Washout Period (4 Weeks)||13
475173|NCT01154699|1165304|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
475174|NCT01154699|1165305|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
475175|NCT01154699|1165304|P2|COMPLETED|First Intervention (4 Weeks)||8
475176|NCT01154699|1165305|P1|COMPLETED|First Intervention (4 Weeks)||13
475177|NCT01154699|1165304|P2|Subjects With Asthma + OSA|First Intervention (4 Weeks)||2
475178|NCT01154699|1165305|P1|Subjects With Asthma + OSA|First Intervention (4 Weeks)||6
475179|NCT01154699|1165304|P2|Subjects With Asthma Only|First Intervention (4 Weeks)||6
475180|NCT01154699|1165305|P1|Subjects With Asthma Only|First Intervention (4 Weeks)||7
475181|NCT01154699|1165304|P2|STARTED|First Intervention (4 Weeks)||8
475182|NCT01154699|1165305|P1|STARTED|First Intervention (4 Weeks)||13
475183|NCT01154673|1165323|P2|NOT COMPLETED|Overall Study||0
475184|NCT01154673|1165324|P1|NOT COMPLETED|Overall Study||2
475185|NCT01154673|1165323|P2|COMPLETED|Overall Study||16
475186|NCT01154673|1165324|P1|COMPLETED|Overall Study||14
475187|NCT01154673|1165323|P2|STARTED|Overall Study||16
475188|NCT01154673|1165324|P1|STARTED|Overall Study||16
475189|NCT01154634|1165334|P4|NOT COMPLETED|Period 7 - Fourth Intervention||0
475190|NCT01154634|1165335|P3|NOT COMPLETED|Period 7 - Fourth Intervention||0
475191|NCT01154634|1165336|P2|NOT COMPLETED|Period 7 - Fourth Intervention||0
475192|NCT01154634|1165337|P1|NOT COMPLETED|Period 7 - Fourth Intervention||0
475193|NCT01154634|1165334|P4|COMPLETED|Period 7 - Fourth Intervention||5
475194|NCT01154634|1165335|P3|COMPLETED|Period 7 - Fourth Intervention||4
475195|NCT01154634|1165336|P2|COMPLETED|Period 7 - Fourth Intervention||7
475196|NCT01154634|1165337|P1|COMPLETED|Period 7 - Fourth Intervention||4
475197|NCT01154634|1165334|P4|STARTED|Period 7 - Fourth Intervention||5
475198|NCT01154634|1165335|P3|STARTED|Period 7 - Fourth Intervention||4
475199|NCT01154634|1165336|P2|STARTED|Period 7 - Fourth Intervention||7
475200|NCT01154634|1165337|P1|STARTED|Period 7 - Fourth Intervention||4
475201|NCT01154634|1165334|P4|NOT COMPLETED|Period 6 - Washout||0
475202|NCT01154634|1165335|P3|NOT COMPLETED|Period 6 - Washout||0
475203|NCT01154634|1165336|P2|NOT COMPLETED|Period 6 - Washout||0
475204|NCT01154634|1165337|P1|NOT COMPLETED|Period 6 - Washout||0
475205|NCT01154634|1165334|P4|COMPLETED|Period 6 - Washout||5
475206|NCT01154634|1165335|P3|COMPLETED|Period 6 - Washout||4
475207|NCT01154634|1165336|P2|COMPLETED|Period 6 - Washout||7
475208|NCT01154634|1165337|P1|COMPLETED|Period 6 - Washout||4
475209|NCT01154634|1165334|P4|STARTED|Period 6 - Washout||5
475210|NCT01154634|1165335|P3|STARTED|Period 6 - Washout||4
475211|NCT01154634|1165336|P2|STARTED|Period 6 - Washout||7
475212|NCT01154634|1165337|P1|STARTED|Period 6 - Washout||4
475213|NCT01154634|1165334|P4|NOT COMPLETED|Period 5 - Third Intervention||0
475214|NCT01154634|1165335|P3|NOT COMPLETED|Period 5 - Third Intervention||0
475215|NCT01154634|1165336|P2|NOT COMPLETED|Period 5 - Third Intervention||0
475216|NCT01154634|1165337|P1|NOT COMPLETED|Period 5 - Third Intervention||0
475217|NCT01154634|1165334|P4|COMPLETED|Period 5 - Third Intervention||5
475218|NCT01154634|1165335|P3|COMPLETED|Period 5 - Third Intervention||4
475219|NCT01154634|1165336|P2|COMPLETED|Period 5 - Third Intervention||7
475220|NCT01154634|1165337|P1|COMPLETED|Period 5 - Third Intervention||4
475221|NCT01154634|1165334|P4|STARTED|Period 5 - Third Intervention||5
475222|NCT01154634|1165335|P3|STARTED|Period 5 - Third Intervention||4
475223|NCT01154634|1165336|P2|STARTED|Period 5 - Third Intervention||7
475224|NCT01154634|1165337|P1|STARTED|Period 5 - Third Intervention||4
475225|NCT01154634|1165334|P4|NOT COMPLETED|Period 4 - Washout||0
475226|NCT01154634|1165335|P3|NOT COMPLETED|Period 4 - Washout||0
475227|NCT01154634|1165336|P2|NOT COMPLETED|Period 4 - Washout||0
475228|NCT01154634|1165337|P1|NOT COMPLETED|Period 4 - Washout||0
475229|NCT01154634|1165334|P4|COMPLETED|Period 4 - Washout||5
475230|NCT01154634|1165335|P3|COMPLETED|Period 4 - Washout||4
475231|NCT01154634|1165336|P2|COMPLETED|Period 4 - Washout||7
475232|NCT01154634|1165337|P1|COMPLETED|Period 4 - Washout||4
475233|NCT01154634|1165334|P4|STARTED|Period 4 - Washout||5
475234|NCT01154634|1165335|P3|STARTED|Period 4 - Washout||4
475235|NCT01154634|1165336|P2|STARTED|Period 4 - Washout||7
475236|NCT01154634|1165337|P1|STARTED|Period 4 - Washout||4
475237|NCT01154634|1165334|P4|NOT COMPLETED|Period 3- Second Intervention||0
475238|NCT01154634|1165335|P3|NOT COMPLETED|Period 3- Second Intervention||0
475239|NCT01154634|1165336|P2|NOT COMPLETED|Period 3- Second Intervention||0
475240|NCT01154634|1165337|P1|NOT COMPLETED|Period 3- Second Intervention||0
475241|NCT01154634|1165334|P4|COMPLETED|Period 3- Second Intervention||5
475242|NCT01154634|1165335|P3|COMPLETED|Period 3- Second Intervention||4
475243|NCT01154634|1165336|P2|COMPLETED|Period 3- Second Intervention||7
475245|NCT01154634|1165334|P4|STARTED|Period 3- Second Intervention||5
475246|NCT01154634|1165335|P3|STARTED|Period 3- Second Intervention||4
475247|NCT01154634|1165336|P2|STARTED|Period 3- Second Intervention||7
475248|NCT01154634|1165337|P1|STARTED|Period 3- Second Intervention||4
475249|NCT01154634|1165334|P4|NOT COMPLETED|Period 2 - Washout||0
475250|NCT01154634|1165335|P3|NOT COMPLETED|Period 2 - Washout||0
475251|NCT01154634|1165336|P2|NOT COMPLETED|Period 2 - Washout||0
475252|NCT01154634|1165337|P1|NOT COMPLETED|Period 2 - Washout||0
475253|NCT01154634|1165334|P4|COMPLETED|Period 2 - Washout||5
475254|NCT01154634|1165335|P3|COMPLETED|Period 2 - Washout||4
475255|NCT01154634|1165336|P2|COMPLETED|Period 2 - Washout||7
475256|NCT01154634|1165337|P1|COMPLETED|Period 2 - Washout||4
475257|NCT01154634|1165334|P4|STARTED|Period 2 - Washout||5
475258|NCT01154634|1165335|P3|STARTED|Period 2 - Washout||4
475259|NCT01154634|1165336|P2|STARTED|Period 2 - Washout||7
475260|NCT01154634|1165337|P1|STARTED|Period 2 - Washout||4
475261|NCT01154634|1165334|P4|NOT COMPLETED|Period 1 - First Intervention||0
475262|NCT01154634|1165335|P3|NOT COMPLETED|Period 1 - First Intervention||0
475263|NCT01154634|1165336|P2|NOT COMPLETED|Period 1 - First Intervention||0
475264|NCT01154634|1165337|P1|NOT COMPLETED|Period 1 - First Intervention||0
475265|NCT01154634|1165334|P4|COMPLETED|Period 1 - First Intervention||5
475266|NCT01154634|1165335|P3|COMPLETED|Period 1 - First Intervention||4
475267|NCT01154634|1165336|P2|COMPLETED|Period 1 - First Intervention||7
475268|NCT01154634|1165337|P1|COMPLETED|Period 1 - First Intervention||4
475269|NCT01154634|1165334|P4|STARTED|Period 1 - First Intervention||5
475270|NCT01154634|1165335|P3|STARTED|Period 1 - First Intervention||4
475271|NCT01154634|1165336|P2|STARTED|Period 1 - First Intervention||7
475272|NCT01154634|1165337|P1|STARTED|Period 1 - First Intervention||4
475273|NCT01154452|1165379|P4|NOT COMPLETED|Phase II||6
475274|NCT01154452|1165380|P3|NOT COMPLETED|Phase II||5
475275|NCT01154452|1165381|P2|NOT COMPLETED|Phase II||0
475276|NCT01154452|1165382|P1|NOT COMPLETED|Phase II||0
475277|NCT01154452|1165379|P4|COMPLETED|Phase II||27
475278|NCT01154452|1165380|P3|COMPLETED|Phase II||30
475279|NCT01154452|1165381|P2|COMPLETED|Phase II||0
475280|NCT01154452|1165382|P1|COMPLETED|Phase II||0
475281|NCT01154452|1165379|P4|STARTED|Phase II||33
475282|NCT01154452|1165380|P3|STARTED|Phase II||35
475283|NCT01154452|1165381|P2|STARTED|Phase II||0
475284|NCT01154452|1165382|P1|STARTED|Phase II||0
475285|NCT01154452|1165379|P4|NOT COMPLETED|Phase Ib||0
475286|NCT01154452|1165380|P3|NOT COMPLETED|Phase Ib||0
475287|NCT01154452|1165381|P2|NOT COMPLETED|Phase Ib||1
475288|NCT01154452|1165382|P1|NOT COMPLETED|Phase Ib||3
475289|NCT01154452|1165379|P4|COMPLETED|Phase Ib||0
475290|NCT01154452|1165380|P3|COMPLETED|Phase Ib||0
475291|NCT01154452|1165381|P2|COMPLETED|Phase Ib||3
475292|NCT01154452|1165382|P1|COMPLETED|Phase Ib||3
475293|NCT01154452|1165379|P4|STARTED|Phase Ib||0
475294|NCT01154452|1165380|P3|STARTED|Phase Ib||0
475295|NCT01154452|1165381|P2|STARTED|Phase Ib||4
475296|NCT01154452|1165382|P1|STARTED|Phase Ib||6
475297|NCT01154335|1165396|P3|NOT COMPLETED|Overall Study||5
475298|NCT01154335|1165397|P2|NOT COMPLETED|Overall Study||6
475299|NCT01154335|1165398|P1|NOT COMPLETED|Overall Study||7
475300|NCT01154335|1165396|P3|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
475301|NCT01154335|1165397|P2|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
475302|NCT01154335|1165398|P1|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
475303|NCT01154335|1165396|P3|STARTED|Overall Study||5
475304|NCT01154335|1165397|P2|STARTED|Overall Study||6
475305|NCT01154335|1165398|P1|STARTED|Overall Study||7
475306|NCT01154322|1165405|P1|NOT COMPLETED|Overall Study||2
475307|NCT01154322|1165405|P1|COMPLETED|Overall Study||14
475308|NCT01154322|1165405|P1|STARTED|Overall Study||16
475309|NCT01154296|1165412|P2|NOT COMPLETED|6-month Follow-up||328
475310|NCT01154296|1165413|P1|NOT COMPLETED|6-month Follow-up||328
475311|NCT01154296|1165412|P2|COMPLETED|6-month Follow-up||2179
475312|NCT01154296|1165413|P1|COMPLETED|6-month Follow-up||2177
475313|NCT01154296|1165412|P2|STARTED|6-month Follow-up||2507
475314|NCT01154296|1165413|P1|STARTED|6-month Follow-up||2505
475315|NCT01154296|1165412|P2|NOT COMPLETED|Randomization and Intervention||2
475316|NCT01154296|1165413|P1|NOT COMPLETED|Randomization and Intervention||5
475317|NCT01154296|1165412|P2|COMPLETED|Randomization and Intervention||2505
475318|NCT01154296|1165413|P1|COMPLETED|Randomization and Intervention||2500
475319|NCT01154296|1165412|P2|STARTED|Randomization and Intervention||2507
475320|NCT01154296|1165413|P1|STARTED|Randomization and Intervention||2505
475321|NCT01154283|1165431|P2|NOT COMPLETED|7-12 Weeks||1
475322|NCT01154283|1165432|P1|NOT COMPLETED|7-12 Weeks||1
475323|NCT01154283|1165431|P2|COMPLETED|7-12 Weeks||10
475324|NCT01154283|1165432|P1|COMPLETED|7-12 Weeks||6
475325|NCT01154283|1165431|P2|STARTED|7-12 Weeks||11
475326|NCT01154283|1165432|P1|STARTED|7-12 Weeks||7
475327|NCT01154283|1165431|P2|NOT COMPLETED|0-6 Weeks||3
475328|NCT01154283|1165432|P1|NOT COMPLETED|0-6 Weeks||7
475329|NCT01154283|1165431|P2|COMPLETED|0-6 Weeks||11
475330|NCT01154283|1165432|P1|COMPLETED|0-6 Weeks||7
475331|NCT01154283|1165431|P2|STARTED|0-6 Weeks||14
475332|NCT01154283|1165432|P1|STARTED|0-6 Weeks||14
475333|NCT01154231|1165444|P1|NOT COMPLETED|Overall Study||2
475334|NCT01154231|1165444|P1|COMPLETED|Overall Study||312
475335|NCT01154231|1165444|P1|STARTED|Overall Study||314
475336|NCT01154218|1165450|P4|NOT COMPLETED|Fourth Intervention Period||0
475337|NCT01154218|1165451|P3|NOT COMPLETED|Fourth Intervention Period||0
475338|NCT01154218|1165452|P2|NOT COMPLETED|Fourth Intervention Period||0
475339|NCT01154218|1165453|P1|NOT COMPLETED|Fourth Intervention Period||1
475340|NCT01154218|1165450|P4|COMPLETED|Fourth Intervention Period||8
475341|NCT01154218|1165451|P3|COMPLETED|Fourth Intervention Period||9
475342|NCT01154218|1165452|P2|COMPLETED|Fourth Intervention Period||8
475343|NCT01154218|1165453|P1|COMPLETED|Fourth Intervention Period||8
475344|NCT01154218|1165450|P4|STARTED|Fourth Intervention Period||8
475345|NCT01154218|1165451|P3|STARTED|Fourth Intervention Period||9
475346|NCT01154218|1165452|P2|STARTED|Fourth Intervention Period||8
475347|NCT01154218|1165453|P1|STARTED|Fourth Intervention Period||9
475348|NCT01154218|1165450|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||1
475349|NCT01154218|1165451|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
475350|NCT01154218|1165452|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
475351|NCT01154218|1165453|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
475352|NCT01154218|1165450|P4|COMPLETED|Washout Period (at Least 14 Days)||8
475353|NCT01154218|1165451|P3|COMPLETED|Washout Period (at Least 14 Days)||9
475354|NCT01154218|1165452|P2|COMPLETED|Washout Period (at Least 14 Days)||8
475355|NCT01154218|1165453|P1|COMPLETED|Washout Period (at Least 14 Days)||9
475356|NCT01154218|1165450|P4|STARTED|Washout Period (at Least 14 Days)||9
475357|NCT01154218|1165451|P3|STARTED|Washout Period (at Least 14 Days)||9
475358|NCT01154218|1165452|P2|STARTED|Washout Period (at Least 14 Days)||8
475359|NCT01154218|1165453|P1|STARTED|Washout Period (at Least 14 Days)||9
475360|NCT01154218|1165450|P4|NOT COMPLETED|Third Intervention Period||0
475361|NCT01154218|1165451|P3|NOT COMPLETED|Third Intervention Period||0
475362|NCT01154218|1165452|P2|NOT COMPLETED|Third Intervention Period||1
475363|NCT01154218|1165453|P1|NOT COMPLETED|Third Intervention Period||0
475364|NCT01154218|1165450|P4|COMPLETED|Third Intervention Period||9
475365|NCT01154218|1165451|P3|COMPLETED|Third Intervention Period||9
475366|NCT01154218|1165452|P2|COMPLETED|Third Intervention Period||8
475367|NCT01154218|1165453|P1|COMPLETED|Third Intervention Period||9
475368|NCT01154218|1165450|P4|STARTED|Third Intervention Period||9
475369|NCT01154218|1165451|P3|STARTED|Third Intervention Period||9
475370|NCT01154218|1165452|P2|STARTED|Third Intervention Period||9
475371|NCT01154218|1165453|P1|STARTED|Third Intervention Period||9
475372|NCT01154218|1165450|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
475373|NCT01154218|1165451|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
475374|NCT01154218|1165452|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
475375|NCT01154218|1165453|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
475376|NCT01154218|1165450|P4|COMPLETED|Washout Period (at Least 14 Days)||9
475377|NCT01154218|1165451|P3|COMPLETED|Washout Period (at Least 14 Days)||9
475378|NCT01154218|1165452|P2|COMPLETED|Washout Period (at Least 14 Days)||9
475379|NCT01154218|1165453|P1|COMPLETED|Washout Period (at Least 14 Days)||9
475380|NCT01154218|1165450|P4|STARTED|Washout Period (at Least 14 Days)||9
475381|NCT01154218|1165451|P3|STARTED|Washout Period (at Least 14 Days)||9
475382|NCT01154218|1165452|P2|STARTED|Washout Period (at Least 14 Days)||9
475383|NCT01154218|1165453|P1|STARTED|Washout Period (at Least 14 Days)||9
475384|NCT01154218|1165450|P4|NOT COMPLETED|Second Intervention Period||0
475385|NCT01154218|1165451|P3|NOT COMPLETED|Second Intervention Period||0
475386|NCT01154218|1165452|P2|NOT COMPLETED|Second Intervention Period||0
475387|NCT01154218|1165453|P1|NOT COMPLETED|Second Intervention Period||0
475388|NCT01154218|1165450|P4|COMPLETED|Second Intervention Period||9
475389|NCT01154218|1165451|P3|COMPLETED|Second Intervention Period||9
475390|NCT01154218|1165452|P2|COMPLETED|Second Intervention Period||9
475391|NCT01154218|1165453|P1|COMPLETED|Second Intervention Period||9
475392|NCT01154218|1165450|P4|STARTED|Second Intervention Period||9
475393|NCT01154218|1165451|P3|STARTED|Second Intervention Period||9
475394|NCT01154218|1165452|P2|STARTED|Second Intervention Period||9
475395|NCT01154218|1165453|P1|STARTED|Second Intervention Period||9
475396|NCT01154218|1165450|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
475397|NCT01154218|1165451|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
475398|NCT01154218|1165452|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
475399|NCT01154218|1165453|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
475400|NCT01154218|1165450|P4|COMPLETED|Washout Period (at Least 14 Days)||9
475401|NCT01154218|1165451|P3|COMPLETED|Washout Period (at Least 14 Days)||9
475402|NCT01154218|1165452|P2|COMPLETED|Washout Period (at Least 14 Days)||9
475403|NCT01154218|1165453|P1|COMPLETED|Washout Period (at Least 14 Days)||9
475404|NCT01154218|1165450|P4|STARTED|Washout Period (at Least 14 Days)||9
475405|NCT01154218|1165451|P3|STARTED|Washout Period (at Least 14 Days)||9
475406|NCT01154218|1165452|P2|STARTED|Washout Period (at Least 14 Days)||9
475407|NCT01154218|1165453|P1|STARTED|Washout Period (at Least 14 Days)||9
475408|NCT01154218|1165450|P4|NOT COMPLETED|First Intervention Period||0
475409|NCT01154218|1165451|P3|NOT COMPLETED|First Intervention Period||0
475410|NCT01154218|1165452|P2|NOT COMPLETED|First Intervention Period||0
475411|NCT01154218|1165453|P1|NOT COMPLETED|First Intervention Period||0
475412|NCT01154218|1165450|P4|COMPLETED|First Intervention Period||9
475413|NCT01154218|1165451|P3|COMPLETED|First Intervention Period||9
475414|NCT01154218|1165452|P2|COMPLETED|First Intervention Period||9
475415|NCT01154218|1165453|P1|COMPLETED|First Intervention Period||9
475416|NCT01154218|1165450|P4|STARTED|First Intervention Period||9
475417|NCT01154218|1165451|P3|STARTED|First Intervention Period||9
475418|NCT01154218|1165452|P2|STARTED|First Intervention Period||9
475419|NCT01154218|1165453|P1|STARTED|First Intervention Period||9
475420|NCT01154166|1165505|P2|NOT COMPLETED|Overall Study||12
475421|NCT01154166|1165506|P1|NOT COMPLETED|Overall Study||34
475422|NCT01154166|1165505|P2|COMPLETED|Overall Study||163
475423|NCT01154166|1165506|P1|COMPLETED|Overall Study||135
475424|NCT01154166|1165505|P2|STARTED|Overall Study||175
475425|NCT01154166|1165506|P1|STARTED|Overall Study||169
475426|NCT01154153|1165538|P2|NOT COMPLETED|Overall Study||3
475427|NCT01154153|1165539|P1|NOT COMPLETED|Overall Study||5
475428|NCT01154153|1165538|P2|COMPLETED|Overall Study||66
475429|NCT01154153|1165539|P1|COMPLETED|Overall Study||66
475430|NCT01154153|1165538|P2|STARTED|Overall Study||69
475431|NCT01154153|1165539|P1|STARTED|Overall Study||71
475432|NCT01154140|1165557|P2|NOT COMPLETED|Overall Study||102
475433|NCT01154140|1165558|P1|NOT COMPLETED|Overall Study||91
475434|NCT01154140|1165557|P2|COMPLETED|Overall Study||69
475435|NCT01154140|1165558|P1|COMPLETED|Overall Study||81
475436|NCT01154140|1165557|P2|Treated|Overall Study||169
475437|NCT01154140|1165558|P1|Treated|Overall Study||171
475438|NCT01154140|1165557|P2|STARTED|Overall Study||171
475439|NCT01154140|1165558|P1|STARTED|Overall Study||172
475440|NCT01154127|1165611|P2|NOT COMPLETED|Period 2 (21 Days)||1
475441|NCT01154127|1165612|P1|NOT COMPLETED|Period 2 (21 Days)||0
475442|NCT01154127|1165611|P2|COMPLETED|Period 2 (21 Days)||46
475443|NCT01154127|1165612|P1|COMPLETED|Period 2 (21 Days)||49
475444|NCT01154127|1165611|P2|STARTED|Period 2 (21 Days)||47
475445|NCT01154127|1165612|P1|STARTED|Period 2 (21 Days)||49
475446|NCT01154127|1165611|P2|NOT COMPLETED|Washout (14 - 28 Days)||0
475447|NCT01154127|1165612|P1|NOT COMPLETED|Washout (14 - 28 Days)||3
475448|NCT01154127|1165611|P2|COMPLETED|Washout (14 - 28 Days)||47
475449|NCT01154127|1165612|P1|COMPLETED|Washout (14 - 28 Days)||49
475450|NCT01154127|1165611|P2|STARTED|Washout (14 - 28 Days)||47
475451|NCT01154127|1165612|P1|STARTED|Washout (14 - 28 Days)||52
475452|NCT01154127|1165611|P2|NOT COMPLETED|Period 1 (21 Days)||6
475453|NCT01154127|1165612|P1|NOT COMPLETED|Period 1 (21 Days)||3
475454|NCT01154127|1165611|P2|COMPLETED|Period 1 (21 Days)||47
475455|NCT01154127|1165612|P1|COMPLETED|Period 1 (21 Days)||52
475456|NCT01154127|1165611|P2|STARTED|Period 1 (21 Days)||53
475457|NCT01154127|1165612|P1|STARTED|Period 1 (21 Days)||55
475458|NCT01154101|1165639|P5|NOT COMPLETED|Overall Study||1
475459|NCT01154101|1165640|P4|NOT COMPLETED|Overall Study||2
475460|NCT01154101|1165641|P3|NOT COMPLETED|Overall Study||3
475461|NCT01154101|1165642|P2|NOT COMPLETED|Overall Study||4
475462|NCT01154101|1165643|P1|NOT COMPLETED|Overall Study||0
475463|NCT01154101|1165639|P5|COMPLETED|Overall Study||0
475464|NCT01154101|1165640|P4|COMPLETED|Overall Study||9
475465|NCT01154101|1165641|P3|COMPLETED|Overall Study||9
475466|NCT01154101|1165642|P2|COMPLETED|Overall Study||5
475467|NCT01154101|1165643|P1|COMPLETED|Overall Study||7
475468|NCT01154101|1165639|P5|STARTED|Overall Study||1
475469|NCT01154101|1165640|P4|STARTED|Overall Study||11
475470|NCT01154101|1165641|P3|STARTED|Overall Study||12
475471|NCT01154101|1165642|P2|STARTED|Overall Study||9
475472|NCT01154101|1165643|P1|STARTED|Overall Study||7
475473|NCT01154036|1165698|P8|NOT COMPLETED|Phase II||6
475474|NCT01154036|1165699|P7|NOT COMPLETED|Phase II||9
475475|NCT01154036|1165700|P6|NOT COMPLETED|Phase II||5
475476|NCT01154036|1165701|P5|NOT COMPLETED|Phase II||8
475477|NCT01154036|1165702|P4|NOT COMPLETED|Phase II||1
475478|NCT01154036|1165703|P3|NOT COMPLETED|Phase II||0
475479|NCT01154036|1165704|P2|NOT COMPLETED|Phase II||0
475480|NCT01154036|1165705|P1|NOT COMPLETED|Phase II||0
475481|NCT01154036|1165698|P8|COMPLETED|Phase II||200
475482|NCT01154036|1165699|P7|COMPLETED|Phase II||225
475483|NCT01154036|1165700|P6|COMPLETED|Phase II||121
475484|NCT01154036|1165701|P5|COMPLETED|Phase II||116
475485|NCT01154036|1165702|P4|COMPLETED|Phase II||27
475486|NCT01154036|1165703|P3|COMPLETED|Phase II||0
475487|NCT01154036|1165704|P2|COMPLETED|Phase II||0
475488|NCT01154036|1165705|P1|COMPLETED|Phase II||0
475489|NCT01154036|1165698|P8|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|206
475490|NCT01154036|1165699|P7|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|234
475491|NCT01154036|1165700|P6|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|126
475492|NCT01154036|1165701|P5|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|124
475493|NCT01154036|1165702|P4|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|28
475494|NCT01154036|1165703|P3|STARTED|Phase II||0
475495|NCT01154036|1165704|P2|STARTED|Phase II||0
475496|NCT01154036|1165705|P1|STARTED|Phase II||0
475497|NCT01154036|1165698|P8|NOT COMPLETED|Phase I||0
475498|NCT01154036|1165699|P7|NOT COMPLETED|Phase I||0
475499|NCT01154036|1165700|P6|NOT COMPLETED|Phase I||0
475500|NCT01154036|1165701|P5|NOT COMPLETED|Phase I||0
475501|NCT01154036|1165702|P4|NOT COMPLETED|Phase I||0
475502|NCT01154036|1165703|P3|NOT COMPLETED|Phase I||56
475503|NCT01154036|1165704|P2|NOT COMPLETED|Phase I||28
475504|NCT01154036|1165705|P1|NOT COMPLETED|Phase I||3
475505|NCT01154036|1165698|P8|COMPLETED|Phase I||0
475506|NCT01154036|1165699|P7|COMPLETED|Phase I||0
475507|NCT01154036|1165700|P6|COMPLETED|Phase I||0
475508|NCT01154036|1165701|P5|COMPLETED|Phase I||0
475509|NCT01154036|1165702|P4|COMPLETED|Phase I||0
475510|NCT01154036|1165703|P3|COMPLETED|Phase I|Not all completers were eligible for Phase II|888
475511|NCT01154036|1165704|P2|COMPLETED|Phase I|Not all completers were eligible for Phase II|455
475512|NCT01154036|1165705|P1|COMPLETED|Phase I|Not all completers were eligible for Phase II|117
475513|NCT01154036|1165698|P8|STARTED|Phase I||0
475514|NCT01154036|1165699|P7|STARTED|Phase I||0
475515|NCT01154036|1165700|P6|STARTED|Phase I||0
475516|NCT01154036|1165701|P5|STARTED|Phase I||0
475517|NCT01154036|1165702|P4|STARTED|Phase I||0
475518|NCT01154036|1165703|P3|STARTED|Phase I||944
475519|NCT01154036|1165704|P2|STARTED|Phase I||483
475520|NCT01154036|1165705|P1|STARTED|Phase I||120
475521|NCT01154010|1165829|P2|NOT COMPLETED|Overall Study||1
475522|NCT01154010|1165830|P1|NOT COMPLETED|Overall Study||0
475523|NCT01154010|1165829|P2|COMPLETED|Overall Study||8
475524|NCT01154010|1165830|P1|COMPLETED|Overall Study||9
475525|NCT01154010|1165829|P2|STARTED|Overall Study||9
475526|NCT01154010|1165830|P1|STARTED|Overall Study||9
475527|NCT01153984|1165836|P1|NOT COMPLETED|Overall Study||2
475528|NCT01153984|1165836|P1|COMPLETED|Overall Study||21
475529|NCT01153984|1165836|P1|STARTED|Overall Study||23
475530|NCT01153971|1165847|P1|NOT COMPLETED|Follow-up (Months 17-40 of Study)||4
475531|NCT01153971|1165847|P1|COMPLETED|Follow-up (Months 17-40 of Study)||37
475532|NCT01153971|1165847|P1|STARTED|Follow-up (Months 17-40 of Study)||41
475533|NCT01153971|1165847|P1|NOT COMPLETED|Maintenance Phase (Months 8-16 of Study)||3
475534|NCT01153971|1165847|P1|COMPLETED|Maintenance Phase (Months 8-16 of Study)||41
475535|NCT01153971|1165847|P1|STARTED|Maintenance Phase (Months 8-16 of Study)||44
475536|NCT01153971|1165847|P1|NOT COMPLETED|Induction Phase (Months 1 to 7 of Study)||3
475537|NCT01153971|1165847|P1|COMPLETED|Induction Phase (Months 1 to 7 of Study)||44
475538|NCT01153971|1165847|P1|STARTED|Induction Phase (Months 1 to 7 of Study)||47
475539|NCT01153958|1165870|P2|NOT COMPLETED|Overall Study||32
475540|NCT01153958|1165871|P1|NOT COMPLETED|Overall Study||36
475541|NCT01153958|1165870|P2|COMPLETED|Overall Study||35
475542|NCT01153958|1165871|P1|COMPLETED|Overall Study||30
475543|NCT01153958|1165870|P2|STARTED|Overall Study||67
475544|NCT01153958|1165871|P1|STARTED|Overall Study||66
475545|NCT01153893|1165889|P2|NOT COMPLETED|Overall Study||0
475546|NCT01153893|1165890|P1|NOT COMPLETED|Overall Study||1
475547|NCT01153893|1165889|P2|COMPLETED|Overall Study|Number of subjects who completed the follow-up visit at Month 3.|36
475548|NCT01153893|1165890|P1|COMPLETED|Overall Study|Number of subjects who completed the follow-up visit at Month 1.|67
475549|NCT01153893|1165889|P2|STARTED|Overall Study||36
475550|NCT01153893|1165890|P1|STARTED|Overall Study|Issues with the informed consent obtained from one child led to related data not used in this report|68
475551|NCT01153841|1165916|P2|NOT COMPLETED|Overall Study||0
475552|NCT01153841|1165917|P1|NOT COMPLETED|Overall Study||6
475553|NCT01153841|1165916|P2|COMPLETED|Overall Study||99
475554|NCT01153841|1165917|P1|COMPLETED|Overall Study||193
475555|NCT01153841|1165916|P2|STARTED|Overall Study||99
475556|NCT01153841|1165917|P1|STARTED|Overall Study||199
475557|NCT01153815|1165933|P2|NOT COMPLETED|Overall Study||5
475558|NCT01153815|1165934|P1|NOT COMPLETED|Overall Study||9
475559|NCT01153815|1165933|P2|COMPLETED|Overall Study||82
475560|NCT01153815|1165934|P1|COMPLETED|Overall Study||74
475561|NCT01153815|1165933|P2|STARTED|Overall Study||87
475562|NCT01153815|1165934|P1|STARTED|Overall Study||83
475563|NCT01153763|1165956|P1|NOT COMPLETED|Overall Study||21
475564|NCT01153763|1165956|P1|COMPLETED|Overall Study||71
475565|NCT01153763|1165956|P1|STARTED|Overall Study||92
475566|NCT01153724|1165972|P1|NOT COMPLETED|Treatment Period 2||2
475567|NCT01153724|1165972|P1|COMPLETED|Treatment Period 2||32
475568|NCT01153724|1165972|P1|STARTED|Treatment Period 2||34
475569|NCT01153724|1165972|P1|NOT COMPLETED|Treatment Period 1||1
475570|NCT01153724|1165972|P1|COMPLETED|Treatment Period 1||34
475571|NCT01153724|1165972|P1|STARTED|Treatment Period 1||35
475572|NCT01153711|1165992|P1|NOT COMPLETED|Overall Study||0
475573|NCT01153711|1165992|P1|COMPLETED|Overall Study||32
475574|NCT01153711|1165992|P1|STARTED|Overall Study||32
475575|NCT01153698|1166012|P1|NOT COMPLETED|Overall Study||29
475576|NCT01153698|1166012|P1|COMPLETED|Overall Study|Completed Pradaxa treatment.|139
475577|NCT01153698|1166012|P1|STARTED|Overall Study|Entered and treated.|168
475578|NCT01153685|1166028|P2|NOT COMPLETED|Overall Study||0
475579|NCT01153685|1166029|P1|NOT COMPLETED|Overall Study||0
475580|NCT01153685|1166028|P2|COMPLETED|Overall Study||70
475581|NCT01153685|1166029|P1|COMPLETED|Overall Study||50
475582|NCT01153685|1166028|P2|STARTED|Overall Study||70
475583|NCT01153685|1166029|P1|STARTED|Overall Study||50
475584|NCT01153672|1166053|P1|NOT COMPLETED|Overall Study||2
475585|NCT01153672|1166053|P1|COMPLETED|Overall Study||6
475586|NCT01153672|1166053|P1|STARTED|Overall Study||8
475587|NCT01153633|1166063|P2|NOT COMPLETED|Overall Study||4
475588|NCT01153633|1166064|P1|NOT COMPLETED|Overall Study||4
475589|NCT01153633|1166063|P2|COMPLETED|Overall Study||13
475590|NCT01153633|1166064|P1|COMPLETED|Overall Study||13
475591|NCT01153633|1166063|P2|STARTED|Overall Study||17
475592|NCT01153633|1166064|P1|STARTED|Overall Study||17
475593|NCT01153620|1166082|P2|NOT COMPLETED|Overall Study||0
475594|NCT01153620|1166083|P1|NOT COMPLETED|Overall Study||0
475595|NCT01153620|1166082|P2|COMPLETED|Overall Study|30 patients (31 wounds)|30
475596|NCT01153620|1166083|P1|COMPLETED|Overall Study||30
475597|NCT01153620|1166082|P2|STARTED|Overall Study|30 patients (31 wounds)|30
475598|NCT01153620|1166083|P1|STARTED|Overall Study||30
475599|NCT01153581|1166089|P1|NOT COMPLETED|Overall Study||0
475600|NCT01153581|1166089|P1|COMPLETED|Overall Study||109
475601|NCT01153581|1166089|P1|STARTED|Overall Study||109
475602|NCT01153503|1166102|P3|NOT COMPLETED|Overall Study||0
475603|NCT01153503|1166103|P2|NOT COMPLETED|Overall Study||1
475604|NCT01153503|1166104|P1|NOT COMPLETED|Overall Study||0
475605|NCT01153503|1166102|P3|COMPLETED|Overall Study||25
475606|NCT01153503|1166103|P2|COMPLETED|Overall Study||24
475607|NCT01153503|1166104|P1|COMPLETED|Overall Study||25
475608|NCT01153503|1166102|P3|STARTED|Overall Study||25
475609|NCT01153503|1166103|P2|STARTED|Overall Study||25
475610|NCT01153503|1166104|P1|STARTED|Overall Study||25
475611|NCT01153425|1166114|P2|NOT COMPLETED|Overall Study||3
475612|NCT01153425|1166115|P1|NOT COMPLETED|Overall Study||3
475613|NCT01153425|1166114|P2|COMPLETED|Overall Study||14
475614|NCT01153425|1166115|P1|COMPLETED|Overall Study||13
475615|NCT01153425|1166114|P2|STARTED|Overall Study||17
475616|NCT01153425|1166115|P1|STARTED|Overall Study||16
475617|NCT01153347|1166127|P4|NOT COMPLETED|Overall Study||32
475618|NCT01153347|1166128|P3|NOT COMPLETED|Overall Study||50
475619|NCT01153347|1166129|P2|NOT COMPLETED|Overall Study||44
475620|NCT01153347|1166130|P1|NOT COMPLETED|Overall Study||33
475621|NCT01153347|1166127|P4|COMPLETED|Overall Study||129
475622|NCT01153347|1166128|P3|COMPLETED|Overall Study||110
475623|NCT01153347|1166129|P2|COMPLETED|Overall Study||116
475624|NCT01153347|1166130|P1|COMPLETED|Overall Study||127
475625|NCT01153347|1166127|P4|Received Treatment|Overall Study||160
475626|NCT01153347|1166128|P3|Received Treatment|Overall Study||158
475627|NCT01153347|1166129|P2|Received Treatment|Overall Study||158
475628|NCT01153347|1166130|P1|Received Treatment|Overall Study||160
475629|NCT01153347|1166127|P4|STARTED|Overall Study||161
475630|NCT01153347|1166128|P3|STARTED|Overall Study||160
475631|NCT01153347|1166129|P2|STARTED|Overall Study||160
475632|NCT01153347|1166130|P1|STARTED|Overall Study||160
475633|NCT01153321|1166230|P2|NOT COMPLETED|Overall Study||3
475634|NCT01153321|1166231|P1|NOT COMPLETED|Overall Study||1
475635|NCT01153321|1166230|P2|COMPLETED|Overall Study||19
475636|NCT01153321|1166231|P1|COMPLETED|Overall Study||21
475637|NCT01153321|1166230|P2|STARTED|Overall Study||22
475638|NCT01153321|1166231|P1|STARTED|Overall Study||22
475639|NCT01153269|1166343|P1|NOT COMPLETED|Overall Study||2
475640|NCT01153269|1166343|P1|COMPLETED|Overall Study||31
475641|NCT01153269|1166343|P1|Participants Analyzed|Overall Study||33
475642|NCT01153269|1166343|P1|STARTED|Overall Study||33
475643|NCT01153009|1166406|P4|NOT COMPLETED|Overall Study||37
475644|NCT01153009|1166407|P3|NOT COMPLETED|Overall Study||41
475645|NCT01153009|1166408|P2|NOT COMPLETED|Overall Study||34
475646|NCT01153009|1166409|P1|NOT COMPLETED|Overall Study||32
475647|NCT01153009|1166406|P4|COMPLETED|Overall Study||115
475648|NCT01153009|1166407|P3|COMPLETED|Overall Study||113
475649|NCT01153009|1166408|P2|COMPLETED|Overall Study||113
475650|NCT01153009|1166409|P1|COMPLETED|Overall Study||129
475651|NCT01153009|1166406|P4|Treated|Overall Study||150
475652|NCT01153009|1166407|P3|Treated|Overall Study||154
475653|NCT01153009|1166408|P2|Treated|Overall Study||147
475654|NCT01153009|1166409|P1|Treated|Overall Study||159
475655|NCT01153009|1166406|P4|STARTED|Overall Study||152
475656|NCT01153009|1166407|P3|STARTED|Overall Study||154
475657|NCT01153009|1166408|P2|STARTED|Overall Study||147
475658|NCT01153009|1166409|P1|STARTED|Overall Study||161
475659|NCT01152996|1166439|P1|NOT COMPLETED|Overall Study||537
475660|NCT01152996|1166439|P1|COMPLETED|Overall Study||538
475661|NCT01152996|1166439|P1|Treated|Overall Study||1073
475662|NCT01152996|1166439|P1|STARTED|Overall Study||1075
475663|NCT01152814|1166452|P1|NOT COMPLETED|Overall Study||2
475664|NCT01152814|1166452|P1|COMPLETED|Overall Study||62
475665|NCT01152814|1166452|P1|STARTED|Overall Study||64
475666|NCT01152788|1166461|P2|NOT COMPLETED|Overall Study||4
475667|NCT01152788|1166462|P1|NOT COMPLETED|Overall Study||0
475668|NCT01152788|1166461|P2|COMPLETED|Overall Study||28
475669|NCT01152788|1166462|P1|COMPLETED|Overall Study||32
475670|NCT01152788|1166461|P2|STARTED|Overall Study||32
475671|NCT01152788|1166462|P1|STARTED|Overall Study||32
475672|NCT01152697|1166474|P1|NOT COMPLETED|Overall Study||19
475673|NCT01152697|1166474|P1|COMPLETED|Overall Study||11
475674|NCT01152697|1166474|P1|STARTED|Overall Study||30
475675|NCT01152580|1166499|P2|NOT COMPLETED|Overall Study||1
475676|NCT01152580|1166500|P1|NOT COMPLETED|Overall Study||0
475677|NCT01152580|1166499|P2|COMPLETED|Overall Study||13
475678|NCT01152580|1166500|P1|COMPLETED|Overall Study||5
475679|NCT01152580|1166499|P2|STARTED|Overall Study||14
475680|NCT01152580|1166500|P1|STARTED|Overall Study||5
475681|NCT01152554|1166522|P2|NOT COMPLETED|Overall Study||111
475682|NCT01152554|1166523|P1|NOT COMPLETED|Overall Study||334
475683|NCT01152554|1166522|P2|COMPLETED|Overall Study||92
475684|NCT01152554|1166523|P1|COMPLETED|Overall Study||276
475685|NCT01152554|1166522|P2|Received Treatment|Overall Study||201
475686|NCT01152554|1166523|P1|Received Treatment|Overall Study||607
475687|NCT01152554|1166522|P2|STARTED|Overall Study||203
475688|NCT01152554|1166523|P1|STARTED|Overall Study||610
475689|NCT01152450|1166545|P6|NOT COMPLETED|Period 3 (4 Weeks)||0
475690|NCT01152450|1166546|P5|NOT COMPLETED|Period 3 (4 Weeks)||0
475691|NCT01152450|1166547|P4|NOT COMPLETED|Period 3 (4 Weeks)||0
475692|NCT01152450|1166548|P3|NOT COMPLETED|Period 3 (4 Weeks)||0
475693|NCT01152450|1166549|P2|NOT COMPLETED|Period 3 (4 Weeks)||0
475694|NCT01152450|1166550|P1|NOT COMPLETED|Period 3 (4 Weeks)||0
475695|NCT01152450|1166545|P6|COMPLETED|Period 3 (4 Weeks)||12
475696|NCT01152450|1166546|P5|COMPLETED|Period 3 (4 Weeks)||16
475697|NCT01152450|1166547|P4|COMPLETED|Period 3 (4 Weeks)||15
475698|NCT01152450|1166548|P3|COMPLETED|Period 3 (4 Weeks)||16
475699|NCT01152450|1166549|P2|COMPLETED|Period 3 (4 Weeks)||15
475700|NCT01152450|1166550|P1|COMPLETED|Period 3 (4 Weeks)||15
475701|NCT01152450|1166545|P6|STARTED|Period 3 (4 Weeks)||12
475702|NCT01152450|1166546|P5|STARTED|Period 3 (4 Weeks)||16
475703|NCT01152450|1166547|P4|STARTED|Period 3 (4 Weeks)||15
475704|NCT01152450|1166548|P3|STARTED|Period 3 (4 Weeks)||16
475705|NCT01152450|1166549|P2|STARTED|Period 3 (4 Weeks)||15
475706|NCT01152450|1166550|P1|STARTED|Period 3 (4 Weeks)||15
475707|NCT01152450|1166545|P6|NOT COMPLETED|Period 2 (4 Weeks)||0
475708|NCT01152450|1166546|P5|NOT COMPLETED|Period 2 (4 Weeks)||0
475709|NCT01152450|1166547|P4|NOT COMPLETED|Period 2 (4 Weeks)||0
475710|NCT01152450|1166548|P3|NOT COMPLETED|Period 2 (4 Weeks)||0
475711|NCT01152450|1166549|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
475712|NCT01152450|1166550|P1|NOT COMPLETED|Period 2 (4 Weeks)||0
475713|NCT01152450|1166545|P6|COMPLETED|Period 2 (4 Weeks)||12
475714|NCT01152450|1166546|P5|COMPLETED|Period 2 (4 Weeks)||16
475715|NCT01152450|1166547|P4|COMPLETED|Period 2 (4 Weeks)||15
475716|NCT01152450|1166548|P3|COMPLETED|Period 2 (4 Weeks)||16
475717|NCT01152450|1166549|P2|COMPLETED|Period 2 (4 Weeks)||15
475718|NCT01152450|1166550|P1|COMPLETED|Period 2 (4 Weeks)||15
475719|NCT01152450|1166545|P6|STARTED|Period 2 (4 Weeks)||12
475720|NCT01152450|1166546|P5|STARTED|Period 2 (4 Weeks)||16
475721|NCT01152450|1166547|P4|STARTED|Period 2 (4 Weeks)||15
475722|NCT01152450|1166548|P3|STARTED|Period 2 (4 Weeks)||16
475723|NCT01152450|1166549|P2|STARTED|Period 2 (4 Weeks)||15
475724|NCT01152450|1166550|P1|STARTED|Period 2 (4 Weeks)||15
475725|NCT01152450|1166545|P6|NOT COMPLETED|Period 1 (4 Weeks)||1
475726|NCT01152450|1166546|P5|NOT COMPLETED|Period 1 (4 Weeks)||2
475727|NCT01152450|1166547|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
475728|NCT01152450|1166548|P3|NOT COMPLETED|Period 1 (4 Weeks)||1
475729|NCT01152450|1166549|P2|NOT COMPLETED|Period 1 (4 Weeks)||1
475730|NCT01152450|1166550|P1|NOT COMPLETED|Period 1 (4 Weeks)||0
475731|NCT01152450|1166545|P6|COMPLETED|Period 1 (4 Weeks)||12
475732|NCT01152450|1166546|P5|COMPLETED|Period 1 (4 Weeks)||16
475733|NCT01152450|1166547|P4|COMPLETED|Period 1 (4 Weeks)||15
475734|NCT01152450|1166548|P3|COMPLETED|Period 1 (4 Weeks)||16
475735|NCT01152450|1166549|P2|COMPLETED|Period 1 (4 Weeks)||15
475736|NCT01152450|1166550|P1|COMPLETED|Period 1 (4 Weeks)||15
475737|NCT01152450|1166545|P6|STARTED|Period 1 (4 Weeks)||13
475738|NCT01152450|1166546|P5|STARTED|Period 1 (4 Weeks)||18
475739|NCT01152450|1166547|P4|STARTED|Period 1 (4 Weeks)||15
475740|NCT01152450|1166548|P3|STARTED|Period 1 (4 Weeks)||17
475741|NCT01152450|1166549|P2|STARTED|Period 1 (4 Weeks)||16
475742|NCT01152450|1166550|P1|STARTED|Period 1 (4 Weeks)||15
475743|NCT01152437|1166621|P3|NOT COMPLETED|Overall Study||43
475744|NCT01152437|1166622|P2|NOT COMPLETED|Overall Study||15
475745|NCT01152437|1166623|P1|NOT COMPLETED|Overall Study||36
475746|NCT01152437|1166621|P3|COMPLETED|Overall Study||0
475747|NCT01152437|1166622|P2|COMPLETED|Overall Study||0
475748|NCT01152437|1166623|P1|COMPLETED|Overall Study||0
475749|NCT01152437|1166621|P3|STARTED|Overall Study|entered|43
475750|NCT01152437|1166622|P2|STARTED|Overall Study|randomised|15
475751|NCT01152437|1166623|P1|STARTED|Overall Study|randomised|36
475752|NCT01152385|1166643|P4|NOT COMPLETED|Overall Study||5
475753|NCT01152385|1166644|P3|NOT COMPLETED|Overall Study||5
475754|NCT01152385|1166645|P2|NOT COMPLETED|Overall Study||6
475755|NCT01152385|1166646|P1|NOT COMPLETED|Overall Study||9
475756|NCT01152385|1166643|P4|COMPLETED|Overall Study||50
475757|NCT01152385|1166644|P3|COMPLETED|Overall Study||51
475758|NCT01152385|1166645|P2|COMPLETED|Overall Study||52
475759|NCT01152385|1166646|P1|COMPLETED|Overall Study||46
475760|NCT01152385|1166643|P4|STARTED|Overall Study||55
475761|NCT01152385|1166644|P3|STARTED|Overall Study||56
475762|NCT01152385|1166645|P2|STARTED|Overall Study||58
475763|NCT01152385|1166646|P1|STARTED|Overall Study||55
475764|NCT01152359|1166686|P2|NOT COMPLETED|Overall Study||22
475765|NCT01152359|1166687|P1|NOT COMPLETED|Overall Study||24
475766|NCT01152359|1166686|P2|COMPLETED|Overall Study||80
475767|NCT01152359|1166687|P1|COMPLETED|Overall Study||81
475768|NCT01152359|1166686|P2|STARTED|Overall Study||102
475769|NCT01152359|1166687|P1|STARTED|Overall Study||105
475770|NCT01152307|1166695|P2|NOT COMPLETED|Overall Study||0
475771|NCT01152307|1166696|P1|NOT COMPLETED|Overall Study||0
475772|NCT01152307|1166695|P2|COMPLETED|Overall Study||214
475773|NCT01152307|1166696|P1|COMPLETED|Overall Study||191
475774|NCT01152307|1166695|P2|STARTED|Overall Study||214
475775|NCT01152307|1166696|P1|STARTED|Overall Study||191
475776|NCT01152294|1166704|P2|NOT COMPLETED|Overall Study||0
475777|NCT01152294|1166705|P1|NOT COMPLETED|Overall Study||0
475778|NCT01152294|1166704|P2|COMPLETED|Overall Study||188
475779|NCT01152294|1166705|P1|COMPLETED|Overall Study||213
475780|NCT01152294|1166704|P2|STARTED|Overall Study||188
475781|NCT01152294|1166705|P1|STARTED|Overall Study||213
475782|NCT01152190|1166713|P2|NOT COMPLETED|Overall Study||8
475783|NCT01152190|1166714|P1|NOT COMPLETED|Overall Study||5
475784|NCT01152190|1166713|P2|COMPLETED|Overall Study||39
475785|NCT01152190|1166714|P1|COMPLETED|Overall Study||45
475786|NCT01152190|1166713|P2|Received at Least 1 Dose of Study Drug|Overall Study||47
475787|NCT01152190|1166714|P1|Received at Least 1 Dose of Study Drug|Overall Study||50
475788|NCT01152190|1166713|P2|STARTED|Overall Study||47
475789|NCT01152190|1166714|P1|STARTED|Overall Study||50
475790|NCT01152112|1166728|P2|NOT COMPLETED|Overall Study||0
475791|NCT01152112|1166729|P1|NOT COMPLETED|Overall Study||0
475792|NCT01152112|1166728|P2|COMPLETED|Overall Study||32
475793|NCT01152112|1166729|P1|COMPLETED|Overall Study||42
475794|NCT01152112|1166728|P2|STARTED|Overall Study||32
475795|NCT01152112|1166729|P1|STARTED|Overall Study||42
475796|NCT01151904|1166735|P1|NOT COMPLETED|Overall Study||0
475797|NCT01151904|1166735|P1|COMPLETED|Overall Study||17
475798|NCT01151904|1166735|P1|STARTED|Overall Study||17
475799|NCT01151852|1166743|P2|NOT COMPLETED|Overall Study||0
475800|NCT01151852|1166744|P1|NOT COMPLETED|Overall Study||0
475801|NCT01151852|1166743|P2|COMPLETED|Overall Study||40
475802|NCT01151852|1166744|P1|COMPLETED|Overall Study||41
475803|NCT01151852|1166743|P2|STARTED|Overall Study||40
475804|NCT01151852|1166744|P1|STARTED|Overall Study||41
475805|NCT01151761|1166760|P1|NOT COMPLETED|Overall Study||0
475806|NCT01151761|1166760|P1|COMPLETED|Overall Study||2
475807|NCT01151761|1166760|P1|STARTED|Overall Study||2
475808|NCT01151579|1166773|P2|NOT COMPLETED|Overall Study||7
475809|NCT01151579|1166774|P1|NOT COMPLETED|Overall Study||12
475810|NCT01151579|1166773|P2|COMPLETED|Overall Study||24
475811|NCT01151579|1166774|P1|COMPLETED|Overall Study||46
475812|NCT01151579|1166773|P2|STARTED|Overall Study||31
475813|NCT01151579|1166774|P1|STARTED|Overall Study||58
475814|NCT01151553|1166784|P1|NOT COMPLETED|Overall Study||0
475815|NCT01151553|1166784|P1|COMPLETED|Overall Study||5
475816|NCT01151553|1166784|P1|STARTED|Overall Study||5
475817|NCT01151449|1166788|P1|NOT COMPLETED|Overall Study||0
475818|NCT01151449|1166788|P1|COMPLETED|Overall Study||6
475819|NCT01151449|1166788|P1|STARTED|Overall Study||6
475820|NCT01151436|1166796|P1|NOT COMPLETED|Overall Study||1
475821|NCT01151436|1166796|P1|COMPLETED|Overall Study||76
475822|NCT01151436|1166796|P1|STARTED|Overall Study||77
475823|NCT01151410|1166828|P2|NOT COMPLETED|Overall Study||15
475824|NCT01151410|1166829|P1|NOT COMPLETED|Overall Study||11
475825|NCT01151410|1166828|P2|COMPLETED|Overall Study||89
475826|NCT01151410|1166829|P1|COMPLETED|Overall Study||93
475827|NCT01151410|1166828|P2|Safety Set (SAF)|Overall Study|Number of patients in SAF differed due to kit dispensing error in 1 patient at Visit 12|103
475828|NCT01151410|1166829|P1|Safety Set (SAF)|Overall Study||105
475829|NCT01151410|1166828|P2|STARTED|Overall Study||104
475830|NCT01151410|1166829|P1|STARTED|Overall Study||104
475831|NCT01151371|1166842|P3|NOT COMPLETED|Overall Study||7
475832|NCT01151371|1166843|P2|NOT COMPLETED|Overall Study||1
475833|NCT01151371|1166844|P1|NOT COMPLETED|Overall Study||5
475834|NCT01151371|1166842|P3|COMPLETED|Overall Study||146
475835|NCT01151371|1166843|P2|COMPLETED|Overall Study||149
475836|NCT01151371|1166844|P1|COMPLETED|Overall Study||144
475837|NCT01151371|1166842|P3|STARTED|Overall Study||153
475838|NCT01151371|1166843|P2|STARTED|Overall Study||150
475839|NCT01151371|1166844|P1|STARTED|Overall Study||149
475840|NCT01151345|1166873|P2|NOT COMPLETED|Second Intervention Period||0
475841|NCT01151345|1166874|P1|NOT COMPLETED|Second Intervention Period||0
475842|NCT01151345|1166873|P2|COMPLETED|Second Intervention Period||12
475843|NCT01151345|1166874|P1|COMPLETED|Second Intervention Period||13
475844|NCT01151345|1166873|P2|STARTED|Second Intervention Period||12
475845|NCT01151345|1166874|P1|STARTED|Second Intervention Period||13
475846|NCT01151345|1166873|P2|NOT COMPLETED|Wash-out Period (7 Days)||0
475847|NCT01151345|1166874|P1|NOT COMPLETED|Wash-out Period (7 Days)||0
475848|NCT01151345|1166873|P2|COMPLETED|Wash-out Period (7 Days)||12
475849|NCT01151345|1166874|P1|COMPLETED|Wash-out Period (7 Days)||13
475850|NCT01151345|1166873|P2|STARTED|Wash-out Period (7 Days)||12
475851|NCT01151345|1166874|P1|STARTED|Wash-out Period (7 Days)||13
475852|NCT01151345|1166873|P2|NOT COMPLETED|First Intervention Period||1
475853|NCT01151345|1166874|P1|NOT COMPLETED|First Intervention Period||0
475854|NCT01151345|1166873|P2|COMPLETED|First Intervention Period||12
475855|NCT01151345|1166874|P1|COMPLETED|First Intervention Period||13
475856|NCT01151345|1166873|P2|Treated|First Intervention Period||12
475857|NCT01151345|1166874|P1|Treated|First Intervention Period||13
475858|NCT01151345|1166873|P2|STARTED|First Intervention Period||13
475859|NCT01151345|1166874|P1|STARTED|First Intervention Period||13
475860|NCT01151280|1166888|P1|NOT COMPLETED|Overall Study||4
475861|NCT01151280|1166888|P1|COMPLETED|Overall Study||6
475862|NCT01151280|1166888|P1|STARTED|Overall Study||10
475863|NCT01151215|1166901|P3|NOT COMPLETED|Overall Study||19
475864|NCT01151215|1166902|P2|NOT COMPLETED|Overall Study||23
475865|NCT01151215|1166903|P1|NOT COMPLETED|Overall Study||20
475866|NCT01151215|1166901|P3|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|102
475867|NCT01151215|1166902|P2|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|95
475868|NCT01151215|1166903|P1|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|100
475869|NCT01151215|1166901|P3|STARTED|Overall Study||121
475870|NCT01151215|1166902|P2|STARTED|Overall Study||118
475871|NCT01151215|1166903|P1|STARTED|Overall Study||120
475872|NCT01151189|1166916|P2|NOT COMPLETED|Overall Study||10
475873|NCT01151189|1166917|P1|NOT COMPLETED|Overall Study||15
475874|NCT01151189|1166916|P2|COMPLETED|Overall Study||314
475875|NCT01151189|1166917|P1|COMPLETED|Overall Study||311
475876|NCT01151189|1166916|P2|Received Vaccine|Overall Study||324
475877|NCT01151189|1166917|P1|Received Vaccine|Overall Study||325
475878|NCT01151189|1166916|P2|STARTED|Overall Study||324
475879|NCT01151189|1166917|P1|STARTED|Overall Study||326
475880|NCT01151137|1166941|P2|NOT COMPLETED|Overall Study||28
475881|NCT01151137|1166942|P1|NOT COMPLETED|Overall Study||16
475882|NCT01151137|1166941|P2|COMPLETED|Overall Study||1591
475883|NCT01151137|1166942|P1|COMPLETED|Overall Study||1601
475884|NCT01151137|1166941|P2|Discontinued Treatment|Overall Study||342
475885|NCT01151137|1166942|P1|Discontinued Treatment|Overall Study||171
475886|NCT01151137|1166941|P2|Treated|Overall Study||1613
475887|NCT01151137|1166942|P1|Treated|Overall Study|One participant randomized to the placebo group received Dronedarone for 7 days by mistake|1610
475888|NCT01151137|1166941|P2|STARTED|Overall Study||1619
475889|NCT01151137|1166942|P1|STARTED|Overall Study||1617
475890|NCT01151098|1166960|P1|NOT COMPLETED|Overall Study||117
475891|NCT01151098|1166960|P1|COMPLETED|Overall Study||72
475892|NCT01151098|1166960|P1|STARTED|Overall Study|Extension Safety Population|189
475893|NCT01151085|1166964|P1|NOT COMPLETED|Overall Study||56
475894|NCT01151085|1166964|P1|COMPLETED|Overall Study||946
475895|NCT01151085|1166964|P1|STARTED|Overall Study||1002
475896|NCT01151046|1166982|P2|NOT COMPLETED|Overall Study||0
475897|NCT01151046|1166983|P1|NOT COMPLETED|Overall Study||3
475898|NCT01151046|1166982|P2|COMPLETED|Overall Study||59
475899|NCT01151046|1166983|P1|COMPLETED|Overall Study||56
475900|NCT01151046|1166982|P2|STARTED|Overall Study||59
475901|NCT01151046|1166983|P1|STARTED|Overall Study||59
475902|NCT01151020|1166995|P1|NOT COMPLETED|Overall Study||110
475903|NCT01151020|1166995|P1|COMPLETED|Overall Study||0
475904|NCT01151020|1166995|P1|12-month|Overall Study||99
475905|NCT01151020|1166995|P1|30-day|Overall Study||110
475906|NCT01151020|1166995|P1|STARTED|Overall Study||110
475907|NCT01150981|1167002|P2|NOT COMPLETED|Overall Study||2
475908|NCT01150981|1167003|P1|NOT COMPLETED|Overall Study||4
475909|NCT01150981|1167002|P2|COMPLETED|Overall Study||13
475910|NCT01150981|1167003|P1|COMPLETED|Overall Study||16
475911|NCT01150981|1167002|P2|STARTED|Overall Study||15
475912|NCT01150981|1167003|P1|STARTED|Overall Study||20
475913|NCT01150903|1167013|P2|NOT COMPLETED|Overall Study||0
475914|NCT01150903|1167014|P1|NOT COMPLETED|Overall Study||0
475915|NCT01150903|1167013|P2|COMPLETED|Overall Study||74124
475916|NCT01150903|1167014|P1|COMPLETED|Overall Study||24708
475917|NCT01150903|1167013|P2|STARTED|Overall Study||74124
475918|NCT01150903|1167014|P1|STARTED|Overall Study||24708
475919|NCT01150760|1167030|P2|NOT COMPLETED|Overall Study||0
475920|NCT01150760|1167031|P1|NOT COMPLETED|Overall Study||0
475921|NCT01150760|1167030|P2|COMPLETED|Overall Study||3525
475922|NCT01150760|1167031|P1|COMPLETED|Overall Study||3525
475923|NCT01150760|1167030|P2|STARTED|Overall Study||3525
475924|NCT01150760|1167031|P1|STARTED|Overall Study||3525
475925|NCT01150500|1167063|P1|NOT COMPLETED|Overall Study||65
475926|NCT01150500|1167063|P1|COMPLETED|Overall Study||0
475927|NCT01150500|1167063|P1|STARTED|Overall Study||65
475928|NCT01150474|1167074|P2|NOT COMPLETED|Overall Study||3
475929|NCT01150474|1167075|P1|NOT COMPLETED|Overall Study||10
475930|NCT01150474|1167074|P2|COMPLETED|Overall Study||49
475931|NCT01150474|1167075|P1|COMPLETED|Overall Study||41
475932|NCT01150474|1167074|P2|STARTED|Overall Study||52
475933|NCT01150474|1167075|P1|STARTED|Overall Study||51
475934|NCT01150461|1167099|P2|NOT COMPLETED|Overall Study||0
475935|NCT01150461|1167100|P1|NOT COMPLETED|Overall Study||0
475936|NCT01150461|1167099|P2|COMPLETED|Overall Study||9
475937|NCT01150461|1167100|P1|COMPLETED|Overall Study||11
475938|NCT01150461|1167099|P2|STARTED|Overall Study||9
475939|NCT01150461|1167100|P1|STARTED|Overall Study||11
475940|NCT01150409|1167110|P2|NOT COMPLETED|Overall Study||0
475941|NCT01150409|1167111|P1|NOT COMPLETED|Overall Study||0
475942|NCT01150409|1167110|P2|COMPLETED|Overall Study||0
475943|NCT01150409|1167111|P1|COMPLETED|Overall Study||11
475944|NCT01150409|1167110|P2|STARTED|Overall Study||0
475945|NCT01150409|1167111|P1|STARTED|Overall Study||11
475946|NCT01150357|1167120|P3|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||2
475947|NCT01150357|1167121|P2|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||0
475948|NCT01150357|1167122|P1|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||3
475949|NCT01150357|1167120|P3|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||100
475950|NCT01150357|1167121|P2|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||51
475951|NCT01150357|1167122|P1|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||104
475952|NCT01150357|1167120|P3|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||51
475953|NCT01150357|1167121|P2|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||21
475954|NCT01150357|1167122|P1|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||54
475955|NCT01150357|1167120|P3|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||52
475956|NCT01150357|1167121|P2|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||21
475957|NCT01150357|1167122|P1|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||57
475958|NCT01150357|1167120|P3|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||49
475959|NCT01150357|1167121|P2|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30
475960|NCT01150357|1167122|P1|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
475961|NCT01150357|1167120|P3|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
475962|NCT01150357|1167121|P2|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30
475963|NCT01150357|1167122|P1|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
475964|NCT01150357|1167120|P3|STARTED|Placebo-controlled Withdrawal (Phase 2)||102
475965|NCT01150357|1167121|P2|STARTED|Placebo-controlled Withdrawal (Phase 2)||51
475966|NCT01150357|1167122|P1|STARTED|Placebo-controlled Withdrawal (Phase 2)||107
475967|NCT01150357|1167120|P3|NOT COMPLETED|Dose Response Phase (Phase 1)||3
475968|NCT01150357|1167121|P2|NOT COMPLETED|Dose Response Phase (Phase 1)||3
475969|NCT01150357|1167122|P1|NOT COMPLETED|Dose Response Phase (Phase 1)||1
475970|NCT01150357|1167120|P3|COMPLETED|Dose Response Phase (Phase 1)||102
475971|NCT01150357|1167121|P2|COMPLETED|Dose Response Phase (Phase 1)||51
475972|NCT01150357|1167122|P1|COMPLETED|Dose Response Phase (Phase 1)||107
475973|NCT01150357|1167120|P3|STARTED|Dose Response Phase (Phase 1)||105
475974|NCT01150357|1167121|P2|STARTED|Dose Response Phase (Phase 1)||54
475975|NCT01150357|1167122|P1|STARTED|Dose Response Phase (Phase 1)||108
475976|NCT01150123|1167202|P18|NOT COMPLETED|Overall Study||1
475977|NCT01150123|1167203|P17|NOT COMPLETED|Overall Study||0
475978|NCT01150123|1167204|P16|NOT COMPLETED|Overall Study||1
475979|NCT01150123|1167205|P15|NOT COMPLETED|Overall Study||0
475980|NCT01150123|1167206|P14|NOT COMPLETED|Overall Study||0
475981|NCT01150123|1167207|P13|NOT COMPLETED|Overall Study||3
475982|NCT01150123|1167208|P12|NOT COMPLETED|Overall Study||1
475983|NCT01150123|1167209|P11|NOT COMPLETED|Overall Study||2
475984|NCT01150123|1167210|P10|NOT COMPLETED|Overall Study||1
475985|NCT01150123|1167211|P9|NOT COMPLETED|Overall Study||5
475986|NCT01150123|1167212|P8|NOT COMPLETED|Overall Study||3
475987|NCT01150123|1167213|P7|NOT COMPLETED|Overall Study||0
475988|NCT01150123|1167214|P6|NOT COMPLETED|Overall Study||6
475989|NCT01150123|1167215|P5|NOT COMPLETED|Overall Study||3
475990|NCT01150123|1167216|P4|NOT COMPLETED|Overall Study||3
475991|NCT01150123|1167217|P3|NOT COMPLETED|Overall Study||4
475992|NCT01150123|1167218|P2|NOT COMPLETED|Overall Study||2
475993|NCT01150123|1167219|P1|NOT COMPLETED|Overall Study||3
475994|NCT01150123|1167202|P18|COMPLETED|Overall Study||19
475995|NCT01150123|1167203|P17|COMPLETED|Overall Study||40
475996|NCT01150123|1167204|P16|COMPLETED|Overall Study||39
475997|NCT01150123|1167205|P15|COMPLETED|Overall Study||40
475998|NCT01150123|1167206|P14|COMPLETED|Overall Study||40
475999|NCT01150123|1167207|P13|COMPLETED|Overall Study||37
476000|NCT01150123|1167208|P12|COMPLETED|Overall Study||39
476001|NCT01150123|1167209|P11|COMPLETED|Overall Study||38
476002|NCT01150123|1167210|P10|COMPLETED|Overall Study||39
476003|NCT01150123|1167211|P9|COMPLETED|Overall Study||15
476004|NCT01150123|1167212|P8|COMPLETED|Overall Study||37
476005|NCT01150123|1167213|P7|COMPLETED|Overall Study||39
476006|NCT01150123|1167214|P6|COMPLETED|Overall Study||34
476007|NCT01150123|1167215|P5|COMPLETED|Overall Study||37
476008|NCT01150123|1167216|P4|COMPLETED|Overall Study||37
476009|NCT01150123|1167217|P3|COMPLETED|Overall Study||35
476010|NCT01150123|1167218|P2|COMPLETED|Overall Study||38
476011|NCT01150123|1167219|P1|COMPLETED|Overall Study||37
476012|NCT01150123|1167202|P18|STARTED|Overall Study||20
476013|NCT01150123|1167203|P17|STARTED|Overall Study||40
476014|NCT01150123|1167204|P16|STARTED|Overall Study||40
476015|NCT01150123|1167205|P15|STARTED|Overall Study||40
476016|NCT01150123|1167206|P14|STARTED|Overall Study||40
476017|NCT01150123|1167207|P13|STARTED|Overall Study||40
476018|NCT01150123|1167208|P12|STARTED|Overall Study||40
476019|NCT01150123|1167209|P11|STARTED|Overall Study||40
476020|NCT01150123|1167210|P10|STARTED|Overall Study||40
476021|NCT01150123|1167211|P9|STARTED|Overall Study||20
476022|NCT01150123|1167212|P8|STARTED|Overall Study||40
476023|NCT01150123|1167213|P7|STARTED|Overall Study||39
476024|NCT01150123|1167214|P6|STARTED|Overall Study||40
476025|NCT01150123|1167215|P5|STARTED|Overall Study||40
476026|NCT01150123|1167216|P4|STARTED|Overall Study||40
476027|NCT01150123|1167217|P3|STARTED|Overall Study||39
476028|NCT01150123|1167218|P2|STARTED|Overall Study||40
476029|NCT01150123|1167219|P1|STARTED|Overall Study||40
476030|NCT01150097|1167395|P3|NOT COMPLETED|Months 24 to 48 Post-transplantation||0
476031|NCT01150097|1167396|P2|NOT COMPLETED|Months 24 to 48 Post-transplantation||4
476032|NCT01150097|1167397|P1|NOT COMPLETED|Months 24 to 48 Post-transplantation||11
476033|NCT01150097|1167395|P3|COMPLETED|Months 24 to 48 Post-transplantation||0
476034|NCT01150097|1167396|P2|COMPLETED|Months 24 to 48 Post-transplantation||47
476035|NCT01150097|1167397|P1|COMPLETED|Months 24 to 48 Post-transplantation||95
476036|NCT01150097|1167395|P3|STARTED|Months 24 to 48 Post-transplantation||0
476037|NCT01150097|1167396|P2|STARTED|Months 24 to 48 Post-transplantation||51
476038|NCT01150097|1167397|P1|STARTED|Months 24 to 48 Post-transplantation||106
476039|NCT01150097|1167395|P3|NOT COMPLETED|Months 24 to 36 Post-transplantation||8
476040|NCT01150097|1167396|P2|NOT COMPLETED|Months 24 to 36 Post-transplantation||2
476041|NCT01150097|1167397|P1|NOT COMPLETED|Months 24 to 36 Post-transplantation||10
476042|NCT01150097|1167395|P3|COMPLETED|Months 24 to 36 Post-transplantation||117
476043|NCT01150097|1167396|P2|COMPLETED|Months 24 to 36 Post-transplantation||49
476044|NCT01150097|1167397|P1|COMPLETED|Months 24 to 36 Post-transplantation||96
476045|NCT01150097|1167395|P3|STARTED|Months 24 to 36 Post-transplantation||125
476046|NCT01150097|1167396|P2|STARTED|Months 24 to 36 Post-transplantation||51
476047|NCT01150097|1167397|P1|STARTED|Months 24 to 36 Post-transplantation||106
476048|NCT01149876|1167424|P4|NOT COMPLETED|Overall Study||0
476049|NCT01149876|1167425|P3|NOT COMPLETED|Overall Study||1
476050|NCT01149876|1167426|P2|NOT COMPLETED|Overall Study||0
476051|NCT01149876|1167427|P1|NOT COMPLETED|Overall Study||1
476052|NCT01149876|1167424|P4|COMPLETED|Overall Study||18
476053|NCT01149876|1167425|P3|COMPLETED|Overall Study||20
476054|NCT01149876|1167426|P2|COMPLETED|Overall Study||20
476055|NCT01149876|1167427|P1|COMPLETED|Overall Study||20
476056|NCT01149876|1167424|P4|STARTED|Overall Study||18
476057|NCT01149876|1167425|P3|STARTED|Overall Study||21
476058|NCT01149876|1167426|P2|STARTED|Overall Study||20
476059|NCT01149876|1167427|P1|STARTED|Overall Study||21
476060|NCT01149863|1167441|P1|NOT COMPLETED|Overall Study||3
476061|NCT01149863|1167441|P1|COMPLETED|Overall Study||31
476062|NCT01149863|1167441|P1|STARTED|Overall Study||34
476063|NCT01149785|1167446|P2|NOT COMPLETED|Second Intervention||0
476064|NCT01149785|1167447|P1|NOT COMPLETED|Second Intervention||0
476065|NCT01149785|1167446|P2|COMPLETED|Second Intervention||15
476066|NCT01149785|1167447|P1|COMPLETED|Second Intervention||0
476067|NCT01149785|1167446|P2|STARTED|Second Intervention||15
476068|NCT01149785|1167447|P1|STARTED|Second Intervention||0
476069|NCT01149785|1167446|P2|NOT COMPLETED|Washout Period of at Least 14 Days||0
476070|NCT01149785|1167447|P1|NOT COMPLETED|Washout Period of at Least 14 Days||0
476071|NCT01149785|1167446|P2|COMPLETED|Washout Period of at Least 14 Days||0
476072|NCT01149785|1167447|P1|COMPLETED|Washout Period of at Least 14 Days||15
476073|NCT01149785|1167446|P2|STARTED|Washout Period of at Least 14 Days||0
476074|NCT01149785|1167447|P1|STARTED|Washout Period of at Least 14 Days||15
476075|NCT01149785|1167446|P2|NOT COMPLETED|First Intervention||0
476076|NCT01149785|1167447|P1|NOT COMPLETED|First Intervention||0
476077|NCT01149785|1167446|P2|COMPLETED|First Intervention||0
476078|NCT01149785|1167447|P1|COMPLETED|First Intervention||15
476079|NCT01149785|1167446|P2|STARTED|First Intervention||0
476080|NCT01149785|1167447|P1|STARTED|First Intervention||15
476081|NCT01149772|1167481|P2|NOT COMPLETED|Overall Study||21
476082|NCT01149772|1167482|P1|NOT COMPLETED|Overall Study||48
476083|NCT01149772|1167481|P2|COMPLETED|Overall Study||101
476084|NCT01149772|1167482|P1|COMPLETED|Overall Study||132
476085|NCT01149772|1167481|P2|STARTED|Overall Study||122
476086|NCT01149772|1167482|P1|STARTED|Overall Study||180
476087|NCT01149759|1167498|P1|NOT COMPLETED|Overall Study||0
476088|NCT01149759|1167498|P1|COMPLETED|Overall Study||9
476089|NCT01149759|1167498|P1|STARTED|Overall Study||9
476090|NCT01149733|1167505|P2|NOT COMPLETED|Overall Study||0
476091|NCT01149733|1167506|P1|NOT COMPLETED|Overall Study||0
476092|NCT01149733|1167505|P2|COMPLETED|Overall Study||16
476093|NCT01149733|1167506|P1|COMPLETED|Overall Study||16
476094|NCT01149733|1167505|P2|STARTED|Overall Study||16
476095|NCT01149733|1167506|P1|STARTED|Overall Study||16
476096|NCT01149655|1167518|P4|NOT COMPLETED|Period 3-DB Maintenance Phase||42
476097|NCT01149655|1167519|P3|NOT COMPLETED|Period 3-DB Maintenance Phase||83
476098|NCT01149655|1167520|P2|NOT COMPLETED|Period 3-DB Maintenance Phase||0
476099|NCT01149655|1167521|P1|NOT COMPLETED|Period 3-DB Maintenance Phase||0
476100|NCT01149655|1167518|P4|COMPLETED|Period 3-DB Maintenance Phase||6
476101|NCT01149655|1167519|P3|COMPLETED|Period 3-DB Maintenance Phase||15
476102|NCT01149655|1167520|P2|COMPLETED|Period 3-DB Maintenance Phase||0
476103|NCT01149655|1167521|P1|COMPLETED|Period 3-DB Maintenance Phase||0
476104|NCT01149655|1167518|P4|STARTED|Period 3-DB Maintenance Phase||48
476105|NCT01149655|1167519|P3|STARTED|Period 3-DB Maintenance Phase||98
476106|NCT01149655|1167520|P2|STARTED|Period 3-DB Maintenance Phase||0
476107|NCT01149655|1167521|P1|STARTED|Period 3-DB Maintenance Phase||0
476108|NCT01149655|1167518|P4|NOT COMPLETED|Period 2-Stabilization Phase||0
476109|NCT01149655|1167519|P3|NOT COMPLETED|Period 2-Stabilization Phase||0
476110|NCT01149655|1167520|P2|NOT COMPLETED|Period 2-Stabilization Phase||37
476111|NCT01149655|1167521|P1|NOT COMPLETED|Period 2-Stabilization Phase||0
476112|NCT01149655|1167518|P4|COMPLETED|Period 2-Stabilization Phase||0
476113|NCT01149655|1167519|P3|COMPLETED|Period 2-Stabilization Phase||0
476114|NCT01149655|1167520|P2|COMPLETED|Period 2-Stabilization Phase||146
476115|NCT01149655|1167521|P1|COMPLETED|Period 2-Stabilization Phase||0
476116|NCT01149655|1167518|P4|STARTED|Period 2-Stabilization Phase||0
476117|NCT01149655|1167519|P3|STARTED|Period 2-Stabilization Phase||0
476118|NCT01149655|1167520|P2|STARTED|Period 2-Stabilization Phase||183
476119|NCT01149655|1167521|P1|STARTED|Period 2-Stabilization Phase||0
476120|NCT01149655|1167518|P4|NOT COMPLETED|Period 1 - Conversion Phase||0
476121|NCT01149655|1167519|P3|NOT COMPLETED|Period 1 - Conversion Phase||0
476122|NCT01149655|1167520|P2|NOT COMPLETED|Period 1 - Conversion Phase||0
476123|NCT01149655|1167521|P1|NOT COMPLETED|Period 1 - Conversion Phase||18
476124|NCT01149655|1167518|P4|COMPLETED|Period 1 - Conversion Phase||0
476125|NCT01149655|1167519|P3|COMPLETED|Period 1 - Conversion Phase||0
476126|NCT01149655|1167520|P2|COMPLETED|Period 1 - Conversion Phase||0
476127|NCT01149655|1167521|P1|COMPLETED|Period 1 - Conversion Phase||168
476128|NCT01149655|1167518|P4|STARTED|Period 1 - Conversion Phase||0
476129|NCT01149655|1167519|P3|STARTED|Period 1 - Conversion Phase||0
476130|NCT01149655|1167520|P2|STARTED|Period 1 - Conversion Phase||0
476131|NCT01149655|1167521|P1|STARTED|Period 1 - Conversion Phase||186
476132|NCT01149616|1167551|P2|NOT COMPLETED|Overall Study||0
476133|NCT01149616|1167552|P1|NOT COMPLETED|Overall Study||0
476134|NCT01149616|1167551|P2|COMPLETED|Overall Study||41
476135|NCT01149616|1167552|P1|COMPLETED|Overall Study||41
476136|NCT01149616|1167551|P2|STARTED|Overall Study||41
476137|NCT01149616|1167552|P1|STARTED|Overall Study||41
476138|NCT01149538|1167564|P2|NOT COMPLETED|Overall Study||4
476139|NCT01149538|1167565|P1|NOT COMPLETED|Overall Study||5
476140|NCT01149538|1167564|P2|COMPLETED|Overall Study||25
476141|NCT01149538|1167565|P1|COMPLETED|Overall Study||26
476142|NCT01149538|1167564|P2|STARTED|Overall Study||29
476143|NCT01149538|1167565|P1|STARTED|Overall Study||31
476144|NCT01149512|1167579|P1|NOT COMPLETED|Overall Study||0
476145|NCT01149512|1167579|P1|COMPLETED|Overall Study||178
476146|NCT01149512|1167579|P1|STARTED|Overall Study||178
476147|NCT01149486|1167586|P2|NOT COMPLETED|Second Intervention||0
476148|NCT01149486|1167587|P1|NOT COMPLETED|Second Intervention||0
476149|NCT01149486|1167586|P2|COMPLETED|Second Intervention||9
476150|NCT01149486|1167587|P1|COMPLETED|Second Intervention||10
476151|NCT01149486|1167586|P2|STARTED|Second Intervention||9
476152|NCT01149486|1167587|P1|STARTED|Second Intervention||10
476153|NCT01149486|1167586|P2|NOT COMPLETED|Washout of 7 Days||0
476154|NCT01149486|1167587|P1|NOT COMPLETED|Washout of 7 Days||0
476155|NCT01149486|1167586|P2|COMPLETED|Washout of 7 Days||9
476156|NCT01149486|1167587|P1|COMPLETED|Washout of 7 Days||10
476157|NCT01149486|1167586|P2|STARTED|Washout of 7 Days||9
476158|NCT01149486|1167587|P1|STARTED|Washout of 7 Days||10
476159|NCT01149486|1167586|P2|NOT COMPLETED|First Intervention||1
476160|NCT01149486|1167587|P1|NOT COMPLETED|First Intervention||0
476161|NCT01149486|1167586|P2|COMPLETED|First Intervention||9
476162|NCT01149486|1167587|P1|COMPLETED|First Intervention||10
476163|NCT01149486|1167586|P2|STARTED|First Intervention||10
476164|NCT01149486|1167587|P1|STARTED|First Intervention||10
476165|NCT01149473|1167611|P2|NOT COMPLETED|Second Intervention||0
476166|NCT01149473|1167612|P1|NOT COMPLETED|Second Intervention||0
476167|NCT01149473|1167611|P2|COMPLETED|Second Intervention||38
476168|NCT01149473|1167612|P1|COMPLETED|Second Intervention||38
476169|NCT01149473|1167611|P2|STARTED|Second Intervention||38
476170|NCT01149473|1167612|P1|STARTED|Second Intervention||38
476171|NCT01149473|1167611|P2|NOT COMPLETED|Washout of 7 Days||1
476172|NCT01149473|1167612|P1|NOT COMPLETED|Washout of 7 Days||1
476173|NCT01149473|1167611|P2|COMPLETED|Washout of 7 Days||38
476174|NCT01149473|1167612|P1|COMPLETED|Washout of 7 Days||38
476175|NCT01149473|1167611|P2|STARTED|Washout of 7 Days||39
476176|NCT01149473|1167612|P1|STARTED|Washout of 7 Days||39
476177|NCT01149473|1167611|P2|NOT COMPLETED|First Intervention||1
476178|NCT01149473|1167612|P1|NOT COMPLETED|First Intervention||1
476179|NCT01149473|1167611|P2|COMPLETED|First Intervention||39
476180|NCT01149473|1167612|P1|COMPLETED|First Intervention||39
476181|NCT01149473|1167611|P2|STARTED|First Intervention||40
476182|NCT01149473|1167612|P1|STARTED|First Intervention||40
476183|NCT01149460|1167630|P2|NOT COMPLETED|Overall Study||2
476184|NCT01149460|1167631|P1|NOT COMPLETED|Overall Study||0
476185|NCT01149460|1167630|P2|COMPLETED|Overall Study||16
476186|NCT01149460|1167631|P1|COMPLETED|Overall Study||18
476187|NCT01149460|1167630|P2|STARTED|Overall Study||18
476188|NCT01149460|1167631|P1|STARTED|Overall Study||18
476189|NCT01149434|1167649|P2|NOT COMPLETED|Overall Study||5
476190|NCT01149434|1167650|P1|NOT COMPLETED|Overall Study||0
476191|NCT01149434|1167649|P2|COMPLETED|Overall Study||10
476192|NCT01149434|1167650|P1|COMPLETED|Overall Study||4
476193|NCT01149434|1167649|P2|STARTED|Overall Study||15
476194|NCT01149434|1167650|P1|STARTED|Overall Study||4
476195|NCT01149421|1167664|P3|NOT COMPLETED|Overall Study||44
476196|NCT01149421|1167665|P2|NOT COMPLETED|Overall Study||29
476197|NCT01149421|1167666|P1|NOT COMPLETED|Overall Study||52
476198|NCT01149421|1167664|P3|COMPLETED|Overall Study||206
476199|NCT01149421|1167665|P2|COMPLETED|Overall Study||225
476200|NCT01149421|1167666|P1|COMPLETED|Overall Study||199
476201|NCT01149421|1167664|P3|Received at Least One Dose of Study Drug|Overall Study||250
476202|NCT01149421|1167665|P2|Received at Least One Dose of Study Drug|Overall Study||254
476203|NCT01149421|1167666|P1|Received at Least One Dose of Study Drug|Overall Study||251
476204|NCT01149421|1167664|P3|STARTED|Overall Study||250
476205|NCT01149421|1167665|P2|STARTED|Overall Study||254
476206|NCT01149421|1167666|P1|STARTED|Overall Study||251
476207|NCT01149148|1167747|P2|NOT COMPLETED|Overall Study||2
476208|NCT01149148|1167748|P1|NOT COMPLETED|Overall Study||2
476209|NCT01149148|1167747|P2|COMPLETED|Overall Study||11
476210|NCT01149148|1167748|P1|COMPLETED|Overall Study||10
476211|NCT01149148|1167747|P2|STARTED|Overall Study||13
476212|NCT01149148|1167748|P1|STARTED|Overall Study||12
476213|NCT01149057|1167756|P1|NOT COMPLETED|Overall Study||57
476214|NCT01149057|1167756|P1|COMPLETED|Overall Study||88
476215|NCT01149057|1167756|P1|STARTED|Overall Study||145
476216|NCT01148979|1167783|P2|NOT COMPLETED|Overall Study||1
476217|NCT01148979|1167784|P1|NOT COMPLETED|Overall Study||0
476218|NCT01148979|1167783|P2|COMPLETED|Overall Study||15
476219|NCT01148979|1167784|P1|COMPLETED|Overall Study||13
476220|NCT01148979|1167783|P2|STARTED|Overall Study||16
476221|NCT01148979|1167784|P1|STARTED|Overall Study||13
476222|NCT01148862|1167790|P2|NOT COMPLETED|Second Intervention||2
476223|NCT01148862|1167791|P1|NOT COMPLETED|Second Intervention||0
476224|NCT01148862|1167790|P2|COMPLETED|Second Intervention||23
476225|NCT01148862|1167791|P1|COMPLETED|Second Intervention||25
476226|NCT01148862|1167790|P2|STARTED|Second Intervention||25
476227|NCT01148862|1167791|P1|STARTED|Second Intervention||25
476228|NCT01148862|1167790|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
476229|NCT01148862|1167791|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
476230|NCT01148862|1167790|P2|COMPLETED|Washout Period of 2 Weeks||25
476231|NCT01148862|1167791|P1|COMPLETED|Washout Period of 2 Weeks||25
476232|NCT01148862|1167790|P2|STARTED|Washout Period of 2 Weeks||25
476233|NCT01148862|1167791|P1|STARTED|Washout Period of 2 Weeks||25
476234|NCT01148862|1167790|P2|NOT COMPLETED|First Intervention||0
476235|NCT01148862|1167791|P1|NOT COMPLETED|First Intervention||0
476236|NCT01148862|1167790|P2|COMPLETED|First Intervention||25
476237|NCT01148862|1167791|P1|COMPLETED|First Intervention||25
476238|NCT01148862|1167790|P2|STARTED|First Intervention||25
476239|NCT01148862|1167791|P1|STARTED|First Intervention||25
476240|NCT01148836|1167801|P2|NOT COMPLETED|Overall Study||2
476241|NCT01148836|1167802|P1|NOT COMPLETED|Overall Study||1
476242|NCT01148836|1167801|P2|COMPLETED|Overall Study||8
476243|NCT01148836|1167802|P1|COMPLETED|Overall Study|Enrollment completed|7
476244|NCT01148836|1167801|P2|STARTED|Overall Study||10
476245|NCT01148836|1167802|P1|STARTED|Overall Study|Enrollment completed|8
476246|NCT01148771|1167823|P2|NOT COMPLETED|Second Intervention||0
476247|NCT01148771|1167824|P1|NOT COMPLETED|Second Intervention||0
476248|NCT01148771|1167823|P2|COMPLETED|Second Intervention||5
476249|NCT01148771|1167824|P1|COMPLETED|Second Intervention||6
476250|NCT01148771|1167823|P2|STARTED|Second Intervention||5
476251|NCT01148771|1167824|P1|STARTED|Second Intervention||6
476252|NCT01148771|1167823|P2|NOT COMPLETED|Washout Period||1
476253|NCT01148771|1167824|P1|NOT COMPLETED|Washout Period||0
476254|NCT01148771|1167823|P2|COMPLETED|Washout Period||5
476255|NCT01148771|1167824|P1|COMPLETED|Washout Period||6
476256|NCT01148771|1167823|P2|STARTED|Washout Period||6
476257|NCT01148771|1167824|P1|STARTED|Washout Period||6
476258|NCT01148771|1167823|P2|NOT COMPLETED|First Intervention||0
476259|NCT01148771|1167824|P1|NOT COMPLETED|First Intervention||0
476260|NCT01148771|1167823|P2|COMPLETED|First Intervention||6
476261|NCT01148771|1167824|P1|COMPLETED|First Intervention||6
476262|NCT01148771|1167823|P2|STARTED|First Intervention||6
476263|NCT01148771|1167824|P1|STARTED|First Intervention||6
476264|NCT01148745|1167836|P1|NOT COMPLETED|Overall Study||0
476265|NCT01148745|1167836|P1|COMPLETED|Overall Study||15
476266|NCT01148745|1167836|P1|STARTED|Overall Study||15
476267|NCT01148693|1167844|P2|NOT COMPLETED|Overall Study||10
476268|NCT01148693|1167845|P1|NOT COMPLETED|Overall Study||13
476269|NCT01148693|1167844|P2|COMPLETED|Overall Study||57
476270|NCT01148693|1167845|P1|COMPLETED|Overall Study||57
476271|NCT01148693|1167844|P2|STARTED|Overall Study||67
476272|NCT01148693|1167845|P1|STARTED|Overall Study||70
476273|NCT01148563|1167853|P2|NOT COMPLETED|Overall Study||30
476274|NCT01148563|1167854|P1|NOT COMPLETED|Overall Study||29
476275|NCT01148563|1167853|P2|COMPLETED|Overall Study||37
476276|NCT01148563|1167854|P1|COMPLETED|Overall Study||40
476277|NCT01148563|1167853|P2|STARTED|Overall Study||67
476278|NCT01148563|1167854|P1|STARTED|Overall Study||69
476279|NCT01148537|1167865|P3|NOT COMPLETED|Overall Study||3
476280|NCT01148537|1167866|P2|NOT COMPLETED|Overall Study||0
476281|NCT01148537|1167867|P1|NOT COMPLETED|Overall Study||3
476282|NCT01148537|1167865|P3|COMPLETED|Overall Study||41
476283|NCT01148537|1167866|P2|COMPLETED|Overall Study||44
476284|NCT01148537|1167867|P1|COMPLETED|Overall Study||41
476285|NCT01148537|1167865|P3|STARTED|Overall Study||44
476286|NCT01148537|1167866|P2|STARTED|Overall Study||44
476287|NCT01148537|1167867|P1|STARTED|Overall Study||44
476288|NCT01148524|1167897|P9|NOT COMPLETED|Overall Study||0
476289|NCT01148524|1167898|P8|NOT COMPLETED|Overall Study||0
476290|NCT01148524|1167899|P7|NOT COMPLETED|Overall Study||0
476291|NCT01148524|1167900|P6|NOT COMPLETED|Overall Study||0
476292|NCT01148524|1167901|P5|NOT COMPLETED|Overall Study||0
476293|NCT01148524|1167902|P4|NOT COMPLETED|Overall Study||0
476294|NCT01148524|1167903|P3|NOT COMPLETED|Overall Study||0
476295|NCT01148524|1167904|P2|NOT COMPLETED|Overall Study||0
476296|NCT01148524|1167905|P1|NOT COMPLETED|Overall Study||0
476297|NCT01148524|1167897|P9|COMPLETED|Overall Study||151
476298|NCT01148524|1167898|P8|COMPLETED|Overall Study||51
476299|NCT01148524|1167899|P7|COMPLETED|Overall Study||153
476300|NCT01148524|1167900|P6|COMPLETED|Overall Study||106
476301|NCT01148524|1167901|P5|COMPLETED|Overall Study||57
476302|NCT01148524|1167902|P4|COMPLETED|Overall Study||102
476303|NCT01148524|1167903|P3|COMPLETED|Overall Study||53
476304|NCT01148524|1167904|P2|COMPLETED|Overall Study||95
476305|NCT01148524|1167905|P1|COMPLETED|Overall Study||49
476306|NCT01148524|1167897|P9|STARTED|Overall Study||151
476307|NCT01148524|1167898|P8|STARTED|Overall Study||51
476308|NCT01148524|1167899|P7|STARTED|Overall Study||153
476309|NCT01148524|1167900|P6|STARTED|Overall Study||106
476310|NCT01148524|1167901|P5|STARTED|Overall Study||57
476311|NCT01148524|1167902|P4|STARTED|Overall Study||102
476312|NCT01148524|1167903|P3|STARTED|Overall Study||53
476313|NCT01148524|1167904|P2|STARTED|Overall Study||95
476314|NCT01148524|1167905|P1|STARTED|Overall Study||49
476315|NCT01148511|1167953|P3|NOT COMPLETED|Randomized||6
476316|NCT01148511|1167954|P2|NOT COMPLETED|Randomized||10
476317|NCT01148511|1167955|P1|NOT COMPLETED|Randomized||0
476318|NCT01148511|1167953|P3|COMPLETED|Randomized||39
476319|NCT01148511|1167954|P2|COMPLETED|Randomized||38
476320|NCT01148511|1167955|P1|COMPLETED|Randomized||0
476321|NCT01148511|1167953|P3|STARTED|Randomized||45
476322|NCT01148511|1167954|P2|STARTED|Randomized||48
476323|NCT01148511|1167955|P1|STARTED|Randomized|All patients were randomized into the Treat and Extend and the Treat and Observe treatment groups.|0
476324|NCT01148511|1167953|P3|NOT COMPLETED|Exposed to Study Drug||0
476325|NCT01148511|1167954|P2|NOT COMPLETED|Exposed to Study Drug||0
476326|NCT01148511|1167955|P1|NOT COMPLETED|Exposed to Study Drug||6
476327|NCT01148511|1167953|P3|COMPLETED|Exposed to Study Drug||0
476328|NCT01148511|1167954|P2|COMPLETED|Exposed to Study Drug||0
476329|NCT01148511|1167955|P1|COMPLETED|Exposed to Study Drug||93
476330|NCT01148511|1167953|P3|STARTED|Exposed to Study Drug|Patients were not randomized to this group until the Randomized Period.|0
476331|NCT01148511|1167954|P2|STARTED|Exposed to Study Drug|Patients were not randomized to this group until the Randomized Period.|0
476332|NCT01148511|1167955|P1|STARTED|Exposed to Study Drug||99
476333|NCT01148420|1167974|P1|NOT COMPLETED|Overall Study||0
476334|NCT01148420|1167974|P1|COMPLETED|Overall Study||48
476335|NCT01148420|1167974|P1|STARTED|Overall Study||48
476336|NCT01148056|1167980|P1|NOT COMPLETED|Overall Study||0
476337|NCT01148056|1167980|P1|COMPLETED|Overall Study||2
476338|NCT01148056|1167980|P1|STARTED|Overall Study||2
476339|NCT01148017|1167993|P4|NOT COMPLETED|Overall Study||0
476340|NCT01148017|1167994|P3|NOT COMPLETED|Overall Study||0
476341|NCT01148017|1167995|P2|NOT COMPLETED|Overall Study||34
476342|NCT01148017|1167996|P1|NOT COMPLETED|Overall Study||80
476343|NCT01148017|1167993|P4|COMPLETED|Overall Study||45
476344|NCT01148017|1167994|P3|COMPLETED|Overall Study||53
476345|NCT01148017|1167995|P2|COMPLETED|Overall Study||87
476346|NCT01148017|1167996|P1|COMPLETED|Overall Study||134
476347|NCT01148017|1167993|P4|STARTED|Overall Study||45
476348|NCT01148017|1167994|P3|STARTED|Overall Study||53
476349|NCT01148017|1167995|P2|STARTED|Overall Study||121
476350|NCT01148017|1167996|P1|STARTED|Overall Study||214
476351|NCT01147926|1168035|P2|NOT COMPLETED|Overall Study||29
476352|NCT01147926|1168036|P1|NOT COMPLETED|Overall Study||27
476353|NCT01147926|1168035|P2|COMPLETED|Overall Study||158
476354|NCT01147926|1168036|P1|COMPLETED|Overall Study||160
476355|NCT01147926|1168035|P2|STARTED|Overall Study||187
476356|NCT01147926|1168036|P1|STARTED|Overall Study||187
476357|NCT01147900|1168071|P3|NOT COMPLETED|At Year 10||0
476358|NCT01147900|1168072|P2|NOT COMPLETED|At Year 10||1
476359|NCT01147900|1168073|P1|NOT COMPLETED|At Year 10||0
476360|NCT01147900|1168071|P3|COMPLETED|At Year 10||62
476361|NCT01147900|1168072|P2|COMPLETED|At Year 10||59
476362|NCT01147900|1168073|P1|COMPLETED|At Year 10||55
476363|NCT01147900|1168071|P3|STARTED|At Year 10|At Year 10, a total of 177 subjects (out of the 180 planned) were enrolled.|62
476364|NCT01147900|1168072|P2|STARTED|At Year 10||60
476365|NCT01147900|1168073|P1|STARTED|At Year 10|At Year 10, a total of 177 subjects (out of the 180 planned) were enrolled|55
476366|NCT01147900|1168071|P3|NOT COMPLETED|At Year 8.5||0
476367|NCT01147900|1168072|P2|NOT COMPLETED|At Year 8.5||0
476368|NCT01147900|1168073|P1|NOT COMPLETED|At Year 8.5||0
476369|NCT01147900|1168071|P3|COMPLETED|At Year 8.5||66
476370|NCT01147900|1168072|P2|COMPLETED|At Year 8.5||60
476371|NCT01147900|1168073|P1|COMPLETED|At Year 8.5||54
476372|NCT01147900|1168071|P3|STARTED|At Year 8.5||66
476373|NCT01147900|1168072|P2|STARTED|At Year 8.5||60
476374|NCT01147900|1168073|P1|STARTED|At Year 8.5||54
476375|NCT01147874|1168132|P1|NOT COMPLETED|Overall Study||67
476376|NCT01147874|1168132|P1|COMPLETED|Overall Study||946
476377|NCT01147874|1168132|P1|STARTED|Overall Study||1013
476378|NCT01147848|1168140|P3|NOT COMPLETED|Randomized Phase||46
476379|NCT01147848|1168141|P2|NOT COMPLETED|Randomized Phase||45
476380|NCT01147848|1168142|P1|NOT COMPLETED|Randomized Phase||0
476381|NCT01147848|1168140|P3|COMPLETED|Randomized Phase||357
476382|NCT01147848|1168141|P2|COMPLETED|Randomized Phase||358
476383|NCT01147848|1168142|P1|COMPLETED|Randomized Phase||0
476384|NCT01147848|1168140|P3|STARTED|Randomized Phase||403
476385|NCT01147848|1168141|P2|STARTED|Randomized Phase||403
476386|NCT01147848|1168142|P1|STARTED|Randomized Phase||0
476387|NCT01147848|1168140|P3|NOT COMPLETED|Run-in Period||0
476388|NCT01147848|1168141|P2|NOT COMPLETED|Run-in Period||0
476389|NCT01147848|1168142|P1|NOT COMPLETED|Run-in Period||758
476390|NCT01147848|1168140|P3|COMPLETED|Run-in Period||0
476391|NCT01147848|1168141|P2|COMPLETED|Run-in Period||0
476392|NCT01147848|1168142|P1|COMPLETED|Run-in Period||806
476393|NCT01147848|1168140|P3|STARTED|Run-in Period||0
476394|NCT01147848|1168141|P2|STARTED|Run-in Period||0
476395|NCT01147848|1168142|P1|STARTED|Run-in Period||1564
476396|NCT01147822|1168174|P2|NOT COMPLETED|Overall Study||179
476397|NCT01147822|1168175|P1|NOT COMPLETED|Overall Study||188
476398|NCT01147822|1168174|P2|COMPLETED|Overall Study||0
476399|NCT01147822|1168175|P1|COMPLETED|Overall Study||0
476400|NCT01147822|1168174|P2|Not Completed/Ongoing|Overall Study||102
476401|NCT01147822|1168175|P1|Not Completed/Ongoing|Overall Study||111
476402|NCT01147822|1168174|P2|STARTED|Overall Study||179
476403|NCT01147822|1168175|P1|STARTED|Overall Study||188
476404|NCT01147809|1168195|P6|NOT COMPLETED|Phase II (168 Days)||33
476405|NCT01147809|1168196|P5|NOT COMPLETED|Phase II (168 Days)||16
476406|NCT01147809|1168197|P4|NOT COMPLETED|Phase II (168 Days)||0
476407|NCT01147809|1168198|P3|NOT COMPLETED|Phase II (168 Days)||0
476408|NCT01147809|1168199|P2|NOT COMPLETED|Phase II (168 Days)||0
476409|NCT01147809|1168200|P1|NOT COMPLETED|Phase II (168 Days)||0
476410|NCT01147809|1168195|P6|COMPLETED|Phase II (168 Days)||19
476411|NCT01147809|1168196|P5|COMPLETED|Phase II (168 Days)||7
476412|NCT01147809|1168197|P4|COMPLETED|Phase II (168 Days)||0
476413|NCT01147809|1168198|P3|COMPLETED|Phase II (168 Days)||0
476414|NCT01147809|1168199|P2|COMPLETED|Phase II (168 Days)||0
476415|NCT01147809|1168200|P1|COMPLETED|Phase II (168 Days)||0
476416|NCT01147809|1168195|P6|Ongoing|Phase II (168 Days)||0
476417|NCT01147809|1168196|P5|Ongoing|Phase II (168 Days)||1
476418|NCT01147809|1168197|P4|Ongoing|Phase II (168 Days)||0
476419|NCT01147809|1168198|P3|Ongoing|Phase II (168 Days)||0
476420|NCT01147809|1168199|P2|Ongoing|Phase II (168 Days)||0
476421|NCT01147809|1168200|P1|Ongoing|Phase II (168 Days)||0
476422|NCT01147809|1168195|P6|STARTED|Phase II (168 Days)||52
476423|NCT01147809|1168196|P5|STARTED|Phase II (168 Days)||23
476424|NCT01147809|1168197|P4|STARTED|Phase II (168 Days)||0
476425|NCT01147809|1168198|P3|STARTED|Phase II (168 Days)||0
476426|NCT01147809|1168199|P2|STARTED|Phase II (168 Days)||0
476427|NCT01147809|1168200|P1|STARTED|Phase II (168 Days)||0
476428|NCT01147809|1168195|P6|NOT COMPLETED|Phase I (168 Days)||0
476429|NCT01147809|1168196|P5|NOT COMPLETED|Phase I (168 Days)||0
476430|NCT01147809|1168197|P4|NOT COMPLETED|Phase I (168 Days)||5
476431|NCT01147809|1168198|P3|NOT COMPLETED|Phase I (168 Days)||2
476432|NCT01147809|1168199|P2|NOT COMPLETED|Phase I (168 Days)||1
476433|NCT01147809|1168200|P1|NOT COMPLETED|Phase I (168 Days)||1
476434|NCT01147809|1168195|P6|COMPLETED|Phase I (168 Days)||0
476435|NCT01147809|1168196|P5|COMPLETED|Phase I (168 Days)||0
476436|NCT01147809|1168197|P4|COMPLETED|Phase I (168 Days)||5
476437|NCT01147809|1168198|P3|COMPLETED|Phase I (168 Days)||2
476438|NCT01147809|1168199|P2|COMPLETED|Phase I (168 Days)||8
476439|NCT01147809|1168200|P1|COMPLETED|Phase I (168 Days)||2
476440|NCT01147809|1168195|P6|STARTED|Phase I (168 Days)||0
476441|NCT01147809|1168196|P5|STARTED|Phase I (168 Days)||0
476442|NCT01147809|1168197|P4|STARTED|Phase I (168 Days)||10
476443|NCT01147809|1168198|P3|STARTED|Phase I (168 Days)||4
476444|NCT01147809|1168199|P2|STARTED|Phase I (168 Days)||9
476445|NCT01147809|1168200|P1|STARTED|Phase I (168 Days)||3
476446|NCT01147744|1168321|P7|NOT COMPLETED|Overall Study||19
476447|NCT01147744|1168322|P6|NOT COMPLETED|Overall Study||20
476448|NCT01147744|1168323|P5|NOT COMPLETED|Overall Study||25
476449|NCT01147744|1168324|P4|NOT COMPLETED|Overall Study||18
476450|NCT01147744|1168325|P3|NOT COMPLETED|Overall Study||18
476451|NCT01147744|1168326|P2|NOT COMPLETED|Overall Study||23
476452|NCT01147744|1168327|P1|NOT COMPLETED|Overall Study||29
476453|NCT01147744|1168321|P7|COMPLETED|Overall Study||78
476454|NCT01147744|1168322|P6|COMPLETED|Overall Study||83
476455|NCT01147744|1168323|P5|COMPLETED|Overall Study||76
476456|NCT01147744|1168324|P4|COMPLETED|Overall Study||82
476457|NCT01147744|1168325|P3|COMPLETED|Overall Study||82
476458|NCT01147744|1168326|P2|COMPLETED|Overall Study||76
476459|NCT01147744|1168327|P1|COMPLETED|Overall Study||71
476460|NCT01147744|1168321|P7|STARTED|Overall Study||97
476461|NCT01147744|1168322|P6|STARTED|Overall Study||103
476462|NCT01147744|1168323|P5|STARTED|Overall Study||101
476463|NCT01147744|1168324|P4|STARTED|Overall Study||100
476464|NCT01147744|1168325|P3|STARTED|Overall Study||100
476465|NCT01147744|1168326|P2|STARTED|Overall Study||99
476466|NCT01147744|1168327|P1|STARTED|Overall Study||100
476467|NCT01147653|1168422|P2|NOT COMPLETED|Year 2||3
476468|NCT01147653|1168423|P1|NOT COMPLETED|Year 2||2
476469|NCT01147653|1168422|P2|COMPLETED|Year 2||28
476470|NCT01147653|1168423|P1|COMPLETED|Year 2||30
476471|NCT01147653|1168422|P2|STARTED|Year 2||31
476472|NCT01147653|1168423|P1|STARTED|Year 2||32
476473|NCT01147653|1168422|P2|NOT COMPLETED|Year 1||0
476474|NCT01147653|1168423|P1|NOT COMPLETED|Year 1||0
476475|NCT01147653|1168422|P2|COMPLETED|Year 1||31
476476|NCT01147653|1168423|P1|COMPLETED|Year 1||32
476477|NCT01147653|1168422|P2|STARTED|Year 1||31
476478|NCT01147653|1168423|P1|STARTED|Year 1||32
476479|NCT01147640|1168484|P2|NOT COMPLETED|Overall Study||1
476480|NCT01147640|1168485|P1|NOT COMPLETED|Overall Study||5
476481|NCT01147640|1168484|P2|COMPLETED|Overall Study||38
476482|NCT01147640|1168485|P1|COMPLETED|Overall Study||78
476483|NCT01147640|1168484|P2|STARTED|Overall Study||39
476484|NCT01147640|1168485|P1|STARTED|Overall Study||83
476485|NCT01147627|1168496|P3|NOT COMPLETED|Overall Study||18
476486|NCT01147627|1168497|P2|NOT COMPLETED|Overall Study||24
476487|NCT01147627|1168498|P1|NOT COMPLETED|Overall Study||32
476488|NCT01147627|1168496|P3|COMPLETED|Overall Study||118
476489|NCT01147627|1168497|P2|COMPLETED|Overall Study||114
476490|NCT01147627|1168498|P1|COMPLETED|Overall Study||110
476491|NCT01147627|1168496|P3|STARTED|Overall Study||136
476492|NCT01147627|1168497|P2|STARTED|Overall Study||138
476493|NCT01147627|1168498|P1|STARTED|Overall Study||142
476494|NCT01147601|1168508|P2|NOT COMPLETED|Overall Study||0
476495|NCT01147601|1168509|P1|NOT COMPLETED|Overall Study||3
476496|NCT01147601|1168508|P2|COMPLETED|Overall Study||1
476497|NCT01147601|1168509|P1|COMPLETED|Overall Study||2
476498|NCT01147601|1168508|P2|STARTED|Overall Study||1
476499|NCT01147601|1168509|P1|STARTED|Overall Study||5
476500|NCT01147497|1168517|P2|NOT COMPLETED|Overall Study||0
476501|NCT01147497|1168518|P1|NOT COMPLETED|Overall Study||2
476502|NCT01147497|1168517|P2|COMPLETED|Overall Study||36
476503|NCT01147497|1168518|P1|COMPLETED|Overall Study||35
476504|NCT01147497|1168517|P2|STARTED|Overall Study||36
476505|NCT01147497|1168518|P1|STARTED|Overall Study||37
476506|NCT01147471|1168538|P2|NOT COMPLETED|6 Month Follow Up||2
476507|NCT01147471|1168539|P1|NOT COMPLETED|6 Month Follow Up||4
476508|NCT01147471|1168538|P2|COMPLETED|6 Month Follow Up||4
476509|NCT01147471|1168539|P1|COMPLETED|6 Month Follow Up||8
476510|NCT01147471|1168538|P2|STARTED|6 Month Follow Up||6
476511|NCT01147471|1168539|P1|STARTED|6 Month Follow Up||12
476512|NCT01147471|1168538|P2|NOT COMPLETED|3 Month Follow Up||2
476513|NCT01147471|1168539|P1|NOT COMPLETED|3 Month Follow Up||1
476514|NCT01147471|1168538|P2|COMPLETED|3 Month Follow Up||6
476515|NCT01147471|1168539|P1|COMPLETED|3 Month Follow Up||12
476516|NCT01147471|1168538|P2|STARTED|3 Month Follow Up||8
476517|NCT01147471|1168539|P1|STARTED|3 Month Follow Up||13
476518|NCT01147471|1168538|P2|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||3
476519|NCT01147471|1168539|P1|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||0
476520|NCT01147471|1168538|P2|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||8
476521|NCT01147471|1168539|P1|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||13
476522|NCT01147471|1168538|P2|STARTED|Post-discharge Follow Up (Approx 2 Wks)||11
476523|NCT01147471|1168539|P1|STARTED|Post-discharge Follow Up (Approx 2 Wks)||13
476524|NCT01147471|1168538|P2|NOT COMPLETED|Through Initial Hospital Discharge||0
476525|NCT01147471|1168539|P1|NOT COMPLETED|Through Initial Hospital Discharge||0
476526|NCT01147471|1168538|P2|COMPLETED|Through Initial Hospital Discharge||11
476527|NCT01147471|1168539|P1|COMPLETED|Through Initial Hospital Discharge||13
476528|NCT01147471|1168538|P2|STARTED|Through Initial Hospital Discharge||11
476529|NCT01147471|1168539|P1|STARTED|Through Initial Hospital Discharge||13
476530|NCT01147458|1168553|P4|NOT COMPLETED|Second Intervention||4
476531|NCT01147458|1168554|P3|NOT COMPLETED|Second Intervention||8
476532|NCT01147458|1168555|P2|NOT COMPLETED|Second Intervention||7
476533|NCT01147458|1168556|P1|NOT COMPLETED|Second Intervention||9
476534|NCT01147458|1168553|P4|COMPLETED|Second Intervention||30
476535|NCT01147458|1168554|P3|COMPLETED|Second Intervention||27
476536|NCT01147458|1168555|P2|COMPLETED|Second Intervention||24
476537|NCT01147458|1168556|P1|COMPLETED|Second Intervention||25
476538|NCT01147458|1168553|P4|STARTED|Second Intervention||34
476539|NCT01147458|1168554|P3|STARTED|Second Intervention||35
476540|NCT01147458|1168555|P2|STARTED|Second Intervention||31
476541|NCT01147458|1168556|P1|STARTED|Second Intervention||34
476542|NCT01147458|1168553|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
476543|NCT01147458|1168554|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
476544|NCT01147458|1168555|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
476545|NCT01147458|1168556|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
476546|NCT01147458|1168553|P4|COMPLETED|Washout Period of 2 Weeks||34
476547|NCT01147458|1168554|P3|COMPLETED|Washout Period of 2 Weeks||35
476548|NCT01147458|1168555|P2|COMPLETED|Washout Period of 2 Weeks||31
476549|NCT01147458|1168556|P1|COMPLETED|Washout Period of 2 Weeks||34
476550|NCT01147458|1168553|P4|STARTED|Washout Period of 2 Weeks||34
476551|NCT01147458|1168554|P3|STARTED|Washout Period of 2 Weeks||35
476552|NCT01147458|1168555|P2|STARTED|Washout Period of 2 Weeks||31
476553|NCT01147458|1168556|P1|STARTED|Washout Period of 2 Weeks||34
476554|NCT01147458|1168553|P4|NOT COMPLETED|First Intervention||14
476555|NCT01147458|1168554|P3|NOT COMPLETED|First Intervention||12
476556|NCT01147458|1168555|P2|NOT COMPLETED|First Intervention||16
476557|NCT01147458|1168556|P1|NOT COMPLETED|First Intervention||14
476558|NCT01147458|1168553|P4|COMPLETED|First Intervention||34
476559|NCT01147458|1168554|P3|COMPLETED|First Intervention||35
476560|NCT01147458|1168555|P2|COMPLETED|First Intervention||31
476561|NCT01147458|1168556|P1|COMPLETED|First Intervention||34
476562|NCT01147458|1168553|P4|STARTED|First Intervention||48
476563|NCT01147458|1168554|P3|STARTED|First Intervention||47
476564|NCT01147458|1168555|P2|STARTED|First Intervention||47
476565|NCT01147458|1168556|P1|STARTED|First Intervention||48
476566|NCT01147406|1168610|P6|NOT COMPLETED|Overall Study||0
476567|NCT01147406|1168611|P5|NOT COMPLETED|Overall Study||0
476568|NCT01147406|1168612|P4|NOT COMPLETED|Overall Study||0
476569|NCT01147406|1168613|P3|NOT COMPLETED|Overall Study||0
476570|NCT01147406|1168614|P2|NOT COMPLETED|Overall Study||0
476571|NCT01147406|1168615|P1|NOT COMPLETED|Overall Study||0
476572|NCT01147406|1168610|P6|COMPLETED|Overall Study||10
476573|NCT01147406|1168611|P5|COMPLETED|Overall Study||6
476574|NCT01147406|1168612|P4|COMPLETED|Overall Study||6
476575|NCT01147406|1168613|P3|COMPLETED|Overall Study||1
476576|NCT01147406|1168614|P2|COMPLETED|Overall Study||12
476577|NCT01147406|1168615|P1|COMPLETED|Overall Study||6
476578|NCT01147406|1168610|P6|STARTED|Overall Study||10
476579|NCT01147406|1168611|P5|STARTED|Overall Study||6
476580|NCT01147406|1168612|P4|STARTED|Overall Study||6
476581|NCT01147406|1168613|P3|STARTED|Overall Study||1
476582|NCT01147406|1168614|P2|STARTED|Overall Study||12
476583|NCT01147406|1168615|P1|STARTED|Overall Study||6
476584|NCT01147393|1168635|P1|NOT COMPLETED|Dose Level -1||1
476585|NCT01147393|1168635|P1|COMPLETED|Dose Level -1||0
476586|NCT01147393|1168635|P1|STARTED|Dose Level -1||1
476587|NCT01147393|1168635|P1|NOT COMPLETED|Dose Level 1||2
476588|NCT01147393|1168635|P1|COMPLETED|Dose Level 1||1
476589|NCT01147393|1168635|P1|STARTED|Dose Level 1||3
476590|NCT01147380|1168645|P2|NOT COMPLETED|Overall Study||0
476591|NCT01147380|1168646|P1|NOT COMPLETED|Overall Study||0
476592|NCT01147380|1168645|P2|COMPLETED|Overall Study||12
476593|NCT01147380|1168646|P1|COMPLETED|Overall Study||6
476594|NCT01147380|1168645|P2|STARTED|Overall Study||12
476595|NCT01147380|1168646|P1|STARTED|Overall Study||6
476596|NCT01147341|1168656|P2|NOT COMPLETED|Open Label Period||0
476597|NCT01147341|1168657|P1|NOT COMPLETED|Open Label Period||4
476598|NCT01147341|1168656|P2|COMPLETED|Open Label Period||8
476599|NCT01147341|1168657|P1|COMPLETED|Open Label Period||22
476600|NCT01147341|1168656|P2|STARTED|Open Label Period||8
476601|NCT01147341|1168657|P1|STARTED|Open Label Period||26
476602|NCT01147341|1168656|P2|NOT COMPLETED|Double Blind Period||2
476603|NCT01147341|1168657|P1|NOT COMPLETED|Double Blind Period||1
476604|NCT01147341|1168656|P2|COMPLETED|Double Blind Period||8
476605|NCT01147341|1168657|P1|COMPLETED|Double Blind Period||26
476606|NCT01147341|1168656|P2|STARTED|Double Blind Period||10
476607|NCT01147341|1168657|P1|STARTED|Double Blind Period||27
476608|NCT01147302|1168687|P2|NOT COMPLETED|Overall Study||0
476609|NCT01147302|1168688|P1|NOT COMPLETED|Overall Study||0
476610|NCT01147302|1168687|P2|COMPLETED|Overall Study||9
476611|NCT01147302|1168688|P1|COMPLETED|Overall Study||9
476612|NCT01147302|1168687|P2|STARTED|Overall Study||9
476613|NCT01147302|1168688|P1|STARTED|Overall Study||9
476614|NCT01147250|1168720|P2|NOT COMPLETED|Overall Study||105
476615|NCT01147250|1168721|P1|NOT COMPLETED|Overall Study||110
476616|NCT01147250|1168720|P2|COMPLETED|Overall Study||2929
476617|NCT01147250|1168721|P1|COMPLETED|Overall Study||2924
476618|NCT01147250|1168720|P2|Treated|Overall Study||3031
476619|NCT01147250|1168721|P1|Treated|Overall Study||3032
476620|NCT01147250|1168720|P2|STARTED|Overall Study||3034
476621|NCT01147250|1168721|P1|STARTED|Overall Study||3034
476622|NCT01147172|1168733|P1|NOT COMPLETED|Overall Study||4
476623|NCT01147172|1168733|P1|COMPLETED|Overall Study||96
476624|NCT01147172|1168733|P1|STARTED|Overall Study||100
476625|NCT01147068|1168751|P7|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
476626|NCT01147068|1168752|P6|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
476627|NCT01147068|1168753|P5|NOT COMPLETED|Subjects That Completed Safety Follow-up||0
476628|NCT01147068|1168754|P4|NOT COMPLETED|Subjects That Completed Safety Follow-up||2
476629|NCT01147068|1168755|P3|NOT COMPLETED|Subjects That Completed Safety Follow-up||0
476630|NCT01147068|1168756|P2|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
476631|NCT01147068|1168757|P1|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
476632|NCT01147068|1168751|P7|COMPLETED|Subjects That Completed Safety Follow-up||54
476633|NCT01147068|1168752|P6|COMPLETED|Subjects That Completed Safety Follow-up||52
476634|NCT01147068|1168753|P5|COMPLETED|Subjects That Completed Safety Follow-up||56
476635|NCT01147068|1168754|P4|COMPLETED|Subjects That Completed Safety Follow-up||54
476636|NCT01147068|1168755|P3|COMPLETED|Subjects That Completed Safety Follow-up||55
476637|NCT01147068|1168756|P2|COMPLETED|Subjects That Completed Safety Follow-up||56
476638|NCT01147068|1168757|P1|COMPLETED|Subjects That Completed Safety Follow-up||59
476639|NCT01147068|1168751|P7|STARTED|Subjects That Completed Safety Follow-up||55
476640|NCT01147068|1168752|P6|STARTED|Subjects That Completed Safety Follow-up|One subject was lost to follow up and one subject did not complete the study.|53
476641|NCT01147068|1168753|P5|STARTED|Subjects That Completed Safety Follow-up|Data for one subject is unknown.|56
476642|NCT01147068|1168754|P4|STARTED|Subjects That Completed Safety Follow-up||56
476643|NCT01147068|1168755|P3|STARTED|Subjects That Completed Safety Follow-up|Data on three subjects is unknown.|55
476644|NCT01147068|1168756|P2|STARTED|Subjects That Completed Safety Follow-up|One subject was ineligible, one subject did not complete the study, and the other data is unknown.|57
476645|NCT01147068|1168757|P1|STARTED|Subjects That Completed Safety Follow-up|Participants were eligible for follow-up regardless of number of doses received.|60
476646|NCT01147068|1168751|P7|NOT COMPLETED|Subjects That Received 2nd Dose||0
476647|NCT01147068|1168752|P6|NOT COMPLETED|Subjects That Received 2nd Dose||2
476648|NCT01147068|1168753|P5|NOT COMPLETED|Subjects That Received 2nd Dose||1
476649|NCT01147068|1168754|P4|NOT COMPLETED|Subjects That Received 2nd Dose||0
476650|NCT01147068|1168755|P3|NOT COMPLETED|Subjects That Received 2nd Dose||3
476651|NCT01147068|1168756|P2|NOT COMPLETED|Subjects That Received 2nd Dose||5
476652|NCT01147068|1168757|P1|NOT COMPLETED|Subjects That Received 2nd Dose||1
476653|NCT01147068|1168751|P7|COMPLETED|Subjects That Received 2nd Dose||55
476654|NCT01147068|1168752|P6|COMPLETED|Subjects That Received 2nd Dose||51
476655|NCT01147068|1168753|P5|COMPLETED|Subjects That Received 2nd Dose||55
476656|NCT01147068|1168754|P4|COMPLETED|Subjects That Received 2nd Dose||56
476657|NCT01147068|1168755|P3|COMPLETED|Subjects That Received 2nd Dose||52
476658|NCT01147068|1168756|P2|COMPLETED|Subjects That Received 2nd Dose||52
476659|NCT01147068|1168757|P1|COMPLETED|Subjects That Received 2nd Dose||59
476660|NCT01147068|1168751|P7|STARTED|Subjects That Received 2nd Dose||55
476661|NCT01147068|1168752|P6|STARTED|Subjects That Received 2nd Dose||53
476662|NCT01147068|1168753|P5|STARTED|Subjects That Received 2nd Dose||56
476663|NCT01147068|1168754|P4|STARTED|Subjects That Received 2nd Dose||56
476664|NCT01147068|1168755|P3|STARTED|Subjects That Received 2nd Dose||55
476665|NCT01147068|1168756|P2|STARTED|Subjects That Received 2nd Dose||57
476666|NCT01147068|1168757|P1|STARTED|Subjects That Received 2nd Dose||60
476667|NCT01147068|1168751|P7|NOT COMPLETED|Subjects That Received 1st Dose||0
476668|NCT01147068|1168752|P6|NOT COMPLETED|Subjects That Received 1st Dose||0
476669|NCT01147068|1168753|P5|NOT COMPLETED|Subjects That Received 1st Dose||0
476670|NCT01147068|1168754|P4|NOT COMPLETED|Subjects That Received 1st Dose||0
476671|NCT01147068|1168755|P3|NOT COMPLETED|Subjects That Received 1st Dose||0
476672|NCT01147068|1168756|P2|NOT COMPLETED|Subjects That Received 1st Dose||0
476673|NCT01147068|1168757|P1|NOT COMPLETED|Subjects That Received 1st Dose||0
476674|NCT01147068|1168751|P7|COMPLETED|Subjects That Received 1st Dose||55
476675|NCT01147068|1168752|P6|COMPLETED|Subjects That Received 1st Dose||53
476676|NCT01147068|1168753|P5|COMPLETED|Subjects That Received 1st Dose||56
476677|NCT01147068|1168754|P4|COMPLETED|Subjects That Received 1st Dose||56
476678|NCT01147068|1168755|P3|COMPLETED|Subjects That Received 1st Dose||55
476679|NCT01147068|1168756|P2|COMPLETED|Subjects That Received 1st Dose||57
476680|NCT01147068|1168757|P1|COMPLETED|Subjects That Received 1st Dose||60
476681|NCT01147068|1168751|P7|STARTED|Subjects That Received 1st Dose||55
476682|NCT01147068|1168752|P6|STARTED|Subjects That Received 1st Dose||53
476683|NCT01147068|1168753|P5|STARTED|Subjects That Received 1st Dose||56
476684|NCT01147068|1168754|P4|STARTED|Subjects That Received 1st Dose||56
476685|NCT01147068|1168755|P3|STARTED|Subjects That Received 1st Dose||55
476686|NCT01147068|1168756|P2|STARTED|Subjects That Received 1st Dose||57
476687|NCT01147068|1168757|P1|STARTED|Subjects That Received 1st Dose||60
476688|NCT01147055|1168787|P2|NOT COMPLETED|Second Intervention Period||0
476689|NCT01147055|1168788|P1|NOT COMPLETED|Second Intervention Period||0
476690|NCT01147055|1168787|P2|COMPLETED|Second Intervention Period||14
476691|NCT01147055|1168788|P1|COMPLETED|Second Intervention Period||0
476692|NCT01147055|1168787|P2|STARTED|Second Intervention Period||14
476693|NCT01147055|1168788|P1|STARTED|Second Intervention Period||0
476694|NCT01147055|1168787|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
476695|NCT01147055|1168788|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
476696|NCT01147055|1168787|P2|COMPLETED|Washout Period (at Least 14 Days)||0
476697|NCT01147055|1168788|P1|COMPLETED|Washout Period (at Least 14 Days)||14
476698|NCT01147055|1168787|P2|STARTED|Washout Period (at Least 14 Days)||0
476699|NCT01147055|1168788|P1|STARTED|Washout Period (at Least 14 Days)||14
476700|NCT01147055|1168787|P2|NOT COMPLETED|First Intervention Period||0
476701|NCT01147055|1168788|P1|NOT COMPLETED|First Intervention Period||1
476702|NCT01147055|1168787|P2|COMPLETED|First Intervention Period||0
476703|NCT01147055|1168788|P1|COMPLETED|First Intervention Period||14
476704|NCT01147055|1168787|P2|STARTED|First Intervention Period||0
476705|NCT01147055|1168788|P1|STARTED|First Intervention Period||15
476706|NCT01147042|1168822|P2|NOT COMPLETED|Overall Study||0
476707|NCT01147042|1168823|P1|NOT COMPLETED|Overall Study||0
476708|NCT01147042|1168822|P2|COMPLETED|Overall Study||0
476709|NCT01147042|1168823|P1|COMPLETED|Overall Study||2
476710|NCT01147042|1168822|P2|STARTED|Overall Study||0
476711|NCT01147042|1168823|P1|STARTED|Overall Study||2
476712|NCT01146951|1168830|P2|NOT COMPLETED|Overall Study||1
476713|NCT01146951|1168831|P1|NOT COMPLETED|Overall Study||4
476714|NCT01146951|1168830|P2|COMPLETED|Overall Study||29
476715|NCT01146951|1168831|P1|COMPLETED|Overall Study||25
476716|NCT01146951|1168830|P2|STARTED|Overall Study||30
476717|NCT01146951|1168831|P1|STARTED|Overall Study||29
476718|NCT01146912|1168852|P8|NOT COMPLETED|Overall Study||0
476719|NCT01146912|1168853|P7|NOT COMPLETED|Overall Study||56
476720|NCT01146912|1168854|P6|NOT COMPLETED|Overall Study||61
476721|NCT01146912|1168855|P5|NOT COMPLETED|Overall Study||41
476722|NCT01146912|1168856|P4|NOT COMPLETED|Overall Study||17
476723|NCT01146912|1168857|P3|NOT COMPLETED|Overall Study||17
476724|NCT01146912|1168858|P2|NOT COMPLETED|Overall Study||822
476725|NCT01146912|1168859|P1|NOT COMPLETED|Overall Study||817
476726|NCT01146912|1168852|P8|COMPLETED|Overall Study|Parents are considered subjects but outcomes are on child level|14675
476727|NCT01146912|1168853|P7|COMPLETED|Overall Study||1764
476728|NCT01146912|1168854|P6|COMPLETED|Overall Study||1760
476729|NCT01146912|1168855|P5|COMPLETED|Overall Study||1780
476730|NCT01146912|1168856|P4|COMPLETED|Overall Study||577
476731|NCT01146912|1168857|P3|COMPLETED|Overall Study||576
476732|NCT01146912|1168858|P2|COMPLETED|Overall Study||3784
476733|NCT01146912|1168859|P1|COMPLETED|Overall Study||3790
476734|NCT01146912|1168852|P8|STARTED|Overall Study||14675
476735|NCT01146912|1168853|P7|STARTED|Overall Study||1820
476736|NCT01146912|1168854|P6|STARTED|Overall Study||1821
476737|NCT01146912|1168855|P5|STARTED|Overall Study||1821
476738|NCT01146912|1168856|P4|STARTED|Overall Study||594
476739|NCT01146912|1168857|P3|STARTED|Overall Study||593
476740|NCT01146912|1168858|P2|STARTED|Overall Study||4606
476741|NCT01146912|1168859|P1|STARTED|Overall Study||4607
476742|NCT01146873|1168881|P2|NOT COMPLETED|Overall Study||6
476743|NCT01146873|1168882|P1|NOT COMPLETED|Overall Study||0
476744|NCT01146873|1168881|P2|COMPLETED|Overall Study||144
476745|NCT01146873|1168882|P1|COMPLETED|Overall Study||148
476746|NCT01146873|1168881|P2|STARTED|Overall Study||150
476747|NCT01146873|1168882|P1|STARTED|Overall Study||148
476748|NCT01146860|1168898|P2|NOT COMPLETED|Overall Study||1
476749|NCT01146860|1168899|P1|NOT COMPLETED|Overall Study||0
476750|NCT01146860|1168898|P2|COMPLETED|Overall Study||191
476751|NCT01146860|1168899|P1|COMPLETED|Overall Study||194
476752|NCT01146860|1168898|P2|STARTED|Overall Study||192
476753|NCT01146860|1168899|P1|STARTED|Overall Study||194
476754|NCT01146808|1168913|P1|NOT COMPLETED|Overall Study||0
476755|NCT01146808|1168913|P1|COMPLETED|Overall Study||16
476756|NCT01146808|1168913|P1|STARTED|Overall Study||16
476757|NCT01146782|1168919|P1|NOT COMPLETED|Primary Endpoint Cohort||6
476758|NCT01146782|1168919|P1|COMPLETED|Primary Endpoint Cohort|57 Subjects in the Primary Endpoint Cohort completed the 28 day study|57
476759|NCT01146782|1168919|P1|STARTED|Primary Endpoint Cohort|63 Subjects in the Primary Endpoint Cohort|63
476760|NCT01146782|1168919|P1|NOT COMPLETED|Safety Cohort||83
476761|NCT01146782|1168919|P1|COMPLETED|Safety Cohort||63
476762|NCT01146782|1168919|P1|STARTED|Safety Cohort||146
476763|NCT01146782|1168919|P1|NOT COMPLETED|Screening Cohort||221
476764|NCT01146782|1168919|P1|COMPLETED|Screening Cohort||146
476765|NCT01146782|1168919|P1|STARTED|Screening Cohort||367
476766|NCT01146613|1168928|P2|NOT COMPLETED|Overall Study||12
476767|NCT01146613|1168929|P1|NOT COMPLETED|Overall Study||7
476768|NCT01146613|1168928|P2|COMPLETED|Overall Study||89
476769|NCT01146613|1168929|P1|COMPLETED|Overall Study||92
476770|NCT01146613|1168928|P2|STARTED|Overall Study||101
476771|NCT01146613|1168929|P1|STARTED|Overall Study||99
476772|NCT01146600|1168937|P2|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0
476773|NCT01146600|1168938|P1|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0
476774|NCT01146600|1168937|P2|COMPLETED|Period 2 (Weeks 4 & 5)||10
476775|NCT01146600|1168938|P1|COMPLETED|Period 2 (Weeks 4 & 5)||10
476776|NCT01146600|1168937|P2|STARTED|Period 2 (Weeks 4 & 5)||10
476777|NCT01146600|1168938|P1|STARTED|Period 2 (Weeks 4 & 5)||10
476778|NCT01146600|1168937|P2|NOT COMPLETED|Washout (Week 3)||0
476779|NCT01146600|1168938|P1|NOT COMPLETED|Washout (Week 3)||0
476780|NCT01146600|1168937|P2|COMPLETED|Washout (Week 3)||10
476781|NCT01146600|1168938|P1|COMPLETED|Washout (Week 3)||10
476782|NCT01146600|1168937|P2|STARTED|Washout (Week 3)||10
476783|NCT01146600|1168938|P1|STARTED|Washout (Week 3)||10
476784|NCT01146600|1168937|P2|NOT COMPLETED|Period 1 (Weeks 1 & 2)||0
476785|NCT01146600|1168938|P1|NOT COMPLETED|Period 1 (Weeks 1 & 2)||3
476786|NCT01146600|1168937|P2|COMPLETED|Period 1 (Weeks 1 & 2)||10
476787|NCT01146600|1168938|P1|COMPLETED|Period 1 (Weeks 1 & 2)||10
476788|NCT01146600|1168937|P2|STARTED|Period 1 (Weeks 1 & 2)||10
476789|NCT01146600|1168938|P1|STARTED|Period 1 (Weeks 1 & 2)||13
476790|NCT01146457|1168968|P5|NOT COMPLETED|Overall Study||0
476791|NCT01146457|1168969|P4|NOT COMPLETED|Overall Study||0
476792|NCT01146457|1168970|P3|NOT COMPLETED|Overall Study||1
476793|NCT01146457|1168971|P2|NOT COMPLETED|Overall Study||0
476794|NCT01146457|1168972|P1|NOT COMPLETED|Overall Study||0
476795|NCT01146457|1168968|P5|COMPLETED|Overall Study||13
476796|NCT01146457|1168969|P4|COMPLETED|Overall Study||13
476797|NCT01146457|1168970|P3|COMPLETED|Overall Study||20
476798|NCT01146457|1168971|P2|COMPLETED|Overall Study||17
476799|NCT01146457|1168972|P1|COMPLETED|Overall Study||19
476800|NCT01146457|1168968|P5|STARTED|Overall Study||13
476801|NCT01146457|1168969|P4|STARTED|Overall Study||13
476802|NCT01146457|1168970|P3|STARTED|Overall Study||21
476803|NCT01146457|1168971|P2|STARTED|Overall Study||17
476804|NCT01146457|1168972|P1|STARTED|Overall Study||19
476805|NCT01146418|1168986|P4|NOT COMPLETED|Live-Born Infant Follow Up||5
476806|NCT01146418|1168987|P3|NOT COMPLETED|Live-Born Infant Follow Up||6
476807|NCT01146418|1168988|P2|NOT COMPLETED|Live-Born Infant Follow Up||0
476808|NCT01146418|1168989|P1|NOT COMPLETED|Live-Born Infant Follow Up||0
476809|NCT01146418|1168986|P4|COMPLETED|Live-Born Infant Follow Up|Infants who completed follow up|51
476810|NCT01146418|1168987|P3|COMPLETED|Live-Born Infant Follow Up|Infants who completed follow up|55
476811|NCT01146418|1168988|P2|COMPLETED|Live-Born Infant Follow Up||0
476812|NCT01146418|1168989|P1|COMPLETED|Live-Born Infant Follow Up||0
476813|NCT01146418|1168986|P4|STARTED|Live-Born Infant Follow Up||56
476814|NCT01146418|1168987|P3|STARTED|Live-Born Infant Follow Up||61
476815|NCT01146418|1168988|P2|STARTED|Live-Born Infant Follow Up||0
476816|NCT01146418|1168989|P1|STARTED|Live-Born Infant Follow Up||0
476817|NCT01146418|1168986|P4|NOT COMPLETED|Women/Expectant Mother Follow Up||0
476818|NCT01146418|1168987|P3|NOT COMPLETED|Women/Expectant Mother Follow Up||0
476819|NCT01146418|1168988|P2|NOT COMPLETED|Women/Expectant Mother Follow Up||40
476820|NCT01146418|1168989|P1|NOT COMPLETED|Women/Expectant Mother Follow Up||44
476821|NCT01146418|1168986|P4|COMPLETED|Women/Expectant Mother Follow Up||0
476822|NCT01146418|1168987|P3|COMPLETED|Women/Expectant Mother Follow Up||0
476823|NCT01146418|1168988|P2|COMPLETED|Women/Expectant Mother Follow Up|Participants with ET transfer who completed follow-up study|110
476824|NCT01146418|1168989|P1|COMPLETED|Women/Expectant Mother Follow Up|Participants with ET transfer who completed follow-up study|113
476825|NCT01146418|1168986|P4|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0
476826|NCT01146418|1168987|P3|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0
476827|NCT01146418|1168988|P2|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up|Ongoing pregnancy defined as intra-uterine pregnancy with fetal heart beat on USS 10 weeks after ET|50
476828|NCT01146418|1168989|P1|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up|Ongoing pregnancy defined as intra-uterine pregnancy with fetal heart beat on USS 10 weeks after ET|52
476829|NCT01146418|1168986|P4|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0
476830|NCT01146418|1168987|P3|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0
476831|NCT01146418|1168988|P2|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||147
476832|NCT01146418|1168989|P1|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||151
476833|NCT01146418|1168986|P4|STARTED|Women/Expectant Mother Follow Up||0
476834|NCT01146418|1168987|P3|STARTED|Women/Expectant Mother Follow Up||0
476835|NCT01146418|1168988|P2|STARTED|Women/Expectant Mother Follow Up|Participants from base study P06029 with at least one embryo thawed for use in FTET cycle.|150
476836|NCT01146418|1168989|P1|STARTED|Women/Expectant Mother Follow Up|Participants from Base Study P06029 with at least one embryo thawed for use in FTET cycle.|157
476837|NCT01146418|1168986|P4|NOT COMPLETED|Base Study P06029 (NCT01144416)||0
476838|NCT01146418|1168987|P3|NOT COMPLETED|Base Study P06029 (NCT01144416)||0
476839|NCT01146418|1168988|P2|NOT COMPLETED|Base Study P06029 (NCT01144416)||49
476840|NCT01146418|1168989|P1|NOT COMPLETED|Base Study P06029 (NCT01144416)||62
476841|NCT01146418|1168986|P4|COMPLETED|Base Study P06029 (NCT01144416)||0
476842|NCT01146418|1168987|P3|COMPLETED|Base Study P06029 (NCT01144416)||0
476843|NCT01146418|1168988|P2|COMPLETED|Base Study P06029 (NCT01144416)|Participants who underwent ET in base study|647
476844|NCT01146418|1168989|P1|COMPLETED|Base Study P06029 (NCT01144416)|Participants who underwent ET in base study|632
476845|NCT01146418|1168986|P4|STARTED|Base Study P06029 (NCT01144416)||0
476846|NCT01146418|1168987|P3|STARTED|Base Study P06029 (NCT01144416)||0
476847|NCT01146418|1168988|P2|STARTED|Base Study P06029 (NCT01144416)||696
476848|NCT01146418|1168989|P1|STARTED|Base Study P06029 (NCT01144416)||694
476849|NCT01146379|1169005|P4|NOT COMPLETED|Overall Study||1
476850|NCT01146379|1169006|P3|NOT COMPLETED|Overall Study||0
476851|NCT01146379|1169007|P2|NOT COMPLETED|Overall Study||1
476852|NCT01146379|1169008|P1|NOT COMPLETED|Overall Study||1
476853|NCT01146379|1169005|P4|COMPLETED|Overall Study||20
476854|NCT01146379|1169006|P3|COMPLETED|Overall Study||21
476855|NCT01146379|1169007|P2|COMPLETED|Overall Study||21
476856|NCT01146379|1169008|P1|COMPLETED|Overall Study||20
476857|NCT01146379|1169005|P4|STARTED|Overall Study||21
476858|NCT01146379|1169006|P3|STARTED|Overall Study||21
476859|NCT01146379|1169007|P2|STARTED|Overall Study||22
476860|NCT01146379|1169008|P1|STARTED|Overall Study||21
476861|NCT01146288|1169020|P2|NOT COMPLETED|Second Intervention (1 Day)||0
476862|NCT01146288|1169021|P1|NOT COMPLETED|Second Intervention (1 Day)||0
476863|NCT01146288|1169020|P2|COMPLETED|Second Intervention (1 Day)||5
476864|NCT01146288|1169021|P1|COMPLETED|Second Intervention (1 Day)||7
476865|NCT01146288|1169020|P2|STARTED|Second Intervention (1 Day)||5
476866|NCT01146288|1169021|P1|STARTED|Second Intervention (1 Day)||7
476867|NCT01146288|1169020|P2|NOT COMPLETED|First Intervention(1 Day)||1
476868|NCT01146288|1169021|P1|NOT COMPLETED|First Intervention(1 Day)||0
476869|NCT01146288|1169020|P2|COMPLETED|First Intervention(1 Day)||5
476870|NCT01146288|1169021|P1|COMPLETED|First Intervention(1 Day)||7
476871|NCT01146288|1169020|P2|STARTED|First Intervention(1 Day)||6
476872|NCT01146288|1169021|P1|STARTED|First Intervention(1 Day)||7
476873|NCT01146275|1169030|P1|NOT COMPLETED|Overall Study||0
476874|NCT01146275|1169030|P1|COMPLETED|Overall Study||6
476875|NCT01146275|1169030|P1|STARTED|Overall Study||6
476876|NCT01146054|1169035|P1|NOT COMPLETED|Overall Study||10
476877|NCT01146054|1169035|P1|COMPLETED|Overall Study||49
476878|NCT01146054|1169035|P1|STARTED|Overall Study||59
476879|NCT01145898|1169045|P2|NOT COMPLETED|3-year Treatment||16
476880|NCT01145898|1169046|P1|NOT COMPLETED|3-year Treatment||3
476881|NCT01145898|1169045|P2|COMPLETED|3-year Treatment||28
476882|NCT01145898|1169046|P1|COMPLETED|3-year Treatment||9
476883|NCT01145898|1169045|P2|STARTED|3-year Treatment||44
476884|NCT01145898|1169046|P1|STARTED|3-year Treatment||12
476885|NCT01145898|1169045|P2|NOT COMPLETED|6-month Treatment||0
476886|NCT01145898|1169046|P1|NOT COMPLETED|6-month Treatment||0
476887|NCT01145898|1169045|P2|COMPLETED|6-month Treatment||44
476888|NCT01145898|1169046|P1|COMPLETED|6-month Treatment||12
476889|NCT01145898|1169045|P2|STARTED|6-month Treatment||44
476890|NCT01145898|1169046|P1|STARTED|6-month Treatment||12
476891|NCT01145755|1169080|P3|NOT COMPLETED|Overall Study||25
476892|NCT01145755|1169081|P2|NOT COMPLETED|Overall Study||28
476893|NCT01145755|1169082|P1|NOT COMPLETED|Overall Study||20
476894|NCT01145755|1169080|P3|COMPLETED|Overall Study||19
476895|NCT01145755|1169081|P2|COMPLETED|Overall Study||19
476896|NCT01145755|1169082|P1|COMPLETED|Overall Study||20
476897|NCT01145755|1169080|P3|STARTED|Overall Study||44
476898|NCT01145755|1169081|P2|STARTED|Overall Study||47
476899|NCT01145755|1169082|P1|STARTED|Overall Study||40
476900|NCT01145638|1169098|P2|NOT COMPLETED|Overall Study||57
476901|NCT01145638|1169099|P1|NOT COMPLETED|Overall Study||90
476902|NCT01145638|1169098|P2|COMPLETED|Overall Study||62
476903|NCT01145638|1169099|P1|COMPLETED|Overall Study||141
476904|NCT01145638|1169098|P2|STARTED|Overall Study||119
476905|NCT01145638|1169099|P1|STARTED|Overall Study||231
476906|NCT01145625|1169109|P2|NOT COMPLETED|Overall Study||31
476907|NCT01145625|1169110|P1|NOT COMPLETED|Overall Study||24
476908|NCT01145625|1169109|P2|COMPLETED|Overall Study||130
476909|NCT01145625|1169110|P1|COMPLETED|Overall Study||137
476910|NCT01145625|1169109|P2|STARTED|Overall Study||161
476911|NCT01145625|1169110|P1|STARTED|Overall Study||161
476912|NCT01145560|1169123|P3|NOT COMPLETED|Overall Study||2
476913|NCT01145560|1169124|P2|NOT COMPLETED|Overall Study||4
476914|NCT01145560|1169125|P1|NOT COMPLETED|Overall Study||4
476915|NCT01145560|1169123|P3|COMPLETED|Overall Study|27 patients died during the study. Death was not a reason for treatment or study discontinuation.|98
476916|NCT01145560|1169124|P2|COMPLETED|Overall Study|33 patients died during the study. Death was not a reason for treatment or study discontinuation.|96
476917|NCT01145560|1169125|P1|COMPLETED|Overall Study|20 patients died during the study. Death was not a reason for treatment or study discontinuation.|96
476918|NCT01145560|1169123|P3|Completed Treatment|Overall Study|7 patients died during the treatment period without completing the full course of treatment.|78
476919|NCT01145560|1169124|P2|Completed Treatment|Overall Study|8 patients died during the treatment period without completing the full course of treatment.|85
476920|NCT01145560|1169125|P1|Completed Treatment|Overall Study|9 patients died during the treatment period without completing the full course of treatment.|69
476921|NCT01145560|1169123|P3|Received Treatment|Overall Study||99
476922|NCT01145560|1169124|P2|Received Treatment|Overall Study||98
476923|NCT01145560|1169125|P1|Received Treatment|Overall Study||99
476924|NCT01145560|1169123|P3|STARTED|Overall Study||100
476925|NCT01145560|1169124|P2|STARTED|Overall Study||100
476926|NCT01145560|1169125|P1|STARTED|Overall Study||100
476927|NCT01145547|1169142|P2|NOT COMPLETED|Overall Study||0
476928|NCT01145547|1169143|P1|NOT COMPLETED|Overall Study||0
476929|NCT01145547|1169142|P2|COMPLETED|Overall Study||3
476930|NCT01145547|1169143|P1|COMPLETED|Overall Study||4
476931|NCT01145547|1169142|P2|STARTED|Overall Study||3
476932|NCT01145547|1169143|P1|STARTED|Overall Study||4
476933|NCT01145508|1169151|P2|NOT COMPLETED|Overall Study||2
476934|NCT01145508|1169152|P1|NOT COMPLETED|Overall Study||5
476935|NCT01145508|1169151|P2|COMPLETED|Overall Study||1
476936|NCT01145508|1169152|P1|COMPLETED|Overall Study||2
476937|NCT01145508|1169151|P2|Treated|Overall Study||2
476938|NCT01145508|1169152|P1|Treated|Overall Study||6
476939|NCT01145508|1169151|P2|STARTED|Overall Study||3
476940|NCT01145508|1169152|P1|STARTED|Overall Study||7
476941|NCT01145495|1169158|P1|NOT COMPLETED|Overall Study||12
476942|NCT01145495|1169158|P1|COMPLETED|Overall Study||51
476943|NCT01145495|1169158|P1|STARTED|Overall Study||63
476944|NCT01145482|1169164|P2|NOT COMPLETED|Second Intervention (1 Day)||0
476945|NCT01145482|1169165|P1|NOT COMPLETED|Second Intervention (1 Day)||0
476946|NCT01145482|1169164|P2|COMPLETED|Second Intervention (1 Day)||6
476947|NCT01145482|1169165|P1|COMPLETED|Second Intervention (1 Day)||5
476948|NCT01145482|1169164|P2|STARTED|Second Intervention (1 Day)||6
476949|NCT01145482|1169165|P1|STARTED|Second Intervention (1 Day)||5
476950|NCT01145482|1169164|P2|NOT COMPLETED|First Intervention (1 Day)||1
476951|NCT01145482|1169165|P1|NOT COMPLETED|First Intervention (1 Day)||0
476952|NCT01145482|1169164|P2|COMPLETED|First Intervention (1 Day)||5
476953|NCT01145482|1169165|P1|COMPLETED|First Intervention (1 Day)||6
476954|NCT01145482|1169164|P2|STARTED|First Intervention (1 Day)||6
476955|NCT01145482|1169165|P1|STARTED|First Intervention (1 Day)||6
476956|NCT01145417|1169175|P2|NOT COMPLETED|Overall Study||47
476957|NCT01145417|1169176|P1|NOT COMPLETED|Overall Study||41
476958|NCT01145417|1169175|P2|COMPLETED|Overall Study||62
476959|NCT01145417|1169176|P1|COMPLETED|Overall Study||67
476960|NCT01145417|1169175|P2|STARTED|Overall Study||109
476961|NCT01145417|1169176|P1|STARTED|Overall Study||108
476962|NCT01145391|1169200|P2|NOT COMPLETED|Overall Study||0
476963|NCT01145391|1169201|P1|NOT COMPLETED|Overall Study||0
476964|NCT01145391|1169200|P2|COMPLETED|Overall Study||298
476965|NCT01145391|1169201|P1|COMPLETED|Overall Study||293
476966|NCT01145391|1169200|P2|9 Months Post-randomization|Overall Study||298
476967|NCT01145391|1169201|P1|9 Months Post-randomization|Overall Study||293
476968|NCT01145391|1169200|P2|STARTED|Overall Study||298
476969|NCT01145391|1169201|P1|STARTED|Overall Study||293
476970|NCT01145352|1169209|P1|NOT COMPLETED|Overall Study||11
476971|NCT01145352|1169209|P1|COMPLETED|Overall Study||102
476972|NCT01145352|1169209|P1|STARTED|Overall Study||113
476973|NCT01145053|1169217|P1|NOT COMPLETED|Overall Study||93
476974|NCT01145053|1169217|P1|COMPLETED|Overall Study||248
476975|NCT01145053|1169217|P1|STARTED|Overall Study||341
476976|NCT01145001|1169231|P4|NOT COMPLETED|Overall Study||6
476977|NCT01145001|1169232|P3|NOT COMPLETED|Overall Study||5
476978|NCT01145001|1169233|P2|NOT COMPLETED|Overall Study||6
476979|NCT01145001|1169234|P1|NOT COMPLETED|Overall Study||8
476980|NCT01145001|1169231|P4|COMPLETED|Overall Study||31
476981|NCT01145001|1169232|P3|COMPLETED|Overall Study||39
476982|NCT01145001|1169233|P2|COMPLETED|Overall Study||31
476983|NCT01145001|1169234|P1|COMPLETED|Overall Study||28
476984|NCT01145001|1169231|P4|STARTED|Overall Study||37
476985|NCT01145001|1169232|P3|STARTED|Overall Study||44
476986|NCT01145001|1169233|P2|STARTED|Overall Study||37
476987|NCT01145001|1169234|P1|STARTED|Overall Study||36
476988|NCT01144949|1169250|P2|NOT COMPLETED|Overall Study||14
476989|NCT01144949|1169251|P1|NOT COMPLETED|Overall Study||11
476990|NCT01144949|1169250|P2|COMPLETED|Overall Study||106
476991|NCT01144949|1169251|P1|COMPLETED|Overall Study||108
476992|NCT01144949|1169250|P2|STARTED|Overall Study||120
476993|NCT01144949|1169251|P1|STARTED|Overall Study||119
476994|NCT01144715|1169269|P2|NOT COMPLETED|Overall Study||3
476995|NCT01144715|1169270|P1|NOT COMPLETED|Overall Study||4
476996|NCT01144715|1169269|P2|COMPLETED|Overall Study||45
476997|NCT01144715|1169270|P1|COMPLETED|Overall Study||47
476998|NCT01144715|1169269|P2|STARTED|Overall Study||48
476999|NCT01144715|1169270|P1|STARTED|Overall Study||51
477000|NCT01144624|1169285|P3|NOT COMPLETED|Overall Study||0
477001|NCT01144624|1169286|P2|NOT COMPLETED|Overall Study||0
477002|NCT01144624|1169287|P1|NOT COMPLETED|Overall Study||0
477003|NCT01144624|1169285|P3|COMPLETED|Overall Study|Two patients died during the study. Death was not a reason for treatment or study discontinuation.|6
477004|NCT01144624|1169286|P2|COMPLETED|Overall Study||7
477005|NCT01144624|1169287|P1|COMPLETED|Overall Study|One patient died during the study. Death was not a reason for treatment or study discontinuation.|7
477006|NCT01144624|1169285|P3|Completed Treatment|Overall Study|Two patients died during the dosing period. Death was not a reason for treatment discontinuation.|6
477007|NCT01144624|1169286|P2|Completed Treatment|Overall Study||7
477008|NCT01144624|1169287|P1|Completed Treatment|Overall Study|One patient died after completing the full course of study treatment.|7
477009|NCT01144624|1169285|P3|Received Treatment|Overall Study||6
477010|NCT01144624|1169286|P2|Received Treatment|Overall Study||7
477011|NCT01144624|1169287|P1|Received Treatment|Overall Study||7
477012|NCT01144624|1169285|P3|STARTED|Overall Study||6
477013|NCT01144624|1169286|P2|STARTED|Overall Study||7
477014|NCT01144624|1169287|P1|STARTED|Overall Study||7
477015|NCT01144598|1169301|P1|NOT COMPLETED|Overall Study||0
477016|NCT01144598|1169301|P1|COMPLETED|Overall Study||356
477017|NCT01144598|1169301|P1|Analysis Population|Overall Study||356
477018|NCT01144598|1169301|P1|STARTED|Overall Study||356
477019|NCT01144455|1169322|P3|NOT COMPLETED|Overall Study||36
477020|NCT01144455|1169323|P2|NOT COMPLETED|Overall Study||42
477021|NCT01144455|1169324|P1|NOT COMPLETED|Overall Study||50
477022|NCT01144455|1169322|P3|COMPLETED|Overall Study||38
477023|NCT01144455|1169323|P2|COMPLETED|Overall Study||29
477024|NCT01144455|1169324|P1|COMPLETED|Overall Study||19
477025|NCT01144455|1169322|P3|STARTED|Overall Study||74
477026|NCT01144455|1169323|P2|STARTED|Overall Study||71
477027|NCT01144455|1169324|P1|STARTED|Overall Study||69
477028|NCT01144442|1169332|P1|NOT COMPLETED|Overall Study||0
477029|NCT01144442|1169332|P1|COMPLETED|Overall Study||10
477030|NCT01144442|1169332|P1|STARTED|Overall Study||10
477031|NCT01144416|1169339|P2|NOT COMPLETED|Pregnancy Follow-up Period||10
477032|NCT01144416|1169340|P1|NOT COMPLETED|Pregnancy Follow-up Period||8
477033|NCT01144416|1169339|P2|COMPLETED|Pregnancy Follow-up Period||157
477034|NCT01144416|1169340|P1|COMPLETED|Pregnancy Follow-up Period||146
477035|NCT01144416|1169339|P2|STARTED|Pregnancy Follow-up Period|Participants received daily injections of 300 IU recFSH in Intervention Period and became pregnant.|167
477036|NCT01144416|1169340|P1|STARTED|Pregnancy Follow-up Period|Participants received 150 ug SCH 900962 in Intervention Period and became pregnant.|154
477037|NCT01144416|1169339|P2|NOT COMPLETED|Intervention Period||49
477038|NCT01144416|1169340|P1|NOT COMPLETED|Intervention Period||62
477039|NCT01144416|1169339|P2|COMPLETED|Intervention Period||647
477040|NCT01144416|1169340|P1|COMPLETED|Intervention Period||632
477041|NCT01144416|1169339|P2|STARTED|Intervention Period||696
477042|NCT01144416|1169340|P1|STARTED|Intervention Period||694
477043|NCT01144403|1169356|P1|NOT COMPLETED|Overall Study||5
477044|NCT01144403|1169356|P1|COMPLETED|Overall Study||3
477045|NCT01144403|1169356|P1|STARTED|Overall Study||8
477046|NCT01144377|1169368|P5|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||2
477047|NCT01144377|1169369|P4|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||0
477048|NCT01144377|1169370|P3|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||0
477049|NCT01144377|1169371|P2|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||1
477050|NCT01144377|1169372|P1|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||1
477051|NCT01144377|1169368|P5|COMPLETED|Optional 40 Week Safety Follow-up Period||21
477052|NCT01144377|1169369|P4|COMPLETED|Optional 40 Week Safety Follow-up Period||3
477053|NCT01144377|1169370|P3|COMPLETED|Optional 40 Week Safety Follow-up Period||23
477054|NCT01144377|1169371|P2|COMPLETED|Optional 40 Week Safety Follow-up Period||24
477055|NCT01144377|1169372|P1|COMPLETED|Optional 40 Week Safety Follow-up Period||21
477056|NCT01144377|1169368|P5|STARTED|Optional 40 Week Safety Follow-up Period||23
477057|NCT01144377|1169369|P4|STARTED|Optional 40 Week Safety Follow-up Period||3
477058|NCT01144377|1169370|P3|STARTED|Optional 40 Week Safety Follow-up Period||23
477059|NCT01144377|1169371|P2|STARTED|Optional 40 Week Safety Follow-up Period||25
477060|NCT01144377|1169372|P1|STARTED|Optional 40 Week Safety Follow-up Period||22
477061|NCT01144377|1169368|P5|NOT COMPLETED|12 Week Safety Follow-up Period||0
477062|NCT01144377|1169369|P4|NOT COMPLETED|12 Week Safety Follow-up Period||0
477063|NCT01144377|1169370|P3|NOT COMPLETED|12 Week Safety Follow-up Period||0
477064|NCT01144377|1169371|P2|NOT COMPLETED|12 Week Safety Follow-up Period||0
477065|NCT01144377|1169372|P1|NOT COMPLETED|12 Week Safety Follow-up Period||0
477066|NCT01144377|1169368|P5|COMPLETED|12 Week Safety Follow-up Period|Of the 34 participants who completed this Period, 23 continued to the Optional 40 Week follow-up.|34
477067|NCT01144377|1169369|P4|COMPLETED|12 Week Safety Follow-up Period|Of the 22 participants who completed this Period, 3 continued to the Optional 40 Week follow-up.|22
477068|NCT01144377|1169370|P3|COMPLETED|12 Week Safety Follow-up Period|Of the 25 participants who completed this Period, 23 continued to the Optional 40 Week follow-up.|25
477069|NCT01144377|1169371|P2|COMPLETED|12 Week Safety Follow-up Period|Of the 29 participants who completed this Period, 25 continued to the Optional 40 Week follow-up.|29
477070|NCT01144377|1169372|P1|COMPLETED|12 Week Safety Follow-up Period|Of the 26 participants who completed this Period, 22 continued to the Optional 40 Week follow-up.|26
477071|NCT01144377|1169368|P5|STARTED|12 Week Safety Follow-up Period||34
477072|NCT01144377|1169369|P4|STARTED|12 Week Safety Follow-up Period||22
477073|NCT01144377|1169370|P3|STARTED|12 Week Safety Follow-up Period||25
477074|NCT01144377|1169371|P2|STARTED|12 Week Safety Follow-up Period||29
477075|NCT01144377|1169372|P1|STARTED|12 Week Safety Follow-up Period||26
477076|NCT01144377|1169368|P5|NOT COMPLETED|52 Week Treatment Period||3
477077|NCT01144377|1169369|P4|NOT COMPLETED|52 Week Treatment Period||4
477078|NCT01144377|1169370|P3|NOT COMPLETED|52 Week Treatment Period||5
477079|NCT01144377|1169371|P2|NOT COMPLETED|52 Week Treatment Period||1
477080|NCT01144377|1169372|P1|NOT COMPLETED|52 Week Treatment Period||5
477081|NCT01144377|1169368|P5|COMPLETED|52 Week Treatment Period||34
477082|NCT01144377|1169369|P4|COMPLETED|52 Week Treatment Period||22
477083|NCT01144377|1169370|P3|COMPLETED|52 Week Treatment Period||25
477084|NCT01144377|1169371|P2|COMPLETED|52 Week Treatment Period||29
477085|NCT01144377|1169372|P1|COMPLETED|52 Week Treatment Period||26
477086|NCT01144377|1169368|P5|Received at Least One Dose of Study Drug|52 Week Treatment Period||37
477087|NCT01144377|1169369|P4|Received at Least One Dose of Study Drug|52 Week Treatment Period||25
477088|NCT01144377|1169370|P3|Received at Least One Dose of Study Drug|52 Week Treatment Period||30
477089|NCT01144377|1169371|P2|Received at Least One Dose of Study Drug|52 Week Treatment Period||30
477090|NCT01144377|1169372|P1|Received at Least One Dose of Study Drug|52 Week Treatment Period||31
477091|NCT01144377|1169368|P5|STARTED|52 Week Treatment Period||37
477092|NCT01144377|1169369|P4|STARTED|52 Week Treatment Period||26
477093|NCT01144377|1169370|P3|STARTED|52 Week Treatment Period||30
477094|NCT01144377|1169371|P2|STARTED|52 Week Treatment Period||30
477095|NCT01144377|1169372|P1|STARTED|52 Week Treatment Period||31
477096|NCT01144364|1169421|P3|NOT COMPLETED|Follow-Up/Maintenance Phase||41
477097|NCT01144364|1169422|P2|NOT COMPLETED|Follow-Up/Maintenance Phase||35
477098|NCT01144364|1169423|P1|NOT COMPLETED|Follow-Up/Maintenance Phase||0
477099|NCT01144364|1169421|P3|COMPLETED|Follow-Up/Maintenance Phase||60
477100|NCT01144364|1169422|P2|COMPLETED|Follow-Up/Maintenance Phase||66
477101|NCT01144364|1169423|P1|COMPLETED|Follow-Up/Maintenance Phase||0
477102|NCT01144364|1169421|P3|STARTED|Follow-Up/Maintenance Phase||101
477103|NCT01144364|1169422|P2|STARTED|Follow-Up/Maintenance Phase||101
477104|NCT01144364|1169423|P1|STARTED|Follow-Up/Maintenance Phase||0
477105|NCT01144364|1169421|P3|NOT COMPLETED|Induction Phase||0
477106|NCT01144364|1169422|P2|NOT COMPLETED|Induction Phase||0
477107|NCT01144364|1169423|P1|NOT COMPLETED|Induction Phase||32
477108|NCT01144364|1169421|P3|COMPLETED|Induction Phase||0
477109|NCT01144364|1169422|P2|COMPLETED|Induction Phase||0
477110|NCT01144364|1169423|P1|COMPLETED|Induction Phase||202
477111|NCT01144364|1169421|P3|STARTED|Induction Phase||0
477112|NCT01144364|1169422|P2|STARTED|Induction Phase||0
477113|NCT01144364|1169423|P1|STARTED|Induction Phase||234
477114|NCT01144299|1169449|P2|NOT COMPLETED|Overall Study||0
477115|NCT01144299|1169450|P1|NOT COMPLETED|Overall Study||2
477116|NCT01144299|1169449|P2|COMPLETED|Overall Study||54
477117|NCT01144299|1169450|P1|COMPLETED|Overall Study||58
477118|NCT01144299|1169449|P2|STARTED|Overall Study||54
477119|NCT01144299|1169450|P1|STARTED|Overall Study||60
477120|NCT01144286|1169476|P4|NOT COMPLETED|Overall Study||0
477121|NCT01144286|1169477|P3|NOT COMPLETED|Overall Study||0
477122|NCT01144286|1169478|P2|NOT COMPLETED|Overall Study||0
477123|NCT01144286|1169479|P1|NOT COMPLETED|Overall Study||0
477124|NCT01144286|1169476|P4|COMPLETED|Overall Study||56
477125|NCT01144286|1169477|P3|COMPLETED|Overall Study||58
477126|NCT01144286|1169478|P2|COMPLETED|Overall Study||58
477127|NCT01144286|1169479|P1|COMPLETED|Overall Study||57
477128|NCT01144286|1169476|P4|STARTED|Overall Study||56
477129|NCT01144286|1169477|P3|STARTED|Overall Study||58
477130|NCT01144286|1169478|P2|STARTED|Overall Study||58
477131|NCT01144286|1169479|P1|STARTED|Overall Study||57
477132|NCT01144182|1169495|P2|NOT COMPLETED|Overall Study||21
477133|NCT01144182|1169496|P1|NOT COMPLETED|Overall Study||17
477134|NCT01144182|1169495|P2|COMPLETED|Overall Study||47
477135|NCT01144182|1169496|P1|COMPLETED|Overall Study||51
477136|NCT01144182|1169495|P2|STARTED|Overall Study||68
477137|NCT01144182|1169496|P1|STARTED|Overall Study||68
477138|NCT01144143|1169529|P3|NOT COMPLETED|Overall Study||0
477139|NCT01144143|1169530|P2|NOT COMPLETED|Overall Study||0
477140|NCT01144143|1169531|P1|NOT COMPLETED|Overall Study||0
477141|NCT01144143|1169529|P3|COMPLETED|Overall Study||4
477142|NCT01144143|1169530|P2|COMPLETED|Overall Study||4
477143|NCT01144143|1169531|P1|COMPLETED|Overall Study||8
477144|NCT01144143|1169529|P3|STARTED|Overall Study||4
477145|NCT01144143|1169530|P2|STARTED|Overall Study||4
477146|NCT01144143|1169531|P1|STARTED|Overall Study||8
477147|NCT01144052|1169556|P2|NOT COMPLETED|Overall Study||1
477148|NCT01144052|1169557|P1|NOT COMPLETED|Overall Study||1
477149|NCT01144052|1169556|P2|COMPLETED|Overall Study||8
477150|NCT01144052|1169557|P1|COMPLETED|Overall Study||9
477151|NCT01144052|1169556|P2|STARTED|Overall Study||9
477152|NCT01144052|1169557|P1|STARTED|Overall Study||10
477153|NCT01144026|1169579|P2|NOT COMPLETED|Overall Study||0
477154|NCT01144026|1169580|P1|NOT COMPLETED|Overall Study||0
477155|NCT01144026|1169579|P2|COMPLETED|Overall Study||5
477156|NCT01144026|1169580|P1|COMPLETED|Overall Study||10
477157|NCT01144026|1169579|P2|STARTED|Overall Study||5
477158|NCT01144026|1169580|P1|STARTED|Overall Study||10
477159|NCT01143896|1169588|P2|NOT COMPLETED|Overall Study||25
477160|NCT01143896|1169589|P1|NOT COMPLETED|Overall Study||42
477161|NCT01143896|1169588|P2|COMPLETED|Overall Study||128
477162|NCT01143896|1169589|P1|COMPLETED|Overall Study||114
477163|NCT01143896|1169588|P2|STARTED|Overall Study||153
477164|NCT01143896|1169589|P1|STARTED|Overall Study||156
477165|NCT01143883|1169607|P2|NOT COMPLETED|Overall Study||0
477166|NCT01143883|1169608|P1|NOT COMPLETED|Overall Study||0
477167|NCT01143883|1169607|P2|COMPLETED|Overall Study||55
477168|NCT01143883|1169608|P1|COMPLETED|Overall Study||55
477169|NCT01143883|1169607|P2|STARTED|Overall Study||55
477170|NCT01143883|1169608|P1|STARTED|Overall Study||55
477171|NCT01143870|1169617|P3|NOT COMPLETED|Overall Study||0
477172|NCT01143870|1169618|P2|NOT COMPLETED|Overall Study||0
477173|NCT01143870|1169619|P1|NOT COMPLETED|Overall Study||0
477174|NCT01143870|1169617|P3|COMPLETED|Overall Study||61
477175|NCT01143870|1169618|P2|COMPLETED|Overall Study||58
477176|NCT01143870|1169619|P1|COMPLETED|Overall Study||58
477177|NCT01143870|1169617|P3|A1C Imputed|Overall Study||30
477178|NCT01143870|1169618|P2|A1C Imputed|Overall Study||29
477179|NCT01143870|1169619|P1|A1C Imputed|Overall Study||31
477180|NCT01143870|1169617|P3|Had Available 6-month A1C|Overall Study||31
477181|NCT01143870|1169618|P2|Had Available 6-month A1C|Overall Study||29
477182|NCT01143870|1169619|P1|Had Available 6-month A1C|Overall Study||27
477183|NCT01143870|1169617|P3|Post-intervention Survey|Overall Study||61
477184|NCT01143870|1169618|P2|Post-intervention Survey|Overall Study||50
477185|NCT01143870|1169619|P1|Post-intervention Survey|Overall Study||53
477186|NCT01143870|1169617|P3|STARTED|Overall Study||61
477187|NCT01143870|1169618|P2|STARTED|Overall Study||58
477188|NCT01143870|1169619|P1|STARTED|Overall Study||58
477189|NCT01143818|1169627|P1|NOT COMPLETED|Overall Study||250
477190|NCT01143818|1169627|P1|COMPLETED|Overall Study||799
477191|NCT01143818|1169627|P1|STARTED|Overall Study|A total of 1053 participants were enrolled but only 1049 received study drug.|1049
477192|NCT01143792|1169637|P3|NOT COMPLETED|Overall Study||0
477193|NCT01143792|1169638|P2|NOT COMPLETED|Overall Study||0
477194|NCT01143792|1169639|P1|NOT COMPLETED|Overall Study||0
477195|NCT01143792|1169637|P3|COMPLETED|Overall Study||91
477196|NCT01143792|1169638|P2|COMPLETED|Overall Study||86
477197|NCT01143792|1169639|P1|COMPLETED|Overall Study||93
477198|NCT01143792|1169637|P3|STARTED|Overall Study||91
477199|NCT01143792|1169638|P2|STARTED|Overall Study||86
477200|NCT01143792|1169639|P1|STARTED|Overall Study||93
477201|NCT01143766|1169673|P2|NOT COMPLETED|Overall Study||0
477202|NCT01143766|1169674|P1|NOT COMPLETED|Overall Study||0
477203|NCT01143766|1169673|P2|COMPLETED|Overall Study||31
477204|NCT01143766|1169674|P1|COMPLETED|Overall Study||25
477205|NCT01143766|1169673|P2|STARTED|Overall Study||31
477206|NCT01143766|1169674|P1|STARTED|Overall Study||25
477207|NCT01143727|1169690|P2|NOT COMPLETED|Overall Study||0
477208|NCT01143727|1169691|P1|NOT COMPLETED|Overall Study||0
477209|NCT01143727|1169690|P2|COMPLETED|Overall Study||8
477210|NCT01143727|1169691|P1|COMPLETED|Overall Study||9
477211|NCT01143727|1169690|P2|STARTED|Overall Study||8
477212|NCT01143727|1169691|P1|STARTED|Overall Study||9
477213|NCT01143714|1169701|P2|NOT COMPLETED|Overall Study||3
477214|NCT01143714|1169702|P1|NOT COMPLETED|Overall Study||7
477215|NCT01143714|1169701|P2|COMPLETED|Overall Study||25
477216|NCT01143714|1169702|P1|COMPLETED|Overall Study||22
477217|NCT01143714|1169701|P2|STARTED|Overall Study||28
477218|NCT01143714|1169702|P1|STARTED|Overall Study||29
477219|NCT01143701|1169712|P2|NOT COMPLETED|Overall Study||32
477220|NCT01143701|1169713|P1|NOT COMPLETED|Overall Study||23
477221|NCT01143701|1169712|P2|COMPLETED|Overall Study|Number of patients for whom at least one set of post-baseline parent-ratings were collected|287
477222|NCT01143701|1169713|P1|COMPLETED|Overall Study|Number of patients for whom at least one set of post-baseline parent-ratings were collected|235
477223|NCT01143701|1169712|P2|STARTED|Overall Study||319
477224|NCT01143701|1169713|P1|STARTED|Overall Study||258
477225|NCT01143688|1169721|P1|NOT COMPLETED|Overall Study||0
477226|NCT01143688|1169721|P1|COMPLETED|Overall Study||39
477227|NCT01143688|1169721|P1|STARTED|Overall Study||39
477228|NCT01143649|1169740|P6|NOT COMPLETED|Overall Study||2
477229|NCT01143649|1169741|P5|NOT COMPLETED|Overall Study||1
477230|NCT01143649|1169742|P4|NOT COMPLETED|Overall Study||0
477231|NCT01143649|1169743|P3|NOT COMPLETED|Overall Study||0
477232|NCT01143649|1169744|P2|NOT COMPLETED|Overall Study||0
477233|NCT01143649|1169745|P1|NOT COMPLETED|Overall Study||0
477234|NCT01143649|1169740|P6|COMPLETED|Overall Study||3
477235|NCT01143649|1169741|P5|COMPLETED|Overall Study||4
477236|NCT01143649|1169742|P4|COMPLETED|Overall Study||10
477237|NCT01143649|1169743|P3|COMPLETED|Overall Study||10
477238|NCT01143649|1169744|P2|COMPLETED|Overall Study||7
477239|NCT01143649|1169745|P1|COMPLETED|Overall Study||7
477240|NCT01143649|1169740|P6|STARTED|Overall Study||5
477241|NCT01143649|1169741|P5|STARTED|Overall Study||5
477242|NCT01143649|1169742|P4|STARTED|Overall Study||10
477243|NCT01143649|1169743|P3|STARTED|Overall Study||10
477244|NCT01143649|1169744|P2|STARTED|Overall Study||7
477245|NCT01143649|1169745|P1|STARTED|Overall Study||7
477246|NCT01143636|1169762|P4|NOT COMPLETED|Overall Study||0
477247|NCT01143636|1169763|P3|NOT COMPLETED|Overall Study||0
477248|NCT01143636|1169764|P2|NOT COMPLETED|Overall Study||1
477249|NCT01143636|1169765|P1|NOT COMPLETED|Overall Study||1
477250|NCT01143636|1169762|P4|COMPLETED|Overall Study||7
477251|NCT01143636|1169763|P3|COMPLETED|Overall Study||8
477252|NCT01143636|1169764|P2|COMPLETED|Overall Study||4
477253|NCT01143636|1169765|P1|COMPLETED|Overall Study||5
477254|NCT01143636|1169762|P4|STARTED|Overall Study||7
477255|NCT01143636|1169763|P3|STARTED|Overall Study||8
477256|NCT01143636|1169764|P2|STARTED|Overall Study||5
477257|NCT01143636|1169765|P1|STARTED|Overall Study||6
477258|NCT01143610|1169795|P2|NOT COMPLETED|Overall Study||0
477259|NCT01143610|1169796|P1|NOT COMPLETED|Overall Study||0
477260|NCT01143610|1169795|P2|COMPLETED|Overall Study||8
477261|NCT01143610|1169796|P1|COMPLETED|Overall Study||7
477262|NCT01143610|1169795|P2|STARTED|Overall Study||8
477263|NCT01143610|1169796|P1|STARTED|Overall Study||7
477264|NCT01143402|1169807|P3|NOT COMPLETED|Overall Study||1
477265|NCT01143402|1169808|P2|NOT COMPLETED|Overall Study||1
477266|NCT01143402|1169809|P1|NOT COMPLETED|Overall Study||1
477267|NCT01143402|1169807|P3|COMPLETED|Overall Study||18
477268|NCT01143402|1169808|P2|COMPLETED|Overall Study||49
477269|NCT01143402|1169809|P1|COMPLETED|Overall Study||50
477270|NCT01143402|1169807|P3|STARTED|Overall Study||19
477271|NCT01143402|1169808|P2|STARTED|Overall Study||50
477272|NCT01143402|1169809|P1|STARTED|Overall Study||51
477273|NCT01143389|1169820|P2|NOT COMPLETED|Overall Study||25
477274|NCT01143389|1169821|P1|NOT COMPLETED|Overall Study||26
477275|NCT01143389|1169820|P2|COMPLETED|Overall Study||232
477276|NCT01143389|1169821|P1|COMPLETED|Overall Study||227
477277|NCT01143389|1169820|P2|STARTED|Overall Study||257
477278|NCT01143389|1169821|P1|STARTED|Overall Study||253
477279|NCT01143337|1169835|P3|NOT COMPLETED|Overall Study||12
477280|NCT01143337|1169836|P2|NOT COMPLETED|Overall Study||11
477281|NCT01143337|1169837|P1|NOT COMPLETED|Overall Study||10
477282|NCT01143337|1169835|P3|COMPLETED|Overall Study|Frequency of this arm AE was higher than assumption before study initiation.|1
477283|NCT01143337|1169836|P2|COMPLETED|Overall Study||39
477284|NCT01143337|1169837|P1|COMPLETED|Overall Study||39
477285|NCT01143337|1169835|P3|STARTED|Overall Study||13
477286|NCT01143337|1169836|P2|STARTED|Overall Study||50
477287|NCT01143337|1169837|P1|STARTED|Overall Study||49
477288|NCT01143324|1169851|P1|NOT COMPLETED|Overall Study||19
477289|NCT01143324|1169851|P1|COMPLETED|Overall Study||233
477290|NCT01143324|1169851|P1|STARTED|Overall Study||252
477291|NCT01143272|1169869|P2|NOT COMPLETED|Overall Study||0
477292|NCT01143272|1169870|P1|NOT COMPLETED|Overall Study||0
477293|NCT01143272|1169869|P2|COMPLETED|Overall Study||231
477294|NCT01143272|1169870|P1|COMPLETED|Overall Study||246
477295|NCT01143272|1169869|P2|STARTED|Overall Study||231
477296|NCT01143272|1169870|P1|STARTED|Overall Study||246
477297|NCT01143259|1169890|P2|NOT COMPLETED|Overall Study||20
477298|NCT01143259|1169891|P1|NOT COMPLETED|Overall Study||23
477299|NCT01143259|1169890|P2|COMPLETED|Overall Study||118
477300|NCT01143259|1169891|P1|COMPLETED|Overall Study||113
477301|NCT01143259|1169890|P2|STARTED|Overall Study||138
477302|NCT01143259|1169891|P1|STARTED|Overall Study||136
477303|NCT01143207|1169899|P1|NOT COMPLETED|Overall Study||2
477304|NCT01143207|1169899|P1|COMPLETED|Overall Study||24
477305|NCT01143207|1169899|P1|STARTED|Overall Study||26
477306|NCT01143142|1169910|P2|NOT COMPLETED|Overall Study||0
477307|NCT01143142|1169911|P1|NOT COMPLETED|Overall Study||0
477308|NCT01143142|1169910|P2|COMPLETED|Overall Study||34
477309|NCT01143142|1169911|P1|COMPLETED|Overall Study||36
477310|NCT01143142|1169910|P2|STARTED|Overall Study||34
477311|NCT01143142|1169911|P1|STARTED|Overall Study||36
477312|NCT01143090|1169919|P1|NOT COMPLETED|Overall Study||51
477313|NCT01143090|1169919|P1|COMPLETED|Overall Study||98
477314|NCT01143090|1169919|P1|STARTED|Overall Study||149
477315|NCT01143077|1169926|P3|NOT COMPLETED|Overall Study||15
477316|NCT01143077|1169927|P2|NOT COMPLETED|Overall Study||15
477317|NCT01143077|1169928|P1|NOT COMPLETED|Overall Study||16
477318|NCT01143077|1169926|P3|COMPLETED|Overall Study||67
477319|NCT01143077|1169927|P2|COMPLETED|Overall Study||73
477320|NCT01143077|1169928|P1|COMPLETED|Overall Study||58
477321|NCT01143077|1169926|P3|STARTED|Overall Study||82
477322|NCT01143077|1169927|P2|STARTED|Overall Study||88
477323|NCT01143077|1169928|P1|STARTED|Overall Study||74
477324|NCT01143051|1169945|P6|NOT COMPLETED|Visit 3||0
477325|NCT01143051|1169946|P5|NOT COMPLETED|Visit 3||0
477326|NCT01143051|1169947|P4|NOT COMPLETED|Visit 3||0
477327|NCT01143051|1169948|P3|NOT COMPLETED|Visit 3||0
477328|NCT01143051|1169949|P2|NOT COMPLETED|Visit 3||0
477329|NCT01143051|1169950|P1|NOT COMPLETED|Visit 3||0
477330|NCT01143051|1169945|P6|COMPLETED|Visit 3||3
477331|NCT01143051|1169946|P5|COMPLETED|Visit 3||4
477332|NCT01143051|1169947|P4|COMPLETED|Visit 3||4
477333|NCT01143051|1169948|P3|COMPLETED|Visit 3||3
477334|NCT01143051|1169949|P2|COMPLETED|Visit 3||4
477335|NCT01143051|1169950|P1|COMPLETED|Visit 3||4
477336|NCT01143051|1169945|P6|STARTED|Visit 3||3
477337|NCT01143051|1169946|P5|STARTED|Visit 3||4
477338|NCT01143051|1169947|P4|STARTED|Visit 3||4
477339|NCT01143051|1169948|P3|STARTED|Visit 3||3
477340|NCT01143051|1169949|P2|STARTED|Visit 3||4
477341|NCT01143051|1169950|P1|STARTED|Visit 3||4
477342|NCT01143051|1169945|P6|NOT COMPLETED|3-14 Day Washout||1
477343|NCT01143051|1169946|P5|NOT COMPLETED|3-14 Day Washout||0
477344|NCT01143051|1169947|P4|NOT COMPLETED|3-14 Day Washout||0
477345|NCT01143051|1169948|P3|NOT COMPLETED|3-14 Day Washout||0
477346|NCT01143051|1169949|P2|NOT COMPLETED|3-14 Day Washout||0
477347|NCT01143051|1169950|P1|NOT COMPLETED|3-14 Day Washout||0
477348|NCT01143051|1169945|P6|COMPLETED|3-14 Day Washout||3
477349|NCT01143051|1169946|P5|COMPLETED|3-14 Day Washout||4
477350|NCT01143051|1169947|P4|COMPLETED|3-14 Day Washout||4
477351|NCT01143051|1169948|P3|COMPLETED|3-14 Day Washout||3
477352|NCT01143051|1169949|P2|COMPLETED|3-14 Day Washout||4
477353|NCT01143051|1169950|P1|COMPLETED|3-14 Day Washout||4
477354|NCT01143051|1169945|P6|STARTED|3-14 Day Washout||4
477355|NCT01143051|1169946|P5|STARTED|3-14 Day Washout||4
477356|NCT01143051|1169947|P4|STARTED|3-14 Day Washout||4
477357|NCT01143051|1169948|P3|STARTED|3-14 Day Washout||3
477358|NCT01143051|1169949|P2|STARTED|3-14 Day Washout||4
477359|NCT01143051|1169950|P1|STARTED|3-14 Day Washout||4
477360|NCT01143051|1169945|P6|NOT COMPLETED|Visit 2||0
477361|NCT01143051|1169946|P5|NOT COMPLETED|Visit 2||0
477362|NCT01143051|1169947|P4|NOT COMPLETED|Visit 2||0
477363|NCT01143051|1169948|P3|NOT COMPLETED|Visit 2||0
477364|NCT01143051|1169949|P2|NOT COMPLETED|Visit 2||0
477365|NCT01143051|1169950|P1|NOT COMPLETED|Visit 2||0
477366|NCT01143051|1169945|P6|COMPLETED|Visit 2||4
477367|NCT01143051|1169946|P5|COMPLETED|Visit 2||4
477368|NCT01143051|1169947|P4|COMPLETED|Visit 2||4
477369|NCT01143051|1169948|P3|COMPLETED|Visit 2||3
477370|NCT01143051|1169949|P2|COMPLETED|Visit 2||4
477371|NCT01143051|1169950|P1|COMPLETED|Visit 2||4
477372|NCT01143051|1169945|P6|STARTED|Visit 2||4
477373|NCT01143051|1169946|P5|STARTED|Visit 2||4
477374|NCT01143051|1169947|P4|STARTED|Visit 2||4
477375|NCT01143051|1169948|P3|STARTED|Visit 2||3
477376|NCT01143051|1169949|P2|STARTED|Visit 2||4
477377|NCT01143051|1169950|P1|STARTED|Visit 2||4
477378|NCT01143051|1169945|P6|NOT COMPLETED|3-14 Day Washout||0
477379|NCT01143051|1169946|P5|NOT COMPLETED|3-14 Day Washout||0
477380|NCT01143051|1169947|P4|NOT COMPLETED|3-14 Day Washout||0
477381|NCT01143051|1169948|P3|NOT COMPLETED|3-14 Day Washout||1
477382|NCT01143051|1169949|P2|NOT COMPLETED|3-14 Day Washout||0
477383|NCT01143051|1169950|P1|NOT COMPLETED|3-14 Day Washout||0
477384|NCT01143051|1169945|P6|COMPLETED|3-14 Day Washout||4
477385|NCT01143051|1169946|P5|COMPLETED|3-14 Day Washout||4
477386|NCT01143051|1169947|P4|COMPLETED|3-14 Day Washout||4
477387|NCT01143051|1169948|P3|COMPLETED|3-14 Day Washout||3
477388|NCT01143051|1169949|P2|COMPLETED|3-14 Day Washout||4
477389|NCT01143051|1169950|P1|COMPLETED|3-14 Day Washout||4
477390|NCT01143051|1169945|P6|STARTED|3-14 Day Washout||4
477391|NCT01143051|1169946|P5|STARTED|3-14 Day Washout||4
477392|NCT01143051|1169947|P4|STARTED|3-14 Day Washout||4
477393|NCT01143051|1169948|P3|STARTED|3-14 Day Washout||4
477394|NCT01143051|1169949|P2|STARTED|3-14 Day Washout||4
477395|NCT01143051|1169950|P1|STARTED|3-14 Day Washout||4
477396|NCT01143051|1169945|P6|NOT COMPLETED|Visit 1||0
477397|NCT01143051|1169946|P5|NOT COMPLETED|Visit 1||0
477398|NCT01143051|1169947|P4|NOT COMPLETED|Visit 1||0
477399|NCT01143051|1169948|P3|NOT COMPLETED|Visit 1||0
477400|NCT01143051|1169949|P2|NOT COMPLETED|Visit 1||0
477401|NCT01143051|1169950|P1|NOT COMPLETED|Visit 1||0
477402|NCT01143051|1169945|P6|COMPLETED|Visit 1||4
477403|NCT01143051|1169946|P5|COMPLETED|Visit 1||4
477404|NCT01143051|1169947|P4|COMPLETED|Visit 1||4
477405|NCT01143051|1169948|P3|COMPLETED|Visit 1||4
477406|NCT01143051|1169949|P2|COMPLETED|Visit 1||4
477407|NCT01143051|1169950|P1|COMPLETED|Visit 1||4
477408|NCT01143051|1169945|P6|STARTED|Visit 1||4
477409|NCT01143051|1169946|P5|STARTED|Visit 1||4
477410|NCT01143051|1169947|P4|STARTED|Visit 1||4
477411|NCT01143051|1169948|P3|STARTED|Visit 1||4
477412|NCT01143051|1169949|P2|STARTED|Visit 1||4
477413|NCT01143051|1169950|P1|STARTED|Visit 1||4
477414|NCT01143038|1169973|P1|NOT COMPLETED|Overall Study||16
477415|NCT01143038|1169973|P1|COMPLETED|Overall Study|Defined as completion of romiplostim treatment|59
477416|NCT01143038|1169973|P1|STARTED|Overall Study||75
477417|NCT01142908|1169983|P2|NOT COMPLETED|Overall Study||22
477418|NCT01142908|1169984|P1|NOT COMPLETED|Overall Study||32
477419|NCT01142908|1169983|P2|COMPLETED|Overall Study||191
477420|NCT01142908|1169984|P1|COMPLETED|Overall Study||183
477421|NCT01142908|1169983|P2|6 Month f/u|Overall Study||196
477422|NCT01142908|1169984|P1|6 Month f/u|Overall Study||188
477423|NCT01142908|1169983|P2|STARTED|Overall Study||213
477424|NCT01142908|1169984|P1|STARTED|Overall Study||215
477425|NCT01142726|1170033|P3|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||3
477426|NCT01142726|1170034|P2|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||2
477427|NCT01142726|1170035|P1|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||1
477428|NCT01142726|1170033|P3|COMPLETED|Re-Exposure Phase: Months 24 up to 30||40
477429|NCT01142726|1170034|P2|COMPLETED|Re-Exposure Phase: Months 24 up to 30||46
477430|NCT01142726|1170035|P1|COMPLETED|Re-Exposure Phase: Months 24 up to 30||54
477431|NCT01142726|1170033|P3|STARTED|Re-Exposure Phase: Months 24 up to 30||43
477432|NCT01142726|1170034|P2|STARTED|Re-Exposure Phase: Months 24 up to 30||48
477433|NCT01142726|1170035|P1|STARTED|Re-Exposure Phase: Months 24 up to 30||55
477434|NCT01142726|1170033|P3|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||58
477435|NCT01142726|1170034|P2|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||56
477436|NCT01142726|1170035|P1|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||70
477437|NCT01142726|1170033|P3|COMPLETED|Withdrawal Phase: Months 12 up to 24||17
477438|NCT01142726|1170034|P2|COMPLETED|Withdrawal Phase: Months 12 up to 24||10
477439|NCT01142726|1170035|P1|COMPLETED|Withdrawal Phase: Months 12 up to 24||14
477440|NCT01142726|1170033|P3|STARTED|Withdrawal Phase: Months 12 up to 24||75
477441|NCT01142726|1170034|P2|STARTED|Withdrawal Phase: Months 12 up to 24||66
477442|NCT01142726|1170035|P1|STARTED|Withdrawal Phase: Months 12 up to 24||84
477443|NCT01142726|1170033|P3|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||20
477444|NCT01142726|1170034|P2|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||25
477445|NCT01142726|1170035|P1|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||16
477446|NCT01142726|1170033|P3|COMPLETED|Treatment Phase: Day 1 Through Month 12||96
477447|NCT01142726|1170034|P2|COMPLETED|Treatment Phase: Day 1 Through Month 12||91
477448|NCT01142726|1170035|P1|COMPLETED|Treatment Phase: Day 1 Through Month 12||103
477449|NCT01142726|1170033|P3|STARTED|Treatment Phase: Day 1 Through Month 12||116
477450|NCT01142726|1170034|P2|STARTED|Treatment Phase: Day 1 Through Month 12||116
477451|NCT01142726|1170035|P1|STARTED|Treatment Phase: Day 1 Through Month 12||119
477452|NCT01142661|1170098|P1|NOT COMPLETED|Overall Study||4
477453|NCT01142661|1170098|P1|COMPLETED|Overall Study||5
477454|NCT01142661|1170098|P1|STARTED|Overall Study||9
477455|NCT01142596|1170105|P2|NOT COMPLETED|Overall Study||86
477456|NCT01142596|1170106|P1|NOT COMPLETED|Overall Study||29
477457|NCT01142596|1170105|P2|COMPLETED|Overall Study||71
477458|NCT01142596|1170106|P1|COMPLETED|Overall Study||15
477459|NCT01142596|1170105|P2|STARTED|Overall Study||157
477460|NCT01142596|1170106|P1|STARTED|Overall Study||44
477461|NCT01142466|1170158|P2|NOT COMPLETED|Overall Study||2
477462|NCT01142466|1170159|P1|NOT COMPLETED|Overall Study||3
477463|NCT01142466|1170158|P2|COMPLETED|Overall Study||13
477464|NCT01142466|1170159|P1|COMPLETED|Overall Study||12
477465|NCT01142466|1170158|P2|STARTED|Overall Study||15
477466|NCT01142466|1170159|P1|STARTED|Overall Study||15
477467|NCT01142388|1170179|P2|NOT COMPLETED|Overall Study||47
477468|NCT01142388|1170180|P1|NOT COMPLETED|Overall Study||47
477469|NCT01142388|1170179|P2|COMPLETED|Overall Study||0
477470|NCT01142388|1170180|P1|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.|0
477471|NCT01142388|1170179|P2|Treated|Overall Study||44
477472|NCT01142388|1170180|P1|Treated|Overall Study||40
477473|NCT01142388|1170179|P2|Eligible|Overall Study||44
477474|NCT01142388|1170180|P1|Eligible|Overall Study||43
477475|NCT01142388|1170179|P2|STARTED|Overall Study||47
477476|NCT01142388|1170180|P1|STARTED|Overall Study||47
477477|NCT01142336|1170192|P2|NOT COMPLETED|Overall Study||2
477478|NCT01142336|1170193|P1|NOT COMPLETED|Overall Study||1
477479|NCT01142336|1170192|P2|COMPLETED|Overall Study||21
477480|NCT01142336|1170193|P1|COMPLETED|Overall Study||25
477481|NCT01142336|1170192|P2|STARTED|Overall Study||23
477482|NCT01142336|1170193|P1|STARTED|Overall Study||26
477483|NCT01142323|1170203|P1|NOT COMPLETED|Overall Study||0
477484|NCT01142323|1170203|P1|COMPLETED|Overall Study||8
477485|NCT01142323|1170203|P1|STARTED|Overall Study||8
477486|NCT01142297|1170209|P1|NOT COMPLETED|Overall Study||6
477487|NCT01142297|1170209|P1|COMPLETED|Overall Study||18
477488|NCT01142297|1170209|P1|STARTED|Overall Study||24
477489|NCT01142193|1170218|P2|NOT COMPLETED|Overall Study||11
477490|NCT01142193|1170219|P1|NOT COMPLETED|Overall Study||21
477491|NCT01142193|1170218|P2|COMPLETED|Overall Study||114
477492|NCT01142193|1170219|P1|COMPLETED|Overall Study||103
477493|NCT01142193|1170218|P2|STARTED|Overall Study||125
477494|NCT01142193|1170219|P1|STARTED|Overall Study||124
477495|NCT01142128|1170247|P1|NOT COMPLETED|Overall Study||4
477496|NCT01142128|1170247|P1|COMPLETED|Overall Study||4
477497|NCT01142128|1170247|P1|Viokase 16 Plus Placebo to Nexium|Overall Study||0
477498|NCT01142128|1170247|P1|Viokase 16 Plus Nexium|Overall Study||2
477499|NCT01142128|1170247|P1|Placebo to Nexium, Alone|Overall Study||3
477500|NCT01142128|1170247|P1|Nexium Alone|Overall Study||3
477501|NCT01142128|1170247|P1|STARTED|Overall Study||8
477502|NCT01142115|1170257|P2|NOT COMPLETED|Second Intervention||0
477503|NCT01142115|1170258|P1|NOT COMPLETED|Second Intervention||0
477504|NCT01142115|1170257|P2|COMPLETED|Second Intervention||19
477505|NCT01142115|1170258|P1|COMPLETED|Second Intervention||19
477506|NCT01142115|1170257|P2|STARTED|Second Intervention||19
477507|NCT01142115|1170258|P1|STARTED|Second Intervention||19
477508|NCT01142115|1170257|P2|NOT COMPLETED|First Intervention||1
477509|NCT01142115|1170258|P1|NOT COMPLETED|First Intervention||2
477510|NCT01142115|1170257|P2|COMPLETED|First Intervention||19
477511|NCT01142115|1170258|P1|COMPLETED|First Intervention||19
477512|NCT01142115|1170257|P2|STARTED|First Intervention||20
477513|NCT01142115|1170258|P1|STARTED|First Intervention||21
477514|NCT01142089|1170275|P2|NOT COMPLETED|Overall Study||21
477515|NCT01142089|1170276|P1|NOT COMPLETED|Overall Study||12
477516|NCT01142089|1170275|P2|COMPLETED|Overall Study||178
477517|NCT01142089|1170276|P1|COMPLETED|Overall Study||53
477518|NCT01142089|1170275|P2|STARTED|Overall Study||199
477519|NCT01142089|1170276|P1|STARTED|Overall Study||65
477520|NCT01141725|1170284|P3|NOT COMPLETED|Overall Study||0
477521|NCT01141725|1170285|P2|NOT COMPLETED|Overall Study||0
477522|NCT01141725|1170286|P1|NOT COMPLETED|Overall Study||0
477523|NCT01141725|1170284|P3|COMPLETED|Overall Study||3
477524|NCT01141725|1170285|P2|COMPLETED|Overall Study||33
477525|NCT01141725|1170286|P1|COMPLETED|Overall Study||3
477526|NCT01141725|1170284|P3|STARTED|Overall Study||3
477527|NCT01141725|1170285|P2|STARTED|Overall Study||33
477528|NCT01141725|1170286|P1|STARTED|Overall Study||3
477529|NCT01141712|1170298|P1|NOT COMPLETED|Overall Study||3
477530|NCT01141712|1170298|P1|COMPLETED|Overall Study||40
477531|NCT01141712|1170298|P1|STARTED|Overall Study||43
477532|NCT01141660|1170319|P2|NOT COMPLETED|Overall Study||12
477533|NCT01141660|1170320|P1|NOT COMPLETED|Overall Study||0
477534|NCT01141660|1170319|P2|COMPLETED|Overall Study||48
477535|NCT01141660|1170320|P1|COMPLETED|Overall Study||71
477536|NCT01141660|1170319|P2|STARTED|Overall Study||60
477537|NCT01141660|1170320|P1|STARTED|Overall Study||71
477538|NCT01141647|1170328|P1|NOT COMPLETED|Overall Study||46
477539|NCT01141647|1170328|P1|COMPLETED|Overall Study||167
477540|NCT01141647|1170328|P1|STARTED|Overall Study||213
477541|NCT01141595|1170341|P1|NOT COMPLETED|Overall Study||2
477542|NCT01141595|1170341|P1|COMPLETED|Overall Study||8
477543|NCT01141595|1170341|P1|STARTED|Overall Study||10
477544|NCT01141569|1170345|P1|NOT COMPLETED|Overall Study||0
477545|NCT01141569|1170345|P1|COMPLETED|Overall Study||12
477546|NCT01141569|1170345|P1|STARTED|Overall Study||12
477547|NCT01141491|1170356|P2|NOT COMPLETED|Overall Study||47
477548|NCT01141491|1170357|P1|NOT COMPLETED|Overall Study||48
477549|NCT01141491|1170356|P2|COMPLETED|Overall Study||21
477550|NCT01141491|1170357|P1|COMPLETED|Overall Study||20
477551|NCT01141491|1170356|P2|STARTED|Overall Study||68
477552|NCT01141491|1170357|P1|STARTED|Overall Study||68
477553|NCT01141374|1170366|P3|NOT COMPLETED|Overall Study||0
477554|NCT01141374|1170367|P2|NOT COMPLETED|Overall Study||0
477555|NCT01141374|1170368|P1|NOT COMPLETED|Overall Study||0
477556|NCT01141374|1170366|P3|COMPLETED|Overall Study||22
477557|NCT01141374|1170367|P2|COMPLETED|Overall Study||27
477558|NCT01141374|1170368|P1|COMPLETED|Overall Study||26
477559|NCT01141374|1170366|P3|STARTED|Overall Study||22
477560|NCT01141374|1170367|P2|STARTED|Overall Study||27
477561|NCT01141374|1170368|P1|STARTED|Overall Study||26
477562|NCT01141283|1170379|P1|NOT COMPLETED|Overall Study||88
477563|NCT01141283|1170379|P1|COMPLETED|Overall Study||202
477564|NCT01141283|1170379|P1|STARTED|Overall Study||290
477565|NCT01141205|1170385|P2|NOT COMPLETED|Overall Study||2
477566|NCT01141205|1170386|P1|NOT COMPLETED|Overall Study||3
477567|NCT01141205|1170385|P2|COMPLETED|Overall Study||3
477568|NCT01141205|1170386|P1|COMPLETED|Overall Study||15
477569|NCT01141205|1170385|P2|STARTED|Overall Study||5
477570|NCT01141205|1170386|P1|STARTED|Overall Study||18
477571|NCT01140906|1170402|P4|NOT COMPLETED|Overall Study||16
477572|NCT01140906|1170403|P3|NOT COMPLETED|Overall Study||26
477573|NCT01140906|1170404|P2|NOT COMPLETED|Overall Study||34
477574|NCT01140906|1170405|P1|NOT COMPLETED|Overall Study||25
477575|NCT01140906|1170402|P4|COMPLETED|Overall Study||131
477576|NCT01140906|1170403|P3|COMPLETED|Overall Study||125
477577|NCT01140906|1170404|P2|COMPLETED|Overall Study||117
477578|NCT01140906|1170405|P1|COMPLETED|Overall Study||133
477579|NCT01140906|1170402|P4|STARTED|Overall Study||147
477580|NCT01140906|1170403|P3|STARTED|Overall Study||151
477581|NCT01140906|1170404|P2|STARTED|Overall Study||151
477582|NCT01140906|1170405|P1|STARTED|Overall Study||158
477583|NCT01140880|1170445|P2|NOT COMPLETED|Overall Study||44
477584|NCT01140880|1170446|P1|NOT COMPLETED|Overall Study||14
477585|NCT01140880|1170445|P2|COMPLETED|Overall Study||56
477586|NCT01140880|1170446|P1|COMPLETED|Overall Study||56
477587|NCT01140880|1170445|P2|STARTED|Overall Study||100
477588|NCT01140880|1170446|P1|STARTED|Overall Study||70
477589|NCT01140867|1170458|P1|NOT COMPLETED|Overall Study||33
477590|NCT01140867|1170458|P1|COMPLETED|Overall Study||88
477591|NCT01140867|1170458|P1|STARTED|Overall Study||121
477592|NCT01140815|1170467|P2|NOT COMPLETED|Overall Study||0
477593|NCT01140815|1170468|P1|NOT COMPLETED|Overall Study||0
477594|NCT01140815|1170467|P2|COMPLETED|Overall Study||25
477595|NCT01140815|1170468|P1|COMPLETED|Overall Study||25
477596|NCT01140815|1170467|P2|STARTED|Overall Study||25
477597|NCT01140815|1170468|P1|STARTED|Overall Study||25
477598|NCT01140646|1170498|P1|NOT COMPLETED|Overall Study||9
477599|NCT01140646|1170498|P1|COMPLETED|Overall Study||34
477600|NCT01140646|1170498|P1|STARTED|Overall Study||43
477601|NCT01140503|1170502|P1|NOT COMPLETED|Overall Study||1
477602|NCT01140503|1170502|P1|COMPLETED|Overall Study||4
477603|NCT01140503|1170502|P1|STARTED|Overall Study||5
477604|NCT01140477|1170510|P2|NOT COMPLETED|Overall Study||6
477605|NCT01140477|1170511|P1|NOT COMPLETED|Overall Study||8
477606|NCT01140477|1170510|P2|COMPLETED|Overall Study||70
477607|NCT01140477|1170511|P1|COMPLETED|Overall Study||145
477608|NCT01140477|1170510|P2|STARTED|Overall Study||76
477609|NCT01140477|1170511|P1|STARTED|Overall Study||153
477610|NCT01140360|1170520|P1|NOT COMPLETED|Overall Study||6
477611|NCT01140360|1170520|P1|COMPLETED|Overall Study||15
477612|NCT01140360|1170520|P1|STARTED|Overall Study||21
477613|NCT01140347|1170526|P2|NOT COMPLETED|Overall Study||14
477614|NCT01140347|1170527|P1|NOT COMPLETED|Overall Study||18
477615|NCT01140347|1170526|P2|COMPLETED|Overall Study||268
477616|NCT01140347|1170527|P1|COMPLETED|Overall Study||265
477617|NCT01140347|1170526|P2|Received at Least 1 Dose of Study Drug|Overall Study||276
477618|NCT01140347|1170527|P1|Received at Least 1 Dose of Study Drug|Overall Study||277
477619|NCT01140347|1170526|P2|STARTED|Overall Study||282
477620|NCT01140347|1170527|P1|STARTED|Overall Study||283
477621|NCT01140295|1170552|P2|NOT COMPLETED|Overall Study||2
477622|NCT01140295|1170553|P1|NOT COMPLETED|Overall Study||1
477623|NCT01140295|1170552|P2|COMPLETED|Overall Study||14
477624|NCT01140295|1170553|P1|COMPLETED|Overall Study||16
477625|NCT01140295|1170552|P2|STARTED|Overall Study||16
477626|NCT01140295|1170553|P1|STARTED|Overall Study||17
477627|NCT01140191|1170561|P1|NOT COMPLETED|Overall Study||0
477628|NCT01140191|1170561|P1|COMPLETED|Overall Study||1
477629|NCT01140191|1170561|P1|STARTED|Overall Study||1
477630|NCT01140061|1170580|P10|NOT COMPLETED|Extension||1
477631|NCT01140061|1170581|P9|NOT COMPLETED|Extension||0
477632|NCT01140061|1170582|P8|NOT COMPLETED|Extension||0
477633|NCT01140061|1170583|P7|NOT COMPLETED|Extension||0
477634|NCT01140061|1170584|P6|NOT COMPLETED|Extension||0
477635|NCT01140061|1170585|P5|NOT COMPLETED|Extension||0
477636|NCT01140061|1170586|P4|NOT COMPLETED|Extension||0
477637|NCT01140061|1170587|P3|NOT COMPLETED|Extension||0
477638|NCT01140061|1170588|P2|NOT COMPLETED|Extension||0
477639|NCT01140061|1170589|P1|NOT COMPLETED|Extension||0
477640|NCT01140061|1170580|P10|COMPLETED|Extension||1
477641|NCT01140061|1170581|P9|COMPLETED|Extension||7
477642|NCT01140061|1170582|P8|COMPLETED|Extension||0
477643|NCT01140061|1170583|P7|COMPLETED|Extension||0
477644|NCT01140061|1170584|P6|COMPLETED|Extension||0
477645|NCT01140061|1170585|P5|COMPLETED|Extension||0
477646|NCT01140061|1170586|P4|COMPLETED|Extension||0
477647|NCT01140061|1170587|P3|COMPLETED|Extension||0
477648|NCT01140061|1170588|P2|COMPLETED|Extension||0
477649|NCT01140061|1170589|P1|COMPLETED|Extension||0
477650|NCT01140061|1170580|P10|STARTED|Extension||2
477651|NCT01140061|1170581|P9|STARTED|Extension||7
477652|NCT01140061|1170582|P8|STARTED|Extension||0
477653|NCT01140061|1170583|P7|STARTED|Extension||0
477654|NCT01140061|1170584|P6|STARTED|Extension||0
477655|NCT01140061|1170585|P5|STARTED|Extension||0
477656|NCT01140061|1170586|P4|STARTED|Extension||0
477657|NCT01140061|1170587|P3|STARTED|Extension||0
477658|NCT01140061|1170588|P2|STARTED|Extension||0
477659|NCT01140061|1170589|P1|STARTED|Extension||0
477660|NCT01140061|1170580|P10|NOT COMPLETED|Part III||0
477661|NCT01140061|1170581|P9|NOT COMPLETED|Part III||0
477662|NCT01140061|1170582|P8|NOT COMPLETED|Part III||0
477663|NCT01140061|1170583|P7|NOT COMPLETED|Part III||0
477664|NCT01140061|1170584|P6|NOT COMPLETED|Part III||0
477665|NCT01140061|1170585|P5|NOT COMPLETED|Part III||0
477666|NCT01140061|1170586|P4|NOT COMPLETED|Part III||0
477667|NCT01140061|1170587|P3|NOT COMPLETED|Part III||0
477668|NCT01140061|1170588|P2|NOT COMPLETED|Part III||0
477669|NCT01140061|1170589|P1|NOT COMPLETED|Part III||0
477670|NCT01140061|1170580|P10|COMPLETED|Part III||2
477671|NCT01140061|1170581|P9|COMPLETED|Part III||7
477672|NCT01140061|1170582|P8|COMPLETED|Part III||0
477673|NCT01140061|1170583|P7|COMPLETED|Part III||0
477674|NCT01140061|1170584|P6|COMPLETED|Part III||0
477675|NCT01140061|1170585|P5|COMPLETED|Part III||0
477676|NCT01140061|1170586|P4|COMPLETED|Part III||0
477677|NCT01140061|1170587|P3|COMPLETED|Part III||0
477678|NCT01140061|1170588|P2|COMPLETED|Part III||0
477679|NCT01140061|1170589|P1|COMPLETED|Part III||0
477680|NCT01140061|1170580|P10|STARTED|Part III|Includes 1 replacement participant|2
477681|NCT01140061|1170581|P9|STARTED|Part III||7
477682|NCT01140061|1170582|P8|STARTED|Part III||0
477683|NCT01140061|1170583|P7|STARTED|Part III||0
477684|NCT01140061|1170584|P6|STARTED|Part III||0
477685|NCT01140061|1170585|P5|STARTED|Part III||0
477686|NCT01140061|1170586|P4|STARTED|Part III||0
477687|NCT01140061|1170587|P3|STARTED|Part III||0
477688|NCT01140061|1170588|P2|STARTED|Part III||0
477689|NCT01140061|1170589|P1|STARTED|Part III||0
477690|NCT01140061|1170580|P10|NOT COMPLETED|Part II||0
477691|NCT01140061|1170581|P9|NOT COMPLETED|Part II||0
477692|NCT01140061|1170582|P8|NOT COMPLETED|Part II||0
477693|NCT01140061|1170583|P7|NOT COMPLETED|Part II||0
477694|NCT01140061|1170584|P6|NOT COMPLETED|Part II||0
477695|NCT01140061|1170585|P5|NOT COMPLETED|Part II||0
477696|NCT01140061|1170586|P4|NOT COMPLETED|Part II||0
477697|NCT01140061|1170587|P3|NOT COMPLETED|Part II||0
477698|NCT01140061|1170588|P2|NOT COMPLETED|Part II||0
477699|NCT01140061|1170589|P1|NOT COMPLETED|Part II||0
477700|NCT01140061|1170580|P10|COMPLETED|Part II||0
477701|NCT01140061|1170581|P9|COMPLETED|Part II||0
477702|NCT01140061|1170582|P8|COMPLETED|Part II||2
477703|NCT01140061|1170583|P7|COMPLETED|Part II||6
477704|NCT01140061|1170584|P6|COMPLETED|Part II||2
477705|NCT01140061|1170585|P5|COMPLETED|Part II||6
477706|NCT01140061|1170586|P4|COMPLETED|Part II||2
477707|NCT01140061|1170587|P3|COMPLETED|Part II||6
477708|NCT01140061|1170588|P2|COMPLETED|Part II||0
477709|NCT01140061|1170589|P1|COMPLETED|Part II||0
477710|NCT01140061|1170580|P10|STARTED|Part II||0
477711|NCT01140061|1170581|P9|STARTED|Part II||0
477712|NCT01140061|1170582|P8|STARTED|Part II||2
477713|NCT01140061|1170583|P7|STARTED|Part II||6
477714|NCT01140061|1170584|P6|STARTED|Part II||2
477715|NCT01140061|1170585|P5|STARTED|Part II||6
477716|NCT01140061|1170586|P4|STARTED|Part II||2
477717|NCT01140061|1170587|P3|STARTED|Part II||6
477718|NCT01140061|1170588|P2|STARTED|Part II||0
477719|NCT01140061|1170589|P1|STARTED|Part II||0
477720|NCT01140061|1170580|P10|NOT COMPLETED|Part I||0
477721|NCT01140061|1170581|P9|NOT COMPLETED|Part I||0
477722|NCT01140061|1170582|P8|NOT COMPLETED|Part I||0
477723|NCT01140061|1170583|P7|NOT COMPLETED|Part I||0
477724|NCT01140061|1170584|P6|NOT COMPLETED|Part I||0
477725|NCT01140061|1170585|P5|NOT COMPLETED|Part I||0
477726|NCT01140061|1170586|P4|NOT COMPLETED|Part I||0
477727|NCT01140061|1170587|P3|NOT COMPLETED|Part I||0
477728|NCT01140061|1170588|P2|NOT COMPLETED|Part I||0
477729|NCT01140061|1170589|P1|NOT COMPLETED|Part I||1
477730|NCT01140061|1170580|P10|COMPLETED|Part I||0
477731|NCT01140061|1170581|P9|COMPLETED|Part I||0
477732|NCT01140061|1170582|P8|COMPLETED|Part I||0
477733|NCT01140061|1170583|P7|COMPLETED|Part I||0
477734|NCT01140061|1170584|P6|COMPLETED|Part I||0
477735|NCT01140061|1170585|P5|COMPLETED|Part I||0
477736|NCT01140061|1170586|P4|COMPLETED|Part I||0
477737|NCT01140061|1170587|P3|COMPLETED|Part I||0
477738|NCT01140061|1170588|P2|COMPLETED|Part I||2
477739|NCT01140061|1170589|P1|COMPLETED|Part I||6
477740|NCT01140061|1170580|P10|STARTED|Part I||0
477741|NCT01140061|1170581|P9|STARTED|Part I||0
477742|NCT01140061|1170582|P8|STARTED|Part I||0
477743|NCT01140061|1170583|P7|STARTED|Part I||0
477744|NCT01140061|1170584|P6|STARTED|Part I||0
477745|NCT01140061|1170585|P5|STARTED|Part I||0
477746|NCT01140061|1170586|P4|STARTED|Part I||0
477747|NCT01140061|1170587|P3|STARTED|Part I||0
477748|NCT01140061|1170588|P2|STARTED|Part I||2
477749|NCT01140061|1170589|P1|STARTED|Part I|Includes 1 replacement participant|7
477750|NCT01140048|1170616|P1|NOT COMPLETED|Overall Study||45
477751|NCT01140048|1170616|P1|COMPLETED|Overall Study||298
477752|NCT01140048|1170616|P1|STARTED|Overall Study||343
477753|NCT01139996|1170624|P2|NOT COMPLETED|Overall Study||0
477754|NCT01139996|1170625|P1|NOT COMPLETED|Overall Study||0
477755|NCT01139996|1170624|P2|COMPLETED|Overall Study||11
477756|NCT01139996|1170625|P1|COMPLETED|Overall Study||11
477757|NCT01139996|1170624|P2|STARTED|Overall Study||11
477758|NCT01139996|1170625|P1|STARTED|Overall Study||11
477759|NCT01139879|1170631|P1|NOT COMPLETED|Overall Study||0
477760|NCT01139879|1170631|P1|COMPLETED|Overall Study||10
477761|NCT01139879|1170631|P1|STARTED|Overall Study||10
477762|NCT01139814|1170637|P1|NOT COMPLETED|Overall Study||0
477763|NCT01139814|1170637|P1|COMPLETED|Overall Study||181
477764|NCT01139814|1170637|P1|STARTED|Overall Study||181
477765|NCT01139775|1170645|P3|NOT COMPLETED|Overall Study||6
477766|NCT01139775|1170646|P2|NOT COMPLETED|Overall Study||13
477767|NCT01139775|1170647|P1|NOT COMPLETED|Overall Study||1
477768|NCT01139775|1170645|P3|COMPLETED|Overall Study||17
477769|NCT01139775|1170646|P2|COMPLETED|Overall Study||26
477770|NCT01139775|1170647|P1|COMPLETED|Overall Study||13
477771|NCT01139775|1170645|P3|Received at Least 1 Dose of Study Drug|Overall Study||22
477772|NCT01139775|1170646|P2|Received at Least 1 Dose of Study Drug|Overall Study||39
477773|NCT01139775|1170647|P1|Received at Least 1 Dose of Study Drug|Overall Study||14
477774|NCT01139775|1170645|P3|STARTED|Overall Study||23
477775|NCT01139775|1170646|P2|STARTED|Overall Study||39
477776|NCT01139775|1170647|P1|STARTED|Overall Study||14
477777|NCT01139762|1170679|P3|NOT COMPLETED|Double-Blind Randomized Active Treatment||64
477778|NCT01139762|1170680|P2|NOT COMPLETED|Double-Blind Randomized Active Treatment||40
477779|NCT01139762|1170681|P1|NOT COMPLETED|Double-Blind Randomized Active Treatment||0
477780|NCT01139762|1170679|P3|COMPLETED|Double-Blind Randomized Active Treatment||286
477781|NCT01139762|1170680|P2|COMPLETED|Double-Blind Randomized Active Treatment||306
477782|NCT01139762|1170681|P1|COMPLETED|Double-Blind Randomized Active Treatment||0
477783|NCT01139762|1170679|P3|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||350
477784|NCT01139762|1170680|P2|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||345
477785|NCT01139762|1170681|P1|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||0
477786|NCT01139762|1170679|P3|STARTED|Double-Blind Randomized Active Treatment||350
477787|NCT01139762|1170680|P2|STARTED|Double-Blind Randomized Active Treatment||346
477788|NCT01139762|1170681|P1|STARTED|Double-Blind Randomized Active Treatment||0
477789|NCT01139762|1170679|P3|NOT COMPLETED|Washout and Placebo Lead-In Period||0
477790|NCT01139762|1170680|P2|NOT COMPLETED|Washout and Placebo Lead-In Period||0
477791|NCT01139762|1170681|P1|NOT COMPLETED|Washout and Placebo Lead-In Period||374
477792|NCT01139762|1170679|P3|COMPLETED|Washout and Placebo Lead-In Period||0
477793|NCT01139762|1170680|P2|COMPLETED|Washout and Placebo Lead-In Period||0
477794|NCT01139762|1170681|P1|COMPLETED|Washout and Placebo Lead-In Period||696
477795|NCT01139762|1170679|P3|STARTED|Washout and Placebo Lead-In Period||0
477796|NCT01139762|1170680|P2|STARTED|Washout and Placebo Lead-In Period||0
477797|NCT01139762|1170681|P1|STARTED|Washout and Placebo Lead-In Period||1070
477798|NCT01139658|1170716|P2|NOT COMPLETED|Overall Study||113
477799|NCT01139658|1170717|P1|NOT COMPLETED|Overall Study||56
477800|NCT01139658|1170716|P2|COMPLETED|Overall Study||816
477801|NCT01139658|1170717|P1|COMPLETED|Overall Study||691
477802|NCT01139658|1170716|P2|STARTED|Overall Study||929
477803|NCT01139658|1170717|P1|STARTED|Overall Study||747
477804|NCT01139580|1170755|P2|NOT COMPLETED|Overall Study||18
477805|NCT01139580|1170756|P1|NOT COMPLETED|Overall Study||23
477806|NCT01139580|1170755|P2|COMPLETED|Overall Study||164
477807|NCT01139580|1170756|P1|COMPLETED|Overall Study||158
477808|NCT01139580|1170755|P2|STARTED|Overall Study||182
477809|NCT01139580|1170756|P1|STARTED|Overall Study||181
477810|NCT01139515|1170772|P4|NOT COMPLETED|Fourth Intervention Period||0
477811|NCT01139515|1170773|P3|NOT COMPLETED|Fourth Intervention Period||0
477812|NCT01139515|1170774|P2|NOT COMPLETED|Fourth Intervention Period||0
477813|NCT01139515|1170775|P1|NOT COMPLETED|Fourth Intervention Period||0
477814|NCT01139515|1170772|P4|COMPLETED|Fourth Intervention Period||4
477815|NCT01139515|1170773|P3|COMPLETED|Fourth Intervention Period||4
477816|NCT01139515|1170774|P2|COMPLETED|Fourth Intervention Period||4
477817|NCT01139515|1170775|P1|COMPLETED|Fourth Intervention Period||4
477818|NCT01139515|1170772|P4|STARTED|Fourth Intervention Period||4
477819|NCT01139515|1170773|P3|STARTED|Fourth Intervention Period||4
477820|NCT01139515|1170774|P2|STARTED|Fourth Intervention Period||4
477821|NCT01139515|1170775|P1|STARTED|Fourth Intervention Period||4
477822|NCT01139515|1170772|P4|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
477823|NCT01139515|1170773|P3|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
477824|NCT01139515|1170774|P2|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
477825|NCT01139515|1170775|P1|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
477826|NCT01139515|1170772|P4|COMPLETED|Washout Period 3 (46 Hrs)||4
477827|NCT01139515|1170773|P3|COMPLETED|Washout Period 3 (46 Hrs)||4
477828|NCT01139515|1170774|P2|COMPLETED|Washout Period 3 (46 Hrs)||4
477829|NCT01139515|1170775|P1|COMPLETED|Washout Period 3 (46 Hrs)||4
477830|NCT01139515|1170772|P4|STARTED|Washout Period 3 (46 Hrs)||4
477831|NCT01139515|1170773|P3|STARTED|Washout Period 3 (46 Hrs)||4
477832|NCT01139515|1170774|P2|STARTED|Washout Period 3 (46 Hrs)||4
477833|NCT01139515|1170775|P1|STARTED|Washout Period 3 (46 Hrs)||4
477834|NCT01139515|1170772|P4|NOT COMPLETED|Third Intervention Period||0
477835|NCT01139515|1170773|P3|NOT COMPLETED|Third Intervention Period||0
477836|NCT01139515|1170774|P2|NOT COMPLETED|Third Intervention Period||0
477837|NCT01139515|1170775|P1|NOT COMPLETED|Third Intervention Period||0
477838|NCT01139515|1170772|P4|COMPLETED|Third Intervention Period||4
477839|NCT01139515|1170773|P3|COMPLETED|Third Intervention Period||4
477840|NCT01139515|1170774|P2|COMPLETED|Third Intervention Period||4
477841|NCT01139515|1170775|P1|COMPLETED|Third Intervention Period||4
477842|NCT01139515|1170772|P4|STARTED|Third Intervention Period||4
477843|NCT01139515|1170773|P3|STARTED|Third Intervention Period||4
477844|NCT01139515|1170774|P2|STARTED|Third Intervention Period||4
477845|NCT01139515|1170775|P1|STARTED|Third Intervention Period||4
477846|NCT01139515|1170772|P4|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
477847|NCT01139515|1170773|P3|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
477848|NCT01139515|1170774|P2|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
477849|NCT01139515|1170775|P1|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
477850|NCT01139515|1170772|P4|COMPLETED|Washout Period 2 (46 Hrs)||4
477851|NCT01139515|1170773|P3|COMPLETED|Washout Period 2 (46 Hrs)||4
477852|NCT01139515|1170774|P2|COMPLETED|Washout Period 2 (46 Hrs)||4
477853|NCT01139515|1170775|P1|COMPLETED|Washout Period 2 (46 Hrs)||4
477854|NCT01139515|1170772|P4|STARTED|Washout Period 2 (46 Hrs)||4
477855|NCT01139515|1170773|P3|STARTED|Washout Period 2 (46 Hrs)||4
477856|NCT01139515|1170774|P2|STARTED|Washout Period 2 (46 Hrs)||4
477857|NCT01139515|1170775|P1|STARTED|Washout Period 2 (46 Hrs)||4
477858|NCT01139515|1170772|P4|NOT COMPLETED|Second Intervention Period||0
477859|NCT01139515|1170773|P3|NOT COMPLETED|Second Intervention Period||0
477860|NCT01139515|1170774|P2|NOT COMPLETED|Second Intervention Period||0
477861|NCT01139515|1170775|P1|NOT COMPLETED|Second Intervention Period||0
477862|NCT01139515|1170772|P4|COMPLETED|Second Intervention Period||4
477863|NCT01139515|1170773|P3|COMPLETED|Second Intervention Period||4
477864|NCT01139515|1170774|P2|COMPLETED|Second Intervention Period||4
477865|NCT01139515|1170775|P1|COMPLETED|Second Intervention Period||4
477866|NCT01139515|1170772|P4|STARTED|Second Intervention Period||4
477867|NCT01139515|1170773|P3|STARTED|Second Intervention Period||4
477868|NCT01139515|1170774|P2|STARTED|Second Intervention Period||4
477869|NCT01139515|1170775|P1|STARTED|Second Intervention Period||4
477870|NCT01139515|1170772|P4|NOT COMPLETED|Washout Period I (46hrs)||0
477871|NCT01139515|1170773|P3|NOT COMPLETED|Washout Period I (46hrs)||0
477872|NCT01139515|1170774|P2|NOT COMPLETED|Washout Period I (46hrs)||0
477873|NCT01139515|1170775|P1|NOT COMPLETED|Washout Period I (46hrs)||0
477874|NCT01139515|1170772|P4|COMPLETED|Washout Period I (46hrs)||4
477875|NCT01139515|1170773|P3|COMPLETED|Washout Period I (46hrs)||4
477876|NCT01139515|1170774|P2|COMPLETED|Washout Period I (46hrs)||4
477877|NCT01139515|1170775|P1|COMPLETED|Washout Period I (46hrs)||4
477878|NCT01139515|1170772|P4|STARTED|Washout Period I (46hrs)||4
477879|NCT01139515|1170773|P3|STARTED|Washout Period I (46hrs)||4
477880|NCT01139515|1170774|P2|STARTED|Washout Period I (46hrs)||4
477881|NCT01139515|1170775|P1|STARTED|Washout Period I (46hrs)||4
477882|NCT01139515|1170772|P4|NOT COMPLETED|First Intervention Period||0
477883|NCT01139515|1170773|P3|NOT COMPLETED|First Intervention Period||0
477884|NCT01139515|1170774|P2|NOT COMPLETED|First Intervention Period||0
477885|NCT01139515|1170775|P1|NOT COMPLETED|First Intervention Period||0
477886|NCT01139515|1170772|P4|COMPLETED|First Intervention Period||4
477887|NCT01139515|1170773|P3|COMPLETED|First Intervention Period||4
477888|NCT01139515|1170774|P2|COMPLETED|First Intervention Period||4
477889|NCT01139515|1170775|P1|COMPLETED|First Intervention Period||4
477890|NCT01139515|1170772|P4|STARTED|First Intervention Period||4
477891|NCT01139515|1170773|P3|STARTED|First Intervention Period||4
477892|NCT01139515|1170774|P2|STARTED|First Intervention Period||4
477893|NCT01139515|1170775|P1|STARTED|First Intervention Period||4
477894|NCT01139450|1170804|P3|NOT COMPLETED|Overall Study||38
477895|NCT01139450|1170805|P2|NOT COMPLETED|Overall Study||25
477896|NCT01139450|1170806|P1|NOT COMPLETED|Overall Study||27
477897|NCT01139450|1170804|P3|COMPLETED|Overall Study||262
477898|NCT01139450|1170805|P2|COMPLETED|Overall Study||272
477899|NCT01139450|1170806|P1|COMPLETED|Overall Study||275
477900|NCT01139450|1170804|P3|STARTED|Overall Study||300
477901|NCT01139450|1170805|P2|STARTED|Overall Study||297
477902|NCT01139450|1170806|P1|STARTED|Overall Study||302
477903|NCT01139411|1170816|P2|NOT COMPLETED|Overall Study||4
477904|NCT01139411|1170817|P1|NOT COMPLETED|Overall Study||2
477905|NCT01139411|1170816|P2|COMPLETED|Overall Study||19
477906|NCT01139411|1170817|P1|COMPLETED|Overall Study||24
477907|NCT01139411|1170816|P2|STARTED|Overall Study||23
477908|NCT01139411|1170817|P1|STARTED|Overall Study||26
477909|NCT01139294|1170837|P2|NOT COMPLETED|Overall Study||0
477910|NCT01139294|1170838|P1|NOT COMPLETED|Overall Study||0
477911|NCT01139294|1170837|P2|COMPLETED|Overall Study||0
477912|NCT01139294|1170838|P1|COMPLETED|Overall Study||0
477913|NCT01139294|1170837|P2|STARTED|Overall Study||0
477914|NCT01139294|1170838|P1|STARTED|Overall Study||0
477915|NCT01139190|1170848|P2|NOT COMPLETED|Overall Study||1
477916|NCT01139190|1170849|P1|NOT COMPLETED|Overall Study||0
477917|NCT01139190|1170848|P2|COMPLETED|Overall Study||38
477918|NCT01139190|1170849|P1|COMPLETED|Overall Study||38
477919|NCT01139190|1170848|P2|STARTED|Overall Study||39
477920|NCT01139190|1170849|P1|STARTED|Overall Study||38
477921|NCT01139164|1170858|P3|NOT COMPLETED|Overall Study||0
477922|NCT01139164|1170859|P2|NOT COMPLETED|Overall Study||2
477923|NCT01139164|1170860|P1|NOT COMPLETED|Overall Study||0
477924|NCT01139164|1170858|P3|COMPLETED|Overall Study||7
477925|NCT01139164|1170859|P2|COMPLETED|Overall Study||65
477926|NCT01139164|1170860|P1|COMPLETED|Overall Study||4
477927|NCT01139164|1170858|P3|STARTED|Overall Study||7
477928|NCT01139164|1170859|P2|STARTED|Overall Study||67
477929|NCT01139164|1170860|P1|STARTED|Overall Study||4
477930|NCT01139125|1170874|P1|NOT COMPLETED|Overall Study||1
477931|NCT01139125|1170874|P1|COMPLETED|Overall Study||2
477932|NCT01139125|1170874|P1|STARTED|Overall Study||3
477933|NCT01139047|1170878|P1|NOT COMPLETED|Overall Study||1
477934|NCT01139047|1170878|P1|COMPLETED|Overall Study||76
477935|NCT01139047|1170878|P1|STARTED|Overall Study||77
477936|NCT01139021|1170893|P6|NOT COMPLETED|Overall Study||0
477937|NCT01139021|1170894|P5|NOT COMPLETED|Overall Study||9
477938|NCT01139021|1170895|P4|NOT COMPLETED|Overall Study||1
477939|NCT01139021|1170896|P3|NOT COMPLETED|Overall Study||0
477940|NCT01139021|1170897|P2|NOT COMPLETED|Overall Study||0
477941|NCT01139021|1170898|P1|NOT COMPLETED|Overall Study||1
477942|NCT01139021|1170893|P6|COMPLETED|Overall Study||1
477943|NCT01139021|1170894|P5|COMPLETED|Overall Study||107
477944|NCT01139021|1170895|P4|COMPLETED|Overall Study||18
477945|NCT01139021|1170896|P3|COMPLETED|Overall Study||67
477946|NCT01139021|1170897|P2|COMPLETED|Overall Study||153
477947|NCT01139021|1170898|P1|COMPLETED|Overall Study||151
477948|NCT01139021|1170893|P6|STARTED|Overall Study||1
477949|NCT01139021|1170894|P5|STARTED|Overall Study||116
477950|NCT01139021|1170895|P4|STARTED|Overall Study||19
477951|NCT01139021|1170896|P3|STARTED|Overall Study||67
477952|NCT01139021|1170897|P2|STARTED|Overall Study||153
477953|NCT01139021|1170898|P1|STARTED|Overall Study||152
477954|NCT01139008|1170934|P1|NOT COMPLETED|Overall Study||6
477955|NCT01139008|1170934|P1|COMPLETED|Overall Study||74
477956|NCT01139008|1170934|P1|STARTED|Overall Study||80
477957|NCT01138995|1170945|P2|NOT COMPLETED|Overall Study||25
477958|NCT01138995|1170946|P1|NOT COMPLETED|Overall Study||10
477959|NCT01138995|1170945|P2|COMPLETED|Overall Study||74
477960|NCT01138995|1170946|P1|COMPLETED|Overall Study||88
477961|NCT01138995|1170945|P2|STARTED|Overall Study||99
477962|NCT01138995|1170946|P1|STARTED|Overall Study||98
477963|NCT01138969|1170958|P2|NOT COMPLETED|Overall Study||0
477964|NCT01138969|1170959|P1|NOT COMPLETED|Overall Study||0
477965|NCT01138969|1170958|P2|COMPLETED|Overall Study||82
477966|NCT01138969|1170959|P1|COMPLETED|Overall Study||83
477967|NCT01138969|1170958|P2|STARTED|Overall Study||82
477968|NCT01138969|1170959|P1|STARTED|Overall Study||83
477969|NCT01138826|1170967|P6|NOT COMPLETED|Third Intervention Period||0
477970|NCT01138826|1170968|P5|NOT COMPLETED|Third Intervention Period||0
477971|NCT01138826|1170969|P4|NOT COMPLETED|Third Intervention Period||0
477972|NCT01138826|1170970|P3|NOT COMPLETED|Third Intervention Period||0
477973|NCT01138826|1170971|P2|NOT COMPLETED|Third Intervention Period||0
477974|NCT01138826|1170972|P1|NOT COMPLETED|Third Intervention Period||0
477975|NCT01138826|1170967|P6|COMPLETED|Third Intervention Period||3
477976|NCT01138826|1170968|P5|COMPLETED|Third Intervention Period||2
477977|NCT01138826|1170969|P4|COMPLETED|Third Intervention Period||3
477978|NCT01138826|1170970|P3|COMPLETED|Third Intervention Period||3
477979|NCT01138826|1170971|P2|COMPLETED|Third Intervention Period||2
477980|NCT01138826|1170972|P1|COMPLETED|Third Intervention Period||2
477981|NCT01138826|1170967|P6|STARTED|Third Intervention Period||3
477982|NCT01138826|1170968|P5|STARTED|Third Intervention Period||2
477983|NCT01138826|1170969|P4|STARTED|Third Intervention Period||3
477984|NCT01138826|1170970|P3|STARTED|Third Intervention Period||3
477985|NCT01138826|1170971|P2|STARTED|Third Intervention Period||2
477986|NCT01138826|1170972|P1|STARTED|Third Intervention Period||2
477987|NCT01138826|1170967|P6|NOT COMPLETED|Washout Period II (of 16 Days)||0
477988|NCT01138826|1170968|P5|NOT COMPLETED|Washout Period II (of 16 Days)||0
477989|NCT01138826|1170969|P4|NOT COMPLETED|Washout Period II (of 16 Days)||0
477990|NCT01138826|1170970|P3|NOT COMPLETED|Washout Period II (of 16 Days)||0
477991|NCT01138826|1170971|P2|NOT COMPLETED|Washout Period II (of 16 Days)||0
477992|NCT01138826|1170972|P1|NOT COMPLETED|Washout Period II (of 16 Days)||0
477993|NCT01138826|1170967|P6|COMPLETED|Washout Period II (of 16 Days)||3
477994|NCT01138826|1170968|P5|COMPLETED|Washout Period II (of 16 Days)||2
477995|NCT01138826|1170969|P4|COMPLETED|Washout Period II (of 16 Days)||3
477996|NCT01138826|1170970|P3|COMPLETED|Washout Period II (of 16 Days)||3
477997|NCT01138826|1170971|P2|COMPLETED|Washout Period II (of 16 Days)||2
477998|NCT01138826|1170972|P1|COMPLETED|Washout Period II (of 16 Days)||2
477999|NCT01138826|1170967|P6|STARTED|Washout Period II (of 16 Days)||3
478000|NCT01138826|1170968|P5|STARTED|Washout Period II (of 16 Days)||2
478001|NCT01138826|1170969|P4|STARTED|Washout Period II (of 16 Days)||3
478002|NCT01138826|1170970|P3|STARTED|Washout Period II (of 16 Days)||3
478003|NCT01138826|1170971|P2|STARTED|Washout Period II (of 16 Days)||2
478004|NCT01138826|1170972|P1|STARTED|Washout Period II (of 16 Days)||2
478005|NCT01138826|1170967|P6|NOT COMPLETED|Second Intervention Period||0
478006|NCT01138826|1170968|P5|NOT COMPLETED|Second Intervention Period||0
478007|NCT01138826|1170969|P4|NOT COMPLETED|Second Intervention Period||0
478008|NCT01138826|1170970|P3|NOT COMPLETED|Second Intervention Period||0
478009|NCT01138826|1170971|P2|NOT COMPLETED|Second Intervention Period||0
478010|NCT01138826|1170972|P1|NOT COMPLETED|Second Intervention Period||0
478011|NCT01138826|1170967|P6|COMPLETED|Second Intervention Period||3
478012|NCT01138826|1170968|P5|COMPLETED|Second Intervention Period||2
478013|NCT01138826|1170969|P4|COMPLETED|Second Intervention Period||3
478014|NCT01138826|1170970|P3|COMPLETED|Second Intervention Period||3
478015|NCT01138826|1170971|P2|COMPLETED|Second Intervention Period||2
478016|NCT01138826|1170972|P1|COMPLETED|Second Intervention Period||2
478017|NCT01138826|1170967|P6|STARTED|Second Intervention Period||3
478018|NCT01138826|1170968|P5|STARTED|Second Intervention Period||2
478019|NCT01138826|1170969|P4|STARTED|Second Intervention Period||3
478020|NCT01138826|1170970|P3|STARTED|Second Intervention Period||3
478021|NCT01138826|1170971|P2|STARTED|Second Intervention Period||2
478022|NCT01138826|1170972|P1|STARTED|Second Intervention Period||2
478023|NCT01138826|1170967|P6|NOT COMPLETED|Washout Period I (of 16 Days)||0
478024|NCT01138826|1170968|P5|NOT COMPLETED|Washout Period I (of 16 Days)||1
478025|NCT01138826|1170969|P4|NOT COMPLETED|Washout Period I (of 16 Days)||0
478026|NCT01138826|1170970|P3|NOT COMPLETED|Washout Period I (of 16 Days)||0
478027|NCT01138826|1170971|P2|NOT COMPLETED|Washout Period I (of 16 Days)||1
478028|NCT01138826|1170972|P1|NOT COMPLETED|Washout Period I (of 16 Days)||1
478029|NCT01138826|1170967|P6|COMPLETED|Washout Period I (of 16 Days)||3
478030|NCT01138826|1170968|P5|COMPLETED|Washout Period I (of 16 Days)||2
478031|NCT01138826|1170969|P4|COMPLETED|Washout Period I (of 16 Days)||3
478032|NCT01138826|1170970|P3|COMPLETED|Washout Period I (of 16 Days)||3
478033|NCT01138826|1170971|P2|COMPLETED|Washout Period I (of 16 Days)||2
478034|NCT01138826|1170972|P1|COMPLETED|Washout Period I (of 16 Days)||2
478035|NCT01138826|1170967|P6|STARTED|Washout Period I (of 16 Days)||3
478036|NCT01138826|1170968|P5|STARTED|Washout Period I (of 16 Days)||3
478037|NCT01138826|1170969|P4|STARTED|Washout Period I (of 16 Days)||3
478038|NCT01138826|1170970|P3|STARTED|Washout Period I (of 16 Days)||3
478039|NCT01138826|1170971|P2|STARTED|Washout Period I (of 16 Days)||3
478040|NCT01138826|1170972|P1|STARTED|Washout Period I (of 16 Days)||3
478041|NCT01138826|1170967|P6|NOT COMPLETED|First Intervention Period||0
478042|NCT01138826|1170968|P5|NOT COMPLETED|First Intervention Period||0
478043|NCT01138826|1170969|P4|NOT COMPLETED|First Intervention Period||0
478044|NCT01138826|1170970|P3|NOT COMPLETED|First Intervention Period||0
478045|NCT01138826|1170971|P2|NOT COMPLETED|First Intervention Period||0
478046|NCT01138826|1170972|P1|NOT COMPLETED|First Intervention Period||0
478047|NCT01138826|1170967|P6|COMPLETED|First Intervention Period||3
478048|NCT01138826|1170968|P5|COMPLETED|First Intervention Period||3
478049|NCT01138826|1170969|P4|COMPLETED|First Intervention Period||3
478050|NCT01138826|1170970|P3|COMPLETED|First Intervention Period||3
478051|NCT01138826|1170971|P2|COMPLETED|First Intervention Period||3
478052|NCT01138826|1170972|P1|COMPLETED|First Intervention Period||3
478053|NCT01138826|1170967|P6|STARTED|First Intervention Period||3
478054|NCT01138826|1170968|P5|STARTED|First Intervention Period||3
478055|NCT01138826|1170969|P4|STARTED|First Intervention Period||3
478056|NCT01138826|1170970|P3|STARTED|First Intervention Period||3
478057|NCT01138826|1170971|P2|STARTED|First Intervention Period||3
478058|NCT01138826|1170972|P1|STARTED|First Intervention Period||3
478059|NCT01138735|1170994|P2|NOT COMPLETED|Overall Study||17
478060|NCT01138735|1170995|P1|NOT COMPLETED|Overall Study||8
478061|NCT01138735|1170994|P2|COMPLETED|Overall Study||126
478062|NCT01138735|1170995|P1|COMPLETED|Overall Study||134
478063|NCT01138735|1170994|P2|STARTED|Overall Study||143
478064|NCT01138735|1170995|P1|STARTED|Overall Study||142
478065|NCT01138657|1171009|P2|NOT COMPLETED|Overall Study||18
478066|NCT01138657|1171010|P1|NOT COMPLETED|Overall Study||8
478067|NCT01138657|1171009|P2|COMPLETED|Overall Study||101
478068|NCT01138657|1171010|P1|COMPLETED|Overall Study||112
478069|NCT01138657|1171009|P2|Enrolled in Japan Sub-study|Overall Study||8
478070|NCT01138657|1171010|P1|Enrolled in Japan Sub-study|Overall Study||8
478071|NCT01138657|1171009|P2|Enrolled in Main Study|Overall Study||111
478072|NCT01138657|1171010|P1|Enrolled in Main Study|Overall Study||112
478073|NCT01138657|1171009|P2|STARTED|Overall Study||119
478074|NCT01138657|1171010|P1|STARTED|Overall Study||120
478075|NCT01138514|1171057|P3|NOT COMPLETED|Overall Study||93
478076|NCT01138514|1171058|P2|NOT COMPLETED|Overall Study||53
478077|NCT01138514|1171059|P1|NOT COMPLETED|Overall Study||48
478078|NCT01138514|1171057|P3|COMPLETED|Overall Study||424
478079|NCT01138514|1171058|P2|COMPLETED|Overall Study||463
478080|NCT01138514|1171059|P1|COMPLETED|Overall Study||474
478081|NCT01138514|1171057|P3|STARTED|Overall Study||517
478082|NCT01138514|1171058|P2|STARTED|Overall Study||516
478083|NCT01138514|1171059|P1|STARTED|Overall Study||522
478084|NCT01138501|1171073|P1|NOT COMPLETED|Overall Study||5
478085|NCT01138501|1171073|P1|COMPLETED|Overall Study||60
478086|NCT01138501|1171073|P1|Exposed|Overall Study||63
478087|NCT01138501|1171073|P1|STARTED|Overall Study|Two subjects withdrew consent after being enrolled but before receiving any trial product.|65
478088|NCT01138475|1171081|P3|NOT COMPLETED|Overall Study||0
478089|NCT01138475|1171082|P2|NOT COMPLETED|Overall Study||0
478090|NCT01138475|1171083|P1|NOT COMPLETED|Overall Study||0
478091|NCT01138475|1171081|P3|COMPLETED|Overall Study||17
478092|NCT01138475|1171082|P2|COMPLETED|Overall Study||16
478093|NCT01138475|1171083|P1|COMPLETED|Overall Study||16
478094|NCT01138475|1171081|P3|STARTED|Overall Study||17
478095|NCT01138475|1171082|P2|STARTED|Overall Study||16
478096|NCT01138475|1171083|P1|STARTED|Overall Study||16
478097|NCT01138150|1171117|P2|NOT COMPLETED|Overall Study||1
478098|NCT01138150|1171118|P1|NOT COMPLETED|Overall Study||1
478099|NCT01138150|1171117|P2|COMPLETED|Overall Study||17
478100|NCT01138150|1171118|P1|COMPLETED|Overall Study||17
478101|NCT01138150|1171117|P2|STARTED|Overall Study||18
478102|NCT01138150|1171118|P1|STARTED|Overall Study||18
478103|NCT01138124|1171174|P4|NOT COMPLETED|Overall Study||0
478104|NCT01138124|1171175|P3|NOT COMPLETED|Overall Study||0
478105|NCT01138124|1171176|P2|NOT COMPLETED|Overall Study||0
478106|NCT01138124|1171177|P1|NOT COMPLETED|Overall Study||0
478107|NCT01138124|1171174|P4|COMPLETED|Overall Study||19046
478108|NCT01138124|1171175|P3|COMPLETED|Overall Study||1981
478109|NCT01138124|1171176|P2|COMPLETED|Overall Study||30026
478110|NCT01138124|1171177|P1|COMPLETED|Overall Study||3149
478111|NCT01138124|1171174|P4|STARTED|Overall Study||19046
478112|NCT01138124|1171175|P3|STARTED|Overall Study||1981
478113|NCT01138124|1171176|P2|STARTED|Overall Study||30026
478114|NCT01138124|1171177|P1|STARTED|Overall Study||3149
478115|NCT01138111|1171199|P1|NOT COMPLETED|Overall Study||9
478116|NCT01138111|1171199|P1|COMPLETED|Overall Study||36
478117|NCT01138111|1171199|P1|STARTED|Overall Study||45
478118|NCT01138098|1171230|P2|NOT COMPLETED|Overall Study||0
478119|NCT01138098|1171231|P1|NOT COMPLETED|Overall Study||0
478120|NCT01138098|1171230|P2|COMPLETED|Overall Study||90
478121|NCT01138098|1171231|P1|COMPLETED|Overall Study||95
478122|NCT01138098|1171230|P2|STARTED|Overall Study||90
478123|NCT01138098|1171231|P1|STARTED|Overall Study||95
478124|NCT01138046|1171253|P1|NOT COMPLETED|Overall Study||6
478125|NCT01138046|1171253|P1|COMPLETED|Overall Study||6
478126|NCT01138046|1171253|P1|STARTED|Overall Study||12
478127|NCT01138007|1171273|P3|NOT COMPLETED|Overall Study||48
478128|NCT01138007|1171274|P2|NOT COMPLETED|Overall Study||30
478129|NCT01138007|1171275|P1|NOT COMPLETED|Overall Study||22
478130|NCT01138007|1171273|P3|COMPLETED|Overall Study||144
478131|NCT01138007|1171274|P2|COMPLETED|Overall Study||160
478132|NCT01138007|1171275|P1|COMPLETED|Overall Study||165
478133|NCT01138007|1171273|P3|STARTED|Overall Study||192
478134|NCT01138007|1171274|P2|STARTED|Overall Study||190
478135|NCT01138007|1171275|P1|STARTED|Overall Study||187
478136|NCT01137890|1171309|P2|NOT COMPLETED|Overall Study||3
478137|NCT01137890|1171310|P1|NOT COMPLETED|Overall Study||6
478138|NCT01137890|1171309|P2|COMPLETED|Overall Study||2
478139|NCT01137890|1171310|P1|COMPLETED|Overall Study||8
478140|NCT01137890|1171309|P2|STARTED|Overall Study||5
478141|NCT01137890|1171310|P1|STARTED|Overall Study||14
478142|NCT01137812|1171382|P2|NOT COMPLETED|Overall Study||168
478143|NCT01137812|1171383|P1|NOT COMPLETED|Overall Study||123
478144|NCT01137812|1171382|P2|COMPLETED|Overall Study||210
478145|NCT01137812|1171383|P1|COMPLETED|Overall Study||254
478146|NCT01137812|1171382|P2|STARTED|Overall Study||378
478147|NCT01137812|1171383|P1|STARTED|Overall Study||377
478148|NCT01137786|1171403|P2|NOT COMPLETED|Overall Study||3
478149|NCT01137786|1171404|P1|NOT COMPLETED|Overall Study||1
478150|NCT01137786|1171403|P2|COMPLETED|Overall Study||21
478151|NCT01137786|1171404|P1|COMPLETED|Overall Study||24
478152|NCT01137786|1171403|P2|STARTED|Overall Study||24
478153|NCT01137786|1171404|P1|STARTED|Overall Study||25
478154|NCT01137773|1171414|P2|NOT COMPLETED|Overall Study||3
478155|NCT01137773|1171415|P1|NOT COMPLETED|Overall Study||9
478156|NCT01137773|1171414|P2|COMPLETED|Overall Study||20
478157|NCT01137773|1171415|P1|COMPLETED|Overall Study||24
478158|NCT01137773|1171414|P2|STARTED|Overall Study||23
478159|NCT01137773|1171415|P1|STARTED|Overall Study||33
478160|NCT01137682|1171426|P3|NOT COMPLETED|Overall Study||34
478161|NCT01137682|1171427|P2|NOT COMPLETED|Overall Study||40
478162|NCT01137682|1171428|P1|NOT COMPLETED|Overall Study||37
478163|NCT01137682|1171426|P3|COMPLETED|Overall Study||34
478164|NCT01137682|1171427|P2|COMPLETED|Overall Study||25
478165|NCT01137682|1171428|P1|COMPLETED|Overall Study||28
478166|NCT01137682|1171426|P3|Safety Set - Extension|Overall Study|1 patient did not receive study treatment|62
478167|NCT01137682|1171427|P2|Safety Set - Extension|Overall Study||54
478168|NCT01137682|1171428|P1|Safety Set - Extension|Overall Study||57
478169|NCT01137682|1171426|P3|Safety Set - CORE|Overall Study|2 patients never received drug.|66
478170|NCT01137682|1171427|P2|Safety Set - CORE|Overall Study|2 patients never received drug. 1 patient had no post baseline safety assement.|62
478171|NCT01137682|1171428|P1|Safety Set - CORE|Overall Study|2 patients never received drug.|63
478172|NCT01137682|1171426|P3|Continuing Into Extension|Overall Study||63
478173|NCT01137682|1171427|P2|Continuing Into Extension|Overall Study||54
478174|NCT01137682|1171428|P1|Continuing Into Extension|Overall Study||57
478175|NCT01137682|1171426|P3|Not Continuing Into Extension|Overall Study||2
478176|NCT01137682|1171427|P2|Not Continuing Into Extension|Overall Study||3
478177|NCT01137682|1171428|P1|Not Continuing Into Extension|Overall Study||2
478178|NCT01137682|1171426|P3|Completed 24-Week Core Phase|Overall Study||65
478179|NCT01137682|1171427|P2|Completed 24-Week Core Phase|Overall Study||57
478180|NCT01137682|1171428|P1|Completed 24-Week Core Phase|Overall Study||59
478181|NCT01137682|1171426|P3|Treated|Overall Study||67
478182|NCT01137682|1171427|P2|Treated|Overall Study||63
478183|NCT01137682|1171428|P1|Treated|Overall Study||63
478184|NCT01137682|1171426|P3|Not Treated|Overall Study||1
478185|NCT01137682|1171427|P2|Not Treated|Overall Study||2
478186|NCT01137682|1171428|P1|Not Treated|Overall Study||2
478187|NCT01137682|1171426|P3|STARTED|Overall Study||68
478188|NCT01137682|1171427|P2|STARTED|Overall Study||65
478189|NCT01137682|1171428|P1|STARTED|Overall Study||65
478190|NCT01137604|1171478|P4|NOT COMPLETED|Overall Study||11
478191|NCT01137604|1171479|P3|NOT COMPLETED|Overall Study||13
478192|NCT01137604|1171480|P2|NOT COMPLETED|Overall Study||10
478193|NCT01137604|1171481|P1|NOT COMPLETED|Overall Study||2
478194|NCT01137604|1171478|P4|COMPLETED|Overall Study||21
478195|NCT01137604|1171479|P3|COMPLETED|Overall Study||26
478196|NCT01137604|1171480|P2|COMPLETED|Overall Study||32
478197|NCT01137604|1171481|P1|COMPLETED|Overall Study|Participants with disease progression and treatment ongoing at data cutoff (19 Mar 2013)|36
478198|NCT01137604|1171478|P4|Treatment Ongoing at Data Cutoff|Overall Study||0
478199|NCT01137604|1171479|P3|Treatment Ongoing at Data Cutoff|Overall Study||1
478200|NCT01137604|1171480|P2|Treatment Ongoing at Data Cutoff|Overall Study||3
478201|NCT01137604|1171481|P1|Treatment Ongoing at Data Cutoff|Overall Study||2
478202|NCT01137604|1171478|P4|Disease Progression|Overall Study||21
478203|NCT01137604|1171479|P3|Disease Progression|Overall Study||25
478204|NCT01137604|1171480|P2|Disease Progression|Overall Study||29
478205|NCT01137604|1171481|P1|Disease Progression|Overall Study||34
478206|NCT01137604|1171478|P4|STARTED|Overall Study||32
478207|NCT01137604|1171479|P3|STARTED|Overall Study||39
478208|NCT01137604|1171480|P2|STARTED|Overall Study||42
478209|NCT01137604|1171481|P1|STARTED|Overall Study|39 participants were randomized but 1 participant died prior to receiving treatment.|38
478210|NCT01137578|1171515|P3|NOT COMPLETED|Overall Study||6
478211|NCT01137578|1171516|P2|NOT COMPLETED|Overall Study||2
478212|NCT01137578|1171517|P1|NOT COMPLETED|Overall Study||16
478213|NCT01137578|1171515|P3|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|37
478214|NCT01137578|1171516|P2|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|12
478215|NCT01137578|1171517|P1|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|61
478216|NCT01137578|1171515|P3|STARTED|Overall Study||43
478217|NCT01137578|1171516|P2|STARTED|Overall Study||14
478218|NCT01137578|1171517|P1|STARTED|Overall Study||77
478219|NCT01137539|1171557|P1|NOT COMPLETED|Overall Study||0
478220|NCT01137539|1171557|P1|COMPLETED|Overall Study||50
478221|NCT01137539|1171557|P1|STARTED|Overall Study||50
478222|NCT01137474|1171566|P4|NOT COMPLETED|Overall Study||21
478223|NCT01137474|1171567|P3|NOT COMPLETED|Overall Study||7
478224|NCT01137474|1171568|P2|NOT COMPLETED|Overall Study||12
478225|NCT01137474|1171569|P1|NOT COMPLETED|Overall Study||24
478226|NCT01137474|1171566|P4|COMPLETED|Overall Study||281
478227|NCT01137474|1171567|P3|COMPLETED|Overall Study||158
478228|NCT01137474|1171568|P2|COMPLETED|Overall Study||154
478229|NCT01137474|1171569|P1|COMPLETED|Overall Study||287
478230|NCT01137474|1171566|P4|Received Treatment|Overall Study||302
478231|NCT01137474|1171567|P3|Received Treatment|Overall Study||165
478232|NCT01137474|1171568|P2|Received Treatment|Overall Study||166
478233|NCT01137474|1171569|P1|Received Treatment|Overall Study||311
478234|NCT01137474|1171566|P4|STARTED|Overall Study||302
478235|NCT01137474|1171567|P3|STARTED|Overall Study||165
478236|NCT01137474|1171568|P2|STARTED|Overall Study||166
478237|NCT01137474|1171569|P1|STARTED|Overall Study||311
478238|NCT01137435|1171587|P1|NOT COMPLETED|Overall Study||28
478239|NCT01137435|1171587|P1|COMPLETED|Overall Study||659
478240|NCT01137435|1171587|P1|STARTED|Overall Study||687
478241|NCT01137396|1171596|P2|NOT COMPLETED|Overall Study||2
478242|NCT01137396|1171597|P1|NOT COMPLETED|Overall Study||8
478243|NCT01137396|1171596|P2|COMPLETED|Overall Study||25
478244|NCT01137396|1171597|P1|COMPLETED|Overall Study||22
478245|NCT01137396|1171596|P2|STARTED|Overall Study||27
478246|NCT01137396|1171597|P1|STARTED|Overall Study||30
478247|NCT01137370|1171607|P2|NOT COMPLETED|Overall Study||0
478248|NCT01137370|1171608|P1|NOT COMPLETED|Overall Study||0
478249|NCT01137370|1171607|P2|COMPLETED|Overall Study||87
478250|NCT01137370|1171608|P1|COMPLETED|Overall Study||116
478251|NCT01137370|1171607|P2|STARTED|Overall Study||87
478252|NCT01137370|1171608|P1|STARTED|Overall Study||116
478253|NCT01137292|1171614|P1|NOT COMPLETED|Overall Study||54
478254|NCT01137292|1171614|P1|COMPLETED|Overall Study||123
478255|NCT01137292|1171614|P1|STARTED|Overall Study||177
478256|NCT01137071|1171621|P1|NOT COMPLETED|Overall Study||14
478257|NCT01137071|1171621|P1|COMPLETED|Overall Study|Of the eligible patients|15
478258|NCT01137071|1171621|P1|STARTED|Overall Study|all patients considered eligible were included on the study|29
478259|NCT01137032|1171682|P1|NOT COMPLETED|Overall Study||0
478260|NCT01137032|1171682|P1|COMPLETED|Overall Study||19
478261|NCT01137032|1171682|P1|STARTED|Overall Study||19
478262|NCT01136967|1171690|P2|NOT COMPLETED|Overall Study||27
478263|NCT01136967|1171691|P1|NOT COMPLETED|Overall Study||24
478264|NCT01136967|1171690|P2|COMPLETED|Overall Study|Disease Progression and treatment ongoing at data cutoff (15 April 2013)|62
478265|NCT01136967|1171691|P1|COMPLETED|Overall Study|Disease Progression and treatment ongoing at data cutoff (18 January 2012)|69
478266|NCT01136967|1171690|P2|Treatment Ongoing at Data Cutoff|Overall Study|Entered Extension Phase on treatment at data cut-off (15 April 2013)|6
478267|NCT01136967|1171691|P1|Treatment Ongoing at Data Cutoff|Overall Study|Entered Extension Phase on treatment at data cut-off (18 January 2012)|14
478268|NCT01136967|1171690|P2|Disease Progression|Overall Study||56
478269|NCT01136967|1171691|P1|Disease Progression|Overall Study||55
478270|NCT01136967|1171690|P2|STARTED|Overall Study||89
478271|NCT01136967|1171691|P1|STARTED|Overall Study||93
478272|NCT01136954|1171709|P2|NOT COMPLETED|Overall Study||21
478273|NCT01136954|1171710|P1|NOT COMPLETED|Overall Study||24
478274|NCT01136954|1171709|P2|COMPLETED|Overall Study||51
478275|NCT01136954|1171710|P1|COMPLETED|Overall Study||48
478276|NCT01136954|1171709|P2|STARTED|Overall Study||72
478277|NCT01136954|1171710|P1|STARTED|Overall Study||72
478278|NCT01136915|1171724|P2|NOT COMPLETED|Overall Study||1
478279|NCT01136915|1171725|P1|NOT COMPLETED|Overall Study||2
478280|NCT01136915|1171724|P2|COMPLETED|Overall Study||6
478281|NCT01136915|1171725|P1|COMPLETED|Overall Study||6
478282|NCT01136915|1171724|P2|STARTED|Overall Study||7
478283|NCT01136915|1171725|P1|STARTED|Overall Study||8
478284|NCT01136876|1171735|P2|NOT COMPLETED|Overall Study||6
478285|NCT01136876|1171736|P1|NOT COMPLETED|Overall Study||3
478286|NCT01136876|1171735|P2|COMPLETED|Overall Study||23
478287|NCT01136876|1171736|P1|COMPLETED|Overall Study||25
478288|NCT01136876|1171735|P2|STARTED|Overall Study||29
478289|NCT01136876|1171736|P1|STARTED|Overall Study||28
478290|NCT01136785|1171746|P2|NOT COMPLETED|Overall Study||1
478291|NCT01136785|1171747|P1|NOT COMPLETED|Overall Study||2
478292|NCT01136785|1171746|P2|COMPLETED|Overall Study||6
478293|NCT01136785|1171747|P1|COMPLETED|Overall Study||13
478294|NCT01136785|1171746|P2|STARTED|Overall Study||7
478295|NCT01136785|1171747|P1|STARTED|Overall Study||15
478296|NCT01136772|1171762|P2|NOT COMPLETED|Overall Study||110
478297|NCT01136772|1171763|P1|NOT COMPLETED|Overall Study||116
478298|NCT01136772|1171762|P2|COMPLETED|Overall Study||44
478299|NCT01136772|1171763|P1|COMPLETED|Overall Study||41
478300|NCT01136772|1171762|P2|Safety Population|Overall Study|Includes all randomized participants who received at least one dose of the injectable medication|147
478301|NCT01136772|1171763|P1|Safety Population|Overall Study|Includes all randomized participants who received at least one dose of the injectable medication|147
478302|NCT01136772|1171762|P2|STARTED|Overall Study||154
478303|NCT01136772|1171763|P1|STARTED|Overall Study||157
478304|NCT01136746|1171773|P2|NOT COMPLETED|Overall Study||3
478305|NCT01136746|1171774|P1|NOT COMPLETED|Overall Study||3
478306|NCT01136746|1171773|P2|COMPLETED|Overall Study||4
478307|NCT01136746|1171774|P1|COMPLETED|Overall Study||6
478308|NCT01136746|1171773|P2|STARTED|Overall Study||7
478309|NCT01136746|1171774|P1|STARTED|Overall Study||9
478310|NCT01136655|1171834|P1|NOT COMPLETED|Washout After BUD 160/ Foradil (7 Days)||0
478311|NCT01136655|1171834|P1|COMPLETED|Washout After BUD 160/ Foradil (7 Days)||50
478312|NCT01136655|1171834|P1|STARTED|Washout After BUD 160/ Foradil (7 Days)||50
478313|NCT01136655|1171834|P1|NOT COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||0
478314|NCT01136655|1171834|P1|COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||50
478315|NCT01136655|1171834|P1|STARTED|BUD 160/ Foradil 12.0 (1 Dose)||50
478316|NCT01136655|1171834|P1|NOT COMPLETED|Washout After BUD 160 (7 Days)||0
478317|NCT01136655|1171834|P1|COMPLETED|Washout After BUD 160 (7 Days)||51
478318|NCT01136655|1171834|P1|STARTED|Washout After BUD 160 (7 Days)||51
478319|NCT01136655|1171834|P1|NOT COMPLETED|BUD 160 (1 Dose)||0
478320|NCT01136655|1171834|P1|COMPLETED|BUD 160 (1 Dose)||51
478321|NCT01136655|1171834|P1|STARTED|BUD 160 (1 Dose)||51
478322|NCT01136655|1171834|P1|NOT COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||2
478323|NCT01136655|1171834|P1|COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||51
478324|NCT01136655|1171834|P1|STARTED|Washout After BUD 160/FM 9.0 (7 Days)||53
478325|NCT01136655|1171834|P1|NOT COMPLETED|BUD 160/FM 9.0 (1 Dose)||0
478326|NCT01136655|1171834|P1|COMPLETED|BUD 160/FM 9.0 (1 Dose)||53
478327|NCT01136655|1171834|P1|STARTED|BUD 160/FM 9.0 (1 Dose)||53
478328|NCT01136655|1171834|P1|NOT COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||1
478329|NCT01136655|1171834|P1|COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||52
478330|NCT01136655|1171834|P1|STARTED|Washout After BUD 160/FM 4.5 (7 Days)||53
478331|NCT01136655|1171834|P1|NOT COMPLETED|BUD 160/FM 4.5 (1 Dose)||0
478332|NCT01136655|1171834|P1|COMPLETED|BUD 160/FM 4.5 (1 Dose)||53
478333|NCT01136655|1171834|P1|STARTED|BUD 160/FM 4.5 (1 Dose)||53
478334|NCT01136655|1171834|P1|NOT COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||1
478335|NCT01136655|1171834|P1|COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||53
478336|NCT01136655|1171834|P1|STARTED|Washout After BUD 160/FM 2.25 (7 Days)||54
478337|NCT01136655|1171834|P1|NOT COMPLETED|BUD 160/FM 2.25 (1 Dose)||0
478338|NCT01136655|1171834|P1|COMPLETED|BUD 160/FM 2.25 (1 Dose)||54
478339|NCT01136655|1171834|P1|STARTED|BUD 160/FM 2.25 (1 Dose)||54
478340|NCT01136486|1171860|P1|NOT COMPLETED|Overall Study||0
478341|NCT01136486|1171860|P1|COMPLETED|Overall Study||56
478342|NCT01136486|1171860|P1|STARTED|Overall Study||56
478343|NCT01136408|1171867|P3|NOT COMPLETED|Overall Study||5
478344|NCT01136408|1171868|P2|NOT COMPLETED|Overall Study||9
478345|NCT01136408|1171869|P1|NOT COMPLETED|Overall Study||5
478346|NCT01136408|1171867|P3|COMPLETED|Overall Study||57
478347|NCT01136408|1171868|P2|COMPLETED|Overall Study||49
478348|NCT01136408|1171869|P1|COMPLETED|Overall Study||41
478349|NCT01136408|1171867|P3|STARTED|Overall Study||62
478350|NCT01136408|1171868|P2|STARTED|Overall Study||58
478351|NCT01136408|1171869|P1|STARTED|Overall Study||46
478352|NCT01136382|1171926|P2|NOT COMPLETED|Overall Study||31
478353|NCT01136382|1171927|P1|NOT COMPLETED|Overall Study||60
478354|NCT01136382|1171926|P2|COMPLETED|Overall Study||121
478355|NCT01136382|1171927|P1|COMPLETED|Overall Study||92
478356|NCT01136382|1171926|P2|STARTED|Overall Study||152
478357|NCT01136382|1171927|P1|STARTED|Overall Study||152
478358|NCT01136356|1171953|P2|NOT COMPLETED|Second 18-day Withdrawal||1
478359|NCT01136356|1171954|P1|NOT COMPLETED|Second 18-day Withdrawal||0
478360|NCT01136356|1171953|P2|COMPLETED|Second 18-day Withdrawal||5
478361|NCT01136356|1171954|P1|COMPLETED|Second 18-day Withdrawal||2
478362|NCT01136356|1171953|P2|STARTED|Second 18-day Withdrawal||6
478363|NCT01136356|1171954|P1|STARTED|Second 18-day Withdrawal||2
478364|NCT01136356|1171953|P2|NOT COMPLETED|Second Intervention||0
478365|NCT01136356|1171954|P1|NOT COMPLETED|Second Intervention||0
478366|NCT01136356|1171953|P2|COMPLETED|Second Intervention||6
478367|NCT01136356|1171954|P1|COMPLETED|Second Intervention||2
478368|NCT01136356|1171953|P2|STARTED|Second Intervention||6
478369|NCT01136356|1171954|P1|STARTED|Second Intervention||2
478370|NCT01136356|1171953|P2|NOT COMPLETED|First 18-day Withdrawal||0
478371|NCT01136356|1171954|P1|NOT COMPLETED|First 18-day Withdrawal||4
478372|NCT01136356|1171953|P2|COMPLETED|First 18-day Withdrawal||6
478373|NCT01136356|1171954|P1|COMPLETED|First 18-day Withdrawal||2
478374|NCT01136356|1171953|P2|STARTED|First 18-day Withdrawal||6
478375|NCT01136356|1171954|P1|STARTED|First 18-day Withdrawal||6
478376|NCT01136356|1171953|P2|NOT COMPLETED|First Intervention||0
478377|NCT01136356|1171954|P1|NOT COMPLETED|First Intervention||0
478378|NCT01136356|1171953|P2|COMPLETED|First Intervention||6
478379|NCT01136356|1171954|P1|COMPLETED|First Intervention||6
478380|NCT01136356|1171953|P2|STARTED|First Intervention||6
478381|NCT01136356|1171954|P1|STARTED|First Intervention||6
478382|NCT01136291|1171965|P2|NOT COMPLETED|Overall Study||1
478383|NCT01136291|1171966|P1|NOT COMPLETED|Overall Study||1
478384|NCT01136291|1171965|P2|COMPLETED|Overall Study||41
478385|NCT01136291|1171966|P1|COMPLETED|Overall Study||39
478386|NCT01136291|1171965|P2|Follow|Overall Study||42
478387|NCT01136291|1171966|P1|Follow|Overall Study||40
478388|NCT01136291|1171965|P2|STARTED|Overall Study||42
478389|NCT01136291|1171966|P1|STARTED|Overall Study||40
478390|NCT01136226|1171976|P1|NOT COMPLETED|Overall Study||13
478391|NCT01136226|1171976|P1|COMPLETED|Overall Study||29
478392|NCT01136226|1171976|P1|STARTED|Overall Study||42
478393|NCT01136174|1171984|P4|NOT COMPLETED|Overall Study||4
478394|NCT01136174|1171985|P3|NOT COMPLETED|Overall Study||0
478395|NCT01136174|1171986|P2|NOT COMPLETED|Overall Study||0
478396|NCT01136174|1171987|P1|NOT COMPLETED|Overall Study||0
478397|NCT01136174|1171984|P4|COMPLETED|Overall Study||20
478398|NCT01136174|1171985|P3|COMPLETED|Overall Study||8
478399|NCT01136174|1171986|P2|COMPLETED|Overall Study||6
478400|NCT01136174|1171987|P1|COMPLETED|Overall Study||12
478401|NCT01136174|1171984|P4|STARTED|Overall Study||24
478402|NCT01136174|1171985|P3|STARTED|Overall Study||8
478403|NCT01136174|1171986|P2|STARTED|Overall Study||6
478404|NCT01136174|1171987|P1|STARTED|Overall Study||12
478405|NCT01135992|1172067|P1|NOT COMPLETED|Overall Study||21
478406|NCT01135992|1172067|P1|COMPLETED|Overall Study||122
478407|NCT01135992|1172067|P1|Full Analysis Set|Overall Study||129
478408|NCT01135992|1172067|P1|Exposed|Overall Study|One subject was withdrawn before being exposed.|142
478409|NCT01135992|1172067|P1|STARTED|Overall Study||143
478410|NCT01135914|1172079|P3|NOT COMPLETED|Overall Study||22
478411|NCT01135914|1172080|P2|NOT COMPLETED|Overall Study||5
478412|NCT01135914|1172081|P1|NOT COMPLETED|Overall Study||4
478413|NCT01135914|1172079|P3|COMPLETED|Overall Study||59
478414|NCT01135914|1172080|P2|COMPLETED|Overall Study||75
478415|NCT01135914|1172081|P1|COMPLETED|Overall Study||74
478416|NCT01135914|1172079|P3|Safety Population|Overall Study||74
478417|NCT01135914|1172080|P2|Safety Population|Overall Study||75
478418|NCT01135914|1172081|P1|Safety Population|Overall Study||73
478419|NCT01135914|1172079|P3|Intent to Treat (ITT) Population|Overall Study||72
478420|NCT01135914|1172080|P2|Intent to Treat (ITT) Population|Overall Study||75
478421|NCT01135914|1172081|P1|Intent to Treat (ITT) Population|Overall Study||73
478422|NCT01135914|1172079|P3|STARTED|Overall Study||81
478423|NCT01135914|1172080|P2|STARTED|Overall Study||80
478424|NCT01135914|1172081|P1|STARTED|Overall Study||78
478425|NCT01135524|1172110|P1|NOT COMPLETED|Overall Study||196
478426|NCT01135524|1172110|P1|COMPLETED|Overall Study||0
478427|NCT01135524|1172110|P1|STARTED|Overall Study||196
478428|NCT01135511|1172123|P9|NOT COMPLETED|Overall Study||1
478429|NCT01135511|1172124|P8|NOT COMPLETED|Overall Study||1
478430|NCT01135511|1172125|P7|NOT COMPLETED|Overall Study||1
478431|NCT01135511|1172126|P6|NOT COMPLETED|Overall Study||1
478432|NCT01135511|1172127|P5|NOT COMPLETED|Overall Study||1
478433|NCT01135511|1172128|P4|NOT COMPLETED|Overall Study||3
478434|NCT01135511|1172129|P3|NOT COMPLETED|Overall Study||8
478435|NCT01135511|1172130|P2|NOT COMPLETED|Overall Study||3
478436|NCT01135511|1172131|P1|NOT COMPLETED|Overall Study||0
478437|NCT01135511|1172123|P9|COMPLETED|Overall Study||20
478438|NCT01135511|1172124|P8|COMPLETED|Overall Study||20
478439|NCT01135511|1172125|P7|COMPLETED|Overall Study||18
478440|NCT01135511|1172126|P6|COMPLETED|Overall Study||20
478441|NCT01135511|1172127|P5|COMPLETED|Overall Study||38
478442|NCT01135511|1172128|P4|COMPLETED|Overall Study||37
478443|NCT01135511|1172129|P3|COMPLETED|Overall Study||33
478444|NCT01135511|1172130|P2|COMPLETED|Overall Study||39
478445|NCT01135511|1172131|P1|COMPLETED|Overall Study||41
478446|NCT01135511|1172123|P9|STARTED|Overall Study||21
478447|NCT01135511|1172124|P8|STARTED|Overall Study||21
478448|NCT01135511|1172125|P7|STARTED|Overall Study||19
478449|NCT01135511|1172126|P6|STARTED|Overall Study||21
478450|NCT01135511|1172127|P5|STARTED|Overall Study||39
478451|NCT01135511|1172128|P4|STARTED|Overall Study||40
478452|NCT01135511|1172129|P3|STARTED|Overall Study||41
478453|NCT01135511|1172130|P2|STARTED|Overall Study||42
478454|NCT01135511|1172131|P1|STARTED|Overall Study||41
478455|NCT01135498|1172413|P1|NOT COMPLETED|Overall Study||90
478456|NCT01135498|1172413|P1|COMPLETED|Overall Study||0
478457|NCT01135498|1172413|P1|STARTED|Overall Study||90
478458|NCT01135420|1172424|P2|NOT COMPLETED|Overall Study||32
478459|NCT01135420|1172425|P1|NOT COMPLETED|Overall Study||44
478460|NCT01135420|1172424|P2|COMPLETED|Overall Study||175
478461|NCT01135420|1172425|P1|COMPLETED|Overall Study||155
478462|NCT01135420|1172424|P2|STARTED|Overall Study||207
478463|NCT01135420|1172425|P1|STARTED|Overall Study||199
478464|NCT01135381|1172435|P4|NOT COMPLETED|Overall Study||1
478465|NCT01135381|1172436|P3|NOT COMPLETED|Overall Study||4
478466|NCT01135381|1172437|P2|NOT COMPLETED|Overall Study||7
478467|NCT01135381|1172438|P1|NOT COMPLETED|Overall Study||21
478468|NCT01135381|1172435|P4|COMPLETED|Overall Study||67
478469|NCT01135381|1172436|P3|COMPLETED|Overall Study||65
478470|NCT01135381|1172437|P2|COMPLETED|Overall Study||178
478471|NCT01135381|1172438|P1|COMPLETED|Overall Study||168
478472|NCT01135381|1172435|P4|STARTED|Overall Study||68
478473|NCT01135381|1172436|P3|STARTED|Overall Study||69
478474|NCT01135381|1172437|P2|STARTED|Overall Study||185
478475|NCT01135381|1172438|P1|STARTED|Overall Study||189
478476|NCT01135368|1172456|P1|NOT COMPLETED|Overall Study||251
478477|NCT01135368|1172456|P1|COMPLETED|Overall Study||255
478478|NCT01135368|1172456|P1|STARTED|Overall Study||506
478479|NCT01135186|1172572|P1|NOT COMPLETED|Overall Study||0
478480|NCT01135186|1172572|P1|COMPLETED|Overall Study||9
478481|NCT01135186|1172572|P1|STARTED|Overall Study||9
478482|NCT01135134|1172581|P2|NOT COMPLETED|Overall Study||1
478483|NCT01135134|1172582|P1|NOT COMPLETED|Overall Study||2
478484|NCT01135134|1172581|P2|COMPLETED|Overall Study||112
478485|NCT01135134|1172582|P1|COMPLETED|Overall Study||218
478486|NCT01135134|1172581|P2|STARTED|Overall Study||113
478487|NCT01135134|1172582|P1|STARTED|Overall Study||220
478488|NCT01135069|1172593|P3|NOT COMPLETED|Overall Study||10
478489|NCT01135069|1172594|P2|NOT COMPLETED|Overall Study||32
478490|NCT01135069|1172595|P1|NOT COMPLETED|Overall Study||36
478491|NCT01135069|1172593|P3|COMPLETED|Overall Study||56
478492|NCT01135069|1172594|P2|COMPLETED|Overall Study||177
478493|NCT01135069|1172595|P1|COMPLETED|Overall Study||169
478494|NCT01135069|1172593|P3|STARTED|Overall Study||66
478495|NCT01135069|1172594|P2|STARTED|Overall Study||209
478496|NCT01135069|1172595|P1|STARTED|Overall Study||205
478497|NCT01135017|1172605|P2|NOT COMPLETED|Overall Study||12
478498|NCT01135017|1172606|P1|NOT COMPLETED|Overall Study||6
478499|NCT01135017|1172605|P2|COMPLETED|Overall Study|The study was terminated after enrolled participants completed the study period as per protocol|45
478500|NCT01135017|1172606|P1|COMPLETED|Overall Study|The study was terminated after enrolled participants completed the study period as per protocol|49
478501|NCT01135017|1172605|P2|Evaluable for Efficacy|Overall Study|Two participants did not have interrogation of the pacemaker after randomization|55
478502|NCT01135017|1172606|P1|Evaluable for Efficacy|Overall Study||55
478503|NCT01135017|1172605|P2|Treated|Overall Study||57
478504|NCT01135017|1172606|P1|Treated|Overall Study||55
478505|NCT01135017|1172605|P2|STARTED|Overall Study||57
478506|NCT01135017|1172606|P1|STARTED|Overall Study||55
478507|NCT01134952|1172622|P1|NOT COMPLETED|Overall Study||0
478508|NCT01134952|1172622|P1|COMPLETED|Overall Study||11
478509|NCT01134952|1172622|P1|STARTED|Overall Study||11
478510|NCT01134939|1172644|P8|NOT COMPLETED|Overall Study||0
478511|NCT01134939|1172645|P7|NOT COMPLETED|Overall Study||9
478512|NCT01134939|1172646|P6|NOT COMPLETED|Overall Study||9
478513|NCT01134939|1172647|P5|NOT COMPLETED|Overall Study||10
478514|NCT01134939|1172648|P4|NOT COMPLETED|Overall Study||14
478515|NCT01134939|1172649|P3|NOT COMPLETED|Overall Study||10
478516|NCT01134939|1172650|P2|NOT COMPLETED|Overall Study||18
478517|NCT01134939|1172651|P1|NOT COMPLETED|Overall Study||17
478518|NCT01134939|1172644|P8|COMPLETED|Overall Study||1
478519|NCT01134939|1172645|P7|COMPLETED|Overall Study||10
478520|NCT01134939|1172646|P6|COMPLETED|Overall Study||5
478521|NCT01134939|1172647|P5|COMPLETED|Overall Study||23
478522|NCT01134939|1172648|P4|COMPLETED|Overall Study||32
478523|NCT01134939|1172649|P3|COMPLETED|Overall Study||41
478524|NCT01134939|1172650|P2|COMPLETED|Overall Study||24
478525|NCT01134939|1172651|P1|COMPLETED|Overall Study||42
478526|NCT01134939|1172644|P8|STARTED|Overall Study||1
478527|NCT01134939|1172645|P7|STARTED|Overall Study||19
478528|NCT01134939|1172646|P6|STARTED|Overall Study||14
478529|NCT01134939|1172647|P5|STARTED|Overall Study||33
478530|NCT01134939|1172648|P4|STARTED|Overall Study||46
478531|NCT01134939|1172649|P3|STARTED|Overall Study||51
478532|NCT01134939|1172650|P2|STARTED|Overall Study||42
478533|NCT01134939|1172651|P1|STARTED|Overall Study||59
478534|NCT01134900|1172763|P2|NOT COMPLETED|Overall Study||0
478535|NCT01134900|1172764|P1|NOT COMPLETED|Overall Study||0
478536|NCT01134900|1172763|P2|COMPLETED|Overall Study||196
478537|NCT01134900|1172764|P1|COMPLETED|Overall Study||200
478538|NCT01134900|1172763|P2|STARTED|Overall Study||196
478539|NCT01134900|1172764|P1|STARTED|Overall Study||200
478540|NCT01134887|1172776|P4|NOT COMPLETED|Overall Study||0
478541|NCT01134887|1172777|P3|NOT COMPLETED|Overall Study||0
478542|NCT01134887|1172778|P2|NOT COMPLETED|Overall Study||4
478543|NCT01134887|1172779|P1|NOT COMPLETED|Overall Study||0
478544|NCT01134887|1172776|P4|COMPLETED|Overall Study||5
478545|NCT01134887|1172777|P3|COMPLETED|Overall Study||5
478546|NCT01134887|1172778|P2|COMPLETED|Overall Study|Four patients in the Veteran-Control arm did not have two clinic visits videotaped and left study.|7
478547|NCT01134887|1172779|P1|COMPLETED|Overall Study||9
478548|NCT01134887|1172776|P4|STARTED|Overall Study||5
478549|NCT01134887|1172777|P3|STARTED|Overall Study||5
478550|NCT01134887|1172778|P2|STARTED|Overall Study||11
478551|NCT01134887|1172779|P1|STARTED|Overall Study||9
478552|NCT01134783|1172789|P2|NOT COMPLETED|Overall Study||37
478553|NCT01134783|1172790|P1|NOT COMPLETED|Overall Study||36
478554|NCT01134783|1172789|P2|COMPLETED|Overall Study||180
478555|NCT01134783|1172790|P1|COMPLETED|Overall Study||188
478556|NCT01134783|1172789|P2|STARTED|Overall Study||217
478557|NCT01134783|1172790|P1|STARTED|Overall Study||224
478558|NCT01134731|1172809|P3|NOT COMPLETED|Overall Study||8
478559|NCT01134731|1172810|P2|NOT COMPLETED|Overall Study||11
478560|NCT01134731|1172811|P1|NOT COMPLETED|Overall Study||13
478561|NCT01134731|1172809|P3|COMPLETED|Overall Study||2
478562|NCT01134731|1172810|P2|COMPLETED|Overall Study||10
478563|NCT01134731|1172811|P1|COMPLETED|Overall Study||10
478564|NCT01134731|1172809|P3|STARTED|Overall Study||10
478565|NCT01134731|1172810|P2|STARTED|Overall Study||21
478566|NCT01134731|1172811|P1|STARTED|Overall Study||23
478567|NCT01134705|1172824|P2|NOT COMPLETED|Overall Study||22
478568|NCT01134705|1172825|P1|NOT COMPLETED|Overall Study||15
478569|NCT01134705|1172824|P2|COMPLETED|Overall Study||216
478570|NCT01134705|1172825|P1|COMPLETED|Overall Study||221
478571|NCT01134705|1172824|P2|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment.|234
478572|NCT01134705|1172825|P1|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment.|232
478573|NCT01134705|1172824|P2|STARTED|Overall Study||238
478574|NCT01134705|1172825|P1|STARTED|Overall Study||236
478575|NCT01134627|1172837|P2|NOT COMPLETED|Overall Study||67
478576|NCT01134627|1172838|P1|NOT COMPLETED|Overall Study||69
478577|NCT01134627|1172837|P2|COMPLETED|Overall Study||88
478578|NCT01134627|1172838|P1|COMPLETED|Overall Study||80
478579|NCT01134627|1172837|P2|STARTED|Overall Study|Number of participants treated.|155
478580|NCT01134627|1172838|P1|STARTED|Overall Study|Number of participants treated.|149
478581|NCT01134614|1172868|P2|NOT COMPLETED|Overall Study||122
478582|NCT01134614|1172869|P1|NOT COMPLETED|Overall Study||123
478583|NCT01134614|1172868|P2|COMPLETED|Overall Study|Treatment continues until disease progression or unacceptable toxicities|0
478584|NCT01134614|1172869|P1|COMPLETED|Overall Study|Treatment continues until disease progression or unacceptable toxicity.|0
478585|NCT01134614|1172868|P2|Treated and Toxicity Assessed|Overall Study||120
478586|NCT01134614|1172869|P1|Treated and Toxicity Assessed|Overall Study||118
478587|NCT01134614|1172868|P2|Treated|Overall Study||121
478588|NCT01134614|1172869|P1|Treated|Overall Study||119
478589|NCT01134614|1172868|P2|STARTED|Overall Study||122
478590|NCT01134614|1172869|P1|STARTED|Overall Study||123
478591|NCT01134562|1172884|P5|NOT COMPLETED|Overall Study||0
478592|NCT01134562|1172885|P4|NOT COMPLETED|Overall Study||0
478593|NCT01134562|1172886|P3|NOT COMPLETED|Overall Study||0
478594|NCT01134562|1172887|P2|NOT COMPLETED|Overall Study||1
478595|NCT01134562|1172888|P1|NOT COMPLETED|Overall Study||0
478596|NCT01134562|1172884|P5|COMPLETED|Overall Study||8
478597|NCT01134562|1172885|P4|COMPLETED|Overall Study||8
478598|NCT01134562|1172886|P3|COMPLETED|Overall Study||4
478599|NCT01134562|1172887|P2|COMPLETED|Overall Study||3
478600|NCT01134562|1172888|P1|COMPLETED|Overall Study||4
478601|NCT01134562|1172884|P5|STARTED|Overall Study||8
478602|NCT01134562|1172885|P4|STARTED|Overall Study||8
478603|NCT01134562|1172886|P3|STARTED|Overall Study||4
478604|NCT01134562|1172887|P2|STARTED|Overall Study||4
478605|NCT01134562|1172888|P1|STARTED|Overall Study||4
478606|NCT01134549|1172957|P5|NOT COMPLETED|Overall Study||0
478607|NCT01134549|1172958|P4|NOT COMPLETED|Overall Study||0
478608|NCT01134549|1172959|P3|NOT COMPLETED|Overall Study||0
478609|NCT01134549|1172960|P2|NOT COMPLETED|Overall Study||0
478610|NCT01134549|1172961|P1|NOT COMPLETED|Overall Study||0
478611|NCT01134549|1172957|P5|COMPLETED|Overall Study||6
478612|NCT01134549|1172958|P4|COMPLETED|Overall Study||6
478613|NCT01134549|1172959|P3|COMPLETED|Overall Study||6
478614|NCT01134549|1172960|P2|COMPLETED|Overall Study||6
478615|NCT01134549|1172961|P1|COMPLETED|Overall Study||8
478616|NCT01134549|1172957|P5|STARTED|Overall Study||6
478617|NCT01134549|1172958|P4|STARTED|Overall Study||6
478618|NCT01134549|1172959|P3|STARTED|Overall Study||6
478619|NCT01134549|1172960|P2|STARTED|Overall Study||6
478620|NCT01134549|1172961|P1|STARTED|Overall Study||8
478621|NCT01134510|1173047|P2|NOT COMPLETED|Overall Study||1
478622|NCT01134510|1173048|P1|NOT COMPLETED|Overall Study||0
478623|NCT01134510|1173047|P2|COMPLETED|Overall Study||9
478624|NCT01134510|1173048|P1|COMPLETED|Overall Study||10
478625|NCT01134510|1173047|P2|Month 3|Overall Study||9
478626|NCT01134510|1173048|P1|Month 3|Overall Study||10
478627|NCT01134510|1173047|P2|Month 1|Overall Study||10
478628|NCT01134510|1173048|P1|Month 1|Overall Study||10
478629|NCT01134510|1173047|P2|Week 4|Overall Study|Infusion #8 C1 esterase inhibitor vs Placebo|10
478630|NCT01134510|1173048|P1|Week 4|Overall Study|Infusion #8 C1 esterase inhibitor vs Placebo|10
478631|NCT01134510|1173047|P2|Week 4|Overall Study|Infusion #7 C1 esterase inhibitor vs Placebo|10
478632|NCT01134510|1173048|P1|Week 4|Overall Study|Infusion #7 C1 esterase inhibitor vs Placebo|10
478633|NCT01134510|1173047|P2|Week 3|Overall Study|Infusion #6 C1 esterase inhibitor vs Placebo|10
478634|NCT01134510|1173048|P1|Week 3|Overall Study|Infusion #6 C1 esterase inhibitor vs Placebo|10
478635|NCT01134510|1173047|P2|Week 3|Overall Study|Infusion #5 C1 esterase inhibitor vs Placebo|10
478636|NCT01134510|1173048|P1|Week 3|Overall Study|Infusion #5 C1 esterase inhibitor vs Placebo|10
478637|NCT01134510|1173047|P2|Week 2|Overall Study|Infusion #4 C1 esterase inhibitor vs Placebo|10
478638|NCT01134510|1173048|P1|Week 2|Overall Study|Infusion #4 C1 esterase inhibitor vs Placebo|10
478639|NCT01134510|1173047|P2|Week 2|Overall Study|Infusion #3 C1 esterase inhibitor vs Placebo|10
478640|NCT01134510|1173048|P1|Week 2|Overall Study|Infusion #3 C1 esterase inhibitor vs Placebo|10
478641|NCT01134510|1173047|P2|Day 2|Overall Study|Infusion #2 C1 esterase inhibitor vs Placebo|10
478642|NCT01134510|1173048|P1|Day 2|Overall Study|Infusion #2 C1 esterase inhibitor vs Placebo|10
478643|NCT01134510|1173047|P2|STARTED|Overall Study|Transplant Day; Infusion #1 C1 esterase inhibitor vs Placebo|10
478644|NCT01134510|1173048|P1|STARTED|Overall Study|Transplant Day; Infusion #1 C1 esterase inhibitor vs Placebo|10
478645|NCT01134393|1173060|P1|NOT COMPLETED|Overall Study||52
478646|NCT01134393|1173060|P1|COMPLETED|Overall Study|Completed trial medication.|449
478647|NCT01134393|1173060|P1|STARTED|Overall Study|Entered and treated.|501
478648|NCT01134328|1173078|P4|NOT COMPLETED|Overall Study||4
478649|NCT01134328|1173079|P3|NOT COMPLETED|Overall Study||3
478650|NCT01134328|1173080|P2|NOT COMPLETED|Overall Study||3
478651|NCT01134328|1173081|P1|NOT COMPLETED|Overall Study||2
478652|NCT01134328|1173078|P4|COMPLETED|Overall Study||17
478653|NCT01134328|1173079|P3|COMPLETED|Overall Study||17
478654|NCT01134328|1173080|P2|COMPLETED|Overall Study||18
478655|NCT01134328|1173081|P1|COMPLETED|Overall Study||19
478656|NCT01134328|1173078|P4|STARTED|Overall Study||21
478657|NCT01134328|1173079|P3|STARTED|Overall Study||20
478658|NCT01134328|1173080|P2|STARTED|Overall Study||21
478659|NCT01134328|1173081|P1|STARTED|Overall Study||21
478660|NCT01134315|1173181|P2|NOT COMPLETED|Overall Study||19
478661|NCT01134315|1173182|P1|NOT COMPLETED|Overall Study||9
478662|NCT01134315|1173181|P2|COMPLETED|Overall Study|Completed study drug treatment during the observational study (ie, prior to study termination).|21
478663|NCT01134315|1173182|P1|COMPLETED|Overall Study|Completed study drug treatment during the observational study (ie, prior to study termination).|12
478664|NCT01134315|1173181|P2|STARTED|Overall Study||40
478665|NCT01134315|1173182|P1|STARTED|Overall Study||21
478666|NCT01134276|1173204|P2|NOT COMPLETED|Overall Study||0
478667|NCT01134276|1173205|P1|NOT COMPLETED|Overall Study||0
478668|NCT01134276|1173204|P2|COMPLETED|Overall Study||107
478669|NCT01134276|1173205|P1|COMPLETED|Overall Study||104
478670|NCT01134276|1173204|P2|STARTED|Overall Study||107
478671|NCT01134276|1173205|P1|STARTED|Overall Study||104
478672|NCT01134107|1173217|P2|NOT COMPLETED|Period 2-Second Treatment Intervention||0
478673|NCT01134107|1173218|P1|NOT COMPLETED|Period 2-Second Treatment Intervention||4
478674|NCT01134107|1173217|P2|COMPLETED|Period 2-Second Treatment Intervention||61
478675|NCT01134107|1173218|P1|COMPLETED|Period 2-Second Treatment Intervention||57
478676|NCT01134107|1173217|P2|STARTED|Period 2-Second Treatment Intervention||61
478677|NCT01134107|1173218|P1|STARTED|Period 2-Second Treatment Intervention||61
478678|NCT01134107|1173217|P2|NOT COMPLETED|Period 1-First Treatment Intervention||5
478679|NCT01134107|1173218|P1|NOT COMPLETED|Period 1-First Treatment Intervention||6
478680|NCT01134107|1173217|P2|COMPLETED|Period 1-First Treatment Intervention||61
478681|NCT01134107|1173218|P1|COMPLETED|Period 1-First Treatment Intervention||61
478682|NCT01134107|1173217|P2|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66
478683|NCT01134107|1173218|P1|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66
478684|NCT01134107|1173217|P2|STARTED|Period 1-First Treatment Intervention||66
478685|NCT01134107|1173218|P1|STARTED|Period 1-First Treatment Intervention||67
478686|NCT01134081|1173250|P1|NOT COMPLETED|Overall Study||0
478687|NCT01134081|1173250|P1|COMPLETED|Overall Study||44
478688|NCT01134081|1173250|P1|STARTED|Overall Study||44
478689|NCT01134055|1173265|P7|NOT COMPLETED|Overall Study||11
478690|NCT01134055|1173266|P6|NOT COMPLETED|Overall Study||7
478691|NCT01134055|1173267|P5|NOT COMPLETED|Overall Study||6
478692|NCT01134055|1173268|P4|NOT COMPLETED|Overall Study||6
478693|NCT01134055|1173269|P3|NOT COMPLETED|Overall Study||3
478694|NCT01134055|1173270|P2|NOT COMPLETED|Overall Study||6
478695|NCT01134055|1173271|P1|NOT COMPLETED|Overall Study||8
478696|NCT01134055|1173265|P7|COMPLETED|Overall Study||62
478697|NCT01134055|1173266|P6|COMPLETED|Overall Study||65
478698|NCT01134055|1173267|P5|COMPLETED|Overall Study||67
478699|NCT01134055|1173268|P4|COMPLETED|Overall Study||67
478700|NCT01134055|1173269|P3|COMPLETED|Overall Study||71
478701|NCT01134055|1173270|P2|COMPLETED|Overall Study||66
478702|NCT01134055|1173271|P1|COMPLETED|Overall Study||65
478703|NCT01134055|1173265|P7|STARTED|Overall Study||73
478704|NCT01134055|1173266|P6|STARTED|Overall Study||72
478705|NCT01134055|1173267|P5|STARTED|Overall Study||73
478706|NCT01134055|1173268|P4|STARTED|Overall Study||73
478707|NCT01134055|1173269|P3|STARTED|Overall Study||74
478708|NCT01134055|1173270|P2|STARTED|Overall Study||72
478709|NCT01134055|1173271|P1|STARTED|Overall Study||73
478710|NCT01134042|1173405|P3|NOT COMPLETED|Overall Study||34
478711|NCT01134042|1173406|P2|NOT COMPLETED|Overall Study||28
478712|NCT01134042|1173407|P1|NOT COMPLETED|Overall Study||48
478713|NCT01134042|1173405|P3|COMPLETED|Overall Study||161
478714|NCT01134042|1173406|P2|COMPLETED|Overall Study||169
478715|NCT01134042|1173407|P1|COMPLETED|Overall Study||146
478716|NCT01134042|1173405|P3|STARTED|Overall Study||195
478717|NCT01134042|1173406|P2|STARTED|Overall Study||197
478718|NCT01134042|1173407|P1|STARTED|Overall Study||194
478719|NCT01134016|1173445|P1|NOT COMPLETED|Overall Study||3
478720|NCT01134016|1173445|P1|COMPLETED|Overall Study||10
478721|NCT01134016|1173445|P1|STARTED|Overall Study||13
478722|NCT01133977|1173483|P5|NOT COMPLETED|Overall Study||38
478723|NCT01133977|1173484|P4|NOT COMPLETED|Overall Study||39
478724|NCT01133977|1173485|P3|NOT COMPLETED|Overall Study||6
478725|NCT01133977|1173486|P2|NOT COMPLETED|Overall Study||7
478726|NCT01133977|1173487|P1|NOT COMPLETED|Overall Study||3
478727|NCT01133977|1173483|P5|COMPLETED|Overall Study||1
478728|NCT01133977|1173484|P4|COMPLETED|Overall Study||3
478729|NCT01133977|1173485|P3|COMPLETED|Overall Study||0
478730|NCT01133977|1173486|P2|COMPLETED|Overall Study||0
478731|NCT01133977|1173487|P1|COMPLETED|Overall Study||0
478732|NCT01133977|1173483|P5|STARTED|Overall Study|Treated|39
478733|NCT01133977|1173484|P4|STARTED|Overall Study|Treated|42
478734|NCT01133977|1173485|P3|STARTED|Overall Study|Treated|6
478735|NCT01133977|1173486|P2|STARTED|Overall Study|Treated|7
478736|NCT01133977|1173487|P1|STARTED|Overall Study|Treated|3
478737|NCT01133860|1173504|P1|NOT COMPLETED|Overall Study||0
478738|NCT01133860|1173504|P1|COMPLETED|Overall Study||12
478739|NCT01133860|1173504|P1|STARTED|Overall Study||12
478740|NCT01133847|1173514|P3|NOT COMPLETED|Follow-Up Phase||7
478741|NCT01133847|1173515|P2|NOT COMPLETED|Follow-Up Phase||3
478742|NCT01133847|1173516|P1|NOT COMPLETED|Follow-Up Phase||1
478743|NCT01133847|1173514|P3|COMPLETED|Follow-Up Phase||60
478744|NCT01133847|1173515|P2|COMPLETED|Follow-Up Phase||70
478745|NCT01133847|1173516|P1|COMPLETED|Follow-Up Phase||72
478746|NCT01133847|1173514|P3|STARTED|Follow-Up Phase||67
478747|NCT01133847|1173515|P2|STARTED|Follow-Up Phase||73
478748|NCT01133847|1173516|P1|STARTED|Follow-Up Phase||73
478749|NCT01133847|1173514|P3|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||3
478750|NCT01133847|1173515|P2|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||1
478751|NCT01133847|1173516|P1|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||5
478752|NCT01133847|1173514|P3|COMPLETED|Active Treatment Phase (Weeks 1-16)||67
478753|NCT01133847|1173515|P2|COMPLETED|Active Treatment Phase (Weeks 1-16)||73
478754|NCT01133847|1173516|P1|COMPLETED|Active Treatment Phase (Weeks 1-16)||73
478755|NCT01133847|1173514|P3|STARTED|Active Treatment Phase (Weeks 1-16)||70
478756|NCT01133847|1173515|P2|STARTED|Active Treatment Phase (Weeks 1-16)||74
478757|NCT01133847|1173516|P1|STARTED|Active Treatment Phase (Weeks 1-16)||78
478758|NCT01133821|1173556|P2|NOT COMPLETED|Overall Study||19
478759|NCT01133821|1173557|P1|NOT COMPLETED|Overall Study||18
478760|NCT01133821|1173556|P2|COMPLETED|Overall Study||28
478761|NCT01133821|1173557|P1|COMPLETED|Overall Study||27
478762|NCT01133821|1173556|P2|STARTED|Overall Study||47
478763|NCT01133821|1173557|P1|STARTED|Overall Study||45
478764|NCT01133756|1173568|P3|NOT COMPLETED|Overall Study||2
478765|NCT01133756|1173569|P2|NOT COMPLETED|Overall Study||3
478766|NCT01133756|1173570|P1|NOT COMPLETED|Overall Study||2
478767|NCT01133756|1173568|P3|COMPLETED|Overall Study||0
478768|NCT01133756|1173569|P2|COMPLETED|Overall Study||0
478769|NCT01133756|1173570|P1|COMPLETED|Overall Study||0
478770|NCT01133756|1173568|P3|Completed 6 Cycles|Overall Study||0
478771|NCT01133756|1173569|P2|Completed 6 Cycles|Overall Study||0
478772|NCT01133756|1173570|P1|Completed 6 Cycles|Overall Study|One participant completed 6 cycles and remained in the study until 18 Sep 2012.|1
478773|NCT01133756|1173568|P3|STARTED|Overall Study||2
478774|NCT01133756|1173569|P2|STARTED|Overall Study||3
478775|NCT01133756|1173570|P1|STARTED|Overall Study||2
478776|NCT01133704|1173586|P2|NOT COMPLETED|Overall Study||26
478777|NCT01133704|1173587|P1|NOT COMPLETED|Overall Study||49
478778|NCT01133704|1173586|P2|COMPLETED|Overall Study|(including 3 year follow-up)|7
478779|NCT01133704|1173587|P1|COMPLETED|Overall Study|(including 3 year follow-up)|16
478780|NCT01133704|1173586|P2|STARTED|Overall Study||33
478781|NCT01133704|1173587|P1|STARTED|Overall Study||65
478782|NCT01133665|1173595|P1|NOT COMPLETED|Overall Study||2
478783|NCT01133665|1173595|P1|COMPLETED|Overall Study||40
478784|NCT01133665|1173595|P1|STARTED|Overall Study||42
478785|NCT01133626|1173639|P3|NOT COMPLETED|Overall Study||2
478786|NCT01133626|1173640|P2|NOT COMPLETED|Overall Study||5
478787|NCT01133626|1173641|P1|NOT COMPLETED|Overall Study||1
478788|NCT01133626|1173639|P3|COMPLETED|Overall Study||9
478789|NCT01133626|1173640|P2|COMPLETED|Overall Study||41
478790|NCT01133626|1173641|P1|COMPLETED|Overall Study||49
478791|NCT01133626|1173639|P3|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|9
478792|NCT01133626|1173640|P2|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|41
478793|NCT01133626|1173641|P1|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|48
478794|NCT01133626|1173639|P3|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|11
478795|NCT01133626|1173640|P2|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|46
478796|NCT01133626|1173641|P1|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|50
478797|NCT01133626|1173639|P3|STARTED|Overall Study||11
478798|NCT01133626|1173640|P2|STARTED|Overall Study||46
478799|NCT01133626|1173641|P1|STARTED|Overall Study||50
478800|NCT01133522|1173659|P10|NOT COMPLETED|Overall Study||0
478801|NCT01133522|1173660|P9|NOT COMPLETED|Overall Study||0
478802|NCT01133522|1173661|P8|NOT COMPLETED|Overall Study||0
478803|NCT01133522|1173662|P7|NOT COMPLETED|Overall Study||0
478804|NCT01133522|1173663|P6|NOT COMPLETED|Overall Study||0
478805|NCT01133522|1173664|P5|NOT COMPLETED|Overall Study||1
478806|NCT01133522|1173665|P4|NOT COMPLETED|Overall Study||1
478807|NCT01133522|1173666|P3|NOT COMPLETED|Overall Study||0
478808|NCT01133522|1173667|P2|NOT COMPLETED|Overall Study||1
478809|NCT01133522|1173668|P1|NOT COMPLETED|Overall Study||0
478810|NCT01133522|1173659|P10|COMPLETED|Overall Study||4
478811|NCT01133522|1173660|P9|COMPLETED|Overall Study||2
478812|NCT01133522|1173661|P8|COMPLETED|Overall Study||9
478813|NCT01133522|1173662|P7|COMPLETED|Overall Study||2
478814|NCT01133522|1173663|P6|COMPLETED|Overall Study||6
478815|NCT01133522|1173664|P5|COMPLETED|Overall Study||6
478816|NCT01133522|1173665|P4|COMPLETED|Overall Study||6
478817|NCT01133522|1173666|P3|COMPLETED|Overall Study||6
478818|NCT01133522|1173667|P2|COMPLETED|Overall Study||6
478819|NCT01133522|1173668|P1|COMPLETED|Overall Study||10
478820|NCT01133522|1173659|P10|Received Treatment|Overall Study||4
478821|NCT01133522|1173660|P9|Received Treatment|Overall Study||2
478822|NCT01133522|1173661|P8|Received Treatment|Overall Study||9
478823|NCT01133522|1173662|P7|Received Treatment|Overall Study||2
478824|NCT01133522|1173663|P6|Received Treatment|Overall Study||6
478825|NCT01133522|1173664|P5|Received Treatment|Overall Study||6
478826|NCT01133522|1173665|P4|Received Treatment|Overall Study||6
478827|NCT01133522|1173666|P3|Received Treatment|Overall Study||6
478828|NCT01133522|1173667|P2|Received Treatment|Overall Study||6
478829|NCT01133522|1173668|P1|Received Treatment|Overall Study||10
478830|NCT01133522|1173659|P10|STARTED|Overall Study||4
478831|NCT01133522|1173660|P9|STARTED|Overall Study||2
478832|NCT01133522|1173661|P8|STARTED|Overall Study||9
478833|NCT01133522|1173662|P7|STARTED|Overall Study||2
478834|NCT01133522|1173663|P6|STARTED|Overall Study||6
478835|NCT01133522|1173664|P5|STARTED|Overall Study||7
478836|NCT01133522|1173665|P4|STARTED|Overall Study||7
478837|NCT01133522|1173666|P3|STARTED|Overall Study||6
478838|NCT01133522|1173667|P2|STARTED|Overall Study||7
478839|NCT01133522|1173668|P1|STARTED|Overall Study||10
478840|NCT01133418|1173736|P2|NOT COMPLETED|Overall Study||6
478841|NCT01133418|1173737|P1|NOT COMPLETED|Overall Study||5
478842|NCT01133418|1173736|P2|COMPLETED|Overall Study||32
478843|NCT01133418|1173737|P1|COMPLETED|Overall Study||29
478844|NCT01133418|1173736|P2|STARTED|Overall Study||38
478845|NCT01133418|1173737|P1|STARTED|Overall Study||34
478846|NCT01133392|1173751|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
478847|NCT01133392|1173752|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
478848|NCT01133392|1173751|P2|COMPLETED|Fourth Intervention (1 Day)||16
478849|NCT01133392|1173752|P1|COMPLETED|Fourth Intervention (1 Day)||20
478850|NCT01133392|1173751|P2|STARTED|Fourth Intervention (1 Day)||16
478851|NCT01133392|1173752|P1|STARTED|Fourth Intervention (1 Day)||20
478852|NCT01133392|1173751|P2|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1
478853|NCT01133392|1173752|P1|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
478854|NCT01133392|1173751|P2|COMPLETED|Interval Between Dosing (4-7 Days)||16
478855|NCT01133392|1173752|P1|COMPLETED|Interval Between Dosing (4-7 Days)||20
478856|NCT01133392|1173751|P2|STARTED|Interval Between Dosing (4-7 Days)||17
478857|NCT01133392|1173752|P1|STARTED|Interval Between Dosing (4-7 Days)||20
478858|NCT01133392|1173751|P2|NOT COMPLETED|Third Intervention (1 Day)||0
478859|NCT01133392|1173752|P1|NOT COMPLETED|Third Intervention (1 Day)||0
478860|NCT01133392|1173751|P2|COMPLETED|Third Intervention (1 Day)||17
478861|NCT01133392|1173752|P1|COMPLETED|Third Intervention (1 Day)||20
478862|NCT01133392|1173751|P2|STARTED|Third Intervention (1 Day)||17
478863|NCT01133392|1173752|P1|STARTED|Third Intervention (1 Day)||20
478864|NCT01133392|1173751|P2|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
478865|NCT01133392|1173752|P1|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
478866|NCT01133392|1173751|P2|COMPLETED|Interval Between Dosing (4-7 Days)||17
478867|NCT01133392|1173752|P1|COMPLETED|Interval Between Dosing (4-7 Days)||20
478868|NCT01133392|1173751|P2|STARTED|Interval Between Dosing (4-7 Days)||17
478869|NCT01133392|1173752|P1|STARTED|Interval Between Dosing (4-7 Days)||20
478870|NCT01133392|1173751|P2|NOT COMPLETED|Second Intervention (1 Day)||0
478871|NCT01133392|1173752|P1|NOT COMPLETED|Second Intervention (1 Day)||0
478872|NCT01133392|1173751|P2|COMPLETED|Second Intervention (1 Day)||17
478873|NCT01133392|1173752|P1|COMPLETED|Second Intervention (1 Day)||20
478874|NCT01133392|1173751|P2|STARTED|Second Intervention (1 Day)||17
478875|NCT01133392|1173752|P1|STARTED|Second Intervention (1 Day)||20
478876|NCT01133392|1173751|P2|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1
478877|NCT01133392|1173752|P1|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
478878|NCT01133392|1173751|P2|COMPLETED|Interval Between Dosing (4-7 Days)||17
478879|NCT01133392|1173752|P1|COMPLETED|Interval Between Dosing (4-7 Days)||20
478880|NCT01133392|1173751|P2|STARTED|Interval Between Dosing (4-7 Days)||18
478881|NCT01133392|1173752|P1|STARTED|Interval Between Dosing (4-7 Days)||20
478882|NCT01133392|1173751|P2|NOT COMPLETED|First Intervention (1 Day )||0
478883|NCT01133392|1173752|P1|NOT COMPLETED|First Intervention (1 Day )||0
478884|NCT01133392|1173751|P2|COMPLETED|First Intervention (1 Day )||18
478885|NCT01133392|1173752|P1|COMPLETED|First Intervention (1 Day )||20
478886|NCT01133392|1173751|P2|STARTED|First Intervention (1 Day )||18
478887|NCT01133392|1173752|P1|STARTED|First Intervention (1 Day )||20
478888|NCT01133379|1173769|P3|NOT COMPLETED|Overall Study||2
478889|NCT01133379|1173770|P2|NOT COMPLETED|Overall Study||2
478890|NCT01133379|1173771|P1|NOT COMPLETED|Overall Study||1
478891|NCT01133379|1173769|P3|COMPLETED|Overall Study||56
478892|NCT01133379|1173770|P2|COMPLETED|Overall Study||56
478893|NCT01133379|1173771|P1|COMPLETED|Overall Study||57
478894|NCT01133379|1173769|P3|STARTED|Overall Study||58
478895|NCT01133379|1173770|P2|STARTED|Overall Study||58
478896|NCT01133379|1173771|P1|STARTED|Overall Study||58
478897|NCT01133288|1173824|P1|NOT COMPLETED|Intervention Allocation||2
478898|NCT01133288|1173824|P1|COMPLETED|Intervention Allocation||0
478899|NCT01133288|1173824|P1|STARTED|Intervention Allocation||2
478900|NCT01133288|1173824|P1|NOT COMPLETED|Eligibility Assessment||5
478901|NCT01133288|1173824|P1|COMPLETED|Eligibility Assessment||2
478902|NCT01133288|1173824|P1|STARTED|Eligibility Assessment||7
478903|NCT01133275|1173829|P1|NOT COMPLETED|Overall Study||2
478904|NCT01133275|1173829|P1|COMPLETED|Overall Study||26
478905|NCT01133275|1173829|P1|STARTED|Overall Study||28
478906|NCT01133171|1173837|P3|NOT COMPLETED|Overall Study||0
478907|NCT01133171|1173838|P2|NOT COMPLETED|Overall Study||2
478908|NCT01133171|1173839|P1|NOT COMPLETED|Overall Study||1
478909|NCT01133171|1173837|P3|COMPLETED|Overall Study||25
478910|NCT01133171|1173838|P2|COMPLETED|Overall Study||25
478911|NCT01133171|1173839|P1|COMPLETED|Overall Study||24
478912|NCT01133171|1173837|P3|STARTED|Overall Study||25
478913|NCT01133171|1173838|P2|STARTED|Overall Study||27
478914|NCT01133171|1173839|P1|STARTED|Overall Study||25
478915|NCT01132846|1173852|P3|NOT COMPLETED|Overall Study||11
478916|NCT01132846|1173853|P2|NOT COMPLETED|Overall Study||18
478917|NCT01132846|1173854|P1|NOT COMPLETED|Overall Study||16
478918|NCT01132846|1173852|P3|COMPLETED|Overall Study||108
478919|NCT01132846|1173853|P2|COMPLETED|Overall Study||101
478920|NCT01132846|1173854|P1|COMPLETED|Overall Study||106
478921|NCT01132846|1173852|P3|STARTED|Overall Study||119
478922|NCT01132846|1173853|P2|STARTED|Overall Study||119
478923|NCT01132846|1173854|P1|STARTED|Overall Study||122
478924|NCT01132820|1173904|P1|NOT COMPLETED|Overall Study||5
478925|NCT01132820|1173904|P1|COMPLETED|Overall Study||48
478926|NCT01132820|1173904|P1|STARTED|Overall Study||53
478927|NCT01132690|1173915|P2|NOT COMPLETED|Overall Study||0
478928|NCT01132690|1173916|P1|NOT COMPLETED|Overall Study||0
478929|NCT01132690|1173915|P2|COMPLETED|Overall Study||5
478930|NCT01132690|1173916|P1|COMPLETED|Overall Study||6
478931|NCT01132690|1173915|P2|STARTED|Overall Study||5
478932|NCT01132690|1173916|P1|STARTED|Overall Study||6
478933|NCT01132664|1173937|P5|NOT COMPLETED|BM Cohort||6
478934|NCT01132664|1173938|P4|NOT COMPLETED|BM Cohort||3
478935|NCT01132664|1173939|P3|NOT COMPLETED|BM Cohort||0
478936|NCT01132664|1173940|P2|NOT COMPLETED|BM Cohort||0
478937|NCT01132664|1173941|P1|NOT COMPLETED|BM Cohort||0
478938|NCT01132664|1173937|P5|COMPLETED|BM Cohort||0
478939|NCT01132664|1173938|P4|COMPLETED|BM Cohort||0
478940|NCT01132664|1173939|P3|COMPLETED|BM Cohort||0
478941|NCT01132664|1173940|P2|COMPLETED|BM Cohort||0
478942|NCT01132664|1173941|P1|COMPLETED|BM Cohort||0
478943|NCT01132664|1173937|P5|STARTED|BM Cohort||6
478944|NCT01132664|1173938|P4|STARTED|BM Cohort||3
478945|NCT01132664|1173939|P3|STARTED|BM Cohort||0
478946|NCT01132664|1173940|P2|STARTED|BM Cohort||0
478947|NCT01132664|1173941|P1|STARTED|BM Cohort||0
478948|NCT01132664|1173937|P5|NOT COMPLETED|Phase ll||0
478949|NCT01132664|1173938|P4|NOT COMPLETED|Phase ll||0
478950|NCT01132664|1173939|P3|NOT COMPLETED|Phase ll||50
478951|NCT01132664|1173940|P2|NOT COMPLETED|Phase ll||0
478952|NCT01132664|1173941|P1|NOT COMPLETED|Phase ll||0
478953|NCT01132664|1173937|P5|COMPLETED|Phase ll||0
478954|NCT01132664|1173938|P4|COMPLETED|Phase ll||0
478955|NCT01132664|1173939|P3|COMPLETED|Phase ll||0
478956|NCT01132664|1173940|P2|COMPLETED|Phase ll||0
478957|NCT01132664|1173941|P1|COMPLETED|Phase ll||0
478958|NCT01132664|1173937|P5|STARTED|Phase ll||0
478959|NCT01132664|1173938|P4|STARTED|Phase ll||0
478960|NCT01132664|1173939|P3|STARTED|Phase ll|Of the 50 patients, 8 were from phase lb & were eligible for inclusion in Phase II|50
478961|NCT01132664|1173940|P2|STARTED|Phase ll||0
478962|NCT01132664|1173941|P1|STARTED|Phase ll||0
478963|NCT01132664|1173937|P5|NOT COMPLETED|Phase lb||0
478964|NCT01132664|1173938|P4|NOT COMPLETED|Phase lb||0
478965|NCT01132664|1173939|P3|NOT COMPLETED|Phase lb||0
478966|NCT01132664|1173940|P2|NOT COMPLETED|Phase lb||12
478967|NCT01132664|1173941|P1|NOT COMPLETED|Phase lb||5
478968|NCT01132664|1173937|P5|COMPLETED|Phase lb||0
478969|NCT01132664|1173938|P4|COMPLETED|Phase lb||0
478970|NCT01132664|1173939|P3|COMPLETED|Phase lb||0
478971|NCT01132664|1173940|P2|COMPLETED|Phase lb||0
478972|NCT01132664|1173941|P1|COMPLETED|Phase lb||0
478973|NCT01132664|1173937|P5|STARTED|Phase lb||0
478974|NCT01132664|1173938|P4|STARTED|Phase lb||0
478975|NCT01132664|1173939|P3|STARTED|Phase lb||0
478976|NCT01132664|1173940|P2|STARTED|Phase lb||12
478977|NCT01132664|1173941|P1|STARTED|Phase lb||5
478978|NCT01132651|1173975|P2|NOT COMPLETED|Overall Study||1
478979|NCT01132651|1173976|P1|NOT COMPLETED|Overall Study||1
478980|NCT01132651|1173975|P2|COMPLETED|Overall Study||4
478981|NCT01132651|1173976|P1|COMPLETED|Overall Study||3
478982|NCT01132651|1173975|P2|STARTED|Overall Study||5
478983|NCT01132651|1173976|P1|STARTED|Overall Study||4
478984|NCT01132612|1173987|P3|NOT COMPLETED|Overall Study||170
478985|NCT01132612|1173988|P2|NOT COMPLETED|Overall Study||35
478986|NCT01132612|1173989|P1|NOT COMPLETED|Overall Study||40
478987|NCT01132612|1173987|P3|COMPLETED|Overall Study||17
478988|NCT01132612|1173988|P2|COMPLETED|Overall Study||7
478989|NCT01132612|1173989|P1|COMPLETED|Overall Study||6
478990|NCT01132612|1173987|P3|STARTED|Overall Study||187
478991|NCT01132612|1173988|P2|STARTED|Overall Study||42
478992|NCT01132612|1173989|P1|STARTED|Overall Study||46
478993|NCT01132547|1174005|P2|NOT COMPLETED|Overall Study||1
478994|NCT01132547|1174006|P1|NOT COMPLETED|Overall Study||4
478995|NCT01132547|1174005|P2|COMPLETED|Overall Study||12
478996|NCT01132547|1174006|P1|COMPLETED|Overall Study||5
478997|NCT01132547|1174005|P2|STARTED|Overall Study||13
478998|NCT01132547|1174006|P1|STARTED|Overall Study||9
478999|NCT01132508|1174016|P1|NOT COMPLETED|Overall Study||9
479000|NCT01132508|1174016|P1|COMPLETED|Overall Study||24
479001|NCT01132508|1174016|P1|104 Weeks|Overall Study||27
479002|NCT01132508|1174016|P1|78 Weeks|Overall Study||28
479003|NCT01132508|1174016|P1|52 Weeks|Overall Study||30
479004|NCT01132508|1174016|P1|26 Weeks|Overall Study||33
479005|NCT01132508|1174016|P1|12 Weeks|Overall Study||33
479006|NCT01132508|1174016|P1|6 Weeks|Overall Study||33
479007|NCT01132508|1174016|P1|Treated at Baseline|Overall Study||33
479008|NCT01132508|1174016|P1|STARTED|Overall Study||33
479009|NCT01132495|1174076|P4|NOT COMPLETED|Overall Study||12
479010|NCT01132495|1174077|P3|NOT COMPLETED|Overall Study||20
479011|NCT01132495|1174078|P2|NOT COMPLETED|Overall Study||38
479012|NCT01132495|1174079|P1|NOT COMPLETED|Overall Study||40
479013|NCT01132495|1174076|P4|COMPLETED|Overall Study||104
479014|NCT01132495|1174077|P3|COMPLETED|Overall Study||146
479015|NCT01132495|1174078|P2|COMPLETED|Overall Study||403
479016|NCT01132495|1174079|P1|COMPLETED|Overall Study||407
479017|NCT01132495|1174076|P4|STARTED|Overall Study||116
479018|NCT01132495|1174077|P3|STARTED|Overall Study||166
479019|NCT01132495|1174078|P2|STARTED|Overall Study||441
479020|NCT01132495|1174079|P1|STARTED|Overall Study||447
479021|NCT01132378|1174087|P1|NOT COMPLETED|Overall Study||0
479022|NCT01132378|1174087|P1|COMPLETED|Overall Study||40
479023|NCT01132378|1174087|P1|STARTED|Overall Study||40
479024|NCT01132326|1174092|P1|NOT COMPLETED|Overall Study||218
479025|NCT01132326|1174092|P1|COMPLETED|Overall Study||132
479026|NCT01132326|1174092|P1|STARTED|Overall Study||350
479027|NCT01132313|1174108|P12|NOT COMPLETED|Overall Study||0
479028|NCT01132313|1174109|P11|NOT COMPLETED|Overall Study||1
479029|NCT01132313|1174110|P10|NOT COMPLETED|Overall Study||20
479030|NCT01132313|1174111|P9|NOT COMPLETED|Overall Study||21
479031|NCT01132313|1174112|P8|NOT COMPLETED|Overall Study||8
479032|NCT01132313|1174113|P7|NOT COMPLETED|Overall Study||30
479033|NCT01132313|1174114|P6|NOT COMPLETED|Overall Study||25
479034|NCT01132313|1174115|P5|NOT COMPLETED|Overall Study||45
479035|NCT01132313|1174116|P4|NOT COMPLETED|Overall Study||32
479036|NCT01132313|1174117|P3|NOT COMPLETED|Overall Study||20
479037|NCT01132313|1174118|P2|NOT COMPLETED|Overall Study||0
479038|NCT01132313|1174119|P1|NOT COMPLETED|Overall Study||3
479039|NCT01132313|1174108|P12|COMPLETED|Overall Study||2
479040|NCT01132313|1174109|P11|COMPLETED|Overall Study||0
479041|NCT01132313|1174110|P10|COMPLETED|Overall Study||5
479042|NCT01132313|1174111|P9|COMPLETED|Overall Study||5
479043|NCT01132313|1174112|P8|COMPLETED|Overall Study||24
479044|NCT01132313|1174113|P7|COMPLETED|Overall Study||19
479045|NCT01132313|1174114|P6|COMPLETED|Overall Study||54
479046|NCT01132313|1174115|P5|COMPLETED|Overall Study||34
479047|NCT01132313|1174116|P4|COMPLETED|Overall Study||48
479048|NCT01132313|1174117|P3|COMPLETED|Overall Study||61
479049|NCT01132313|1174118|P2|COMPLETED|Overall Study||17
479050|NCT01132313|1174119|P1|COMPLETED|Overall Study||14
479051|NCT01132313|1174108|P12|STARTED|Overall Study||2
479052|NCT01132313|1174109|P11|STARTED|Overall Study||1
479053|NCT01132313|1174110|P10|STARTED|Overall Study||25
479054|NCT01132313|1174111|P9|STARTED|Overall Study||26
479055|NCT01132313|1174112|P8|STARTED|Overall Study||32
479056|NCT01132313|1174113|P7|STARTED|Overall Study||49
479057|NCT01132313|1174114|P6|STARTED|Overall Study||79
479058|NCT01132313|1174115|P5|STARTED|Overall Study||79
479059|NCT01132313|1174116|P4|STARTED|Overall Study||80
479060|NCT01132313|1174117|P3|STARTED|Overall Study||81
479061|NCT01132313|1174118|P2|STARTED|Overall Study||17
479062|NCT01132313|1174119|P1|STARTED|Overall Study||17
479063|NCT01132144|1174176|P2|NOT COMPLETED|Overall Study||0
479064|NCT01132144|1174177|P1|NOT COMPLETED|Overall Study||0
479065|NCT01132144|1174176|P2|COMPLETED|Overall Study||79
479066|NCT01132144|1174177|P1|COMPLETED|Overall Study||79
479067|NCT01132144|1174176|P2|STARTED|Overall Study||79
479068|NCT01132144|1174177|P1|STARTED|Overall Study||79
479069|NCT01132118|1174199|P2|NOT COMPLETED|Second Intervention (8 Weeks)||1
479070|NCT01132118|1174200|P1|NOT COMPLETED|Second Intervention (8 Weeks)||0
479071|NCT01132118|1174199|P2|COMPLETED|Second Intervention (8 Weeks)||11
479072|NCT01132118|1174200|P1|COMPLETED|Second Intervention (8 Weeks)||12
479073|NCT01132118|1174199|P2|STARTED|Second Intervention (8 Weeks)||12
479074|NCT01132118|1174200|P1|STARTED|Second Intervention (8 Weeks)||12
479075|NCT01132118|1174199|P2|NOT COMPLETED|First Intervention (8 Weeks)||3
479076|NCT01132118|1174200|P1|NOT COMPLETED|First Intervention (8 Weeks)||3
479077|NCT01132118|1174199|P2|COMPLETED|First Intervention (8 Weeks)||12
479078|NCT01132118|1174200|P1|COMPLETED|First Intervention (8 Weeks)||12
479079|NCT01132118|1174199|P2|STARTED|First Intervention (8 Weeks)||15
479080|NCT01132118|1174200|P1|STARTED|First Intervention (8 Weeks)||15
479081|NCT01131884|1174220|P2|NOT COMPLETED|Overall Study||0
479082|NCT01131884|1174221|P1|NOT COMPLETED|Overall Study||0
479083|NCT01131884|1174220|P2|COMPLETED|Overall Study||0
479084|NCT01131884|1174221|P1|COMPLETED|Overall Study||1
479085|NCT01131884|1174220|P2|STARTED|Overall Study||0
479086|NCT01131884|1174221|P1|STARTED|Overall Study||1
479087|NCT01131676|1174230|P3|NOT COMPLETED|Discontinuation From Study (Treated Set)||63
479088|NCT01131676|1174231|P2|NOT COMPLETED|Discontinuation From Study (Treated Set)||81
479089|NCT01131676|1174232|P1|NOT COMPLETED|Discontinuation From Study (Treated Set)||67
479090|NCT01131676|1174230|P3|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2279
479091|NCT01131676|1174231|P2|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2264
479092|NCT01131676|1174232|P1|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2266
479093|NCT01131676|1174230|P3|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2327
479094|NCT01131676|1174231|P2|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2324
479095|NCT01131676|1174232|P1|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2316
479096|NCT01131676|1174230|P3|STARTED|Discontinuation From Study (Treated Set)||2342
479097|NCT01131676|1174231|P2|STARTED|Discontinuation From Study (Treated Set)||2345
479098|NCT01131676|1174232|P1|STARTED|Discontinuation From Study (Treated Set)||2333
479099|NCT01131676|1174230|P3|NOT COMPLETED|Discontinuation From Treatment||544
479100|NCT01131676|1174231|P2|NOT COMPLETED|Discontinuation From Treatment||557
479101|NCT01131676|1174232|P1|NOT COMPLETED|Discontinuation From Treatment||687
479102|NCT01131676|1174230|P3|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1800
479103|NCT01131676|1174231|P2|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1790
479104|NCT01131676|1174232|P1|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1650
479105|NCT01131676|1174230|P3|STARTED|Discontinuation From Treatment|Randomised|2344
479106|NCT01131676|1174231|P2|STARTED|Discontinuation From Treatment|Randomised|2347
479107|NCT01131676|1174232|P1|STARTED|Discontinuation From Treatment|Randomised|2337
479108|NCT01131585|1174267|P2|NOT COMPLETED|Overall Study||43
479109|NCT01131585|1174268|P1|NOT COMPLETED|Overall Study||85
479110|NCT01131585|1174267|P2|COMPLETED|Overall Study||0
479111|NCT01131585|1174268|P1|COMPLETED|Overall Study||0
479112|NCT01131585|1174267|P2|STARTED|Overall Study||43
479113|NCT01131585|1174268|P1|STARTED|Overall Study||85
479114|NCT01131520|1174276|P2|NOT COMPLETED|Overall Study||4
479115|NCT01131520|1174277|P1|NOT COMPLETED|Overall Study||1
479116|NCT01131520|1174276|P2|COMPLETED|Overall Study||176
479117|NCT01131520|1174277|P1|COMPLETED|Overall Study||179
479118|NCT01131520|1174276|P2|STARTED|Overall Study||180
479119|NCT01131520|1174277|P1|STARTED|Overall Study||180
479120|NCT01131507|1174299|P1|NOT COMPLETED|Overall Study||3
479121|NCT01131507|1174299|P1|COMPLETED|Overall Study||12
479122|NCT01131507|1174299|P1|STARTED|Overall Study||15
479123|NCT01131494|1174304|P1|NOT COMPLETED|Overall Study||2
479124|NCT01131494|1174304|P1|COMPLETED|Overall Study||15
479125|NCT01131494|1174304|P1|STARTED|Overall Study||17
479126|NCT01131455|1174314|P3|NOT COMPLETED|Overall Study||0
479127|NCT01131455|1174315|P2|NOT COMPLETED|Overall Study||4
479128|NCT01131455|1174316|P1|NOT COMPLETED|Overall Study||6
479129|NCT01131455|1174314|P3|COMPLETED|Overall Study||0
479130|NCT01131455|1174315|P2|COMPLETED|Overall Study||0
479131|NCT01131455|1174316|P1|COMPLETED|Overall Study||0
479132|NCT01131455|1174314|P3|STARTED|Overall Study||0
479133|NCT01131455|1174315|P2|STARTED|Overall Study||4
479134|NCT01131455|1174316|P1|STARTED|Overall Study||6
479135|NCT01131299|1174324|P2|NOT COMPLETED|Overall Study||7
479136|NCT01131299|1174325|P1|NOT COMPLETED|Overall Study||4
479137|NCT01131299|1174324|P2|COMPLETED|Overall Study||37
479138|NCT01131299|1174325|P1|COMPLETED|Overall Study||38
479139|NCT01131299|1174324|P2|STARTED|Overall Study||44
479140|NCT01131299|1174325|P1|STARTED|Overall Study||42
479141|NCT01131182|1174338|P2|NOT COMPLETED|Overall Study||16
479142|NCT01131182|1174339|P1|NOT COMPLETED|Overall Study||16
479143|NCT01131182|1174338|P2|COMPLETED|Overall Study||521
479144|NCT01131182|1174339|P1|COMPLETED|Overall Study||513
479145|NCT01131182|1174338|P2|STARTED|Overall Study||537
479146|NCT01131182|1174339|P1|STARTED|Overall Study||529
479147|NCT01131130|1174347|P1|NOT COMPLETED|Period 3- Crossover||1
479148|NCT01131130|1174347|P1|COMPLETED|Period 3- Crossover||116
479149|NCT01131130|1174347|P1|STARTED|Period 3- Crossover||117
479150|NCT01131130|1174347|P1|NOT COMPLETED|Period 2 - Crossover||0
479151|NCT01131130|1174347|P1|COMPLETED|Period 2 - Crossover||117
479152|NCT01131130|1174347|P1|STARTED|Period 2 - Crossover||117
479153|NCT01131130|1174347|P1|NOT COMPLETED|Period 1 - Baseline||1
479154|NCT01131130|1174347|P1|COMPLETED|Period 1 - Baseline|Participant was discontinued 1 day following dispensing and not reported in result tables|117
479155|NCT01131130|1174347|P1|STARTED|Period 1 - Baseline||118
479156|NCT01131104|1174360|P1|NOT COMPLETED|Overall Study||13
479157|NCT01131104|1174360|P1|COMPLETED|Overall Study||332
479158|NCT01131104|1174360|P1|12-Month Analysis Set|Overall Study||26
479159|NCT01131104|1174360|P1|42-Day Analysis Set|Overall Study||28
479160|NCT01131104|1174360|P1|30-Day Analysis Set|Overall Study||24
479161|NCT01131104|1174360|P1|Adjudication-Confirmed NAION Set|Overall Study||279
479162|NCT01131104|1174360|P1|Study Set|Overall Study||344
479163|NCT01131104|1174360|P1|STARTED|Overall Study||345
479164|NCT01131078|1174367|P3|NOT COMPLETED|Overall Study||102
479165|NCT01131078|1174368|P2|NOT COMPLETED|Overall Study||101
479166|NCT01131078|1174369|P1|NOT COMPLETED|Overall Study||101
479167|NCT01131078|1174367|P3|COMPLETED|Overall Study||1
479168|NCT01131078|1174368|P2|COMPLETED|Overall Study||1
479169|NCT01131078|1174369|P1|COMPLETED|Overall Study||0
479170|NCT01131078|1174367|P3|STARTED|Overall Study||103
479171|NCT01131078|1174368|P2|STARTED|Overall Study||102
479172|NCT01131078|1174369|P1|STARTED|Overall Study||101
479173|NCT01131065|1174425|P1|NOT COMPLETED|Overall Study||0
479174|NCT01131065|1174425|P1|COMPLETED|Overall Study||15
479175|NCT01131065|1174425|P1|STARTED|Overall Study||15
479176|NCT01131052|1174433|P2|NOT COMPLETED|Overall Study||0
479177|NCT01131052|1174434|P1|NOT COMPLETED|Overall Study||0
479178|NCT01131052|1174433|P2|COMPLETED|Overall Study||75
479179|NCT01131052|1174434|P1|COMPLETED|Overall Study||75
479180|NCT01131052|1174433|P2|STARTED|Overall Study||75
479181|NCT01131052|1174434|P1|STARTED|Overall Study||75
479182|NCT01130974|1174456|P2|NOT COMPLETED|Overall Study||13
479183|NCT01130974|1174457|P1|NOT COMPLETED|Overall Study||15
479184|NCT01130974|1174456|P2|COMPLETED|Overall Study||87
479185|NCT01130974|1174457|P1|COMPLETED|Overall Study||85
479186|NCT01130974|1174456|P2|STARTED|Overall Study||100
479187|NCT01130974|1174457|P1|STARTED|Overall Study||100
479188|NCT01130883|1174477|P1|NOT COMPLETED|Overall Study||10
479189|NCT01130883|1174477|P1|COMPLETED|Overall Study||3120
479190|NCT01130883|1174477|P1|Participants Analyzed|Overall Study||3128
479191|NCT01130883|1174477|P1|STARTED|Overall Study||3130
479192|NCT01130844|1174494|P3|NOT COMPLETED|Overall Study||0
479193|NCT01130844|1174495|P2|NOT COMPLETED|Overall Study||0
479194|NCT01130844|1174496|P1|NOT COMPLETED|Overall Study||0
479195|NCT01130844|1174494|P3|COMPLETED|Overall Study||9
479196|NCT01130844|1174495|P2|COMPLETED|Overall Study||22
479197|NCT01130844|1174496|P1|COMPLETED|Overall Study||21
479198|NCT01130844|1174494|P3|STARTED|Overall Study||9
479199|NCT01130844|1174495|P2|STARTED|Overall Study||22
479200|NCT01130844|1174496|P1|STARTED|Overall Study||21
479201|NCT01130831|1174534|P1|NOT COMPLETED|Overall Study||14
479202|NCT01130831|1174534|P1|COMPLETED|Overall Study||52
479203|NCT01130831|1174534|P1|STARTED|Overall Study||66
479204|NCT01130740|1174562|P2|NOT COMPLETED|Overall Study||15
479205|NCT01130740|1174563|P1|NOT COMPLETED|Overall Study||12
479206|NCT01130740|1174562|P2|COMPLETED|Overall Study||136
479207|NCT01130740|1174563|P1|COMPLETED|Overall Study||137
479208|NCT01130740|1174562|P2|STARTED|Overall Study||151
479209|NCT01130740|1174563|P1|STARTED|Overall Study||149
479210|NCT01130597|1174573|P1|NOT COMPLETED|Overall Study||7
479211|NCT01130597|1174573|P1|COMPLETED|Overall Study||56
479212|NCT01130597|1174573|P1|STARTED|Overall Study||63
479213|NCT01130532|1174598|P4|NOT COMPLETED|Period IV (Weeks 13-16)||10
479214|NCT01130532|1174599|P3|NOT COMPLETED|Period IV (Weeks 13-16)||0
479215|NCT01130532|1174600|P2|NOT COMPLETED|Period IV (Weeks 13-16)||0
479216|NCT01130532|1174601|P1|NOT COMPLETED|Period IV (Weeks 13-16)||0
479217|NCT01130532|1174598|P4|COMPLETED|Period IV (Weeks 13-16)||552
479218|NCT01130532|1174599|P3|COMPLETED|Period IV (Weeks 13-16)||0
479219|NCT01130532|1174600|P2|COMPLETED|Period IV (Weeks 13-16)||0
479220|NCT01130532|1174601|P1|COMPLETED|Period IV (Weeks 13-16)||0
479221|NCT01130532|1174598|P4|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||546
479222|NCT01130532|1174599|P3|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
479223|NCT01130532|1174600|P2|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
479224|NCT01130532|1174601|P1|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
479225|NCT01130532|1174598|P4|STARTED|Period IV (Weeks 13-16)|Three participants who completed Period III chose not to continue into Period IV.|562
479226|NCT01130532|1174599|P3|STARTED|Period IV (Weeks 13-16)||0
479227|NCT01130532|1174600|P2|STARTED|Period IV (Weeks 13-16)||0
479228|NCT01130532|1174601|P1|STARTED|Period IV (Weeks 13-16)||0
479229|NCT01130532|1174598|P4|NOT COMPLETED|Period III (Weeks 0-12)||0
479230|NCT01130532|1174599|P3|NOT COMPLETED|Period III (Weeks 0-12)||19
479231|NCT01130532|1174600|P2|NOT COMPLETED|Period III (Weeks 0-12)||18
479232|NCT01130532|1174601|P1|NOT COMPLETED|Period III (Weeks 0-12)||21
479233|NCT01130532|1174598|P4|COMPLETED|Period III (Weeks 0-12)||0
479234|NCT01130532|1174599|P3|COMPLETED|Period III (Weeks 0-12)||190
479235|NCT01130532|1174600|P2|COMPLETED|Period III (Weeks 0-12)||189
479236|NCT01130532|1174601|P1|COMPLETED|Period III (Weeks 0-12)||186
479237|NCT01130532|1174598|P4|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||0
479238|NCT01130532|1174599|P3|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||207
479239|NCT01130532|1174600|P2|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205
479240|NCT01130532|1174601|P1|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205
479241|NCT01130532|1174598|P4|STARTED|Period III (Weeks 0-12)||0
479242|NCT01130532|1174599|P3|STARTED|Period III (Weeks 0-12)||209
479243|NCT01130532|1174600|P2|STARTED|Period III (Weeks 0-12)||207
479244|NCT01130532|1174601|P1|STARTED|Period III (Weeks 0-12)||207
479245|NCT01130493|1174646|P3|NOT COMPLETED|Part 2: OLE||5
479246|NCT01130493|1174647|P2|NOT COMPLETED|Part 2: OLE||3
479247|NCT01130493|1174648|P1|NOT COMPLETED|Part 2: OLE||0
479248|NCT01130493|1174646|P3|COMPLETED|Part 2: OLE||30
479249|NCT01130493|1174647|P2|COMPLETED|Part 2: OLE||36
479250|NCT01130493|1174648|P1|COMPLETED|Part 2: OLE||0
479251|NCT01130493|1174646|P3|STARTED|Part 2: OLE|No subjects received CLE during OLE|35
479252|NCT01130493|1174647|P2|STARTED|Part 2: OLE|All subjects received IPX066 during OLE|39
479253|NCT01130493|1174648|P1|STARTED|Part 2: OLE||0
479254|NCT01130493|1174646|P3|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||2
479255|NCT01130493|1174647|P2|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||0
479256|NCT01130493|1174648|P1|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||0
479257|NCT01130493|1174646|P3|COMPLETED|Part 1: Double-blind Treatment Period 2||39
479258|NCT01130493|1174647|P2|COMPLETED|Part 1: Double-blind Treatment Period 2||45
479259|NCT01130493|1174648|P1|COMPLETED|Part 1: Double-blind Treatment Period 2||0
479260|NCT01130493|1174646|P3|STARTED|Part 1: Double-blind Treatment Period 2||41
479261|NCT01130493|1174647|P2|STARTED|Part 1: Double-blind Treatment Period 2||45
479262|NCT01130493|1174648|P1|STARTED|Part 1: Double-blind Treatment Period 2||0
479263|NCT01130493|1174646|P3|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||2
479264|NCT01130493|1174647|P2|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||1
479265|NCT01130493|1174648|P1|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||0
479266|NCT01130493|1174646|P3|COMPLETED|Part 1: Open-Label IPX066 Washout||41
479267|NCT01130493|1174647|P2|COMPLETED|Part 1: Open-Label IPX066 Washout||45
479268|NCT01130493|1174648|P1|COMPLETED|Part 1: Open-Label IPX066 Washout||0
479269|NCT01130493|1174646|P3|STARTED|Part 1: Open-Label IPX066 Washout||43
479270|NCT01130493|1174647|P2|STARTED|Part 1: Open-Label IPX066 Washout||46
479271|NCT01130493|1174648|P1|STARTED|Part 1: Open-Label IPX066 Washout||0
479272|NCT01130493|1174646|P3|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||0
479273|NCT01130493|1174647|P2|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||2
479274|NCT01130493|1174648|P1|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||0
479275|NCT01130493|1174646|P3|COMPLETED|Part 1: Double-blind Treatment Period 1||43
479276|NCT01130493|1174647|P2|COMPLETED|Part 1: Double-blind Treatment Period 1||46
479277|NCT01130493|1174648|P1|COMPLETED|Part 1: Double-blind Treatment Period 1||0
479278|NCT01130493|1174646|P3|STARTED|Part 1: Double-blind Treatment Period 1|43 were randomized to CLE-IPX066 double-blind treatment sequence|43
479279|NCT01130493|1174647|P2|STARTED|Part 1: Double-blind Treatment Period 1|48 were randomized to IPX066-CLE double-blind treatment sequence|48
479280|NCT01130493|1174648|P1|STARTED|Part 1: Double-blind Treatment Period 1|91 subjects completed IPX066 dose conversion and were then randomized to the two treatment sequences|0
479281|NCT01130493|1174646|P3|NOT COMPLETED|Open-label Dose Conversion to IPX066||0
479282|NCT01130493|1174647|P2|NOT COMPLETED|Open-label Dose Conversion to IPX066||0
479283|NCT01130493|1174648|P1|NOT COMPLETED|Open-label Dose Conversion to IPX066||19
479284|NCT01130493|1174646|P3|COMPLETED|Open-label Dose Conversion to IPX066||0
479285|NCT01130493|1174647|P2|COMPLETED|Open-label Dose Conversion to IPX066||0
479286|NCT01130493|1174648|P1|COMPLETED|Open-label Dose Conversion to IPX066||91
479287|NCT01130493|1174646|P3|STARTED|Open-label Dose Conversion to IPX066||0
479288|NCT01130493|1174647|P2|STARTED|Open-label Dose Conversion to IPX066||0
479289|NCT01130493|1174648|P1|STARTED|Open-label Dose Conversion to IPX066|During the open-label dose conversion to IPX066, all subjects received IPX066|110
479290|NCT01130337|1174665|P1|NOT COMPLETED|Overall Study||14
479291|NCT01130337|1174665|P1|COMPLETED|Overall Study||22
479292|NCT01130337|1174665|P1|STARTED|Overall Study||36
479293|NCT01130168|1174672|P6|NOT COMPLETED|Period 3||0
479294|NCT01130168|1174673|P5|NOT COMPLETED|Period 3||0
479295|NCT01130168|1174674|P4|NOT COMPLETED|Period 3||0
479296|NCT01130168|1174675|P3|NOT COMPLETED|Period 3||0
479297|NCT01130168|1174676|P2|NOT COMPLETED|Period 3||0
479298|NCT01130168|1174677|P1|NOT COMPLETED|Period 3||0
479299|NCT01130168|1174672|P6|COMPLETED|Period 3||6
479300|NCT01130168|1174673|P5|COMPLETED|Period 3||5
479301|NCT01130168|1174674|P4|COMPLETED|Period 3||5
479302|NCT01130168|1174675|P3|COMPLETED|Period 3||5
479303|NCT01130168|1174676|P2|COMPLETED|Period 3||6
479304|NCT01130168|1174677|P1|COMPLETED|Period 3||6
479305|NCT01130168|1174672|P6|STARTED|Period 3||6
479306|NCT01130168|1174673|P5|STARTED|Period 3||5
479307|NCT01130168|1174674|P4|STARTED|Period 3||5
479308|NCT01130168|1174675|P3|STARTED|Period 3||5
479309|NCT01130168|1174676|P2|STARTED|Period 3||6
479310|NCT01130168|1174677|P1|STARTED|Period 3||6
479311|NCT01130168|1174672|P6|NOT COMPLETED|Period 2||0
479312|NCT01130168|1174673|P5|NOT COMPLETED|Period 2||0
479313|NCT01130168|1174674|P4|NOT COMPLETED|Period 2||0
479314|NCT01130168|1174675|P3|NOT COMPLETED|Period 2||0
479315|NCT01130168|1174676|P2|NOT COMPLETED|Period 2||0
479316|NCT01130168|1174677|P1|NOT COMPLETED|Period 2||0
479317|NCT01130168|1174672|P6|COMPLETED|Period 2||6
479318|NCT01130168|1174673|P5|COMPLETED|Period 2||5
479319|NCT01130168|1174674|P4|COMPLETED|Period 2||5
479320|NCT01130168|1174675|P3|COMPLETED|Period 2||5
479321|NCT01130168|1174676|P2|COMPLETED|Period 2||6
479322|NCT01130168|1174677|P1|COMPLETED|Period 2||6
479323|NCT01130168|1174672|P6|STARTED|Period 2||6
479324|NCT01130168|1174673|P5|STARTED|Period 2||5
479325|NCT01130168|1174674|P4|STARTED|Period 2||5
479326|NCT01130168|1174675|P3|STARTED|Period 2||5
479327|NCT01130168|1174676|P2|STARTED|Period 2||6
479328|NCT01130168|1174677|P1|STARTED|Period 2||6
479329|NCT01130168|1174672|P6|NOT COMPLETED|Period 1||0
479330|NCT01130168|1174673|P5|NOT COMPLETED|Period 1||0
479331|NCT01130168|1174674|P4|NOT COMPLETED|Period 1||3
479332|NCT01130168|1174675|P3|NOT COMPLETED|Period 1||1
479333|NCT01130168|1174676|P2|NOT COMPLETED|Period 1||1
479334|NCT01130168|1174677|P1|NOT COMPLETED|Period 1||0
479335|NCT01130168|1174672|P6|COMPLETED|Period 1||6
479336|NCT01130168|1174673|P5|COMPLETED|Period 1||5
479337|NCT01130168|1174674|P4|COMPLETED|Period 1||5
479338|NCT01130168|1174675|P3|COMPLETED|Period 1||5
479339|NCT01130168|1174676|P2|COMPLETED|Period 1||6
479340|NCT01130168|1174677|P1|COMPLETED|Period 1||6
479341|NCT01130168|1174672|P6|STARTED|Period 1||6
479342|NCT01130168|1174673|P5|STARTED|Period 1||5
479343|NCT01130168|1174674|P4|STARTED|Period 1||8
479344|NCT01130168|1174675|P3|STARTED|Period 1||6
479345|NCT01130168|1174676|P2|STARTED|Period 1||7
479346|NCT01130168|1174677|P1|STARTED|Period 1||6
479347|NCT01130103|1174714|P2|NOT COMPLETED|Maintenance Treatment||2
479348|NCT01130103|1174715|P1|NOT COMPLETED|Maintenance Treatment||2
479349|NCT01130103|1174714|P2|COMPLETED|Maintenance Treatment||11
479350|NCT01130103|1174715|P1|COMPLETED|Maintenance Treatment||11
479351|NCT01130103|1174714|P2|STARTED|Maintenance Treatment||13
479352|NCT01130103|1174715|P1|STARTED|Maintenance Treatment||13
479353|NCT01130103|1174714|P2|NOT COMPLETED|Randomized Treatment||5
479354|NCT01130103|1174715|P1|NOT COMPLETED|Randomized Treatment||6
479355|NCT01130103|1174714|P2|COMPLETED|Randomized Treatment||13
479356|NCT01130103|1174715|P1|COMPLETED|Randomized Treatment||13
479357|NCT01130103|1174714|P2|STARTED|Randomized Treatment||18
479358|NCT01130103|1174715|P1|STARTED|Randomized Treatment||19
479359|NCT01130051|1174729|P2|NOT COMPLETED|Period 2||0
479360|NCT01130051|1174730|P1|NOT COMPLETED|Period 2||0
479361|NCT01130051|1174729|P2|COMPLETED|Period 2||6
479362|NCT01130051|1174730|P1|COMPLETED|Period 2||7
479363|NCT01130051|1174729|P2|STARTED|Period 2||6
479364|NCT01130051|1174730|P1|STARTED|Period 2||7
479365|NCT01130051|1174729|P2|NOT COMPLETED|Washout Period of 14 Days||2
479366|NCT01130051|1174730|P1|NOT COMPLETED|Washout Period of 14 Days||1
479367|NCT01130051|1174729|P2|COMPLETED|Washout Period of 14 Days||6
479368|NCT01130051|1174730|P1|COMPLETED|Washout Period of 14 Days||7
479369|NCT01130051|1174729|P2|STARTED|Washout Period of 14 Days||8
479370|NCT01130051|1174730|P1|STARTED|Washout Period of 14 Days||8
479371|NCT01130051|1174729|P2|NOT COMPLETED|Period 1||0
479372|NCT01130051|1174730|P1|NOT COMPLETED|Period 1||0
479373|NCT01130051|1174729|P2|COMPLETED|Period 1||8
479374|NCT01130051|1174730|P1|COMPLETED|Period 1||8
479375|NCT01130051|1174729|P2|STARTED|Period 1||8
479376|NCT01130051|1174730|P1|STARTED|Period 1||8
479377|NCT01129960|1174744|P4|NOT COMPLETED|Overall Study||13
479378|NCT01129960|1174745|P3|NOT COMPLETED|Overall Study||26
479379|NCT01129960|1174746|P2|NOT COMPLETED|Overall Study||22
479380|NCT01129960|1174747|P1|NOT COMPLETED|Overall Study||30
479381|NCT01129960|1174744|P4|COMPLETED|Overall Study||70
479382|NCT01129960|1174745|P3|COMPLETED|Overall Study||56
479383|NCT01129960|1174746|P2|COMPLETED|Overall Study||61
479384|NCT01129960|1174747|P1|COMPLETED|Overall Study||54
479385|NCT01129960|1174744|P4|Full Analysis Set (FAS|Overall Study||71
479386|NCT01129960|1174745|P3|Full Analysis Set (FAS|Overall Study||68
479387|NCT01129960|1174746|P2|Full Analysis Set (FAS|Overall Study||67
479388|NCT01129960|1174747|P1|Full Analysis Set (FAS|Overall Study||71
479389|NCT01129960|1174744|P4|Per-Protocol|Overall Study||55
479390|NCT01129960|1174745|P3|Per-Protocol|Overall Study||49
479391|NCT01129960|1174746|P2|Per-Protocol|Overall Study||52
479392|NCT01129960|1174747|P1|Per-Protocol|Overall Study||34
479393|NCT01129960|1174744|P4|Intent-to-Treat|Overall Study||83
479394|NCT01129960|1174745|P3|Intent-to-Treat|Overall Study||82
479395|NCT01129960|1174746|P2|Intent-to-Treat|Overall Study||83
479396|NCT01129960|1174747|P1|Intent-to-Treat|Overall Study||84
479397|NCT01129960|1174744|P4|Safety|Overall Study||82
479398|NCT01129960|1174745|P3|Safety|Overall Study|One subject was randomized to placebo, but was dispensed in error with an ESL 800 mg kit at DB Visit|83
479399|NCT01129960|1174746|P2|Safety|Overall Study||83
479400|NCT01129960|1174747|P1|Safety|Overall Study||84
479401|NCT01129960|1174744|P4|STARTED|Overall Study||83
479402|NCT01129960|1174745|P3|STARTED|Overall Study||82
479403|NCT01129960|1174746|P2|STARTED|Overall Study||83
479404|NCT01129960|1174747|P1|STARTED|Overall Study||84
479405|NCT01129921|1174759|P2|NOT COMPLETED|After Sham Cross-over to Mild, One Year||7
479406|NCT01129921|1174760|P1|NOT COMPLETED|After Sham Cross-over to Mild, One Year||2
479407|NCT01129921|1174759|P2|COMPLETED|After Sham Cross-over to Mild, One Year|All 20 completed Wk 6-12 Intent to Treat analysis prior to x-over. After x-over 13 reported Year 1.|13
479408|NCT01129921|1174760|P1|COMPLETED|After Sham Cross-over to Mild, One Year|All 20 completed Wk 6-12 Intent to Treat analysis. Eighteen reported Year 1 outcomes.|18
479409|NCT01129921|1174759|P2|STARTED|After Sham Cross-over to Mild, One Year||20
479410|NCT01129921|1174760|P1|STARTED|After Sham Cross-over to Mild, One Year||20
479411|NCT01129921|1174759|P2|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0
479412|NCT01129921|1174760|P1|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0
479413|NCT01129921|1174759|P2|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20
479414|NCT01129921|1174760|P1|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20
479415|NCT01129921|1174759|P2|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20
479416|NCT01129921|1174760|P1|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20
479417|NCT01129778|1174770|P1|NOT COMPLETED|Overall Study||7
479418|NCT01129778|1174770|P1|COMPLETED|Overall Study||15
479419|NCT01129778|1174770|P1|STARTED|Overall Study||22
479420|NCT01129765|1174775|P1|NOT COMPLETED|Overall Study||0
479421|NCT01129765|1174775|P1|COMPLETED|Overall Study||30
479422|NCT01129765|1174775|P1|STARTED|Overall Study||30
479423|NCT01129622|1174784|P1|NOT COMPLETED|Overall Study||2
479424|NCT01129622|1174784|P1|COMPLETED|Overall Study||14
479425|NCT01129622|1174784|P1|STARTED|Overall Study||16
479426|NCT01129583|1174791|P2|NOT COMPLETED|Overall Study||2
479427|NCT01129583|1174792|P1|NOT COMPLETED|Overall Study||3
479428|NCT01129583|1174791|P2|COMPLETED|Overall Study||7
479429|NCT01129583|1174792|P1|COMPLETED|Overall Study||6
479430|NCT01129583|1174791|P2|STARTED|Overall Study||9
479431|NCT01129583|1174792|P1|STARTED|Overall Study||9
479432|NCT01129557|1174805|P3|NOT COMPLETED|Overall Study||4
479433|NCT01129557|1174806|P2|NOT COMPLETED|Overall Study||5
479434|NCT01129557|1174807|P1|NOT COMPLETED|Overall Study||4
479435|NCT01129557|1174805|P3|COMPLETED|Overall Study||10
479436|NCT01129557|1174806|P2|COMPLETED|Overall Study||12
479437|NCT01129557|1174807|P1|COMPLETED|Overall Study||11
479438|NCT01129557|1174805|P3|STARTED|Overall Study||14
479439|NCT01129557|1174806|P2|STARTED|Overall Study||17
479440|NCT01129557|1174807|P1|STARTED|Overall Study||15
479441|NCT01129531|1174878|P3|NOT COMPLETED|Treatment Cycle 2||5
479442|NCT01129531|1174879|P2|NOT COMPLETED|Treatment Cycle 2||3
479443|NCT01129531|1174880|P1|NOT COMPLETED|Treatment Cycle 2||6
479444|NCT01129531|1174878|P3|COMPLETED|Treatment Cycle 2||74
479445|NCT01129531|1174879|P2|COMPLETED|Treatment Cycle 2||92
479446|NCT01129531|1174880|P1|COMPLETED|Treatment Cycle 2||88
479447|NCT01129531|1174878|P3|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|79
479448|NCT01129531|1174879|P2|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|95
479449|NCT01129531|1174880|P1|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|94
479450|NCT01129531|1174878|P3|NOT COMPLETED|Treatment Cycle 1||16
479451|NCT01129531|1174879|P2|NOT COMPLETED|Treatment Cycle 1||6
479452|NCT01129531|1174880|P1|NOT COMPLETED|Treatment Cycle 1||4
479453|NCT01129531|1174878|P3|COMPLETED|Treatment Cycle 1||110
479454|NCT01129531|1174879|P2|COMPLETED|Treatment Cycle 1||78
479455|NCT01129531|1174880|P1|COMPLETED|Treatment Cycle 1||80
479456|NCT01129531|1174878|P3|STARTED|Treatment Cycle 1||126
479457|NCT01129531|1174879|P2|STARTED|Treatment Cycle 1||84
479458|NCT01129531|1174880|P1|STARTED|Treatment Cycle 1||84
479459|NCT01129336|1174902|P2|NOT COMPLETED|Overall Study||16
479460|NCT01129336|1174903|P1|NOT COMPLETED|Overall Study||12
479461|NCT01129336|1174902|P2|COMPLETED|Overall Study|Completed indicates Completed Study as per protocol.|13
479462|NCT01129336|1174903|P1|COMPLETED|Overall Study|Completed indicates Completed Study as per protocol.|3
479463|NCT01129336|1174902|P2|Completed Treatment|Overall Study||3
479464|NCT01129336|1174903|P1|Completed Treatment|Overall Study||1
479465|NCT01129336|1174902|P2|STARTED|Overall Study||29
479466|NCT01129336|1174903|P1|STARTED|Overall Study||15
479467|NCT01129284|1174918|P3|NOT COMPLETED|Overall Study||1
479468|NCT01129284|1174919|P2|NOT COMPLETED|Overall Study||0
479469|NCT01129284|1174920|P1|NOT COMPLETED|Overall Study||2
479470|NCT01129284|1174918|P3|COMPLETED|Overall Study||4
479471|NCT01129284|1174919|P2|COMPLETED|Overall Study||5
479472|NCT01129284|1174920|P1|COMPLETED|Overall Study||3
479473|NCT01129284|1174918|P3|STARTED|Overall Study||5
479474|NCT01129284|1174919|P2|STARTED|Overall Study||5
479475|NCT01129284|1174920|P1|STARTED|Overall Study||5
479476|NCT01129245|1174933|P2|NOT COMPLETED|Overall Study||0
479477|NCT01129245|1174934|P1|NOT COMPLETED|Overall Study||0
479478|NCT01129245|1174933|P2|COMPLETED|Overall Study||4
479479|NCT01129245|1174934|P1|COMPLETED|Overall Study||7
479480|NCT01129245|1174933|P2|STARTED|Overall Study||4
479481|NCT01129245|1174934|P1|STARTED|Overall Study||7
479482|NCT01129206|1174940|P1|NOT COMPLETED|Overall Study||0
479483|NCT01129206|1174940|P1|COMPLETED|Overall Study||6
479484|NCT01129206|1174940|P1|STARTED|Overall Study||6
479485|NCT01129141|1174950|P2|NOT COMPLETED|Overall Study||13
479486|NCT01129141|1174951|P1|NOT COMPLETED|Overall Study||15
479487|NCT01129141|1174950|P2|COMPLETED|Overall Study||91
479488|NCT01129141|1174951|P1|COMPLETED|Overall Study||86
479489|NCT01129141|1174950|P2|STARTED|Overall Study||104
479490|NCT01129141|1174951|P1|STARTED|Overall Study||101
479491|NCT01129128|1174960|P3|NOT COMPLETED|Overall Study||4
479492|NCT01129128|1174961|P2|NOT COMPLETED|Overall Study||4
479493|NCT01129128|1174962|P1|NOT COMPLETED|Overall Study||3
479494|NCT01129128|1174960|P3|COMPLETED|Overall Study||19
479495|NCT01129128|1174961|P2|COMPLETED|Overall Study||18
479496|NCT01129128|1174962|P1|COMPLETED|Overall Study||19
479497|NCT01129128|1174960|P3|STARTED|Overall Study||23
479498|NCT01129128|1174961|P2|STARTED|Overall Study||22
479499|NCT01129128|1174962|P1|STARTED|Overall Study||22
479500|NCT01129115|1174986|P4|NOT COMPLETED|Overall Study||9
479501|NCT01129115|1174987|P3|NOT COMPLETED|Overall Study||6
479502|NCT01129115|1174988|P2|NOT COMPLETED|Overall Study||7
479503|NCT01129115|1174989|P1|NOT COMPLETED|Overall Study||2
479504|NCT01129115|1174986|P4|COMPLETED|Overall Study||15
479505|NCT01129115|1174987|P3|COMPLETED|Overall Study||21
479506|NCT01129115|1174988|P2|COMPLETED|Overall Study||18
479507|NCT01129115|1174989|P1|COMPLETED|Overall Study||23
479508|NCT01129115|1174986|P4|STARTED|Overall Study||24
479509|NCT01129115|1174987|P3|STARTED|Overall Study||27
479510|NCT01129115|1174988|P2|STARTED|Overall Study||25
479511|NCT01129115|1174989|P1|STARTED|Overall Study||25
479512|NCT01129102|1175026|P3|NOT COMPLETED|Overall Study||7
479513|NCT01129102|1175027|P2|NOT COMPLETED|Overall Study||6
479514|NCT01129102|1175028|P1|NOT COMPLETED|Overall Study||8
479515|NCT01129102|1175026|P3|COMPLETED|Overall Study||48
479516|NCT01129102|1175027|P2|COMPLETED|Overall Study||44
479517|NCT01129102|1175028|P1|COMPLETED|Overall Study||102
479518|NCT01129102|1175026|P3|STARTED|Overall Study||55
479519|NCT01129102|1175027|P2|STARTED|Overall Study||50
479520|NCT01129102|1175028|P1|STARTED|Overall Study||110
479521|NCT01129011|1175039|P2|NOT COMPLETED|Overall Study||57
479522|NCT01129011|1175040|P1|NOT COMPLETED|Overall Study||59
479523|NCT01129011|1175039|P2|COMPLETED|Overall Study||153
479524|NCT01129011|1175040|P1|COMPLETED|Overall Study||151
479525|NCT01129011|1175039|P2|STARTED|Overall Study|Safety, Intent-to-Treat population|210
479526|NCT01129011|1175040|P1|STARTED|Overall Study|Safety, Intent-to-Treat population|210
479527|NCT01128972|1175062|P5|NOT COMPLETED|Period V||0
479528|NCT01128972|1175063|P4|NOT COMPLETED|Period V||0
479529|NCT01128972|1175064|P3|NOT COMPLETED|Period V||0
479530|NCT01128972|1175065|P2|NOT COMPLETED|Period V||0
479531|NCT01128972|1175066|P1|NOT COMPLETED|Period V||0
479532|NCT01128972|1175062|P5|COMPLETED|Period V||7
479533|NCT01128972|1175063|P4|COMPLETED|Period V||7
479534|NCT01128972|1175064|P3|COMPLETED|Period V||7
479535|NCT01128972|1175065|P2|COMPLETED|Period V||7
479536|NCT01128972|1175066|P1|COMPLETED|Period V||8
479537|NCT01128972|1175062|P5|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
479538|NCT01128972|1175063|P4|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
479539|NCT01128972|1175064|P3|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
479540|NCT01128972|1175065|P2|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
479541|NCT01128972|1175066|P1|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|8
479542|NCT01128972|1175062|P5|NOT COMPLETED|Period IV||0
479543|NCT01128972|1175063|P4|NOT COMPLETED|Period IV||0
479544|NCT01128972|1175064|P3|NOT COMPLETED|Period IV||0
479545|NCT01128972|1175065|P2|NOT COMPLETED|Period IV||0
479546|NCT01128972|1175066|P1|NOT COMPLETED|Period IV||0
479547|NCT01128972|1175062|P5|COMPLETED|Period IV||7
479548|NCT01128972|1175063|P4|COMPLETED|Period IV||7
479549|NCT01128972|1175064|P3|COMPLETED|Period IV||7
479550|NCT01128972|1175065|P2|COMPLETED|Period IV||8
479551|NCT01128972|1175066|P1|COMPLETED|Period IV||7
479552|NCT01128972|1175062|P5|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
479553|NCT01128972|1175063|P4|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
479554|NCT01128972|1175064|P3|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
479555|NCT01128972|1175065|P2|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|8
479556|NCT01128972|1175066|P1|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
479557|NCT01128972|1175062|P5|NOT COMPLETED|Period III||0
479558|NCT01128972|1175063|P4|NOT COMPLETED|Period III||0
479559|NCT01128972|1175064|P3|NOT COMPLETED|Period III||0
479560|NCT01128972|1175065|P2|NOT COMPLETED|Period III||0
479561|NCT01128972|1175066|P1|NOT COMPLETED|Period III||0
479562|NCT01128972|1175062|P5|COMPLETED|Period III||7
479563|NCT01128972|1175063|P4|COMPLETED|Period III||7
479564|NCT01128972|1175064|P3|COMPLETED|Period III||8
479565|NCT01128972|1175065|P2|COMPLETED|Period III||7
479566|NCT01128972|1175066|P1|COMPLETED|Period III||7
479567|NCT01128972|1175062|P5|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
479568|NCT01128972|1175063|P4|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
479569|NCT01128972|1175064|P3|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|8
479570|NCT01128972|1175065|P2|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
479571|NCT01128972|1175066|P1|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
479572|NCT01128972|1175062|P5|NOT COMPLETED|Period II||0
479573|NCT01128972|1175063|P4|NOT COMPLETED|Period II||0
479574|NCT01128972|1175064|P3|NOT COMPLETED|Period II||0
479575|NCT01128972|1175065|P2|NOT COMPLETED|Period II||0
479576|NCT01128972|1175066|P1|NOT COMPLETED|Period II||0
479577|NCT01128972|1175062|P5|COMPLETED|Period II||7
479578|NCT01128972|1175063|P4|COMPLETED|Period II||8
479579|NCT01128972|1175064|P3|COMPLETED|Period II||7
479580|NCT01128972|1175065|P2|COMPLETED|Period II||7
479581|NCT01128972|1175066|P1|COMPLETED|Period II||7
479582|NCT01128972|1175062|P5|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
479583|NCT01128972|1175063|P4|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|8
479584|NCT01128972|1175064|P3|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
479585|NCT01128972|1175065|P2|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
479586|NCT01128972|1175066|P1|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
479587|NCT01128972|1175062|P5|NOT COMPLETED|Period I||0
479588|NCT01128972|1175063|P4|NOT COMPLETED|Period I||0
479589|NCT01128972|1175064|P3|NOT COMPLETED|Period I||0
479590|NCT01128972|1175065|P2|NOT COMPLETED|Period I||0
479591|NCT01128972|1175066|P1|NOT COMPLETED|Period I||0
479592|NCT01128972|1175062|P5|COMPLETED|Period I||8
479593|NCT01128972|1175063|P4|COMPLETED|Period I||7
479594|NCT01128972|1175064|P3|COMPLETED|Period I||7
479595|NCT01128972|1175065|P2|COMPLETED|Period I||7
479596|NCT01128972|1175066|P1|COMPLETED|Period I||7
479597|NCT01128972|1175062|P5|STARTED|Period I||8
479598|NCT01128972|1175063|P4|STARTED|Period I||7
479599|NCT01128972|1175064|P3|STARTED|Period I||7
479600|NCT01128972|1175065|P2|STARTED|Period I||7
479601|NCT01128972|1175066|P1|STARTED|Period I||7
479602|NCT01128959|1175095|P1|NOT COMPLETED|Treatment Period||4
479603|NCT01128959|1175095|P1|COMPLETED|Treatment Period||101
479604|NCT01128959|1175095|P1|STARTED|Treatment Period||105
479605|NCT01128959|1175095|P1|NOT COMPLETED|Lead in Period||3
479606|NCT01128959|1175095|P1|COMPLETED|Lead in Period||105
479607|NCT01128959|1175095|P1|STARTED|Lead in Period||108
479608|NCT01128946|1175101|P4|NOT COMPLETED|Period IV||0
479609|NCT01128946|1175102|P3|NOT COMPLETED|Period IV||0
479610|NCT01128946|1175103|P2|NOT COMPLETED|Period IV||0
479611|NCT01128946|1175104|P1|NOT COMPLETED|Period IV||0
479612|NCT01128946|1175101|P4|COMPLETED|Period IV||19
479613|NCT01128946|1175102|P3|COMPLETED|Period IV||19
479614|NCT01128946|1175103|P2|COMPLETED|Period IV||20
479615|NCT01128946|1175104|P1|COMPLETED|Period IV||19
479616|NCT01128946|1175101|P4|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
479617|NCT01128946|1175102|P3|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
479699|NCT01128595|1175399|P1|COMPLETED|Treatment Period 4||7
479618|NCT01128946|1175103|P2|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|20
479619|NCT01128946|1175104|P1|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
479620|NCT01128946|1175101|P4|NOT COMPLETED|Period III||0
479621|NCT01128946|1175102|P3|NOT COMPLETED|Period III||0
479622|NCT01128946|1175103|P2|NOT COMPLETED|Period III||0
479623|NCT01128946|1175104|P1|NOT COMPLETED|Period III||1
479624|NCT01128946|1175101|P4|COMPLETED|Period III||19
479625|NCT01128946|1175102|P3|COMPLETED|Period III||20
479626|NCT01128946|1175103|P2|COMPLETED|Period III||19
479627|NCT01128946|1175104|P1|COMPLETED|Period III||19
479628|NCT01128946|1175101|P4|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|19
479629|NCT01128946|1175102|P3|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|20
479630|NCT01128946|1175103|P2|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|19
479631|NCT01128946|1175104|P1|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|20
479632|NCT01128946|1175101|P4|NOT COMPLETED|Period II||1
479633|NCT01128946|1175102|P3|NOT COMPLETED|Period II||0
479634|NCT01128946|1175103|P2|NOT COMPLETED|Period II||1
479635|NCT01128946|1175104|P1|NOT COMPLETED|Period II||0
479636|NCT01128946|1175101|P4|COMPLETED|Period II||19
479637|NCT01128946|1175102|P3|COMPLETED|Period II||20
479638|NCT01128946|1175103|P2|COMPLETED|Period II||19
479639|NCT01128946|1175104|P1|COMPLETED|Period II||20
479640|NCT01128946|1175101|P4|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
479641|NCT01128946|1175102|P3|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
479642|NCT01128946|1175103|P2|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
479643|NCT01128946|1175104|P1|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
479644|NCT01128946|1175101|P4|NOT COMPLETED|Period I||1
479645|NCT01128946|1175102|P3|NOT COMPLETED|Period I||1
479646|NCT01128946|1175103|P2|NOT COMPLETED|Period I||1
479647|NCT01128946|1175104|P1|NOT COMPLETED|Period I||0
479648|NCT01128946|1175101|P4|COMPLETED|Period I||20
479649|NCT01128946|1175102|P3|COMPLETED|Period I||20
479650|NCT01128946|1175103|P2|COMPLETED|Period I||20
479651|NCT01128946|1175104|P1|COMPLETED|Period I||20
479652|NCT01128946|1175101|P4|STARTED|Period I||21
479653|NCT01128946|1175102|P3|STARTED|Period I||21
479654|NCT01128946|1175103|P2|STARTED|Period I||21
479655|NCT01128946|1175104|P1|STARTED|Period I||20
479656|NCT01128894|1175122|P2|NOT COMPLETED|Overall Study||68
479657|NCT01128894|1175123|P1|NOT COMPLETED|Overall Study||58
479658|NCT01128894|1175122|P2|COMPLETED|Overall Study||340
479659|NCT01128894|1175123|P1|COMPLETED|Overall Study||346
479660|NCT01128894|1175122|P2|STARTED|Overall Study||408
479661|NCT01128894|1175123|P1|STARTED|Overall Study||404
479662|NCT01128829|1175141|P2|NOT COMPLETED|Overall Study||0
479663|NCT01128829|1175142|P1|NOT COMPLETED|Overall Study||0
479664|NCT01128829|1175141|P2|COMPLETED|Overall Study||11
479665|NCT01128829|1175142|P1|COMPLETED|Overall Study||6
479666|NCT01128829|1175141|P2|STARTED|Overall Study||11
479667|NCT01128829|1175142|P1|STARTED|Overall Study||6
479668|NCT01128738|1175148|P2|NOT COMPLETED|Second TP||3
479669|NCT01128738|1175149|P1|NOT COMPLETED|Second TP||0
479670|NCT01128738|1175148|P2|COMPLETED|Second TP||63
479671|NCT01128738|1175149|P1|COMPLETED|Second TP||34
479672|NCT01128738|1175148|P2|STARTED|Second TP|Only participants who received a second treatment entered this phase.|66
479673|NCT01128738|1175149|P1|STARTED|Second TP|Only participants who received a second treatment entered this phase.|34
479674|NCT01128738|1175148|P2|NOT COMPLETED|First Treatment Phase (TP)||1
479675|NCT01128738|1175149|P1|NOT COMPLETED|First Treatment Phase (TP)||4
479676|NCT01128738|1175148|P2|COMPLETED|First Treatment Phase (TP)||73
479677|NCT01128738|1175149|P1|COMPLETED|First Treatment Phase (TP)||74
479678|NCT01128738|1175148|P2|STARTED|First Treatment Phase (TP)||74
479679|NCT01128738|1175149|P1|STARTED|First Treatment Phase (TP)||78
479680|NCT01128621|1175274|P2|NOT COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||2
479681|NCT01128621|1175275|P1|NOT COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
479682|NCT01128621|1175274|P2|COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||65
479683|NCT01128621|1175275|P1|COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
479684|NCT01128621|1175274|P2|STARTED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||67
479685|NCT01128621|1175275|P1|STARTED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
479686|NCT01128621|1175274|P2|NOT COMPLETED|Part A: GSK1292263 300 mg||0
479687|NCT01128621|1175275|P1|NOT COMPLETED|Part A: GSK1292263 300 mg||0
479688|NCT01128621|1175274|P2|COMPLETED|Part A: GSK1292263 300 mg||0
479689|NCT01128621|1175275|P1|COMPLETED|Part A: GSK1292263 300 mg||6
479690|NCT01128621|1175274|P2|STARTED|Part A: GSK1292263 300 mg||0
479691|NCT01128621|1175275|P1|STARTED|Part A: GSK1292263 300 mg||6
479692|NCT01128595|1175396|P4|NOT COMPLETED|Treatment Period 4||0
479693|NCT01128595|1175397|P3|NOT COMPLETED|Treatment Period 4||0
479694|NCT01128595|1175398|P2|NOT COMPLETED|Treatment Period 4||0
479695|NCT01128595|1175399|P1|NOT COMPLETED|Treatment Period 4||0
479696|NCT01128595|1175396|P4|COMPLETED|Treatment Period 4||7
479697|NCT01128595|1175397|P3|COMPLETED|Treatment Period 4||7
479698|NCT01128595|1175398|P2|COMPLETED|Treatment Period 4||5
479700|NCT01128595|1175396|P4|STARTED|Treatment Period 4||7
479701|NCT01128595|1175397|P3|STARTED|Treatment Period 4||7
479702|NCT01128595|1175398|P2|STARTED|Treatment Period 4||5
479703|NCT01128595|1175399|P1|STARTED|Treatment Period 4||7
479704|NCT01128595|1175396|P4|NOT COMPLETED|Washout Period 3||0
479705|NCT01128595|1175397|P3|NOT COMPLETED|Washout Period 3||0
479706|NCT01128595|1175398|P2|NOT COMPLETED|Washout Period 3||0
479707|NCT01128595|1175399|P1|NOT COMPLETED|Washout Period 3||0
479708|NCT01128595|1175396|P4|COMPLETED|Washout Period 3||7
479709|NCT01128595|1175397|P3|COMPLETED|Washout Period 3||7
479710|NCT01128595|1175398|P2|COMPLETED|Washout Period 3||5
479711|NCT01128595|1175399|P1|COMPLETED|Washout Period 3||7
479712|NCT01128595|1175396|P4|STARTED|Washout Period 3||7
479713|NCT01128595|1175397|P3|STARTED|Washout Period 3||7
479714|NCT01128595|1175398|P2|STARTED|Washout Period 3||5
479715|NCT01128595|1175399|P1|STARTED|Washout Period 3||7
479716|NCT01128595|1175396|P4|NOT COMPLETED|Treatment Period 3||0
479717|NCT01128595|1175397|P3|NOT COMPLETED|Treatment Period 3||0
479718|NCT01128595|1175398|P2|NOT COMPLETED|Treatment Period 3||1
479719|NCT01128595|1175399|P1|NOT COMPLETED|Treatment Period 3||0
479720|NCT01128595|1175396|P4|COMPLETED|Treatment Period 3||7
479721|NCT01128595|1175397|P3|COMPLETED|Treatment Period 3||7
479722|NCT01128595|1175398|P2|COMPLETED|Treatment Period 3||5
479723|NCT01128595|1175399|P1|COMPLETED|Treatment Period 3||7
479724|NCT01128595|1175396|P4|STARTED|Treatment Period 3||7
479725|NCT01128595|1175397|P3|STARTED|Treatment Period 3||7
479726|NCT01128595|1175398|P2|STARTED|Treatment Period 3||6
479727|NCT01128595|1175399|P1|STARTED|Treatment Period 3||7
479728|NCT01128595|1175396|P4|NOT COMPLETED|Washout Period 2||0
479729|NCT01128595|1175397|P3|NOT COMPLETED|Washout Period 2||0
479730|NCT01128595|1175398|P2|NOT COMPLETED|Washout Period 2||0
479731|NCT01128595|1175399|P1|NOT COMPLETED|Washout Period 2||0
479732|NCT01128595|1175396|P4|COMPLETED|Washout Period 2||7
479733|NCT01128595|1175397|P3|COMPLETED|Washout Period 2||7
479734|NCT01128595|1175398|P2|COMPLETED|Washout Period 2||6
479735|NCT01128595|1175399|P1|COMPLETED|Washout Period 2||7
479736|NCT01128595|1175396|P4|STARTED|Washout Period 2||7
479737|NCT01128595|1175397|P3|STARTED|Washout Period 2||7
479738|NCT01128595|1175398|P2|STARTED|Washout Period 2||6
479739|NCT01128595|1175399|P1|STARTED|Washout Period 2||7
479740|NCT01128595|1175396|P4|NOT COMPLETED|Treatment Period 2||0
479741|NCT01128595|1175397|P3|NOT COMPLETED|Treatment Period 2||0
479742|NCT01128595|1175398|P2|NOT COMPLETED|Treatment Period 2||0
479743|NCT01128595|1175399|P1|NOT COMPLETED|Treatment Period 2||0
479744|NCT01128595|1175396|P4|COMPLETED|Treatment Period 2||7
479745|NCT01128595|1175397|P3|COMPLETED|Treatment Period 2||7
479746|NCT01128595|1175398|P2|COMPLETED|Treatment Period 2||6
479747|NCT01128595|1175399|P1|COMPLETED|Treatment Period 2||7
479748|NCT01128595|1175396|P4|STARTED|Treatment Period 2||7
479749|NCT01128595|1175397|P3|STARTED|Treatment Period 2||7
479750|NCT01128595|1175398|P2|STARTED|Treatment Period 2||6
479751|NCT01128595|1175399|P1|STARTED|Treatment Period 2||7
479752|NCT01128595|1175396|P4|NOT COMPLETED|Washout Period 1||0
479753|NCT01128595|1175397|P3|NOT COMPLETED|Washout Period 1||0
479754|NCT01128595|1175398|P2|NOT COMPLETED|Washout Period 1||0
479755|NCT01128595|1175399|P1|NOT COMPLETED|Washout Period 1||0
479756|NCT01128595|1175396|P4|COMPLETED|Washout Period 1||7
479757|NCT01128595|1175397|P3|COMPLETED|Washout Period 1||7
479758|NCT01128595|1175398|P2|COMPLETED|Washout Period 1||6
479759|NCT01128595|1175399|P1|COMPLETED|Washout Period 1||7
479760|NCT01128595|1175396|P4|STARTED|Washout Period 1||7
479761|NCT01128595|1175397|P3|STARTED|Washout Period 1||7
479762|NCT01128595|1175398|P2|STARTED|Washout Period 1||6
479763|NCT01128595|1175399|P1|STARTED|Washout Period 1||7
479764|NCT01128595|1175396|P4|NOT COMPLETED|Treatment Period 1||0
479765|NCT01128595|1175397|P3|NOT COMPLETED|Treatment Period 1||0
479766|NCT01128595|1175398|P2|NOT COMPLETED|Treatment Period 1||0
479767|NCT01128595|1175399|P1|NOT COMPLETED|Treatment Period 1||0
479768|NCT01128595|1175396|P4|COMPLETED|Treatment Period 1||7
479769|NCT01128595|1175397|P3|COMPLETED|Treatment Period 1||7
479770|NCT01128595|1175398|P2|COMPLETED|Treatment Period 1||6
479771|NCT01128595|1175399|P1|COMPLETED|Treatment Period 1||7
479772|NCT01128595|1175396|P4|STARTED|Treatment Period 1||7
479773|NCT01128595|1175397|P3|STARTED|Treatment Period 1||7
479774|NCT01128595|1175398|P2|STARTED|Treatment Period 1||6
479775|NCT01128595|1175399|P1|STARTED|Treatment Period 1||7
479776|NCT01128569|1175429|P6|NOT COMPLETED|Treatment Period 3||0
479777|NCT01128569|1175430|P5|NOT COMPLETED|Treatment Period 3||0
479778|NCT01128569|1175431|P4|NOT COMPLETED|Treatment Period 3||0
479779|NCT01128569|1175432|P3|NOT COMPLETED|Treatment Period 3||0
479780|NCT01128569|1175433|P2|NOT COMPLETED|Treatment Period 3||0
479781|NCT01128569|1175434|P1|NOT COMPLETED|Treatment Period 3||0
479782|NCT01128569|1175429|P6|COMPLETED|Treatment Period 3||9
479783|NCT01128569|1175430|P5|COMPLETED|Treatment Period 3||9
479784|NCT01128569|1175431|P4|COMPLETED|Treatment Period 3||8
479785|NCT01128569|1175432|P3|COMPLETED|Treatment Period 3||8
479786|NCT01128569|1175433|P2|COMPLETED|Treatment Period 3||7
479787|NCT01128569|1175434|P1|COMPLETED|Treatment Period 3||9
479788|NCT01128569|1175429|P6|STARTED|Treatment Period 3||9
479789|NCT01128569|1175430|P5|STARTED|Treatment Period 3||9
479790|NCT01128569|1175431|P4|STARTED|Treatment Period 3||8
479791|NCT01128569|1175432|P3|STARTED|Treatment Period 3||8
479792|NCT01128569|1175433|P2|STARTED|Treatment Period 3||7
479793|NCT01128569|1175434|P1|STARTED|Treatment Period 3||9
479794|NCT01128569|1175429|P6|NOT COMPLETED|Washout Period 2||0
479795|NCT01128569|1175430|P5|NOT COMPLETED|Washout Period 2||0
479796|NCT01128569|1175431|P4|NOT COMPLETED|Washout Period 2||0
479797|NCT01128569|1175432|P3|NOT COMPLETED|Washout Period 2||0
479798|NCT01128569|1175433|P2|NOT COMPLETED|Washout Period 2||0
479799|NCT01128569|1175434|P1|NOT COMPLETED|Washout Period 2||0
479800|NCT01128569|1175429|P6|COMPLETED|Washout Period 2||9
479801|NCT01128569|1175430|P5|COMPLETED|Washout Period 2||9
479802|NCT01128569|1175431|P4|COMPLETED|Washout Period 2||8
479803|NCT01128569|1175432|P3|COMPLETED|Washout Period 2||8
479804|NCT01128569|1175433|P2|COMPLETED|Washout Period 2||7
479805|NCT01128569|1175434|P1|COMPLETED|Washout Period 2||9
479806|NCT01128569|1175429|P6|STARTED|Washout Period 2||9
479807|NCT01128569|1175430|P5|STARTED|Washout Period 2||9
479808|NCT01128569|1175431|P4|STARTED|Washout Period 2||8
479809|NCT01128569|1175432|P3|STARTED|Washout Period 2||8
479810|NCT01128569|1175433|P2|STARTED|Washout Period 2||7
479811|NCT01128569|1175434|P1|STARTED|Washout Period 2||9
479812|NCT01128569|1175429|P6|NOT COMPLETED|Treatment Period 2||0
479813|NCT01128569|1175430|P5|NOT COMPLETED|Treatment Period 2||0
479814|NCT01128569|1175431|P4|NOT COMPLETED|Treatment Period 2||0
479815|NCT01128569|1175432|P3|NOT COMPLETED|Treatment Period 2||0
479816|NCT01128569|1175433|P2|NOT COMPLETED|Treatment Period 2||1
479817|NCT01128569|1175434|P1|NOT COMPLETED|Treatment Period 2||0
479818|NCT01128569|1175429|P6|COMPLETED|Treatment Period 2||9
479819|NCT01128569|1175430|P5|COMPLETED|Treatment Period 2||9
479820|NCT01128569|1175431|P4|COMPLETED|Treatment Period 2||8
479821|NCT01128569|1175432|P3|COMPLETED|Treatment Period 2||8
479822|NCT01128569|1175433|P2|COMPLETED|Treatment Period 2||7
479823|NCT01128569|1175434|P1|COMPLETED|Treatment Period 2||9
479824|NCT01128569|1175429|P6|STARTED|Treatment Period 2||9
479825|NCT01128569|1175430|P5|STARTED|Treatment Period 2||9
479826|NCT01128569|1175431|P4|STARTED|Treatment Period 2||8
479827|NCT01128569|1175432|P3|STARTED|Treatment Period 2||8
479828|NCT01128569|1175433|P2|STARTED|Treatment Period 2||8
479829|NCT01128569|1175434|P1|STARTED|Treatment Period 2||9
479830|NCT01128569|1175429|P6|NOT COMPLETED|Washout Period 1||0
479831|NCT01128569|1175430|P5|NOT COMPLETED|Washout Period 1||0
479832|NCT01128569|1175431|P4|NOT COMPLETED|Washout Period 1||0
479833|NCT01128569|1175432|P3|NOT COMPLETED|Washout Period 1||1
479834|NCT01128569|1175433|P2|NOT COMPLETED|Washout Period 1||0
479835|NCT01128569|1175434|P1|NOT COMPLETED|Washout Period 1||0
479836|NCT01128569|1175429|P6|COMPLETED|Washout Period 1||9
479837|NCT01128569|1175430|P5|COMPLETED|Washout Period 1||9
479838|NCT01128569|1175431|P4|COMPLETED|Washout Period 1||8
479839|NCT01128569|1175432|P3|COMPLETED|Washout Period 1||8
479840|NCT01128569|1175433|P2|COMPLETED|Washout Period 1||8
479841|NCT01128569|1175434|P1|COMPLETED|Washout Period 1||9
479842|NCT01128569|1175429|P6|STARTED|Washout Period 1||9
479843|NCT01128569|1175430|P5|STARTED|Washout Period 1||9
479844|NCT01128569|1175431|P4|STARTED|Washout Period 1||8
479845|NCT01128569|1175432|P3|STARTED|Washout Period 1||9
479846|NCT01128569|1175433|P2|STARTED|Washout Period 1||8
479847|NCT01128569|1175434|P1|STARTED|Washout Period 1||9
479848|NCT01128569|1175429|P6|NOT COMPLETED|Treatment Period 1||0
479849|NCT01128569|1175430|P5|NOT COMPLETED|Treatment Period 1||0
479850|NCT01128569|1175431|P4|NOT COMPLETED|Treatment Period 1||0
479851|NCT01128569|1175432|P3|NOT COMPLETED|Treatment Period 1||0
479852|NCT01128569|1175433|P2|NOT COMPLETED|Treatment Period 1||0
479853|NCT01128569|1175434|P1|NOT COMPLETED|Treatment Period 1||0
479854|NCT01128569|1175429|P6|COMPLETED|Treatment Period 1||9
479855|NCT01128569|1175430|P5|COMPLETED|Treatment Period 1||9
479856|NCT01128569|1175431|P4|COMPLETED|Treatment Period 1||8
479857|NCT01128569|1175432|P3|COMPLETED|Treatment Period 1||9
479858|NCT01128569|1175433|P2|COMPLETED|Treatment Period 1||8
479859|NCT01128569|1175434|P1|COMPLETED|Treatment Period 1||9
479860|NCT01128569|1175429|P6|STARTED|Treatment Period 1||9
479861|NCT01128569|1175430|P5|STARTED|Treatment Period 1||9
479862|NCT01128569|1175431|P4|STARTED|Treatment Period 1||8
479863|NCT01128569|1175432|P3|STARTED|Treatment Period 1||9
479864|NCT01128569|1175433|P2|STARTED|Treatment Period 1||8
479865|NCT01128569|1175434|P1|STARTED|Treatment Period 1||9
479866|NCT01128543|1175451|P1|NOT COMPLETED|Overall Study||4
479867|NCT01128543|1175451|P1|COMPLETED|Overall Study||25
479868|NCT01128543|1175451|P1|STARTED|Overall Study||29
479869|NCT01128426|1175457|P1|NOT COMPLETED|Overall Study||0
479870|NCT01128426|1175457|P1|COMPLETED|Overall Study||53902
479871|NCT01128426|1175457|P1|STARTED|Overall Study||53902
479872|NCT01128413|1175477|P2|NOT COMPLETED|Overall Study||1
479873|NCT01128413|1175478|P1|NOT COMPLETED|Overall Study||4
479874|NCT01128413|1175477|P2|COMPLETED|Overall Study||10
479875|NCT01128413|1175478|P1|COMPLETED|Overall Study||7
479876|NCT01128413|1175477|P2|STARTED|Overall Study||11
479877|NCT01128413|1175478|P1|STARTED|Overall Study||11
479878|NCT01128400|1175487|P3|NOT COMPLETED|Overall Study||16
479879|NCT01128400|1175488|P2|NOT COMPLETED|Overall Study||0
479880|NCT01128400|1175489|P1|NOT COMPLETED|Overall Study||2
479881|NCT01128400|1175487|P3|COMPLETED|Overall Study||7
479882|NCT01128400|1175488|P2|COMPLETED|Overall Study||9
479883|NCT01128400|1175489|P1|COMPLETED|Overall Study||6
479884|NCT01128400|1175487|P3|STARTED|Overall Study||23
479885|NCT01128400|1175488|P2|STARTED|Overall Study||9
479886|NCT01128400|1175489|P1|STARTED|Overall Study||8
479887|NCT01128387|1175502|P2|NOT COMPLETED|Overall Study||1
479888|NCT01128387|1175503|P1|NOT COMPLETED|Overall Study||0
479889|NCT01128387|1175502|P2|COMPLETED|Overall Study||5
479890|NCT01128387|1175503|P1|COMPLETED|Overall Study||5
479891|NCT01128387|1175502|P2|STARTED|Overall Study||6
479892|NCT01128387|1175503|P1|STARTED|Overall Study||5
479893|NCT01128361|1175513|P2|NOT COMPLETED|Overall Study||3
479894|NCT01128361|1175514|P1|NOT COMPLETED|Overall Study||5
479895|NCT01128361|1175513|P2|COMPLETED|Overall Study||34
479896|NCT01128361|1175514|P1|COMPLETED|Overall Study||34
479897|NCT01128361|1175513|P2|STARTED|Overall Study||37
479898|NCT01128361|1175514|P1|STARTED|Overall Study||39
479899|NCT01128296|1175526|P6|NOT COMPLETED|Overall Study||5
479900|NCT01128296|1175527|P5|NOT COMPLETED|Overall Study||0
479901|NCT01128296|1175528|P4|NOT COMPLETED|Overall Study||0
479902|NCT01128296|1175529|P3|NOT COMPLETED|Overall Study||0
479903|NCT01128296|1175530|P2|NOT COMPLETED|Overall Study||0
479904|NCT01128296|1175531|P1|NOT COMPLETED|Overall Study||0
479905|NCT01128296|1175526|P6|COMPLETED|Overall Study||21
479906|NCT01128296|1175527|P5|COMPLETED|Overall Study||1
479907|NCT01128296|1175528|P4|COMPLETED|Overall Study||1
479908|NCT01128296|1175529|P3|COMPLETED|Overall Study||1
479909|NCT01128296|1175530|P2|COMPLETED|Overall Study||1
479910|NCT01128296|1175531|P1|COMPLETED|Overall Study||1
479911|NCT01128296|1175526|P6|STARTED|Overall Study||26
479912|NCT01128296|1175527|P5|STARTED|Overall Study||1
479913|NCT01128296|1175528|P4|STARTED|Overall Study||1
479914|NCT01128296|1175529|P3|STARTED|Overall Study||1
479915|NCT01128296|1175530|P2|STARTED|Overall Study||1
479916|NCT01128296|1175531|P1|STARTED|Overall Study||1
479917|NCT01128270|1175549|P1|NOT COMPLETED|Therapeutic Chloral Hydrate (2B)||0
479918|NCT01128270|1175549|P1|COMPLETED|Therapeutic Chloral Hydrate (2B)||8
479919|NCT01128270|1175549|P1|STARTED|Therapeutic Chloral Hydrate (2B)||8
479920|NCT01128270|1175549|P1|NOT COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||0
479921|NCT01128270|1175549|P1|COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||8
479922|NCT01128270|1175549|P1|STARTED|Therapeutic Chloral Hydrate and DCA (2A)||8
479923|NCT01128270|1175549|P1|NOT COMPLETED|Environmental Chloral Hydrate (1B)||0
479924|NCT01128270|1175549|P1|COMPLETED|Environmental Chloral Hydrate (1B)||8
479925|NCT01128270|1175549|P1|STARTED|Environmental Chloral Hydrate (1B)|Per the suggestion from Heather, periods are not in chronological order, but defined by treatment.|8
479926|NCT01128270|1175549|P1|NOT COMPLETED|Environment Chloral Hydrate and DCA (1A)||0
479927|NCT01128270|1175549|P1|COMPLETED|Environment Chloral Hydrate and DCA (1A)||7
479928|NCT01128270|1175549|P1|STARTED|Environment Chloral Hydrate and DCA (1A)||7
479929|NCT01128244|1175562|P1|NOT COMPLETED|Overall Study||3
479930|NCT01128244|1175562|P1|COMPLETED|Overall Study||10
479931|NCT01128244|1175562|P1|STARTED|Overall Study||13
479932|NCT01128192|1175572|P3|NOT COMPLETED|Overall Study||0
479933|NCT01128192|1175573|P2|NOT COMPLETED|Overall Study||0
479934|NCT01128192|1175574|P1|NOT COMPLETED|Overall Study||0
479935|NCT01128192|1175572|P3|COMPLETED|Overall Study||7
479936|NCT01128192|1175573|P2|COMPLETED|Overall Study||19
479937|NCT01128192|1175574|P1|COMPLETED|Overall Study||19
479938|NCT01128192|1175572|P3|STARTED|Overall Study||7
479939|NCT01128192|1175573|P2|STARTED|Overall Study||19
479940|NCT01128192|1175574|P1|STARTED|Overall Study||19
479941|NCT01128179|1175603|P2|NOT COMPLETED|Overall Study||0
479942|NCT01128179|1175604|P1|NOT COMPLETED|Overall Study||2
479943|NCT01128179|1175603|P2|COMPLETED|Overall Study||12
479944|NCT01128179|1175604|P1|COMPLETED|Overall Study||21
479945|NCT01128179|1175603|P2|STARTED|Overall Study||12
479946|NCT01128179|1175604|P1|STARTED|Overall Study||23
479947|NCT01128153|1175624|P2|NOT COMPLETED|Overall Study||15
479948|NCT01128153|1175625|P1|NOT COMPLETED|Overall Study||16
479949|NCT01128153|1175624|P2|COMPLETED|Overall Study|Completed 24 weeks|113
479950|NCT01128153|1175625|P1|COMPLETED|Overall Study|Completed 24 weeks|113
479951|NCT01128153|1175624|P2|Full Analysis Set|Overall Study|Received at least 1 dose of investigational product during 24 week blinded period|128
479952|NCT01128153|1175625|P1|Full Analysis Set|Overall Study|Received at least 1 dose of investigational product during 24 week blinded period|127
479953|NCT01128153|1175624|P2|STARTED|Overall Study|Randomised|128
479954|NCT01128153|1175625|P1|STARTED|Overall Study|Randomised|129
479955|NCT01128114|1175641|P1|NOT COMPLETED|Overall Study||8
479956|NCT01128114|1175641|P1|COMPLETED|Overall Study||24
479957|NCT01128114|1175641|P1|STARTED|Overall Study||32
479958|NCT01128049|1175648|P3|NOT COMPLETED|Overall Study||0
479959|NCT01128049|1175649|P2|NOT COMPLETED|Overall Study||0
479960|NCT01128049|1175650|P1|NOT COMPLETED|Overall Study||0
479961|NCT01128049|1175648|P3|COMPLETED|Overall Study||5
479962|NCT01128049|1175649|P2|COMPLETED|Overall Study||5
479963|NCT01128049|1175650|P1|COMPLETED|Overall Study||5
479964|NCT01128049|1175648|P3|STARTED|Overall Study||5
479965|NCT01128049|1175649|P2|STARTED|Overall Study||5
479966|NCT01128049|1175650|P1|STARTED|Overall Study||5
479967|NCT01127763|1175658|P1|NOT COMPLETED|Overall Study||5
479968|NCT01127763|1175658|P1|COMPLETED|Overall Study|Patients off study due to disease progression were considered to have completed the study.|20
479969|NCT01127763|1175658|P1|STARTED|Overall Study||25
479970|NCT01127737|1175669|P2|NOT COMPLETED|Overall Study||0
479971|NCT01127737|1175670|P1|NOT COMPLETED|Overall Study||0
479972|NCT01127737|1175669|P2|COMPLETED|Overall Study||38
479973|NCT01127737|1175670|P1|COMPLETED|Overall Study||37
479974|NCT01127737|1175669|P2|STARTED|Overall Study||38
479975|NCT01127737|1175670|P1|STARTED|Overall Study||37
479976|NCT01127659|1175682|P6|NOT COMPLETED|Overall Study||0
479977|NCT01127659|1175683|P5|NOT COMPLETED|Overall Study||0
479978|NCT01127659|1175684|P4|NOT COMPLETED|Overall Study||4
479979|NCT01127659|1175685|P3|NOT COMPLETED|Overall Study||2
479980|NCT01127659|1175686|P2|NOT COMPLETED|Overall Study||8
479981|NCT01127659|1175687|P1|NOT COMPLETED|Overall Study||2
479982|NCT01127659|1175682|P6|COMPLETED|Overall Study||21
479983|NCT01127659|1175683|P5|COMPLETED|Overall Study||50
479984|NCT01127659|1175684|P4|COMPLETED|Overall Study||6
479985|NCT01127659|1175685|P3|COMPLETED|Overall Study||10
479986|NCT01127659|1175686|P2|COMPLETED|Overall Study||14
479987|NCT01127659|1175687|P1|COMPLETED|Overall Study||20
479988|NCT01127659|1175682|P6|STARTED|Overall Study||21
479989|NCT01127659|1175683|P5|STARTED|Overall Study||50
479990|NCT01127659|1175684|P4|STARTED|Overall Study||10
479991|NCT01127659|1175685|P3|STARTED|Overall Study||12
479992|NCT01127659|1175686|P2|STARTED|Overall Study||22
479993|NCT01127659|1175687|P1|STARTED|Overall Study||22
479994|NCT01127646|1175703|P2|NOT COMPLETED|Overall Study||1
479995|NCT01127646|1175704|P1|NOT COMPLETED|Overall Study||1
479996|NCT01127646|1175703|P2|COMPLETED|Overall Study||7
479997|NCT01127646|1175704|P1|COMPLETED|Overall Study||14
479998|NCT01127646|1175703|P2|STARTED|Overall Study||8
479999|NCT01127646|1175704|P1|STARTED|Overall Study||15
480000|NCT01127633|1175738|P2|NOT COMPLETED|Overall Study||673
480001|NCT01127633|1175739|P1|NOT COMPLETED|Overall Study||653
480002|NCT01127633|1175738|P2|COMPLETED|Overall Study||61
480003|NCT01127633|1175739|P1|COMPLETED|Overall Study||70
480004|NCT01127633|1175738|P2|Received at Least 1 Dose of Study Drug|Overall Study||734
480005|NCT01127633|1175739|P1|Received at Least 1 Dose of Study Drug|Overall Study||723
480006|NCT01127633|1175738|P2|STARTED|Overall Study||734
480007|NCT01127633|1175739|P1|STARTED|Overall Study||723
480008|NCT01127607|1175771|P2|NOT COMPLETED|Phase II (Between Subjects)||2
480009|NCT01127607|1175772|P1|NOT COMPLETED|Phase II (Between Subjects)||1
480010|NCT01127607|1175771|P2|COMPLETED|Phase II (Between Subjects)||11
480011|NCT01127607|1175772|P1|COMPLETED|Phase II (Between Subjects)||13
480012|NCT01127607|1175771|P2|STARTED|Phase II (Between Subjects)||13
480013|NCT01127607|1175772|P1|STARTED|Phase II (Between Subjects)||14
480014|NCT01127607|1175771|P2|NOT COMPLETED|Phase I (Within Subjects)||0
480015|NCT01127607|1175772|P1|NOT COMPLETED|Phase I (Within Subjects)||0
480016|NCT01127607|1175771|P2|COMPLETED|Phase I (Within Subjects)||13
480017|NCT01127607|1175772|P1|COMPLETED|Phase I (Within Subjects)||14
480018|NCT01127607|1175771|P2|STARTED|Phase I (Within Subjects)||13
480019|NCT01127607|1175772|P1|STARTED|Phase I (Within Subjects)||14
480020|NCT01127581|1175845|P2|NOT COMPLETED|Overall Study||0
480021|NCT01127581|1175846|P1|NOT COMPLETED|Overall Study||0
480022|NCT01127581|1175845|P2|COMPLETED|Overall Study||680
480023|NCT01127581|1175846|P1|COMPLETED|Overall Study||678
480024|NCT01127581|1175845|P2|STARTED|Overall Study||680
480025|NCT01127581|1175846|P1|STARTED|Overall Study||678
480026|NCT01127503|1175874|P2|NOT COMPLETED|Overall Study||0
480027|NCT01127503|1175875|P1|NOT COMPLETED|Overall Study||0
480028|NCT01127503|1175874|P2|COMPLETED|Overall Study||1
480029|NCT01127503|1175875|P1|COMPLETED|Overall Study||1
480030|NCT01127503|1175874|P2|STARTED|Overall Study||1
480031|NCT01127503|1175875|P1|STARTED|Overall Study||1
480032|NCT01127438|1175887|P6|NOT COMPLETED|Overall Study||0
480033|NCT01127438|1175888|P5|NOT COMPLETED|Overall Study||0
480034|NCT01127438|1175889|P4|NOT COMPLETED|Overall Study||0
480035|NCT01127438|1175890|P3|NOT COMPLETED|Overall Study||0
480036|NCT01127438|1175891|P2|NOT COMPLETED|Overall Study||0
480037|NCT01127438|1175892|P1|NOT COMPLETED|Overall Study||0
480038|NCT01127438|1175887|P6|COMPLETED|Overall Study||25
480039|NCT01127438|1175888|P5|COMPLETED|Overall Study||28
480040|NCT01127438|1175889|P4|COMPLETED|Overall Study|(n=25) One subject randomized to the approved dose group received a lower dose in error.|24
480041|NCT01127438|1175890|P3|COMPLETED|Overall Study|(n=25) One subject randomized to the approved dose group received a lower dose in error.|26
480042|NCT01127438|1175891|P2|COMPLETED|Overall Study||25
480043|NCT01127438|1175892|P1|COMPLETED|Overall Study||25
480044|NCT01127438|1175887|P6|STARTED|Overall Study||25
480045|NCT01127438|1175888|P5|STARTED|Overall Study||28
480046|NCT01127438|1175889|P4|STARTED|Overall Study||24
480047|NCT01127438|1175890|P3|STARTED|Overall Study||26
480048|NCT01127438|1175891|P2|STARTED|Overall Study||25
480049|NCT01127438|1175892|P1|STARTED|Overall Study||25
480050|NCT01127321|1175919|P5|NOT COMPLETED|Overall Study||0
480051|NCT01127321|1175920|P4|NOT COMPLETED|Overall Study||0
480052|NCT01127321|1175921|P3|NOT COMPLETED|Overall Study||0
480053|NCT01127321|1175922|P2|NOT COMPLETED|Overall Study||0
480054|NCT01127321|1175923|P1|NOT COMPLETED|Overall Study||0
480055|NCT01127321|1175919|P5|COMPLETED|Overall Study||5
480056|NCT01127321|1175920|P4|COMPLETED|Overall Study||7
480057|NCT01127321|1175921|P3|COMPLETED|Overall Study||1
480058|NCT01127321|1175922|P2|COMPLETED|Overall Study||1
480059|NCT01127321|1175923|P1|COMPLETED|Overall Study||3
480060|NCT01127321|1175919|P5|STARTED|Overall Study||5
480061|NCT01127321|1175920|P4|STARTED|Overall Study||7
480062|NCT01127321|1175921|P3|STARTED|Overall Study||1
480063|NCT01127321|1175922|P2|STARTED|Overall Study||1
480064|NCT01127321|1175923|P1|STARTED|Overall Study||3
480065|NCT01127256|1175947|P2|NOT COMPLETED|Overall Study||39
480066|NCT01127256|1175948|P1|NOT COMPLETED|Overall Study||39
480067|NCT01127256|1175947|P2|COMPLETED|Overall Study||65
480068|NCT01127256|1175948|P1|COMPLETED|Overall Study||57
480069|NCT01127256|1175947|P2|STARTED|Overall Study||104
480070|NCT01127256|1175948|P1|STARTED|Overall Study||96
480071|NCT01127165|1175960|P2|NOT COMPLETED|Overall Study||19
480072|NCT01127165|1175961|P1|NOT COMPLETED|Overall Study||16
480073|NCT01127165|1175960|P2|COMPLETED|Overall Study||41
480074|NCT01127165|1175961|P1|COMPLETED|Overall Study||49
480075|NCT01127165|1175960|P2|STARTED|Overall Study||60
480076|NCT01127165|1175961|P1|STARTED|Overall Study||65
480077|NCT01127139|1175973|P1|NOT COMPLETED|Overall Study||57
480078|NCT01127139|1175973|P1|COMPLETED|Overall Study||3771
480079|NCT01127139|1175973|P1|Number of Participants Analyzed|Overall Study||3828
480080|NCT01127139|1175973|P1|STARTED|Overall Study||3828
480081|NCT01127087|1175990|P2|NOT COMPLETED|Overall Study||0
480082|NCT01127087|1175991|P1|NOT COMPLETED|Overall Study||0
480083|NCT01127087|1175990|P2|COMPLETED|Overall Study||2
480084|NCT01127087|1175991|P1|COMPLETED|Overall Study||8
480085|NCT01127087|1175990|P2|STARTED|Overall Study||2
480086|NCT01127087|1175991|P1|STARTED|Overall Study||8
480087|NCT01126957|1175999|P1|NOT COMPLETED|Overall Study||0
480088|NCT01126957|1175999|P1|COMPLETED|Overall Study||103
480089|NCT01126957|1175999|P1|STARTED|Overall Study||103
480090|NCT01126801|1176006|P2|NOT COMPLETED|Overall Study||0
480091|NCT01126801|1176007|P1|NOT COMPLETED|Overall Study||0
480092|NCT01126801|1176006|P2|COMPLETED|Overall Study||1
480093|NCT01126801|1176007|P1|COMPLETED|Overall Study||1
480094|NCT01126801|1176006|P2|STARTED|Overall Study||1
480095|NCT01126801|1176007|P1|STARTED|Overall Study||1
480096|NCT01126723|1176017|P2|NOT COMPLETED|Overall Study||3
480097|NCT01126723|1176018|P1|NOT COMPLETED|Overall Study||6
480098|NCT01126723|1176017|P2|COMPLETED|Overall Study||28
480099|NCT01126723|1176018|P1|COMPLETED|Overall Study||29
480100|NCT01126723|1176017|P2|STARTED|Overall Study||31
480101|NCT01126723|1176018|P1|STARTED|Overall Study||35
480102|NCT01126671|1176026|P2|NOT COMPLETED|Overall Study||1
480103|NCT01126671|1176027|P1|NOT COMPLETED|Overall Study||2
480104|NCT01126671|1176026|P2|COMPLETED|Overall Study||29
480105|NCT01126671|1176027|P1|COMPLETED|Overall Study||24
480106|NCT01126671|1176026|P2|STARTED|Overall Study||30
480107|NCT01126671|1176027|P1|STARTED|Overall Study||26
480108|NCT01126619|1176039|P1|NOT COMPLETED|Overall Study||17
480109|NCT01126619|1176039|P1|COMPLETED|Overall Study|The completed population was used for all effectiveness analyses.|86
480110|NCT01126619|1176039|P1|STARTED|Overall Study||103
480111|NCT01126593|1176054|P3|NOT COMPLETED|Overall Study||2
480112|NCT01126593|1176055|P2|NOT COMPLETED|Overall Study||2
480113|NCT01126593|1176056|P1|NOT COMPLETED|Overall Study||4
480114|NCT01126593|1176054|P3|COMPLETED|Overall Study||32
480115|NCT01126593|1176055|P2|COMPLETED|Overall Study||27
480116|NCT01126593|1176056|P1|COMPLETED|Overall Study||29
480117|NCT01126593|1176054|P3|STARTED|Overall Study||34
480118|NCT01126593|1176055|P2|STARTED|Overall Study||29
480119|NCT01126593|1176056|P1|STARTED|Overall Study||33
480120|NCT01126580|1176067|P3|NOT COMPLETED|Overall Study||55
480121|NCT01126580|1176068|P2|NOT COMPLETED|Overall Study||52
480122|NCT01126580|1176069|P1|NOT COMPLETED|Overall Study||49
480123|NCT01126580|1176067|P3|COMPLETED|Overall Study||213
480124|NCT01126580|1176068|P2|COMPLETED|Overall Study||218
480125|NCT01126580|1176069|P1|COMPLETED|Overall Study||220
480126|NCT01126580|1176067|P3|Completed 26 Weeks|Overall Study||226
480127|NCT01126580|1176068|P2|Completed 26 Weeks|Overall Study||242
480128|NCT01126580|1176069|P1|Completed 26 Weeks|Overall Study||233
480129|NCT01126580|1176067|P3|Received at Least 1 Dose of Study Drug|Overall Study||268
480130|NCT01126580|1176068|P2|Received at Least 1 Dose of Study Drug|Overall Study||270
480131|NCT01126580|1176069|P1|Received at Least 1 Dose of Study Drug|Overall Study||269
480132|NCT01126580|1176067|P3|STARTED|Overall Study||268
480133|NCT01126580|1176068|P2|STARTED|Overall Study||270
480134|NCT01126580|1176069|P1|STARTED|Overall Study||269
480135|NCT01126541|1176164|P3|NOT COMPLETED|Overall Study||26
480136|NCT01126541|1176165|P2|NOT COMPLETED|Overall Study||12
480137|NCT01126541|1176166|P1|NOT COMPLETED|Overall Study||10
480138|NCT01126541|1176164|P3|COMPLETED|Overall Study||55
480139|NCT01126541|1176165|P2|COMPLETED|Overall Study||61
480140|NCT01126541|1176166|P1|COMPLETED|Overall Study||60
480141|NCT01126541|1176164|P3|STARTED|Overall Study||81
480142|NCT01126541|1176165|P2|STARTED|Overall Study||73
480143|NCT01126541|1176166|P1|STARTED|Overall Study||70
480144|NCT01126437|1176250|P3|NOT COMPLETED|Overall Study||1313
480145|NCT01126437|1176251|P2|NOT COMPLETED|Overall Study||1330
480146|NCT01126437|1176252|P1|NOT COMPLETED|Overall Study||1341
480147|NCT01126437|1176250|P3|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4400
480148|NCT01126437|1176251|P2|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4399
480149|NCT01126437|1176252|P1|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4400
480150|NCT01126437|1176250|P3|STARTED|Overall Study||5713
480151|NCT01126437|1176251|P2|STARTED|Overall Study||5729
480152|NCT01126437|1176252|P1|STARTED|Overall Study||5741
480153|NCT01126424|1176290|P6|NOT COMPLETED|Overall Study||0
480154|NCT01126424|1176291|P5|NOT COMPLETED|Overall Study||2
480155|NCT01126424|1176292|P4|NOT COMPLETED|Overall Study||3
480156|NCT01126424|1176293|P3|NOT COMPLETED|Overall Study||1
480157|NCT01126424|1176294|P2|NOT COMPLETED|Overall Study||0
480158|NCT01126424|1176295|P1|NOT COMPLETED|Overall Study||0
480159|NCT01126424|1176290|P6|COMPLETED|Overall Study||4
480160|NCT01126424|1176291|P5|COMPLETED|Overall Study||2
480161|NCT01126424|1176292|P4|COMPLETED|Overall Study||3
480162|NCT01126424|1176293|P3|COMPLETED|Overall Study||4
480163|NCT01126424|1176294|P2|COMPLETED|Overall Study||4
480164|NCT01126424|1176295|P1|COMPLETED|Overall Study||3
480165|NCT01126424|1176290|P6|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
480166|NCT01126424|1176291|P5|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
480167|NCT01126424|1176292|P4|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
480168|NCT01126424|1176293|P3|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
480169|NCT01126424|1176294|P2|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
480170|NCT01126424|1176295|P1|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|3
480171|NCT01126424|1176290|P6|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
480172|NCT01126424|1176291|P5|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
480173|NCT01126424|1176292|P4|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|6
480174|NCT01126424|1176293|P3|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|5
480175|NCT01126424|1176294|P2|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
480176|NCT01126424|1176295|P1|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|3
480177|NCT01126359|1176318|P2|NOT COMPLETED|Second Intervention (20-minutes)||0
480178|NCT01126359|1176319|P1|NOT COMPLETED|Second Intervention (20-minutes)||0
480179|NCT01126359|1176318|P2|COMPLETED|Second Intervention (20-minutes)||5
480180|NCT01126359|1176319|P1|COMPLETED|Second Intervention (20-minutes)||5
480181|NCT01126359|1176318|P2|STARTED|Second Intervention (20-minutes)||5
480182|NCT01126359|1176319|P1|STARTED|Second Intervention (20-minutes)||5
480183|NCT01126359|1176318|P2|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0
480184|NCT01126359|1176319|P1|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0
480185|NCT01126359|1176318|P2|COMPLETED|Dressing Replacement/Healing (48-hours)||5
480186|NCT01126359|1176319|P1|COMPLETED|Dressing Replacement/Healing (48-hours)||5
480187|NCT01126359|1176318|P2|STARTED|Dressing Replacement/Healing (48-hours)||5
480188|NCT01126359|1176319|P1|STARTED|Dressing Replacement/Healing (48-hours)||5
480189|NCT01126359|1176318|P2|NOT COMPLETED|First Intervention (20-minutes)||1
480190|NCT01126359|1176319|P1|NOT COMPLETED|First Intervention (20-minutes)||0
480191|NCT01126359|1176318|P2|COMPLETED|First Intervention (20-minutes)||5
480192|NCT01126359|1176319|P1|COMPLETED|First Intervention (20-minutes)||5
480193|NCT01126359|1176318|P2|STARTED|First Intervention (20-minutes)||6
480194|NCT01126359|1176319|P1|STARTED|First Intervention (20-minutes)||5
480195|NCT01126268|1176331|P1|NOT COMPLETED|Overall Study||1
480196|NCT01126268|1176331|P1|COMPLETED|Overall Study||37
480197|NCT01126268|1176331|P1|STARTED|Overall Study||38
480198|NCT01126099|1176355|P2|NOT COMPLETED|Open-label Extension||1
480199|NCT01126099|1176356|P1|NOT COMPLETED|Open-label Extension||1
480200|NCT01126099|1176355|P2|COMPLETED|Open-label Extension||6
480201|NCT01126099|1176356|P1|COMPLETED|Open-label Extension||4
480202|NCT01126099|1176355|P2|STARTED|Open-label Extension||7
480203|NCT01126099|1176356|P1|STARTED|Open-label Extension|2 in the Prazosin arm of the Double Blind Phase elected not to enter the Open-Label extension|5
480204|NCT01126099|1176355|P2|NOT COMPLETED|Double Blind Phase||2
480205|NCT01126099|1176356|P1|NOT COMPLETED|Double Blind Phase||4
480206|NCT01126099|1176355|P2|COMPLETED|Double Blind Phase||7
480207|NCT01126099|1176356|P1|COMPLETED|Double Blind Phase||7
480208|NCT01126099|1176355|P2|STARTED|Double Blind Phase||9
480209|NCT01126099|1176356|P1|STARTED|Double Blind Phase||11
480210|NCT01126060|1176370|P2|NOT COMPLETED|Overall Study||2
480211|NCT01126060|1176371|P1|NOT COMPLETED|Overall Study||0
480212|NCT01126060|1176370|P2|COMPLETED|Overall Study||38
480213|NCT01126060|1176371|P1|COMPLETED|Overall Study||40
480214|NCT01126060|1176370|P2|STARTED|Overall Study||40
480215|NCT01126060|1176371|P1|STARTED|Overall Study||40
480216|NCT01125930|1176379|P2|NOT COMPLETED|Overall Study||10
480217|NCT01125930|1176380|P1|NOT COMPLETED|Overall Study||1
480218|NCT01125930|1176379|P2|COMPLETED|Overall Study||36
480219|NCT01125930|1176380|P1|COMPLETED|Overall Study||21
480220|NCT01125930|1176379|P2|STARTED|Overall Study||46
480221|NCT01125930|1176380|P1|STARTED|Overall Study||22
480222|NCT01125917|1176534|P1|NOT COMPLETED|Overall Study||339
480223|NCT01125917|1176534|P1|COMPLETED|Overall Study||15
480224|NCT01125917|1176534|P1|STARTED|Overall Study||354
480225|NCT01125813|1176538|P1|NOT COMPLETED|Overall Study||6
480226|NCT01125813|1176538|P1|COMPLETED|Overall Study||30
480227|NCT01125813|1176538|P1|STARTED|Overall Study||36
480228|NCT01125800|1176548|P5|NOT COMPLETED|Phase II||11
480229|NCT01125800|1176549|P4|NOT COMPLETED|Phase II||1
480230|NCT01125800|1176550|P3|NOT COMPLETED|Phase II||0
480231|NCT01125800|1176551|P2|NOT COMPLETED|Phase II||0
480232|NCT01125800|1176552|P1|NOT COMPLETED|Phase II||0
480233|NCT01125800|1176548|P5|COMPLETED|Phase II||5
480234|NCT01125800|1176549|P4|COMPLETED|Phase II||0
480235|NCT01125800|1176550|P3|COMPLETED|Phase II||0
480236|NCT01125800|1176551|P2|COMPLETED|Phase II||0
480237|NCT01125800|1176552|P1|COMPLETED|Phase II||0
480238|NCT01125800|1176548|P5|STARTED|Phase II|Additional participants were enrolled to this treatment in this period.|16
480239|NCT01125800|1176549|P4|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|1
480240|NCT01125800|1176550|P3|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
480241|NCT01125800|1176551|P2|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
480242|NCT01125800|1176552|P1|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
480243|NCT01125800|1176548|P5|NOT COMPLETED|Phase I||0
480244|NCT01125800|1176549|P4|NOT COMPLETED|Phase I||11
480245|NCT01125800|1176550|P3|NOT COMPLETED|Phase I||4
480246|NCT01125800|1176551|P2|NOT COMPLETED|Phase I||9
480247|NCT01125800|1176552|P1|NOT COMPLETED|Phase I||8
480248|NCT01125800|1176548|P5|COMPLETED|Phase I||0
480249|NCT01125800|1176549|P4|COMPLETED|Phase I||10
480250|NCT01125800|1176550|P3|COMPLETED|Phase I||7
480251|NCT01125800|1176551|P2|COMPLETED|Phase I||7
480252|NCT01125800|1176552|P1|COMPLETED|Phase I||3
480253|NCT01125800|1176548|P5|STARTED|Phase I|None of participants were enrolled to this treatment in this period.|0
480254|NCT01125800|1176549|P4|STARTED|Phase I||21
480255|NCT01125800|1176550|P3|STARTED|Phase I||11
480256|NCT01125800|1176551|P2|STARTED|Phase I||16
480257|NCT01125800|1176552|P1|STARTED|Phase I||11
480258|NCT01125774|1176591|P4|NOT COMPLETED|Overall Study||3
480259|NCT01125774|1176592|P3|NOT COMPLETED|Overall Study||9
480260|NCT01125774|1176593|P2|NOT COMPLETED|Overall Study||554
480261|NCT01125774|1176594|P1|NOT COMPLETED|Overall Study||1125
480262|NCT01125774|1176591|P4|COMPLETED|Overall Study|Completed study at least once|3
480263|NCT01125774|1176592|P3|COMPLETED|Overall Study|"Completed study at least once while treated with telcagepant (otherwise counted Not Completed)"|13
480264|NCT01125774|1176593|P2|COMPLETED|Overall Study||948
480265|NCT01125774|1176594|P1|COMPLETED|Overall Study||1893
480266|NCT01125774|1176591|P4|Treated|Overall Study||5
480267|NCT01125774|1176592|P3|Treated|Overall Study|Received telcagepant|21
480268|NCT01125774|1176593|P2|Treated|Overall Study|1 mistakenly took telcagepant and is included with telcagepant group for adverse event analysis|1322
480269|NCT01125774|1176594|P1|Treated|Overall Study||2638
480270|NCT01125774|1176591|P4|STARTED|Overall Study|Unique participants randomized|6
480271|NCT01125774|1176592|P3|STARTED|Overall Study|Unique participants randomized|22
480272|NCT01125774|1176593|P2|STARTED|Overall Study|Randomized|1502
480273|NCT01125774|1176594|P1|STARTED|Overall Study|Randomized|3018
480274|NCT01125748|1176618|P2|NOT COMPLETED|Overall Study||14
480275|NCT01125748|1176619|P1|NOT COMPLETED|Overall Study||10
480276|NCT01125748|1176618|P2|COMPLETED|Overall Study||74
480277|NCT01125748|1176619|P1|COMPLETED|Overall Study||78
480278|NCT01125748|1176618|P2|STARTED|Overall Study||88
480279|NCT01125748|1176619|P1|STARTED|Overall Study||88
480280|NCT01125722|1176629|P2|NOT COMPLETED|Overall Study||1
480281|NCT01125722|1176630|P1|NOT COMPLETED|Overall Study||3
480282|NCT01125722|1176629|P2|COMPLETED|Overall Study||36
480283|NCT01125722|1176630|P1|COMPLETED|Overall Study||34
480284|NCT01125722|1176629|P2|STARTED|Overall Study||37
480285|NCT01125722|1176630|P1|STARTED|Overall Study||37
480286|NCT01125605|1176644|P1|NOT COMPLETED|Overall Study||0
480287|NCT01125605|1176644|P1|COMPLETED|Overall Study||325
480288|NCT01125605|1176644|P1|Safety|Overall Study|1 patient was only analysed for safety|326
480289|NCT01125605|1176644|P1|STARTED|Overall Study|started = had baseline values|325
480290|NCT01125566|1176677|P3|NOT COMPLETED|Patients Who Switched From AV to TV||24
480291|NCT01125566|1176678|P2|NOT COMPLETED|Patients Who Switched From AV to TV||0
480292|NCT01125566|1176679|P1|NOT COMPLETED|Patients Who Switched From AV to TV||0
480293|NCT01125566|1176677|P3|COMPLETED|Patients Who Switched From AV to TV|On TV treatment at analysis cut-off date (03Sep2013)|49
480294|NCT01125566|1176678|P2|COMPLETED|Patients Who Switched From AV to TV||0
480295|NCT01125566|1176679|P1|COMPLETED|Patients Who Switched From AV to TV||0
480296|NCT01125566|1176677|P3|STARTED|Patients Who Switched From AV to TV|All patients without disease progression who chose to switch from AV to TV by 08Jun2013|73
480297|NCT01125566|1176678|P2|STARTED|Patients Who Switched From AV to TV||0
480298|NCT01125566|1176679|P1|STARTED|Patients Who Switched From AV to TV||0
480299|NCT01125566|1176677|P3|NOT COMPLETED|Patients Before the Switch (26Apr2013)||0
480300|NCT01125566|1176678|P2|NOT COMPLETED|Patients Before the Switch (26Apr2013)||136
480301|NCT01125566|1176679|P1|NOT COMPLETED|Patients Before the Switch (26Apr2013)||260
480302|NCT01125566|1176677|P3|COMPLETED|Patients Before the Switch (26Apr2013)||0
480303|NCT01125566|1176678|P2|COMPLETED|Patients Before the Switch (26Apr2013)|On treatment at analysis cut-off date (03Sep2013)|33
480304|NCT01125566|1176679|P1|COMPLETED|Patients Before the Switch (26Apr2013)|All patients without disease progression who were on treatment on 08Jun2013|79
480305|NCT01125566|1176677|P3|STARTED|Patients Before the Switch (26Apr2013)||0
480306|NCT01125566|1176678|P2|STARTED|Patients Before the Switch (26Apr2013)|Randomised|169
480307|NCT01125566|1176679|P1|STARTED|Patients Before the Switch (26Apr2013)|Randomised|339
480308|NCT01125514|1176692|P1|NOT COMPLETED|Treatment Period2(Day9-Day27) and Day 28||4
480309|NCT01125514|1176692|P1|COMPLETED|Treatment Period2(Day9-Day27) and Day 28||28
480310|NCT01125514|1176692|P1|STARTED|Treatment Period2(Day9-Day27) and Day 28||32
480311|NCT01125514|1176692|P1|NOT COMPLETED|Treatment Period 2 (Day 8 - Day 17)||3
480312|NCT01125514|1176692|P1|COMPLETED|Treatment Period 2 (Day 8 - Day 17)||32
480313|NCT01125514|1176692|P1|Pharmacodynamics (PD) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33
480314|NCT01125514|1176692|P1|Pharmacokinetic (PK) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33
480315|NCT01125514|1176692|P1|STARTED|Treatment Period 2 (Day 8 - Day 17)||35
480316|NCT01125514|1176692|P1|NOT COMPLETED|Treatment Period 1 (Day 1 - Day 7)||2
480317|NCT01125514|1176692|P1|COMPLETED|Treatment Period 1 (Day 1 - Day 7)||35
480318|NCT01125514|1176692|P1|STARTED|Treatment Period 1 (Day 1 - Day 7)|Randomized and safety population|37
480319|NCT01125202|1176766|P2|NOT COMPLETED|Overall Study||7
480320|NCT01125202|1176767|P1|NOT COMPLETED|Overall Study||12
480321|NCT01125202|1176766|P2|COMPLETED|Overall Study||79
480322|NCT01125202|1176767|P1|COMPLETED|Overall Study||81
480323|NCT01125202|1176766|P2|STARTED|Overall Study||86
480324|NCT01125202|1176767|P1|STARTED|Overall Study||93
480325|NCT01125189|1176792|P3|NOT COMPLETED|Follow up Period||16
480326|NCT01125189|1176793|P2|NOT COMPLETED|Follow up Period||15
480327|NCT01125189|1176794|P1|NOT COMPLETED|Follow up Period||20
480328|NCT01125189|1176792|P3|COMPLETED|Follow up Period||58
480329|NCT01125189|1176793|P2|COMPLETED|Follow up Period||138
480330|NCT01125189|1176794|P1|COMPLETED|Follow up Period||132
480331|NCT01125189|1176792|P3|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|74
480332|NCT01125189|1176793|P2|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|153
480333|NCT01125189|1176794|P1|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|152
480334|NCT01125189|1176792|P3|NOT COMPLETED|Treatment Period||41
480335|NCT01125189|1176793|P2|NOT COMPLETED|Treatment Period||35
480336|NCT01125189|1176794|P1|NOT COMPLETED|Treatment Period||31
480337|NCT01125189|1176792|P3|COMPLETED|Treatment Period||37
480338|NCT01125189|1176793|P2|COMPLETED|Treatment Period||123
480339|NCT01125189|1176794|P1|COMPLETED|Treatment Period||128
480340|NCT01125189|1176792|P3|STARTED|Treatment Period||78
480341|NCT01125189|1176793|P2|STARTED|Treatment Period||158
480342|NCT01125189|1176794|P1|STARTED|Treatment Period||159
480343|NCT01125098|1176822|P2|NOT COMPLETED|Overall Study||0
480344|NCT01125098|1176823|P1|NOT COMPLETED|Overall Study||3
480345|NCT01125098|1176822|P2|COMPLETED|Overall Study||90
480346|NCT01125098|1176823|P1|COMPLETED|Overall Study||88
480347|NCT01125098|1176822|P2|STARTED|Overall Study||90
480348|NCT01125098|1176823|P1|STARTED|Overall Study||91
480349|NCT01124955|1176831|P2|NOT COMPLETED|Overall Study||0
480350|NCT01124955|1176832|P1|NOT COMPLETED|Overall Study||0
480351|NCT01124955|1176831|P2|COMPLETED|Overall Study||40
480352|NCT01124955|1176832|P1|COMPLETED|Overall Study||40
480353|NCT01124955|1176831|P2|STARTED|Overall Study||40
480354|NCT01124955|1176832|P1|STARTED|Overall Study||40
480355|NCT01124916|1176848|P2|NOT COMPLETED|Overall Study||2
480356|NCT01124916|1176849|P1|NOT COMPLETED|Overall Study||3
480357|NCT01124916|1176848|P2|COMPLETED|Overall Study||38
480358|NCT01124916|1176849|P1|COMPLETED|Overall Study||35
480359|NCT01124916|1176848|P2|STARTED|Overall Study||40
480360|NCT01124916|1176849|P1|STARTED|Overall Study||38
480361|NCT01124864|1176863|P6|NOT COMPLETED|Overall Study||3
480362|NCT01124864|1176864|P5|NOT COMPLETED|Overall Study||30
480363|NCT01124864|1176865|P4|NOT COMPLETED|Overall Study||21
480364|NCT01124864|1176866|P3|NOT COMPLETED|Overall Study||34
480365|NCT01124864|1176867|P2|NOT COMPLETED|Overall Study||35
480366|NCT01124864|1176868|P1|NOT COMPLETED|Overall Study||28
480367|NCT01124864|1176863|P6|COMPLETED|Overall Study||0
480368|NCT01124864|1176864|P5|COMPLETED|Overall Study|1 patient ongoing at time of data cut-off 30-Jul-2013|1
480369|NCT01124864|1176865|P4|COMPLETED|Overall Study|1 patient ongoing at time of data cut-off 30-Jul-2013|1
480370|NCT01124864|1176866|P3|COMPLETED|Overall Study||0
480371|NCT01124864|1176867|P2|COMPLETED|Overall Study||0
480372|NCT01124864|1176868|P1|COMPLETED|Overall Study||0
480373|NCT01124864|1176863|P6|STARTED|Overall Study||3
480374|NCT01124864|1176864|P5|STARTED|Overall Study||31
480375|NCT01124864|1176865|P4|STARTED|Overall Study||22
480376|NCT01124864|1176866|P3|STARTED|Overall Study||34
480377|NCT01124864|1176867|P2|STARTED|Overall Study||35
480378|NCT01124864|1176868|P1|STARTED|Overall Study||28
480379|NCT01124838|1176902|P2|NOT COMPLETED|Overall Study||15
480380|NCT01124838|1176903|P1|NOT COMPLETED|Overall Study||18
480381|NCT01124838|1176902|P2|COMPLETED|Overall Study||116
480382|NCT01124838|1176903|P1|COMPLETED|Overall Study||112
480383|NCT01124838|1176902|P2|Enrolled in Japan Sub-study|Overall Study||16
480384|NCT01124838|1176903|P1|Enrolled in Japan Sub-study|Overall Study||16
480385|NCT01124838|1176902|P2|Enrolled in Main Study|Overall Study||115
480386|NCT01124838|1176903|P1|Enrolled in Main Study|Overall Study||114
480387|NCT01124838|1176902|P2|STARTED|Overall Study||131
480388|NCT01124838|1176903|P1|STARTED|Overall Study||130
480389|NCT01124786|1176949|P2|NOT COMPLETED|Overall Study||5
480390|NCT01124786|1176950|P1|NOT COMPLETED|Overall Study||4
480391|NCT01124786|1176949|P2|COMPLETED|Overall Study||180
480392|NCT01124786|1176950|P1|COMPLETED|Overall Study||178
480393|NCT01124786|1176949|P2|Tumor Evaluable Population|Overall Study||180
480394|NCT01124786|1176950|P1|Tumor Evaluable Population|Overall Study|All pts with measurable/evaluable tumor at baseline per RECIST and have received ≥ one dose of drug|178
480395|NCT01124786|1176949|P2|Safety Population|Overall Study||181
480396|NCT01124786|1176950|P1|Safety Population|Overall Study|All pts who received at least one dose of study drug|179
480397|NCT01124786|1176949|P2|Intent-to-Treat (ITT) Population|Overall Study||185
480398|NCT01124786|1176950|P1|Intent-to-Treat (ITT) Population|Overall Study|All randomized patients (pts)|182
480399|NCT01124786|1176949|P2|STARTED|Overall Study||185
480400|NCT01124786|1176950|P1|STARTED|Overall Study||182
480401|NCT01124643|1176970|P1|NOT COMPLETED|Overall Study||1
480402|NCT01124643|1176970|P1|COMPLETED|Overall Study||34
480403|NCT01124643|1176970|P1|STARTED|Overall Study||35
480404|NCT01124617|1176984|P2|NOT COMPLETED|Overall Study||6
480405|NCT01124617|1176985|P1|NOT COMPLETED|Overall Study||19
480406|NCT01124617|1176984|P2|COMPLETED|Overall Study||25
480407|NCT01124617|1176985|P1|COMPLETED|Overall Study||41
480408|NCT01124617|1176984|P2|STARTED|Overall Study||31
480409|NCT01124617|1176985|P1|STARTED|Overall Study||60
480410|NCT01124604|1177017|P2|NOT COMPLETED|Overall Study||2
480411|NCT01124604|1177018|P1|NOT COMPLETED|Overall Study||15
480412|NCT01124604|1177017|P2|COMPLETED|Overall Study||29
480413|NCT01124604|1177018|P1|COMPLETED|Overall Study||45
480414|NCT01124604|1177017|P2|STARTED|Overall Study||31
480415|NCT01124604|1177018|P1|STARTED|Overall Study||60
480416|NCT01124448|1177057|P2|NOT COMPLETED|Overall Study||3
480417|NCT01124448|1177058|P1|NOT COMPLETED|Overall Study||2
480418|NCT01124448|1177057|P2|COMPLETED|Overall Study||12
480419|NCT01124448|1177058|P1|COMPLETED|Overall Study||23
480420|NCT01124448|1177057|P2|STARTED|Overall Study||15
480421|NCT01124448|1177058|P1|STARTED|Overall Study||25
480422|NCT01124422|1177066|P3|NOT COMPLETED|4-Week Double-blind Treatment Phase||9
480423|NCT01124422|1177067|P2|NOT COMPLETED|4-Week Double-blind Treatment Phase||11
480424|NCT01124422|1177068|P1|NOT COMPLETED|4-Week Double-blind Treatment Phase||0
480425|NCT01124422|1177066|P3|COMPLETED|4-Week Double-blind Treatment Phase||115
480426|NCT01124422|1177067|P2|COMPLETED|4-Week Double-blind Treatment Phase||120
480427|NCT01124422|1177068|P1|COMPLETED|4-Week Double-blind Treatment Phase||0
480428|NCT01124422|1177066|P3|STARTED|4-Week Double-blind Treatment Phase||124
480429|NCT01124422|1177067|P2|STARTED|4-Week Double-blind Treatment Phase||131
480430|NCT01124422|1177068|P1|STARTED|4-Week Double-blind Treatment Phase||0
480431|NCT01124422|1177066|P3|NOT COMPLETED|4-Week Open-label Run-in Phase||0
480432|NCT01124422|1177067|P2|NOT COMPLETED|4-Week Open-label Run-in Phase||0
480433|NCT01124422|1177068|P1|NOT COMPLETED|4-Week Open-label Run-in Phase||83
480434|NCT01124422|1177066|P3|COMPLETED|4-Week Open-label Run-in Phase||0
480435|NCT01124422|1177067|P2|COMPLETED|4-Week Open-label Run-in Phase||0
480436|NCT01124422|1177068|P1|COMPLETED|4-Week Open-label Run-in Phase||255
480437|NCT01124422|1177066|P3|STARTED|4-Week Open-label Run-in Phase||0
480438|NCT01124422|1177067|P2|STARTED|4-Week Open-label Run-in Phase||0
480439|NCT01124422|1177068|P1|STARTED|4-Week Open-label Run-in Phase||338
480440|NCT01124370|1177110|P1|NOT COMPLETED|Overall Study||20
480441|NCT01124370|1177110|P1|COMPLETED|Overall Study|Completed 2 year post-implant follow-up|37
480442|NCT01124370|1177110|P1|3 Month Visit|Overall Study|Defines evaluable population|47
480443|NCT01124370|1177110|P1|Therapy Initiated|Overall Study||48
480444|NCT01124370|1177110|P1|Successfully Implanted|Overall Study||50
480445|NCT01124370|1177110|P1|STARTED|Overall Study|Underwent implant attempt|57
480446|NCT01124305|1177122|P2|NOT COMPLETED|Overall Study||10
480447|NCT01124305|1177123|P1|NOT COMPLETED|Overall Study||8
480448|NCT01124305|1177122|P2|COMPLETED|Overall Study||26
480449|NCT01124305|1177123|P1|COMPLETED|Overall Study||26
480450|NCT01124305|1177122|P2|STARTED|Overall Study||36
480451|NCT01124305|1177123|P1|STARTED|Overall Study||34
480452|NCT01124292|1177138|P3|NOT COMPLETED|Overall Study||10
480453|NCT01124292|1177139|P2|NOT COMPLETED|Overall Study||15
480454|NCT01124292|1177140|P1|NOT COMPLETED|Overall Study||2
480455|NCT01124292|1177138|P3|COMPLETED|Overall Study||11
480456|NCT01124292|1177139|P2|COMPLETED|Overall Study||9
480457|NCT01124292|1177140|P1|COMPLETED|Overall Study||14
480458|NCT01124292|1177138|P3|STARTED|Overall Study||21
480459|NCT01124292|1177139|P2|STARTED|Overall Study||24
480460|NCT01124292|1177140|P1|STARTED|Overall Study||16
480461|NCT01124188|1177198|P2|NOT COMPLETED|Overall Study||6
480462|NCT01124188|1177199|P1|NOT COMPLETED|Overall Study||8
480463|NCT01124188|1177198|P2|COMPLETED|Overall Study||65
480464|NCT01124188|1177199|P1|COMPLETED|Overall Study||60
480465|NCT01124188|1177198|P2|STARTED|Overall Study||71
480466|NCT01124188|1177199|P1|STARTED|Overall Study||68
480467|NCT01124175|1177211|P2|NOT COMPLETED|Second Intervention||0
480468|NCT01124175|1177212|P1|NOT COMPLETED|Second Intervention||0
480469|NCT01124175|1177211|P2|COMPLETED|Second Intervention||38
480470|NCT01124175|1177212|P1|COMPLETED|Second Intervention||40
480471|NCT01124175|1177211|P2|STARTED|Second Intervention||38
480472|NCT01124175|1177212|P1|STARTED|Second Intervention||40
480473|NCT01124175|1177211|P2|NOT COMPLETED|Washout of 7 Days||2
480474|NCT01124175|1177212|P1|NOT COMPLETED|Washout of 7 Days||0
480475|NCT01124175|1177211|P2|COMPLETED|Washout of 7 Days||38
480476|NCT01124175|1177212|P1|COMPLETED|Washout of 7 Days||40
480477|NCT01124175|1177211|P2|STARTED|Washout of 7 Days||40
480478|NCT01124175|1177212|P1|STARTED|Washout of 7 Days||40
480479|NCT01124175|1177211|P2|NOT COMPLETED|First Intervention||0
480480|NCT01124175|1177212|P1|NOT COMPLETED|First Intervention||0
480481|NCT01124175|1177211|P2|COMPLETED|First Intervention||40
480482|NCT01124175|1177212|P1|COMPLETED|First Intervention||40
480483|NCT01124175|1177211|P2|STARTED|First Intervention||40
480484|NCT01124175|1177212|P1|STARTED|First Intervention||40
480485|NCT01124162|1177230|P2|NOT COMPLETED|Second Intervention||0
480486|NCT01124162|1177231|P1|NOT COMPLETED|Second Intervention||0
480487|NCT01124162|1177230|P2|COMPLETED|Second Intervention||40
480488|NCT01124162|1177231|P1|COMPLETED|Second Intervention||37
480489|NCT01124162|1177230|P2|STARTED|Second Intervention||40
480490|NCT01124162|1177231|P1|STARTED|Second Intervention||37
480491|NCT01124162|1177230|P2|NOT COMPLETED|Washout of 7 Days||0
480492|NCT01124162|1177231|P1|NOT COMPLETED|Washout of 7 Days||1
480493|NCT01124162|1177230|P2|COMPLETED|Washout of 7 Days||40
480494|NCT01124162|1177231|P1|COMPLETED|Washout of 7 Days||37
480495|NCT01124162|1177230|P2|STARTED|Washout of 7 Days||40
480496|NCT01124162|1177231|P1|STARTED|Washout of 7 Days||38
480497|NCT01124162|1177230|P2|NOT COMPLETED|First Intervention||0
480498|NCT01124162|1177231|P1|NOT COMPLETED|First Intervention||2
480499|NCT01124162|1177230|P2|COMPLETED|First Intervention||40
480500|NCT01124162|1177231|P1|COMPLETED|First Intervention||38
480501|NCT01124162|1177230|P2|STARTED|First Intervention||40
480502|NCT01124162|1177231|P1|STARTED|First Intervention||40
480503|NCT01124149|1177247|P1|NOT COMPLETED|Maintenance Phase||96
480504|NCT01124149|1177247|P1|COMPLETED|Maintenance Phase||373
480505|NCT01124149|1177247|P1|STARTED|Maintenance Phase||469
480506|NCT01124149|1177247|P1|NOT COMPLETED|Acute Phase||83
480507|NCT01124149|1177247|P1|COMPLETED|Acute Phase||639
480508|NCT01124149|1177247|P1|STARTED|Acute Phase||722
480509|NCT01124097|1177267|P4|NOT COMPLETED|Overall Study||14
480510|NCT01124097|1177268|P3|NOT COMPLETED|Overall Study||20
480511|NCT01124097|1177269|P2|NOT COMPLETED|Overall Study||22
480512|NCT01124097|1177270|P1|NOT COMPLETED|Overall Study||34
480513|NCT01124097|1177267|P4|COMPLETED|Overall Study||46
480514|NCT01124097|1177268|P3|COMPLETED|Overall Study||40
480515|NCT01124097|1177269|P2|COMPLETED|Overall Study||38
480516|NCT01124097|1177270|P1|COMPLETED|Overall Study||26
480517|NCT01124097|1177267|P4|Efficacy Population|Overall Study||51
480518|NCT01124097|1177268|P3|Efficacy Population|Overall Study||53
480519|NCT01124097|1177269|P2|Efficacy Population|Overall Study||53
480520|NCT01124097|1177270|P1|Efficacy Population|Overall Study||52
480521|NCT01124097|1177267|P4|Safety Population|Overall Study||60
480522|NCT01124097|1177268|P3|Safety Population|Overall Study||60
480523|NCT01124097|1177269|P2|Safety Population|Overall Study||60
480524|NCT01124097|1177270|P1|Safety Population|Overall Study||60
480525|NCT01124097|1177267|P4|STARTED|Overall Study||60
480526|NCT01124097|1177268|P3|STARTED|Overall Study||60
480527|NCT01124097|1177269|P2|STARTED|Overall Study||60
480528|NCT01124097|1177270|P1|STARTED|Overall Study||60
480529|NCT01124045|1177282|P2|NOT COMPLETED|Overall Study||3
480530|NCT01124045|1177283|P1|NOT COMPLETED|Overall Study||0
480531|NCT01124045|1177282|P2|COMPLETED|Overall Study||37
480532|NCT01124045|1177283|P1|COMPLETED|Overall Study||39
480533|NCT01124045|1177282|P2|STARTED|Overall Study||40
480534|NCT01124045|1177283|P1|STARTED|Overall Study||39
480535|NCT01124006|1177316|P3|NOT COMPLETED|Overall Study||2
480536|NCT01124006|1177317|P2|NOT COMPLETED|Overall Study||2
480537|NCT01124006|1177318|P1|NOT COMPLETED|Overall Study||3
480538|NCT01124006|1177316|P3|COMPLETED|Overall Study||2
480539|NCT01124006|1177317|P2|COMPLETED|Overall Study||8
480540|NCT01124006|1177318|P1|COMPLETED|Overall Study||7
480541|NCT01124006|1177316|P3|STARTED|Overall Study||4
480542|NCT01124006|1177317|P2|STARTED|Overall Study||10
480543|NCT01124006|1177318|P1|STARTED|Overall Study||10
480544|NCT01123980|1177346|P2|NOT COMPLETED|Overall Study||24
480545|NCT01123980|1177347|P1|NOT COMPLETED|Overall Study||19
480546|NCT01123980|1177346|P2|COMPLETED|Overall Study||236
480547|NCT01123980|1177347|P1|COMPLETED|Overall Study||242
480548|NCT01123980|1177346|P2|STARTED|Overall Study||260
480549|NCT01123980|1177347|P1|STARTED|Overall Study||261
480550|NCT01123941|1177367|P2|NOT COMPLETED|Overall Study||1
480551|NCT01123941|1177368|P1|NOT COMPLETED|Overall Study||2
480552|NCT01123941|1177367|P2|COMPLETED|Overall Study||24
480553|NCT01123941|1177368|P1|COMPLETED|Overall Study||23
480554|NCT01123941|1177367|P2|STARTED|Overall Study||25
480555|NCT01123941|1177368|P1|STARTED|Overall Study||25
480556|NCT01123928|1177382|P2|NOT COMPLETED|Overall Study||0
480557|NCT01123928|1177383|P1|NOT COMPLETED|Overall Study||0
480558|NCT01123928|1177382|P2|COMPLETED|Overall Study||222
480559|NCT01123928|1177383|P1|COMPLETED|Overall Study||212
480560|NCT01123928|1177382|P2|STARTED|Overall Study||222
480561|NCT01123928|1177383|P1|STARTED|Overall Study||212
480562|NCT01123889|1177403|P2|NOT COMPLETED|Overall Study||1
480563|NCT01123889|1177404|P1|NOT COMPLETED|Overall Study||3
480564|NCT01123889|1177403|P2|COMPLETED|Overall Study||6
480565|NCT01123889|1177404|P1|COMPLETED|Overall Study||2
480566|NCT01123889|1177403|P2|STARTED|Overall Study||7
480567|NCT01123889|1177404|P1|STARTED|Overall Study||5
480568|NCT01123850|1177414|P1|NOT COMPLETED|Overall Study||45
480569|NCT01123850|1177414|P1|COMPLETED|Overall Study||0
480570|NCT01123850|1177414|P1|STARTED|Overall Study||45
480571|NCT01123642|1177419|P1|NOT COMPLETED|Overall Study||68
480572|NCT01123642|1177419|P1|COMPLETED|Overall Study||277
480573|NCT01123642|1177419|P1|STARTED|Overall Study||345
480574|NCT01123512|1177425|P2|NOT COMPLETED|Overall Study||21
480575|NCT01123512|1177426|P1|NOT COMPLETED|Overall Study||26
480576|NCT01123512|1177425|P2|COMPLETED|Overall Study||126
480577|NCT01123512|1177426|P1|COMPLETED|Overall Study||127
480578|NCT01123512|1177425|P2|STARTED|Overall Study||147
480579|NCT01123512|1177426|P1|STARTED|Overall Study||153
480580|NCT01123395|1177432|P2|NOT COMPLETED|Period 2||0
480581|NCT01123395|1177433|P1|NOT COMPLETED|Period 2||0
480582|NCT01123395|1177432|P2|COMPLETED|Period 2||7
480583|NCT01123395|1177433|P1|COMPLETED|Period 2||8
480584|NCT01123395|1177432|P2|STARTED|Period 2||7
480585|NCT01123395|1177433|P1|STARTED|Period 2||8
480586|NCT01123395|1177432|P2|NOT COMPLETED|Washout Period of 14 Days||1
480587|NCT01123395|1177433|P1|NOT COMPLETED|Washout Period of 14 Days||0
480588|NCT01123395|1177432|P2|COMPLETED|Washout Period of 14 Days||7
480589|NCT01123395|1177433|P1|COMPLETED|Washout Period of 14 Days||8
480590|NCT01123395|1177432|P2|STARTED|Washout Period of 14 Days||8
480591|NCT01123395|1177433|P1|STARTED|Washout Period of 14 Days||8
480592|NCT01123395|1177432|P2|NOT COMPLETED|Period 1||0
480593|NCT01123395|1177433|P1|NOT COMPLETED|Period 1||0
480594|NCT01123395|1177432|P2|COMPLETED|Period 1||8
480595|NCT01123395|1177433|P1|COMPLETED|Period 1||8
480596|NCT01123395|1177432|P2|STARTED|Period 1||8
480597|NCT01123395|1177433|P1|STARTED|Period 1||8
480598|NCT01123382|1177445|P2|NOT COMPLETED|Overall Study||6
480599|NCT01123382|1177446|P1|NOT COMPLETED|Overall Study||2
480600|NCT01123382|1177445|P2|COMPLETED|Overall Study||6
480601|NCT01123382|1177446|P1|COMPLETED|Overall Study||11
480602|NCT01123382|1177445|P2|Received Intervention|Overall Study||10
480603|NCT01123382|1177446|P1|Received Intervention|Overall Study||12
480604|NCT01123382|1177445|P2|STARTED|Overall Study||12
480605|NCT01123382|1177446|P1|STARTED|Overall Study||13
480606|NCT01123356|1177468|P1|NOT COMPLETED|Overall Study||7
480607|NCT01123356|1177468|P1|COMPLETED|Overall Study||14
480608|NCT01123356|1177468|P1|STARTED|Overall Study||21
480609|NCT01123200|1177476|P1|NOT COMPLETED|Overall Study||1
480610|NCT01123200|1177476|P1|COMPLETED|Overall Study||0
480611|NCT01123200|1177476|P1|STARTED|Overall Study||1
480612|NCT01123161|1177483|P2|NOT COMPLETED|Overall Study||0
480613|NCT01123161|1177484|P1|NOT COMPLETED|Overall Study||2
480614|NCT01123161|1177483|P2|COMPLETED|Overall Study||63
480615|NCT01123161|1177484|P1|COMPLETED|Overall Study||55
480616|NCT01123161|1177483|P2|STARTED|Overall Study||63
480617|NCT01123161|1177484|P1|STARTED|Overall Study||57
480618|NCT01123148|1177502|P1|NOT COMPLETED|Overall Study||2
480619|NCT01123148|1177502|P1|COMPLETED|Overall Study||12
480620|NCT01123148|1177502|P1|BCI Calibration >50% Accuracy|Overall Study||13
480621|NCT01123148|1177502|P1|STARTED|Overall Study||14
480622|NCT01123083|1177508|P2|NOT COMPLETED|Overall Study||15
480623|NCT01123083|1177509|P1|NOT COMPLETED|Overall Study||11
480624|NCT01123083|1177508|P2|COMPLETED|Overall Study||103
480625|NCT01123083|1177509|P1|COMPLETED|Overall Study||50
480626|NCT01123083|1177508|P2|STARTED|Overall Study||118
480627|NCT01123083|1177509|P1|STARTED|Overall Study||61
480628|NCT01122927|1177533|P2|NOT COMPLETED|Period 2- Open-label Treatment Phase||312
480629|NCT01122927|1177534|P1|NOT COMPLETED|Period 2- Open-label Treatment Phase||0
480630|NCT01122927|1177533|P2|COMPLETED|Period 2- Open-label Treatment Phase|De novo participants who completed Month 24 visit or rolled over from study NCT01149655.|198
480631|NCT01122927|1177534|P1|COMPLETED|Period 2- Open-label Treatment Phase||0
480632|NCT01122927|1177533|P2|STARTED|Period 2- Open-label Treatment Phase|362 were de novo participants and 148 had rolled over from study NCT01149655.|510
480633|NCT01122927|1177534|P1|STARTED|Period 2- Open-label Treatment Phase||0
480634|NCT01122927|1177533|P2|NOT COMPLETED|Period 1 - Conversion Phase||0
480635|NCT01122927|1177534|P1|NOT COMPLETED|Period 1 - Conversion Phase||14
480636|NCT01122927|1177533|P2|COMPLETED|Period 1 - Conversion Phase||0
480637|NCT01122927|1177534|P1|COMPLETED|Period 1 - Conversion Phase||283
480638|NCT01122927|1177533|P2|STARTED|Period 1 - Conversion Phase||0
480639|NCT01122927|1177534|P1|STARTED|Period 1 - Conversion Phase||297
480640|NCT01122901|1177567|P2|NOT COMPLETED|Overall Study||0
480641|NCT01122901|1177568|P1|NOT COMPLETED|Overall Study||0
480642|NCT01122901|1177567|P2|COMPLETED|Overall Study||7
480643|NCT01122901|1177568|P1|COMPLETED|Overall Study||40
480644|NCT01122901|1177567|P2|STARTED|Overall Study||7
480645|NCT01122901|1177568|P1|STARTED|Overall Study||40
480646|NCT01122862|1177586|P3|NOT COMPLETED|Period 3||0
480647|NCT01122862|1177587|P2|NOT COMPLETED|Period 3||0
480648|NCT01122862|1177588|P1|NOT COMPLETED|Period 3||0
480649|NCT01122862|1177586|P3|COMPLETED|Period 3||8
480650|NCT01122862|1177587|P2|COMPLETED|Period 3||7
480651|NCT01122862|1177588|P1|COMPLETED|Period 3||6
480652|NCT01122862|1177586|P3|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|8
480653|NCT01122862|1177587|P2|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|7
480654|NCT01122862|1177588|P1|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|6
480655|NCT01122862|1177586|P3|NOT COMPLETED|Period 2||1
480656|NCT01122862|1177587|P2|NOT COMPLETED|Period 2||0
480657|NCT01122862|1177588|P1|NOT COMPLETED|Period 2||0
480658|NCT01122862|1177586|P3|COMPLETED|Period 2||6
480659|NCT01122862|1177587|P2|COMPLETED|Period 2||7
480660|NCT01122862|1177588|P1|COMPLETED|Period 2||8
480661|NCT01122862|1177586|P3|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|7
480662|NCT01122862|1177587|P2|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|7
480663|NCT01122862|1177588|P1|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|8
480664|NCT01122862|1177586|P3|NOT COMPLETED|Period 1||0
480665|NCT01122862|1177587|P2|NOT COMPLETED|Period 1||1
480666|NCT01122862|1177588|P1|NOT COMPLETED|Period 1||0
480667|NCT01122862|1177586|P3|COMPLETED|Period 1||7
480668|NCT01122862|1177587|P2|COMPLETED|Period 1||7
480669|NCT01122862|1177588|P1|COMPLETED|Period 1||8
480670|NCT01122862|1177586|P3|STARTED|Period 1||7
480671|NCT01122862|1177587|P2|STARTED|Period 1||8
480672|NCT01122862|1177588|P1|STARTED|Period 1||8
480673|NCT01122849|1177609|P3|NOT COMPLETED|Overall Study||0
480674|NCT01122849|1177610|P2|NOT COMPLETED|Overall Study||0
480675|NCT01122849|1177611|P1|NOT COMPLETED|Overall Study||0
480676|NCT01122849|1177609|P3|COMPLETED|Overall Study||20
480677|NCT01122849|1177610|P2|COMPLETED|Overall Study||21
480678|NCT01122849|1177611|P1|COMPLETED|Overall Study||20
480679|NCT01122849|1177609|P3|STARTED|Overall Study||20
480680|NCT01122849|1177610|P2|STARTED|Overall Study||21
480681|NCT01122849|1177611|P1|STARTED|Overall Study||20
480682|NCT01122680|1177694|P4|NOT COMPLETED|Period 3 (4 Weeks)||0
480683|NCT01122680|1177695|P3|NOT COMPLETED|Period 3 (4 Weeks)||0
480684|NCT01122680|1177696|P2|NOT COMPLETED|Period 3 (4 Weeks)||1
480685|NCT01122680|1177697|P1|NOT COMPLETED|Period 3 (4 Weeks)||1
480686|NCT01122680|1177694|P4|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|23
480687|NCT01122680|1177695|P3|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|26
480688|NCT01122680|1177696|P2|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|24
480689|NCT01122680|1177697|P1|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|24
480690|NCT01122680|1177694|P4|STARTED|Period 3 (4 Weeks)|Entered this study period.|23
480691|NCT01122680|1177695|P3|STARTED|Period 3 (4 Weeks)|Entered this study period.|26
480692|NCT01122680|1177696|P2|STARTED|Period 3 (4 Weeks)|Entered this study period.|25
480693|NCT01122680|1177697|P1|STARTED|Period 3 (4 Weeks)|Entered this study period.|25
480694|NCT01122680|1177694|P4|NOT COMPLETED|Period 2 (4 Weeks)||1
480695|NCT01122680|1177695|P3|NOT COMPLETED|Period 2 (4 Weeks)||0
480696|NCT01122680|1177696|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
480697|NCT01122680|1177697|P1|NOT COMPLETED|Period 2 (4 Weeks)||1
480698|NCT01122680|1177694|P4|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|23
480699|NCT01122680|1177695|P3|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|26
480700|NCT01122680|1177696|P2|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|25
480701|NCT01122680|1177697|P1|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|25
480702|NCT01122680|1177694|P4|STARTED|Period 2 (4 Weeks)|Entered this study period.|24
480703|NCT01122680|1177695|P3|STARTED|Period 2 (4 Weeks)|Entered this study period.|26
480704|NCT01122680|1177696|P2|STARTED|Period 2 (4 Weeks)|Entered this study period.|25
480705|NCT01122680|1177697|P1|STARTED|Period 2 (4 Weeks)|Entered this study period.|26
480706|NCT01122680|1177694|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
480707|NCT01122680|1177695|P3|NOT COMPLETED|Period 1 (4 Weeks)||0
480708|NCT01122680|1177696|P2|NOT COMPLETED|Period 1 (4 Weeks)||1
480709|NCT01122680|1177697|P1|NOT COMPLETED|Period 1 (4 Weeks)||3
480710|NCT01122680|1177694|P4|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|24
480711|NCT01122680|1177695|P3|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|26
480712|NCT01122680|1177696|P2|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|25
480713|NCT01122680|1177697|P1|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|26
480714|NCT01122680|1177694|P4|STARTED|Period 1 (4 Weeks)|Entered this study period.|24
480715|NCT01122680|1177695|P3|STARTED|Period 1 (4 Weeks)|Entered this study period.|26
480716|NCT01122680|1177696|P2|STARTED|Period 1 (4 Weeks)|Entered this study period.|26
480717|NCT01122680|1177697|P1|STARTED|Period 1 (4 Weeks)|Entered this study period.|29
480718|NCT01122576|1177762|P3|NOT COMPLETED|Post-Cataract Surgery||2
480719|NCT01122576|1177763|P2|NOT COMPLETED|Post-Cataract Surgery||0
480720|NCT01122576|1177764|P1|NOT COMPLETED|Post-Cataract Surgery||0
480721|NCT01122576|1177762|P3|COMPLETED|Post-Cataract Surgery||22
480722|NCT01122576|1177763|P2|COMPLETED|Post-Cataract Surgery||25
480723|NCT01122576|1177764|P1|COMPLETED|Post-Cataract Surgery||26
480724|NCT01122576|1177762|P3|STARTED|Post-Cataract Surgery||24
480725|NCT01122576|1177763|P2|STARTED|Post-Cataract Surgery||25
480726|NCT01122576|1177764|P1|STARTED|Post-Cataract Surgery||26
480727|NCT01122576|1177762|P3|NOT COMPLETED|Pre-Cataract Surgery||2
480728|NCT01122576|1177763|P2|NOT COMPLETED|Pre-Cataract Surgery||1
480729|NCT01122576|1177764|P1|NOT COMPLETED|Pre-Cataract Surgery||0
480730|NCT01122576|1177762|P3|COMPLETED|Pre-Cataract Surgery||24
480731|NCT01122576|1177763|P2|COMPLETED|Pre-Cataract Surgery||25
480732|NCT01122576|1177764|P1|COMPLETED|Pre-Cataract Surgery||26
480733|NCT01122576|1177762|P3|STARTED|Pre-Cataract Surgery||26
480734|NCT01122576|1177763|P2|STARTED|Pre-Cataract Surgery||26
480735|NCT01122576|1177764|P1|STARTED|Pre-Cataract Surgery||26
480736|NCT01122511|1177903|P2|NOT COMPLETED|Overall Study||2
480737|NCT01122511|1177904|P1|NOT COMPLETED|Overall Study||2
480738|NCT01122511|1177903|P2|COMPLETED|Overall Study||0
480739|NCT01122511|1177904|P1|COMPLETED|Overall Study||0
480740|NCT01122511|1177903|P2|STARTED|Overall Study||2
480741|NCT01122511|1177904|P1|STARTED|Overall Study||2
480742|NCT01122394|1177918|P2|NOT COMPLETED|Overall Study||4
480743|NCT01122394|1177919|P1|NOT COMPLETED|Overall Study||3
480744|NCT01122394|1177918|P2|COMPLETED|Overall Study||70
480745|NCT01122394|1177919|P1|COMPLETED|Overall Study||63
480746|NCT01122394|1177918|P2|STARTED|Overall Study||74
480747|NCT01122394|1177919|P1|STARTED|Overall Study||66
480748|NCT01122381|1177935|P2|NOT COMPLETED|Overall Study||1
480749|NCT01122381|1177936|P1|NOT COMPLETED|Overall Study||0
480750|NCT01122381|1177935|P2|COMPLETED|Overall Study||0
480751|NCT01122381|1177936|P1|COMPLETED|Overall Study|Subject never took the drug per review of ESX levels after unblinding|1
480752|NCT01122381|1177935|P2|STARTED|Overall Study||1
480753|NCT01122381|1177936|P1|STARTED|Overall Study||1
480754|NCT01122264|1177945|P3|NOT COMPLETED|Overall Study||47
480755|NCT01122264|1177946|P2|NOT COMPLETED|Overall Study||29
480756|NCT01122264|1177947|P1|NOT COMPLETED|Overall Study||32
480757|NCT01122264|1177945|P3|COMPLETED|Overall Study||214
480758|NCT01122264|1177946|P2|COMPLETED|Overall Study||228
480759|NCT01122264|1177947|P1|COMPLETED|Overall Study||220
480760|NCT01122264|1177945|P3|Received at Least 1 Dose of Study Drug|Overall Study||260
480761|NCT01122264|1177946|P2|Received at Least 1 Dose of Study Drug|Overall Study||257
480762|NCT01122264|1177947|P1|Received at Least 1 Dose of Study Drug|Overall Study||250
480763|NCT01122264|1177945|P3|STARTED|Overall Study||261
480764|NCT01122264|1177946|P2|STARTED|Overall Study||257
480765|NCT01122264|1177947|P1|STARTED|Overall Study||252
480766|NCT01122238|1178020|P16|NOT COMPLETED|Overall Study||0
480767|NCT01122238|1178021|P15|NOT COMPLETED|Overall Study||0
480768|NCT01122238|1178022|P14|NOT COMPLETED|Overall Study||1
480769|NCT01122238|1178023|P13|NOT COMPLETED|Overall Study||2
480770|NCT01122238|1178024|P12|NOT COMPLETED|Overall Study||2
480771|NCT01122238|1178025|P11|NOT COMPLETED|Overall Study||0
480772|NCT01122238|1178026|P10|NOT COMPLETED|Overall Study||1
480773|NCT01122238|1178027|P9|NOT COMPLETED|Overall Study||1
480774|NCT01122238|1178028|P8|NOT COMPLETED|Overall Study||0
480775|NCT01122238|1178029|P7|NOT COMPLETED|Overall Study||1
480776|NCT01122238|1178030|P6|NOT COMPLETED|Overall Study||1
480777|NCT01122238|1178031|P5|NOT COMPLETED|Overall Study||0
480778|NCT01122238|1178032|P4|NOT COMPLETED|Overall Study||0
480779|NCT01122238|1178033|P3|NOT COMPLETED|Overall Study||5
480780|NCT01122238|1178034|P2|NOT COMPLETED|Overall Study||1
480781|NCT01122238|1178035|P1|NOT COMPLETED|Overall Study||2
480782|NCT01122238|1178020|P16|COMPLETED|Overall Study||31
480783|NCT01122238|1178021|P15|COMPLETED|Overall Study||28
480784|NCT01122238|1178022|P14|COMPLETED|Overall Study||31
480785|NCT01122238|1178023|P13|COMPLETED|Overall Study||28
480786|NCT01122238|1178024|P12|COMPLETED|Overall Study||31
480787|NCT01122238|1178025|P11|COMPLETED|Overall Study||32
480788|NCT01122238|1178026|P10|COMPLETED|Overall Study||33
480789|NCT01122238|1178027|P9|COMPLETED|Overall Study||31
480790|NCT01122238|1178028|P8|COMPLETED|Overall Study||32
480791|NCT01122238|1178029|P7|COMPLETED|Overall Study||34
480792|NCT01122238|1178030|P6|COMPLETED|Overall Study||31
480793|NCT01122238|1178031|P5|COMPLETED|Overall Study||33
480794|NCT01122238|1178032|P4|COMPLETED|Overall Study||33
480795|NCT01122238|1178033|P3|COMPLETED|Overall Study||28
480796|NCT01122238|1178034|P2|COMPLETED|Overall Study||36
480797|NCT01122238|1178035|P1|COMPLETED|Overall Study||28
480798|NCT01122238|1178020|P16|STARTED|Overall Study||31
480799|NCT01122238|1178021|P15|STARTED|Overall Study||28
480800|NCT01122238|1178022|P14|STARTED|Overall Study||32
480801|NCT01122238|1178023|P13|STARTED|Overall Study||30
480802|NCT01122238|1178024|P12|STARTED|Overall Study||33
480803|NCT01122238|1178025|P11|STARTED|Overall Study||32
480804|NCT01122238|1178026|P10|STARTED|Overall Study||34
480805|NCT01122238|1178027|P9|STARTED|Overall Study||32
480806|NCT01122238|1178028|P8|STARTED|Overall Study||32
480807|NCT01122238|1178029|P7|STARTED|Overall Study||35
480808|NCT01122238|1178030|P6|STARTED|Overall Study||32
480809|NCT01122238|1178031|P5|STARTED|Overall Study||33
480810|NCT01122238|1178032|P4|STARTED|Overall Study||33
480811|NCT01122238|1178033|P3|STARTED|Overall Study||33
480812|NCT01122238|1178034|P2|STARTED|Overall Study||37
480813|NCT01122238|1178035|P1|STARTED|Overall Study||30
480814|NCT01122160|1178057|P2|NOT COMPLETED|Second Intervention (7 Days)||0
480815|NCT01122160|1178058|P1|NOT COMPLETED|Second Intervention (7 Days)||0
480816|NCT01122160|1178057|P2|COMPLETED|Second Intervention (7 Days)||5
480817|NCT01122160|1178058|P1|COMPLETED|Second Intervention (7 Days)||6
480818|NCT01122160|1178057|P2|STARTED|Second Intervention (7 Days)||5
480819|NCT01122160|1178058|P1|STARTED|Second Intervention (7 Days)||6
480820|NCT01122160|1178057|P2|NOT COMPLETED|Washout (7-14 Days)||0
480821|NCT01122160|1178058|P1|NOT COMPLETED|Washout (7-14 Days)||0
480822|NCT01122160|1178057|P2|COMPLETED|Washout (7-14 Days)||5
480823|NCT01122160|1178058|P1|COMPLETED|Washout (7-14 Days)||6
480824|NCT01122160|1178057|P2|STARTED|Washout (7-14 Days)||5
480825|NCT01122160|1178058|P1|STARTED|Washout (7-14 Days)||6
480826|NCT01122160|1178057|P2|NOT COMPLETED|First Intervention (7 Days)||0
480827|NCT01122160|1178058|P1|NOT COMPLETED|First Intervention (7 Days)||0
480828|NCT01122160|1178057|P2|COMPLETED|First Intervention (7 Days)||5
480829|NCT01122160|1178058|P1|COMPLETED|First Intervention (7 Days)||6
480830|NCT01122160|1178057|P2|STARTED|First Intervention (7 Days)||5
480831|NCT01122160|1178058|P1|STARTED|First Intervention (7 Days)||6
480832|NCT01122108|1178064|P2|NOT COMPLETED|Overall Study||0
480833|NCT01122108|1178065|P1|NOT COMPLETED|Overall Study||0
480834|NCT01122108|1178064|P2|COMPLETED|Overall Study||21
480835|NCT01122108|1178065|P1|COMPLETED|Overall Study||21
480836|NCT01122108|1178064|P2|STARTED|Overall Study||21
480837|NCT01122108|1178065|P1|STARTED|Overall Study||21
480838|NCT01122030|1178081|P7|NOT COMPLETED|Overall Study||0
480839|NCT01122030|1178082|P6|NOT COMPLETED|Overall Study||0
480840|NCT01122030|1178083|P5|NOT COMPLETED|Overall Study||0
480841|NCT01122030|1178084|P4|NOT COMPLETED|Overall Study||0
480842|NCT01122030|1178085|P3|NOT COMPLETED|Overall Study||0
480843|NCT01122030|1178086|P2|NOT COMPLETED|Overall Study||0
480844|NCT01122030|1178087|P1|NOT COMPLETED|Overall Study||0
480845|NCT01122030|1178081|P7|COMPLETED|Overall Study||9
480846|NCT01122030|1178082|P6|COMPLETED|Overall Study||9
480847|NCT01122030|1178083|P5|COMPLETED|Overall Study||9
480848|NCT01122030|1178084|P4|COMPLETED|Overall Study||9
480849|NCT01122030|1178085|P3|COMPLETED|Overall Study||9
480850|NCT01122030|1178086|P2|COMPLETED|Overall Study||9
480851|NCT01122030|1178087|P1|COMPLETED|Overall Study||18
480852|NCT01122030|1178081|P7|Received Treatment|Overall Study||9
480853|NCT01122030|1178082|P6|Received Treatment|Overall Study||9
480854|NCT01122030|1178083|P5|Received Treatment|Overall Study||9
480855|NCT01122030|1178084|P4|Received Treatment|Overall Study||9
480856|NCT01122030|1178085|P3|Received Treatment|Overall Study||9
480857|NCT01122030|1178086|P2|Received Treatment|Overall Study||9
480858|NCT01122030|1178087|P1|Received Treatment|Overall Study||18
480859|NCT01122030|1178081|P7|STARTED|Overall Study||9
480860|NCT01122030|1178082|P6|STARTED|Overall Study||9
480861|NCT01122030|1178083|P5|STARTED|Overall Study||9
480862|NCT01122030|1178084|P4|STARTED|Overall Study||9
480863|NCT01122030|1178085|P3|STARTED|Overall Study||9
480864|NCT01122030|1178086|P2|STARTED|Overall Study||9
480865|NCT01122030|1178087|P1|STARTED|Overall Study||18
480866|NCT01121991|1178273|P1|NOT COMPLETED|Overall Study||6
480867|NCT01121991|1178273|P1|COMPLETED|Overall Study||46
480868|NCT01121991|1178273|P1|STARTED|Overall Study|Number of participants treated|52
480869|NCT01121939|1178284|P1|NOT COMPLETED|Overall Study||43
480870|NCT01121939|1178284|P1|COMPLETED|Overall Study|Patients remained on-study until disease progression or unacceptable toxicity occurred.|0
480871|NCT01121939|1178284|P1|STARTED|Overall Study||43
480872|NCT01121926|1178298|P2|NOT COMPLETED|Second Intervention Period||0
480873|NCT01121926|1178299|P1|NOT COMPLETED|Second Intervention Period||0
480874|NCT01121926|1178298|P2|COMPLETED|Second Intervention Period||13
480875|NCT01121926|1178299|P1|COMPLETED|Second Intervention Period||14
480876|NCT01121926|1178298|P2|STARTED|Second Intervention Period||13
480877|NCT01121926|1178299|P1|STARTED|Second Intervention Period||14
480878|NCT01121926|1178298|P2|NOT COMPLETED|Washout Period||2
480879|NCT01121926|1178299|P1|NOT COMPLETED|Washout Period||0
480880|NCT01121926|1178298|P2|COMPLETED|Washout Period||13
480881|NCT01121926|1178299|P1|COMPLETED|Washout Period||14
480882|NCT01121926|1178298|P2|STARTED|Washout Period||15
480883|NCT01121926|1178299|P1|STARTED|Washout Period||14
480884|NCT01121926|1178298|P2|NOT COMPLETED|First Intervention Period||0
480885|NCT01121926|1178299|P1|NOT COMPLETED|First Intervention Period||1
480886|NCT01121926|1178298|P2|COMPLETED|First Intervention Period||15
480887|NCT01121926|1178299|P1|COMPLETED|First Intervention Period||14
480888|NCT01121926|1178298|P2|STARTED|First Intervention Period||15
480889|NCT01121926|1178299|P1|STARTED|First Intervention Period||15
480890|NCT01121913|1178317|P4|NOT COMPLETED|Fourth Intervention Period||0
480891|NCT01121913|1178318|P3|NOT COMPLETED|Fourth Intervention Period||0
480892|NCT01121913|1178319|P2|NOT COMPLETED|Fourth Intervention Period||0
480893|NCT01121913|1178320|P1|NOT COMPLETED|Fourth Intervention Period||0
480894|NCT01121913|1178317|P4|COMPLETED|Fourth Intervention Period||6
480895|NCT01121913|1178318|P3|COMPLETED|Fourth Intervention Period||3
480896|NCT01121913|1178319|P2|COMPLETED|Fourth Intervention Period||6
480897|NCT01121913|1178320|P1|COMPLETED|Fourth Intervention Period||4
480898|NCT01121913|1178317|P4|STARTED|Fourth Intervention Period||6
480899|NCT01121913|1178318|P3|STARTED|Fourth Intervention Period||3
480900|NCT01121913|1178319|P2|STARTED|Fourth Intervention Period||6
480901|NCT01121913|1178320|P1|STARTED|Fourth Intervention Period||4
480902|NCT01121913|1178317|P4|NOT COMPLETED|Third Washout Period||0
480903|NCT01121913|1178318|P3|NOT COMPLETED|Third Washout Period||0
480904|NCT01121913|1178319|P2|NOT COMPLETED|Third Washout Period||0
480905|NCT01121913|1178320|P1|NOT COMPLETED|Third Washout Period||1
480906|NCT01121913|1178317|P4|COMPLETED|Third Washout Period||6
480907|NCT01121913|1178318|P3|COMPLETED|Third Washout Period||3
480908|NCT01121913|1178319|P2|COMPLETED|Third Washout Period||6
480909|NCT01121913|1178320|P1|COMPLETED|Third Washout Period||4
480910|NCT01121913|1178317|P4|STARTED|Third Washout Period||6
480911|NCT01121913|1178318|P3|STARTED|Third Washout Period||3
480912|NCT01121913|1178319|P2|STARTED|Third Washout Period||6
480913|NCT01121913|1178320|P1|STARTED|Third Washout Period||5
480914|NCT01121913|1178317|P4|NOT COMPLETED|Third Intervention Period||0
480915|NCT01121913|1178318|P3|NOT COMPLETED|Third Intervention Period||0
480916|NCT01121913|1178319|P2|NOT COMPLETED|Third Intervention Period||0
480917|NCT01121913|1178320|P1|NOT COMPLETED|Third Intervention Period||0
480918|NCT01121913|1178317|P4|COMPLETED|Third Intervention Period||6
480919|NCT01121913|1178318|P3|COMPLETED|Third Intervention Period||3
480920|NCT01121913|1178319|P2|COMPLETED|Third Intervention Period||6
480921|NCT01121913|1178320|P1|COMPLETED|Third Intervention Period||5
480922|NCT01121913|1178317|P4|STARTED|Third Intervention Period||6
480923|NCT01121913|1178318|P3|STARTED|Third Intervention Period||3
480924|NCT01121913|1178319|P2|STARTED|Third Intervention Period||6
480925|NCT01121913|1178320|P1|STARTED|Third Intervention Period||5
480926|NCT01121913|1178317|P4|NOT COMPLETED|Second Washout Period||0
480927|NCT01121913|1178318|P3|NOT COMPLETED|Second Washout Period||1
480928|NCT01121913|1178319|P2|NOT COMPLETED|Second Washout Period||0
480929|NCT01121913|1178320|P1|NOT COMPLETED|Second Washout Period||0
480930|NCT01121913|1178317|P4|COMPLETED|Second Washout Period||6
480931|NCT01121913|1178318|P3|COMPLETED|Second Washout Period||3
480932|NCT01121913|1178319|P2|COMPLETED|Second Washout Period||6
480933|NCT01121913|1178320|P1|COMPLETED|Second Washout Period||5
480934|NCT01121913|1178317|P4|STARTED|Second Washout Period||6
480935|NCT01121913|1178318|P3|STARTED|Second Washout Period||4
480936|NCT01121913|1178319|P2|STARTED|Second Washout Period||6
480937|NCT01121913|1178320|P1|STARTED|Second Washout Period||5
480938|NCT01121913|1178317|P4|NOT COMPLETED|Second Intervention Period||0
480939|NCT01121913|1178318|P3|NOT COMPLETED|Second Intervention Period||1
480940|NCT01121913|1178319|P2|NOT COMPLETED|Second Intervention Period||0
480941|NCT01121913|1178320|P1|NOT COMPLETED|Second Intervention Period||0
480942|NCT01121913|1178317|P4|COMPLETED|Second Intervention Period||6
480943|NCT01121913|1178318|P3|COMPLETED|Second Intervention Period||4
480944|NCT01121913|1178319|P2|COMPLETED|Second Intervention Period||6
480945|NCT01121913|1178320|P1|COMPLETED|Second Intervention Period||5
480946|NCT01121913|1178317|P4|STARTED|Second Intervention Period||6
480947|NCT01121913|1178318|P3|STARTED|Second Intervention Period||5
480948|NCT01121913|1178319|P2|STARTED|Second Intervention Period||6
480949|NCT01121913|1178320|P1|STARTED|Second Intervention Period||5
480950|NCT01121913|1178317|P4|NOT COMPLETED|First Washout Period||0
480951|NCT01121913|1178318|P3|NOT COMPLETED|First Washout Period||0
480952|NCT01121913|1178319|P2|NOT COMPLETED|First Washout Period||0
480953|NCT01121913|1178320|P1|NOT COMPLETED|First Washout Period||1
480954|NCT01121913|1178317|P4|COMPLETED|First Washout Period||6
480955|NCT01121913|1178318|P3|COMPLETED|First Washout Period||5
480956|NCT01121913|1178319|P2|COMPLETED|First Washout Period||6
480957|NCT01121913|1178320|P1|COMPLETED|First Washout Period||5
480958|NCT01121913|1178317|P4|STARTED|First Washout Period||6
480959|NCT01121913|1178318|P3|STARTED|First Washout Period||5
480960|NCT01121913|1178319|P2|STARTED|First Washout Period||6
480961|NCT01121913|1178320|P1|STARTED|First Washout Period||6
480962|NCT01121913|1178317|P4|NOT COMPLETED|First Intervention Period||0
480963|NCT01121913|1178318|P3|NOT COMPLETED|First Intervention Period||1
480964|NCT01121913|1178319|P2|NOT COMPLETED|First Intervention Period||0
480965|NCT01121913|1178320|P1|NOT COMPLETED|First Intervention Period||0
480966|NCT01121913|1178317|P4|COMPLETED|First Intervention Period||6
480967|NCT01121913|1178318|P3|COMPLETED|First Intervention Period||5
480968|NCT01121913|1178319|P2|COMPLETED|First Intervention Period||6
480969|NCT01121913|1178320|P1|COMPLETED|First Intervention Period||6
480970|NCT01121913|1178317|P4|STARTED|First Intervention Period||6
480971|NCT01121913|1178318|P3|STARTED|First Intervention Period||6
480972|NCT01121913|1178319|P2|STARTED|First Intervention Period||6
480973|NCT01121913|1178320|P1|STARTED|First Intervention Period||6
480974|NCT01121900|1178350|P2|NOT COMPLETED|Second Intervention Period||0
480975|NCT01121900|1178351|P1|NOT COMPLETED|Second Intervention Period||0
480976|NCT01121900|1178350|P2|COMPLETED|Second Intervention Period||11
480977|NCT01121900|1178351|P1|COMPLETED|Second Intervention Period||12
480978|NCT01121900|1178350|P2|STARTED|Second Intervention Period||11
480979|NCT01121900|1178351|P1|STARTED|Second Intervention Period||12
480980|NCT01121900|1178350|P2|NOT COMPLETED|Washout Period of 7 Days||1
480981|NCT01121900|1178351|P1|NOT COMPLETED|Washout Period of 7 Days||0
480982|NCT01121900|1178350|P2|COMPLETED|Washout Period of 7 Days||11
480983|NCT01121900|1178351|P1|COMPLETED|Washout Period of 7 Days||12
480984|NCT01121900|1178350|P2|STARTED|Washout Period of 7 Days||12
480985|NCT01121900|1178351|P1|STARTED|Washout Period of 7 Days||12
480986|NCT01121900|1178350|P2|NOT COMPLETED|First Intervention Period||1
480987|NCT01121900|1178351|P1|NOT COMPLETED|First Intervention Period||1
480988|NCT01121900|1178350|P2|COMPLETED|First Intervention Period||12
480989|NCT01121900|1178351|P1|COMPLETED|First Intervention Period||12
480990|NCT01121900|1178350|P2|STARTED|First Intervention Period||13
480991|NCT01121900|1178351|P1|STARTED|First Intervention Period||13
480992|NCT01121757|1178371|P2|NOT COMPLETED|Combination||1
480993|NCT01121757|1178372|P1|NOT COMPLETED|Combination||2
480994|NCT01121757|1178371|P2|COMPLETED|Combination||0
480995|NCT01121757|1178372|P1|COMPLETED|Combination||0
480996|NCT01121757|1178371|P2|STARTED|Combination||1
480997|NCT01121757|1178372|P1|STARTED|Combination|2 subjects did not start combination drug. 1 elected surgery 1 had a complete response after drug 2.|2
480998|NCT01121757|1178371|P2|NOT COMPLETED|Second Drug||0
480999|NCT01121757|1178372|P1|NOT COMPLETED|Second Drug||0
481000|NCT01121757|1178371|P2|COMPLETED|Second Drug||1
481001|NCT01121757|1178372|P1|COMPLETED|Second Drug||4
481002|NCT01121757|1178371|P2|STARTED|Second Drug||1
481003|NCT01121757|1178372|P1|STARTED|Second Drug|1 subject did not start drug 2 due to disease progression|4
481004|NCT01121757|1178371|P2|NOT COMPLETED|First Drug||2
481005|NCT01121757|1178372|P1|NOT COMPLETED|First Drug||1
481006|NCT01121757|1178371|P2|COMPLETED|First Drug|Completed a minimum of 4 cycles of Lenalidomide|1
481007|NCT01121757|1178372|P1|COMPLETED|First Drug|Completed a minimum of 4 cycles of Azacitidine.|5
481008|NCT01121757|1178371|P2|STARTED|First Drug||3
481009|NCT01121757|1178372|P1|STARTED|First Drug||6
481010|NCT01121666|1178388|P2|NOT COMPLETED|Overall Study||10
481011|NCT01121666|1178389|P1|NOT COMPLETED|Overall Study||29
481012|NCT01121666|1178388|P2|COMPLETED|Overall Study||113
481013|NCT01121666|1178389|P1|COMPLETED|Overall Study||220
481014|NCT01121666|1178388|P2|STARTED|Overall Study||123
481015|NCT01121666|1178389|P1|STARTED|Overall Study||249
481016|NCT01121575|1178445|P6|NOT COMPLETED|Overall Study||12
481017|NCT01121575|1178446|P5|NOT COMPLETED|Overall Study||25
481018|NCT01121575|1178447|P4|NOT COMPLETED|Overall Study||6
481019|NCT01121575|1178448|P3|NOT COMPLETED|Overall Study||7
481020|NCT01121575|1178449|P2|NOT COMPLETED|Overall Study||6
481021|NCT01121575|1178450|P1|NOT COMPLETED|Overall Study||14
481022|NCT01121575|1178445|P6|COMPLETED|Overall Study||0
481023|NCT01121575|1178446|P5|COMPLETED|Overall Study||0
481024|NCT01121575|1178447|P4|COMPLETED|Overall Study||0
481025|NCT01121575|1178448|P3|COMPLETED|Overall Study||0
481026|NCT01121575|1178449|P2|COMPLETED|Overall Study||0
481027|NCT01121575|1178450|P1|COMPLETED|Overall Study||0
481028|NCT01121575|1178445|P6|Treated|Overall Study||12
481029|NCT01121575|1178446|P5|Treated|Overall Study||25
481030|NCT01121575|1178447|P4|Treated|Overall Study||6
481031|NCT01121575|1178448|P3|Treated|Overall Study||7
481032|NCT01121575|1178449|P2|Treated|Overall Study||6
481033|NCT01121575|1178450|P1|Treated|Overall Study||14
481034|NCT01121575|1178445|P6|STARTED|Overall Study||12
481035|NCT01121575|1178446|P5|STARTED|Overall Study||25
481036|NCT01121575|1178447|P4|STARTED|Overall Study||6
481037|NCT01121575|1178448|P3|STARTED|Overall Study||7
481038|NCT01121575|1178449|P2|STARTED|Overall Study||6
481039|NCT01121575|1178450|P1|STARTED|Overall Study||14
481040|NCT01121562|1178574|P1|NOT COMPLETED|Overall Study||12
481041|NCT01121562|1178574|P1|COMPLETED|Overall Study||0
481042|NCT01121562|1178574|P1|STARTED|Overall Study||12
481043|NCT01121549|1178583|P1|NOT COMPLETED|Overall Study||347
481044|NCT01121549|1178583|P1|COMPLETED|Overall Study||31
481045|NCT01121549|1178583|P1|STARTED|Overall Study||378
481046|NCT01121536|1178594|P1|NOT COMPLETED|Overall Study||361
481047|NCT01121536|1178594|P1|COMPLETED|Overall Study|One participant 'completed' early due to study closeout.|506
481048|NCT01121536|1178594|P1|Full Analysis Population|Overall Study|Treated participants who had at least 1 post-baseline efficacy assessment.|859
481049|NCT01121536|1178594|P1|Safety Population|Overall Study|Participants treated|863
481050|NCT01121536|1178594|P1|STARTED|Overall Study||867
481051|NCT01121484|1178615|P2|NOT COMPLETED|Overall Study||43
481052|NCT01121484|1178616|P1|NOT COMPLETED|Overall Study||33
481053|NCT01121484|1178615|P2|COMPLETED|Overall Study||178
481054|NCT01121484|1178616|P1|COMPLETED|Overall Study||185
481055|NCT01121484|1178615|P2|Treated|Overall Study||217
481056|NCT01121484|1178616|P1|Treated|Overall Study||217
481057|NCT01121484|1178615|P2|STARTED|Overall Study||221
481058|NCT01121484|1178616|P1|STARTED|Overall Study||218
481059|NCT01121406|1178634|P2|NOT COMPLETED|Overall Study||55
481060|NCT01121406|1178635|P1|NOT COMPLETED|Overall Study||55
481061|NCT01121406|1178634|P2|COMPLETED|Overall Study||0
481062|NCT01121406|1178635|P1|COMPLETED|Overall Study||0
481063|NCT01121406|1178634|P2|STARTED|Overall Study|24 patients switched to Volasertib (BI 6727) due to disease progression or occurrence of toxicity|55
481064|NCT01121406|1178635|P1|STARTED|Overall Study||55
481065|NCT01121393|1178685|P2|NOT COMPLETED|Overall Study||84
481066|NCT01121393|1178686|P1|NOT COMPLETED|Overall Study||219
481067|NCT01121393|1178685|P2|COMPLETED|Overall Study|Completed 6 courses of chemotherapy|38
481068|NCT01121393|1178686|P1|COMPLETED|Overall Study|On-treatment at analysis cut-off date (27 December 2013)|23
481069|NCT01121393|1178685|P2|STARTED|Overall Study|randomised|122
481070|NCT01121393|1178686|P1|STARTED|Overall Study|randomised|242
481071|NCT01121263|1178731|P2|NOT COMPLETED|Overall Study||15
481072|NCT01121263|1178732|P1|NOT COMPLETED|Overall Study||25
481073|NCT01121263|1178731|P2|COMPLETED|Overall Study||83
481074|NCT01121263|1178732|P1|COMPLETED|Overall Study||175
481075|NCT01121263|1178731|P2|STARTED|Overall Study||98
481076|NCT01121263|1178732|P1|STARTED|Overall Study||200
481077|NCT01121224|1178742|P2|NOT COMPLETED|Overall Study||17
481078|NCT01121224|1178743|P1|NOT COMPLETED|Overall Study||25
481079|NCT01121224|1178742|P2|COMPLETED|Overall Study||275
481080|NCT01121224|1178743|P1|COMPLETED|Overall Study||280
481081|NCT01121224|1178742|P2|STARTED|Overall Study||292
481082|NCT01121224|1178743|P1|STARTED|Overall Study||305
481083|NCT01121211|1178767|P2|NOT COMPLETED|Overall Study||12
481084|NCT01121211|1178768|P1|NOT COMPLETED|Overall Study||11
481085|NCT01121211|1178767|P2|COMPLETED|Overall Study||35
481086|NCT01121211|1178768|P1|COMPLETED|Overall Study||32
481087|NCT01121211|1178767|P2|STARTED|Overall Study||47
481088|NCT01121211|1178768|P1|STARTED|Overall Study||43
481089|NCT01121185|1178778|P2|NOT COMPLETED|Overall Study||1
481090|NCT01121185|1178779|P1|NOT COMPLETED|Overall Study||1
481091|NCT01121185|1178778|P2|COMPLETED|Overall Study||5
481092|NCT01121185|1178779|P1|COMPLETED|Overall Study||6
481093|NCT01121185|1178778|P2|Transplanted|Overall Study||5
481094|NCT01121185|1178779|P1|Transplanted|Overall Study|One subject initiated the first study infusion, but transplant surgery was subsequently cancelled.|6
481095|NCT01121185|1178778|P2|Infused|Overall Study|Excluded medical condition identified in one subject after randomization but before study infusion.|5
481096|NCT01121185|1178779|P1|Infused|Overall Study||7
481097|NCT01121185|1178778|P2|STARTED|Overall Study||6
481098|NCT01121185|1178779|P1|STARTED|Overall Study||7
481099|NCT01121172|1178803|P2|NOT COMPLETED|Overall Study||0
481100|NCT01121172|1178804|P1|NOT COMPLETED|Overall Study||0
481101|NCT01121172|1178803|P2|COMPLETED|Overall Study||90
481102|NCT01121172|1178804|P1|COMPLETED|Overall Study||90
481103|NCT01121172|1178803|P2|STARTED|Overall Study||90
481104|NCT01121172|1178804|P1|STARTED|Overall Study||90
481105|NCT01121146|1178813|P2|NOT COMPLETED|Overall Study||42
481106|NCT01121146|1178814|P1|NOT COMPLETED|Overall Study||26
481107|NCT01121146|1178813|P2|COMPLETED|Overall Study|The 72 hips include those that were not revised and had a minimum 9-year questionnaire or radiograph|72
481108|NCT01121146|1178814|P1|COMPLETED|Overall Study|The 90 hips include those that were not revised and had a minimum 9-year questionnaire or radiograph|90
481109|NCT01121146|1178813|P2|STARTED|Overall Study||114
481110|NCT01121146|1178814|P1|STARTED|Overall Study||116
481111|NCT01120990|1178828|P1|NOT COMPLETED|Overall Study||0
481112|NCT01120990|1178828|P1|COMPLETED|Overall Study||51
481113|NCT01120990|1178828|P1|STARTED|Overall Study||51
481114|NCT01120899|1178835|P1|NOT COMPLETED|Overall Study||3
481115|NCT01120899|1178835|P1|COMPLETED|Overall Study||3
481116|NCT01120899|1178835|P1|Month 18|Overall Study||3
481117|NCT01120899|1178835|P1|Month 12|Overall Study||3
481118|NCT01120899|1178835|P1|Month 6|Overall Study||5
481119|NCT01120899|1178835|P1|STARTED|Overall Study||6
481120|NCT01120834|1178855|P1|NOT COMPLETED|Overall Study||0
481121|NCT01120834|1178855|P1|COMPLETED|Overall Study||18
481122|NCT01120834|1178855|P1|STARTED|Overall Study||18
481123|NCT01120808|1178859|P1|NOT COMPLETED|Overall Study||46
481124|NCT01120808|1178859|P1|COMPLETED|Overall Study||90
481125|NCT01120808|1178859|P1|STARTED|Overall Study||136
481126|NCT01120782|1178863|P1|NOT COMPLETED|Overall Study||11
481127|NCT01120782|1178863|P1|COMPLETED|Overall Study||34
481128|NCT01120782|1178863|P1|STARTED|Overall Study||45
481129|NCT01120717|1178869|P2|NOT COMPLETED|Overall Study||24
481130|NCT01120717|1178870|P1|NOT COMPLETED|Overall Study||32
481131|NCT01120717|1178869|P2|COMPLETED|Overall Study||89
481132|NCT01120717|1178870|P1|COMPLETED|Overall Study||194
481133|NCT01120717|1178869|P2|Safety Population: Received Study Drug|Overall Study||113
481134|NCT01120717|1178870|P1|Safety Population: Received Study Drug|Overall Study||225
481135|NCT01120717|1178869|P2|STARTED|Overall Study||113
481136|NCT01120717|1178870|P1|STARTED|Overall Study||226
481137|NCT01120704|1178918|P32|NOT COMPLETED|Overall Study||1
481138|NCT01120704|1178919|P31|NOT COMPLETED|Overall Study||2
481139|NCT01120704|1178920|P30|NOT COMPLETED|Overall Study||3
481140|NCT01120704|1178921|P29|NOT COMPLETED|Overall Study||5
481141|NCT01120704|1178922|P28|NOT COMPLETED|Overall Study||2
481142|NCT01120704|1178923|P27|NOT COMPLETED|Overall Study||3
481143|NCT01120704|1178924|P26|NOT COMPLETED|Overall Study||0
481144|NCT01120704|1178925|P25|NOT COMPLETED|Overall Study||2
481145|NCT01120704|1178926|P24|NOT COMPLETED|Overall Study||3
481146|NCT01120704|1178927|P23|NOT COMPLETED|Overall Study||4
481147|NCT01120704|1178928|P22|NOT COMPLETED|Overall Study||0
481148|NCT01120704|1178929|P21|NOT COMPLETED|Overall Study||3
481149|NCT01120704|1178930|P20|NOT COMPLETED|Overall Study||3
481150|NCT01120704|1178931|P19|NOT COMPLETED|Overall Study||2
481151|NCT01120704|1178932|P18|NOT COMPLETED|Overall Study||0
481152|NCT01120704|1178933|P17|NOT COMPLETED|Overall Study||1
481153|NCT01120704|1178934|P16|NOT COMPLETED|Overall Study||2
481154|NCT01120704|1178935|P15|NOT COMPLETED|Overall Study||1
481155|NCT01120704|1178936|P14|NOT COMPLETED|Overall Study||4
481156|NCT01120704|1178937|P13|NOT COMPLETED|Overall Study||3
481157|NCT01120704|1178938|P12|NOT COMPLETED|Overall Study||2
481158|NCT01120704|1178939|P11|NOT COMPLETED|Overall Study||1
481159|NCT01120704|1178940|P10|NOT COMPLETED|Overall Study||1
481160|NCT01120704|1178941|P9|NOT COMPLETED|Overall Study||3
481161|NCT01120704|1178942|P8|NOT COMPLETED|Overall Study||2
481162|NCT01120704|1178943|P7|NOT COMPLETED|Overall Study||3
481163|NCT01120704|1178944|P6|NOT COMPLETED|Overall Study||1
481164|NCT01120704|1178945|P5|NOT COMPLETED|Overall Study||2
481165|NCT01120704|1178946|P4|NOT COMPLETED|Overall Study||4
481166|NCT01120704|1178947|P3|NOT COMPLETED|Overall Study||1
481167|NCT01120704|1178948|P2|NOT COMPLETED|Overall Study||4
481168|NCT01120704|1178949|P1|NOT COMPLETED|Overall Study||3
481169|NCT01120704|1178918|P32|COMPLETED|Overall Study||17
481170|NCT01120704|1178919|P31|COMPLETED|Overall Study||12
481171|NCT01120704|1178920|P30|COMPLETED|Overall Study||12
481172|NCT01120704|1178921|P29|COMPLETED|Overall Study||14
481173|NCT01120704|1178922|P28|COMPLETED|Overall Study||16
481174|NCT01120704|1178923|P27|COMPLETED|Overall Study||15
481175|NCT01120704|1178924|P26|COMPLETED|Overall Study||14
481176|NCT01120704|1178925|P25|COMPLETED|Overall Study||16
481177|NCT01120704|1178926|P24|COMPLETED|Overall Study||13
481178|NCT01120704|1178927|P23|COMPLETED|Overall Study||17
481179|NCT01120704|1178928|P22|COMPLETED|Overall Study||16
481180|NCT01120704|1178929|P21|COMPLETED|Overall Study||14
481181|NCT01120704|1178930|P20|COMPLETED|Overall Study||15
481182|NCT01120704|1178931|P19|COMPLETED|Overall Study||15
481183|NCT01120704|1178932|P18|COMPLETED|Overall Study||16
481184|NCT01120704|1178933|P17|COMPLETED|Overall Study||13
481185|NCT01120704|1178934|P16|COMPLETED|Overall Study||16
481186|NCT01120704|1178935|P15|COMPLETED|Overall Study||17
481187|NCT01120704|1178936|P14|COMPLETED|Overall Study||15
481188|NCT01120704|1178937|P13|COMPLETED|Overall Study||14
481189|NCT01120704|1178938|P12|COMPLETED|Overall Study||14
481190|NCT01120704|1178939|P11|COMPLETED|Overall Study||16
481191|NCT01120704|1178940|P10|COMPLETED|Overall Study||19
481192|NCT01120704|1178941|P9|COMPLETED|Overall Study||19
481193|NCT01120704|1178942|P8|COMPLETED|Overall Study||13
481194|NCT01120704|1178943|P7|COMPLETED|Overall Study||12
481195|NCT01120704|1178944|P6|COMPLETED|Overall Study||18
481196|NCT01120704|1178945|P5|COMPLETED|Overall Study||14
481197|NCT01120704|1178946|P4|COMPLETED|Overall Study||15
481198|NCT01120704|1178947|P3|COMPLETED|Overall Study||13
481199|NCT01120704|1178948|P2|COMPLETED|Overall Study||13
481200|NCT01120704|1178949|P1|COMPLETED|Overall Study||10
481201|NCT01120704|1178918|P32|STARTED|Overall Study||18
481202|NCT01120704|1178919|P31|STARTED|Overall Study||14
481203|NCT01120704|1178920|P30|STARTED|Overall Study||15
481204|NCT01120704|1178921|P29|STARTED|Overall Study||19
481205|NCT01120704|1178922|P28|STARTED|Overall Study||18
481206|NCT01120704|1178923|P27|STARTED|Overall Study||18
481207|NCT01120704|1178924|P26|STARTED|Overall Study||14
481208|NCT01120704|1178925|P25|STARTED|Overall Study||18
481209|NCT01120704|1178926|P24|STARTED|Overall Study||16
481210|NCT01120704|1178927|P23|STARTED|Overall Study||21
481211|NCT01120704|1178928|P22|STARTED|Overall Study||16
481212|NCT01120704|1178929|P21|STARTED|Overall Study||17
481213|NCT01120704|1178930|P20|STARTED|Overall Study||18
481214|NCT01120704|1178931|P19|STARTED|Overall Study||17
481215|NCT01120704|1178932|P18|STARTED|Overall Study||16
481216|NCT01120704|1178933|P17|STARTED|Overall Study||14
481217|NCT01120704|1178934|P16|STARTED|Overall Study||18
481218|NCT01120704|1178935|P15|STARTED|Overall Study||18
481219|NCT01120704|1178936|P14|STARTED|Overall Study||19
481220|NCT01120704|1178937|P13|STARTED|Overall Study||17
481221|NCT01120704|1178938|P12|STARTED|Overall Study||16
481222|NCT01120704|1178939|P11|STARTED|Overall Study||17
481223|NCT01120704|1178940|P10|STARTED|Overall Study||20
481224|NCT01120704|1178941|P9|STARTED|Overall Study||22
481225|NCT01120704|1178942|P8|STARTED|Overall Study||15
481226|NCT01120704|1178943|P7|STARTED|Overall Study||15
481227|NCT01120704|1178944|P6|STARTED|Overall Study||19
481228|NCT01120704|1178945|P5|STARTED|Overall Study||16
481229|NCT01120704|1178946|P4|STARTED|Overall Study||19
481230|NCT01120704|1178947|P3|STARTED|Overall Study||14
481231|NCT01120704|1178948|P2|STARTED|Overall Study||17
481232|NCT01120704|1178949|P1|STARTED|Overall Study||13
481233|NCT01120691|1178976|P3|NOT COMPLETED|Overall Study||183
481234|NCT01120691|1178977|P2|NOT COMPLETED|Overall Study||203
481235|NCT01120691|1178978|P1|NOT COMPLETED|Overall Study||171
481236|NCT01120691|1178976|P3|COMPLETED|Overall Study||559
481237|NCT01120691|1178977|P2|COMPLETED|Overall Study||538
481238|NCT01120691|1178978|P1|COMPLETED|Overall Study||570
481239|NCT01120691|1178976|P3|Modified Full Analysis Set (mFAS)|Overall Study||737
481240|NCT01120691|1178977|P2|Modified Full Analysis Set (mFAS)|Overall Study||739
481241|NCT01120691|1178978|P1|Modified Full Analysis Set (mFAS)|Overall Study||729
481242|NCT01120691|1178976|P3|Modified Safety Set (mSAF)|Overall Study||737
481243|NCT01120691|1178977|P2|Modified Safety Set (mSAF)|Overall Study||740
481244|NCT01120691|1178978|P1|Modified Safety Set (mSAF)|Overall Study||729
481245|NCT01120691|1178976|P3|Safety Set (SAF)|Overall Study||739
481246|NCT01120691|1178977|P2|Safety Set (SAF)|Overall Study||740
481247|NCT01120691|1178978|P1|Safety Set (SAF)|Overall Study||736
481248|NCT01120691|1178976|P3|Full Analysis Set (FAS)|Overall Study||739
481249|NCT01120691|1178977|P2|Full Analysis Set (FAS)|Overall Study||739
481250|NCT01120691|1178978|P1|Full Analysis Set (FAS)|Overall Study||736
481251|NCT01120691|1178976|P3|STARTED|Overall Study||742
481252|NCT01120691|1178977|P2|STARTED|Overall Study||741
481253|NCT01120691|1178978|P1|STARTED|Overall Study||741
481254|NCT01120626|1179022|P2|NOT COMPLETED|Overall Study||0
481255|NCT01120626|1179023|P1|NOT COMPLETED|Overall Study||1
481256|NCT01120626|1179022|P2|COMPLETED|Overall Study||22
481257|NCT01120626|1179023|P1|COMPLETED|Overall Study||19
481258|NCT01120626|1179022|P2|STARTED|Overall Study||22
481259|NCT01120626|1179023|P1|STARTED|Overall Study||20
481260|NCT01120600|1179033|P2|NOT COMPLETED|Overall Study||32
481261|NCT01120600|1179034|P1|NOT COMPLETED|Overall Study||19
481262|NCT01120600|1179033|P2|COMPLETED|Overall Study||115
481263|NCT01120600|1179034|P1|COMPLETED|Overall Study||128
481264|NCT01120600|1179033|P2|Treated|Overall Study||146
481265|NCT01120600|1179034|P1|Treated|Overall Study||146
481266|NCT01120600|1179033|P2|STARTED|Overall Study||147
481267|NCT01120600|1179034|P1|STARTED|Overall Study||147
481268|NCT01120405|1179060|P2|NOT COMPLETED|Overall Study||33
481269|NCT01120405|1179061|P1|NOT COMPLETED|Overall Study||27
481270|NCT01120405|1179060|P2|COMPLETED|Overall Study||269
481271|NCT01120405|1179061|P1|COMPLETED|Overall Study||271
481272|NCT01120405|1179060|P2|STARTED|Overall Study||302
481273|NCT01120405|1179061|P1|STARTED|Overall Study||298
481274|NCT01120379|1179089|P1|NOT COMPLETED|Four Year Timepoint||368
481275|NCT01120379|1179089|P1|COMPLETED|Four Year Timepoint||3923
481276|NCT01120379|1179089|P1|STARTED|Four Year Timepoint||4291
481277|NCT01120379|1179089|P1|NOT COMPLETED|Three Year Timepoint||214
481278|NCT01120379|1179089|P1|COMPLETED|Three Year Timepoint||4291
481279|NCT01120379|1179089|P1|STARTED|Three Year Timepoint||4505
481280|NCT01120379|1179089|P1|NOT COMPLETED|Two Year Timepoint||237
481281|NCT01120379|1179089|P1|COMPLETED|Two Year Timepoint||4505
481282|NCT01120379|1179089|P1|STARTED|Two Year Timepoint||4742
481283|NCT01120379|1179089|P1|NOT COMPLETED|One Year Timepoint||278
481284|NCT01120379|1179089|P1|COMPLETED|One Year Timepoint||4742
481285|NCT01120379|1179089|P1|STARTED|One Year Timepoint||5020
481286|NCT01120275|1179125|P1|NOT COMPLETED|Overall Study||36
481287|NCT01120275|1179125|P1|COMPLETED|Overall Study||0
481288|NCT01120275|1179125|P1|Eligible and Treated|Overall Study||32
481289|NCT01120275|1179125|P1|STARTED|Overall Study||36
481290|NCT01120236|1179134|P2|NOT COMPLETED|Overall Study||1
481291|NCT01120236|1179135|P1|NOT COMPLETED|Overall Study||0
481292|NCT01120236|1179134|P2|COMPLETED|Overall Study||105
481293|NCT01120236|1179135|P1|COMPLETED|Overall Study||105
481294|NCT01120236|1179134|P2|Ineligble|Overall Study|Patient ineligible due to no demonstable radiographic metastasis and is excluded from all analyses.|1
481295|NCT01120236|1179135|P1|Ineligble|Overall Study||0
481296|NCT01120236|1179134|P2|STARTED|Overall Study||106
481297|NCT01120236|1179135|P1|STARTED|Overall Study||105
481298|NCT01120223|1179162|P1|NOT COMPLETED|Overall Study||4
481299|NCT01120223|1179162|P1|COMPLETED|Overall Study||74
481300|NCT01120223|1179162|P1|STARTED|Overall Study||78
481301|NCT01120210|1179192|P2|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0
481302|NCT01120210|1179193|P1|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0
481303|NCT01120210|1179192|P2|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||7
481304|NCT01120210|1179193|P1|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||3
481305|NCT01120210|1179192|P2|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||7
481306|NCT01120210|1179193|P1|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||3
481307|NCT01120210|1179192|P2|NOT COMPLETED|MAIN INFUSION||1
481308|NCT01120210|1179193|P1|NOT COMPLETED|MAIN INFUSION||1
481309|NCT01120210|1179192|P2|COMPLETED|MAIN INFUSION||45
481310|NCT01120210|1179193|P1|COMPLETED|MAIN INFUSION||15
481311|NCT01120210|1179192|P2|STARTED|MAIN INFUSION||46
481312|NCT01120210|1179193|P1|STARTED|MAIN INFUSION||16
481313|NCT01120197|1179225|P2|NOT COMPLETED|Overall Study||10
481314|NCT01120197|1179226|P1|NOT COMPLETED|Overall Study||9
481315|NCT01120197|1179225|P2|COMPLETED|Overall Study||32
481316|NCT01120197|1179226|P1|COMPLETED|Overall Study||38
481317|NCT01120197|1179225|P2|STARTED|Overall Study||42
481318|NCT01120197|1179226|P1|STARTED|Overall Study||47
481319|NCT01120184|1179243|P3|NOT COMPLETED|Overall Study||363
481320|NCT01120184|1179244|P2|NOT COMPLETED|Overall Study||367
481321|NCT01120184|1179245|P1|NOT COMPLETED|Overall Study||365
481322|NCT01120184|1179243|P3|COMPLETED|Overall Study||0
481323|NCT01120184|1179244|P2|COMPLETED|Overall Study||0
481324|NCT01120184|1179245|P1|COMPLETED|Overall Study||0
481325|NCT01120184|1179243|P3|Treated|Overall Study||360
481326|NCT01120184|1179244|P2|Treated|Overall Study||365
481327|NCT01120184|1179245|P1|Treated|Overall Study||355
481328|NCT01120184|1179243|P3|STARTED|Overall Study||363
481329|NCT01120184|1179244|P2|STARTED|Overall Study||367
481330|NCT01120184|1179245|P1|STARTED|Overall Study||365
481331|NCT01120093|1179367|P5|NOT COMPLETED|Treatment Period 5||0
481332|NCT01120093|1179368|P4|NOT COMPLETED|Treatment Period 5||1
481333|NCT01120093|1179369|P3|NOT COMPLETED|Treatment Period 5||0
481334|NCT01120093|1179370|P2|NOT COMPLETED|Treatment Period 5||1
481335|NCT01120093|1179371|P1|NOT COMPLETED|Treatment Period 5||0
481336|NCT01120093|1179367|P5|COMPLETED|Treatment Period 5||13
481337|NCT01120093|1179368|P4|COMPLETED|Treatment Period 5||11
481338|NCT01120093|1179369|P3|COMPLETED|Treatment Period 5||15
481339|NCT01120093|1179370|P2|COMPLETED|Treatment Period 5||12
481340|NCT01120093|1179371|P1|COMPLETED|Treatment Period 5||17
481341|NCT01120093|1179367|P5|STARTED|Treatment Period 5||13
481342|NCT01120093|1179368|P4|STARTED|Treatment Period 5||12
481343|NCT01120093|1179369|P3|STARTED|Treatment Period 5||15
481344|NCT01120093|1179370|P2|STARTED|Treatment Period 5||13
481345|NCT01120093|1179371|P1|STARTED|Treatment Period 5||17
481346|NCT01120093|1179367|P5|NOT COMPLETED|Treatment Period 4||0
481347|NCT01120093|1179368|P4|NOT COMPLETED|Treatment Period 4||0
481348|NCT01120093|1179369|P3|NOT COMPLETED|Treatment Period 4||0
481349|NCT01120093|1179370|P2|NOT COMPLETED|Treatment Period 4||0
481350|NCT01120093|1179371|P1|NOT COMPLETED|Treatment Period 4||1
481351|NCT01120093|1179367|P5|COMPLETED|Treatment Period 4||13
481352|NCT01120093|1179368|P4|COMPLETED|Treatment Period 4||12
481353|NCT01120093|1179369|P3|COMPLETED|Treatment Period 4||15
481354|NCT01120093|1179370|P2|COMPLETED|Treatment Period 4||13
481355|NCT01120093|1179371|P1|COMPLETED|Treatment Period 4||17
481356|NCT01120093|1179367|P5|STARTED|Treatment Period 4||13
481357|NCT01120093|1179368|P4|STARTED|Treatment Period 4||12
481358|NCT01120093|1179369|P3|STARTED|Treatment Period 4||15
481359|NCT01120093|1179370|P2|STARTED|Treatment Period 4||13
481360|NCT01120093|1179371|P1|STARTED|Treatment Period 4||18
481361|NCT01120093|1179367|P5|NOT COMPLETED|Treatment Period 3||1
481362|NCT01120093|1179368|P4|NOT COMPLETED|Treatment Period 3||1
481363|NCT01120093|1179369|P3|NOT COMPLETED|Treatment Period 3||1
481364|NCT01120093|1179370|P2|NOT COMPLETED|Treatment Period 3||0
481365|NCT01120093|1179371|P1|NOT COMPLETED|Treatment Period 3||0
481366|NCT01120093|1179367|P5|COMPLETED|Treatment Period 3||13
481367|NCT01120093|1179368|P4|COMPLETED|Treatment Period 3||12
481368|NCT01120093|1179369|P3|COMPLETED|Treatment Period 3||15
481369|NCT01120093|1179370|P2|COMPLETED|Treatment Period 3||13
481370|NCT01120093|1179371|P1|COMPLETED|Treatment Period 3||18
481371|NCT01120093|1179367|P5|STARTED|Treatment Period 3||14
481372|NCT01120093|1179368|P4|STARTED|Treatment Period 3||13
481373|NCT01120093|1179369|P3|STARTED|Treatment Period 3||16
481374|NCT01120093|1179370|P2|STARTED|Treatment Period 3||13
481375|NCT01120093|1179371|P1|STARTED|Treatment Period 3||18
481376|NCT01120093|1179367|P5|NOT COMPLETED|Treatment Period 2||1
481377|NCT01120093|1179368|P4|NOT COMPLETED|Treatment Period 2||1
481378|NCT01120093|1179369|P3|NOT COMPLETED|Treatment Period 2||0
481379|NCT01120093|1179370|P2|NOT COMPLETED|Treatment Period 2||0
481380|NCT01120093|1179371|P1|NOT COMPLETED|Treatment Period 2||0
481381|NCT01120093|1179367|P5|COMPLETED|Treatment Period 2||14
481382|NCT01120093|1179368|P4|COMPLETED|Treatment Period 2||13
481383|NCT01120093|1179369|P3|COMPLETED|Treatment Period 2||16
481384|NCT01120093|1179370|P2|COMPLETED|Treatment Period 2||13
481385|NCT01120093|1179371|P1|COMPLETED|Treatment Period 2||18
481386|NCT01120093|1179367|P5|STARTED|Treatment Period 2||15
481387|NCT01120093|1179368|P4|STARTED|Treatment Period 2||14
481388|NCT01120093|1179369|P3|STARTED|Treatment Period 2||16
481389|NCT01120093|1179370|P2|STARTED|Treatment Period 2||13
481390|NCT01120093|1179371|P1|STARTED|Treatment Period 2||18
481391|NCT01120093|1179367|P5|NOT COMPLETED|Treatment Period 1||1
481392|NCT01120093|1179368|P4|NOT COMPLETED|Treatment Period 1||0
481393|NCT01120093|1179369|P3|NOT COMPLETED|Treatment Period 1||1
481394|NCT01120093|1179370|P2|NOT COMPLETED|Treatment Period 1||1
481395|NCT01120093|1179371|P1|NOT COMPLETED|Treatment Period 1||0
481396|NCT01120093|1179367|P5|COMPLETED|Treatment Period 1||15
481397|NCT01120093|1179368|P4|COMPLETED|Treatment Period 1||14
481398|NCT01120093|1179369|P3|COMPLETED|Treatment Period 1||16
481399|NCT01120093|1179370|P2|COMPLETED|Treatment Period 1||13
481400|NCT01120093|1179371|P1|COMPLETED|Treatment Period 1||18
481401|NCT01120093|1179367|P5|STARTED|Treatment Period 1||16
481402|NCT01120093|1179368|P4|STARTED|Treatment Period 1||14
481403|NCT01120093|1179369|P3|STARTED|Treatment Period 1||17
481404|NCT01120093|1179370|P2|STARTED|Treatment Period 1||14
481405|NCT01120093|1179371|P1|STARTED|Treatment Period 1||18
481406|NCT01120067|1179400|P2|NOT COMPLETED|Overall Study||1
481407|NCT01120067|1179401|P1|NOT COMPLETED|Overall Study||5
481408|NCT01120067|1179400|P2|COMPLETED|Overall Study||10
481409|NCT01120067|1179401|P1|COMPLETED|Overall Study||7
481410|NCT01120067|1179400|P2|STARTED|Overall Study||11
481411|NCT01120067|1179401|P1|STARTED|Overall Study||12
481412|NCT01119963|1179409|P2|NOT COMPLETED|Overall Study||1
481413|NCT01119963|1179410|P1|NOT COMPLETED|Overall Study||1
481414|NCT01119963|1179409|P2|COMPLETED|Overall Study||77
481415|NCT01119963|1179410|P1|COMPLETED|Overall Study||73
481416|NCT01119963|1179409|P2|STARTED|Overall Study||78
481417|NCT01119963|1179410|P1|STARTED|Overall Study||74
481418|NCT01119950|1179420|P1|NOT COMPLETED|Overall Study||47
481419|NCT01119950|1179420|P1|COMPLETED|Overall Study|These participants completed both periods 1 and 2|341
481420|NCT01119950|1179420|P1|Placebo|Overall Study|3 randomized participants did not receive study drug, 82 completed treatment, 5 discontinued.|94
481421|NCT01119950|1179420|P1|NVA237 50 ug b.i.d.|Overall Study|6 randomized and 1 misrandomized patients did not receive study drug, 82 completed, 5 discontinued.|94
481422|NCT01119950|1179420|P1|NVA237 100 ug q.d.|Overall Study|2 randomized participants did not receive study drug, 92 completed treatment, 4 discontinued.|98
481423|NCT01119950|1179420|P1|NVA237 25 ug b.i.d.|Overall Study|4 randomized participants did not receive study drug, 89 completed treatment, 7 discontinued.|100
481424|NCT01119950|1179420|P1|NVA237 50 ug q.d.|Overall Study|4 randomized participants did not receive study drug, 89 completed treatment, 3 discontinued.|96
481425|NCT01119950|1179420|P1|NVA237 12.5 ug b.i.d.|Overall Study|4 randomized participants did not receive study drug, 93 completed treatment, 2 discontinued.|99
481426|NCT01119950|1179420|P1|NVA237 25 ug q.d.|Overall Study|3 randomized participants did not receive study drug, 91 completed treatment, 5 discontinued.|99
481427|NCT01119950|1179420|P1|NVA237 12.5 ug q.d.|Overall Study|5 randomized and 2 misrandomized patients did not receive study drug, 80 completed, 9 discontinued.|96
481428|NCT01119950|1179420|P1|STARTED|Overall Study|These participants were randomized to 2 different treatment sequences during period 1 and 2.|388
481429|NCT01119937|1179667|P2|NOT COMPLETED|Overall Study||7
481430|NCT01119937|1179668|P1|NOT COMPLETED|Overall Study||19
481431|NCT01119937|1179667|P2|COMPLETED|Overall Study||33
481432|NCT01119937|1179668|P1|COMPLETED|Overall Study||104
481433|NCT01119937|1179667|P2|STARTED|Overall Study||40
481434|NCT01119937|1179668|P1|STARTED|Overall Study||123
481435|NCT01119859|1179696|P2|NOT COMPLETED|Overall Study||30
481436|NCT01119859|1179697|P1|NOT COMPLETED|Overall Study||24
481437|NCT01119859|1179696|P2|COMPLETED|Overall Study||133
481438|NCT01119859|1179697|P1|COMPLETED|Overall Study||139
481439|NCT01119859|1179696|P2|STARTED|Overall Study||163
481440|NCT01119859|1179697|P1|STARTED|Overall Study||163
481441|NCT01119846|1179716|P3|NOT COMPLETED|Overall Study||11
481442|NCT01119846|1179717|P2|NOT COMPLETED|Overall Study||0
481443|NCT01119846|1179718|P1|NOT COMPLETED|Overall Study||2
481444|NCT01119846|1179716|P3|COMPLETED|Overall Study||72
481445|NCT01119846|1179717|P2|COMPLETED|Overall Study||4
481446|NCT01119846|1179718|P1|COMPLETED|Overall Study||11
481447|NCT01119846|1179716|P3|STARTED|Overall Study||83
481448|NCT01119846|1179717|P2|STARTED|Overall Study||4
481449|NCT01119846|1179718|P1|STARTED|Overall Study||13
481450|NCT01119794|1179926|P1|NOT COMPLETED|Overall Study||0
481451|NCT01119794|1179926|P1|COMPLETED|Overall Study||10
481452|NCT01119794|1179926|P1|STARTED|Overall Study||10
481453|NCT01119768|1179932|P2|NOT COMPLETED|Follow-up||2
481454|NCT01119768|1179933|P1|NOT COMPLETED|Follow-up||1
481455|NCT01119768|1179932|P2|COMPLETED|Follow-up||122
481456|NCT01119768|1179933|P1|COMPLETED|Follow-up||135
481457|NCT01119768|1179932|P2|STARTED|Follow-up||124
481458|NCT01119768|1179933|P1|STARTED|Follow-up||136
481459|NCT01119768|1179932|P2|NOT COMPLETED|Treatment Period||25
481460|NCT01119768|1179933|P1|NOT COMPLETED|Treatment Period||18
481461|NCT01119768|1179932|P2|COMPLETED|Treatment Period||126
481462|NCT01119768|1179933|P1|COMPLETED|Treatment Period||136
481463|NCT01119768|1179932|P2|STARTED|Treatment Period||151
481464|NCT01119768|1179933|P1|STARTED|Treatment Period||154
481465|NCT01119755|1179955|P1|NOT COMPLETED|Overall Study||0
481466|NCT01119755|1179955|P1|COMPLETED|Overall Study||80
481467|NCT01119755|1179955|P1|STARTED|Overall Study||80
481468|NCT01119716|1179966|P1|NOT COMPLETED|Overall Study||0
481469|NCT01119716|1179966|P1|COMPLETED|Overall Study||4658
481470|NCT01119716|1179966|P1|STARTED|Overall Study||4658
481471|NCT01119703|1179989|P2|NOT COMPLETED|Overall Study||1
481472|NCT01119703|1179990|P1|NOT COMPLETED|Overall Study||0
481473|NCT01119703|1179989|P2|COMPLETED|Overall Study||143
481474|NCT01119703|1179990|P1|COMPLETED|Overall Study||30
481475|NCT01119703|1179989|P2|STARTED|Overall Study||144
481476|NCT01119703|1179990|P1|STARTED|Overall Study||30
481477|NCT01119625|1180004|P2|NOT COMPLETED|Overall Study||4
481478|NCT01119625|1180005|P1|NOT COMPLETED|Overall Study||3
481479|NCT01119625|1180004|P2|COMPLETED|Overall Study||116
481480|NCT01119625|1180005|P1|COMPLETED|Overall Study||115
481481|NCT01119625|1180004|P2|STARTED|Overall Study||120
481482|NCT01119625|1180005|P1|STARTED|Overall Study||118
481483|NCT01119443|1180047|P2|NOT COMPLETED|End of Study (All Patients)||0
481484|NCT01119443|1180048|P1|NOT COMPLETED|End of Study (All Patients)||0
481485|NCT01119443|1180047|P2|COMPLETED|End of Study (All Patients)||14
481486|NCT01119443|1180048|P1|COMPLETED|End of Study (All Patients)||14
481487|NCT01119443|1180047|P2|STARTED|End of Study (All Patients)||14
481488|NCT01119443|1180048|P1|STARTED|End of Study (All Patients)||14
481489|NCT01119443|1180047|P2|NOT COMPLETED|Down-titration Period (1 Day)||0
481490|NCT01119443|1180048|P1|NOT COMPLETED|Down-titration Period (1 Day)||0
481491|NCT01119443|1180047|P2|COMPLETED|Down-titration Period (1 Day)||13
481492|NCT01119443|1180048|P1|COMPLETED|Down-titration Period (1 Day)||14
481493|NCT01119443|1180047|P2|STARTED|Down-titration Period (1 Day)||13
481494|NCT01119443|1180048|P1|STARTED|Down-titration Period (1 Day)||14
481495|NCT01119443|1180047|P2|NOT COMPLETED|Crossover Period 4 (5 Days)||0
481496|NCT01119443|1180048|P1|NOT COMPLETED|Crossover Period 4 (5 Days)||0
481497|NCT01119443|1180047|P2|COMPLETED|Crossover Period 4 (5 Days)||13
481498|NCT01119443|1180048|P1|COMPLETED|Crossover Period 4 (5 Days)||14
481499|NCT01119443|1180047|P2|STARTED|Crossover Period 4 (5 Days)||13
481500|NCT01119443|1180048|P1|STARTED|Crossover Period 4 (5 Days)||14
481501|NCT01119443|1180047|P2|NOT COMPLETED|Crossover Period 3 (5 Days)||0
481502|NCT01119443|1180048|P1|NOT COMPLETED|Crossover Period 3 (5 Days)||0
481503|NCT01119443|1180047|P2|COMPLETED|Crossover Period 3 (5 Days)||13
481504|NCT01119443|1180048|P1|COMPLETED|Crossover Period 3 (5 Days)||14
481505|NCT01119443|1180047|P2|STARTED|Crossover Period 3 (5 Days)||13
481506|NCT01119443|1180048|P1|STARTED|Crossover Period 3 (5 Days)||14
481507|NCT01119443|1180047|P2|NOT COMPLETED|Crossover Period 2 (5 Days)||0
481508|NCT01119443|1180048|P1|NOT COMPLETED|Crossover Period 2 (5 Days)||0
481509|NCT01119443|1180047|P2|COMPLETED|Crossover Period 2 (5 Days)||13
481510|NCT01119443|1180048|P1|COMPLETED|Crossover Period 2 (5 Days)||14
481511|NCT01119443|1180047|P2|STARTED|Crossover Period 2 (5 Days)||13
481512|NCT01119443|1180048|P1|STARTED|Crossover Period 2 (5 Days)||14
481513|NCT01119443|1180047|P2|NOT COMPLETED|Crossover Period 1 (5 Days)||1
481514|NCT01119443|1180048|P1|NOT COMPLETED|Crossover Period 1 (5 Days)||0
481515|NCT01119443|1180047|P2|COMPLETED|Crossover Period 1 (5 Days)||13
481516|NCT01119443|1180048|P1|COMPLETED|Crossover Period 1 (5 Days)||14
481517|NCT01119443|1180047|P2|STARTED|Crossover Period 1 (5 Days)||14
481518|NCT01119443|1180048|P1|STARTED|Crossover Period 1 (5 Days)||14
481519|NCT01119443|1180047|P2|NOT COMPLETED|Up-titration Period (10 Days)||0
481520|NCT01119443|1180048|P1|NOT COMPLETED|Up-titration Period (10 Days)||0
481521|NCT01119443|1180047|P2|COMPLETED|Up-titration Period (10 Days)||14
481522|NCT01119443|1180048|P1|COMPLETED|Up-titration Period (10 Days)||14
481523|NCT01119443|1180047|P2|STARTED|Up-titration Period (10 Days)||14
481524|NCT01119443|1180048|P1|STARTED|Up-titration Period (10 Days)||14
481525|NCT01119287|1180091|P6|NOT COMPLETED|Overall Study||0
481526|NCT01119287|1180092|P5|NOT COMPLETED|Overall Study||1
481527|NCT01119287|1180093|P4|NOT COMPLETED|Overall Study||2
481528|NCT01119287|1180094|P3|NOT COMPLETED|Overall Study||2
481529|NCT01119287|1180095|P2|NOT COMPLETED|Overall Study||0
481530|NCT01119287|1180096|P1|NOT COMPLETED|Overall Study||0
481531|NCT01119287|1180091|P6|COMPLETED|Overall Study||32
481532|NCT01119287|1180092|P5|COMPLETED|Overall Study||30
481533|NCT01119287|1180093|P4|COMPLETED|Overall Study||29
481534|NCT01119287|1180094|P3|COMPLETED|Overall Study||24
481535|NCT01119287|1180095|P2|COMPLETED|Overall Study||24
481536|NCT01119287|1180096|P1|COMPLETED|Overall Study||26
481537|NCT01119287|1180091|P6|STARTED|Overall Study||32
481538|NCT01119287|1180092|P5|STARTED|Overall Study||31
481539|NCT01119287|1180093|P4|STARTED|Overall Study||31
481540|NCT01119287|1180094|P3|STARTED|Overall Study||26
481541|NCT01119287|1180095|P2|STARTED|Overall Study||24
481542|NCT01119287|1180096|P1|STARTED|Overall Study||26
481543|NCT01119248|1180109|P1|NOT COMPLETED|Overall Study||5
481544|NCT01119248|1180109|P1|COMPLETED|Overall Study||115
481545|NCT01119248|1180109|P1|STARTED|Overall Study||120
481546|NCT01119222|1180115|P4|NOT COMPLETED|Overall Study||0
481547|NCT01119222|1180116|P3|NOT COMPLETED|Overall Study||0
481548|NCT01119222|1180117|P2|NOT COMPLETED|Overall Study||0
481549|NCT01119222|1180118|P1|NOT COMPLETED|Overall Study||0
481550|NCT01119222|1180115|P4|COMPLETED|Overall Study||4
481551|NCT01119222|1180116|P3|COMPLETED|Overall Study||5
481552|NCT01119222|1180117|P2|COMPLETED|Overall Study||5
481553|NCT01119222|1180118|P1|COMPLETED|Overall Study||5
481554|NCT01119222|1180115|P4|STARTED|Overall Study||4
481555|NCT01119222|1180116|P3|STARTED|Overall Study||5
481556|NCT01119222|1180117|P2|STARTED|Overall Study||5
481557|NCT01119222|1180118|P1|STARTED|Overall Study||5
481558|NCT01119131|1180159|P3|NOT COMPLETED|Overall Study||6
481559|NCT01119131|1180160|P2|NOT COMPLETED|Overall Study||1
481560|NCT01119131|1180161|P1|NOT COMPLETED|Overall Study||2
481561|NCT01119131|1180159|P3|COMPLETED|Overall Study||24
481562|NCT01119131|1180160|P2|COMPLETED|Overall Study||27
481563|NCT01119131|1180161|P1|COMPLETED|Overall Study||8
481564|NCT01119131|1180159|P3|STARTED|Overall Study||30
481565|NCT01119131|1180160|P2|STARTED|Overall Study||28
481566|NCT01119131|1180161|P1|STARTED|Overall Study||10
481567|NCT01119118|1180190|P1|NOT COMPLETED|Overall Study||1
481568|NCT01119118|1180190|P1|COMPLETED|Overall Study||5
481569|NCT01119118|1180190|P1|STARTED|Overall Study||6
481570|NCT01119040|1180198|P1|NOT COMPLETED|Overall Study||1
481571|NCT01119040|1180198|P1|COMPLETED|Overall Study||0
481572|NCT01119040|1180198|P1|STARTED|Overall Study||1
481573|NCT01119001|1180202|P1|NOT COMPLETED|Overall Study||2
481574|NCT01119001|1180202|P1|COMPLETED|Overall Study||11
481575|NCT01119001|1180202|P1|STARTED|Overall Study||13
481576|NCT01118988|1180211|P3|NOT COMPLETED|Overall Study||4
481577|NCT01118988|1180212|P2|NOT COMPLETED|Overall Study||1
481578|NCT01118988|1180213|P1|NOT COMPLETED|Overall Study||5
481579|NCT01118988|1180211|P3|COMPLETED|Overall Study||3
481580|NCT01118988|1180212|P2|COMPLETED|Overall Study||3
481581|NCT01118988|1180213|P1|COMPLETED|Overall Study||11
481582|NCT01118988|1180211|P3|STARTED|Overall Study||7
481583|NCT01118988|1180212|P2|STARTED|Overall Study||4
481584|NCT01118988|1180213|P1|STARTED|Overall Study||16
481585|NCT01118975|1180246|P2|NOT COMPLETED|Overall Study||1
481586|NCT01118975|1180247|P1|NOT COMPLETED|Overall Study||0
481587|NCT01118975|1180246|P2|COMPLETED|Overall Study||2
481588|NCT01118975|1180247|P1|COMPLETED|Overall Study||9
481589|NCT01118975|1180246|P2|STARTED|Overall Study||3
481590|NCT01118975|1180247|P1|STARTED|Overall Study||9
481591|NCT01118962|1180253|P1|NOT COMPLETED|Overall Study||10
481592|NCT01118962|1180253|P1|COMPLETED|Overall Study||29
481593|NCT01118962|1180253|P1|STARTED|Overall Study||39
481594|NCT01118949|1180258|P1|NOT COMPLETED|Overall Study||9
481595|NCT01118949|1180258|P1|COMPLETED|Overall Study||40
481596|NCT01118949|1180258|P1|STARTED|Overall Study||49
481597|NCT01118845|1180267|P1|NOT COMPLETED|Overall Study||42
481598|NCT01118845|1180267|P1|COMPLETED|Overall Study||17
481599|NCT01118845|1180267|P1|STARTED|Overall Study||59
481600|NCT01118780|1180288|P2|NOT COMPLETED|Overall Study||35
481601|NCT01118780|1180289|P1|NOT COMPLETED|Overall Study||36
481602|NCT01118780|1180288|P2|COMPLETED|Overall Study||105
481603|NCT01118780|1180289|P1|COMPLETED|Overall Study||115
481604|NCT01118780|1180288|P2|STARTED|Overall Study||140
481605|NCT01118780|1180289|P1|STARTED|Overall Study||151
481606|NCT01118741|1180338|P2|NOT COMPLETED|Overall Study||0
481607|NCT01118741|1180339|P1|NOT COMPLETED|Overall Study||0
481608|NCT01118741|1180338|P2|COMPLETED|Overall Study||10
481609|NCT01118741|1180339|P1|COMPLETED|Overall Study||9
481610|NCT01118741|1180338|P2|STARTED|Overall Study||10
481611|NCT01118741|1180339|P1|STARTED|Overall Study||9
481612|NCT01118728|1180347|P1|NOT COMPLETED|Overall Study||223
481613|NCT01118728|1180347|P1|COMPLETED|Overall Study||0
481614|NCT01118728|1180347|P1|STARTED|Overall Study||223
481615|NCT01118663|1180354|P2|NOT COMPLETED|Overall Study||2
481616|NCT01118663|1180355|P1|NOT COMPLETED|Overall Study||2
481617|NCT01118663|1180354|P2|COMPLETED|Overall Study||8
481618|NCT01118663|1180355|P1|COMPLETED|Overall Study||5
481619|NCT01118663|1180354|P2|STARTED|Overall Study||10
481620|NCT01118663|1180355|P1|STARTED|Overall Study||7
481621|NCT01118624|1180369|P1|NOT COMPLETED|Overall Study||22
481622|NCT01118624|1180369|P1|COMPLETED|Overall Study||0
481623|NCT01118624|1180369|P1|STARTED|Overall Study||22
481624|NCT01118455|1180378|P2|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0
481625|NCT01118455|1180379|P1|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0
481626|NCT01118455|1180378|P2|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||69
481627|NCT01118455|1180379|P1|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||65
481628|NCT01118455|1180378|P2|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||69
481629|NCT01118455|1180379|P1|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||65
481630|NCT01118455|1180378|P2|NOT COMPLETED|Baseline [Visits 1 & 2]||0
481631|NCT01118455|1180379|P1|NOT COMPLETED|Baseline [Visits 1 & 2]||1
481632|NCT01118455|1180378|P2|COMPLETED|Baseline [Visits 1 & 2]||69
481633|NCT01118455|1180379|P1|COMPLETED|Baseline [Visits 1 & 2]||65
481634|NCT01118455|1180378|P2|Actual Patients Treated|Baseline [Visits 1 & 2]||69
481635|NCT01118455|1180379|P1|Actual Patients Treated|Baseline [Visits 1 & 2]||65
481636|NCT01118455|1180378|P2|STARTED|Baseline [Visits 1 & 2]||69
481637|NCT01118455|1180379|P1|STARTED|Baseline [Visits 1 & 2]||66
481638|NCT01118377|1180407|P1|NOT COMPLETED|Overall Study||42
481639|NCT01118377|1180407|P1|COMPLETED|Overall Study||3
481640|NCT01118377|1180407|P1|STARTED|Overall Study||45
481641|NCT01118325|1180416|P3|NOT COMPLETED|Overall Study||1
481642|NCT01118325|1180417|P2|NOT COMPLETED|Overall Study||0
481643|NCT01118325|1180418|P1|NOT COMPLETED|Overall Study||1
481644|NCT01118325|1180416|P3|COMPLETED|Overall Study||45
481645|NCT01118325|1180417|P2|COMPLETED|Overall Study||43
481646|NCT01118325|1180418|P1|COMPLETED|Overall Study||49
481647|NCT01118325|1180416|P3|STARTED|Overall Study||46
481648|NCT01118325|1180417|P2|STARTED|Overall Study||43
481649|NCT01118325|1180418|P1|STARTED|Overall Study||50
481650|NCT01118312|1180464|P2|NOT COMPLETED|Overall Study||35
481651|NCT01118312|1180465|P1|NOT COMPLETED|Overall Study||34
481652|NCT01118312|1180464|P2|COMPLETED|Overall Study||164
481653|NCT01118312|1180465|P1|COMPLETED|Overall Study||155
481654|NCT01118312|1180464|P2|STARTED|Overall Study||199
481655|NCT01118312|1180465|P1|STARTED|Overall Study||189
481656|NCT01118273|1180479|P6|NOT COMPLETED|Overall Study||0
481657|NCT01118273|1180480|P5|NOT COMPLETED|Overall Study||0
481658|NCT01118273|1180481|P4|NOT COMPLETED|Overall Study||0
481659|NCT01118273|1180482|P3|NOT COMPLETED|Overall Study||0
481660|NCT01118273|1180483|P2|NOT COMPLETED|Overall Study||0
481661|NCT01118273|1180484|P1|NOT COMPLETED|Overall Study||0
481662|NCT01118273|1180479|P6|COMPLETED|Overall Study||27
481663|NCT01118273|1180480|P5|COMPLETED|Overall Study||27
481664|NCT01118273|1180481|P4|COMPLETED|Overall Study||27
481665|NCT01118273|1180482|P3|COMPLETED|Overall Study||27
481666|NCT01118273|1180483|P2|COMPLETED|Overall Study||27
481667|NCT01118273|1180484|P1|COMPLETED|Overall Study||27
481668|NCT01118273|1180479|P6|STARTED|Overall Study||27
481669|NCT01118273|1180480|P5|STARTED|Overall Study||27
481670|NCT01118273|1180481|P4|STARTED|Overall Study||27
481671|NCT01118273|1180482|P3|STARTED|Overall Study||27
481672|NCT01118273|1180483|P2|STARTED|Overall Study||27
481673|NCT01118273|1180484|P1|STARTED|Overall Study||27
481674|NCT01118221|1180650|P2|NOT COMPLETED|Overall Study||1
481675|NCT01118221|1180651|P1|NOT COMPLETED|Overall Study||3
481676|NCT01118221|1180650|P2|COMPLETED|Overall Study||10
481677|NCT01118221|1180651|P1|COMPLETED|Overall Study||11
481678|NCT01118221|1180650|P2|STARTED|Overall Study||11
481679|NCT01118221|1180651|P1|STARTED|Overall Study||14
481680|NCT01118143|1180663|P2|NOT COMPLETED|Overall Study||5
481681|NCT01118143|1180664|P1|NOT COMPLETED|Overall Study||2
481682|NCT01118143|1180663|P2|COMPLETED|Overall Study||64
481683|NCT01118143|1180664|P1|COMPLETED|Overall Study||62
481684|NCT01118143|1180663|P2|STARTED|Overall Study||69
481685|NCT01118143|1180664|P1|STARTED|Overall Study||64
481686|NCT01118117|1180674|P2|NOT COMPLETED|Overall Study||0
481687|NCT01118117|1180675|P1|NOT COMPLETED|Overall Study||21
481688|NCT01118117|1180674|P2|COMPLETED|Overall Study||15
481689|NCT01118117|1180675|P1|COMPLETED|Overall Study||240
481690|NCT01118117|1180674|P2|STARTED|Overall Study||15
481691|NCT01118117|1180675|P1|STARTED|Overall Study||261
481692|NCT01118091|1180696|P2|NOT COMPLETED|Overall Study||0
481693|NCT01118091|1180697|P1|NOT COMPLETED|Overall Study||0
481694|NCT01118091|1180696|P2|COMPLETED|Overall Study||5
481695|NCT01118091|1180697|P1|COMPLETED|Overall Study|Continued from above: These 2 pts are only represented in Arm 1 (and not Arm 2).|7
481696|NCT01118091|1180696|P2|STARTED|Overall Study||5
481697|NCT01118091|1180697|P1|STARTED|Overall Study|2pts were randomized to Arm 2, were not able to grow cell product, were treated with Arm 1 regimen.|7
481698|NCT01118052|1180707|P1|NOT COMPLETED|Overall Study||2
481699|NCT01118052|1180707|P1|COMPLETED|Overall Study||20
481700|NCT01118052|1180707|P1|STARTED|Overall Study||22
481701|NCT01118013|1180720|P1|NOT COMPLETED|Overall Study||0
481702|NCT01118013|1180720|P1|COMPLETED|Overall Study||6
481703|NCT01118013|1180720|P1|STARTED|Overall Study||6
481704|NCT01117987|1180730|P2|NOT COMPLETED|Overall Study||74
481705|NCT01117987|1180731|P1|NOT COMPLETED|Overall Study||61
481706|NCT01117987|1180730|P2|COMPLETED|Overall Study||4
481707|NCT01117987|1180731|P1|COMPLETED|Overall Study||5
481708|NCT01117987|1180730|P2|STARTED|Overall Study||78
481709|NCT01117987|1180731|P1|STARTED|Overall Study||66
481710|NCT01117948|1180743|P2|NOT COMPLETED|Open Label||47
481711|NCT01117948|1180744|P1|NOT COMPLETED|Open Label||52
481712|NCT01117948|1180743|P2|COMPLETED|Open Label||51
481713|NCT01117948|1180744|P1|COMPLETED|Open Label||41
481714|NCT01117948|1180743|P2|STARTED|Open Label||98
481715|NCT01117948|1180744|P1|STARTED|Open Label||93
481716|NCT01117948|1180743|P2|NOT COMPLETED|Double Blind||10
481717|NCT01117948|1180744|P1|NOT COMPLETED|Double Blind||18
481718|NCT01117948|1180743|P2|COMPLETED|Double Blind||98
481719|NCT01117948|1180744|P1|COMPLETED|Double Blind||93
481720|NCT01117948|1180743|P2|STARTED|Double Blind||108
481721|NCT01117948|1180744|P1|STARTED|Double Blind||111
481722|NCT01117870|1180752|P2|NOT COMPLETED|Overall Study||0
481723|NCT01117870|1180753|P1|NOT COMPLETED|Overall Study||1
481724|NCT01117870|1180752|P2|COMPLETED|Overall Study||16
481725|NCT01117870|1180753|P1|COMPLETED|Overall Study|One did not receive the allocated intervention; (degenerate spine/inability to place needle).|14
481726|NCT01117870|1180752|P2|STARTED|Overall Study||16
481727|NCT01117870|1180753|P1|STARTED|Overall Study||15
481728|NCT01117857|1180767|P1|NOT COMPLETED|Overall Study||9
481729|NCT01117857|1180767|P1|COMPLETED|Overall Study||13
481730|NCT01117857|1180767|P1|STARTED|Overall Study||22
481731|NCT01117766|1180775|P2|NOT COMPLETED|Second Intervention||5
481732|NCT01117766|1180776|P1|NOT COMPLETED|Second Intervention||2
481733|NCT01117766|1180775|P2|COMPLETED|Second Intervention||9
481734|NCT01117766|1180776|P1|COMPLETED|Second Intervention||11
481735|NCT01117766|1180775|P2|STARTED|Second Intervention||14
481736|NCT01117766|1180776|P1|STARTED|Second Intervention||13
481737|NCT01117766|1180775|P2|NOT COMPLETED|Washout Period||2
481738|NCT01117766|1180776|P1|NOT COMPLETED|Washout Period||0
481739|NCT01117766|1180775|P2|COMPLETED|Washout Period||14
481740|NCT01117766|1180776|P1|COMPLETED|Washout Period||13
481741|NCT01117766|1180775|P2|STARTED|Washout Period||16
481742|NCT01117766|1180776|P1|STARTED|Washout Period||13
481743|NCT01117766|1180775|P2|NOT COMPLETED|First Intervention||1
481744|NCT01117766|1180776|P1|NOT COMPLETED|First Intervention||1
481745|NCT01117766|1180775|P2|COMPLETED|First Intervention||16
481746|NCT01117766|1180776|P1|COMPLETED|First Intervention||13
481747|NCT01117766|1180775|P2|Received Treatment|First Intervention||17
481748|NCT01117766|1180776|P1|Received Treatment|First Intervention||14
481749|NCT01117766|1180775|P2|STARTED|First Intervention||17
481750|NCT01117766|1180776|P1|STARTED|First Intervention||14
481751|NCT01117727|1180800|P1|NOT COMPLETED|Overall Study||0
481752|NCT01117727|1180800|P1|COMPLETED|Overall Study||1
481753|NCT01117727|1180800|P1|STARTED|Overall Study||1
481754|NCT01117623|1180813|P8|NOT COMPLETED|Overall Study||26
481755|NCT01117623|1180814|P7|NOT COMPLETED|Overall Study||6
481756|NCT01117623|1180815|P6|NOT COMPLETED|Overall Study||16
481757|NCT01117623|1180816|P5|NOT COMPLETED|Overall Study||10
481758|NCT01117623|1180817|P4|NOT COMPLETED|Overall Study||6
481759|NCT01117623|1180818|P3|NOT COMPLETED|Overall Study||11
481760|NCT01117623|1180819|P2|NOT COMPLETED|Overall Study||8
481761|NCT01117623|1180820|P1|NOT COMPLETED|Overall Study||3
481762|NCT01117623|1180813|P8|COMPLETED|Overall Study||0
481763|NCT01117623|1180814|P7|COMPLETED|Overall Study||0
481764|NCT01117623|1180815|P6|COMPLETED|Overall Study||0
481765|NCT01117623|1180816|P5|COMPLETED|Overall Study||0
481766|NCT01117623|1180817|P4|COMPLETED|Overall Study||0
481767|NCT01117623|1180818|P3|COMPLETED|Overall Study||0
481768|NCT01117623|1180819|P2|COMPLETED|Overall Study||0
481769|NCT01117623|1180820|P1|COMPLETED|Overall Study||0
481770|NCT01117623|1180813|P8|PK Population|Overall Study||24
481771|NCT01117623|1180814|P7|PK Population|Overall Study||6
481772|NCT01117623|1180815|P6|PK Population|Overall Study||14
481773|NCT01117623|1180816|P5|PK Population|Overall Study||10
481774|NCT01117623|1180817|P4|PK Population|Overall Study||6
481775|NCT01117623|1180818|P3|PK Population|Overall Study||10
481776|NCT01117623|1180819|P2|PK Population|Overall Study||8
481777|NCT01117623|1180820|P1|PK Population|Overall Study||3
481778|NCT01117623|1180813|P8|ITT Efficacy Analysis Population|Overall Study||22
481779|NCT01117623|1180814|P7|ITT Efficacy Analysis Population|Overall Study||6
481780|NCT01117623|1180815|P6|ITT Efficacy Analysis Population|Overall Study||16
481781|NCT01117623|1180816|P5|ITT Efficacy Analysis Population|Overall Study||10
481782|NCT01117623|1180817|P4|ITT Efficacy Analysis Population|Overall Study||5
481783|NCT01117623|1180818|P3|ITT Efficacy Analysis Population|Overall Study||11
481784|NCT01117623|1180819|P2|ITT Efficacy Analysis Population|Overall Study||8
481785|NCT01117623|1180820|P1|ITT Efficacy Analysis Population|Overall Study||3
481786|NCT01117623|1180813|P8|STARTED|Overall Study||26
481787|NCT01117623|1180814|P7|STARTED|Overall Study||6
481788|NCT01117623|1180815|P6|STARTED|Overall Study||16
481789|NCT01117623|1180816|P5|STARTED|Overall Study||10
481790|NCT01117623|1180817|P4|STARTED|Overall Study||6
481791|NCT01117623|1180818|P3|STARTED|Overall Study||11
481792|NCT01117623|1180819|P2|STARTED|Overall Study||8
481793|NCT01117623|1180820|P1|STARTED|Overall Study||3
481794|NCT01117480|1180972|P1|NOT COMPLETED|Overall Study||28
481795|NCT01117480|1180972|P1|COMPLETED|Overall Study||985
481796|NCT01117480|1180972|P1|STARTED|Overall Study||1013
481797|NCT01117454|1180980|P2|NOT COMPLETED|Overall Study||1
481798|NCT01117454|1180981|P1|NOT COMPLETED|Overall Study||0
481799|NCT01117454|1180980|P2|COMPLETED|Overall Study||7
481800|NCT01117454|1180981|P1|COMPLETED|Overall Study||6
481801|NCT01117454|1180980|P2|STARTED|Overall Study||8
481802|NCT01117454|1180981|P1|STARTED|Overall Study||6
481803|NCT01117428|1180993|P6|NOT COMPLETED|Overall Study||20
481804|NCT01117428|1180994|P5|NOT COMPLETED|Overall Study||17
481805|NCT01117428|1180995|P4|NOT COMPLETED|Overall Study||12
481806|NCT01117428|1180996|P3|NOT COMPLETED|Overall Study||13
481807|NCT01117428|1180997|P2|NOT COMPLETED|Overall Study||29
481808|NCT01117428|1180998|P1|NOT COMPLETED|Overall Study||20
481809|NCT01117428|1180993|P6|COMPLETED|Overall Study||0
481810|NCT01117428|1180994|P5|COMPLETED|Overall Study||0
481811|NCT01117428|1180995|P4|COMPLETED|Overall Study||0
481812|NCT01117428|1180996|P3|COMPLETED|Overall Study||0
481813|NCT01117428|1180997|P2|COMPLETED|Overall Study||0
481814|NCT01117428|1180998|P1|COMPLETED|Overall Study||0
481815|NCT01117428|1180993|P6|STARTED|Overall Study||20
481816|NCT01117428|1180994|P5|STARTED|Overall Study||17
481817|NCT01117428|1180995|P4|STARTED|Overall Study||12
481818|NCT01117428|1180996|P3|STARTED|Overall Study||13
481819|NCT01117428|1180997|P2|STARTED|Overall Study||29
481820|NCT01117428|1180998|P1|STARTED|Overall Study|"0.4 mg/kg=1~0.75 mg/kg=1~1.5 mg/kg=3~3 mg/kg=3~6 mg/kg=3~9 mg/kg=6~12 mg/kg=3"|20
481821|NCT01117350|1181032|P2|NOT COMPLETED|Extension Period||63
481822|NCT01117350|1181033|P1|NOT COMPLETED|Extension Period||0
481823|NCT01117350|1181032|P2|COMPLETED|Extension Period||147
481824|NCT01117350|1181033|P1|COMPLETED|Extension Period||0
481825|NCT01117350|1181032|P2|mITT Population (Extension)|Extension Period|mITT (extension): treated patients with at least 1 efficacy value both at entry and during extension|154
481826|NCT01117350|1181033|P1|mITT Population (Extension)|Extension Period||0
481827|NCT01117350|1181032|P2|TREATED = Safety Population (Extension)|Extension Period|Safety population (extension): treated with insulin glargine during the extension period|160
481828|NCT01117350|1181033|P1|TREATED = Safety Population (Extension)|Extension Period||0
481829|NCT01117350|1181032|P2|STARTED|Extension Period|STARTED: patients having completed the comparative period and eligible for the extension period|210
481830|NCT01117350|1181033|P1|STARTED|Extension Period||0
481831|NCT01117350|1181032|P2|NOT COMPLETED|Comparative Period||75
481832|NCT01117350|1181033|P1|NOT COMPLETED|Comparative Period||42
481833|NCT01117350|1181032|P2|COMPLETED|Comparative Period||414
481834|NCT01117350|1181033|P1|COMPLETED|Comparative Period||447
481835|NCT01117350|1181032|P2|mITT Population|Comparative Period||470
481836|NCT01117350|1181033|P1|mITT Population|Comparative Period|modified Intent-To-Treat population: treated patients with at least one efficacy post-baseline value|474
481837|NCT01117350|1181032|P2|TREATED = Safety Population|Comparative Period||481
481838|NCT01117350|1181033|P1|TREATED = Safety Population|Comparative Period|Safety population: all randomized and treated patients (received at least one dose)|484
481839|NCT01117350|1181032|P2|STARTED|Comparative Period||489
481840|NCT01117350|1181033|P1|STARTED|Comparative Period|STARTED: randomized|489
481841|NCT01117337|1181065|P2|NOT COMPLETED|Overall Study||0
481842|NCT01117337|1181066|P1|NOT COMPLETED|Overall Study||4
481843|NCT01117337|1181065|P2|COMPLETED|Overall Study||52
481844|NCT01117337|1181066|P1|COMPLETED|Overall Study|48 completed one year follow-up. 4 lost to follow-up.|48
481845|NCT01117337|1181065|P2|Underwent Surgery|Overall Study||52
481846|NCT01117337|1181066|P1|Underwent Surgery|Overall Study|52 patients underwent surgery|52
481847|NCT01117337|1181065|P2|STARTED|Overall Study||52
481848|NCT01117337|1181066|P1|STARTED|Overall Study|52 pateints on inguinal hernia were randomized to mesh fixation group|52
481849|NCT01117311|1181076|P2|NOT COMPLETED|Second Intervention - Mixed Meal 3||0
481850|NCT01117311|1181077|P1|NOT COMPLETED|Second Intervention - Mixed Meal 3||0
481851|NCT01117311|1181076|P2|COMPLETED|Second Intervention - Mixed Meal 3||4
481852|NCT01117311|1181077|P1|COMPLETED|Second Intervention - Mixed Meal 3||3
481853|NCT01117311|1181076|P2|STARTED|Second Intervention - Mixed Meal 3||4
481854|NCT01117311|1181077|P1|STARTED|Second Intervention - Mixed Meal 3||3
481855|NCT01117311|1181076|P2|NOT COMPLETED|First Intervention - Mixed Meal 2||0
481856|NCT01117311|1181077|P1|NOT COMPLETED|First Intervention - Mixed Meal 2||0
481857|NCT01117311|1181076|P2|COMPLETED|First Intervention - Mixed Meal 2||4
481858|NCT01117311|1181077|P1|COMPLETED|First Intervention - Mixed Meal 2||3
481859|NCT01117311|1181076|P2|STARTED|First Intervention - Mixed Meal 2||4
481860|NCT01117311|1181077|P1|STARTED|First Intervention - Mixed Meal 2||3
481861|NCT01117311|1181076|P2|NOT COMPLETED|Lead-in Mixed Meal 1||0
481862|NCT01117311|1181077|P1|NOT COMPLETED|Lead-in Mixed Meal 1||0
481863|NCT01117311|1181076|P2|COMPLETED|Lead-in Mixed Meal 1||4
481864|NCT01117311|1181077|P1|COMPLETED|Lead-in Mixed Meal 1||3
481865|NCT01117311|1181076|P2|STARTED|Lead-in Mixed Meal 1||4
481866|NCT01117311|1181077|P1|STARTED|Lead-in Mixed Meal 1||3
481867|NCT01117181|1181087|P2|NOT COMPLETED|Overall Study||2
481868|NCT01117181|1181088|P1|NOT COMPLETED|Overall Study||1
481869|NCT01117181|1181087|P2|COMPLETED|Overall Study||29
481870|NCT01117181|1181088|P1|COMPLETED|Overall Study||28
481871|NCT01117181|1181087|P2|STARTED|Overall Study||31
481872|NCT01117181|1181088|P1|STARTED|Overall Study||29
481873|NCT01117090|1181108|P1|NOT COMPLETED|Overall Study||0
481874|NCT01117090|1181108|P1|COMPLETED|Overall Study||47
481875|NCT01117090|1181108|P1|STARTED|Overall Study||47
481876|NCT01117051|1181121|P2|NOT COMPLETED|Overall Study||11
481877|NCT01117051|1181122|P1|NOT COMPLETED|Overall Study||13
481878|NCT01117051|1181121|P2|COMPLETED|Overall Study||77
481879|NCT01117051|1181122|P1|COMPLETED|Overall Study||73
481880|NCT01117051|1181121|P2|STARTED|Overall Study||88
481881|NCT01117051|1181122|P1|STARTED|Overall Study||86
481882|NCT01117012|1181132|P2|NOT COMPLETED|Overall Study||5
481883|NCT01117012|1181133|P1|NOT COMPLETED|Overall Study||8
481884|NCT01117012|1181132|P2|COMPLETED|Overall Study||98
481885|NCT01117012|1181133|P1|COMPLETED|Overall Study||81
481886|NCT01117012|1181132|P2|STARTED|Overall Study||103
481887|NCT01117012|1181133|P1|STARTED|Overall Study||89
481888|NCT01116986|1181181|P32|NOT COMPLETED|Overall Study||3
481889|NCT01116986|1181182|P31|NOT COMPLETED|Overall Study||1
481890|NCT01116986|1181183|P30|NOT COMPLETED|Overall Study||0
481891|NCT01116986|1181184|P29|NOT COMPLETED|Overall Study||0
481892|NCT01116986|1181185|P28|NOT COMPLETED|Overall Study||1
481893|NCT01116986|1181186|P27|NOT COMPLETED|Overall Study||4
481894|NCT01116986|1181187|P26|NOT COMPLETED|Overall Study||0
481895|NCT01116986|1181188|P25|NOT COMPLETED|Overall Study||3
481896|NCT01116986|1181189|P24|NOT COMPLETED|Overall Study||2
481897|NCT01116986|1181190|P23|NOT COMPLETED|Overall Study||4
481898|NCT01116986|1181191|P22|NOT COMPLETED|Overall Study||2
481899|NCT01116986|1181192|P21|NOT COMPLETED|Overall Study||2
481900|NCT01116986|1181193|P20|NOT COMPLETED|Overall Study||2
481901|NCT01116986|1181194|P19|NOT COMPLETED|Overall Study||3
481902|NCT01116986|1181195|P18|NOT COMPLETED|Overall Study||5
481903|NCT01116986|1181196|P17|NOT COMPLETED|Overall Study||3
481904|NCT01116986|1181197|P16|NOT COMPLETED|Overall Study||6
481905|NCT01116986|1181198|P15|NOT COMPLETED|Overall Study||0
481906|NCT01116986|1181199|P14|NOT COMPLETED|Overall Study||3
481907|NCT01116986|1181200|P13|NOT COMPLETED|Overall Study||1
481908|NCT01116986|1181201|P12|NOT COMPLETED|Overall Study||0
481909|NCT01116986|1181202|P11|NOT COMPLETED|Overall Study||1
481910|NCT01116986|1181203|P10|NOT COMPLETED|Overall Study||4
481911|NCT01116986|1181204|P9|NOT COMPLETED|Overall Study||1
481912|NCT01116986|1181205|P8|NOT COMPLETED|Overall Study||2
481913|NCT01116986|1181206|P7|NOT COMPLETED|Overall Study||2
481914|NCT01116986|1181207|P6|NOT COMPLETED|Overall Study||2
481915|NCT01116986|1181208|P5|NOT COMPLETED|Overall Study||4
481916|NCT01116986|1181209|P4|NOT COMPLETED|Overall Study||2
481917|NCT01116986|1181210|P3|NOT COMPLETED|Overall Study||2
481918|NCT01116986|1181211|P2|NOT COMPLETED|Overall Study||3
481919|NCT01116986|1181212|P1|NOT COMPLETED|Overall Study||2
481920|NCT01116986|1181181|P32|COMPLETED|Overall Study||14
481921|NCT01116986|1181182|P31|COMPLETED|Overall Study||16
481922|NCT01116986|1181183|P30|COMPLETED|Overall Study||17
481923|NCT01116986|1181184|P29|COMPLETED|Overall Study||17
481924|NCT01116986|1181185|P28|COMPLETED|Overall Study||18
481925|NCT01116986|1181186|P27|COMPLETED|Overall Study||14
481926|NCT01116986|1181187|P26|COMPLETED|Overall Study||19
481927|NCT01116986|1181188|P25|COMPLETED|Overall Study||15
481928|NCT01116986|1181189|P24|COMPLETED|Overall Study||19
481929|NCT01116986|1181190|P23|COMPLETED|Overall Study||19
481930|NCT01116986|1181191|P22|COMPLETED|Overall Study||18
481931|NCT01116986|1181192|P21|COMPLETED|Overall Study||22
481932|NCT01116986|1181193|P20|COMPLETED|Overall Study||13
481933|NCT01116986|1181194|P19|COMPLETED|Overall Study||20
481934|NCT01116986|1181195|P18|COMPLETED|Overall Study||19
481935|NCT01116986|1181196|P17|COMPLETED|Overall Study||13
481936|NCT01116986|1181197|P16|COMPLETED|Overall Study||15
481937|NCT01116986|1181198|P15|COMPLETED|Overall Study||17
481938|NCT01116986|1181199|P14|COMPLETED|Overall Study||16
481939|NCT01116986|1181200|P13|COMPLETED|Overall Study||16
481940|NCT01116986|1181201|P12|COMPLETED|Overall Study||20
481941|NCT01116986|1181202|P11|COMPLETED|Overall Study||18
481942|NCT01116986|1181203|P10|COMPLETED|Overall Study||19
481943|NCT01116986|1181204|P9|COMPLETED|Overall Study||19
481944|NCT01116986|1181205|P8|COMPLETED|Overall Study||20
481945|NCT01116986|1181206|P7|COMPLETED|Overall Study||20
481946|NCT01116986|1181207|P6|COMPLETED|Overall Study||20
481947|NCT01116986|1181208|P5|COMPLETED|Overall Study||20
481948|NCT01116986|1181209|P4|COMPLETED|Overall Study||20
481949|NCT01116986|1181210|P3|COMPLETED|Overall Study||16
481950|NCT01116986|1181211|P2|COMPLETED|Overall Study||16
481951|NCT01116986|1181212|P1|COMPLETED|Overall Study||22
481952|NCT01116986|1181181|P32|STARTED|Overall Study||17
481953|NCT01116986|1181182|P31|STARTED|Overall Study||17
481954|NCT01116986|1181183|P30|STARTED|Overall Study||17
481955|NCT01116986|1181184|P29|STARTED|Overall Study||17
481956|NCT01116986|1181185|P28|STARTED|Overall Study||19
481957|NCT01116986|1181186|P27|STARTED|Overall Study||18
481958|NCT01116986|1181187|P26|STARTED|Overall Study||19
481959|NCT01116986|1181188|P25|STARTED|Overall Study||18
481960|NCT01116986|1181189|P24|STARTED|Overall Study||21
481961|NCT01116986|1181190|P23|STARTED|Overall Study||23
481962|NCT01116986|1181191|P22|STARTED|Overall Study||20
481963|NCT01116986|1181192|P21|STARTED|Overall Study||24
481964|NCT01116986|1181193|P20|STARTED|Overall Study||15
481965|NCT01116986|1181194|P19|STARTED|Overall Study||23
481966|NCT01116986|1181195|P18|STARTED|Overall Study||24
481967|NCT01116986|1181196|P17|STARTED|Overall Study||16
481968|NCT01116986|1181197|P16|STARTED|Overall Study||21
481969|NCT01116986|1181198|P15|STARTED|Overall Study||17
481970|NCT01116986|1181199|P14|STARTED|Overall Study||19
481971|NCT01116986|1181200|P13|STARTED|Overall Study||17
481972|NCT01116986|1181201|P12|STARTED|Overall Study||20
481973|NCT01116986|1181202|P11|STARTED|Overall Study||19
481974|NCT01116986|1181203|P10|STARTED|Overall Study||23
481975|NCT01116986|1181204|P9|STARTED|Overall Study||20
481976|NCT01116986|1181205|P8|STARTED|Overall Study||22
481977|NCT01116986|1181206|P7|STARTED|Overall Study||22
481978|NCT01116986|1181207|P6|STARTED|Overall Study||22
481979|NCT01116986|1181208|P5|STARTED|Overall Study||24
481980|NCT01116986|1181209|P4|STARTED|Overall Study||22
481981|NCT01116986|1181210|P3|STARTED|Overall Study||18
481982|NCT01116986|1181211|P2|STARTED|Overall Study||19
481983|NCT01116986|1181212|P1|STARTED|Overall Study||24
481984|NCT01116934|1181246|P2|NOT COMPLETED|Overall Study||0
481985|NCT01116934|1181247|P1|NOT COMPLETED|Overall Study||0
481986|NCT01116934|1181246|P2|COMPLETED|Overall Study||9
481987|NCT01116934|1181247|P1|COMPLETED|Overall Study||8
481988|NCT01116934|1181246|P2|STARTED|Overall Study||9
481989|NCT01116934|1181247|P1|STARTED|Overall Study||8
481990|NCT01116921|1181255|P2|NOT COMPLETED|Overall Study||0
481991|NCT01116921|1181256|P1|NOT COMPLETED|Overall Study||0
481992|NCT01116921|1181255|P2|COMPLETED|Overall Study||50
481993|NCT01116921|1181256|P1|COMPLETED|Overall Study||53
481994|NCT01116921|1181255|P2|STARTED|Overall Study||50
481995|NCT01116921|1181256|P1|STARTED|Overall Study||53
481996|NCT01116882|1181274|P2|NOT COMPLETED|12-month||99
481997|NCT01116882|1181275|P1|NOT COMPLETED|12-month||267
481998|NCT01116882|1181274|P2|COMPLETED|12-month||787
481999|NCT01116882|1181275|P1|COMPLETED|12-month||2439
482000|NCT01116882|1181274|P2|STARTED|12-month||886
482001|NCT01116882|1181275|P1|STARTED|12-month||2706
482002|NCT01116882|1181274|P2|NOT COMPLETED|30-day||31
482003|NCT01116882|1181275|P1|NOT COMPLETED|30-day||68
482004|NCT01116882|1181274|P2|COMPLETED|30-day||886
482005|NCT01116882|1181275|P1|COMPLETED|30-day||2706
482006|NCT01116882|1181274|P2|STARTED|30-day||917
482007|NCT01116882|1181275|P1|STARTED|30-day||2774
482008|NCT01116687|1181313|P1|NOT COMPLETED|Overall Study||4
482009|NCT01116687|1181313|P1|COMPLETED|Overall Study||33
482010|NCT01116687|1181313|P1|STARTED|Overall Study||37
482011|NCT01116466|1181320|P1|NOT COMPLETED|Overall Study||0
482012|NCT01116466|1181320|P1|COMPLETED|Overall Study||5
482013|NCT01116466|1181320|P1|STARTED|Overall Study||5
482014|NCT01116427|1181330|P2|NOT COMPLETED|Extension Phase||2
482015|NCT01116427|1181331|P1|NOT COMPLETED|Extension Phase||9
482016|NCT01116427|1181330|P2|COMPLETED|Extension Phase||18
482017|NCT01116427|1181331|P1|COMPLETED|Extension Phase||29
482018|NCT01116427|1181330|P2|STARTED|Extension Phase||20
482019|NCT01116427|1181331|P1|STARTED|Extension Phase|One participant that completed core phase did not meet eligibility for Extension Phase|38
482020|NCT01116427|1181330|P2|NOT COMPLETED|Core Phase||1
482021|NCT01116427|1181331|P1|NOT COMPLETED|Core Phase||5
482022|NCT01116427|1181330|P2|COMPLETED|Core Phase||20
482023|NCT01116427|1181331|P1|COMPLETED|Core Phase||39
482024|NCT01116427|1181330|P2|STARTED|Core Phase||21
482025|NCT01116427|1181331|P1|STARTED|Core Phase||44
482026|NCT01116401|1181367|P1|NOT COMPLETED|Overall Study||0
482027|NCT01116401|1181367|P1|COMPLETED|Overall Study||29
482028|NCT01116401|1181367|P1|STARTED|Overall Study||29
482029|NCT01116232|1181372|P1|NOT COMPLETED|Overall Study||4
482030|NCT01116232|1181372|P1|COMPLETED|Overall Study||0
482031|NCT01116232|1181372|P1|STARTED|Overall Study||4
482032|NCT01116102|1181385|P8|NOT COMPLETED|Overall Study||0
482033|NCT01116102|1181386|P7|NOT COMPLETED|Overall Study||0
482034|NCT01116102|1181387|P6|NOT COMPLETED|Overall Study||0
482035|NCT01116102|1181388|P5|NOT COMPLETED|Overall Study||0
482036|NCT01116102|1181389|P4|NOT COMPLETED|Overall Study||0
482037|NCT01116102|1181390|P3|NOT COMPLETED|Overall Study||0
482038|NCT01116102|1181391|P2|NOT COMPLETED|Overall Study||0
482039|NCT01116102|1181392|P1|NOT COMPLETED|Overall Study||0
482040|NCT01116102|1181385|P8|COMPLETED|Overall Study||3
482041|NCT01116102|1181386|P7|COMPLETED|Overall Study||2
482042|NCT01116102|1181387|P6|COMPLETED|Overall Study||2
482043|NCT01116102|1181388|P5|COMPLETED|Overall Study||2
482044|NCT01116102|1181389|P4|COMPLETED|Overall Study||3
482045|NCT01116102|1181390|P3|COMPLETED|Overall Study||3
482046|NCT01116102|1181391|P2|COMPLETED|Overall Study||3
482047|NCT01116102|1181392|P1|COMPLETED|Overall Study||2
482048|NCT01116102|1181385|P8|STARTED|Overall Study||3
482049|NCT01116102|1181386|P7|STARTED|Overall Study||2
482050|NCT01116102|1181387|P6|STARTED|Overall Study||2
482051|NCT01116102|1181388|P5|STARTED|Overall Study||2
482052|NCT01116102|1181389|P4|STARTED|Overall Study||3
482053|NCT01116102|1181390|P3|STARTED|Overall Study||3
482054|NCT01116102|1181391|P2|STARTED|Overall Study||3
482055|NCT01116102|1181392|P1|STARTED|Overall Study||2
482056|NCT01116037|1181434|P1|NOT COMPLETED|Overall Study||25
482057|NCT01116037|1181434|P1|COMPLETED|Overall Study||1
482058|NCT01116037|1181434|P1|STARTED|Overall Study||26
482059|NCT01116024|1181439|P1|NOT COMPLETED|Overall Study||52
482060|NCT01116024|1181439|P1|COMPLETED|Overall Study|Patient Enrollment stop date|96
482061|NCT01116024|1181439|P1|STARTED|Overall Study|148 subjects left operating room with the device implanted and were included in the analysis.|148
482062|NCT01115998|1181480|P2|NOT COMPLETED|Overall Study||6
482063|NCT01115998|1181481|P1|NOT COMPLETED|Overall Study||6
482064|NCT01115998|1181480|P2|COMPLETED|Overall Study||11
482065|NCT01115998|1181481|P1|COMPLETED|Overall Study||11
482066|NCT01115998|1181480|P2|STARTED|Overall Study||17
482067|NCT01115998|1181481|P1|STARTED|Overall Study||17
482068|NCT01115933|1181491|P1|NOT COMPLETED|Overall Study||1
482069|NCT01115933|1181491|P1|COMPLETED|Overall Study||64
482070|NCT01115933|1181491|P1|STARTED|Overall Study||65
482071|NCT01115855|1181588|P2|NOT COMPLETED|Overall Study||36
482072|NCT01115855|1181589|P1|NOT COMPLETED|Overall Study||36
482073|NCT01115855|1181588|P2|COMPLETED|Overall Study||74
482074|NCT01115855|1181589|P1|COMPLETED|Overall Study||75
482075|NCT01115855|1181588|P2|STARTED|Overall Study||110
482076|NCT01115855|1181589|P1|STARTED|Overall Study||111
482077|NCT01115738|1181640|P3|NOT COMPLETED|Overall Study||27
482078|NCT01115738|1181641|P2|NOT COMPLETED|Overall Study||21
482079|NCT01115738|1181642|P1|NOT COMPLETED|Overall Study||25
482080|NCT01115738|1181640|P3|COMPLETED|Overall Study||62
482081|NCT01115738|1181641|P2|COMPLETED|Overall Study||62
482082|NCT01115738|1181642|P1|COMPLETED|Overall Study||85
482083|NCT01115738|1181640|P3|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|50
482084|NCT01115738|1181641|P2|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|47
482085|NCT01115738|1181642|P1|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|52
482086|NCT01115738|1181640|P3|Received Any Treatment|Overall Study||88
482087|NCT01115738|1181641|P2|Received Any Treatment|Overall Study||79
482088|NCT01115738|1181642|P1|Received Any Treatment|Overall Study||109
482089|NCT01115738|1181640|P3|STARTED|Overall Study||89
482090|NCT01115738|1181641|P2|STARTED|Overall Study||83
482091|NCT01115738|1181642|P1|STARTED|Overall Study||110
482092|NCT01115699|1181676|P1|NOT COMPLETED|Overall Study||0
482093|NCT01115699|1181676|P1|COMPLETED|Overall Study||2
482094|NCT01115699|1181676|P1|STARTED|Overall Study||2
482095|NCT01115673|1181684|P3|NOT COMPLETED|Overall Study||0
482096|NCT01115673|1181685|P2|NOT COMPLETED|Overall Study||0
482097|NCT01115673|1181686|P1|NOT COMPLETED|Overall Study||0
482098|NCT01115673|1181684|P3|COMPLETED|Overall Study||60
482099|NCT01115673|1181685|P2|COMPLETED|Overall Study||241
482100|NCT01115673|1181686|P1|COMPLETED|Overall Study||239
482101|NCT01115673|1181684|P3|STARTED|Overall Study||60
482102|NCT01115673|1181685|P2|STARTED|Overall Study||241
482103|NCT01115673|1181686|P1|STARTED|Overall Study||239
482104|NCT01115660|1181822|P2|NOT COMPLETED|Overall Study||0
482105|NCT01115660|1181823|P1|NOT COMPLETED|Overall Study||1
482106|NCT01115660|1181822|P2|COMPLETED|Overall Study||10
482107|NCT01115660|1181823|P1|COMPLETED|Overall Study||19
482108|NCT01115660|1181822|P2|STARTED|Overall Study||10
482109|NCT01115660|1181823|P1|STARTED|Overall Study||20
482110|NCT01115582|1181831|P1|NOT COMPLETED|Overall Study||0
482111|NCT01115582|1181831|P1|COMPLETED|Overall Study||16
482112|NCT01115582|1181831|P1|STARTED|Overall Study||16
482113|NCT01115569|1181840|P2|NOT COMPLETED|Maintenance Phase||139
482114|NCT01115569|1181841|P1|NOT COMPLETED|Maintenance Phase||0
482115|NCT01115569|1181840|P2|COMPLETED|Maintenance Phase||285
482116|NCT01115569|1181841|P1|COMPLETED|Maintenance Phase||0
482117|NCT01115569|1181840|P2|STARTED|Maintenance Phase||424
482118|NCT01115569|1181841|P1|STARTED|Maintenance Phase||0
482119|NCT01115569|1181840|P2|NOT COMPLETED|Conversion/Titration Phase||0
482120|NCT01115569|1181841|P1|NOT COMPLETED|Conversion/Titration Phase||214
482121|NCT01115569|1181840|P2|COMPLETED|Conversion/Titration Phase||0
482122|NCT01115569|1181841|P1|COMPLETED|Conversion/Titration Phase||424
482123|NCT01115569|1181840|P2|STARTED|Conversion/Titration Phase||0
482124|NCT01115569|1181841|P1|STARTED|Conversion/Titration Phase||638
482125|NCT01115556|1181848|P2|NOT COMPLETED|Overall Study||0
482126|NCT01115556|1181849|P1|NOT COMPLETED|Overall Study||0
482127|NCT01115556|1181848|P2|COMPLETED|Overall Study||2
482128|NCT01115556|1181849|P1|COMPLETED|Overall Study||7
482129|NCT01115556|1181848|P2|STARTED|Overall Study||2
482130|NCT01115556|1181849|P1|STARTED|Overall Study||7
482131|NCT01115517|1181859|P2|NOT COMPLETED|Overall Study||5
482132|NCT01115517|1181860|P1|NOT COMPLETED|Overall Study||4
482133|NCT01115517|1181859|P2|COMPLETED|Overall Study||16
482134|NCT01115517|1181860|P1|COMPLETED|Overall Study||14
482135|NCT01115517|1181859|P2|STARTED|Overall Study||21
482136|NCT01115517|1181860|P1|STARTED|Overall Study||18
482137|NCT01115491|1181870|P1|NOT COMPLETED|Overall Study||30
482138|NCT01115491|1181870|P1|COMPLETED|Overall Study||2
482139|NCT01115491|1181870|P1|STARTED|Overall Study||32
482140|NCT01115452|1181879|P1|NOT COMPLETED|Overall Study||0
482141|NCT01115452|1181879|P1|COMPLETED|Overall Study||32
482142|NCT01115452|1181879|P1|STARTED|Overall Study||32
482143|NCT01115244|1181931|P2|NOT COMPLETED|Overall Study||0
482144|NCT01115244|1181932|P1|NOT COMPLETED|Overall Study||0
482145|NCT01115244|1181931|P2|COMPLETED|Overall Study||0
482146|NCT01115244|1181932|P1|COMPLETED|Overall Study||0
482147|NCT01115244|1181931|P2|STARTED|Overall Study||0
482148|NCT01115244|1181932|P1|STARTED|Overall Study||0
482149|NCT01115166|1181942|P1|NOT COMPLETED|Overall Study||0
482150|NCT01115166|1181942|P1|COMPLETED|Overall Study||10
482151|NCT01115166|1181942|P1|STARTED|Overall Study||10
482152|NCT01115101|1181950|P2|NOT COMPLETED|Overall Study||0
482153|NCT01115101|1181951|P1|NOT COMPLETED|Overall Study||0
482154|NCT01115101|1181950|P2|COMPLETED|Overall Study||126
482155|NCT01115101|1181951|P1|COMPLETED|Overall Study||113
482156|NCT01115101|1181950|P2|STARTED|Overall Study||126
482157|NCT01115101|1181951|P1|STARTED|Overall Study||113
482158|NCT01114997|1181960|P3|NOT COMPLETED|Overall Study||0
482159|NCT01114997|1181961|P2|NOT COMPLETED|Overall Study||0
482160|NCT01114997|1181962|P1|NOT COMPLETED|Overall Study||0
482161|NCT01114997|1181960|P3|COMPLETED|Overall Study||11
482162|NCT01114997|1181961|P2|COMPLETED|Overall Study||10
482163|NCT01114997|1181962|P1|COMPLETED|Overall Study||11
482164|NCT01114997|1181960|P3|STARTED|Overall Study||11
482165|NCT01114997|1181961|P2|STARTED|Overall Study||10
482166|NCT01114997|1181962|P1|STARTED|Overall Study||11
482167|NCT01114945|1181992|P4|NOT COMPLETED|Overall Study||0
482168|NCT01114945|1181993|P3|NOT COMPLETED|Overall Study||0
482169|NCT01114945|1181994|P2|NOT COMPLETED|Overall Study||0
482170|NCT01114945|1181995|P1|NOT COMPLETED|Overall Study||0
482171|NCT01114945|1181992|P4|COMPLETED|Overall Study||31
482172|NCT01114945|1181993|P3|COMPLETED|Overall Study||30
482173|NCT01114945|1181994|P2|COMPLETED|Overall Study||30
482174|NCT01114945|1181995|P1|COMPLETED|Overall Study||30
482175|NCT01114945|1181992|P4|STARTED|Overall Study||31
482176|NCT01114945|1181993|P3|STARTED|Overall Study||30
482177|NCT01114945|1181994|P2|STARTED|Overall Study||30
482178|NCT01114945|1181995|P1|STARTED|Overall Study||30
482179|NCT01114893|1182022|P5|NOT COMPLETED|Overall Study||0
482180|NCT01114893|1182023|P4|NOT COMPLETED|Overall Study||0
482181|NCT01114893|1182024|P3|NOT COMPLETED|Overall Study||0
482182|NCT01114893|1182025|P2|NOT COMPLETED|Overall Study||0
482183|NCT01114893|1182026|P1|NOT COMPLETED|Overall Study||0
482184|NCT01114893|1182022|P5|COMPLETED|Overall Study||12
482185|NCT01114893|1182023|P4|COMPLETED|Overall Study||13
482186|NCT01114893|1182024|P3|COMPLETED|Overall Study||14
482187|NCT01114893|1182025|P2|COMPLETED|Overall Study||14
482188|NCT01114893|1182026|P1|COMPLETED|Overall Study||14
482189|NCT01114893|1182022|P5|STARTED|Overall Study||12
482190|NCT01114893|1182023|P4|STARTED|Overall Study||13
482191|NCT01114893|1182024|P3|STARTED|Overall Study||14
482192|NCT01114893|1182025|P2|STARTED|Overall Study||14
482193|NCT01114893|1182026|P1|STARTED|Overall Study||14
482194|NCT01114880|1182045|P2|NOT COMPLETED|Period 2 (Week 12 to Week 24)||2
482195|NCT01114880|1182046|P1|NOT COMPLETED|Period 2 (Week 12 to Week 24)||3
482196|NCT01114880|1182045|P2|COMPLETED|Period 2 (Week 12 to Week 24)||111
482197|NCT01114880|1182046|P1|COMPLETED|Period 2 (Week 12 to Week 24)||221
482198|NCT01114880|1182045|P2|STARTED|Period 2 (Week 12 to Week 24)||113
482199|NCT01114880|1182046|P1|STARTED|Period 2 (Week 12 to Week 24)||224
482200|NCT01114880|1182045|P2|NOT COMPLETED|Period 1 (Week 0 to Week 12)||2
482201|NCT01114880|1182046|P1|NOT COMPLETED|Period 1 (Week 0 to Week 12)||5
482202|NCT01114880|1182045|P2|COMPLETED|Period 1 (Week 0 to Week 12)||113
482203|NCT01114880|1182046|P1|COMPLETED|Period 1 (Week 0 to Week 12)||224
482204|NCT01114880|1182045|P2|STARTED|Period 1 (Week 0 to Week 12)||115
482205|NCT01114880|1182046|P1|STARTED|Period 1 (Week 0 to Week 12)||229
482206|NCT01114828|1182098|P2|NOT COMPLETED|Overall Study||4
482207|NCT01114828|1182099|P1|NOT COMPLETED|Overall Study||3
482208|NCT01114828|1182098|P2|COMPLETED|Overall Study||17
482209|NCT01114828|1182099|P1|COMPLETED|Overall Study||16
482210|NCT01114828|1182098|P2|STARTED|Overall Study||21
482211|NCT01114828|1182099|P1|STARTED|Overall Study||19
482212|NCT01114737|1182109|P2|NOT COMPLETED|Open-Label Treatment Period||2
482213|NCT01114737|1182110|P1|NOT COMPLETED|Open-Label Treatment Period||5
482214|NCT01114737|1182109|P2|COMPLETED|Open-Label Treatment Period||95
482215|NCT01114737|1182110|P1|COMPLETED|Open-Label Treatment Period||100
482216|NCT01114737|1182109|P2|STARTED|Open-Label Treatment Period|Two subjects did not receive a single dose of the study drug|97
482217|NCT01114737|1182110|P1|STARTED|Open-Label Treatment Period|One subject did not receive a single dose of the study drug|105
482218|NCT01114737|1182109|P2|NOT COMPLETED|Randomized Treatment Period||1
482219|NCT01114737|1182110|P1|NOT COMPLETED|Randomized Treatment Period||3
482220|NCT01114737|1182109|P2|COMPLETED|Randomized Treatment Period||97
482221|NCT01114737|1182110|P1|COMPLETED|Randomized Treatment Period||105
482222|NCT01114737|1182109|P2|STARTED|Randomized Treatment Period||98
482223|NCT01114737|1182110|P1|STARTED|Randomized Treatment Period||108
482224|NCT01114724|1182158|P1|NOT COMPLETED|Overall Study||10
482225|NCT01114724|1182158|P1|COMPLETED|Overall Study||40
482226|NCT01114724|1182158|P1|STARTED|Overall Study||50
482227|NCT01114672|1182178|P2|NOT COMPLETED|Overall Study||2
482228|NCT01114672|1182179|P1|NOT COMPLETED|Overall Study||4
482229|NCT01114672|1182178|P2|COMPLETED|Overall Study||23
482230|NCT01114672|1182179|P1|COMPLETED|Overall Study||21
482231|NCT01114672|1182178|P2|STARTED|Overall Study||25
482232|NCT01114672|1182179|P1|STARTED|Overall Study||25
482233|NCT01114620|1182185|P1|NOT COMPLETED|Overall Study||0
482234|NCT01114620|1182185|P1|COMPLETED|Overall Study||50
482235|NCT01114620|1182185|P1|STARTED|Overall Study||50
482236|NCT01114581|1182218|P2|NOT COMPLETED|Overall Study||0
482237|NCT01114581|1182219|P1|NOT COMPLETED|Overall Study||0
482238|NCT01114581|1182218|P2|COMPLETED|Overall Study||19
482239|NCT01114581|1182219|P1|COMPLETED|Overall Study||19
482240|NCT01114581|1182218|P2|STARTED|Overall Study||19
482241|NCT01114581|1182219|P1|STARTED|Overall Study||19
482242|NCT01114529|1182230|P3|NOT COMPLETED|Completed Study Phase at Month 24||14
482243|NCT01114529|1182231|P2|NOT COMPLETED|Completed Study Phase at Month 24||16
482244|NCT01114529|1182232|P1|NOT COMPLETED|Completed Study Phase at Month 24||40
482245|NCT01114529|1182230|P3|COMPLETED|Completed Study Phase at Month 24|at month 24|111
482246|NCT01114529|1182231|P2|COMPLETED|Completed Study Phase at Month 24|at month 24|215
482247|NCT01114529|1182232|P1|COMPLETED|Completed Study Phase at Month 24|at month 24|313
482248|NCT01114529|1182230|P3|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|125
482249|NCT01114529|1182231|P2|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|231
482250|NCT01114529|1182232|P1|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|353
482251|NCT01114529|1182230|P3|NOT COMPLETED|Completed Study Medication at Month 24||32
482252|NCT01114529|1182231|P2|NOT COMPLETED|Completed Study Medication at Month 24||41
482253|NCT01114529|1182232|P1|NOT COMPLETED|Completed Study Medication at Month 24||124
482254|NCT01114529|1182230|P3|COMPLETED|Completed Study Medication at Month 24|completed at month 24|93
482255|NCT01114529|1182231|P2|COMPLETED|Completed Study Medication at Month 24|completed at month 24|190
482256|NCT01114529|1182232|P1|COMPLETED|Completed Study Medication at Month 24|completed at month 24|229
482257|NCT01114529|1182230|P3|STARTED|Completed Study Medication at Month 24|Randomized set-125 Full analysis set -125 Safety analysis set -121***|125
482258|NCT01114529|1182231|P2|STARTED|Completed Study Medication at Month 24|Randomized set -231 Full analysis set -231 Safety analysis set -238**|231
482259|NCT01114529|1182232|P1|STARTED|Completed Study Medication at Month 24|Randomized set - 360 Full analysis set - 353 Safety analysis set -346*|353
482260|NCT01114516|1182251|P2|NOT COMPLETED|Overall Study||1
482261|NCT01114516|1182252|P1|NOT COMPLETED|Overall Study||2
482262|NCT01114516|1182251|P2|COMPLETED|Overall Study||26
482263|NCT01114516|1182252|P1|COMPLETED|Overall Study||24
482264|NCT01114516|1182251|P2|STARTED|Overall Study||27
482265|NCT01114516|1182252|P1|STARTED|Overall Study||26
482266|NCT01114503|1182266|P1|NOT COMPLETED|Overall Study||0
482267|NCT01114503|1182266|P1|COMPLETED|Overall Study||2
482268|NCT01114503|1182266|P1|STARTED|Overall Study||2
482269|NCT01114438|1182287|P1|NOT COMPLETED|Overall Study||14
482270|NCT01114438|1182287|P1|COMPLETED|Overall Study||31
482271|NCT01114438|1182287|P1|STARTED|Overall Study||45
482272|NCT01114373|1182297|P2|NOT COMPLETED|Intervention 2 (4 Weeks)||1
482273|NCT01114373|1182298|P1|NOT COMPLETED|Intervention 2 (4 Weeks)||0
482274|NCT01114373|1182297|P2|COMPLETED|Intervention 2 (4 Weeks)||18
482275|NCT01114373|1182298|P1|COMPLETED|Intervention 2 (4 Weeks)||18
482276|NCT01114373|1182297|P2|STARTED|Intervention 2 (4 Weeks)||19
482277|NCT01114373|1182298|P1|STARTED|Intervention 2 (4 Weeks)||18
482278|NCT01114373|1182297|P2|NOT COMPLETED|Intervention 1 (4 Weeks)||0
482279|NCT01114373|1182298|P1|NOT COMPLETED|Intervention 1 (4 Weeks)||3
482280|NCT01114373|1182297|P2|COMPLETED|Intervention 1 (4 Weeks)||19
482281|NCT01114373|1182298|P1|COMPLETED|Intervention 1 (4 Weeks)||18
482282|NCT01114373|1182297|P2|STARTED|Intervention 1 (4 Weeks)||19
482283|NCT01114373|1182298|P1|STARTED|Intervention 1 (4 Weeks)||21
482284|NCT01114360|1182330|P2|NOT COMPLETED|Intervention 2 (4 Weeks)||0
482285|NCT01114360|1182331|P1|NOT COMPLETED|Intervention 2 (4 Weeks)||0
482286|NCT01114360|1182330|P2|COMPLETED|Intervention 2 (4 Weeks)||18
482287|NCT01114360|1182331|P1|COMPLETED|Intervention 2 (4 Weeks)||18
482288|NCT01114360|1182330|P2|STARTED|Intervention 2 (4 Weeks)||18
482289|NCT01114360|1182331|P1|STARTED|Intervention 2 (4 Weeks)||18
482290|NCT01114360|1182330|P2|NOT COMPLETED|Intervention 1 (4 Weeks)||1
482291|NCT01114360|1182331|P1|NOT COMPLETED|Intervention 1 (4 Weeks)||0
482292|NCT01114360|1182330|P2|COMPLETED|Intervention 1 (4 Weeks)||18
482293|NCT01114360|1182331|P1|COMPLETED|Intervention 1 (4 Weeks)||18
482294|NCT01114360|1182330|P2|STARTED|Intervention 1 (4 Weeks)||19
482295|NCT01114360|1182331|P1|STARTED|Intervention 1 (4 Weeks)||18
482296|NCT01114334|1182369|P2|NOT COMPLETED|Overall Study||22
482297|NCT01114334|1182370|P1|NOT COMPLETED|Overall Study||21
482298|NCT01114334|1182369|P2|COMPLETED|Overall Study||58
482299|NCT01114334|1182370|P1|COMPLETED|Overall Study||67
482300|NCT01114334|1182369|P2|STARTED|Overall Study||80
482301|NCT01114334|1182370|P1|STARTED|Overall Study||88
482302|NCT01114217|1182382|P2|NOT COMPLETED|Overall Study||98
482303|NCT01114217|1182383|P1|NOT COMPLETED|Overall Study||75
482304|NCT01114217|1182382|P2|COMPLETED|Overall Study||199
482305|NCT01114217|1182383|P1|COMPLETED|Overall Study|Two participants lacked study completion data: one site stopped communicating during the study.|262
482306|NCT01114217|1182382|P2|Received at Least 1 Dose of Ferumoxytol|Overall Study||0
482307|NCT01114217|1182383|P1|Received at Least 1 Dose of Ferumoxytol|Overall Study||337
482308|NCT01114217|1182382|P2|STARTED|Overall Study||297
482309|NCT01114217|1182383|P1|STARTED|Overall Study||337
482310|NCT01114204|1182395|P2|NOT COMPLETED|Overall Study||8
482311|NCT01114204|1182396|P1|NOT COMPLETED|Overall Study||21
482312|NCT01114204|1182395|P2|COMPLETED|Overall Study||191
482313|NCT01114204|1182396|P1|COMPLETED|Overall Study||385
482314|NCT01114204|1182395|P2|Received at Least 1 Dose of Study Drug|Overall Study||199
482315|NCT01114204|1182396|P1|Received at Least 1 Dose of Study Drug|Overall Study||406
482316|NCT01114204|1182395|P2|STARTED|Overall Study||199
482317|NCT01114204|1182396|P1|STARTED|Overall Study||406
482318|NCT01114139|1182414|P2|NOT COMPLETED|Overall Study||16
482319|NCT01114139|1182415|P1|NOT COMPLETED|Overall Study||40
482320|NCT01114139|1182414|P2|COMPLETED|Overall Study||187
482321|NCT01114139|1182415|P1|COMPLETED|Overall Study||569
482322|NCT01114139|1182414|P2|Received at Least 1 Dose of Study Drug|Overall Study||200
482323|NCT01114139|1182415|P1|Received at Least 1 Dose of Study Drug|Overall Study||608
482324|NCT01114139|1182414|P2|STARTED|Overall Study||203
482325|NCT01114139|1182415|P1|STARTED|Overall Study||609
482326|NCT01113931|1182433|P2|NOT COMPLETED|Overall Study||17
482327|NCT01113931|1182434|P1|NOT COMPLETED|Overall Study||19
482328|NCT01113931|1182433|P2|COMPLETED|Overall Study||231
482329|NCT01113931|1182434|P1|COMPLETED|Overall Study||228
482330|NCT01113931|1182433|P2|mITT Population|Overall Study||190
482331|NCT01113931|1182434|P1|mITT Population|Overall Study||188
482332|NCT01113931|1182433|P2|Safety Population|Overall Study||248
482333|NCT01113931|1182434|P1|Safety Population|Overall Study|1 subject did not take any study medication|246
482334|NCT01113931|1182433|P2|STARTED|Overall Study||248
482335|NCT01113931|1182434|P1|STARTED|Overall Study||247
482336|NCT01113801|1182450|P4|NOT COMPLETED|Overall Study||41
482337|NCT01113801|1182451|P3|NOT COMPLETED|Overall Study||37
482338|NCT01113801|1182452|P2|NOT COMPLETED|Overall Study||40
482339|NCT01113801|1182453|P1|NOT COMPLETED|Overall Study||41
482340|NCT01113801|1182450|P4|COMPLETED|Overall Study||65
482341|NCT01113801|1182451|P3|COMPLETED|Overall Study||66
482342|NCT01113801|1182452|P2|COMPLETED|Overall Study||65
482343|NCT01113801|1182453|P1|COMPLETED|Overall Study||62
482344|NCT01113801|1182450|P4|Received at Least One Dose of Drug|Overall Study||105
482345|NCT01113801|1182451|P3|Received at Least One Dose of Drug|Overall Study||103
482346|NCT01113801|1182452|P2|Received at Least One Dose of Drug|Overall Study||105
482347|NCT01113801|1182453|P1|Received at Least One Dose of Drug|Overall Study||103
482348|NCT01113801|1182450|P4|STARTED|Overall Study||106
482349|NCT01113801|1182451|P3|STARTED|Overall Study||103
482350|NCT01113801|1182452|P2|STARTED|Overall Study||105
482351|NCT01113801|1182453|P1|STARTED|Overall Study||103
482352|NCT01113749|1182481|P2|NOT COMPLETED|Overall Study||2
482353|NCT01113749|1182482|P1|NOT COMPLETED|Overall Study||1
482354|NCT01113749|1182481|P2|COMPLETED|Overall Study||127
482355|NCT01113749|1182482|P1|COMPLETED|Overall Study||126
482356|NCT01113749|1182481|P2|STARTED|Overall Study||129
482357|NCT01113749|1182482|P1|STARTED|Overall Study||127
482358|NCT01113723|1182494|P2|NOT COMPLETED|Overall Study||0
482359|NCT01113723|1182495|P1|NOT COMPLETED|Overall Study||0
482360|NCT01113723|1182494|P2|COMPLETED|Overall Study||70
482361|NCT01113723|1182495|P1|COMPLETED|Overall Study||70
482362|NCT01113723|1182494|P2|STARTED|Overall Study||70
482363|NCT01113723|1182495|P1|STARTED|Overall Study||70
482364|NCT01113710|1182505|P1|NOT COMPLETED|Overall Study||269
482365|NCT01113710|1182505|P1|COMPLETED|Overall Study|"Discontinued reasons for Other are listed in the Participant Flow."|418
482366|NCT01113710|1182505|P1|STARTED|Overall Study|See Additional Study Description for further information regarding withdrawal due to Adverse Event.|687
482367|NCT01113632|1182516|P2|NOT COMPLETED|Overall Study||25
482368|NCT01113632|1182517|P1|NOT COMPLETED|Overall Study||31
482369|NCT01113632|1182516|P2|COMPLETED|Overall Study||19
482370|NCT01113632|1182517|P1|COMPLETED|Overall Study||2
482371|NCT01113632|1182516|P2|STARTED|Overall Study||44
482372|NCT01113632|1182517|P1|STARTED|Overall Study||33
482373|NCT01113580|1182533|P2|NOT COMPLETED|Overall Study||0
482374|NCT01113580|1182534|P1|NOT COMPLETED|Overall Study||1
482375|NCT01113580|1182533|P2|COMPLETED|Overall Study||60
482376|NCT01113580|1182534|P1|COMPLETED|Overall Study||59
482377|NCT01113580|1182533|P2|STARTED|Overall Study||60
482378|NCT01113580|1182534|P1|STARTED|Overall Study||60
482379|NCT01113541|1182548|P1|NOT COMPLETED|Overall Study||13
482380|NCT01113541|1182548|P1|COMPLETED|Overall Study||0
482381|NCT01113541|1182548|P1|STARTED|Overall Study||13
482382|NCT01113463|1182581|P1|NOT COMPLETED|Overall Study||5
482383|NCT01113463|1182581|P1|COMPLETED|Overall Study||12
482384|NCT01113463|1182581|P1|STARTED|Overall Study||17
482385|NCT01113398|1182586|P1|NOT COMPLETED|Overall Study||0
482386|NCT01113398|1182586|P1|COMPLETED|Overall Study|Completed= Discontinued study drug due to disease progression, death, toxicity or any other reason|36
482387|NCT01113398|1182586|P1|STARTED|Overall Study||36
482388|NCT01113385|1182593|P1|NOT COMPLETED|Overall Study||0
482389|NCT01113385|1182593|P1|COMPLETED|Overall Study||7
482390|NCT01113385|1182593|P1|STARTED|Overall Study||7
482391|NCT01113008|1182600|P2|NOT COMPLETED|Overall Study||0
482392|NCT01113008|1182601|P1|NOT COMPLETED|Overall Study||0
482393|NCT01113008|1182600|P2|COMPLETED|Overall Study||133
482394|NCT01113008|1182601|P1|COMPLETED|Overall Study||133
482395|NCT01113008|1182600|P2|STARTED|Overall Study||133
482396|NCT01113008|1182601|P1|STARTED|Overall Study||133
482397|NCT01112917|1182611|P2|NOT COMPLETED|Overall Study||15
482398|NCT01112917|1182612|P1|NOT COMPLETED|Overall Study||7
482399|NCT01112917|1182611|P2|COMPLETED|Overall Study||38
482400|NCT01112917|1182612|P1|COMPLETED|Overall Study||89
482401|NCT01112917|1182611|P2|STARTED|Overall Study||53
482402|NCT01112917|1182612|P1|STARTED|Overall Study||96
482403|NCT01112865|1182617|P2|NOT COMPLETED|Second Intervention||0
482404|NCT01112865|1182618|P1|NOT COMPLETED|Second Intervention||0
482405|NCT01112865|1182617|P2|COMPLETED|Second Intervention||61
482406|NCT01112865|1182618|P1|COMPLETED|Second Intervention||59
482407|NCT01112865|1182617|P2|STARTED|Second Intervention||61
482408|NCT01112865|1182618|P1|STARTED|Second Intervention||59
482409|NCT01112865|1182617|P2|NOT COMPLETED|First Intervention||0
482410|NCT01112865|1182618|P1|NOT COMPLETED|First Intervention||0
482411|NCT01112865|1182617|P2|COMPLETED|First Intervention||61
482412|NCT01112865|1182618|P1|COMPLETED|First Intervention||59
482413|NCT01112865|1182617|P2|STARTED|First Intervention||61
482414|NCT01112865|1182618|P1|STARTED|First Intervention||59
482415|NCT01112696|1182628|P1|NOT COMPLETED|Overall Study||2
482416|NCT01112696|1182628|P1|COMPLETED|Overall Study||98
482417|NCT01112696|1182628|P1|STARTED|Overall Study||100
482418|NCT01112683|1182635|P2|NOT COMPLETED|Overall Study||1
482419|NCT01112683|1182636|P1|NOT COMPLETED|Overall Study||1
482420|NCT01112683|1182635|P2|COMPLETED|Overall Study||19
482421|NCT01112683|1182636|P1|COMPLETED|Overall Study||18
482422|NCT01112683|1182635|P2|STARTED|Overall Study||20
482423|NCT01112683|1182636|P1|STARTED|Overall Study||19
482424|NCT01112670|1182646|P6|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
482425|NCT01112670|1182647|P5|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
482426|NCT01112670|1182648|P4|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
482427|NCT01112670|1182649|P3|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
482428|NCT01112670|1182650|P2|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
482429|NCT01112670|1182651|P1|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
482430|NCT01112670|1182646|P6|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||5
482431|NCT01112670|1182647|P5|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
482432|NCT01112670|1182648|P4|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||4
482433|NCT01112670|1182649|P3|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
482434|NCT01112670|1182650|P2|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||3
482435|NCT01112670|1182651|P1|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
482436|NCT01112670|1182646|P6|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||5
482437|NCT01112670|1182647|P5|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
482438|NCT01112670|1182648|P4|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||4
482439|NCT01112670|1182649|P3|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
482440|NCT01112670|1182650|P2|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||3
482441|NCT01112670|1182651|P1|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
482442|NCT01112670|1182646|P6|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
482443|NCT01112670|1182647|P5|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
482444|NCT01112670|1182648|P4|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
482445|NCT01112670|1182649|P3|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
482446|NCT01112670|1182650|P2|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
482447|NCT01112670|1182651|P1|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
482448|NCT01112670|1182646|P6|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
482449|NCT01112670|1182647|P5|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||5
482450|NCT01112670|1182648|P4|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
482451|NCT01112670|1182649|P3|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||6
482452|NCT01112670|1182650|P2|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
482453|NCT01112670|1182651|P1|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||7
482454|NCT01112670|1182646|P6|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
482455|NCT01112670|1182647|P5|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||6
482456|NCT01112670|1182648|P4|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
482457|NCT01112670|1182649|P3|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||7
482458|NCT01112670|1182650|P2|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
482459|NCT01112670|1182651|P1|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||8
482460|NCT01112579|1182689|P2|NOT COMPLETED|Overall Study||3
482461|NCT01112579|1182690|P1|NOT COMPLETED|Overall Study||1
482462|NCT01112579|1182689|P2|COMPLETED|Overall Study||21
482463|NCT01112579|1182690|P1|COMPLETED|Overall Study||41
482464|NCT01112579|1182689|P2|STARTED|Overall Study||24
482465|NCT01112579|1182690|P1|STARTED|Overall Study||42
482466|NCT01112514|1182700|P1|NOT COMPLETED|Overall Study||1
482467|NCT01112514|1182700|P1|COMPLETED|Overall Study||3
482468|NCT01112514|1182700|P1|STARTED|Overall Study||4
482469|NCT01112267|1182706|P2|NOT COMPLETED|Overall Study||18
482470|NCT01112267|1182707|P1|NOT COMPLETED|Overall Study||34
482471|NCT01112267|1182706|P2|COMPLETED|Overall Study||104
482472|NCT01112267|1182707|P1|COMPLETED|Overall Study||92
482473|NCT01112267|1182706|P2|Treated|Overall Study||120
482474|NCT01112267|1182707|P1|Treated|Overall Study||125
482475|NCT01112267|1182706|P2|STARTED|Overall Study||122
482476|NCT01112267|1182707|P1|STARTED|Overall Study||126
482477|NCT01112241|1182725|P1|NOT COMPLETED|Overall Study||0
482478|NCT01112241|1182725|P1|COMPLETED|Overall Study||17
482479|NCT01112241|1182725|P1|STARTED|Overall Study||17
482480|NCT01112059|1182740|P2|NOT COMPLETED|Overall Study||0
482481|NCT01112059|1182741|P1|NOT COMPLETED|Overall Study||1
482482|NCT01112059|1182740|P2|COMPLETED|Overall Study||20
482483|NCT01112059|1182741|P1|COMPLETED|Overall Study||19
482484|NCT01112059|1182740|P2|STARTED|Overall Study||20
482485|NCT01112059|1182741|P1|STARTED|Overall Study||20
482486|NCT01111851|1182755|P2|NOT COMPLETED|Overall Study||0
482487|NCT01111851|1182756|P1|NOT COMPLETED|Overall Study||2
482488|NCT01111851|1182755|P2|COMPLETED|Overall Study||8
482489|NCT01111851|1182756|P1|COMPLETED|Overall Study||6
482490|NCT01111851|1182755|P2|STARTED|Overall Study||8
482491|NCT01111851|1182756|P1|STARTED|Overall Study||8
482492|NCT01111838|1182768|P1|NOT COMPLETED|Overall Study||7
482493|NCT01111838|1182768|P1|COMPLETED|Overall Study||15
482494|NCT01111838|1182768|P1|STARTED|Overall Study||22
482495|NCT01111825|1182776|P4|NOT COMPLETED|Overall Study||21
482496|NCT01111825|1182777|P3|NOT COMPLETED|Overall Study||8
482497|NCT01111825|1182778|P2|NOT COMPLETED|Overall Study||1
482498|NCT01111825|1182779|P1|NOT COMPLETED|Overall Study||3
482499|NCT01111825|1182776|P4|COMPLETED|Overall Study||27
482500|NCT01111825|1182777|P3|COMPLETED|Overall Study||29
482501|NCT01111825|1182778|P2|COMPLETED|Overall Study||5
482502|NCT01111825|1182779|P1|COMPLETED|Overall Study||5
482503|NCT01111825|1182776|P4|STARTED|Overall Study||48
482504|NCT01111825|1182777|P3|STARTED|Overall Study||37
482505|NCT01111825|1182778|P2|STARTED|Overall Study||6
482506|NCT01111825|1182779|P1|STARTED|Overall Study||8
482507|NCT01111526|1182798|P3|NOT COMPLETED|Overall Study||2
482508|NCT01111526|1182799|P2|NOT COMPLETED|Overall Study||1
482509|NCT01111526|1182800|P1|NOT COMPLETED|Overall Study||0
482510|NCT01111526|1182798|P3|COMPLETED|Overall Study||8
482511|NCT01111526|1182799|P2|COMPLETED|Overall Study||7
482512|NCT01111526|1182800|P1|COMPLETED|Overall Study||4
482513|NCT01111526|1182798|P3|STARTED|Overall Study||10
482514|NCT01111526|1182799|P2|STARTED|Overall Study||8
482515|NCT01111526|1182800|P1|STARTED|Overall Study||4
482516|NCT01111461|1182812|P1|NOT COMPLETED|Overall Study||51
482517|NCT01111461|1182812|P1|COMPLETED|Overall Study|On treatment at data cut-off or on treatment until disease progression|82
482518|NCT01111461|1182812|P1|STARTED|Overall Study||133
482519|NCT01111370|1182825|P1|NOT COMPLETED|Overall Study||2
482520|NCT01111370|1182825|P1|COMPLETED|Overall Study||58
482521|NCT01111370|1182825|P1|STARTED|Overall Study||60
482522|NCT01111331|1182829|P2|NOT COMPLETED|Overall Study||0
482523|NCT01111331|1182830|P1|NOT COMPLETED|Overall Study||0
482524|NCT01111331|1182829|P2|COMPLETED|Overall Study||9
482525|NCT01111331|1182830|P1|COMPLETED|Overall Study||9
482526|NCT01111331|1182829|P2|STARTED|Overall Study||9
482527|NCT01111331|1182830|P1|STARTED|Overall Study||9
482528|NCT01111318|1182912|P4|NOT COMPLETED|Overall Study||0
482529|NCT01111318|1182913|P3|NOT COMPLETED|Overall Study||0
482530|NCT01111318|1182914|P2|NOT COMPLETED|Overall Study||0
482531|NCT01111318|1182915|P1|NOT COMPLETED|Overall Study||0
482532|NCT01111318|1182912|P4|COMPLETED|Overall Study||8
482533|NCT01111318|1182913|P3|COMPLETED|Overall Study||8
482534|NCT01111318|1182914|P2|COMPLETED|Overall Study||8
482535|NCT01111318|1182915|P1|COMPLETED|Overall Study||12
482536|NCT01111318|1182912|P4|STARTED|Overall Study||8
482537|NCT01111318|1182913|P3|STARTED|Overall Study||8
482538|NCT01111318|1182914|P2|STARTED|Overall Study||8
482539|NCT01111318|1182915|P1|STARTED|Overall Study||12
482540|NCT01111305|1182979|P2|NOT COMPLETED|Overall Study||0
482541|NCT01111305|1182980|P1|NOT COMPLETED|Overall Study||0
482542|NCT01111305|1182979|P2|COMPLETED|Overall Study||4
482543|NCT01111305|1182980|P1|COMPLETED|Overall Study||4
482544|NCT01111305|1182979|P2|STARTED|Overall Study||4
482545|NCT01111305|1182980|P1|STARTED|Overall Study||4
482546|NCT01111292|1182992|P2|NOT COMPLETED|Follow-Up||0
482547|NCT01111292|1182993|P1|NOT COMPLETED|Follow-Up||0
482548|NCT01111292|1182992|P2|COMPLETED|Follow-Up||1
482549|NCT01111292|1182993|P1|COMPLETED|Follow-Up||2
482550|NCT01111292|1182992|P2|STARTED|Follow-Up||1
482551|NCT01111292|1182993|P1|STARTED|Follow-Up||2
482552|NCT01111292|1182992|P2|NOT COMPLETED|Post Treatment Biopsy||0
482553|NCT01111292|1182993|P1|NOT COMPLETED|Post Treatment Biopsy||0
482554|NCT01111292|1182992|P2|COMPLETED|Post Treatment Biopsy||1
482555|NCT01111292|1182993|P1|COMPLETED|Post Treatment Biopsy||2
482556|NCT01111292|1182992|P2|STARTED|Post Treatment Biopsy||1
482557|NCT01111292|1182993|P1|STARTED|Post Treatment Biopsy||2
482558|NCT01111292|1182992|P2|NOT COMPLETED|Treatment||1
482559|NCT01111292|1182993|P1|NOT COMPLETED|Treatment||1
482560|NCT01111292|1182992|P2|COMPLETED|Treatment||1
482561|NCT01111292|1182993|P1|COMPLETED|Treatment||2
482562|NCT01111292|1182992|P2|STARTED|Treatment||2
482563|NCT01111292|1182993|P1|STARTED|Treatment||3
482564|NCT01111292|1182992|P2|NOT COMPLETED|Randomization||0
482565|NCT01111292|1182993|P1|NOT COMPLETED|Randomization||0
482566|NCT01111292|1182992|P2|COMPLETED|Randomization||2
482567|NCT01111292|1182993|P1|COMPLETED|Randomization||3
482568|NCT01111292|1182992|P2|STARTED|Randomization||2
482569|NCT01111292|1182993|P1|STARTED|Randomization||3
482570|NCT01111240|1182999|P1|NOT COMPLETED|Overall Study||1066
482571|NCT01111240|1182999|P1|COMPLETED|Overall Study||3569
482572|NCT01111240|1182999|P1|STARTED|Overall Study||4635
482573|NCT01111162|1183021|P1|NOT COMPLETED|Overall Study||0
482574|NCT01111162|1183021|P1|COMPLETED|Overall Study||120
482575|NCT01111162|1183021|P1|STARTED|Overall Study||120
482576|NCT01111149|1183029|P3|NOT COMPLETED|Overall Study||4
482577|NCT01111149|1183030|P2|NOT COMPLETED|Overall Study||1
482578|NCT01111149|1183031|P1|NOT COMPLETED|Overall Study||2
482579|NCT01111149|1183029|P3|COMPLETED|Overall Study||5
482580|NCT01111149|1183030|P2|COMPLETED|Overall Study||5
482581|NCT01111149|1183031|P1|COMPLETED|Overall Study||7
482582|NCT01111149|1183029|P3|STARTED|Overall Study||9
482583|NCT01111149|1183030|P2|STARTED|Overall Study||6
482584|NCT01111149|1183031|P1|STARTED|Overall Study||9
482585|NCT01111123|1183107|P2|NOT COMPLETED|Maintenance Phase||2
482586|NCT01111123|1183108|P1|NOT COMPLETED|Maintenance Phase||0
482587|NCT01111123|1183107|P2|COMPLETED|Maintenance Phase||18
482588|NCT01111123|1183108|P1|COMPLETED|Maintenance Phase||21
482589|NCT01111123|1183107|P2|STARTED|Maintenance Phase||20
482590|NCT01111123|1183108|P1|STARTED|Maintenance Phase||21
482591|NCT01111123|1183107|P2|NOT COMPLETED|Open- Label Phase||0
482592|NCT01111123|1183108|P1|NOT COMPLETED|Open- Label Phase||14
482593|NCT01111123|1183107|P2|COMPLETED|Open- Label Phase||0
482594|NCT01111123|1183108|P1|COMPLETED|Open- Label Phase||41
482595|NCT01111123|1183107|P2|STARTED|Open- Label Phase||0
482596|NCT01111123|1183108|P1|STARTED|Open- Label Phase||55
482597|NCT01111110|1183118|P2|NOT COMPLETED|Overall Study||0
482598|NCT01111110|1183119|P1|NOT COMPLETED|Overall Study||0
482599|NCT01111110|1183118|P2|COMPLETED|Overall Study||4
482600|NCT01111110|1183119|P1|COMPLETED|Overall Study||3
482601|NCT01111110|1183118|P2|STARTED|Overall Study||4
482602|NCT01111110|1183119|P1|STARTED|Overall Study||3
482603|NCT01110967|1183129|P1|NOT COMPLETED|Overall Study||9
482604|NCT01110967|1183129|P1|COMPLETED|Overall Study||31
482605|NCT01110967|1183129|P1|12 Months Follow up|Overall Study||31
482606|NCT01110967|1183129|P1|6 Months Follow up|Overall Study||24
482607|NCT01110967|1183129|P1|3 Months Follow up|Overall Study||28
482608|NCT01110967|1183129|P1|1 Month Follow up|Overall Study||26
482609|NCT01110967|1183129|P1|Surgery|Overall Study||40
482610|NCT01110967|1183129|P1|STARTED|Overall Study||40
482611|NCT01110915|1183142|P2|NOT COMPLETED|Overall Study||2
482612|NCT01110915|1183143|P1|NOT COMPLETED|Overall Study||10
482613|NCT01110915|1183142|P2|COMPLETED|Overall Study|Subjects completing at least 4 months of follow-up.|84
482614|NCT01110915|1183143|P1|COMPLETED|Overall Study|Subjects completing at least 4 months of follow-up.|167
482615|NCT01110915|1183142|P2|STARTED|Overall Study|Subjects being randomized to the Control group.|86
482616|NCT01110915|1183143|P1|STARTED|Overall Study|Subjects being randomized to the MRI group.|177
482617|NCT01110707|1183160|P2|NOT COMPLETED|Overall Study||3
482618|NCT01110707|1183161|P1|NOT COMPLETED|Overall Study||0
482619|NCT01110707|1183160|P2|COMPLETED|Overall Study||65
482620|NCT01110707|1183161|P1|COMPLETED|Overall Study||63
482621|NCT01110707|1183160|P2|STARTED|Overall Study||68
482622|NCT01110707|1183161|P1|STARTED|Overall Study||63
482623|NCT01110499|1183191|P8|NOT COMPLETED|Overall Study||0
482624|NCT01110499|1183192|P7|NOT COMPLETED|Overall Study||0
482625|NCT01110499|1183193|P6|NOT COMPLETED|Overall Study||0
482626|NCT01110499|1183194|P5|NOT COMPLETED|Overall Study||0
482627|NCT01110499|1183195|P4|NOT COMPLETED|Overall Study||0
482628|NCT01110499|1183196|P3|NOT COMPLETED|Overall Study||0
482629|NCT01110499|1183197|P2|NOT COMPLETED|Overall Study||0
482630|NCT01110499|1183198|P1|NOT COMPLETED|Overall Study||0
482631|NCT01110499|1183191|P8|COMPLETED|Overall Study||40
482632|NCT01110499|1183192|P7|COMPLETED|Overall Study||39
482633|NCT01110499|1183193|P6|COMPLETED|Overall Study||14
482634|NCT01110499|1183194|P5|COMPLETED|Overall Study||14
482635|NCT01110499|1183195|P4|COMPLETED|Overall Study||14
482636|NCT01110499|1183196|P3|COMPLETED|Overall Study||14
482637|NCT01110499|1183197|P2|COMPLETED|Overall Study||14
482638|NCT01110499|1183198|P1|COMPLETED|Overall Study||14
482639|NCT01110499|1183191|P8|STARTED|Overall Study||40
482640|NCT01110499|1183192|P7|STARTED|Overall Study||39
482641|NCT01110499|1183193|P6|STARTED|Overall Study||14
482642|NCT01110499|1183194|P5|STARTED|Overall Study||14
482643|NCT01110499|1183195|P4|STARTED|Overall Study||14
482644|NCT01110499|1183196|P3|STARTED|Overall Study||14
482645|NCT01110499|1183197|P2|STARTED|Overall Study||14
482646|NCT01110499|1183198|P1|STARTED|Overall Study||14
482647|NCT01110421|1183220|P2|NOT COMPLETED|Overall Study||0
482648|NCT01110421|1183221|P1|NOT COMPLETED|Overall Study||0
482649|NCT01110421|1183220|P2|COMPLETED|Overall Study||2
482650|NCT01110421|1183221|P1|COMPLETED|Overall Study|Includes 1 participant who discontinued study drug due to an adverse event of empyema on Days 9-13.|5
482651|NCT01110421|1183220|P2|STARTED|Overall Study||2
482652|NCT01110421|1183221|P1|STARTED|Overall Study||5
482653|NCT01110408|1183241|P2|NOT COMPLETED|Overall Study||0
482654|NCT01110408|1183242|P1|NOT COMPLETED|Overall Study||1
482655|NCT01110408|1183241|P2|COMPLETED|Overall Study||10
482656|NCT01110408|1183242|P1|COMPLETED|Overall Study||30
482657|NCT01110408|1183241|P2|STARTED|Overall Study||10
482658|NCT01110408|1183242|P1|STARTED|Overall Study||31
482659|NCT01110382|1183262|P2|NOT COMPLETED|Overall Study||2
482660|NCT01110382|1183263|P1|NOT COMPLETED|Overall Study||0
482661|NCT01110382|1183262|P2|COMPLETED|Overall Study||8
482662|NCT01110382|1183263|P1|COMPLETED|Overall Study||31
482663|NCT01110382|1183262|P2|STARTED|Overall Study||10
482664|NCT01110382|1183263|P1|STARTED|Overall Study||31
482665|NCT01110330|1183284|P3|NOT COMPLETED|Overall Study||26
482666|NCT01110330|1183285|P2|NOT COMPLETED|Overall Study||23
482667|NCT01110330|1183286|P1|NOT COMPLETED|Overall Study||15
482668|NCT01110330|1183284|P3|COMPLETED|Overall Study||208
482669|NCT01110330|1183285|P2|COMPLETED|Overall Study||207
482670|NCT01110330|1183286|P1|COMPLETED|Overall Study||104
482671|NCT01110330|1183284|P3|Positive Baseline Culture Set|Overall Study||114
482672|NCT01110330|1183285|P2|Positive Baseline Culture Set|Overall Study||111
482673|NCT01110330|1183286|P1|Positive Baseline Culture Set|Overall Study||56
482674|NCT01110330|1183284|P3|STARTED|Overall Study||234
482675|NCT01110330|1183285|P2|STARTED|Overall Study||230
482676|NCT01110330|1183286|P1|STARTED|Overall Study||119
482677|NCT01110252|1183297|P1|NOT COMPLETED|Post-procedure (Stem Cells Infusion)||0
482678|NCT01110252|1183297|P1|COMPLETED|Post-procedure (Stem Cells Infusion)||4
482679|NCT01110252|1183297|P1|STARTED|Post-procedure (Stem Cells Infusion)||4
482680|NCT01110252|1183297|P1|NOT COMPLETED|Pre-procedure (Stem Cells Infusion)||0
482681|NCT01110252|1183297|P1|COMPLETED|Pre-procedure (Stem Cells Infusion)||4
482682|NCT01110252|1183297|P1|STARTED|Pre-procedure (Stem Cells Infusion)||4
482683|NCT01110239|1183314|P4|NOT COMPLETED|10 Min Ischemia||0
482684|NCT01110239|1183315|P3|NOT COMPLETED|10 Min Ischemia||0
482685|NCT01110239|1183316|P2|NOT COMPLETED|10 Min Ischemia||0
482686|NCT01110239|1183317|P1|NOT COMPLETED|10 Min Ischemia||0
482687|NCT01110239|1183314|P4|COMPLETED|10 Min Ischemia||6
482688|NCT01110239|1183315|P3|COMPLETED|10 Min Ischemia||0
482689|NCT01110239|1183316|P2|COMPLETED|10 Min Ischemia||0
482690|NCT01110239|1183317|P1|COMPLETED|10 Min Ischemia||0
482691|NCT01110239|1183314|P4|STARTED|10 Min Ischemia||6
482692|NCT01110239|1183315|P3|STARTED|10 Min Ischemia||0
482693|NCT01110239|1183316|P2|STARTED|10 Min Ischemia||0
482694|NCT01110239|1183317|P1|STARTED|10 Min Ischemia||0
482695|NCT01110239|1183314|P4|NOT COMPLETED|7.5 Min Ischemia||0
482696|NCT01110239|1183315|P3|NOT COMPLETED|7.5 Min Ischemia||1
482697|NCT01110239|1183316|P2|NOT COMPLETED|7.5 Min Ischemia||0
482698|NCT01110239|1183317|P1|NOT COMPLETED|7.5 Min Ischemia||0
482699|NCT01110239|1183314|P4|COMPLETED|7.5 Min Ischemia||0
482700|NCT01110239|1183315|P3|COMPLETED|7.5 Min Ischemia||6
482701|NCT01110239|1183316|P2|COMPLETED|7.5 Min Ischemia||0
482702|NCT01110239|1183317|P1|COMPLETED|7.5 Min Ischemia||0
482703|NCT01110239|1183314|P4|STARTED|7.5 Min Ischemia||0
482704|NCT01110239|1183315|P3|STARTED|7.5 Min Ischemia||7
482705|NCT01110239|1183316|P2|STARTED|7.5 Min Ischemia||0
482706|NCT01110239|1183317|P1|STARTED|7.5 Min Ischemia||0
482707|NCT01110239|1183314|P4|NOT COMPLETED|5 Min Ischemia||0
482708|NCT01110239|1183315|P3|NOT COMPLETED|5 Min Ischemia||0
482709|NCT01110239|1183316|P2|NOT COMPLETED|5 Min Ischemia||14
482710|NCT01110239|1183317|P1|NOT COMPLETED|5 Min Ischemia||0
482711|NCT01110239|1183314|P4|COMPLETED|5 Min Ischemia||0
482712|NCT01110239|1183315|P3|COMPLETED|5 Min Ischemia||0
482713|NCT01110239|1183316|P2|COMPLETED|5 Min Ischemia||0
482714|NCT01110239|1183317|P1|COMPLETED|5 Min Ischemia||0
482715|NCT01110239|1183314|P4|STARTED|5 Min Ischemia||0
482716|NCT01110239|1183315|P3|STARTED|5 Min Ischemia||0
482717|NCT01110239|1183316|P2|STARTED|5 Min Ischemia||14
482718|NCT01110239|1183317|P1|STARTED|5 Min Ischemia||0
482719|NCT01110239|1183314|P4|NOT COMPLETED|Sham Preconditioning||0
482720|NCT01110239|1183315|P3|NOT COMPLETED|Sham Preconditioning||1
482721|NCT01110239|1183316|P2|NOT COMPLETED|Sham Preconditioning||0
482722|NCT01110239|1183317|P1|NOT COMPLETED|Sham Preconditioning||0
482723|NCT01110239|1183314|P4|COMPLETED|Sham Preconditioning||6
482724|NCT01110239|1183315|P3|COMPLETED|Sham Preconditioning||6
482725|NCT01110239|1183316|P2|COMPLETED|Sham Preconditioning||14
482726|NCT01110239|1183317|P1|COMPLETED|Sham Preconditioning||7
482727|NCT01110239|1183314|P4|STARTED|Sham Preconditioning||6
482728|NCT01110239|1183315|P3|STARTED|Sham Preconditioning||7
482729|NCT01110239|1183316|P2|STARTED|Sham Preconditioning||14
482730|NCT01110239|1183317|P1|STARTED|Sham Preconditioning||7
482731|NCT01110200|1183333|P2|NOT COMPLETED|Overall Study||121
482732|NCT01110200|1183334|P1|NOT COMPLETED|Overall Study||106
482733|NCT01110200|1183333|P2|COMPLETED|Overall Study||204
482734|NCT01110200|1183334|P1|COMPLETED|Overall Study||208
482735|NCT01110200|1183333|P2|STARTED|Overall Study||325
482736|NCT01110200|1183334|P1|STARTED|Overall Study||314
482737|NCT01110187|1183350|P2|NOT COMPLETED|Overall Study||0
482738|NCT01110187|1183351|P1|NOT COMPLETED|Overall Study||0
482739|NCT01110187|1183350|P2|COMPLETED|Overall Study|completed 7 day treatment|4
482740|NCT01110187|1183351|P1|COMPLETED|Overall Study|completed 7 day treatment|7
482741|NCT01110187|1183350|P2|STARTED|Overall Study||4
482742|NCT01110187|1183351|P1|STARTED|Overall Study||7
482743|NCT01110135|1183359|P1|NOT COMPLETED|Overall Study||9
482744|NCT01110135|1183359|P1|COMPLETED|Overall Study||34
482745|NCT01110135|1183359|P1|STARTED|Overall Study||43
482746|NCT01110005|1183365|P2|NOT COMPLETED|Overall Study||5
482747|NCT01110005|1183366|P1|NOT COMPLETED|Overall Study||4
482748|NCT01110005|1183365|P2|COMPLETED|Overall Study||156
482749|NCT01110005|1183366|P1|COMPLETED|Overall Study||153
482750|NCT01110005|1183365|P2|STARTED|Overall Study||161
482751|NCT01110005|1183366|P1|STARTED|Overall Study||157
482752|NCT01109979|1183378|P2|NOT COMPLETED|Overall Study||1
482753|NCT01109979|1183379|P1|NOT COMPLETED|Overall Study||2
482754|NCT01109979|1183378|P2|COMPLETED|Overall Study||11
482755|NCT01109979|1183379|P1|COMPLETED|Overall Study||10
482756|NCT01109979|1183378|P2|STARTED|Overall Study||12
482757|NCT01109979|1183379|P1|STARTED|Overall Study||12
482758|NCT01109849|1183387|P5|NOT COMPLETED|Adaptive Randomization: Weight Recovery||1
482759|NCT01109849|1183388|P4|NOT COMPLETED|Adaptive Randomization: Weight Recovery||3
482760|NCT01109849|1183389|P3|NOT COMPLETED|Adaptive Randomization: Weight Recovery||1
482761|NCT01109849|1183390|P2|NOT COMPLETED|Adaptive Randomization: Weight Recovery||0
482762|NCT01109849|1183391|P1|NOT COMPLETED|Adaptive Randomization: Weight Recovery||0
482763|NCT01109849|1183387|P5|COMPLETED|Adaptive Randomization: Weight Recovery||24
482764|NCT01109849|1183388|P4|COMPLETED|Adaptive Randomization: Weight Recovery||20
482765|NCT01109849|1183389|P3|COMPLETED|Adaptive Randomization: Weight Recovery||23
482766|NCT01109849|1183390|P2|COMPLETED|Adaptive Randomization: Weight Recovery||0
482767|NCT01109849|1183391|P1|COMPLETED|Adaptive Randomization: Weight Recovery||0
482768|NCT01109849|1183387|P5|STARTED|Adaptive Randomization: Weight Recovery||25
482769|NCT01109849|1183388|P4|STARTED|Adaptive Randomization: Weight Recovery||23
482770|NCT01109849|1183389|P3|STARTED|Adaptive Randomization: Weight Recovery||24
482771|NCT01109849|1183390|P2|STARTED|Adaptive Randomization: Weight Recovery||0
482772|NCT01109849|1183391|P1|STARTED|Adaptive Randomization: Weight Recovery||0
482773|NCT01109849|1183387|P5|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
482774|NCT01109849|1183388|P4|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
482775|NCT01109849|1183389|P3|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
482776|NCT01109849|1183390|P2|NOT COMPLETED|Initial Randomization: ADHD Treatment||49
482777|NCT01109849|1183391|P1|NOT COMPLETED|Initial Randomization: ADHD Treatment||18
482778|NCT01109849|1183387|P5|COMPLETED|Initial Randomization: ADHD Treatment||0
482779|NCT01109849|1183388|P4|COMPLETED|Initial Randomization: ADHD Treatment||0
482780|NCT01109849|1183389|P3|COMPLETED|Initial Randomization: ADHD Treatment||0
482781|NCT01109849|1183390|P2|COMPLETED|Initial Randomization: ADHD Treatment||131
482782|NCT01109849|1183391|P1|COMPLETED|Initial Randomization: ADHD Treatment||32
482783|NCT01109849|1183387|P5|STARTED|Initial Randomization: ADHD Treatment||0
482784|NCT01109849|1183388|P4|STARTED|Initial Randomization: ADHD Treatment||0
482785|NCT01109849|1183389|P3|STARTED|Initial Randomization: ADHD Treatment||0
482786|NCT01109849|1183390|P2|STARTED|Initial Randomization: ADHD Treatment||180
482787|NCT01109849|1183391|P1|STARTED|Initial Randomization: ADHD Treatment||50
482788|NCT01109602|1183443|P3|NOT COMPLETED|Overall Study||1
482789|NCT01109602|1183444|P2|NOT COMPLETED|Overall Study||2
482790|NCT01109602|1183445|P1|NOT COMPLETED|Overall Study||1
482791|NCT01109602|1183443|P3|COMPLETED|Overall Study||9
482792|NCT01109602|1183444|P2|COMPLETED|Overall Study||21
482793|NCT01109602|1183445|P1|COMPLETED|Overall Study||13
482794|NCT01109602|1183443|P3|STARTED|Overall Study||10
482795|NCT01109602|1183444|P2|STARTED|Overall Study||23
482796|NCT01109602|1183445|P1|STARTED|Overall Study||14
482797|NCT01109576|1183456|P1|NOT COMPLETED|Overall Study||1
482798|NCT01109576|1183456|P1|COMPLETED|Overall Study||12
482799|NCT01109576|1183456|P1|STARTED|Overall Study||13
482800|NCT01109524|1183460|P1|NOT COMPLETED|Overall Study||57
482801|NCT01109524|1183460|P1|COMPLETED|Overall Study||3
482802|NCT01109524|1183460|P1|STARTED|Overall Study||60
482803|NCT01109381|1183470|P1|NOT COMPLETED|Overall Study||2
482804|NCT01109381|1183470|P1|COMPLETED|Overall Study||31
482805|NCT01109381|1183470|P1|STARTED|Overall Study||33
482806|NCT01109316|1183482|P3|NOT COMPLETED|Study Period 3||1
482807|NCT01109316|1183483|P2|NOT COMPLETED|Study Period 3||2
482808|NCT01109316|1183484|P1|NOT COMPLETED|Study Period 3||0
482809|NCT01109316|1183482|P3|COMPLETED|Study Period 3||38
482810|NCT01109316|1183483|P2|COMPLETED|Study Period 3||39
482811|NCT01109316|1183484|P1|COMPLETED|Study Period 3||39
482812|NCT01109316|1183482|P3|STARTED|Study Period 3||39
482813|NCT01109316|1183483|P2|STARTED|Study Period 3||41
482814|NCT01109316|1183484|P1|STARTED|Study Period 3||39
482815|NCT01109316|1183482|P3|NOT COMPLETED|Study Period 2||2
482816|NCT01109316|1183483|P2|NOT COMPLETED|Study Period 2||2
482817|NCT01109316|1183484|P1|NOT COMPLETED|Study Period 2||1
482818|NCT01109316|1183482|P3|COMPLETED|Study Period 2||41
482819|NCT01109316|1183483|P2|COMPLETED|Study Period 2||40
482820|NCT01109316|1183484|P1|COMPLETED|Study Period 2||38
482821|NCT01109316|1183482|P3|STARTED|Study Period 2||43
482822|NCT01109316|1183483|P2|STARTED|Study Period 2||42
482823|NCT01109316|1183484|P1|STARTED|Study Period 2||39
482824|NCT01109316|1183482|P3|NOT COMPLETED|Study Period 1||4
482825|NCT01109316|1183483|P2|NOT COMPLETED|Study Period 1||4
482826|NCT01109316|1183484|P1|NOT COMPLETED|Study Period 1||0
482827|NCT01109316|1183482|P3|COMPLETED|Study Period 1||40
482828|NCT01109316|1183483|P2|COMPLETED|Study Period 1||40
482829|NCT01109316|1183484|P1|COMPLETED|Study Period 1||44
482830|NCT01109316|1183482|P3|Received at Least One Dose of Study Drug|Study Period 1||42
482831|NCT01109316|1183483|P2|Received at Least One Dose of Study Drug|Study Period 1||44
482832|NCT01109316|1183484|P1|Received at Least One Dose of Study Drug|Study Period 1||44
482833|NCT01109316|1183482|P3|STARTED|Study Period 1||44
482834|NCT01109316|1183483|P2|STARTED|Study Period 1||44
482835|NCT01109316|1183484|P1|STARTED|Study Period 1||44
482836|NCT01109173|1183532|P4|NOT COMPLETED|Overall Study||93
482837|NCT01109173|1183533|P3|NOT COMPLETED|Overall Study||101
482838|NCT01109173|1183534|P2|NOT COMPLETED|Overall Study||86
482839|NCT01109173|1183535|P1|NOT COMPLETED|Overall Study||88
482840|NCT01109173|1183532|P4|COMPLETED|Overall Study||120
482841|NCT01109173|1183533|P3|COMPLETED|Overall Study||110
482842|NCT01109173|1183534|P2|COMPLETED|Overall Study||759
482843|NCT01109173|1183535|P1|COMPLETED|Overall Study||763
482844|NCT01109173|1183532|P4|STARTED|Overall Study||213
482845|NCT01109173|1183533|P3|STARTED|Overall Study||211
482846|NCT01109173|1183534|P2|STARTED|Overall Study||845
482847|NCT01109173|1183535|P1|STARTED|Overall Study||851
482848|NCT01109147|1183552|P3|NOT COMPLETED|Overall Study||10
482849|NCT01109147|1183553|P2|NOT COMPLETED|Overall Study||3
482850|NCT01109147|1183554|P1|NOT COMPLETED|Overall Study||2
482851|NCT01109147|1183552|P3|COMPLETED|Overall Study|10 have been excluded of the results|26
482852|NCT01109147|1183553|P2|COMPLETED|Overall Study|3 have been excluded of the results|11
482853|NCT01109147|1183554|P1|COMPLETED|Overall Study|2 have been excluded of the results|15
482854|NCT01109147|1183552|P3|STARTED|Overall Study||36
482855|NCT01109147|1183553|P2|STARTED|Overall Study||14
482856|NCT01109147|1183554|P1|STARTED|Overall Study||17
482857|NCT01109108|1183564|P2|NOT COMPLETED|Overall Study||0
482858|NCT01109108|1183565|P1|NOT COMPLETED|Overall Study||0
482859|NCT01109108|1183564|P2|COMPLETED|Overall Study||4755
482860|NCT01109108|1183565|P1|COMPLETED|Overall Study||4035
482861|NCT01109108|1183564|P2|STARTED|Overall Study||4755
482862|NCT01109108|1183565|P1|STARTED|Overall Study||4035
482863|NCT01109056|1183573|P2|NOT COMPLETED|Overall Study||5
482864|NCT01109056|1183574|P1|NOT COMPLETED|Overall Study||7
482865|NCT01109056|1183573|P2|COMPLETED|Overall Study||53
482866|NCT01109056|1183574|P1|COMPLETED|Overall Study||50
482867|NCT01109056|1183573|P2|STARTED|Overall Study||58
482868|NCT01109056|1183574|P1|STARTED|Overall Study||57
482869|NCT01109004|1183587|P3|NOT COMPLETED|Overall Study||0
482870|NCT01109004|1183588|P2|NOT COMPLETED|Overall Study||0
482871|NCT01109004|1183589|P1|NOT COMPLETED|Overall Study||0
482872|NCT01109004|1183587|P3|COMPLETED|Overall Study||257
482873|NCT01109004|1183588|P2|COMPLETED|Overall Study||254
482874|NCT01109004|1183589|P1|COMPLETED|Overall Study||247
482875|NCT01109004|1183587|P3|STARTED|Overall Study||257
482876|NCT01109004|1183588|P2|STARTED|Overall Study||254
482877|NCT01109004|1183589|P1|STARTED|Overall Study||247
482878|NCT01108835|1183599|P2|NOT COMPLETED|Overall Study||21
482879|NCT01108835|1183600|P1|NOT COMPLETED|Overall Study||17
482880|NCT01108835|1183599|P2|COMPLETED|Overall Study||69
482881|NCT01108835|1183600|P1|COMPLETED|Overall Study||73
482882|NCT01108835|1183599|P2|STARTED|Overall Study||90
482883|NCT01108835|1183600|P1|STARTED|Overall Study||90
482884|NCT01108809|1183614|P1|NOT COMPLETED|Overall Study||4
482885|NCT01108809|1183614|P1|COMPLETED|Overall Study||291
482886|NCT01108809|1183614|P1|STARTED|Overall Study||295
482887|NCT01108796|1183631|P2|NOT COMPLETED|Overall Study||7
482888|NCT01108796|1183632|P1|NOT COMPLETED|Overall Study||7
482889|NCT01108796|1183631|P2|COMPLETED|Overall Study||1060
482890|NCT01108796|1183632|P1|COMPLETED|Overall Study||767
482891|NCT01108796|1183631|P2|STARTED|Overall Study||1067
482892|NCT01108796|1183632|P1|STARTED|Overall Study||774
482893|NCT01108757|1183666|P2|NOT COMPLETED|Overall Study||0
482894|NCT01108757|1183667|P1|NOT COMPLETED|Overall Study||0
482895|NCT01108757|1183666|P2|COMPLETED|Overall Study||26
482896|NCT01108757|1183667|P1|COMPLETED|Overall Study||26
482897|NCT01108757|1183666|P2|STARTED|Overall Study||26
482898|NCT01108757|1183667|P1|STARTED|Overall Study||26
482899|NCT01108731|1183675|P2|NOT COMPLETED|Overall Study||4
482900|NCT01108731|1183676|P1|NOT COMPLETED|Overall Study||4
482901|NCT01108731|1183675|P2|COMPLETED|Overall Study||13
482902|NCT01108731|1183676|P1|COMPLETED|Overall Study||13
482903|NCT01108731|1183675|P2|STARTED|Overall Study||17
482904|NCT01108731|1183676|P1|STARTED|Overall Study||17
482905|NCT01108718|1183688|P2|NOT COMPLETED|Received Second Intervention (2 Months)||0
482906|NCT01108718|1183689|P1|NOT COMPLETED|Received Second Intervention (2 Months)||1
482907|NCT01108718|1183688|P2|COMPLETED|Received Second Intervention (2 Months)||7
482908|NCT01108718|1183689|P1|COMPLETED|Received Second Intervention (2 Months)||4
482909|NCT01108718|1183688|P2|STARTED|Received Second Intervention (2 Months)||7
482910|NCT01108718|1183689|P1|STARTED|Received Second Intervention (2 Months)|Used control mattress was delivered to participant at crossover causing her to withdraw.|5
482911|NCT01108718|1183688|P2|NOT COMPLETED|Received First Intervention (2 Months)||0
482912|NCT01108718|1183689|P1|NOT COMPLETED|Received First Intervention (2 Months)||0
482913|NCT01108718|1183688|P2|COMPLETED|Received First Intervention (2 Months)||7
482914|NCT01108718|1183689|P1|COMPLETED|Received First Intervention (2 Months)||5
482915|NCT01108718|1183688|P2|STARTED|Received First Intervention (2 Months)||7
482916|NCT01108718|1183689|P1|STARTED|Received First Intervention (2 Months)||5
482917|NCT01108523|1183694|P1|NOT COMPLETED|Overall Study||4
482918|NCT01108523|1183694|P1|COMPLETED|Overall Study||3
482919|NCT01108523|1183694|P1|STARTED|Overall Study||7
482920|NCT01108510|1183701|P2|NOT COMPLETED|Overall Study||268
482921|NCT01108510|1183702|P1|NOT COMPLETED|Overall Study||279
482922|NCT01108510|1183701|P2|COMPLETED|Overall Study||81
482923|NCT01108510|1183702|P1|COMPLETED|Overall Study||70
482924|NCT01108510|1183701|P2|STARTED|Overall Study||349
482925|NCT01108510|1183702|P1|STARTED|Overall Study||349
482926|NCT01108458|1183722|P1|NOT COMPLETED|Overall Study||1
482927|NCT01108458|1183722|P1|COMPLETED|Overall Study||0
482928|NCT01108458|1183722|P1|STARTED|Overall Study||1
482929|NCT01108445|1183733|P2|NOT COMPLETED|Overall Study||49
482930|NCT01108445|1183734|P1|NOT COMPLETED|Overall Study||56
482931|NCT01108445|1183733|P2|COMPLETED|Overall Study||2
482932|NCT01108445|1183734|P1|COMPLETED|Overall Study||1
482933|NCT01108445|1183733|P2|STARTED|Overall Study||51
482934|NCT01108445|1183734|P1|STARTED|Overall Study||57
482935|NCT01108406|1183768|P1|NOT COMPLETED|Overall Study||0
482936|NCT01108406|1183768|P1|COMPLETED|Overall Study||22
482937|NCT01108406|1183768|P1|STARTED|Overall Study||22
482938|NCT01108341|1183774|P1|NOT COMPLETED|Overall Study||5
482939|NCT01108341|1183774|P1|COMPLETED|Overall Study||45
482940|NCT01108341|1183774|P1|Safety Set (Enrolled and Treated)|Overall Study||49
482941|NCT01108341|1183774|P1|STARTED|Overall Study||50
482942|NCT01108263|1183781|P2|NOT COMPLETED|Overall Study||1
482943|NCT01108263|1183782|P1|NOT COMPLETED|Overall Study||0
482944|NCT01108263|1183781|P2|COMPLETED|Overall Study||2
482945|NCT01108263|1183782|P1|COMPLETED|Overall Study||2
482946|NCT01108263|1183781|P2|STARTED|Overall Study||3
482947|NCT01108263|1183782|P1|STARTED|Overall Study||2
482948|NCT01108237|1183792|P2|NOT COMPLETED|Overall Study||17
482949|NCT01108237|1183793|P1|NOT COMPLETED|Overall Study||9
482950|NCT01108237|1183792|P2|COMPLETED|Overall Study||84
482951|NCT01108237|1183793|P1|COMPLETED|Overall Study|66 subjects underwent surgery per the protocol, however, only 64 met the primary end point.|64
482952|NCT01108237|1183792|P2|STARTED|Overall Study||101
482953|NCT01108237|1183793|P1|STARTED|Overall Study|78 subjects were consented with intent to treat, however, 73 had surgery.|73
482954|NCT01108185|1183799|P1|NOT COMPLETED|Overall Study||27
482955|NCT01108185|1183799|P1|COMPLETED|Overall Study||3154
482956|NCT01108185|1183799|P1|Per Protocol Population|Overall Study||3181
482957|NCT01108185|1183799|P1|STARTED|Overall Study||3181
482958|NCT01108081|1183816|P4|NOT COMPLETED|Overall Study||4
482959|NCT01108081|1183817|P3|NOT COMPLETED|Overall Study||0
482960|NCT01108081|1183818|P2|NOT COMPLETED|Overall Study||2
482961|NCT01108081|1183819|P1|NOT COMPLETED|Overall Study||2
482962|NCT01108081|1183816|P4|COMPLETED|Overall Study||39
482963|NCT01108081|1183817|P3|COMPLETED|Overall Study||38
482964|NCT01108081|1183818|P2|COMPLETED|Overall Study||40
482965|NCT01108081|1183819|P1|COMPLETED|Overall Study||44
482966|NCT01108081|1183816|P4|STARTED|Overall Study||43
482967|NCT01108081|1183817|P3|STARTED|Overall Study||38
482968|NCT01108081|1183818|P2|STARTED|Overall Study||42
482969|NCT01108081|1183819|P1|STARTED|Overall Study||46
482970|NCT01108068|1183835|P2|NOT COMPLETED|Overall Study||0
482971|NCT01108068|1183836|P1|NOT COMPLETED|Overall Study||6
482972|NCT01108068|1183835|P2|COMPLETED|Overall Study||16
482973|NCT01108068|1183836|P1|COMPLETED|Overall Study|Only 5 individuals were recruited into the Lithium treatment arm|4
482974|NCT01108068|1183835|P2|STARTED|Overall Study||16
482975|NCT01108068|1183836|P1|STARTED|Overall Study||10
482976|NCT01108055|1183843|P1|NOT COMPLETED|Overall Study||15
482977|NCT01108055|1183843|P1|COMPLETED|Overall Study||28
482978|NCT01108055|1183843|P1|Eligible and Started Treatment|Overall Study||32
482979|NCT01108055|1183843|P1|STARTED|Overall Study||43
482980|NCT01108003|1183853|P2|NOT COMPLETED|Overall Study||0
482981|NCT01108003|1183854|P1|NOT COMPLETED|Overall Study||0
482982|NCT01108003|1183853|P2|COMPLETED|Overall Study||3
482983|NCT01108003|1183854|P1|COMPLETED|Overall Study||4
482984|NCT01108003|1183853|P2|STARTED|Overall Study||3
482985|NCT01108003|1183854|P1|STARTED|Overall Study||4
482986|NCT01107964|1183864|P2|NOT COMPLETED|Overall Study||1
482987|NCT01107964|1183865|P1|NOT COMPLETED|Overall Study||1
482988|NCT01107964|1183864|P2|COMPLETED|Overall Study||13
482989|NCT01107964|1183865|P1|COMPLETED|Overall Study||12
482990|NCT01107964|1183864|P2|STARTED|Overall Study||14
482991|NCT01107964|1183865|P1|STARTED|Overall Study||13
482992|NCT01107925|1183881|P6|NOT COMPLETED|Period 3||0
482993|NCT01107925|1183882|P5|NOT COMPLETED|Period 3||0
482994|NCT01107925|1183883|P4|NOT COMPLETED|Period 3||0
482995|NCT01107925|1183884|P3|NOT COMPLETED|Period 3||0
482996|NCT01107925|1183885|P2|NOT COMPLETED|Period 3||0
482997|NCT01107925|1183886|P1|NOT COMPLETED|Period 3||0
482998|NCT01107925|1183881|P6|COMPLETED|Period 3||20
482999|NCT01107925|1183882|P5|COMPLETED|Period 3||0
483000|NCT01107925|1183883|P4|COMPLETED|Period 3||16
483001|NCT01107925|1183884|P3|COMPLETED|Period 3||15
483002|NCT01107925|1183885|P2|COMPLETED|Period 3||17
483003|NCT01107925|1183886|P1|COMPLETED|Period 3||0
483004|NCT01107925|1183881|P6|Took at Least 1 Dose of Study Drug|Period 3||20
483005|NCT01107925|1183882|P5|Took at Least 1 Dose of Study Drug|Period 3||0
483006|NCT01107925|1183883|P4|Took at Least 1 Dose of Study Drug|Period 3||16
483007|NCT01107925|1183884|P3|Took at Least 1 Dose of Study Drug|Period 3||15
483008|NCT01107925|1183885|P2|Took at Least 1 Dose of Study Drug|Period 3||17
483009|NCT01107925|1183886|P1|Took at Least 1 Dose of Study Drug|Period 3||0
483010|NCT01107925|1183881|P6|STARTED|Period 3|5 mg prasugrel (Period 2, HBW treatment sequence) crossed over to 75 mg clopidogrel (Period 3).|20
483011|NCT01107925|1183882|P5|STARTED|Period 3||0
483012|NCT01107925|1183883|P4|STARTED|Period 3|75 mg clopidogrel (Period 2, HBW treatment sequence) crossed over to 5 mg prasugrel (Period 3).|16
483013|NCT01107925|1183884|P3|STARTED|Period 3|10 mg prasugrel (Period 2, LBW treatment sequence) crossed over to 75 mg clopidogrel (Period 3).|15
483014|NCT01107925|1183885|P2|STARTED|Period 3|75 mg clopidogrel (Period 2, LBW treatment sequence) crossed over to 10 mg prasugrel (Period 3).|17
483015|NCT01107925|1183886|P1|STARTED|Period 3||0
483016|NCT01107925|1183881|P6|NOT COMPLETED|Period 2||1
483017|NCT01107925|1183882|P5|NOT COMPLETED|Period 2||0
483018|NCT01107925|1183883|P4|NOT COMPLETED|Period 2||0
483019|NCT01107925|1183884|P3|NOT COMPLETED|Period 2||0
483020|NCT01107925|1183885|P2|NOT COMPLETED|Period 2||1
483021|NCT01107925|1183886|P1|NOT COMPLETED|Period 2||0
483022|NCT01107925|1183881|P6|COMPLETED|Period 2||16
483023|NCT01107925|1183882|P5|COMPLETED|Period 2||0
483024|NCT01107925|1183883|P4|COMPLETED|Period 2||20
483025|NCT01107925|1183884|P3|COMPLETED|Period 2||17
483026|NCT01107925|1183885|P2|COMPLETED|Period 2||15
483027|NCT01107925|1183886|P1|COMPLETED|Period 2||0
483028|NCT01107925|1183881|P6|Took at Least 1 Dose of Study Drug|Period 2||17
483029|NCT01107925|1183882|P5|Took at Least 1 Dose of Study Drug|Period 2||0
483030|NCT01107925|1183883|P4|Took at Least 1 Dose of Study Drug|Period 2||20
483031|NCT01107925|1183884|P3|Took at Least 1 Dose of Study Drug|Period 2||17
483032|NCT01107925|1183885|P2|Took at Least 1 Dose of Study Drug|Period 2||16
483033|NCT01107925|1183886|P1|Took at Least 1 Dose of Study Drug|Period 2||0
483034|NCT01107925|1183881|P6|STARTED|Period 2||17
483035|NCT01107925|1183882|P5|STARTED|Period 2|10 mg prasugrel (Period 1, HBW treatment) switched to 5 mg prasugrel or 75 mg clopidogrel (Period 2)|0
483036|NCT01107925|1183883|P4|STARTED|Period 2||20
483037|NCT01107925|1183884|P3|STARTED|Period 2||17
483038|NCT01107925|1183885|P2|STARTED|Period 2||16
483039|NCT01107925|1183886|P1|STARTED|Period 2|5 mg prasugrel (Period 1, LBW treatment) switched to 10 mg prasugrel or 75 mg clopidogrel (Period 2)|0
483040|NCT01107925|1183881|P6|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
483041|NCT01107925|1183882|P5|NOT COMPLETED|Period 1-Randomization up Through Day 12||1
483042|NCT01107925|1183883|P4|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
483043|NCT01107925|1183884|P3|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
483044|NCT01107925|1183885|P2|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
483045|NCT01107925|1183886|P1|NOT COMPLETED|Period 1-Randomization up Through Day 12||1
483046|NCT01107925|1183881|P6|COMPLETED|Period 1-Randomization up Through Day 12||0
483047|NCT01107925|1183882|P5|COMPLETED|Period 1-Randomization up Through Day 12||37
483048|NCT01107925|1183883|P4|COMPLETED|Period 1-Randomization up Through Day 12||0
483049|NCT01107925|1183884|P3|COMPLETED|Period 1-Randomization up Through Day 12||0
483050|NCT01107925|1183885|P2|COMPLETED|Period 1-Randomization up Through Day 12||0
483051|NCT01107925|1183886|P1|COMPLETED|Period 1-Randomization up Through Day 12||33
483052|NCT01107925|1183881|P6|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
483053|NCT01107925|1183882|P5|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||38
483054|NCT01107925|1183883|P4|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
483055|NCT01107925|1183884|P3|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
483056|NCT01107925|1183885|P2|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
483057|NCT01107925|1183886|P1|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||34
483058|NCT01107925|1183881|P6|STARTED|Period 1-Randomization up Through Day 12||0
483059|NCT01107925|1183882|P5|STARTED|Period 1-Randomization up Through Day 12||38
483060|NCT01107925|1183883|P4|STARTED|Period 1-Randomization up Through Day 12||0
483061|NCT01107925|1183884|P3|STARTED|Period 1-Randomization up Through Day 12||0
483062|NCT01107925|1183885|P2|STARTED|Period 1-Randomization up Through Day 12||0
483063|NCT01107925|1183886|P1|STARTED|Period 1-Randomization up Through Day 12||34
483064|NCT01107912|1183924|P6|NOT COMPLETED|Period 3||0
483065|NCT01107912|1183925|P5|NOT COMPLETED|Period 3||0
483066|NCT01107912|1183926|P4|NOT COMPLETED|Period 3||1
483067|NCT01107912|1183927|P3|NOT COMPLETED|Period 3||1
483068|NCT01107912|1183928|P2|NOT COMPLETED|Period 3||1
483069|NCT01107912|1183929|P1|NOT COMPLETED|Period 3||0
483070|NCT01107912|1183924|P6|COMPLETED|Period 3||41
483071|NCT01107912|1183925|P5|COMPLETED|Period 3||0
483072|NCT01107912|1183926|P4|COMPLETED|Period 3||37
483073|NCT01107912|1183927|P3|COMPLETED|Period 3||35
483074|NCT01107912|1183928|P2|COMPLETED|Period 3||34
483075|NCT01107912|1183929|P1|COMPLETED|Period 3||0
483076|NCT01107912|1183924|P6|STARTED|Period 3|Participants who received 5 mg prasugrel in Period 2 received 75 mg clopidogrel in Period 3|41
483077|NCT01107912|1183925|P5|STARTED|Period 3||0
483078|NCT01107912|1183926|P4|STARTED|Period 3|Participants who received 75 mg clopidogrel in Period 2 received 5 mg prasugrel in Period 3|38
483079|NCT01107912|1183927|P3|STARTED|Period 3|Participants who received 10 mg prasugrel in Period 2 received 75 mg clopidogrel in Period 3|36
483080|NCT01107912|1183928|P2|STARTED|Period 3|Participants who received 75 mg clopidogrel in Period 2 received 10 mg prasugrel in Period 3|35
483081|NCT01107912|1183929|P1|STARTED|Period 3||0
483082|NCT01107912|1183924|P6|NOT COMPLETED|Period 2||0
483083|NCT01107912|1183925|P5|NOT COMPLETED|Period 2||0
483084|NCT01107912|1183926|P4|NOT COMPLETED|Period 2||0
483085|NCT01107912|1183927|P3|NOT COMPLETED|Period 2||1
483086|NCT01107912|1183928|P2|NOT COMPLETED|Period 2||0
483087|NCT01107912|1183929|P1|NOT COMPLETED|Period 2||0
483088|NCT01107912|1183924|P6|COMPLETED|Period 2||38
483089|NCT01107912|1183925|P5|COMPLETED|Period 2||0
483090|NCT01107912|1183926|P4|COMPLETED|Period 2||41
483091|NCT01107912|1183927|P3|COMPLETED|Period 2||35
483092|NCT01107912|1183928|P2|COMPLETED|Period 2||36
483093|NCT01107912|1183929|P1|COMPLETED|Period 2||0
483094|NCT01107912|1183924|P6|STARTED|Period 2||38
483095|NCT01107912|1183925|P5|STARTED|Period 2|Participants switched to either 5 mg prasugrel or 75 mg clopidogrel in Period 2.|0
483096|NCT01107912|1183926|P4|STARTED|Period 2||41
483097|NCT01107912|1183927|P3|STARTED|Period 2||36
483098|NCT01107912|1183928|P2|STARTED|Period 2||36
483099|NCT01107912|1183929|P1|STARTED|Period 2|Participants switched to either 10 mg prasugrel or 75 mg clopidogrel in Period 2.|0
483100|NCT01107912|1183924|P6|NOT COMPLETED|Period 1||0
483101|NCT01107912|1183925|P5|NOT COMPLETED|Period 1||3
483102|NCT01107912|1183926|P4|NOT COMPLETED|Period 1||0
483103|NCT01107912|1183927|P3|NOT COMPLETED|Period 1||0
483104|NCT01107912|1183928|P2|NOT COMPLETED|Period 1||0
483105|NCT01107912|1183929|P1|NOT COMPLETED|Period 1||1
483106|NCT01107912|1183924|P6|COMPLETED|Period 1||0
483107|NCT01107912|1183925|P5|COMPLETED|Period 1||79
483108|NCT01107912|1183926|P4|COMPLETED|Period 1||0
483109|NCT01107912|1183927|P3|COMPLETED|Period 1||0
483110|NCT01107912|1183928|P2|COMPLETED|Period 1||0
483111|NCT01107912|1183929|P1|COMPLETED|Period 1||72
483112|NCT01107912|1183924|P6|Received at Least 1 Dose of Study Drug|Period 1||0
483113|NCT01107912|1183925|P5|Received at Least 1 Dose of Study Drug|Period 1||82
483114|NCT01107912|1183926|P4|Received at Least 1 Dose of Study Drug|Period 1||0
483115|NCT01107912|1183927|P3|Received at Least 1 Dose of Study Drug|Period 1||0
483116|NCT01107912|1183928|P2|Received at Least 1 Dose of Study Drug|Period 1||0
483117|NCT01107912|1183929|P1|Received at Least 1 Dose of Study Drug|Period 1||73
483118|NCT01107912|1183924|P6|STARTED|Period 1||0
483119|NCT01107912|1183925|P5|STARTED|Period 1||82
483120|NCT01107912|1183926|P4|STARTED|Period 1||0
483121|NCT01107912|1183927|P3|STARTED|Period 1||0
483122|NCT01107912|1183928|P2|STARTED|Period 1||0
483123|NCT01107912|1183929|P1|STARTED|Period 1||73
483124|NCT01107899|1183966|P3|NOT COMPLETED|Overall Study||4
483125|NCT01107899|1183967|P2|NOT COMPLETED|Overall Study||0
483126|NCT01107899|1183968|P1|NOT COMPLETED|Overall Study||5
483127|NCT01107899|1183966|P3|COMPLETED|Overall Study||5
483128|NCT01107899|1183967|P2|COMPLETED|Overall Study||10
483129|NCT01107899|1183968|P1|COMPLETED|Overall Study||5
483130|NCT01107899|1183966|P3|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|4
483131|NCT01107899|1183967|P2|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|10
483132|NCT01107899|1183968|P1|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|5
483133|NCT01107899|1183966|P3|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|6
483134|NCT01107899|1183967|P2|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|10
483135|NCT01107899|1183968|P1|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|5
483136|NCT01107899|1183966|P3|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|6
483137|NCT01107899|1183967|P2|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|10
483138|NCT01107899|1183968|P1|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|5
483139|NCT01107899|1183966|P3|Received at Least One Dose of Study Drug|Overall Study||8
483140|NCT01107899|1183967|P2|Received at Least One Dose of Study Drug|Overall Study||10
483141|NCT01107899|1183968|P1|Received at Least One Dose of Study Drug|Overall Study||10
483142|NCT01107899|1183966|P3|STARTED|Overall Study||9
483143|NCT01107899|1183967|P2|STARTED|Overall Study||10
483144|NCT01107899|1183968|P1|STARTED|Overall Study||10
483145|NCT01107886|1184014|P2|NOT COMPLETED|Overall Study||214
483146|NCT01107886|1184015|P1|NOT COMPLETED|Overall Study||202
483147|NCT01107886|1184014|P2|COMPLETED|Overall Study|Completed subjects|7998
483148|NCT01107886|1184015|P1|COMPLETED|Overall Study|Completed subjects|8078
483149|NCT01107886|1184014|P2|STARTED|Overall Study|Randomized subjects|8212
483150|NCT01107886|1184015|P1|STARTED|Overall Study|Randomized subjects|8280
483151|NCT01107834|1184027|P2|NOT COMPLETED|Overall Study||0
483152|NCT01107834|1184028|P1|NOT COMPLETED|Overall Study||0
483153|NCT01107834|1184027|P2|COMPLETED|Overall Study||30
483154|NCT01107834|1184028|P1|COMPLETED|Overall Study||30
483155|NCT01107834|1184027|P2|STARTED|Overall Study||30
483156|NCT01107834|1184028|P1|STARTED|Overall Study||30
483157|NCT01107743|1184044|P1|NOT COMPLETED|Overall Study||46
483158|NCT01107743|1184044|P1|COMPLETED|Overall Study||1245
483159|NCT01107743|1184044|P1|STARTED|Overall Study||1291
483160|NCT01107730|1184133|P3|NOT COMPLETED|Overall Study||0
483161|NCT01107730|1184134|P2|NOT COMPLETED|Overall Study||0
483162|NCT01107730|1184135|P1|NOT COMPLETED|Overall Study||0
483163|NCT01107730|1184133|P3|COMPLETED|Overall Study||11
483164|NCT01107730|1184134|P2|COMPLETED|Overall Study||11
483165|NCT01107730|1184135|P1|COMPLETED|Overall Study||11
483166|NCT01107730|1184133|P3|STARTED|Overall Study||11
483167|NCT01107730|1184134|P2|STARTED|Overall Study||11
483168|NCT01107730|1184135|P1|STARTED|Overall Study||11
483169|NCT01107535|1184143|P1|NOT COMPLETED|Overall Study||5
483170|NCT01107535|1184143|P1|COMPLETED|Overall Study||77
483171|NCT01107535|1184143|P1|Number of Participants Analyzed|Overall Study||82
483172|NCT01107535|1184143|P1|STARTED|Overall Study||82
483173|NCT01107457|1184156|P6|NOT COMPLETED|Part B and C||120
483174|NCT01107457|1184157|P5|NOT COMPLETED|Part B and C||0
483175|NCT01107457|1184158|P4|NOT COMPLETED|Part B and C||0
483176|NCT01107457|1184159|P3|NOT COMPLETED|Part B and C||0
483177|NCT01107457|1184160|P2|NOT COMPLETED|Part B and C||0
483178|NCT01107457|1184161|P1|NOT COMPLETED|Part B and C||0
483179|NCT01107457|1184156|P6|COMPLETED|Part B and C|No participants completed the study as Part C was stopped.|0
483180|NCT01107457|1184157|P5|COMPLETED|Part B and C||0
483181|NCT01107457|1184158|P4|COMPLETED|Part B and C||0
483182|NCT01107457|1184159|P3|COMPLETED|Part B and C||0
483183|NCT01107457|1184160|P2|COMPLETED|Part B and C||0
483184|NCT01107457|1184161|P1|COMPLETED|Part B and C||0
483185|NCT01107457|1184156|P6|Post Treatment Safety Visits|Part B and C|Only participants with neutropenia entered the post treatment safety visits.|6
483186|NCT01107457|1184157|P5|Post Treatment Safety Visits|Part B and C||0
483187|NCT01107457|1184158|P4|Post Treatment Safety Visits|Part B and C||0
483188|NCT01107457|1184159|P3|Post Treatment Safety Visits|Part B and C||0
483189|NCT01107457|1184160|P2|Post Treatment Safety Visits|Part B and C||0
483190|NCT01107457|1184161|P1|Post Treatment Safety Visits|Part B and C||0
483191|NCT01107457|1184156|P6|Completed Part C|Part B and C|Part C was stopped once ixekizumab became available through marketing authorization.|0
483192|NCT01107457|1184157|P5|Completed Part C|Part B and C||0
483193|NCT01107457|1184158|P4|Completed Part C|Part B and C||0
483194|NCT01107457|1184159|P3|Completed Part C|Part B and C||0
483195|NCT01107457|1184160|P2|Completed Part C|Part B and C||0
483196|NCT01107457|1184161|P1|Completed Part C|Part B and C||0
483197|NCT01107457|1184156|P6|Completed Part B (Week 240)|Part B and C||74
483198|NCT01107457|1184157|P5|Completed Part B (Week 240)|Part B and C||0
483199|NCT01107457|1184158|P4|Completed Part B (Week 240)|Part B and C||0
483200|NCT01107457|1184159|P3|Completed Part B (Week 240)|Part B and C||0
483201|NCT01107457|1184160|P2|Completed Part B (Week 240)|Part B and C||0
483202|NCT01107457|1184161|P1|Completed Part B (Week 240)|Part B and C||0
483203|NCT01107457|1184156|P6|STARTED|Part B and C|80 and 120 mg ixekizumab were administered during Part B and C.|120
483204|NCT01107457|1184157|P5|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
483205|NCT01107457|1184158|P4|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
483206|NCT01107457|1184159|P3|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
483207|NCT01107457|1184160|P2|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
483208|NCT01107457|1184161|P1|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
483209|NCT01107457|1184156|P6|NOT COMPLETED|Part A||0
483210|NCT01107457|1184157|P5|NOT COMPLETED|Part A||1
483211|NCT01107457|1184158|P4|NOT COMPLETED|Part A||3
483212|NCT01107457|1184159|P3|NOT COMPLETED|Part A||1
483213|NCT01107457|1184160|P2|NOT COMPLETED|Part A||7
483214|NCT01107457|1184161|P1|NOT COMPLETED|Part A||5
483215|NCT01107457|1184156|P6|COMPLETED|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
483216|NCT01107457|1184157|P5|COMPLETED|Part A||27
483217|NCT01107457|1184158|P4|COMPLETED|Part A||26
483218|NCT01107457|1184159|P3|COMPLETED|Part A||29
483219|NCT01107457|1184160|P2|COMPLETED|Part A||21
483220|NCT01107457|1184161|P1|COMPLETED|Part A||22
483221|NCT01107457|1184156|P6|Received at Least 1 Dose of Study Drug|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
483222|NCT01107457|1184157|P5|Received at Least 1 Dose of Study Drug|Part A||28
483223|NCT01107457|1184158|P4|Received at Least 1 Dose of Study Drug|Part A||29
483224|NCT01107457|1184159|P3|Received at Least 1 Dose of Study Drug|Part A||30
483225|NCT01107457|1184160|P2|Received at Least 1 Dose of Study Drug|Part A||28
483226|NCT01107457|1184161|P1|Received at Least 1 Dose of Study Drug|Part A||27
483227|NCT01107457|1184156|P6|STARTED|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
483228|NCT01107457|1184157|P5|STARTED|Part A||28
483229|NCT01107457|1184158|P4|STARTED|Part A||29
483230|NCT01107457|1184159|P3|STARTED|Part A||30
483231|NCT01107457|1184160|P2|STARTED|Part A||28
483232|NCT01107457|1184161|P1|STARTED|Part A||27
483233|NCT01107418|1184291|P1|NOT COMPLETED|Overall Study||52
483234|NCT01107418|1184291|P1|COMPLETED|Overall Study||0
483235|NCT01107418|1184291|P1|STARTED|Overall Study||52
483236|NCT01107405|1184364|P5|NOT COMPLETED|Overall Study||3
483237|NCT01107405|1184365|P4|NOT COMPLETED|Overall Study||3
483238|NCT01107405|1184366|P3|NOT COMPLETED|Overall Study||2
483239|NCT01107405|1184367|P2|NOT COMPLETED|Overall Study||1
483240|NCT01107405|1184368|P1|NOT COMPLETED|Overall Study||2
483241|NCT01107405|1184364|P5|COMPLETED|Overall Study||17
483242|NCT01107405|1184365|P4|COMPLETED|Overall Study||17
483243|NCT01107405|1184366|P3|COMPLETED|Overall Study||18
483244|NCT01107405|1184367|P2|COMPLETED|Overall Study||19
483245|NCT01107405|1184368|P1|COMPLETED|Overall Study||19
483246|NCT01107405|1184364|P5|STARTED|Overall Study||20
483247|NCT01107405|1184365|P4|STARTED|Overall Study||20
483248|NCT01107405|1184366|P3|STARTED|Overall Study||20
483249|NCT01107405|1184367|P2|STARTED|Overall Study||20
483250|NCT01107405|1184368|P1|STARTED|Overall Study||21
483251|NCT01107392|1184407|P2|NOT COMPLETED|Overall Study||3
483252|NCT01107392|1184408|P1|NOT COMPLETED|Overall Study||5
483253|NCT01107392|1184407|P2|COMPLETED|Overall Study||154
483254|NCT01107392|1184408|P1|COMPLETED|Overall Study||153
483255|NCT01107392|1184407|P2|STARTED|Overall Study||157
483256|NCT01107392|1184408|P1|STARTED|Overall Study||158
483257|NCT01107379|1184420|P1|NOT COMPLETED|Overall Study||21
483258|NCT01107379|1184420|P1|COMPLETED|Overall Study||182
483259|NCT01107379|1184420|P1|STARTED|Overall Study||203
483260|NCT01107353|1184431|P2|NOT COMPLETED|Overall Study||0
483261|NCT01107353|1184432|P1|NOT COMPLETED|Overall Study||1
483262|NCT01107353|1184431|P2|COMPLETED|Overall Study||20
483263|NCT01107353|1184432|P1|COMPLETED|Overall Study||19
483264|NCT01107353|1184431|P2|STARTED|Overall Study||20
483265|NCT01107353|1184432|P1|STARTED|Overall Study||20
483266|NCT01107197|1184440|P2|NOT COMPLETED|Overall Study||23
483267|NCT01107197|1184441|P1|NOT COMPLETED|Overall Study||20
483268|NCT01107197|1184440|P2|COMPLETED|Overall Study|Included in intention-to-treat efficacy analyses (per-protocol analyses were based on 64 patients )|78
483269|NCT01107197|1184441|P1|COMPLETED|Overall Study|Included in intention-to-treat efficacy analyses (per-protocol analyses were based on 67 patients )|79
483270|NCT01107197|1184440|P2|STARTED|Overall Study||101
483271|NCT01107197|1184441|P1|STARTED|Overall Study||99
483272|NCT01107015|1184463|P4|NOT COMPLETED|Overall Study||18
483273|NCT01107015|1184464|P3|NOT COMPLETED|Overall Study||11
483274|NCT01107015|1184465|P2|NOT COMPLETED|Overall Study||15
483275|NCT01107015|1184466|P1|NOT COMPLETED|Overall Study||6
483276|NCT01107015|1184463|P4|COMPLETED|Overall Study||62
483277|NCT01107015|1184464|P3|COMPLETED|Overall Study||22
483278|NCT01107015|1184465|P2|COMPLETED|Overall Study||23
483279|NCT01107015|1184466|P1|COMPLETED|Overall Study||56
483280|NCT01107015|1184463|P4|STARTED|Overall Study||80
483281|NCT01107015|1184464|P3|STARTED|Overall Study||33
483282|NCT01107015|1184465|P2|STARTED|Overall Study||38
483283|NCT01107015|1184466|P1|STARTED|Overall Study||62
483284|NCT01106976|1184476|P1|NOT COMPLETED|Overall Study||8
483285|NCT01106976|1184476|P1|COMPLETED|Overall Study||59
483286|NCT01106976|1184476|P1|STARTED|Overall Study||67
483287|NCT01106950|1184480|P1|NOT COMPLETED|Overall Study||0
483288|NCT01106950|1184480|P1|COMPLETED|Overall Study||15
483289|NCT01106950|1184480|P1|STARTED|Overall Study||15
483290|NCT01106911|1184490|P1|NOT COMPLETED|Overall Study||5
483291|NCT01106911|1184490|P1|COMPLETED|Overall Study||1080
483292|NCT01106911|1184490|P1|STARTED|Overall Study||1085
483293|NCT01106898|1184494|P1|NOT COMPLETED|Overall Study||6
483294|NCT01106898|1184494|P1|COMPLETED|Overall Study||94
483295|NCT01106898|1184494|P1|STARTED|Overall Study||100
483296|NCT01106859|1184498|P1|NOT COMPLETED|Overall Study||0
483297|NCT01106859|1184498|P1|COMPLETED|Overall Study||40
483298|NCT01106859|1184498|P1|STARTED|Overall Study|Intent to treat population and safety population are the same (40 participants)|40
483299|NCT01106846|1184539|P2|NOT COMPLETED|Overall Study||1
483300|NCT01106846|1184540|P1|NOT COMPLETED|Overall Study||0
483301|NCT01106846|1184539|P2|COMPLETED|Overall Study||9
483302|NCT01106846|1184540|P1|COMPLETED|Overall Study||12
483303|NCT01106846|1184539|P2|STARTED|Overall Study||10
483304|NCT01106846|1184540|P1|STARTED|Overall Study||12
483305|NCT01106690|1184549|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||7
483306|NCT01106690|1184550|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||7
483307|NCT01106690|1184551|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||12
483308|NCT01106690|1184549|P3|COMPLETED|Extension Period: Week 26 to Week 52||89
483309|NCT01106690|1184550|P2|COMPLETED|Extension Period: Week 26 to Week 52||96
483310|NCT01106690|1184551|P1|COMPLETED|Extension Period: Week 26 to Week 52||78
483311|NCT01106690|1184549|P3|STARTED|Extension Period: Week 26 to Week 52|5 pts completed core but did not exter ext: lost to f/u(1), not spec(2), AE(1), eGFR criteria(1).|96
483312|NCT01106690|1184550|P2|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext: physician decision(1).|103
483313|NCT01106690|1184551|P1|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext: physician decision(1).|90
483314|NCT01106690|1184549|P3|NOT COMPLETED|Core Period: Baseline to Week 26||13
483315|NCT01106690|1184550|P2|NOT COMPLETED|Core Period: Baseline to Week 26||9
483316|NCT01106690|1184551|P1|NOT COMPLETED|Core Period: Baseline to Week 26||24
483317|NCT01106690|1184549|P3|COMPLETED|Core Period: Baseline to Week 26||101
483318|NCT01106690|1184550|P2|COMPLETED|Core Period: Baseline to Week 26||104
483319|NCT01106690|1184551|P1|COMPLETED|Core Period: Baseline to Week 26||91
483320|NCT01106690|1184549|P3|STARTED|Core Period: Baseline to Week 26||114
483321|NCT01106690|1184550|P2|STARTED|Core Period: Baseline to Week 26||113
483322|NCT01106690|1184551|P1|STARTED|Core Period: Baseline to Week 26||115
483323|NCT01106677|1184587|P4|NOT COMPLETED|Extension Period: Week 26 to Week 52||28
483324|NCT01106677|1184588|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||22
483325|NCT01106677|1184589|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
483326|NCT01106677|1184590|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||15
483327|NCT01106677|1184587|P4|COMPLETED|Extension Period: Week 26 to Week 52||285
483328|NCT01106677|1184588|P3|COMPLETED|Extension Period: Week 26 to Week 52||299
483329|NCT01106677|1184589|P2|COMPLETED|Extension Period: Week 26 to Week 52||298
483330|NCT01106677|1184590|P1|COMPLETED|Extension Period: Week 26 to Week 52||138
483331|NCT01106677|1184587|P4|STARTED|Extension Period: Week 26 to Week 52|6 pts completed core but did not enter ext: not specified(3), physician decision(2), lost to f/u(1).|313
483332|NCT01106677|1184588|P3|STARTED|Extension Period: Week 26 to Week 52|2 pts completed core but did not enter ext: not specified(1), withdrawal by subject(1).|321
483333|NCT01106677|1184589|P2|STARTED|Extension Period: Week 26 to Week 52|6 pts completed core but did not enter ext: not specified(5), withdrawal by subject(1).|316
483334|NCT01106677|1184590|P1|STARTED|Extension Period: Week 26 to Week 52|2 pts completed core but did not enter ext: protcol violation(1), lost to f/u(1).|153
483335|NCT01106677|1184587|P4|NOT COMPLETED|Core Period: Baseline to Week 26||47
483336|NCT01106677|1184588|P3|NOT COMPLETED|Core Period: Baseline to Week 26||44
483337|NCT01106677|1184589|P2|NOT COMPLETED|Core Period: Baseline to Week 26||46
483338|NCT01106677|1184590|P1|NOT COMPLETED|Core Period: Baseline to Week 26||28
483339|NCT01106677|1184587|P4|COMPLETED|Core Period: Baseline to Week 26||319
483340|NCT01106677|1184588|P3|COMPLETED|Core Period: Baseline to Week 26||323
483341|NCT01106677|1184589|P2|COMPLETED|Core Period: Baseline to Week 26||322
483342|NCT01106677|1184590|P1|COMPLETED|Core Period: Baseline to Week 26||155
483343|NCT01106677|1184587|P4|STARTED|Core Period: Baseline to Week 26||366
483344|NCT01106677|1184588|P3|STARTED|Core Period: Baseline to Week 26||367
483345|NCT01106677|1184589|P2|STARTED|Core Period: Baseline to Week 26||368
483346|NCT01106677|1184590|P1|STARTED|Core Period: Baseline to Week 26||183
483347|NCT01106651|1184653|P3|NOT COMPLETED|Overall Study||58
483348|NCT01106651|1184654|P2|NOT COMPLETED|Overall Study||57
483349|NCT01106651|1184655|P1|NOT COMPLETED|Overall Study||79
483350|NCT01106651|1184653|P3|COMPLETED|Overall Study||178
483351|NCT01106651|1184654|P2|COMPLETED|Overall Study||184
483352|NCT01106651|1184655|P1|COMPLETED|Overall Study||158
483353|NCT01106651|1184653|P3|STARTED|Overall Study||236
483354|NCT01106651|1184654|P2|STARTED|Overall Study||241
483355|NCT01106651|1184655|P1|STARTED|Overall Study||237
483356|NCT01106625|1184708|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||17
483357|NCT01106625|1184709|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
483358|NCT01106625|1184710|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||29
483359|NCT01106625|1184708|P3|COMPLETED|Extension Period: Week 26 to Week 52||111
483360|NCT01106625|1184709|P2|COMPLETED|Extension Period: Week 26 to Week 52||109
483361|NCT01106625|1184710|P1|COMPLETED|Extension Period: Week 26 to Week 52||90
483362|NCT01106625|1184708|P3|STARTED|Extension Period: Week 26 to Week 52|1 pt discontinued last day of core: withdrawal by subject (1).|128
483363|NCT01106625|1184709|P2|STARTED|Extension Period: Week 26 to Week 52|2 pts discontinued last day of core: adverse event (1), not specified (1).|127
483364|NCT01106625|1184710|P1|STARTED|Extension Period: Week 26 to Week 52|4 pts discontinued last day of core: physician decision (1), noncompliance (1), not specified (2).|119
483365|NCT01106625|1184708|P3|NOT COMPLETED|Core Period: Baseline to Week 26||27
483366|NCT01106625|1184709|P2|NOT COMPLETED|Core Period: Baseline to Week 26||28
483367|NCT01106625|1184710|P1|NOT COMPLETED|Core Period: Baseline to Week 26||33
483368|NCT01106625|1184708|P3|COMPLETED|Core Period: Baseline to Week 26||129
483369|NCT01106625|1184709|P2|COMPLETED|Core Period: Baseline to Week 26||129
483370|NCT01106625|1184710|P1|COMPLETED|Core Period: Baseline to Week 26||123
483371|NCT01106625|1184708|P3|STARTED|Core Period: Baseline to Week 26||156
483372|NCT01106625|1184709|P2|STARTED|Core Period: Baseline to Week 26||157
483373|NCT01106625|1184710|P1|STARTED|Core Period: Baseline to Week 26||156
483374|NCT01106586|1184741|P2|NOT COMPLETED|Overall Study||285
483375|NCT01106586|1184742|P1|NOT COMPLETED|Overall Study||285
483376|NCT01106586|1184741|P2|COMPLETED|Overall Study||70
483377|NCT01106586|1184742|P1|COMPLETED|Overall Study||68
483378|NCT01106586|1184741|P2|STARTED|Overall Study||355
483379|NCT01106586|1184742|P1|STARTED|Overall Study||353
483380|NCT01106534|1184760|P1|NOT COMPLETED|Overall Study||37
483381|NCT01106534|1184760|P1|COMPLETED|Overall Study||2960
483382|NCT01106534|1184760|P1|STARTED|Overall Study||2997
483383|NCT01106456|1184783|P2|NOT COMPLETED|Overall Study||124
483384|NCT01106456|1184784|P1|NOT COMPLETED|Overall Study||103
483385|NCT01106456|1184783|P2|COMPLETED|Overall Study||96
483386|NCT01106456|1184784|P1|COMPLETED|Overall Study||140
483387|NCT01106456|1184783|P2|STARTED|Overall Study||220
483388|NCT01106456|1184784|P1|STARTED|Overall Study||243
483389|NCT01106430|1184792|P2|NOT COMPLETED|Overall Study||33
483390|NCT01106430|1184793|P1|NOT COMPLETED|Overall Study||33
483391|NCT01106430|1184792|P2|COMPLETED|Overall Study||101
483392|NCT01106430|1184793|P1|COMPLETED|Overall Study||100
483393|NCT01106430|1184792|P2|STARTED|Overall Study||134
483394|NCT01106430|1184793|P1|STARTED|Overall Study||133
483395|NCT01106404|1184815|P2|NOT COMPLETED|Period II (Second 6 Weeks)||0
483396|NCT01106404|1184816|P1|NOT COMPLETED|Period II (Second 6 Weeks)||0
483397|NCT01106404|1184815|P2|COMPLETED|Period II (Second 6 Weeks)||38
483398|NCT01106404|1184816|P1|COMPLETED|Period II (Second 6 Weeks)||33
483399|NCT01106404|1184815|P2|STARTED|Period II (Second 6 Weeks)||38
483400|NCT01106404|1184816|P1|STARTED|Period II (Second 6 Weeks)||33
483401|NCT01106404|1184815|P2|NOT COMPLETED|Period I (First 6 Weeks)||2
483402|NCT01106404|1184816|P1|NOT COMPLETED|Period I (First 6 Weeks)||3
483403|NCT01106404|1184815|P2|COMPLETED|Period I (First 6 Weeks)||38
483404|NCT01106404|1184816|P1|COMPLETED|Period I (First 6 Weeks)||33
483405|NCT01106404|1184815|P2|STARTED|Period I (First 6 Weeks)||40
483406|NCT01106404|1184816|P1|STARTED|Period I (First 6 Weeks)||36
483407|NCT01106391|1184829|P1|NOT COMPLETED|Overall Study||0
483408|NCT01106391|1184829|P1|COMPLETED|Overall Study||60
483409|NCT01106391|1184829|P1|STARTED|Overall Study||60
483410|NCT01106352|1184839|P5|NOT COMPLETED|Overall Study||8
483411|NCT01106352|1184840|P4|NOT COMPLETED|Overall Study||13
483412|NCT01106352|1184841|P3|NOT COMPLETED|Overall Study||2
483413|NCT01106352|1184842|P2|NOT COMPLETED|Overall Study||0
483414|NCT01106352|1184843|P1|NOT COMPLETED|Overall Study||1
483415|NCT01106352|1184839|P5|COMPLETED|Overall Study|This group is only applicable for Safety cohort period.|9
483416|NCT01106352|1184840|P4|COMPLETED|Overall Study|This group is only applicable for Safety cohort period.|23
483417|NCT01106352|1184841|P3|COMPLETED|Overall Study||5
483418|NCT01106352|1184842|P2|COMPLETED|Overall Study||3
483419|NCT01106352|1184843|P1|COMPLETED|Overall Study||6
483420|NCT01106352|1184839|P5|Completed Safety Cohort|Overall Study||9
483421|NCT01106352|1184840|P4|Completed Safety Cohort|Overall Study||23
483422|NCT01106352|1184841|P3|Completed Safety Cohort|Overall Study||0
483423|NCT01106352|1184842|P2|Completed Safety Cohort|Overall Study||0
483424|NCT01106352|1184843|P1|Completed Safety Cohort|Overall Study||0
483425|NCT01106352|1184839|P5|Treated Safety Cohort|Overall Study|Number of subjects for safety analysis set.|13
483426|NCT01106352|1184840|P4|Treated Safety Cohort|Overall Study|Number of subjects for safety analysis set.|33
483427|NCT01106352|1184841|P3|Treated Safety Cohort|Overall Study||0
483428|NCT01106352|1184842|P2|Treated Safety Cohort|Overall Study||0
483429|NCT01106352|1184843|P1|Treated Safety Cohort|Overall Study||0
483430|NCT01106352|1184839|P5|Started Safety Cohort|Overall Study||17
483431|NCT01106352|1184840|P4|Started Safety Cohort|Overall Study||36
483432|NCT01106352|1184841|P3|Started Safety Cohort|Overall Study||0
483433|NCT01106352|1184842|P2|Started Safety Cohort|Overall Study||0
483434|NCT01106352|1184843|P1|Started Safety Cohort|Overall Study||0
483435|NCT01106352|1184839|P5|Completed Dose Escalation|Overall Study||0
483436|NCT01106352|1184840|P4|Completed Dose Escalation|Overall Study||0
483437|NCT01106352|1184841|P3|Completed Dose Escalation|Overall Study||5
483438|NCT01106352|1184842|P2|Completed Dose Escalation|Overall Study||3
483439|NCT01106352|1184843|P1|Completed Dose Escalation|Overall Study||6
483440|NCT01106352|1184839|P5|Started Dose Escalation|Overall Study||0
483441|NCT01106352|1184840|P4|Started Dose Escalation|Overall Study||0
483442|NCT01106352|1184841|P3|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|7
483443|NCT01106352|1184842|P2|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|3
483444|NCT01106352|1184843|P1|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|7
483445|NCT01106352|1184839|P5|STARTED|Overall Study||17
483446|NCT01106352|1184840|P4|STARTED|Overall Study||36
483447|NCT01106352|1184841|P3|STARTED|Overall Study||7
483448|NCT01106352|1184842|P2|STARTED|Overall Study||3
483449|NCT01106352|1184843|P1|STARTED|Overall Study||7
483450|NCT01106326|1184929|P1|NOT COMPLETED|Overall Study||2
483451|NCT01106326|1184929|P1|COMPLETED|Overall Study||28
483452|NCT01106326|1184929|P1|STARTED|Overall Study||30
483453|NCT01106287|1184939|P4|NOT COMPLETED|Overall Study||0
483454|NCT01106287|1184940|P3|NOT COMPLETED|Overall Study||0
483455|NCT01106287|1184941|P2|NOT COMPLETED|Overall Study||0
483456|NCT01106287|1184942|P1|NOT COMPLETED|Overall Study||1
483457|NCT01106287|1184939|P4|COMPLETED|Overall Study||3
483458|NCT01106287|1184940|P3|COMPLETED|Overall Study||3
483459|NCT01106287|1184941|P2|COMPLETED|Overall Study||3
483460|NCT01106287|1184942|P1|COMPLETED|Overall Study||3
483461|NCT01106287|1184939|P4|STARTED|Overall Study||3
483462|NCT01106287|1184940|P3|STARTED|Overall Study||3
483463|NCT01106287|1184941|P2|STARTED|Overall Study||3
483464|NCT01106287|1184942|P1|STARTED|Overall Study|One participant that discontinued the study due to a pre-treatment adverse event was replaced.|4
483465|NCT01106248|1184962|P1|NOT COMPLETED|Overall Study||3
483466|NCT01106248|1184962|P1|COMPLETED|Overall Study||23
483467|NCT01106248|1184962|P1|STARTED|Overall Study||26
483468|NCT01106157|1184970|P2|NOT COMPLETED|Overall Study||0
483469|NCT01106157|1184971|P1|NOT COMPLETED|Overall Study||1
483470|NCT01106157|1184970|P2|COMPLETED|Overall Study||8
483471|NCT01106157|1184971|P1|COMPLETED|Overall Study||16
483472|NCT01106157|1184970|P2|STARTED|Overall Study||8
483473|NCT01106157|1184971|P1|STARTED|Overall Study||17
483474|NCT01106092|1184999|P4|NOT COMPLETED|Overall Study||1
483475|NCT01106092|1185000|P3|NOT COMPLETED|Overall Study||0
483476|NCT01106092|1185001|P2|NOT COMPLETED|Overall Study||0
483477|NCT01106092|1185002|P1|NOT COMPLETED|Overall Study||0
483478|NCT01106092|1184999|P4|COMPLETED|Overall Study||77
483479|NCT01106092|1185000|P3|COMPLETED|Overall Study||78
483480|NCT01106092|1185001|P2|COMPLETED|Overall Study||78
483481|NCT01106092|1185002|P1|COMPLETED|Overall Study||78
483482|NCT01106092|1184999|P4|STARTED|Overall Study||78
483483|NCT01106092|1185000|P3|STARTED|Overall Study||78
483484|NCT01106092|1185001|P2|STARTED|Overall Study||78
483485|NCT01106092|1185002|P1|STARTED|Overall Study||78
483486|NCT01106040|1185080|P1|NOT COMPLETED|Overall Study||11
483487|NCT01106040|1185080|P1|COMPLETED|Overall Study||152
483488|NCT01106040|1185080|P1|STARTED|Overall Study||163
483489|NCT01106027|1185085|P1|NOT COMPLETED|Overall Study||1
483490|NCT01106027|1185085|P1|COMPLETED|Overall Study||1
483491|NCT01106027|1185085|P1|STARTED|Overall Study||2
483492|NCT01106014|1185091|P2|NOT COMPLETED|Overall Study||330
483493|NCT01106014|1185092|P1|NOT COMPLETED|Overall Study||285
483494|NCT01106014|1185091|P2|COMPLETED|Overall Study||252
483495|NCT01106014|1185092|P1|COMPLETED|Overall Study||289
483496|NCT01106014|1185091|P2|STARTED|Overall Study||582
483497|NCT01106014|1185092|P1|STARTED|Overall Study||574
483498|NCT01105975|1185112|P10|NOT COMPLETED|Overall Study||9
483499|NCT01105975|1185113|P9|NOT COMPLETED|Overall Study||6
483500|NCT01105975|1185114|P8|NOT COMPLETED|Overall Study||7
483501|NCT01105975|1185115|P7|NOT COMPLETED|Overall Study||8
483502|NCT01105975|1185116|P6|NOT COMPLETED|Overall Study||5
483503|NCT01105975|1185117|P5|NOT COMPLETED|Overall Study||6
483504|NCT01105975|1185118|P4|NOT COMPLETED|Overall Study||2
483505|NCT01105975|1185119|P3|NOT COMPLETED|Overall Study||10
483506|NCT01105975|1185120|P2|NOT COMPLETED|Overall Study||5
483507|NCT01105975|1185121|P1|NOT COMPLETED|Overall Study||5
483508|NCT01105975|1185112|P10|COMPLETED|Overall Study||32
483509|NCT01105975|1185113|P9|COMPLETED|Overall Study||34
483510|NCT01105975|1185114|P8|COMPLETED|Overall Study||33
483511|NCT01105975|1185115|P7|COMPLETED|Overall Study||34
483512|NCT01105975|1185116|P6|COMPLETED|Overall Study||30
483513|NCT01105975|1185117|P5|COMPLETED|Overall Study||35
483514|NCT01105975|1185118|P4|COMPLETED|Overall Study||36
483515|NCT01105975|1185119|P3|COMPLETED|Overall Study||32
483516|NCT01105975|1185120|P2|COMPLETED|Overall Study||34
483517|NCT01105975|1185121|P1|COMPLETED|Overall Study||35
483518|NCT01105975|1185112|P10|Took at Least One Dose of Study Drug|Overall Study||41
483519|NCT01105975|1185113|P9|Took at Least One Dose of Study Drug|Overall Study||39
483520|NCT01105975|1185114|P8|Took at Least One Dose of Study Drug|Overall Study||40
483521|NCT01105975|1185115|P7|Took at Least One Dose of Study Drug|Overall Study||41
483522|NCT01105975|1185116|P6|Took at Least One Dose of Study Drug|Overall Study||35
483523|NCT01105975|1185117|P5|Took at Least One Dose of Study Drug|Overall Study||41
483524|NCT01105975|1185118|P4|Took at Least One Dose of Study Drug|Overall Study||38
483525|NCT01105975|1185119|P3|Took at Least One Dose of Study Drug|Overall Study||40
483526|NCT01105975|1185120|P2|Took at Least One Dose of Study Drug|Overall Study||38
483527|NCT01105975|1185121|P1|Took at Least One Dose of Study Drug|Overall Study||40
483528|NCT01105975|1185112|P10|STARTED|Overall Study||41
483529|NCT01105975|1185113|P9|STARTED|Overall Study||40
483530|NCT01105975|1185114|P8|STARTED|Overall Study||40
483531|NCT01105975|1185115|P7|STARTED|Overall Study||42
483532|NCT01105975|1185116|P6|STARTED|Overall Study||35
483533|NCT01105975|1185117|P5|STARTED|Overall Study||41
483534|NCT01105975|1185118|P4|STARTED|Overall Study||38
483535|NCT01105975|1185119|P3|STARTED|Overall Study||42
483536|NCT01105975|1185120|P2|STARTED|Overall Study||39
483537|NCT01105975|1185121|P1|STARTED|Overall Study||40
483538|NCT01105936|1185269|P4|NOT COMPLETED|Period 3||0
483539|NCT01105936|1185270|P3|NOT COMPLETED|Period 3||0
483540|NCT01105936|1185271|P2|NOT COMPLETED|Period 3||2
483541|NCT01105936|1185272|P1|NOT COMPLETED|Period 3||0
483542|NCT01105936|1185269|P4|COMPLETED|Period 3||7
483543|NCT01105936|1185270|P3|COMPLETED|Period 3||7
483544|NCT01105936|1185271|P2|COMPLETED|Period 3||6
483545|NCT01105936|1185272|P1|COMPLETED|Period 3||7
483546|NCT01105936|1185269|P4|STARTED|Period 3||7
483547|NCT01105936|1185270|P3|STARTED|Period 3||7
483548|NCT01105936|1185271|P2|STARTED|Period 3||8
483549|NCT01105936|1185272|P1|STARTED|Period 3||7
483550|NCT01105936|1185269|P4|NOT COMPLETED|Wash-out Period 2||0
483551|NCT01105936|1185270|P3|NOT COMPLETED|Wash-out Period 2||0
483552|NCT01105936|1185271|P2|NOT COMPLETED|Wash-out Period 2||0
483553|NCT01105936|1185272|P1|NOT COMPLETED|Wash-out Period 2||0
483554|NCT01105936|1185269|P4|COMPLETED|Wash-out Period 2||7
483555|NCT01105936|1185270|P3|COMPLETED|Wash-out Period 2||7
483556|NCT01105936|1185271|P2|COMPLETED|Wash-out Period 2||8
483557|NCT01105936|1185272|P1|COMPLETED|Wash-out Period 2||7
483558|NCT01105936|1185269|P4|STARTED|Wash-out Period 2||7
483559|NCT01105936|1185270|P3|STARTED|Wash-out Period 2||7
483560|NCT01105936|1185271|P2|STARTED|Wash-out Period 2||8
483561|NCT01105936|1185272|P1|STARTED|Wash-out Period 2||7
483562|NCT01105936|1185269|P4|NOT COMPLETED|Period 2||0
483563|NCT01105936|1185270|P3|NOT COMPLETED|Period 2||0
483564|NCT01105936|1185271|P2|NOT COMPLETED|Period 2||0
483565|NCT01105936|1185272|P1|NOT COMPLETED|Period 2||1
483566|NCT01105936|1185269|P4|COMPLETED|Period 2||7
483567|NCT01105936|1185270|P3|COMPLETED|Period 2||7
483568|NCT01105936|1185271|P2|COMPLETED|Period 2||8
483569|NCT01105936|1185272|P1|COMPLETED|Period 2||7
483570|NCT01105936|1185269|P4|STARTED|Period 2||7
483571|NCT01105936|1185270|P3|STARTED|Period 2||7
483572|NCT01105936|1185271|P2|STARTED|Period 2||8
483573|NCT01105936|1185272|P1|STARTED|Period 2||8
483574|NCT01105936|1185269|P4|NOT COMPLETED|Wash-out Period 1||0
483575|NCT01105936|1185270|P3|NOT COMPLETED|Wash-out Period 1||0
483576|NCT01105936|1185271|P2|NOT COMPLETED|Wash-out Period 1||0
483577|NCT01105936|1185272|P1|NOT COMPLETED|Wash-out Period 1||0
483578|NCT01105936|1185269|P4|COMPLETED|Wash-out Period 1||7
483579|NCT01105936|1185270|P3|COMPLETED|Wash-out Period 1||7
483580|NCT01105936|1185271|P2|COMPLETED|Wash-out Period 1||8
483581|NCT01105936|1185272|P1|COMPLETED|Wash-out Period 1||8
483582|NCT01105936|1185269|P4|STARTED|Wash-out Period 1||7
483583|NCT01105936|1185270|P3|STARTED|Wash-out Period 1||7
483584|NCT01105936|1185271|P2|STARTED|Wash-out Period 1||8
483585|NCT01105936|1185272|P1|STARTED|Wash-out Period 1||8
483586|NCT01105936|1185269|P4|NOT COMPLETED|Period 1||1
483587|NCT01105936|1185270|P3|NOT COMPLETED|Period 1||0
483588|NCT01105936|1185271|P2|NOT COMPLETED|Period 1||0
483589|NCT01105936|1185272|P1|NOT COMPLETED|Period 1||0
483590|NCT01105936|1185269|P4|COMPLETED|Period 1||7
483591|NCT01105936|1185270|P3|COMPLETED|Period 1||7
483592|NCT01105936|1185271|P2|COMPLETED|Period 1||8
483593|NCT01105936|1185272|P1|COMPLETED|Period 1||8
483594|NCT01105936|1185269|P4|STARTED|Period 1||8
483595|NCT01105936|1185270|P3|STARTED|Period 1||7
483596|NCT01105936|1185271|P2|STARTED|Period 1||8
483597|NCT01105936|1185272|P1|STARTED|Period 1||8
483598|NCT01105767|1185301|P3|NOT COMPLETED|Overall Study||1184
483599|NCT01105767|1185302|P2|NOT COMPLETED|Overall Study||1614
483600|NCT01105767|1185303|P1|NOT COMPLETED|Overall Study||1160
483601|NCT01105767|1185301|P3|COMPLETED|Overall Study||8846
483602|NCT01105767|1185302|P2|COMPLETED|Overall Study||9250
483603|NCT01105767|1185303|P1|COMPLETED|Overall Study||8155
483604|NCT01105767|1185301|P3|STARTED|Overall Study||10030
483605|NCT01105767|1185302|P2|STARTED|Overall Study||10864
483606|NCT01105767|1185303|P1|STARTED|Overall Study||9315
483607|NCT01105754|1185316|P2|NOT COMPLETED|Overall Study||12
483608|NCT01105754|1185317|P1|NOT COMPLETED|Overall Study||15
483609|NCT01105754|1185316|P2|COMPLETED|Overall Study||307
483610|NCT01105754|1185317|P1|COMPLETED|Overall Study||304
483611|NCT01105754|1185316|P2|STARTED|Overall Study||319
483612|NCT01105754|1185317|P1|STARTED|Overall Study||319
483613|NCT01105702|1185325|P1|NOT COMPLETED|Overall Study||18
483614|NCT01105702|1185325|P1|COMPLETED|Overall Study||10
483615|NCT01105702|1185325|P1|STARTED|Overall Study||28
483616|NCT01105650|1185335|P4|NOT COMPLETED|Overall Study||0
483617|NCT01105650|1185336|P3|NOT COMPLETED|Overall Study||0
483618|NCT01105650|1185337|P2|NOT COMPLETED|Overall Study||0
483619|NCT01105650|1185338|P1|NOT COMPLETED|Overall Study||0
483620|NCT01105650|1185335|P4|COMPLETED|Overall Study||0
483621|NCT01105650|1185336|P3|COMPLETED|Overall Study||7
483622|NCT01105650|1185337|P2|COMPLETED|Overall Study||3
483623|NCT01105650|1185338|P1|COMPLETED|Overall Study||3
483624|NCT01105650|1185335|P4|STARTED|Overall Study|Arm 3 was determined to be successful, thus eliminating the need to test Arm 4.|0
483625|NCT01105650|1185336|P3|STARTED|Overall Study||7
483626|NCT01105650|1185337|P2|STARTED|Overall Study||3
483627|NCT01105650|1185338|P1|STARTED|Overall Study||3
483628|NCT01105533|1185355|P9|NOT COMPLETED|Overall Study||12
483629|NCT01105533|1185356|P8|NOT COMPLETED|Overall Study||4
483630|NCT01105533|1185357|P7|NOT COMPLETED|Overall Study||8
483631|NCT01105533|1185358|P6|NOT COMPLETED|Overall Study||7
483632|NCT01105533|1185359|P5|NOT COMPLETED|Overall Study||7
483633|NCT01105533|1185360|P4|NOT COMPLETED|Overall Study||3
483634|NCT01105533|1185361|P3|NOT COMPLETED|Overall Study||3
483635|NCT01105533|1185362|P2|NOT COMPLETED|Overall Study||1
483636|NCT01105533|1185363|P1|NOT COMPLETED|Overall Study||1
483637|NCT01105533|1185355|P9|COMPLETED|Overall Study||0
483638|NCT01105533|1185356|P8|COMPLETED|Overall Study||0
483639|NCT01105533|1185357|P7|COMPLETED|Overall Study||0
483640|NCT01105533|1185358|P6|COMPLETED|Overall Study||0
483641|NCT01105533|1185359|P5|COMPLETED|Overall Study||0
483642|NCT01105533|1185360|P4|COMPLETED|Overall Study||0
483643|NCT01105533|1185361|P3|COMPLETED|Overall Study||0
483644|NCT01105533|1185362|P2|COMPLETED|Overall Study||0
483645|NCT01105533|1185363|P1|COMPLETED|Overall Study||0
483646|NCT01105533|1185355|P9|STARTED|Overall Study||12
483647|NCT01105533|1185356|P8|STARTED|Overall Study||4
483648|NCT01105533|1185357|P7|STARTED|Overall Study||8
483649|NCT01105533|1185358|P6|STARTED|Overall Study||7
483650|NCT01105533|1185359|P5|STARTED|Overall Study||7
483651|NCT01105533|1185360|P4|STARTED|Overall Study||3
483652|NCT01105533|1185361|P3|STARTED|Overall Study||3
483653|NCT01105533|1185362|P2|STARTED|Overall Study||1
483654|NCT01105533|1185363|P1|STARTED|Overall Study||1
483655|NCT01105377|1185453|P2|NOT COMPLETED|Overall Study||1
483656|NCT01105377|1185454|P1|NOT COMPLETED|Overall Study||0
483657|NCT01105377|1185453|P2|COMPLETED|Overall Study||22
483658|NCT01105377|1185454|P1|COMPLETED|Overall Study||24
483659|NCT01105377|1185453|P2|STARTED|Overall Study||23
483660|NCT01105377|1185454|P1|STARTED|Overall Study||24
483661|NCT01105312|1185465|P3|NOT COMPLETED|Overall Study||0
483662|NCT01105312|1185466|P2|NOT COMPLETED|Overall Study||0
483663|NCT01105312|1185467|P1|NOT COMPLETED|Overall Study||3
483664|NCT01105312|1185465|P3|COMPLETED|Overall Study||6
483665|NCT01105312|1185466|P2|COMPLETED|Overall Study||6
483666|NCT01105312|1185467|P1|COMPLETED|Overall Study||13
483667|NCT01105312|1185465|P3|STARTED|Overall Study||6
483668|NCT01105312|1185466|P2|STARTED|Overall Study||6
483669|NCT01105312|1185467|P1|STARTED|Overall Study||16
483670|NCT01105247|1185485|P2|NOT COMPLETED|Overall Study||0
483671|NCT01105247|1185486|P1|NOT COMPLETED|Overall Study||37
483672|NCT01105247|1185485|P2|COMPLETED|Overall Study||16
483673|NCT01105247|1185486|P1|COMPLETED|Overall Study||79
483674|NCT01105247|1185485|P2|STARTED|Overall Study||16
483675|NCT01105247|1185486|P1|STARTED|Overall Study||116
483676|NCT01105130|1185502|P3|NOT COMPLETED|Overall Study||10
483677|NCT01105130|1185503|P2|NOT COMPLETED|Overall Study||11
483678|NCT01105130|1185504|P1|NOT COMPLETED|Overall Study||10
483679|NCT01105130|1185502|P3|COMPLETED|Overall Study||37
483680|NCT01105130|1185503|P2|COMPLETED|Overall Study||34
483681|NCT01105130|1185504|P1|COMPLETED|Overall Study||38
483682|NCT01105130|1185502|P3|STARTED|Overall Study||47
483683|NCT01105130|1185503|P2|STARTED|Overall Study||45
483684|NCT01105130|1185504|P1|STARTED|Overall Study||48
483685|NCT01105117|1185523|P2|NOT COMPLETED|Overall Study||0
483686|NCT01105117|1185524|P1|NOT COMPLETED|Overall Study||0
483687|NCT01105117|1185523|P2|COMPLETED|Overall Study||1
483688|NCT01105117|1185524|P1|COMPLETED|Overall Study||1
483689|NCT01105117|1185523|P2|STARTED|Overall Study||1
483690|NCT01105117|1185524|P1|STARTED|Overall Study||1
483691|NCT01105091|1185534|P2|NOT COMPLETED|Overall Study||0
483692|NCT01105091|1185535|P1|NOT COMPLETED|Overall Study||2
483693|NCT01105091|1185534|P2|COMPLETED|Overall Study||10
483694|NCT01105091|1185535|P1|COMPLETED|Overall Study||18
483695|NCT01105091|1185534|P2|STARTED|Overall Study||10
483696|NCT01105091|1185535|P1|STARTED|Overall Study||20
483697|NCT01105065|1185559|P1|NOT COMPLETED|Overall Study||6
483698|NCT01105065|1185559|P1|COMPLETED|Overall Study||17
483699|NCT01105065|1185559|P1|STARTED|Overall Study||23
483700|NCT01104870|1185568|P3|NOT COMPLETED|Overall Study||2
483701|NCT01104870|1185569|P2|NOT COMPLETED|Overall Study||1
483702|NCT01104870|1185570|P1|NOT COMPLETED|Overall Study||1
483703|NCT01104870|1185568|P3|COMPLETED|Overall Study||18
483704|NCT01104870|1185569|P2|COMPLETED|Overall Study||18
483705|NCT01104870|1185570|P1|COMPLETED|Overall Study||10
483706|NCT01104870|1185568|P3|STARTED|Overall Study||20
483707|NCT01104870|1185569|P2|STARTED|Overall Study||19
483708|NCT01104870|1185570|P1|STARTED|Overall Study||11
483709|NCT01104701|1185603|P4|NOT COMPLETED|Overall Study||2
483710|NCT01104701|1185604|P3|NOT COMPLETED|Overall Study||2
483711|NCT01104701|1185605|P2|NOT COMPLETED|Overall Study||3
483712|NCT01104701|1185606|P1|NOT COMPLETED|Overall Study||0
483713|NCT01104701|1185603|P4|COMPLETED|Overall Study||28
483714|NCT01104701|1185604|P3|COMPLETED|Overall Study||29
483715|NCT01104701|1185605|P2|COMPLETED|Overall Study||27
483716|NCT01104701|1185606|P1|COMPLETED|Overall Study||30
483717|NCT01104701|1185603|P4|STARTED|Overall Study||30
483718|NCT01104701|1185604|P3|STARTED|Overall Study||31
483719|NCT01104701|1185605|P2|STARTED|Overall Study||30
483720|NCT01104701|1185606|P1|STARTED|Overall Study||30
483721|NCT01104662|1185668|P8|NOT COMPLETED|Overall Study||0
483722|NCT01104662|1185669|P7|NOT COMPLETED|Overall Study||0
483723|NCT01104662|1185670|P6|NOT COMPLETED|Overall Study||4
483724|NCT01104662|1185671|P5|NOT COMPLETED|Overall Study||1
483725|NCT01104662|1185672|P4|NOT COMPLETED|Overall Study||1
483726|NCT01104662|1185673|P3|NOT COMPLETED|Overall Study||1
483727|NCT01104662|1185674|P2|NOT COMPLETED|Overall Study||10
483728|NCT01104662|1185675|P1|NOT COMPLETED|Overall Study||10
483729|NCT01104662|1185668|P8|COMPLETED|Overall Study||6
483730|NCT01104662|1185669|P7|COMPLETED|Overall Study||5
483731|NCT01104662|1185670|P6|COMPLETED|Overall Study||12
483732|NCT01104662|1185671|P5|COMPLETED|Overall Study||14
483733|NCT01104662|1185672|P4|COMPLETED|Overall Study||3
483734|NCT01104662|1185673|P3|COMPLETED|Overall Study||4
483735|NCT01104662|1185674|P2|COMPLETED|Overall Study||11
483736|NCT01104662|1185675|P1|COMPLETED|Overall Study||10
483737|NCT01104662|1185668|P8|Received at Least 1 Dose of Study Drug|Overall Study||6
483738|NCT01104662|1185669|P7|Received at Least 1 Dose of Study Drug|Overall Study||5
483739|NCT01104662|1185670|P6|Received at Least 1 Dose of Study Drug|Overall Study||15
483740|NCT01104662|1185671|P5|Received at Least 1 Dose of Study Drug|Overall Study||15
483741|NCT01104662|1185672|P4|Received at Least 1 Dose of Study Drug|Overall Study||4
483742|NCT01104662|1185673|P3|Received at Least 1 Dose of Study Drug|Overall Study||4
483743|NCT01104662|1185674|P2|Received at Least 1 Dose of Study Drug|Overall Study||17
483744|NCT01104662|1185675|P1|Received at Least 1 Dose of Study Drug|Overall Study||17
483745|NCT01104662|1185668|P8|STARTED|Overall Study||6
483746|NCT01104662|1185669|P7|STARTED|Overall Study||5
483747|NCT01104662|1185670|P6|STARTED|Overall Study||16
483748|NCT01104662|1185671|P5|STARTED|Overall Study||15
483749|NCT01104662|1185672|P4|STARTED|Overall Study||4
483750|NCT01104662|1185673|P3|STARTED|Overall Study||5
483751|NCT01104662|1185674|P2|STARTED|Overall Study||21
483752|NCT01104662|1185675|P1|STARTED|Overall Study||20
483753|NCT01104636|1185701|P1|NOT COMPLETED|Overall Study||178
483754|NCT01104636|1185701|P1|COMPLETED|Overall Study||999
483755|NCT01104636|1185701|P1|STARTED|Overall Study||1177
483756|NCT01104584|1185706|P1|NOT COMPLETED|Overall Study||23
483757|NCT01104584|1185706|P1|COMPLETED|Overall Study|study course completed|437
483758|NCT01104584|1185706|P1|Fulfilled Requirements of FAS Population|Overall Study||397
483759|NCT01104584|1185706|P1|Received Treatment|Overall Study|treatment started|439
483760|NCT01104584|1185706|P1|STARTED|Overall Study|screened and enrolled|460
483761|NCT01104558|1185776|P1|NOT COMPLETED|Overall Study||17
483762|NCT01104558|1185776|P1|COMPLETED|Overall Study||83
483763|NCT01104558|1185776|P1|STARTED|Overall Study||100
483764|NCT01104493|1185819|P2|NOT COMPLETED|Overall Study||2
483765|NCT01104493|1185820|P1|NOT COMPLETED|Overall Study||0
483766|NCT01104493|1185819|P2|COMPLETED|Overall Study||58
483767|NCT01104493|1185820|P1|COMPLETED|Overall Study||240
483768|NCT01104493|1185819|P2|STARTED|Overall Study||60
483769|NCT01104493|1185820|P1|STARTED|Overall Study||240
483770|NCT01104415|1185838|P1|NOT COMPLETED|Overall Study||1
483771|NCT01104415|1185838|P1|COMPLETED|Overall Study||14
483772|NCT01104415|1185838|P1|STARTED|Overall Study||15
483773|NCT01104402|1185862|P2|NOT COMPLETED|Overall Study||33
483774|NCT01104402|1185863|P1|NOT COMPLETED|Overall Study||21
483775|NCT01104402|1185862|P2|COMPLETED|Overall Study||102
483776|NCT01104402|1185863|P1|COMPLETED|Overall Study||111
483777|NCT01104402|1185862|P2|STARTED|Overall Study||135
483778|NCT01104402|1185863|P1|STARTED|Overall Study||132
483779|NCT01104376|1185881|P1|NOT COMPLETED|Overall Study||28
483780|NCT01104376|1185881|P1|COMPLETED|Overall Study||61
483781|NCT01104376|1185881|P1|STARTED|Overall Study||89
483782|NCT01104311|1185887|P2|NOT COMPLETED|Overall Study||12
483783|NCT01104311|1185888|P1|NOT COMPLETED|Overall Study||10
483784|NCT01104311|1185887|P2|COMPLETED|Overall Study||54
483785|NCT01104311|1185888|P1|COMPLETED|Overall Study||56
483786|NCT01104311|1185887|P2|STARTED|Overall Study||66
483787|NCT01104311|1185888|P1|STARTED|Overall Study||66
483788|NCT01104285|1185908|P2|NOT COMPLETED|Overall Study||0
483789|NCT01104285|1185909|P1|NOT COMPLETED|Overall Study||0
483790|NCT01104285|1185908|P2|COMPLETED|Overall Study||86
483791|NCT01104285|1185909|P1|COMPLETED|Overall Study||112
483792|NCT01104285|1185908|P2|STARTED|Overall Study||86
483793|NCT01104285|1185909|P1|STARTED|Overall Study||112
483794|NCT01104246|1185915|P1|NOT COMPLETED|Overall Study||5
483795|NCT01104246|1185915|P1|COMPLETED|Overall Study||35
483796|NCT01104246|1185915|P1|Baseline Characteristics Measured|Overall Study||35
483797|NCT01104246|1185915|P1|STARTED|Overall Study||40
483798|NCT01104207|1185921|P2|NOT COMPLETED|Overall Study||3
483799|NCT01104207|1185922|P1|NOT COMPLETED|Overall Study||3
483800|NCT01104207|1185921|P2|COMPLETED|Overall Study||32
483801|NCT01104207|1185922|P1|COMPLETED|Overall Study||32
483802|NCT01104207|1185921|P2|STARTED|Overall Study||35
483803|NCT01104207|1185922|P1|STARTED|Overall Study||35
483804|NCT01104155|1185930|P2|NOT COMPLETED|Overall Study||18
483805|NCT01104155|1185931|P1|NOT COMPLETED|Overall Study||25
483806|NCT01104155|1185930|P2|COMPLETED|Overall Study||42
483807|NCT01104155|1185931|P1|COMPLETED|Overall Study||38
483808|NCT01104155|1185930|P2|STARTED|Overall Study||60
483809|NCT01104155|1185931|P1|STARTED|Overall Study||63
483810|NCT01104116|1185945|P1|NOT COMPLETED|Overall Study||0
483811|NCT01104116|1185945|P1|COMPLETED|Overall Study||1
483812|NCT01104116|1185945|P1|STARTED|Overall Study||1
483813|NCT01104103|1185952|P2|NOT COMPLETED|Overall Study||0
483814|NCT01104103|1185953|P1|NOT COMPLETED|Overall Study||0
483815|NCT01104103|1185952|P2|COMPLETED|Overall Study||224
483816|NCT01104103|1185953|P1|COMPLETED|Overall Study||243
483817|NCT01104103|1185952|P2|STARTED|Overall Study||224
483818|NCT01104103|1185953|P1|STARTED|Overall Study||243
483819|NCT01103973|1185963|P2|NOT COMPLETED|Overall Study||0
483820|NCT01103973|1185964|P1|NOT COMPLETED|Overall Study||0
483821|NCT01103973|1185963|P2|COMPLETED|Overall Study||46
483822|NCT01103973|1185964|P1|COMPLETED|Overall Study||51
483823|NCT01103973|1185963|P2|STARTED|Overall Study||46
483824|NCT01103973|1185964|P1|STARTED|Overall Study||51
483825|NCT01103960|1185974|P2|NOT COMPLETED|Overall Study||2
483826|NCT01103960|1185975|P1|NOT COMPLETED|Overall Study||5
483827|NCT01103960|1185974|P2|COMPLETED|Overall Study|Completed study medication.|158
483828|NCT01103960|1185975|P1|COMPLETED|Overall Study|Completed study medication.|159
483829|NCT01103960|1185974|P2|STARTED|Overall Study|Randomised and treated.|160
483830|NCT01103960|1185975|P1|STARTED|Overall Study|Randomised and treated.|164
483831|NCT01103934|1186001|P2|NOT COMPLETED|Overall Study||0
483832|NCT01103934|1186002|P1|NOT COMPLETED|Overall Study||0
483833|NCT01103934|1186001|P2|COMPLETED|Overall Study||18
483834|NCT01103934|1186002|P1|COMPLETED|Overall Study||17
483835|NCT01103934|1186001|P2|STARTED|Overall Study||18
483836|NCT01103934|1186002|P1|STARTED|Overall Study||17
483837|NCT01103713|1186010|P1|NOT COMPLETED|Overall Study||13
483838|NCT01103713|1186010|P1|COMPLETED|Overall Study||155
483839|NCT01103713|1186010|P1|STARTED|Overall Study||168
483840|NCT01103492|1186036|P1|NOT COMPLETED|Overall Study||0
483841|NCT01103492|1186036|P1|COMPLETED|Overall Study||1
483842|NCT01103492|1186036|P1|STARTED|Overall Study||1
483843|NCT01103479|1186043|P3|NOT COMPLETED|Overall Study||14
483844|NCT01103479|1186044|P2|NOT COMPLETED|Overall Study||9
483845|NCT01103479|1186045|P1|NOT COMPLETED|Overall Study||5
483846|NCT01103479|1186043|P3|COMPLETED|Overall Study||174
483847|NCT01103479|1186044|P2|COMPLETED|Overall Study||201
483848|NCT01103479|1186045|P1|COMPLETED|Overall Study||163
483849|NCT01103479|1186043|P3|STARTED|Overall Study||188
483850|NCT01103479|1186044|P2|STARTED|Overall Study||210
483851|NCT01103479|1186045|P1|STARTED|Overall Study||168
483852|NCT01103466|1186058|P3|NOT COMPLETED|Third Period (14 +/- 3 Days)||1
483853|NCT01103466|1186059|P2|NOT COMPLETED|Third Period (14 +/- 3 Days)||0
483854|NCT01103466|1186060|P1|NOT COMPLETED|Third Period (14 +/- 3 Days)||2
483855|NCT01103466|1186058|P3|COMPLETED|Third Period (14 +/- 3 Days)||13
483856|NCT01103466|1186059|P2|COMPLETED|Third Period (14 +/- 3 Days)||8
483857|NCT01103466|1186060|P1|COMPLETED|Third Period (14 +/- 3 Days)||6
483858|NCT01103466|1186058|P3|STARTED|Third Period (14 +/- 3 Days)||14
483859|NCT01103466|1186059|P2|STARTED|Third Period (14 +/- 3 Days)||8
483860|NCT01103466|1186060|P1|STARTED|Third Period (14 +/- 3 Days)||8
483861|NCT01103466|1186058|P3|NOT COMPLETED|Second Period (14 +/- 3 Days)||1
483862|NCT01103466|1186059|P2|NOT COMPLETED|Second Period (14 +/- 3 Days)||2
483863|NCT01103466|1186060|P1|NOT COMPLETED|Second Period (14 +/- 3 Days)||2
483864|NCT01103466|1186058|P3|COMPLETED|Second Period (14 +/- 3 Days)||6
483865|NCT01103466|1186059|P2|COMPLETED|Second Period (14 +/- 3 Days)||11
483866|NCT01103466|1186060|P1|COMPLETED|Second Period (14 +/- 3 Days)||13
483867|NCT01103466|1186058|P3|STARTED|Second Period (14 +/- 3 Days)||7
483868|NCT01103466|1186059|P2|STARTED|Second Period (14 +/- 3 Days)||13
483869|NCT01103466|1186060|P1|STARTED|Second Period (14 +/- 3 Days)||15
483870|NCT01103466|1186058|P3|NOT COMPLETED|First Period (14 +/- 3 Days)||0
483871|NCT01103466|1186059|P2|NOT COMPLETED|First Period (14 +/- 3 Days)||0
483872|NCT01103466|1186060|P1|NOT COMPLETED|First Period (14 +/- 3 Days)||2
483873|NCT01103466|1186058|P3|COMPLETED|First Period (14 +/- 3 Days)||13
483874|NCT01103466|1186059|P2|COMPLETED|First Period (14 +/- 3 Days)||12
483875|NCT01103466|1186060|P1|COMPLETED|First Period (14 +/- 3 Days)||10
483876|NCT01103466|1186058|P3|STARTED|First Period (14 +/- 3 Days)||13
483877|NCT01103466|1186059|P2|STARTED|First Period (14 +/- 3 Days)||12
483878|NCT01103466|1186060|P1|STARTED|First Period (14 +/- 3 Days)||12
483879|NCT01103440|1186070|P2|NOT COMPLETED|Overall Study||0
483880|NCT01103440|1186071|P1|NOT COMPLETED|Overall Study||0
483881|NCT01103440|1186070|P2|COMPLETED|Overall Study||18
483882|NCT01103440|1186071|P1|COMPLETED|Overall Study||18
483883|NCT01103440|1186070|P2|STARTED|Overall Study||18
483884|NCT01103440|1186071|P1|STARTED|Overall Study||18
483885|NCT01103414|1186084|P5|NOT COMPLETED|Overall Study||15
483886|NCT01103414|1186085|P4|NOT COMPLETED|Overall Study||7
483887|NCT01103414|1186086|P3|NOT COMPLETED|Overall Study||15
483888|NCT01103414|1186087|P2|NOT COMPLETED|Overall Study||9
483889|NCT01103414|1186088|P1|NOT COMPLETED|Overall Study||13
483890|NCT01103414|1186084|P5|COMPLETED|Overall Study||56
483891|NCT01103414|1186085|P4|COMPLETED|Overall Study||64
483892|NCT01103414|1186086|P3|COMPLETED|Overall Study||56
483893|NCT01103414|1186087|P2|COMPLETED|Overall Study||62
483894|NCT01103414|1186088|P1|COMPLETED|Overall Study||59
483895|NCT01103414|1186084|P5|STARTED|Overall Study||71
483896|NCT01103414|1186085|P4|STARTED|Overall Study||71
483897|NCT01103414|1186086|P3|STARTED|Overall Study||71
483898|NCT01103414|1186087|P2|STARTED|Overall Study||71
483899|NCT01103414|1186088|P1|STARTED|Overall Study||72
483900|NCT01103362|1186150|P1|NOT COMPLETED|Overall Study||596
483901|NCT01103362|1186150|P1|COMPLETED|Overall Study||0
483902|NCT01103362|1186150|P1|STARTED|Overall Study||596
483903|NCT01103323|1186156|P2|NOT COMPLETED|Switched From Placebo to Regorafenib||1
483904|NCT01103323|1186157|P1|NOT COMPLETED|Switched From Placebo to Regorafenib||0
483905|NCT01103323|1186156|P2|COMPLETED|Switched From Placebo to Regorafenib||3
483906|NCT01103323|1186157|P1|COMPLETED|Switched From Placebo to Regorafenib||0
483907|NCT01103323|1186156|P2|STARTED|Switched From Placebo to Regorafenib|Participants in the placebo+BSC group switched to Regorafenib treatment after unblinding.|4
483908|NCT01103323|1186157|P1|STARTED|Switched From Placebo to Regorafenib||0
483909|NCT01103323|1186156|P2|NOT COMPLETED|Without/Before Drug Switch||18
483910|NCT01103323|1186157|P1|NOT COMPLETED|Without/Before Drug Switch||76
483911|NCT01103323|1186156|P2|COMPLETED|Without/Before Drug Switch||237
483912|NCT01103323|1186157|P1|COMPLETED|Without/Before Drug Switch||429
483913|NCT01103323|1186156|P2|Participants Received Treatment|Without/Before Drug Switch||253
483914|NCT01103323|1186157|P1|Participants Received Treatment|Without/Before Drug Switch||500
483915|NCT01103323|1186156|P2|STARTED|Without/Before Drug Switch||255
483916|NCT01103323|1186157|P1|STARTED|Without/Before Drug Switch||505
483917|NCT01103284|1186174|P2|NOT COMPLETED|Overall Study||44
483918|NCT01103284|1186175|P1|NOT COMPLETED|Overall Study||42
483919|NCT01103284|1186174|P2|COMPLETED|Overall Study||195
483920|NCT01103284|1186175|P1|COMPLETED|Overall Study||194
483921|NCT01103284|1186174|P2|At Least One Post-baseline Visit (FAS)|Overall Study|Patients reaching this milestone were included in the Full Analysis Set (FAS)|235
483922|NCT01103284|1186175|P1|At Least One Post-baseline Visit (FAS)|Overall Study|Patients reaching this milestone were included in the Full Analysis Set (FAS) population|233
483923|NCT01103284|1186174|P2|Treated|Overall Study||238
483924|NCT01103284|1186175|P1|Treated|Overall Study||236
483925|NCT01103284|1186174|P2|STARTED|Overall Study||239
483926|NCT01103284|1186175|P1|STARTED|Overall Study||236
483927|NCT01103271|1186191|P2|NOT COMPLETED|Overall Study||4
483928|NCT01103271|1186192|P1|NOT COMPLETED|Overall Study||1
483929|NCT01103271|1186191|P2|COMPLETED|Overall Study||5
483930|NCT01103271|1186192|P1|COMPLETED|Overall Study||10
483931|NCT01103271|1186191|P2|STARTED|Overall Study||9
483932|NCT01103271|1186192|P1|STARTED|Overall Study||11
483933|NCT01103232|1186201|P2|NOT COMPLETED|Overall Study||2
483934|NCT01103232|1186202|P1|NOT COMPLETED|Overall Study||1
483935|NCT01103232|1186201|P2|COMPLETED|Overall Study||11
483936|NCT01103232|1186202|P1|COMPLETED|Overall Study||12
483937|NCT01103232|1186201|P2|STARTED|Overall Study||13
483938|NCT01103232|1186202|P1|STARTED|Overall Study||13
483939|NCT01103141|1186210|P2|NOT COMPLETED|Overall Study||2
483940|NCT01103141|1186211|P1|NOT COMPLETED|Overall Study||2
483941|NCT01103141|1186210|P2|COMPLETED|Overall Study||74
483942|NCT01103141|1186211|P1|COMPLETED|Overall Study||65
483943|NCT01103141|1186210|P2|STARTED|Overall Study||76
483944|NCT01103141|1186211|P1|STARTED|Overall Study||67
483945|NCT01103063|1186219|P2|NOT COMPLETED|Overall Study||421
483946|NCT01103063|1186220|P1|NOT COMPLETED|Overall Study||477
483947|NCT01103063|1186219|P2|COMPLETED|Overall Study||1024
483948|NCT01103063|1186220|P1|COMPLETED|Overall Study||969
483949|NCT01103063|1186219|P2|STARTED|Overall Study||1445
483950|NCT01103063|1186220|P1|STARTED|Overall Study||1446
483951|NCT01102972|1186288|P2|NOT COMPLETED|Overall Study||14
483952|NCT01102972|1186289|P1|NOT COMPLETED|Overall Study||29
483953|NCT01102972|1186288|P2|COMPLETED|Overall Study|These participants completed Study Week 48.|83
483954|NCT01102972|1186289|P1|COMPLETED|Overall Study|These participants completed Study Week 48.|170
483955|NCT01102972|1186288|P2|Completed Week 24|Overall Study||88
483956|NCT01102972|1186289|P1|Completed Week 24|Overall Study||180
483957|NCT01102972|1186288|P2|STARTED|Overall Study|297 PAR enrolled. 1 PAR withdrew before taking investigational product and didn’t “start” the study.|97
483958|NCT01102972|1186289|P1|STARTED|Overall Study|297 PAR enrolled. 1 PAR withdrew before taking investigational product and didn’t “start” the study.|199
483959|NCT01102894|1186341|P1|NOT COMPLETED|Overall Study||0
483960|NCT01102894|1186341|P1|COMPLETED|Overall Study||10
483961|NCT01102894|1186341|P1|STARTED|Overall Study||10
483962|NCT01102803|1186353|P2|NOT COMPLETED|Post to Follow-Up||3
483963|NCT01102803|1186354|P1|NOT COMPLETED|Post to Follow-Up||1
483964|NCT01102803|1186353|P2|COMPLETED|Post to Follow-Up||12
483965|NCT01102803|1186354|P1|COMPLETED|Post to Follow-Up||10
483966|NCT01102803|1186353|P2|STARTED|Post to Follow-Up||15
483967|NCT01102803|1186354|P1|STARTED|Post to Follow-Up||11
483968|NCT01102803|1186353|P2|NOT COMPLETED|Baseline to Post-Treatment||0
483969|NCT01102803|1186354|P1|NOT COMPLETED|Baseline to Post-Treatment||3
483970|NCT01102803|1186353|P2|COMPLETED|Baseline to Post-Treatment||15
483971|NCT01102803|1186354|P1|COMPLETED|Baseline to Post-Treatment||11
483972|NCT01102803|1186353|P2|STARTED|Baseline to Post-Treatment||15
483973|NCT01102803|1186354|P1|STARTED|Baseline to Post-Treatment||14
483974|NCT01102777|1186368|P2|NOT COMPLETED|Overall Study||16
483975|NCT01102777|1186369|P1|NOT COMPLETED|Overall Study||9
483976|NCT01102777|1186368|P2|COMPLETED|Overall Study||139
483977|NCT01102777|1186369|P1|COMPLETED|Overall Study||75
483978|NCT01102777|1186368|P2|STARTED|Overall Study||155
483979|NCT01102777|1186369|P1|STARTED|Overall Study||84
483980|NCT01102764|1186395|P2|NOT COMPLETED|Overall Study||13
483981|NCT01102764|1186396|P1|NOT COMPLETED|Overall Study||21
483982|NCT01102764|1186395|P2|COMPLETED|Overall Study||55
483983|NCT01102764|1186396|P1|COMPLETED|Overall Study||43
483984|NCT01102764|1186395|P2|STARTED|Overall Study||68
483985|NCT01102764|1186396|P1|STARTED|Overall Study||64
483986|NCT01102491|1186408|P2|NOT COMPLETED|Overall Study||12
483987|NCT01102491|1186409|P1|NOT COMPLETED|Overall Study||11
483988|NCT01102491|1186408|P2|COMPLETED|Overall Study|12 patients were excluded|59
483989|NCT01102491|1186409|P1|COMPLETED|Overall Study|11 patient excluded|60
483990|NCT01102491|1186408|P2|STARTED|Overall Study||71
483991|NCT01102491|1186409|P1|STARTED|Overall Study||71
483992|NCT01102413|1186417|P2|NOT COMPLETED|Overall Study||12
483993|NCT01102413|1186418|P1|NOT COMPLETED|Overall Study||25
483994|NCT01102413|1186417|P2|COMPLETED|Overall Study||106
483995|NCT01102413|1186418|P1|COMPLETED|Overall Study||208
483996|NCT01102413|1186417|P2|STARTED|Overall Study||118
483997|NCT01102413|1186418|P1|STARTED|Overall Study||233
483998|NCT01102374|1186428|P2|NOT COMPLETED|Overall Study||19
483999|NCT01102374|1186429|P1|NOT COMPLETED|Overall Study||16
484000|NCT01102374|1186428|P2|COMPLETED|Overall Study||33
484001|NCT01102374|1186429|P1|COMPLETED|Overall Study||39
484002|NCT01102374|1186428|P2|STARTED|Overall Study||52
484003|NCT01102374|1186429|P1|STARTED|Overall Study||55
484004|NCT01102270|1186463|P2|NOT COMPLETED|Overall Study||0
484005|NCT01102270|1186464|P1|NOT COMPLETED|Overall Study||0
484006|NCT01102270|1186463|P2|COMPLETED|Overall Study||9
484007|NCT01102270|1186464|P1|COMPLETED|Overall Study||8
484008|NCT01102270|1186463|P2|STARTED|Overall Study||9
484009|NCT01102270|1186464|P1|STARTED|Overall Study||8
484010|NCT01102257|1186478|P2|NOT COMPLETED|Overall Study||0
484011|NCT01102257|1186479|P1|NOT COMPLETED|Overall Study||2
484012|NCT01102257|1186478|P2|COMPLETED|Overall Study||9
484013|NCT01102257|1186479|P1|COMPLETED|Overall Study|2 withdrew from the study d/t adverse events. 1 had shortness of breath and the other had chest pain|7
484014|NCT01102257|1186478|P2|STARTED|Overall Study||9
484015|NCT01102257|1186479|P1|STARTED|Overall Study||9
484016|NCT01102218|1186487|P2|NOT COMPLETED|Overall Study||10
484017|NCT01102218|1186488|P1|NOT COMPLETED|Overall Study||11
484018|NCT01102218|1186487|P2|COMPLETED|Overall Study||14
484019|NCT01102218|1186488|P1|COMPLETED|Overall Study||13
484020|NCT01102218|1186487|P2|STARTED|Overall Study||24
484021|NCT01102218|1186488|P1|STARTED|Overall Study||24
484022|NCT01102140|1186496|P2|NOT COMPLETED|Overall Study||2
484023|NCT01102140|1186497|P1|NOT COMPLETED|Overall Study||3
484024|NCT01102140|1186496|P2|COMPLETED|Overall Study||5
484025|NCT01102140|1186497|P1|COMPLETED|Overall Study||10
484026|NCT01102140|1186496|P2|STARTED|Overall Study||7
484027|NCT01102140|1186497|P1|STARTED|Overall Study||13
484028|NCT01101971|1186509|P1|NOT COMPLETED|Overall Study||0
484029|NCT01101971|1186509|P1|COMPLETED|Overall Study||45
484030|NCT01101971|1186509|P1|STARTED|Overall Study||45
484031|NCT01101958|1186515|P2|NOT COMPLETED|Overall Study||5
484032|NCT01101958|1186516|P1|NOT COMPLETED|Overall Study||11
484033|NCT01101958|1186515|P2|COMPLETED|Overall Study||29
484034|NCT01101958|1186516|P1|COMPLETED|Overall Study||51
484035|NCT01101958|1186515|P2|STARTED|Overall Study||34
484036|NCT01101958|1186516|P1|STARTED|Overall Study||62
484037|NCT01101880|1186522|P1|NOT COMPLETED|Overall Study||0
484038|NCT01101880|1186522|P1|COMPLETED|Overall Study||50
484039|NCT01101880|1186522|P1|STARTED|Overall Study||50
484040|NCT01101867|1186533|P2|NOT COMPLETED|Overall Study||4
484041|NCT01101867|1186534|P1|NOT COMPLETED|Overall Study||1
484042|NCT01101867|1186533|P2|COMPLETED|Overall Study||59
484043|NCT01101867|1186534|P1|COMPLETED|Overall Study||62
484044|NCT01101867|1186533|P2|STARTED|Overall Study||63
484045|NCT01101867|1186534|P1|STARTED|Overall Study||63
484046|NCT01101841|1186552|P2|NOT COMPLETED|Overall Study||67
484047|NCT01101841|1186553|P1|NOT COMPLETED|Overall Study||50
484048|NCT01101841|1186552|P2|COMPLETED|Overall Study||218
484049|NCT01101841|1186553|P1|COMPLETED|Overall Study||235
484050|NCT01101841|1186552|P2|STARTED|Overall Study||285
484051|NCT01101841|1186553|P1|STARTED|Overall Study||285
484052|NCT01101542|1186591|P1|NOT COMPLETED|Year 6 Surveillance Period||991
484053|NCT01101542|1186591|P1|COMPLETED|Year 6 Surveillance Period||2100
484054|NCT01101542|1186591|P1|STARTED|Year 6 Surveillance Period||3091
484055|NCT01101542|1186591|P1|NOT COMPLETED|Year 5 Surveillance Period||141
484056|NCT01101542|1186591|P1|COMPLETED|Year 5 Surveillance Period||668
484057|NCT01101542|1186591|P1|STARTED|Year 5 Surveillance Period||809
484058|NCT01101542|1186591|P1|NOT COMPLETED|Year 4 Surveillance Period||287
484059|NCT01101542|1186591|P1|COMPLETED|Year 4 Surveillance Period||282
484060|NCT01101542|1186591|P1|STARTED|Year 4 Surveillance Period||569
484061|NCT01101542|1186591|P1|NOT COMPLETED|Year 3 Surveillance Period||11
484062|NCT01101542|1186591|P1|COMPLETED|Year 3 Surveillance Period||94
484063|NCT01101542|1186591|P1|STARTED|Year 3 Surveillance Period||105
484064|NCT01101477|1186610|P3|NOT COMPLETED|Overall Study||1
484065|NCT01101477|1186611|P2|NOT COMPLETED|Overall Study||3
484066|NCT01101477|1186612|P1|NOT COMPLETED|Overall Study||5
484067|NCT01101477|1186610|P3|COMPLETED|Overall Study||45
484068|NCT01101477|1186611|P2|COMPLETED|Overall Study||46
484069|NCT01101477|1186612|P1|COMPLETED|Overall Study||44
484070|NCT01101477|1186610|P3|STARTED|Overall Study||46
484071|NCT01101477|1186611|P2|STARTED|Overall Study||49
484072|NCT01101477|1186612|P1|STARTED|Overall Study||49
484073|NCT01101464|1186622|P2|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0
484074|NCT01101464|1186623|P1|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0
484075|NCT01101464|1186622|P2|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4
484076|NCT01101464|1186623|P1|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4
484077|NCT01101464|1186622|P2|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4
484078|NCT01101464|1186623|P1|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4
484079|NCT01101464|1186622|P2|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0
484080|NCT01101464|1186623|P1|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0
484081|NCT01101464|1186622|P2|COMPLETED|Day 1 Through AM Dose of Day 5||4
484082|NCT01101464|1186623|P1|COMPLETED|Day 1 Through AM Dose of Day 5||4
484083|NCT01101464|1186622|P2|STARTED|Day 1 Through AM Dose of Day 5||4
484084|NCT01101464|1186623|P1|STARTED|Day 1 Through AM Dose of Day 5||4
484085|NCT01101321|1186633|P2|NOT COMPLETED|Period 2||0
484086|NCT01101321|1186634|P1|NOT COMPLETED|Period 2||0
484087|NCT01101321|1186633|P2|COMPLETED|Period 2||24
484088|NCT01101321|1186634|P1|COMPLETED|Period 2||26
484089|NCT01101321|1186633|P2|STARTED|Period 2||24
484090|NCT01101321|1186634|P1|STARTED|Period 2||26
484091|NCT01101321|1186633|P2|NOT COMPLETED|Period 1||4
484092|NCT01101321|1186634|P1|NOT COMPLETED|Period 1||4
484093|NCT01101321|1186633|P2|COMPLETED|Period 1||24
484094|NCT01101321|1186634|P1|COMPLETED|Period 1||26
484095|NCT01101321|1186633|P2|STARTED|Period 1||28
484096|NCT01101321|1186634|P1|STARTED|Period 1||30
484097|NCT01101308|1186644|P2|NOT COMPLETED|Period 2||0
484098|NCT01101308|1186645|P1|NOT COMPLETED|Period 2||0
484099|NCT01101308|1186644|P2|COMPLETED|Period 2||27
484100|NCT01101308|1186645|P1|COMPLETED|Period 2||24
484101|NCT01101308|1186644|P2|STARTED|Period 2||27
484102|NCT01101308|1186645|P1|STARTED|Period 2||24
484103|NCT01101308|1186644|P2|NOT COMPLETED|Period 1||1
484104|NCT01101308|1186645|P1|NOT COMPLETED|Period 1||3
484105|NCT01101308|1186644|P2|COMPLETED|Period 1||27
484106|NCT01101308|1186645|P1|COMPLETED|Period 1||24
484107|NCT01101308|1186644|P2|STARTED|Period 1||28
484108|NCT01101308|1186645|P1|STARTED|Period 1||27
484109|NCT01101191|1186656|P2|NOT COMPLETED|Period 2||0
484110|NCT01101191|1186657|P1|NOT COMPLETED|Period 2||0
484111|NCT01101191|1186656|P2|COMPLETED|Period 2||40
484112|NCT01101191|1186657|P1|COMPLETED|Period 2||40
484113|NCT01101191|1186656|P2|STARTED|Period 2||40
484114|NCT01101191|1186657|P1|STARTED|Period 2||40
484115|NCT01101191|1186656|P2|NOT COMPLETED|Period 1||2
484116|NCT01101191|1186657|P1|NOT COMPLETED|Period 1||2
484117|NCT01101191|1186656|P2|COMPLETED|Period 1||40
484118|NCT01101191|1186657|P1|COMPLETED|Period 1||40
484119|NCT01101191|1186656|P2|STARTED|Period 1||42
484120|NCT01101191|1186657|P1|STARTED|Period 1||42
484121|NCT01101178|1186668|P2|NOT COMPLETED|Period 2||1
484122|NCT01101178|1186669|P1|NOT COMPLETED|Period 2||0
484123|NCT01101178|1186668|P2|COMPLETED|Period 2||34
484124|NCT01101178|1186669|P1|COMPLETED|Period 2||36
484125|NCT01101178|1186668|P2|STARTED|Period 2||35
484126|NCT01101178|1186669|P1|STARTED|Period 2||36
484127|NCT01101178|1186668|P2|NOT COMPLETED|Period 1||4
484128|NCT01101178|1186669|P1|NOT COMPLETED|Period 1||4
484129|NCT01101178|1186668|P2|COMPLETED|Period 1||35
484130|NCT01101178|1186669|P1|COMPLETED|Period 1||36
484131|NCT01101178|1186668|P2|STARTED|Period 1||39
484132|NCT01101178|1186669|P1|STARTED|Period 1||40
484133|NCT01101165|1186680|P2|NOT COMPLETED|Period 2||1
484134|NCT01101165|1186681|P1|NOT COMPLETED|Period 2||4
484135|NCT01101165|1186680|P2|COMPLETED|Period 2||39
484136|NCT01101165|1186681|P1|COMPLETED|Period 2||41
484137|NCT01101165|1186680|P2|STARTED|Period 2||40
484138|NCT01101165|1186681|P1|STARTED|Period 2||45
484139|NCT01101165|1186680|P2|NOT COMPLETED|Period 1||5
484140|NCT01101165|1186681|P1|NOT COMPLETED|Period 1||2
484141|NCT01101165|1186680|P2|COMPLETED|Period 1||40
484142|NCT01101165|1186681|P1|COMPLETED|Period 1||45
484143|NCT01101165|1186680|P2|STARTED|Period 1||45
484144|NCT01101165|1186681|P1|STARTED|Period 1||47
484145|NCT01101035|1186693|P2|NOT COMPLETED|Overall Study||1391
484146|NCT01101035|1186694|P1|NOT COMPLETED|Overall Study||1397
484147|NCT01101035|1186693|P2|COMPLETED|Overall Study||1706
484148|NCT01101035|1186694|P1|COMPLETED|Overall Study||1704
484149|NCT01101035|1186693|P2|STARTED|Overall Study||3097
484150|NCT01101035|1186694|P1|STARTED|Overall Study||3101
484151|NCT01101022|1186714|P2|NOT COMPLETED|Overall Study||27
484152|NCT01101022|1186715|P1|NOT COMPLETED|Overall Study||17
484153|NCT01101022|1186714|P2|COMPLETED|Overall Study||53
484154|NCT01101022|1186715|P1|COMPLETED|Overall Study||62
484155|NCT01101022|1186714|P2|STARTED|Overall Study||80
484156|NCT01101022|1186715|P1|STARTED|Overall Study||79
484157|NCT01100944|1186749|P3|NOT COMPLETED|Expansion Phase - Phase 2||0
484158|NCT01100944|1186750|P2|NOT COMPLETED|Expansion Phase - Phase 2||0
484159|NCT01100944|1186751|P1|NOT COMPLETED|Expansion Phase - Phase 2||0
484160|NCT01100944|1186749|P3|COMPLETED|Expansion Phase - Phase 2||18
484161|NCT01100944|1186750|P2|COMPLETED|Expansion Phase - Phase 2||0
484162|NCT01100944|1186751|P1|COMPLETED|Expansion Phase - Phase 2||0
484163|NCT01100944|1186749|P3|STARTED|Expansion Phase - Phase 2||18
484164|NCT01100944|1186750|P2|STARTED|Expansion Phase - Phase 2||0
484165|NCT01100944|1186751|P1|STARTED|Expansion Phase - Phase 2||0
484166|NCT01100944|1186749|P3|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
484167|NCT01100944|1186750|P2|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||2
484168|NCT01100944|1186751|P1|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
484169|NCT01100944|1186749|P3|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
484170|NCT01100944|1186750|P2|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
484171|NCT01100944|1186751|P1|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
484172|NCT01100944|1186749|P3|STARTED|Dose Escalation Phase 1 Dose Level 2||0
484173|NCT01100944|1186750|P2|STARTED|Dose Escalation Phase 1 Dose Level 2||2
484174|NCT01100944|1186751|P1|STARTED|Dose Escalation Phase 1 Dose Level 2||0
484175|NCT01100944|1186749|P3|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
484176|NCT01100944|1186750|P2|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
484177|NCT01100944|1186751|P1|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||4
484178|NCT01100944|1186749|P3|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
484179|NCT01100944|1186750|P2|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
484180|NCT01100944|1186751|P1|COMPLETED|Dose Escalation Phase 1 Dose Level 1||2
484181|NCT01100944|1186749|P3|STARTED|Dose Escalation Phase 1 Dose Level 1||0
484182|NCT01100944|1186750|P2|STARTED|Dose Escalation Phase 1 Dose Level 1||0
484183|NCT01100944|1186751|P1|STARTED|Dose Escalation Phase 1 Dose Level 1||6
484184|NCT01100931|1186798|P2|NOT COMPLETED|Phase II||0
484185|NCT01100931|1186799|P1|NOT COMPLETED|Phase II||0
484186|NCT01100931|1186798|P2|COMPLETED|Phase II||19
484187|NCT01100931|1186799|P1|COMPLETED|Phase II||0
484188|NCT01100931|1186798|P2|STARTED|Phase II||19
484189|NCT01100931|1186799|P1|STARTED|Phase II||0
484190|NCT01100931|1186798|P2|NOT COMPLETED|Phase I||0
484191|NCT01100931|1186799|P1|NOT COMPLETED|Phase I||0
484192|NCT01100931|1186798|P2|COMPLETED|Phase I||0
484193|NCT01100931|1186799|P1|COMPLETED|Phase I||22
484194|NCT01100931|1186798|P2|STARTED|Phase I||0
484195|NCT01100931|1186799|P1|STARTED|Phase I||22
484196|NCT01100853|1186809|P2|NOT COMPLETED|Overall Study||23
484197|NCT01100853|1186810|P1|NOT COMPLETED|Overall Study||27
484198|NCT01100853|1186809|P2|COMPLETED|Overall Study||26
484199|NCT01100853|1186810|P1|COMPLETED|Overall Study||24
484200|NCT01100853|1186809|P2|STARTED|Overall Study||49
484201|NCT01100853|1186810|P1|STARTED|Overall Study||51
484202|NCT01100762|1186826|P1|NOT COMPLETED|Overall Study||0
484203|NCT01100762|1186826|P1|COMPLETED|Overall Study||10
484204|NCT01100762|1186826|P1|STARTED|Overall Study||10
484205|NCT01100723|1186847|P1|NOT COMPLETED|Overall Study||14
484206|NCT01100723|1186847|P1|COMPLETED|Overall Study|78 subjects had laboratory data at the 12 month analysis and were compared to their baseline data.|78
484207|NCT01100723|1186847|P1|6 Month Analysis|Overall Study|85 subjects had laboratory data at the 6 month analysis and were compared to their baseline data.|85
484208|NCT01100723|1186847|P1|STARTED|Overall Study||92
484209|NCT01100658|1186856|P1|NOT COMPLETED|Overall Study||1
484210|NCT01100658|1186856|P1|COMPLETED|Overall Study||0
484211|NCT01100658|1186856|P1|STARTED|Overall Study||1
484212|NCT01100606|1186861|P2|NOT COMPLETED|Second Treatment Period||0
484213|NCT01100606|1186862|P1|NOT COMPLETED|Second Treatment Period||0
484214|NCT01100606|1186861|P2|COMPLETED|Second Treatment Period|Due to difficulty with syringe nurser, 1 participant completed study using apple sauce|7
484215|NCT01100606|1186862|P1|COMPLETED|Second Treatment Period|Due to intolerance to apple sauce & apple juice,1 participant completed study with banana-based food|8
484216|NCT01100606|1186861|P2|STARTED|Second Treatment Period||7
484217|NCT01100606|1186862|P1|STARTED|Second Treatment Period||8
484218|NCT01100606|1186861|P2|NOT COMPLETED|First Treatment Period||0
484219|NCT01100606|1186862|P1|NOT COMPLETED|First Treatment Period||0
484220|NCT01100606|1186861|P2|COMPLETED|First Treatment Period||7
484221|NCT01100606|1186862|P1|COMPLETED|First Treatment Period|Due to difficulty with syringe nurser,1 participant completed study with apple sauce,not apple juice|8
484222|NCT01100606|1186861|P2|STARTED|First Treatment Period||7
484223|NCT01100606|1186862|P1|STARTED|First Treatment Period||8
484224|NCT01100567|1186888|P2|NOT COMPLETED|Overall Study||16
484225|NCT01100567|1186889|P1|NOT COMPLETED|Overall Study||12
484226|NCT01100567|1186888|P2|COMPLETED|Overall Study||35
484227|NCT01100567|1186889|P1|COMPLETED|Overall Study||38
484228|NCT01100567|1186888|P2|STARTED|Overall Study||51
484229|NCT01100567|1186889|P1|STARTED|Overall Study||50
484230|NCT01100502|1186899|P2|NOT COMPLETED|Long-Term Follow-up||139
484231|NCT01100502|1186900|P1|NOT COMPLETED|Long-Term Follow-up||137
484232|NCT01100502|1186899|P2|COMPLETED|Long-Term Follow-up|Completed follow-up due to death|25
484233|NCT01100502|1186900|P1|COMPLETED|Long-Term Follow-up|Completed follow-up due to death|28
484234|NCT01100502|1186899|P2|STARTED|Long-Term Follow-up|All participants were to be followed after treatment|164
484235|NCT01100502|1186900|P1|STARTED|Long-Term Follow-up|All participants were to be followed after treatment|165
484236|NCT01100502|1186899|P2|NOT COMPLETED|Treatment Period||83
484237|NCT01100502|1186900|P1|NOT COMPLETED|Treatment Period||87
484238|NCT01100502|1186899|P2|COMPLETED|Treatment Period||81
484239|NCT01100502|1186900|P1|COMPLETED|Treatment Period||78
484240|NCT01100502|1186899|P2|STARTED|Treatment Period||164
484241|NCT01100502|1186900|P1|STARTED|Treatment Period||165
484242|NCT01100437|1186910|P3|NOT COMPLETED|Treatment 2||0
484243|NCT01100437|1186911|P2|NOT COMPLETED|Treatment 2||0
484244|NCT01100437|1186912|P1|NOT COMPLETED|Treatment 2||0
484245|NCT01100437|1186910|P3|COMPLETED|Treatment 2||0
484246|NCT01100437|1186911|P2|COMPLETED|Treatment 2||2
484247|NCT01100437|1186912|P1|COMPLETED|Treatment 2||4
484248|NCT01100437|1186910|P3|STARTED|Treatment 2||0
484249|NCT01100437|1186911|P2|STARTED|Treatment 2||2
484250|NCT01100437|1186912|P1|STARTED|Treatment 2||4
484251|NCT01100437|1186910|P3|NOT COMPLETED|Washout (4 Days)||0
484252|NCT01100437|1186911|P2|NOT COMPLETED|Washout (4 Days)||0
484253|NCT01100437|1186912|P1|NOT COMPLETED|Washout (4 Days)||0
484254|NCT01100437|1186910|P3|COMPLETED|Washout (4 Days)||0
484255|NCT01100437|1186911|P2|COMPLETED|Washout (4 Days)||2
484256|NCT01100437|1186912|P1|COMPLETED|Washout (4 Days)||4
484257|NCT01100437|1186910|P3|STARTED|Washout (4 Days)||0
484258|NCT01100437|1186911|P2|STARTED|Washout (4 Days)||2
484259|NCT01100437|1186912|P1|STARTED|Washout (4 Days)||4
484260|NCT01100437|1186910|P3|NOT COMPLETED|Treatment 1||0
484261|NCT01100437|1186911|P2|NOT COMPLETED|Treatment 1||0
484262|NCT01100437|1186912|P1|NOT COMPLETED|Treatment 1||0
484263|NCT01100437|1186910|P3|COMPLETED|Treatment 1||0
484264|NCT01100437|1186911|P2|COMPLETED|Treatment 1||2
484265|NCT01100437|1186912|P1|COMPLETED|Treatment 1||4
484266|NCT01100437|1186910|P3|STARTED|Treatment 1||0
484267|NCT01100437|1186911|P2|STARTED|Treatment 1||2
484268|NCT01100437|1186912|P1|STARTED|Treatment 1||4
484269|NCT01100437|1186910|P3|NOT COMPLETED|Maintenance||2
484270|NCT01100437|1186911|P2|NOT COMPLETED|Maintenance||0
484271|NCT01100437|1186912|P1|NOT COMPLETED|Maintenance||0
484272|NCT01100437|1186910|P3|COMPLETED|Maintenance||0
484273|NCT01100437|1186911|P2|COMPLETED|Maintenance||2
484274|NCT01100437|1186912|P1|COMPLETED|Maintenance||4
484275|NCT01100437|1186910|P3|STARTED|Maintenance||2
484276|NCT01100437|1186911|P2|STARTED|Maintenance||2
484277|NCT01100437|1186912|P1|STARTED|Maintenance||4
484278|NCT01100437|1186910|P3|NOT COMPLETED|Titration/Stabilization||6
484279|NCT01100437|1186911|P2|NOT COMPLETED|Titration/Stabilization||0
484280|NCT01100437|1186912|P1|NOT COMPLETED|Titration/Stabilization||0
484281|NCT01100437|1186910|P3|COMPLETED|Titration/Stabilization||2
484282|NCT01100437|1186911|P2|COMPLETED|Titration/Stabilization||2
484283|NCT01100437|1186912|P1|COMPLETED|Titration/Stabilization||4
484284|NCT01100437|1186910|P3|STARTED|Titration/Stabilization||8
484285|NCT01100437|1186911|P2|STARTED|Titration/Stabilization||2
484286|NCT01100437|1186912|P1|STARTED|Titration/Stabilization||4
484287|NCT01100437|1186910|P3|NOT COMPLETED|Screening||0
484288|NCT01100437|1186911|P2|NOT COMPLETED|Screening||0
484289|NCT01100437|1186912|P1|NOT COMPLETED|Screening||0
484290|NCT01100437|1186910|P3|COMPLETED|Screening||8
484291|NCT01100437|1186911|P2|COMPLETED|Screening||2
484292|NCT01100437|1186912|P1|COMPLETED|Screening||4
484293|NCT01100437|1186910|P3|STARTED|Screening||8
484294|NCT01100437|1186911|P2|STARTED|Screening||2
484295|NCT01100437|1186912|P1|STARTED|Screening||4
484296|NCT01100320|1186949|P2|NOT COMPLETED|Period 2||1
484297|NCT01100320|1186950|P1|NOT COMPLETED|Period 2||1
484298|NCT01100320|1186949|P2|COMPLETED|Period 2||37
484299|NCT01100320|1186950|P1|COMPLETED|Period 2||37
484300|NCT01100320|1186949|P2|STARTED|Period 2||38
484301|NCT01100320|1186950|P1|STARTED|Period 2||38
484302|NCT01100320|1186949|P2|NOT COMPLETED|Period 1||7
484303|NCT01100320|1186950|P1|NOT COMPLETED|Period 1||5
484304|NCT01100320|1186949|P2|COMPLETED|Period 1||38
484305|NCT01100320|1186950|P1|COMPLETED|Period 1||38
484306|NCT01100320|1186949|P2|STARTED|Period 1||45
484307|NCT01100320|1186950|P1|STARTED|Period 1||43
484308|NCT01100307|1186962|P2|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||13
484309|NCT01100307|1186963|P1|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||6
484310|NCT01100307|1186962|P2|COMPLETED|Open Phase (Week 24 up to Week 54)||99
484311|NCT01100307|1186963|P1|COMPLETED|Open Phase (Week 24 up to Week 54)||110
484312|NCT01100307|1186962|P2|STARTED|Open Phase (Week 24 up to Week 54)|Four participants did not enter to the open phase after completing the double masked phase.|112
484313|NCT01100307|1186963|P1|STARTED|Open Phase (Week 24 up to Week 54)|One participant discontinued from the study due to adverse event before study drug administration.|116
484314|NCT01100307|1186962|P2|NOT COMPLETED|Double Masked Phase (Up to Week 24)||4
484315|NCT01100307|1186963|P1|NOT COMPLETED|Double Masked Phase (Up to Week 24)||6
484316|NCT01100307|1186962|P2|COMPLETED|Double Masked Phase (Up to Week 24)||116
484317|NCT01100307|1186963|P1|COMPLETED|Double Masked Phase (Up to Week 24)||117
484318|NCT01100307|1186962|P2|STARTED|Double Masked Phase (Up to Week 24)||120
484319|NCT01100307|1186963|P1|STARTED|Double Masked Phase (Up to Week 24)||123
484320|NCT01100268|1187005|P1|NOT COMPLETED|Overall Study||0
484321|NCT01100268|1187005|P1|COMPLETED|Overall Study||4
484322|NCT01100268|1187005|P1|STARTED|Overall Study||4
484323|NCT01100255|1187012|P2|NOT COMPLETED|Overall Study||0
484324|NCT01100255|1187013|P1|NOT COMPLETED|Overall Study||0
484325|NCT01100255|1187012|P2|COMPLETED|Overall Study||7
484326|NCT01100255|1187013|P1|COMPLETED|Overall Study||8
484327|NCT01100255|1187012|P2|STARTED|Overall Study||7
484328|NCT01100255|1187013|P1|STARTED|Overall Study||8
484329|NCT01100242|1187019|P1|NOT COMPLETED|Overall Study||0
484330|NCT01100242|1187019|P1|COMPLETED|Overall Study||17
484331|NCT01100242|1187019|P1|STARTED|Overall Study||17
484332|NCT01100112|1187025|P1|NOT COMPLETED|Overall Study||8
484333|NCT01100112|1187025|P1|COMPLETED|Overall Study||52
484334|NCT01100112|1187025|P1|STARTED|Overall Study||60
484335|NCT01100086|1187032|P2|NOT COMPLETED|Period 2||0
484336|NCT01100086|1187033|P1|NOT COMPLETED|Period 2||0
484337|NCT01100086|1187032|P2|COMPLETED|Period 2||41
484338|NCT01100086|1187033|P1|COMPLETED|Period 2||42
484339|NCT01100086|1187032|P2|STARTED|Period 2||41
484340|NCT01100086|1187033|P1|STARTED|Period 2||42
484341|NCT01100086|1187032|P2|NOT COMPLETED|Period 1||0
484342|NCT01100086|1187033|P1|NOT COMPLETED|Period 1||1
484343|NCT01100086|1187032|P2|COMPLETED|Period 1||41
484344|NCT01100086|1187033|P1|COMPLETED|Period 1||42
484345|NCT01100086|1187032|P2|STARTED|Period 1||41
484346|NCT01100086|1187033|P1|STARTED|Period 1||43
484347|NCT01100073|1187043|P1|NOT COMPLETED|Overall Study||100
484348|NCT01100073|1187043|P1|COMPLETED|Overall Study|End of study (Visit 3)|1599
484349|NCT01100073|1187043|P1|STARTED|Overall Study|Baseline (Visit 1)|1699
484350|NCT01099969|1187062|P4|NOT COMPLETED|Overall Study||0
484351|NCT01099969|1187063|P3|NOT COMPLETED|Overall Study||0
484352|NCT01099969|1187064|P2|NOT COMPLETED|Overall Study||0
484353|NCT01099969|1187065|P1|NOT COMPLETED|Overall Study||0
484354|NCT01099969|1187062|P4|COMPLETED|Overall Study||15
484355|NCT01099969|1187063|P3|COMPLETED|Overall Study||15
484356|NCT01099969|1187064|P2|COMPLETED|Overall Study||15
484357|NCT01099969|1187065|P1|COMPLETED|Overall Study||15
484358|NCT01099969|1187062|P4|STARTED|Overall Study||15
484359|NCT01099969|1187063|P3|STARTED|Overall Study||15
484360|NCT01099969|1187064|P2|STARTED|Overall Study||15
484361|NCT01099969|1187065|P1|STARTED|Overall Study||15
484362|NCT01099917|1187087|P1|NOT COMPLETED|Overall Study||27
484363|NCT01099917|1187087|P1|COMPLETED|Overall Study||18
484364|NCT01099917|1187087|P1|STARTED|Overall Study||45
484365|NCT01099774|1187093|P2|NOT COMPLETED|Overall Study||6
484366|NCT01099774|1187094|P1|NOT COMPLETED|Overall Study||6
484367|NCT01099774|1187093|P2|COMPLETED|Overall Study||289
484368|NCT01099774|1187094|P1|COMPLETED|Overall Study||296
484369|NCT01099774|1187093|P2|STARTED|Overall Study||295
484370|NCT01099774|1187094|P1|STARTED|Overall Study||302
484371|NCT01099761|1187110|P4|NOT COMPLETED|Overall Study||0
484372|NCT01099761|1187111|P3|NOT COMPLETED|Overall Study||0
484373|NCT01099761|1187112|P2|NOT COMPLETED|Overall Study||0
484374|NCT01099761|1187113|P1|NOT COMPLETED|Overall Study||0
484375|NCT01099761|1187110|P4|COMPLETED|Overall Study||6
484376|NCT01099761|1187111|P3|COMPLETED|Overall Study||0
484377|NCT01099761|1187112|P2|COMPLETED|Overall Study||9
484378|NCT01099761|1187113|P1|COMPLETED|Overall Study||9
484379|NCT01099761|1187110|P4|STARTED|Overall Study||6
484380|NCT01099761|1187111|P3|STARTED|Overall Study|Study terminated prior to enrolling cohort 3|0
484381|NCT01099761|1187112|P2|STARTED|Overall Study||9
484382|NCT01099761|1187113|P1|STARTED|Overall Study||9
484383|NCT01099709|1187149|P2|NOT COMPLETED|Period 2||0
484384|NCT01099709|1187150|P1|NOT COMPLETED|Period 2||0
484385|NCT01099709|1187149|P2|COMPLETED|Period 2||41
484386|NCT01099709|1187150|P1|COMPLETED|Period 2||41
484387|NCT01099709|1187149|P2|STARTED|Period 2||41
484388|NCT01099709|1187150|P1|STARTED|Period 2||41
484389|NCT01099709|1187149|P2|NOT COMPLETED|Period 1||2
484390|NCT01099709|1187150|P1|NOT COMPLETED|Period 1||1
484391|NCT01099709|1187149|P2|COMPLETED|Period 1||41
484392|NCT01099709|1187150|P1|COMPLETED|Period 1||41
484393|NCT01099709|1187149|P2|STARTED|Period 1||43
484394|NCT01099709|1187150|P1|STARTED|Period 1||42
484395|NCT01099618|1187163|P3|NOT COMPLETED|Overall Study||0
484396|NCT01099618|1187164|P2|NOT COMPLETED|Overall Study||0
484397|NCT01099618|1187165|P1|NOT COMPLETED|Overall Study||0
484398|NCT01099618|1187163|P3|COMPLETED|Overall Study||15
484399|NCT01099618|1187164|P2|COMPLETED|Overall Study||16
484400|NCT01099618|1187165|P1|COMPLETED|Overall Study||17
484401|NCT01099618|1187163|P3|STARTED|Overall Study||15
484402|NCT01099618|1187164|P2|STARTED|Overall Study||16
484403|NCT01099618|1187165|P1|STARTED|Overall Study||17
484404|NCT01099579|1187176|P3|NOT COMPLETED|Stage 2 (ATV Capsule)||6
484405|NCT01099579|1187177|P2|NOT COMPLETED|Stage 2 (ATV Capsule)||5
484406|NCT01099579|1187178|P1|NOT COMPLETED|Stage 2 (ATV Capsule)||6
484407|NCT01099579|1187176|P3|COMPLETED|Stage 2 (ATV Capsule)||9
484408|NCT01099579|1187177|P2|COMPLETED|Stage 2 (ATV Capsule)||9
484409|NCT01099579|1187178|P1|COMPLETED|Stage 2 (ATV Capsule)||10
484410|NCT01099579|1187176|P3|STARTED|Stage 2 (ATV Capsule)||15
484411|NCT01099579|1187177|P2|STARTED|Stage 2 (ATV Capsule)||14
484412|NCT01099579|1187178|P1|STARTED|Stage 2 (ATV Capsule)||16
484413|NCT01099579|1187176|P3|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||1
484414|NCT01099579|1187177|P2|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||5
484415|NCT01099579|1187178|P1|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||4
484416|NCT01099579|1187176|P3|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|15
484417|NCT01099579|1187177|P2|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|14
484418|NCT01099579|1187178|P1|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|17
484419|NCT01099579|1187176|P3|STARTED|Stage 1 (ATV Powder Formulation)||16
484420|NCT01099579|1187177|P2|STARTED|Stage 1 (ATV Powder Formulation)||19
484421|NCT01099579|1187178|P1|STARTED|Stage 1 (ATV Powder Formulation)||21
484422|NCT01099475|1187234|P2|NOT COMPLETED|Overall Study||0
484423|NCT01099475|1187235|P1|NOT COMPLETED|Overall Study||0
484424|NCT01099475|1187234|P2|COMPLETED|Overall Study||10
484425|NCT01099475|1187235|P1|COMPLETED|Overall Study||10
484426|NCT01099475|1187234|P2|STARTED|Overall Study||10
484427|NCT01099475|1187235|P1|STARTED|Overall Study||10
484428|NCT01099397|1187247|P1|NOT COMPLETED|Overall Study||13
484429|NCT01099397|1187247|P1|COMPLETED|Overall Study||26
484430|NCT01099397|1187247|P1|STARTED|Overall Study||39
484431|NCT01099358|1187252|P4|NOT COMPLETED|Overall Study||4
484432|NCT01099358|1187253|P3|NOT COMPLETED|Overall Study||8
484433|NCT01099358|1187254|P2|NOT COMPLETED|Overall Study||1
484434|NCT01099358|1187255|P1|NOT COMPLETED|Overall Study||3
484435|NCT01099358|1187252|P4|COMPLETED|Overall Study||12
484436|NCT01099358|1187253|P3|COMPLETED|Overall Study||13
484437|NCT01099358|1187254|P2|COMPLETED|Overall Study||5
484438|NCT01099358|1187255|P1|COMPLETED|Overall Study||1
484439|NCT01099358|1187252|P4|Received at Least One Dose of Study Drug|Overall Study||15
484440|NCT01099358|1187253|P3|Received at Least One Dose of Study Drug|Overall Study||20
484441|NCT01099358|1187254|P2|Received at Least One Dose of Study Drug|Overall Study||6
484442|NCT01099358|1187255|P1|Received at Least One Dose of Study Drug|Overall Study||3
484443|NCT01099358|1187252|P4|STARTED|Overall Study||16
484444|NCT01099358|1187253|P3|STARTED|Overall Study||21
484445|NCT01099358|1187254|P2|STARTED|Overall Study||6
484446|NCT01099358|1187255|P1|STARTED|Overall Study||4
484447|NCT01099267|1187274|P1|NOT COMPLETED|MDS-009 Extension Follow-up||0
484448|NCT01099267|1187274|P1|COMPLETED|MDS-009 Extension Follow-up||54
484449|NCT01099267|1187274|P1|Other Source of Follow-up Info Used|MDS-009 Extension Follow-up|Social Security Death Index, public records, verbal reports from health providers and next of kin.|21
484450|NCT01099267|1187274|P1|Informed Consent Given|MDS-009 Extension Follow-up||33
484451|NCT01099267|1187274|P1|STARTED|MDS-009 Extension Follow-up|Participants from MDS-003 (including some who did not complete) at sites participating in MDS-009.|54
484452|NCT01099267|1187274|P1|NOT COMPLETED|MDS-003 Study||124
484453|NCT01099267|1187274|P1|COMPLETED|MDS-003 Study||24
484454|NCT01099267|1187274|P1|STARTED|MDS-003 Study|This information duplicates results in NCT00065156.|148
484455|NCT01099215|1187284|P2|NOT COMPLETED|Overall Study||1
484456|NCT01099215|1187285|P1|NOT COMPLETED|Overall Study||1
484457|NCT01099215|1187284|P2|COMPLETED|Overall Study||9
484458|NCT01099215|1187285|P1|COMPLETED|Overall Study||10
484459|NCT01099215|1187284|P2|STARTED|Overall Study||10
484460|NCT01099215|1187285|P1|STARTED|Overall Study||11
484461|NCT01099202|1187323|P2|NOT COMPLETED|Overall Study||0
484462|NCT01099202|1187324|P1|NOT COMPLETED|Overall Study||0
484463|NCT01099202|1187323|P2|COMPLETED|Overall Study||54
484464|NCT01099202|1187324|P1|COMPLETED|Overall Study||55
484465|NCT01099202|1187323|P2|STARTED|Overall Study||54
484466|NCT01099202|1187324|P1|STARTED|Overall Study||55
484467|NCT01099111|1187337|P5|NOT COMPLETED|Overall Study||0
484468|NCT01099111|1187338|P4|NOT COMPLETED|Overall Study||0
484469|NCT01099111|1187339|P3|NOT COMPLETED|Overall Study||0
484470|NCT01099111|1187340|P2|NOT COMPLETED|Overall Study||0
484471|NCT01099111|1187341|P1|NOT COMPLETED|Overall Study||0
484472|NCT01099111|1187337|P5|COMPLETED|Overall Study|6 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
484473|NCT01099111|1187338|P4|COMPLETED|Overall Study||29
484474|NCT01099111|1187339|P3|COMPLETED|Overall Study|2 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|46
484475|NCT01099111|1187340|P2|COMPLETED|Overall Study|3 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
484476|NCT01099111|1187341|P1|COMPLETED|Overall Study|5 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
484477|NCT01099111|1187337|P5|STARTED|Overall Study||50
484478|NCT01099111|1187338|P4|STARTED|Overall Study||29
484479|NCT01099111|1187339|P3|STARTED|Overall Study||46
484480|NCT01099111|1187340|P2|STARTED|Overall Study||50
484481|NCT01099111|1187341|P1|STARTED|Overall Study||50
484482|NCT01098851|1187355|P2|NOT COMPLETED|Overall Study||0
484483|NCT01098851|1187356|P1|NOT COMPLETED|Overall Study||1
484484|NCT01098851|1187355|P2|COMPLETED|Overall Study||10
484485|NCT01098851|1187356|P1|COMPLETED|Overall Study||10
484486|NCT01098851|1187355|P2|STARTED|Overall Study||10
484487|NCT01098851|1187356|P1|STARTED|Overall Study||11
484488|NCT01098812|1187367|P3|NOT COMPLETED|Overall Study||1
484489|NCT01098812|1187368|P2|NOT COMPLETED|Overall Study||1
484490|NCT01098812|1187369|P1|NOT COMPLETED|Overall Study||2
484491|NCT01098812|1187367|P3|COMPLETED|Overall Study||71
484492|NCT01098812|1187368|P2|COMPLETED|Overall Study||101
484493|NCT01098812|1187369|P1|COMPLETED|Overall Study||93
484494|NCT01098812|1187367|P3|STARTED|Overall Study||72
484495|NCT01098812|1187368|P2|STARTED|Overall Study||102
484496|NCT01098812|1187369|P1|STARTED|Overall Study||95
484497|NCT01098747|1187383|P4|NOT COMPLETED|Overall Study||0
484498|NCT01098747|1187384|P3|NOT COMPLETED|Overall Study||0
484499|NCT01098747|1187385|P2|NOT COMPLETED|Overall Study||0
484500|NCT01098747|1187386|P1|NOT COMPLETED|Overall Study||0
484501|NCT01098747|1187383|P4|COMPLETED|Overall Study||87
484502|NCT01098747|1187384|P3|COMPLETED|Overall Study||86
484503|NCT01098747|1187385|P2|COMPLETED|Overall Study||95
484504|NCT01098747|1187386|P1|COMPLETED|Overall Study||48
484505|NCT01098747|1187383|P4|STARTED|Overall Study||87
484506|NCT01098747|1187384|P3|STARTED|Overall Study||86
484507|NCT01098747|1187385|P2|STARTED|Overall Study||95
484508|NCT01098747|1187386|P1|STARTED|Overall Study||48
484509|NCT01098578|1187436|P1|NOT COMPLETED|Overall Study||0
484510|NCT01098578|1187436|P1|COMPLETED|Overall Study||20
484511|NCT01098578|1187436|P1|STARTED|Overall Study||20
484512|NCT01098539|1187445|P2|NOT COMPLETED|Overall Study||68
484513|NCT01098539|1187446|P1|NOT COMPLETED|Overall Study||51
484514|NCT01098539|1187445|P2|COMPLETED|Overall Study||178
484515|NCT01098539|1187446|P1|COMPLETED|Overall Study||198
484516|NCT01098539|1187445|P2|STARTED|Overall Study||246
484517|NCT01098539|1187446|P1|STARTED|Overall Study||249
484518|NCT01098500|1187482|P1|NOT COMPLETED|Overall Study||0
484519|NCT01098500|1187482|P1|COMPLETED|Overall Study||3800
484520|NCT01098500|1187482|P1|STARTED|Overall Study||3800
484521|NCT01098487|1187497|P1|NOT COMPLETED|Overall Study||44
484522|NCT01098487|1187497|P1|COMPLETED|Overall Study||118
484523|NCT01098487|1187497|P1|STARTED|Overall Study||162
484524|NCT01098461|1187513|P4|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0
484525|NCT01098461|1187514|P3|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||1
484526|NCT01098461|1187515|P2|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||3
484527|NCT01098461|1187516|P1|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0
484528|NCT01098461|1187513|P4|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
484529|NCT01098461|1187514|P3|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
484530|NCT01098461|1187515|P2|COMPLETED|Follow-up (FU) Period (8 Weeks)||49
484531|NCT01098461|1187516|P1|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
484532|NCT01098461|1187513|P4|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|52
484533|NCT01098461|1187514|P3|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|53
484534|NCT01098461|1187515|P2|STARTED|Follow-up (FU) Period (8 Weeks)||52
484535|NCT01098461|1187516|P1|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|52
484536|NCT01098461|1187513|P4|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||3
484537|NCT01098461|1187514|P3|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||1
484538|NCT01098461|1187515|P2|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||7
484539|NCT01098461|1187516|P1|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||12
484540|NCT01098461|1187513|P4|COMPLETED|Treatment Period (TP) (16 Weeks)||50
484541|NCT01098461|1187514|P3|COMPLETED|Treatment Period (TP) (16 Weeks)||53
484542|NCT01098461|1187515|P2|COMPLETED|Treatment Period (TP) (16 Weeks)||45
484543|NCT01098461|1187516|P1|COMPLETED|Treatment Period (TP) (16 Weeks)||41
484544|NCT01098461|1187513|P4|STARTED|Treatment Period (TP) (16 Weeks)||53
484545|NCT01098461|1187514|P3|STARTED|Treatment Period (TP) (16 Weeks)||54
484546|NCT01098461|1187515|P2|STARTED|Treatment Period (TP) (16 Weeks)||52
484547|NCT01098461|1187516|P1|STARTED|Treatment Period (TP) (16 Weeks)||53
484548|NCT01098318|1187549|P3|NOT COMPLETED|Overall Study||3
484549|NCT01098318|1187550|P2|NOT COMPLETED|Overall Study||7
484550|NCT01098318|1187551|P1|NOT COMPLETED|Overall Study||3
484551|NCT01098318|1187549|P3|COMPLETED|Overall Study||15
484552|NCT01098318|1187550|P2|COMPLETED|Overall Study||12
484553|NCT01098318|1187551|P1|COMPLETED|Overall Study||17
484554|NCT01098318|1187549|P3|STARTED|Overall Study||18
484555|NCT01098318|1187550|P2|STARTED|Overall Study||19
484556|NCT01098318|1187551|P1|STARTED|Overall Study||20
484557|NCT01098305|1187576|P2|NOT COMPLETED|Overall Study||33
484558|NCT01098305|1187577|P1|NOT COMPLETED|Overall Study||31
484559|NCT01098305|1187576|P2|COMPLETED|Overall Study||85
484560|NCT01098305|1187577|P1|COMPLETED|Overall Study||88
484561|NCT01098305|1187576|P2|STARTED|Overall Study||118
484562|NCT01098305|1187577|P1|STARTED|Overall Study||119
484563|NCT01098253|1187587|P2|NOT COMPLETED|Overall Study||0
484564|NCT01098253|1187588|P1|NOT COMPLETED|Overall Study||2
484565|NCT01098253|1187587|P2|COMPLETED|Overall Study||88
484566|NCT01098253|1187588|P1|COMPLETED|Overall Study||92
484567|NCT01098253|1187587|P2|STARTED|Overall Study||88
484568|NCT01098253|1187588|P1|STARTED|Overall Study||94
484569|NCT01098240|1187596|P3|NOT COMPLETED|Double-Blind Phase||22
484570|NCT01098240|1187597|P2|NOT COMPLETED|Double-Blind Phase||17
484571|NCT01098240|1187598|P1|NOT COMPLETED|Double-Blind Phase||0
484572|NCT01098240|1187596|P3|COMPLETED|Double-Blind Phase||63
484573|NCT01098240|1187597|P2|COMPLETED|Double-Blind Phase||60
484574|NCT01098240|1187598|P1|COMPLETED|Double-Blind Phase||0
484575|NCT01098240|1187596|P3|STARTED|Double-Blind Phase||85
484576|NCT01098240|1187597|P2|STARTED|Double-Blind Phase||77
484577|NCT01098240|1187598|P1|STARTED|Double-Blind Phase||0
484578|NCT01098240|1187596|P3|NOT COMPLETED|Open-Label Phase||0
484579|NCT01098240|1187597|P2|NOT COMPLETED|Open-Label Phase||0
484580|NCT01098240|1187598|P1|NOT COMPLETED|Open-Label Phase||135
484581|NCT01098240|1187596|P3|COMPLETED|Open-Label Phase||0
484582|NCT01098240|1187597|P2|COMPLETED|Open-Label Phase||0
484583|NCT01098240|1187598|P1|COMPLETED|Open-Label Phase||162
484584|NCT01098240|1187596|P3|STARTED|Open-Label Phase||0
484585|NCT01098240|1187597|P2|STARTED|Open-Label Phase||0
484586|NCT01098240|1187598|P1|STARTED|Open-Label Phase||297
484587|NCT01098162|1187628|P1|NOT COMPLETED|Overall Study||112
484588|NCT01098162|1187628|P1|COMPLETED|Overall Study||461
484589|NCT01098162|1187628|P1|STARTED|Overall Study||573
484590|NCT01098110|1187640|P3|NOT COMPLETED|Overall Study||94
484591|NCT01098110|1187641|P2|NOT COMPLETED|Overall Study||73
484592|NCT01098110|1187642|P1|NOT COMPLETED|Overall Study||62
484593|NCT01098110|1187640|P3|COMPLETED|Overall Study||80
484594|NCT01098110|1187641|P2|COMPLETED|Overall Study||109
484595|NCT01098110|1187642|P1|COMPLETED|Overall Study||114
484596|NCT01098110|1187640|P3|Treated|Overall Study|Received at least one dose of trial medication|174
484597|NCT01098110|1187641|P2|Treated|Overall Study|Received at least one dose of trial medication|181
484598|NCT01098110|1187642|P1|Treated|Overall Study|Received at least one dose of trial medication|175
484599|NCT01098110|1187640|P3|STARTED|Overall Study|Randomized participants|174
484600|NCT01098110|1187641|P2|STARTED|Overall Study|Randomized participants|182
484601|NCT01098110|1187642|P1|STARTED|Overall Study|Randomized participants|176
484602|NCT01098097|1187683|P1|NOT COMPLETED|Overall Study||82
484603|NCT01098097|1187683|P1|COMPLETED|Overall Study|Participants completing the study received at least 12 weeks of treatment|881
484604|NCT01098097|1187683|P1|STARTED|Overall Study||963
484605|NCT01098071|1187692|P1|NOT COMPLETED|Overall Study||15
484606|NCT01098071|1187692|P1|COMPLETED|Overall Study||19
484607|NCT01098071|1187692|P1|STARTED|Overall Study||34
484608|NCT01098032|1187705|P2|NOT COMPLETED|Overall Study||1
484609|NCT01098032|1187706|P1|NOT COMPLETED|Overall Study||1
484610|NCT01098032|1187705|P2|COMPLETED|Overall Study||146
484611|NCT01098032|1187706|P1|COMPLETED|Overall Study||146
484612|NCT01098032|1187705|P2|STARTED|Overall Study|1 patient di not receive the treatment. Therefore this patient was excluded from the analysis.|147
484613|NCT01098032|1187706|P1|STARTED|Overall Study|1 patient di not receive the treatment. Therefore this patient was excluded from the analysis.|147
484614|NCT01098006|1187716|P4|NOT COMPLETED|Overall Study||0
484615|NCT01098006|1187717|P3|NOT COMPLETED|Overall Study||0
484616|NCT01098006|1187718|P2|NOT COMPLETED|Overall Study||0
484617|NCT01098006|1187719|P1|NOT COMPLETED|Overall Study||0
484618|NCT01098006|1187716|P4|COMPLETED|Overall Study||21
484619|NCT01098006|1187717|P3|COMPLETED|Overall Study||60
484620|NCT01098006|1187718|P2|COMPLETED|Overall Study||11
484621|NCT01098006|1187719|P1|COMPLETED|Overall Study||7
484622|NCT01098006|1187716|P4|STARTED|Overall Study||21
484623|NCT01098006|1187717|P3|STARTED|Overall Study||60
484624|NCT01098006|1187718|P2|STARTED|Overall Study||11
484625|NCT01098006|1187719|P1|STARTED|Overall Study||7
484626|NCT01097915|1187796|P3|NOT COMPLETED|Overall Study||30
484627|NCT01097915|1187797|P2|NOT COMPLETED|Overall Study||42
484628|NCT01097915|1187798|P1|NOT COMPLETED|Overall Study||23
484629|NCT01097915|1187796|P3|COMPLETED|Overall Study||20
484630|NCT01097915|1187797|P2|COMPLETED|Overall Study||28
484631|NCT01097915|1187798|P1|COMPLETED|Overall Study||27
484632|NCT01097915|1187796|P3|STARTED|Overall Study||50
484633|NCT01097915|1187797|P2|STARTED|Overall Study||70
484634|NCT01097915|1187798|P1|STARTED|Overall Study||50
484635|NCT01097863|1187815|P3|NOT COMPLETED|Overall Study||2
484636|NCT01097863|1187816|P2|NOT COMPLETED|Overall Study||0
484637|NCT01097863|1187817|P1|NOT COMPLETED|Overall Study||1
484638|NCT01097863|1187815|P3|COMPLETED|Overall Study||89
484639|NCT01097863|1187816|P2|COMPLETED|Overall Study||98
484640|NCT01097863|1187817|P1|COMPLETED|Overall Study||89
484641|NCT01097863|1187815|P3|STARTED|Overall Study||91
484642|NCT01097863|1187816|P2|STARTED|Overall Study||98
484643|NCT01097863|1187817|P1|STARTED|Overall Study||90
484644|NCT01097785|1187827|P2|NOT COMPLETED|Cycle 3 (30 Days)||0
484645|NCT01097785|1187828|P1|NOT COMPLETED|Cycle 3 (30 Days)||0
484646|NCT01097785|1187827|P2|COMPLETED|Cycle 3 (30 Days)||6
484647|NCT01097785|1187828|P1|COMPLETED|Cycle 3 (30 Days)||6
484648|NCT01097785|1187827|P2|STARTED|Cycle 3 (30 Days)||6
484649|NCT01097785|1187828|P1|STARTED|Cycle 3 (30 Days)||6
484650|NCT01097785|1187827|P2|NOT COMPLETED|Washout (2 Weeks)||0
484651|NCT01097785|1187828|P1|NOT COMPLETED|Washout (2 Weeks)||0
484652|NCT01097785|1187827|P2|COMPLETED|Washout (2 Weeks)||6
484653|NCT01097785|1187828|P1|COMPLETED|Washout (2 Weeks)||6
484654|NCT01097785|1187827|P2|STARTED|Washout (2 Weeks)||6
484655|NCT01097785|1187828|P1|STARTED|Washout (2 Weeks)||6
484656|NCT01097785|1187827|P2|NOT COMPLETED|Cycle 1 (30 Days)||0
484657|NCT01097785|1187828|P1|NOT COMPLETED|Cycle 1 (30 Days)||0
484658|NCT01097785|1187827|P2|COMPLETED|Cycle 1 (30 Days)||6
484659|NCT01097785|1187828|P1|COMPLETED|Cycle 1 (30 Days)||6
484660|NCT01097785|1187827|P2|STARTED|Cycle 1 (30 Days)||6
484661|NCT01097785|1187828|P1|STARTED|Cycle 1 (30 Days)||6
484662|NCT01097694|1187838|P2|NOT COMPLETED|Overall Study||4
484663|NCT01097694|1187839|P1|NOT COMPLETED|Overall Study||8
484664|NCT01097694|1187838|P2|COMPLETED|Overall Study||26
484665|NCT01097694|1187839|P1|COMPLETED|Overall Study||24
484666|NCT01097694|1187838|P2|STARTED|Overall Study||30
484667|NCT01097694|1187839|P1|STARTED|Overall Study||32
484668|NCT01097668|1187901|P2|NOT COMPLETED|Overall Study||2
484669|NCT01097668|1187902|P1|NOT COMPLETED|Overall Study||2
484670|NCT01097668|1187901|P2|COMPLETED|Overall Study||20
484671|NCT01097668|1187902|P1|COMPLETED|Overall Study||19
484672|NCT01097668|1187901|P2|Week 48|Overall Study||20
484673|NCT01097668|1187902|P1|Week 48|Overall Study||19
484674|NCT01097668|1187901|P2|Week 20|Overall Study|Patient evaluability time point = week 20|22
484675|NCT01097668|1187902|P1|Week 20|Overall Study|Patient evaluability time point = week 20|21
484676|NCT01097668|1187901|P2|STARTED|Overall Study||22
484677|NCT01097668|1187902|P1|STARTED|Overall Study||21
484678|NCT01097655|1187912|P1|NOT COMPLETED|Overall Study||10
484679|NCT01097655|1187912|P1|COMPLETED|Overall Study|participants included for analysis|3039
484680|NCT01097655|1187912|P1|STARTED|Overall Study||3049
484681|NCT01097629|1187922|P8|NOT COMPLETED|DB RO Phase||1
484682|NCT01097629|1187923|P7|NOT COMPLETED|DB RO Phase||3
484683|NCT01097629|1187924|P6|NOT COMPLETED|DB RO Phase||1
484684|NCT01097629|1187925|P5|NOT COMPLETED|DB RO Phase||0
484685|NCT01097629|1187926|P4|NOT COMPLETED|DB RO Phase||1
484686|NCT01097629|1187927|P3|NOT COMPLETED|DB RO Phase||0
484687|NCT01097629|1187928|P2|NOT COMPLETED|DB RO Phase||0
484688|NCT01097629|1187929|P1|NOT COMPLETED|DB RO Phase||0
484689|NCT01097629|1187922|P8|COMPLETED|DB RO Phase||326
484690|NCT01097629|1187923|P7|COMPLETED|DB RO Phase||168
484691|NCT01097629|1187924|P6|COMPLETED|DB RO Phase||172
484692|NCT01097629|1187925|P5|COMPLETED|DB RO Phase||108
484693|NCT01097629|1187926|P4|COMPLETED|DB RO Phase||96
484694|NCT01097629|1187927|P3|COMPLETED|DB RO Phase||0
484695|NCT01097629|1187928|P2|COMPLETED|DB RO Phase||0
484696|NCT01097629|1187929|P1|COMPLETED|DB RO Phase||0
484697|NCT01097629|1187922|P8|STARTED|DB RO Phase||327
484698|NCT01097629|1187923|P7|STARTED|DB RO Phase||171
484699|NCT01097629|1187924|P6|STARTED|DB RO Phase||173
484700|NCT01097629|1187925|P5|STARTED|DB RO Phase||108
484701|NCT01097629|1187926|P4|STARTED|DB RO Phase||97
484702|NCT01097629|1187927|P3|STARTED|DB RO Phase||0
484703|NCT01097629|1187928|P2|STARTED|DB RO Phase||0
484704|NCT01097629|1187929|P1|STARTED|DB RO Phase||0
484705|NCT01097629|1187922|P8|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
484706|NCT01097629|1187923|P7|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
484707|NCT01097629|1187924|P6|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
484708|NCT01097629|1187925|P5|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
484709|NCT01097629|1187926|P4|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
484710|NCT01097629|1187927|P3|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||57
484711|NCT01097629|1187928|P2|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||46
484712|NCT01097629|1187929|P1|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||35
484713|NCT01097629|1187922|P8|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
484714|NCT01097629|1187923|P7|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
484715|NCT01097629|1187924|P6|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
484716|NCT01097629|1187925|P5|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
484717|NCT01097629|1187926|P4|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
484718|NCT01097629|1187927|P3|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|3 did not continue into RO|330
484719|NCT01097629|1187928|P2|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|2 did not continue into RO|346
484720|NCT01097629|1187929|P1|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||205
484721|NCT01097629|1187922|P8|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
484722|NCT01097629|1187923|P7|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
484723|NCT01097629|1187924|P6|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
484724|NCT01097629|1187925|P5|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
484725|NCT01097629|1187926|P4|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
484726|NCT01097629|1187927|P3|Treated|Double-Blind (DB) Treatment (TRT) Phase||383
484727|NCT01097629|1187928|P2|Treated|Double-Blind (DB) Treatment (TRT) Phase||387
484728|NCT01097629|1187929|P1|Treated|Double-Blind (DB) Treatment (TRT) Phase||239
484729|NCT01097629|1187922|P8|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
484730|NCT01097629|1187923|P7|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
484731|NCT01097629|1187924|P6|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
484732|NCT01097629|1187925|P5|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
484733|NCT01097629|1187926|P4|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
484734|NCT01097629|1187927|P3|STARTED|Double-Blind (DB) Treatment (TRT) Phase||387
484735|NCT01097629|1187928|P2|STARTED|Double-Blind (DB) Treatment (TRT) Phase||392
484736|NCT01097629|1187929|P1|STARTED|Double-Blind (DB) Treatment (TRT) Phase||240
484737|NCT01097616|1187980|P8|NOT COMPLETED|DB RO Phase||1
484738|NCT01097616|1187981|P7|NOT COMPLETED|DB RO Phase||1
484739|NCT01097616|1187982|P6|NOT COMPLETED|DB RO Phase||2
484740|NCT01097616|1187983|P5|NOT COMPLETED|DB RO Phase||1
484741|NCT01097616|1187984|P4|NOT COMPLETED|DB RO Phase||1
484742|NCT01097616|1187985|P3|NOT COMPLETED|DB RO Phase||0
484743|NCT01097616|1187986|P2|NOT COMPLETED|DB RO Phase||0
484744|NCT01097616|1187987|P1|NOT COMPLETED|DB RO Phase||0
484745|NCT01097616|1187980|P8|COMPLETED|DB RO Phase||326
484746|NCT01097616|1187981|P7|COMPLETED|DB RO Phase||161
484747|NCT01097616|1187982|P6|COMPLETED|DB RO Phase||159
484748|NCT01097616|1187983|P5|COMPLETED|DB RO Phase||111
484749|NCT01097616|1187984|P4|COMPLETED|DB RO Phase||100
484750|NCT01097616|1187985|P3|COMPLETED|DB RO Phase||0
484751|NCT01097616|1187986|P2|COMPLETED|DB RO Phase||0
484752|NCT01097616|1187987|P1|COMPLETED|DB RO Phase||0
484753|NCT01097616|1187980|P8|STARTED|DB RO Phase||327
484754|NCT01097616|1187981|P7|STARTED|DB RO Phase||162
484755|NCT01097616|1187982|P6|STARTED|DB RO Phase|1 entered RO but was not treated during RO|161
484756|NCT01097616|1187983|P5|STARTED|DB RO Phase|1 was randomized to this group but actually received suvorexant LD during RO|112
484757|NCT01097616|1187984|P4|STARTED|DB RO Phase||101
484758|NCT01097616|1187985|P3|STARTED|DB RO Phase||0
484759|NCT01097616|1187986|P2|STARTED|DB RO Phase||0
484760|NCT01097616|1187987|P1|STARTED|DB RO Phase||0
484761|NCT01097616|1187980|P8|NOT COMPLETED|Optional DB EXT Phase||0
484762|NCT01097616|1187981|P7|NOT COMPLETED|Optional DB EXT Phase||0
484763|NCT01097616|1187982|P6|NOT COMPLETED|Optional DB EXT Phase||0
484764|NCT01097616|1187983|P5|NOT COMPLETED|Optional DB EXT Phase||0
484765|NCT01097616|1187984|P4|NOT COMPLETED|Optional DB EXT Phase||0
484766|NCT01097616|1187985|P3|NOT COMPLETED|Optional DB EXT Phase||10
484767|NCT01097616|1187986|P2|NOT COMPLETED|Optional DB EXT Phase||21
484768|NCT01097616|1187987|P1|NOT COMPLETED|Optional DB EXT Phase||15
484769|NCT01097616|1187980|P8|COMPLETED|Optional DB EXT Phase||0
484770|NCT01097616|1187981|P7|COMPLETED|Optional DB EXT Phase||0
484771|NCT01097616|1187982|P6|COMPLETED|Optional DB EXT Phase||0
484772|NCT01097616|1187983|P5|COMPLETED|Optional DB EXT Phase||0
484773|NCT01097616|1187984|P4|COMPLETED|Optional DB EXT Phase||0
484774|NCT01097616|1187985|P3|COMPLETED|Optional DB EXT Phase|All 141 continued into RO|141
484775|NCT01097616|1187986|P2|COMPLETED|Optional DB EXT Phase|All 151 continued into RO|151
484776|NCT01097616|1187987|P1|COMPLETED|Optional DB EXT Phase|All 85 continued into RO|85
484777|NCT01097616|1187980|P8|STARTED|Optional DB EXT Phase||0
484778|NCT01097616|1187981|P7|STARTED|Optional DB EXT Phase||0
484779|NCT01097616|1187982|P6|STARTED|Optional DB EXT Phase||0
484780|NCT01097616|1187983|P5|STARTED|Optional DB EXT Phase||0
484781|NCT01097616|1187984|P4|STARTED|Optional DB EXT Phase||0
484782|NCT01097616|1187985|P3|STARTED|Optional DB EXT Phase||151
484783|NCT01097616|1187986|P2|STARTED|Optional DB EXT Phase||172
484784|NCT01097616|1187987|P1|STARTED|Optional DB EXT Phase||100
484785|NCT01097616|1187980|P8|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
484786|NCT01097616|1187981|P7|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
484787|NCT01097616|1187982|P6|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
484788|NCT01097616|1187983|P5|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
484789|NCT01097616|1187984|P4|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
484790|NCT01097616|1187985|P3|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||44
484791|NCT01097616|1187986|P2|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||38
484792|NCT01097616|1187987|P1|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||24
484793|NCT01097616|1187980|P8|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
484794|NCT01097616|1187981|P7|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
484795|NCT01097616|1187982|P6|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
484796|NCT01097616|1187983|P5|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
484797|NCT01097616|1187984|P4|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
484798|NCT01097616|1187985|P3|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|151 continued into EXT, 186 continued directly into RO, 4 did not continue into either Phase|341
484799|NCT01097616|1187986|P2|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|172 continued into EXT, 172 continued directly into RO, 1 did not continue into either Phase|345
484800|NCT01097616|1187987|P1|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|100 continued into EXT, 128 continued directly into RO, 2 did not continue into either Phase|230
484801|NCT01097616|1187980|P8|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
484802|NCT01097616|1187981|P7|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
484803|NCT01097616|1187982|P6|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
484804|NCT01097616|1187983|P5|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
484805|NCT01097616|1187984|P4|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
484806|NCT01097616|1187985|P3|Treated|Double-Blind (DB) Treatment (TRT) Phase||384
484807|NCT01097616|1187986|P2|Treated|Double-Blind (DB) Treatment (TRT) Phase||383
484808|NCT01097616|1187987|P1|Treated|Double-Blind (DB) Treatment (TRT) Phase||254
484809|NCT01097616|1187980|P8|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
484810|NCT01097616|1187981|P7|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
484811|NCT01097616|1187982|P6|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
484812|NCT01097616|1187983|P5|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
484813|NCT01097616|1187984|P4|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
484814|NCT01097616|1187985|P3|STARTED|Double-Blind (DB) Treatment (TRT) Phase||385
484815|NCT01097616|1187986|P2|STARTED|Double-Blind (DB) Treatment (TRT) Phase||383
484816|NCT01097616|1187987|P1|STARTED|Double-Blind (DB) Treatment (TRT) Phase||254
484817|NCT01097460|1188058|P1|NOT COMPLETED|Overall Study||0
484818|NCT01097460|1188058|P1|COMPLETED|Overall Study||16
484819|NCT01097460|1188058|P1|STARTED|Overall Study||16
484820|NCT01097421|1188062|P1|NOT COMPLETED|Overall Study||14
484821|NCT01097421|1188062|P1|COMPLETED|Overall Study||314
484822|NCT01097421|1188062|P1|STARTED|Overall Study||328
484823|NCT01097343|1188072|P2|NOT COMPLETED|Second Intervention- 30 Days||0
484824|NCT01097343|1188073|P1|NOT COMPLETED|Second Intervention- 30 Days||0
484825|NCT01097343|1188072|P2|COMPLETED|Second Intervention- 30 Days||25
484826|NCT01097343|1188073|P1|COMPLETED|Second Intervention- 30 Days||25
484827|NCT01097343|1188072|P2|STARTED|Second Intervention- 30 Days||25
484828|NCT01097343|1188073|P1|STARTED|Second Intervention- 30 Days||25
484829|NCT01097343|1188072|P2|NOT COMPLETED|First Intervention- 30 Days||0
484830|NCT01097343|1188073|P1|NOT COMPLETED|First Intervention- 30 Days||0
484831|NCT01097343|1188072|P2|COMPLETED|First Intervention- 30 Days||25
484832|NCT01097343|1188073|P1|COMPLETED|First Intervention- 30 Days||25
484833|NCT01097343|1188072|P2|STARTED|First Intervention- 30 Days||25
484834|NCT01097343|1188073|P1|STARTED|First Intervention- 30 Days||25
484835|NCT01097304|1188079|P1|NOT COMPLETED|Overall Study||7
484836|NCT01097304|1188079|P1|COMPLETED|Overall Study||29
484837|NCT01097304|1188079|P1|STARTED|Overall Study||36
484838|NCT01097057|1188086|P1|NOT COMPLETED|Overall Study||3
484839|NCT01097057|1188086|P1|COMPLETED|Overall Study||17
484840|NCT01097057|1188086|P1|STARTED|Overall Study||20
484841|NCT01097005|1188093|P1|NOT COMPLETED|Overall Study||365
484842|NCT01097005|1188093|P1|COMPLETED|Overall Study||101
484843|NCT01097005|1188093|P1|Analysis of CGI|Overall Study|number of participants who were measured for Clinical Global Improvement (CGI)|249
484844|NCT01097005|1188093|P1|Analysis of Bacilli Negative Conversion|Overall Study|number of participants who were analysed for bacilli negative conversion|285
484845|NCT01097005|1188093|P1|Analysis of NTM Lung Disease|Overall Study|number of participants who contributed to the Baseline data|340
484846|NCT01097005|1188093|P1|Analysis of Safety|Overall Study|number of participants who could be measured for Adverse Events|441
484847|NCT01097005|1188093|P1|STARTED|Overall Study|number of participants who were enrolled for this study.|466
484848|NCT01096875|1188101|P2|NOT COMPLETED|Overall Study||1
484849|NCT01096875|1188102|P1|NOT COMPLETED|Overall Study||0
484850|NCT01096875|1188101|P2|COMPLETED|Overall Study||29
484851|NCT01096875|1188102|P1|COMPLETED|Overall Study||30
484852|NCT01096875|1188101|P2|STARTED|Overall Study||30
484853|NCT01096875|1188102|P1|STARTED|Overall Study||30
484854|NCT01096823|1188116|P2|NOT COMPLETED|Overall Study||1
484855|NCT01096823|1188117|P1|NOT COMPLETED|Overall Study||3
484856|NCT01096823|1188116|P2|COMPLETED|Overall Study||15
484857|NCT01096823|1188117|P1|COMPLETED|Overall Study||11
484858|NCT01096823|1188116|P2|STARTED|Overall Study||16
484859|NCT01096823|1188117|P1|STARTED|Overall Study||14
484860|NCT01096810|1188129|P1|NOT COMPLETED|Overall Study||0
484861|NCT01096810|1188129|P1|COMPLETED|Overall Study||20
484862|NCT01096810|1188129|P1|STARTED|Overall Study||20
484863|NCT01096784|1188137|P2|NOT COMPLETED|Overall Study||14
484864|NCT01096784|1188138|P1|NOT COMPLETED|Overall Study||15
484865|NCT01096784|1188137|P2|COMPLETED|Overall Study||46
484866|NCT01096784|1188138|P1|COMPLETED|Overall Study||46
484867|NCT01096784|1188137|P2|STARTED|Overall Study||60
484868|NCT01096784|1188138|P1|STARTED|Overall Study||61
484869|NCT01096771|1188172|P2|NOT COMPLETED|Overall Study||0
484870|NCT01096771|1188173|P1|NOT COMPLETED|Overall Study||0
484871|NCT01096771|1188172|P2|COMPLETED|Overall Study||7
484872|NCT01096771|1188173|P1|COMPLETED|Overall Study||7
484873|NCT01096771|1188172|P2|STARTED|Overall Study||7
484874|NCT01096771|1188173|P1|STARTED|Overall Study||7
484875|NCT01096680|1188202|P5|NOT COMPLETED|Overall Study||0
484876|NCT01096680|1188203|P4|NOT COMPLETED|Overall Study||0
484877|NCT01096680|1188204|P3|NOT COMPLETED|Overall Study||0
484878|NCT01096680|1188205|P2|NOT COMPLETED|Overall Study||0
484879|NCT01096680|1188206|P1|NOT COMPLETED|Overall Study||0
484880|NCT01096680|1188202|P5|COMPLETED|Overall Study||27
484881|NCT01096680|1188203|P4|COMPLETED|Overall Study||27
484882|NCT01096680|1188204|P3|COMPLETED|Overall Study||27
484883|NCT01096680|1188205|P2|COMPLETED|Overall Study||27
484884|NCT01096680|1188206|P1|COMPLETED|Overall Study||27
484885|NCT01096680|1188202|P5|STARTED|Overall Study||27
484886|NCT01096680|1188203|P4|STARTED|Overall Study||27
484887|NCT01096680|1188204|P3|STARTED|Overall Study||27
484888|NCT01096680|1188205|P2|STARTED|Overall Study||27
484889|NCT01096680|1188206|P1|STARTED|Overall Study||27
484890|NCT01096667|1188243|P5|NOT COMPLETED|Overall Study||0
484891|NCT01096667|1188244|P4|NOT COMPLETED|Overall Study||3
484892|NCT01096667|1188245|P3|NOT COMPLETED|Overall Study||2
484893|NCT01096667|1188246|P2|NOT COMPLETED|Overall Study||2
484894|NCT01096667|1188247|P1|NOT COMPLETED|Overall Study||3
484895|NCT01096667|1188243|P5|COMPLETED|Overall Study||39
484896|NCT01096667|1188244|P4|COMPLETED|Overall Study||36
484897|NCT01096667|1188245|P3|COMPLETED|Overall Study||36
484898|NCT01096667|1188246|P2|COMPLETED|Overall Study||37
484899|NCT01096667|1188247|P1|COMPLETED|Overall Study||36
484900|NCT01096667|1188243|P5|Treated|Overall Study||39
484901|NCT01096667|1188244|P4|Treated|Overall Study||39
484902|NCT01096667|1188245|P3|Treated|Overall Study||38
484903|NCT01096667|1188246|P2|Treated|Overall Study||39
484904|NCT01096667|1188247|P1|Treated|Overall Study||38
484905|NCT01096667|1188243|P5|STARTED|Overall Study||39
484906|NCT01096667|1188244|P4|STARTED|Overall Study||39
484907|NCT01096667|1188245|P3|STARTED|Overall Study||38
484908|NCT01096667|1188246|P2|STARTED|Overall Study||39
484909|NCT01096667|1188247|P1|STARTED|Overall Study||39
484910|NCT01096589|1188389|P4|NOT COMPLETED|Overall Study||3
484911|NCT01096589|1188390|P3|NOT COMPLETED|Overall Study||4
484912|NCT01096589|1188391|P2|NOT COMPLETED|Overall Study||2
484913|NCT01096589|1188392|P1|NOT COMPLETED|Overall Study||4
484914|NCT01096589|1188389|P4|COMPLETED|Overall Study||15
484915|NCT01096589|1188390|P3|COMPLETED|Overall Study||18
484916|NCT01096589|1188391|P2|COMPLETED|Overall Study||18
484917|NCT01096589|1188392|P1|COMPLETED|Overall Study||18
484918|NCT01096589|1188389|P4|STARTED|Overall Study||18
484919|NCT01096589|1188390|P3|STARTED|Overall Study||22
484920|NCT01096589|1188391|P2|STARTED|Overall Study||20
484921|NCT01096589|1188392|P1|STARTED|Overall Study||22
484922|NCT01096550|1188404|P2|NOT COMPLETED|Overall Study||29
484923|NCT01096550|1188405|P1|NOT COMPLETED|Overall Study||37
484924|NCT01096550|1188404|P2|COMPLETED|Overall Study||146
484925|NCT01096550|1188405|P1|COMPLETED|Overall Study||133
484926|NCT01096550|1188404|P2|STARTED|Overall Study||175
484927|NCT01096550|1188405|P1|STARTED|Overall Study||170
484928|NCT01096446|1188413|P2|NOT COMPLETED|Overall Study||0
484929|NCT01096446|1188414|P1|NOT COMPLETED|Overall Study||3
484930|NCT01096446|1188413|P2|COMPLETED|Overall Study||10
484931|NCT01096446|1188414|P1|COMPLETED|Overall Study|One infant was SGA; one infant had a congenital anomaly; and one discontinued medical management|9
484932|NCT01096446|1188413|P2|STARTED|Overall Study||10
484933|NCT01096446|1188414|P1|STARTED|Overall Study||12
484934|NCT01096342|1188419|P1|NOT COMPLETED|Overall Study||1
484935|NCT01096342|1188419|P1|COMPLETED|Overall Study||15
484936|NCT01096342|1188419|P1|STARTED|Overall Study||16
484937|NCT01096316|1188427|P2|NOT COMPLETED|Overall Study||9
484938|NCT01096316|1188428|P1|NOT COMPLETED|Overall Study||15
484939|NCT01096316|1188427|P2|COMPLETED|Overall Study||94
484940|NCT01096316|1188428|P1|COMPLETED|Overall Study||87
484941|NCT01096316|1188427|P2|STARTED|Overall Study||103
484942|NCT01096316|1188428|P1|STARTED|Overall Study||102
484943|NCT01096186|1188438|P1|NOT COMPLETED|Overall Study||50
484944|NCT01096186|1188438|P1|COMPLETED|Overall Study||567
484945|NCT01096186|1188438|P1|STARTED|Overall Study||617
484946|NCT01096056|1188446|P2|NOT COMPLETED|Overall Study||1
484947|NCT01096056|1188447|P1|NOT COMPLETED|Overall Study||0
484948|NCT01096056|1188446|P2|COMPLETED|Overall Study||19
484949|NCT01096056|1188447|P1|COMPLETED|Overall Study||20
484950|NCT01096056|1188446|P2|Completed at Day 42|Overall Study||20
484951|NCT01096056|1188447|P1|Completed at Day 42|Overall Study||20
484952|NCT01096056|1188446|P2|STARTED|Overall Study||20
484953|NCT01096056|1188447|P1|STARTED|Overall Study||20
484954|NCT01096017|1188479|P2|NOT COMPLETED|Treatment Period 2||1
484955|NCT01096017|1188480|P1|NOT COMPLETED|Treatment Period 2||1
484956|NCT01096017|1188479|P2|COMPLETED|Treatment Period 2||11
484957|NCT01096017|1188480|P1|COMPLETED|Treatment Period 2||11
484958|NCT01096017|1188479|P2|STARTED|Treatment Period 2||12
484959|NCT01096017|1188480|P1|STARTED|Treatment Period 2||12
484960|NCT01096017|1188479|P2|NOT COMPLETED|Washout 1 - 14 Days||0
484961|NCT01096017|1188480|P1|NOT COMPLETED|Washout 1 - 14 Days||0
484962|NCT01096017|1188479|P2|COMPLETED|Washout 1 - 14 Days||12
484963|NCT01096017|1188480|P1|COMPLETED|Washout 1 - 14 Days||12
484964|NCT01096017|1188479|P2|STARTED|Washout 1 - 14 Days||12
484965|NCT01096017|1188480|P1|STARTED|Washout 1 - 14 Days||12
484966|NCT01096017|1188479|P2|NOT COMPLETED|Treatment Period 1||0
484967|NCT01096017|1188480|P1|NOT COMPLETED|Treatment Period 1||0
484968|NCT01096017|1188479|P2|COMPLETED|Treatment Period 1||12
484969|NCT01096017|1188480|P1|COMPLETED|Treatment Period 1||12
484970|NCT01096017|1188479|P2|STARTED|Treatment Period 1||12
484971|NCT01096017|1188480|P1|STARTED|Treatment Period 1||12
484972|NCT01095978|1188508|P1|NOT COMPLETED|Overall Study||3
484973|NCT01095978|1188508|P1|COMPLETED|Overall Study||2819
484974|NCT01095978|1188508|P1|STARTED|Overall Study||2822
484975|NCT01095887|1188535|P1|NOT COMPLETED|Overall Study||0
484976|NCT01095887|1188535|P1|COMPLETED|Overall Study||6
484977|NCT01095887|1188535|P1|STARTED|Overall Study||6
484978|NCT01095835|1188542|P3|NOT COMPLETED|Overall Study||8
484979|NCT01095835|1188543|P2|NOT COMPLETED|Overall Study||12
484980|NCT01095835|1188544|P1|NOT COMPLETED|Overall Study||10
484981|NCT01095835|1188542|P3|COMPLETED|Overall Study||17
484982|NCT01095835|1188543|P2|COMPLETED|Overall Study||40
484983|NCT01095835|1188544|P1|COMPLETED|Overall Study||41
484984|NCT01095835|1188542|P3|STARTED|Overall Study||25
484985|NCT01095835|1188543|P2|STARTED|Overall Study||52
484986|NCT01095835|1188544|P1|STARTED|Overall Study||51
484987|NCT01095796|1188582|P2|NOT COMPLETED|Overall Study||289
484988|NCT01095796|1188583|P1|NOT COMPLETED|Overall Study||295
484989|NCT01095796|1188582|P2|COMPLETED|Overall Study||65
484990|NCT01095796|1188583|P1|COMPLETED|Overall Study||58
484991|NCT01095796|1188582|P2|STARTED|Overall Study||354
484992|NCT01095796|1188583|P1|STARTED|Overall Study||353
484993|NCT01095757|1188601|P1|NOT COMPLETED|Overall Study||0
484994|NCT01095757|1188601|P1|COMPLETED|Overall Study||45
484995|NCT01095757|1188601|P1|STARTED|Overall Study||45
484996|NCT01095666|1188613|P3|NOT COMPLETED|Overall Study||7
484997|NCT01095666|1188614|P2|NOT COMPLETED|Overall Study||11
484998|NCT01095666|1188615|P1|NOT COMPLETED|Overall Study||17
484999|NCT01095666|1188613|P3|COMPLETED|Overall Study||145
485000|NCT01095666|1188614|P2|COMPLETED|Overall Study||136
485001|NCT01095666|1188615|P1|COMPLETED|Overall Study||128
485002|NCT01095666|1188613|P3|STARTED|Overall Study||152
485003|NCT01095666|1188614|P2|STARTED|Overall Study||147
485004|NCT01095666|1188615|P1|STARTED|Overall Study||145
485005|NCT01095653|1188638|P3|NOT COMPLETED|Overall Study||16
485006|NCT01095653|1188639|P2|NOT COMPLETED|Overall Study||15
485007|NCT01095653|1188640|P1|NOT COMPLETED|Overall Study||19
485008|NCT01095653|1188638|P3|COMPLETED|Overall Study||117
485009|NCT01095653|1188639|P2|COMPLETED|Overall Study||113
485010|NCT01095653|1188640|P1|COMPLETED|Overall Study||113
485011|NCT01095653|1188638|P3|STARTED|Overall Study||133
485012|NCT01095653|1188639|P2|STARTED|Overall Study||128
485013|NCT01095653|1188640|P1|STARTED|Overall Study||132
485014|NCT01095510|1188663|P4|NOT COMPLETED|Overall Study||0
485015|NCT01095510|1188664|P3|NOT COMPLETED|Overall Study||0
485016|NCT01095510|1188665|P2|NOT COMPLETED|Overall Study||0
485017|NCT01095510|1188666|P1|NOT COMPLETED|Overall Study||0
485018|NCT01095510|1188663|P4|COMPLETED|Overall Study||3
485019|NCT01095510|1188664|P3|COMPLETED|Overall Study||3
485020|NCT01095510|1188665|P2|COMPLETED|Overall Study||0
485021|NCT01095510|1188666|P1|COMPLETED|Overall Study||3
485022|NCT01095510|1188663|P4|STARTED|Overall Study||3
485023|NCT01095510|1188664|P3|STARTED|Overall Study||3
485024|NCT01095510|1188665|P2|STARTED|Overall Study||0
485025|NCT01095510|1188666|P1|STARTED|Overall Study||3
485026|NCT01095497|1188685|P2|NOT COMPLETED|Subcutaneous CINRYZE||0
485027|NCT01095497|1188686|P1|NOT COMPLETED|Subcutaneous CINRYZE||1
485028|NCT01095497|1188685|P2|COMPLETED|Subcutaneous CINRYZE||12
485029|NCT01095497|1188686|P1|COMPLETED|Subcutaneous CINRYZE||12
485030|NCT01095497|1188685|P2|STARTED|Subcutaneous CINRYZE||12
485031|NCT01095497|1188686|P1|STARTED|Subcutaneous CINRYZE||13
485032|NCT01095497|1188685|P2|NOT COMPLETED|Intravenous CINRYZE||0
485033|NCT01095497|1188686|P1|NOT COMPLETED|Intravenous CINRYZE||1
485034|NCT01095497|1188685|P2|COMPLETED|Intravenous CINRYZE||12
485035|NCT01095497|1188686|P1|COMPLETED|Intravenous CINRYZE||13
485036|NCT01095497|1188685|P2|STARTED|Intravenous CINRYZE||12
485037|NCT01095497|1188686|P1|STARTED|Intravenous CINRYZE||14
485038|NCT01095250|1188698|P4|NOT COMPLETED|Overall Study||5
485039|NCT01095250|1188699|P3|NOT COMPLETED|Overall Study||8
485040|NCT01095250|1188700|P2|NOT COMPLETED|Overall Study||10
485041|NCT01095250|1188701|P1|NOT COMPLETED|Overall Study||8
485042|NCT01095250|1188698|P4|COMPLETED|Overall Study||0
485043|NCT01095250|1188699|P3|COMPLETED|Overall Study||0
485044|NCT01095250|1188700|P2|COMPLETED|Overall Study||0
485045|NCT01095250|1188701|P1|COMPLETED|Overall Study||0
485046|NCT01095250|1188698|P4|STARTED|Overall Study||5
485047|NCT01095250|1188699|P3|STARTED|Overall Study||8
485048|NCT01095250|1188700|P2|STARTED|Overall Study||10
485049|NCT01095250|1188701|P1|STARTED|Overall Study||8
485050|NCT01095094|1188731|P1|NOT COMPLETED|Overall Study||3
485051|NCT01095094|1188731|P1|COMPLETED|Overall Study||16
485052|NCT01095094|1188731|P1|STARTED|Overall Study||19
485053|NCT01094886|1188736|P1|NOT COMPLETED|Overall Study||7
485054|NCT01094886|1188736|P1|COMPLETED|Overall Study||46
485055|NCT01094886|1188736|P1|STARTED|Overall Study||53
485056|NCT01094808|1188746|P3|NOT COMPLETED|Overall Study||0
485057|NCT01094808|1188747|P2|NOT COMPLETED|Overall Study||1
485058|NCT01094808|1188748|P1|NOT COMPLETED|Overall Study||1
485059|NCT01094808|1188746|P3|COMPLETED|Overall Study||21
485060|NCT01094808|1188747|P2|COMPLETED|Overall Study||19
485061|NCT01094808|1188748|P1|COMPLETED|Overall Study||20
485062|NCT01094808|1188746|P3|STARTED|Overall Study||21
485063|NCT01094808|1188747|P2|STARTED|Overall Study||20
485064|NCT01094808|1188748|P1|STARTED|Overall Study||21
485065|NCT01094743|1188783|P1|NOT COMPLETED|Period 2||0
485066|NCT01094743|1188783|P1|COMPLETED|Period 2||50
485067|NCT01094743|1188783|P1|STARTED|Period 2||50
485068|NCT01094743|1188783|P1|NOT COMPLETED|Period 1||2
485069|NCT01094743|1188783|P1|COMPLETED|Period 1||50
485070|NCT01094743|1188783|P1|STARTED|Period 1||52
485071|NCT01094730|1188800|P2|NOT COMPLETED|Period 2 (14 Days)||2
485072|NCT01094730|1188801|P1|NOT COMPLETED|Period 2 (14 Days)||3
485073|NCT01094730|1188800|P2|COMPLETED|Period 2 (14 Days)||84
485074|NCT01094730|1188801|P1|COMPLETED|Period 2 (14 Days)||87
485075|NCT01094730|1188800|P2|STARTED|Period 2 (14 Days)||86
485076|NCT01094730|1188801|P1|STARTED|Period 2 (14 Days)||90
485077|NCT01094730|1188800|P2|NOT COMPLETED|Period 1 (14 Days)||2
485078|NCT01094730|1188801|P1|NOT COMPLETED|Period 1 (14 Days)||2
485079|NCT01094730|1188800|P2|COMPLETED|Period 1 (14 Days)||86
485080|NCT01094730|1188801|P1|COMPLETED|Period 1 (14 Days)||90
485081|NCT01094730|1188800|P2|STARTED|Period 1 (14 Days)||88
485082|NCT01094730|1188801|P1|STARTED|Period 1 (14 Days)||92
485083|NCT01094704|1188814|P2|NOT COMPLETED|Overall Study||0
485084|NCT01094704|1188815|P1|NOT COMPLETED|Overall Study||0
485085|NCT01094704|1188814|P2|COMPLETED|Overall Study||8
485086|NCT01094704|1188815|P1|COMPLETED|Overall Study||8
485087|NCT01094704|1188814|P2|STARTED|Overall Study||8
485088|NCT01094704|1188815|P1|STARTED|Overall Study||8
485089|NCT01094574|1188827|P6|NOT COMPLETED|Overall Study||0
485090|NCT01094574|1188828|P5|NOT COMPLETED|Overall Study||0
485091|NCT01094574|1188829|P4|NOT COMPLETED|Overall Study||0
485092|NCT01094574|1188830|P3|NOT COMPLETED|Overall Study||0
485093|NCT01094574|1188831|P2|NOT COMPLETED|Overall Study||0
485094|NCT01094574|1188832|P1|NOT COMPLETED|Overall Study||0
485095|NCT01094574|1188827|P6|COMPLETED|Overall Study||2
485096|NCT01094574|1188828|P5|COMPLETED|Overall Study||2
485097|NCT01094574|1188829|P4|COMPLETED|Overall Study||2
485098|NCT01094574|1188830|P3|COMPLETED|Overall Study||2
485099|NCT01094574|1188831|P2|COMPLETED|Overall Study||1
485100|NCT01094574|1188832|P1|COMPLETED|Overall Study||1
485101|NCT01094574|1188827|P6|STARTED|Overall Study||2
485102|NCT01094574|1188828|P5|STARTED|Overall Study||2
485103|NCT01094574|1188829|P4|STARTED|Overall Study||2
485104|NCT01094574|1188830|P3|STARTED|Overall Study||2
485105|NCT01094574|1188831|P2|STARTED|Overall Study||1
485106|NCT01094574|1188832|P1|STARTED|Overall Study||1
485107|NCT01094561|1188879|P1|NOT COMPLETED|Overall Study||6
485108|NCT01094561|1188879|P1|COMPLETED|Overall Study||17
485109|NCT01094561|1188879|P1|STARTED|Overall Study||23
485110|NCT01094548|1188886|P2|NOT COMPLETED|Overall Study||0
485111|NCT01094548|1188887|P1|NOT COMPLETED|Overall Study||0
485112|NCT01094548|1188886|P2|COMPLETED|Overall Study||17
485113|NCT01094548|1188887|P1|COMPLETED|Overall Study||17
485114|NCT01094548|1188886|P2|STARTED|Overall Study||17
485115|NCT01094548|1188887|P1|STARTED|Overall Study||17
485116|NCT01094522|1188907|P2|NOT COMPLETED|Overall Study||0
485117|NCT01094522|1188908|P1|NOT COMPLETED|Overall Study||0
485118|NCT01094522|1188907|P2|COMPLETED|Overall Study||20
485119|NCT01094522|1188908|P1|COMPLETED|Overall Study||20
485120|NCT01094522|1188907|P2|STARTED|Overall Study||20
485121|NCT01094522|1188908|P1|STARTED|Overall Study||20
485122|NCT01094184|1188920|P2|NOT COMPLETED|Overall Study||11
485123|NCT01094184|1188921|P1|NOT COMPLETED|Overall Study||35
485124|NCT01094184|1188920|P2|COMPLETED|Overall Study||2
485125|NCT01094184|1188921|P1|COMPLETED|Overall Study||1
485126|NCT01094184|1188920|P2|STARTED|Overall Study||13
485127|NCT01094184|1188921|P1|STARTED|Overall Study||36
485128|NCT01094171|1189155|P1|NOT COMPLETED|Overall Study||10
485129|NCT01094171|1189155|P1|COMPLETED|Overall Study||390
485130|NCT01094171|1189155|P1|STARTED|Overall Study||400
485131|NCT01094119|1189164|P2|NOT COMPLETED|Overall Study||4
485132|NCT01094119|1189165|P1|NOT COMPLETED|Overall Study||2
485133|NCT01094119|1189164|P2|COMPLETED|Overall Study||32
485134|NCT01094119|1189165|P1|COMPLETED|Overall Study||32
485135|NCT01094119|1189164|P2|STARTED|Overall Study||36
485136|NCT01094119|1189165|P1|STARTED|Overall Study||34
485137|NCT01093976|1189173|P1|NOT COMPLETED|Overall Study||0
485138|NCT01093976|1189173|P1|COMPLETED|Overall Study||14
485139|NCT01093976|1189173|P1|STARTED|Overall Study||14
485140|NCT01093846|1189180|P3|NOT COMPLETED|Overall Study||21
485141|NCT01093846|1189181|P2|NOT COMPLETED|Overall Study||18
485142|NCT01093846|1189182|P1|NOT COMPLETED|Overall Study||19
485143|NCT01093846|1189180|P3|COMPLETED|Overall Study||1
485144|NCT01093846|1189181|P2|COMPLETED|Overall Study||0
485145|NCT01093846|1189182|P1|COMPLETED|Overall Study||0
485146|NCT01093846|1189180|P3|STARTED|Overall Study||22
485147|NCT01093846|1189181|P2|STARTED|Overall Study||18
485148|NCT01093846|1189182|P1|STARTED|Overall Study||19
485149|NCT01093794|1189188|P4|NOT COMPLETED|Treatment Period 4||0
485150|NCT01093794|1189189|P3|NOT COMPLETED|Treatment Period 4||0
485151|NCT01093794|1189190|P2|NOT COMPLETED|Treatment Period 4||0
485152|NCT01093794|1189191|P1|NOT COMPLETED|Treatment Period 4||0
485153|NCT01093794|1189188|P4|COMPLETED|Treatment Period 4||7
485154|NCT01093794|1189189|P3|COMPLETED|Treatment Period 4||6
485155|NCT01093794|1189190|P2|COMPLETED|Treatment Period 4||7
485156|NCT01093794|1189191|P1|COMPLETED|Treatment Period 4||7
485157|NCT01093794|1189188|P4|STARTED|Treatment Period 4||7
485158|NCT01093794|1189189|P3|STARTED|Treatment Period 4||6
485159|NCT01093794|1189190|P2|STARTED|Treatment Period 4||7
485160|NCT01093794|1189191|P1|STARTED|Treatment Period 4||7
485161|NCT01093794|1189188|P4|NOT COMPLETED|Treatment Period 3||0
485162|NCT01093794|1189189|P3|NOT COMPLETED|Treatment Period 3||0
485163|NCT01093794|1189190|P2|NOT COMPLETED|Treatment Period 3||0
485164|NCT01093794|1189191|P1|NOT COMPLETED|Treatment Period 3||0
485165|NCT01093794|1189188|P4|COMPLETED|Treatment Period 3||7
485166|NCT01093794|1189189|P3|COMPLETED|Treatment Period 3||6
485167|NCT01093794|1189190|P2|COMPLETED|Treatment Period 3||7
485168|NCT01093794|1189191|P1|COMPLETED|Treatment Period 3||7
485169|NCT01093794|1189188|P4|STARTED|Treatment Period 3||7
485170|NCT01093794|1189189|P3|STARTED|Treatment Period 3||6
485171|NCT01093794|1189190|P2|STARTED|Treatment Period 3||7
485172|NCT01093794|1189191|P1|STARTED|Treatment Period 3||7
485173|NCT01093794|1189188|P4|NOT COMPLETED|Treatment Period 2||0
485174|NCT01093794|1189189|P3|NOT COMPLETED|Treatment Period 2||0
485175|NCT01093794|1189190|P2|NOT COMPLETED|Treatment Period 2||0
485176|NCT01093794|1189191|P1|NOT COMPLETED|Treatment Period 2||0
485177|NCT01093794|1189188|P4|COMPLETED|Treatment Period 2||7
485178|NCT01093794|1189189|P3|COMPLETED|Treatment Period 2||6
485179|NCT01093794|1189190|P2|COMPLETED|Treatment Period 2||7
485180|NCT01093794|1189191|P1|COMPLETED|Treatment Period 2||7
485181|NCT01093794|1189188|P4|STARTED|Treatment Period 2||7
485182|NCT01093794|1189189|P3|STARTED|Treatment Period 2|After period 1, one participant was discontinued by the investigator due to a protocol deviation.|6
485183|NCT01093794|1189190|P2|STARTED|Treatment Period 2||7
485184|NCT01093794|1189191|P1|STARTED|Treatment Period 2||7
485185|NCT01093794|1189188|P4|NOT COMPLETED|Treatment Period 1||0
485186|NCT01093794|1189189|P3|NOT COMPLETED|Treatment Period 1||0
485187|NCT01093794|1189190|P2|NOT COMPLETED|Treatment Period 1||0
485188|NCT01093794|1189191|P1|NOT COMPLETED|Treatment Period 1||0
485189|NCT01093794|1189188|P4|COMPLETED|Treatment Period 1||7
485190|NCT01093794|1189189|P3|COMPLETED|Treatment Period 1||7
485191|NCT01093794|1189190|P2|COMPLETED|Treatment Period 1||7
485192|NCT01093794|1189191|P1|COMPLETED|Treatment Period 1||7
485193|NCT01093794|1189188|P4|STARTED|Treatment Period 1||7
485194|NCT01093794|1189189|P3|STARTED|Treatment Period 1||7
485195|NCT01093794|1189190|P2|STARTED|Treatment Period 1||7
485196|NCT01093794|1189191|P1|STARTED|Treatment Period 1||7
485197|NCT01093755|1189207|P2|NOT COMPLETED|Overall Study||4
485198|NCT01093755|1189208|P1|NOT COMPLETED|Overall Study||3
485199|NCT01093755|1189207|P2|COMPLETED|Overall Study||10
485200|NCT01093755|1189208|P1|COMPLETED|Overall Study||13
485201|NCT01093755|1189207|P2|STARTED|Overall Study||14
485202|NCT01093755|1189208|P1|STARTED|Overall Study||16
485203|NCT01093690|1189218|P2|NOT COMPLETED|Overall Study||0
485204|NCT01093690|1189219|P1|NOT COMPLETED|Overall Study||0
485205|NCT01093690|1189218|P2|COMPLETED|Overall Study||79
485206|NCT01093690|1189219|P1|COMPLETED|Overall Study||83
485207|NCT01093690|1189218|P2|STARTED|Overall Study||79
485208|NCT01093690|1189219|P1|STARTED|Overall Study||83
485209|NCT01093651|1189227|P2|NOT COMPLETED|Overall Study||0
485210|NCT01093651|1189228|P1|NOT COMPLETED|Overall Study||0
485211|NCT01093651|1189227|P2|COMPLETED|Overall Study||10
485212|NCT01093651|1189228|P1|COMPLETED|Overall Study||10
485213|NCT01093651|1189227|P2|STARTED|Overall Study||10
485214|NCT01093651|1189228|P1|STARTED|Overall Study||10
485215|NCT01093625|1189248|P2|NOT COMPLETED|1-Year Visit||3
485216|NCT01093625|1189249|P1|NOT COMPLETED|1-Year Visit||5
485217|NCT01093625|1189248|P2|COMPLETED|1-Year Visit||37
485218|NCT01093625|1189249|P1|COMPLETED|1-Year Visit||29
485219|NCT01093625|1189248|P2|STARTED|1-Year Visit||40
485220|NCT01093625|1189249|P1|STARTED|1-Year Visit||34
485221|NCT01093625|1189248|P2|NOT COMPLETED|6-Month Visit||9
485222|NCT01093625|1189249|P1|NOT COMPLETED|6-Month Visit||8
485223|NCT01093625|1189248|P2|COMPLETED|6-Month Visit||40
485224|NCT01093625|1189249|P1|COMPLETED|6-Month Visit||34
485225|NCT01093625|1189248|P2|STARTED|6-Month Visit||49
485226|NCT01093625|1189249|P1|STARTED|6-Month Visit||42
485227|NCT01093625|1189248|P2|NOT COMPLETED|3-Month Visit||0
485228|NCT01093625|1189249|P1|NOT COMPLETED|3-Month Visit||2
485229|NCT01093625|1189248|P2|COMPLETED|3-Month Visit||49
485230|NCT01093625|1189249|P1|COMPLETED|3-Month Visit||42
485231|NCT01093625|1189248|P2|STARTED|3-Month Visit||49
485232|NCT01093625|1189249|P1|STARTED|3-Month Visit||44
485233|NCT01093625|1189248|P2|NOT COMPLETED|1-Month Visit||0
485234|NCT01093625|1189249|P1|NOT COMPLETED|1-Month Visit||2
485235|NCT01093625|1189248|P2|COMPLETED|1-Month Visit||49
485236|NCT01093625|1189249|P1|COMPLETED|1-Month Visit||44
485237|NCT01093625|1189248|P2|STARTED|1-Month Visit||49
485238|NCT01093625|1189249|P1|STARTED|1-Month Visit||46
485239|NCT01093625|1189248|P2|NOT COMPLETED|2-Week Visit||0
485240|NCT01093625|1189249|P1|NOT COMPLETED|2-Week Visit||1
485241|NCT01093625|1189248|P2|COMPLETED|2-Week Visit||49
485242|NCT01093625|1189249|P1|COMPLETED|2-Week Visit||46
485243|NCT01093625|1189248|P2|STARTED|2-Week Visit||49
485244|NCT01093625|1189249|P1|STARTED|2-Week Visit||47
485245|NCT01093625|1189248|P2|NOT COMPLETED|Baseline and Dispensed||0
485246|NCT01093625|1189249|P1|NOT COMPLETED|Baseline and Dispensed||2
485247|NCT01093625|1189248|P2|COMPLETED|Baseline and Dispensed||49
485248|NCT01093625|1189249|P1|COMPLETED|Baseline and Dispensed||47
485249|NCT01093625|1189248|P2|STARTED|Baseline and Dispensed||49
485250|NCT01093625|1189249|P1|STARTED|Baseline and Dispensed||49
485251|NCT01093599|1189269|P2|NOT COMPLETED|Overall Study||46
485252|NCT01093599|1189270|P1|NOT COMPLETED|Overall Study||32
485253|NCT01093599|1189269|P2|COMPLETED|Overall Study||59
485254|NCT01093599|1189270|P1|COMPLETED|Overall Study||59
485255|NCT01093599|1189269|P2|STARTED|Overall Study||105
485256|NCT01093599|1189270|P1|STARTED|Overall Study||91
485257|NCT01093534|1189279|P3|NOT COMPLETED|Overall Study||9
485258|NCT01093534|1189280|P2|NOT COMPLETED|Overall Study||16
485259|NCT01093534|1189281|P1|NOT COMPLETED|Overall Study||10
485260|NCT01093534|1189279|P3|COMPLETED|Overall Study||169
485261|NCT01093534|1189280|P2|COMPLETED|Overall Study||167
485262|NCT01093534|1189281|P1|COMPLETED|Overall Study||176
485263|NCT01093534|1189279|P3|Received Study Treatment|Overall Study||175
485264|NCT01093534|1189280|P2|Received Study Treatment|Overall Study||182
485265|NCT01093534|1189281|P1|Received Study Treatment|Overall Study||186
485266|NCT01093534|1189279|P3|STARTED|Overall Study||178
485267|NCT01093534|1189280|P2|STARTED|Overall Study||183
485268|NCT01093534|1189281|P1|STARTED|Overall Study||186
485269|NCT01093521|1189386|P1|NOT COMPLETED|Overall Study||0
485270|NCT01093521|1189386|P1|COMPLETED|Overall Study||20
485271|NCT01093521|1189386|P1|STARTED|Overall Study||20
485272|NCT01093482|1189401|P1|NOT COMPLETED|Overall Study||0
485273|NCT01093482|1189401|P1|COMPLETED|Overall Study||8151
485274|NCT01093482|1189401|P1|STARTED|Overall Study||8151
485275|NCT01093469|1189408|P3|NOT COMPLETED|Overall Study||1
485276|NCT01093469|1189409|P2|NOT COMPLETED|Overall Study||0
485277|NCT01093469|1189410|P1|NOT COMPLETED|Overall Study||0
485278|NCT01093469|1189408|P3|COMPLETED|Overall Study||12
485279|NCT01093469|1189409|P2|COMPLETED|Overall Study||13
485280|NCT01093469|1189410|P1|COMPLETED|Overall Study||13
485281|NCT01093469|1189408|P3|STARTED|Overall Study||13
485282|NCT01093469|1189409|P2|STARTED|Overall Study||13
485283|NCT01093469|1189410|P1|STARTED|Overall Study||13
485284|NCT01093417|1189420|P2|NOT COMPLETED|Overall Study||1
485285|NCT01093417|1189421|P1|NOT COMPLETED|Overall Study||0
485286|NCT01093417|1189420|P2|COMPLETED|Overall Study||29
485287|NCT01093417|1189421|P1|COMPLETED|Overall Study||15
485288|NCT01093417|1189420|P2|STARTED|Overall Study||30
485289|NCT01093417|1189421|P1|STARTED|Overall Study||15
485290|NCT01093222|1189429|P1|NOT COMPLETED|Overall Study||40
485291|NCT01093222|1189429|P1|COMPLETED|Overall Study||0
485292|NCT01093222|1189429|P1|Eligible and Began Protocol Therapy|Overall Study||34
485293|NCT01093222|1189429|P1|STARTED|Overall Study||40
485294|NCT01093183|1189436|P2|NOT COMPLETED|Overall Study||2
485295|NCT01093183|1189437|P1|NOT COMPLETED|Overall Study||1
485296|NCT01093183|1189436|P2|COMPLETED|Overall Study||4
485297|NCT01093183|1189437|P1|COMPLETED|Overall Study||18
485298|NCT01093183|1189436|P2|STARTED|Overall Study||6
485299|NCT01093183|1189437|P1|STARTED|Overall Study||19
485300|NCT01093027|1189447|P2|NOT COMPLETED|Visit 2||0
485301|NCT01093027|1189448|P1|NOT COMPLETED|Visit 2||0
485302|NCT01093027|1189447|P2|COMPLETED|Visit 2||10
485303|NCT01093027|1189448|P1|COMPLETED|Visit 2||10
485304|NCT01093027|1189447|P2|STARTED|Visit 2||10
485305|NCT01093027|1189448|P1|STARTED|Visit 2||10
485306|NCT01093027|1189447|P2|NOT COMPLETED|Visit 1||0
485307|NCT01093027|1189448|P1|NOT COMPLETED|Visit 1||0
485308|NCT01093027|1189447|P2|COMPLETED|Visit 1||10
485309|NCT01093027|1189448|P1|COMPLETED|Visit 1||10
485310|NCT01093027|1189447|P2|STARTED|Visit 1||10
485311|NCT01093027|1189448|P1|STARTED|Visit 1||10
485312|NCT01093014|1189459|P3|NOT COMPLETED|Overall Study||0
485313|NCT01093014|1189460|P2|NOT COMPLETED|Overall Study||0
485314|NCT01093014|1189461|P1|NOT COMPLETED|Overall Study||0
485315|NCT01093014|1189459|P3|COMPLETED|Overall Study||12
485316|NCT01093014|1189460|P2|COMPLETED|Overall Study||9
485317|NCT01093014|1189461|P1|COMPLETED|Overall Study||12
485318|NCT01093014|1189459|P3|STARTED|Overall Study||12
485319|NCT01093014|1189460|P2|STARTED|Overall Study||9
485320|NCT01093014|1189461|P1|STARTED|Overall Study||12
485321|NCT01092923|1189480|P2|NOT COMPLETED|Overall Study||0
485322|NCT01092923|1189481|P1|NOT COMPLETED|Overall Study||0
485323|NCT01092923|1189480|P2|COMPLETED|Overall Study||10
485324|NCT01092923|1189481|P1|COMPLETED|Overall Study||10
485325|NCT01092923|1189480|P2|STARTED|Overall Study||10
485326|NCT01092923|1189481|P1|STARTED|Overall Study||10
485327|NCT01092910|1189490|P1|NOT COMPLETED|Overall Study||5
485328|NCT01092910|1189490|P1|COMPLETED|Overall Study||52
485329|NCT01092910|1189490|P1|10 Month Follow-up|Overall Study||52
485330|NCT01092910|1189490|P1|4 Month Follow-up|Overall Study||54
485331|NCT01092910|1189490|P1|STARTED|Overall Study||57
485332|NCT01092832|1189502|P2|NOT COMPLETED|Overall Study||0
485333|NCT01092832|1189503|P1|NOT COMPLETED|Overall Study||1
485334|NCT01092832|1189502|P2|COMPLETED|Overall Study||8
485335|NCT01092832|1189503|P1|COMPLETED|Overall Study||13
485336|NCT01092832|1189502|P2|STARTED|Overall Study||8
485337|NCT01092832|1189503|P1|STARTED|Overall Study||14
485338|NCT01092780|1189515|P4|NOT COMPLETED|Treatment Period 4||0
485339|NCT01092780|1189516|P3|NOT COMPLETED|Treatment Period 4||0
485340|NCT01092780|1189517|P2|NOT COMPLETED|Treatment Period 4||0
485341|NCT01092780|1189518|P1|NOT COMPLETED|Treatment Period 4||0
485342|NCT01092780|1189515|P4|COMPLETED|Treatment Period 4||13
485343|NCT01092780|1189516|P3|COMPLETED|Treatment Period 4||13
485344|NCT01092780|1189517|P2|COMPLETED|Treatment Period 4||13
485345|NCT01092780|1189518|P1|COMPLETED|Treatment Period 4||13
485346|NCT01092780|1189515|P4|STARTED|Treatment Period 4||13
485347|NCT01092780|1189516|P3|STARTED|Treatment Period 4||13
485348|NCT01092780|1189517|P2|STARTED|Treatment Period 4||13
485349|NCT01092780|1189518|P1|STARTED|Treatment Period 4||13
485350|NCT01092780|1189515|P4|NOT COMPLETED|Washout Period 3||0
485351|NCT01092780|1189516|P3|NOT COMPLETED|Washout Period 3||0
485352|NCT01092780|1189517|P2|NOT COMPLETED|Washout Period 3||0
485353|NCT01092780|1189518|P1|NOT COMPLETED|Washout Period 3||0
485354|NCT01092780|1189515|P4|COMPLETED|Washout Period 3||13
485355|NCT01092780|1189516|P3|COMPLETED|Washout Period 3||13
485356|NCT01092780|1189517|P2|COMPLETED|Washout Period 3||13
485357|NCT01092780|1189518|P1|COMPLETED|Washout Period 3||13
485358|NCT01092780|1189515|P4|STARTED|Washout Period 3||13
485359|NCT01092780|1189516|P3|STARTED|Washout Period 3||13
485360|NCT01092780|1189517|P2|STARTED|Washout Period 3||13
485361|NCT01092780|1189518|P1|STARTED|Washout Period 3||13
485362|NCT01092780|1189515|P4|NOT COMPLETED|Treatment Period 3||0
485363|NCT01092780|1189516|P3|NOT COMPLETED|Treatment Period 3||0
485364|NCT01092780|1189517|P2|NOT COMPLETED|Treatment Period 3||0
485365|NCT01092780|1189518|P1|NOT COMPLETED|Treatment Period 3||0
485366|NCT01092780|1189515|P4|COMPLETED|Treatment Period 3||13
485367|NCT01092780|1189516|P3|COMPLETED|Treatment Period 3||13
485368|NCT01092780|1189517|P2|COMPLETED|Treatment Period 3||13
485369|NCT01092780|1189518|P1|COMPLETED|Treatment Period 3||13
485370|NCT01092780|1189515|P4|STARTED|Treatment Period 3||13
485371|NCT01092780|1189516|P3|STARTED|Treatment Period 3||13
485372|NCT01092780|1189517|P2|STARTED|Treatment Period 3||13
485373|NCT01092780|1189518|P1|STARTED|Treatment Period 3||13
485374|NCT01092780|1189515|P4|NOT COMPLETED|Washout Period 2||0
485375|NCT01092780|1189516|P3|NOT COMPLETED|Washout Period 2||1
485376|NCT01092780|1189517|P2|NOT COMPLETED|Washout Period 2||1
485377|NCT01092780|1189518|P1|NOT COMPLETED|Washout Period 2||0
485378|NCT01092780|1189515|P4|COMPLETED|Washout Period 2||13
485379|NCT01092780|1189516|P3|COMPLETED|Washout Period 2||13
485380|NCT01092780|1189517|P2|COMPLETED|Washout Period 2||13
485381|NCT01092780|1189518|P1|COMPLETED|Washout Period 2||13
485382|NCT01092780|1189515|P4|STARTED|Washout Period 2||13
485383|NCT01092780|1189516|P3|STARTED|Washout Period 2||14
485384|NCT01092780|1189517|P2|STARTED|Washout Period 2||14
485385|NCT01092780|1189518|P1|STARTED|Washout Period 2||13
485386|NCT01092780|1189515|P4|NOT COMPLETED|Treatment Period 2||0
485387|NCT01092780|1189516|P3|NOT COMPLETED|Treatment Period 2||0
485388|NCT01092780|1189517|P2|NOT COMPLETED|Treatment Period 2||0
485389|NCT01092780|1189518|P1|NOT COMPLETED|Treatment Period 2||0
485390|NCT01092780|1189515|P4|COMPLETED|Treatment Period 2||13
485391|NCT01092780|1189516|P3|COMPLETED|Treatment Period 2||14
485392|NCT01092780|1189517|P2|COMPLETED|Treatment Period 2||14
485393|NCT01092780|1189518|P1|COMPLETED|Treatment Period 2||13
485394|NCT01092780|1189515|P4|STARTED|Treatment Period 2||13
485395|NCT01092780|1189516|P3|STARTED|Treatment Period 2||14
485396|NCT01092780|1189517|P2|STARTED|Treatment Period 2||14
485397|NCT01092780|1189518|P1|STARTED|Treatment Period 2||13
485398|NCT01092780|1189515|P4|NOT COMPLETED|Washout Period 1||0
485399|NCT01092780|1189516|P3|NOT COMPLETED|Washout Period 1||0
485400|NCT01092780|1189517|P2|NOT COMPLETED|Washout Period 1||1
485401|NCT01092780|1189518|P1|NOT COMPLETED|Washout Period 1||1
485402|NCT01092780|1189515|P4|COMPLETED|Washout Period 1||13
485403|NCT01092780|1189516|P3|COMPLETED|Washout Period 1||14
485404|NCT01092780|1189517|P2|COMPLETED|Washout Period 1||14
485405|NCT01092780|1189518|P1|COMPLETED|Washout Period 1||13
485406|NCT01092780|1189515|P4|STARTED|Washout Period 1||13
485407|NCT01092780|1189516|P3|STARTED|Washout Period 1||14
485408|NCT01092780|1189517|P2|STARTED|Washout Period 1||15
485409|NCT01092780|1189518|P1|STARTED|Washout Period 1||14
485410|NCT01092780|1189515|P4|NOT COMPLETED|Treatment Period 1||0
485411|NCT01092780|1189516|P3|NOT COMPLETED|Treatment Period 1||0
485412|NCT01092780|1189517|P2|NOT COMPLETED|Treatment Period 1||0
485413|NCT01092780|1189518|P1|NOT COMPLETED|Treatment Period 1||0
485414|NCT01092780|1189515|P4|COMPLETED|Treatment Period 1||13
485415|NCT01092780|1189516|P3|COMPLETED|Treatment Period 1||14
485416|NCT01092780|1189517|P2|COMPLETED|Treatment Period 1||15
485417|NCT01092780|1189518|P1|COMPLETED|Treatment Period 1||14
485418|NCT01092780|1189515|P4|STARTED|Treatment Period 1||13
485419|NCT01092780|1189516|P3|STARTED|Treatment Period 1||14
485420|NCT01092780|1189517|P2|STARTED|Treatment Period 1||15
485421|NCT01092780|1189518|P1|STARTED|Treatment Period 1||14
485422|NCT01092767|1189548|P1|NOT COMPLETED|Overall Study||5
485423|NCT01092767|1189548|P1|COMPLETED|Overall Study||45
485424|NCT01092767|1189548|P1|STARTED|Overall Study||50
485425|NCT01092728|1189554|P2|NOT COMPLETED|Overall Study||14
485426|NCT01092728|1189555|P1|NOT COMPLETED|Overall Study||4
485427|NCT01092728|1189554|P2|COMPLETED|Overall Study||0
485428|NCT01092728|1189555|P1|COMPLETED|Overall Study||0
485429|NCT01092728|1189554|P2|STARTED|Overall Study||14
485430|NCT01092728|1189555|P1|STARTED|Overall Study||4
485431|NCT01092702|1189563|P1|NOT COMPLETED|Overall Study||9
485432|NCT01092702|1189563|P1|COMPLETED|Overall Study||23
485433|NCT01092702|1189563|P1|STARTED|Overall Study||32
485434|NCT01092663|1189569|P2|NOT COMPLETED|Overall Study||4
485435|NCT01092663|1189570|P1|NOT COMPLETED|Overall Study||7
485436|NCT01092663|1189569|P2|COMPLETED|Overall Study||26
485437|NCT01092663|1189570|P1|COMPLETED|Overall Study||24
485438|NCT01092663|1189569|P2|STARTED|Overall Study||30
485439|NCT01092663|1189570|P1|STARTED|Overall Study||31
485440|NCT01092637|1189618|P2|NOT COMPLETED|Overall Study||49
485441|NCT01092637|1189619|P1|NOT COMPLETED|Overall Study||47
485442|NCT01092637|1189618|P2|COMPLETED|Overall Study||86
485443|NCT01092637|1189619|P1|COMPLETED|Overall Study||98
485444|NCT01092637|1189618|P2|STARTED|Overall Study||135
485445|NCT01092637|1189619|P1|STARTED|Overall Study||145
485446|NCT01092559|1189629|P1|NOT COMPLETED|Overall Study||0
485447|NCT01092559|1189629|P1|COMPLETED|Overall Study||10
485448|NCT01092559|1189629|P1|STARTED|Overall Study||10
485449|NCT01092546|1189634|P1|NOT COMPLETED|Overall Study||4
485450|NCT01092546|1189634|P1|COMPLETED|Overall Study||12
485451|NCT01092546|1189634|P1|STARTED|Overall Study||16
485452|NCT01092507|1189641|P2|NOT COMPLETED|Overall Study||0
485453|NCT01092507|1189642|P1|NOT COMPLETED|Overall Study||2
485454|NCT01092507|1189641|P2|COMPLETED|Overall Study||150
485455|NCT01092507|1189642|P1|COMPLETED|Overall Study||147
485456|NCT01092507|1189641|P2|STARTED|Overall Study||150
485457|NCT01092507|1189642|P1|STARTED|Overall Study||149
485458|NCT01092442|1189662|P2|NOT COMPLETED|Overall Study||0
485459|NCT01092442|1189663|P1|NOT COMPLETED|Overall Study||0
485460|NCT01092442|1189662|P2|COMPLETED|Overall Study||60
485461|NCT01092442|1189663|P1|COMPLETED|Overall Study||80
485462|NCT01092442|1189662|P2|STARTED|Overall Study||60
485463|NCT01092442|1189663|P1|STARTED|Overall Study||80
485464|NCT01092416|1189677|P1|NOT COMPLETED|12-Month Follow-up||25
485465|NCT01092416|1189677|P1|COMPLETED|12-Month Follow-up||413
485466|NCT01092416|1189677|P1|STARTED|12-Month Follow-up||438
485467|NCT01092416|1189677|P1|NOT COMPLETED|30-Day Follow-up||10
485468|NCT01092416|1189677|P1|COMPLETED|30-Day Follow-up||430
485469|NCT01092416|1189677|P1|STARTED|30-Day Follow-up||440
485470|NCT01092416|1189677|P1|NOT COMPLETED|Enrollment||3
485471|NCT01092416|1189677|P1|COMPLETED|Enrollment||440
485472|NCT01092416|1189677|P1|STARTED|Enrollment||443
485473|NCT01092364|1189689|P3|NOT COMPLETED|Overall Study||18
485474|NCT01092364|1189690|P2|NOT COMPLETED|Overall Study||16
485475|NCT01092364|1189691|P1|NOT COMPLETED|Overall Study||18
485476|NCT01092364|1189689|P3|COMPLETED|Overall Study||105
485477|NCT01092364|1189690|P2|COMPLETED|Overall Study||104
485478|NCT01092364|1189691|P1|COMPLETED|Overall Study||104
485479|NCT01092364|1189689|P3|STARTED|Overall Study||123
485480|NCT01092364|1189690|P2|STARTED|Overall Study||120
485481|NCT01092364|1189691|P1|STARTED|Overall Study||122
485482|NCT01092338|1189701|P2|NOT COMPLETED|Overall Study||1
485483|NCT01092338|1189702|P1|NOT COMPLETED|Overall Study||1
485484|NCT01092338|1189701|P2|COMPLETED|Overall Study||21
485485|NCT01092338|1189702|P1|COMPLETED|Overall Study||21
485486|NCT01092338|1189701|P2|STARTED|Overall Study||22
485487|NCT01092338|1189702|P1|STARTED|Overall Study||22
485488|NCT01091974|1189714|P4|NOT COMPLETED|Overall Study||7
485489|NCT01091974|1189715|P3|NOT COMPLETED|Overall Study||6
485490|NCT01091974|1189716|P2|NOT COMPLETED|Overall Study||5
485491|NCT01091974|1189717|P1|NOT COMPLETED|Overall Study||5
485492|NCT01091974|1189714|P4|COMPLETED|Overall Study||17
485493|NCT01091974|1189715|P3|COMPLETED|Overall Study||19
485494|NCT01091974|1189716|P2|COMPLETED|Overall Study||18
485495|NCT01091974|1189717|P1|COMPLETED|Overall Study||19
485496|NCT01091974|1189714|P4|STARTED|Overall Study||24
485497|NCT01091974|1189715|P3|STARTED|Overall Study||25
485498|NCT01091974|1189716|P2|STARTED|Overall Study||23
485499|NCT01091974|1189717|P1|STARTED|Overall Study||24
485500|NCT01091948|1189733|P2|NOT COMPLETED|Overall Study||0
485501|NCT01091948|1189734|P1|NOT COMPLETED|Overall Study||0
485502|NCT01091948|1189733|P2|COMPLETED|Overall Study||38
485503|NCT01091948|1189734|P1|COMPLETED|Overall Study||37
485504|NCT01091948|1189733|P2|STARTED|Overall Study||38
485505|NCT01091948|1189734|P1|STARTED|Overall Study||37
485506|NCT01091675|1189752|P1|NOT COMPLETED|Overall Study||34
485507|NCT01091675|1189752|P1|COMPLETED|Overall Study||23
485508|NCT01091675|1189752|P1|STARTED|Overall Study|7 patients leave the study due to hypertension, 27 patients withdrew due to lack of efficacy|57
485509|NCT01091662|1189758|P2|NOT COMPLETED|Overall Study||34
485510|NCT01091662|1189759|P1|NOT COMPLETED|Overall Study||17
485511|NCT01091662|1189758|P2|COMPLETED|Overall Study||80
485512|NCT01091662|1189759|P1|COMPLETED|Overall Study||41
485513|NCT01091662|1189758|P2|STARTED|Overall Study||114
485514|NCT01091662|1189759|P1|STARTED|Overall Study||58
485515|NCT01091519|1189797|P2|NOT COMPLETED|Overall Study||73
485516|NCT01091519|1189798|P1|NOT COMPLETED|Overall Study||55
485517|NCT01091519|1189797|P2|COMPLETED|Overall Study||362
485518|NCT01091519|1189798|P1|COMPLETED|Overall Study||291
485519|NCT01091519|1189797|P2|Treated|Overall Study||431
485520|NCT01091519|1189798|P1|Treated|Overall Study||342
485521|NCT01091519|1189797|P2|STARTED|Overall Study||435
485522|NCT01091519|1189798|P1|STARTED|Overall Study||346
485523|NCT01091454|1189810|P1|NOT COMPLETED|Overall Study||1
485524|NCT01091454|1189810|P1|COMPLETED|Overall Study||47
485525|NCT01091454|1189810|P1|STARTED|Overall Study||48
485526|NCT01091428|1189823|P4|NOT COMPLETED|Phase 2||69
485527|NCT01091428|1189824|P3|NOT COMPLETED|Phase 2||73
485528|NCT01091428|1189825|P2|NOT COMPLETED|Phase 2||0
485529|NCT01091428|1189826|P1|NOT COMPLETED|Phase 2||0
485530|NCT01091428|1189823|P4|COMPLETED|Phase 2||0
485531|NCT01091428|1189824|P3|COMPLETED|Phase 2||0
485532|NCT01091428|1189825|P2|COMPLETED|Phase 2||0
485533|NCT01091428|1189826|P1|COMPLETED|Phase 2||0
485534|NCT01091428|1189823|P4|STARTED|Phase 2||69
485535|NCT01091428|1189824|P3|STARTED|Phase 2||73
485536|NCT01091428|1189825|P2|STARTED|Phase 2||0
485537|NCT01091428|1189826|P1|STARTED|Phase 2||0
485538|NCT01091428|1189823|P4|NOT COMPLETED|Phase 1||0
485539|NCT01091428|1189824|P3|NOT COMPLETED|Phase 1||0
485540|NCT01091428|1189825|P2|NOT COMPLETED|Phase 1||11
485541|NCT01091428|1189826|P1|NOT COMPLETED|Phase 1||38
485542|NCT01091428|1189823|P4|COMPLETED|Phase 1||0
485543|NCT01091428|1189824|P3|COMPLETED|Phase 1||0
485544|NCT01091428|1189825|P2|COMPLETED|Phase 1||0
485545|NCT01091428|1189826|P1|COMPLETED|Phase 1|Completed = participants who completed the treatment.|0
485546|NCT01091428|1189823|P4|STARTED|Phase 1||0
485547|NCT01091428|1189824|P3|STARTED|Phase 1||0
485548|NCT01091428|1189825|P2|STARTED|Phase 1||11
485549|NCT01091428|1189826|P1|STARTED|Phase 1||38
485550|NCT01091259|1189927|P1|NOT COMPLETED|Overall Study||5
485551|NCT01091259|1189927|P1|COMPLETED|Overall Study|Number of patients who had at least 2 cycles of treatments|24
485552|NCT01091259|1189927|P1|STARTED|Overall Study||29
485553|NCT01091246|1189938|P3|NOT COMPLETED|Overall Study||13
485554|NCT01091246|1189939|P2|NOT COMPLETED|Overall Study||16
485555|NCT01091246|1189940|P1|NOT COMPLETED|Overall Study||35
485556|NCT01091246|1189938|P3|COMPLETED|Overall Study||450
485557|NCT01091246|1189939|P2|COMPLETED|Overall Study||448
485558|NCT01091246|1189940|P1|COMPLETED|Overall Study||1350
485559|NCT01091246|1189938|P3|STARTED|Overall Study||463
485560|NCT01091246|1189939|P2|STARTED|Overall Study||464
485561|NCT01091246|1189940|P1|STARTED|Overall Study||1385
485562|NCT01091155|1190014|P1|NOT COMPLETED|Overall Study||9
485563|NCT01091155|1190014|P1|COMPLETED|Overall Study||279
485564|NCT01091155|1190014|P1|STARTED|Overall Study||288
485565|NCT01091116|1190023|P5|NOT COMPLETED|Overall Study||11
485566|NCT01091116|1190024|P4|NOT COMPLETED|Overall Study||4
485567|NCT01091116|1190025|P3|NOT COMPLETED|Overall Study||11
485568|NCT01091116|1190026|P2|NOT COMPLETED|Overall Study||8
485569|NCT01091116|1190027|P1|NOT COMPLETED|Overall Study||6
485570|NCT01091116|1190023|P5|COMPLETED|Overall Study||73
485571|NCT01091116|1190024|P4|COMPLETED|Overall Study||80
485572|NCT01091116|1190025|P3|COMPLETED|Overall Study||73
485573|NCT01091116|1190026|P2|COMPLETED|Overall Study||80
485574|NCT01091116|1190027|P1|COMPLETED|Overall Study||77
485575|NCT01091116|1190023|P5|STARTED|Overall Study||84
485576|NCT01091116|1190024|P4|STARTED|Overall Study||84
485577|NCT01091116|1190025|P3|STARTED|Overall Study||84
485578|NCT01091116|1190026|P2|STARTED|Overall Study||88
485579|NCT01091116|1190027|P1|STARTED|Overall Study||83
485580|NCT01091103|1190079|P1|NOT COMPLETED|Overall Study||4
485581|NCT01091103|1190079|P1|COMPLETED|Overall Study|Patients on study drug and completed Week 9 visit assessments.|56
485582|NCT01091103|1190079|P1|STARTED|Overall Study||60
485583|NCT01090973|1190099|P1|NOT COMPLETED|Overall Study||1
485584|NCT01090973|1190099|P1|COMPLETED|Overall Study||0
485585|NCT01090973|1190099|P1|STARTED|Overall Study||1
485586|NCT01090765|1190115|P6|NOT COMPLETED|Overall Study||1
485587|NCT01090765|1190116|P5|NOT COMPLETED|Overall Study||2
485588|NCT01090765|1190117|P4|NOT COMPLETED|Overall Study||1
485589|NCT01090765|1190118|P3|NOT COMPLETED|Overall Study||0
485590|NCT01090765|1190119|P2|NOT COMPLETED|Overall Study||0
485591|NCT01090765|1190120|P1|NOT COMPLETED|Overall Study||0
485592|NCT01090765|1190115|P6|COMPLETED|Overall Study||3
485593|NCT01090765|1190116|P5|COMPLETED|Overall Study||4
485594|NCT01090765|1190117|P4|COMPLETED|Overall Study||1
485595|NCT01090765|1190118|P3|COMPLETED|Overall Study||3
485596|NCT01090765|1190119|P2|COMPLETED|Overall Study||3
485597|NCT01090765|1190120|P1|COMPLETED|Overall Study||3
485598|NCT01090765|1190115|P6|STARTED|Overall Study||4
485599|NCT01090765|1190116|P5|STARTED|Overall Study||6
485600|NCT01090765|1190117|P4|STARTED|Overall Study||2
485601|NCT01090765|1190118|P3|STARTED|Overall Study||3
485602|NCT01090765|1190119|P2|STARTED|Overall Study||3
485603|NCT01090765|1190120|P1|STARTED|Overall Study||3
485604|NCT01090752|1190155|P2|NOT COMPLETED|Overall Study||0
485605|NCT01090752|1190156|P1|NOT COMPLETED|Overall Study||0
485606|NCT01090752|1190155|P2|COMPLETED|Overall Study||8
485607|NCT01090752|1190156|P1|COMPLETED|Overall Study||8
485608|NCT01090752|1190155|P2|STARTED|Overall Study||8
485609|NCT01090752|1190156|P1|STARTED|Overall Study||8
485610|NCT01090739|1190166|P1|NOT COMPLETED|36 Month Follow-up||23
485611|NCT01090739|1190166|P1|COMPLETED|36 Month Follow-up||115
485612|NCT01090739|1190166|P1|STARTED|36 Month Follow-up||138
485613|NCT01090739|1190166|P1|NOT COMPLETED|24 Month Follow-up||9
485614|NCT01090739|1190166|P1|COMPLETED|24 Month Follow-up||138
485615|NCT01090739|1190166|P1|STARTED|24 Month Follow-up||147
485616|NCT01090739|1190166|P1|NOT COMPLETED|12 Month Follow-up||5
485617|NCT01090739|1190166|P1|COMPLETED|12 Month Follow-up||147
485618|NCT01090739|1190166|P1|STARTED|12 Month Follow-up||152
485619|NCT01090739|1190166|P1|NOT COMPLETED|Enrollment||55
485620|NCT01090739|1190166|P1|COMPLETED|Enrollment||152
485621|NCT01090739|1190166|P1|STARTED|Enrollment|Subject enrollment = signed informed consent form|207
485622|NCT01090492|1190191|P8|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
485623|NCT01090492|1190192|P7|NOT COMPLETED|Second Intervention Period (4 Weeks)||9
485624|NCT01090492|1190193|P6|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
485625|NCT01090492|1190194|P5|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
485626|NCT01090492|1190195|P4|NOT COMPLETED|Second Intervention Period (4 Weeks)||0
485627|NCT01090492|1190196|P3|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
485628|NCT01090492|1190197|P2|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
485629|NCT01090492|1190198|P1|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
485630|NCT01090492|1190191|P8|COMPLETED|Second Intervention Period (4 Weeks)||25
485631|NCT01090492|1190192|P7|COMPLETED|Second Intervention Period (4 Weeks)||22
485632|NCT01090492|1190193|P6|COMPLETED|Second Intervention Period (4 Weeks)||29
485633|NCT01090492|1190194|P5|COMPLETED|Second Intervention Period (4 Weeks)||27
485634|NCT01090492|1190195|P4|COMPLETED|Second Intervention Period (4 Weeks)||22
485635|NCT01090492|1190196|P3|COMPLETED|Second Intervention Period (4 Weeks)||24
485636|NCT01090492|1190197|P2|COMPLETED|Second Intervention Period (4 Weeks)||22
485637|NCT01090492|1190198|P1|COMPLETED|Second Intervention Period (4 Weeks)||25
485638|NCT01090492|1190191|P8|STARTED|Second Intervention Period (4 Weeks)||27
485639|NCT01090492|1190192|P7|STARTED|Second Intervention Period (4 Weeks)||31
485640|NCT01090492|1190193|P6|STARTED|Second Intervention Period (4 Weeks)||30
485641|NCT01090492|1190194|P5|STARTED|Second Intervention Period (4 Weeks)||29
485642|NCT01090492|1190195|P4|STARTED|Second Intervention Period (4 Weeks)||22
485643|NCT01090492|1190196|P3|STARTED|Second Intervention Period (4 Weeks)||26
485644|NCT01090492|1190197|P2|STARTED|Second Intervention Period (4 Weeks)||24
485645|NCT01090492|1190198|P1|STARTED|Second Intervention Period (4 Weeks)||26
485646|NCT01090492|1190191|P8|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
485647|NCT01090492|1190192|P7|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
485648|NCT01090492|1190193|P6|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
485649|NCT01090492|1190194|P5|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
485650|NCT01090492|1190195|P4|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
485651|NCT01090492|1190196|P3|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
485652|NCT01090492|1190197|P2|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
485653|NCT01090492|1190198|P1|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
485654|NCT01090492|1190191|P8|COMPLETED|Placebo Washout Period ( 2 Weeks)||27
485655|NCT01090492|1190192|P7|COMPLETED|Placebo Washout Period ( 2 Weeks)||31
485656|NCT01090492|1190193|P6|COMPLETED|Placebo Washout Period ( 2 Weeks)||30
485657|NCT01090492|1190194|P5|COMPLETED|Placebo Washout Period ( 2 Weeks)||29
485658|NCT01090492|1190195|P4|COMPLETED|Placebo Washout Period ( 2 Weeks)||22
485659|NCT01090492|1190196|P3|COMPLETED|Placebo Washout Period ( 2 Weeks)||26
485660|NCT01090492|1190197|P2|COMPLETED|Placebo Washout Period ( 2 Weeks)||24
485661|NCT01090492|1190198|P1|COMPLETED|Placebo Washout Period ( 2 Weeks)||26
485662|NCT01090492|1190191|P8|STARTED|Placebo Washout Period ( 2 Weeks)||27
485663|NCT01090492|1190192|P7|STARTED|Placebo Washout Period ( 2 Weeks)||31
485664|NCT01090492|1190193|P6|STARTED|Placebo Washout Period ( 2 Weeks)||30
485665|NCT01090492|1190194|P5|STARTED|Placebo Washout Period ( 2 Weeks)||29
485666|NCT01090492|1190195|P4|STARTED|Placebo Washout Period ( 2 Weeks)||22
485667|NCT01090492|1190196|P3|STARTED|Placebo Washout Period ( 2 Weeks)||26
485668|NCT01090492|1190197|P2|STARTED|Placebo Washout Period ( 2 Weeks)||24
485669|NCT01090492|1190198|P1|STARTED|Placebo Washout Period ( 2 Weeks)||26
485670|NCT01090492|1190191|P8|NOT COMPLETED|First Intervention Period (4 Weeks)||6
485671|NCT01090492|1190192|P7|NOT COMPLETED|First Intervention Period (4 Weeks)||1
485672|NCT01090492|1190193|P6|NOT COMPLETED|First Intervention Period (4 Weeks)||2
485673|NCT01090492|1190194|P5|NOT COMPLETED|First Intervention Period (4 Weeks)||4
485674|NCT01090492|1190195|P4|NOT COMPLETED|First Intervention Period (4 Weeks)||6
485675|NCT01090492|1190196|P3|NOT COMPLETED|First Intervention Period (4 Weeks)||3
485676|NCT01090492|1190197|P2|NOT COMPLETED|First Intervention Period (4 Weeks)||5
485677|NCT01090492|1190198|P1|NOT COMPLETED|First Intervention Period (4 Weeks)||1
485678|NCT01090492|1190191|P8|COMPLETED|First Intervention Period (4 Weeks)||27
485679|NCT01090492|1190192|P7|COMPLETED|First Intervention Period (4 Weeks)||31
485680|NCT01090492|1190193|P6|COMPLETED|First Intervention Period (4 Weeks)||30
485681|NCT01090492|1190194|P5|COMPLETED|First Intervention Period (4 Weeks)||29
485682|NCT01090492|1190195|P4|COMPLETED|First Intervention Period (4 Weeks)||22
485683|NCT01090492|1190196|P3|COMPLETED|First Intervention Period (4 Weeks)||26
485684|NCT01090492|1190197|P2|COMPLETED|First Intervention Period (4 Weeks)||24
485685|NCT01090492|1190198|P1|COMPLETED|First Intervention Period (4 Weeks)||26
485686|NCT01090492|1190191|P8|STARTED|First Intervention Period (4 Weeks)||33
485687|NCT01090492|1190192|P7|STARTED|First Intervention Period (4 Weeks)||32
485688|NCT01090492|1190193|P6|STARTED|First Intervention Period (4 Weeks)||32
485689|NCT01090492|1190194|P5|STARTED|First Intervention Period (4 Weeks)||33
485690|NCT01090492|1190195|P4|STARTED|First Intervention Period (4 Weeks)||28
485691|NCT01090492|1190196|P3|STARTED|First Intervention Period (4 Weeks)||29
485692|NCT01090492|1190197|P2|STARTED|First Intervention Period (4 Weeks)||29
485693|NCT01090492|1190198|P1|STARTED|First Intervention Period (4 Weeks)||27
485694|NCT01090479|1190257|P2|NOT COMPLETED|Overall Study||0
485695|NCT01090479|1190258|P1|NOT COMPLETED|Overall Study||0
485696|NCT01090479|1190257|P2|COMPLETED|Overall Study||50
485697|NCT01090479|1190258|P1|COMPLETED|Overall Study||50
485698|NCT01090479|1190257|P2|STARTED|Overall Study||50
485699|NCT01090479|1190258|P1|STARTED|Overall Study||50
485700|NCT01090453|1190266|P2|NOT COMPLETED|Overall Study||14
485701|NCT01090453|1190267|P1|NOT COMPLETED|Overall Study||13
485702|NCT01090453|1190266|P2|COMPLETED|Overall Study||228
485703|NCT01090453|1190267|P1|COMPLETED|Overall Study||225
485704|NCT01090453|1190266|P2|STARTED|Overall Study||242
485705|NCT01090453|1190267|P1|STARTED|Overall Study||238
485706|NCT01090427|1190314|P7|NOT COMPLETED|After Controlled Period||2
485707|NCT01090427|1190315|P6|NOT COMPLETED|After Controlled Period||5
485708|NCT01090427|1190316|P5|NOT COMPLETED|After Controlled Period||0
485709|NCT01090427|1190317|P4|NOT COMPLETED|After Controlled Period||2
485710|NCT01090427|1190318|P3|NOT COMPLETED|After Controlled Period||0
485711|NCT01090427|1190319|P2|NOT COMPLETED|After Controlled Period||0
485712|NCT01090427|1190320|P1|NOT COMPLETED|After Controlled Period||0
485713|NCT01090427|1190314|P7|COMPLETED|After Controlled Period||34
485714|NCT01090427|1190315|P6|COMPLETED|After Controlled Period||32
485715|NCT01090427|1190316|P5|COMPLETED|After Controlled Period||18
485716|NCT01090427|1190317|P4|COMPLETED|After Controlled Period||17
485717|NCT01090427|1190318|P3|COMPLETED|After Controlled Period||0
485718|NCT01090427|1190319|P2|COMPLETED|After Controlled Period||0
485719|NCT01090427|1190320|P1|COMPLETED|After Controlled Period||0
485720|NCT01090427|1190314|P7|STARTED|After Controlled Period||36
485721|NCT01090427|1190315|P6|STARTED|After Controlled Period||37
485722|NCT01090427|1190316|P5|STARTED|After Controlled Period||18
485723|NCT01090427|1190317|P4|STARTED|After Controlled Period||19
485724|NCT01090427|1190318|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
485725|NCT01090427|1190319|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
485726|NCT01090427|1190320|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
485727|NCT01090427|1190314|P7|NOT COMPLETED|Controlled Period||0
485728|NCT01090427|1190315|P6|NOT COMPLETED|Controlled Period||0
485729|NCT01090427|1190316|P5|NOT COMPLETED|Controlled Period||0
485730|NCT01090427|1190317|P4|NOT COMPLETED|Controlled Period||0
485731|NCT01090427|1190318|P3|NOT COMPLETED|Controlled Period||0
485732|NCT01090427|1190319|P2|NOT COMPLETED|Controlled Period||0
485733|NCT01090427|1190320|P1|NOT COMPLETED|Controlled Period||0
485734|NCT01090427|1190314|P7|COMPLETED|Controlled Period||0
485735|NCT01090427|1190315|P6|COMPLETED|Controlled Period||0
485736|NCT01090427|1190316|P5|COMPLETED|Controlled Period||0
485737|NCT01090427|1190317|P4|COMPLETED|Controlled Period||0
485738|NCT01090427|1190318|P3|COMPLETED|Controlled Period||36
485739|NCT01090427|1190319|P2|COMPLETED|Controlled Period||37
485740|NCT01090427|1190320|P1|COMPLETED|Controlled Period||37
485741|NCT01090427|1190314|P7|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
485742|NCT01090427|1190315|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
485743|NCT01090427|1190316|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
485744|NCT01090427|1190317|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
485745|NCT01090427|1190318|P3|STARTED|Controlled Period||36
485746|NCT01090427|1190319|P2|STARTED|Controlled Period||37
485747|NCT01090427|1190320|P1|STARTED|Controlled Period||37
485748|NCT01090323|1190355|P2|NOT COMPLETED|Overall Study||34
485749|NCT01090323|1190356|P1|NOT COMPLETED|Overall Study||89
485750|NCT01090323|1190355|P2|COMPLETED|Overall Study||19
485751|NCT01090323|1190356|P1|COMPLETED|Overall Study||43
485752|NCT01090323|1190355|P2|STARTED|Overall Study||53
485753|NCT01090323|1190356|P1|STARTED|Overall Study||132
485754|NCT01090310|1190368|P4|NOT COMPLETED|Extension Study||20
485755|NCT01090310|1190369|P3|NOT COMPLETED|Extension Study||15
485756|NCT01090310|1190370|P2|NOT COMPLETED|Extension Study||16
485757|NCT01090310|1190371|P1|NOT COMPLETED|Extension Study||14
485758|NCT01090310|1190368|P4|COMPLETED|Extension Study||1
485759|NCT01090310|1190369|P3|COMPLETED|Extension Study||1
485760|NCT01090310|1190370|P2|COMPLETED|Extension Study||0
485761|NCT01090310|1190371|P1|COMPLETED|Extension Study||3
485762|NCT01090310|1190368|P4|STARTED|Extension Study||21
485763|NCT01090310|1190369|P3|STARTED|Extension Study||16
485764|NCT01090310|1190370|P2|STARTED|Extension Study||16
485765|NCT01090310|1190371|P1|STARTED|Extension Study||17
485766|NCT01090310|1190368|P4|NOT COMPLETED|Core Study||7
485767|NCT01090310|1190369|P3|NOT COMPLETED|Core Study||7
485768|NCT01090310|1190370|P2|NOT COMPLETED|Core Study||11
485769|NCT01090310|1190371|P1|NOT COMPLETED|Core Study||8
485770|NCT01090310|1190368|P4|COMPLETED|Core Study||27
485771|NCT01090310|1190369|P3|COMPLETED|Core Study||24
485772|NCT01090310|1190370|P2|COMPLETED|Core Study||20
485773|NCT01090310|1190371|P1|COMPLETED|Core Study||21
485774|NCT01090310|1190368|P4|STARTED|Core Study||34
485775|NCT01090310|1190369|P3|STARTED|Core Study||31
485776|NCT01090310|1190370|P2|STARTED|Core Study||31
485777|NCT01090310|1190371|P1|STARTED|Core Study||29
485778|NCT01090180|1190399|P2|NOT COMPLETED|Overall Study||8
485779|NCT01090180|1190400|P1|NOT COMPLETED|Overall Study||11
485780|NCT01090180|1190399|P2|COMPLETED|Overall Study||21
485781|NCT01090180|1190400|P1|COMPLETED|Overall Study||22
485782|NCT01090180|1190399|P2|STARTED|Overall Study||29
485783|NCT01090180|1190400|P1|STARTED|Overall Study||33
485784|NCT01090102|1190410|P2|NOT COMPLETED|Second 12 Weeks||1
485785|NCT01090102|1190411|P1|NOT COMPLETED|Second 12 Weeks||0
485786|NCT01090102|1190410|P2|COMPLETED|Second 12 Weeks||15
485787|NCT01090102|1190411|P1|COMPLETED|Second 12 Weeks||11
485788|NCT01090102|1190410|P2|STARTED|Second 12 Weeks||16
485789|NCT01090102|1190411|P1|STARTED|Second 12 Weeks||11
485790|NCT01090102|1190410|P2|NOT COMPLETED|First 12 Weeks||2
485791|NCT01090102|1190411|P1|NOT COMPLETED|First 12 Weeks||4
485792|NCT01090102|1190410|P2|COMPLETED|First 12 Weeks||16
485793|NCT01090102|1190411|P1|COMPLETED|First 12 Weeks||11
485794|NCT01090102|1190410|P2|STARTED|First 12 Weeks||18
485795|NCT01090102|1190411|P1|STARTED|First 12 Weeks||15
485796|NCT01090076|1190421|P2|NOT COMPLETED|Overall Study||2
485797|NCT01090076|1190422|P1|NOT COMPLETED|Overall Study||1
485798|NCT01090076|1190421|P2|COMPLETED|Overall Study||12
485799|NCT01090076|1190422|P1|COMPLETED|Overall Study||11
485800|NCT01090076|1190421|P2|STARTED|Overall Study||14
485801|NCT01090076|1190422|P1|STARTED|Overall Study||12
485802|NCT01090063|1190432|P1|NOT COMPLETED|Treatment||4
485803|NCT01090063|1190432|P1|COMPLETED|Treatment||20
485804|NCT01090063|1190432|P1|STARTED|Treatment||24
485805|NCT01090063|1190432|P1|NOT COMPLETED|Screen||4
485806|NCT01090063|1190432|P1|COMPLETED|Screen||24
485807|NCT01090063|1190432|P1|STARTED|Screen||28
485808|NCT01090050|1190448|P2|NOT COMPLETED|Overall Study||7
485809|NCT01090050|1190449|P1|NOT COMPLETED|Overall Study||1
485810|NCT01090050|1190448|P2|COMPLETED|Overall Study||5
485811|NCT01090050|1190449|P1|COMPLETED|Overall Study||15
485812|NCT01090050|1190448|P2|STARTED|Overall Study||12
485813|NCT01090050|1190449|P1|STARTED|Overall Study||16
485814|NCT01090011|1190469|P1|NOT COMPLETED|Overall Study||171
485815|NCT01090011|1190469|P1|COMPLETED|Overall Study||0
485816|NCT01090011|1190469|P1|STARTED|Overall Study||171
485817|NCT01089751|1190539|P2|NOT COMPLETED|Overall Study||27
485818|NCT01089751|1190540|P1|NOT COMPLETED|Overall Study||34
485819|NCT01089751|1190539|P2|COMPLETED|Overall Study||132
485820|NCT01089751|1190540|P1|COMPLETED|Overall Study||129
485821|NCT01089751|1190539|P2|STARTED|Overall Study||159
485822|NCT01089751|1190540|P1|STARTED|Overall Study||163
485823|NCT01089608|1190562|P2|NOT COMPLETED|Overall Study||6
485824|NCT01089608|1190563|P1|NOT COMPLETED|Overall Study||0
485825|NCT01089608|1190562|P2|COMPLETED|Overall Study||44
485826|NCT01089608|1190563|P1|COMPLETED|Overall Study||43
485827|NCT01089608|1190562|P2|STARTED|Overall Study||50
485828|NCT01089608|1190563|P1|STARTED|Overall Study||43
485829|NCT01089595|1190571|P2|NOT COMPLETED|Overall Study||0
485830|NCT01089595|1190572|P1|NOT COMPLETED|Overall Study||0
485831|NCT01089595|1190571|P2|COMPLETED|Overall Study||3
485832|NCT01089595|1190572|P1|COMPLETED|Overall Study||2
485833|NCT01089595|1190571|P2|STARTED|Overall Study||3
485834|NCT01089595|1190572|P1|STARTED|Overall Study||2
485835|NCT01089582|1190580|P1|NOT COMPLETED|Overall Study||30
485836|NCT01089582|1190580|P1|COMPLETED|Overall Study|1 subject died during the study; 1 subject died following permanent discontinuation from the study.|573
485837|NCT01089582|1190580|P1|STARTED|Overall Study||603
485838|NCT01089569|1190593|P3|NOT COMPLETED|Overall Study||4
485839|NCT01089569|1190594|P2|NOT COMPLETED|Overall Study||3
485840|NCT01089569|1190595|P1|NOT COMPLETED|Overall Study||4
485841|NCT01089569|1190593|P3|COMPLETED|Overall Study||16
485842|NCT01089569|1190594|P2|COMPLETED|Overall Study||17
485843|NCT01089569|1190595|P1|COMPLETED|Overall Study||16
485844|NCT01089569|1190593|P3|STARTED|Overall Study||20
485845|NCT01089569|1190594|P2|STARTED|Overall Study||20
485846|NCT01089569|1190595|P1|STARTED|Overall Study||20
485847|NCT01089556|1190623|P6|NOT COMPLETED|Study Period III (Weeks 9-16)||7
485848|NCT01089556|1190624|P5|NOT COMPLETED|Study Period III (Weeks 9-16)||12
485849|NCT01089556|1190625|P4|NOT COMPLETED|Study Period III (Weeks 9-16)||9
485850|NCT01089556|1190626|P3|NOT COMPLETED|Study Period III (Weeks 9-16)||14
485851|NCT01089556|1190627|P2|NOT COMPLETED|Study Period III (Weeks 9-16)||0
485852|NCT01089556|1190628|P1|NOT COMPLETED|Study Period III (Weeks 9-16)||0
485853|NCT01089556|1190623|P6|COMPLETED|Study Period III (Weeks 9-16)||92
485854|NCT01089556|1190624|P5|COMPLETED|Study Period III (Weeks 9-16)||83
485855|NCT01089556|1190625|P4|COMPLETED|Study Period III (Weeks 9-16)||66
485856|NCT01089556|1190626|P3|COMPLETED|Study Period III (Weeks 9-16)||60
485857|NCT01089556|1190627|P2|COMPLETED|Study Period III (Weeks 9-16)||0
485858|NCT01089556|1190628|P1|COMPLETED|Study Period III (Weeks 9-16)||0
485859|NCT01089556|1190623|P6|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|97
485860|NCT01089556|1190624|P5|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|94
485861|NCT01089556|1190625|P4|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|75
485862|NCT01089556|1190626|P3|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|73
485863|NCT01089556|1190627|P2|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0
485864|NCT01089556|1190628|P1|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0
485865|NCT01089556|1190623|P6|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 6 non-responders did not enter SPIII, while 1 responders entered SPIII|99
485866|NCT01089556|1190624|P5|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 10 non-responders did not enter SPIII, while 4 responders entered SPIII|95
485867|NCT01089556|1190625|P4|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 6 non-responders did not enter SPIII, while 3 responders entered SPIII|75
485868|NCT01089556|1190626|P3|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 10 non-responders did not enter SPIII, while 4 responders entered SPIII|74
485869|NCT01089556|1190627|P2|STARTED|Study Period III (Weeks 9-16)||0
485870|NCT01089556|1190628|P1|STARTED|Study Period III (Weeks 9-16)||0
485871|NCT01089556|1190623|P6|NOT COMPLETED|Study Period II (Weeks 1-8)||0
485872|NCT01089556|1190624|P5|NOT COMPLETED|Study Period II (Weeks 1-8)||0
485873|NCT01089556|1190625|P4|NOT COMPLETED|Study Period II (Weeks 1-8)||0
485874|NCT01089556|1190626|P3|NOT COMPLETED|Study Period II (Weeks 1-8)||0
485875|NCT01089556|1190627|P2|NOT COMPLETED|Study Period II (Weeks 1-8)||74
485876|NCT01089556|1190628|P1|NOT COMPLETED|Study Period II (Weeks 1-8)||71
485877|NCT01089556|1190623|P6|COMPLETED|Study Period II (Weeks 1-8)||0
485878|NCT01089556|1190624|P5|COMPLETED|Study Period II (Weeks 1-8)||0
485879|NCT01089556|1190625|P4|COMPLETED|Study Period II (Weeks 1-8)||0
485880|NCT01089556|1190626|P3|COMPLETED|Study Period II (Weeks 1-8)||0
485881|NCT01089556|1190627|P2|COMPLETED|Study Period II (Weeks 1-8)||333
485882|NCT01089556|1190628|P1|COMPLETED|Study Period II (Weeks 1-8)||333
485883|NCT01089556|1190623|P6|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
485884|NCT01089556|1190624|P5|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
485885|NCT01089556|1190625|P4|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
485886|NCT01089556|1190626|P3|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
485887|NCT01089556|1190627|P2|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||205
485888|NCT01089556|1190628|P1|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||158
485889|NCT01089556|1190623|P6|Safety Population|Study Period II (Weeks 1-8)||0
485890|NCT01089556|1190624|P5|Safety Population|Study Period II (Weeks 1-8)||0
485891|NCT01089556|1190625|P4|Safety Population|Study Period II (Weeks 1-8)||0
485892|NCT01089556|1190626|P3|Safety Population|Study Period II (Weeks 1-8)||0
485893|NCT01089556|1190627|P2|Safety Population|Study Period II (Weeks 1-8)|Received at least 1 dose of study drug.|403
485894|NCT01089556|1190628|P1|Safety Population|Study Period II (Weeks 1-8)|Received at least 1 dose of study drug.|401
485895|NCT01089556|1190623|P6|STARTED|Study Period II (Weeks 1-8)||0
485896|NCT01089556|1190624|P5|STARTED|Study Period II (Weeks 1-8)||0
485897|NCT01089556|1190625|P4|STARTED|Study Period II (Weeks 1-8)||0
485898|NCT01089556|1190626|P3|STARTED|Study Period II (Weeks 1-8)||0
485899|NCT01089556|1190627|P2|STARTED|Study Period II (Weeks 1-8)||407
485900|NCT01089556|1190628|P1|STARTED|Study Period II (Weeks 1-8)||404
485901|NCT01089543|1190702|P4|NOT COMPLETED|Overall Study||2
485902|NCT01089543|1190703|P3|NOT COMPLETED|Overall Study||3
485903|NCT01089543|1190704|P2|NOT COMPLETED|Overall Study||4
485904|NCT01089543|1190705|P1|NOT COMPLETED|Overall Study||3
485905|NCT01089543|1190702|P4|COMPLETED|Overall Study||83
485906|NCT01089543|1190703|P3|COMPLETED|Overall Study||81
485907|NCT01089543|1190704|P2|COMPLETED|Overall Study||81
485908|NCT01089543|1190705|P1|COMPLETED|Overall Study||81
485909|NCT01089543|1190702|P4|STARTED|Overall Study||85
485910|NCT01089543|1190703|P3|STARTED|Overall Study||84
485911|NCT01089543|1190704|P2|STARTED|Overall Study||85
485912|NCT01089543|1190705|P1|STARTED|Overall Study||84
485913|NCT01089517|1190722|P3|NOT COMPLETED|Overall Study||5
485914|NCT01089517|1190723|P2|NOT COMPLETED|Overall Study||5
485915|NCT01089517|1190724|P1|NOT COMPLETED|Overall Study||4
485916|NCT01089517|1190722|P3|COMPLETED|Overall Study||147
485917|NCT01089517|1190723|P2|COMPLETED|Overall Study||144
485918|NCT01089517|1190724|P1|COMPLETED|Overall Study||144
485919|NCT01089517|1190722|P3|STARTED|Overall Study||152
485920|NCT01089517|1190723|P2|STARTED|Overall Study||149
485921|NCT01089517|1190724|P1|STARTED|Overall Study||148
485922|NCT01089504|1190740|P2|NOT COMPLETED|Overall Study||1
485923|NCT01089504|1190741|P1|NOT COMPLETED|Overall Study||3
485924|NCT01089504|1190740|P2|COMPLETED|Overall Study||4
485925|NCT01089504|1190741|P1|COMPLETED|Overall Study||5
485926|NCT01089504|1190740|P2|STARTED|Overall Study||5
485927|NCT01089504|1190741|P1|STARTED|Overall Study||8
485928|NCT01089413|1190754|P1|NOT COMPLETED|Overall Study||201
485929|NCT01089413|1190754|P1|COMPLETED|Overall Study||0
485930|NCT01089413|1190754|P1|Received Bevacizumab in First Line|Overall Study||199
485931|NCT01089413|1190754|P1|STARTED|Overall Study||201
485932|NCT01089361|1190773|P2|NOT COMPLETED|Overall Study||0
485933|NCT01089361|1190774|P1|NOT COMPLETED|Overall Study||1
485934|NCT01089361|1190773|P2|COMPLETED|Overall Study||10
485935|NCT01089361|1190774|P1|COMPLETED|Overall Study||8
485936|NCT01089361|1190773|P2|STARTED|Overall Study||10
485937|NCT01089361|1190774|P1|STARTED|Overall Study||9
485938|NCT01089231|1190796|P4|NOT COMPLETED|Overall Study||1
485939|NCT01089231|1190797|P3|NOT COMPLETED|Overall Study||2
485940|NCT01089231|1190798|P2|NOT COMPLETED|Overall Study||2
485941|NCT01089231|1190799|P1|NOT COMPLETED|Overall Study||4
485942|NCT01089231|1190796|P4|COMPLETED|Overall Study|1 subject excluded (low RNA yield)|9
485943|NCT01089231|1190797|P3|COMPLETED|Overall Study|2 subject excluded (1 use of not allowed drugs; 1 low RNA yield)|8
485944|NCT01089231|1190798|P2|COMPLETED|Overall Study|2 subjects excluded (1 highly elevated TG and TC data; 1 elevated inflammation (CRP level))|8
485945|NCT01089231|1190799|P1|COMPLETED|Overall Study|4 subjects excluded (2 alcohol use / TG level changes; 1 use of not allowed drugs; 1 low RNA yield)|6
485946|NCT01089231|1190796|P4|STARTED|Overall Study||10
485947|NCT01089231|1190797|P3|STARTED|Overall Study||10
485948|NCT01089231|1190798|P2|STARTED|Overall Study||10
485949|NCT01089231|1190799|P1|STARTED|Overall Study||10
485950|NCT01089127|1190823|P6|NOT COMPLETED|Overall Study||3
485951|NCT01089127|1190824|P5|NOT COMPLETED|Overall Study||2
485952|NCT01089127|1190825|P4|NOT COMPLETED|Overall Study||1
485953|NCT01089127|1190826|P3|NOT COMPLETED|Overall Study||2
485954|NCT01089127|1190827|P2|NOT COMPLETED|Overall Study||5
485955|NCT01089127|1190828|P1|NOT COMPLETED|Overall Study||8
485956|NCT01089127|1190823|P6|COMPLETED|Overall Study||88
485957|NCT01089127|1190824|P5|COMPLETED|Overall Study||90
485958|NCT01089127|1190825|P4|COMPLETED|Overall Study||91
485959|NCT01089127|1190826|P3|COMPLETED|Overall Study||92
485960|NCT01089127|1190827|P2|COMPLETED|Overall Study||86
485961|NCT01089127|1190828|P1|COMPLETED|Overall Study||84
485962|NCT01089127|1190823|P6|Exposed to Study Drug|Overall Study||91
485963|NCT01089127|1190824|P5|Exposed to Study Drug|Overall Study|1 randomized patient in this group was not exposed to study treatment.|91
485964|NCT01089127|1190825|P4|Exposed to Study Drug|Overall Study||92
485965|NCT01089127|1190826|P3|Exposed to Study Drug|Overall Study||94
485966|NCT01089127|1190827|P2|Exposed to Study Drug|Overall Study|1 randomized patient in this group was not exposed to study treatment.|90
485967|NCT01089127|1190828|P1|Exposed to Study Drug|Overall Study|3 randomized patients in this group were not exposed to study treatment.|89
485968|NCT01089127|1190823|P6|STARTED|Overall Study||91
485969|NCT01089127|1190824|P5|STARTED|Overall Study||92
485970|NCT01089127|1190825|P4|STARTED|Overall Study||92
485971|NCT01089127|1190826|P3|STARTED|Overall Study||94
485972|NCT01089127|1190827|P2|STARTED|Overall Study||91
485973|NCT01089127|1190828|P1|STARTED|Overall Study||92
485974|NCT01089062|1190854|P6|NOT COMPLETED|Follow-up Visit (Final Visit)||0
485975|NCT01089062|1190855|P5|NOT COMPLETED|Follow-up Visit (Final Visit)||0
485976|NCT01089062|1190856|P4|NOT COMPLETED|Follow-up Visit (Final Visit)||0
485977|NCT01089062|1190857|P3|NOT COMPLETED|Follow-up Visit (Final Visit)||0
485978|NCT01089062|1190858|P2|NOT COMPLETED|Follow-up Visit (Final Visit)||0
485979|NCT01089062|1190859|P1|NOT COMPLETED|Follow-up Visit (Final Visit)||0
485980|NCT01089062|1190854|P6|COMPLETED|Follow-up Visit (Final Visit)||3
485981|NCT01089062|1190855|P5|COMPLETED|Follow-up Visit (Final Visit)||3
485982|NCT01089062|1190856|P4|COMPLETED|Follow-up Visit (Final Visit)||3
485983|NCT01089062|1190857|P3|COMPLETED|Follow-up Visit (Final Visit)||3
485984|NCT01089062|1190858|P2|COMPLETED|Follow-up Visit (Final Visit)||3
485985|NCT01089062|1190859|P1|COMPLETED|Follow-up Visit (Final Visit)||3
485986|NCT01089062|1190854|P6|STARTED|Follow-up Visit (Final Visit)||3
485987|NCT01089062|1190855|P5|STARTED|Follow-up Visit (Final Visit)||3
485988|NCT01089062|1190856|P4|STARTED|Follow-up Visit (Final Visit)||3
485989|NCT01089062|1190857|P3|STARTED|Follow-up Visit (Final Visit)||3
485990|NCT01089062|1190858|P2|STARTED|Follow-up Visit (Final Visit)||3
485991|NCT01089062|1190859|P1|STARTED|Follow-up Visit (Final Visit)||3
485992|NCT01089062|1190854|P6|NOT COMPLETED|Visit 4||0
485993|NCT01089062|1190855|P5|NOT COMPLETED|Visit 4||0
485994|NCT01089062|1190856|P4|NOT COMPLETED|Visit 4||0
485995|NCT01089062|1190857|P3|NOT COMPLETED|Visit 4||0
485996|NCT01089062|1190858|P2|NOT COMPLETED|Visit 4||0
485997|NCT01089062|1190859|P1|NOT COMPLETED|Visit 4||0
485998|NCT01089062|1190854|P6|COMPLETED|Visit 4||3
485999|NCT01089062|1190855|P5|COMPLETED|Visit 4||3
486000|NCT01089062|1190856|P4|COMPLETED|Visit 4||3
486001|NCT01089062|1190857|P3|COMPLETED|Visit 4||3
486002|NCT01089062|1190858|P2|COMPLETED|Visit 4||3
486003|NCT01089062|1190859|P1|COMPLETED|Visit 4||3
486004|NCT01089062|1190854|P6|STARTED|Visit 4||3
486005|NCT01089062|1190855|P5|STARTED|Visit 4||3
486006|NCT01089062|1190856|P4|STARTED|Visit 4||3
486007|NCT01089062|1190857|P3|STARTED|Visit 4||3
486008|NCT01089062|1190858|P2|STARTED|Visit 4||3
486009|NCT01089062|1190859|P1|STARTED|Visit 4||3
486010|NCT01089062|1190854|P6|NOT COMPLETED|Visit 3||0
486011|NCT01089062|1190855|P5|NOT COMPLETED|Visit 3||0
486012|NCT01089062|1190856|P4|NOT COMPLETED|Visit 3||1
486013|NCT01089062|1190857|P3|NOT COMPLETED|Visit 3||0
486014|NCT01089062|1190858|P2|NOT COMPLETED|Visit 3||0
486015|NCT01089062|1190859|P1|NOT COMPLETED|Visit 3||0
486016|NCT01089062|1190854|P6|COMPLETED|Visit 3||3
486017|NCT01089062|1190855|P5|COMPLETED|Visit 3||3
486018|NCT01089062|1190856|P4|COMPLETED|Visit 3||3
486019|NCT01089062|1190857|P3|COMPLETED|Visit 3||3
486020|NCT01089062|1190858|P2|COMPLETED|Visit 3||3
486021|NCT01089062|1190859|P1|COMPLETED|Visit 3||3
486022|NCT01089062|1190854|P6|STARTED|Visit 3||3
486023|NCT01089062|1190855|P5|STARTED|Visit 3||3
486024|NCT01089062|1190856|P4|STARTED|Visit 3||4
486025|NCT01089062|1190857|P3|STARTED|Visit 3||3
486026|NCT01089062|1190858|P2|STARTED|Visit 3||3
486027|NCT01089062|1190859|P1|STARTED|Visit 3||3
486028|NCT01089062|1190854|P6|NOT COMPLETED|Visit 2 (Randomization)||1
486029|NCT01089062|1190855|P5|NOT COMPLETED|Visit 2 (Randomization)||1
486030|NCT01089062|1190856|P4|NOT COMPLETED|Visit 2 (Randomization)||0
486031|NCT01089062|1190857|P3|NOT COMPLETED|Visit 2 (Randomization)||1
486032|NCT01089062|1190858|P2|NOT COMPLETED|Visit 2 (Randomization)||1
486033|NCT01089062|1190859|P1|NOT COMPLETED|Visit 2 (Randomization)||1
486034|NCT01089062|1190854|P6|COMPLETED|Visit 2 (Randomization)||3
486035|NCT01089062|1190855|P5|COMPLETED|Visit 2 (Randomization)||3
486036|NCT01089062|1190856|P4|COMPLETED|Visit 2 (Randomization)||4
486037|NCT01089062|1190857|P3|COMPLETED|Visit 2 (Randomization)||3
486038|NCT01089062|1190858|P2|COMPLETED|Visit 2 (Randomization)||3
486039|NCT01089062|1190859|P1|COMPLETED|Visit 2 (Randomization)||3
486040|NCT01089062|1190854|P6|STARTED|Visit 2 (Randomization)||4
486041|NCT01089062|1190855|P5|STARTED|Visit 2 (Randomization)||4
486042|NCT01089062|1190856|P4|STARTED|Visit 2 (Randomization)||4
486043|NCT01089062|1190857|P3|STARTED|Visit 2 (Randomization)||4
486044|NCT01089062|1190858|P2|STARTED|Visit 2 (Randomization)||4
486045|NCT01089062|1190859|P1|STARTED|Visit 2 (Randomization)||4
486046|NCT01089023|1190882|P1|NOT COMPLETED|Overall Study||7
486047|NCT01089023|1190882|P1|COMPLETED|Overall Study||88
486048|NCT01089023|1190882|P1|STARTED|Overall Study||95
486049|NCT01088997|1190896|P2|NOT COMPLETED|Overall Study||3
486050|NCT01088997|1190897|P1|NOT COMPLETED|Overall Study||3
486051|NCT01088997|1190896|P2|COMPLETED|Overall Study||2
486052|NCT01088997|1190897|P1|COMPLETED|Overall Study||4
486053|NCT01088997|1190896|P2|STARTED|Overall Study||5
486054|NCT01088997|1190897|P1|STARTED|Overall Study||7
486055|NCT01088984|1190908|P2|NOT COMPLETED|Phase 2||32
486056|NCT01088984|1190909|P1|NOT COMPLETED|Phase 2||0
486057|NCT01088984|1190908|P2|COMPLETED|Phase 2|completed follow-up up to 12 month from last dose of study drug|0
486058|NCT01088984|1190909|P1|COMPLETED|Phase 2|completed follow-up up to 12 month from last dose of study drug|0
486059|NCT01088984|1190908|P2|STARTED|Phase 2||32
486060|NCT01088984|1190909|P1|STARTED|Phase 2||0
486061|NCT01088984|1190908|P2|NOT COMPLETED|Phase 1||6
486062|NCT01088984|1190909|P1|NOT COMPLETED|Phase 1||5
486063|NCT01088984|1190908|P2|COMPLETED|Phase 1|completed follow-up up to 12 month from last dose of study drug|0
486064|NCT01088984|1190909|P1|COMPLETED|Phase 1|completed follow-up up to 12 month from last dose of study drug|0
486065|NCT01088984|1190908|P2|STARTED|Phase 1||6
486066|NCT01088984|1190909|P1|STARTED|Phase 1||5
486067|NCT01088711|1190931|P4|NOT COMPLETED|Overall Study||0
486068|NCT01088711|1190932|P3|NOT COMPLETED|Overall Study||0
486069|NCT01088711|1190933|P2|NOT COMPLETED|Overall Study||0
486070|NCT01088711|1190934|P1|NOT COMPLETED|Overall Study||0
486071|NCT01088711|1190931|P4|COMPLETED|Overall Study||2
486072|NCT01088711|1190932|P3|COMPLETED|Overall Study||6
486073|NCT01088711|1190933|P2|COMPLETED|Overall Study||6
486074|NCT01088711|1190934|P1|COMPLETED|Overall Study||18
486075|NCT01088711|1190931|P4|STARTED|Overall Study||2
486076|NCT01088711|1190932|P3|STARTED|Overall Study||6
486077|NCT01088711|1190933|P2|STARTED|Overall Study||6
486078|NCT01088711|1190934|P1|STARTED|Overall Study||18
486079|NCT01088672|1190958|P1|NOT COMPLETED|Overall Study||0
486080|NCT01088672|1190958|P1|COMPLETED|Overall Study||60
486081|NCT01088672|1190958|P1|STARTED|Overall Study||60
486082|NCT01088646|1190964|P1|NOT COMPLETED|Overall Study||0
486083|NCT01088646|1190964|P1|COMPLETED|Overall Study||25
486084|NCT01088646|1190964|P1|STARTED|Overall Study||25
486085|NCT01088529|1190970|P2|NOT COMPLETED|Overall Study||1
486086|NCT01088529|1190971|P1|NOT COMPLETED|Overall Study||0
486087|NCT01088529|1190970|P2|COMPLETED|Overall Study||21
486088|NCT01088529|1190971|P1|COMPLETED|Overall Study||44
486089|NCT01088529|1190970|P2|Received Treatment|Overall Study||21
486090|NCT01088529|1190971|P1|Received Treatment|Overall Study||44
486091|NCT01088529|1190970|P2|STARTED|Overall Study||22
486092|NCT01088529|1190971|P1|STARTED|Overall Study||44
486093|NCT01088503|1190984|P3|NOT COMPLETED|Overall Study||17
486094|NCT01088503|1190985|P2|NOT COMPLETED|Overall Study||685
486095|NCT01088503|1190986|P1|NOT COMPLETED|Overall Study||182
486096|NCT01088503|1190984|P3|COMPLETED|Overall Study||241
486097|NCT01088503|1190985|P2|COMPLETED|Overall Study||8161
486098|NCT01088503|1190986|P1|COMPLETED|Overall Study||2941
486099|NCT01088503|1190984|P3|STARTED|Overall Study||258
486100|NCT01088503|1190985|P2|STARTED|Overall Study||8846
486101|NCT01088503|1190986|P1|STARTED|Overall Study||3123
486102|NCT01088464|1191010|P3|NOT COMPLETED|Overall Study||0
486103|NCT01088464|1191011|P2|NOT COMPLETED|Overall Study||0
486104|NCT01088464|1191012|P1|NOT COMPLETED|Overall Study||0
486105|NCT01088464|1191010|P3|COMPLETED|Overall Study||6
486106|NCT01088464|1191011|P2|COMPLETED|Overall Study||6
486107|NCT01088464|1191012|P1|COMPLETED|Overall Study||3
486108|NCT01088464|1191010|P3|Received Any Quantity of Study Drug|Overall Study||6
486109|NCT01088464|1191011|P2|Received Any Quantity of Study Drug|Overall Study||6
486110|NCT01088464|1191012|P1|Received Any Quantity of Study Drug|Overall Study||3
486111|NCT01088464|1191010|P3|STARTED|Overall Study||6
486112|NCT01088464|1191011|P2|STARTED|Overall Study||6
486113|NCT01088464|1191012|P1|STARTED|Overall Study||3
486114|NCT01088438|1191064|P2|NOT COMPLETED|Overall Study||36
486115|NCT01088438|1191065|P1|NOT COMPLETED|Overall Study||29
486116|NCT01088438|1191064|P2|COMPLETED|Overall Study||59
486117|NCT01088438|1191065|P1|COMPLETED|Overall Study||65
486118|NCT01088438|1191064|P2|STARTED|Overall Study||95
486119|NCT01088438|1191065|P1|STARTED|Overall Study||94
486120|NCT01088399|1191078|P3|NOT COMPLETED|Overall Study||281
486121|NCT01088399|1191079|P2|NOT COMPLETED|Overall Study||1347
486122|NCT01088399|1191080|P1|NOT COMPLETED|Overall Study||7121
486123|NCT01088399|1191078|P3|COMPLETED|Overall Study||21
486124|NCT01088399|1191079|P2|COMPLETED|Overall Study||308
486125|NCT01088399|1191080|P1|COMPLETED|Overall Study||1595
486126|NCT01088399|1191078|P3|STARTED|Overall Study||302
486127|NCT01088399|1191079|P2|STARTED|Overall Study||1655
486128|NCT01088399|1191080|P1|STARTED|Overall Study||8716
486129|NCT01088295|1191103|P1|NOT COMPLETED|Overall Study||1
486130|NCT01088295|1191103|P1|COMPLETED|Overall Study||35
486131|NCT01088295|1191103|P1|STARTED|Overall Study||36
486132|NCT01088243|1191109|P2|NOT COMPLETED|Overall Study||0
486133|NCT01088243|1191110|P1|NOT COMPLETED|Overall Study||1
486134|NCT01088243|1191109|P2|COMPLETED|Overall Study||5
486135|NCT01088243|1191110|P1|COMPLETED|Overall Study||12
486136|NCT01088243|1191109|P2|STARTED|Overall Study||5
486137|NCT01088243|1191110|P1|STARTED|Overall Study||13
486138|NCT01087996|1191128|P2|NOT COMPLETED|Overall Study||0
486139|NCT01087996|1191129|P1|NOT COMPLETED|Overall Study||0
486140|NCT01087996|1191128|P2|COMPLETED|Overall Study||15
486141|NCT01087996|1191129|P1|COMPLETED|Overall Study||15
486142|NCT01087996|1191128|P2|STARTED|Overall Study||15
486143|NCT01087996|1191129|P1|STARTED|Overall Study||15
486144|NCT01087970|1191151|P1|NOT COMPLETED|Overall Study||2
486145|NCT01087970|1191151|P1|COMPLETED|Overall Study||67
486146|NCT01087970|1191151|P1|Received Carboplatin|Overall Study||63
486147|NCT01087970|1191151|P1|Efficacy Population|Overall Study|All treated participants excluding those from a noncompliant study site.|58
486148|NCT01087970|1191151|P1|Completed 6 Cycles|Overall Study||69
486149|NCT01087970|1191151|P1|Received ≥1 Dose of Any Study Drug|Overall Study||69
486150|NCT01087970|1191151|P1|STARTED|Overall Study||69
486151|NCT01087957|1191163|P2|NOT COMPLETED|Overall Study||55
486152|NCT01087957|1191164|P1|NOT COMPLETED|Overall Study||41
486153|NCT01087957|1191163|P2|COMPLETED|Overall Study||187
486154|NCT01087957|1191164|P1|COMPLETED|Overall Study||212
486155|NCT01087957|1191163|P2|STARTED|Overall Study||242
486156|NCT01087957|1191164|P1|STARTED|Overall Study||253
486157|NCT01087944|1191190|P2|NOT COMPLETED|Period 2 (Week 4-6)||2
486158|NCT01087944|1191191|P1|NOT COMPLETED|Period 2 (Week 4-6)||0
486159|NCT01087944|1191190|P2|COMPLETED|Period 2 (Week 4-6)||28
486160|NCT01087944|1191191|P1|COMPLETED|Period 2 (Week 4-6)||29
486161|NCT01087944|1191190|P2|STARTED|Period 2 (Week 4-6)||30
486162|NCT01087944|1191191|P1|STARTED|Period 2 (Week 4-6)||29
486163|NCT01087944|1191190|P2|NOT COMPLETED|Period 1 (Week 1-3)||0
486164|NCT01087944|1191191|P1|NOT COMPLETED|Period 1 (Week 1-3)||1
486165|NCT01087944|1191190|P2|COMPLETED|Period 1 (Week 1-3)||30
486166|NCT01087944|1191191|P1|COMPLETED|Period 1 (Week 1-3)||29
486167|NCT01087944|1191190|P2|STARTED|Period 1 (Week 1-3)||30
486168|NCT01087944|1191191|P1|STARTED|Period 1 (Week 1-3)||30
486169|NCT01087931|1191221|P2|NOT COMPLETED|Overall Study||0
486170|NCT01087931|1191222|P1|NOT COMPLETED|Overall Study||0
486171|NCT01087931|1191221|P2|COMPLETED|Overall Study||20
486172|NCT01087931|1191222|P1|COMPLETED|Overall Study||20
486173|NCT01087931|1191221|P2|Final Follow up|Overall Study||17
486174|NCT01087931|1191222|P1|Final Follow up|Overall Study||19
486175|NCT01087931|1191221|P2|1st Follow up|Overall Study||19
486176|NCT01087931|1191222|P1|1st Follow up|Overall Study||20
486177|NCT01087931|1191221|P2|STARTED|Overall Study||20
486178|NCT01087931|1191222|P1|STARTED|Overall Study||20
486179|NCT01087918|1191236|P2|NOT COMPLETED|Overall Study||0
486180|NCT01087918|1191237|P1|NOT COMPLETED|Overall Study||0
486181|NCT01087918|1191236|P2|COMPLETED|Overall Study||4
486182|NCT01087918|1191237|P1|COMPLETED|Overall Study||5
486183|NCT01087918|1191236|P2|STARTED|Overall Study||4
486184|NCT01087918|1191237|P1|STARTED|Overall Study||5
486185|NCT01087905|1191271|P8|NOT COMPLETED|Overall Study||29
486186|NCT01087905|1191272|P7|NOT COMPLETED|Overall Study||23
486187|NCT01087905|1191273|P6|NOT COMPLETED|Overall Study||28
486188|NCT01087905|1191274|P5|NOT COMPLETED|Overall Study||31
486189|NCT01087905|1191275|P4|NOT COMPLETED|Overall Study||36
486190|NCT01087905|1191276|P3|NOT COMPLETED|Overall Study||22
486191|NCT01087905|1191277|P2|NOT COMPLETED|Overall Study||32
486192|NCT01087905|1191278|P1|NOT COMPLETED|Overall Study||29
486193|NCT01087905|1191271|P8|COMPLETED|Overall Study||98
486194|NCT01087905|1191272|P7|COMPLETED|Overall Study||98
486195|NCT01087905|1191273|P6|COMPLETED|Overall Study||99
486196|NCT01087905|1191274|P5|COMPLETED|Overall Study||91
486197|NCT01087905|1191275|P4|COMPLETED|Overall Study||86
486198|NCT01087905|1191276|P3|COMPLETED|Overall Study||101
486199|NCT01087905|1191277|P2|COMPLETED|Overall Study||94
486200|NCT01087905|1191278|P1|COMPLETED|Overall Study||90
486201|NCT01087905|1191271|P8|STARTED|Overall Study||127
486202|NCT01087905|1191272|P7|STARTED|Overall Study||121
486203|NCT01087905|1191273|P6|STARTED|Overall Study||127
486204|NCT01087905|1191274|P5|STARTED|Overall Study||122
486205|NCT01087905|1191275|P4|STARTED|Overall Study||122
486206|NCT01087905|1191276|P3|STARTED|Overall Study||123
486207|NCT01087905|1191277|P2|STARTED|Overall Study||126
486208|NCT01087905|1191278|P1|STARTED|Overall Study||119
486209|NCT01087814|1191300|P2|NOT COMPLETED|Second Intervention (5 Days)||0
486210|NCT01087814|1191301|P1|NOT COMPLETED|Second Intervention (5 Days)||1
486211|NCT01087814|1191300|P2|COMPLETED|Second Intervention (5 Days)||6
486212|NCT01087814|1191301|P1|COMPLETED|Second Intervention (5 Days)||4
486213|NCT01087814|1191300|P2|STARTED|Second Intervention (5 Days)||6
486214|NCT01087814|1191301|P1|STARTED|Second Intervention (5 Days)||5
486215|NCT01087814|1191300|P2|NOT COMPLETED|First Intervention (5 Days)||1
486216|NCT01087814|1191301|P1|NOT COMPLETED|First Intervention (5 Days)||3
486217|NCT01087814|1191300|P2|COMPLETED|First Intervention (5 Days)||6
486218|NCT01087814|1191301|P1|COMPLETED|First Intervention (5 Days)||5
486219|NCT01087814|1191300|P2|STARTED|First Intervention (5 Days)||7
486220|NCT01087814|1191301|P1|STARTED|First Intervention (5 Days)||8
486221|NCT01087801|1191309|P2|NOT COMPLETED|Overall Study||5
486222|NCT01087801|1191310|P1|NOT COMPLETED|Overall Study||4
486223|NCT01087801|1191309|P2|COMPLETED|Overall Study||29
486224|NCT01087801|1191310|P1|COMPLETED|Overall Study||26
486225|NCT01087801|1191309|P2|STARTED|Overall Study||34
486226|NCT01087801|1191310|P1|STARTED|Overall Study||30
486227|NCT01087788|1191319|P3|NOT COMPLETED|Open-Label Period (OL-P)||28
486228|NCT01087788|1191320|P2|NOT COMPLETED|Open-Label Period (OL-P)||24
486229|NCT01087788|1191321|P1|NOT COMPLETED|Open-Label Period (OL-P)||30
486230|NCT01087788|1191319|P3|COMPLETED|Open-Label Period (OL-P)||86
486231|NCT01087788|1191320|P2|COMPLETED|Open-Label Period (OL-P)||97
486232|NCT01087788|1191321|P1|COMPLETED|Open-Label Period (OL-P)||81
486233|NCT01087788|1191319|P3|STARTED|Open-Label Period (OL-P)||114
486234|NCT01087788|1191320|P2|STARTED|Open-Label Period (OL-P)|2 subj. completed the Dose-Blind Period, then withdrew from the study rather than entering the OL-P.|121
486235|NCT01087788|1191321|P1|STARTED|Open-Label Period (OL-P)|2 subj. completed the Dose-Blind Period, then withdrew from the study rather than entering the OL-P.|111
486236|NCT01087788|1191319|P3|NOT COMPLETED|24-weeks Dose-blind Period||6
486237|NCT01087788|1191320|P2|NOT COMPLETED|24-weeks Dose-blind Period||5
486238|NCT01087788|1191321|P1|NOT COMPLETED|24-weeks Dose-blind Period||7
486239|NCT01087788|1191319|P3|COMPLETED|24-weeks Dose-blind Period||114
486240|NCT01087788|1191320|P2|COMPLETED|24-weeks Dose-blind Period||123
486241|NCT01087788|1191321|P1|COMPLETED|24-weeks Dose-blind Period||113
486242|NCT01087788|1191319|P3|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
486243|NCT01087788|1191320|P2|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
486244|NCT01087788|1191321|P1|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|Sum of subjects re-randomized to CZP 400mg Q2W at week 16 (29 subjects) and at week 24 (31 subjects)|60
486245|NCT01087788|1191319|P3|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
486246|NCT01087788|1191320|P2|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
486247|NCT01087788|1191321|P1|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|Sum of subjects re-randomized to CZP 200mg Q2W at week 16 (30 subjects) and at week 24 (30 subjects)|60
486248|NCT01087788|1191319|P3|STARTED|24-weeks Dose-blind Period||120
486249|NCT01087788|1191320|P2|STARTED|24-weeks Dose-blind Period||128
486250|NCT01087788|1191321|P1|STARTED|24-weeks Dose-blind Period||120
486251|NCT01087788|1191319|P3|NOT COMPLETED|24-weeks Double-blind Period||15
486252|NCT01087788|1191320|P2|NOT COMPLETED|24-weeks Double-blind Period||10
486253|NCT01087788|1191321|P1|NOT COMPLETED|24-weeks Double-blind Period||16
486254|NCT01087788|1191319|P3|COMPLETED|24-weeks Double-blind Period||120
486255|NCT01087788|1191320|P2|COMPLETED|24-weeks Double-blind Period||128
486256|NCT01087788|1191321|P1|COMPLETED|24-weeks Double-blind Period||120
486257|NCT01087788|1191319|P3|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
486258|NCT01087788|1191320|P2|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
486259|NCT01087788|1191321|P1|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|29 subjects left the Placebo group and were re-randomized to CZP 400 mg Q4W on Week 16.|29
486260|NCT01087788|1191319|P3|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
486261|NCT01087788|1191320|P2|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
486262|NCT01087788|1191321|P1|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|30 subjects left the Placebo group and were re-randomized to CZP 200 mg Q2W on Week 16.|30
486263|NCT01087788|1191319|P3|STARTED|24-weeks Double-blind Period||135
486264|NCT01087788|1191320|P2|STARTED|24-weeks Double-blind Period||138
486265|NCT01087788|1191321|P1|STARTED|24-weeks Double-blind Period||136
486266|NCT01087762|1191351|P5|NOT COMPLETED|Open-Label Period (Weeks 48-204)||57
486267|NCT01087762|1191352|P4|NOT COMPLETED|Open-Label Period (Weeks 48-204)||59
486268|NCT01087762|1191353|P3|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
486269|NCT01087762|1191354|P2|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
486270|NCT01087762|1191355|P1|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
486271|NCT01087762|1191351|P5|COMPLETED|Open-Label Period (Weeks 48-204)||100
486272|NCT01087762|1191352|P4|COMPLETED|Open-Label Period (Weeks 48-204)||99
486273|NCT01087762|1191353|P3|COMPLETED|Open-Label Period (Weeks 48-204)||0
486274|NCT01087762|1191354|P2|COMPLETED|Open-Label Period (Weeks 48-204)||0
486275|NCT01087762|1191355|P1|COMPLETED|Open-Label Period (Weeks 48-204)||0
486276|NCT01087762|1191351|P5|STARTED|Open-Label Period (Weeks 48-204)||157
486277|NCT01087762|1191352|P4|STARTED|Open-Label Period (Weeks 48-204)||158
486278|NCT01087762|1191353|P3|STARTED|Open-Label Period (Weeks 48-204)||0
486279|NCT01087762|1191354|P2|STARTED|Open-Label Period (Weeks 48-204)||0
486280|NCT01087762|1191355|P1|STARTED|Open-Label Period (Weeks 48-204)||0
486281|NCT01087762|1191351|P5|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0
486282|NCT01087762|1191352|P4|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0
486283|NCT01087762|1191353|P3|NOT COMPLETED|Double Blind Period (Weeks 0-24)||9
486284|NCT01087762|1191354|P2|NOT COMPLETED|Double Blind Period (Weeks 0-24)||6
486285|NCT01087762|1191355|P1|NOT COMPLETED|Double Blind Period (Weeks 0-24)||12
486286|NCT01087762|1191351|P5|COMPLETED|Double Blind Period (Weeks 0-24)||0
486287|NCT01087762|1191352|P4|COMPLETED|Double Blind Period (Weeks 0-24)||0
486288|NCT01087762|1191353|P3|COMPLETED|Double Blind Period (Weeks 0-24)||98
486289|NCT01087762|1191354|P2|COMPLETED|Double Blind Period (Weeks 0-24)||105
486290|NCT01087762|1191355|P1|COMPLETED|Double Blind Period (Weeks 0-24)||95
486291|NCT01087762|1191351|P5|STARTED|Double Blind Period (Weeks 0-24)||0
486292|NCT01087762|1191352|P4|STARTED|Double Blind Period (Weeks 0-24)||0
486293|NCT01087762|1191353|P3|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|107
486294|NCT01087762|1191354|P2|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|111
486295|NCT01087762|1191355|P1|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|107
486296|NCT01087736|1191403|P2|NOT COMPLETED|Overall Study||2
486297|NCT01087736|1191404|P1|NOT COMPLETED|Overall Study||1
486298|NCT01087736|1191403|P2|COMPLETED|Overall Study||14
486299|NCT01087736|1191404|P1|COMPLETED|Overall Study||13
486300|NCT01087736|1191403|P2|STARTED|Overall Study||16
486301|NCT01087736|1191404|P1|STARTED|Overall Study||14
486302|NCT01087723|1191414|P2|NOT COMPLETED|Overall Study||20
486303|NCT01087723|1191415|P1|NOT COMPLETED|Overall Study||14
486304|NCT01087723|1191414|P2|COMPLETED|Overall Study|Completed 1-year follow-up in the study|1089
486305|NCT01087723|1191415|P1|COMPLETED|Overall Study|Completed 1-year follow-up in the study|1075
486306|NCT01087723|1191414|P2|Received at Least 1 Dose of Study Drug|Overall Study|Participants who were randomized with signed ICF by treatment actually received; Safety population|1094
486307|NCT01087723|1191415|P1|Received at Least 1 Dose of Study Drug|Overall Study|Participants who were randomized with signed ICF by treatment actually received; Safety population|1099
486308|NCT01087723|1191414|P2|STARTED|Overall Study|Randomized participants who signed an informed consent form (ICF); Intent-to-treat (ITT) population|1109
486309|NCT01087723|1191415|P1|STARTED|Overall Study|Randomized participants who signed an informed consent form (ICF); Intent-to-treat (ITT) population|1089
486310|NCT01087541|1191439|P2|NOT COMPLETED|Overall Study||0
486311|NCT01087541|1191440|P1|NOT COMPLETED|Overall Study||0
486312|NCT01087541|1191439|P2|COMPLETED|Overall Study||3523
486313|NCT01087541|1191440|P1|COMPLETED|Overall Study||3307
486314|NCT01087541|1191439|P2|STARTED|Overall Study||3523
486315|NCT01087541|1191440|P1|STARTED|Overall Study||3307
486316|NCT01087528|1191456|P1|NOT COMPLETED|Overall Study||7
486317|NCT01087528|1191456|P1|COMPLETED|Overall Study|withdrawn from the study prior to any procedure|44
486318|NCT01087528|1191456|P1|STARTED|Overall Study||51
486319|NCT01087502|1191462|P2|NOT COMPLETED|Up to Final Analysis (Week 52)||23
486320|NCT01087502|1191463|P1|NOT COMPLETED|Up to Final Analysis (Week 52)||33
486321|NCT01087502|1191462|P2|COMPLETED|Up to Final Analysis (Week 52)||95
486322|NCT01087502|1191463|P1|COMPLETED|Up to Final Analysis (Week 52)||90
486323|NCT01087502|1191462|P2|STARTED|Up to Final Analysis (Week 52)||118
486324|NCT01087502|1191463|P1|STARTED|Up to Final Analysis (Week 52)||123
486325|NCT01087502|1191462|P2|NOT COMPLETED|Up to Interim Analysis (Week 12)||8
486326|NCT01087502|1191463|P1|NOT COMPLETED|Up to Interim Analysis (Week 12)||9
486327|NCT01087502|1191462|P2|COMPLETED|Up to Interim Analysis (Week 12)||110
486328|NCT01087502|1191463|P1|COMPLETED|Up to Interim Analysis (Week 12)||114
486329|NCT01087502|1191462|P2|STARTED|Up to Interim Analysis (Week 12)||118
486330|NCT01087502|1191463|P1|STARTED|Up to Interim Analysis (Week 12)||123
486331|NCT01087489|1191482|P2|NOT COMPLETED|Overall Study||3
486332|NCT01087489|1191483|P1|NOT COMPLETED|Overall Study||0
486333|NCT01087489|1191482|P2|COMPLETED|Overall Study||31
486334|NCT01087489|1191483|P1|COMPLETED|Overall Study||19
486335|NCT01087489|1191482|P2|STARTED|Overall Study||34
486336|NCT01087489|1191483|P1|STARTED|Overall Study||19
486337|NCT01086969|1191496|P3|NOT COMPLETED|Overall Study||0
486338|NCT01086969|1191497|P2|NOT COMPLETED|Overall Study||2
486339|NCT01086969|1191498|P1|NOT COMPLETED|Overall Study||1
486340|NCT01086969|1191496|P3|COMPLETED|Overall Study||100
486341|NCT01086969|1191497|P2|COMPLETED|Overall Study||98
486342|NCT01086969|1191498|P1|COMPLETED|Overall Study||99
486343|NCT01086969|1191496|P3|STARTED|Overall Study||100
486344|NCT01086969|1191497|P2|STARTED|Overall Study||100
486345|NCT01086969|1191498|P1|STARTED|Overall Study||100
486346|NCT01086852|1191515|P1|NOT COMPLETED|Overall Study||0
486347|NCT01086852|1191515|P1|COMPLETED|Overall Study||4
486348|NCT01086852|1191515|P1|STARTED|Overall Study||4
486349|NCT01086761|1191531|P6|NOT COMPLETED|Overall Study||0
486350|NCT01086761|1191532|P5|NOT COMPLETED|Overall Study||0
486351|NCT01086761|1191533|P4|NOT COMPLETED|Overall Study||0
486352|NCT01086761|1191534|P3|NOT COMPLETED|Overall Study||0
486353|NCT01086761|1191535|P2|NOT COMPLETED|Overall Study||0
486354|NCT01086761|1191536|P1|NOT COMPLETED|Overall Study||0
486355|NCT01086761|1191531|P6|COMPLETED|Overall Study||0
486356|NCT01086761|1191532|P5|COMPLETED|Overall Study||4
486357|NCT01086761|1191533|P4|COMPLETED|Overall Study||6
486358|NCT01086761|1191534|P3|COMPLETED|Overall Study||6
486359|NCT01086761|1191535|P2|COMPLETED|Overall Study||7
486360|NCT01086761|1191536|P1|COMPLETED|Overall Study||9
486361|NCT01086761|1191531|P6|STARTED|Overall Study||0
486362|NCT01086761|1191532|P5|STARTED|Overall Study||4
486363|NCT01086761|1191533|P4|STARTED|Overall Study||6
486364|NCT01086761|1191534|P3|STARTED|Overall Study||6
486365|NCT01086761|1191535|P2|STARTED|Overall Study||7
486366|NCT01086761|1191536|P1|STARTED|Overall Study||9
486367|NCT01086605|1191576|P2|NOT COMPLETED|Overall Study||0
486368|NCT01086605|1191577|P1|NOT COMPLETED|Overall Study||0
486369|NCT01086605|1191576|P2|COMPLETED|Overall Study||22
486370|NCT01086605|1191577|P1|COMPLETED|Overall Study||24
486371|NCT01086605|1191576|P2|STARTED|Overall Study||22
486372|NCT01086605|1191577|P1|STARTED|Overall Study||24
486373|NCT01086475|1191594|P2|NOT COMPLETED|Overall Study||0
486374|NCT01086475|1191595|P1|NOT COMPLETED|Overall Study||0
486375|NCT01086475|1191594|P2|COMPLETED|Overall Study||33
486376|NCT01086475|1191595|P1|COMPLETED|Overall Study||34
486377|NCT01086475|1191594|P2|STARTED|Overall Study||33
486378|NCT01086475|1191595|P1|STARTED|Overall Study||34
486379|NCT01086423|1191608|P3|NOT COMPLETED|Overall Study||9
486380|NCT01086423|1191609|P2|NOT COMPLETED|Overall Study||3
486381|NCT01086423|1191610|P1|NOT COMPLETED|Overall Study||10
486382|NCT01086423|1191608|P3|COMPLETED|Overall Study||321
486383|NCT01086423|1191609|P2|COMPLETED|Overall Study||321
486384|NCT01086423|1191610|P1|COMPLETED|Overall Study||320
486385|NCT01086423|1191608|P3|STARTED|Overall Study||330
486386|NCT01086423|1191609|P2|STARTED|Overall Study||324
486387|NCT01086423|1191610|P1|STARTED|Overall Study||330
486388|NCT01086410|1191655|P4|NOT COMPLETED|Overall Study||2
486389|NCT01086410|1191656|P3|NOT COMPLETED|Overall Study||1
486390|NCT01086410|1191657|P2|NOT COMPLETED|Overall Study||2
486391|NCT01086410|1191658|P1|NOT COMPLETED|Overall Study||3
486392|NCT01086410|1191655|P4|COMPLETED|Overall Study||13
486393|NCT01086410|1191656|P3|COMPLETED|Overall Study||55
486394|NCT01086410|1191657|P2|COMPLETED|Overall Study||54
486395|NCT01086410|1191658|P1|COMPLETED|Overall Study||55
486396|NCT01086410|1191655|P4|STARTED|Overall Study||15
486397|NCT01086410|1191656|P3|STARTED|Overall Study||56
486398|NCT01086410|1191657|P2|STARTED|Overall Study||56
486399|NCT01086410|1191658|P1|STARTED|Overall Study||58
486400|NCT01086384|1191754|P3|NOT COMPLETED|Treatment Period||124
486401|NCT01086384|1191755|P2|NOT COMPLETED|Treatment Period||148
486402|NCT01086384|1191756|P1|NOT COMPLETED|Treatment Period||0
486403|NCT01086384|1191754|P3|COMPLETED|Treatment Period||885
486404|NCT01086384|1191755|P2|COMPLETED|Treatment Period||863
486405|NCT01086384|1191756|P1|COMPLETED|Treatment Period||0
486406|NCT01086384|1191754|P3|STARTED|Treatment Period||1009
486407|NCT01086384|1191755|P2|STARTED|Treatment Period||1011
486408|NCT01086384|1191756|P1|STARTED|Treatment Period||0
486409|NCT01086384|1191754|P3|NOT COMPLETED|2-week Run-in Period||0
486410|NCT01086384|1191755|P2|NOT COMPLETED|2-week Run-in Period||0
486411|NCT01086384|1191756|P1|NOT COMPLETED|2-week Run-in Period||163
486412|NCT01086384|1191754|P3|COMPLETED|2-week Run-in Period||0
486413|NCT01086384|1191755|P2|COMPLETED|2-week Run-in Period||0
486414|NCT01086384|1191756|P1|COMPLETED|2-week Run-in Period||2020
486415|NCT01086384|1191754|P3|STARTED|2-week Run-in Period||0
486416|NCT01086384|1191755|P2|STARTED|2-week Run-in Period||0
486417|NCT01086384|1191756|P1|STARTED|2-week Run-in Period||2183
486418|NCT01086358|1191766|P2|NOT COMPLETED|Second Intervention||4
486419|NCT01086358|1191767|P1|NOT COMPLETED|Second Intervention||4
486420|NCT01086358|1191766|P2|COMPLETED|Second Intervention||20
486421|NCT01086358|1191767|P1|COMPLETED|Second Intervention||17
486422|NCT01086358|1191766|P2|STARTED|Second Intervention||24
486423|NCT01086358|1191767|P1|STARTED|Second Intervention||21
486424|NCT01086358|1191766|P2|NOT COMPLETED|First Intervention||5
486425|NCT01086358|1191767|P1|NOT COMPLETED|First Intervention||9
486426|NCT01086358|1191766|P2|COMPLETED|First Intervention||24
486427|NCT01086358|1191767|P1|COMPLETED|First Intervention||21
486428|NCT01086358|1191766|P2|STARTED|First Intervention|30 subjects enrolled, 1 withdrew before randomization|29
486429|NCT01086358|1191767|P1|STARTED|First Intervention|30 subjects enrolled.|30
486430|NCT01086228|1191779|P1|NOT COMPLETED|5-year Follow-up||652
486431|NCT01086228|1191779|P1|COMPLETED|5-year Follow-up||1012
486432|NCT01086228|1191779|P1|STARTED|5-year Follow-up||1664
486433|NCT01086228|1191779|P1|NOT COMPLETED|4-year Follow-up||103
486434|NCT01086228|1191779|P1|COMPLETED|4-year Follow-up||1664
486435|NCT01086228|1191779|P1|STARTED|4-year Follow-up||1767
486436|NCT01086228|1191779|P1|NOT COMPLETED|3-year Follow-up||67
486437|NCT01086228|1191779|P1|COMPLETED|3-year Follow-up||1767
486438|NCT01086228|1191779|P1|STARTED|3-year Follow-up||1834
486439|NCT01086228|1191779|P1|NOT COMPLETED|2-year Follow-up||60
486440|NCT01086228|1191779|P1|COMPLETED|2-year Follow-up||1834
486441|NCT01086228|1191779|P1|STARTED|2-year Follow-up||1894
486442|NCT01086228|1191779|P1|NOT COMPLETED|1-year Follow-up||44
486443|NCT01086228|1191779|P1|COMPLETED|1-year Follow-up||1894
486444|NCT01086228|1191779|P1|STARTED|1-year Follow-up||1938
486445|NCT01086228|1191779|P1|NOT COMPLETED|8 Month Follow-up||71
486446|NCT01086228|1191779|P1|COMPLETED|8 Month Follow-up||1938
486447|NCT01086228|1191779|P1|STARTED|8 Month Follow-up|Analysis population|2009
486448|NCT01086215|1191837|P4|NOT COMPLETED|Overall Study||3
486449|NCT01086215|1191838|P3|NOT COMPLETED|Overall Study||26
486450|NCT01086215|1191839|P2|NOT COMPLETED|Overall Study||47
486451|NCT01086215|1191840|P1|NOT COMPLETED|Overall Study||36
486452|NCT01086215|1191837|P4|COMPLETED|Overall Study||11
486453|NCT01086215|1191838|P3|COMPLETED|Overall Study||47
486454|NCT01086215|1191839|P2|COMPLETED|Overall Study||154
486455|NCT01086215|1191840|P1|COMPLETED|Overall Study||176
486456|NCT01086215|1191837|P4|12 Month Follow Up|Overall Study|0 LTF; 1 Death|11
486457|NCT01086215|1191838|P3|12 Month Follow Up|Overall Study|9 LTF; 4 Deaths|47
486458|NCT01086215|1191839|P2|12 Month Follow Up|Overall Study|16 LTF; 2 Deaths|154
486459|NCT01086215|1191840|P1|12 Month Follow Up|Overall Study|10 LTF; 6 Deaths|176
486460|NCT01086215|1191837|P4|6 Month Follow Up|Overall Study|1 LTF; 0 Deaths|12
486461|NCT01086215|1191838|P3|6 Month Follow Up|Overall Study|4 LTF; 0 Deaths|60
486462|NCT01086215|1191839|P2|6 Month Follow Up|Overall Study|13 LTF; 2 Deaths|172
486463|NCT01086215|1191840|P1|6 Month Follow Up|Overall Study|5 LTF; 4 Deaths|192
486464|NCT01086215|1191837|P4|3 Month Follow Up|Overall Study|1 LTF; 0 Deaths|13
486465|NCT01086215|1191838|P3|3 Month Follow Up|Overall Study|5 LTF; 4 Deaths|64
486466|NCT01086215|1191839|P2|3 Month Follow Up|Overall Study|10 LTF; 4 Deaths|187
486467|NCT01086215|1191840|P1|3 Month Follow Up|Overall Study|7 LTF; 4 Deaths|201
486468|NCT01086215|1191837|P4|STARTED|Overall Study||14
486469|NCT01086215|1191838|P3|STARTED|Overall Study||73
486470|NCT01086215|1191839|P2|STARTED|Overall Study||201
486471|NCT01086215|1191840|P1|STARTED|Overall Study||212
486472|NCT01086033|1191858|P1|NOT COMPLETED|Overall Study||304
486473|NCT01086033|1191858|P1|COMPLETED|Overall Study||262
486474|NCT01086033|1191858|P1|STARTED|Overall Study||566
486475|NCT01085968|1191872|P2|NOT COMPLETED|Overall Study||4
486476|NCT01085968|1191873|P1|NOT COMPLETED|Overall Study||10
486477|NCT01085968|1191872|P2|COMPLETED|Overall Study||21
486478|NCT01085968|1191873|P1|COMPLETED|Overall Study||19
486479|NCT01085968|1191872|P2|STARTED|Overall Study||25
486480|NCT01085968|1191873|P1|STARTED|Overall Study||29
486481|NCT01085903|1191889|P3|NOT COMPLETED|Overall Study||0
486482|NCT01085903|1191890|P2|NOT COMPLETED|Overall Study||0
486483|NCT01085903|1191891|P1|NOT COMPLETED|Overall Study||0
486484|NCT01085903|1191889|P3|COMPLETED|Overall Study||3
486485|NCT01085903|1191890|P2|COMPLETED|Overall Study||4
486486|NCT01085903|1191891|P1|COMPLETED|Overall Study||21
486487|NCT01085903|1191889|P3|STARTED|Overall Study||3
486488|NCT01085903|1191890|P2|STARTED|Overall Study||4
486489|NCT01085903|1191891|P1|STARTED|Overall Study||21
486490|NCT01085825|1191917|P2|NOT COMPLETED|Overall Study||1
486491|NCT01085825|1191918|P1|NOT COMPLETED|Overall Study||1
486492|NCT01085825|1191917|P2|COMPLETED|Overall Study||247
486493|NCT01085825|1191918|P1|COMPLETED|Overall Study||251
486494|NCT01085825|1191917|P2|STARTED|Overall Study||248
486495|NCT01085825|1191918|P1|STARTED|Overall Study|1st participant enrolled|252
486496|NCT01085786|1191926|P2|NOT COMPLETED|Overall Study||0
486497|NCT01085786|1191927|P1|NOT COMPLETED|Overall Study||0
486498|NCT01085786|1191926|P2|COMPLETED|Overall Study||117
486499|NCT01085786|1191927|P1|COMPLETED|Overall Study||123
486500|NCT01085786|1191926|P2|STARTED|Overall Study||117
486501|NCT01085786|1191927|P1|STARTED|Overall Study||123
486502|NCT01085760|1191937|P4|NOT COMPLETED|Overall Study||3
486503|NCT01085760|1191938|P3|NOT COMPLETED|Overall Study||2
486504|NCT01085760|1191939|P2|NOT COMPLETED|Overall Study||1
486505|NCT01085760|1191940|P1|NOT COMPLETED|Overall Study||1
486506|NCT01085760|1191937|P4|COMPLETED|Overall Study||6
486507|NCT01085760|1191938|P3|COMPLETED|Overall Study||7
486508|NCT01085760|1191939|P2|COMPLETED|Overall Study||8
486509|NCT01085760|1191940|P1|COMPLETED|Overall Study||7
486510|NCT01085760|1191937|P4|STARTED|Overall Study||9
486511|NCT01085760|1191938|P3|STARTED|Overall Study||9
486512|NCT01085760|1191939|P2|STARTED|Overall Study||9
486513|NCT01085760|1191940|P1|STARTED|Overall Study||8
486514|NCT01085734|1191964|P2|NOT COMPLETED|Overall Study||4
486515|NCT01085734|1191965|P1|NOT COMPLETED|Overall Study||1
486516|NCT01085734|1191964|P2|COMPLETED|Overall Study||11
486517|NCT01085734|1191965|P1|COMPLETED|Overall Study||14
486518|NCT01085734|1191964|P2|STARTED|Overall Study||15
486519|NCT01085734|1191965|P1|STARTED|Overall Study||15
486520|NCT01085682|1191977|P2|NOT COMPLETED|Overall Study||25
486521|NCT01085682|1191978|P1|NOT COMPLETED|Overall Study||25
486522|NCT01085682|1191977|P2|COMPLETED|Overall Study||3
486523|NCT01085682|1191978|P1|COMPLETED|Overall Study||6
486524|NCT01085682|1191977|P2|STARTED|Overall Study||28
486525|NCT01085682|1191978|P1|STARTED|Overall Study||31
486526|NCT01085643|1191984|P1|NOT COMPLETED|Overall Study||0
486527|NCT01085643|1191984|P1|COMPLETED|Overall Study||4
486528|NCT01085643|1191984|P1|STARTED|Overall Study||4
486529|NCT01085591|1191996|P3|NOT COMPLETED|Overall Study||7
486530|NCT01085591|1191997|P2|NOT COMPLETED|Overall Study||6
486531|NCT01085591|1191998|P1|NOT COMPLETED|Overall Study||3
486532|NCT01085591|1191996|P3|COMPLETED|Overall Study||63
486533|NCT01085591|1191997|P2|COMPLETED|Overall Study||65
486534|NCT01085591|1191998|P1|COMPLETED|Overall Study||66
486535|NCT01085591|1191996|P3|Received at Least 1 Dose of Study Drug|Overall Study||70
486536|NCT01085591|1191997|P2|Received at Least 1 Dose of Study Drug|Overall Study||69
486537|NCT01085591|1191998|P1|Received at Least 1 Dose of Study Drug|Overall Study||68
486538|NCT01085591|1191996|P3|STARTED|Overall Study||70
486539|NCT01085591|1191997|P2|STARTED|Overall Study||71
486540|NCT01085591|1191998|P1|STARTED|Overall Study||69
486541|NCT01085539|1192021|P1|NOT COMPLETED|100Sat Secs-100 Second Alarm Evaluation||0
486542|NCT01085539|1192021|P1|COMPLETED|100Sat Secs-100 Second Alarm Evaluation||50
486543|NCT01085539|1192021|P1|STARTED|100Sat Secs-100 Second Alarm Evaluation||50
486544|NCT01085539|1192021|P1|NOT COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||0
486545|NCT01085539|1192021|P1|COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||50
486546|NCT01085539|1192021|P1|STARTED|50 Sat Secs--50 Second Alarm Evaluation||50
486547|NCT01085539|1192021|P1|NOT COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||0
486548|NCT01085539|1192021|P1|COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||50
486549|NCT01085539|1192021|P1|STARTED|25 Sat Secs--25 Second Alarm Evaluation||50
486550|NCT01085539|1192021|P1|NOT COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||0
486551|NCT01085539|1192021|P1|COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||50
486552|NCT01085539|1192021|P1|STARTED|10 Sat Secs--10 Second Alarm Evaluation||50
486553|NCT01085539|1192021|P1|NOT COMPLETED|Sat Secs Off--No Alarm Evaluation||0
486554|NCT01085539|1192021|P1|COMPLETED|Sat Secs Off--No Alarm Evaluation||50
486555|NCT01085539|1192021|P1|STARTED|Sat Secs Off--No Alarm Evaluation||50
486556|NCT01085513|1192027|P2|NOT COMPLETED|Overall Study||0
486557|NCT01085513|1192028|P1|NOT COMPLETED|Overall Study||0
486558|NCT01085513|1192027|P2|COMPLETED|Overall Study||68
486559|NCT01085513|1192028|P1|COMPLETED|Overall Study|recruitment was premature terminated|75
486560|NCT01085513|1192027|P2|STARTED|Overall Study||68
486561|NCT01085513|1192028|P1|STARTED|Overall Study||75
486562|NCT01085500|1192036|P2|NOT COMPLETED|Overall Study||0
486563|NCT01085500|1192037|P1|NOT COMPLETED|Overall Study||0
486564|NCT01085500|1192036|P2|COMPLETED|Overall Study||24
486565|NCT01085500|1192037|P1|COMPLETED|Overall Study||26
486566|NCT01085500|1192036|P2|STARTED|Overall Study||24
486567|NCT01085500|1192037|P1|STARTED|Overall Study||26
486568|NCT01085357|1192049|P2|NOT COMPLETED|Overall Study||6
486569|NCT01085357|1192050|P1|NOT COMPLETED|Overall Study||19
486570|NCT01085357|1192049|P2|COMPLETED|Overall Study||125
486571|NCT01085357|1192050|P1|COMPLETED|Overall Study||355
486572|NCT01085357|1192049|P2|STARTED|Overall Study||131
486573|NCT01085357|1192050|P1|STARTED|Overall Study||374
486574|NCT01085331|1192062|P2|NOT COMPLETED|Overall Study||0
486575|NCT01085331|1192063|P1|NOT COMPLETED|Overall Study||0
486576|NCT01085331|1192062|P2|COMPLETED|Overall Study||6
486577|NCT01085331|1192063|P1|COMPLETED|Overall Study||10
486578|NCT01085331|1192062|P2|STARTED|Overall Study||6
486579|NCT01085331|1192063|P1|STARTED|Overall Study||10
486580|NCT01085318|1192102|P2|NOT COMPLETED|Overall Study||0
486581|NCT01085318|1192103|P1|NOT COMPLETED|Overall Study||2
486582|NCT01085318|1192102|P2|COMPLETED|Overall Study||15
486583|NCT01085318|1192103|P1|COMPLETED|Overall Study||21
486584|NCT01085318|1192102|P2|STARTED|Overall Study||15
486585|NCT01085318|1192103|P1|STARTED|Overall Study||23
486586|NCT01085214|1192113|P1|NOT COMPLETED|Overall Study||1
486587|NCT01085214|1192113|P1|COMPLETED|Overall Study||36
486588|NCT01085214|1192113|P1|STARTED|Overall Study||37
486589|NCT01085201|1192125|P5|NOT COMPLETED|Overall Study||0
486590|NCT01085201|1192126|P4|NOT COMPLETED|Overall Study||0
486591|NCT01085201|1192127|P3|NOT COMPLETED|Overall Study||2
486592|NCT01085201|1192128|P2|NOT COMPLETED|Overall Study||1
486593|NCT01085201|1192129|P1|NOT COMPLETED|Overall Study||3
486594|NCT01085201|1192125|P5|COMPLETED|Overall Study||3
486595|NCT01085201|1192126|P4|COMPLETED|Overall Study||6
486596|NCT01085201|1192127|P3|COMPLETED|Overall Study||3
486597|NCT01085201|1192128|P2|COMPLETED|Overall Study||6
486598|NCT01085201|1192129|P1|COMPLETED|Overall Study||15
486599|NCT01085201|1192125|P5|STARTED|Overall Study||3
486600|NCT01085201|1192126|P4|STARTED|Overall Study||6
486601|NCT01085201|1192127|P3|STARTED|Overall Study||5
486602|NCT01085201|1192128|P2|STARTED|Overall Study||7
486603|NCT01085201|1192129|P1|STARTED|Overall Study||18
486604|NCT01085136|1192151|P3|NOT COMPLETED|Part B||26
486605|NCT01085136|1192152|P2|NOT COMPLETED|Part B||51
486606|NCT01085136|1192153|P1|NOT COMPLETED|Part B||0
486607|NCT01085136|1192151|P3|COMPLETED|Part B|Completed trial as per protocol, had progressive disease, clinical signs or symptoms of progression|42
486608|NCT01085136|1192152|P2|COMPLETED|Part B|Completed trial as per protocol, had progressive disease, clinical signs or symptoms of progression|87
486609|NCT01085136|1192153|P1|COMPLETED|Part B|Afatinib monotherapy not administered in Part B|0
486610|NCT01085136|1192151|P3|STARTED|Part B||68
486611|NCT01085136|1192152|P2|STARTED|Part B||138
486612|NCT01085136|1192153|P1|STARTED|Part B|Afatinib monotherapy not administered in Part B|0
486613|NCT01085136|1192151|P3|NOT COMPLETED|Part A||0
486614|NCT01085136|1192152|P2|NOT COMPLETED|Part A||0
486615|NCT01085136|1192153|P1|NOT COMPLETED|Part A||323
486616|NCT01085136|1192151|P3|COMPLETED|Part A||0
486617|NCT01085136|1192152|P2|COMPLETED|Part A||0
486618|NCT01085136|1192153|P1|COMPLETED|Part A|Randomized to Part B & completed trial as per protocol, had PD, clinical progression.|831
486619|NCT01085136|1192151|P3|Randomized to Part B|Part A||0
486620|NCT01085136|1192152|P2|Randomized to Part B|Part A||0
486621|NCT01085136|1192153|P1|Randomized to Part B|Part A|Discontinued Part A -Randomized to Part B|206
486622|NCT01085136|1192151|P3|STARTED|Part A||0
486623|NCT01085136|1192152|P2|STARTED|Part A|Only Afatinib monotherapy administered in Part A|0
486624|NCT01085136|1192153|P1|STARTED|Part A||1154
486625|NCT01085045|1192169|P1|NOT COMPLETED|Part B||15
486626|NCT01085045|1192169|P1|COMPLETED|Part B||89
486627|NCT01085045|1192169|P1|GP MDI 36 µg (PT001)|Part B||0
486628|NCT01085045|1192169|P1|Foradil 12 µg|Part B||41
486629|NCT01085045|1192169|P1|Placebo MDI|Part B||47
486630|NCT01085045|1192169|P1|FF MDI 7.2 µg (PT005)|Part B||43
486631|NCT01085045|1192169|P1|FF MDI 9.6 µg (PT005)|Part B||43
486632|NCT01085045|1192169|P1|Spiriva 18 µg|Part B||0
486633|NCT01085045|1192169|P1|GFF MDI 36/9.6 µg|Part B||0
486634|NCT01085045|1192169|P1|GFF MDI 72/9.6mcg (PT003)|Part B||0
486635|NCT01085045|1192169|P1|STARTED|Part B||104
486636|NCT01085045|1192169|P1|NOT COMPLETED|Part A||18
486637|NCT01085045|1192169|P1|COMPLETED|Part A||104
486638|NCT01085045|1192169|P1|Foradil 12 µg|Part A||14
486639|NCT01085045|1192169|P1|Placebo MDI|Part A||5
486640|NCT01085045|1192169|P1|FF MDI 7.2 µg (PT005)|Part A||21
486641|NCT01085045|1192169|P1|FF MDI 9.6 µg (PT005)|Part A||20
486642|NCT01085045|1192169|P1|Spiriva 18 µg|Part A||58
486643|NCT01085045|1192169|P1|GP MDI 36 µg (PT001)|Part A||40
486644|NCT01085045|1192169|P1|GFF MDI 36/9.6 µg (PT003)|Part A||42
486645|NCT01085045|1192169|P1|GFF MDI 72/9.6mcg|Part A||40
486646|NCT01085045|1192169|P1|STARTED|Part A||122
486647|NCT01085006|1192271|P2|NOT COMPLETED|Overall Study||0
486648|NCT01085006|1192272|P1|NOT COMPLETED|Overall Study||0
486649|NCT01085006|1192271|P2|COMPLETED|Overall Study||50
486650|NCT01085006|1192272|P1|COMPLETED|Overall Study||50
486651|NCT01085006|1192271|P2|STARTED|Overall Study||50
486652|NCT01085006|1192272|P1|STARTED|Overall Study||50
486653|NCT01084759|1192278|P1|NOT COMPLETED|Overall Study||2
486654|NCT01084759|1192278|P1|COMPLETED|Overall Study||14
486655|NCT01084759|1192278|P1|STARTED|Overall Study||16
486656|NCT01084707|1192284|P1|NOT COMPLETED|Overall Study||6
486657|NCT01084707|1192284|P1|COMPLETED|Overall Study||34
486658|NCT01084707|1192284|P1|STARTED|Overall Study||40
486659|NCT01084668|1192318|P1|NOT COMPLETED|Overall Study||9
486660|NCT01084668|1192318|P1|COMPLETED|Overall Study||33
486661|NCT01084668|1192318|P1|STARTED|Overall Study|Three participants who took Humira prior to study entry have been excluded from the database.|42
486662|NCT01084603|1192327|P1|NOT COMPLETED|Oral Nicotine 4||0
486663|NCT01084603|1192327|P1|COMPLETED|Oral Nicotine 4||39
486664|NCT01084603|1192327|P1|STARTED|Oral Nicotine 4||39
486665|NCT01084603|1192327|P1|NOT COMPLETED|Washout Period 4||1
486666|NCT01084603|1192327|P1|COMPLETED|Washout Period 4||39
486667|NCT01084603|1192327|P1|STARTED|Washout Period 4||40
486668|NCT01084603|1192327|P1|NOT COMPLETED|Oral Nicotine 2||0
486669|NCT01084603|1192327|P1|COMPLETED|Oral Nicotine 2||40
486670|NCT01084603|1192327|P1|STARTED|Oral Nicotine 2||40
486671|NCT01084603|1192327|P1|NOT COMPLETED|Washout Period 3||0
486672|NCT01084603|1192327|P1|COMPLETED|Washout Period 3||40
486673|NCT01084603|1192327|P1|STARTED|Washout Period 3||40
486674|NCT01084603|1192327|P1|NOT COMPLETED|Oral Nicotine 1||1
486675|NCT01084603|1192327|P1|COMPLETED|Oral Nicotine 1||40
486676|NCT01084603|1192327|P1|STARTED|Oral Nicotine 1||41
486677|NCT01084603|1192327|P1|NOT COMPLETED|Washout Period 2||0
486678|NCT01084603|1192327|P1|COMPLETED|Washout Period 2||41
486679|NCT01084603|1192327|P1|STARTED|Washout Period 2||41
486680|NCT01084603|1192327|P1|NOT COMPLETED|Nicorette® Gum||1
486681|NCT01084603|1192327|P1|COMPLETED|Nicorette® Gum||41
486682|NCT01084603|1192327|P1|STARTED|Nicorette® Gum||42
486683|NCT01084603|1192327|P1|NOT COMPLETED|Washout Period 1||0
486684|NCT01084603|1192327|P1|COMPLETED|Washout Period 1||42
486685|NCT01084603|1192327|P1|STARTED|Washout Period 1||42
486686|NCT01084603|1192327|P1|NOT COMPLETED|NiQuitinTM Lozenge||1
486687|NCT01084603|1192327|P1|COMPLETED|NiQuitinTM Lozenge||42
486688|NCT01084603|1192327|P1|STARTED|NiQuitinTM Lozenge||43
486689|NCT01084603|1192327|P1|NOT COMPLETED|Baseline||2
486690|NCT01084603|1192327|P1|COMPLETED|Baseline||43
486691|NCT01084603|1192327|P1|STARTED|Baseline||45
486692|NCT01084551|1192363|P3|NOT COMPLETED|Overall Study||8
486693|NCT01084551|1192364|P2|NOT COMPLETED|Overall Study||14
486694|NCT01084551|1192365|P1|NOT COMPLETED|Overall Study||9
486695|NCT01084551|1192363|P3|COMPLETED|Overall Study||86
486696|NCT01084551|1192364|P2|COMPLETED|Overall Study||81
486697|NCT01084551|1192365|P1|COMPLETED|Overall Study||86
486698|NCT01084551|1192363|P3|STARTED|Overall Study||94
486699|NCT01084551|1192364|P2|STARTED|Overall Study||95
486700|NCT01084551|1192365|P1|STARTED|Overall Study||95
486701|NCT01084538|1192403|P1|NOT COMPLETED|Overall Study||68
486702|NCT01084538|1192403|P1|COMPLETED|Overall Study||113
486703|NCT01084538|1192403|P1|STARTED|Overall Study||181
486704|NCT01084278|1192415|P5|NOT COMPLETED|Overall Study||0
486705|NCT01084278|1192416|P4|NOT COMPLETED|Overall Study||0
486706|NCT01084278|1192417|P3|NOT COMPLETED|Overall Study||0
486707|NCT01084278|1192418|P2|NOT COMPLETED|Overall Study||0
486708|NCT01084278|1192419|P1|NOT COMPLETED|Overall Study||0
486709|NCT01084278|1192415|P5|COMPLETED|Overall Study||8
486710|NCT01084278|1192416|P4|COMPLETED|Overall Study||8
486711|NCT01084278|1192417|P3|COMPLETED|Overall Study||8
486712|NCT01084278|1192418|P2|COMPLETED|Overall Study||8
486713|NCT01084278|1192419|P1|COMPLETED|Overall Study||8
486714|NCT01084278|1192415|P5|STARTED|Overall Study||8
486715|NCT01084278|1192416|P4|STARTED|Overall Study||8
486716|NCT01084278|1192417|P3|STARTED|Overall Study||8
486717|NCT01084278|1192418|P2|STARTED|Overall Study||8
486718|NCT01084278|1192419|P1|STARTED|Overall Study||8
486719|NCT01084265|1192500|P1|NOT COMPLETED|Overall Study||0
486720|NCT01084265|1192500|P1|COMPLETED|Overall Study||31
486721|NCT01084265|1192500|P1|STARTED|Overall Study||31
486722|NCT01084239|1192514|P2|NOT COMPLETED|28-Day Follow-up||9
486723|NCT01084239|1192515|P1|NOT COMPLETED|28-Day Follow-up||4
486724|NCT01084239|1192514|P2|COMPLETED|28-Day Follow-up||490
486725|NCT01084239|1192515|P1|COMPLETED|28-Day Follow-up||497
486726|NCT01084239|1192514|P2|STARTED|28-Day Follow-up||499
486727|NCT01084239|1192515|P1|STARTED|28-Day Follow-up|All 501 patients enrolled were evaluated for follow-up at 28 days.|501
486728|NCT01084239|1192514|P2|NOT COMPLETED|Randomization - Index Hospitalization||0
486729|NCT01084239|1192515|P1|NOT COMPLETED|Randomization - Index Hospitalization||0
486730|NCT01084239|1192514|P2|COMPLETED|Randomization - Index Hospitalization||499
486731|NCT01084239|1192515|P1|COMPLETED|Randomization - Index Hospitalization||501
486732|NCT01084239|1192514|P2|STARTED|Randomization - Index Hospitalization||499
486733|NCT01084239|1192515|P1|STARTED|Randomization - Index Hospitalization||501
486734|NCT01084174|1192533|P2|NOT COMPLETED|Overall Study||4
486735|NCT01084174|1192534|P1|NOT COMPLETED|Overall Study||1
486736|NCT01084174|1192533|P2|COMPLETED|Overall Study||7
486737|NCT01084174|1192534|P1|COMPLETED|Overall Study||9
486738|NCT01084174|1192533|P2|STARTED|Overall Study||11
486739|NCT01084174|1192534|P1|STARTED|Overall Study||10
486740|NCT01084148|1192554|P2|NOT COMPLETED|Overall Study||16
486741|NCT01084148|1192555|P1|NOT COMPLETED|Overall Study||30
486742|NCT01084148|1192554|P2|COMPLETED|Overall Study||102
486743|NCT01084148|1192555|P1|COMPLETED|Overall Study||88
486744|NCT01084148|1192554|P2|Treated Patients|Overall Study|Patients who received test product at least once|117
486745|NCT01084148|1192555|P1|Treated Patients|Overall Study||118
486746|NCT01084148|1192554|P2|STARTED|Overall Study|Among those 118 patients randomized into V0034 CR 01B vehicle arm, one patient not treated.|118
486747|NCT01084148|1192555|P1|STARTED|Overall Study||118
486748|NCT01084135|1192567|P2|NOT COMPLETED|20 Week||1
486749|NCT01084135|1192568|P1|NOT COMPLETED|20 Week||0
486750|NCT01084135|1192567|P2|COMPLETED|20 Week||10
486751|NCT01084135|1192568|P1|COMPLETED|20 Week||12
486752|NCT01084135|1192567|P2|STARTED|20 Week||11
486753|NCT01084135|1192568|P1|STARTED|20 Week||12
486754|NCT01084135|1192567|P2|NOT COMPLETED|12 Week||0
486755|NCT01084135|1192568|P1|NOT COMPLETED|12 Week||0
486756|NCT01084135|1192567|P2|COMPLETED|12 Week||4
486757|NCT01084135|1192568|P1|COMPLETED|12 Week||4
486758|NCT01084135|1192567|P2|STARTED|12 Week||4
486759|NCT01084135|1192568|P1|STARTED|12 Week||4
486760|NCT01084083|1192578|P1|NOT COMPLETED|Overall Study||12
486761|NCT01084083|1192578|P1|COMPLETED|Overall Study||78
486762|NCT01084083|1192578|P1|CR and Treated With 5400 cGy IMRT|Overall Study|This is the primary study population for the primary endpoint (24-month PFS).|44
486763|NCT01084083|1192578|P1|CR to Induction Therapy|Overall Study||56
486764|NCT01084083|1192578|P1|Eligible and Treated|Overall Study|This is the eligible and treated patients for secondary efficacy endpoints|80
486765|NCT01084083|1192578|P1|Eligible|Overall Study||81
486766|NCT01084083|1192578|P1|Treated|Overall Study|This is the all treated patients for toxicity analysis|89
486767|NCT01084083|1192578|P1|STARTED|Overall Study||90
486768|NCT01084005|1192586|P2|NOT COMPLETED|Overall Study||16
486769|NCT01084005|1192587|P1|NOT COMPLETED|Overall Study||5
486770|NCT01084005|1192586|P2|COMPLETED|Overall Study||146
486771|NCT01084005|1192587|P1|COMPLETED|Overall Study||74
486772|NCT01084005|1192586|P2|STARTED|Overall Study||162
486773|NCT01084005|1192587|P1|STARTED|Overall Study||79
486774|NCT01083979|1192615|P1|NOT COMPLETED|Overall Study||0
486775|NCT01083979|1192615|P1|COMPLETED|Overall Study||1
486776|NCT01083979|1192615|P1|STARTED|Overall Study||1
486777|NCT01083901|1192623|P3|NOT COMPLETED|Overall Study||2
486778|NCT01083901|1192624|P2|NOT COMPLETED|Overall Study||2
486779|NCT01083901|1192625|P1|NOT COMPLETED|Overall Study||1
486780|NCT01083901|1192623|P3|COMPLETED|Overall Study||11
486781|NCT01083901|1192624|P2|COMPLETED|Overall Study||6
486782|NCT01083901|1192625|P1|COMPLETED|Overall Study||12
486783|NCT01083901|1192623|P3|STARTED|Overall Study||13
486784|NCT01083901|1192624|P2|STARTED|Overall Study||8
486785|NCT01083901|1192625|P1|STARTED|Overall Study||13
486786|NCT01083849|1192644|P2|NOT COMPLETED|Overall Study||111
486787|NCT01083849|1192645|P1|NOT COMPLETED|Overall Study||60
486788|NCT01083849|1192644|P2|COMPLETED|Overall Study||527
486789|NCT01083849|1192645|P1|COMPLETED|Overall Study||61
486790|NCT01083849|1192644|P2|STARTED|Overall Study||638
486791|NCT01083849|1192645|P1|STARTED|Overall Study||121
486792|NCT01083810|1192668|P3|NOT COMPLETED|Overall Study||20
486793|NCT01083810|1192669|P2|NOT COMPLETED|Overall Study||45
486794|NCT01083810|1192670|P1|NOT COMPLETED|Overall Study||65
486795|NCT01083810|1192668|P3|COMPLETED|Overall Study||35
486796|NCT01083810|1192669|P2|COMPLETED|Overall Study||47
486797|NCT01083810|1192670|P1|COMPLETED|Overall Study||72
486798|NCT01083810|1192668|P3|STARTED|Overall Study||55
486799|NCT01083810|1192669|P2|STARTED|Overall Study||92
486800|NCT01083810|1192670|P1|STARTED|Overall Study||137
486801|NCT01083771|1192691|P1|NOT COMPLETED|Overall Study||5
486802|NCT01083771|1192691|P1|COMPLETED|Overall Study||16
486803|NCT01083771|1192691|P1|STARTED|Overall Study||21
486804|NCT01083758|1192696|P1|NOT COMPLETED|Overall Study||2
486805|NCT01083758|1192696|P1|COMPLETED|Overall Study||29
486806|NCT01083758|1192696|P1|STARTED|Overall Study||31
486807|NCT01083732|1192730|P3|NOT COMPLETED|Overall Study||0
486808|NCT01083732|1192731|P2|NOT COMPLETED|Overall Study||0
486809|NCT01083732|1192732|P1|NOT COMPLETED|Overall Study||0
486810|NCT01083732|1192730|P3|COMPLETED|Overall Study||3
486811|NCT01083732|1192731|P2|COMPLETED|Overall Study||9
486812|NCT01083732|1192732|P1|COMPLETED|Overall Study||6
486813|NCT01083732|1192730|P3|STARTED|Overall Study||3
486814|NCT01083732|1192731|P2|STARTED|Overall Study||9
486815|NCT01083732|1192732|P1|STARTED|Overall Study||6
486816|NCT01083706|1192783|P1|NOT COMPLETED|Overall Study||0
486817|NCT01083706|1192783|P1|COMPLETED|Overall Study||39
486818|NCT01083706|1192783|P1|STARTED|Overall Study||39
486819|NCT01083693|1192792|P3|NOT COMPLETED|Overall Study||7
486820|NCT01083693|1192793|P2|NOT COMPLETED|Overall Study||6
486821|NCT01083693|1192794|P1|NOT COMPLETED|Overall Study||20
486822|NCT01083693|1192792|P3|COMPLETED|Overall Study||33
486823|NCT01083693|1192793|P2|COMPLETED|Overall Study||22
486824|NCT01083693|1192794|P1|COMPLETED|Overall Study||73
486825|NCT01083693|1192792|P3|STARTED|Overall Study||40
486826|NCT01083693|1192793|P2|STARTED|Overall Study||28
486827|NCT01083693|1192794|P1|STARTED|Overall Study||93
486828|NCT01083680|1192829|P1|NOT COMPLETED|Overall Study||3844
486829|NCT01083680|1192829|P1|COMPLETED|Overall Study||263
486830|NCT01083680|1192829|P1|Full Analysis Set (FAS), Efficacy|Overall Study||1621
486831|NCT01083680|1192829|P1|STARTED|Overall Study||4107
486832|NCT01083667|1192838|P1|NOT COMPLETED|Overall Study||10
486833|NCT01083667|1192838|P1|COMPLETED|Overall Study|22 completed to visit 9, the last visit on study.|22
486834|NCT01083667|1192838|P1|STARTED|Overall Study|enrolled|32
486835|NCT01083654|1192845|P2|NOT COMPLETED|Overall Study||0
486836|NCT01083654|1192846|P1|NOT COMPLETED|Overall Study||0
486837|NCT01083654|1192845|P2|COMPLETED|Overall Study||50
486838|NCT01083654|1192846|P1|COMPLETED|Overall Study||53
486839|NCT01083654|1192845|P2|STARTED|Overall Study||50
486840|NCT01083654|1192846|P1|STARTED|Overall Study||53
486841|NCT01083641|1192852|P1|NOT COMPLETED|Overall Study||2
486842|NCT01083641|1192852|P1|COMPLETED|Overall Study||15
486843|NCT01083641|1192852|P1|STARTED|Overall Study||17
486844|NCT01083602|1192859|P1|NOT COMPLETED|Overall Study||55
486845|NCT01083602|1192859|P1|COMPLETED|Overall Study||0
486846|NCT01083602|1192859|P1|STARTED|Overall Study||55
486847|NCT01083576|1192870|P2|NOT COMPLETED|Overall Study||1
486848|NCT01083576|1192871|P1|NOT COMPLETED|Overall Study||6
486849|NCT01083576|1192870|P2|COMPLETED|Overall Study||14
486850|NCT01083576|1192871|P1|COMPLETED|Overall Study||9
486851|NCT01083576|1192870|P2|STARTED|Overall Study||15
486852|NCT01083576|1192871|P1|STARTED|Overall Study||15
486853|NCT01083485|1192901|P2|NOT COMPLETED|Overall Study||3
486854|NCT01083485|1192902|P1|NOT COMPLETED|Overall Study||7
486855|NCT01083485|1192901|P2|COMPLETED|Overall Study||64
486856|NCT01083485|1192902|P1|COMPLETED|Overall Study||63
486857|NCT01083485|1192901|P2|STARTED|Overall Study||67
486858|NCT01083485|1192902|P1|STARTED|Overall Study||70
486859|NCT01083472|1192912|P2|NOT COMPLETED|Overall Study||0
486860|NCT01083472|1192913|P1|NOT COMPLETED|Overall Study||0
486861|NCT01083472|1192912|P2|COMPLETED|Overall Study||19
486862|NCT01083472|1192913|P1|COMPLETED|Overall Study||18
486863|NCT01083472|1192912|P2|STARTED|Overall Study||19
486864|NCT01083472|1192913|P1|STARTED|Overall Study||18
486865|NCT01083316|1192919|P1|NOT COMPLETED|Overall Study||3
486866|NCT01083316|1192919|P1|COMPLETED|Overall Study||32
486867|NCT01083316|1192919|P1|STARTED|Overall Study||35
486868|NCT01083199|1192925|P1|NOT COMPLETED|Overall Study||0
486869|NCT01083199|1192925|P1|COMPLETED|Overall Study||10
486870|NCT01083199|1192925|P1|STARTED|Overall Study||10
486871|NCT01083186|1192930|P1|NOT COMPLETED|Overall Study||94
486872|NCT01083186|1192930|P1|COMPLETED|Overall Study||406
486873|NCT01083186|1192930|P1|STARTED|Overall Study||500
486874|NCT01083173|1192971|P2|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||377
486875|NCT01083173|1192972|P1|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||0
486876|NCT01083173|1192971|P2|COMPLETED|Long-term Surveillance: Effectiveness Gr||102
486877|NCT01083173|1192972|P1|COMPLETED|Long-term Surveillance: Effectiveness Gr||0
486878|NCT01083173|1192971|P2|STARTED|Long-term Surveillance: Effectiveness Gr||479
486879|NCT01083173|1192972|P1|STARTED|Long-term Surveillance: Effectiveness Gr||0
486880|NCT01083173|1192971|P2|NOT COMPLETED|Long-term Surveillance: Safety Group||116
486881|NCT01083173|1192972|P1|NOT COMPLETED|Long-term Surveillance: Safety Group||0
486882|NCT01083173|1192971|P2|COMPLETED|Long-term Surveillance: Safety Group||479
486883|NCT01083173|1192972|P1|COMPLETED|Long-term Surveillance: Safety Group||0
486884|NCT01083173|1192971|P2|STARTED|Long-term Surveillance: Safety Group||595
486885|NCT01083173|1192972|P1|STARTED|Long-term Surveillance: Safety Group||0
486886|NCT01083173|1192971|P2|NOT COMPLETED|Main Surveillance: Effectiveness Group||0
486887|NCT01083173|1192972|P1|NOT COMPLETED|Main Surveillance: Effectiveness Group||382
486888|NCT01083173|1192971|P2|COMPLETED|Main Surveillance: Effectiveness Group||0
486889|NCT01083173|1192972|P1|COMPLETED|Main Surveillance: Effectiveness Group||198
486890|NCT01083173|1192971|P2|STARTED|Main Surveillance: Effectiveness Group||0
486891|NCT01083173|1192972|P1|STARTED|Main Surveillance: Effectiveness Group||580
486892|NCT01083173|1192971|P2|NOT COMPLETED|Main Surveillance: Safety Group||0
486893|NCT01083173|1192972|P1|NOT COMPLETED|Main Surveillance: Safety Group||15
486894|NCT01083173|1192971|P2|COMPLETED|Main Surveillance: Safety Group||0
486895|NCT01083173|1192972|P1|COMPLETED|Main Surveillance: Safety Group||580
486896|NCT01083173|1192971|P2|STARTED|Main Surveillance: Safety Group||0
486897|NCT01083173|1192972|P1|STARTED|Main Surveillance: Safety Group||595
486898|NCT01083160|1192990|P1|NOT COMPLETED|Overall Study||1
486899|NCT01083160|1192990|P1|COMPLETED|Overall Study||81
486900|NCT01083160|1192990|P1|Evaluable Population|Overall Study||71
486901|NCT01083160|1192990|P1|STARTED|Overall Study||82
486902|NCT01083121|1192997|P1|NOT COMPLETED|Overall Study||81
486903|NCT01083121|1192997|P1|COMPLETED|Overall Study|Participants included in the analysis|1698
486904|NCT01083121|1192997|P1|STARTED|Overall Study|Participants who were enrolled in the study|1779
486905|NCT01082965|1193007|P2|NOT COMPLETED|Overall Study||2
486906|NCT01082965|1193008|P1|NOT COMPLETED|Overall Study||1
486907|NCT01082965|1193007|P2|COMPLETED|Overall Study||6
486908|NCT01082965|1193008|P1|COMPLETED|Overall Study||9
486909|NCT01082965|1193007|P2|STARTED|Overall Study||8
486910|NCT01082965|1193008|P1|STARTED|Overall Study||10
486911|NCT01082952|1193028|P2|NOT COMPLETED|Overall Study||0
486912|NCT01082952|1193029|P1|NOT COMPLETED|Overall Study||0
486913|NCT01082952|1193028|P2|COMPLETED|Overall Study||6
486914|NCT01082952|1193029|P1|COMPLETED|Overall Study||6
486915|NCT01082952|1193028|P2|STARTED|Overall Study||6
486916|NCT01082952|1193029|P1|STARTED|Overall Study||6
486917|NCT01082939|1193037|P1|NOT COMPLETED|Overall Study||0
486918|NCT01082939|1193037|P1|COMPLETED|Overall Study||80
486919|NCT01082939|1193037|P1|STARTED|Overall Study||80
486920|NCT01082874|1193045|P4|NOT COMPLETED|Overall Study||13
486921|NCT01082874|1193046|P3|NOT COMPLETED|Overall Study||11
486922|NCT01082874|1193047|P2|NOT COMPLETED|Overall Study||12
486923|NCT01082874|1193048|P1|NOT COMPLETED|Overall Study||11
486924|NCT01082874|1193045|P4|COMPLETED|Overall Study||2489
486925|NCT01082874|1193046|P3|COMPLETED|Overall Study||2488
486926|NCT01082874|1193047|P2|COMPLETED|Overall Study||2498
486927|NCT01082874|1193048|P1|COMPLETED|Overall Study||2488
486928|NCT01082874|1193045|P4|STARTED|Overall Study||2502
486929|NCT01082874|1193046|P3|STARTED|Overall Study||2499
486930|NCT01082874|1193047|P2|STARTED|Overall Study||2510
486931|NCT01082874|1193048|P1|STARTED|Overall Study||2499
486932|NCT01082640|1193061|P3|NOT COMPLETED|Overall Study||8
486933|NCT01082640|1193062|P2|NOT COMPLETED|Overall Study||15
486934|NCT01082640|1193063|P1|NOT COMPLETED|Overall Study||17
486935|NCT01082640|1193061|P3|COMPLETED|Overall Study||24
486936|NCT01082640|1193062|P2|COMPLETED|Overall Study||17
486937|NCT01082640|1193063|P1|COMPLETED|Overall Study||15
486938|NCT01082640|1193061|P3|STARTED|Overall Study||32
486939|NCT01082640|1193062|P2|STARTED|Overall Study||32
486940|NCT01082640|1193063|P1|STARTED|Overall Study||32
486941|NCT01082614|1193085|P2|NOT COMPLETED|Overall Study||5
486942|NCT01082614|1193086|P1|NOT COMPLETED|Overall Study||3
486943|NCT01082614|1193085|P2|COMPLETED|Overall Study||18
486944|NCT01082614|1193086|P1|COMPLETED|Overall Study||20
486945|NCT01082614|1193085|P2|STARTED|Overall Study||23
486946|NCT01082614|1193086|P1|STARTED|Overall Study||23
486947|NCT01082588|1193098|P2|NOT COMPLETED|Overall Study||5
486948|NCT01082588|1193099|P1|NOT COMPLETED|Overall Study||6
486949|NCT01082588|1193098|P2|COMPLETED|Overall Study||25
486950|NCT01082588|1193099|P1|COMPLETED|Overall Study||24
486951|NCT01082588|1193098|P2|STARTED|Overall Study||30
486952|NCT01082588|1193099|P1|STARTED|Overall Study||30
486953|NCT01082575|1193117|P1|NOT COMPLETED|Overall Study||0
486954|NCT01082575|1193117|P1|COMPLETED|Overall Study||100
486955|NCT01082575|1193117|P1|STARTED|Overall Study||100
486956|NCT01082380|1193122|P1|NOT COMPLETED|Overall Study||0
486957|NCT01082380|1193122|P1|COMPLETED|Overall Study||6
486958|NCT01082380|1193122|P1|STARTED|Overall Study||6
486959|NCT01082367|1193157|P2|NOT COMPLETED|Follow-up (F-U) Period||1
486960|NCT01082367|1193158|P1|NOT COMPLETED|Follow-up (F-U) Period||2
486961|NCT01082367|1193157|P2|COMPLETED|Follow-up (F-U) Period||9
486962|NCT01082367|1193158|P1|COMPLETED|Follow-up (F-U) Period||17
486963|NCT01082367|1193157|P2|Treated in F-U|Follow-up (F-U) Period||5
486964|NCT01082367|1193158|P1|Treated in F-U|Follow-up (F-U) Period||5
486965|NCT01082367|1193157|P2|STARTED|Follow-up (F-U) Period||10
486966|NCT01082367|1193158|P1|STARTED|Follow-up (F-U) Period||19
486967|NCT01082367|1193157|P2|NOT COMPLETED|Double-blind Period||13
486968|NCT01082367|1193158|P1|NOT COMPLETED|Double-blind Period||5
486969|NCT01082367|1193157|P2|COMPLETED|Double-blind Period||12
486970|NCT01082367|1193158|P1|COMPLETED|Double-blind Period||21
486971|NCT01082367|1193157|P2|Stage 4:no tx for Patients Not in co|Double-blind Period||0
486972|NCT01082367|1193158|P1|Stage 4:no tx for Patients Not in co|Double-blind Period||0
486973|NCT01082367|1193157|P2|Stage 3: Cross-over (co) tx|Double-blind Period||6
486974|NCT01082367|1193158|P1|Stage 3: Cross-over (co) tx|Double-blind Period||13
486975|NCT01082367|1193157|P2|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||0
486976|NCT01082367|1193158|P1|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||9
486977|NCT01082367|1193157|P2|Entered OL TOBI|Double-blind Period||18
486978|NCT01082367|1193158|P1|Entered OL TOBI|Double-blind Period||4
486979|NCT01082367|1193157|P2|Stage 2:no tx|Double-blind Period||0
486980|NCT01082367|1193158|P1|Stage 2:no tx|Double-blind Period||0
486981|NCT01082367|1193157|P2|Stage 1:1st Treatment (tx) Cycle|Double-blind Period|1 participant discontinued after cycle 1 due to an SAE|25
486982|NCT01082367|1193158|P1|Stage 1:1st Treatment (tx) Cycle|Double-blind Period||26
486983|NCT01082367|1193157|P2|STARTED|Double-blind Period||25
486984|NCT01082367|1193158|P1|STARTED|Double-blind Period||26
486985|NCT01082328|1193172|P1|NOT COMPLETED|Overall Study||1
486986|NCT01082328|1193172|P1|COMPLETED|Overall Study||58
486987|NCT01082328|1193172|P1|STARTED|Overall Study||59
486988|NCT01082211|1193181|P1|NOT COMPLETED|Overall Study||7
486989|NCT01082211|1193181|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|58
486990|NCT01082211|1193181|P1|STARTED|Overall Study||65
486991|NCT01082159|1193193|P1|NOT COMPLETED|Overall Study||9
486992|NCT01082159|1193193|P1|COMPLETED|Overall Study||46
486993|NCT01082159|1193193|P1|STARTED|Overall Study||55
486994|NCT01082081|1193202|P3|NOT COMPLETED|Overall Study||2
486995|NCT01082081|1193203|P2|NOT COMPLETED|Overall Study||1
486996|NCT01082081|1193204|P1|NOT COMPLETED|Overall Study||0
486997|NCT01082081|1193202|P3|COMPLETED|Overall Study||58
486998|NCT01082081|1193203|P2|COMPLETED|Overall Study||118
486999|NCT01082081|1193204|P1|COMPLETED|Overall Study||121
487000|NCT01082081|1193202|P3|STARTED|Overall Study||60
487001|NCT01082081|1193203|P2|STARTED|Overall Study||119
487002|NCT01082081|1193204|P1|STARTED|Overall Study||121
487003|NCT01081951|1193256|P2|NOT COMPLETED|Overall Study||55
487004|NCT01081951|1193257|P1|NOT COMPLETED|Overall Study||56
487005|NCT01081951|1193256|P2|COMPLETED|Overall Study|Completed is ongoing study at DCO (Data cut-off), either on-treatment or in survival follow-up|26
487006|NCT01081951|1193257|P1|COMPLETED|Overall Study|Completed is ongoing study at DCO (Data cut-off),either on-treatment or in survival follow-up|25
487007|NCT01081951|1193256|P2|Ongoing Study Treatment at Data Cut-off|Overall Study||0
487008|NCT01081951|1193257|P1|Ongoing Study Treatment at Data Cut-off|Overall Study||11
487009|NCT01081951|1193256|P2|Entered Maintenance Phase|Overall Study||55
487010|NCT01081951|1193257|P1|Entered Maintenance Phase|Overall Study||66
487011|NCT01081951|1193256|P2|Received Study Treatment|Overall Study||75
487012|NCT01081951|1193257|P1|Received Study Treatment|Overall Study||81
487013|NCT01081951|1193256|P2|STARTED|Overall Study||81
487014|NCT01081951|1193257|P1|STARTED|Overall Study||81
487015|NCT01081912|1193267|P3|NOT COMPLETED|Maintenance Treatment||92
487016|NCT01081912|1193268|P2|NOT COMPLETED|Maintenance Treatment||27
487017|NCT01081912|1193269|P1|NOT COMPLETED|Maintenance Treatment||0
487018|NCT01081912|1193267|P3|COMPLETED|Maintenance Treatment||59
487019|NCT01081912|1193268|P2|COMPLETED|Maintenance Treatment||124
487020|NCT01081912|1193269|P1|COMPLETED|Maintenance Treatment||0
487021|NCT01081912|1193267|P3|STARTED|Maintenance Treatment||151
487022|NCT01081912|1193268|P2|STARTED|Maintenance Treatment||151
487023|NCT01081912|1193269|P1|STARTED|Maintenance Treatment||0
487024|NCT01081912|1193267|P3|NOT COMPLETED|Conversion/Titration||0
487025|NCT01081912|1193268|P2|NOT COMPLETED|Conversion/Titration||0
487026|NCT01081912|1193269|P1|NOT COMPLETED|Conversion/Titration||208
487027|NCT01081912|1193267|P3|COMPLETED|Conversion/Titration||0
487028|NCT01081912|1193268|P2|COMPLETED|Conversion/Titration||0
487029|NCT01081912|1193269|P1|COMPLETED|Conversion/Titration||302
487030|NCT01081912|1193267|P3|STARTED|Conversion/Titration||0
487031|NCT01081912|1193268|P2|STARTED|Conversion/Titration||0
487032|NCT01081912|1193269|P1|STARTED|Conversion/Titration||510
487033|NCT01081886|1193278|P2|NOT COMPLETED|Overall Study||13
487034|NCT01081886|1193279|P1|NOT COMPLETED|Overall Study||11
487035|NCT01081886|1193278|P2|COMPLETED|Overall Study||0
487036|NCT01081886|1193279|P1|COMPLETED|Overall Study||0
487037|NCT01081886|1193278|P2|STARTED|Overall Study||13
487038|NCT01081886|1193279|P1|STARTED|Overall Study||11
487039|NCT01081873|1193287|P1|NOT COMPLETED|Overall Study||298
487040|NCT01081873|1193287|P1|COMPLETED|Overall Study||2416
487041|NCT01081873|1193287|P1|STARTED|Overall Study|3 patients were excluded from this and all analyses due to no available data from Baseline.|2714
487042|NCT01081834|1193359|P5|NOT COMPLETED|Extension Period: Week 26 to Week 52||0
487043|NCT01081834|1193360|P4|NOT COMPLETED|Extension Period: Week 26 to Week 52||0
487044|NCT01081834|1193361|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
487045|NCT01081834|1193362|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
487046|NCT01081834|1193363|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||20
487047|NCT01081834|1193359|P5|COMPLETED|Extension Period: Week 26 to Week 52||0
487048|NCT01081834|1193360|P4|COMPLETED|Extension Period: Week 26 to Week 52||0
487049|NCT01081834|1193361|P3|COMPLETED|Extension Period: Week 26 to Week 52||165
487050|NCT01081834|1193362|P2|COMPLETED|Extension Period: Week 26 to Week 52||152
487051|NCT01081834|1193363|P1|COMPLETED|Extension Period: Week 26 to Week 52||135
487052|NCT01081834|1193359|P5|STARTED|Extension Period: Week 26 to Week 52|The treatment duration for the High Glycemic Substudy was 26 weeks only.|0
487053|NCT01081834|1193360|P4|STARTED|Extension Period: Week 26 to Week 52|The treatment duration for the High Glycemic Substudy was 26 weeks only.|0
487054|NCT01081834|1193361|P3|STARTED|Extension Period: Week 26 to Week 52|5 pts discontinued last day of core: AE (1), lost f/u (1), PV (1), NS (1), physician decision (1).|170
487055|NCT01081834|1193362|P2|STARTED|Extension Period: Week 26 to Week 52|2 pts discontinued on last day of core: adverse event (AE) (1), protocol violation (PV) (1).|170
487056|NCT01081834|1193363|P1|STARTED|Extension Period: Week 26 to Week 52|5 pts discontinued on last day of core: lack of efficacy on rescue (2), not specified (NS) (3).|155
487057|NCT01081834|1193359|P5|NOT COMPLETED|Core Period: Baseline to Week 26||4
487058|NCT01081834|1193360|P4|NOT COMPLETED|Core Period: Baseline to Week 26||7
487059|NCT01081834|1193361|P3|NOT COMPLETED|Core Period: Baseline to Week 26||22
487060|NCT01081834|1193362|P2|NOT COMPLETED|Core Period: Baseline to Week 26||23
487061|NCT01081834|1193363|P1|NOT COMPLETED|Core Period: Baseline to Week 26||32
487062|NCT01081834|1193359|P5|COMPLETED|Core Period: Baseline to Week 26||40
487063|NCT01081834|1193360|P4|COMPLETED|Core Period: Baseline to Week 26||40
487064|NCT01081834|1193361|P3|COMPLETED|Core Period: Baseline to Week 26||175
487065|NCT01081834|1193362|P2|COMPLETED|Core Period: Baseline to Week 26||172
487066|NCT01081834|1193363|P1|COMPLETED|Core Period: Baseline to Week 26||160
487067|NCT01081834|1193359|P5|STARTED|Core Period: Baseline to Week 26||44
487068|NCT01081834|1193360|P4|STARTED|Core Period: Baseline to Week 26||47
487069|NCT01081834|1193361|P3|STARTED|Core Period: Baseline to Week 26||197
487070|NCT01081834|1193362|P2|STARTED|Core Period: Baseline to Week 26||195
487071|NCT01081834|1193363|P1|STARTED|Core Period: Baseline to Week 26||192
487072|NCT01081795|1193424|P3|NOT COMPLETED|Overall Study||30
487073|NCT01081795|1193425|P2|NOT COMPLETED|Overall Study||35
487074|NCT01081795|1193426|P1|NOT COMPLETED|Overall Study||33
487075|NCT01081795|1193424|P3|COMPLETED|Overall Study||97
487076|NCT01081795|1193425|P2|COMPLETED|Overall Study||95
487077|NCT01081795|1193426|P1|COMPLETED|Overall Study||97
487078|NCT01081795|1193424|P3|STARTED|Overall Study||127
487079|NCT01081795|1193425|P2|STARTED|Overall Study||130
487080|NCT01081795|1193426|P1|STARTED|Overall Study||130
487081|NCT01081769|1193463|P2|NOT COMPLETED|CORE Intent-To-Treat||97
487082|NCT01081769|1193464|P1|NOT COMPLETED|CORE Intent-To-Treat||80
487083|NCT01081769|1193463|P2|COMPLETED|CORE Intent-To-Treat||266
487084|NCT01081769|1193464|P1|COMPLETED|CORE Intent-To-Treat||272
487085|NCT01081769|1193463|P2|STARTED|CORE Intent-To-Treat||363
487086|NCT01081769|1193464|P1|STARTED|CORE Intent-To-Treat||352
487087|NCT01081769|1193463|P2|NOT COMPLETED|Whole Intent-to-Treat||25
487088|NCT01081769|1193464|P1|NOT COMPLETED|Whole Intent-to-Treat||24
487089|NCT01081769|1193463|P2|COMPLETED|Whole Intent-to-Treat||363
487090|NCT01081769|1193464|P1|COMPLETED|Whole Intent-to-Treat||352
487091|NCT01081769|1193463|P2|STARTED|Whole Intent-to-Treat||388
487092|NCT01081769|1193464|P1|STARTED|Whole Intent-to-Treat||376
487093|NCT01081665|1193498|P1|NOT COMPLETED|Overall Study||95
487094|NCT01081665|1193498|P1|COMPLETED|Overall Study||142
487095|NCT01081665|1193498|P1|Evaluable Population|Overall Study|Participants with baseline and at least 2 post-baseline parathormone measurements at 24 months.|212
487096|NCT01081665|1193498|P1|Full Analysis Set|Overall Study||237
487097|NCT01081665|1193498|P1|STARTED|Overall Study||237
487098|NCT01081626|1193510|P2|NOT COMPLETED|Overall Study||61
487099|NCT01081626|1193511|P1|NOT COMPLETED|Overall Study||60
487100|NCT01081626|1193510|P2|COMPLETED|Overall Study||94
487101|NCT01081626|1193511|P1|COMPLETED|Overall Study||95
487102|NCT01081626|1193510|P2|Assessed for Efficacy|Overall Study||125
487103|NCT01081626|1193511|P1|Assessed for Efficacy|Overall Study||122
487104|NCT01081626|1193510|P2|STARTED|Overall Study||155
487105|NCT01081626|1193511|P1|STARTED|Overall Study||155
487106|NCT01081301|1193537|P1|NOT COMPLETED|Overall Study||14
487107|NCT01081301|1193537|P1|COMPLETED|Overall Study||22
487108|NCT01081301|1193537|P1|STARTED|Overall Study||36
487109|NCT01081249|1193575|P2|NOT COMPLETED|Overall Study||1
487110|NCT01081249|1193576|P1|NOT COMPLETED|Overall Study||0
487111|NCT01081249|1193575|P2|COMPLETED|Overall Study||6
487112|NCT01081249|1193576|P1|COMPLETED|Overall Study||11
487113|NCT01081249|1193575|P2|Second Psychotherapy Appointment (1 Day)|Overall Study||6
487114|NCT01081249|1193576|P1|Second Psychotherapy Appointment (1 Day)|Overall Study||11
487115|NCT01081249|1193575|P2|Washout (5-10 Days)|Overall Study||6
487116|NCT01081249|1193576|P1|Washout (5-10 Days)|Overall Study||11
487117|NCT01081249|1193575|P2|First Psychotherapy Appointment (1 Day)|Overall Study||6
487118|NCT01081249|1193576|P1|First Psychotherapy Appointment (1 Day)|Overall Study||11
487119|NCT01081249|1193575|P2|STARTED|Overall Study||7
487120|NCT01081249|1193576|P1|STARTED|Overall Study||11
487121|NCT01081145|1193582|P2|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||106
487122|NCT01081145|1193583|P1|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||81
487123|NCT01081145|1193582|P2|COMPLETED|Double-Blind Randomized-Withdrawal Phase||53
487124|NCT01081145|1193583|P1|COMPLETED|Double-Blind Randomized-Withdrawal Phase||76
487125|NCT01081145|1193582|P2|STARTED|Double-Blind Randomized-Withdrawal Phase||159
487126|NCT01081145|1193583|P1|STARTED|Double-Blind Randomized-Withdrawal Phase||157
487127|NCT01081145|1193582|P2|NOT COMPLETED|Open-Label Phase||0
487128|NCT01081145|1193583|P1|NOT COMPLETED|Open-Label Phase||212
487129|NCT01081145|1193582|P2|COMPLETED|Open-Label Phase||0
487130|NCT01081145|1193583|P1|COMPLETED|Open-Label Phase||316
487131|NCT01081145|1193582|P2|STARTED|Open-Label Phase||0
487132|NCT01081145|1193583|P1|STARTED|Open-Label Phase||528
487133|NCT01081132|1193611|P2|NOT COMPLETED|Overall Study||52
487134|NCT01081132|1193612|P1|NOT COMPLETED|Overall Study||55
487135|NCT01081132|1193611|P2|COMPLETED|Overall Study||105
487136|NCT01081132|1193612|P1|COMPLETED|Overall Study||102
487137|NCT01081132|1193611|P2|STARTED|Overall Study||157
487138|NCT01081132|1193612|P1|STARTED|Overall Study||157
487139|NCT01081041|1193653|P3|NOT COMPLETED|Overall Study||2
487140|NCT01081041|1193654|P2|NOT COMPLETED|Overall Study||4
487141|NCT01081041|1193655|P1|NOT COMPLETED|Overall Study||0
487142|NCT01081041|1193653|P3|COMPLETED|Overall Study||71
487143|NCT01081041|1193654|P2|COMPLETED|Overall Study||77
487144|NCT01081041|1193655|P1|COMPLETED|Overall Study||33
487145|NCT01081041|1193653|P3|Received at Least 1 Dose of Study Drug|Overall Study||71
487146|NCT01081041|1193654|P2|Received at Least 1 Dose of Study Drug|Overall Study||77
487147|NCT01081041|1193655|P1|Received at Least 1 Dose of Study Drug|Overall Study||33
487148|NCT01081041|1193653|P3|STARTED|Overall Study||73
487149|NCT01081041|1193654|P2|STARTED|Overall Study||81
487150|NCT01081041|1193655|P1|STARTED|Overall Study||33
487151|NCT01080976|1193685|P2|NOT COMPLETED|Overall Study||0
487152|NCT01080976|1193686|P1|NOT COMPLETED|Overall Study||0
487153|NCT01080976|1193685|P2|COMPLETED|Overall Study||5
487154|NCT01080976|1193686|P1|COMPLETED|Overall Study||5
487155|NCT01080976|1193685|P2|STARTED|Overall Study||5
487156|NCT01080976|1193686|P1|STARTED|Overall Study||5
487157|NCT01080807|1193696|P2|NOT COMPLETED|Overall Study||23
487158|NCT01080807|1193697|P1|NOT COMPLETED|Overall Study||35
487159|NCT01080807|1193696|P2|COMPLETED|Overall Study||167
487160|NCT01080807|1193697|P1|COMPLETED|Overall Study||158
487252|NCT01080131|1193962|P1|COMPLETED|Extension Study 2 (25-72 Weeks)||64
487161|NCT01080807|1193696|P2|STARTED|Overall Study|Three patients randomly assigned to the placebo treatment group did not receive study drug.|190
487162|NCT01080807|1193697|P1|STARTED|Overall Study|Nine patients randomly assigned to the armodafinil treatment group did not receive study drug.|193
487163|NCT01080794|1193755|P4|NOT COMPLETED|Overall Study||2
487164|NCT01080794|1193756|P3|NOT COMPLETED|Overall Study||2
487165|NCT01080794|1193757|P2|NOT COMPLETED|Overall Study||2
487166|NCT01080794|1193758|P1|NOT COMPLETED|Overall Study||5
487167|NCT01080794|1193755|P4|COMPLETED|Overall Study||13
487168|NCT01080794|1193756|P3|COMPLETED|Overall Study||10
487169|NCT01080794|1193757|P2|COMPLETED|Overall Study||12
487170|NCT01080794|1193758|P1|COMPLETED|Overall Study||15
487171|NCT01080794|1193755|P4|STARTED|Overall Study||15
487172|NCT01080794|1193756|P3|STARTED|Overall Study||12
487173|NCT01080794|1193757|P2|STARTED|Overall Study||14
487174|NCT01080794|1193758|P1|STARTED|Overall Study||20
487175|NCT01080768|1193806|P2|NOT COMPLETED|Overall Study||1
487176|NCT01080768|1193807|P1|NOT COMPLETED|Overall Study||2
487177|NCT01080768|1193806|P2|COMPLETED|Overall Study||16
487178|NCT01080768|1193807|P1|COMPLETED|Overall Study||12
487179|NCT01080768|1193806|P2|STARTED|Overall Study||17
487180|NCT01080768|1193807|P1|STARTED|Overall Study||14
487181|NCT01080677|1193816|P3|NOT COMPLETED|Overall Study||0
487182|NCT01080677|1193817|P2|NOT COMPLETED|Overall Study||0
487183|NCT01080677|1193818|P1|NOT COMPLETED|Overall Study||0
487184|NCT01080677|1193816|P3|COMPLETED|Overall Study||20
487185|NCT01080677|1193817|P2|COMPLETED|Overall Study||20
487186|NCT01080677|1193818|P1|COMPLETED|Overall Study||20
487187|NCT01080677|1193816|P3|STARTED|Overall Study||20
487188|NCT01080677|1193817|P2|STARTED|Overall Study||20
487189|NCT01080677|1193818|P1|STARTED|Overall Study||20
487190|NCT01080625|1193838|P3|NOT COMPLETED|Overall Study||1
487191|NCT01080625|1193839|P2|NOT COMPLETED|Overall Study||2
487192|NCT01080625|1193840|P1|NOT COMPLETED|Overall Study||0
487193|NCT01080625|1193838|P3|COMPLETED|Overall Study||31
487194|NCT01080625|1193839|P2|COMPLETED|Overall Study||31
487195|NCT01080625|1193840|P1|COMPLETED|Overall Study||31
487196|NCT01080625|1193838|P3|STARTED|Overall Study||32
487197|NCT01080625|1193839|P2|STARTED|Overall Study||33
487198|NCT01080625|1193840|P1|STARTED|Overall Study||31
487199|NCT01080391|1193850|P2|NOT COMPLETED|Overall Study||13
487200|NCT01080391|1193851|P1|NOT COMPLETED|Overall Study||23
487201|NCT01080391|1193850|P2|COMPLETED|Overall Study|Participants are ongoing as of 16 June 2014 or who have died on study.|383
487202|NCT01080391|1193851|P1|COMPLETED|Overall Study|Participants are ongoing as of 16 June 2014 or who have died on study.|373
487203|NCT01080391|1193850|P2|Treated|Overall Study||392
487204|NCT01080391|1193851|P1|Treated|Overall Study||389
487205|NCT01080391|1193850|P2|STARTED|Overall Study||396
487206|NCT01080391|1193851|P1|STARTED|Overall Study||396
487207|NCT01080326|1193869|P1|NOT COMPLETED|Overall Study||4
487208|NCT01080326|1193869|P1|COMPLETED|Overall Study||3
487209|NCT01080326|1193869|P1|STARTED|Overall Study||7
487210|NCT01080300|1193875|P2|NOT COMPLETED|Overall Study||104
487211|NCT01080300|1193876|P1|NOT COMPLETED|Overall Study||94
487212|NCT01080300|1193875|P2|COMPLETED|Overall Study||191
487213|NCT01080300|1193876|P1|COMPLETED|Overall Study||206
487214|NCT01080300|1193875|P2|STARTED|Overall Study|298 subjects were randomized, but only 295 received study treatment.|295
487215|NCT01080300|1193876|P1|STARTED|Overall Study|302 subjects were randomized, but only 300 received study treatment.|300
487216|NCT01080261|1193884|P1|NOT COMPLETED|Overall Study||0
487217|NCT01080261|1193884|P1|COMPLETED|Overall Study||60
487218|NCT01080261|1193884|P1|STARTED|Overall Study||60
487219|NCT01080248|1193899|P1|NOT COMPLETED|Overall Study||0
487220|NCT01080248|1193899|P1|COMPLETED|Overall Study||2
487221|NCT01080248|1193899|P1|STARTED|Overall Study||2
487222|NCT01080209|1193913|P7|NOT COMPLETED|Overall Study||7
487223|NCT01080209|1193914|P6|NOT COMPLETED|Overall Study||0
487224|NCT01080209|1193915|P5|NOT COMPLETED|Overall Study||0
487225|NCT01080209|1193916|P4|NOT COMPLETED|Overall Study||5
487226|NCT01080209|1193917|P3|NOT COMPLETED|Overall Study||5
487227|NCT01080209|1193918|P2|NOT COMPLETED|Overall Study||11
487228|NCT01080209|1193919|P1|NOT COMPLETED|Overall Study||6
487229|NCT01080209|1193913|P7|COMPLETED|Overall Study||44
487230|NCT01080209|1193914|P6|COMPLETED|Overall Study||2
487231|NCT01080209|1193915|P5|COMPLETED|Overall Study||6
487232|NCT01080209|1193916|P4|COMPLETED|Overall Study||37
487233|NCT01080209|1193917|P3|COMPLETED|Overall Study||28
487234|NCT01080209|1193918|P2|COMPLETED|Overall Study||42
487235|NCT01080209|1193919|P1|COMPLETED|Overall Study||22
487236|NCT01080209|1193913|P7|STARTED|Overall Study||51
487237|NCT01080209|1193914|P6|STARTED|Overall Study||2
487238|NCT01080209|1193915|P5|STARTED|Overall Study||6
487239|NCT01080209|1193916|P4|STARTED|Overall Study||42
487240|NCT01080209|1193917|P3|STARTED|Overall Study||33
487241|NCT01080209|1193918|P2|STARTED|Overall Study||53
487242|NCT01080209|1193919|P1|STARTED|Overall Study||28
487243|NCT01080196|1193944|P2|NOT COMPLETED|Overall Study||0
487244|NCT01080196|1193945|P1|NOT COMPLETED|Overall Study||0
487245|NCT01080196|1193944|P2|COMPLETED|Overall Study||66
487246|NCT01080196|1193945|P1|COMPLETED|Overall Study||68
487247|NCT01080196|1193944|P2|STARTED|Overall Study||66
487248|NCT01080196|1193945|P1|STARTED|Overall Study||68
487249|NCT01080131|1193961|P2|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||11
487250|NCT01080131|1193962|P1|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||8
487251|NCT01080131|1193961|P2|COMPLETED|Extension Study 2 (25-72 Weeks)||54
487253|NCT01080131|1193961|P2|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients switched to canakinumab from Week 25 - Week 72|41
487254|NCT01080131|1193962|P1|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients re-treated with canakinumab at any time during the 72 weeks|62
487255|NCT01080131|1193961|P2|STARTED|Extension Study 2 (25-72 Weeks)||65
487256|NCT01080131|1193962|P1|STARTED|Extension Study 2 (25-72 Weeks)||72
487257|NCT01080131|1193961|P2|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||4
487258|NCT01080131|1193962|P1|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||6
487259|NCT01080131|1193961|P2|COMPLETED|Extension Study 1 (12 -24 Weeks)||72
487260|NCT01080131|1193962|P1|COMPLETED|Extension Study 1 (12 -24 Weeks)||78
487261|NCT01080131|1193961|P2|STARTED|Extension Study 1 (12 -24 Weeks)||76
487262|NCT01080131|1193962|P1|STARTED|Extension Study 1 (12 -24 Weeks)||84
487263|NCT01080131|1193961|P2|NOT COMPLETED|Core Study (0- 12 Weeks)||11
487264|NCT01080131|1193962|P1|NOT COMPLETED|Core Study (0- 12 Weeks)||13
487265|NCT01080131|1193961|P2|COMPLETED|Core Study (0- 12 Weeks)||103
487266|NCT01080131|1193962|P1|COMPLETED|Core Study (0- 12 Weeks)||99
487267|NCT01080131|1193961|P2|STARTED|Core Study (0- 12 Weeks)||114
487268|NCT01080131|1193962|P1|STARTED|Core Study (0- 12 Weeks)||112
487269|NCT01080118|1194041|P4|NOT COMPLETED|Overall Study||0
487270|NCT01080118|1194042|P3|NOT COMPLETED|Overall Study||0
487271|NCT01080118|1194043|P2|NOT COMPLETED|Overall Study||0
487272|NCT01080118|1194044|P1|NOT COMPLETED|Overall Study||0
487273|NCT01080118|1194041|P4|COMPLETED|Overall Study||30
487274|NCT01080118|1194042|P3|COMPLETED|Overall Study||30
487275|NCT01080118|1194043|P2|COMPLETED|Overall Study||15
487276|NCT01080118|1194044|P1|COMPLETED|Overall Study||15
487277|NCT01080118|1194041|P4|STARTED|Overall Study||30
487278|NCT01080118|1194042|P3|STARTED|Overall Study||30
487279|NCT01080118|1194043|P2|STARTED|Overall Study||15
487280|NCT01080118|1194044|P1|STARTED|Overall Study||15
487281|NCT01079988|1194057|P5|NOT COMPLETED|Overall Study||1
487282|NCT01079988|1194058|P4|NOT COMPLETED|Overall Study||3
487283|NCT01079988|1194059|P3|NOT COMPLETED|Overall Study||0
487284|NCT01079988|1194060|P2|NOT COMPLETED|Overall Study||0
487285|NCT01079988|1194061|P1|NOT COMPLETED|Overall Study||1
487286|NCT01079988|1194057|P5|COMPLETED|Overall Study||1
487287|NCT01079988|1194058|P4|COMPLETED|Overall Study||17
487288|NCT01079988|1194059|P3|COMPLETED|Overall Study||8
487289|NCT01079988|1194060|P2|COMPLETED|Overall Study||1
487290|NCT01079988|1194061|P1|COMPLETED|Overall Study||9
487291|NCT01079988|1194057|P5|STARTED|Overall Study||2
487292|NCT01079988|1194058|P4|STARTED|Overall Study||20
487293|NCT01079988|1194059|P3|STARTED|Overall Study||8
487294|NCT01079988|1194060|P2|STARTED|Overall Study||1
487295|NCT01079988|1194061|P1|STARTED|Overall Study||10
487296|NCT01079962|1194080|P2|NOT COMPLETED|Overall Study||15
487297|NCT01079962|1194081|P1|NOT COMPLETED|Overall Study||15
487298|NCT01079962|1194080|P2|COMPLETED|Overall Study||89
487299|NCT01079962|1194081|P1|COMPLETED|Overall Study||90
487300|NCT01079962|1194080|P2|STARTED|Overall Study||104
487301|NCT01079962|1194081|P1|STARTED|Overall Study||105
487302|NCT01079949|1194109|P2|NOT COMPLETED|Overall Study||13
487303|NCT01079949|1194110|P1|NOT COMPLETED|Overall Study||15
487304|NCT01079949|1194109|P2|COMPLETED|Overall Study||34
487305|NCT01079949|1194110|P1|COMPLETED|Overall Study||31
487306|NCT01079949|1194109|P2|STARTED|Overall Study||47
487307|NCT01079949|1194110|P1|STARTED|Overall Study||46
487308|NCT01079936|1194156|P5|NOT COMPLETED|Phase II||1
487309|NCT01079936|1194157|P4|NOT COMPLETED|Phase II||0
487310|NCT01079936|1194158|P3|NOT COMPLETED|Phase II||1
487311|NCT01079936|1194159|P2|NOT COMPLETED|Phase II||0
487312|NCT01079936|1194160|P1|NOT COMPLETED|Phase II||0
487313|NCT01079936|1194156|P5|COMPLETED|Phase II||25
487314|NCT01079936|1194157|P4|COMPLETED|Phase II||24
487315|NCT01079936|1194158|P3|COMPLETED|Phase II||5
487316|NCT01079936|1194159|P2|COMPLETED|Phase II||3
487317|NCT01079936|1194160|P1|COMPLETED|Phase II||0
487318|NCT01079936|1194156|P5|STARTED|Phase II||26
487319|NCT01079936|1194157|P4|STARTED|Phase II||24
487320|NCT01079936|1194158|P3|STARTED|Phase II||6
487321|NCT01079936|1194159|P2|STARTED|Phase II||3
487322|NCT01079936|1194160|P1|STARTED|Phase II||0
487323|NCT01079936|1194156|P5|NOT COMPLETED|Phase I: MTD||0
487324|NCT01079936|1194157|P4|NOT COMPLETED|Phase I: MTD||0
487325|NCT01079936|1194158|P3|NOT COMPLETED|Phase I: MTD||0
487326|NCT01079936|1194159|P2|NOT COMPLETED|Phase I: MTD||0
487327|NCT01079936|1194160|P1|NOT COMPLETED|Phase I: MTD||4
487328|NCT01079936|1194156|P5|COMPLETED|Phase I: MTD||0
487329|NCT01079936|1194157|P4|COMPLETED|Phase I: MTD||0
487330|NCT01079936|1194158|P3|COMPLETED|Phase I: MTD||0
487331|NCT01079936|1194159|P2|COMPLETED|Phase I: MTD||0
487332|NCT01079936|1194160|P1|COMPLETED|Phase I: MTD|The 12 Phase I participants were randomized across 4 dose arms for Phase II.|12
487333|NCT01079936|1194156|P5|STARTED|Phase I: MTD||0
487334|NCT01079936|1194157|P4|STARTED|Phase I: MTD||0
487335|NCT01079936|1194158|P3|STARTED|Phase I: MTD||0
487336|NCT01079936|1194159|P2|STARTED|Phase I: MTD||0
487337|NCT01079936|1194160|P1|STARTED|Phase I: MTD||16
487338|NCT01079832|1194179|P1|NOT COMPLETED|Overall Study||1
487339|NCT01079832|1194179|P1|COMPLETED|Overall Study||49
487340|NCT01079832|1194179|P1|STARTED|Overall Study||50
487341|NCT01079806|1194189|P2|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||2
487342|NCT01079806|1194190|P1|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||0
487423|NCT01079390|1194243|P3|COMPLETED|Overall Study||10
487343|NCT01079806|1194189|P2|COMPLETED|Long-term Follow-up: Day 1-End of Study||4
487344|NCT01079806|1194190|P1|COMPLETED|Long-term Follow-up: Day 1-End of Study||14
487345|NCT01079806|1194189|P2|STARTED|Long-term Follow-up: Day 1-End of Study||6
487346|NCT01079806|1194190|P1|STARTED|Long-term Follow-up: Day 1-End of Study||14
487347|NCT01079806|1194189|P2|NOT COMPLETED|Day 1 to Week 96||4
487348|NCT01079806|1194190|P1|NOT COMPLETED|Day 1 to Week 96||4
487349|NCT01079806|1194189|P2|COMPLETED|Day 1 to Week 96|Includes 53 continuing treatment|56
487350|NCT01079806|1194190|P1|COMPLETED|Day 1 to Week 96|Includes 91 continuing treatment|116
487351|NCT01079806|1194189|P2|Primary Endpoint Cohort|Day 1 to Week 96||41
487352|NCT01079806|1194190|P1|Primary Endpoint Cohort|Day 1 to Week 96||82
487353|NCT01079806|1194189|P2|Received Treatment|Day 1 to Week 96||60
487354|NCT01079806|1194190|P1|Received Treatment|Day 1 to Week 96||120
487355|NCT01079806|1194189|P2|STARTED|Day 1 to Week 96|Randomized|60
487356|NCT01079806|1194190|P1|STARTED|Day 1 to Week 96|Randomized|120
487357|NCT01079741|1194215|P5|NOT COMPLETED|Phase 2 (Weeks 37-48)||3
487358|NCT01079741|1194216|P4|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
487359|NCT01079741|1194217|P3|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
487360|NCT01079741|1194218|P2|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
487361|NCT01079741|1194219|P1|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
487362|NCT01079741|1194215|P5|COMPLETED|Phase 2 (Weeks 37-48)||9
487363|NCT01079741|1194216|P4|COMPLETED|Phase 2 (Weeks 37-48)||12
487364|NCT01079741|1194217|P3|COMPLETED|Phase 2 (Weeks 37-48)||0
487365|NCT01079741|1194218|P2|COMPLETED|Phase 2 (Weeks 37-48)||0
487366|NCT01079741|1194219|P1|COMPLETED|Phase 2 (Weeks 37-48)||0
487367|NCT01079741|1194215|P5|STARTED|Phase 2 (Weeks 37-48)||12
487368|NCT01079741|1194216|P4|STARTED|Phase 2 (Weeks 37-48)||12
487369|NCT01079741|1194217|P3|STARTED|Phase 2 (Weeks 37-48)||0
487370|NCT01079741|1194218|P2|STARTED|Phase 2 (Weeks 37-48)||0
487371|NCT01079741|1194219|P1|STARTED|Phase 2 (Weeks 37-48)||0
487372|NCT01079741|1194215|P5|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
487373|NCT01079741|1194216|P4|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
487374|NCT01079741|1194217|P3|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||3
487375|NCT01079741|1194218|P2|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
487376|NCT01079741|1194219|P1|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
487377|NCT01079741|1194215|P5|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
487378|NCT01079741|1194216|P4|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
487379|NCT01079741|1194217|P3|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
487380|NCT01079741|1194218|P2|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
487381|NCT01079741|1194219|P1|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
487382|NCT01079741|1194215|P5|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
487383|NCT01079741|1194216|P4|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
487384|NCT01079741|1194217|P3|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||3
487385|NCT01079741|1194218|P2|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
487386|NCT01079741|1194219|P1|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
487387|NCT01079741|1194215|P5|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
487388|NCT01079741|1194216|P4|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
487389|NCT01079741|1194217|P3|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
487390|NCT01079741|1194218|P2|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||1
487391|NCT01079741|1194219|P1|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
487392|NCT01079741|1194215|P5|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
487393|NCT01079741|1194216|P4|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
487394|NCT01079741|1194217|P3|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
487395|NCT01079741|1194218|P2|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||3
487396|NCT01079741|1194219|P1|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
487397|NCT01079741|1194215|P5|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
487398|NCT01079741|1194216|P4|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
487399|NCT01079741|1194217|P3|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
487400|NCT01079741|1194218|P2|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||4
487401|NCT01079741|1194219|P1|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
487402|NCT01079741|1194215|P5|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
487403|NCT01079741|1194216|P4|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
487404|NCT01079741|1194217|P3|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
487405|NCT01079741|1194218|P2|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
487406|NCT01079741|1194219|P1|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
487407|NCT01079741|1194215|P5|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
487408|NCT01079741|1194216|P4|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
487409|NCT01079741|1194217|P3|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
487410|NCT01079741|1194218|P2|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
487411|NCT01079741|1194219|P1|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||3
487412|NCT01079741|1194215|P5|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
487413|NCT01079741|1194216|P4|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
487414|NCT01079741|1194217|P3|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
487415|NCT01079741|1194218|P2|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
487416|NCT01079741|1194219|P1|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||3
487417|NCT01079598|1194233|P1|NOT COMPLETED|Overall Study||0
487418|NCT01079598|1194233|P1|COMPLETED|Overall Study||8
487419|NCT01079598|1194233|P1|STARTED|Overall Study||8
487420|NCT01079390|1194243|P3|NOT COMPLETED|Overall Study||4
487421|NCT01079390|1194244|P2|NOT COMPLETED|Overall Study||5
487422|NCT01079390|1194245|P1|NOT COMPLETED|Overall Study||5
487424|NCT01079390|1194244|P2|COMPLETED|Overall Study||10
487425|NCT01079390|1194245|P1|COMPLETED|Overall Study||10
487426|NCT01079390|1194243|P3|STARTED|Overall Study||14
487427|NCT01079390|1194244|P2|STARTED|Overall Study||15
487428|NCT01079390|1194245|P1|STARTED|Overall Study||15
487429|NCT01079299|1194257|P2|NOT COMPLETED|Overall Study||0
487430|NCT01079299|1194258|P1|NOT COMPLETED|Overall Study||0
487431|NCT01079299|1194257|P2|COMPLETED|Overall Study||25
487432|NCT01079299|1194258|P1|COMPLETED|Overall Study||27
487433|NCT01079299|1194257|P2|STARTED|Overall Study||25
487434|NCT01079299|1194258|P1|STARTED|Overall Study||27
487435|NCT01079234|1194267|P4|NOT COMPLETED|Extension: Week 27 to 52||16
487436|NCT01079234|1194268|P3|NOT COMPLETED|Extension: Week 27 to 52||11
487437|NCT01079234|1194269|P2|NOT COMPLETED|Extension: Week 27 to 52||0
487438|NCT01079234|1194270|P1|NOT COMPLETED|Extension: Week 27 to 52||0
487439|NCT01079234|1194267|P4|COMPLETED|Extension: Week 27 to 52||223
487440|NCT01079234|1194268|P3|COMPLETED|Extension: Week 27 to 52||122
487441|NCT01079234|1194269|P2|COMPLETED|Extension: Week 27 to 52||0
487442|NCT01079234|1194270|P1|COMPLETED|Extension: Week 27 to 52||0
487443|NCT01079234|1194267|P4|STARTED|Extension: Week 27 to 52|Thirty eight subjects did not continue into extension trial.|239
487444|NCT01079234|1194268|P3|STARTED|Extension: Week 27 to 52|Nineteen subjects from main trial did not continue into extension trial|133
487445|NCT01079234|1194269|P2|STARTED|Extension: Week 27 to 52||0
487446|NCT01079234|1194270|P1|STARTED|Extension: Week 27 to 52||0
487447|NCT01079234|1194267|P4|NOT COMPLETED|Main: Week 0 to 26||0
487448|NCT01079234|1194268|P3|NOT COMPLETED|Main: Week 0 to 26||12
487449|NCT01079234|1194269|P2|NOT COMPLETED|Main: Week 0 to 26||26
487450|NCT01079234|1194270|P1|NOT COMPLETED|Main: Week 0 to 26||26
487451|NCT01079234|1194267|P4|COMPLETED|Main: Week 0 to 26||0
487452|NCT01079234|1194268|P3|COMPLETED|Main: Week 0 to 26||152
487453|NCT01079234|1194269|P2|COMPLETED|Main: Week 0 to 26||139
487454|NCT01079234|1194270|P1|COMPLETED|Main: Week 0 to 26||138
487455|NCT01079234|1194267|P4|Exposed|Main: Week 0 to 26||0
487456|NCT01079234|1194268|P3|Exposed|Main: Week 0 to 26|Three subjects withdrew prior to exposure to trial drug.|161
487457|NCT01079234|1194269|P2|Exposed|Main: Week 0 to 26||165
487458|NCT01079234|1194270|P1|Exposed|Main: Week 0 to 26||164
487459|NCT01079234|1194267|P4|STARTED|Main: Week 0 to 26||0
487460|NCT01079234|1194268|P3|STARTED|Main: Week 0 to 26||164
487461|NCT01079234|1194269|P2|STARTED|Main: Week 0 to 26||165
487462|NCT01079234|1194270|P1|STARTED|Main: Week 0 to 26||164
487463|NCT01079195|1194288|P1|NOT COMPLETED|Overall Study||1431
487464|NCT01079195|1194288|P1|COMPLETED|Overall Study||14442
487465|NCT01079195|1194288|P1|STARTED|Overall Study||15873
487466|NCT01079182|1194294|P1|NOT COMPLETED|Overall Study||2719
487467|NCT01079182|1194294|P1|COMPLETED|Overall Study||1962
487468|NCT01079182|1194294|P1|STARTED|Overall Study||4681
487469|NCT01079143|1194325|P4|NOT COMPLETED|Overall Study||5
487470|NCT01079143|1194326|P3|NOT COMPLETED|Overall Study||5
487471|NCT01079143|1194327|P2|NOT COMPLETED|Overall Study||17
487472|NCT01079143|1194328|P1|NOT COMPLETED|Overall Study||9
487473|NCT01079143|1194325|P4|COMPLETED|Overall Study||54
487474|NCT01079143|1194326|P3|COMPLETED|Overall Study||34
487475|NCT01079143|1194327|P2|COMPLETED|Overall Study||43
487476|NCT01079143|1194328|P1|COMPLETED|Overall Study||27
487477|NCT01079143|1194325|P4|M3 and M12 Biopsies|Overall Study|Only 53 out of 59 participants in this group had graft biopsy that was eligible for analysis.|53
487478|NCT01079143|1194326|P3|M3 and M12 Biopsies|Overall Study|Only 32 out of 39 participants in this group had graft biopsy that was eligible for analysis.|32
487479|NCT01079143|1194327|P2|M3 and M12 Biopsies|Overall Study||43
487480|NCT01079143|1194328|P1|M3 and M12 Biopsies|Overall Study|Only 26 out of 36 participants in this group had graft biopsy that was eligible for analysis.|26
487481|NCT01079143|1194325|P4|Month 12 (M12) Biopsies|Overall Study|Only 53 out of 59 participants in this group had graft biopsy that was eligible for analysis.|53
487482|NCT01079143|1194326|P3|Month 12 (M12) Biopsies|Overall Study|Only 32 out of 39 participants in this group had graft biopsy that was eligible for analysis.|32
487483|NCT01079143|1194327|P2|Month 12 (M12) Biopsies|Overall Study||43
487484|NCT01079143|1194328|P1|Month 12 (M12) Biopsies|Overall Study|Only 26 out of 36 participants in this group had graft biopsy that was eligible for analysis.|26
487485|NCT01079143|1194325|P4|Month 3 (M3) Biopsies|Overall Study||59
487486|NCT01079143|1194326|P3|Month 3 (M3) Biopsies|Overall Study||39
487487|NCT01079143|1194327|P2|Month 3 (M3) Biopsies|Overall Study|1 patient was excluded due to an IF/TA Grade of III at the M3 Biopsy|59
487488|NCT01079143|1194328|P1|Month 3 (M3) Biopsies|Overall Study||36
487489|NCT01079143|1194325|P4|Exposed|Overall Study||59
487490|NCT01079143|1194326|P3|Exposed|Overall Study||39
487491|NCT01079143|1194327|P2|Exposed|Overall Study||60
487492|NCT01079143|1194328|P1|Exposed|Overall Study||36
487493|NCT01079143|1194325|P4|STARTED|Overall Study||59
487494|NCT01079143|1194326|P3|STARTED|Overall Study||39
487495|NCT01079143|1194327|P2|STARTED|Overall Study||60
487496|NCT01079143|1194328|P1|STARTED|Overall Study||36
487497|NCT01079130|1194402|P6|NOT COMPLETED|Overall Study||5
487498|NCT01079130|1194403|P5|NOT COMPLETED|Overall Study||8
487499|NCT01079130|1194404|P4|NOT COMPLETED|Overall Study||5
487500|NCT01079130|1194405|P3|NOT COMPLETED|Overall Study||1
487501|NCT01079130|1194406|P2|NOT COMPLETED|Overall Study||7
487502|NCT01079130|1194407|P1|NOT COMPLETED|Overall Study||2
487503|NCT01079130|1194402|P6|COMPLETED|Overall Study||80
487504|NCT01079130|1194403|P5|COMPLETED|Overall Study||78
487505|NCT01079130|1194404|P4|COMPLETED|Overall Study||81
487506|NCT01079130|1194405|P3|COMPLETED|Overall Study||83
487507|NCT01079130|1194406|P2|COMPLETED|Overall Study||78
487508|NCT01079130|1194407|P1|COMPLETED|Overall Study||83
487509|NCT01079130|1194402|P6|Full Analysis Set (FAS)|Overall Study||84
487510|NCT01079130|1194403|P5|Full Analysis Set (FAS)|Overall Study||84
487511|NCT01079130|1194404|P4|Full Analysis Set (FAS)|Overall Study||85
487512|NCT01079130|1194405|P3|Full Analysis Set (FAS)|Overall Study||83
487513|NCT01079130|1194406|P2|Full Analysis Set (FAS)|Overall Study|2 patients (1 in 37.5 µg;1 in 75 µg group) randomized more than once and were excluded from the FAS.|80
487514|NCT01079130|1194407|P1|Full Analysis Set (FAS)|Overall Study||84
487515|NCT01079130|1194402|P6|Safety Set: Received Study Drug|Overall Study||84
487516|NCT01079130|1194403|P5|Safety Set: Received Study Drug|Overall Study||84
487517|NCT01079130|1194404|P4|Safety Set: Received Study Drug|Overall Study||85
487518|NCT01079130|1194405|P3|Safety Set: Received Study Drug|Overall Study||84
487519|NCT01079130|1194406|P2|Safety Set: Received Study Drug|Overall Study||81
487520|NCT01079130|1194407|P1|Safety Set: Received Study Drug|Overall Study||84
487521|NCT01079130|1194402|P6|STARTED|Overall Study||85
487522|NCT01079130|1194403|P5|STARTED|Overall Study||86
487523|NCT01079130|1194404|P4|STARTED|Overall Study||86
487524|NCT01079130|1194405|P3|STARTED|Overall Study||84
487525|NCT01079130|1194406|P2|STARTED|Overall Study||85
487526|NCT01079130|1194407|P1|STARTED|Overall Study||85
487527|NCT01078974|1194427|P1|NOT COMPLETED|Overall Study||3
487528|NCT01078974|1194427|P1|COMPLETED|Overall Study||4
487529|NCT01078974|1194427|P1|STARTED|Overall Study||7
487530|NCT01078922|1194432|P1|NOT COMPLETED|Overall Study||1
487531|NCT01078922|1194432|P1|COMPLETED|Overall Study||10
487532|NCT01078922|1194432|P1|STARTED|Overall Study||11
487533|NCT01078909|1194442|P5|NOT COMPLETED|Overall Study||2
487534|NCT01078909|1194443|P4|NOT COMPLETED|Overall Study||1
487535|NCT01078909|1194444|P3|NOT COMPLETED|Overall Study||1
487536|NCT01078909|1194445|P2|NOT COMPLETED|Overall Study||4
487537|NCT01078909|1194446|P1|NOT COMPLETED|Overall Study||2
487538|NCT01078909|1194442|P5|COMPLETED|Overall Study||23
487539|NCT01078909|1194443|P4|COMPLETED|Overall Study||24
487540|NCT01078909|1194444|P3|COMPLETED|Overall Study||24
487541|NCT01078909|1194445|P2|COMPLETED|Overall Study||21
487542|NCT01078909|1194446|P1|COMPLETED|Overall Study||23
487543|NCT01078909|1194442|P5|STARTED|Overall Study||25
487544|NCT01078909|1194443|P4|STARTED|Overall Study||25
487545|NCT01078909|1194444|P3|STARTED|Overall Study||25
487546|NCT01078909|1194445|P2|STARTED|Overall Study||25
487547|NCT01078909|1194446|P1|STARTED|Overall Study||25
487548|NCT01078844|1194468|P1|NOT COMPLETED|Overall Study||4
487549|NCT01078844|1194468|P1|COMPLETED|Overall Study||0
487550|NCT01078844|1194468|P1|STARTED|Overall Study||4
487551|NCT01078805|1194473|P1|NOT COMPLETED|Overall Study||2050
487552|NCT01078805|1194473|P1|COMPLETED|Overall Study||2117
487553|NCT01078805|1194473|P1|Modified Intent-To-Treat|Overall Study|≥1 dose of study drug (SD) and didn't discontinue SD more than 3 consecutive months during treatment|3720
487554|NCT01078805|1194473|P1|Took at Least 1 Dose of Study Drug|Overall Study||4085
487555|NCT01078805|1194473|P1|STARTED|Overall Study||4167
487556|NCT01078753|1194487|P2|NOT COMPLETED|Treatment Period II||0
487557|NCT01078753|1194488|P1|NOT COMPLETED|Treatment Period II||0
487558|NCT01078753|1194487|P2|COMPLETED|Treatment Period II||44
487559|NCT01078753|1194488|P1|COMPLETED|Treatment Period II||45
487560|NCT01078753|1194487|P2|Full Analysis Set|Treatment Period II||44
487561|NCT01078753|1194488|P1|Full Analysis Set|Treatment Period II|One patient was excluded from the full analysis set due to failure to satisfy the entry criteria.|44
487562|NCT01078753|1194487|P2|STARTED|Treatment Period II||44
487563|NCT01078753|1194488|P1|STARTED|Treatment Period II|Desmopressin 120 µg - 4 participants Desmopressin 240 µg - 41 participants|45
487564|NCT01078753|1194487|P2|NOT COMPLETED|Treatment Period I||0
487565|NCT01078753|1194488|P1|NOT COMPLETED|Treatment Period I||0
487566|NCT01078753|1194487|P2|COMPLETED|Treatment Period I||44
487567|NCT01078753|1194488|P1|COMPLETED|Treatment Period I||45
487568|NCT01078753|1194487|P2|Full Analysis Set|Treatment Period I||44
487569|NCT01078753|1194488|P1|Full Analysis Set|Treatment Period I|One patient was excluded from the full analysis set due to failure to satisfy the entry criteria.|44
487570|NCT01078753|1194487|P2|STARTED|Treatment Period I||44
487571|NCT01078753|1194488|P1|STARTED|Treatment Period I||45
487572|NCT01078675|1194500|P2|NOT COMPLETED|Overall Study||6
487573|NCT01078675|1194501|P1|NOT COMPLETED|Overall Study||68
487574|NCT01078675|1194500|P2|COMPLETED|Overall Study|Healthy siblings did not participate in investigational product administration.|59
487575|NCT01078675|1194501|P1|COMPLETED|Overall Study||182
487576|NCT01078675|1194500|P2|Patients Treated|Overall Study||0
487577|NCT01078675|1194501|P1|Patients Treated|Overall Study||198
487578|NCT01078675|1194500|P2|STARTED|Overall Study||65
487579|NCT01078675|1194501|P1|STARTED|Overall Study||250
487580|NCT01078662|1194523|P5|NOT COMPLETED|Overall Study||11
487581|NCT01078662|1194524|P4|NOT COMPLETED|Overall Study||7
487582|NCT01078662|1194525|P3|NOT COMPLETED|Overall Study||21
487583|NCT01078662|1194526|P2|NOT COMPLETED|Overall Study||168
487584|NCT01078662|1194527|P1|NOT COMPLETED|Overall Study||58
487585|NCT01078662|1194523|P5|COMPLETED|Overall Study||1
487586|NCT01078662|1194524|P4|COMPLETED|Overall Study||1
487587|NCT01078662|1194525|P3|COMPLETED|Overall Study||2
487588|NCT01078662|1194526|P2|COMPLETED|Overall Study||25
487589|NCT01078662|1194527|P1|COMPLETED|Overall Study||4
487590|NCT01078662|1194523|P5|STARTED|Overall Study||12
487591|NCT01078662|1194524|P4|STARTED|Overall Study||8
487592|NCT01078662|1194525|P3|STARTED|Overall Study||23
487593|NCT01078662|1194526|P2|STARTED|Overall Study||193
487594|NCT01078662|1194527|P1|STARTED|Overall Study||62
487595|NCT01078623|1194566|P20|NOT COMPLETED|Treatment Period 4||0
487596|NCT01078623|1194567|P19|NOT COMPLETED|Treatment Period 4||0
487597|NCT01078623|1194568|P18|NOT COMPLETED|Treatment Period 4||0
487598|NCT01078623|1194569|P17|NOT COMPLETED|Treatment Period 4||0
487599|NCT01078623|1194570|P16|NOT COMPLETED|Treatment Period 4||1
487600|NCT01078623|1194571|P15|NOT COMPLETED|Treatment Period 4||0
487601|NCT01078623|1194572|P14|NOT COMPLETED|Treatment Period 4||0
487602|NCT01078623|1194573|P13|NOT COMPLETED|Treatment Period 4||0
487603|NCT01078623|1194574|P12|NOT COMPLETED|Treatment Period 4||0
487604|NCT01078623|1194575|P11|NOT COMPLETED|Treatment Period 4||0
487605|NCT01078623|1194576|P10|NOT COMPLETED|Treatment Period 4||0
487606|NCT01078623|1194577|P9|NOT COMPLETED|Treatment Period 4||0
487607|NCT01078623|1194578|P8|NOT COMPLETED|Treatment Period 4||0
487608|NCT01078623|1194579|P7|NOT COMPLETED|Treatment Period 4||0
487609|NCT01078623|1194580|P6|NOT COMPLETED|Treatment Period 4||0
487610|NCT01078623|1194581|P5|NOT COMPLETED|Treatment Period 4||0
487611|NCT01078623|1194582|P4|NOT COMPLETED|Treatment Period 4||0
487612|NCT01078623|1194583|P3|NOT COMPLETED|Treatment Period 4||1
487613|NCT01078623|1194584|P2|NOT COMPLETED|Treatment Period 4||0
487614|NCT01078623|1194585|P1|NOT COMPLETED|Treatment Period 4||0
487615|NCT01078623|1194566|P20|COMPLETED|Treatment Period 4||7
487616|NCT01078623|1194567|P19|COMPLETED|Treatment Period 4||6
487617|NCT01078623|1194568|P18|COMPLETED|Treatment Period 4||7
487618|NCT01078623|1194569|P17|COMPLETED|Treatment Period 4||7
487619|NCT01078623|1194570|P16|COMPLETED|Treatment Period 4||6
487620|NCT01078623|1194571|P15|COMPLETED|Treatment Period 4||7
487621|NCT01078623|1194572|P14|COMPLETED|Treatment Period 4||6
487622|NCT01078623|1194573|P13|COMPLETED|Treatment Period 4||7
487623|NCT01078623|1194574|P12|COMPLETED|Treatment Period 4||7
487624|NCT01078623|1194575|P11|COMPLETED|Treatment Period 4||6
487625|NCT01078623|1194576|P10|COMPLETED|Treatment Period 4||6
487626|NCT01078623|1194577|P9|COMPLETED|Treatment Period 4||5
487627|NCT01078623|1194578|P8|COMPLETED|Treatment Period 4||6
487628|NCT01078623|1194579|P7|COMPLETED|Treatment Period 4||5
487629|NCT01078623|1194580|P6|COMPLETED|Treatment Period 4||4
487630|NCT01078623|1194581|P5|COMPLETED|Treatment Period 4||6
487631|NCT01078623|1194582|P4|COMPLETED|Treatment Period 4||6
487632|NCT01078623|1194583|P3|COMPLETED|Treatment Period 4||5
487633|NCT01078623|1194584|P2|COMPLETED|Treatment Period 4||5
487634|NCT01078623|1194585|P1|COMPLETED|Treatment Period 4||5
487635|NCT01078623|1194566|P20|STARTED|Treatment Period 4||7
487636|NCT01078623|1194567|P19|STARTED|Treatment Period 4||6
487637|NCT01078623|1194568|P18|STARTED|Treatment Period 4||7
487638|NCT01078623|1194569|P17|STARTED|Treatment Period 4||7
487639|NCT01078623|1194570|P16|STARTED|Treatment Period 4||7
487640|NCT01078623|1194571|P15|STARTED|Treatment Period 4||7
487641|NCT01078623|1194572|P14|STARTED|Treatment Period 4||6
487642|NCT01078623|1194573|P13|STARTED|Treatment Period 4||7
487643|NCT01078623|1194574|P12|STARTED|Treatment Period 4||7
487644|NCT01078623|1194575|P11|STARTED|Treatment Period 4||6
487645|NCT01078623|1194576|P10|STARTED|Treatment Period 4||6
487646|NCT01078623|1194577|P9|STARTED|Treatment Period 4||5
487647|NCT01078623|1194578|P8|STARTED|Treatment Period 4||6
487648|NCT01078623|1194579|P7|STARTED|Treatment Period 4||5
487649|NCT01078623|1194580|P6|STARTED|Treatment Period 4||4
487650|NCT01078623|1194581|P5|STARTED|Treatment Period 4||6
487651|NCT01078623|1194582|P4|STARTED|Treatment Period 4||6
487652|NCT01078623|1194583|P3|STARTED|Treatment Period 4||6
487653|NCT01078623|1194584|P2|STARTED|Treatment Period 4||5
487654|NCT01078623|1194585|P1|STARTED|Treatment Period 4||5
487655|NCT01078623|1194566|P20|NOT COMPLETED|Treatment Period 3||0
487656|NCT01078623|1194567|P19|NOT COMPLETED|Treatment Period 3||0
487657|NCT01078623|1194568|P18|NOT COMPLETED|Treatment Period 3||0
487658|NCT01078623|1194569|P17|NOT COMPLETED|Treatment Period 3||0
487659|NCT01078623|1194570|P16|NOT COMPLETED|Treatment Period 3||0
487660|NCT01078623|1194571|P15|NOT COMPLETED|Treatment Period 3||0
487661|NCT01078623|1194572|P14|NOT COMPLETED|Treatment Period 3||1
487662|NCT01078623|1194573|P13|NOT COMPLETED|Treatment Period 3||0
487663|NCT01078623|1194574|P12|NOT COMPLETED|Treatment Period 3||0
487664|NCT01078623|1194575|P11|NOT COMPLETED|Treatment Period 3||0
487665|NCT01078623|1194576|P10|NOT COMPLETED|Treatment Period 3||0
487666|NCT01078623|1194577|P9|NOT COMPLETED|Treatment Period 3||0
487667|NCT01078623|1194578|P8|NOT COMPLETED|Treatment Period 3||0
487668|NCT01078623|1194579|P7|NOT COMPLETED|Treatment Period 3||0
487669|NCT01078623|1194580|P6|NOT COMPLETED|Treatment Period 3||0
487670|NCT01078623|1194581|P5|NOT COMPLETED|Treatment Period 3||1
487671|NCT01078623|1194582|P4|NOT COMPLETED|Treatment Period 3||0
487672|NCT01078623|1194583|P3|NOT COMPLETED|Treatment Period 3||0
487673|NCT01078623|1194584|P2|NOT COMPLETED|Treatment Period 3||0
487674|NCT01078623|1194585|P1|NOT COMPLETED|Treatment Period 3||0
487675|NCT01078623|1194566|P20|COMPLETED|Treatment Period 3||7
487676|NCT01078623|1194567|P19|COMPLETED|Treatment Period 3||6
487677|NCT01078623|1194568|P18|COMPLETED|Treatment Period 3||7
487678|NCT01078623|1194569|P17|COMPLETED|Treatment Period 3||7
487679|NCT01078623|1194570|P16|COMPLETED|Treatment Period 3||7
487680|NCT01078623|1194571|P15|COMPLETED|Treatment Period 3||7
487681|NCT01078623|1194572|P14|COMPLETED|Treatment Period 3||6
487682|NCT01078623|1194573|P13|COMPLETED|Treatment Period 3||7
487683|NCT01078623|1194574|P12|COMPLETED|Treatment Period 3||7
487684|NCT01078623|1194575|P11|COMPLETED|Treatment Period 3||6
487685|NCT01078623|1194576|P10|COMPLETED|Treatment Period 3||6
487686|NCT01078623|1194577|P9|COMPLETED|Treatment Period 3||5
487687|NCT01078623|1194578|P8|COMPLETED|Treatment Period 3||6
487688|NCT01078623|1194579|P7|COMPLETED|Treatment Period 3||5
487689|NCT01078623|1194580|P6|COMPLETED|Treatment Period 3||4
487690|NCT01078623|1194581|P5|COMPLETED|Treatment Period 3||6
487691|NCT01078623|1194582|P4|COMPLETED|Treatment Period 3||6
487692|NCT01078623|1194583|P3|COMPLETED|Treatment Period 3||6
487693|NCT01078623|1194584|P2|COMPLETED|Treatment Period 3||5
487694|NCT01078623|1194585|P1|COMPLETED|Treatment Period 3||5
487695|NCT01078623|1194566|P20|STARTED|Treatment Period 3||7
487696|NCT01078623|1194567|P19|STARTED|Treatment Period 3||6
487697|NCT01078623|1194568|P18|STARTED|Treatment Period 3||7
487698|NCT01078623|1194569|P17|STARTED|Treatment Period 3||7
487699|NCT01078623|1194570|P16|STARTED|Treatment Period 3||7
487700|NCT01078623|1194571|P15|STARTED|Treatment Period 3||7
487701|NCT01078623|1194572|P14|STARTED|Treatment Period 3||7
487702|NCT01078623|1194573|P13|STARTED|Treatment Period 3||7
487703|NCT01078623|1194574|P12|STARTED|Treatment Period 3||7
487704|NCT01078623|1194575|P11|STARTED|Treatment Period 3||6
487705|NCT01078623|1194576|P10|STARTED|Treatment Period 3||6
487706|NCT01078623|1194577|P9|STARTED|Treatment Period 3||5
487707|NCT01078623|1194578|P8|STARTED|Treatment Period 3||6
487708|NCT01078623|1194579|P7|STARTED|Treatment Period 3||5
487709|NCT01078623|1194580|P6|STARTED|Treatment Period 3||4
487710|NCT01078623|1194581|P5|STARTED|Treatment Period 3||7
487711|NCT01078623|1194582|P4|STARTED|Treatment Period 3||6
487712|NCT01078623|1194583|P3|STARTED|Treatment Period 3||6
487713|NCT01078623|1194584|P2|STARTED|Treatment Period 3||5
487714|NCT01078623|1194585|P1|STARTED|Treatment Period 3||5
487715|NCT01078623|1194566|P20|NOT COMPLETED|Treatment Period 2||0
487716|NCT01078623|1194567|P19|NOT COMPLETED|Treatment Period 2||1
487717|NCT01078623|1194568|P18|NOT COMPLETED|Treatment Period 2||0
487718|NCT01078623|1194569|P17|NOT COMPLETED|Treatment Period 2||0
487719|NCT01078623|1194570|P16|NOT COMPLETED|Treatment Period 2||0
487720|NCT01078623|1194571|P15|NOT COMPLETED|Treatment Period 2||0
487721|NCT01078623|1194572|P14|NOT COMPLETED|Treatment Period 2||0
487722|NCT01078623|1194573|P13|NOT COMPLETED|Treatment Period 2||0
487723|NCT01078623|1194574|P12|NOT COMPLETED|Treatment Period 2||0
487724|NCT01078623|1194575|P11|NOT COMPLETED|Treatment Period 2||0
487725|NCT01078623|1194576|P10|NOT COMPLETED|Treatment Period 2||0
487726|NCT01078623|1194577|P9|NOT COMPLETED|Treatment Period 2||0
487727|NCT01078623|1194578|P8|NOT COMPLETED|Treatment Period 2||0
487728|NCT01078623|1194579|P7|NOT COMPLETED|Treatment Period 2||1
487729|NCT01078623|1194580|P6|NOT COMPLETED|Treatment Period 2||1
487730|NCT01078623|1194581|P5|NOT COMPLETED|Treatment Period 2||0
487731|NCT01078623|1194582|P4|NOT COMPLETED|Treatment Period 2||0
487732|NCT01078623|1194583|P3|NOT COMPLETED|Treatment Period 2||0
487733|NCT01078623|1194584|P2|NOT COMPLETED|Treatment Period 2||0
487734|NCT01078623|1194585|P1|NOT COMPLETED|Treatment Period 2||0
487735|NCT01078623|1194566|P20|COMPLETED|Treatment Period 2||7
487736|NCT01078623|1194567|P19|COMPLETED|Treatment Period 2||6
487737|NCT01078623|1194568|P18|COMPLETED|Treatment Period 2||7
487738|NCT01078623|1194569|P17|COMPLETED|Treatment Period 2||7
487739|NCT01078623|1194570|P16|COMPLETED|Treatment Period 2||7
487740|NCT01078623|1194571|P15|COMPLETED|Treatment Period 2||7
487741|NCT01078623|1194572|P14|COMPLETED|Treatment Period 2||7
487742|NCT01078623|1194573|P13|COMPLETED|Treatment Period 2||7
487743|NCT01078623|1194574|P12|COMPLETED|Treatment Period 2||7
487744|NCT01078623|1194575|P11|COMPLETED|Treatment Period 2||6
487745|NCT01078623|1194576|P10|COMPLETED|Treatment Period 2||6
487746|NCT01078623|1194577|P9|COMPLETED|Treatment Period 2||5
487747|NCT01078623|1194578|P8|COMPLETED|Treatment Period 2||6
487748|NCT01078623|1194579|P7|COMPLETED|Treatment Period 2||5
487749|NCT01078623|1194580|P6|COMPLETED|Treatment Period 2||4
487750|NCT01078623|1194581|P5|COMPLETED|Treatment Period 2||7
487751|NCT01078623|1194582|P4|COMPLETED|Treatment Period 2||6
487752|NCT01078623|1194583|P3|COMPLETED|Treatment Period 2||6
487753|NCT01078623|1194584|P2|COMPLETED|Treatment Period 2||5
487754|NCT01078623|1194585|P1|COMPLETED|Treatment Period 2||5
487755|NCT01078623|1194566|P20|STARTED|Treatment Period 2||7
487756|NCT01078623|1194567|P19|STARTED|Treatment Period 2||7
487757|NCT01078623|1194568|P18|STARTED|Treatment Period 2||7
487758|NCT01078623|1194569|P17|STARTED|Treatment Period 2||7
487759|NCT01078623|1194570|P16|STARTED|Treatment Period 2||7
487760|NCT01078623|1194571|P15|STARTED|Treatment Period 2||7
487761|NCT01078623|1194572|P14|STARTED|Treatment Period 2||7
487762|NCT01078623|1194573|P13|STARTED|Treatment Period 2||7
487763|NCT01078623|1194574|P12|STARTED|Treatment Period 2||7
487764|NCT01078623|1194575|P11|STARTED|Treatment Period 2||6
487765|NCT01078623|1194576|P10|STARTED|Treatment Period 2||6
487766|NCT01078623|1194577|P9|STARTED|Treatment Period 2||5
487767|NCT01078623|1194578|P8|STARTED|Treatment Period 2||6
487768|NCT01078623|1194579|P7|STARTED|Treatment Period 2||6
487769|NCT01078623|1194580|P6|STARTED|Treatment Period 2||5
487770|NCT01078623|1194581|P5|STARTED|Treatment Period 2||7
487771|NCT01078623|1194582|P4|STARTED|Treatment Period 2||6
487772|NCT01078623|1194583|P3|STARTED|Treatment Period 2||6
487773|NCT01078623|1194584|P2|STARTED|Treatment Period 2||5
487774|NCT01078623|1194585|P1|STARTED|Treatment Period 2||5
487775|NCT01078623|1194566|P20|NOT COMPLETED|Treatment Period 1||0
487776|NCT01078623|1194567|P19|NOT COMPLETED|Treatment Period 1||0
487777|NCT01078623|1194568|P18|NOT COMPLETED|Treatment Period 1||0
487778|NCT01078623|1194569|P17|NOT COMPLETED|Treatment Period 1||0
487779|NCT01078623|1194570|P16|NOT COMPLETED|Treatment Period 1||0
487780|NCT01078623|1194571|P15|NOT COMPLETED|Treatment Period 1||0
487781|NCT01078623|1194572|P14|NOT COMPLETED|Treatment Period 1||0
487782|NCT01078623|1194573|P13|NOT COMPLETED|Treatment Period 1||0
487783|NCT01078623|1194574|P12|NOT COMPLETED|Treatment Period 1||0
487784|NCT01078623|1194575|P11|NOT COMPLETED|Treatment Period 1||1
487785|NCT01078623|1194576|P10|NOT COMPLETED|Treatment Period 1||1
487786|NCT01078623|1194577|P9|NOT COMPLETED|Treatment Period 1||1
487787|NCT01078623|1194578|P8|NOT COMPLETED|Treatment Period 1||1
487788|NCT01078623|1194579|P7|NOT COMPLETED|Treatment Period 1||1
487789|NCT01078623|1194580|P6|NOT COMPLETED|Treatment Period 1||1
487790|NCT01078623|1194581|P5|NOT COMPLETED|Treatment Period 1||0
487791|NCT01078623|1194582|P4|NOT COMPLETED|Treatment Period 1||0
487792|NCT01078623|1194583|P3|NOT COMPLETED|Treatment Period 1||1
487793|NCT01078623|1194584|P2|NOT COMPLETED|Treatment Period 1||1
487794|NCT01078623|1194585|P1|NOT COMPLETED|Treatment Period 1||1
487795|NCT01078623|1194566|P20|COMPLETED|Treatment Period 1||7
487796|NCT01078623|1194567|P19|COMPLETED|Treatment Period 1||7
487797|NCT01078623|1194568|P18|COMPLETED|Treatment Period 1||7
487798|NCT01078623|1194569|P17|COMPLETED|Treatment Period 1||7
487799|NCT01078623|1194570|P16|COMPLETED|Treatment Period 1||7
487800|NCT01078623|1194571|P15|COMPLETED|Treatment Period 1||7
487801|NCT01078623|1194572|P14|COMPLETED|Treatment Period 1||7
487802|NCT01078623|1194573|P13|COMPLETED|Treatment Period 1||7
487803|NCT01078623|1194574|P12|COMPLETED|Treatment Period 1||7
487804|NCT01078623|1194575|P11|COMPLETED|Treatment Period 1||6
487805|NCT01078623|1194576|P10|COMPLETED|Treatment Period 1||6
487806|NCT01078623|1194577|P9|COMPLETED|Treatment Period 1||5
487807|NCT01078623|1194578|P8|COMPLETED|Treatment Period 1||6
487808|NCT01078623|1194579|P7|COMPLETED|Treatment Period 1||6
487809|NCT01078623|1194580|P6|COMPLETED|Treatment Period 1||5
487810|NCT01078623|1194581|P5|COMPLETED|Treatment Period 1||7
487811|NCT01078623|1194582|P4|COMPLETED|Treatment Period 1||6
487812|NCT01078623|1194583|P3|COMPLETED|Treatment Period 1||6
487813|NCT01078623|1194584|P2|COMPLETED|Treatment Period 1||5
487814|NCT01078623|1194585|P1|COMPLETED|Treatment Period 1||5
487815|NCT01078623|1194566|P20|STARTED|Treatment Period 1||7
487816|NCT01078623|1194567|P19|STARTED|Treatment Period 1||7
487817|NCT01078623|1194568|P18|STARTED|Treatment Period 1||7
487818|NCT01078623|1194569|P17|STARTED|Treatment Period 1||7
487819|NCT01078623|1194570|P16|STARTED|Treatment Period 1||7
487820|NCT01078623|1194571|P15|STARTED|Treatment Period 1||7
487821|NCT01078623|1194572|P14|STARTED|Treatment Period 1||7
487822|NCT01078623|1194573|P13|STARTED|Treatment Period 1||7
487823|NCT01078623|1194574|P12|STARTED|Treatment Period 1||7
487824|NCT01078623|1194575|P11|STARTED|Treatment Period 1||7
487825|NCT01078623|1194576|P10|STARTED|Treatment Period 1||7
487826|NCT01078623|1194577|P9|STARTED|Treatment Period 1||6
487827|NCT01078623|1194578|P8|STARTED|Treatment Period 1||7
487828|NCT01078623|1194579|P7|STARTED|Treatment Period 1||7
487829|NCT01078623|1194580|P6|STARTED|Treatment Period 1||6
487830|NCT01078623|1194581|P5|STARTED|Treatment Period 1||7
487831|NCT01078623|1194582|P4|STARTED|Treatment Period 1||6
487832|NCT01078623|1194583|P3|STARTED|Treatment Period 1||7
487833|NCT01078623|1194584|P2|STARTED|Treatment Period 1||6
487834|NCT01078623|1194585|P1|STARTED|Treatment Period 1||6
487835|NCT01078584|1194607|P1|NOT COMPLETED|Overall Study||3010
487836|NCT01078584|1194607|P1|COMPLETED|Overall Study||4983
487837|NCT01078584|1194607|P1|Participants Conducted Visit 4(12-month)|Overall Study||4983
487838|NCT01078584|1194607|P1|Participants Conducted Visit 3 (6-month)|Overall Study||5833
487839|NCT01078584|1194607|P1|Participants Conducted Visit 2 (3-month)|Overall Study||7125
487840|NCT01078584|1194607|P1|STARTED|Overall Study||7993
487841|NCT01078571|1194688|P1|NOT COMPLETED|Overall Study||115
487842|NCT01078571|1194688|P1|COMPLETED|Overall Study||590
487843|NCT01078571|1194688|P1|Intent-to-treat (ITT) Population|Overall Study||591
487844|NCT01078571|1194688|P1|Safety Population|Overall Study||675
487845|NCT01078571|1194688|P1|STARTED|Overall Study||705
487846|NCT01078545|1194704|P1|NOT COMPLETED|Overall Study||26
487847|NCT01078545|1194704|P1|COMPLETED|Overall Study||703
487848|NCT01078545|1194704|P1|Per Protocol Population|Overall Study||661
487849|NCT01078545|1194704|P1|Intent-to-treat Population|Overall Study||729
487850|NCT01078545|1194704|P1|STARTED|Overall Study||729
487851|NCT01078454|1194714|P2|NOT COMPLETED|Overall Study||2
487852|NCT01078454|1194715|P1|NOT COMPLETED|Overall Study||1
487853|NCT01078454|1194714|P2|COMPLETED|Overall Study||3
487854|NCT01078454|1194715|P1|COMPLETED|Overall Study||5
487855|NCT01078454|1194714|P2|STARTED|Overall Study||5
487856|NCT01078454|1194715|P1|STARTED|Overall Study||6
487857|NCT01078441|1194721|P1|NOT COMPLETED|Overall Study||1
487858|NCT01078441|1194721|P1|COMPLETED|Overall Study||1
487859|NCT01078441|1194721|P1|STARTED|Overall Study||2
487860|NCT01078402|1194728|P3|NOT COMPLETED|Overall Study||68
487861|NCT01078402|1194729|P2|NOT COMPLETED|Overall Study||29
487862|NCT01078402|1194730|P1|NOT COMPLETED|Overall Study||107
487863|NCT01078402|1194728|P3|COMPLETED|Overall Study||166
487864|NCT01078402|1194729|P2|COMPLETED|Overall Study||95
487865|NCT01078402|1194730|P1|COMPLETED|Overall Study||324
487866|NCT01078402|1194728|P3|STARTED|Overall Study||234
487867|NCT01078402|1194729|P2|STARTED|Overall Study||124
487868|NCT01078402|1194730|P1|STARTED|Overall Study||431
487869|NCT01078389|1194761|P2|NOT COMPLETED|Overall Study||67
487870|NCT01078389|1194762|P1|NOT COMPLETED|Overall Study||64
487871|NCT01078389|1194761|P2|COMPLETED|Overall Study||90
487872|NCT01078389|1194762|P1|COMPLETED|Overall Study||93
487873|NCT01078389|1194761|P2|STARTED|Overall Study||157
487874|NCT01078389|1194762|P1|STARTED|Overall Study||157
487875|NCT01078376|1194780|P4|NOT COMPLETED|Overall Study||0
487876|NCT01078376|1194781|P3|NOT COMPLETED|Overall Study||0
487877|NCT01078376|1194782|P2|NOT COMPLETED|Overall Study||0
487878|NCT01078376|1194783|P1|NOT COMPLETED|Overall Study||0
487879|NCT01078376|1194780|P4|COMPLETED|Overall Study||3
487880|NCT01078376|1194781|P3|COMPLETED|Overall Study||8
487881|NCT01078376|1194782|P2|COMPLETED|Overall Study||9
487882|NCT01078376|1194783|P1|COMPLETED|Overall Study||9
487883|NCT01078376|1194780|P4|STARTED|Overall Study||3
487884|NCT01078376|1194781|P3|STARTED|Overall Study||8
487885|NCT01078376|1194782|P2|STARTED|Overall Study||9
487886|NCT01078376|1194783|P1|STARTED|Overall Study||9
487887|NCT01078363|1194904|P2|NOT COMPLETED|Overall Study||0
487888|NCT01078363|1194905|P1|NOT COMPLETED|Overall Study||0
487889|NCT01078363|1194904|P2|COMPLETED|Overall Study||49
487890|NCT01078363|1194905|P1|COMPLETED|Overall Study||47
487891|NCT01078363|1194904|P2|STARTED|Overall Study||49
487892|NCT01078363|1194905|P1|STARTED|Overall Study||47
487893|NCT01078298|1194923|P2|NOT COMPLETED|Overall Study||90
487894|NCT01078298|1194924|P1|NOT COMPLETED|Overall Study||81
487895|NCT01078298|1194923|P2|COMPLETED|Overall Study||179
487896|NCT01078298|1194924|P1|COMPLETED|Overall Study||175
487897|NCT01078298|1194923|P2|STARTED|Overall Study||269
487898|NCT01078298|1194924|P1|STARTED|Overall Study||256
487899|NCT01078246|1194957|P7|NOT COMPLETED|Overall Study||0
487900|NCT01078246|1194958|P6|NOT COMPLETED|Overall Study||0
487901|NCT01078246|1194959|P5|NOT COMPLETED|Overall Study||0
487902|NCT01078246|1194960|P4|NOT COMPLETED|Overall Study||0
487903|NCT01078246|1194961|P3|NOT COMPLETED|Overall Study||0
487904|NCT01078246|1194962|P2|NOT COMPLETED|Overall Study||0
487905|NCT01078246|1194963|P1|NOT COMPLETED|Overall Study||0
487906|NCT01078246|1194957|P7|COMPLETED|Overall Study||22
487907|NCT01078246|1194958|P6|COMPLETED|Overall Study||231
487908|NCT01078246|1194959|P5|COMPLETED|Overall Study||3310
487909|NCT01078246|1194960|P4|COMPLETED|Overall Study||152
487910|NCT01078246|1194961|P3|COMPLETED|Overall Study||1963
487911|NCT01078246|1194962|P2|COMPLETED|Overall Study||405
487912|NCT01078246|1194963|P1|COMPLETED|Overall Study||1041
487913|NCT01078246|1194957|P7|STARTED|Overall Study||22
487914|NCT01078246|1194958|P6|STARTED|Overall Study||231
487915|NCT01078246|1194959|P5|STARTED|Overall Study||3310
487916|NCT01078246|1194960|P4|STARTED|Overall Study||152
487917|NCT01078246|1194961|P3|STARTED|Overall Study||1963
487918|NCT01078246|1194962|P2|STARTED|Overall Study||405
487919|NCT01078246|1194963|P1|STARTED|Overall Study||1041
487920|NCT01078233|1194995|P6|NOT COMPLETED|Overall Study||0
487921|NCT01078233|1194996|P5|NOT COMPLETED|Overall Study||0
487922|NCT01078233|1194997|P4|NOT COMPLETED|Overall Study||0
487923|NCT01078233|1194998|P3|NOT COMPLETED|Overall Study||0
487924|NCT01078233|1194999|P2|NOT COMPLETED|Overall Study||0
487925|NCT01078233|1195000|P1|NOT COMPLETED|Overall Study||0
487926|NCT01078233|1194995|P6|COMPLETED|Overall Study||154
487927|NCT01078233|1194996|P5|COMPLETED|Overall Study||3199
487928|NCT01078233|1194997|P4|COMPLETED|Overall Study||631
487929|NCT01078233|1194998|P3|COMPLETED|Overall Study||1681
487930|NCT01078233|1194999|P2|COMPLETED|Overall Study||296
487931|NCT01078233|1195000|P1|COMPLETED|Overall Study||656
487932|NCT01078233|1194995|P6|STARTED|Overall Study||154
487933|NCT01078233|1194996|P5|STARTED|Overall Study||3199
487934|NCT01078233|1194997|P4|STARTED|Overall Study||631
487935|NCT01078233|1194998|P3|STARTED|Overall Study||1681
487936|NCT01078233|1194999|P2|STARTED|Overall Study||296
487937|NCT01078233|1195000|P1|STARTED|Overall Study||656
487938|NCT01078220|1195017|P1|NOT COMPLETED|Overall Study||0
487939|NCT01078220|1195017|P1|COMPLETED|Overall Study||189629
487940|NCT01078220|1195017|P1|STARTED|Overall Study||189629
487941|NCT01078207|1195027|P1|NOT COMPLETED|Overall Study||0
487942|NCT01078207|1195027|P1|COMPLETED|Overall Study||100
487943|NCT01078207|1195027|P1|STARTED|Overall Study||100
487944|NCT01078168|1195034|P2|NOT COMPLETED|Overall Study||1
487945|NCT01078168|1195035|P1|NOT COMPLETED|Overall Study||0
487946|NCT01078168|1195034|P2|COMPLETED|Overall Study||10
487947|NCT01078168|1195035|P1|COMPLETED|Overall Study||11
487948|NCT01078168|1195034|P2|STARTED|Overall Study||11
487949|NCT01078168|1195035|P1|STARTED|Overall Study||11
487950|NCT01078155|1195041|P1|NOT COMPLETED|Overall Study||44
487951|NCT01078155|1195041|P1|COMPLETED|Overall Study||87
487952|NCT01078155|1195041|P1|STARTED|Overall Study||131
487953|NCT01078116|1195057|P1|NOT COMPLETED|Overall Study||48
487954|NCT01078116|1195057|P1|COMPLETED|Overall Study||76
487955|NCT01078116|1195057|P1|STARTED|Overall Study|121 participants were included in analysis (3 were excluded due to missing case report form data).|124
487956|NCT01078090|1195065|P1|NOT COMPLETED|Overall Study||4593
487957|NCT01078090|1195065|P1|COMPLETED|Overall Study||1152
487958|NCT01078090|1195065|P1|STARTED|Overall Study||5745
487959|NCT01077973|1195109|P3|NOT COMPLETED|Overall Study||0
487960|NCT01077973|1195110|P2|NOT COMPLETED|Overall Study||0
487961|NCT01077973|1195111|P1|NOT COMPLETED|Overall Study||0
487962|NCT01077973|1195109|P3|COMPLETED|Overall Study||80
487963|NCT01077973|1195110|P2|COMPLETED|Overall Study||79
487964|NCT01077973|1195111|P1|COMPLETED|Overall Study||41
487965|NCT01077973|1195109|P3|STARTED|Overall Study||80
487966|NCT01077973|1195110|P2|STARTED|Overall Study||79
487967|NCT01077973|1195111|P1|STARTED|Overall Study||41
487968|NCT01077960|1195159|P1|NOT COMPLETED|Overall Study||16
487969|NCT01077960|1195159|P1|COMPLETED|Overall Study|Modified Intent To Treat (ITT) Population|110
487970|NCT01077960|1195159|P1|STARTED|Overall Study|130 subjects consented to participate, 129 enrolled in the study, and 126 received study drug|126
487971|NCT01077921|1195170|P2|NOT COMPLETED|Second Intervention||1
487972|NCT01077921|1195171|P1|NOT COMPLETED|Second Intervention||0
487973|NCT01077921|1195170|P2|COMPLETED|Second Intervention||9
487974|NCT01077921|1195171|P1|COMPLETED|Second Intervention||13
487975|NCT01077921|1195170|P2|STARTED|Second Intervention||10
487976|NCT01077921|1195171|P1|STARTED|Second Intervention||13
487977|NCT01077921|1195170|P2|NOT COMPLETED|Washout||2
487978|NCT01077921|1195171|P1|NOT COMPLETED|Washout||0
487979|NCT01077921|1195170|P2|COMPLETED|Washout||10
487980|NCT01077921|1195171|P1|COMPLETED|Washout||13
487981|NCT01077921|1195170|P2|STARTED|Washout||12
487982|NCT01077921|1195171|P1|STARTED|Washout||13
487983|NCT01077921|1195170|P2|NOT COMPLETED|First Intervention||1
487984|NCT01077921|1195171|P1|NOT COMPLETED|First Intervention||1
487985|NCT01077921|1195170|P2|COMPLETED|First Intervention||12
487986|NCT01077921|1195171|P1|COMPLETED|First Intervention||13
487987|NCT01077921|1195170|P2|STARTED|First Intervention||13
487988|NCT01077921|1195171|P1|STARTED|First Intervention||14
487989|NCT01077856|1195204|P3|NOT COMPLETED|Overall Study||0
487990|NCT01077856|1195205|P2|NOT COMPLETED|Overall Study||0
487991|NCT01077856|1195206|P1|NOT COMPLETED|Overall Study||0
487992|NCT01077856|1195204|P3|COMPLETED|Overall Study||15713
487993|NCT01077856|1195205|P2|COMPLETED|Overall Study||16604
487994|NCT01077856|1195206|P1|COMPLETED|Overall Study||22199
487995|NCT01077856|1195204|P3|STARTED|Overall Study||15713
487996|NCT01077856|1195205|P2|STARTED|Overall Study||16604
487997|NCT01077856|1195206|P1|STARTED|Overall Study||22199
487998|NCT01077830|1195387|P2|NOT COMPLETED|Overall Study||0
487999|NCT01077830|1195388|P1|NOT COMPLETED|Overall Study||0
488000|NCT01077830|1195387|P2|COMPLETED|Overall Study||682
488001|NCT01077830|1195388|P1|COMPLETED|Overall Study||677
488002|NCT01077830|1195387|P2|STARTED|Overall Study||682
488003|NCT01077830|1195388|P1|STARTED|Overall Study||677
488004|NCT01077817|1195398|P1|NOT COMPLETED|Overall Study||0
488005|NCT01077817|1195398|P1|COMPLETED|Overall Study||684815
488006|NCT01077817|1195398|P1|STARTED|Overall Study|STARTED and COMPLETED is the number of participants meeting incl./excl. criteria in the GPRD.|684815
488007|NCT01077804|1195409|P1|NOT COMPLETED|Overall Study||199
488008|NCT01077804|1195409|P1|COMPLETED|Overall Study||7386
488009|NCT01077804|1195409|P1|STARTED|Overall Study||7585
488010|NCT01077739|1195418|P2|NOT COMPLETED|Overall Study||10
488011|NCT01077739|1195419|P1|NOT COMPLETED|Overall Study||5
488012|NCT01077739|1195418|P2|COMPLETED|Overall Study||40
488013|NCT01077739|1195419|P1|COMPLETED|Overall Study||20
488014|NCT01077739|1195418|P2|STARTED|Overall Study||50
488015|NCT01077739|1195419|P1|STARTED|Overall Study||25
488016|NCT01077713|1195433|P2|NOT COMPLETED|Overall Study||36
488017|NCT01077713|1195434|P1|NOT COMPLETED|Overall Study||36
488018|NCT01077713|1195433|P2|COMPLETED|Overall Study||6
488019|NCT01077713|1195434|P1|COMPLETED|Overall Study||8
488020|NCT01077713|1195433|P2|STARTED|Overall Study||42
488021|NCT01077713|1195434|P1|STARTED|Overall Study||44
488022|NCT01077622|1195458|P1|NOT COMPLETED|Overall Study||3
488023|NCT01077622|1195458|P1|COMPLETED|Overall Study||7
488024|NCT01077622|1195458|P1|STARTED|Overall Study||10
488025|NCT01077596|1195516|P12|NOT COMPLETED|Overall Study||0
488026|NCT01077596|1195517|P11|NOT COMPLETED|Overall Study||0
488027|NCT01077596|1195518|P10|NOT COMPLETED|Overall Study||0
488028|NCT01077596|1195519|P9|NOT COMPLETED|Overall Study||0
488029|NCT01077596|1195520|P8|NOT COMPLETED|Overall Study||0
488030|NCT01077596|1195521|P7|NOT COMPLETED|Overall Study||0
488031|NCT01077596|1195522|P6|NOT COMPLETED|Overall Study||0
488032|NCT01077596|1195523|P5|NOT COMPLETED|Overall Study||0
488033|NCT01077596|1195524|P4|NOT COMPLETED|Overall Study||0
488034|NCT01077596|1195525|P3|NOT COMPLETED|Overall Study||0
488035|NCT01077596|1195526|P2|NOT COMPLETED|Overall Study||0
488036|NCT01077596|1195527|P1|NOT COMPLETED|Overall Study||0
488037|NCT01077596|1195516|P12|COMPLETED|Overall Study||22150
488038|NCT01077596|1195517|P11|COMPLETED|Overall Study||2215
488039|NCT01077596|1195518|P10|COMPLETED|Overall Study||28420
488040|NCT01077596|1195519|P9|COMPLETED|Overall Study||2842
488041|NCT01077596|1195520|P8|COMPLETED|Overall Study||837
488042|NCT01077596|1195521|P7|COMPLETED|Overall Study||308
488043|NCT01077596|1195522|P6|COMPLETED|Overall Study||882
488044|NCT01077596|1195523|P5|COMPLETED|Overall Study||294
488045|NCT01077596|1195524|P4|COMPLETED|Overall Study||1370
488046|NCT01077596|1195525|P3|COMPLETED|Overall Study||457
488047|NCT01077596|1195526|P2|COMPLETED|Overall Study||1050
488048|NCT01077596|1195527|P1|COMPLETED|Overall Study||350
488049|NCT01077596|1195516|P12|STARTED|Overall Study||22150
488050|NCT01077596|1195517|P11|STARTED|Overall Study||2215
488051|NCT01077596|1195518|P10|STARTED|Overall Study||28420
488052|NCT01077596|1195519|P9|STARTED|Overall Study||2842
488053|NCT01077596|1195520|P8|STARTED|Overall Study||837
488054|NCT01077596|1195521|P7|STARTED|Overall Study||308
488055|NCT01077596|1195522|P6|STARTED|Overall Study||882
488056|NCT01077596|1195523|P5|STARTED|Overall Study||294
488057|NCT01077596|1195524|P4|STARTED|Overall Study||1370
488058|NCT01077596|1195525|P3|STARTED|Overall Study||457
488059|NCT01077596|1195526|P2|STARTED|Overall Study||1050
488060|NCT01077596|1195527|P1|STARTED|Overall Study||350
488061|NCT01077544|1195578|P2|NOT COMPLETED|Overall Study||5
488062|NCT01077544|1195579|P1|NOT COMPLETED|Overall Study||3
488063|NCT01077544|1195578|P2|COMPLETED|Overall Study||2
488064|NCT01077544|1195579|P1|COMPLETED|Overall Study||5
488065|NCT01077544|1195578|P2|STARTED|Overall Study||7
488066|NCT01077544|1195579|P1|STARTED|Overall Study||8
488067|NCT01077401|1195607|P2|NOT COMPLETED|Overall Study||21
488068|NCT01077401|1195608|P1|NOT COMPLETED|Overall Study||18
488069|NCT01077401|1195607|P2|COMPLETED|Overall Study||54
488070|NCT01077401|1195608|P1|COMPLETED|Overall Study||59
488071|NCT01077401|1195607|P2|STARTED|Overall Study||75
488072|NCT01077401|1195608|P1|STARTED|Overall Study||77
488073|NCT01077375|1195620|P2|NOT COMPLETED|Overall Study||35
488074|NCT01077375|1195621|P1|NOT COMPLETED|Overall Study||10
488075|NCT01077375|1195620|P2|COMPLETED|Overall Study||51
488076|NCT01077375|1195621|P1|COMPLETED|Overall Study||11
488077|NCT01077375|1195620|P2|STARTED|Overall Study|One randomized patient not taking study drug was excluded from the Double-blind Safety Population.|86
488078|NCT01077375|1195621|P1|STARTED|Overall Study||21
488079|NCT01077362|1195632|P3|NOT COMPLETED|Overall Study||24
488080|NCT01077362|1195633|P2|NOT COMPLETED|Overall Study||19
488081|NCT01077362|1195634|P1|NOT COMPLETED|Overall Study||31
488082|NCT01077362|1195632|P3|COMPLETED|Overall Study||81
488083|NCT01077362|1195633|P2|COMPLETED|Overall Study||84
488084|NCT01077362|1195634|P1|COMPLETED|Overall Study||73
488085|NCT01077362|1195632|P3|STARTED|Overall Study||105
488086|NCT01077362|1195633|P2|STARTED|Overall Study||103
488087|NCT01077362|1195634|P1|STARTED|Overall Study||104
488088|NCT01077323|1195670|P3|NOT COMPLETED|Overall Study||11912089
488089|NCT01077323|1195671|P2|NOT COMPLETED|Overall Study||386263
488090|NCT01077323|1195672|P1|NOT COMPLETED|Overall Study||11378
488091|NCT01077323|1195670|P3|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|103511
488092|NCT01077323|1195671|P2|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|234536
488093|NCT01077323|1195672|P1|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|25719
488094|NCT01077323|1195670|P3|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|12015600
488095|NCT01077323|1195671|P2|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|620799
488096|NCT01077323|1195672|P1|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|37097
488097|NCT01077310|1195691|P2|NOT COMPLETED|Overall Study||0
488098|NCT01077310|1195692|P1|NOT COMPLETED|Overall Study||0
488099|NCT01077310|1195691|P2|COMPLETED|Overall Study||33
488100|NCT01077310|1195692|P1|COMPLETED|Overall Study||67
488101|NCT01077310|1195691|P2|STARTED|Overall Study||33
488102|NCT01077310|1195692|P1|STARTED|Overall Study||67
488103|NCT01077284|1195715|P3|NOT COMPLETED|Overall Study||3
488104|NCT01077284|1195716|P2|NOT COMPLETED|Overall Study||5
488105|NCT01077284|1195717|P1|NOT COMPLETED|Overall Study||5
488106|NCT01077284|1195715|P3|COMPLETED|Overall Study||30
488107|NCT01077284|1195716|P2|COMPLETED|Overall Study||28
488108|NCT01077284|1195717|P1|COMPLETED|Overall Study||28
488109|NCT01077284|1195715|P3|STARTED|Overall Study||33
488110|NCT01077284|1195716|P2|STARTED|Overall Study||33
488111|NCT01077284|1195717|P1|STARTED|Overall Study||33
488112|NCT01077271|1195738|P1|NOT COMPLETED|Overall Study||22
488113|NCT01077271|1195738|P1|COMPLETED|Overall Study||102
488114|NCT01077271|1195738|P1|Number of Participants Analyzed|Overall Study||120
488115|NCT01077271|1195738|P1|Participants Treated With Palivizumab|Overall Study||120
488116|NCT01077271|1195738|P1|STARTED|Overall Study||124
488117|NCT01077258|1195776|P1|NOT COMPLETED|Overall Study||2568
488118|NCT01077258|1195776|P1|COMPLETED|Overall Study||1640
488119|NCT01077258|1195776|P1|STARTED|Overall Study||4208
488120|NCT01077193|1195812|P1|NOT COMPLETED|Overall Study||44
488121|NCT01077193|1195812|P1|COMPLETED|Overall Study||0
488122|NCT01077193|1195812|P1|STARTED|Overall Study||44
488123|NCT01077128|1195816|P1|NOT COMPLETED|Overall Study||67
488124|NCT01077128|1195816|P1|COMPLETED|Overall Study||433
488125|NCT01077128|1195816|P1|STARTED|Overall Study||500
488126|NCT01077076|1195874|P6|NOT COMPLETED|Third Intervention||1
488127|NCT01077076|1195875|P5|NOT COMPLETED|Third Intervention||0
488128|NCT01077076|1195876|P4|NOT COMPLETED|Third Intervention||0
488129|NCT01077076|1195877|P3|NOT COMPLETED|Third Intervention||0
488130|NCT01077076|1195878|P2|NOT COMPLETED|Third Intervention||0
488131|NCT01077076|1195879|P1|NOT COMPLETED|Third Intervention||0
488132|NCT01077076|1195874|P6|COMPLETED|Third Intervention||4
488133|NCT01077076|1195875|P5|COMPLETED|Third Intervention||5
488134|NCT01077076|1195876|P4|COMPLETED|Third Intervention||5
488135|NCT01077076|1195877|P3|COMPLETED|Third Intervention||5
488136|NCT01077076|1195878|P2|COMPLETED|Third Intervention||5
488137|NCT01077076|1195879|P1|COMPLETED|Third Intervention||4
488138|NCT01077076|1195874|P6|STARTED|Third Intervention||5
488139|NCT01077076|1195875|P5|STARTED|Third Intervention||5
488140|NCT01077076|1195876|P4|STARTED|Third Intervention||5
488141|NCT01077076|1195877|P3|STARTED|Third Intervention||5
488142|NCT01077076|1195878|P2|STARTED|Third Intervention||5
488143|NCT01077076|1195879|P1|STARTED|Third Intervention||4
488144|NCT01077076|1195874|P6|NOT COMPLETED|Washout Period of 2 Weeks||0
488145|NCT01077076|1195875|P5|NOT COMPLETED|Washout Period of 2 Weeks||0
488146|NCT01077076|1195876|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
488147|NCT01077076|1195877|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
488148|NCT01077076|1195878|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
488149|NCT01077076|1195879|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
488150|NCT01077076|1195874|P6|COMPLETED|Washout Period of 2 Weeks||5
488151|NCT01077076|1195875|P5|COMPLETED|Washout Period of 2 Weeks||5
488152|NCT01077076|1195876|P4|COMPLETED|Washout Period of 2 Weeks||5
488153|NCT01077076|1195877|P3|COMPLETED|Washout Period of 2 Weeks||5
488154|NCT01077076|1195878|P2|COMPLETED|Washout Period of 2 Weeks||5
488155|NCT01077076|1195879|P1|COMPLETED|Washout Period of 2 Weeks||4
488156|NCT01077076|1195874|P6|STARTED|Washout Period of 2 Weeks||5
488157|NCT01077076|1195875|P5|STARTED|Washout Period of 2 Weeks||5
488158|NCT01077076|1195876|P4|STARTED|Washout Period of 2 Weeks||5
488159|NCT01077076|1195877|P3|STARTED|Washout Period of 2 Weeks||5
488160|NCT01077076|1195878|P2|STARTED|Washout Period of 2 Weeks||5
488161|NCT01077076|1195879|P1|STARTED|Washout Period of 2 Weeks||4
488162|NCT01077076|1195874|P6|NOT COMPLETED|Second Intervention||0
488163|NCT01077076|1195875|P5|NOT COMPLETED|Second Intervention||0
488164|NCT01077076|1195876|P4|NOT COMPLETED|Second Intervention||0
488165|NCT01077076|1195877|P3|NOT COMPLETED|Second Intervention||0
488166|NCT01077076|1195878|P2|NOT COMPLETED|Second Intervention||0
488167|NCT01077076|1195879|P1|NOT COMPLETED|Second Intervention||0
488168|NCT01077076|1195874|P6|COMPLETED|Second Intervention||5
488169|NCT01077076|1195875|P5|COMPLETED|Second Intervention||5
488170|NCT01077076|1195876|P4|COMPLETED|Second Intervention||5
488171|NCT01077076|1195877|P3|COMPLETED|Second Intervention||5
488172|NCT01077076|1195878|P2|COMPLETED|Second Intervention||5
488173|NCT01077076|1195879|P1|COMPLETED|Second Intervention||4
488174|NCT01077076|1195874|P6|STARTED|Second Intervention||5
488175|NCT01077076|1195875|P5|STARTED|Second Intervention||5
488176|NCT01077076|1195876|P4|STARTED|Second Intervention||5
488177|NCT01077076|1195877|P3|STARTED|Second Intervention||5
488178|NCT01077076|1195878|P2|STARTED|Second Intervention||5
488179|NCT01077076|1195879|P1|STARTED|Second Intervention||4
488180|NCT01077076|1195874|P6|NOT COMPLETED|Washout Period of 2 Weeks||0
488181|NCT01077076|1195875|P5|NOT COMPLETED|Washout Period of 2 Weeks||0
488182|NCT01077076|1195876|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
488183|NCT01077076|1195877|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
488184|NCT01077076|1195878|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
488185|NCT01077076|1195879|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
488186|NCT01077076|1195874|P6|COMPLETED|Washout Period of 2 Weeks||5
488187|NCT01077076|1195875|P5|COMPLETED|Washout Period of 2 Weeks||5
488188|NCT01077076|1195876|P4|COMPLETED|Washout Period of 2 Weeks||5
488189|NCT01077076|1195877|P3|COMPLETED|Washout Period of 2 Weeks||5
488190|NCT01077076|1195878|P2|COMPLETED|Washout Period of 2 Weeks||5
488191|NCT01077076|1195879|P1|COMPLETED|Washout Period of 2 Weeks||4
488192|NCT01077076|1195874|P6|STARTED|Washout Period of 2 Weeks||5
488193|NCT01077076|1195875|P5|STARTED|Washout Period of 2 Weeks||5
488194|NCT01077076|1195876|P4|STARTED|Washout Period of 2 Weeks||5
488195|NCT01077076|1195877|P3|STARTED|Washout Period of 2 Weeks||5
488196|NCT01077076|1195878|P2|STARTED|Washout Period of 2 Weeks||5
488197|NCT01077076|1195879|P1|STARTED|Washout Period of 2 Weeks||4
488198|NCT01077076|1195874|P6|NOT COMPLETED|First Intervention||0
488199|NCT01077076|1195875|P5|NOT COMPLETED|First Intervention||0
488200|NCT01077076|1195876|P4|NOT COMPLETED|First Intervention||0
488201|NCT01077076|1195877|P3|NOT COMPLETED|First Intervention||0
488202|NCT01077076|1195878|P2|NOT COMPLETED|First Intervention||0
488203|NCT01077076|1195879|P1|NOT COMPLETED|First Intervention||1
488204|NCT01077076|1195874|P6|COMPLETED|First Intervention||5
488205|NCT01077076|1195875|P5|COMPLETED|First Intervention||5
488206|NCT01077076|1195876|P4|COMPLETED|First Intervention||5
488207|NCT01077076|1195877|P3|COMPLETED|First Intervention||5
488208|NCT01077076|1195878|P2|COMPLETED|First Intervention||5
488209|NCT01077076|1195879|P1|COMPLETED|First Intervention||4
488210|NCT01077076|1195874|P6|STARTED|First Intervention||5
488211|NCT01077076|1195875|P5|STARTED|First Intervention||5
488212|NCT01077076|1195876|P4|STARTED|First Intervention||5
488213|NCT01077076|1195877|P3|STARTED|First Intervention||5
488214|NCT01077076|1195878|P2|STARTED|First Intervention||5
488215|NCT01077076|1195879|P1|STARTED|First Intervention||5
488216|NCT01077063|1195889|P2|NOT COMPLETED|Overall Study||3
488217|NCT01077063|1195890|P1|NOT COMPLETED|Overall Study||4
488218|NCT01077063|1195889|P2|COMPLETED|Overall Study||0
488219|NCT01077063|1195890|P1|COMPLETED|Overall Study||0
488220|NCT01077063|1195889|P2|STARTED|Overall Study||3
488221|NCT01077063|1195890|P1|STARTED|Overall Study||4
488222|NCT01077050|1195896|P1|NOT COMPLETED|Overall Study||9
488223|NCT01077050|1195896|P1|COMPLETED|Overall Study||1942
488224|NCT01077050|1195896|P1|STARTED|Overall Study||1951
488225|NCT01077024|1195902|P2|NOT COMPLETED|Overall Study||28
488226|NCT01077024|1195903|P1|NOT COMPLETED|Overall Study||31
488227|NCT01077024|1195902|P2|COMPLETED|Overall Study||243
488228|NCT01077024|1195903|P1|COMPLETED|Overall Study||236
488229|NCT01077024|1195902|P2|STARTED|Overall Study||271
488230|NCT01077024|1195903|P1|STARTED|Overall Study||267
488231|NCT01076985|1195921|P1|NOT COMPLETED|Overall Study||0
488232|NCT01076985|1195921|P1|COMPLETED|Overall Study||24
488233|NCT01076985|1195921|P1|STARTED|Overall Study||24
488234|NCT01076972|1195927|P1|NOT COMPLETED|Overall Study||0
488235|NCT01076972|1195927|P1|COMPLETED|Overall Study||1184
488236|NCT01076972|1195927|P1|STARTED|Overall Study||1184
488237|NCT01076959|1195942|P1|NOT COMPLETED|Overall Study||2250
488238|NCT01076959|1195942|P1|COMPLETED|Overall Study||5490
488239|NCT01076959|1195942|P1|STARTED|Overall Study||7740
488240|NCT01076686|1195963|P4|NOT COMPLETED|Overall Study||0
488241|NCT01076686|1195964|P3|NOT COMPLETED|Overall Study||0
488242|NCT01076686|1195965|P2|NOT COMPLETED|Overall Study||0
488243|NCT01076686|1195966|P1|NOT COMPLETED|Overall Study||0
488244|NCT01076686|1195963|P4|COMPLETED|Overall Study||31
488245|NCT01076686|1195964|P3|COMPLETED|Overall Study||32
488246|NCT01076686|1195965|P2|COMPLETED|Overall Study||14
488247|NCT01076686|1195966|P1|COMPLETED|Overall Study||17
488248|NCT01076686|1195963|P4|STARTED|Overall Study||31
488249|NCT01076686|1195964|P3|STARTED|Overall Study||32
488250|NCT01076686|1195965|P2|STARTED|Overall Study||14
488251|NCT01076686|1195966|P1|STARTED|Overall Study||17
488252|NCT01076647|1195978|P2|NOT COMPLETED|Overall Study||25
488253|NCT01076647|1195979|P1|NOT COMPLETED|Overall Study||25
488254|NCT01076647|1195978|P2|COMPLETED|Overall Study||209
488255|NCT01076647|1195979|P1|COMPLETED|Overall Study||208
488256|NCT01076647|1195978|P2|STARTED|Overall Study||234
488257|NCT01076647|1195979|P1|STARTED|Overall Study||233
488258|NCT01076504|1195987|P1|NOT COMPLETED|Overall Study||80
488259|NCT01076504|1195987|P1|COMPLETED|Overall Study|Patients remained on study until disease progression or withdrawal for any other reason|0
488260|NCT01076504|1195987|P1|STARTED|Overall Study||80
488261|NCT01076452|1195997|P2|NOT COMPLETED|Overall Study||14
488262|NCT01076452|1195998|P1|NOT COMPLETED|Overall Study||24
488263|NCT01076452|1195997|P2|COMPLETED|Overall Study||138
488264|NCT01076452|1195998|P1|COMPLETED|Overall Study||123
488265|NCT01076452|1195997|P2|STARTED|Overall Study||152
488266|NCT01076452|1195998|P1|STARTED|Overall Study||147
488267|NCT01076400|1196010|P3|NOT COMPLETED|Overall Study||0
488268|NCT01076400|1196011|P2|NOT COMPLETED|Overall Study||0
488269|NCT01076400|1196012|P1|NOT COMPLETED|Overall Study||7
488270|NCT01076400|1196010|P3|COMPLETED|Overall Study||0
488271|NCT01076400|1196011|P2|COMPLETED|Overall Study||0
488272|NCT01076400|1196012|P1|COMPLETED|Overall Study||0
488273|NCT01076400|1196010|P3|STARTED|Overall Study|No participants were enrolled in Part 2 of the study.|0
488274|NCT01076400|1196011|P2|STARTED|Overall Study|No participants were enrolled in Part 2 of the study.|0
488275|NCT01076400|1196012|P1|STARTED|Overall Study||7
488276|NCT01076361|1196018|P1|NOT COMPLETED|Overall Study||21
488277|NCT01076361|1196018|P1|COMPLETED|Overall Study|Follow-up data was not available for 21 participants (22 leads)|349
488278|NCT01076361|1196018|P1|STARTED|Overall Study|631 leads were implanted in 370 patients. 22 leads in 21 patients were excluded from analysis.|370
488279|NCT01076348|1196022|P1|NOT COMPLETED|Overall Study||22
488280|NCT01076348|1196022|P1|COMPLETED|Overall Study||51
488281|NCT01076348|1196022|P1|STARTED|Overall Study||73
488282|NCT01076335|1196026|P1|NOT COMPLETED|Overall Study||4
488283|NCT01076335|1196026|P1|COMPLETED|Overall Study||36
488284|NCT01076335|1196026|P1|STARTED|Overall Study||40
488285|NCT01076296|1196030|P8|NOT COMPLETED|Overall Study||0
488286|NCT01076296|1196031|P7|NOT COMPLETED|Overall Study||0
488287|NCT01076296|1196032|P6|NOT COMPLETED|Overall Study||0
488288|NCT01076296|1196033|P5|NOT COMPLETED|Overall Study||0
488289|NCT01076296|1196034|P4|NOT COMPLETED|Overall Study||0
488290|NCT01076296|1196035|P3|NOT COMPLETED|Overall Study||0
488291|NCT01076296|1196036|P2|NOT COMPLETED|Overall Study||0
488292|NCT01076296|1196037|P1|NOT COMPLETED|Overall Study||0
488293|NCT01076296|1196030|P8|COMPLETED|Overall Study||199
488294|NCT01076296|1196031|P7|COMPLETED|Overall Study||51
488295|NCT01076296|1196032|P6|COMPLETED|Overall Study||191
488296|NCT01076296|1196033|P5|COMPLETED|Overall Study||59
488297|NCT01076296|1196034|P4|COMPLETED|Overall Study||199
488298|NCT01076296|1196035|P3|COMPLETED|Overall Study||51
488299|NCT01076296|1196036|P2|COMPLETED|Overall Study||196
488300|NCT01076296|1196037|P1|COMPLETED|Overall Study||54
488301|NCT01076296|1196030|P8|STARTED|Overall Study||199
488302|NCT01076296|1196031|P7|STARTED|Overall Study||51
488303|NCT01076296|1196032|P6|STARTED|Overall Study||191
488304|NCT01076296|1196033|P5|STARTED|Overall Study||59
488305|NCT01076296|1196034|P4|STARTED|Overall Study||199
488306|NCT01076296|1196035|P3|STARTED|Overall Study||51
488307|NCT01076296|1196036|P2|STARTED|Overall Study||196
488308|NCT01076296|1196037|P1|STARTED|Overall Study||54
488309|NCT01076283|1196057|P2|NOT COMPLETED|Overall Study||0
488310|NCT01076283|1196058|P1|NOT COMPLETED|Overall Study||1
488311|NCT01076283|1196057|P2|COMPLETED|Overall Study||7
488312|NCT01076283|1196058|P1|COMPLETED|Overall Study||6
488313|NCT01076283|1196057|P2|STARTED|Overall Study||7
488314|NCT01076283|1196058|P1|STARTED|Overall Study||7
488315|NCT01076270|1196066|P1|NOT COMPLETED|Overall Study||0
488316|NCT01076270|1196066|P1|COMPLETED|Overall Study||1
488317|NCT01076270|1196066|P1|STARTED|Overall Study||1
488318|NCT01076244|1196071|P1|NOT COMPLETED|Overall Study||4
488319|NCT01076244|1196071|P1|COMPLETED|Overall Study||42
488320|NCT01076244|1196071|P1|STARTED|Overall Study||46
488321|NCT01076192|1196078|P1|NOT COMPLETED|Overall Study||197
488322|NCT01076192|1196078|P1|COMPLETED|Overall Study||350
488323|NCT01076192|1196078|P1|STARTED|Overall Study||547
488324|NCT01076179|1196093|P1|NOT COMPLETED|Overall Study||1
488325|NCT01076179|1196093|P1|COMPLETED|Overall Study||501
488326|NCT01076179|1196093|P1|STARTED|Overall Study||502
488327|NCT01076166|1196116|P1|NOT COMPLETED|Overall Study||9
488328|NCT01076166|1196116|P1|COMPLETED|Overall Study||328
488329|NCT01076166|1196116|P1|STARTED|Overall Study||337
488330|NCT01076153|1196123|P1|NOT COMPLETED|Overall Study||11
488331|NCT01076153|1196123|P1|COMPLETED|Overall Study||749
488332|NCT01076153|1196123|P1|STARTED|Overall Study||760
488333|NCT01076088|1196137|P6|NOT COMPLETED|Overall Study||23
488334|NCT01076088|1196138|P5|NOT COMPLETED|Overall Study||16
488335|NCT01076088|1196139|P4|NOT COMPLETED|Overall Study||15
488336|NCT01076088|1196140|P3|NOT COMPLETED|Overall Study||17
488337|NCT01076088|1196141|P2|NOT COMPLETED|Overall Study||18
488338|NCT01076088|1196142|P1|NOT COMPLETED|Overall Study||11
488339|NCT01076088|1196137|P6|COMPLETED|Overall Study||104
488340|NCT01076088|1196138|P5|COMPLETED|Overall Study||104
488341|NCT01076088|1196139|P4|COMPLETED|Overall Study||109
488342|NCT01076088|1196140|P3|COMPLETED|Overall Study||109
488343|NCT01076088|1196141|P2|COMPLETED|Overall Study||107
488344|NCT01076088|1196142|P1|COMPLETED|Overall Study||111
488345|NCT01076088|1196137|P6|STARTED|Overall Study||127
488346|NCT01076088|1196138|P5|STARTED|Overall Study||120
488347|NCT01076088|1196139|P4|STARTED|Overall Study||124
488348|NCT01076088|1196140|P3|STARTED|Overall Study||126
488349|NCT01076088|1196141|P2|STARTED|Overall Study||125
488350|NCT01076088|1196142|P1|STARTED|Overall Study||122
488351|NCT01076075|1196170|P2|NOT COMPLETED|Overall Study||47
488352|NCT01076075|1196171|P1|NOT COMPLETED|Overall Study||41
488353|NCT01076075|1196170|P2|COMPLETED|Overall Study||167
488354|NCT01076075|1196171|P1|COMPLETED|Overall Study||172
488355|NCT01076075|1196170|P2|Completed Phase A|Overall Study||189
488356|NCT01076075|1196171|P1|Completed Phase A|Overall Study||199
488357|NCT01076075|1196170|P2|STARTED|Overall Study|2 participants were excluded from safety and efficacy analyses due to one site's non-compliance|214
488358|NCT01076075|1196171|P1|STARTED|Overall Study|3 participants were excluded from safety and efficacy analyses due to one site's non-compliance|213
488359|NCT01076036|1196185|P1|NOT COMPLETED|Overall Study||2
488360|NCT01076036|1196185|P1|COMPLETED|Overall Study||8
488361|NCT01076036|1196185|P1|Complete CorPath Procedures|Overall Study||8
488362|NCT01076036|1196185|P1|# of Procedures|Overall Study||8
488363|NCT01076036|1196185|P1|STARTED|Overall Study||10
488364|NCT01075984|1196195|P5|NOT COMPLETED|Follow-up Phase||47
488365|NCT01075984|1196196|P4|NOT COMPLETED|Follow-up Phase||2
488366|NCT01075984|1196197|P3|NOT COMPLETED|Follow-up Phase||1
488367|NCT01075984|1196198|P2|NOT COMPLETED|Follow-up Phase||0
488368|NCT01075984|1196199|P1|NOT COMPLETED|Follow-up Phase||0
488369|NCT01075984|1196195|P5|COMPLETED|Follow-up Phase||165
488370|NCT01075984|1196196|P4|COMPLETED|Follow-up Phase||19
488371|NCT01075984|1196197|P3|COMPLETED|Follow-up Phase||19
488372|NCT01075984|1196198|P2|COMPLETED|Follow-up Phase||10
488373|NCT01075984|1196199|P1|COMPLETED|Follow-up Phase||10
488374|NCT01075984|1196195|P5|STARTED|Follow-up Phase|One participant withdrew consent before the start of the follow-up phase.|212
488375|NCT01075984|1196196|P4|STARTED|Follow-up Phase|Three participants did not start the follow-up phase: one died and two were lost to follow-up.|21
488376|NCT01075984|1196197|P3|STARTED|Follow-up Phase|One participant did not start the follow-up phase for reasons unrelated to study procedures.|20
488377|NCT01075984|1196198|P2|STARTED|Follow-up Phase||10
488378|NCT01075984|1196199|P1|STARTED|Follow-up Phase||10
488379|NCT01075984|1196195|P5|NOT COMPLETED|Treatment Phase||60
488380|NCT01075984|1196196|P4|NOT COMPLETED|Treatment Phase||7
488381|NCT01075984|1196197|P3|NOT COMPLETED|Treatment Phase||7
488382|NCT01075984|1196198|P2|NOT COMPLETED|Treatment Phase||1
488383|NCT01075984|1196199|P1|NOT COMPLETED|Treatment Phase||0
488384|NCT01075984|1196195|P5|COMPLETED|Treatment Phase||153
488385|NCT01075984|1196196|P4|COMPLETED|Treatment Phase||17
488386|NCT01075984|1196197|P3|COMPLETED|Treatment Phase||14
488387|NCT01075984|1196198|P2|COMPLETED|Treatment Phase||10
488388|NCT01075984|1196199|P1|COMPLETED|Treatment Phase||10
488389|NCT01075984|1196195|P5|STARTED|Treatment Phase||213
488390|NCT01075984|1196196|P4|STARTED|Treatment Phase||24
488391|NCT01075984|1196197|P3|STARTED|Treatment Phase||21
488392|NCT01075984|1196198|P2|STARTED|Treatment Phase||11
488393|NCT01075984|1196199|P1|STARTED|Treatment Phase||10
488394|NCT01075971|1196253|P1|NOT COMPLETED|Overall Study||0
488395|NCT01075971|1196253|P1|COMPLETED|Overall Study||52
488396|NCT01075971|1196253|P1|STARTED|Overall Study||52
488397|NCT01075958|1196257|P1|NOT COMPLETED|Overall Study||44
488398|NCT01075958|1196257|P1|COMPLETED|Overall Study||239
488399|NCT01075958|1196257|P1|STARTED|Overall Study||283
488400|NCT01075815|1196273|P2|NOT COMPLETED|Overall Study||4
488401|NCT01075815|1196274|P1|NOT COMPLETED|Overall Study||10
488402|NCT01075815|1196273|P2|COMPLETED|Overall Study||31
488403|NCT01075815|1196274|P1|COMPLETED|Overall Study||30
488404|NCT01075815|1196273|P2|STARTED|Overall Study|Number of participants treated.|35
488405|NCT01075815|1196274|P1|STARTED|Overall Study|Number of participants treated.|40
488406|NCT01075763|1196312|P2|NOT COMPLETED|Overall Study||4
488407|NCT01075763|1196313|P1|NOT COMPLETED|Overall Study||4
488408|NCT01075763|1196312|P2|COMPLETED|Overall Study||15
488409|NCT01075763|1196313|P1|COMPLETED|Overall Study||19
488410|NCT01075763|1196312|P2|STARTED|Overall Study||19
488411|NCT01075763|1196313|P1|STARTED|Overall Study||23
488412|NCT01075685|1196337|P2|NOT COMPLETED|Overall Study||226
488413|NCT01075685|1196338|P1|NOT COMPLETED|Overall Study||592
488414|NCT01075685|1196337|P2|COMPLETED|Overall Study||188
488415|NCT01075685|1196338|P1|COMPLETED|Overall Study||151
488416|NCT01075685|1196337|P2|Completed Baseline Measures|Overall Study||263
488417|NCT01075685|1196338|P1|Completed Baseline Measures|Overall Study||225
488418|NCT01075685|1196337|P2|Met Inclusion Criteria|Overall Study||413
488419|NCT01075685|1196338|P1|Met Inclusion Criteria|Overall Study||734
488420|NCT01075685|1196337|P2|STARTED|Overall Study||414
488421|NCT01075685|1196338|P1|STARTED|Overall Study||743
488422|NCT01075646|1196354|P4|NOT COMPLETED|Overall Study||2
488423|NCT01075646|1196355|P3|NOT COMPLETED|Overall Study||1
488424|NCT01075646|1196356|P2|NOT COMPLETED|Overall Study||3
488425|NCT01075646|1196357|P1|NOT COMPLETED|Overall Study||4
488426|NCT01075646|1196354|P4|COMPLETED|Overall Study||44
488427|NCT01075646|1196355|P3|COMPLETED|Overall Study||52
488428|NCT01075646|1196356|P2|COMPLETED|Overall Study||31
488429|NCT01075646|1196357|P1|COMPLETED|Overall Study||29
488430|NCT01075646|1196354|P4|STARTED|Overall Study||46
488431|NCT01075646|1196355|P3|STARTED|Overall Study||53
488432|NCT01075646|1196356|P2|STARTED|Overall Study||34
488433|NCT01075646|1196357|P1|STARTED|Overall Study||33
488434|NCT01075412|1196389|P2|NOT COMPLETED|Overall Study||1
488435|NCT01075412|1196390|P1|NOT COMPLETED|Overall Study||0
488436|NCT01075412|1196389|P2|COMPLETED|Overall Study||1
488437|NCT01075412|1196390|P1|COMPLETED|Overall Study||4
488438|NCT01075412|1196389|P2|STARTED|Overall Study||2
488439|NCT01075412|1196390|P1|STARTED|Overall Study||4
488440|NCT01075399|1196400|P1|NOT COMPLETED|Overall Study||8
488441|NCT01075399|1196400|P1|COMPLETED|Overall Study|42 of 50 patients received at least one dose and 39 of 50 patients completed two pre-treatment scan|42
488442|NCT01075399|1196400|P1|STARTED|Overall Study|A total of 50 patients were enrolled into the study.|50
488443|NCT01075347|1196406|P2|NOT COMPLETED|Overall Study||0
488444|NCT01075347|1196407|P1|NOT COMPLETED|Overall Study||0
488445|NCT01075347|1196406|P2|COMPLETED|Overall Study||83
488446|NCT01075347|1196407|P1|COMPLETED|Overall Study||82
488447|NCT01075347|1196406|P2|STARTED|Overall Study||83
488448|NCT01075347|1196407|P1|STARTED|Overall Study||82
488449|NCT01075282|1196418|P3|NOT COMPLETED|Overall Study||27
488450|NCT01075282|1196419|P2|NOT COMPLETED|Overall Study||29
488451|NCT01075282|1196420|P1|NOT COMPLETED|Overall Study||31
488452|NCT01075282|1196418|P3|COMPLETED|Overall Study||238
488453|NCT01075282|1196419|P2|COMPLETED|Overall Study||243
488454|NCT01075282|1196420|P1|COMPLETED|Overall Study||242
488455|NCT01075282|1196418|P3|Received at Least One Dose of Study Drug|Overall Study||262
488456|NCT01075282|1196419|P2|Received at Least One Dose of Study Drug|Overall Study||272
488457|NCT01075282|1196420|P1|Received at Least One Dose of Study Drug|Overall Study||273
488458|NCT01075282|1196418|P3|STARTED|Overall Study|Of 265 participants randomized to Insulin Glargine, 3 chose not to take study drug.|265
488459|NCT01075282|1196419|P2|STARTED|Overall Study||272
488460|NCT01075282|1196420|P1|STARTED|Overall Study||273
488461|NCT01075256|1196503|P3|NOT COMPLETED|Overall Study||0
488462|NCT01075256|1196504|P2|NOT COMPLETED|Overall Study||0
488463|NCT01075256|1196505|P1|NOT COMPLETED|Overall Study||1
488464|NCT01075256|1196503|P3|COMPLETED|Overall Study||65
488465|NCT01075256|1196504|P2|COMPLETED|Overall Study||66
488466|NCT01075256|1196505|P1|COMPLETED|Overall Study||63
488467|NCT01075256|1196503|P3|STARTED|Overall Study||65
488468|NCT01075256|1196504|P2|STARTED|Overall Study||66
488469|NCT01075256|1196505|P1|STARTED|Overall Study||64
488470|NCT01075243|1196537|P3|NOT COMPLETED|Overall Study||0
488471|NCT01075243|1196538|P2|NOT COMPLETED|Overall Study||3
488472|NCT01075243|1196539|P1|NOT COMPLETED|Overall Study||6
488473|NCT01075243|1196537|P3|COMPLETED|Overall Study||80
488474|NCT01075243|1196538|P2|COMPLETED|Overall Study||155
488475|NCT01075243|1196539|P1|COMPLETED|Overall Study||157
488476|NCT01075243|1196537|P3|STARTED|Overall Study||80
488477|NCT01075243|1196538|P2|STARTED|Overall Study||158
488478|NCT01075243|1196539|P1|STARTED|Overall Study||163
488479|NCT01075217|1196591|P2|NOT COMPLETED|Overall Study||1
488480|NCT01075217|1196592|P1|NOT COMPLETED|Overall Study||2
488481|NCT01075217|1196591|P2|COMPLETED|Overall Study||84
488482|NCT01075217|1196592|P1|COMPLETED|Overall Study||82
488483|NCT01075217|1196591|P2|STARTED|Overall Study|86 patients randomized to receive Visipaque; 1 of the patients did not meet entry requirements|85
488484|NCT01075217|1196592|P1|STARTED|Overall Study|88 patients randomized to receive Isovue; 4 of the patients did not meet entry requirements|84
488485|NCT01075204|1196608|P1|NOT COMPLETED|Overall Study||0
488486|NCT01075204|1196608|P1|COMPLETED|Overall Study||335
488487|NCT01075204|1196608|P1|STARTED|Overall Study||335
488488|NCT01075191|1196625|P1|NOT COMPLETED|Overall Study||18
488489|NCT01075191|1196625|P1|COMPLETED|Overall Study||42
488490|NCT01075191|1196625|P1|Discontinued Year 3|Overall Study||5
488491|NCT01075191|1196625|P1|Discontinued Year 2|Overall Study||6
488492|NCT01075191|1196625|P1|Discontinued Year 1|Overall Study||7
488493|NCT01075191|1196625|P1|STARTED|Overall Study|65 participants were enrolled; 5 protocol violations were excluded from all analyses except safety.|60
488494|NCT01075178|1196636|P2|NOT COMPLETED|Subject Chart Review||9
488495|NCT01075178|1196637|P1|NOT COMPLETED|Subject Chart Review||9
488496|NCT01075178|1196636|P2|COMPLETED|Subject Chart Review|subjects in full analysis set|1009
488497|NCT01075178|1196637|P1|COMPLETED|Subject Chart Review|subjects in full analysis set|1009
488498|NCT01075178|1196636|P2|STARTED|Subject Chart Review|subjects matched|1018
488499|NCT01075178|1196637|P1|STARTED|Subject Chart Review|subjects matched|1018
488500|NCT01075178|1196636|P2|NOT COMPLETED|Subject Matching||403
488501|NCT01075178|1196637|P1|NOT COMPLETED|Subject Matching||130
488502|NCT01075178|1196636|P2|COMPLETED|Subject Matching|subjects matched|1018
488503|NCT01075178|1196637|P1|COMPLETED|Subject Matching|subjects matched|1018
488504|NCT01075178|1196636|P2|STARTED|Subject Matching|eligible for matching|1421
488505|NCT01075178|1196637|P1|STARTED|Subject Matching|eligible for matching|1148
488506|NCT01075152|1196651|P2|NOT COMPLETED|Overall Study||0
488507|NCT01075152|1196652|P1|NOT COMPLETED|Overall Study||1
488508|NCT01075152|1196651|P2|COMPLETED|Overall Study||89
488509|NCT01075152|1196652|P1|COMPLETED|Overall Study||87
488510|NCT01075152|1196651|P2|STARTED|Overall Study|randomized|89
488511|NCT01075152|1196652|P1|STARTED|Overall Study|randomized|88
488512|NCT01075100|1196678|P2|NOT COMPLETED|Overall Study||53
488513|NCT01075100|1196679|P1|NOT COMPLETED|Overall Study||49
488514|NCT01075100|1196678|P2|COMPLETED|Overall Study||1
488515|NCT01075100|1196679|P1|COMPLETED|Overall Study||0
488516|NCT01075100|1196678|P2|STARTED|Overall Study||54
488517|NCT01075100|1196679|P1|STARTED|Overall Study||49
488518|NCT01075087|1196697|P2|NOT COMPLETED|Overall Study||0
488519|NCT01075087|1196698|P1|NOT COMPLETED|Overall Study||0
488520|NCT01075087|1196697|P2|COMPLETED|Overall Study||10
488521|NCT01075087|1196698|P1|COMPLETED|Overall Study||9
488522|NCT01075087|1196697|P2|STARTED|Overall Study||10
488523|NCT01075087|1196698|P1|STARTED|Overall Study||9
488524|NCT01075074|1196709|P3|NOT COMPLETED|Overall Study||2
488525|NCT01075074|1196710|P2|NOT COMPLETED|Overall Study||2
488526|NCT01075074|1196711|P1|NOT COMPLETED|Overall Study||1
488527|NCT01075074|1196709|P3|COMPLETED|Overall Study||23
488528|NCT01075074|1196710|P2|COMPLETED|Overall Study||23
488529|NCT01075074|1196711|P1|COMPLETED|Overall Study||24
488530|NCT01075074|1196709|P3|STARTED|Overall Study||25
488531|NCT01075074|1196710|P2|STARTED|Overall Study||25
488532|NCT01075074|1196711|P1|STARTED|Overall Study||25
488533|NCT01074944|1196728|P5|NOT COMPLETED|Extended Treatment (up to 42 Months)||5
488534|NCT01074944|1196729|P4|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
488535|NCT01074944|1196730|P3|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
488536|NCT01074944|1196731|P2|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
488537|NCT01074944|1196732|P1|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
488538|NCT01074944|1196728|P5|COMPLETED|Extended Treatment (up to 42 Months)||20
488539|NCT01074944|1196729|P4|COMPLETED|Extended Treatment (up to 42 Months)||0
488540|NCT01074944|1196730|P3|COMPLETED|Extended Treatment (up to 42 Months)||0
488541|NCT01074944|1196731|P2|COMPLETED|Extended Treatment (up to 42 Months)||0
488542|NCT01074944|1196732|P1|COMPLETED|Extended Treatment (up to 42 Months)||0
488543|NCT01074944|1196728|P5|STARTED|Extended Treatment (up to 42 Months)|Participants who were failed to meet the randomization criteria during the lead-in period.|25
488544|NCT01074944|1196729|P4|STARTED|Extended Treatment (up to 42 Months)||0
488545|NCT01074944|1196730|P3|STARTED|Extended Treatment (up to 42 Months)||0
488546|NCT01074944|1196731|P2|STARTED|Extended Treatment (up to 42 Months)||0
488547|NCT01074944|1196732|P1|STARTED|Extended Treatment (up to 42 Months)||0
488548|NCT01074944|1196728|P5|NOT COMPLETED|Long Term Treatment||0
488549|NCT01074944|1196729|P4|NOT COMPLETED|Long Term Treatment||26
488550|NCT01074944|1196730|P3|NOT COMPLETED|Long Term Treatment||0
488551|NCT01074944|1196731|P2|NOT COMPLETED|Long Term Treatment||0
488552|NCT01074944|1196732|P1|NOT COMPLETED|Long Term Treatment||0
488553|NCT01074944|1196728|P5|COMPLETED|Long Term Treatment||0
488554|NCT01074944|1196729|P4|COMPLETED|Long Term Treatment||95
488555|NCT01074944|1196730|P3|COMPLETED|Long Term Treatment||0
488556|NCT01074944|1196731|P2|COMPLETED|Long Term Treatment||0
488557|NCT01074944|1196732|P1|COMPLETED|Long Term Treatment||0
488558|NCT01074944|1196728|P5|STARTED|Long Term Treatment||0
488559|NCT01074944|1196729|P4|STARTED|Long Term Treatment|Participants who completed PAP (114) including those who considered as treatment failure in PAP (7).|121
488560|NCT01074944|1196730|P3|STARTED|Long Term Treatment||0
488561|NCT01074944|1196731|P2|STARTED|Long Term Treatment||0
488562|NCT01074944|1196732|P1|STARTED|Long Term Treatment||0
488563|NCT01074944|1196728|P5|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
488564|NCT01074944|1196729|P4|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
488565|NCT01074944|1196730|P3|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||6
488566|NCT01074944|1196731|P2|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||11
488567|NCT01074944|1196732|P1|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
488568|NCT01074944|1196728|P5|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
488569|NCT01074944|1196729|P4|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
488570|NCT01074944|1196730|P3|COMPLETED|Primary Analysis Period (up to 52 Weeks)||60
488571|NCT01074944|1196731|P2|COMPLETED|Primary Analysis Period (up to 52 Weeks)||54
488572|NCT01074944|1196732|P1|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
488573|NCT01074944|1196728|P5|STARTED|Primary Analysis Period (up to 52 Weeks)||0
488574|NCT01074944|1196729|P4|STARTED|Primary Analysis Period (up to 52 Weeks)||0
488575|NCT01074944|1196730|P3|STARTED|Primary Analysis Period (up to 52 Weeks)|Participants who were randomized after LIP received treatment in PAP.|66
488576|NCT01074944|1196731|P2|STARTED|Primary Analysis Period (up to 52 Weeks)|Participants who were randomized after LIP received treatment in PAP.|65
488577|NCT01074944|1196732|P1|STARTED|Primary Analysis Period (up to 52 Weeks)||0
488578|NCT01074944|1196728|P5|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
488579|NCT01074944|1196729|P4|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
488580|NCT01074944|1196730|P3|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
488581|NCT01074944|1196731|P2|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
488582|NCT01074944|1196732|P1|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||13
488583|NCT01074944|1196728|P5|COMPLETED|Lead-in Period (up to 78 Weeks)||0
488584|NCT01074944|1196729|P4|COMPLETED|Lead-in Period (up to 78 Weeks)||0
488585|NCT01074944|1196730|P3|COMPLETED|Lead-in Period (up to 78 Weeks)||0
488586|NCT01074944|1196731|P2|COMPLETED|Lead-in Period (up to 78 Weeks)||0
488587|NCT01074944|1196732|P1|COMPLETED|Lead-in Period (up to 78 Weeks)||157
488588|NCT01074944|1196728|P5|STARTED|Lead-in Period (up to 78 Weeks)||0
488589|NCT01074944|1196729|P4|STARTED|Lead-in Period (up to 78 Weeks)||0
488590|NCT01074944|1196730|P3|STARTED|Lead-in Period (up to 78 Weeks)||0
488591|NCT01074944|1196731|P2|STARTED|Lead-in Period (up to 78 Weeks)||0
488592|NCT01074944|1196732|P1|STARTED|Lead-in Period (up to 78 Weeks)|LIP conducted to assess randomization criteria of all participants in single reporting arm.|170
488593|NCT01074931|1196786|P1|NOT COMPLETED|Overall Study||6
488594|NCT01074931|1196786|P1|COMPLETED|Overall Study||92
488595|NCT01074931|1196786|P1|STARTED|Overall Study||98
488596|NCT01074658|1196798|P1|NOT COMPLETED|Overall Study||19
488597|NCT01074658|1196798|P1|COMPLETED|Overall Study||996
488598|NCT01074658|1196798|P1|Attempted Implant|Overall Study||996
488599|NCT01074658|1196798|P1|STARTED|Overall Study||1015
488600|NCT01074554|1196806|P2|NOT COMPLETED|Overall Study||4
488601|NCT01074554|1196807|P1|NOT COMPLETED|Overall Study||3
488602|NCT01074554|1196806|P2|COMPLETED|Overall Study||11
488603|NCT01074554|1196807|P1|COMPLETED|Overall Study||11
488604|NCT01074554|1196806|P2|STARTED|Overall Study||15
488605|NCT01074554|1196807|P1|STARTED|Overall Study||14
488606|NCT01074502|1196817|P1|NOT COMPLETED|Overall Study||1
488607|NCT01074502|1196817|P1|COMPLETED|Overall Study||2
488608|NCT01074502|1196817|P1|STARTED|Overall Study||3
488609|NCT01074463|1196828|P2|NOT COMPLETED|Second Intervention||0
488610|NCT01074463|1196829|P1|NOT COMPLETED|Second Intervention||0
488611|NCT01074463|1196828|P2|COMPLETED|Second Intervention||12
488612|NCT01074463|1196829|P1|COMPLETED|Second Intervention||12
488613|NCT01074463|1196828|P2|STARTED|Second Intervention||12
488614|NCT01074463|1196829|P1|STARTED|Second Intervention||12
488615|NCT01074463|1196828|P2|NOT COMPLETED|Washout of 7 Days||0
488616|NCT01074463|1196829|P1|NOT COMPLETED|Washout of 7 Days||0
488617|NCT01074463|1196828|P2|COMPLETED|Washout of 7 Days||12
488618|NCT01074463|1196829|P1|COMPLETED|Washout of 7 Days||12
488619|NCT01074463|1196828|P2|STARTED|Washout of 7 Days||12
488620|NCT01074463|1196829|P1|STARTED|Washout of 7 Days||12
488621|NCT01074463|1196828|P2|NOT COMPLETED|First Intervention||0
488622|NCT01074463|1196829|P1|NOT COMPLETED|First Intervention||0
488623|NCT01074463|1196828|P2|COMPLETED|First Intervention||12
488624|NCT01074463|1196829|P1|COMPLETED|First Intervention||12
488625|NCT01074463|1196828|P2|STARTED|First Intervention||12
488626|NCT01074463|1196829|P1|STARTED|First Intervention||12
488627|NCT01074450|1196841|P2|NOT COMPLETED|Second Intervention||1
488628|NCT01074450|1196842|P1|NOT COMPLETED|Second Intervention||1
488629|NCT01074450|1196841|P2|COMPLETED|Second Intervention|Influenze Symptoms Present at Check in.|9
488630|NCT01074450|1196842|P1|COMPLETED|Second Intervention|Positive Drug Screen at Check in.|11
488631|NCT01074450|1196841|P2|STARTED|Second Intervention||10
488632|NCT01074450|1196842|P1|STARTED|Second Intervention||12
488633|NCT01074450|1196841|P2|NOT COMPLETED|Washout of 7 Days||0
488634|NCT01074450|1196842|P1|NOT COMPLETED|Washout of 7 Days||0
488635|NCT01074450|1196841|P2|COMPLETED|Washout of 7 Days||10
488636|NCT01074450|1196842|P1|COMPLETED|Washout of 7 Days||12
488637|NCT01074450|1196841|P2|STARTED|Washout of 7 Days||10
488638|NCT01074450|1196842|P1|STARTED|Washout of 7 Days||12
488639|NCT01074450|1196841|P2|NOT COMPLETED|First Intervention||2
488640|NCT01074450|1196842|P1|NOT COMPLETED|First Intervention||0
488641|NCT01074450|1196841|P2|COMPLETED|First Intervention||10
488642|NCT01074450|1196842|P1|COMPLETED|First Intervention||12
488643|NCT01074450|1196841|P2|STARTED|First Intervention||12
488644|NCT01074450|1196842|P1|STARTED|First Intervention||12
488645|NCT01074437|1196854|P2|NOT COMPLETED|Overall Study||0
488646|NCT01074437|1196855|P1|NOT COMPLETED|Overall Study||0
488647|NCT01074437|1196854|P2|COMPLETED|Overall Study||5
488648|NCT01074437|1196855|P1|COMPLETED|Overall Study||4
488649|NCT01074437|1196854|P2|STARTED|Overall Study||5
488650|NCT01074437|1196855|P1|STARTED|Overall Study||4
488651|NCT01074307|1196863|P2|NOT COMPLETED|Overall Study||12
488652|NCT01074307|1196864|P1|NOT COMPLETED|Overall Study||22
488653|NCT01074307|1196863|P2|COMPLETED|Overall Study||102
488654|NCT01074307|1196864|P1|COMPLETED|Overall Study||44
488655|NCT01074307|1196863|P2|STARTED|Overall Study||114
488656|NCT01074307|1196864|P1|STARTED|Overall Study||66
488657|NCT01074268|1196886|P2|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||7
488658|NCT01074268|1196887|P1|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||6
488659|NCT01074268|1196886|P2|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||115
488660|NCT01074268|1196887|P1|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||242
488661|NCT01074268|1196886|P2|STARTED|Extension: Week 27 to 52 (NN1250-3725)|Sixteen subjects from main trial did not continue into the extension|122
488662|NCT01074268|1196887|P1|STARTED|Extension: Week 27 to 52 (NN1250-3725)|Thirty five subjects from main trial did not continue into the extension|248
488663|NCT01074268|1196886|P2|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||15
488664|NCT01074268|1196887|P1|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||20
488665|NCT01074268|1196886|P2|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||138
488666|NCT01074268|1196887|P1|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||283
488667|NCT01074268|1196886|P2|Exposed|Main: Week 0 to 26 (NN1250-3585)|One subject withdrew prior to exposure to trial drugs|152
488668|NCT01074268|1196887|P1|Exposed|Main: Week 0 to 26 (NN1250-3585)|Two subjects withdrew prior to exposure to trial drugs|301
488669|NCT01074268|1196886|P2|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)||153
488670|NCT01074268|1196887|P1|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)|One subject was withdrawn because the subject was randomised in error (screening failure)|302
488671|NCT01074268|1196886|P2|STARTED|Main: Week 0 to 26 (NN1250-3585)||153
488672|NCT01074268|1196887|P1|STARTED|Main: Week 0 to 26 (NN1250-3585)||303
488673|NCT01074255|1196913|P1|NOT COMPLETED|Overall Study||2
488674|NCT01074255|1196913|P1|COMPLETED|Overall Study||3139
488675|NCT01074255|1196913|P1|Treated|Overall Study||3139
488676|NCT01074255|1196913|P1|STARTED|Overall Study||3141
488677|NCT01074242|1196917|P1|NOT COMPLETED|Overall Study||403
488678|NCT01074242|1196917|P1|COMPLETED|Overall Study||3395
488679|NCT01074242|1196917|P1|Received at Least 1 Dose of Vaccine|Overall Study||3395
488680|NCT01074242|1196917|P1|STARTED|Overall Study||3798
488681|NCT01074229|1196925|P3|NOT COMPLETED|Overall Study||4
488682|NCT01074229|1196926|P2|NOT COMPLETED|Overall Study||3
488683|NCT01074229|1196927|P1|NOT COMPLETED|Overall Study||2
488684|NCT01074229|1196925|P3|COMPLETED|Overall Study||21
488685|NCT01074229|1196926|P2|COMPLETED|Overall Study||22
488686|NCT01074229|1196927|P1|COMPLETED|Overall Study||23
488687|NCT01074229|1196925|P3|STARTED|Overall Study||25
488688|NCT01074229|1196926|P2|STARTED|Overall Study||25
488689|NCT01074229|1196927|P1|STARTED|Overall Study||25
488690|NCT01074216|1196938|P1|NOT COMPLETED|Overall Study||13
488691|NCT01074216|1196938|P1|COMPLETED|Overall Study||41
488692|NCT01074216|1196938|P1|STARTED|Overall Study||54
488693|NCT01074177|1196942|P1|NOT COMPLETED|Overall Study||0
488694|NCT01074177|1196942|P1|COMPLETED|Overall Study||24
488695|NCT01074177|1196942|P1|STARTED|Overall Study||24
488696|NCT01074164|1196951|P2|NOT COMPLETED|Overall Study||1
488697|NCT01074164|1196952|P1|NOT COMPLETED|Overall Study||3
488698|NCT01074164|1196951|P2|COMPLETED|Overall Study||7
488699|NCT01074164|1196952|P1|COMPLETED|Overall Study||4
488700|NCT01074164|1196951|P2|STARTED|Overall Study||8
488701|NCT01074164|1196952|P1|STARTED|Overall Study||7
488702|NCT01074125|1196973|P3|NOT COMPLETED|Overall Study||12
488703|NCT01074125|1196974|P2|NOT COMPLETED|Overall Study||5
488704|NCT01074125|1196975|P1|NOT COMPLETED|Overall Study||12
488705|NCT01074125|1196973|P3|COMPLETED|Overall Study||36
488706|NCT01074125|1196974|P2|COMPLETED|Overall Study||47
488707|NCT01074125|1196975|P1|COMPLETED|Overall Study||39
488708|NCT01074125|1196973|P3|STARTED|Overall Study||48
488709|NCT01074125|1196974|P2|STARTED|Overall Study||52
488710|NCT01074125|1196975|P1|STARTED|Overall Study||51
488711|NCT01074099|1196991|P2|NOT COMPLETED|Overall Study||0
488712|NCT01074099|1196992|P1|NOT COMPLETED|Overall Study||0
488713|NCT01074099|1196991|P2|COMPLETED|Overall Study||3
488714|NCT01074099|1196992|P1|COMPLETED|Overall Study||2
488715|NCT01074099|1196991|P2|STARTED|Overall Study||3
488716|NCT01074099|1196992|P1|STARTED|Overall Study||2
488717|NCT01074047|1197002|P2|NOT COMPLETED|Extension Phase||0
488718|NCT01074047|1197003|P1|NOT COMPLETED|Extension Phase||22
488719|NCT01074047|1197002|P2|COMPLETED|Extension Phase||0
488720|NCT01074047|1197003|P1|COMPLETED|Extension Phase||0
488721|NCT01074047|1197002|P2|Safety Population|Extension Phase||0
488722|NCT01074047|1197003|P1|Safety Population|Extension Phase|Participants who enrolled in the extension phase|22
488723|NCT01074047|1197002|P2|STARTED|Extension Phase||0
488724|NCT01074047|1197003|P1|STARTED|Extension Phase|2 participants did not enroll in the extension period.|22
488725|NCT01074047|1197002|P2|NOT COMPLETED|Survival Follow-Up Phase||136
488726|NCT01074047|1197003|P1|NOT COMPLETED|Survival Follow-Up Phase||124
488727|NCT01074047|1197002|P2|COMPLETED|Survival Follow-Up Phase||27
488728|NCT01074047|1197003|P1|COMPLETED|Survival Follow-Up Phase||16
488729|NCT01074047|1197002|P2|STARTED|Survival Follow-Up Phase||163
488730|NCT01074047|1197003|P1|STARTED|Survival Follow-Up Phase||140
488731|NCT01074047|1197002|P2|NOT COMPLETED|Treatment Phase||234
488732|NCT01074047|1197003|P1|NOT COMPLETED|Treatment Phase||217
488733|NCT01074047|1197002|P2|COMPLETED|Treatment Phase|Participants who were continuing study treatment at the time of study closure|13
488734|NCT01074047|1197003|P1|COMPLETED|Treatment Phase|Participants who were continuing study treatment at the time of study closure|24
488735|NCT01074047|1197002|P2|Evaluable Population|Treatment Phase|Did not meet criteria for exclusion, received ≥1 cycle of treatment and had ≥ 1 efficacy assessment|191
488736|NCT01074047|1197003|P1|Evaluable Population|Treatment Phase|Did not meet criteria for exclusion, received ≥1 cycle of treatment and had ≥ 1 efficacy assessment|179
488737|NCT01074047|1197002|P2|Safety Population|Treatment Phase|Received at least one dose of study medication and had at least 1 post dose safety assessment|235
488738|NCT01074047|1197003|P1|Safety Population|Treatment Phase|Received at least one dose of study medication and had at least 1 post dose safety assessment|236
488739|NCT01074047|1197002|P2|Treated Population|Treatment Phase|7 patients not treated with any drug regimen|240
488740|NCT01074047|1197003|P1|Treated Population|Treatment Phase|5 patients not treated with any drug regimen|236
488741|NCT01074047|1197002|P2|STARTED|Treatment Phase||247
488742|NCT01074047|1197003|P1|STARTED|Treatment Phase||241
488743|NCT01074034|1197077|P1|NOT COMPLETED|Overall Study||6
488744|NCT01074034|1197077|P1|COMPLETED|Overall Study||205
488745|NCT01074034|1197077|P1|STARTED|Overall Study||211
488746|NCT01074008|1197091|P9|NOT COMPLETED|Overall Study||4
488747|NCT01074008|1197092|P8|NOT COMPLETED|Overall Study||0
488748|NCT01074008|1197093|P7|NOT COMPLETED|Overall Study||1
488749|NCT01074008|1197094|P6|NOT COMPLETED|Overall Study||0
488750|NCT01074008|1197095|P5|NOT COMPLETED|Overall Study||2
488751|NCT01074008|1197096|P4|NOT COMPLETED|Overall Study||1
488752|NCT01074008|1197097|P3|NOT COMPLETED|Overall Study||2
488753|NCT01074008|1197098|P2|NOT COMPLETED|Overall Study||3
488754|NCT01074008|1197099|P1|NOT COMPLETED|Overall Study||1
488755|NCT01074008|1197091|P9|COMPLETED|Overall Study||7
488756|NCT01074008|1197092|P8|COMPLETED|Overall Study||8
488757|NCT01074008|1197093|P7|COMPLETED|Overall Study||7
488758|NCT01074008|1197094|P6|COMPLETED|Overall Study||7
488759|NCT01074008|1197095|P5|COMPLETED|Overall Study||6
488760|NCT01074008|1197096|P4|COMPLETED|Overall Study||7
488761|NCT01074008|1197097|P3|COMPLETED|Overall Study||6
488762|NCT01074008|1197098|P2|COMPLETED|Overall Study||5
488763|NCT01074008|1197099|P1|COMPLETED|Overall Study||7
488764|NCT01074008|1197091|P9|Completed Direct-acting Antiviral Agent|Overall Study||5
488765|NCT01074008|1197092|P8|Completed Direct-acting Antiviral Agent|Overall Study||7
488766|NCT01074008|1197093|P7|Completed Direct-acting Antiviral Agent|Overall Study||8
488767|NCT01074008|1197094|P6|Completed Direct-acting Antiviral Agent|Overall Study||5
488768|NCT01074008|1197095|P5|Completed Direct-acting Antiviral Agent|Overall Study||8
488769|NCT01074008|1197096|P4|Completed Direct-acting Antiviral Agent|Overall Study||8
488770|NCT01074008|1197097|P3|Completed Direct-acting Antiviral Agent|Overall Study||7
488771|NCT01074008|1197098|P2|Completed Direct-acting Antiviral Agent|Overall Study||7
488772|NCT01074008|1197099|P1|Completed Direct-acting Antiviral Agent|Overall Study||8
488773|NCT01074008|1197091|P9|STARTED|Overall Study||11
488774|NCT01074008|1197092|P8|STARTED|Overall Study||8
488775|NCT01074008|1197093|P7|STARTED|Overall Study||8
488776|NCT01074008|1197094|P6|STARTED|Overall Study||7
488777|NCT01074008|1197095|P5|STARTED|Overall Study||8
488778|NCT01074008|1197096|P4|STARTED|Overall Study||8
488779|NCT01074008|1197097|P3|STARTED|Overall Study||8
488780|NCT01074008|1197098|P2|STARTED|Overall Study||8
488781|NCT01074008|1197099|P1|STARTED|Overall Study||8
488782|NCT01073943|1197209|P2|NOT COMPLETED|Overall Study||8
488783|NCT01073943|1197210|P1|NOT COMPLETED|Overall Study||13
488784|NCT01073943|1197209|P2|COMPLETED|Overall Study||295
488785|NCT01073943|1197210|P1|COMPLETED|Overall Study||287
488786|NCT01073943|1197209|P2|Intent to Treat Population|Overall Study|Two treated participants did not have an efficacy assessment performed.|300
488787|NCT01073943|1197210|P1|Intent to Treat Population|Overall Study|Two treated participants did not have an efficacy assessment performed.|294
488788|NCT01073943|1197209|P2|Safety Population (Treated)|Overall Study||302
488789|NCT01073943|1197210|P1|Safety Population (Treated)|Overall Study||296
488790|NCT01073943|1197209|P2|STARTED|Overall Study||303
488791|NCT01073943|1197210|P1|STARTED|Overall Study||300
488792|NCT01073930|1197236|P2|NOT COMPLETED|Overall Study||6
488793|NCT01073930|1197237|P1|NOT COMPLETED|Overall Study||3
488794|NCT01073930|1197236|P2|COMPLETED|Overall Study||295
488795|NCT01073930|1197237|P1|COMPLETED|Overall Study||304
488796|NCT01073930|1197236|P2|Intent to Treat Population|Overall Study|One treated participant did not have an efficacy assessment performed.|297
488797|NCT01073930|1197237|P1|Intent to Treat Population|Overall Study|One treated participant did not have an efficacy assessment performed.|304
488798|NCT01073930|1197236|P2|Safety Population (Treated)|Overall Study||298
488799|NCT01073930|1197237|P1|Safety Population (Treated)|Overall Study||305
488800|NCT01073930|1197236|P2|STARTED|Overall Study||301
488801|NCT01073930|1197237|P1|STARTED|Overall Study||307
488802|NCT01073865|1197261|P2|NOT COMPLETED|Overall Study||39
488803|NCT01073865|1197262|P1|NOT COMPLETED|Overall Study||28
488804|NCT01073865|1197261|P2|COMPLETED|Overall Study|Number of patients completed the study|74
488805|NCT01073865|1197262|P1|COMPLETED|Overall Study|Number of patients completed the study|81
488806|NCT01073865|1197261|P2|Received Randomised Treatment|Overall Study|Number of patients received randomised treatment|113
488807|NCT01073865|1197262|P1|Received Randomised Treatment|Overall Study|Number of patients received randomised treatment|108
488808|NCT01073865|1197261|P2|STARTED|Overall Study|Number of patients randomised|113
488809|NCT01073865|1197262|P1|STARTED|Overall Study|Number of patients randomised|109
488810|NCT01073657|1197274|P2|NOT COMPLETED|Overall Study||0
488811|NCT01073657|1197275|P1|NOT COMPLETED|Overall Study||0
488812|NCT01073657|1197274|P2|COMPLETED|Overall Study||16
488813|NCT01073657|1197275|P1|COMPLETED|Overall Study||17
488814|NCT01073657|1197274|P2|STARTED|Overall Study||16
488815|NCT01073657|1197275|P1|STARTED|Overall Study||17
488816|NCT01073631|1197281|P1|NOT COMPLETED|Overall Study||169
488817|NCT01073631|1197281|P1|COMPLETED|Overall Study||374
488818|NCT01073631|1197281|P1|STARTED|Overall Study||543
488819|NCT01073618|1197286|P1|NOT COMPLETED|Overall Study||307
488820|NCT01073618|1197286|P1|COMPLETED|Overall Study||385
488821|NCT01073618|1197286|P1|STARTED|Overall Study||692
488822|NCT01073605|1197294|P3|NOT COMPLETED|Overall Study||61
488823|NCT01073605|1197295|P2|NOT COMPLETED|Overall Study||67
488824|NCT01073605|1197296|P1|NOT COMPLETED|Overall Study||62
488825|NCT01073605|1197294|P3|COMPLETED|Overall Study|Corresponds to follow-up until final height|8
488826|NCT01073605|1197295|P2|COMPLETED|Overall Study|Corresponds to follow-up until final height|4
488827|NCT01073605|1197296|P1|COMPLETED|Overall Study|Corresponds to follow-up until final height|6
488828|NCT01073605|1197294|P3|Received Treatment|Overall Study||68
488829|NCT01073605|1197295|P2|Received Treatment|Overall Study||70
488830|NCT01073605|1197296|P1|Received Treatment|Overall Study||68
488831|NCT01073605|1197294|P3|STARTED|Overall Study||69
488832|NCT01073605|1197295|P2|STARTED|Overall Study||71
488833|NCT01073605|1197296|P1|STARTED|Overall Study||68
488834|NCT01073566|1197342|P2|NOT COMPLETED|Period 2 (6 Weeks)||0
488835|NCT01073566|1197343|P1|NOT COMPLETED|Period 2 (6 Weeks)||1
488836|NCT01073566|1197342|P2|COMPLETED|Period 2 (6 Weeks)||19
488837|NCT01073566|1197343|P1|COMPLETED|Period 2 (6 Weeks)||18
488838|NCT01073566|1197342|P2|STARTED|Period 2 (6 Weeks)||19
488839|NCT01073566|1197343|P1|STARTED|Period 2 (6 Weeks)||19
488840|NCT01073566|1197342|P2|NOT COMPLETED|Period 1 (6 Weeks)||0
488841|NCT01073566|1197343|P1|NOT COMPLETED|Period 1 (6 Weeks)||0
488842|NCT01073566|1197342|P2|COMPLETED|Period 1 (6 Weeks)||19
488843|NCT01073566|1197343|P1|COMPLETED|Period 1 (6 Weeks)||19
488844|NCT01073566|1197342|P2|STARTED|Period 1 (6 Weeks)||19
488845|NCT01073566|1197343|P1|STARTED|Period 1 (6 Weeks)||19
488846|NCT01073462|1197355|P1|NOT COMPLETED|Overall Study||41
488847|NCT01073462|1197355|P1|COMPLETED|Overall Study||26
488848|NCT01073462|1197355|P1|STARTED|Overall Study||67
488849|NCT01073449|1197366|P1|NOT COMPLETED|Overall Study||0
488850|NCT01073449|1197366|P1|COMPLETED|Overall Study||3362
488851|NCT01073449|1197366|P1|STARTED|Overall Study||3362
488852|NCT01073293|1197374|P2|NOT COMPLETED|Overall Study||11
488853|NCT01073293|1197375|P1|NOT COMPLETED|Overall Study||5
488854|NCT01073293|1197374|P2|COMPLETED|Overall Study||517
488855|NCT01073293|1197375|P1|COMPLETED|Overall Study||521
488856|NCT01073293|1197374|P2|STARTED|Overall Study||528
488857|NCT01073293|1197375|P1|STARTED|Overall Study||526
488858|NCT01073267|1197397|P1|NOT COMPLETED|Overall Study||3
488859|NCT01073267|1197397|P1|COMPLETED|Overall Study||1
488860|NCT01073267|1197397|P1|STARTED|Overall Study||4
488861|NCT01073163|1197401|P1|NOT COMPLETED|Overall Study||3
488862|NCT01073163|1197401|P1|COMPLETED|Overall Study|Patients completed study|51
488863|NCT01073163|1197401|P1|Treated With >=6 Cycles|Overall Study||49
488864|NCT01073163|1197401|P1|Treated With <6 Cycles|Overall Study||4
488865|NCT01073163|1197401|P1|Enrolled But Not Treated|Overall Study||1
488866|NCT01073163|1197401|P1|STARTED|Overall Study||54
488867|NCT01072929|1197424|P3|NOT COMPLETED|Overall Study||9
488868|NCT01072929|1197425|P2|NOT COMPLETED|Overall Study||51
488869|NCT01072929|1197426|P1|NOT COMPLETED|Overall Study||44
488870|NCT01072929|1197424|P3|COMPLETED|Overall Study||24
488871|NCT01072929|1197425|P2|COMPLETED|Overall Study||150
488872|NCT01072929|1197426|P1|COMPLETED|Overall Study||155
488873|NCT01072929|1197424|P3|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|31
488874|NCT01072929|1197425|P2|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|197
488875|NCT01072929|1197426|P1|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|196
488876|NCT01072929|1197424|P3|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|32
488877|NCT01072929|1197425|P2|Safety Population|Overall Study|Treated participants. Three participants were randomized but not treated.|198
488878|NCT01072929|1197426|P1|Safety Population|Overall Study|Treated participants|199
488879|NCT01072929|1197424|P3|STARTED|Overall Study||33
488880|NCT01072929|1197425|P2|STARTED|Overall Study||201
488881|NCT01072929|1197426|P1|STARTED|Overall Study||199
488882|NCT01072877|1197505|P5|NOT COMPLETED|Overall Study||0
488883|NCT01072877|1197506|P4|NOT COMPLETED|Overall Study||2
488884|NCT01072877|1197507|P3|NOT COMPLETED|Overall Study||0
488885|NCT01072877|1197508|P2|NOT COMPLETED|Overall Study||1
488886|NCT01072877|1197509|P1|NOT COMPLETED|Overall Study||1
488887|NCT01072877|1197505|P5|COMPLETED|Overall Study||63
488888|NCT01072877|1197506|P4|COMPLETED|Overall Study||50
488889|NCT01072877|1197507|P3|COMPLETED|Overall Study||51
488890|NCT01072877|1197508|P2|COMPLETED|Overall Study||56
488891|NCT01072877|1197509|P1|COMPLETED|Overall Study||55
488892|NCT01072877|1197505|P5|STARTED|Overall Study||63
488893|NCT01072877|1197506|P4|STARTED|Overall Study||52
488894|NCT01072877|1197507|P3|STARTED|Overall Study||51
488895|NCT01072877|1197508|P2|STARTED|Overall Study||57
488896|NCT01072877|1197509|P1|STARTED|Overall Study||56
488897|NCT01072773|1197531|P1|NOT COMPLETED|Overall Study||0
488898|NCT01072773|1197531|P1|COMPLETED|Overall Study||2
488899|NCT01072773|1197531|P1|STARTED|Overall Study||2
488900|NCT01072669|1197542|P2|NOT COMPLETED|Overall Study||0
488901|NCT01072669|1197543|P1|NOT COMPLETED|Overall Study||0
488902|NCT01072669|1197542|P2|COMPLETED|Overall Study||5
488903|NCT01072669|1197543|P1|COMPLETED|Overall Study||15
488904|NCT01072669|1197542|P2|STARTED|Overall Study||5
488905|NCT01072669|1197543|P1|STARTED|Overall Study||15
488906|NCT01072656|1197551|P2|NOT COMPLETED|Second Intervention||0
488907|NCT01072656|1197552|P1|NOT COMPLETED|Second Intervention||0
488908|NCT01072656|1197551|P2|COMPLETED|Second Intervention||4
488909|NCT01072656|1197552|P1|COMPLETED|Second Intervention||5
488910|NCT01072656|1197551|P2|STARTED|Second Intervention||4
488911|NCT01072656|1197552|P1|STARTED|Second Intervention||5
488912|NCT01072656|1197551|P2|NOT COMPLETED|First Intervention||0
488913|NCT01072656|1197552|P1|NOT COMPLETED|First Intervention||0
488914|NCT01072656|1197551|P2|COMPLETED|First Intervention||4
488915|NCT01072656|1197552|P1|COMPLETED|First Intervention||5
488916|NCT01072656|1197551|P2|STARTED|First Intervention||4
488917|NCT01072656|1197552|P1|STARTED|First Intervention||5
488918|NCT01072643|1197562|P1|NOT COMPLETED|Overall Study||0
488919|NCT01072643|1197562|P1|COMPLETED|Overall Study||4
488920|NCT01072643|1197562|P1|STARTED|Overall Study||4
488921|NCT01072630|1197572|P3|NOT COMPLETED|Overall Study||13
488922|NCT01072630|1197573|P2|NOT COMPLETED|Overall Study||60
488923|NCT01072630|1197574|P1|NOT COMPLETED|Overall Study||55
488924|NCT01072630|1197572|P3|COMPLETED|Overall Study||17
488925|NCT01072630|1197573|P2|COMPLETED|Overall Study||172
488926|NCT01072630|1197574|P1|COMPLETED|Overall Study||175
488927|NCT01072630|1197572|P3|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|28
488928|NCT01072630|1197573|P2|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|230
488929|NCT01072630|1197574|P1|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|224
488930|NCT01072630|1197572|P3|Safety Population|Overall Study|Treated participants.|30
488931|NCT01072630|1197573|P2|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|231
488932|NCT01072630|1197574|P1|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|229
488933|NCT01072630|1197572|P3|STARTED|Overall Study||30
488934|NCT01072630|1197573|P2|STARTED|Overall Study||232
488935|NCT01072630|1197574|P1|STARTED|Overall Study||230
488936|NCT01072617|1197648|P1|NOT COMPLETED|Overall Study||0
488937|NCT01072617|1197648|P1|COMPLETED|Overall Study||8
488938|NCT01072617|1197648|P1|STARTED|Overall Study||8
488939|NCT01072539|1197655|P1|NOT COMPLETED|Overall Study||3
488940|NCT01072539|1197655|P1|COMPLETED|Overall Study|Refer to the Safety Analysis Set. Data for completion were not collected.|3169
488941|NCT01072539|1197655|P1|STARTED|Overall Study||3172
488942|NCT01072526|1197663|P2|NOT COMPLETED|Overall Study||0
488943|NCT01072526|1197664|P1|NOT COMPLETED|Overall Study||0
488944|NCT01072526|1197663|P2|COMPLETED|Overall Study||0
488945|NCT01072526|1197664|P1|COMPLETED|Overall Study|Study completed in September 2008(recruited 6 patients total of 20 anticipated)|6
488946|NCT01072526|1197663|P2|STARTED|Overall Study||0
488947|NCT01072526|1197664|P1|STARTED|Overall Study|Study started in December 2007 (recruited 6 patients total of 20 anticipated)|6
488948|NCT01072500|1197679|P2|NOT COMPLETED|Overall Study||14
488949|NCT01072500|1197680|P1|NOT COMPLETED|Overall Study||24
488950|NCT01072500|1197679|P2|COMPLETED|Overall Study||803
488951|NCT01072500|1197680|P1|COMPLETED|Overall Study||794
488952|NCT01072500|1197679|P2|STARTED|Overall Study||817
488953|NCT01072500|1197680|P1|STARTED|Overall Study||818
488954|NCT01072448|1197690|P2|NOT COMPLETED|Overall Study||30
488955|NCT01072448|1197691|P1|NOT COMPLETED|Overall Study||19
488956|NCT01072448|1197690|P2|COMPLETED|Overall Study||130
488957|NCT01072448|1197691|P1|COMPLETED|Overall Study||144
488958|NCT01072448|1197690|P2|STARTED|Overall Study||160
488959|NCT01072448|1197691|P1|STARTED|Overall Study||163
488960|NCT01072409|1197699|P1|NOT COMPLETED|Overall Study||7
488961|NCT01072409|1197699|P1|COMPLETED|Overall Study||38
488962|NCT01072409|1197699|P1|STARTED|Overall Study||45
488963|NCT01072396|1197705|P2|NOT COMPLETED|Period Two||3
488964|NCT01072396|1197706|P1|NOT COMPLETED|Period Two||1
488965|NCT01072396|1197705|P2|COMPLETED|Period Two||57
488966|NCT01072396|1197706|P1|COMPLETED|Period Two||57
488967|NCT01072396|1197705|P2|STARTED|Period Two||60
488968|NCT01072396|1197706|P1|STARTED|Period Two||58
488969|NCT01072396|1197705|P2|NOT COMPLETED|Washout Period||1
488970|NCT01072396|1197706|P1|NOT COMPLETED|Washout Period||0
488971|NCT01072396|1197705|P2|COMPLETED|Washout Period||60
488972|NCT01072396|1197706|P1|COMPLETED|Washout Period||58
488973|NCT01072396|1197705|P2|STARTED|Washout Period||61
488974|NCT01072396|1197706|P1|STARTED|Washout Period||58
488975|NCT01072396|1197705|P2|NOT COMPLETED|Period One||2
488976|NCT01072396|1197706|P1|NOT COMPLETED|Period One||5
488977|NCT01072396|1197705|P2|COMPLETED|Period One||61
488978|NCT01072396|1197706|P1|COMPLETED|Period One||58
488979|NCT01072396|1197705|P2|STARTED|Period One||63
488980|NCT01072396|1197706|P1|STARTED|Period One||63
488981|NCT01072357|1197718|P2|NOT COMPLETED|Overall Study||1
488982|NCT01072357|1197719|P1|NOT COMPLETED|Overall Study||0
488983|NCT01072357|1197718|P2|COMPLETED|Overall Study||14
488984|NCT01072357|1197719|P1|COMPLETED|Overall Study||15
488985|NCT01072357|1197718|P2|STARTED|Overall Study||15
488986|NCT01072357|1197719|P1|STARTED|Overall Study||15
488987|NCT01072344|1197729|P2|NOT COMPLETED|Overall Study||18
488988|NCT01072344|1197730|P1|NOT COMPLETED|Overall Study||11
488989|NCT01072344|1197729|P2|COMPLETED|Overall Study||29
488990|NCT01072344|1197730|P1|COMPLETED|Overall Study||35
488991|NCT01072344|1197729|P2|STARTED|Overall Study||47
488992|NCT01072344|1197730|P1|STARTED|Overall Study||46
488993|NCT01072331|1197747|P3|NOT COMPLETED|Overall Study||0
488994|NCT01072331|1197748|P2|NOT COMPLETED|Overall Study||0
488995|NCT01072331|1197749|P1|NOT COMPLETED|Overall Study||0
488996|NCT01072331|1197747|P3|COMPLETED|Overall Study||32
488997|NCT01072331|1197748|P2|COMPLETED|Overall Study||33
488998|NCT01072331|1197749|P1|COMPLETED|Overall Study||34
488999|NCT01072331|1197747|P3|STARTED|Overall Study||32
489000|NCT01072331|1197748|P2|STARTED|Overall Study||33
489001|NCT01072331|1197749|P1|STARTED|Overall Study||34
489002|NCT01072201|1197768|P2|NOT COMPLETED|Overall Study||1
489003|NCT01072201|1197769|P1|NOT COMPLETED|Overall Study||0
489004|NCT01072201|1197768|P2|COMPLETED|Overall Study||29
489005|NCT01072201|1197769|P1|COMPLETED|Overall Study||30
489006|NCT01072201|1197768|P2|STARTED|Overall Study||30
489007|NCT01072201|1197769|P1|STARTED|Overall Study||30
489008|NCT01072188|1197781|P2|NOT COMPLETED|Overall Study||0
489009|NCT01072188|1197782|P1|NOT COMPLETED|Overall Study||0
489010|NCT01072188|1197781|P2|COMPLETED|Overall Study||23
489011|NCT01072188|1197782|P1|COMPLETED|Overall Study||22
489012|NCT01072188|1197781|P2|STARTED|Overall Study||23
489013|NCT01072188|1197782|P1|STARTED|Overall Study||22
489014|NCT01072175|1197802|P13|NOT COMPLETED|Part D (HPMC Capsules)||39
489015|NCT01072175|1197803|P12|NOT COMPLETED|Part D (HPMC Capsules)||43
489016|NCT01072175|1197804|P11|NOT COMPLETED|Part D (HPMC Capsules)||16
489017|NCT01072175|1197805|P10|NOT COMPLETED|Part D (HPMC Capsules)||12
489018|NCT01072175|1197806|P9|NOT COMPLETED|Part D (HPMC Capsules)||0
489019|NCT01072175|1197807|P8|NOT COMPLETED|Part D (HPMC Capsules)||0
489020|NCT01072175|1197808|P7|NOT COMPLETED|Part D (HPMC Capsules)||0
489021|NCT01072175|1197809|P6|NOT COMPLETED|Part D (HPMC Capsules)||0
489022|NCT01072175|1197810|P5|NOT COMPLETED|Part D (HPMC Capsules)||0
489023|NCT01072175|1197811|P4|NOT COMPLETED|Part D (HPMC Capsules)||0
489024|NCT01072175|1197812|P3|NOT COMPLETED|Part D (HPMC Capsules)||0
489025|NCT01072175|1197813|P2|NOT COMPLETED|Part D (HPMC Capsules)||0
489026|NCT01072175|1197814|P1|NOT COMPLETED|Part D (HPMC Capsules)||0
489027|NCT01072175|1197802|P13|COMPLETED|Part D (HPMC Capsules)||0
489028|NCT01072175|1197803|P12|COMPLETED|Part D (HPMC Capsules)||0
489029|NCT01072175|1197804|P11|COMPLETED|Part D (HPMC Capsules)||0
489030|NCT01072175|1197805|P10|COMPLETED|Part D (HPMC Capsules)||0
489031|NCT01072175|1197806|P9|COMPLETED|Part D (HPMC Capsules)||0
489032|NCT01072175|1197807|P8|COMPLETED|Part D (HPMC Capsules)||0
489033|NCT01072175|1197808|P7|COMPLETED|Part D (HPMC Capsules)||0
489034|NCT01072175|1197809|P6|COMPLETED|Part D (HPMC Capsules)||0
489035|NCT01072175|1197810|P5|COMPLETED|Part D (HPMC Capsules)||0
489036|NCT01072175|1197811|P4|COMPLETED|Part D (HPMC Capsules)||0
489037|NCT01072175|1197812|P3|COMPLETED|Part D (HPMC Capsules)||0
489038|NCT01072175|1197813|P2|COMPLETED|Part D (HPMC Capsules)||0
489039|NCT01072175|1197814|P1|COMPLETED|Part D (HPMC Capsules)||0
489040|NCT01072175|1197802|P13|Ongoing|Part D (HPMC Capsules)||34
489041|NCT01072175|1197803|P12|Ongoing|Part D (HPMC Capsules)||34
489042|NCT01072175|1197804|P11|Ongoing|Part D (HPMC Capsules)||12
489043|NCT01072175|1197805|P10|Ongoing|Part D (HPMC Capsules)||10
489044|NCT01072175|1197806|P9|Ongoing|Part D (HPMC Capsules)||0
489045|NCT01072175|1197807|P8|Ongoing|Part D (HPMC Capsules)||0
489046|NCT01072175|1197808|P7|Ongoing|Part D (HPMC Capsules)||0
489047|NCT01072175|1197809|P6|Ongoing|Part D (HPMC Capsules)||0
489048|NCT01072175|1197810|P5|Ongoing|Part D (HPMC Capsules)||0
489049|NCT01072175|1197811|P4|Ongoing|Part D (HPMC Capsules)||0
489050|NCT01072175|1197812|P3|Ongoing|Part D (HPMC Capsules)||0
489051|NCT01072175|1197813|P2|Ongoing|Part D (HPMC Capsules)||0
489052|NCT01072175|1197814|P1|Ongoing|Part D (HPMC Capsules)||0
489053|NCT01072175|1197802|P13|STARTED|Part D (HPMC Capsules)||39
489054|NCT01072175|1197803|P12|STARTED|Part D (HPMC Capsules)||43
489055|NCT01072175|1197804|P11|STARTED|Part D (HPMC Capsules)||16
489056|NCT01072175|1197805|P10|STARTED|Part D (HPMC Capsules)||12
489057|NCT01072175|1197806|P9|STARTED|Part D (HPMC Capsules)||0
489058|NCT01072175|1197807|P8|STARTED|Part D (HPMC Capsules)||0
489059|NCT01072175|1197808|P7|STARTED|Part D (HPMC Capsules)||0
489060|NCT01072175|1197809|P6|STARTED|Part D (HPMC Capsules)||0
489061|NCT01072175|1197810|P5|STARTED|Part D (HPMC Capsules)||0
489062|NCT01072175|1197811|P4|STARTED|Part D (HPMC Capsules)||0
489063|NCT01072175|1197812|P3|STARTED|Part D (HPMC Capsules)||0
489064|NCT01072175|1197813|P2|STARTED|Part D (HPMC Capsules)||0
489065|NCT01072175|1197814|P1|STARTED|Part D (HPMC Capsules)||0
489066|NCT01072175|1197802|P13|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
489067|NCT01072175|1197803|P12|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
489068|NCT01072175|1197804|P11|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
489069|NCT01072175|1197805|P10|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
489070|NCT01072175|1197806|P9|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||43
489071|NCT01072175|1197807|P8|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
489072|NCT01072175|1197808|P7|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
489073|NCT01072175|1197809|P6|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
489074|NCT01072175|1197810|P5|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
489075|NCT01072175|1197811|P4|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
489076|NCT01072175|1197812|P3|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
489077|NCT01072175|1197813|P2|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
489078|NCT01072175|1197814|P1|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
489079|NCT01072175|1197802|P13|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
489080|NCT01072175|1197803|P12|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
489081|NCT01072175|1197804|P11|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
489082|NCT01072175|1197805|P10|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
489083|NCT01072175|1197806|P9|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
489084|NCT01072175|1197807|P8|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
489085|NCT01072175|1197808|P7|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
489086|NCT01072175|1197809|P6|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
489087|NCT01072175|1197810|P5|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
489088|NCT01072175|1197811|P4|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
489089|NCT01072175|1197812|P3|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
489090|NCT01072175|1197813|P2|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
489091|NCT01072175|1197814|P1|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
489092|NCT01072175|1197802|P13|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
489093|NCT01072175|1197803|P12|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
489094|NCT01072175|1197804|P11|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
489095|NCT01072175|1197805|P10|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
489096|NCT01072175|1197806|P9|Ongoing|Part C (Phase II: Crossover Phase [CP])||28
489097|NCT01072175|1197807|P8|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
489098|NCT01072175|1197808|P7|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
489099|NCT01072175|1197809|P6|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
489100|NCT01072175|1197810|P5|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
489101|NCT01072175|1197811|P4|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
489102|NCT01072175|1197812|P3|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
489103|NCT01072175|1197813|P2|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
489104|NCT01072175|1197814|P1|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
489105|NCT01072175|1197802|P13|STARTED|Part C (Phase II: Crossover Phase [CP])||0
489106|NCT01072175|1197803|P12|STARTED|Part C (Phase II: Crossover Phase [CP])||0
489107|NCT01072175|1197804|P11|STARTED|Part C (Phase II: Crossover Phase [CP])||0
489108|NCT01072175|1197805|P10|STARTED|Part C (Phase II: Crossover Phase [CP])||0
489109|NCT01072175|1197806|P9|STARTED|Part C (Phase II: Crossover Phase [CP])||43
489110|NCT01072175|1197807|P8|STARTED|Part C (Phase II: Crossover Phase [CP])||0
489111|NCT01072175|1197808|P7|STARTED|Part C (Phase II: Crossover Phase [CP])||0
489112|NCT01072175|1197809|P6|STARTED|Part C (Phase II: Crossover Phase [CP])||0
489113|NCT01072175|1197810|P5|STARTED|Part C (Phase II: Crossover Phase [CP])||0
489114|NCT01072175|1197811|P4|STARTED|Part C (Phase II: Crossover Phase [CP])||0
489115|NCT01072175|1197812|P3|STARTED|Part C (Phase II: Crossover Phase [CP])||0
489116|NCT01072175|1197813|P2|STARTED|Part C (Phase II: Crossover Phase [CP])||0
489117|NCT01072175|1197814|P1|STARTED|Part C (Phase II: Crossover Phase [CP])||0
489118|NCT01072175|1197802|P13|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
489119|NCT01072175|1197803|P12|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
489120|NCT01072175|1197804|P11|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
489121|NCT01072175|1197805|P10|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
489122|NCT01072175|1197806|P9|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
489123|NCT01072175|1197807|P8|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
489124|NCT01072175|1197808|P7|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
489125|NCT01072175|1197809|P6|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
489126|NCT01072175|1197810|P5|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
489127|NCT01072175|1197811|P4|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
489128|NCT01072175|1197812|P3|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
489129|NCT01072175|1197813|P2|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
489130|NCT01072175|1197814|P1|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
489131|NCT01072175|1197802|P13|COMPLETED|Part C (Phase II: Randomized Phase)||0
489132|NCT01072175|1197803|P12|COMPLETED|Part C (Phase II: Randomized Phase)||0
489133|NCT01072175|1197804|P11|COMPLETED|Part C (Phase II: Randomized Phase)||0
489134|NCT01072175|1197805|P10|COMPLETED|Part C (Phase II: Randomized Phase)||0
489135|NCT01072175|1197806|P9|COMPLETED|Part C (Phase II: Randomized Phase)||0
489136|NCT01072175|1197807|P8|COMPLETED|Part C (Phase II: Randomized Phase)||0
489137|NCT01072175|1197808|P7|COMPLETED|Part C (Phase II: Randomized Phase)||0
489138|NCT01072175|1197809|P6|COMPLETED|Part C (Phase II: Randomized Phase)||0
489139|NCT01072175|1197810|P5|COMPLETED|Part C (Phase II: Randomized Phase)||0
489140|NCT01072175|1197811|P4|COMPLETED|Part C (Phase II: Randomized Phase)||0
489141|NCT01072175|1197812|P3|COMPLETED|Part C (Phase II: Randomized Phase)||0
489142|NCT01072175|1197813|P2|COMPLETED|Part C (Phase II: Randomized Phase)||0
489143|NCT01072175|1197814|P1|COMPLETED|Part C (Phase II: Randomized Phase)||0
489144|NCT01072175|1197802|P13|Ongoing|Part C (Phase II: Randomized Phase)||0
489145|NCT01072175|1197803|P12|Ongoing|Part C (Phase II: Randomized Phase)||0
489146|NCT01072175|1197804|P11|Ongoing|Part C (Phase II: Randomized Phase)||0
489147|NCT01072175|1197805|P10|Ongoing|Part C (Phase II: Randomized Phase)||0
489148|NCT01072175|1197806|P9|Ongoing|Part C (Phase II: Randomized Phase)||0
489149|NCT01072175|1197807|P8|Ongoing|Part C (Phase II: Randomized Phase)||40
489150|NCT01072175|1197808|P7|Ongoing|Part C (Phase II: Randomized Phase)||32
489151|NCT01072175|1197809|P6|Ongoing|Part C (Phase II: Randomized Phase)||35
489152|NCT01072175|1197810|P5|Ongoing|Part C (Phase II: Randomized Phase)||0
489153|NCT01072175|1197811|P4|Ongoing|Part C (Phase II: Randomized Phase)||0
489154|NCT01072175|1197812|P3|Ongoing|Part C (Phase II: Randomized Phase)||0
489155|NCT01072175|1197813|P2|Ongoing|Part C (Phase II: Randomized Phase)||0
489156|NCT01072175|1197814|P1|Ongoing|Part C (Phase II: Randomized Phase)||0
489157|NCT01072175|1197802|P13|STARTED|Part C (Phase II: Randomized Phase)||0
489158|NCT01072175|1197803|P12|STARTED|Part C (Phase II: Randomized Phase)||0
489159|NCT01072175|1197804|P11|STARTED|Part C (Phase II: Randomized Phase)||0
489160|NCT01072175|1197805|P10|STARTED|Part C (Phase II: Randomized Phase)||0
489161|NCT01072175|1197806|P9|STARTED|Part C (Phase II: Randomized Phase)||0
489162|NCT01072175|1197807|P8|STARTED|Part C (Phase II: Randomized Phase)||54
489163|NCT01072175|1197808|P7|STARTED|Part C (Phase II: Randomized Phase)||54
489164|NCT01072175|1197809|P6|STARTED|Part C (Phase II: Randomized Phase)||54
489165|NCT01072175|1197810|P5|STARTED|Part C (Phase II: Randomized Phase)||0
489166|NCT01072175|1197811|P4|STARTED|Part C (Phase II: Randomized Phase)||0
489167|NCT01072175|1197812|P3|STARTED|Part C (Phase II: Randomized Phase)||0
489168|NCT01072175|1197813|P2|STARTED|Part C (Phase II: Randomized Phase)||0
489169|NCT01072175|1197814|P1|STARTED|Part C (Phase II: Randomized Phase)||0
489245|NCT01072175|1197812|P3|COMPLETED|Part A (Drug-Drug Interaction)||0
489170|NCT01072175|1197802|P13|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
489171|NCT01072175|1197803|P12|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
489172|NCT01072175|1197804|P11|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
489173|NCT01072175|1197805|P10|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
489174|NCT01072175|1197806|P9|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
489175|NCT01072175|1197807|P8|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
489176|NCT01072175|1197808|P7|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
489177|NCT01072175|1197809|P6|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
489178|NCT01072175|1197810|P5|NOT COMPLETED|Part B (Dose Escalation and Expansion)||79
489179|NCT01072175|1197811|P4|NOT COMPLETED|Part B (Dose Escalation and Expansion)||27
489180|NCT01072175|1197812|P3|NOT COMPLETED|Part B (Dose Escalation and Expansion)||23
489181|NCT01072175|1197813|P2|NOT COMPLETED|Part B (Dose Escalation and Expansion)||6
489182|NCT01072175|1197814|P1|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
489183|NCT01072175|1197802|P13|COMPLETED|Part B (Dose Escalation and Expansion)||0
489184|NCT01072175|1197803|P12|COMPLETED|Part B (Dose Escalation and Expansion)||0
489185|NCT01072175|1197804|P11|COMPLETED|Part B (Dose Escalation and Expansion)||0
489186|NCT01072175|1197805|P10|COMPLETED|Part B (Dose Escalation and Expansion)||0
489187|NCT01072175|1197806|P9|COMPLETED|Part B (Dose Escalation and Expansion)||0
489188|NCT01072175|1197807|P8|COMPLETED|Part B (Dose Escalation and Expansion)||0
489189|NCT01072175|1197808|P7|COMPLETED|Part B (Dose Escalation and Expansion)||0
489190|NCT01072175|1197809|P6|COMPLETED|Part B (Dose Escalation and Expansion)||0
489191|NCT01072175|1197810|P5|COMPLETED|Part B (Dose Escalation and Expansion)||0
489192|NCT01072175|1197811|P4|COMPLETED|Part B (Dose Escalation and Expansion)||0
489193|NCT01072175|1197812|P3|COMPLETED|Part B (Dose Escalation and Expansion)||0
489194|NCT01072175|1197813|P2|COMPLETED|Part B (Dose Escalation and Expansion)||0
489195|NCT01072175|1197814|P1|COMPLETED|Part B (Dose Escalation and Expansion)||0
489196|NCT01072175|1197802|P13|Ongoing|Part B (Dose Escalation and Expansion)||0
489197|NCT01072175|1197803|P12|Ongoing|Part B (Dose Escalation and Expansion)||0
489198|NCT01072175|1197804|P11|Ongoing|Part B (Dose Escalation and Expansion)||0
489199|NCT01072175|1197805|P10|Ongoing|Part B (Dose Escalation and Expansion)||0
489200|NCT01072175|1197806|P9|Ongoing|Part B (Dose Escalation and Expansion)||0
489201|NCT01072175|1197807|P8|Ongoing|Part B (Dose Escalation and Expansion)||0
489202|NCT01072175|1197808|P7|Ongoing|Part B (Dose Escalation and Expansion)||0
489203|NCT01072175|1197809|P6|Ongoing|Part B (Dose Escalation and Expansion)||0
489204|NCT01072175|1197810|P5|Ongoing|Part B (Dose Escalation and Expansion)||28
489205|NCT01072175|1197811|P4|Ongoing|Part B (Dose Escalation and Expansion)||9
489206|NCT01072175|1197812|P3|Ongoing|Part B (Dose Escalation and Expansion)||10
489207|NCT01072175|1197813|P2|Ongoing|Part B (Dose Escalation and Expansion)||2
489208|NCT01072175|1197814|P1|Ongoing|Part B (Dose Escalation and Expansion)||0
489209|NCT01072175|1197802|P13|STARTED|Part B (Dose Escalation and Expansion)||0
489210|NCT01072175|1197803|P12|STARTED|Part B (Dose Escalation and Expansion)||0
489211|NCT01072175|1197804|P11|STARTED|Part B (Dose Escalation and Expansion)||0
489212|NCT01072175|1197805|P10|STARTED|Part B (Dose Escalation and Expansion)||0
489213|NCT01072175|1197806|P9|STARTED|Part B (Dose Escalation and Expansion)||0
489214|NCT01072175|1197807|P8|STARTED|Part B (Dose Escalation and Expansion)||0
489215|NCT01072175|1197808|P7|STARTED|Part B (Dose Escalation and Expansion)||0
489216|NCT01072175|1197809|P6|STARTED|Part B (Dose Escalation and Expansion)||0
489217|NCT01072175|1197810|P5|STARTED|Part B (Dose Escalation and Expansion)||79
489218|NCT01072175|1197811|P4|STARTED|Part B (Dose Escalation and Expansion)||27
489219|NCT01072175|1197812|P3|STARTED|Part B (Dose Escalation and Expansion)||23
489220|NCT01072175|1197813|P2|STARTED|Part B (Dose Escalation and Expansion)||6
489221|NCT01072175|1197814|P1|STARTED|Part B (Dose Escalation and Expansion)||0
489222|NCT01072175|1197802|P13|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
489223|NCT01072175|1197803|P12|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
489224|NCT01072175|1197804|P11|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
489225|NCT01072175|1197805|P10|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
489226|NCT01072175|1197806|P9|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
489227|NCT01072175|1197807|P8|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
489228|NCT01072175|1197808|P7|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
489229|NCT01072175|1197809|P6|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
489230|NCT01072175|1197810|P5|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
489231|NCT01072175|1197811|P4|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
489232|NCT01072175|1197812|P3|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
489233|NCT01072175|1197813|P2|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
489234|NCT01072175|1197814|P1|NOT COMPLETED|Part A (Drug-Drug Interaction)||8
489235|NCT01072175|1197802|P13|COMPLETED|Part A (Drug-Drug Interaction)||0
489236|NCT01072175|1197803|P12|COMPLETED|Part A (Drug-Drug Interaction)||0
489237|NCT01072175|1197804|P11|COMPLETED|Part A (Drug-Drug Interaction)||0
489238|NCT01072175|1197805|P10|COMPLETED|Part A (Drug-Drug Interaction)||0
489239|NCT01072175|1197806|P9|COMPLETED|Part A (Drug-Drug Interaction)||0
489240|NCT01072175|1197807|P8|COMPLETED|Part A (Drug-Drug Interaction)||0
489241|NCT01072175|1197808|P7|COMPLETED|Part A (Drug-Drug Interaction)||0
489242|NCT01072175|1197809|P6|COMPLETED|Part A (Drug-Drug Interaction)||0
489243|NCT01072175|1197810|P5|COMPLETED|Part A (Drug-Drug Interaction)||0
489244|NCT01072175|1197811|P4|COMPLETED|Part A (Drug-Drug Interaction)||0
489246|NCT01072175|1197813|P2|COMPLETED|Part A (Drug-Drug Interaction)||0
489247|NCT01072175|1197814|P1|COMPLETED|Part A (Drug-Drug Interaction)||0
489248|NCT01072175|1197802|P13|STARTED|Part A (Drug-Drug Interaction)||0
489249|NCT01072175|1197803|P12|STARTED|Part A (Drug-Drug Interaction)||0
489250|NCT01072175|1197804|P11|STARTED|Part A (Drug-Drug Interaction)||0
489251|NCT01072175|1197805|P10|STARTED|Part A (Drug-Drug Interaction)||0
489252|NCT01072175|1197806|P9|STARTED|Part A (Drug-Drug Interaction)||0
489253|NCT01072175|1197807|P8|STARTED|Part A (Drug-Drug Interaction)||0
489254|NCT01072175|1197808|P7|STARTED|Part A (Drug-Drug Interaction)||0
489255|NCT01072175|1197809|P6|STARTED|Part A (Drug-Drug Interaction)||0
489256|NCT01072175|1197810|P5|STARTED|Part A (Drug-Drug Interaction)||0
489257|NCT01072175|1197811|P4|STARTED|Part A (Drug-Drug Interaction)||0
489258|NCT01072175|1197812|P3|STARTED|Part A (Drug-Drug Interaction)||0
489259|NCT01072175|1197813|P2|STARTED|Part A (Drug-Drug Interaction)||0
489260|NCT01072175|1197814|P1|STARTED|Part A (Drug-Drug Interaction)||8
489261|NCT01072149|1197997|P18|NOT COMPLETED|Treatment Period 3 (28 Days)||0
489262|NCT01072149|1197998|P17|NOT COMPLETED|Treatment Period 3 (28 Days)||0
489263|NCT01072149|1197999|P16|NOT COMPLETED|Treatment Period 3 (28 Days)||0
489264|NCT01072149|1198000|P15|NOT COMPLETED|Treatment Period 3 (28 Days)||0
489265|NCT01072149|1198001|P14|NOT COMPLETED|Treatment Period 3 (28 Days)||1
489266|NCT01072149|1198002|P13|NOT COMPLETED|Treatment Period 3 (28 Days)||0
489267|NCT01072149|1198003|P12|NOT COMPLETED|Treatment Period 3 (28 Days)||0
489268|NCT01072149|1198004|P11|NOT COMPLETED|Treatment Period 3 (28 Days)||0
489269|NCT01072149|1198005|P10|NOT COMPLETED|Treatment Period 3 (28 Days)||0
489270|NCT01072149|1198006|P9|NOT COMPLETED|Treatment Period 3 (28 Days)||0
489271|NCT01072149|1198007|P8|NOT COMPLETED|Treatment Period 3 (28 Days)||0
489272|NCT01072149|1198008|P7|NOT COMPLETED|Treatment Period 3 (28 Days)||0
489273|NCT01072149|1198009|P6|NOT COMPLETED|Treatment Period 3 (28 Days)||0
489274|NCT01072149|1198010|P5|NOT COMPLETED|Treatment Period 3 (28 Days)||0
489275|NCT01072149|1198011|P4|NOT COMPLETED|Treatment Period 3 (28 Days)||0
489276|NCT01072149|1198012|P3|NOT COMPLETED|Treatment Period 3 (28 Days)||1
489277|NCT01072149|1198013|P2|NOT COMPLETED|Treatment Period 3 (28 Days)||0
489278|NCT01072149|1198014|P1|NOT COMPLETED|Treatment Period 3 (28 Days)||0
489279|NCT01072149|1197997|P18|COMPLETED|Treatment Period 3 (28 Days)||2
489280|NCT01072149|1197998|P17|COMPLETED|Treatment Period 3 (28 Days)||3
489281|NCT01072149|1197999|P16|COMPLETED|Treatment Period 3 (28 Days)||1
489282|NCT01072149|1198000|P15|COMPLETED|Treatment Period 3 (28 Days)||3
489283|NCT01072149|1198001|P14|COMPLETED|Treatment Period 3 (28 Days)||2
489284|NCT01072149|1198002|P13|COMPLETED|Treatment Period 3 (28 Days)||2
489285|NCT01072149|1198003|P12|COMPLETED|Treatment Period 3 (28 Days)||3
489286|NCT01072149|1198004|P11|COMPLETED|Treatment Period 3 (28 Days)||2
489287|NCT01072149|1198005|P10|COMPLETED|Treatment Period 3 (28 Days)||3
489288|NCT01072149|1198006|P9|COMPLETED|Treatment Period 3 (28 Days)||3
489289|NCT01072149|1198007|P8|COMPLETED|Treatment Period 3 (28 Days)||2
489290|NCT01072149|1198008|P7|COMPLETED|Treatment Period 3 (28 Days)||3
489291|NCT01072149|1198009|P6|COMPLETED|Treatment Period 3 (28 Days)||3
489292|NCT01072149|1198010|P5|COMPLETED|Treatment Period 3 (28 Days)||3
489293|NCT01072149|1198011|P4|COMPLETED|Treatment Period 3 (28 Days)||3
489294|NCT01072149|1198012|P3|COMPLETED|Treatment Period 3 (28 Days)||0
489295|NCT01072149|1198013|P2|COMPLETED|Treatment Period 3 (28 Days)||2
489296|NCT01072149|1198014|P1|COMPLETED|Treatment Period 3 (28 Days)||2
489297|NCT01072149|1197997|P18|STARTED|Treatment Period 3 (28 Days)||2
489298|NCT01072149|1197998|P17|STARTED|Treatment Period 3 (28 Days)||3
489299|NCT01072149|1197999|P16|STARTED|Treatment Period 3 (28 Days)||1
489300|NCT01072149|1198000|P15|STARTED|Treatment Period 3 (28 Days)||3
489301|NCT01072149|1198001|P14|STARTED|Treatment Period 3 (28 Days)||3
489302|NCT01072149|1198002|P13|STARTED|Treatment Period 3 (28 Days)||2
489303|NCT01072149|1198003|P12|STARTED|Treatment Period 3 (28 Days)||3
489304|NCT01072149|1198004|P11|STARTED|Treatment Period 3 (28 Days)||2
489305|NCT01072149|1198005|P10|STARTED|Treatment Period 3 (28 Days)||3
489306|NCT01072149|1198006|P9|STARTED|Treatment Period 3 (28 Days)||3
489307|NCT01072149|1198007|P8|STARTED|Treatment Period 3 (28 Days)||2
489308|NCT01072149|1198008|P7|STARTED|Treatment Period 3 (28 Days)||3
489309|NCT01072149|1198009|P6|STARTED|Treatment Period 3 (28 Days)||3
489310|NCT01072149|1198010|P5|STARTED|Treatment Period 3 (28 Days)||3
489311|NCT01072149|1198011|P4|STARTED|Treatment Period 3 (28 Days)||3
489312|NCT01072149|1198012|P3|STARTED|Treatment Period 3 (28 Days)||1
489313|NCT01072149|1198013|P2|STARTED|Treatment Period 3 (28 Days)||2
489314|NCT01072149|1198014|P1|STARTED|Treatment Period 3 (28 Days)||2
489315|NCT01072149|1197997|P18|NOT COMPLETED|Washout Period 2 (14 Days)||0
489316|NCT01072149|1197998|P17|NOT COMPLETED|Washout Period 2 (14 Days)||0
489317|NCT01072149|1197999|P16|NOT COMPLETED|Washout Period 2 (14 Days)||2
489318|NCT01072149|1198000|P15|NOT COMPLETED|Washout Period 2 (14 Days)||0
489319|NCT01072149|1198001|P14|NOT COMPLETED|Washout Period 2 (14 Days)||0
489320|NCT01072149|1198002|P13|NOT COMPLETED|Washout Period 2 (14 Days)||1
489321|NCT01072149|1198003|P12|NOT COMPLETED|Washout Period 2 (14 Days)||0
489322|NCT01072149|1198004|P11|NOT COMPLETED|Washout Period 2 (14 Days)||0
489323|NCT01072149|1198005|P10|NOT COMPLETED|Washout Period 2 (14 Days)||0
489324|NCT01072149|1198006|P9|NOT COMPLETED|Washout Period 2 (14 Days)||0
489325|NCT01072149|1198007|P8|NOT COMPLETED|Washout Period 2 (14 Days)||0
489326|NCT01072149|1198008|P7|NOT COMPLETED|Washout Period 2 (14 Days)||0
489327|NCT01072149|1198009|P6|NOT COMPLETED|Washout Period 2 (14 Days)||0
489328|NCT01072149|1198010|P5|NOT COMPLETED|Washout Period 2 (14 Days)||0
489329|NCT01072149|1198011|P4|NOT COMPLETED|Washout Period 2 (14 Days)||0
489330|NCT01072149|1198012|P3|NOT COMPLETED|Washout Period 2 (14 Days)||0
489331|NCT01072149|1198013|P2|NOT COMPLETED|Washout Period 2 (14 Days)||0
489332|NCT01072149|1198014|P1|NOT COMPLETED|Washout Period 2 (14 Days)||1
489333|NCT01072149|1197997|P18|COMPLETED|Washout Period 2 (14 Days)||2
489334|NCT01072149|1197998|P17|COMPLETED|Washout Period 2 (14 Days)||3
489335|NCT01072149|1197999|P16|COMPLETED|Washout Period 2 (14 Days)||1
489336|NCT01072149|1198000|P15|COMPLETED|Washout Period 2 (14 Days)||3
489337|NCT01072149|1198001|P14|COMPLETED|Washout Period 2 (14 Days)||3
489338|NCT01072149|1198002|P13|COMPLETED|Washout Period 2 (14 Days)||2
489339|NCT01072149|1198003|P12|COMPLETED|Washout Period 2 (14 Days)||3
489340|NCT01072149|1198004|P11|COMPLETED|Washout Period 2 (14 Days)||2
489341|NCT01072149|1198005|P10|COMPLETED|Washout Period 2 (14 Days)||3
489342|NCT01072149|1198006|P9|COMPLETED|Washout Period 2 (14 Days)||3
489343|NCT01072149|1198007|P8|COMPLETED|Washout Period 2 (14 Days)||2
489344|NCT01072149|1198008|P7|COMPLETED|Washout Period 2 (14 Days)||3
489345|NCT01072149|1198009|P6|COMPLETED|Washout Period 2 (14 Days)||3
489346|NCT01072149|1198010|P5|COMPLETED|Washout Period 2 (14 Days)||3
489347|NCT01072149|1198011|P4|COMPLETED|Washout Period 2 (14 Days)||3
489348|NCT01072149|1198012|P3|COMPLETED|Washout Period 2 (14 Days)||1
489349|NCT01072149|1198013|P2|COMPLETED|Washout Period 2 (14 Days)||2
489350|NCT01072149|1198014|P1|COMPLETED|Washout Period 2 (14 Days)||2
489351|NCT01072149|1197997|P18|STARTED|Washout Period 2 (14 Days)||2
489352|NCT01072149|1197998|P17|STARTED|Washout Period 2 (14 Days)||3
489353|NCT01072149|1197999|P16|STARTED|Washout Period 2 (14 Days)||3
489354|NCT01072149|1198000|P15|STARTED|Washout Period 2 (14 Days)||3
489355|NCT01072149|1198001|P14|STARTED|Washout Period 2 (14 Days)||3
489356|NCT01072149|1198002|P13|STARTED|Washout Period 2 (14 Days)||3
489357|NCT01072149|1198003|P12|STARTED|Washout Period 2 (14 Days)||3
489358|NCT01072149|1198004|P11|STARTED|Washout Period 2 (14 Days)||2
489359|NCT01072149|1198005|P10|STARTED|Washout Period 2 (14 Days)||3
489360|NCT01072149|1198006|P9|STARTED|Washout Period 2 (14 Days)||3
489361|NCT01072149|1198007|P8|STARTED|Washout Period 2 (14 Days)||2
489362|NCT01072149|1198008|P7|STARTED|Washout Period 2 (14 Days)||3
489363|NCT01072149|1198009|P6|STARTED|Washout Period 2 (14 Days)||3
489364|NCT01072149|1198010|P5|STARTED|Washout Period 2 (14 Days)||3
489365|NCT01072149|1198011|P4|STARTED|Washout Period 2 (14 Days)||3
489366|NCT01072149|1198012|P3|STARTED|Washout Period 2 (14 Days)||1
489367|NCT01072149|1198013|P2|STARTED|Washout Period 2 (14 Days)||2
489368|NCT01072149|1198014|P1|STARTED|Washout Period 2 (14 Days)||3
489369|NCT01072149|1197997|P18|NOT COMPLETED|Treatment Period 2 (28 Days)||0
489370|NCT01072149|1197998|P17|NOT COMPLETED|Treatment Period 2 (28 Days)||0
489371|NCT01072149|1197999|P16|NOT COMPLETED|Treatment Period 2 (28 Days)||0
489372|NCT01072149|1198000|P15|NOT COMPLETED|Treatment Period 2 (28 Days)||0
489373|NCT01072149|1198001|P14|NOT COMPLETED|Treatment Period 2 (28 Days)||0
489374|NCT01072149|1198002|P13|NOT COMPLETED|Treatment Period 2 (28 Days)||0
489375|NCT01072149|1198003|P12|NOT COMPLETED|Treatment Period 2 (28 Days)||0
489376|NCT01072149|1198004|P11|NOT COMPLETED|Treatment Period 2 (28 Days)||0
489377|NCT01072149|1198005|P10|NOT COMPLETED|Treatment Period 2 (28 Days)||0
489378|NCT01072149|1198006|P9|NOT COMPLETED|Treatment Period 2 (28 Days)||0
489379|NCT01072149|1198007|P8|NOT COMPLETED|Treatment Period 2 (28 Days)||1
489380|NCT01072149|1198008|P7|NOT COMPLETED|Treatment Period 2 (28 Days)||0
489381|NCT01072149|1198009|P6|NOT COMPLETED|Treatment Period 2 (28 Days)||0
489382|NCT01072149|1198010|P5|NOT COMPLETED|Treatment Period 2 (28 Days)||0
489383|NCT01072149|1198011|P4|NOT COMPLETED|Treatment Period 2 (28 Days)||0
489384|NCT01072149|1198012|P3|NOT COMPLETED|Treatment Period 2 (28 Days)||1
489385|NCT01072149|1198013|P2|NOT COMPLETED|Treatment Period 2 (28 Days)||1
489386|NCT01072149|1198014|P1|NOT COMPLETED|Treatment Period 2 (28 Days)||0
489387|NCT01072149|1197997|P18|COMPLETED|Treatment Period 2 (28 Days)||2
489388|NCT01072149|1197998|P17|COMPLETED|Treatment Period 2 (28 Days)||3
489389|NCT01072149|1197999|P16|COMPLETED|Treatment Period 2 (28 Days)||3
489390|NCT01072149|1198000|P15|COMPLETED|Treatment Period 2 (28 Days)||3
489391|NCT01072149|1198001|P14|COMPLETED|Treatment Period 2 (28 Days)||3
489392|NCT01072149|1198002|P13|COMPLETED|Treatment Period 2 (28 Days)||3
489393|NCT01072149|1198003|P12|COMPLETED|Treatment Period 2 (28 Days)||3
489394|NCT01072149|1198004|P11|COMPLETED|Treatment Period 2 (28 Days)||2
489395|NCT01072149|1198005|P10|COMPLETED|Treatment Period 2 (28 Days)||3
489396|NCT01072149|1198006|P9|COMPLETED|Treatment Period 2 (28 Days)||3
489397|NCT01072149|1198007|P8|COMPLETED|Treatment Period 2 (28 Days)||2
489398|NCT01072149|1198008|P7|COMPLETED|Treatment Period 2 (28 Days)||3
489399|NCT01072149|1198009|P6|COMPLETED|Treatment Period 2 (28 Days)||3
489400|NCT01072149|1198010|P5|COMPLETED|Treatment Period 2 (28 Days)||3
489401|NCT01072149|1198011|P4|COMPLETED|Treatment Period 2 (28 Days)||3
489402|NCT01072149|1198012|P3|COMPLETED|Treatment Period 2 (28 Days)||1
489403|NCT01072149|1198013|P2|COMPLETED|Treatment Period 2 (28 Days)||2
489404|NCT01072149|1198014|P1|COMPLETED|Treatment Period 2 (28 Days)||3
489405|NCT01072149|1197997|P18|STARTED|Treatment Period 2 (28 Days)||2
489406|NCT01072149|1197998|P17|STARTED|Treatment Period 2 (28 Days)||3
489407|NCT01072149|1197999|P16|STARTED|Treatment Period 2 (28 Days)||3
489408|NCT01072149|1198000|P15|STARTED|Treatment Period 2 (28 Days)||3
489409|NCT01072149|1198001|P14|STARTED|Treatment Period 2 (28 Days)||3
489410|NCT01072149|1198002|P13|STARTED|Treatment Period 2 (28 Days)||3
489411|NCT01072149|1198003|P12|STARTED|Treatment Period 2 (28 Days)||3
489412|NCT01072149|1198004|P11|STARTED|Treatment Period 2 (28 Days)||2
489413|NCT01072149|1198005|P10|STARTED|Treatment Period 2 (28 Days)||3
489414|NCT01072149|1198006|P9|STARTED|Treatment Period 2 (28 Days)||3
489415|NCT01072149|1198007|P8|STARTED|Treatment Period 2 (28 Days)||3
489416|NCT01072149|1198008|P7|STARTED|Treatment Period 2 (28 Days)||3
489417|NCT01072149|1198009|P6|STARTED|Treatment Period 2 (28 Days)||3
489418|NCT01072149|1198010|P5|STARTED|Treatment Period 2 (28 Days)||3
489419|NCT01072149|1198011|P4|STARTED|Treatment Period 2 (28 Days)||3
489420|NCT01072149|1198012|P3|STARTED|Treatment Period 2 (28 Days)||2
489421|NCT01072149|1198013|P2|STARTED|Treatment Period 2 (28 Days)||3
489422|NCT01072149|1198014|P1|STARTED|Treatment Period 2 (28 Days)||3
489423|NCT01072149|1197997|P18|NOT COMPLETED|Washout Period 1 (14 Days)||0
489424|NCT01072149|1197998|P17|NOT COMPLETED|Washout Period 1 (14 Days)||0
489425|NCT01072149|1197999|P16|NOT COMPLETED|Washout Period 1 (14 Days)||0
489426|NCT01072149|1198000|P15|NOT COMPLETED|Washout Period 1 (14 Days)||0
489427|NCT01072149|1198001|P14|NOT COMPLETED|Washout Period 1 (14 Days)||0
489428|NCT01072149|1198002|P13|NOT COMPLETED|Washout Period 1 (14 Days)||0
489429|NCT01072149|1198003|P12|NOT COMPLETED|Washout Period 1 (14 Days)||0
489430|NCT01072149|1198004|P11|NOT COMPLETED|Washout Period 1 (14 Days)||0
489431|NCT01072149|1198005|P10|NOT COMPLETED|Washout Period 1 (14 Days)||0
489432|NCT01072149|1198006|P9|NOT COMPLETED|Washout Period 1 (14 Days)||0
489433|NCT01072149|1198007|P8|NOT COMPLETED|Washout Period 1 (14 Days)||0
489434|NCT01072149|1198008|P7|NOT COMPLETED|Washout Period 1 (14 Days)||0
489435|NCT01072149|1198009|P6|NOT COMPLETED|Washout Period 1 (14 Days)||0
489436|NCT01072149|1198010|P5|NOT COMPLETED|Washout Period 1 (14 Days)||0
489437|NCT01072149|1198011|P4|NOT COMPLETED|Washout Period 1 (14 Days)||0
489438|NCT01072149|1198012|P3|NOT COMPLETED|Washout Period 1 (14 Days)||0
489439|NCT01072149|1198013|P2|NOT COMPLETED|Washout Period 1 (14 Days)||0
489440|NCT01072149|1198014|P1|NOT COMPLETED|Washout Period 1 (14 Days)||0
489441|NCT01072149|1197997|P18|COMPLETED|Washout Period 1 (14 Days)||2
489442|NCT01072149|1197998|P17|COMPLETED|Washout Period 1 (14 Days)||3
489443|NCT01072149|1197999|P16|COMPLETED|Washout Period 1 (14 Days)||3
489444|NCT01072149|1198000|P15|COMPLETED|Washout Period 1 (14 Days)||3
489445|NCT01072149|1198001|P14|COMPLETED|Washout Period 1 (14 Days)||3
489446|NCT01072149|1198002|P13|COMPLETED|Washout Period 1 (14 Days)||3
489447|NCT01072149|1198003|P12|COMPLETED|Washout Period 1 (14 Days)||3
489448|NCT01072149|1198004|P11|COMPLETED|Washout Period 1 (14 Days)||2
489449|NCT01072149|1198005|P10|COMPLETED|Washout Period 1 (14 Days)||3
489450|NCT01072149|1198006|P9|COMPLETED|Washout Period 1 (14 Days)||3
489451|NCT01072149|1198007|P8|COMPLETED|Washout Period 1 (14 Days)||3
489452|NCT01072149|1198008|P7|COMPLETED|Washout Period 1 (14 Days)||3
489453|NCT01072149|1198009|P6|COMPLETED|Washout Period 1 (14 Days)||3
489454|NCT01072149|1198010|P5|COMPLETED|Washout Period 1 (14 Days)||3
489455|NCT01072149|1198011|P4|COMPLETED|Washout Period 1 (14 Days)||3
489456|NCT01072149|1198012|P3|COMPLETED|Washout Period 1 (14 Days)||2
489457|NCT01072149|1198013|P2|COMPLETED|Washout Period 1 (14 Days)||3
489458|NCT01072149|1198014|P1|COMPLETED|Washout Period 1 (14 Days)||3
489459|NCT01072149|1197997|P18|STARTED|Washout Period 1 (14 Days)||2
489460|NCT01072149|1197998|P17|STARTED|Washout Period 1 (14 Days)||3
489461|NCT01072149|1197999|P16|STARTED|Washout Period 1 (14 Days)||3
489462|NCT01072149|1198000|P15|STARTED|Washout Period 1 (14 Days)||3
489463|NCT01072149|1198001|P14|STARTED|Washout Period 1 (14 Days)||3
489464|NCT01072149|1198002|P13|STARTED|Washout Period 1 (14 Days)||3
489465|NCT01072149|1198003|P12|STARTED|Washout Period 1 (14 Days)||3
489466|NCT01072149|1198004|P11|STARTED|Washout Period 1 (14 Days)||2
489467|NCT01072149|1198005|P10|STARTED|Washout Period 1 (14 Days)||3
489468|NCT01072149|1198006|P9|STARTED|Washout Period 1 (14 Days)||3
489469|NCT01072149|1198007|P8|STARTED|Washout Period 1 (14 Days)||3
489470|NCT01072149|1198008|P7|STARTED|Washout Period 1 (14 Days)||3
489471|NCT01072149|1198009|P6|STARTED|Washout Period 1 (14 Days)||3
489472|NCT01072149|1198010|P5|STARTED|Washout Period 1 (14 Days)||3
489473|NCT01072149|1198011|P4|STARTED|Washout Period 1 (14 Days)||3
489474|NCT01072149|1198012|P3|STARTED|Washout Period 1 (14 Days)||2
489475|NCT01072149|1198013|P2|STARTED|Washout Period 1 (14 Days)||3
489476|NCT01072149|1198014|P1|STARTED|Washout Period 1 (14 Days)||3
489477|NCT01072149|1197997|P18|NOT COMPLETED|Treatment Period 1 (28 Days)||1
489478|NCT01072149|1197998|P17|NOT COMPLETED|Treatment Period 1 (28 Days)||0
489479|NCT01072149|1197999|P16|NOT COMPLETED|Treatment Period 1 (28 Days)||0
489480|NCT01072149|1198000|P15|NOT COMPLETED|Treatment Period 1 (28 Days)||0
489481|NCT01072149|1198001|P14|NOT COMPLETED|Treatment Period 1 (28 Days)||0
489482|NCT01072149|1198002|P13|NOT COMPLETED|Treatment Period 1 (28 Days)||0
489483|NCT01072149|1198003|P12|NOT COMPLETED|Treatment Period 1 (28 Days)||0
489484|NCT01072149|1198004|P11|NOT COMPLETED|Treatment Period 1 (28 Days)||1
489485|NCT01072149|1198005|P10|NOT COMPLETED|Treatment Period 1 (28 Days)||0
489486|NCT01072149|1198006|P9|NOT COMPLETED|Treatment Period 1 (28 Days)||0
489487|NCT01072149|1198007|P8|NOT COMPLETED|Treatment Period 1 (28 Days)||0
489488|NCT01072149|1198008|P7|NOT COMPLETED|Treatment Period 1 (28 Days)||0
489489|NCT01072149|1198009|P6|NOT COMPLETED|Treatment Period 1 (28 Days)||0
489490|NCT01072149|1198010|P5|NOT COMPLETED|Treatment Period 1 (28 Days)||0
489491|NCT01072149|1198011|P4|NOT COMPLETED|Treatment Period 1 (28 Days)||0
489492|NCT01072149|1198012|P3|NOT COMPLETED|Treatment Period 1 (28 Days)||1
489493|NCT01072149|1198013|P2|NOT COMPLETED|Treatment Period 1 (28 Days)||0
489494|NCT01072149|1198014|P1|NOT COMPLETED|Treatment Period 1 (28 Days)||0
489495|NCT01072149|1197997|P18|COMPLETED|Treatment Period 1 (28 Days)||2
489496|NCT01072149|1197998|P17|COMPLETED|Treatment Period 1 (28 Days)||3
489497|NCT01072149|1197999|P16|COMPLETED|Treatment Period 1 (28 Days)||3
489498|NCT01072149|1198000|P15|COMPLETED|Treatment Period 1 (28 Days)||3
489499|NCT01072149|1198001|P14|COMPLETED|Treatment Period 1 (28 Days)||3
489500|NCT01072149|1198002|P13|COMPLETED|Treatment Period 1 (28 Days)||3
489501|NCT01072149|1198003|P12|COMPLETED|Treatment Period 1 (28 Days)||3
489502|NCT01072149|1198004|P11|COMPLETED|Treatment Period 1 (28 Days)||2
489503|NCT01072149|1198005|P10|COMPLETED|Treatment Period 1 (28 Days)||3
489504|NCT01072149|1198006|P9|COMPLETED|Treatment Period 1 (28 Days)||3
489505|NCT01072149|1198007|P8|COMPLETED|Treatment Period 1 (28 Days)||3
489506|NCT01072149|1198008|P7|COMPLETED|Treatment Period 1 (28 Days)||3
489507|NCT01072149|1198009|P6|COMPLETED|Treatment Period 1 (28 Days)||3
489508|NCT01072149|1198010|P5|COMPLETED|Treatment Period 1 (28 Days)||3
489509|NCT01072149|1198011|P4|COMPLETED|Treatment Period 1 (28 Days)||3
489510|NCT01072149|1198012|P3|COMPLETED|Treatment Period 1 (28 Days)||2
489511|NCT01072149|1198013|P2|COMPLETED|Treatment Period 1 (28 Days)||3
489512|NCT01072149|1198014|P1|COMPLETED|Treatment Period 1 (28 Days)||3
489513|NCT01072149|1197997|P18|STARTED|Treatment Period 1 (28 Days)||3
489514|NCT01072149|1197998|P17|STARTED|Treatment Period 1 (28 Days)||3
489515|NCT01072149|1197999|P16|STARTED|Treatment Period 1 (28 Days)||3
489516|NCT01072149|1198000|P15|STARTED|Treatment Period 1 (28 Days)||3
489517|NCT01072149|1198001|P14|STARTED|Treatment Period 1 (28 Days)||3
489518|NCT01072149|1198002|P13|STARTED|Treatment Period 1 (28 Days)||3
489519|NCT01072149|1198003|P12|STARTED|Treatment Period 1 (28 Days)||3
489520|NCT01072149|1198004|P11|STARTED|Treatment Period 1 (28 Days)||3
489521|NCT01072149|1198005|P10|STARTED|Treatment Period 1 (28 Days)||3
489522|NCT01072149|1198006|P9|STARTED|Treatment Period 1 (28 Days)||3
489523|NCT01072149|1198007|P8|STARTED|Treatment Period 1 (28 Days)||3
489524|NCT01072149|1198008|P7|STARTED|Treatment Period 1 (28 Days)||3
489525|NCT01072149|1198009|P6|STARTED|Treatment Period 1 (28 Days)||3
489526|NCT01072149|1198010|P5|STARTED|Treatment Period 1 (28 Days)||3
489527|NCT01072149|1198011|P4|STARTED|Treatment Period 1 (28 Days)||3
489528|NCT01072149|1198012|P3|STARTED|Treatment Period 1 (28 Days)||3
489529|NCT01072149|1198013|P2|STARTED|Treatment Period 1 (28 Days)||3
489530|NCT01072149|1198014|P1|STARTED|Treatment Period 1 (28 Days)||3
489531|NCT01072136|1198034|P2|NOT COMPLETED|Overall Study||31
489532|NCT01072136|1198035|P1|NOT COMPLETED|Overall Study||23
489533|NCT01072136|1198034|P2|COMPLETED|Overall Study||12
489534|NCT01072136|1198035|P1|COMPLETED|Overall Study||21
489535|NCT01072136|1198034|P2|Met All Enrollment Criteria|Overall Study||25
489536|NCT01072136|1198035|P1|Met All Enrollment Criteria|Overall Study|Some eligibility test results were not available until after randomization.|30
489537|NCT01072136|1198034|P2|STARTED|Overall Study||43
489538|NCT01072136|1198035|P1|STARTED|Overall Study||44
489539|NCT01072032|1198059|P2|NOT COMPLETED|Overall Study||9
489540|NCT01072032|1198060|P1|NOT COMPLETED|Overall Study||8
489541|NCT01072032|1198059|P2|COMPLETED|Overall Study||5
489542|NCT01072032|1198060|P1|COMPLETED|Overall Study||5
489543|NCT01072032|1198059|P2|STARTED|Overall Study||14
489544|NCT01072032|1198060|P1|STARTED|Overall Study||13
489545|NCT01072006|1198074|P4|NOT COMPLETED|Overall Study||0
489546|NCT01072006|1198075|P3|NOT COMPLETED|Overall Study||0
489547|NCT01072006|1198076|P2|NOT COMPLETED|Overall Study||0
489548|NCT01072006|1198077|P1|NOT COMPLETED|Overall Study||0
489549|NCT01072006|1198074|P4|COMPLETED|Overall Study||11
489550|NCT01072006|1198075|P3|COMPLETED|Overall Study||0
489551|NCT01072006|1198076|P2|COMPLETED|Overall Study||5
489552|NCT01072006|1198077|P1|COMPLETED|Overall Study||14
489553|NCT01072006|1198074|P4|STARTED|Overall Study||11
489554|NCT01072006|1198075|P3|STARTED|Overall Study||0
489555|NCT01072006|1198076|P2|STARTED|Overall Study||5
489556|NCT01072006|1198077|P1|STARTED|Overall Study||14
489557|NCT01071993|1198096|P2|NOT COMPLETED|Overall Study||0
489558|NCT01071993|1198097|P1|NOT COMPLETED|Overall Study||0
489559|NCT01071993|1198096|P2|COMPLETED|Overall Study||0
489560|NCT01071993|1198097|P1|COMPLETED|Overall Study||0
489561|NCT01071993|1198096|P2|STARTED|Overall Study||0
489562|NCT01071993|1198097|P1|STARTED|Overall Study||0
489563|NCT01071915|1198103|P1|NOT COMPLETED|Overall Study||9
489564|NCT01071915|1198103|P1|COMPLETED|Overall Study||148
489565|NCT01071915|1198103|P1|Safety Analysis Set|Overall Study||156
489566|NCT01071915|1198103|P1|Full Analysis Set (FAS)|Overall Study||155
489567|NCT01071915|1198103|P1|STARTED|Overall Study|Intention to Treat Analysis Set|157
489568|NCT01071798|1198113|P1|NOT COMPLETED|Subpopulation Who Received Two Cycles||15
489569|NCT01071798|1198113|P1|COMPLETED|Subpopulation Who Received Two Cycles||805
489570|NCT01071798|1198113|P1|Baseline and Safety Analysis Set|Subpopulation Who Received Two Cycles||820
489571|NCT01071798|1198113|P1|STARTED|Subpopulation Who Received Two Cycles||820
489572|NCT01071798|1198113|P1|NOT COMPLETED|Participants Who Received One Cycle||65
489573|NCT01071798|1198113|P1|COMPLETED|Participants Who Received One Cycle||1588
489574|NCT01071798|1198113|P1|Baseline and Safety Analysis Set|Participants Who Received One Cycle||1653
489575|NCT01071798|1198113|P1|STARTED|Participants Who Received One Cycle||1653
489576|NCT01071538|1198133|P1|NOT COMPLETED|Overall Study||2
489577|NCT01071538|1198133|P1|COMPLETED|Overall Study||13
489578|NCT01071538|1198133|P1|STARTED|Overall Study||15
489579|NCT01071512|1198143|P1|NOT COMPLETED|Overall Study||5
489580|NCT01071512|1198143|P1|COMPLETED|Overall Study||15
489581|NCT01071512|1198143|P1|STARTED|Overall Study||20
489582|NCT01071395|1198153|P2|NOT COMPLETED|Overall Study||2
489583|NCT01071395|1198154|P1|NOT COMPLETED|Overall Study||5
489584|NCT01071395|1198153|P2|COMPLETED|Overall Study||30
489585|NCT01071395|1198154|P1|COMPLETED|Overall Study||31
489586|NCT01071395|1198153|P2|STARTED|Overall Study||32
489587|NCT01071395|1198154|P1|STARTED|Overall Study||36
489588|NCT01071356|1198162|P2|NOT COMPLETED|Overall Study||9
489589|NCT01071356|1198163|P1|NOT COMPLETED|Overall Study||7
489590|NCT01071356|1198162|P2|COMPLETED|Overall Study||97
489591|NCT01071356|1198163|P1|COMPLETED|Overall Study||104
489592|NCT01071356|1198162|P2|STARTED|Overall Study||106
489593|NCT01071356|1198163|P1|STARTED|Overall Study||111
489594|NCT01071278|1198171|P1|NOT COMPLETED|Overall Study||713
489595|NCT01071278|1198171|P1|COMPLETED|Overall Study||1677
489596|NCT01071278|1198171|P1|STARTED|Overall Study||2390
489597|NCT01071252|1198182|P5|NOT COMPLETED|Overall Study||11
489598|NCT01071252|1198183|P4|NOT COMPLETED|Overall Study||7
489599|NCT01071252|1198184|P3|NOT COMPLETED|Overall Study||4
489600|NCT01071252|1198185|P2|NOT COMPLETED|Overall Study||10
489601|NCT01071252|1198186|P1|NOT COMPLETED|Overall Study||15
489602|NCT01071252|1198182|P5|COMPLETED|Overall Study||11
489603|NCT01071252|1198183|P4|COMPLETED|Overall Study||20
489604|NCT01071252|1198184|P3|COMPLETED|Overall Study||17
489605|NCT01071252|1198185|P2|COMPLETED|Overall Study||16
489606|NCT01071252|1198186|P1|COMPLETED|Overall Study||14
489607|NCT01071252|1198182|P5|STARTED|Overall Study||22
489608|NCT01071252|1198183|P4|STARTED|Overall Study||27
489609|NCT01071252|1198184|P3|STARTED|Overall Study||21
489610|NCT01071252|1198185|P2|STARTED|Overall Study||26
489611|NCT01071252|1198186|P1|STARTED|Overall Study||29
489612|NCT01071200|1198214|P2|NOT COMPLETED|Overall Study||3
489613|NCT01071200|1198215|P1|NOT COMPLETED|Overall Study||7
489614|NCT01071200|1198214|P2|COMPLETED|Overall Study||63
489615|NCT01071200|1198215|P1|COMPLETED|Overall Study||60
489616|NCT01071200|1198214|P2|STARTED|Overall Study||66
489617|NCT01071200|1198215|P1|STARTED|Overall Study||67
489618|NCT01071096|1198247|P2|NOT COMPLETED|Second Intervention (90 Days)||0
489619|NCT01071096|1198248|P1|NOT COMPLETED|Second Intervention (90 Days)||0
489620|NCT01071096|1198247|P2|COMPLETED|Second Intervention (90 Days)||10
489621|NCT01071096|1198248|P1|COMPLETED|Second Intervention (90 Days)||9
489622|NCT01071096|1198247|P2|STARTED|Second Intervention (90 Days)||10
489623|NCT01071096|1198248|P1|STARTED|Second Intervention (90 Days)||9
489624|NCT01071096|1198247|P2|NOT COMPLETED|Washout Period (30 Days)||0
489625|NCT01071096|1198248|P1|NOT COMPLETED|Washout Period (30 Days)||0
489626|NCT01071096|1198247|P2|COMPLETED|Washout Period (30 Days)||10
489627|NCT01071096|1198248|P1|COMPLETED|Washout Period (30 Days)||9
489628|NCT01071096|1198247|P2|STARTED|Washout Period (30 Days)||10
489629|NCT01071096|1198248|P1|STARTED|Washout Period (30 Days)||9
489630|NCT01071096|1198247|P2|NOT COMPLETED|First Intervention (90 Days)||0
489631|NCT01071096|1198248|P1|NOT COMPLETED|First Intervention (90 Days)||1
489632|NCT01071096|1198247|P2|COMPLETED|First Intervention (90 Days)||10
489633|NCT01071096|1198248|P1|COMPLETED|First Intervention (90 Days)||9
489634|NCT01071096|1198247|P2|STARTED|First Intervention (90 Days)||10
489635|NCT01071096|1198248|P1|STARTED|First Intervention (90 Days)||10
489636|NCT01071083|1198272|P5|NOT COMPLETED|Overall Study||8
489637|NCT01071083|1198273|P4|NOT COMPLETED|Overall Study||2
489638|NCT01071083|1198274|P3|NOT COMPLETED|Overall Study||5
489639|NCT01071083|1198275|P2|NOT COMPLETED|Overall Study||2
489640|NCT01071083|1198276|P1|NOT COMPLETED|Overall Study||7
489641|NCT01071083|1198272|P5|COMPLETED|Overall Study||46
489642|NCT01071083|1198273|P4|COMPLETED|Overall Study||15
489643|NCT01071083|1198274|P3|COMPLETED|Overall Study||12
489644|NCT01071083|1198275|P2|COMPLETED|Overall Study||43
489645|NCT01071083|1198276|P1|COMPLETED|Overall Study||35
489646|NCT01071083|1198272|P5|STARTED|Overall Study||54
489647|NCT01071083|1198273|P4|STARTED|Overall Study||17
489648|NCT01071083|1198274|P3|STARTED|Overall Study||17
489649|NCT01071083|1198275|P2|STARTED|Overall Study||45
489650|NCT01071083|1198276|P1|STARTED|Overall Study||42
489651|NCT01071070|1198295|P2|NOT COMPLETED|Overall Study||3
489652|NCT01071070|1198296|P1|NOT COMPLETED|Overall Study||4
489653|NCT01071070|1198295|P2|COMPLETED|Overall Study||105
489654|NCT01071070|1198296|P1|COMPLETED|Overall Study||104
489655|NCT01071070|1198295|P2|STARTED|Overall Study||108
489656|NCT01071070|1198296|P1|STARTED|Overall Study||108
489657|NCT01071044|1198320|P2|NOT COMPLETED|Overall Study||0
489658|NCT01071044|1198321|P1|NOT COMPLETED|Overall Study||2
489659|NCT01071044|1198320|P2|COMPLETED|Overall Study||11
489660|NCT01071044|1198321|P1|COMPLETED|Overall Study||13
489661|NCT01071044|1198320|P2|STARTED|Overall Study||11
489662|NCT01071044|1198321|P1|STARTED|Overall Study||15
489663|NCT01070979|1198342|P3|NOT COMPLETED|Overall Study||13
489664|NCT01070979|1198343|P2|NOT COMPLETED|Overall Study||12
489665|NCT01070979|1198344|P1|NOT COMPLETED|Overall Study||11
489666|NCT01070979|1198342|P3|COMPLETED|Overall Study||72
489667|NCT01070979|1198343|P2|COMPLETED|Overall Study||73
489668|NCT01070979|1198344|P1|COMPLETED|Overall Study||68
489669|NCT01070979|1198342|P3|STARTED|Overall Study||85
489670|NCT01070979|1198343|P2|STARTED|Overall Study||85
489671|NCT01070979|1198344|P1|STARTED|Overall Study||79
489672|NCT01070966|1198370|P1|NOT COMPLETED|Participants for Efficacy Evaluation||82
489673|NCT01070966|1198370|P1|COMPLETED|Participants for Efficacy Evaluation||1929
489674|NCT01070966|1198370|P1|STARTED|Participants for Efficacy Evaluation||2011
489675|NCT01070966|1198370|P1|NOT COMPLETED|Participants for Safety Evaluation||78
489676|NCT01070966|1198370|P1|COMPLETED|Participants for Safety Evaluation||2011
489677|NCT01070966|1198370|P1|STARTED|Participants for Safety Evaluation||2089
489678|NCT01070953|1198381|P1|NOT COMPLETED|Participants for Efficacy Evaluation||227
489679|NCT01070953|1198381|P1|COMPLETED|Participants for Efficacy Evaluation||3309
489680|NCT01070953|1198381|P1|STARTED|Participants for Efficacy Evaluation||3536
489681|NCT01070953|1198381|P1|NOT COMPLETED|Participants for Safety Evaluation||931
489682|NCT01070953|1198381|P1|COMPLETED|Participants for Safety Evaluation||3536
489683|NCT01070953|1198381|P1|STARTED|Participants for Safety Evaluation||4467
489684|NCT01070888|1198394|P2|NOT COMPLETED|Second Intervention (14 Days)||0
489685|NCT01070888|1198395|P1|NOT COMPLETED|Second Intervention (14 Days)||0
489686|NCT01070888|1198394|P2|COMPLETED|Second Intervention (14 Days)||2
489687|NCT01070888|1198395|P1|COMPLETED|Second Intervention (14 Days)||1
489688|NCT01070888|1198394|P2|STARTED|Second Intervention (14 Days)||2
489689|NCT01070888|1198395|P1|STARTED|Second Intervention (14 Days)||1
489690|NCT01070888|1198394|P2|NOT COMPLETED|Washout (14 Days)||0
489691|NCT01070888|1198395|P1|NOT COMPLETED|Washout (14 Days)||1
489692|NCT01070888|1198394|P2|COMPLETED|Washout (14 Days)||2
489693|NCT01070888|1198395|P1|COMPLETED|Washout (14 Days)||1
489694|NCT01070888|1198394|P2|STARTED|Washout (14 Days)||2
489695|NCT01070888|1198395|P1|STARTED|Washout (14 Days)||2
489696|NCT01070888|1198394|P2|NOT COMPLETED|First Intervention (14 Days)||2
489697|NCT01070888|1198395|P1|NOT COMPLETED|First Intervention (14 Days)||0
489698|NCT01070888|1198394|P2|COMPLETED|First Intervention (14 Days)||2
489699|NCT01070888|1198395|P1|COMPLETED|First Intervention (14 Days)||2
489700|NCT01070888|1198394|P2|STARTED|First Intervention (14 Days)||4
489701|NCT01070888|1198395|P1|STARTED|First Intervention (14 Days)||2
489702|NCT01070810|1198403|P2|NOT COMPLETED|Overall Study||0
489703|NCT01070810|1198404|P1|NOT COMPLETED|Overall Study||0
489704|NCT01070810|1198403|P2|COMPLETED|Overall Study||43
489705|NCT01070810|1198404|P1|COMPLETED|Overall Study||45
489706|NCT01070810|1198403|P2|STARTED|Overall Study||43
489707|NCT01070810|1198404|P1|STARTED|Overall Study||45
489708|NCT01070784|1198420|P2|NOT COMPLETED|Overall Study||18
489709|NCT01070784|1198421|P1|NOT COMPLETED|Overall Study||20
489710|NCT01070784|1198420|P2|COMPLETED|Overall Study||112
489711|NCT01070784|1198421|P1|COMPLETED|Overall Study||110
489712|NCT01070784|1198420|P2|STARTED|Overall Study||130
489713|NCT01070784|1198421|P1|STARTED|Overall Study||130
489714|NCT01070771|1198509|P1|NOT COMPLETED|Overall Study||3
489715|NCT01070771|1198509|P1|COMPLETED|Overall Study|August 2012|200
489716|NCT01070771|1198509|P1|STARTED|Overall Study|September 2008|203
489717|NCT01070693|1198516|P2|NOT COMPLETED|Overall Study||39
489718|NCT01070693|1198517|P1|NOT COMPLETED|Overall Study||28
489719|NCT01070693|1198516|P2|COMPLETED|Overall Study||110
489720|NCT01070693|1198517|P1|COMPLETED|Overall Study||122
489721|NCT01070693|1198516|P2|STARTED|Overall Study||149
489722|NCT01070693|1198517|P1|STARTED|Overall Study||150
489723|NCT01070550|1198529|P6|NOT COMPLETED|Overall Study||7
489724|NCT01070550|1198530|P5|NOT COMPLETED|Overall Study||1
489725|NCT01070550|1198531|P4|NOT COMPLETED|Overall Study||77
489726|NCT01070550|1198532|P3|NOT COMPLETED|Overall Study||216
489727|NCT01070550|1198533|P2|NOT COMPLETED|Overall Study||62
489728|NCT01070550|1198534|P1|NOT COMPLETED|Overall Study||1285
489729|NCT01070550|1198529|P6|COMPLETED|Overall Study||35
489730|NCT01070550|1198530|P5|COMPLETED|Overall Study||20
489731|NCT01070550|1198531|P4|COMPLETED|Overall Study||124
489732|NCT01070550|1198532|P3|COMPLETED|Overall Study||528
489733|NCT01070550|1198533|P2|COMPLETED|Overall Study||254
489734|NCT01070550|1198534|P1|COMPLETED|Overall Study||2071
489735|NCT01070550|1198529|P6|STARTED|Overall Study||42
489736|NCT01070550|1198530|P5|STARTED|Overall Study||21
489737|NCT01070550|1198531|P4|STARTED|Overall Study||201
489738|NCT01070550|1198532|P3|STARTED|Overall Study||744
489739|NCT01070550|1198533|P2|STARTED|Overall Study||316
489740|NCT01070550|1198534|P1|STARTED|Overall Study||3356
489741|NCT01070394|1198674|P1|NOT COMPLETED|Overall Study||7
489742|NCT01070394|1198674|P1|COMPLETED|Overall Study||33
489743|NCT01070394|1198674|P1|STARTED|Overall Study||40
489744|NCT01070381|1198685|P2|NOT COMPLETED|Period 2, 1 Week of Wear||1
489745|NCT01070381|1198686|P1|NOT COMPLETED|Period 2, 1 Week of Wear||1
489746|NCT01070381|1198685|P2|COMPLETED|Period 2, 1 Week of Wear||106
489747|NCT01070381|1198686|P1|COMPLETED|Period 2, 1 Week of Wear||108
489748|NCT01070381|1198685|P2|STARTED|Period 2, 1 Week of Wear||107
489749|NCT01070381|1198686|P1|STARTED|Period 2, 1 Week of Wear||109
489750|NCT01070381|1198685|P2|NOT COMPLETED|Period 1, 1 Week of Wear||0
489751|NCT01070381|1198686|P1|NOT COMPLETED|Period 1, 1 Week of Wear||0
489752|NCT01070381|1198685|P2|COMPLETED|Period 1, 1 Week of Wear||107
489753|NCT01070381|1198686|P1|COMPLETED|Period 1, 1 Week of Wear|One subject could not continue into Period 2 due to product unavailability.|109
489754|NCT01070381|1198685|P2|STARTED|Period 1, 1 Week of Wear||107
489755|NCT01070381|1198686|P1|STARTED|Period 1, 1 Week of Wear|One subject could not be dispensed into Period 1 product. Subject started Period 2 wear.|109
489756|NCT01070329|1198694|P2|NOT COMPLETED|Overall Study||49
489757|NCT01070329|1198695|P1|NOT COMPLETED|Overall Study||52
489758|NCT01070329|1198694|P2|COMPLETED|Overall Study||217
489759|NCT01070329|1198695|P1|COMPLETED|Overall Study||209
489760|NCT01070329|1198694|P2|STARTED|Overall Study||266
489761|NCT01070329|1198695|P1|STARTED|Overall Study||261
489762|NCT01070316|1198727|P1|NOT COMPLETED|Extension Phase||4
489763|NCT01070316|1198727|P1|COMPLETED|Extension Phase||14
489764|NCT01070316|1198727|P1|STARTED|Extension Phase|Two participants did not qualify for Extension Phase as defined by protocol|18
489765|NCT01070316|1198727|P1|NOT COMPLETED|Main Phase||0
489766|NCT01070316|1198727|P1|COMPLETED|Main Phase||20
489767|NCT01070316|1198727|P1|STARTED|Main Phase||20
489768|NCT01070303|1198734|P1|NOT COMPLETED|Overall Study||89
489769|NCT01070303|1198734|P1|COMPLETED|Overall Study||88
489770|NCT01070303|1198734|P1|STARTED|Overall Study||177
489771|NCT01070173|1198793|P3|NOT COMPLETED|Overall Study||0
489772|NCT01070173|1198794|P2|NOT COMPLETED|Overall Study||0
489773|NCT01070173|1198795|P1|NOT COMPLETED|Overall Study||0
489774|NCT01070173|1198793|P3|COMPLETED|Overall Study||11
489775|NCT01070173|1198794|P2|COMPLETED|Overall Study||8
489776|NCT01070173|1198795|P1|COMPLETED|Overall Study||33
489777|NCT01070173|1198793|P3|STARTED|Overall Study||11
489778|NCT01070173|1198794|P2|STARTED|Overall Study||8
489779|NCT01070173|1198795|P1|STARTED|Overall Study||33
489780|NCT01070043|1198808|P3|NOT COMPLETED|Double-Blind Treatment||2
489781|NCT01070043|1198809|P2|NOT COMPLETED|Double-Blind Treatment||0
489782|NCT01070043|1198810|P1|NOT COMPLETED|Double-Blind Treatment||0
489783|NCT01070043|1198808|P3|COMPLETED|Double-Blind Treatment||19
489784|NCT01070043|1198809|P2|COMPLETED|Double-Blind Treatment||21
489785|NCT01070043|1198810|P1|COMPLETED|Double-Blind Treatment||0
489786|NCT01070043|1198808|P3|STARTED|Double-Blind Treatment||21
489787|NCT01070043|1198809|P2|STARTED|Double-Blind Treatment||21
489788|NCT01070043|1198810|P1|STARTED|Double-Blind Treatment||0
489789|NCT01070043|1198808|P3|NOT COMPLETED|Run-In Phase||0
489790|NCT01070043|1198809|P2|NOT COMPLETED|Run-In Phase||0
489791|NCT01070043|1198810|P1|NOT COMPLETED|Run-In Phase||18
489792|NCT01070043|1198808|P3|COMPLETED|Run-In Phase||0
489793|NCT01070043|1198809|P2|COMPLETED|Run-In Phase||0
489794|NCT01070043|1198810|P1|COMPLETED|Run-In Phase||42
489795|NCT01070043|1198808|P3|STARTED|Run-In Phase|This monotherapy (Valsartan 160 mg) treatment arm is used only for double-blind phase.|0
489796|NCT01070043|1198809|P2|STARTED|Run-In Phase|This combination therapy arm is used only for double-blind phase.|0
489797|NCT01070043|1198810|P1|STARTED|Run-In Phase||60
489798|NCT01069939|1198826|P2|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||32
489799|NCT01069939|1198827|P1|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||31
489800|NCT01069939|1198826|P2|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182
489801|NCT01069939|1198827|P1|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182
489802|NCT01069939|1198826|P2|STARTED|At Data Cut Off Date (26 Feb 2011)||214
489803|NCT01069939|1198827|P1|STARTED|At Data Cut Off Date (26 Feb 2011)||213
489804|NCT01069939|1198826|P2|NOT COMPLETED|Randomised and Included in the Analyses||77
489805|NCT01069939|1198827|P1|NOT COMPLETED|Randomised and Included in the Analyses||49
489806|NCT01069939|1198826|P2|COMPLETED|Randomised and Included in the Analyses||137
489807|NCT01069939|1198827|P1|COMPLETED|Randomised and Included in the Analyses||164
489808|NCT01069939|1198826|P2|STARTED|Randomised and Included in the Analyses||214
489809|NCT01069939|1198827|P1|STARTED|Randomised and Included in the Analyses||213
489810|NCT01069900|1198853|P2|NOT COMPLETED|Overall Study||4
489811|NCT01069900|1198854|P1|NOT COMPLETED|Overall Study||18
489812|NCT01069900|1198853|P2|COMPLETED|Overall Study||149
489813|NCT01069900|1198854|P1|COMPLETED|Overall Study||287
489814|NCT01069900|1198853|P2|Treated|Overall Study||150
489815|NCT01069900|1198854|P1|Treated|Overall Study||301
489816|NCT01069900|1198853|P2|STARTED|Overall Study||153
489817|NCT01069900|1198854|P1|STARTED|Overall Study||305
489818|NCT01069861|1198898|P1|NOT COMPLETED|Overall Study||3
489819|NCT01069861|1198898|P1|COMPLETED|Overall Study||1
489820|NCT01069861|1198898|P1|STARTED|Overall Study||4
489821|NCT01069627|1198911|P1|NOT COMPLETED|Overall Study||20
489822|NCT01069627|1198911|P1|COMPLETED|Overall Study||0
489823|NCT01069627|1198911|P1|STARTED|Overall Study||20
489824|NCT01069562|1198934|P2|NOT COMPLETED|Overall Study||0
489825|NCT01069562|1198935|P1|NOT COMPLETED|Overall Study||0
489826|NCT01069562|1198934|P2|COMPLETED|Overall Study||20
489827|NCT01069562|1198935|P1|COMPLETED|Overall Study||20
489828|NCT01069562|1198934|P2|STARTED|Overall Study||20
489829|NCT01069562|1198935|P1|STARTED|Overall Study||20
489830|NCT01069523|1198961|P2|NOT COMPLETED|Overall Study||7
489831|NCT01069523|1198962|P1|NOT COMPLETED|Overall Study||4
489832|NCT01069523|1198961|P2|COMPLETED|Overall Study||9
489833|NCT01069523|1198962|P1|COMPLETED|Overall Study||9
489834|NCT01069523|1198961|P2|STARTED|Overall Study||16
489835|NCT01069523|1198962|P1|STARTED|Overall Study||13
489836|NCT01069484|1198972|P2|NOT COMPLETED|Overall Study||3
489837|NCT01069484|1198973|P1|NOT COMPLETED|Overall Study||12
489838|NCT01069484|1198972|P2|COMPLETED|Overall Study|27 in the stratum with major levator ani muscle defects and 58 in the stratum without such defects.|85
489839|NCT01069484|1198973|P1|COMPLETED|Overall Study|24 in the stratum with major levator ani muscle defects and 51 in the stratum without such defects.|75
489840|NCT01069484|1198972|P2|STARTED|Overall Study|28 in the stratum with major levator ani muscle defects and 60 in the stratum without such defects.|88
489841|NCT01069484|1198973|P1|STARTED|Overall Study|27 in the stratum with major levator ani muscle defects and 60 in the stratum without such defects.|87
489842|NCT01069419|1198981|P1|NOT COMPLETED|Overall Study||715
489843|NCT01069419|1198981|P1|COMPLETED|Overall Study||402
489844|NCT01069419|1198981|P1|Full Analysis Set|Overall Study||851
489845|NCT01069419|1198981|P1|Safety Set|Overall Study||1111
489846|NCT01069419|1198981|P1|STARTED|Overall Study||1117
489847|NCT01069354|1198988|P1|NOT COMPLETED|Overall Study||1
489848|NCT01069354|1198988|P1|COMPLETED|Overall Study|One subject's treatment fold not injected due to adverse event during control fold injection|101
489849|NCT01069354|1198988|P1|STARTED|Overall Study||102
489850|NCT01069341|1199010|P1|NOT COMPLETED|Overall Study||1
489851|NCT01069341|1199010|P1|COMPLETED|Overall Study||3
489852|NCT01069341|1199010|P1|STARTED|Overall Study||4
489853|NCT01069289|1199023|P2|NOT COMPLETED|Overall Study||56
489854|NCT01069289|1199024|P1|NOT COMPLETED|Overall Study||42
489855|NCT01069289|1199023|P2|COMPLETED|Overall Study||601
489856|NCT01069289|1199024|P1|COMPLETED|Overall Study||594
489857|NCT01069289|1199023|P2|STARTED|Overall Study||657
489858|NCT01069289|1199024|P1|STARTED|Overall Study||636
489859|NCT01069185|1199064|P2|NOT COMPLETED|Overall Study||0
489860|NCT01069185|1199065|P1|NOT COMPLETED|Overall Study||0
489861|NCT01069185|1199064|P2|COMPLETED|Overall Study||45
489862|NCT01069185|1199065|P1|COMPLETED|Overall Study||47
489863|NCT01069185|1199064|P2|STARTED|Overall Study||45
489864|NCT01069185|1199065|P1|STARTED|Overall Study||47
489865|NCT01069172|1199073|P2|NOT COMPLETED|Overall Study||0
489866|NCT01069172|1199074|P1|NOT COMPLETED|Overall Study||1
489867|NCT01069172|1199073|P2|COMPLETED|Overall Study|30 eyes|30
489868|NCT01069172|1199074|P1|COMPLETED|Overall Study|29 eyes|29
489869|NCT01069172|1199073|P2|STARTED|Overall Study|30 eyes|30
489870|NCT01069172|1199074|P1|STARTED|Overall Study|30 eyes|30
489871|NCT01069120|1199084|P1|NOT COMPLETED|Overall Study||27
489872|NCT01069120|1199084|P1|COMPLETED|Overall Study||0
489873|NCT01069120|1199084|P1|STARTED|Overall Study||27
489874|NCT01069003|1199093|P3|NOT COMPLETED|Overall Study||475
489875|NCT01069003|1199094|P2|NOT COMPLETED|Overall Study||54
489876|NCT01069003|1199095|P1|NOT COMPLETED|Overall Study||46
489877|NCT01069003|1199093|P3|COMPLETED|Overall Study||976
489878|NCT01069003|1199094|P2|COMPLETED|Overall Study||358
489879|NCT01069003|1199095|P1|COMPLETED|Overall Study||353
489880|NCT01069003|1199093|P3|STARTED|Overall Study||1451
489881|NCT01069003|1199094|P2|STARTED|Overall Study||412
489882|NCT01069003|1199095|P1|STARTED|Overall Study||399
489883|NCT01068964|1199111|P2|NOT COMPLETED|Overall Study||10
489884|NCT01068964|1199112|P1|NOT COMPLETED|Overall Study||8
489885|NCT01068964|1199111|P2|COMPLETED|Overall Study||104
489886|NCT01068964|1199112|P1|COMPLETED|Overall Study||113
489887|NCT01068964|1199111|P2|STARTED|Overall Study||114
489888|NCT01068964|1199112|P1|STARTED|Overall Study||121
489889|NCT01068912|1199121|P3|NOT COMPLETED|Overall Study||15
489890|NCT01068912|1199122|P2|NOT COMPLETED|Overall Study||22
489891|NCT01068912|1199123|P1|NOT COMPLETED|Overall Study||11
489892|NCT01068912|1199121|P3|COMPLETED|Overall Study||186
489893|NCT01068912|1199122|P2|COMPLETED|Overall Study||173
489894|NCT01068912|1199123|P1|COMPLETED|Overall Study||123
489895|NCT01068912|1199121|P3|STARTED|Overall Study||201
489896|NCT01068912|1199122|P2|STARTED|Overall Study||195
489897|NCT01068912|1199123|P1|STARTED|Overall Study||134
489898|NCT01068860|1199141|P10|NOT COMPLETED|Overall Study||4
489899|NCT01068860|1199142|P9|NOT COMPLETED|Overall Study||0
489900|NCT01068860|1199143|P8|NOT COMPLETED|Overall Study||0
489901|NCT01068860|1199144|P7|NOT COMPLETED|Overall Study||0
489902|NCT01068860|1199145|P6|NOT COMPLETED|Overall Study||2
489903|NCT01068860|1199146|P5|NOT COMPLETED|Overall Study||0
489904|NCT01068860|1199147|P4|NOT COMPLETED|Overall Study||1
489905|NCT01068860|1199148|P3|NOT COMPLETED|Overall Study||0
489906|NCT01068860|1199149|P2|NOT COMPLETED|Overall Study||1
489907|NCT01068860|1199150|P1|NOT COMPLETED|Overall Study||0
489908|NCT01068860|1199141|P10|COMPLETED|Overall Study||23
489909|NCT01068860|1199142|P9|COMPLETED|Overall Study||28
489910|NCT01068860|1199143|P8|COMPLETED|Overall Study||15
489911|NCT01068860|1199144|P7|COMPLETED|Overall Study||28
489912|NCT01068860|1199145|P6|COMPLETED|Overall Study||14
489913|NCT01068860|1199146|P5|COMPLETED|Overall Study||32
489914|NCT01068860|1199147|P4|COMPLETED|Overall Study||16
489915|NCT01068860|1199148|P3|COMPLETED|Overall Study||33
489916|NCT01068860|1199149|P2|COMPLETED|Overall Study||16
489917|NCT01068860|1199150|P1|COMPLETED|Overall Study||33
489918|NCT01068860|1199141|P10|STARTED|Overall Study||27
489919|NCT01068860|1199142|P9|STARTED|Overall Study||28
489920|NCT01068860|1199143|P8|STARTED|Overall Study||15
489921|NCT01068860|1199144|P7|STARTED|Overall Study||28
489922|NCT01068860|1199145|P6|STARTED|Overall Study||16
489923|NCT01068860|1199146|P5|STARTED|Overall Study||32
489924|NCT01068860|1199147|P4|STARTED|Overall Study||17
489925|NCT01068860|1199148|P3|STARTED|Overall Study||33
489926|NCT01068860|1199149|P2|STARTED|Overall Study||17
489927|NCT01068860|1199150|P1|STARTED|Overall Study||33
489928|NCT01068821|1199324|P2|NOT COMPLETED|Overall Study||0
489929|NCT01068821|1199325|P1|NOT COMPLETED|Overall Study||1
489930|NCT01068821|1199324|P2|COMPLETED|Overall Study||29
489931|NCT01068821|1199325|P1|COMPLETED|Overall Study|1 patient had slide measured, but her patient ID not listed; couldn't do postoperative followup.|30
489932|NCT01068821|1199324|P2|STARTED|Overall Study||29
489933|NCT01068821|1199325|P1|STARTED|Overall Study||31
489934|NCT01068769|1199333|P1|NOT COMPLETED|Overall Study||1
489935|NCT01068769|1199333|P1|COMPLETED|Overall Study||33
489936|NCT01068769|1199333|P1|STARTED|Overall Study||34
489937|NCT01068743|1199338|P4|NOT COMPLETED|Period 4||0
489938|NCT01068743|1199339|P3|NOT COMPLETED|Period 4||0
489939|NCT01068743|1199340|P2|NOT COMPLETED|Period 4||0
489940|NCT01068743|1199341|P1|NOT COMPLETED|Period 4||0
489941|NCT01068743|1199338|P4|COMPLETED|Period 4||6
489942|NCT01068743|1199339|P3|COMPLETED|Period 4||6
489943|NCT01068743|1199340|P2|COMPLETED|Period 4||5
489944|NCT01068743|1199341|P1|COMPLETED|Period 4||6
489945|NCT01068743|1199338|P4|STARTED|Period 4||6
489946|NCT01068743|1199339|P3|STARTED|Period 4||6
489947|NCT01068743|1199340|P2|STARTED|Period 4||5
489948|NCT01068743|1199341|P1|STARTED|Period 4||6
489949|NCT01068743|1199338|P4|NOT COMPLETED|Period 3||0
489950|NCT01068743|1199339|P3|NOT COMPLETED|Period 3||0
489951|NCT01068743|1199340|P2|NOT COMPLETED|Period 3||1
489952|NCT01068743|1199341|P1|NOT COMPLETED|Period 3||0
489953|NCT01068743|1199338|P4|COMPLETED|Period 3||6
489954|NCT01068743|1199339|P3|COMPLETED|Period 3||6
489955|NCT01068743|1199340|P2|COMPLETED|Period 3||5
489956|NCT01068743|1199341|P1|COMPLETED|Period 3||6
489957|NCT01068743|1199338|P4|STARTED|Period 3||6
489958|NCT01068743|1199339|P3|STARTED|Period 3||6
489959|NCT01068743|1199340|P2|STARTED|Period 3||6
489960|NCT01068743|1199341|P1|STARTED|Period 3||6
489961|NCT01068743|1199338|P4|NOT COMPLETED|Period 2||0
489962|NCT01068743|1199339|P3|NOT COMPLETED|Period 2||0
489963|NCT01068743|1199340|P2|NOT COMPLETED|Period 2||0
489964|NCT01068743|1199341|P1|NOT COMPLETED|Period 2||0
489965|NCT01068743|1199338|P4|COMPLETED|Period 2||6
489966|NCT01068743|1199339|P3|COMPLETED|Period 2||6
489967|NCT01068743|1199340|P2|COMPLETED|Period 2||6
489968|NCT01068743|1199341|P1|COMPLETED|Period 2||6
489969|NCT01068743|1199338|P4|STARTED|Period 2||6
489970|NCT01068743|1199339|P3|STARTED|Period 2||6
489971|NCT01068743|1199340|P2|STARTED|Period 2||6
489972|NCT01068743|1199341|P1|STARTED|Period 2||6
489973|NCT01068743|1199338|P4|NOT COMPLETED|Period 1||0
489974|NCT01068743|1199339|P3|NOT COMPLETED|Period 1||0
489975|NCT01068743|1199340|P2|NOT COMPLETED|Period 1||0
489976|NCT01068743|1199341|P1|NOT COMPLETED|Period 1||0
489977|NCT01068743|1199338|P4|COMPLETED|Period 1||6
489978|NCT01068743|1199339|P3|COMPLETED|Period 1||6
489979|NCT01068743|1199340|P2|COMPLETED|Period 1||6
489980|NCT01068743|1199341|P1|COMPLETED|Period 1||6
489981|NCT01068743|1199338|P4|STARTED|Period 1||6
489982|NCT01068743|1199339|P3|STARTED|Period 1||6
489983|NCT01068743|1199340|P2|STARTED|Period 1||6
489984|NCT01068743|1199341|P1|STARTED|Period 1||6
489985|NCT01068730|1199415|P4|NOT COMPLETED|Period 4||0
489986|NCT01068730|1199416|P3|NOT COMPLETED|Period 4||0
489987|NCT01068730|1199417|P2|NOT COMPLETED|Period 4||1
489988|NCT01068730|1199418|P1|NOT COMPLETED|Period 4||0
489989|NCT01068730|1199415|P4|COMPLETED|Period 4||7
489990|NCT01068730|1199416|P3|COMPLETED|Period 4||7
489991|NCT01068730|1199417|P2|COMPLETED|Period 4||6
489992|NCT01068730|1199418|P1|COMPLETED|Period 4||6
489993|NCT01068730|1199415|P4|STARTED|Period 4||7
489994|NCT01068730|1199416|P3|STARTED|Period 4||7
489995|NCT01068730|1199417|P2|STARTED|Period 4||7
489996|NCT01068730|1199418|P1|STARTED|Period 4||6
489997|NCT01068730|1199415|P4|NOT COMPLETED|Period 3||0
489998|NCT01068730|1199416|P3|NOT COMPLETED|Period 3||0
489999|NCT01068730|1199417|P2|NOT COMPLETED|Period 3||0
490000|NCT01068730|1199418|P1|NOT COMPLETED|Period 3||1
490001|NCT01068730|1199415|P4|COMPLETED|Period 3||7
490002|NCT01068730|1199416|P3|COMPLETED|Period 3||7
490003|NCT01068730|1199417|P2|COMPLETED|Period 3||7
490004|NCT01068730|1199418|P1|COMPLETED|Period 3||6
490005|NCT01068730|1199415|P4|STARTED|Period 3||7
490006|NCT01068730|1199416|P3|STARTED|Period 3||7
490007|NCT01068730|1199417|P2|STARTED|Period 3||7
490008|NCT01068730|1199418|P1|STARTED|Period 3||7
490009|NCT01068730|1199415|P4|NOT COMPLETED|Period 2||0
490010|NCT01068730|1199416|P3|NOT COMPLETED|Period 2||0
490011|NCT01068730|1199417|P2|NOT COMPLETED|Period 2||0
490012|NCT01068730|1199418|P1|NOT COMPLETED|Period 2||0
490013|NCT01068730|1199415|P4|COMPLETED|Period 2||7
490014|NCT01068730|1199416|P3|COMPLETED|Period 2||7
490015|NCT01068730|1199417|P2|COMPLETED|Period 2||7
490016|NCT01068730|1199418|P1|COMPLETED|Period 2||7
490017|NCT01068730|1199415|P4|STARTED|Period 2||7
490018|NCT01068730|1199416|P3|STARTED|Period 2||7
490019|NCT01068730|1199417|P2|STARTED|Period 2||7
490020|NCT01068730|1199418|P1|STARTED|Period 2||7
490021|NCT01068730|1199415|P4|NOT COMPLETED|Period 1||0
490022|NCT01068730|1199416|P3|NOT COMPLETED|Period 1||0
490023|NCT01068730|1199417|P2|NOT COMPLETED|Period 1||0
490024|NCT01068730|1199418|P1|NOT COMPLETED|Period 1||0
490025|NCT01068730|1199415|P4|COMPLETED|Period 1||7
490026|NCT01068730|1199416|P3|COMPLETED|Period 1||7
490027|NCT01068730|1199417|P2|COMPLETED|Period 1||7
490028|NCT01068730|1199418|P1|COMPLETED|Period 1||7
490029|NCT01068730|1199415|P4|STARTED|Period 1||7
490030|NCT01068730|1199416|P3|STARTED|Period 1||7
490031|NCT01068730|1199417|P2|STARTED|Period 1||7
490032|NCT01068730|1199418|P1|STARTED|Period 1||7
490033|NCT01068717|1199472|P4|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
490034|NCT01068717|1199473|P3|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
490035|NCT01068717|1199474|P2|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
490036|NCT01068717|1199475|P1|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
490037|NCT01068717|1199472|P4|COMPLETED|Period 4: Treatment Schedule Phase 4||7
490038|NCT01068717|1199473|P3|COMPLETED|Period 4: Treatment Schedule Phase 4||7
490039|NCT01068717|1199474|P2|COMPLETED|Period 4: Treatment Schedule Phase 4||6
490040|NCT01068717|1199475|P1|COMPLETED|Period 4: Treatment Schedule Phase 4||7
490041|NCT01068717|1199472|P4|STARTED|Period 4: Treatment Schedule Phase 4||7
490042|NCT01068717|1199473|P3|STARTED|Period 4: Treatment Schedule Phase 4||7
490043|NCT01068717|1199474|P2|STARTED|Period 4: Treatment Schedule Phase 4||6
490044|NCT01068717|1199475|P1|STARTED|Period 4: Treatment Schedule Phase 4|Patient who withdrew during Treatment Period 1 returned for Treatment Periods 3 and 4.|7
490045|NCT01068717|1199472|P4|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
490046|NCT01068717|1199473|P3|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
490047|NCT01068717|1199474|P2|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
490048|NCT01068717|1199475|P1|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
490049|NCT01068717|1199472|P4|COMPLETED|Period 3: Treatment Schedule Phase 3||7
490050|NCT01068717|1199473|P3|COMPLETED|Period 3: Treatment Schedule Phase 3||7
490051|NCT01068717|1199474|P2|COMPLETED|Period 3: Treatment Schedule Phase 3||6
490052|NCT01068717|1199475|P1|COMPLETED|Period 3: Treatment Schedule Phase 3||7
490053|NCT01068717|1199472|P4|STARTED|Period 3: Treatment Schedule Phase 3||7
490054|NCT01068717|1199473|P3|STARTED|Period 3: Treatment Schedule Phase 3||7
490055|NCT01068717|1199474|P2|STARTED|Period 3: Treatment Schedule Phase 3||6
490056|NCT01068717|1199475|P1|STARTED|Period 3: Treatment Schedule Phase 3|Patient who withdrew during Treatment Period 1 returned for Treatment Periods 3 and 4.|7
490057|NCT01068717|1199472|P4|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
490058|NCT01068717|1199473|P3|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
490059|NCT01068717|1199474|P2|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
490060|NCT01068717|1199475|P1|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
490061|NCT01068717|1199472|P4|COMPLETED|Period 2: Treatment Schedule Phase 2||7
490062|NCT01068717|1199473|P3|COMPLETED|Period 2: Treatment Schedule Phase 2||7
490063|NCT01068717|1199474|P2|COMPLETED|Period 2: Treatment Schedule Phase 2||6
490064|NCT01068717|1199475|P1|COMPLETED|Period 2: Treatment Schedule Phase 2||6
490065|NCT01068717|1199472|P4|STARTED|Period 2: Treatment Schedule Phase 2||7
490066|NCT01068717|1199473|P3|STARTED|Period 2: Treatment Schedule Phase 2||7
490067|NCT01068717|1199474|P2|STARTED|Period 2: Treatment Schedule Phase 2||6
490068|NCT01068717|1199475|P1|STARTED|Period 2: Treatment Schedule Phase 2||6
490069|NCT01068717|1199472|P4|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
490070|NCT01068717|1199473|P3|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
490071|NCT01068717|1199474|P2|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
490072|NCT01068717|1199475|P1|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||1
490073|NCT01068717|1199472|P4|COMPLETED|Period 1: Treatment Schedule Phase 1||7
490074|NCT01068717|1199473|P3|COMPLETED|Period 1: Treatment Schedule Phase 1||7
490075|NCT01068717|1199474|P2|COMPLETED|Period 1: Treatment Schedule Phase 1||6
490076|NCT01068717|1199475|P1|COMPLETED|Period 1: Treatment Schedule Phase 1|Patient who withdrew returned for Treatment Periods 3 and 4.|6
490077|NCT01068717|1199472|P4|STARTED|Period 1: Treatment Schedule Phase 1||7
490078|NCT01068717|1199473|P3|STARTED|Period 1: Treatment Schedule Phase 1||7
490079|NCT01068717|1199474|P2|STARTED|Period 1: Treatment Schedule Phase 1||6
490080|NCT01068717|1199475|P1|STARTED|Period 1: Treatment Schedule Phase 1||7
490081|NCT01068678|1199531|P2|NOT COMPLETED|Overall Study||24
490082|NCT01068678|1199532|P1|NOT COMPLETED|Overall Study||38
490083|NCT01068678|1199531|P2|COMPLETED|Overall Study||206
490084|NCT01068678|1199532|P1|COMPLETED|Overall Study||192
490085|NCT01068678|1199531|P2|Exposed|Overall Study|one subject withdrew prior to exposure to trial product|229
490086|NCT01068678|1199532|P1|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial product.|227
490087|NCT01068678|1199531|P2|STARTED|Overall Study||230
490088|NCT01068678|1199532|P1|STARTED|Overall Study||230
490089|NCT01068665|1199542|P2|NOT COMPLETED|Overall Study||29
490090|NCT01068665|1199543|P1|NOT COMPLETED|Overall Study||30
490091|NCT01068665|1199542|P2|COMPLETED|Overall Study||201
490092|NCT01068665|1199543|P1|COMPLETED|Overall Study||200
490093|NCT01068665|1199542|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug.|228
490094|NCT01068665|1199543|P1|Exposed|Overall Study||228
490095|NCT01068665|1199542|P2|Full Analysis Set|Overall Study|One subject was withdrawn because the subject was randomised in error.|229
490096|NCT01068665|1199543|P1|Full Analysis Set|Overall Study|Two subjects were withdrawn because the subjects were randomised in error.|228
490097|NCT01068665|1199542|P2|STARTED|Overall Study||230
490098|NCT01068665|1199543|P1|STARTED|Overall Study||230
490099|NCT01068652|1199553|P2|NOT COMPLETED|Overall Study||15
490100|NCT01068652|1199554|P1|NOT COMPLETED|Overall Study||18
490101|NCT01068652|1199553|P2|COMPLETED|Overall Study||188
490102|NCT01068652|1199554|P1|COMPLETED|Overall Study||182
490103|NCT01068652|1199553|P2|STARTED|Overall Study||203
490104|NCT01068652|1199554|P1|STARTED|Overall Study||200
490105|NCT01068626|1199594|P2|NOT COMPLETED|Overall Study||2
490106|NCT01068626|1199595|P1|NOT COMPLETED|Overall Study||3
490107|NCT01068626|1199594|P2|COMPLETED|Overall Study||27
490108|NCT01068626|1199595|P1|COMPLETED|Overall Study||27
490109|NCT01068626|1199594|P2|STARTED|Overall Study||29
490110|NCT01068626|1199595|P1|STARTED|Overall Study||30
490111|NCT01068600|1199613|P2|NOT COMPLETED|Overall Study||17
490112|NCT01068600|1199614|P1|NOT COMPLETED|Overall Study||11
490113|NCT01068600|1199613|P2|COMPLETED|Overall Study||142
490114|NCT01068600|1199614|P1|COMPLETED|Overall Study||148
490115|NCT01068600|1199613|P2|STARTED|Overall Study||159
490116|NCT01068600|1199614|P1|STARTED|Overall Study||159
490117|NCT01068548|1199624|P2|NOT COMPLETED|Overall Study||0
490118|NCT01068548|1199625|P1|NOT COMPLETED|Overall Study||0
490119|NCT01068548|1199624|P2|COMPLETED|Overall Study||63
490120|NCT01068548|1199625|P1|COMPLETED|Overall Study||66
490121|NCT01068548|1199624|P2|STARTED|Overall Study||63
490122|NCT01068548|1199625|P1|STARTED|Overall Study||66
490123|NCT01068509|1199634|P3|NOT COMPLETED|Overall Study||21
490124|NCT01068509|1199635|P2|NOT COMPLETED|Overall Study||22
490125|NCT01068509|1199636|P1|NOT COMPLETED|Overall Study||6
490126|NCT01068509|1199634|P3|COMPLETED|Overall Study||6
490127|NCT01068509|1199635|P2|COMPLETED|Overall Study||7
490128|NCT01068509|1199636|P1|COMPLETED|Overall Study||1
490129|NCT01068509|1199634|P3|STARTED|Overall Study||27
490130|NCT01068509|1199635|P2|STARTED|Overall Study||29
490131|NCT01068509|1199636|P1|STARTED|Overall Study||7
490132|NCT01068418|1199649|P1|NOT COMPLETED|Overall Study||12
490133|NCT01068418|1199649|P1|COMPLETED|Overall Study|14 participants completed all study procedures.|14
490134|NCT01068418|1199649|P1|Medication Washout|Overall Study|9 participants were disempaneled during the medication washout phase due to noncompliance or high BP|17
490135|NCT01068418|1199649|P1|STARTED|Overall Study|26 participants found to be eligible|26
490136|NCT01068262|1199658|P4|NOT COMPLETED|Overall Study||0
490137|NCT01068262|1199659|P3|NOT COMPLETED|Overall Study||1
490138|NCT01068262|1199660|P2|NOT COMPLETED|Overall Study||1
490139|NCT01068262|1199661|P1|NOT COMPLETED|Overall Study||3
490140|NCT01068262|1199658|P4|COMPLETED|Overall Study||2
490141|NCT01068262|1199659|P3|COMPLETED|Overall Study||9
490142|NCT01068262|1199660|P2|COMPLETED|Overall Study||8
490143|NCT01068262|1199661|P1|COMPLETED|Overall Study||20
490144|NCT01068262|1199658|P4|STARTED|Overall Study||2
490145|NCT01068262|1199659|P3|STARTED|Overall Study||10
490146|NCT01068262|1199660|P2|STARTED|Overall Study||9
490147|NCT01068262|1199661|P1|STARTED|Overall Study||23
490148|NCT01068158|1199691|P2|NOT COMPLETED|Overall Study||4
490149|NCT01068158|1199692|P1|NOT COMPLETED|Overall Study||8
490150|NCT01068158|1199691|P2|COMPLETED|Overall Study||198
490151|NCT01068158|1199692|P1|COMPLETED|Overall Study||161
490152|NCT01068158|1199691|P2|STARTED|Overall Study||202
490153|NCT01068158|1199692|P1|STARTED|Overall Study||169
490154|NCT01067976|1199704|P1|NOT COMPLETED|Overall Study||22
490155|NCT01067976|1199704|P1|COMPLETED|Overall Study|study course completed|424
490156|NCT01067976|1199704|P1|Fulfilled Requirements of FAS Population|Overall Study||390
490157|NCT01067976|1199704|P1|Received Treatment|Overall Study|treatment started|426
490158|NCT01067976|1199704|P1|STARTED|Overall Study|screened and enrolled|446
490159|NCT01067846|1199765|P2|NOT COMPLETED|Overall Study||19
490160|NCT01067846|1199766|P1|NOT COMPLETED|Overall Study||19
490161|NCT01067846|1199765|P2|COMPLETED|Overall Study|Participants that completed all 4 weeks of treatment.|11
490162|NCT01067846|1199766|P1|COMPLETED|Overall Study|Participants that completed all 4 weeks of treatment.|10
490163|NCT01067846|1199765|P2|Completed 3 Tx Sessions|Overall Study|Our final analysis includes these participants.|15
490164|NCT01067846|1199766|P1|Completed 3 Tx Sessions|Overall Study|Our final analysis includes these participants.|15
490165|NCT01067846|1199765|P2|STARTED|Overall Study|Due to exclusion prior to group assignment, Study Enrollment will not equal Total # of Participants.|30
490166|NCT01067846|1199766|P1|STARTED|Overall Study|Due to exclusion prior to group assignment, Study Enrollment will not equal Total # of Participants.|29
490167|NCT01067781|1199778|P4|NOT COMPLETED|180 to Day 720||89
490168|NCT01067781|1199779|P3|NOT COMPLETED|180 to Day 720||89
490169|NCT01067781|1199780|P2|NOT COMPLETED|180 to Day 720||164
490170|NCT01067781|1199781|P1|NOT COMPLETED|180 to Day 720||170
490171|NCT01067781|1199778|P4|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|0
490172|NCT01067781|1199779|P3|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|0
490173|NCT01067781|1199780|P2|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|4
490174|NCT01067781|1199781|P1|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|3
490175|NCT01067781|1199778|P4|STARTED|180 to Day 720||89
490176|NCT01067781|1199779|P3|STARTED|180 to Day 720||89
490177|NCT01067781|1199780|P2|STARTED|180 to Day 720||168
490178|NCT01067781|1199781|P1|STARTED|180 to Day 720||173
490179|NCT01067781|1199778|P4|NOT COMPLETED|Up to Day 180||12
490180|NCT01067781|1199779|P3|NOT COMPLETED|Up to Day 180||8
490181|NCT01067781|1199780|P2|NOT COMPLETED|Up to Day 180||31
490182|NCT01067781|1199781|P1|NOT COMPLETED|Up to Day 180||30
490183|NCT01067781|1199778|P4|COMPLETED|Up to Day 180||89
490184|NCT01067781|1199779|P3|COMPLETED|Up to Day 180||89
490185|NCT01067781|1199780|P2|COMPLETED|Up to Day 180||168
490186|NCT01067781|1199781|P1|COMPLETED|Up to Day 180||173
490187|NCT01067781|1199778|P4|STARTED|Up to Day 180||101
490188|NCT01067781|1199779|P3|STARTED|Up to Day 180||97
490189|NCT01067781|1199780|P2|STARTED|Up to Day 180||199
490190|NCT01067781|1199781|P1|STARTED|Up to Day 180||203
490191|NCT01067768|1199791|P2|NOT COMPLETED|Overall Study||0
490192|NCT01067768|1199792|P1|NOT COMPLETED|Overall Study||0
490193|NCT01067768|1199791|P2|COMPLETED|Overall Study||605
490194|NCT01067768|1199792|P1|COMPLETED|Overall Study||604
490195|NCT01067768|1199791|P2|STARTED|Overall Study||605
490196|NCT01067768|1199792|P1|STARTED|Overall Study||604
490197|NCT01067716|1199803|P3|NOT COMPLETED|Overall Study||0
490198|NCT01067716|1199804|P2|NOT COMPLETED|Overall Study||0
490199|NCT01067716|1199805|P1|NOT COMPLETED|Overall Study||0
490200|NCT01067716|1199803|P3|COMPLETED|Overall Study|15 eyes|9
490201|NCT01067716|1199804|P2|COMPLETED|Overall Study|25 eyes|13
490202|NCT01067716|1199805|P1|COMPLETED|Overall Study|110 eyes|57
490203|NCT01067716|1199803|P3|STARTED|Overall Study|15 eyes|9
490204|NCT01067716|1199804|P2|STARTED|Overall Study|25 eyes|13
490205|NCT01067716|1199805|P1|STARTED|Overall Study|110 eyes|57
490206|NCT01067456|1199824|P2|NOT COMPLETED|Overall Study||0
490207|NCT01067456|1199825|P1|NOT COMPLETED|Overall Study||0
490208|NCT01067456|1199824|P2|COMPLETED|Overall Study||29
490209|NCT01067456|1199825|P1|COMPLETED|Overall Study||30
490210|NCT01067456|1199824|P2|STARTED|Overall Study||29
490211|NCT01067456|1199825|P1|STARTED|Overall Study||30
490212|NCT01067352|1199838|P3|NOT COMPLETED|Overall Study||1
490213|NCT01067352|1199839|P2|NOT COMPLETED|Overall Study||3
490214|NCT01067352|1199840|P1|NOT COMPLETED|Overall Study||1
490215|NCT01067352|1199838|P3|COMPLETED|Overall Study||9
490216|NCT01067352|1199839|P2|COMPLETED|Overall Study||3
490217|NCT01067352|1199840|P1|COMPLETED|Overall Study||8
490218|NCT01067352|1199838|P3|STARTED|Overall Study||10
490219|NCT01067352|1199839|P2|STARTED|Overall Study||6
490220|NCT01067352|1199840|P1|STARTED|Overall Study||9
490221|NCT01067339|1199856|P2|NOT COMPLETED|Overall Study||5
490222|NCT01067339|1199857|P1|NOT COMPLETED|Overall Study||6
490223|NCT01067339|1199856|P2|COMPLETED|Overall Study||29
490224|NCT01067339|1199857|P1|COMPLETED|Overall Study||25
490225|NCT01067339|1199856|P2|STARTED|Overall Study||34
490226|NCT01067339|1199857|P1|STARTED|Overall Study||31
490227|NCT01067326|1199867|P2|NOT COMPLETED|Overall Study||3
490228|NCT01067326|1199868|P1|NOT COMPLETED|Overall Study||2
490229|NCT01067326|1199867|P2|COMPLETED|Overall Study||5
490230|NCT01067326|1199868|P1|COMPLETED|Overall Study||12
490231|NCT01067326|1199867|P2|STARTED|Overall Study||8
490232|NCT01067326|1199868|P1|STARTED|Overall Study||14
490233|NCT01067144|1199882|P2|NOT COMPLETED|Follow-up||56
490234|NCT01067144|1199883|P1|NOT COMPLETED|Follow-up||59
490235|NCT01067144|1199882|P2|COMPLETED|Follow-up||152
490236|NCT01067144|1199883|P1|COMPLETED|Follow-up||144
490237|NCT01067144|1199882|P2|Intention-to-Treat Analysis Set|Follow-up||208
490238|NCT01067144|1199883|P1|Intention-to-Treat Analysis Set|Follow-up||202
490239|NCT01067144|1199882|P2|STARTED|Follow-up||208
490240|NCT01067144|1199883|P1|STARTED|Follow-up||203
490241|NCT01067144|1199882|P2|NOT COMPLETED|Treatment||7
490242|NCT01067144|1199883|P1|NOT COMPLETED|Treatment||4
490243|NCT01067144|1199882|P2|COMPLETED|Treatment||208
490244|NCT01067144|1199883|P1|COMPLETED|Treatment||203
490245|NCT01067144|1199882|P2|STARTED|Treatment||215
490246|NCT01067144|1199883|P1|STARTED|Treatment||207
490247|NCT01067105|1199891|P1|NOT COMPLETED|Overall Study||141
490248|NCT01067105|1199891|P1|COMPLETED|Overall Study||683
490249|NCT01067105|1199891|P1|STARTED|Overall Study||824
490250|NCT01066923|1199912|P4|NOT COMPLETED|Overall Study||8
490251|NCT01066923|1199913|P3|NOT COMPLETED|Overall Study||8
490252|NCT01066923|1199914|P2|NOT COMPLETED|Overall Study||3
490253|NCT01066923|1199915|P1|NOT COMPLETED|Overall Study||3
490254|NCT01066923|1199912|P4|COMPLETED|Overall Study||23
490255|NCT01066923|1199913|P3|COMPLETED|Overall Study||25
490256|NCT01066923|1199914|P2|COMPLETED|Overall Study||29
490257|NCT01066923|1199915|P1|COMPLETED|Overall Study||25
490258|NCT01066923|1199912|P4|Retinal Imaging|Overall Study||0
490259|NCT01066923|1199913|P3|Retinal Imaging|Overall Study||0
490260|NCT01066923|1199914|P2|Retinal Imaging|Overall Study||0
490261|NCT01066923|1199915|P1|Retinal Imaging|Overall Study||0
490262|NCT01066923|1199912|P4|Activation of Coagulation|Overall Study||0
490263|NCT01066923|1199913|P3|Activation of Coagulation|Overall Study||0
490264|NCT01066923|1199914|P2|Activation of Coagulation|Overall Study||0
490265|NCT01066923|1199915|P1|Activation of Coagulation|Overall Study||0
490266|NCT01066923|1199912|P4|Vascular Function|Overall Study||13
490267|NCT01066923|1199913|P3|Vascular Function|Overall Study||12
490268|NCT01066923|1199914|P2|Vascular Function|Overall Study||14
490269|NCT01066923|1199915|P1|Vascular Function|Overall Study||13
490270|NCT01066923|1199912|P4|Platelet Closure Time|Overall Study||23
490271|NCT01066923|1199913|P3|Platelet Closure Time|Overall Study||25
490272|NCT01066923|1199914|P2|Platelet Closure Time|Overall Study||29
490273|NCT01066923|1199915|P1|Platelet Closure Time|Overall Study||25
490274|NCT01066923|1199912|P4|STARTED|Overall Study||31
490275|NCT01066923|1199913|P3|STARTED|Overall Study||33
490276|NCT01066923|1199914|P2|STARTED|Overall Study||32
490277|NCT01066923|1199915|P1|STARTED|Overall Study||28
490278|NCT01066897|1199939|P2|NOT COMPLETED|Overall Study||0
490279|NCT01066897|1199940|P1|NOT COMPLETED|Overall Study||2
490280|NCT01066897|1199939|P2|COMPLETED|Overall Study||9
490281|NCT01066897|1199940|P1|COMPLETED|Overall Study||5
490282|NCT01066897|1199939|P2|STARTED|Overall Study||9
490283|NCT01066897|1199940|P1|STARTED|Overall Study||7
490284|NCT01066871|1199954|P4|NOT COMPLETED|Overall Study||5
490285|NCT01066871|1199955|P3|NOT COMPLETED|Overall Study||6
490286|NCT01066871|1199956|P2|NOT COMPLETED|Overall Study||5
490287|NCT01066871|1199957|P1|NOT COMPLETED|Overall Study||4
490288|NCT01066871|1199954|P4|COMPLETED|Overall Study||13
490289|NCT01066871|1199955|P3|COMPLETED|Overall Study||12
490290|NCT01066871|1199956|P2|COMPLETED|Overall Study||13
490291|NCT01066871|1199957|P1|COMPLETED|Overall Study||16
490292|NCT01066871|1199954|P4|STARTED|Overall Study||18
490293|NCT01066871|1199955|P3|STARTED|Overall Study||18
490294|NCT01066871|1199956|P2|STARTED|Overall Study||18
490295|NCT01066871|1199957|P1|STARTED|Overall Study||20
490296|NCT01066819|1200021|P6|NOT COMPLETED|Overall Study||6
490297|NCT01066819|1200022|P5|NOT COMPLETED|Overall Study||4
490298|NCT01066819|1200023|P4|NOT COMPLETED|Overall Study||17
490299|NCT01066819|1200024|P3|NOT COMPLETED|Overall Study||146
490300|NCT01066819|1200025|P2|NOT COMPLETED|Overall Study||171
490301|NCT01066819|1200026|P1|NOT COMPLETED|Overall Study||689
490302|NCT01066819|1200021|P6|COMPLETED|Overall Study||7
490303|NCT01066819|1200022|P5|COMPLETED|Overall Study||3
490304|NCT01066819|1200023|P4|COMPLETED|Overall Study||8
490305|NCT01066819|1200024|P3|COMPLETED|Overall Study||111
490306|NCT01066819|1200025|P2|COMPLETED|Overall Study||177
490307|NCT01066819|1200026|P1|COMPLETED|Overall Study||317
490308|NCT01066819|1200021|P6|STARTED|Overall Study||13
490309|NCT01066819|1200022|P5|STARTED|Overall Study||7
490310|NCT01066819|1200023|P4|STARTED|Overall Study||25
490311|NCT01066819|1200024|P3|STARTED|Overall Study||257
490312|NCT01066819|1200025|P2|STARTED|Overall Study||348
490313|NCT01066819|1200026|P1|STARTED|Overall Study||1006
490314|NCT01066793|1200167|P6|NOT COMPLETED|Overall Study||1
490315|NCT01066793|1200168|P5|NOT COMPLETED|Overall Study||0
490316|NCT01066793|1200169|P4|NOT COMPLETED|Overall Study||49
490317|NCT01066793|1200170|P3|NOT COMPLETED|Overall Study||115
490318|NCT01066793|1200171|P2|NOT COMPLETED|Overall Study||77
490319|NCT01066793|1200172|P1|NOT COMPLETED|Overall Study||374
490320|NCT01066793|1200167|P6|COMPLETED|Overall Study||4
490321|NCT01066793|1200168|P5|COMPLETED|Overall Study||11
490322|NCT01066793|1200169|P4|COMPLETED|Overall Study||94
490323|NCT01066793|1200170|P3|COMPLETED|Overall Study||369
490324|NCT01066793|1200171|P2|COMPLETED|Overall Study||495
490325|NCT01066793|1200172|P1|COMPLETED|Overall Study||754
490326|NCT01066793|1200167|P6|STARTED|Overall Study||5
490327|NCT01066793|1200168|P5|STARTED|Overall Study||11
490328|NCT01066793|1200169|P4|STARTED|Overall Study||143
490329|NCT01066793|1200170|P3|STARTED|Overall Study||484
490330|NCT01066793|1200171|P2|STARTED|Overall Study||572
490331|NCT01066793|1200172|P1|STARTED|Overall Study||1128
490332|NCT01066780|1200312|P2|NOT COMPLETED|Overall Study||1
490333|NCT01066780|1200313|P1|NOT COMPLETED|Overall Study||1
490334|NCT01066780|1200312|P2|COMPLETED|Overall Study||23
490335|NCT01066780|1200313|P1|COMPLETED|Overall Study||23
490336|NCT01066780|1200312|P2|STARTED|Overall Study||24
490337|NCT01066780|1200313|P1|STARTED|Overall Study||24
490338|NCT01066624|1200320|P3|NOT COMPLETED|Overall Study||0
490339|NCT01066624|1200321|P2|NOT COMPLETED|Overall Study||0
490340|NCT01066624|1200322|P1|NOT COMPLETED|Overall Study||0
490341|NCT01066624|1200320|P3|COMPLETED|Overall Study||39
490342|NCT01066624|1200321|P2|COMPLETED|Overall Study||40
490343|NCT01066624|1200322|P1|COMPLETED|Overall Study||38
490344|NCT01066624|1200320|P3|STARTED|Overall Study||39
490345|NCT01066624|1200321|P2|STARTED|Overall Study||40
490346|NCT01066624|1200322|P1|STARTED|Overall Study||38
490347|NCT01066585|1200332|P2|NOT COMPLETED|Overall Study||3
490348|NCT01066585|1200333|P1|NOT COMPLETED|Overall Study||1
490349|NCT01066585|1200332|P2|COMPLETED|Overall Study||196
490350|NCT01066585|1200333|P1|COMPLETED|Overall Study||210
490351|NCT01066585|1200332|P2|STARTED|Overall Study||199
490352|NCT01066585|1200333|P1|STARTED|Overall Study||211
490353|NCT01066546|1200345|P1|NOT COMPLETED|Overall Study||5
490354|NCT01066546|1200345|P1|COMPLETED|Overall Study||0
490355|NCT01066546|1200345|P1|STARTED|Overall Study||5
490356|NCT01066520|1200359|P3|NOT COMPLETED|Overall Study||0
490357|NCT01066520|1200360|P2|NOT COMPLETED|Overall Study||0
490358|NCT01066520|1200361|P1|NOT COMPLETED|Overall Study||0
490359|NCT01066520|1200359|P3|COMPLETED|Overall Study||137
490360|NCT01066520|1200360|P2|COMPLETED|Overall Study||140
490361|NCT01066520|1200361|P1|COMPLETED|Overall Study||143
490362|NCT01066520|1200359|P3|STARTED|Overall Study||137
490363|NCT01066520|1200360|P2|STARTED|Overall Study||140
490364|NCT01066520|1200361|P1|STARTED|Overall Study||143
490365|NCT01066156|1200375|P1|NOT COMPLETED|Overall Study||10
490366|NCT01066156|1200375|P1|COMPLETED|Overall Study||24
490367|NCT01066156|1200375|P1|STARTED|Overall Study||34
490368|NCT01066143|1200379|P1|NOT COMPLETED|Overall Study||8
490369|NCT01066143|1200379|P1|COMPLETED|Overall Study||0
490370|NCT01066143|1200379|P1|STARTED|Overall Study||8
490371|NCT01066104|1200385|P2|NOT COMPLETED|Overall Study||1
490372|NCT01066104|1200386|P1|NOT COMPLETED|Overall Study||2
490373|NCT01066104|1200385|P2|COMPLETED|Overall Study||12
490374|NCT01066104|1200386|P1|COMPLETED|Overall Study||12
490375|NCT01066104|1200385|P2|STARTED|Overall Study||13
490376|NCT01066104|1200386|P1|STARTED|Overall Study||14
490377|NCT01066039|1200394|P1|NOT COMPLETED|Overall Study||44
490378|NCT01066039|1200394|P1|COMPLETED|Overall Study||158
490379|NCT01066039|1200394|P1|Treated|Overall Study||200
490380|NCT01066039|1200394|P1|STARTED|Overall Study||202
490381|NCT01066000|1200407|P1|NOT COMPLETED|Overall Study||9
490382|NCT01066000|1200407|P1|COMPLETED|Overall Study||24
490383|NCT01066000|1200407|P1|STARTED|Overall Study||33
490384|NCT01065844|1200418|P1|NOT COMPLETED|Overall Study||5
490385|NCT01065844|1200418|P1|COMPLETED|Overall Study||10
490386|NCT01065844|1200418|P1|STARTED|Overall Study||15
490387|NCT01065818|1200422|P1|NOT COMPLETED|Overall Study||2
490388|NCT01065818|1200422|P1|COMPLETED|Overall Study||4
490389|NCT01065818|1200422|P1|STARTED|Overall Study||6
490390|NCT01065779|1200426|P1|NOT COMPLETED|Overall Study||82
490391|NCT01065779|1200426|P1|COMPLETED|Overall Study||798
490392|NCT01065779|1200426|P1|STARTED|Overall Study||880
490393|NCT01065766|1200437|P1|NOT COMPLETED|Overall Study||32
490394|NCT01065766|1200437|P1|COMPLETED|Overall Study||4033
490395|NCT01065766|1200437|P1|STARTED|Overall Study||4065
490396|NCT01065714|1200449|P1|NOT COMPLETED|Overall Study||0
490397|NCT01065714|1200449|P1|COMPLETED|Overall Study||20
490398|NCT01065714|1200449|P1|STARTED|Overall Study|"This was a split body Study. All participants used both Hydrogel and Eucerin"|20
490399|NCT01065597|1200456|P1|NOT COMPLETED|Overall Study||1
490400|NCT01065597|1200456|P1|COMPLETED|Overall Study||12
490401|NCT01065597|1200456|P1|STARTED|Overall Study||13
490402|NCT01065558|1200463|P1|NOT COMPLETED|Overall Study||0
490403|NCT01065558|1200463|P1|COMPLETED|Overall Study||5
490404|NCT01065558|1200463|P1|STARTED|Overall Study||5
490405|NCT01065506|1200470|P2|NOT COMPLETED|Overall Study||38
490406|NCT01065506|1200471|P1|NOT COMPLETED|Overall Study||32
490407|NCT01065506|1200470|P2|COMPLETED|Overall Study||34
490408|NCT01065506|1200471|P1|COMPLETED|Overall Study||32
490409|NCT01065506|1200470|P2|4-Month Follow-Up|Overall Study||34
490410|NCT01065506|1200471|P1|4-Month Follow-Up|Overall Study||35
490411|NCT01065506|1200470|P2|End of Treatment|Overall Study||37
490412|NCT01065506|1200471|P1|End of Treatment|Overall Study||44
490413|NCT01065506|1200470|P2|STARTED|Overall Study||72
490414|NCT01065506|1200471|P1|STARTED|Overall Study||64
490415|NCT01065480|1200479|P2|NOT COMPLETED|Overall Study||0
490416|NCT01065480|1200480|P1|NOT COMPLETED|Overall Study||0
490417|NCT01065480|1200479|P2|COMPLETED|Overall Study||43
490418|NCT01065480|1200480|P1|COMPLETED|Overall Study||48
490419|NCT01065480|1200479|P2|STARTED|Overall Study||43
490420|NCT01065480|1200480|P1|STARTED|Overall Study||48
490421|NCT01065454|1200490|P4|NOT COMPLETED|Follow up||44
490422|NCT01065454|1200491|P3|NOT COMPLETED|Follow up||17
490423|NCT01065454|1200492|P2|NOT COMPLETED|Follow up||24
490424|NCT01065454|1200493|P1|NOT COMPLETED|Follow up||39
490425|NCT01065454|1200490|P4|COMPLETED|Follow up||13
490426|NCT01065454|1200491|P3|COMPLETED|Follow up||6
490427|NCT01065454|1200492|P2|COMPLETED|Follow up||4
490428|NCT01065454|1200493|P1|COMPLETED|Follow up||15
490429|NCT01065454|1200490|P4|Entering Follow-up|Follow up||51
490430|NCT01065454|1200491|P3|Entering Follow-up|Follow up||23
490431|NCT01065454|1200492|P2|Entering Follow-up|Follow up||27
490432|NCT01065454|1200493|P1|Entering Follow-up|Follow up||49
490433|NCT01065454|1200490|P4|STARTED|Follow up||57
490434|NCT01065454|1200491|P3|STARTED|Follow up||23
490435|NCT01065454|1200492|P2|STARTED|Follow up||28
490436|NCT01065454|1200493|P1|STARTED|Follow up||54
490437|NCT01065454|1200490|P4|NOT COMPLETED|Treatment||12
490438|NCT01065454|1200491|P3|NOT COMPLETED|Treatment||9
490439|NCT01065454|1200492|P2|NOT COMPLETED|Treatment||5
490440|NCT01065454|1200493|P1|NOT COMPLETED|Treatment||13
490441|NCT01065454|1200490|P4|COMPLETED|Treatment||57
490442|NCT01065454|1200491|P3|COMPLETED|Treatment||23
490443|NCT01065454|1200492|P2|COMPLETED|Treatment||28
490444|NCT01065454|1200493|P1|COMPLETED|Treatment||54
490445|NCT01065454|1200490|P4|STARTED|Treatment||69
490446|NCT01065454|1200491|P3|STARTED|Treatment||32
490447|NCT01065454|1200492|P2|STARTED|Treatment||33
490448|NCT01065454|1200493|P1|STARTED|Treatment||67
490449|NCT01065428|1200605|P2|NOT COMPLETED|Overall Study||0
490450|NCT01065428|1200606|P1|NOT COMPLETED|Overall Study||0
490451|NCT01065428|1200605|P2|COMPLETED|Overall Study||35
490452|NCT01065428|1200606|P1|COMPLETED|Overall Study||17
490453|NCT01065428|1200605|P2|STARTED|Overall Study||35
490454|NCT01065428|1200606|P1|STARTED|Overall Study||17
490455|NCT01065350|1200616|P2|NOT COMPLETED|Overall Study||1
490456|NCT01065350|1200617|P1|NOT COMPLETED|Overall Study||0
490457|NCT01065350|1200616|P2|COMPLETED|Overall Study||41
490458|NCT01065350|1200617|P1|COMPLETED|Overall Study||43
490459|NCT01065350|1200616|P2|STARTED|Overall Study||42
490460|NCT01065350|1200617|P1|STARTED|Overall Study||43
490461|NCT01065051|1200651|P2|NOT COMPLETED|Overall Study||0
490462|NCT01065051|1200652|P1|NOT COMPLETED|Overall Study||0
490463|NCT01065051|1200651|P2|COMPLETED|Overall Study||0
490464|NCT01065051|1200652|P1|COMPLETED|Overall Study||1
490465|NCT01065051|1200651|P2|STARTED|Overall Study||0
490466|NCT01065051|1200652|P1|STARTED|Overall Study||1
490467|NCT01064947|1200678|P1|NOT COMPLETED|Overall Study||41
490468|NCT01064947|1200678|P1|COMPLETED|Overall Study||29
490469|NCT01064947|1200678|P1|STARTED|Overall Study||70
490470|NCT01064882|1200689|P3|NOT COMPLETED|Overall Study||2
490471|NCT01064882|1200690|P2|NOT COMPLETED|Overall Study||2
490472|NCT01064882|1200691|P1|NOT COMPLETED|Overall Study||2
490473|NCT01064882|1200689|P3|COMPLETED|Overall Study||32
490474|NCT01064882|1200690|P2|COMPLETED|Overall Study||32
490475|NCT01064882|1200691|P1|COMPLETED|Overall Study||34
490476|NCT01064882|1200689|P3|STARTED|Overall Study||34
490477|NCT01064882|1200690|P2|STARTED|Overall Study||34
490478|NCT01064882|1200691|P1|STARTED|Overall Study||36
490479|NCT01064856|1200719|P4|NOT COMPLETED|Open-label (OL) Period||20
490480|NCT01064856|1200720|P3|NOT COMPLETED|Open-label (OL) Period||26
490481|NCT01064856|1200721|P2|NOT COMPLETED|Open-label (OL) Period||0
490482|NCT01064856|1200722|P1|NOT COMPLETED|Open-label (OL) Period||0
490483|NCT01064856|1200719|P4|COMPLETED|Open-label (OL) Period||61
490484|NCT01064856|1200720|P3|COMPLETED|Open-label (OL) Period||56
490485|NCT01064856|1200721|P2|COMPLETED|Open-label (OL) Period||0
490486|NCT01064856|1200722|P1|COMPLETED|Open-label (OL) Period||0
490487|NCT01064856|1200719|P4|STARTED|Open-label (OL) Period||81
490488|NCT01064856|1200720|P3|STARTED|Open-label (OL) Period||82
490489|NCT01064856|1200721|P2|STARTED|Open-label (OL) Period|This treatment group is not applicable for this period.|0
490490|NCT01064856|1200722|P1|STARTED|Open-label (OL) Period|This treatment group is not applicable for this period.|0
490491|NCT01064856|1200719|P4|NOT COMPLETED|Double-blind (DB) Period||0
490492|NCT01064856|1200720|P3|NOT COMPLETED|Double-blind (DB) Period||0
490493|NCT01064856|1200721|P2|NOT COMPLETED|Double-blind (DB) Period||0
490494|NCT01064856|1200722|P1|NOT COMPLETED|Double-blind (DB) Period||2
490495|NCT01064856|1200719|P4|COMPLETED|Double-blind (DB) Period||0
490496|NCT01064856|1200720|P3|COMPLETED|Double-blind (DB) Period||0
490497|NCT01064856|1200721|P2|COMPLETED|Double-blind (DB) Period||81
490498|NCT01064856|1200722|P1|COMPLETED|Double-blind (DB) Period||82
490499|NCT01064856|1200719|P4|STARTED|Double-blind (DB) Period|This treatment group is not applicable for this period.|0
490500|NCT01064856|1200720|P3|STARTED|Double-blind (DB) Period|This treatment group is not applicable for this period.|0
490501|NCT01064856|1200721|P2|STARTED|Double-blind (DB) Period||81
490502|NCT01064856|1200722|P1|STARTED|Double-blind (DB) Period||84
490503|NCT01064830|1200755|P2|NOT COMPLETED|Overall Study||4
490504|NCT01064830|1200756|P1|NOT COMPLETED|Overall Study||2
490505|NCT01064830|1200755|P2|COMPLETED|Overall Study||7
490506|NCT01064830|1200756|P1|COMPLETED|Overall Study||8
490507|NCT01064830|1200755|P2|STARTED|Overall Study||11
490508|NCT01064830|1200756|P1|STARTED|Overall Study||10
490509|NCT01064817|1200766|P2|NOT COMPLETED|Study Completion||0
490510|NCT01064817|1200767|P1|NOT COMPLETED|Study Completion||2
490511|NCT01064817|1200766|P2|COMPLETED|Study Completion||62
490512|NCT01064817|1200767|P1|COMPLETED|Study Completion||60
490513|NCT01064817|1200766|P2|STARTED|Study Completion||62
490514|NCT01064817|1200767|P1|STARTED|Study Completion||62
490515|NCT01064817|1200766|P2|NOT COMPLETED|All Study Treatment Days 1-9||0
490516|NCT01064817|1200767|P1|NOT COMPLETED|All Study Treatment Days 1-9||0
490517|NCT01064817|1200766|P2|COMPLETED|All Study Treatment Days 1-9||62
490518|NCT01064817|1200767|P1|COMPLETED|All Study Treatment Days 1-9||62
490519|NCT01064817|1200766|P2|STARTED|All Study Treatment Days 1-9||62
490520|NCT01064817|1200767|P1|STARTED|All Study Treatment Days 1-9||62
490521|NCT01064739|1200779|P1|NOT COMPLETED|Fixed Sodium Diet + Fava Beans||1
490522|NCT01064739|1200779|P1|COMPLETED|Fixed Sodium Diet + Fava Beans|1 participant withdrew with blood in his urine on the fava bean study day.|13
490523|NCT01064739|1200779|P1|STARTED|Fixed Sodium Diet + Fava Beans||14
490524|NCT01064739|1200779|P1|NOT COMPLETED|Fixed Sodium Study Diet||0
490525|NCT01064739|1200779|P1|COMPLETED|Fixed Sodium Study Diet||14
490526|NCT01064739|1200779|P1|STARTED|Fixed Sodium Study Diet|14 participants consumed the fixed-sodium study diet prior to the fava bean supplement study day.|14
490527|NCT01064687|1200839|P4|NOT COMPLETED|Overall Study||17
490528|NCT01064687|1200840|P3|NOT COMPLETED|Overall Study||41
490529|NCT01064687|1200841|P2|NOT COMPLETED|Overall Study||26
490530|NCT01064687|1200842|P1|NOT COMPLETED|Overall Study||34
490531|NCT01064687|1200839|P4|COMPLETED|Overall Study||124
490532|NCT01064687|1200840|P3|COMPLETED|Overall Study||237
490533|NCT01064687|1200841|P2|COMPLETED|Overall Study||254
490534|NCT01064687|1200842|P1|COMPLETED|Overall Study||245
490535|NCT01064687|1200839|P4|Completed 26 Weeks|Overall Study||124
490536|NCT01064687|1200840|P3|Completed 26 Weeks|Overall Study||252
490537|NCT01064687|1200841|P2|Completed 26 Weeks|Overall Study||263
490538|NCT01064687|1200842|P1|Completed 26 Weeks|Overall Study||260
490539|NCT01064687|1200839|P4|Received at Least 1 Dose of Study Drug|Overall Study||141
490540|NCT01064687|1200840|P3|Received at Least 1 Dose of Study Drug|Overall Study||276
490541|NCT01064687|1200841|P2|Received at Least 1 Dose of Study Drug|Overall Study||280
490542|NCT01064687|1200842|P1|Received at Least 1 Dose of Study Drug|Overall Study||279
490543|NCT01064687|1200839|P4|STARTED|Overall Study||141
490544|NCT01064687|1200840|P3|STARTED|Overall Study|Of 278 participants randomized to Exenatide, 2 chose not to take study drug.|278
490545|NCT01064687|1200841|P2|STARTED|Overall Study||280
490546|NCT01064687|1200842|P1|STARTED|Overall Study||279
490547|NCT01064622|1201022|P2|NOT COMPLETED|Crossover of Arm I||0
490548|NCT01064622|1201023|P1|NOT COMPLETED|Crossover of Arm I||0
490549|NCT01064622|1201022|P2|COMPLETED|Crossover of Arm I||0
490550|NCT01064622|1201023|P1|COMPLETED|Crossover of Arm I||22
490551|NCT01064622|1201022|P2|STARTED|Crossover of Arm I||0
490552|NCT01064622|1201023|P1|STARTED|Crossover of Arm I|Among 53 patients, 45 had disease progression; however 23 elected not to crossover to vismodegib.|22
490553|NCT01064622|1201022|P2|NOT COMPLETED|Randomized Phase II||3
490554|NCT01064622|1201023|P1|NOT COMPLETED|Randomized Phase II||2
490555|NCT01064622|1201022|P2|COMPLETED|Randomized Phase II||53
490556|NCT01064622|1201023|P1|COMPLETED|Randomized Phase II||53
490557|NCT01064622|1201022|P2|STARTED|Randomized Phase II||56
490558|NCT01064622|1201023|P1|STARTED|Randomized Phase II||55
490559|NCT01064622|1201022|P2|NOT COMPLETED|Lead-in Phase I||0
490560|NCT01064622|1201023|P1|NOT COMPLETED|Lead-in Phase I||0
490561|NCT01064622|1201022|P2|COMPLETED|Lead-in Phase I||7
490562|NCT01064622|1201023|P1|COMPLETED|Lead-in Phase I||0
490563|NCT01064622|1201022|P2|STARTED|Lead-in Phase I||7
490564|NCT01064622|1201023|P1|STARTED|Lead-in Phase I||0
490565|NCT01064414|1201047|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
490566|NCT01064414|1201048|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
490567|NCT01064414|1201049|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||12
490568|NCT01064414|1201047|P3|COMPLETED|Extension Period: Week 26 to Week 52||76
490569|NCT01064414|1201048|P2|COMPLETED|Extension Period: Week 26 to Week 52||67
490570|NCT01064414|1201049|P1|COMPLETED|Extension Period: Week 26 to Week 52||64
490571|NCT01064414|1201047|P3|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext. Reason: other (not specified).|81
490572|NCT01064414|1201048|P2|STARTED|Extension Period: Week 26 to Week 52|3 pts completed core but did not enter ext. Reason: other (not specified) (3).|72
490573|NCT01064414|1201049|P1|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext. Reason: other (not specified).|76
490574|NCT01064414|1201047|P3|NOT COMPLETED|Core Period: Baseline to Week 26||7
490575|NCT01064414|1201048|P2|NOT COMPLETED|Core Period: Baseline to Week 26||15
490576|NCT01064414|1201049|P1|NOT COMPLETED|Core Period: Baseline to Week 26||13
490577|NCT01064414|1201047|P3|COMPLETED|Core Period: Baseline to Week 26||82
490578|NCT01064414|1201048|P2|COMPLETED|Core Period: Baseline to Week 26||75
490579|NCT01064414|1201049|P1|COMPLETED|Core Period: Baseline to Week 26||77
490580|NCT01064414|1201047|P3|STARTED|Core Period: Baseline to Week 26||89
490581|NCT01064414|1201048|P2|STARTED|Core Period: Baseline to Week 26||90
490582|NCT01064414|1201049|P1|STARTED|Core Period: Baseline to Week 26||90
490583|NCT01064401|1201068|P2|NOT COMPLETED|Overall Study||195
490584|NCT01064401|1201069|P1|NOT COMPLETED|Overall Study||228
490585|NCT01064401|1201068|P2|COMPLETED|Overall Study||724
490586|NCT01064401|1201069|P1|COMPLETED|Overall Study||694
490587|NCT01064401|1201068|P2|STARTED|Overall Study||919
490588|NCT01064401|1201069|P1|STARTED|Overall Study||922
490589|NCT01064362|1201085|P2|NOT COMPLETED|Overall Study||0
490590|NCT01064362|1201086|P1|NOT COMPLETED|Overall Study||0
490591|NCT01064362|1201085|P2|COMPLETED|Overall Study||11883
490592|NCT01064362|1201086|P1|COMPLETED|Overall Study||1559
490593|NCT01064362|1201085|P2|STARTED|Overall Study||11883
490594|NCT01064362|1201086|P1|STARTED|Overall Study||1559
490595|NCT01064323|1201094|P1|NOT COMPLETED|Overall Study||0
490596|NCT01064323|1201094|P1|COMPLETED|Overall Study||10
490597|NCT01064323|1201094|P1|STARTED|Overall Study||10
490598|NCT01064310|1201118|P3|NOT COMPLETED|Open Label Pazopinib||84
490599|NCT01064310|1201119|P2|NOT COMPLETED|Open Label Pazopinib||0
490600|NCT01064310|1201120|P1|NOT COMPLETED|Open Label Pazopinib||0
490601|NCT01064310|1201118|P3|COMPLETED|Open Label Pazopinib||0
490602|NCT01064310|1201119|P2|COMPLETED|Open Label Pazopinib||0
490603|NCT01064310|1201120|P1|COMPLETED|Open Label Pazopinib||0
490604|NCT01064310|1201118|P3|STARTED|Open Label Pazopinib||84
490605|NCT01064310|1201119|P2|STARTED|Open Label Pazopinib||0
490606|NCT01064310|1201120|P1|STARTED|Open Label Pazopinib||0
490607|NCT01064310|1201118|P3|NOT COMPLETED|Period 2||0
490608|NCT01064310|1201119|P2|NOT COMPLETED|Period 2||6
490609|NCT01064310|1201120|P1|NOT COMPLETED|Period 2||4
490610|NCT01064310|1201118|P3|COMPLETED|Period 2||0
490611|NCT01064310|1201119|P2|COMPLETED|Period 2||62
490612|NCT01064310|1201120|P1|COMPLETED|Period 2||64
490613|NCT01064310|1201118|P3|STARTED|Period 2||0
490614|NCT01064310|1201119|P2|STARTED|Period 2||68
490615|NCT01064310|1201120|P1|STARTED|Period 2||68
490616|NCT01064310|1201118|P3|NOT COMPLETED|Period 1||0
490617|NCT01064310|1201119|P2|NOT COMPLETED|Period 1||18
490618|NCT01064310|1201120|P1|NOT COMPLETED|Period 1||14
490619|NCT01064310|1201118|P3|COMPLETED|Period 1||0
490620|NCT01064310|1201119|P2|COMPLETED|Period 1||68
490621|NCT01064310|1201120|P1|COMPLETED|Period 1||68
490622|NCT01064310|1201118|P3|STARTED|Period 1||0
490623|NCT01064310|1201119|P2|STARTED|Period 1||86
490624|NCT01064310|1201120|P1|STARTED|Period 1||82
490625|NCT01064297|1201150|P3|NOT COMPLETED|Overall Study||133
490626|NCT01064297|1201151|P2|NOT COMPLETED|Overall Study||48
490627|NCT01064297|1201152|P1|NOT COMPLETED|Overall Study||791
490628|NCT01064297|1201150|P3|COMPLETED|Overall Study||497
490629|NCT01064297|1201151|P2|COMPLETED|Overall Study||171
490630|NCT01064297|1201152|P1|COMPLETED|Overall Study||1776
490631|NCT01064297|1201150|P3|STARTED|Overall Study||630
490632|NCT01064297|1201151|P2|STARTED|Overall Study||219
490633|NCT01064297|1201152|P1|STARTED|Overall Study||2567
490634|NCT01064284|1201198|P2|NOT COMPLETED|Overall Study||17
490635|NCT01064284|1201199|P1|NOT COMPLETED|Overall Study||18
490636|NCT01064284|1201198|P2|COMPLETED|Overall Study||109
490637|NCT01064284|1201199|P1|COMPLETED|Overall Study||107
490638|NCT01064284|1201198|P2|STARTED|Overall Study|Taking into account the analyzed patients only|126
490639|NCT01064284|1201199|P1|STARTED|Overall Study|Taking into account the analyzed patients only|125
490640|NCT01064167|1201221|P2|NOT COMPLETED|Overall Study||15
490641|NCT01064167|1201222|P1|NOT COMPLETED|Overall Study||14
490642|NCT01064167|1201221|P2|COMPLETED|Overall Study||115
490643|NCT01064167|1201222|P1|COMPLETED|Overall Study||116
490644|NCT01064167|1201221|P2|STARTED|Overall Study||130
490645|NCT01064167|1201222|P1|STARTED|Overall Study||130
490646|NCT01064076|1201230|P1|NOT COMPLETED|Overall Study||18
490647|NCT01064076|1201230|P1|COMPLETED|Overall Study|303 subjects completed a minimum of 180 days of follow up|303
490648|NCT01064076|1201230|P1|STARTED|Overall Study|321 subjects underwent an implant procedure for the S-ICD System|321
490649|NCT01063907|1201235|P2|NOT COMPLETED|Overall Study||0
490650|NCT01063907|1201236|P1|NOT COMPLETED|Overall Study||0
490651|NCT01063907|1201235|P2|COMPLETED|Overall Study||80
490652|NCT01063907|1201236|P1|COMPLETED|Overall Study||15
490653|NCT01063907|1201235|P2|STARTED|Overall Study||80
490654|NCT01063907|1201236|P1|STARTED|Overall Study||15
490655|NCT01063881|1201269|P3|NOT COMPLETED|Overall Study||1
490656|NCT01063881|1201270|P2|NOT COMPLETED|Overall Study||11
490657|NCT01063881|1201271|P1|NOT COMPLETED|Overall Study||55
490658|NCT01063881|1201269|P3|COMPLETED|Overall Study||12
490659|NCT01063881|1201270|P2|COMPLETED|Overall Study||114
490660|NCT01063881|1201271|P1|COMPLETED|Overall Study||92
490661|NCT01063881|1201269|P3|STARTED|Overall Study||13
490662|NCT01063881|1201270|P2|STARTED|Overall Study||125
490663|NCT01063881|1201271|P1|STARTED|Overall Study||147
490664|NCT01063868|1201295|P2|NOT COMPLETED|Overall Study||12
490665|NCT01063868|1201296|P1|NOT COMPLETED|Overall Study||35
490666|NCT01063868|1201295|P2|COMPLETED|Overall Study||0
490667|NCT01063868|1201296|P1|COMPLETED|Overall Study||0
490668|NCT01063868|1201295|P2|STARTED|Overall Study||12
490669|NCT01063868|1201296|P1|STARTED|Overall Study||35
490670|NCT01063855|1201304|P2|NOT COMPLETED|Overall Study||29
490671|NCT01063855|1201305|P1|NOT COMPLETED|Overall Study||37
490672|NCT01063855|1201304|P2|COMPLETED|Overall Study||221
490673|NCT01063855|1201305|P1|COMPLETED|Overall Study||208
490674|NCT01063855|1201304|P2|STARTED|Overall Study||250
490675|NCT01063855|1201305|P1|STARTED|Overall Study||245
490676|NCT01063829|1201331|P4|NOT COMPLETED|Overall Study||21
490677|NCT01063829|1201332|P3|NOT COMPLETED|Overall Study||10
490678|NCT01063829|1201333|P2|NOT COMPLETED|Overall Study||10
490679|NCT01063829|1201334|P1|NOT COMPLETED|Overall Study||16
490680|NCT01063829|1201331|P4|COMPLETED|Overall Study|Non-completers considered as failure; FAS|12
490681|NCT01063829|1201332|P3|COMPLETED|Overall Study|Non-completers considered as failure; FAS|24
490682|NCT01063829|1201333|P2|COMPLETED|Overall Study|Non-completers considered as failure; FAS|21
490683|NCT01063829|1201334|P1|COMPLETED|Overall Study|Non-completers considered as failure; FAS|17
490684|NCT01063829|1201331|P4|STARTED|Overall Study||33
490685|NCT01063829|1201332|P3|STARTED|Overall Study||34
490686|NCT01063829|1201333|P2|STARTED|Overall Study||31
490687|NCT01063829|1201334|P1|STARTED|Overall Study||33
490688|NCT01063764|1201352|P1|NOT COMPLETED|2nd Period (Week 22 to the End of Study)||20
490689|NCT01063764|1201352|P1|COMPLETED|2nd Period (Week 22 to the End of Study)||35
490690|NCT01063764|1201352|P1|STARTED|2nd Period (Week 22 to the End of Study)|7 subjects who completed Period 1 did not enter the Second Period.|55
490691|NCT01063764|1201352|P1|NOT COMPLETED|1st Period (From Week 8 to Week 22)||11
490692|NCT01063764|1201352|P1|COMPLETED|1st Period (From Week 8 to Week 22)|62 subjects completed the First Period, but 7 of these subjects did not enter the Second Period.|62
490693|NCT01063764|1201352|P1|STARTED|1st Period (From Week 8 to Week 22)||73
490694|NCT01063712|1201366|P1|NOT COMPLETED|Overall Study||0
490695|NCT01063712|1201366|P1|COMPLETED|Overall Study||29
490696|NCT01063712|1201366|P1|STARTED|Overall Study||29
490697|NCT01063595|1201371|P2|NOT COMPLETED|Second Intervention||0
490698|NCT01063595|1201372|P1|NOT COMPLETED|Second Intervention||0
490699|NCT01063595|1201371|P2|COMPLETED|Second Intervention||24
490700|NCT01063595|1201372|P1|COMPLETED|Second Intervention||29
490701|NCT01063595|1201371|P2|STARTED|Second Intervention||24
490702|NCT01063595|1201372|P1|STARTED|Second Intervention||29
490703|NCT01063595|1201371|P2|NOT COMPLETED|First Intervention||5
490704|NCT01063595|1201372|P1|NOT COMPLETED|First Intervention||2
490705|NCT01063595|1201371|P2|COMPLETED|First Intervention||24
490706|NCT01063595|1201372|P1|COMPLETED|First Intervention||29
490707|NCT01063595|1201371|P2|STARTED|First Intervention||29
490708|NCT01063595|1201372|P1|STARTED|First Intervention||31
490709|NCT01063595|1201371|P2|NOT COMPLETED|Enrolled in Study and Randomized||2
490710|NCT01063595|1201372|P1|NOT COMPLETED|Enrolled in Study and Randomized||1
490711|NCT01063595|1201371|P2|COMPLETED|Enrolled in Study and Randomized||29
490712|NCT01063595|1201372|P1|COMPLETED|Enrolled in Study and Randomized||31
490713|NCT01063595|1201371|P2|Received Treatment|Enrolled in Study and Randomized||29
490714|NCT01063595|1201372|P1|Received Treatment|Enrolled in Study and Randomized||31
490715|NCT01063595|1201371|P2|STARTED|Enrolled in Study and Randomized||31
490716|NCT01063595|1201372|P1|STARTED|Enrolled in Study and Randomized||32
490717|NCT01063517|1201384|P2|NOT COMPLETED|Overall Study||60
490718|NCT01063517|1201385|P1|NOT COMPLETED|Overall Study||58
490719|NCT01063517|1201384|P2|COMPLETED|Overall Study||2
490720|NCT01063517|1201385|P1|COMPLETED|Overall Study||4
490721|NCT01063517|1201384|P2|Received Randomised Treatment|Overall Study||62
490722|NCT01063517|1201385|P1|Received Randomised Treatment|Overall Study||61
490723|NCT01063517|1201384|P2|STARTED|Overall Study||62
490724|NCT01063517|1201385|P1|STARTED|Overall Study||62
490725|NCT01063348|1201425|P2|NOT COMPLETED|Overall Study||10
490726|NCT01063348|1201426|P1|NOT COMPLETED|Overall Study||3
490727|NCT01063348|1201425|P2|COMPLETED|Overall Study||21
490728|NCT01063348|1201426|P1|COMPLETED|Overall Study||32
490729|NCT01063348|1201425|P2|STARTED|Overall Study||31
490730|NCT01063348|1201426|P1|STARTED|Overall Study||35
490731|NCT01063153|1201436|P2|NOT COMPLETED|Overall Study||12
490732|NCT01063153|1201437|P1|NOT COMPLETED|Overall Study||2
490733|NCT01063153|1201436|P2|COMPLETED|Overall Study||26
490734|NCT01063153|1201437|P1|COMPLETED|Overall Study||31
490735|NCT01063153|1201436|P2|STARTED|Overall Study||38
490736|NCT01063153|1201437|P1|STARTED|Overall Study||33
490737|NCT01063075|1201447|P4|NOT COMPLETED|Overall Study||1
490738|NCT01063075|1201448|P3|NOT COMPLETED|Overall Study||5
490739|NCT01063075|1201449|P2|NOT COMPLETED|Overall Study||2
490740|NCT01063075|1201450|P1|NOT COMPLETED|Overall Study||1
490741|NCT01063075|1201447|P4|COMPLETED|Overall Study||14
490742|NCT01063075|1201448|P3|COMPLETED|Overall Study||9
490743|NCT01063075|1201449|P2|COMPLETED|Overall Study||1
490744|NCT01063075|1201450|P1|COMPLETED|Overall Study||1
490745|NCT01063075|1201447|P4|STARTED|Overall Study||15
490746|NCT01063075|1201448|P3|STARTED|Overall Study||14
490747|NCT01063075|1201449|P2|STARTED|Overall Study||3
490748|NCT01063075|1201450|P1|STARTED|Overall Study||2
490749|NCT01063062|1201468|P2|NOT COMPLETED|Overall Study||12
490750|NCT01063062|1201469|P1|NOT COMPLETED|Overall Study||8
490751|NCT01063062|1201468|P2|COMPLETED|Overall Study||65
490752|NCT01063062|1201469|P1|COMPLETED|Overall Study||22
490753|NCT01063062|1201468|P2|Received Study Drug|Overall Study||76
490754|NCT01063062|1201469|P1|Received Study Drug|Overall Study||29
490755|NCT01063062|1201468|P2|STARTED|Overall Study||77
490756|NCT01063062|1201469|P1|STARTED|Overall Study||30
490757|NCT01063049|1201510|P3|NOT COMPLETED|Overall Study||0
490758|NCT01063049|1201511|P2|NOT COMPLETED|Overall Study||0
490759|NCT01063049|1201512|P1|NOT COMPLETED|Overall Study||0
490760|NCT01063049|1201510|P3|COMPLETED|Overall Study||200
490761|NCT01063049|1201511|P2|COMPLETED|Overall Study||200
490762|NCT01063049|1201512|P1|COMPLETED|Overall Study||200
490763|NCT01063049|1201510|P3|STARTED|Overall Study||200
490764|NCT01063049|1201511|P2|STARTED|Overall Study||200
490765|NCT01063049|1201512|P1|STARTED|Overall Study||200
490766|NCT01063036|1201523|P1|NOT COMPLETED|Post Dosing Follow-up Through 24 Weeks||39
490767|NCT01063036|1201523|P1|COMPLETED|Post Dosing Follow-up Through 24 Weeks||46
490768|NCT01063036|1201523|P1|STARTED|Post Dosing Follow-up Through 24 Weeks|2 included did not complete treatment; 3 completed treatment but not included (lost to follow-up).|85
490769|NCT01063036|1201523|P1|NOT COMPLETED|Participants Treated With Study Drug||6
490770|NCT01063036|1201523|P1|COMPLETED|Participants Treated With Study Drug||86
490771|NCT01063036|1201523|P1|STARTED|Participants Treated With Study Drug||92
490772|NCT01062841|1201539|P2|NOT COMPLETED|Overall Study||53
490773|NCT01062841|1201540|P1|NOT COMPLETED|Overall Study||49
490774|NCT01062841|1201539|P2|COMPLETED|Overall Study||162
490775|NCT01062841|1201540|P1|COMPLETED|Overall Study||154
490776|NCT01062841|1201539|P2|STARTED|Overall Study||215
490777|NCT01062841|1201540|P1|STARTED|Overall Study||203
490778|NCT01062763|1201570|P2|NOT COMPLETED|Overall Study||4
490779|NCT01062763|1201571|P1|NOT COMPLETED|Overall Study||3
490780|NCT01062763|1201570|P2|COMPLETED|Overall Study||57
490781|NCT01062763|1201571|P1|COMPLETED|Overall Study||55
490782|NCT01062763|1201570|P2|STARTED|Overall Study||61
490783|NCT01062763|1201571|P1|STARTED|Overall Study|119 randomized.|58
490784|NCT01062425|1201583|P2|NOT COMPLETED|Overall Study||6
490785|NCT01062425|1201584|P1|NOT COMPLETED|Overall Study||3
490786|NCT01062425|1201583|P2|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|97
490787|NCT01062425|1201584|P1|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|52
490788|NCT01062425|1201583|P2|STARTED|Overall Study||103
490789|NCT01062425|1201584|P1|STARTED|Overall Study||55
490790|NCT01062399|1201601|P5|NOT COMPLETED|Overall Study||4
490791|NCT01062399|1201602|P4|NOT COMPLETED|Overall Study||6
490792|NCT01062399|1201603|P3|NOT COMPLETED|Overall Study||0
490793|NCT01062399|1201604|P2|NOT COMPLETED|Overall Study||1
490794|NCT01062399|1201605|P1|NOT COMPLETED|Overall Study||0
490795|NCT01062399|1201601|P5|COMPLETED|Overall Study||88
490796|NCT01062399|1201602|P4|COMPLETED|Overall Study||83
490797|NCT01062399|1201603|P3|COMPLETED|Overall Study||8
490798|NCT01062399|1201604|P2|COMPLETED|Overall Study||9
490799|NCT01062399|1201605|P1|COMPLETED|Overall Study|Subjects with data available for the primary analyses are considered to have completed the study.|8
490800|NCT01062399|1201601|P5|STARTED|Overall Study||92
490801|NCT01062399|1201602|P4|STARTED|Overall Study||89
490802|NCT01062399|1201603|P3|STARTED|Overall Study||8
490803|NCT01062399|1201604|P2|STARTED|Overall Study||10
490804|NCT01062399|1201605|P1|STARTED|Overall Study||8
490805|NCT01062308|1201626|P2|NOT COMPLETED|Overall Study||10
490806|NCT01062308|1201627|P1|NOT COMPLETED|Overall Study||16
490807|NCT01062308|1201626|P2|COMPLETED|Overall Study||72
490808|NCT01062308|1201627|P1|COMPLETED|Overall Study||64
490809|NCT01062308|1201626|P2|STARTED|Overall Study||82
490810|NCT01062308|1201627|P1|STARTED|Overall Study||80
490811|NCT01062269|1201635|P1|NOT COMPLETED|Overall Study||0
490812|NCT01062269|1201635|P1|COMPLETED|Overall Study||42
490813|NCT01062269|1201635|P1|STARTED|Overall Study||42
490814|NCT01062256|1201649|P3|NOT COMPLETED|Overall Study||4
490815|NCT01062256|1201650|P2|NOT COMPLETED|Overall Study||7
490816|NCT01062256|1201651|P1|NOT COMPLETED|Overall Study||3
490817|NCT01062256|1201649|P3|COMPLETED|Overall Study||103
490818|NCT01062256|1201650|P2|COMPLETED|Overall Study||96
490819|NCT01062256|1201651|P1|COMPLETED|Overall Study||52
490820|NCT01062256|1201649|P3|STARTED|Overall Study||107
490821|NCT01062256|1201650|P2|STARTED|Overall Study||103
490822|NCT01062256|1201651|P1|STARTED|Overall Study||55
490823|NCT01062230|1201674|P1|NOT COMPLETED|Overall Study||0
490824|NCT01062230|1201674|P1|COMPLETED|Overall Study||6
490825|NCT01062230|1201674|P1|STARTED|Overall Study||6
490826|NCT01062165|1201678|P1|NOT COMPLETED|Overall Study||0
490827|NCT01062165|1201678|P1|COMPLETED|Overall Study||18
490828|NCT01062165|1201678|P1|STARTED|Overall Study||18
490829|NCT01062113|1201685|P3|NOT COMPLETED|Overall Study||31
490830|NCT01062113|1201686|P2|NOT COMPLETED|Overall Study||22
490831|NCT01062113|1201687|P1|NOT COMPLETED|Overall Study||40
490832|NCT01062113|1201685|P3|COMPLETED|Overall Study||27
490833|NCT01062113|1201686|P2|COMPLETED|Overall Study||42
490834|NCT01062113|1201687|P1|COMPLETED|Overall Study||93
490835|NCT01062113|1201685|P3|STARTED|Overall Study||58
490836|NCT01062113|1201686|P2|STARTED|Overall Study||64
490837|NCT01062113|1201687|P1|STARTED|Overall Study||133
490838|NCT01062074|1201700|P1|NOT COMPLETED|Overall Study||0
490839|NCT01062074|1201700|P1|COMPLETED|Overall Study||3605
490840|NCT01062074|1201700|P1|STARTED|Overall Study||3605
490841|NCT01062061|1201705|P1|NOT COMPLETED|Overall Study||27
490842|NCT01062061|1201705|P1|COMPLETED|Overall Study||727
490843|NCT01062061|1201705|P1|STARTED|Overall Study||754
490844|NCT01061866|1201719|P1|NOT COMPLETED|Overall Study||2
490845|NCT01061866|1201719|P1|COMPLETED|Overall Study||5
490846|NCT01061866|1201719|P1|STARTED|Overall Study||7
490847|NCT01061775|1201723|P1|NOT COMPLETED|Overall Study||3
490848|NCT01061775|1201723|P1|COMPLETED|Overall Study||16
490849|NCT01061775|1201723|P1|STARTED|Overall Study||19
490850|NCT01061736|1201740|P10|NOT COMPLETED|Overall Study||74
490851|NCT01061736|1201741|P9|NOT COMPLETED|Overall Study||97
490852|NCT01061736|1201742|P8|NOT COMPLETED|Overall Study||94
490853|NCT01061736|1201743|P7|NOT COMPLETED|Overall Study||84
490854|NCT01061736|1201744|P6|NOT COMPLETED|Overall Study||3
490855|NCT01061736|1201745|P5|NOT COMPLETED|Overall Study||7
490856|NCT01061736|1201746|P4|NOT COMPLETED|Overall Study||3
490857|NCT01061736|1201747|P3|NOT COMPLETED|Overall Study||6
490858|NCT01061736|1201748|P2|NOT COMPLETED|Overall Study||4
490859|NCT01061736|1201749|P1|NOT COMPLETED|Overall Study||13
490860|NCT01061736|1201740|P10|COMPLETED|Overall Study||354
490861|NCT01061736|1201741|P9|COMPLETED|Overall Study||330
490862|NCT01061736|1201742|P8|COMPLETED|Overall Study||336
490863|NCT01061736|1201743|P7|COMPLETED|Overall Study||0
490864|NCT01061736|1201744|P6|COMPLETED|Overall Study||49
490865|NCT01061736|1201745|P5|COMPLETED|Overall Study||45
490866|NCT01061736|1201746|P4|COMPLETED|Overall Study||48
490867|NCT01061736|1201747|P3|COMPLETED|Overall Study||45
490868|NCT01061736|1201748|P2|COMPLETED|Overall Study||46
490869|NCT01061736|1201749|P1|COMPLETED|Overall Study||37
490870|NCT01061736|1201740|P10|Rescued|Overall Study|Included both participants who completed and did not complete the study.|168
490871|NCT01061736|1201741|P9|Rescued|Overall Study|Included both participants who completed and did not complete the study.|55
490872|NCT01061736|1201742|P8|Rescued|Overall Study|Included both participants who completed and did not complete the study.|61
490873|NCT01061736|1201743|P7|Rescued|Overall Study||0
490874|NCT01061736|1201744|P6|Rescued|Overall Study||0
490875|NCT01061736|1201745|P5|Rescued|Overall Study||0
490876|NCT01061736|1201746|P4|Rescued|Overall Study||0
490877|NCT01061736|1201747|P3|Rescued|Overall Study||0
490878|NCT01061736|1201748|P2|Rescued|Overall Study||0
490879|NCT01061736|1201749|P1|Rescued|Overall Study||0
490880|NCT01061736|1201740|P10|Treated|Overall Study||428
490881|NCT01061736|1201741|P9|Treated|Overall Study||426
490882|NCT01061736|1201742|P8|Treated|Overall Study||428
490883|NCT01061736|1201743|P7|Treated|Overall Study||84
490884|NCT01061736|1201744|P6|Treated|Overall Study||52
490885|NCT01061736|1201745|P5|Treated|Overall Study||51
490886|NCT01061736|1201746|P4|Treated|Overall Study||51
490887|NCT01061736|1201747|P3|Treated|Overall Study||51
490888|NCT01061736|1201748|P2|Treated|Overall Study||50
490889|NCT01061736|1201749|P1|Treated|Overall Study||50
490890|NCT01061736|1201740|P10|STARTED|Overall Study||428
490891|NCT01061736|1201741|P9|STARTED|Overall Study||427
490892|NCT01061736|1201742|P8|STARTED|Overall Study||430
490893|NCT01061736|1201743|P7|STARTED|Overall Study||84
490894|NCT01061736|1201744|P6|STARTED|Overall Study||52
490895|NCT01061736|1201745|P5|STARTED|Overall Study||52
490896|NCT01061736|1201746|P4|STARTED|Overall Study||51
490897|NCT01061736|1201747|P3|STARTED|Overall Study||51
490898|NCT01061736|1201748|P2|STARTED|Overall Study||50
490899|NCT01061736|1201749|P1|STARTED|Overall Study||50
490900|NCT01061723|1201788|P6|NOT COMPLETED|Overall Study||9
490901|NCT01061723|1201789|P5|NOT COMPLETED|Overall Study||3
490902|NCT01061723|1201790|P4|NOT COMPLETED|Overall Study||8
490903|NCT01061723|1201791|P3|NOT COMPLETED|Overall Study||10
490904|NCT01061723|1201792|P2|NOT COMPLETED|Overall Study||6
490905|NCT01061723|1201793|P1|NOT COMPLETED|Overall Study||4
490906|NCT01061723|1201788|P6|COMPLETED|Overall Study||41
490907|NCT01061723|1201789|P5|COMPLETED|Overall Study||47
490908|NCT01061723|1201790|P4|COMPLETED|Overall Study||44
490909|NCT01061723|1201791|P3|COMPLETED|Overall Study||40
490910|NCT01061723|1201792|P2|COMPLETED|Overall Study||43
490911|NCT01061723|1201793|P1|COMPLETED|Overall Study||46
490912|NCT01061723|1201788|P6|Treated|Overall Study||49
490913|NCT01061723|1201789|P5|Treated|Overall Study||50
490914|NCT01061723|1201790|P4|Treated|Overall Study||52
490915|NCT01061723|1201791|P3|Treated|Overall Study||50
490916|NCT01061723|1201792|P2|Treated|Overall Study||49
490917|NCT01061723|1201793|P1|Treated|Overall Study||50
490918|NCT01061723|1201788|P6|STARTED|Overall Study||50
490919|NCT01061723|1201789|P5|STARTED|Overall Study||50
490920|NCT01061723|1201790|P4|STARTED|Overall Study||52
490921|NCT01061723|1201791|P3|STARTED|Overall Study||50
490922|NCT01061723|1201792|P2|STARTED|Overall Study||49
490923|NCT01061723|1201793|P1|STARTED|Overall Study||50
490924|NCT01061710|1201873|P1|NOT COMPLETED|Overall Study||14
490925|NCT01061710|1201873|P1|COMPLETED|Overall Study||6
490926|NCT01061710|1201873|P1|STARTED|Overall Study||20
490927|NCT01061671|1201883|P2|NOT COMPLETED|Overall Study||55
490928|NCT01061671|1201884|P1|NOT COMPLETED|Overall Study||47
490929|NCT01061671|1201883|P2|COMPLETED|Overall Study||397
490930|NCT01061671|1201884|P1|COMPLETED|Overall Study||386
490931|NCT01061671|1201883|P2|STARTED|Overall Study||452
490932|NCT01061671|1201884|P1|STARTED|Overall Study||433
490933|NCT01061606|1201896|P1|NOT COMPLETED|Overall Study||8
490934|NCT01061606|1201896|P1|COMPLETED|Overall Study||0
490935|NCT01061606|1201896|P1|STARTED|Overall Study||8
490936|NCT01061567|1201905|P1|NOT COMPLETED|Overall Study||76
490937|NCT01061567|1201905|P1|COMPLETED|Overall Study||1738
490938|NCT01061567|1201905|P1|STARTED|Overall Study||1814
490939|NCT01061528|1201916|P2|NOT COMPLETED|Overall Study||2
490940|NCT01061528|1201917|P1|NOT COMPLETED|Overall Study||3
490941|NCT01061528|1201916|P2|COMPLETED|Overall Study||52
490942|NCT01061528|1201917|P1|COMPLETED|Overall Study||59
490943|NCT01061528|1201916|P2|STARTED|Overall Study||54
490944|NCT01061528|1201917|P1|STARTED|Overall Study||62
490945|NCT01061476|1201923|P1|NOT COMPLETED|Overall Study||0
490946|NCT01061476|1201923|P1|COMPLETED|Overall Study||12
490947|NCT01061476|1201923|P1|STARTED|Overall Study||12
490948|NCT01061385|1201929|P2|NOT COMPLETED|Overall Study||1
490949|NCT01061385|1201930|P1|NOT COMPLETED|Overall Study||1
490950|NCT01061385|1201929|P2|COMPLETED|Overall Study||8
490951|NCT01061385|1201930|P1|COMPLETED|Overall Study||20
490952|NCT01061385|1201929|P2|STARTED|Overall Study||9
490953|NCT01061385|1201930|P1|STARTED|Overall Study||21
490954|NCT01061359|1201938|P1|NOT COMPLETED|Overall Study||1302
490955|NCT01061359|1201938|P1|COMPLETED|Overall Study|Completed 5 years of follow-up: 668 Disease free and 2 Relapsed|670
490956|NCT01061359|1201938|P1|STARTED|Overall Study||1972
490957|NCT01061333|1201944|P2|NOT COMPLETED|Period 7: Mometasone||0
490958|NCT01061333|1201945|P1|NOT COMPLETED|Period 7: Mometasone||0
490959|NCT01061333|1201944|P2|COMPLETED|Period 7: Mometasone||7
490960|NCT01061333|1201945|P1|COMPLETED|Period 7: Mometasone||8
490961|NCT01061333|1201944|P2|STARTED|Period 7: Mometasone||7
490962|NCT01061333|1201945|P1|STARTED|Period 7: Mometasone||8
490963|NCT01061333|1201944|P2|NOT COMPLETED|Period 6: 20-day Washout||0
490964|NCT01061333|1201945|P1|NOT COMPLETED|Period 6: 20-day Washout||0
490965|NCT01061333|1201944|P2|COMPLETED|Period 6: 20-day Washout||7
490966|NCT01061333|1201945|P1|COMPLETED|Period 6: 20-day Washout||8
490967|NCT01061333|1201944|P2|STARTED|Period 6: 20-day Washout||7
490968|NCT01061333|1201945|P1|STARTED|Period 6: 20-day Washout||8
490969|NCT01061333|1201944|P2|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0
490970|NCT01061333|1201945|P1|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0
490971|NCT01061333|1201944|P2|COMPLETED|Period 5: Nedocromil-Montelukast X-over||7
490972|NCT01061333|1201945|P1|COMPLETED|Period 5: Nedocromil-Montelukast X-over||8
490973|NCT01061333|1201944|P2|STARTED|Period 5: Nedocromil-Montelukast X-over||7
490974|NCT01061333|1201945|P1|STARTED|Period 5: Nedocromil-Montelukast X-over||8
490975|NCT01061333|1201944|P2|NOT COMPLETED|Period 4: 20-day Washout||1
490976|NCT01061333|1201945|P1|NOT COMPLETED|Period 4: 20-day Washout||0
490977|NCT01061333|1201944|P2|COMPLETED|Period 4: 20-day Washout||7
490978|NCT01061333|1201945|P1|COMPLETED|Period 4: 20-day Washout||8
490979|NCT01061333|1201944|P2|STARTED|Period 4: 20-day Washout||8
490980|NCT01061333|1201945|P1|STARTED|Period 4: 20-day Washout||8
490981|NCT01061333|1201944|P2|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0
490982|NCT01061333|1201945|P1|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0
490983|NCT01061333|1201944|P2|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8
490984|NCT01061333|1201945|P1|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8
490985|NCT01061333|1201944|P2|STARTED|Period 3: Nedocromil-Montelukast X-over||8
490986|NCT01061333|1201945|P1|STARTED|Period 3: Nedocromil-Montelukast X-over||8
490987|NCT01061333|1201944|P2|NOT COMPLETED|Period 2: 20-day Washout||0
490988|NCT01061333|1201945|P1|NOT COMPLETED|Period 2: 20-day Washout||0
490989|NCT01061333|1201944|P2|COMPLETED|Period 2: 20-day Washout||8
490990|NCT01061333|1201945|P1|COMPLETED|Period 2: 20-day Washout||8
490991|NCT01061333|1201944|P2|STARTED|Period 2: 20-day Washout||8
490992|NCT01061333|1201945|P1|STARTED|Period 2: 20-day Washout||8
490993|NCT01061333|1201944|P2|NOT COMPLETED|Period 1: Placebo Run-in||0
490994|NCT01061333|1201945|P1|NOT COMPLETED|Period 1: Placebo Run-in||0
490995|NCT01061333|1201944|P2|COMPLETED|Period 1: Placebo Run-in||8
490996|NCT01061333|1201945|P1|COMPLETED|Period 1: Placebo Run-in||8
490997|NCT01061333|1201944|P2|STARTED|Period 1: Placebo Run-in||8
490998|NCT01061333|1201945|P1|STARTED|Period 1: Placebo Run-in||8
490999|NCT01061177|1201983|P1|NOT COMPLETED|Overall Study||208
491000|NCT01061177|1201983|P1|COMPLETED|Overall Study||881
491001|NCT01061177|1201983|P1|ITT_CyR (Ph+ Patients Only)|Overall Study||983
491002|NCT01061177|1201983|P1|ITT_MR (b2a2 &/or b3a2 +ve Pts Only)|Overall Study||1056
491003|NCT01061177|1201983|P1|STARTED|Overall Study||1089
491004|NCT01061151|1202006|P4|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||20
491005|NCT01061151|1202007|P3|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||77
491006|NCT01061151|1202008|P2|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||138
491007|NCT01061151|1202009|P1|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||152
491008|NCT01061151|1202006|P4|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||55
491009|NCT01061151|1202007|P3|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||345
491010|NCT01061151|1202008|P2|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||548
491011|NCT01061151|1202009|P1|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||542
491012|NCT01061151|1202006|P4|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||75
491013|NCT01061151|1202007|P3|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||421
491014|NCT01061151|1202008|P2|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||684
491015|NCT01061151|1202009|P1|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||694
491016|NCT01061151|1202006|P4|STARTED|Protocol Version 3.0: 10/2012-10/2014||75
491017|NCT01061151|1202007|P3|STARTED|Protocol Version 3.0: 10/2012-10/2014||422
491018|NCT01061151|1202008|P2|STARTED|Protocol Version 3.0: 10/2012-10/2014||686
491019|NCT01061151|1202009|P1|STARTED|Protocol Version 3.0: 10/2012-10/2014||694
491020|NCT01061151|1202006|P4|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||28
491021|NCT01061151|1202007|P3|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||9
491022|NCT01061151|1202008|P2|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||241
491023|NCT01061151|1202009|P1|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||232
491024|NCT01061151|1202006|P4|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||101
491025|NCT01061151|1202007|P3|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||16
491026|NCT01061151|1202008|P2|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||620
491027|NCT01061151|1202009|P1|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||623
491028|NCT01061151|1202006|P4|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||129
491029|NCT01061151|1202007|P3|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||24
491030|NCT01061151|1202008|P2|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||861
491031|NCT01061151|1202009|P1|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||853
491032|NCT01061151|1202006|P4|STARTED|Protocol Version 2.0: 04/2011-09/2012||129
491033|NCT01061151|1202007|P3|STARTED|Protocol Version 2.0: 04/2011-09/2012||25
491034|NCT01061151|1202008|P2|STARTED|Protocol Version 2.0: 04/2011-09/2012||861
491035|NCT01061151|1202009|P1|STARTED|Protocol Version 2.0: 04/2011-09/2012||855
491036|NCT01061034|1202061|P1|NOT COMPLETED|Aspirin Plus Omeprazole||0
491037|NCT01061034|1202061|P1|COMPLETED|Aspirin Plus Omeprazole||9
491038|NCT01061034|1202061|P1|STARTED|Aspirin Plus Omeprazole||9
491039|NCT01061034|1202061|P1|NOT COMPLETED|Aspirin||0
491040|NCT01061034|1202061|P1|COMPLETED|Aspirin||9
491041|NCT01061034|1202061|P1|STARTED|Aspirin||9
491042|NCT01061008|1202068|P2|NOT COMPLETED|Overall Study||6
491043|NCT01061008|1202069|P1|NOT COMPLETED|Overall Study||6
491044|NCT01061008|1202068|P2|COMPLETED|Overall Study||9
491045|NCT01061008|1202069|P1|COMPLETED|Overall Study||10
491046|NCT01061008|1202068|P2|STARTED|Overall Study||15
491047|NCT01061008|1202069|P1|STARTED|Overall Study||16
491048|NCT01060670|1202077|P2|NOT COMPLETED|Follow up Phase||35
491049|NCT01060670|1202078|P1|NOT COMPLETED|Follow up Phase||22
491050|NCT01060670|1202077|P2|COMPLETED|Follow up Phase||82
491051|NCT01060670|1202078|P1|COMPLETED|Follow up Phase||106
491052|NCT01060670|1202077|P2|Withdrew From Follow up Phase|Follow up Phase||35
491053|NCT01060670|1202078|P1|Withdrew From Follow up Phase|Follow up Phase||22
491054|NCT01060670|1202077|P2|Recurrence|Follow up Phase||9
491055|NCT01060670|1202078|P1|Recurrence|Follow up Phase||14
491056|NCT01060670|1202077|P2|STARTED|Follow up Phase||117
491057|NCT01060670|1202078|P1|STARTED|Follow up Phase||128
491058|NCT01060670|1202077|P2|NOT COMPLETED|Treatment Phase||36
491059|NCT01060670|1202078|P1|NOT COMPLETED|Treatment Phase||26
491060|NCT01060670|1202077|P2|COMPLETED|Treatment Phase||117
491061|NCT01060670|1202078|P1|COMPLETED|Treatment Phase||128
491062|NCT01060670|1202077|P2|Withdrew From Treatment|Treatment Phase||36
491063|NCT01060670|1202078|P1|Withdrew From Treatment|Treatment Phase||26
491064|NCT01060670|1202077|P2|Did Not Heal by Treatment Visit 17|Treatment Phase||68
491065|NCT01060670|1202078|P1|Did Not Heal by Treatment Visit 17|Treatment Phase||49
491066|NCT01060670|1202077|P2|Healed at End of Treatment Phase|Treatment Phase||49
491067|NCT01060670|1202078|P1|Healed at End of Treatment Phase|Treatment Phase||79
491068|NCT01060670|1202077|P2|STARTED|Treatment Phase||153
491069|NCT01060670|1202078|P1|STARTED|Treatment Phase||154
491070|NCT01060670|1202077|P2|NOT COMPLETED|Run In||238
491071|NCT01060670|1202078|P1|NOT COMPLETED|Run In||0
491072|NCT01060670|1202077|P2|COMPLETED|Run In||307
491073|NCT01060670|1202078|P1|COMPLETED|Run In||0
491074|NCT01060670|1202077|P2|STARTED|Run In||545
491075|NCT01060670|1202078|P1|STARTED|Run In||0
491076|NCT01060592|1202098|P2|NOT COMPLETED|12m||18
491077|NCT01060592|1202099|P1|NOT COMPLETED|12m||0
491078|NCT01060592|1202098|P2|COMPLETED|12m|Historic data was not available at 12m for 18 of the historic controls|31
491079|NCT01060592|1202099|P1|COMPLETED|12m||35
491080|NCT01060592|1202098|P2|STARTED|12m|For some pts, %EWL were not taken/available in the 4-6w period but were available for the 12m period|49
491081|NCT01060592|1202099|P1|STARTED|12m|For some pts, %EWL were not taken/available in the 4-6w period but were available for the 12m period|35
491082|NCT01060592|1202098|P2|NOT COMPLETED|4-6w||10
491083|NCT01060592|1202099|P1|NOT COMPLETED|4-6w||12
491084|NCT01060592|1202098|P2|COMPLETED|4-6w||39
491085|NCT01060592|1202099|P1|COMPLETED|4-6w||23
491086|NCT01060592|1202098|P2|STARTED|4-6w||49
491087|NCT01060592|1202099|P1|STARTED|4-6w||35
491088|NCT01060553|1202113|P2|NOT COMPLETED|Overall Study||10
491089|NCT01060553|1202114|P1|NOT COMPLETED|Overall Study||9
491090|NCT01060553|1202113|P2|COMPLETED|Overall Study||5
491091|NCT01060553|1202114|P1|COMPLETED|Overall Study|5 subjects completed more than half the sessions and midpoint outcome measures were obtained|6
491092|NCT01060553|1202113|P2|STARTED|Overall Study||15
491093|NCT01060553|1202114|P1|STARTED|Overall Study||15
491094|NCT01060540|1202121|P2|NOT COMPLETED|Overall Study||65
491095|NCT01060540|1202122|P1|NOT COMPLETED|Overall Study||64
491096|NCT01060540|1202121|P2|COMPLETED|Overall Study||233
491097|NCT01060540|1202122|P1|COMPLETED|Overall Study||239
491098|NCT01060540|1202121|P2|STARTED|Overall Study||298
491099|NCT01060540|1202122|P1|STARTED|Overall Study||303
491100|NCT01060150|1202136|P1|NOT COMPLETED|Overall Study||23
491101|NCT01060150|1202136|P1|COMPLETED|Overall Study||92
491102|NCT01060150|1202136|P1|Treated|Overall Study||113
491103|NCT01060150|1202136|P1|STARTED|Overall Study||115
491104|NCT01060124|1202151|P1|NOT COMPLETED|Overall Study||37
491105|NCT01060124|1202151|P1|COMPLETED|Overall Study||66
491106|NCT01060124|1202151|P1|STARTED|Overall Study||103
491107|NCT01060111|1202162|P3|NOT COMPLETED|Overall Study||35
491108|NCT01060111|1202163|P2|NOT COMPLETED|Overall Study||23
491109|NCT01060111|1202164|P1|NOT COMPLETED|Overall Study||27
491110|NCT01060111|1202162|P3|COMPLETED|Overall Study||45
491111|NCT01060111|1202163|P2|COMPLETED|Overall Study||61
491112|NCT01060111|1202164|P1|COMPLETED|Overall Study||54
491113|NCT01060111|1202162|P3|Treated|Overall Study||79
491114|NCT01060111|1202163|P2|Treated|Overall Study||83
491115|NCT01060111|1202164|P1|Treated|Overall Study||81
491116|NCT01060111|1202162|P3|STARTED|Overall Study||80
491117|NCT01060111|1202163|P2|STARTED|Overall Study||84
491118|NCT01060111|1202164|P1|STARTED|Overall Study||81
491119|NCT01060072|1202183|P2|NOT COMPLETED|Overall Study||5
491120|NCT01060072|1202184|P1|NOT COMPLETED|Overall Study||2
491121|NCT01060072|1202183|P2|COMPLETED|Overall Study||196
491122|NCT01060072|1202184|P1|COMPLETED|Overall Study||204
491123|NCT01060072|1202183|P2|STARTED|Overall Study||201
491124|NCT01060072|1202184|P1|STARTED|Overall Study||206
491125|NCT01060059|1202200|P2|NOT COMPLETED|Overall Study||67
491126|NCT01060059|1202201|P1|NOT COMPLETED|Overall Study||67
491127|NCT01060059|1202200|P2|COMPLETED|Overall Study||371
491128|NCT01060059|1202201|P1|COMPLETED|Overall Study||377
491129|NCT01060059|1202200|P2|STARTED|Overall Study||438
491130|NCT01060059|1202201|P1|STARTED|Overall Study||444
491131|NCT01060020|1202251|P1|NOT COMPLETED|Overall Study||0
491132|NCT01060020|1202251|P1|COMPLETED|Overall Study||20
491133|NCT01060020|1202251|P1|STARTED|Overall Study||20
491134|NCT01060007|1202259|P1|NOT COMPLETED|Overall Study||4
491135|NCT01060007|1202259|P1|COMPLETED|Overall Study||76
491136|NCT01060007|1202259|P1|STARTED|Overall Study||80
491137|NCT01059994|1202277|P4|NOT COMPLETED|Overall Study||1
491138|NCT01059994|1202278|P3|NOT COMPLETED|Overall Study||0
491139|NCT01059994|1202279|P2|NOT COMPLETED|Overall Study||0
491140|NCT01059994|1202280|P1|NOT COMPLETED|Overall Study||0
491141|NCT01059994|1202277|P4|COMPLETED|Overall Study||3
491142|NCT01059994|1202278|P3|COMPLETED|Overall Study||3
491143|NCT01059994|1202279|P2|COMPLETED|Overall Study||2
491144|NCT01059994|1202280|P1|COMPLETED|Overall Study||3
491145|NCT01059994|1202277|P4|STARTED|Overall Study||4
491146|NCT01059994|1202278|P3|STARTED|Overall Study||3
491147|NCT01059994|1202279|P2|STARTED|Overall Study||2
491148|NCT01059994|1202280|P1|STARTED|Overall Study||3
491149|NCT01059903|1202296|P2|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0
491150|NCT01059903|1202297|P1|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0
491151|NCT01059903|1202296|P2|COMPLETED|Period 3: Second Intervention- 24 Hours||24
491152|NCT01059903|1202297|P1|COMPLETED|Period 3: Second Intervention- 24 Hours||24
491153|NCT01059903|1202296|P2|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours|Two subjects who fullfilled predefined criteria for patch adhesiveness were excluded from the PKS|22
491154|NCT01059903|1202297|P1|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours|Six subjects who fullfilled predefined criteria for patch adhesiveness were excluded from the PKS|18
491155|NCT01059903|1202296|P2|STARTED|Period 3: Second Intervention- 24 Hours||24
491156|NCT01059903|1202297|P1|STARTED|Period 3: Second Intervention- 24 Hours||24
491157|NCT01059903|1202296|P2|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0
491158|NCT01059903|1202297|P1|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0
491159|NCT01059903|1202296|P2|COMPLETED|Period 2: Washout Period (>= 5 Days)||24
491160|NCT01059903|1202297|P1|COMPLETED|Period 2: Washout Period (>= 5 Days)||24
491161|NCT01059903|1202296|P2|STARTED|Period 2: Washout Period (>= 5 Days)||24
491162|NCT01059903|1202297|P1|STARTED|Period 2: Washout Period (>= 5 Days)||24
491163|NCT01059903|1202296|P2|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1
491164|NCT01059903|1202297|P1|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1
491165|NCT01059903|1202296|P2|COMPLETED|Period 1: First Intervention- 24 Hours||24
491166|NCT01059903|1202297|P1|COMPLETED|Period 1: First Intervention- 24 Hours||24
491167|NCT01059903|1202296|P2|STARTED|Period 1: First Intervention- 24 Hours||25
491168|NCT01059903|1202297|P1|STARTED|Period 1: First Intervention- 24 Hours||25
491169|NCT01059864|1202331|P3|NOT COMPLETED|Double-Blind Treatment Phase||3
491170|NCT01059864|1202332|P2|NOT COMPLETED|Double-Blind Treatment Phase||3
491171|NCT01059864|1202333|P1|NOT COMPLETED|Double-Blind Treatment Phase||0
491172|NCT01059864|1202331|P3|COMPLETED|Double-Blind Treatment Phase||45
491173|NCT01059864|1202332|P2|COMPLETED|Double-Blind Treatment Phase||47
491174|NCT01059864|1202333|P1|COMPLETED|Double-Blind Treatment Phase||0
491175|NCT01059864|1202331|P3|Treated|Double-Blind Treatment Phase||47
491176|NCT01059864|1202332|P2|Treated|Double-Blind Treatment Phase||50
491177|NCT01059864|1202333|P1|Treated|Double-Blind Treatment Phase||0
491178|NCT01059864|1202331|P3|STARTED|Double-Blind Treatment Phase||48
491179|NCT01059864|1202332|P2|STARTED|Double-Blind Treatment Phase||50
491180|NCT01059864|1202333|P1|STARTED|Double-Blind Treatment Phase||0
491181|NCT01059864|1202331|P3|NOT COMPLETED|Open-Label Run-In Phase||0
491182|NCT01059864|1202332|P2|NOT COMPLETED|Open-Label Run-In Phase||0
491183|NCT01059864|1202333|P1|NOT COMPLETED|Open-Label Run-In Phase||13
491184|NCT01059864|1202331|P3|COMPLETED|Open-Label Run-In Phase||0
491185|NCT01059864|1202332|P2|COMPLETED|Open-Label Run-In Phase||0
491186|NCT01059864|1202333|P1|COMPLETED|Open-Label Run-In Phase||98
491187|NCT01059864|1202331|P3|STARTED|Open-Label Run-In Phase||0
491188|NCT01059864|1202332|P2|STARTED|Open-Label Run-In Phase||0
491189|NCT01059864|1202333|P1|STARTED|Open-Label Run-In Phase||111
491190|NCT01059851|1202382|P6|NOT COMPLETED|Overall Study||0
491191|NCT01059851|1202383|P5|NOT COMPLETED|Overall Study||0
491192|NCT01059851|1202384|P4|NOT COMPLETED|Overall Study||0
491193|NCT01059851|1202385|P3|NOT COMPLETED|Overall Study||0
491194|NCT01059851|1202386|P2|NOT COMPLETED|Overall Study||0
491195|NCT01059851|1202387|P1|NOT COMPLETED|Overall Study||0
491196|NCT01059851|1202382|P6|COMPLETED|Overall Study||0
491197|NCT01059851|1202383|P5|COMPLETED|Overall Study||0
491198|NCT01059851|1202384|P4|COMPLETED|Overall Study||0
491199|NCT01059851|1202385|P3|COMPLETED|Overall Study||0
491200|NCT01059851|1202386|P2|COMPLETED|Overall Study||8
491201|NCT01059851|1202387|P1|COMPLETED|Overall Study||8
491202|NCT01059851|1202382|P6|STARTED|Overall Study||0
491203|NCT01059851|1202383|P5|STARTED|Overall Study||0
491204|NCT01059851|1202384|P4|STARTED|Overall Study||0
491205|NCT01059851|1202385|P3|STARTED|Overall Study||0
491206|NCT01059851|1202386|P2|STARTED|Overall Study||8
491207|NCT01059851|1202387|P1|STARTED|Overall Study||8
491208|NCT01059825|1202407|P7|NOT COMPLETED|Treatment Period||0
491209|NCT01059825|1202408|P6|NOT COMPLETED|Treatment Period||3
491210|NCT01059825|1202409|P5|NOT COMPLETED|Treatment Period||8
491211|NCT01059825|1202410|P4|NOT COMPLETED|Treatment Period||11
491212|NCT01059825|1202411|P3|NOT COMPLETED|Treatment Period||6
491213|NCT01059825|1202412|P2|NOT COMPLETED|Treatment Period||4
491214|NCT01059825|1202413|P1|NOT COMPLETED|Treatment Period||10
491215|NCT01059825|1202407|P7|COMPLETED|Treatment Period||0
491216|NCT01059825|1202408|P6|COMPLETED|Treatment Period||52
491217|NCT01059825|1202409|P5|COMPLETED|Treatment Period||47
491218|NCT01059825|1202410|P4|COMPLETED|Treatment Period||44
491219|NCT01059825|1202411|P3|COMPLETED|Treatment Period||49
491220|NCT01059825|1202412|P2|COMPLETED|Treatment Period||50
491221|NCT01059825|1202413|P1|COMPLETED|Treatment Period||44
491222|NCT01059825|1202407|P7|STARTED|Treatment Period|Participants who completed run-in were randomized to 1 of 6 treatment groups.|0
491223|NCT01059825|1202408|P6|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
491224|NCT01059825|1202409|P5|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
491225|NCT01059825|1202410|P4|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
491226|NCT01059825|1202411|P3|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
491227|NCT01059825|1202412|P2|STARTED|Treatment Period|54 participants who completed the run-in period were randomized to this treatment group.|54
491228|NCT01059825|1202413|P1|STARTED|Treatment Period|54 participants who completed the run-in period were randomized to this treatment group.|54
491229|NCT01059825|1202407|P7|NOT COMPLETED|Enrolled, Run-in Period||47
491230|NCT01059825|1202408|P6|NOT COMPLETED|Enrolled, Run-in Period||0
491231|NCT01059825|1202409|P5|NOT COMPLETED|Enrolled, Run-in Period||0
491232|NCT01059825|1202410|P4|NOT COMPLETED|Enrolled, Run-in Period||0
491233|NCT01059825|1202411|P3|NOT COMPLETED|Enrolled, Run-in Period||0
491234|NCT01059825|1202412|P2|NOT COMPLETED|Enrolled, Run-in Period||0
491235|NCT01059825|1202413|P1|NOT COMPLETED|Enrolled, Run-in Period||0
491236|NCT01059825|1202407|P7|COMPLETED|Enrolled, Run-in Period||328
491237|NCT01059825|1202408|P6|COMPLETED|Enrolled, Run-in Period||0
491238|NCT01059825|1202409|P5|COMPLETED|Enrolled, Run-in Period||0
491239|NCT01059825|1202410|P4|COMPLETED|Enrolled, Run-in Period||0
491240|NCT01059825|1202411|P3|COMPLETED|Enrolled, Run-in Period||0
491241|NCT01059825|1202412|P2|COMPLETED|Enrolled, Run-in Period||0
491242|NCT01059825|1202413|P1|COMPLETED|Enrolled, Run-in Period||0
491243|NCT01059825|1202407|P7|STARTED|Enrolled, Run-in Period||375
491244|NCT01059825|1202408|P6|STARTED|Enrolled, Run-in Period||0
491245|NCT01059825|1202409|P5|STARTED|Enrolled, Run-in Period||0
491246|NCT01059825|1202410|P4|STARTED|Enrolled, Run-in Period||0
491247|NCT01059825|1202411|P3|STARTED|Enrolled, Run-in Period||0
491248|NCT01059825|1202412|P2|STARTED|Enrolled, Run-in Period||0
491249|NCT01059825|1202413|P1|STARTED|Enrolled, Run-in Period||0
491250|NCT01059812|1202600|P2|NOT COMPLETED|Overall Study||16
491251|NCT01059812|1202601|P1|NOT COMPLETED|Overall Study||37
491252|NCT01059812|1202600|P2|COMPLETED|Overall Study||126
491253|NCT01059812|1202601|P1|COMPLETED|Overall Study||245
491254|NCT01059812|1202600|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|141
491255|NCT01059812|1202601|P1|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug|279
491256|NCT01059812|1202600|P2|STARTED|Overall Study||142
491257|NCT01059812|1202601|P1|STARTED|Overall Study||282
491258|NCT01059799|1202617|P2|NOT COMPLETED|Overall Study||10
491259|NCT01059799|1202618|P1|NOT COMPLETED|Overall Study||31
491260|NCT01059799|1202617|P2|COMPLETED|Overall Study||136
491261|NCT01059799|1202618|P1|COMPLETED|Overall Study||258
491262|NCT01059799|1202617|P2|Exposed|Overall Study||146
491263|NCT01059799|1202618|P1|Exposed|Overall Study|Five subjects withdrew before exposure to trial drug|284
491264|NCT01059799|1202617|P2|STARTED|Overall Study||146
491265|NCT01059799|1202618|P1|STARTED|Overall Study||289
491266|NCT01059773|1202632|P2|NOT COMPLETED|Overall Study||24
491267|NCT01059773|1202633|P1|NOT COMPLETED|Overall Study||20
491268|NCT01059773|1202632|P2|COMPLETED|Overall Study|Completed is refering to no Discontinuation of Study Agent Through Week 52|221
491269|NCT01059773|1202633|P1|COMPLETED|Overall Study|Completed is refering to no Discontinuation of Study Agent Through Week 52|224
491270|NCT01059773|1202632|P2|STARTED|Overall Study||245
491271|NCT01059773|1202633|P1|STARTED|Overall Study||244
491272|NCT01059760|1202665|P2|NOT COMPLETED|Overall Study||0
491273|NCT01059760|1202666|P1|NOT COMPLETED|Overall Study||0
491274|NCT01059760|1202665|P2|COMPLETED|Overall Study||14
491275|NCT01059760|1202666|P1|COMPLETED|Overall Study||16
491276|NCT01059760|1202665|P2|STARTED|Overall Study||14
491277|NCT01059760|1202666|P1|STARTED|Overall Study||16
491278|NCT01059643|1202772|P1|NOT COMPLETED|Overall Study||6
491279|NCT01059643|1202772|P1|COMPLETED|Overall Study||97
491280|NCT01059643|1202772|P1|Received at Least 1 Dose of Study Drug|Overall Study||103
491281|NCT01059643|1202772|P1|STARTED|Overall Study||103
491282|NCT01059630|1202787|P2|NOT COMPLETED|Maintenance Period (up to 2 Years)||108
491283|NCT01059630|1202788|P1|NOT COMPLETED|Maintenance Period (up to 2 Years)||0
491284|NCT01059630|1202787|P2|COMPLETED|Maintenance Period (up to 2 Years)||35
491285|NCT01059630|1202788|P1|COMPLETED|Maintenance Period (up to 2 Years)||0
491286|NCT01059630|1202787|P2|STARTED|Maintenance Period (up to 2 Years)|Of all participants who completed induction, 13 participants did not start maintenance.|143
491287|NCT01059630|1202788|P1|STARTED|Maintenance Period (up to 2 Years)|Maintenance was not planned for this arm.|0
491288|NCT01059630|1202787|P2|NOT COMPLETED|Induction Period (6 Months)||38
491289|NCT01059630|1202788|P1|NOT COMPLETED|Induction Period (6 Months)||73
491290|NCT01059630|1202787|P2|COMPLETED|Induction Period (6 Months)||156
491291|NCT01059630|1202788|P1|COMPLETED|Induction Period (6 Months)||129
491292|NCT01059630|1202787|P2|Treated|Induction Period (6 Months)||194
491293|NCT01059630|1202788|P1|Treated|Induction Period (6 Months)||198
491294|NCT01059630|1202787|P2|STARTED|Induction Period (6 Months)||194
491295|NCT01059630|1202788|P1|STARTED|Induction Period (6 Months)||202
491296|NCT01059617|1202848|P4|NOT COMPLETED|Overall Study||6
491297|NCT01059617|1202849|P3|NOT COMPLETED|Overall Study||8
491298|NCT01059617|1202850|P2|NOT COMPLETED|Overall Study||1
491299|NCT01059617|1202851|P1|NOT COMPLETED|Overall Study||7
491300|NCT01059617|1202848|P4|COMPLETED|Overall Study||27
491301|NCT01059617|1202849|P3|COMPLETED|Overall Study||25
491302|NCT01059617|1202850|P2|COMPLETED|Overall Study||33
491303|NCT01059617|1202851|P1|COMPLETED|Overall Study||26
491304|NCT01059617|1202848|P4|STARTED|Overall Study||33
491305|NCT01059617|1202849|P3|STARTED|Overall Study||33
491306|NCT01059617|1202850|P2|STARTED|Overall Study||34
491307|NCT01059617|1202851|P1|STARTED|Overall Study||33
491308|NCT01059565|1203021|P2|NOT COMPLETED|24-Week Open-Label Phase||3
491309|NCT01059565|1203022|P1|NOT COMPLETED|24-Week Open-Label Phase||5
491310|NCT01059565|1203021|P2|COMPLETED|24-Week Open-Label Phase||42
491311|NCT01059565|1203022|P1|COMPLETED|24-Week Open-Label Phase||34
491312|NCT01059565|1203021|P2|STARTED|24-Week Open-Label Phase||45
491313|NCT01059565|1203022|P1|STARTED|24-Week Open-Label Phase||39
491314|NCT01059565|1203021|P2|NOT COMPLETED|24-Week Randomized Phase||7
491315|NCT01059565|1203022|P1|NOT COMPLETED|24-Week Randomized Phase||10
491316|NCT01059565|1203021|P2|COMPLETED|24-Week Randomized Phase||45
491317|NCT01059565|1203022|P1|COMPLETED|24-Week Randomized Phase||39
491318|NCT01059565|1203021|P2|Randomized and Treated|24-Week Randomized Phase||52
491319|NCT01059565|1203022|P1|Randomized and Treated|24-Week Randomized Phase||48
491320|NCT01059565|1203021|P2|STARTED|24-Week Randomized Phase||52
491321|NCT01059565|1203022|P1|STARTED|24-Week Randomized Phase||49
491322|NCT01059526|1203058|P2|NOT COMPLETED|Overall Study||22
491323|NCT01059526|1203059|P1|NOT COMPLETED|Overall Study||30
491324|NCT01059526|1203058|P2|COMPLETED|Overall Study||18
491325|NCT01059526|1203059|P1|COMPLETED|Overall Study||11
491326|NCT01059526|1203058|P2|Treated|Overall Study|Safety population; defined as all patients who received at least 1 treatment dose of KALBITOR|23
491327|NCT01059526|1203059|P1|Treated|Overall Study|Safety population; defined as all patients who received at least 1 treatment dose of KALBITOR|21
491328|NCT01059526|1203058|P2|STARTED|Overall Study|ITT population; defined as signing informed consent and meeting all inclusion/ exclusion criteria|40
491329|NCT01059526|1203059|P1|STARTED|Overall Study|ITT population; defined as signing informed consent and meeting all inclusion/ exclusion criteria|41
491330|NCT01059344|1203069|P2|NOT COMPLETED|Overall Study||46
491331|NCT01059344|1203070|P1|NOT COMPLETED|Overall Study||22
491332|NCT01059344|1203069|P2|COMPLETED|Overall Study||95
491333|NCT01059344|1203070|P1|COMPLETED|Overall Study||118
491334|NCT01059344|1203069|P2|STARTED|Overall Study||141
491335|NCT01059344|1203070|P1|STARTED|Overall Study||140
491336|NCT01059305|1203088|P1|NOT COMPLETED|Overall Study||0
491337|NCT01059305|1203088|P1|COMPLETED|Overall Study||10
491338|NCT01059305|1203088|P1|STARTED|Overall Study||10
491339|NCT01059175|1203094|P2|NOT COMPLETED|Overall Study||20
491340|NCT01059175|1203095|P1|NOT COMPLETED|Overall Study||21
491341|NCT01059175|1203094|P2|COMPLETED|Overall Study|17 patients deceased 3 patients were prematurely exited|21
491342|NCT01059175|1203095|P1|COMPLETED|Overall Study|17 patients deceased 4 additional patients were prematurely exited|22
491343|NCT01059175|1203094|P2|STARTED|Overall Study||41
491344|NCT01059175|1203095|P1|STARTED|Overall Study||43
491345|NCT01059071|1203117|P4|NOT COMPLETED|Overall Study||6
491346|NCT01059071|1203118|P3|NOT COMPLETED|Overall Study||2
491347|NCT01059071|1203119|P2|NOT COMPLETED|Overall Study||4
491348|NCT01059071|1203120|P1|NOT COMPLETED|Overall Study||2
491349|NCT01059071|1203117|P4|COMPLETED|Overall Study||3
491350|NCT01059071|1203118|P3|COMPLETED|Overall Study||1
491351|NCT01059071|1203119|P2|COMPLETED|Overall Study||1
491352|NCT01059071|1203120|P1|COMPLETED|Overall Study||2
491353|NCT01059071|1203117|P4|STARTED|Overall Study||9
491354|NCT01059071|1203118|P3|STARTED|Overall Study||3
491355|NCT01059071|1203119|P2|STARTED|Overall Study||5
491356|NCT01059071|1203120|P1|STARTED|Overall Study||4
491357|NCT01058993|1203132|P1|NOT COMPLETED|Overall Study||0
491358|NCT01058993|1203132|P1|COMPLETED|Overall Study||6
491359|NCT01058993|1203132|P1|STARTED|Overall Study||6
491360|NCT01058941|1203138|P2|NOT COMPLETED|Overall Study||11
491361|NCT01058941|1203139|P1|NOT COMPLETED|Overall Study||9
491362|NCT01058941|1203138|P2|COMPLETED|Overall Study||22
491363|NCT01058941|1203139|P1|COMPLETED|Overall Study||25
491364|NCT01058941|1203138|P2|STARTED|Overall Study||33
491365|NCT01058941|1203139|P1|STARTED|Overall Study||34
491366|NCT01058863|1203147|P1|NOT COMPLETED|Overall Study||4
491367|NCT01058863|1203147|P1|COMPLETED|Overall Study||68
491368|NCT01058863|1203147|P1|Treated With Placebo Inhaler|Overall Study||69
491369|NCT01058863|1203147|P1|Treated With ProAir® HFA 180 mcg|Overall Study||68
491370|NCT01058863|1203147|P1|Treated With ProAir® HFA 90 mcg|Overall Study||70
491371|NCT01058863|1203147|P1|Treated With Albuterol Spiromax® 180 mcg|Overall Study||68
491372|NCT01058863|1203147|P1|Treated With Albuterol Spiromax® 90 mcg|Overall Study||68
491373|NCT01058863|1203147|P1|Safety and ITT Populations|Overall Study|One patient was randomized in error and never received the study drug.|71
491374|NCT01058863|1203147|P1|STARTED|Overall Study||72
491375|NCT01058668|1203168|P3|NOT COMPLETED|Safety Follow-up||7
491376|NCT01058668|1203169|P2|NOT COMPLETED|Safety Follow-up||0
491377|NCT01058668|1203170|P1|NOT COMPLETED|Safety Follow-up||5
491378|NCT01058668|1203168|P3|COMPLETED|Safety Follow-up||141
491379|NCT01058668|1203169|P2|COMPLETED|Safety Follow-up||146
491380|NCT01058668|1203170|P1|COMPLETED|Safety Follow-up||139
491381|NCT01058668|1203168|P3|STARTED|Safety Follow-up||148
491382|NCT01058668|1203169|P2|STARTED|Safety Follow-up||146
491383|NCT01058668|1203170|P1|STARTED|Safety Follow-up|Not all participants entered the Safety-Follow-up|144
491384|NCT01058668|1203168|P3|NOT COMPLETED|Double-blind Treatment Phase||50
491385|NCT01058668|1203169|P2|NOT COMPLETED|Double-blind Treatment Phase||38
491386|NCT01058668|1203170|P1|NOT COMPLETED|Double-blind Treatment Phase||39
491387|NCT01058668|1203168|P3|COMPLETED|Double-blind Treatment Phase||119
491388|NCT01058668|1203169|P2|COMPLETED|Double-blind Treatment Phase||129
491389|NCT01058668|1203170|P1|COMPLETED|Double-blind Treatment Phase||122
491390|NCT01058668|1203168|P3|STARTED|Double-blind Treatment Phase||169
491391|NCT01058668|1203169|P2|STARTED|Double-blind Treatment Phase||167
491392|NCT01058668|1203170|P1|STARTED|Double-blind Treatment Phase||161
491393|NCT01058655|1203185|P4|NOT COMPLETED|Overall Study||42
491394|NCT01058655|1203186|P3|NOT COMPLETED|Overall Study||8
491395|NCT01058655|1203187|P2|NOT COMPLETED|Overall Study||3
491396|NCT01058655|1203188|P1|NOT COMPLETED|Overall Study||3
491397|NCT01058655|1203185|P4|COMPLETED|Overall Study||0
491398|NCT01058655|1203186|P3|COMPLETED|Overall Study||0
491399|NCT01058655|1203187|P2|COMPLETED|Overall Study||0
491400|NCT01058655|1203188|P1|COMPLETED|Overall Study||0
491401|NCT01058655|1203185|P4|Evaluable|Overall Study||40
491402|NCT01058655|1203186|P3|Evaluable|Overall Study||6
491403|NCT01058655|1203187|P2|Evaluable|Overall Study||3
491404|NCT01058655|1203188|P1|Evaluable|Overall Study||3
491405|NCT01058655|1203185|P4|STARTED|Overall Study||42
491406|NCT01058655|1203186|P3|STARTED|Overall Study||8
491407|NCT01058655|1203187|P2|STARTED|Overall Study||3
491408|NCT01058655|1203188|P1|STARTED|Overall Study||3
491409|NCT01058642|1203206|P4|NOT COMPLETED|Treatment Period 2||0
491410|NCT01058642|1203207|P3|NOT COMPLETED|Treatment Period 2||0
491411|NCT01058642|1203208|P2|NOT COMPLETED|Treatment Period 2||0
491412|NCT01058642|1203209|P1|NOT COMPLETED|Treatment Period 2||0
491413|NCT01058642|1203206|P4|COMPLETED|Treatment Period 2||7
491414|NCT01058642|1203207|P3|COMPLETED|Treatment Period 2||9
491415|NCT01058642|1203208|P2|COMPLETED|Treatment Period 2||11
491416|NCT01058642|1203209|P1|COMPLETED|Treatment Period 2||7
491417|NCT01058642|1203206|P4|Received at Least 1 Dose of Study Drug|Treatment Period 2||7
491418|NCT01058642|1203207|P3|Received at Least 1 Dose of Study Drug|Treatment Period 2||9
491419|NCT01058642|1203208|P2|Received at Least 1 Dose of Study Drug|Treatment Period 2||11
491420|NCT01058642|1203209|P1|Received at Least 1 Dose of Study Drug|Treatment Period 2||7
491421|NCT01058642|1203206|P4|STARTED|Treatment Period 2||7
491422|NCT01058642|1203207|P3|STARTED|Treatment Period 2||9
491423|NCT01058642|1203208|P2|STARTED|Treatment Period 2||11
491424|NCT01058642|1203209|P1|STARTED|Treatment Period 2||7
491425|NCT01058642|1203206|P4|NOT COMPLETED|Washout Period||0
491426|NCT01058642|1203207|P3|NOT COMPLETED|Washout Period||0
491427|NCT01058642|1203208|P2|NOT COMPLETED|Washout Period||0
491428|NCT01058642|1203209|P1|NOT COMPLETED|Washout Period||0
491429|NCT01058642|1203206|P4|COMPLETED|Washout Period||7
491430|NCT01058642|1203207|P3|COMPLETED|Washout Period||9
491431|NCT01058642|1203208|P2|COMPLETED|Washout Period||11
491432|NCT01058642|1203209|P1|COMPLETED|Washout Period||7
491433|NCT01058642|1203206|P4|STARTED|Washout Period||7
491434|NCT01058642|1203207|P3|STARTED|Washout Period||9
491435|NCT01058642|1203208|P2|STARTED|Washout Period||11
491436|NCT01058642|1203209|P1|STARTED|Washout Period||7
491437|NCT01058642|1203206|P4|NOT COMPLETED|Treatment Period 1||2
491438|NCT01058642|1203207|P3|NOT COMPLETED|Treatment Period 1||2
491439|NCT01058642|1203208|P2|NOT COMPLETED|Treatment Period 1||1
491440|NCT01058642|1203209|P1|NOT COMPLETED|Treatment Period 1||2
491441|NCT01058642|1203206|P4|COMPLETED|Treatment Period 1||7
491442|NCT01058642|1203207|P3|COMPLETED|Treatment Period 1||9
491443|NCT01058642|1203208|P2|COMPLETED|Treatment Period 1||11
491444|NCT01058642|1203209|P1|COMPLETED|Treatment Period 1||7
491445|NCT01058642|1203206|P4|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
491446|NCT01058642|1203207|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1||11
491447|NCT01058642|1203208|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||12
491448|NCT01058642|1203209|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
491449|NCT01058642|1203206|P4|STARTED|Treatment Period 1||9
491450|NCT01058642|1203207|P3|STARTED|Treatment Period 1||11
491451|NCT01058642|1203208|P2|STARTED|Treatment Period 1||12
491452|NCT01058642|1203209|P1|STARTED|Treatment Period 1||9
491453|NCT01058421|1203219|P2|NOT COMPLETED|6 Month Outcomes||26
491454|NCT01058421|1203220|P1|NOT COMPLETED|6 Month Outcomes||19
491455|NCT01058421|1203219|P2|COMPLETED|6 Month Outcomes||24
491456|NCT01058421|1203220|P1|COMPLETED|6 Month Outcomes||27
491457|NCT01058421|1203219|P2|STARTED|6 Month Outcomes|61 (subjects started Period 1) minus 11 (deceased subjects in Periods 1 & 2) = 50 started Period 3.|50
491458|NCT01058421|1203220|P1|STARTED|6 Month Outcomes|55 (subjects started Period 1) minus 13 (deceased subjects in Periods 1 & 2) = 46 started Period 3.|46
491459|NCT01058421|1203219|P2|NOT COMPLETED|3 Month Outcomes||26
491460|NCT01058421|1203220|P1|NOT COMPLETED|3 Month Outcomes||20
491461|NCT01058421|1203219|P2|COMPLETED|3 Month Outcomes||29
491462|NCT01058421|1203220|P1|COMPLETED|3 Month Outcomes||29
491463|NCT01058421|1203219|P2|STARTED|3 Month Outcomes|61 (Subjects started Period 1) minus 6 (deceased subjects during Period 1) = 55 started Period 2.|55
491464|NCT01058421|1203220|P1|STARTED|3 Month Outcomes|59 (Subjects started Period 1) minus 10 (deceased subjects during Period 1) = 49 started Period 2.|49
491465|NCT01058421|1203219|P2|NOT COMPLETED|1 Month Outcomes||42
491466|NCT01058421|1203220|P1|NOT COMPLETED|1 Month Outcomes||39
491467|NCT01058421|1203219|P2|COMPLETED|1 Month Outcomes||19
491468|NCT01058421|1203220|P1|COMPLETED|1 Month Outcomes||20
491469|NCT01058421|1203219|P2|STARTED|1 Month Outcomes||61
491470|NCT01058421|1203220|P1|STARTED|1 Month Outcomes||59
491471|NCT01058356|1203242|P1|NOT COMPLETED|Overall Study||42
491472|NCT01058356|1203242|P1|COMPLETED|Overall Study||172
491473|NCT01058356|1203242|P1|STARTED|Overall Study||214
491474|NCT01058304|1203249|P2|NOT COMPLETED|Overall Study||33
491475|NCT01058304|1203250|P1|NOT COMPLETED|Overall Study||27
491476|NCT01058304|1203249|P2|COMPLETED|Overall Study||128
491477|NCT01058304|1203250|P1|COMPLETED|Overall Study||132
491478|NCT01058304|1203249|P2|STARTED|Overall Study||161
491479|NCT01058304|1203250|P1|STARTED|Overall Study||159
491480|NCT01058265|1203260|P2|NOT COMPLETED|Overall Study||12
491481|NCT01058265|1203261|P1|NOT COMPLETED|Overall Study||11
491482|NCT01058265|1203260|P2|COMPLETED|Overall Study||13
491483|NCT01058265|1203261|P1|COMPLETED|Overall Study||11
491484|NCT01058265|1203260|P2|STARTED|Overall Study||25
491485|NCT01058265|1203261|P1|STARTED|Overall Study||22
491486|NCT01058239|1203269|P1|NOT COMPLETED|Overall Study||0
491487|NCT01058239|1203269|P1|COMPLETED|Overall Study||7
491488|NCT01058239|1203269|P1|STARTED|Overall Study||7
491489|NCT01058096|1203280|P2|NOT COMPLETED|Safety Follow-up||4
491490|NCT01058096|1203281|P1|NOT COMPLETED|Safety Follow-up||4
491491|NCT01058096|1203280|P2|COMPLETED|Safety Follow-up||130
491492|NCT01058096|1203281|P1|COMPLETED|Safety Follow-up||129
491493|NCT01058096|1203280|P2|STARTED|Safety Follow-up||134
491494|NCT01058096|1203281|P1|STARTED|Safety Follow-up|Not all participants continued to Safety Follow-up.|133
491495|NCT01058096|1203280|P2|NOT COMPLETED|Double-blind Treatment Phase||50
491496|NCT01058096|1203281|P1|NOT COMPLETED|Double-blind Treatment Phase||48
491497|NCT01058096|1203280|P2|COMPLETED|Double-blind Treatment Phase||108
491498|NCT01058096|1203281|P1|COMPLETED|Double-blind Treatment Phase||106
491499|NCT01058096|1203280|P2|STARTED|Double-blind Treatment Phase||158
491500|NCT01058096|1203281|P1|STARTED|Double-blind Treatment Phase||154
491501|NCT01058070|1203289|P1|NOT COMPLETED|Overall Study||11
491502|NCT01058070|1203289|P1|COMPLETED|Overall Study||33
491503|NCT01058070|1203289|P1|STARTED|Overall Study||44
491504|NCT01058005|1203297|P3|NOT COMPLETED|Overall Study||20
491505|NCT01058005|1203298|P2|NOT COMPLETED|Overall Study||25
491506|NCT01058005|1203299|P1|NOT COMPLETED|Overall Study||38
491507|NCT01058005|1203297|P3|COMPLETED|Overall Study||1
491508|NCT01058005|1203298|P2|COMPLETED|Overall Study||0
491509|NCT01058005|1203299|P1|COMPLETED|Overall Study||0
491510|NCT01058005|1203297|P3|Dosed With Study Treatment|Overall Study||17
491511|NCT01058005|1203298|P2|Dosed With Study Treatment|Overall Study||22
491512|NCT01058005|1203299|P1|Dosed With Study Treatment|Overall Study||36
491513|NCT01058005|1203297|P3|STARTED|Overall Study||21
491514|NCT01058005|1203298|P2|STARTED|Overall Study||25
491515|NCT01058005|1203299|P1|STARTED|Overall Study||38
491516|NCT01057901|1203309|P2|NOT COMPLETED|Overall Study||246
491517|NCT01057901|1203310|P1|NOT COMPLETED|Overall Study||260
491518|NCT01057901|1203309|P2|COMPLETED|Overall Study||126
491519|NCT01057901|1203310|P1|COMPLETED|Overall Study||116
491520|NCT01057901|1203309|P2|STARTED|Overall Study||372
491521|NCT01057901|1203310|P1|STARTED|Overall Study||376
491522|NCT01057888|1203321|P3|NOT COMPLETED|Overall Study||0
491523|NCT01057888|1203322|P2|NOT COMPLETED|Overall Study||0
491524|NCT01057888|1203323|P1|NOT COMPLETED|Overall Study||0
491525|NCT01057888|1203321|P3|COMPLETED|Overall Study||2494
491526|NCT01057888|1203322|P2|COMPLETED|Overall Study||2406
491527|NCT01057888|1203323|P1|COMPLETED|Overall Study||2504
491528|NCT01057888|1203321|P3|STARTED|Overall Study||2494
491529|NCT01057888|1203322|P2|STARTED|Overall Study||2406
491530|NCT01057888|1203323|P1|STARTED|Overall Study||2504
491531|NCT01057862|1203334|P2|NOT COMPLETED|Overall Study||2
491532|NCT01057862|1203335|P1|NOT COMPLETED|Overall Study||1
491533|NCT01057862|1203334|P2|COMPLETED|Overall Study||2
491534|NCT01057862|1203335|P1|COMPLETED|Overall Study||4
491535|NCT01057862|1203334|P2|STARTED|Overall Study||4
491536|NCT01057862|1203335|P1|STARTED|Overall Study||5
491537|NCT01057810|1203345|P2|NOT COMPLETED|Overall Study||398
491538|NCT01057810|1203346|P1|NOT COMPLETED|Overall Study||198
491539|NCT01057810|1203345|P2|COMPLETED|Overall Study||1
491540|NCT01057810|1203346|P1|COMPLETED|Overall Study||1
491541|NCT01057810|1203345|P2|STARTED|Overall Study||399
491542|NCT01057810|1203346|P1|STARTED|Overall Study||199
491543|NCT01057693|1203362|P3|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||36
491544|NCT01057693|1203363|P2|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||22
491545|NCT01057693|1203364|P1|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0
491546|NCT01057693|1203362|P3|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||113
491547|NCT01057693|1203363|P2|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||125
491548|NCT01057693|1203364|P1|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0
491549|NCT01057693|1203362|P3|Treated|Double-Blind Phase (Week 7 to Week 19)||147
491550|NCT01057693|1203363|P2|Treated|Double-Blind Phase (Week 7 to Week 19)||147
491551|NCT01057693|1203364|P1|Treated|Double-Blind Phase (Week 7 to Week 19)||0
491552|NCT01057693|1203362|P3|STARTED|Double-Blind Phase (Week 7 to Week 19)||149
491553|NCT01057693|1203363|P2|STARTED|Double-Blind Phase (Week 7 to Week 19)||147
491554|NCT01057693|1203364|P1|STARTED|Double-Blind Phase (Week 7 to Week 19)||0
491555|NCT01057693|1203362|P3|NOT COMPLETED|Between Single-Blind and Double-Blind||0
491556|NCT01057693|1203363|P2|NOT COMPLETED|Between Single-Blind and Double-Blind||0
491557|NCT01057693|1203364|P1|NOT COMPLETED|Between Single-Blind and Double-Blind||270
491558|NCT01057693|1203362|P3|COMPLETED|Between Single-Blind and Double-Blind||0
491559|NCT01057693|1203363|P2|COMPLETED|Between Single-Blind and Double-Blind||0
491560|NCT01057693|1203364|P1|COMPLETED|Between Single-Blind and Double-Blind||296
491561|NCT01057693|1203362|P3|STARTED|Between Single-Blind and Double-Blind||0
491562|NCT01057693|1203363|P2|STARTED|Between Single-Blind and Double-Blind||0
491563|NCT01057693|1203364|P1|STARTED|Between Single-Blind and Double-Blind||566
491564|NCT01057693|1203362|P3|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0
491565|NCT01057693|1203363|P2|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0
491566|NCT01057693|1203364|P1|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||99
491567|NCT01057693|1203362|P3|COMPLETED|Single-Blind Phase (Up to Week 6)||0
491568|NCT01057693|1203363|P2|COMPLETED|Single-Blind Phase (Up to Week 6)||0
491569|NCT01057693|1203364|P1|COMPLETED|Single-Blind Phase (Up to Week 6)||566
491570|NCT01057693|1203362|P3|STARTED|Single-Blind Phase (Up to Week 6)||0
491571|NCT01057693|1203363|P2|STARTED|Single-Blind Phase (Up to Week 6)||0
491572|NCT01057693|1203364|P1|STARTED|Single-Blind Phase (Up to Week 6)||665
491573|NCT01057589|1203410|P1|NOT COMPLETED|Overall Study||66
491574|NCT01057589|1203410|P1|COMPLETED|Overall Study||0
491575|NCT01057589|1203410|P1|STARTED|Overall Study||66
491576|NCT01057433|1203419|P1|NOT COMPLETED|Overall Study||1
491577|NCT01057433|1203419|P1|COMPLETED|Overall Study||23
491578|NCT01057433|1203419|P1|STARTED|Overall Study||24
491579|NCT01057394|1203423|P2|NOT COMPLETED|Overall Study||2
491580|NCT01057394|1203424|P1|NOT COMPLETED|Overall Study||0
491581|NCT01057394|1203423|P2|COMPLETED|Overall Study|19 treated participants|19
491582|NCT01057394|1203424|P1|COMPLETED|Overall Study||0
491583|NCT01057394|1203423|P2|STARTED|Overall Study|21 enrolled participants|21
491584|NCT01057394|1203424|P1|STARTED|Overall Study||0
491585|NCT01057277|1203428|P1|NOT COMPLETED|Overall Study||0
491586|NCT01057277|1203428|P1|COMPLETED|Overall Study||3
491587|NCT01057277|1203428|P1|STARTED|Overall Study||3
491588|NCT01057251|1203434|P2|NOT COMPLETED|Overall Study||29
491589|NCT01057251|1203435|P1|NOT COMPLETED|Overall Study||28
491590|NCT01057251|1203434|P2|COMPLETED|Overall Study||114
491591|NCT01057251|1203435|P1|COMPLETED|Overall Study||262
491592|NCT01057251|1203434|P2|STARTED|Overall Study|The safety population is 142, as one patient was randomized, but never received study drug.|143
491593|NCT01057251|1203435|P1|STARTED|Overall Study||290
491594|NCT01057225|1203443|P6|NOT COMPLETED|Overall Study||0
491595|NCT01057225|1203444|P5|NOT COMPLETED|Overall Study||0
491596|NCT01057225|1203445|P4|NOT COMPLETED|Overall Study||0
491597|NCT01057225|1203446|P3|NOT COMPLETED|Overall Study||0
491598|NCT01057225|1203447|P2|NOT COMPLETED|Overall Study||0
491599|NCT01057225|1203448|P1|NOT COMPLETED|Overall Study||0
491600|NCT01057225|1203443|P6|COMPLETED|Overall Study||23
491601|NCT01057225|1203444|P5|COMPLETED|Overall Study||22
491602|NCT01057225|1203445|P4|COMPLETED|Overall Study||7
491603|NCT01057225|1203446|P3|COMPLETED|Overall Study||6
491604|NCT01057225|1203447|P2|COMPLETED|Overall Study||3
491605|NCT01057225|1203448|P1|COMPLETED|Overall Study||3
491606|NCT01057225|1203443|P6|STARTED|Overall Study||23
491607|NCT01057225|1203444|P5|STARTED|Overall Study||22
491608|NCT01057225|1203445|P4|STARTED|Overall Study||7
491609|NCT01057225|1203446|P3|STARTED|Overall Study||6
491610|NCT01057225|1203447|P2|STARTED|Overall Study||3
491611|NCT01057225|1203448|P1|STARTED|Overall Study||3
491612|NCT01057121|1203470|P5|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
491613|NCT01057121|1203471|P4|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
491614|NCT01057121|1203472|P3|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
491615|NCT01057121|1203473|P2|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
491616|NCT01057121|1203474|P1|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
491617|NCT01057121|1203470|P5|COMPLETED|Phase II: 25 mg/Day Lenalidomide||23
491618|NCT01057121|1203471|P4|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
491619|NCT01057121|1203472|P3|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
491620|NCT01057121|1203473|P2|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
491621|NCT01057121|1203474|P1|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
491622|NCT01057121|1203470|P5|STARTED|Phase II: 25 mg/Day Lenalidomide||23
491623|NCT01057121|1203471|P4|STARTED|Phase II: 25 mg/Day Lenalidomide||0
491624|NCT01057121|1203472|P3|STARTED|Phase II: 25 mg/Day Lenalidomide||0
491625|NCT01057121|1203473|P2|STARTED|Phase II: 25 mg/Day Lenalidomide||0
491626|NCT01057121|1203474|P1|STARTED|Phase II: 25 mg/Day Lenalidomide||0
491627|NCT01057121|1203470|P5|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
491628|NCT01057121|1203471|P4|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
491629|NCT01057121|1203472|P3|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
491630|NCT01057121|1203473|P2|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
491631|NCT01057121|1203474|P1|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
491632|NCT01057121|1203470|P5|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
491633|NCT01057121|1203471|P4|COMPLETED|Phase I: 25 mg/Day Lenalidomide||6
491634|NCT01057121|1203472|P3|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
491635|NCT01057121|1203473|P2|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
491636|NCT01057121|1203474|P1|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
491637|NCT01057121|1203470|P5|STARTED|Phase I: 25 mg/Day Lenalidomide||0
491638|NCT01057121|1203471|P4|STARTED|Phase I: 25 mg/Day Lenalidomide||6
491639|NCT01057121|1203472|P3|STARTED|Phase I: 25 mg/Day Lenalidomide||0
491640|NCT01057121|1203473|P2|STARTED|Phase I: 25 mg/Day Lenalidomide||0
491641|NCT01057121|1203474|P1|STARTED|Phase I: 25 mg/Day Lenalidomide||0
491642|NCT01057121|1203470|P5|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
491643|NCT01057121|1203471|P4|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
491644|NCT01057121|1203472|P3|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
491645|NCT01057121|1203473|P2|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
491646|NCT01057121|1203474|P1|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
491647|NCT01057121|1203470|P5|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
491648|NCT01057121|1203471|P4|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
491649|NCT01057121|1203472|P3|COMPLETED|Phase I: 20 mg/Day Lenalidomide||3
491650|NCT01057121|1203473|P2|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
491651|NCT01057121|1203474|P1|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
491652|NCT01057121|1203470|P5|STARTED|Phase I: 20 mg/Day Lenalidomide||0
491653|NCT01057121|1203471|P4|STARTED|Phase I: 20 mg/Day Lenalidomide||0
491654|NCT01057121|1203472|P3|STARTED|Phase I: 20 mg/Day Lenalidomide||3
491655|NCT01057121|1203473|P2|STARTED|Phase I: 20 mg/Day Lenalidomide||0
491656|NCT01057121|1203474|P1|STARTED|Phase I: 20 mg/Day Lenalidomide||0
491657|NCT01057121|1203470|P5|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
491658|NCT01057121|1203471|P4|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
491659|NCT01057121|1203472|P3|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
491660|NCT01057121|1203473|P2|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
491661|NCT01057121|1203474|P1|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
491662|NCT01057121|1203470|P5|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
491663|NCT01057121|1203471|P4|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
491664|NCT01057121|1203472|P3|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
491665|NCT01057121|1203473|P2|COMPLETED|Phase I: 15 mg/Day Lenolidomide||3
491666|NCT01057121|1203474|P1|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
491667|NCT01057121|1203470|P5|STARTED|Phase I: 15 mg/Day Lenolidomide||0
491668|NCT01057121|1203471|P4|STARTED|Phase I: 15 mg/Day Lenolidomide||0
491669|NCT01057121|1203472|P3|STARTED|Phase I: 15 mg/Day Lenolidomide||0
491670|NCT01057121|1203473|P2|STARTED|Phase I: 15 mg/Day Lenolidomide||3
491671|NCT01057121|1203474|P1|STARTED|Phase I: 15 mg/Day Lenolidomide||0
491672|NCT01057121|1203470|P5|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
491673|NCT01057121|1203471|P4|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
491674|NCT01057121|1203472|P3|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
491675|NCT01057121|1203473|P2|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
491676|NCT01057121|1203474|P1|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
491677|NCT01057121|1203470|P5|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
491678|NCT01057121|1203471|P4|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
491679|NCT01057121|1203472|P3|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
491680|NCT01057121|1203473|P2|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
491681|NCT01057121|1203474|P1|COMPLETED|Phase I: 10 mg/Day Lenalidomide||3
491682|NCT01057121|1203470|P5|STARTED|Phase I: 10 mg/Day Lenalidomide||0
491683|NCT01057121|1203471|P4|STARTED|Phase I: 10 mg/Day Lenalidomide||0
491684|NCT01057121|1203472|P3|STARTED|Phase I: 10 mg/Day Lenalidomide||0
491685|NCT01057121|1203473|P2|STARTED|Phase I: 10 mg/Day Lenalidomide||0
491686|NCT01057121|1203474|P1|STARTED|Phase I: 10 mg/Day Lenalidomide||3
491687|NCT01057017|1203503|P1|NOT COMPLETED|Overall Study||0
491688|NCT01057017|1203503|P1|COMPLETED|Overall Study||5
491689|NCT01057017|1203503|P1|STARTED|Overall Study||5
491690|NCT01056913|1203507|P1|NOT COMPLETED|Overall Study||0
491691|NCT01056913|1203507|P1|COMPLETED|Overall Study||62
491692|NCT01056913|1203507|P1|STARTED|Overall Study||62
491693|NCT01056822|1203513|P2|NOT COMPLETED|Overall Study||7
491694|NCT01056822|1203514|P1|NOT COMPLETED|Overall Study||8
491695|NCT01056822|1203513|P2|COMPLETED|Overall Study||35
491696|NCT01056822|1203514|P1|COMPLETED|Overall Study||39
491697|NCT01056822|1203513|P2|Safety (SAF) Population: NO|Overall Study||2
491698|NCT01056822|1203514|P1|Safety (SAF) Population: NO|Overall Study||1
491699|NCT01056822|1203513|P2|Safety (SAF) Population: YES|Overall Study||40
491700|NCT01056822|1203514|P1|Safety (SAF) Population: YES|Overall Study||46
491701|NCT01056822|1203513|P2|Per-protocol (PP) Population: NO|Overall Study||17
491702|NCT01056822|1203514|P1|Per-protocol (PP) Population: NO|Overall Study||18
491703|NCT01056822|1203513|P2|Per-protocol (PP) Population: YES|Overall Study||25
491704|NCT01056822|1203514|P1|Per-protocol (PP) Population: YES|Overall Study||29
491705|NCT01056822|1203513|P2|Intention-to-treat (ITT) Population: NO|Overall Study||4
491706|NCT01056822|1203514|P1|Intention-to-treat (ITT) Population: NO|Overall Study||4
491707|NCT01056822|1203513|P2|Intention-to-treat (ITT) Population: YES|Overall Study||38
491708|NCT01056822|1203514|P1|Intention-to-treat (ITT) Population: YES|Overall Study||43
491709|NCT01056822|1203513|P2|STARTED|Overall Study||42
491710|NCT01056822|1203514|P1|STARTED|Overall Study||47
491711|NCT01056718|1203563|P1|NOT COMPLETED|Overall Study||3
491712|NCT01056718|1203563|P1|COMPLETED|Overall Study||50
491713|NCT01056718|1203563|P1|STARTED|Overall Study||53
491714|NCT01056653|1203596|P3|NOT COMPLETED|Overall Study||2
491715|NCT01056653|1203597|P2|NOT COMPLETED|Overall Study||0
491716|NCT01056653|1203598|P1|NOT COMPLETED|Overall Study||0
491717|NCT01056653|1203596|P3|COMPLETED|Overall Study|2 were lost to follow-up because one mother left the country and one father was too busy.|42
491718|NCT01056653|1203597|P2|COMPLETED|Overall Study||23
491719|NCT01056653|1203598|P1|COMPLETED|Overall Study||46
491720|NCT01056653|1203596|P3|STARTED|Overall Study||44
491721|NCT01056653|1203597|P2|STARTED|Overall Study||23
491722|NCT01056653|1203598|P1|STARTED|Overall Study||46
491723|NCT01056640|1203614|P2|NOT COMPLETED|Overall Study||12
491724|NCT01056640|1203615|P1|NOT COMPLETED|Overall Study||26
491725|NCT01056640|1203614|P2|COMPLETED|Overall Study||91
491726|NCT01056640|1203615|P1|COMPLETED|Overall Study||76
491727|NCT01056640|1203614|P2|STARTED|Overall Study||103
491728|NCT01056640|1203615|P1|STARTED|Overall Study||102
491729|NCT01056601|1203621|P1|NOT COMPLETED|Overall Study||0
491730|NCT01056601|1203621|P1|COMPLETED|Overall Study||7
491731|NCT01056601|1203621|P1|STARTED|Overall Study||7
491732|NCT01056523|1203627|P7|NOT COMPLETED|Overall Study||1
491733|NCT01056523|1203628|P6|NOT COMPLETED|Overall Study||0
491734|NCT01056523|1203629|P5|NOT COMPLETED|Overall Study||0
491735|NCT01056523|1203630|P4|NOT COMPLETED|Overall Study||3
491736|NCT01056523|1203631|P3|NOT COMPLETED|Overall Study||2
491737|NCT01056523|1203632|P2|NOT COMPLETED|Overall Study||0
491738|NCT01056523|1203633|P1|NOT COMPLETED|Overall Study||1
491739|NCT01056523|1203627|P7|COMPLETED|Overall Study||4
491740|NCT01056523|1203628|P6|COMPLETED|Overall Study||3
491741|NCT01056523|1203629|P5|COMPLETED|Overall Study||3
491742|NCT01056523|1203630|P4|COMPLETED|Overall Study||3
491743|NCT01056523|1203631|P3|COMPLETED|Overall Study||3
491744|NCT01056523|1203632|P2|COMPLETED|Overall Study||3
491745|NCT01056523|1203633|P1|COMPLETED|Overall Study||3
491746|NCT01056523|1203627|P7|STARTED|Overall Study||5
491747|NCT01056523|1203628|P6|STARTED|Overall Study||3
491748|NCT01056523|1203629|P5|STARTED|Overall Study||3
491749|NCT01056523|1203630|P4|STARTED|Overall Study||6
491750|NCT01056523|1203631|P3|STARTED|Overall Study||5
491751|NCT01056523|1203632|P2|STARTED|Overall Study||3
491752|NCT01056523|1203633|P1|STARTED|Overall Study||4
491753|NCT01056510|1203643|P2|NOT COMPLETED|Overall Study||64
491754|NCT01056510|1203644|P1|NOT COMPLETED|Overall Study||54
491755|NCT01056510|1203643|P2|COMPLETED|Overall Study||115
491756|NCT01056510|1203644|P1|COMPLETED|Overall Study||124
491757|NCT01056510|1203643|P2|STARTED|Overall Study||179
491758|NCT01056510|1203644|P1|STARTED|Overall Study||178
491759|NCT01056484|1203690|P2|NOT COMPLETED|Follow up - Non-randomized||2
491760|NCT01056484|1203691|P1|NOT COMPLETED|Follow up - Non-randomized||0
491761|NCT01056484|1203690|P2|COMPLETED|Follow up - Non-randomized||56
491762|NCT01056484|1203691|P1|COMPLETED|Follow up - Non-randomized||57
491763|NCT01056484|1203690|P2|STARTED|Follow up - Non-randomized|Out of the enrolled control subjects (N=59), 58 completed Period 1 and entered into Period 2.|58
491764|NCT01056484|1203691|P1|STARTED|Follow up - Non-randomized|Out of the enrolled experimental subjects (N=64), 57 completed Period 1 and entered into Period 2.|57
491765|NCT01056484|1203690|P2|NOT COMPLETED|Randomized Controlled Trial||1
491766|NCT01056484|1203691|P1|NOT COMPLETED|Randomized Controlled Trial||7
491767|NCT01056484|1203690|P2|COMPLETED|Randomized Controlled Trial||58
491768|NCT01056484|1203691|P1|COMPLETED|Randomized Controlled Trial||57
491769|NCT01056484|1203690|P2|STARTED|Randomized Controlled Trial||59
491770|NCT01056484|1203691|P1|STARTED|Randomized Controlled Trial||64
491771|NCT01056380|1203707|P2|NOT COMPLETED|Overall Study||3
491772|NCT01056380|1203708|P1|NOT COMPLETED|Overall Study||2
491773|NCT01056380|1203707|P2|COMPLETED|Overall Study||39
491774|NCT01056380|1203708|P1|COMPLETED|Overall Study||35
491775|NCT01056380|1203707|P2|STARTED|Overall Study||42
491776|NCT01056380|1203708|P1|STARTED|Overall Study||37
491777|NCT01056341|1203735|P5|NOT COMPLETED|Overall Study||14
491778|NCT01056341|1203736|P4|NOT COMPLETED|Overall Study||36
491779|NCT01056341|1203737|P3|NOT COMPLETED|Overall Study||15
491780|NCT01056341|1203738|P2|NOT COMPLETED|Overall Study||36
491781|NCT01056341|1203739|P1|NOT COMPLETED|Overall Study||36
491782|NCT01056341|1203735|P5|COMPLETED|Overall Study||88
491783|NCT01056341|1203736|P4|COMPLETED|Overall Study||65
491784|NCT01056341|1203737|P3|COMPLETED|Overall Study||88
491785|NCT01056341|1203738|P2|COMPLETED|Overall Study||63
491786|NCT01056341|1203739|P1|COMPLETED|Overall Study||19
491787|NCT01056341|1203735|P5|Interim Analysis|Overall Study||43
491788|NCT01056341|1203736|P4|Interim Analysis|Overall Study||40
491789|NCT01056341|1203737|P3|Interim Analysis|Overall Study||41
491790|NCT01056341|1203738|P2|Interim Analysis|Overall Study||41
491791|NCT01056341|1203739|P1|Interim Analysis|Overall Study||25
491792|NCT01056341|1203735|P5|STARTED|Overall Study||102
491793|NCT01056341|1203736|P4|STARTED|Overall Study||101
491794|NCT01056341|1203737|P3|STARTED|Overall Study||103
491795|NCT01056341|1203738|P2|STARTED|Overall Study||99
491796|NCT01056341|1203739|P1|STARTED|Overall Study||55
491797|NCT01056328|1203760|P2|NOT COMPLETED|Overall Study||16
491798|NCT01056328|1203761|P1|NOT COMPLETED|Overall Study||17
491799|NCT01056328|1203760|P2|COMPLETED|Overall Study||144
491800|NCT01056328|1203761|P1|COMPLETED|Overall Study||147
491801|NCT01056328|1203760|P2|STARTED|Overall Study||160
491802|NCT01056328|1203761|P1|STARTED|Overall Study||164
491803|NCT01056315|1203777|P2|NOT COMPLETED|Overall Study||11
491804|NCT01056315|1203778|P1|NOT COMPLETED|Overall Study||14
491805|NCT01056315|1203777|P2|COMPLETED|Overall Study||12
491806|NCT01056315|1203778|P1|COMPLETED|Overall Study||13
491807|NCT01056315|1203777|P2|STARTED|Overall Study||23
491808|NCT01056315|1203778|P1|STARTED|Overall Study||27
491809|NCT01056289|1203812|P4|NOT COMPLETED|Double-blind Phase||10
491810|NCT01056289|1203813|P3|NOT COMPLETED|Double-blind Phase||13
491811|NCT01056289|1203814|P2|NOT COMPLETED|Double-blind Phase||4
491812|NCT01056289|1203815|P1|NOT COMPLETED|Double-blind Phase||0
491813|NCT01056289|1203812|P4|COMPLETED|Double-blind Phase||138
491814|NCT01056289|1203813|P3|COMPLETED|Double-blind Phase||127
491815|NCT01056289|1203814|P2|COMPLETED|Double-blind Phase||69
491816|NCT01056289|1203815|P1|COMPLETED|Double-blind Phase||0
491817|NCT01056289|1203812|P4|STARTED|Double-blind Phase||148
491818|NCT01056289|1203813|P3|STARTED|Double-blind Phase||140
491819|NCT01056289|1203814|P2|STARTED|Double-blind Phase||73
491820|NCT01056289|1203815|P1|STARTED|Double-blind Phase||0
491821|NCT01056289|1203812|P4|NOT COMPLETED|Open-label Phase||0
491822|NCT01056289|1203813|P3|NOT COMPLETED|Open-label Phase||0
491823|NCT01056289|1203814|P2|NOT COMPLETED|Open-label Phase||0
491824|NCT01056289|1203815|P1|NOT COMPLETED|Open-label Phase||119
491825|NCT01056289|1203812|P4|COMPLETED|Open-label Phase||0
491826|NCT01056289|1203813|P3|COMPLETED|Open-label Phase||0
491827|NCT01056289|1203814|P2|COMPLETED|Open-label Phase||0
491828|NCT01056289|1203815|P1|COMPLETED|Open-label Phase|Participants transitioned to Double-blind phase|361
491829|NCT01056289|1203812|P4|STARTED|Open-label Phase||0
491830|NCT01056289|1203813|P3|STARTED|Open-label Phase||0
491831|NCT01056289|1203814|P2|STARTED|Open-label Phase||0
491832|NCT01056289|1203815|P1|STARTED|Open-label Phase||480
491833|NCT01056276|1203832|P2|NOT COMPLETED|Maintenance Therapy||28
491834|NCT01056276|1203833|P1|NOT COMPLETED|Maintenance Therapy||0
491835|NCT01056276|1203832|P2|COMPLETED|Maintenance Therapy|14 patients are continuing maintenance therapy.|0
491836|NCT01056276|1203833|P1|COMPLETED|Maintenance Therapy||0
491837|NCT01056276|1203832|P2|STARTED|Maintenance Therapy|5 patients completed 8 cycles but did not have maintenance therapy.|28
491838|NCT01056276|1203833|P1|STARTED|Maintenance Therapy|Original regimen did not include maintenance therapy.|0
491839|NCT01056276|1203832|P2|NOT COMPLETED|Treatment Period-Cycles 1-8||8
491840|NCT01056276|1203833|P1|NOT COMPLETED|Treatment Period-Cycles 1-8||13
491841|NCT01056276|1203832|P2|COMPLETED|Treatment Period-Cycles 1-8||33
491842|NCT01056276|1203833|P1|COMPLETED|Treatment Period-Cycles 1-8||5
491843|NCT01056276|1203832|P2|STARTED|Treatment Period-Cycles 1-8||41
491844|NCT01056276|1203833|P1|STARTED|Treatment Period-Cycles 1-8||18
491845|NCT01056263|1203847|P1|NOT COMPLETED|Overall Study||52
491846|NCT01056263|1203847|P1|COMPLETED|Overall Study||0
491847|NCT01056263|1203847|P1|STARTED|Overall Study||52
491848|NCT01056198|1203853|P2|NOT COMPLETED|Overall Study||0
491849|NCT01056198|1203854|P1|NOT COMPLETED|Overall Study||0
491850|NCT01056198|1203853|P2|COMPLETED|Overall Study||24
491851|NCT01056198|1203854|P1|COMPLETED|Overall Study||24
491852|NCT01056198|1203853|P2|STARTED|Overall Study||24
491853|NCT01056198|1203854|P1|STARTED|Overall Study||24
491854|NCT01056107|1203870|P4|NOT COMPLETED|Overall Study||0
491855|NCT01056107|1203871|P3|NOT COMPLETED|Overall Study||3
491856|NCT01056107|1203872|P2|NOT COMPLETED|Overall Study||1
491857|NCT01056107|1203873|P1|NOT COMPLETED|Overall Study||0
491858|NCT01056107|1203870|P4|COMPLETED|Overall Study||12
491859|NCT01056107|1203871|P3|COMPLETED|Overall Study||9
491860|NCT01056107|1203872|P2|COMPLETED|Overall Study||10
491861|NCT01056107|1203873|P1|COMPLETED|Overall Study||11
491862|NCT01056107|1203870|P4|STARTED|Overall Study||12
491863|NCT01056107|1203871|P3|STARTED|Overall Study||12
491864|NCT01056107|1203872|P2|STARTED|Overall Study||11
491865|NCT01056107|1203873|P1|STARTED|Overall Study||11
491866|NCT01056016|1203921|P2|NOT COMPLETED|Overall Study||1
491867|NCT01056016|1203922|P1|NOT COMPLETED|Overall Study||2
491868|NCT01056016|1203921|P2|COMPLETED|Overall Study||26
491869|NCT01056016|1203922|P1|COMPLETED|Overall Study||20
491870|NCT01056016|1203921|P2|STARTED|Overall Study|27 pediatricians were at 4 practices; practices were unit of randomization|27
491871|NCT01056016|1203922|P1|STARTED|Overall Study|22 pediatricians were at 4 practices; practices were unit of randomization|22
491872|NCT01055886|1203930|P2|NOT COMPLETED|Overall Study||11
491873|NCT01055886|1203931|P1|NOT COMPLETED|Overall Study||5
491874|NCT01055886|1203930|P2|COMPLETED|Overall Study|This includes those who completed all sessions and those with w/d post quit (missing = smoking).|21
491875|NCT01055886|1203931|P1|COMPLETED|Overall Study|This includes those who completed all sessions and those with w/d post quit (missing = smoking).|28
491876|NCT01055886|1203930|P2|Reached Pre-quit Period|Overall Study|1 lost to contact|31
491877|NCT01055886|1203931|P1|Reached Pre-quit Period|Overall Study|2 withdrawals, 1 lost to contact|30
491878|NCT01055886|1203930|P2|STARTED|Overall Study||32
491879|NCT01055886|1203931|P1|STARTED|Overall Study||33
491880|NCT01055834|1203943|P2|NOT COMPLETED|Treatment Period III||0
491881|NCT01055834|1203944|P1|NOT COMPLETED|Treatment Period III||0
491882|NCT01055834|1203943|P2|COMPLETED|Treatment Period III||14
491883|NCT01055834|1203944|P1|COMPLETED|Treatment Period III||0
491884|NCT01055834|1203943|P2|STARTED|Treatment Period III|14 of 21 participants in Group B who were treated in Period II participated in Period III.|14
491885|NCT01055834|1203944|P1|STARTED|Treatment Period III|Participants from Group A did not continue into Period III.|0
491886|NCT01055834|1203943|P2|NOT COMPLETED|Treatment Period II||0
491887|NCT01055834|1203944|P1|NOT COMPLETED|Treatment Period II||0
491888|NCT01055834|1203943|P2|COMPLETED|Treatment Period II||21
491889|NCT01055834|1203944|P1|COMPLETED|Treatment Period II||20
491890|NCT01055834|1203943|P2|STARTED|Treatment Period II||21
491891|NCT01055834|1203944|P1|STARTED|Treatment Period II||20
491892|NCT01055834|1203943|P2|NOT COMPLETED|Treatment Period I||0
491893|NCT01055834|1203944|P1|NOT COMPLETED|Treatment Period I||1
491894|NCT01055834|1203943|P2|COMPLETED|Treatment Period I||21
491895|NCT01055834|1203944|P1|COMPLETED|Treatment Period I||20
491896|NCT01055834|1203943|P2|STARTED|Treatment Period I||21
491897|NCT01055834|1203944|P1|STARTED|Treatment Period I||21
491898|NCT01055782|1203958|P2|NOT COMPLETED|Overall Study||0
491899|NCT01055782|1203959|P1|NOT COMPLETED|Overall Study||0
491900|NCT01055782|1203958|P2|COMPLETED|Overall Study||449
491901|NCT01055782|1203959|P1|COMPLETED|Overall Study||555
491902|NCT01055782|1203958|P2|STARTED|Overall Study||449
491903|NCT01055782|1203959|P1|STARTED|Overall Study||555
491904|NCT01055769|1203967|P2|NOT COMPLETED|Second Intervention||0
491905|NCT01055769|1203968|P1|NOT COMPLETED|Second Intervention||0
491906|NCT01055769|1203967|P2|COMPLETED|Second Intervention||10
491907|NCT01055769|1203968|P1|COMPLETED|Second Intervention||10
491908|NCT01055769|1203967|P2|STARTED|Second Intervention||10
491909|NCT01055769|1203968|P1|STARTED|Second Intervention||10
491910|NCT01055769|1203967|P2|NOT COMPLETED|Washout Period of Atleast 4 Days||0
491911|NCT01055769|1203968|P1|NOT COMPLETED|Washout Period of Atleast 4 Days||0
491912|NCT01055769|1203967|P2|COMPLETED|Washout Period of Atleast 4 Days||10
491913|NCT01055769|1203968|P1|COMPLETED|Washout Period of Atleast 4 Days||10
491914|NCT01055769|1203967|P2|STARTED|Washout Period of Atleast 4 Days||10
491915|NCT01055769|1203968|P1|STARTED|Washout Period of Atleast 4 Days||10
491916|NCT01055769|1203967|P2|NOT COMPLETED|First Intervention||0
491917|NCT01055769|1203968|P1|NOT COMPLETED|First Intervention||0
491918|NCT01055769|1203967|P2|COMPLETED|First Intervention||10
491919|NCT01055769|1203968|P1|COMPLETED|First Intervention||10
491920|NCT01055769|1203967|P2|STARTED|First Intervention||10
491921|NCT01055769|1203968|P1|STARTED|First Intervention||10
491922|NCT01055704|1203986|P4|NOT COMPLETED|Overall Study||0
491923|NCT01055704|1203987|P3|NOT COMPLETED|Overall Study||0
491924|NCT01055704|1203988|P2|NOT COMPLETED|Overall Study||0
491925|NCT01055704|1203989|P1|NOT COMPLETED|Overall Study||0
491926|NCT01055704|1203986|P4|COMPLETED|Overall Study||8
491927|NCT01055704|1203987|P3|COMPLETED|Overall Study||16
491928|NCT01055704|1203988|P2|COMPLETED|Overall Study||8
491929|NCT01055704|1203989|P1|COMPLETED|Overall Study||16
491930|NCT01055704|1203986|P4|STARTED|Overall Study||8
491931|NCT01055704|1203987|P3|STARTED|Overall Study||16
491932|NCT01055704|1203988|P2|STARTED|Overall Study||8
491933|NCT01055704|1203989|P1|STARTED|Overall Study||16
491934|NCT01055639|1204029|P2|NOT COMPLETED|Overall Study||29
491935|NCT01055639|1204030|P1|NOT COMPLETED|Overall Study||21
491936|NCT01055639|1204029|P2|COMPLETED|Overall Study||31
491937|NCT01055639|1204030|P1|COMPLETED|Overall Study||45
491938|NCT01055639|1204029|P2|STARTED|Overall Study||60
491939|NCT01055639|1204030|P1|STARTED|Overall Study||66
491940|NCT01055613|1204054|P2|NOT COMPLETED|Overall Study||4
491941|NCT01055613|1204055|P1|NOT COMPLETED|Overall Study||9
491942|NCT01055613|1204054|P2|COMPLETED|Overall Study||96
491943|NCT01055613|1204055|P1|COMPLETED|Overall Study||191
491944|NCT01055613|1204054|P2|STARTED|Overall Study||100
491945|NCT01055613|1204055|P1|STARTED|Overall Study||200
491946|NCT01055457|1204073|P10|NOT COMPLETED|Overall Study||1
491947|NCT01055457|1204074|P9|NOT COMPLETED|Overall Study||0
491948|NCT01055457|1204075|P8|NOT COMPLETED|Overall Study||1
491949|NCT01055457|1204076|P7|NOT COMPLETED|Overall Study||1
491950|NCT01055457|1204077|P6|NOT COMPLETED|Overall Study||3
491951|NCT01055457|1204078|P5|NOT COMPLETED|Overall Study||3
491952|NCT01055457|1204079|P4|NOT COMPLETED|Overall Study||3
491953|NCT01055457|1204080|P3|NOT COMPLETED|Overall Study||2
491954|NCT01055457|1204081|P2|NOT COMPLETED|Overall Study||1
491955|NCT01055457|1204082|P1|NOT COMPLETED|Overall Study||1
491956|NCT01055457|1204073|P10|COMPLETED|Overall Study||19
491957|NCT01055457|1204074|P9|COMPLETED|Overall Study||20
491958|NCT01055457|1204075|P8|COMPLETED|Overall Study||18
491959|NCT01055457|1204076|P7|COMPLETED|Overall Study||18
491960|NCT01055457|1204077|P6|COMPLETED|Overall Study||15
491961|NCT01055457|1204078|P5|COMPLETED|Overall Study||38
491962|NCT01055457|1204079|P4|COMPLETED|Overall Study||37
491963|NCT01055457|1204080|P3|COMPLETED|Overall Study||36
491964|NCT01055457|1204081|P2|COMPLETED|Overall Study||39
491965|NCT01055457|1204082|P1|COMPLETED|Overall Study||39
491966|NCT01055457|1204073|P10|STARTED|Overall Study||20
491967|NCT01055457|1204074|P9|STARTED|Overall Study||20
491968|NCT01055457|1204075|P8|STARTED|Overall Study||19
491969|NCT01055457|1204076|P7|STARTED|Overall Study||19
491970|NCT01055457|1204077|P6|STARTED|Overall Study||18
491971|NCT01055457|1204078|P5|STARTED|Overall Study||41
491972|NCT01055457|1204079|P4|STARTED|Overall Study||40
491973|NCT01055457|1204080|P3|STARTED|Overall Study||38
491974|NCT01055457|1204081|P2|STARTED|Overall Study||40
491975|NCT01055457|1204082|P1|STARTED|Overall Study||40
491976|NCT01055314|1204116|P2|NOT COMPLETED|Overall Study||38
491977|NCT01055314|1204117|P1|NOT COMPLETED|Overall Study||45
491978|NCT01055314|1204116|P2|COMPLETED|Overall Study||37
491979|NCT01055314|1204117|P1|COMPLETED|Overall Study||55
491980|NCT01055314|1204116|P2|STARTED|Overall Study||75
491981|NCT01055314|1204117|P1|STARTED|Overall Study||100
491982|NCT01055262|1204129|P1|NOT COMPLETED|Overall Study||9
491983|NCT01055262|1204129|P1|COMPLETED|Overall Study||160
491984|NCT01055262|1204129|P1|STARTED|Overall Study||169
491985|NCT01055223|1204140|P1|NOT COMPLETED|Overall Study||0
491986|NCT01055223|1204140|P1|COMPLETED|Overall Study||98483
491987|NCT01055223|1204140|P1|STARTED|Overall Study||98483
491988|NCT01055197|1204170|P2|NOT COMPLETED|Overall Study||2
491989|NCT01055197|1204171|P1|NOT COMPLETED|Overall Study||9
491990|NCT01055197|1204170|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|44
491991|NCT01055197|1204171|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|42
491992|NCT01055197|1204170|P2|STARTED|Overall Study||46
491993|NCT01055197|1204171|P1|STARTED|Overall Study||51
491994|NCT01055184|1204177|P1|NOT COMPLETED|Overall Study||0
491995|NCT01055184|1204177|P1|COMPLETED|Overall Study||34
491996|NCT01055184|1204177|P1|STARTED|Overall Study||34
491997|NCT01055171|1204183|P2|NOT COMPLETED|Overall Study||7
491998|NCT01055171|1204184|P1|NOT COMPLETED|Overall Study||11
491999|NCT01055171|1204183|P2|COMPLETED|Overall Study|Received the sugar pill and completed all visits including the one-week follow-up.|21
492000|NCT01055171|1204184|P1|COMPLETED|Overall Study|Received the medication and completed all visits including the one-week follow-up.|18
492001|NCT01055171|1204183|P2|Test Procedure Completion|Overall Study|Received the placebo and completed the first test session.|23
492002|NCT01055171|1204184|P1|Test Procedure Completion|Overall Study|Received the medication and completed the first test session.|21
492003|NCT01055171|1204183|P2|Retrieval Completion|Overall Study|Received the sugar pill and completed the retrieval session.|24
492004|NCT01055171|1204184|P1|Retrieval Completion|Overall Study|Received the medication and completed the retrieval session.|25
492005|NCT01055171|1204183|P2|STARTED|Overall Study|Randomized to receive placebo.|28
492006|NCT01055171|1204184|P1|STARTED|Overall Study|Randomized to receive medication.|29
492007|NCT01055132|1204198|P2|NOT COMPLETED|Period 2 (5-9 Days)||1
492008|NCT01055132|1204199|P1|NOT COMPLETED|Period 2 (5-9 Days)||0
492009|NCT01055132|1204198|P2|COMPLETED|Period 2 (5-9 Days)||32
492010|NCT01055132|1204199|P1|COMPLETED|Period 2 (5-9 Days)||35
492011|NCT01055132|1204198|P2|STARTED|Period 2 (5-9 Days)||33
492012|NCT01055132|1204199|P1|STARTED|Period 2 (5-9 Days)||35
492013|NCT01055132|1204198|P2|NOT COMPLETED|Period 1 (5-9 Days)||0
492014|NCT01055132|1204199|P1|NOT COMPLETED|Period 1 (5-9 Days)||1
492015|NCT01055132|1204198|P2|COMPLETED|Period 1 (5-9 Days)||33
492016|NCT01055132|1204199|P1|COMPLETED|Period 1 (5-9 Days)||35
492017|NCT01055132|1204198|P2|STARTED|Period 1 (5-9 Days)||33
492018|NCT01055132|1204199|P1|STARTED|Period 1 (5-9 Days)||36
492019|NCT01055028|1204212|P2|NOT COMPLETED|Treatment Cycles 4 to 6||0
492020|NCT01055028|1204213|P1|NOT COMPLETED|Treatment Cycles 4 to 6||0
492021|NCT01055028|1204212|P2|COMPLETED|Treatment Cycles 4 to 6||2
492022|NCT01055028|1204213|P1|COMPLETED|Treatment Cycles 4 to 6||6
492023|NCT01055028|1204212|P2|STARTED|Treatment Cycles 4 to 6||2
492024|NCT01055028|1204213|P1|STARTED|Treatment Cycles 4 to 6||6
492025|NCT01055028|1204212|P2|NOT COMPLETED|Inter-treatment Period||3
492026|NCT01055028|1204213|P1|NOT COMPLETED|Inter-treatment Period||0
492027|NCT01055028|1204212|P2|COMPLETED|Inter-treatment Period||2
492028|NCT01055028|1204213|P1|COMPLETED|Inter-treatment Period||6
492029|NCT01055028|1204212|P2|STARTED|Inter-treatment Period||5
492030|NCT01055028|1204213|P1|STARTED|Inter-treatment Period||6
492031|NCT01055028|1204212|P2|NOT COMPLETED|Treatment Cycles 1 to 3||3
492032|NCT01055028|1204213|P1|NOT COMPLETED|Treatment Cycles 1 to 3||2
492033|NCT01055028|1204212|P2|COMPLETED|Treatment Cycles 1 to 3||5
492034|NCT01055028|1204213|P1|COMPLETED|Treatment Cycles 1 to 3||6
492035|NCT01055028|1204212|P2|STARTED|Treatment Cycles 1 to 3||8
492036|NCT01055028|1204213|P1|STARTED|Treatment Cycles 1 to 3||8
492037|NCT01055028|1204212|P2|NOT COMPLETED|Screening||1
492038|NCT01055028|1204213|P1|NOT COMPLETED|Screening||1
492039|NCT01055028|1204212|P2|COMPLETED|Screening||8
492040|NCT01055028|1204213|P1|COMPLETED|Screening||8
492041|NCT01055028|1204212|P2|STARTED|Screening||9
492042|NCT01055028|1204213|P1|STARTED|Screening||9
492043|NCT01054976|1204227|P1|NOT COMPLETED|Overall Study||35
492044|NCT01054976|1204227|P1|COMPLETED|Overall Study||57
492045|NCT01054976|1204227|P1|STARTED|Overall Study||92
492046|NCT01054911|1204235|P1|NOT COMPLETED|Overall Study||0
492047|NCT01054911|1204235|P1|COMPLETED|Overall Study||5
492048|NCT01054911|1204235|P1|STARTED|Overall Study||5
492049|NCT01054885|1204248|P7|NOT COMPLETED|24-week, Double-blind Treatment Period||47
492050|NCT01054885|1204249|P6|NOT COMPLETED|24-week, Double-blind Treatment Period||60
492051|NCT01054885|1204250|P5|NOT COMPLETED|24-week, Double-blind Treatment Period||42
492052|NCT01054885|1204251|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||43
492053|NCT01054885|1204252|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||49
492054|NCT01054885|1204253|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||59
492055|NCT01054885|1204254|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
492056|NCT01054885|1204248|P7|COMPLETED|24-week, Double-blind Treatment Period||158
492057|NCT01054885|1204249|P6|COMPLETED|24-week, Double-blind Treatment Period||144
492058|NCT01054885|1204250|P5|COMPLETED|24-week, Double-blind Treatment Period||161
492059|NCT01054885|1204251|P4|COMPLETED|24-week, Double-blind Treatment Period||160
492060|NCT01054885|1204252|P3|COMPLETED|24-week, Double-blind Treatment Period||155
492061|NCT01054885|1204253|P2|COMPLETED|24-week, Double-blind Treatment Period||146
492062|NCT01054885|1204254|P1|COMPLETED|24-week, Double-blind Treatment Period||0
492063|NCT01054885|1204248|P7|STARTED|24-week, Double-blind Treatment Period||205
492064|NCT01054885|1204249|P6|STARTED|24-week, Double-blind Treatment Period||204
492065|NCT01054885|1204250|P5|STARTED|24-week, Double-blind Treatment Period||203
492066|NCT01054885|1204251|P4|STARTED|24-week, Double-blind Treatment Period||203
492067|NCT01054885|1204252|P3|STARTED|24-week, Double-blind Treatment Period||204
492068|NCT01054885|1204253|P2|STARTED|24-week, Double-blind Treatment Period||205
492069|NCT01054885|1204254|P1|STARTED|24-week, Double-blind Treatment Period||0
492070|NCT01054885|1204248|P7|NOT COMPLETED|2-week, Single-blind Run-In Period||0
492071|NCT01054885|1204249|P6|NOT COMPLETED|2-week, Single-blind Run-In Period||0
492072|NCT01054885|1204250|P5|NOT COMPLETED|2-week, Single-blind Run-In Period||0
492073|NCT01054885|1204251|P4|NOT COMPLETED|2-week, Single-blind Run-In Period||0
492074|NCT01054885|1204252|P3|NOT COMPLETED|2-week, Single-blind Run-In Period||0
492075|NCT01054885|1204253|P2|NOT COMPLETED|2-week, Single-blind Run-In Period||0
492076|NCT01054885|1204254|P1|NOT COMPLETED|2-week, Single-blind Run-In Period||351
492077|NCT01054885|1204248|P7|COMPLETED|2-week, Single-blind Run-In Period||0
492078|NCT01054885|1204249|P6|COMPLETED|2-week, Single-blind Run-In Period||0
492079|NCT01054885|1204250|P5|COMPLETED|2-week, Single-blind Run-In Period||0
492080|NCT01054885|1204251|P4|COMPLETED|2-week, Single-blind Run-In Period||0
492081|NCT01054885|1204252|P3|COMPLETED|2-week, Single-blind Run-In Period||0
492082|NCT01054885|1204253|P2|COMPLETED|2-week, Single-blind Run-In Period||0
492083|NCT01054885|1204254|P1|COMPLETED|2-week, Single-blind Run-In Period||1226
492084|NCT01054885|1204248|P7|STARTED|2-week, Single-blind Run-In Period||0
492085|NCT01054885|1204249|P6|STARTED|2-week, Single-blind Run-In Period||0
492086|NCT01054885|1204250|P5|STARTED|2-week, Single-blind Run-In Period||0
492087|NCT01054885|1204251|P4|STARTED|2-week, Single-blind Run-In Period||0
492088|NCT01054885|1204252|P3|STARTED|2-week, Single-blind Run-In Period||0
492089|NCT01054885|1204253|P2|STARTED|2-week, Single-blind Run-In Period||0
492090|NCT01054885|1204254|P1|STARTED|2-week, Single-blind Run-In Period||1577
492091|NCT01054846|1204294|P2|NOT COMPLETED|Overall Study||17
492092|NCT01054846|1204295|P1|NOT COMPLETED|Overall Study||76
492093|NCT01054846|1204294|P2|COMPLETED|Overall Study||51
492094|NCT01054846|1204295|P1|COMPLETED|Overall Study||246
492095|NCT01054846|1204294|P2|STARTED|Overall Study||68
492096|NCT01054846|1204295|P1|STARTED|Overall Study||322
492097|NCT01054820|1204302|P1|NOT COMPLETED|Overall Study||2
492098|NCT01054820|1204302|P1|COMPLETED|Overall Study||121
492099|NCT01054820|1204302|P1|STARTED|Overall Study||123
492100|NCT01054742|1204316|P1|NOT COMPLETED|Overall Study||0
492101|NCT01054742|1204316|P1|COMPLETED|Overall Study||2
492102|NCT01054742|1204316|P1|STARTED|Overall Study||2
492103|NCT01054729|1204324|P4|NOT COMPLETED|Overall Study||3
492104|NCT01054729|1204325|P3|NOT COMPLETED|Overall Study||6
492105|NCT01054729|1204326|P2|NOT COMPLETED|Overall Study||5
492106|NCT01054729|1204327|P1|NOT COMPLETED|Overall Study||4
492107|NCT01054729|1204324|P4|COMPLETED|Overall Study||11
492108|NCT01054729|1204325|P3|COMPLETED|Overall Study||9
492109|NCT01054729|1204326|P2|COMPLETED|Overall Study||14
492110|NCT01054729|1204327|P1|COMPLETED|Overall Study||12
492111|NCT01054729|1204324|P4|Randomized and Treated|Overall Study||14
492112|NCT01054729|1204325|P3|Randomized and Treated|Overall Study||15
492113|NCT01054729|1204326|P2|Randomized and Treated|Overall Study||18
492114|NCT01054729|1204327|P1|Randomized and Treated|Overall Study||16
492115|NCT01054729|1204324|P4|STARTED|Overall Study||14
492116|NCT01054729|1204325|P3|STARTED|Overall Study||15
492117|NCT01054729|1204326|P2|STARTED|Overall Study||19
492118|NCT01054729|1204327|P1|STARTED|Overall Study||16
492119|NCT01054703|1204388|P1|NOT COMPLETED|Overall Study||0
492120|NCT01054703|1204388|P1|COMPLETED|Overall Study||14
492121|NCT01054703|1204388|P1|STARTED|Overall Study||14
492122|NCT01054625|1204395|P3|NOT COMPLETED|Overall Study||1
492123|NCT01054625|1204396|P2|NOT COMPLETED|Overall Study||3
492124|NCT01054625|1204397|P1|NOT COMPLETED|Overall Study||2
492125|NCT01054625|1204395|P3|COMPLETED|Overall Study||9
492126|NCT01054625|1204396|P2|COMPLETED|Overall Study||9
492127|NCT01054625|1204397|P1|COMPLETED|Overall Study||6
492128|NCT01054625|1204395|P3|STARTED|Overall Study||10
492129|NCT01054625|1204396|P2|STARTED|Overall Study||12
492130|NCT01054625|1204397|P1|STARTED|Overall Study|A total of 31 patients were enrolled, 1 patient died before receiving any zalutumumab|8
492131|NCT01054599|1204425|P2|NOT COMPLETED|Overall Study||7
492132|NCT01054599|1204426|P1|NOT COMPLETED|Overall Study||4
492133|NCT01054599|1204425|P2|COMPLETED|Overall Study||9
492134|NCT01054599|1204426|P1|COMPLETED|Overall Study||9
492135|NCT01054599|1204425|P2|STARTED|Overall Study||16
492136|NCT01054599|1204426|P1|STARTED|Overall Study||13
492137|NCT01054586|1204438|P4|NOT COMPLETED|Overall Study||0
492138|NCT01054586|1204439|P3|NOT COMPLETED|Overall Study||0
492139|NCT01054586|1204440|P2|NOT COMPLETED|Overall Study||0
492140|NCT01054586|1204441|P1|NOT COMPLETED|Overall Study||0
492141|NCT01054586|1204438|P4|COMPLETED|Overall Study||101
492142|NCT01054586|1204439|P3|COMPLETED|Overall Study||8
492143|NCT01054586|1204440|P2|COMPLETED|Overall Study||15
492144|NCT01054586|1204441|P1|COMPLETED|Overall Study||43
492145|NCT01054586|1204438|P4|STARTED|Overall Study||101
492146|NCT01054586|1204439|P3|STARTED|Overall Study||8
492147|NCT01054586|1204440|P2|STARTED|Overall Study||15
492148|NCT01054586|1204441|P1|STARTED|Overall Study||43
492149|NCT01054573|1204533|P4|NOT COMPLETED|Overall Study||2
492150|NCT01054573|1204534|P3|NOT COMPLETED|Overall Study||3
492151|NCT01054573|1204535|P2|NOT COMPLETED|Overall Study||4
492152|NCT01054573|1204536|P1|NOT COMPLETED|Overall Study||1
492153|NCT01054573|1204533|P4|COMPLETED|Overall Study||25
492154|NCT01054573|1204534|P3|COMPLETED|Overall Study||19
492155|NCT01054573|1204535|P2|COMPLETED|Overall Study||28
492156|NCT01054573|1204536|P1|COMPLETED|Overall Study||8
492157|NCT01054573|1204533|P4|STARTED|Overall Study||27
492158|NCT01054573|1204534|P3|STARTED|Overall Study||22
492159|NCT01054573|1204535|P2|STARTED|Overall Study||32
492160|NCT01054573|1204536|P1|STARTED|Overall Study||9
492161|NCT01054560|1204582|P2|NOT COMPLETED|Overall Study||28
492162|NCT01054560|1204583|P1|NOT COMPLETED|Overall Study||13
492163|NCT01054560|1204582|P2|COMPLETED|Overall Study||27
492164|NCT01054560|1204583|P1|COMPLETED|Overall Study||45
492165|NCT01054560|1204582|P2|STARTED|Overall Study||55
492166|NCT01054560|1204583|P1|STARTED|Overall Study||58
492167|NCT01054404|1204607|P2|NOT COMPLETED|Overall Study||0
492168|NCT01054404|1204608|P1|NOT COMPLETED|Overall Study||0
492169|NCT01054404|1204607|P2|COMPLETED|Overall Study||13
492170|NCT01054404|1204608|P1|COMPLETED|Overall Study||10
492171|NCT01054404|1204607|P2|STARTED|Overall Study||13
492172|NCT01054404|1204608|P1|STARTED|Overall Study||10
492173|NCT01054339|1204617|P3|NOT COMPLETED|Overall Study||0
492174|NCT01054339|1204618|P2|NOT COMPLETED|Overall Study||0
492175|NCT01054339|1204619|P1|NOT COMPLETED|Overall Study||0
492176|NCT01054339|1204617|P3|COMPLETED|Overall Study||3
492177|NCT01054339|1204618|P2|COMPLETED|Overall Study||3
492178|NCT01054339|1204619|P1|COMPLETED|Overall Study||3
492179|NCT01054339|1204617|P3|STARTED|Overall Study||3
492180|NCT01054339|1204618|P2|STARTED|Overall Study||3
492181|NCT01054339|1204619|P1|STARTED|Overall Study||3
492182|NCT01054222|1204633|P1|NOT COMPLETED|Overall Study||11
492183|NCT01054222|1204633|P1|COMPLETED|Overall Study||20
492184|NCT01054222|1204633|P1|STARTED|Overall Study||31
492185|NCT01054183|1204654|P2|NOT COMPLETED|Overall Study||0
492186|NCT01054183|1204655|P1|NOT COMPLETED|Overall Study||0
492187|NCT01054183|1204654|P2|COMPLETED|Overall Study||12
492188|NCT01054183|1204655|P1|COMPLETED|Overall Study||10
492189|NCT01054183|1204654|P2|STARTED|Overall Study||12
492190|NCT01054183|1204655|P1|STARTED|Overall Study||10
492191|NCT01054170|1204665|P2|NOT COMPLETED|Overall Study||6
492192|NCT01054170|1204666|P1|NOT COMPLETED|Overall Study||4
492193|NCT01054170|1204665|P2|COMPLETED|Overall Study||21
492194|NCT01054170|1204666|P1|COMPLETED|Overall Study||21
492195|NCT01054170|1204665|P2|STARTED|Overall Study||27
492196|NCT01054170|1204666|P1|STARTED|Overall Study||25
492197|NCT01054079|1204718|P1|NOT COMPLETED|Overall Study||0
492198|NCT01054079|1204718|P1|COMPLETED|Overall Study|while all 20 patients received at least some of the intervention, some did not get proper PSA tests.|20
492199|NCT01054079|1204718|P1|# Recieved Proper PSA Testing|Overall Study||10
492200|NCT01054079|1204718|P1|STARTED|Overall Study||20
492201|NCT01053988|1204731|P6|NOT COMPLETED|24-week, Double-blind Treatment Period||55
492202|NCT01053988|1204732|P5|NOT COMPLETED|24-week, Double-blind Treatment Period||59
492203|NCT01053988|1204733|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||63
492204|NCT01053988|1204734|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||61
492205|NCT01053988|1204735|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||69
492206|NCT01053988|1204736|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
492207|NCT01053988|1204731|P6|COMPLETED|24-week, Double-blind Treatment Period||151
492208|NCT01053988|1204732|P5|COMPLETED|24-week, Double-blind Treatment Period||147
492209|NCT01053988|1204733|P4|COMPLETED|24-week, Double-blind Treatment Period||142
492210|NCT01053988|1204734|P3|COMPLETED|24-week, Double-blind Treatment Period||145
492211|NCT01053988|1204735|P2|COMPLETED|24-week, Double-blind Treatment Period||138
492212|NCT01053988|1204736|P1|COMPLETED|24-week, Double-blind Treatment Period||0
492213|NCT01053988|1204731|P6|STARTED|24-week, Double-blind Treatment Period||206
492214|NCT01053988|1204732|P5|STARTED|24-week, Double-blind Treatment Period||206
492215|NCT01053988|1204733|P4|STARTED|24-week, Double-blind Treatment Period||205
492216|NCT01053988|1204734|P3|STARTED|24-week, Double-blind Treatment Period||206
492217|NCT01053988|1204735|P2|STARTED|24-week, Double-blind Treatment Period||207
492218|NCT01053988|1204736|P1|STARTED|24-week, Double-blind Treatment Period||0
492219|NCT01053988|1204731|P6|NOT COMPLETED|2-week, Single-blind Run-In Period||0
492220|NCT01053988|1204732|P5|NOT COMPLETED|2-week, Single-blind Run-In Period||0
492221|NCT01053988|1204733|P4|NOT COMPLETED|2-week, Single-blind Run-In Period||0
492222|NCT01053988|1204734|P3|NOT COMPLETED|2-week, Single-blind Run-In Period||0
492223|NCT01053988|1204735|P2|NOT COMPLETED|2-week, Single-blind Run-In Period||0
492224|NCT01053988|1204736|P1|NOT COMPLETED|2-week, Single-blind Run-In Period||360
492225|NCT01053988|1204731|P6|COMPLETED|2-week, Single-blind Run-In Period||0
492226|NCT01053988|1204732|P5|COMPLETED|2-week, Single-blind Run-In Period||0
492227|NCT01053988|1204733|P4|COMPLETED|2-week, Single-blind Run-In Period||0
492228|NCT01053988|1204734|P3|COMPLETED|2-week, Single-blind Run-In Period||0
492229|NCT01053988|1204735|P2|COMPLETED|2-week, Single-blind Run-In Period||0
492230|NCT01053988|1204736|P1|COMPLETED|2-week, Single-blind Run-In Period||1030
492231|NCT01053988|1204731|P6|STARTED|2-week, Single-blind Run-In Period||0
492232|NCT01053988|1204732|P5|STARTED|2-week, Single-blind Run-In Period||0
492233|NCT01053988|1204733|P4|STARTED|2-week, Single-blind Run-In Period||0
492234|NCT01053988|1204734|P3|STARTED|2-week, Single-blind Run-In Period||0
492235|NCT01053988|1204735|P2|STARTED|2-week, Single-blind Run-In Period||0
492236|NCT01053988|1204736|P1|STARTED|2-week, Single-blind Run-In Period||1390
492237|NCT01053897|1204768|P1|NOT COMPLETED|Overall Study||0
492238|NCT01053897|1204768|P1|COMPLETED|Overall Study||5
492239|NCT01053897|1204768|P1|STARTED|Overall Study||5
492240|NCT01053819|1204780|P1|NOT COMPLETED|Overall Study||0
492241|NCT01053819|1204780|P1|COMPLETED|Overall Study||6
492242|NCT01053819|1204780|P1|STARTED|Overall Study||6
492243|NCT01053741|1204787|P2|NOT COMPLETED|2nd Study Intervention||1
492244|NCT01053741|1204788|P1|NOT COMPLETED|2nd Study Intervention||0
492245|NCT01053741|1204787|P2|COMPLETED|2nd Study Intervention||5
492246|NCT01053741|1204788|P1|COMPLETED|2nd Study Intervention||5
492247|NCT01053741|1204787|P2|STARTED|2nd Study Intervention||6
492248|NCT01053741|1204788|P1|STARTED|2nd Study Intervention||5
492249|NCT01053741|1204787|P2|NOT COMPLETED|14 Day Washout||0
492250|NCT01053741|1204788|P1|NOT COMPLETED|14 Day Washout||0
492251|NCT01053741|1204787|P2|COMPLETED|14 Day Washout||6
492252|NCT01053741|1204788|P1|COMPLETED|14 Day Washout||5
492253|NCT01053741|1204787|P2|STARTED|14 Day Washout||6
492254|NCT01053741|1204788|P1|STARTED|14 Day Washout||5
492255|NCT01053741|1204787|P2|NOT COMPLETED|1st Intervention||0
492256|NCT01053741|1204788|P1|NOT COMPLETED|1st Intervention||0
492257|NCT01053741|1204787|P2|COMPLETED|1st Intervention||6
492258|NCT01053741|1204788|P1|COMPLETED|1st Intervention||5
492259|NCT01053741|1204787|P2|STARTED|1st Intervention||6
492260|NCT01053741|1204788|P1|STARTED|1st Intervention||5
492261|NCT01053663|1204797|P1|NOT COMPLETED|Overall Study||6
492262|NCT01053663|1204797|P1|COMPLETED|Overall Study||3
492263|NCT01053663|1204797|P1|STARTED|Overall Study||9
492264|NCT01053507|1204840|P2|NOT COMPLETED|Overall Study||1
492265|NCT01053507|1204841|P1|NOT COMPLETED|Overall Study||3
492266|NCT01053507|1204840|P2|COMPLETED|Overall Study||11
492267|NCT01053507|1204841|P1|COMPLETED|Overall Study||8
492268|NCT01053507|1204840|P2|STARTED|Overall Study||12
492269|NCT01053507|1204841|P1|STARTED|Overall Study||11
492270|NCT01053429|1204855|P1|NOT COMPLETED|Overall Study||373
492271|NCT01053429|1204855|P1|COMPLETED|Overall Study||3018
492272|NCT01053429|1204855|P1|STARTED|Overall Study||3391
492273|NCT01053312|1204864|P1|NOT COMPLETED|Overall Study||0
492274|NCT01053312|1204864|P1|COMPLETED|Overall Study||7
492275|NCT01053312|1204864|P1|STARTED|Overall Study||7
492276|NCT01053247|1204885|P3|NOT COMPLETED|Overall Study||28
492277|NCT01053247|1204886|P2|NOT COMPLETED|Overall Study||19
492278|NCT01053247|1204887|P1|NOT COMPLETED|Overall Study||20
492279|NCT01053247|1204885|P3|COMPLETED|Overall Study||236
492280|NCT01053247|1204886|P2|COMPLETED|Overall Study||241
492281|NCT01053247|1204887|P1|COMPLETED|Overall Study||249
492282|NCT01053247|1204885|P3|STARTED|Overall Study||264
492283|NCT01053247|1204886|P2|STARTED|Overall Study||260
492284|NCT01053247|1204887|P1|STARTED|Overall Study||269
492285|NCT01053156|1204897|P2|NOT COMPLETED|Second Intervention (Week 13-24)||5
492286|NCT01053156|1204898|P1|NOT COMPLETED|Second Intervention (Week 13-24)||2
492287|NCT01053156|1204897|P2|COMPLETED|Second Intervention (Week 13-24)||22
492288|NCT01053156|1204898|P1|COMPLETED|Second Intervention (Week 13-24)||26
492289|NCT01053156|1204897|P2|STARTED|Second Intervention (Week 13-24)||27
492290|NCT01053156|1204898|P1|STARTED|Second Intervention (Week 13-24)||28
492291|NCT01053156|1204897|P2|NOT COMPLETED|First Intervention (Week 1-12)||6
492292|NCT01053156|1204898|P1|NOT COMPLETED|First Intervention (Week 1-12)||5
492293|NCT01053156|1204897|P2|COMPLETED|First Intervention (Week 1-12)||27
492294|NCT01053156|1204898|P1|COMPLETED|First Intervention (Week 1-12)||28
492295|NCT01053156|1204897|P2|STARTED|First Intervention (Week 1-12)||33
492296|NCT01053156|1204898|P1|STARTED|First Intervention (Week 1-12)||33
492297|NCT01053078|1204936|P2|NOT COMPLETED|Overall Study||3
492298|NCT01053078|1204937|P1|NOT COMPLETED|Overall Study||4
492299|NCT01053078|1204936|P2|COMPLETED|Overall Study||12
492300|NCT01053078|1204937|P1|COMPLETED|Overall Study||10
492301|NCT01053078|1204936|P2|STARTED|Overall Study||15
492302|NCT01053078|1204937|P1|STARTED|Overall Study||14
492303|NCT01053000|1204943|P2|NOT COMPLETED|Overall Study||0
492304|NCT01053000|1204944|P1|NOT COMPLETED|Overall Study||0
492305|NCT01053000|1204943|P2|COMPLETED|Overall Study||5
492306|NCT01053000|1204944|P1|COMPLETED|Overall Study||5
492307|NCT01053000|1204943|P2|STARTED|Overall Study||5
492308|NCT01053000|1204944|P1|STARTED|Overall Study||5
492309|NCT01052948|1204954|P4|NOT COMPLETED|Overall Study||0
492310|NCT01052948|1204955|P3|NOT COMPLETED|Overall Study||0
492311|NCT01052948|1204956|P2|NOT COMPLETED|Overall Study||0
492312|NCT01052948|1204957|P1|NOT COMPLETED|Overall Study||0
492313|NCT01052948|1204954|P4|COMPLETED|Overall Study||29311
492314|NCT01052948|1204955|P3|COMPLETED|Overall Study||15147
492315|NCT01052948|1204956|P2|COMPLETED|Overall Study||14669
492316|NCT01052948|1204957|P1|COMPLETED|Overall Study||27812
492317|NCT01052948|1204954|P4|STARTED|Overall Study||29311
492318|NCT01052948|1204955|P3|STARTED|Overall Study||15147
492319|NCT01052948|1204956|P2|STARTED|Overall Study||14669
492320|NCT01052948|1204957|P1|STARTED|Overall Study||27812
492321|NCT01052844|1204981|P2|NOT COMPLETED|Overall Study||1
492322|NCT01052844|1204982|P1|NOT COMPLETED|Overall Study||0
492323|NCT01052844|1204981|P2|COMPLETED|Overall Study||39
492324|NCT01052844|1204982|P1|COMPLETED|Overall Study||40
492325|NCT01052844|1204981|P2|STARTED|Overall Study||40
492326|NCT01052844|1204982|P1|STARTED|Overall Study||40
492327|NCT01052831|1204992|P2|NOT COMPLETED|Overall Study||1
492328|NCT01052831|1204993|P1|NOT COMPLETED|Overall Study||4
492329|NCT01052831|1204992|P2|COMPLETED|Overall Study||23
492330|NCT01052831|1204993|P1|COMPLETED|Overall Study||22
492331|NCT01052831|1204992|P2|STARTED|Overall Study||24
492332|NCT01052831|1204993|P1|STARTED|Overall Study||26
492333|NCT01052779|1205003|P2|NOT COMPLETED|Overall Study||9
492334|NCT01052779|1205004|P1|NOT COMPLETED|Overall Study||5
492335|NCT01052779|1205003|P2|COMPLETED|Overall Study||73
492336|NCT01052779|1205004|P1|COMPLETED|Overall Study||75
492337|NCT01052779|1205003|P2|Received at Least 1 Dose of Study Drug|Overall Study||81
492338|NCT01052779|1205004|P1|Received at Least 1 Dose of Study Drug|Overall Study||80
492339|NCT01052779|1205003|P2|STARTED|Overall Study||82
492340|NCT01052779|1205004|P1|STARTED|Overall Study||80
492341|NCT01052714|1205014|P3|NOT COMPLETED|Overall Study||2
492342|NCT01052714|1205015|P2|NOT COMPLETED|Overall Study||29
492343|NCT01052714|1205016|P1|NOT COMPLETED|Overall Study||25
492344|NCT01052714|1205014|P3|COMPLETED|Overall Study||15
492345|NCT01052714|1205015|P2|COMPLETED|Overall Study||33
492346|NCT01052714|1205016|P1|COMPLETED|Overall Study||17
492347|NCT01052714|1205014|P3|STARTED|Overall Study||17
492348|NCT01052714|1205015|P2|STARTED|Overall Study||62
492349|NCT01052714|1205016|P1|STARTED|Overall Study||42
492350|NCT01052701|1205058|P2|NOT COMPLETED|Overall Study||0
492351|NCT01052701|1205059|P1|NOT COMPLETED|Overall Study||0
492352|NCT01052701|1205058|P2|COMPLETED|Overall Study||12
492353|NCT01052701|1205059|P1|COMPLETED|Overall Study||14
492354|NCT01052701|1205058|P2|STARTED|Overall Study||12
492355|NCT01052701|1205059|P1|STARTED|Overall Study||14
492356|NCT01052662|1205070|P3|NOT COMPLETED|Overall Study||22
492357|NCT01052662|1205071|P2|NOT COMPLETED|Overall Study||22
492358|NCT01052662|1205072|P1|NOT COMPLETED|Overall Study||22
492359|NCT01052662|1205070|P3|COMPLETED|Overall Study||10
492360|NCT01052662|1205071|P2|COMPLETED|Overall Study||5
492361|NCT01052662|1205072|P1|COMPLETED|Overall Study||6
492362|NCT01052662|1205070|P3|Discontinuation Phase|Overall Study||10
492363|NCT01052662|1205071|P2|Discontinuation Phase|Overall Study||5
492364|NCT01052662|1205072|P1|Discontinuation Phase|Overall Study||6
492365|NCT01052662|1205070|P3|Stabilization Phase|Overall Study||26
492366|NCT01052662|1205071|P2|Stabilization Phase|Overall Study||21
492367|NCT01052662|1205072|P1|Stabilization Phase|Overall Study||21
492368|NCT01052662|1205070|P3|STARTED|Overall Study|3 subjects excluded from Intent-to-treat sample for final analysis due to pharmacy issue|32
492369|NCT01052662|1205071|P2|STARTED|Overall Study|3 subjects excluded from Intent-to-treat sample for final analysis due to pharmacy issue|27
492370|NCT01052662|1205072|P1|STARTED|Overall Study|1 subject excluded from Intent-to-treat sample for final analysis due to pharmacy issue.|28
492371|NCT01052545|1205088|P2|NOT COMPLETED|Overall Study||0
492372|NCT01052545|1205089|P1|NOT COMPLETED|Overall Study||0
492373|NCT01052545|1205088|P2|COMPLETED|Overall Study||731
492374|NCT01052545|1205089|P1|COMPLETED|Overall Study||867
492375|NCT01052545|1205088|P2|STARTED|Overall Study||731
492376|NCT01052545|1205089|P1|STARTED|Overall Study||867
492377|NCT01052480|1205103|P2|NOT COMPLETED|Overall Study||17
492378|NCT01052480|1205104|P1|NOT COMPLETED|Overall Study||8
492379|NCT01052480|1205103|P2|COMPLETED|Overall Study||32
492380|NCT01052480|1205104|P1|COMPLETED|Overall Study||41
492381|NCT01052480|1205103|P2|STARTED|Overall Study||49
492382|NCT01052480|1205104|P1|STARTED|Overall Study||49
492383|NCT01052428|1205154|P2|NOT COMPLETED|Overall Study||1
492384|NCT01052428|1205155|P1|NOT COMPLETED|Overall Study||1
492385|NCT01052428|1205154|P2|COMPLETED|Overall Study||18
492386|NCT01052428|1205155|P1|COMPLETED|Overall Study||18
492387|NCT01052428|1205154|P2|STARTED|Overall Study||19
492388|NCT01052428|1205155|P1|STARTED|Overall Study||19
492389|NCT01052272|1205177|P4|NOT COMPLETED|Overall Study||7
492390|NCT01052272|1205178|P3|NOT COMPLETED|Overall Study||8
492391|NCT01052272|1205179|P2|NOT COMPLETED|Overall Study||7
492392|NCT01052272|1205180|P1|NOT COMPLETED|Overall Study||5
492393|NCT01052272|1205177|P4|COMPLETED|Overall Study||11
492394|NCT01052272|1205178|P3|COMPLETED|Overall Study||10
492395|NCT01052272|1205179|P2|COMPLETED|Overall Study||11
492396|NCT01052272|1205180|P1|COMPLETED|Overall Study||13
492397|NCT01052272|1205177|P4|STARTED|Overall Study||18
492398|NCT01052272|1205178|P3|STARTED|Overall Study||18
492399|NCT01052272|1205179|P2|STARTED|Overall Study||18
492400|NCT01052272|1205180|P1|STARTED|Overall Study||18
492401|NCT01052207|1205216|P2|NOT COMPLETED|Overall Study||0
492402|NCT01052207|1205217|P1|NOT COMPLETED|Overall Study||0
492403|NCT01052207|1205216|P2|COMPLETED|Overall Study||42
492404|NCT01052207|1205217|P1|COMPLETED|Overall Study||60
492405|NCT01052207|1205216|P2|STARTED|Overall Study||42
492406|NCT01052207|1205217|P1|STARTED|Overall Study||60
492407|NCT01052116|1205225|P2|NOT COMPLETED|Overall Study||27
492408|NCT01052116|1205226|P1|NOT COMPLETED|Overall Study||14
492409|NCT01052116|1205225|P2|COMPLETED|Overall Study|Completed: defined as having an FEV1 measurement at 24 weeks|166
492410|NCT01052116|1205226|P1|COMPLETED|Overall Study|Completed: defined as having an FEV1 measurement at 24 weeks|179
492411|NCT01052116|1205225|P2|STARTED|Overall Study||193
492412|NCT01052116|1205226|P1|STARTED|Overall Study||193
492413|NCT01052077|1205234|P4|NOT COMPLETED|Phase A+||21
492414|NCT01052077|1205235|P3|NOT COMPLETED|Phase A+||0
492415|NCT01052077|1205236|P2|NOT COMPLETED|Phase A+||0
492416|NCT01052077|1205237|P1|NOT COMPLETED|Phase A+||0
492417|NCT01052077|1205234|P4|COMPLETED|Phase A+||230
492418|NCT01052077|1205235|P3|COMPLETED|Phase A+||0
492419|NCT01052077|1205236|P2|COMPLETED|Phase A+||0
492420|NCT01052077|1205237|P1|COMPLETED|Phase A+||0
492421|NCT01052077|1205234|P4|STARTED|Phase A+||251
492422|NCT01052077|1205235|P3|STARTED|Phase A+||0
492423|NCT01052077|1205236|P2|STARTED|Phase A+||0
492424|NCT01052077|1205237|P1|STARTED|Phase A+||0
492425|NCT01052077|1205234|P4|NOT COMPLETED|Phase B||0
492426|NCT01052077|1205235|P3|NOT COMPLETED|Phase B||16
492427|NCT01052077|1205236|P2|NOT COMPLETED|Phase B||18
492428|NCT01052077|1205237|P1|NOT COMPLETED|Phase B||0
492429|NCT01052077|1205234|P4|COMPLETED|Phase B||0
492430|NCT01052077|1205235|P3|COMPLETED|Phase B||171
492431|NCT01052077|1205236|P2|COMPLETED|Phase B||167
492432|NCT01052077|1205237|P1|COMPLETED|Phase B||0
492433|NCT01052077|1205234|P4|STARTED|Phase B||0
492434|NCT01052077|1205235|P3|STARTED|Phase B||187
492435|NCT01052077|1205236|P2|STARTED|Phase B||185
492436|NCT01052077|1205237|P1|STARTED|Phase B||0
492437|NCT01052077|1205234|P4|NOT COMPLETED|Phase A||0
492438|NCT01052077|1205235|P3|NOT COMPLETED|Phase A||0
492439|NCT01052077|1205236|P2|NOT COMPLETED|Phase A||0
492440|NCT01052077|1205237|P1|NOT COMPLETED|Phase A||146
492441|NCT01052077|1205234|P4|COMPLETED|Phase A||0
492442|NCT01052077|1205235|P3|COMPLETED|Phase A||0
492443|NCT01052077|1205236|P2|COMPLETED|Phase A||0
492444|NCT01052077|1205237|P1|COMPLETED|Phase A||623
492445|NCT01052077|1205234|P4|STARTED|Phase A||0
492446|NCT01052077|1205235|P3|STARTED|Phase A||0
492447|NCT01052077|1205236|P2|STARTED|Phase A||0
492448|NCT01052077|1205237|P1|STARTED|Phase A||769
492449|NCT01052038|1205264|P3|NOT COMPLETED|Overall Study||4
492450|NCT01052038|1205265|P2|NOT COMPLETED|Overall Study||6
492451|NCT01052038|1205266|P1|NOT COMPLETED|Overall Study||4
492452|NCT01052038|1205264|P3|COMPLETED|Overall Study||36
492453|NCT01052038|1205265|P2|COMPLETED|Overall Study||34
492454|NCT01052038|1205266|P1|COMPLETED|Overall Study||36
492455|NCT01052038|1205264|P3|STARTED|Overall Study||40
492456|NCT01052038|1205265|P2|STARTED|Overall Study||40
492457|NCT01052038|1205266|P1|STARTED|Overall Study||40
492458|NCT01051986|1205288|P2|NOT COMPLETED|Overall Study||4
492459|NCT01051986|1205289|P1|NOT COMPLETED|Overall Study||5
492460|NCT01051986|1205288|P2|COMPLETED|Overall Study||108
492461|NCT01051986|1205289|P1|COMPLETED|Overall Study||107
492462|NCT01051986|1205288|P2|STARTED|Overall Study||112
492463|NCT01051986|1205289|P1|STARTED|Overall Study||112
492464|NCT01051921|1205303|P1|NOT COMPLETED|Overall Study||30
492465|NCT01051921|1205303|P1|COMPLETED|Overall Study||37
492466|NCT01051921|1205303|P1|STARTED|Overall Study||67
492467|NCT01051856|1205310|P2|NOT COMPLETED|Overall Study||0
492468|NCT01051856|1205311|P1|NOT COMPLETED|Overall Study||1
492469|NCT01051856|1205310|P2|COMPLETED|Overall Study||35
492470|NCT01051856|1205311|P1|COMPLETED|Overall Study||32
492471|NCT01051856|1205310|P2|STARTED|Overall Study||35
492472|NCT01051856|1205311|P1|STARTED|Overall Study||33
492473|NCT01051817|1205321|P2|NOT COMPLETED|Overall Study||9
492474|NCT01051817|1205322|P1|NOT COMPLETED|Overall Study||3
492475|NCT01051817|1205321|P2|COMPLETED|Overall Study||26
492476|NCT01051817|1205322|P1|COMPLETED|Overall Study||35
492477|NCT01051817|1205321|P2|STARTED|Overall Study||35
492478|NCT01051817|1205322|P1|STARTED|Overall Study||38
492479|NCT01051791|1205332|P1|NOT COMPLETED|Overall Study||4
492480|NCT01051791|1205332|P1|COMPLETED|Overall Study||9
492481|NCT01051791|1205332|P1|STARTED|Overall Study||13
492482|NCT01051778|1205341|P2|NOT COMPLETED|Overall Study||0
492483|NCT01051778|1205342|P1|NOT COMPLETED|Overall Study||0
492484|NCT01051778|1205341|P2|COMPLETED|Overall Study|November 2009|30
492485|NCT01051778|1205342|P1|COMPLETED|Overall Study|November 2009|30
492486|NCT01051778|1205341|P2|STARTED|Overall Study|June 2006|30
492487|NCT01051778|1205342|P1|STARTED|Overall Study|June 2006|30
492488|NCT01051739|1205350|P2|NOT COMPLETED|Overall Study||13
492489|NCT01051739|1205351|P1|NOT COMPLETED|Overall Study||28
492490|NCT01051739|1205350|P2|COMPLETED|Overall Study||47
492491|NCT01051739|1205351|P1|COMPLETED|Overall Study||92
492492|NCT01051739|1205350|P2|STARTED|Overall Study||60
492493|NCT01051739|1205351|P1|STARTED|Overall Study||120
492494|NCT01051570|1205357|P1|NOT COMPLETED|Overall Study||0
492495|NCT01051570|1205357|P1|COMPLETED|Overall Study||26
492496|NCT01051570|1205357|P1|STARTED|Overall Study||26
492497|NCT01051557|1205368|P7|NOT COMPLETED|Overall Study||6
492498|NCT01051557|1205369|P6|NOT COMPLETED|Overall Study||6
492499|NCT01051557|1205370|P5|NOT COMPLETED|Overall Study||7
492500|NCT01051557|1205371|P4|NOT COMPLETED|Overall Study||3
492501|NCT01051557|1205372|P3|NOT COMPLETED|Overall Study||6
492502|NCT01051557|1205373|P2|NOT COMPLETED|Overall Study||3
492503|NCT01051557|1205374|P1|NOT COMPLETED|Overall Study||4
492504|NCT01051557|1205368|P7|COMPLETED|Overall Study||0
492505|NCT01051557|1205369|P6|COMPLETED|Overall Study||0
492506|NCT01051557|1205370|P5|COMPLETED|Overall Study||1
492507|NCT01051557|1205371|P4|COMPLETED|Overall Study||0
492508|NCT01051557|1205372|P3|COMPLETED|Overall Study||0
492509|NCT01051557|1205373|P2|COMPLETED|Overall Study||0
492510|NCT01051557|1205374|P1|COMPLETED|Overall Study||0
492511|NCT01051557|1205368|P7|STARTED|Overall Study||6
492512|NCT01051557|1205369|P6|STARTED|Overall Study||6
492513|NCT01051557|1205370|P5|STARTED|Overall Study||8
492514|NCT01051557|1205371|P4|STARTED|Overall Study||3
492515|NCT01051557|1205372|P3|STARTED|Overall Study||6
492516|NCT01051557|1205373|P2|STARTED|Overall Study||3
492517|NCT01051557|1205374|P1|STARTED|Overall Study||4
492518|NCT01051466|1205393|P2|NOT COMPLETED|Overall Study||5
492519|NCT01051466|1205394|P1|NOT COMPLETED|Overall Study||8
492520|NCT01051466|1205393|P2|COMPLETED|Overall Study||23
492521|NCT01051466|1205394|P1|COMPLETED|Overall Study||24
492522|NCT01051466|1205393|P2|STARTED|Overall Study||28
492523|NCT01051466|1205394|P1|STARTED|Overall Study||32
492524|NCT01051440|1205428|P2|NOT COMPLETED|Overall Study||0
492525|NCT01051440|1205429|P1|NOT COMPLETED|Overall Study||0
492526|NCT01051440|1205428|P2|COMPLETED|Overall Study||1
492527|NCT01051440|1205429|P1|COMPLETED|Overall Study||1
492528|NCT01051440|1205428|P2|STARTED|Overall Study||1
492529|NCT01051440|1205429|P1|STARTED|Overall Study||1
492530|NCT01051323|1205441|P1|NOT COMPLETED|Overall Study||539
492531|NCT01051323|1205441|P1|COMPLETED|Overall Study||1041
492532|NCT01051323|1205441|P1|Received at Least One Dose|Overall Study||1547
492533|NCT01051323|1205441|P1|STARTED|Overall Study||1580
492534|NCT01050998|1205468|P5|NOT COMPLETED|Overall Study||14
492535|NCT01050998|1205469|P4|NOT COMPLETED|Overall Study||3
492536|NCT01050998|1205470|P3|NOT COMPLETED|Overall Study||3
492537|NCT01050998|1205471|P2|NOT COMPLETED|Overall Study||2
492538|NCT01050998|1205472|P1|NOT COMPLETED|Overall Study||4
492539|NCT01050998|1205468|P5|COMPLETED|Overall Study||82
492540|NCT01050998|1205469|P4|COMPLETED|Overall Study||45
492541|NCT01050998|1205470|P3|COMPLETED|Overall Study||46
492542|NCT01050998|1205471|P2|COMPLETED|Overall Study||47
492543|NCT01050998|1205472|P1|COMPLETED|Overall Study||44
492544|NCT01050998|1205468|P5|STARTED|Overall Study||96
492545|NCT01050998|1205469|P4|STARTED|Overall Study||48
492546|NCT01050998|1205470|P3|STARTED|Overall Study||49
492547|NCT01050998|1205471|P2|STARTED|Overall Study||49
492548|NCT01050998|1205472|P1|STARTED|Overall Study||48
492549|NCT01050946|1205796|P1|NOT COMPLETED|Overall Study||0
492550|NCT01050946|1205796|P1|COMPLETED|Overall Study|Patient signed consent 2/3/2011. Patient had their transplant 2/15/2011. Patient died 9/2/2011|1
492551|NCT01050946|1205796|P1|STARTED|Overall Study||1
492552|NCT01050816|1205806|P1|NOT COMPLETED|Overall Study||4
492553|NCT01050816|1205806|P1|COMPLETED|Overall Study||26
492554|NCT01050816|1205806|P1|STARTED|Overall Study||30
492555|NCT01050790|1205812|P1|NOT COMPLETED|Overall Study||1
492556|NCT01050790|1205812|P1|COMPLETED|Overall Study||16
492557|NCT01050790|1205812|P1|STARTED|Overall Study||17
492558|NCT01050764|1205822|P1|NOT COMPLETED|Overall Study||3
492559|NCT01050764|1205822|P1|COMPLETED|Overall Study||7
492560|NCT01050764|1205822|P1|Received Infusion of T-con Cells|Overall Study||7
492561|NCT01050764|1205822|P1|Received Infusion of T-reg Cells|Overall Study||7
492562|NCT01050764|1205822|P1|Received HSCT Graft|Overall Study||8
492563|NCT01050764|1205822|P1|STARTED|Overall Study||10
492564|NCT01050673|1205833|P2|NOT COMPLETED|Overall Study||5
492565|NCT01050673|1205834|P1|NOT COMPLETED|Overall Study||4
492566|NCT01050673|1205833|P2|COMPLETED|Overall Study||14
492567|NCT01050673|1205834|P1|COMPLETED|Overall Study||17
492568|NCT01050673|1205833|P2|STARTED|Overall Study||19
492569|NCT01050673|1205834|P1|STARTED|Overall Study||21
492570|NCT01050660|1205858|P2|NOT COMPLETED|Overall Study||0
492571|NCT01050660|1205859|P1|NOT COMPLETED|Overall Study||0
492572|NCT01050660|1205858|P2|COMPLETED|Overall Study||69
492573|NCT01050660|1205859|P1|COMPLETED|Overall Study||67
492574|NCT01050660|1205858|P2|STARTED|Overall Study||69
492575|NCT01050660|1205859|P1|STARTED|Overall Study||67
492576|NCT01050647|1205885|P2|NOT COMPLETED|Overall Study||0
492577|NCT01050647|1205886|P1|NOT COMPLETED|Overall Study||0
492578|NCT01050647|1205885|P2|COMPLETED|Overall Study||11
492579|NCT01050647|1205886|P1|COMPLETED|Overall Study||10
492580|NCT01050647|1205885|P2|STARTED|Overall Study||11
492581|NCT01050647|1205886|P1|STARTED|Overall Study||10
492582|NCT01050634|1205902|P1|NOT COMPLETED|Overall Study||128
492583|NCT01050634|1205902|P1|COMPLETED|Overall Study||852
492584|NCT01050634|1205902|P1|Received Treatment|Overall Study||924
492585|NCT01050634|1205902|P1|STARTED|Overall Study||980
492586|NCT01050582|1205912|P2|NOT COMPLETED|Overall Study||0
492587|NCT01050582|1205913|P1|NOT COMPLETED|Overall Study||0
492588|NCT01050582|1205912|P2|COMPLETED|Overall Study||51
492589|NCT01050582|1205913|P1|COMPLETED|Overall Study||133
492590|NCT01050582|1205912|P2|STARTED|Overall Study||51
492591|NCT01050582|1205913|P1|STARTED|Overall Study||133
492592|NCT01050569|1205926|P3|NOT COMPLETED|Overall Study||33
492593|NCT01050569|1205927|P2|NOT COMPLETED|Overall Study||24
492594|NCT01050569|1205928|P1|NOT COMPLETED|Overall Study||38
492595|NCT01050569|1205926|P3|COMPLETED|Overall Study||47
492596|NCT01050569|1205927|P2|COMPLETED|Overall Study||52
492597|NCT01050569|1205928|P1|COMPLETED|Overall Study||41
492598|NCT01050569|1205926|P3|STARTED|Overall Study||80
492599|NCT01050569|1205927|P2|STARTED|Overall Study||76
492600|NCT01050569|1205928|P1|STARTED|Overall Study||79
492601|NCT01050543|1205947|P2|NOT COMPLETED|Overall Study||4
492602|NCT01050543|1205948|P1|NOT COMPLETED|Overall Study||4
492603|NCT01050543|1205947|P2|COMPLETED|Overall Study|Includes 1 participant who started & completed the study but was excluded from Full Analysis Set.|60
492604|NCT01050543|1205948|P1|COMPLETED|Overall Study|Includes 1 participant who started & completed the study but was excluded from Full Analysis Set.|60
492605|NCT01050543|1205947|P2|STARTED|Overall Study|Includes 4 participants who were randomized but discontinued before Treatment Phase.|64
492606|NCT01050543|1205948|P1|STARTED|Overall Study|Includes 4 participants who were randomized but discontinued before Treatment Phase.|64
492607|NCT01050530|1205956|P2|NOT COMPLETED|Overall Study||10
492608|NCT01050530|1205957|P1|NOT COMPLETED|Overall Study||8
492609|NCT01050530|1205956|P2|COMPLETED|Overall Study||70
492610|NCT01050530|1205957|P1|COMPLETED|Overall Study||74
492611|NCT01050530|1205956|P2|STARTED|Overall Study||80
492612|NCT01050530|1205957|P1|STARTED|Overall Study||82
492613|NCT01050257|1205968|P3|NOT COMPLETED|Overall Study||7
492614|NCT01050257|1205969|P2|NOT COMPLETED|Overall Study||13
492615|NCT01050257|1205970|P1|NOT COMPLETED|Overall Study||11
492616|NCT01050257|1205968|P3|COMPLETED|Overall Study||8
492617|NCT01050257|1205969|P2|COMPLETED|Overall Study||40
492618|NCT01050257|1205970|P1|COMPLETED|Overall Study|Completed 5 days of treatment either IV or Oral|39
492619|NCT01050257|1205968|P3|Switched to Oral Treatment|Overall Study||3
492620|NCT01050257|1205969|P2|Switched to Oral Treatment|Overall Study||31
492621|NCT01050257|1205970|P1|Switched to Oral Treatment|Overall Study||28
492622|NCT01050257|1205968|P3|Intent-to-treat Infected Confirmed|Overall Study||10
492623|NCT01050257|1205969|P2|Intent-to-treat Infected Confirmed|Overall Study||32
492624|NCT01050257|1205970|P1|Intent-to-treat Infected Confirmed|Overall Study||30
492625|NCT01050257|1205968|P3|Safety Population: Actual Dose Received|Overall Study||14
492626|NCT01050257|1205969|P2|Safety Population: Actual Dose Received|Overall Study|One participant randomized to 100 mg actually received the 200 mg doses.|51
492627|NCT01050257|1205970|P1|Safety Population: Actual Dose Received|Overall Study||48
492628|NCT01050257|1205968|P3|Received Treatment|Overall Study||14
492629|NCT01050257|1205969|P2|Received Treatment|Overall Study||50
492630|NCT01050257|1205970|P1|Received Treatment|Overall Study||49
492631|NCT01050257|1205968|P3|STARTED|Overall Study||15
492632|NCT01050257|1205969|P2|STARTED|Overall Study||53
492633|NCT01050257|1205970|P1|STARTED|Overall Study||50
492634|NCT01050218|1206005|P1|NOT COMPLETED|Overall Study||95
492635|NCT01050218|1206005|P1|COMPLETED|Overall Study||142
492636|NCT01050218|1206005|P1|STARTED|Overall Study||237
492637|NCT01050205|1206011|P2|NOT COMPLETED|Overall Study||4
492638|NCT01050205|1206012|P1|NOT COMPLETED|Overall Study||11
492639|NCT01050205|1206011|P2|COMPLETED|Overall Study||71
492640|NCT01050205|1206012|P1|COMPLETED|Overall Study||137
492641|NCT01050205|1206011|P2|STARTED|Overall Study||75
492642|NCT01050205|1206012|P1|STARTED|Overall Study||148
492643|NCT01050153|1206042|P2|NOT COMPLETED|Overall Study||0
492644|NCT01050153|1206043|P1|NOT COMPLETED|Overall Study||0
492645|NCT01050153|1206042|P2|COMPLETED|Overall Study||25
492646|NCT01050153|1206043|P1|COMPLETED|Overall Study||25
492647|NCT01050153|1206042|P2|STARTED|Overall Study||25
492648|NCT01050153|1206043|P1|STARTED|Overall Study||25
492649|NCT01050062|1206069|P2|NOT COMPLETED|Overall Study||112
492650|NCT01050062|1206070|P1|NOT COMPLETED|Overall Study||271
492651|NCT01050062|1206069|P2|COMPLETED|Overall Study||243
492652|NCT01050062|1206070|P1|COMPLETED|Overall Study||799
492653|NCT01050062|1206069|P2|STARTED|Overall Study||355
492654|NCT01050062|1206070|P1|STARTED|Overall Study||1070
492655|NCT01049984|1206092|P2|NOT COMPLETED|Overall Study||19
492656|NCT01049984|1206093|P1|NOT COMPLETED|Overall Study||19
492657|NCT01049984|1206092|P2|COMPLETED|Overall Study||146
492658|NCT01049984|1206093|P1|COMPLETED|Overall Study||144
492659|NCT01049984|1206092|P2|Modified Intent-to-treat Pop|Overall Study|Took >= 1 dose of study drug and had both baseline and at least 1 post-baseline efficacy assessment|162
492660|NCT01049984|1206093|P1|Modified Intent-to-treat Pop|Overall Study|Took >= 1 dose of study drug and had both baseline and at least 1 post-baseline efficacy assessment|159
492661|NCT01049984|1206092|P2|Safety Population|Overall Study|One patient was randomized but not dosed; omitted from safety population|164
492662|NCT01049984|1206093|P1|Safety Population|Overall Study|One patient was randomized but not dosed; omitted from safety population|162
492663|NCT01049984|1206092|P2|STARTED|Overall Study||165
492664|NCT01049984|1206093|P1|STARTED|Overall Study||163
492665|NCT01049945|1206111|P6|NOT COMPLETED|Overall Study||0
492666|NCT01049945|1206112|P5|NOT COMPLETED|Overall Study||0
492667|NCT01049945|1206113|P4|NOT COMPLETED|Overall Study||0
492668|NCT01049945|1206114|P3|NOT COMPLETED|Overall Study||0
492669|NCT01049945|1206115|P2|NOT COMPLETED|Overall Study||0
492670|NCT01049945|1206116|P1|NOT COMPLETED|Overall Study||0
492671|NCT01049945|1206111|P6|COMPLETED|Overall Study||49
492672|NCT01049945|1206112|P5|COMPLETED|Overall Study||3
492673|NCT01049945|1206113|P4|COMPLETED|Overall Study||6
492674|NCT01049945|1206114|P3|COMPLETED|Overall Study||3
492675|NCT01049945|1206115|P2|COMPLETED|Overall Study||6
492676|NCT01049945|1206116|P1|COMPLETED|Overall Study||3
492677|NCT01049945|1206111|P6|STARTED|Overall Study||49
492678|NCT01049945|1206112|P5|STARTED|Overall Study||3
492679|NCT01049945|1206113|P4|STARTED|Overall Study||6
492680|NCT01049945|1206114|P3|STARTED|Overall Study||3
492681|NCT01049945|1206115|P2|STARTED|Overall Study||6
492682|NCT01049945|1206116|P1|STARTED|Overall Study||3
492683|NCT01049802|1206132|P2|NOT COMPLETED|Overall Study||0
492684|NCT01049802|1206133|P1|NOT COMPLETED|Overall Study||0
492685|NCT01049802|1206132|P2|COMPLETED|Overall Study||10
492686|NCT01049802|1206133|P1|COMPLETED|Overall Study||20
492687|NCT01049802|1206132|P2|STARTED|Overall Study||10
492688|NCT01049802|1206133|P1|STARTED|Overall Study||20
492689|NCT01049776|1206147|P1|NOT COMPLETED|Overall Study||20
492690|NCT01049776|1206147|P1|COMPLETED|Overall Study||12
492691|NCT01049776|1206147|P1|STARTED|Overall Study||32
492692|NCT01049581|1206153|P2|NOT COMPLETED|Overall Study||1
492693|NCT01049581|1206154|P1|NOT COMPLETED|Overall Study||2
492694|NCT01049581|1206153|P2|COMPLETED|Overall Study||13
492695|NCT01049581|1206154|P1|COMPLETED|Overall Study||11
492696|NCT01049581|1206153|P2|STARTED|Overall Study||14
492697|NCT01049581|1206154|P1|STARTED|Overall Study||13
492698|NCT01049503|1206169|P6|NOT COMPLETED|Overall Study||8
492699|NCT01049503|1206170|P5|NOT COMPLETED|Overall Study||27
492700|NCT01049503|1206171|P4|NOT COMPLETED|Overall Study||26
492701|NCT01049503|1206172|P3|NOT COMPLETED|Overall Study||24
492702|NCT01049503|1206173|P2|NOT COMPLETED|Overall Study||12
492703|NCT01049503|1206174|P1|NOT COMPLETED|Overall Study||11
492704|NCT01049503|1206169|P6|COMPLETED|Overall Study||40
492705|NCT01049503|1206170|P5|COMPLETED|Overall Study||29
492706|NCT01049503|1206171|P4|COMPLETED|Overall Study||29
492707|NCT01049503|1206172|P3|COMPLETED|Overall Study||32
492708|NCT01049503|1206173|P2|COMPLETED|Overall Study||36
492709|NCT01049503|1206174|P1|COMPLETED|Overall Study||41
492710|NCT01049503|1206169|P6|STARTED|Overall Study||48
492711|NCT01049503|1206170|P5|STARTED|Overall Study||56
492712|NCT01049503|1206171|P4|STARTED|Overall Study||55
492713|NCT01049503|1206172|P3|STARTED|Overall Study||56
492714|NCT01049503|1206173|P2|STARTED|Overall Study||48
492715|NCT01049503|1206174|P1|STARTED|Overall Study||52
492716|NCT01049412|1206205|P2|NOT COMPLETED|Period II||3
492717|NCT01049412|1206206|P1|NOT COMPLETED|Period II||4
492718|NCT01049412|1206205|P2|COMPLETED|Period II||52
492719|NCT01049412|1206206|P1|COMPLETED|Period II||58
492720|NCT01049412|1206205|P2|STARTED|Period II||55
492721|NCT01049412|1206206|P1|STARTED|Period II||62
492722|NCT01049412|1206205|P2|NOT COMPLETED|Period I||13
492723|NCT01049412|1206206|P1|NOT COMPLETED|Period I||8
492724|NCT01049412|1206205|P2|COMPLETED|Period I||55
492725|NCT01049412|1206206|P1|COMPLETED|Period I||62
492726|NCT01049412|1206205|P2|Took at Least One Dose of Study Drug|Period I||68
492727|NCT01049412|1206206|P1|Took at Least One Dose of Study Drug|Period I||69
492728|NCT01049412|1206205|P2|STARTED|Period I||68
492729|NCT01049412|1206206|P1|STARTED|Period I||70
492730|NCT01049373|1206235|P2|NOT COMPLETED|Overall Study||44
492731|NCT01049373|1206236|P1|NOT COMPLETED|Overall Study||39
492732|NCT01049373|1206235|P2|COMPLETED|Overall Study||65
492733|NCT01049373|1206236|P1|COMPLETED|Overall Study||73
492734|NCT01049373|1206235|P2|STARTED|Overall Study||109
492735|NCT01049373|1206236|P1|STARTED|Overall Study||112
492736|NCT01049360|1206250|P20|NOT COMPLETED|Period 4||0
492737|NCT01049360|1206251|P19|NOT COMPLETED|Period 4||0
492738|NCT01049360|1206252|P18|NOT COMPLETED|Period 4||1
492739|NCT01049360|1206253|P17|NOT COMPLETED|Period 4||0
492740|NCT01049360|1206254|P16|NOT COMPLETED|Period 4||0
492741|NCT01049360|1206255|P15|NOT COMPLETED|Period 4||0
492742|NCT01049360|1206256|P14|NOT COMPLETED|Period 4||0
492743|NCT01049360|1206257|P13|NOT COMPLETED|Period 4||0
492744|NCT01049360|1206258|P12|NOT COMPLETED|Period 4||0
492745|NCT01049360|1206259|P11|NOT COMPLETED|Period 4||0
492746|NCT01049360|1206260|P10|NOT COMPLETED|Period 4||0
492747|NCT01049360|1206261|P9|NOT COMPLETED|Period 4||0
492748|NCT01049360|1206262|P8|NOT COMPLETED|Period 4||0
492749|NCT01049360|1206263|P7|NOT COMPLETED|Period 4||0
492750|NCT01049360|1206264|P6|NOT COMPLETED|Period 4||0
492751|NCT01049360|1206265|P5|NOT COMPLETED|Period 4||0
492752|NCT01049360|1206266|P4|NOT COMPLETED|Period 4||1
492753|NCT01049360|1206267|P3|NOT COMPLETED|Period 4||0
492754|NCT01049360|1206268|P2|NOT COMPLETED|Period 4||0
492755|NCT01049360|1206269|P1|NOT COMPLETED|Period 4||0
492756|NCT01049360|1206250|P20|COMPLETED|Period 4||5
492757|NCT01049360|1206251|P19|COMPLETED|Period 4||5
492758|NCT01049360|1206252|P18|COMPLETED|Period 4||5
492759|NCT01049360|1206253|P17|COMPLETED|Period 4||5
492760|NCT01049360|1206254|P16|COMPLETED|Period 4||6
492761|NCT01049360|1206255|P15|COMPLETED|Period 4||5
492762|NCT01049360|1206256|P14|COMPLETED|Period 4||6
492763|NCT01049360|1206257|P13|COMPLETED|Period 4||4
492764|NCT01049360|1206258|P12|COMPLETED|Period 4||6
492765|NCT01049360|1206259|P11|COMPLETED|Period 4||5
492766|NCT01049360|1206260|P10|COMPLETED|Period 4||6
492767|NCT01049360|1206261|P9|COMPLETED|Period 4||4
492768|NCT01049360|1206262|P8|COMPLETED|Period 4||4
492769|NCT01049360|1206263|P7|COMPLETED|Period 4||6
492770|NCT01049360|1206264|P6|COMPLETED|Period 4||5
492771|NCT01049360|1206265|P5|COMPLETED|Period 4||7
492772|NCT01049360|1206266|P4|COMPLETED|Period 4||3
492773|NCT01049360|1206267|P3|COMPLETED|Period 4||7
492774|NCT01049360|1206268|P2|COMPLETED|Period 4||4
492775|NCT01049360|1206269|P1|COMPLETED|Period 4||6
492776|NCT01049360|1206250|P20|STARTED|Period 4||5
492777|NCT01049360|1206251|P19|STARTED|Period 4||5
492778|NCT01049360|1206252|P18|STARTED|Period 4||6
492779|NCT01049360|1206253|P17|STARTED|Period 4||5
492780|NCT01049360|1206254|P16|STARTED|Period 4||6
492781|NCT01049360|1206255|P15|STARTED|Period 4||5
492782|NCT01049360|1206256|P14|STARTED|Period 4||6
492783|NCT01049360|1206257|P13|STARTED|Period 4||4
492784|NCT01049360|1206258|P12|STARTED|Period 4||6
492785|NCT01049360|1206259|P11|STARTED|Period 4||5
492786|NCT01049360|1206260|P10|STARTED|Period 4||6
492787|NCT01049360|1206261|P9|STARTED|Period 4||4
492788|NCT01049360|1206262|P8|STARTED|Period 4||4
492789|NCT01049360|1206263|P7|STARTED|Period 4||6
492790|NCT01049360|1206264|P6|STARTED|Period 4||5
492791|NCT01049360|1206265|P5|STARTED|Period 4||7
492792|NCT01049360|1206266|P4|STARTED|Period 4||4
492793|NCT01049360|1206267|P3|STARTED|Period 4||7
492794|NCT01049360|1206268|P2|STARTED|Period 4||4
492795|NCT01049360|1206269|P1|STARTED|Period 4||6
492796|NCT01049360|1206250|P20|NOT COMPLETED|Period 3||0
492797|NCT01049360|1206251|P19|NOT COMPLETED|Period 3||0
492798|NCT01049360|1206252|P18|NOT COMPLETED|Period 3||0
492799|NCT01049360|1206253|P17|NOT COMPLETED|Period 3||0
492800|NCT01049360|1206254|P16|NOT COMPLETED|Period 3||0
492801|NCT01049360|1206255|P15|NOT COMPLETED|Period 3||0
492802|NCT01049360|1206256|P14|NOT COMPLETED|Period 3||0
492803|NCT01049360|1206257|P13|NOT COMPLETED|Period 3||0
492804|NCT01049360|1206258|P12|NOT COMPLETED|Period 3||0
492805|NCT01049360|1206259|P11|NOT COMPLETED|Period 3||0
492806|NCT01049360|1206260|P10|NOT COMPLETED|Period 3||0
492807|NCT01049360|1206261|P9|NOT COMPLETED|Period 3||0
492808|NCT01049360|1206262|P8|NOT COMPLETED|Period 3||0
492809|NCT01049360|1206263|P7|NOT COMPLETED|Period 3||0
492810|NCT01049360|1206264|P6|NOT COMPLETED|Period 3||0
492811|NCT01049360|1206265|P5|NOT COMPLETED|Period 3||0
492812|NCT01049360|1206266|P4|NOT COMPLETED|Period 3||0
492813|NCT01049360|1206267|P3|NOT COMPLETED|Period 3||0
492814|NCT01049360|1206268|P2|NOT COMPLETED|Period 3||0
492815|NCT01049360|1206269|P1|NOT COMPLETED|Period 3||0
492816|NCT01049360|1206250|P20|COMPLETED|Period 3||5
492817|NCT01049360|1206251|P19|COMPLETED|Period 3||5
492818|NCT01049360|1206252|P18|COMPLETED|Period 3||6
492819|NCT01049360|1206253|P17|COMPLETED|Period 3||5
492820|NCT01049360|1206254|P16|COMPLETED|Period 3||6
492821|NCT01049360|1206255|P15|COMPLETED|Period 3||5
492822|NCT01049360|1206256|P14|COMPLETED|Period 3||6
492823|NCT01049360|1206257|P13|COMPLETED|Period 3||4
492824|NCT01049360|1206258|P12|COMPLETED|Period 3||6
492825|NCT01049360|1206259|P11|COMPLETED|Period 3||5
492826|NCT01049360|1206260|P10|COMPLETED|Period 3||6
492827|NCT01049360|1206261|P9|COMPLETED|Period 3||4
492828|NCT01049360|1206262|P8|COMPLETED|Period 3||4
492829|NCT01049360|1206263|P7|COMPLETED|Period 3||6
492830|NCT01049360|1206264|P6|COMPLETED|Period 3||5
492831|NCT01049360|1206265|P5|COMPLETED|Period 3||7
492832|NCT01049360|1206266|P4|COMPLETED|Period 3||4
492833|NCT01049360|1206267|P3|COMPLETED|Period 3||7
492834|NCT01049360|1206268|P2|COMPLETED|Period 3||4
492835|NCT01049360|1206269|P1|COMPLETED|Period 3||6
492836|NCT01049360|1206250|P20|STARTED|Period 3||5
492837|NCT01049360|1206251|P19|STARTED|Period 3||5
492838|NCT01049360|1206252|P18|STARTED|Period 3||6
492839|NCT01049360|1206253|P17|STARTED|Period 3||5
492840|NCT01049360|1206254|P16|STARTED|Period 3||6
492841|NCT01049360|1206255|P15|STARTED|Period 3||5
492842|NCT01049360|1206256|P14|STARTED|Period 3||6
492843|NCT01049360|1206257|P13|STARTED|Period 3||4
492844|NCT01049360|1206258|P12|STARTED|Period 3||6
492845|NCT01049360|1206259|P11|STARTED|Period 3||5
492846|NCT01049360|1206260|P10|STARTED|Period 3||6
492847|NCT01049360|1206261|P9|STARTED|Period 3||4
492848|NCT01049360|1206262|P8|STARTED|Period 3||4
492849|NCT01049360|1206263|P7|STARTED|Period 3||6
492850|NCT01049360|1206264|P6|STARTED|Period 3||5
492851|NCT01049360|1206265|P5|STARTED|Period 3||7
492852|NCT01049360|1206266|P4|STARTED|Period 3||4
492853|NCT01049360|1206267|P3|STARTED|Period 3||7
492854|NCT01049360|1206268|P2|STARTED|Period 3||4
492855|NCT01049360|1206269|P1|STARTED|Period 3||6
492856|NCT01049360|1206250|P20|NOT COMPLETED|Period 2||2
492857|NCT01049360|1206251|P19|NOT COMPLETED|Period 2||0
492858|NCT01049360|1206252|P18|NOT COMPLETED|Period 2||0
492859|NCT01049360|1206253|P17|NOT COMPLETED|Period 2||0
492860|NCT01049360|1206254|P16|NOT COMPLETED|Period 2||1
492861|NCT01049360|1206255|P15|NOT COMPLETED|Period 2||2
492862|NCT01049360|1206256|P14|NOT COMPLETED|Period 2||0
492863|NCT01049360|1206257|P13|NOT COMPLETED|Period 2||0
492864|NCT01049360|1206258|P12|NOT COMPLETED|Period 2||0
492865|NCT01049360|1206259|P11|NOT COMPLETED|Period 2||0
492866|NCT01049360|1206260|P10|NOT COMPLETED|Period 2||0
492867|NCT01049360|1206261|P9|NOT COMPLETED|Period 2||1
492868|NCT01049360|1206262|P8|NOT COMPLETED|Period 2||0
492869|NCT01049360|1206263|P7|NOT COMPLETED|Period 2||0
492870|NCT01049360|1206264|P6|NOT COMPLETED|Period 2||1
492871|NCT01049360|1206265|P5|NOT COMPLETED|Period 2||0
492872|NCT01049360|1206266|P4|NOT COMPLETED|Period 2||2
492873|NCT01049360|1206267|P3|NOT COMPLETED|Period 2||0
492874|NCT01049360|1206268|P2|NOT COMPLETED|Period 2||1
492875|NCT01049360|1206269|P1|NOT COMPLETED|Period 2||0
492876|NCT01049360|1206250|P20|COMPLETED|Period 2||5
492877|NCT01049360|1206251|P19|COMPLETED|Period 2||5
492878|NCT01049360|1206252|P18|COMPLETED|Period 2||6
492879|NCT01049360|1206253|P17|COMPLETED|Period 2||5
492880|NCT01049360|1206254|P16|COMPLETED|Period 2||6
492881|NCT01049360|1206255|P15|COMPLETED|Period 2||5
492882|NCT01049360|1206256|P14|COMPLETED|Period 2||6
492883|NCT01049360|1206257|P13|COMPLETED|Period 2||4
492884|NCT01049360|1206258|P12|COMPLETED|Period 2||6
492885|NCT01049360|1206259|P11|COMPLETED|Period 2||5
492886|NCT01049360|1206260|P10|COMPLETED|Period 2||6
492887|NCT01049360|1206261|P9|COMPLETED|Period 2||4
492888|NCT01049360|1206262|P8|COMPLETED|Period 2||4
492889|NCT01049360|1206263|P7|COMPLETED|Period 2||6
492890|NCT01049360|1206264|P6|COMPLETED|Period 2||5
492891|NCT01049360|1206265|P5|COMPLETED|Period 2||7
492892|NCT01049360|1206266|P4|COMPLETED|Period 2||4
492893|NCT01049360|1206267|P3|COMPLETED|Period 2||7
492894|NCT01049360|1206268|P2|COMPLETED|Period 2||4
492895|NCT01049360|1206269|P1|COMPLETED|Period 2||6
492896|NCT01049360|1206250|P20|STARTED|Period 2||7
492897|NCT01049360|1206251|P19|STARTED|Period 2||5
492898|NCT01049360|1206252|P18|STARTED|Period 2||6
492899|NCT01049360|1206253|P17|STARTED|Period 2||5
492900|NCT01049360|1206254|P16|STARTED|Period 2||7
492901|NCT01049360|1206255|P15|STARTED|Period 2||7
492902|NCT01049360|1206256|P14|STARTED|Period 2||6
492903|NCT01049360|1206257|P13|STARTED|Period 2||4
492904|NCT01049360|1206258|P12|STARTED|Period 2||6
492905|NCT01049360|1206259|P11|STARTED|Period 2||5
492906|NCT01049360|1206260|P10|STARTED|Period 2||6
492907|NCT01049360|1206261|P9|STARTED|Period 2||5
492908|NCT01049360|1206262|P8|STARTED|Period 2||4
492909|NCT01049360|1206263|P7|STARTED|Period 2||6
492910|NCT01049360|1206264|P6|STARTED|Period 2||6
492911|NCT01049360|1206265|P5|STARTED|Period 2||7
492912|NCT01049360|1206266|P4|STARTED|Period 2||6
492913|NCT01049360|1206267|P3|STARTED|Period 2||7
492914|NCT01049360|1206268|P2|STARTED|Period 2||5
492915|NCT01049360|1206269|P1|STARTED|Period 2||6
492916|NCT01049360|1206250|P20|NOT COMPLETED|Period 1||0
492917|NCT01049360|1206251|P19|NOT COMPLETED|Period 1||1
492918|NCT01049360|1206252|P18|NOT COMPLETED|Period 1||0
492919|NCT01049360|1206253|P17|NOT COMPLETED|Period 1||1
492920|NCT01049360|1206254|P16|NOT COMPLETED|Period 1||0
492921|NCT01049360|1206255|P15|NOT COMPLETED|Period 1||0
492922|NCT01049360|1206256|P14|NOT COMPLETED|Period 1||1
492923|NCT01049360|1206257|P13|NOT COMPLETED|Period 1||2
492924|NCT01049360|1206258|P12|NOT COMPLETED|Period 1||0
492925|NCT01049360|1206259|P11|NOT COMPLETED|Period 1||1
492926|NCT01049360|1206260|P10|NOT COMPLETED|Period 1||0
492927|NCT01049360|1206261|P9|NOT COMPLETED|Period 1||2
492928|NCT01049360|1206262|P8|NOT COMPLETED|Period 1||2
492929|NCT01049360|1206263|P7|NOT COMPLETED|Period 1||0
492930|NCT01049360|1206264|P6|NOT COMPLETED|Period 1||0
492931|NCT01049360|1206265|P5|NOT COMPLETED|Period 1||0
492932|NCT01049360|1206266|P4|NOT COMPLETED|Period 1||1
492933|NCT01049360|1206267|P3|NOT COMPLETED|Period 1||0
492934|NCT01049360|1206268|P2|NOT COMPLETED|Period 1||1
492935|NCT01049360|1206269|P1|NOT COMPLETED|Period 1||0
492936|NCT01049360|1206250|P20|COMPLETED|Period 1||7
492937|NCT01049360|1206251|P19|COMPLETED|Period 1||5
492938|NCT01049360|1206252|P18|COMPLETED|Period 1||6
492939|NCT01049360|1206253|P17|COMPLETED|Period 1||5
492940|NCT01049360|1206254|P16|COMPLETED|Period 1||7
492941|NCT01049360|1206255|P15|COMPLETED|Period 1||7
492942|NCT01049360|1206256|P14|COMPLETED|Period 1||6
492943|NCT01049360|1206257|P13|COMPLETED|Period 1||4
492944|NCT01049360|1206258|P12|COMPLETED|Period 1||6
492945|NCT01049360|1206259|P11|COMPLETED|Period 1||5
492946|NCT01049360|1206260|P10|COMPLETED|Period 1||6
492947|NCT01049360|1206261|P9|COMPLETED|Period 1||5
492948|NCT01049360|1206262|P8|COMPLETED|Period 1||4
492949|NCT01049360|1206263|P7|COMPLETED|Period 1||6
492950|NCT01049360|1206264|P6|COMPLETED|Period 1||6
492951|NCT01049360|1206265|P5|COMPLETED|Period 1||7
492952|NCT01049360|1206266|P4|COMPLETED|Period 1||6
492953|NCT01049360|1206267|P3|COMPLETED|Period 1||7
492954|NCT01049360|1206268|P2|COMPLETED|Period 1||5
492955|NCT01049360|1206269|P1|COMPLETED|Period 1||6
492956|NCT01049360|1206250|P20|STARTED|Period 1||7
492957|NCT01049360|1206251|P19|STARTED|Period 1||6
492958|NCT01049360|1206252|P18|STARTED|Period 1||6
492959|NCT01049360|1206253|P17|STARTED|Period 1||6
492960|NCT01049360|1206254|P16|STARTED|Period 1||7
492961|NCT01049360|1206255|P15|STARTED|Period 1||7
492962|NCT01049360|1206256|P14|STARTED|Period 1||7
492963|NCT01049360|1206257|P13|STARTED|Period 1||6
492964|NCT01049360|1206258|P12|STARTED|Period 1||6
492965|NCT01049360|1206259|P11|STARTED|Period 1||6
492966|NCT01049360|1206260|P10|STARTED|Period 1||6
492967|NCT01049360|1206261|P9|STARTED|Period 1||7
492968|NCT01049360|1206262|P8|STARTED|Period 1||6
492969|NCT01049360|1206263|P7|STARTED|Period 1||6
492970|NCT01049360|1206264|P6|STARTED|Period 1||6
492971|NCT01049360|1206265|P5|STARTED|Period 1||7
492972|NCT01049360|1206266|P4|STARTED|Period 1||7
492973|NCT01049360|1206267|P3|STARTED|Period 1||7
492974|NCT01049360|1206268|P2|STARTED|Period 1||6
492975|NCT01049360|1206269|P1|STARTED|Period 1||6
492976|NCT01049334|1206293|P2|NOT COMPLETED|Overall Study||7
492977|NCT01049334|1206294|P1|NOT COMPLETED|Overall Study||9
492978|NCT01049334|1206293|P2|COMPLETED|Overall Study||95
492979|NCT01049334|1206294|P1|COMPLETED|Overall Study||93
492980|NCT01049334|1206293|P2|STARTED|Overall Study||102
492981|NCT01049334|1206294|P1|STARTED|Overall Study||102
492982|NCT01049308|1206330|P1|NOT COMPLETED|Pill Counts||83
492983|NCT01049308|1206330|P1|COMPLETED|Pill Counts||168
492984|NCT01049308|1206330|P1|STARTED|Pill Counts||251
492985|NCT01049308|1206330|P1|NOT COMPLETED|Evaluation of Cognitive Impairment||0
492986|NCT01049308|1206330|P1|COMPLETED|Evaluation of Cognitive Impairment||251
492987|NCT01049308|1206330|P1|STARTED|Evaluation of Cognitive Impairment||251
492988|NCT01049243|1206337|P1|NOT COMPLETED|Overall Study||2
492989|NCT01049243|1206337|P1|COMPLETED|Overall Study||18
492990|NCT01049243|1206337|P1|STARTED|Overall Study||20
492991|NCT01049217|1206344|P2|NOT COMPLETED|Overall Study||63
492992|NCT01049217|1206345|P1|NOT COMPLETED|Overall Study||56
492993|NCT01049217|1206344|P2|COMPLETED|Overall Study||131
492994|NCT01049217|1206345|P1|COMPLETED|Overall Study||127
492995|NCT01049217|1206344|P2|Treated|Overall Study||192
492996|NCT01049217|1206345|P1|Treated|Overall Study||183
492997|NCT01049217|1206344|P2|STARTED|Overall Study||194
492998|NCT01049217|1206345|P1|STARTED|Overall Study||183
492999|NCT01049009|1206417|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10
493000|NCT01049009|1206418|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10
493001|NCT01049009|1206417|P2|COMPLETED|Treatment Period 2 (12 Weeks)||8
493002|NCT01049009|1206418|P1|COMPLETED|Treatment Period 2 (12 Weeks)||11
493003|NCT01049009|1206417|P2|STARTED|Treatment Period 2 (12 Weeks)||18
493004|NCT01049009|1206418|P1|STARTED|Treatment Period 2 (12 Weeks)||21
493005|NCT01049009|1206417|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3
493006|NCT01049009|1206418|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2
493007|NCT01049009|1206417|P2|COMPLETED|Treatment Period 1 (12 Weeks)||18
493008|NCT01049009|1206418|P1|COMPLETED|Treatment Period 1 (12 Weeks)||21
493009|NCT01049009|1206417|P2|STARTED|Treatment Period 1 (12 Weeks)||21
493010|NCT01049009|1206418|P1|STARTED|Treatment Period 1 (12 Weeks)||23
493011|NCT01048944|1206430|P4|NOT COMPLETED|Overall Study||2
493012|NCT01048944|1206431|P3|NOT COMPLETED|Overall Study||10
493013|NCT01048944|1206432|P2|NOT COMPLETED|Overall Study||10
493014|NCT01048944|1206433|P1|NOT COMPLETED|Overall Study||8
493015|NCT01048944|1206430|P4|COMPLETED|Overall Study||19
493016|NCT01048944|1206431|P3|COMPLETED|Overall Study||25
493017|NCT01048944|1206432|P2|COMPLETED|Overall Study||28
493018|NCT01048944|1206433|P1|COMPLETED|Overall Study||24
493019|NCT01048944|1206430|P4|STARTED|Overall Study||21
493020|NCT01048944|1206431|P3|STARTED|Overall Study||35
493021|NCT01048944|1206432|P2|STARTED|Overall Study||38
493022|NCT01048944|1206433|P1|STARTED|Overall Study||32
493023|NCT01048879|1206450|P3|NOT COMPLETED|Overall Study||0
493024|NCT01048879|1206451|P2|NOT COMPLETED|Overall Study||0
493025|NCT01048879|1206452|P1|NOT COMPLETED|Overall Study||0
493026|NCT01048879|1206450|P3|COMPLETED|Overall Study||5
493027|NCT01048879|1206451|P2|COMPLETED|Overall Study||9
493028|NCT01048879|1206452|P1|COMPLETED|Overall Study||1
493029|NCT01048879|1206450|P3|STARTED|Overall Study||5
493030|NCT01048879|1206451|P2|STARTED|Overall Study||9
493031|NCT01048879|1206452|P1|STARTED|Overall Study||1
493032|NCT01048866|1206465|P2|NOT COMPLETED|Overall Study||5
493033|NCT01048866|1206466|P1|NOT COMPLETED|Overall Study||4
493034|NCT01048866|1206465|P2|COMPLETED|Overall Study||92
493035|NCT01048866|1206466|P1|COMPLETED|Overall Study||97
493036|NCT01048866|1206465|P2|STARTED|Overall Study||97
493037|NCT01048866|1206466|P1|STARTED|Overall Study||101
493038|NCT01048788|1206511|P3|NOT COMPLETED|Overall Study||2
493039|NCT01048788|1206512|P2|NOT COMPLETED|Overall Study||2
493040|NCT01048788|1206513|P1|NOT COMPLETED|Overall Study||5
493041|NCT01048788|1206511|P3|COMPLETED|Overall Study||11
493042|NCT01048788|1206512|P2|COMPLETED|Overall Study||28
493043|NCT01048788|1206513|P1|COMPLETED|Overall Study||3
493044|NCT01048788|1206511|P3|STARTED|Overall Study||13
493045|NCT01048788|1206512|P2|STARTED|Overall Study||30
493046|NCT01048788|1206513|P1|STARTED|Overall Study||8
493047|NCT01048723|1206521|P1|NOT COMPLETED|Overall Study||0
493048|NCT01048723|1206521|P1|COMPLETED|Overall Study||2
493049|NCT01048723|1206521|P1|STARTED|Overall Study||2
493050|NCT01048697|1206528|P1|NOT COMPLETED|Overall Study||0
493051|NCT01048697|1206528|P1|COMPLETED|Overall Study||18
493052|NCT01048697|1206528|P1|STARTED|Overall Study||18
493053|NCT01048671|1206535|P3|NOT COMPLETED|Overall Study||1
493054|NCT01048671|1206536|P2|NOT COMPLETED|Overall Study||1
493055|NCT01048671|1206537|P1|NOT COMPLETED|Overall Study||0
493056|NCT01048671|1206535|P3|COMPLETED|Overall Study||151
493057|NCT01048671|1206536|P2|COMPLETED|Overall Study||263
493058|NCT01048671|1206537|P1|COMPLETED|Overall Study||66
493059|NCT01048671|1206535|P3|STARTED|Overall Study||152
493060|NCT01048671|1206536|P2|STARTED|Overall Study||264
493061|NCT01048671|1206537|P1|STARTED|Overall Study||66
493062|NCT01048658|1206560|P2|NOT COMPLETED|Overall Study||0
493063|NCT01048658|1206561|P1|NOT COMPLETED|Overall Study||0
493064|NCT01048658|1206560|P2|COMPLETED|Overall Study||80
493065|NCT01048658|1206561|P1|COMPLETED|Overall Study||80
493066|NCT01048658|1206560|P2|STARTED|Overall Study||80
493067|NCT01048658|1206561|P1|STARTED|Overall Study||80
493068|NCT01048606|1206579|P4|NOT COMPLETED|Overall Study||5
493069|NCT01048606|1206580|P3|NOT COMPLETED|Overall Study||10
493070|NCT01048606|1206581|P2|NOT COMPLETED|Overall Study||7
493071|NCT01048606|1206582|P1|NOT COMPLETED|Overall Study||12
493072|NCT01048606|1206579|P4|COMPLETED|Overall Study||5
493073|NCT01048606|1206580|P3|COMPLETED|Overall Study||16
493074|NCT01048606|1206581|P2|COMPLETED|Overall Study||8
493075|NCT01048606|1206582|P1|COMPLETED|Overall Study||16
493076|NCT01048606|1206579|P4|STARTED|Overall Study||10
493077|NCT01048606|1206580|P3|STARTED|Overall Study||26
493078|NCT01048606|1206581|P2|STARTED|Overall Study||15
493079|NCT01048606|1206582|P1|STARTED|Overall Study||28
493080|NCT01048593|1206595|P3|NOT COMPLETED|Overall Study||0
493081|NCT01048593|1206596|P2|NOT COMPLETED|Overall Study||0
493082|NCT01048593|1206597|P1|NOT COMPLETED|Overall Study||0
493083|NCT01048593|1206595|P3|COMPLETED|Overall Study||1
493084|NCT01048593|1206596|P2|COMPLETED|Overall Study||2
493085|NCT01048593|1206597|P1|COMPLETED|Overall Study||3
493086|NCT01048593|1206595|P3|STARTED|Overall Study||1
493087|NCT01048593|1206596|P2|STARTED|Overall Study||2
493088|NCT01048593|1206597|P1|STARTED|Overall Study||3
493089|NCT01048541|1206605|P2|NOT COMPLETED|Overall Study||0
493090|NCT01048541|1206606|P1|NOT COMPLETED|Overall Study||1
493091|NCT01048541|1206605|P2|COMPLETED|Overall Study||19
493092|NCT01048541|1206606|P1|COMPLETED|Overall Study||17
493093|NCT01048541|1206605|P2|STARTED|Overall Study||19
493094|NCT01048541|1206606|P1|STARTED|Overall Study||18
493095|NCT01048502|1206616|P4|NOT COMPLETED|Overall Study||4
493096|NCT01048502|1206617|P3|NOT COMPLETED|Overall Study||5
493097|NCT01048502|1206618|P2|NOT COMPLETED|Overall Study||7
493098|NCT01048502|1206619|P1|NOT COMPLETED|Overall Study||4
493099|NCT01048502|1206616|P4|COMPLETED|Overall Study||21
493100|NCT01048502|1206617|P3|COMPLETED|Overall Study||23
493101|NCT01048502|1206618|P2|COMPLETED|Overall Study||16
493102|NCT01048502|1206619|P1|COMPLETED|Overall Study||20
493103|NCT01048502|1206616|P4|STARTED|Overall Study||25
493104|NCT01048502|1206617|P3|STARTED|Overall Study||28
493105|NCT01048502|1206618|P2|STARTED|Overall Study||23
493106|NCT01048502|1206619|P1|STARTED|Overall Study||24
493107|NCT01048424|1206632|P2|NOT COMPLETED|Overall Study||0
493108|NCT01048424|1206633|P1|NOT COMPLETED|Overall Study||2
493109|NCT01048424|1206632|P2|COMPLETED|Overall Study||10
493110|NCT01048424|1206633|P1|COMPLETED|Overall Study||8
493111|NCT01048424|1206632|P2|STARTED|Overall Study||10
493112|NCT01048424|1206633|P1|STARTED|Overall Study||10
493113|NCT01048333|1206655|P6|NOT COMPLETED|Treatment Period 3||0
493114|NCT01048333|1206656|P5|NOT COMPLETED|Treatment Period 3||0
493115|NCT01048333|1206657|P4|NOT COMPLETED|Treatment Period 3||0
493116|NCT01048333|1206658|P3|NOT COMPLETED|Treatment Period 3||0
493117|NCT01048333|1206659|P2|NOT COMPLETED|Treatment Period 3||0
493118|NCT01048333|1206660|P1|NOT COMPLETED|Treatment Period 3||0
493119|NCT01048333|1206655|P6|COMPLETED|Treatment Period 3||18
493120|NCT01048333|1206656|P5|COMPLETED|Treatment Period 3||17
493121|NCT01048333|1206657|P4|COMPLETED|Treatment Period 3||18
493122|NCT01048333|1206658|P3|COMPLETED|Treatment Period 3||16
493123|NCT01048333|1206659|P2|COMPLETED|Treatment Period 3||18
493124|NCT01048333|1206660|P1|COMPLETED|Treatment Period 3||21
493125|NCT01048333|1206655|P6|STARTED|Treatment Period 3||18
493126|NCT01048333|1206656|P5|STARTED|Treatment Period 3||17
493127|NCT01048333|1206657|P4|STARTED|Treatment Period 3||18
493128|NCT01048333|1206658|P3|STARTED|Treatment Period 3||16
493129|NCT01048333|1206659|P2|STARTED|Treatment Period 3||18
493130|NCT01048333|1206660|P1|STARTED|Treatment Period 3||21
493131|NCT01048333|1206655|P6|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
493132|NCT01048333|1206656|P5|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
493133|NCT01048333|1206657|P4|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
493134|NCT01048333|1206658|P3|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
493135|NCT01048333|1206659|P2|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||1
493136|NCT01048333|1206660|P1|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
493137|NCT01048333|1206655|P6|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
493138|NCT01048333|1206656|P5|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||17
493139|NCT01048333|1206657|P4|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
493140|NCT01048333|1206658|P3|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||16
493141|NCT01048333|1206659|P2|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
493142|NCT01048333|1206660|P1|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||21
493143|NCT01048333|1206655|P6|STARTED|Wash-Out Period 2 of 2 - 7 Days||18
493144|NCT01048333|1206656|P5|STARTED|Wash-Out Period 2 of 2 - 7 Days||17
493145|NCT01048333|1206657|P4|STARTED|Wash-Out Period 2 of 2 - 7 Days||18
493146|NCT01048333|1206658|P3|STARTED|Wash-Out Period 2 of 2 - 7 Days||16
493147|NCT01048333|1206659|P2|STARTED|Wash-Out Period 2 of 2 - 7 Days||19
493148|NCT01048333|1206660|P1|STARTED|Wash-Out Period 2 of 2 - 7 Days||21
493149|NCT01048333|1206655|P6|NOT COMPLETED|Treatment Period 2||0
493150|NCT01048333|1206656|P5|NOT COMPLETED|Treatment Period 2||0
493151|NCT01048333|1206657|P4|NOT COMPLETED|Treatment Period 2||0
493152|NCT01048333|1206658|P3|NOT COMPLETED|Treatment Period 2||0
493153|NCT01048333|1206659|P2|NOT COMPLETED|Treatment Period 2||0
493154|NCT01048333|1206660|P1|NOT COMPLETED|Treatment Period 2||0
493155|NCT01048333|1206655|P6|COMPLETED|Treatment Period 2||18
493156|NCT01048333|1206656|P5|COMPLETED|Treatment Period 2||17
493157|NCT01048333|1206657|P4|COMPLETED|Treatment Period 2||18
493158|NCT01048333|1206658|P3|COMPLETED|Treatment Period 2||16
493159|NCT01048333|1206659|P2|COMPLETED|Treatment Period 2||19
493160|NCT01048333|1206660|P1|COMPLETED|Treatment Period 2||21
493161|NCT01048333|1206655|P6|STARTED|Treatment Period 2||18
493162|NCT01048333|1206656|P5|STARTED|Treatment Period 2||17
493163|NCT01048333|1206657|P4|STARTED|Treatment Period 2||18
493164|NCT01048333|1206658|P3|STARTED|Treatment Period 2||16
493165|NCT01048333|1206659|P2|STARTED|Treatment Period 2||19
493166|NCT01048333|1206660|P1|STARTED|Treatment Period 2||21
493167|NCT01048333|1206655|P6|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
493168|NCT01048333|1206656|P5|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
493169|NCT01048333|1206657|P4|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
493170|NCT01048333|1206658|P3|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
493171|NCT01048333|1206659|P2|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
493172|NCT01048333|1206660|P1|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
493173|NCT01048333|1206655|P6|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18
493174|NCT01048333|1206656|P5|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||17
493175|NCT01048333|1206657|P4|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18
493176|NCT01048333|1206658|P3|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||16
493177|NCT01048333|1206659|P2|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||19
493178|NCT01048333|1206660|P1|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||21
493179|NCT01048333|1206655|P6|STARTED|Wash-Out Period 1 of 2 - 7 Days||18
493180|NCT01048333|1206656|P5|STARTED|Wash-Out Period 1 of 2 - 7 Days||17
493181|NCT01048333|1206657|P4|STARTED|Wash-Out Period 1 of 2 - 7 Days||18
493182|NCT01048333|1206658|P3|STARTED|Wash-Out Period 1 of 2 - 7 Days||16
493183|NCT01048333|1206659|P2|STARTED|Wash-Out Period 1 of 2 - 7 Days||19
493184|NCT01048333|1206660|P1|STARTED|Wash-Out Period 1 of 2 - 7 Days||21
493185|NCT01048333|1206655|P6|NOT COMPLETED|Treatment Period 1||0
493186|NCT01048333|1206656|P5|NOT COMPLETED|Treatment Period 1||0
493187|NCT01048333|1206657|P4|NOT COMPLETED|Treatment Period 1||0
493188|NCT01048333|1206658|P3|NOT COMPLETED|Treatment Period 1||0
493189|NCT01048333|1206659|P2|NOT COMPLETED|Treatment Period 1||0
493190|NCT01048333|1206660|P1|NOT COMPLETED|Treatment Period 1||0
493191|NCT01048333|1206655|P6|COMPLETED|Treatment Period 1||18
493192|NCT01048333|1206656|P5|COMPLETED|Treatment Period 1||17
493193|NCT01048333|1206657|P4|COMPLETED|Treatment Period 1||18
493194|NCT01048333|1206658|P3|COMPLETED|Treatment Period 1||16
493195|NCT01048333|1206659|P2|COMPLETED|Treatment Period 1||19
493196|NCT01048333|1206660|P1|COMPLETED|Treatment Period 1||21
493197|NCT01048333|1206655|P6|STARTED|Treatment Period 1||18
493198|NCT01048333|1206656|P5|STARTED|Treatment Period 1||17
493199|NCT01048333|1206657|P4|STARTED|Treatment Period 1||18
493200|NCT01048333|1206658|P3|STARTED|Treatment Period 1||16
493201|NCT01048333|1206659|P2|STARTED|Treatment Period 1||19
493202|NCT01048333|1206660|P1|STARTED|Treatment Period 1||21
493203|NCT01048242|1206682|P2|NOT COMPLETED|Overall Study||2
493204|NCT01048242|1206683|P1|NOT COMPLETED|Overall Study||4
493205|NCT01048242|1206682|P2|COMPLETED|Overall Study||13
493206|NCT01048242|1206683|P1|COMPLETED|Overall Study||8
493207|NCT01048242|1206682|P2|STARTED|Overall Study||15
493208|NCT01048242|1206683|P1|STARTED|Overall Study||12
493209|NCT01048125|1206691|P2|NOT COMPLETED|Overall Study||0
493210|NCT01048125|1206692|P1|NOT COMPLETED|Overall Study||0
493211|NCT01048125|1206691|P2|COMPLETED|Overall Study||0
493212|NCT01048125|1206692|P1|COMPLETED|Overall Study||0
493213|NCT01048125|1206691|P2|STARTED|Overall Study||0
493214|NCT01048125|1206692|P1|STARTED|Overall Study||0
493215|NCT01048099|1206698|P1|NOT COMPLETED|Treatment Per Protocol||14
493216|NCT01048099|1206698|P1|COMPLETED|Treatment Per Protocol|Patients continued treatment until disease progression or coming off-study for any other reason|0
493217|NCT01048099|1206698|P1|STARTED|Treatment Per Protocol||14
493218|NCT01048099|1206698|P1|NOT COMPLETED|Pts w/ HER2 Overexpression/Activation||10
493219|NCT01048099|1206698|P1|COMPLETED|Pts w/ HER2 Overexpression/Activation|Patients who proceeded to treatment|14
493220|NCT01048099|1206698|P1|STARTED|Pts w/ HER2 Overexpression/Activation|Patients with detected HER2 activation and/or overexpression|24
493221|NCT01048099|1206698|P1|NOT COMPLETED|Patients Evaluated by PRO Onc Assay||202
493222|NCT01048099|1206698|P1|COMPLETED|Patients Evaluated by PRO Onc Assay|Patients evaluated by PRO Onc Assay with HER2 overexpression/activation detected|24
493223|NCT01048099|1206698|P1|STARTED|Patients Evaluated by PRO Onc Assay|Patients with CTCs who were evaluated by PRO Onc Assay|226
493224|NCT01048099|1206698|P1|NOT COMPLETED|Patients Enrolled and Blood Collected||57
493225|NCT01048099|1206698|P1|COMPLETED|Patients Enrolled and Blood Collected|Patients with circulating tumor cells (CTCs)|226
493226|NCT01048099|1206698|P1|STARTED|Patients Enrolled and Blood Collected|Patients enrolled|283
493227|NCT01047839|1206709|P3|NOT COMPLETED|Overall Study||6
493228|NCT01047839|1206710|P2|NOT COMPLETED|Overall Study||0
493229|NCT01047839|1206711|P1|NOT COMPLETED|Overall Study||2
493230|NCT01047839|1206709|P3|COMPLETED|Overall Study||53
493231|NCT01047839|1206710|P2|COMPLETED|Overall Study||29
493232|NCT01047839|1206711|P1|COMPLETED|Overall Study||10
493233|NCT01047839|1206709|P3|STARTED|Overall Study||59
493234|NCT01047839|1206710|P2|STARTED|Overall Study||29
493235|NCT01047839|1206711|P1|STARTED|Overall Study||12
493236|NCT01047709|1206719|P2|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0
493237|NCT01047709|1206720|P1|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0
493238|NCT01047709|1206719|P2|COMPLETED|Control/Positioning ad Lib (1 Night)||9
493239|NCT01047709|1206720|P1|COMPLETED|Control/Positioning ad Lib (1 Night)||9
493240|NCT01047709|1206719|P2|STARTED|Control/Positioning ad Lib (1 Night)||9
493241|NCT01047709|1206720|P1|STARTED|Control/Positioning ad Lib (1 Night)||9
493242|NCT01047709|1206719|P2|NOT COMPLETED|Positional Therapy (1 Night)||0
493243|NCT01047709|1206720|P1|NOT COMPLETED|Positional Therapy (1 Night)||0
493244|NCT01047709|1206719|P2|COMPLETED|Positional Therapy (1 Night)||9
493245|NCT01047709|1206720|P1|COMPLETED|Positional Therapy (1 Night)||9
493246|NCT01047709|1206719|P2|STARTED|Positional Therapy (1 Night)||9
493247|NCT01047709|1206720|P1|STARTED|Positional Therapy (1 Night)||9
493248|NCT01047553|1206728|P2|NOT COMPLETED|Overall Study||9
493249|NCT01047553|1206729|P1|NOT COMPLETED|Overall Study||17
493250|NCT01047553|1206728|P2|COMPLETED|Overall Study||117
493251|NCT01047553|1206729|P1|COMPLETED|Overall Study||108
493252|NCT01047553|1206728|P2|STARTED|Overall Study||126
493253|NCT01047553|1206729|P1|STARTED|Overall Study||125
493254|NCT01047527|1206814|P3|NOT COMPLETED|Overall Study||65
493255|NCT01047527|1206815|P2|NOT COMPLETED|Overall Study||61
493256|NCT01047527|1206816|P1|NOT COMPLETED|Overall Study||85
493257|NCT01047527|1206814|P3|COMPLETED|Overall Study||107
493258|NCT01047527|1206815|P2|COMPLETED|Overall Study||112
493259|NCT01047527|1206816|P1|COMPLETED|Overall Study||95
493260|NCT01047527|1206814|P3|24 Weeks|Overall Study||119
493261|NCT01047527|1206815|P2|24 Weeks|Overall Study||123
493262|NCT01047527|1206816|P1|24 Weeks|Overall Study||111
493263|NCT01047527|1206814|P3|8 Weeks|Overall Study||138
493264|NCT01047527|1206815|P2|8 Weeks|Overall Study||142
493265|NCT01047527|1206816|P1|8 Weeks|Overall Study||148
493266|NCT01047527|1206814|P3|STARTED|Overall Study||172
493267|NCT01047527|1206815|P2|STARTED|Overall Study||173
493268|NCT01047527|1206816|P1|STARTED|Overall Study||180
493269|NCT01047475|1206827|P2|NOT COMPLETED|Overall Study||7
493270|NCT01047475|1206828|P1|NOT COMPLETED|Overall Study||5
493271|NCT01047475|1206827|P2|COMPLETED|Overall Study||31
493272|NCT01047475|1206828|P1|COMPLETED|Overall Study||29
493273|NCT01047475|1206827|P2|STARTED|Overall Study||38
493274|NCT01047475|1206828|P1|STARTED|Overall Study||34
493275|NCT01047436|1206836|P2|NOT COMPLETED|Overall Study||0
493276|NCT01047436|1206837|P1|NOT COMPLETED|Overall Study||1
493277|NCT01047436|1206836|P2|COMPLETED|Overall Study||15
493278|NCT01047436|1206837|P1|COMPLETED|Overall Study||15
493279|NCT01047436|1206836|P2|STARTED|Overall Study||15
493280|NCT01047436|1206837|P1|STARTED|Overall Study||16
493281|NCT01047358|1206853|P1|NOT COMPLETED|Overall Study||0
493282|NCT01047358|1206853|P1|COMPLETED|Overall Study|At least one safety assessment (Safety Population)|206
493283|NCT01047358|1206853|P1|STARTED|Overall Study||206
493284|NCT01047345|1206862|P3|NOT COMPLETED|Extension||6
493285|NCT01047345|1206863|P2|NOT COMPLETED|Extension||0
493286|NCT01047345|1206864|P1|NOT COMPLETED|Extension||0
493287|NCT01047345|1206862|P3|COMPLETED|Extension||96
493288|NCT01047345|1206863|P2|COMPLETED|Extension||0
493289|NCT01047345|1206864|P1|COMPLETED|Extension||0
493290|NCT01047345|1206862|P3|Vaccination 6|Extension|1 participant received 6th vaccination outside the context of study but completed the study.|95
493291|NCT01047345|1206863|P2|Vaccination 6|Extension||0
493292|NCT01047345|1206864|P1|Vaccination 6|Extension||0
493293|NCT01047345|1206862|P3|Vaccination 5|Extension||99
493294|NCT01047345|1206863|P2|Vaccination 5|Extension||0
493295|NCT01047345|1206864|P1|Vaccination 5|Extension||0
493296|NCT01047345|1206862|P3|Vaccination 4|Extension||102
493297|NCT01047345|1206863|P2|Vaccination 4|Extension||0
493298|NCT01047345|1206864|P1|Vaccination 4|Extension||0
493299|NCT01047345|1206862|P3|STARTED|Extension|Not all eligible participants elected to participate in extension|102
493300|NCT01047345|1206863|P2|STARTED|Extension||0
493301|NCT01047345|1206864|P1|STARTED|Extension||0
493302|NCT01047345|1206862|P3|NOT COMPLETED|Base Study||0
493303|NCT01047345|1206863|P2|NOT COMPLETED|Base Study||6
493304|NCT01047345|1206864|P1|NOT COMPLETED|Base Study||22
493305|NCT01047345|1206862|P3|COMPLETED|Base Study||0
493306|NCT01047345|1206863|P2|COMPLETED|Base Study||300
493307|NCT01047345|1206864|P1|COMPLETED|Base Study|Includes 1 participant for whom completion status is unknown|596
493308|NCT01047345|1206862|P3|Vaccination 3|Base Study||0
493309|NCT01047345|1206863|P2|Vaccination 3|Base Study||300
493310|NCT01047345|1206864|P1|Vaccination 3|Base Study||597
493311|NCT01047345|1206862|P3|Vaccination 2|Base Study||0
493312|NCT01047345|1206863|P2|Vaccination 2|Base Study||304
493313|NCT01047345|1206864|P1|Vaccination 2|Base Study||604
493314|NCT01047345|1206862|P3|Vaccination 1|Base Study||0
493315|NCT01047345|1206863|P2|Vaccination 1|Base Study||306
493316|NCT01047345|1206864|P1|Vaccination 1|Base Study||615
493317|NCT01047345|1206862|P3|STARTED|Base Study||0
493318|NCT01047345|1206863|P2|STARTED|Base Study||306
493319|NCT01047345|1206864|P1|STARTED|Base Study||618
493320|NCT01047332|1206886|P2|NOT COMPLETED|Overall Study||64
493321|NCT01047332|1206887|P1|NOT COMPLETED|Overall Study||57
493322|NCT01047332|1206886|P2|COMPLETED|Overall Study|Alive at final follow-up|4
493323|NCT01047332|1206887|P1|COMPLETED|Overall Study|Alive at final follow-up|4
493324|NCT01047332|1206886|P2|STARTED|Overall Study||68
493325|NCT01047332|1206887|P1|STARTED|Overall Study||61
493326|NCT01047306|1206901|P2|NOT COMPLETED|Overall Study||0
493327|NCT01047306|1206902|P1|NOT COMPLETED|Overall Study||3
493328|NCT01047306|1206901|P2|COMPLETED|Overall Study||6
493329|NCT01047306|1206902|P1|COMPLETED|Overall Study||16
493330|NCT01047306|1206901|P2|Discontinued From the Study|Overall Study||0
493331|NCT01047306|1206902|P1|Discontinued From the Study|Overall Study||3
493332|NCT01047306|1206901|P2|STARTED|Overall Study||6
493333|NCT01047306|1206902|P1|STARTED|Overall Study||19
493334|NCT01047293|1206976|P4|NOT COMPLETED|Overall Study||0
493335|NCT01047293|1206977|P3|NOT COMPLETED|Overall Study||0
493336|NCT01047293|1206978|P2|NOT COMPLETED|Overall Study||1
493337|NCT01047293|1206979|P1|NOT COMPLETED|Overall Study||1
493338|NCT01047293|1206976|P4|COMPLETED|Overall Study||26
493339|NCT01047293|1206977|P3|COMPLETED|Overall Study||9
493340|NCT01047293|1206978|P2|COMPLETED|Overall Study||7
493341|NCT01047293|1206979|P1|COMPLETED|Overall Study||3
493342|NCT01047293|1206976|P4|STARTED|Overall Study||26
493343|NCT01047293|1206977|P3|STARTED|Overall Study||9
493344|NCT01047293|1206978|P2|STARTED|Overall Study||8
493345|NCT01047293|1206979|P1|STARTED|Overall Study||4
493346|NCT01047241|1206986|P1|NOT COMPLETED|Overall Study||0
493347|NCT01047241|1206986|P1|COMPLETED|Overall Study||50
493348|NCT01047241|1206986|P1|STARTED|Overall Study||50
493349|NCT01047189|1206997|P2|NOT COMPLETED|Overall Study||0
493350|NCT01047189|1206998|P1|NOT COMPLETED|Overall Study||4
493351|NCT01047189|1206997|P2|COMPLETED|Overall Study||13
493352|NCT01047189|1206998|P1|COMPLETED|Overall Study||9
493353|NCT01047189|1206997|P2|STARTED|Overall Study||13
493354|NCT01047189|1206998|P1|STARTED|Overall Study||13
493355|NCT01046903|1207006|P1|NOT COMPLETED|Overall Study||28
493356|NCT01046903|1207006|P1|COMPLETED|Overall Study||475
493357|NCT01046903|1207006|P1|STARTED|Overall Study||503
493358|NCT01046877|1207019|P1|NOT COMPLETED|Overall Study||18
493359|NCT01046877|1207019|P1|COMPLETED|Overall Study||7
493360|NCT01046877|1207019|P1|Completed Study Late|Overall Study|One completed (evidencing extrusions) at 23.5 mos. Missed 9 mo visit. Exam not possible at 12 mo.|1
493361|NCT01046877|1207019|P1|Completed on Schedule|Overall Study|Final visit = the earlier of 24 months post-procedure or 12 months after extrusion.|6
493362|NCT01046877|1207019|P1|STARTED|Overall Study||25
493363|NCT01046695|1207035|P2|NOT COMPLETED|Overall Study||2
493364|NCT01046695|1207036|P1|NOT COMPLETED|Overall Study||0
493365|NCT01046695|1207035|P2|COMPLETED|Overall Study||20
493366|NCT01046695|1207036|P1|COMPLETED|Overall Study||20
493367|NCT01046695|1207035|P2|STARTED|Overall Study||22
493368|NCT01046695|1207036|P1|STARTED|Overall Study||20
493369|NCT01046682|1207048|P2|NOT COMPLETED|Overall Study||0
493370|NCT01046682|1207049|P1|NOT COMPLETED|Overall Study||2
493371|NCT01046682|1207048|P2|COMPLETED|Overall Study||20
493372|NCT01046682|1207049|P1|COMPLETED|Overall Study||18
493373|NCT01046682|1207048|P2|STARTED|Overall Study||20
493374|NCT01046682|1207049|P1|STARTED|Overall Study||20
493375|NCT01046643|1207057|P4|NOT COMPLETED|Second Period Treatment or Placebo||0
493376|NCT01046643|1207058|P3|NOT COMPLETED|Second Period Treatment or Placebo||0
493377|NCT01046643|1207059|P2|NOT COMPLETED|Second Period Treatment or Placebo||0
493378|NCT01046643|1207060|P1|NOT COMPLETED|Second Period Treatment or Placebo||0
493379|NCT01046643|1207057|P4|COMPLETED|Second Period Treatment or Placebo||7
493380|NCT01046643|1207058|P3|COMPLETED|Second Period Treatment or Placebo||7
493381|NCT01046643|1207059|P2|COMPLETED|Second Period Treatment or Placebo||6
493382|NCT01046643|1207060|P1|COMPLETED|Second Period Treatment or Placebo||9
493383|NCT01046643|1207057|P4|STARTED|Second Period Treatment or Placebo||7
493384|NCT01046643|1207058|P3|STARTED|Second Period Treatment or Placebo||7
493385|NCT01046643|1207059|P2|STARTED|Second Period Treatment or Placebo||6
493386|NCT01046643|1207060|P1|STARTED|Second Period Treatment or Placebo||9
493387|NCT01046643|1207057|P4|NOT COMPLETED|Washout Period||0
493388|NCT01046643|1207058|P3|NOT COMPLETED|Washout Period||0
493389|NCT01046643|1207059|P2|NOT COMPLETED|Washout Period||0
493390|NCT01046643|1207060|P1|NOT COMPLETED|Washout Period||0
493391|NCT01046643|1207057|P4|COMPLETED|Washout Period||7
493392|NCT01046643|1207058|P3|COMPLETED|Washout Period||7
493393|NCT01046643|1207059|P2|COMPLETED|Washout Period||6
493394|NCT01046643|1207060|P1|COMPLETED|Washout Period||9
493395|NCT01046643|1207057|P4|STARTED|Washout Period||7
493396|NCT01046643|1207058|P3|STARTED|Washout Period||7
493397|NCT01046643|1207059|P2|STARTED|Washout Period||6
493398|NCT01046643|1207060|P1|STARTED|Washout Period||9
493399|NCT01046643|1207057|P4|NOT COMPLETED|First Period Treatment or Placebo||0
493400|NCT01046643|1207058|P3|NOT COMPLETED|First Period Treatment or Placebo||0
493401|NCT01046643|1207059|P2|NOT COMPLETED|First Period Treatment or Placebo||1
493402|NCT01046643|1207060|P1|NOT COMPLETED|First Period Treatment or Placebo||0
493403|NCT01046643|1207057|P4|COMPLETED|First Period Treatment or Placebo||7
493404|NCT01046643|1207058|P3|COMPLETED|First Period Treatment or Placebo||7
493405|NCT01046643|1207059|P2|COMPLETED|First Period Treatment or Placebo||6
493406|NCT01046643|1207060|P1|COMPLETED|First Period Treatment or Placebo||9
493407|NCT01046643|1207057|P4|STARTED|First Period Treatment or Placebo||7
493408|NCT01046643|1207058|P3|STARTED|First Period Treatment or Placebo||7
493409|NCT01046643|1207059|P2|STARTED|First Period Treatment or Placebo||7
493410|NCT01046643|1207060|P1|STARTED|First Period Treatment or Placebo||9
493411|NCT01046565|1207082|P1|NOT COMPLETED|Overall Study||9
493412|NCT01046565|1207082|P1|COMPLETED|Overall Study||66
493413|NCT01046565|1207082|P1|STARTED|Overall Study||75
493414|NCT01046396|1207091|P1|NOT COMPLETED|Overall Study||5
493415|NCT01046396|1207091|P1|COMPLETED|Overall Study||64
493416|NCT01046396|1207091|P1|STARTED|Overall Study||69
493417|NCT01046253|1207102|P2|NOT COMPLETED|Fourth Intervention||0
493418|NCT01046253|1207103|P1|NOT COMPLETED|Fourth Intervention||0
493419|NCT01046253|1207102|P2|COMPLETED|Fourth Intervention||23
493420|NCT01046253|1207103|P1|COMPLETED|Fourth Intervention||25
493421|NCT01046253|1207102|P2|STARTED|Fourth Intervention||23
493422|NCT01046253|1207103|P1|STARTED|Fourth Intervention||25
493423|NCT01046253|1207102|P2|NOT COMPLETED|Third Washout of 7 Days||0
493424|NCT01046253|1207103|P1|NOT COMPLETED|Third Washout of 7 Days||0
493425|NCT01046253|1207102|P2|COMPLETED|Third Washout of 7 Days||23
493426|NCT01046253|1207103|P1|COMPLETED|Third Washout of 7 Days||25
493427|NCT01046253|1207102|P2|STARTED|Third Washout of 7 Days||23
493428|NCT01046253|1207103|P1|STARTED|Third Washout of 7 Days||25
493429|NCT01046253|1207102|P2|NOT COMPLETED|Third Intervention||0
493430|NCT01046253|1207103|P1|NOT COMPLETED|Third Intervention||0
493431|NCT01046253|1207102|P2|COMPLETED|Third Intervention||23
493432|NCT01046253|1207103|P1|COMPLETED|Third Intervention||25
493433|NCT01046253|1207102|P2|STARTED|Third Intervention||23
493434|NCT01046253|1207103|P1|STARTED|Third Intervention||25
493435|NCT01046253|1207102|P2|NOT COMPLETED|Second Washout of 7 Days||0
493436|NCT01046253|1207103|P1|NOT COMPLETED|Second Washout of 7 Days||0
493437|NCT01046253|1207102|P2|COMPLETED|Second Washout of 7 Days||23
493438|NCT01046253|1207103|P1|COMPLETED|Second Washout of 7 Days||25
493439|NCT01046253|1207102|P2|STARTED|Second Washout of 7 Days||23
493440|NCT01046253|1207103|P1|STARTED|Second Washout of 7 Days||25
493441|NCT01046253|1207102|P2|NOT COMPLETED|Second Intervention||2
493442|NCT01046253|1207103|P1|NOT COMPLETED|Second Intervention||0
493443|NCT01046253|1207102|P2|COMPLETED|Second Intervention||23
493444|NCT01046253|1207103|P1|COMPLETED|Second Intervention||25
493445|NCT01046253|1207102|P2|STARTED|Second Intervention||25
493446|NCT01046253|1207103|P1|STARTED|Second Intervention||25
493447|NCT01046253|1207102|P2|NOT COMPLETED|First Washout of 7 Days||0
493448|NCT01046253|1207103|P1|NOT COMPLETED|First Washout of 7 Days||0
493449|NCT01046253|1207102|P2|COMPLETED|First Washout of 7 Days||25
493450|NCT01046253|1207103|P1|COMPLETED|First Washout of 7 Days||25
493451|NCT01046253|1207102|P2|STARTED|First Washout of 7 Days||25
493452|NCT01046253|1207103|P1|STARTED|First Washout of 7 Days||25
493453|NCT01046253|1207102|P2|NOT COMPLETED|First Intervention||0
493454|NCT01046253|1207103|P1|NOT COMPLETED|First Intervention||0
493455|NCT01046253|1207102|P2|COMPLETED|First Intervention||25
493456|NCT01046253|1207103|P1|COMPLETED|First Intervention||25
493457|NCT01046253|1207102|P2|STARTED|First Intervention||25
493458|NCT01046253|1207103|P1|STARTED|First Intervention||25
493459|NCT01046136|1207115|P2|NOT COMPLETED|Overall Study||8
493460|NCT01046136|1207116|P1|NOT COMPLETED|Overall Study||4
493461|NCT01046136|1207115|P2|COMPLETED|Overall Study||182
493462|NCT01046136|1207116|P1|COMPLETED|Overall Study||184
493463|NCT01046136|1207115|P2|STARTED|Overall Study||190
493464|NCT01046136|1207116|P1|STARTED|Overall Study||188
493465|NCT01046110|1207128|P2|NOT COMPLETED|Overall Study||55
493466|NCT01046110|1207129|P1|NOT COMPLETED|Overall Study||55
493467|NCT01046110|1207128|P2|COMPLETED|Overall Study||174
493468|NCT01046110|1207129|P1|COMPLETED|Overall Study||174
493469|NCT01046110|1207128|P2|Exposed|Overall Study|1 subject was randomised in error|228
493470|NCT01046110|1207129|P1|Exposed|Overall Study|2 subjects were randomised in error and 1 subject did not want to take insulin|226
493471|NCT01046110|1207128|P2|STARTED|Overall Study||229
493472|NCT01046110|1207129|P1|STARTED|Overall Study||229
493473|NCT01046084|1207139|P2|NOT COMPLETED|Fourth Intervention||0
493474|NCT01046084|1207140|P1|NOT COMPLETED|Fourth Intervention||0
493475|NCT01046084|1207139|P2|COMPLETED|Fourth Intervention||25
493476|NCT01046084|1207140|P1|COMPLETED|Fourth Intervention||23
493477|NCT01046084|1207139|P2|STARTED|Fourth Intervention||25
493478|NCT01046084|1207140|P1|STARTED|Fourth Intervention||23
493479|NCT01046084|1207139|P2|NOT COMPLETED|Third Washout of 7 Days||0
493480|NCT01046084|1207140|P1|NOT COMPLETED|Third Washout of 7 Days||2
493481|NCT01046084|1207139|P2|COMPLETED|Third Washout of 7 Days||25
493482|NCT01046084|1207140|P1|COMPLETED|Third Washout of 7 Days||23
493483|NCT01046084|1207139|P2|STARTED|Third Washout of 7 Days||25
493484|NCT01046084|1207140|P1|STARTED|Third Washout of 7 Days||25
493485|NCT01046084|1207139|P2|NOT COMPLETED|Third Intervention||0
493486|NCT01046084|1207140|P1|NOT COMPLETED|Third Intervention||0
493487|NCT01046084|1207139|P2|COMPLETED|Third Intervention||25
493488|NCT01046084|1207140|P1|COMPLETED|Third Intervention||25
493489|NCT01046084|1207139|P2|STARTED|Third Intervention||25
493490|NCT01046084|1207140|P1|STARTED|Third Intervention||25
493491|NCT01046084|1207139|P2|NOT COMPLETED|Second Washout of 7 Days||0
493492|NCT01046084|1207140|P1|NOT COMPLETED|Second Washout of 7 Days||0
493493|NCT01046084|1207139|P2|COMPLETED|Second Washout of 7 Days||25
493494|NCT01046084|1207140|P1|COMPLETED|Second Washout of 7 Days||25
493495|NCT01046084|1207139|P2|STARTED|Second Washout of 7 Days||25
493496|NCT01046084|1207140|P1|STARTED|Second Washout of 7 Days||25
493497|NCT01046084|1207139|P2|NOT COMPLETED|Second Intervention||0
493498|NCT01046084|1207140|P1|NOT COMPLETED|Second Intervention||0
493499|NCT01046084|1207139|P2|COMPLETED|Second Intervention||25
493500|NCT01046084|1207140|P1|COMPLETED|Second Intervention||25
493501|NCT01046084|1207139|P2|STARTED|Second Intervention||25
493502|NCT01046084|1207140|P1|STARTED|Second Intervention||25
493503|NCT01046084|1207139|P2|NOT COMPLETED|First Washout of 7 Days||0
493504|NCT01046084|1207140|P1|NOT COMPLETED|First Washout of 7 Days||0
493505|NCT01046084|1207139|P2|COMPLETED|First Washout of 7 Days||25
493506|NCT01046084|1207140|P1|COMPLETED|First Washout of 7 Days||25
493507|NCT01046084|1207139|P2|STARTED|First Washout of 7 Days||25
493508|NCT01046084|1207140|P1|STARTED|First Washout of 7 Days||25
493509|NCT01046084|1207139|P2|NOT COMPLETED|First Intervention||0
493510|NCT01046084|1207140|P1|NOT COMPLETED|First Intervention||0
493511|NCT01046084|1207139|P2|COMPLETED|First Intervention||25
493512|NCT01046084|1207140|P1|COMPLETED|First Intervention||25
493513|NCT01046084|1207139|P2|STARTED|First Intervention||25
493514|NCT01046084|1207140|P1|STARTED|First Intervention||25
493515|NCT01045993|1207154|P4|NOT COMPLETED|Overall Study||0
493516|NCT01045993|1207155|P3|NOT COMPLETED|Overall Study||0
493517|NCT01045993|1207156|P2|NOT COMPLETED|Overall Study||1
493518|NCT01045993|1207157|P1|NOT COMPLETED|Overall Study||0
493519|NCT01045993|1207154|P4|COMPLETED|Overall Study||25
493520|NCT01045993|1207155|P3|COMPLETED|Overall Study||5
493521|NCT01045993|1207156|P2|COMPLETED|Overall Study||4
493522|NCT01045993|1207157|P1|COMPLETED|Overall Study||26
493523|NCT01045993|1207154|P4|STARTED|Overall Study||25
493524|NCT01045993|1207155|P3|STARTED|Overall Study||5
493525|NCT01045993|1207156|P2|STARTED|Overall Study||5
493526|NCT01045993|1207157|P1|STARTED|Overall Study||26
493527|NCT01045967|1207233|P2|NOT COMPLETED|Second Intervention||1
493528|NCT01045967|1207234|P1|NOT COMPLETED|Second Intervention||0
493529|NCT01045967|1207233|P2|COMPLETED|Second Intervention||27
493530|NCT01045967|1207234|P1|COMPLETED|Second Intervention||28
493531|NCT01045967|1207233|P2|STARTED|Second Intervention|Subject was dropped prior to dosing in Period II due to positive drug screen.|28
493532|NCT01045967|1207234|P1|STARTED|Second Intervention||28
493533|NCT01045967|1207233|P2|NOT COMPLETED|Washout of 7 Days||0
493534|NCT01045967|1207234|P1|NOT COMPLETED|Washout of 7 Days||0
493535|NCT01045967|1207233|P2|COMPLETED|Washout of 7 Days||28
493536|NCT01045967|1207234|P1|COMPLETED|Washout of 7 Days||28
493537|NCT01045967|1207233|P2|STARTED|Washout of 7 Days||28
493538|NCT01045967|1207234|P1|STARTED|Washout of 7 Days||28
493539|NCT01045967|1207233|P2|NOT COMPLETED|First Intervention||0
493540|NCT01045967|1207234|P1|NOT COMPLETED|First Intervention||0
493541|NCT01045967|1207233|P2|COMPLETED|First Intervention||28
493542|NCT01045967|1207234|P1|COMPLETED|First Intervention||28
493543|NCT01045967|1207233|P2|STARTED|First Intervention||28
493544|NCT01045967|1207234|P1|STARTED|First Intervention||28
493545|NCT01045798|1207246|P2|NOT COMPLETED|Overall Study||4
493546|NCT01045798|1207247|P1|NOT COMPLETED|Overall Study||2
493547|NCT01045798|1207246|P2|COMPLETED|Overall Study||5
493548|NCT01045798|1207247|P1|COMPLETED|Overall Study||4
493549|NCT01045798|1207246|P2|STARTED|Overall Study||9
493550|NCT01045798|1207247|P1|STARTED|Overall Study||6
493551|NCT01045707|1207255|P2|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||12
493552|NCT01045707|1207256|P1|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||13
493553|NCT01045707|1207255|P2|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||209
493554|NCT01045707|1207256|P1|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||179
493555|NCT01045707|1207255|P2|STARTED|Extension: Week 27 to 52 (NN5401-3726)|Eleven subjects from main trial did not continue into the extension|221
493556|NCT01045707|1207256|P1|STARTED|Extension: Week 27 to 52 (NN5401-3726)|Twenty seven subjects from main trial did not continue into the extension|192
493557|NCT01045707|1207255|P2|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||32
493558|NCT01045707|1207256|P1|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||47
493559|NCT01045707|1207255|P2|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||232
493560|NCT01045707|1207256|P1|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||219
493561|NCT01045707|1207255|P2|Exposed|Main: Week 0 to 26 (NN5401-3590)|Three subjects withdrew prior to exposure to trial drug|261
493562|NCT01045707|1207256|P1|Exposed|Main: Week 0 to 26 (NN5401-3590)|One subject withdrew prior to exposure to trial drug|265
493563|NCT01045707|1207255|P2|STARTED|Main: Week 0 to 26 (NN5401-3590)||264
493564|NCT01045707|1207256|P1|STARTED|Main: Week 0 to 26 (NN5401-3590)||266
493565|NCT01045694|1207272|P1|NOT COMPLETED|Overall Study||2
493566|NCT01045694|1207272|P1|COMPLETED|Overall Study||6
493567|NCT01045694|1207272|P1|STARTED|Overall Study||8
493568|NCT01045551|1207278|P1|NOT COMPLETED|Overall Study||0
493569|NCT01045551|1207278|P1|COMPLETED|Overall Study||10
493570|NCT01045551|1207278|P1|STARTED|Overall Study||10
493571|NCT01045447|1207288|P2|NOT COMPLETED|Overall Study||28
493572|NCT01045447|1207289|P1|NOT COMPLETED|Overall Study||36
493573|NCT01045447|1207288|P2|COMPLETED|Overall Study||205
493574|NCT01045447|1207289|P1|COMPLETED|Overall Study||196
493575|NCT01045447|1207288|P2|Exposed|Overall Study||233
493576|NCT01045447|1207289|P1|Exposed|Overall Study|Two subjects withdrew prior to exposure to trial drug|230
493577|NCT01045447|1207288|P2|STARTED|Overall Study||233
493578|NCT01045447|1207289|P1|STARTED|Overall Study||232
493579|NCT01045421|1207303|P11|NOT COMPLETED|Phase 2||2
493580|NCT01045421|1207304|P10|NOT COMPLETED|Phase 2||3
493581|NCT01045421|1207305|P9|NOT COMPLETED|Phase 2||2
493582|NCT01045421|1207306|P8|NOT COMPLETED|Phase 2||5
493583|NCT01045421|1207307|P7|NOT COMPLETED|Phase 2||0
493584|NCT01045421|1207308|P6|NOT COMPLETED|Phase 2||0
493585|NCT01045421|1207309|P5|NOT COMPLETED|Phase 2||0
493586|NCT01045421|1207310|P4|NOT COMPLETED|Phase 2||0
493587|NCT01045421|1207311|P3|NOT COMPLETED|Phase 2||0
493588|NCT01045421|1207312|P2|NOT COMPLETED|Phase 2||0
493589|NCT01045421|1207313|P1|NOT COMPLETED|Phase 2||0
493590|NCT01045421|1207303|P11|COMPLETED|Phase 2||58
493591|NCT01045421|1207304|P10|COMPLETED|Phase 2||23
493592|NCT01045421|1207305|P9|COMPLETED|Phase 2||53
493593|NCT01045421|1207306|P8|COMPLETED|Phase 2||50
493594|NCT01045421|1207307|P7|COMPLETED|Phase 2||53
493595|NCT01045421|1207308|P6|COMPLETED|Phase 2||0
493596|NCT01045421|1207309|P5|COMPLETED|Phase 2||0
493597|NCT01045421|1207310|P4|COMPLETED|Phase 2||0
493598|NCT01045421|1207311|P3|COMPLETED|Phase 2||0
493599|NCT01045421|1207312|P2|COMPLETED|Phase 2||0
493600|NCT01045421|1207313|P1|COMPLETED|Phase 2||0
493601|NCT01045421|1207303|P11|STARTED|Phase 2||60
493602|NCT01045421|1207304|P10|STARTED|Phase 2||26
493603|NCT01045421|1207305|P9|STARTED|Phase 2||55
493604|NCT01045421|1207306|P8|STARTED|Phase 2||55
493605|NCT01045421|1207307|P7|STARTED|Phase 2||53
493606|NCT01045421|1207308|P6|STARTED|Phase 2||0
493607|NCT01045421|1207309|P5|STARTED|Phase 2||0
493608|NCT01045421|1207310|P4|STARTED|Phase 2||0
493609|NCT01045421|1207311|P3|STARTED|Phase 2||0
493610|NCT01045421|1207312|P2|STARTED|Phase 2||0
493611|NCT01045421|1207313|P1|STARTED|Phase 2||0
493612|NCT01045421|1207303|P11|NOT COMPLETED|Phase 1||0
493613|NCT01045421|1207304|P10|NOT COMPLETED|Phase 1||0
493614|NCT01045421|1207305|P9|NOT COMPLETED|Phase 1||0
493615|NCT01045421|1207306|P8|NOT COMPLETED|Phase 1||0
493616|NCT01045421|1207307|P7|NOT COMPLETED|Phase 1||0
493617|NCT01045421|1207308|P6|NOT COMPLETED|Phase 1||0
493618|NCT01045421|1207309|P5|NOT COMPLETED|Phase 1||1
493619|NCT01045421|1207310|P4|NOT COMPLETED|Phase 1||1
493620|NCT01045421|1207311|P3|NOT COMPLETED|Phase 1||0
493621|NCT01045421|1207312|P2|NOT COMPLETED|Phase 1||0
493622|NCT01045421|1207313|P1|NOT COMPLETED|Phase 1||0
493623|NCT01045421|1207303|P11|COMPLETED|Phase 1||0
493624|NCT01045421|1207304|P10|COMPLETED|Phase 1||0
493625|NCT01045421|1207305|P9|COMPLETED|Phase 1||0
493626|NCT01045421|1207306|P8|COMPLETED|Phase 1||0
493627|NCT01045421|1207307|P7|COMPLETED|Phase 1||0
493628|NCT01045421|1207308|P6|COMPLETED|Phase 1||1
493629|NCT01045421|1207309|P5|COMPLETED|Phase 1||2
493630|NCT01045421|1207310|P4|COMPLETED|Phase 1||11
493631|NCT01045421|1207311|P3|COMPLETED|Phase 1||4
493632|NCT01045421|1207312|P2|COMPLETED|Phase 1||3
493633|NCT01045421|1207313|P1|COMPLETED|Phase 1||1
493634|NCT01045421|1207303|P11|STARTED|Phase 1||0
493635|NCT01045421|1207304|P10|STARTED|Phase 1||0
493636|NCT01045421|1207305|P9|STARTED|Phase 1||0
493637|NCT01045421|1207306|P8|STARTED|Phase 1||0
493638|NCT01045421|1207307|P7|STARTED|Phase 1||0
493639|NCT01045421|1207308|P6|STARTED|Phase 1||1
493640|NCT01045421|1207309|P5|STARTED|Phase 1||3
493641|NCT01045421|1207310|P4|STARTED|Phase 1||12
493642|NCT01045421|1207311|P3|STARTED|Phase 1||4
493643|NCT01045421|1207312|P2|STARTED|Phase 1||3
493644|NCT01045421|1207313|P1|STARTED|Phase 1||1
493645|NCT01045265|1207393|P1|NOT COMPLETED|Overall Study||0
493646|NCT01045265|1207393|P1|COMPLETED|Overall Study||16
493647|NCT01045265|1207393|P1|STARTED|Overall Study||16
493648|NCT01045187|1207400|P1|NOT COMPLETED|Overall Study||0
493649|NCT01045187|1207400|P1|COMPLETED|Overall Study||15
493650|NCT01045187|1207400|P1|STARTED|Overall Study||15
493651|NCT01045161|1207407|P3|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||32
493652|NCT01045161|1207408|P2|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36
493653|NCT01045161|1207409|P1|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36
493654|NCT01045161|1207407|P3|COMPLETED|Part B - 40 Additional Weeks Open Label||115
493655|NCT01045161|1207408|P2|COMPLETED|Part B - 40 Additional Weeks Open Label||118
493656|NCT01045161|1207409|P1|COMPLETED|Part B - 40 Additional Weeks Open Label||111
493657|NCT01045161|1207407|P3|STARTED|Part B - 40 Additional Weeks Open Label||147
493658|NCT01045161|1207408|P2|STARTED|Part B - 40 Additional Weeks Open Label||154
493659|NCT01045161|1207409|P1|STARTED|Part B - 40 Additional Weeks Open Label||147
493660|NCT01045161|1207407|P3|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||30
493661|NCT01045161|1207408|P2|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||29
493662|NCT01045161|1207409|P1|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||31
493663|NCT01045161|1207407|P3|COMPLETED|Part A - 12 Weeks Double Blind Treatment||148
493664|NCT01045161|1207408|P2|COMPLETED|Part A - 12 Weeks Double Blind Treatment||155
493665|NCT01045161|1207409|P1|COMPLETED|Part A - 12 Weeks Double Blind Treatment||151
493666|NCT01045161|1207407|P3|STARTED|Part A - 12 Weeks Double Blind Treatment||178
493667|NCT01045161|1207408|P2|STARTED|Part A - 12 Weeks Double Blind Treatment||184
493668|NCT01045161|1207409|P1|STARTED|Part A - 12 Weeks Double Blind Treatment||182
493669|NCT01045122|1207429|P2|NOT COMPLETED|Propofol Then Dexmedetomidine||0
493670|NCT01045122|1207430|P1|NOT COMPLETED|Propofol Then Dexmedetomidine||0
493671|NCT01045122|1207429|P2|COMPLETED|Propofol Then Dexmedetomidine||6
493672|NCT01045122|1207430|P1|COMPLETED|Propofol Then Dexmedetomidine||5
493673|NCT01045122|1207429|P2|STARTED|Propofol Then Dexmedetomidine||6
493674|NCT01045122|1207430|P1|STARTED|Propofol Then Dexmedetomidine||5
493675|NCT01045122|1207429|P2|NOT COMPLETED|Dexmedetomidine Then Propofol||0
493676|NCT01045122|1207430|P1|NOT COMPLETED|Dexmedetomidine Then Propofol||0
493677|NCT01045122|1207429|P2|COMPLETED|Dexmedetomidine Then Propofol||6
493678|NCT01045122|1207430|P1|COMPLETED|Dexmedetomidine Then Propofol||5
493679|NCT01045122|1207429|P2|STARTED|Dexmedetomidine Then Propofol||6
493680|NCT01045122|1207430|P1|STARTED|Dexmedetomidine Then Propofol||5
493681|NCT01045096|1207439|P3|NOT COMPLETED|Overall Study||0
493682|NCT01045096|1207440|P2|NOT COMPLETED|Overall Study||0
493683|NCT01045096|1207441|P1|NOT COMPLETED|Overall Study||3
493684|NCT01045096|1207439|P3|COMPLETED|Overall Study||12
493685|NCT01045096|1207440|P2|COMPLETED|Overall Study||12
493686|NCT01045096|1207441|P1|COMPLETED|Overall Study||9
493687|NCT01045096|1207439|P3|Pharmacokinetic Set|Overall Study||11
493688|NCT01045096|1207440|P2|Pharmacokinetic Set|Overall Study||11
493689|NCT01045096|1207441|P1|Pharmacokinetic Set|Overall Study|All patients with at least one estimable PK parameter for dexlansoprazole on Day 7.|9
493690|NCT01045096|1207439|P3|STARTED|Overall Study||12
493691|NCT01045096|1207440|P2|STARTED|Overall Study||12
493692|NCT01045096|1207441|P1|STARTED|Overall Study||12
493693|NCT01045057|1207467|P1|NOT COMPLETED|Overall Study||0
493694|NCT01045057|1207467|P1|COMPLETED|Overall Study||27
493695|NCT01045057|1207467|P1|STARTED|Overall Study||27
493696|NCT01045031|1207476|P2|NOT COMPLETED|Overall Study||6
493697|NCT01045031|1207477|P1|NOT COMPLETED|Overall Study||9
493698|NCT01045031|1207476|P2|COMPLETED|Overall Study||50
493699|NCT01045031|1207477|P1|COMPLETED|Overall Study||49
493700|NCT01045031|1207476|P2|STARTED|Overall Study||56
493701|NCT01045031|1207477|P1|STARTED|Overall Study||58
493702|NCT01044862|1207490|P3|NOT COMPLETED|Overall Study||52
493703|NCT01044862|1207491|P2|NOT COMPLETED|Overall Study||49
493704|NCT01044862|1207492|P1|NOT COMPLETED|Overall Study||53
493705|NCT01044862|1207490|P3|COMPLETED|Overall Study||249
493706|NCT01044862|1207491|P2|COMPLETED|Overall Study||251
493707|NCT01044862|1207492|P1|COMPLETED|Overall Study||246
493708|NCT01044862|1207490|P3|STARTED|Overall Study||301
493709|NCT01044862|1207491|P2|STARTED|Overall Study||300
493710|NCT01044862|1207492|P1|STARTED|Overall Study||299
493711|NCT01044771|1207509|P1|NOT COMPLETED|Overall Study||0
493712|NCT01044771|1207509|P1|COMPLETED|Overall Study||20
493713|NCT01044771|1207509|P1|STARTED|Overall Study||20
493714|NCT01044758|1207521|P7|NOT COMPLETED|Overall Study||10
493715|NCT01044758|1207522|P6|NOT COMPLETED|Overall Study||3
493716|NCT01044758|1207523|P5|NOT COMPLETED|Overall Study||2
493717|NCT01044758|1207524|P4|NOT COMPLETED|Overall Study||2
493718|NCT01044758|1207525|P3|NOT COMPLETED|Overall Study||4
493719|NCT01044758|1207526|P2|NOT COMPLETED|Overall Study||0
493720|NCT01044758|1207527|P1|NOT COMPLETED|Overall Study||4
493721|NCT01044758|1207521|P7|COMPLETED|Overall Study||17
493722|NCT01044758|1207522|P6|COMPLETED|Overall Study||8
493723|NCT01044758|1207523|P5|COMPLETED|Overall Study||9
493724|NCT01044758|1207524|P4|COMPLETED|Overall Study||10
493725|NCT01044758|1207525|P3|COMPLETED|Overall Study||7
493726|NCT01044758|1207526|P2|COMPLETED|Overall Study||12
493727|NCT01044758|1207527|P1|COMPLETED|Overall Study||8
493728|NCT01044758|1207521|P7|STARTED|Overall Study||27
493729|NCT01044758|1207522|P6|STARTED|Overall Study||11
493730|NCT01044758|1207523|P5|STARTED|Overall Study||11
493731|NCT01044758|1207524|P4|STARTED|Overall Study||12
493732|NCT01044758|1207525|P3|STARTED|Overall Study||11
493733|NCT01044758|1207526|P2|STARTED|Overall Study||12
493734|NCT01044758|1207527|P1|STARTED|Overall Study||12
493735|NCT01044732|1207552|P2|NOT COMPLETED|Overall Study||50
493736|NCT01044732|1207553|P1|NOT COMPLETED|Overall Study||49
493737|NCT01044732|1207552|P2|COMPLETED|Overall Study||176
493738|NCT01044732|1207553|P1|COMPLETED|Overall Study||173
493739|NCT01044732|1207552|P2|STARTED|Overall Study||226
493740|NCT01044732|1207553|P1|STARTED|Overall Study||222
493741|NCT01044706|1207563|P2|NOT COMPLETED|Overall Study||0
493742|NCT01044706|1207564|P1|NOT COMPLETED|Overall Study||0
493743|NCT01044706|1207563|P2|COMPLETED|Overall Study||30
493744|NCT01044706|1207564|P1|COMPLETED|Overall Study||30
493745|NCT01044706|1207563|P2|STARTED|Overall Study||30
493746|NCT01044706|1207564|P1|STARTED|Overall Study||30
493747|NCT01044693|1207572|P16|NOT COMPLETED|Overall Study||0
493748|NCT01044693|1207573|P15|NOT COMPLETED|Overall Study||0
493749|NCT01044693|1207574|P14|NOT COMPLETED|Overall Study||0
493750|NCT01044693|1207575|P13|NOT COMPLETED|Overall Study||0
493751|NCT01044693|1207576|P12|NOT COMPLETED|Overall Study||0
493752|NCT01044693|1207577|P11|NOT COMPLETED|Overall Study||0
493753|NCT01044693|1207578|P10|NOT COMPLETED|Overall Study||0
493754|NCT01044693|1207579|P9|NOT COMPLETED|Overall Study||0
493755|NCT01044693|1207580|P8|NOT COMPLETED|Overall Study||0
493756|NCT01044693|1207581|P7|NOT COMPLETED|Overall Study||0
493757|NCT01044693|1207582|P6|NOT COMPLETED|Overall Study||0
493758|NCT01044693|1207583|P5|NOT COMPLETED|Overall Study||0
493759|NCT01044693|1207584|P4|NOT COMPLETED|Overall Study||0
493760|NCT01044693|1207585|P3|NOT COMPLETED|Overall Study||0
493761|NCT01044693|1207586|P2|NOT COMPLETED|Overall Study||0
493762|NCT01044693|1207587|P1|NOT COMPLETED|Overall Study||0
493763|NCT01044693|1207572|P16|COMPLETED|Overall Study||1
493764|NCT01044693|1207573|P15|COMPLETED|Overall Study||1
493765|NCT01044693|1207574|P14|COMPLETED|Overall Study||1
493766|NCT01044693|1207575|P13|COMPLETED|Overall Study||2
493767|NCT01044693|1207576|P12|COMPLETED|Overall Study||1
493768|NCT01044693|1207577|P11|COMPLETED|Overall Study||1
493769|NCT01044693|1207578|P10|COMPLETED|Overall Study||1
493770|NCT01044693|1207579|P9|COMPLETED|Overall Study||1
493771|NCT01044693|1207580|P8|COMPLETED|Overall Study||1
493772|NCT01044693|1207581|P7|COMPLETED|Overall Study||1
493773|NCT01044693|1207582|P6|COMPLETED|Overall Study||2
493774|NCT01044693|1207583|P5|COMPLETED|Overall Study||1
493775|NCT01044693|1207584|P4|COMPLETED|Overall Study||1
493776|NCT01044693|1207585|P3|COMPLETED|Overall Study||1
493777|NCT01044693|1207586|P2|COMPLETED|Overall Study||1
493778|NCT01044693|1207587|P1|COMPLETED|Overall Study||3
493779|NCT01044693|1207572|P16|STARTED|Overall Study||1
493780|NCT01044693|1207573|P15|STARTED|Overall Study||1
493781|NCT01044693|1207574|P14|STARTED|Overall Study||1
493782|NCT01044693|1207575|P13|STARTED|Overall Study||2
493783|NCT01044693|1207576|P12|STARTED|Overall Study||1
493784|NCT01044693|1207577|P11|STARTED|Overall Study||1
493785|NCT01044693|1207578|P10|STARTED|Overall Study||1
493786|NCT01044693|1207579|P9|STARTED|Overall Study||1
493787|NCT01044693|1207580|P8|STARTED|Overall Study||1
493788|NCT01044693|1207581|P7|STARTED|Overall Study||1
493789|NCT01044693|1207582|P6|STARTED|Overall Study||2
493790|NCT01044693|1207583|P5|STARTED|Overall Study||1
493791|NCT01044693|1207584|P4|STARTED|Overall Study||1
493792|NCT01044693|1207585|P3|STARTED|Overall Study||1
493793|NCT01044693|1207586|P2|STARTED|Overall Study||1
493794|NCT01044693|1207587|P1|STARTED|Overall Study||3
493795|NCT01044589|1207611|P2|NOT COMPLETED|Overall Study||5
493796|NCT01044589|1207612|P1|NOT COMPLETED|Overall Study||3
493797|NCT01044589|1207611|P2|COMPLETED|Overall Study||2
493798|NCT01044589|1207612|P1|COMPLETED|Overall Study||3
493799|NCT01044589|1207611|P2|STARTED|Overall Study||7
493800|NCT01044589|1207612|P1|STARTED|Overall Study||6
493801|NCT01044537|1207627|P7|NOT COMPLETED|Overall Study||0
493802|NCT01044537|1207628|P6|NOT COMPLETED|Overall Study||0
493803|NCT01044537|1207629|P5|NOT COMPLETED|Overall Study||0
493804|NCT01044537|1207630|P4|NOT COMPLETED|Overall Study||0
493805|NCT01044537|1207631|P3|NOT COMPLETED|Overall Study||0
493806|NCT01044537|1207632|P2|NOT COMPLETED|Overall Study||0
493807|NCT01044537|1207633|P1|NOT COMPLETED|Overall Study||0
493808|NCT01044537|1207627|P7|COMPLETED|Overall Study||16
493809|NCT01044537|1207628|P6|COMPLETED|Overall Study||5
493810|NCT01044537|1207629|P5|COMPLETED|Overall Study||5
493811|NCT01044537|1207630|P4|COMPLETED|Overall Study||6
493812|NCT01044537|1207631|P3|COMPLETED|Overall Study||6
493813|NCT01044537|1207632|P2|COMPLETED|Overall Study||6
493814|NCT01044537|1207633|P1|COMPLETED|Overall Study||6
493815|NCT01044537|1207627|P7|STARTED|Overall Study||16
493816|NCT01044537|1207628|P6|STARTED|Overall Study||5
493817|NCT01044537|1207629|P5|STARTED|Overall Study||5
493818|NCT01044537|1207630|P4|STARTED|Overall Study||6
493819|NCT01044537|1207631|P3|STARTED|Overall Study||6
493820|NCT01044537|1207632|P2|STARTED|Overall Study||6
493821|NCT01044537|1207633|P1|STARTED|Overall Study||6
493822|NCT01044498|1207742|P2|NOT COMPLETED|Overall Study||2
493823|NCT01044498|1207743|P1|NOT COMPLETED|Overall Study||3
493824|NCT01044498|1207742|P2|COMPLETED|Overall Study||21
493825|NCT01044498|1207743|P1|COMPLETED|Overall Study||20
493826|NCT01044498|1207742|P2|STARTED|Overall Study||23
493827|NCT01044498|1207743|P1|STARTED|Overall Study||23
493828|NCT01044459|1207769|P2|NOT COMPLETED|Overall Study||131
493829|NCT01044459|1207770|P1|NOT COMPLETED|Overall Study||133
493830|NCT01044459|1207769|P2|COMPLETED|Overall Study||162
493831|NCT01044459|1207770|P1|COMPLETED|Overall Study||179
493832|NCT01044459|1207769|P2|STARTED|Overall Study||293
493833|NCT01044459|1207770|P1|STARTED|Overall Study||312
493834|NCT01044303|1207778|P1|NOT COMPLETED|Overall Study||2
493835|NCT01044303|1207778|P1|COMPLETED|Overall Study||30
493836|NCT01044303|1207778|P1|STARTED|Overall Study||32
493837|NCT01044290|1207788|P3|NOT COMPLETED|Follow-Up 2||2
493838|NCT01044290|1207789|P2|NOT COMPLETED|Follow-Up 2||2
493839|NCT01044290|1207790|P1|NOT COMPLETED|Follow-Up 2||0
493840|NCT01044290|1207788|P3|COMPLETED|Follow-Up 2||69
493841|NCT01044290|1207789|P2|COMPLETED|Follow-Up 2||67
493842|NCT01044290|1207790|P1|COMPLETED|Follow-Up 2||70
493843|NCT01044290|1207788|P3|Completed F2 Interview|Follow-Up 2||64
493844|NCT01044290|1207789|P2|Completed F2 Interview|Follow-Up 2||57
493845|NCT01044290|1207790|P1|Completed F2 Interview|Follow-Up 2||64
493846|NCT01044290|1207788|P3|STARTED|Follow-Up 2||71
493847|NCT01044290|1207789|P2|STARTED|Follow-Up 2||69
493848|NCT01044290|1207790|P1|STARTED|Follow-Up 2||70
493849|NCT01044290|1207788|P3|NOT COMPLETED|Follow-up 1||1
493850|NCT01044290|1207789|P2|NOT COMPLETED|Follow-up 1||5
493851|NCT01044290|1207790|P1|NOT COMPLETED|Follow-up 1||5
493852|NCT01044290|1207788|P3|COMPLETED|Follow-up 1||71
493853|NCT01044290|1207789|P2|COMPLETED|Follow-up 1||69
493854|NCT01044290|1207790|P1|COMPLETED|Follow-up 1||70
493855|NCT01044290|1207788|P3|Completed F1 Interview|Follow-up 1||61
493856|NCT01044290|1207789|P2|Completed F1 Interview|Follow-up 1||60
493857|NCT01044290|1207790|P1|Completed F1 Interview|Follow-up 1||61
493858|NCT01044290|1207788|P3|STARTED|Follow-up 1||72
493859|NCT01044290|1207789|P2|STARTED|Follow-up 1||74
493860|NCT01044290|1207790|P1|STARTED|Follow-up 1||75
493861|NCT01044290|1207788|P3|NOT COMPLETED|Randomization||0
493862|NCT01044290|1207789|P2|NOT COMPLETED|Randomization||0
493863|NCT01044290|1207790|P1|NOT COMPLETED|Randomization||0
493864|NCT01044290|1207788|P3|COMPLETED|Randomization||72
493865|NCT01044290|1207789|P2|COMPLETED|Randomization||74
493866|NCT01044290|1207790|P1|COMPLETED|Randomization||75
493867|NCT01044290|1207788|P3|Randomized|Randomization||72
493868|NCT01044290|1207789|P2|Randomized|Randomization||74
493869|NCT01044290|1207790|P1|Randomized|Randomization||75
493870|NCT01044290|1207788|P3|STARTED|Randomization||72
493871|NCT01044290|1207789|P2|STARTED|Randomization||74
493872|NCT01044290|1207790|P1|STARTED|Randomization||75
493873|NCT01044264|1207816|P3|NOT COMPLETED|Overall Study||92
493874|NCT01044264|1207817|P2|NOT COMPLETED|Overall Study||94
493875|NCT01044264|1207818|P1|NOT COMPLETED|Overall Study||90
493876|NCT01044264|1207816|P3|COMPLETED|Overall Study||108
493877|NCT01044264|1207817|P2|COMPLETED|Overall Study||108
493878|NCT01044264|1207818|P1|COMPLETED|Overall Study||110
493879|NCT01044264|1207816|P3|STARTED|Overall Study||200
493880|NCT01044264|1207817|P2|STARTED|Overall Study||202
493881|NCT01044264|1207818|P1|STARTED|Overall Study||200
493882|NCT01044212|1207828|P2|NOT COMPLETED|Overall Study||7
493883|NCT01044212|1207829|P1|NOT COMPLETED|Overall Study||5
493884|NCT01044212|1207828|P2|COMPLETED|Overall Study||30
493885|NCT01044212|1207829|P1|COMPLETED|Overall Study||30
493886|NCT01044212|1207828|P2|STARTED|Overall Study||37
493887|NCT01044212|1207829|P1|STARTED|Overall Study||35
493888|NCT01044056|1207842|P3|NOT COMPLETED|Overall Study||0
493889|NCT01044056|1207843|P2|NOT COMPLETED|Overall Study||0
493890|NCT01044056|1207844|P1|NOT COMPLETED|Overall Study||0
493891|NCT01044056|1207842|P3|COMPLETED|Overall Study||8
493892|NCT01044056|1207843|P2|COMPLETED|Overall Study||8
493893|NCT01044056|1207844|P1|COMPLETED|Overall Study||8
493894|NCT01044056|1207842|P3|STARTED|Overall Study||8
493895|NCT01044056|1207843|P2|STARTED|Overall Study||8
493896|NCT01044056|1207844|P1|STARTED|Overall Study||8
493897|NCT01044030|1207863|P2|NOT COMPLETED|Overall Study||20
493898|NCT01044030|1207864|P1|NOT COMPLETED|Overall Study||19
493899|NCT01044030|1207863|P2|COMPLETED|Overall Study||146
493900|NCT01044030|1207864|P1|COMPLETED|Overall Study||141
493901|NCT01044030|1207863|P2|STARTED|Overall Study||166
493902|NCT01044030|1207864|P1|STARTED|Overall Study||160
493903|NCT01043939|1207878|P2|NOT COMPLETED|Second Intervention||0
493904|NCT01043939|1207879|P1|NOT COMPLETED|Second Intervention||0
493905|NCT01043939|1207878|P2|COMPLETED|Second Intervention||12
493906|NCT01043939|1207879|P1|COMPLETED|Second Intervention||12
493907|NCT01043939|1207878|P2|STARTED|Second Intervention||12
493908|NCT01043939|1207879|P1|STARTED|Second Intervention||12
493909|NCT01043939|1207878|P2|NOT COMPLETED|Washout Period||0
493910|NCT01043939|1207879|P1|NOT COMPLETED|Washout Period||0
493911|NCT01043939|1207878|P2|COMPLETED|Washout Period||12
493912|NCT01043939|1207879|P1|COMPLETED|Washout Period||12
493913|NCT01043939|1207878|P2|STARTED|Washout Period||12
493914|NCT01043939|1207879|P1|STARTED|Washout Period||12
493915|NCT01043939|1207878|P2|NOT COMPLETED|First Intervention||0
493916|NCT01043939|1207879|P1|NOT COMPLETED|First Intervention||0
493917|NCT01043939|1207878|P2|COMPLETED|First Intervention||12
493918|NCT01043939|1207879|P1|COMPLETED|First Intervention||12
493919|NCT01043939|1207878|P2|STARTED|First Intervention||12
493920|NCT01043939|1207879|P1|STARTED|First Intervention||12
493921|NCT01043926|1207893|P4|NOT COMPLETED|Overall Study||0
493922|NCT01043926|1207894|P3|NOT COMPLETED|Overall Study||0
493923|NCT01043926|1207895|P2|NOT COMPLETED|Overall Study||0
493924|NCT01043926|1207896|P1|NOT COMPLETED|Overall Study||0
493925|NCT01043926|1207893|P4|COMPLETED|Overall Study||0
493926|NCT01043926|1207894|P3|COMPLETED|Overall Study||0
493927|NCT01043926|1207895|P2|COMPLETED|Overall Study||8
493928|NCT01043926|1207896|P1|COMPLETED|Overall Study||8
493929|NCT01043926|1207893|P4|STARTED|Overall Study||0
493930|NCT01043926|1207894|P3|STARTED|Overall Study||0
493931|NCT01043926|1207895|P2|STARTED|Overall Study||8
493932|NCT01043926|1207896|P1|STARTED|Overall Study||8
493933|NCT01043874|1207910|P1|NOT COMPLETED|Overall Study||6
493934|NCT01043874|1207910|P1|COMPLETED|Overall Study||39
493935|NCT01043874|1207910|P1|STARTED|Overall Study||45
493936|NCT01043705|1207920|P3|NOT COMPLETED|Overall Study||80
493937|NCT01043705|1207921|P2|NOT COMPLETED|Overall Study||131
493938|NCT01043705|1207922|P1|NOT COMPLETED|Overall Study||107
493939|NCT01043705|1207920|P3|COMPLETED|Overall Study||498
493940|NCT01043705|1207921|P2|COMPLETED|Overall Study||447
493941|NCT01043705|1207922|P1|COMPLETED|Overall Study||352
493942|NCT01043705|1207920|P3|STARTED|Overall Study||578
493943|NCT01043705|1207921|P2|STARTED|Overall Study||578
493944|NCT01043705|1207922|P1|STARTED|Overall Study||459
493945|NCT01043653|1207932|P1|NOT COMPLETED|Overall Study||64
493946|NCT01043653|1207932|P1|COMPLETED|Overall Study||186
493947|NCT01043653|1207932|P1|STARTED|Overall Study||250
493948|NCT01043640|1207937|P1|NOT COMPLETED|Overall Study||0
493949|NCT01043640|1207937|P1|COMPLETED|Overall Study||46
493950|NCT01043640|1207937|P1|STARTED|Overall Study||46
493951|NCT01043562|1207952|P1|NOT COMPLETED|Overall Study||0
493952|NCT01043562|1207952|P1|COMPLETED|Overall Study||20
493953|NCT01043562|1207952|P1|STARTED|Overall Study||20
493954|NCT01043523|1207959|P1|NOT COMPLETED|Overall Study||0
493955|NCT01043523|1207959|P1|COMPLETED|Overall Study||52
493956|NCT01043523|1207959|P1|Participants With Unenhanced Images|Overall Study||51
493957|NCT01043523|1207959|P1|STARTED|Overall Study||52
493958|NCT01043432|1207988|P4|NOT COMPLETED|Overall Study||0
493959|NCT01043432|1207989|P3|NOT COMPLETED|Overall Study||0
493960|NCT01043432|1207990|P2|NOT COMPLETED|Overall Study||0
493961|NCT01043432|1207991|P1|NOT COMPLETED|Overall Study||0
493962|NCT01043432|1207988|P4|COMPLETED|Overall Study||48
493963|NCT01043432|1207989|P3|COMPLETED|Overall Study||12
493964|NCT01043432|1207990|P2|COMPLETED|Overall Study||51
493965|NCT01043432|1207991|P1|COMPLETED|Overall Study||22
493966|NCT01043432|1207988|P4|STARTED|Overall Study||48
493967|NCT01043432|1207989|P3|STARTED|Overall Study||12
493968|NCT01043432|1207990|P2|STARTED|Overall Study||51
493969|NCT01043432|1207991|P1|STARTED|Overall Study||22
493970|NCT01043393|1208000|P2|NOT COMPLETED|Overall Study||0
493971|NCT01043393|1208001|P1|NOT COMPLETED|Overall Study||0
493972|NCT01043393|1208000|P2|COMPLETED|Overall Study||12
493973|NCT01043393|1208001|P1|COMPLETED|Overall Study||12
493974|NCT01043393|1208000|P2|STARTED|Overall Study||12
493975|NCT01043393|1208001|P1|STARTED|Overall Study||12
493976|NCT01043185|1208011|P10|NOT COMPLETED|Period 7 - Fourth Intervention||0
493977|NCT01043185|1208012|P9|NOT COMPLETED|Period 7 - Fourth Intervention||0
493978|NCT01043185|1208013|P8|NOT COMPLETED|Period 7 - Fourth Intervention||0
493979|NCT01043185|1208014|P7|NOT COMPLETED|Period 7 - Fourth Intervention||0
493980|NCT01043185|1208015|P6|NOT COMPLETED|Period 7 - Fourth Intervention||0
493981|NCT01043185|1208016|P5|NOT COMPLETED|Period 7 - Fourth Intervention||0
493982|NCT01043185|1208017|P4|NOT COMPLETED|Period 7 - Fourth Intervention||0
493983|NCT01043185|1208018|P3|NOT COMPLETED|Period 7 - Fourth Intervention||0
493984|NCT01043185|1208019|P2|NOT COMPLETED|Period 7 - Fourth Intervention||0
493985|NCT01043185|1208020|P1|NOT COMPLETED|Period 7 - Fourth Intervention||0
493986|NCT01043185|1208011|P10|COMPLETED|Period 7 - Fourth Intervention||3
493987|NCT01043185|1208012|P9|COMPLETED|Period 7 - Fourth Intervention||2
493988|NCT01043185|1208013|P8|COMPLETED|Period 7 - Fourth Intervention||3
493989|NCT01043185|1208014|P7|COMPLETED|Period 7 - Fourth Intervention||3
493990|NCT01043185|1208015|P6|COMPLETED|Period 7 - Fourth Intervention||3
493991|NCT01043185|1208016|P5|COMPLETED|Period 7 - Fourth Intervention||2
493992|NCT01043185|1208017|P4|COMPLETED|Period 7 - Fourth Intervention||2
493993|NCT01043185|1208018|P3|COMPLETED|Period 7 - Fourth Intervention||3
493994|NCT01043185|1208019|P2|COMPLETED|Period 7 - Fourth Intervention||2
493995|NCT01043185|1208020|P1|COMPLETED|Period 7 - Fourth Intervention||3
493996|NCT01043185|1208011|P10|STARTED|Period 7 - Fourth Intervention||3
493997|NCT01043185|1208012|P9|STARTED|Period 7 - Fourth Intervention||2
493998|NCT01043185|1208013|P8|STARTED|Period 7 - Fourth Intervention||3
493999|NCT01043185|1208014|P7|STARTED|Period 7 - Fourth Intervention||3
494000|NCT01043185|1208015|P6|STARTED|Period 7 - Fourth Intervention||3
494001|NCT01043185|1208016|P5|STARTED|Period 7 - Fourth Intervention||2
494002|NCT01043185|1208017|P4|STARTED|Period 7 - Fourth Intervention||2
494003|NCT01043185|1208018|P3|STARTED|Period 7 - Fourth Intervention||3
494004|NCT01043185|1208019|P2|STARTED|Period 7 - Fourth Intervention||2
494005|NCT01043185|1208020|P1|STARTED|Period 7 - Fourth Intervention||3
494006|NCT01043185|1208011|P10|NOT COMPLETED|Period 6 - Third Washout Period||0
494007|NCT01043185|1208012|P9|NOT COMPLETED|Period 6 - Third Washout Period||1
494008|NCT01043185|1208013|P8|NOT COMPLETED|Period 6 - Third Washout Period||0
494009|NCT01043185|1208014|P7|NOT COMPLETED|Period 6 - Third Washout Period||0
494010|NCT01043185|1208015|P6|NOT COMPLETED|Period 6 - Third Washout Period||0
494011|NCT01043185|1208016|P5|NOT COMPLETED|Period 6 - Third Washout Period||0
494012|NCT01043185|1208017|P4|NOT COMPLETED|Period 6 - Third Washout Period||0
494013|NCT01043185|1208018|P3|NOT COMPLETED|Period 6 - Third Washout Period||0
494014|NCT01043185|1208019|P2|NOT COMPLETED|Period 6 - Third Washout Period||0
494015|NCT01043185|1208020|P1|NOT COMPLETED|Period 6 - Third Washout Period||0
494016|NCT01043185|1208011|P10|COMPLETED|Period 6 - Third Washout Period||3
494017|NCT01043185|1208012|P9|COMPLETED|Period 6 - Third Washout Period||2
494018|NCT01043185|1208013|P8|COMPLETED|Period 6 - Third Washout Period||3
494019|NCT01043185|1208014|P7|COMPLETED|Period 6 - Third Washout Period||3
494020|NCT01043185|1208015|P6|COMPLETED|Period 6 - Third Washout Period||3
494021|NCT01043185|1208016|P5|COMPLETED|Period 6 - Third Washout Period||2
494022|NCT01043185|1208017|P4|COMPLETED|Period 6 - Third Washout Period||2
494023|NCT01043185|1208018|P3|COMPLETED|Period 6 - Third Washout Period||3
494024|NCT01043185|1208019|P2|COMPLETED|Period 6 - Third Washout Period||2
494025|NCT01043185|1208020|P1|COMPLETED|Period 6 - Third Washout Period||3
494026|NCT01043185|1208011|P10|STARTED|Period 6 - Third Washout Period||3
494027|NCT01043185|1208012|P9|STARTED|Period 6 - Third Washout Period||3
494028|NCT01043185|1208013|P8|STARTED|Period 6 - Third Washout Period||3
494029|NCT01043185|1208014|P7|STARTED|Period 6 - Third Washout Period||3
494030|NCT01043185|1208015|P6|STARTED|Period 6 - Third Washout Period||3
494031|NCT01043185|1208016|P5|STARTED|Period 6 - Third Washout Period||2
494032|NCT01043185|1208017|P4|STARTED|Period 6 - Third Washout Period||2
494033|NCT01043185|1208018|P3|STARTED|Period 6 - Third Washout Period||3
494034|NCT01043185|1208019|P2|STARTED|Period 6 - Third Washout Period||2
494035|NCT01043185|1208020|P1|STARTED|Period 6 - Third Washout Period||3
494036|NCT01043185|1208011|P10|NOT COMPLETED|Period 5 - Third Intervention||0
494037|NCT01043185|1208012|P9|NOT COMPLETED|Period 5 - Third Intervention||0
494038|NCT01043185|1208013|P8|NOT COMPLETED|Period 5 - Third Intervention||0
494039|NCT01043185|1208014|P7|NOT COMPLETED|Period 5 - Third Intervention||0
494040|NCT01043185|1208015|P6|NOT COMPLETED|Period 5 - Third Intervention||0
494041|NCT01043185|1208016|P5|NOT COMPLETED|Period 5 - Third Intervention||0
494042|NCT01043185|1208017|P4|NOT COMPLETED|Period 5 - Third Intervention||0
494043|NCT01043185|1208018|P3|NOT COMPLETED|Period 5 - Third Intervention||0
494044|NCT01043185|1208019|P2|NOT COMPLETED|Period 5 - Third Intervention||0
494045|NCT01043185|1208020|P1|NOT COMPLETED|Period 5 - Third Intervention||0
494046|NCT01043185|1208011|P10|COMPLETED|Period 5 - Third Intervention||3
494047|NCT01043185|1208012|P9|COMPLETED|Period 5 - Third Intervention||3
494048|NCT01043185|1208013|P8|COMPLETED|Period 5 - Third Intervention||3
494049|NCT01043185|1208014|P7|COMPLETED|Period 5 - Third Intervention||3
494050|NCT01043185|1208015|P6|COMPLETED|Period 5 - Third Intervention||3
494051|NCT01043185|1208016|P5|COMPLETED|Period 5 - Third Intervention||2
494052|NCT01043185|1208017|P4|COMPLETED|Period 5 - Third Intervention||2
494053|NCT01043185|1208018|P3|COMPLETED|Period 5 - Third Intervention||3
494054|NCT01043185|1208019|P2|COMPLETED|Period 5 - Third Intervention||2
494055|NCT01043185|1208020|P1|COMPLETED|Period 5 - Third Intervention||3
494056|NCT01043185|1208011|P10|STARTED|Period 5 - Third Intervention||3
494057|NCT01043185|1208012|P9|STARTED|Period 5 - Third Intervention||3
494058|NCT01043185|1208013|P8|STARTED|Period 5 - Third Intervention||3
494059|NCT01043185|1208014|P7|STARTED|Period 5 - Third Intervention||3
494060|NCT01043185|1208015|P6|STARTED|Period 5 - Third Intervention||3
494061|NCT01043185|1208016|P5|STARTED|Period 5 - Third Intervention||2
494062|NCT01043185|1208017|P4|STARTED|Period 5 - Third Intervention||2
494063|NCT01043185|1208018|P3|STARTED|Period 5 - Third Intervention||3
494064|NCT01043185|1208019|P2|STARTED|Period 5 - Third Intervention||2
494065|NCT01043185|1208020|P1|STARTED|Period 5 - Third Intervention||3
494066|NCT01043185|1208011|P10|NOT COMPLETED|Period 4 - Second Washout Period||0
494067|NCT01043185|1208012|P9|NOT COMPLETED|Period 4 - Second Washout Period||0
494068|NCT01043185|1208013|P8|NOT COMPLETED|Period 4 - Second Washout Period||0
494069|NCT01043185|1208014|P7|NOT COMPLETED|Period 4 - Second Washout Period||0
494070|NCT01043185|1208015|P6|NOT COMPLETED|Period 4 - Second Washout Period||0
494071|NCT01043185|1208016|P5|NOT COMPLETED|Period 4 - Second Washout Period||0
494072|NCT01043185|1208017|P4|NOT COMPLETED|Period 4 - Second Washout Period||0
494073|NCT01043185|1208018|P3|NOT COMPLETED|Period 4 - Second Washout Period||0
494074|NCT01043185|1208019|P2|NOT COMPLETED|Period 4 - Second Washout Period||0
494075|NCT01043185|1208020|P1|NOT COMPLETED|Period 4 - Second Washout Period||0
494076|NCT01043185|1208011|P10|COMPLETED|Period 4 - Second Washout Period||3
494077|NCT01043185|1208012|P9|COMPLETED|Period 4 - Second Washout Period||3
494078|NCT01043185|1208013|P8|COMPLETED|Period 4 - Second Washout Period||3
494079|NCT01043185|1208014|P7|COMPLETED|Period 4 - Second Washout Period||3
494080|NCT01043185|1208015|P6|COMPLETED|Period 4 - Second Washout Period||3
494081|NCT01043185|1208016|P5|COMPLETED|Period 4 - Second Washout Period||2
494082|NCT01043185|1208017|P4|COMPLETED|Period 4 - Second Washout Period||2
494083|NCT01043185|1208018|P3|COMPLETED|Period 4 - Second Washout Period||3
494084|NCT01043185|1208019|P2|COMPLETED|Period 4 - Second Washout Period||2
494085|NCT01043185|1208020|P1|COMPLETED|Period 4 - Second Washout Period||3
494086|NCT01043185|1208011|P10|STARTED|Period 4 - Second Washout Period||3
494087|NCT01043185|1208012|P9|STARTED|Period 4 - Second Washout Period||3
494088|NCT01043185|1208013|P8|STARTED|Period 4 - Second Washout Period||3
494089|NCT01043185|1208014|P7|STARTED|Period 4 - Second Washout Period||3
494090|NCT01043185|1208015|P6|STARTED|Period 4 - Second Washout Period||3
494091|NCT01043185|1208016|P5|STARTED|Period 4 - Second Washout Period||2
494092|NCT01043185|1208017|P4|STARTED|Period 4 - Second Washout Period||2
494093|NCT01043185|1208018|P3|STARTED|Period 4 - Second Washout Period||3
494094|NCT01043185|1208019|P2|STARTED|Period 4 - Second Washout Period||2
494095|NCT01043185|1208020|P1|STARTED|Period 4 - Second Washout Period||3
494096|NCT01043185|1208011|P10|NOT COMPLETED|Period 3 - Second Intervention||0
494097|NCT01043185|1208012|P9|NOT COMPLETED|Period 3 - Second Intervention||0
494098|NCT01043185|1208013|P8|NOT COMPLETED|Period 3 - Second Intervention||0
494099|NCT01043185|1208014|P7|NOT COMPLETED|Period 3 - Second Intervention||0
494100|NCT01043185|1208015|P6|NOT COMPLETED|Period 3 - Second Intervention||0
494101|NCT01043185|1208016|P5|NOT COMPLETED|Period 3 - Second Intervention||0
494102|NCT01043185|1208017|P4|NOT COMPLETED|Period 3 - Second Intervention||0
494103|NCT01043185|1208018|P3|NOT COMPLETED|Period 3 - Second Intervention||0
494104|NCT01043185|1208019|P2|NOT COMPLETED|Period 3 - Second Intervention||0
494105|NCT01043185|1208020|P1|NOT COMPLETED|Period 3 - Second Intervention||0
494106|NCT01043185|1208011|P10|COMPLETED|Period 3 - Second Intervention||3
494107|NCT01043185|1208012|P9|COMPLETED|Period 3 - Second Intervention||3
494108|NCT01043185|1208013|P8|COMPLETED|Period 3 - Second Intervention||3
494109|NCT01043185|1208014|P7|COMPLETED|Period 3 - Second Intervention||3
494110|NCT01043185|1208015|P6|COMPLETED|Period 3 - Second Intervention||3
494111|NCT01043185|1208016|P5|COMPLETED|Period 3 - Second Intervention||2
494112|NCT01043185|1208017|P4|COMPLETED|Period 3 - Second Intervention||2
494113|NCT01043185|1208018|P3|COMPLETED|Period 3 - Second Intervention||3
494114|NCT01043185|1208019|P2|COMPLETED|Period 3 - Second Intervention||2
494115|NCT01043185|1208020|P1|COMPLETED|Period 3 - Second Intervention||3
494116|NCT01043185|1208011|P10|STARTED|Period 3 - Second Intervention||3
494117|NCT01043185|1208012|P9|STARTED|Period 3 - Second Intervention||3
494118|NCT01043185|1208013|P8|STARTED|Period 3 - Second Intervention||3
494119|NCT01043185|1208014|P7|STARTED|Period 3 - Second Intervention||3
494120|NCT01043185|1208015|P6|STARTED|Period 3 - Second Intervention||3
494121|NCT01043185|1208016|P5|STARTED|Period 3 - Second Intervention||2
494122|NCT01043185|1208017|P4|STARTED|Period 3 - Second Intervention||2
494123|NCT01043185|1208018|P3|STARTED|Period 3 - Second Intervention||3
494124|NCT01043185|1208019|P2|STARTED|Period 3 - Second Intervention||2
494125|NCT01043185|1208020|P1|STARTED|Period 3 - Second Intervention||3
494126|NCT01043185|1208011|P10|NOT COMPLETED|Period 2 - First Washout Period||0
494127|NCT01043185|1208012|P9|NOT COMPLETED|Period 2 - First Washout Period||0
494128|NCT01043185|1208013|P8|NOT COMPLETED|Period 2 - First Washout Period||0
494129|NCT01043185|1208014|P7|NOT COMPLETED|Period 2 - First Washout Period||0
494130|NCT01043185|1208015|P6|NOT COMPLETED|Period 2 - First Washout Period||0
494131|NCT01043185|1208016|P5|NOT COMPLETED|Period 2 - First Washout Period||0
494132|NCT01043185|1208017|P4|NOT COMPLETED|Period 2 - First Washout Period||0
494133|NCT01043185|1208018|P3|NOT COMPLETED|Period 2 - First Washout Period||0
494134|NCT01043185|1208019|P2|NOT COMPLETED|Period 2 - First Washout Period||0
494135|NCT01043185|1208020|P1|NOT COMPLETED|Period 2 - First Washout Period||0
494136|NCT01043185|1208011|P10|COMPLETED|Period 2 - First Washout Period||3
494137|NCT01043185|1208012|P9|COMPLETED|Period 2 - First Washout Period||3
494138|NCT01043185|1208013|P8|COMPLETED|Period 2 - First Washout Period||3
494139|NCT01043185|1208014|P7|COMPLETED|Period 2 - First Washout Period||3
494140|NCT01043185|1208015|P6|COMPLETED|Period 2 - First Washout Period||3
494141|NCT01043185|1208016|P5|COMPLETED|Period 2 - First Washout Period||2
494142|NCT01043185|1208017|P4|COMPLETED|Period 2 - First Washout Period||2
494143|NCT01043185|1208018|P3|COMPLETED|Period 2 - First Washout Period||3
494144|NCT01043185|1208019|P2|COMPLETED|Period 2 - First Washout Period||2
494145|NCT01043185|1208020|P1|COMPLETED|Period 2 - First Washout Period||3
494146|NCT01043185|1208011|P10|STARTED|Period 2 - First Washout Period||3
494147|NCT01043185|1208012|P9|STARTED|Period 2 - First Washout Period||3
494148|NCT01043185|1208013|P8|STARTED|Period 2 - First Washout Period||3
494149|NCT01043185|1208014|P7|STARTED|Period 2 - First Washout Period||3
494150|NCT01043185|1208015|P6|STARTED|Period 2 - First Washout Period||3
494151|NCT01043185|1208016|P5|STARTED|Period 2 - First Washout Period||2
494152|NCT01043185|1208017|P4|STARTED|Period 2 - First Washout Period||2
494153|NCT01043185|1208018|P3|STARTED|Period 2 - First Washout Period||3
494154|NCT01043185|1208019|P2|STARTED|Period 2 - First Washout Period||2
494155|NCT01043185|1208020|P1|STARTED|Period 2 - First Washout Period||3
494156|NCT01043185|1208011|P10|NOT COMPLETED|Period 1 - First Intervention||0
494157|NCT01043185|1208012|P9|NOT COMPLETED|Period 1 - First Intervention||0
494158|NCT01043185|1208013|P8|NOT COMPLETED|Period 1 - First Intervention||0
494159|NCT01043185|1208014|P7|NOT COMPLETED|Period 1 - First Intervention||0
494160|NCT01043185|1208015|P6|NOT COMPLETED|Period 1 - First Intervention||0
494161|NCT01043185|1208016|P5|NOT COMPLETED|Period 1 - First Intervention||0
494162|NCT01043185|1208017|P4|NOT COMPLETED|Period 1 - First Intervention||0
494163|NCT01043185|1208018|P3|NOT COMPLETED|Period 1 - First Intervention||0
494164|NCT01043185|1208019|P2|NOT COMPLETED|Period 1 - First Intervention||0
494165|NCT01043185|1208020|P1|NOT COMPLETED|Period 1 - First Intervention||0
494166|NCT01043185|1208011|P10|COMPLETED|Period 1 - First Intervention||3
494167|NCT01043185|1208012|P9|COMPLETED|Period 1 - First Intervention||3
494168|NCT01043185|1208013|P8|COMPLETED|Period 1 - First Intervention||3
494169|NCT01043185|1208014|P7|COMPLETED|Period 1 - First Intervention||3
494170|NCT01043185|1208015|P6|COMPLETED|Period 1 - First Intervention||3
494171|NCT01043185|1208016|P5|COMPLETED|Period 1 - First Intervention||2
494172|NCT01043185|1208017|P4|COMPLETED|Period 1 - First Intervention||2
494173|NCT01043185|1208018|P3|COMPLETED|Period 1 - First Intervention||3
494174|NCT01043185|1208019|P2|COMPLETED|Period 1 - First Intervention||2
494175|NCT01043185|1208020|P1|COMPLETED|Period 1 - First Intervention||3
494176|NCT01043185|1208011|P10|STARTED|Period 1 - First Intervention||3
494177|NCT01043185|1208012|P9|STARTED|Period 1 - First Intervention||3
494178|NCT01043185|1208013|P8|STARTED|Period 1 - First Intervention||3
494179|NCT01043185|1208014|P7|STARTED|Period 1 - First Intervention||3
494180|NCT01043185|1208015|P6|STARTED|Period 1 - First Intervention||3
494181|NCT01043185|1208016|P5|STARTED|Period 1 - First Intervention||2
494182|NCT01043185|1208017|P4|STARTED|Period 1 - First Intervention||2
494183|NCT01043185|1208018|P3|STARTED|Period 1 - First Intervention||3
494184|NCT01043185|1208019|P2|STARTED|Period 1 - First Intervention||2
494185|NCT01043185|1208020|P1|STARTED|Period 1 - First Intervention||3
494186|NCT01043146|1208053|P6|NOT COMPLETED|Overall Study||0
494187|NCT01043146|1208054|P5|NOT COMPLETED|Overall Study||0
494188|NCT01043146|1208055|P4|NOT COMPLETED|Overall Study||0
494189|NCT01043146|1208056|P3|NOT COMPLETED|Overall Study||0
494190|NCT01043146|1208057|P2|NOT COMPLETED|Overall Study||0
494191|NCT01043146|1208058|P1|NOT COMPLETED|Overall Study||0
494192|NCT01043146|1208053|P6|COMPLETED|Overall Study||8
494193|NCT01043146|1208054|P5|COMPLETED|Overall Study||8
494194|NCT01043146|1208055|P4|COMPLETED|Overall Study||8
494195|NCT01043146|1208056|P3|COMPLETED|Overall Study||8
494196|NCT01043146|1208057|P2|COMPLETED|Overall Study||8
494197|NCT01043146|1208058|P1|COMPLETED|Overall Study||10
494198|NCT01043146|1208053|P6|STARTED|Overall Study||8
494199|NCT01043146|1208054|P5|STARTED|Overall Study||8
494200|NCT01043146|1208055|P4|STARTED|Overall Study||8
494201|NCT01043146|1208056|P3|STARTED|Overall Study||8
494202|NCT01043146|1208057|P2|STARTED|Overall Study||8
494203|NCT01043146|1208058|P1|STARTED|Overall Study||10
494204|NCT01043133|1208074|P2|NOT COMPLETED|Overall Study||2
494205|NCT01043133|1208075|P1|NOT COMPLETED|Overall Study||1
494206|NCT01043133|1208074|P2|COMPLETED|Overall Study||78
494207|NCT01043133|1208075|P1|COMPLETED|Overall Study||74
494208|NCT01043133|1208074|P2|STARTED|Overall Study||80
494209|NCT01043133|1208075|P1|STARTED|Overall Study||75
494210|NCT01043094|1208085|P2|NOT COMPLETED|Overall Study||0
494211|NCT01043094|1208086|P1|NOT COMPLETED|Overall Study||0
494212|NCT01043094|1208085|P2|COMPLETED|Overall Study||8
494213|NCT01043094|1208086|P1|COMPLETED|Overall Study||8
494214|NCT01043094|1208085|P2|STARTED|Overall Study||8
494215|NCT01043094|1208086|P1|STARTED|Overall Study||8
494216|NCT01042977|1208096|P2|NOT COMPLETED|Overall Study||55
494217|NCT01042977|1208097|P1|NOT COMPLETED|Overall Study||41
494218|NCT01042977|1208096|P2|COMPLETED|Overall Study||428
494219|NCT01042977|1208097|P1|COMPLETED|Overall Study||441
494220|NCT01042977|1208096|P2|STARTED|Overall Study|Of the 483 participants only 482 were included in the full analysis set.|483
494221|NCT01042977|1208097|P1|STARTED|Overall Study|Of 482 part. 480 were included in full analysis set. Thereof, 1 part. treated but not randomized.|482
494222|NCT01042938|1208117|P2|NOT COMPLETED|Overall Study||2
494223|NCT01042938|1208118|P1|NOT COMPLETED|Overall Study||3
494224|NCT01042938|1208117|P2|COMPLETED|Overall Study||16
494225|NCT01042938|1208118|P1|COMPLETED|Overall Study||14
494226|NCT01042938|1208117|P2|STARTED|Overall Study|1 withdrew before radiation; 1 non-compliance.|18
494227|NCT01042938|1208118|P1|STARTED|Overall Study|1 withdrew before radiation; 1 ineligible due to other clinical trial; 1 non-compliance.|17
494228|NCT01042795|1208130|P1|NOT COMPLETED|Follow up - 22 Months After Drug Start||2
494229|NCT01042795|1208130|P1|COMPLETED|Follow up - 22 Months After Drug Start||0
494230|NCT01042795|1208130|P1|STARTED|Follow up - 22 Months After Drug Start||2
494231|NCT01042795|1208130|P1|NOT COMPLETED|Dosing Period - 16 Weeks of Daily Doses||5
494232|NCT01042795|1208130|P1|COMPLETED|Dosing Period - 16 Weeks of Daily Doses||2
494233|NCT01042795|1208130|P1|STARTED|Dosing Period - 16 Weeks of Daily Doses||7
494234|NCT01042678|1208137|P6|NOT COMPLETED|Overall Study||0
494235|NCT01042678|1208138|P5|NOT COMPLETED|Overall Study||0
494236|NCT01042678|1208139|P4|NOT COMPLETED|Overall Study||0
494237|NCT01042678|1208140|P3|NOT COMPLETED|Overall Study||0
494238|NCT01042678|1208141|P2|NOT COMPLETED|Overall Study||0
494239|NCT01042678|1208142|P1|NOT COMPLETED|Overall Study||1
494240|NCT01042678|1208137|P6|COMPLETED|Overall Study||0
494241|NCT01042678|1208138|P5|COMPLETED|Overall Study||0
494242|NCT01042678|1208139|P4|COMPLETED|Overall Study||0
494243|NCT01042678|1208140|P3|COMPLETED|Overall Study||6
494244|NCT01042678|1208141|P2|COMPLETED|Overall Study||6
494245|NCT01042678|1208142|P1|COMPLETED|Overall Study||5
494246|NCT01042678|1208137|P6|STARTED|Overall Study||0
494247|NCT01042678|1208138|P5|STARTED|Overall Study||0
494248|NCT01042678|1208139|P4|STARTED|Overall Study||0
494249|NCT01042678|1208140|P3|STARTED|Overall Study||6
494250|NCT01042678|1208141|P2|STARTED|Overall Study||6
494251|NCT01042678|1208142|P1|STARTED|Overall Study||6
494252|NCT01042613|1208167|P2|NOT COMPLETED|Overall Study||0
494253|NCT01042613|1208168|P1|NOT COMPLETED|Overall Study||0
494254|NCT01042613|1208167|P2|COMPLETED|Overall Study||74
494255|NCT01042613|1208168|P1|COMPLETED|Overall Study||72
494256|NCT01042613|1208167|P2|STARTED|Overall Study||74
494257|NCT01042613|1208168|P1|STARTED|Overall Study||72
494258|NCT01042600|1208180|P2|NOT COMPLETED|Overall Study||0
494259|NCT01042600|1208181|P1|NOT COMPLETED|Overall Study||1
494260|NCT01042600|1208180|P2|COMPLETED|Overall Study||30
494261|NCT01042600|1208181|P1|COMPLETED|Overall Study||30
494262|NCT01042600|1208180|P2|STARTED|Overall Study||30
494263|NCT01042600|1208181|P1|STARTED|Overall Study||31
494264|NCT01042535|1208189|P1|NOT COMPLETED|Overall Study||8
494265|NCT01042535|1208189|P1|COMPLETED|Overall Study||36
494266|NCT01042535|1208189|P1|STARTED|Overall Study||44
494267|NCT01042509|1208197|P1|NOT COMPLETED|Overall Study||0
494268|NCT01042509|1208197|P1|COMPLETED|Overall Study||15
494269|NCT01042509|1208197|P1|STARTED|Overall Study||15
494270|NCT01042496|1208204|P2|NOT COMPLETED|Overall Study||0
494271|NCT01042496|1208205|P1|NOT COMPLETED|Overall Study||0
494272|NCT01042496|1208204|P2|COMPLETED|Overall Study||33
494273|NCT01042496|1208205|P1|COMPLETED|Overall Study||29
494274|NCT01042496|1208204|P2|STARTED|Overall Study||33
494275|NCT01042496|1208205|P1|STARTED|Overall Study||29
494276|NCT01042392|1208223|P4|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1
494277|NCT01042392|1208224|P3|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||4
494278|NCT01042392|1208225|P2|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1
494279|NCT01042392|1208226|P1|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||2
494280|NCT01042392|1208223|P4|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||121
494281|NCT01042392|1208224|P3|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||115
494282|NCT01042392|1208225|P2|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||117
494283|NCT01042392|1208226|P1|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||127
494284|NCT01042392|1208223|P4|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||82
494285|NCT01042392|1208224|P3|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||93
494286|NCT01042392|1208225|P2|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||73
494287|NCT01042392|1208226|P1|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)|PPMD excluded patients violated protocol instructions for period 3 (duration and treatment intake)|98
494288|NCT01042392|1208223|P4|STARTED|Period III (Unblinded,Controlled, 1 Day)||122
494289|NCT01042392|1208224|P3|STARTED|Period III (Unblinded,Controlled, 1 Day)||119
494290|NCT01042392|1208225|P2|STARTED|Period III (Unblinded,Controlled, 1 Day)||118
494291|NCT01042392|1208226|P1|STARTED|Period III (Unblinded,Controlled, 1 Day)||129
494292|NCT01042392|1208223|P4|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
494293|NCT01042392|1208224|P3|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||8
494294|NCT01042392|1208225|P2|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
494295|NCT01042392|1208226|P1|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||10
494296|NCT01042392|1208223|P4|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
494297|NCT01042392|1208224|P3|COMPLETED|Period II(Randomized,Double Blinded,8wk)||241
494298|NCT01042392|1208225|P2|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
494299|NCT01042392|1208226|P1|COMPLETED|Period II(Randomized,Double Blinded,8wk)||247
494300|NCT01042392|1208223|P4|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0
494301|NCT01042392|1208224|P3|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||222
494302|NCT01042392|1208225|P2|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0
494303|NCT01042392|1208226|P1|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)|ITT excluded patients from centers where 90% of BP measurements were rounded to 5 or 0|222
494304|NCT01042392|1208223|P4|STARTED|Period II(Randomized,Double Blinded,8wk)|This arm is used only in Period III.|0
494305|NCT01042392|1208224|P3|STARTED|Period II(Randomized,Double Blinded,8wk)||249
494306|NCT01042392|1208225|P2|STARTED|Period II(Randomized,Double Blinded,8wk)|This arm is used only in Period III.|0
494307|NCT01042392|1208226|P1|STARTED|Period II(Randomized,Double Blinded,8wk)||257
494308|NCT01042366|1208255|P3|NOT COMPLETED|Overall Study||0
494309|NCT01042366|1208256|P2|NOT COMPLETED|Overall Study||0
494310|NCT01042366|1208257|P1|NOT COMPLETED|Overall Study||0
494311|NCT01042366|1208255|P3|COMPLETED|Overall Study||4
494312|NCT01042366|1208256|P2|COMPLETED|Overall Study||6
494313|NCT01042366|1208257|P1|COMPLETED|Overall Study||5
494314|NCT01042366|1208255|P3|STARTED|Overall Study||4
494315|NCT01042366|1208256|P2|STARTED|Overall Study||6
494316|NCT01042366|1208257|P1|STARTED|Overall Study||5
494317|NCT01042288|1208266|P1|NOT COMPLETED|Overall Study||69
494318|NCT01042288|1208266|P1|COMPLETED|Overall Study|Patients remained on maintenance until disease progression, toxicity or other reason to come off|0
494319|NCT01042288|1208266|P1|Maintenance|Overall Study||27
494320|NCT01042288|1208266|P1|STARTED|Overall Study||69
494321|NCT01042236|1208274|P6|NOT COMPLETED|Treatment Period 3||0
494322|NCT01042236|1208275|P5|NOT COMPLETED|Treatment Period 3||0
494323|NCT01042236|1208276|P4|NOT COMPLETED|Treatment Period 3||2
494324|NCT01042236|1208277|P3|NOT COMPLETED|Treatment Period 3||0
494325|NCT01042236|1208278|P2|NOT COMPLETED|Treatment Period 3||0
494326|NCT01042236|1208279|P1|NOT COMPLETED|Treatment Period 3||0
494327|NCT01042236|1208274|P6|COMPLETED|Treatment Period 3||3
494328|NCT01042236|1208275|P5|COMPLETED|Treatment Period 3||3
494329|NCT01042236|1208276|P4|COMPLETED|Treatment Period 3||3
494330|NCT01042236|1208277|P3|COMPLETED|Treatment Period 3||3
494331|NCT01042236|1208278|P2|COMPLETED|Treatment Period 3||3
494332|NCT01042236|1208279|P1|COMPLETED|Treatment Period 3||3
494333|NCT01042236|1208274|P6|STARTED|Treatment Period 3||3
494334|NCT01042236|1208275|P5|STARTED|Treatment Period 3||3
494335|NCT01042236|1208276|P4|STARTED|Treatment Period 3||5
494336|NCT01042236|1208277|P3|STARTED|Treatment Period 3||3
494337|NCT01042236|1208278|P2|STARTED|Treatment Period 3||3
494338|NCT01042236|1208279|P1|STARTED|Treatment Period 3||3
494339|NCT01042236|1208274|P6|NOT COMPLETED|Treatment Period 2||0
494340|NCT01042236|1208275|P5|NOT COMPLETED|Treatment Period 2||0
494341|NCT01042236|1208276|P4|NOT COMPLETED|Treatment Period 2||0
494342|NCT01042236|1208277|P3|NOT COMPLETED|Treatment Period 2||0
494343|NCT01042236|1208278|P2|NOT COMPLETED|Treatment Period 2||0
494344|NCT01042236|1208279|P1|NOT COMPLETED|Treatment Period 2||0
494345|NCT01042236|1208274|P6|COMPLETED|Treatment Period 2||3
494346|NCT01042236|1208275|P5|COMPLETED|Treatment Period 2||3
494347|NCT01042236|1208276|P4|COMPLETED|Treatment Period 2||5
494348|NCT01042236|1208277|P3|COMPLETED|Treatment Period 2||3
494349|NCT01042236|1208278|P2|COMPLETED|Treatment Period 2||3
494350|NCT01042236|1208279|P1|COMPLETED|Treatment Period 2||3
494351|NCT01042236|1208274|P6|STARTED|Treatment Period 2||3
494352|NCT01042236|1208275|P5|STARTED|Treatment Period 2||3
494353|NCT01042236|1208276|P4|STARTED|Treatment Period 2||5
494354|NCT01042236|1208277|P3|STARTED|Treatment Period 2||3
494355|NCT01042236|1208278|P2|STARTED|Treatment Period 2||3
494356|NCT01042236|1208279|P1|STARTED|Treatment Period 2||3
494357|NCT01042236|1208274|P6|NOT COMPLETED|Treatment Period 1||0
494358|NCT01042236|1208275|P5|NOT COMPLETED|Treatment Period 1||1
494359|NCT01042236|1208276|P4|NOT COMPLETED|Treatment Period 1||0
494360|NCT01042236|1208277|P3|NOT COMPLETED|Treatment Period 1||0
494361|NCT01042236|1208278|P2|NOT COMPLETED|Treatment Period 1||1
494362|NCT01042236|1208279|P1|NOT COMPLETED|Treatment Period 1||0
494363|NCT01042236|1208274|P6|COMPLETED|Treatment Period 1||3
494364|NCT01042236|1208275|P5|COMPLETED|Treatment Period 1||3
494365|NCT01042236|1208276|P4|COMPLETED|Treatment Period 1||5
494366|NCT01042236|1208277|P3|COMPLETED|Treatment Period 1||3
494367|NCT01042236|1208278|P2|COMPLETED|Treatment Period 1||3
494368|NCT01042236|1208279|P1|COMPLETED|Treatment Period 1||3
494369|NCT01042236|1208274|P6|STARTED|Treatment Period 1||3
494370|NCT01042236|1208275|P5|STARTED|Treatment Period 1||4
494371|NCT01042236|1208276|P4|STARTED|Treatment Period 1||5
494372|NCT01042236|1208277|P3|STARTED|Treatment Period 1||3
494373|NCT01042236|1208278|P2|STARTED|Treatment Period 1||4
494374|NCT01042236|1208279|P1|STARTED|Treatment Period 1||3
494375|NCT01042158|1208316|P1|NOT COMPLETED|Overall Study||1
494376|NCT01042158|1208316|P1|COMPLETED|Overall Study||24
494377|NCT01042158|1208316|P1|STARTED|Overall Study||25
494378|NCT01042145|1208325|P2|NOT COMPLETED|Overall Study||1
494379|NCT01042145|1208326|P1|NOT COMPLETED|Overall Study||1
494380|NCT01042145|1208325|P2|COMPLETED|Overall Study||45
494381|NCT01042145|1208326|P1|COMPLETED|Overall Study||40
494382|NCT01042145|1208325|P2|STARTED|Overall Study||46
494383|NCT01042145|1208326|P1|STARTED|Overall Study||41
494384|NCT01042093|1208346|P4|NOT COMPLETED|Overall Study||4
494385|NCT01042093|1208347|P3|NOT COMPLETED|Overall Study||2
494386|NCT01042093|1208348|P2|NOT COMPLETED|Overall Study||2
494387|NCT01042093|1208349|P1|NOT COMPLETED|Overall Study||2
494388|NCT01042093|1208346|P4|COMPLETED|Overall Study||36
494389|NCT01042093|1208347|P3|COMPLETED|Overall Study||38
494390|NCT01042093|1208348|P2|COMPLETED|Overall Study||38
494391|NCT01042093|1208349|P1|COMPLETED|Overall Study||38
494392|NCT01042093|1208346|P4|STARTED|Overall Study||40
494393|NCT01042093|1208347|P3|STARTED|Overall Study||40
494394|NCT01042093|1208348|P2|STARTED|Overall Study||40
494395|NCT01042093|1208349|P1|STARTED|Overall Study||40
494396|NCT01041976|1208369|P2|NOT COMPLETED|Overall Study||4
494397|NCT01041976|1208370|P1|NOT COMPLETED|Overall Study||5
494398|NCT01041976|1208369|P2|COMPLETED|Overall Study||38
494399|NCT01041976|1208370|P1|COMPLETED|Overall Study||37
494400|NCT01041976|1208369|P2|18 Month Follow-up|Overall Study||38
494401|NCT01041976|1208370|P1|18 Month Follow-up|Overall Study||37
494402|NCT01041976|1208369|P2|12 Month Follow-up|Overall Study||38
494403|NCT01041976|1208370|P1|12 Month Follow-up|Overall Study||37
494404|NCT01041976|1208369|P2|6 Month Follow-up|Overall Study||41
494405|NCT01041976|1208370|P1|6 Month Follow-up|Overall Study||39
494406|NCT01041976|1208369|P2|STARTED|Overall Study||42
494407|NCT01041976|1208370|P1|STARTED|Overall Study||42
494408|NCT01041859|1208380|P3|NOT COMPLETED|Double-Blind Maintenance||45
494409|NCT01041859|1208381|P2|NOT COMPLETED|Double-Blind Maintenance||46
494410|NCT01041859|1208382|P1|NOT COMPLETED|Double-Blind Maintenance||0
494411|NCT01041859|1208380|P3|COMPLETED|Double-Blind Maintenance||107
494412|NCT01041859|1208381|P2|COMPLETED|Double-Blind Maintenance||120
494413|NCT01041859|1208382|P1|COMPLETED|Double-Blind Maintenance||0
494414|NCT01041859|1208380|P3|STARTED|Double-Blind Maintenance|152 randomized, all were treated.|152
494415|NCT01041859|1208381|P2|STARTED|Double-Blind Maintenance|168 were randomized, 2 were not treated (1 randomized in error, 1 withdrew consent).|166
494416|NCT01041859|1208382|P1|STARTED|Double-Blind Maintenance||0
494417|NCT01041859|1208380|P3|NOT COMPLETED|Open-Label Titration||0
494418|NCT01041859|1208381|P2|NOT COMPLETED|Open-Label Titration||0
494419|NCT01041859|1208382|P1|NOT COMPLETED|Open-Label Titration||101
494420|NCT01041859|1208380|P3|COMPLETED|Open-Label Titration||0
494421|NCT01041859|1208381|P2|COMPLETED|Open-Label Titration||0
494422|NCT01041859|1208382|P1|COMPLETED|Open-Label Titration|Of 358 completed subjects, 320 were randomized to the Double-Blind Maintenance Period.|358
494423|NCT01041859|1208380|P3|STARTED|Open-Label Titration||0
494424|NCT01041859|1208381|P2|STARTED|Open-Label Titration||0
494425|NCT01041859|1208382|P1|STARTED|Open-Label Titration|Of 460 total enrollment, one subject enrolled twice; this subject's second enrollment is excluded.|459
494426|NCT01041638|1208397|P1|NOT COMPLETED|Overall Study||27
494427|NCT01041638|1208397|P1|COMPLETED|Overall Study||78
494428|NCT01041638|1208397|P1|STARTED|Overall Study||105
494429|NCT01041573|1208405|P4|NOT COMPLETED|Overall Study||2
494430|NCT01041573|1208406|P3|NOT COMPLETED|Overall Study||7
494431|NCT01041573|1208407|P2|NOT COMPLETED|Overall Study||13
494432|NCT01041573|1208408|P1|NOT COMPLETED|Overall Study||5
494433|NCT01041573|1208405|P4|COMPLETED|Overall Study||62
494434|NCT01041573|1208406|P3|COMPLETED|Overall Study||387
494435|NCT01041573|1208407|P2|COMPLETED|Overall Study||858
494436|NCT01041573|1208408|P1|COMPLETED|Overall Study||535
494437|NCT01041573|1208405|P4|STARTED|Overall Study||64
494438|NCT01041573|1208406|P3|STARTED|Overall Study||394
494439|NCT01041573|1208407|P2|STARTED|Overall Study||871
494440|NCT01041573|1208408|P1|STARTED|Overall Study||540
494441|NCT01041417|1208420|P2|NOT COMPLETED|Overall Study||3
494442|NCT01041417|1208421|P1|NOT COMPLETED|Overall Study||7
494443|NCT01041417|1208420|P2|COMPLETED|Overall Study||76
494444|NCT01041417|1208421|P1|COMPLETED|Overall Study||73
494445|NCT01041417|1208420|P2|STARTED|Overall Study||79
494446|NCT01041417|1208421|P1|STARTED|Overall Study||80
494447|NCT01041404|1208459|P2|NOT COMPLETED|Overall Study||294
494448|NCT01041404|1208460|P1|NOT COMPLETED|Overall Study||290
494449|NCT01041404|1208459|P2|COMPLETED|Overall Study|Summary of withdrawals represents withdrawals from treatment, rather than withdrawals from study.|0
494450|NCT01041404|1208460|P1|COMPLETED|Overall Study|Summary of withdrawals represents withdrawals from treatment, rather than withdrawals from study.|0
494451|NCT01041404|1208459|P2|Alive in Follow-up|Overall Study||41
494452|NCT01041404|1208460|P1|Alive in Follow-up|Overall Study||40
494453|NCT01041404|1208459|P2|Lost to Follow-up|Overall Study||10
494454|NCT01041404|1208460|P1|Lost to Follow-up|Overall Study||12
494455|NCT01041404|1208459|P2|Died in Follow-up|Overall Study||200
494456|NCT01041404|1208460|P1|Died in Follow-up|Overall Study||199
494457|NCT01041404|1208459|P2|Entered Follow-Up|Overall Study||251
494458|NCT01041404|1208460|P1|Entered Follow-Up|Overall Study||251
494459|NCT01041404|1208459|P2|STARTED|Overall Study||294
494460|NCT01041404|1208460|P1|STARTED|Overall Study||290
494461|NCT01041287|1208501|P2|NOT COMPLETED|Treatment Period 2 (3 Months)||5
494462|NCT01041287|1208502|P1|NOT COMPLETED|Treatment Period 2 (3 Months)||3
494463|NCT01041287|1208501|P2|COMPLETED|Treatment Period 2 (3 Months)||14
494464|NCT01041287|1208502|P1|COMPLETED|Treatment Period 2 (3 Months)||16
494465|NCT01041287|1208501|P2|STARTED|Treatment Period 2 (3 Months)||19
494466|NCT01041287|1208502|P1|STARTED|Treatment Period 2 (3 Months)||19
494467|NCT01041287|1208501|P2|NOT COMPLETED|Treatment Period 1 (3 Months)||0
494468|NCT01041287|1208502|P1|NOT COMPLETED|Treatment Period 1 (3 Months)||0
494469|NCT01041287|1208501|P2|COMPLETED|Treatment Period 1 (3 Months)||19
494470|NCT01041287|1208502|P1|COMPLETED|Treatment Period 1 (3 Months)||19
494471|NCT01041287|1208501|P2|STARTED|Treatment Period 1 (3 Months)||19
494472|NCT01041287|1208502|P1|STARTED|Treatment Period 1 (3 Months)||19
494473|NCT01041209|1208514|P2|NOT COMPLETED|Overall Study||0
494474|NCT01041209|1208515|P1|NOT COMPLETED|Overall Study||0
494475|NCT01041209|1208514|P2|COMPLETED|Overall Study||60
494476|NCT01041209|1208515|P1|COMPLETED|Overall Study||60
494477|NCT01041209|1208514|P2|STARTED|Overall Study||60
494478|NCT01041209|1208515|P1|STARTED|Overall Study||60
494479|NCT01040871|1208525|P2|NOT COMPLETED|Overall Study||7
494480|NCT01040871|1208526|P1|NOT COMPLETED|Overall Study||13
494481|NCT01040871|1208525|P2|COMPLETED|Overall Study||73
494482|NCT01040871|1208526|P1|COMPLETED|Overall Study||71
494483|NCT01040871|1208525|P2|STARTED|Overall Study|Intent to Treat, Randomized|80
494484|NCT01040871|1208526|P1|STARTED|Overall Study|Intent to Treat, Randomized|84
494485|NCT01040858|1208546|P2|NOT COMPLETED|Overall Study||0
494486|NCT01040858|1208547|P1|NOT COMPLETED|Overall Study||9
494487|NCT01040858|1208546|P2|COMPLETED|Overall Study||69
494488|NCT01040858|1208547|P1|COMPLETED|Overall Study||50
494489|NCT01040858|1208546|P2|STARTED|Overall Study||69
494490|NCT01040858|1208547|P1|STARTED|Overall Study||59
494491|NCT01040845|1208577|P2|NOT COMPLETED|Overall Study||1
494492|NCT01040845|1208578|P1|NOT COMPLETED|Overall Study||2
494493|NCT01040845|1208577|P2|COMPLETED|Overall Study|withdrew consent due to schedule conflict (1)|14
494494|NCT01040845|1208578|P1|COMPLETED|Overall Study|withdrew consent due to schedule conflict (1); dropped by physician due to positive drug screen (1)|13
494495|NCT01040845|1208577|P2|STARTED|Overall Study||15
494496|NCT01040845|1208578|P1|STARTED|Overall Study||15
494497|NCT01040832|1208593|P2|NOT COMPLETED|Overall Study||37
494498|NCT01040832|1208594|P1|NOT COMPLETED|Overall Study||46
494499|NCT01040832|1208593|P2|COMPLETED|Overall Study||16
494500|NCT01040832|1208594|P1|COMPLETED|Overall Study||8
494501|NCT01040832|1208593|P2|STARTED|Overall Study||53
494502|NCT01040832|1208594|P1|STARTED|Overall Study|One participant was treated with study drug 'Cetuximab Plus EMD 1201081' but was not randomized|54
494503|NCT01040819|1208610|P2|NOT COMPLETED|Overall Study||0
494504|NCT01040819|1208611|P1|NOT COMPLETED|Overall Study||0
494505|NCT01040819|1208610|P2|COMPLETED|Overall Study||12
494506|NCT01040819|1208611|P1|COMPLETED|Overall Study||13
494507|NCT01040819|1208610|P2|STARTED|Overall Study||12
494508|NCT01040819|1208611|P1|STARTED|Overall Study||13
494509|NCT01040793|1208617|P6|NOT COMPLETED|Overall Study||1
494510|NCT01040793|1208618|P5|NOT COMPLETED|Overall Study||4
494511|NCT01040793|1208619|P4|NOT COMPLETED|Overall Study||4
494512|NCT01040793|1208620|P3|NOT COMPLETED|Overall Study||3
494513|NCT01040793|1208621|P2|NOT COMPLETED|Overall Study||5
494514|NCT01040793|1208622|P1|NOT COMPLETED|Overall Study||6
494515|NCT01040793|1208617|P6|COMPLETED|Overall Study||26
494516|NCT01040793|1208618|P5|COMPLETED|Overall Study||22
494517|NCT01040793|1208619|P4|COMPLETED|Overall Study||22
494518|NCT01040793|1208620|P3|COMPLETED|Overall Study||23
494519|NCT01040793|1208621|P2|COMPLETED|Overall Study||21
494520|NCT01040793|1208622|P1|COMPLETED|Overall Study||20
494521|NCT01040793|1208617|P6|STARTED|Overall Study||27
494522|NCT01040793|1208618|P5|STARTED|Overall Study||26
494523|NCT01040793|1208619|P4|STARTED|Overall Study||26
494524|NCT01040793|1208620|P3|STARTED|Overall Study||26
494525|NCT01040793|1208621|P2|STARTED|Overall Study||26
494526|NCT01040793|1208622|P1|STARTED|Overall Study|Entered and treated|26
494527|NCT01040780|1208701|P2|NOT COMPLETED|Overall Study||3
494528|NCT01040780|1208702|P1|NOT COMPLETED|Overall Study||1
494529|NCT01040780|1208701|P2|COMPLETED|Overall Study||196
494530|NCT01040780|1208702|P1|COMPLETED|Overall Study||199
494531|NCT01040780|1208701|P2|STARTED|Overall Study||199
494532|NCT01040780|1208702|P1|STARTED|Overall Study||200
494533|NCT01040728|1208716|P4|NOT COMPLETED|Overall Study||6
494534|NCT01040728|1208717|P3|NOT COMPLETED|Overall Study||1
494535|NCT01040728|1208718|P2|NOT COMPLETED|Overall Study||11
494536|NCT01040728|1208719|P1|NOT COMPLETED|Overall Study||4
494537|NCT01040728|1208716|P4|COMPLETED|Overall Study||24
494538|NCT01040728|1208717|P3|COMPLETED|Overall Study||30
494539|NCT01040728|1208718|P2|COMPLETED|Overall Study||19
494540|NCT01040728|1208719|P1|COMPLETED|Overall Study||27
494541|NCT01040728|1208716|P4|STARTED|Overall Study||30
494542|NCT01040728|1208717|P3|STARTED|Overall Study||31
494543|NCT01040728|1208718|P2|STARTED|Overall Study||30
494544|NCT01040728|1208719|P1|STARTED|Overall Study||31
494545|NCT01040689|1208789|P4|NOT COMPLETED|Overall Study||4
494546|NCT01040689|1208790|P3|NOT COMPLETED|Overall Study||4
494547|NCT01040689|1208791|P2|NOT COMPLETED|Overall Study||2
494548|NCT01040689|1208792|P1|NOT COMPLETED|Overall Study||3
494549|NCT01040689|1208789|P4|COMPLETED|Overall Study||23
494550|NCT01040689|1208790|P3|COMPLETED|Overall Study||23
494551|NCT01040689|1208791|P2|COMPLETED|Overall Study||25
494552|NCT01040689|1208792|P1|COMPLETED|Overall Study||24
494553|NCT01040689|1208789|P4|STARTED|Overall Study||27
494554|NCT01040689|1208790|P3|STARTED|Overall Study||27
494555|NCT01040689|1208791|P2|STARTED|Overall Study||27
494556|NCT01040689|1208792|P1|STARTED|Overall Study||27
494563|NCT01040403|1208871|P1|NOT COMPLETED|Overall Study||20
494564|NCT01040403|1208871|P1|COMPLETED|Overall Study|All treatment periods|213
494565|NCT01040403|1208871|P1|Completed T+O 5/10|Overall Study||107
494566|NCT01040403|1208871|P1|Completed T+O 2.5/10|Overall Study||110
494567|NCT01040403|1208871|P1|Completed T+O 1.25/10|Overall Study||106
494568|NCT01040403|1208871|P1|Completed Olo 10|Overall Study||109
494569|NCT01040403|1208871|P1|Completed T+O 5/5|Overall Study||106
494570|NCT01040403|1208871|P1|Completed T+O 2.5/5|Overall Study||111
494571|NCT01040403|1208871|P1|Completed T+O 1.25/5|Overall Study||105
494572|NCT01040403|1208871|P1|Completed Olo 5|Overall Study||106
494573|NCT01040403|1208871|P1|STARTED|Overall Study||233
494574|NCT01040351|1209059|P2|NOT COMPLETED|Overall Study||2
494575|NCT01040351|1209060|P1|NOT COMPLETED|Overall Study||1
494576|NCT01040351|1209059|P2|COMPLETED|Overall Study|May 2010|53
494577|NCT01040351|1209060|P1|COMPLETED|Overall Study|May 2010|54
494578|NCT01040351|1209059|P2|STARTED|Overall Study|October 2006|55
494579|NCT01040351|1209060|P1|STARTED|Overall Study|October 2006|55
494580|NCT01040260|1209070|P2|NOT COMPLETED|Overall Study||11
494581|NCT01040260|1209071|P1|NOT COMPLETED|Overall Study||15
494582|NCT01040260|1209070|P2|COMPLETED|Overall Study||39
494583|NCT01040260|1209071|P1|COMPLETED|Overall Study||38
494584|NCT01040260|1209070|P2|STARTED|Overall Study||50
494585|NCT01040260|1209071|P1|STARTED|Overall Study||53
494586|NCT01040208|1209080|P3|NOT COMPLETED|Overall Study||3
494587|NCT01040208|1209081|P2|NOT COMPLETED|Overall Study||13
494588|NCT01040208|1209082|P1|NOT COMPLETED|Overall Study||6
494589|NCT01040208|1209080|P3|COMPLETED|Overall Study||35
494590|NCT01040208|1209081|P2|COMPLETED|Overall Study||15
494591|NCT01040208|1209082|P1|COMPLETED|Overall Study||39
494592|NCT01040208|1209080|P3|STARTED|Overall Study||38
494593|NCT01040208|1209081|P2|STARTED|Overall Study||28
494594|NCT01040208|1209082|P1|STARTED|Overall Study||45
494595|NCT01040169|1209098|P2|NOT COMPLETED|Overall Study||8
494596|NCT01040169|1209099|P1|NOT COMPLETED|Overall Study||3
494597|NCT01040169|1209098|P2|COMPLETED|Overall Study||36
494598|NCT01040169|1209099|P1|COMPLETED|Overall Study||32
494599|NCT01040169|1209098|P2|STARTED|Overall Study||44
494600|NCT01040169|1209099|P1|STARTED|Overall Study||35
494601|NCT01040130|1209107|P6|NOT COMPLETED|Overall Study||4
494602|NCT01040130|1209108|P5|NOT COMPLETED|Overall Study||0
494603|NCT01040130|1209109|P4|NOT COMPLETED|Overall Study||5
494604|NCT01040130|1209110|P3|NOT COMPLETED|Overall Study||2
494605|NCT01040130|1209111|P2|NOT COMPLETED|Overall Study||3
494606|NCT01040130|1209112|P1|NOT COMPLETED|Overall Study||3
494607|NCT01040130|1209107|P6|COMPLETED|Overall Study||22
494608|NCT01040130|1209108|P5|COMPLETED|Overall Study||25
494609|NCT01040130|1209109|P4|COMPLETED|Overall Study||20
494610|NCT01040130|1209110|P3|COMPLETED|Overall Study||23
494611|NCT01040130|1209111|P2|COMPLETED|Overall Study||22
494612|NCT01040130|1209112|P1|COMPLETED|Overall Study|Number of patients who did not discontinue from the trial.|22
494613|NCT01040130|1209107|P6|STARTED|Overall Study||26
494614|NCT01040130|1209108|P5|STARTED|Overall Study||25
494615|NCT01040130|1209109|P4|STARTED|Overall Study||25
494616|NCT01040130|1209110|P3|STARTED|Overall Study||25
494617|NCT01040130|1209111|P2|STARTED|Overall Study||25
494618|NCT01040130|1209112|P1|STARTED|Overall Study|Number of patients entered and treated|25
494619|NCT01040052|1209189|P1|NOT COMPLETED|Overall Study||0
494620|NCT01040052|1209189|P1|COMPLETED|Overall Study||30
494621|NCT01040052|1209189|P1|STARTED|Overall Study||30
494622|NCT01039792|1209195|P2|NOT COMPLETED|Overall Study||1
494623|NCT01039792|1209196|P1|NOT COMPLETED|Overall Study||6
494624|NCT01039792|1209195|P2|COMPLETED|Overall Study||27
494625|NCT01039792|1209196|P1|COMPLETED|Overall Study||23
494626|NCT01039792|1209195|P2|STARTED|Overall Study||28
494627|NCT01039792|1209196|P1|STARTED|Overall Study||29
494628|NCT01039688|1209205|P3|NOT COMPLETED|Overall Study||80
494629|NCT01039688|1209206|P2|NOT COMPLETED|Overall Study||111
494630|NCT01039688|1209207|P1|NOT COMPLETED|Overall Study||107
494631|NCT01039688|1209205|P3|COMPLETED|Overall Study||106
494632|NCT01039688|1209206|P2|COMPLETED|Overall Study||286
494633|NCT01039688|1209207|P1|COMPLETED|Overall Study||266
494634|NCT01039688|1209205|P3|STARTED|Overall Study||186
494635|NCT01039688|1209206|P2|STARTED|Overall Study||397
494636|NCT01039688|1209207|P1|STARTED|Overall Study||373
494637|NCT01039675|1209478|P2|NOT COMPLETED|Overall Study||7
494638|NCT01039675|1209479|P1|NOT COMPLETED|Overall Study||0
494639|NCT01039675|1209478|P2|COMPLETED|Overall Study||35
494640|NCT01039675|1209479|P1|COMPLETED|Overall Study||9
494641|NCT01039675|1209478|P2|STARTED|Overall Study||42
494642|NCT01039675|1209479|P1|STARTED|Overall Study||9
494643|NCT01039584|1209492|P3|NOT COMPLETED|Overall Study||57
494644|NCT01039584|1209493|P2|NOT COMPLETED|Overall Study||97
494645|NCT01039584|1209494|P1|NOT COMPLETED|Overall Study||103
494646|NCT01039584|1209492|P3|COMPLETED|Overall Study||65
494647|NCT01039584|1209493|P2|COMPLETED|Overall Study||146
494648|NCT01039584|1209494|P1|COMPLETED|Overall Study||143
494649|NCT01039584|1209492|P3|STARTED|Overall Study||122
494650|NCT01039584|1209493|P2|STARTED|Overall Study||243
494651|NCT01039584|1209494|P1|STARTED|Overall Study||246
494652|NCT01039519|1209508|P1|NOT COMPLETED|Survival Follow-up||27
494653|NCT01039519|1209508|P1|COMPLETED|Survival Follow-up||0
494654|NCT01039519|1209508|P1|STARTED|Survival Follow-up||27
494655|NCT01039519|1209508|P1|NOT COMPLETED|Treatment||27
494656|NCT01039519|1209508|P1|COMPLETED|Treatment|Reason not completed represents reason for terminating treatment.|0
494657|NCT01039519|1209508|P1|STARTED|Treatment||27
494658|NCT01039428|1209519|P2|NOT COMPLETED|Overall Study||0
494659|NCT01039428|1209520|P1|NOT COMPLETED|Overall Study||2
494660|NCT01039428|1209519|P2|COMPLETED|Overall Study||28
494661|NCT01039428|1209520|P1|COMPLETED|Overall Study||33
494662|NCT01039428|1209519|P2|STARTED|Overall Study||28
494663|NCT01039428|1209520|P1|STARTED|Overall Study||35
494664|NCT01039376|1209544|P2|NOT COMPLETED|Overall Study||202
494665|NCT01039376|1209545|P1|NOT COMPLETED|Overall Study||206
494666|NCT01039376|1209544|P2|COMPLETED|Overall Study||34
494667|NCT01039376|1209545|P1|COMPLETED|Overall Study||32
494668|NCT01039376|1209544|P2|Ongoing|Overall Study||182
494669|NCT01039376|1209545|P1|Ongoing|Overall Study||189
494670|NCT01039376|1209544|P2|STARTED|Overall Study||236
494671|NCT01039376|1209545|P1|STARTED|Overall Study||238
494672|NCT01039207|1209603|P1|NOT COMPLETED|Overall Study||0
494673|NCT01039207|1209603|P1|COMPLETED|Overall Study||31
494674|NCT01039207|1209603|P1|STARTED|Overall Study||31
494675|NCT01038921|1209613|P2|NOT COMPLETED|Overall Study||0
494676|NCT01038921|1209614|P1|NOT COMPLETED|Overall Study||2
494677|NCT01038921|1209613|P2|COMPLETED|Overall Study||20
494678|NCT01038921|1209614|P1|COMPLETED|Overall Study|2 subjects withdrew|17
494679|NCT01038921|1209613|P2|STARTED|Overall Study|20 subjects received placebo first (10 weeks), washout (6 weeks), melatonin second ( 10 weeks)|20
494680|NCT01038921|1209614|P1|STARTED|Overall Study|19 subjects received melatonin first(10 weeks), washout (6 weeks), placebo second (10 weeks)|19
494681|NCT01038869|1209620|P1|NOT COMPLETED|Overall Study||7
494682|NCT01038869|1209620|P1|COMPLETED|Overall Study||13
494683|NCT01038869|1209620|P1|STARTED|Overall Study||20
494684|NCT01038856|1209628|P1|NOT COMPLETED|Overall Study||2
494685|NCT01038856|1209628|P1|COMPLETED|Overall Study||3
494686|NCT01038856|1209628|P1|STARTED|Overall Study||5
494687|NCT01038752|1209637|P2|NOT COMPLETED|Overall Study||5
494688|NCT01038752|1209638|P1|NOT COMPLETED|Overall Study||5
494689|NCT01038752|1209637|P2|COMPLETED|Overall Study||1
494690|NCT01038752|1209638|P1|COMPLETED|Overall Study||3
494691|NCT01038752|1209637|P2|STARTED|Overall Study||6
494692|NCT01038752|1209638|P1|STARTED|Overall Study||8
494693|NCT01038713|1209661|P3|NOT COMPLETED|Overall Study||1
494694|NCT01038713|1209662|P2|NOT COMPLETED|Overall Study||3
494695|NCT01038713|1209663|P1|NOT COMPLETED|Overall Study||5
494696|NCT01038713|1209661|P3|COMPLETED|Overall Study||16
494697|NCT01038713|1209662|P2|COMPLETED|Overall Study||17
494698|NCT01038713|1209663|P1|COMPLETED|Overall Study||21
494699|NCT01038713|1209661|P3|STARTED|Overall Study||17
494700|NCT01038713|1209662|P2|STARTED|Overall Study||20
494701|NCT01038713|1209663|P1|STARTED|Overall Study||26
494702|NCT01038635|1209692|P9|NOT COMPLETED|Overall Study||2
494703|NCT01038635|1209693|P8|NOT COMPLETED|Overall Study||5
494704|NCT01038635|1209694|P7|NOT COMPLETED|Overall Study||2
494705|NCT01038635|1209695|P6|NOT COMPLETED|Overall Study||0
494706|NCT01038635|1209696|P5|NOT COMPLETED|Overall Study||1
494707|NCT01038635|1209697|P4|NOT COMPLETED|Overall Study||0
494708|NCT01038635|1209698|P3|NOT COMPLETED|Overall Study||0
494709|NCT01038635|1209699|P2|NOT COMPLETED|Overall Study||0
494710|NCT01038635|1209700|P1|NOT COMPLETED|Overall Study||2
494711|NCT01038635|1209692|P9|COMPLETED|Overall Study||38
494712|NCT01038635|1209693|P8|COMPLETED|Overall Study||15
494713|NCT01038635|1209694|P7|COMPLETED|Overall Study||5
494714|NCT01038635|1209695|P6|COMPLETED|Overall Study||3
494715|NCT01038635|1209696|P5|COMPLETED|Overall Study||3
494716|NCT01038635|1209697|P4|COMPLETED|Overall Study||3
494717|NCT01038635|1209698|P3|COMPLETED|Overall Study||3
494718|NCT01038635|1209699|P2|COMPLETED|Overall Study||3
494719|NCT01038635|1209700|P1|COMPLETED|Overall Study||3
494720|NCT01038635|1209692|P9|STARTED|Overall Study||40
494721|NCT01038635|1209693|P8|STARTED|Overall Study||20
494722|NCT01038635|1209694|P7|STARTED|Overall Study||7
494723|NCT01038635|1209695|P6|STARTED|Overall Study||3
494724|NCT01038635|1209696|P5|STARTED|Overall Study||4
494725|NCT01038635|1209697|P4|STARTED|Overall Study||3
494726|NCT01038635|1209698|P3|STARTED|Overall Study||3
494727|NCT01038635|1209699|P2|STARTED|Overall Study||3
494728|NCT01038635|1209700|P1|STARTED|Overall Study||5
494729|NCT01038609|1209726|P5|NOT COMPLETED|Overall Study||1
494730|NCT01038609|1209727|P4|NOT COMPLETED|Overall Study||1
494731|NCT01038609|1209728|P3|NOT COMPLETED|Overall Study||1
494732|NCT01038609|1209729|P2|NOT COMPLETED|Overall Study||1
494733|NCT01038609|1209730|P1|NOT COMPLETED|Overall Study||1
494734|NCT01038609|1209726|P5|COMPLETED|Overall Study||50
494735|NCT01038609|1209727|P4|COMPLETED|Overall Study||47
494736|NCT01038609|1209728|P3|COMPLETED|Overall Study||48
494737|NCT01038609|1209729|P2|COMPLETED|Overall Study||51
494738|NCT01038609|1209730|P1|COMPLETED|Overall Study||49
494739|NCT01038609|1209726|P5|STARTED|Overall Study||51
494740|NCT01038609|1209727|P4|STARTED|Overall Study||48
494741|NCT01038609|1209728|P3|STARTED|Overall Study||49
494742|NCT01038609|1209729|P2|STARTED|Overall Study||52
494743|NCT01038609|1209730|P1|STARTED|Overall Study||50
494744|NCT01038336|1209775|P3|NOT COMPLETED|Overall Study||0
494745|NCT01038336|1209776|P2|NOT COMPLETED|Overall Study||0
494746|NCT01038336|1209777|P1|NOT COMPLETED|Overall Study||0
494747|NCT01038336|1209775|P3|COMPLETED|Overall Study||44
494748|NCT01038336|1209776|P2|COMPLETED|Overall Study||42
494749|NCT01038336|1209777|P1|COMPLETED|Overall Study||43
494750|NCT01038336|1209775|P3|STARTED|Overall Study||44
494751|NCT01038336|1209776|P2|STARTED|Overall Study||42
494752|NCT01038336|1209777|P1|STARTED|Overall Study||43
494753|NCT01038323|1209809|P3|NOT COMPLETED|Overall Study||4
494754|NCT01038323|1209810|P2|NOT COMPLETED|Overall Study||2
494755|NCT01038323|1209811|P1|NOT COMPLETED|Overall Study||3
494756|NCT01038323|1209809|P3|COMPLETED|Overall Study||15
494757|NCT01038323|1209810|P2|COMPLETED|Overall Study||17
494758|NCT01038323|1209811|P1|COMPLETED|Overall Study||17
494759|NCT01038323|1209809|P3|STARTED|Overall Study||19
494760|NCT01038323|1209810|P2|STARTED|Overall Study||19
494761|NCT01038323|1209811|P1|STARTED|Overall Study||20
494762|NCT01038128|1209825|P1|NOT COMPLETED|Overall Study||4
494763|NCT01038128|1209825|P1|COMPLETED|Overall Study||1
494764|NCT01038128|1209825|P1|Baseline Visit|Overall Study||3
494765|NCT01038128|1209825|P1|STARTED|Overall Study||5
494766|NCT01037452|1209837|P4|NOT COMPLETED|Overall Study||0
494767|NCT01037452|1209838|P3|NOT COMPLETED|Overall Study||0
494768|NCT01037452|1209839|P2|NOT COMPLETED|Overall Study||0
494769|NCT01037452|1209840|P1|NOT COMPLETED|Overall Study||0
494770|NCT01037452|1209837|P4|COMPLETED|Overall Study||30
494771|NCT01037452|1209838|P3|COMPLETED|Overall Study||30
494772|NCT01037452|1209839|P2|COMPLETED|Overall Study||30
494773|NCT01037452|1209840|P1|COMPLETED|Overall Study||30
494774|NCT01037452|1209837|P4|STARTED|Overall Study||30
494775|NCT01037452|1209838|P3|STARTED|Overall Study||30
494776|NCT01037452|1209839|P2|STARTED|Overall Study||30
494777|NCT01037452|1209840|P1|STARTED|Overall Study||30
494778|NCT01037309|1209868|P9|NOT COMPLETED|Intravenous Period 7 - 9||0
494779|NCT01037309|1209869|P8|NOT COMPLETED|Intravenous Period 7 - 9||0
494780|NCT01037309|1209870|P7|NOT COMPLETED|Intravenous Period 7 - 9||0
494781|NCT01037309|1209871|P6|NOT COMPLETED|Intravenous Period 7 - 9||0
494782|NCT01037309|1209872|P5|NOT COMPLETED|Intravenous Period 7 - 9||0
494783|NCT01037309|1209873|P4|NOT COMPLETED|Intravenous Period 7 - 9||0
494784|NCT01037309|1209874|P3|NOT COMPLETED|Intravenous Period 7 - 9||0
494785|NCT01037309|1209875|P2|NOT COMPLETED|Intravenous Period 7 - 9||0
494786|NCT01037309|1209876|P1|NOT COMPLETED|Intravenous Period 7 - 9||0
494787|NCT01037309|1209868|P9|COMPLETED|Intravenous Period 7 - 9||3
494788|NCT01037309|1209869|P8|COMPLETED|Intravenous Period 7 - 9||3
494789|NCT01037309|1209870|P7|COMPLETED|Intravenous Period 7 - 9||3
494790|NCT01037309|1209871|P6|COMPLETED|Intravenous Period 7 - 9||0
494791|NCT01037309|1209872|P5|COMPLETED|Intravenous Period 7 - 9||0
494792|NCT01037309|1209873|P4|COMPLETED|Intravenous Period 7 - 9||0
494793|NCT01037309|1209874|P3|COMPLETED|Intravenous Period 7 - 9||0
494794|NCT01037309|1209875|P2|COMPLETED|Intravenous Period 7 - 9||0
494795|NCT01037309|1209876|P1|COMPLETED|Intravenous Period 7 - 9||0
494796|NCT01037309|1209868|P9|STARTED|Intravenous Period 7 - 9||3
494797|NCT01037309|1209869|P8|STARTED|Intravenous Period 7 - 9||3
494798|NCT01037309|1209870|P7|STARTED|Intravenous Period 7 - 9||3
494799|NCT01037309|1209871|P6|STARTED|Intravenous Period 7 - 9||0
494800|NCT01037309|1209872|P5|STARTED|Intravenous Period 7 - 9||0
494801|NCT01037309|1209873|P4|STARTED|Intravenous Period 7 - 9||0
494802|NCT01037309|1209874|P3|STARTED|Intravenous Period 7 - 9||0
494803|NCT01037309|1209875|P2|STARTED|Intravenous Period 7 - 9||0
494804|NCT01037309|1209876|P1|STARTED|Intravenous Period 7 - 9||0
494805|NCT01037309|1209868|P9|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
494806|NCT01037309|1209869|P8|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
494807|NCT01037309|1209870|P7|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
494808|NCT01037309|1209871|P6|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
494809|NCT01037309|1209872|P5|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
494810|NCT01037309|1209873|P4|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
494811|NCT01037309|1209874|P3|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
494812|NCT01037309|1209875|P2|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
494813|NCT01037309|1209876|P1|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
494814|NCT01037309|1209868|P9|COMPLETED|Subcutaneous Cohort 1 - 6||0
494815|NCT01037309|1209869|P8|COMPLETED|Subcutaneous Cohort 1 - 6||0
494816|NCT01037309|1209870|P7|COMPLETED|Subcutaneous Cohort 1 - 6||0
494817|NCT01037309|1209871|P6|COMPLETED|Subcutaneous Cohort 1 - 6||3
494818|NCT01037309|1209872|P5|COMPLETED|Subcutaneous Cohort 1 - 6||3
494819|NCT01037309|1209873|P4|COMPLETED|Subcutaneous Cohort 1 - 6||3
494820|NCT01037309|1209874|P3|COMPLETED|Subcutaneous Cohort 1 - 6||3
494821|NCT01037309|1209875|P2|COMPLETED|Subcutaneous Cohort 1 - 6||3
494822|NCT01037309|1209876|P1|COMPLETED|Subcutaneous Cohort 1 - 6||3
494823|NCT01037309|1209868|P9|STARTED|Subcutaneous Cohort 1 - 6||0
494824|NCT01037309|1209869|P8|STARTED|Subcutaneous Cohort 1 - 6||0
494825|NCT01037309|1209870|P7|STARTED|Subcutaneous Cohort 1 - 6||0
494826|NCT01037309|1209871|P6|STARTED|Subcutaneous Cohort 1 - 6||3
494827|NCT01037309|1209872|P5|STARTED|Subcutaneous Cohort 1 - 6||3
494828|NCT01037309|1209873|P4|STARTED|Subcutaneous Cohort 1 - 6||3
494829|NCT01037309|1209874|P3|STARTED|Subcutaneous Cohort 1 - 6||3
494830|NCT01037309|1209875|P2|STARTED|Subcutaneous Cohort 1 - 6||3
494831|NCT01037309|1209876|P1|STARTED|Subcutaneous Cohort 1 - 6||3
494832|NCT01037244|1209909|P4|NOT COMPLETED|Overall Study||14
494833|NCT01037244|1209910|P3|NOT COMPLETED|Overall Study||14
494834|NCT01037244|1209911|P2|NOT COMPLETED|Overall Study||14
494835|NCT01037244|1209912|P1|NOT COMPLETED|Overall Study||13
494836|NCT01037244|1209909|P4|COMPLETED|Overall Study||140
494837|NCT01037244|1209910|P3|COMPLETED|Overall Study||144
494838|NCT01037244|1209911|P2|COMPLETED|Overall Study||138
494839|NCT01037244|1209912|P1|COMPLETED|Overall Study||141
494840|NCT01037244|1209909|P4|Safety Population|Overall Study||152
494841|NCT01037244|1209910|P3|Safety Population|Overall Study|Two subjects randomized to receive placebo inadvertently received udenafil (1 - 50 mg and 1- 150 mg)|159
494842|NCT01037244|1209911|P2|Safety Population|Overall Study||150
494843|NCT01037244|1209912|P1|Safety Population|Overall Study|Two subjects randomized to receive placebo inadvertently received udenafil (1 - 50 mg and 1- 150 mg)|155
494844|NCT01037244|1209909|P4|mITT (Modified Intent-to-Treat)|Overall Study||153
494845|NCT01037244|1209910|P3|mITT (Modified Intent-to-Treat)|Overall Study||154
494846|NCT01037244|1209911|P2|mITT (Modified Intent-to-Treat)|Overall Study||148
494847|NCT01037244|1209912|P1|mITT (Modified Intent-to-Treat)|Overall Study||150
494848|NCT01037244|1209909|P4|STARTED|Overall Study||154
494849|NCT01037244|1209910|P3|STARTED|Overall Study||158
494850|NCT01037244|1209911|P2|STARTED|Overall Study||152
494851|NCT01037244|1209912|P1|STARTED|Overall Study||154
494852|NCT01037218|1209974|P4|NOT COMPLETED|Overall Study||16
494853|NCT01037218|1209975|P3|NOT COMPLETED|Overall Study||21
494854|NCT01037218|1209976|P2|NOT COMPLETED|Overall Study||21
494855|NCT01037218|1209977|P1|NOT COMPLETED|Overall Study||16
494856|NCT01037218|1209974|P4|COMPLETED|Overall Study||134
494857|NCT01037218|1209975|P3|COMPLETED|Overall Study||134
494858|NCT01037218|1209976|P2|COMPLETED|Overall Study||128
494859|NCT01037218|1209977|P1|COMPLETED|Overall Study||131
494860|NCT01037218|1209974|P4|mITT Population|Overall Study||141
494861|NCT01037218|1209975|P3|mITT Population|Overall Study||147
494862|NCT01037218|1209976|P2|mITT Population|Overall Study||140
494863|NCT01037218|1209977|P1|mITT Population|Overall Study||141
494864|NCT01037218|1209974|P4|Safety Population|Overall Study||150
494865|NCT01037218|1209975|P3|Safety Population|Overall Study||154
494866|NCT01037218|1209976|P2|Safety Population|Overall Study||148
494867|NCT01037218|1209977|P1|Safety Population|Overall Study||147
494868|NCT01037218|1209974|P4|STARTED|Overall Study||150
494869|NCT01037218|1209975|P3|STARTED|Overall Study||155
494870|NCT01037218|1209976|P2|STARTED|Overall Study||149
494871|NCT01037218|1209977|P1|STARTED|Overall Study||147
494872|NCT01037192|1210037|P2|NOT COMPLETED|Overall Study||0
494873|NCT01037192|1210038|P1|NOT COMPLETED|Overall Study||0
494874|NCT01037192|1210037|P2|COMPLETED|Overall Study||1
494875|NCT01037192|1210038|P1|COMPLETED|Overall Study||3
494876|NCT01037192|1210037|P2|STARTED|Overall Study||1
494877|NCT01037192|1210038|P1|STARTED|Overall Study||3
494878|NCT01037127|1210048|P2|NOT COMPLETED|Overall Study||21
494879|NCT01037127|1210049|P1|NOT COMPLETED|Overall Study||5
494880|NCT01037127|1210048|P2|COMPLETED|Overall Study||36
494881|NCT01037127|1210049|P1|COMPLETED|Overall Study||35
494882|NCT01037127|1210048|P2|STARTED|Overall Study||57
494883|NCT01037127|1210049|P1|STARTED|Overall Study||40
494884|NCT01037114|1210081|P1|NOT COMPLETED|Year 20||1
494885|NCT01037114|1210081|P1|COMPLETED|Year 20|One subject returned at Y20 but did not do lab test because subject met a study exclusion criteria.|44
494886|NCT01037114|1210081|P1|STARTED|Year 20||45
494887|NCT01037114|1210081|P1|NOT COMPLETED|Year 19||0
494888|NCT01037114|1210081|P1|COMPLETED|Year 19||45
494889|NCT01037114|1210081|P1|STARTED|Year 19||45
494890|NCT01037114|1210081|P1|NOT COMPLETED|Year 18||0
494891|NCT01037114|1210081|P1|COMPLETED|Year 18||44
494892|NCT01037114|1210081|P1|STARTED|Year 18||44
494893|NCT01037114|1210081|P1|NOT COMPLETED|Year 17||0
494894|NCT01037114|1210081|P1|COMPLETED|Year 17||48
494895|NCT01037114|1210081|P1|STARTED|Year 17||48
494896|NCT01037114|1210081|P1|NOT COMPLETED|Year 16||0
494897|NCT01037114|1210081|P1|COMPLETED|Year 16||49
494898|NCT01037114|1210081|P1|STARTED|Year 16||49
494899|NCT01037088|1210094|P1|NOT COMPLETED|Overall Study||3
494900|NCT01037088|1210094|P1|COMPLETED|Overall Study||36
494901|NCT01037088|1210094|P1|Received Placebo|Overall Study||38
494902|NCT01037088|1210094|P1|Received 1.29% THC|Overall Study||37
494903|NCT01037088|1210094|P1|Received 3.53% THC|Overall Study||36
494904|NCT01037088|1210094|P1|STARTED|Overall Study||39
494905|NCT01036802|1210107|P2|NOT COMPLETED|Overall Study||0
494906|NCT01036802|1210108|P1|NOT COMPLETED|Overall Study||0
494907|NCT01036802|1210107|P2|COMPLETED|Overall Study|Patient was taken off study after 7 months as she required hip replacement surgery.|1
494908|NCT01036802|1210108|P1|COMPLETED|Overall Study||2
494909|NCT01036802|1210107|P2|STARTED|Overall Study||1
494910|NCT01036802|1210108|P1|STARTED|Overall Study||2
494911|NCT01036763|1210126|P1|NOT COMPLETED|Overall Study||93
494912|NCT01036763|1210126|P1|COMPLETED|Overall Study||1171
494913|NCT01036763|1210126|P1|STARTED|Overall Study||1264
494914|NCT01036724|1210138|P2|NOT COMPLETED|Overall Study||8
494915|NCT01036724|1210139|P1|NOT COMPLETED|Overall Study||6
494916|NCT01036724|1210138|P2|COMPLETED|Overall Study||47
494917|NCT01036724|1210139|P1|COMPLETED|Overall Study||46
494918|NCT01036724|1210138|P2|STARTED|Overall Study||55
494919|NCT01036724|1210139|P1|STARTED|Overall Study||52
494920|NCT01036529|1210149|P2|NOT COMPLETED|Overall Study||15
494921|NCT01036529|1210150|P1|NOT COMPLETED|Overall Study||13
494922|NCT01036529|1210149|P2|COMPLETED|Overall Study||0
494923|NCT01036529|1210150|P1|COMPLETED|Overall Study||0
494924|NCT01036529|1210149|P2|Crossover to Other Group|Overall Study||1
494925|NCT01036529|1210150|P1|Crossover to Other Group|Overall Study||1
494926|NCT01036529|1210149|P2|Requested Crossover|Overall Study||2
494927|NCT01036529|1210150|P1|Requested Crossover|Overall Study||1
494928|NCT01036529|1210149|P2|12 Month Follow-up|Overall Study||3
494929|NCT01036529|1210150|P1|12 Month Follow-up|Overall Study||4
494930|NCT01036529|1210149|P2|6 Month Follow-up|Overall Study||7
494931|NCT01036529|1210150|P1|6 Month Follow-up|Overall Study||6
494932|NCT01036529|1210149|P2|3 Month Follow-up|Overall Study||9
494933|NCT01036529|1210150|P1|3 Month Follow-up|Overall Study||7
494934|NCT01036529|1210149|P2|Index Procedure|Overall Study|Index Procedure: Surgery|11
494935|NCT01036529|1210150|P1|Index Procedure|Overall Study|Index Procedure: Trial Stimulation|10
494936|NCT01036529|1210149|P2|Baseline Visit|Overall Study||13
494937|NCT01036529|1210150|P1|Baseline Visit|Overall Study||10
494938|NCT01036529|1210149|P2|STARTED|Overall Study||15
494939|NCT01036529|1210150|P1|STARTED|Overall Study||13
494940|NCT01036490|1210158|P2|NOT COMPLETED|Overall Study||0
494941|NCT01036490|1210159|P1|NOT COMPLETED|Overall Study||4
494942|NCT01036490|1210158|P2|COMPLETED|Overall Study||18
494943|NCT01036490|1210159|P1|COMPLETED|Overall Study||14
494944|NCT01036490|1210158|P2|STARTED|Overall Study||18
494945|NCT01036490|1210159|P1|STARTED|Overall Study||18
494946|NCT01036438|1210177|P2|NOT COMPLETED|Overall Study||10
494947|NCT01036438|1210178|P1|NOT COMPLETED|Overall Study||10
494948|NCT01036438|1210177|P2|COMPLETED|Overall Study||90
494949|NCT01036438|1210178|P1|COMPLETED|Overall Study||91
494950|NCT01036438|1210177|P2|STARTED|Overall Study||100
494951|NCT01036438|1210178|P1|STARTED|Overall Study||101
494952|NCT01036321|1210186|P2|NOT COMPLETED|Overall Study||4
494953|NCT01036321|1210187|P1|NOT COMPLETED|Overall Study||5
494954|NCT01036321|1210186|P2|COMPLETED|Overall Study||31
494955|NCT01036321|1210187|P1|COMPLETED|Overall Study||31
494956|NCT01036321|1210186|P2|STARTED|Overall Study||35
494957|NCT01036321|1210187|P1|STARTED|Overall Study||36
494958|NCT01036165|1210211|P1|NOT COMPLETED|Overall Study||15
494959|NCT01036165|1210211|P1|COMPLETED|Overall Study||88
494960|NCT01036165|1210211|P1|STARTED|Overall Study||103
494961|NCT01036022|1210222|P6|NOT COMPLETED|Overall Study||3
494962|NCT01036022|1210223|P5|NOT COMPLETED|Overall Study||3
494963|NCT01036022|1210224|P4|NOT COMPLETED|Overall Study||2
494964|NCT01036022|1210225|P3|NOT COMPLETED|Overall Study||4
494965|NCT01036022|1210226|P2|NOT COMPLETED|Overall Study||4
494966|NCT01036022|1210227|P1|NOT COMPLETED|Overall Study||2
494967|NCT01036022|1210222|P6|COMPLETED|Overall Study||13
494968|NCT01036022|1210223|P5|COMPLETED|Overall Study||9
494969|NCT01036022|1210224|P4|COMPLETED|Overall Study||10
494970|NCT01036022|1210225|P3|COMPLETED|Overall Study||8
494971|NCT01036022|1210226|P2|COMPLETED|Overall Study||7
494972|NCT01036022|1210227|P1|COMPLETED|Overall Study||13
494973|NCT01036022|1210222|P6|STARTED|Overall Study||16
494974|NCT01036022|1210223|P5|STARTED|Overall Study||12
494975|NCT01036022|1210224|P4|STARTED|Overall Study||12
494976|NCT01036022|1210225|P3|STARTED|Overall Study||12
494977|NCT01036022|1210226|P2|STARTED|Overall Study||11
494978|NCT01036022|1210227|P1|STARTED|Overall Study||15
494979|NCT01036009|1210329|P2|NOT COMPLETED|Overall Study||0
494980|NCT01036009|1210330|P1|NOT COMPLETED|Overall Study||0
494981|NCT01036009|1210329|P2|COMPLETED|Overall Study||26
494982|NCT01036009|1210330|P1|COMPLETED|Overall Study||17
494983|NCT01036009|1210329|P2|STARTED|Overall Study||26
494984|NCT01036009|1210330|P1|STARTED|Overall Study||17
494985|NCT01035944|1210348|P4|NOT COMPLETED|Overall Study||0
494986|NCT01035944|1210349|P3|NOT COMPLETED|Overall Study||1
494987|NCT01035944|1210350|P2|NOT COMPLETED|Overall Study||1
494988|NCT01035944|1210351|P1|NOT COMPLETED|Overall Study||3
494989|NCT01035944|1210348|P4|COMPLETED|Overall Study||4
494990|NCT01035944|1210349|P3|COMPLETED|Overall Study||4
494991|NCT01035944|1210350|P2|COMPLETED|Overall Study||13
494992|NCT01035944|1210351|P1|COMPLETED|Overall Study||11
494993|NCT01035944|1210348|P4|STARTED|Overall Study||4
494994|NCT01035944|1210349|P3|STARTED|Overall Study||5
494995|NCT01035944|1210350|P2|STARTED|Overall Study||14
494996|NCT01035944|1210351|P1|STARTED|Overall Study||14
494997|NCT01035905|1210363|P2|NOT COMPLETED|Overall Study||1
494998|NCT01035905|1210364|P1|NOT COMPLETED|Overall Study||1
494999|NCT01035905|1210363|P2|COMPLETED|Overall Study||30
495000|NCT01035905|1210364|P1|COMPLETED|Overall Study||31
495001|NCT01035905|1210363|P2|STARTED|Overall Study||31
495002|NCT01035905|1210364|P1|STARTED|Overall Study||32
495003|NCT01035788|1210372|P2|NOT COMPLETED|Overall Study||14
495004|NCT01035788|1210373|P1|NOT COMPLETED|Overall Study||6
495005|NCT01035788|1210372|P2|COMPLETED|Overall Study||9
495006|NCT01035788|1210373|P1|COMPLETED|Overall Study||17
495007|NCT01035788|1210372|P2|STARTED|Overall Study|23 couples = 23 Veterans + 23 partners; only data for Veterans will be included for primary outcome.|23
495008|NCT01035788|1210373|P1|STARTED|Overall Study|23 couples = 23 Veterans + 23 partners; only data for Veterans will be included for primary outcome.|23
495009|NCT01035749|1210383|P4|NOT COMPLETED|Overall Study||0
495010|NCT01035749|1210384|P3|NOT COMPLETED|Overall Study||0
495011|NCT01035749|1210385|P2|NOT COMPLETED|Overall Study||0
495012|NCT01035749|1210386|P1|NOT COMPLETED|Overall Study||0
495013|NCT01035749|1210383|P4|COMPLETED|Overall Study||110
495014|NCT01035749|1210384|P3|COMPLETED|Overall Study||68
495015|NCT01035749|1210385|P2|COMPLETED|Overall Study||66
495016|NCT01035749|1210386|P1|COMPLETED|Overall Study||66
495017|NCT01035749|1210383|P4|STARTED|Overall Study||110
495018|NCT01035749|1210384|P3|STARTED|Overall Study||68
495019|NCT01035749|1210385|P2|STARTED|Overall Study||66
495020|NCT01035749|1210386|P1|STARTED|Overall Study||66
495021|NCT01035658|1210508|P4|NOT COMPLETED|Overall Study||0
495022|NCT01035658|1210509|P3|NOT COMPLETED|Overall Study||0
495023|NCT01035658|1210510|P2|NOT COMPLETED|Overall Study||0
495024|NCT01035658|1210511|P1|NOT COMPLETED|Overall Study||0
495025|NCT01035658|1210508|P4|COMPLETED|Overall Study||6
495026|NCT01035658|1210509|P3|COMPLETED|Overall Study||3
495027|NCT01035658|1210510|P2|COMPLETED|Overall Study||8
495028|NCT01035658|1210511|P1|COMPLETED|Overall Study||5
495029|NCT01035658|1210508|P4|STARTED|Overall Study||6
495030|NCT01035658|1210509|P3|STARTED|Overall Study||3
495031|NCT01035658|1210510|P2|STARTED|Overall Study||8
495032|NCT01035658|1210511|P1|STARTED|Overall Study||5
495033|NCT01035606|1210537|P3|NOT COMPLETED|Overall Study||4
495034|NCT01035606|1210538|P2|NOT COMPLETED|Overall Study||3
495035|NCT01035606|1210539|P1|NOT COMPLETED|Overall Study||3
495036|NCT01035606|1210537|P3|COMPLETED|Overall Study||7
495037|NCT01035606|1210538|P2|COMPLETED|Overall Study||16
495038|NCT01035606|1210539|P1|COMPLETED|Overall Study||16
495039|NCT01035606|1210537|P3|STARTED|Overall Study||11
495040|NCT01035606|1210538|P2|STARTED|Overall Study||19
495041|NCT01035606|1210539|P1|STARTED|Overall Study||19
495042|NCT01035346|1210555|P2|NOT COMPLETED|Overall Study||0
495043|NCT01035346|1210556|P1|NOT COMPLETED|Overall Study||0
495044|NCT01035346|1210555|P2|COMPLETED|Overall Study||9
495045|NCT01035346|1210556|P1|COMPLETED|Overall Study||7
495046|NCT01035346|1210555|P2|STARTED|Overall Study||9
495047|NCT01035346|1210556|P1|STARTED|Overall Study||7
495048|NCT01035333|1210574|P1|NOT COMPLETED|Overall Study||10
495049|NCT01035333|1210574|P1|COMPLETED|Overall Study||9
495050|NCT01035333|1210574|P1|STARTED|Overall Study||19
495051|NCT01035255|1210581|P2|NOT COMPLETED|Overall Study||862
495052|NCT01035255|1210582|P1|NOT COMPLETED|Overall Study||741
495053|NCT01035255|1210581|P2|COMPLETED|Overall Study||3371
495054|NCT01035255|1210582|P1|COMPLETED|Overall Study||3468
495055|NCT01035255|1210581|P2|Full Analysis Set (FAS)|Overall Study|patents with GCP violation and mis-randomized are not included in FAS|4212
495056|NCT01035255|1210582|P1|Full Analysis Set (FAS)|Overall Study|patents with GCP violation and mis-randomized are not included in FAS|4187
495057|NCT01035255|1210581|P2|Mis-randomized|Overall Study||2
495058|NCT01035255|1210582|P1|Mis-randomized|Overall Study||4
495059|NCT01035255|1210581|P2|GCP Violations|Overall Study||19
495060|NCT01035255|1210582|P1|GCP Violations|Overall Study||18
495061|NCT01035255|1210581|P2|STARTED|Overall Study||4233
495062|NCT01035255|1210582|P1|STARTED|Overall Study||4209
495063|NCT01035229|1210600|P2|NOT COMPLETED|Overall Study||184
495064|NCT01035229|1210601|P1|NOT COMPLETED|Overall Study||362
495065|NCT01035229|1210600|P2|COMPLETED|Overall Study||0
495066|NCT01035229|1210601|P1|COMPLETED|Overall Study||0
495067|NCT01035229|1210600|P2|STARTED|Overall Study||184
495068|NCT01035229|1210601|P1|STARTED|Overall Study||362
495069|NCT01035138|1210622|P3|NOT COMPLETED|Overall Study||47
495070|NCT01035138|1210623|P2|NOT COMPLETED|Overall Study||60
495071|NCT01035138|1210624|P1|NOT COMPLETED|Overall Study||73
495072|NCT01035138|1210622|P3|COMPLETED|Overall Study||0
495073|NCT01035138|1210623|P2|COMPLETED|Overall Study||0
495074|NCT01035138|1210624|P1|COMPLETED|Overall Study||0
495075|NCT01035138|1210622|P3|STARTED|Overall Study||47
495076|NCT01035138|1210623|P2|STARTED|Overall Study||60
495077|NCT01035138|1210624|P1|STARTED|Overall Study||73
495078|NCT01035060|1210680|P2|NOT COMPLETED|Overall Study||14
495079|NCT01035060|1210681|P1|NOT COMPLETED|Overall Study||24
495080|NCT01035060|1210680|P2|COMPLETED|Overall Study||15
495081|NCT01035060|1210681|P1|COMPLETED|Overall Study||15
495082|NCT01035060|1210680|P2|STARTED|Overall Study||29
495083|NCT01035060|1210681|P1|STARTED|Overall Study||39
495084|NCT01035047|1210689|P2|NOT COMPLETED|Overall Study||0
495085|NCT01035047|1210690|P1|NOT COMPLETED|Overall Study||0
495086|NCT01035047|1210689|P2|COMPLETED|Overall Study||53
495087|NCT01035047|1210690|P1|COMPLETED|Overall Study||52
495088|NCT01035047|1210689|P2|STARTED|Overall Study||53
495089|NCT01035047|1210690|P1|STARTED|Overall Study||52
495090|NCT01034709|1210706|P2|NOT COMPLETED|Overall Study||16
495091|NCT01034709|1210707|P1|NOT COMPLETED|Overall Study||9
495092|NCT01034709|1210706|P2|COMPLETED|Overall Study||42
495093|NCT01034709|1210707|P1|COMPLETED|Overall Study||44
495094|NCT01034709|1210706|P2|STARTED|Overall Study||58
495095|NCT01034709|1210707|P1|STARTED|Overall Study||53
495096|NCT01034657|1210713|P3|NOT COMPLETED|Randomized Phase||1
495097|NCT01034657|1210714|P2|NOT COMPLETED|Randomized Phase||6
495098|NCT01034657|1210715|P1|NOT COMPLETED|Randomized Phase||5
495099|NCT01034657|1210713|P3|COMPLETED|Randomized Phase||0
495100|NCT01034657|1210714|P2|COMPLETED|Randomized Phase||0
495101|NCT01034657|1210715|P1|COMPLETED|Randomized Phase||1
495102|NCT01034657|1210713|P3|STARTED|Randomized Phase||1
495103|NCT01034657|1210714|P2|STARTED|Randomized Phase||6
495104|NCT01034657|1210715|P1|STARTED|Randomized Phase||6
495105|NCT01034657|1210713|P3|NOT COMPLETED|Core Phase||0
495106|NCT01034657|1210714|P2|NOT COMPLETED|Core Phase||0
495107|NCT01034657|1210715|P1|NOT COMPLETED|Core Phase||14
495108|NCT01034657|1210713|P3|COMPLETED|Core Phase||0
495109|NCT01034657|1210714|P2|COMPLETED|Core Phase||0
495110|NCT01034657|1210715|P1|COMPLETED|Core Phase||20
495111|NCT01034657|1210713|P3|STARTED|Core Phase||0
495112|NCT01034657|1210714|P2|STARTED|Core Phase||0
495113|NCT01034657|1210715|P1|STARTED|Core Phase||34
495114|NCT01034631|1210756|P3|NOT COMPLETED|Phase II||2
495115|NCT01034631|1210757|P2|NOT COMPLETED|Phase II||1
495116|NCT01034631|1210758|P1|NOT COMPLETED|Phase II||0
495117|NCT01034631|1210756|P3|COMPLETED|Phase II||67
495118|NCT01034631|1210757|P2|COMPLETED|Phase II||69
495119|NCT01034631|1210758|P1|COMPLETED|Phase II||0
495120|NCT01034631|1210756|P3|STARTED|Phase II||69
495121|NCT01034631|1210757|P2|STARTED|Phase II||70
495122|NCT01034631|1210758|P1|STARTED|Phase II|No Phase I Participants were enrolled during this time period.|0
495123|NCT01034631|1210756|P3|NOT COMPLETED|Phase I||0
495124|NCT01034631|1210757|P2|NOT COMPLETED|Phase I||0
495125|NCT01034631|1210758|P1|NOT COMPLETED|Phase I||3
495126|NCT01034631|1210756|P3|COMPLETED|Phase I||0
495127|NCT01034631|1210757|P2|COMPLETED|Phase I||0
495128|NCT01034631|1210758|P1|COMPLETED|Phase I||12
495129|NCT01034631|1210756|P3|STARTED|Phase I|No Phase II Participants were enrolled during this time period|0
495130|NCT01034631|1210757|P2|STARTED|Phase I|No Phase II Participants were enrolled during this time period|0
495131|NCT01034631|1210758|P1|STARTED|Phase I||15
495132|NCT01034592|1210777|P1|NOT COMPLETED|Overall Study||0
495133|NCT01034592|1210777|P1|COMPLETED|Overall Study||2
495134|NCT01034592|1210777|P1|STARTED|Overall Study||2
495135|NCT01034579|1210789|P2|NOT COMPLETED|Overall Study||0
495136|NCT01034579|1210790|P1|NOT COMPLETED|Overall Study||0
495137|NCT01034579|1210789|P2|COMPLETED|Overall Study||166
495138|NCT01034579|1210790|P1|COMPLETED|Overall Study||158
495139|NCT01034579|1210789|P2|STARTED|Overall Study||166
495140|NCT01034579|1210790|P1|STARTED|Overall Study||158
495141|NCT01034553|1210804|P6|NOT COMPLETED|Overall Study||0
495142|NCT01034553|1210805|P5|NOT COMPLETED|Overall Study||0
495143|NCT01034553|1210806|P4|NOT COMPLETED|Overall Study||0
495144|NCT01034553|1210807|P3|NOT COMPLETED|Overall Study||0
495145|NCT01034553|1210808|P2|NOT COMPLETED|Overall Study||0
495146|NCT01034553|1210809|P1|NOT COMPLETED|Overall Study||0
495147|NCT01034553|1210804|P6|COMPLETED|Overall Study||7
495148|NCT01034553|1210805|P5|COMPLETED|Overall Study||6
495149|NCT01034553|1210806|P4|COMPLETED|Overall Study||3
495150|NCT01034553|1210807|P3|COMPLETED|Overall Study||3
495151|NCT01034553|1210808|P2|COMPLETED|Overall Study||4
495152|NCT01034553|1210809|P1|COMPLETED|Overall Study||3
495153|NCT01034553|1210804|P6|STARTED|Overall Study||7
495154|NCT01034553|1210805|P5|STARTED|Overall Study||6
495155|NCT01034553|1210806|P4|STARTED|Overall Study||3
495156|NCT01034553|1210807|P3|STARTED|Overall Study||3
495157|NCT01034553|1210808|P2|STARTED|Overall Study||4
495158|NCT01034553|1210809|P1|STARTED|Overall Study||3
495159|NCT01034540|1210825|P2|NOT COMPLETED|Overall Study||1
495160|NCT01034540|1210826|P1|NOT COMPLETED|Overall Study||0
495161|NCT01034540|1210825|P2|COMPLETED|Overall Study||11
495162|NCT01034540|1210826|P1|COMPLETED|Overall Study||11
495163|NCT01034540|1210825|P2|Completed 1st Treatment Intervention|Overall Study||11
495164|NCT01034540|1210826|P1|Completed 1st Treatment Intervention|Overall Study||11
495165|NCT01034540|1210825|P2|STARTED|Overall Study||12
495166|NCT01034540|1210826|P1|STARTED|Overall Study||11
495167|NCT01034462|1210836|P2|NOT COMPLETED|Overall Study||54
495168|NCT01034462|1210837|P1|NOT COMPLETED|Overall Study||45
495169|NCT01034462|1210836|P2|COMPLETED|Overall Study||163
495170|NCT01034462|1210837|P1|COMPLETED|Overall Study||172
495171|NCT01034462|1210836|P2|STARTED|Overall Study||217
495172|NCT01034462|1210837|P1|STARTED|Overall Study||217
495173|NCT01034397|1210847|P2|NOT COMPLETED|Overall Study||2
495174|NCT01034397|1210848|P1|NOT COMPLETED|Overall Study||7
495175|NCT01034397|1210847|P2|COMPLETED|Overall Study||17
495176|NCT01034397|1210848|P1|COMPLETED|Overall Study||28
495177|NCT01034397|1210847|P2|STARTED|Overall Study||19
495178|NCT01034397|1210848|P1|STARTED|Overall Study||35
495179|NCT01034358|1210997|P1|NOT COMPLETED|Overall Study||2
495180|NCT01034358|1210997|P1|COMPLETED|Overall Study|One patient was found after enrollment to have already received one prior dose of the HPV vaccine.|13
495181|NCT01034358|1210997|P1|STARTED|Overall Study||15
495182|NCT01034306|1211003|P2|NOT COMPLETED|Overall Study||3
495183|NCT01034306|1211004|P1|NOT COMPLETED|Overall Study||5
495184|NCT01034306|1211003|P2|COMPLETED|Overall Study||34
495185|NCT01034306|1211004|P1|COMPLETED|Overall Study||37
495186|NCT01034306|1211003|P2|STARTED|Overall Study||37
495187|NCT01034306|1211004|P1|STARTED|Overall Study||42
495188|NCT01034176|1211012|P2|NOT COMPLETED|Overall Study||2
495189|NCT01034176|1211013|P1|NOT COMPLETED|Overall Study||2
495190|NCT01034176|1211012|P2|COMPLETED|Overall Study||19
495191|NCT01034176|1211013|P1|COMPLETED|Overall Study||20
495192|NCT01034176|1211012|P2|STARTED|Overall Study||21
495193|NCT01034176|1211013|P1|STARTED|Overall Study||22
495194|NCT01034163|1211023|P2|NOT COMPLETED|Overall Study||14
495195|NCT01034163|1211024|P1|NOT COMPLETED|Overall Study||27
495196|NCT01034163|1211023|P2|COMPLETED|Overall Study||0
495197|NCT01034163|1211024|P1|COMPLETED|Overall Study||0
495198|NCT01034163|1211023|P2|In Open Label Phase After Unblinding|Overall Study||0
495199|NCT01034163|1211024|P1|In Open Label Phase After Unblinding|Overall Study||5
495200|NCT01034163|1211023|P2|Safety Set|Overall Study||12
495201|NCT01034163|1211024|P1|Safety Set|Overall Study||26
495202|NCT01034163|1211023|P2|Untreated (Not in Safety Set)|Overall Study||2
495203|NCT01034163|1211024|P1|Untreated (Not in Safety Set)|Overall Study||1
495204|NCT01034163|1211023|P2|STARTED|Overall Study||14
495205|NCT01034163|1211024|P1|STARTED|Overall Study||27
495206|NCT01034137|1211033|P3|NOT COMPLETED|Overall Study||30
495207|NCT01034137|1211034|P2|NOT COMPLETED|Overall Study||22
495208|NCT01034137|1211035|P1|NOT COMPLETED|Overall Study||28
495209|NCT01034137|1211033|P3|COMPLETED|Overall Study||78
495210|NCT01034137|1211034|P2|COMPLETED|Overall Study||81
495211|NCT01034137|1211035|P1|COMPLETED|Overall Study||78
495212|NCT01034137|1211033|P3|STARTED|Overall Study||108
495213|NCT01034137|1211034|P2|STARTED|Overall Study||103
495214|NCT01034137|1211035|P1|STARTED|Overall Study||106
495215|NCT01034111|1211166|P1|NOT COMPLETED|Overall Study||0
495216|NCT01034111|1211166|P1|COMPLETED|Overall Study||30
495217|NCT01034111|1211166|P1|STARTED|Overall Study||30
495218|NCT01033942|1211174|P3|NOT COMPLETED|Overall Study||1
495219|NCT01033942|1211175|P2|NOT COMPLETED|Overall Study||4
495220|NCT01033942|1211176|P1|NOT COMPLETED|Overall Study||2
495221|NCT01033942|1211174|P3|COMPLETED|Overall Study||18
495222|NCT01033942|1211175|P2|COMPLETED|Overall Study||15
495223|NCT01033942|1211176|P1|COMPLETED|Overall Study||18
495224|NCT01033942|1211174|P3|STARTED|Overall Study||19
495225|NCT01033942|1211175|P2|STARTED|Overall Study||19
495226|NCT01033942|1211176|P1|STARTED|Overall Study||20
495227|NCT01033864|1211448|P2|NOT COMPLETED|Overall Study||0
495228|NCT01033864|1211449|P1|NOT COMPLETED|Overall Study||0
495229|NCT01033864|1211448|P2|COMPLETED|Overall Study||11
495230|NCT01033864|1211449|P1|COMPLETED|Overall Study||12
495231|NCT01033864|1211448|P2|STARTED|Overall Study||11
495232|NCT01033864|1211449|P1|STARTED|Overall Study||12
495233|NCT01033851|1211474|P2|NOT COMPLETED|Overall Study||7
495234|NCT01033851|1211475|P1|NOT COMPLETED|Overall Study||3
495235|NCT01033851|1211474|P2|COMPLETED|Overall Study||34
495236|NCT01033851|1211475|P1|COMPLETED|Overall Study||45
495237|NCT01033851|1211474|P2|STARTED|Overall Study||41
495238|NCT01033851|1211475|P1|STARTED|Overall Study||48
495239|NCT01033825|1211490|P7|NOT COMPLETED|Overall Study||0
495240|NCT01033825|1211491|P6|NOT COMPLETED|Overall Study||0
495241|NCT01033825|1211492|P5|NOT COMPLETED|Overall Study||2
495242|NCT01033825|1211493|P4|NOT COMPLETED|Overall Study||2
495243|NCT01033825|1211494|P3|NOT COMPLETED|Overall Study||2
495244|NCT01033825|1211495|P2|NOT COMPLETED|Overall Study||3
495245|NCT01033825|1211496|P1|NOT COMPLETED|Overall Study||3
495246|NCT01033825|1211490|P7|COMPLETED|Overall Study||18
495247|NCT01033825|1211491|P6|COMPLETED|Overall Study||18
495248|NCT01033825|1211492|P5|COMPLETED|Overall Study||56
495249|NCT01033825|1211493|P4|COMPLETED|Overall Study||46
495250|NCT01033825|1211494|P3|COMPLETED|Overall Study||55
495251|NCT01033825|1211495|P2|COMPLETED|Overall Study||57
495252|NCT01033825|1211496|P1|COMPLETED|Overall Study||48
495253|NCT01033825|1211490|P7|STARTED|Overall Study||18
495254|NCT01033825|1211491|P6|STARTED|Overall Study||18
495255|NCT01033825|1211492|P5|STARTED|Overall Study||58
495256|NCT01033825|1211493|P4|STARTED|Overall Study||48
495257|NCT01033825|1211494|P3|STARTED|Overall Study||57
495258|NCT01033825|1211495|P2|STARTED|Overall Study||60
495259|NCT01033825|1211496|P1|STARTED|Overall Study||51
495260|NCT01033747|1211717|P2|NOT COMPLETED|Overall Study||15
495261|NCT01033747|1211718|P1|NOT COMPLETED|Overall Study||37
495262|NCT01033747|1211717|P2|COMPLETED|Overall Study||4
495263|NCT01033747|1211718|P1|COMPLETED|Overall Study||14
495264|NCT01033747|1211717|P2|STARTED|Overall Study||19
495265|NCT01033747|1211718|P1|STARTED|Overall Study||51
495266|NCT01033734|1211726|P1|NOT COMPLETED|Overall Study||1
495267|NCT01033734|1211726|P1|COMPLETED|Overall Study||7
495268|NCT01033734|1211726|P1|STARTED|Overall Study||8
495269|NCT01033565|1211778|P1|NOT COMPLETED|Overall Study||0
495270|NCT01033565|1211778|P1|COMPLETED|Overall Study||1
495271|NCT01033565|1211778|P1|STARTED|Overall Study||1
495272|NCT01033487|1211782|P10|NOT COMPLETED|Fifth Intervention Period||0
495273|NCT01033487|1211783|P9|NOT COMPLETED|Fifth Intervention Period||0
495274|NCT01033487|1211784|P8|NOT COMPLETED|Fifth Intervention Period||0
495275|NCT01033487|1211785|P7|NOT COMPLETED|Fifth Intervention Period||0
495276|NCT01033487|1211786|P6|NOT COMPLETED|Fifth Intervention Period||0
495277|NCT01033487|1211787|P5|NOT COMPLETED|Fifth Intervention Period||0
495278|NCT01033487|1211788|P4|NOT COMPLETED|Fifth Intervention Period||0
495279|NCT01033487|1211789|P3|NOT COMPLETED|Fifth Intervention Period||0
495280|NCT01033487|1211790|P2|NOT COMPLETED|Fifth Intervention Period||0
495281|NCT01033487|1211791|P1|NOT COMPLETED|Fifth Intervention Period||0
495282|NCT01033487|1211782|P10|COMPLETED|Fifth Intervention Period||2
495283|NCT01033487|1211783|P9|COMPLETED|Fifth Intervention Period||1
495284|NCT01033487|1211784|P8|COMPLETED|Fifth Intervention Period||3
495285|NCT01033487|1211785|P7|COMPLETED|Fifth Intervention Period||2
495286|NCT01033487|1211786|P6|COMPLETED|Fifth Intervention Period||2
495287|NCT01033487|1211787|P5|COMPLETED|Fifth Intervention Period||2
495288|NCT01033487|1211788|P4|COMPLETED|Fifth Intervention Period||2
495289|NCT01033487|1211789|P3|COMPLETED|Fifth Intervention Period||2
495290|NCT01033487|1211790|P2|COMPLETED|Fifth Intervention Period||3
495291|NCT01033487|1211791|P1|COMPLETED|Fifth Intervention Period||2
495292|NCT01033487|1211782|P10|STARTED|Fifth Intervention Period||2
495293|NCT01033487|1211783|P9|STARTED|Fifth Intervention Period||1
495294|NCT01033487|1211784|P8|STARTED|Fifth Intervention Period||3
495295|NCT01033487|1211785|P7|STARTED|Fifth Intervention Period||2
495296|NCT01033487|1211786|P6|STARTED|Fifth Intervention Period||2
495297|NCT01033487|1211787|P5|STARTED|Fifth Intervention Period||2
495298|NCT01033487|1211788|P4|STARTED|Fifth Intervention Period||2
495299|NCT01033487|1211789|P3|STARTED|Fifth Intervention Period||2
495300|NCT01033487|1211790|P2|STARTED|Fifth Intervention Period||3
495301|NCT01033487|1211791|P1|STARTED|Fifth Intervention Period||2
495302|NCT01033487|1211782|P10|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
495303|NCT01033487|1211783|P9|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
495304|NCT01033487|1211784|P8|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
495305|NCT01033487|1211785|P7|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
495306|NCT01033487|1211786|P6|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
495307|NCT01033487|1211787|P5|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
495308|NCT01033487|1211788|P4|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
495309|NCT01033487|1211789|P3|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
495310|NCT01033487|1211790|P2|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
495311|NCT01033487|1211791|P1|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
495312|NCT01033487|1211782|P10|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
495313|NCT01033487|1211783|P9|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||1
495314|NCT01033487|1211784|P8|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3
495315|NCT01033487|1211785|P7|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
495316|NCT01033487|1211786|P6|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
495317|NCT01033487|1211787|P5|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
495318|NCT01033487|1211788|P4|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
495319|NCT01033487|1211789|P3|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
495320|NCT01033487|1211790|P2|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3
495321|NCT01033487|1211791|P1|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
495322|NCT01033487|1211782|P10|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
495323|NCT01033487|1211783|P9|STARTED|Between Period 4 and 5 (At Least 7 Days)||1
495324|NCT01033487|1211784|P8|STARTED|Between Period 4 and 5 (At Least 7 Days)||3
495325|NCT01033487|1211785|P7|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
495326|NCT01033487|1211786|P6|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
495327|NCT01033487|1211787|P5|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
495328|NCT01033487|1211788|P4|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
495329|NCT01033487|1211789|P3|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
495330|NCT01033487|1211790|P2|STARTED|Between Period 4 and 5 (At Least 7 Days)||3
495331|NCT01033487|1211791|P1|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
495332|NCT01033487|1211782|P10|NOT COMPLETED|Fourth Intervention Period||0
495333|NCT01033487|1211783|P9|NOT COMPLETED|Fourth Intervention Period||1
495334|NCT01033487|1211784|P8|NOT COMPLETED|Fourth Intervention Period||0
495335|NCT01033487|1211785|P7|NOT COMPLETED|Fourth Intervention Period||0
495336|NCT01033487|1211786|P6|NOT COMPLETED|Fourth Intervention Period||0
495337|NCT01033487|1211787|P5|NOT COMPLETED|Fourth Intervention Period||0
495338|NCT01033487|1211788|P4|NOT COMPLETED|Fourth Intervention Period||0
495339|NCT01033487|1211789|P3|NOT COMPLETED|Fourth Intervention Period||0
495340|NCT01033487|1211790|P2|NOT COMPLETED|Fourth Intervention Period||0
495341|NCT01033487|1211791|P1|NOT COMPLETED|Fourth Intervention Period||0
495342|NCT01033487|1211782|P10|COMPLETED|Fourth Intervention Period||2
495343|NCT01033487|1211783|P9|COMPLETED|Fourth Intervention Period||1
495344|NCT01033487|1211784|P8|COMPLETED|Fourth Intervention Period||3
495345|NCT01033487|1211785|P7|COMPLETED|Fourth Intervention Period||2
495346|NCT01033487|1211786|P6|COMPLETED|Fourth Intervention Period||2
495347|NCT01033487|1211787|P5|COMPLETED|Fourth Intervention Period||2
495348|NCT01033487|1211788|P4|COMPLETED|Fourth Intervention Period||2
495349|NCT01033487|1211789|P3|COMPLETED|Fourth Intervention Period||2
495350|NCT01033487|1211790|P2|COMPLETED|Fourth Intervention Period||3
495351|NCT01033487|1211791|P1|COMPLETED|Fourth Intervention Period||2
495352|NCT01033487|1211782|P10|STARTED|Fourth Intervention Period||2
495353|NCT01033487|1211783|P9|STARTED|Fourth Intervention Period||2
495354|NCT01033487|1211784|P8|STARTED|Fourth Intervention Period||3
495355|NCT01033487|1211785|P7|STARTED|Fourth Intervention Period||2
495356|NCT01033487|1211786|P6|STARTED|Fourth Intervention Period||2
495357|NCT01033487|1211787|P5|STARTED|Fourth Intervention Period||2
495358|NCT01033487|1211788|P4|STARTED|Fourth Intervention Period||2
495359|NCT01033487|1211789|P3|STARTED|Fourth Intervention Period||2
495360|NCT01033487|1211790|P2|STARTED|Fourth Intervention Period||3
495361|NCT01033487|1211791|P1|STARTED|Fourth Intervention Period||2
495362|NCT01033487|1211782|P10|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
495363|NCT01033487|1211783|P9|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
495364|NCT01033487|1211784|P8|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
495365|NCT01033487|1211785|P7|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
495366|NCT01033487|1211786|P6|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
495367|NCT01033487|1211787|P5|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
495368|NCT01033487|1211788|P4|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
495369|NCT01033487|1211789|P3|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
495370|NCT01033487|1211790|P2|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
495371|NCT01033487|1211791|P1|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
495372|NCT01033487|1211782|P10|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
495373|NCT01033487|1211783|P9|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
495374|NCT01033487|1211784|P8|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3
495375|NCT01033487|1211785|P7|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
495376|NCT01033487|1211786|P6|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
495377|NCT01033487|1211787|P5|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
495378|NCT01033487|1211788|P4|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
495379|NCT01033487|1211789|P3|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
495380|NCT01033487|1211790|P2|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3
495381|NCT01033487|1211791|P1|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
495382|NCT01033487|1211782|P10|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
495383|NCT01033487|1211783|P9|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
495384|NCT01033487|1211784|P8|STARTED|Between Period 3 and 4 (At Least 7 Days)||3
495385|NCT01033487|1211785|P7|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
495386|NCT01033487|1211786|P6|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
495387|NCT01033487|1211787|P5|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
495388|NCT01033487|1211788|P4|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
495389|NCT01033487|1211789|P3|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
495390|NCT01033487|1211790|P2|STARTED|Between Period 3 and 4 (At Least 7 Days)||3
495391|NCT01033487|1211791|P1|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
495392|NCT01033487|1211782|P10|NOT COMPLETED|Third Intervention Period||0
495393|NCT01033487|1211783|P9|NOT COMPLETED|Third Intervention Period||0
495394|NCT01033487|1211784|P8|NOT COMPLETED|Third Intervention Period||0
495395|NCT01033487|1211785|P7|NOT COMPLETED|Third Intervention Period||0
495396|NCT01033487|1211786|P6|NOT COMPLETED|Third Intervention Period||0
495397|NCT01033487|1211787|P5|NOT COMPLETED|Third Intervention Period||0
495398|NCT01033487|1211788|P4|NOT COMPLETED|Third Intervention Period||0
495399|NCT01033487|1211789|P3|NOT COMPLETED|Third Intervention Period||0
495400|NCT01033487|1211790|P2|NOT COMPLETED|Third Intervention Period||0
495401|NCT01033487|1211791|P1|NOT COMPLETED|Third Intervention Period||0
495402|NCT01033487|1211782|P10|COMPLETED|Third Intervention Period||2
495403|NCT01033487|1211783|P9|COMPLETED|Third Intervention Period||2
495404|NCT01033487|1211784|P8|COMPLETED|Third Intervention Period||3
495405|NCT01033487|1211785|P7|COMPLETED|Third Intervention Period||2
495406|NCT01033487|1211786|P6|COMPLETED|Third Intervention Period||2
495407|NCT01033487|1211787|P5|COMPLETED|Third Intervention Period||2
495408|NCT01033487|1211788|P4|COMPLETED|Third Intervention Period||2
495409|NCT01033487|1211789|P3|COMPLETED|Third Intervention Period||2
495410|NCT01033487|1211790|P2|COMPLETED|Third Intervention Period||3
495411|NCT01033487|1211791|P1|COMPLETED|Third Intervention Period||2
495412|NCT01033487|1211782|P10|STARTED|Third Intervention Period||2
495413|NCT01033487|1211783|P9|STARTED|Third Intervention Period||2
495414|NCT01033487|1211784|P8|STARTED|Third Intervention Period||3
495415|NCT01033487|1211785|P7|STARTED|Third Intervention Period||2
495416|NCT01033487|1211786|P6|STARTED|Third Intervention Period||2
495417|NCT01033487|1211787|P5|STARTED|Third Intervention Period||2
495418|NCT01033487|1211788|P4|STARTED|Third Intervention Period||2
495419|NCT01033487|1211789|P3|STARTED|Third Intervention Period||2
495420|NCT01033487|1211790|P2|STARTED|Third Intervention Period||3
495421|NCT01033487|1211791|P1|STARTED|Third Intervention Period||2
495422|NCT01033487|1211782|P10|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
495423|NCT01033487|1211783|P9|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
495424|NCT01033487|1211784|P8|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
495425|NCT01033487|1211785|P7|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
495426|NCT01033487|1211786|P6|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
495427|NCT01033487|1211787|P5|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
495428|NCT01033487|1211788|P4|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
495429|NCT01033487|1211789|P3|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
495430|NCT01033487|1211790|P2|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
495431|NCT01033487|1211791|P1|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
495432|NCT01033487|1211782|P10|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
495433|NCT01033487|1211783|P9|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
495434|NCT01033487|1211784|P8|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3
495435|NCT01033487|1211785|P7|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
495436|NCT01033487|1211786|P6|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
495437|NCT01033487|1211787|P5|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
495438|NCT01033487|1211788|P4|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
495439|NCT01033487|1211789|P3|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
495440|NCT01033487|1211790|P2|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3
495441|NCT01033487|1211791|P1|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
495442|NCT01033487|1211782|P10|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
495443|NCT01033487|1211783|P9|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
495444|NCT01033487|1211784|P8|STARTED|Between Period 2 and 3 (At Least 7 Days)||3
495445|NCT01033487|1211785|P7|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
495446|NCT01033487|1211786|P6|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
495447|NCT01033487|1211787|P5|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
495448|NCT01033487|1211788|P4|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
495449|NCT01033487|1211789|P3|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
495450|NCT01033487|1211790|P2|STARTED|Between Period 2 and 3 (At Least 7 Days)||3
495451|NCT01033487|1211791|P1|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
495452|NCT01033487|1211782|P10|NOT COMPLETED|Second Intervention Period||0
495453|NCT01033487|1211783|P9|NOT COMPLETED|Second Intervention Period||0
495454|NCT01033487|1211784|P8|NOT COMPLETED|Second Intervention Period||0
495455|NCT01033487|1211785|P7|NOT COMPLETED|Second Intervention Period||0
495456|NCT01033487|1211786|P6|NOT COMPLETED|Second Intervention Period||0
495457|NCT01033487|1211787|P5|NOT COMPLETED|Second Intervention Period||0
495458|NCT01033487|1211788|P4|NOT COMPLETED|Second Intervention Period||0
495459|NCT01033487|1211789|P3|NOT COMPLETED|Second Intervention Period||0
495460|NCT01033487|1211790|P2|NOT COMPLETED|Second Intervention Period||0
495461|NCT01033487|1211791|P1|NOT COMPLETED|Second Intervention Period||0
495462|NCT01033487|1211782|P10|COMPLETED|Second Intervention Period||2
495463|NCT01033487|1211783|P9|COMPLETED|Second Intervention Period||2
495464|NCT01033487|1211784|P8|COMPLETED|Second Intervention Period||3
495465|NCT01033487|1211785|P7|COMPLETED|Second Intervention Period||2
495466|NCT01033487|1211786|P6|COMPLETED|Second Intervention Period||2
495467|NCT01033487|1211787|P5|COMPLETED|Second Intervention Period||2
495468|NCT01033487|1211788|P4|COMPLETED|Second Intervention Period||2
495469|NCT01033487|1211789|P3|COMPLETED|Second Intervention Period||2
495470|NCT01033487|1211790|P2|COMPLETED|Second Intervention Period||3
495471|NCT01033487|1211791|P1|COMPLETED|Second Intervention Period||2
495472|NCT01033487|1211782|P10|STARTED|Second Intervention Period||2
495473|NCT01033487|1211783|P9|STARTED|Second Intervention Period||2
495474|NCT01033487|1211784|P8|STARTED|Second Intervention Period||3
495475|NCT01033487|1211785|P7|STARTED|Second Intervention Period||2
495476|NCT01033487|1211786|P6|STARTED|Second Intervention Period||2
495477|NCT01033487|1211787|P5|STARTED|Second Intervention Period||2
495478|NCT01033487|1211788|P4|STARTED|Second Intervention Period||2
495479|NCT01033487|1211789|P3|STARTED|Second Intervention Period||2
495480|NCT01033487|1211790|P2|STARTED|Second Intervention Period||3
495481|NCT01033487|1211791|P1|STARTED|Second Intervention Period||2
495482|NCT01033487|1211782|P10|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
495483|NCT01033487|1211783|P9|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
495484|NCT01033487|1211784|P8|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
495485|NCT01033487|1211785|P7|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
495486|NCT01033487|1211786|P6|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
495487|NCT01033487|1211787|P5|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
495488|NCT01033487|1211788|P4|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
495489|NCT01033487|1211789|P3|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
495490|NCT01033487|1211790|P2|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
495491|NCT01033487|1211791|P1|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
495492|NCT01033487|1211782|P10|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
495493|NCT01033487|1211783|P9|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
495494|NCT01033487|1211784|P8|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3
495495|NCT01033487|1211785|P7|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
495496|NCT01033487|1211786|P6|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
495497|NCT01033487|1211787|P5|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
495498|NCT01033487|1211788|P4|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
495499|NCT01033487|1211789|P3|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
495500|NCT01033487|1211790|P2|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3
495501|NCT01033487|1211791|P1|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
495502|NCT01033487|1211782|P10|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
495503|NCT01033487|1211783|P9|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
495504|NCT01033487|1211784|P8|STARTED|Between Period 1 and 2 (At Least 7 Days)||3
495505|NCT01033487|1211785|P7|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
495506|NCT01033487|1211786|P6|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
495507|NCT01033487|1211787|P5|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
495508|NCT01033487|1211788|P4|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
495509|NCT01033487|1211789|P3|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
495510|NCT01033487|1211790|P2|STARTED|Between Period 1 and 2 (At Least 7 Days)||3
495511|NCT01033487|1211791|P1|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
495512|NCT01033487|1211782|P10|NOT COMPLETED|First Intervention Period||0
495513|NCT01033487|1211783|P9|NOT COMPLETED|First Intervention Period||0
495514|NCT01033487|1211784|P8|NOT COMPLETED|First Intervention Period||0
495515|NCT01033487|1211785|P7|NOT COMPLETED|First Intervention Period||0
495516|NCT01033487|1211786|P6|NOT COMPLETED|First Intervention Period||0
495517|NCT01033487|1211787|P5|NOT COMPLETED|First Intervention Period||0
495518|NCT01033487|1211788|P4|NOT COMPLETED|First Intervention Period||0
495519|NCT01033487|1211789|P3|NOT COMPLETED|First Intervention Period||0
495520|NCT01033487|1211790|P2|NOT COMPLETED|First Intervention Period||0
495521|NCT01033487|1211791|P1|NOT COMPLETED|First Intervention Period||0
495522|NCT01033487|1211782|P10|COMPLETED|First Intervention Period||2
495523|NCT01033487|1211783|P9|COMPLETED|First Intervention Period||2
495524|NCT01033487|1211784|P8|COMPLETED|First Intervention Period||3
495525|NCT01033487|1211785|P7|COMPLETED|First Intervention Period||2
495526|NCT01033487|1211786|P6|COMPLETED|First Intervention Period||2
495527|NCT01033487|1211787|P5|COMPLETED|First Intervention Period||2
495528|NCT01033487|1211788|P4|COMPLETED|First Intervention Period||2
495529|NCT01033487|1211789|P3|COMPLETED|First Intervention Period||2
495530|NCT01033487|1211790|P2|COMPLETED|First Intervention Period||3
495531|NCT01033487|1211791|P1|COMPLETED|First Intervention Period||2
495532|NCT01033487|1211782|P10|STARTED|First Intervention Period||2
495533|NCT01033487|1211783|P9|STARTED|First Intervention Period||2
495534|NCT01033487|1211784|P8|STARTED|First Intervention Period||3
495535|NCT01033487|1211785|P7|STARTED|First Intervention Period||2
495536|NCT01033487|1211786|P6|STARTED|First Intervention Period||2
495537|NCT01033487|1211787|P5|STARTED|First Intervention Period||2
495538|NCT01033487|1211788|P4|STARTED|First Intervention Period||2
495539|NCT01033487|1211789|P3|STARTED|First Intervention Period||2
495540|NCT01033487|1211790|P2|STARTED|First Intervention Period||3
495541|NCT01033487|1211791|P1|STARTED|First Intervention Period||2
495542|NCT01033448|1211845|P1|NOT COMPLETED|Overall Study||12
495543|NCT01033448|1211845|P1|COMPLETED|Overall Study||47
495544|NCT01033448|1211845|P1|STARTED|Overall Study||59
495545|NCT01033383|1211857|P4|NOT COMPLETED|Overall Study||0
495546|NCT01033383|1211858|P3|NOT COMPLETED|Overall Study||0
495547|NCT01033383|1211859|P2|NOT COMPLETED|Overall Study||0
495548|NCT01033383|1211860|P1|NOT COMPLETED|Overall Study||0
495549|NCT01033383|1211857|P4|COMPLETED|Overall Study||20
495550|NCT01033383|1211858|P3|COMPLETED|Overall Study||20
495551|NCT01033383|1211859|P2|COMPLETED|Overall Study||20
495552|NCT01033383|1211860|P1|COMPLETED|Overall Study||20
495553|NCT01033383|1211857|P4|STARTED|Overall Study||20
495554|NCT01033383|1211858|P3|STARTED|Overall Study||20
495555|NCT01033383|1211859|P2|STARTED|Overall Study||20
495556|NCT01033383|1211860|P1|STARTED|Overall Study||20
495557|NCT01033227|1211880|P2|NOT COMPLETED|Overall Study||0
495558|NCT01033227|1211881|P1|NOT COMPLETED|Overall Study||0
495559|NCT01033227|1211880|P2|COMPLETED|Overall Study||2
495560|NCT01033227|1211881|P1|COMPLETED|Overall Study||3
495561|NCT01033227|1211880|P2|STARTED|Overall Study||2
495562|NCT01033227|1211881|P1|STARTED|Overall Study||3
495563|NCT01033071|1211892|P3|NOT COMPLETED|Overall Study||47
495564|NCT01033071|1211893|P2|NOT COMPLETED|Overall Study||77
495565|NCT01033071|1211894|P1|NOT COMPLETED|Overall Study||55
495566|NCT01033071|1211892|P3|COMPLETED|Overall Study||317
495567|NCT01033071|1211893|P2|COMPLETED|Overall Study||275
495568|NCT01033071|1211894|P1|COMPLETED|Overall Study||300
495569|NCT01033071|1211892|P3|STARTED|Overall Study||364
495570|NCT01033071|1211893|P2|STARTED|Overall Study||352
495571|NCT01033071|1211894|P1|STARTED|Overall Study||355
495572|NCT01033032|1211953|P4|NOT COMPLETED|Phase II||0
495573|NCT01033032|1211954|P3|NOT COMPLETED|Phase II||66
495574|NCT01033032|1211955|P2|NOT COMPLETED|Phase II||0
495575|NCT01033032|1211956|P1|NOT COMPLETED|Phase II||0
495576|NCT01033032|1211953|P4|COMPLETED|Phase II||0
495577|NCT01033032|1211954|P3|COMPLETED|Phase II|Patients continued recieving treatment until disease progression or unacceptable toxicity|0
495578|NCT01033032|1211955|P2|COMPLETED|Phase II||0
495579|NCT01033032|1211956|P1|COMPLETED|Phase II||0
495580|NCT01033032|1211953|P4|STARTED|Phase II||0
495581|NCT01033032|1211954|P3|STARTED|Phase II|Includes patients treated at MTD during Phase I (3 patients); 63 additional patients enrolled|66
495582|NCT01033032|1211955|P2|STARTED|Phase II||0
495583|NCT01033032|1211956|P1|STARTED|Phase II||0
495584|NCT01033032|1211953|P4|NOT COMPLETED|Phase I||6
495585|NCT01033032|1211954|P3|NOT COMPLETED|Phase I||0
495586|NCT01033032|1211955|P2|NOT COMPLETED|Phase I||3
495587|NCT01033032|1211956|P1|NOT COMPLETED|Phase I||3
495588|NCT01033032|1211953|P4|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
495589|NCT01033032|1211954|P3|COMPLETED|Phase I||3
495590|NCT01033032|1211955|P2|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
495591|NCT01033032|1211956|P1|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
495592|NCT01033032|1211953|P4|STARTED|Phase I||6
495593|NCT01033032|1211954|P3|STARTED|Phase I||3
495594|NCT01033032|1211955|P2|STARTED|Phase I||3
495595|NCT01033032|1211956|P1|STARTED|Phase I||3
495596|NCT01033019|1211965|P2|NOT COMPLETED|Overall Study||0
495597|NCT01033019|1211966|P1|NOT COMPLETED|Overall Study||1
495598|NCT01033019|1211965|P2|COMPLETED|Overall Study||8
495599|NCT01033019|1211966|P1|COMPLETED|Overall Study||15
495600|NCT01033019|1211965|P2|STARTED|Overall Study||8
495601|NCT01033019|1211966|P1|STARTED|Overall Study||16
495602|NCT01032993|1211975|P2|NOT COMPLETED|Overall Study||0
495603|NCT01032993|1211976|P1|NOT COMPLETED|Overall Study||0
495604|NCT01032993|1211975|P2|COMPLETED|Overall Study||20
495605|NCT01032993|1211976|P1|COMPLETED|Overall Study||19
495606|NCT01032993|1211975|P2|STARTED|Overall Study||20
495607|NCT01032993|1211976|P1|STARTED|Overall Study||19
495608|NCT01032928|1211988|P1|NOT COMPLETED|Overall Study||0
495609|NCT01032928|1211988|P1|COMPLETED|Overall Study||30
495610|NCT01032928|1211988|P1|STARTED|Overall Study||30
495611|NCT01032915|1212004|P4|NOT COMPLETED|Overall Study||7
495612|NCT01032915|1212005|P3|NOT COMPLETED|Overall Study||7
495613|NCT01032915|1212006|P2|NOT COMPLETED|Overall Study||11
495614|NCT01032915|1212007|P1|NOT COMPLETED|Overall Study||8
495615|NCT01032915|1212004|P4|COMPLETED|Overall Study||27
495616|NCT01032915|1212005|P3|COMPLETED|Overall Study||24
495617|NCT01032915|1212006|P2|COMPLETED|Overall Study||20
495618|NCT01032915|1212007|P1|COMPLETED|Overall Study||21
495619|NCT01032915|1212004|P4|STARTED|Overall Study||34
495620|NCT01032915|1212005|P3|STARTED|Overall Study||31
495621|NCT01032915|1212006|P2|STARTED|Overall Study||31
495622|NCT01032915|1212007|P1|STARTED|Overall Study||29
495623|NCT01032889|1212032|P3|NOT COMPLETED|Overall Study||3
495624|NCT01032889|1212033|P2|NOT COMPLETED|Overall Study||15
495625|NCT01032889|1212034|P1|NOT COMPLETED|Overall Study||8
495626|NCT01032889|1212032|P3|COMPLETED|Overall Study||42
495627|NCT01032889|1212033|P2|COMPLETED|Overall Study||28
495628|NCT01032889|1212034|P1|COMPLETED|Overall Study||33
495629|NCT01032889|1212032|P3|Received Treatment|Overall Study||45
495630|NCT01032889|1212033|P2|Received Treatment|Overall Study||43
495631|NCT01032889|1212034|P1|Received Treatment|Overall Study||41
495632|NCT01032889|1212032|P3|STARTED|Overall Study||45
495633|NCT01032889|1212033|P2|STARTED|Overall Study||43
495634|NCT01032889|1212034|P1|STARTED|Overall Study||41
495635|NCT01032850|1212054|P1|NOT COMPLETED|Overall Study||2
495636|NCT01032850|1212054|P1|COMPLETED|Overall Study||13
495637|NCT01032850|1212054|P1|STARTED|Overall Study||15
495638|NCT01032837|1212065|P4|NOT COMPLETED|Overall Study||3
495639|NCT01032837|1212066|P3|NOT COMPLETED|Overall Study||1
495640|NCT01032837|1212067|P2|NOT COMPLETED|Overall Study||3
495641|NCT01032837|1212068|P1|NOT COMPLETED|Overall Study||0
495642|NCT01032837|1212065|P4|COMPLETED|Overall Study|Represents patients who completed treatment.|22
495643|NCT01032837|1212066|P3|COMPLETED|Overall Study|Represents patients who completed treatment.|24
495644|NCT01032837|1212067|P2|COMPLETED|Overall Study|Represents patients who completed treatment.|23
495645|NCT01032837|1212068|P1|COMPLETED|Overall Study|Represents patients who completed treatment.|26
495646|NCT01032837|1212065|P4|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|24
495647|NCT01032837|1212066|P3|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|25
495648|NCT01032837|1212067|P2|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|26
495649|NCT01032837|1212068|P1|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|26
495650|NCT01032837|1212065|P4|STARTED|Overall Study||25
495651|NCT01032837|1212066|P3|STARTED|Overall Study||25
495652|NCT01032837|1212067|P2|STARTED|Overall Study||26
495653|NCT01032837|1212068|P1|STARTED|Overall Study||26
495654|NCT01032759|1212116|P2|NOT COMPLETED|Overall Study||3
495655|NCT01032759|1212117|P1|NOT COMPLETED|Overall Study||1
495656|NCT01032759|1212116|P2|COMPLETED|Overall Study||28
495657|NCT01032759|1212117|P1|COMPLETED|Overall Study||31
495658|NCT01032759|1212116|P2|Completed 48 Hour Assessment|Overall Study||28
495659|NCT01032759|1212117|P1|Completed 48 Hour Assessment|Overall Study||31
495660|NCT01032759|1212116|P2|Completed 24 Hour Assessment|Overall Study||30
495661|NCT01032759|1212117|P1|Completed 24 Hour Assessment|Overall Study||32
495662|NCT01032759|1212116|P2|STARTED|Overall Study||31
495663|NCT01032759|1212117|P1|STARTED|Overall Study||32
495664|NCT01032733|1212137|P2|NOT COMPLETED|Overall Study||1
495665|NCT01032733|1212138|P1|NOT COMPLETED|Overall Study||1
495666|NCT01032733|1212137|P2|COMPLETED|Overall Study||16
495667|NCT01032733|1212138|P1|COMPLETED|Overall Study||16
495668|NCT01032733|1212137|P2|STARTED|Overall Study||17
495669|NCT01032733|1212138|P1|STARTED|Overall Study||17
495670|NCT01032694|1212154|P2|NOT COMPLETED|Overall Study||0
495671|NCT01032694|1212155|P1|NOT COMPLETED|Overall Study||0
495672|NCT01032694|1212154|P2|COMPLETED|Overall Study||10
495673|NCT01032694|1212155|P1|COMPLETED|Overall Study||20
495674|NCT01032694|1212154|P2|STARTED|Overall Study||10
495675|NCT01032694|1212155|P1|STARTED|Overall Study||20
495676|NCT01032538|1212165|P1|NOT COMPLETED|Overall Study||0
495677|NCT01032538|1212165|P1|COMPLETED|Overall Study|Knees|99
495678|NCT01032538|1212165|P1|STARTED|Overall Study|Knees|99
495679|NCT01032382|1212173|P2|NOT COMPLETED|Overall Study||5
495680|NCT01032382|1212174|P1|NOT COMPLETED|Overall Study||5
495681|NCT01032382|1212173|P2|COMPLETED|Overall Study||9
495682|NCT01032382|1212174|P1|COMPLETED|Overall Study||11
495683|NCT01032382|1212173|P2|STARTED|Overall Study||14
495684|NCT01032382|1212174|P1|STARTED|Overall Study||16
495685|NCT01032291|1212203|P3|NOT COMPLETED|Proof of Concept||3
495686|NCT01032291|1212204|P2|NOT COMPLETED|Proof of Concept||8
495687|NCT01032291|1212205|P1|NOT COMPLETED|Proof of Concept||0
495688|NCT01032291|1212203|P3|COMPLETED|Proof of Concept|Participants with disease progression|18
495689|NCT01032291|1212204|P2|COMPLETED|Proof of Concept|Participants with disease progression|14
495690|NCT01032291|1212205|P1|COMPLETED|Proof of Concept||0
495691|NCT01032291|1212203|P3|Intent to Treat and Safety Populations|Proof of Concept|Participants who took at least one dose of study drug|21
495692|NCT01032291|1212204|P2|Intent to Treat and Safety Populations|Proof of Concept|Participants who took at least one dose of study drug|21
495693|NCT01032291|1212205|P1|Intent to Treat and Safety Populations|Proof of Concept||0
495694|NCT01032291|1212203|P3|STARTED|Proof of Concept||21
495695|NCT01032291|1212204|P2|STARTED|Proof of Concept||22
495696|NCT01032291|1212205|P1|STARTED|Proof of Concept||0
495697|NCT01032291|1212203|P3|NOT COMPLETED|Safety Lead-in||0
495698|NCT01032291|1212204|P2|NOT COMPLETED|Safety Lead-in||0
495699|NCT01032291|1212205|P1|NOT COMPLETED|Safety Lead-in||2
495700|NCT01032291|1212203|P3|COMPLETED|Safety Lead-in||0
495701|NCT01032291|1212204|P2|COMPLETED|Safety Lead-in||0
495702|NCT01032291|1212205|P1|COMPLETED|Safety Lead-in|Participants with disease progression|6
495703|NCT01032291|1212203|P3|STARTED|Safety Lead-in||0
495704|NCT01032291|1212204|P2|STARTED|Safety Lead-in||0
495705|NCT01032291|1212205|P1|STARTED|Safety Lead-in||8
495706|NCT01032265|1212231|P2|NOT COMPLETED|Overall Study||17
495707|NCT01032265|1212232|P1|NOT COMPLETED|Overall Study||13
495708|NCT01032265|1212231|P2|COMPLETED|Overall Study||107
495709|NCT01032265|1212232|P1|COMPLETED|Overall Study||113
495710|NCT01032265|1212231|P2|STARTED|Overall Study||124
495711|NCT01032265|1212232|P1|STARTED|Overall Study||126
495712|NCT01032239|1212252|P2|NOT COMPLETED|Overall Study||5
495713|NCT01032239|1212253|P1|NOT COMPLETED|Overall Study||7
495714|NCT01032239|1212252|P2|COMPLETED|Overall Study||24
495715|NCT01032239|1212253|P1|COMPLETED|Overall Study||24
495716|NCT01032239|1212252|P2|Implant|Overall Study||0
495717|NCT01032239|1212253|P1|Implant|Overall Study|implanted|25
495718|NCT01032239|1212252|P2|STARTED|Overall Study|randomized to BMT arm|29
495719|NCT01032239|1212253|P1|STARTED|Overall Study|randomized to ITB arm|31
495720|NCT01032200|1212283|P2|NOT COMPLETED|Overall Study||7
495721|NCT01032200|1212284|P1|NOT COMPLETED|Overall Study||4
495722|NCT01032200|1212283|P2|COMPLETED|Overall Study||21
495723|NCT01032200|1212284|P1|COMPLETED|Overall Study||22
495724|NCT01032200|1212283|P2|STARTED|Overall Study||28
495725|NCT01032200|1212284|P1|STARTED|Overall Study||26
495726|NCT01032174|1212300|P2|NOT COMPLETED|Overall Study||1
495727|NCT01032174|1212301|P1|NOT COMPLETED|Overall Study||0
495728|NCT01032174|1212300|P2|COMPLETED|Overall Study||59
495729|NCT01032174|1212301|P1|COMPLETED|Overall Study||63
495730|NCT01032174|1212300|P2|STARTED|Overall Study||60
495731|NCT01032174|1212301|P1|STARTED|Overall Study||63
495732|NCT01032135|1212316|P7|NOT COMPLETED|8 Week Randomization||18
495733|NCT01032135|1212317|P6|NOT COMPLETED|8 Week Randomization||17
495734|NCT01032135|1212318|P5|NOT COMPLETED|8 Week Randomization||9
495735|NCT01032135|1212319|P4|NOT COMPLETED|8 Week Randomization||11
495736|NCT01032135|1212320|P3|NOT COMPLETED|8 Week Randomization||0
495737|NCT01032135|1212321|P2|NOT COMPLETED|8 Week Randomization||0
495738|NCT01032135|1212322|P1|NOT COMPLETED|8 Week Randomization||26
495739|NCT01032135|1212316|P7|COMPLETED|8 Week Randomization||36
495740|NCT01032135|1212317|P6|COMPLETED|8 Week Randomization||31
495741|NCT01032135|1212318|P5|COMPLETED|8 Week Randomization||34
495742|NCT01032135|1212319|P4|COMPLETED|8 Week Randomization||30
495743|NCT01032135|1212320|P3|COMPLETED|8 Week Randomization||0
495744|NCT01032135|1212321|P2|COMPLETED|8 Week Randomization||0
495745|NCT01032135|1212322|P1|COMPLETED|8 Week Randomization|These participants were'nt included in analyses as they didn't meet criteria for study intervention.|201
495746|NCT01032135|1212316|P7|12 Week Follow up|8 Week Randomization||41
495747|NCT01032135|1212317|P6|12 Week Follow up|8 Week Randomization||36
495748|NCT01032135|1212318|P5|12 Week Follow up|8 Week Randomization||38
495749|NCT01032135|1212319|P4|12 Week Follow up|8 Week Randomization||34
495750|NCT01032135|1212320|P3|12 Week Follow up|8 Week Randomization||0
495751|NCT01032135|1212321|P2|12 Week Follow up|8 Week Randomization||0
495752|NCT01032135|1212322|P1|12 Week Follow up|8 Week Randomization|These participants were'nt included in analyses as they didn't meet criteria for study intervention.|217
495753|NCT01032135|1212316|P7|STARTED|8 Week Randomization||54
495754|NCT01032135|1212317|P6|STARTED|8 Week Randomization||48
495755|NCT01032135|1212318|P5|STARTED|8 Week Randomization||43
495756|NCT01032135|1212319|P4|STARTED|8 Week Randomization||41
495757|NCT01032135|1212320|P3|STARTED|8 Week Randomization||0
495758|NCT01032135|1212321|P2|STARTED|8 Week Randomization||0
495759|NCT01032135|1212322|P1|STARTED|8 Week Randomization||227
495760|NCT01032135|1212316|P7|NOT COMPLETED|2 Week Randomization||0
495761|NCT01032135|1212317|P6|NOT COMPLETED|2 Week Randomization||0
495762|NCT01032135|1212318|P5|NOT COMPLETED|2 Week Randomization||0
495763|NCT01032135|1212319|P4|NOT COMPLETED|2 Week Randomization||0
495764|NCT01032135|1212320|P3|NOT COMPLETED|2 Week Randomization||0
495765|NCT01032135|1212321|P2|NOT COMPLETED|2 Week Randomization||0
495766|NCT01032135|1212322|P1|NOT COMPLETED|2 Week Randomization||0
495767|NCT01032135|1212316|P7|COMPLETED|2 Week Randomization||0
495768|NCT01032135|1212317|P6|COMPLETED|2 Week Randomization||0
495769|NCT01032135|1212318|P5|COMPLETED|2 Week Randomization||0
495770|NCT01032135|1212319|P4|COMPLETED|2 Week Randomization||0
495771|NCT01032135|1212320|P3|COMPLETED|2 Week Randomization||96
495772|NCT01032135|1212321|P2|COMPLETED|2 Week Randomization||93
495773|NCT01032135|1212322|P1|COMPLETED|2 Week Randomization||311
495774|NCT01032135|1212316|P7|STARTED|2 Week Randomization||0
495775|NCT01032135|1212317|P6|STARTED|2 Week Randomization||0
495776|NCT01032135|1212318|P5|STARTED|2 Week Randomization||0
495777|NCT01032135|1212319|P4|STARTED|2 Week Randomization||0
495778|NCT01032135|1212320|P3|STARTED|2 Week Randomization||96
495779|NCT01032135|1212321|P2|STARTED|2 Week Randomization||93
495780|NCT01032135|1212322|P1|STARTED|2 Week Randomization||311
495781|NCT01032070|1212541|P2|NOT COMPLETED|Overall Study||12
495782|NCT01032070|1212542|P1|NOT COMPLETED|Overall Study||13
495783|NCT01032070|1212541|P2|COMPLETED|Overall Study||0
495784|NCT01032070|1212542|P1|COMPLETED|Overall Study||0
495785|NCT01032070|1212541|P2|STARTED|Overall Study||12
495786|NCT01032070|1212542|P1|STARTED|Overall Study||13
495787|NCT01032044|1212571|P2|NOT COMPLETED|Overall Study||20
495788|NCT01032044|1212572|P1|NOT COMPLETED|Overall Study||25
495789|NCT01032044|1212571|P2|COMPLETED|Overall Study||62
495790|NCT01032044|1212572|P1|COMPLETED|Overall Study||57
495791|NCT01032044|1212571|P2|Procedure|Overall Study||75
495792|NCT01032044|1212572|P1|Procedure|Overall Study||74
495793|NCT01032044|1212571|P2|STARTED|Overall Study||82
495794|NCT01032044|1212572|P1|STARTED|Overall Study||82
495795|NCT01032018|1212580|P2|NOT COMPLETED|Overall Study||6
495796|NCT01032018|1212581|P1|NOT COMPLETED|Overall Study||6
495797|NCT01032018|1212580|P2|COMPLETED|Overall Study||67
495798|NCT01032018|1212581|P1|COMPLETED|Overall Study||71
495799|NCT01032018|1212580|P2|STARTED|Overall Study||73
495800|NCT01032018|1212581|P1|STARTED|Overall Study||77
495801|NCT01031979|1212591|P2|NOT COMPLETED|Overall Study||4
495802|NCT01031979|1212592|P1|NOT COMPLETED|Overall Study||5
495803|NCT01031979|1212591|P2|COMPLETED|Overall Study|These are individuals who completed treatment in the study.|8
495804|NCT01031979|1212592|P1|COMPLETED|Overall Study|These are individuals who completed treatment in the study.|9
495805|NCT01031979|1212591|P2|Completed Primary Outcome Measure|Overall Study||12
495806|NCT01031979|1212592|P1|Completed Primary Outcome Measure|Overall Study||12
495807|NCT01031979|1212591|P2|STARTED|Overall Study|To meet eligibility requirements for randomization, subjects had to reach session 3 w/o dropping.|12
495808|NCT01031979|1212592|P1|STARTED|Overall Study|To meet eligibility requirements for randomization, subjects had to reach session 3 w/o dropping.|14
495809|NCT01031953|1212604|P1|NOT COMPLETED|Overall Study||0
495810|NCT01031953|1212604|P1|COMPLETED|Overall Study||11
495811|NCT01031953|1212604|P1|STARTED|Overall Study||11
495812|NCT01031914|1212615|P1|NOT COMPLETED|Overall Study||0
495813|NCT01031914|1212615|P1|COMPLETED|Overall Study||36
495814|NCT01031914|1212615|P1|STARTED|Overall Study||36
495815|NCT01031810|1212619|P1|NOT COMPLETED|Overall Study||4
495816|NCT01031810|1212619|P1|COMPLETED|Overall Study||9
495817|NCT01031810|1212619|P1|STARTED|Overall Study||13
495818|NCT01031706|1212630|P2|NOT COMPLETED|Overall Study||1
495819|NCT01031706|1212631|P1|NOT COMPLETED|Overall Study||2
495820|NCT01031706|1212630|P2|COMPLETED|Overall Study||8
495821|NCT01031706|1212631|P1|COMPLETED|Overall Study||12
495822|NCT01031706|1212630|P2|STARTED|Overall Study||9
495823|NCT01031706|1212631|P1|STARTED|Overall Study||14
495824|NCT01031680|1212641|P2|NOT COMPLETED|Overall Study||58
495825|NCT01031680|1212642|P1|NOT COMPLETED|Overall Study||57
495826|NCT01031680|1212641|P2|COMPLETED|Overall Study||404
495827|NCT01031680|1212642|P1|COMPLETED|Overall Study||403
495828|NCT01031680|1212641|P2|STARTED|Overall Study|Of the 462 randomized participants only 459 were included in the full analysis set.|462
495829|NCT01031680|1212642|P1|STARTED|Overall Study|Of the 460 randomized participants only 455 were included in the full analysis set.|460
495830|NCT01031628|1212662|P4|NOT COMPLETED|Overall Study||0
495831|NCT01031628|1212663|P3|NOT COMPLETED|Overall Study||3
495832|NCT01031628|1212664|P2|NOT COMPLETED|Overall Study||1
495833|NCT01031628|1212665|P1|NOT COMPLETED|Overall Study||0
495834|NCT01031628|1212662|P4|COMPLETED|Overall Study||0
495835|NCT01031628|1212663|P3|COMPLETED|Overall Study||0
495836|NCT01031628|1212664|P2|COMPLETED|Overall Study||0
495837|NCT01031628|1212665|P1|COMPLETED|Overall Study||0
495838|NCT01031628|1212662|P4|STARTED|Overall Study||0
495839|NCT01031628|1212663|P3|STARTED|Overall Study||3
495840|NCT01031628|1212664|P2|STARTED|Overall Study||1
495841|NCT01031628|1212665|P1|STARTED|Overall Study||0
495842|NCT01031550|1212677|P2|NOT COMPLETED|Overall Study||0
495843|NCT01031550|1212678|P1|NOT COMPLETED|Overall Study||0
495844|NCT01031550|1212677|P2|COMPLETED|Overall Study||3
495845|NCT01031550|1212678|P1|COMPLETED|Overall Study||5
495846|NCT01031550|1212677|P2|STARTED|Overall Study||3
495847|NCT01031550|1212678|P1|STARTED|Overall Study||5
495848|NCT01031498|1212693|P3|NOT COMPLETED|Overall Study||2
495849|NCT01031498|1212694|P2|NOT COMPLETED|Overall Study||3
495850|NCT01031498|1212695|P1|NOT COMPLETED|Overall Study||2
495851|NCT01031498|1212693|P3|COMPLETED|Overall Study||48
495852|NCT01031498|1212694|P2|COMPLETED|Overall Study||48
495853|NCT01031498|1212695|P1|COMPLETED|Overall Study||47
495854|NCT01031498|1212693|P3|STARTED|Overall Study|2 patients were not evaluable in arm 3.|50
495855|NCT01031498|1212694|P2|STARTED|Overall Study|3 patients were not evaluable in arm 2|51
495856|NCT01031498|1212695|P1|STARTED|Overall Study|2 patients were not evaluable in arm 1.|49
495857|NCT01031446|1212703|P1|NOT COMPLETED|Overall Study||55
495858|NCT01031446|1212703|P1|COMPLETED|Overall Study||0
495859|NCT01031446|1212703|P1|STARTED|Overall Study||55
495860|NCT01031381|1212712|P1|NOT COMPLETED|Overall Study||9
495861|NCT01031381|1212712|P1|COMPLETED|Overall Study||50
495862|NCT01031381|1212712|P1|STARTED|Overall Study||59
495863|NCT01031134|1212719|P2|NOT COMPLETED|Overall Study||10
495864|NCT01031134|1212720|P1|NOT COMPLETED|Overall Study||11
495865|NCT01031134|1212719|P2|COMPLETED|Overall Study||78
495866|NCT01031134|1212720|P1|COMPLETED|Overall Study||103
495867|NCT01031134|1212719|P2|STARTED|Overall Study||88
495868|NCT01031134|1212720|P1|STARTED|Overall Study||114
495869|NCT01031095|1212730|P2|NOT COMPLETED|Overall Study||0
495870|NCT01031095|1212731|P1|NOT COMPLETED|Overall Study||0
495871|NCT01031095|1212730|P2|COMPLETED|Overall Study||100
495872|NCT01031095|1212731|P1|COMPLETED|Overall Study||100
495873|NCT01031095|1212730|P2|STARTED|Overall Study||100
495874|NCT01031095|1212731|P1|STARTED|Overall Study||100
495875|NCT01031043|1212737|P1|NOT COMPLETED|Overall Study||1
495876|NCT01031043|1212737|P1|COMPLETED|Overall Study||4
495877|NCT01031043|1212737|P1|STARTED|Overall Study||5
495878|NCT01031004|1212743|P2|NOT COMPLETED|Overall Study||1
495879|NCT01031004|1212744|P1|NOT COMPLETED|Overall Study||1
495880|NCT01031004|1212743|P2|COMPLETED|Overall Study||24
495881|NCT01031004|1212744|P1|COMPLETED|Overall Study||24
495882|NCT01031004|1212743|P2|STARTED|Overall Study||25
495883|NCT01031004|1212744|P1|STARTED|Overall Study||25
495884|NCT01030965|1212788|P4|NOT COMPLETED|Overall Study||7
495885|NCT01030965|1212789|P3|NOT COMPLETED|Overall Study||4
495886|NCT01030965|1212790|P2|NOT COMPLETED|Overall Study||6
495887|NCT01030965|1212791|P1|NOT COMPLETED|Overall Study||4
495888|NCT01030965|1212788|P4|COMPLETED|Overall Study||64
495889|NCT01030965|1212789|P3|COMPLETED|Overall Study||68
495890|NCT01030965|1212790|P2|COMPLETED|Overall Study||65
495891|NCT01030965|1212791|P1|COMPLETED|Overall Study||67
495892|NCT01030965|1212788|P4|STARTED|Overall Study||71
495893|NCT01030965|1212789|P3|STARTED|Overall Study||72
495894|NCT01030965|1212790|P2|STARTED|Overall Study||71
495895|NCT01030965|1212791|P1|STARTED|Overall Study||71
495896|NCT01030952|1212811|P2|NOT COMPLETED|Overall Study||3
495897|NCT01030952|1212812|P1|NOT COMPLETED|Overall Study||2
495898|NCT01030952|1212811|P2|COMPLETED|Overall Study||49
495899|NCT01030952|1212812|P1|COMPLETED|Overall Study||49
495900|NCT01030952|1212811|P2|STARTED|Overall Study||52
495901|NCT01030952|1212812|P1|STARTED|Overall Study||51
495902|NCT01030822|1212849|P3|NOT COMPLETED|Overall Study||26
495903|NCT01030822|1212850|P2|NOT COMPLETED|Overall Study||24
495904|NCT01030822|1212851|P1|NOT COMPLETED|Overall Study||31
495905|NCT01030822|1212849|P3|COMPLETED|Overall Study||61
495906|NCT01030822|1212850|P2|COMPLETED|Overall Study||71
495907|NCT01030822|1212851|P1|COMPLETED|Overall Study||69
495908|NCT01030822|1212849|P3|STARTED|Overall Study||87
495909|NCT01030822|1212850|P2|STARTED|Overall Study||95
495910|NCT01030822|1212851|P1|STARTED|Overall Study||100
495911|NCT01030757|1212898|P1|NOT COMPLETED|Overall Study||0
495912|NCT01030757|1212898|P1|COMPLETED|Overall Study||2
495913|NCT01030757|1212898|P1|STARTED|Overall Study||2
495914|NCT01030718|1212906|P3|NOT COMPLETED|Study CA180-036 Only||5
495915|NCT01030718|1212907|P2|NOT COMPLETED|Study CA180-036 Only||7
495916|NCT01030718|1212908|P1|NOT COMPLETED|Study CA180-036 Only||3
495917|NCT01030718|1212906|P3|COMPLETED|Study CA180-036 Only||1
495918|NCT01030718|1212907|P2|COMPLETED|Study CA180-036 Only||2
495919|NCT01030718|1212908|P1|COMPLETED|Study CA180-036 Only||26
495920|NCT01030718|1212906|P3|STARTED|Study CA180-036 Only||6
495921|NCT01030718|1212907|P2|STARTED|Study CA180-036 Only||9
495922|NCT01030718|1212908|P1|STARTED|Study CA180-036 Only||29
495923|NCT01030718|1212906|P3|NOT COMPLETED|Studies CA180-031 and -036 Combined||12
495924|NCT01030718|1212907|P2|NOT COMPLETED|Studies CA180-031 and -036 Combined||9
495925|NCT01030718|1212908|P1|NOT COMPLETED|Studies CA180-031 and -036 Combined||4
495926|NCT01030718|1212906|P3|COMPLETED|Studies CA180-031 and -036 Combined||1
495927|NCT01030718|1212907|P2|COMPLETED|Studies CA180-031 and -036 Combined||2
495928|NCT01030718|1212908|P1|COMPLETED|Studies CA180-031 and -036 Combined||26
495929|NCT01030718|1212906|P3|STARTED|Studies CA180-031 and -036 Combined||13
495930|NCT01030718|1212907|P2|STARTED|Studies CA180-031 and -036 Combined||11
495931|NCT01030718|1212908|P1|STARTED|Studies CA180-031 and -036 Combined||30
495932|NCT01030666|1212969|P2|NOT COMPLETED|Overall Study||2
495933|NCT01030666|1212970|P1|NOT COMPLETED|Overall Study||3
495934|NCT01030666|1212969|P2|COMPLETED|Overall Study||31
495935|NCT01030666|1212970|P1|COMPLETED|Overall Study||25
495936|NCT01030666|1212969|P2|STARTED|Overall Study||33
495937|NCT01030666|1212970|P1|STARTED|Overall Study||28
495938|NCT01030653|1212980|P2|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0
495939|NCT01030653|1212981|P1|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0
495940|NCT01030653|1212980|P2|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4
495941|NCT01030653|1212981|P1|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4
495942|NCT01030653|1212980|P2|STARTED|Loading Dose & 2nd Maintenance Regimen||4
495943|NCT01030653|1212981|P1|STARTED|Loading Dose & 2nd Maintenance Regimen||4
495944|NCT01030653|1212980|P2|NOT COMPLETED|7-Day Washout Period||0
495945|NCT01030653|1212981|P1|NOT COMPLETED|7-Day Washout Period||0
495946|NCT01030653|1212980|P2|COMPLETED|7-Day Washout Period||4
495947|NCT01030653|1212981|P1|COMPLETED|7-Day Washout Period||4
495948|NCT01030653|1212980|P2|STARTED|7-Day Washout Period||4
495949|NCT01030653|1212981|P1|STARTED|7-Day Washout Period||4
495950|NCT01030653|1212980|P2|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0
495951|NCT01030653|1212981|P1|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0
495952|NCT01030653|1212980|P2|COMPLETED|Loading Dose & First Maintenance Regimen||4
495953|NCT01030653|1212981|P1|COMPLETED|Loading Dose & First Maintenance Regimen||4
495954|NCT01030653|1212980|P2|STARTED|Loading Dose & First Maintenance Regimen||4
495955|NCT01030653|1212981|P1|STARTED|Loading Dose & First Maintenance Regimen||4
495956|NCT01030536|1212995|P5|NOT COMPLETED|Overall Study||1
495957|NCT01030536|1212996|P4|NOT COMPLETED|Overall Study||3
495958|NCT01030536|1212997|P3|NOT COMPLETED|Overall Study||6
495959|NCT01030536|1212998|P2|NOT COMPLETED|Overall Study||6
495960|NCT01030536|1212999|P1|NOT COMPLETED|Overall Study||7
495961|NCT01030536|1212995|P5|COMPLETED|Overall Study||0
495962|NCT01030536|1212996|P4|COMPLETED|Overall Study||0
495963|NCT01030536|1212997|P3|COMPLETED|Overall Study||0
495964|NCT01030536|1212998|P2|COMPLETED|Overall Study||0
495965|NCT01030536|1212999|P1|COMPLETED|Overall Study||0
495966|NCT01030536|1212995|P5|STARTED|Overall Study||1
495967|NCT01030536|1212996|P4|STARTED|Overall Study||3
495968|NCT01030536|1212997|P3|STARTED|Overall Study||6
495969|NCT01030536|1212998|P2|STARTED|Overall Study||6
495970|NCT01030536|1212999|P1|STARTED|Overall Study||7
495971|NCT01030458|1213104|P2|NOT COMPLETED|Overall Study||32
495972|NCT01030458|1213105|P1|NOT COMPLETED|Overall Study||27
495973|NCT01030458|1213104|P2|COMPLETED|Overall Study||57
495974|NCT01030458|1213105|P1|COMPLETED|Overall Study||67
495975|NCT01030458|1213104|P2|STARTED|Overall Study||89
495976|NCT01030458|1213105|P1|STARTED|Overall Study||94
495977|NCT01030289|1213117|P2|NOT COMPLETED|Overall Study||0
495978|NCT01030289|1213118|P1|NOT COMPLETED|Overall Study||0
495979|NCT01030289|1213117|P2|COMPLETED|Overall Study||10
495980|NCT01030289|1213118|P1|COMPLETED|Overall Study||9
495981|NCT01030289|1213117|P2|STARTED|Overall Study||10
495982|NCT01030289|1213118|P1|STARTED|Overall Study||9
495983|NCT01029925|1213133|P1|NOT COMPLETED|Completion of Cycle 2 (56 Days)||1
495984|NCT01029925|1213133|P1|COMPLETED|Completion of Cycle 2 (56 Days)||2
495985|NCT01029925|1213133|P1|STARTED|Completion of Cycle 2 (56 Days)||3
495986|NCT01029925|1213133|P1|NOT COMPLETED|Completion of Cycle 1 (28 Days)||4
495987|NCT01029925|1213133|P1|COMPLETED|Completion of Cycle 1 (28 Days)||3
495988|NCT01029925|1213133|P1|STARTED|Completion of Cycle 1 (28 Days)||7
495989|NCT01029912|1213139|P2|NOT COMPLETED|Overall Study||0
495990|NCT01029912|1213140|P1|NOT COMPLETED|Overall Study||2
495991|NCT01029912|1213139|P2|COMPLETED|Overall Study||12
495992|NCT01029912|1213140|P1|COMPLETED|Overall Study||12
495993|NCT01029912|1213139|P2|STARTED|Overall Study||12
495994|NCT01029912|1213140|P1|STARTED|Overall Study||14
495995|NCT01029886|1213152|P2|NOT COMPLETED|Overall Study||60
495996|NCT01029886|1213153|P1|NOT COMPLETED|Overall Study||61
495997|NCT01029886|1213152|P2|COMPLETED|Overall Study||391
495998|NCT01029886|1213153|P1|COMPLETED|Overall Study||400
495999|NCT01029886|1213152|P2|Intent to Treat (ITT)|Overall Study||450
496000|NCT01029886|1213153|P1|Intent to Treat (ITT)|Overall Study||461
496001|NCT01029886|1213152|P2|STARTED|Overall Study||451
496002|NCT01029886|1213153|P1|STARTED|Overall Study||461
496003|NCT01029795|1213181|P2|NOT COMPLETED|Overall Study||22
496004|NCT01029795|1213182|P1|NOT COMPLETED|Overall Study||16
496005|NCT01029795|1213181|P2|COMPLETED|Overall Study||0
496006|NCT01029795|1213182|P1|COMPLETED|Overall Study||0
496007|NCT01029795|1213181|P2|STARTED|Overall Study||22
496008|NCT01029795|1213182|P1|STARTED|Overall Study||16
496009|NCT01029730|1213234|P1|NOT COMPLETED|Maintenance Therapy||23
496010|NCT01029730|1213234|P1|COMPLETED|Maintenance Therapy||14
496011|NCT01029730|1213234|P1|STARTED|Maintenance Therapy|Two patients complete study treatment but declined subsequent maintenance therapy|37
496012|NCT01029730|1213234|P1|NOT COMPLETED|Combination Therapy||16
496013|NCT01029730|1213234|P1|COMPLETED|Combination Therapy|Patients remained on-study until completing 6 cycles or coming off-treatment for any other reason|39
496014|NCT01029730|1213234|P1|STARTED|Combination Therapy||55
496015|NCT01029704|1213246|P5|NOT COMPLETED|Overall Study||0
496016|NCT01029704|1213247|P4|NOT COMPLETED|Overall Study||0
496017|NCT01029704|1213248|P3|NOT COMPLETED|Overall Study||0
496018|NCT01029704|1213249|P2|NOT COMPLETED|Overall Study||0
496019|NCT01029704|1213250|P1|NOT COMPLETED|Overall Study||0
496020|NCT01029704|1213246|P5|COMPLETED|Overall Study||26
496021|NCT01029704|1213247|P4|COMPLETED|Overall Study||28
496022|NCT01029704|1213248|P3|COMPLETED|Overall Study||23
496023|NCT01029704|1213249|P2|COMPLETED|Overall Study||24
496024|NCT01029704|1213250|P1|COMPLETED|Overall Study||28
496025|NCT01029704|1213246|P5|STARTED|Overall Study||26
496026|NCT01029704|1213247|P4|STARTED|Overall Study||28
496027|NCT01029704|1213248|P3|STARTED|Overall Study||23
496028|NCT01029704|1213249|P2|STARTED|Overall Study||24
496029|NCT01029704|1213250|P1|STARTED|Overall Study||28
496030|NCT01029691|1213280|P3|NOT COMPLETED|Continued APAP to Delivery||1
496031|NCT01029691|1213281|P2|NOT COMPLETED|Continued APAP to Delivery||0
496032|NCT01029691|1213282|P1|NOT COMPLETED|Continued APAP to Delivery||0
496033|NCT01029691|1213280|P3|COMPLETED|Continued APAP to Delivery||76
496034|NCT01029691|1213281|P2|COMPLETED|Continued APAP to Delivery||16
496035|NCT01029691|1213282|P1|COMPLETED|Continued APAP to Delivery||20
496036|NCT01029691|1213280|P3|STARTED|Continued APAP to Delivery||77
496037|NCT01029691|1213281|P2|STARTED|Continued APAP to Delivery||16
496038|NCT01029691|1213282|P1|STARTED|Continued APAP to Delivery||20
496039|NCT01029691|1213280|P3|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||0
496040|NCT01029691|1213281|P2|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||11
496041|NCT01029691|1213282|P1|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||0
496042|NCT01029691|1213280|P3|COMPLETED|APAP Initiation to Week 1 or Delivery||77
496043|NCT01029691|1213281|P2|COMPLETED|APAP Initiation to Week 1 or Delivery||16
496044|NCT01029691|1213282|P1|COMPLETED|APAP Initiation to Week 1 or Delivery||20
496045|NCT01029691|1213280|P3|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||77
496046|NCT01029691|1213281|P2|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||16
496047|NCT01029691|1213282|P1|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||20
496048|NCT01029691|1213280|P3|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||77
496049|NCT01029691|1213281|P2|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||23
496050|NCT01029691|1213282|P1|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||20
496051|NCT01029691|1213280|P3|STARTED|APAP Initiation to Week 1 or Delivery||77
496052|NCT01029691|1213281|P2|STARTED|APAP Initiation to Week 1 or Delivery|4 delivered before APAP initiation 7 elected not to have APAP following baseline study|27
496053|NCT01029691|1213282|P1|STARTED|APAP Initiation to Week 1 or Delivery||20
496054|NCT01029652|1213307|P2|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||3
496055|NCT01029652|1213308|P1|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||1
496056|NCT01029652|1213307|P2|COMPLETED|Extension Study 2 (25-72 Weeks)||63
496057|NCT01029652|1213308|P1|COMPLETED|Extension Study 2 (25-72 Weeks)||68
496058|NCT01029652|1213307|P2|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients switched to canakinumab from Week 25 - Week 72|39
496059|NCT01029652|1213308|P1|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients re-treated with canakinumab over 72 weeks study duration overall|69
496060|NCT01029652|1213307|P2|STARTED|Extension Study 2 (25-72 Weeks)||66
496061|NCT01029652|1213308|P1|STARTED|Extension Study 2 (25-72 Weeks)||69
496062|NCT01029652|1213307|P2|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||5
496063|NCT01029652|1213308|P1|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||3
496064|NCT01029652|1213307|P2|COMPLETED|Extension Study 1 (12-24 Weeks)||80
496065|NCT01029652|1213308|P1|COMPLETED|Extension Study 1 (12-24 Weeks)||87
496066|NCT01029652|1213307|P2|STARTED|Extension Study 1 (12-24 Weeks)||85
496067|NCT01029652|1213308|P1|STARTED|Extension Study 1 (12-24 Weeks)||90
496068|NCT01029652|1213307|P2|NOT COMPLETED|Core Study (0-12 Weeks)||10
496069|NCT01029652|1213308|P1|NOT COMPLETED|Core Study (0-12 Weeks)||6
496070|NCT01029652|1213307|P2|COMPLETED|Core Study (0-12 Weeks)||105
496071|NCT01029652|1213308|P1|COMPLETED|Core Study (0-12 Weeks)||109
496072|NCT01029652|1213307|P2|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||115
496073|NCT01029652|1213308|P1|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||113
496074|NCT01029652|1213307|P2|STARTED|Core Study (0-12 Weeks)||115
496075|NCT01029652|1213308|P1|STARTED|Core Study (0-12 Weeks)||115
496076|NCT01029535|1213386|P1|NOT COMPLETED|Overall Study||31
496077|NCT01029535|1213386|P1|COMPLETED|Overall Study||72
496078|NCT01029535|1213386|P1|STARTED|Overall Study||103
496079|NCT01029405|1213415|P4|NOT COMPLETED|Overall Study||5
496080|NCT01029405|1213416|P3|NOT COMPLETED|Overall Study||4
496081|NCT01029405|1213417|P2|NOT COMPLETED|Overall Study||3
496082|NCT01029405|1213418|P1|NOT COMPLETED|Overall Study||2
496083|NCT01029405|1213415|P4|COMPLETED|Overall Study||32
496084|NCT01029405|1213416|P3|COMPLETED|Overall Study||31
496085|NCT01029405|1213417|P2|COMPLETED|Overall Study||34
496086|NCT01029405|1213418|P1|COMPLETED|Overall Study||34
496087|NCT01029405|1213415|P4|STARTED|Overall Study||37
496088|NCT01029405|1213416|P3|STARTED|Overall Study||35
496089|NCT01029405|1213417|P2|STARTED|Overall Study||37
496090|NCT01029405|1213418|P1|STARTED|Overall Study||36
496091|NCT01029392|1213430|P2|NOT COMPLETED|Overall Study||11
496092|NCT01029392|1213431|P1|NOT COMPLETED|Overall Study||20
496093|NCT01029392|1213430|P2|COMPLETED|Overall Study||27
496094|NCT01029392|1213431|P1|COMPLETED|Overall Study||17
496095|NCT01029392|1213430|P2|STARTED|Overall Study||38
496096|NCT01029392|1213431|P1|STARTED|Overall Study||37
496097|NCT01029366|1213441|P2|NOT COMPLETED|Overall Study||2
496098|NCT01029366|1213442|P1|NOT COMPLETED|Overall Study||4
496099|NCT01029366|1213441|P2|COMPLETED|Overall Study||6
496100|NCT01029366|1213442|P1|COMPLETED|Overall Study||14
496101|NCT01029366|1213441|P2|STARTED|Overall Study||8
496102|NCT01029366|1213442|P1|STARTED|Overall Study||18
496103|NCT01029340|1213454|P6|NOT COMPLETED|Part C Follow up Period||0
496104|NCT01029340|1213455|P5|NOT COMPLETED|Part C Follow up Period||0
496105|NCT01029340|1213456|P4|NOT COMPLETED|Part C Follow up Period||0
496106|NCT01029340|1213457|P3|NOT COMPLETED|Part C Follow up Period||0
496107|NCT01029340|1213458|P2|NOT COMPLETED|Part C Follow up Period||0
496108|NCT01029340|1213459|P1|NOT COMPLETED|Part C Follow up Period||0
496109|NCT01029340|1213454|P6|COMPLETED|Part C Follow up Period||0
496110|NCT01029340|1213455|P5|COMPLETED|Part C Follow up Period||5
496111|NCT01029340|1213456|P4|COMPLETED|Part C Follow up Period||0
496112|NCT01029340|1213457|P3|COMPLETED|Part C Follow up Period||0
496113|NCT01029340|1213458|P2|COMPLETED|Part C Follow up Period||0
496114|NCT01029340|1213459|P1|COMPLETED|Part C Follow up Period||0
496115|NCT01029340|1213454|P6|STARTED|Part C Follow up Period||0
496116|NCT01029340|1213455|P5|STARTED|Part C Follow up Period||5
496117|NCT01029340|1213456|P4|STARTED|Part C Follow up Period||0
496118|NCT01029340|1213457|P3|STARTED|Part C Follow up Period||0
496119|NCT01029340|1213458|P2|STARTED|Part C Follow up Period||0
496120|NCT01029340|1213459|P1|STARTED|Part C Follow up Period||0
496121|NCT01029340|1213454|P6|NOT COMPLETED|Part C Treatment Period||0
496122|NCT01029340|1213455|P5|NOT COMPLETED|Part C Treatment Period||0
496123|NCT01029340|1213456|P4|NOT COMPLETED|Part C Treatment Period||0
496124|NCT01029340|1213457|P3|NOT COMPLETED|Part C Treatment Period||0
496125|NCT01029340|1213458|P2|NOT COMPLETED|Part C Treatment Period||0
496126|NCT01029340|1213459|P1|NOT COMPLETED|Part C Treatment Period||0
496127|NCT01029340|1213454|P6|COMPLETED|Part C Treatment Period||0
496128|NCT01029340|1213455|P5|COMPLETED|Part C Treatment Period||5
496129|NCT01029340|1213456|P4|COMPLETED|Part C Treatment Period||0
496130|NCT01029340|1213457|P3|COMPLETED|Part C Treatment Period||0
496131|NCT01029340|1213458|P2|COMPLETED|Part C Treatment Period||0
496132|NCT01029340|1213459|P1|COMPLETED|Part C Treatment Period||0
496133|NCT01029340|1213454|P6|Participants Received Treatment|Part C Treatment Period||0
496134|NCT01029340|1213455|P5|Participants Received Treatment|Part C Treatment Period||5
496135|NCT01029340|1213456|P4|Participants Received Treatment|Part C Treatment Period||0
496136|NCT01029340|1213457|P3|Participants Received Treatment|Part C Treatment Period||0
496137|NCT01029340|1213458|P2|Participants Received Treatment|Part C Treatment Period||0
496138|NCT01029340|1213459|P1|Participants Received Treatment|Part C Treatment Period||0
496139|NCT01029340|1213454|P6|STARTED|Part C Treatment Period||0
496140|NCT01029340|1213455|P5|STARTED|Part C Treatment Period||5
496141|NCT01029340|1213456|P4|STARTED|Part C Treatment Period||0
496142|NCT01029340|1213457|P3|STARTED|Part C Treatment Period||0
496143|NCT01029340|1213458|P2|STARTED|Part C Treatment Period||0
496144|NCT01029340|1213459|P1|STARTED|Part C Treatment Period||0
496145|NCT01029340|1213454|P6|NOT COMPLETED|Extension Period||12
496146|NCT01029340|1213455|P5|NOT COMPLETED|Extension Period||0
496147|NCT01029340|1213456|P4|NOT COMPLETED|Extension Period||0
496148|NCT01029340|1213457|P3|NOT COMPLETED|Extension Period||0
496149|NCT01029340|1213458|P2|NOT COMPLETED|Extension Period||0
496150|NCT01029340|1213459|P1|NOT COMPLETED|Extension Period||0
496151|NCT01029340|1213454|P6|COMPLETED|Extension Period||43
496152|NCT01029340|1213455|P5|COMPLETED|Extension Period||0
496153|NCT01029340|1213456|P4|COMPLETED|Extension Period||0
496154|NCT01029340|1213457|P3|COMPLETED|Extension Period||0
496155|NCT01029340|1213458|P2|COMPLETED|Extension Period||0
496156|NCT01029340|1213459|P1|COMPLETED|Extension Period||0
496157|NCT01029340|1213454|P6|STARTED|Extension Period||55
496158|NCT01029340|1213455|P5|STARTED|Extension Period||0
496159|NCT01029340|1213456|P4|STARTED|Extension Period||0
496160|NCT01029340|1213457|P3|STARTED|Extension Period||0
496161|NCT01029340|1213458|P2|STARTED|Extension Period||0
496162|NCT01029340|1213459|P1|STARTED|Extension Period||0
496163|NCT01029340|1213454|P6|NOT COMPLETED|Part B Follow up Period||0
496164|NCT01029340|1213455|P5|NOT COMPLETED|Part B Follow up Period||0
496165|NCT01029340|1213456|P4|NOT COMPLETED|Part B Follow up Period||0
496166|NCT01029340|1213457|P3|NOT COMPLETED|Part B Follow up Period||0
496167|NCT01029340|1213458|P2|NOT COMPLETED|Part B Follow up Period||0
496168|NCT01029340|1213459|P1|NOT COMPLETED|Part B Follow up Period||0
496169|NCT01029340|1213454|P6|COMPLETED|Part B Follow up Period||0
496170|NCT01029340|1213455|P5|COMPLETED|Part B Follow up Period||0
496171|NCT01029340|1213456|P4|COMPLETED|Part B Follow up Period||32
496172|NCT01029340|1213457|P3|COMPLETED|Part B Follow up Period||29
496173|NCT01029340|1213458|P2|COMPLETED|Part B Follow up Period||0
496174|NCT01029340|1213459|P1|COMPLETED|Part B Follow up Period||0
496175|NCT01029340|1213454|P6|STARTED|Part B Follow up Period||0
496176|NCT01029340|1213455|P5|STARTED|Part B Follow up Period||0
496177|NCT01029340|1213456|P4|STARTED|Part B Follow up Period||32
496178|NCT01029340|1213457|P3|STARTED|Part B Follow up Period||29
496179|NCT01029340|1213458|P2|STARTED|Part B Follow up Period||0
496180|NCT01029340|1213459|P1|STARTED|Part B Follow up Period||0
496181|NCT01029340|1213454|P6|NOT COMPLETED|Part B Treatment Period||0
496182|NCT01029340|1213455|P5|NOT COMPLETED|Part B Treatment Period||0
496183|NCT01029340|1213456|P4|NOT COMPLETED|Part B Treatment Period||0
496184|NCT01029340|1213457|P3|NOT COMPLETED|Part B Treatment Period||2
496185|NCT01029340|1213458|P2|NOT COMPLETED|Part B Treatment Period||0
496186|NCT01029340|1213459|P1|NOT COMPLETED|Part B Treatment Period||0
496187|NCT01029340|1213454|P6|COMPLETED|Part B Treatment Period||0
496188|NCT01029340|1213455|P5|COMPLETED|Part B Treatment Period||0
496189|NCT01029340|1213456|P4|COMPLETED|Part B Treatment Period||32
496190|NCT01029340|1213457|P3|COMPLETED|Part B Treatment Period||29
496191|NCT01029340|1213458|P2|COMPLETED|Part B Treatment Period||0
496192|NCT01029340|1213459|P1|COMPLETED|Part B Treatment Period||0
496193|NCT01029340|1213454|P6|Participants Received Treatment|Part B Treatment Period||0
496194|NCT01029340|1213455|P5|Participants Received Treatment|Part B Treatment Period||0
496195|NCT01029340|1213456|P4|Participants Received Treatment|Part B Treatment Period||32
496196|NCT01029340|1213457|P3|Participants Received Treatment|Part B Treatment Period||30
496197|NCT01029340|1213458|P2|Participants Received Treatment|Part B Treatment Period||0
496198|NCT01029340|1213459|P1|Participants Received Treatment|Part B Treatment Period||0
496199|NCT01029340|1213454|P6|STARTED|Part B Treatment Period||0
496200|NCT01029340|1213455|P5|STARTED|Part B Treatment Period||0
496201|NCT01029340|1213456|P4|STARTED|Part B Treatment Period|Enrolled 7 participants from Arm 1 and 4 participants from Arm 2|32
496202|NCT01029340|1213457|P3|STARTED|Part B Treatment Period|Enrolled 4 participants from Arm 1 and 7 participants from Arm 2|31
496203|NCT01029340|1213458|P2|STARTED|Part B Treatment Period||0
496204|NCT01029340|1213459|P1|STARTED|Part B Treatment Period||0
496205|NCT01029340|1213454|P6|NOT COMPLETED|Part A Follow up Period||0
496206|NCT01029340|1213455|P5|NOT COMPLETED|Part A Follow up Period||0
496207|NCT01029340|1213456|P4|NOT COMPLETED|Part A Follow up Period||0
496208|NCT01029340|1213457|P3|NOT COMPLETED|Part A Follow up Period||0
496209|NCT01029340|1213458|P2|NOT COMPLETED|Part A Follow up Period||0
496210|NCT01029340|1213459|P1|NOT COMPLETED|Part A Follow up Period||0
496211|NCT01029340|1213454|P6|COMPLETED|Part A Follow up Period||0
496212|NCT01029340|1213455|P5|COMPLETED|Part A Follow up Period||0
496213|NCT01029340|1213456|P4|COMPLETED|Part A Follow up Period||0
496214|NCT01029340|1213457|P3|COMPLETED|Part A Follow up Period||0
496215|NCT01029340|1213458|P2|COMPLETED|Part A Follow up Period||14
496216|NCT01029340|1213459|P1|COMPLETED|Part A Follow up Period||14
496217|NCT01029340|1213454|P6|STARTED|Part A Follow up Period||0
496218|NCT01029340|1213455|P5|STARTED|Part A Follow up Period||0
496219|NCT01029340|1213456|P4|STARTED|Part A Follow up Period||0
496220|NCT01029340|1213457|P3|STARTED|Part A Follow up Period||0
496221|NCT01029340|1213458|P2|STARTED|Part A Follow up Period||14
496222|NCT01029340|1213459|P1|STARTED|Part A Follow up Period||14
496223|NCT01029340|1213454|P6|NOT COMPLETED|Part A Treatment Period||0
496224|NCT01029340|1213455|P5|NOT COMPLETED|Part A Treatment Period||0
496225|NCT01029340|1213456|P4|NOT COMPLETED|Part A Treatment Period||0
496226|NCT01029340|1213457|P3|NOT COMPLETED|Part A Treatment Period||0
496227|NCT01029340|1213458|P2|NOT COMPLETED|Part A Treatment Period||0
496228|NCT01029340|1213459|P1|NOT COMPLETED|Part A Treatment Period||0
496229|NCT01029340|1213454|P6|COMPLETED|Part A Treatment Period||0
496230|NCT01029340|1213455|P5|COMPLETED|Part A Treatment Period||0
496231|NCT01029340|1213456|P4|COMPLETED|Part A Treatment Period||0
496232|NCT01029340|1213457|P3|COMPLETED|Part A Treatment Period||0
496233|NCT01029340|1213458|P2|COMPLETED|Part A Treatment Period||14
496234|NCT01029340|1213459|P1|COMPLETED|Part A Treatment Period||14
496235|NCT01029340|1213454|P6|Safety Population|Part A Treatment Period||0
496236|NCT01029340|1213455|P5|Safety Population|Part A Treatment Period||0
496237|NCT01029340|1213456|P4|Safety Population|Part A Treatment Period||0
496238|NCT01029340|1213457|P3|Safety Population|Part A Treatment Period||0
496239|NCT01029340|1213458|P2|Safety Population|Part A Treatment Period||14
496240|NCT01029340|1213459|P1|Safety Population|Part A Treatment Period|One excluded because receiving Kogenate FS twice.|13
496241|NCT01029340|1213454|P6|Participants Received Treatment|Part A Treatment Period||0
496242|NCT01029340|1213455|P5|Participants Received Treatment|Part A Treatment Period||0
496243|NCT01029340|1213456|P4|Participants Received Treatment|Part A Treatment Period||0
496244|NCT01029340|1213457|P3|Participants Received Treatment|Part A Treatment Period||0
496245|NCT01029340|1213458|P2|Participants Received Treatment|Part A Treatment Period||14
496246|NCT01029340|1213459|P1|Participants Received Treatment|Part A Treatment Period||14
496247|NCT01029340|1213454|P6|STARTED|Part A Treatment Period||0
496248|NCT01029340|1213455|P5|STARTED|Part A Treatment Period||0
496249|NCT01029340|1213456|P4|STARTED|Part A Treatment Period||0
496250|NCT01029340|1213457|P3|STARTED|Part A Treatment Period||0
496251|NCT01029340|1213458|P2|STARTED|Part A Treatment Period||14
496252|NCT01029340|1213459|P1|STARTED|Part A Treatment Period||14
496253|NCT01029262|1213490|P2|NOT COMPLETED|Overall Study||145
496254|NCT01029262|1213491|P1|NOT COMPLETED|Overall Study||78
496255|NCT01029262|1213490|P2|COMPLETED|Overall Study|Completed participants are those who were continuing to receive study drug at time of data cut-off|15
496256|NCT01029262|1213491|P1|COMPLETED|Overall Study|Completed participants are those who were continuing to receive study drug at time of data cut-off|1
496257|NCT01029262|1213490|P2|STARTED|Overall Study||160
496258|NCT01029262|1213491|P1|STARTED|Overall Study||79
496259|NCT01029054|1213547|P3|NOT COMPLETED|Phase II||0
496260|NCT01029054|1213548|P2|NOT COMPLETED|Phase II||0
496261|NCT01029054|1213549|P1|NOT COMPLETED|Phase II||0
496262|NCT01029054|1213547|P3|COMPLETED|Phase II||18
496263|NCT01029054|1213548|P2|COMPLETED|Phase II||0
496264|NCT01029054|1213549|P1|COMPLETED|Phase II||0
496265|NCT01029054|1213547|P3|STARTED|Phase II|35 participants were enrolled in Ph I. 18 additional participants were enrolled in Ph II at the MTD.|18
496266|NCT01029054|1213548|P2|STARTED|Phase II||0
496267|NCT01029054|1213549|P1|STARTED|Phase II||0
496268|NCT01029054|1213547|P3|NOT COMPLETED|Phase I||0
496269|NCT01029054|1213548|P2|NOT COMPLETED|Phase I||0
496270|NCT01029054|1213549|P1|NOT COMPLETED|Phase I||0
496271|NCT01029054|1213547|P3|COMPLETED|Phase I||18
496272|NCT01029054|1213548|P2|COMPLETED|Phase I||13
496273|NCT01029054|1213549|P1|COMPLETED|Phase I||4
496274|NCT01029054|1213547|P3|STARTED|Phase I||18
496275|NCT01029054|1213548|P2|STARTED|Phase I||13
496276|NCT01029054|1213549|P1|STARTED|Phase I||4
496277|NCT01028911|1213557|P2|NOT COMPLETED|Overall Study||0
496278|NCT01028911|1213558|P1|NOT COMPLETED|Overall Study||0
496279|NCT01028911|1213557|P2|COMPLETED|Overall Study||2
496280|NCT01028911|1213558|P1|COMPLETED|Overall Study||7
496281|NCT01028911|1213557|P2|STARTED|Overall Study||2
496282|NCT01028911|1213558|P1|STARTED|Overall Study||7
496283|NCT01028820|1213623|P1|NOT COMPLETED|Overall Study||1
496284|NCT01028820|1213623|P1|COMPLETED|Overall Study||12
496285|NCT01028820|1213623|P1|STARTED|Overall Study||13
496286|NCT01028677|1213632|P2|NOT COMPLETED|Overall Study||1
496287|NCT01028677|1213633|P1|NOT COMPLETED|Overall Study||2
496288|NCT01028677|1213632|P2|COMPLETED|Overall Study||6
496289|NCT01028677|1213633|P1|COMPLETED|Overall Study||8
496290|NCT01028677|1213632|P2|STARTED|Overall Study||7
496291|NCT01028677|1213633|P1|STARTED|Overall Study||10
496292|NCT01028651|1213649|P1|NOT COMPLETED|Overall Study||3
496293|NCT01028651|1213649|P1|COMPLETED|Overall Study||10
496294|NCT01028651|1213649|P1|STARTED|Overall Study||13
496295|NCT01028391|1213672|P2|NOT COMPLETED|Overall Study||11
496296|NCT01028391|1213673|P1|NOT COMPLETED|Overall Study||14
496297|NCT01028391|1213672|P2|COMPLETED|Overall Study||142
496298|NCT01028391|1213673|P1|COMPLETED|Overall Study||150
496299|NCT01028391|1213672|P2|STARTED|Overall Study||153
496300|NCT01028391|1213673|P1|STARTED|Overall Study||164
496301|NCT01028378|1213681|P1|NOT COMPLETED|Overall Study||17
496302|NCT01028378|1213681|P1|COMPLETED|Overall Study|195 participants (230 eyes) with myopia|195
496303|NCT01028378|1213681|P1|STARTED|Overall Study|212 participants (249 eyes) with myopia|212
496304|NCT01028352|1213693|P1|NOT COMPLETED|Overall Study||6
496305|NCT01028352|1213693|P1|COMPLETED|Overall Study||29
496306|NCT01028352|1213693|P1|STARTED|Overall Study||35
496307|NCT01028300|1213698|P1|NOT COMPLETED|Overall Study||4
496308|NCT01028300|1213698|P1|COMPLETED|Overall Study||0
496309|NCT01028300|1213698|P1|STARTED|Overall Study||4
496310|NCT01028222|1213707|P2|NOT COMPLETED|Overall Study||13
496311|NCT01028222|1213708|P1|NOT COMPLETED|Overall Study||38
496312|NCT01028222|1213707|P2|COMPLETED|Overall Study||0
496313|NCT01028222|1213708|P1|COMPLETED|Overall Study||4
496314|NCT01028222|1213707|P2|Cross Over From DTIC to Nilotinib|Overall Study||10
496315|NCT01028222|1213708|P1|Cross Over From DTIC to Nilotinib|Overall Study||0
496316|NCT01028222|1213707|P2|STARTED|Overall Study||13
496317|NCT01028222|1213708|P1|STARTED|Overall Study||42
496318|NCT01028131|1213733|P4|NOT COMPLETED|Overall Study||4
496319|NCT01028131|1213734|P3|NOT COMPLETED|Overall Study||6
496320|NCT01028131|1213735|P2|NOT COMPLETED|Overall Study||3
496321|NCT01028131|1213736|P1|NOT COMPLETED|Overall Study||3
496322|NCT01028131|1213733|P4|COMPLETED|Overall Study||26
496323|NCT01028131|1213734|P3|COMPLETED|Overall Study||22
496324|NCT01028131|1213735|P2|COMPLETED|Overall Study||23
496325|NCT01028131|1213736|P1|COMPLETED|Overall Study||23
496326|NCT01028131|1213733|P4|Completed Intervention/Control Session|Overall Study||30
496327|NCT01028131|1213734|P3|Completed Intervention/Control Session|Overall Study||28
496328|NCT01028131|1213735|P2|Completed Intervention/Control Session|Overall Study||26
496329|NCT01028131|1213736|P1|Completed Intervention/Control Session|Overall Study||26
496330|NCT01028131|1213733|P4|STARTED|Overall Study||30
496331|NCT01028131|1213734|P3|STARTED|Overall Study||28
496332|NCT01028131|1213735|P2|STARTED|Overall Study||26
496333|NCT01028131|1213736|P1|STARTED|Overall Study||26
496334|NCT01028053|1213750|P1|NOT COMPLETED|Overall Study||133
496335|NCT01028053|1213750|P1|COMPLETED|Overall Study||232
496336|NCT01028053|1213750|P1|STARTED|Overall Study||365
496337|NCT01028027|1213758|P2|NOT COMPLETED|Overall Study||13
496338|NCT01028027|1213759|P1|NOT COMPLETED|Overall Study||16
496339|NCT01028027|1213758|P2|COMPLETED|Overall Study||164
496340|NCT01028027|1213759|P1|COMPLETED|Overall Study||164
496341|NCT01028027|1213758|P2|STARTED|Overall Study||177
496342|NCT01028027|1213759|P1|STARTED|Overall Study||180
496343|NCT01028014|1213781|P6|NOT COMPLETED|Overall Study||2
496344|NCT01028014|1213782|P5|NOT COMPLETED|Overall Study||1
496345|NCT01028014|1213783|P4|NOT COMPLETED|Overall Study||1
496346|NCT01028014|1213784|P3|NOT COMPLETED|Overall Study||0
496347|NCT01028014|1213785|P2|NOT COMPLETED|Overall Study||2
496348|NCT01028014|1213786|P1|NOT COMPLETED|Overall Study||1
496349|NCT01028014|1213781|P6|COMPLETED|Overall Study||4
496350|NCT01028014|1213782|P5|COMPLETED|Overall Study||9
496351|NCT01028014|1213783|P4|COMPLETED|Overall Study||9
496352|NCT01028014|1213784|P3|COMPLETED|Overall Study||10
496353|NCT01028014|1213785|P2|COMPLETED|Overall Study||8
496354|NCT01028014|1213786|P1|COMPLETED|Overall Study||9
496355|NCT01028014|1213781|P6|STARTED|Overall Study||6
496356|NCT01028014|1213782|P5|STARTED|Overall Study||10
496357|NCT01028014|1213783|P4|STARTED|Overall Study||10
496358|NCT01028014|1213784|P3|STARTED|Overall Study||10
496359|NCT01028014|1213785|P2|STARTED|Overall Study||10
496360|NCT01028014|1213786|P1|STARTED|Overall Study||10
496361|NCT01027910|1213814|P2|NOT COMPLETED|Overall Study||0
496362|NCT01027910|1213815|P1|NOT COMPLETED|Overall Study||0
496363|NCT01027910|1213814|P2|COMPLETED|Overall Study||14
496364|NCT01027910|1213815|P1|COMPLETED|Overall Study||6
496365|NCT01027910|1213814|P2|STARTED|Overall Study||14
496366|NCT01027910|1213815|P1|STARTED|Overall Study||6
496367|NCT01027897|1213827|P1|NOT COMPLETED|Overall Study||2
496368|NCT01027897|1213827|P1|COMPLETED|Overall Study||28
496369|NCT01027897|1213827|P1|STARTED|Overall Study||30
496370|NCT01027884|1213835|P2|NOT COMPLETED|Overall Study||7
496371|NCT01027884|1213836|P1|NOT COMPLETED|Overall Study||4
496372|NCT01027884|1213835|P2|COMPLETED|Overall Study||25
496373|NCT01027884|1213836|P1|COMPLETED|Overall Study||30
496374|NCT01027884|1213835|P2|STARTED|Overall Study||32
496375|NCT01027884|1213836|P1|STARTED|Overall Study||34
496376|NCT01027871|1213853|P3|NOT COMPLETED|Overall Study||7
496377|NCT01027871|1213854|P2|NOT COMPLETED|Overall Study||13
496378|NCT01027871|1213855|P1|NOT COMPLETED|Overall Study||2
496379|NCT01027871|1213853|P3|COMPLETED|Overall Study||91
496380|NCT01027871|1213854|P2|COMPLETED|Overall Study||85
496381|NCT01027871|1213855|P1|COMPLETED|Overall Study||91
496382|NCT01027871|1213853|P3|Received at Least One Dose of Study Drug|Overall Study||97
496383|NCT01027871|1213854|P2|Received at Least One Dose of Study Drug|Overall Study||98
496384|NCT01027871|1213855|P1|Received at Least One Dose of Study Drug|Overall Study||93
496385|NCT01027871|1213853|P3|STARTED|Overall Study||98
496386|NCT01027871|1213854|P2|STARTED|Overall Study||98
496387|NCT01027871|1213855|P1|STARTED|Overall Study||93
496388|NCT01027819|1213914|P2|NOT COMPLETED|Overall Study||0
496389|NCT01027819|1213915|P1|NOT COMPLETED|Overall Study||0
496390|NCT01027819|1213914|P2|COMPLETED|Overall Study||40
496391|NCT01027819|1213915|P1|COMPLETED|Overall Study||40
496392|NCT01027819|1213914|P2|STARTED|Overall Study||40
496393|NCT01027819|1213915|P1|STARTED|Overall Study||40
496394|NCT01027780|1213923|P2|NOT COMPLETED|Overall Study||1
496395|NCT01027780|1213924|P1|NOT COMPLETED|Overall Study||0
496396|NCT01027780|1213923|P2|COMPLETED|Overall Study||102
496397|NCT01027780|1213924|P1|COMPLETED|Overall Study||105
496398|NCT01027780|1213923|P2|STARTED|Overall Study||103
496399|NCT01027780|1213924|P1|STARTED|Overall Study||105
496400|NCT01027702|1213934|P7|NOT COMPLETED|Overall Study||1
496401|NCT01027702|1213935|P6|NOT COMPLETED|Overall Study||0
496402|NCT01027702|1213936|P5|NOT COMPLETED|Overall Study||1
496403|NCT01027702|1213937|P4|NOT COMPLETED|Overall Study||4
496404|NCT01027702|1213938|P3|NOT COMPLETED|Overall Study||1
496405|NCT01027702|1213939|P2|NOT COMPLETED|Overall Study||2
496406|NCT01027702|1213940|P1|NOT COMPLETED|Overall Study||1
496407|NCT01027702|1213934|P7|COMPLETED|Overall Study||1
496408|NCT01027702|1213935|P6|COMPLETED|Overall Study||1
496409|NCT01027702|1213936|P5|COMPLETED|Overall Study||9
496410|NCT01027702|1213937|P4|COMPLETED|Overall Study||10
496411|NCT01027702|1213938|P3|COMPLETED|Overall Study||2
496412|NCT01027702|1213939|P2|COMPLETED|Overall Study||2
496413|NCT01027702|1213940|P1|COMPLETED|Overall Study||3
496414|NCT01027702|1213934|P7|STARTED|Overall Study||2
496415|NCT01027702|1213935|P6|STARTED|Overall Study||1
496416|NCT01027702|1213936|P5|STARTED|Overall Study||10
496417|NCT01027702|1213937|P4|STARTED|Overall Study||14
496418|NCT01027702|1213938|P3|STARTED|Overall Study||3
496419|NCT01027702|1213939|P2|STARTED|Overall Study||4
496420|NCT01027702|1213940|P1|STARTED|Overall Study||4
496421|NCT01027650|1213966|P8|NOT COMPLETED|Overall Study||0
496422|NCT01027650|1213967|P7|NOT COMPLETED|Overall Study||1
496423|NCT01027650|1213968|P6|NOT COMPLETED|Overall Study||2
496424|NCT01027650|1213969|P5|NOT COMPLETED|Overall Study||2
496425|NCT01027650|1213970|P4|NOT COMPLETED|Overall Study||0
496426|NCT01027650|1213971|P3|NOT COMPLETED|Overall Study||0
496427|NCT01027650|1213972|P2|NOT COMPLETED|Overall Study||0
496428|NCT01027650|1213973|P1|NOT COMPLETED|Overall Study||0
496429|NCT01027650|1213966|P8|COMPLETED|Overall Study||24
496430|NCT01027650|1213967|P7|COMPLETED|Overall Study||24
496431|NCT01027650|1213968|P6|COMPLETED|Overall Study||24
496432|NCT01027650|1213969|P5|COMPLETED|Overall Study||23
496433|NCT01027650|1213970|P4|COMPLETED|Overall Study||3
496434|NCT01027650|1213971|P3|COMPLETED|Overall Study||6
496435|NCT01027650|1213972|P2|COMPLETED|Overall Study||6
496436|NCT01027650|1213973|P1|COMPLETED|Overall Study||6
496437|NCT01027650|1213966|P8|STARTED|Overall Study||24
496438|NCT01027650|1213967|P7|STARTED|Overall Study||25
496439|NCT01027650|1213968|P6|STARTED|Overall Study||26
496440|NCT01027650|1213969|P5|STARTED|Overall Study||25
496441|NCT01027650|1213970|P4|STARTED|Overall Study||3
496442|NCT01027650|1213971|P3|STARTED|Overall Study||6
496443|NCT01027650|1213972|P2|STARTED|Overall Study||6
496444|NCT01027650|1213973|P1|STARTED|Overall Study||6
496445|NCT01027598|1214017|P2|NOT COMPLETED|Overall Study||67
496446|NCT01027598|1214018|P1|NOT COMPLETED|Overall Study||134
496447|NCT01027598|1214017|P2|COMPLETED|Overall Study|Patients remained on treatment until coming off for progression, toxicity or any other reason|0
496448|NCT01027598|1214018|P1|COMPLETED|Overall Study|Patients remained on treatment until coming off for progression, toxicity or any other reason|0
496449|NCT01027598|1214017|P2|STARTED|Overall Study||67
496450|NCT01027598|1214018|P1|STARTED|Overall Study|One patient was enrolled but not treated|134
496451|NCT01027559|1214031|P3|NOT COMPLETED|Overall Study||9
496452|NCT01027559|1214032|P2|NOT COMPLETED|Overall Study||8
496453|NCT01027559|1214033|P1|NOT COMPLETED|Overall Study||6
496454|NCT01027559|1214031|P3|COMPLETED|Overall Study||22
496455|NCT01027559|1214032|P2|COMPLETED|Overall Study||26
496456|NCT01027559|1214033|P1|COMPLETED|Overall Study||20
496457|NCT01027559|1214031|P3|STARTED|Overall Study||31
496458|NCT01027559|1214032|P2|STARTED|Overall Study||34
496459|NCT01027559|1214033|P1|STARTED|Overall Study||26
496460|NCT01027468|1214043|P1|NOT COMPLETED|Overall Study||0
496461|NCT01027468|1214043|P1|COMPLETED|Overall Study||160
496462|NCT01027468|1214043|P1|STARTED|Overall Study||160
496463|NCT01027416|1214049|P2|NOT COMPLETED|Overall Study||5
496464|NCT01027416|1214050|P1|NOT COMPLETED|Overall Study||1
496465|NCT01027416|1214049|P2|COMPLETED|Overall Study||23
496466|NCT01027416|1214050|P1|COMPLETED|Overall Study||30
496467|NCT01027416|1214049|P2|STARTED|Overall Study||28
496468|NCT01027416|1214050|P1|STARTED|Overall Study||31
496469|NCT01027364|1214062|P4|NOT COMPLETED|Overall Study||1
496470|NCT01027364|1214063|P3|NOT COMPLETED|Overall Study||1
496471|NCT01027364|1214064|P2|NOT COMPLETED|Overall Study||2
496472|NCT01027364|1214065|P1|NOT COMPLETED|Overall Study||4
496473|NCT01027364|1214062|P4|COMPLETED|Overall Study|11 participants total completed Arm 4 (3: compl. Arm 4 only; 7: cont. to Arm 1; 1: cont. to Arm 3)|3
496474|NCT01027364|1214063|P3|COMPLETED|Overall Study||26
496475|NCT01027364|1214064|P2|COMPLETED|Overall Study||27
496476|NCT01027364|1214065|P1|COMPLETED|Overall Study||59
496477|NCT01027364|1214062|P4|Started Arm 4 Then Joined Another Arm|Overall Study||0
496478|NCT01027364|1214063|P3|Started Arm 4 Then Joined Another Arm|Overall Study||0
496479|NCT01027364|1214064|P2|Started Arm 4 Then Joined Another Arm|Overall Study||0
496480|NCT01027364|1214065|P1|Started Arm 4 Then Joined Another Arm|Overall Study||2
496481|NCT01027364|1214062|P4|Joined Arm 4 for Surgery Then Returned|Overall Study||0
496482|NCT01027364|1214063|P3|Joined Arm 4 for Surgery Then Returned|Overall Study||1
496483|NCT01027364|1214064|P2|Joined Arm 4 for Surgery Then Returned|Overall Study||0
496484|NCT01027364|1214065|P1|Joined Arm 4 for Surgery Then Returned|Overall Study||5
496485|NCT01027364|1214062|P4|Enrolled in Sequential PK Subgroup|Overall Study||0
496486|NCT01027364|1214063|P3|Enrolled in Sequential PK Subgroup|Overall Study||0
496487|NCT01027364|1214064|P2|Enrolled in Sequential PK Subgroup|Overall Study||0
496488|NCT01027364|1214065|P1|Enrolled in Sequential PK Subgroup|Overall Study||22
496489|NCT01027364|1214062|P4|STARTED|Overall Study|12 total participants in Arm 4 (6 started in Arm 4; 5 joined from Arm 1; 1 joined from Arm 3)|4
496490|NCT01027364|1214063|P3|STARTED|Overall Study||27
496491|NCT01027364|1214064|P2|STARTED|Overall Study||29
496492|NCT01027364|1214065|P1|STARTED|Overall Study||63
496493|NCT01027351|1214160|P6|NOT COMPLETED|Overall Study||5
496494|NCT01027351|1214161|P5|NOT COMPLETED|Overall Study||11
496495|NCT01027351|1214162|P4|NOT COMPLETED|Overall Study||2
496496|NCT01027351|1214163|P3|NOT COMPLETED|Overall Study||1
496497|NCT01027351|1214164|P2|NOT COMPLETED|Overall Study||1
496498|NCT01027351|1214165|P1|NOT COMPLETED|Overall Study||3
496499|NCT01027351|1214160|P6|COMPLETED|Overall Study||45
496500|NCT01027351|1214161|P5|COMPLETED|Overall Study||32
496501|NCT01027351|1214162|P4|COMPLETED|Overall Study||6
496502|NCT01027351|1214163|P3|COMPLETED|Overall Study||13
496503|NCT01027351|1214164|P2|COMPLETED|Overall Study||18
496504|NCT01027351|1214165|P1|COMPLETED|Overall Study||26
496505|NCT01027351|1214160|P6|STARTED|Overall Study||50
496506|NCT01027351|1214161|P5|STARTED|Overall Study||43
496507|NCT01027351|1214162|P4|STARTED|Overall Study||8
496508|NCT01027351|1214163|P3|STARTED|Overall Study||14
496509|NCT01027351|1214164|P2|STARTED|Overall Study||19
496510|NCT01027351|1214165|P1|STARTED|Overall Study||29
496511|NCT01027286|1214249|P2|NOT COMPLETED|Overall Study||1
496512|NCT01027286|1214250|P1|NOT COMPLETED|Overall Study||1
496513|NCT01027286|1214249|P2|COMPLETED|Overall Study||49
496514|NCT01027286|1214250|P1|COMPLETED|Overall Study||49
496515|NCT01027286|1214249|P2|12 Week Postoperative|Overall Study||49
496516|NCT01027286|1214250|P1|12 Week Postoperative|Overall Study||49
496517|NCT01027286|1214249|P2|4 Week Postoperative|Overall Study||50
496518|NCT01027286|1214250|P1|4 Week Postoperative|Overall Study||49
496519|NCT01027286|1214249|P2|Day of Surgery|Overall Study||50
496520|NCT01027286|1214250|P1|Day of Surgery|Overall Study||50
496521|NCT01027286|1214249|P2|Preoperative|Overall Study||50
496522|NCT01027286|1214250|P1|Preoperative|Overall Study||50
496523|NCT01027286|1214249|P2|STARTED|Overall Study||50
496524|NCT01027286|1214250|P1|STARTED|Overall Study||50
496525|NCT01027273|1214270|P2|NOT COMPLETED|Overall Study||33
496526|NCT01027273|1214271|P1|NOT COMPLETED|Overall Study||59
496527|NCT01027273|1214270|P2|COMPLETED|Overall Study||266
496528|NCT01027273|1214271|P1|COMPLETED|Overall Study||242
496529|NCT01027273|1214270|P2|STARTED|Overall Study||299
496530|NCT01027273|1214271|P1|STARTED|Overall Study||301
496531|NCT01027195|1214289|P2|NOT COMPLETED|Overall Study||0
496532|NCT01027195|1214290|P1|NOT COMPLETED|Overall Study||0
496533|NCT01027195|1214289|P2|COMPLETED|Overall Study||69
496534|NCT01027195|1214290|P1|COMPLETED|Overall Study||71
496535|NCT01027195|1214289|P2|STARTED|Overall Study||69
496536|NCT01027195|1214290|P1|STARTED|Overall Study||71
496537|NCT01027000|1214310|P1|NOT COMPLETED|Overall Study||0
496538|NCT01027000|1214310|P1|COMPLETED|Overall Study||68
496539|NCT01027000|1214310|P1|STARTED|Overall Study||68
496540|NCT01026974|1214318|P4|NOT COMPLETED|Overall Study||3
496541|NCT01026974|1214319|P3|NOT COMPLETED|Overall Study||12
496542|NCT01026974|1214320|P2|NOT COMPLETED|Overall Study||2
496543|NCT01026974|1214321|P1|NOT COMPLETED|Overall Study||1
496544|NCT01026974|1214318|P4|COMPLETED|Overall Study||46
496545|NCT01026974|1214319|P3|COMPLETED|Overall Study||29
496546|NCT01026974|1214320|P2|COMPLETED|Overall Study||12
496547|NCT01026974|1214321|P1|COMPLETED|Overall Study||15
496548|NCT01026974|1214318|P4|STARTED|Overall Study||49
496549|NCT01026974|1214319|P3|STARTED|Overall Study||41
496550|NCT01026974|1214320|P2|STARTED|Overall Study||14
496551|NCT01026974|1214321|P1|STARTED|Overall Study||16
496552|NCT01026948|1214378|P1|NOT COMPLETED|Overall Study||8
496553|NCT01026948|1214378|P1|COMPLETED|Overall Study|8 Women were recalled because of signal loss|62
496554|NCT01026948|1214378|P1|STARTED|Overall Study||70
496555|NCT01026909|1214385|P2|NOT COMPLETED|Overall Study||0
496556|NCT01026909|1214386|P1|NOT COMPLETED|Overall Study||0
496557|NCT01026909|1214385|P2|COMPLETED|Overall Study||2
496558|NCT01026909|1214386|P1|COMPLETED|Overall Study||1
496559|NCT01026909|1214385|P2|STARTED|Overall Study||2
496560|NCT01026909|1214386|P1|STARTED|Overall Study||1
496561|NCT01026844|1214396|P2|NOT COMPLETED|Overall Study||0
496562|NCT01026844|1214397|P1|NOT COMPLETED|Overall Study||0
496563|NCT01026844|1214396|P2|COMPLETED|Overall Study||8
496564|NCT01026844|1214397|P1|COMPLETED|Overall Study||19
496565|NCT01026844|1214396|P2|STARTED|Overall Study||8
496566|NCT01026844|1214397|P1|STARTED|Overall Study||19
496567|NCT01026831|1214411|P2|NOT COMPLETED|Overall Study||11
496568|NCT01026831|1214412|P1|NOT COMPLETED|Overall Study||14
496569|NCT01026831|1214411|P2|COMPLETED|Overall Study||312
496570|NCT01026831|1214412|P1|COMPLETED|Overall Study||306
496571|NCT01026831|1214411|P2|STARTED|Overall Study|randomized|323
496572|NCT01026831|1214412|P1|STARTED|Overall Study|randomized|320
496573|NCT01026818|1214423|P4|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||3
496574|NCT01026818|1214424|P3|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||5
496575|NCT01026818|1214425|P2|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||7
496576|NCT01026818|1214426|P1|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||0
496577|NCT01026818|1214423|P4|COMPLETED|OL Period (Month 10.5 - 13.5)||105
496578|NCT01026818|1214424|P3|COMPLETED|OL Period (Month 10.5 - 13.5)||112
496579|NCT01026818|1214425|P2|COMPLETED|OL Period (Month 10.5 - 13.5)||98
496580|NCT01026818|1214426|P1|COMPLETED|OL Period (Month 10.5 - 13.5)||0
496581|NCT01026818|1214423|P4|STARTED|OL Period (Month 10.5 - 13.5)||108
496582|NCT01026818|1214424|P3|STARTED|OL Period (Month 10.5 - 13.5)||117
496583|NCT01026818|1214425|P2|STARTED|OL Period (Month 10.5 - 13.5)||105
496584|NCT01026818|1214426|P1|STARTED|OL Period (Month 10.5 - 13.5)||0
496585|NCT01026818|1214423|P4|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||7
496586|NCT01026818|1214424|P3|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||5
496587|NCT01026818|1214425|P2|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||9
496588|NCT01026818|1214426|P1|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0
496589|NCT01026818|1214423|P4|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||108
496590|NCT01026818|1214424|P3|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||117
496591|NCT01026818|1214425|P2|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||105
496592|NCT01026818|1214426|P1|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0
496593|NCT01026818|1214423|P4|STARTED|Drug-Free Washout Period (Month 9-10.5)||115
496594|NCT01026818|1214424|P3|STARTED|Drug-Free Washout Period (Month 9-10.5)||122
496595|NCT01026818|1214425|P2|STARTED|Drug-Free Washout Period (Month 9-10.5)||114
496596|NCT01026818|1214426|P1|STARTED|Drug-Free Washout Period (Month 9-10.5)||0
496597|NCT01026818|1214423|P4|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||26
496598|NCT01026818|1214424|P3|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||21
496599|NCT01026818|1214425|P2|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||25
496600|NCT01026818|1214426|P1|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||0
496601|NCT01026818|1214423|P4|COMPLETED|DB Treatment Period (Month 0 - 9)||115
496602|NCT01026818|1214424|P3|COMPLETED|DB Treatment Period (Month 0 - 9)||122
496603|NCT01026818|1214425|P2|COMPLETED|DB Treatment Period (Month 0 - 9)||114
496604|NCT01026818|1214426|P1|COMPLETED|DB Treatment Period (Month 0 - 9)||0
496605|NCT01026818|1214423|P4|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||141
496606|NCT01026818|1214424|P3|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||143
496607|NCT01026818|1214425|P2|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||139
496608|NCT01026818|1214426|P1|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||0
496609|NCT01026818|1214423|P4|STARTED|DB Treatment Period (Month 0 - 9)||141
496610|NCT01026818|1214424|P3|STARTED|DB Treatment Period (Month 0 - 9)||143
496611|NCT01026818|1214425|P2|STARTED|DB Treatment Period (Month 0 - 9)||139
496612|NCT01026818|1214426|P1|STARTED|DB Treatment Period (Month 0 - 9)||0
496613|NCT01026818|1214423|P4|NOT COMPLETED|Screening Period||0
496614|NCT01026818|1214424|P3|NOT COMPLETED|Screening Period||0
496615|NCT01026818|1214425|P2|NOT COMPLETED|Screening Period||0
496616|NCT01026818|1214426|P1|NOT COMPLETED|Screening Period||160
496617|NCT01026818|1214423|P4|COMPLETED|Screening Period||0
496618|NCT01026818|1214424|P3|COMPLETED|Screening Period||0
496619|NCT01026818|1214425|P2|COMPLETED|Screening Period||0
496620|NCT01026818|1214426|P1|COMPLETED|Screening Period||423
496621|NCT01026818|1214423|P4|STARTED|Screening Period||0
496622|NCT01026818|1214424|P3|STARTED|Screening Period||0
496623|NCT01026818|1214425|P2|STARTED|Screening Period||0
496624|NCT01026818|1214426|P1|STARTED|Screening Period||583
496625|NCT01026805|1214504|P1|NOT COMPLETED|Overall Study||0
496626|NCT01026805|1214504|P1|COMPLETED|Overall Study||11
496627|NCT01026805|1214504|P1|STARTED|Overall Study||11
496628|NCT01026792|1214514|P1|NOT COMPLETED|Overall Study||1
496629|NCT01026792|1214514|P1|COMPLETED|Overall Study||37
496630|NCT01026792|1214514|P1|STARTED|Overall Study||38
496631|NCT01026493|1214526|P8|NOT COMPLETED|Overall Study||1
496632|NCT01026493|1214527|P7|NOT COMPLETED|Overall Study||4
496633|NCT01026493|1214528|P6|NOT COMPLETED|Overall Study||3
496634|NCT01026493|1214529|P5|NOT COMPLETED|Overall Study||2
496635|NCT01026493|1214530|P4|NOT COMPLETED|Overall Study||0
496636|NCT01026493|1214531|P3|NOT COMPLETED|Overall Study||0
496637|NCT01026493|1214532|P2|NOT COMPLETED|Overall Study||1
496638|NCT01026493|1214533|P1|NOT COMPLETED|Overall Study||0
496639|NCT01026493|1214526|P8|COMPLETED|Overall Study||37
496640|NCT01026493|1214527|P7|COMPLETED|Overall Study||32
496641|NCT01026493|1214528|P6|COMPLETED|Overall Study||73
496642|NCT01026493|1214529|P5|COMPLETED|Overall Study||73
496643|NCT01026493|1214530|P4|COMPLETED|Overall Study||8
496644|NCT01026493|1214531|P3|COMPLETED|Overall Study||9
496645|NCT01026493|1214532|P2|COMPLETED|Overall Study||6
496646|NCT01026493|1214533|P1|COMPLETED|Overall Study||8
496647|NCT01026493|1214526|P8|STARTED|Overall Study||38
496648|NCT01026493|1214527|P7|STARTED|Overall Study||36
496649|NCT01026493|1214528|P6|STARTED|Overall Study||76
496650|NCT01026493|1214529|P5|STARTED|Overall Study||75
496651|NCT01026493|1214530|P4|STARTED|Overall Study||8
496652|NCT01026493|1214531|P3|STARTED|Overall Study||9
496653|NCT01026493|1214532|P2|STARTED|Overall Study||7
496654|NCT01026493|1214533|P1|STARTED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|8
496655|NCT01026454|1214561|P2|NOT COMPLETED|Second Intervention||1
496656|NCT01026454|1214562|P1|NOT COMPLETED|Second Intervention||1
496657|NCT01026454|1214561|P2|COMPLETED|Second Intervention||13
496658|NCT01026454|1214562|P1|COMPLETED|Second Intervention||16
496659|NCT01026454|1214561|P2|STARTED|Second Intervention||14
496660|NCT01026454|1214562|P1|STARTED|Second Intervention||17
496661|NCT01026454|1214561|P2|NOT COMPLETED|Washout||0
496662|NCT01026454|1214562|P1|NOT COMPLETED|Washout||0
496663|NCT01026454|1214561|P2|COMPLETED|Washout||14
496664|NCT01026454|1214562|P1|COMPLETED|Washout||18
496665|NCT01026454|1214561|P2|STARTED|Washout||14
496666|NCT01026454|1214562|P1|STARTED|Washout||18
496667|NCT01026454|1214561|P2|NOT COMPLETED|First Intervention||0
496668|NCT01026454|1214562|P1|NOT COMPLETED|First Intervention||0
496669|NCT01026454|1214561|P2|COMPLETED|First Intervention||14
496670|NCT01026454|1214562|P1|COMPLETED|First Intervention||18
496671|NCT01026454|1214561|P2|STARTED|First Intervention||14
496672|NCT01026454|1214562|P1|STARTED|First Intervention||18
496673|NCT01026402|1214585|P17|NOT COMPLETED|Overall Study||0
496674|NCT01026402|1214586|P16|NOT COMPLETED|Overall Study||0
496675|NCT01026402|1214587|P15|NOT COMPLETED|Overall Study||0
496676|NCT01026402|1214588|P14|NOT COMPLETED|Overall Study||0
496677|NCT01026402|1214589|P13|NOT COMPLETED|Overall Study||0
496678|NCT01026402|1214590|P12|NOT COMPLETED|Overall Study||0
496679|NCT01026402|1214591|P11|NOT COMPLETED|Overall Study||0
496680|NCT01026402|1214592|P10|NOT COMPLETED|Overall Study||0
496681|NCT01026402|1214593|P9|NOT COMPLETED|Overall Study||0
496682|NCT01026402|1214594|P8|NOT COMPLETED|Overall Study||0
496683|NCT01026402|1214595|P7|NOT COMPLETED|Overall Study||0
496684|NCT01026402|1214596|P6|NOT COMPLETED|Overall Study||0
496685|NCT01026402|1214597|P5|NOT COMPLETED|Overall Study||0
496686|NCT01026402|1214598|P4|NOT COMPLETED|Overall Study||0
496687|NCT01026402|1214599|P3|NOT COMPLETED|Overall Study||0
496688|NCT01026402|1214600|P2|NOT COMPLETED|Overall Study||0
496689|NCT01026402|1214601|P1|NOT COMPLETED|Overall Study||0
496690|NCT01026402|1214585|P17|COMPLETED|Overall Study||4
496691|NCT01026402|1214586|P16|COMPLETED|Overall Study||5
496692|NCT01026402|1214587|P15|COMPLETED|Overall Study||3
496693|NCT01026402|1214588|P14|COMPLETED|Overall Study||6
496694|NCT01026402|1214589|P13|COMPLETED|Overall Study||8
496695|NCT01026402|1214590|P12|COMPLETED|Overall Study||8
496696|NCT01026402|1214591|P11|COMPLETED|Overall Study||7
496697|NCT01026402|1214592|P10|COMPLETED|Overall Study||3
496698|NCT01026402|1214593|P9|COMPLETED|Overall Study||7
496699|NCT01026402|1214594|P8|COMPLETED|Overall Study||3
496700|NCT01026402|1214595|P7|COMPLETED|Overall Study||8
496701|NCT01026402|1214596|P6|COMPLETED|Overall Study||5
496702|NCT01026402|1214597|P5|COMPLETED|Overall Study||3
496703|NCT01026402|1214598|P4|COMPLETED|Overall Study||18
496704|NCT01026402|1214599|P3|COMPLETED|Overall Study||33
496705|NCT01026402|1214600|P2|COMPLETED|Overall Study||8
496706|NCT01026402|1214601|P1|COMPLETED|Overall Study||6
496707|NCT01026402|1214585|P17|STARTED|Overall Study||4
496708|NCT01026402|1214586|P16|STARTED|Overall Study||5
496709|NCT01026402|1214587|P15|STARTED|Overall Study||3
496710|NCT01026402|1214588|P14|STARTED|Overall Study||6
496711|NCT01026402|1214589|P13|STARTED|Overall Study||8
496712|NCT01026402|1214590|P12|STARTED|Overall Study||8
496713|NCT01026402|1214591|P11|STARTED|Overall Study||7
496714|NCT01026402|1214592|P10|STARTED|Overall Study||3
496715|NCT01026402|1214593|P9|STARTED|Overall Study||7
496716|NCT01026402|1214594|P8|STARTED|Overall Study||3
496717|NCT01026402|1214595|P7|STARTED|Overall Study||8
496718|NCT01026402|1214596|P6|STARTED|Overall Study||5
496719|NCT01026402|1214597|P5|STARTED|Overall Study||3
496720|NCT01026402|1214598|P4|STARTED|Overall Study||18
496721|NCT01026402|1214599|P3|STARTED|Overall Study||33
496722|NCT01026402|1214600|P2|STARTED|Overall Study||8
496723|NCT01026402|1214601|P1|STARTED|Overall Study||6
496724|NCT01026389|1214911|P2|NOT COMPLETED|Overall Study||5
496725|NCT01026389|1214912|P1|NOT COMPLETED|Overall Study||5
496726|NCT01026389|1214911|P2|COMPLETED|Overall Study||88
496727|NCT01026389|1214912|P1|COMPLETED|Overall Study||88
496728|NCT01026389|1214911|P2|STARTED|Overall Study||93
496729|NCT01026389|1214912|P1|STARTED|Overall Study||93
496730|NCT01026324|1214927|P3|NOT COMPLETED|Follow up/Survival||0
496731|NCT01026324|1214928|P2|NOT COMPLETED|Follow up/Survival||0
496732|NCT01026324|1214929|P1|NOT COMPLETED|Follow up/Survival||1
496733|NCT01026324|1214927|P3|COMPLETED|Follow up/Survival||4
496734|NCT01026324|1214928|P2|COMPLETED|Follow up/Survival||3
496735|NCT01026324|1214929|P1|COMPLETED|Follow up/Survival||4
496736|NCT01026324|1214927|P3|Follow up Discontinuation (Death)|Follow up/Survival||4
496737|NCT01026324|1214928|P2|Follow up Discontinuation (Death)|Follow up/Survival||3
496738|NCT01026324|1214929|P1|Follow up Discontinuation (Death)|Follow up/Survival||4
496739|NCT01026324|1214927|P3|STARTED|Follow up/Survival||4
496740|NCT01026324|1214928|P2|STARTED|Follow up/Survival||3
496741|NCT01026324|1214929|P1|STARTED|Follow up/Survival||5
496742|NCT01026324|1214927|P3|NOT COMPLETED|Treatment Allocation||0
496743|NCT01026324|1214928|P2|NOT COMPLETED|Treatment Allocation||0
496744|NCT01026324|1214929|P1|NOT COMPLETED|Treatment Allocation||0
496745|NCT01026324|1214927|P3|COMPLETED|Treatment Allocation||4
496746|NCT01026324|1214928|P2|COMPLETED|Treatment Allocation||3
496747|NCT01026324|1214929|P1|COMPLETED|Treatment Allocation||5
496748|NCT01026324|1214927|P3|Discontinued Intervention (Withdrew)|Treatment Allocation||0
496749|NCT01026324|1214928|P2|Discontinued Intervention (Withdrew)|Treatment Allocation||0
496750|NCT01026324|1214929|P1|Discontinued Intervention (Withdrew)|Treatment Allocation||1
496751|NCT01026324|1214927|P3|Discontinuted Intervention (Progression)|Treatment Allocation||4
496752|NCT01026324|1214928|P2|Discontinuted Intervention (Progression)|Treatment Allocation||3
496753|NCT01026324|1214929|P1|Discontinuted Intervention (Progression)|Treatment Allocation||3
496754|NCT01026324|1214927|P3|Discontinued Intervention (Toxicity)|Treatment Allocation||0
496755|NCT01026324|1214928|P2|Discontinued Intervention (Toxicity)|Treatment Allocation||0
496756|NCT01026324|1214929|P1|Discontinued Intervention (Toxicity)|Treatment Allocation||1
496757|NCT01026324|1214927|P3|STARTED|Treatment Allocation||4
496758|NCT01026324|1214928|P2|STARTED|Treatment Allocation||3
496759|NCT01026324|1214929|P1|STARTED|Treatment Allocation||5
496760|NCT01026220|1214939|P3|NOT COMPLETED|Consolidation Maintenance||14
496761|NCT01026220|1214940|P2|NOT COMPLETED|Consolidation Maintenance||6
496762|NCT01026220|1214941|P1|NOT COMPLETED|Consolidation Maintenance||0
496763|NCT01026220|1214939|P3|COMPLETED|Consolidation Maintenance||66
496764|NCT01026220|1214940|P2|COMPLETED|Consolidation Maintenance||75
496765|NCT01026220|1214941|P1|COMPLETED|Consolidation Maintenance||0
496766|NCT01026220|1214939|P3|STARTED|Consolidation Maintenance||80
496767|NCT01026220|1214940|P2|STARTED|Consolidation Maintenance||81
496768|NCT01026220|1214941|P1|STARTED|Consolidation Maintenance||0
496769|NCT01026220|1214939|P3|NOT COMPLETED|Induction||0
496770|NCT01026220|1214940|P2|NOT COMPLETED|Induction||0
496771|NCT01026220|1214941|P1|NOT COMPLETED|Induction||25
496772|NCT01026220|1214939|P3|COMPLETED|Induction||0
496773|NCT01026220|1214940|P2|COMPLETED|Induction||0
496774|NCT01026220|1214941|P1|COMPLETED|Induction||141
496775|NCT01026220|1214939|P3|STARTED|Induction||0
496776|NCT01026220|1214940|P2|STARTED|Induction||0
496777|NCT01026220|1214941|P1|STARTED|Induction||166
496778|NCT01026194|1214965|P2|NOT COMPLETED|Period 2：Open-label Period||10
496779|NCT01026194|1214966|P1|NOT COMPLETED|Period 2：Open-label Period||7
496780|NCT01026194|1214965|P2|COMPLETED|Period 2：Open-label Period||88
496781|NCT01026194|1214966|P1|COMPLETED|Period 2：Open-label Period||91
496782|NCT01026194|1214965|P2|STARTED|Period 2：Open-label Period||98
496783|NCT01026194|1214966|P1|STARTED|Period 2：Open-label Period||98
496784|NCT01026194|1214965|P2|NOT COMPLETED|Period 1：Double Blind Period||5
496785|NCT01026194|1214966|P1|NOT COMPLETED|Period 1：Double Blind Period||3
496786|NCT01026194|1214965|P2|COMPLETED|Period 1：Double Blind Period||98
496787|NCT01026194|1214966|P1|COMPLETED|Period 1：Double Blind Period||98
496788|NCT01026194|1214965|P2|STARTED|Period 1：Double Blind Period||103
496789|NCT01026194|1214966|P1|STARTED|Period 1：Double Blind Period||101
496790|NCT01026181|1214983|P3|NOT COMPLETED|Overall Study||0
496791|NCT01026181|1214984|P2|NOT COMPLETED|Overall Study||0
496792|NCT01026181|1214985|P1|NOT COMPLETED|Overall Study||0
496793|NCT01026181|1214983|P3|COMPLETED|Overall Study||48
496794|NCT01026181|1214984|P2|COMPLETED|Overall Study||51
496795|NCT01026181|1214985|P1|COMPLETED|Overall Study||51
496796|NCT01026181|1214983|P3|STARTED|Overall Study||48
496797|NCT01026181|1214984|P2|STARTED|Overall Study||51
496798|NCT01026181|1214985|P1|STARTED|Overall Study||51
496799|NCT01026142|1214998|P2|NOT COMPLETED|Overall Study||121
496800|NCT01026142|1214999|P1|NOT COMPLETED|Overall Study||139
496801|NCT01026142|1214998|P2|COMPLETED|Overall Study||107
496802|NCT01026142|1214999|P1|COMPLETED|Overall Study||79
496803|NCT01026142|1214998|P2|STARTED|Overall Study||228
496804|NCT01026142|1214999|P1|STARTED|Overall Study||218
496805|NCT01026103|1215021|P1|NOT COMPLETED|Overall Study||2
496806|NCT01026103|1215021|P1|COMPLETED|Overall Study||28
496807|NCT01026103|1215021|P1|Consented|Overall Study||30
496808|NCT01026103|1215021|P1|STARTED|Overall Study||30
496809|NCT01026038|1215031|P3|NOT COMPLETED|Overall Study||0
496810|NCT01026038|1215032|P2|NOT COMPLETED|Overall Study||1
496811|NCT01026038|1215033|P1|NOT COMPLETED|Overall Study||1
496812|NCT01026038|1215031|P3|COMPLETED|Overall Study||67
496813|NCT01026038|1215032|P2|COMPLETED|Overall Study||64
496814|NCT01026038|1215033|P1|COMPLETED|Overall Study||129
496815|NCT01026038|1215031|P3|STARTED|Overall Study||67
496816|NCT01026038|1215032|P2|STARTED|Overall Study||65
496817|NCT01026038|1215033|P1|STARTED|Overall Study||130
496818|NCT01026012|1215068|P1|NOT COMPLETED|Overall Study||0
496819|NCT01026012|1215068|P1|COMPLETED|Overall Study||40
496820|NCT01026012|1215068|P1|STARTED|Overall Study||40
496821|NCT01025843|1215082|P10|NOT COMPLETED|Period 5||0
496822|NCT01025843|1215083|P9|NOT COMPLETED|Period 5||0
496823|NCT01025843|1215084|P8|NOT COMPLETED|Period 5||0
496824|NCT01025843|1215085|P7|NOT COMPLETED|Period 5||0
496825|NCT01025843|1215086|P6|NOT COMPLETED|Period 5||0
496826|NCT01025843|1215087|P5|NOT COMPLETED|Period 5||0
496827|NCT01025843|1215088|P4|NOT COMPLETED|Period 5||0
496828|NCT01025843|1215089|P3|NOT COMPLETED|Period 5||0
496829|NCT01025843|1215090|P2|NOT COMPLETED|Period 5||0
496830|NCT01025843|1215091|P1|NOT COMPLETED|Period 5||0
496831|NCT01025843|1215082|P10|COMPLETED|Period 5||2
496832|NCT01025843|1215083|P9|COMPLETED|Period 5||2
496833|NCT01025843|1215084|P8|COMPLETED|Period 5||2
496834|NCT01025843|1215085|P7|COMPLETED|Period 5||2
496835|NCT01025843|1215086|P6|COMPLETED|Period 5||2
496836|NCT01025843|1215087|P5|COMPLETED|Period 5||2
496837|NCT01025843|1215088|P4|COMPLETED|Period 5||1
496838|NCT01025843|1215089|P3|COMPLETED|Period 5||1
496839|NCT01025843|1215090|P2|COMPLETED|Period 5||2
496840|NCT01025843|1215091|P1|COMPLETED|Period 5||2
496841|NCT01025843|1215082|P10|STARTED|Period 5||2
496842|NCT01025843|1215083|P9|STARTED|Period 5||2
496843|NCT01025843|1215084|P8|STARTED|Period 5||2
496844|NCT01025843|1215085|P7|STARTED|Period 5||2
496845|NCT01025843|1215086|P6|STARTED|Period 5||2
496846|NCT01025843|1215087|P5|STARTED|Period 5||2
496847|NCT01025843|1215088|P4|STARTED|Period 5||1
496848|NCT01025843|1215089|P3|STARTED|Period 5||1
496849|NCT01025843|1215090|P2|STARTED|Period 5||2
496850|NCT01025843|1215091|P1|STARTED|Period 5||2
496851|NCT01025843|1215082|P10|NOT COMPLETED|Washout 4||0
496852|NCT01025843|1215083|P9|NOT COMPLETED|Washout 4||0
496853|NCT01025843|1215084|P8|NOT COMPLETED|Washout 4||0
496854|NCT01025843|1215085|P7|NOT COMPLETED|Washout 4||0
496855|NCT01025843|1215086|P6|NOT COMPLETED|Washout 4||0
496856|NCT01025843|1215087|P5|NOT COMPLETED|Washout 4||0
496857|NCT01025843|1215088|P4|NOT COMPLETED|Washout 4||1
496858|NCT01025843|1215089|P3|NOT COMPLETED|Washout 4||1
496859|NCT01025843|1215090|P2|NOT COMPLETED|Washout 4||0
496860|NCT01025843|1215091|P1|NOT COMPLETED|Washout 4||0
496861|NCT01025843|1215082|P10|COMPLETED|Washout 4||2
496862|NCT01025843|1215083|P9|COMPLETED|Washout 4||2
496863|NCT01025843|1215084|P8|COMPLETED|Washout 4||2
496864|NCT01025843|1215085|P7|COMPLETED|Washout 4||2
496865|NCT01025843|1215086|P6|COMPLETED|Washout 4||2
496866|NCT01025843|1215087|P5|COMPLETED|Washout 4||2
496867|NCT01025843|1215088|P4|COMPLETED|Washout 4||1
496868|NCT01025843|1215089|P3|COMPLETED|Washout 4||1
496869|NCT01025843|1215090|P2|COMPLETED|Washout 4||2
496870|NCT01025843|1215091|P1|COMPLETED|Washout 4||2
496871|NCT01025843|1215082|P10|STARTED|Washout 4||2
496872|NCT01025843|1215083|P9|STARTED|Washout 4||2
496873|NCT01025843|1215084|P8|STARTED|Washout 4||2
496874|NCT01025843|1215085|P7|STARTED|Washout 4||2
496875|NCT01025843|1215086|P6|STARTED|Washout 4||2
496876|NCT01025843|1215087|P5|STARTED|Washout 4||2
496877|NCT01025843|1215088|P4|STARTED|Washout 4||2
496878|NCT01025843|1215089|P3|STARTED|Washout 4||2
496879|NCT01025843|1215090|P2|STARTED|Washout 4||2
496880|NCT01025843|1215091|P1|STARTED|Washout 4||2
496881|NCT01025843|1215082|P10|NOT COMPLETED|Period 4||0
496882|NCT01025843|1215083|P9|NOT COMPLETED|Period 4||0
496883|NCT01025843|1215084|P8|NOT COMPLETED|Period 4||0
496884|NCT01025843|1215085|P7|NOT COMPLETED|Period 4||0
496885|NCT01025843|1215086|P6|NOT COMPLETED|Period 4||0
496886|NCT01025843|1215087|P5|NOT COMPLETED|Period 4||0
496887|NCT01025843|1215088|P4|NOT COMPLETED|Period 4||0
496888|NCT01025843|1215089|P3|NOT COMPLETED|Period 4||0
496889|NCT01025843|1215090|P2|NOT COMPLETED|Period 4||0
496890|NCT01025843|1215091|P1|NOT COMPLETED|Period 4||0
496891|NCT01025843|1215082|P10|COMPLETED|Period 4||2
496892|NCT01025843|1215083|P9|COMPLETED|Period 4||2
496893|NCT01025843|1215084|P8|COMPLETED|Period 4||2
496894|NCT01025843|1215085|P7|COMPLETED|Period 4||2
496895|NCT01025843|1215086|P6|COMPLETED|Period 4||2
496896|NCT01025843|1215087|P5|COMPLETED|Period 4||2
496897|NCT01025843|1215088|P4|COMPLETED|Period 4||2
496898|NCT01025843|1215089|P3|COMPLETED|Period 4||2
496899|NCT01025843|1215090|P2|COMPLETED|Period 4||2
496900|NCT01025843|1215091|P1|COMPLETED|Period 4||2
496901|NCT01025843|1215082|P10|STARTED|Period 4||2
496902|NCT01025843|1215083|P9|STARTED|Period 4||2
496903|NCT01025843|1215084|P8|STARTED|Period 4||2
496904|NCT01025843|1215085|P7|STARTED|Period 4||2
496905|NCT01025843|1215086|P6|STARTED|Period 4||2
496906|NCT01025843|1215087|P5|STARTED|Period 4||2
496907|NCT01025843|1215088|P4|STARTED|Period 4||2
496908|NCT01025843|1215089|P3|STARTED|Period 4||2
496909|NCT01025843|1215090|P2|STARTED|Period 4||2
496910|NCT01025843|1215091|P1|STARTED|Period 4||2
496911|NCT01025843|1215082|P10|NOT COMPLETED|Washout 3||0
496912|NCT01025843|1215083|P9|NOT COMPLETED|Washout 3||0
496913|NCT01025843|1215084|P8|NOT COMPLETED|Washout 3||0
496914|NCT01025843|1215085|P7|NOT COMPLETED|Washout 3||0
496915|NCT01025843|1215086|P6|NOT COMPLETED|Washout 3||0
496916|NCT01025843|1215087|P5|NOT COMPLETED|Washout 3||0
496917|NCT01025843|1215088|P4|NOT COMPLETED|Washout 3||0
496918|NCT01025843|1215089|P3|NOT COMPLETED|Washout 3||0
496919|NCT01025843|1215090|P2|NOT COMPLETED|Washout 3||0
496920|NCT01025843|1215091|P1|NOT COMPLETED|Washout 3||0
496921|NCT01025843|1215082|P10|COMPLETED|Washout 3||2
496922|NCT01025843|1215083|P9|COMPLETED|Washout 3||2
496923|NCT01025843|1215084|P8|COMPLETED|Washout 3||2
496924|NCT01025843|1215085|P7|COMPLETED|Washout 3||2
496925|NCT01025843|1215086|P6|COMPLETED|Washout 3||2
496926|NCT01025843|1215087|P5|COMPLETED|Washout 3||2
496927|NCT01025843|1215088|P4|COMPLETED|Washout 3||2
496928|NCT01025843|1215089|P3|COMPLETED|Washout 3||2
496929|NCT01025843|1215090|P2|COMPLETED|Washout 3||2
496930|NCT01025843|1215091|P1|COMPLETED|Washout 3||2
496931|NCT01025843|1215082|P10|STARTED|Washout 3||2
496932|NCT01025843|1215083|P9|STARTED|Washout 3||2
496933|NCT01025843|1215084|P8|STARTED|Washout 3||2
496934|NCT01025843|1215085|P7|STARTED|Washout 3||2
496935|NCT01025843|1215086|P6|STARTED|Washout 3||2
496936|NCT01025843|1215087|P5|STARTED|Washout 3||2
496937|NCT01025843|1215088|P4|STARTED|Washout 3||2
496938|NCT01025843|1215089|P3|STARTED|Washout 3||2
496939|NCT01025843|1215090|P2|STARTED|Washout 3||2
496940|NCT01025843|1215091|P1|STARTED|Washout 3||2
496941|NCT01025843|1215082|P10|NOT COMPLETED|Period 3||0
496942|NCT01025843|1215083|P9|NOT COMPLETED|Period 3||0
496943|NCT01025843|1215084|P8|NOT COMPLETED|Period 3||0
496944|NCT01025843|1215085|P7|NOT COMPLETED|Period 3||0
496945|NCT01025843|1215086|P6|NOT COMPLETED|Period 3||0
496946|NCT01025843|1215087|P5|NOT COMPLETED|Period 3||0
496947|NCT01025843|1215088|P4|NOT COMPLETED|Period 3||0
496948|NCT01025843|1215089|P3|NOT COMPLETED|Period 3||0
496949|NCT01025843|1215090|P2|NOT COMPLETED|Period 3||0
496950|NCT01025843|1215091|P1|NOT COMPLETED|Period 3||0
496951|NCT01025843|1215082|P10|COMPLETED|Period 3||2
496952|NCT01025843|1215083|P9|COMPLETED|Period 3||2
496953|NCT01025843|1215084|P8|COMPLETED|Period 3||2
496954|NCT01025843|1215085|P7|COMPLETED|Period 3||2
496955|NCT01025843|1215086|P6|COMPLETED|Period 3||2
496956|NCT01025843|1215087|P5|COMPLETED|Period 3||2
496957|NCT01025843|1215088|P4|COMPLETED|Period 3||2
496958|NCT01025843|1215089|P3|COMPLETED|Period 3||2
496959|NCT01025843|1215090|P2|COMPLETED|Period 3||2
496960|NCT01025843|1215091|P1|COMPLETED|Period 3||2
496961|NCT01025843|1215082|P10|STARTED|Period 3||2
496962|NCT01025843|1215083|P9|STARTED|Period 3||2
496963|NCT01025843|1215084|P8|STARTED|Period 3||2
496964|NCT01025843|1215085|P7|STARTED|Period 3||2
496965|NCT01025843|1215086|P6|STARTED|Period 3||2
496966|NCT01025843|1215087|P5|STARTED|Period 3||2
496967|NCT01025843|1215088|P4|STARTED|Period 3||2
496968|NCT01025843|1215089|P3|STARTED|Period 3||2
496969|NCT01025843|1215090|P2|STARTED|Period 3||2
496970|NCT01025843|1215091|P1|STARTED|Period 3||2
496971|NCT01025843|1215082|P10|NOT COMPLETED|Washout 2||0
496972|NCT01025843|1215083|P9|NOT COMPLETED|Washout 2||0
496973|NCT01025843|1215084|P8|NOT COMPLETED|Washout 2||0
496974|NCT01025843|1215085|P7|NOT COMPLETED|Washout 2||0
496975|NCT01025843|1215086|P6|NOT COMPLETED|Washout 2||0
496976|NCT01025843|1215087|P5|NOT COMPLETED|Washout 2||0
496977|NCT01025843|1215088|P4|NOT COMPLETED|Washout 2||0
496978|NCT01025843|1215089|P3|NOT COMPLETED|Washout 2||0
496979|NCT01025843|1215090|P2|NOT COMPLETED|Washout 2||0
496980|NCT01025843|1215091|P1|NOT COMPLETED|Washout 2||0
496981|NCT01025843|1215082|P10|COMPLETED|Washout 2||2
496982|NCT01025843|1215083|P9|COMPLETED|Washout 2||2
496983|NCT01025843|1215084|P8|COMPLETED|Washout 2||2
496984|NCT01025843|1215085|P7|COMPLETED|Washout 2||2
496985|NCT01025843|1215086|P6|COMPLETED|Washout 2||2
496986|NCT01025843|1215087|P5|COMPLETED|Washout 2||2
496987|NCT01025843|1215088|P4|COMPLETED|Washout 2||2
496988|NCT01025843|1215089|P3|COMPLETED|Washout 2||2
496989|NCT01025843|1215090|P2|COMPLETED|Washout 2||2
496990|NCT01025843|1215091|P1|COMPLETED|Washout 2||2
496991|NCT01025843|1215082|P10|STARTED|Washout 2||2
496992|NCT01025843|1215083|P9|STARTED|Washout 2||2
496993|NCT01025843|1215084|P8|STARTED|Washout 2||2
496994|NCT01025843|1215085|P7|STARTED|Washout 2||2
496995|NCT01025843|1215086|P6|STARTED|Washout 2||2
496996|NCT01025843|1215087|P5|STARTED|Washout 2||2
496997|NCT01025843|1215088|P4|STARTED|Washout 2||2
496998|NCT01025843|1215089|P3|STARTED|Washout 2||2
496999|NCT01025843|1215090|P2|STARTED|Washout 2||2
497000|NCT01025843|1215091|P1|STARTED|Washout 2||2
497001|NCT01025843|1215082|P10|NOT COMPLETED|Period 2||0
497002|NCT01025843|1215083|P9|NOT COMPLETED|Period 2||0
497003|NCT01025843|1215084|P8|NOT COMPLETED|Period 2||0
497004|NCT01025843|1215085|P7|NOT COMPLETED|Period 2||0
497005|NCT01025843|1215086|P6|NOT COMPLETED|Period 2||0
497006|NCT01025843|1215087|P5|NOT COMPLETED|Period 2||0
497007|NCT01025843|1215088|P4|NOT COMPLETED|Period 2||0
497008|NCT01025843|1215089|P3|NOT COMPLETED|Period 2||0
497009|NCT01025843|1215090|P2|NOT COMPLETED|Period 2||0
497010|NCT01025843|1215091|P1|NOT COMPLETED|Period 2||0
497011|NCT01025843|1215082|P10|COMPLETED|Period 2||2
497012|NCT01025843|1215083|P9|COMPLETED|Period 2||2
497013|NCT01025843|1215084|P8|COMPLETED|Period 2||2
497014|NCT01025843|1215085|P7|COMPLETED|Period 2||2
497015|NCT01025843|1215086|P6|COMPLETED|Period 2||2
497016|NCT01025843|1215087|P5|COMPLETED|Period 2||2
497017|NCT01025843|1215088|P4|COMPLETED|Period 2||2
497018|NCT01025843|1215089|P3|COMPLETED|Period 2||2
497019|NCT01025843|1215090|P2|COMPLETED|Period 2||2
497020|NCT01025843|1215091|P1|COMPLETED|Period 2||2
497021|NCT01025843|1215082|P10|STARTED|Period 2||2
497022|NCT01025843|1215083|P9|STARTED|Period 2||2
497023|NCT01025843|1215084|P8|STARTED|Period 2||2
497024|NCT01025843|1215085|P7|STARTED|Period 2||2
497025|NCT01025843|1215086|P6|STARTED|Period 2||2
497026|NCT01025843|1215087|P5|STARTED|Period 2||2
497027|NCT01025843|1215088|P4|STARTED|Period 2||2
497028|NCT01025843|1215089|P3|STARTED|Period 2||2
497029|NCT01025843|1215090|P2|STARTED|Period 2||2
497030|NCT01025843|1215091|P1|STARTED|Period 2||2
497031|NCT01025843|1215082|P10|NOT COMPLETED|Washout 1||0
497032|NCT01025843|1215083|P9|NOT COMPLETED|Washout 1||0
497033|NCT01025843|1215084|P8|NOT COMPLETED|Washout 1||0
497034|NCT01025843|1215085|P7|NOT COMPLETED|Washout 1||0
497035|NCT01025843|1215086|P6|NOT COMPLETED|Washout 1||0
497036|NCT01025843|1215087|P5|NOT COMPLETED|Washout 1||0
497037|NCT01025843|1215088|P4|NOT COMPLETED|Washout 1||0
497038|NCT01025843|1215089|P3|NOT COMPLETED|Washout 1||0
497039|NCT01025843|1215090|P2|NOT COMPLETED|Washout 1||0
497040|NCT01025843|1215091|P1|NOT COMPLETED|Washout 1||0
497041|NCT01025843|1215082|P10|COMPLETED|Washout 1||2
497042|NCT01025843|1215083|P9|COMPLETED|Washout 1||2
497043|NCT01025843|1215084|P8|COMPLETED|Washout 1||2
497044|NCT01025843|1215085|P7|COMPLETED|Washout 1||2
497045|NCT01025843|1215086|P6|COMPLETED|Washout 1||2
497046|NCT01025843|1215087|P5|COMPLETED|Washout 1||2
497047|NCT01025843|1215088|P4|COMPLETED|Washout 1||2
497048|NCT01025843|1215089|P3|COMPLETED|Washout 1||2
497049|NCT01025843|1215090|P2|COMPLETED|Washout 1||2
497050|NCT01025843|1215091|P1|COMPLETED|Washout 1||2
497051|NCT01025843|1215082|P10|STARTED|Washout 1||2
497052|NCT01025843|1215083|P9|STARTED|Washout 1||2
497053|NCT01025843|1215084|P8|STARTED|Washout 1||2
497054|NCT01025843|1215085|P7|STARTED|Washout 1||2
497055|NCT01025843|1215086|P6|STARTED|Washout 1||2
497056|NCT01025843|1215087|P5|STARTED|Washout 1||2
497057|NCT01025843|1215088|P4|STARTED|Washout 1||2
497058|NCT01025843|1215089|P3|STARTED|Washout 1||2
497059|NCT01025843|1215090|P2|STARTED|Washout 1||2
497060|NCT01025843|1215091|P1|STARTED|Washout 1||2
497061|NCT01025843|1215082|P10|NOT COMPLETED|Period 1||0
497062|NCT01025843|1215083|P9|NOT COMPLETED|Period 1||0
497063|NCT01025843|1215084|P8|NOT COMPLETED|Period 1||0
497064|NCT01025843|1215085|P7|NOT COMPLETED|Period 1||0
497065|NCT01025843|1215086|P6|NOT COMPLETED|Period 1||0
497066|NCT01025843|1215087|P5|NOT COMPLETED|Period 1||0
497067|NCT01025843|1215088|P4|NOT COMPLETED|Period 1||0
497068|NCT01025843|1215089|P3|NOT COMPLETED|Period 1||0
497069|NCT01025843|1215090|P2|NOT COMPLETED|Period 1||0
497070|NCT01025843|1215091|P1|NOT COMPLETED|Period 1||0
497071|NCT01025843|1215082|P10|COMPLETED|Period 1||2
497072|NCT01025843|1215083|P9|COMPLETED|Period 1||2
497073|NCT01025843|1215084|P8|COMPLETED|Period 1||2
497074|NCT01025843|1215085|P7|COMPLETED|Period 1||2
497075|NCT01025843|1215086|P6|COMPLETED|Period 1||2
497076|NCT01025843|1215087|P5|COMPLETED|Period 1||2
497077|NCT01025843|1215088|P4|COMPLETED|Period 1||2
497078|NCT01025843|1215089|P3|COMPLETED|Period 1||2
497079|NCT01025843|1215090|P2|COMPLETED|Period 1||2
497080|NCT01025843|1215091|P1|COMPLETED|Period 1||2
497081|NCT01025843|1215082|P10|STARTED|Period 1||2
497082|NCT01025843|1215083|P9|STARTED|Period 1||2
497083|NCT01025843|1215084|P8|STARTED|Period 1||2
497084|NCT01025843|1215085|P7|STARTED|Period 1||2
497085|NCT01025843|1215086|P6|STARTED|Period 1||2
497086|NCT01025843|1215087|P5|STARTED|Period 1||2
497087|NCT01025843|1215088|P4|STARTED|Period 1||2
497088|NCT01025843|1215089|P3|STARTED|Period 1||2
497089|NCT01025843|1215090|P2|STARTED|Period 1||2
497090|NCT01025843|1215091|P1|STARTED|Period 1||2
497091|NCT01025830|1215165|P2|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0
497092|NCT01025830|1215166|P1|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0
497093|NCT01025830|1215165|P2|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12
497094|NCT01025830|1215166|P1|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8
497095|NCT01025830|1215165|P2|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12
497096|NCT01025830|1215166|P1|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8
497097|NCT01025830|1215165|P2|NOT COMPLETED|Washout Period of 30 Days||0
497098|NCT01025830|1215166|P1|NOT COMPLETED|Washout Period of 30 Days||0
497099|NCT01025830|1215165|P2|COMPLETED|Washout Period of 30 Days||12
497100|NCT01025830|1215166|P1|COMPLETED|Washout Period of 30 Days||8
497101|NCT01025830|1215165|P2|STARTED|Washout Period of 30 Days||12
497102|NCT01025830|1215166|P1|STARTED|Washout Period of 30 Days||8
497103|NCT01025830|1215165|P2|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0
497104|NCT01025830|1215166|P1|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0
497105|NCT01025830|1215165|P2|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12
497106|NCT01025830|1215166|P1|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8
497107|NCT01025830|1215165|P2|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12
497108|NCT01025830|1215166|P1|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8
497109|NCT01025817|1215185|P2|NOT COMPLETED|Completed Study||22
497110|NCT01025817|1215186|P1|NOT COMPLETED|Completed Study||16
497111|NCT01025817|1215185|P2|COMPLETED|Completed Study|Completed study phase|282
497112|NCT01025817|1215186|P1|COMPLETED|Completed Study|Completed study phase|293
497113|NCT01025817|1215185|P2|STARTED|Completed Study||304
497114|NCT01025817|1215186|P1|STARTED|Completed Study||309
497115|NCT01025817|1215185|P2|NOT COMPLETED|Completed Study Medication||72
497116|NCT01025817|1215186|P1|NOT COMPLETED|Completed Study Medication||105
497117|NCT01025817|1215185|P2|COMPLETED|Completed Study Medication||232
497118|NCT01025817|1215186|P1|COMPLETED|Completed Study Medication||204
497119|NCT01025817|1215185|P2|STARTED|Completed Study Medication||304
497120|NCT01025817|1215186|P1|STARTED|Completed Study Medication||309
497121|NCT01025635|1215206|P2|NOT COMPLETED|Overall Study||25
497122|NCT01025635|1215207|P1|NOT COMPLETED|Overall Study||23
497123|NCT01025635|1215206|P2|COMPLETED|Overall Study||178
497124|NCT01025635|1215207|P1|COMPLETED|Overall Study||175
497125|NCT01025635|1215206|P2|STARTED|Overall Study||203
497126|NCT01025635|1215207|P1|STARTED|Overall Study||198
497127|NCT01025492|1215219|P1|NOT COMPLETED|Overall Study||0
497128|NCT01025492|1215219|P1|COMPLETED|Overall Study||24
497129|NCT01025492|1215219|P1|STARTED|Overall Study||24
497130|NCT01025336|1215228|P5|NOT COMPLETED|Overall Study||0
497131|NCT01025336|1215229|P4|NOT COMPLETED|Overall Study||2
497132|NCT01025336|1215230|P3|NOT COMPLETED|Overall Study||0
497133|NCT01025336|1215231|P2|NOT COMPLETED|Overall Study||0
497134|NCT01025336|1215232|P1|NOT COMPLETED|Overall Study||0
497135|NCT01025336|1215228|P5|COMPLETED|Overall Study||222
497136|NCT01025336|1215229|P4|COMPLETED|Overall Study||219
497137|NCT01025336|1215230|P3|COMPLETED|Overall Study||179
497138|NCT01025336|1215231|P2|COMPLETED|Overall Study||210
497139|NCT01025336|1215232|P1|COMPLETED|Overall Study||130
497140|NCT01025336|1215228|P5|STARTED|Overall Study||222
497141|NCT01025336|1215229|P4|STARTED|Overall Study||221
497142|NCT01025336|1215230|P3|STARTED|Overall Study||179
497143|NCT01025336|1215231|P2|STARTED|Overall Study||210
497144|NCT01025336|1215232|P1|STARTED|Overall Study||130
497145|NCT01025284|1215287|P3|NOT COMPLETED|Overall Study||0
497146|NCT01025284|1215288|P2|NOT COMPLETED|Overall Study||2
497147|NCT01025284|1215289|P1|NOT COMPLETED|Overall Study||0
497148|NCT01025284|1215287|P3|COMPLETED|Overall Study||8
497149|NCT01025284|1215288|P2|COMPLETED|Overall Study||16
497150|NCT01025284|1215289|P1|COMPLETED|Overall Study||38
497151|NCT01025284|1215287|P3|Received at Least 1 Dose of Study Drug|Overall Study||8
497152|NCT01025284|1215288|P2|Received at Least 1 Dose of Study Drug|Overall Study||18
497153|NCT01025284|1215289|P1|Received at Least 1 Dose of Study Drug|Overall Study||38
497154|NCT01025284|1215287|P3|STARTED|Overall Study||8
497155|NCT01025284|1215288|P2|STARTED|Overall Study||18
497156|NCT01025284|1215289|P1|STARTED|Overall Study||38
497157|NCT01025271|1215307|P1|NOT COMPLETED|Overall Study||0
497158|NCT01025271|1215307|P1|COMPLETED|Overall Study|unable to meet enrollment no data available. Study terminated early|2
497159|NCT01025271|1215307|P1|STARTED|Overall Study|unable to meet enrollment no data available. Study terminated early|2
497160|NCT01025232|1215314|P2|NOT COMPLETED|Overall Study||6
497161|NCT01025232|1215315|P1|NOT COMPLETED|Overall Study||3
497162|NCT01025232|1215314|P2|COMPLETED|Overall Study||36
497163|NCT01025232|1215315|P1|COMPLETED|Overall Study||43
497164|NCT01025232|1215314|P2|STARTED|Overall Study||42
497165|NCT01025232|1215315|P1|STARTED|Overall Study||46
497166|NCT01025193|1215333|P1|NOT COMPLETED|Overall Study||4
497167|NCT01025193|1215333|P1|COMPLETED|Overall Study|one patient was transplanted 2 weeks after 8 month belimumab dose and did not receive further doses.|4
497168|NCT01025193|1215333|P1|STARTED|Overall Study||8
497169|NCT01025154|1215343|P1|NOT COMPLETED|Overall Study||2
497170|NCT01025154|1215343|P1|COMPLETED|Overall Study||57
497171|NCT01025154|1215343|P1|STARTED|Overall Study||59
497172|NCT01025076|1215348|P1|NOT COMPLETED|Overall Study||0
497173|NCT01025076|1215348|P1|COMPLETED|Overall Study||14
497174|NCT01025076|1215348|P1|STARTED|Overall Study||14
497175|NCT01025037|1215352|P1|NOT COMPLETED|Overall Study||11
497176|NCT01025037|1215352|P1|COMPLETED|Overall Study||50
497177|NCT01025037|1215352|P1|STARTED|Overall Study||61
497178|NCT01024972|1215363|P2|NOT COMPLETED|Overall Study||0
497179|NCT01024972|1215364|P1|NOT COMPLETED|Overall Study||0
497180|NCT01024972|1215363|P2|COMPLETED|Overall Study||15
497181|NCT01024972|1215364|P1|COMPLETED|Overall Study||16
497182|NCT01024972|1215363|P2|STARTED|Overall Study||15
497183|NCT01024972|1215364|P1|STARTED|Overall Study||16
497184|NCT01024959|1215374|P1|NOT COMPLETED|Overall Study||41
497185|NCT01024959|1215374|P1|COMPLETED|Overall Study||466
497186|NCT01024959|1215374|P1|STARTED|Overall Study||507
497187|NCT01024946|1215383|P1|NOT COMPLETED|Overall Study||5
497188|NCT01024946|1215383|P1|COMPLETED|Overall Study||6
497189|NCT01024946|1215383|P1|STARTED|Overall Study||11
497190|NCT01024855|1215387|P1|NOT COMPLETED|Overall Study||1
497191|NCT01024855|1215387|P1|COMPLETED|Overall Study|One subject of the 30 seen for baseline did not meet the inclusion/exclusion criteria|29
497192|NCT01024855|1215387|P1|STARTED|Overall Study|30 subjects enrolled in a paired/split-eye evaluation; each subject used both study treatments|30
497193|NCT01024751|1215394|P2|NOT COMPLETED|Eligible Participants||3
497194|NCT01024751|1215395|P1|NOT COMPLETED|Eligible Participants||0
497195|NCT01024751|1215394|P2|COMPLETED|Eligible Participants||149
497196|NCT01024751|1215395|P1|COMPLETED|Eligible Participants||153
497197|NCT01024751|1215394|P2|STARTED|Eligible Participants||152
497198|NCT01024751|1215395|P1|STARTED|Eligible Participants||153
497199|NCT01024751|1215394|P2|NOT COMPLETED|Enrolled Participants||4
497200|NCT01024751|1215395|P1|NOT COMPLETED|Enrolled Participants||3
497201|NCT01024751|1215394|P2|COMPLETED|Enrolled Participants||152
497202|NCT01024751|1215395|P1|COMPLETED|Enrolled Participants||153
497203|NCT01024751|1215394|P2|STARTED|Enrolled Participants||156
497204|NCT01024751|1215395|P1|STARTED|Enrolled Participants||156
497205|NCT01024738|1215406|P3|NOT COMPLETED|Third Intervention:||0
497206|NCT01024738|1215407|P2|NOT COMPLETED|Third Intervention:||0
497207|NCT01024738|1215408|P1|NOT COMPLETED|Third Intervention:||0
497208|NCT01024738|1215406|P3|COMPLETED|Third Intervention:||8
497209|NCT01024738|1215407|P2|COMPLETED|Third Intervention:||7
497210|NCT01024738|1215408|P1|COMPLETED|Third Intervention:||7
497211|NCT01024738|1215406|P3|STARTED|Third Intervention:||8
497212|NCT01024738|1215407|P2|STARTED|Third Intervention:||7
497213|NCT01024738|1215408|P1|STARTED|Third Intervention:||7
497214|NCT01024738|1215406|P3|NOT COMPLETED|Washout After 2nd Intervention||0
497215|NCT01024738|1215407|P2|NOT COMPLETED|Washout After 2nd Intervention||0
497216|NCT01024738|1215408|P1|NOT COMPLETED|Washout After 2nd Intervention||0
497217|NCT01024738|1215406|P3|COMPLETED|Washout After 2nd Intervention||8
497218|NCT01024738|1215407|P2|COMPLETED|Washout After 2nd Intervention||7
497219|NCT01024738|1215408|P1|COMPLETED|Washout After 2nd Intervention||7
497220|NCT01024738|1215406|P3|STARTED|Washout After 2nd Intervention||8
497221|NCT01024738|1215407|P2|STARTED|Washout After 2nd Intervention||7
497222|NCT01024738|1215408|P1|STARTED|Washout After 2nd Intervention||7
497223|NCT01024738|1215406|P3|NOT COMPLETED|Second Intervention:||0
497224|NCT01024738|1215407|P2|NOT COMPLETED|Second Intervention:||0
497225|NCT01024738|1215408|P1|NOT COMPLETED|Second Intervention:||0
497226|NCT01024738|1215406|P3|COMPLETED|Second Intervention:||8
497227|NCT01024738|1215407|P2|COMPLETED|Second Intervention:||7
497228|NCT01024738|1215408|P1|COMPLETED|Second Intervention:||7
497229|NCT01024738|1215406|P3|STARTED|Second Intervention:||8
497230|NCT01024738|1215407|P2|STARTED|Second Intervention:||7
497231|NCT01024738|1215408|P1|STARTED|Second Intervention:||7
497232|NCT01024738|1215406|P3|NOT COMPLETED|Washout After 1st Intervention||0
497233|NCT01024738|1215407|P2|NOT COMPLETED|Washout After 1st Intervention||0
497234|NCT01024738|1215408|P1|NOT COMPLETED|Washout After 1st Intervention||0
497235|NCT01024738|1215406|P3|COMPLETED|Washout After 1st Intervention||8
497236|NCT01024738|1215407|P2|COMPLETED|Washout After 1st Intervention||7
497237|NCT01024738|1215408|P1|COMPLETED|Washout After 1st Intervention||7
497238|NCT01024738|1215406|P3|STARTED|Washout After 1st Intervention||8
497239|NCT01024738|1215407|P2|STARTED|Washout After 1st Intervention||7
497240|NCT01024738|1215408|P1|STARTED|Washout After 1st Intervention||7
497241|NCT01024738|1215406|P3|NOT COMPLETED|First Intervention:||0
497242|NCT01024738|1215407|P2|NOT COMPLETED|First Intervention:||0
497243|NCT01024738|1215408|P1|NOT COMPLETED|First Intervention:||0
497244|NCT01024738|1215406|P3|COMPLETED|First Intervention:||8
497245|NCT01024738|1215407|P2|COMPLETED|First Intervention:||7
497246|NCT01024738|1215408|P1|COMPLETED|First Intervention:||7
497247|NCT01024738|1215406|P3|STARTED|First Intervention:||8
497248|NCT01024738|1215407|P2|STARTED|First Intervention:||7
497249|NCT01024738|1215408|P1|STARTED|First Intervention:||7
497250|NCT01024608|1215418|P2|NOT COMPLETED|Overall Study||4
497251|NCT01024608|1215419|P1|NOT COMPLETED|Overall Study||4
497252|NCT01024608|1215418|P2|COMPLETED|Overall Study||167
497253|NCT01024608|1215419|P1|COMPLETED|Overall Study||165
497254|NCT01024608|1215418|P2|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|171
497255|NCT01024608|1215419|P1|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|167
497256|NCT01024608|1215418|P2|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|171
497257|NCT01024608|1215419|P1|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|167
497258|NCT01024608|1215418|P2|STARTED|Overall Study||171
497259|NCT01024608|1215419|P1|STARTED|Overall Study||169
497260|NCT01024465|1215431|P1|NOT COMPLETED|Overall Study||3
497261|NCT01024465|1215431|P1|COMPLETED|Overall Study||23
497262|NCT01024465|1215431|P1|STARTED|Overall Study||26
497263|NCT01024387|1215435|P1|NOT COMPLETED|Overall Study||60
497264|NCT01024387|1215435|P1|COMPLETED|Overall Study||0
497265|NCT01024387|1215435|P1|Evaluable for Response|Overall Study||53
497266|NCT01024387|1215435|P1|Evaluable for PFS|Overall Study||54
497267|NCT01024387|1215435|P1|STARTED|Overall Study||60
497268|NCT01024335|1215445|P2|NOT COMPLETED|Overall Study||26
497269|NCT01024335|1215446|P1|NOT COMPLETED|Overall Study||13
497270|NCT01024335|1215445|P2|COMPLETED|Overall Study||14
497271|NCT01024335|1215446|P1|COMPLETED|Overall Study||7
497272|NCT01024335|1215445|P2|STARTED|Overall Study||40
497273|NCT01024335|1215446|P1|STARTED|Overall Study||20
497274|NCT01024309|1215456|P2|NOT COMPLETED|Overall Study||4
497275|NCT01024309|1215457|P1|NOT COMPLETED|Overall Study||8
497276|NCT01024309|1215456|P2|COMPLETED|Overall Study||27
497277|NCT01024309|1215457|P1|COMPLETED|Overall Study||27
497278|NCT01024309|1215456|P2|STARTED|Overall Study||31
497279|NCT01024309|1215457|P1|STARTED|Overall Study||35
497280|NCT01024296|1215479|P1|NOT COMPLETED|Overall Study||0
497281|NCT01024296|1215479|P1|COMPLETED|Overall Study||4
497282|NCT01024296|1215479|P1|STARTED|Overall Study||4
497283|NCT01024244|1215489|P5|NOT COMPLETED|Overall Study||14
497284|NCT01024244|1215490|P4|NOT COMPLETED|Overall Study||13
497285|NCT01024244|1215491|P3|NOT COMPLETED|Overall Study||14
497286|NCT01024244|1215492|P2|NOT COMPLETED|Overall Study||11
497287|NCT01024244|1215493|P1|NOT COMPLETED|Overall Study||17
497288|NCT01024244|1215489|P5|COMPLETED|Overall Study||1
497289|NCT01024244|1215490|P4|COMPLETED|Overall Study||1
497290|NCT01024244|1215491|P3|COMPLETED|Overall Study||1
497291|NCT01024244|1215492|P2|COMPLETED|Overall Study||1
497292|NCT01024244|1215493|P1|COMPLETED|Overall Study||5
497293|NCT01024244|1215489|P5|STARTED|Overall Study||15
497294|NCT01024244|1215490|P4|STARTED|Overall Study||14
497295|NCT01024244|1215491|P3|STARTED|Overall Study||15
497296|NCT01024244|1215492|P2|STARTED|Overall Study||12
497297|NCT01024244|1215493|P1|STARTED|Overall Study||22
497298|NCT01024036|1215607|P2|NOT COMPLETED|Follow-Up Period||3
497299|NCT01024036|1215608|P1|NOT COMPLETED|Follow-Up Period||5
497300|NCT01024036|1215607|P2|COMPLETED|Follow-Up Period||3
497301|NCT01024036|1215608|P1|COMPLETED|Follow-Up Period||9
497302|NCT01024036|1215607|P2|STARTED|Follow-Up Period||6
497303|NCT01024036|1215608|P1|STARTED|Follow-Up Period||14
497304|NCT01024036|1215607|P2|NOT COMPLETED|Unblinded Treatment||3
497305|NCT01024036|1215608|P1|NOT COMPLETED|Unblinded Treatment||0
497306|NCT01024036|1215607|P2|COMPLETED|Unblinded Treatment||10
497307|NCT01024036|1215608|P1|COMPLETED|Unblinded Treatment||0
497308|NCT01024036|1215607|P2|STARTED|Unblinded Treatment|Placebo participants had an option to receive siltuximab in unblinded treatment period|13
497309|NCT01024036|1215608|P1|STARTED|Unblinded Treatment|No participants in this group received treatment during unblinded treatment period|0
497310|NCT01024036|1215607|P2|NOT COMPLETED|Blinded Treatment||20
497311|NCT01024036|1215608|P1|NOT COMPLETED|Blinded Treatment||22
497312|NCT01024036|1215607|P2|COMPLETED|Blinded Treatment||6
497313|NCT01024036|1215608|P1|COMPLETED|Blinded Treatment||31
497314|NCT01024036|1215607|P2|STARTED|Blinded Treatment||26
497315|NCT01024036|1215608|P1|STARTED|Blinded Treatment||53
497316|NCT01023958|1215639|P1|NOT COMPLETED|Overall Study||50
497317|NCT01023958|1215639|P1|COMPLETED|Overall Study||0
497318|NCT01023958|1215639|P1|STARTED|Overall Study||50
497319|NCT01023841|1215668|P2|NOT COMPLETED|Overall Study||0
497320|NCT01023841|1215669|P1|NOT COMPLETED|Overall Study||1
497321|NCT01023841|1215668|P2|COMPLETED|Overall Study||23
497322|NCT01023841|1215669|P1|COMPLETED|Overall Study||47
497323|NCT01023841|1215668|P2|STARTED|Overall Study||23
497324|NCT01023841|1215669|P1|STARTED|Overall Study||48
497325|NCT01023815|1215687|P4|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3
497326|NCT01023815|1215688|P3|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||8
497327|NCT01023815|1215689|P2|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3
497328|NCT01023815|1215690|P1|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||0
497329|NCT01023815|1215687|P4|COMPLETED|Randomized Period (Day 90 to Month 12)||68
497330|NCT01023815|1215688|P3|COMPLETED|Randomized Period (Day 90 to Month 12)||60
497331|NCT01023815|1215689|P2|COMPLETED|Randomized Period (Day 90 to Month 12)||42
497332|NCT01023815|1215690|P1|COMPLETED|Randomized Period (Day 90 to Month 12)||0
497333|NCT01023815|1215687|P4|STARTED|Randomized Period (Day 90 to Month 12)||71
497334|NCT01023815|1215688|P3|STARTED|Randomized Period (Day 90 to Month 12)||68
497335|NCT01023815|1215689|P2|STARTED|Randomized Period (Day 90 to Month 12)|Randomized patients to Group A, B and C are also intent to treat population.|45
497336|NCT01023815|1215690|P1|STARTED|Randomized Period (Day 90 to Month 12)||0
497337|NCT01023815|1215687|P4|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
497338|NCT01023815|1215688|P3|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
497339|NCT01023815|1215689|P2|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
497340|NCT01023815|1215690|P1|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||144
497341|NCT01023815|1215687|P4|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
497342|NCT01023815|1215688|P3|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
497343|NCT01023815|1215689|P2|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
497344|NCT01023815|1215690|P1|COMPLETED|Pre-randomization Period (Day 1 to 90)||184
497345|NCT01023815|1215687|P4|STARTED|Pre-randomization Period (Day 1 to 90)||0
497346|NCT01023815|1215688|P3|STARTED|Pre-randomization Period (Day 1 to 90)||0
497347|NCT01023815|1215689|P2|STARTED|Pre-randomization Period (Day 1 to 90)||0
497348|NCT01023815|1215690|P1|STARTED|Pre-randomization Period (Day 1 to 90)|Out of 330 enrolled, 2 patients never received everolimus.|328
497349|NCT01023789|1215709|P1|NOT COMPLETED|3 - Year Visit||43
497350|NCT01023789|1215709|P1|COMPLETED|3 - Year Visit||769
497351|NCT01023789|1215709|P1|STARTED|3 - Year Visit||812
497352|NCT01023789|1215709|P1|NOT COMPLETED|2 - Year Visit||0
497353|NCT01023789|1215709|P1|COMPLETED|2 - Year Visit||812
497354|NCT01023789|1215709|P1|STARTED|2 - Year Visit||812
497355|NCT01023789|1215709|P1|NOT COMPLETED|1 - Year Visit||0
497356|NCT01023789|1215709|P1|COMPLETED|1 - Year Visit||812
497357|NCT01023789|1215709|P1|STARTED|1 - Year Visit||812
497358|NCT01023789|1215709|P1|NOT COMPLETED|180-day Clinical Follow-up||0
497359|NCT01023789|1215709|P1|COMPLETED|180-day Clinical Follow-up||812
497360|NCT01023789|1215709|P1|STARTED|180-day Clinical Follow-up||812
497361|NCT01023789|1215709|P1|NOT COMPLETED|30-day Follow-up Visit||0
497362|NCT01023789|1215709|P1|COMPLETED|30-day Follow-up Visit||812
497363|NCT01023789|1215709|P1|STARTED|30-day Follow-up Visit|Intent-to-treat population (ITT).|812
497364|NCT01023776|1215776|P1|NOT COMPLETED|Overall Study||0
497365|NCT01023776|1215776|P1|COMPLETED|Overall Study||20
497366|NCT01023776|1215776|P1|STARTED|Overall Study|Subjects received 2 dose of vaccine 0.1 ml in each nostril intra nasally 28 days apart|20
497367|NCT01023724|1215783|P2|NOT COMPLETED|Overall Study||3
497368|NCT01023724|1215784|P1|NOT COMPLETED|Overall Study||4
497369|NCT01023724|1215783|P2|COMPLETED|Overall Study||22
497370|NCT01023724|1215784|P1|COMPLETED|Overall Study||21
497371|NCT01023724|1215783|P2|STARTED|Overall Study||25
497372|NCT01023724|1215784|P1|STARTED|Overall Study||25
497373|NCT01023711|1215790|P1|NOT COMPLETED|Overall Study||0
497374|NCT01023711|1215790|P1|COMPLETED|Overall Study||107
497375|NCT01023711|1215790|P1|STARTED|Overall Study||107
497376|NCT01023672|1215795|P1|NOT COMPLETED|Overall Study||3
497377|NCT01023672|1215795|P1|COMPLETED|Overall Study||17
497378|NCT01023672|1215795|P1|STARTED|Overall Study||20
497379|NCT01023659|1215802|P3|NOT COMPLETED|Overall Study||99
497380|NCT01023659|1215803|P2|NOT COMPLETED|Overall Study||228
497381|NCT01023659|1215804|P1|NOT COMPLETED|Overall Study||73
497382|NCT01023659|1215802|P3|COMPLETED|Overall Study||165
497383|NCT01023659|1215803|P2|COMPLETED|Overall Study||137
497384|NCT01023659|1215804|P1|COMPLETED|Overall Study||185
497385|NCT01023659|1215802|P3|STARTED|Overall Study||264
497386|NCT01023659|1215803|P2|STARTED|Overall Study||365
497387|NCT01023659|1215804|P1|STARTED|Overall Study||258
497388|NCT01023581|1215820|P7|NOT COMPLETED|Overall Study||20
497389|NCT01023581|1215821|P6|NOT COMPLETED|Overall Study||19
497390|NCT01023581|1215822|P5|NOT COMPLETED|Overall Study||16
497391|NCT01023581|1215823|P4|NOT COMPLETED|Overall Study||20
497392|NCT01023581|1215824|P3|NOT COMPLETED|Overall Study||42
497393|NCT01023581|1215825|P2|NOT COMPLETED|Overall Study||23
497394|NCT01023581|1215826|P1|NOT COMPLETED|Overall Study||35
497395|NCT01023581|1215820|P7|COMPLETED|Overall Study||94
497396|NCT01023581|1215821|P6|COMPLETED|Overall Study||92
497397|NCT01023581|1215822|P5|COMPLETED|Overall Study||95
497398|NCT01023581|1215823|P4|COMPLETED|Overall Study||94
497399|NCT01023581|1215824|P3|COMPLETED|Overall Study||71
497400|NCT01023581|1215825|P2|COMPLETED|Overall Study||89
497401|NCT01023581|1215826|P1|COMPLETED|Overall Study|The number of completed patients represents those who completed study drug.|74
497402|NCT01023581|1215820|P7|Received Study Treatment|Overall Study||114
497403|NCT01023581|1215821|P6|Received Study Treatment|Overall Study||106
497404|NCT01023581|1215822|P5|Received Study Treatment|Overall Study||111
497405|NCT01023581|1215823|P4|Received Study Treatment|Overall Study||109
497406|NCT01023581|1215824|P3|Received Study Treatment|Overall Study||110
497407|NCT01023581|1215825|P2|Received Study Treatment|Overall Study||112
497408|NCT01023581|1215826|P1|Received Study Treatment|Overall Study||106
497409|NCT01023581|1215820|P7|STARTED|Overall Study||114
497410|NCT01023581|1215821|P6|STARTED|Overall Study||111
497411|NCT01023581|1215822|P5|STARTED|Overall Study||111
497412|NCT01023581|1215823|P4|STARTED|Overall Study||114
497413|NCT01023581|1215824|P3|STARTED|Overall Study||113
497414|NCT01023581|1215825|P2|STARTED|Overall Study||112
497415|NCT01023581|1215826|P1|STARTED|Overall Study||109
497416|NCT01023568|1215859|P3|NOT COMPLETED|Overall Study||0
497417|NCT01023568|1215860|P2|NOT COMPLETED|Overall Study||0
497418|NCT01023568|1215861|P1|NOT COMPLETED|Overall Study||0
497419|NCT01023568|1215859|P3|COMPLETED|Overall Study||45
497420|NCT01023568|1215860|P2|COMPLETED|Overall Study||44
497421|NCT01023568|1215861|P1|COMPLETED|Overall Study||45
497422|NCT01023568|1215859|P3|STARTED|Overall Study||45
497423|NCT01023568|1215860|P2|STARTED|Overall Study||44
497424|NCT01023568|1215861|P1|STARTED|Overall Study||45
497425|NCT01023516|1215883|P2|NOT COMPLETED|Overall Study||18
497426|NCT01023516|1215884|P1|NOT COMPLETED|Overall Study||24
497427|NCT01023516|1215883|P2|COMPLETED|Overall Study||284
497428|NCT01023516|1215884|P1|COMPLETED|Overall Study||289
497429|NCT01023516|1215883|P2|STARTED|Overall Study||302
497430|NCT01023516|1215884|P1|STARTED|Overall Study||313
497431|NCT01023308|1215966|P2|NOT COMPLETED|Overall Study||279
497432|NCT01023308|1215967|P1|NOT COMPLETED|Overall Study||285
497433|NCT01023308|1215966|P2|COMPLETED|Overall Study|completed all planned cycles of study treatment as per protocol|102
497434|NCT01023308|1215967|P1|COMPLETED|Overall Study|completed all planned cycles of study treatment as per protocol|102
497435|NCT01023308|1215966|P2|STARTED|Overall Study||381
497436|NCT01023308|1215967|P1|STARTED|Overall Study||387
497437|NCT01023256|1215997|P4|NOT COMPLETED|Overall Study||5
497438|NCT01023256|1215998|P3|NOT COMPLETED|Overall Study||1
497439|NCT01023256|1215999|P2|NOT COMPLETED|Overall Study||3
497440|NCT01023256|1216000|P1|NOT COMPLETED|Overall Study||4
497441|NCT01023256|1215997|P4|COMPLETED|Overall Study||22
497442|NCT01023256|1215998|P3|COMPLETED|Overall Study||23
497443|NCT01023256|1215999|P2|COMPLETED|Overall Study||19
497444|NCT01023256|1216000|P1|COMPLETED|Overall Study||21
497445|NCT01023256|1215997|P4|STARTED|Overall Study||27
497446|NCT01023256|1215998|P3|STARTED|Overall Study||24
497447|NCT01023256|1215999|P2|STARTED|Overall Study||22
497448|NCT01023256|1216000|P1|STARTED|Overall Study||25
497449|NCT01023217|1216042|P2|NOT COMPLETED|Overall Study||0
497450|NCT01023217|1216043|P1|NOT COMPLETED|Overall Study||1
497451|NCT01023217|1216042|P2|COMPLETED|Overall Study||45
497452|NCT01023217|1216043|P1|COMPLETED|Overall Study||44
497453|NCT01023217|1216042|P2|STARTED|Overall Study||45
497454|NCT01023217|1216043|P1|STARTED|Overall Study||45
497455|NCT01023178|1216052|P3|NOT COMPLETED|Overall Study||3
497456|NCT01023178|1216053|P2|NOT COMPLETED|Overall Study||2
497457|NCT01023178|1216054|P1|NOT COMPLETED|Overall Study||2
497458|NCT01023178|1216052|P3|COMPLETED|Overall Study||4
497459|NCT01023178|1216053|P2|COMPLETED|Overall Study||6
497460|NCT01023178|1216054|P1|COMPLETED|Overall Study||3
497461|NCT01023178|1216052|P3|STARTED|Overall Study||7
497462|NCT01023178|1216053|P2|STARTED|Overall Study||8
497463|NCT01023178|1216054|P1|STARTED|Overall Study||5
497464|NCT01023074|1216065|P3|NOT COMPLETED|Overall Study||0
497465|NCT01023074|1216066|P2|NOT COMPLETED|Overall Study||0
497466|NCT01023074|1216067|P1|NOT COMPLETED|Overall Study||0
497467|NCT01023074|1216065|P3|COMPLETED|Overall Study||13
497468|NCT01023074|1216066|P2|COMPLETED|Overall Study||13
497469|NCT01023074|1216067|P1|COMPLETED|Overall Study||26
497470|NCT01023074|1216065|P3|STARTED|Overall Study||13
497471|NCT01023074|1216066|P2|STARTED|Overall Study||13
497472|NCT01023074|1216067|P1|STARTED|Overall Study||26
497473|NCT01023061|1216081|P1|NOT COMPLETED|Overall Study||2
497474|NCT01023061|1216081|P1|COMPLETED|Overall Study||22
497475|NCT01023061|1216081|P1|STARTED|Overall Study||24
497476|NCT01023035|1216090|P3|NOT COMPLETED|Follow-up Period (up to Week 72)||39
497477|NCT01023035|1216091|P2|NOT COMPLETED|Follow-up Period (up to Week 72)||28
497478|NCT01023035|1216092|P1|NOT COMPLETED|Follow-up Period (up to Week 72)||28
497479|NCT01023035|1216090|P3|COMPLETED|Follow-up Period (up to Week 72)||108
497480|NCT01023035|1216091|P2|COMPLETED|Follow-up Period (up to Week 72)||207
497481|NCT01023035|1216092|P1|COMPLETED|Follow-up Period (up to Week 72)||210
497482|NCT01023035|1216090|P3|STARTED|Follow-up Period (up to Week 72)||147
497483|NCT01023035|1216091|P2|STARTED|Follow-up Period (up to Week 72)||235
497484|NCT01023035|1216092|P1|STARTED|Follow-up Period (up to Week 72)||238
497485|NCT01023035|1216090|P3|NOT COMPLETED|Treatment Period||118
497486|NCT01023035|1216091|P2|NOT COMPLETED|Treatment Period||85
497487|NCT01023035|1216092|P1|NOT COMPLETED|Treatment Period||72
497488|NCT01023035|1216090|P3|COMPLETED|Treatment Period||69
497489|NCT01023035|1216091|P2|COMPLETED|Treatment Period||166
497490|NCT01023035|1216092|P1|COMPLETED|Treatment Period||177
497491|NCT01023035|1216090|P3|STARTED|Treatment Period||187
497492|NCT01023035|1216091|P2|STARTED|Treatment Period||251
497493|NCT01023035|1216092|P1|STARTED|Treatment Period||249
497494|NCT01023022|1216102|P1|NOT COMPLETED|Overall Study||14
497495|NCT01023022|1216102|P1|COMPLETED|Overall Study||162
497496|NCT01023022|1216102|P1|STARTED|Overall Study|Previous No.: 178 subjects incl. 2 pts who withdraw their approval for processing personal data|176
497497|NCT01022996|1216108|P1|NOT COMPLETED|Overall Study||57
497498|NCT01022996|1216108|P1|COMPLETED|Overall Study||0
497499|NCT01022996|1216108|P1|STARTED|Overall Study||57
497500|NCT01022762|1216119|P2|NOT COMPLETED|Overall Study||28
497501|NCT01022762|1216120|P1|NOT COMPLETED|Overall Study||22
497502|NCT01022762|1216119|P2|COMPLETED|Overall Study||194
497503|NCT01022762|1216120|P1|COMPLETED|Overall Study||196
497504|NCT01022762|1216119|P2|Exposed to Trial Drug|Overall Study|Four participants were not exposed to the treatment due to non-compliance or lost to follow-up|218
497505|NCT01022762|1216120|P1|Exposed to Trial Drug|Overall Study|One participant was not exposed to the treatment due to fulfillment of exclusion criteria|217
497506|NCT01022762|1216119|P2|STARTED|Overall Study||222
497507|NCT01022762|1216120|P1|STARTED|Overall Study||218
497508|NCT01022567|1216148|P2|NOT COMPLETED|Overall Study||15
497509|NCT01022567|1216149|P1|NOT COMPLETED|Overall Study||1
497510|NCT01022567|1216148|P2|COMPLETED|Overall Study||242
497511|NCT01022567|1216149|P1|COMPLETED|Overall Study||272
497512|NCT01022567|1216148|P2|STARTED|Overall Study||257
497513|NCT01022567|1216149|P1|STARTED|Overall Study||273
497514|NCT01022502|1216155|P1|NOT COMPLETED|Overall Study||3
497515|NCT01022502|1216155|P1|COMPLETED|Overall Study|3 participants withdrew at week 4,5,6,respectively.|35
497516|NCT01022502|1216155|P1|STARTED|Overall Study|19 used the refined ointment on the right site, 19 used the crude ointment on the left site.|38
497517|NCT01022398|1216171|P2|NOT COMPLETED|Overall Study||2
497518|NCT01022398|1216172|P1|NOT COMPLETED|Overall Study||2
497519|NCT01022398|1216171|P2|COMPLETED|Overall Study||0
497520|NCT01022398|1216172|P1|COMPLETED|Overall Study||0
497521|NCT01022398|1216171|P2|STARTED|Overall Study||2
497522|NCT01022398|1216172|P1|STARTED|Overall Study||2
497523|NCT01022307|1216179|P2|NOT COMPLETED|Overall Study||4
497524|NCT01022307|1216180|P1|NOT COMPLETED|Overall Study||0
497525|NCT01022307|1216179|P2|COMPLETED|Overall Study|Some TBI patients could not undergo MR scanning due to contraindications.|24
497526|NCT01022307|1216180|P1|COMPLETED|Overall Study||184
497527|NCT01022307|1216179|P2|STARTED|Overall Study||28
497528|NCT01022307|1216180|P1|STARTED|Overall Study||184
497529|NCT01022242|1216188|P2|NOT COMPLETED|Overall Study||19
497530|NCT01022242|1216189|P1|NOT COMPLETED|Overall Study||21
497531|NCT01022242|1216188|P2|COMPLETED|Overall Study||46
497532|NCT01022242|1216189|P1|COMPLETED|Overall Study||49
497533|NCT01022242|1216188|P2|STARTED|Overall Study|67 pat rand to PXL01. 2 got incorrect mix of PXL01. 65 patients treated with the correct PXL01 mix.|65
497534|NCT01022242|1216189|P1|STARTED|Overall Study|71 pat rand to placebo. 1 got incorrect mix of placebo. 70 patients treated with the correct mix.|70
497535|NCT01022203|1216197|P2|NOT COMPLETED|Follow-Up Assessment||2
497536|NCT01022203|1216198|P1|NOT COMPLETED|Follow-Up Assessment||2
497537|NCT01022203|1216197|P2|COMPLETED|Follow-Up Assessment||40
497538|NCT01022203|1216198|P1|COMPLETED|Follow-Up Assessment||42
497539|NCT01022203|1216197|P2|STARTED|Follow-Up Assessment||42
497540|NCT01022203|1216198|P1|STARTED|Follow-Up Assessment||44
497541|NCT01022203|1216197|P2|NOT COMPLETED|Post Treatment Assessment||14
497542|NCT01022203|1216198|P1|NOT COMPLETED|Post Treatment Assessment||14
497543|NCT01022203|1216197|P2|COMPLETED|Post Treatment Assessment||42
497544|NCT01022203|1216198|P1|COMPLETED|Post Treatment Assessment||44
497545|NCT01022203|1216197|P2|STARTED|Post Treatment Assessment||56
497546|NCT01022203|1216198|P1|STARTED|Post Treatment Assessment||58
497547|NCT01022203|1216197|P2|NOT COMPLETED|PreTreatment Assessment||0
497548|NCT01022203|1216198|P1|NOT COMPLETED|PreTreatment Assessment||0
497549|NCT01022203|1216197|P2|COMPLETED|PreTreatment Assessment||56
497550|NCT01022203|1216198|P1|COMPLETED|PreTreatment Assessment||58
497551|NCT01022203|1216197|P2|STARTED|PreTreatment Assessment||56
497552|NCT01022203|1216198|P1|STARTED|PreTreatment Assessment||58
497553|NCT01022190|1216208|P1|NOT COMPLETED|Overall Study||0
497554|NCT01022190|1216208|P1|COMPLETED|Overall Study||42
497555|NCT01022190|1216208|P1|STARTED|Overall Study||42
497556|NCT01022112|1216217|P5|NOT COMPLETED|Overall Study||10
497557|NCT01022112|1216218|P4|NOT COMPLETED|Overall Study||3
497558|NCT01022112|1216219|P3|NOT COMPLETED|Overall Study||3
497559|NCT01022112|1216220|P2|NOT COMPLETED|Overall Study||3
497560|NCT01022112|1216221|P1|NOT COMPLETED|Overall Study||3
497561|NCT01022112|1216217|P5|COMPLETED|Overall Study||65
497562|NCT01022112|1216218|P4|COMPLETED|Overall Study||72
497563|NCT01022112|1216219|P3|COMPLETED|Overall Study||74
497564|NCT01022112|1216220|P2|COMPLETED|Overall Study||71
497565|NCT01022112|1216221|P1|COMPLETED|Overall Study||79
497566|NCT01022112|1216217|P5|STARTED|Overall Study||75
497567|NCT01022112|1216218|P4|STARTED|Overall Study||75
497568|NCT01022112|1216219|P3|STARTED|Overall Study||77
497569|NCT01022112|1216220|P2|STARTED|Overall Study||74
497570|NCT01022112|1216221|P1|STARTED|Overall Study||82
497571|NCT01022073|1216235|P2|NOT COMPLETED|Overall Study||18
497572|NCT01022073|1216236|P1|NOT COMPLETED|Overall Study||19
497573|NCT01022073|1216235|P2|COMPLETED|Overall Study||52
497574|NCT01022073|1216236|P1|COMPLETED|Overall Study||67
497575|NCT01022073|1216235|P2|STARTED|Overall Study||70
497576|NCT01022073|1216236|P1|STARTED|Overall Study||86
497577|NCT01021878|1216244|P2|NOT COMPLETED|Overall Study||10
497578|NCT01021878|1216245|P1|NOT COMPLETED|Overall Study||16
497579|NCT01021878|1216244|P2|COMPLETED|Overall Study||17
497580|NCT01021878|1216245|P1|COMPLETED|Overall Study||17
497581|NCT01021878|1216244|P2|Completed Follow-up|Overall Study||17
497582|NCT01021878|1216245|P1|Completed Follow-up|Overall Study||17
497583|NCT01021878|1216244|P2|STARTED|Overall Study||27
497584|NCT01021878|1216245|P1|STARTED|Overall Study||33
497585|NCT01021852|1216267|P8|NOT COMPLETED|Treatment Period 2||2
497586|NCT01021852|1216268|P7|NOT COMPLETED|Treatment Period 2||3
497587|NCT01021852|1216269|P6|NOT COMPLETED|Treatment Period 2||1
497588|NCT01021852|1216270|P5|NOT COMPLETED|Treatment Period 2||2
497589|NCT01021852|1216271|P4|NOT COMPLETED|Treatment Period 2||0
497590|NCT01021852|1216272|P3|NOT COMPLETED|Treatment Period 2||1
497591|NCT01021852|1216273|P2|NOT COMPLETED|Treatment Period 2||1
497592|NCT01021852|1216274|P1|NOT COMPLETED|Treatment Period 2||0
497593|NCT01021852|1216267|P8|COMPLETED|Treatment Period 2||38
497594|NCT01021852|1216268|P7|COMPLETED|Treatment Period 2||37
497595|NCT01021852|1216269|P6|COMPLETED|Treatment Period 2||37
497596|NCT01021852|1216270|P5|COMPLETED|Treatment Period 2||37
497597|NCT01021852|1216271|P4|COMPLETED|Treatment Period 2||37
497598|NCT01021852|1216272|P3|COMPLETED|Treatment Period 2||38
497599|NCT01021852|1216273|P2|COMPLETED|Treatment Period 2||38
497600|NCT01021852|1216274|P1|COMPLETED|Treatment Period 2||37
497601|NCT01021852|1216267|P8|STARTED|Treatment Period 2||40
497602|NCT01021852|1216268|P7|STARTED|Treatment Period 2||40
497603|NCT01021852|1216269|P6|STARTED|Treatment Period 2||38
497604|NCT01021852|1216270|P5|STARTED|Treatment Period 2||39
497605|NCT01021852|1216271|P4|STARTED|Treatment Period 2||37
497606|NCT01021852|1216272|P3|STARTED|Treatment Period 2||39
497607|NCT01021852|1216273|P2|STARTED|Treatment Period 2||39
497608|NCT01021852|1216274|P1|STARTED|Treatment Period 2||37
497609|NCT01021852|1216267|P8|NOT COMPLETED|Washout Period-No Drug||0
497610|NCT01021852|1216268|P7|NOT COMPLETED|Washout Period-No Drug||0
497611|NCT01021852|1216269|P6|NOT COMPLETED|Washout Period-No Drug||1
497612|NCT01021852|1216270|P5|NOT COMPLETED|Washout Period-No Drug||0
497613|NCT01021852|1216271|P4|NOT COMPLETED|Washout Period-No Drug||0
497614|NCT01021852|1216272|P3|NOT COMPLETED|Washout Period-No Drug||0
497615|NCT01021852|1216273|P2|NOT COMPLETED|Washout Period-No Drug||0
497616|NCT01021852|1216274|P1|NOT COMPLETED|Washout Period-No Drug||1
497617|NCT01021852|1216267|P8|COMPLETED|Washout Period-No Drug||40
497618|NCT01021852|1216268|P7|COMPLETED|Washout Period-No Drug||40
497619|NCT01021852|1216269|P6|COMPLETED|Washout Period-No Drug||38
497620|NCT01021852|1216270|P5|COMPLETED|Washout Period-No Drug||39
497621|NCT01021852|1216271|P4|COMPLETED|Washout Period-No Drug||37
497622|NCT01021852|1216272|P3|COMPLETED|Washout Period-No Drug||39
497623|NCT01021852|1216273|P2|COMPLETED|Washout Period-No Drug||39
497624|NCT01021852|1216274|P1|COMPLETED|Washout Period-No Drug||37
497625|NCT01021852|1216267|P8|STARTED|Washout Period-No Drug||40
497626|NCT01021852|1216268|P7|STARTED|Washout Period-No Drug||40
497627|NCT01021852|1216269|P6|STARTED|Washout Period-No Drug|Includes 1 participant who completed Treatment Period 1 but missed Placebo Washout.|39
497628|NCT01021852|1216270|P5|STARTED|Washout Period-No Drug||39
497629|NCT01021852|1216271|P4|STARTED|Washout Period-No Drug||37
497630|NCT01021852|1216272|P3|STARTED|Washout Period-No Drug||39
497631|NCT01021852|1216273|P2|STARTED|Washout Period-No Drug||39
497632|NCT01021852|1216274|P1|STARTED|Washout Period-No Drug|Includes 1 participant who discontinued Treatment Period 1 (AE) and missed Placebo Washout.|38
497633|NCT01021852|1216267|P8|NOT COMPLETED|Washout Period-Placebo||0
497634|NCT01021852|1216268|P7|NOT COMPLETED|Washout Period-Placebo||1
497635|NCT01021852|1216269|P6|NOT COMPLETED|Washout Period-Placebo||1
497636|NCT01021852|1216270|P5|NOT COMPLETED|Washout Period-Placebo||1
497637|NCT01021852|1216271|P4|NOT COMPLETED|Washout Period-Placebo||1
497638|NCT01021852|1216272|P3|NOT COMPLETED|Washout Period-Placebo||0
497639|NCT01021852|1216273|P2|NOT COMPLETED|Washout Period-Placebo||0
497640|NCT01021852|1216274|P1|NOT COMPLETED|Washout Period-Placebo||0
497641|NCT01021852|1216267|P8|COMPLETED|Washout Period-Placebo||40
497642|NCT01021852|1216268|P7|COMPLETED|Washout Period-Placebo||40
497643|NCT01021852|1216269|P6|COMPLETED|Washout Period-Placebo||38
497644|NCT01021852|1216270|P5|COMPLETED|Washout Period-Placebo||39
497645|NCT01021852|1216271|P4|COMPLETED|Washout Period-Placebo||37
497646|NCT01021852|1216272|P3|COMPLETED|Washout Period-Placebo||39
497647|NCT01021852|1216273|P2|COMPLETED|Washout Period-Placebo||39
497648|NCT01021852|1216274|P1|COMPLETED|Washout Period-Placebo||37
497649|NCT01021852|1216267|P8|STARTED|Washout Period-Placebo||40
497650|NCT01021852|1216268|P7|STARTED|Washout Period-Placebo||41
497651|NCT01021852|1216269|P6|STARTED|Washout Period-Placebo|Excludes 1 participant who completed Treatment Period 1 but missed Placebo Washout|39
497652|NCT01021852|1216270|P5|STARTED|Washout Period-Placebo|Includes 1 participant that discontinued Treatment Period 1 (AE).|40
497653|NCT01021852|1216271|P4|STARTED|Washout Period-Placebo||38
497654|NCT01021852|1216272|P3|STARTED|Washout Period-Placebo||39
497655|NCT01021852|1216273|P2|STARTED|Washout Period-Placebo||39
497656|NCT01021852|1216274|P1|STARTED|Washout Period-Placebo||37
497657|NCT01021852|1216267|P8|NOT COMPLETED|Treatment Period 1||1
497658|NCT01021852|1216268|P7|NOT COMPLETED|Treatment Period 1||0
497659|NCT01021852|1216269|P6|NOT COMPLETED|Treatment Period 1||2
497660|NCT01021852|1216270|P5|NOT COMPLETED|Treatment Period 1||3
497661|NCT01021852|1216271|P4|NOT COMPLETED|Treatment Period 1||2
497662|NCT01021852|1216272|P3|NOT COMPLETED|Treatment Period 1||2
497663|NCT01021852|1216273|P2|NOT COMPLETED|Treatment Period 1||1
497664|NCT01021852|1216274|P1|NOT COMPLETED|Treatment Period 1||3
497665|NCT01021852|1216267|P8|COMPLETED|Treatment Period 1||40
497666|NCT01021852|1216268|P7|COMPLETED|Treatment Period 1||41
497667|NCT01021852|1216269|P6|COMPLETED|Treatment Period 1||39
497668|NCT01021852|1216270|P5|COMPLETED|Treatment Period 1||39
497669|NCT01021852|1216271|P4|COMPLETED|Treatment Period 1||38
497670|NCT01021852|1216272|P3|COMPLETED|Treatment Period 1||39
497671|NCT01021852|1216273|P2|COMPLETED|Treatment Period 1||39
497672|NCT01021852|1216274|P1|COMPLETED|Treatment Period 1||37
497673|NCT01021852|1216267|P8|Treated|Treatment Period 1||41
497674|NCT01021852|1216268|P7|Treated|Treatment Period 1||41
497675|NCT01021852|1216269|P6|Treated|Treatment Period 1|1 participant discontinued Treatment Period 1 (AE) but continued in Placebo Washout|41
497676|NCT01021852|1216270|P5|Treated|Treatment Period 1||42
497677|NCT01021852|1216271|P4|Treated|Treatment Period 1||38
497678|NCT01021852|1216272|P3|Treated|Treatment Period 1||41
497679|NCT01021852|1216273|P2|Treated|Treatment Period 1||40
497680|NCT01021852|1216274|P1|Treated|Treatment Period 1||40
497681|NCT01021852|1216267|P8|STARTED|Treatment Period 1||41
497682|NCT01021852|1216268|P7|STARTED|Treatment Period 1||41
497683|NCT01021852|1216269|P6|STARTED|Treatment Period 1||41
497684|NCT01021852|1216270|P5|STARTED|Treatment Period 1||42
497685|NCT01021852|1216271|P4|STARTED|Treatment Period 1||40
497686|NCT01021852|1216272|P3|STARTED|Treatment Period 1||41
497687|NCT01021852|1216273|P2|STARTED|Treatment Period 1||40
497688|NCT01021852|1216274|P1|STARTED|Treatment Period 1||40
497689|NCT01021813|1216310|P5|NOT COMPLETED|DB Randomized Discontinuation Phase||5
497690|NCT01021813|1216311|P4|NOT COMPLETED|DB Randomized Discontinuation Phase||5
497691|NCT01021813|1216312|P3|NOT COMPLETED|DB Randomized Discontinuation Phase||4
497692|NCT01021813|1216313|P2|NOT COMPLETED|DB Randomized Discontinuation Phase||0
497693|NCT01021813|1216314|P1|NOT COMPLETED|DB Randomized Discontinuation Phase||0
497694|NCT01021813|1216310|P5|COMPLETED|DB Randomized Discontinuation Phase||157
497695|NCT01021813|1216311|P4|COMPLETED|DB Randomized Discontinuation Phase||161
497696|NCT01021813|1216312|P3|COMPLETED|DB Randomized Discontinuation Phase||152
497697|NCT01021813|1216313|P2|COMPLETED|DB Randomized Discontinuation Phase||0
497698|NCT01021813|1216314|P1|COMPLETED|DB Randomized Discontinuation Phase||0
497699|NCT01021813|1216310|P5|STARTED|DB Randomized Discontinuation Phase||162
497700|NCT01021813|1216311|P4|STARTED|DB Randomized Discontinuation Phase||166
497701|NCT01021813|1216312|P3|STARTED|DB Randomized Discontinuation Phase||156
497702|NCT01021813|1216313|P2|STARTED|DB Randomized Discontinuation Phase||0
497703|NCT01021813|1216314|P1|STARTED|DB Randomized Discontinuation Phase||0
497704|NCT01021813|1216310|P5|NOT COMPLETED|DB Treatment Phase||0
497705|NCT01021813|1216311|P4|NOT COMPLETED|DB Treatment Phase||0
497706|NCT01021813|1216312|P3|NOT COMPLETED|DB Treatment Phase||0
497707|NCT01021813|1216313|P2|NOT COMPLETED|DB Treatment Phase||97
497708|NCT01021813|1216314|P1|NOT COMPLETED|DB Treatment Phase||200
497709|NCT01021813|1216310|P5|COMPLETED|DB Treatment Phase||0
497710|NCT01021813|1216311|P4|COMPLETED|DB Treatment Phase||0
497711|NCT01021813|1216312|P3|COMPLETED|DB Treatment Phase||0
497712|NCT01021813|1216313|P2|COMPLETED|DB Treatment Phase||162
497713|NCT01021813|1216314|P1|COMPLETED|DB Treatment Phase||322
497714|NCT01021813|1216310|P5|Treated|DB Treatment Phase||0
497715|NCT01021813|1216311|P4|Treated|DB Treatment Phase||0
497716|NCT01021813|1216312|P3|Treated|DB Treatment Phase||0
497717|NCT01021813|1216313|P2|Treated|DB Treatment Phase||258
497718|NCT01021813|1216314|P1|Treated|DB Treatment Phase||521
497719|NCT01021813|1216310|P5|STARTED|DB Treatment Phase||0
497720|NCT01021813|1216311|P4|STARTED|DB Treatment Phase||0
497721|NCT01021813|1216312|P3|STARTED|DB Treatment Phase||0
497722|NCT01021813|1216313|P2|STARTED|DB Treatment Phase||259
497723|NCT01021813|1216314|P1|STARTED|DB Treatment Phase||522
497724|NCT01021761|1216356|P3|NOT COMPLETED|Overall Study||0
497725|NCT01021761|1216357|P2|NOT COMPLETED|Overall Study||4
497726|NCT01021761|1216358|P1|NOT COMPLETED|Overall Study||1
497727|NCT01021761|1216356|P3|COMPLETED|Overall Study||42
497728|NCT01021761|1216357|P2|COMPLETED|Overall Study||38
497729|NCT01021761|1216358|P1|COMPLETED|Overall Study||41
497730|NCT01021761|1216356|P3|STARTED|Overall Study||42
497731|NCT01021761|1216357|P2|STARTED|Overall Study||42
497732|NCT01021761|1216358|P1|STARTED|Overall Study||42
497733|NCT01021683|1216366|P1|NOT COMPLETED|Overall Study||71
497734|NCT01021683|1216366|P1|COMPLETED|Overall Study||132
497735|NCT01021683|1216366|P1|STARTED|Overall Study||203
497736|NCT01021618|1216380|P2|NOT COMPLETED|Overall Study||0
497737|NCT01021618|1216381|P1|NOT COMPLETED|Overall Study||0
497738|NCT01021618|1216380|P2|COMPLETED|Overall Study||96
497739|NCT01021618|1216381|P1|COMPLETED|Overall Study||44
497740|NCT01021618|1216380|P2|STARTED|Overall Study||96
497741|NCT01021618|1216381|P1|STARTED|Overall Study||44
497742|NCT01021553|1216392|P3|NOT COMPLETED|Overall Study||3
497743|NCT01021553|1216393|P2|NOT COMPLETED|Overall Study||5
497744|NCT01021553|1216394|P1|NOT COMPLETED|Overall Study||4
497745|NCT01021553|1216392|P3|COMPLETED|Overall Study||25
497746|NCT01021553|1216393|P2|COMPLETED|Overall Study||17
497747|NCT01021553|1216394|P1|COMPLETED|Overall Study||23
497748|NCT01021553|1216392|P3|STARTED|Overall Study||28
497749|NCT01021553|1216393|P2|STARTED|Overall Study||22
497750|NCT01021553|1216394|P1|STARTED|Overall Study||27
497751|NCT01021423|1216448|P2|NOT COMPLETED|Overall Study||5
497752|NCT01021423|1216449|P1|NOT COMPLETED|Overall Study||4
497753|NCT01021423|1216448|P2|COMPLETED|Overall Study||0
497754|NCT01021423|1216449|P1|COMPLETED|Overall Study||0
497755|NCT01021423|1216448|P2|STARTED|Overall Study|One participant discontinued treatment (continued in the study) due to disease progression|5
497756|NCT01021423|1216449|P1|STARTED|Overall Study|One participant discontinued treatment (continued in the study) due to an AE|4
497757|NCT01021332|1216465|P1|NOT COMPLETED|Overall Study||106
497758|NCT01021332|1216465|P1|COMPLETED|Overall Study||960
497759|NCT01021332|1216465|P1|Full Analysis Set (FAS)|Overall Study||1009
497760|NCT01021332|1216465|P1|Safety Analysis Set (SAF)|Overall Study||1066
497761|NCT01021332|1216465|P1|STARTED|Overall Study|Took ≥ 1 dose of FDC open-label study drug|1066
497762|NCT01021306|1216503|P4|NOT COMPLETED|6 Month (Follow-up)||3
497763|NCT01021306|1216504|P3|NOT COMPLETED|6 Month (Follow-up)||0
497764|NCT01021306|1216505|P2|NOT COMPLETED|6 Month (Follow-up)||1
497765|NCT01021306|1216506|P1|NOT COMPLETED|6 Month (Follow-up)||3
497766|NCT01021306|1216503|P4|COMPLETED|6 Month (Follow-up)||14
497767|NCT01021306|1216504|P3|COMPLETED|6 Month (Follow-up)||14
497768|NCT01021306|1216505|P2|COMPLETED|6 Month (Follow-up)||13
497769|NCT01021306|1216506|P1|COMPLETED|6 Month (Follow-up)||11
497770|NCT01021306|1216503|P4|STARTED|6 Month (Follow-up)||17
497771|NCT01021306|1216504|P3|STARTED|6 Month (Follow-up)||14
497772|NCT01021306|1216505|P2|STARTED|6 Month (Follow-up)||14
497773|NCT01021306|1216506|P1|STARTED|6 Month (Follow-up)||14
497774|NCT01021306|1216503|P4|NOT COMPLETED|2 Month (Primary Outcome)||4
497775|NCT01021306|1216504|P3|NOT COMPLETED|2 Month (Primary Outcome)||5
497776|NCT01021306|1216505|P2|NOT COMPLETED|2 Month (Primary Outcome)||6
497777|NCT01021306|1216506|P1|NOT COMPLETED|2 Month (Primary Outcome)||6
497778|NCT01021306|1216503|P4|COMPLETED|2 Month (Primary Outcome)||17
497779|NCT01021306|1216504|P3|COMPLETED|2 Month (Primary Outcome)||14
497780|NCT01021306|1216505|P2|COMPLETED|2 Month (Primary Outcome)||14
497781|NCT01021306|1216506|P1|COMPLETED|2 Month (Primary Outcome)||14
497782|NCT01021306|1216503|P4|STARTED|2 Month (Primary Outcome)||21
497783|NCT01021306|1216504|P3|STARTED|2 Month (Primary Outcome)||19
497784|NCT01021306|1216505|P2|STARTED|2 Month (Primary Outcome)||20
497785|NCT01021306|1216506|P1|STARTED|2 Month (Primary Outcome)||20
497786|NCT01021293|1216526|P2|NOT COMPLETED|Overall Study||24
497787|NCT01021293|1216527|P1|NOT COMPLETED|Overall Study||12
497788|NCT01021293|1216526|P2|COMPLETED|Overall Study||526
497789|NCT01021293|1216527|P1|COMPLETED|Overall Study||538
497790|NCT01021293|1216526|P2|STARTED|Overall Study||550
497791|NCT01021293|1216527|P1|STARTED|Overall Study||550
497792|NCT01021215|1216546|P2|NOT COMPLETED|Overall Study||0
497793|NCT01021215|1216547|P1|NOT COMPLETED|Overall Study||3
497794|NCT01021215|1216546|P2|COMPLETED|Overall Study||20
497795|NCT01021215|1216547|P1|COMPLETED|Overall Study||57
497796|NCT01021215|1216546|P2|Received Allocated Intervention|Overall Study||20
497797|NCT01021215|1216547|P1|Received Allocated Intervention|Overall Study||60
497798|NCT01021215|1216546|P2|STARTED|Overall Study||20
497799|NCT01021215|1216547|P1|STARTED|Overall Study||60
497800|NCT01021111|1216557|P1|NOT COMPLETED|Overall Study||0
497801|NCT01021111|1216557|P1|COMPLETED|Overall Study||17
497802|NCT01021111|1216557|P1|STARTED|Overall Study||17
497803|NCT01021020|1216562|P1|NOT COMPLETED|Period III||0
497804|NCT01021020|1216562|P1|COMPLETED|Period III||25
497805|NCT01021020|1216562|P1|STARTED|Period III||25
497806|NCT01021020|1216562|P1|NOT COMPLETED|14 Day Washout Period B||0
497807|NCT01021020|1216562|P1|COMPLETED|14 Day Washout Period B||25
497808|NCT01021020|1216562|P1|STARTED|14 Day Washout Period B||25
497809|NCT01021020|1216562|P1|NOT COMPLETED|Period II||0
497810|NCT01021020|1216562|P1|COMPLETED|Period II||25
497811|NCT01021020|1216562|P1|STARTED|Period II||25
497812|NCT01021020|1216562|P1|NOT COMPLETED|14 Day Washout Period A||1
497813|NCT01021020|1216562|P1|COMPLETED|14 Day Washout Period A|Colchicine/Probenecid-medical investigator dropped due to abnormal check-in lab results.|25
497814|NCT01021020|1216562|P1|STARTED|14 Day Washout Period A||26
497815|NCT01021020|1216562|P1|NOT COMPLETED|Period I||2
497816|NCT01021020|1216562|P1|COMPLETED|Period I|Colchicine(fasted)-subject took Claritin-D 12hour.Colchicine(fed)arm-subject had schedule conflict.|26
497817|NCT01021020|1216562|P1|STARTED|Period I||28
497818|NCT01021007|1216578|P2|NOT COMPLETED|Overall Study||4
497819|NCT01021007|1216579|P1|NOT COMPLETED|Overall Study||2
497820|NCT01021007|1216578|P2|COMPLETED|Overall Study||33
497821|NCT01021007|1216579|P1|COMPLETED|Overall Study||34
497822|NCT01021007|1216578|P2|STARTED|Overall Study||37
497823|NCT01021007|1216579|P1|STARTED|Overall Study||36
497824|NCT01020981|1216591|P2|NOT COMPLETED|Overall Study||90
497825|NCT01020981|1216592|P1|NOT COMPLETED|Overall Study||84
497826|NCT01020981|1216591|P2|COMPLETED|Overall Study||60
497827|NCT01020981|1216592|P1|COMPLETED|Overall Study||66
497828|NCT01020981|1216591|P2|STARTED|Overall Study||150
497829|NCT01020981|1216592|P1|STARTED|Overall Study||150
497830|NCT01020903|1216604|P2|NOT COMPLETED|Overall Study||0
497831|NCT01020903|1216605|P1|NOT COMPLETED|Overall Study||0
497832|NCT01020903|1216604|P2|COMPLETED|Overall Study|Please be advised that the investigator of the study entitled left the institution in 2011.|100
497833|NCT01020903|1216605|P1|COMPLETED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
497834|NCT01020903|1216604|P2|STARTED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
497835|NCT01020903|1216605|P1|STARTED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
497836|NCT01020877|1216613|P2|NOT COMPLETED|Second Intervention||0
497837|NCT01020877|1216614|P1|NOT COMPLETED|Second Intervention||1
497838|NCT01020877|1216613|P2|COMPLETED|Second Intervention||19
497839|NCT01020877|1216614|P1|COMPLETED|Second Intervention||18
497840|NCT01020877|1216613|P2|STARTED|Second Intervention||19
497841|NCT01020877|1216614|P1|STARTED|Second Intervention||19
497842|NCT01020877|1216613|P2|NOT COMPLETED|Washout of 7 Days||0
497843|NCT01020877|1216614|P1|NOT COMPLETED|Washout of 7 Days||0
497844|NCT01020877|1216613|P2|COMPLETED|Washout of 7 Days||19
497845|NCT01020877|1216614|P1|COMPLETED|Washout of 7 Days||19
497846|NCT01020877|1216613|P2|STARTED|Washout of 7 Days||19
497847|NCT01020877|1216614|P1|STARTED|Washout of 7 Days||19
497848|NCT01020877|1216613|P2|NOT COMPLETED|First Intervention||0
497849|NCT01020877|1216614|P1|NOT COMPLETED|First Intervention||0
497850|NCT01020877|1216613|P2|COMPLETED|First Intervention||19
497851|NCT01020877|1216614|P1|COMPLETED|First Intervention||19
497852|NCT01020877|1216613|P2|STARTED|First Intervention||19
497853|NCT01020877|1216614|P1|STARTED|First Intervention||19
497854|NCT01020838|1216624|P1|NOT COMPLETED|Overall Study||183
497855|NCT01020838|1216624|P1|COMPLETED|Overall Study||35
497856|NCT01020838|1216624|P1|Second Annual Repeat Injection|Overall Study|Patients returning for second follow-up administration and PET-scan.|34
497857|NCT01020838|1216624|P1|First Annual Repeat Injection|Overall Study|Patients returning for first follow-up administration and PET-scan.|91
497858|NCT01020838|1216624|P1|Final Analysis Set (Whole Brain)|Overall Study|Final analysis set comparing PET scans with different histopathological evaluations.|97
497859|NCT01020838|1216624|P1|Interim Analysis Set (Primary Efficacy)|Overall Study|Primary efficacy analysis of initial study period (tissue-scan matched regional analysis)|41
497860|NCT01020838|1216624|P1|Safety Analysis Set|Overall Study|Two patients were excluded from this population because injection of florbetaben was not done.|216
497861|NCT01020838|1216624|P1|STARTED|Overall Study||218
497862|NCT01020812|1216639|P1|NOT COMPLETED|Overall Study||3
497863|NCT01020812|1216639|P1|COMPLETED|Overall Study||8
497864|NCT01020812|1216639|P1|STARTED|Overall Study||11
497865|NCT01020799|1216649|P3|NOT COMPLETED|Overall Study||7
497866|NCT01020799|1216650|P2|NOT COMPLETED|Overall Study||14
497867|NCT01020799|1216651|P1|NOT COMPLETED|Overall Study||19
497868|NCT01020799|1216649|P3|COMPLETED|Overall Study||43
497869|NCT01020799|1216650|P2|COMPLETED|Overall Study||85
497870|NCT01020799|1216651|P1|COMPLETED|Overall Study||79
497871|NCT01020799|1216649|P3|Full Analysis Set|Overall Study||49
497872|NCT01020799|1216650|P2|Full Analysis Set|Overall Study||94
497873|NCT01020799|1216651|P1|Full Analysis Set|Overall Study||91
497874|NCT01020799|1216649|P3|Patients Received Treatment|Overall Study||50
497875|NCT01020799|1216650|P2|Patients Received Treatment|Overall Study||99
497876|NCT01020799|1216651|P1|Patients Received Treatment|Overall Study||96
497877|NCT01020799|1216649|P3|STARTED|Overall Study||50
497878|NCT01020799|1216650|P2|STARTED|Overall Study||99
497879|NCT01020799|1216651|P1|STARTED|Overall Study||98
497880|NCT01020786|1216674|P1|NOT COMPLETED|Maintenance Period||60
497881|NCT01020786|1216674|P1|COMPLETED|Maintenance Period||0
497882|NCT01020786|1216674|P1|STARTED|Maintenance Period||60
497883|NCT01020786|1216674|P1|NOT COMPLETED|Induction Period||49
497884|NCT01020786|1216674|P1|COMPLETED|Induction Period|Completed induction therapy. Completed=starting the maintenance therapy.|60
497885|NCT01020786|1216674|P1|STARTED|Induction Period||109
497886|NCT01020773|1216688|P2|NOT COMPLETED|Overall Study||3
497887|NCT01020773|1216689|P1|NOT COMPLETED|Overall Study||4
497888|NCT01020773|1216688|P2|COMPLETED|Overall Study||29
497889|NCT01020773|1216689|P1|COMPLETED|Overall Study||31
497890|NCT01020773|1216688|P2|STARTED|Overall Study||32
497891|NCT01020773|1216689|P1|STARTED|Overall Study||35
497892|NCT01020747|1216695|P1|NOT COMPLETED|Overall Study||1
497893|NCT01020747|1216695|P1|COMPLETED|Overall Study||19
497894|NCT01020747|1216695|P1|STARTED|Overall Study||20
497895|NCT01020591|1216702|P2|NOT COMPLETED|Overall Study||0
497896|NCT01020591|1216703|P1|NOT COMPLETED|Overall Study||0
497897|NCT01020591|1216702|P2|COMPLETED|Overall Study||15
497898|NCT01020591|1216703|P1|COMPLETED|Overall Study||15
497899|NCT01020591|1216702|P2|STARTED|Overall Study||15
497900|NCT01020591|1216703|P1|STARTED|Overall Study||15
497901|NCT01020526|1216711|P1|NOT COMPLETED|Overall Study||14
497902|NCT01020526|1216711|P1|COMPLETED|Overall Study||49
497903|NCT01020526|1216711|P1|STARTED|Overall Study||63
497904|NCT01020474|1216717|P2|NOT COMPLETED|Overall Study||17
497905|NCT01020474|1216718|P1|NOT COMPLETED|Overall Study||10
497906|NCT01020474|1216717|P2|COMPLETED|Overall Study||36
497907|NCT01020474|1216718|P1|COMPLETED|Overall Study||44
497908|NCT01020474|1216717|P2|STARTED|Overall Study||53
497909|NCT01020474|1216718|P1|STARTED|Overall Study||54
497910|NCT01020448|1216738|P1|NOT COMPLETED|Treatment||26
497911|NCT01020448|1216738|P1|COMPLETED|Treatment||299
497912|NCT01020448|1216738|P1|STARTED|Treatment|One patient was excluded from the safety population as no post-baseline assessment was available|325
497913|NCT01020448|1216738|P1|NOT COMPLETED|Pre-assignment||13
497914|NCT01020448|1216738|P1|COMPLETED|Pre-assignment||326
497915|NCT01020448|1216738|P1|STARTED|Pre-assignment||339
497916|NCT01020435|1216749|P2|NOT COMPLETED|Overall Study||1
497917|NCT01020435|1216750|P1|NOT COMPLETED|Overall Study||0
497918|NCT01020435|1216749|P2|COMPLETED|Overall Study||26
497919|NCT01020435|1216750|P1|COMPLETED|Overall Study||24
497920|NCT01020435|1216749|P2|STARTED|Overall Study||27
497921|NCT01020435|1216750|P1|STARTED|Overall Study||24
497922|NCT01020305|1216758|P1|NOT COMPLETED|Overall Study||2
497923|NCT01020305|1216758|P1|COMPLETED|Overall Study||3
497924|NCT01020305|1216758|P1|STARTED|Overall Study||5
497925|NCT01020123|1216769|P7|NOT COMPLETED|Extention Period||1
497926|NCT01020123|1216770|P6|NOT COMPLETED|Extention Period||2
497927|NCT01020123|1216771|P5|NOT COMPLETED|Extention Period||0
497928|NCT01020123|1216772|P4|NOT COMPLETED|Extention Period||1
497929|NCT01020123|1216773|P3|NOT COMPLETED|Extention Period||2
497930|NCT01020123|1216774|P2|NOT COMPLETED|Extention Period||2
497931|NCT01020123|1216775|P1|NOT COMPLETED|Extention Period||3
497932|NCT01020123|1216769|P7|COMPLETED|Extention Period||18
497933|NCT01020123|1216770|P6|COMPLETED|Extention Period||36
497934|NCT01020123|1216771|P5|COMPLETED|Extention Period||31
497935|NCT01020123|1216772|P4|COMPLETED|Extention Period||12
497936|NCT01020123|1216773|P3|COMPLETED|Extention Period||17
497937|NCT01020123|1216774|P2|COMPLETED|Extention Period||33
497938|NCT01020123|1216775|P1|COMPLETED|Extention Period||37
497939|NCT01020123|1216769|P7|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|19
497940|NCT01020123|1216770|P6|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|38
497941|NCT01020123|1216771|P5|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|31
497942|NCT01020123|1216772|P4|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|13
497943|NCT01020123|1216773|P3|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|19
497944|NCT01020123|1216774|P2|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|35
497945|NCT01020123|1216775|P1|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|40
497946|NCT01020123|1216769|P7|NOT COMPLETED|Main Period||11
497947|NCT01020123|1216770|P6|NOT COMPLETED|Main Period||11
497948|NCT01020123|1216771|P5|NOT COMPLETED|Main Period||11
497949|NCT01020123|1216772|P4|NOT COMPLETED|Main Period||7
497950|NCT01020123|1216773|P3|NOT COMPLETED|Main Period||8
497951|NCT01020123|1216774|P2|NOT COMPLETED|Main Period||14
497952|NCT01020123|1216775|P1|NOT COMPLETED|Main Period||17
497953|NCT01020123|1216769|P7|COMPLETED|Main Period||61
497954|NCT01020123|1216770|P6|COMPLETED|Main Period||83
497955|NCT01020123|1216771|P5|COMPLETED|Main Period||77
497956|NCT01020123|1216772|P4|COMPLETED|Main Period||33
497957|NCT01020123|1216773|P3|COMPLETED|Main Period||44
497958|NCT01020123|1216774|P2|COMPLETED|Main Period||77
497959|NCT01020123|1216775|P1|COMPLETED|Main Period||76
497960|NCT01020123|1216769|P7|STARTED|Main Period||72
497961|NCT01020123|1216770|P6|STARTED|Main Period||94
497962|NCT01020123|1216771|P5|STARTED|Main Period||88
497963|NCT01020123|1216772|P4|STARTED|Main Period||40
497964|NCT01020123|1216773|P3|STARTED|Main Period||52
497965|NCT01020123|1216774|P2|STARTED|Main Period||91
497966|NCT01020123|1216775|P1|STARTED|Main Period||93
497967|NCT01020019|1216970|P2|NOT COMPLETED|Overall Study||29
497968|NCT01020019|1216971|P1|NOT COMPLETED|Overall Study||26
497969|NCT01020019|1216970|P2|COMPLETED|Overall Study||32
497970|NCT01020019|1216971|P1|COMPLETED|Overall Study||35
497971|NCT01020019|1216970|P2|STARTED|Overall Study||61
497972|NCT01020019|1216971|P1|STARTED|Overall Study||61
497973|NCT01020006|1216980|P3|NOT COMPLETED|Overall Study||16
497974|NCT01020006|1216981|P2|NOT COMPLETED|Overall Study||18
497975|NCT01020006|1216982|P1|NOT COMPLETED|Overall Study||8
497976|NCT01020006|1216980|P3|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
497977|NCT01020006|1216981|P2|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
497978|NCT01020006|1216982|P1|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
497979|NCT01020006|1216980|P3|STARTED|Overall Study||16
497980|NCT01020006|1216981|P2|STARTED|Overall Study||18
497981|NCT01020006|1216982|P1|STARTED|Overall Study||8
497982|NCT01019980|1216992|P2|NOT COMPLETED|Overall Study||0
497983|NCT01019980|1216993|P1|NOT COMPLETED|Overall Study||2
497984|NCT01019980|1216992|P2|COMPLETED|Overall Study||0
497985|NCT01019980|1216993|P1|COMPLETED|Overall Study||0
497986|NCT01019980|1216992|P2|Discontinued|Overall Study||0
497987|NCT01019980|1216993|P1|Discontinued|Overall Study||2
497988|NCT01019980|1216992|P2|STARTED|Overall Study||0
497989|NCT01019980|1216993|P1|STARTED|Overall Study|2 patients entered study but did not receive any drug since it was not available in the region.|2
497990|NCT01019928|1217001|P2|NOT COMPLETED|Period 3||0
497991|NCT01019928|1217002|P1|NOT COMPLETED|Period 3||0
497992|NCT01019928|1217001|P2|COMPLETED|Period 3|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
497993|NCT01019928|1217002|P1|COMPLETED|Period 3||7
497994|NCT01019928|1217001|P2|STARTED|Period 3|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
497995|NCT01019928|1217002|P1|STARTED|Period 3||7
497996|NCT01019928|1217001|P2|NOT COMPLETED|Period 2||1
497997|NCT01019928|1217002|P1|NOT COMPLETED|Period 2||0
497998|NCT01019928|1217001|P2|COMPLETED|Period 2|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
497999|NCT01019928|1217002|P1|COMPLETED|Period 2||7
498000|NCT01019928|1217001|P2|STARTED|Period 2||7
498001|NCT01019928|1217002|P1|STARTED|Period 2||7
498002|NCT01019928|1217001|P2|NOT COMPLETED|Period 1||0
498003|NCT01019928|1217002|P1|NOT COMPLETED|Period 1||0
498004|NCT01019928|1217001|P2|COMPLETED|Period 1||7
498005|NCT01019928|1217002|P1|COMPLETED|Period 1||7
498006|NCT01019928|1217001|P2|STARTED|Period 1||7
498007|NCT01019928|1217002|P1|STARTED|Period 1||7
498008|NCT01019707|1217042|P2|NOT COMPLETED|Second Phase||0
498009|NCT01019707|1217043|P1|NOT COMPLETED|Second Phase||0
498010|NCT01019707|1217042|P2|COMPLETED|Second Phase||1
498011|NCT01019707|1217043|P1|COMPLETED|Second Phase||3
498012|NCT01019707|1217042|P2|STARTED|Second Phase||1
498013|NCT01019707|1217043|P1|STARTED|Second Phase||3
498014|NCT01019707|1217042|P2|NOT COMPLETED|Washout||2
498015|NCT01019707|1217043|P1|NOT COMPLETED|Washout||0
498016|NCT01019707|1217042|P2|COMPLETED|Washout||1
498017|NCT01019707|1217043|P1|COMPLETED|Washout||3
498018|NCT01019707|1217042|P2|STARTED|Washout||3
498019|NCT01019707|1217043|P1|STARTED|Washout||3
498020|NCT01019707|1217042|P2|NOT COMPLETED|First Phase||0
498021|NCT01019707|1217043|P1|NOT COMPLETED|First Phase||0
498022|NCT01019707|1217042|P2|COMPLETED|First Phase||3
498023|NCT01019707|1217043|P1|COMPLETED|First Phase||3
498024|NCT01019707|1217042|P2|STARTED|First Phase||3
498025|NCT01019707|1217043|P1|STARTED|First Phase||3
498026|NCT01019694|1217056|P3|NOT COMPLETED|Overall Study||47
498027|NCT01019694|1217057|P2|NOT COMPLETED|Overall Study||38
498028|NCT01019694|1217058|P1|NOT COMPLETED|Overall Study||24
498029|NCT01019694|1217056|P3|COMPLETED|Overall Study||110
498030|NCT01019694|1217057|P2|COMPLETED|Overall Study||118
498031|NCT01019694|1217058|P1|COMPLETED|Overall Study||133
498032|NCT01019694|1217056|P3|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|157
498033|NCT01019694|1217057|P2|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|156
498034|NCT01019694|1217058|P1|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|157
498035|NCT01019486|1217183|P3|NOT COMPLETED|Overall Study||1
498036|NCT01019486|1217184|P2|NOT COMPLETED|Overall Study||1
498037|NCT01019486|1217185|P1|NOT COMPLETED|Overall Study||1
498038|NCT01019486|1217183|P3|COMPLETED|Overall Study||15
498039|NCT01019486|1217184|P2|COMPLETED|Overall Study||4
498040|NCT01019486|1217185|P1|COMPLETED|Overall Study||4
498041|NCT01019486|1217183|P3|STARTED|Overall Study||16
498042|NCT01019486|1217184|P2|STARTED|Overall Study||5
498043|NCT01019486|1217185|P1|STARTED|Overall Study||5
498044|NCT01019369|1217199|P2|NOT COMPLETED|Overall Study||7
498045|NCT01019369|1217200|P1|NOT COMPLETED|Overall Study||10
498046|NCT01019369|1217199|P2|COMPLETED|Overall Study||39
498047|NCT01019369|1217200|P1|COMPLETED|Overall Study||76
498048|NCT01019369|1217199|P2|STARTED|Overall Study||46
498049|NCT01019369|1217200|P1|STARTED|Overall Study||86
498050|NCT01019317|1217206|P1|NOT COMPLETED|Overall Study||4
498051|NCT01019317|1217206|P1|COMPLETED|Overall Study||147
498052|NCT01019317|1217206|P1|STARTED|Overall Study||151
498053|NCT01019135|1217213|P3|NOT COMPLETED|Overall Study||31
498054|NCT01019135|1217214|P2|NOT COMPLETED|Overall Study||19
498055|NCT01019135|1217215|P1|NOT COMPLETED|Overall Study||20
498056|NCT01019135|1217213|P3|COMPLETED|Overall Study||24
498057|NCT01019135|1217214|P2|COMPLETED|Overall Study||40
498058|NCT01019135|1217215|P1|COMPLETED|Overall Study||35
498059|NCT01019135|1217213|P3|STARTED|Overall Study||55
498060|NCT01019135|1217214|P2|STARTED|Overall Study||59
498061|NCT01019135|1217215|P1|STARTED|Overall Study||55
498062|NCT01018992|1217243|P2|NOT COMPLETED|Overall Study||16
498063|NCT01018992|1217244|P1|NOT COMPLETED|Overall Study||16
498064|NCT01018992|1217243|P2|COMPLETED|Overall Study||49
498065|NCT01018992|1217244|P1|COMPLETED|Overall Study||47
498066|NCT01018992|1217243|P2|STARTED|Overall Study||65
498067|NCT01018992|1217244|P1|STARTED|Overall Study||63
498068|NCT01018979|1217258|P2|NOT COMPLETED|Overall Study||10
498069|NCT01018979|1217259|P1|NOT COMPLETED|Overall Study||3
498070|NCT01018979|1217258|P2|COMPLETED|Overall Study||3
498071|NCT01018979|1217259|P1|COMPLETED|Overall Study||4
498072|NCT01018979|1217258|P2|Received at Least One Dose|Overall Study||12
498073|NCT01018979|1217259|P1|Received at Least One Dose|Overall Study||7
498074|NCT01018979|1217258|P2|STARTED|Overall Study|A total of 20 subjects were randomized.|13
498075|NCT01018979|1217259|P1|STARTED|Overall Study||7
498076|NCT01018953|1217289|P1|NOT COMPLETED|Overall Study||8
498077|NCT01018953|1217289|P1|COMPLETED|Overall Study||0
498078|NCT01018953|1217289|P1|BIM 23A760 4 mg|Overall Study||3
498079|NCT01018953|1217289|P1|BIM 23A760 2 mg|Overall Study||2
498080|NCT01018953|1217289|P1|BIM 23A760 1 mg|Overall Study||3
498081|NCT01018953|1217289|P1|STARTED|Overall Study||8
498082|NCT01018862|1217302|P3|NOT COMPLETED|Overall Study||16
498083|NCT01018862|1217303|P2|NOT COMPLETED|Overall Study||10
498084|NCT01018862|1217304|P1|NOT COMPLETED|Overall Study||13
498085|NCT01018862|1217302|P3|COMPLETED|Overall Study||146
498086|NCT01018862|1217303|P2|COMPLETED|Overall Study||156
498087|NCT01018862|1217304|P1|COMPLETED|Overall Study||148
498088|NCT01018862|1217302|P3|STARTED|Overall Study||162
498089|NCT01018862|1217303|P2|STARTED|Overall Study||166
498090|NCT01018862|1217304|P1|STARTED|Overall Study||161
498091|NCT01018810|1217326|P5|NOT COMPLETED|Overall Study||1
498092|NCT01018810|1217327|P4|NOT COMPLETED|Overall Study||1
498093|NCT01018810|1217328|P3|NOT COMPLETED|Overall Study||1
498094|NCT01018810|1217329|P2|NOT COMPLETED|Overall Study||1
498095|NCT01018810|1217330|P1|NOT COMPLETED|Overall Study||2
498096|NCT01018810|1217326|P5|COMPLETED|Overall Study||0
498097|NCT01018810|1217327|P4|COMPLETED|Overall Study||0
498098|NCT01018810|1217328|P3|COMPLETED|Overall Study||0
498099|NCT01018810|1217329|P2|COMPLETED|Overall Study||0
498100|NCT01018810|1217330|P1|COMPLETED|Overall Study||2
498101|NCT01018810|1217326|P5|STARTED|Overall Study||1
498102|NCT01018810|1217327|P4|STARTED|Overall Study||1
498103|NCT01018810|1217328|P3|STARTED|Overall Study||1
498104|NCT01018810|1217329|P2|STARTED|Overall Study||1
498105|NCT01018810|1217330|P1|STARTED|Overall Study||4
498106|NCT01018732|1217390|P3|NOT COMPLETED|Overall Study||4
498107|NCT01018732|1217391|P2|NOT COMPLETED|Overall Study||2
498108|NCT01018732|1217392|P1|NOT COMPLETED|Overall Study||1
498109|NCT01018732|1217390|P3|COMPLETED|Overall Study||50
498110|NCT01018732|1217391|P2|COMPLETED|Overall Study||49
498111|NCT01018732|1217392|P1|COMPLETED|Overall Study||49
498112|NCT01018732|1217390|P3|STARTED|Overall Study||54
498113|NCT01018732|1217391|P2|STARTED|Overall Study||51
498114|NCT01018732|1217392|P1|STARTED|Overall Study||50
498115|NCT01018680|1217426|P2|NOT COMPLETED|Overall Study||75
498116|NCT01018680|1217427|P1|NOT COMPLETED|Overall Study||61
498117|NCT01018680|1217426|P2|COMPLETED|Overall Study||189
498118|NCT01018680|1217427|P1|COMPLETED|Overall Study||199
498119|NCT01018680|1217426|P2|STARTED|Overall Study||264
498120|NCT01018680|1217427|P1|STARTED|Overall Study||260
498121|NCT01020487|1217470|P3|NOT COMPLETED|Part 2 Open-label Period||1
498122|NCT01020487|1217471|P2|NOT COMPLETED|Part 2 Open-label Period||4
498123|NCT01020487|1217472|P1|NOT COMPLETED|Part 2 Open-label Period||0
498124|NCT01020487|1217470|P3|COMPLETED|Part 2 Open-label Period||12
498125|NCT01020487|1217471|P2|COMPLETED|Part 2 Open-label Period||12
498126|NCT01020487|1217472|P1|COMPLETED|Part 2 Open-label Period||0
498127|NCT01020487|1217470|P3|STARTED|Part 2 Open-label Period||13
498128|NCT01020487|1217471|P2|STARTED|Part 2 Open-label Period||16
498129|NCT01020487|1217472|P1|STARTED|Part 2 Open-label Period||0
498130|NCT01020487|1217470|P3|NOT COMPLETED|Part 2 Double-blind Treatment Period||6
498131|NCT01020487|1217471|P2|NOT COMPLETED|Part 2 Double-blind Treatment Period||2
498132|NCT01020487|1217472|P1|NOT COMPLETED|Part 2 Double-blind Treatment Period||0
498133|NCT01020487|1217470|P3|COMPLETED|Part 2 Double-blind Treatment Period||13
498134|NCT01020487|1217471|P2|COMPLETED|Part 2 Double-blind Treatment Period||16
498135|NCT01020487|1217472|P1|COMPLETED|Part 2 Double-blind Treatment Period||0
498136|NCT01020487|1217470|P3|Received Treatment|Part 2 Double-blind Treatment Period||18
498137|NCT01020487|1217471|P2|Received Treatment|Part 2 Double-blind Treatment Period||18
498138|NCT01020487|1217472|P1|Received Treatment|Part 2 Double-blind Treatment Period||0
498139|NCT01020487|1217470|P3|STARTED|Part 2 Double-blind Treatment Period|Includes one participant who enrolled in Part 2 after completing Part 1|19
498140|NCT01020487|1217471|P2|STARTED|Part 2 Double-blind Treatment Period|Includes one participant who enrolled in Part 2 after completing Part 1|18
498141|NCT01020487|1217472|P1|STARTED|Part 2 Double-blind Treatment Period||0
498142|NCT01020487|1217470|P3|NOT COMPLETED|Part 1||0
498143|NCT01020487|1217471|P2|NOT COMPLETED|Part 1||0
498144|NCT01020487|1217472|P1|NOT COMPLETED|Part 1||0
498145|NCT01020487|1217470|P3|COMPLETED|Part 1||0
498146|NCT01020487|1217471|P2|COMPLETED|Part 1||0
498147|NCT01020487|1217472|P1|COMPLETED|Part 1||12
498148|NCT01020487|1217470|P3|STARTED|Part 1||0
498149|NCT01020487|1217471|P2|STARTED|Part 1||0
498150|NCT01020487|1217472|P1|STARTED|Part 1||12
498151|NCT01018511|1217497|P4|NOT COMPLETED|Overall Study||33
498152|NCT01018511|1217498|P3|NOT COMPLETED|Overall Study||40
498153|NCT01018511|1217499|P2|NOT COMPLETED|Overall Study||32
498154|NCT01018511|1217500|P1|NOT COMPLETED|Overall Study||26
498155|NCT01018511|1217497|P4|COMPLETED|Overall Study||294
498156|NCT01018511|1217498|P3|COMPLETED|Overall Study||299
498157|NCT01018511|1217499|P2|COMPLETED|Overall Study||295
498158|NCT01018511|1217500|P1|COMPLETED|Overall Study||315
498159|NCT01018511|1217497|P4|Randomized and Treated|Overall Study||324
498160|NCT01018511|1217498|P3|Randomized and Treated|Overall Study||338
498161|NCT01018511|1217499|P2|Randomized and Treated|Overall Study||326
498162|NCT01018511|1217500|P1|Randomized and Treated|Overall Study||341
498163|NCT01018511|1217497|P4|STARTED|Overall Study||327
498164|NCT01018511|1217498|P3|STARTED|Overall Study||339
498165|NCT01018511|1217499|P2|STARTED|Overall Study||327
498166|NCT01018511|1217500|P1|STARTED|Overall Study||341
498167|NCT01018420|1217669|P2|NOT COMPLETED|Overall Study||0
498168|NCT01018420|1217670|P1|NOT COMPLETED|Overall Study||0
498169|NCT01018420|1217669|P2|COMPLETED|Overall Study||3
498170|NCT01018420|1217670|P1|COMPLETED|Overall Study||15
498171|NCT01018420|1217669|P2|STARTED|Overall Study||3
498172|NCT01018420|1217670|P1|STARTED|Overall Study||15
498173|NCT01018394|1217697|P2|NOT COMPLETED|Overall Study||8
498174|NCT01018394|1217698|P1|NOT COMPLETED|Overall Study||9
498175|NCT01018394|1217697|P2|COMPLETED|Overall Study||33
498176|NCT01018394|1217698|P1|COMPLETED|Overall Study||31
498177|NCT01018394|1217697|P2|STARTED|Overall Study||41
498178|NCT01018394|1217698|P1|STARTED|Overall Study||40
498179|NCT01018264|1217708|P2|NOT COMPLETED|Overall Study||1
498180|NCT01018264|1217709|P1|NOT COMPLETED|Overall Study||1
498181|NCT01018264|1217708|P2|COMPLETED|Overall Study||12
498182|NCT01018264|1217709|P1|COMPLETED|Overall Study||9
498183|NCT01018264|1217708|P2|STARTED|Overall Study||13
498184|NCT01018264|1217709|P1|STARTED|Overall Study||10
498185|NCT01018186|1217726|P4|NOT COMPLETED|52-week Double-blind Treatment Period||29
498186|NCT01018186|1217727|P3|NOT COMPLETED|52-week Double-blind Treatment Period||41
498187|NCT01018186|1217728|P2|NOT COMPLETED|52-week Double-blind Treatment Period||40
498188|NCT01018186|1217729|P1|NOT COMPLETED|52-week Double-blind Treatment Period||0
498189|NCT01018186|1217726|P4|COMPLETED|52-week Double-blind Treatment Period||71
498190|NCT01018186|1217727|P3|COMPLETED|52-week Double-blind Treatment Period||161
498191|NCT01018186|1217728|P2|COMPLETED|52-week Double-blind Treatment Period||161
498192|NCT01018186|1217729|P1|COMPLETED|52-week Double-blind Treatment Period||0
498193|NCT01018186|1217726|P4|STARTED|52-week Double-blind Treatment Period||100
498194|NCT01018186|1217727|P3|STARTED|52-week Double-blind Treatment Period||202
498195|NCT01018186|1217728|P2|STARTED|52-week Double-blind Treatment Period||201
498196|NCT01018186|1217729|P1|STARTED|52-week Double-blind Treatment Period||0
498197|NCT01018186|1217726|P4|NOT COMPLETED|2-week Run-in Period||0
498198|NCT01018186|1217727|P3|NOT COMPLETED|2-week Run-in Period||0
498199|NCT01018186|1217728|P2|NOT COMPLETED|2-week Run-in Period||0
498200|NCT01018186|1217729|P1|NOT COMPLETED|2-week Run-in Period||114
498201|NCT01018186|1217726|P4|COMPLETED|2-week Run-in Period||0
498202|NCT01018186|1217727|P3|COMPLETED|2-week Run-in Period||0
498203|NCT01018186|1217728|P2|COMPLETED|2-week Run-in Period||0
498204|NCT01018186|1217729|P1|COMPLETED|2-week Run-in Period||503
498205|NCT01018186|1217726|P4|STARTED|2-week Run-in Period||0
498206|NCT01018186|1217727|P3|STARTED|2-week Run-in Period||0
498207|NCT01018186|1217728|P2|STARTED|2-week Run-in Period||0
498208|NCT01018186|1217729|P1|STARTED|2-week Run-in Period||617
498209|NCT01018134|1217821|P6|NOT COMPLETED|Overall Study||0
498210|NCT01018134|1217822|P5|NOT COMPLETED|Overall Study||0
498211|NCT01018134|1217823|P4|NOT COMPLETED|Overall Study||0
498212|NCT01018134|1217824|P3|NOT COMPLETED|Overall Study||1
498213|NCT01018134|1217825|P2|NOT COMPLETED|Overall Study||1
498214|NCT01018134|1217826|P1|NOT COMPLETED|Overall Study||0
498215|NCT01018134|1217821|P6|COMPLETED|Overall Study||15
498216|NCT01018134|1217822|P5|COMPLETED|Overall Study||15
498217|NCT01018134|1217823|P4|COMPLETED|Overall Study||29
498218|NCT01018134|1217824|P3|COMPLETED|Overall Study||29
498219|NCT01018134|1217825|P2|COMPLETED|Overall Study||30
498220|NCT01018134|1217826|P1|COMPLETED|Overall Study||30
498221|NCT01018134|1217821|P6|STARTED|Overall Study||15
498222|NCT01018134|1217822|P5|STARTED|Overall Study||15
498223|NCT01018134|1217823|P4|STARTED|Overall Study|30 enrolled patients, one who did not use the study medication was excluded from all analyses|29
498224|NCT01018134|1217824|P3|STARTED|Overall Study||30
498225|NCT01018134|1217825|P2|STARTED|Overall Study||31
498226|NCT01018134|1217826|P1|STARTED|Overall Study||30
498227|NCT01018095|1217866|P2|NOT COMPLETED|Overall Study||62
498228|NCT01018095|1217867|P1|NOT COMPLETED|Overall Study||56
498229|NCT01018095|1217866|P2|COMPLETED|Overall Study||73
498230|NCT01018095|1217867|P1|COMPLETED|Overall Study||79
498231|NCT01018095|1217866|P2|STARTED|Overall Study||135
498232|NCT01018095|1217867|P1|STARTED|Overall Study||135
498233|NCT01018056|1217878|P3|NOT COMPLETED|Overall Study||1
498234|NCT01018056|1217879|P2|NOT COMPLETED|Overall Study||2
498235|NCT01018056|1217880|P1|NOT COMPLETED|Overall Study||3
498236|NCT01018056|1217878|P3|COMPLETED|Overall Study||5
498237|NCT01018056|1217879|P2|COMPLETED|Overall Study||10
498238|NCT01018056|1217880|P1|COMPLETED|Overall Study||9
498239|NCT01018056|1217878|P3|STARTED|Overall Study||6
498240|NCT01018056|1217879|P2|STARTED|Overall Study||12
498241|NCT01018056|1217880|P1|STARTED|Overall Study||12
498242|NCT01018030|1217930|P3|NOT COMPLETED|Overall Study||13
498243|NCT01018030|1217931|P2|NOT COMPLETED|Overall Study||11
498244|NCT01018030|1217932|P1|NOT COMPLETED|Overall Study||19
498245|NCT01018030|1217930|P3|COMPLETED|Overall Study||239
498246|NCT01018030|1217931|P2|COMPLETED|Overall Study||232
498247|NCT01018030|1217932|P1|COMPLETED|Overall Study||227
498248|NCT01018030|1217930|P3|STARTED|Overall Study||252
498249|NCT01018030|1217931|P2|STARTED|Overall Study||243
498250|NCT01018030|1217932|P1|STARTED|Overall Study||246
498251|NCT01017952|1217983|P5|NOT COMPLETED|52-week, Double-blind Treatment Period||103
498252|NCT01017952|1217984|P4|NOT COMPLETED|52-week, Double-blind Treatment Period||112
498253|NCT01017952|1217985|P3|NOT COMPLETED|52-week, Double-blind Treatment Period||109
498254|NCT01017952|1217986|P2|NOT COMPLETED|52-week, Double-blind Treatment Period||125
498255|NCT01017952|1217987|P1|NOT COMPLETED|52-week, Double-blind Treatment Period||0
498256|NCT01017952|1217983|P5|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|306
498257|NCT01017952|1217984|P4|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|291
498258|NCT01017952|1217985|P3|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|303
498259|NCT01017952|1217986|P2|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|284
498260|NCT01017952|1217987|P1|COMPLETED|52-week, Double-blind Treatment Period||0
498261|NCT01017952|1217983|P5|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|307
498262|NCT01017952|1217984|P4|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|293
498263|NCT01017952|1217985|P3|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|305
498264|NCT01017952|1217986|P2|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|285
498265|NCT01017952|1217987|P1|Completed the Treatment Period|52-week, Double-blind Treatment Period||0
498266|NCT01017952|1217983|P5|STARTED|52-week, Double-blind Treatment Period||409
498267|NCT01017952|1217984|P4|STARTED|52-week, Double-blind Treatment Period||403
498268|NCT01017952|1217985|P3|STARTED|52-week, Double-blind Treatment Period||412
498269|NCT01017952|1217986|P2|STARTED|52-week, Double-blind Treatment Period||409
498270|NCT01017952|1217987|P1|STARTED|52-week, Double-blind Treatment Period||0
498271|NCT01017952|1217983|P5|NOT COMPLETED|4-week, Open-label Run-In Period||0
498272|NCT01017952|1217984|P4|NOT COMPLETED|4-week, Open-label Run-In Period||0
498273|NCT01017952|1217985|P3|NOT COMPLETED|4-week, Open-label Run-In Period||0
498274|NCT01017952|1217986|P2|NOT COMPLETED|4-week, Open-label Run-In Period||0
498275|NCT01017952|1217987|P1|NOT COMPLETED|4-week, Open-label Run-In Period||459
498276|NCT01017952|1217983|P5|COMPLETED|4-week, Open-label Run-In Period||0
498277|NCT01017952|1217984|P4|COMPLETED|4-week, Open-label Run-In Period||0
498278|NCT01017952|1217985|P3|COMPLETED|4-week, Open-label Run-In Period||0
498279|NCT01017952|1217986|P2|COMPLETED|4-week, Open-label Run-In Period||0
498280|NCT01017952|1217987|P1|COMPLETED|4-week, Open-label Run-In Period||1633
498281|NCT01017952|1217983|P5|STARTED|4-week, Open-label Run-In Period||0
498282|NCT01017952|1217984|P4|STARTED|4-week, Open-label Run-In Period||0
498283|NCT01017952|1217985|P3|STARTED|4-week, Open-label Run-In Period||0
498284|NCT01017952|1217986|P2|STARTED|4-week, Open-label Run-In Period||0
498285|NCT01017952|1217987|P1|STARTED|4-week, Open-label Run-In Period||2092
498286|NCT01017874|1218011|P2|NOT COMPLETED|Overall Study||26
498287|NCT01017874|1218012|P1|NOT COMPLETED|Overall Study||30
498288|NCT01017874|1218011|P2|COMPLETED|Overall Study||92
498289|NCT01017874|1218012|P1|COMPLETED|Overall Study||88
498290|NCT01017874|1218011|P2|Received at Least 1 Dose of Study Drug|Overall Study||118
498291|NCT01017874|1218012|P1|Received at Least 1 Dose of Study Drug|Overall Study||114
498292|NCT01017874|1218011|P2|STARTED|Overall Study||118
498293|NCT01017874|1218012|P1|STARTED|Overall Study||118
498294|NCT01017731|1218030|P1|NOT COMPLETED|Overall Study||8
498295|NCT01017731|1218030|P1|COMPLETED|Overall Study||60
498296|NCT01017731|1218030|P1|Received at Least 1 Dose of Study Drug|Overall Study||66
498297|NCT01017731|1218030|P1|STARTED|Overall Study||68
498298|NCT01017653|1218047|P1|NOT COMPLETED|Overall Study||0
498299|NCT01017653|1218047|P1|COMPLETED|Overall Study||16
498300|NCT01017653|1218047|P1|STARTED|Overall Study||16
498301|NCT01017601|1218059|P2|NOT COMPLETED|Overall Study||13
498302|NCT01017601|1218060|P1|NOT COMPLETED|Overall Study||12
498303|NCT01017601|1218059|P2|COMPLETED|Overall Study||11
498304|NCT01017601|1218060|P1|COMPLETED|Overall Study||14
498305|NCT01017601|1218059|P2|STARTED|Overall Study||24
498306|NCT01017601|1218060|P1|STARTED|Overall Study||26
498307|NCT01017575|1218087|P5|NOT COMPLETED|Overall Study||3
498308|NCT01017575|1218088|P4|NOT COMPLETED|Overall Study||1
498309|NCT01017575|1218089|P3|NOT COMPLETED|Overall Study||0
498310|NCT01017575|1218090|P2|NOT COMPLETED|Overall Study||2
498311|NCT01017575|1218091|P1|NOT COMPLETED|Overall Study||1
498312|NCT01017575|1218087|P5|COMPLETED|Overall Study||6
498313|NCT01017575|1218088|P4|COMPLETED|Overall Study||7
498314|NCT01017575|1218089|P3|COMPLETED|Overall Study||8
498315|NCT01017575|1218090|P2|COMPLETED|Overall Study||7
498316|NCT01017575|1218091|P1|COMPLETED|Overall Study||7
498317|NCT01017575|1218087|P5|STARTED|Overall Study||9
498318|NCT01017575|1218088|P4|STARTED|Overall Study||8
498319|NCT01017575|1218089|P3|STARTED|Overall Study||8
498320|NCT01017575|1218090|P2|STARTED|Overall Study||9
498321|NCT01017575|1218091|P1|STARTED|Overall Study||8
498322|NCT01017549|1218128|P1|NOT COMPLETED|One-year Follow-up||7
498323|NCT01017549|1218128|P1|COMPLETED|One-year Follow-up||36
498324|NCT01017549|1218128|P1|STARTED|One-year Follow-up||43
498325|NCT01017549|1218128|P1|NOT COMPLETED|Eligibility Through 6 Month Follow-up||1
498326|NCT01017549|1218128|P1|COMPLETED|Eligibility Through 6 Month Follow-up|6 month follow-up complete Oct 2008; data through 6 months and 1 year are published.|43
498327|NCT01017549|1218128|P1|STARTED|Eligibility Through 6 Month Follow-up||44
498328|NCT01017536|1218135|P2|NOT COMPLETED|Overall Study||0
498329|NCT01017536|1218136|P1|NOT COMPLETED|Overall Study||0
498330|NCT01017536|1218135|P2|COMPLETED|Overall Study||13
498331|NCT01017536|1218136|P1|COMPLETED|Overall Study||13
498332|NCT01017536|1218135|P2|STARTED|Overall Study||13
498333|NCT01017536|1218136|P1|STARTED|Overall Study||13
498334|NCT01017497|1218146|P1|NOT COMPLETED|Overall Study||0
498335|NCT01017497|1218146|P1|COMPLETED|Overall Study||49
498336|NCT01017497|1218146|P1|STARTED|Overall Study||49
498337|NCT01017263|1218159|P1|NOT COMPLETED|Overall Study||12
498338|NCT01017263|1218159|P1|COMPLETED|Overall Study|A total of 14 participants screened: 2 qualified and received drug the remaining 12 failed screen|2
498339|NCT01017263|1218159|P1|STARTED|Overall Study||14
498340|NCT01017250|1218163|P1|NOT COMPLETED|Overall Study||0
498341|NCT01017250|1218163|P1|COMPLETED|Overall Study||15
498342|NCT01017250|1218163|P1|2-month MRI|Overall Study|1 participant did not return for the 2 month MRI at treating facility. Resides out of state.|14
498343|NCT01017250|1218163|P1|STARTED|Overall Study||15
498344|NCT01017237|1218185|P2|NOT COMPLETED|Overall Study||2
498345|NCT01017237|1218186|P1|NOT COMPLETED|Overall Study||5
498346|NCT01017237|1218185|P2|COMPLETED|Overall Study||6
498347|NCT01017237|1218186|P1|COMPLETED|Overall Study||5
498348|NCT01017237|1218185|P2|STARTED|Overall Study||8
498349|NCT01017237|1218186|P1|STARTED|Overall Study||10
498350|NCT01017146|1218240|P2|NOT COMPLETED|Overall Study||39
498351|NCT01017146|1218241|P1|NOT COMPLETED|Overall Study||66
498352|NCT01017146|1218240|P2|COMPLETED|Overall Study||333
498353|NCT01017146|1218241|P1|COMPLETED|Overall Study||306
498354|NCT01017146|1218240|P2|STARTED|Overall Study||372
498355|NCT01017146|1218241|P1|STARTED|Overall Study||372
498356|NCT01017120|1218279|P2|NOT COMPLETED|Overall Study||35
498357|NCT01017120|1218280|P1|NOT COMPLETED|Overall Study||66
498358|NCT01017120|1218279|P2|COMPLETED|Overall Study||334
498359|NCT01017120|1218280|P1|COMPLETED|Overall Study||307
498360|NCT01017120|1218279|P2|STARTED|Overall Study||369
498361|NCT01017120|1218280|P1|STARTED|Overall Study||373
498362|NCT01017042|1218328|P1|NOT COMPLETED|Overall Study||0
498363|NCT01017042|1218328|P1|COMPLETED|Overall Study||13
498364|NCT01017042|1218328|P1|STARTED|Overall Study||13
498365|NCT01017029|1218341|P2|NOT COMPLETED|Overall Study||2
498366|NCT01017029|1218342|P1|NOT COMPLETED|Overall Study||4
498367|NCT01017029|1218341|P2|COMPLETED|Overall Study||90
498368|NCT01017029|1218342|P1|COMPLETED|Overall Study||85
498369|NCT01017029|1218341|P2|STARTED|Overall Study||92
498370|NCT01017029|1218342|P1|STARTED|Overall Study||89
498371|NCT01017003|1218358|P1|NOT COMPLETED|Colchicine 0.6 mg Final Dose||0
498372|NCT01017003|1218358|P1|COMPLETED|Colchicine 0.6 mg Final Dose||13
498373|NCT01017003|1218358|P1|STARTED|Colchicine 0.6 mg Final Dose||13
498374|NCT01017003|1218358|P1|NOT COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||0
498375|NCT01017003|1218358|P1|COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||13
498376|NCT01017003|1218358|P1|STARTED|Colchicine 0.6 mg Twice Daily x 10 Days||13
498377|NCT01017003|1218358|P1|NOT COMPLETED|14 Day Washout Period||0
498378|NCT01017003|1218358|P1|COMPLETED|14 Day Washout Period||13
498379|NCT01017003|1218358|P1|STARTED|14 Day Washout Period||13
498380|NCT01017003|1218358|P1|NOT COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||0
498381|NCT01017003|1218358|P1|COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||13
498382|NCT01017003|1218358|P1|STARTED|Single Dose Colchicine 0.6 mg, Day 1||13
498383|NCT01016977|1218370|P2|NOT COMPLETED|Overall Study||2
498384|NCT01016977|1218371|P1|NOT COMPLETED|Overall Study||3
498385|NCT01016977|1218370|P2|COMPLETED|Overall Study||18
498386|NCT01016977|1218371|P1|COMPLETED|Overall Study||17
498387|NCT01016977|1218370|P2|STARTED|Overall Study||20
498388|NCT01016977|1218371|P1|STARTED|Overall Study||20
498389|NCT01016964|1218407|P2|NOT COMPLETED|Overall Study||3
498390|NCT01016964|1218408|P1|NOT COMPLETED|Overall Study||3
498391|NCT01016964|1218407|P2|COMPLETED|Overall Study||39
498392|NCT01016964|1218408|P1|COMPLETED|Overall Study||18
498393|NCT01016964|1218407|P2|STARTED|Overall Study||42
498394|NCT01016964|1218408|P1|STARTED|Overall Study||21
498395|NCT01016938|1218414|P1|NOT COMPLETED|Overall Study||9
498396|NCT01016938|1218414|P1|COMPLETED|Overall Study||7
498397|NCT01016938|1218414|P1|STARTED|Overall Study||16
498398|NCT01016912|1218424|P5|NOT COMPLETED|Follow-up Period||0
498399|NCT01016912|1218425|P4|NOT COMPLETED|Follow-up Period||1
498400|NCT01016912|1218426|P3|NOT COMPLETED|Follow-up Period||1
498401|NCT01016912|1218427|P2|NOT COMPLETED|Follow-up Period||0
498402|NCT01016912|1218428|P1|NOT COMPLETED|Follow-up Period||0
498403|NCT01016912|1218424|P5|COMPLETED|Follow-up Period||9
498404|NCT01016912|1218425|P4|COMPLETED|Follow-up Period||8
498405|NCT01016912|1218426|P3|COMPLETED|Follow-up Period||9
498406|NCT01016912|1218427|P2|COMPLETED|Follow-up Period||9
498407|NCT01016912|1218428|P1|COMPLETED|Follow-up Period||8
498408|NCT01016912|1218424|P5|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
498409|NCT01016912|1218425|P4|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
498410|NCT01016912|1218426|P3|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|10
498411|NCT01016912|1218427|P2|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
498412|NCT01016912|1218428|P1|STARTED|Follow-up Period||8
498413|NCT01016912|1218424|P5|NOT COMPLETED|End of Treatment Period||4
498414|NCT01016912|1218425|P4|NOT COMPLETED|End of Treatment Period||4
498415|NCT01016912|1218426|P3|NOT COMPLETED|End of Treatment Period||1
498416|NCT01016912|1218427|P2|NOT COMPLETED|End of Treatment Period||3
498417|NCT01016912|1218428|P1|NOT COMPLETED|End of Treatment Period||0
498418|NCT01016912|1218424|P5|COMPLETED|End of Treatment Period||5
498419|NCT01016912|1218425|P4|COMPLETED|End of Treatment Period||5
498420|NCT01016912|1218426|P3|COMPLETED|End of Treatment Period||9
498421|NCT01016912|1218427|P2|COMPLETED|End of Treatment Period||6
498422|NCT01016912|1218428|P1|COMPLETED|End of Treatment Period||8
498423|NCT01016912|1218424|P5|Received Treatment|End of Treatment Period||9
498424|NCT01016912|1218425|P4|Received Treatment|End of Treatment Period||9
498425|NCT01016912|1218426|P3|Received Treatment|End of Treatment Period||10
498426|NCT01016912|1218427|P2|Received Treatment|End of Treatment Period||9
498427|NCT01016912|1218428|P1|Received Treatment|End of Treatment Period||8
498428|NCT01016912|1218424|P5|STARTED|End of Treatment Period||9
498429|NCT01016912|1218425|P4|STARTED|End of Treatment Period||9
498430|NCT01016912|1218426|P3|STARTED|End of Treatment Period||10
498431|NCT01016912|1218427|P2|STARTED|End of Treatment Period||9
498432|NCT01016912|1218428|P1|STARTED|End of Treatment Period||8
498433|NCT01016873|1218473|P3|NOT COMPLETED|36 Months||6
498434|NCT01016873|1218474|P2|NOT COMPLETED|36 Months||4
498435|NCT01016873|1218475|P1|NOT COMPLETED|36 Months||11
498436|NCT01016873|1218473|P3|COMPLETED|36 Months||67
498437|NCT01016873|1218474|P2|COMPLETED|36 Months||64
498438|NCT01016873|1218475|P1|COMPLETED|36 Months||58
498439|NCT01016873|1218473|P3|STARTED|36 Months||73
498440|NCT01016873|1218474|P2|STARTED|36 Months||68
498441|NCT01016873|1218475|P1|STARTED|36 Months||69
498442|NCT01016873|1218473|P3|NOT COMPLETED|24 Months||6
498443|NCT01016873|1218474|P2|NOT COMPLETED|24 Months||4
498444|NCT01016873|1218475|P1|NOT COMPLETED|24 Months||5
498445|NCT01016873|1218473|P3|COMPLETED|24 Months||73
498446|NCT01016873|1218474|P2|COMPLETED|24 Months||68
498447|NCT01016873|1218475|P1|COMPLETED|24 Months||69
498448|NCT01016873|1218473|P3|STARTED|24 Months||79
498449|NCT01016873|1218474|P2|STARTED|24 Months||72
498450|NCT01016873|1218475|P1|STARTED|24 Months||74
498451|NCT01016873|1218473|P3|NOT COMPLETED|12 Months||1
498452|NCT01016873|1218474|P2|NOT COMPLETED|12 Months||3
498453|NCT01016873|1218475|P1|NOT COMPLETED|12 Months||1
498454|NCT01016873|1218473|P3|COMPLETED|12 Months||79
498455|NCT01016873|1218474|P2|COMPLETED|12 Months||72
498456|NCT01016873|1218475|P1|COMPLETED|12 Months||74
498457|NCT01016873|1218473|P3|STARTED|12 Months||80
498458|NCT01016873|1218474|P2|STARTED|12 Months||75
498459|NCT01016873|1218475|P1|STARTED|12 Months||75
498460|NCT01016847|1218506|P2|NOT COMPLETED|Overall Study||0
498461|NCT01016847|1218507|P1|NOT COMPLETED|Overall Study||0
498462|NCT01016847|1218506|P2|COMPLETED|Overall Study||2
498463|NCT01016847|1218507|P1|COMPLETED|Overall Study||1
498464|NCT01016847|1218506|P2|STARTED|Overall Study||2
498465|NCT01016847|1218507|P1|STARTED|Overall Study||1
498466|NCT01016834|1218523|P1|NOT COMPLETED|Overall Study||22
498467|NCT01016834|1218523|P1|COMPLETED|Overall Study||220
498468|NCT01016834|1218523|P1|STARTED|Overall Study||242
498469|NCT01016691|1218532|P3|NOT COMPLETED|Overall Study||0
498470|NCT01016691|1218533|P2|NOT COMPLETED|Overall Study||0
498471|NCT01016691|1218534|P1|NOT COMPLETED|Overall Study||0
498472|NCT01016691|1218532|P3|COMPLETED|Overall Study||18
498473|NCT01016691|1218533|P2|COMPLETED|Overall Study||12
498474|NCT01016691|1218534|P1|COMPLETED|Overall Study||17
498475|NCT01016691|1218532|P3|STARTED|Overall Study||18
498476|NCT01016691|1218533|P2|STARTED|Overall Study||12
498477|NCT01016691|1218534|P1|STARTED|Overall Study||17
498478|NCT01016678|1218542|P5|NOT COMPLETED|Overall Study||6
498479|NCT01016678|1218543|P4|NOT COMPLETED|Overall Study||0
498480|NCT01016678|1218544|P3|NOT COMPLETED|Overall Study||4
498481|NCT01016678|1218545|P2|NOT COMPLETED|Overall Study||3
498482|NCT01016678|1218546|P1|NOT COMPLETED|Overall Study||2
498483|NCT01016678|1218542|P5|COMPLETED|Overall Study||13
498484|NCT01016678|1218543|P4|COMPLETED|Overall Study||19
498485|NCT01016678|1218544|P3|COMPLETED|Overall Study||15
498486|NCT01016678|1218545|P2|COMPLETED|Overall Study||14
498487|NCT01016678|1218546|P1|COMPLETED|Overall Study||18
498488|NCT01016678|1218542|P5|STARTED|Overall Study||19
498489|NCT01016678|1218543|P4|STARTED|Overall Study||19
498490|NCT01016678|1218544|P3|STARTED|Overall Study||19
498491|NCT01016678|1218545|P2|STARTED|Overall Study||17
498492|NCT01016678|1218546|P1|STARTED|Overall Study||20
498493|NCT01016652|1218568|P2|NOT COMPLETED|Period 2||0
498494|NCT01016652|1218569|P1|NOT COMPLETED|Period 2||0
498495|NCT01016652|1218568|P2|COMPLETED|Period 2||24
498496|NCT01016652|1218569|P1|COMPLETED|Period 2||25
498497|NCT01016652|1218568|P2|STARTED|Period 2|Crossover study: the completed from period 1 will crossover in period 2 to the opposite arm.|24
498498|NCT01016652|1218569|P1|STARTED|Period 2|Crossover study: the completed from period 1 will crossover in period 2 to the opposite arm.|25
498499|NCT01016652|1218568|P2|NOT COMPLETED|Period 1||0
498500|NCT01016652|1218569|P1|NOT COMPLETED|Period 1||0
498501|NCT01016652|1218568|P2|COMPLETED|Period 1||24
498502|NCT01016652|1218569|P1|COMPLETED|Period 1||25
498503|NCT01016652|1218568|P2|STARTED|Period 1||24
498504|NCT01016652|1218569|P1|STARTED|Period 1||25
498505|NCT01016600|1218589|P4|NOT COMPLETED|Overall Study||0
498506|NCT01016600|1218590|P3|NOT COMPLETED|Overall Study||0
498507|NCT01016600|1218591|P2|NOT COMPLETED|Overall Study||0
498508|NCT01016600|1218592|P1|NOT COMPLETED|Overall Study||1
498509|NCT01016600|1218589|P4|COMPLETED|Overall Study||12
498510|NCT01016600|1218590|P3|COMPLETED|Overall Study||6
498511|NCT01016600|1218591|P2|COMPLETED|Overall Study||4
498512|NCT01016600|1218592|P1|COMPLETED|Overall Study||8
498513|NCT01016600|1218589|P4|STARTED|Overall Study||12
498514|NCT01016600|1218590|P3|STARTED|Overall Study||6
498515|NCT01016600|1218591|P2|STARTED|Overall Study||4
498516|NCT01016600|1218592|P1|STARTED|Overall Study||9
498517|NCT01016483|1218659|P4|NOT COMPLETED|Phase II||0
498518|NCT01016483|1218660|P3|NOT COMPLETED|Phase II||0
498519|NCT01016483|1218661|P2|NOT COMPLETED|Phase II||0
498520|NCT01016483|1218662|P1|NOT COMPLETED|Phase II||0
498521|NCT01016483|1218659|P4|COMPLETED|Phase II||44
498522|NCT01016483|1218660|P3|COMPLETED|Phase II||44
498523|NCT01016483|1218661|P2|COMPLETED|Phase II||0
498524|NCT01016483|1218662|P1|COMPLETED|Phase II||0
498525|NCT01016483|1218659|P4|Treated (Safety Analysis Set [SAF])|Phase II|Subjects presented as treated (SAF).|45
498526|NCT01016483|1218660|P3|Treated (Safety Analysis Set [SAF])|Phase II|Subjects presented as treated (SAF).|42
498527|NCT01016483|1218661|P2|Treated (Safety Analysis Set [SAF])|Phase II||0
498528|NCT01016483|1218662|P1|Treated (Safety Analysis Set [SAF])|Phase II||0
498529|NCT01016483|1218659|P4|STARTED|Phase II|Subjects presented as randomized (ITT Analysis Set).|44
498530|NCT01016483|1218660|P3|STARTED|Phase II|Subjects presented as randomized (Intention-to-Treat [ITT] Analysis Set).|44
498531|NCT01016483|1218661|P2|STARTED|Phase II||0
498532|NCT01016483|1218662|P1|STARTED|Phase II||0
498533|NCT01016483|1218659|P4|NOT COMPLETED|Safety Run-in Part||0
498534|NCT01016483|1218660|P3|NOT COMPLETED|Safety Run-in Part||0
498535|NCT01016483|1218661|P2|NOT COMPLETED|Safety Run-in Part||0
498536|NCT01016483|1218662|P1|NOT COMPLETED|Safety Run-in Part||0
498537|NCT01016483|1218659|P4|COMPLETED|Safety Run-in Part||0
498538|NCT01016483|1218660|P3|COMPLETED|Safety Run-in Part||0
498539|NCT01016483|1218661|P2|COMPLETED|Safety Run-in Part||26
498540|NCT01016483|1218662|P1|COMPLETED|Safety Run-in Part||27
498541|NCT01016483|1218659|P4|STARTED|Safety Run-in Part||0
498542|NCT01016483|1218660|P3|STARTED|Safety Run-in Part||0
498543|NCT01016483|1218661|P2|STARTED|Safety Run-in Part||26
498544|NCT01016483|1218662|P1|STARTED|Safety Run-in Part||27
498545|NCT01016353|1218770|P2|NOT COMPLETED|Overall Study||1
498546|NCT01016353|1218771|P1|NOT COMPLETED|Overall Study||2
498547|NCT01016353|1218770|P2|COMPLETED|Overall Study||102
498548|NCT01016353|1218771|P1|COMPLETED|Overall Study||178
498549|NCT01016353|1218770|P2|STARTED|Overall Study||103
498550|NCT01016353|1218771|P1|STARTED|Overall Study||180
498551|NCT01016132|1218777|P1|NOT COMPLETED|Overall Study||1
498552|NCT01016132|1218777|P1|COMPLETED|Overall Study||151
498553|NCT01016132|1218777|P1|STARTED|Overall Study||152
498554|NCT01016106|1218783|P2|NOT COMPLETED|Overall Study||0
498555|NCT01016106|1218784|P1|NOT COMPLETED|Overall Study||0
498556|NCT01016106|1218783|P2|COMPLETED|Overall Study||18
498557|NCT01016106|1218784|P1|COMPLETED|Overall Study||17
498558|NCT01016106|1218783|P2|STARTED|Overall Study||18
498559|NCT01016106|1218784|P1|STARTED|Overall Study||17
498560|NCT01016067|1218792|P2|NOT COMPLETED|Overall Study||4
498561|NCT01016067|1218793|P1|NOT COMPLETED|Overall Study||2
498562|NCT01016067|1218792|P2|COMPLETED|Overall Study||8
498563|NCT01016067|1218793|P1|COMPLETED|Overall Study||9
498564|NCT01016067|1218792|P2|STARTED|Overall Study||12
498565|NCT01016067|1218793|P1|STARTED|Overall Study||11
498566|NCT01016015|1218811|P1|NOT COMPLETED|Overall Study||19
498567|NCT01016015|1218811|P1|COMPLETED|Overall Study||159
498568|NCT01016015|1218811|P1|STARTED|Overall Study||178
498569|NCT01015976|1218815|P2|NOT COMPLETED|Overall Study||0
498570|NCT01015976|1218816|P1|NOT COMPLETED|Overall Study||0
498571|NCT01015976|1218815|P2|COMPLETED|Overall Study||5
498572|NCT01015976|1218816|P1|COMPLETED|Overall Study||5
498573|NCT01015976|1218815|P2|STARTED|Overall Study||5
498574|NCT01015976|1218816|P1|STARTED|Overall Study||5
498575|NCT01015833|1218822|P2|NOT COMPLETED|Overall Study||5
498576|NCT01015833|1218823|P1|NOT COMPLETED|Overall Study||13
498577|NCT01015833|1218822|P2|COMPLETED|Overall Study||171
498578|NCT01015833|1218823|P1|COMPLETED|Overall Study||167
498579|NCT01015833|1218822|P2|STARTED|Overall Study||176
498580|NCT01015833|1218823|P1|STARTED|Overall Study||180
498581|NCT01015820|1218839|P2|NOT COMPLETED|Overall Study||0
498582|NCT01015820|1218840|P1|NOT COMPLETED|Overall Study||1
498583|NCT01015820|1218839|P2|COMPLETED|Overall Study||15
498584|NCT01015820|1218840|P1|COMPLETED|Overall Study||14
498585|NCT01015820|1218839|P2|STARTED|Overall Study||15
498586|NCT01015820|1218840|P1|STARTED|Overall Study||15
498587|NCT01015807|1218851|P3|NOT COMPLETED|Overall Study||0
498588|NCT01015807|1218852|P2|NOT COMPLETED|Overall Study||0
498589|NCT01015807|1218853|P1|NOT COMPLETED|Overall Study||0
498590|NCT01015807|1218851|P3|COMPLETED|Overall Study||30
498591|NCT01015807|1218852|P2|COMPLETED|Overall Study||30
498592|NCT01015807|1218853|P1|COMPLETED|Overall Study||30
498593|NCT01015807|1218851|P3|STARTED|Overall Study||30
498594|NCT01015807|1218852|P2|STARTED|Overall Study||30
498595|NCT01015807|1218853|P1|STARTED|Overall Study||30
498596|NCT01015781|1218863|P2|NOT COMPLETED|Overall Study||29
498597|NCT01015781|1218864|P1|NOT COMPLETED|Overall Study||37
498598|NCT01015781|1218863|P2|COMPLETED|Overall Study||121
498599|NCT01015781|1218864|P1|COMPLETED|Overall Study||113
498600|NCT01015781|1218863|P2|STARTED|Overall Study||150
498601|NCT01015781|1218864|P1|STARTED|Overall Study||150
498602|NCT01015703|1218875|P5|NOT COMPLETED|Overall Study||0
498603|NCT01015703|1218876|P4|NOT COMPLETED|Overall Study||0
498604|NCT01015703|1218877|P3|NOT COMPLETED|Overall Study||0
498605|NCT01015703|1218878|P2|NOT COMPLETED|Overall Study||1
498606|NCT01015703|1218879|P1|NOT COMPLETED|Overall Study||2
498607|NCT01015703|1218875|P5|COMPLETED|Overall Study||10
498608|NCT01015703|1218876|P4|COMPLETED|Overall Study||10
498609|NCT01015703|1218877|P3|COMPLETED|Overall Study||10
498610|NCT01015703|1218878|P2|COMPLETED|Overall Study||9
498611|NCT01015703|1218879|P1|COMPLETED|Overall Study||8
498612|NCT01015703|1218875|P5|STARTED|Overall Study||10
498613|NCT01015703|1218876|P4|STARTED|Overall Study||10
498614|NCT01015703|1218877|P3|STARTED|Overall Study||10
498615|NCT01015703|1218878|P2|STARTED|Overall Study||10
498616|NCT01015703|1218879|P1|STARTED|Overall Study||10
498617|NCT01015677|1218894|P3|NOT COMPLETED|Overall Study||0
498618|NCT01015677|1218895|P2|NOT COMPLETED|Overall Study||4
498619|NCT01015677|1218896|P1|NOT COMPLETED|Overall Study||1
498620|NCT01015677|1218894|P3|COMPLETED|Overall Study||33
498621|NCT01015677|1218895|P2|COMPLETED|Overall Study||28
498622|NCT01015677|1218896|P1|COMPLETED|Overall Study||33
498623|NCT01015677|1218894|P3|STARTED|Overall Study||33
498624|NCT01015677|1218895|P2|STARTED|Overall Study||32
498625|NCT01015677|1218896|P1|STARTED|Overall Study||34
498626|NCT01015638|1218918|P2|NOT COMPLETED|Overall Study||0
498627|NCT01015638|1218919|P1|NOT COMPLETED|Overall Study||1
498628|NCT01015638|1218918|P2|COMPLETED|Overall Study||19
498629|NCT01015638|1218919|P1|COMPLETED|Overall Study||16
498630|NCT01015638|1218918|P2|STARTED|Overall Study||19
498631|NCT01015638|1218919|P1|STARTED|Overall Study||17
498632|NCT01015560|1218947|P1|NOT COMPLETED|Overall Study||3
498633|NCT01015560|1218947|P1|COMPLETED|Overall Study||41
498634|NCT01015560|1218947|P1|Eligible and Analyzable|Overall Study||43
498635|NCT01015560|1218947|P1|STARTED|Overall Study||44
498636|NCT01015534|1218953|P2|NOT COMPLETED|Overall Study||0
498637|NCT01015534|1218954|P1|NOT COMPLETED|Overall Study||1
498638|NCT01015534|1218953|P2|COMPLETED|Overall Study||27
498639|NCT01015534|1218954|P1|COMPLETED|Overall Study||27
498640|NCT01015534|1218953|P2|STARTED|Overall Study||27
498641|NCT01015534|1218954|P1|STARTED|Overall Study||28
498642|NCT01015443|1218968|P2|NOT COMPLETED|Overall Study||0
498643|NCT01015443|1218969|P1|NOT COMPLETED|Overall Study||0
498644|NCT01015443|1218968|P2|COMPLETED|Overall Study||94
498645|NCT01015443|1218969|P1|COMPLETED|Overall Study||191
498646|NCT01015443|1218968|P2|Treated|Overall Study||93
498647|NCT01015443|1218969|P1|Treated|Overall Study||191
498648|NCT01015443|1218968|P2|STARTED|Overall Study||94
498649|NCT01015443|1218969|P1|STARTED|Overall Study||191
498650|NCT01015326|1218987|P2|NOT COMPLETED|Overall Study||2
498651|NCT01015326|1218988|P1|NOT COMPLETED|Overall Study||1
498652|NCT01015326|1218987|P2|COMPLETED|Overall Study||18
498653|NCT01015326|1218988|P1|COMPLETED|Overall Study||11
498654|NCT01015326|1218987|P2|STARTED|Overall Study||20
498655|NCT01015326|1218988|P1|STARTED|Overall Study||12
498656|NCT01015287|1218996|P2|NOT COMPLETED|Overall Study||79
498657|NCT01015287|1218997|P1|NOT COMPLETED|Overall Study||72
498658|NCT01015287|1218996|P2|COMPLETED|Overall Study||1958
498659|NCT01015287|1218997|P1|COMPLETED|Overall Study||1924
498660|NCT01015287|1218996|P2|Received at Least 1 Dose of Study Drug|Overall Study||2037
498661|NCT01015287|1218997|P1|Received at Least 1 Dose of Study Drug|Overall Study||1996
498662|NCT01015287|1218996|P2|STARTED|Overall Study||2037
498663|NCT01015287|1218997|P1|STARTED|Overall Study||1996
498664|NCT01015170|1219023|P1|NOT COMPLETED|Overall Study||239
498665|NCT01015170|1219023|P1|COMPLETED|Overall Study||215
498666|NCT01015170|1219023|P1|STARTED|Overall Study||454
498667|NCT01015131|1219029|P1|NOT COMPLETED|Overall Study||8
498668|NCT01015131|1219029|P1|COMPLETED|Overall Study||36
498669|NCT01015131|1219029|P1|STARTED|Overall Study||44
498670|NCT01015118|1219045|P2|NOT COMPLETED|Overall Study||327
498671|NCT01015118|1219046|P1|NOT COMPLETED|Overall Study||669
498672|NCT01015118|1219045|P2|COMPLETED|Overall Study|Patients who completed max trial therapy duration.|128
498673|NCT01015118|1219046|P1|COMPLETED|Overall Study|Patients who completed max trial therapy duration.|242
498674|NCT01015118|1219045|P2|STARTED|Overall Study||455
498675|NCT01015118|1219046|P1|STARTED|Overall Study||911
498676|NCT01014988|1219074|P6|NOT COMPLETED|Overall Study||3
498677|NCT01014988|1219075|P5|NOT COMPLETED|Overall Study||1
498678|NCT01014988|1219076|P4|NOT COMPLETED|Overall Study||0
498679|NCT01014988|1219077|P3|NOT COMPLETED|Overall Study||2
498680|NCT01014988|1219078|P2|NOT COMPLETED|Overall Study||0
498681|NCT01014988|1219079|P1|NOT COMPLETED|Overall Study||23
498682|NCT01014988|1219074|P6|COMPLETED|Overall Study||11
498683|NCT01014988|1219075|P5|COMPLETED|Overall Study||26
498684|NCT01014988|1219076|P4|COMPLETED|Overall Study||12
498685|NCT01014988|1219077|P3|COMPLETED|Overall Study||9
498686|NCT01014988|1219078|P2|COMPLETED|Overall Study||7
498687|NCT01014988|1219079|P1|COMPLETED|Overall Study||107
498688|NCT01014988|1219074|P6|STARTED|Overall Study||14
498689|NCT01014988|1219075|P5|STARTED|Overall Study||27
498690|NCT01014988|1219076|P4|STARTED|Overall Study||12
498691|NCT01014988|1219077|P3|STARTED|Overall Study||11
498692|NCT01014988|1219078|P2|STARTED|Overall Study||7
498693|NCT01014988|1219079|P1|STARTED|Overall Study||130
498694|NCT01014975|1219251|P3|NOT COMPLETED|Overall Study||6
498695|NCT01014975|1219252|P2|NOT COMPLETED|Overall Study||3
498696|NCT01014975|1219253|P1|NOT COMPLETED|Overall Study||4
498697|NCT01014975|1219251|P3|COMPLETED|Overall Study||10
498698|NCT01014975|1219252|P2|COMPLETED|Overall Study||13
498699|NCT01014975|1219253|P1|COMPLETED|Overall Study||4
498700|NCT01014975|1219251|P3|STARTED|Overall Study||16
498701|NCT01014975|1219252|P2|STARTED|Overall Study||16
498702|NCT01014975|1219253|P1|STARTED|Overall Study||8
498703|NCT01014936|1219264|P3|NOT COMPLETED|Overall Study||0
498704|NCT01014936|1219265|P2|NOT COMPLETED|Overall Study||0
498705|NCT01014936|1219266|P1|NOT COMPLETED|Overall Study||0
498706|NCT01014936|1219264|P3|COMPLETED|Overall Study||62
498707|NCT01014936|1219265|P2|COMPLETED|Overall Study||45
498708|NCT01014936|1219266|P1|COMPLETED|Overall Study||42
498709|NCT01014936|1219264|P3|STARTED|Overall Study||62
498710|NCT01014936|1219265|P2|STARTED|Overall Study||45
498711|NCT01014936|1219266|P1|STARTED|Overall Study||42
498712|NCT01014910|1219758|P2|NOT COMPLETED|Overall Study||2
498713|NCT01014910|1219759|P1|NOT COMPLETED|Overall Study||0
498714|NCT01014910|1219758|P2|COMPLETED|Overall Study||79
498715|NCT01014910|1219759|P1|COMPLETED|Overall Study||80
498716|NCT01014910|1219758|P2|STARTED|Overall Study||81
498717|NCT01014910|1219759|P1|STARTED|Overall Study||80
498718|NCT01014871|1219767|P1|NOT COMPLETED|Overall Study||0
498719|NCT01014871|1219767|P1|COMPLETED|Overall Study||30
498720|NCT01014871|1219767|P1|STARTED|Overall Study||30
498721|NCT01014741|1219775|P2|NOT COMPLETED|Overall Study||5
498722|NCT01014741|1219776|P1|NOT COMPLETED|Overall Study||11
498723|NCT01014741|1219775|P2|COMPLETED|Overall Study||90
498724|NCT01014741|1219776|P1|COMPLETED|Overall Study||94
498725|NCT01014741|1219775|P2|STARTED|Overall Study||95
498726|NCT01014741|1219776|P1|STARTED|Overall Study||105
498727|NCT01014728|1219790|P2|NOT COMPLETED|Overall Study||0
498728|NCT01014728|1219791|P1|NOT COMPLETED|Overall Study||0
498729|NCT01014728|1219790|P2|COMPLETED|Overall Study||15
498730|NCT01014728|1219791|P1|COMPLETED|Overall Study||18
498731|NCT01014728|1219790|P2|STARTED|Overall Study||15
498732|NCT01014728|1219791|P1|STARTED|Overall Study||18
498733|NCT01014689|1219803|P2|NOT COMPLETED|Overall Study||13
498734|NCT01014689|1219804|P1|NOT COMPLETED|Overall Study||13
498735|NCT01014689|1219803|P2|COMPLETED|Overall Study||174
498736|NCT01014689|1219804|P1|COMPLETED|Overall Study||178
498737|NCT01014689|1219803|P2|STARTED|Overall Study||187
498738|NCT01014689|1219804|P1|STARTED|Overall Study||191
498739|NCT01014624|1219814|P2|NOT COMPLETED|Overall Study||1
498740|NCT01014624|1219815|P1|NOT COMPLETED|Overall Study||2
498741|NCT01014624|1219814|P2|COMPLETED|Overall Study||26
498742|NCT01014624|1219815|P1|COMPLETED|Overall Study||27
498743|NCT01014624|1219814|P2|STARTED|Overall Study||27
498744|NCT01014624|1219815|P1|STARTED|Overall Study||29
498745|NCT01014585|1219839|P4|NOT COMPLETED|Overall Study||30
498746|NCT01014585|1219840|P3|NOT COMPLETED|Overall Study||23
498747|NCT01014585|1219841|P2|NOT COMPLETED|Overall Study||25
498748|NCT01014585|1219842|P1|NOT COMPLETED|Overall Study||20
498749|NCT01014585|1219839|P4|COMPLETED|Overall Study||99
498750|NCT01014585|1219840|P3|COMPLETED|Overall Study||37
498751|NCT01014585|1219841|P2|COMPLETED|Overall Study||75
498752|NCT01014585|1219842|P1|COMPLETED|Overall Study||31
498753|NCT01014585|1219839|P4|STARTED|Overall Study||129
498754|NCT01014585|1219840|P3|STARTED|Overall Study||60
498755|NCT01014585|1219841|P2|STARTED|Overall Study||100
498756|NCT01014585|1219842|P1|STARTED|Overall Study||51
498757|NCT01014533|1219862|P2|NOT COMPLETED|Overall Study||5
498758|NCT01014533|1219863|P1|NOT COMPLETED|Overall Study||5
498759|NCT01014533|1219862|P2|COMPLETED|Overall Study||25
498760|NCT01014533|1219863|P1|COMPLETED|Overall Study||24
498761|NCT01014533|1219862|P2|STARTED|Overall Study||30
498762|NCT01014533|1219863|P1|STARTED|Overall Study||29
498763|NCT01014455|1219875|P2|NOT COMPLETED|Overall Study||0
498764|NCT01014455|1219876|P1|NOT COMPLETED|Overall Study||0
498765|NCT01014455|1219875|P2|COMPLETED|Overall Study||87
498766|NCT01014455|1219876|P1|COMPLETED|Overall Study||82
498767|NCT01014455|1219875|P2|STARTED|Overall Study||87
498768|NCT01014455|1219876|P1|STARTED|Overall Study||82
498769|NCT01014442|1219884|P2|NOT COMPLETED|Overall Study||19
498770|NCT01014442|1219885|P1|NOT COMPLETED|Overall Study||7
498771|NCT01014442|1219884|P2|COMPLETED|Overall Study||16
498772|NCT01014442|1219885|P1|COMPLETED|Overall Study||26
498773|NCT01014442|1219884|P2|STARTED|Overall Study||35
498774|NCT01014442|1219885|P1|STARTED|Overall Study||33
498775|NCT01014351|1219997|P1|NOT COMPLETED|Overall Study||37
498776|NCT01014351|1219997|P1|COMPLETED|Overall Study||33
498777|NCT01014351|1219997|P1|STARTED|Overall Study||70
498778|NCT01014208|1220005|P2|NOT COMPLETED|Overall Study||100
498779|NCT01014208|1220006|P1|NOT COMPLETED|Overall Study||94
498780|NCT01014208|1220005|P2|COMPLETED|Overall Study||122
498781|NCT01014208|1220006|P1|COMPLETED|Overall Study||131
498782|NCT01014208|1220005|P2|Intent-to-Treat Population|Overall Study||222
498783|NCT01014208|1220006|P1|Intent-to-Treat Population|Overall Study||223
498784|NCT01014208|1220005|P2|STARTED|Overall Study||222
498785|NCT01014208|1220006|P1|STARTED|Overall Study||225
498786|NCT01014169|1220034|P2|NOT COMPLETED|Overall Study||13
498787|NCT01014169|1220035|P1|NOT COMPLETED|Overall Study||7
498788|NCT01014169|1220034|P2|COMPLETED|Overall Study||48
498789|NCT01014169|1220035|P1|COMPLETED|Overall Study||58
498790|NCT01014169|1220034|P2|STARTED|Overall Study||61
498791|NCT01014169|1220035|P1|STARTED|Overall Study||65
498792|NCT01014143|1220048|P3|NOT COMPLETED|Third Intervention||0
498793|NCT01014143|1220049|P2|NOT COMPLETED|Third Intervention||0
498794|NCT01014143|1220050|P1|NOT COMPLETED|Third Intervention||0
498795|NCT01014143|1220048|P3|COMPLETED|Third Intervention||9
498796|NCT01014143|1220049|P2|COMPLETED|Third Intervention||9
498797|NCT01014143|1220050|P1|COMPLETED|Third Intervention||8
498798|NCT01014143|1220048|P3|STARTED|Third Intervention||9
498799|NCT01014143|1220049|P2|STARTED|Third Intervention||9
498800|NCT01014143|1220050|P1|STARTED|Third Intervention||8
498801|NCT01014143|1220048|P3|NOT COMPLETED|Washout After 2nd Intervention||0
498802|NCT01014143|1220049|P2|NOT COMPLETED|Washout After 2nd Intervention||0
498803|NCT01014143|1220050|P1|NOT COMPLETED|Washout After 2nd Intervention||0
498804|NCT01014143|1220048|P3|COMPLETED|Washout After 2nd Intervention||9
498805|NCT01014143|1220049|P2|COMPLETED|Washout After 2nd Intervention||9
498806|NCT01014143|1220050|P1|COMPLETED|Washout After 2nd Intervention||8
498807|NCT01014143|1220048|P3|STARTED|Washout After 2nd Intervention||9
498808|NCT01014143|1220049|P2|STARTED|Washout After 2nd Intervention||9
498809|NCT01014143|1220050|P1|STARTED|Washout After 2nd Intervention||8
498810|NCT01014143|1220048|P3|NOT COMPLETED|Second Intervention||0
498811|NCT01014143|1220049|P2|NOT COMPLETED|Second Intervention||0
498812|NCT01014143|1220050|P1|NOT COMPLETED|Second Intervention||2
498813|NCT01014143|1220048|P3|COMPLETED|Second Intervention||9
498814|NCT01014143|1220049|P2|COMPLETED|Second Intervention||9
498815|NCT01014143|1220050|P1|COMPLETED|Second Intervention||8
498816|NCT01014143|1220048|P3|STARTED|Second Intervention||9
498817|NCT01014143|1220049|P2|STARTED|Second Intervention||9
498818|NCT01014143|1220050|P1|STARTED|Second Intervention||10
498819|NCT01014143|1220048|P3|NOT COMPLETED|Washout Period After 1st Intervention||0
498820|NCT01014143|1220049|P2|NOT COMPLETED|Washout Period After 1st Intervention||0
498821|NCT01014143|1220050|P1|NOT COMPLETED|Washout Period After 1st Intervention||0
498822|NCT01014143|1220048|P3|COMPLETED|Washout Period After 1st Intervention||9
498823|NCT01014143|1220049|P2|COMPLETED|Washout Period After 1st Intervention||9
498824|NCT01014143|1220050|P1|COMPLETED|Washout Period After 1st Intervention||10
498825|NCT01014143|1220048|P3|STARTED|Washout Period After 1st Intervention||9
498826|NCT01014143|1220049|P2|STARTED|Washout Period After 1st Intervention||9
498827|NCT01014143|1220050|P1|STARTED|Washout Period After 1st Intervention||10
498828|NCT01014143|1220048|P3|NOT COMPLETED|First Intervention||0
498829|NCT01014143|1220049|P2|NOT COMPLETED|First Intervention||0
498830|NCT01014143|1220050|P1|NOT COMPLETED|First Intervention||0
498831|NCT01014143|1220048|P3|COMPLETED|First Intervention||9
498832|NCT01014143|1220049|P2|COMPLETED|First Intervention||9
498833|NCT01014143|1220050|P1|COMPLETED|First Intervention||10
498834|NCT01014143|1220048|P3|STARTED|First Intervention||9
498835|NCT01014143|1220049|P2|STARTED|First Intervention||9
498836|NCT01014143|1220050|P1|STARTED|First Intervention||10
498837|NCT01014091|1220064|P6|NOT COMPLETED|Overall Study||0
498838|NCT01014091|1220065|P5|NOT COMPLETED|Overall Study||0
498839|NCT01014091|1220066|P4|NOT COMPLETED|Overall Study||0
498840|NCT01014091|1220067|P3|NOT COMPLETED|Overall Study||0
498841|NCT01014091|1220068|P2|NOT COMPLETED|Overall Study||0
498842|NCT01014091|1220069|P1|NOT COMPLETED|Overall Study||0
498843|NCT01014091|1220064|P6|COMPLETED|Overall Study||12
498844|NCT01014091|1220065|P5|COMPLETED|Overall Study||6
498845|NCT01014091|1220066|P4|COMPLETED|Overall Study||15
498846|NCT01014091|1220067|P3|COMPLETED|Overall Study||5
498847|NCT01014091|1220068|P2|COMPLETED|Overall Study||13
498848|NCT01014091|1220069|P1|COMPLETED|Overall Study||7
498849|NCT01014091|1220064|P6|STARTED|Overall Study||12
498850|NCT01014091|1220065|P5|STARTED|Overall Study||6
498851|NCT01014091|1220066|P4|STARTED|Overall Study||15
498852|NCT01014091|1220067|P3|STARTED|Overall Study||5
498853|NCT01014091|1220068|P2|STARTED|Overall Study||13
498854|NCT01014091|1220069|P1|STARTED|Overall Study||7
498855|NCT01014013|1220145|P2|NOT COMPLETED|Overall Study||56
498856|NCT01014013|1220146|P1|NOT COMPLETED|Overall Study||51
498857|NCT01014013|1220145|P2|COMPLETED|Overall Study|Patients who completed 7 days therapy including minimum 3 days of Ceftriaxone parentheral therapy|80
498858|NCT01014013|1220146|P1|COMPLETED|Overall Study|Patients who completed 7 days therapy including minimum 3 days of MK0826 parentheral therapy|84
498859|NCT01014013|1220145|P2|Completed Parenteral Therapy|Overall Study|Patients completing Ceftriaxone as a single daily dose of 2.0g intravenous infusion at least 3 days|88
498860|NCT01014013|1220146|P1|Completed Parenteral Therapy|Overall Study|"Patients completing MK0826 as a single daily dose of 1.0g intravenous~infusion at least 3 days"|87
498861|NCT01014013|1220145|P2|Adverse Event Reporting|Overall Study|Patients who received at least 1 dose of Ceftriaxone parenteral therapy|135
498862|NCT01014013|1220146|P1|Adverse Event Reporting|Overall Study|Patients who received at least 1 dose of MK0826 parenteral therapy|132
498863|NCT01014013|1220145|P2|STARTED|Overall Study||136
498864|NCT01014013|1220146|P1|STARTED|Overall Study||135
498865|NCT01013961|1220158|P2|NOT COMPLETED|Overall Study||3
498866|NCT01013961|1220159|P1|NOT COMPLETED|Overall Study||3
498867|NCT01013961|1220158|P2|COMPLETED|Overall Study||12
498868|NCT01013961|1220159|P1|COMPLETED|Overall Study||13
498869|NCT01013961|1220158|P2|STARTED|Overall Study||15
498870|NCT01013961|1220159|P1|STARTED|Overall Study||16
498871|NCT01013883|1220177|P2|NOT COMPLETED|Overall Study||2
498872|NCT01013883|1220178|P1|NOT COMPLETED|Overall Study||2
498873|NCT01013883|1220177|P2|COMPLETED|Overall Study||241
498874|NCT01013883|1220178|P1|COMPLETED|Overall Study||268
498875|NCT01013883|1220177|P2|STARTED|Overall Study||243
498876|NCT01013883|1220178|P1|STARTED|Overall Study||270
498877|NCT01013870|1220190|P2|NOT COMPLETED|Overall Study||3
498878|NCT01013870|1220191|P1|NOT COMPLETED|Overall Study||1
498879|NCT01013870|1220190|P2|COMPLETED|Overall Study||21
498880|NCT01013870|1220191|P1|COMPLETED|Overall Study||27
498881|NCT01013870|1220190|P2|STARTED|Overall Study||24
498882|NCT01013870|1220191|P1|STARTED|Overall Study||28
498883|NCT01013844|1220215|P2|NOT COMPLETED|Overall Study||0
498884|NCT01013844|1220216|P1|NOT COMPLETED|Overall Study||0
498885|NCT01013844|1220215|P2|COMPLETED|Overall Study||65
498886|NCT01013844|1220216|P1|COMPLETED|Overall Study||65
498887|NCT01013844|1220215|P2|STARTED|Overall Study||65
498888|NCT01013844|1220216|P1|STARTED|Overall Study||65
498889|NCT01013792|1220240|P2|NOT COMPLETED|Overall Study||5
498890|NCT01013792|1220241|P1|NOT COMPLETED|Overall Study||2
498891|NCT01013792|1220240|P2|COMPLETED|Overall Study||11
498892|NCT01013792|1220241|P1|COMPLETED|Overall Study||12
498893|NCT01013792|1220240|P2|STARTED|Overall Study||16
498894|NCT01013792|1220241|P1|STARTED|Overall Study||14
498895|NCT01013753|1220247|P1|NOT COMPLETED|Overall Study||16
498896|NCT01013753|1220247|P1|COMPLETED|Overall Study||182
498897|NCT01013753|1220247|P1|Received Form 12 mcg Bid|Overall Study||125
498898|NCT01013753|1220247|P1|Received Olo 20 mcg qd|Overall Study||124
498899|NCT01013753|1220247|P1|Received Olo 10 mcg qd|Overall Study||127
498900|NCT01013753|1220247|P1|Received Olo 5 mcg qd|Overall Study||130
498901|NCT01013753|1220247|P1|Received Olo 2 mcg qd|Overall Study||121
498902|NCT01013753|1220247|P1|Received Placebo|Overall Study||125
498903|NCT01013753|1220247|P1|STARTED|Overall Study|Entered and treated|198
498904|NCT01013740|1220443|P2|NOT COMPLETED|Overall Study||19
498905|NCT01013740|1220444|P1|NOT COMPLETED|Overall Study||11
498906|NCT01013740|1220443|P2|COMPLETED|Overall Study|Completion also = 18 mos.of a new anti-cancer therapy initiation +/or progression of disease|56
498907|NCT01013740|1220444|P1|COMPLETED|Overall Study|Completion also = 18 mos.of a new anti-cancer therapy initiation +/or progression of disease|26
498908|NCT01013740|1220443|P2|Ongoing|Overall Study||0
498909|NCT01013740|1220444|P1|Ongoing|Overall Study||0
498910|NCT01013740|1220443|P2|STARTED|Overall Study|29 participants experiencing PD in the RP elected to enroll in the optional CP.|75
498911|NCT01013740|1220444|P1|STARTED|Overall Study|13 participants (par.) experiencing PD in the RP elected to enroll in the optional CP.|37
498912|NCT01013701|1220468|P1|NOT COMPLETED|Overall Study||7
498913|NCT01013701|1220468|P1|COMPLETED|Overall Study||0
498914|NCT01013701|1220468|P1|STARTED|Overall Study||7
498915|NCT01013597|1220475|P1|NOT COMPLETED|Overall Study||1
498916|NCT01013597|1220475|P1|COMPLETED|Overall Study||12
498917|NCT01013597|1220475|P1|STARTED|Overall Study||13
498918|NCT01013207|1220485|P1|NOT COMPLETED|CPAP Post Nexus (S9)||6
498919|NCT01013207|1220485|P1|COMPLETED|CPAP Post Nexus (S9)||44
498920|NCT01013207|1220485|P1|STARTED|CPAP Post Nexus (S9)||50
498921|NCT01013207|1220485|P1|NOT COMPLETED|Nexus (S9)||0
498922|NCT01013207|1220485|P1|COMPLETED|Nexus (S9)||50
498923|NCT01013207|1220485|P1|STARTED|Nexus (S9)||50
498924|NCT01013207|1220485|P1|NOT COMPLETED|CPAP Pre Nexus (S9)||0
498925|NCT01013207|1220485|P1|COMPLETED|CPAP Pre Nexus (S9)||50
498926|NCT01013207|1220485|P1|STARTED|CPAP Pre Nexus (S9)||50
498927|NCT01013194|1220492|P2|NOT COMPLETED|Overall Study||0
498928|NCT01013194|1220493|P1|NOT COMPLETED|Overall Study||0
498929|NCT01013194|1220492|P2|COMPLETED|Overall Study|Retrospectively contemporary matched-pair group|16
498930|NCT01013194|1220493|P1|COMPLETED|Overall Study|Consecutive patients|9
498931|NCT01013194|1220492|P2|STARTED|Overall Study||16
498932|NCT01013194|1220493|P1|STARTED|Overall Study||9
498933|NCT01012999|1220503|P1|NOT COMPLETED|Overall Study||1
498934|NCT01012999|1220503|P1|COMPLETED|Overall Study||15
498935|NCT01012999|1220503|P1|STARTED|Overall Study||16
498936|NCT01012973|1220509|P2|NOT COMPLETED|Overall Study||19
498937|NCT01012973|1220510|P1|NOT COMPLETED|Overall Study||16
498938|NCT01012973|1220509|P2|COMPLETED|Overall Study||52
498939|NCT01012973|1220510|P1|COMPLETED|Overall Study||90
498940|NCT01012973|1220509|P2|Completed Week 52, From FAS|Overall Study||52
498941|NCT01012973|1220510|P1|Completed Week 52, From FAS|Overall Study||91
498942|NCT01012973|1220509|P2|Completed Week 24, From FAS|Overall Study||57
498943|NCT01012973|1220510|P1|Completed Week 24, From FAS|Overall Study||97
498944|NCT01012973|1220509|P2|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) Population: Participants received treatment with post baseline measurements|68
498945|NCT01012973|1220510|P1|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) Population: Participants received treatment with post baseline measurements|103
498946|NCT01012973|1220509|P2|Participants Received Treatment|Overall Study|Safety Population: Participants received treatment|68
498947|NCT01012973|1220510|P1|Participants Received Treatment|Overall Study|Safety Population: Participants received treatment|104
498948|NCT01012973|1220509|P2|STARTED|Overall Study||71
498949|NCT01012973|1220510|P1|STARTED|Overall Study||106
498950|NCT01012947|1220535|P5|NOT COMPLETED|Overall Study||142
498951|NCT01012947|1220536|P4|NOT COMPLETED|Overall Study||118
498952|NCT01012947|1220537|P3|NOT COMPLETED|Overall Study||130
498953|NCT01012947|1220538|P2|NOT COMPLETED|Overall Study||135
498954|NCT01012947|1220539|P1|NOT COMPLETED|Overall Study||131
498955|NCT01012947|1220535|P5|COMPLETED|Overall Study||94
498956|NCT01012947|1220536|P4|COMPLETED|Overall Study||93
498957|NCT01012947|1220537|P3|COMPLETED|Overall Study||111
498958|NCT01012947|1220538|P2|COMPLETED|Overall Study||80
498959|NCT01012947|1220539|P1|COMPLETED|Overall Study||81
498960|NCT01012947|1220535|P5|STARTED|Overall Study||236
498961|NCT01012947|1220536|P4|STARTED|Overall Study||211
498962|NCT01012947|1220537|P3|STARTED|Overall Study||241
498963|NCT01012947|1220538|P2|STARTED|Overall Study||215
498964|NCT01012947|1220539|P1|STARTED|Overall Study||212
498965|NCT01012921|1220553|P2|NOT COMPLETED|Overall Study||13
498966|NCT01012921|1220554|P1|NOT COMPLETED|Overall Study||10
498967|NCT01012921|1220553|P2|COMPLETED|Overall Study||47
498968|NCT01012921|1220554|P1|COMPLETED|Overall Study||47
498969|NCT01012921|1220553|P2|STARTED|Overall Study||60
498970|NCT01012921|1220554|P1|STARTED|Overall Study||57
498971|NCT01012765|1220560|P6|NOT COMPLETED|Treatment Period 3||0
498972|NCT01012765|1220561|P5|NOT COMPLETED|Treatment Period 3||0
498973|NCT01012765|1220562|P4|NOT COMPLETED|Treatment Period 3||0
498974|NCT01012765|1220563|P3|NOT COMPLETED|Treatment Period 3||0
498975|NCT01012765|1220564|P2|NOT COMPLETED|Treatment Period 3||0
498976|NCT01012765|1220565|P1|NOT COMPLETED|Treatment Period 3||0
498977|NCT01012765|1220560|P6|COMPLETED|Treatment Period 3||24
498978|NCT01012765|1220561|P5|COMPLETED|Treatment Period 3||18
498979|NCT01012765|1220562|P4|COMPLETED|Treatment Period 3||15
498980|NCT01012765|1220563|P3|COMPLETED|Treatment Period 3||18
498981|NCT01012765|1220564|P2|COMPLETED|Treatment Period 3||19
498982|NCT01012765|1220565|P1|COMPLETED|Treatment Period 3||16
498983|NCT01012765|1220560|P6|STARTED|Treatment Period 3||24
498984|NCT01012765|1220561|P5|STARTED|Treatment Period 3||18
498985|NCT01012765|1220562|P4|STARTED|Treatment Period 3||15
498986|NCT01012765|1220563|P3|STARTED|Treatment Period 3||18
498987|NCT01012765|1220564|P2|STARTED|Treatment Period 3||19
498988|NCT01012765|1220565|P1|STARTED|Treatment Period 3||16
498989|NCT01012765|1220560|P6|NOT COMPLETED|Treatment Period 2||1
498990|NCT01012765|1220561|P5|NOT COMPLETED|Treatment Period 2||1
498991|NCT01012765|1220562|P4|NOT COMPLETED|Treatment Period 2||0
498992|NCT01012765|1220563|P3|NOT COMPLETED|Treatment Period 2||3
498993|NCT01012765|1220564|P2|NOT COMPLETED|Treatment Period 2||2
498994|NCT01012765|1220565|P1|NOT COMPLETED|Treatment Period 2||1
498995|NCT01012765|1220560|P6|COMPLETED|Treatment Period 2||24
498996|NCT01012765|1220561|P5|COMPLETED|Treatment Period 2||18
498997|NCT01012765|1220562|P4|COMPLETED|Treatment Period 2||15
498998|NCT01012765|1220563|P3|COMPLETED|Treatment Period 2||18
498999|NCT01012765|1220564|P2|COMPLETED|Treatment Period 2||19
499000|NCT01012765|1220565|P1|COMPLETED|Treatment Period 2||16
499001|NCT01012765|1220560|P6|STARTED|Treatment Period 2||25
499002|NCT01012765|1220561|P5|STARTED|Treatment Period 2||19
499003|NCT01012765|1220562|P4|STARTED|Treatment Period 2||15
499004|NCT01012765|1220563|P3|STARTED|Treatment Period 2||21
499005|NCT01012765|1220564|P2|STARTED|Treatment Period 2||21
499006|NCT01012765|1220565|P1|STARTED|Treatment Period 2||17
499007|NCT01012765|1220560|P6|NOT COMPLETED|Treatment Period 1||0
499008|NCT01012765|1220561|P5|NOT COMPLETED|Treatment Period 1||3
499009|NCT01012765|1220562|P4|NOT COMPLETED|Treatment Period 1||3
499010|NCT01012765|1220563|P3|NOT COMPLETED|Treatment Period 1||2
499011|NCT01012765|1220564|P2|NOT COMPLETED|Treatment Period 1||0
499012|NCT01012765|1220565|P1|NOT COMPLETED|Treatment Period 1||3
499013|NCT01012765|1220560|P6|COMPLETED|Treatment Period 1||25
499014|NCT01012765|1220561|P5|COMPLETED|Treatment Period 1||19
499015|NCT01012765|1220562|P4|COMPLETED|Treatment Period 1||15
499016|NCT01012765|1220563|P3|COMPLETED|Treatment Period 1||21
499017|NCT01012765|1220564|P2|COMPLETED|Treatment Period 1||21
499018|NCT01012765|1220565|P1|COMPLETED|Treatment Period 1||17
499019|NCT01012765|1220560|P6|STARTED|Treatment Period 1||25
499020|NCT01012765|1220561|P5|STARTED|Treatment Period 1||22
499021|NCT01012765|1220562|P4|STARTED|Treatment Period 1||18
499022|NCT01012765|1220563|P3|STARTED|Treatment Period 1||23
499023|NCT01012765|1220564|P2|STARTED|Treatment Period 1||21
499024|NCT01012765|1220565|P1|STARTED|Treatment Period 1||20
499025|NCT01012739|1220594|P4|NOT COMPLETED|Treatment Period 4||0
499026|NCT01012739|1220595|P3|NOT COMPLETED|Treatment Period 4||0
499027|NCT01012739|1220596|P2|NOT COMPLETED|Treatment Period 4||0
499028|NCT01012739|1220597|P1|NOT COMPLETED|Treatment Period 4||0
499029|NCT01012739|1220594|P4|COMPLETED|Treatment Period 4||7
499030|NCT01012739|1220595|P3|COMPLETED|Treatment Period 4||9
499031|NCT01012739|1220596|P2|COMPLETED|Treatment Period 4||8
499032|NCT01012739|1220597|P1|COMPLETED|Treatment Period 4||9
499033|NCT01012739|1220594|P4|STARTED|Treatment Period 4||7
499034|NCT01012739|1220595|P3|STARTED|Treatment Period 4||9
499035|NCT01012739|1220596|P2|STARTED|Treatment Period 4||8
499036|NCT01012739|1220597|P1|STARTED|Treatment Period 4||9
499037|NCT01012739|1220594|P4|NOT COMPLETED|Treatment Period 3||0
499038|NCT01012739|1220595|P3|NOT COMPLETED|Treatment Period 3||0
499039|NCT01012739|1220596|P2|NOT COMPLETED|Treatment Period 3||0
499040|NCT01012739|1220597|P1|NOT COMPLETED|Treatment Period 3||0
499041|NCT01012739|1220594|P4|COMPLETED|Treatment Period 3||7
499042|NCT01012739|1220595|P3|COMPLETED|Treatment Period 3||9
499043|NCT01012739|1220596|P2|COMPLETED|Treatment Period 3||8
499044|NCT01012739|1220597|P1|COMPLETED|Treatment Period 3||9
499045|NCT01012739|1220594|P4|STARTED|Treatment Period 3||7
499046|NCT01012739|1220595|P3|STARTED|Treatment Period 3||9
499047|NCT01012739|1220596|P2|STARTED|Treatment Period 3||8
499048|NCT01012739|1220597|P1|STARTED|Treatment Period 3||9
499049|NCT01012739|1220594|P4|NOT COMPLETED|Treatment Period 2||1
499050|NCT01012739|1220595|P3|NOT COMPLETED|Treatment Period 2||0
499051|NCT01012739|1220596|P2|NOT COMPLETED|Treatment Period 2||0
499052|NCT01012739|1220597|P1|NOT COMPLETED|Treatment Period 2||0
499053|NCT01012739|1220594|P4|COMPLETED|Treatment Period 2||7
499054|NCT01012739|1220595|P3|COMPLETED|Treatment Period 2||9
499055|NCT01012739|1220596|P2|COMPLETED|Treatment Period 2||8
499056|NCT01012739|1220597|P1|COMPLETED|Treatment Period 2||9
499057|NCT01012739|1220594|P4|STARTED|Treatment Period 2||8
499058|NCT01012739|1220595|P3|STARTED|Treatment Period 2||9
499059|NCT01012739|1220596|P2|STARTED|Treatment Period 2||8
499060|NCT01012739|1220597|P1|STARTED|Treatment Period 2||9
499061|NCT01012739|1220594|P4|NOT COMPLETED|Treatment Period 1||1
499062|NCT01012739|1220595|P3|NOT COMPLETED|Treatment Period 1||0
499063|NCT01012739|1220596|P2|NOT COMPLETED|Treatment Period 1||0
499064|NCT01012739|1220597|P1|NOT COMPLETED|Treatment Period 1||0
499065|NCT01012739|1220594|P4|COMPLETED|Treatment Period 1||8
499066|NCT01012739|1220595|P3|COMPLETED|Treatment Period 1||9
499067|NCT01012739|1220596|P2|COMPLETED|Treatment Period 1||8
499068|NCT01012739|1220597|P1|COMPLETED|Treatment Period 1||9
499069|NCT01012739|1220594|P4|STARTED|Treatment Period 1||9
499070|NCT01012739|1220595|P3|STARTED|Treatment Period 1||9
499071|NCT01012739|1220596|P2|STARTED|Treatment Period 1||8
499072|NCT01012739|1220597|P1|STARTED|Treatment Period 1||9
499073|NCT01012713|1220625|P1|NOT COMPLETED|Overall Study||3
499074|NCT01012713|1220625|P1|COMPLETED|Overall Study||27
499075|NCT01012713|1220625|P1|STARTED|Overall Study||30
499076|NCT01012674|1220631|P1|NOT COMPLETED|Overall Study||24
499077|NCT01012674|1220631|P1|COMPLETED|Overall Study||187
499078|NCT01012674|1220631|P1|STARTED|Overall Study||211
499079|NCT01012661|1220643|P1|NOT COMPLETED|Overall Study||0
499080|NCT01012661|1220643|P1|COMPLETED|Overall Study||50
499081|NCT01012661|1220643|P1|STARTED|Overall Study||50
499082|NCT01012622|1220651|P1|NOT COMPLETED|Overall Study||31
499083|NCT01012622|1220651|P1|COMPLETED|Overall Study||111
499084|NCT01012622|1220651|P1|STARTED|Overall Study||142
499085|NCT01012492|1220670|P1|NOT COMPLETED|Overall Study||0
499086|NCT01012492|1220670|P1|COMPLETED|Overall Study||10
499087|NCT01012492|1220670|P1|STARTED|Overall Study||10
499088|NCT01012440|1220675|P1|NOT COMPLETED|Overall Study||2
499089|NCT01012440|1220675|P1|COMPLETED|Overall Study||3
499090|NCT01012440|1220675|P1|STARTED|Overall Study||5
499091|NCT01012414|1220679|P1|NOT COMPLETED|Overall Study||10
499092|NCT01012414|1220679|P1|COMPLETED|Overall Study|No subjects completed the study.|0
499093|NCT01012414|1220679|P1|STARTED|Overall Study||10
499094|NCT01012388|1220686|P1|NOT COMPLETED|Overall Study||0
499095|NCT01012388|1220686|P1|COMPLETED|Overall Study||100
499096|NCT01012388|1220686|P1|STARTED|Overall Study||100
499097|NCT01012362|1220696|P5|NOT COMPLETED|Overall Study||0
499098|NCT01012362|1220697|P4|NOT COMPLETED|Overall Study||0
499099|NCT01012362|1220698|P3|NOT COMPLETED|Overall Study||0
499100|NCT01012362|1220699|P2|NOT COMPLETED|Overall Study||0
499101|NCT01012362|1220700|P1|NOT COMPLETED|Overall Study||0
499102|NCT01012362|1220696|P5|COMPLETED|Overall Study||9
499103|NCT01012362|1220697|P4|COMPLETED|Overall Study||4
499104|NCT01012362|1220698|P3|COMPLETED|Overall Study||3
499105|NCT01012362|1220699|P2|COMPLETED|Overall Study||6
499106|NCT01012362|1220700|P1|COMPLETED|Overall Study||9
499107|NCT01012362|1220696|P5|STARTED|Overall Study||9
499108|NCT01012362|1220697|P4|STARTED|Overall Study||4
499109|NCT01012362|1220698|P3|STARTED|Overall Study||3
499110|NCT01012362|1220699|P2|STARTED|Overall Study||6
499111|NCT01012362|1220700|P1|STARTED|Overall Study||9
499112|NCT01012336|1220716|P1|NOT COMPLETED|Overall Study||0
499113|NCT01012336|1220716|P1|COMPLETED|Overall Study||85
499114|NCT01012336|1220716|P1|STARTED|Overall Study||85
499115|NCT01012323|1220720|P1|NOT COMPLETED|Overall Study||1
499116|NCT01012323|1220720|P1|COMPLETED|Overall Study||50
499117|NCT01012323|1220720|P1|STARTED|Overall Study||51
499118|NCT01012297|1220744|P2|NOT COMPLETED|Overall Study||0
499119|NCT01012297|1220745|P1|NOT COMPLETED|Overall Study||0
499120|NCT01012297|1220744|P2|COMPLETED|Overall Study||53
499121|NCT01012297|1220745|P1|COMPLETED|Overall Study||54
499122|NCT01012297|1220744|P2|STARTED|Overall Study||53
499123|NCT01012297|1220745|P1|STARTED|Overall Study||54
499124|NCT01012258|1220757|P1|NOT COMPLETED|Overall Study||66
499125|NCT01012258|1220757|P1|COMPLETED|Overall Study||0
499126|NCT01012258|1220757|P1|STARTED|Overall Study||66
499127|NCT01012245|1220767|P1|NOT COMPLETED|Overall Study||2427
499128|NCT01012245|1220767|P1|COMPLETED|Overall Study|More than 1 discontinuation (DC) reason possible per subject. See outcome measure Reasons for DC.|26385
499129|NCT01012245|1220767|P1|STARTED|Overall Study||28812
499130|NCT01012219|1220804|P1|NOT COMPLETED|Period 3||0
499131|NCT01012219|1220804|P1|COMPLETED|Period 3||20
499132|NCT01012219|1220804|P1|STARTED|Period 3|of the 36 who started Period 1|20
499133|NCT01012219|1220804|P1|NOT COMPLETED|Period 2||1
499134|NCT01012219|1220804|P1|COMPLETED|Period 2||34
499135|NCT01012219|1220804|P1|STARTED|Period 2|Number who completed Period 1|35
499136|NCT01012219|1220804|P1|NOT COMPLETED|Period 1||1
499137|NCT01012219|1220804|P1|COMPLETED|Period 1||35
499138|NCT01012219|1220804|P1|STARTED|Period 1|Number randomized|36
499139|NCT01012167|1220814|P3|NOT COMPLETED|Overall Study||4
499140|NCT01012167|1220815|P2|NOT COMPLETED|Overall Study||2
499141|NCT01012167|1220816|P1|NOT COMPLETED|Overall Study||2
499142|NCT01012167|1220814|P3|COMPLETED|Overall Study||17
499143|NCT01012167|1220815|P2|COMPLETED|Overall Study||18
499144|NCT01012167|1220816|P1|COMPLETED|Overall Study||15
499145|NCT01012167|1220814|P3|Exposed to Study Drug|Overall Study||20
499146|NCT01012167|1220815|P2|Exposed to Study Drug|Overall Study||20
499147|NCT01012167|1220816|P1|Exposed to Study Drug|Overall Study||16
499148|NCT01012167|1220814|P3|Withdrawn Prior to Study Drug Exposure|Overall Study||1
499149|NCT01012167|1220815|P2|Withdrawn Prior to Study Drug Exposure|Overall Study||0
499150|NCT01012167|1220816|P1|Withdrawn Prior to Study Drug Exposure|Overall Study||1
499151|NCT01012167|1220814|P3|STARTED|Overall Study||21
499152|NCT01012167|1220815|P2|STARTED|Overall Study||20
499153|NCT01012167|1220816|P1|STARTED|Overall Study||17
499154|NCT01012089|1221072|P1|NOT COMPLETED|Overall Study||0
499155|NCT01012089|1221072|P1|COMPLETED|Overall Study||6
499156|NCT01012089|1221072|P1|STARTED|Overall Study||6
499157|NCT01012037|1221095|P3|NOT COMPLETED|Overall Study||10
499158|NCT01012037|1221096|P2|NOT COMPLETED|Overall Study||16
499159|NCT01012037|1221097|P1|NOT COMPLETED|Overall Study||1
499160|NCT01012037|1221095|P3|COMPLETED|Overall Study||214
499161|NCT01012037|1221096|P2|COMPLETED|Overall Study||207
499162|NCT01012037|1221097|P1|COMPLETED|Overall Study||43
499163|NCT01012037|1221095|P3|STARTED|Overall Study||224
499164|NCT01012037|1221096|P2|STARTED|Overall Study||223
499165|NCT01012037|1221097|P1|STARTED|Overall Study||44
499166|NCT01011946|1221132|P1|NOT COMPLETED|Overall Study||3
499167|NCT01011946|1221132|P1|COMPLETED|Overall Study||33
499168|NCT01011946|1221132|P1|STARTED|Overall Study||36
499169|NCT01011933|1221136|P1|NOT COMPLETED|Overall Study||4
499170|NCT01011933|1221136|P1|COMPLETED|Overall Study|total eligible and evaluable|50
499171|NCT01011933|1221136|P1|STARTED|Overall Study|total enrolled|54
499172|NCT01011907|1221153|P2|NOT COMPLETED|Overall Study||15
499173|NCT01011907|1221154|P1|NOT COMPLETED|Overall Study||14
499174|NCT01011907|1221153|P2|COMPLETED|Overall Study||18
499175|NCT01011907|1221154|P1|COMPLETED|Overall Study||17
499176|NCT01011907|1221153|P2|STARTED|Overall Study||33
499177|NCT01011907|1221154|P1|STARTED|Overall Study||31
499178|NCT01011894|1221164|P1|NOT COMPLETED|Overall Study||0
499179|NCT01011894|1221164|P1|COMPLETED|Overall Study||26
499180|NCT01011894|1221164|P1|STARTED|Overall Study||26
499181|NCT01011868|1221171|P3|NOT COMPLETED|After Week 78 Follow-up||44
499182|NCT01011868|1221172|P2|NOT COMPLETED|After Week 78 Follow-up||38
499183|NCT01011868|1221173|P1|NOT COMPLETED|After Week 78 Follow-up||52
499184|NCT01011868|1221171|P3|COMPLETED|After Week 78 Follow-up||111
499185|NCT01011868|1221172|P2|COMPLETED|After Week 78 Follow-up||131
499186|NCT01011868|1221173|P1|COMPLETED|After Week 78 Follow-up||118
499187|NCT01011868|1221171|P3|STARTED|After Week 78 Follow-up||155
499188|NCT01011868|1221172|P2|STARTED|After Week 78 Follow-up||169
499189|NCT01011868|1221173|P1|STARTED|After Week 78 Follow-up||170
499190|NCT01011868|1221171|P3|NOT COMPLETED|After Week 18 Follow-up||26
499191|NCT01011868|1221172|P2|NOT COMPLETED|After Week 18 Follow-up||16
499192|NCT01011868|1221173|P1|NOT COMPLETED|After Week 18 Follow-up||23
499193|NCT01011868|1221171|P3|COMPLETED|After Week 18 Follow-up||129
499194|NCT01011868|1221172|P2|COMPLETED|After Week 18 Follow-up||153
499195|NCT01011868|1221173|P1|COMPLETED|After Week 18 Follow-up||147
499196|NCT01011868|1221171|P3|STARTED|After Week 18 Follow-up||155
499197|NCT01011868|1221172|P2|STARTED|After Week 18 Follow-up||169
499198|NCT01011868|1221173|P1|STARTED|After Week 18 Follow-up||170
499199|NCT01011829|1221210|P2|NOT COMPLETED|Overall Study||9
499200|NCT01011829|1221211|P1|NOT COMPLETED|Overall Study||4
499201|NCT01011829|1221210|P2|COMPLETED|Overall Study||1
499202|NCT01011829|1221211|P1|COMPLETED|Overall Study||6
499203|NCT01011829|1221210|P2|STARTED|Overall Study||10
499204|NCT01011829|1221211|P1|STARTED|Overall Study||10
499205|NCT01011816|1221221|P2|NOT COMPLETED|78-Week Extended Follow-up||28
499206|NCT01011816|1221222|P1|NOT COMPLETED|78-Week Extended Follow-up||72
499207|NCT01011816|1221221|P2|COMPLETED|78-Week Extended Follow-up||26
499208|NCT01011816|1221222|P1|COMPLETED|78-Week Extended Follow-up||85
499209|NCT01011816|1221221|P2|STARTED|78-Week Extended Follow-up||54
499210|NCT01011816|1221222|P1|STARTED|78-Week Extended Follow-up||157
499211|NCT01011816|1221221|P2|NOT COMPLETED|26-Week Primary Endpoint||2
499212|NCT01011816|1221222|P1|NOT COMPLETED|26-Week Primary Endpoint||7
499213|NCT01011816|1221221|P2|COMPLETED|26-Week Primary Endpoint||54
499214|NCT01011816|1221222|P1|COMPLETED|26-Week Primary Endpoint||157
499215|NCT01011816|1221221|P2|STARTED|26-Week Primary Endpoint||56
499216|NCT01011816|1221222|P1|STARTED|26-Week Primary Endpoint||164
499217|NCT01011738|1221235|P3|NOT COMPLETED|Overall Study||17
499218|NCT01011738|1221236|P2|NOT COMPLETED|Overall Study||294
499219|NCT01011738|1221237|P1|NOT COMPLETED|Overall Study||324
499220|NCT01011738|1221235|P3|COMPLETED|Overall Study||36
499221|NCT01011738|1221236|P2|COMPLETED|Overall Study||618
499222|NCT01011738|1221237|P1|COMPLETED|Overall Study||553
499223|NCT01011738|1221235|P3|STARTED|Overall Study||53
499224|NCT01011738|1221236|P2|STARTED|Overall Study||912
499225|NCT01011738|1221237|P1|STARTED|Overall Study||877
499226|NCT01011673|1221277|P2|NOT COMPLETED|24 Hour Follow-up||3
499227|NCT01011673|1221278|P1|NOT COMPLETED|24 Hour Follow-up||3
499228|NCT01011673|1221277|P2|COMPLETED|24 Hour Follow-up||57
499229|NCT01011673|1221278|P1|COMPLETED|24 Hour Follow-up||57
499230|NCT01011673|1221277|P2|STARTED|24 Hour Follow-up||60
499231|NCT01011673|1221278|P1|STARTED|24 Hour Follow-up||60
499232|NCT01011673|1221277|P2|NOT COMPLETED|Emergency Department Portion||0
499233|NCT01011673|1221278|P1|NOT COMPLETED|Emergency Department Portion||0
499234|NCT01011673|1221277|P2|COMPLETED|Emergency Department Portion||60
499235|NCT01011673|1221278|P1|COMPLETED|Emergency Department Portion||60
499236|NCT01011673|1221277|P2|STARTED|Emergency Department Portion||60
499237|NCT01011673|1221278|P1|STARTED|Emergency Department Portion||60
499238|NCT01011673|1221277|P2|NOT COMPLETED|Randomized||1
499239|NCT01011673|1221278|P1|NOT COMPLETED|Randomized||2
499240|NCT01011673|1221277|P2|COMPLETED|Randomized|1 patient was randomized but not included in analyses bc they did not truly meet study criteria.|60
499241|NCT01011673|1221278|P1|COMPLETED|Randomized|2 patients were randomized but not included in analyses bc they did not truly meet study criteria.|60
499242|NCT01011673|1221277|P2|STARTED|Randomized||61
499243|NCT01011673|1221278|P1|STARTED|Randomized||62
499244|NCT01011634|1221288|P2|NOT COMPLETED|Overall Study||1
499245|NCT01011634|1221289|P1|NOT COMPLETED|Overall Study||0
499246|NCT01011634|1221288|P2|COMPLETED|Overall Study||8
499247|NCT01011634|1221289|P1|COMPLETED|Overall Study||9
499248|NCT01011634|1221288|P2|STARTED|Overall Study||9
499249|NCT01011634|1221289|P1|STARTED|Overall Study||9
499250|NCT01011556|1221301|P4|NOT COMPLETED|Overall Study||13
499251|NCT01011556|1221302|P3|NOT COMPLETED|Overall Study||10
499252|NCT01011556|1221303|P2|NOT COMPLETED|Overall Study||8
499253|NCT01011556|1221304|P1|NOT COMPLETED|Overall Study||6
499254|NCT01011556|1221301|P4|COMPLETED|Overall Study||51
499255|NCT01011556|1221302|P3|COMPLETED|Overall Study||45
499256|NCT01011556|1221303|P2|COMPLETED|Overall Study||48
499257|NCT01011556|1221304|P1|COMPLETED|Overall Study||52
499258|NCT01011556|1221301|P4|Received at Least 1 Dose of Study Drug|Overall Study||64
499259|NCT01011556|1221302|P3|Received at Least 1 Dose of Study Drug|Overall Study||54
499260|NCT01011556|1221303|P2|Received at Least 1 Dose of Study Drug|Overall Study||56
499261|NCT01011556|1221304|P1|Received at Least 1 Dose of Study Drug|Overall Study||57
499262|NCT01011556|1221301|P4|STARTED|Overall Study||64
499263|NCT01011556|1221302|P3|STARTED|Overall Study||55
499264|NCT01011556|1221303|P2|STARTED|Overall Study||56
499265|NCT01011556|1221304|P1|STARTED|Overall Study||58
499266|NCT01011465|1221382|P8|NOT COMPLETED|Overall Study||0
499267|NCT01011465|1221383|P7|NOT COMPLETED|Overall Study||1
499268|NCT01011465|1221384|P6|NOT COMPLETED|Overall Study||0
499269|NCT01011465|1221385|P5|NOT COMPLETED|Overall Study||1
499270|NCT01011465|1221386|P4|NOT COMPLETED|Overall Study||0
499271|NCT01011465|1221387|P3|NOT COMPLETED|Overall Study||0
499272|NCT01011465|1221388|P2|NOT COMPLETED|Overall Study||1
499273|NCT01011465|1221389|P1|NOT COMPLETED|Overall Study||2
499274|NCT01011465|1221382|P8|COMPLETED|Overall Study||32
499275|NCT01011465|1221383|P7|COMPLETED|Overall Study||51
499276|NCT01011465|1221384|P6|COMPLETED|Overall Study||29
499277|NCT01011465|1221385|P5|COMPLETED|Overall Study||46
499278|NCT01011465|1221386|P4|COMPLETED|Overall Study||18
499279|NCT01011465|1221387|P3|COMPLETED|Overall Study||36
499280|NCT01011465|1221388|P2|COMPLETED|Overall Study||19
499281|NCT01011465|1221389|P1|COMPLETED|Overall Study||34
499282|NCT01011465|1221382|P8|STARTED|Overall Study||32
499283|NCT01011465|1221383|P7|STARTED|Overall Study||52
499284|NCT01011465|1221384|P6|STARTED|Overall Study||29
499285|NCT01011465|1221385|P5|STARTED|Overall Study||47
499286|NCT01011465|1221386|P4|STARTED|Overall Study||18
499287|NCT01011465|1221387|P3|STARTED|Overall Study||36
499288|NCT01011465|1221388|P2|STARTED|Overall Study||20
499289|NCT01011465|1221389|P1|STARTED|Overall Study||36
499290|NCT01011387|1221417|P1|NOT COMPLETED|Overall Study||6
499291|NCT01011387|1221417|P1|COMPLETED|Overall Study||10
499292|NCT01011387|1221417|P1|STARTED|Overall Study||16
499293|NCT01011335|1221425|P13|NOT COMPLETED|Overall Study||3
499294|NCT01011335|1221426|P12|NOT COMPLETED|Overall Study||1
499295|NCT01011335|1221427|P11|NOT COMPLETED|Overall Study||6
499296|NCT01011335|1221428|P10|NOT COMPLETED|Overall Study||0
499297|NCT01011335|1221429|P9|NOT COMPLETED|Overall Study||2
499298|NCT01011335|1221430|P8|NOT COMPLETED|Overall Study||2
499299|NCT01011335|1221431|P7|NOT COMPLETED|Overall Study||3
499300|NCT01011335|1221432|P6|NOT COMPLETED|Overall Study||1
499301|NCT01011335|1221433|P5|NOT COMPLETED|Overall Study||1
499302|NCT01011335|1221434|P4|NOT COMPLETED|Overall Study||2
499303|NCT01011335|1221435|P3|NOT COMPLETED|Overall Study||1
499304|NCT01011335|1221436|P2|NOT COMPLETED|Overall Study||1
499305|NCT01011335|1221437|P1|NOT COMPLETED|Overall Study||1
499306|NCT01011335|1221425|P13|COMPLETED|Overall Study||19
499307|NCT01011335|1221426|P12|COMPLETED|Overall Study||21
499308|NCT01011335|1221427|P11|COMPLETED|Overall Study||6
499309|NCT01011335|1221428|P10|COMPLETED|Overall Study||12
499310|NCT01011335|1221429|P9|COMPLETED|Overall Study||10
499311|NCT01011335|1221430|P8|COMPLETED|Overall Study||10
499312|NCT01011335|1221431|P7|COMPLETED|Overall Study||9
499313|NCT01011335|1221432|P6|COMPLETED|Overall Study||11
499314|NCT01011335|1221433|P5|COMPLETED|Overall Study||12
499315|NCT01011335|1221434|P4|COMPLETED|Overall Study||10
499316|NCT01011335|1221435|P3|COMPLETED|Overall Study||11
499317|NCT01011335|1221436|P2|COMPLETED|Overall Study||11
499318|NCT01011335|1221437|P1|COMPLETED|Overall Study||10
499319|NCT01011335|1221425|P13|STARTED|Overall Study||22
499320|NCT01011335|1221426|P12|STARTED|Overall Study||22
499321|NCT01011335|1221427|P11|STARTED|Overall Study||12
499322|NCT01011335|1221428|P10|STARTED|Overall Study||12
499323|NCT01011335|1221429|P9|STARTED|Overall Study||12
499324|NCT01011335|1221430|P8|STARTED|Overall Study||12
499325|NCT01011335|1221431|P7|STARTED|Overall Study||12
499326|NCT01011335|1221432|P6|STARTED|Overall Study||12
499327|NCT01011335|1221433|P5|STARTED|Overall Study||13
499328|NCT01011335|1221434|P4|STARTED|Overall Study||12
499329|NCT01011335|1221435|P3|STARTED|Overall Study||12
499330|NCT01011335|1221436|P2|STARTED|Overall Study||12
499331|NCT01011335|1221437|P1|STARTED|Overall Study||11
499332|NCT01011309|1221477|P3|NOT COMPLETED|Overall Study||5
499333|NCT01011309|1221478|P2|NOT COMPLETED|Overall Study||3
499334|NCT01011309|1221479|P1|NOT COMPLETED|Overall Study||2
499335|NCT01011309|1221477|P3|COMPLETED|Overall Study||16
499336|NCT01011309|1221478|P2|COMPLETED|Overall Study||7
499337|NCT01011309|1221479|P1|COMPLETED|Overall Study||12
499338|NCT01011309|1221477|P3|STARTED|Overall Study||21
499339|NCT01011309|1221478|P2|STARTED|Overall Study||10
499340|NCT01011309|1221479|P1|STARTED|Overall Study||14
499341|NCT01011283|1221495|P2|NOT COMPLETED|Overall Study||11
499342|NCT01011283|1221496|P1|NOT COMPLETED|Overall Study||11
499343|NCT01011283|1221495|P2|COMPLETED|Overall Study||2
499344|NCT01011283|1221496|P1|COMPLETED|Overall Study||2
499345|NCT01011283|1221495|P2|STARTED|Overall Study||13
499346|NCT01011283|1221496|P1|STARTED|Overall Study||13
499347|NCT01011179|1221506|P2|NOT COMPLETED|Overall Study||2
499348|NCT01011179|1221507|P1|NOT COMPLETED|Overall Study||4
499349|NCT01011179|1221506|P2|COMPLETED|Overall Study||20
499350|NCT01011179|1221507|P1|COMPLETED|Overall Study||20
499351|NCT01011179|1221506|P2|STARTED|Overall Study||22
499352|NCT01011179|1221507|P1|STARTED|Overall Study||24
499353|NCT01011153|1221516|P3|NOT COMPLETED|Overall Study||9
499354|NCT01011153|1221517|P2|NOT COMPLETED|Overall Study||11
499355|NCT01011153|1221518|P1|NOT COMPLETED|Overall Study||8
499356|NCT01011153|1221516|P3|COMPLETED|Overall Study||45
499357|NCT01011153|1221517|P2|COMPLETED|Overall Study||64
499358|NCT01011153|1221518|P1|COMPLETED|Overall Study||46
499359|NCT01011153|1221516|P3|STARTED|Overall Study||54
499360|NCT01011153|1221517|P2|STARTED|Overall Study||75
499361|NCT01011153|1221518|P1|STARTED|Overall Study||54
499362|NCT01011075|1221536|P1|NOT COMPLETED|Overall Study||0
499363|NCT01011075|1221536|P1|COMPLETED|Overall Study||34
499364|NCT01011075|1221536|P1|STARTED|Overall Study||34
499365|NCT01011049|1221547|P4|NOT COMPLETED|Overall Study||0
499366|NCT01011049|1221548|P3|NOT COMPLETED|Overall Study||4
499367|NCT01011049|1221549|P2|NOT COMPLETED|Overall Study||2
499368|NCT01011049|1221550|P1|NOT COMPLETED|Overall Study||1
499369|NCT01011049|1221547|P4|COMPLETED|Overall Study||246
499370|NCT01011049|1221548|P3|COMPLETED|Overall Study||239
499371|NCT01011049|1221549|P2|COMPLETED|Overall Study||250
499372|NCT01011049|1221550|P1|COMPLETED|Overall Study||506
499373|NCT01011049|1221547|P4|STARTED|Overall Study||246
499374|NCT01011049|1221548|P3|STARTED|Overall Study||243
499375|NCT01011049|1221549|P2|STARTED|Overall Study||252
499376|NCT01011049|1221550|P1|STARTED|Overall Study||507
499377|NCT01010984|1221572|P1|NOT COMPLETED|Overall Study||0
499378|NCT01010984|1221572|P1|COMPLETED|Overall Study||20
499379|NCT01010984|1221572|P1|STARTED|Overall Study||20
499380|NCT01010971|1221580|P3|NOT COMPLETED|Overall Study||13
499381|NCT01010971|1221581|P2|NOT COMPLETED|Overall Study||8
499382|NCT01010971|1221582|P1|NOT COMPLETED|Overall Study||3
499383|NCT01010971|1221580|P3|COMPLETED|Overall Study||207
499384|NCT01010971|1221581|P2|COMPLETED|Overall Study||218
499385|NCT01010971|1221582|P1|COMPLETED|Overall Study||222
499386|NCT01010971|1221580|P3|STARTED|Overall Study||220
499387|NCT01010971|1221581|P2|STARTED|Overall Study||226
499388|NCT01010971|1221582|P1|STARTED|Overall Study||225
499389|NCT01010932|1221667|P1|NOT COMPLETED|Overall Study||22
499390|NCT01010932|1221667|P1|COMPLETED|Overall Study||200
499391|NCT01010932|1221667|P1|STARTED|Overall Study||222
499392|NCT01010906|1221685|P6|NOT COMPLETED|Overall Study||0
499393|NCT01010906|1221686|P5|NOT COMPLETED|Overall Study||0
499394|NCT01010906|1221687|P4|NOT COMPLETED|Overall Study||0
499395|NCT01010906|1221688|P3|NOT COMPLETED|Overall Study||0
499396|NCT01010906|1221689|P2|NOT COMPLETED|Overall Study||0
499397|NCT01010906|1221690|P1|NOT COMPLETED|Overall Study||0
499398|NCT01010906|1221685|P6|COMPLETED|Overall Study||10
499399|NCT01010906|1221686|P5|COMPLETED|Overall Study||10
499400|NCT01010906|1221687|P4|COMPLETED|Overall Study||10
499401|NCT01010906|1221688|P3|COMPLETED|Overall Study||10
499402|NCT01010906|1221689|P2|COMPLETED|Overall Study||10
499403|NCT01010906|1221690|P1|COMPLETED|Overall Study||10
499404|NCT01010906|1221685|P6|STARTED|Overall Study||10
499405|NCT01010906|1221686|P5|STARTED|Overall Study||10
499406|NCT01010906|1221687|P4|STARTED|Overall Study||10
499407|NCT01010906|1221688|P3|STARTED|Overall Study||10
499408|NCT01010906|1221689|P2|STARTED|Overall Study||10
499409|NCT01010906|1221690|P1|STARTED|Overall Study||10
499410|NCT01010867|1221710|P1|NOT COMPLETED|Overall Study||1
499411|NCT01010867|1221710|P1|COMPLETED|Overall Study||30
499412|NCT01010867|1221710|P1|STARTED|Overall Study||31
499413|NCT01010854|1221717|P1|NOT COMPLETED|Overall Study||0
499414|NCT01010854|1221717|P1|COMPLETED|Overall Study||6
499415|NCT01010854|1221717|P1|STARTED|Overall Study||6
499416|NCT01010776|1221722|P1|NOT COMPLETED|Extension Phase||3
499417|NCT01010776|1221722|P1|COMPLETED|Extension Phase||156
499418|NCT01010776|1221722|P1|STARTED|Extension Phase||159
499419|NCT01010776|1221722|P1|NOT COMPLETED|In-Between Main Phase & Extension Phase||15
499420|NCT01010776|1221722|P1|COMPLETED|In-Between Main Phase & Extension Phase||159
499421|NCT01010776|1221722|P1|STARTED|In-Between Main Phase & Extension Phase||174
499422|NCT01010776|1221722|P1|NOT COMPLETED|Main Phase||49
499423|NCT01010776|1221722|P1|COMPLETED|Main Phase||174
499424|NCT01010776|1221722|P1|Treated|Main Phase||218
499425|NCT01010776|1221722|P1|STARTED|Main Phase||223
499426|NCT01010750|1221750|P6|NOT COMPLETED|Third Intervention||0
499427|NCT01010750|1221751|P5|NOT COMPLETED|Third Intervention||0
499428|NCT01010750|1221752|P4|NOT COMPLETED|Third Intervention||0
499429|NCT01010750|1221753|P3|NOT COMPLETED|Third Intervention||0
499430|NCT01010750|1221754|P2|NOT COMPLETED|Third Intervention||0
499431|NCT01010750|1221755|P1|NOT COMPLETED|Third Intervention||0
499432|NCT01010750|1221750|P6|COMPLETED|Third Intervention||3
499433|NCT01010750|1221751|P5|COMPLETED|Third Intervention||2
499434|NCT01010750|1221752|P4|COMPLETED|Third Intervention||3
499435|NCT01010750|1221753|P3|COMPLETED|Third Intervention||3
499436|NCT01010750|1221754|P2|COMPLETED|Third Intervention||3
499437|NCT01010750|1221755|P1|COMPLETED|Third Intervention||3
499438|NCT01010750|1221750|P6|STARTED|Third Intervention||3
499439|NCT01010750|1221751|P5|STARTED|Third Intervention||2
499440|NCT01010750|1221752|P4|STARTED|Third Intervention||3
499441|NCT01010750|1221753|P3|STARTED|Third Intervention||3
499442|NCT01010750|1221754|P2|STARTED|Third Intervention||3
499443|NCT01010750|1221755|P1|STARTED|Third Intervention||3
499444|NCT01010750|1221750|P6|NOT COMPLETED|Second Intervention||0
499445|NCT01010750|1221751|P5|NOT COMPLETED|Second Intervention||0
499446|NCT01010750|1221752|P4|NOT COMPLETED|Second Intervention||0
499447|NCT01010750|1221753|P3|NOT COMPLETED|Second Intervention||0
499448|NCT01010750|1221754|P2|NOT COMPLETED|Second Intervention||1
499449|NCT01010750|1221755|P1|NOT COMPLETED|Second Intervention||0
499450|NCT01010750|1221750|P6|COMPLETED|Second Intervention||3
499451|NCT01010750|1221751|P5|COMPLETED|Second Intervention||2
499452|NCT01010750|1221752|P4|COMPLETED|Second Intervention||3
499453|NCT01010750|1221753|P3|COMPLETED|Second Intervention||3
499454|NCT01010750|1221754|P2|COMPLETED|Second Intervention||3
499455|NCT01010750|1221755|P1|COMPLETED|Second Intervention||3
499456|NCT01010750|1221750|P6|STARTED|Second Intervention||3
499457|NCT01010750|1221751|P5|STARTED|Second Intervention||2
499458|NCT01010750|1221752|P4|STARTED|Second Intervention||3
499459|NCT01010750|1221753|P3|STARTED|Second Intervention||3
499460|NCT01010750|1221754|P2|STARTED|Second Intervention||4
499461|NCT01010750|1221755|P1|STARTED|Second Intervention||3
499462|NCT01010750|1221750|P6|NOT COMPLETED|First Intervention||0
499463|NCT01010750|1221751|P5|NOT COMPLETED|First Intervention||0
499464|NCT01010750|1221752|P4|NOT COMPLETED|First Intervention||0
499465|NCT01010750|1221753|P3|NOT COMPLETED|First Intervention||0
499466|NCT01010750|1221754|P2|NOT COMPLETED|First Intervention||0
499467|NCT01010750|1221755|P1|NOT COMPLETED|First Intervention||0
499468|NCT01010750|1221750|P6|COMPLETED|First Intervention||3
499469|NCT01010750|1221751|P5|COMPLETED|First Intervention||2
499470|NCT01010750|1221752|P4|COMPLETED|First Intervention||3
499471|NCT01010750|1221753|P3|COMPLETED|First Intervention||3
499472|NCT01010750|1221754|P2|COMPLETED|First Intervention||4
499473|NCT01010750|1221755|P1|COMPLETED|First Intervention||3
499474|NCT01010750|1221750|P6|STARTED|First Intervention||3
499475|NCT01010750|1221751|P5|STARTED|First Intervention||2
499476|NCT01010750|1221752|P4|STARTED|First Intervention||3
499477|NCT01010750|1221753|P3|STARTED|First Intervention||3
499478|NCT01010750|1221754|P2|STARTED|First Intervention||4
499479|NCT01010750|1221755|P1|STARTED|First Intervention||3
499480|NCT01010633|1221780|P2|NOT COMPLETED|Overall Study||5
499481|NCT01010633|1221781|P1|NOT COMPLETED|Overall Study||4
499482|NCT01010633|1221780|P2|COMPLETED|Overall Study||198
499483|NCT01010633|1221781|P1|COMPLETED|Overall Study||199
499484|NCT01010633|1221780|P2|STARTED|Overall Study||203
499485|NCT01010633|1221781|P1|STARTED|Overall Study||203
499486|NCT01010568|1221791|P1|NOT COMPLETED|Overall Study||5
499487|NCT01010568|1221791|P1|COMPLETED|Overall Study||5
499488|NCT01010568|1221791|P1|STARTED|Overall Study||10
499489|NCT01010555|1221797|P2|NOT COMPLETED|Second Four Weeks of Wear||0
499490|NCT01010555|1221798|P1|NOT COMPLETED|Second Four Weeks of Wear||0
499491|NCT01010555|1221797|P2|COMPLETED|Second Four Weeks of Wear||9
499492|NCT01010555|1221798|P1|COMPLETED|Second Four Weeks of Wear||10
499493|NCT01010555|1221797|P2|STARTED|Second Four Weeks of Wear||9
499494|NCT01010555|1221798|P1|STARTED|Second Four Weeks of Wear||10
499495|NCT01010555|1221797|P2|NOT COMPLETED|First Four Weeks of Wear||0
499496|NCT01010555|1221798|P1|NOT COMPLETED|First Four Weeks of Wear||0
499497|NCT01010555|1221797|P2|COMPLETED|First Four Weeks of Wear|One participant who completed Period 1 did not start Period 2. Non-compliance with visit schedule.|10
499498|NCT01010555|1221798|P1|COMPLETED|First Four Weeks of Wear|One participant who completed Period 1 did not start Period 2. Relocation.|11
499499|NCT01010555|1221797|P2|STARTED|First Four Weeks of Wear||10
499500|NCT01010555|1221798|P1|STARTED|First Four Weeks of Wear||11
499501|NCT01010503|1221808|P1|NOT COMPLETED|Overall Study||2
499502|NCT01010503|1221808|P1|COMPLETED|Overall Study||30
499503|NCT01010503|1221808|P1|STARTED|Overall Study||32
499504|NCT01010477|1221828|P2|NOT COMPLETED|Overall Study||3
499505|NCT01010477|1221829|P1|NOT COMPLETED|Overall Study||6
499506|NCT01010477|1221828|P2|COMPLETED|Overall Study||22
499507|NCT01010477|1221829|P1|COMPLETED|Overall Study||21
499508|NCT01010477|1221828|P2|STARTED|Overall Study||25
499509|NCT01010477|1221829|P1|STARTED|Overall Study||27
499510|NCT01010399|1221835|P1|NOT COMPLETED|Overall Study||5
499511|NCT01010399|1221835|P1|COMPLETED|Overall Study||31
499512|NCT01010399|1221835|P1|STARTED|Overall Study||36
499513|NCT01010282|1221843|P3|NOT COMPLETED|Overall Study||19
499514|NCT01010282|1221844|P2|NOT COMPLETED|Overall Study||7
499515|NCT01010282|1221845|P1|NOT COMPLETED|Overall Study||6
499516|NCT01010282|1221843|P3|COMPLETED|Overall Study||77
499517|NCT01010282|1221844|P2|COMPLETED|Overall Study||88
499518|NCT01010282|1221845|P1|COMPLETED|Overall Study||91
499519|NCT01010282|1221843|P3|STARTED|Overall Study||96
499520|NCT01010282|1221844|P2|STARTED|Overall Study||95
499521|NCT01010282|1221845|P1|STARTED|Overall Study||97
499522|NCT01010230|1221867|P2|NOT COMPLETED|Overall Study||7
499523|NCT01010230|1221868|P1|NOT COMPLETED|Overall Study||10
499524|NCT01010230|1221867|P2|COMPLETED|Overall Study||26
499525|NCT01010230|1221868|P1|COMPLETED|Overall Study||22
499526|NCT01010230|1221867|P2|STARTED|Overall Study||33
499527|NCT01010230|1221868|P1|STARTED|Overall Study||32
499528|NCT01010204|1221900|P2|NOT COMPLETED|Overall Study||9
499529|NCT01010204|1221901|P1|NOT COMPLETED|Overall Study||7
499530|NCT01010204|1221900|P2|COMPLETED|Overall Study||20
499531|NCT01010204|1221901|P1|COMPLETED|Overall Study||24
499532|NCT01010204|1221900|P2|STARTED|Overall Study||29
499533|NCT01010204|1221901|P1|STARTED|Overall Study||31
499534|NCT01010061|1221913|P2|NOT COMPLETED|Overall Study||95
499535|NCT01010061|1221914|P1|NOT COMPLETED|Overall Study||133
499536|NCT01010061|1221913|P2|COMPLETED|Overall Study||23
499537|NCT01010061|1221914|P1|COMPLETED|Overall Study|Completed=Completed treatment.|105
499538|NCT01010061|1221913|P2|Received Study Drug|Overall Study||116
499539|NCT01010061|1221914|P1|Received Study Drug|Overall Study||236
499540|NCT01010061|1221913|P2|STARTED|Overall Study||118
499541|NCT01010061|1221914|P1|STARTED|Overall Study||238
499542|NCT01010009|1221948|P3|NOT COMPLETED|Overall Study||0
499543|NCT01010009|1221949|P2|NOT COMPLETED|Overall Study||0
499544|NCT01010009|1221950|P1|NOT COMPLETED|Overall Study||0
499545|NCT01010009|1221948|P3|COMPLETED|Overall Study||8
499546|NCT01010009|1221949|P2|COMPLETED|Overall Study||8
499547|NCT01010009|1221950|P1|COMPLETED|Overall Study||8
499548|NCT01010009|1221948|P3|STARTED|Overall Study||8
499549|NCT01010009|1221949|P2|STARTED|Overall Study||8
499550|NCT01010009|1221950|P1|STARTED|Overall Study||8
499551|NCT01009983|1221964|P1|NOT COMPLETED|Overall Study||1
499552|NCT01009983|1221964|P1|COMPLETED|Overall Study||13
499553|NCT01009983|1221964|P1|STARTED|Overall Study||14
499554|NCT01009931|1221971|P1|NOT COMPLETED|Overall Study||1
499555|NCT01009931|1221971|P1|COMPLETED|Overall Study||0
499556|NCT01009931|1221971|P1|STARTED|Overall Study||1
499557|NCT01009840|1221977|P1|NOT COMPLETED|Overall Study||14
499558|NCT01009840|1221977|P1|COMPLETED|Overall Study||16
499559|NCT01009840|1221977|P1|STARTED|Overall Study||30
499560|NCT01009762|1221992|P2|NOT COMPLETED|Overall Study||0
499561|NCT01009762|1221993|P1|NOT COMPLETED|Overall Study||0
499562|NCT01009762|1221992|P2|COMPLETED|Overall Study|10 participants received vaccine|10
499563|NCT01009762|1221993|P1|COMPLETED|Overall Study|according to randomization this one participant received placebo|1
499564|NCT01009762|1221992|P2|Primary Outcome|Overall Study|no SAE, no treatment related side effects DLT grade 3 or more|0
499565|NCT01009762|1221993|P1|Primary Outcome|Overall Study|no Serious Adverse Events (SAE), no treatment related side effects DLT grade 3 or more|0
499566|NCT01009762|1221992|P2|STARTED|Overall Study||10
499567|NCT01009762|1221993|P1|STARTED|Overall Study||1
499568|NCT01009645|1222007|P4|NOT COMPLETED|Overall Study||5
499569|NCT01009645|1222008|P3|NOT COMPLETED|Overall Study||4
499570|NCT01009645|1222009|P2|NOT COMPLETED|Overall Study||8
499571|NCT01009645|1222010|P1|NOT COMPLETED|Overall Study||2
499572|NCT01009645|1222007|P4|COMPLETED|Overall Study||26
499573|NCT01009645|1222008|P3|COMPLETED|Overall Study||28
499574|NCT01009645|1222009|P2|COMPLETED|Overall Study||23
499575|NCT01009645|1222010|P1|COMPLETED|Overall Study||29
499576|NCT01009645|1222007|P4|STARTED|Overall Study||31
499577|NCT01009645|1222008|P3|STARTED|Overall Study||32
499578|NCT01009645|1222009|P2|STARTED|Overall Study||31
499579|NCT01009645|1222010|P1|STARTED|Overall Study||31
499580|NCT01009619|1222026|P2|NOT COMPLETED|Overall Study||0
499581|NCT01009619|1222027|P1|NOT COMPLETED|Overall Study||0
499582|NCT01009619|1222026|P2|COMPLETED|Overall Study||43
499583|NCT01009619|1222027|P1|COMPLETED|Overall Study||40
499584|NCT01009619|1222026|P2|STARTED|Overall Study||43
499585|NCT01009619|1222027|P1|STARTED|Overall Study||40
499586|NCT01009580|1222047|P2|NOT COMPLETED|Overall Study||35
499587|NCT01009580|1222048|P1|NOT COMPLETED|Overall Study||27
499588|NCT01009580|1222047|P2|COMPLETED|Overall Study||188
499589|NCT01009580|1222048|P1|COMPLETED|Overall Study||197
499590|NCT01009580|1222047|P2|Exposed|Overall Study|One subject was randomised in error and withdrew prior to exposure to drug|222
499591|NCT01009580|1222048|P1|Exposed|Overall Study||224
499592|NCT01009580|1222047|P2|STARTED|Overall Study||223
499593|NCT01009580|1222048|P1|STARTED|Overall Study||224
499594|NCT01009554|1222062|P2|NOT COMPLETED|Overall Study||7
499595|NCT01009554|1222063|P1|NOT COMPLETED|Overall Study||2
499596|NCT01009554|1222062|P2|COMPLETED|Overall Study||41
499597|NCT01009554|1222063|P1|COMPLETED|Overall Study||46
499598|NCT01009554|1222062|P2|STARTED|Overall Study||48
499599|NCT01009554|1222063|P1|STARTED|Overall Study||48
499600|NCT01009515|1222195|P1|NOT COMPLETED|Overall Study||3
499601|NCT01009515|1222195|P1|COMPLETED|Overall Study||16
499602|NCT01009515|1222195|P1|STARTED|Overall Study||19
499603|NCT01009463|1222206|P5|NOT COMPLETED|52-week, Double-blind Treatment Period||101
499604|NCT01009463|1222207|P4|NOT COMPLETED|52-week, Double-blind Treatment Period||91
499605|NCT01009463|1222208|P3|NOT COMPLETED|52-week, Double-blind Treatment Period||93
499606|NCT01009463|1222209|P2|NOT COMPLETED|52-week, Double-blind Treatment Period||115
499607|NCT01009463|1222210|P1|NOT COMPLETED|52-week, Double-blind Treatment Period||0
499608|NCT01009463|1222206|P5|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|301
499609|NCT01009463|1222207|P4|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|312
499610|NCT01009463|1222208|P3|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|315
499611|NCT01009463|1222209|P2|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|294
499612|NCT01009463|1222210|P1|COMPLETED|52-week, Double-blind Treatment Period||0
499613|NCT01009463|1222206|P5|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|303
499614|NCT01009463|1222207|P4|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|314
499615|NCT01009463|1222208|P3|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|318
499616|NCT01009463|1222209|P2|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|295
499617|NCT01009463|1222210|P1|Completed the Treatment Period|52-week, Double-blind Treatment Period||0
499618|NCT01009463|1222206|P5|STARTED|52-week, Double-blind Treatment Period||402
499619|NCT01009463|1222207|P4|STARTED|52-week, Double-blind Treatment Period||403
499620|NCT01009463|1222208|P3|STARTED|52-week, Double-blind Treatment Period||408
499621|NCT01009463|1222209|P2|STARTED|52-week, Double-blind Treatment Period||409
499622|NCT01009463|1222210|P1|STARTED|52-week, Double-blind Treatment Period||0
499623|NCT01009463|1222206|P5|NOT COMPLETED|4-week, Open-label Run-In Period||0
499624|NCT01009463|1222207|P4|NOT COMPLETED|4-week, Open-label Run-In Period||0
499625|NCT01009463|1222208|P3|NOT COMPLETED|4-week, Open-label Run-In Period||0
499626|NCT01009463|1222209|P2|NOT COMPLETED|4-week, Open-label Run-In Period||0
499627|NCT01009463|1222210|P1|NOT COMPLETED|4-week, Open-label Run-In Period||449
499628|NCT01009463|1222206|P5|COMPLETED|4-week, Open-label Run-In Period||0
499629|NCT01009463|1222207|P4|COMPLETED|4-week, Open-label Run-In Period||0
499630|NCT01009463|1222208|P3|COMPLETED|4-week, Open-label Run-In Period||0
499631|NCT01009463|1222209|P2|COMPLETED|4-week, Open-label Run-In Period||0
499632|NCT01009463|1222210|P1|COMPLETED|4-week, Open-label Run-In Period||1622
499633|NCT01009463|1222206|P5|STARTED|4-week, Open-label Run-In Period||0
499634|NCT01009463|1222207|P4|STARTED|4-week, Open-label Run-In Period||0
499635|NCT01009463|1222208|P3|STARTED|4-week, Open-label Run-In Period||0
499636|NCT01009463|1222209|P2|STARTED|4-week, Open-label Run-In Period||0
499637|NCT01009463|1222210|P1|STARTED|4-week, Open-label Run-In Period||2071
499638|NCT01009346|1222232|P1|NOT COMPLETED|Overall Study||4
499639|NCT01009346|1222232|P1|COMPLETED|Overall Study||5
499640|NCT01009346|1222232|P1|Toxicity|Overall Study||8
499641|NCT01009346|1222232|P1|STARTED|Overall Study||9
499642|NCT01009333|1222236|P6|NOT COMPLETED|Week 3||0
499643|NCT01009333|1222237|P5|NOT COMPLETED|Week 3||0
499644|NCT01009333|1222238|P4|NOT COMPLETED|Week 3||0
499645|NCT01009333|1222239|P3|NOT COMPLETED|Week 3||0
499646|NCT01009333|1222240|P2|NOT COMPLETED|Week 3||0
499647|NCT01009333|1222241|P1|NOT COMPLETED|Week 3||0
499648|NCT01009333|1222236|P6|COMPLETED|Week 3||2
499649|NCT01009333|1222237|P5|COMPLETED|Week 3||2
499650|NCT01009333|1222238|P4|COMPLETED|Week 3||2
499651|NCT01009333|1222239|P3|COMPLETED|Week 3||2
499652|NCT01009333|1222240|P2|COMPLETED|Week 3||2
499653|NCT01009333|1222241|P1|COMPLETED|Week 3||2
499654|NCT01009333|1222236|P6|STARTED|Week 3||2
499655|NCT01009333|1222237|P5|STARTED|Week 3||2
499656|NCT01009333|1222238|P4|STARTED|Week 3||2
499657|NCT01009333|1222239|P3|STARTED|Week 3||2
499658|NCT01009333|1222240|P2|STARTED|Week 3||2
499659|NCT01009333|1222241|P1|STARTED|Week 3||2
499660|NCT01009333|1222236|P6|NOT COMPLETED|Week 2||0
499661|NCT01009333|1222237|P5|NOT COMPLETED|Week 2||0
499662|NCT01009333|1222238|P4|NOT COMPLETED|Week 2||0
499663|NCT01009333|1222239|P3|NOT COMPLETED|Week 2||0
499664|NCT01009333|1222240|P2|NOT COMPLETED|Week 2||0
499665|NCT01009333|1222241|P1|NOT COMPLETED|Week 2||0
499666|NCT01009333|1222236|P6|COMPLETED|Week 2||2
499667|NCT01009333|1222237|P5|COMPLETED|Week 2||2
499668|NCT01009333|1222238|P4|COMPLETED|Week 2||2
499669|NCT01009333|1222239|P3|COMPLETED|Week 2||2
499670|NCT01009333|1222240|P2|COMPLETED|Week 2||2
499671|NCT01009333|1222241|P1|COMPLETED|Week 2||2
499672|NCT01009333|1222236|P6|STARTED|Week 2||2
499673|NCT01009333|1222237|P5|STARTED|Week 2||2
499674|NCT01009333|1222238|P4|STARTED|Week 2||2
499675|NCT01009333|1222239|P3|STARTED|Week 2||2
499676|NCT01009333|1222240|P2|STARTED|Week 2||2
499677|NCT01009333|1222241|P1|STARTED|Week 2||2
499678|NCT01009333|1222236|P6|NOT COMPLETED|Week 1||0
499679|NCT01009333|1222237|P5|NOT COMPLETED|Week 1||0
499680|NCT01009333|1222238|P4|NOT COMPLETED|Week 1||0
499681|NCT01009333|1222239|P3|NOT COMPLETED|Week 1||0
499682|NCT01009333|1222240|P2|NOT COMPLETED|Week 1||0
499683|NCT01009333|1222241|P1|NOT COMPLETED|Week 1||0
499684|NCT01009333|1222236|P6|COMPLETED|Week 1||2
499685|NCT01009333|1222237|P5|COMPLETED|Week 1||2
499686|NCT01009333|1222238|P4|COMPLETED|Week 1||2
499687|NCT01009333|1222239|P3|COMPLETED|Week 1||2
499688|NCT01009333|1222240|P2|COMPLETED|Week 1|1 participant did not progress to the second period due to a protocol violation.|3
499689|NCT01009333|1222241|P1|COMPLETED|Week 1||2
499690|NCT01009333|1222236|P6|STARTED|Week 1||2
499691|NCT01009333|1222237|P5|STARTED|Week 1||2
499692|NCT01009333|1222238|P4|STARTED|Week 1||2
499693|NCT01009333|1222239|P3|STARTED|Week 1||2
499694|NCT01009333|1222240|P2|STARTED|Week 1||3
499695|NCT01009333|1222241|P1|STARTED|Week 1||2
499696|NCT01009203|1222255|P1|NOT COMPLETED|Overall Study||7
499697|NCT01009203|1222255|P1|COMPLETED|Overall Study||6
499698|NCT01009203|1222255|P1|Received Treatment|Overall Study|One patient withdrew consent before treatment started.|12
499699|NCT01009203|1222255|P1|STARTED|Overall Study||13
499700|NCT01009138|1222264|P2|NOT COMPLETED|Overall Study||20
499701|NCT01009138|1222265|P1|NOT COMPLETED|Overall Study||13
499702|NCT01009138|1222264|P2|COMPLETED|Overall Study||88
499703|NCT01009138|1222265|P1|COMPLETED|Overall Study||93
499704|NCT01009138|1222264|P2|STARTED|Overall Study||108
499705|NCT01009138|1222265|P1|STARTED|Overall Study||106
499706|NCT01009099|1222295|P2|NOT COMPLETED|Overall Study||4
499707|NCT01009099|1222296|P1|NOT COMPLETED|Overall Study||5
499708|NCT01009099|1222295|P2|COMPLETED|Overall Study||57
499709|NCT01009099|1222296|P1|COMPLETED|Overall Study||53
499710|NCT01009099|1222295|P2|STARTED|Overall Study||61
499711|NCT01009099|1222296|P1|STARTED|Overall Study||58
499712|NCT01009086|1222305|P3|NOT COMPLETED|Overall Study||34
499713|NCT01009086|1222306|P2|NOT COMPLETED|Overall Study||47
499714|NCT01009086|1222307|P1|NOT COMPLETED|Overall Study||44
499715|NCT01009086|1222305|P3|COMPLETED|Overall Study||170
499716|NCT01009086|1222306|P2|COMPLETED|Overall Study||158
499717|NCT01009086|1222307|P1|COMPLETED|Overall Study||162
499718|NCT01009086|1222305|P3|STARTED|Overall Study||204
499719|NCT01009086|1222306|P2|STARTED|Overall Study||205
499720|NCT01009086|1222307|P1|STARTED|Overall Study||206
499721|NCT01009060|1222342|P2|NOT COMPLETED|Overall Study||5
499722|NCT01009060|1222343|P1|NOT COMPLETED|Overall Study||4
499723|NCT01009060|1222342|P2|COMPLETED|Overall Study||20
499724|NCT01009060|1222343|P1|COMPLETED|Overall Study||21
499725|NCT01009060|1222342|P2|STARTED|Overall Study||25
499726|NCT01009060|1222343|P1|STARTED|Overall Study||25
499727|NCT01009047|1222381|P2|NOT COMPLETED|Overall Study||26
499728|NCT01009047|1222382|P1|NOT COMPLETED|Overall Study||28
499729|NCT01009047|1222381|P2|COMPLETED|Overall Study||89
499730|NCT01009047|1222382|P1|COMPLETED|Overall Study||85
499731|NCT01009047|1222381|P2|STARTED|Overall Study||115
499732|NCT01009047|1222382|P1|STARTED|Overall Study||113
499733|NCT01009034|1222404|P1|NOT COMPLETED|Overall Study||4
499734|NCT01009034|1222404|P1|COMPLETED|Overall Study||10
499735|NCT01009034|1222404|P1|STARTED|Overall Study||14
499736|NCT01008995|1222412|P4|NOT COMPLETED|After Controlled Period||1
499737|NCT01008995|1222413|P3|NOT COMPLETED|After Controlled Period||2
499738|NCT01008995|1222414|P2|NOT COMPLETED|After Controlled Period||0
499739|NCT01008995|1222415|P1|NOT COMPLETED|After Controlled Period||0
499740|NCT01008995|1222412|P4|COMPLETED|After Controlled Period||156
499741|NCT01008995|1222413|P3|COMPLETED|After Controlled Period||156
499742|NCT01008995|1222414|P2|COMPLETED|After Controlled Period||0
499743|NCT01008995|1222415|P1|COMPLETED|After Controlled Period||0
499744|NCT01008995|1222412|P4|STARTED|After Controlled Period|2 participants discontinued in CP, had follow-up, and are among frequent and serious adverse events.|157
499745|NCT01008995|1222413|P3|STARTED|After Controlled Period|1 placebo participant discontinued after completing the CP and did not receive ustekinumab 45 mg.|158
499746|NCT01008995|1222414|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
499747|NCT01008995|1222415|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
499748|NCT01008995|1222412|P4|NOT COMPLETED|Controlled Period||0
499749|NCT01008995|1222413|P3|NOT COMPLETED|Controlled Period||0
499750|NCT01008995|1222414|P2|NOT COMPLETED|Controlled Period||3
499751|NCT01008995|1222415|P1|NOT COMPLETED|Controlled Period||3
499752|NCT01008995|1222412|P4|COMPLETED|Controlled Period||0
499753|NCT01008995|1222413|P3|COMPLETED|Controlled Period||0
499754|NCT01008995|1222414|P2|COMPLETED|Controlled Period||157
499755|NCT01008995|1222415|P1|COMPLETED|Controlled Period||159
499756|NCT01008995|1222412|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
499757|NCT01008995|1222413|P3|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
499758|NCT01008995|1222414|P2|STARTED|Controlled Period||160
499759|NCT01008995|1222415|P1|STARTED|Controlled Period||162
499760|NCT01008969|1222427|P1|NOT COMPLETED|Overall Study||0
499761|NCT01008969|1222427|P1|COMPLETED|Overall Study||10
499762|NCT01008969|1222427|P1|STARTED|Overall Study||10
499763|NCT01008943|1222432|P1|NOT COMPLETED|Overall Study||1
499764|NCT01008943|1222432|P1|COMPLETED|Overall Study||15
499765|NCT01008943|1222432|P1|STARTED|Overall Study||16
499766|NCT01008904|1222439|P1|NOT COMPLETED|Overall Study||4
499767|NCT01008904|1222439|P1|COMPLETED|Overall Study||25
499768|NCT01008904|1222439|P1|STARTED|Overall Study||29
499769|NCT01008722|1222446|P2|NOT COMPLETED|Overall Study||0
499770|NCT01008722|1222447|P1|NOT COMPLETED|Overall Study||0
499771|NCT01008722|1222446|P2|COMPLETED|Overall Study||71
499772|NCT01008722|1222447|P1|COMPLETED|Overall Study||36
499773|NCT01008722|1222446|P2|STARTED|Overall Study|Based on Power Calculations to see 20% outcome improvement by adding FIRM-guided ablation to PVI|71
499774|NCT01008722|1222447|P1|STARTED|Overall Study|Based on Power Calculations to see 20% outcome improvement by adding FIRM-guided ablation to PVI|36
499775|NCT01008696|1222457|P2|NOT COMPLETED|Overall Study||17
499776|NCT01008696|1222458|P1|NOT COMPLETED|Overall Study||17
499777|NCT01008696|1222457|P2|COMPLETED|Overall Study||92
499778|NCT01008696|1222458|P1|COMPLETED|Overall Study||91
499779|NCT01008696|1222457|P2|STARTED|Overall Study||109
499780|NCT01008696|1222458|P1|STARTED|Overall Study||108
499781|NCT01008618|1222468|P3|NOT COMPLETED|Period 2 (Double-Blind Period)||38
499782|NCT01008618|1222469|P2|NOT COMPLETED|Period 2 (Double-Blind Period)||36
499783|NCT01008618|1222470|P1|NOT COMPLETED|Period 2 (Double-Blind Period)||0
499784|NCT01008618|1222468|P3|COMPLETED|Period 2 (Double-Blind Period)||39
499785|NCT01008618|1222469|P2|COMPLETED|Period 2 (Double-Blind Period)||37
499786|NCT01008618|1222470|P1|COMPLETED|Period 2 (Double-Blind Period)||0
499787|NCT01008618|1222468|P3|STARTED|Period 2 (Double-Blind Period)||77
499788|NCT01008618|1222469|P2|STARTED|Period 2 (Double-Blind Period)||73
499789|NCT01008618|1222470|P1|STARTED|Period 2 (Double-Blind Period)||0
499790|NCT01008618|1222468|P3|NOT COMPLETED|Period 1 (Titration Period)||0
499791|NCT01008618|1222469|P2|NOT COMPLETED|Period 1 (Titration Period)||0
499792|NCT01008618|1222470|P1|NOT COMPLETED|Period 1 (Titration Period)||68
499793|NCT01008618|1222468|P3|COMPLETED|Period 1 (Titration Period)||0
499794|NCT01008618|1222469|P2|COMPLETED|Period 1 (Titration Period)||0
499795|NCT01008618|1222470|P1|COMPLETED|Period 1 (Titration Period)||150
499796|NCT01008618|1222468|P3|STARTED|Period 1 (Titration Period)||0
499797|NCT01008618|1222469|P2|STARTED|Period 1 (Titration Period)||0
499798|NCT01008618|1222470|P1|STARTED|Period 1 (Titration Period)||218
499799|NCT01008605|1222495|P1|NOT COMPLETED|Overall Study||0
499800|NCT01008605|1222495|P1|COMPLETED|Overall Study||48
499801|NCT01008605|1222495|P1|STARTED|Overall Study||48
499802|NCT01008553|1222519|P3|NOT COMPLETED|Period 2 (Double-Blind Period)||51
499803|NCT01008553|1222520|P2|NOT COMPLETED|Period 2 (Double-Blind Period)||37
499804|NCT01008553|1222521|P1|NOT COMPLETED|Period 2 (Double-Blind Period)||0
499805|NCT01008553|1222519|P3|COMPLETED|Period 2 (Double-Blind Period)||28
499806|NCT01008553|1222520|P2|COMPLETED|Period 2 (Double-Blind Period)||47
499807|NCT01008553|1222521|P1|COMPLETED|Period 2 (Double-Blind Period)||0
499808|NCT01008553|1222519|P3|STARTED|Period 2 (Double-Blind Period)||79
499809|NCT01008553|1222520|P2|STARTED|Period 2 (Double-Blind Period)||84
499810|NCT01008553|1222521|P1|STARTED|Period 2 (Double-Blind Period)||0
499811|NCT01008553|1222519|P3|NOT COMPLETED|Period 1 (Titration Period)||0
499812|NCT01008553|1222520|P2|NOT COMPLETED|Period 1 (Titration Period)||0
499813|NCT01008553|1222521|P1|NOT COMPLETED|Period 1 (Titration Period)||95
499814|NCT01008553|1222519|P3|COMPLETED|Period 1 (Titration Period)||0
499815|NCT01008553|1222520|P2|COMPLETED|Period 1 (Titration Period)||0
499816|NCT01008553|1222521|P1|COMPLETED|Period 1 (Titration Period)||163
499817|NCT01008553|1222519|P3|STARTED|Period 1 (Titration Period)||0
499818|NCT01008553|1222520|P2|STARTED|Period 1 (Titration Period)||0
499819|NCT01008553|1222521|P1|STARTED|Period 1 (Titration Period)||258
499820|NCT01008475|1222553|P7|NOT COMPLETED|Overall Study||4
499821|NCT01008475|1222554|P6|NOT COMPLETED|Overall Study||6
499822|NCT01008475|1222555|P5|NOT COMPLETED|Overall Study||5
499823|NCT01008475|1222556|P4|NOT COMPLETED|Overall Study||0
499824|NCT01008475|1222557|P3|NOT COMPLETED|Overall Study||0
499825|NCT01008475|1222558|P2|NOT COMPLETED|Overall Study||0
499826|NCT01008475|1222559|P1|NOT COMPLETED|Overall Study||0
499827|NCT01008475|1222553|P7|COMPLETED|Overall Study||67
499828|NCT01008475|1222554|P6|COMPLETED|Overall Study||67
499829|NCT01008475|1222555|P5|COMPLETED|Overall Study||67
499830|NCT01008475|1222556|P4|COMPLETED|Overall Study||3
499831|NCT01008475|1222557|P3|COMPLETED|Overall Study||7
499832|NCT01008475|1222558|P2|COMPLETED|Overall Study||3
499833|NCT01008475|1222559|P1|COMPLETED|Overall Study||3
499834|NCT01008475|1222553|P7|Safety Analysis Set|Overall Study||69
499835|NCT01008475|1222554|P6|Safety Analysis Set|Overall Study||72
499836|NCT01008475|1222555|P5|Safety Analysis Set|Overall Study|1 subject randomized to EMD525797 1000 mg group received only SoC. Hence, reported under SOC group.|73
499837|NCT01008475|1222556|P4|Safety Analysis Set|Overall Study||3
499838|NCT01008475|1222557|P3|Safety Analysis Set|Overall Study||7
499839|NCT01008475|1222558|P2|Safety Analysis Set|Overall Study||3
499840|NCT01008475|1222559|P1|Safety Analysis Set|Overall Study||3
499841|NCT01008475|1222553|P7|STARTED|Overall Study||71
499842|NCT01008475|1222554|P6|STARTED|Overall Study||73
499843|NCT01008475|1222555|P5|STARTED|Overall Study||72
499844|NCT01008475|1222556|P4|STARTED|Overall Study||3
499845|NCT01008475|1222557|P3|STARTED|Overall Study||7
499846|NCT01008475|1222558|P2|STARTED|Overall Study||3
499847|NCT01008475|1222559|P1|STARTED|Overall Study||3
499848|NCT01008449|1222589|P2|NOT COMPLETED|Overall Study||19
499849|NCT01008449|1222590|P1|NOT COMPLETED|Overall Study||29
499850|NCT01008449|1222589|P2|COMPLETED|Overall Study||179
499851|NCT01008449|1222590|P1|COMPLETED|Overall Study||171
499852|NCT01008449|1222589|P2|STARTED|Overall Study||198
499853|NCT01008449|1222590|P1|STARTED|Overall Study||200
499854|NCT01008319|1222612|P2|NOT COMPLETED|Overall Study||0
499855|NCT01008319|1222613|P1|NOT COMPLETED|Overall Study||0
499856|NCT01008319|1222612|P2|COMPLETED|Overall Study||60
499857|NCT01008319|1222613|P1|COMPLETED|Overall Study||60
499858|NCT01008319|1222612|P2|STARTED|Overall Study||60
499859|NCT01008319|1222613|P1|STARTED|Overall Study||60
499860|NCT01008280|1222625|P2|NOT COMPLETED|Overall Study||19
499861|NCT01008280|1222626|P1|NOT COMPLETED|Overall Study||21
499862|NCT01008280|1222625|P2|COMPLETED|Overall Study||73
499863|NCT01008280|1222626|P1|COMPLETED|Overall Study||67
499864|NCT01008280|1222625|P2|STARTED|Overall Study||92
499865|NCT01008280|1222626|P1|STARTED|Overall Study||88
499866|NCT01007916|1222636|P2|NOT COMPLETED|Period 2, 4 Weeks of Wear||0
499867|NCT01007916|1222637|P1|NOT COMPLETED|Period 2, 4 Weeks of Wear||1
499868|NCT01007916|1222636|P2|COMPLETED|Period 2, 4 Weeks of Wear||25
499869|NCT01007916|1222637|P1|COMPLETED|Period 2, 4 Weeks of Wear||21
499870|NCT01007916|1222636|P2|STARTED|Period 2, 4 Weeks of Wear|One participant completed Period 1 but did not start Period 2 due to failing inclusion criteria.|25
499871|NCT01007916|1222637|P1|STARTED|Period 2, 4 Weeks of Wear||22
499872|NCT01007916|1222636|P2|NOT COMPLETED|Period 1, 4 Weeks of Wear||0
499873|NCT01007916|1222637|P1|NOT COMPLETED|Period 1, 4 Weeks of Wear||1
499874|NCT01007916|1222636|P2|COMPLETED|Period 1, 4 Weeks of Wear||26
499875|NCT01007916|1222637|P1|COMPLETED|Period 1, 4 Weeks of Wear||22
499876|NCT01007916|1222636|P2|STARTED|Period 1, 4 Weeks of Wear||26
499877|NCT01007916|1222637|P1|STARTED|Period 1, 4 Weeks of Wear||23
499878|NCT01007942|1222645|P2|NOT COMPLETED|Overall Study||278
499879|NCT01007942|1222646|P1|NOT COMPLETED|Overall Study||281
499880|NCT01007942|1222645|P2|COMPLETED|Overall Study|Pts completed= on treatment at time of DCO. Not Completed = ended treatment as per protocol.|7
499881|NCT01007942|1222646|P1|COMPLETED|Overall Study|Pts completed= on treatment at time of DCO. Not Completed = ended treatment as per protocol.|3
499882|NCT01007942|1222645|P2|STARTED|Overall Study||285
499883|NCT01007942|1222646|P1|STARTED|Overall Study||284
499884|NCT01007838|1222672|P4|NOT COMPLETED|Overall Study||0
499885|NCT01007838|1222673|P3|NOT COMPLETED|Overall Study||0
499886|NCT01007838|1222674|P2|NOT COMPLETED|Overall Study||0
499887|NCT01007838|1222675|P1|NOT COMPLETED|Overall Study||3
499888|NCT01007838|1222672|P4|COMPLETED|Overall Study||4
499889|NCT01007838|1222673|P3|COMPLETED|Overall Study||5
499890|NCT01007838|1222674|P2|COMPLETED|Overall Study||11
499891|NCT01007838|1222675|P1|COMPLETED|Overall Study||9
499892|NCT01007838|1222672|P4|STARTED|Overall Study||4
499893|NCT01007838|1222673|P3|STARTED|Overall Study||5
499894|NCT01007838|1222674|P2|STARTED|Overall Study||11
499895|NCT01007838|1222675|P1|STARTED|Overall Study||12
499896|NCT01007812|1222685|P2|NOT COMPLETED|Period 2, One Week||0
499897|NCT01007812|1222686|P1|NOT COMPLETED|Period 2, One Week||0
499898|NCT01007812|1222685|P2|COMPLETED|Period 2, One Week||24
499899|NCT01007812|1222686|P1|COMPLETED|Period 2, One Week||24
499900|NCT01007812|1222685|P2|STARTED|Period 2, One Week||24
499901|NCT01007812|1222686|P1|STARTED|Period 2, One Week||24
499902|NCT01007812|1222685|P2|NOT COMPLETED|Period 1, One Week||1
499903|NCT01007812|1222686|P1|NOT COMPLETED|Period 1, One Week||1
499904|NCT01007812|1222685|P2|COMPLETED|Period 1, One Week||24
499905|NCT01007812|1222686|P1|COMPLETED|Period 1, One Week||24
499906|NCT01007812|1222685|P2|STARTED|Period 1, One Week||25
499907|NCT01007812|1222686|P1|STARTED|Period 1, One Week||25
499908|NCT01007656|1222692|P1|NOT COMPLETED|Overall Study||0
499909|NCT01007656|1222692|P1|COMPLETED|Overall Study||31
499910|NCT01007656|1222692|P1|STARTED|Overall Study||31
499911|NCT01007643|1222712|P2|NOT COMPLETED|Overall Study||0
499912|NCT01007643|1222713|P1|NOT COMPLETED|Overall Study||0
499913|NCT01007643|1222712|P2|COMPLETED|Overall Study||14
499914|NCT01007643|1222713|P1|COMPLETED|Overall Study||8
499915|NCT01007643|1222712|P2|STARTED|Overall Study||14
499916|NCT01007643|1222713|P1|STARTED|Overall Study||8
499917|NCT01007552|1222719|P1|NOT COMPLETED|Overall Study||1
499918|NCT01007552|1222719|P1|COMPLETED|Overall Study||49
499919|NCT01007552|1222719|P1|STARTED|Overall Study||50
499920|NCT01007435|1222733|P4|NOT COMPLETED|Overall Study||56
499921|NCT01007435|1222734|P3|NOT COMPLETED|Overall Study||64
499922|NCT01007435|1222735|P2|NOT COMPLETED|Overall Study||59
499923|NCT01007435|1222736|P1|NOT COMPLETED|Overall Study||63
499924|NCT01007435|1222733|P4|COMPLETED|Overall Study||236
499925|NCT01007435|1222734|P3|COMPLETED|Overall Study||227
499926|NCT01007435|1222735|P2|COMPLETED|Overall Study||231
499927|NCT01007435|1222736|P1|COMPLETED|Overall Study||226
499928|NCT01007435|1222733|P4|STARTED|Overall Study||292
499929|NCT01007435|1222734|P3|STARTED|Overall Study||291
499930|NCT01007435|1222735|P2|STARTED|Overall Study||290
499931|NCT01007435|1222736|P1|STARTED|Overall Study||289
499932|NCT01007396|1222778|P1|NOT COMPLETED|Overall Study||47
499933|NCT01007396|1222778|P1|COMPLETED|Overall Study||275
499934|NCT01007396|1222778|P1|STARTED|Overall Study||322
499935|NCT01007253|1222783|P4|NOT COMPLETED|Fourth Intervention||0
499936|NCT01007253|1222784|P3|NOT COMPLETED|Fourth Intervention||0
499937|NCT01007253|1222785|P2|NOT COMPLETED|Fourth Intervention||0
499938|NCT01007253|1222786|P1|NOT COMPLETED|Fourth Intervention||0
499939|NCT01007253|1222783|P4|COMPLETED|Fourth Intervention||5
499940|NCT01007253|1222784|P3|COMPLETED|Fourth Intervention||5
499941|NCT01007253|1222785|P2|COMPLETED|Fourth Intervention||5
499942|NCT01007253|1222786|P1|COMPLETED|Fourth Intervention||5
499943|NCT01007253|1222783|P4|STARTED|Fourth Intervention||5
499944|NCT01007253|1222784|P3|STARTED|Fourth Intervention||5
499945|NCT01007253|1222785|P2|STARTED|Fourth Intervention||5
499946|NCT01007253|1222786|P1|STARTED|Fourth Intervention||5
499947|NCT01007253|1222783|P4|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
499948|NCT01007253|1222784|P3|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
499949|NCT01007253|1222785|P2|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
499950|NCT01007253|1222786|P1|NOT COMPLETED|Washout Period (2 Weeks) # 3||1
499951|NCT01007253|1222783|P4|COMPLETED|Washout Period (2 Weeks) # 3||5
499952|NCT01007253|1222784|P3|COMPLETED|Washout Period (2 Weeks) # 3||5
499953|NCT01007253|1222785|P2|COMPLETED|Washout Period (2 Weeks) # 3||5
499954|NCT01007253|1222786|P1|COMPLETED|Washout Period (2 Weeks) # 3||5
499955|NCT01007253|1222783|P4|STARTED|Washout Period (2 Weeks) # 3||5
499956|NCT01007253|1222784|P3|STARTED|Washout Period (2 Weeks) # 3||5
499957|NCT01007253|1222785|P2|STARTED|Washout Period (2 Weeks) # 3||5
499958|NCT01007253|1222786|P1|STARTED|Washout Period (2 Weeks) # 3||6
499959|NCT01007253|1222783|P4|NOT COMPLETED|Third Intervention||0
499960|NCT01007253|1222784|P3|NOT COMPLETED|Third Intervention||0
499961|NCT01007253|1222785|P2|NOT COMPLETED|Third Intervention||0
499962|NCT01007253|1222786|P1|NOT COMPLETED|Third Intervention||0
499963|NCT01007253|1222783|P4|COMPLETED|Third Intervention||5
499964|NCT01007253|1222784|P3|COMPLETED|Third Intervention||5
499965|NCT01007253|1222785|P2|COMPLETED|Third Intervention||5
499966|NCT01007253|1222786|P1|COMPLETED|Third Intervention||6
499967|NCT01007253|1222783|P4|STARTED|Third Intervention||5
499968|NCT01007253|1222784|P3|STARTED|Third Intervention||5
499969|NCT01007253|1222785|P2|STARTED|Third Intervention||5
499970|NCT01007253|1222786|P1|STARTED|Third Intervention||6
499971|NCT01007253|1222783|P4|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
499972|NCT01007253|1222784|P3|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
499973|NCT01007253|1222785|P2|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
499974|NCT01007253|1222786|P1|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
499975|NCT01007253|1222783|P4|COMPLETED|Washout Period (2 Weeks) # 2||5
499976|NCT01007253|1222784|P3|COMPLETED|Washout Period (2 Weeks) # 2||5
499977|NCT01007253|1222785|P2|COMPLETED|Washout Period (2 Weeks) # 2||5
499978|NCT01007253|1222786|P1|COMPLETED|Washout Period (2 Weeks) # 2||6
499979|NCT01007253|1222783|P4|STARTED|Washout Period (2 Weeks) # 2||5
499980|NCT01007253|1222784|P3|STARTED|Washout Period (2 Weeks) # 2||5
499981|NCT01007253|1222785|P2|STARTED|Washout Period (2 Weeks) # 2||5
499982|NCT01007253|1222786|P1|STARTED|Washout Period (2 Weeks) # 2||6
499983|NCT01007253|1222783|P4|NOT COMPLETED|Second Intervention||0
499984|NCT01007253|1222784|P3|NOT COMPLETED|Second Intervention||0
499985|NCT01007253|1222785|P2|NOT COMPLETED|Second Intervention||0
499986|NCT01007253|1222786|P1|NOT COMPLETED|Second Intervention||0
499987|NCT01007253|1222783|P4|COMPLETED|Second Intervention||5
499988|NCT01007253|1222784|P3|COMPLETED|Second Intervention||5
499989|NCT01007253|1222785|P2|COMPLETED|Second Intervention||5
499990|NCT01007253|1222786|P1|COMPLETED|Second Intervention||6
499991|NCT01007253|1222783|P4|STARTED|Second Intervention||5
499992|NCT01007253|1222784|P3|STARTED|Second Intervention||5
499993|NCT01007253|1222785|P2|STARTED|Second Intervention||5
499994|NCT01007253|1222786|P1|STARTED|Second Intervention||6
499995|NCT01007253|1222783|P4|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
499996|NCT01007253|1222784|P3|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
499997|NCT01007253|1222785|P2|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
499998|NCT01007253|1222786|P1|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
499999|NCT01007253|1222783|P4|COMPLETED|Washout Period (2 Weeks) # 1||5
500000|NCT01007253|1222784|P3|COMPLETED|Washout Period (2 Weeks) # 1||5
500001|NCT01007253|1222785|P2|COMPLETED|Washout Period (2 Weeks) # 1||5
500002|NCT01007253|1222786|P1|COMPLETED|Washout Period (2 Weeks) # 1||6
500003|NCT01007253|1222783|P4|STARTED|Washout Period (2 Weeks) # 1||5
500004|NCT01007253|1222784|P3|STARTED|Washout Period (2 Weeks) # 1||5
500005|NCT01007253|1222785|P2|STARTED|Washout Period (2 Weeks) # 1||5
500006|NCT01007253|1222786|P1|STARTED|Washout Period (2 Weeks) # 1||6
500007|NCT01007253|1222783|P4|NOT COMPLETED|First Intervention||0
500008|NCT01007253|1222784|P3|NOT COMPLETED|First Intervention||0
500009|NCT01007253|1222785|P2|NOT COMPLETED|First Intervention||0
500010|NCT01007253|1222786|P1|NOT COMPLETED|First Intervention||0
500011|NCT01007253|1222783|P4|COMPLETED|First Intervention||5
500012|NCT01007253|1222784|P3|COMPLETED|First Intervention||5
500013|NCT01007253|1222785|P2|COMPLETED|First Intervention||5
500014|NCT01007253|1222786|P1|COMPLETED|First Intervention||6
500015|NCT01007253|1222783|P4|STARTED|First Intervention||5
500016|NCT01007253|1222784|P3|STARTED|First Intervention||5
500017|NCT01007253|1222785|P2|STARTED|First Intervention||5
500018|NCT01007253|1222786|P1|STARTED|First Intervention||6
500019|NCT01007149|1222818|P2|NOT COMPLETED|Overall Study||1
500020|NCT01007149|1222819|P1|NOT COMPLETED|Overall Study||0
500021|NCT01007149|1222818|P2|COMPLETED|Overall Study||20
500022|NCT01007149|1222819|P1|COMPLETED|Overall Study||20
500023|NCT01007149|1222818|P2|STARTED|Overall Study||21
500024|NCT01007149|1222819|P1|STARTED|Overall Study||20
500025|NCT01007123|1222845|P4|NOT COMPLETED|Overall Study||6
500026|NCT01007123|1222846|P3|NOT COMPLETED|Overall Study||11
500027|NCT01007123|1222847|P2|NOT COMPLETED|Overall Study||6
500028|NCT01007123|1222848|P1|NOT COMPLETED|Overall Study||6
500029|NCT01007123|1222845|P4|COMPLETED|Overall Study||41
500030|NCT01007123|1222846|P3|COMPLETED|Overall Study||37
500031|NCT01007123|1222847|P2|COMPLETED|Overall Study||41
500032|NCT01007123|1222848|P1|COMPLETED|Overall Study||42
500033|NCT01007123|1222845|P4|STARTED|Overall Study||47
500034|NCT01007123|1222846|P3|STARTED|Overall Study||48
500035|NCT01007123|1222847|P2|STARTED|Overall Study||47
500036|NCT01007123|1222848|P1|STARTED|Overall Study||48
500037|NCT01007110|1222879|P2|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||5
500038|NCT01007110|1222880|P1|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||12
500039|NCT01007110|1222879|P2|COMPLETED|Neonatal Behavioral Assessment Scale (NB||15
500040|NCT01007110|1222880|P1|COMPLETED|Neonatal Behavioral Assessment Scale (NB||12
500041|NCT01007110|1222879|P2|STARTED|Neonatal Behavioral Assessment Scale (NB||20
500042|NCT01007110|1222880|P1|STARTED|Neonatal Behavioral Assessment Scale (NB||24
500043|NCT01007110|1222879|P2|NOT COMPLETED|Follow-Up at 36 Weeks||2
500044|NCT01007110|1222880|P1|NOT COMPLETED|Follow-Up at 36 Weeks||0
500045|NCT01007110|1222879|P2|COMPLETED|Follow-Up at 36 Weeks||20
500046|NCT01007110|1222880|P1|COMPLETED|Follow-Up at 36 Weeks||24
500047|NCT01007110|1222879|P2|STARTED|Follow-Up at 36 Weeks||22
500048|NCT01007110|1222880|P1|STARTED|Follow-Up at 36 Weeks||24
500049|NCT01007110|1222879|P2|NOT COMPLETED|Follow-Up at 32 Weeks||1
500050|NCT01007110|1222880|P1|NOT COMPLETED|Follow-Up at 32 Weeks||1
500051|NCT01007110|1222879|P2|COMPLETED|Follow-Up at 32 Weeks||22
500052|NCT01007110|1222880|P1|COMPLETED|Follow-Up at 32 Weeks||24
500053|NCT01007110|1222879|P2|STARTED|Follow-Up at 32 Weeks||23
500054|NCT01007110|1222880|P1|STARTED|Follow-Up at 32 Weeks||25
500055|NCT01007110|1222879|P2|NOT COMPLETED|Follow-Up at 24 Weeks||4
500056|NCT01007110|1222880|P1|NOT COMPLETED|Follow-Up at 24 Weeks||0
500057|NCT01007110|1222879|P2|COMPLETED|Follow-Up at 24 Weeks||23
500058|NCT01007110|1222880|P1|COMPLETED|Follow-Up at 24 Weeks||25
500059|NCT01007110|1222879|P2|STARTED|Follow-Up at 24 Weeks||27
500060|NCT01007110|1222880|P1|STARTED|Follow-Up at 24 Weeks||25
500061|NCT01007110|1222879|P2|NOT COMPLETED|Allocation||8
500062|NCT01007110|1222880|P1|NOT COMPLETED|Allocation||7
500063|NCT01007110|1222879|P2|COMPLETED|Allocation||27
500064|NCT01007110|1222880|P1|COMPLETED|Allocation||25
500065|NCT01007110|1222879|P2|STARTED|Allocation||35
500066|NCT01007110|1222880|P1|STARTED|Allocation||32
500067|NCT01007071|1222896|P2|NOT COMPLETED|Overall Study||0
500068|NCT01007071|1222897|P1|NOT COMPLETED|Overall Study||0
500069|NCT01007071|1222896|P2|COMPLETED|Overall Study||5
500070|NCT01007071|1222897|P1|COMPLETED|Overall Study||6
500071|NCT01007071|1222896|P2|STARTED|Overall Study||5
500072|NCT01007071|1222897|P1|STARTED|Overall Study||6
500073|NCT01006980|1222907|P2|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||84
500074|NCT01006980|1222908|P1|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
500075|NCT01006980|1222907|P2|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
500076|NCT01006980|1222908|P1|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
500077|NCT01006980|1222907|P2|STARTED|Crossover: Dacarbazine to Vemurafenib|Participants who crossed over from dacarbazine to vemurafenib treatment.|84
500078|NCT01006980|1222908|P1|STARTED|Crossover: Dacarbazine to Vemurafenib||0
500079|NCT01006980|1222907|P2|NOT COMPLETED|Vemurafenib and Dacarbazine||338
500080|NCT01006980|1222908|P1|NOT COMPLETED|Vemurafenib and Dacarbazine||337
500081|NCT01006980|1222907|P2|COMPLETED|Vemurafenib and Dacarbazine||0
500082|NCT01006980|1222908|P1|COMPLETED|Vemurafenib and Dacarbazine||0
500083|NCT01006980|1222907|P2|Treated|Vemurafenib and Dacarbazine||293
500084|NCT01006980|1222908|P1|Treated|Vemurafenib and Dacarbazine||336
500085|NCT01006980|1222907|P2|STARTED|Vemurafenib and Dacarbazine||338
500086|NCT01006980|1222908|P1|STARTED|Vemurafenib and Dacarbazine||337
500087|NCT01006889|1222928|P1|NOT COMPLETED|Overall Study||3
500088|NCT01006889|1222928|P1|COMPLETED|Overall Study||17
500089|NCT01006889|1222928|P1|STARTED|Overall Study||20
500090|NCT01006707|1222939|P3|NOT COMPLETED|Study Session 3||0
500091|NCT01006707|1222940|P2|NOT COMPLETED|Study Session 3||0
500092|NCT01006707|1222941|P1|NOT COMPLETED|Study Session 3||0
500093|NCT01006707|1222939|P3|COMPLETED|Study Session 3||6
500094|NCT01006707|1222940|P2|COMPLETED|Study Session 3||4
500095|NCT01006707|1222941|P1|COMPLETED|Study Session 3||0
500096|NCT01006707|1222939|P3|STARTED|Study Session 3||6
500097|NCT01006707|1222940|P2|STARTED|Study Session 3||4
500098|NCT01006707|1222941|P1|STARTED|Study Session 3||0
500099|NCT01006707|1222939|P3|NOT COMPLETED|Study Session 2||0
500100|NCT01006707|1222940|P2|NOT COMPLETED|Study Session 2||0
500101|NCT01006707|1222941|P1|NOT COMPLETED|Study Session 2||0
500102|NCT01006707|1222939|P3|COMPLETED|Study Session 2||6
500103|NCT01006707|1222940|P2|COMPLETED|Study Session 2||4
500104|NCT01006707|1222941|P1|COMPLETED|Study Session 2||0
500105|NCT01006707|1222939|P3|STARTED|Study Session 2||6
500106|NCT01006707|1222940|P2|STARTED|Study Session 2||4
500107|NCT01006707|1222941|P1|STARTED|Study Session 2||0
500108|NCT01006707|1222939|P3|NOT COMPLETED|Study Session 1||0
500109|NCT01006707|1222940|P2|NOT COMPLETED|Study Session 1||0
500110|NCT01006707|1222941|P1|NOT COMPLETED|Study Session 1||5
500111|NCT01006707|1222939|P3|COMPLETED|Study Session 1||0
500112|NCT01006707|1222940|P2|COMPLETED|Study Session 1||0
500113|NCT01006707|1222941|P1|COMPLETED|Study Session 1||10
500114|NCT01006707|1222939|P3|STARTED|Study Session 1||0
500115|NCT01006707|1222940|P2|STARTED|Study Session 1||0
500116|NCT01006707|1222941|P1|STARTED|Study Session 1||15
500117|NCT01006655|1222954|P2|NOT COMPLETED|Second Intervention||0
500118|NCT01006655|1222955|P1|NOT COMPLETED|Second Intervention||0
500119|NCT01006655|1222954|P2|COMPLETED|Second Intervention||10
500120|NCT01006655|1222955|P1|COMPLETED|Second Intervention||11
500121|NCT01006655|1222954|P2|STARTED|Second Intervention||10
500122|NCT01006655|1222955|P1|STARTED|Second Intervention||11
500123|NCT01006655|1222954|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
500124|NCT01006655|1222955|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
500125|NCT01006655|1222954|P2|COMPLETED|Washout Period of 2 Weeks||10
500126|NCT01006655|1222955|P1|COMPLETED|Washout Period of 2 Weeks||11
500127|NCT01006655|1222954|P2|STARTED|Washout Period of 2 Weeks||10
500128|NCT01006655|1222955|P1|STARTED|Washout Period of 2 Weeks||11
500129|NCT01006655|1222954|P2|NOT COMPLETED|First Intervention||0
500130|NCT01006655|1222955|P1|NOT COMPLETED|First Intervention||0
500131|NCT01006655|1222954|P2|COMPLETED|First Intervention||10
500132|NCT01006655|1222955|P1|COMPLETED|First Intervention||11
500133|NCT01006655|1222954|P2|STARTED|First Intervention||10
500134|NCT01006655|1222955|P1|STARTED|First Intervention||11
500135|NCT01006629|1222961|P1|NOT COMPLETED|Overall Study||6
500136|NCT01006629|1222961|P1|COMPLETED|Overall Study||94
500137|NCT01006629|1222961|P1|STARTED|Overall Study||100
500138|NCT01006616|1222976|P4|NOT COMPLETED|Period 2 (18 Months)||82
500139|NCT01006616|1222977|P3|NOT COMPLETED|Period 2 (18 Months)||55
500140|NCT01006616|1222978|P2|NOT COMPLETED|Period 2 (18 Months)||63
500141|NCT01006616|1222979|P1|NOT COMPLETED|Period 2 (18 Months)||75
500142|NCT01006616|1222976|P4|COMPLETED|Period 2 (18 Months)||0
500143|NCT01006616|1222977|P3|COMPLETED|Period 2 (18 Months)||0
500144|NCT01006616|1222978|P2|COMPLETED|Period 2 (18 Months)||0
500145|NCT01006616|1222979|P1|COMPLETED|Period 2 (18 Months)||0
500146|NCT01006616|1222976|P4|Treated|Period 2 (18 Months)||82
500147|NCT01006616|1222977|P3|Treated|Period 2 (18 Months)||55
500148|NCT01006616|1222978|P2|Treated|Period 2 (18 Months)||63
500149|NCT01006616|1222979|P1|Treated|Period 2 (18 Months)||75
500150|NCT01006616|1222976|P4|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|82
500151|NCT01006616|1222977|P3|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|55
500152|NCT01006616|1222978|P2|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|63
500153|NCT01006616|1222979|P1|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|75
500154|NCT01006616|1222976|P4|NOT COMPLETED|Period 1 (6 Months)||27
500155|NCT01006616|1222977|P3|NOT COMPLETED|Period 1 (6 Months)||51
500156|NCT01006616|1222978|P2|NOT COMPLETED|Period 1 (6 Months)||54
500157|NCT01006616|1222979|P1|NOT COMPLETED|Period 1 (6 Months)||26
500158|NCT01006616|1222976|P4|COMPLETED|Period 1 (6 Months)||128
500159|NCT01006616|1222977|P3|COMPLETED|Period 1 (6 Months)||102
500160|NCT01006616|1222978|P2|COMPLETED|Period 1 (6 Months)||102
500161|NCT01006616|1222979|P1|COMPLETED|Period 1 (6 Months)||126
500162|NCT01006616|1222976|P4|Treated|Period 1 (6 Months)||154
500163|NCT01006616|1222977|P3|Treated|Period 1 (6 Months)||152
500164|NCT01006616|1222978|P2|Treated|Period 1 (6 Months)||156
500165|NCT01006616|1222979|P1|Treated|Period 1 (6 Months)||152
500166|NCT01006616|1222976|P4|STARTED|Period 1 (6 Months)||155
500167|NCT01006616|1222977|P3|STARTED|Period 1 (6 Months)||153
500168|NCT01006616|1222978|P2|STARTED|Period 1 (6 Months)||156
500169|NCT01006616|1222979|P1|STARTED|Period 1 (6 Months)||152
500170|NCT01006603|1223115|P2|NOT COMPLETED|Overall Study||75
500171|NCT01006603|1223116|P1|NOT COMPLETED|Overall Study||71
500172|NCT01006603|1223115|P2|COMPLETED|Overall Study||285
500173|NCT01006603|1223116|P1|COMPLETED|Overall Study||289
500174|NCT01006603|1223115|P2|STARTED|Overall Study|Completed lead-in period and were randomised|360
500175|NCT01006603|1223116|P1|STARTED|Overall Study|Completed lead-in period and were randomised|360
500176|NCT01006590|1223136|P2|NOT COMPLETED|Overall Study||32
500177|NCT01006590|1223137|P1|NOT COMPLETED|Overall Study||28
500178|NCT01006590|1223136|P2|COMPLETED|Overall Study|Completed 24 weeks of treatment|107
500179|NCT01006590|1223137|P1|COMPLETED|Overall Study|Completed 24 weeks of treatment|119
500180|NCT01006590|1223136|P2|STARTED|Overall Study|Randomised and treated|139
500181|NCT01006590|1223137|P1|STARTED|Overall Study|Randomised and treated|147
500182|NCT01006356|1223153|P1|NOT COMPLETED|Overall Study||42
500183|NCT01006356|1223153|P1|COMPLETED|Overall Study||99
500184|NCT01006356|1223153|P1|STARTED|Overall Study||141
500185|NCT01006291|1223168|P3|NOT COMPLETED|Overall Study||27
500186|NCT01006291|1223169|P2|NOT COMPLETED|Overall Study||24
500187|NCT01006291|1223170|P1|NOT COMPLETED|Overall Study||26
500188|NCT01006291|1223168|P3|COMPLETED|Overall Study||203
500189|NCT01006291|1223169|P2|COMPLETED|Overall Study||204
500190|NCT01006291|1223170|P1|COMPLETED|Overall Study||203
500191|NCT01006291|1223168|P3|Exposed|Overall Study|1 subject withdrew prior to exposure to trial drug|229
500192|NCT01006291|1223169|P2|Exposed|Overall Study|2 subjects received IDeg OD FF|226
500193|NCT01006291|1223170|P1|Exposed|Overall Study|1 subject withdrew before exposure to drug. 2 subjects randomised to IDeg OD received IDeg OD FF|230
500194|NCT01006291|1223168|P3|STARTED|Overall Study||230
500195|NCT01006291|1223169|P2|STARTED|Overall Study||228
500196|NCT01006291|1223170|P1|STARTED|Overall Study||229
500197|NCT01006135|1223187|P1|NOT COMPLETED|Overall Study||140
500198|NCT01006135|1223187|P1|COMPLETED|Overall Study||4712
500199|NCT01006135|1223187|P1|STARTED|Overall Study||4852
500200|NCT01006122|1223194|P2|NOT COMPLETED|Second Double-blind Intervention Period||7
500201|NCT01006122|1223195|P1|NOT COMPLETED|Second Double-blind Intervention Period||2
500202|NCT01006122|1223194|P2|COMPLETED|Second Double-blind Intervention Period||24
500203|NCT01006122|1223195|P1|COMPLETED|Second Double-blind Intervention Period||29
500204|NCT01006122|1223194|P2|STARTED|Second Double-blind Intervention Period||31
500205|NCT01006122|1223195|P1|STARTED|Second Double-blind Intervention Period||31
500206|NCT01006122|1223194|P2|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
500207|NCT01006122|1223195|P1|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
500208|NCT01006122|1223194|P2|COMPLETED|Wash-out Period (at Least 7 Days)||31
500209|NCT01006122|1223195|P1|COMPLETED|Wash-out Period (at Least 7 Days)||31
500210|NCT01006122|1223194|P2|STARTED|Wash-out Period (at Least 7 Days)||31
500211|NCT01006122|1223195|P1|STARTED|Wash-out Period (at Least 7 Days)||31
500212|NCT01006122|1223194|P2|NOT COMPLETED|First Double-blind Intervention Period||17
500213|NCT01006122|1223195|P1|NOT COMPLETED|First Double-blind Intervention Period||16
500214|NCT01006122|1223194|P2|COMPLETED|First Double-blind Intervention Period||31
500215|NCT01006122|1223195|P1|COMPLETED|First Double-blind Intervention Period||31
500216|NCT01006122|1223194|P2|STARTED|First Double-blind Intervention Period||48
500217|NCT01006122|1223195|P1|STARTED|First Double-blind Intervention Period||47
500218|NCT01006018|1223236|P3|NOT COMPLETED|Overall Study||0
500219|NCT01006018|1223237|P2|NOT COMPLETED|Overall Study||0
500220|NCT01006018|1223238|P1|NOT COMPLETED|Overall Study||0
500221|NCT01006018|1223236|P3|COMPLETED|Overall Study||0
500222|NCT01006018|1223237|P2|COMPLETED|Overall Study||0
500223|NCT01006018|1223238|P1|COMPLETED|Overall Study||0
500224|NCT01006018|1223236|P3|STARTED|Overall Study||0
500225|NCT01006018|1223237|P2|STARTED|Overall Study||0
500226|NCT01006018|1223238|P1|STARTED|Overall Study||0
500227|NCT01005966|1223246|P5|NOT COMPLETED|Treatment Period 5 (14 Days)||0
500228|NCT01005966|1223247|P4|NOT COMPLETED|Treatment Period 5 (14 Days)||0
500229|NCT01005966|1223248|P3|NOT COMPLETED|Treatment Period 5 (14 Days)||0
500230|NCT01005966|1223249|P2|NOT COMPLETED|Treatment Period 5 (14 Days)||0
500231|NCT01005966|1223250|P1|NOT COMPLETED|Treatment Period 5 (14 Days)||0
500232|NCT01005966|1223246|P5|COMPLETED|Treatment Period 5 (14 Days)||10
500233|NCT01005966|1223247|P4|COMPLETED|Treatment Period 5 (14 Days)||11
500234|NCT01005966|1223248|P3|COMPLETED|Treatment Period 5 (14 Days)||11
500235|NCT01005966|1223249|P2|COMPLETED|Treatment Period 5 (14 Days)||12
500236|NCT01005966|1223250|P1|COMPLETED|Treatment Period 5 (14 Days)||9
500237|NCT01005966|1223246|P5|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|10
500238|NCT01005966|1223247|P4|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|11
500239|NCT01005966|1223248|P3|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|11
500240|NCT01005966|1223249|P2|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|12
500241|NCT01005966|1223250|P1|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|9
500242|NCT01005966|1223246|P5|NOT COMPLETED|Washout Period 4 (4 Days)||0
500243|NCT01005966|1223247|P4|NOT COMPLETED|Washout Period 4 (4 Days)||0
500244|NCT01005966|1223248|P3|NOT COMPLETED|Washout Period 4 (4 Days)||0
500245|NCT01005966|1223249|P2|NOT COMPLETED|Washout Period 4 (4 Days)||0
500246|NCT01005966|1223250|P1|NOT COMPLETED|Washout Period 4 (4 Days)||0
500247|NCT01005966|1223246|P5|COMPLETED|Washout Period 4 (4 Days)||12
500248|NCT01005966|1223247|P4|COMPLETED|Washout Period 4 (4 Days)||10
500249|NCT01005966|1223248|P3|COMPLETED|Washout Period 4 (4 Days)||11
500250|NCT01005966|1223249|P2|COMPLETED|Washout Period 4 (4 Days)||10
500251|NCT01005966|1223250|P1|COMPLETED|Washout Period 4 (4 Days)||10
500252|NCT01005966|1223246|P5|STARTED|Washout Period 4 (4 Days)||12
500253|NCT01005966|1223247|P4|STARTED|Washout Period 4 (4 Days)||10
500254|NCT01005966|1223248|P3|STARTED|Washout Period 4 (4 Days)||11
500255|NCT01005966|1223249|P2|STARTED|Washout Period 4 (4 Days)||10
500256|NCT01005966|1223250|P1|STARTED|Washout Period 4 (4 Days)||10
500257|NCT01005966|1223246|P5|NOT COMPLETED|Treatment Period 4 (14 Days)||1
500258|NCT01005966|1223247|P4|NOT COMPLETED|Treatment Period 4 (14 Days)||0
500259|NCT01005966|1223248|P3|NOT COMPLETED|Treatment Period 4 (14 Days)||0
500260|NCT01005966|1223249|P2|NOT COMPLETED|Treatment Period 4 (14 Days)||1
500261|NCT01005966|1223250|P1|NOT COMPLETED|Treatment Period 4 (14 Days)||0
500262|NCT01005966|1223246|P5|COMPLETED|Treatment Period 4 (14 Days)||12
500263|NCT01005966|1223247|P4|COMPLETED|Treatment Period 4 (14 Days)||10
500264|NCT01005966|1223248|P3|COMPLETED|Treatment Period 4 (14 Days)||11
500265|NCT01005966|1223249|P2|COMPLETED|Treatment Period 4 (14 Days)||10
500266|NCT01005966|1223250|P1|COMPLETED|Treatment Period 4 (14 Days)||10
500267|NCT01005966|1223246|P5|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|13
500268|NCT01005966|1223247|P4|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
500269|NCT01005966|1223248|P3|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
500270|NCT01005966|1223249|P2|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
500271|NCT01005966|1223250|P1|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
500272|NCT01005966|1223246|P5|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
500273|NCT01005966|1223247|P4|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
500274|NCT01005966|1223248|P3|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
500275|NCT01005966|1223249|P2|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
500276|NCT01005966|1223250|P1|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
500277|NCT01005966|1223246|P5|COMPLETED|Washout Period 3 ( 4 Days)||11
500278|NCT01005966|1223247|P4|COMPLETED|Washout Period 3 ( 4 Days)||13
500279|NCT01005966|1223248|P3|COMPLETED|Washout Period 3 ( 4 Days)||12
500280|NCT01005966|1223249|P2|COMPLETED|Washout Period 3 ( 4 Days)||7
500281|NCT01005966|1223250|P1|COMPLETED|Washout Period 3 ( 4 Days)||12
500282|NCT01005966|1223246|P5|STARTED|Washout Period 3 ( 4 Days)||11
500283|NCT01005966|1223247|P4|STARTED|Washout Period 3 ( 4 Days)||13
500284|NCT01005966|1223248|P3|STARTED|Washout Period 3 ( 4 Days)||12
500285|NCT01005966|1223249|P2|STARTED|Washout Period 3 ( 4 Days)||7
500286|NCT01005966|1223250|P1|STARTED|Washout Period 3 ( 4 Days)||12
500287|NCT01005966|1223246|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||1
500288|NCT01005966|1223247|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
500289|NCT01005966|1223248|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||0
500290|NCT01005966|1223249|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||1
500291|NCT01005966|1223250|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
500292|NCT01005966|1223246|P5|COMPLETED|Treatment Period 3 (14 Days)||11
500293|NCT01005966|1223247|P4|COMPLETED|Treatment Period 3 (14 Days)||13
500294|NCT01005966|1223248|P3|COMPLETED|Treatment Period 3 (14 Days)||12
500295|NCT01005966|1223249|P2|COMPLETED|Treatment Period 3 (14 Days)||7
500296|NCT01005966|1223250|P1|COMPLETED|Treatment Period 3 (14 Days)||12
500297|NCT01005966|1223246|P5|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
500298|NCT01005966|1223247|P4|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|13
500299|NCT01005966|1223248|P3|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
500300|NCT01005966|1223249|P2|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|8
500301|NCT01005966|1223250|P1|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
500302|NCT01005966|1223246|P5|NOT COMPLETED|Washout Period 2 (4 Days)||0
500303|NCT01005966|1223247|P4|NOT COMPLETED|Washout Period 2 (4 Days)||0
500304|NCT01005966|1223248|P3|NOT COMPLETED|Washout Period 2 (4 Days)||0
500305|NCT01005966|1223249|P2|NOT COMPLETED|Washout Period 2 (4 Days)||0
500306|NCT01005966|1223250|P1|NOT COMPLETED|Washout Period 2 (4 Days)||0
500307|NCT01005966|1223246|P5|COMPLETED|Washout Period 2 (4 Days)||11
500308|NCT01005966|1223247|P4|COMPLETED|Washout Period 2 (4 Days)||11
500309|NCT01005966|1223248|P3|COMPLETED|Washout Period 2 (4 Days)||10
500310|NCT01005966|1223249|P2|COMPLETED|Washout Period 2 (4 Days)||12
500311|NCT01005966|1223250|P1|COMPLETED|Washout Period 2 (4 Days)||13
500312|NCT01005966|1223246|P5|STARTED|Washout Period 2 (4 Days)||11
500313|NCT01005966|1223247|P4|STARTED|Washout Period 2 (4 Days)||11
500314|NCT01005966|1223248|P3|STARTED|Washout Period 2 (4 Days)||10
500315|NCT01005966|1223249|P2|STARTED|Washout Period 2 (4 Days)||12
500316|NCT01005966|1223250|P1|STARTED|Washout Period 2 (4 Days)||13
500317|NCT01005966|1223246|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||0
500318|NCT01005966|1223247|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||1
500319|NCT01005966|1223248|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||2
500320|NCT01005966|1223249|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||1
500321|NCT01005966|1223250|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||0
500322|NCT01005966|1223246|P5|COMPLETED|Treatment Period 2 (14 Days)||11
500323|NCT01005966|1223247|P4|COMPLETED|Treatment Period 2 (14 Days)||11
500324|NCT01005966|1223248|P3|COMPLETED|Treatment Period 2 (14 Days)||10
500325|NCT01005966|1223249|P2|COMPLETED|Treatment Period 2 (14 Days)||12
500326|NCT01005966|1223250|P1|COMPLETED|Treatment Period 2 (14 Days)||13
500327|NCT01005966|1223246|P5|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|11
500328|NCT01005966|1223247|P4|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|12
500329|NCT01005966|1223248|P3|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|12
500330|NCT01005966|1223249|P2|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
500331|NCT01005966|1223250|P1|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
500332|NCT01005966|1223246|P5|NOT COMPLETED|Washout Period 1 (4 Days)||0
500333|NCT01005966|1223247|P4|NOT COMPLETED|Washout Period 1 (4 Days)||1
500334|NCT01005966|1223248|P3|NOT COMPLETED|Washout Period 1 (4 Days)||0
500335|NCT01005966|1223249|P2|NOT COMPLETED|Washout Period 1 (4 Days)||0
500336|NCT01005966|1223250|P1|NOT COMPLETED|Washout Period 1 (4 Days)||0
500337|NCT01005966|1223246|P5|COMPLETED|Washout Period 1 (4 Days)||13
500338|NCT01005966|1223247|P4|COMPLETED|Washout Period 1 (4 Days)||12
500339|NCT01005966|1223248|P3|COMPLETED|Washout Period 1 (4 Days)||12
500340|NCT01005966|1223249|P2|COMPLETED|Washout Period 1 (4 Days)||13
500341|NCT01005966|1223250|P1|COMPLETED|Washout Period 1 (4 Days)||11
500342|NCT01005966|1223246|P5|STARTED|Washout Period 1 (4 Days)||13
500343|NCT01005966|1223247|P4|STARTED|Washout Period 1 (4 Days)||13
500344|NCT01005966|1223248|P3|STARTED|Washout Period 1 (4 Days)||12
500345|NCT01005966|1223249|P2|STARTED|Washout Period 1 (4 Days)||13
500346|NCT01005966|1223250|P1|STARTED|Washout Period 1 (4 Days)||11
500347|NCT01005966|1223246|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||0
500348|NCT01005966|1223247|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||0
500349|NCT01005966|1223248|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||1
500350|NCT01005966|1223249|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||0
500351|NCT01005966|1223250|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||2
500352|NCT01005966|1223246|P5|COMPLETED|Treatment Period 1 (14 Days)||13
500353|NCT01005966|1223247|P4|COMPLETED|Treatment Period 1 (14 Days)||13
500354|NCT01005966|1223248|P3|COMPLETED|Treatment Period 1 (14 Days)||12
500355|NCT01005966|1223249|P2|COMPLETED|Treatment Period 1 (14 Days)||13
500356|NCT01005966|1223250|P1|COMPLETED|Treatment Period 1 (14 Days)||11
500357|NCT01005966|1223246|P5|STARTED|Treatment Period 1 (14 Days)||13
500358|NCT01005966|1223247|P4|STARTED|Treatment Period 1 (14 Days)||13
500359|NCT01005966|1223248|P3|STARTED|Treatment Period 1 (14 Days)||13
500360|NCT01005966|1223249|P2|STARTED|Treatment Period 1 (14 Days)||13
500361|NCT01005966|1223250|P1|STARTED|Treatment Period 1 (14 Days)||13
500362|NCT01005914|1223270|P1|NOT COMPLETED|Overall Study||10
500363|NCT01005914|1223270|P1|COMPLETED|Overall Study||1
500364|NCT01005914|1223270|P1|STARTED|Overall Study||11
500365|NCT01005901|1223276|P2|NOT COMPLETED|Overall Study||58
500366|NCT01005901|1223277|P1|NOT COMPLETED|Overall Study||102
500367|NCT01005901|1223276|P2|COMPLETED|Overall Study||212
500368|NCT01005901|1223277|P1|COMPLETED|Overall Study||450
500369|NCT01005901|1223276|P2|Full Analysis Set|Overall Study||260
500370|NCT01005901|1223277|P1|Full Analysis Set|Overall Study||534
500371|NCT01005901|1223276|P2|Safety Population|Overall Study||267
500372|NCT01005901|1223277|P1|Safety Population|Overall Study||550
500373|NCT01005901|1223276|P2|STARTED|Overall Study||270
500374|NCT01005901|1223277|P1|STARTED|Overall Study||552
500375|NCT01005888|1223319|P2|NOT COMPLETED|Second Intervention||1
500376|NCT01005888|1223320|P1|NOT COMPLETED|Second Intervention||1
500377|NCT01005888|1223319|P2|COMPLETED|Second Intervention||10
500378|NCT01005888|1223320|P1|COMPLETED|Second Intervention||10
500379|NCT01005888|1223319|P2|STARTED|Second Intervention||11
500380|NCT01005888|1223320|P1|STARTED|Second Intervention||11
500381|NCT01005888|1223319|P2|NOT COMPLETED|First Intervention||1
500382|NCT01005888|1223320|P1|NOT COMPLETED|First Intervention||1
500383|NCT01005888|1223319|P2|COMPLETED|First Intervention||11
500384|NCT01005888|1223320|P1|COMPLETED|First Intervention||11
500385|NCT01005888|1223319|P2|STARTED|First Intervention||12
500386|NCT01005888|1223320|P1|STARTED|First Intervention||12
500387|NCT01005875|1223340|P1|NOT COMPLETED|Overall Study||3
500388|NCT01005875|1223340|P1|COMPLETED|Overall Study||2
500389|NCT01005875|1223340|P1|STARTED|Overall Study||5
500390|NCT01005745|1223348|P1|NOT COMPLETED|Overall Study||6
500391|NCT01005745|1223348|P1|COMPLETED|Overall Study||13
500392|NCT01005745|1223348|P1|STARTED|Overall Study||19
500393|NCT01005732|1223353|P1|NOT COMPLETED|Overall Study||11
500394|NCT01005732|1223353|P1|COMPLETED|Overall Study||43
500395|NCT01005732|1223353|P1|STARTED|Overall Study||54
500396|NCT01005719|1223369|P6|NOT COMPLETED|Period 3||0
500397|NCT01005719|1223370|P5|NOT COMPLETED|Period 3||0
500398|NCT01005719|1223371|P4|NOT COMPLETED|Period 3||0
500399|NCT01005719|1223372|P3|NOT COMPLETED|Period 3||0
500400|NCT01005719|1223373|P2|NOT COMPLETED|Period 3||0
500401|NCT01005719|1223374|P1|NOT COMPLETED|Period 3||0
500402|NCT01005719|1223369|P6|COMPLETED|Period 3||9
500403|NCT01005719|1223370|P5|COMPLETED|Period 3||10
500404|NCT01005719|1223371|P4|COMPLETED|Period 3||10
500405|NCT01005719|1223372|P3|COMPLETED|Period 3||10
500406|NCT01005719|1223373|P2|COMPLETED|Period 3||10
500407|NCT01005719|1223374|P1|COMPLETED|Period 3||10
500408|NCT01005719|1223369|P6|STARTED|Period 3||9
500409|NCT01005719|1223370|P5|STARTED|Period 3||10
500410|NCT01005719|1223371|P4|STARTED|Period 3||10
500411|NCT01005719|1223372|P3|STARTED|Period 3||10
500412|NCT01005719|1223373|P2|STARTED|Period 3||10
500413|NCT01005719|1223374|P1|STARTED|Period 3||10
500414|NCT01005719|1223369|P6|NOT COMPLETED|Period 2||1
500415|NCT01005719|1223370|P5|NOT COMPLETED|Period 2||1
500416|NCT01005719|1223371|P4|NOT COMPLETED|Period 2||0
500417|NCT01005719|1223372|P3|NOT COMPLETED|Period 2||0
500418|NCT01005719|1223373|P2|NOT COMPLETED|Period 2||0
500419|NCT01005719|1223374|P1|NOT COMPLETED|Period 2||0
500420|NCT01005719|1223369|P6|COMPLETED|Period 2||9
500421|NCT01005719|1223370|P5|COMPLETED|Period 2||10
500422|NCT01005719|1223371|P4|COMPLETED|Period 2||10
500423|NCT01005719|1223372|P3|COMPLETED|Period 2||10
500424|NCT01005719|1223373|P2|COMPLETED|Period 2||10
500425|NCT01005719|1223374|P1|COMPLETED|Period 2||10
500426|NCT01005719|1223369|P6|STARTED|Period 2||10
500427|NCT01005719|1223370|P5|STARTED|Period 2||11
500428|NCT01005719|1223371|P4|STARTED|Period 2||10
500429|NCT01005719|1223372|P3|STARTED|Period 2||10
500430|NCT01005719|1223373|P2|STARTED|Period 2||10
500431|NCT01005719|1223374|P1|STARTED|Period 2||10
500432|NCT01005719|1223369|P6|NOT COMPLETED|Period 1||1
500433|NCT01005719|1223370|P5|NOT COMPLETED|Period 1||0
500434|NCT01005719|1223371|P4|NOT COMPLETED|Period 1||1
500435|NCT01005719|1223372|P3|NOT COMPLETED|Period 1||0
500436|NCT01005719|1223373|P2|NOT COMPLETED|Period 1||0
500437|NCT01005719|1223374|P1|NOT COMPLETED|Period 1||0
500438|NCT01005719|1223369|P6|COMPLETED|Period 1||10
500439|NCT01005719|1223370|P5|COMPLETED|Period 1||11
500440|NCT01005719|1223371|P4|COMPLETED|Period 1||10
500441|NCT01005719|1223372|P3|COMPLETED|Period 1||10
500442|NCT01005719|1223373|P2|COMPLETED|Period 1||10
500443|NCT01005719|1223374|P1|COMPLETED|Period 1||10
500444|NCT01005719|1223369|P6|STARTED|Period 1||11
500445|NCT01005719|1223370|P5|STARTED|Period 1||11
500446|NCT01005719|1223371|P4|STARTED|Period 1||11
500447|NCT01005719|1223372|P3|STARTED|Period 1||10
500448|NCT01005719|1223373|P2|STARTED|Period 1||10
500449|NCT01005719|1223374|P1|STARTED|Period 1||10
500450|NCT01005706|1223432|P2|NOT COMPLETED|Overall Study||0
500451|NCT01005706|1223433|P1|NOT COMPLETED|Overall Study||0
500452|NCT01005706|1223432|P2|COMPLETED|Overall Study||17
500453|NCT01005706|1223433|P1|COMPLETED|Overall Study||23
500454|NCT01005706|1223432|P2|STARTED|Overall Study||17
500455|NCT01005706|1223433|P1|STARTED|Overall Study||23
500456|NCT01005680|1223441|P2|NOT COMPLETED|Overall Study||11
500457|NCT01005680|1223442|P1|NOT COMPLETED|Overall Study||6
500458|NCT01005680|1223441|P2|COMPLETED|Overall Study||119
500459|NCT01005680|1223442|P1|COMPLETED|Overall Study||120
500460|NCT01005680|1223441|P2|Received at Least 1 Dose of Study Drug|Overall Study||127
500461|NCT01005680|1223442|P1|Received at Least 1 Dose of Study Drug|Overall Study||125
500462|NCT01005680|1223441|P2|STARTED|Overall Study||130
500463|NCT01005680|1223442|P1|STARTED|Overall Study||126
500464|NCT01005602|1223466|P2|NOT COMPLETED|Overall Study||0
500465|NCT01005602|1223467|P1|NOT COMPLETED|Overall Study||1
500466|NCT01005602|1223466|P2|COMPLETED|Overall Study||66
500467|NCT01005602|1223467|P1|COMPLETED|Overall Study|One patient completed the trial but was excluded from data analyses due to unreliable clinical data.|65
500468|NCT01005602|1223466|P2|STARTED|Overall Study||66
500469|NCT01005602|1223467|P1|STARTED|Overall Study||66
500470|NCT01005576|1223487|P1|NOT COMPLETED|Overall Study||0
500471|NCT01005576|1223487|P1|COMPLETED|Overall Study|All participants completed the conditioning regimen and received their stem cell transplant|21
500472|NCT01005576|1223487|P1|STARTED|Overall Study||21
500473|NCT01005459|1223497|P2|NOT COMPLETED|Overall Study||0
500474|NCT01005459|1223498|P1|NOT COMPLETED|Overall Study||0
500475|NCT01005459|1223497|P2|COMPLETED|Overall Study||23
500476|NCT01005459|1223498|P1|COMPLETED|Overall Study||23
500477|NCT01005459|1223497|P2|STARTED|Overall Study||23
500478|NCT01005459|1223498|P1|STARTED|Overall Study||23
500479|NCT01005407|1223506|P2|NOT COMPLETED|Overall Study||32
500480|NCT01005407|1223507|P1|NOT COMPLETED|Overall Study||151
500481|NCT01005407|1223506|P2|COMPLETED|Overall Study||451
500482|NCT01005407|1223507|P1|COMPLETED|Overall Study||1818
500483|NCT01005407|1223506|P2|STARTED|Overall Study||483
500484|NCT01005407|1223507|P1|STARTED|Overall Study||1969
500485|NCT01005355|1223518|P3|NOT COMPLETED|Overall Study||0
500486|NCT01005355|1223519|P2|NOT COMPLETED|Overall Study||0
500487|NCT01005355|1223520|P1|NOT COMPLETED|Overall Study||0
500488|NCT01005355|1223518|P3|COMPLETED|Overall Study||6
500489|NCT01005355|1223519|P2|COMPLETED|Overall Study||6
500490|NCT01005355|1223520|P1|COMPLETED|Overall Study||3
500491|NCT01005355|1223518|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
500492|NCT01005355|1223519|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
500493|NCT01005355|1223520|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
500494|NCT01005355|1223518|P3|STARTED|Overall Study||6
500495|NCT01005355|1223519|P2|STARTED|Overall Study||6
500496|NCT01005355|1223520|P1|STARTED|Overall Study||3
500497|NCT01005329|1223555|P1|NOT COMPLETED|Overall Study||4
500498|NCT01005329|1223555|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|30
500499|NCT01005329|1223555|P1|STARTED|Overall Study||34
500500|NCT01005316|1223568|P4|NOT COMPLETED|Overall Study||108
500501|NCT01005316|1223569|P3|NOT COMPLETED|Overall Study||11
500502|NCT01005316|1223570|P2|NOT COMPLETED|Overall Study||76
500503|NCT01005316|1223571|P1|NOT COMPLETED|Overall Study||50
500504|NCT01005316|1223568|P4|COMPLETED|Overall Study||19
500505|NCT01005316|1223569|P3|COMPLETED|Overall Study||5
500506|NCT01005316|1223570|P2|COMPLETED|Overall Study||21
500507|NCT01005316|1223571|P1|COMPLETED|Overall Study||0
500508|NCT01005316|1223568|P4|STARTED|Overall Study||127
500509|NCT01005316|1223569|P3|STARTED|Overall Study||16
500510|NCT01005316|1223570|P2|STARTED|Overall Study||97
500511|NCT01005316|1223571|P1|STARTED|Overall Study||50
500512|NCT01005290|1223623|P3|NOT COMPLETED|Period 2 (5 Weeks)||2
500513|NCT01005290|1223624|P2|NOT COMPLETED|Period 2 (5 Weeks)||0
500514|NCT01005290|1223625|P1|NOT COMPLETED|Period 2 (5 Weeks)||0
500515|NCT01005290|1223623|P3|COMPLETED|Period 2 (5 Weeks)||7
500516|NCT01005290|1223624|P2|COMPLETED|Period 2 (5 Weeks)||13
500517|NCT01005290|1223625|P1|COMPLETED|Period 2 (5 Weeks)||0
500518|NCT01005290|1223623|P3|STARTED|Period 2 (5 Weeks)||9
500519|NCT01005290|1223624|P2|STARTED|Period 2 (5 Weeks)||13
500520|NCT01005290|1223625|P1|STARTED|Period 2 (5 Weeks)||0
500521|NCT01005290|1223623|P3|NOT COMPLETED|Washout Period (2 Weeks)||0
500522|NCT01005290|1223624|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
500523|NCT01005290|1223625|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
500524|NCT01005290|1223623|P3|COMPLETED|Washout Period (2 Weeks)||9
500525|NCT01005290|1223624|P2|COMPLETED|Washout Period (2 Weeks)||13
500526|NCT01005290|1223625|P1|COMPLETED|Washout Period (2 Weeks)||0
500527|NCT01005290|1223623|P3|STARTED|Washout Period (2 Weeks)||9
500528|NCT01005290|1223624|P2|STARTED|Washout Period (2 Weeks)||13
500529|NCT01005290|1223625|P1|STARTED|Washout Period (2 Weeks)||0
500530|NCT01005290|1223623|P3|NOT COMPLETED|Period 1 (5 Weeks)||9
500531|NCT01005290|1223624|P2|NOT COMPLETED|Period 1 (5 Weeks)||7
500532|NCT01005290|1223625|P1|NOT COMPLETED|Period 1 (5 Weeks)||0
500533|NCT01005290|1223623|P3|COMPLETED|Period 1 (5 Weeks)||9
500534|NCT01005290|1223624|P2|COMPLETED|Period 1 (5 Weeks)||13
500535|NCT01005290|1223625|P1|COMPLETED|Period 1 (5 Weeks)||0
500536|NCT01005290|1223623|P3|STARTED|Period 1 (5 Weeks)||18
500537|NCT01005290|1223624|P2|STARTED|Period 1 (5 Weeks)||20
500538|NCT01005290|1223625|P1|STARTED|Period 1 (5 Weeks)||0
500539|NCT01005290|1223623|P3|NOT COMPLETED|Run-In||0
500540|NCT01005290|1223624|P2|NOT COMPLETED|Run-In||0
500541|NCT01005290|1223625|P1|NOT COMPLETED|Run-In||14
500542|NCT01005290|1223623|P3|COMPLETED|Run-In||0
500543|NCT01005290|1223624|P2|COMPLETED|Run-In||0
500544|NCT01005290|1223625|P1|COMPLETED|Run-In||38
500545|NCT01005290|1223623|P3|STARTED|Run-In||0
500546|NCT01005290|1223624|P2|STARTED|Run-In||0
500547|NCT01005290|1223625|P1|STARTED|Run-In||52
500548|NCT01005251|1223638|P5|NOT COMPLETED|Overall Study||18
500549|NCT01005251|1223639|P4|NOT COMPLETED|Overall Study||12
500550|NCT01005251|1223640|P3|NOT COMPLETED|Overall Study||22
500551|NCT01005251|1223641|P2|NOT COMPLETED|Overall Study||16
500552|NCT01005251|1223642|P1|NOT COMPLETED|Overall Study||13
500553|NCT01005251|1223638|P5|COMPLETED|Overall Study||122
500554|NCT01005251|1223639|P4|COMPLETED|Overall Study||114
500555|NCT01005251|1223640|P3|COMPLETED|Overall Study||114
500556|NCT01005251|1223641|P2|COMPLETED|Overall Study||109
500557|NCT01005251|1223642|P1|COMPLETED|Overall Study||121
500558|NCT01005251|1223638|P5|STARTED|Overall Study||140
500559|NCT01005251|1223639|P4|STARTED|Overall Study||126
500560|NCT01005251|1223640|P3|STARTED|Overall Study||136
500561|NCT01005251|1223641|P2|STARTED|Overall Study||125
500562|NCT01005251|1223642|P1|STARTED|Overall Study||134
500563|NCT01004991|1223659|P1|NOT COMPLETED|Overall Study||0
500564|NCT01004991|1223659|P1|COMPLETED|Overall Study||12
500565|NCT01004991|1223659|P1|STARTED|Overall Study||12
500566|NCT01004939|1223663|P1|NOT COMPLETED|Overall Study||0
500567|NCT01004939|1223663|P1|COMPLETED|Overall Study||120
500568|NCT01004939|1223663|P1|STARTED|Overall Study||120
500569|NCT01004874|1223704|P1|NOT COMPLETED|Overall Study||0
500570|NCT01004874|1223704|P1|COMPLETED|Overall Study||80
500571|NCT01004874|1223704|P1|STARTED|Overall Study||80
500572|NCT01004848|1223715|P2|NOT COMPLETED|Overall Study||45
500573|NCT01004848|1223716|P1|NOT COMPLETED|Overall Study||55
500574|NCT01004848|1223715|P2|COMPLETED|Overall Study||147
500575|NCT01004848|1223716|P1|COMPLETED|Overall Study||155
500576|NCT01004848|1223715|P2|STARTED|Overall Study||192
500577|NCT01004848|1223716|P1|STARTED|Overall Study||210
500578|NCT01004822|1223754|P8|NOT COMPLETED|Overall Study||5
500579|NCT01004822|1223755|P7|NOT COMPLETED|Overall Study||4
500580|NCT01004822|1223756|P6|NOT COMPLETED|Overall Study||4
500581|NCT01004822|1223757|P5|NOT COMPLETED|Overall Study||4
500582|NCT01004822|1223758|P4|NOT COMPLETED|Overall Study||4
500583|NCT01004822|1223759|P3|NOT COMPLETED|Overall Study||4
500584|NCT01004822|1223760|P2|NOT COMPLETED|Overall Study||3
500585|NCT01004822|1223761|P1|NOT COMPLETED|Overall Study||3
500586|NCT01004822|1223754|P8|COMPLETED|Overall Study||0
500587|NCT01004822|1223755|P7|COMPLETED|Overall Study||0
500588|NCT01004822|1223756|P6|COMPLETED|Overall Study||0
500589|NCT01004822|1223757|P5|COMPLETED|Overall Study||0
500590|NCT01004822|1223758|P4|COMPLETED|Overall Study||0
500591|NCT01004822|1223759|P3|COMPLETED|Overall Study||0
500592|NCT01004822|1223760|P2|COMPLETED|Overall Study||0
500593|NCT01004822|1223761|P1|COMPLETED|Overall Study||0
500594|NCT01004822|1223754|P8|Treated|Overall Study||5
500595|NCT01004822|1223755|P7|Treated|Overall Study||4
500596|NCT01004822|1223756|P6|Treated|Overall Study||4
500597|NCT01004822|1223757|P5|Treated|Overall Study||4
500598|NCT01004822|1223758|P4|Treated|Overall Study||4
500599|NCT01004822|1223759|P3|Treated|Overall Study||3
500600|NCT01004822|1223760|P2|Treated|Overall Study||3
500601|NCT01004822|1223761|P1|Treated|Overall Study||3
500602|NCT01004822|1223754|P8|STARTED|Overall Study||5
500603|NCT01004822|1223755|P7|STARTED|Overall Study||4
500604|NCT01004822|1223756|P6|STARTED|Overall Study||4
500605|NCT01004822|1223757|P5|STARTED|Overall Study||4
500606|NCT01004822|1223758|P4|STARTED|Overall Study||4
500607|NCT01004822|1223759|P3|STARTED|Overall Study||4
500608|NCT01004822|1223760|P2|STARTED|Overall Study||3
500609|NCT01004822|1223761|P1|STARTED|Overall Study||3
500610|NCT01004770|1223875|P5|NOT COMPLETED|Overall Study||0
500611|NCT01004770|1223876|P4|NOT COMPLETED|Overall Study||0
500612|NCT01004770|1223877|P3|NOT COMPLETED|Overall Study||0
500613|NCT01004770|1223878|P2|NOT COMPLETED|Overall Study||0
500614|NCT01004770|1223879|P1|NOT COMPLETED|Overall Study||0
500615|NCT01004770|1223875|P5|COMPLETED|Overall Study||10
500616|NCT01004770|1223876|P4|COMPLETED|Overall Study||10
500617|NCT01004770|1223877|P3|COMPLETED|Overall Study||10
500618|NCT01004770|1223878|P2|COMPLETED|Overall Study||10
500619|NCT01004770|1223879|P1|COMPLETED|Overall Study||10
500620|NCT01004770|1223875|P5|STARTED|Overall Study||10
500621|NCT01004770|1223876|P4|STARTED|Overall Study||10
500622|NCT01004770|1223877|P3|STARTED|Overall Study||10
500623|NCT01004770|1223878|P2|STARTED|Overall Study||10
500624|NCT01004770|1223879|P1|STARTED|Overall Study||10
500625|NCT01004705|1223911|P3|NOT COMPLETED|Period 2 (12 Weeks)||4
500626|NCT01004705|1223912|P2|NOT COMPLETED|Period 2 (12 Weeks)||0
500627|NCT01004705|1223913|P1|NOT COMPLETED|Period 2 (12 Weeks)||0
500628|NCT01004705|1223911|P3|COMPLETED|Period 2 (12 Weeks)||9
500629|NCT01004705|1223912|P2|COMPLETED|Period 2 (12 Weeks)||13
500630|NCT01004705|1223913|P1|COMPLETED|Period 2 (12 Weeks)||0
500631|NCT01004705|1223911|P3|STARTED|Period 2 (12 Weeks)||13
500632|NCT01004705|1223912|P2|STARTED|Period 2 (12 Weeks)||13
500633|NCT01004705|1223913|P1|STARTED|Period 2 (12 Weeks)||0
500634|NCT01004705|1223911|P3|NOT COMPLETED|Washout Period (6 Weeks)||0
500635|NCT01004705|1223912|P2|NOT COMPLETED|Washout Period (6 Weeks)||0
500636|NCT01004705|1223913|P1|NOT COMPLETED|Washout Period (6 Weeks)||0
500637|NCT01004705|1223911|P3|COMPLETED|Washout Period (6 Weeks)||13
500638|NCT01004705|1223912|P2|COMPLETED|Washout Period (6 Weeks)||13
500639|NCT01004705|1223913|P1|COMPLETED|Washout Period (6 Weeks)||0
500640|NCT01004705|1223911|P3|STARTED|Washout Period (6 Weeks)||13
500641|NCT01004705|1223912|P2|STARTED|Washout Period (6 Weeks)||13
500642|NCT01004705|1223913|P1|STARTED|Washout Period (6 Weeks)||0
500643|NCT01004705|1223911|P3|NOT COMPLETED|Period 1 (12 Weeks)||5
500644|NCT01004705|1223912|P2|NOT COMPLETED|Period 1 (12 Weeks)||5
500645|NCT01004705|1223913|P1|NOT COMPLETED|Period 1 (12 Weeks)||0
500646|NCT01004705|1223911|P3|COMPLETED|Period 1 (12 Weeks)||13
500647|NCT01004705|1223912|P2|COMPLETED|Period 1 (12 Weeks)||13
500648|NCT01004705|1223913|P1|COMPLETED|Period 1 (12 Weeks)||0
500649|NCT01004705|1223911|P3|STARTED|Period 1 (12 Weeks)||18
500650|NCT01004705|1223912|P2|STARTED|Period 1 (12 Weeks)||18
500651|NCT01004705|1223913|P1|STARTED|Period 1 (12 Weeks)||0
500652|NCT01004705|1223911|P3|NOT COMPLETED|Run-In||0
500653|NCT01004705|1223912|P2|NOT COMPLETED|Run-In||0
500654|NCT01004705|1223913|P1|NOT COMPLETED|Run-In||8
500655|NCT01004705|1223911|P3|COMPLETED|Run-In||0
500656|NCT01004705|1223912|P2|COMPLETED|Run-In||0
500657|NCT01004705|1223913|P1|COMPLETED|Run-In||36
500658|NCT01004705|1223911|P3|STARTED|Run-In||0
500659|NCT01004705|1223912|P2|STARTED|Run-In||0
500660|NCT01004705|1223913|P1|STARTED|Run-In||44
500661|NCT01004614|1223926|P4|NOT COMPLETED|Second Intervention||0
500662|NCT01004614|1223927|P3|NOT COMPLETED|Second Intervention||0
500663|NCT01004614|1223928|P2|NOT COMPLETED|Second Intervention||0
500664|NCT01004614|1223929|P1|NOT COMPLETED|Second Intervention||0
500665|NCT01004614|1223926|P4|COMPLETED|Second Intervention||12
500666|NCT01004614|1223927|P3|COMPLETED|Second Intervention||12
500667|NCT01004614|1223928|P2|COMPLETED|Second Intervention||11
500668|NCT01004614|1223929|P1|COMPLETED|Second Intervention||12
500669|NCT01004614|1223926|P4|STARTED|Second Intervention||12
500670|NCT01004614|1223927|P3|STARTED|Second Intervention||12
500671|NCT01004614|1223928|P2|STARTED|Second Intervention||11
500672|NCT01004614|1223929|P1|STARTED|Second Intervention||12
500673|NCT01004614|1223926|P4|NOT COMPLETED|Washout||0
500674|NCT01004614|1223927|P3|NOT COMPLETED|Washout||0
500675|NCT01004614|1223928|P2|NOT COMPLETED|Washout||1
500676|NCT01004614|1223929|P1|NOT COMPLETED|Washout||0
500677|NCT01004614|1223926|P4|COMPLETED|Washout||12
500678|NCT01004614|1223927|P3|COMPLETED|Washout||12
500679|NCT01004614|1223928|P2|COMPLETED|Washout||11
500680|NCT01004614|1223929|P1|COMPLETED|Washout||12
500681|NCT01004614|1223926|P4|STARTED|Washout||12
500682|NCT01004614|1223927|P3|STARTED|Washout||12
500683|NCT01004614|1223928|P2|STARTED|Washout||12
500684|NCT01004614|1223929|P1|STARTED|Washout||12
500685|NCT01004614|1223926|P4|NOT COMPLETED|First Intervention||0
500686|NCT01004614|1223927|P3|NOT COMPLETED|First Intervention||0
500687|NCT01004614|1223928|P2|NOT COMPLETED|First Intervention||0
500688|NCT01004614|1223929|P1|NOT COMPLETED|First Intervention||0
500689|NCT01004614|1223926|P4|COMPLETED|First Intervention||12
500690|NCT01004614|1223927|P3|COMPLETED|First Intervention||12
500691|NCT01004614|1223928|P2|COMPLETED|First Intervention||12
500692|NCT01004614|1223929|P1|COMPLETED|First Intervention||12
500693|NCT01004614|1223926|P4|STARTED|First Intervention||12
500694|NCT01004614|1223927|P3|STARTED|First Intervention||12
500695|NCT01004614|1223928|P2|STARTED|First Intervention||12
500696|NCT01004614|1223929|P1|STARTED|First Intervention||12
500697|NCT01004510|1223963|P1|NOT COMPLETED|Overall Study||1
500698|NCT01004510|1223963|P1|COMPLETED|Overall Study||2
500699|NCT01004510|1223963|P1|STARTED|Overall Study||3
500700|NCT01004432|1223967|P5|NOT COMPLETED|OL Study Extension (Week 52 - 76)||18
500701|NCT01004432|1223968|P4|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
500702|NCT01004432|1223969|P3|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
500703|NCT01004432|1223970|P2|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
500704|NCT01004432|1223971|P1|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
500705|NCT01004432|1223967|P5|COMPLETED|OL Study Extension (Week 52 - 76)||194
500706|NCT01004432|1223968|P4|COMPLETED|OL Study Extension (Week 52 - 76)||0
500707|NCT01004432|1223969|P3|COMPLETED|OL Study Extension (Week 52 - 76)||0
500708|NCT01004432|1223970|P2|COMPLETED|OL Study Extension (Week 52 - 76)||0
500709|NCT01004432|1223971|P1|COMPLETED|OL Study Extension (Week 52 - 76)||0
500710|NCT01004432|1223967|P5|STARTED|OL Study Extension (Week 52 - 76)||212
500711|NCT01004432|1223968|P4|STARTED|OL Study Extension (Week 52 - 76)||0
500712|NCT01004432|1223969|P3|STARTED|OL Study Extension (Week 52 - 76)||0
500713|NCT01004432|1223970|P2|STARTED|OL Study Extension (Week 52 - 76)||0
500714|NCT01004432|1223971|P1|STARTED|OL Study Extension (Week 52 - 76)||0
500715|NCT01004432|1223967|P5|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
500716|NCT01004432|1223968|P4|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||58
500717|NCT01004432|1223969|P3|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||37
500718|NCT01004432|1223970|P2|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||10
500719|NCT01004432|1223971|P1|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
500720|NCT01004432|1223967|P5|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
500721|NCT01004432|1223968|P4|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||126
500722|NCT01004432|1223969|P3|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||54
500723|NCT01004432|1223970|P2|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||65
500724|NCT01004432|1223971|P1|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
500725|NCT01004432|1223967|P5|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0
500726|NCT01004432|1223968|P4|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||184
500727|NCT01004432|1223969|P3|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||91
500728|NCT01004432|1223970|P2|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||75
500729|NCT01004432|1223971|P1|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0
500730|NCT01004432|1223967|P5|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
500731|NCT01004432|1223968|P4|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
500732|NCT01004432|1223969|P3|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
500733|NCT01004432|1223970|P2|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
500734|NCT01004432|1223971|P1|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||83
500735|NCT01004432|1223967|P5|COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
500736|NCT01004432|1223968|P4|COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
500737|NCT01004432|1223969|P3|COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
500738|NCT01004432|1223970|P2|COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
500739|NCT01004432|1223971|P1|COMPLETED|Open-label (OL) Period (Week 0 – 16)|1 Participant died after completing open-label period. Discontinuation was noted as adverse event.|350
500740|NCT01004432|1223967|P5|STARTED|Open-label (OL) Period (Week 0 – 16)||0
500741|NCT01004432|1223968|P4|STARTED|Open-label (OL) Period (Week 0 – 16)||0
500742|NCT01004432|1223969|P3|STARTED|Open-label (OL) Period (Week 0 – 16)||0
500743|NCT01004432|1223970|P2|STARTED|Open-label (OL) Period (Week 0 – 16)||0
500744|NCT01004432|1223971|P1|STARTED|Open-label (OL) Period (Week 0 – 16)||433
500745|NCT01004393|1223991|P1|NOT COMPLETED|Overall Study||0
500746|NCT01004393|1223991|P1|COMPLETED|Overall Study||12
500747|NCT01004393|1223991|P1|STARTED|Overall Study||12
500748|NCT01004354|1224002|P1|NOT COMPLETED|Overall Study||0
500749|NCT01004354|1224002|P1|COMPLETED|Overall Study||12
500750|NCT01004354|1224002|P1|STARTED|Overall Study||12
500751|NCT01004263|1224014|P1|NOT COMPLETED|Overall Study||179
500752|NCT01004263|1224014|P1|COMPLETED|Overall Study||427
500753|NCT01004263|1224014|P1|STARTED|Overall Study|Participants who took study drug|606
500754|NCT01004250|1224022|P1|NOT COMPLETED|Follow-Up (FU) Period||1
500755|NCT01004250|1224022|P1|COMPLETED|Follow-Up (FU) Period||100
500756|NCT01004250|1224022|P1|STARTED|Follow-Up (FU) Period|Did not enter FU:Death-4pts Ind,1pts Maint; Pt Withdrew-1 pts Ind,1pts Maint; Lost to FU-1 pts Maint|101
500757|NCT01004250|1224022|P1|NOT COMPLETED|Maintenance Therapy Period||26
500758|NCT01004250|1224022|P1|COMPLETED|Maintenance Therapy Period||46
500759|NCT01004250|1224022|P1|Death (Any Cause) or Disease Progression|Maintenance Therapy Period|Pts with death or disease progression considered to have completed phase.|46
500760|NCT01004250|1224022|P1|STARTED|Maintenance Therapy Period|Did not enter Maint: 21 pts due to death or disease progression; 1 pts had performance status 2.|72
500761|NCT01004250|1224022|P1|NOT COMPLETED|Induction Therapy Period||15
500762|NCT01004250|1224022|P1|COMPLETED|Induction Therapy Period||94
500763|NCT01004250|1224022|P1|Death (Any Cause) or Disease Progression|Induction Therapy Period|Participants (pts) with death or disease progression considered to have completed phase.|21
500764|NCT01004250|1224022|P1|Received at Least One Dose of Study Drug|Induction Therapy Period||109
500765|NCT01004250|1224022|P1|STARTED|Induction Therapy Period||109
500766|NCT01004185|1224034|P2|NOT COMPLETED|Overall Study||9
500767|NCT01004185|1224035|P1|NOT COMPLETED|Overall Study||9
500768|NCT01004185|1224034|P2|COMPLETED|Overall Study||11
500769|NCT01004185|1224035|P1|COMPLETED|Overall Study||10
500770|NCT01004185|1224034|P2|STARTED|Overall Study||20
500771|NCT01004185|1224035|P1|STARTED|Overall Study||19
500772|NCT01004172|1224043|P1|NOT COMPLETED|Overall Study||38
500773|NCT01004172|1224043|P1|COMPLETED|Overall Study||0
500774|NCT01004172|1224043|P1|STARTED|Overall Study||38
500775|NCT01004159|1224049|P1|NOT COMPLETED|Overall Study||20
500776|NCT01004159|1224049|P1|COMPLETED|Overall Study||0
500777|NCT01004159|1224049|P1|STARTED|Overall Study||20
500778|NCT01004146|1224056|P2|NOT COMPLETED|Overall Study||5
500779|NCT01004146|1224057|P1|NOT COMPLETED|Overall Study||4
500780|NCT01004146|1224056|P2|COMPLETED|Overall Study||20
500781|NCT01004146|1224057|P1|COMPLETED|Overall Study||21
500782|NCT01004146|1224056|P2|Have Incentive Spirometry Data|Overall Study||20
500783|NCT01004146|1224057|P1|Have Incentive Spirometry Data|Overall Study||21
500784|NCT01004146|1224056|P2|STARTED|Overall Study||25
500785|NCT01004146|1224057|P1|STARTED|Overall Study||25
500786|NCT01004003|1224072|P9|NOT COMPLETED|Overall Study||30
500787|NCT01004003|1224073|P8|NOT COMPLETED|Overall Study||60
500788|NCT01004003|1224074|P7|NOT COMPLETED|Overall Study||8
500789|NCT01004003|1224075|P6|NOT COMPLETED|Overall Study||4
500790|NCT01004003|1224076|P5|NOT COMPLETED|Overall Study||4
500791|NCT01004003|1224077|P4|NOT COMPLETED|Overall Study||3
500792|NCT01004003|1224078|P3|NOT COMPLETED|Overall Study||4
500793|NCT01004003|1224079|P2|NOT COMPLETED|Overall Study||3
500794|NCT01004003|1224080|P1|NOT COMPLETED|Overall Study||6
500795|NCT01004003|1224072|P9|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 July 2014).|1
500796|NCT01004003|1224073|P8|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 July 2014).|2
500797|NCT01004003|1224074|P7|COMPLETED|Overall Study||0
500798|NCT01004003|1224075|P6|COMPLETED|Overall Study||0
500799|NCT01004003|1224076|P5|COMPLETED|Overall Study||0
500800|NCT01004003|1224077|P4|COMPLETED|Overall Study||0
500801|NCT01004003|1224078|P3|COMPLETED|Overall Study||0
500802|NCT01004003|1224079|P2|COMPLETED|Overall Study||0
500803|NCT01004003|1224080|P1|COMPLETED|Overall Study||0
500804|NCT01004003|1224072|P9|STARTED|Overall Study||31
500805|NCT01004003|1224073|P8|STARTED|Overall Study||62
500806|NCT01004003|1224074|P7|STARTED|Overall Study||8
500807|NCT01004003|1224075|P6|STARTED|Overall Study||4
500808|NCT01004003|1224076|P5|STARTED|Overall Study||4
500809|NCT01004003|1224077|P4|STARTED|Overall Study||3
500810|NCT01004003|1224078|P3|STARTED|Overall Study||4
500811|NCT01004003|1224079|P2|STARTED|Overall Study||3
500812|NCT01004003|1224080|P1|STARTED|Overall Study||6
500813|NCT01003990|1224111|P3|NOT COMPLETED|Overall Study||43
500814|NCT01003990|1224112|P2|NOT COMPLETED|Overall Study||51
500815|NCT01003990|1224113|P1|NOT COMPLETED|Overall Study||92
500816|NCT01003990|1224111|P3|COMPLETED|Overall Study||53
500817|NCT01003990|1224112|P2|COMPLETED|Overall Study||103
500818|NCT01003990|1224113|P1|COMPLETED|Overall Study||367
500819|NCT01003990|1224111|P3|STARTED|Overall Study||96
500820|NCT01003990|1224112|P2|STARTED|Overall Study||154
500821|NCT01003990|1224113|P1|STARTED|Overall Study||459
500822|NCT01003938|1224121|P1|NOT COMPLETED|Overall Study||0
500823|NCT01003938|1224121|P1|COMPLETED|Overall Study||6
500824|NCT01003938|1224121|P1|STARTED|Overall Study||6
500825|NCT01003899|1224130|P1|NOT COMPLETED|Overall Study||47
500826|NCT01003899|1224130|P1|COMPLETED|Overall Study||0
500827|NCT01003899|1224130|P1|STARTED|Overall Study|enrolled|47
500828|NCT01003886|1224139|P1|NOT COMPLETED|Overall Study||230
500829|NCT01003886|1224139|P1|COMPLETED|Overall Study||759
500830|NCT01003886|1224139|P1|STARTED|Overall Study||989
500831|NCT01003301|1224150|P2|NOT COMPLETED|Overall Study||0
500832|NCT01003301|1224151|P1|NOT COMPLETED|Overall Study||0
500833|NCT01003301|1224150|P2|COMPLETED|Overall Study||9
500834|NCT01003301|1224151|P1|COMPLETED|Overall Study||10
500835|NCT01003301|1224150|P2|STARTED|Overall Study||9
500836|NCT01003301|1224151|P1|STARTED|Overall Study||10
500837|NCT01003288|1224159|P1|NOT COMPLETED|Overall Study||0
500838|NCT01003288|1224159|P1|COMPLETED|Overall Study||255
500839|NCT01003288|1224159|P1|STARTED|Overall Study||255
500840|NCT01003275|1224166|P2|NOT COMPLETED|Overall Study||0
500841|NCT01003275|1224167|P1|NOT COMPLETED|Overall Study||1
500842|NCT01003275|1224166|P2|COMPLETED|Overall Study||11
500843|NCT01003275|1224167|P1|COMPLETED|Overall Study||10
500844|NCT01003275|1224166|P2|STARTED|Overall Study||11
500845|NCT01003275|1224167|P1|STARTED|Overall Study||11
500846|NCT01003249|1224173|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
500847|NCT01003249|1224174|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
500848|NCT01003249|1224173|P2|COMPLETED|Second Intervention (4 Weeks)||2
500849|NCT01003249|1224174|P1|COMPLETED|Second Intervention (4 Weeks)||3
500850|NCT01003249|1224173|P2|STARTED|Second Intervention (4 Weeks)||3
500851|NCT01003249|1224174|P1|STARTED|Second Intervention (4 Weeks)||4
500852|NCT01003249|1224173|P2|NOT COMPLETED|Washout (3 Weeks)||0
500853|NCT01003249|1224174|P1|NOT COMPLETED|Washout (3 Weeks)||0
500854|NCT01003249|1224173|P2|COMPLETED|Washout (3 Weeks)||3
500855|NCT01003249|1224174|P1|COMPLETED|Washout (3 Weeks)||4
500856|NCT01003249|1224173|P2|STARTED|Washout (3 Weeks)||3
500857|NCT01003249|1224174|P1|STARTED|Washout (3 Weeks)||4
500858|NCT01003249|1224173|P2|NOT COMPLETED|First Intervention (4 Weeks)||2
500859|NCT01003249|1224174|P1|NOT COMPLETED|First Intervention (4 Weeks)||2
500860|NCT01003249|1224173|P2|COMPLETED|First Intervention (4 Weeks)||3
500861|NCT01003249|1224174|P1|COMPLETED|First Intervention (4 Weeks)||5
500862|NCT01003249|1224173|P2|Received Intervention|First Intervention (4 Weeks)||5
500863|NCT01003249|1224174|P1|Received Intervention|First Intervention (4 Weeks)||7
500864|NCT01003249|1224173|P2|STARTED|First Intervention (4 Weeks)||5
500865|NCT01003249|1224174|P1|STARTED|First Intervention (4 Weeks)||7
500866|NCT01003210|1224192|P2|NOT COMPLETED|Overall Study||3
500867|NCT01003210|1224193|P1|NOT COMPLETED|Overall Study||1
500868|NCT01003210|1224192|P2|COMPLETED|Overall Study||102
500869|NCT01003210|1224193|P1|COMPLETED|Overall Study||104
500870|NCT01003210|1224192|P2|STARTED|Overall Study||105
500871|NCT01003210|1224193|P1|STARTED|Overall Study||105
500872|NCT01003184|1224205|P2|NOT COMPLETED|Overall Study||12
500873|NCT01003184|1224206|P1|NOT COMPLETED|Overall Study||19
500874|NCT01003184|1224205|P2|COMPLETED|Overall Study||99
500875|NCT01003184|1224206|P1|COMPLETED|Overall Study||92
500876|NCT01003184|1224205|P2|Full Analysis Set (FAS)|Overall Study||105
500877|NCT01003184|1224206|P1|Full Analysis Set (FAS)|Overall Study||111
500878|NCT01003184|1224205|P2|STARTED|Overall Study||111
500879|NCT01003184|1224206|P1|STARTED|Overall Study||111
500880|NCT01003106|1224242|P8|NOT COMPLETED|Month 6-Month 36||0
500881|NCT01003106|1224243|P7|NOT COMPLETED|Month 6-Month 36||1
500882|NCT01003106|1224244|P6|NOT COMPLETED|Month 6-Month 36||0
500883|NCT01003106|1224245|P5|NOT COMPLETED|Month 6-Month 36||0
500884|NCT01003106|1224246|P4|NOT COMPLETED|Month 6-Month 36||0
500885|NCT01003106|1224247|P3|NOT COMPLETED|Month 6-Month 36||1
500886|NCT01003106|1224248|P2|NOT COMPLETED|Month 6-Month 36||0
500887|NCT01003106|1224249|P1|NOT COMPLETED|Month 6-Month 36||0
500888|NCT01003106|1224242|P8|COMPLETED|Month 6-Month 36||18
500889|NCT01003106|1224243|P7|COMPLETED|Month 6-Month 36||19
500890|NCT01003106|1224244|P6|COMPLETED|Month 6-Month 36||0
500891|NCT01003106|1224245|P5|COMPLETED|Month 6-Month 36||0
500892|NCT01003106|1224246|P4|COMPLETED|Month 6-Month 36||20
500893|NCT01003106|1224247|P3|COMPLETED|Month 6-Month 36||18
500894|NCT01003106|1224248|P2|COMPLETED|Month 6-Month 36||0
500895|NCT01003106|1224249|P1|COMPLETED|Month 6-Month 36||0
500896|NCT01003106|1224242|P8|STARTED|Month 6-Month 36||18
500897|NCT01003106|1224243|P7|STARTED|Month 6-Month 36||20
500898|NCT01003106|1224244|P6|STARTED|Month 6-Month 36||0
500899|NCT01003106|1224245|P5|STARTED|Month 6-Month 36||0
500900|NCT01003106|1224246|P4|STARTED|Month 6-Month 36||20
500901|NCT01003106|1224247|P3|STARTED|Month 6-Month 36||19
500902|NCT01003106|1224248|P2|STARTED|Month 6-Month 36||0
500903|NCT01003106|1224249|P1|STARTED|Month 6-Month 36||0
500904|NCT01003106|1224242|P8|NOT COMPLETED|Baseline to Month 6||0
500905|NCT01003106|1224243|P7|NOT COMPLETED|Baseline to Month 6||0
500906|NCT01003106|1224244|P6|NOT COMPLETED|Baseline to Month 6||0
500907|NCT01003106|1224245|P5|NOT COMPLETED|Baseline to Month 6||0
500908|NCT01003106|1224246|P4|NOT COMPLETED|Baseline to Month 6||0
500909|NCT01003106|1224247|P3|NOT COMPLETED|Baseline to Month 6||0
500910|NCT01003106|1224248|P2|NOT COMPLETED|Baseline to Month 6||0
500911|NCT01003106|1224249|P1|NOT COMPLETED|Baseline to Month 6||0
500912|NCT01003106|1224242|P8|COMPLETED|Baseline to Month 6||0
500913|NCT01003106|1224243|P7|COMPLETED|Baseline to Month 6||0
500914|NCT01003106|1224244|P6|COMPLETED|Baseline to Month 6||20
500915|NCT01003106|1224245|P5|COMPLETED|Baseline to Month 6||19
500916|NCT01003106|1224246|P4|COMPLETED|Baseline to Month 6||0
500917|NCT01003106|1224247|P3|COMPLETED|Baseline to Month 6||0
500918|NCT01003106|1224248|P2|COMPLETED|Baseline to Month 6||20
500919|NCT01003106|1224249|P1|COMPLETED|Baseline to Month 6||22
500920|NCT01003106|1224242|P8|STARTED|Baseline to Month 6||0
500921|NCT01003106|1224243|P7|STARTED|Baseline to Month 6||0
500922|NCT01003106|1224244|P6|STARTED|Baseline to Month 6||20
500923|NCT01003106|1224245|P5|STARTED|Baseline to Month 6||19
500924|NCT01003106|1224246|P4|STARTED|Baseline to Month 6||0
500925|NCT01003106|1224247|P3|STARTED|Baseline to Month 6||0
500926|NCT01003106|1224248|P2|STARTED|Baseline to Month 6||20
500927|NCT01003106|1224249|P1|STARTED|Baseline to Month 6||22
500928|NCT01003080|1224273|P2|NOT COMPLETED|Overall Study||0
500929|NCT01003080|1224274|P1|NOT COMPLETED|Overall Study||0
500930|NCT01003080|1224273|P2|COMPLETED|Overall Study||61
500931|NCT01003080|1224274|P1|COMPLETED|Overall Study||50
500932|NCT01003080|1224273|P2|STARTED|Overall Study||61
500933|NCT01003080|1224274|P1|STARTED|Overall Study||50
500934|NCT01003067|1224282|P2|NOT COMPLETED|Overall Study||24
500935|NCT01003067|1224283|P1|NOT COMPLETED|Overall Study||33
500936|NCT01003067|1224282|P2|COMPLETED|Overall Study||107
500937|NCT01003067|1224283|P1|COMPLETED|Overall Study||103
500938|NCT01003067|1224282|P2|STARTED|Overall Study||131
500939|NCT01003067|1224283|P1|STARTED|Overall Study||136
500940|NCT01002989|1224289|P1|NOT COMPLETED|Overall Study||5
500941|NCT01002989|1224289|P1|COMPLETED|Overall Study||93
500942|NCT01002989|1224289|P1|STARTED|Overall Study||98
500943|NCT01002742|1224298|P2|NOT COMPLETED|Overall Study||1
500944|NCT01002742|1224299|P1|NOT COMPLETED|Overall Study||0
500945|NCT01002742|1224298|P2|COMPLETED|Overall Study||116
500946|NCT01002742|1224299|P1|COMPLETED|Overall Study||119
500947|NCT01002742|1224298|P2|STARTED|Overall Study||117
500948|NCT01002742|1224299|P1|STARTED|Overall Study||119
500949|NCT01002573|1224335|P2|NOT COMPLETED|Overall Study||7
500950|NCT01002573|1224336|P1|NOT COMPLETED|Overall Study||11
500951|NCT01002573|1224335|P2|COMPLETED|Overall Study||53
500952|NCT01002573|1224336|P1|COMPLETED|Overall Study||47
500953|NCT01002573|1224335|P2|STARTED|Overall Study||60
500954|NCT01002573|1224336|P1|STARTED|Overall Study||58
500955|NCT01002482|1224356|P2|NOT COMPLETED|Overall Study||21
500956|NCT01002482|1224357|P1|NOT COMPLETED|Overall Study||15
500957|NCT01002482|1224356|P2|COMPLETED|Overall Study||1312
500958|NCT01002482|1224357|P1|COMPLETED|Overall Study||1336
500959|NCT01002482|1224356|P2|STARTED|Overall Study||1333
500960|NCT01002482|1224357|P1|STARTED|Overall Study||1351
500961|NCT01002456|1224379|P2|NOT COMPLETED|Overall Study||0
500962|NCT01002456|1224380|P1|NOT COMPLETED|Overall Study||0
500963|NCT01002456|1224379|P2|COMPLETED|Overall Study||122
500964|NCT01002456|1224380|P1|COMPLETED|Overall Study||98
500965|NCT01002456|1224379|P2|STARTED|Overall Study||122
500966|NCT01002456|1224380|P1|STARTED|Overall Study||98
500967|NCT01002339|1224391|P3|NOT COMPLETED|Overall Study||5
500968|NCT01002339|1224392|P2|NOT COMPLETED|Overall Study||1
500969|NCT01002339|1224393|P1|NOT COMPLETED|Overall Study||0
500970|NCT01002339|1224391|P3|COMPLETED|Overall Study||42
500971|NCT01002339|1224392|P2|COMPLETED|Overall Study||42
500972|NCT01002339|1224393|P1|COMPLETED|Overall Study||44
500973|NCT01002339|1224391|P3|STARTED|Overall Study||47
500974|NCT01002339|1224392|P2|STARTED|Overall Study||43
500975|NCT01002339|1224393|P1|STARTED|Overall Study||44
500976|NCT01002287|1224448|P2|NOT COMPLETED|Overall Study||0
500977|NCT01002287|1224449|P1|NOT COMPLETED|Overall Study||0
500978|NCT01002287|1224448|P2|COMPLETED|Overall Study||3
500979|NCT01002287|1224449|P1|COMPLETED|Overall Study||8
500980|NCT01002287|1224448|P2|STARTED|Overall Study||3
500981|NCT01002287|1224449|P1|STARTED|Overall Study||8
500982|NCT01002118|1224461|P1|NOT COMPLETED|Overall Study||0
500983|NCT01002118|1224461|P1|COMPLETED|Overall Study||1
500984|NCT01002118|1224461|P1|Randomized Only Patient|Overall Study||1
500985|NCT01002118|1224461|P1|STARTED|Overall Study||1
500986|NCT01002105|1224469|P2|NOT COMPLETED|Overall Study||21
500987|NCT01002105|1224470|P1|NOT COMPLETED|Overall Study||19
500988|NCT01002105|1224469|P2|COMPLETED|Overall Study||11
500989|NCT01002105|1224470|P1|COMPLETED|Overall Study||13
500990|NCT01002105|1224469|P2|STARTED|Overall Study||32
500991|NCT01002105|1224470|P1|STARTED|Overall Study||32
500992|NCT01001988|1224486|P1|NOT COMPLETED|Overall Study||117
500993|NCT01001988|1224486|P1|COMPLETED|Overall Study||479
500994|NCT01001988|1224486|P1|STARTED|Overall Study||596
500995|NCT01001975|1224493|P2|NOT COMPLETED|Overall Study||0
500996|NCT01001975|1224494|P1|NOT COMPLETED|Overall Study||0
500997|NCT01001975|1224493|P2|COMPLETED|Overall Study||5
500998|NCT01001975|1224494|P1|COMPLETED|Overall Study||5
500999|NCT01001975|1224493|P2|STARTED|Overall Study||5
501000|NCT01001975|1224494|P1|STARTED|Overall Study||5
501001|NCT01001832|1224504|P2|NOT COMPLETED|Follow-up Period||21
501002|NCT01001832|1224505|P1|NOT COMPLETED|Follow-up Period||18
501003|NCT01001832|1224504|P2|COMPLETED|Follow-up Period||30
501004|NCT01001832|1224505|P1|COMPLETED|Follow-up Period||34
501005|NCT01001832|1224504|P2|STARTED|Follow-up Period||51
501006|NCT01001832|1224505|P1|STARTED|Follow-up Period||52
501007|NCT01001832|1224504|P2|NOT COMPLETED|Long-term Period||5
501008|NCT01001832|1224505|P1|NOT COMPLETED|Long-term Period||4
501009|NCT01001832|1224504|P2|COMPLETED|Long-term Period||51
501010|NCT01001832|1224505|P1|COMPLETED|Long-term Period||52
501011|NCT01001832|1224504|P2|STARTED|Long-term Period||56
501012|NCT01001832|1224505|P1|STARTED|Long-term Period|1 participant completed the short term period but discontinued before start of the Long-term Period.|56
501013|NCT01001832|1224504|P2|NOT COMPLETED|Short-term Period||3
501014|NCT01001832|1224505|P1|NOT COMPLETED|Short-term Period||2
501015|NCT01001832|1224504|P2|COMPLETED|Short-term Period||56
501016|NCT01001832|1224505|P1|COMPLETED|Short-term Period||57
501017|NCT01001832|1224504|P2|STARTED|Short-term Period||59
501018|NCT01001832|1224505|P1|STARTED|Short-term Period||59
501019|NCT01001806|1224551|P3|NOT COMPLETED|Overall Study||4
501020|NCT01001806|1224552|P2|NOT COMPLETED|Overall Study||1
501021|NCT01001806|1224553|P1|NOT COMPLETED|Overall Study||0
501022|NCT01001806|1224551|P3|COMPLETED|Overall Study||38
501023|NCT01001806|1224552|P2|COMPLETED|Overall Study||41
501024|NCT01001806|1224553|P1|COMPLETED|Overall Study||42
501025|NCT01001806|1224551|P3|STARTED|Overall Study||42
501026|NCT01001806|1224552|P2|STARTED|Overall Study||42
501027|NCT01001806|1224553|P1|STARTED|Overall Study||42
501028|NCT01001767|1224563|P2|NOT COMPLETED|Overall Study||0
501029|NCT01001767|1224564|P1|NOT COMPLETED|Overall Study||4
501030|NCT01001767|1224563|P2|COMPLETED|Overall Study||17
501031|NCT01001767|1224564|P1|COMPLETED|Overall Study||14
501032|NCT01001767|1224563|P2|STARTED|Overall Study||17
501033|NCT01001767|1224564|P1|STARTED|Overall Study||18
501034|NCT01001702|1224570|P1|NOT COMPLETED|Overall Study||72
501035|NCT01001702|1224570|P1|COMPLETED|Overall Study||13
501036|NCT01001702|1224570|P1|STARTED|Overall Study||85
501037|NCT01001572|1224583|P3|NOT COMPLETED|Double-Blind Treatment Phase||19
501038|NCT01001572|1224584|P2|NOT COMPLETED|Double-Blind Treatment Phase||10
501039|NCT01001572|1224585|P1|NOT COMPLETED|Double-Blind Treatment Phase||0
501040|NCT01001572|1224583|P3|COMPLETED|Double-Blind Treatment Phase||306
501041|NCT01001572|1224584|P2|COMPLETED|Double-Blind Treatment Phase||319
501042|NCT01001572|1224585|P1|COMPLETED|Double-Blind Treatment Phase||0
501043|NCT01001572|1224583|P3|Full Analysis Set (FAS)|Double-Blind Treatment Phase|Two patients were excluded from full analysis set for having no post-baseline efficacy assessment.|323
501044|NCT01001572|1224584|P2|Full Analysis Set (FAS)|Double-Blind Treatment Phase|One patient was excluded from full analysis set for having no post-baseline efficacy assessment.|328
501045|NCT01001572|1224585|P1|Full Analysis Set (FAS)|Double-Blind Treatment Phase||0
501046|NCT01001572|1224583|P3|STARTED|Double-Blind Treatment Phase||325
501047|NCT01001572|1224584|P2|STARTED|Double-Blind Treatment Phase||329
501048|NCT01001572|1224585|P1|STARTED|Double-Blind Treatment Phase|This arm is only used for single blind period. So, no enrollment during double blind period.|0
501049|NCT01001572|1224583|P3|NOT COMPLETED|Single-Blind Valsartan 160 mg||0
501050|NCT01001572|1224584|P2|NOT COMPLETED|Single-Blind Valsartan 160 mg||0
501051|NCT01001572|1224585|P1|NOT COMPLETED|Single-Blind Valsartan 160 mg||278
501052|NCT01001572|1224583|P3|COMPLETED|Single-Blind Valsartan 160 mg||0
501053|NCT01001572|1224584|P2|COMPLETED|Single-Blind Valsartan 160 mg||0
501054|NCT01001572|1224585|P1|COMPLETED|Single-Blind Valsartan 160 mg||654
501055|NCT01001572|1224583|P3|STARTED|Single-Blind Valsartan 160 mg|Participants did not enroll into this arm during single blind period.|0
501056|NCT01001572|1224584|P2|STARTED|Single-Blind Valsartan 160 mg|Participants did not enroll into this arm during single blind period.|0
501057|NCT01001572|1224585|P1|STARTED|Single-Blind Valsartan 160 mg||932
501058|NCT01001559|1224601|P2|NOT COMPLETED|Overall Study||0
501059|NCT01001559|1224602|P1|NOT COMPLETED|Overall Study||0
501060|NCT01001559|1224601|P2|COMPLETED|Overall Study||147
501061|NCT01001559|1224602|P1|COMPLETED|Overall Study||95
501062|NCT01001559|1224601|P2|STARTED|Overall Study||147
501063|NCT01001559|1224602|P1|STARTED|Overall Study||95
501064|NCT01001546|1224616|P2|NOT COMPLETED|Overall Study||0
501065|NCT01001546|1224617|P1|NOT COMPLETED|Overall Study||0
501066|NCT01001546|1224616|P2|COMPLETED|Overall Study||207
501067|NCT01001546|1224617|P1|COMPLETED|Overall Study||206
501068|NCT01001546|1224616|P2|STARTED|Overall Study||207
501069|NCT01001546|1224617|P1|STARTED|Overall Study||206
501070|NCT01001520|1224623|P2|NOT COMPLETED|Medication Period 2||3
501071|NCT01001520|1224624|P1|NOT COMPLETED|Medication Period 2||0
501072|NCT01001520|1224623|P2|COMPLETED|Medication Period 2||13
501073|NCT01001520|1224624|P1|COMPLETED|Medication Period 2||16
501074|NCT01001520|1224623|P2|STARTED|Medication Period 2||16
501075|NCT01001520|1224624|P1|STARTED|Medication Period 2||16
501076|NCT01001520|1224623|P2|NOT COMPLETED|Washout Period||1
501077|NCT01001520|1224624|P1|NOT COMPLETED|Washout Period||2
501078|NCT01001520|1224623|P2|COMPLETED|Washout Period||16
501079|NCT01001520|1224624|P1|COMPLETED|Washout Period||16
501080|NCT01001520|1224623|P2|STARTED|Washout Period||17
501081|NCT01001520|1224624|P1|STARTED|Washout Period||18
501082|NCT01001520|1224623|P2|NOT COMPLETED|Medication Period 1||7
501083|NCT01001520|1224624|P1|NOT COMPLETED|Medication Period 1||4
501084|NCT01001520|1224623|P2|COMPLETED|Medication Period 1||17
501085|NCT01001520|1224624|P1|COMPLETED|Medication Period 1||18
501086|NCT01001520|1224623|P2|STARTED|Medication Period 1||24
501087|NCT01001520|1224624|P1|STARTED|Medication Period 1||22
501088|NCT01001494|1224651|P3|NOT COMPLETED|Overall Study||41
501089|NCT01001494|1224652|P2|NOT COMPLETED|Overall Study||17
501090|NCT01001494|1224653|P1|NOT COMPLETED|Overall Study||24
501091|NCT01001494|1224651|P3|COMPLETED|Overall Study||232
501092|NCT01001494|1224652|P2|COMPLETED|Overall Study||252
501093|NCT01001494|1224653|P1|COMPLETED|Overall Study||253
501094|NCT01001494|1224651|P3|STARTED|Overall Study|276 patients were randomized, but baseline data was missing from 3 patients in one center|273
501095|NCT01001494|1224652|P2|STARTED|Overall Study|272 patients were randomized, but baseline data was missing from 3 patients in one center|269
501096|NCT01001494|1224653|P1|STARTED|Overall Study|280 patients were randomized, but baseline data was missing from 3 patients in one center|277
501097|NCT01001442|1224681|P8|NOT COMPLETED|Overall Study||2
501098|NCT01001442|1224682|P7|NOT COMPLETED|Overall Study||4
501099|NCT01001442|1224683|P6|NOT COMPLETED|Overall Study||0
501100|NCT01001442|1224684|P5|NOT COMPLETED|Overall Study||2
501101|NCT01001442|1224685|P4|NOT COMPLETED|Overall Study||0
501102|NCT01001442|1224686|P3|NOT COMPLETED|Overall Study||0
501103|NCT01001442|1224687|P2|NOT COMPLETED|Overall Study||0
501104|NCT01001442|1224688|P1|NOT COMPLETED|Overall Study||0
501105|NCT01001442|1224681|P8|COMPLETED|Overall Study||2
501106|NCT01001442|1224682|P7|COMPLETED|Overall Study||6
501107|NCT01001442|1224683|P6|COMPLETED|Overall Study||3
501108|NCT01001442|1224684|P5|COMPLETED|Overall Study||2
501109|NCT01001442|1224685|P4|COMPLETED|Overall Study||3
501110|NCT01001442|1224686|P3|COMPLETED|Overall Study||4
501111|NCT01001442|1224687|P2|COMPLETED|Overall Study||3
501112|NCT01001442|1224688|P1|COMPLETED|Overall Study||4
501113|NCT01001442|1224681|P8|STARTED|Overall Study||4
501114|NCT01001442|1224682|P7|STARTED|Overall Study||10
501115|NCT01001442|1224683|P6|STARTED|Overall Study||3
501116|NCT01001442|1224684|P5|STARTED|Overall Study||4
501117|NCT01001442|1224685|P4|STARTED|Overall Study||3
501118|NCT01001442|1224686|P3|STARTED|Overall Study||4
501119|NCT01001442|1224687|P2|STARTED|Overall Study||3
501120|NCT01001442|1224688|P1|STARTED|Overall Study||4
501121|NCT01001429|1224738|P2|NOT COMPLETED|Overall Study||1
501122|NCT01001429|1224739|P1|NOT COMPLETED|Overall Study||0
501123|NCT01001429|1224738|P2|COMPLETED|Overall Study||37
501124|NCT01001429|1224739|P1|COMPLETED|Overall Study||39
501125|NCT01001429|1224738|P2|STARTED|Overall Study||38
501126|NCT01001429|1224739|P1|STARTED|Overall Study||39
501127|NCT01001403|1224771|P2|NOT COMPLETED|Overall Study||0
501128|NCT01001403|1224772|P1|NOT COMPLETED|Overall Study||0
501129|NCT01001403|1224771|P2|COMPLETED|Overall Study||31
501130|NCT01001403|1224772|P1|COMPLETED|Overall Study||31
501131|NCT01001403|1224771|P2|STARTED|Overall Study||31
501132|NCT01001403|1224772|P1|STARTED|Overall Study||31
501133|NCT01001390|1224778|P2|NOT COMPLETED|Overall Study||0
501134|NCT01001390|1224779|P1|NOT COMPLETED|Overall Study||2
501135|NCT01001390|1224778|P2|COMPLETED|Overall Study||0
501136|NCT01001390|1224779|P1|COMPLETED|Overall Study||0
501137|NCT01001390|1224778|P2|STARTED|Overall Study||0
501138|NCT01001390|1224779|P1|STARTED|Overall Study||2
501139|NCT01001377|1224787|P2|NOT COMPLETED|Overall Study||421
501140|NCT01001377|1224788|P1|NOT COMPLETED|Overall Study||426
501141|NCT01001377|1224787|P2|COMPLETED|Overall Study|Indicates participants continuing in study|85
501142|NCT01001377|1224788|P1|COMPLETED|Overall Study|Indicates participants continuing in study|78
501143|NCT01001377|1224787|P2|Received Treatment|Overall Study||499
501144|NCT01001377|1224788|P1|Received Treatment|Overall Study||500
501145|NCT01001377|1224787|P2|STARTED|Overall Study||506
501146|NCT01001377|1224788|P1|STARTED|Overall Study||504
501147|NCT01001325|1224818|P2|NOT COMPLETED|Overall Study||10
501148|NCT01001325|1224819|P1|NOT COMPLETED|Overall Study||18
501149|NCT01001325|1224818|P2|COMPLETED|Overall Study||224
501150|NCT01001325|1224819|P1|COMPLETED|Overall Study||216
501151|NCT01001325|1224818|P2|STARTED|Overall Study||234
501152|NCT01001325|1224819|P1|STARTED|Overall Study||234
501153|NCT01001299|1224825|P1|NOT COMPLETED|Overall Study||25
501154|NCT01001299|1224825|P1|COMPLETED|Overall Study||0
501155|NCT01001299|1224825|P1|STARTED|Overall Study||25
501156|NCT01001234|1224854|P5|NOT COMPLETED|Overall Study||0
501157|NCT01001234|1224855|P4|NOT COMPLETED|Overall Study||25
501158|NCT01001234|1224856|P3|NOT COMPLETED|Overall Study||32
501159|NCT01001234|1224857|P2|NOT COMPLETED|Overall Study||26
501160|NCT01001234|1224858|P1|NOT COMPLETED|Overall Study||405
501161|NCT01001234|1224854|P5|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|40
501162|NCT01001234|1224855|P4|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|385
501163|NCT01001234|1224856|P3|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|377
501164|NCT01001234|1224857|P2|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|5
501165|NCT01001234|1224858|P1|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|87
501166|NCT01001234|1224854|P5|Participants Not Treated|Overall Study|Participants who did not take study drug|0
501167|NCT01001234|1224855|P4|Participants Not Treated|Overall Study|Participants who did not take study drug|5
501168|NCT01001234|1224856|P3|Participants Not Treated|Overall Study|Participants who did not take study drug|9
501169|NCT01001234|1224857|P2|Participants Not Treated|Overall Study|Participants who did not take study drug|23
501170|NCT01001234|1224858|P1|Participants Not Treated|Overall Study|Participants who did not take study drug|368
501171|NCT01001234|1224854|P5|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|40
501172|NCT01001234|1224855|P4|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|405
501173|NCT01001234|1224856|P3|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|400
501174|NCT01001234|1224857|P2|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|8
501175|NCT01001234|1224858|P1|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|124
501176|NCT01001234|1224854|P5|STARTED|Overall Study|Participants who were randomized to study drug|40
501177|NCT01001234|1224855|P4|STARTED|Overall Study|Participants who were randomized to study drug|410
501178|NCT01001234|1224856|P3|STARTED|Overall Study|Participants who were randomized to study drug|409
501179|NCT01001234|1224857|P2|STARTED|Overall Study|Participants who were randomized to study drug|31
501180|NCT01001234|1224858|P1|STARTED|Overall Study|Participants who were randomized to study drug|492
501181|NCT01001221|1224874|P5|NOT COMPLETED|Overall Study||0
501182|NCT01001221|1224875|P4|NOT COMPLETED|Overall Study||6
501183|NCT01001221|1224876|P3|NOT COMPLETED|Overall Study||3
501184|NCT01001221|1224877|P2|NOT COMPLETED|Overall Study||5
501185|NCT01001221|1224878|P1|NOT COMPLETED|Overall Study||5
501186|NCT01001221|1224874|P5|COMPLETED|Overall Study||0
501187|NCT01001221|1224875|P4|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
501188|NCT01001221|1224876|P3|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
501189|NCT01001221|1224877|P2|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
501190|NCT01001221|1224878|P1|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
501191|NCT01001221|1224874|P5|Completed 1st Treatment Cycle|Overall Study||0
501192|NCT01001221|1224875|P4|Completed 1st Treatment Cycle|Overall Study||6
501193|NCT01001221|1224876|P3|Completed 1st Treatment Cycle|Overall Study||2
501194|NCT01001221|1224877|P2|Completed 1st Treatment Cycle|Overall Study||5
501195|NCT01001221|1224878|P1|Completed 1st Treatment Cycle|Overall Study||5
501196|NCT01001221|1224874|P5|Treated|Overall Study||0
501197|NCT01001221|1224875|P4|Treated|Overall Study||6
501198|NCT01001221|1224876|P3|Treated|Overall Study||2
501199|NCT01001221|1224877|P2|Treated|Overall Study||5
501200|NCT01001221|1224878|P1|Treated|Overall Study||5
501201|NCT01001221|1224874|P5|STARTED|Overall Study|Inability to determine the MTD during study part 1|0
501202|NCT01001221|1224875|P4|STARTED|Overall Study||6
501203|NCT01001221|1224876|P3|STARTED|Overall Study||3
501204|NCT01001221|1224877|P2|STARTED|Overall Study||5
501205|NCT01001221|1224878|P1|STARTED|Overall Study||5
501206|NCT01001208|1225053|P2|NOT COMPLETED|Overall Study||33
501207|NCT01001208|1225054|P1|NOT COMPLETED|Overall Study||28
501208|NCT01001208|1225053|P2|COMPLETED|Overall Study||206
501209|NCT01001208|1225054|P1|COMPLETED|Overall Study||211
501210|NCT01001208|1225053|P2|STARTED|Overall Study||239
501211|NCT01001208|1225054|P1|STARTED|Overall Study||239
501212|NCT01001195|1225082|P4|NOT COMPLETED|Overall Study||0
501213|NCT01001195|1225083|P3|NOT COMPLETED|Overall Study||0
501214|NCT01001195|1225084|P2|NOT COMPLETED|Overall Study||2
501215|NCT01001195|1225085|P1|NOT COMPLETED|Overall Study||2
501216|NCT01001195|1225082|P4|COMPLETED|Overall Study||41
501217|NCT01001195|1225083|P3|COMPLETED|Overall Study||44
501218|NCT01001195|1225084|P2|COMPLETED|Overall Study||39
501219|NCT01001195|1225085|P1|COMPLETED|Overall Study||37
501220|NCT01001195|1225082|P4|STARTED|Overall Study||41
501221|NCT01001195|1225083|P3|STARTED|Overall Study||44
501222|NCT01001195|1225084|P2|STARTED|Overall Study||41
501223|NCT01001195|1225085|P1|STARTED|Overall Study||39
501224|NCT01001169|1225097|P2|NOT COMPLETED|Overall Study||1
501225|NCT01001169|1225098|P1|NOT COMPLETED|Overall Study||2
501226|NCT01001169|1225097|P2|COMPLETED|Overall Study||29
501227|NCT01001169|1225098|P1|COMPLETED|Overall Study||28
501228|NCT01001169|1225097|P2|STARTED|Overall Study||30
501229|NCT01001169|1225098|P1|STARTED|Overall Study||30
501230|NCT01001104|1225206|P4|NOT COMPLETED|Overall Study||3
501231|NCT01001104|1225207|P3|NOT COMPLETED|Overall Study||1
501232|NCT01001104|1225208|P2|NOT COMPLETED|Overall Study||1
501233|NCT01001104|1225209|P1|NOT COMPLETED|Overall Study||2
501234|NCT01001104|1225206|P4|COMPLETED|Overall Study||34
501235|NCT01001104|1225207|P3|COMPLETED|Overall Study||35
501236|NCT01001104|1225208|P2|COMPLETED|Overall Study||36
501237|NCT01001104|1225209|P1|COMPLETED|Overall Study||33
501238|NCT01001104|1225206|P4|STARTED|Overall Study||37
501239|NCT01001104|1225207|P3|STARTED|Overall Study||36
501240|NCT01001104|1225208|P2|STARTED|Overall Study||37
501241|NCT01001104|1225209|P1|STARTED|Overall Study||35
501242|NCT01001078|1225256|P2|NOT COMPLETED|Overall Study||0
501243|NCT01001078|1225257|P1|NOT COMPLETED|Overall Study||0
501244|NCT01001078|1225256|P2|COMPLETED|Overall Study|Analyzed: 46, excluded from interview analysis: 2|50
501245|NCT01001078|1225257|P1|COMPLETED|Overall Study|Analyzed: 46, excluded from interview analysis: 5|50
501246|NCT01001078|1225256|P2|Lost to Followup Interview|Overall Study|Could not be interviewed.|2
501247|NCT01001078|1225257|P1|Lost to Followup Interview|Overall Study|Could not be interviewed.|5
501248|NCT01001078|1225256|P2|Intubated|Overall Study||1
501249|NCT01001078|1225257|P1|Intubated|Overall Study||2
501250|NCT01001078|1225256|P2|Received Crossover|Overall Study||3
501251|NCT01001078|1225257|P1|Received Crossover|Overall Study||2
501252|NCT01001078|1225256|P2|Received Allocated Intervention|Overall Study||46
501253|NCT01001078|1225257|P1|Received Allocated Intervention|Overall Study||46
501254|NCT01001078|1225256|P2|STARTED|Overall Study||50
501255|NCT01001078|1225257|P1|STARTED|Overall Study||50
501256|NCT01001052|1225273|P2|NOT COMPLETED|Overall Study||0
501257|NCT01001052|1225274|P1|NOT COMPLETED|Overall Study||0
501258|NCT01001052|1225273|P2|COMPLETED|Overall Study||18
501259|NCT01001052|1225274|P1|COMPLETED|Overall Study||20
501260|NCT01001052|1225273|P2|STARTED|Overall Study||18
501261|NCT01001052|1225274|P1|STARTED|Overall Study||20
501262|NCT01000987|1225287|P3|NOT COMPLETED|Overall Study||0
501263|NCT01000987|1225288|P2|NOT COMPLETED|Overall Study||0
501264|NCT01000987|1225289|P1|NOT COMPLETED|Overall Study||0
501265|NCT01000987|1225287|P3|COMPLETED|Overall Study||17
501266|NCT01000987|1225288|P2|COMPLETED|Overall Study||15
501267|NCT01000987|1225289|P1|COMPLETED|Overall Study||12
501268|NCT01000987|1225287|P3|STARTED|Overall Study||17
501269|NCT01000987|1225288|P2|STARTED|Overall Study||15
501270|NCT01000987|1225289|P1|STARTED|Overall Study||12
501271|NCT01000974|1225300|P3|NOT COMPLETED|Booster Vaccination Phase||14
501272|NCT01000974|1225301|P2|NOT COMPLETED|Booster Vaccination Phase||12
501273|NCT01000974|1225302|P1|NOT COMPLETED|Booster Vaccination Phase||67
501274|NCT01000974|1225300|P3|COMPLETED|Booster Vaccination Phase||386
501275|NCT01000974|1225301|P2|COMPLETED|Booster Vaccination Phase||423
501276|NCT01000974|1225302|P1|COMPLETED|Booster Vaccination Phase||2270
501277|NCT01000974|1225300|P3|STARTED|Booster Vaccination Phase||400
501278|NCT01000974|1225301|P2|STARTED|Booster Vaccination Phase||435
501279|NCT01000974|1225302|P1|STARTED|Booster Vaccination Phase||2337
501280|NCT01000974|1225300|P3|NOT COMPLETED|Primary Vaccination Phase||63
501281|NCT01000974|1225301|P2|NOT COMPLETED|Primary Vaccination Phase||50
501282|NCT01000974|1225302|P1|NOT COMPLETED|Primary Vaccination Phase||338
501283|NCT01000974|1225300|P3|COMPLETED|Primary Vaccination Phase||457
501284|NCT01000974|1225301|P2|COMPLETED|Primary Vaccination Phase||470
501285|NCT01000974|1225302|P1|COMPLETED|Primary Vaccination Phase||2625
501286|NCT01000974|1225300|P3|STARTED|Primary Vaccination Phase||520
501287|NCT01000974|1225301|P2|STARTED|Primary Vaccination Phase||520
501288|NCT01000974|1225302|P1|STARTED|Primary Vaccination Phase||2963
501289|NCT01000961|1225409|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
501290|NCT01000961|1225410|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
501291|NCT01000961|1225409|P2|COMPLETED|Second Intervention (3 Weeks)|Part of Efficacy analysis set|20
501292|NCT01000961|1225410|P1|COMPLETED|Second Intervention (3 Weeks)|Part of Efficacy analysis set|21
501293|NCT01000961|1225409|P2|STARTED|Second Intervention (3 Weeks)||20
501294|NCT01000961|1225410|P1|STARTED|Second Intervention (3 Weeks)||21
501295|NCT01000961|1225409|P2|NOT COMPLETED|First Intervention (3 Weeks)||2
501296|NCT01000961|1225410|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
501297|NCT01000961|1225409|P2|COMPLETED|First Intervention (3 Weeks)||20
501298|NCT01000961|1225410|P1|COMPLETED|First Intervention (3 Weeks)||21
501299|NCT01000961|1225409|P2|STARTED|First Intervention (3 Weeks)||22
501300|NCT01000961|1225410|P1|STARTED|First Intervention (3 Weeks)||21
501301|NCT01000961|1225409|P2|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0
501302|NCT01000961|1225410|P1|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0
501303|NCT01000961|1225409|P2|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||22
501304|NCT01000961|1225410|P1|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||21
501305|NCT01000961|1225409|P2|STARTED|Run-in Period of 2-3 Weeks on Cystagon|Part of the Safety analysis set|22
501306|NCT01000961|1225410|P1|STARTED|Run-in Period of 2-3 Weeks on Cystagon|Part of the Safety analysis set|21
501307|NCT01000818|1225422|P1|NOT COMPLETED|Omeprazole + Raltegravir||0
501308|NCT01000818|1225422|P1|COMPLETED|Omeprazole + Raltegravir||18
501309|NCT01000818|1225422|P1|STARTED|Omeprazole + Raltegravir||18
501310|NCT01000818|1225422|P1|NOT COMPLETED|Famotidine + Raltegravir||0
501311|NCT01000818|1225422|P1|COMPLETED|Famotidine + Raltegravir||18
501312|NCT01000818|1225422|P1|STARTED|Famotidine + Raltegravir||18
501313|NCT01000818|1225422|P1|NOT COMPLETED|Raltegravir||0
501314|NCT01000818|1225422|P1|COMPLETED|Raltegravir||18
501315|NCT01000818|1225422|P1|STARTED|Raltegravir||18
501316|NCT01000805|1225433|P2|NOT COMPLETED|Overall Study||62
501317|NCT01000805|1225434|P1|NOT COMPLETED|Overall Study||70
501318|NCT01000805|1225433|P2|COMPLETED|Overall Study||204
501319|NCT01000805|1225434|P1|COMPLETED|Overall Study||192
501320|NCT01000805|1225433|P2|STARTED|Overall Study||266
501321|NCT01000805|1225434|P1|STARTED|Overall Study||262
501322|NCT01000727|1225468|P2|NOT COMPLETED|Overall Study||176
501323|NCT01000727|1225469|P1|NOT COMPLETED|Overall Study||175
501324|NCT01000727|1225468|P2|COMPLETED|Overall Study||6328
501325|NCT01000727|1225469|P1|COMPLETED|Overall Study||6347
501326|NCT01000727|1225468|P2|STARTED|Overall Study||6504
501327|NCT01000727|1225469|P1|STARTED|Overall Study||6522
501328|NCT01000662|1225499|P2|NOT COMPLETED|Overall Study||8
501329|NCT01000662|1225500|P1|NOT COMPLETED|Overall Study||4
501330|NCT01000662|1225499|P2|COMPLETED|Overall Study||198
501331|NCT01000662|1225500|P1|COMPLETED|Overall Study||202
501332|NCT01000662|1225499|P2|STARTED|Overall Study||206
501333|NCT01000662|1225500|P1|STARTED|Overall Study||206
501334|NCT01000649|1225510|P4|NOT COMPLETED|Overall Study||6
501335|NCT01000649|1225511|P3|NOT COMPLETED|Overall Study||2
501336|NCT01000649|1225512|P2|NOT COMPLETED|Overall Study||3
501337|NCT01000649|1225513|P1|NOT COMPLETED|Overall Study||5
501338|NCT01000649|1225510|P4|COMPLETED|Overall Study||15
501339|NCT01000649|1225511|P3|COMPLETED|Overall Study||0
501340|NCT01000649|1225512|P2|COMPLETED|Overall Study||16
501341|NCT01000649|1225513|P1|COMPLETED|Overall Study||5
501342|NCT01000649|1225510|P4|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|21
501343|NCT01000649|1225511|P3|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|2
501344|NCT01000649|1225512|P2|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|20
501345|NCT01000649|1225513|P1|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|10
501346|NCT01000649|1225510|P4|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|21
501347|NCT01000649|1225511|P3|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|2
501348|NCT01000649|1225512|P2|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|19
501349|NCT01000649|1225513|P1|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|10
501350|NCT01000610|1225594|P1|NOT COMPLETED|Overall Study||6
501351|NCT01000610|1225594|P1|COMPLETED|Overall Study||12
501352|NCT01000610|1225594|P1|STARTED|Overall Study||18
501353|NCT01000506|1225605|P4|NOT COMPLETED|Overall Study||23
501354|NCT01000506|1225606|P3|NOT COMPLETED|Overall Study||21
501355|NCT01000506|1225607|P2|NOT COMPLETED|Overall Study||24
501356|NCT01000506|1225608|P1|NOT COMPLETED|Overall Study||28
501357|NCT01000506|1225605|P4|COMPLETED|Overall Study||133
501358|NCT01000506|1225606|P3|COMPLETED|Overall Study||131
501359|NCT01000506|1225607|P2|COMPLETED|Overall Study||129
501360|NCT01000506|1225608|P1|COMPLETED|Overall Study||127
501361|NCT01000506|1225605|P4|STARTED|Overall Study||156
501362|NCT01000506|1225606|P3|STARTED|Overall Study||152
501363|NCT01000506|1225607|P2|STARTED|Overall Study||153
501364|NCT01000506|1225608|P1|STARTED|Overall Study||155
501365|NCT01000493|1225652|P2|NOT COMPLETED|Overall Study||55
501366|NCT01000493|1225653|P1|NOT COMPLETED|Overall Study||39
501367|NCT01000493|1225652|P2|COMPLETED|Overall Study||14
501368|NCT01000493|1225653|P1|COMPLETED|Overall Study||21
501369|NCT01000493|1225652|P2|STARTED|Overall Study||69
501370|NCT01000493|1225653|P1|STARTED|Overall Study||60
501371|NCT01000480|1225703|P1|NOT COMPLETED|Follow-Up Period||0
501372|NCT01000480|1225703|P1|COMPLETED|Follow-Up Period||88
501373|NCT01000480|1225703|P1|STARTED|Follow-Up Period|One pt lost to follow-up during induction, 1 pt died in concurrent therapy, both not enter follow-up|88
501374|NCT01000480|1225703|P1|NOT COMPLETED|Concurrent Therapy Phase||10
501375|NCT01000480|1225703|P1|COMPLETED|Concurrent Therapy Phase||65
501376|NCT01000480|1225703|P1|Death (Any Cause) or Disease Progression|Concurrent Therapy Phase|Pts who died (any cause) or had disease progression considered to have completed the phase.|1
501377|NCT01000480|1225703|P1|STARTED|Concurrent Therapy Phase|Eight participants (pts) who completed Induction Phase, not eligible for Concurrent Therapy Phase.|75
501378|NCT01000480|1225703|P1|NOT COMPLETED|Induction Phase||7
501379|NCT01000480|1225703|P1|COMPLETED|Induction Phase||83
501380|NCT01000480|1225703|P1|Death (Any Cause) or Disease Progression|Induction Phase|Participants who died (any cause) or had disease progression considered to have completed phase.|8
501381|NCT01000480|1225703|P1|Received at Least 1 Dose of Either Drug|Induction Phase||90
501382|NCT01000480|1225703|P1|STARTED|Induction Phase||90
501383|NCT01000376|1225711|P2|NOT COMPLETED|Cycle 1 Day 15||0
501384|NCT01000376|1225712|P1|NOT COMPLETED|Cycle 1 Day 15||0
501385|NCT01000376|1225711|P2|COMPLETED|Cycle 1 Day 15||6
501386|NCT01000376|1225712|P1|COMPLETED|Cycle 1 Day 15||4
501387|NCT01000376|1225711|P2|STARTED|Cycle 1 Day 15||6
501388|NCT01000376|1225712|P1|STARTED|Cycle 1 Day 15||4
501389|NCT01000376|1225711|P2|NOT COMPLETED|Cycle 1 Day 1||0
501390|NCT01000376|1225712|P1|NOT COMPLETED|Cycle 1 Day 1||2
501391|NCT01000376|1225711|P2|COMPLETED|Cycle 1 Day 1||6
501392|NCT01000376|1225712|P1|COMPLETED|Cycle 1 Day 1||4
501393|NCT01000376|1225711|P2|STARTED|Cycle 1 Day 1||6
501394|NCT01000376|1225712|P1|STARTED|Cycle 1 Day 1||6
501395|NCT01000337|1225722|P2|NOT COMPLETED|Overall Study||3
501396|NCT01000337|1225723|P1|NOT COMPLETED|Overall Study||4
501397|NCT01000337|1225722|P2|COMPLETED|Overall Study||30
501398|NCT01000337|1225723|P1|COMPLETED|Overall Study||30
501399|NCT01000337|1225722|P2|STARTED|Overall Study||33
501400|NCT01000337|1225723|P1|STARTED|Overall Study||34
501401|NCT01000324|1225729|P1|NOT COMPLETED|Year 20||0
501402|NCT01000324|1225729|P1|COMPLETED|Year 20||28
501403|NCT01000324|1225729|P1|STARTED|Year 20||28
501404|NCT01000324|1225729|P1|NOT COMPLETED|Year 19||0
501405|NCT01000324|1225729|P1|COMPLETED|Year 19||28
501406|NCT01000324|1225729|P1|STARTED|Year 19||28
501407|NCT01000324|1225729|P1|NOT COMPLETED|Year 18||0
501408|NCT01000324|1225729|P1|COMPLETED|Year 18||29
501409|NCT01000324|1225729|P1|STARTED|Year 18||29
501410|NCT01000324|1225729|P1|NOT COMPLETED|Year 17||0
501411|NCT01000324|1225729|P1|COMPLETED|Year 17||32
501412|NCT01000324|1225729|P1|STARTED|Year 17||32
501413|NCT01000324|1225729|P1|NOT COMPLETED|Year 16||0
501414|NCT01000324|1225729|P1|COMPLETED|Year 16||40
501415|NCT01000324|1225729|P1|STARTED|Year 16||40
501416|NCT01000311|1225741|P2|NOT COMPLETED|Overall Study||70
501417|NCT01000311|1225742|P1|NOT COMPLETED|Overall Study||45
501418|NCT01000311|1225741|P2|COMPLETED|Overall Study||201
501419|NCT01000311|1225742|P1|COMPLETED|Overall Study||213
501420|NCT01000311|1225741|P2|STARTED|Overall Study||271
501421|NCT01000311|1225742|P1|STARTED|Overall Study||258
501422|NCT01000285|1225772|P1|NOT COMPLETED|Overall Study||0
501423|NCT01000285|1225772|P1|COMPLETED|Overall Study||18
501424|NCT01000285|1225772|P1|STARTED|Overall Study||18
501425|NCT01000155|1225792|P1|NOT COMPLETED|Overall Study||2
501426|NCT01000155|1225792|P1|COMPLETED|Overall Study||3
501427|NCT01000155|1225792|P1|STARTED|Overall Study||5
501428|NCT01000064|1225798|P2|NOT COMPLETED|Overall Study||1
501429|NCT01000064|1225799|P1|NOT COMPLETED|Overall Study||1
501430|NCT01000064|1225798|P2|COMPLETED|Overall Study||5
501431|NCT01000064|1225799|P1|COMPLETED|Overall Study||6
501432|NCT01000064|1225798|P2|STARTED|Overall Study||6
501433|NCT01000064|1225799|P1|STARTED|Overall Study||7
501434|NCT01000025|1225822|P2|NOT COMPLETED|Overall Study||238
501435|NCT01000025|1225823|P1|NOT COMPLETED|Overall Study||468
501436|NCT01000025|1225822|P2|COMPLETED|Overall Study||2
501437|NCT01000025|1225823|P1|COMPLETED|Overall Study||12
501438|NCT01000025|1225822|P2|STARTED|Overall Study||240
501439|NCT01000025|1225823|P1|STARTED|Overall Study||480
501440|NCT00999921|1225841|P2|NOT COMPLETED|Overall Study||19
501441|NCT00999921|1225842|P1|NOT COMPLETED|Overall Study||10
501442|NCT00999921|1225841|P2|COMPLETED|Overall Study||110
501443|NCT00999921|1225842|P1|COMPLETED|Overall Study||117
501444|NCT00999921|1225841|P2|STARTED|Overall Study||129
501445|NCT00999921|1225842|P1|STARTED|Overall Study||127
501446|NCT00999908|1225852|P3|NOT COMPLETED|Treatment Period 3||0
501447|NCT00999908|1225853|P2|NOT COMPLETED|Treatment Period 3||0
501448|NCT00999908|1225854|P1|NOT COMPLETED|Treatment Period 3||0
501449|NCT00999908|1225852|P3|COMPLETED|Treatment Period 3||19
501450|NCT00999908|1225853|P2|COMPLETED|Treatment Period 3||16
501451|NCT00999908|1225854|P1|COMPLETED|Treatment Period 3||16
501452|NCT00999908|1225852|P3|STARTED|Treatment Period 3||19
501453|NCT00999908|1225853|P2|STARTED|Treatment Period 3||16
501454|NCT00999908|1225854|P1|STARTED|Treatment Period 3||16
501455|NCT00999908|1225852|P3|NOT COMPLETED|Treatment Period 2||0
501456|NCT00999908|1225853|P2|NOT COMPLETED|Treatment Period 2||0
501457|NCT00999908|1225854|P1|NOT COMPLETED|Treatment Period 2||1
501458|NCT00999908|1225852|P3|COMPLETED|Treatment Period 2||19
501459|NCT00999908|1225853|P2|COMPLETED|Treatment Period 2||16
501460|NCT00999908|1225854|P1|COMPLETED|Treatment Period 2||16
501461|NCT00999908|1225852|P3|STARTED|Treatment Period 2||19
501462|NCT00999908|1225853|P2|STARTED|Treatment Period 2||16
501463|NCT00999908|1225854|P1|STARTED|Treatment Period 2||17
501464|NCT00999908|1225852|P3|NOT COMPLETED|Treatment Period 1||0
501465|NCT00999908|1225853|P2|NOT COMPLETED|Treatment Period 1||0
501466|NCT00999908|1225854|P1|NOT COMPLETED|Treatment Period 1||2
501467|NCT00999908|1225852|P3|COMPLETED|Treatment Period 1||19
501468|NCT00999908|1225853|P2|COMPLETED|Treatment Period 1||16
501469|NCT00999908|1225854|P1|COMPLETED|Treatment Period 1||17
501470|NCT00999908|1225852|P3|STARTED|Treatment Period 1||19
501471|NCT00999908|1225853|P2|STARTED|Treatment Period 1||16
501472|NCT00999908|1225854|P1|STARTED|Treatment Period 1||19
501473|NCT00999830|1225870|P2|NOT COMPLETED|Overall Study||0
501474|NCT00999830|1225871|P1|NOT COMPLETED|Overall Study||0
501475|NCT00999830|1225870|P2|COMPLETED|Overall Study||13
501476|NCT00999830|1225871|P1|COMPLETED|Overall Study||14
501477|NCT00999830|1225870|P2|STARTED|Overall Study||13
501478|NCT00999830|1225871|P1|STARTED|Overall Study||14
501479|NCT00999804|1225883|P2|NOT COMPLETED|Overall Study||5
501480|NCT00999804|1225884|P1|NOT COMPLETED|Overall Study||21
501481|NCT00999804|1225883|P2|COMPLETED|Overall Study||38
501482|NCT00999804|1225884|P1|COMPLETED|Overall Study||64
501483|NCT00999804|1225883|P2|STARTED|Overall Study||43
501484|NCT00999804|1225884|P1|STARTED|Overall Study||85
501485|NCT00999713|1225898|P2|NOT COMPLETED|Overall Study||0
501486|NCT00999713|1225899|P1|NOT COMPLETED|Overall Study||2
501487|NCT00999713|1225898|P2|COMPLETED|Overall Study||17
501488|NCT00999713|1225899|P1|COMPLETED|Overall Study||24
501489|NCT00999713|1225898|P2|STARTED|Overall Study||17
501490|NCT00999713|1225899|P1|STARTED|Overall Study||26
501491|NCT00999687|1225913|P1|NOT COMPLETED|Second Intervention||3
501492|NCT00999687|1225913|P1|COMPLETED|Second Intervention||27
501493|NCT00999687|1225913|P1|STARTED|Second Intervention|From week 13 to 24, all participants applied INOE to both hands twice daily.|30
501494|NCT00999687|1225913|P1|NOT COMPLETED|First Intervention||1
501495|NCT00999687|1225913|P1|COMPLETED|First Intervention||30
501496|NCT00999687|1225913|P1|STARTED|First Intervention|16 used the INOE on the right hand,15 used the INOE on the left hand.|31
501497|NCT00999661|1225920|P1|NOT COMPLETED|Overall Study||70
501498|NCT00999661|1225920|P1|COMPLETED|Overall Study||161
501499|NCT00999661|1225920|P1|STARTED|Overall Study||231
501500|NCT00999609|1225928|P2|NOT COMPLETED|Overall Study||1
501501|NCT00999609|1225929|P1|NOT COMPLETED|Overall Study||1
501502|NCT00999609|1225928|P2|COMPLETED|Overall Study|1 year post intervention|9
501503|NCT00999609|1225929|P1|COMPLETED|Overall Study|1 year post intervention|20
501504|NCT00999609|1225928|P2|STARTED|Overall Study||10
501505|NCT00999609|1225929|P1|STARTED|Overall Study|Before intervention|21
501506|NCT00999596|1225941|P1|NOT COMPLETED|Overall Study||101
501507|NCT00999596|1225941|P1|COMPLETED|Overall Study|Not all patient images were used for the reader evaluation based on new FDA Guidelines|6
501508|NCT00999596|1225941|P1|New FDA Guideline Released|Overall Study|FDA Guidance: Class II Special Controls Guidance Document: Full-Field Digital Mammography System|6
501509|NCT00999596|1225941|P1|STARTED|Overall Study||107
501510|NCT00999544|1225946|P1|NOT COMPLETED|Overall Study||1
501511|NCT00999544|1225946|P1|COMPLETED|Overall Study||8
501512|NCT00999544|1225946|P1|STARTED|Overall Study||9
501513|NCT00999466|1225982|P3|NOT COMPLETED|Main Part||4
501514|NCT00999466|1225983|P2|NOT COMPLETED|Main Part||4
501515|NCT00999466|1225984|P1|NOT COMPLETED|Main Part||0
501516|NCT00999466|1225982|P3|COMPLETED|Main Part||21
501517|NCT00999466|1225983|P2|COMPLETED|Main Part||22
501518|NCT00999466|1225984|P1|COMPLETED|Main Part||0
501519|NCT00999466|1225982|P3|STARTED|Main Part||25
501520|NCT00999466|1225983|P2|STARTED|Main Part||26
501521|NCT00999466|1225984|P1|STARTED|Main Part|AZD8848 nasal spray 30 μg group was not participated in the Main part|0
501522|NCT00999466|1225982|P3|NOT COMPLETED|Pilot Part||0
501523|NCT00999466|1225983|P2|NOT COMPLETED|Pilot Part||0
501524|NCT00999466|1225984|P1|NOT COMPLETED|Pilot Part||0
501525|NCT00999466|1225982|P3|COMPLETED|Pilot Part||3
501526|NCT00999466|1225983|P2|COMPLETED|Pilot Part||0
501527|NCT00999466|1225984|P1|COMPLETED|Pilot Part||6
501528|NCT00999466|1225982|P3|STARTED|Pilot Part||3
501529|NCT00999466|1225983|P2|STARTED|Pilot Part|AZD8848 nasal spray 60 μg group was not participated in the Pilot part|0
501530|NCT00999466|1225984|P1|STARTED|Pilot Part||6
501531|NCT00999167|1226261|P3|NOT COMPLETED|Part B: Randomized, Placebo Controlled||21
501532|NCT00999167|1226262|P2|NOT COMPLETED|Part B: Randomized, Placebo Controlled||35
501533|NCT00999167|1226263|P1|NOT COMPLETED|Part B: Randomized, Placebo Controlled||0
501534|NCT00999167|1226261|P3|COMPLETED|Part B: Randomized, Placebo Controlled||67
501535|NCT00999167|1226262|P2|COMPLETED|Part B: Randomized, Placebo Controlled||55
501536|NCT00999167|1226263|P1|COMPLETED|Part B: Randomized, Placebo Controlled||0
501537|NCT00999167|1226261|P3|STARTED|Part B: Randomized, Placebo Controlled||88
501538|NCT00999167|1226262|P2|STARTED|Part B: Randomized, Placebo Controlled|4 subjects who participated in Part A enrolled in Part B and remainder were newly enrolled|90
501539|NCT00999167|1226263|P1|STARTED|Part B: Randomized, Placebo Controlled||0
501540|NCT00999167|1226261|P3|NOT COMPLETED|Part A: Open Label Safety run-in||0
501541|NCT00999167|1226262|P2|NOT COMPLETED|Part A: Open Label Safety run-in||0
501542|NCT00999167|1226263|P1|NOT COMPLETED|Part A: Open Label Safety run-in||7
501543|NCT00999167|1226261|P3|COMPLETED|Part A: Open Label Safety run-in||0
501544|NCT00999167|1226262|P2|COMPLETED|Part A: Open Label Safety run-in||0
501545|NCT00999167|1226263|P1|COMPLETED|Part A: Open Label Safety run-in||8
501546|NCT00999167|1226261|P3|Received 9 mL BID|Part A: Open Label Safety run-in||0
501547|NCT00999167|1226262|P2|Received 9 mL BID|Part A: Open Label Safety run-in||0
501548|NCT00999167|1226263|P1|Received 9 mL BID|Part A: Open Label Safety run-in||15
501549|NCT00999167|1226261|P3|STARTED|Part A: Open Label Safety run-in||0
501550|NCT00999167|1226262|P2|STARTED|Part A: Open Label Safety run-in||0
501551|NCT00999167|1226263|P1|STARTED|Part A: Open Label Safety run-in||15
501552|NCT00999141|1226277|P1|NOT COMPLETED|Overall Study||0
501553|NCT00999141|1226277|P1|COMPLETED|Overall Study||75
501554|NCT00999141|1226277|P1|STARTED|Overall Study|Randomized and treated|75
501555|NCT00999037|1226361|P2|NOT COMPLETED|Overall Study||0
501556|NCT00999037|1226362|P1|NOT COMPLETED|Overall Study||0
501557|NCT00999037|1226361|P2|COMPLETED|Overall Study||9
501558|NCT00999037|1226362|P1|COMPLETED|Overall Study||9
501559|NCT00999037|1226361|P2|STARTED|Overall Study|20|9
501560|NCT00999037|1226362|P1|STARTED|Overall Study||9
501561|NCT00998985|1226386|P14|NOT COMPLETED|Overall Study||0
501562|NCT00998985|1226387|P13|NOT COMPLETED|Overall Study||0
501563|NCT00998985|1226388|P12|NOT COMPLETED|Overall Study||0
501564|NCT00998985|1226389|P11|NOT COMPLETED|Overall Study||0
501565|NCT00998985|1226390|P10|NOT COMPLETED|Overall Study||0
501566|NCT00998985|1226391|P9|NOT COMPLETED|Overall Study||1
501567|NCT00998985|1226392|P8|NOT COMPLETED|Overall Study||0
501568|NCT00998985|1226393|P7|NOT COMPLETED|Overall Study||0
501569|NCT00998985|1226394|P6|NOT COMPLETED|Overall Study||1
501570|NCT00998985|1226395|P5|NOT COMPLETED|Overall Study||0
501571|NCT00998985|1226396|P4|NOT COMPLETED|Overall Study||0
501572|NCT00998985|1226397|P3|NOT COMPLETED|Overall Study||0
501573|NCT00998985|1226398|P2|NOT COMPLETED|Overall Study||0
501574|NCT00998985|1226399|P1|NOT COMPLETED|Overall Study||0
501575|NCT00998985|1226386|P14|COMPLETED|Overall Study||15
501576|NCT00998985|1226387|P13|COMPLETED|Overall Study||5
501577|NCT00998985|1226388|P12|COMPLETED|Overall Study||5
501578|NCT00998985|1226389|P11|COMPLETED|Overall Study||5
501579|NCT00998985|1226390|P10|COMPLETED|Overall Study||5
501580|NCT00998985|1226391|P9|COMPLETED|Overall Study||5
501581|NCT00998985|1226392|P8|COMPLETED|Overall Study||5
501582|NCT00998985|1226393|P7|COMPLETED|Overall Study||5
501583|NCT00998985|1226394|P6|COMPLETED|Overall Study||4
501584|NCT00998985|1226395|P5|COMPLETED|Overall Study||5
501585|NCT00998985|1226396|P4|COMPLETED|Overall Study||5
501586|NCT00998985|1226397|P3|COMPLETED|Overall Study||15
501587|NCT00998985|1226398|P2|COMPLETED|Overall Study||5
501588|NCT00998985|1226399|P1|COMPLETED|Overall Study||5
501589|NCT00998985|1226386|P14|STARTED|Overall Study||15
501590|NCT00998985|1226387|P13|STARTED|Overall Study||5
501591|NCT00998985|1226388|P12|STARTED|Overall Study||5
501592|NCT00998985|1226389|P11|STARTED|Overall Study||5
501593|NCT00998985|1226390|P10|STARTED|Overall Study||5
501594|NCT00998985|1226391|P9|STARTED|Overall Study||6
501595|NCT00998985|1226392|P8|STARTED|Overall Study||5
501596|NCT00998985|1226393|P7|STARTED|Overall Study||5
501597|NCT00998985|1226394|P6|STARTED|Overall Study||5
501598|NCT00998985|1226395|P5|STARTED|Overall Study||5
501599|NCT00998985|1226396|P4|STARTED|Overall Study||5
501600|NCT00998985|1226397|P3|STARTED|Overall Study||15
501601|NCT00998985|1226398|P2|STARTED|Overall Study||5
501602|NCT00998985|1226399|P1|STARTED|Overall Study||5
501603|NCT00998881|1226467|P2|NOT COMPLETED|Overall Study||2
501604|NCT00998881|1226468|P1|NOT COMPLETED|Overall Study||8
501605|NCT00998881|1226467|P2|COMPLETED|Overall Study||97
501606|NCT00998881|1226468|P1|COMPLETED|Overall Study||96
501607|NCT00998881|1226467|P2|STARTED|Overall Study||99
501608|NCT00998881|1226468|P1|STARTED|Overall Study||104
501609|NCT00998868|1226480|P1|NOT COMPLETED|Overall Study||0
501610|NCT00998868|1226480|P1|COMPLETED|Overall Study||51
501611|NCT00998868|1226480|P1|STARTED|Overall Study|>=10 for each muscle strength per MRC scale, after excluding the cases following exclusion criteria|51
501612|NCT00998764|1226489|P2|NOT COMPLETED|Overall Study||274
501613|NCT00998764|1226490|P1|NOT COMPLETED|Overall Study||216
501614|NCT00998764|1226489|P2|COMPLETED|Overall Study||2
501615|NCT00998764|1226490|P1|COMPLETED|Overall Study||0
501616|NCT00998764|1226489|P2|Treated|Overall Study||275
501617|NCT00998764|1226490|P1|Treated|Overall Study||215
501618|NCT00998764|1226489|P2|STARTED|Overall Study||276
501619|NCT00998764|1226490|P1|STARTED|Overall Study||216
501620|NCT00998738|1226512|P1|NOT COMPLETED|Overall Study||1
501621|NCT00998738|1226512|P1|COMPLETED|Overall Study||0
501622|NCT00998738|1226512|P1|STARTED|Overall Study||1
501623|NCT00998660|1226527|P1|NOT COMPLETED|Overall Study||13
501624|NCT00998660|1226527|P1|COMPLETED|Overall Study|87 subjects reached the final study visit at Month 6.|87
501625|NCT00998660|1226527|P1|Month 3 Visit|Overall Study||87
501626|NCT00998660|1226527|P1|Implanted|Overall Study||93
501627|NCT00998660|1226527|P1|STARTED|Overall Study||100
501628|NCT00998582|1226533|P2|NOT COMPLETED|Overall Study||0
501629|NCT00998582|1226534|P1|NOT COMPLETED|Overall Study||0
501630|NCT00998582|1226533|P2|COMPLETED|Overall Study||14
501631|NCT00998582|1226534|P1|COMPLETED|Overall Study||13
501632|NCT00998582|1226533|P2|STARTED|Overall Study||14
501633|NCT00998582|1226534|P1|STARTED|Overall Study||13
501634|NCT00998517|1226545|P3|NOT COMPLETED|Overall Study||0
501635|NCT00998517|1226546|P2|NOT COMPLETED|Overall Study||0
501636|NCT00998517|1226547|P1|NOT COMPLETED|Overall Study||0
501637|NCT00998517|1226545|P3|COMPLETED|Overall Study||918
501638|NCT00998517|1226546|P2|COMPLETED|Overall Study||906
501639|NCT00998517|1226547|P1|COMPLETED|Overall Study||888
501640|NCT00998517|1226545|P3|STARTED|Overall Study||918
501641|NCT00998517|1226546|P2|STARTED|Overall Study||906
501642|NCT00998517|1226547|P1|STARTED|Overall Study||888
501643|NCT00998426|1226573|P1|NOT COMPLETED|Overall Study||0
501644|NCT00998426|1226573|P1|COMPLETED|Overall Study||5
501645|NCT00998426|1226573|P1|Blood Glucose Monitoring|Overall Study||5
501646|NCT00998426|1226573|P1|STARTED|Overall Study||5
501647|NCT00998374|1226580|P2|NOT COMPLETED|Overall Study||11
501648|NCT00998374|1226581|P1|NOT COMPLETED|Overall Study||12
501649|NCT00998374|1226580|P2|COMPLETED|Overall Study||12
501650|NCT00998374|1226581|P1|COMPLETED|Overall Study||27
501651|NCT00998374|1226580|P2|STARTED|Overall Study||23
501652|NCT00998374|1226581|P1|STARTED|Overall Study||39
501653|NCT00998335|1226595|P2|NOT COMPLETED|Randomized Period (Months 3 to 6)||2
501654|NCT00998335|1226596|P1|NOT COMPLETED|Randomized Period (Months 3 to 6)||0
501655|NCT00998335|1226595|P2|COMPLETED|Randomized Period (Months 3 to 6)||20
501656|NCT00998335|1226596|P1|COMPLETED|Randomized Period (Months 3 to 6)||8
501657|NCT00998335|1226595|P2|STARTED|Randomized Period (Months 3 to 6)|"All participants started in the Insulin detemir only arm. At month 3 subjects were randomized 2:1."|22
501658|NCT00998335|1226596|P1|STARTED|Randomized Period (Months 3 to 6)|"All participants started in the Insulin detemir only arm. At month 3 subjects were randomized 2:1."|8
501659|NCT00998335|1226595|P2|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0
501660|NCT00998335|1226596|P1|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0
501661|NCT00998335|1226595|P2|COMPLETED|Initial Treatment (Months 0 - 3)||0
501662|NCT00998335|1226596|P1|COMPLETED|Initial Treatment (Months 0 - 3)||30
501663|NCT00998335|1226595|P2|STARTED|Initial Treatment (Months 0 - 3)||0
501664|NCT00998335|1226596|P1|STARTED|Initial Treatment (Months 0 - 3)||30
501665|NCT00998309|1226624|P1|NOT COMPLETED|Overall Study||4
501666|NCT00998309|1226624|P1|COMPLETED|Overall Study||498
501667|NCT00998309|1226624|P1|STARTED|Overall Study||502
501668|NCT00998296|1226691|P11|NOT COMPLETED|Overall Study||7
501669|NCT00998296|1226692|P10|NOT COMPLETED|Overall Study||18
501670|NCT00998296|1226693|P9|NOT COMPLETED|Overall Study||2
501671|NCT00998296|1226694|P8|NOT COMPLETED|Overall Study||2
501672|NCT00998296|1226695|P7|NOT COMPLETED|Overall Study||1
501673|NCT00998296|1226696|P6|NOT COMPLETED|Overall Study||0
501674|NCT00998296|1226697|P5|NOT COMPLETED|Overall Study||2
501675|NCT00998296|1226698|P4|NOT COMPLETED|Overall Study||0
501676|NCT00998296|1226699|P3|NOT COMPLETED|Overall Study||0
501677|NCT00998296|1226700|P2|NOT COMPLETED|Overall Study||1
501678|NCT00998296|1226701|P1|NOT COMPLETED|Overall Study||0
501679|NCT00998296|1226691|P11|COMPLETED|Overall Study||0
501680|NCT00998296|1226692|P10|COMPLETED|Overall Study||0
501681|NCT00998296|1226693|P9|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|4
501682|NCT00998296|1226694|P8|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|4
501683|NCT00998296|1226695|P7|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
501684|NCT00998296|1226696|P6|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
501685|NCT00998296|1226697|P5|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
501686|NCT00998296|1226698|P4|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
501687|NCT00998296|1226699|P3|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
501688|NCT00998296|1226700|P2|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|2
501689|NCT00998296|1226701|P1|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
501690|NCT00998296|1226691|P11|STARTED|Overall Study||7
501691|NCT00998296|1226692|P10|STARTED|Overall Study||18
501692|NCT00998296|1226693|P9|STARTED|Overall Study||6
501693|NCT00998296|1226694|P8|STARTED|Overall Study||6
501694|NCT00998296|1226695|P7|STARTED|Overall Study||7
501695|NCT00998296|1226696|P6|STARTED|Overall Study||3
501696|NCT00998296|1226697|P5|STARTED|Overall Study||8
501697|NCT00998296|1226698|P4|STARTED|Overall Study||3
501698|NCT00998296|1226699|P3|STARTED|Overall Study||3
501699|NCT00998296|1226700|P2|STARTED|Overall Study||3
501700|NCT00998296|1226701|P1|STARTED|Overall Study||6
501701|NCT00998205|1226768|P1|NOT COMPLETED|Overall Study||0
501702|NCT00998205|1226768|P1|COMPLETED|Overall Study||16
501703|NCT00998205|1226768|P1|STARTED|Overall Study||16
501704|NCT00998049|1226773|P1|NOT COMPLETED|Overall Study||0
501705|NCT00998049|1226773|P1|COMPLETED|Overall Study||39
501706|NCT00998049|1226773|P1|STARTED|Overall Study||39
501707|NCT00998023|1226784|P2|NOT COMPLETED|Overall Study||0
501708|NCT00998023|1226785|P1|NOT COMPLETED|Overall Study||0
501709|NCT00998023|1226784|P2|COMPLETED|Overall Study||32
501710|NCT00998023|1226785|P1|COMPLETED|Overall Study||32
501711|NCT00998023|1226784|P2|STARTED|Overall Study||32
501712|NCT00998023|1226785|P1|STARTED|Overall Study||32
501713|NCT00997984|1226796|P3|NOT COMPLETED|Overall Study||26
501714|NCT00997984|1226797|P2|NOT COMPLETED|Overall Study||34
501715|NCT00997984|1226798|P1|NOT COMPLETED|Overall Study||37
501716|NCT00997984|1226796|P3|COMPLETED|Overall Study||88
501717|NCT00997984|1226797|P2|COMPLETED|Overall Study||79
501718|NCT00997984|1226798|P1|COMPLETED|Overall Study||76
501719|NCT00997984|1226796|P3|STARTED|Overall Study||114
501720|NCT00997984|1226797|P2|STARTED|Overall Study||113
501721|NCT00997984|1226798|P1|STARTED|Overall Study||113
501722|NCT00997932|1226864|P1|NOT COMPLETED|Overall Study||2
501723|NCT00997932|1226864|P1|COMPLETED|Overall Study||27
501724|NCT00997932|1226864|P1|STARTED|Overall Study||29
501725|NCT00997672|1226871|P2|NOT COMPLETED|Overall Study||4
501726|NCT00997672|1226872|P1|NOT COMPLETED|Overall Study||4
501727|NCT00997672|1226871|P2|COMPLETED|Overall Study||1
501728|NCT00997672|1226872|P1|COMPLETED|Overall Study||0
501729|NCT00997672|1226871|P2|STARTED|Overall Study||5
501730|NCT00997672|1226872|P1|STARTED|Overall Study||4
501731|NCT00997620|1226880|P2|NOT COMPLETED|Overall Study||0
501732|NCT00997620|1226881|P1|NOT COMPLETED|Overall Study||0
501733|NCT00997620|1226880|P2|COMPLETED|Overall Study||21
501734|NCT00997620|1226881|P1|COMPLETED|Overall Study||19
501735|NCT00997620|1226880|P2|STARTED|Overall Study||21
501736|NCT00997620|1226881|P1|STARTED|Overall Study||19
501737|NCT00997594|1226899|P2|NOT COMPLETED|Overall Study||0
501738|NCT00997594|1226900|P1|NOT COMPLETED|Overall Study||0
501739|NCT00997594|1226899|P2|COMPLETED|Overall Study||9
501740|NCT00997594|1226900|P1|COMPLETED|Overall Study||9
501741|NCT00997594|1226899|P2|Completion of Ablation Procedure|Overall Study||9
501742|NCT00997594|1226900|P1|Completion of Ablation Procedure|Overall Study||9
501743|NCT00997594|1226899|P2|STARTED|Overall Study||9
501744|NCT00997594|1226900|P1|STARTED|Overall Study||9
501745|NCT00997555|1226908|P2|NOT COMPLETED|Overall Study||0
501746|NCT00997555|1226909|P1|NOT COMPLETED|Overall Study||0
501747|NCT00997555|1226908|P2|COMPLETED|Overall Study||15
501748|NCT00997555|1226909|P1|COMPLETED|Overall Study||13
501749|NCT00997555|1226908|P2|STARTED|Overall Study||15
501750|NCT00997555|1226909|P1|STARTED|Overall Study||13
501751|NCT00997516|1226927|P2|NOT COMPLETED|Long-term Follow-up (After 6 Months)||2
501752|NCT00997516|1226928|P1|NOT COMPLETED|Long-term Follow-up (After 6 Months)||6
501753|NCT00997516|1226927|P2|COMPLETED|Long-term Follow-up (After 6 Months)||36
501754|NCT00997516|1226928|P1|COMPLETED|Long-term Follow-up (After 6 Months)||31
501755|NCT00997516|1226927|P2|STARTED|Long-term Follow-up (After 6 Months)||38
501756|NCT00997516|1226928|P1|STARTED|Long-term Follow-up (After 6 Months)||37
501757|NCT00997516|1226927|P2|NOT COMPLETED|Short-term Follow-up (Post Operative)||0
501758|NCT00997516|1226928|P1|NOT COMPLETED|Short-term Follow-up (Post Operative)||0
501759|NCT00997516|1226927|P2|COMPLETED|Short-term Follow-up (Post Operative)||38
501760|NCT00997516|1226928|P1|COMPLETED|Short-term Follow-up (Post Operative)||37
501761|NCT00997516|1226927|P2|STARTED|Short-term Follow-up (Post Operative)||38
501762|NCT00997516|1226928|P1|STARTED|Short-term Follow-up (Post Operative)||37
501763|NCT00997503|1226956|P1|NOT COMPLETED|Overall Study||273
501764|NCT00997503|1226956|P1|COMPLETED|Overall Study||3926
501765|NCT00997503|1226956|P1|12 Months|Overall Study|4059 subjects evaluable at 12-months (cardiac death/MI within 365 days or completed follow-up)|4059
501766|NCT00997503|1226956|P1|STARTED|Overall Study||4199
501767|NCT00997438|1226999|P3|NOT COMPLETED|Overall Study||4
501768|NCT00997438|1227000|P2|NOT COMPLETED|Overall Study||3
501769|NCT00997438|1227001|P1|NOT COMPLETED|Overall Study||5
501770|NCT00997438|1226999|P3|COMPLETED|Overall Study||20
501771|NCT00997438|1227000|P2|COMPLETED|Overall Study||21
501772|NCT00997438|1227001|P1|COMPLETED|Overall Study||16
501773|NCT00997438|1226999|P3|STARTED|Overall Study||24
501774|NCT00997438|1227000|P2|STARTED|Overall Study||24
501775|NCT00997438|1227001|P1|STARTED|Overall Study||21
501776|NCT00997425|1227036|P1|NOT COMPLETED|Overall Study||0
501777|NCT00997425|1227036|P1|COMPLETED|Overall Study||19
501778|NCT00997425|1227036|P1|STARTED|Overall Study||19
501779|NCT00997373|1227043|P2|NOT COMPLETED|Overall Study||0
501780|NCT00997373|1227044|P1|NOT COMPLETED|Overall Study||15
501781|NCT00997373|1227043|P2|COMPLETED|Overall Study||15
501782|NCT00997373|1227044|P1|COMPLETED|Overall Study||13
501783|NCT00997373|1227043|P2|Completed Hysterectomy|Overall Study||15
501784|NCT00997373|1227044|P1|Completed Hysterectomy|Overall Study||17
501785|NCT00997373|1227043|P2|Received Letrozole|Overall Study||0
501786|NCT00997373|1227044|P1|Received Letrozole|Overall Study||23
501787|NCT00997373|1227043|P2|STARTED|Overall Study||15
501788|NCT00997373|1227044|P1|STARTED|Overall Study||28
501789|NCT00997334|1227050|P1|NOT COMPLETED|Overall Study||25
501790|NCT00997334|1227050|P1|COMPLETED|Overall Study||35
501791|NCT00997334|1227050|P1|Evaluable|Overall Study|Patients with tissue available for re-biopsy at time of progression|35
501792|NCT00997334|1227050|P1|Eligible for Repeat Biopsy|Overall Study|Patients who experience disease progression on treatment were eligible for repeat biopsy|44
501793|NCT00997334|1227050|P1|STARTED|Overall Study||60
501794|NCT00997321|1227059|P2|NOT COMPLETED|Overall Study||3
501795|NCT00997321|1227060|P1|NOT COMPLETED|Overall Study||0
501796|NCT00997321|1227059|P2|COMPLETED|Overall Study||47
501797|NCT00997321|1227060|P1|COMPLETED|Overall Study||50
501798|NCT00997321|1227059|P2|STARTED|Overall Study||50
501799|NCT00997321|1227060|P1|STARTED|Overall Study||50
501800|NCT00997243|1227072|P1|NOT COMPLETED|Overall Study||7
501801|NCT00997243|1227072|P1|COMPLETED|Overall Study||0
501802|NCT00997243|1227072|P1|STARTED|Overall Study||7
501803|NCT00997204|1227084|P2|NOT COMPLETED|Self-administration Phase||1
501804|NCT00997204|1227085|P1|NOT COMPLETED|Self-administration Phase||0
501805|NCT00997204|1227084|P2|COMPLETED|Self-administration Phase||77
501806|NCT00997204|1227085|P1|COMPLETED|Self-administration Phase||19
501807|NCT00997204|1227084|P2|STARTED|Self-administration Phase|1 subject did not self-administered icatibant but had a HCP to perform. the data were not included.|78
501808|NCT00997204|1227085|P1|STARTED|Self-administration Phase||19
501809|NCT00997204|1227084|P2|NOT COMPLETED|Naive Treatment Phase||79
501810|NCT00997204|1227085|P1|NOT COMPLETED|Naive Treatment Phase||6
501811|NCT00997204|1227084|P2|COMPLETED|Naive Treatment Phase||0
501812|NCT00997204|1227085|P1|COMPLETED|Naive Treatment Phase||19
501813|NCT00997204|1227084|P2|STARTED|Naive Treatment Phase|Non-naive patients participated in the study but they were not treated in the naive treatment phase|79
501814|NCT00997204|1227085|P1|STARTED|Naive Treatment Phase||25
501815|NCT00997139|1227096|P1|NOT COMPLETED|Overall Study||186
501816|NCT00997139|1227096|P1|COMPLETED|Overall Study||30
501817|NCT00997139|1227096|P1|Treated for Positive Baseline Culture|Overall Study||30
501818|NCT00997139|1227096|P1|STARTED|Overall Study||216
501819|NCT00997126|1227104|P2|NOT COMPLETED|Overall Study||11
501820|NCT00997126|1227105|P1|NOT COMPLETED|Overall Study||7
501821|NCT00997126|1227104|P2|COMPLETED|Overall Study||52
501822|NCT00997126|1227105|P1|COMPLETED|Overall Study||56
501823|NCT00997126|1227104|P2|STARTED|Overall Study||63
501824|NCT00997126|1227105|P1|STARTED|Overall Study||63
501825|NCT00997113|1227121|P2|NOT COMPLETED|Overall Study||0
501826|NCT00997113|1227122|P1|NOT COMPLETED|Overall Study||0
501827|NCT00997113|1227121|P2|COMPLETED|Overall Study||10
501828|NCT00997113|1227122|P1|COMPLETED|Overall Study||10
501829|NCT00997113|1227121|P2|STARTED|Overall Study||10
501830|NCT00997113|1227122|P1|STARTED|Overall Study||10
501831|NCT00997035|1227134|P2|NOT COMPLETED|3-month Follow-up Visit||6
501832|NCT00997035|1227135|P1|NOT COMPLETED|3-month Follow-up Visit||12
501833|NCT00997035|1227134|P2|COMPLETED|3-month Follow-up Visit||107
501834|NCT00997035|1227135|P1|COMPLETED|3-month Follow-up Visit||100
501835|NCT00997035|1227134|P2|STARTED|3-month Follow-up Visit||113
501836|NCT00997035|1227135|P1|STARTED|3-month Follow-up Visit||112
501837|NCT00997035|1227134|P2|NOT COMPLETED|3-week Followup Visit||6
501838|NCT00997035|1227135|P1|NOT COMPLETED|3-week Followup Visit||9
501839|NCT00997035|1227134|P2|COMPLETED|3-week Followup Visit||113
501840|NCT00997035|1227135|P1|COMPLETED|3-week Followup Visit||112
501841|NCT00997035|1227134|P2|STARTED|3-week Followup Visit||119
501842|NCT00997035|1227135|P1|STARTED|3-week Followup Visit||121
501843|NCT00996996|1227155|P1|NOT COMPLETED|Overall Study||33
501844|NCT00996996|1227155|P1|COMPLETED|Overall Study|These participants completed 12 years of follow-up.|44
501845|NCT00996996|1227155|P1|STARTED|Overall Study||77
501846|NCT00996944|1227189|P2|NOT COMPLETED|Long-term Treatment Period||5
501847|NCT00996944|1227190|P1|NOT COMPLETED|Long-term Treatment Period||12
501848|NCT00996944|1227189|P2|COMPLETED|Long-term Treatment Period||0
501849|NCT00996944|1227190|P1|COMPLETED|Long-term Treatment Period||0
501850|NCT00996944|1227189|P2|STARTED|Long-term Treatment Period||5
501851|NCT00996944|1227190|P1|STARTED|Long-term Treatment Period||12
501852|NCT00996944|1227189|P2|NOT COMPLETED|Double-blind Treatment Period||7
501853|NCT00996944|1227190|P1|NOT COMPLETED|Double-blind Treatment Period||10
501854|NCT00996944|1227189|P2|COMPLETED|Double-blind Treatment Period||5
501855|NCT00996944|1227190|P1|COMPLETED|Double-blind Treatment Period||12
501856|NCT00996944|1227189|P2|STARTED|Double-blind Treatment Period||12
501857|NCT00996944|1227190|P1|STARTED|Double-blind Treatment Period||22
501858|NCT00996931|1227232|P1|NOT COMPLETED|Overall Study||0
501859|NCT00996931|1227232|P1|COMPLETED|Overall Study||6
501860|NCT00996931|1227232|P1|STARTED|Overall Study||6
501861|NCT00996918|1227242|P5|NOT COMPLETED|Overall Study||4
501862|NCT00996918|1227243|P4|NOT COMPLETED|Overall Study||56
501863|NCT00996918|1227244|P3|NOT COMPLETED|Overall Study||37
501864|NCT00996918|1227245|P2|NOT COMPLETED|Overall Study||66
501865|NCT00996918|1227246|P1|NOT COMPLETED|Overall Study||39
501866|NCT00996918|1227242|P5|COMPLETED|Overall Study||0
501867|NCT00996918|1227243|P4|COMPLETED|Overall Study||0
501868|NCT00996918|1227244|P3|COMPLETED|Overall Study||0
501869|NCT00996918|1227245|P2|COMPLETED|Overall Study||0
501870|NCT00996918|1227246|P1|COMPLETED|Overall Study||0
501871|NCT00996918|1227242|P5|Treated|Overall Study||4
501872|NCT00996918|1227243|P4|Treated|Overall Study||56
501873|NCT00996918|1227244|P3|Treated|Overall Study||37
501874|NCT00996918|1227245|P2|Treated|Overall Study||66
501875|NCT00996918|1227246|P1|Treated|Overall Study||39
501876|NCT00996918|1227242|P5|STARTED|Overall Study||4
501877|NCT00996918|1227243|P4|STARTED|Overall Study||56
501878|NCT00996918|1227244|P3|STARTED|Overall Study||37
501879|NCT00996918|1227245|P2|STARTED|Overall Study||66
501880|NCT00996918|1227246|P1|STARTED|Overall Study||39
501881|NCT00996892|1227290|P20|NOT COMPLETED|Expansion Stage 2A||45
501882|NCT00996892|1227291|P19|NOT COMPLETED|Expansion Stage 2A||0
501883|NCT00996892|1227292|P18|NOT COMPLETED|Expansion Stage 2A||0
501884|NCT00996892|1227293|P17|NOT COMPLETED|Expansion Stage 2A||0
501885|NCT00996892|1227294|P16|NOT COMPLETED|Expansion Stage 2A||0
501886|NCT00996892|1227295|P15|NOT COMPLETED|Expansion Stage 2A||0
501887|NCT00996892|1227296|P14|NOT COMPLETED|Expansion Stage 2A||0
501888|NCT00996892|1227297|P13|NOT COMPLETED|Expansion Stage 2A||0
501889|NCT00996892|1227298|P12|NOT COMPLETED|Expansion Stage 2A||0
501890|NCT00996892|1227299|P11|NOT COMPLETED|Expansion Stage 2A||0
501891|NCT00996892|1227300|P10|NOT COMPLETED|Expansion Stage 2A||0
501892|NCT00996892|1227301|P9|NOT COMPLETED|Expansion Stage 2A||0
501893|NCT00996892|1227302|P8|NOT COMPLETED|Expansion Stage 2A||0
501894|NCT00996892|1227303|P7|NOT COMPLETED|Expansion Stage 2A||0
501895|NCT00996892|1227304|P6|NOT COMPLETED|Expansion Stage 2A||0
501896|NCT00996892|1227305|P5|NOT COMPLETED|Expansion Stage 2A||0
501897|NCT00996892|1227306|P4|NOT COMPLETED|Expansion Stage 2A||0
501898|NCT00996892|1227307|P3|NOT COMPLETED|Expansion Stage 2A||0
501899|NCT00996892|1227308|P2|NOT COMPLETED|Expansion Stage 2A||0
501900|NCT00996892|1227309|P1|NOT COMPLETED|Expansion Stage 2A||0
501901|NCT00996892|1227290|P20|COMPLETED|Expansion Stage 2A||0
501902|NCT00996892|1227291|P19|COMPLETED|Expansion Stage 2A||0
501903|NCT00996892|1227292|P18|COMPLETED|Expansion Stage 2A||0
501904|NCT00996892|1227293|P17|COMPLETED|Expansion Stage 2A||0
501905|NCT00996892|1227294|P16|COMPLETED|Expansion Stage 2A||0
501906|NCT00996892|1227295|P15|COMPLETED|Expansion Stage 2A||0
501907|NCT00996892|1227296|P14|COMPLETED|Expansion Stage 2A||0
501908|NCT00996892|1227297|P13|COMPLETED|Expansion Stage 2A||0
501909|NCT00996892|1227298|P12|COMPLETED|Expansion Stage 2A||0
501910|NCT00996892|1227299|P11|COMPLETED|Expansion Stage 2A||0
501911|NCT00996892|1227300|P10|COMPLETED|Expansion Stage 2A||0
501912|NCT00996892|1227301|P9|COMPLETED|Expansion Stage 2A||0
501913|NCT00996892|1227302|P8|COMPLETED|Expansion Stage 2A||0
501914|NCT00996892|1227303|P7|COMPLETED|Expansion Stage 2A||0
501915|NCT00996892|1227304|P6|COMPLETED|Expansion Stage 2A||0
501916|NCT00996892|1227305|P5|COMPLETED|Expansion Stage 2A||0
501917|NCT00996892|1227306|P4|COMPLETED|Expansion Stage 2A||0
501918|NCT00996892|1227307|P3|COMPLETED|Expansion Stage 2A||0
501919|NCT00996892|1227308|P2|COMPLETED|Expansion Stage 2A||0
501920|NCT00996892|1227309|P1|COMPLETED|Expansion Stage 2A||0
501921|NCT00996892|1227290|P20|STARTED|Expansion Stage 2A||45
501922|NCT00996892|1227291|P19|STARTED|Expansion Stage 2A||0
501923|NCT00996892|1227292|P18|STARTED|Expansion Stage 2A||0
501924|NCT00996892|1227293|P17|STARTED|Expansion Stage 2A||0
501925|NCT00996892|1227294|P16|STARTED|Expansion Stage 2A||0
501926|NCT00996892|1227295|P15|STARTED|Expansion Stage 2A||0
501927|NCT00996892|1227296|P14|STARTED|Expansion Stage 2A||0
501928|NCT00996892|1227297|P13|STARTED|Expansion Stage 2A||0
501929|NCT00996892|1227298|P12|STARTED|Expansion Stage 2A||0
501930|NCT00996892|1227299|P11|STARTED|Expansion Stage 2A||0
501931|NCT00996892|1227300|P10|STARTED|Expansion Stage 2A||0
501932|NCT00996892|1227301|P9|STARTED|Expansion Stage 2A||0
501933|NCT00996892|1227302|P8|STARTED|Expansion Stage 2A||0
501934|NCT00996892|1227303|P7|STARTED|Expansion Stage 2A||0
501935|NCT00996892|1227304|P6|STARTED|Expansion Stage 2A||0
501936|NCT00996892|1227305|P5|STARTED|Expansion Stage 2A||0
501937|NCT00996892|1227306|P4|STARTED|Expansion Stage 2A||0
501938|NCT00996892|1227307|P3|STARTED|Expansion Stage 2A||0
501939|NCT00996892|1227308|P2|STARTED|Expansion Stage 2A||0
501940|NCT00996892|1227309|P1|STARTED|Expansion Stage 2A||0
501941|NCT00996892|1227290|P20|NOT COMPLETED|Expansion Stage 2||0
501942|NCT00996892|1227291|P19|NOT COMPLETED|Expansion Stage 2||35
501943|NCT00996892|1227292|P18|NOT COMPLETED|Expansion Stage 2||0
501944|NCT00996892|1227293|P17|NOT COMPLETED|Expansion Stage 2||0
501945|NCT00996892|1227294|P16|NOT COMPLETED|Expansion Stage 2||0
501946|NCT00996892|1227295|P15|NOT COMPLETED|Expansion Stage 2||0
501947|NCT00996892|1227296|P14|NOT COMPLETED|Expansion Stage 2||0
501948|NCT00996892|1227297|P13|NOT COMPLETED|Expansion Stage 2||0
501949|NCT00996892|1227298|P12|NOT COMPLETED|Expansion Stage 2||0
501950|NCT00996892|1227299|P11|NOT COMPLETED|Expansion Stage 2||0
501951|NCT00996892|1227300|P10|NOT COMPLETED|Expansion Stage 2||0
501952|NCT00996892|1227301|P9|NOT COMPLETED|Expansion Stage 2||0
501953|NCT00996892|1227302|P8|NOT COMPLETED|Expansion Stage 2||0
501954|NCT00996892|1227303|P7|NOT COMPLETED|Expansion Stage 2||0
501955|NCT00996892|1227304|P6|NOT COMPLETED|Expansion Stage 2||0
501956|NCT00996892|1227305|P5|NOT COMPLETED|Expansion Stage 2||0
501957|NCT00996892|1227306|P4|NOT COMPLETED|Expansion Stage 2||0
501958|NCT00996892|1227307|P3|NOT COMPLETED|Expansion Stage 2||0
501959|NCT00996892|1227308|P2|NOT COMPLETED|Expansion Stage 2||0
501960|NCT00996892|1227309|P1|NOT COMPLETED|Expansion Stage 2||0
501961|NCT00996892|1227290|P20|COMPLETED|Expansion Stage 2||0
501962|NCT00996892|1227291|P19|COMPLETED|Expansion Stage 2||0
501963|NCT00996892|1227292|P18|COMPLETED|Expansion Stage 2||0
501964|NCT00996892|1227293|P17|COMPLETED|Expansion Stage 2||0
501965|NCT00996892|1227294|P16|COMPLETED|Expansion Stage 2||0
501966|NCT00996892|1227295|P15|COMPLETED|Expansion Stage 2||0
501967|NCT00996892|1227296|P14|COMPLETED|Expansion Stage 2||0
501968|NCT00996892|1227297|P13|COMPLETED|Expansion Stage 2||0
501969|NCT00996892|1227298|P12|COMPLETED|Expansion Stage 2||0
501970|NCT00996892|1227299|P11|COMPLETED|Expansion Stage 2||0
501971|NCT00996892|1227300|P10|COMPLETED|Expansion Stage 2||0
501972|NCT00996892|1227301|P9|COMPLETED|Expansion Stage 2||0
501973|NCT00996892|1227302|P8|COMPLETED|Expansion Stage 2||0
501974|NCT00996892|1227303|P7|COMPLETED|Expansion Stage 2||0
501975|NCT00996892|1227304|P6|COMPLETED|Expansion Stage 2||0
501976|NCT00996892|1227305|P5|COMPLETED|Expansion Stage 2||0
501977|NCT00996892|1227306|P4|COMPLETED|Expansion Stage 2||0
501978|NCT00996892|1227307|P3|COMPLETED|Expansion Stage 2||0
501979|NCT00996892|1227308|P2|COMPLETED|Expansion Stage 2||0
501980|NCT00996892|1227309|P1|COMPLETED|Expansion Stage 2||0
501981|NCT00996892|1227290|P20|STARTED|Expansion Stage 2||0
501982|NCT00996892|1227291|P19|STARTED|Expansion Stage 2||35
501983|NCT00996892|1227292|P18|STARTED|Expansion Stage 2||0
501984|NCT00996892|1227293|P17|STARTED|Expansion Stage 2||0
501985|NCT00996892|1227294|P16|STARTED|Expansion Stage 2||0
501986|NCT00996892|1227295|P15|STARTED|Expansion Stage 2||0
501987|NCT00996892|1227296|P14|STARTED|Expansion Stage 2||0
501988|NCT00996892|1227297|P13|STARTED|Expansion Stage 2||0
501989|NCT00996892|1227298|P12|STARTED|Expansion Stage 2||0
501990|NCT00996892|1227299|P11|STARTED|Expansion Stage 2||0
501991|NCT00996892|1227300|P10|STARTED|Expansion Stage 2||0
501992|NCT00996892|1227301|P9|STARTED|Expansion Stage 2||0
501993|NCT00996892|1227302|P8|STARTED|Expansion Stage 2||0
501994|NCT00996892|1227303|P7|STARTED|Expansion Stage 2||0
501995|NCT00996892|1227304|P6|STARTED|Expansion Stage 2||0
501996|NCT00996892|1227305|P5|STARTED|Expansion Stage 2||0
501997|NCT00996892|1227306|P4|STARTED|Expansion Stage 2||0
501998|NCT00996892|1227307|P3|STARTED|Expansion Stage 2||0
501999|NCT00996892|1227308|P2|STARTED|Expansion Stage 2||0
502000|NCT00996892|1227309|P1|STARTED|Expansion Stage 2||0
502001|NCT00996892|1227290|P20|NOT COMPLETED|Dose-Escalation Stage 1B||0
502002|NCT00996892|1227291|P19|NOT COMPLETED|Dose-Escalation Stage 1B||0
502003|NCT00996892|1227292|P18|NOT COMPLETED|Dose-Escalation Stage 1B||5
502004|NCT00996892|1227293|P17|NOT COMPLETED|Dose-Escalation Stage 1B||3
502005|NCT00996892|1227294|P16|NOT COMPLETED|Dose-Escalation Stage 1B||3
502006|NCT00996892|1227295|P15|NOT COMPLETED|Dose-Escalation Stage 1B||4
502007|NCT00996892|1227296|P14|NOT COMPLETED|Dose-Escalation Stage 1B||0
502008|NCT00996892|1227297|P13|NOT COMPLETED|Dose-Escalation Stage 1B||0
502009|NCT00996892|1227298|P12|NOT COMPLETED|Dose-Escalation Stage 1B||0
502010|NCT00996892|1227299|P11|NOT COMPLETED|Dose-Escalation Stage 1B||0
502011|NCT00996892|1227300|P10|NOT COMPLETED|Dose-Escalation Stage 1B||0
502012|NCT00996892|1227301|P9|NOT COMPLETED|Dose-Escalation Stage 1B||0
502013|NCT00996892|1227302|P8|NOT COMPLETED|Dose-Escalation Stage 1B||0
502014|NCT00996892|1227303|P7|NOT COMPLETED|Dose-Escalation Stage 1B||0
502015|NCT00996892|1227304|P6|NOT COMPLETED|Dose-Escalation Stage 1B||0
502016|NCT00996892|1227305|P5|NOT COMPLETED|Dose-Escalation Stage 1B||0
502017|NCT00996892|1227306|P4|NOT COMPLETED|Dose-Escalation Stage 1B||0
502018|NCT00996892|1227307|P3|NOT COMPLETED|Dose-Escalation Stage 1B||0
502019|NCT00996892|1227308|P2|NOT COMPLETED|Dose-Escalation Stage 1B||0
502020|NCT00996892|1227309|P1|NOT COMPLETED|Dose-Escalation Stage 1B||0
502021|NCT00996892|1227290|P20|COMPLETED|Dose-Escalation Stage 1B||0
502022|NCT00996892|1227291|P19|COMPLETED|Dose-Escalation Stage 1B||0
502023|NCT00996892|1227292|P18|COMPLETED|Dose-Escalation Stage 1B||0
502024|NCT00996892|1227293|P17|COMPLETED|Dose-Escalation Stage 1B||0
502025|NCT00996892|1227294|P16|COMPLETED|Dose-Escalation Stage 1B||0
502026|NCT00996892|1227295|P15|COMPLETED|Dose-Escalation Stage 1B||0
502027|NCT00996892|1227296|P14|COMPLETED|Dose-Escalation Stage 1B||0
502028|NCT00996892|1227297|P13|COMPLETED|Dose-Escalation Stage 1B||0
502029|NCT00996892|1227298|P12|COMPLETED|Dose-Escalation Stage 1B||0
502030|NCT00996892|1227299|P11|COMPLETED|Dose-Escalation Stage 1B||0
502031|NCT00996892|1227300|P10|COMPLETED|Dose-Escalation Stage 1B||0
502032|NCT00996892|1227301|P9|COMPLETED|Dose-Escalation Stage 1B||0
502033|NCT00996892|1227302|P8|COMPLETED|Dose-Escalation Stage 1B||0
502034|NCT00996892|1227303|P7|COMPLETED|Dose-Escalation Stage 1B||0
502035|NCT00996892|1227304|P6|COMPLETED|Dose-Escalation Stage 1B||0
502036|NCT00996892|1227305|P5|COMPLETED|Dose-Escalation Stage 1B||0
502037|NCT00996892|1227306|P4|COMPLETED|Dose-Escalation Stage 1B||0
502038|NCT00996892|1227307|P3|COMPLETED|Dose-Escalation Stage 1B||0
502039|NCT00996892|1227308|P2|COMPLETED|Dose-Escalation Stage 1B||0
502040|NCT00996892|1227309|P1|COMPLETED|Dose-Escalation Stage 1B||0
502041|NCT00996892|1227290|P20|STARTED|Dose-Escalation Stage 1B||0
502042|NCT00996892|1227291|P19|STARTED|Dose-Escalation Stage 1B||0
502043|NCT00996892|1227292|P18|STARTED|Dose-Escalation Stage 1B||5
502044|NCT00996892|1227293|P17|STARTED|Dose-Escalation Stage 1B||3
502045|NCT00996892|1227294|P16|STARTED|Dose-Escalation Stage 1B||3
502046|NCT00996892|1227295|P15|STARTED|Dose-Escalation Stage 1B||4
502047|NCT00996892|1227296|P14|STARTED|Dose-Escalation Stage 1B||0
502048|NCT00996892|1227297|P13|STARTED|Dose-Escalation Stage 1B||0
502049|NCT00996892|1227298|P12|STARTED|Dose-Escalation Stage 1B||0
502050|NCT00996892|1227299|P11|STARTED|Dose-Escalation Stage 1B||0
502051|NCT00996892|1227300|P10|STARTED|Dose-Escalation Stage 1B||0
502052|NCT00996892|1227301|P9|STARTED|Dose-Escalation Stage 1B||0
502053|NCT00996892|1227302|P8|STARTED|Dose-Escalation Stage 1B||0
502054|NCT00996892|1227303|P7|STARTED|Dose-Escalation Stage 1B||0
502055|NCT00996892|1227304|P6|STARTED|Dose-Escalation Stage 1B||0
502056|NCT00996892|1227305|P5|STARTED|Dose-Escalation Stage 1B||0
502057|NCT00996892|1227306|P4|STARTED|Dose-Escalation Stage 1B||0
502058|NCT00996892|1227307|P3|STARTED|Dose-Escalation Stage 1B||0
502059|NCT00996892|1227308|P2|STARTED|Dose-Escalation Stage 1B||0
502060|NCT00996892|1227309|P1|STARTED|Dose-Escalation Stage 1B||0
502061|NCT00996892|1227290|P20|NOT COMPLETED|Dose-Escalation Stage 1A||0
502062|NCT00996892|1227291|P19|NOT COMPLETED|Dose-Escalation Stage 1A||0
502063|NCT00996892|1227292|P18|NOT COMPLETED|Dose-Escalation Stage 1A||0
502064|NCT00996892|1227293|P17|NOT COMPLETED|Dose-Escalation Stage 1A||0
502065|NCT00996892|1227294|P16|NOT COMPLETED|Dose-Escalation Stage 1A||0
502066|NCT00996892|1227295|P15|NOT COMPLETED|Dose-Escalation Stage 1A||0
502067|NCT00996892|1227296|P14|NOT COMPLETED|Dose-Escalation Stage 1A||5
502068|NCT00996892|1227297|P13|NOT COMPLETED|Dose-Escalation Stage 1A||8
502069|NCT00996892|1227298|P12|NOT COMPLETED|Dose-Escalation Stage 1A||9
502070|NCT00996892|1227299|P11|NOT COMPLETED|Dose-Escalation Stage 1A||7
502071|NCT00996892|1227300|P10|NOT COMPLETED|Dose-Escalation Stage 1A||4
502072|NCT00996892|1227301|P9|NOT COMPLETED|Dose-Escalation Stage 1A||3
502073|NCT00996892|1227302|P8|NOT COMPLETED|Dose-Escalation Stage 1A||3
502074|NCT00996892|1227303|P7|NOT COMPLETED|Dose-Escalation Stage 1A||0
502075|NCT00996892|1227304|P6|NOT COMPLETED|Dose-Escalation Stage 1A||0
502076|NCT00996892|1227305|P5|NOT COMPLETED|Dose-Escalation Stage 1A||0
502077|NCT00996892|1227306|P4|NOT COMPLETED|Dose-Escalation Stage 1A||0
502078|NCT00996892|1227307|P3|NOT COMPLETED|Dose-Escalation Stage 1A||0
502079|NCT00996892|1227308|P2|NOT COMPLETED|Dose-Escalation Stage 1A||0
502080|NCT00996892|1227309|P1|NOT COMPLETED|Dose-Escalation Stage 1A||0
502081|NCT00996892|1227290|P20|COMPLETED|Dose-Escalation Stage 1A||0
502082|NCT00996892|1227291|P19|COMPLETED|Dose-Escalation Stage 1A||0
502083|NCT00996892|1227292|P18|COMPLETED|Dose-Escalation Stage 1A||0
502084|NCT00996892|1227293|P17|COMPLETED|Dose-Escalation Stage 1A||0
502085|NCT00996892|1227294|P16|COMPLETED|Dose-Escalation Stage 1A||0
502086|NCT00996892|1227295|P15|COMPLETED|Dose-Escalation Stage 1A||0
502087|NCT00996892|1227296|P14|COMPLETED|Dose-Escalation Stage 1A||0
502088|NCT00996892|1227297|P13|COMPLETED|Dose-Escalation Stage 1A||0
502089|NCT00996892|1227298|P12|COMPLETED|Dose-Escalation Stage 1A||0
502090|NCT00996892|1227299|P11|COMPLETED|Dose-Escalation Stage 1A||0
502091|NCT00996892|1227300|P10|COMPLETED|Dose-Escalation Stage 1A||0
502092|NCT00996892|1227301|P9|COMPLETED|Dose-Escalation Stage 1A||0
502093|NCT00996892|1227302|P8|COMPLETED|Dose-Escalation Stage 1A||0
502094|NCT00996892|1227303|P7|COMPLETED|Dose-Escalation Stage 1A||0
502095|NCT00996892|1227304|P6|COMPLETED|Dose-Escalation Stage 1A||0
502096|NCT00996892|1227305|P5|COMPLETED|Dose-Escalation Stage 1A||0
502097|NCT00996892|1227306|P4|COMPLETED|Dose-Escalation Stage 1A||0
502098|NCT00996892|1227307|P3|COMPLETED|Dose-Escalation Stage 1A||0
502099|NCT00996892|1227308|P2|COMPLETED|Dose-Escalation Stage 1A||0
502100|NCT00996892|1227309|P1|COMPLETED|Dose-Escalation Stage 1A||0
502101|NCT00996892|1227290|P20|STARTED|Dose-Escalation Stage 1A||0
502102|NCT00996892|1227291|P19|STARTED|Dose-Escalation Stage 1A||0
502103|NCT00996892|1227292|P18|STARTED|Dose-Escalation Stage 1A||0
502104|NCT00996892|1227293|P17|STARTED|Dose-Escalation Stage 1A||0
502105|NCT00996892|1227294|P16|STARTED|Dose-Escalation Stage 1A||0
502106|NCT00996892|1227295|P15|STARTED|Dose-Escalation Stage 1A||0
502107|NCT00996892|1227296|P14|STARTED|Dose-Escalation Stage 1A||5
502108|NCT00996892|1227297|P13|STARTED|Dose-Escalation Stage 1A||8
502109|NCT00996892|1227298|P12|STARTED|Dose-Escalation Stage 1A||9
502110|NCT00996892|1227299|P11|STARTED|Dose-Escalation Stage 1A||7
502111|NCT00996892|1227300|P10|STARTED|Dose-Escalation Stage 1A||4
502112|NCT00996892|1227301|P9|STARTED|Dose-Escalation Stage 1A||3
502113|NCT00996892|1227302|P8|STARTED|Dose-Escalation Stage 1A||3
502114|NCT00996892|1227303|P7|STARTED|Dose-Escalation Stage 1A||0
502115|NCT00996892|1227304|P6|STARTED|Dose-Escalation Stage 1A||0
502116|NCT00996892|1227305|P5|STARTED|Dose-Escalation Stage 1A||0
502117|NCT00996892|1227306|P4|STARTED|Dose-Escalation Stage 1A||0
502118|NCT00996892|1227307|P3|STARTED|Dose-Escalation Stage 1A||0
502119|NCT00996892|1227308|P2|STARTED|Dose-Escalation Stage 1A||0
502120|NCT00996892|1227309|P1|STARTED|Dose-Escalation Stage 1A||0
502121|NCT00996892|1227290|P20|NOT COMPLETED|Dose-Escalation Stage 1||0
502122|NCT00996892|1227291|P19|NOT COMPLETED|Dose-Escalation Stage 1||0
502123|NCT00996892|1227292|P18|NOT COMPLETED|Dose-Escalation Stage 1||0
502124|NCT00996892|1227293|P17|NOT COMPLETED|Dose-Escalation Stage 1||0
502125|NCT00996892|1227294|P16|NOT COMPLETED|Dose-Escalation Stage 1||0
502126|NCT00996892|1227295|P15|NOT COMPLETED|Dose-Escalation Stage 1||0
502127|NCT00996892|1227296|P14|NOT COMPLETED|Dose-Escalation Stage 1||0
502128|NCT00996892|1227297|P13|NOT COMPLETED|Dose-Escalation Stage 1||0
502129|NCT00996892|1227298|P12|NOT COMPLETED|Dose-Escalation Stage 1||0
502130|NCT00996892|1227299|P11|NOT COMPLETED|Dose-Escalation Stage 1||0
502131|NCT00996892|1227300|P10|NOT COMPLETED|Dose-Escalation Stage 1||0
502132|NCT00996892|1227301|P9|NOT COMPLETED|Dose-Escalation Stage 1||0
502133|NCT00996892|1227302|P8|NOT COMPLETED|Dose-Escalation Stage 1||0
502134|NCT00996892|1227303|P7|NOT COMPLETED|Dose-Escalation Stage 1||4
502135|NCT00996892|1227304|P6|NOT COMPLETED|Dose-Escalation Stage 1||10
502136|NCT00996892|1227305|P5|NOT COMPLETED|Dose-Escalation Stage 1||11
502137|NCT00996892|1227306|P4|NOT COMPLETED|Dose-Escalation Stage 1||9
502138|NCT00996892|1227307|P3|NOT COMPLETED|Dose-Escalation Stage 1||3
502139|NCT00996892|1227308|P2|NOT COMPLETED|Dose-Escalation Stage 1||3
502140|NCT00996892|1227309|P1|NOT COMPLETED|Dose-Escalation Stage 1||4
502141|NCT00996892|1227290|P20|COMPLETED|Dose-Escalation Stage 1||0
502142|NCT00996892|1227291|P19|COMPLETED|Dose-Escalation Stage 1||0
502143|NCT00996892|1227292|P18|COMPLETED|Dose-Escalation Stage 1||0
502144|NCT00996892|1227293|P17|COMPLETED|Dose-Escalation Stage 1||0
502145|NCT00996892|1227294|P16|COMPLETED|Dose-Escalation Stage 1||0
502146|NCT00996892|1227295|P15|COMPLETED|Dose-Escalation Stage 1||0
502147|NCT00996892|1227296|P14|COMPLETED|Dose-Escalation Stage 1||0
502148|NCT00996892|1227297|P13|COMPLETED|Dose-Escalation Stage 1||0
502149|NCT00996892|1227298|P12|COMPLETED|Dose-Escalation Stage 1||0
502150|NCT00996892|1227299|P11|COMPLETED|Dose-Escalation Stage 1||0
502151|NCT00996892|1227300|P10|COMPLETED|Dose-Escalation Stage 1||0
502152|NCT00996892|1227301|P9|COMPLETED|Dose-Escalation Stage 1||0
502153|NCT00996892|1227302|P8|COMPLETED|Dose-Escalation Stage 1||0
502154|NCT00996892|1227303|P7|COMPLETED|Dose-Escalation Stage 1||0
502155|NCT00996892|1227304|P6|COMPLETED|Dose-Escalation Stage 1||0
502156|NCT00996892|1227305|P5|COMPLETED|Dose-Escalation Stage 1||0
502157|NCT00996892|1227306|P4|COMPLETED|Dose-Escalation Stage 1||0
502158|NCT00996892|1227307|P3|COMPLETED|Dose-Escalation Stage 1||0
502159|NCT00996892|1227308|P2|COMPLETED|Dose-Escalation Stage 1||0
502160|NCT00996892|1227309|P1|COMPLETED|Dose-Escalation Stage 1||0
502161|NCT00996892|1227290|P20|STARTED|Dose-Escalation Stage 1||0
502162|NCT00996892|1227291|P19|STARTED|Dose-Escalation Stage 1||0
502163|NCT00996892|1227292|P18|STARTED|Dose-Escalation Stage 1||0
502164|NCT00996892|1227293|P17|STARTED|Dose-Escalation Stage 1||0
502165|NCT00996892|1227294|P16|STARTED|Dose-Escalation Stage 1||0
502166|NCT00996892|1227295|P15|STARTED|Dose-Escalation Stage 1||0
502167|NCT00996892|1227296|P14|STARTED|Dose-Escalation Stage 1||0
502168|NCT00996892|1227297|P13|STARTED|Dose-Escalation Stage 1||0
502169|NCT00996892|1227298|P12|STARTED|Dose-Escalation Stage 1||0
502170|NCT00996892|1227299|P11|STARTED|Dose-Escalation Stage 1||0
502171|NCT00996892|1227300|P10|STARTED|Dose-Escalation Stage 1||0
502172|NCT00996892|1227301|P9|STARTED|Dose-Escalation Stage 1||0
502173|NCT00996892|1227302|P8|STARTED|Dose-Escalation Stage 1||0
502174|NCT00996892|1227303|P7|STARTED|Dose-Escalation Stage 1||4
502175|NCT00996892|1227304|P6|STARTED|Dose-Escalation Stage 1||10
502176|NCT00996892|1227305|P5|STARTED|Dose-Escalation Stage 1||11
502177|NCT00996892|1227306|P4|STARTED|Dose-Escalation Stage 1||9
502178|NCT00996892|1227307|P3|STARTED|Dose-Escalation Stage 1||3
502179|NCT00996892|1227308|P2|STARTED|Dose-Escalation Stage 1||3
502180|NCT00996892|1227309|P1|STARTED|Dose-Escalation Stage 1||4
502181|NCT00996840|1227903|P5|NOT COMPLETED|Overall Study||2
502182|NCT00996840|1227904|P4|NOT COMPLETED|Overall Study||1
502183|NCT00996840|1227905|P3|NOT COMPLETED|Overall Study||1
502184|NCT00996840|1227906|P2|NOT COMPLETED|Overall Study||2
502185|NCT00996840|1227907|P1|NOT COMPLETED|Overall Study||1
502186|NCT00996840|1227903|P5|COMPLETED|Overall Study||16
502187|NCT00996840|1227904|P4|COMPLETED|Overall Study||17
502188|NCT00996840|1227905|P3|COMPLETED|Overall Study||11
502189|NCT00996840|1227906|P2|COMPLETED|Overall Study||7
502190|NCT00996840|1227907|P1|COMPLETED|Overall Study||19
502191|NCT00996840|1227903|P5|STARTED|Overall Study||18
502192|NCT00996840|1227904|P4|STARTED|Overall Study||18
502193|NCT00996840|1227905|P3|STARTED|Overall Study||12
502194|NCT00996840|1227906|P2|STARTED|Overall Study||9
502195|NCT00996840|1227907|P1|STARTED|Overall Study||20
502196|NCT00996801|1228057|P6|NOT COMPLETED|Overall Study||19
502197|NCT00996801|1228058|P5|NOT COMPLETED|Overall Study||88
502198|NCT00996801|1228059|P4|NOT COMPLETED|Overall Study||31
502199|NCT00996801|1228060|P3|NOT COMPLETED|Overall Study||23
502200|NCT00996801|1228061|P2|NOT COMPLETED|Overall Study||16
502201|NCT00996801|1228062|P1|NOT COMPLETED|Overall Study||20
502202|NCT00996801|1228057|P6|COMPLETED|Overall Study||68
502203|NCT00996801|1228058|P5|COMPLETED|Overall Study||0
502204|NCT00996801|1228059|P4|COMPLETED|Overall Study||56
502205|NCT00996801|1228060|P3|COMPLETED|Overall Study||65
502206|NCT00996801|1228061|P2|COMPLETED|Overall Study||72
502207|NCT00996801|1228062|P1|COMPLETED|Overall Study||68
502208|NCT00996801|1228057|P6|STARTED|Overall Study||87
502209|NCT00996801|1228058|P5|STARTED|Overall Study|15-mg arm was discontinued as a result of Protocol Amendment 1.|88
502210|NCT00996801|1228059|P4|STARTED|Overall Study||87
502211|NCT00996801|1228060|P3|STARTED|Overall Study||88
502212|NCT00996801|1228061|P2|STARTED|Overall Study||88
502213|NCT00996801|1228062|P1|STARTED|Overall Study||88
502214|NCT00996775|1228165|P2|NOT COMPLETED|Overall Study||14
502215|NCT00996775|1228166|P1|NOT COMPLETED|Overall Study||11
502216|NCT00996775|1228165|P2|COMPLETED|Overall Study||75
502217|NCT00996775|1228166|P1|COMPLETED|Overall Study||67
502218|NCT00996775|1228165|P2|STARTED|Overall Study||89
502219|NCT00996775|1228166|P1|STARTED|Overall Study||78
502220|NCT00996736|1228174|P2|NOT COMPLETED|Overall Study||18
502221|NCT00996736|1228175|P1|NOT COMPLETED|Overall Study||21
502222|NCT00996736|1228174|P2|COMPLETED|Overall Study||143
502223|NCT00996736|1228175|P1|COMPLETED|Overall Study||141
502224|NCT00996736|1228174|P2|3-month Visit|Overall Study||146
502225|NCT00996736|1228175|P1|3-month Visit|Overall Study||146
502226|NCT00996736|1228174|P2|3-week Visit|Overall Study|144 visited within pre-specified 3-week window (2.5-5 weeks); 7 had a second visit not within window|151
502227|NCT00996736|1228175|P1|3-week Visit|Overall Study|149 visited within pre-specified 3-week window (2.5-5 weeks); 6 had a second visit not within window|155
502228|NCT00996736|1228174|P2|STARTED|Overall Study||161
502229|NCT00996736|1228175|P1|STARTED|Overall Study||162
502230|NCT00996658|1228195|P2|NOT COMPLETED|Overall Study||21
502231|NCT00996658|1228196|P1|NOT COMPLETED|Overall Study||16
502232|NCT00996658|1228195|P2|COMPLETED|Overall Study||165
502233|NCT00996658|1228196|P1|COMPLETED|Overall Study||76
502234|NCT00996658|1228195|P2|STARTED|Overall Study||186
502235|NCT00996658|1228196|P1|STARTED|Overall Study||92
502236|NCT00996632|1228224|P2|NOT COMPLETED|Overall Study||0
502237|NCT00996632|1228225|P1|NOT COMPLETED|Overall Study||0
502238|NCT00996632|1228224|P2|COMPLETED|Overall Study||56
502239|NCT00996632|1228225|P1|COMPLETED|Overall Study||38
502240|NCT00996632|1228224|P2|STARTED|Overall Study||56
502241|NCT00996632|1228225|P1|STARTED|Overall Study||38
502242|NCT00996606|1228233|P1|NOT COMPLETED|Overall Study||8
502243|NCT00996606|1228233|P1|COMPLETED|Overall Study||50
502244|NCT00996606|1228233|P1|STARTED|Overall Study||58
502245|NCT00996593|1228327|P1|NOT COMPLETED|Long-Term Follow-Up||3
502246|NCT00996593|1228327|P1|COMPLETED|Long-Term Follow-Up||6
502247|NCT00996593|1228327|P1|STARTED|Long-Term Follow-Up|9 of the 40 participants withdrawing from Study BEX104507 enrolled in long-term follow-up study.|9
502248|NCT00996593|1228327|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||43
502249|NCT00996593|1228327|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
502250|NCT00996593|1228327|P1|STARTED|Dosimetric and Therapeutic Treatment||43
502251|NCT00996580|1228355|P1|NOT COMPLETED|Overall Study||1453
502252|NCT00996580|1228355|P1|COMPLETED|Overall Study||2144
502253|NCT00996580|1228355|P1|Pregnancy Intent-to-Treat Population|Overall Study||3019
502254|NCT00996580|1228355|P1|STARTED|Overall Study||3597
502255|NCT00996502|1228383|P1|NOT COMPLETED|Overall Study||0
502256|NCT00996502|1228383|P1|COMPLETED|Overall Study||4
502257|NCT00996502|1228383|P1|STARTED|Overall Study||4
502258|NCT00996476|1228392|P5|NOT COMPLETED|Overall Study||2
502259|NCT00996476|1228393|P4|NOT COMPLETED|Overall Study||0
502260|NCT00996476|1228394|P3|NOT COMPLETED|Overall Study||1
502261|NCT00996476|1228395|P2|NOT COMPLETED|Overall Study||3
502262|NCT00996476|1228396|P1|NOT COMPLETED|Overall Study||1
502263|NCT00996476|1228392|P5|COMPLETED|Overall Study||11
502264|NCT00996476|1228393|P4|COMPLETED|Overall Study||13
502265|NCT00996476|1228394|P3|COMPLETED|Overall Study||12
502266|NCT00996476|1228395|P2|COMPLETED|Overall Study||23
502267|NCT00996476|1228396|P1|COMPLETED|Overall Study||26
502268|NCT00996476|1228392|P5|STARTED|Overall Study||13
502269|NCT00996476|1228393|P4|STARTED|Overall Study||13
502270|NCT00996476|1228394|P3|STARTED|Overall Study||13
502271|NCT00996476|1228395|P2|STARTED|Overall Study||26
502272|NCT00996476|1228396|P1|STARTED|Overall Study||27
502273|NCT00996437|1228464|P2|NOT COMPLETED|Overall Study||7
502274|NCT00996437|1228465|P1|NOT COMPLETED|Overall Study||5
502275|NCT00996437|1228464|P2|COMPLETED|Overall Study||129
502276|NCT00996437|1228465|P1|COMPLETED|Overall Study||120
502277|NCT00996437|1228464|P2|STARTED|Overall Study||136
502278|NCT00996437|1228465|P1|STARTED|Overall Study||125
502279|NCT00996372|1228487|P2|NOT COMPLETED|Overall Study||84
502280|NCT00996372|1228488|P1|NOT COMPLETED|Overall Study||103
502281|NCT00996372|1228487|P2|COMPLETED|Overall Study||397
502282|NCT00996372|1228488|P1|COMPLETED|Overall Study||365
502283|NCT00996372|1228487|P2|STARTED|Overall Study||481
502284|NCT00996372|1228488|P1|STARTED|Overall Study||468
502285|NCT00996346|1228501|P3|NOT COMPLETED|Overall Study||0
502286|NCT00996346|1228502|P2|NOT COMPLETED|Overall Study||0
502287|NCT00996346|1228503|P1|NOT COMPLETED|Overall Study||0
502288|NCT00996346|1228501|P3|COMPLETED|Overall Study||3
502289|NCT00996346|1228502|P2|COMPLETED|Overall Study||8
502290|NCT00996346|1228503|P1|COMPLETED|Overall Study||6
502291|NCT00996346|1228501|P3|STARTED|Overall Study||3
502292|NCT00996346|1228502|P2|STARTED|Overall Study||8
502293|NCT00996346|1228503|P1|STARTED|Overall Study||6
502294|NCT00996333|1228510|P1|NOT COMPLETED|Overall Study||13
502295|NCT00996333|1228510|P1|COMPLETED|Overall Study||33
502296|NCT00996333|1228510|P1|STARTED|Overall Study||46
502297|NCT00996307|1228520|P4|NOT COMPLETED|Overall Study||21
502298|NCT00996307|1228521|P3|NOT COMPLETED|Overall Study||14
502299|NCT00996307|1228522|P2|NOT COMPLETED|Overall Study||17
502300|NCT00996307|1228523|P1|NOT COMPLETED|Overall Study||20
502301|NCT00996307|1228520|P4|COMPLETED|Overall Study||144
502302|NCT00996307|1228521|P3|COMPLETED|Overall Study||146
502303|NCT00996307|1228522|P2|COMPLETED|Overall Study||148
502304|NCT00996307|1228523|P1|COMPLETED|Overall Study||144
502305|NCT00996307|1228520|P4|STARTED|Overall Study||165
502306|NCT00996307|1228521|P3|STARTED|Overall Study||160
502307|NCT00996307|1228522|P2|STARTED|Overall Study||165
502308|NCT00996307|1228523|P1|STARTED|Overall Study||164
502309|NCT00996281|1228583|P2|NOT COMPLETED|Overall Study||89
502310|NCT00996281|1228584|P1|NOT COMPLETED|Overall Study||131
502311|NCT00996281|1228583|P2|COMPLETED|Overall Study||330
502312|NCT00996281|1228584|P1|COMPLETED|Overall Study||287
502313|NCT00996281|1228583|P2|STARTED|Overall Study||419
502314|NCT00996281|1228584|P1|STARTED|Overall Study||418
502315|NCT00996216|1228592|P1|NOT COMPLETED|Part 2 (Antiviral Treatment Phase)||4
502316|NCT00996216|1228592|P1|COMPLETED|Part 2 (Antiviral Treatment Phase)||21
502317|NCT00996216|1228592|P1|STARTED|Part 2 (Antiviral Treatment Phase)|One participant who completed Part 1 didn’t qualify to begin antiviral treatment in Part 2.|25
502318|NCT00996216|1228592|P1|NOT COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||1
502319|NCT00996216|1228592|P1|COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||26
502320|NCT00996216|1228592|P1|STARTED|Part 1 (Pre-Antiviral Treatment Phase)||27
502321|NCT00996203|1228608|P1|NOT COMPLETED|Overall Study||7
502322|NCT00996203|1228608|P1|COMPLETED|Overall Study||194
502323|NCT00996203|1228608|P1|STARTED|Overall Study||201
502324|NCT00996164|1228629|P2|NOT COMPLETED|Overall Study||101
502325|NCT00996164|1228630|P1|NOT COMPLETED|Overall Study||135
502326|NCT00996164|1228629|P2|COMPLETED|Overall Study||446
502327|NCT00996164|1228630|P1|COMPLETED|Overall Study||408
502328|NCT00996164|1228629|P2|STARTED|Overall Study||547
502329|NCT00996164|1228630|P1|STARTED|Overall Study||543
502330|NCT00996125|1228640|P2|NOT COMPLETED|Overall Study||11
502331|NCT00996125|1228641|P1|NOT COMPLETED|Overall Study||5
502332|NCT00996125|1228640|P2|COMPLETED|Overall Study||365
502333|NCT00996125|1228641|P1|COMPLETED|Overall Study||369
502334|NCT00996125|1228640|P2|STARTED|Overall Study||376
502335|NCT00996125|1228641|P1|STARTED|Overall Study||374
502336|NCT00996034|1228661|P1|NOT COMPLETED|Overall Study||3
502337|NCT00996034|1228661|P1|COMPLETED|Overall Study||11
502338|NCT00996034|1228661|P1|STARTED|Overall Study||14
502339|NCT00995930|1228667|P2|NOT COMPLETED|Overall Study||28
502340|NCT00995930|1228668|P1|NOT COMPLETED|Overall Study||21
502341|NCT00995930|1228667|P2|COMPLETED|Overall Study||67
502342|NCT00995930|1228668|P1|COMPLETED|Overall Study||73
502343|NCT00995930|1228667|P2|Imaging Analysis Set|Overall Study||92
502344|NCT00995930|1228668|P1|Imaging Analysis Set|Overall Study||92
502345|NCT00995930|1228667|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||92
502346|NCT00995930|1228668|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||92
502347|NCT00995930|1228667|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||95
502348|NCT00995930|1228668|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||0
502349|NCT00995930|1228667|P2|Safety Analysis Set|Overall Study||95
502350|NCT00995930|1228668|P1|Safety Analysis Set|Overall Study||94
502351|NCT00995930|1228667|P2|STARTED|Overall Study||95
502352|NCT00995930|1228668|P1|STARTED|Overall Study||94
502353|NCT00995904|1228697|P6|NOT COMPLETED|Follow-up Visit (Final Visit)||0
502354|NCT00995904|1228698|P5|NOT COMPLETED|Follow-up Visit (Final Visit)||0
502355|NCT00995904|1228699|P4|NOT COMPLETED|Follow-up Visit (Final Visit)||0
502356|NCT00995904|1228700|P3|NOT COMPLETED|Follow-up Visit (Final Visit)||0
502357|NCT00995904|1228701|P2|NOT COMPLETED|Follow-up Visit (Final Visit)||0
502358|NCT00995904|1228702|P1|NOT COMPLETED|Follow-up Visit (Final Visit)||0
502359|NCT00995904|1228697|P6|COMPLETED|Follow-up Visit (Final Visit)||3
502360|NCT00995904|1228698|P5|COMPLETED|Follow-up Visit (Final Visit)||5
502361|NCT00995904|1228699|P4|COMPLETED|Follow-up Visit (Final Visit)||5
502362|NCT00995904|1228700|P3|COMPLETED|Follow-up Visit (Final Visit)||4
502363|NCT00995904|1228701|P2|COMPLETED|Follow-up Visit (Final Visit)||3
502364|NCT00995904|1228702|P1|COMPLETED|Follow-up Visit (Final Visit)||4
502365|NCT00995904|1228697|P6|STARTED|Follow-up Visit (Final Visit)||3
502366|NCT00995904|1228698|P5|STARTED|Follow-up Visit (Final Visit)||5
502367|NCT00995904|1228699|P4|STARTED|Follow-up Visit (Final Visit)||5
502368|NCT00995904|1228700|P3|STARTED|Follow-up Visit (Final Visit)||4
502369|NCT00995904|1228701|P2|STARTED|Follow-up Visit (Final Visit)||3
502370|NCT00995904|1228702|P1|STARTED|Follow-up Visit (Final Visit)||4
502371|NCT00995904|1228697|P6|NOT COMPLETED|Visit 4||0
502372|NCT00995904|1228698|P5|NOT COMPLETED|Visit 4||0
502373|NCT00995904|1228699|P4|NOT COMPLETED|Visit 4||0
502374|NCT00995904|1228700|P3|NOT COMPLETED|Visit 4||0
502375|NCT00995904|1228701|P2|NOT COMPLETED|Visit 4||0
502376|NCT00995904|1228702|P1|NOT COMPLETED|Visit 4||0
502377|NCT00995904|1228697|P6|COMPLETED|Visit 4||3
502378|NCT00995904|1228698|P5|COMPLETED|Visit 4||5
502379|NCT00995904|1228699|P4|COMPLETED|Visit 4||5
502380|NCT00995904|1228700|P3|COMPLETED|Visit 4||4
502381|NCT00995904|1228701|P2|COMPLETED|Visit 4||3
502382|NCT00995904|1228702|P1|COMPLETED|Visit 4||4
502383|NCT00995904|1228697|P6|STARTED|Visit 4||3
502384|NCT00995904|1228698|P5|STARTED|Visit 4||5
502385|NCT00995904|1228699|P4|STARTED|Visit 4||5
502386|NCT00995904|1228700|P3|STARTED|Visit 4||4
502387|NCT00995904|1228701|P2|STARTED|Visit 4||3
502388|NCT00995904|1228702|P1|STARTED|Visit 4||4
502389|NCT00995904|1228697|P6|NOT COMPLETED|Visit 3||0
502390|NCT00995904|1228698|P5|NOT COMPLETED|Visit 3||0
502391|NCT00995904|1228699|P4|NOT COMPLETED|Visit 3||0
502392|NCT00995904|1228700|P3|NOT COMPLETED|Visit 3||0
502393|NCT00995904|1228701|P2|NOT COMPLETED|Visit 3||0
502394|NCT00995904|1228702|P1|NOT COMPLETED|Visit 3||0
502395|NCT00995904|1228697|P6|COMPLETED|Visit 3||3
502396|NCT00995904|1228698|P5|COMPLETED|Visit 3||5
502397|NCT00995904|1228699|P4|COMPLETED|Visit 3||5
502398|NCT00995904|1228700|P3|COMPLETED|Visit 3||4
502399|NCT00995904|1228701|P2|COMPLETED|Visit 3||3
502400|NCT00995904|1228702|P1|COMPLETED|Visit 3||4
502401|NCT00995904|1228697|P6|STARTED|Visit 3|One subject was withdrawn from the study after completion of Visit 2 but prior to Visit 3.|3
502402|NCT00995904|1228698|P5|STARTED|Visit 3||5
502403|NCT00995904|1228699|P4|STARTED|Visit 3||5
502404|NCT00995904|1228700|P3|STARTED|Visit 3||4
502405|NCT00995904|1228701|P2|STARTED|Visit 3||3
502406|NCT00995904|1228702|P1|STARTED|Visit 3||4
502407|NCT00995904|1228697|P6|NOT COMPLETED|Visit 2 (Randomization)||0
502408|NCT00995904|1228698|P5|NOT COMPLETED|Visit 2 (Randomization)||0
502409|NCT00995904|1228699|P4|NOT COMPLETED|Visit 2 (Randomization)||0
502410|NCT00995904|1228700|P3|NOT COMPLETED|Visit 2 (Randomization)||0
502411|NCT00995904|1228701|P2|NOT COMPLETED|Visit 2 (Randomization)||0
502412|NCT00995904|1228702|P1|NOT COMPLETED|Visit 2 (Randomization)||0
502413|NCT00995904|1228697|P6|COMPLETED|Visit 2 (Randomization)||4
502414|NCT00995904|1228698|P5|COMPLETED|Visit 2 (Randomization)||5
502415|NCT00995904|1228699|P4|COMPLETED|Visit 2 (Randomization)||5
502416|NCT00995904|1228700|P3|COMPLETED|Visit 2 (Randomization)||4
502417|NCT00995904|1228701|P2|COMPLETED|Visit 2 (Randomization)||3
502418|NCT00995904|1228702|P1|COMPLETED|Visit 2 (Randomization)||4
502419|NCT00995904|1228697|P6|STARTED|Visit 2 (Randomization)||4
502420|NCT00995904|1228698|P5|STARTED|Visit 2 (Randomization)||5
502421|NCT00995904|1228699|P4|STARTED|Visit 2 (Randomization)||5
502422|NCT00995904|1228700|P3|STARTED|Visit 2 (Randomization)||4
502423|NCT00995904|1228701|P2|STARTED|Visit 2 (Randomization)||3
502424|NCT00995904|1228702|P1|STARTED|Visit 2 (Randomization)||4
502425|NCT00995865|1228719|P3|NOT COMPLETED|Overall Study||1
502426|NCT00995865|1228720|P2|NOT COMPLETED|Overall Study||0
502427|NCT00995865|1228721|P1|NOT COMPLETED|Overall Study||2
502428|NCT00995865|1228719|P3|COMPLETED|Overall Study||11
502429|NCT00995865|1228720|P2|COMPLETED|Overall Study||24
502430|NCT00995865|1228721|P1|COMPLETED|Overall Study||22
502431|NCT00995865|1228719|P3|STARTED|Overall Study||12
502432|NCT00995865|1228720|P2|STARTED|Overall Study||24
502433|NCT00995865|1228721|P1|STARTED|Overall Study||24
502434|NCT00995774|1228743|P2|NOT COMPLETED|Training Period 2||0
502435|NCT00995774|1228744|P1|NOT COMPLETED|Training Period 2||2
502436|NCT00995774|1228743|P2|COMPLETED|Training Period 2||5
502437|NCT00995774|1228744|P1|COMPLETED|Training Period 2||5
502438|NCT00995774|1228743|P2|STARTED|Training Period 2||5
502439|NCT00995774|1228744|P1|STARTED|Training Period 2||7
502440|NCT00995774|1228743|P2|NOT COMPLETED|Washout Period||0
502441|NCT00995774|1228744|P1|NOT COMPLETED|Washout Period||0
502442|NCT00995774|1228743|P2|COMPLETED|Washout Period||5
502443|NCT00995774|1228744|P1|COMPLETED|Washout Period||7
502444|NCT00995774|1228743|P2|STARTED|Washout Period||5
502445|NCT00995774|1228744|P1|STARTED|Washout Period||7
502446|NCT00995774|1228743|P2|NOT COMPLETED|Training Period 1||0
502447|NCT00995774|1228744|P1|NOT COMPLETED|Training Period 1||0
502448|NCT00995774|1228743|P2|COMPLETED|Training Period 1||5
502449|NCT00995774|1228744|P1|COMPLETED|Training Period 1||7
502450|NCT00995774|1228743|P2|STARTED|Training Period 1||5
502451|NCT00995774|1228744|P1|STARTED|Training Period 1||7
502452|NCT00995761|1228752|P1|NOT COMPLETED|Overall Study||0
502453|NCT00995761|1228752|P1|COMPLETED|Overall Study||48
502454|NCT00995761|1228752|P1|STARTED|Overall Study||48
502455|NCT00995722|1228758|P2|NOT COMPLETED|Overall Study: 36 Weeks||2
502456|NCT00995722|1228759|P1|NOT COMPLETED|Overall Study: 36 Weeks||2
502457|NCT00995722|1228758|P2|COMPLETED|Overall Study: 36 Weeks||2
502458|NCT00995722|1228759|P1|COMPLETED|Overall Study: 36 Weeks||3
502459|NCT00995722|1228758|P2|STARTED|Overall Study: 36 Weeks||4
502460|NCT00995722|1228759|P1|STARTED|Overall Study: 36 Weeks||5
502461|NCT00995722|1228758|P2|NOT COMPLETED|Double Blinded: 16 Weeks||1
502462|NCT00995722|1228759|P1|NOT COMPLETED|Double Blinded: 16 Weeks||1
502463|NCT00995722|1228758|P2|COMPLETED|Double Blinded: 16 Weeks||4
502464|NCT00995722|1228759|P1|COMPLETED|Double Blinded: 16 Weeks||5
502465|NCT00995722|1228758|P2|STARTED|Double Blinded: 16 Weeks||5
502466|NCT00995722|1228759|P1|STARTED|Double Blinded: 16 Weeks||6
502467|NCT00995709|1228776|P3|NOT COMPLETED|Overall Study||5
502468|NCT00995709|1228777|P2|NOT COMPLETED|Overall Study||9
502469|NCT00995709|1228778|P1|NOT COMPLETED|Overall Study||7
502470|NCT00995709|1228776|P3|COMPLETED|Overall Study||34
502471|NCT00995709|1228777|P2|COMPLETED|Overall Study|patient in the 300 mg monthly group was randomized,was not eligible,never received study medication|31
502472|NCT00995709|1228778|P1|COMPLETED|Overall Study||32
502473|NCT00995709|1228776|P3|STARTED|Overall Study||39
502474|NCT00995709|1228777|P2|STARTED|Overall Study||40
502475|NCT00995709|1228778|P1|STARTED|Overall Study||39
502476|NCT00995670|1228804|P3|NOT COMPLETED|Overall Study||3
502477|NCT00995670|1228805|P2|NOT COMPLETED|Overall Study||0
502478|NCT00995670|1228806|P1|NOT COMPLETED|Overall Study||1
502479|NCT00995670|1228804|P3|COMPLETED|Overall Study|These 17 volunteers underwent 33 studies on the effect of statins, glucose, and glucose & statins.|14
502480|NCT00995670|1228805|P2|COMPLETED|Overall Study|These 16 subjects underwent a total of 25 studies on the effect of Vitamin C.|16
502481|NCT00995670|1228806|P1|COMPLETED|Overall Study|These 26 subjects underwent a total of 58 studies to determine the effect of dose of glucose on I/R.|25
502482|NCT00995670|1228804|P3|STARTED|Overall Study||17
502483|NCT00995670|1228805|P2|STARTED|Overall Study||16
502484|NCT00995670|1228806|P1|STARTED|Overall Study||26
502485|NCT00995566|1228814|P1|NOT COMPLETED|Overall Study||54
502486|NCT00995566|1228814|P1|COMPLETED|Overall Study||0
502487|NCT00995566|1228814|P1|STARTED|Overall Study||54
502488|NCT00995553|1228828|P2|NOT COMPLETED|Overall Study||6
502489|NCT00995553|1228829|P1|NOT COMPLETED|Overall Study||2
502490|NCT00995553|1228828|P2|COMPLETED|Overall Study||35
502491|NCT00995553|1228829|P1|COMPLETED|Overall Study||38
502492|NCT00995553|1228828|P2|STARTED|Overall Study||41
502493|NCT00995553|1228829|P1|STARTED|Overall Study||40
502494|NCT00995501|1228845|P8|NOT COMPLETED|Overall Study||0
502495|NCT00995501|1228846|P7|NOT COMPLETED|Overall Study||0
502496|NCT00995501|1228847|P6|NOT COMPLETED|Overall Study||0
502497|NCT00995501|1228848|P5|NOT COMPLETED|Overall Study||0
502498|NCT00995501|1228849|P4|NOT COMPLETED|Overall Study||0
502499|NCT00995501|1228850|P3|NOT COMPLETED|Overall Study||0
502500|NCT00995501|1228851|P2|NOT COMPLETED|Overall Study||0
502501|NCT00995501|1228852|P1|NOT COMPLETED|Overall Study||0
502502|NCT00995501|1228845|P8|COMPLETED|Overall Study||46
502503|NCT00995501|1228846|P7|COMPLETED|Overall Study||49
502504|NCT00995501|1228847|P6|COMPLETED|Overall Study||44
502505|NCT00995501|1228848|P5|COMPLETED|Overall Study||46
502506|NCT00995501|1228849|P4|COMPLETED|Overall Study||46
502507|NCT00995501|1228850|P3|COMPLETED|Overall Study||47
502508|NCT00995501|1228851|P2|COMPLETED|Overall Study||51
502509|NCT00995501|1228852|P1|COMPLETED|Overall Study||52
502510|NCT00995501|1228845|P8|STARTED|Overall Study||46
502511|NCT00995501|1228846|P7|STARTED|Overall Study||49
502512|NCT00995501|1228847|P6|STARTED|Overall Study||44
502513|NCT00995501|1228848|P5|STARTED|Overall Study||46
502514|NCT00995501|1228849|P4|STARTED|Overall Study||46
502515|NCT00995501|1228850|P3|STARTED|Overall Study||47
502516|NCT00995501|1228851|P2|STARTED|Overall Study||51
502517|NCT00995501|1228852|P1|STARTED|Overall Study||52
502518|NCT00995488|1228878|P1|NOT COMPLETED|Overall Study||1
502519|NCT00995488|1228878|P1|COMPLETED|Overall Study||15
502520|NCT00995488|1228878|P1|STARTED|Overall Study||16
502521|NCT00995449|1228887|P4|NOT COMPLETED|Overall Study||0
502522|NCT00995449|1228888|P3|NOT COMPLETED|Overall Study||2
502523|NCT00995449|1228889|P2|NOT COMPLETED|Overall Study||0
502524|NCT00995449|1228890|P1|NOT COMPLETED|Overall Study||0
502525|NCT00995449|1228887|P4|COMPLETED|Overall Study||2
502526|NCT00995449|1228888|P3|COMPLETED|Overall Study||5
502527|NCT00995449|1228889|P2|COMPLETED|Overall Study||0
502528|NCT00995449|1228890|P1|COMPLETED|Overall Study||0
502529|NCT00995449|1228887|P4|STARTED|Overall Study||2
502530|NCT00995449|1228888|P3|STARTED|Overall Study||7
502531|NCT00995449|1228889|P2|STARTED|Overall Study||0
502532|NCT00995449|1228890|P1|STARTED|Overall Study||0
502533|NCT00995436|1228901|P3|NOT COMPLETED|Overall Study||0
502534|NCT00995436|1228902|P2|NOT COMPLETED|Overall Study||5
502535|NCT00995436|1228903|P1|NOT COMPLETED|Overall Study||2
502536|NCT00995436|1228901|P3|COMPLETED|Overall Study||26
502537|NCT00995436|1228902|P2|COMPLETED|Overall Study||22
502538|NCT00995436|1228903|P1|COMPLETED|Overall Study||23
502539|NCT00995436|1228901|P3|STARTED|Overall Study||26
502540|NCT00995436|1228902|P2|STARTED|Overall Study||27
502541|NCT00995436|1228903|P1|STARTED|Overall Study|25|25
502542|NCT00995410|1228911|P1|NOT COMPLETED|Overall Study||88
502543|NCT00995410|1228911|P1|COMPLETED|Overall Study||292
502544|NCT00995410|1228911|P1|Treated|Overall Study||379
502545|NCT00995410|1228911|P1|STARTED|Overall Study||380
502546|NCT00995371|1228918|P2|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5
502547|NCT00995371|1228919|P1|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5
502548|NCT00995371|1228918|P2|COMPLETED|After ESI Cross-over to Mild, 26 Weeks|All 17 completed Wk 6 Intent to Treat analysis prior to x-over. After x-over 12 reported Wk 26|12
502549|NCT00995371|1228919|P1|COMPLETED|After ESI Cross-over to Mild, 26 Weeks|All 21 completed Wk 6 Intent to Treat analysis. Sixteen reported Week 26 outcomes.|16
502550|NCT00995371|1228918|P2|STARTED|After ESI Cross-over to Mild, 26 Weeks||17
502551|NCT00995371|1228919|P1|STARTED|After ESI Cross-over to Mild, 26 Weeks||21
502552|NCT00995371|1228918|P2|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0
502553|NCT00995371|1228919|P1|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0
502554|NCT00995371|1228918|P2|COMPLETED|Prior to ESI Cross-over, 6 Weeks||17
502555|NCT00995371|1228919|P1|COMPLETED|Prior to ESI Cross-over, 6 Weeks||21
502556|NCT00995371|1228918|P2|STARTED|Prior to ESI Cross-over, 6 Weeks||17
502557|NCT00995371|1228919|P1|STARTED|Prior to ESI Cross-over, 6 Weeks||21
502558|NCT00995345|1228937|P5|NOT COMPLETED|Overall Study||5
502559|NCT00995345|1228938|P4|NOT COMPLETED|Overall Study||5
502560|NCT00995345|1228939|P3|NOT COMPLETED|Overall Study||7
502561|NCT00995345|1228940|P2|NOT COMPLETED|Overall Study||7
502562|NCT00995345|1228941|P1|NOT COMPLETED|Overall Study||11
502563|NCT00995345|1228937|P5|COMPLETED|Overall Study||75
502564|NCT00995345|1228938|P4|COMPLETED|Overall Study||76
502565|NCT00995345|1228939|P3|COMPLETED|Overall Study||73
502566|NCT00995345|1228940|P2|COMPLETED|Overall Study||74
502567|NCT00995345|1228941|P1|COMPLETED|Overall Study||70
502568|NCT00995345|1228937|P5|STARTED|Overall Study||80
502569|NCT00995345|1228938|P4|STARTED|Overall Study||81
502570|NCT00995345|1228939|P3|STARTED|Overall Study||80
502571|NCT00995345|1228940|P2|STARTED|Overall Study||81
502572|NCT00995345|1228941|P1|STARTED|Overall Study||81
502573|NCT00995085|1228968|P1|NOT COMPLETED|Overall Study||5
502574|NCT00995085|1228968|P1|COMPLETED|Overall Study||38
502575|NCT00995085|1228968|P1|STARTED|Overall Study||43
502576|NCT00995020|1228974|P2|NOT COMPLETED|Overall Study||7
502577|NCT00995020|1228975|P1|NOT COMPLETED|Overall Study||3
502578|NCT00995020|1228974|P2|COMPLETED|Overall Study|"Reasons for not completed:~margin analysis not performed specimen fragmentation thermal damage"|45
502579|NCT00995020|1228975|P1|COMPLETED|Overall Study|"Reasons for not completed:~margin analysis not performed specimen fragmentation thermal damage"|48
502580|NCT00995020|1228974|P2|STARTED|Overall Study||52
502581|NCT00995020|1228975|P1|STARTED|Overall Study||51
502582|NCT00995007|1228985|P2|NOT COMPLETED|Overall Study||2
502583|NCT00995007|1228986|P1|NOT COMPLETED|Overall Study||17
502584|NCT00995007|1228985|P2|COMPLETED|Overall Study||54
502585|NCT00995007|1228986|P1|COMPLETED|Overall Study||39
502586|NCT00995007|1228985|P2|Crossover to Vandetanib|Overall Study||0
502587|NCT00995007|1228986|P1|Crossover to Vandetanib|Overall Study||42
502588|NCT00995007|1228985|P2|STARTED|Overall Study||56
502589|NCT00995007|1228986|P1|STARTED|Overall Study||56
502590|NCT00994929|1229002|P1|NOT COMPLETED|Overall Study||0
502591|NCT00994929|1229002|P1|COMPLETED|Overall Study||9
502592|NCT00994929|1229002|P1|STARTED|Overall Study||9
502593|NCT00994760|1229008|P1|NOT COMPLETED|Overall Study||24
502594|NCT00994760|1229008|P1|COMPLETED|Overall Study||107
502595|NCT00994760|1229008|P1|STARTED|Overall Study||131
502596|NCT00994682|1229049|P2|NOT COMPLETED|Pioglitazone Open Label||7
502597|NCT00994682|1229050|P1|NOT COMPLETED|Pioglitazone Open Label||13
502598|NCT00994682|1229049|P2|COMPLETED|Pioglitazone Open Label||34
502599|NCT00994682|1229050|P1|COMPLETED|Pioglitazone Open Label||29
502600|NCT00994682|1229049|P2|STARTED|Pioglitazone Open Label||41
502601|NCT00994682|1229050|P1|STARTED|Pioglitazone Open Label||42
502602|NCT00994682|1229049|P2|NOT COMPLETED|Double Bilnd||9
502603|NCT00994682|1229050|P1|NOT COMPLETED|Double Bilnd||9
502604|NCT00994682|1229049|P2|COMPLETED|Double Bilnd||41
502605|NCT00994682|1229050|P1|COMPLETED|Double Bilnd||42
502606|NCT00994682|1229049|P2|STARTED|Double Bilnd||50
502607|NCT00994682|1229050|P1|STARTED|Double Bilnd||51
502608|NCT00994643|1229094|P1|NOT COMPLETED|Overall Study||1
502609|NCT00994643|1229094|P1|COMPLETED|Overall Study||10
502610|NCT00994643|1229094|P1|STARTED|Overall Study||11
502611|NCT00994604|1229098|P1|NOT COMPLETED|Overall Study||6
502612|NCT00994604|1229098|P1|COMPLETED|Overall Study||45
502613|NCT00994604|1229098|P1|STARTED|Overall Study||51
502614|NCT00994461|1229108|P3|NOT COMPLETED|Overall Study||0
502615|NCT00994461|1229109|P2|NOT COMPLETED|Overall Study||1
502616|NCT00994461|1229110|P1|NOT COMPLETED|Overall Study||2
502617|NCT00994461|1229108|P3|COMPLETED|Overall Study||37
502618|NCT00994461|1229109|P2|COMPLETED|Overall Study||75
502619|NCT00994461|1229110|P1|COMPLETED|Overall Study||74
502620|NCT00994461|1229108|P3|STARTED|Overall Study|One subject was randomized but did not receive study drug.|37
502621|NCT00994461|1229109|P2|STARTED|Overall Study||76
502622|NCT00994461|1229110|P1|STARTED|Overall Study||76
502623|NCT00994448|1229138|P2|NOT COMPLETED|Overall Study||2
502624|NCT00994448|1229139|P1|NOT COMPLETED|Overall Study||8
502625|NCT00994448|1229138|P2|COMPLETED|Overall Study||5
502626|NCT00994448|1229139|P1|COMPLETED|Overall Study||4
502627|NCT00994448|1229138|P2|STARTED|Overall Study||7
502628|NCT00994448|1229139|P1|STARTED|Overall Study||12
502629|NCT00994422|1229147|P2|NOT COMPLETED|Overall Study||1
502630|NCT00994422|1229148|P1|NOT COMPLETED|Overall Study||7
502631|NCT00994422|1229147|P2|COMPLETED|Overall Study||54
502632|NCT00994422|1229148|P1|COMPLETED|Overall Study||185
502633|NCT00994422|1229147|P2|STARTED|Overall Study||55
502634|NCT00994422|1229148|P1|STARTED|Overall Study||192
502635|NCT00994318|1229161|P3|NOT COMPLETED|Overall Study||67
502636|NCT00994318|1229162|P2|NOT COMPLETED|Overall Study||18
502637|NCT00994318|1229163|P1|NOT COMPLETED|Overall Study||22
502638|NCT00994318|1229161|P3|COMPLETED|Overall Study||250
502639|NCT00994318|1229162|P2|COMPLETED|Overall Study||136
502640|NCT00994318|1229163|P1|COMPLETED|Overall Study||133
502641|NCT00994318|1229161|P3|STARTED|Overall Study||317
502642|NCT00994318|1229162|P2|STARTED|Overall Study||154
502643|NCT00994318|1229163|P1|STARTED|Overall Study||155
502644|NCT00994279|1229173|P2|NOT COMPLETED|Overall Study||5
502645|NCT00994279|1229174|P1|NOT COMPLETED|Overall Study||4
502646|NCT00994279|1229173|P2|COMPLETED|Overall Study||13
502647|NCT00994279|1229174|P1|COMPLETED|Overall Study||18
502648|NCT00994279|1229173|P2|STARTED|Overall Study||18
502649|NCT00994279|1229174|P1|STARTED|Overall Study||22
502650|NCT00994240|1229184|P2|NOT COMPLETED|Overall Study||5
502651|NCT00994240|1229185|P1|NOT COMPLETED|Overall Study||6
502652|NCT00994240|1229184|P2|COMPLETED|Overall Study||39
502653|NCT00994240|1229185|P1|COMPLETED|Overall Study||35
502654|NCT00994240|1229184|P2|STARTED|Overall Study||44
502655|NCT00994240|1229185|P1|STARTED|Overall Study||41
502656|NCT00994214|1229195|P4|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3
502657|NCT00994214|1229196|P3|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||2
502658|NCT00994214|1229197|P2|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3
502659|NCT00994214|1229198|P1|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||4
502660|NCT00994214|1229195|P4|COMPLETED|ITT (Intention-to-Treat) - Part B||0
502661|NCT00994214|1229196|P3|COMPLETED|ITT (Intention-to-Treat) - Part B||0
502662|NCT00994214|1229197|P2|COMPLETED|ITT (Intention-to-Treat) - Part B||0
502663|NCT00994214|1229198|P1|COMPLETED|ITT (Intention-to-Treat) - Part B||0
502664|NCT00994214|1229195|P4|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||3
502665|NCT00994214|1229196|P3|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||2
502666|NCT00994214|1229197|P2|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0
502667|NCT00994214|1229198|P1|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0
502668|NCT00994214|1229195|P4|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0
502669|NCT00994214|1229196|P3|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0
502670|NCT00994214|1229197|P2|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||3
502671|NCT00994214|1229198|P1|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||1
502672|NCT00994214|1229195|P4|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
502673|NCT00994214|1229196|P3|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
502674|NCT00994214|1229197|P2|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
502675|NCT00994214|1229198|P1|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||3
502676|NCT00994214|1229195|P4|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
502677|NCT00994214|1229196|P3|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
502678|NCT00994214|1229197|P2|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
502679|NCT00994214|1229198|P1|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
502680|NCT00994214|1229195|P4|STARTED|ITT (Intention-to-Treat) - Part B|2 subjects did not enter Part B Arm D|3
502681|NCT00994214|1229196|P3|STARTED|ITT (Intention-to-Treat) - Part B|3 subjects did not enter Part B Arm C|2
502682|NCT00994214|1229197|P2|STARTED|ITT (Intention-to-Treat) - Part B|3 subjects did not enter Part B Arm B|3
502683|NCT00994214|1229198|P1|STARTED|ITT (Intention-to-Treat) - Part B|1 subject did not enter Part B Arm A|4
502684|NCT00994214|1229195|P4|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||15
502685|NCT00994214|1229196|P3|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13
502686|NCT00994214|1229197|P2|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13
502687|NCT00994214|1229198|P1|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||14
502688|NCT00994214|1229195|P4|COMPLETED|ITT (Intention-to-Treat) - Part A||5
502689|NCT00994214|1229196|P3|COMPLETED|ITT (Intention-to-Treat) - Part A||5
502690|NCT00994214|1229197|P2|COMPLETED|ITT (Intention-to-Treat) - Part A||6
502691|NCT00994214|1229198|P1|COMPLETED|ITT (Intention-to-Treat) - Part A||5
502692|NCT00994214|1229195|P4|STARTED|ITT (Intention-to-Treat) - Part A||20
502693|NCT00994214|1229196|P3|STARTED|ITT (Intention-to-Treat) - Part A||18
502694|NCT00994214|1229197|P2|STARTED|ITT (Intention-to-Treat) - Part A||19
502695|NCT00994214|1229198|P1|STARTED|ITT (Intention-to-Treat) - Part A||19
502696|NCT00994175|1229242|P2|NOT COMPLETED|Second Intervention||0
502697|NCT00994175|1229243|P1|NOT COMPLETED|Second Intervention||0
502698|NCT00994175|1229242|P2|COMPLETED|Second Intervention||8
502699|NCT00994175|1229243|P1|COMPLETED|Second Intervention||4
502700|NCT00994175|1229242|P2|STARTED|Second Intervention||8
502701|NCT00994175|1229243|P1|STARTED|Second Intervention||4
502702|NCT00994175|1229242|P2|NOT COMPLETED|First Intervention||1
502703|NCT00994175|1229243|P1|NOT COMPLETED|First Intervention||2
502704|NCT00994175|1229242|P2|COMPLETED|First Intervention||8
502705|NCT00994175|1229243|P1|COMPLETED|First Intervention||4
502706|NCT00994175|1229242|P2|STARTED|First Intervention||9
502707|NCT00994175|1229243|P1|STARTED|First Intervention||6
502708|NCT00994123|1229254|P3|NOT COMPLETED|Overall Study||0
502709|NCT00994123|1229255|P2|NOT COMPLETED|Overall Study||0
502710|NCT00994123|1229256|P1|NOT COMPLETED|Overall Study||0
502711|NCT00994123|1229254|P3|COMPLETED|Overall Study||44
502712|NCT00994123|1229255|P2|COMPLETED|Overall Study||85
502713|NCT00994123|1229256|P1|COMPLETED|Overall Study||33
502714|NCT00994123|1229254|P3|STARTED|Overall Study||44
502715|NCT00994123|1229255|P2|STARTED|Overall Study||85
502716|NCT00994123|1229256|P1|STARTED|Overall Study||33
502717|NCT00994110|1229277|P2|NOT COMPLETED|Overall Study||74
502718|NCT00994110|1229278|P1|NOT COMPLETED|Overall Study||65
502719|NCT00994110|1229277|P2|COMPLETED|Overall Study||148
502720|NCT00994110|1229278|P1|COMPLETED|Overall Study||152
502721|NCT00994110|1229277|P2|STARTED|Overall Study||222
502722|NCT00994110|1229278|P1|STARTED|Overall Study||217
502723|NCT00993967|1229284|P1|NOT COMPLETED|Overall Study||61
502724|NCT00993967|1229284|P1|COMPLETED|Overall Study||139
502725|NCT00993967|1229284|P1|STARTED|Overall Study||200
502726|NCT00993954|1229291|P2|NOT COMPLETED|Overall Study||2
502727|NCT00993954|1229292|P1|NOT COMPLETED|Overall Study||21
502728|NCT00993954|1229291|P2|COMPLETED|Overall Study||121
502729|NCT00993954|1229292|P1|COMPLETED|Overall Study||124
502730|NCT00993954|1229291|P2|STARTED|Overall Study||123
502731|NCT00993954|1229292|P1|STARTED|Overall Study||145
502732|NCT00993928|1229305|P2|NOT COMPLETED|Overall Study||7
502733|NCT00993928|1229306|P1|NOT COMPLETED|Overall Study||5
502734|NCT00993928|1229305|P2|COMPLETED|Overall Study||38
502735|NCT00993928|1229306|P1|COMPLETED|Overall Study||43
502736|NCT00993928|1229305|P2|STARTED|Overall Study||45
502737|NCT00993928|1229306|P1|STARTED|Overall Study||48
502738|NCT00993915|1229320|P1|NOT COMPLETED|Overall Study||9
502739|NCT00993915|1229320|P1|COMPLETED|Overall Study||678
502740|NCT00993915|1229320|P1|STARTED|Overall Study||687
502741|NCT00993824|1229331|P2|NOT COMPLETED|Overall Study||0
502742|NCT00993824|1229332|P1|NOT COMPLETED|Overall Study||0
502743|NCT00993824|1229331|P2|COMPLETED|Overall Study||10
502744|NCT00993824|1229332|P1|COMPLETED|Overall Study||11
502745|NCT00993824|1229331|P2|STARTED|Overall Study||10
502746|NCT00993824|1229332|P1|STARTED|Overall Study||11
502747|NCT00993668|1229346|P2|NOT COMPLETED|Open-Label Period||15
502748|NCT00993668|1229347|P1|NOT COMPLETED|Open-Label Period||23
502749|NCT00993668|1229346|P2|COMPLETED|Open-Label Period||91
502750|NCT00993668|1229347|P1|COMPLETED|Open-Label Period||86
502751|NCT00993668|1229346|P2|STARTED|Open-Label Period|1 subject chose not to enter the optional open-label period|106
502752|NCT00993668|1229347|P1|STARTED|Open-Label Period|1 subject chose not to enter the optional open-label period|109
502753|NCT00993668|1229346|P2|NOT COMPLETED|Single-Blind Period||3
502754|NCT00993668|1229347|P1|NOT COMPLETED|Single-Blind Period||4
502755|NCT00993668|1229346|P2|COMPLETED|Single-Blind Period||107
502756|NCT00993668|1229347|P1|COMPLETED|Single-Blind Period||110
502757|NCT00993668|1229346|P2|STARTED|Single-Blind Period||110
502758|NCT00993668|1229347|P1|STARTED|Single-Blind Period||114
502759|NCT00993655|1229375|P3|NOT COMPLETED|Overall Study||0
502760|NCT00993655|1229376|P2|NOT COMPLETED|Overall Study||0
502761|NCT00993655|1229377|P1|NOT COMPLETED|Overall Study||0
502762|NCT00993655|1229375|P3|COMPLETED|Overall Study||102
502763|NCT00993655|1229376|P2|COMPLETED|Overall Study||72
502764|NCT00993655|1229377|P1|COMPLETED|Overall Study||101
502765|NCT00993655|1229375|P3|STARTED|Overall Study||102
502766|NCT00993655|1229376|P2|STARTED|Overall Study||72
502767|NCT00993655|1229377|P1|STARTED|Overall Study||101
502768|NCT00993616|1229391|P1|NOT COMPLETED|Overall Study||2
502769|NCT00993616|1229391|P1|COMPLETED|Overall Study|Number of eligible and evaluable participants|27
502770|NCT00993616|1229391|P1|STARTED|Overall Study||29
502771|NCT00993499|1229409|P6|NOT COMPLETED|Discontinued After Starting Course 3||3
502772|NCT00993499|1229410|P5|NOT COMPLETED|Discontinued After Starting Course 3||3
502773|NCT00993499|1229411|P4|NOT COMPLETED|Discontinued After Starting Course 3||2
502774|NCT00993499|1229412|P3|NOT COMPLETED|Discontinued After Starting Course 3||6
502775|NCT00993499|1229413|P2|NOT COMPLETED|Discontinued After Starting Course 3||5
502776|NCT00993499|1229414|P1|NOT COMPLETED|Discontinued After Starting Course 3||8
502777|NCT00993499|1229409|P6|COMPLETED|Discontinued After Starting Course 3||0
502778|NCT00993499|1229410|P5|COMPLETED|Discontinued After Starting Course 3||0
502779|NCT00993499|1229411|P4|COMPLETED|Discontinued After Starting Course 3||1
502780|NCT00993499|1229412|P3|COMPLETED|Discontinued After Starting Course 3||3
502781|NCT00993499|1229413|P2|COMPLETED|Discontinued After Starting Course 3||4
502782|NCT00993499|1229414|P1|COMPLETED|Discontinued After Starting Course 3||4
502783|NCT00993499|1229409|P6|STARTED|Discontinued After Starting Course 3||3
502784|NCT00993499|1229410|P5|STARTED|Discontinued After Starting Course 3||3
502785|NCT00993499|1229411|P4|STARTED|Discontinued After Starting Course 3||3
502786|NCT00993499|1229412|P3|STARTED|Discontinued After Starting Course 3||9
502787|NCT00993499|1229413|P2|STARTED|Discontinued After Starting Course 3||9
502788|NCT00993499|1229414|P1|STARTED|Discontinued After Starting Course 3||12
502789|NCT00993499|1229409|P6|NOT COMPLETED|Discontinued Before Starting Course 3||0
502790|NCT00993499|1229410|P5|NOT COMPLETED|Discontinued Before Starting Course 3||0
502791|NCT00993499|1229411|P4|NOT COMPLETED|Discontinued Before Starting Course 3||1
502792|NCT00993499|1229412|P3|NOT COMPLETED|Discontinued Before Starting Course 3||3
502793|NCT00993499|1229413|P2|NOT COMPLETED|Discontinued Before Starting Course 3||4
502794|NCT00993499|1229414|P1|NOT COMPLETED|Discontinued Before Starting Course 3||4
502795|NCT00993499|1229409|P6|COMPLETED|Discontinued Before Starting Course 3||3
502796|NCT00993499|1229410|P5|COMPLETED|Discontinued Before Starting Course 3||3
502797|NCT00993499|1229411|P4|COMPLETED|Discontinued Before Starting Course 3||2
502798|NCT00993499|1229412|P3|COMPLETED|Discontinued Before Starting Course 3||6
502799|NCT00993499|1229413|P2|COMPLETED|Discontinued Before Starting Course 3||5
502800|NCT00993499|1229414|P1|COMPLETED|Discontinued Before Starting Course 3||8
502801|NCT00993499|1229409|P6|STARTED|Discontinued Before Starting Course 3||3
502802|NCT00993499|1229410|P5|STARTED|Discontinued Before Starting Course 3||3
502803|NCT00993499|1229411|P4|STARTED|Discontinued Before Starting Course 3||3
502804|NCT00993499|1229412|P3|STARTED|Discontinued Before Starting Course 3||9
502805|NCT00993499|1229413|P2|STARTED|Discontinued Before Starting Course 3||9
502806|NCT00993499|1229414|P1|STARTED|Discontinued Before Starting Course 3||12
502807|NCT00993499|1229409|P6|NOT COMPLETED|Run-in Period (8 Days)||0
502808|NCT00993499|1229410|P5|NOT COMPLETED|Run-in Period (8 Days)||0
502809|NCT00993499|1229411|P4|NOT COMPLETED|Run-in Period (8 Days)||0
502810|NCT00993499|1229412|P3|NOT COMPLETED|Run-in Period (8 Days)||1
502811|NCT00993499|1229413|P2|NOT COMPLETED|Run-in Period (8 Days)||3
502812|NCT00993499|1229414|P1|NOT COMPLETED|Run-in Period (8 Days)||1
502813|NCT00993499|1229409|P6|COMPLETED|Run-in Period (8 Days)||3
502814|NCT00993499|1229410|P5|COMPLETED|Run-in Period (8 Days)||3
502815|NCT00993499|1229411|P4|COMPLETED|Run-in Period (8 Days)||3
502816|NCT00993499|1229412|P3|COMPLETED|Run-in Period (8 Days)||9
502817|NCT00993499|1229413|P2|COMPLETED|Run-in Period (8 Days)||9
502818|NCT00993499|1229414|P1|COMPLETED|Run-in Period (8 Days)||12
502819|NCT00993499|1229409|P6|STARTED|Run-in Period (8 Days)||3
502820|NCT00993499|1229410|P5|STARTED|Run-in Period (8 Days)||3
502821|NCT00993499|1229411|P4|STARTED|Run-in Period (8 Days)||3
502822|NCT00993499|1229412|P3|STARTED|Run-in Period (8 Days)||10
502823|NCT00993499|1229413|P2|STARTED|Run-in Period (8 Days)||12
502824|NCT00993499|1229414|P1|STARTED|Run-in Period (8 Days)||13
502825|NCT00993473|1229496|P2|NOT COMPLETED|Overall Study||10
502826|NCT00993473|1229497|P1|NOT COMPLETED|Overall Study||4
502827|NCT00993473|1229496|P2|COMPLETED|Overall Study||54
502828|NCT00993473|1229497|P1|COMPLETED|Overall Study||57
502829|NCT00993473|1229496|P2|STARTED|Overall Study|64 patients randomized to NPH but only 63 patients treated with NPH due to a dispensation's error|64
502830|NCT00993473|1229497|P1|STARTED|Overall Study|61 patients randomized to Lantus but 62 patients treated with Lantus due to a dispensation's error|61
502831|NCT00993447|1229535|P2|NOT COMPLETED|Overall Study||19
502832|NCT00993447|1229536|P1|NOT COMPLETED|Overall Study||37
502833|NCT00993447|1229535|P2|COMPLETED|Overall Study||180
502834|NCT00993447|1229536|P1|COMPLETED|Overall Study||364
502835|NCT00993447|1229535|P2|STARTED|Overall Study||199
502836|NCT00993447|1229536|P1|STARTED|Overall Study||401
502837|NCT00993421|1229573|P7|NOT COMPLETED|Overall Study||42
502838|NCT00993421|1229574|P6|NOT COMPLETED|Overall Study||46
502839|NCT00993421|1229575|P5|NOT COMPLETED|Overall Study||46
502840|NCT00993421|1229576|P4|NOT COMPLETED|Overall Study||45
502841|NCT00993421|1229577|P3|NOT COMPLETED|Overall Study||43
502842|NCT00993421|1229578|P2|NOT COMPLETED|Overall Study||45
502843|NCT00993421|1229579|P1|NOT COMPLETED|Overall Study||44
502844|NCT00993421|1229573|P7|COMPLETED|Overall Study||4
502845|NCT00993421|1229574|P6|COMPLETED|Overall Study||4
502846|NCT00993421|1229575|P5|COMPLETED|Overall Study||6
502847|NCT00993421|1229576|P4|COMPLETED|Overall Study||4
502848|NCT00993421|1229577|P3|COMPLETED|Overall Study||5
502849|NCT00993421|1229578|P2|COMPLETED|Overall Study||4
502850|NCT00993421|1229579|P1|COMPLETED|Overall Study||5
502851|NCT00993421|1229573|P7|STARTED|Overall Study||46
502852|NCT00993421|1229574|P6|STARTED|Overall Study||50
502853|NCT00993421|1229575|P5|STARTED|Overall Study||52
502854|NCT00993421|1229576|P4|STARTED|Overall Study||49
502855|NCT00993421|1229577|P3|STARTED|Overall Study||48
502856|NCT00993421|1229578|P2|STARTED|Overall Study||49
502857|NCT00993421|1229579|P1|STARTED|Overall Study||49
502858|NCT00993317|1229730|P2|NOT COMPLETED|Overall Study||25
502859|NCT00993317|1229731|P1|NOT COMPLETED|Overall Study||21
502860|NCT00993317|1229730|P2|COMPLETED|Overall Study||60
502861|NCT00993317|1229731|P1|COMPLETED|Overall Study||21
502862|NCT00993317|1229730|P2|STARTED|Overall Study||85
502863|NCT00993317|1229731|P1|STARTED|Overall Study||42
502864|NCT00993291|1229749|P1|NOT COMPLETED|Overall Study||1
502865|NCT00993291|1229749|P1|COMPLETED|Overall Study||19
502866|NCT00993291|1229749|P1|STARTED|Overall Study||20
502867|NCT00993265|1229755|P2|NOT COMPLETED|Overall Study||0
502868|NCT00993265|1229756|P1|NOT COMPLETED|Overall Study||4
502869|NCT00993265|1229755|P2|COMPLETED|Overall Study||19
502870|NCT00993265|1229756|P1|COMPLETED|Overall Study||16
502871|NCT00993265|1229755|P2|STARTED|Overall Study||19
502872|NCT00993265|1229756|P1|STARTED|Overall Study||20
502873|NCT00993200|1229776|P2|NOT COMPLETED|Overall Study||0
502874|NCT00993200|1229777|P1|NOT COMPLETED|Overall Study||0
502875|NCT00993200|1229776|P2|COMPLETED|Overall Study||13
502876|NCT00993200|1229777|P1|COMPLETED|Overall Study||13
502877|NCT00993200|1229776|P2|STARTED|Overall Study||13
502878|NCT00993200|1229777|P1|STARTED|Overall Study||13
502879|NCT00993187|1229789|P2|NOT COMPLETED|Overall Study||37
502880|NCT00993187|1229790|P1|NOT COMPLETED|Overall Study||26
502881|NCT00993187|1229789|P2|COMPLETED|Overall Study||108
502882|NCT00993187|1229790|P1|COMPLETED|Overall Study||121
502883|NCT00993187|1229789|P2|Received at Least 1 Dose of Study Drug|Overall Study||144
502884|NCT00993187|1229790|P1|Received at Least 1 Dose of Study Drug|Overall Study||146
502885|NCT00993187|1229789|P2|STARTED|Overall Study||145
502886|NCT00993187|1229790|P1|STARTED|Overall Study||147
502887|NCT00993148|1229808|P1|NOT COMPLETED|Overall Study||3
502888|NCT00993148|1229808|P1|COMPLETED|Overall Study||22
502889|NCT00993148|1229808|P1|STARTED|Overall Study||25
502890|NCT00993044|1229820|P1|NOT COMPLETED|Irinotecan 50 mg||1
502891|NCT00993044|1229820|P1|COMPLETED|Irinotecan 50 mg||6
502892|NCT00993044|1229820|P1|STARTED|Irinotecan 50 mg||7
502893|NCT00993044|1229820|P1|NOT COMPLETED|Irinotecan 30 mg||0
502894|NCT00993044|1229820|P1|COMPLETED|Irinotecan 30 mg||6
502895|NCT00993044|1229820|P1|STARTED|Irinotecan 30 mg||6
502896|NCT00993031|1229827|P2|NOT COMPLETED|Overall Study||19
502897|NCT00993031|1229828|P1|NOT COMPLETED|Overall Study||22
502898|NCT00993031|1229827|P2|COMPLETED|Overall Study||175
502899|NCT00993031|1229828|P1|COMPLETED|Overall Study||173
502900|NCT00993031|1229827|P2|Delivered|Overall Study||190
502901|NCT00993031|1229828|P1|Delivered|Overall Study||187
502902|NCT00993031|1229827|P2|STARTED|Overall Study||194
502903|NCT00993031|1229828|P1|STARTED|Overall Study||195
502904|NCT00992992|1229846|P1|NOT COMPLETED|Overall Study||25
502905|NCT00992992|1229846|P1|COMPLETED|Overall Study||0
502906|NCT00992992|1229846|P1|STARTED|Overall Study||25
502907|NCT00992927|1229868|P2|NOT COMPLETED|Overall Study||0
502908|NCT00992927|1229869|P1|NOT COMPLETED|Overall Study||0
502909|NCT00992927|1229868|P2|COMPLETED|Overall Study||22
502910|NCT00992927|1229869|P1|COMPLETED|Overall Study||32
502911|NCT00992927|1229868|P2|STARTED|Overall Study||22
502912|NCT00992927|1229869|P1|STARTED|Overall Study||32
502913|NCT00992836|1229877|P1|NOT COMPLETED|Overall Study||5
502914|NCT00992836|1229877|P1|COMPLETED|Overall Study||150
502915|NCT00992836|1229877|P1|Received Both Study Vaccinations|Overall Study||150
502916|NCT00992836|1229877|P1|STARTED|Overall Study||155
502917|NCT00992784|1229892|P3|NOT COMPLETED|Overall Study||1
502918|NCT00992784|1229893|P2|NOT COMPLETED|Overall Study||2
502919|NCT00992784|1229894|P1|NOT COMPLETED|Overall Study||3
502920|NCT00992784|1229892|P3|COMPLETED|Overall Study||85
502921|NCT00992784|1229893|P2|COMPLETED|Overall Study||102
502922|NCT00992784|1229894|P1|COMPLETED|Overall Study||177
502923|NCT00992784|1229892|P3|STARTED|Overall Study||86
502924|NCT00992784|1229893|P2|STARTED|Overall Study||104
502925|NCT00992784|1229894|P1|STARTED|Overall Study||180
502926|NCT00992719|1229965|P3|NOT COMPLETED|Overall Study||0
502927|NCT00992719|1229966|P2|NOT COMPLETED|Overall Study||1
502928|NCT00992719|1229967|P1|NOT COMPLETED|Overall Study||1
502929|NCT00992719|1229965|P3|COMPLETED|Overall Study||28
502930|NCT00992719|1229966|P2|COMPLETED|Overall Study||27
502931|NCT00992719|1229967|P1|COMPLETED|Overall Study||27
502932|NCT00992719|1229965|P3|STARTED|Overall Study||28
502933|NCT00992719|1229966|P2|STARTED|Overall Study||28
502934|NCT00992719|1229967|P1|STARTED|Overall Study||28
502935|NCT00992602|1230001|P1|NOT COMPLETED|Overall Study||3
502936|NCT00992602|1230001|P1|COMPLETED|Overall Study||0
502937|NCT00992602|1230001|P1|STARTED|Overall Study||3
502938|NCT00992589|1230006|P4|NOT COMPLETED|Double-Blind Phase||10
502939|NCT00992589|1230007|P3|NOT COMPLETED|Double-Blind Phase||13
502940|NCT00992589|1230008|P2|NOT COMPLETED|Double-Blind Phase||13
502941|NCT00992589|1230009|P1|NOT COMPLETED|Double-Blind Phase||0
502942|NCT00992589|1230006|P4|COMPLETED|Double-Blind Phase||78
502943|NCT00992589|1230007|P3|COMPLETED|Double-Blind Phase||77
502944|NCT00992589|1230008|P2|COMPLETED|Double-Blind Phase||76
502945|NCT00992589|1230009|P1|COMPLETED|Double-Blind Phase||0
502946|NCT00992589|1230006|P4|STARTED|Double-Blind Phase||88
502947|NCT00992589|1230007|P3|STARTED|Double-Blind Phase||90
502948|NCT00992589|1230008|P2|STARTED|Double-Blind Phase||89
502949|NCT00992589|1230009|P1|STARTED|Double-Blind Phase||0
502950|NCT00992589|1230006|P4|NOT COMPLETED|Open-Label Phase||0
502951|NCT00992589|1230007|P3|NOT COMPLETED|Open-Label Phase||0
502952|NCT00992589|1230008|P2|NOT COMPLETED|Open-Label Phase||0
502953|NCT00992589|1230009|P1|NOT COMPLETED|Open-Label Phase||77
502954|NCT00992589|1230006|P4|COMPLETED|Open-Label Phase||0
502955|NCT00992589|1230007|P3|COMPLETED|Open-Label Phase||0
502956|NCT00992589|1230008|P2|COMPLETED|Open-Label Phase||0
502957|NCT00992589|1230009|P1|COMPLETED|Open-Label Phase||267
502958|NCT00992589|1230006|P4|STARTED|Open-Label Phase||0
502959|NCT00992589|1230007|P3|STARTED|Open-Label Phase||0
502960|NCT00992589|1230008|P2|STARTED|Open-Label Phase||0
502961|NCT00992589|1230009|P1|STARTED|Open-Label Phase||344
502962|NCT00992459|1230053|P2|NOT COMPLETED|Overall Study||1
502963|NCT00992459|1230054|P1|NOT COMPLETED|Overall Study||1
502964|NCT00992459|1230053|P2|COMPLETED|Overall Study|Totals enrolled and completed in Arm B HPN 100 treatment + NaPBA Placebo are not mutually exclusive.|23
502965|NCT00992459|1230054|P1|COMPLETED|Overall Study|Totals enrolled and completed in Arm A NaPBA treatment + HPN 100 Placebo are not mutually exclusive.|21
502966|NCT00992459|1230053|P2|STARTED|Overall Study|All patients received NaPBA placebo in Arm B (+ concomitant active HPN 100)|24
502967|NCT00992459|1230054|P1|STARTED|Overall Study|All patients received HPN 100 placebo in Arm A (+ concomitant active NaPBA)|22
502968|NCT00992446|1230078|P1|NOT COMPLETED|Overall Study||8
502969|NCT00992446|1230078|P1|COMPLETED|Overall Study||19
502970|NCT00992446|1230078|P1|STARTED|Overall Study||27
502971|NCT00992433|1230085|P2|NOT COMPLETED|Overall Study||7
502972|NCT00992433|1230086|P1|NOT COMPLETED|Overall Study||4
502973|NCT00992433|1230085|P2|COMPLETED|Overall Study||90
502974|NCT00992433|1230086|P1|COMPLETED|Overall Study||91
502975|NCT00992433|1230085|P2|STARTED|Overall Study||97
502976|NCT00992433|1230086|P1|STARTED|Overall Study||95
502977|NCT00992407|1230150|P2|NOT COMPLETED|Overall Study||24
502978|NCT00992407|1230151|P1|NOT COMPLETED|Overall Study||31
502979|NCT00992407|1230150|P2|COMPLETED|Overall Study||14
502980|NCT00992407|1230151|P1|COMPLETED|Overall Study||6
502981|NCT00992407|1230150|P2|Treated|Overall Study||25
502982|NCT00992407|1230151|P1|Treated|Overall Study||20
502983|NCT00992407|1230150|P2|STARTED|Overall Study||38
502984|NCT00992407|1230151|P1|STARTED|Overall Study||37
502985|NCT00992394|1230201|P2|NOT COMPLETED|Overall Study||14
502986|NCT00992394|1230202|P1|NOT COMPLETED|Overall Study||24
502987|NCT00992394|1230201|P2|COMPLETED|Overall Study||72
502988|NCT00992394|1230202|P1|COMPLETED|Overall Study||64
502989|NCT00992394|1230201|P2|mITT Population|Overall Study||84
502990|NCT00992394|1230202|P1|mITT Population|Overall Study||86
502991|NCT00992394|1230201|P2|Safety Population|Overall Study||84
502992|NCT00992394|1230202|P1|Safety Population|Overall Study||87
502993|NCT00992394|1230201|P2|STARTED|Overall Study||86
502994|NCT00992394|1230202|P1|STARTED|Overall Study||88
502995|NCT00992264|1230260|P16|NOT COMPLETED|Overall Study||0
502996|NCT00992264|1230261|P15|NOT COMPLETED|Overall Study||0
502997|NCT00992264|1230262|P14|NOT COMPLETED|Overall Study||0
502998|NCT00992264|1230263|P13|NOT COMPLETED|Overall Study||0
502999|NCT00992264|1230264|P12|NOT COMPLETED|Overall Study||0
503000|NCT00992264|1230265|P11|NOT COMPLETED|Overall Study||0
503001|NCT00992264|1230266|P10|NOT COMPLETED|Overall Study||0
503002|NCT00992264|1230267|P9|NOT COMPLETED|Overall Study||0
503003|NCT00992264|1230268|P8|NOT COMPLETED|Overall Study||0
503004|NCT00992264|1230269|P7|NOT COMPLETED|Overall Study||0
503005|NCT00992264|1230270|P6|NOT COMPLETED|Overall Study||0
503006|NCT00992264|1230271|P5|NOT COMPLETED|Overall Study||0
503007|NCT00992264|1230272|P4|NOT COMPLETED|Overall Study||0
503008|NCT00992264|1230273|P3|NOT COMPLETED|Overall Study||0
503009|NCT00992264|1230274|P2|NOT COMPLETED|Overall Study||0
503010|NCT00992264|1230275|P1|NOT COMPLETED|Overall Study||0
503011|NCT00992264|1230260|P16|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
503012|NCT00992264|1230261|P15|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
503013|NCT00992264|1230262|P14|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
503014|NCT00992264|1230263|P13|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
503015|NCT00992264|1230264|P12|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
503016|NCT00992264|1230265|P11|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
503017|NCT00992264|1230266|P10|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
503018|NCT00992264|1230267|P9|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
503019|NCT00992264|1230268|P8|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
503020|NCT00992264|1230269|P7|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
503021|NCT00992264|1230270|P6|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
503022|NCT00992264|1230271|P5|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
503023|NCT00992264|1230272|P4|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
503024|NCT00992264|1230273|P3|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
503025|NCT00992264|1230274|P2|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
503026|NCT00992264|1230275|P1|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
503027|NCT00992264|1230260|P16|STARTED|Overall Study||116
503028|NCT00992264|1230261|P15|STARTED|Overall Study||117
503029|NCT00992264|1230262|P14|STARTED|Overall Study||117
503030|NCT00992264|1230263|P13|STARTED|Overall Study||116
503031|NCT00992264|1230264|P12|STARTED|Overall Study||117
503032|NCT00992264|1230265|P11|STARTED|Overall Study||117
503033|NCT00992264|1230266|P10|STARTED|Overall Study||116
503034|NCT00992264|1230267|P9|STARTED|Overall Study||116
503035|NCT00992264|1230268|P8|STARTED|Overall Study||117
503036|NCT00992264|1230269|P7|STARTED|Overall Study||116
503037|NCT00992264|1230270|P6|STARTED|Overall Study||117
503038|NCT00992264|1230271|P5|STARTED|Overall Study||117
503039|NCT00992264|1230272|P4|STARTED|Overall Study||117
503040|NCT00992264|1230273|P3|STARTED|Overall Study||117
503041|NCT00992264|1230274|P2|STARTED|Overall Study||116
503042|NCT00992264|1230275|P1|STARTED|Overall Study||116
503043|NCT00992186|1230289|P1|NOT COMPLETED|Overall Study||46
503044|NCT00992186|1230289|P1|COMPLETED|Overall Study||0
503045|NCT00992186|1230289|P1|STARTED|Overall Study||46
503046|NCT00992108|1230308|P2|NOT COMPLETED|Overall Study||1
503047|NCT00992108|1230309|P1|NOT COMPLETED|Overall Study||0
503048|NCT00992108|1230308|P2|COMPLETED|Overall Study||9
503049|NCT00992108|1230309|P1|COMPLETED|Overall Study||7
503050|NCT00992108|1230308|P2|STARTED|Overall Study||10
503051|NCT00992108|1230309|P1|STARTED|Overall Study||7
503052|NCT00992056|1230323|P2|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0
503053|NCT00992056|1230324|P1|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0
503054|NCT00992056|1230323|P2|COMPLETED|Treatment Period 2 (6 Weeks)||10
503055|NCT00992056|1230324|P1|COMPLETED|Treatment Period 2 (6 Weeks)||10
503056|NCT00992056|1230323|P2|STARTED|Treatment Period 2 (6 Weeks)||10
503057|NCT00992056|1230324|P1|STARTED|Treatment Period 2 (6 Weeks)||10
503058|NCT00992056|1230323|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
503059|NCT00992056|1230324|P1|NOT COMPLETED|Washout Period (2 Weeks)||1
503060|NCT00992056|1230323|P2|COMPLETED|Washout Period (2 Weeks)||10
503061|NCT00992056|1230324|P1|COMPLETED|Washout Period (2 Weeks)||10
503062|NCT00992056|1230323|P2|STARTED|Washout Period (2 Weeks)||10
503063|NCT00992056|1230324|P1|STARTED|Washout Period (2 Weeks)||11
503064|NCT00992056|1230323|P2|NOT COMPLETED|Treatment Period 1 (6 Weeks)||2
503065|NCT00992056|1230324|P1|NOT COMPLETED|Treatment Period 1 (6 Weeks)||1
503066|NCT00992056|1230323|P2|COMPLETED|Treatment Period 1 (6 Weeks)||10
503067|NCT00992056|1230324|P1|COMPLETED|Treatment Period 1 (6 Weeks)|February 2012|11
503068|NCT00992056|1230323|P2|STARTED|Treatment Period 1 (6 Weeks)||12
503069|NCT00992056|1230324|P1|STARTED|Treatment Period 1 (6 Weeks)||12
503070|NCT00992017|1230330|P1|NOT COMPLETED|Overall Study||10
503071|NCT00992017|1230330|P1|COMPLETED|Overall Study||118
503072|NCT00992017|1230330|P1|Received Only One Study Vaccination|Overall Study|Reasons: delivered and LFU; moved; no transportation; ineligible - blood transfusion at delivery|4
503073|NCT00992017|1230330|P1|Received Both Study Vaccinations|Overall Study||124
503074|NCT00992017|1230330|P1|STARTED|Overall Study|Two additional women were enrolled but left the clinic before vaccine was administered.|128
503075|NCT00991952|1230345|P2|NOT COMPLETED|Overall Study||1
503076|NCT00991952|1230346|P1|NOT COMPLETED|Overall Study||0
503077|NCT00991952|1230345|P2|COMPLETED|Overall Study||5
503078|NCT00991952|1230346|P1|COMPLETED|Overall Study||13
503079|NCT00991952|1230345|P2|STARTED|Overall Study||6
503080|NCT00991952|1230346|P1|STARTED|Overall Study||13
503081|NCT00991939|1230354|P2|NOT COMPLETED|Overall Study||2
503082|NCT00991939|1230355|P1|NOT COMPLETED|Overall Study||5
503083|NCT00991939|1230354|P2|COMPLETED|Overall Study||1
503084|NCT00991939|1230355|P1|COMPLETED|Overall Study||0
503085|NCT00991939|1230354|P2|STARTED|Overall Study||3
503086|NCT00991939|1230355|P1|STARTED|Overall Study||5
503087|NCT00991887|1230389|P2|NOT COMPLETED|Overall Study||1
503088|NCT00991887|1230390|P1|NOT COMPLETED|Overall Study||2
503089|NCT00991887|1230389|P2|COMPLETED|Overall Study||21
503090|NCT00991887|1230390|P1|COMPLETED|Overall Study||24
503091|NCT00991887|1230389|P2|STARTED|Overall Study||22
503092|NCT00991887|1230390|P1|STARTED|Overall Study||26
503093|NCT00991809|1230398|P2|NOT COMPLETED|Overall Study||6
503094|NCT00991809|1230399|P1|NOT COMPLETED|Overall Study||4
503095|NCT00991809|1230398|P2|COMPLETED|Overall Study||4
503096|NCT00991809|1230399|P1|COMPLETED|Overall Study||8
503097|NCT00991809|1230398|P2|STARTED|Overall Study||10
503098|NCT00991809|1230399|P1|STARTED|Overall Study||12
503099|NCT00991510|1230409|P2|NOT COMPLETED|Period III (Days 29-112)||1
503100|NCT00991510|1230410|P1|NOT COMPLETED|Period III (Days 29-112)||1
503101|NCT00991510|1230409|P2|COMPLETED|Period III (Days 29-112)||20
503102|NCT00991510|1230410|P1|COMPLETED|Period III (Days 29-112)||20
503103|NCT00991510|1230409|P2|STARTED|Period III (Days 29-112)||21
503104|NCT00991510|1230410|P1|STARTED|Period III (Days 29-112)||21
503105|NCT00991510|1230409|P2|NOT COMPLETED|Period II (Days 15-28)||0
503106|NCT00991510|1230410|P1|NOT COMPLETED|Period II (Days 15-28)||0
503107|NCT00991510|1230409|P2|COMPLETED|Period II (Days 15-28)||21
503108|NCT00991510|1230410|P1|COMPLETED|Period II (Days 15-28)||21
503109|NCT00991510|1230409|P2|STARTED|Period II (Days 15-28)||21
503110|NCT00991510|1230410|P1|STARTED|Period II (Days 15-28)||21
503111|NCT00991510|1230409|P2|NOT COMPLETED|Period I (Days 1-14)||0
503112|NCT00991510|1230410|P1|NOT COMPLETED|Period I (Days 1-14)||1
503113|NCT00991510|1230409|P2|COMPLETED|Period I (Days 1-14)||21
503114|NCT00991510|1230410|P1|COMPLETED|Period I (Days 1-14)||21
503115|NCT00991510|1230409|P2|STARTED|Period I (Days 1-14)||21
503116|NCT00991510|1230410|P1|STARTED|Period I (Days 1-14)||22
503117|NCT00991458|1230435|P3|NOT COMPLETED|Overall Study||25
503118|NCT00991458|1230436|P2|NOT COMPLETED|Overall Study||28
503119|NCT00991458|1230437|P1|NOT COMPLETED|Overall Study||20
503120|NCT00991458|1230435|P3|COMPLETED|Overall Study||180
503121|NCT00991458|1230436|P2|COMPLETED|Overall Study||181
503122|NCT00991458|1230437|P1|COMPLETED|Overall Study||187
503123|NCT00991458|1230435|P3|STARTED|Overall Study||205
503124|NCT00991458|1230436|P2|STARTED|Overall Study||209
503125|NCT00991458|1230437|P1|STARTED|Overall Study||207
503126|NCT00991341|1230456|P2|NOT COMPLETED|Overall Study||179
503127|NCT00991341|1230457|P1|NOT COMPLETED|Overall Study||204
503128|NCT00991341|1230456|P2|COMPLETED|Overall Study||560
503129|NCT00991341|1230457|P1|COMPLETED|Overall Study||538
503130|NCT00991341|1230456|P2|STARTED|Overall Study||739
503131|NCT00991341|1230457|P1|STARTED|Overall Study||742
503132|NCT00991302|1230495|P2|NOT COMPLETED|Overall Study||13
503133|NCT00991302|1230496|P1|NOT COMPLETED|Overall Study||14
503134|NCT00991302|1230495|P2|COMPLETED|Overall Study||73
503135|NCT00991302|1230496|P1|COMPLETED|Overall Study||72
503136|NCT00991302|1230495|P2|STARTED|Overall Study||86
503137|NCT00991302|1230496|P1|STARTED|Overall Study||86
503138|NCT00991289|1230512|P1|NOT COMPLETED|Overall Study||12
503139|NCT00991289|1230512|P1|COMPLETED|Overall Study|Completed study.|55
503140|NCT00991289|1230512|P1|COMPLETED Week 16|Overall Study|Completed 16 weeks of the study (the primary endpoint time point). The study continued to Week 76.|61
503141|NCT00991289|1230512|P1|STARTED|Overall Study|68 participants enrolled, one was found to have been ineligible and was excluded.|67
503142|NCT00991276|1230532|P6|NOT COMPLETED|Third Intervention Period||1
503143|NCT00991276|1230533|P5|NOT COMPLETED|Third Intervention Period||0
503144|NCT00991276|1230534|P4|NOT COMPLETED|Third Intervention Period||1
503145|NCT00991276|1230535|P3|NOT COMPLETED|Third Intervention Period||1
503146|NCT00991276|1230536|P2|NOT COMPLETED|Third Intervention Period||0
503147|NCT00991276|1230537|P1|NOT COMPLETED|Third Intervention Period||1
503148|NCT00991276|1230532|P6|COMPLETED|Third Intervention Period||10
503149|NCT00991276|1230533|P5|COMPLETED|Third Intervention Period||10
503150|NCT00991276|1230534|P4|COMPLETED|Third Intervention Period||8
503151|NCT00991276|1230535|P3|COMPLETED|Third Intervention Period||13
503152|NCT00991276|1230536|P2|COMPLETED|Third Intervention Period||8
503153|NCT00991276|1230537|P1|COMPLETED|Third Intervention Period||13
503154|NCT00991276|1230532|P6|STARTED|Third Intervention Period||11
503155|NCT00991276|1230533|P5|STARTED|Third Intervention Period||10
503156|NCT00991276|1230534|P4|STARTED|Third Intervention Period||9
503157|NCT00991276|1230535|P3|STARTED|Third Intervention Period||14
503158|NCT00991276|1230536|P2|STARTED|Third Intervention Period||8
503159|NCT00991276|1230537|P1|STARTED|Third Intervention Period||14
503160|NCT00991276|1230532|P6|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
503161|NCT00991276|1230533|P5|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
503162|NCT00991276|1230534|P4|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
503163|NCT00991276|1230535|P3|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
503164|NCT00991276|1230536|P2|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
503165|NCT00991276|1230537|P1|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
503166|NCT00991276|1230532|P6|COMPLETED|Placebo Wash-out Period (7 Days)||11
503167|NCT00991276|1230533|P5|COMPLETED|Placebo Wash-out Period (7 Days)||10
503168|NCT00991276|1230534|P4|COMPLETED|Placebo Wash-out Period (7 Days)||9
503169|NCT00991276|1230535|P3|COMPLETED|Placebo Wash-out Period (7 Days)||14
503170|NCT00991276|1230536|P2|COMPLETED|Placebo Wash-out Period (7 Days)||8
503171|NCT00991276|1230537|P1|COMPLETED|Placebo Wash-out Period (7 Days)||14
503172|NCT00991276|1230532|P6|STARTED|Placebo Wash-out Period (7 Days)||11
503173|NCT00991276|1230533|P5|STARTED|Placebo Wash-out Period (7 Days)||10
503174|NCT00991276|1230534|P4|STARTED|Placebo Wash-out Period (7 Days)||9
503175|NCT00991276|1230535|P3|STARTED|Placebo Wash-out Period (7 Days)||14
503176|NCT00991276|1230536|P2|STARTED|Placebo Wash-out Period (7 Days)||8
503177|NCT00991276|1230537|P1|STARTED|Placebo Wash-out Period (7 Days)||14
503178|NCT00991276|1230532|P6|NOT COMPLETED|Second Intervention Period||1
503179|NCT00991276|1230533|P5|NOT COMPLETED|Second Intervention Period||1
503180|NCT00991276|1230534|P4|NOT COMPLETED|Second Intervention Period||2
503181|NCT00991276|1230535|P3|NOT COMPLETED|Second Intervention Period||0
503182|NCT00991276|1230536|P2|NOT COMPLETED|Second Intervention Period||2
503183|NCT00991276|1230537|P1|NOT COMPLETED|Second Intervention Period||1
503184|NCT00991276|1230532|P6|COMPLETED|Second Intervention Period||11
503185|NCT00991276|1230533|P5|COMPLETED|Second Intervention Period||10
503186|NCT00991276|1230534|P4|COMPLETED|Second Intervention Period||9
503187|NCT00991276|1230535|P3|COMPLETED|Second Intervention Period||14
503188|NCT00991276|1230536|P2|COMPLETED|Second Intervention Period||8
503189|NCT00991276|1230537|P1|COMPLETED|Second Intervention Period||14
503190|NCT00991276|1230532|P6|STARTED|Second Intervention Period||12
503191|NCT00991276|1230533|P5|STARTED|Second Intervention Period||11
503192|NCT00991276|1230534|P4|STARTED|Second Intervention Period||11
503193|NCT00991276|1230535|P3|STARTED|Second Intervention Period||14
503194|NCT00991276|1230536|P2|STARTED|Second Intervention Period||10
503195|NCT00991276|1230537|P1|STARTED|Second Intervention Period||15
503196|NCT00991276|1230532|P6|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
503197|NCT00991276|1230533|P5|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
503198|NCT00991276|1230534|P4|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
503199|NCT00991276|1230535|P3|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
503200|NCT00991276|1230536|P2|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
503201|NCT00991276|1230537|P1|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
503202|NCT00991276|1230532|P6|COMPLETED|Placebo Wash-out Period (7 Days)||12
503203|NCT00991276|1230533|P5|COMPLETED|Placebo Wash-out Period (7 Days)||11
503204|NCT00991276|1230534|P4|COMPLETED|Placebo Wash-out Period (7 Days)||11
503205|NCT00991276|1230535|P3|COMPLETED|Placebo Wash-out Period (7 Days)||14
503206|NCT00991276|1230536|P2|COMPLETED|Placebo Wash-out Period (7 Days)||10
503207|NCT00991276|1230537|P1|COMPLETED|Placebo Wash-out Period (7 Days)||15
503208|NCT00991276|1230532|P6|STARTED|Placebo Wash-out Period (7 Days)||12
503209|NCT00991276|1230533|P5|STARTED|Placebo Wash-out Period (7 Days)||11
503210|NCT00991276|1230534|P4|STARTED|Placebo Wash-out Period (7 Days)||11
503211|NCT00991276|1230535|P3|STARTED|Placebo Wash-out Period (7 Days)||14
503212|NCT00991276|1230536|P2|STARTED|Placebo Wash-out Period (7 Days)||10
503213|NCT00991276|1230537|P1|STARTED|Placebo Wash-out Period (7 Days)||15
503214|NCT00991276|1230532|P6|NOT COMPLETED|First Intervention Period||1
503215|NCT00991276|1230533|P5|NOT COMPLETED|First Intervention Period||4
503216|NCT00991276|1230534|P4|NOT COMPLETED|First Intervention Period||4
503217|NCT00991276|1230535|P3|NOT COMPLETED|First Intervention Period||0
503218|NCT00991276|1230536|P2|NOT COMPLETED|First Intervention Period||3
503219|NCT00991276|1230537|P1|NOT COMPLETED|First Intervention Period||0
503220|NCT00991276|1230532|P6|COMPLETED|First Intervention Period||12
503221|NCT00991276|1230533|P5|COMPLETED|First Intervention Period||11
503222|NCT00991276|1230534|P4|COMPLETED|First Intervention Period||11
503223|NCT00991276|1230535|P3|COMPLETED|First Intervention Period||14
503224|NCT00991276|1230536|P2|COMPLETED|First Intervention Period||10
503225|NCT00991276|1230537|P1|COMPLETED|First Intervention Period||15
503226|NCT00991276|1230532|P6|STARTED|First Intervention Period||13
503227|NCT00991276|1230533|P5|STARTED|First Intervention Period||15
503228|NCT00991276|1230534|P4|STARTED|First Intervention Period||15
503229|NCT00991276|1230535|P3|STARTED|First Intervention Period||14
503230|NCT00991276|1230536|P2|STARTED|First Intervention Period||13
503231|NCT00991276|1230537|P1|STARTED|First Intervention Period||15
503232|NCT00991185|1230635|P1|NOT COMPLETED|Overall Study||0
503233|NCT00991185|1230635|P1|COMPLETED|Overall Study||8
503234|NCT00991185|1230635|P1|STARTED|Overall Study||8
503235|NCT00991081|1230641|P3|NOT COMPLETED|Phase II, Randomized Control Trial||4
503236|NCT00991081|1230642|P2|NOT COMPLETED|Phase II, Randomized Control Trial||2
503237|NCT00991081|1230643|P1|NOT COMPLETED|Phase II, Randomized Control Trial||0
503238|NCT00991081|1230641|P3|COMPLETED|Phase II, Randomized Control Trial||15
503239|NCT00991081|1230642|P2|COMPLETED|Phase II, Randomized Control Trial||15
503240|NCT00991081|1230643|P1|COMPLETED|Phase II, Randomized Control Trial||0
503241|NCT00991081|1230641|P3|Received First Clinical Call|Phase II, Randomized Control Trial||17
503242|NCT00991081|1230642|P2|Received First Clinical Call|Phase II, Randomized Control Trial||16
503243|NCT00991081|1230643|P1|Received First Clinical Call|Phase II, Randomized Control Trial||0
503244|NCT00991081|1230641|P3|STARTED|Phase II, Randomized Control Trial|Phase I interview participants were not enrolled in the Phase II RCT.|19
503245|NCT00991081|1230642|P2|STARTED|Phase II, Randomized Control Trial|Phase I interview participants were not enrolled in the Phase II RCT.|17
503246|NCT00991081|1230643|P1|STARTED|Phase II, Randomized Control Trial||0
503247|NCT00991081|1230641|P3|NOT COMPLETED|Phase I, Formative Research||0
503248|NCT00991081|1230642|P2|NOT COMPLETED|Phase I, Formative Research||0
503249|NCT00991081|1230643|P1|NOT COMPLETED|Phase I, Formative Research||0
503250|NCT00991081|1230641|P3|COMPLETED|Phase I, Formative Research||0
503251|NCT00991081|1230642|P2|COMPLETED|Phase I, Formative Research||0
503252|NCT00991081|1230643|P1|COMPLETED|Phase I, Formative Research|The 10 smokers interviewed were not enrolled in the Phase II RCT.|20
503253|NCT00991081|1230641|P3|STARTED|Phase I, Formative Research||0
503254|NCT00991081|1230642|P2|STARTED|Phase I, Formative Research||0
503255|NCT00991081|1230643|P1|STARTED|Phase I, Formative Research||20
503256|NCT00990964|1230675|P1|NOT COMPLETED|Overall Study||212
503257|NCT00990964|1230675|P1|COMPLETED|Overall Study|Total number of subjects with successful Attain Family lead using Attain Family catheter|1802
503258|NCT00990964|1230675|P1|Attain Family Study System Attempt|Overall Study|Total number of subjects with an Attain Family lead attempt after an Attain Family catheter attempt|1917
503259|NCT00990964|1230675|P1|STARTED|Overall Study|Total number of subjects enrolled|2014
503260|NCT00990821|1230694|P14|NOT COMPLETED|Overall Study||1
503261|NCT00990821|1230695|P13|NOT COMPLETED|Overall Study||2
503262|NCT00990821|1230696|P12|NOT COMPLETED|Overall Study||5
503263|NCT00990821|1230697|P11|NOT COMPLETED|Overall Study||3
503264|NCT00990821|1230698|P10|NOT COMPLETED|Overall Study||1
503265|NCT00990821|1230699|P9|NOT COMPLETED|Overall Study||0
503266|NCT00990821|1230700|P8|NOT COMPLETED|Overall Study||0
503267|NCT00990821|1230701|P7|NOT COMPLETED|Overall Study||1
503268|NCT00990821|1230702|P6|NOT COMPLETED|Overall Study||3
503269|NCT00990821|1230703|P5|NOT COMPLETED|Overall Study||3
503270|NCT00990821|1230704|P4|NOT COMPLETED|Overall Study||0
503271|NCT00990821|1230705|P3|NOT COMPLETED|Overall Study||0
503272|NCT00990821|1230706|P2|NOT COMPLETED|Overall Study||2
503273|NCT00990821|1230707|P1|NOT COMPLETED|Overall Study||0
503274|NCT00990821|1230694|P14|COMPLETED|Overall Study||11
503275|NCT00990821|1230695|P13|COMPLETED|Overall Study||10
503276|NCT00990821|1230696|P12|COMPLETED|Overall Study||9
503277|NCT00990821|1230697|P11|COMPLETED|Overall Study||9
503278|NCT00990821|1230698|P10|COMPLETED|Overall Study||13
503279|NCT00990821|1230699|P9|COMPLETED|Overall Study||12
503280|NCT00990821|1230700|P8|COMPLETED|Overall Study||14
503281|NCT00990821|1230701|P7|COMPLETED|Overall Study||11
503282|NCT00990821|1230702|P6|COMPLETED|Overall Study||14
503283|NCT00990821|1230703|P5|COMPLETED|Overall Study||14
503284|NCT00990821|1230704|P4|COMPLETED|Overall Study||8
503285|NCT00990821|1230705|P3|COMPLETED|Overall Study||14
503286|NCT00990821|1230706|P2|COMPLETED|Overall Study||14
503287|NCT00990821|1230707|P1|COMPLETED|Overall Study||14
503288|NCT00990821|1230694|P14|STARTED|Overall Study||12
503289|NCT00990821|1230695|P13|STARTED|Overall Study||12
503290|NCT00990821|1230696|P12|STARTED|Overall Study||14
503291|NCT00990821|1230697|P11|STARTED|Overall Study||12
503292|NCT00990821|1230698|P10|STARTED|Overall Study||14
503293|NCT00990821|1230699|P9|STARTED|Overall Study||12
503294|NCT00990821|1230700|P8|STARTED|Overall Study||14
503295|NCT00990821|1230701|P7|STARTED|Overall Study||12
503296|NCT00990821|1230702|P6|STARTED|Overall Study||17
503297|NCT00990821|1230703|P5|STARTED|Overall Study||17
503298|NCT00990821|1230704|P4|STARTED|Overall Study||8
503299|NCT00990821|1230705|P3|STARTED|Overall Study||14
503300|NCT00990821|1230706|P2|STARTED|Overall Study||16
503301|NCT00990821|1230707|P1|STARTED|Overall Study||14
503302|NCT00990782|1230724|P1|NOT COMPLETED|Overall Study||5
503303|NCT00990782|1230724|P1|COMPLETED|Overall Study||88
503304|NCT00990782|1230724|P1|STARTED|Overall Study||93
503305|NCT00990769|1230731|P2|NOT COMPLETED|Overall Study||0
503306|NCT00990769|1230732|P1|NOT COMPLETED|Overall Study||0
503307|NCT00990769|1230731|P2|COMPLETED|Overall Study||18
503308|NCT00990769|1230732|P1|COMPLETED|Overall Study||22
503309|NCT00990769|1230731|P2|STARTED|Overall Study|Signed consent and assigned to Low-normal BIS|18
503310|NCT00990769|1230732|P1|STARTED|Overall Study|Signed consent and assigned to High-normal BIS|22
503311|NCT00990704|1230744|P2|NOT COMPLETED|Overall Study||2
503312|NCT00990704|1230745|P1|NOT COMPLETED|Overall Study||1
503313|NCT00990704|1230744|P2|COMPLETED|Overall Study||31
503314|NCT00990704|1230745|P1|COMPLETED|Overall Study||13
503315|NCT00990704|1230744|P2|STARTED|Overall Study||33
503316|NCT00990704|1230745|P1|STARTED|Overall Study||14
503317|NCT00990652|1230765|P1|NOT COMPLETED|Post-sugery Bortezomib + Temozolomide||1
503318|NCT00990652|1230765|P1|COMPLETED|Post-sugery Bortezomib + Temozolomide||8
503319|NCT00990652|1230765|P1|STARTED|Post-sugery Bortezomib + Temozolomide||9
503320|NCT00990652|1230765|P1|NOT COMPLETED|Surgical Resection||0
503321|NCT00990652|1230765|P1|COMPLETED|Surgical Resection||9
503322|NCT00990652|1230765|P1|STARTED|Surgical Resection||9
503323|NCT00990652|1230765|P1|NOT COMPLETED|Pre-surgical Bortezomib||1
503324|NCT00990652|1230765|P1|COMPLETED|Pre-surgical Bortezomib||9
503325|NCT00990652|1230765|P1|STARTED|Pre-surgical Bortezomib||10
503326|NCT00990561|1230775|P4|NOT COMPLETED|Period 2||2
503327|NCT00990561|1230776|P3|NOT COMPLETED|Period 2||0
503328|NCT00990561|1230777|P2|NOT COMPLETED|Period 2||0
503329|NCT00990561|1230778|P1|NOT COMPLETED|Period 2||0
503330|NCT00990561|1230775|P4|COMPLETED|Period 2||17
503331|NCT00990561|1230776|P3|COMPLETED|Period 2||20
503332|NCT00990561|1230777|P2|COMPLETED|Period 2||0
503333|NCT00990561|1230778|P1|COMPLETED|Period 2||0
503334|NCT00990561|1230775|P4|STARTED|Period 2||19
503335|NCT00990561|1230776|P3|STARTED|Period 2||20
503336|NCT00990561|1230777|P2|STARTED|Period 2||0
503337|NCT00990561|1230778|P1|STARTED|Period 2||0
503338|NCT00990561|1230775|P4|NOT COMPLETED|Period 1||0
503339|NCT00990561|1230776|P3|NOT COMPLETED|Period 1||0
503340|NCT00990561|1230777|P2|NOT COMPLETED|Period 1||1
503341|NCT00990561|1230778|P1|NOT COMPLETED|Period 1||0
503342|NCT00990561|1230775|P4|COMPLETED|Period 1||0
503343|NCT00990561|1230776|P3|COMPLETED|Period 1||0
503344|NCT00990561|1230777|P2|COMPLETED|Period 1||19
503345|NCT00990561|1230778|P1|COMPLETED|Period 1||20
503346|NCT00990561|1230775|P4|STARTED|Period 1||0
503347|NCT00990561|1230776|P3|STARTED|Period 1||0
503348|NCT00990561|1230777|P2|STARTED|Period 1||20
503349|NCT00990561|1230778|P1|STARTED|Period 1||20
503350|NCT00990509|1230786|P2|NOT COMPLETED|Overall Study||1
503351|NCT00990509|1230787|P1|NOT COMPLETED|Overall Study||0
503352|NCT00990509|1230786|P2|COMPLETED|Overall Study||8
503353|NCT00990509|1230787|P1|COMPLETED|Overall Study||5
503354|NCT00990509|1230786|P2|STARTED|Overall Study||9
503355|NCT00990509|1230787|P1|STARTED|Overall Study||5
503356|NCT00990340|1230799|P2|NOT COMPLETED|Second 14-day Treatment||0
503357|NCT00990340|1230800|P1|NOT COMPLETED|Second 14-day Treatment||0
503358|NCT00990340|1230799|P2|COMPLETED|Second 14-day Treatment||21
503359|NCT00990340|1230800|P1|COMPLETED|Second 14-day Treatment||21
503360|NCT00990340|1230799|P2|STARTED|Second 14-day Treatment||21
503361|NCT00990340|1230800|P1|STARTED|Second 14-day Treatment||21
503362|NCT00990340|1230799|P2|NOT COMPLETED|First 14-day Treatment||4
503363|NCT00990340|1230800|P1|NOT COMPLETED|First 14-day Treatment||6
503364|NCT00990340|1230799|P2|COMPLETED|First 14-day Treatment||21
503365|NCT00990340|1230800|P1|COMPLETED|First 14-day Treatment||21
503366|NCT00990340|1230799|P2|STARTED|First 14-day Treatment||25
503367|NCT00990340|1230800|P1|STARTED|First 14-day Treatment||27
503368|NCT00990288|1230816|P2|NOT COMPLETED|Overall Study||0
503369|NCT00990288|1230817|P1|NOT COMPLETED|Overall Study||0
503370|NCT00990288|1230816|P2|COMPLETED|Overall Study||99
503371|NCT00990288|1230817|P1|COMPLETED|Overall Study||97
503372|NCT00990288|1230816|P2|STARTED|Overall Study||99
503373|NCT00990288|1230817|P1|STARTED|Overall Study||97
503374|NCT00990184|1230847|P1|NOT COMPLETED|Overall Study||1
503375|NCT00990184|1230847|P1|COMPLETED|Overall Study||20
503376|NCT00990184|1230847|P1|STARTED|Overall Study||21
503377|NCT00990106|1230855|P2|NOT COMPLETED|Overall Study||12
503378|NCT00990106|1230856|P1|NOT COMPLETED|Overall Study||9
503379|NCT00990106|1230855|P2|COMPLETED|Overall Study||23
503380|NCT00990106|1230856|P1|COMPLETED|Overall Study||23
503381|NCT00990106|1230855|P2|STARTED|Overall Study||35
503382|NCT00990106|1230856|P1|STARTED|Overall Study||32
503383|NCT00990093|1230866|P2|NOT COMPLETED|Test Period 2 (15-28 Days)||1
503384|NCT00990093|1230867|P1|NOT COMPLETED|Test Period 2 (15-28 Days)||2
503385|NCT00990093|1230866|P2|COMPLETED|Test Period 2 (15-28 Days)||14
503386|NCT00990093|1230867|P1|COMPLETED|Test Period 2 (15-28 Days)||13
503387|NCT00990093|1230866|P2|STARTED|Test Period 2 (15-28 Days)||15
503388|NCT00990093|1230867|P1|STARTED|Test Period 2 (15-28 Days)||15
503389|NCT00990093|1230866|P2|NOT COMPLETED|Test Period 1 (1-14 Days)||2
503390|NCT00990093|1230867|P1|NOT COMPLETED|Test Period 1 (1-14 Days)||4
503391|NCT00990093|1230866|P2|COMPLETED|Test Period 1 (1-14 Days)||15
503392|NCT00990093|1230867|P1|COMPLETED|Test Period 1 (1-14 Days)||15
503393|NCT00990093|1230866|P2|STARTED|Test Period 1 (1-14 Days)||17
503394|NCT00990093|1230867|P1|STARTED|Test Period 1 (1-14 Days)||19
503395|NCT00989989|1230876|P3|NOT COMPLETED|Overall Study||23
503396|NCT00989989|1230877|P2|NOT COMPLETED|Overall Study||10
503397|NCT00989989|1230878|P1|NOT COMPLETED|Overall Study||18
503398|NCT00989989|1230876|P3|COMPLETED|Overall Study||108
503399|NCT00989989|1230877|P2|COMPLETED|Overall Study||123
503400|NCT00989989|1230878|P1|COMPLETED|Overall Study||114
503401|NCT00989989|1230876|P3|STARTED|Overall Study||131
503402|NCT00989989|1230877|P2|STARTED|Overall Study||133
503403|NCT00989989|1230878|P1|STARTED|Overall Study||132
503404|NCT00989950|1230920|P4|NOT COMPLETED|Randomized Phase||0
503405|NCT00989950|1230921|P3|NOT COMPLETED|Randomized Phase||0
503406|NCT00989950|1230922|P2|NOT COMPLETED|Randomized Phase||1
503407|NCT00989950|1230923|P1|NOT COMPLETED|Randomized Phase||1
503408|NCT00989950|1230920|P4|COMPLETED|Randomized Phase||7
503409|NCT00989950|1230921|P3|COMPLETED|Randomized Phase||4
503410|NCT00989950|1230922|P2|COMPLETED|Randomized Phase||8
503411|NCT00989950|1230923|P1|COMPLETED|Randomized Phase||5
503412|NCT00989950|1230920|P4|STARTED|Randomized Phase||7
503413|NCT00989950|1230921|P3|STARTED|Randomized Phase||4
503414|NCT00989950|1230922|P2|STARTED|Randomized Phase||9
503415|NCT00989950|1230923|P1|STARTED|Randomized Phase||6
503416|NCT00989950|1230920|P4|NOT COMPLETED|Open Label Dose Optimization||0
503417|NCT00989950|1230921|P3|NOT COMPLETED|Open Label Dose Optimization||0
503418|NCT00989950|1230922|P2|NOT COMPLETED|Open Label Dose Optimization||0
503419|NCT00989950|1230923|P1|NOT COMPLETED|Open Label Dose Optimization||0
503420|NCT00989950|1230920|P4|COMPLETED|Open Label Dose Optimization||7
503421|NCT00989950|1230921|P3|COMPLETED|Open Label Dose Optimization||4
503422|NCT00989950|1230922|P2|COMPLETED|Open Label Dose Optimization||9
503423|NCT00989950|1230923|P1|COMPLETED|Open Label Dose Optimization||6
503424|NCT00989950|1230920|P4|STARTED|Open Label Dose Optimization||7
503425|NCT00989950|1230921|P3|STARTED|Open Label Dose Optimization||4
503426|NCT00989950|1230922|P2|STARTED|Open Label Dose Optimization||9
503427|NCT00989950|1230923|P1|STARTED|Open Label Dose Optimization||6
503428|NCT00989911|1230933|P1|NOT COMPLETED|Overall Study||3
503429|NCT00989911|1230933|P1|COMPLETED|Overall Study||7
503430|NCT00989911|1230933|P1|STARTED|Overall Study||10
503431|NCT00989833|1230940|P3|NOT COMPLETED|Overall Study||2
503432|NCT00989833|1230941|P2|NOT COMPLETED|Overall Study||3
503433|NCT00989833|1230942|P1|NOT COMPLETED|Overall Study||2
503434|NCT00989833|1230940|P3|COMPLETED|Overall Study||21
503435|NCT00989833|1230941|P2|COMPLETED|Overall Study||19
503436|NCT00989833|1230942|P1|COMPLETED|Overall Study||19
503437|NCT00989833|1230940|P3|STARTED|Overall Study||23
503438|NCT00989833|1230941|P2|STARTED|Overall Study||22
503439|NCT00989833|1230942|P1|STARTED|Overall Study||21
503440|NCT00989781|1230973|P2|NOT COMPLETED|Adrenal Response ot ACTH||3
503441|NCT00989781|1230974|P1|NOT COMPLETED|Adrenal Response ot ACTH||5
503442|NCT00989781|1230973|P2|COMPLETED|Adrenal Response ot ACTH|Of 18 eligible, 15 consented and completed study|15
503443|NCT00989781|1230974|P1|COMPLETED|Adrenal Response ot ACTH|Of 18 eligible, 15 consented. 2 dropped out and 13 completed study|13
503444|NCT00989781|1230973|P2|STARTED|Adrenal Response ot ACTH|15 subjects that completed part 1 elected to participate in Part 2|18
503445|NCT00989781|1230974|P1|STARTED|Adrenal Response ot ACTH|15 subjects that completed part 1 elected to participate in Part 2|18
503446|NCT00989781|1230973|P2|NOT COMPLETED|Ovarian Response to hCG||2
503447|NCT00989781|1230974|P1|NOT COMPLETED|Ovarian Response to hCG||3
503448|NCT00989781|1230973|P2|COMPLETED|Ovarian Response to hCG||18
503449|NCT00989781|1230974|P1|COMPLETED|Ovarian Response to hCG||18
503450|NCT00989781|1230973|P2|STARTED|Ovarian Response to hCG||20
503451|NCT00989781|1230974|P1|STARTED|Ovarian Response to hCG||21
503452|NCT00989768|1230993|P1|NOT COMPLETED|Overall Study||1
503453|NCT00989768|1230993|P1|COMPLETED|Overall Study||28
503454|NCT00989768|1230993|P1|STARTED|Overall Study|All patients received both treatments. They are their own controls|29
503455|NCT00989664|1231004|P1|NOT COMPLETED|Long-Term Follow-Up||3
503456|NCT00989664|1231004|P1|COMPLETED|Long-Term Follow-Up||11
503457|NCT00989664|1231004|P1|STARTED|Long-Term Follow-Up|14 of the 61 participants withdrawing from Study BEX104504 enrolled in the LTFU study.|14
503458|NCT00989664|1231004|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||61
503459|NCT00989664|1231004|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
503460|NCT00989664|1231004|P1|STARTED|Dosimetric and Therapeutic Treatment||61
503461|NCT00989586|1231034|P2|NOT COMPLETED|Overall Study||0
503462|NCT00989586|1231035|P1|NOT COMPLETED|Overall Study||0
503463|NCT00989586|1231034|P2|COMPLETED|Overall Study||17
503464|NCT00989586|1231035|P1|COMPLETED|Overall Study||18
503465|NCT00989586|1231034|P2|STARTED|Overall Study||17
503466|NCT00989586|1231035|P1|STARTED|Overall Study||18
503467|NCT00989287|1231050|P2|NOT COMPLETED|Overall Study||1
503468|NCT00989287|1231051|P1|NOT COMPLETED|Overall Study||1
503469|NCT00989287|1231050|P2|COMPLETED|Overall Study||65
503470|NCT00989287|1231051|P1|COMPLETED|Overall Study||64
503471|NCT00989287|1231050|P2|STARTED|Overall Study||66
503472|NCT00989287|1231051|P1|STARTED|Overall Study||65
503473|NCT00989235|1231153|P2|NOT COMPLETED|Overall Study||6
503474|NCT00989235|1231154|P1|NOT COMPLETED|Overall Study||3
503475|NCT00989235|1231153|P2|COMPLETED|Overall Study||44
503476|NCT00989235|1231154|P1|COMPLETED|Overall Study||55
503477|NCT00989235|1231153|P2|Number Completing Double-Blind Treatment|Overall Study||41
503478|NCT00989235|1231154|P1|Number Completing Double-Blind Treatment|Overall Study||51
503479|NCT00989235|1231153|P2|Number Rescued to Open-Label Treatment|Overall Study|Of these, 1 was discontinued from open-label treatment (lost to follow-up).|4
503480|NCT00989235|1231154|P1|Number Rescued to Open-Label Treatment|Overall Study||4
503481|NCT00989235|1231153|P2|STARTED|Overall Study||50
503482|NCT00989235|1231154|P1|STARTED|Overall Study||58
503483|NCT00989196|1231199|P2|NOT COMPLETED|Treatment Period||0
503484|NCT00989196|1231200|P1|NOT COMPLETED|Treatment Period||1
503485|NCT00989196|1231199|P2|COMPLETED|Treatment Period||12
503486|NCT00989196|1231200|P1|COMPLETED|Treatment Period||9
503487|NCT00989196|1231199|P2|STARTED|Treatment Period||12
503488|NCT00989196|1231200|P1|STARTED|Treatment Period||10
503489|NCT00989196|1231199|P2|NOT COMPLETED|PK Crossover Period||0
503490|NCT00989196|1231200|P1|NOT COMPLETED|PK Crossover Period||0
503491|NCT00989196|1231199|P2|COMPLETED|PK Crossover Period||12
503492|NCT00989196|1231200|P1|COMPLETED|PK Crossover Period||10
503493|NCT00989196|1231199|P2|STARTED|PK Crossover Period||12
503494|NCT00989196|1231200|P1|STARTED|PK Crossover Period||10
503495|NCT00989157|1231221|P2|NOT COMPLETED|Overall Study||0
503496|NCT00989157|1231222|P1|NOT COMPLETED|Overall Study||0
503497|NCT00989157|1231221|P2|COMPLETED|Overall Study||10
503498|NCT00989157|1231222|P1|COMPLETED|Overall Study||10
503499|NCT00989157|1231221|P2|STARTED|Overall Study||10
503500|NCT00989157|1231222|P1|STARTED|Overall Study||10
503501|NCT00989092|1231238|P2|NOT COMPLETED|Overall Study||28
503502|NCT00989092|1231239|P1|NOT COMPLETED|Overall Study||90
503503|NCT00989092|1231238|P2|COMPLETED|Overall Study||31
503504|NCT00989092|1231239|P1|COMPLETED|Overall Study||138
503505|NCT00989092|1231238|P2|Treated With Darbepoetin Alfa|Overall Study||33
503506|NCT00989092|1231239|P1|Treated With Darbepoetin Alfa|Overall Study||226
503507|NCT00989092|1231238|P2|STARTED|Overall Study||59
503508|NCT00989092|1231239|P1|STARTED|Overall Study||228
503509|NCT00989014|1231276|P4|NOT COMPLETED|Overall Study||0
503510|NCT00989014|1231277|P3|NOT COMPLETED|Overall Study||0
503511|NCT00989014|1231278|P2|NOT COMPLETED|Overall Study||0
503512|NCT00989014|1231279|P1|NOT COMPLETED|Overall Study||0
503513|NCT00989014|1231276|P4|COMPLETED|Overall Study||32
503514|NCT00989014|1231277|P3|COMPLETED|Overall Study||28
503515|NCT00989014|1231278|P2|COMPLETED|Overall Study||31
503516|NCT00989014|1231279|P1|COMPLETED|Overall Study||31
503517|NCT00989014|1231276|P4|STARTED|Overall Study||32
503518|NCT00989014|1231277|P3|STARTED|Overall Study||28
503519|NCT00989014|1231278|P2|STARTED|Overall Study||31
503520|NCT00989014|1231279|P1|STARTED|Overall Study||31
503521|NCT00988884|1231291|P2|NOT COMPLETED|Overall Study||36
503522|NCT00988884|1231292|P1|NOT COMPLETED|Overall Study||35
503523|NCT00988884|1231291|P2|COMPLETED|Overall Study||584
503524|NCT00988884|1231292|P1|COMPLETED|Overall Study||586
503525|NCT00988884|1231291|P2|STARTED|Overall Study||620
503526|NCT00988884|1231292|P1|STARTED|Overall Study||621
503527|NCT00988858|1231314|P1|NOT COMPLETED|Overall Study||10
503528|NCT00988858|1231314|P1|COMPLETED|Overall Study||45
503529|NCT00988858|1231314|P1|STARTED|Overall Study||55
503530|NCT00988832|1231326|P1|NOT COMPLETED|Overall Study||0
503531|NCT00988832|1231326|P1|COMPLETED|Overall Study||380
503532|NCT00988832|1231326|P1|STARTED|Overall Study||380
503533|NCT00988637|1231363|P2|NOT COMPLETED|Overall Study||3
503534|NCT00988637|1231364|P1|NOT COMPLETED|Overall Study||3
503535|NCT00988637|1231363|P2|COMPLETED|Overall Study||65
503536|NCT00988637|1231364|P1|COMPLETED|Overall Study||67
503537|NCT00988637|1231363|P2|STARTED|Overall Study||68
503538|NCT00988637|1231364|P1|STARTED|Overall Study||70
503539|NCT00988533|1231394|P1|NOT COMPLETED|Overall Study||3
503540|NCT00988533|1231394|P1|COMPLETED|Overall Study||27
503541|NCT00988533|1231394|P1|STARTED|Overall Study||30
503542|NCT00988442|1231408|P2|NOT COMPLETED|Overall Study||28
503543|NCT00988442|1231409|P1|NOT COMPLETED|Overall Study||30
503544|NCT00988442|1231408|P2|COMPLETED|Overall Study||1
503545|NCT00988442|1231409|P1|COMPLETED|Overall Study||0
503546|NCT00988442|1231408|P2|STARTED|Overall Study||29
503547|NCT00988442|1231409|P1|STARTED|Overall Study||30
503548|NCT00988429|1231472|P3|NOT COMPLETED|Overall Study||69
503549|NCT00988429|1231473|P2|NOT COMPLETED|Overall Study||43
503550|NCT00988429|1231474|P1|NOT COMPLETED|Overall Study||37
503551|NCT00988429|1231472|P3|COMPLETED|Overall Study||142
503552|NCT00988429|1231473|P2|COMPLETED|Overall Study||173
503553|NCT00988429|1231474|P1|COMPLETED|Overall Study||189
503554|NCT00988429|1231472|P3|Intention-to-treat (ITT) Population|Overall Study||205
503555|NCT00988429|1231473|P2|Intention-to-treat (ITT) Population|Overall Study||215
503556|NCT00988429|1231474|P1|Intention-to-treat (ITT) Population|Overall Study||220
503557|NCT00988429|1231472|P3|Safety Population|Overall Study||210
503558|NCT00988429|1231473|P2|Safety Population|Overall Study||216
503559|NCT00988429|1231474|P1|Safety Population|Overall Study||224
503560|NCT00988429|1231472|P3|STARTED|Overall Study||211
503561|NCT00988429|1231473|P2|STARTED|Overall Study||216
503562|NCT00988429|1231474|P1|STARTED|Overall Study||226
503563|NCT00988351|1231487|P2|NOT COMPLETED|Overall Study||12
503564|NCT00988351|1231488|P1|NOT COMPLETED|Overall Study||19
503565|NCT00988351|1231487|P2|COMPLETED|Overall Study||66
503566|NCT00988351|1231488|P1|COMPLETED|Overall Study||59
503567|NCT00988351|1231487|P2|Using CPAP or APAP|Overall Study|3 not using APAP (less than 1/2 hour per night)|66
503568|NCT00988351|1231488|P1|Using CPAP or APAP|Overall Study|5 not using CPAP (use < 1/2 hour per night)|59
503569|NCT00988351|1231487|P2|Clinic Visit|Overall Study|9 lost to follow-up or no show for clinic|69
503570|NCT00988351|1231488|P1|Clinic Visit|Overall Study|6 lost to follow-up or no show for clinic|64
503571|NCT00988351|1231487|P2|PAP Setup|Overall Study|APAP treatment started|78
503572|NCT00988351|1231488|P1|PAP Setup|Overall Study|CPAP treatment started|70
503573|NCT00988351|1231487|P2|CPAP Titration|Overall Study|no titration needed|78
503574|NCT00988351|1231488|P1|CPAP Titration|Overall Study|8 declined CPAP treatment|78
503575|NCT00988351|1231487|P2|STARTED|Overall Study||78
503576|NCT00988351|1231488|P1|STARTED|Overall Study||78
503577|NCT00988325|1231505|P3|NOT COMPLETED|Overall Study||0
503578|NCT00988325|1231506|P2|NOT COMPLETED|Overall Study||0
503579|NCT00988325|1231507|P1|NOT COMPLETED|Overall Study||0
503580|NCT00988325|1231505|P3|COMPLETED|Overall Study||5
503581|NCT00988325|1231506|P2|COMPLETED|Overall Study||20
503582|NCT00988325|1231507|P1|COMPLETED|Overall Study||40
503583|NCT00988325|1231505|P3|STARTED|Overall Study||5
503584|NCT00988325|1231506|P2|STARTED|Overall Study||20
503585|NCT00988325|1231507|P1|STARTED|Overall Study||40
503586|NCT00988247|1231565|P2|NOT COMPLETED|Overall Study||26
503587|NCT00988247|1231566|P1|NOT COMPLETED|Overall Study||83
503588|NCT00988247|1231565|P2|COMPLETED|Overall Study||85
503589|NCT00988247|1231566|P1|COMPLETED|Overall Study||335
503590|NCT00988247|1231565|P2|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|110
503591|NCT00988247|1231566|P1|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|414
503592|NCT00988247|1231565|P2|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|111
503593|NCT00988247|1231566|P1|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|415
503594|NCT00988247|1231565|P2|STARTED|Overall Study||111
503595|NCT00988247|1231566|P1|STARTED|Overall Study||418
503596|NCT00988221|1231585|P4|NOT COMPLETED|Part III||0
503597|NCT00988221|1231586|P3|NOT COMPLETED|Part III||3
503598|NCT00988221|1231587|P2|NOT COMPLETED|Part III||1
503599|NCT00988221|1231588|P1|NOT COMPLETED|Part III||1
503600|NCT00988221|1231585|P4|COMPLETED|Part III||0
503601|NCT00988221|1231586|P3|COMPLETED|Part III||103
503602|NCT00988221|1231587|P2|COMPLETED|Part III||23
503603|NCT00988221|1231588|P1|COMPLETED|Part III||29
503604|NCT00988221|1231585|P4|STARTED|Part III|No patients received placebo in Part III of this study.|0
503605|NCT00988221|1231586|P3|STARTED|Part III||106
503606|NCT00988221|1231587|P2|STARTED|Part III||24
503607|NCT00988221|1231588|P1|STARTED|Part III||30
503608|NCT00988221|1231585|P4|NOT COMPLETED|Part II||3
503609|NCT00988221|1231586|P3|NOT COMPLETED|Part II||3
503610|NCT00988221|1231587|P2|NOT COMPLETED|Part II||0
503611|NCT00988221|1231588|P1|NOT COMPLETED|Part II||1
503612|NCT00988221|1231585|P4|COMPLETED|Part II||81
503613|NCT00988221|1231586|P3|COMPLETED|Part II|One participant who did not complete Part II was available to continue in the study and did.|52
503614|NCT00988221|1231587|P2|COMPLETED|Part II||11
503615|NCT00988221|1231588|P1|COMPLETED|Part II||15
503616|NCT00988221|1231585|P4|STARTED|Part II||84
503617|NCT00988221|1231586|P3|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|55
503618|NCT00988221|1231587|P2|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|11
503619|NCT00988221|1231588|P1|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|16
503620|NCT00988221|1231585|P4|NOT COMPLETED|Part I||0
503621|NCT00988221|1231586|P3|NOT COMPLETED|Part I||8
503622|NCT00988221|1231587|P2|NOT COMPLETED|Part I||10
503623|NCT00988221|1231588|P1|NOT COMPLETED|Part I||4
503624|NCT00988221|1231585|P4|COMPLETED|Part I||0
503625|NCT00988221|1231586|P3|COMPLETED|Part I||111
503626|NCT00988221|1231587|P2|COMPLETED|Part I||24
503627|NCT00988221|1231588|P1|COMPLETED|Part I||31
503628|NCT00988221|1231585|P4|STARTED|Part I|No patients received placebo in Part I of this study.|0
503629|NCT00988221|1231586|P3|STARTED|Part I||119
503630|NCT00988221|1231587|P2|STARTED|Part I||34
503631|NCT00988221|1231588|P1|STARTED|Part I||35
503632|NCT00988208|1231761|P2|NOT COMPLETED|Overall Study||438
503633|NCT00988208|1231762|P1|NOT COMPLETED|Overall Study||431
503634|NCT00988208|1231761|P2|COMPLETED|Overall Study|DPL Completed = kept on treatment with docetaxel/prednisone; Lenalidomide discontinued in DPL arm|95
503635|NCT00988208|1231762|P1|COMPLETED|Overall Study|DP Completed = kept on treatment with docetaxel/prednisone; Placebo was discontinued in DP arm|95
503636|NCT00988208|1231761|P2|Treated|Overall Study||525
503637|NCT00988208|1231762|P1|Treated|Overall Study||521
503638|NCT00988208|1231761|P2|STARTED|Overall Study||533
503639|NCT00988208|1231762|P1|STARTED|Overall Study||526
503640|NCT00988169|1231780|P1|NOT COMPLETED|Overall Study||1
503641|NCT00988169|1231780|P1|COMPLETED|Overall Study||5
503642|NCT00988169|1231780|P1|STARTED|Overall Study||6
503643|NCT00988156|1231786|P2|NOT COMPLETED|Overall Study||20
503644|NCT00988156|1231787|P1|NOT COMPLETED|Overall Study||17
503645|NCT00988156|1231786|P2|COMPLETED|Overall Study||135
503646|NCT00988156|1231787|P1|COMPLETED|Overall Study||132
503647|NCT00988156|1231786|P2|Safety Set|Overall Study||134
503648|NCT00988156|1231787|P1|Safety Set|Overall Study||129
503649|NCT00988156|1231786|P2|Per Protocol Set (PP)|Overall Study||97
503650|NCT00988156|1231787|P1|Per Protocol Set (PP)|Overall Study||101
503651|NCT00988156|1231786|P2|Intention-to-Treat Set (ITT)|Overall Study||134
503652|NCT00988156|1231787|P1|Intention-to-Treat Set (ITT)|Overall Study||129
503653|NCT00988156|1231786|P2|STARTED|Overall Study||155
503654|NCT00988156|1231787|P1|STARTED|Overall Study||149
503655|NCT00988143|1231798|P3|NOT COMPLETED|Overall Study||0
503656|NCT00988143|1231799|P2|NOT COMPLETED|Overall Study||0
503657|NCT00988143|1231800|P1|NOT COMPLETED|Overall Study||0
503658|NCT00988143|1231798|P3|COMPLETED|Overall Study||190
503659|NCT00988143|1231799|P2|COMPLETED|Overall Study||190
503660|NCT00988143|1231800|P1|COMPLETED|Overall Study||220
503661|NCT00988143|1231798|P3|STARTED|Overall Study||190
503662|NCT00988143|1231799|P2|STARTED|Overall Study||190
503663|NCT00988143|1231800|P1|STARTED|Overall Study||220
503664|NCT00988117|1231832|P1|NOT COMPLETED|9.5 mg/24 Hours From Week 4 to 12||2
503665|NCT00988117|1231832|P1|COMPLETED|9.5 mg/24 Hours From Week 4 to 12||12
503666|NCT00988117|1231832|P1|STARTED|9.5 mg/24 Hours From Week 4 to 12||14
503667|NCT00988117|1231832|P1|NOT COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||1
503668|NCT00988117|1231832|P1|COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||14
503669|NCT00988117|1231832|P1|STARTED|4.6 mg/24 Hours From Baseline to Week 4||15
503670|NCT00988091|1231841|P2|NOT COMPLETED|Open-label Period||33
503671|NCT00988091|1231842|P1|NOT COMPLETED|Open-label Period||21
503672|NCT00988091|1231841|P2|COMPLETED|Open-label Period||192
503673|NCT00988091|1231842|P1|COMPLETED|Open-label Period||208
503674|NCT00988091|1231841|P2|STARTED|Open-label Period|Participation in the Open-label period was optional.|225
503675|NCT00988091|1231842|P1|STARTED|Open-label Period|Participation in the Open-label period was optional.|229
503676|NCT00988091|1231841|P2|NOT COMPLETED|Double-blind Period||47
503677|NCT00988091|1231842|P1|NOT COMPLETED|Double-blind Period||43
503678|NCT00988091|1231841|P2|COMPLETED|Double-blind Period||251
503679|NCT00988091|1231842|P1|COMPLETED|Double-blind Period||255
503680|NCT00988091|1231841|P2|Intent to Treat Population|Double-blind Period|ITT population excludes participants from one site which was closed for non-compliance.|295
503681|NCT00988091|1231842|P1|Intent to Treat Population|Double-blind Period|ITT population excludes participants from one site which was closed for non-compliance.|294
503682|NCT00988091|1231841|P2|STARTED|Double-blind Period||298
503683|NCT00988091|1231842|P1|STARTED|Double-blind Period||298
503684|NCT00988065|1231864|P3|NOT COMPLETED|Overall Study||15
503685|NCT00988065|1231865|P2|NOT COMPLETED|Overall Study||23
503686|NCT00988065|1231866|P1|NOT COMPLETED|Overall Study||13
503687|NCT00988065|1231864|P3|COMPLETED|Overall Study||135
503688|NCT00988065|1231865|P2|COMPLETED|Overall Study||127
503689|NCT00988065|1231866|P1|COMPLETED|Overall Study||135
503690|NCT00988065|1231864|P3|Received Third Randomized Dose|Overall Study||135
503691|NCT00988065|1231865|P2|Received Third Randomized Dose|Overall Study||127
503692|NCT00988065|1231866|P1|Received Third Randomized Dose|Overall Study||135
503693|NCT00988065|1231864|P3|Received Second Randomized Dose|Overall Study||145
503694|NCT00988065|1231865|P2|Received Second Randomized Dose|Overall Study||135
503695|NCT00988065|1231866|P1|Received Second Randomized Dose|Overall Study||139
503696|NCT00988065|1231864|P3|Received First Randomized Dose|Overall Study||150
503697|NCT00988065|1231865|P2|Received First Randomized Dose|Overall Study||150
503698|NCT00988065|1231866|P1|Received First Randomized Dose|Overall Study||148
503699|NCT00988065|1231864|P3|STARTED|Overall Study|Randomized to double-blind treatment|150
503700|NCT00988065|1231865|P2|STARTED|Overall Study|Randomized to double-blind treatment|150
503701|NCT00988065|1231866|P1|STARTED|Overall Study|Randomized to double-blind treatment|148
503702|NCT00987948|1231886|P1|NOT COMPLETED|Overall Study||3
503703|NCT00987948|1231886|P1|COMPLETED|Overall Study||12
503704|NCT00987948|1231886|P1|STARTED|Overall Study||15
503705|NCT00987935|1231900|P9|NOT COMPLETED|Overall Study||32
503706|NCT00987935|1231901|P8|NOT COMPLETED|Overall Study||62
503707|NCT00987935|1231902|P7|NOT COMPLETED|Overall Study||15
503708|NCT00987935|1231903|P6|NOT COMPLETED|Overall Study||3
503709|NCT00987935|1231904|P5|NOT COMPLETED|Overall Study||7
503710|NCT00987935|1231905|P4|NOT COMPLETED|Overall Study||3
503711|NCT00987935|1231906|P3|NOT COMPLETED|Overall Study||3
503712|NCT00987935|1231907|P2|NOT COMPLETED|Overall Study||3
503713|NCT00987935|1231908|P1|NOT COMPLETED|Overall Study||4
503714|NCT00987935|1231900|P9|COMPLETED|Overall Study||0
503715|NCT00987935|1231901|P8|COMPLETED|Overall Study|On-treatment at analysis cut-off date (16 July 2014).|1
503716|NCT00987935|1231902|P7|COMPLETED|Overall Study|On-treatment at analysis cut-off date (16 July 2014).|1
503717|NCT00987935|1231903|P6|COMPLETED|Overall Study||0
503718|NCT00987935|1231904|P5|COMPLETED|Overall Study||0
503719|NCT00987935|1231905|P4|COMPLETED|Overall Study||0
503720|NCT00987935|1231906|P3|COMPLETED|Overall Study||0
503721|NCT00987935|1231907|P2|COMPLETED|Overall Study||0
503722|NCT00987935|1231908|P1|COMPLETED|Overall Study||0
503723|NCT00987935|1231900|P9|STARTED|Overall Study||32
503724|NCT00987935|1231901|P8|STARTED|Overall Study||63
503725|NCT00987935|1231902|P7|STARTED|Overall Study||16
503726|NCT00987935|1231903|P6|STARTED|Overall Study||3
503727|NCT00987935|1231904|P5|STARTED|Overall Study||7
503728|NCT00987935|1231905|P4|STARTED|Overall Study||3
503729|NCT00987935|1231906|P3|STARTED|Overall Study||3
503730|NCT00987935|1231907|P2|STARTED|Overall Study||3
503731|NCT00987935|1231908|P1|STARTED|Overall Study||4
503732|NCT00987831|1231964|P3|NOT COMPLETED|Overall Study||0
503733|NCT00987831|1231965|P2|NOT COMPLETED|Overall Study||3
503734|NCT00987831|1231966|P1|NOT COMPLETED|Overall Study||1
503735|NCT00987831|1231964|P3|COMPLETED|Overall Study|Anyone who entered this arm completed it the same day|62
503736|NCT00987831|1231965|P2|COMPLETED|Overall Study|all controls returned for two visits|52
503737|NCT00987831|1231966|P1|COMPLETED|Overall Study|40 patients completed in 6 months. 1 patient did not meet completion definition in 12 months.|40
503738|NCT00987831|1231964|P3|STARTED|Overall Study|Anyone who entered this arm completed it the same day|62
503739|NCT00987831|1231965|P2|STARTED|Overall Study|52 healthy controls donated biomarkers on two occasions in order to verify biomarkers ranges|55
503740|NCT00987831|1231966|P1|STARTED|Overall Study|41 patients improved after depomedrol, if not improved, treated and moved to Group B|41
503741|NCT00987727|1231977|P2|NOT COMPLETED|Overall Study||7
503742|NCT00987727|1231978|P1|NOT COMPLETED|Overall Study||5
503743|NCT00987727|1231977|P2|COMPLETED|Overall Study||34
503744|NCT00987727|1231978|P1|COMPLETED|Overall Study||36
503745|NCT00987727|1231977|P2|STARTED|Overall Study||41
503746|NCT00987727|1231978|P1|STARTED|Overall Study||41
503747|NCT00987623|1231988|P2|NOT COMPLETED|Overall Study||3
503748|NCT00987623|1231989|P1|NOT COMPLETED|Overall Study||5
503749|NCT00987623|1231988|P2|COMPLETED|Overall Study||151
503750|NCT00987623|1231989|P1|COMPLETED|Overall Study||140
503751|NCT00987623|1231988|P2|STARTED|Overall Study||154
503752|NCT00987623|1231989|P1|STARTED|Overall Study||145
503753|NCT00987558|1231995|P2|NOT COMPLETED|Overall Study||5
503754|NCT00987558|1231996|P1|NOT COMPLETED|Overall Study||1
503755|NCT00987558|1231995|P2|COMPLETED|Overall Study||12
503756|NCT00987558|1231996|P1|COMPLETED|Overall Study||12
503757|NCT00987558|1231995|P2|Eslicarbazepine Acetate + Simvastatin|Overall Study||17
503758|NCT00987558|1231996|P1|Eslicarbazepine Acetate + Simvastatin|Overall Study||13
503759|NCT00987558|1231995|P2|Washout|Overall Study||12
503760|NCT00987558|1231996|P1|Washout|Overall Study||13
503761|NCT00987558|1231995|P2|Simvastatin|Overall Study||12
503762|NCT00987558|1231996|P1|Simvastatin|Overall Study||13
503763|NCT00987558|1231995|P2|STARTED|Overall Study||17
503764|NCT00987558|1231996|P1|STARTED|Overall Study||13
503765|NCT00987467|1232009|P1|NOT COMPLETED|Overall Study||2
503766|NCT00987467|1232009|P1|COMPLETED|Overall Study||10
503767|NCT00987467|1232009|P1|STARTED|Overall Study||12
503768|NCT00987415|1232016|P2|NOT COMPLETED|Overall Study||9
503769|NCT00987415|1232017|P1|NOT COMPLETED|Overall Study||9
503770|NCT00987415|1232016|P2|COMPLETED|Overall Study||116
503771|NCT00987415|1232017|P1|COMPLETED|Overall Study||119
503772|NCT00987415|1232016|P2|STARTED|Overall Study||125
503773|NCT00987415|1232017|P1|STARTED|Overall Study||128
503774|NCT00987402|1232033|P2|NOT COMPLETED|Overall Study||98
503775|NCT00987402|1232034|P1|NOT COMPLETED|Overall Study||86
503776|NCT00987402|1232033|P2|COMPLETED|Overall Study|98 patients did not have sufficient data|1537
503777|NCT00987402|1232034|P1|COMPLETED|Overall Study|86 patients did not have some data, and could not be evaluated|1596
503778|NCT00987402|1232033|P2|STARTED|Overall Study|January 2007 with crossover every 2 months|1635
503779|NCT00987402|1232034|P1|STARTED|Overall Study|January 2007, with crossover every 2 months|1682
503780|NCT00987337|1232043|P3|NOT COMPLETED|Overall Study||51
503781|NCT00987337|1232044|P2|NOT COMPLETED|Overall Study||55
503782|NCT00987337|1232045|P1|NOT COMPLETED|Overall Study||57
503783|NCT00987337|1232043|P3|COMPLETED|Overall Study||45
503784|NCT00987337|1232044|P2|COMPLETED|Overall Study||41
503785|NCT00987337|1232045|P1|COMPLETED|Overall Study||39
503786|NCT00987337|1232043|P3|STARTED|Overall Study||96
503787|NCT00987337|1232044|P2|STARTED|Overall Study||96
503788|NCT00987337|1232045|P1|STARTED|Overall Study||96
503789|NCT00986999|1232089|P1|NOT COMPLETED|Overall Study||1
503790|NCT00986999|1232089|P1|COMPLETED|Overall Study||6
503791|NCT00986999|1232089|P1|STARTED|Overall Study||7
503792|NCT00986986|1232100|P2|NOT COMPLETED|Overall Study||1
503793|NCT00986986|1232101|P1|NOT COMPLETED|Overall Study||0
503794|NCT00986986|1232100|P2|COMPLETED|Overall Study||9
503795|NCT00986986|1232101|P1|COMPLETED|Overall Study||10
503796|NCT00986986|1232100|P2|STARTED|Overall Study||10
503797|NCT00986986|1232101|P1|STARTED|Overall Study||10
503798|NCT00986973|1232111|P1|NOT COMPLETED|Overall Study||1
503799|NCT00986973|1232111|P1|COMPLETED|Overall Study|One subject was withdrawn from the study due to poor compliance with KUVAN therapy.|5
503800|NCT00986973|1232111|P1|STARTED|Overall Study||6
503801|NCT00986960|1232123|P2|NOT COMPLETED|Overall Study||0
503802|NCT00986960|1232124|P1|NOT COMPLETED|Overall Study||0
503803|NCT00986960|1232123|P2|COMPLETED|Overall Study||0
503804|NCT00986960|1232124|P1|COMPLETED|Overall Study||0
503805|NCT00986960|1232123|P2|STARTED|Overall Study||0
503806|NCT00986960|1232124|P1|STARTED|Overall Study||0
503807|NCT00986947|1232130|P1|NOT COMPLETED|Overall Study||20
503808|NCT00986947|1232130|P1|COMPLETED|Overall Study||0
503809|NCT00986947|1232130|P1|STARTED|Overall Study||20
503810|NCT00986921|1232137|P2|NOT COMPLETED|Overall Study||0
503811|NCT00986921|1232138|P1|NOT COMPLETED|Overall Study||1
503812|NCT00986921|1232137|P2|COMPLETED|Overall Study||25
503813|NCT00986921|1232138|P1|COMPLETED|Overall Study||24
503814|NCT00986921|1232137|P2|STARTED|Overall Study||25
503815|NCT00986921|1232138|P1|STARTED|Overall Study||25
503816|NCT00986856|1232150|P2|NOT COMPLETED|Overall Study||0
503817|NCT00986856|1232151|P1|NOT COMPLETED|Overall Study||0
503818|NCT00986856|1232150|P2|COMPLETED|Overall Study||16
503819|NCT00986856|1232151|P1|COMPLETED|Overall Study||42
503820|NCT00986856|1232150|P2|STARTED|Overall Study||16
503821|NCT00986856|1232151|P1|STARTED|Overall Study||42
503822|NCT00986674|1232174|P3|NOT COMPLETED|Overall Study||48
503823|NCT00986674|1232175|P2|NOT COMPLETED|Overall Study||45
503824|NCT00986674|1232176|P1|NOT COMPLETED|Overall Study||47
503825|NCT00986674|1232174|P3|COMPLETED|Overall Study||0
503826|NCT00986674|1232175|P2|COMPLETED|Overall Study||0
503827|NCT00986674|1232176|P1|COMPLETED|Overall Study||0
503828|NCT00986674|1232174|P3|Eligible and Treated|Overall Study||47
503829|NCT00986674|1232175|P2|Eligible and Treated|Overall Study||41
503830|NCT00986674|1232176|P1|Eligible and Treated|Overall Study||39
503831|NCT00986674|1232174|P3|Treated|Overall Study||47
503832|NCT00986674|1232175|P2|Treated|Overall Study||42
503833|NCT00986674|1232176|P1|Treated|Overall Study||43
503834|NCT00986674|1232174|P3|STARTED|Overall Study||48
503835|NCT00986674|1232175|P2|STARTED|Overall Study||45
503836|NCT00986674|1232176|P1|STARTED|Overall Study||47
503837|NCT00986583|1232192|P2|NOT COMPLETED|Overall Study||0
503838|NCT00986583|1232193|P1|NOT COMPLETED|Overall Study||0
503839|NCT00986583|1232192|P2|COMPLETED|Overall Study||32
503840|NCT00986583|1232193|P1|COMPLETED|Overall Study||38
503841|NCT00986583|1232192|P2|STARTED|Overall Study||32
503842|NCT00986583|1232193|P1|STARTED|Overall Study||38
503843|NCT00986570|1232209|P1|NOT COMPLETED|Overall Study||7
503844|NCT00986570|1232209|P1|COMPLETED|Overall Study||114
503845|NCT00986570|1232209|P1|STARTED|Overall Study||121
503846|NCT00986544|1232215|P2|NOT COMPLETED|Overall Study||0
503847|NCT00986544|1232216|P1|NOT COMPLETED|Overall Study||0
503848|NCT00986544|1232215|P2|COMPLETED|Overall Study||53
503849|NCT00986544|1232216|P1|COMPLETED|Overall Study||53
503850|NCT00986544|1232215|P2|STARTED|Overall Study||53
503851|NCT00986544|1232216|P1|STARTED|Overall Study||53
503852|NCT00986479|1232226|P2|NOT COMPLETED|Period 2||0
503853|NCT00986479|1232227|P1|NOT COMPLETED|Period 2||0
503854|NCT00986479|1232226|P2|COMPLETED|Period 2||10
503855|NCT00986479|1232227|P1|COMPLETED|Period 2||10
503856|NCT00986479|1232226|P2|STARTED|Period 2||10
503857|NCT00986479|1232227|P1|STARTED|Period 2||10
503858|NCT00986479|1232226|P2|NOT COMPLETED|Period 1||0
503859|NCT00986479|1232227|P1|NOT COMPLETED|Period 1||2
503860|NCT00986479|1232226|P2|COMPLETED|Period 1||10
503861|NCT00986479|1232227|P1|COMPLETED|Period 1||10
503862|NCT00986479|1232226|P2|STARTED|Period 1||10
503863|NCT00986479|1232227|P1|STARTED|Period 1||12
503864|NCT00986453|1232257|P1|NOT COMPLETED|Overall Study||2
503865|NCT00986453|1232257|P1|COMPLETED|Overall Study||43
503866|NCT00986453|1232257|P1|STARTED|Overall Study||45
503867|NCT00986427|1232273|P2|NOT COMPLETED|Overall Study||0
503868|NCT00986427|1232274|P1|NOT COMPLETED|Overall Study||4
503869|NCT00986427|1232273|P2|COMPLETED|Overall Study||12
503870|NCT00986427|1232274|P1|COMPLETED|Overall Study||8
503871|NCT00986427|1232273|P2|STARTED|Overall Study||12
503872|NCT00986427|1232274|P1|STARTED|Overall Study||12
503873|NCT00986401|1232290|P2|NOT COMPLETED|Period 2||0
503874|NCT00986401|1232291|P1|NOT COMPLETED|Period 2||0
503875|NCT00986401|1232290|P2|COMPLETED|Period 2||21
503876|NCT00986401|1232291|P1|COMPLETED|Period 2||22
503877|NCT00986401|1232290|P2|STARTED|Period 2||21
503878|NCT00986401|1232291|P1|STARTED|Period 2||22
503879|NCT00986401|1232290|P2|NOT COMPLETED|Period 1||1
503880|NCT00986401|1232291|P1|NOT COMPLETED|Period 1||0
503881|NCT00986401|1232290|P2|COMPLETED|Period 1||21
503882|NCT00986401|1232291|P1|COMPLETED|Period 1||22
503883|NCT00986401|1232290|P2|STARTED|Period 1||22
503884|NCT00986401|1232291|P1|STARTED|Period 1||22
503885|NCT00986362|1232302|P2|NOT COMPLETED|Overall Study||1
503886|NCT00986362|1232303|P1|NOT COMPLETED|Overall Study||2
503887|NCT00986362|1232302|P2|COMPLETED|Overall Study|7 eyes completed the study (in 7 subjects).|7
503888|NCT00986362|1232303|P1|COMPLETED|Overall Study|14 eyes completed the study (in 14 subjects).|14
503889|NCT00986362|1232302|P2|STARTED|Overall Study|8 eyes randomized and treated (in 8 subjects).|8
503890|NCT00986362|1232303|P1|STARTED|Overall Study|16 eyes randomized and treated (in 15 subjects).|16
503891|NCT00986349|1232309|P1|NOT COMPLETED|Overall Study||7
503892|NCT00986349|1232309|P1|COMPLETED|Overall Study||16
503893|NCT00986349|1232309|P1|Early Explant|Overall Study||4
503894|NCT00986349|1232309|P1|Successful Implant Procedure|Overall Study|successful device implant procedure|20
503895|NCT00986349|1232309|P1|STARTED|Overall Study|attempted implant procedures|23
503896|NCT00986258|1232322|P1|NOT COMPLETED|Maintenance Period||9
503897|NCT00986258|1232322|P1|COMPLETED|Maintenance Period||93
503898|NCT00986258|1232322|P1|STARTED|Maintenance Period||102
503899|NCT00986258|1232322|P1|NOT COMPLETED|Titration and Optimal Dose Period||23
503900|NCT00986258|1232322|P1|COMPLETED|Titration and Optimal Dose Period||102
503901|NCT00986258|1232322|P1|STARTED|Titration and Optimal Dose Period||125
503902|NCT00986258|1232322|P1|NOT COMPLETED|Observation Period||11
503903|NCT00986258|1232322|P1|COMPLETED|Observation Period||125
503904|NCT00986258|1232322|P1|STARTED|Observation Period||136
503905|NCT00986245|1232350|P2|NOT COMPLETED|Second Intervention||1
503906|NCT00986245|1232351|P1|NOT COMPLETED|Second Intervention||2
503907|NCT00986245|1232350|P2|COMPLETED|Second Intervention||32
503908|NCT00986245|1232351|P1|COMPLETED|Second Intervention||29
503909|NCT00986245|1232350|P2|STARTED|Second Intervention||33
503910|NCT00986245|1232351|P1|STARTED|Second Intervention||31
503911|NCT00986245|1232350|P2|NOT COMPLETED|First Intervention||8
503912|NCT00986245|1232351|P1|NOT COMPLETED|First Intervention||10
503913|NCT00986245|1232350|P2|COMPLETED|First Intervention||33
503914|NCT00986245|1232351|P1|COMPLETED|First Intervention||31
503915|NCT00986245|1232350|P2|STARTED|First Intervention||41
503916|NCT00986245|1232351|P1|STARTED|First Intervention||41
503917|NCT00986232|1232388|P4|NOT COMPLETED|Overall Study||20
503918|NCT00986232|1232389|P3|NOT COMPLETED|Overall Study||35
503919|NCT00986232|1232390|P2|NOT COMPLETED|Overall Study||50
503920|NCT00986232|1232391|P1|NOT COMPLETED|Overall Study||51
503921|NCT00986232|1232388|P4|COMPLETED|Overall Study||370
503922|NCT00986232|1232389|P3|COMPLETED|Overall Study||346
503923|NCT00986232|1232390|P2|COMPLETED|Overall Study||343
503924|NCT00986232|1232391|P1|COMPLETED|Overall Study||336
503925|NCT00986232|1232388|P4|Vaccination Visit 2|Overall Study||0
503926|NCT00986232|1232389|P3|Vaccination Visit 2|Overall Study||360
503927|NCT00986232|1232390|P2|Vaccination Visit 2|Overall Study||365
503928|NCT00986232|1232391|P1|Vaccination Visit 2|Overall Study||360
503929|NCT00986232|1232388|P4|Vaccination Visit 1|Overall Study||390
503930|NCT00986232|1232389|P3|Vaccination Visit 1|Overall Study||381
503931|NCT00986232|1232390|P2|Vaccination Visit 1|Overall Study||393
503932|NCT00986232|1232391|P1|Vaccination Visit 1|Overall Study||387
503933|NCT00986232|1232388|P4|STARTED|Overall Study|Excludes 1 patient who was randomized to receive M-M-R™ II + PUVV, but was not vaccinated.|390
503934|NCT00986232|1232389|P3|STARTED|Overall Study||381
503935|NCT00986232|1232390|P2|STARTED|Overall Study|Excludes 1 patient who was randomized to receive ProQuad (Middle Dose), but was not vaccinated.|393
503936|NCT00986232|1232391|P1|STARTED|Overall Study||387
503937|NCT00986180|1232465|P2|NOT COMPLETED|Overall Study||56
503938|NCT00986180|1232466|P1|NOT COMPLETED|Overall Study||44
503939|NCT00986180|1232465|P2|COMPLETED|Overall Study||268
503940|NCT00986180|1232466|P1|COMPLETED|Overall Study||277
503941|NCT00986180|1232465|P2|STARTED|Overall Study||324
503942|NCT00986180|1232466|P1|STARTED|Overall Study||321
503943|NCT00986154|1232544|P2|NOT COMPLETED|Overall Study||194
503944|NCT00986154|1232545|P1|NOT COMPLETED|Overall Study||206
503945|NCT00986154|1232544|P2|COMPLETED|Overall Study||3955
503946|NCT00986154|1232545|P1|COMPLETED|Overall Study||3937
503947|NCT00986154|1232544|P2|Safety Analysis Set (Received Drug)|Overall Study||4122
503948|NCT00986154|1232545|P1|Safety Analysis Set (Received Drug)|Overall Study||4118
503949|NCT00986154|1232544|P2|STARTED|Overall Study||4149
503950|NCT00986154|1232545|P1|STARTED|Overall Study||4143
503951|NCT00986102|1232559|P4|NOT COMPLETED|Overall Study||1
503952|NCT00986102|1232560|P3|NOT COMPLETED|Overall Study||0
503953|NCT00986102|1232561|P2|NOT COMPLETED|Overall Study||2
503954|NCT00986102|1232562|P1|NOT COMPLETED|Overall Study||1
503955|NCT00986102|1232559|P4|COMPLETED|Overall Study||66
503956|NCT00986102|1232560|P3|COMPLETED|Overall Study||19
503957|NCT00986102|1232561|P2|COMPLETED|Overall Study||75
503958|NCT00986102|1232562|P1|COMPLETED|Overall Study||52
503959|NCT00986102|1232559|P4|STARTED|Overall Study|Number of participants who received study medication|67
503960|NCT00986102|1232560|P3|STARTED|Overall Study|Number of participants who received study medication|19
503961|NCT00986102|1232561|P2|STARTED|Overall Study|Number of participants who received study medication|77
503962|NCT00986102|1232562|P1|STARTED|Overall Study|Number of participants who received study medication|53
503963|NCT00985985|1232612|P4|NOT COMPLETED|Overall Study||13
503964|NCT00985985|1232613|P3|NOT COMPLETED|Overall Study||11
503965|NCT00985985|1232614|P2|NOT COMPLETED|Overall Study||24
503966|NCT00985985|1232615|P1|NOT COMPLETED|Overall Study||24
503967|NCT00985985|1232612|P4|COMPLETED|Overall Study||107
503968|NCT00985985|1232613|P3|COMPLETED|Overall Study||109
503969|NCT00985985|1232614|P2|COMPLETED|Overall Study||218
503970|NCT00985985|1232615|P1|COMPLETED|Overall Study||217
503971|NCT00985985|1232612|P4|Full Analysis Set (FAS) Population|Overall Study|One participant withdrew consent and was not included as the FAS population.|119
503972|NCT00985985|1232613|P3|Full Analysis Set (FAS) Population|Overall Study||120
503973|NCT00985985|1232614|P2|Full Analysis Set (FAS) Population|Overall Study||242
503974|NCT00985985|1232615|P1|Full Analysis Set (FAS) Population|Overall Study||241
503975|NCT00985985|1232612|P4|Safety Population|Overall Study||118
503976|NCT00985985|1232613|P3|Safety Population|Overall Study||119
503977|NCT00985985|1232614|P2|Safety Population|Overall Study||242
503978|NCT00985985|1232615|P1|Safety Population|Overall Study||241
503979|NCT00985985|1232612|P4|STARTED|Overall Study||120
503980|NCT00985985|1232613|P3|STARTED|Overall Study||120
503981|NCT00985985|1232614|P2|STARTED|Overall Study||242
503982|NCT00985985|1232615|P1|STARTED|Overall Study||241
503983|NCT00985959|1232656|P3|NOT COMPLETED|Overall Study||59
503984|NCT00985959|1232657|P2|NOT COMPLETED|Overall Study||3
503985|NCT00985959|1232658|P1|NOT COMPLETED|Overall Study||3
503986|NCT00985959|1232656|P3|COMPLETED|Overall Study||28
503987|NCT00985959|1232657|P2|COMPLETED|Overall Study|Completed all 9 cycles|3
503988|NCT00985959|1232658|P1|COMPLETED|Overall Study|Completed all 9 cycles|3
503989|NCT00985959|1232656|P3|STARTED|Overall Study|Number of participants treated|87
503990|NCT00985959|1232657|P2|STARTED|Overall Study|Number of participants treated|6
503991|NCT00985959|1232658|P1|STARTED|Overall Study|Number of participants treated|6
503992|NCT00985946|1232681|P1|NOT COMPLETED|Overall Study||7
503993|NCT00985946|1232681|P1|COMPLETED|Overall Study||8
503994|NCT00985946|1232681|P1|STARTED|Overall Study|Eighty-seven percent (n=13) were evaluable for response.|15
503995|NCT00985829|1232689|P1|NOT COMPLETED|Overall Study||0
503996|NCT00985829|1232689|P1|COMPLETED|Overall Study||28
503997|NCT00985829|1232689|P1|STARTED|Overall Study||28
503998|NCT00985790|1232700|P2|NOT COMPLETED|Overall Study||8
503999|NCT00985790|1232701|P1|NOT COMPLETED|Overall Study||7
504000|NCT00985790|1232700|P2|COMPLETED|Overall Study||293
504001|NCT00985790|1232701|P1|COMPLETED|Overall Study||291
504002|NCT00985790|1232700|P2|STARTED|Overall Study|97 were primed and 204 were unprimed subjects.|301
504003|NCT00985790|1232701|P1|STARTED|Overall Study|95 were primed and 203 were unprimed subjects.|298
504004|NCT00985751|1232742|P5|NOT COMPLETED|Overall Study||1
504005|NCT00985751|1232743|P4|NOT COMPLETED|Overall Study||0
504006|NCT00985751|1232744|P3|NOT COMPLETED|Overall Study||0
504007|NCT00985751|1232745|P2|NOT COMPLETED|Overall Study||0
504008|NCT00985751|1232746|P1|NOT COMPLETED|Overall Study||0
504009|NCT00985751|1232742|P5|COMPLETED|Overall Study||50
504010|NCT00985751|1232743|P4|COMPLETED|Overall Study||51
504011|NCT00985751|1232744|P3|COMPLETED|Overall Study||52
504012|NCT00985751|1232745|P2|COMPLETED|Overall Study||52
504013|NCT00985751|1232746|P1|COMPLETED|Overall Study||51
504014|NCT00985751|1232742|P5|STARTED|Overall Study||51
504015|NCT00985751|1232743|P4|STARTED|Overall Study||51
504016|NCT00985751|1232744|P3|STARTED|Overall Study||52
504017|NCT00985751|1232745|P2|STARTED|Overall Study||52
504018|NCT00985751|1232746|P1|STARTED|Overall Study||51
504019|NCT00985738|1232809|P2|NOT COMPLETED|Overall Study||8
504020|NCT00985738|1232810|P1|NOT COMPLETED|Overall Study||8
504021|NCT00985738|1232809|P2|COMPLETED|Overall Study||0
504022|NCT00985738|1232810|P1|COMPLETED|Overall Study||0
504023|NCT00985738|1232809|P2|STARTED|Overall Study||8
504024|NCT00985738|1232810|P1|STARTED|Overall Study||8
504025|NCT00985725|1232818|P2|NOT COMPLETED|Overall Study||13
504026|NCT00985725|1232819|P1|NOT COMPLETED|Overall Study||11
504027|NCT00985725|1232818|P2|COMPLETED|Overall Study||59
504028|NCT00985725|1232819|P1|COMPLETED|Overall Study||60
504029|NCT00985725|1232818|P2|STARTED|Overall Study||72
504030|NCT00985725|1232819|P1|STARTED|Overall Study||71
504031|NCT00985712|1232855|P2|NOT COMPLETED|Overall Study||7
504032|NCT00985712|1232856|P1|NOT COMPLETED|Overall Study||6
504033|NCT00985712|1232855|P2|COMPLETED|Overall Study||123
504034|NCT00985712|1232856|P1|COMPLETED|Overall Study||127
504035|NCT00985712|1232855|P2|Full Analysis Set (FAS)|Overall Study|Participants completed baseline and had at least 1 post-baseline measurement for efficacy analysis.|129
504036|NCT00985712|1232856|P1|Full Analysis Set (FAS)|Overall Study|Participants completed baseline and had at least 1 post-baseline measurement for efficacy analysis.|128
504037|NCT00985712|1232855|P2|Received at Least One Dose of Study Drug|Overall Study||130
504038|NCT00985712|1232856|P1|Received at Least One Dose of Study Drug|Overall Study||131
504039|NCT00985712|1232855|P2|STARTED|Overall Study||130
504040|NCT00985712|1232856|P1|STARTED|Overall Study||133
504041|NCT00985686|1232874|P4|NOT COMPLETED|Overall Study||2
504042|NCT00985686|1232875|P3|NOT COMPLETED|Overall Study||0
504043|NCT00985686|1232876|P2|NOT COMPLETED|Overall Study||1
504044|NCT00985686|1232877|P1|NOT COMPLETED|Overall Study||1
504045|NCT00985686|1232874|P4|COMPLETED|Overall Study||14
504046|NCT00985686|1232875|P3|COMPLETED|Overall Study||13
504047|NCT00985686|1232876|P2|COMPLETED|Overall Study||15
504048|NCT00985686|1232877|P1|COMPLETED|Overall Study||17
504049|NCT00985686|1232874|P4|Visit 4: Data Collection at 24 Weeks|Overall Study||14
504050|NCT00985686|1232875|P3|Visit 4: Data Collection at 24 Weeks|Overall Study||13
504051|NCT00985686|1232876|P2|Visit 4: Data Collection at 24 Weeks|Overall Study||15
504052|NCT00985686|1232877|P1|Visit 4: Data Collection at 24 Weeks|Overall Study||17
504053|NCT00985686|1232874|P4|Visit 3: Data Collection at 16 Weeks|Overall Study||16
504054|NCT00985686|1232875|P3|Visit 3: Data Collection at 16 Weeks|Overall Study||13
504055|NCT00985686|1232876|P2|Visit 3: Data Collection at 16 Weeks|Overall Study||15
504056|NCT00985686|1232877|P1|Visit 3: Data Collection at 16 Weeks|Overall Study||17
504057|NCT00985686|1232874|P4|Visit 2: Data Collection at 8 Weeks|Overall Study||16
504058|NCT00985686|1232875|P3|Visit 2: Data Collection at 8 Weeks|Overall Study||13
504059|NCT00985686|1232876|P2|Visit 2: Data Collection at 8 Weeks|Overall Study||15
504060|NCT00985686|1232877|P1|Visit 2: Data Collection at 8 Weeks|Overall Study||18
504061|NCT00985686|1232874|P4|Visit 1: Baseline Data Collection|Overall Study||16
504062|NCT00985686|1232875|P3|Visit 1: Baseline Data Collection|Overall Study||13
504063|NCT00985686|1232876|P2|Visit 1: Baseline Data Collection|Overall Study||15
504064|NCT00985686|1232877|P1|Visit 1: Baseline Data Collection|Overall Study||18
504065|NCT00985686|1232874|P4|STARTED|Overall Study||16
504066|NCT00985686|1232875|P3|STARTED|Overall Study||13
504067|NCT00985686|1232876|P2|STARTED|Overall Study||16
504068|NCT00985686|1232877|P1|STARTED|Overall Study||18
504069|NCT00985673|1232891|P6|NOT COMPLETED|Overall Study||6
504070|NCT00985673|1232892|P5|NOT COMPLETED|Overall Study||8
504071|NCT00985673|1232893|P4|NOT COMPLETED|Overall Study||12
504072|NCT00985673|1232894|P3|NOT COMPLETED|Overall Study||12
504073|NCT00985673|1232895|P2|NOT COMPLETED|Overall Study||11
504074|NCT00985673|1232896|P1|NOT COMPLETED|Overall Study||7
504075|NCT00985673|1232891|P6|COMPLETED|Overall Study||96
504076|NCT00985673|1232892|P5|COMPLETED|Overall Study||93
504077|NCT00985673|1232893|P4|COMPLETED|Overall Study||88
504078|NCT00985673|1232894|P3|COMPLETED|Overall Study||90
504079|NCT00985673|1232895|P2|COMPLETED|Overall Study||93
504080|NCT00985673|1232896|P1|COMPLETED|Overall Study||95
504081|NCT00985673|1232891|P6|STARTED|Overall Study||102
504082|NCT00985673|1232892|P5|STARTED|Overall Study||101
504083|NCT00985673|1232893|P4|STARTED|Overall Study||100
504084|NCT00985673|1232894|P3|STARTED|Overall Study||102
504085|NCT00985673|1232895|P2|STARTED|Overall Study||104
504086|NCT00985673|1232896|P1|STARTED|Overall Study||102
504087|NCT00985543|1233147|P1|NOT COMPLETED|Overall Study||0
504088|NCT00985543|1233147|P1|COMPLETED|Overall Study||22
504089|NCT00985543|1233147|P1|STARTED|Overall Study||22
504090|NCT00985504|1233158|P2|NOT COMPLETED|Optimization Period||23
504091|NCT00985504|1233159|P1|NOT COMPLETED|Optimization Period||26
504092|NCT00985504|1233158|P2|COMPLETED|Optimization Period||204
504093|NCT00985504|1233159|P1|COMPLETED|Optimization Period||203
504094|NCT00985504|1233158|P2|STARTED|Optimization Period||227
504095|NCT00985504|1233159|P1|STARTED|Optimization Period||229
504096|NCT00985504|1233158|P2|NOT COMPLETED|Acute Treatment Period||12
504097|NCT00985504|1233159|P1|NOT COMPLETED|Acute Treatment Period||15
504098|NCT00985504|1233158|P2|COMPLETED|Acute Treatment Period||227
504099|NCT00985504|1233159|P1|COMPLETED|Acute Treatment Period||229
504100|NCT00985504|1233158|P2|STARTED|Acute Treatment Period||239
504101|NCT00985504|1233159|P1|STARTED|Acute Treatment Period||244
504102|NCT00985491|1233185|P1|NOT COMPLETED|Overall Study||19
504103|NCT00985491|1233185|P1|COMPLETED|Overall Study|43 subjects received a device, 27 subjects completed 12 month implant period|27
504104|NCT00985491|1233185|P1|Received Device|Overall Study||43
504105|NCT00985491|1233185|P1|STARTED|Overall Study|46 subjects underwent an attempted implantation procedure|46
504106|NCT00985439|1233194|P4|NOT COMPLETED|Overall Study||0
504107|NCT00985439|1233195|P3|NOT COMPLETED|Overall Study||1
504108|NCT00985439|1233196|P2|NOT COMPLETED|Overall Study||0
504109|NCT00985439|1233197|P1|NOT COMPLETED|Overall Study||0
504110|NCT00985439|1233194|P4|COMPLETED|Overall Study||51
504111|NCT00985439|1233195|P3|COMPLETED|Overall Study||50
504112|NCT00985439|1233196|P2|COMPLETED|Overall Study||51
504113|NCT00985439|1233197|P1|COMPLETED|Overall Study||49
504114|NCT00985439|1233194|P4|STARTED|Overall Study||51
504115|NCT00985439|1233195|P3|STARTED|Overall Study||51
504116|NCT00985439|1233196|P2|STARTED|Overall Study||51
504117|NCT00985439|1233197|P1|STARTED|Overall Study||49
504118|NCT00985257|1233207|P1|NOT COMPLETED|Overall Study||0
504119|NCT00985257|1233207|P1|COMPLETED|Overall Study||123
504120|NCT00985257|1233207|P1|STARTED|Overall Study||123
504121|NCT00985231|1233213|P2|NOT COMPLETED|Overall Study||3
504122|NCT00985231|1233214|P1|NOT COMPLETED|Overall Study||3
504123|NCT00985231|1233213|P2|COMPLETED|Overall Study||129
504124|NCT00985231|1233214|P1|COMPLETED|Overall Study||130
504125|NCT00985231|1233213|P2|STARTED|Overall Study||132
504126|NCT00985231|1233214|P1|STARTED|Overall Study||133
504127|NCT00985192|1233222|P1|NOT COMPLETED|Overall Study||4
504128|NCT00985192|1233222|P1|COMPLETED|Overall Study||45
504129|NCT00985192|1233222|P1|STARTED|Overall Study||49
504130|NCT00985166|1233234|P3|NOT COMPLETED|Overall Study||7
504131|NCT00985166|1233235|P2|NOT COMPLETED|Overall Study||4
504132|NCT00985166|1233236|P1|NOT COMPLETED|Overall Study||9
504133|NCT00985166|1233234|P3|COMPLETED|Overall Study||188
504134|NCT00985166|1233235|P2|COMPLETED|Overall Study||201
504135|NCT00985166|1233236|P1|COMPLETED|Overall Study||392
504136|NCT00985166|1233234|P3|Vaccinated at Visit 1|Overall Study||195
504137|NCT00985166|1233235|P2|Vaccinated at Visit 1|Overall Study||205
504138|NCT00985166|1233236|P1|Vaccinated at Visit 1|Overall Study||399
504139|NCT00985166|1233234|P3|STARTED|Overall Study||195
504140|NCT00985166|1233235|P2|STARTED|Overall Study||205
504141|NCT00985166|1233236|P1|STARTED|Overall Study|Two randomized subjects withdrew consent before vaccination: no demographic information available.|401
504142|NCT00985153|1233256|P4|NOT COMPLETED|Overall Study||47
504143|NCT00985153|1233257|P3|NOT COMPLETED|Overall Study||44
504144|NCT00985153|1233258|P2|NOT COMPLETED|Overall Study||44
504145|NCT00985153|1233259|P1|NOT COMPLETED|Overall Study||35
504146|NCT00985153|1233256|P4|COMPLETED|Overall Study||965
504147|NCT00985153|1233257|P3|COMPLETED|Overall Study||918
504148|NCT00985153|1233258|P2|COMPLETED|Overall Study||924
504149|NCT00985153|1233259|P1|COMPLETED|Overall Study||950
504150|NCT00985153|1233256|P4|Vaccinated at Visit 1|Overall Study||1012
504151|NCT00985153|1233257|P3|Vaccinated at Visit 1|Overall Study||962
504152|NCT00985153|1233258|P2|Vaccinated at Visit 1|Overall Study||968
504153|NCT00985153|1233259|P1|Vaccinated at Visit 1|Overall Study||985
504154|NCT00985153|1233256|P4|STARTED|Overall Study||1012
504155|NCT00985153|1233257|P3|STARTED|Overall Study||962
504156|NCT00985153|1233258|P2|STARTED|Overall Study||968
504157|NCT00985153|1233259|P1|STARTED|Overall Study||985
504158|NCT00985140|1233301|P1|NOT COMPLETED|Overall Study||0
504159|NCT00985140|1233301|P1|COMPLETED|Overall Study||15
504160|NCT00985140|1233301|P1|STARTED|Overall Study||15
504161|NCT00985114|1233307|P2|NOT COMPLETED|Overall Study||2
504162|NCT00985114|1233308|P1|NOT COMPLETED|Overall Study||1
504163|NCT00985114|1233307|P2|COMPLETED|Overall Study||37
504164|NCT00985114|1233308|P1|COMPLETED|Overall Study||33
504165|NCT00985114|1233307|P2|Diet + Lifestyle Counseling Cross-over|Overall Study|Received device for intended period of 12 months with 6 months follow up|28
504166|NCT00985114|1233308|P1|Diet + Lifestyle Counseling Cross-over|Overall Study||0
504167|NCT00985114|1233307|P2|STARTED|Overall Study||39
504168|NCT00985114|1233308|P1|STARTED|Overall Study|38 randomized, 34 received the device|34
504169|NCT00985088|1233322|P8|NOT COMPLETED|Overall Study||6
504170|NCT00985088|1233323|P7|NOT COMPLETED|Overall Study||4
504171|NCT00985088|1233324|P6|NOT COMPLETED|Overall Study||7
504172|NCT00985088|1233325|P5|NOT COMPLETED|Overall Study||9
504173|NCT00985088|1233326|P4|NOT COMPLETED|Overall Study||7
504174|NCT00985088|1233327|P3|NOT COMPLETED|Overall Study||4
504175|NCT00985088|1233328|P2|NOT COMPLETED|Overall Study||2
504176|NCT00985088|1233329|P1|NOT COMPLETED|Overall Study||11
504177|NCT00985088|1233322|P8|COMPLETED|Overall Study||216
504178|NCT00985088|1233323|P7|COMPLETED|Overall Study||107
504179|NCT00985088|1233324|P6|COMPLETED|Overall Study||108
504180|NCT00985088|1233325|P5|COMPLETED|Overall Study||214
504181|NCT00985088|1233326|P4|COMPLETED|Overall Study||214
504182|NCT00985088|1233327|P3|COMPLETED|Overall Study||108
504183|NCT00985088|1233328|P2|COMPLETED|Overall Study||112
504184|NCT00985088|1233329|P1|COMPLETED|Overall Study||211
504185|NCT00985088|1233322|P8|STARTED|Overall Study||222
504186|NCT00985088|1233323|P7|STARTED|Overall Study||111
504187|NCT00985088|1233324|P6|STARTED|Overall Study||115
504188|NCT00985088|1233325|P5|STARTED|Overall Study||223
504189|NCT00985088|1233326|P4|STARTED|Overall Study||221
504190|NCT00985088|1233327|P3|STARTED|Overall Study||112
504191|NCT00985088|1233328|P2|STARTED|Overall Study||114
504192|NCT00985088|1233329|P1|STARTED|Overall Study||222
504193|NCT00985010|1233587|P2|NOT COMPLETED|Overall Study||0
504194|NCT00985010|1233588|P1|NOT COMPLETED|Overall Study||0
504195|NCT00985010|1233587|P2|COMPLETED|Overall Study||5
504196|NCT00985010|1233588|P1|COMPLETED|Overall Study||4
504197|NCT00985010|1233587|P2|STARTED|Overall Study||5
504198|NCT00985010|1233588|P1|STARTED|Overall Study||4
504199|NCT00984867|1233598|P2|NOT COMPLETED|Overall Study||17
504200|NCT00984867|1233599|P1|NOT COMPLETED|Overall Study||23
504201|NCT00984867|1233598|P2|COMPLETED|Overall Study||208
504202|NCT00984867|1233599|P1|COMPLETED|Overall Study||203
504203|NCT00984867|1233598|P2|STARTED|Overall Study|Of the 225 randomized and treated participants only 223 were included in the full analysis set.|225
504204|NCT00984867|1233599|P1|STARTED|Overall Study|Of the 226 randomized and treated participants only 224 were included in the full analysis set.|226
504205|NCT00984815|1233617|P1|NOT COMPLETED|Overall Study||30
504206|NCT00984815|1233617|P1|COMPLETED|Overall Study||56
504207|NCT00984815|1233617|P1|STARTED|Overall Study||86
504208|NCT00984698|1233626|P2|NOT COMPLETED|Overall Study||8
504209|NCT00984698|1233627|P1|NOT COMPLETED|Overall Study||3
504210|NCT00984698|1233626|P2|COMPLETED|Overall Study||14
504211|NCT00984698|1233627|P1|COMPLETED|Overall Study||18
504212|NCT00984698|1233626|P2|STARTED|Overall Study||22
504213|NCT00984698|1233627|P1|STARTED|Overall Study||21
504214|NCT00984659|1233639|P4|NOT COMPLETED|6-week Double-blind Treatment Period||13
504215|NCT00984659|1233640|P3|NOT COMPLETED|6-week Double-blind Treatment Period||11
504216|NCT00984659|1233641|P2|NOT COMPLETED|6-week Double-blind Treatment Period||6
504217|NCT00984659|1233642|P1|NOT COMPLETED|6-week Double-blind Treatment Period||0
504218|NCT00984659|1233639|P4|COMPLETED|6-week Double-blind Treatment Period||126
504219|NCT00984659|1233640|P3|COMPLETED|6-week Double-blind Treatment Period||141
504220|NCT00984659|1233641|P2|COMPLETED|6-week Double-blind Treatment Period||69
504221|NCT00984659|1233642|P1|COMPLETED|6-week Double-blind Treatment Period||0
504222|NCT00984659|1233639|P4|STARTED|6-week Double-blind Treatment Period||139
504223|NCT00984659|1233640|P3|STARTED|6-week Double-blind Treatment Period||152
504224|NCT00984659|1233641|P2|STARTED|6-week Double-blind Treatment Period||75
504225|NCT00984659|1233642|P1|STARTED|6-week Double-blind Treatment Period||0
504226|NCT00984659|1233639|P4|NOT COMPLETED|2-week Run-in Period||0
504227|NCT00984659|1233640|P3|NOT COMPLETED|2-week Run-in Period||0
504228|NCT00984659|1233641|P2|NOT COMPLETED|2-week Run-in Period||0
504229|NCT00984659|1233642|P1|NOT COMPLETED|2-week Run-in Period||52
504230|NCT00984659|1233639|P4|COMPLETED|2-week Run-in Period||0
504231|NCT00984659|1233640|P3|COMPLETED|2-week Run-in Period||0
504232|NCT00984659|1233641|P2|COMPLETED|2-week Run-in Period||0
504233|NCT00984659|1233642|P1|COMPLETED|2-week Run-in Period||366
504234|NCT00984659|1233639|P4|STARTED|2-week Run-in Period||0
504235|NCT00984659|1233640|P3|STARTED|2-week Run-in Period||0
504236|NCT00984659|1233641|P2|STARTED|2-week Run-in Period||0
504237|NCT00984659|1233642|P1|STARTED|2-week Run-in Period||418
504238|NCT00984620|1233669|P2|NOT COMPLETED|Overall Study||12
504239|NCT00984620|1233670|P1|NOT COMPLETED|Overall Study||6
504240|NCT00984620|1233669|P2|COMPLETED|Overall Study||67
504241|NCT00984620|1233670|P1|COMPLETED|Overall Study||75
504242|NCT00984620|1233669|P2|STARTED|Overall Study||79
504243|NCT00984620|1233670|P1|STARTED|Overall Study||81
504244|NCT00984594|1233708|P2|NOT COMPLETED|Overall Study||1
504245|NCT00984594|1233709|P1|NOT COMPLETED|Overall Study||1
504246|NCT00984594|1233708|P2|COMPLETED|Overall Study||1
504247|NCT00984594|1233709|P1|COMPLETED|Overall Study||1
504248|NCT00984594|1233708|P2|STARTED|Overall Study|One patient withdrew consent and left the study before treatment.|2
504249|NCT00984594|1233709|P1|STARTED|Overall Study||2
504250|NCT00984568|1233725|P2|NOT COMPLETED|Overall Study||6
504251|NCT00984568|1233726|P1|NOT COMPLETED|Overall Study||8
504252|NCT00984568|1233725|P2|COMPLETED|Overall Study||7
504253|NCT00984568|1233726|P1|COMPLETED|Overall Study||7
504254|NCT00984568|1233725|P2|STARTED|Overall Study||13
504255|NCT00984568|1233726|P1|STARTED|Overall Study||15
504256|NCT00984542|1233734|P1|NOT COMPLETED|Overall Study||41
504257|NCT00984542|1233734|P1|COMPLETED|Overall Study||9
504258|NCT00984542|1233734|P1|STARTED|Overall Study||50
504259|NCT00984490|1233742|P1|NOT COMPLETED|Overall Study||0
504260|NCT00984490|1233742|P1|COMPLETED|Overall Study||5
504261|NCT00984490|1233742|P1|STARTED|Overall Study||5
504262|NCT00984334|1233752|P5|NOT COMPLETED|Overall Study||1
504263|NCT00984334|1233753|P4|NOT COMPLETED|Overall Study||1
504264|NCT00984334|1233754|P3|NOT COMPLETED|Overall Study||0
504265|NCT00984334|1233755|P2|NOT COMPLETED|Overall Study||1
504266|NCT00984334|1233756|P1|NOT COMPLETED|Overall Study||1
504267|NCT00984334|1233752|P5|COMPLETED|Overall Study||7
504268|NCT00984334|1233753|P4|COMPLETED|Overall Study||7
504269|NCT00984334|1233754|P3|COMPLETED|Overall Study||8
504270|NCT00984334|1233755|P2|COMPLETED|Overall Study||7
504271|NCT00984334|1233756|P1|COMPLETED|Overall Study||7
504272|NCT00984334|1233752|P5|STARTED|Overall Study||8
504273|NCT00984334|1233753|P4|STARTED|Overall Study||8
504274|NCT00984334|1233754|P3|STARTED|Overall Study||8
504275|NCT00984334|1233755|P2|STARTED|Overall Study||8
504276|NCT00984334|1233756|P1|STARTED|Overall Study||8
504277|NCT00984308|1233770|P2|NOT COMPLETED|Overall Study||6
504278|NCT00984308|1233771|P1|NOT COMPLETED|Overall Study||18
504279|NCT00984308|1233770|P2|COMPLETED|Overall Study||109
504280|NCT00984308|1233771|P1|COMPLETED|Overall Study||92
504281|NCT00984308|1233770|P2|STARTED|Overall Study||115
504282|NCT00984308|1233771|P1|STARTED|Overall Study||110
504283|NCT00984295|1233784|P3|NOT COMPLETED|Overall Study||37
504284|NCT00984295|1233785|P2|NOT COMPLETED|Overall Study||32
504285|NCT00984295|1233786|P1|NOT COMPLETED|Overall Study||65
504286|NCT00984295|1233784|P3|COMPLETED|Overall Study||442
504287|NCT00984295|1233785|P2|COMPLETED|Overall Study||453
504288|NCT00984295|1233786|P1|COMPLETED|Overall Study||884
504289|NCT00984295|1233784|P3|Visit 2|Overall Study||453
504290|NCT00984295|1233785|P2|Visit 2|Overall Study||468
504291|NCT00984295|1233786|P1|Visit 2|Overall Study||909
504292|NCT00984295|1233784|P3|Visit 1|Overall Study||479
504293|NCT00984295|1233785|P2|Visit 1|Overall Study||485
504294|NCT00984295|1233786|P1|Visit 1|Overall Study||949
504295|NCT00984295|1233784|P3|STARTED|Overall Study||479
504296|NCT00984295|1233785|P2|STARTED|Overall Study||485
504297|NCT00984295|1233786|P1|STARTED|Overall Study|2 patients were incorrectly vaccinated and are excluded from this table.|949
504298|NCT00984282|1233853|P2|NOT COMPLETED|Long Term Follow-up||117
504299|NCT00984282|1233854|P1|NOT COMPLETED|Long Term Follow-up||114
504300|NCT00984282|1233853|P2|COMPLETED|Long Term Follow-up||0
504301|NCT00984282|1233854|P1|COMPLETED|Long Term Follow-up||0
504302|NCT00984282|1233853|P2|STARTED|Long Term Follow-up|Participants entered long-term follow-up if terminated double-blind or open-label periods|117
504303|NCT00984282|1233854|P1|STARTED|Long Term Follow-up|Participants entered long-term follow-up if terminated double-blind or open-label periods|114
504304|NCT00984282|1233853|P2|NOT COMPLETED|Open-label Treatment||161
504305|NCT00984282|1233854|P1|NOT COMPLETED|Open-label Treatment||86
504306|NCT00984282|1233853|P2|COMPLETED|Open-label Treatment||0
504307|NCT00984282|1233854|P1|COMPLETED|Open-label Treatment||0
504308|NCT00984282|1233853|P2|Received Treatment|Open-label Treatment|Subjects at Risk/Safety Population - in RG4 (RG= Reporting Group for Safety Data)|161
504309|NCT00984282|1233854|P1|Received Treatment|Open-label Treatment|Subjects at Risk/Safety Population - in RG3 (RG= Reporting Group for Safety Data)|86
504310|NCT00984282|1233853|P2|STARTED|Open-label Treatment||161
504311|NCT00984282|1233854|P1|STARTED|Open-label Treatment||86
504312|NCT00984282|1233853|P2|NOT COMPLETED|Double Blind Treatment||38
504313|NCT00984282|1233854|P1|NOT COMPLETED|Double Blind Treatment||104
504314|NCT00984282|1233853|P2|COMPLETED|Double Blind Treatment||172
504315|NCT00984282|1233854|P1|COMPLETED|Double Blind Treatment||103
504316|NCT00984282|1233853|P2|Received Treatment|Double Blind Treatment|Subjects at Risk/Safety Population - in RG2 (RG= Reporting Group for Safety Data)|209
504317|NCT00984282|1233854|P1|Received Treatment|Double Blind Treatment|Subjects at Risk/Safety Population - in RG1 (RG= Reporting Group for Safety Data)|207
504318|NCT00984282|1233853|P2|STARTED|Double Blind Treatment||210
504319|NCT00984282|1233854|P1|STARTED|Double Blind Treatment||207
504320|NCT00984256|1233877|P2|NOT COMPLETED|Overall Study||1
504321|NCT00984256|1233878|P1|NOT COMPLETED|Overall Study||0
504322|NCT00984256|1233877|P2|COMPLETED|Overall Study||29
504323|NCT00984256|1233878|P1|COMPLETED|Overall Study||6
504324|NCT00984256|1233877|P2|STARTED|Overall Study||30
504325|NCT00984256|1233878|P1|STARTED|Overall Study||6
504326|NCT00984204|1233898|P1|NOT COMPLETED|Overall Study||15
504327|NCT00984204|1233898|P1|COMPLETED|Overall Study|"Seven subjects of the ten Lack of efficacy were acute failures that had no block after 30 min"|173
504328|NCT00984204|1233898|P1|STARTED|Overall Study||188
504329|NCT00984165|1233908|P4|NOT COMPLETED|Overall Study||4
504330|NCT00984165|1233909|P3|NOT COMPLETED|Overall Study||0
504331|NCT00984165|1233910|P2|NOT COMPLETED|Overall Study||1
504332|NCT00984165|1233911|P1|NOT COMPLETED|Overall Study||7
504333|NCT00984165|1233908|P4|COMPLETED|Overall Study||0
504334|NCT00984165|1233909|P3|COMPLETED|Overall Study||4
504335|NCT00984165|1233910|P2|COMPLETED|Overall Study||0
504336|NCT00984165|1233911|P1|COMPLETED|Overall Study||2
504337|NCT00984165|1233908|P4|STARTED|Overall Study||4
504338|NCT00984165|1233909|P3|STARTED|Overall Study||4
504339|NCT00984165|1233910|P2|STARTED|Overall Study||1
504340|NCT00984165|1233911|P1|STARTED|Overall Study||9
504341|NCT00984139|1233924|P1|NOT COMPLETED|Overall Study||0
504342|NCT00984139|1233924|P1|COMPLETED|Overall Study||306
504343|NCT00984139|1233924|P1|STARTED|Overall Study||306
504344|NCT00984126|1233940|P4|NOT COMPLETED|Overall Study||59
504345|NCT00984126|1233941|P3|NOT COMPLETED|Overall Study||7
504346|NCT00984126|1233942|P2|NOT COMPLETED|Overall Study||8
504347|NCT00984126|1233943|P1|NOT COMPLETED|Overall Study||7
504348|NCT00984126|1233940|P4|COMPLETED|Overall Study||76
504349|NCT00984126|1233941|P3|COMPLETED|Overall Study||16
504350|NCT00984126|1233942|P2|COMPLETED|Overall Study||20
504351|NCT00984126|1233943|P1|COMPLETED|Overall Study||20
504352|NCT00984126|1233940|P4|STARTED|Overall Study||135
504353|NCT00984126|1233941|P3|STARTED|Overall Study||23
504354|NCT00984126|1233942|P2|STARTED|Overall Study||28
504355|NCT00984126|1233943|P1|STARTED|Overall Study||27
504356|NCT00984061|1233968|P1|NOT COMPLETED|Colchicine With Clarithromycin||0
504357|NCT00984061|1233968|P1|COMPLETED|Colchicine With Clarithromycin||23
504358|NCT00984061|1233968|P1|STARTED|Colchicine With Clarithromycin||23
504359|NCT00984061|1233968|P1|NOT COMPLETED|Clarithromycin Alone||1
504360|NCT00984061|1233968|P1|COMPLETED|Clarithromycin Alone|One subject was dropped due to noncompliance with outpatient clarithromycin regimen.|23
504361|NCT00984061|1233968|P1|STARTED|Clarithromycin Alone||24
504362|NCT00984061|1233968|P1|NOT COMPLETED|21 Day Washout Period||0
504363|NCT00984061|1233968|P1|COMPLETED|21 Day Washout Period||24
504364|NCT00984061|1233968|P1|STARTED|21 Day Washout Period||24
504365|NCT00984061|1233968|P1|NOT COMPLETED|Colchicine Alone||0
504366|NCT00984061|1233968|P1|COMPLETED|Colchicine Alone||24
504367|NCT00984061|1233968|P1|STARTED|Colchicine Alone||24
504368|NCT00984022|1233981|P2|NOT COMPLETED|Overall Study||14
504369|NCT00984022|1233982|P1|NOT COMPLETED|Overall Study||10
504370|NCT00984022|1233981|P2|COMPLETED|Overall Study||35
504371|NCT00984022|1233982|P1|COMPLETED|Overall Study||33
504372|NCT00984022|1233981|P2|STARTED|Overall Study||49
504373|NCT00984022|1233982|P1|STARTED|Overall Study||43
504374|NCT00984009|1233992|P1|NOT COMPLETED|Colchicine With Grapefruit Juice||0
504375|NCT00984009|1233992|P1|COMPLETED|Colchicine With Grapefruit Juice||21
504376|NCT00984009|1233992|P1|STARTED|Colchicine With Grapefruit Juice||21
504377|NCT00984009|1233992|P1|NOT COMPLETED|Grapefruit Juice Alone||1
504378|NCT00984009|1233992|P1|COMPLETED|Grapefruit Juice Alone|one subject dropped due to missed a.m. serving of grapefruit juice on Day 16|21
504379|NCT00984009|1233992|P1|STARTED|Grapefruit Juice Alone||22
504380|NCT00984009|1233992|P1|NOT COMPLETED|14 Day Washout Period||0
504381|NCT00984009|1233992|P1|COMPLETED|14 Day Washout Period||22
504382|NCT00984009|1233992|P1|STARTED|14 Day Washout Period||22
504383|NCT00984009|1233992|P1|NOT COMPLETED|Colchicine Alone||0
504384|NCT00984009|1233992|P1|COMPLETED|Colchicine Alone||22
504385|NCT00984009|1233992|P1|STARTED|Colchicine Alone||22
504386|NCT00983983|1234006|P3|NOT COMPLETED|Overall Study||1
504387|NCT00983983|1234007|P2|NOT COMPLETED|Overall Study||1
504388|NCT00983983|1234008|P1|NOT COMPLETED|Overall Study||2
504389|NCT00983983|1234006|P3|COMPLETED|Overall Study||6
504390|NCT00983983|1234007|P2|COMPLETED|Overall Study||8
504391|NCT00983983|1234008|P1|COMPLETED|Overall Study||6
504392|NCT00983983|1234006|P3|STARTED|Overall Study||7
504393|NCT00983983|1234007|P2|STARTED|Overall Study||9
504394|NCT00983983|1234008|P1|STARTED|Overall Study||8
504395|NCT00983957|1234025|P1|NOT COMPLETED|Overall Study||2
504396|NCT00983957|1234025|P1|COMPLETED|Overall Study||18
504397|NCT00983957|1234025|P1|Treatment C|Overall Study||18
504398|NCT00983957|1234025|P1|Treatment B|Overall Study||20
504399|NCT00983957|1234025|P1|Treatment A|Overall Study||20
504400|NCT00983957|1234025|P1|STARTED|Overall Study||20
504401|NCT00983931|1234059|P1|NOT COMPLETED|Colchicine With Cyclosporine||0
504402|NCT00983931|1234059|P1|COMPLETED|Colchicine With Cyclosporine||23
504403|NCT00983931|1234059|P1|STARTED|Colchicine With Cyclosporine||23
504404|NCT00983931|1234059|P1|NOT COMPLETED|14 Day Washout Period||1
504405|NCT00983931|1234059|P1|COMPLETED|14 Day Washout Period|one subject withdrawn due to creatine kinase out of range|23
504406|NCT00983931|1234059|P1|STARTED|14 Day Washout Period||24
504407|NCT00983931|1234059|P1|NOT COMPLETED|Colchicine Alone||0
504408|NCT00983931|1234059|P1|COMPLETED|Colchicine Alone||24
504409|NCT00983931|1234059|P1|STARTED|Colchicine Alone||24
504410|NCT00983918|1234073|P4|NOT COMPLETED|Overall Study||2
504411|NCT00983918|1234074|P3|NOT COMPLETED|Overall Study||2
504412|NCT00983918|1234075|P2|NOT COMPLETED|Overall Study||2
504413|NCT00983918|1234076|P1|NOT COMPLETED|Overall Study||0
504414|NCT00983918|1234073|P4|COMPLETED|Overall Study||18
504415|NCT00983918|1234074|P3|COMPLETED|Overall Study||18
504416|NCT00983918|1234075|P2|COMPLETED|Overall Study||18
504417|NCT00983918|1234076|P1|COMPLETED|Overall Study||20
504418|NCT00983918|1234073|P4|STARTED|Overall Study||20
504419|NCT00983918|1234074|P3|STARTED|Overall Study||20
504420|NCT00983918|1234075|P2|STARTED|Overall Study||20
504421|NCT00983918|1234076|P1|STARTED|Overall Study||20
504422|NCT00983905|1234086|P1|NOT COMPLETED|Theophylline With Colchicine||0
504423|NCT00983905|1234086|P1|COMPLETED|Theophylline With Colchicine||27
504424|NCT00983905|1234086|P1|STARTED|Theophylline With Colchicine||27
504425|NCT00983905|1234086|P1|NOT COMPLETED|Colchicine Alone||2
504426|NCT00983905|1234086|P1|COMPLETED|Colchicine Alone|withdrawn by sponsor due to: diarrhea(1); vomiting and diarrhea(1)|27
504427|NCT00983905|1234086|P1|STARTED|Colchicine Alone||29
504428|NCT00983905|1234086|P1|NOT COMPLETED|4 Day Washout Period||0
504429|NCT00983905|1234086|P1|COMPLETED|4 Day Washout Period||29
504430|NCT00983905|1234086|P1|STARTED|4 Day Washout Period||29
504431|NCT00983905|1234086|P1|NOT COMPLETED|Theophylline Alone||1
504432|NCT00983905|1234086|P1|COMPLETED|Theophylline Alone|withdrawn by sponsor due to vomiting(1)|29
504433|NCT00983905|1234086|P1|STARTED|Theophylline Alone||30
504434|NCT00983892|1234099|P2|NOT COMPLETED|Overall Study||12
504435|NCT00983892|1234100|P1|NOT COMPLETED|Overall Study||10
504436|NCT00983892|1234099|P2|COMPLETED|Overall Study||56
504437|NCT00983892|1234100|P1|COMPLETED|Overall Study||56
504438|NCT00983892|1234099|P2|STARTED|Overall Study||68
504439|NCT00983892|1234100|P1|STARTED|Overall Study||66
504440|NCT00983853|1234112|P6|NOT COMPLETED|Overall Study||1
504441|NCT00983853|1234113|P5|NOT COMPLETED|Overall Study||3
504442|NCT00983853|1234114|P4|NOT COMPLETED|Overall Study||2
504443|NCT00983853|1234115|P3|NOT COMPLETED|Overall Study||3
504444|NCT00983853|1234116|P2|NOT COMPLETED|Overall Study||2
504445|NCT00983853|1234117|P1|NOT COMPLETED|Overall Study||1
504446|NCT00983853|1234112|P6|COMPLETED|Overall Study||7
504447|NCT00983853|1234113|P5|COMPLETED|Overall Study||12
504448|NCT00983853|1234114|P4|COMPLETED|Overall Study||6
504449|NCT00983853|1234115|P3|COMPLETED|Overall Study||14
504450|NCT00983853|1234116|P2|COMPLETED|Overall Study||5
504451|NCT00983853|1234117|P1|COMPLETED|Overall Study||6
504452|NCT00983853|1234112|P6|STARTED|Overall Study||8
504453|NCT00983853|1234113|P5|STARTED|Overall Study||15
504454|NCT00983853|1234114|P4|STARTED|Overall Study||8
504455|NCT00983853|1234115|P3|STARTED|Overall Study|1 subject was randomized but not dosed|17
504456|NCT00983853|1234116|P2|STARTED|Overall Study|1 subject was randomized but not dosed|7
504457|NCT00983853|1234117|P1|STARTED|Overall Study||7
504458|NCT00983827|1234145|P1|NOT COMPLETED|Overall Study||1
504459|NCT00983827|1234145|P1|COMPLETED|Overall Study||7
504460|NCT00983827|1234145|P1|STARTED|Overall Study||8
504461|NCT00983801|1234149|P1|NOT COMPLETED|Overall Study||0
504462|NCT00983801|1234149|P1|COMPLETED|Overall Study|Participants who were taken off treatment.|52
504463|NCT00983801|1234149|P1|STARTED|Overall Study|Participants who received treatment.|52
504464|NCT00983749|1234163|P2|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||3
504465|NCT00983749|1234164|P1|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||1
504466|NCT00983749|1234163|P2|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||7
504467|NCT00983749|1234164|P1|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||12
504468|NCT00983749|1234163|P2|STARTED|Follow-up Phase (Hospital DC to 30 Days)||10
504469|NCT00983749|1234164|P1|STARTED|Follow-up Phase (Hospital DC to 30 Days)||13
504470|NCT00983749|1234163|P2|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0
504471|NCT00983749|1234164|P1|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0
504472|NCT00983749|1234163|P2|COMPLETED|Acute Phase (Enrollment to Hospital DC)||10
504473|NCT00983749|1234164|P1|COMPLETED|Acute Phase (Enrollment to Hospital DC)||13
504474|NCT00983749|1234163|P2|STARTED|Acute Phase (Enrollment to Hospital DC)||10
504475|NCT00983749|1234164|P1|STARTED|Acute Phase (Enrollment to Hospital DC)||13
504476|NCT00983645|1234174|P2|NOT COMPLETED|Overall Study||0
504477|NCT00983645|1234175|P1|NOT COMPLETED|Overall Study||0
504478|NCT00983645|1234174|P2|COMPLETED|Overall Study||7
504479|NCT00983645|1234175|P1|COMPLETED|Overall Study||8
504480|NCT00983645|1234174|P2|STARTED|Overall Study||7
504481|NCT00983645|1234175|P1|STARTED|Overall Study||8
504482|NCT00983580|1234189|P2|NOT COMPLETED|Overall Study||4
504483|NCT00983580|1234190|P1|NOT COMPLETED|Overall Study||5
504484|NCT00983580|1234189|P2|COMPLETED|Overall Study||49
504485|NCT00983580|1234190|P1|COMPLETED|Overall Study||49
504486|NCT00983580|1234189|P2|STARTED|Overall Study||53
504487|NCT00983580|1234190|P1|STARTED|Overall Study||54
504488|NCT00983541|1234206|P1|NOT COMPLETED|Overall Study||0
504489|NCT00983541|1234206|P1|COMPLETED|Overall Study||1
504490|NCT00983541|1234206|P1|STARTED|Overall Study||1
504491|NCT00983515|1234216|P1|NOT COMPLETED|Colchicine With Ritonavir||1
504492|NCT00983515|1234216|P1|COMPLETED|Colchicine With Ritonavir|pharmacokinetic data included since parameters could be estimated for both dosing conditions|17
504493|NCT00983515|1234216|P1|STARTED|Colchicine With Ritonavir||18
504494|NCT00983515|1234216|P1|NOT COMPLETED|Ritonavir Alone||6
504495|NCT00983515|1234216|P1|COMPLETED|Ritonavir Alone||18
504496|NCT00983515|1234216|P1|STARTED|Ritonavir Alone||24
504497|NCT00983515|1234216|P1|NOT COMPLETED|14 Day Washout Period||0
504498|NCT00983515|1234216|P1|COMPLETED|14 Day Washout Period||24
504499|NCT00983515|1234216|P1|STARTED|14 Day Washout Period||24
504500|NCT00983515|1234216|P1|NOT COMPLETED|Colchicine Alone||0
504501|NCT00983515|1234216|P1|COMPLETED|Colchicine Alone||24
504502|NCT00983515|1234216|P1|STARTED|Colchicine Alone||24
504503|NCT00983489|1234230|P3|NOT COMPLETED|Overall Study||312
504504|NCT00983489|1234231|P2|NOT COMPLETED|Overall Study||285
504505|NCT00983489|1234232|P1|NOT COMPLETED|Overall Study||185
504506|NCT00983489|1234230|P3|COMPLETED|Overall Study||135
504507|NCT00983489|1234231|P2|COMPLETED|Overall Study||168
504508|NCT00983489|1234232|P1|COMPLETED|Overall Study||326
504509|NCT00983489|1234230|P3|STARTED|Overall Study||447
504510|NCT00983489|1234231|P2|STARTED|Overall Study||453
504511|NCT00983489|1234232|P1|STARTED|Overall Study||511
504512|NCT00983476|1234243|P3|NOT COMPLETED|Overall Study||0
504513|NCT00983476|1234244|P2|NOT COMPLETED|Overall Study||22
504514|NCT00983476|1234245|P1|NOT COMPLETED|Overall Study||17
504515|NCT00983476|1234243|P3|COMPLETED|Overall Study||88
504516|NCT00983476|1234244|P2|COMPLETED|Overall Study||71
504517|NCT00983476|1234245|P1|COMPLETED|Overall Study||78
504518|NCT00983476|1234243|P3|6 Month Follow up Assessment|Overall Study||74
504519|NCT00983476|1234244|P2|6 Month Follow up Assessment|Overall Study||62
504520|NCT00983476|1234245|P1|6 Month Follow up Assessment|Overall Study||71
504521|NCT00983476|1234243|P3|STARTED|Overall Study||88
504522|NCT00983476|1234244|P2|STARTED|Overall Study||93
504523|NCT00983476|1234245|P1|STARTED|Overall Study||95
504524|NCT00983437|1234277|P1|NOT COMPLETED|Overall Study||47
504525|NCT00983437|1234277|P1|COMPLETED|Overall Study|Completed 12 months of treatment with armodafinil.|0
504526|NCT00983437|1234277|P1|Full Analysis Set (FAS)|Overall Study|Participants had to have at least 1 postbaseline efficacy assessment to be evaluable for efficacy.|45
504527|NCT00983437|1234277|P1|Safety Analysis Set (SAS)|Overall Study|Participants who received at least 1 dose of study drug were evaluable for safety.|47
504528|NCT00983437|1234277|P1|STARTED|Overall Study||47
504529|NCT00983385|1234296|P1|NOT COMPLETED|Maintenance Period||23
504530|NCT00983385|1234296|P1|COMPLETED|Maintenance Period||117
504531|NCT00983385|1234296|P1|STARTED|Maintenance Period||140
504532|NCT00983385|1234296|P1|NOT COMPLETED|Titration and Optimal Dose Period||36
504533|NCT00983385|1234296|P1|COMPLETED|Titration and Optimal Dose Period||140
504534|NCT00983385|1234296|P1|STARTED|Titration and Optimal Dose Period||176
504535|NCT00983385|1234296|P1|NOT COMPLETED|Observation Period||32
504536|NCT00983385|1234296|P1|COMPLETED|Observation Period||176
504537|NCT00983385|1234296|P1|STARTED|Observation Period||208
504538|NCT00983372|1234341|P1|NOT COMPLETED|Colchicine With Diltiazem ER||0
504539|NCT00983372|1234341|P1|COMPLETED|Colchicine With Diltiazem ER||20
504540|NCT00983372|1234341|P1|STARTED|Colchicine With Diltiazem ER||20
504541|NCT00983372|1234341|P1|NOT COMPLETED|Diltiazem ER Alone||3
504542|NCT00983372|1234341|P1|COMPLETED|Diltiazem ER Alone|two subjects dropped due to missed diltiazem ER dose; one subject dropped due to vomitting|20
504543|NCT00983372|1234341|P1|STARTED|Diltiazem ER Alone||23
504544|NCT00983372|1234341|P1|NOT COMPLETED|14 Day Washout Period||1
504545|NCT00983372|1234341|P1|COMPLETED|14 Day Washout Period|subject withdrew consent due to schedule conflict - during washout period or diltiazem alone|23
504546|NCT00983372|1234341|P1|STARTED|14 Day Washout Period||24
504547|NCT00983372|1234341|P1|NOT COMPLETED|Colchicine Alone||0
504548|NCT00983372|1234341|P1|COMPLETED|Colchicine Alone||24
504549|NCT00983372|1234341|P1|STARTED|Colchicine Alone||24
504550|NCT00983359|1234352|P1|NOT COMPLETED|Overall Study||1
504551|NCT00983359|1234352|P1|COMPLETED|Overall Study||39
504552|NCT00983359|1234352|P1|Not Eligible for Analysis|Overall Study||1
504553|NCT00983359|1234352|P1|STARTED|Overall Study||40
504554|NCT00983346|1234360|P1|NOT COMPLETED|Overall Study||0
504555|NCT00983346|1234360|P1|COMPLETED|Overall Study||17
504556|NCT00983346|1234360|P1|STARTED|Overall Study||17
504557|NCT00983307|1234364|P1|NOT COMPLETED|Overall Study||0
504558|NCT00983307|1234364|P1|COMPLETED|Overall Study||17
504559|NCT00983307|1234364|P1|STARTED|Overall Study||17
504560|NCT00983294|1234368|P1|NOT COMPLETED|Colchicine With Azithromycin||1
504561|NCT00983294|1234368|P1|COMPLETED|Colchicine With Azithromycin|withdrawn by sponsor on Day 21 due to vomiting on Day 15, prior to azithromycin dosing(1)|21
504562|NCT00983294|1234368|P1|STARTED|Colchicine With Azithromycin||22
504563|NCT00983294|1234368|P1|NOT COMPLETED|Azithromycin Alone||0
504564|NCT00983294|1234368|P1|COMPLETED|Azithromycin Alone||22
504565|NCT00983294|1234368|P1|STARTED|Azithromycin Alone||22
504566|NCT00983294|1234368|P1|NOT COMPLETED|14 Day Washout Period||2
504567|NCT00983294|1234368|P1|COMPLETED|14 Day Washout Period|two subjects withdrew consent due to personal reasons|22
504568|NCT00983294|1234368|P1|STARTED|14 Day Washout Period||24
504569|NCT00983294|1234368|P1|NOT COMPLETED|Colchicine Alone||0
504570|NCT00983294|1234368|P1|COMPLETED|Colchicine Alone||24
504571|NCT00983294|1234368|P1|STARTED|Colchicine Alone||24
504572|NCT00983281|1234381|P2|NOT COMPLETED|Overall Study||0
504573|NCT00983281|1234382|P1|NOT COMPLETED|Overall Study||0
504574|NCT00983281|1234381|P2|COMPLETED|Overall Study||909
504575|NCT00983281|1234382|P1|COMPLETED|Overall Study||805
504576|NCT00983281|1234381|P2|STARTED|Overall Study||909
504577|NCT00983281|1234382|P1|STARTED|Overall Study||805
504578|NCT00983242|1234388|P1|NOT COMPLETED|Colchicine With Verapamil HCl ER||0
504579|NCT00983242|1234388|P1|COMPLETED|Colchicine With Verapamil HCl ER||24
504580|NCT00983242|1234388|P1|STARTED|Colchicine With Verapamil HCl ER||24
504581|NCT00983242|1234388|P1|NOT COMPLETED|Verapamil HCl ER Alone||0
504582|NCT00983242|1234388|P1|COMPLETED|Verapamil HCl ER Alone||24
504583|NCT00983242|1234388|P1|STARTED|Verapamil HCl ER Alone||24
504584|NCT00983242|1234388|P1|NOT COMPLETED|14 Day Washout Period||0
504585|NCT00983242|1234388|P1|COMPLETED|14 Day Washout Period||24
504586|NCT00983242|1234388|P1|STARTED|14 Day Washout Period||24
504587|NCT00983242|1234388|P1|NOT COMPLETED|Colchicine Alone||0
504588|NCT00983242|1234388|P1|COMPLETED|Colchicine Alone||24
504589|NCT00983242|1234388|P1|STARTED|Colchicine Alone||24
504590|NCT00983216|1234399|P1|NOT COMPLETED|Colchicine With Ketoconazole||0
504591|NCT00983216|1234399|P1|COMPLETED|Colchicine With Ketoconazole||24
504592|NCT00983216|1234399|P1|STARTED|Colchicine With Ketoconazole||24
504593|NCT00983216|1234399|P1|NOT COMPLETED|Ketoconazole Alone||0
504594|NCT00983216|1234399|P1|COMPLETED|Ketoconazole Alone||24
504595|NCT00983216|1234399|P1|STARTED|Ketoconazole Alone||24
504596|NCT00983216|1234399|P1|NOT COMPLETED|14 Day Washout Period||0
504597|NCT00983216|1234399|P1|COMPLETED|14 Day Washout Period||24
504598|NCT00983216|1234399|P1|STARTED|14 Day Washout Period||24
504599|NCT00983216|1234399|P1|NOT COMPLETED|Colchicine Alone||0
504600|NCT00983216|1234399|P1|COMPLETED|Colchicine Alone||24
504601|NCT00983216|1234399|P1|STARTED|Colchicine Alone||24
504602|NCT00983073|1234410|P1|NOT COMPLETED|Maintenance Period||16
504603|NCT00983073|1234410|P1|COMPLETED|Maintenance Period||144
504604|NCT00983073|1234410|P1|STARTED|Maintenance Period||160
504605|NCT00983073|1234410|P1|NOT COMPLETED|Titration and Optimal Dose Period||40
504606|NCT00983073|1234410|P1|COMPLETED|Titration and Optimal Dose Period||160
504607|NCT00983073|1234410|P1|STARTED|Titration and Optimal Dose Period||200
504608|NCT00983073|1234410|P1|NOT COMPLETED|Observation Period||24
504609|NCT00983073|1234410|P1|COMPLETED|Observation Period|24 participants not eligible to be dosed.|200
504610|NCT00983073|1234410|P1|STARTED|Observation Period||224
504611|NCT00982995|1234431|P1|NOT COMPLETED|Overall Study||0
504612|NCT00982995|1234431|P1|COMPLETED|Overall Study||3
504613|NCT00982995|1234431|P1|STARTED|Overall Study||3
504614|NCT00982735|1234436|P1|NOT COMPLETED|Overall Study||230
504615|NCT00982735|1234436|P1|COMPLETED|Overall Study||757
504616|NCT00982735|1234436|P1|STARTED|Overall Study||987
504617|NCT00982657|1234446|P4|NOT COMPLETED|Overall Study||9
504618|NCT00982657|1234447|P3|NOT COMPLETED|Overall Study||2
504619|NCT00982657|1234448|P2|NOT COMPLETED|Overall Study||0
504620|NCT00982657|1234449|P1|NOT COMPLETED|Overall Study||1
504621|NCT00982657|1234446|P4|COMPLETED|Overall Study||7
504622|NCT00982657|1234447|P3|COMPLETED|Overall Study||1
504623|NCT00982657|1234448|P2|COMPLETED|Overall Study||3
504624|NCT00982657|1234449|P1|COMPLETED|Overall Study||11
504625|NCT00982657|1234446|P4|STARTED|Overall Study||16
504626|NCT00982657|1234447|P3|STARTED|Overall Study||3
504627|NCT00982657|1234448|P2|STARTED|Overall Study||3
504628|NCT00982657|1234449|P1|STARTED|Overall Study||12
504629|NCT00982644|1234490|P2|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||20
504630|NCT00982644|1234491|P1|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||46
504631|NCT00982644|1234490|P2|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||154
504632|NCT00982644|1234491|P1|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||505
504711|NCT00982345|1234615|P1|NOT COMPLETED|Overall Study||2
504633|NCT00982644|1234490|P2|STARTED|Extension: Week 53 to 104 (NN1250-3643)|Twenty-three subjects did not continue into extension trial|174
504634|NCT00982644|1234491|P1|STARTED|Extension: Week 53 to 104 (NN1250-3643)|Fifty-six subjects did not continue into extension trial|551
504635|NCT00982644|1234490|P2|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||60
504636|NCT00982644|1234491|P1|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||166
504637|NCT00982644|1234490|P2|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||197
504638|NCT00982644|1234491|P1|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||607
504639|NCT00982644|1234490|P2|Exposed|Main: Week 0 to 52 (NN1250-3579)||257
504640|NCT00982644|1234491|P1|Exposed|Main: Week 0 to 52 (NN1250-3579)|7 subjects were withdrawn prior to exposure to trial products|766
504641|NCT00982644|1234490|P2|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||257
504642|NCT00982644|1234491|P1|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||773
504643|NCT00982644|1234490|P2|STARTED|Main: Week 0 to 52 (NN1250-3579)||257
504644|NCT00982644|1234491|P1|STARTED|Main: Week 0 to 52 (NN1250-3579)||773
504645|NCT00982592|1234515|P2|NOT COMPLETED|Overall Study||33
504646|NCT00982592|1234516|P1|NOT COMPLETED|Overall Study||31
504647|NCT00982592|1234515|P2|COMPLETED|Overall Study|patients who were off treatment due to disease progression|27
504648|NCT00982592|1234516|P1|COMPLETED|Overall Study|patients who were off treatment due to disease progression|33
504649|NCT00982592|1234515|P2|Treatment Received|Overall Study||52
504650|NCT00982592|1234516|P1|Treatment Received|Overall Study||63
504651|NCT00982592|1234515|P2|STARTED|Overall Study||60
504652|NCT00982592|1234516|P1|STARTED|Overall Study||64
504653|NCT00982553|1234530|P1|NOT COMPLETED|Overall Study||0
504654|NCT00982553|1234530|P1|COMPLETED|Overall Study||14
504655|NCT00982553|1234530|P1|STARTED|Overall Study||14
504656|NCT00982488|1234542|P5|NOT COMPLETED|Overall Study||1
504657|NCT00982488|1234543|P4|NOT COMPLETED|Overall Study||3
504658|NCT00982488|1234544|P3|NOT COMPLETED|Overall Study||34
504659|NCT00982488|1234545|P2|NOT COMPLETED|Overall Study||14
504660|NCT00982488|1234546|P1|NOT COMPLETED|Overall Study||185
504661|NCT00982488|1234542|P5|COMPLETED|Overall Study|Still receiving treatment|0
504662|NCT00982488|1234543|P4|COMPLETED|Overall Study|Still receiving treatment|0
504663|NCT00982488|1234544|P3|COMPLETED|Overall Study|Still receiving treatment|0
504664|NCT00982488|1234545|P2|COMPLETED|Overall Study|Still receiving treatment|0
504665|NCT00982488|1234546|P1|COMPLETED|Overall Study|Still receiving treatment|0
504666|NCT00982488|1234542|P5|STARTED|Overall Study|Received treatment|1
504667|NCT00982488|1234543|P4|STARTED|Overall Study|Received treatment|3
504668|NCT00982488|1234544|P3|STARTED|Overall Study|Received treatment|34
504669|NCT00982488|1234545|P2|STARTED|Overall Study|Received treatment|14
504670|NCT00982488|1234546|P1|STARTED|Overall Study|Received treatment|185
504671|NCT00982423|1234560|P2|NOT COMPLETED|Overall Study||0
504672|NCT00982423|1234561|P1|NOT COMPLETED|Overall Study||0
504673|NCT00982423|1234560|P2|COMPLETED|Overall Study||19
504674|NCT00982423|1234561|P1|COMPLETED|Overall Study||13
504675|NCT00982423|1234560|P2|STARTED|Overall Study||19
504676|NCT00982423|1234561|P1|STARTED|Overall Study||13
504677|NCT00982410|1234579|P2|NOT COMPLETED|12-month Follow-up Assessment||9
504678|NCT00982410|1234580|P1|NOT COMPLETED|12-month Follow-up Assessment||9
504679|NCT00982410|1234579|P2|COMPLETED|12-month Follow-up Assessment||55
504680|NCT00982410|1234580|P1|COMPLETED|12-month Follow-up Assessment||56
504681|NCT00982410|1234579|P2|STARTED|12-month Follow-up Assessment|n=2 persons withdrew before 3-mo. f/u, reducing pool of participants to N=64 with intent to treat.|64
504682|NCT00982410|1234580|P1|STARTED|12-month Follow-up Assessment|n=65 : intent to treat. Some persons missed follow-up assessment without withdrawing from study.|65
504683|NCT00982410|1234579|P2|NOT COMPLETED|6-month Follow-up Assessment||11
504684|NCT00982410|1234580|P1|NOT COMPLETED|6-month Follow-up Assessment||6
504685|NCT00982410|1234579|P2|COMPLETED|6-month Follow-up Assessment||53
504686|NCT00982410|1234580|P1|COMPLETED|6-month Follow-up Assessment||59
504687|NCT00982410|1234579|P2|STARTED|6-month Follow-up Assessment|n=2 persons withdrew before 3-mo. f/u, reducing pool of participants to N=64 with intent to treat.|64
504688|NCT00982410|1234580|P1|STARTED|6-month Follow-up Assessment|n=65 : intent to treat. Some persons missed follow-up assessment without withdrawing from study.|65
504689|NCT00982410|1234579|P2|NOT COMPLETED|3-month Follow-up Assessment||13
504690|NCT00982410|1234580|P1|NOT COMPLETED|3-month Follow-up Assessment||9
504691|NCT00982410|1234579|P2|COMPLETED|3-month Follow-up Assessment||53
504692|NCT00982410|1234580|P1|COMPLETED|3-month Follow-up Assessment||56
504693|NCT00982410|1234579|P2|STARTED|3-month Follow-up Assessment||66
504694|NCT00982410|1234580|P1|STARTED|3-month Follow-up Assessment||65
504695|NCT00982397|1234604|P2|NOT COMPLETED|Phase II/Overall Study||0
504696|NCT00982397|1234605|P1|NOT COMPLETED|Phase II/Overall Study||0
504697|NCT00982397|1234604|P2|COMPLETED|Phase II/Overall Study||751
504698|NCT00982397|1234605|P1|COMPLETED|Phase II/Overall Study||2019
504699|NCT00982397|1234604|P2|Secondary Prevention Randomized 30/40NID|Phase II/Overall Study||131
504700|NCT00982397|1234605|P1|Secondary Prevention Randomized 30/40NID|Phase II/Overall Study||221
504701|NCT00982397|1234604|P2|Secondary Prevention Randomized 18/24NID|Phase II/Overall Study||122
504702|NCT00982397|1234605|P1|Secondary Prevention Randomized 18/24NID|Phase II/Overall Study||231
504703|NCT00982397|1234604|P2|STARTED|Phase II/Overall Study||751
504704|NCT00982397|1234605|P1|STARTED|Phase II/Overall Study||2019
504705|NCT00982397|1234604|P2|NOT COMPLETED|Phase I||0
504706|NCT00982397|1234605|P1|NOT COMPLETED|Phase I||0
504707|NCT00982397|1234604|P2|COMPLETED|Phase I||0
504708|NCT00982397|1234605|P1|COMPLETED|Phase I||236
504709|NCT00982397|1234604|P2|STARTED|Phase I||0
504710|NCT00982397|1234605|P1|STARTED|Phase I||236
504712|NCT00982345|1234615|P1|COMPLETED|Overall Study||18
504713|NCT00982345|1234615|P1|STARTED|Overall Study||20
504714|NCT00982280|1234619|P1|NOT COMPLETED|Maintenance Period||1
504715|NCT00982280|1234619|P1|COMPLETED|Maintenance Period||54
504716|NCT00982280|1234619|P1|STARTED|Maintenance Period||55
504717|NCT00982280|1234619|P1|NOT COMPLETED|Titration and Optimal Dose Period||8
504718|NCT00982280|1234619|P1|COMPLETED|Titration and Optimal Dose Period||55
504719|NCT00982280|1234619|P1|STARTED|Titration and Optimal Dose Period||63
504720|NCT00982280|1234619|P1|NOT COMPLETED|Observation Period||19
504721|NCT00982280|1234619|P1|COMPLETED|Observation Period||63
504722|NCT00982280|1234619|P1|STARTED|Observation Period||82
504723|NCT00982228|1234644|P2|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||5
504724|NCT00982228|1234645|P1|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||21
504725|NCT00982228|1234644|P2|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||113
504726|NCT00982228|1234645|P1|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||330
504727|NCT00982228|1234644|P2|STARTED|Extension: Week 53 to 104 (NN1250-3644)|Nineteen subjects from the main trial did not continue into the extension|118
504728|NCT00982228|1234645|P1|STARTED|Extension: Week 53 to 104 (NN1250-3644)|Fifty-three subjects from the main trial did not continue into the extension|351
504729|NCT00982228|1234644|P2|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||20
504730|NCT00982228|1234645|P1|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||68
504731|NCT00982228|1234644|P2|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||137
504732|NCT00982228|1234645|P1|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||404
504733|NCT00982228|1234644|P2|Exposed|Main: Week 0 to 52 (NN1250-3583)|Three subjects withdrew prior to exposure to trial drug|154
504734|NCT00982228|1234645|P1|Exposed|Main: Week 0 to 52 (NN1250-3583)||472
504735|NCT00982228|1234644|P2|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||157
504736|NCT00982228|1234645|P1|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||472
504737|NCT00982228|1234644|P2|STARTED|Main: Week 0 to 52 (NN1250-3583)||157
504738|NCT00982228|1234645|P1|STARTED|Main: Week 0 to 52 (NN1250-3583)||472
504739|NCT00982189|1234673|P4|NOT COMPLETED|Overall Study||0
504740|NCT00982189|1234674|P3|NOT COMPLETED|Overall Study||0
504741|NCT00982189|1234675|P2|NOT COMPLETED|Overall Study||0
504742|NCT00982189|1234676|P1|NOT COMPLETED|Overall Study||0
504743|NCT00982189|1234673|P4|COMPLETED|Overall Study||9
504744|NCT00982189|1234674|P3|COMPLETED|Overall Study||9
504745|NCT00982189|1234675|P2|COMPLETED|Overall Study||9
504746|NCT00982189|1234676|P1|COMPLETED|Overall Study||10
504747|NCT00982189|1234673|P4|STARTED|Overall Study||9
504748|NCT00982189|1234674|P3|STARTED|Overall Study||9
504749|NCT00982189|1234675|P2|STARTED|Overall Study||9
504750|NCT00982189|1234676|P1|STARTED|Overall Study||10
504751|NCT00982137|1234704|P4|NOT COMPLETED|Overall Study||1
504752|NCT00982137|1234705|P3|NOT COMPLETED|Overall Study||0
504753|NCT00982137|1234706|P2|NOT COMPLETED|Overall Study||1
504754|NCT00982137|1234707|P1|NOT COMPLETED|Overall Study||0
504755|NCT00982137|1234704|P4|COMPLETED|Overall Study||17
504756|NCT00982137|1234705|P3|COMPLETED|Overall Study||18
504757|NCT00982137|1234706|P2|COMPLETED|Overall Study||35
504758|NCT00982137|1234707|P1|COMPLETED|Overall Study||36
504759|NCT00982137|1234704|P4|STARTED|Overall Study||18
504760|NCT00982137|1234705|P3|STARTED|Overall Study||18
504761|NCT00982137|1234706|P2|STARTED|Overall Study||36
504762|NCT00982137|1234707|P1|STARTED|Overall Study||36
504763|NCT00982111|1234739|P2|NOT COMPLETED|Overall Study||66
504764|NCT00982111|1234740|P1|NOT COMPLETED|Overall Study||75
504765|NCT00982111|1234739|P2|COMPLETED|Overall Study||252
504766|NCT00982111|1234740|P1|COMPLETED|Overall Study||240
504767|NCT00982111|1234739|P2|On Study at Conclusion, Off Treatment|Overall Study||6
504768|NCT00982111|1234740|P1|On Study at Conclusion, Off Treatment|Overall Study||4
504769|NCT00982111|1234739|P2|Death Due to Any Cause|Overall Study||246
504770|NCT00982111|1234740|P1|Death Due to Any Cause|Overall Study||236
504771|NCT00982111|1234739|P2|Received at Least 1 Dose of Study Drug|Overall Study||312
504772|NCT00982111|1234740|P1|Received at Least 1 Dose of Study Drug|Overall Study||304
504773|NCT00982111|1234739|P2|STARTED|Overall Study||318
504774|NCT00982111|1234740|P1|STARTED|Overall Study||315
504775|NCT00982033|1234764|P2|NOT COMPLETED|Overall Study||0
504776|NCT00982033|1234765|P1|NOT COMPLETED|Overall Study||0
504777|NCT00982033|1234764|P2|COMPLETED|Overall Study||27
504778|NCT00982033|1234765|P1|COMPLETED|Overall Study||25
504779|NCT00982033|1234764|P2|STARTED|Overall Study||27
504780|NCT00982033|1234765|P1|STARTED|Overall Study||25
504781|NCT00982020|1234773|P2|NOT COMPLETED|Overall Study||64
504782|NCT00982020|1234774|P1|NOT COMPLETED|Overall Study||57
504783|NCT00982020|1234773|P2|COMPLETED|Overall Study||37
504784|NCT00982020|1234774|P1|COMPLETED|Overall Study||45
504785|NCT00982020|1234773|P2|Received at Least 1 Dose of Study Drug|Overall Study||101
504786|NCT00982020|1234774|P1|Received at Least 1 Dose of Study Drug|Overall Study||102
504787|NCT00982020|1234773|P2|STARTED|Overall Study||101
504788|NCT00982020|1234774|P1|STARTED|Overall Study||102
504789|NCT00982007|1234798|P4|NOT COMPLETED|Overall Study||6
504790|NCT00982007|1234799|P3|NOT COMPLETED|Overall Study||0
504791|NCT00982007|1234800|P2|NOT COMPLETED|Overall Study||4
504792|NCT00982007|1234801|P1|NOT COMPLETED|Overall Study||4
504793|NCT00982007|1234798|P4|COMPLETED|Overall Study||245
504794|NCT00982007|1234799|P3|COMPLETED|Overall Study||253
504795|NCT00982007|1234800|P2|COMPLETED|Overall Study||253
504796|NCT00982007|1234801|P1|COMPLETED|Overall Study||246
504797|NCT00982007|1234798|P4|STARTED|Overall Study||251
504798|NCT00982007|1234799|P3|STARTED|Overall Study||253
504799|NCT00982007|1234800|P2|STARTED|Overall Study||257
504800|NCT00982007|1234801|P1|STARTED|Overall Study||250
504801|NCT00981825|1234813|P2|NOT COMPLETED|Second Intervention||0
504802|NCT00981825|1234814|P1|NOT COMPLETED|Second Intervention||0
504803|NCT00981825|1234813|P2|COMPLETED|Second Intervention||11
504804|NCT00981825|1234814|P1|COMPLETED|Second Intervention||11
504805|NCT00981825|1234813|P2|STARTED|Second Intervention||11
504806|NCT00981825|1234814|P1|STARTED|Second Intervention||11
504807|NCT00981825|1234813|P2|NOT COMPLETED|Washout After 1st Intervention||0
504808|NCT00981825|1234814|P1|NOT COMPLETED|Washout After 1st Intervention||0
504809|NCT00981825|1234813|P2|COMPLETED|Washout After 1st Intervention||11
504810|NCT00981825|1234814|P1|COMPLETED|Washout After 1st Intervention||11
504811|NCT00981825|1234813|P2|STARTED|Washout After 1st Intervention||11
504812|NCT00981825|1234814|P1|STARTED|Washout After 1st Intervention||11
504813|NCT00981825|1234813|P2|NOT COMPLETED|First Intervention||0
504814|NCT00981825|1234814|P1|NOT COMPLETED|First Intervention||0
504815|NCT00981825|1234813|P2|COMPLETED|First Intervention||11
504816|NCT00981825|1234814|P1|COMPLETED|First Intervention||11
504817|NCT00981825|1234813|P2|STARTED|First Intervention||11
504818|NCT00981825|1234814|P1|STARTED|First Intervention||11
504819|NCT00981812|1234820|P1|NOT COMPLETED|Overall Study||0
504820|NCT00981812|1234820|P1|COMPLETED|Overall Study||20
504821|NCT00981812|1234820|P1|STARTED|Overall Study||20
504822|NCT00981669|1234826|P2|NOT COMPLETED|Overall Study||0
504823|NCT00981669|1234827|P1|NOT COMPLETED|Overall Study||1
504824|NCT00981669|1234826|P2|COMPLETED|Overall Study||40
504825|NCT00981669|1234827|P1|COMPLETED|Overall Study||39
504826|NCT00981669|1234826|P2|STARTED|Overall Study||40
504827|NCT00981669|1234827|P1|STARTED|Overall Study||40
504828|NCT00981630|1234839|P4|NOT COMPLETED|Overall Study||0
504829|NCT00981630|1234840|P3|NOT COMPLETED|Overall Study||0
504830|NCT00981630|1234841|P2|NOT COMPLETED|Overall Study||0
504831|NCT00981630|1234842|P1|NOT COMPLETED|Overall Study||0
504832|NCT00981630|1234839|P4|COMPLETED|Overall Study||32
504833|NCT00981630|1234840|P3|COMPLETED|Overall Study||32
504834|NCT00981630|1234841|P2|COMPLETED|Overall Study||32
504835|NCT00981630|1234842|P1|COMPLETED|Overall Study||32
504836|NCT00981630|1234839|P4|STARTED|Overall Study||32
504837|NCT00981630|1234840|P3|STARTED|Overall Study||32
504838|NCT00981630|1234841|P2|STARTED|Overall Study||32
504839|NCT00981630|1234842|P1|STARTED|Overall Study||32
504840|NCT00981526|1234874|P2|NOT COMPLETED|Overall Study||6
504841|NCT00981526|1234875|P1|NOT COMPLETED|Overall Study||4
504842|NCT00981526|1234874|P2|COMPLETED|Overall Study||22
504843|NCT00981526|1234875|P1|COMPLETED|Overall Study||22
504844|NCT00981526|1234874|P2|STARTED|Overall Study||28
504845|NCT00981526|1234875|P1|STARTED|Overall Study||26
504846|NCT00981461|1234893|P2|NOT COMPLETED|Overall Study||2
504847|NCT00981461|1234894|P1|NOT COMPLETED|Overall Study||5
504848|NCT00981461|1234893|P2|COMPLETED|Overall Study||22
504849|NCT00981461|1234894|P1|COMPLETED|Overall Study||43
504850|NCT00981461|1234893|P2|STARTED|Overall Study||24
504851|NCT00981461|1234894|P1|STARTED|Overall Study||48
504852|NCT00981435|1234903|P3|NOT COMPLETED|Overall Study||0
504853|NCT00981435|1234904|P2|NOT COMPLETED|Overall Study||0
504854|NCT00981435|1234905|P1|NOT COMPLETED|Overall Study||0
504855|NCT00981435|1234903|P3|COMPLETED|Overall Study||37
504856|NCT00981435|1234904|P2|COMPLETED|Overall Study||29
504857|NCT00981435|1234905|P1|COMPLETED|Overall Study||31
504858|NCT00981435|1234903|P3|STARTED|Overall Study||37
504859|NCT00981435|1234904|P2|STARTED|Overall Study||29
504860|NCT00981435|1234905|P1|STARTED|Overall Study||31
504861|NCT00981409|1234918|P2|NOT COMPLETED|Overall Study||1
504862|NCT00981409|1234919|P1|NOT COMPLETED|Overall Study||6
504863|NCT00981409|1234918|P2|COMPLETED|Overall Study||10
504864|NCT00981409|1234919|P1|COMPLETED|Overall Study||24
504865|NCT00981409|1234918|P2|STARTED|Overall Study||11
504866|NCT00981409|1234919|P1|STARTED|Overall Study||30
504867|NCT00981370|1234933|P1|NOT COMPLETED|Overall Study||0
504868|NCT00981370|1234933|P1|COMPLETED|Overall Study||0
504869|NCT00981370|1234933|P1|STARTED|Overall Study||0
504870|NCT00981305|1234939|P2|NOT COMPLETED|Overall Study||10
504871|NCT00981305|1234940|P1|NOT COMPLETED|Overall Study||19
504872|NCT00981305|1234939|P2|COMPLETED|Overall Study||57
504873|NCT00981305|1234940|P1|COMPLETED|Overall Study||50
504874|NCT00981305|1234939|P2|STARTED|Overall Study||67
504875|NCT00981305|1234940|P1|STARTED|Overall Study||69
504876|NCT00981292|1234958|P6|NOT COMPLETED|Day 3||1
504877|NCT00981292|1234959|P5|NOT COMPLETED|Day 3||0
504878|NCT00981292|1234960|P4|NOT COMPLETED|Day 3||0
504879|NCT00981292|1234961|P3|NOT COMPLETED|Day 3||0
504880|NCT00981292|1234962|P2|NOT COMPLETED|Day 3||0
504881|NCT00981292|1234963|P1|NOT COMPLETED|Day 3||0
504882|NCT00981292|1234958|P6|COMPLETED|Day 3||4
504883|NCT00981292|1234959|P5|COMPLETED|Day 3||4
504884|NCT00981292|1234960|P4|COMPLETED|Day 3||4
504885|NCT00981292|1234961|P3|COMPLETED|Day 3||6
504886|NCT00981292|1234962|P2|COMPLETED|Day 3||4
504887|NCT00981292|1234963|P1|COMPLETED|Day 3||4
504888|NCT00981292|1234958|P6|STARTED|Day 3||5
504889|NCT00981292|1234959|P5|STARTED|Day 3||4
504890|NCT00981292|1234960|P4|STARTED|Day 3||4
504891|NCT00981292|1234961|P3|STARTED|Day 3||6
504892|NCT00981292|1234962|P2|STARTED|Day 3||4
504893|NCT00981292|1234963|P1|STARTED|Day 3||4
504894|NCT00981292|1234958|P6|NOT COMPLETED|Day 2||0
504895|NCT00981292|1234959|P5|NOT COMPLETED|Day 2||0
504896|NCT00981292|1234960|P4|NOT COMPLETED|Day 2||0
504897|NCT00981292|1234961|P3|NOT COMPLETED|Day 2||0
504898|NCT00981292|1234962|P2|NOT COMPLETED|Day 2||0
504899|NCT00981292|1234963|P1|NOT COMPLETED|Day 2||2
504900|NCT00981292|1234958|P6|COMPLETED|Day 2||5
504901|NCT00981292|1234959|P5|COMPLETED|Day 2||4
504902|NCT00981292|1234960|P4|COMPLETED|Day 2||4
504903|NCT00981292|1234961|P3|COMPLETED|Day 2||6
504904|NCT00981292|1234962|P2|COMPLETED|Day 2||4
504905|NCT00981292|1234963|P1|COMPLETED|Day 2||4
504906|NCT00981292|1234958|P6|STARTED|Day 2||5
504907|NCT00981292|1234959|P5|STARTED|Day 2||4
504908|NCT00981292|1234960|P4|STARTED|Day 2||4
504909|NCT00981292|1234961|P3|STARTED|Day 2||6
504910|NCT00981292|1234962|P2|STARTED|Day 2||4
504911|NCT00981292|1234963|P1|STARTED|Day 2||6
504912|NCT00981292|1234958|P6|NOT COMPLETED|Day 1||2
504913|NCT00981292|1234959|P5|NOT COMPLETED|Day 1||0
504914|NCT00981292|1234960|P4|NOT COMPLETED|Day 1||0
504915|NCT00981292|1234961|P3|NOT COMPLETED|Day 1||0
504916|NCT00981292|1234962|P2|NOT COMPLETED|Day 1||0
504917|NCT00981292|1234963|P1|NOT COMPLETED|Day 1||1
504918|NCT00981292|1234958|P6|COMPLETED|Day 1||5
504919|NCT00981292|1234959|P5|COMPLETED|Day 1||4
504920|NCT00981292|1234960|P4|COMPLETED|Day 1||4
504921|NCT00981292|1234961|P3|COMPLETED|Day 1||6
504922|NCT00981292|1234962|P2|COMPLETED|Day 1||4
504923|NCT00981292|1234963|P1|COMPLETED|Day 1||6
504924|NCT00981292|1234958|P6|STARTED|Day 1||7
504925|NCT00981292|1234959|P5|STARTED|Day 1||4
504926|NCT00981292|1234960|P4|STARTED|Day 1||4
504927|NCT00981292|1234961|P3|STARTED|Day 1||6
504928|NCT00981292|1234962|P2|STARTED|Day 1||4
504929|NCT00981292|1234963|P1|STARTED|Day 1||7
504930|NCT00981253|1234982|P2|NOT COMPLETED|Overall Study||3
504931|NCT00981253|1234983|P1|NOT COMPLETED|Overall Study||3
504932|NCT00981253|1234982|P2|COMPLETED|Overall Study||72
504933|NCT00981253|1234983|P1|COMPLETED|Overall Study||73
504934|NCT00981253|1234982|P2|STARTED|Overall Study||75
504935|NCT00981253|1234983|P1|STARTED|Overall Study||76
504936|NCT00981227|1235007|P6|NOT COMPLETED|Overall Study||18
504937|NCT00981227|1235008|P5|NOT COMPLETED|Overall Study||30
504938|NCT00981227|1235009|P4|NOT COMPLETED|Overall Study||21
504939|NCT00981227|1235010|P3|NOT COMPLETED|Overall Study||21
504940|NCT00981227|1235011|P2|NOT COMPLETED|Overall Study||19
504941|NCT00981227|1235012|P1|NOT COMPLETED|Overall Study||22
504942|NCT00981227|1235007|P6|COMPLETED|Overall Study||75
504943|NCT00981227|1235008|P5|COMPLETED|Overall Study||60
504944|NCT00981227|1235009|P4|COMPLETED|Overall Study||73
504945|NCT00981227|1235010|P3|COMPLETED|Overall Study||73
504946|NCT00981227|1235011|P2|COMPLETED|Overall Study||75
504947|NCT00981227|1235012|P1|COMPLETED|Overall Study||80
504948|NCT00981227|1235007|P6|Per–Protocol|Overall Study||70
504949|NCT00981227|1235008|P5|Per–Protocol|Overall Study||50
504950|NCT00981227|1235009|P4|Per–Protocol|Overall Study||68
504951|NCT00981227|1235010|P3|Per–Protocol|Overall Study||67
504952|NCT00981227|1235011|P2|Per–Protocol|Overall Study||72
504953|NCT00981227|1235012|P1|Per–Protocol|Overall Study||69
504954|NCT00981227|1235007|P6|Safety Population|Overall Study||93
504955|NCT00981227|1235008|P5|Safety Population|Overall Study||90
504956|NCT00981227|1235009|P4|Safety Population|Overall Study||94
504957|NCT00981227|1235010|P3|Safety Population|Overall Study||94
504958|NCT00981227|1235011|P2|Safety Population|Overall Study||94
504959|NCT00981227|1235012|P1|Safety Population|Overall Study||102
504960|NCT00981227|1235007|P6|Randomized|Overall Study||93
504961|NCT00981227|1235008|P5|Randomized|Overall Study||90
504962|NCT00981227|1235009|P4|Randomized|Overall Study||94
504963|NCT00981227|1235010|P3|Randomized|Overall Study||94
504964|NCT00981227|1235011|P2|Randomized|Overall Study||94
504965|NCT00981227|1235012|P1|Randomized|Overall Study||102
504966|NCT00981227|1235007|P6|STARTED|Overall Study||93
504967|NCT00981227|1235008|P5|STARTED|Overall Study||90
504968|NCT00981227|1235009|P4|STARTED|Overall Study||94
504969|NCT00981227|1235010|P3|STARTED|Overall Study||94
504970|NCT00981227|1235011|P2|STARTED|Overall Study||94
504971|NCT00981227|1235012|P1|STARTED|Overall Study||102
504972|NCT00981214|1235030|P1|NOT COMPLETED|Overall Study||0
504973|NCT00981214|1235030|P1|COMPLETED|Overall Study||19
504974|NCT00981214|1235030|P1|STARTED|Overall Study||19
504975|NCT00981175|1235047|P2|NOT COMPLETED|Booster Dose Vaccination||3
504976|NCT00981175|1235048|P1|NOT COMPLETED|Booster Dose Vaccination||2
504977|NCT00981175|1235047|P2|COMPLETED|Booster Dose Vaccination||40
504978|NCT00981175|1235048|P1|COMPLETED|Booster Dose Vaccination||53
504979|NCT00981175|1235047|P2|STARTED|Booster Dose Vaccination|A sub-set of participants in the group received the booster ChimeriVax™-JE vaccine.|43
504980|NCT00981175|1235048|P1|STARTED|Booster Dose Vaccination|A sub-set of participants in the group received the booster ChimeriVax™-JE vaccine.|55
504981|NCT00981175|1235047|P2|NOT COMPLETED|Primary Dose Vaccination||2
504982|NCT00981175|1235048|P1|NOT COMPLETED|Primary Dose Vaccination||3
504983|NCT00981175|1235047|P2|COMPLETED|Primary Dose Vaccination||99
504984|NCT00981175|1235048|P1|COMPLETED|Primary Dose Vaccination||98
504985|NCT00981175|1235047|P2|STARTED|Primary Dose Vaccination||101
504986|NCT00981175|1235048|P1|STARTED|Primary Dose Vaccination||101
504987|NCT00981149|1235073|P2|NOT COMPLETED|Overall Study||3
504988|NCT00981149|1235074|P1|NOT COMPLETED|Overall Study||2
504989|NCT00981149|1235073|P2|COMPLETED|Overall Study||9
504990|NCT00981149|1235074|P1|COMPLETED|Overall Study||10
504991|NCT00981149|1235073|P2|STARTED|Overall Study||12
504992|NCT00981149|1235074|P1|STARTED|Overall Study||12
504993|NCT00981084|1235084|P2|NOT COMPLETED|Post Intervention (Data Analysis)||1
504994|NCT00981084|1235085|P1|NOT COMPLETED|Post Intervention (Data Analysis)||2
504995|NCT00981084|1235084|P2|COMPLETED|Post Intervention (Data Analysis)||16
504996|NCT00981084|1235085|P1|COMPLETED|Post Intervention (Data Analysis)||14
504997|NCT00981084|1235084|P2|STARTED|Post Intervention (Data Analysis)||17
504998|NCT00981084|1235085|P1|STARTED|Post Intervention (Data Analysis)||16
504999|NCT00981084|1235084|P2|NOT COMPLETED|Second Intervention (One Day)||0
505000|NCT00981084|1235085|P1|NOT COMPLETED|Second Intervention (One Day)||0
505001|NCT00981084|1235084|P2|COMPLETED|Second Intervention (One Day)||17
505002|NCT00981084|1235085|P1|COMPLETED|Second Intervention (One Day)||16
505003|NCT00981084|1235084|P2|STARTED|Second Intervention (One Day)||17
505004|NCT00981084|1235085|P1|STARTED|Second Intervention (One Day)||16
505005|NCT00981084|1235084|P2|NOT COMPLETED|Washout Period (7 Days)||0
505006|NCT00981084|1235085|P1|NOT COMPLETED|Washout Period (7 Days)||0
505007|NCT00981084|1235084|P2|COMPLETED|Washout Period (7 Days)||17
505008|NCT00981084|1235085|P1|COMPLETED|Washout Period (7 Days)||16
505009|NCT00981084|1235084|P2|STARTED|Washout Period (7 Days)||17
505010|NCT00981084|1235085|P1|STARTED|Washout Period (7 Days)||16
505011|NCT00981084|1235084|P2|NOT COMPLETED|First Intervention (One Day)||0
505012|NCT00981084|1235085|P1|NOT COMPLETED|First Intervention (One Day)||0
505013|NCT00981084|1235084|P2|COMPLETED|First Intervention (One Day)||17
505014|NCT00981084|1235085|P1|COMPLETED|First Intervention (One Day)||16
505015|NCT00981084|1235084|P2|STARTED|First Intervention (One Day)||17
505016|NCT00981084|1235085|P1|STARTED|First Intervention (One Day)||16
505017|NCT00981058|1235101|P2|NOT COMPLETED|Overall Study||97
505018|NCT00981058|1235102|P1|NOT COMPLETED|Overall Study||120
505019|NCT00981058|1235101|P2|COMPLETED|Overall Study||451
505020|NCT00981058|1235102|P1|COMPLETED|Overall Study||425
505021|NCT00981058|1235101|P2|Death Due to Any Cause|Overall Study||442
505022|NCT00981058|1235102|P1|Death Due to Any Cause|Overall Study||418
505023|NCT00981058|1235101|P2|Received at Least 1 Dose of Study Drug|Overall Study||541
505024|NCT00981058|1235102|P1|Received at Least 1 Dose of Study Drug|Overall Study||538
505025|NCT00981058|1235101|P2|STARTED|Overall Study||548
505026|NCT00981058|1235102|P1|STARTED|Overall Study||545
505027|NCT00981045|1235124|P2|NOT COMPLETED|Overall Study||9
505028|NCT00981045|1235125|P1|NOT COMPLETED|Overall Study||14
505029|NCT00981045|1235124|P2|COMPLETED|Overall Study||1285
505030|NCT00981045|1235125|P1|COMPLETED|Overall Study||1276
505031|NCT00981045|1235124|P2|STARTED|Overall Study||1294
505032|NCT00981045|1235125|P1|STARTED|Overall Study||1290
505033|NCT00981019|1235133|P1|NOT COMPLETED|Overall Study||477
505034|NCT00981019|1235133|P1|COMPLETED|Overall Study||301
505035|NCT00981019|1235133|P1|STARTED|Overall Study||778
505036|NCT00980980|1235140|P3|NOT COMPLETED|Overall Study||0
505037|NCT00980980|1235141|P2|NOT COMPLETED|Overall Study||1
505038|NCT00980980|1235142|P1|NOT COMPLETED|Overall Study||0
505039|NCT00980980|1235140|P3|COMPLETED|Overall Study||13
505040|NCT00980980|1235141|P2|COMPLETED|Overall Study||13
505041|NCT00980980|1235142|P1|COMPLETED|Overall Study||16
505042|NCT00980980|1235140|P3|STARTED|Overall Study||13
505043|NCT00980980|1235141|P2|STARTED|Overall Study||14
505044|NCT00980980|1235142|P1|STARTED|Overall Study||16
505045|NCT00980798|1235173|P2|NOT COMPLETED|Overall Study||55
505046|NCT00980798|1235174|P1|NOT COMPLETED|Overall Study||33
505047|NCT00980798|1235173|P2|COMPLETED|Overall Study||84
505048|NCT00980798|1235174|P1|COMPLETED|Overall Study||116
505049|NCT00980798|1235173|P2|STARTED|Overall Study||139
505050|NCT00980798|1235174|P1|STARTED|Overall Study||149
505051|NCT00980746|1235188|P6|NOT COMPLETED|Overall Study||18
505052|NCT00980746|1235189|P5|NOT COMPLETED|Overall Study||17
505053|NCT00980746|1235190|P4|NOT COMPLETED|Overall Study||36
505054|NCT00980746|1235191|P3|NOT COMPLETED|Overall Study||20
505055|NCT00980746|1235192|P2|NOT COMPLETED|Overall Study||22
505056|NCT00980746|1235193|P1|NOT COMPLETED|Overall Study||27
505057|NCT00980746|1235188|P6|COMPLETED|Overall Study||78
505058|NCT00980746|1235189|P5|COMPLETED|Overall Study||75
505059|NCT00980746|1235190|P4|COMPLETED|Overall Study||64
505060|NCT00980746|1235191|P3|COMPLETED|Overall Study||75
505061|NCT00980746|1235192|P2|COMPLETED|Overall Study||67
505062|NCT00980746|1235193|P1|COMPLETED|Overall Study||58
505063|NCT00980746|1235188|P6|Per-protocol|Overall Study||74
505064|NCT00980746|1235189|P5|Per-protocol|Overall Study||73
505065|NCT00980746|1235190|P4|Per-protocol|Overall Study||62
505066|NCT00980746|1235191|P3|Per-protocol|Overall Study||73
505067|NCT00980746|1235192|P2|Per-protocol|Overall Study||66
505068|NCT00980746|1235193|P1|Per-protocol|Overall Study||55
505069|NCT00980746|1235188|P6|Safety Population|Overall Study||96
505070|NCT00980746|1235189|P5|Safety Population|Overall Study||92
505071|NCT00980746|1235190|P4|Safety Population|Overall Study||100
505072|NCT00980746|1235191|P3|Safety Population|Overall Study||95
505073|NCT00980746|1235192|P2|Safety Population|Overall Study||89
505074|NCT00980746|1235193|P1|Safety Population|Overall Study||85
505075|NCT00980746|1235188|P6|Randomized|Overall Study||96
505076|NCT00980746|1235189|P5|Randomized|Overall Study||92
505077|NCT00980746|1235190|P4|Randomized|Overall Study||100
505078|NCT00980746|1235191|P3|Randomized|Overall Study||95
505079|NCT00980746|1235192|P2|Randomized|Overall Study||89
505080|NCT00980746|1235193|P1|Randomized|Overall Study||85
505081|NCT00980746|1235188|P6|STARTED|Overall Study||96
505082|NCT00980746|1235189|P5|STARTED|Overall Study||92
505083|NCT00980746|1235190|P4|STARTED|Overall Study||100
505084|NCT00980746|1235191|P3|STARTED|Overall Study||95
505085|NCT00980746|1235192|P2|STARTED|Overall Study||89
505086|NCT00980746|1235193|P1|STARTED|Overall Study||85
505087|NCT00980681|1235207|P1|NOT COMPLETED|Dotarem MRA||0
505088|NCT00980681|1235207|P1|COMPLETED|Dotarem MRA||10
505089|NCT00980681|1235207|P1|STARTED|Dotarem MRA|Out of the 13 enrolled patients, three did not receive treatment|10
505090|NCT00980681|1235207|P1|NOT COMPLETED|TOF MRA||0
505091|NCT00980681|1235207|P1|COMPLETED|TOF MRA||10
505092|NCT00980681|1235207|P1|STARTED|TOF MRA|Out of the 13 enrolled patients, three did not receive treatment|10
505093|NCT00980655|1235215|P2|NOT COMPLETED|Overall Study||51
505094|NCT00980655|1235216|P1|NOT COMPLETED|Overall Study||16
505095|NCT00980655|1235215|P2|COMPLETED|Overall Study||139
505096|NCT00980655|1235216|P1|COMPLETED|Overall Study||45
505097|NCT00980655|1235215|P2|Vaccinated 23vPS Dose|Overall Study||140
505098|NCT00980655|1235216|P1|Vaccinated 23vPS Dose|Overall Study||45
505099|NCT00980655|1235215|P2|Vaccinated 13vPnC Dose 4|Overall Study||146
505100|NCT00980655|1235216|P1|Vaccinated 13vPnC Dose 4|Overall Study||46
505101|NCT00980655|1235215|P2|Vaccinated 13vPnC Dose 3|Overall Study||167
505102|NCT00980655|1235216|P1|Vaccinated 13vPnC Dose 3|Overall Study||54
505103|NCT00980655|1235215|P2|Vaccinated 13vPnC Dose 2|Overall Study||176
505104|NCT00980655|1235216|P1|Vaccinated 13vPnC Dose 2|Overall Study||55
505105|NCT00980655|1235215|P2|Vaccinated 13vPnC Dose 1|Overall Study||188
505106|NCT00980655|1235216|P1|Vaccinated 13vPnC Dose 1|Overall Study||59
505107|NCT00980655|1235215|P2|STARTED|Overall Study||190
505108|NCT00980655|1235216|P1|STARTED|Overall Study||61
505109|NCT00980642|1235264|P2|NOT COMPLETED|Overall Study||0
505110|NCT00980642|1235265|P1|NOT COMPLETED|Overall Study||0
505111|NCT00980642|1235264|P2|COMPLETED|Overall Study||20
505112|NCT00980642|1235265|P1|COMPLETED|Overall Study||36
505113|NCT00980642|1235264|P2|STARTED|Overall Study||20
505114|NCT00980642|1235265|P1|STARTED|Overall Study||36
505115|NCT00980590|1235277|P2|NOT COMPLETED|Overall Study||0
505116|NCT00980590|1235278|P1|NOT COMPLETED|Overall Study||0
505117|NCT00980590|1235277|P2|COMPLETED|Overall Study||50
505118|NCT00980590|1235278|P1|COMPLETED|Overall Study||50
505119|NCT00980590|1235277|P2|STARTED|Overall Study||50
505120|NCT00980590|1235278|P1|STARTED|Overall Study||50
505121|NCT00980343|1235292|P2|NOT COMPLETED|Overall Study||3
505122|NCT00980343|1235293|P1|NOT COMPLETED|Overall Study||1
505123|NCT00980343|1235292|P2|COMPLETED|Overall Study||20
505124|NCT00980343|1235293|P1|COMPLETED|Overall Study||20
505125|NCT00980343|1235292|P2|STARTED|Overall Study||23
505126|NCT00980343|1235293|P1|STARTED|Overall Study||21
505127|NCT00980330|1235317|P7|NOT COMPLETED|Overall Study||7
505128|NCT00980330|1235318|P6|NOT COMPLETED|Overall Study||4
505129|NCT00980330|1235319|P5|NOT COMPLETED|Overall Study||5
505130|NCT00980330|1235320|P4|NOT COMPLETED|Overall Study||5
505131|NCT00980330|1235321|P3|NOT COMPLETED|Overall Study||8
505132|NCT00980330|1235322|P2|NOT COMPLETED|Overall Study||5
505133|NCT00980330|1235323|P1|NOT COMPLETED|Overall Study||5
505134|NCT00980330|1235317|P7|COMPLETED|Overall Study||59
505135|NCT00980330|1235318|P6|COMPLETED|Overall Study||61
505136|NCT00980330|1235319|P5|COMPLETED|Overall Study||63
505137|NCT00980330|1235320|P4|COMPLETED|Overall Study||61
505138|NCT00980330|1235321|P3|COMPLETED|Overall Study||58
505139|NCT00980330|1235322|P2|COMPLETED|Overall Study||60
505140|NCT00980330|1235323|P1|COMPLETED|Overall Study||61
505141|NCT00980330|1235317|P7|STARTED|Overall Study||66
505142|NCT00980330|1235318|P6|STARTED|Overall Study||65
505143|NCT00980330|1235319|P5|STARTED|Overall Study||68
505144|NCT00980330|1235320|P4|STARTED|Overall Study||66
505145|NCT00980330|1235321|P3|STARTED|Overall Study||66
505146|NCT00980330|1235322|P2|STARTED|Overall Study||65
505147|NCT00980330|1235323|P1|STARTED|Overall Study||66
505148|NCT00980278|1235423|P2|NOT COMPLETED|Overall Study||0
505149|NCT00980278|1235424|P1|NOT COMPLETED|Overall Study||2
505150|NCT00980278|1235423|P2|COMPLETED|Overall Study||13
505151|NCT00980278|1235424|P1|COMPLETED|Overall Study||11
505152|NCT00980278|1235423|P2|STARTED|Overall Study||13
505153|NCT00980278|1235424|P1|STARTED|Overall Study||13
505154|NCT00980200|1235438|P5|NOT COMPLETED|7-day Treatment Period 5||0
505155|NCT00980200|1235439|P4|NOT COMPLETED|7-day Treatment Period 5||0
505156|NCT00980200|1235440|P3|NOT COMPLETED|7-day Treatment Period 5||0
505157|NCT00980200|1235441|P2|NOT COMPLETED|7-day Treatment Period 5||0
505158|NCT00980200|1235442|P1|NOT COMPLETED|7-day Treatment Period 5||0
505159|NCT00980200|1235438|P5|COMPLETED|7-day Treatment Period 5||14
505160|NCT00980200|1235439|P4|COMPLETED|7-day Treatment Period 5||16
505161|NCT00980200|1235440|P3|COMPLETED|7-day Treatment Period 5||15
505162|NCT00980200|1235441|P2|COMPLETED|7-day Treatment Period 5||12
505163|NCT00980200|1235442|P1|COMPLETED|7-day Treatment Period 5||15
505164|NCT00980200|1235438|P5|STARTED|7-day Treatment Period 5||14
505165|NCT00980200|1235439|P4|STARTED|7-day Treatment Period 5||16
505166|NCT00980200|1235440|P3|STARTED|7-day Treatment Period 5||15
505167|NCT00980200|1235441|P2|STARTED|7-day Treatment Period 5||12
505168|NCT00980200|1235442|P1|STARTED|7-day Treatment Period 5||15
505169|NCT00980200|1235438|P5|NOT COMPLETED|7-day Washout Period 4||0
505170|NCT00980200|1235439|P4|NOT COMPLETED|7-day Washout Period 4||0
505171|NCT00980200|1235440|P3|NOT COMPLETED|7-day Washout Period 4||0
505172|NCT00980200|1235441|P2|NOT COMPLETED|7-day Washout Period 4||0
505173|NCT00980200|1235442|P1|NOT COMPLETED|7-day Washout Period 4||0
505174|NCT00980200|1235438|P5|COMPLETED|7-day Washout Period 4||14
505175|NCT00980200|1235439|P4|COMPLETED|7-day Washout Period 4||16
505176|NCT00980200|1235440|P3|COMPLETED|7-day Washout Period 4||15
505177|NCT00980200|1235441|P2|COMPLETED|7-day Washout Period 4||12
505178|NCT00980200|1235442|P1|COMPLETED|7-day Washout Period 4||15
505179|NCT00980200|1235438|P5|STARTED|7-day Washout Period 4||14
505180|NCT00980200|1235439|P4|STARTED|7-day Washout Period 4||16
505181|NCT00980200|1235440|P3|STARTED|7-day Washout Period 4||15
505182|NCT00980200|1235441|P2|STARTED|7-day Washout Period 4||12
505183|NCT00980200|1235442|P1|STARTED|7-day Washout Period 4||15
505184|NCT00980200|1235438|P5|NOT COMPLETED|7-day Treatment Period 4||0
505185|NCT00980200|1235439|P4|NOT COMPLETED|7-day Treatment Period 4||0
505186|NCT00980200|1235440|P3|NOT COMPLETED|7-day Treatment Period 4||0
505187|NCT00980200|1235441|P2|NOT COMPLETED|7-day Treatment Period 4||0
505188|NCT00980200|1235442|P1|NOT COMPLETED|7-day Treatment Period 4||0
505189|NCT00980200|1235438|P5|COMPLETED|7-day Treatment Period 4||14
505190|NCT00980200|1235439|P4|COMPLETED|7-day Treatment Period 4||16
505191|NCT00980200|1235440|P3|COMPLETED|7-day Treatment Period 4||15
505192|NCT00980200|1235441|P2|COMPLETED|7-day Treatment Period 4||12
505193|NCT00980200|1235442|P1|COMPLETED|7-day Treatment Period 4||15
505194|NCT00980200|1235438|P5|STARTED|7-day Treatment Period 4||14
505195|NCT00980200|1235439|P4|STARTED|7-day Treatment Period 4||16
505196|NCT00980200|1235440|P3|STARTED|7-day Treatment Period 4||15
505197|NCT00980200|1235441|P2|STARTED|7-day Treatment Period 4||12
505198|NCT00980200|1235442|P1|STARTED|7-day Treatment Period 4||15
505199|NCT00980200|1235438|P5|NOT COMPLETED|7-day Washout Period 3||0
505200|NCT00980200|1235439|P4|NOT COMPLETED|7-day Washout Period 3||0
505201|NCT00980200|1235440|P3|NOT COMPLETED|7-day Washout Period 3||0
505202|NCT00980200|1235441|P2|NOT COMPLETED|7-day Washout Period 3||0
505203|NCT00980200|1235442|P1|NOT COMPLETED|7-day Washout Period 3||0
505204|NCT00980200|1235438|P5|COMPLETED|7-day Washout Period 3||14
505205|NCT00980200|1235439|P4|COMPLETED|7-day Washout Period 3||16
505206|NCT00980200|1235440|P3|COMPLETED|7-day Washout Period 3||15
505207|NCT00980200|1235441|P2|COMPLETED|7-day Washout Period 3||12
505208|NCT00980200|1235442|P1|COMPLETED|7-day Washout Period 3||15
505209|NCT00980200|1235438|P5|STARTED|7-day Washout Period 3||14
505210|NCT00980200|1235439|P4|STARTED|7-day Washout Period 3||16
505211|NCT00980200|1235440|P3|STARTED|7-day Washout Period 3||15
505212|NCT00980200|1235441|P2|STARTED|7-day Washout Period 3||12
505213|NCT00980200|1235442|P1|STARTED|7-day Washout Period 3||15
505214|NCT00980200|1235438|P5|NOT COMPLETED|7-day Treatment Period 3||1
505215|NCT00980200|1235439|P4|NOT COMPLETED|7-day Treatment Period 3||0
505216|NCT00980200|1235440|P3|NOT COMPLETED|7-day Treatment Period 3||0
505217|NCT00980200|1235441|P2|NOT COMPLETED|7-day Treatment Period 3||1
505218|NCT00980200|1235442|P1|NOT COMPLETED|7-day Treatment Period 3||0
505219|NCT00980200|1235438|P5|COMPLETED|7-day Treatment Period 3||14
505220|NCT00980200|1235439|P4|COMPLETED|7-day Treatment Period 3||16
505221|NCT00980200|1235440|P3|COMPLETED|7-day Treatment Period 3||15
505222|NCT00980200|1235441|P2|COMPLETED|7-day Treatment Period 3||12
505223|NCT00980200|1235442|P1|COMPLETED|7-day Treatment Period 3||15
505224|NCT00980200|1235438|P5|STARTED|7-day Treatment Period 3||15
505225|NCT00980200|1235439|P4|STARTED|7-day Treatment Period 3||16
505226|NCT00980200|1235440|P3|STARTED|7-day Treatment Period 3||15
505227|NCT00980200|1235441|P2|STARTED|7-day Treatment Period 3||13
505228|NCT00980200|1235442|P1|STARTED|7-day Treatment Period 3||15
505229|NCT00980200|1235438|P5|NOT COMPLETED|7-day Washout Period 2||0
505230|NCT00980200|1235439|P4|NOT COMPLETED|7-day Washout Period 2||0
505231|NCT00980200|1235440|P3|NOT COMPLETED|7-day Washout Period 2||0
505232|NCT00980200|1235441|P2|NOT COMPLETED|7-day Washout Period 2||0
505233|NCT00980200|1235442|P1|NOT COMPLETED|7-day Washout Period 2||0
505234|NCT00980200|1235438|P5|COMPLETED|7-day Washout Period 2||15
505235|NCT00980200|1235439|P4|COMPLETED|7-day Washout Period 2||16
505236|NCT00980200|1235440|P3|COMPLETED|7-day Washout Period 2||15
505237|NCT00980200|1235441|P2|COMPLETED|7-day Washout Period 2||13
505238|NCT00980200|1235442|P1|COMPLETED|7-day Washout Period 2||15
505239|NCT00980200|1235438|P5|STARTED|7-day Washout Period 2||15
505240|NCT00980200|1235439|P4|STARTED|7-day Washout Period 2||16
505241|NCT00980200|1235440|P3|STARTED|7-day Washout Period 2||15
505242|NCT00980200|1235441|P2|STARTED|7-day Washout Period 2||13
505243|NCT00980200|1235442|P1|STARTED|7-day Washout Period 2||15
505244|NCT00980200|1235438|P5|NOT COMPLETED|7-day Treatment Period 2||0
505245|NCT00980200|1235439|P4|NOT COMPLETED|7-day Treatment Period 2||0
505246|NCT00980200|1235440|P3|NOT COMPLETED|7-day Treatment Period 2||0
505247|NCT00980200|1235441|P2|NOT COMPLETED|7-day Treatment Period 2||0
505248|NCT00980200|1235442|P1|NOT COMPLETED|7-day Treatment Period 2||0
505249|NCT00980200|1235438|P5|COMPLETED|7-day Treatment Period 2||15
505250|NCT00980200|1235439|P4|COMPLETED|7-day Treatment Period 2||16
505251|NCT00980200|1235440|P3|COMPLETED|7-day Treatment Period 2||15
505252|NCT00980200|1235441|P2|COMPLETED|7-day Treatment Period 2||13
505253|NCT00980200|1235442|P1|COMPLETED|7-day Treatment Period 2||15
505254|NCT00980200|1235438|P5|STARTED|7-day Treatment Period 2||15
505255|NCT00980200|1235439|P4|STARTED|7-day Treatment Period 2||16
505256|NCT00980200|1235440|P3|STARTED|7-day Treatment Period 2||15
505257|NCT00980200|1235441|P2|STARTED|7-day Treatment Period 2||13
505258|NCT00980200|1235442|P1|STARTED|7-day Treatment Period 2||15
505259|NCT00980200|1235438|P5|NOT COMPLETED|7-day Washout Period 1||0
505260|NCT00980200|1235439|P4|NOT COMPLETED|7-day Washout Period 1||0
505261|NCT00980200|1235440|P3|NOT COMPLETED|7-day Washout Period 1||0
505262|NCT00980200|1235441|P2|NOT COMPLETED|7-day Washout Period 1||0
505263|NCT00980200|1235442|P1|NOT COMPLETED|7-day Washout Period 1||0
505264|NCT00980200|1235438|P5|COMPLETED|7-day Washout Period 1||15
505265|NCT00980200|1235439|P4|COMPLETED|7-day Washout Period 1||16
505266|NCT00980200|1235440|P3|COMPLETED|7-day Washout Period 1||15
505267|NCT00980200|1235441|P2|COMPLETED|7-day Washout Period 1||13
505268|NCT00980200|1235442|P1|COMPLETED|7-day Washout Period 1||15
505269|NCT00980200|1235438|P5|STARTED|7-day Washout Period 1||15
505270|NCT00980200|1235439|P4|STARTED|7-day Washout Period 1||16
505271|NCT00980200|1235440|P3|STARTED|7-day Washout Period 1||15
505272|NCT00980200|1235441|P2|STARTED|7-day Washout Period 1||13
505273|NCT00980200|1235442|P1|STARTED|7-day Washout Period 1||15
505274|NCT00980200|1235438|P5|NOT COMPLETED|7-day Treatment Period 1||0
505275|NCT00980200|1235439|P4|NOT COMPLETED|7-day Treatment Period 1||0
505276|NCT00980200|1235440|P3|NOT COMPLETED|7-day Treatment Period 1||0
505277|NCT00980200|1235441|P2|NOT COMPLETED|7-day Treatment Period 1||1
505278|NCT00980200|1235442|P1|NOT COMPLETED|7-day Treatment Period 1||0
505279|NCT00980200|1235438|P5|COMPLETED|7-day Treatment Period 1||15
505280|NCT00980200|1235439|P4|COMPLETED|7-day Treatment Period 1||16
505281|NCT00980200|1235440|P3|COMPLETED|7-day Treatment Period 1||15
505282|NCT00980200|1235441|P2|COMPLETED|7-day Treatment Period 1||13
505283|NCT00980200|1235442|P1|COMPLETED|7-day Treatment Period 1||15
505284|NCT00980200|1235438|P5|STARTED|7-day Treatment Period 1||15
505285|NCT00980200|1235439|P4|STARTED|7-day Treatment Period 1||16
505286|NCT00980200|1235440|P3|STARTED|7-day Treatment Period 1||15
505287|NCT00980200|1235441|P2|STARTED|7-day Treatment Period 1||14
505288|NCT00980200|1235442|P1|STARTED|7-day Treatment Period 1||15
505289|NCT00980174|1235461|P2|NOT COMPLETED|Overall Study||10
505290|NCT00980174|1235462|P1|NOT COMPLETED|Overall Study||4
505291|NCT00980174|1235461|P2|COMPLETED|Overall Study||111
505292|NCT00980174|1235462|P1|COMPLETED|Overall Study||117
505293|NCT00980174|1235461|P2|STARTED|Overall Study||121
505294|NCT00980174|1235462|P1|STARTED|Overall Study||121
505295|NCT00980148|1235480|P2|NOT COMPLETED|Overall Study||128
505296|NCT00980148|1235481|P1|NOT COMPLETED|Overall Study||129
505297|NCT00980148|1235480|P2|COMPLETED|Overall Study|Completed primary evaluation at study visit # 2 (day 28 after therapy started)|155
505298|NCT00980148|1235481|P1|COMPLETED|Overall Study|Completed primary evaluation at study visit # 2 (day 28 after therapy started)|155
505299|NCT00980148|1235480|P2|STARTED|Overall Study||283
505300|NCT00980148|1235481|P1|STARTED|Overall Study||284
505301|NCT00980044|1235490|P3|NOT COMPLETED|Overall Study||5
505302|NCT00980044|1235491|P2|NOT COMPLETED|Overall Study||7
505303|NCT00980044|1235492|P1|NOT COMPLETED|Overall Study||5
505304|NCT00980044|1235490|P3|COMPLETED|Overall Study||12
505305|NCT00980044|1235491|P2|COMPLETED|Overall Study||12
505306|NCT00980044|1235492|P1|COMPLETED|Overall Study||12
505307|NCT00980044|1235490|P3|STARTED|Overall Study||17
505308|NCT00980044|1235491|P2|STARTED|Overall Study||19
505309|NCT00980044|1235492|P1|STARTED|Overall Study||17
505310|NCT00980005|1235511|P2|NOT COMPLETED|Overall Study||63
505311|NCT00980005|1235512|P1|NOT COMPLETED|Overall Study||47
505312|NCT00980005|1235511|P2|COMPLETED|Overall Study||998
505313|NCT00980005|1235512|P1|COMPLETED|Overall Study||1008
505314|NCT00980005|1235511|P2|STARTED|Overall Study||1061
505315|NCT00980005|1235512|P1|STARTED|Overall Study||1055
505316|NCT00979992|1235552|P1|NOT COMPLETED|Overall Study||5
505317|NCT00979992|1235552|P1|COMPLETED|Overall Study||30
505318|NCT00979992|1235552|P1|STARTED|Overall Study||35
505319|NCT00979953|1235564|P4|NOT COMPLETED|Overall Study||7
505320|NCT00979953|1235565|P3|NOT COMPLETED|Overall Study||22
505321|NCT00979953|1235566|P2|NOT COMPLETED|Overall Study||5
505322|NCT00979953|1235567|P1|NOT COMPLETED|Overall Study||8
505323|NCT00979953|1235564|P4|COMPLETED|Overall Study||97
505324|NCT00979953|1235565|P3|COMPLETED|Overall Study||82
505325|NCT00979953|1235566|P2|COMPLETED|Overall Study||94
505326|NCT00979953|1235567|P1|COMPLETED|Overall Study||93
505327|NCT00979953|1235564|P4|Received at Least 1 Dose of Study Drug|Overall Study||104
505328|NCT00979953|1235565|P3|Received at Least 1 Dose of Study Drug|Overall Study||104
505329|NCT00979953|1235566|P2|Received at Least 1 Dose of Study Drug|Overall Study||99
505330|NCT00979953|1235567|P1|Received at Least 1 Dose of Study Drug|Overall Study||101
505331|NCT00979953|1235564|P4|STARTED|Overall Study||104
505332|NCT00979953|1235565|P3|STARTED|Overall Study||104
505333|NCT00979953|1235566|P2|STARTED|Overall Study||99
505334|NCT00979953|1235567|P1|STARTED|Overall Study||101
505335|NCT00979940|1235579|P2|NOT COMPLETED|Overall Study||0
505336|NCT00979940|1235580|P1|NOT COMPLETED|Overall Study||0
505337|NCT00979940|1235579|P2|COMPLETED|Overall Study||28
505338|NCT00979940|1235580|P1|COMPLETED|Overall Study||32
505339|NCT00979940|1235579|P2|STARTED|Overall Study||28
505340|NCT00979940|1235580|P1|STARTED|Overall Study||32
505341|NCT00979901|1235590|P4|NOT COMPLETED|Overall Study||116
505342|NCT00979901|1235591|P3|NOT COMPLETED|Overall Study||29
505343|NCT00979901|1235592|P2|NOT COMPLETED|Overall Study||12
505344|NCT00979901|1235593|P1|NOT COMPLETED|Overall Study||18
505345|NCT00979901|1235590|P4|COMPLETED|Overall Study||159
505346|NCT00979901|1235591|P3|COMPLETED|Overall Study||573
505347|NCT00979901|1235592|P2|COMPLETED|Overall Study||336
505348|NCT00979901|1235593|P1|COMPLETED|Overall Study||334
505349|NCT00979901|1235590|P4|STARTED|Overall Study||275
505350|NCT00979901|1235591|P3|STARTED|Overall Study||602
505351|NCT00979901|1235592|P2|STARTED|Overall Study||348
505352|NCT00979901|1235593|P1|STARTED|Overall Study||352
505353|NCT00979875|1235617|P6|NOT COMPLETED|Intervention 3||0
505354|NCT00979875|1235618|P5|NOT COMPLETED|Intervention 3||0
505355|NCT00979875|1235619|P4|NOT COMPLETED|Intervention 3||0
505356|NCT00979875|1235620|P3|NOT COMPLETED|Intervention 3||0
505357|NCT00979875|1235621|P2|NOT COMPLETED|Intervention 3||0
505358|NCT00979875|1235622|P1|NOT COMPLETED|Intervention 3||0
505359|NCT00979875|1235617|P6|COMPLETED|Intervention 3||2
505360|NCT00979875|1235618|P5|COMPLETED|Intervention 3||3
505361|NCT00979875|1235619|P4|COMPLETED|Intervention 3||2
505362|NCT00979875|1235620|P3|COMPLETED|Intervention 3||3
505363|NCT00979875|1235621|P2|COMPLETED|Intervention 3||2
505364|NCT00979875|1235622|P1|COMPLETED|Intervention 3||2
505365|NCT00979875|1235617|P6|STARTED|Intervention 3||2
505366|NCT00979875|1235618|P5|STARTED|Intervention 3||3
505367|NCT00979875|1235619|P4|STARTED|Intervention 3||2
505368|NCT00979875|1235620|P3|STARTED|Intervention 3||3
505369|NCT00979875|1235621|P2|STARTED|Intervention 3||2
505370|NCT00979875|1235622|P1|STARTED|Intervention 3||2
505371|NCT00979875|1235617|P6|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
505372|NCT00979875|1235618|P5|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
505373|NCT00979875|1235619|P4|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
505374|NCT00979875|1235620|P3|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
505375|NCT00979875|1235621|P2|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
505376|NCT00979875|1235622|P1|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
505377|NCT00979875|1235617|P6|COMPLETED|Washout 2 (3 to 14 Days)||2
505378|NCT00979875|1235618|P5|COMPLETED|Washout 2 (3 to 14 Days)||3
505379|NCT00979875|1235619|P4|COMPLETED|Washout 2 (3 to 14 Days)||2
505380|NCT00979875|1235620|P3|COMPLETED|Washout 2 (3 to 14 Days)||3
505381|NCT00979875|1235621|P2|COMPLETED|Washout 2 (3 to 14 Days)||2
505382|NCT00979875|1235622|P1|COMPLETED|Washout 2 (3 to 14 Days)||2
505383|NCT00979875|1235617|P6|STARTED|Washout 2 (3 to 14 Days)||2
505384|NCT00979875|1235618|P5|STARTED|Washout 2 (3 to 14 Days)||3
505385|NCT00979875|1235619|P4|STARTED|Washout 2 (3 to 14 Days)||2
505386|NCT00979875|1235620|P3|STARTED|Washout 2 (3 to 14 Days)||3
505387|NCT00979875|1235621|P2|STARTED|Washout 2 (3 to 14 Days)||2
505388|NCT00979875|1235622|P1|STARTED|Washout 2 (3 to 14 Days)||2
505389|NCT00979875|1235617|P6|NOT COMPLETED|Intervention 2||0
505390|NCT00979875|1235618|P5|NOT COMPLETED|Intervention 2||0
505391|NCT00979875|1235619|P4|NOT COMPLETED|Intervention 2||0
505392|NCT00979875|1235620|P3|NOT COMPLETED|Intervention 2||0
505393|NCT00979875|1235621|P2|NOT COMPLETED|Intervention 2||0
505394|NCT00979875|1235622|P1|NOT COMPLETED|Intervention 2||0
505395|NCT00979875|1235617|P6|COMPLETED|Intervention 2||2
505396|NCT00979875|1235618|P5|COMPLETED|Intervention 2||3
505397|NCT00979875|1235619|P4|COMPLETED|Intervention 2||2
505398|NCT00979875|1235620|P3|COMPLETED|Intervention 2||3
505399|NCT00979875|1235621|P2|COMPLETED|Intervention 2||2
505400|NCT00979875|1235622|P1|COMPLETED|Intervention 2||2
505401|NCT00979875|1235617|P6|STARTED|Intervention 2||2
505402|NCT00979875|1235618|P5|STARTED|Intervention 2||3
505403|NCT00979875|1235619|P4|STARTED|Intervention 2||2
505404|NCT00979875|1235620|P3|STARTED|Intervention 2||3
505405|NCT00979875|1235621|P2|STARTED|Intervention 2||2
505406|NCT00979875|1235622|P1|STARTED|Intervention 2||2
505407|NCT00979875|1235617|P6|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
505408|NCT00979875|1235618|P5|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
505409|NCT00979875|1235619|P4|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
505410|NCT00979875|1235620|P3|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
505411|NCT00979875|1235621|P2|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
505412|NCT00979875|1235622|P1|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
505413|NCT00979875|1235617|P6|COMPLETED|Washout 1 (3 to 14 Days)||2
505414|NCT00979875|1235618|P5|COMPLETED|Washout 1 (3 to 14 Days)||3
505415|NCT00979875|1235619|P4|COMPLETED|Washout 1 (3 to 14 Days)||2
505416|NCT00979875|1235620|P3|COMPLETED|Washout 1 (3 to 14 Days)||3
505417|NCT00979875|1235621|P2|COMPLETED|Washout 1 (3 to 14 Days)||2
505418|NCT00979875|1235622|P1|COMPLETED|Washout 1 (3 to 14 Days)||2
505419|NCT00979875|1235617|P6|STARTED|Washout 1 (3 to 14 Days)||2
505420|NCT00979875|1235618|P5|STARTED|Washout 1 (3 to 14 Days)||3
505421|NCT00979875|1235619|P4|STARTED|Washout 1 (3 to 14 Days)||2
505422|NCT00979875|1235620|P3|STARTED|Washout 1 (3 to 14 Days)||3
505423|NCT00979875|1235621|P2|STARTED|Washout 1 (3 to 14 Days)||2
505424|NCT00979875|1235622|P1|STARTED|Washout 1 (3 to 14 Days)||2
505425|NCT00979875|1235617|P6|NOT COMPLETED|Intervention 1||0
505426|NCT00979875|1235618|P5|NOT COMPLETED|Intervention 1||0
505427|NCT00979875|1235619|P4|NOT COMPLETED|Intervention 1||0
505428|NCT00979875|1235620|P3|NOT COMPLETED|Intervention 1||0
505429|NCT00979875|1235621|P2|NOT COMPLETED|Intervention 1||0
505430|NCT00979875|1235622|P1|NOT COMPLETED|Intervention 1||0
505431|NCT00979875|1235617|P6|COMPLETED|Intervention 1||2
505432|NCT00979875|1235618|P5|COMPLETED|Intervention 1||3
505433|NCT00979875|1235619|P4|COMPLETED|Intervention 1||2
505434|NCT00979875|1235620|P3|COMPLETED|Intervention 1||3
505435|NCT00979875|1235621|P2|COMPLETED|Intervention 1||2
505436|NCT00979875|1235622|P1|COMPLETED|Intervention 1||2
505437|NCT00979875|1235617|P6|Received at Least 1 Dose of Study Drug|Intervention 1||2
505438|NCT00979875|1235618|P5|Received at Least 1 Dose of Study Drug|Intervention 1||3
505439|NCT00979875|1235619|P4|Received at Least 1 Dose of Study Drug|Intervention 1||2
505440|NCT00979875|1235620|P3|Received at Least 1 Dose of Study Drug|Intervention 1||3
505441|NCT00979875|1235621|P2|Received at Least 1 Dose of Study Drug|Intervention 1||2
505442|NCT00979875|1235622|P1|Received at Least 1 Dose of Study Drug|Intervention 1||2
505443|NCT00979875|1235617|P6|STARTED|Intervention 1||2
505444|NCT00979875|1235618|P5|STARTED|Intervention 1||3
505445|NCT00979875|1235619|P4|STARTED|Intervention 1||2
505446|NCT00979875|1235620|P3|STARTED|Intervention 1||3
505447|NCT00979875|1235621|P2|STARTED|Intervention 1||2
505448|NCT00979875|1235622|P1|STARTED|Intervention 1||2
505449|NCT00979654|1235666|P1|NOT COMPLETED|Overall Study||36
505450|NCT00979654|1235666|P1|COMPLETED|Overall Study||67
505451|NCT00979654|1235666|P1|STARTED|Overall Study||103
505452|NCT00979628|1235681|P3|NOT COMPLETED|Overall Study||6
505453|NCT00979628|1235682|P2|NOT COMPLETED|Overall Study||9
505454|NCT00979628|1235683|P1|NOT COMPLETED|Overall Study||9
505455|NCT00979628|1235681|P3|COMPLETED|Overall Study||74
505456|NCT00979628|1235682|P2|COMPLETED|Overall Study||133
505457|NCT00979628|1235683|P1|COMPLETED|Overall Study||144
505458|NCT00979628|1235681|P3|STARTED|Overall Study||80
505459|NCT00979628|1235682|P2|STARTED|Overall Study||142
505460|NCT00979628|1235683|P1|STARTED|Overall Study||153
505461|NCT00979615|1235693|P2|NOT COMPLETED|Overall Study||8
505462|NCT00979615|1235694|P1|NOT COMPLETED|Overall Study||6
505463|NCT00979615|1235693|P2|COMPLETED|Overall Study||58
505464|NCT00979615|1235694|P1|COMPLETED|Overall Study||57
505465|NCT00979615|1235693|P2|STARTED|Overall Study||66
505466|NCT00979615|1235694|P1|STARTED|Overall Study||63
505467|NCT00979602|1235710|P2|NOT COMPLETED|Overall Study||133
505468|NCT00979602|1235711|P1|NOT COMPLETED|Overall Study||145
505469|NCT00979602|1235710|P2|COMPLETED|Overall Study||1890
505470|NCT00979602|1235711|P1|COMPLETED|Overall Study||1880
505471|NCT00979602|1235710|P2|STARTED|Overall Study||2023
505472|NCT00979602|1235711|P1|STARTED|Overall Study||2025
505473|NCT00979576|1235882|P3|NOT COMPLETED|Combination Followed by Monotherapy||1
505474|NCT00979576|1235883|P2|NOT COMPLETED|Combination Followed by Monotherapy||2
505475|NCT00979576|1235884|P1|NOT COMPLETED|Combination Followed by Monotherapy||0
505476|NCT00979576|1235882|P3|COMPLETED|Combination Followed by Monotherapy||0
505477|NCT00979576|1235883|P2|COMPLETED|Combination Followed by Monotherapy||0
505478|NCT00979576|1235884|P1|COMPLETED|Combination Followed by Monotherapy||0
505479|NCT00979576|1235882|P3|STARTED|Combination Followed by Monotherapy||1
505480|NCT00979576|1235883|P2|STARTED|Combination Followed by Monotherapy||2
505481|NCT00979576|1235884|P1|STARTED|Combination Followed by Monotherapy||0
505482|NCT00979576|1235882|P3|NOT COMPLETED|Combination Treatment Phase||9
505483|NCT00979576|1235883|P2|NOT COMPLETED|Combination Treatment Phase||6
505484|NCT00979576|1235884|P1|NOT COMPLETED|Combination Treatment Phase||3
505485|NCT00979576|1235882|P3|COMPLETED|Combination Treatment Phase||0
505486|NCT00979576|1235883|P2|COMPLETED|Combination Treatment Phase||0
505487|NCT00979576|1235884|P1|COMPLETED|Combination Treatment Phase||0
505488|NCT00979576|1235882|P3|STARTED|Combination Treatment Phase||9
505489|NCT00979576|1235883|P2|STARTED|Combination Treatment Phase||6
505490|NCT00979576|1235884|P1|STARTED|Combination Treatment Phase||3
505491|NCT00979550|1235917|P2|NOT COMPLETED|Overall Study||0
505492|NCT00979550|1235918|P1|NOT COMPLETED|Overall Study||0
505493|NCT00979550|1235917|P2|COMPLETED|Overall Study||3
505494|NCT00979550|1235918|P1|COMPLETED|Overall Study||4
505495|NCT00979550|1235917|P2|STARTED|Overall Study||3
505496|NCT00979550|1235918|P1|STARTED|Overall Study||4
505497|NCT00979459|1235924|P2|NOT COMPLETED|Second Intervention||0
505498|NCT00979459|1235925|P1|NOT COMPLETED|Second Intervention||0
505499|NCT00979459|1235924|P2|COMPLETED|Second Intervention||6
505500|NCT00979459|1235925|P1|COMPLETED|Second Intervention||6
505501|NCT00979459|1235924|P2|STARTED|Second Intervention||6
505502|NCT00979459|1235925|P1|STARTED|Second Intervention||6
505503|NCT00979459|1235924|P2|NOT COMPLETED|7-day Washout Period||0
505504|NCT00979459|1235925|P1|NOT COMPLETED|7-day Washout Period||0
505505|NCT00979459|1235924|P2|COMPLETED|7-day Washout Period||6
505506|NCT00979459|1235925|P1|COMPLETED|7-day Washout Period||6
505507|NCT00979459|1235924|P2|STARTED|7-day Washout Period||6
505508|NCT00979459|1235925|P1|STARTED|7-day Washout Period||6
505509|NCT00979459|1235924|P2|NOT COMPLETED|First Intervention||0
505510|NCT00979459|1235925|P1|NOT COMPLETED|First Intervention||0
505511|NCT00979459|1235924|P2|COMPLETED|First Intervention||6
505512|NCT00979459|1235925|P1|COMPLETED|First Intervention||6
505513|NCT00979459|1235924|P2|STARTED|First Intervention||6
505514|NCT00979459|1235925|P1|STARTED|First Intervention||6
505515|NCT00979420|1235941|P4|NOT COMPLETED|Overall Study||2
505516|NCT00979420|1235942|P3|NOT COMPLETED|Overall Study||1
505517|NCT00979420|1235943|P2|NOT COMPLETED|Overall Study||0
505518|NCT00979420|1235944|P1|NOT COMPLETED|Overall Study||7
505519|NCT00979420|1235941|P4|COMPLETED|Overall Study||59
505520|NCT00979420|1235942|P3|COMPLETED|Overall Study||59
505521|NCT00979420|1235943|P2|COMPLETED|Overall Study||57
505522|NCT00979420|1235944|P1|COMPLETED|Overall Study||171
505523|NCT00979420|1235941|P4|STARTED|Overall Study||61
505524|NCT00979420|1235942|P3|STARTED|Overall Study||60
505525|NCT00979420|1235943|P2|STARTED|Overall Study||57
505526|NCT00979420|1235944|P1|STARTED|Overall Study||178
505527|NCT00979303|1236014|P2|NOT COMPLETED|Overall Study||0
505528|NCT00979303|1236015|P1|NOT COMPLETED|Overall Study||0
505529|NCT00979303|1236014|P2|COMPLETED|Overall Study||37
505530|NCT00979303|1236015|P1|COMPLETED|Overall Study||37
505531|NCT00979303|1236014|P2|STARTED|Overall Study||37
505532|NCT00979303|1236015|P1|STARTED|Overall Study||37
505533|NCT00979212|1236025|P2|NOT COMPLETED|Overall Study||8
505534|NCT00979212|1236026|P1|NOT COMPLETED|Overall Study||2
505535|NCT00979212|1236025|P2|COMPLETED|Overall Study|Subjects with data available for primary analysis are considered to have completed the study.|39
505536|NCT00979212|1236026|P1|COMPLETED|Overall Study|Subjects with data available for primary analysis are considered to have completed the study.|22
505537|NCT00979212|1236025|P2|STARTED|Overall Study||47
505538|NCT00979212|1236026|P1|STARTED|Overall Study||24
505539|NCT00979199|1236044|P1|NOT COMPLETED|Overall Study||222
505540|NCT00979199|1236044|P1|COMPLETED|Overall Study||475
505541|NCT00979199|1236044|P1|STARTED|Overall Study||697
505542|NCT00979121|1236050|P2|NOT COMPLETED|Overall Study||0
505543|NCT00979121|1236051|P1|NOT COMPLETED|Overall Study||0
505544|NCT00979121|1236050|P2|COMPLETED|Overall Study||366
505545|NCT00979121|1236051|P1|COMPLETED|Overall Study||379
505546|NCT00979121|1236050|P2|STARTED|Overall Study||366
505547|NCT00979121|1236051|P1|STARTED|Overall Study||379
505548|NCT00979069|1236069|P2|NOT COMPLETED|Overall Study||2
505549|NCT00979069|1236070|P1|NOT COMPLETED|Overall Study||0
505550|NCT00979069|1236069|P2|COMPLETED|Overall Study||8
505551|NCT00979069|1236070|P1|COMPLETED|Overall Study||10
505552|NCT00979069|1236069|P2|STARTED|Overall Study||10
505553|NCT00979069|1236070|P1|STARTED|Overall Study||10
505554|NCT00979017|1236076|P1|NOT COMPLETED|Overall Study||0
505555|NCT00979017|1236076|P1|COMPLETED|Overall Study||41
505556|NCT00979017|1236076|P1|STARTED|Overall Study||41
505557|NCT00978757|1236086|P2|NOT COMPLETED|Overall Study||3
505558|NCT00978757|1236087|P1|NOT COMPLETED|Overall Study||1
505559|NCT00978757|1236086|P2|COMPLETED|Overall Study|June 2008|17
505560|NCT00978757|1236087|P1|COMPLETED|Overall Study|June 2008|21
505561|NCT00978757|1236086|P2|STARTED|Overall Study|June 2001|20
505562|NCT00978757|1236087|P1|STARTED|Overall Study|June 2001|22
505563|NCT00978731|1236097|P4|NOT COMPLETED|Overall Study||4
505564|NCT00978731|1236098|P3|NOT COMPLETED|Overall Study||5
505565|NCT00978731|1236099|P2|NOT COMPLETED|Overall Study||15
505566|NCT00978731|1236100|P1|NOT COMPLETED|Overall Study||22
505567|NCT00978731|1236097|P4|COMPLETED|Overall Study||0
505568|NCT00978731|1236098|P3|COMPLETED|Overall Study||0
505569|NCT00978731|1236099|P2|COMPLETED|Overall Study||0
505570|NCT00978731|1236100|P1|COMPLETED|Overall Study||0
505571|NCT00978731|1236097|P4|STARTED|Overall Study||4
505572|NCT00978731|1236098|P3|STARTED|Overall Study||5
505573|NCT00978731|1236099|P2|STARTED|Overall Study||15
505574|NCT00978731|1236100|P1|STARTED|Overall Study||22
505575|NCT00978627|1236140|P2|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||9
505576|NCT00978627|1236141|P1|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||21
505577|NCT00978627|1236140|P2|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||113
505578|NCT00978627|1236141|P1|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||233
505579|NCT00978627|1236140|P2|STARTED|Extension: Week 27 to 52 (NN5401-3645)|Thirty four subjects from main trial did not continue into extension trial|122
505580|NCT00978627|1236141|P1|STARTED|Extension: Week 27 to 52 (NN5401-3645)|Sixty six subjects from main trial did not continue into extension trial|254
505581|NCT00978627|1236140|P2|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||26
505582|NCT00978627|1236141|P1|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||46
505583|NCT00978627|1236140|P2|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||156
505584|NCT00978627|1236141|P1|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||320
505585|NCT00978627|1236140|P2|Exposed|Main: Week 0 to 26 (NN5401-3594)|Two subjects withdrew prior to exposure to trial products|180
505586|NCT00978627|1236141|P1|Exposed|Main: Week 0 to 26 (NN5401-3594)|Four subjects withdrew prior to exposure to trial products|362
505587|NCT00978627|1236140|P2|STARTED|Main: Week 0 to 26 (NN5401-3594)||182
505588|NCT00978627|1236141|P1|STARTED|Main: Week 0 to 26 (NN5401-3594)||366
505589|NCT00978562|1236163|P1|NOT COMPLETED|Overall Study||0
505590|NCT00978562|1236163|P1|COMPLETED|Overall Study||7
505591|NCT00978562|1236163|P1|STARTED|Overall Study||7
505592|NCT00978445|1236168|P2|NOT COMPLETED|Overall Study||1
505593|NCT00978445|1236169|P1|NOT COMPLETED|Overall Study||2
505594|NCT00978445|1236168|P2|COMPLETED|Overall Study||12
505595|NCT00978445|1236169|P1|COMPLETED|Overall Study||10
505596|NCT00978445|1236168|P2|STARTED|Overall Study||13
505597|NCT00978445|1236169|P1|STARTED|Overall Study||12
505598|NCT00978432|1236179|P3|NOT COMPLETED|Overall Study||5
505599|NCT00978432|1236180|P2|NOT COMPLETED|Overall Study||1
505600|NCT00978432|1236181|P1|NOT COMPLETED|Overall Study||3
505601|NCT00978432|1236179|P3|COMPLETED|Overall Study||13
505602|NCT00978432|1236180|P2|COMPLETED|Overall Study||4
505603|NCT00978432|1236181|P1|COMPLETED|Overall Study||7
505604|NCT00978432|1236179|P3|STARTED|Overall Study||18
505605|NCT00978432|1236180|P2|STARTED|Overall Study||5
505606|NCT00978432|1236181|P1|STARTED|Overall Study||10
505607|NCT00978419|1236203|P2|NOT COMPLETED|Overall Study||0
505608|NCT00978419|1236204|P1|NOT COMPLETED|Overall Study||0
505609|NCT00978419|1236203|P2|COMPLETED|Overall Study||0
505610|NCT00978419|1236204|P1|COMPLETED|Overall Study||0
505611|NCT00978419|1236203|P2|STARTED|Overall Study||0
505612|NCT00978419|1236204|P1|STARTED|Overall Study||0
505613|NCT00978380|1236232|P1|NOT COMPLETED|Overall Study||19
505614|NCT00978380|1236232|P1|COMPLETED|Overall Study||44
505615|NCT00978380|1236232|P1|STARTED|Overall Study||63
505616|NCT00978341|1236238|P2|NOT COMPLETED|Second Intervention||0
505617|NCT00978341|1236239|P1|NOT COMPLETED|Second Intervention||0
505618|NCT00978341|1236238|P2|COMPLETED|Second Intervention||7
505619|NCT00978341|1236239|P1|COMPLETED|Second Intervention||7
505620|NCT00978341|1236238|P2|STARTED|Second Intervention||7
505621|NCT00978341|1236239|P1|STARTED|Second Intervention||7
505622|NCT00978341|1236238|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
505623|NCT00978341|1236239|P1|NOT COMPLETED|Washout Period of 2 Weeks||1
505624|NCT00978341|1236238|P2|COMPLETED|Washout Period of 2 Weeks||7
505625|NCT00978341|1236239|P1|COMPLETED|Washout Period of 2 Weeks||7
505626|NCT00978341|1236238|P2|STARTED|Washout Period of 2 Weeks||7
505627|NCT00978341|1236239|P1|STARTED|Washout Period of 2 Weeks||8
505628|NCT00978341|1236238|P2|NOT COMPLETED|First Intervention||0
505629|NCT00978341|1236239|P1|NOT COMPLETED|First Intervention||0
505630|NCT00978341|1236238|P2|COMPLETED|First Intervention||7
505631|NCT00978341|1236239|P1|COMPLETED|First Intervention||8
505632|NCT00978341|1236238|P2|STARTED|First Intervention||7
505633|NCT00978341|1236239|P1|STARTED|First Intervention||8
505634|NCT00978120|1236261|P4|NOT COMPLETED|Overall Study||2
505635|NCT00978120|1236262|P3|NOT COMPLETED|Overall Study||3
505636|NCT00978120|1236263|P2|NOT COMPLETED|Overall Study||0
505637|NCT00978120|1236264|P1|NOT COMPLETED|Overall Study||2
505638|NCT00978120|1236261|P4|COMPLETED|Overall Study||84
505639|NCT00978120|1236262|P3|COMPLETED|Overall Study||84
505640|NCT00978120|1236263|P2|COMPLETED|Overall Study||107
505641|NCT00978120|1236264|P1|COMPLETED|Overall Study||108
505642|NCT00978120|1236261|P4|STARTED|Overall Study||86
505643|NCT00978120|1236262|P3|STARTED|Overall Study||87
505644|NCT00978120|1236263|P2|STARTED|Overall Study||107
505645|NCT00978120|1236264|P1|STARTED|Overall Study||110
505646|NCT00978042|1236316|P2|NOT COMPLETED|Received Repeat Treatment||3
505647|NCT00978042|1236317|P1|NOT COMPLETED|Received Repeat Treatment||43
505648|NCT00978042|1236316|P2|COMPLETED|Received Repeat Treatment||23
505649|NCT00978042|1236317|P1|COMPLETED|Received Repeat Treatment|Completed=Completed Repeat Treatment Follow-up|98
505650|NCT00978042|1236316|P2|STARTED|Received Repeat Treatment|Participants who were deemed eligible for re-treatment.|26
505651|NCT00978042|1236317|P1|STARTED|Received Repeat Treatment|Participants who were deemed eligible for re-treatment.|141
505652|NCT00978042|1236316|P2|NOT COMPLETED|Initial Treatment Period||15
505653|NCT00978042|1236317|P1|NOT COMPLETED|Initial Treatment Period||61
505654|NCT00978042|1236316|P2|COMPLETED|Initial Treatment Period||32
505655|NCT00978042|1236317|P1|COMPLETED|Initial Treatment Period|Completed 24-month Follow-Up|174
505656|NCT00978042|1236316|P2|MITT_treated With VOLUMA XC|Initial Treatment Period||35
505657|NCT00978042|1236317|P1|MITT_treated With VOLUMA XC|Initial Treatment Period||235
505658|NCT00978042|1236316|P2|STARTED|Initial Treatment Period||47
505659|NCT00978042|1236317|P1|STARTED|Initial Treatment Period||235
505660|NCT00978029|1236330|P3|NOT COMPLETED|Overall Study||6
505661|NCT00978029|1236331|P2|NOT COMPLETED|Overall Study||3
505662|NCT00978029|1236332|P1|NOT COMPLETED|Overall Study||1
505663|NCT00978029|1236330|P3|COMPLETED|Overall Study||59
505664|NCT00978029|1236331|P2|COMPLETED|Overall Study||63
505665|NCT00978029|1236332|P1|COMPLETED|Overall Study||64
505666|NCT00978029|1236330|P3|STARTED|Overall Study||65
505667|NCT00978029|1236331|P2|STARTED|Overall Study||66
505668|NCT00978029|1236332|P1|STARTED|Overall Study||65
505669|NCT00977938|1236359|P4|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||3
505670|NCT00977938|1236360|P3|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||12
505671|NCT00977938|1236361|P2|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||58
505672|NCT00977938|1236362|P1|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||51
505673|NCT00977938|1236359|P4|COMPLETED|Observation (30-33 mo. Post Procedure)||781
505674|NCT00977938|1236360|P3|COMPLETED|Observation (30-33 mo. Post Procedure)||784
505675|NCT00977938|1236361|P2|COMPLETED|Observation (30-33 mo. Post Procedure)||4658
505676|NCT00977938|1236362|P1|COMPLETED|Observation (30-33 mo. Post Procedure)||4732
505677|NCT00977938|1236359|P4|STARTED|Observation (30-33 mo. Post Procedure)||784
505678|NCT00977938|1236360|P3|STARTED|Observation (30-33 mo. Post Procedure)||796
505679|NCT00977938|1236361|P2|STARTED|Observation (30-33 mo. Post Procedure)||4716
505680|NCT00977938|1236362|P1|STARTED|Observation (30-33 mo. Post Procedure)||4783
505681|NCT00977938|1236359|P4|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||61
505682|NCT00977938|1236360|P3|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||46
505683|NCT00977938|1236361|P2|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||225
505684|NCT00977938|1236362|P1|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||237
505685|NCT00977938|1236359|P4|COMPLETED|Treatment (12-30 mo. Post Procedure)||784
505686|NCT00977938|1236360|P3|COMPLETED|Treatment (12-30 mo. Post Procedure)||796
505687|NCT00977938|1236361|P2|COMPLETED|Treatment (12-30 mo. Post Procedure)||4716
505688|NCT00977938|1236362|P1|COMPLETED|Treatment (12-30 mo. Post Procedure)||4783
505689|NCT00977938|1236359|P4|STARTED|Treatment (12-30 mo. Post Procedure)||845
505690|NCT00977938|1236360|P3|STARTED|Treatment (12-30 mo. Post Procedure)||842
505691|NCT00977938|1236361|P2|STARTED|Treatment (12-30 mo. Post Procedure)||4941
505692|NCT00977938|1236362|P1|STARTED|Treatment (12-30 mo. Post Procedure)||5020
505693|NCT00977808|1236396|P1|NOT COMPLETED|Overall Study||1
505694|NCT00977808|1236396|P1|COMPLETED|Overall Study||11
505695|NCT00977808|1236396|P1|Completion of Closed-Loop Admission|Overall Study||11
505696|NCT00977808|1236396|P1|Completion of Open-Loop Admission|Overall Study||12
505697|NCT00977808|1236396|P1|STARTED|Overall Study||12
505698|NCT00977769|1236404|P3|NOT COMPLETED|Overall Study||0
505699|NCT00977769|1236405|P2|NOT COMPLETED|Overall Study||0
505700|NCT00977769|1236406|P1|NOT COMPLETED|Overall Study||0
505701|NCT00977769|1236404|P3|COMPLETED|Overall Study||25
505702|NCT00977769|1236405|P2|COMPLETED|Overall Study||26
505703|NCT00977769|1236406|P1|COMPLETED|Overall Study||25
505704|NCT00977769|1236404|P3|STARTED|Overall Study||25
505705|NCT00977769|1236405|P2|STARTED|Overall Study||26
505706|NCT00977769|1236406|P1|STARTED|Overall Study||25
505707|NCT00977704|1236420|P1|NOT COMPLETED|Overall Study||0
505708|NCT00977704|1236420|P1|COMPLETED|Overall Study||20
505709|NCT00977704|1236420|P1|STARTED|Overall Study||20
505710|NCT00977665|1236426|P2|NOT COMPLETED|Overall Study||15
505711|NCT00977665|1236427|P1|NOT COMPLETED|Overall Study||21
505712|NCT00977665|1236426|P2|COMPLETED|Overall Study||75
505713|NCT00977665|1236427|P1|COMPLETED|Overall Study||63
505714|NCT00977665|1236426|P2|STARTED|Overall Study||90
505715|NCT00977665|1236427|P1|STARTED|Overall Study||84
505716|NCT00977613|1236459|P1|NOT COMPLETED|Overall Study||16
505717|NCT00977613|1236459|P1|COMPLETED|Overall Study||34
505718|NCT00977613|1236459|P1|STARTED|Overall Study||50
505719|NCT00977574|1236466|P3|NOT COMPLETED|Overall Study||4
505720|NCT00977574|1236467|P2|NOT COMPLETED|Overall Study||2
505721|NCT00977574|1236468|P1|NOT COMPLETED|Overall Study||4
505722|NCT00977574|1236466|P3|COMPLETED|Overall Study||114
505723|NCT00977574|1236467|P2|COMPLETED|Overall Study||113
505724|NCT00977574|1236468|P1|COMPLETED|Overall Study||112
505725|NCT00977574|1236466|P3|STARTED|Overall Study||118
505726|NCT00977574|1236467|P2|STARTED|Overall Study||115
505727|NCT00977574|1236468|P1|STARTED|Overall Study||116
505728|NCT00977561|1236487|P2|NOT COMPLETED|Overall Study||4
505729|NCT00977561|1236488|P1|NOT COMPLETED|Overall Study||5
505730|NCT00977561|1236487|P2|COMPLETED|Overall Study||0
505731|NCT00977561|1236488|P1|COMPLETED|Overall Study||0
505732|NCT00977561|1236487|P2|STARTED|Overall Study||4
505733|NCT00977561|1236488|P1|STARTED|Overall Study||5
505734|NCT00977548|1236515|P1|NOT COMPLETED|Overall Study||13
505735|NCT00977548|1236515|P1|COMPLETED|Overall Study||26
505736|NCT00977548|1236515|P1|STARTED|Overall Study||39
505737|NCT00977470|1236524|P2|NOT COMPLETED|Overall Study||38
505738|NCT00977470|1236525|P1|NOT COMPLETED|Overall Study||38
505739|NCT00977470|1236524|P2|COMPLETED|Overall Study||0
505740|NCT00977470|1236525|P1|COMPLETED|Overall Study||0
505741|NCT00977470|1236524|P2|STARTED|Overall Study||38
505742|NCT00977470|1236525|P1|STARTED|Overall Study||38
505743|NCT00977379|1236545|P2|NOT COMPLETED|Overall Study||12
505744|NCT00977379|1236546|P1|NOT COMPLETED|Overall Study||12
505745|NCT00977379|1236545|P2|COMPLETED|Overall Study||0
505746|NCT00977379|1236546|P1|COMPLETED|Overall Study||0
505747|NCT00977379|1236545|P2|Treated|Overall Study||11
505748|NCT00977379|1236546|P1|Treated|Overall Study||12
505749|NCT00977379|1236545|P2|STARTED|Overall Study|Randomized|12
505750|NCT00977379|1236546|P1|STARTED|Overall Study|Randomized|12
505751|NCT00977314|1236582|P2|NOT COMPLETED|Overall Study||0
505752|NCT00977314|1236583|P1|NOT COMPLETED|Overall Study||2
505753|NCT00977314|1236582|P2|COMPLETED|Overall Study|First 5 subjects enrolled were pilot subjects and not included in analysis.|5
505754|NCT00977314|1236583|P1|COMPLETED|Overall Study||28
505755|NCT00977314|1236582|P2|STARTED|Overall Study|First 5 subjects enrolled were pilot subjects and not included in analysis.|5
505756|NCT00977314|1236583|P1|STARTED|Overall Study||30
505757|NCT00977197|1236591|P2|NOT COMPLETED|Overall Study||9
505758|NCT00977197|1236592|P1|NOT COMPLETED|Overall Study||9
505759|NCT00977197|1236591|P2|COMPLETED|Overall Study||35
505760|NCT00977197|1236592|P1|COMPLETED|Overall Study||32
505761|NCT00977197|1236591|P2|STARTED|Overall Study||44
505762|NCT00977197|1236592|P1|STARTED|Overall Study||41
505763|NCT00977184|1236622|P2|NOT COMPLETED|Overall Study||0
505764|NCT00977184|1236623|P1|NOT COMPLETED|Overall Study||0
505765|NCT00977184|1236622|P2|COMPLETED|Overall Study||13
505766|NCT00977184|1236623|P1|COMPLETED|Overall Study||13
505767|NCT00977184|1236622|P2|STARTED|Overall Study||13
505768|NCT00977184|1236623|P1|STARTED|Overall Study||13
505769|NCT00977171|1236649|P1|NOT COMPLETED|Overall Study||0
505770|NCT00977171|1236649|P1|COMPLETED|Overall Study||3
505771|NCT00977171|1236649|P1|STARTED|Overall Study||3
505772|NCT00977106|1236655|P2|NOT COMPLETED|Overall Study||11
505773|NCT00977106|1236656|P1|NOT COMPLETED|Overall Study||10
505774|NCT00977106|1236655|P2|COMPLETED|Overall Study||45
505775|NCT00977106|1236656|P1|COMPLETED|Overall Study||37
505776|NCT00977106|1236655|P2|STARTED|Overall Study|Includes 3 participants who were randomized to placebo, but received tocilizumab.|56
505777|NCT00977106|1236656|P1|STARTED|Overall Study||47
505778|NCT00977080|1236748|P4|NOT COMPLETED|Overall Study||17
505779|NCT00977080|1236749|P3|NOT COMPLETED|Overall Study||16
505780|NCT00977080|1236750|P2|NOT COMPLETED|Overall Study||20
505781|NCT00977080|1236751|P1|NOT COMPLETED|Overall Study||12
505782|NCT00977080|1236748|P4|COMPLETED|Overall Study||53
505783|NCT00977080|1236749|P3|COMPLETED|Overall Study||56
505784|NCT00977080|1236750|P2|COMPLETED|Overall Study||44
505785|NCT00977080|1236751|P1|COMPLETED|Overall Study||50
505786|NCT00977080|1236748|P4|STARTED|Overall Study||70
505787|NCT00977080|1236749|P3|STARTED|Overall Study||72
505788|NCT00977080|1236750|P2|STARTED|Overall Study||64
505789|NCT00977080|1236751|P1|STARTED|Overall Study||62
505790|NCT00976989|1236784|P3|NOT COMPLETED|Overall Study||17
505791|NCT00976989|1236785|P2|NOT COMPLETED|Overall Study||12
505792|NCT00976989|1236786|P1|NOT COMPLETED|Overall Study||13
505793|NCT00976989|1236784|P3|COMPLETED|Overall Study||60
505794|NCT00976989|1236785|P2|COMPLETED|Overall Study||63
505795|NCT00976989|1236786|P1|COMPLETED|Overall Study||60
505796|NCT00976989|1236784|P3|STARTED|Overall Study||77
505797|NCT00976989|1236785|P2|STARTED|Overall Study||75
505798|NCT00976989|1236786|P1|STARTED|Overall Study||73
505799|NCT00976950|1236827|P1|NOT COMPLETED|Overall Study||6
505800|NCT00976950|1236827|P1|COMPLETED|Overall Study||36
505801|NCT00976950|1236827|P1|STARTED|Overall Study||42
505802|NCT00976937|1236835|P2|NOT COMPLETED|Overall Study||11
505803|NCT00976937|1236836|P1|NOT COMPLETED|Overall Study||16
505804|NCT00976937|1236835|P2|COMPLETED|Overall Study||150
505805|NCT00976937|1236836|P1|COMPLETED|Overall Study||142
505806|NCT00976937|1236835|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||161
505807|NCT00976937|1236836|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All randomized patients who received at least 1 dose of study drug.|158
505808|NCT00976937|1236835|P2|Treated/Safety Population|Overall Study||161
505809|NCT00976937|1236836|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|158
505810|NCT00976937|1236835|P2|STARTED|Overall Study||161
505811|NCT00976937|1236836|P1|STARTED|Overall Study|Randomized|158
505812|NCT00976911|1236878|P2|NOT COMPLETED|Overall Study||179
505813|NCT00976911|1236879|P1|NOT COMPLETED|Overall Study||182
505814|NCT00976911|1236878|P2|COMPLETED|Overall Study|At time of clinical cutoff for overall survival and safety (25 January 2013)|0
505815|NCT00976911|1236879|P1|COMPLETED|Overall Study|At time of clinical cutoff for overall survival and safety (25 January 2013)|0
505816|NCT00976911|1236878|P2|STARTED|Overall Study||179
505817|NCT00976911|1236879|P1|STARTED|Overall Study||182
505818|NCT00976898|1236897|P1|NOT COMPLETED|Overall Study||5
505819|NCT00976898|1236897|P1|COMPLETED|Overall Study||78
505820|NCT00976898|1236897|P1|STARTED|Overall Study||83
505821|NCT00976820|1236908|P4|NOT COMPLETED|Overall Study||7
505822|NCT00976820|1236909|P3|NOT COMPLETED|Overall Study||4
505823|NCT00976820|1236910|P2|NOT COMPLETED|Overall Study||20
505824|NCT00976820|1236911|P1|NOT COMPLETED|Overall Study||8
505825|NCT00976820|1236908|P4|COMPLETED|Overall Study||56
505826|NCT00976820|1236909|P3|COMPLETED|Overall Study||60
505827|NCT00976820|1236910|P2|COMPLETED|Overall Study||108
505828|NCT00976820|1236911|P1|COMPLETED|Overall Study||59
505829|NCT00976820|1236908|P4|STARTED|Overall Study||63
505830|NCT00976820|1236909|P3|STARTED|Overall Study||64
505831|NCT00976820|1236910|P2|STARTED|Overall Study||128
505832|NCT00976820|1236911|P1|STARTED|Overall Study||67
505833|NCT00976716|1237247|P1|NOT COMPLETED|Overall Study||1
505834|NCT00976716|1237247|P1|COMPLETED|Overall Study||79
505835|NCT00976716|1237247|P1|STARTED|Overall Study||80
505836|NCT00976703|1237265|P2|NOT COMPLETED|Overall Study||3
505837|NCT00976703|1237266|P1|NOT COMPLETED|Overall Study||3
505838|NCT00976703|1237265|P2|COMPLETED|Overall Study||95
505839|NCT00976703|1237266|P1|COMPLETED|Overall Study||96
505840|NCT00976703|1237265|P2|STARTED|Overall Study||98
505841|NCT00976703|1237266|P1|STARTED|Overall Study||99
505842|NCT00976677|1237280|P2|NOT COMPLETED|Overall Study||5
505843|NCT00976677|1237281|P1|NOT COMPLETED|Overall Study||5
505844|NCT00976677|1237280|P2|COMPLETED|Overall Study||0
505845|NCT00976677|1237281|P1|COMPLETED|Overall Study||0
505846|NCT00976677|1237280|P2|STARTED|Overall Study||5
505847|NCT00976677|1237281|P1|STARTED|Overall Study||5
505848|NCT00976664|1237289|P2|NOT COMPLETED|Overall Study||1
505849|NCT00976664|1237290|P1|NOT COMPLETED|Overall Study||3
505850|NCT00976664|1237289|P2|COMPLETED|Overall Study||24
505851|NCT00976664|1237290|P1|COMPLETED|Overall Study||22
505852|NCT00976664|1237289|P2|STARTED|Overall Study||25
505853|NCT00976664|1237290|P1|STARTED|Overall Study||25
505854|NCT00976599|1237300|P2|NOT COMPLETED|Overall Study||0
505855|NCT00976599|1237301|P1|NOT COMPLETED|Overall Study||0
505856|NCT00976599|1237300|P2|COMPLETED|Overall Study||14
505857|NCT00976599|1237301|P1|COMPLETED|Overall Study||15
505858|NCT00976599|1237300|P2|STARTED|Overall Study||14
505859|NCT00976599|1237301|P1|STARTED|Overall Study||15
505860|NCT00976573|1237489|P2|NOT COMPLETED|Overall Study||3
505861|NCT00976573|1237490|P1|NOT COMPLETED|Overall Study||4
505862|NCT00976573|1237489|P2|COMPLETED|Overall Study||71
505863|NCT00976573|1237490|P1|COMPLETED|Overall Study||71
505864|NCT00976573|1237489|P2|STARTED|Overall Study||74
505865|NCT00976573|1237490|P1|STARTED|Overall Study||75
505866|NCT00976560|1237504|P2|NOT COMPLETED|Overall Study||13
505867|NCT00976560|1237505|P1|NOT COMPLETED|Overall Study||14
505868|NCT00976560|1237504|P2|COMPLETED|Overall Study||51
505869|NCT00976560|1237505|P1|COMPLETED|Overall Study||50
505870|NCT00976560|1237504|P2|STARTED|Overall Study||64
505871|NCT00976560|1237505|P1|STARTED|Overall Study||64
505872|NCT00976521|1237557|P4|NOT COMPLETED|Overall Study||19
505873|NCT00976521|1237558|P3|NOT COMPLETED|Overall Study||9
505874|NCT00976521|1237559|P2|NOT COMPLETED|Overall Study||12
505875|NCT00976521|1237560|P1|NOT COMPLETED|Overall Study||9
505876|NCT00976521|1237557|P4|COMPLETED|Overall Study||93
505877|NCT00976521|1237558|P3|COMPLETED|Overall Study||102
505878|NCT00976521|1237559|P2|COMPLETED|Overall Study||99
505879|NCT00976521|1237560|P1|COMPLETED|Overall Study||109
505880|NCT00976521|1237557|P4|STARTED|Overall Study||112
505881|NCT00976521|1237558|P3|STARTED|Overall Study||111
505882|NCT00976521|1237559|P2|STARTED|Overall Study||111
505883|NCT00976521|1237560|P1|STARTED|Overall Study||118
505884|NCT00976508|1237574|P2|NOT COMPLETED|Overall Study||6
505885|NCT00976508|1237575|P1|NOT COMPLETED|Overall Study||14
505886|NCT00976508|1237574|P2|COMPLETED|Overall Study||0
505887|NCT00976508|1237575|P1|COMPLETED|Overall Study|These subjects withdrew from last study treatment due to progressive disease.|3
505888|NCT00976508|1237574|P2|STARTED|Overall Study||6
505889|NCT00976508|1237575|P1|STARTED|Overall Study|18 subjects were enrolled; 17 subjects were treated; 1 subject was not eligible.|17
505890|NCT00976495|1237608|P3|NOT COMPLETED|Overall Study||0
505891|NCT00976495|1237609|P2|NOT COMPLETED|Overall Study||1
505892|NCT00976495|1237610|P1|NOT COMPLETED|Overall Study||0
505893|NCT00976495|1237608|P3|COMPLETED|Overall Study||26
505894|NCT00976495|1237609|P2|COMPLETED|Overall Study||23
505895|NCT00976495|1237610|P1|COMPLETED|Overall Study||25
505896|NCT00976495|1237608|P3|STARTED|Overall Study||26
505897|NCT00976495|1237609|P2|STARTED|Overall Study||24
505898|NCT00976495|1237610|P1|STARTED|Overall Study||25
505899|NCT00976482|1237627|P1|NOT COMPLETED|Overall Study||259
505900|NCT00976482|1237627|P1|COMPLETED|Overall Study||1486
505901|NCT00976482|1237627|P1|Eligible for Last Follow up|Overall Study||1487
505902|NCT00976482|1237627|P1|STARTED|Overall Study||1745
505903|NCT00976456|1237633|P2|NOT COMPLETED|Overall Study||38
505904|NCT00976456|1237634|P1|NOT COMPLETED|Overall Study||43
505905|NCT00976456|1237633|P2|COMPLETED|Overall Study||98
505906|NCT00976456|1237634|P1|COMPLETED|Overall Study||92
505907|NCT00976456|1237633|P2|STARTED|Overall Study||136
505908|NCT00976456|1237634|P1|STARTED|Overall Study||135
505909|NCT00976404|1237644|P2|NOT COMPLETED|Overall Study||0
505910|NCT00976404|1237645|P1|NOT COMPLETED|Overall Study||0
505911|NCT00976404|1237644|P2|COMPLETED|Overall Study||14
505912|NCT00976404|1237645|P1|COMPLETED|Overall Study||14
505913|NCT00976404|1237644|P2|STARTED|Overall Study||14
505914|NCT00976404|1237645|P1|STARTED|Overall Study||14
505915|NCT00976391|1237661|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||34
505916|NCT00976391|1237662|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||29
505917|NCT00976391|1237661|P2|COMPLETED|Follow-up Period (8 Weeks)||247
505918|NCT00976391|1237662|P1|COMPLETED|Follow-up Period (8 Weeks)||256
505919|NCT00976391|1237661|P2|STARTED|Follow-up Period (8 Weeks)||281
505920|NCT00976391|1237662|P1|STARTED|Follow-up Period (8 Weeks)||285
505921|NCT00976391|1237661|P2|NOT COMPLETED|Treatment Period (52 Weeks)||39
505922|NCT00976391|1237662|P1|NOT COMPLETED|Treatment Period (52 Weeks)||42
505923|NCT00976391|1237661|P2|COMPLETED|Treatment Period (52 Weeks)||242
505924|NCT00976391|1237662|P1|COMPLETED|Treatment Period (52 Weeks)||243
505925|NCT00976391|1237661|P2|STARTED|Treatment Period (52 Weeks)||281
505926|NCT00976391|1237662|P1|STARTED|Treatment Period (52 Weeks)||285
505927|NCT00976352|1237684|P2|NOT COMPLETED|Overall Study||4
505928|NCT00976352|1237685|P1|NOT COMPLETED|Overall Study||0
505929|NCT00976352|1237684|P2|COMPLETED|Overall Study|Last evaluation of last subject in cohort.|6
505930|NCT00976352|1237685|P1|COMPLETED|Overall Study||3
505931|NCT00976352|1237684|P2|STARTED|Overall Study||10
505932|NCT00976352|1237685|P1|STARTED|Overall Study||3
505933|NCT00976339|1237699|P2|NOT COMPLETED|Overall Study||0
505934|NCT00976339|1237700|P1|NOT COMPLETED|Overall Study||0
505935|NCT00976339|1237699|P2|COMPLETED|Overall Study||10
505936|NCT00976339|1237700|P1|COMPLETED|Overall Study||10
505937|NCT00976339|1237699|P2|STARTED|Overall Study||10
505938|NCT00976339|1237700|P1|STARTED|Overall Study||10
505939|NCT00976274|1237710|P2|NOT COMPLETED|Overall Study||8
505940|NCT00976274|1237711|P1|NOT COMPLETED|Overall Study||7
505941|NCT00976274|1237710|P2|COMPLETED|Overall Study||21
505942|NCT00976274|1237711|P1|COMPLETED|Overall Study||24
505943|NCT00976274|1237710|P2|STARTED|Overall Study||29
505944|NCT00976274|1237711|P1|STARTED|Overall Study||31
505945|NCT00976248|1237719|P1|NOT COMPLETED|Overall Study||0
505946|NCT00976248|1237719|P1|COMPLETED|Overall Study||33
505947|NCT00976248|1237719|P1|STARTED|Overall Study||33
505948|NCT00976209|1237727|P2|NOT COMPLETED|Treatment Period 2||2
505949|NCT00976209|1237728|P1|NOT COMPLETED|Treatment Period 2||0
505950|NCT00976209|1237727|P2|COMPLETED|Treatment Period 2||161
505951|NCT00976209|1237728|P1|COMPLETED|Treatment Period 2||158
505952|NCT00976209|1237727|P2|STARTED|Treatment Period 2||163
505953|NCT00976209|1237728|P1|STARTED|Treatment Period 2||158
505954|NCT00976209|1237727|P2|NOT COMPLETED|Wash-out Period||2
505955|NCT00976209|1237728|P1|NOT COMPLETED|Wash-out Period||4
505956|NCT00976209|1237727|P2|COMPLETED|Wash-out Period||163
505957|NCT00976209|1237728|P1|COMPLETED|Wash-out Period||158
505958|NCT00976209|1237727|P2|STARTED|Wash-out Period||165
505959|NCT00976209|1237728|P1|STARTED|Wash-out Period||162
505960|NCT00976209|1237727|P2|NOT COMPLETED|Treatment Period 1||1
505961|NCT00976209|1237728|P1|NOT COMPLETED|Treatment Period 1||3
505962|NCT00976209|1237727|P2|COMPLETED|Treatment Period 1||165
505963|NCT00976209|1237728|P1|COMPLETED|Treatment Period 1||162
505964|NCT00976209|1237727|P2|STARTED|Treatment Period 1||166
505965|NCT00976209|1237728|P1|STARTED|Treatment Period 1||165
505966|NCT00976183|1237734|P1|NOT COMPLETED|Overall Study||0
505967|NCT00976183|1237734|P1|COMPLETED|Overall Study|The study was closed on 05/30/12 due to adverse events. We did not complete enrollment|18
505968|NCT00976183|1237734|P1|STARTED|Overall Study||18
505969|NCT00976027|1237741|P2|NOT COMPLETED|Overall Study||215
505970|NCT00976027|1237742|P1|NOT COMPLETED|Overall Study||411
505971|NCT00976027|1237741|P2|COMPLETED|Overall Study||2835
505972|NCT00976027|1237742|P1|COMPLETED|Overall Study||5697
505973|NCT00976027|1237741|P2|STARTED|Overall Study||3050
505974|NCT00976027|1237742|P1|STARTED|Overall Study||6108
505975|NCT00975975|1237754|P1|NOT COMPLETED|Overall Study||6
505976|NCT00975975|1237754|P1|COMPLETED|Overall Study||11
505977|NCT00975975|1237754|P1|STARTED|Overall Study||17
505978|NCT00975923|1237762|P2|NOT COMPLETED|Overall Study||1
505979|NCT00975923|1237763|P1|NOT COMPLETED|Overall Study||0
505980|NCT00975923|1237762|P2|COMPLETED|Overall Study|1 hospital was sold, yielding 29 hospitals in the Tool Kit Group|29
505981|NCT00975923|1237763|P1|COMPLETED|Overall Study||30
505982|NCT00975923|1237762|P2|STARTED|Overall Study||30
505983|NCT00975923|1237763|P1|STARTED|Overall Study||30
505984|NCT00975806|1237774|P3|NOT COMPLETED|Overall Study||4
505985|NCT00975806|1237775|P2|NOT COMPLETED|Overall Study||7
505986|NCT00975806|1237776|P1|NOT COMPLETED|Overall Study||5
505987|NCT00975806|1237774|P3|COMPLETED|Overall Study|Participants were prematurely discontinued|0
505988|NCT00975806|1237775|P2|COMPLETED|Overall Study|Participants were prematurely discontinued|0
505989|NCT00975806|1237776|P1|COMPLETED|Overall Study|Participants were prematurely discontinued|0
505990|NCT00975806|1237774|P3|STARTED|Overall Study||4
505991|NCT00975806|1237775|P2|STARTED|Overall Study||7
505992|NCT00975806|1237776|P1|STARTED|Overall Study||5
505993|NCT00975780|1237800|P2|NOT COMPLETED|Follow Up||157
505994|NCT00975780|1237801|P1|NOT COMPLETED|Follow Up||102
505995|NCT00975780|1237800|P2|COMPLETED|Follow Up||277
505996|NCT00975780|1237801|P1|COMPLETED|Follow Up||298
505997|NCT00975780|1237800|P2|STARTED|Follow Up||434
505998|NCT00975780|1237801|P1|STARTED|Follow Up||400
505999|NCT00975780|1237800|P2|NOT COMPLETED|Allocation||0
506000|NCT00975780|1237801|P1|NOT COMPLETED|Allocation||0
506001|NCT00975780|1237800|P2|COMPLETED|Allocation||434
506002|NCT00975780|1237801|P1|COMPLETED|Allocation||400
506003|NCT00975780|1237800|P2|STARTED|Allocation||434
506004|NCT00975780|1237801|P1|STARTED|Allocation||400
506005|NCT00975715|1237811|P2|NOT COMPLETED|Maintenance Period||1
506006|NCT00975715|1237812|P1|NOT COMPLETED|Maintenance Period||2
506007|NCT00975715|1237811|P2|COMPLETED|Maintenance Period||50
506008|NCT00975715|1237812|P1|COMPLETED|Maintenance Period||39
506009|NCT00975715|1237811|P2|STARTED|Maintenance Period||51
506010|NCT00975715|1237812|P1|STARTED|Maintenance Period||41
506011|NCT00975715|1237811|P2|NOT COMPLETED|Titration Period||0
506012|NCT00975715|1237812|P1|NOT COMPLETED|Titration Period||7
506013|NCT00975715|1237811|P2|COMPLETED|Titration Period||51
506014|NCT00975715|1237812|P1|COMPLETED|Titration Period||41
506015|NCT00975715|1237811|P2|STARTED|Titration Period||51
506016|NCT00975715|1237812|P1|STARTED|Titration Period||48
506017|NCT00975689|1237828|P2|NOT COMPLETED|Overall Study||3
506018|NCT00975689|1237829|P1|NOT COMPLETED|Overall Study||2
506019|NCT00975689|1237828|P2|COMPLETED|Overall Study||15
506020|NCT00975689|1237829|P1|COMPLETED|Overall Study||15
506021|NCT00975689|1237828|P2|STARTED|Overall Study||18
506022|NCT00975689|1237829|P1|STARTED|Overall Study||17
506023|NCT00975637|1237840|P5|NOT COMPLETED|Overall Study||2
506024|NCT00975637|1237841|P4|NOT COMPLETED|Overall Study||6
506025|NCT00975637|1237842|P3|NOT COMPLETED|Overall Study||2
506026|NCT00975637|1237843|P2|NOT COMPLETED|Overall Study||1
506027|NCT00975637|1237844|P1|NOT COMPLETED|Overall Study||3
506028|NCT00975637|1237840|P5|COMPLETED|Overall Study||37
506029|NCT00975637|1237841|P4|COMPLETED|Overall Study||32
506030|NCT00975637|1237842|P3|COMPLETED|Overall Study||40
506031|NCT00975637|1237843|P2|COMPLETED|Overall Study||38
506032|NCT00975637|1237844|P1|COMPLETED|Overall Study||37
506033|NCT00975637|1237840|P5|STARTED|Overall Study||39
506034|NCT00975637|1237841|P4|STARTED|Overall Study||38
506035|NCT00975637|1237842|P3|STARTED|Overall Study||42
506036|NCT00975637|1237843|P2|STARTED|Overall Study||39
506037|NCT00975637|1237844|P1|STARTED|Overall Study||40
506038|NCT00975611|1237861|P1|NOT COMPLETED|Overall Study||17
506039|NCT00975611|1237861|P1|COMPLETED|Overall Study||5
506040|NCT00975611|1237861|P1|STARTED|Overall Study||22
506041|NCT00975585|1237867|P2|NOT COMPLETED|Overall Study||12
506042|NCT00975585|1237868|P1|NOT COMPLETED|Overall Study||7
506043|NCT00975585|1237867|P2|COMPLETED|Overall Study||183
506044|NCT00975585|1237868|P1|COMPLETED|Overall Study||177
506045|NCT00975585|1237867|P2|STARTED|Overall Study||195
506046|NCT00975585|1237868|P1|STARTED|Overall Study||184
506047|NCT00975507|1237888|P2|NOT COMPLETED|Overall Study||4
506048|NCT00975507|1237889|P1|NOT COMPLETED|Overall Study||20
506049|NCT00975507|1237888|P2|COMPLETED|Overall Study||153
506050|NCT00975507|1237889|P1|COMPLETED|Overall Study||303
506051|NCT00975507|1237888|P2|Vaccinated at Visit 2|Overall Study|Per-protocol, subjects receiving M-M-R™ II + VARIVAX™ at Visit 1 were not vaccinated at Visit 2|0
506052|NCT00975507|1237889|P1|Vaccinated at Visit 2|Overall Study||310
506053|NCT00975507|1237888|P2|Vaccinated at Visit 1|Overall Study||157
506054|NCT00975507|1237889|P1|Vaccinated at Visit 1|Overall Study||323
506055|NCT00975507|1237888|P2|STARTED|Overall Study||157
506056|NCT00975507|1237889|P1|STARTED|Overall Study||323
506057|NCT00975481|1237909|P6|NOT COMPLETED|Sixth Intervention Period||0
506058|NCT00975481|1237910|P5|NOT COMPLETED|Sixth Intervention Period||0
506059|NCT00975481|1237911|P4|NOT COMPLETED|Sixth Intervention Period||0
506060|NCT00975481|1237912|P3|NOT COMPLETED|Sixth Intervention Period||0
506061|NCT00975481|1237913|P2|NOT COMPLETED|Sixth Intervention Period||0
506062|NCT00975481|1237914|P1|NOT COMPLETED|Sixth Intervention Period||0
506063|NCT00975481|1237909|P6|COMPLETED|Sixth Intervention Period||6
506064|NCT00975481|1237910|P5|COMPLETED|Sixth Intervention Period||5
506065|NCT00975481|1237911|P4|COMPLETED|Sixth Intervention Period||5
506066|NCT00975481|1237912|P3|COMPLETED|Sixth Intervention Period||4
506067|NCT00975481|1237913|P2|COMPLETED|Sixth Intervention Period||5
506068|NCT00975481|1237914|P1|COMPLETED|Sixth Intervention Period||4
506069|NCT00975481|1237909|P6|STARTED|Sixth Intervention Period||6
506070|NCT00975481|1237910|P5|STARTED|Sixth Intervention Period||5
506071|NCT00975481|1237911|P4|STARTED|Sixth Intervention Period||5
506072|NCT00975481|1237912|P3|STARTED|Sixth Intervention Period||4
506073|NCT00975481|1237913|P2|STARTED|Sixth Intervention Period||5
506074|NCT00975481|1237914|P1|STARTED|Sixth Intervention Period||4
506075|NCT00975481|1237909|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
506076|NCT00975481|1237910|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
506077|NCT00975481|1237911|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
506078|NCT00975481|1237912|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
506079|NCT00975481|1237913|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
506080|NCT00975481|1237914|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
506081|NCT00975481|1237909|P6|COMPLETED|Washout Period (at Least 7 Days)||6
506082|NCT00975481|1237910|P5|COMPLETED|Washout Period (at Least 7 Days)||5
506083|NCT00975481|1237911|P4|COMPLETED|Washout Period (at Least 7 Days)||5
506084|NCT00975481|1237912|P3|COMPLETED|Washout Period (at Least 7 Days)||4
506085|NCT00975481|1237913|P2|COMPLETED|Washout Period (at Least 7 Days)||5
506086|NCT00975481|1237914|P1|COMPLETED|Washout Period (at Least 7 Days)||4
506087|NCT00975481|1237909|P6|STARTED|Washout Period (at Least 7 Days)||6
506088|NCT00975481|1237910|P5|STARTED|Washout Period (at Least 7 Days)||5
506089|NCT00975481|1237911|P4|STARTED|Washout Period (at Least 7 Days)||5
506090|NCT00975481|1237912|P3|STARTED|Washout Period (at Least 7 Days)||4
506091|NCT00975481|1237913|P2|STARTED|Washout Period (at Least 7 Days)||5
506092|NCT00975481|1237914|P1|STARTED|Washout Period (at Least 7 Days)||4
506093|NCT00975481|1237909|P6|NOT COMPLETED|Fifth Intervention Period||0
506094|NCT00975481|1237910|P5|NOT COMPLETED|Fifth Intervention Period||1
506095|NCT00975481|1237911|P4|NOT COMPLETED|Fifth Intervention Period||0
506096|NCT00975481|1237912|P3|NOT COMPLETED|Fifth Intervention Period||0
506097|NCT00975481|1237913|P2|NOT COMPLETED|Fifth Intervention Period||0
506098|NCT00975481|1237914|P1|NOT COMPLETED|Fifth Intervention Period||0
506099|NCT00975481|1237909|P6|COMPLETED|Fifth Intervention Period||6
506100|NCT00975481|1237910|P5|COMPLETED|Fifth Intervention Period||5
506101|NCT00975481|1237911|P4|COMPLETED|Fifth Intervention Period||5
506102|NCT00975481|1237912|P3|COMPLETED|Fifth Intervention Period||4
506103|NCT00975481|1237913|P2|COMPLETED|Fifth Intervention Period||5
506104|NCT00975481|1237914|P1|COMPLETED|Fifth Intervention Period||4
506105|NCT00975481|1237909|P6|STARTED|Fifth Intervention Period||6
506106|NCT00975481|1237910|P5|STARTED|Fifth Intervention Period||6
506107|NCT00975481|1237911|P4|STARTED|Fifth Intervention Period||5
506108|NCT00975481|1237912|P3|STARTED|Fifth Intervention Period||4
506109|NCT00975481|1237913|P2|STARTED|Fifth Intervention Period||5
506110|NCT00975481|1237914|P1|STARTED|Fifth Intervention Period||4
506111|NCT00975481|1237909|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
506112|NCT00975481|1237910|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
506113|NCT00975481|1237911|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
506114|NCT00975481|1237912|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
506115|NCT00975481|1237913|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
506116|NCT00975481|1237914|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
506117|NCT00975481|1237909|P6|COMPLETED|Washout Period (at Least 7 Days)||6
506118|NCT00975481|1237910|P5|COMPLETED|Washout Period (at Least 7 Days)||6
506119|NCT00975481|1237911|P4|COMPLETED|Washout Period (at Least 7 Days)||5
506120|NCT00975481|1237912|P3|COMPLETED|Washout Period (at Least 7 Days)||4
506121|NCT00975481|1237913|P2|COMPLETED|Washout Period (at Least 7 Days)||5
506122|NCT00975481|1237914|P1|COMPLETED|Washout Period (at Least 7 Days)||4
506123|NCT00975481|1237909|P6|STARTED|Washout Period (at Least 7 Days)||6
506124|NCT00975481|1237910|P5|STARTED|Washout Period (at Least 7 Days)||6
506125|NCT00975481|1237911|P4|STARTED|Washout Period (at Least 7 Days)||5
506126|NCT00975481|1237912|P3|STARTED|Washout Period (at Least 7 Days)||4
506127|NCT00975481|1237913|P2|STARTED|Washout Period (at Least 7 Days)||5
506128|NCT00975481|1237914|P1|STARTED|Washout Period (at Least 7 Days)||4
506129|NCT00975481|1237909|P6|NOT COMPLETED|Fourth Intervention Period||0
506130|NCT00975481|1237910|P5|NOT COMPLETED|Fourth Intervention Period||0
506131|NCT00975481|1237911|P4|NOT COMPLETED|Fourth Intervention Period||1
506132|NCT00975481|1237912|P3|NOT COMPLETED|Fourth Intervention Period||1
506133|NCT00975481|1237913|P2|NOT COMPLETED|Fourth Intervention Period||0
506134|NCT00975481|1237914|P1|NOT COMPLETED|Fourth Intervention Period||0
506135|NCT00975481|1237909|P6|COMPLETED|Fourth Intervention Period||6
506136|NCT00975481|1237910|P5|COMPLETED|Fourth Intervention Period||6
506137|NCT00975481|1237911|P4|COMPLETED|Fourth Intervention Period||5
506138|NCT00975481|1237912|P3|COMPLETED|Fourth Intervention Period||4
506139|NCT00975481|1237913|P2|COMPLETED|Fourth Intervention Period||5
506140|NCT00975481|1237914|P1|COMPLETED|Fourth Intervention Period||4
506141|NCT00975481|1237909|P6|STARTED|Fourth Intervention Period||6
506142|NCT00975481|1237910|P5|STARTED|Fourth Intervention Period||6
506143|NCT00975481|1237911|P4|STARTED|Fourth Intervention Period||6
506144|NCT00975481|1237912|P3|STARTED|Fourth Intervention Period||5
506145|NCT00975481|1237913|P2|STARTED|Fourth Intervention Period||5
506146|NCT00975481|1237914|P1|STARTED|Fourth Intervention Period||4
506147|NCT00975481|1237909|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
506148|NCT00975481|1237910|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
506149|NCT00975481|1237911|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
506150|NCT00975481|1237912|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
506151|NCT00975481|1237913|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
506152|NCT00975481|1237914|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
506153|NCT00975481|1237909|P6|COMPLETED|Washout Period (at Least 7 Days)||6
506154|NCT00975481|1237910|P5|COMPLETED|Washout Period (at Least 7 Days)||6
506155|NCT00975481|1237911|P4|COMPLETED|Washout Period (at Least 7 Days)||6
506156|NCT00975481|1237912|P3|COMPLETED|Washout Period (at Least 7 Days)||5
506157|NCT00975481|1237913|P2|COMPLETED|Washout Period (at Least 7 Days)||5
506158|NCT00975481|1237914|P1|COMPLETED|Washout Period (at Least 7 Days)||4
506159|NCT00975481|1237909|P6|STARTED|Washout Period (at Least 7 Days)||6
506160|NCT00975481|1237910|P5|STARTED|Washout Period (at Least 7 Days)||6
506161|NCT00975481|1237911|P4|STARTED|Washout Period (at Least 7 Days)||6
506162|NCT00975481|1237912|P3|STARTED|Washout Period (at Least 7 Days)||5
506163|NCT00975481|1237913|P2|STARTED|Washout Period (at Least 7 Days)||5
506164|NCT00975481|1237914|P1|STARTED|Washout Period (at Least 7 Days)||4
506165|NCT00975481|1237909|P6|NOT COMPLETED|Third Intervention Period||0
506166|NCT00975481|1237910|P5|NOT COMPLETED|Third Intervention Period||0
506167|NCT00975481|1237911|P4|NOT COMPLETED|Third Intervention Period||0
506168|NCT00975481|1237912|P3|NOT COMPLETED|Third Intervention Period||0
506169|NCT00975481|1237913|P2|NOT COMPLETED|Third Intervention Period||0
506170|NCT00975481|1237914|P1|NOT COMPLETED|Third Intervention Period||0
506171|NCT00975481|1237909|P6|COMPLETED|Third Intervention Period||6
506172|NCT00975481|1237910|P5|COMPLETED|Third Intervention Period||6
506173|NCT00975481|1237911|P4|COMPLETED|Third Intervention Period||6
506174|NCT00975481|1237912|P3|COMPLETED|Third Intervention Period||5
506175|NCT00975481|1237913|P2|COMPLETED|Third Intervention Period||5
506176|NCT00975481|1237914|P1|COMPLETED|Third Intervention Period||4
506177|NCT00975481|1237909|P6|STARTED|Third Intervention Period||6
506178|NCT00975481|1237910|P5|STARTED|Third Intervention Period||6
506179|NCT00975481|1237911|P4|STARTED|Third Intervention Period||6
506180|NCT00975481|1237912|P3|STARTED|Third Intervention Period||5
506181|NCT00975481|1237913|P2|STARTED|Third Intervention Period||5
506182|NCT00975481|1237914|P1|STARTED|Third Intervention Period||4
506183|NCT00975481|1237909|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
506184|NCT00975481|1237910|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
506185|NCT00975481|1237911|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
506186|NCT00975481|1237912|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
506187|NCT00975481|1237913|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
506188|NCT00975481|1237914|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
506189|NCT00975481|1237909|P6|COMPLETED|Washout Period (at Least 7 Days)||6
506190|NCT00975481|1237910|P5|COMPLETED|Washout Period (at Least 7 Days)||6
506191|NCT00975481|1237911|P4|COMPLETED|Washout Period (at Least 7 Days)||6
506192|NCT00975481|1237912|P3|COMPLETED|Washout Period (at Least 7 Days)||5
506193|NCT00975481|1237913|P2|COMPLETED|Washout Period (at Least 7 Days)||5
506194|NCT00975481|1237914|P1|COMPLETED|Washout Period (at Least 7 Days)||4
506195|NCT00975481|1237909|P6|STARTED|Washout Period (at Least 7 Days)||6
506196|NCT00975481|1237910|P5|STARTED|Washout Period (at Least 7 Days)||6
506197|NCT00975481|1237911|P4|STARTED|Washout Period (at Least 7 Days)||6
506198|NCT00975481|1237912|P3|STARTED|Washout Period (at Least 7 Days)||5
506199|NCT00975481|1237913|P2|STARTED|Washout Period (at Least 7 Days)||5
506200|NCT00975481|1237914|P1|STARTED|Washout Period (at Least 7 Days)||4
506201|NCT00975481|1237909|P6|NOT COMPLETED|Second Intervention Period||0
506202|NCT00975481|1237910|P5|NOT COMPLETED|Second Intervention Period||0
506203|NCT00975481|1237911|P4|NOT COMPLETED|Second Intervention Period||0
506204|NCT00975481|1237912|P3|NOT COMPLETED|Second Intervention Period||1
506205|NCT00975481|1237913|P2|NOT COMPLETED|Second Intervention Period||1
506206|NCT00975481|1237914|P1|NOT COMPLETED|Second Intervention Period||2
506207|NCT00975481|1237909|P6|COMPLETED|Second Intervention Period||6
506208|NCT00975481|1237910|P5|COMPLETED|Second Intervention Period||6
506209|NCT00975481|1237911|P4|COMPLETED|Second Intervention Period||6
506210|NCT00975481|1237912|P3|COMPLETED|Second Intervention Period||5
506211|NCT00975481|1237913|P2|COMPLETED|Second Intervention Period||5
506212|NCT00975481|1237914|P1|COMPLETED|Second Intervention Period||4
506213|NCT00975481|1237909|P6|STARTED|Second Intervention Period||6
506214|NCT00975481|1237910|P5|STARTED|Second Intervention Period||6
506215|NCT00975481|1237911|P4|STARTED|Second Intervention Period||6
506216|NCT00975481|1237912|P3|STARTED|Second Intervention Period||6
506217|NCT00975481|1237913|P2|STARTED|Second Intervention Period||6
506218|NCT00975481|1237914|P1|STARTED|Second Intervention Period||6
506219|NCT00975481|1237909|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
506220|NCT00975481|1237910|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
506221|NCT00975481|1237911|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
506222|NCT00975481|1237912|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
506223|NCT00975481|1237913|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
506224|NCT00975481|1237914|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
506225|NCT00975481|1237909|P6|COMPLETED|Washout Period (at Least 7 Days)||6
506226|NCT00975481|1237910|P5|COMPLETED|Washout Period (at Least 7 Days)||6
506227|NCT00975481|1237911|P4|COMPLETED|Washout Period (at Least 7 Days)||6
506228|NCT00975481|1237912|P3|COMPLETED|Washout Period (at Least 7 Days)||6
506229|NCT00975481|1237913|P2|COMPLETED|Washout Period (at Least 7 Days)||6
506230|NCT00975481|1237914|P1|COMPLETED|Washout Period (at Least 7 Days)||6
506231|NCT00975481|1237909|P6|STARTED|Washout Period (at Least 7 Days)||6
506232|NCT00975481|1237910|P5|STARTED|Washout Period (at Least 7 Days)||6
506233|NCT00975481|1237911|P4|STARTED|Washout Period (at Least 7 Days)||6
506234|NCT00975481|1237912|P3|STARTED|Washout Period (at Least 7 Days)||6
506235|NCT00975481|1237913|P2|STARTED|Washout Period (at Least 7 Days)||6
506236|NCT00975481|1237914|P1|STARTED|Washout Period (at Least 7 Days)||6
506237|NCT00975481|1237909|P6|NOT COMPLETED|First Intervention Period||0
506238|NCT00975481|1237910|P5|NOT COMPLETED|First Intervention Period||0
506239|NCT00975481|1237911|P4|NOT COMPLETED|First Intervention Period||0
506240|NCT00975481|1237912|P3|NOT COMPLETED|First Intervention Period||0
506241|NCT00975481|1237913|P2|NOT COMPLETED|First Intervention Period||0
506242|NCT00975481|1237914|P1|NOT COMPLETED|First Intervention Period||0
506243|NCT00975481|1237909|P6|COMPLETED|First Intervention Period||6
506244|NCT00975481|1237910|P5|COMPLETED|First Intervention Period||6
506245|NCT00975481|1237911|P4|COMPLETED|First Intervention Period||6
506246|NCT00975481|1237912|P3|COMPLETED|First Intervention Period||6
506247|NCT00975481|1237913|P2|COMPLETED|First Intervention Period||6
506248|NCT00975481|1237914|P1|COMPLETED|First Intervention Period||6
506249|NCT00975481|1237909|P6|STARTED|First Intervention Period||6
506250|NCT00975481|1237910|P5|STARTED|First Intervention Period||6
506251|NCT00975481|1237911|P4|STARTED|First Intervention Period||6
506252|NCT00975481|1237912|P3|STARTED|First Intervention Period||6
506253|NCT00975481|1237913|P2|STARTED|First Intervention Period||6
506254|NCT00975481|1237914|P1|STARTED|First Intervention Period||6
506255|NCT00975416|1238014|P2|NOT COMPLETED|Overall Study||5
506256|NCT00975416|1238015|P1|NOT COMPLETED|Overall Study||3
506257|NCT00975416|1238014|P2|COMPLETED|Overall Study||11
506258|NCT00975416|1238015|P1|COMPLETED|Overall Study||11
506259|NCT00975416|1238014|P2|STARTED|Overall Study||16
506260|NCT00975416|1238015|P1|STARTED|Overall Study||14
506261|NCT00975286|1238024|P2|NOT COMPLETED|Overall Study||29
506262|NCT00975286|1238025|P1|NOT COMPLETED|Overall Study||12
506263|NCT00975286|1238024|P2|COMPLETED|Overall Study||194
506264|NCT00975286|1238025|P1|COMPLETED|Overall Study||211
506265|NCT00975286|1238024|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||223
506266|NCT00975286|1238025|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|223
506267|NCT00975286|1238024|P2|Safety Population|Overall Study||223
506268|NCT00975286|1238025|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|223
506269|NCT00975286|1238024|P2|STARTED|Overall Study||223
506270|NCT00975286|1238025|P1|STARTED|Overall Study|Randomized.|223
506271|NCT00975221|1238057|P2|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||1
506272|NCT00975221|1238058|P1|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||2
506273|NCT00975221|1238057|P2|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27
506274|NCT00975221|1238058|P1|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27
506275|NCT00975221|1238057|P2|STARTED|Open-label Extension Phase (Weeks 29-52)||28
506276|NCT00975221|1238058|P1|STARTED|Open-label Extension Phase (Weeks 29-52)|1 participant who completed the EAP did not enter the open-label phase|29
506277|NCT00975221|1238057|P2|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||1
506278|NCT00975221|1238058|P1|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||0
506279|NCT00975221|1238057|P2|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||28
506280|NCT00975221|1238058|P1|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||30
506281|NCT00975221|1238057|P2|STARTED|Efficacy Assessment Phase (Weeks 13-28)||29
506282|NCT00975221|1238058|P1|STARTED|Efficacy Assessment Phase (Weeks 13-28)|1 participant who completed the Titration Phase did not enter the EAP|30
506283|NCT00975221|1238057|P2|NOT COMPLETED|Titration Phase (Weeks 1-12)||4
506284|NCT00975221|1238058|P1|NOT COMPLETED|Titration Phase (Weeks 1-12)||3
506285|NCT00975221|1238057|P2|COMPLETED|Titration Phase (Weeks 1-12)||29
506286|NCT00975221|1238058|P1|COMPLETED|Titration Phase (Weeks 1-12)||31
506287|NCT00975221|1238057|P2|Received Study Drug|Titration Phase (Weeks 1-12)||33
506288|NCT00975221|1238058|P1|Received Study Drug|Titration Phase (Weeks 1-12)||34
506289|NCT00975221|1238057|P2|STARTED|Titration Phase (Weeks 1-12)||33
506290|NCT00975221|1238058|P1|STARTED|Titration Phase (Weeks 1-12)||34
506291|NCT00975195|1238074|P2|NOT COMPLETED|Overall Study||233
506292|NCT00975195|1238075|P1|NOT COMPLETED|Overall Study||228
506293|NCT00975195|1238074|P2|COMPLETED|Overall Study|Includes open-label treatment if appropriate|1011
506294|NCT00975195|1238075|P1|COMPLETED|Overall Study|Includes open-label treatment if appropriate|1016
506295|NCT00975195|1238074|P2|STARTED|Overall Study||1244
506296|NCT00975195|1238075|P1|STARTED|Overall Study||1244
506297|NCT00975156|1238135|P2|NOT COMPLETED|Overall Study||1
506298|NCT00975156|1238136|P1|NOT COMPLETED|Overall Study||0
506299|NCT00975156|1238135|P2|COMPLETED|Overall Study||9
506300|NCT00975156|1238136|P1|COMPLETED|Overall Study||11
506301|NCT00975156|1238135|P2|STARTED|Overall Study||10
506302|NCT00975156|1238136|P1|STARTED|Overall Study||11
506303|NCT00975143|1238148|P2|NOT COMPLETED|Overall Study||60
506304|NCT00975143|1238149|P1|NOT COMPLETED|Overall Study||70
506305|NCT00975143|1238148|P2|COMPLETED|Overall Study||401
506306|NCT00975143|1238149|P1|COMPLETED|Overall Study||394
506307|NCT00975143|1238148|P2|Completed Treatment (Week 20)|Overall Study||410
506308|NCT00975143|1238149|P1|Completed Treatment (Week 20)|Overall Study||403
506309|NCT00975143|1238148|P2|STARTED|Overall Study||461
506310|NCT00975143|1238149|P1|STARTED|Overall Study||464
506311|NCT00975130|1238159|P3|NOT COMPLETED|Study Part 2||17
506312|NCT00975130|1238160|P2|NOT COMPLETED|Study Part 2||38
506313|NCT00975130|1238161|P1|NOT COMPLETED|Study Part 2||0
506314|NCT00975130|1238159|P3|COMPLETED|Study Part 2||238
506315|NCT00975130|1238160|P2|COMPLETED|Study Part 2||212
506316|NCT00975130|1238161|P1|COMPLETED|Study Part 2||0
506317|NCT00975130|1238159|P3|STARTED|Study Part 2|Good/moderate responders without remission at the end of Part 1 were invited to enroll in Part 2.|255
506318|NCT00975130|1238160|P2|STARTED|Study Part 2|Good/moderate responders without remission at the end of Part 1 were invited to enroll in Part 2.|250
506319|NCT00975130|1238161|P1|STARTED|Study Part 2||0
506320|NCT00975130|1238159|P3|NOT COMPLETED|Study Part 1||0
506321|NCT00975130|1238160|P2|NOT COMPLETED|Study Part 1||0
506322|NCT00975130|1238161|P1|NOT COMPLETED|Study Part 1||280
506323|NCT00975130|1238159|P3|COMPLETED|Study Part 1||0
506324|NCT00975130|1238160|P2|COMPLETED|Study Part 1||0
506325|NCT00975130|1238161|P1|COMPLETED|Study Part 1||3086
506326|NCT00975130|1238159|P3|STARTED|Study Part 1||0
506327|NCT00975130|1238160|P2|STARTED|Study Part 1||0
506328|NCT00975130|1238161|P1|STARTED|Study Part 1||3366
506329|NCT00975000|1238345|P2|NOT COMPLETED|Overall Study||5
506330|NCT00975000|1238346|P1|NOT COMPLETED|Overall Study||5
506331|NCT00975000|1238345|P2|COMPLETED|Overall Study|Completed post-treatment follow-up phase|52
506332|NCT00975000|1238346|P1|COMPLETED|Overall Study|Completed post-treatment follow-up phase|52
506333|NCT00975000|1238345|P2|Completed Maintenance Phase|Overall Study||52
506334|NCT00975000|1238346|P1|Completed Maintenance Phase|Overall Study||52
506335|NCT00975000|1238345|P2|Completed Efficacy Assessment Phase|Overall Study||54
506336|NCT00975000|1238346|P1|Completed Efficacy Assessment Phase|Overall Study||54
506337|NCT00975000|1238345|P2|Completed Titration Phase|Overall Study||55
506338|NCT00975000|1238346|P1|Completed Titration Phase|Overall Study||54
506339|NCT00975000|1238345|P2|STARTED|Overall Study||57
506340|NCT00975000|1238346|P1|STARTED|Overall Study||57
506341|NCT00974974|1238370|P2|NOT COMPLETED|Maintenance - Double Blind Treatment||10
506342|NCT00974974|1238371|P1|NOT COMPLETED|Maintenance - Double Blind Treatment||15
506343|NCT00974974|1238370|P2|COMPLETED|Maintenance - Double Blind Treatment||182
506344|NCT00974974|1238371|P1|COMPLETED|Maintenance - Double Blind Treatment||186
506345|NCT00974974|1238370|P2|STARTED|Maintenance - Double Blind Treatment|All subjects who completed IPX066 Dose Conversion were randomized to either IPX066 or IR.|192
506346|NCT00974974|1238371|P1|STARTED|Maintenance - Double Blind Treatment|All subjects who completed IPX066 Dose Conversion were randomized to either IPX066 or IR.|201
506347|NCT00974974|1238370|P2|NOT COMPLETED|IPX066 Dose Conversion||0
506348|NCT00974974|1238371|P1|NOT COMPLETED|IPX066 Dose Conversion||57
506349|NCT00974974|1238370|P2|COMPLETED|IPX066 Dose Conversion||0
506350|NCT00974974|1238371|P1|COMPLETED|IPX066 Dose Conversion||393
506351|NCT00974974|1238370|P2|STARTED|IPX066 Dose Conversion|IR is not applicable in IPX066 dose conversion.|0
506352|NCT00974974|1238371|P1|STARTED|IPX066 Dose Conversion|All subjects who completed IR Dose adjustment entered into IPX066 dose conversion.|450
506353|NCT00974974|1238370|P2|NOT COMPLETED|IR CD-LD Dose Adjustment||21
506354|NCT00974974|1238371|P1|NOT COMPLETED|IR CD-LD Dose Adjustment||0
506355|NCT00974974|1238370|P2|COMPLETED|IR CD-LD Dose Adjustment||450
506356|NCT00974974|1238371|P1|COMPLETED|IR CD-LD Dose Adjustment||0
506357|NCT00974974|1238370|P2|STARTED|IR CD-LD Dose Adjustment||471
506358|NCT00974974|1238371|P1|STARTED|IR CD-LD Dose Adjustment||0
506359|NCT00974922|1238381|P1|NOT COMPLETED|Overall Study||24
506360|NCT00974922|1238381|P1|COMPLETED|Overall Study||16
506361|NCT00974922|1238381|P1|STARTED|Overall Study||40
506362|NCT00974818|1238388|P2|NOT COMPLETED|Overall Study||0
506363|NCT00974818|1238389|P1|NOT COMPLETED|Overall Study||0
506364|NCT00974818|1238388|P2|COMPLETED|Overall Study||25
506365|NCT00974818|1238389|P1|COMPLETED|Overall Study||25
506366|NCT00974818|1238388|P2|STARTED|Overall Study||25
506367|NCT00974818|1238389|P1|STARTED|Overall Study||25
506368|NCT00974675|1238399|P4|NOT COMPLETED|Overall Study||2
506369|NCT00974675|1238400|P3|NOT COMPLETED|Overall Study||2
506370|NCT00974675|1238401|P2|NOT COMPLETED|Overall Study||1
506371|NCT00974675|1238402|P1|NOT COMPLETED|Overall Study||2
506372|NCT00974675|1238399|P4|COMPLETED|Overall Study||2
506373|NCT00974675|1238400|P3|COMPLETED|Overall Study||1
506374|NCT00974675|1238401|P2|COMPLETED|Overall Study||7
506375|NCT00974675|1238402|P1|COMPLETED|Overall Study||6
506376|NCT00974675|1238399|P4|STARTED|Overall Study||4
506377|NCT00974675|1238400|P3|STARTED|Overall Study||3
506378|NCT00974675|1238401|P2|STARTED|Overall Study||8
506379|NCT00974675|1238402|P1|STARTED|Overall Study||8
506380|NCT00974571|1238451|P3|NOT COMPLETED|Overall Study||83
506381|NCT00974571|1238452|P2|NOT COMPLETED|Overall Study||16
506382|NCT00974571|1238453|P1|NOT COMPLETED|Overall Study||68
506383|NCT00974571|1238451|P3|COMPLETED|Overall Study||530
506384|NCT00974571|1238452|P2|COMPLETED|Overall Study||106
506385|NCT00974571|1238453|P1|COMPLETED|Overall Study||562
506386|NCT00974571|1238451|P3|STARTED|Overall Study||613
506387|NCT00974571|1238452|P2|STARTED|Overall Study||122
506388|NCT00974571|1238453|P1|STARTED|Overall Study||630
506389|NCT00974480|1238476|P3|NOT COMPLETED|Overall Study||10
506390|NCT00974480|1238477|P2|NOT COMPLETED|Overall Study||7
506391|NCT00974480|1238478|P1|NOT COMPLETED|Overall Study||11
506392|NCT00974480|1238476|P3|COMPLETED|Overall Study||30
506393|NCT00974480|1238477|P2|COMPLETED|Overall Study||33
506394|NCT00974480|1238478|P1|COMPLETED|Overall Study||29
506395|NCT00974480|1238476|P3|STARTED|Overall Study||40
506396|NCT00974480|1238477|P2|STARTED|Overall Study||40
506397|NCT00974480|1238478|P1|STARTED|Overall Study||40
506398|NCT00974376|1238518|P2|NOT COMPLETED|Overall Study||33
506399|NCT00974376|1238519|P1|NOT COMPLETED|Overall Study||34
506400|NCT00974376|1238518|P2|COMPLETED|Overall Study||42
506401|NCT00974376|1238519|P1|COMPLETED|Overall Study||41
506402|NCT00974376|1238518|P2|STARTED|Overall Study||75
506403|NCT00974376|1238519|P1|STARTED|Overall Study||75
506404|NCT00974363|1238527|P2|NOT COMPLETED|Overall Study||0
506405|NCT00974363|1238528|P1|NOT COMPLETED|Overall Study||0
506406|NCT00974363|1238527|P2|COMPLETED|Overall Study||168
506407|NCT00974363|1238528|P1|COMPLETED|Overall Study||521
506408|NCT00974363|1238527|P2|STARTED|Overall Study||168
506409|NCT00974363|1238528|P1|STARTED|Overall Study||521
506410|NCT00974311|1238550|P2|NOT COMPLETED|Overall Study||236
506411|NCT00974311|1238551|P1|NOT COMPLETED|Overall Study||546
506412|NCT00974311|1238550|P2|COMPLETED|Overall Study|Indicates participants continuing long-term follow-up as of 25 September 2011.|163
506413|NCT00974311|1238551|P1|COMPLETED|Overall Study|Indicates participants continuing long-term follow-up as of 25 September 2011.|254
506414|NCT00974311|1238550|P2|STARTED|Overall Study||399
506415|NCT00974311|1238551|P1|STARTED|Overall Study||800
506416|NCT00974246|1238575|P1|NOT COMPLETED|Overall Study||0
506417|NCT00974246|1238575|P1|COMPLETED|Overall Study||27
506418|NCT00974246|1238575|P1|STARTED|Overall Study||27
506419|NCT00974233|1238581|P1|NOT COMPLETED|Maintenance Lenalidomide||13
506420|NCT00974233|1238581|P1|COMPLETED|Maintenance Lenalidomide||6
506421|NCT00974233|1238581|P1|STARTED|Maintenance Lenalidomide||19
506422|NCT00974233|1238581|P1|NOT COMPLETED|Induction Chemoimmunotherapy||15
506423|NCT00974233|1238581|P1|COMPLETED|Induction Chemoimmunotherapy||19
506424|NCT00974233|1238581|P1|STARTED|Induction Chemoimmunotherapy||34
506425|NCT00974220|1238596|P2|NOT COMPLETED|Treatment Period 2||0
506426|NCT00974220|1238597|P1|NOT COMPLETED|Treatment Period 2||0
506427|NCT00974220|1238596|P2|COMPLETED|Treatment Period 2||5
506428|NCT00974220|1238597|P1|COMPLETED|Treatment Period 2||7
506429|NCT00974220|1238596|P2|STARTED|Treatment Period 2||5
506430|NCT00974220|1238597|P1|STARTED|Treatment Period 2||7
506431|NCT00974220|1238596|P2|NOT COMPLETED|Treatment Period 1||2
506432|NCT00974220|1238597|P1|NOT COMPLETED|Treatment Period 1||2
506433|NCT00974220|1238596|P2|COMPLETED|Treatment Period 1||5
506434|NCT00974220|1238597|P1|COMPLETED|Treatment Period 1||7
506435|NCT00974220|1238596|P2|STARTED|Treatment Period 1||7
506436|NCT00974220|1238597|P1|STARTED|Treatment Period 1||9
506437|NCT00974142|1238607|P2|NOT COMPLETED|Overall Study||0
506438|NCT00974142|1238608|P1|NOT COMPLETED|Overall Study||0
506439|NCT00974142|1238607|P2|COMPLETED|Overall Study||9
506440|NCT00974142|1238608|P1|COMPLETED|Overall Study||8
506441|NCT00974142|1238607|P2|STARTED|Overall Study||9
506442|NCT00974142|1238608|P1|STARTED|Overall Study||8
506443|NCT00974090|1238642|P2|NOT COMPLETED|Period 2: Open-label Period||10
506444|NCT00974090|1238643|P1|NOT COMPLETED|Period 2: Open-label Period||8
506445|NCT00974090|1238642|P2|COMPLETED|Period 2: Open-label Period||85
506446|NCT00974090|1238643|P1|COMPLETED|Period 2: Open-label Period||87
506447|NCT00974090|1238642|P2|STARTED|Period 2: Open-label Period||95
506448|NCT00974090|1238643|P1|STARTED|Period 2: Open-label Period||95
506449|NCT00974090|1238642|P2|NOT COMPLETED|Period 1: Double Blind Period||1
506450|NCT00974090|1238643|P1|NOT COMPLETED|Period 1: Double Blind Period||3
506451|NCT00974090|1238642|P2|COMPLETED|Period 1: Double Blind Period||95
506452|NCT00974090|1238643|P1|COMPLETED|Period 1: Double Blind Period||95
506453|NCT00974090|1238642|P2|STARTED|Period 1: Double Blind Period||96
506454|NCT00974090|1238643|P1|STARTED|Period 1: Double Blind Period||98
506455|NCT00974051|1238657|P3|NOT COMPLETED|Overall Study||0
506456|NCT00974051|1238658|P2|NOT COMPLETED|Overall Study||0
506457|NCT00974051|1238659|P1|NOT COMPLETED|Overall Study||0
506458|NCT00974051|1238657|P3|COMPLETED|Overall Study||6
506459|NCT00974051|1238658|P2|COMPLETED|Overall Study||4
506460|NCT00974051|1238659|P1|COMPLETED|Overall Study||6
506461|NCT00974051|1238657|P3|STARTED|Overall Study||6
506462|NCT00974051|1238658|P2|STARTED|Overall Study||4
506463|NCT00974051|1238659|P1|STARTED|Overall Study||6
506464|NCT00973921|1238677|P1|NOT COMPLETED|Overall Study||9
506465|NCT00973921|1238677|P1|COMPLETED|Overall Study||31
506466|NCT00973921|1238677|P1|STARTED|Overall Study||40
506467|NCT00973765|1238686|P2|NOT COMPLETED|Overall Study||14
506468|NCT00973765|1238687|P1|NOT COMPLETED|Overall Study||8
506469|NCT00973765|1238686|P2|COMPLETED|Overall Study|102|102
506470|NCT00973765|1238687|P1|COMPLETED|Overall Study|88|88
506471|NCT00973765|1238686|P2|STARTED|Overall Study|116|116
506472|NCT00973765|1238687|P1|STARTED|Overall Study|96|96
506473|NCT00973752|1238693|P1|NOT COMPLETED|Overall Study||0
506474|NCT00973752|1238693|P1|COMPLETED|Overall Study||30
506475|NCT00973752|1238693|P1|STARTED|Overall Study||30
506476|NCT00973739|1238697|P1|NOT COMPLETED|Overall Study||4
506477|NCT00973739|1238697|P1|COMPLETED|Overall Study||17
506478|NCT00973739|1238697|P1|STARTED|Overall Study||21
506479|NCT00973700|1238709|P5|NOT COMPLETED|Overall Study||10
506480|NCT00973700|1238710|P4|NOT COMPLETED|Overall Study||18
506481|NCT00973700|1238711|P3|NOT COMPLETED|Overall Study||10
506482|NCT00973700|1238712|P2|NOT COMPLETED|Overall Study||2
506483|NCT00973700|1238713|P1|NOT COMPLETED|Overall Study||7
506484|NCT00973700|1238709|P5|COMPLETED|Overall Study||158
506485|NCT00973700|1238710|P4|COMPLETED|Overall Study||318
506486|NCT00973700|1238711|P3|COMPLETED|Overall Study||158
506487|NCT00973700|1238712|P2|COMPLETED|Overall Study||54
506488|NCT00973700|1238713|P1|COMPLETED|Overall Study||49
506489|NCT00973700|1238709|P5|STARTED|Overall Study||168
506490|NCT00973700|1238710|P4|STARTED|Overall Study||336
506491|NCT00973700|1238711|P3|STARTED|Overall Study||168
506492|NCT00973700|1238712|P2|STARTED|Overall Study||56
506493|NCT00973700|1238713|P1|STARTED|Overall Study||56
506494|NCT00973622|1238762|P2|NOT COMPLETED|Overall Study||5
506495|NCT00973622|1238763|P1|NOT COMPLETED|Overall Study||31
506496|NCT00973622|1238762|P2|COMPLETED|Overall Study|Completed three sessions of rTMS|14
506497|NCT00973622|1238763|P1|COMPLETED|Overall Study|Completed three sessions of rTMS|16
506498|NCT00973622|1238762|P2|STARTED|Overall Study|21 passed telephone interview; 19 passed the in-person interview, were enrolled, and sent for MRI.|19
506499|NCT00973622|1238763|P1|STARTED|Overall Study|75 passed telephone interview; 28 passed in-person interview, were enrolled, and sent for MRI.|47
506500|NCT00973479|1238771|P2|NOT COMPLETED|Overall Study||69
506501|NCT00973479|1238772|P1|NOT COMPLETED|Overall Study||37
506502|NCT00973479|1238771|P2|COMPLETED|Overall Study||326
506503|NCT00973479|1238772|P1|COMPLETED|Overall Study||160
506504|NCT00973479|1238771|P2|STARTED|Overall Study||395
506505|NCT00973479|1238772|P1|STARTED|Overall Study||197
506506|NCT00973362|1238790|P2|NOT COMPLETED|3-Year Follow-up||0
506507|NCT00973362|1238791|P1|NOT COMPLETED|3-Year Follow-up||17
506508|NCT00973362|1238790|P2|COMPLETED|3-Year Follow-up||0
506509|NCT00973362|1238791|P1|COMPLETED|3-Year Follow-up||10854
506510|NCT00973362|1238790|P2|STARTED|3-Year Follow-up|ASC-US study arm did not have a follow-up period|0
506511|NCT00973362|1238791|P1|STARTED|3-Year Follow-up||10871
506512|NCT00973362|1238790|P2|NOT COMPLETED|Baseline Evaluation||223
506513|NCT00973362|1238791|P1|NOT COMPLETED|Baseline Evaluation||773
506514|NCT00973362|1238790|P2|COMPLETED|Baseline Evaluation||1029
506515|NCT00973362|1238791|P1|COMPLETED|Baseline Evaluation||10871
506516|NCT00973362|1238790|P2|Conclusive Disease Status|Baseline Evaluation||939
506517|NCT00973362|1238791|P1|Conclusive Disease Status|Baseline Evaluation||819
506518|NCT00973362|1238790|P2|Evaluable for Analysis|Baseline Evaluation||958
506519|NCT00973362|1238791|P1|Evaluable for Analysis|Baseline Evaluation||10871
506520|NCT00973362|1238790|P2|STARTED|Baseline Evaluation||1252
506521|NCT00973362|1238791|P1|STARTED|Baseline Evaluation||11644
506522|NCT00973349|1238816|P16|NOT COMPLETED|Overall Study||2
506523|NCT00973349|1238817|P15|NOT COMPLETED|Overall Study||2
506524|NCT00973349|1238818|P14|NOT COMPLETED|Overall Study||0
506525|NCT00973349|1238819|P13|NOT COMPLETED|Overall Study||1
506526|NCT00973349|1238820|P12|NOT COMPLETED|Overall Study||2
506527|NCT00973349|1238821|P11|NOT COMPLETED|Overall Study||0
506528|NCT00973349|1238822|P10|NOT COMPLETED|Overall Study||6
506529|NCT00973349|1238823|P9|NOT COMPLETED|Overall Study||4
506530|NCT00973349|1238824|P8|NOT COMPLETED|Overall Study||3
506531|NCT00973349|1238825|P7|NOT COMPLETED|Overall Study||2
506532|NCT00973349|1238826|P6|NOT COMPLETED|Overall Study||4
506533|NCT00973349|1238827|P5|NOT COMPLETED|Overall Study||5
506534|NCT00973349|1238828|P4|NOT COMPLETED|Overall Study||5
506535|NCT00973349|1238829|P3|NOT COMPLETED|Overall Study||5
506536|NCT00973349|1238830|P2|NOT COMPLETED|Overall Study||3
506537|NCT00973349|1238831|P1|NOT COMPLETED|Overall Study||4
506538|NCT00973349|1238816|P16|COMPLETED|Overall Study||165
506539|NCT00973349|1238817|P15|COMPLETED|Overall Study||168
506540|NCT00973349|1238818|P14|COMPLETED|Overall Study||171
506541|NCT00973349|1238819|P13|COMPLETED|Overall Study||168
506542|NCT00973349|1238820|P12|COMPLETED|Overall Study||167
506543|NCT00973349|1238821|P11|COMPLETED|Overall Study||174
506544|NCT00973349|1238822|P10|COMPLETED|Overall Study||163
506545|NCT00973349|1238823|P9|COMPLETED|Overall Study||167
506546|NCT00973349|1238824|P8|COMPLETED|Overall Study||166
506547|NCT00973349|1238825|P7|COMPLETED|Overall Study||172
506548|NCT00973349|1238826|P6|COMPLETED|Overall Study||165
506549|NCT00973349|1238827|P5|COMPLETED|Overall Study||165
506550|NCT00973349|1238828|P4|COMPLETED|Overall Study||163
506551|NCT00973349|1238829|P3|COMPLETED|Overall Study||166
506552|NCT00973349|1238830|P2|COMPLETED|Overall Study||165
506553|NCT00973349|1238831|P1|COMPLETED|Overall Study||166
506554|NCT00973349|1238816|P16|STARTED|Overall Study||167
506555|NCT00973349|1238817|P15|STARTED|Overall Study||170
506556|NCT00973349|1238818|P14|STARTED|Overall Study||171
506557|NCT00973349|1238819|P13|STARTED|Overall Study||169
506558|NCT00973349|1238820|P12|STARTED|Overall Study||169
506559|NCT00973349|1238821|P11|STARTED|Overall Study||174
506560|NCT00973349|1238822|P10|STARTED|Overall Study||169
506561|NCT00973349|1238823|P9|STARTED|Overall Study||171
506562|NCT00973349|1238824|P8|STARTED|Overall Study||169
506563|NCT00973349|1238825|P7|STARTED|Overall Study||174
506564|NCT00973349|1238826|P6|STARTED|Overall Study||169
506565|NCT00973349|1238827|P5|STARTED|Overall Study||170
506566|NCT00973349|1238828|P4|STARTED|Overall Study||168
506567|NCT00973349|1238829|P3|STARTED|Overall Study||171
506568|NCT00973349|1238830|P2|STARTED|Overall Study||168
506569|NCT00973349|1238831|P1|STARTED|Overall Study||170
506570|NCT00972959|1238929|P1|NOT COMPLETED|Overall Study||0
506571|NCT00972959|1238929|P1|COMPLETED|Overall Study||17
506572|NCT00972959|1238929|P1|STARTED|Overall Study||17
506573|NCT00972816|1238952|P8|NOT COMPLETED|Overall Study||9
506574|NCT00972816|1238953|P7|NOT COMPLETED|Overall Study||10
506575|NCT00972816|1238954|P6|NOT COMPLETED|Overall Study||11
506576|NCT00972816|1238955|P5|NOT COMPLETED|Overall Study||12
506577|NCT00972816|1238956|P4|NOT COMPLETED|Overall Study||8
506578|NCT00972816|1238957|P3|NOT COMPLETED|Overall Study||9
506579|NCT00972816|1238958|P2|NOT COMPLETED|Overall Study||11
506580|NCT00972816|1238959|P1|NOT COMPLETED|Overall Study||17
506581|NCT00972816|1238952|P8|COMPLETED|Overall Study||161
506582|NCT00972816|1238953|P7|COMPLETED|Overall Study||159
506583|NCT00972816|1238954|P6|COMPLETED|Overall Study||158
506584|NCT00972816|1238955|P5|COMPLETED|Overall Study||157
506585|NCT00972816|1238956|P4|COMPLETED|Overall Study||161
506586|NCT00972816|1238957|P3|COMPLETED|Overall Study||160
506587|NCT00972816|1238958|P2|COMPLETED|Overall Study||158
506588|NCT00972816|1238959|P1|COMPLETED|Overall Study||156
506589|NCT00972816|1238952|P8|STARTED|Overall Study||170
506590|NCT00972816|1238953|P7|STARTED|Overall Study||169
506591|NCT00972816|1238954|P6|STARTED|Overall Study||169
506592|NCT00972816|1238955|P5|STARTED|Overall Study||169
506593|NCT00972816|1238956|P4|STARTED|Overall Study||169
506594|NCT00972816|1238957|P3|STARTED|Overall Study||169
506595|NCT00972816|1238958|P2|STARTED|Overall Study||169
506596|NCT00972816|1238959|P1|STARTED|Overall Study||173
506597|NCT00972777|1239043|P2|NOT COMPLETED|Overall Study||14
506598|NCT00972777|1239044|P1|NOT COMPLETED|Overall Study||14
506599|NCT00972777|1239043|P2|COMPLETED|Overall Study||229
506600|NCT00972777|1239044|P1|COMPLETED|Overall Study||217
506601|NCT00972777|1239043|P2|STARTED|Overall Study||243
506602|NCT00972777|1239044|P1|STARTED|Overall Study||231
506603|NCT00972738|1239059|P3|NOT COMPLETED|Overall Study||29
506604|NCT00972738|1239060|P2|NOT COMPLETED|Overall Study||6
506605|NCT00972738|1239061|P1|NOT COMPLETED|Overall Study||21
506606|NCT00972738|1239059|P3|COMPLETED|Overall Study||492
506607|NCT00972738|1239060|P2|COMPLETED|Overall Study||165
506608|NCT00972738|1239061|P1|COMPLETED|Overall Study||501
506609|NCT00972738|1239059|P3|STARTED|Overall Study||521
506610|NCT00972738|1239060|P2|STARTED|Overall Study||171
506611|NCT00972738|1239061|P1|STARTED|Overall Study||522
506612|NCT00972725|1239086|P2|NOT COMPLETED|Overall Study||0
506613|NCT00972725|1239087|P1|NOT COMPLETED|Overall Study||0
506614|NCT00972725|1239086|P2|COMPLETED|Overall Study||15
506615|NCT00972725|1239087|P1|COMPLETED|Overall Study||13
506616|NCT00972725|1239086|P2|STARTED|Overall Study||15
506617|NCT00972725|1239087|P1|STARTED|Overall Study||13
506618|NCT00972621|1239169|P2|NOT COMPLETED|Overall Study||1
506619|NCT00972621|1239170|P1|NOT COMPLETED|Overall Study||0
506620|NCT00972621|1239169|P2|COMPLETED|Overall Study|One subject discontinued due to lens exchange.|199
506621|NCT00972621|1239170|P1|COMPLETED|Overall Study||200
506622|NCT00972621|1239169|P2|STARTED|Overall Study||200
506623|NCT00972621|1239170|P1|STARTED|Overall Study||200
506624|NCT00972595|1239178|P2|NOT COMPLETED|Period 2||0
506625|NCT00972595|1239179|P1|NOT COMPLETED|Period 2||0
506626|NCT00972595|1239178|P2|COMPLETED|Period 2||22
506627|NCT00972595|1239179|P1|COMPLETED|Period 2||22
506628|NCT00972595|1239178|P2|STARTED|Period 2||22
506629|NCT00972595|1239179|P1|STARTED|Period 2||22
506630|NCT00972595|1239178|P2|NOT COMPLETED|Period 1||0
506631|NCT00972595|1239179|P1|NOT COMPLETED|Period 1||1
506632|NCT00972595|1239178|P2|COMPLETED|Period 1||22
506633|NCT00972595|1239179|P1|COMPLETED|Period 1||22
506634|NCT00972595|1239178|P2|STARTED|Period 1||22
506635|NCT00972595|1239179|P1|STARTED|Period 1||23
506636|NCT00972543|1239189|P2|NOT COMPLETED|Overall Study||1
506637|NCT00972543|1239190|P1|NOT COMPLETED|Overall Study||5
506638|NCT00972543|1239189|P2|COMPLETED|Overall Study||0
506639|NCT00972543|1239190|P1|COMPLETED|Overall Study||0
506640|NCT00972543|1239189|P2|STARTED|Overall Study||1
506641|NCT00972543|1239190|P1|STARTED|Overall Study||5
506642|NCT00972530|1239266|P2|NOT COMPLETED|Overall Study||0
506643|NCT00972530|1239267|P1|NOT COMPLETED|Overall Study||0
506644|NCT00972530|1239266|P2|COMPLETED|Overall Study||46
506645|NCT00972530|1239267|P1|COMPLETED|Overall Study||44
506646|NCT00972530|1239266|P2|STARTED|Overall Study||46
506647|NCT00972530|1239267|P1|STARTED|Overall Study||44
506648|NCT00972504|1239273|P1|NOT COMPLETED|Overall Study||3
506649|NCT00972504|1239273|P1|COMPLETED|Overall Study||51
506650|NCT00972504|1239273|P1|STARTED|Overall Study||54
506651|NCT00972478|1239305|P2|NOT COMPLETED|Overall Study||38
506652|NCT00972478|1239306|P1|NOT COMPLETED|Overall Study||7
506653|NCT00972478|1239305|P2|COMPLETED|Overall Study||34
506654|NCT00972478|1239306|P1|COMPLETED|Overall Study||4
506655|NCT00972478|1239305|P2|Eligible and Began Protocol Therapy|Overall Study||63
506656|NCT00972478|1239306|P1|Eligible and Began Protocol Therapy|Overall Study||9
506657|NCT00972478|1239305|P2|STARTED|Overall Study||72
506658|NCT00972478|1239306|P1|STARTED|Overall Study||11
506659|NCT00972439|1239318|P2|NOT COMPLETED|Overall Study||0
506660|NCT00972439|1239319|P1|NOT COMPLETED|Overall Study||0
506661|NCT00972439|1239318|P2|COMPLETED|Overall Study||16
506662|NCT00972439|1239319|P1|COMPLETED|Overall Study||17
506663|NCT00972439|1239318|P2|STARTED|Overall Study||16
506664|NCT00972439|1239319|P1|STARTED|Overall Study||17
506665|NCT00972374|1239328|P3|NOT COMPLETED|Overall Study||1
506666|NCT00972374|1239329|P2|NOT COMPLETED|Overall Study||0
506667|NCT00972374|1239330|P1|NOT COMPLETED|Overall Study||2
506668|NCT00972374|1239328|P3|COMPLETED|Overall Study||13
506669|NCT00972374|1239329|P2|COMPLETED|Overall Study||15
506670|NCT00972374|1239330|P1|COMPLETED|Overall Study||13
506671|NCT00972374|1239328|P3|STARTED|Overall Study||14
506672|NCT00972374|1239329|P2|STARTED|Overall Study||15
506673|NCT00972374|1239330|P1|STARTED|Overall Study||15
506674|NCT00972335|1239344|P1|NOT COMPLETED|Overall Study||17
506675|NCT00972335|1239344|P1|COMPLETED|Overall Study|Patients were on study until an event or condition occured which required them to come off study|0
506676|NCT00972335|1239344|P1|STARTED|Overall Study|One patient was enrolled but showed no evidence of disease at study entry and was not treated|17
506677|NCT00972322|1239351|P2|NOT COMPLETED|Overall Study||3
506678|NCT00972322|1239352|P1|NOT COMPLETED|Overall Study||3
506679|NCT00972322|1239351|P2|COMPLETED|Overall Study||25
506680|NCT00972322|1239352|P1|COMPLETED|Overall Study||25
506681|NCT00972322|1239351|P2|STARTED|Overall Study||28
506682|NCT00972322|1239352|P1|STARTED|Overall Study||28
506683|NCT00972283|1239364|P2|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||8
506684|NCT00972283|1239365|P1|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||27
506685|NCT00972283|1239364|P2|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||183
506686|NCT00972283|1239365|P1|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||539
506687|NCT00972283|1239364|P2|STARTED|Extension: Week 53 to 78 (NN1250-3667)|20 subjects did not continue into the extension from main trial|191
506688|NCT00972283|1239365|P1|STARTED|Extension: Week 53 to 78 (NN1250-3667)|52 subjects did not continue into the extension from main trial|566
506689|NCT00972283|1239364|P2|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||40
506690|NCT00972283|1239365|P1|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||137
506691|NCT00972283|1239364|P2|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||211
506692|NCT00972283|1239365|P1|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||618
506693|NCT00972283|1239364|P2|Exposed|Main: Week 0 to 52 (NN1250-3582)||251
506694|NCT00972283|1239365|P1|Exposed|Main: Week 0 to 52 (NN1250-3582)|2 subjects were withdrawn prior to exposure to trial products|753
506695|NCT00972283|1239364|P2|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)|3 subjects were excluded due to closure of a site|248
506696|NCT00972283|1239365|P1|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)|11 subjects were excluded due to closure of a site|744
506697|NCT00972283|1239364|P2|STARTED|Main: Week 0 to 52 (NN1250-3582)||251
506698|NCT00972283|1239365|P1|STARTED|Main: Week 0 to 52 (NN1250-3582)||755
506699|NCT00972244|1239392|P5|NOT COMPLETED|Overall Study||9
506700|NCT00972244|1239393|P4|NOT COMPLETED|Overall Study||0
506701|NCT00972244|1239394|P3|NOT COMPLETED|Overall Study||2
506702|NCT00972244|1239395|P2|NOT COMPLETED|Overall Study||5
506703|NCT00972244|1239396|P1|NOT COMPLETED|Overall Study||5
506704|NCT00972244|1239392|P5|COMPLETED|Overall Study||45
506705|NCT00972244|1239393|P4|COMPLETED|Overall Study||52
506706|NCT00972244|1239394|P3|COMPLETED|Overall Study||56
506707|NCT00972244|1239395|P2|COMPLETED|Overall Study||51
506708|NCT00972244|1239396|P1|COMPLETED|Overall Study||54
506709|NCT00972244|1239392|P5|STARTED|Overall Study||54
506710|NCT00972244|1239393|P4|STARTED|Overall Study||52
506711|NCT00972244|1239394|P3|STARTED|Overall Study||58
506712|NCT00972244|1239395|P2|STARTED|Overall Study||56
506713|NCT00972244|1239396|P1|STARTED|Overall Study||59
506714|NCT00972205|1239418|P1|NOT COMPLETED|Overall Study||0
506715|NCT00972205|1239418|P1|COMPLETED|Overall Study||12
506716|NCT00972205|1239418|P1|STARTED|Overall Study||12
506717|NCT00972153|1239428|P3|NOT COMPLETED|Overall Study||0
506718|NCT00972153|1239429|P2|NOT COMPLETED|Overall Study||1
506719|NCT00972153|1239430|P1|NOT COMPLETED|Overall Study||0
506720|NCT00972153|1239428|P3|COMPLETED|Overall Study||12
506721|NCT00972153|1239429|P2|COMPLETED|Overall Study|One case excluded due to technical problem with measuring equipment.|11
506722|NCT00972153|1239430|P1|COMPLETED|Overall Study||12
506723|NCT00972153|1239428|P3|STARTED|Overall Study||12
506724|NCT00972153|1239429|P2|STARTED|Overall Study||12
506725|NCT00972153|1239430|P1|STARTED|Overall Study||12
506726|NCT00972088|1239441|P1|NOT COMPLETED|Overall Study||0
506727|NCT00972088|1239441|P1|COMPLETED|Overall Study||26
506728|NCT00972088|1239441|P1|STARTED|Overall Study||26
506729|NCT00972023|1239445|P1|NOT COMPLETED|Overall Study||1
506730|NCT00972023|1239445|P1|COMPLETED|Overall Study||0
506731|NCT00972023|1239445|P1|STARTED|Overall Study||1
506732|NCT00971997|1239452|P1|NOT COMPLETED|Overall Study||19
506733|NCT00971997|1239452|P1|COMPLETED|Overall Study||116
506734|NCT00971997|1239452|P1|STARTED|Overall Study||135
506735|NCT00971932|1239470|P1|NOT COMPLETED|Overall Study||7
506736|NCT00971932|1239470|P1|COMPLETED|Overall Study||26
506737|NCT00971932|1239470|P1|STARTED|Overall Study|Number of participants treated.|33
506738|NCT00971841|1239480|P1|NOT COMPLETED|Overall Study||0
506739|NCT00971841|1239480|P1|COMPLETED|Overall Study||1
506740|NCT00971841|1239480|P1|STARTED|Overall Study||1
506741|NCT00971789|1239485|P1|NOT COMPLETED|Overall Study||0
506742|NCT00971789|1239485|P1|COMPLETED|Overall Study||18
506743|NCT00971789|1239485|P1|STARTED|Overall Study||18
506744|NCT00971750|1239490|P1|NOT COMPLETED|Overall Study||0
506745|NCT00971750|1239490|P1|COMPLETED|Overall Study||253
506746|NCT00971750|1239490|P1|STARTED|Overall Study||253
506747|NCT00971633|1239499|P6|NOT COMPLETED|Period 3||0
506748|NCT00971633|1239500|P5|NOT COMPLETED|Period 3||0
506749|NCT00971633|1239501|P4|NOT COMPLETED|Period 3||0
506750|NCT00971633|1239502|P3|NOT COMPLETED|Period 3||0
506751|NCT00971633|1239503|P2|NOT COMPLETED|Period 3||0
506752|NCT00971633|1239504|P1|NOT COMPLETED|Period 3||0
506753|NCT00971633|1239499|P6|COMPLETED|Period 3||2
506754|NCT00971633|1239500|P5|COMPLETED|Period 3||2
506755|NCT00971633|1239501|P4|COMPLETED|Period 3||2
506756|NCT00971633|1239502|P3|COMPLETED|Period 3||2
506757|NCT00971633|1239503|P2|COMPLETED|Period 3||2
506758|NCT00971633|1239504|P1|COMPLETED|Period 3||2
506759|NCT00971633|1239499|P6|STARTED|Period 3||2
506760|NCT00971633|1239500|P5|STARTED|Period 3||2
506761|NCT00971633|1239501|P4|STARTED|Period 3||2
506762|NCT00971633|1239502|P3|STARTED|Period 3||2
506763|NCT00971633|1239503|P2|STARTED|Period 3||2
506764|NCT00971633|1239504|P1|STARTED|Period 3||2
506765|NCT00971633|1239499|P6|NOT COMPLETED|Period 2||0
506766|NCT00971633|1239500|P5|NOT COMPLETED|Period 2||0
506767|NCT00971633|1239501|P4|NOT COMPLETED|Period 2||0
506768|NCT00971633|1239502|P3|NOT COMPLETED|Period 2||0
506769|NCT00971633|1239503|P2|NOT COMPLETED|Period 2||0
506770|NCT00971633|1239504|P1|NOT COMPLETED|Period 2||0
506771|NCT00971633|1239499|P6|COMPLETED|Period 2||2
506772|NCT00971633|1239500|P5|COMPLETED|Period 2||2
506773|NCT00971633|1239501|P4|COMPLETED|Period 2||2
506774|NCT00971633|1239502|P3|COMPLETED|Period 2||2
506775|NCT00971633|1239503|P2|COMPLETED|Period 2||2
506776|NCT00971633|1239504|P1|COMPLETED|Period 2||2
506777|NCT00971633|1239499|P6|STARTED|Period 2||2
506778|NCT00971633|1239500|P5|STARTED|Period 2||2
506779|NCT00971633|1239501|P4|STARTED|Period 2||2
506780|NCT00971633|1239502|P3|STARTED|Period 2||2
506781|NCT00971633|1239503|P2|STARTED|Period 2||2
506782|NCT00971633|1239504|P1|STARTED|Period 2||2
506783|NCT00971633|1239499|P6|NOT COMPLETED|Period 1||0
506784|NCT00971633|1239500|P5|NOT COMPLETED|Period 1||0
506785|NCT00971633|1239501|P4|NOT COMPLETED|Period 1||0
506786|NCT00971633|1239502|P3|NOT COMPLETED|Period 1||0
506787|NCT00971633|1239503|P2|NOT COMPLETED|Period 1||0
506788|NCT00971633|1239504|P1|NOT COMPLETED|Period 1||0
506789|NCT00971633|1239499|P6|COMPLETED|Period 1||2
506790|NCT00971633|1239500|P5|COMPLETED|Period 1||2
506791|NCT00971633|1239501|P4|COMPLETED|Period 1||2
506792|NCT00971633|1239502|P3|COMPLETED|Period 1||2
506793|NCT00971633|1239503|P2|COMPLETED|Period 1||2
506794|NCT00971633|1239504|P1|COMPLETED|Period 1||2
506795|NCT00971633|1239499|P6|STARTED|Period 1||2
506796|NCT00971633|1239500|P5|STARTED|Period 1||2
506797|NCT00971633|1239501|P4|STARTED|Period 1||2
506798|NCT00971633|1239502|P3|STARTED|Period 1||2
506799|NCT00971633|1239503|P2|STARTED|Period 1||2
506800|NCT00971633|1239504|P1|STARTED|Period 1||2
506801|NCT00971620|1239517|P2|NOT COMPLETED|Overall Study||0
506802|NCT00971620|1239518|P1|NOT COMPLETED|Overall Study||0
506803|NCT00971620|1239517|P2|COMPLETED|Overall Study||9
506804|NCT00971620|1239518|P1|COMPLETED|Overall Study||9
506805|NCT00971620|1239517|P2|STARTED|Overall Study||9
506806|NCT00971620|1239518|P1|STARTED|Overall Study||9
506807|NCT00971425|1239550|P2|NOT COMPLETED|Overall Study||2
506808|NCT00971425|1239551|P1|NOT COMPLETED|Overall Study||1
506809|NCT00971425|1239550|P2|COMPLETED|Overall Study||71
506810|NCT00971425|1239551|P1|COMPLETED|Overall Study||71
506811|NCT00971425|1239550|P2|STARTED|Overall Study||73
506812|NCT00971425|1239551|P1|STARTED|Overall Study||72
506813|NCT00971295|1239585|P2|NOT COMPLETED|Overall Study||1
506814|NCT00971295|1239586|P1|NOT COMPLETED|Overall Study||0
506815|NCT00971295|1239585|P2|COMPLETED|Overall Study||9
506816|NCT00971295|1239586|P1|COMPLETED|Overall Study||10
506817|NCT00971295|1239585|P2|STARTED|Overall Study||10
506818|NCT00971295|1239586|P1|STARTED|Overall Study||10
506819|NCT00971282|1239596|P1|NOT COMPLETED|Overall Study||0
506820|NCT00971282|1239596|P1|COMPLETED|Overall Study||30
506821|NCT00971282|1239596|P1|STARTED|Overall Study||30
506822|NCT00971243|1239615|P5|NOT COMPLETED|Open-label Period||6
506823|NCT00971243|1239616|P4|NOT COMPLETED|Open-label Period||10
506824|NCT00971243|1239617|P3|NOT COMPLETED|Open-label Period||5
506825|NCT00971243|1239618|P2|NOT COMPLETED|Open-label Period||10
506826|NCT00971243|1239619|P1|NOT COMPLETED|Open-label Period||8
506827|NCT00971243|1239615|P5|COMPLETED|Open-label Period||64
506828|NCT00971243|1239616|P4|COMPLETED|Open-label Period||64
506829|NCT00971243|1239617|P3|COMPLETED|Open-label Period||66
506830|NCT00971243|1239618|P2|COMPLETED|Open-label Period||71
506831|NCT00971243|1239619|P1|COMPLETED|Open-label Period||60
506832|NCT00971243|1239615|P5|STARTED|Open-label Period||70
506833|NCT00971243|1239616|P4|STARTED|Open-label Period||74
506834|NCT00971243|1239617|P3|STARTED|Open-label Period|One Subject did not entered the Open-label Period because of the withdrawal of consent.|71
506835|NCT00971243|1239618|P2|STARTED|Open-label Period|One Subject did not entered because of the failure of inclusion/exclusion criteria.|81
506836|NCT00971243|1239619|P1|STARTED|Open-label Period||68
506837|NCT00971243|1239615|P5|NOT COMPLETED|Double Blind Period||18
506838|NCT00971243|1239616|P4|NOT COMPLETED|Double Blind Period||14
506839|NCT00971243|1239617|P3|NOT COMPLETED|Double Blind Period||19
506840|NCT00971243|1239618|P2|NOT COMPLETED|Double Blind Period||11
506841|NCT00971243|1239619|P1|NOT COMPLETED|Double Blind Period||19
506842|NCT00971243|1239615|P5|COMPLETED|Double Blind Period||70
506843|NCT00971243|1239616|P4|COMPLETED|Double Blind Period||74
506844|NCT00971243|1239617|P3|COMPLETED|Double Blind Period||72
506845|NCT00971243|1239618|P2|COMPLETED|Double Blind Period||82
506846|NCT00971243|1239619|P1|COMPLETED|Double Blind Period||68
506847|NCT00971243|1239615|P5|STARTED|Double Blind Period||88
506848|NCT00971243|1239616|P4|STARTED|Double Blind Period|One subject who did not receive any study drug was excluded from the ITT|88
506849|NCT00971243|1239617|P3|STARTED|Double Blind Period||91
506850|NCT00971243|1239618|P2|STARTED|Double Blind Period||93
506851|NCT00971243|1239619|P1|STARTED|Double Blind Period||87
506852|NCT00971204|1239636|P1|NOT COMPLETED|Overall Study||24
506949|NCT00970281|1239939|P1|COMPLETED|Overall Study||44
506853|NCT00971204|1239636|P1|COMPLETED|Overall Study|86 participants were treated and of these 86, 76 completed the study.|76
506854|NCT00971204|1239636|P1|Treated|Overall Study||86
506855|NCT00971204|1239636|P1|STARTED|Overall Study|100 enrolled participants|100
506856|NCT00971048|1239644|P4|NOT COMPLETED|Overall Study||2
506857|NCT00971048|1239645|P3|NOT COMPLETED|Overall Study||1
506858|NCT00971048|1239646|P2|NOT COMPLETED|Overall Study||2
506859|NCT00971048|1239647|P1|NOT COMPLETED|Overall Study||1
506860|NCT00971048|1239644|P4|COMPLETED|Overall Study||11
506861|NCT00971048|1239645|P3|COMPLETED|Overall Study||11
506862|NCT00971048|1239646|P2|COMPLETED|Overall Study||31
506863|NCT00971048|1239647|P1|COMPLETED|Overall Study||29
506864|NCT00971048|1239644|P4|STARTED|Overall Study||13
506865|NCT00971048|1239645|P3|STARTED|Overall Study||12
506866|NCT00971048|1239646|P2|STARTED|Overall Study||33
506867|NCT00971048|1239647|P1|STARTED|Overall Study||30
506868|NCT00970944|1239671|P2|NOT COMPLETED|Overall Study||2
506869|NCT00970944|1239672|P1|NOT COMPLETED|Overall Study||1
506870|NCT00970944|1239671|P2|COMPLETED|Overall Study||95
506871|NCT00970944|1239672|P1|COMPLETED|Overall Study||86
506872|NCT00970944|1239671|P2|STARTED|Overall Study||97
506873|NCT00970944|1239672|P1|STARTED|Overall Study||87
506874|NCT00970853|1239682|P2|NOT COMPLETED|Overall Study||0
506875|NCT00970853|1239683|P1|NOT COMPLETED|Overall Study||0
506876|NCT00970853|1239682|P2|COMPLETED|Overall Study||98
506877|NCT00970853|1239683|P1|COMPLETED|Overall Study||89
506878|NCT00970853|1239682|P2|STARTED|Overall Study||98
506879|NCT00970853|1239683|P1|STARTED|Overall Study||89
506880|NCT00970814|1239707|P2|NOT COMPLETED|Overall Study||14
506881|NCT00970814|1239708|P1|NOT COMPLETED|Overall Study||8
506882|NCT00970814|1239707|P2|COMPLETED|Overall Study||50
506883|NCT00970814|1239708|P1|COMPLETED|Overall Study||58
506884|NCT00970814|1239707|P2|STARTED|Overall Study||64
506885|NCT00970814|1239708|P1|STARTED|Overall Study||66
506886|NCT00970736|1239718|P1|NOT COMPLETED|Overall Study||2
506887|NCT00970736|1239718|P1|COMPLETED|Overall Study||18
506888|NCT00970736|1239718|P1|STARTED|Overall Study||20
506889|NCT00970684|1239724|P1|NOT COMPLETED|Overall Study||10
506890|NCT00970684|1239724|P1|COMPLETED|Overall Study||3
506891|NCT00970684|1239724|P1|STARTED|Overall Study||13
506892|NCT00970632|1239733|P3|NOT COMPLETED|Overall Study||18
506893|NCT00970632|1239734|P2|NOT COMPLETED|Overall Study||15
506894|NCT00970632|1239735|P1|NOT COMPLETED|Overall Study||24
506895|NCT00970632|1239733|P3|COMPLETED|Overall Study||150
506896|NCT00970632|1239734|P2|COMPLETED|Overall Study||156
506897|NCT00970632|1239735|P1|COMPLETED|Overall Study||148
506898|NCT00970632|1239733|P3|STARTED|Overall Study||168
506899|NCT00970632|1239734|P2|STARTED|Overall Study||171
506900|NCT00970632|1239735|P1|STARTED|Overall Study||172
506901|NCT00970606|1239793|P2|NOT COMPLETED|Overall Study||0
506902|NCT00970606|1239794|P1|NOT COMPLETED|Overall Study||0
506903|NCT00970606|1239793|P2|COMPLETED|Overall Study||3
506904|NCT00970606|1239794|P1|COMPLETED|Overall Study||4
506905|NCT00970606|1239793|P2|STARTED|Overall Study||3
506906|NCT00970606|1239794|P1|STARTED|Overall Study||4
506907|NCT00970502|1239800|P1|NOT COMPLETED|Overall Study||1
506908|NCT00970502|1239800|P1|COMPLETED|Overall Study||14
506909|NCT00970502|1239800|P1|STARTED|Overall Study||15
506910|NCT00970489|1239811|P2|NOT COMPLETED|Overall Study||41
506911|NCT00970489|1239812|P1|NOT COMPLETED|Overall Study||54
506912|NCT00970489|1239811|P2|COMPLETED|Overall Study||717
506913|NCT00970489|1239812|P1|COMPLETED|Overall Study||704
506914|NCT00970489|1239811|P2|STARTED|Overall Study||758
506915|NCT00970489|1239812|P1|STARTED|Overall Study||758
506916|NCT00970359|1239824|P1|NOT COMPLETED|Overall Study||4
506917|NCT00970359|1239824|P1|COMPLETED|Overall Study||20
506918|NCT00970359|1239824|P1|STARTED|Overall Study||24
506919|NCT00970320|1239835|P5|NOT COMPLETED|Overall Study||540
506920|NCT00970320|1239836|P4|NOT COMPLETED|Overall Study||14
506921|NCT00970320|1239837|P3|NOT COMPLETED|Overall Study||13
506922|NCT00970320|1239838|P2|NOT COMPLETED|Overall Study||11
506923|NCT00970320|1239839|P1|NOT COMPLETED|Overall Study||0
506924|NCT00970320|1239835|P5|COMPLETED|Overall Study||1031
506925|NCT00970320|1239836|P4|COMPLETED|Overall Study||36
506926|NCT00970320|1239837|P3|COMPLETED|Overall Study||35
506927|NCT00970320|1239838|P2|COMPLETED|Overall Study||13
506928|NCT00970320|1239839|P1|COMPLETED|Overall Study||25
506929|NCT00970320|1239835|P5|STARTED|Overall Study||1571
506930|NCT00970320|1239836|P4|STARTED|Overall Study||50
506931|NCT00970320|1239837|P3|STARTED|Overall Study||48
506932|NCT00970320|1239838|P2|STARTED|Overall Study||24
506933|NCT00970320|1239839|P1|STARTED|Overall Study||25
506934|NCT00970307|1239854|P3|NOT COMPLETED|Overall Study||2
506935|NCT00970307|1239855|P2|NOT COMPLETED|Overall Study||3
506936|NCT00970307|1239856|P1|NOT COMPLETED|Overall Study||3
506937|NCT00970307|1239854|P3|COMPLETED|Overall Study||139
506938|NCT00970307|1239855|P2|COMPLETED|Overall Study||136
506939|NCT00970307|1239856|P1|COMPLETED|Overall Study||138
506940|NCT00970307|1239854|P3|STARTED|Overall Study||141
506941|NCT00970307|1239855|P2|STARTED|Overall Study||139
506942|NCT00970307|1239856|P1|STARTED|Overall Study||141
506943|NCT00970294|1239930|P1|NOT COMPLETED|Overall Study||5
506944|NCT00970294|1239930|P1|COMPLETED|Overall Study||6
506945|NCT00970294|1239930|P1|STARTED|Overall Study||11
506946|NCT00970281|1239938|P2|NOT COMPLETED|Overall Study||16
506947|NCT00970281|1239939|P1|NOT COMPLETED|Overall Study||2
506948|NCT00970281|1239938|P2|COMPLETED|Overall Study||29
506950|NCT00970281|1239938|P2|Full Analysis Set|Overall Study||45
506951|NCT00970281|1239939|P1|Full Analysis Set|Overall Study|1 participant in the olanzapine arm discontinued before the first intramuscular (IM) injection.|45
506952|NCT00970281|1239938|P2|STARTED|Overall Study||45
506953|NCT00970281|1239939|P1|STARTED|Overall Study||46
506954|NCT00970268|1239957|P2|NOT COMPLETED|Overall Study||49
506955|NCT00970268|1239958|P1|NOT COMPLETED|Overall Study||43
506956|NCT00970268|1239957|P2|COMPLETED|Overall Study||103
506957|NCT00970268|1239958|P1|COMPLETED|Overall Study||96
506958|NCT00970268|1239957|P2|STARTED|Overall Study||152
506959|NCT00970268|1239958|P1|STARTED|Overall Study||139
506960|NCT00970216|1239972|P1|NOT COMPLETED|Overall Study||80
506961|NCT00970216|1239972|P1|COMPLETED|Overall Study||80
506962|NCT00970216|1239972|P1|STARTED|Overall Study||160
506963|NCT00969878|1239978|P2|NOT COMPLETED|Overall Study||26
506964|NCT00969878|1239979|P1|NOT COMPLETED|Overall Study||30
506965|NCT00969878|1239978|P2|COMPLETED|Overall Study||126
506966|NCT00969878|1239979|P1|COMPLETED|Overall Study||118
506967|NCT00969878|1239978|P2|STARTED|Overall Study||152
506968|NCT00969878|1239979|P1|STARTED|Overall Study||148
506969|NCT00969709|1239991|P4|NOT COMPLETED|Overall Study||63
506970|NCT00969709|1239992|P3|NOT COMPLETED|Overall Study||58
506971|NCT00969709|1239993|P2|NOT COMPLETED|Overall Study||48
506972|NCT00969709|1239994|P1|NOT COMPLETED|Overall Study||38
506973|NCT00969709|1239991|P4|COMPLETED|Overall Study||117
506974|NCT00969709|1239992|P3|COMPLETED|Overall Study||121
506975|NCT00969709|1239993|P2|COMPLETED|Overall Study||130
506976|NCT00969709|1239994|P1|COMPLETED|Overall Study||138
506977|NCT00969709|1239991|P4|STARTED|Overall Study||180
506978|NCT00969709|1239992|P3|STARTED|Overall Study||179
506979|NCT00969709|1239993|P2|STARTED|Overall Study||178
506980|NCT00969709|1239994|P1|STARTED|Overall Study||176
506981|NCT00969618|1240008|P1|NOT COMPLETED|Overall Study||78
506982|NCT00969618|1240008|P1|COMPLETED|Overall Study||133
506983|NCT00969618|1240008|P1|STARTED|Overall Study||211
506984|NCT00969540|1240021|P2|NOT COMPLETED|Overall Study||1
506985|NCT00969540|1240022|P1|NOT COMPLETED|Overall Study||1
506986|NCT00969540|1240021|P2|COMPLETED|Overall Study||3
506987|NCT00969540|1240022|P1|COMPLETED|Overall Study||3
506988|NCT00969540|1240021|P2|STARTED|Overall Study||4
506989|NCT00969540|1240022|P1|STARTED|Overall Study||4
506990|NCT00969501|1240040|P1|NOT COMPLETED|Overall Study||5
506991|NCT00969501|1240040|P1|COMPLETED|Overall Study||27
506992|NCT00969501|1240040|P1|STARTED|Overall Study||32
506993|NCT00969436|1240047|P3|NOT COMPLETED|Overall Study||11
506994|NCT00969436|1240048|P2|NOT COMPLETED|Overall Study||21
506995|NCT00969436|1240049|P1|NOT COMPLETED|Overall Study||25
506996|NCT00969436|1240047|P3|COMPLETED|Overall Study||79
506997|NCT00969436|1240048|P2|COMPLETED|Overall Study||159
506998|NCT00969436|1240049|P1|COMPLETED|Overall Study||155
506999|NCT00969436|1240047|P3|STARTED|Overall Study||90
507000|NCT00969436|1240048|P2|STARTED|Overall Study||180
507001|NCT00969436|1240049|P1|STARTED|Overall Study||180
507002|NCT00969280|1240083|P2|NOT COMPLETED|Overall Study||3
507003|NCT00969280|1240084|P1|NOT COMPLETED|Overall Study||2
507004|NCT00969280|1240083|P2|COMPLETED|Overall Study||18
507005|NCT00969280|1240084|P1|COMPLETED|Overall Study||19
507006|NCT00969280|1240083|P2|STARTED|Overall Study||21
507007|NCT00969280|1240084|P1|STARTED|Overall Study||21
507008|NCT00969228|1240092|P2|NOT COMPLETED|Overall Study||14
507009|NCT00969228|1240093|P1|NOT COMPLETED|Overall Study||43
507010|NCT00969228|1240092|P2|COMPLETED|Overall Study||162
507011|NCT00969228|1240093|P1|COMPLETED|Overall Study||465
507012|NCT00969228|1240092|P2|STARTED|Overall Study||176
507013|NCT00969228|1240093|P1|STARTED|Overall Study||508
507014|NCT00969150|1240111|P2|NOT COMPLETED|Overall Study||40
507015|NCT00969150|1240112|P1|NOT COMPLETED|Overall Study||33
507016|NCT00969150|1240111|P2|COMPLETED|Overall Study||135
507017|NCT00969150|1240112|P1|COMPLETED|Overall Study||149
507018|NCT00969150|1240111|P2|STARTED|Overall Study||175
507019|NCT00969150|1240112|P1|STARTED|Overall Study||182
507020|NCT00969124|1240120|P1|NOT COMPLETED|Overall Study||30
507021|NCT00969124|1240120|P1|COMPLETED|Overall Study||298
507022|NCT00969124|1240120|P1|STARTED|Overall Study||328
507023|NCT00968981|1240129|P3|NOT COMPLETED|Overall Study||22
507024|NCT00968981|1240130|P2|NOT COMPLETED|Overall Study||22
507025|NCT00968981|1240131|P1|NOT COMPLETED|Overall Study||22
507026|NCT00968981|1240129|P3|COMPLETED|Overall Study||0
507027|NCT00968981|1240130|P2|COMPLETED|Overall Study||0
507028|NCT00968981|1240131|P1|COMPLETED|Overall Study||1
507029|NCT00968981|1240129|P3|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|22
507030|NCT00968981|1240130|P2|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|21
507031|NCT00968981|1240131|P1|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|20
507032|NCT00968981|1240129|P3|STARTED|Overall Study||22
507033|NCT00968981|1240130|P2|STARTED|Overall Study||22
507034|NCT00968981|1240131|P1|STARTED|Overall Study||23
507035|NCT00968890|1240169|P2|NOT COMPLETED|Overall Study||0
507036|NCT00968890|1240170|P1|NOT COMPLETED|Overall Study||0
507037|NCT00968890|1240169|P2|COMPLETED|Overall Study||84
507038|NCT00968890|1240170|P1|COMPLETED|Overall Study||84
507039|NCT00968890|1240169|P2|STARTED|Overall Study||84
507040|NCT00968890|1240170|P1|STARTED|Overall Study||84
507041|NCT00968864|1240198|P1|NOT COMPLETED|Overall Study||1
507042|NCT00968864|1240198|P1|COMPLETED|Overall Study||52
507043|NCT00968864|1240198|P1|STARTED|Overall Study|One patient, FDA and IRB approved to enroll as an exception, was not evaluable for study endpoints.|53
507044|NCT00968838|1240216|P2|NOT COMPLETED|Overall Study||0
507045|NCT00968838|1240217|P1|NOT COMPLETED|Overall Study||0
507046|NCT00968838|1240216|P2|COMPLETED|Overall Study||58
507047|NCT00968838|1240217|P1|COMPLETED|Overall Study||50
507048|NCT00968838|1240216|P2|STARTED|Overall Study||58
507049|NCT00968838|1240217|P1|STARTED|Overall Study||50
507050|NCT00968812|1240226|P3|NOT COMPLETED|Overall Study||168
507051|NCT00968812|1240227|P2|NOT COMPLETED|Overall Study||162
507052|NCT00968812|1240228|P1|NOT COMPLETED|Overall Study||140
507053|NCT00968812|1240226|P3|COMPLETED|Overall Study||314
507054|NCT00968812|1240227|P2|COMPLETED|Overall Study||323
507055|NCT00968812|1240228|P1|COMPLETED|Overall Study||343
507056|NCT00968812|1240226|P3|STARTED|Overall Study||482
507057|NCT00968812|1240227|P2|STARTED|Overall Study||485
507058|NCT00968812|1240228|P1|STARTED|Overall Study||483
507059|NCT00968799|1240248|P1|NOT COMPLETED|Overall Study||2
507060|NCT00968799|1240248|P1|COMPLETED|Overall Study||4
507061|NCT00968799|1240248|P1|STARTED|Overall Study||6
507062|NCT00968708|1240258|P2|NOT COMPLETED|Overall Study||298
507063|NCT00968708|1240259|P1|NOT COMPLETED|Overall Study||318
507064|NCT00968708|1240258|P2|COMPLETED|Overall Study||2403
507065|NCT00968708|1240259|P1|COMPLETED|Overall Study||2361
507066|NCT00968708|1240258|P2|Treated|Overall Study||2698
507067|NCT00968708|1240259|P1|Treated|Overall Study||2676
507068|NCT00968708|1240258|P2|STARTED|Overall Study||2701
507069|NCT00968708|1240259|P1|STARTED|Overall Study||2679
507070|NCT00968669|1240271|P4|NOT COMPLETED|Overall Study||9
507071|NCT00968669|1240272|P3|NOT COMPLETED|Overall Study||11
507072|NCT00968669|1240273|P2|NOT COMPLETED|Overall Study||18
507073|NCT00968669|1240274|P1|NOT COMPLETED|Overall Study||18
507074|NCT00968669|1240271|P4|COMPLETED|Overall Study||72
507075|NCT00968669|1240272|P3|COMPLETED|Overall Study||72
507076|NCT00968669|1240273|P2|COMPLETED|Overall Study||63
507077|NCT00968669|1240274|P1|COMPLETED|Overall Study||64
507078|NCT00968669|1240271|P4|STARTED|Overall Study||81
507079|NCT00968669|1240272|P3|STARTED|Overall Study||83
507080|NCT00968669|1240273|P2|STARTED|Overall Study||81
507081|NCT00968669|1240274|P1|STARTED|Overall Study||82
507082|NCT00968617|1240364|P1|NOT COMPLETED|Overall Study||6
507083|NCT00968617|1240364|P1|COMPLETED|Overall Study||1
507084|NCT00968617|1240364|P1|STARTED|Overall Study||7
507085|NCT00968539|1240378|P2|NOT COMPLETED|Overall Study||0
507086|NCT00968539|1240379|P1|NOT COMPLETED|Overall Study||1
507087|NCT00968539|1240378|P2|COMPLETED|Overall Study||66
507088|NCT00968539|1240379|P1|COMPLETED|Overall Study||63
507089|NCT00968539|1240378|P2|STARTED|Overall Study||66
507090|NCT00968539|1240379|P1|STARTED|Overall Study||64
507091|NCT00968253|1240440|P3|NOT COMPLETED|Overall Study||7
507092|NCT00968253|1240441|P2|NOT COMPLETED|Overall Study||3
507093|NCT00968253|1240442|P1|NOT COMPLETED|Overall Study||0
507094|NCT00968253|1240440|P3|COMPLETED|Overall Study||5
507095|NCT00968253|1240441|P2|COMPLETED|Overall Study||6
507096|NCT00968253|1240442|P1|COMPLETED|Overall Study||3
507097|NCT00968253|1240440|P3|STARTED|Overall Study||12
507098|NCT00968253|1240441|P2|STARTED|Overall Study||9
507099|NCT00968253|1240442|P1|STARTED|Overall Study||3
507100|NCT00968227|1240456|P1|NOT COMPLETED|Overall Study||0
507101|NCT00968227|1240456|P1|COMPLETED|Overall Study||56
507102|NCT00968227|1240456|P1|STARTED|Overall Study||56
507103|NCT00968201|1240463|P3|NOT COMPLETED|Extension Study - (Period III)||280
507104|NCT00968201|1240464|P2|NOT COMPLETED|Extension Study - (Period III)||124
507105|NCT00968201|1240465|P1|NOT COMPLETED|Extension Study - (Period III)||0
507106|NCT00968201|1240463|P3|COMPLETED|Extension Study - (Period III)||84
507107|NCT00968201|1240464|P2|COMPLETED|Extension Study - (Period III)||33
507108|NCT00968201|1240465|P1|COMPLETED|Extension Study - (Period III)||0
507109|NCT00968201|1240463|P3|STARTED|Extension Study - (Period III)|Eligible Patients who completed Period II and entered the optional Extension Study (Period III)|364
507110|NCT00968201|1240464|P2|STARTED|Extension Study - (Period III)|Eligible Patients who completed Period II and entered the optional Extension Study (Period III)|157
507111|NCT00968201|1240465|P1|STARTED|Extension Study - (Period III)||0
507112|NCT00968201|1240463|P3|NOT COMPLETED|Base Study - (Period II)||45
507113|NCT00968201|1240464|P2|NOT COMPLETED|Base Study - (Period II)||0
507114|NCT00968201|1240465|P1|NOT COMPLETED|Base Study - (Period II)||26
507115|NCT00968201|1240463|P3|COMPLETED|Base Study - (Period II)|Patients completing Period II were eligible to enter the optional Period III|416
507116|NCT00968201|1240464|P2|COMPLETED|Base Study - (Period II)||0
507117|NCT00968201|1240465|P1|COMPLETED|Base Study - (Period II)|Patients completing Period II were eligible to enter the optional Period III|202
507118|NCT00968201|1240463|P3|STARTED|Base Study - (Period II)|Includes patients who completed Period I (2-week placebo run-in) and were randomized to montelukast.|461
507119|NCT00968201|1240464|P2|STARTED|Base Study - (Period II)||0
507120|NCT00968201|1240465|P1|STARTED|Base Study - (Period II)|Includes patients who completed Period I (2-week placebo run-in) and were randomized to placebo.|228
507121|NCT00968149|1240526|P2|NOT COMPLETED|Overall Study||6
507122|NCT00968149|1240527|P1|NOT COMPLETED|Overall Study||11
507123|NCT00968149|1240526|P2|COMPLETED|Overall Study||127
507124|NCT00968149|1240527|P1|COMPLETED|Overall Study||269
507125|NCT00968149|1240526|P2|STARTED|Overall Study||133
507126|NCT00968149|1240527|P1|STARTED|Overall Study||280
507127|NCT00968071|1240547|P1|NOT COMPLETED|Overall Study||0
507128|NCT00968071|1240547|P1|COMPLETED|Overall Study||71
507129|NCT00968071|1240547|P1|STARTED|Overall Study||71
507130|NCT00968032|1240551|P1|NOT COMPLETED|Overall Study||2
507131|NCT00968032|1240551|P1|COMPLETED|Overall Study|"1 patient not receiving investigational device due to failure in usage~1 patient denied latest FU"|61
507132|NCT00968032|1240551|P1|STARTED|Overall Study||63
507133|NCT00968019|1240555|P1|NOT COMPLETED|Overall Study||15
507134|NCT00968019|1240555|P1|COMPLETED|Overall Study||303
507135|NCT00968019|1240555|P1|STARTED|Overall Study||318
507136|NCT00967993|1240576|P1|NOT COMPLETED|Overall Study||4
507137|NCT00967993|1240576|P1|COMPLETED|Overall Study||18
507138|NCT00967993|1240576|P1|STARTED|Overall Study||22
507139|NCT00967798|1240582|P2|NOT COMPLETED|Overall Study||3
507140|NCT00967798|1240583|P1|NOT COMPLETED|Overall Study||9
507141|NCT00967798|1240582|P2|COMPLETED|Overall Study||13
507142|NCT00967798|1240583|P1|COMPLETED|Overall Study||8
507143|NCT00967798|1240582|P2|STARTED|Overall Study||16
507144|NCT00967798|1240583|P1|STARTED|Overall Study||17
507145|NCT00967694|1240597|P1|NOT COMPLETED|Overall Study||6
507146|NCT00967694|1240597|P1|COMPLETED|Overall Study|5 discontinued during N2O administration due to agitation ⁄ dysphoria, one due to nausea⁄vomiting.|20
507147|NCT00967694|1240597|P1|STARTED|Overall Study||26
507148|NCT00967668|1240604|P3|NOT COMPLETED|Overall Study||69
507149|NCT00967668|1240605|P2|NOT COMPLETED|Overall Study||56
507150|NCT00967668|1240606|P1|NOT COMPLETED|Overall Study||71
507151|NCT00967668|1240604|P3|COMPLETED|Overall Study||90
507152|NCT00967668|1240605|P2|COMPLETED|Overall Study||104
507153|NCT00967668|1240606|P1|COMPLETED|Overall Study||91
507154|NCT00967668|1240604|P3|18-mo Assessment|Overall Study||92
507155|NCT00967668|1240605|P2|18-mo Assessment|Overall Study||102
507156|NCT00967668|1240606|P1|18-mo Assessment|Overall Study||95
507157|NCT00967668|1240604|P3|Completed Year 1 - 12-mo Assessment|Overall Study||119
507158|NCT00967668|1240605|P2|Completed Year 1 - 12-mo Assessment|Overall Study||122
507159|NCT00967668|1240606|P1|Completed Year 1 - 12-mo Assessment|Overall Study||120
507160|NCT00967668|1240604|P3|3-mo Assessment|Overall Study||115
507161|NCT00967668|1240605|P2|3-mo Assessment|Overall Study||127
507162|NCT00967668|1240606|P1|3-mo Assessment|Overall Study||131
507163|NCT00967668|1240604|P3|STARTED|Overall Study||159
507164|NCT00967668|1240605|P2|STARTED|Overall Study||160
507165|NCT00967668|1240606|P1|STARTED|Overall Study||162
507166|NCT00967551|1240619|P2|NOT COMPLETED|Overall Study||0
507167|NCT00967551|1240620|P1|NOT COMPLETED|Overall Study||0
507168|NCT00967551|1240619|P2|COMPLETED|Overall Study||75
507169|NCT00967551|1240620|P1|COMPLETED|Overall Study||68
507170|NCT00967551|1240619|P2|STARTED|Overall Study||75
507171|NCT00967551|1240620|P1|STARTED|Overall Study||68
507172|NCT00967486|1240630|P2|NOT COMPLETED|Overall Study||0
507173|NCT00967486|1240631|P1|NOT COMPLETED|Overall Study||0
507174|NCT00967486|1240630|P2|COMPLETED|Overall Study||102
507175|NCT00967486|1240631|P1|COMPLETED|Overall Study||98
507176|NCT00967486|1240630|P2|STARTED|Overall Study||102
507177|NCT00967486|1240631|P1|STARTED|Overall Study||98
507178|NCT00967473|1240637|P1|NOT COMPLETED|Overall Study||0
507179|NCT00967473|1240637|P1|COMPLETED|Overall Study||15
507180|NCT00967473|1240637|P1|STARTED|Overall Study||15
507181|NCT00967447|1240643|P1|NOT COMPLETED|Overall Study||0
507182|NCT00967447|1240643|P1|COMPLETED|Overall Study|there are no collected data in CRF|2
507183|NCT00967447|1240643|P1|STARTED|Overall Study|there are no collected data in CRF|2
507184|NCT00967330|1240652|P2|NOT COMPLETED|Overall Study||60
507185|NCT00967330|1240653|P1|NOT COMPLETED|Overall Study||122
507186|NCT00967330|1240652|P2|COMPLETED|Overall Study||0
507187|NCT00967330|1240653|P1|COMPLETED|Overall Study||0
507188|NCT00967330|1240652|P2|STARTED|Overall Study||60
507189|NCT00967330|1240653|P1|STARTED|Overall Study||122
507190|NCT00967226|1240683|P2|NOT COMPLETED|Overall Study||6
507191|NCT00967226|1240684|P1|NOT COMPLETED|Overall Study||2
507192|NCT00967226|1240683|P2|COMPLETED|Overall Study||2
507193|NCT00967226|1240684|P1|COMPLETED|Overall Study||9
507194|NCT00967226|1240683|P2|STARTED|Overall Study||8
507195|NCT00967226|1240684|P1|STARTED|Overall Study||11
507196|NCT00967044|1240714|P1|NOT COMPLETED|Overall Study||0
507197|NCT00967044|1240714|P1|COMPLETED|Overall Study||30
507198|NCT00967044|1240714|P1|STARTED|Overall Study||30
507199|NCT00967018|1240718|P1|NOT COMPLETED|Overall Study||21
507200|NCT00967018|1240718|P1|COMPLETED|Overall Study||56
507201|NCT00967018|1240718|P1|STARTED|Overall Study||77
507202|NCT00967005|1240727|P2|NOT COMPLETED|Overall Study||10
507203|NCT00967005|1240728|P1|NOT COMPLETED|Overall Study||7
507204|NCT00967005|1240727|P2|COMPLETED|Overall Study||5
507205|NCT00967005|1240728|P1|COMPLETED|Overall Study||6
507206|NCT00967005|1240727|P2|Treatment Completion|Overall Study||10
507207|NCT00967005|1240728|P1|Treatment Completion|Overall Study||10
507208|NCT00967005|1240727|P2|STARTED|Overall Study||15
507209|NCT00967005|1240728|P1|STARTED|Overall Study||13
507210|NCT00966992|1240782|P2|NOT COMPLETED|Overall Study||0
507211|NCT00966992|1240783|P1|NOT COMPLETED|Overall Study||0
507212|NCT00966992|1240782|P2|COMPLETED|Overall Study||0
507213|NCT00966992|1240783|P1|COMPLETED|Overall Study||3
507214|NCT00966992|1240782|P2|STARTED|Overall Study||0
507215|NCT00966992|1240783|P1|STARTED|Overall Study||3
507216|NCT00966953|1240803|P4|NOT COMPLETED|4th Intervention Order||0
507217|NCT00966953|1240804|P3|NOT COMPLETED|4th Intervention Order||0
507218|NCT00966953|1240805|P2|NOT COMPLETED|4th Intervention Order||0
507219|NCT00966953|1240806|P1|NOT COMPLETED|4th Intervention Order||0
507220|NCT00966953|1240803|P4|COMPLETED|4th Intervention Order||7
507221|NCT00966953|1240804|P3|COMPLETED|4th Intervention Order||6
507222|NCT00966953|1240805|P2|COMPLETED|4th Intervention Order||6
507223|NCT00966953|1240806|P1|COMPLETED|4th Intervention Order||6
507224|NCT00966953|1240803|P4|STARTED|4th Intervention Order||7
507225|NCT00966953|1240804|P3|STARTED|4th Intervention Order||6
507226|NCT00966953|1240805|P2|STARTED|4th Intervention Order||6
507227|NCT00966953|1240806|P1|STARTED|4th Intervention Order||6
507228|NCT00966953|1240803|P4|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
507229|NCT00966953|1240804|P3|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
507230|NCT00966953|1240805|P2|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
507231|NCT00966953|1240806|P1|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
507232|NCT00966953|1240803|P4|COMPLETED|1 Week Washout After 3rd Intervention||7
507233|NCT00966953|1240804|P3|COMPLETED|1 Week Washout After 3rd Intervention||6
507234|NCT00966953|1240805|P2|COMPLETED|1 Week Washout After 3rd Intervention||6
507235|NCT00966953|1240806|P1|COMPLETED|1 Week Washout After 3rd Intervention||6
507236|NCT00966953|1240803|P4|STARTED|1 Week Washout After 3rd Intervention||7
507237|NCT00966953|1240804|P3|STARTED|1 Week Washout After 3rd Intervention||6
507238|NCT00966953|1240805|P2|STARTED|1 Week Washout After 3rd Intervention||6
507239|NCT00966953|1240806|P1|STARTED|1 Week Washout After 3rd Intervention||6
507240|NCT00966953|1240803|P4|NOT COMPLETED|3rd Intervention Order||0
507241|NCT00966953|1240804|P3|NOT COMPLETED|3rd Intervention Order||0
507242|NCT00966953|1240805|P2|NOT COMPLETED|3rd Intervention Order||0
507243|NCT00966953|1240806|P1|NOT COMPLETED|3rd Intervention Order||0
507244|NCT00966953|1240803|P4|COMPLETED|3rd Intervention Order||7
507245|NCT00966953|1240804|P3|COMPLETED|3rd Intervention Order||6
507246|NCT00966953|1240805|P2|COMPLETED|3rd Intervention Order||6
507247|NCT00966953|1240806|P1|COMPLETED|3rd Intervention Order||6
507248|NCT00966953|1240803|P4|STARTED|3rd Intervention Order||7
507249|NCT00966953|1240804|P3|STARTED|3rd Intervention Order||6
507250|NCT00966953|1240805|P2|STARTED|3rd Intervention Order||6
507251|NCT00966953|1240806|P1|STARTED|3rd Intervention Order||6
507252|NCT00966953|1240803|P4|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
507253|NCT00966953|1240804|P3|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
507254|NCT00966953|1240805|P2|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
507255|NCT00966953|1240806|P1|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
507256|NCT00966953|1240803|P4|COMPLETED|1 Week Washout After 2nd Intervention||7
507257|NCT00966953|1240804|P3|COMPLETED|1 Week Washout After 2nd Intervention||6
507258|NCT00966953|1240805|P2|COMPLETED|1 Week Washout After 2nd Intervention||6
507259|NCT00966953|1240806|P1|COMPLETED|1 Week Washout After 2nd Intervention||6
507260|NCT00966953|1240803|P4|STARTED|1 Week Washout After 2nd Intervention||7
507261|NCT00966953|1240804|P3|STARTED|1 Week Washout After 2nd Intervention||6
507262|NCT00966953|1240805|P2|STARTED|1 Week Washout After 2nd Intervention||6
507263|NCT00966953|1240806|P1|STARTED|1 Week Washout After 2nd Intervention||6
507264|NCT00966953|1240803|P4|NOT COMPLETED|2nd Intervention||0
507265|NCT00966953|1240804|P3|NOT COMPLETED|2nd Intervention||0
507266|NCT00966953|1240805|P2|NOT COMPLETED|2nd Intervention||0
507267|NCT00966953|1240806|P1|NOT COMPLETED|2nd Intervention||0
507268|NCT00966953|1240803|P4|COMPLETED|2nd Intervention||7
507269|NCT00966953|1240804|P3|COMPLETED|2nd Intervention||6
507270|NCT00966953|1240805|P2|COMPLETED|2nd Intervention||6
507271|NCT00966953|1240806|P1|COMPLETED|2nd Intervention||6
507272|NCT00966953|1240803|P4|STARTED|2nd Intervention||7
507273|NCT00966953|1240804|P3|STARTED|2nd Intervention||6
507274|NCT00966953|1240805|P2|STARTED|2nd Intervention||6
507275|NCT00966953|1240806|P1|STARTED|2nd Intervention||6
507276|NCT00966953|1240803|P4|NOT COMPLETED|1 Week Washout After 1st Intervention||0
507277|NCT00966953|1240804|P3|NOT COMPLETED|1 Week Washout After 1st Intervention||0
507278|NCT00966953|1240805|P2|NOT COMPLETED|1 Week Washout After 1st Intervention||0
507279|NCT00966953|1240806|P1|NOT COMPLETED|1 Week Washout After 1st Intervention||0
507280|NCT00966953|1240803|P4|COMPLETED|1 Week Washout After 1st Intervention||7
507281|NCT00966953|1240804|P3|COMPLETED|1 Week Washout After 1st Intervention||6
507282|NCT00966953|1240805|P2|COMPLETED|1 Week Washout After 1st Intervention||6
507283|NCT00966953|1240806|P1|COMPLETED|1 Week Washout After 1st Intervention||6
507284|NCT00966953|1240803|P4|STARTED|1 Week Washout After 1st Intervention||7
507285|NCT00966953|1240804|P3|STARTED|1 Week Washout After 1st Intervention||6
507286|NCT00966953|1240805|P2|STARTED|1 Week Washout After 1st Intervention||6
507287|NCT00966953|1240806|P1|STARTED|1 Week Washout After 1st Intervention||6
507288|NCT00966953|1240803|P4|NOT COMPLETED|1st Intervention||0
507289|NCT00966953|1240804|P3|NOT COMPLETED|1st Intervention||0
507290|NCT00966953|1240805|P2|NOT COMPLETED|1st Intervention||0
507291|NCT00966953|1240806|P1|NOT COMPLETED|1st Intervention||0
507292|NCT00966953|1240803|P4|COMPLETED|1st Intervention||7
507293|NCT00966953|1240804|P3|COMPLETED|1st Intervention||6
507294|NCT00966953|1240805|P2|COMPLETED|1st Intervention||6
507295|NCT00966953|1240806|P1|COMPLETED|1st Intervention||6
507296|NCT00966953|1240803|P4|STARTED|1st Intervention||7
507297|NCT00966953|1240804|P3|STARTED|1st Intervention||6
507298|NCT00966953|1240805|P2|STARTED|1st Intervention||6
507299|NCT00966953|1240806|P1|STARTED|1st Intervention||6
507300|NCT00966940|1240814|P2|NOT COMPLETED|Period 2, Second 6 Weeks||0
507301|NCT00966940|1240815|P1|NOT COMPLETED|Period 2, Second 6 Weeks||0
507302|NCT00966940|1240814|P2|COMPLETED|Period 2, Second 6 Weeks||23
507303|NCT00966940|1240815|P1|COMPLETED|Period 2, Second 6 Weeks||25
507304|NCT00966940|1240814|P2|STARTED|Period 2, Second 6 Weeks||23
507305|NCT00966940|1240815|P1|STARTED|Period 2, Second 6 Weeks||25
507306|NCT00966940|1240814|P2|NOT COMPLETED|Period 1, First 6 Weeks||0
507307|NCT00966940|1240815|P1|NOT COMPLETED|Period 1, First 6 Weeks||3
507308|NCT00966940|1240814|P2|COMPLETED|Period 1, First 6 Weeks||23
507309|NCT00966940|1240815|P1|COMPLETED|Period 1, First 6 Weeks||25
507310|NCT00966940|1240814|P2|STARTED|Period 1, First 6 Weeks||23
507311|NCT00966940|1240815|P1|STARTED|Period 1, First 6 Weeks||28
507312|NCT00966875|1240842|P9|NOT COMPLETED|Part B||18
507313|NCT00966875|1240843|P8|NOT COMPLETED|Part B||19
507314|NCT00966875|1240844|P7|NOT COMPLETED|Part B||22
507315|NCT00966875|1240845|P6|NOT COMPLETED|Part B||6
507316|NCT00966875|1240846|P5|NOT COMPLETED|Part B||7
507317|NCT00966875|1240847|P4|NOT COMPLETED|Part B||3
507318|NCT00966875|1240848|P3|NOT COMPLETED|Part B||6
507319|NCT00966875|1240849|P2|NOT COMPLETED|Part B||3
507320|NCT00966875|1240850|P1|NOT COMPLETED|Part B||5
507321|NCT00966875|1240842|P9|COMPLETED|Part B||32
507322|NCT00966875|1240843|P8|COMPLETED|Part B||38
507323|NCT00966875|1240844|P7|COMPLETED|Part B||29
507324|NCT00966875|1240845|P6|COMPLETED|Part B||26
507325|NCT00966875|1240846|P5|COMPLETED|Part B||44
507326|NCT00966875|1240847|P4|COMPLETED|Part B||31
507327|NCT00966875|1240848|P3|COMPLETED|Part B||27
507328|NCT00966875|1240849|P2|COMPLETED|Part B||33
507329|NCT00966875|1240850|P1|COMPLETED|Part B||41
507330|NCT00966875|1240842|P9|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|50
507331|NCT00966875|1240843|P8|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|57
507332|NCT00966875|1240844|P7|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|51
507333|NCT00966875|1240845|P6|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|32
507334|NCT00966875|1240846|P5|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|51
507335|NCT00966875|1240847|P4|STARTED|Part B||34
507336|NCT00966875|1240848|P3|STARTED|Part B||33
507337|NCT00966875|1240849|P2|STARTED|Part B||36
507338|NCT00966875|1240850|P1|STARTED|Part B|Two (2) participants who completed Part A did not enter Part B.|46
507339|NCT00966875|1240842|P9|NOT COMPLETED|Part A||8
507340|NCT00966875|1240843|P8|NOT COMPLETED|Part A||7
507341|NCT00966875|1240844|P7|NOT COMPLETED|Part A||12
507342|NCT00966875|1240845|P6|NOT COMPLETED|Part A||4
507343|NCT00966875|1240846|P5|NOT COMPLETED|Part A||5
507344|NCT00966875|1240847|P4|NOT COMPLETED|Part A||3
507345|NCT00966875|1240848|P3|NOT COMPLETED|Part A||2
507346|NCT00966875|1240849|P2|NOT COMPLETED|Part A||4
507347|NCT00966875|1240850|P1|NOT COMPLETED|Part A||6
507348|NCT00966875|1240842|P9|COMPLETED|Part A||51
507349|NCT00966875|1240843|P8|COMPLETED|Part A||58
507350|NCT00966875|1240844|P7|COMPLETED|Part A||52
507351|NCT00966875|1240845|P6|COMPLETED|Part A||33
507352|NCT00966875|1240846|P5|COMPLETED|Part A||52
507353|NCT00966875|1240847|P4|COMPLETED|Part A||34
507354|NCT00966875|1240848|P3|COMPLETED|Part A||33
507355|NCT00966875|1240849|P2|COMPLETED|Part A||36
507356|NCT00966875|1240850|P1|COMPLETED|Part A||48
507357|NCT00966875|1240842|P9|Received ≥1 Doses of Study Drug|Part A||59
507358|NCT00966875|1240843|P8|Received ≥1 Doses of Study Drug|Part A||65
507359|NCT00966875|1240844|P7|Received ≥1 Doses of Study Drug|Part A||64
507360|NCT00966875|1240845|P6|Received ≥1 Doses of Study Drug|Part A||37
507361|NCT00966875|1240846|P5|Received ≥1 Doses of Study Drug|Part A||57
507362|NCT00966875|1240847|P4|Received ≥1 Doses of Study Drug|Part A||37
507363|NCT00966875|1240848|P3|Received ≥1 Doses of Study Drug|Part A||35
507364|NCT00966875|1240849|P2|Received ≥1 Doses of Study Drug|Part A||40
507365|NCT00966875|1240850|P1|Received ≥1 Doses of Study Drug|Part A||54
507366|NCT00966875|1240842|P9|STARTED|Part A||59
507367|NCT00966875|1240843|P8|STARTED|Part A||65
507368|NCT00966875|1240844|P7|STARTED|Part A||64
507369|NCT00966875|1240845|P6|STARTED|Part A||37
507370|NCT00966875|1240846|P5|STARTED|Part A||57
507371|NCT00966875|1240847|P4|STARTED|Part A||37
507372|NCT00966875|1240848|P3|STARTED|Part A||35
507373|NCT00966875|1240849|P2|STARTED|Part A||40
507374|NCT00966875|1240850|P1|STARTED|Part A||54
507375|NCT00966823|1241169|P1|NOT COMPLETED|Overall Study||1
507376|NCT00966823|1241169|P1|COMPLETED|Overall Study||2
507377|NCT00966823|1241169|P1|STARTED|Overall Study||3
507378|NCT00966654|1241177|P1|NOT COMPLETED|Overall Study||12
507379|NCT00966654|1241177|P1|COMPLETED|Overall Study||0
507380|NCT00966654|1241177|P1|STARTED|Overall Study||12
507381|NCT00966641|1241185|P2|NOT COMPLETED|Second Intervention||0
507382|NCT00966641|1241186|P1|NOT COMPLETED|Second Intervention||0
507383|NCT00966641|1241185|P2|COMPLETED|Second Intervention||17
507384|NCT00966641|1241186|P1|COMPLETED|Second Intervention||17
507385|NCT00966641|1241185|P2|STARTED|Second Intervention||17
507386|NCT00966641|1241186|P1|STARTED|Second Intervention||17
507387|NCT00966641|1241185|P2|NOT COMPLETED|First Intervention||0
507388|NCT00966641|1241186|P1|NOT COMPLETED|First Intervention||0
507389|NCT00966641|1241185|P2|COMPLETED|First Intervention||17
507390|NCT00966641|1241186|P1|COMPLETED|First Intervention||17
507391|NCT00966641|1241185|P2|STARTED|First Intervention||17
507392|NCT00966641|1241186|P1|STARTED|First Intervention||17
507393|NCT00966550|1241194|P2|NOT COMPLETED|Overall Study||0
507394|NCT00966550|1241195|P1|NOT COMPLETED|Overall Study||0
507395|NCT00966550|1241194|P2|COMPLETED|Overall Study||12
507396|NCT00966550|1241195|P1|COMPLETED|Overall Study||13
507397|NCT00966550|1241194|P2|STARTED|Overall Study||12
507398|NCT00966550|1241195|P1|STARTED|Overall Study||13
507399|NCT00966446|1241204|P3|NOT COMPLETED|Overall Study||21
507400|NCT00966446|1241205|P2|NOT COMPLETED|Overall Study||25
507401|NCT00966446|1241206|P1|NOT COMPLETED|Overall Study||28
507402|NCT00966446|1241204|P3|COMPLETED|Overall Study||52
507403|NCT00966446|1241205|P2|COMPLETED|Overall Study||49
507404|NCT00966446|1241206|P1|COMPLETED|Overall Study||48
507405|NCT00966446|1241204|P3|STARTED|Overall Study||73
507406|NCT00966446|1241205|P2|STARTED|Overall Study||74
507407|NCT00966446|1241206|P1|STARTED|Overall Study||76
507408|NCT00966355|1241223|P3|NOT COMPLETED|Overall Study||84
507409|NCT00966355|1241224|P2|NOT COMPLETED|Overall Study||86
507410|NCT00966355|1241225|P1|NOT COMPLETED|Overall Study||84
507411|NCT00966355|1241223|P3|COMPLETED|Overall Study||261
507412|NCT00966355|1241224|P2|COMPLETED|Overall Study||259
507413|NCT00966355|1241225|P1|COMPLETED|Overall Study||260
507414|NCT00966355|1241223|P3|STARTED|Overall Study||345
507415|NCT00966355|1241224|P2|STARTED|Overall Study||345
507416|NCT00966355|1241225|P1|STARTED|Overall Study||344
507417|NCT00966277|1241238|P2|NOT COMPLETED|Overall Study||4
507418|NCT00966277|1241239|P1|NOT COMPLETED|Overall Study||4
507419|NCT00966277|1241238|P2|COMPLETED|Overall Study|Four participants did not receive study treatment, see 'Reasons Not Completed.'|33
507420|NCT00966277|1241239|P1|COMPLETED|Overall Study|Four participants did not receive study treatment, see 'Reasons Not Completed.'|34
507421|NCT00966277|1241238|P2|STARTED|Overall Study||37
507422|NCT00966277|1241239|P1|STARTED|Overall Study||38
507423|NCT00966264|1241247|P2|NOT COMPLETED|Overall Study||3
507424|NCT00966264|1241248|P1|NOT COMPLETED|Overall Study||4
507425|NCT00966264|1241247|P2|COMPLETED|Overall Study|5 years results|114
507426|NCT00966264|1241248|P1|COMPLETED|Overall Study|5 years results|115
507427|NCT00966264|1241247|P2|STARTED|Overall Study||117
507428|NCT00966264|1241248|P1|STARTED|Overall Study||119
507429|NCT00966238|1241260|P6|NOT COMPLETED|Overall Study||0
507430|NCT00966238|1241261|P5|NOT COMPLETED|Overall Study||0
507431|NCT00966238|1241262|P4|NOT COMPLETED|Overall Study||0
507432|NCT00966238|1241263|P3|NOT COMPLETED|Overall Study||0
507433|NCT00966238|1241264|P2|NOT COMPLETED|Overall Study||0
507434|NCT00966238|1241265|P1|NOT COMPLETED|Overall Study||0
507435|NCT00966238|1241260|P6|COMPLETED|Overall Study||20
507436|NCT00966238|1241261|P5|COMPLETED|Overall Study||20
507437|NCT00966238|1241262|P4|COMPLETED|Overall Study||20
507438|NCT00966238|1241263|P3|COMPLETED|Overall Study||20
507439|NCT00966238|1241264|P2|COMPLETED|Overall Study||20
507440|NCT00966238|1241265|P1|COMPLETED|Overall Study||20
507441|NCT00966238|1241260|P6|STARTED|Overall Study||20
507442|NCT00966238|1241261|P5|STARTED|Overall Study||20
507443|NCT00966238|1241262|P4|STARTED|Overall Study||20
507444|NCT00966238|1241263|P3|STARTED|Overall Study||20
507445|NCT00966238|1241264|P2|STARTED|Overall Study||20
507446|NCT00966238|1241265|P1|STARTED|Overall Study||20
507447|NCT00966186|1241287|P2|NOT COMPLETED|Overall Study||0
507448|NCT00966186|1241288|P1|NOT COMPLETED|Overall Study||0
507449|NCT00966186|1241287|P2|COMPLETED|Overall Study||60
507450|NCT00966186|1241288|P1|COMPLETED|Overall Study||60
507451|NCT00966186|1241287|P2|STARTED|Overall Study||60
507452|NCT00966186|1241288|P1|STARTED|Overall Study||60
507453|NCT00965848|1241294|P3|NOT COMPLETED|Overall Study||10
507454|NCT00965848|1241295|P2|NOT COMPLETED|Overall Study||2
507455|NCT00965848|1241296|P1|NOT COMPLETED|Overall Study||29
507456|NCT00965848|1241294|P3|COMPLETED|Overall Study||117
507457|NCT00965848|1241295|P2|COMPLETED|Overall Study||32
507458|NCT00965848|1241296|P1|COMPLETED|Overall Study||78
507459|NCT00965848|1241294|P3|STARTED|Overall Study||127
507460|NCT00965848|1241295|P2|STARTED|Overall Study||34
507461|NCT00965848|1241296|P1|STARTED|Overall Study||107
507462|NCT00965757|1241315|P4|NOT COMPLETED|Extension Phase||24
507463|NCT00965757|1241316|P3|NOT COMPLETED|Extension Phase||33
507464|NCT00965757|1241317|P2|NOT COMPLETED|Extension Phase||0
507465|NCT00965757|1241318|P1|NOT COMPLETED|Extension Phase||0
507466|NCT00965757|1241315|P4|COMPLETED|Extension Phase||64
507467|NCT00965757|1241316|P3|COMPLETED|Extension Phase||132
507468|NCT00965757|1241317|P2|COMPLETED|Extension Phase||0
507469|NCT00965757|1241318|P1|COMPLETED|Extension Phase||0
507470|NCT00965757|1241315|P4|STARTED|Extension Phase||88
507471|NCT00965757|1241316|P3|STARTED|Extension Phase||165
507472|NCT00965757|1241317|P2|STARTED|Extension Phase||0
507473|NCT00965757|1241318|P1|STARTED|Extension Phase||0
507474|NCT00965757|1241315|P4|NOT COMPLETED|Double-blind Phase||0
507475|NCT00965757|1241316|P3|NOT COMPLETED|Double-blind Phase||0
507476|NCT00965757|1241317|P2|NOT COMPLETED|Double-blind Phase||18
507477|NCT00965757|1241318|P1|NOT COMPLETED|Double-blind Phase||17
507478|NCT00965757|1241315|P4|COMPLETED|Double-blind Phase||0
507479|NCT00965757|1241316|P3|COMPLETED|Double-blind Phase||0
507480|NCT00965757|1241317|P2|COMPLETED|Double-blind Phase||70
507481|NCT00965757|1241318|P1|COMPLETED|Double-blind Phase||148
507482|NCT00965757|1241315|P4|STARTED|Double-blind Phase||0
507483|NCT00965757|1241316|P3|STARTED|Double-blind Phase||0
507484|NCT00965757|1241317|P2|STARTED|Double-blind Phase||88
507485|NCT00965757|1241318|P1|STARTED|Double-blind Phase||165
507486|NCT00965731|1241352|P2|NOT COMPLETED|Overall Study||20
507487|NCT00965731|1241353|P1|NOT COMPLETED|Overall Study||7
507488|NCT00965731|1241352|P2|COMPLETED|Overall Study||0
507489|NCT00965731|1241353|P1|COMPLETED|Overall Study||0
507490|NCT00965731|1241352|P2|STARTED|Overall Study|Dose level given only after lower dose was successfully administered|20
507491|NCT00965731|1241353|P1|STARTED|Overall Study||7
507492|NCT00965718|1241417|P1|NOT COMPLETED|Overall Study||4
507493|NCT00965718|1241417|P1|COMPLETED|Overall Study||16
507494|NCT00965718|1241417|P1|STARTED|Overall Study||20
507495|NCT00965562|1241430|P3|NOT COMPLETED|Overall Study||3
507496|NCT00965562|1241431|P2|NOT COMPLETED|Overall Study||4
507497|NCT00965562|1241432|P1|NOT COMPLETED|Overall Study||3
507498|NCT00965562|1241430|P3|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
507499|NCT00965562|1241431|P2|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
507500|NCT00965562|1241432|P1|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
507501|NCT00965562|1241430|P3|Women Who Participated Full Follow up|Overall Study|2 patients discontinued intervention: 2 patient requests|11
507502|NCT00965562|1241431|P2|Women Who Participated Full Follow up|Overall Study|3 patients discontinued intervention: 1 out of contact, 2 patient requests|10
507503|NCT00965562|1241432|P1|Women Who Participated Full Follow up|Overall Study|7 patients discontinued intervention: 2 out of contact, 4 patient requests, 1 suspended by IRB|6
507504|NCT00965562|1241430|P3|Women With at Least 2 Follow up Visits|Overall Study|3 patients with no follow up visits: 3 out of contact|13
507505|NCT00965562|1241431|P2|Women With at Least 2 Follow up Visits|Overall Study|4 patients with no follow up visits: 2 out of contact, 2 patient requests|13
507506|NCT00965562|1241432|P1|Women With at Least 2 Follow up Visits|Overall Study|3 patients with no follow up visits: 1 out of contact, 2 patient requests|13
507507|NCT00965562|1241430|P3|STARTED|Overall Study||16
507508|NCT00965562|1241431|P2|STARTED|Overall Study||17
507509|NCT00965562|1241432|P1|STARTED|Overall Study||16
507510|NCT00965523|1241470|P1|NOT COMPLETED|Study 224||6
507511|NCT00965523|1241470|P1|COMPLETED|Study 224||0
507512|NCT00965523|1241470|P1|STARTED|Study 224|Six subjects continued into Study 224 from Study 221.|6
507513|NCT00965523|1241470|P1|NOT COMPLETED|Study 221||7
507514|NCT00965523|1241470|P1|COMPLETED|Study 221||74
507515|NCT00965523|1241470|P1|STARTED|Study 221|Study 221 (Safety Analysis Set).|81
507516|NCT00965497|1241475|P1|NOT COMPLETED|Overall Study||1
507517|NCT00965497|1241475|P1|COMPLETED|Overall Study||13
507518|NCT00965497|1241475|P1|STARTED|Overall Study||14
507519|NCT00965484|1241480|P1|NOT COMPLETED|Overall Study||2
507520|NCT00965484|1241480|P1|COMPLETED|Overall Study||134
507521|NCT00965484|1241480|P1|STARTED|Overall Study||136
507522|NCT00965458|1241489|P2|NOT COMPLETED|Overall Study||4
507523|NCT00965458|1241490|P1|NOT COMPLETED|Overall Study||2
507524|NCT00965458|1241489|P2|COMPLETED|Overall Study||12
507525|NCT00965458|1241490|P1|COMPLETED|Overall Study||31
507526|NCT00965458|1241489|P2|STARTED|Overall Study||16
507527|NCT00965458|1241490|P1|STARTED|Overall Study||33
507528|NCT00965419|1241506|P1|NOT COMPLETED|Follow-up Phase||62
507529|NCT00965419|1241506|P1|COMPLETED|Follow-up Phase||18
507530|NCT00965419|1241506|P1|STARTED|Follow-up Phase||80
507531|NCT00965419|1241506|P1|NOT COMPLETED|Open Label Treatment for Responders||247
507532|NCT00965419|1241506|P1|COMPLETED|Open Label Treatment for Responders||20
507533|NCT00965419|1241506|P1|Not Lost to f/u at First Post-baseline|Open Label Treatment for Responders||264
507534|NCT00965419|1241506|P1|STARTED|Open Label Treatment for Responders||267
507535|NCT00965341|1241552|P2|NOT COMPLETED|Overall Study||8
507536|NCT00965341|1241553|P1|NOT COMPLETED|Overall Study||6
507537|NCT00965341|1241552|P2|COMPLETED|Overall Study||16
507538|NCT00965341|1241553|P1|COMPLETED|Overall Study||13
507539|NCT00965341|1241552|P2|STARTED|Overall Study||24
507540|NCT00965341|1241553|P1|STARTED|Overall Study||19
507541|NCT00965263|1241563|P2|NOT COMPLETED|Overall Study||3
507542|NCT00965263|1241564|P1|NOT COMPLETED|Overall Study||2
507543|NCT00965263|1241563|P2|COMPLETED|Overall Study||6
507544|NCT00965263|1241564|P1|COMPLETED|Overall Study||4
507545|NCT00965263|1241563|P2|STARTED|Overall Study||9
507546|NCT00965263|1241564|P1|STARTED|Overall Study||6
507547|NCT00965250|1241596|P2|NOT COMPLETED|Overall Study||0
507548|NCT00965250|1241597|P1|NOT COMPLETED|Overall Study||0
507549|NCT00965250|1241596|P2|COMPLETED|Overall Study||12
507550|NCT00965250|1241597|P1|COMPLETED|Overall Study||37
507551|NCT00965250|1241596|P2|STARTED|Overall Study||12
507552|NCT00965250|1241597|P1|STARTED|Overall Study||37
507553|NCT00965237|1241615|P2|NOT COMPLETED|Period 2, One Week of Wear||0
507554|NCT00965237|1241616|P1|NOT COMPLETED|Period 2, One Week of Wear||0
507555|NCT00965237|1241615|P2|COMPLETED|Period 2, One Week of Wear||8
507556|NCT00965237|1241616|P1|COMPLETED|Period 2, One Week of Wear||8
507557|NCT00965237|1241615|P2|STARTED|Period 2, One Week of Wear||8
507558|NCT00965237|1241616|P1|STARTED|Period 2, One Week of Wear||8
507559|NCT00965237|1241615|P2|NOT COMPLETED|Period 1, One Week of Wear||0
507560|NCT00965237|1241616|P1|NOT COMPLETED|Period 1, One Week of Wear||0
507561|NCT00965237|1241615|P2|COMPLETED|Period 1, One Week of Wear||8
507562|NCT00965237|1241616|P1|COMPLETED|Period 1, One Week of Wear||8
507563|NCT00965237|1241615|P2|STARTED|Period 1, One Week of Wear||8
507564|NCT00965237|1241616|P1|STARTED|Period 1, One Week of Wear||8
507565|NCT00965185|1241624|P2|NOT COMPLETED|Overall Study||1
507566|NCT00965185|1241625|P1|NOT COMPLETED|Overall Study||2
507567|NCT00965185|1241624|P2|COMPLETED|Overall Study||20
507568|NCT00965185|1241625|P1|COMPLETED|Overall Study||17
507569|NCT00965185|1241624|P2|9 Month Visit|Overall Study||21
507570|NCT00965185|1241625|P1|9 Month Visit|Overall Study||18
507571|NCT00965185|1241624|P2|6 Month Visit|Overall Study||21
507572|NCT00965185|1241625|P1|6 Month Visit|Overall Study||18
507573|NCT00965185|1241624|P2|3 Month Visit|Overall Study||21
507574|NCT00965185|1241625|P1|3 Month Visit|Overall Study||18
507575|NCT00965185|1241624|P2|1 Month Visit|Overall Study||21
507576|NCT00965185|1241625|P1|1 Month Visit|Overall Study||18
507577|NCT00965185|1241624|P2|STARTED|Overall Study||21
507578|NCT00965185|1241625|P1|STARTED|Overall Study||19
507579|NCT00965146|1241645|P1|NOT COMPLETED|Overall Study||210
507580|NCT00965146|1241645|P1|COMPLETED|Overall Study|Study was terminated prior to reaching 15 year endpoint.|0
507581|NCT00965146|1241645|P1|STARTED|Overall Study||210
507582|NCT00965094|1241652|P2|NOT COMPLETED|Overall Study||1
507583|NCT00965094|1241653|P1|NOT COMPLETED|Overall Study||5
507584|NCT00965094|1241652|P2|COMPLETED|Overall Study||16
507585|NCT00965094|1241653|P1|COMPLETED|Overall Study||14
507586|NCT00965094|1241652|P2|STARTED|Overall Study||17
507587|NCT00965094|1241653|P1|STARTED|Overall Study||19
507588|NCT00965081|1241669|P2|NOT COMPLETED|Overall Study||43
507589|NCT00965081|1241670|P1|NOT COMPLETED|Overall Study||34
507590|NCT00965081|1241669|P2|COMPLETED|Overall Study||110
507591|NCT00965081|1241670|P1|COMPLETED|Overall Study|In addition, 16/17 rescue participants completed study on protocol-specified study medication.|121
507592|NCT00965081|1241669|P2|STARTED|Overall Study||153
507593|NCT00965081|1241670|P1|STARTED|Overall Study|2 randomized participants had no post-baseline measures and are not included in outcome measures.|155
507594|NCT00964886|1241697|P4|NOT COMPLETED|Overall Study||9
507595|NCT00964886|1241698|P3|NOT COMPLETED|Overall Study||16
507596|NCT00964886|1241699|P2|NOT COMPLETED|Overall Study||7
507597|NCT00964886|1241700|P1|NOT COMPLETED|Overall Study||11
507598|NCT00964886|1241697|P4|COMPLETED|Overall Study||24
507599|NCT00964886|1241698|P3|COMPLETED|Overall Study||21
507600|NCT00964886|1241699|P2|COMPLETED|Overall Study||27
507601|NCT00964886|1241700|P1|COMPLETED|Overall Study||27
507602|NCT00964886|1241697|P4|STARTED|Overall Study||33
507603|NCT00964886|1241698|P3|STARTED|Overall Study||37
507604|NCT00964886|1241699|P2|STARTED|Overall Study||34
507605|NCT00964886|1241700|P1|STARTED|Overall Study||38
507606|NCT00964860|1241716|P2|NOT COMPLETED|Overall Study||1
507607|NCT00964860|1241717|P1|NOT COMPLETED|Overall Study||0
507608|NCT00964860|1241716|P2|COMPLETED|Overall Study||29
507609|NCT00964860|1241717|P1|COMPLETED|Overall Study||30
507610|NCT00964860|1241716|P2|STARTED|Overall Study||30
507611|NCT00964860|1241717|P1|STARTED|Overall Study||30
507612|NCT00964795|1241725|P1|NOT COMPLETED|Overall Study||307
507613|NCT00964795|1241725|P1|COMPLETED|Overall Study|Prior to amendment 4, 16 participants completed up to Week 120. No participants completed Week 180.|16
507614|NCT00964795|1241725|P1|Number of Participants Treated|Overall Study||320
507615|NCT00964795|1241725|P1|STARTED|Overall Study|randomized|323
507616|NCT00964743|1241732|P1|NOT COMPLETED|Overall Study||2
507617|NCT00964743|1241732|P1|COMPLETED|Overall Study||0
507618|NCT00964743|1241732|P1|STARTED|Overall Study||2
507619|NCT00964678|1241740|P1|NOT COMPLETED|Overall Study||4
507620|NCT00964678|1241740|P1|COMPLETED|Overall Study||6
507621|NCT00964678|1241740|P1|STARTED|Overall Study||10
507622|NCT00964548|1241749|P2|NOT COMPLETED|Overall Study||0
507623|NCT00964548|1241750|P1|NOT COMPLETED|Overall Study||0
507624|NCT00964548|1241749|P2|COMPLETED|Overall Study||5
507625|NCT00964548|1241750|P1|COMPLETED|Overall Study||5
507626|NCT00964548|1241749|P2|STARTED|Overall Study||5
507627|NCT00964548|1241750|P1|STARTED|Overall Study||5
507628|NCT00964496|1241762|P2|NOT COMPLETED|Overall Study||1
507629|NCT00964496|1241763|P1|NOT COMPLETED|Overall Study||2
507630|NCT00964496|1241762|P2|COMPLETED|Overall Study||26
507631|NCT00964496|1241763|P1|COMPLETED|Overall Study||26
507632|NCT00964496|1241762|P2|STARTED|Overall Study||27
507633|NCT00964496|1241763|P1|STARTED|Overall Study||28
507634|NCT00964444|1241781|P1|NOT COMPLETED|Overall Study||0
507635|NCT00964444|1241781|P1|COMPLETED|Overall Study||10
507636|NCT00964444|1241781|P1|STARTED|Overall Study||10
507637|NCT00964431|1241789|P4|NOT COMPLETED|Overall Study||0
507638|NCT00964431|1241790|P3|NOT COMPLETED|Overall Study||0
507639|NCT00964431|1241791|P2|NOT COMPLETED|Overall Study||0
507640|NCT00964431|1241792|P1|NOT COMPLETED|Overall Study||0
507641|NCT00964431|1241789|P4|COMPLETED|Overall Study||51
507642|NCT00964431|1241790|P3|COMPLETED|Overall Study||51
507643|NCT00964431|1241791|P2|COMPLETED|Overall Study||51
507644|NCT00964431|1241792|P1|COMPLETED|Overall Study||50
507645|NCT00964431|1241789|P4|STARTED|Overall Study||51
507646|NCT00964431|1241790|P3|STARTED|Overall Study||51
507647|NCT00964431|1241791|P2|STARTED|Overall Study||51
507648|NCT00964431|1241792|P1|STARTED|Overall Study||50
507649|NCT00964392|1241804|P2|NOT COMPLETED|Overall Study||190
507650|NCT00964392|1241805|P1|NOT COMPLETED|Overall Study||53
507651|NCT00964392|1241804|P2|COMPLETED|Overall Study||92
507652|NCT00964392|1241805|P1|COMPLETED|Overall Study||72
507653|NCT00964392|1241804|P2|STARTED|Overall Study|Both safety and efficacy cohort: Total 292 (10 LEP Excluded)|282
507654|NCT00964392|1241805|P1|STARTED|Overall Study|Both safety and efficacy cohort: Total 128 (3 MEP Excluded)|125
507655|NCT00964366|1241815|P2|NOT COMPLETED|Overall Study||1
507656|NCT00964366|1241816|P1|NOT COMPLETED|Overall Study||1
507657|NCT00964366|1241815|P2|COMPLETED|Overall Study||24
507658|NCT00964366|1241816|P1|COMPLETED|Overall Study||27
507659|NCT00964366|1241815|P2|STARTED|Overall Study||25
507660|NCT00964366|1241816|P1|STARTED|Overall Study|27 of the 28 enrolled were eligible after screening.|28
507661|NCT00964223|1241830|P1|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||1
507662|NCT00964223|1241830|P1|COMPLETED|Full Face Treatment (Weeks 5 and 8)||27
507663|NCT00964223|1241830|P1|STARTED|Full Face Treatment (Weeks 5 and 8)||28
507664|NCT00964223|1241830|P1|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0
507665|NCT00964223|1241830|P1|COMPLETED|Split Face Treatment (Weeks 1 and 2)||28
507666|NCT00964223|1241830|P1|STARTED|Split Face Treatment (Weeks 1 and 2)||28
507667|NCT00964158|1241898|P3|NOT COMPLETED|Overall Study||8
507668|NCT00964158|1241899|P2|NOT COMPLETED|Overall Study||1
507669|NCT00964158|1241900|P1|NOT COMPLETED|Overall Study||0
507670|NCT00964158|1241898|P3|COMPLETED|Overall Study||92
507671|NCT00964158|1241899|P2|COMPLETED|Overall Study||56
507672|NCT00964158|1241900|P1|COMPLETED|Overall Study||53
507673|NCT00964158|1241898|P3|STARTED|Overall Study||100
507674|NCT00964158|1241899|P2|STARTED|Overall Study||57
507675|NCT00964158|1241900|P1|STARTED|Overall Study||53
507676|NCT00964119|1241969|P1|NOT COMPLETED|Overall Study||0
507677|NCT00964119|1241969|P1|COMPLETED|Overall Study||15
507678|NCT00964119|1241969|P1|STARTED|Overall Study||15
507679|NCT00964028|1241975|P2|NOT COMPLETED|Overall Study||1
507680|NCT00964028|1241976|P1|NOT COMPLETED|Overall Study||0
507681|NCT00964028|1241975|P2|COMPLETED|Overall Study||24
507682|NCT00964028|1241976|P1|COMPLETED|Overall Study||25
507683|NCT00964028|1241975|P2|STARTED|Overall Study||25
507684|NCT00964028|1241976|P1|STARTED|Overall Study||25
507685|NCT00963937|1241991|P3|NOT COMPLETED|Overall Study||4
507686|NCT00963937|1241992|P2|NOT COMPLETED|Overall Study||11
507687|NCT00963937|1241993|P1|NOT COMPLETED|Overall Study||19
507688|NCT00963937|1241991|P3|COMPLETED|Overall Study||41
507689|NCT00963937|1241992|P2|COMPLETED|Overall Study||33
507690|NCT00963937|1241993|P1|COMPLETED|Overall Study||70
507691|NCT00963937|1241991|P3|STARTED|Overall Study||45
507692|NCT00963937|1241992|P2|STARTED|Overall Study||44
507693|NCT00963937|1241993|P1|STARTED|Overall Study||89
507694|NCT00963924|1242031|P2|NOT COMPLETED|Overall Study||3
507695|NCT00963924|1242032|P1|NOT COMPLETED|Overall Study||1
507696|NCT00963924|1242031|P2|COMPLETED|Overall Study||15
507697|NCT00963924|1242032|P1|COMPLETED|Overall Study||17
507698|NCT00963924|1242031|P2|STARTED|Overall Study||18
507699|NCT00963924|1242032|P1|STARTED|Overall Study||18
507700|NCT00963872|1242056|P2|NOT COMPLETED|Overall Study||1
507701|NCT00963872|1242057|P1|NOT COMPLETED|Overall Study||1
507702|NCT00963872|1242056|P2|COMPLETED|Overall Study||5
507703|NCT00963872|1242057|P1|COMPLETED|Overall Study||24
507704|NCT00963872|1242056|P2|STARTED|Overall Study||6
507705|NCT00963872|1242057|P1|STARTED|Overall Study||25
507706|NCT00963859|1242101|P1|NOT COMPLETED|Overall Study||0
507707|NCT00963859|1242101|P1|COMPLETED|Overall Study||11
507708|NCT00963859|1242101|P1|STARTED|Overall Study||11
507709|NCT00963820|1242106|P12|NOT COMPLETED|Expansion Phase||4
507710|NCT00963820|1242107|P11|NOT COMPLETED|Expansion Phase||5
507711|NCT00963820|1242108|P10|NOT COMPLETED|Expansion Phase||9
507712|NCT00963820|1242109|P9|NOT COMPLETED|Expansion Phase||10
507713|NCT00963820|1242110|P8|NOT COMPLETED|Expansion Phase||0
507714|NCT00963820|1242111|P7|NOT COMPLETED|Expansion Phase||0
507715|NCT00963820|1242112|P6|NOT COMPLETED|Expansion Phase||0
507716|NCT00963820|1242113|P5|NOT COMPLETED|Expansion Phase||0
507717|NCT00963820|1242114|P4|NOT COMPLETED|Expansion Phase||0
507718|NCT00963820|1242115|P3|NOT COMPLETED|Expansion Phase||0
507719|NCT00963820|1242116|P2|NOT COMPLETED|Expansion Phase||0
507720|NCT00963820|1242117|P1|NOT COMPLETED|Expansion Phase||0
507721|NCT00963820|1242106|P12|COMPLETED|Expansion Phase||0
507722|NCT00963820|1242107|P11|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
507723|NCT00963820|1242108|P10|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
507724|NCT00963820|1242109|P9|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
507725|NCT00963820|1242110|P8|COMPLETED|Expansion Phase||0
507726|NCT00963820|1242111|P7|COMPLETED|Expansion Phase||0
507727|NCT00963820|1242112|P6|COMPLETED|Expansion Phase||0
507728|NCT00963820|1242113|P5|COMPLETED|Expansion Phase||0
507729|NCT00963820|1242114|P4|COMPLETED|Expansion Phase||0
507730|NCT00963820|1242115|P3|COMPLETED|Expansion Phase||0
507731|NCT00963820|1242116|P2|COMPLETED|Expansion Phase||0
507732|NCT00963820|1242117|P1|COMPLETED|Expansion Phase||0
507733|NCT00963820|1242106|P12|STARTED|Expansion Phase|Includes participants with last dose of carfilzomib 21 to 60 days before 1st ixazomib citrate dose.|4
507734|NCT00963820|1242107|P11|STARTED|Expansion Phase|Includes only participants who are proteasome inhibitor (PI)-naïve.|6
507735|NCT00963820|1242108|P10|STARTED|Expansion Phase|Includes 1 participant from the dose escalation cohort 2.97 mg/m^2.|10
507736|NCT00963820|1242109|P9|STARTED|Expansion Phase|Includes 2 participants from the dose escalation cohort 2.97 mg/m^2.|11
507737|NCT00963820|1242110|P8|STARTED|Expansion Phase||0
507738|NCT00963820|1242111|P7|STARTED|Expansion Phase||0
507739|NCT00963820|1242112|P6|STARTED|Expansion Phase||0
507740|NCT00963820|1242113|P5|STARTED|Expansion Phase||0
507741|NCT00963820|1242114|P4|STARTED|Expansion Phase||0
507742|NCT00963820|1242115|P3|STARTED|Expansion Phase||0
507743|NCT00963820|1242116|P2|STARTED|Expansion Phase||0
507744|NCT00963820|1242117|P1|STARTED|Expansion Phase|Dose escalation cohorts were not part of the Expansion Phase except as noted in comments.|0
507745|NCT00963820|1242106|P12|NOT COMPLETED|Dose Escalation Phase||0
507746|NCT00963820|1242107|P11|NOT COMPLETED|Dose Escalation Phase||0
507747|NCT00963820|1242108|P10|NOT COMPLETED|Dose Escalation Phase||0
507748|NCT00963820|1242109|P9|NOT COMPLETED|Dose Escalation Phase||0
507749|NCT00963820|1242110|P8|NOT COMPLETED|Dose Escalation Phase||5
507750|NCT00963820|1242111|P7|NOT COMPLETED|Dose Escalation Phase||8
507751|NCT00963820|1242112|P6|NOT COMPLETED|Dose Escalation Phase||3
507752|NCT00963820|1242113|P5|NOT COMPLETED|Dose Escalation Phase||4
507753|NCT00963820|1242114|P4|NOT COMPLETED|Dose Escalation Phase||3
507754|NCT00963820|1242115|P3|NOT COMPLETED|Dose Escalation Phase||3
507755|NCT00963820|1242116|P2|NOT COMPLETED|Dose Escalation Phase||3
507756|NCT00963820|1242117|P1|NOT COMPLETED|Dose Escalation Phase||3
507757|NCT00963820|1242106|P12|COMPLETED|Dose Escalation Phase||0
507758|NCT00963820|1242107|P11|COMPLETED|Dose Escalation Phase||0
507759|NCT00963820|1242108|P10|COMPLETED|Dose Escalation Phase||0
507760|NCT00963820|1242109|P9|COMPLETED|Dose Escalation Phase||0
507761|NCT00963820|1242110|P8|COMPLETED|Dose Escalation Phase||0
507762|NCT00963820|1242111|P7|COMPLETED|Dose Escalation Phase||0
507763|NCT00963820|1242112|P6|COMPLETED|Dose Escalation Phase||0
507764|NCT00963820|1242113|P5|COMPLETED|Dose Escalation Phase||0
507765|NCT00963820|1242114|P4|COMPLETED|Dose Escalation Phase||0
507766|NCT00963820|1242115|P3|COMPLETED|Dose Escalation Phase||0
507767|NCT00963820|1242116|P2|COMPLETED|Dose Escalation Phase||0
507768|NCT00963820|1242117|P1|COMPLETED|Dose Escalation Phase||0
507769|NCT00963820|1242106|P12|STARTED|Dose Escalation Phase||0
507770|NCT00963820|1242107|P11|STARTED|Dose Escalation Phase||0
507771|NCT00963820|1242108|P10|STARTED|Dose Escalation Phase||0
507772|NCT00963820|1242109|P9|STARTED|Dose Escalation Phase|Expansion cohorts were not part of Dose Escalation except as noted in comments.|0
507773|NCT00963820|1242110|P8|STARTED|Dose Escalation Phase||5
507774|NCT00963820|1242111|P7|STARTED|Dose Escalation Phase||8
507775|NCT00963820|1242112|P6|STARTED|Dose Escalation Phase||3
507776|NCT00963820|1242113|P5|STARTED|Dose Escalation Phase||4
507777|NCT00963820|1242114|P4|STARTED|Dose Escalation Phase||3
507778|NCT00963820|1242115|P3|STARTED|Dose Escalation Phase||3
507779|NCT00963820|1242116|P2|STARTED|Dose Escalation Phase||3
507780|NCT00963820|1242117|P1|STARTED|Dose Escalation Phase||3
507781|NCT00963807|1242253|P1|NOT COMPLETED|Overall Study||18
507782|NCT00963807|1242253|P1|COMPLETED|Overall Study||8
507783|NCT00963807|1242253|P1|Completed Post-Cycle 2 FDG Imaging|Overall Study||8
507784|NCT00963807|1242253|P1|Completed Post-Cycle 2 FLT Imaging|Overall Study||9
507785|NCT00963807|1242253|P1|Completed Post-Cycle 1 Imaging|Overall Study||9
507786|NCT00963807|1242253|P1|Completed Baseline Imaging|Overall Study||11
507787|NCT00963807|1242253|P1|STARTED|Overall Study||26
507788|NCT00963677|1242264|P2|NOT COMPLETED|Overall Study||2
507789|NCT00963677|1242265|P1|NOT COMPLETED|Overall Study||0
507790|NCT00963677|1242264|P2|COMPLETED|Overall Study|Two patients were excluded from the study due to the difficult ventilation with facemask ventilation|18
507791|NCT00963677|1242265|P1|COMPLETED|Overall Study||35
507792|NCT00963677|1242264|P2|STARTED|Overall Study|Patients with predicted difficult intubation but not ventilation|20
507793|NCT00963677|1242265|P1|STARTED|Overall Study|Patients without predicted difficult intubation|35
507794|NCT00963638|1242275|P2|NOT COMPLETED|Overall Study||0
507795|NCT00963638|1242276|P1|NOT COMPLETED|Overall Study||0
507796|NCT00963638|1242275|P2|COMPLETED|Overall Study||20
507797|NCT00963638|1242276|P1|COMPLETED|Overall Study||20
507798|NCT00963638|1242275|P2|STARTED|Overall Study||20
507799|NCT00963638|1242276|P1|STARTED|Overall Study||20
507800|NCT00963599|1242286|P4|NOT COMPLETED|Overall Study||14
507801|NCT00963599|1242287|P3|NOT COMPLETED|Overall Study||9
507802|NCT00963599|1242288|P2|NOT COMPLETED|Overall Study||6
507803|NCT00963599|1242289|P1|NOT COMPLETED|Overall Study||6
507804|NCT00963599|1242286|P4|COMPLETED|Overall Study||288
507805|NCT00963599|1242287|P3|COMPLETED|Overall Study||292
507806|NCT00963599|1242288|P2|COMPLETED|Overall Study||149
507807|NCT00963599|1242289|P1|COMPLETED|Overall Study||143
507808|NCT00963599|1242286|P4|STARTED|Overall Study||302
507809|NCT00963599|1242287|P3|STARTED|Overall Study||301
507810|NCT00963599|1242288|P2|STARTED|Overall Study||155
507811|NCT00963599|1242289|P1|STARTED|Overall Study||149
507812|NCT00963560|1242346|P3|NOT COMPLETED|Overall Study||0
507813|NCT00963560|1242347|P2|NOT COMPLETED|Overall Study||3
507814|NCT00963560|1242348|P1|NOT COMPLETED|Overall Study||3
507815|NCT00963560|1242346|P3|COMPLETED|Overall Study||41
507816|NCT00963560|1242347|P2|COMPLETED|Overall Study||41
507817|NCT00963560|1242348|P1|COMPLETED|Overall Study||44
507818|NCT00963560|1242346|P3|STARTED|Overall Study||41
507819|NCT00963560|1242347|P2|STARTED|Overall Study||44
507820|NCT00963560|1242348|P1|STARTED|Overall Study||47
507821|NCT00963508|1242358|P2|NOT COMPLETED|Overall Study||28
507822|NCT00963508|1242359|P1|NOT COMPLETED|Overall Study||10
507823|NCT00963508|1242358|P2|COMPLETED|Overall Study||169
507824|NCT00963508|1242359|P1|COMPLETED|Overall Study||196
507825|NCT00963508|1242358|P2|STARTED|Overall Study||197
507826|NCT00963508|1242359|P1|STARTED|Overall Study||206
507827|NCT00963482|1242369|P2|NOT COMPLETED|Overall Study||17
507828|NCT00963482|1242370|P1|NOT COMPLETED|Overall Study||28
507829|NCT00963482|1242369|P2|COMPLETED|Overall Study||33
507830|NCT00963482|1242370|P1|COMPLETED|Overall Study||25
507831|NCT00963482|1242369|P2|STARTED|Overall Study||50
507832|NCT00963482|1242370|P1|STARTED|Overall Study||53
507833|NCT00963469|1242379|P3|NOT COMPLETED|Overall Study||10
507834|NCT00963469|1242380|P2|NOT COMPLETED|Overall Study||28
507835|NCT00963469|1242381|P1|NOT COMPLETED|Overall Study||41
507836|NCT00963469|1242379|P3|COMPLETED|Overall Study||170
507837|NCT00963469|1242380|P2|COMPLETED|Overall Study||420
507838|NCT00963469|1242381|P1|COMPLETED|Overall Study||410
507839|NCT00963469|1242379|P3|STARTED|Overall Study||180
507840|NCT00963469|1242380|P2|STARTED|Overall Study||448
507841|NCT00963469|1242381|P1|STARTED|Overall Study||451
507842|NCT00963430|1242409|P2|NOT COMPLETED|Overall Study||3
507843|NCT00963430|1242410|P1|NOT COMPLETED|Overall Study||1
507844|NCT00963430|1242409|P2|COMPLETED|Overall Study||57
507845|NCT00963430|1242410|P1|COMPLETED|Overall Study||59
507846|NCT00963430|1242409|P2|STARTED|Overall Study||60
507847|NCT00963430|1242410|P1|STARTED|Overall Study||60
507848|NCT00963235|1242448|P1|NOT COMPLETED|Overall Study||60
507849|NCT00963235|1242448|P1|COMPLETED|Overall Study||271
507850|NCT00963235|1242448|P1|Completed Dose 3 1-month Blood Draw|Overall Study||277
507851|NCT00963235|1242448|P1|Vaccinated Dose 3|Overall Study||279
507852|NCT00963235|1242448|P1|Vaccinated Dose 2|Overall Study||300
507853|NCT00963235|1242448|P1|Vaccinated Dose 1|Overall Study||329
507854|NCT00963235|1242448|P1|STARTED|Overall Study||331
507855|NCT00963157|1242472|P5|NOT COMPLETED|Overall Study||2
507856|NCT00963157|1242473|P4|NOT COMPLETED|Overall Study||7
507857|NCT00963157|1242474|P3|NOT COMPLETED|Overall Study||5
507858|NCT00963157|1242475|P2|NOT COMPLETED|Overall Study||4
507859|NCT00963157|1242476|P1|NOT COMPLETED|Overall Study||5
507860|NCT00963157|1242472|P5|COMPLETED|Overall Study||151
507861|NCT00963157|1242473|P4|COMPLETED|Overall Study||150
507862|NCT00963157|1242474|P3|COMPLETED|Overall Study||155
507863|NCT00963157|1242475|P2|COMPLETED|Overall Study||159
507864|NCT00963157|1242476|P1|COMPLETED|Overall Study||151
507865|NCT00963157|1242472|P5|STARTED|Overall Study||153
507866|NCT00963157|1242473|P4|STARTED|Overall Study||157
507867|NCT00963157|1242474|P3|STARTED|Overall Study||160
507868|NCT00963157|1242475|P2|STARTED|Overall Study||163
507869|NCT00963157|1242476|P1|STARTED|Overall Study||156
507870|NCT00962871|1242672|P4|NOT COMPLETED|Overall Study||0
507871|NCT00962871|1242673|P3|NOT COMPLETED|Overall Study||0
507872|NCT00962871|1242674|P2|NOT COMPLETED|Overall Study||0
507873|NCT00962871|1242675|P1|NOT COMPLETED|Overall Study||0
507874|NCT00962871|1242672|P4|COMPLETED|Overall Study||6
507875|NCT00962871|1242673|P3|COMPLETED|Overall Study||12
507876|NCT00962871|1242674|P2|COMPLETED|Overall Study||6
507877|NCT00962871|1242675|P1|COMPLETED|Overall Study||6
507878|NCT00962871|1242672|P4|STARTED|Overall Study||6
507879|NCT00962871|1242673|P3|STARTED|Overall Study||12
507880|NCT00962871|1242674|P2|STARTED|Overall Study||6
507881|NCT00962871|1242675|P1|STARTED|Overall Study||6
507882|NCT00962780|1242691|P2|NOT COMPLETED|Overall Study||14
507883|NCT00962780|1242692|P1|NOT COMPLETED|Overall Study||10
507884|NCT00962780|1242691|P2|COMPLETED|Overall Study||138
507885|NCT00962780|1242692|P1|COMPLETED|Overall Study||141
507886|NCT00962780|1242691|P2|Vaccinated 23vPS Dose|Overall Study||139
507887|NCT00962780|1242692|P1|Vaccinated 23vPS Dose|Overall Study||143
507888|NCT00962780|1242691|P2|Vaccinated 13vPnC Dose 3|Overall Study||142
507889|NCT00962780|1242692|P1|Vaccinated 13vPnC Dose 3|Overall Study||144
507890|NCT00962780|1242691|P2|Vaccinated 13vPnC Dose 2|Overall Study||145
507891|NCT00962780|1242692|P1|Vaccinated 13vPnC Dose 2|Overall Study||145
507892|NCT00962780|1242691|P2|Vaccinated 13vPnC Dose 1|Overall Study||151
507893|NCT00962780|1242692|P1|Vaccinated 13vPnC Dose 1|Overall Study||150
507894|NCT00962780|1242691|P2|STARTED|Overall Study||152
507895|NCT00962780|1242692|P1|STARTED|Overall Study||151
507896|NCT00962754|1242756|P2|NOT COMPLETED|Overall Study||0
507897|NCT00962754|1242757|P1|NOT COMPLETED|Overall Study||0
507898|NCT00962754|1242756|P2|COMPLETED|Overall Study||84
507899|NCT00962754|1242757|P1|COMPLETED|Overall Study||86
507900|NCT00962754|1242756|P2|STARTED|Overall Study||84
507901|NCT00962754|1242757|P1|STARTED|Overall Study||86
507902|NCT00962741|1242767|P1|NOT COMPLETED|Overall Study||8
507903|NCT00962741|1242767|P1|COMPLETED|Overall Study||119
507904|NCT00962741|1242767|P1|STARTED|Overall Study||127
507905|NCT00962650|1242858|P1|NOT COMPLETED|Overall Study||2
507906|NCT00962650|1242858|P1|COMPLETED|Overall Study||8
507907|NCT00962650|1242858|P1|STARTED|Overall Study||10
507908|NCT00962598|1242864|P2|NOT COMPLETED|Overall Study||0
507909|NCT00962598|1242865|P1|NOT COMPLETED|Overall Study||0
507910|NCT00962598|1242864|P2|COMPLETED|Overall Study||9
507911|NCT00962598|1242865|P1|COMPLETED|Overall Study||7
507912|NCT00962598|1242864|P2|STARTED|Overall Study||9
507913|NCT00962598|1242865|P1|STARTED|Overall Study||7
507914|NCT00962585|1242877|P4|NOT COMPLETED|Overall Study||0
507915|NCT00962585|1242878|P3|NOT COMPLETED|Overall Study||3
507916|NCT00962585|1242879|P2|NOT COMPLETED|Overall Study||2
507917|NCT00962585|1242880|P1|NOT COMPLETED|Overall Study||6
507918|NCT00962585|1242877|P4|COMPLETED|Overall Study||42
507919|NCT00962585|1242878|P3|COMPLETED|Overall Study||39
507920|NCT00962585|1242879|P2|COMPLETED|Overall Study||40
507921|NCT00962585|1242880|P1|COMPLETED|Overall Study||37
507922|NCT00962585|1242877|P4|STARTED|Overall Study||42
507923|NCT00962585|1242878|P3|STARTED|Overall Study||42
507924|NCT00962585|1242879|P2|STARTED|Overall Study||42
507925|NCT00962585|1242880|P1|STARTED|Overall Study||43
507926|NCT00962390|1242942|P4|NOT COMPLETED|Overall Study||1
507927|NCT00962390|1242943|P3|NOT COMPLETED|Overall Study||4
507928|NCT00962390|1242944|P2|NOT COMPLETED|Overall Study||3
507929|NCT00962390|1242945|P1|NOT COMPLETED|Overall Study||4
507930|NCT00962390|1242942|P4|COMPLETED|Overall Study||28
507931|NCT00962390|1242943|P3|COMPLETED|Overall Study||25
507932|NCT00962390|1242944|P2|COMPLETED|Overall Study||26
507933|NCT00962390|1242945|P1|COMPLETED|Overall Study||25
507934|NCT00962390|1242942|P4|STARTED|Overall Study||29
507935|NCT00962390|1242943|P3|STARTED|Overall Study||29
507936|NCT00962390|1242944|P2|STARTED|Overall Study||29
507937|NCT00962390|1242945|P1|STARTED|Overall Study||29
507938|NCT00962247|1243007|P1|NOT COMPLETED|50% Reduction of Sedentary Activity||0
507939|NCT00962247|1243007|P1|COMPLETED|50% Reduction of Sedentary Activity||56
507940|NCT00962247|1243007|P1|STARTED|50% Reduction of Sedentary Activity||56
507941|NCT00962247|1243007|P1|NOT COMPLETED|25% Reduction of Sedentary Activity||5
507942|NCT00962247|1243007|P1|COMPLETED|25% Reduction of Sedentary Activity||56
507943|NCT00962247|1243007|P1|STARTED|25% Reduction of Sedentary Activity||61
507944|NCT00962247|1243007|P1|NOT COMPLETED|Usual Sedentary||18
507945|NCT00962247|1243007|P1|COMPLETED|Usual Sedentary||61
507946|NCT00962247|1243007|P1|STARTED|Usual Sedentary||79
507947|NCT00962208|1243018|P2|NOT COMPLETED|Overall Study||10
507948|NCT00962208|1243019|P1|NOT COMPLETED|Overall Study||14
507949|NCT00962208|1243018|P2|COMPLETED|Overall Study||41
507950|NCT00962208|1243019|P1|COMPLETED|Overall Study||37
507951|NCT00962208|1243018|P2|STARTED|Overall Study||51
507952|NCT00962208|1243019|P1|STARTED|Overall Study||51
507953|NCT00962104|1243027|P2|NOT COMPLETED|Overall Study||25
507954|NCT00962104|1243028|P1|NOT COMPLETED|Overall Study||40
507955|NCT00962104|1243027|P2|COMPLETED|Overall Study||171
507956|NCT00962104|1243028|P1|COMPLETED|Overall Study||155
507957|NCT00962104|1243027|P2|Full Analysis Set|Overall Study|1 participant was excluded because that participant failed to take the assigned study medication.|195
507958|NCT00962104|1243028|P1|Full Analysis Set|Overall Study|2 participants were excluded because they failed to take the assigned study medication.|193
507959|NCT00962104|1243027|P2|STARTED|Overall Study||196
507960|NCT00962104|1243028|P1|STARTED|Overall Study||195
507961|NCT00962065|1243057|P3|NOT COMPLETED|Overall Study||0
507962|NCT00962065|1243058|P2|NOT COMPLETED|Overall Study||0
507963|NCT00962065|1243059|P1|NOT COMPLETED|Overall Study||0
507964|NCT00962065|1243057|P3|COMPLETED|Overall Study||12
507965|NCT00962065|1243058|P2|COMPLETED|Overall Study||12
507966|NCT00962065|1243059|P1|COMPLETED|Overall Study||12
507967|NCT00962065|1243057|P3|STARTED|Overall Study||12
507968|NCT00962065|1243058|P2|STARTED|Overall Study||12
507969|NCT00962065|1243059|P1|STARTED|Overall Study||12
507970|NCT00962013|1243082|P1|NOT COMPLETED|Overall Study||68
507971|NCT00962013|1243082|P1|COMPLETED|Overall Study|Number of participants with 5 year primary endpoint data|52
507972|NCT00962013|1243082|P1|STARTED|Overall Study||120
507973|NCT00962000|1243091|P2|NOT COMPLETED|Period 4 - 1 Week||0
507974|NCT00962000|1243092|P1|NOT COMPLETED|Period 4 - 1 Week||0
507975|NCT00962000|1243091|P2|COMPLETED|Period 4 - 1 Week||21
507976|NCT00962000|1243092|P1|COMPLETED|Period 4 - 1 Week||21
507977|NCT00962000|1243091|P2|STARTED|Period 4 - 1 Week||21
507978|NCT00962000|1243092|P1|STARTED|Period 4 - 1 Week||21
507979|NCT00962000|1243091|P2|NOT COMPLETED|Period 3 - 1 Week||0
507980|NCT00962000|1243092|P1|NOT COMPLETED|Period 3 - 1 Week||0
507981|NCT00962000|1243091|P2|COMPLETED|Period 3 - 1 Week||21
507982|NCT00962000|1243092|P1|COMPLETED|Period 3 - 1 Week||21
507983|NCT00962000|1243091|P2|STARTED|Period 3 - 1 Week||21
507984|NCT00962000|1243092|P1|STARTED|Period 3 - 1 Week||21
507985|NCT00962000|1243091|P2|NOT COMPLETED|Period 2 - 1 Week||0
507986|NCT00962000|1243092|P1|NOT COMPLETED|Period 2 - 1 Week||0
507987|NCT00962000|1243091|P2|COMPLETED|Period 2 - 1 Week||21
507988|NCT00962000|1243092|P1|COMPLETED|Period 2 - 1 Week||21
507989|NCT00962000|1243091|P2|STARTED|Period 2 - 1 Week||21
507990|NCT00962000|1243092|P1|STARTED|Period 2 - 1 Week||21
507991|NCT00962000|1243091|P2|NOT COMPLETED|Period 1 - 1 Week||0
507992|NCT00962000|1243092|P1|NOT COMPLETED|Period 1 - 1 Week||0
507993|NCT00962000|1243091|P2|COMPLETED|Period 1 - 1 Week||21
507994|NCT00962000|1243092|P1|COMPLETED|Period 1 - 1 Week||21
507995|NCT00962000|1243091|P2|STARTED|Period 1 - 1 Week||21
507996|NCT00962000|1243092|P1|STARTED|Period 1 - 1 Week||21
507997|NCT00961896|1243105|P3|NOT COMPLETED|Overall Study||1
507998|NCT00961896|1243106|P2|NOT COMPLETED|Overall Study||0
507999|NCT00961896|1243107|P1|NOT COMPLETED|Overall Study||0
508000|NCT00961896|1243105|P3|COMPLETED|Overall Study||6
508001|NCT00961896|1243106|P2|COMPLETED|Overall Study||3
508002|NCT00961896|1243107|P1|COMPLETED|Overall Study||8
508003|NCT00961896|1243105|P3|STARTED|Overall Study||7
508004|NCT00961896|1243106|P2|STARTED|Overall Study||3
508005|NCT00961896|1243107|P1|STARTED|Overall Study||8
508006|NCT00961805|1243128|P2|NOT COMPLETED|Overall Study||0
508007|NCT00961805|1243129|P1|NOT COMPLETED|Overall Study||0
508008|NCT00961805|1243128|P2|COMPLETED|Overall Study||40
508009|NCT00961805|1243129|P1|COMPLETED|Overall Study||40
508010|NCT00961805|1243128|P2|STARTED|Overall Study||40
508011|NCT00961805|1243129|P1|STARTED|Overall Study||40
508012|NCT00961662|1243160|P3|NOT COMPLETED|Overall Study||19
508013|NCT00961662|1243161|P2|NOT COMPLETED|Overall Study||19
508014|NCT00961662|1243162|P1|NOT COMPLETED|Overall Study||22
508015|NCT00961662|1243160|P3|COMPLETED|Overall Study||34
508016|NCT00961662|1243161|P2|COMPLETED|Overall Study||32
508017|NCT00961662|1243162|P1|COMPLETED|Overall Study||35
508018|NCT00961662|1243160|P3|STARTED|Overall Study||53
508019|NCT00961662|1243161|P2|STARTED|Overall Study||51
508020|NCT00961662|1243162|P1|STARTED|Overall Study||57
508021|NCT00961649|1243174|P4|NOT COMPLETED|Overall Study||4
508022|NCT00961649|1243175|P3|NOT COMPLETED|Overall Study||5
508023|NCT00961649|1243176|P2|NOT COMPLETED|Overall Study||4
508024|NCT00961649|1243177|P1|NOT COMPLETED|Overall Study||9
508025|NCT00961649|1243174|P4|COMPLETED|Overall Study||37
508026|NCT00961649|1243175|P3|COMPLETED|Overall Study||39
508027|NCT00961649|1243176|P2|COMPLETED|Overall Study||40
508028|NCT00961649|1243177|P1|COMPLETED|Overall Study||32
508029|NCT00961649|1243174|P4|STARTED|Overall Study||41
508030|NCT00961649|1243175|P3|STARTED|Overall Study||44
508031|NCT00961649|1243176|P2|STARTED|Overall Study||44
508032|NCT00961649|1243177|P1|STARTED|Overall Study||41
508033|NCT00961636|1243191|P3|NOT COMPLETED|Overall Study||32
508034|NCT00961636|1243192|P2|NOT COMPLETED|Overall Study||131
508035|NCT00961636|1243193|P1|NOT COMPLETED|Overall Study||107
508036|NCT00961636|1243191|P3|COMPLETED|Overall Study||201
508037|NCT00961636|1243192|P2|COMPLETED|Overall Study||325
508038|NCT00961636|1243193|P1|COMPLETED|Overall Study||356
508039|NCT00961636|1243191|P3|STARTED|Overall Study||233
508040|NCT00961636|1243192|P2|STARTED|Overall Study||456
508041|NCT00961636|1243193|P1|STARTED|Overall Study||463
508042|NCT00961571|1243204|P1|NOT COMPLETED|Overall Study||39
508043|NCT00961571|1243204|P1|COMPLETED|Overall Study|high percentage of patient drop-off study prior cancer progression|11
508044|NCT00961571|1243204|P1|STARTED|Overall Study||50
508045|NCT00961532|1243208|P1|NOT COMPLETED|Overall Study||0
508046|NCT00961532|1243208|P1|COMPLETED|Overall Study||14
508047|NCT00961532|1243208|P1|STARTED|Overall Study||14
508048|NCT00961441|1243215|P2|NOT COMPLETED|Overall Study||0
508049|NCT00961441|1243216|P1|NOT COMPLETED|Overall Study||0
508050|NCT00961441|1243215|P2|COMPLETED|Overall Study||13
508051|NCT00961441|1243216|P1|COMPLETED|Overall Study||12
508052|NCT00961441|1243215|P2|Pharmacokinetic (PK-PP) Population|Overall Study|Two subjects were excluded due to study medication noncompliance, one due to wrong dosing regimen.|10
508053|NCT00961441|1243216|P1|Pharmacokinetic (PK-PP) Population|Overall Study||12
508054|NCT00961441|1243215|P2|STARTED|Overall Study||13
508055|NCT00961441|1243216|P1|STARTED|Overall Study||12
508056|NCT00961415|1243232|P3|NOT COMPLETED|Maintenance Treatment Phase||45
508057|NCT00961415|1243233|P2|NOT COMPLETED|Maintenance Treatment Phase||48
508058|NCT00961415|1243234|P1|NOT COMPLETED|Maintenance Treatment Phase||0
508059|NCT00961415|1243232|P3|COMPLETED|Maintenance Treatment Phase||83
508060|NCT00961415|1243233|P2|COMPLETED|Maintenance Treatment Phase||77
508061|NCT00961415|1243234|P1|COMPLETED|Maintenance Treatment Phase||0
508062|NCT00961415|1243232|P3|STARTED|Maintenance Treatment Phase||128
508063|NCT00961415|1243233|P2|STARTED|Maintenance Treatment Phase||125
508064|NCT00961415|1243234|P1|STARTED|Maintenance Treatment Phase||0
508065|NCT00961415|1243232|P3|NOT COMPLETED|Induction Treatment Phase||0
508066|NCT00961415|1243233|P2|NOT COMPLETED|Induction Treatment Phase||0
508067|NCT00961415|1243234|P1|NOT COMPLETED|Induction Treatment Phase||123
508068|NCT00961415|1243232|P3|COMPLETED|Induction Treatment Phase||0
508069|NCT00961415|1243233|P2|COMPLETED|Induction Treatment Phase||0
508070|NCT00961415|1243234|P1|COMPLETED|Induction Treatment Phase||253
508071|NCT00961415|1243232|P3|STARTED|Induction Treatment Phase||0
508072|NCT00961415|1243233|P2|STARTED|Induction Treatment Phase||0
508073|NCT00961415|1243234|P1|STARTED|Induction Treatment Phase||376
508074|NCT00961402|1243259|P2|NOT COMPLETED|Overall Study||5
508075|NCT00961402|1243260|P1|NOT COMPLETED|Overall Study||1
508076|NCT00961402|1243259|P2|COMPLETED|Overall Study||61
508077|NCT00961402|1243260|P1|COMPLETED|Overall Study||63
508078|NCT00961402|1243259|P2|Randomized|Overall Study||66
508079|NCT00961402|1243260|P1|Randomized|Overall Study||64
508080|NCT00961402|1243259|P2|STARTED|Overall Study||66
508081|NCT00961402|1243260|P1|STARTED|Overall Study||64
508082|NCT00961350|1243274|P2|NOT COMPLETED|Overall Study||67
508083|NCT00961350|1243275|P1|NOT COMPLETED|Overall Study||47
508084|NCT00961350|1243274|P2|COMPLETED|Overall Study||198
508085|NCT00961350|1243275|P1|COMPLETED|Overall Study||218
508086|NCT00961350|1243274|P2|Safety Population|Overall Study||265
508087|NCT00961350|1243275|P1|Safety Population|Overall Study|1. One sub rand to PA32540 took EC-Aspirin|264
508088|NCT00961350|1243274|P2|Intent-to-Treat Population (ITT)|Overall Study||265
508089|NCT00961350|1243275|P1|Intent-to-Treat Population (ITT)|Overall Study||265
508090|NCT00961350|1243274|P2|STARTED|Overall Study||265
508091|NCT00961350|1243275|P1|STARTED|Overall Study||265
508092|NCT00961311|1243289|P1|NOT COMPLETED|Overall Study||0
508093|NCT00961311|1243289|P1|COMPLETED|Overall Study||51
508094|NCT00961311|1243289|P1|STARTED|Overall Study||51
508095|NCT00961298|1243296|P1|NOT COMPLETED|12 Weeks Duloxetine Treatment Phase||3
508096|NCT00961298|1243296|P1|COMPLETED|12 Weeks Duloxetine Treatment Phase||11
508097|NCT00961298|1243296|P1|STARTED|12 Weeks Duloxetine Treatment Phase||14
508098|NCT00961298|1243296|P1|NOT COMPLETED|Two Week Placebo Run in||1
508099|NCT00961298|1243296|P1|COMPLETED|Two Week Placebo Run in||14
508100|NCT00961298|1243296|P1|STARTED|Two Week Placebo Run in||15
508101|NCT00961259|1243303|P3|NOT COMPLETED|Third Intervention||0
508102|NCT00961259|1243304|P2|NOT COMPLETED|Third Intervention||0
508103|NCT00961259|1243305|P1|NOT COMPLETED|Third Intervention||0
508104|NCT00961259|1243303|P3|COMPLETED|Third Intervention||18
508105|NCT00961259|1243304|P2|COMPLETED|Third Intervention||17
508106|NCT00961259|1243305|P1|COMPLETED|Third Intervention||18
508107|NCT00961259|1243303|P3|STARTED|Third Intervention||18
508108|NCT00961259|1243304|P2|STARTED|Third Intervention||17
508109|NCT00961259|1243305|P1|STARTED|Third Intervention||18
508110|NCT00961259|1243303|P3|NOT COMPLETED|Washout Period of 7 Days||0
508111|NCT00961259|1243304|P2|NOT COMPLETED|Washout Period of 7 Days||0
508112|NCT00961259|1243305|P1|NOT COMPLETED|Washout Period of 7 Days||0
508113|NCT00961259|1243303|P3|COMPLETED|Washout Period of 7 Days||18
508114|NCT00961259|1243304|P2|COMPLETED|Washout Period of 7 Days||17
508115|NCT00961259|1243305|P1|COMPLETED|Washout Period of 7 Days||18
508116|NCT00961259|1243303|P3|STARTED|Washout Period of 7 Days||18
508117|NCT00961259|1243304|P2|STARTED|Washout Period of 7 Days||17
508118|NCT00961259|1243305|P1|STARTED|Washout Period of 7 Days||18
508119|NCT00961259|1243303|P3|NOT COMPLETED|Second Intervention||0
508120|NCT00961259|1243304|P2|NOT COMPLETED|Second Intervention||0
508121|NCT00961259|1243305|P1|NOT COMPLETED|Second Intervention||0
508122|NCT00961259|1243303|P3|COMPLETED|Second Intervention||18
508123|NCT00961259|1243304|P2|COMPLETED|Second Intervention||17
508124|NCT00961259|1243305|P1|COMPLETED|Second Intervention||18
508125|NCT00961259|1243303|P3|STARTED|Second Intervention||18
508126|NCT00961259|1243304|P2|STARTED|Second Intervention||17
508127|NCT00961259|1243305|P1|STARTED|Second Intervention||18
508128|NCT00961259|1243303|P3|NOT COMPLETED|Washout Period of 7 Days||0
508129|NCT00961259|1243304|P2|NOT COMPLETED|Washout Period of 7 Days||1
508130|NCT00961259|1243305|P1|NOT COMPLETED|Washout Period of 7 Days||0
508131|NCT00961259|1243303|P3|COMPLETED|Washout Period of 7 Days||18
508132|NCT00961259|1243304|P2|COMPLETED|Washout Period of 7 Days|dropped due to concomitant medication used prior to admission.|17
508133|NCT00961259|1243305|P1|COMPLETED|Washout Period of 7 Days||18
508134|NCT00961259|1243303|P3|STARTED|Washout Period of 7 Days||18
508135|NCT00961259|1243304|P2|STARTED|Washout Period of 7 Days||18
508136|NCT00961259|1243305|P1|STARTED|Washout Period of 7 Days||18
508137|NCT00961259|1243303|P3|NOT COMPLETED|First Intervention||0
508138|NCT00961259|1243304|P2|NOT COMPLETED|First Intervention||0
508139|NCT00961259|1243305|P1|NOT COMPLETED|First Intervention||0
508140|NCT00961259|1243303|P3|COMPLETED|First Intervention||18
508141|NCT00961259|1243304|P2|COMPLETED|First Intervention||18
508142|NCT00961259|1243305|P1|COMPLETED|First Intervention||18
508143|NCT00961259|1243303|P3|STARTED|First Intervention||18
508144|NCT00961259|1243304|P2|STARTED|First Intervention||18
508145|NCT00961259|1243305|P1|STARTED|First Intervention||18
508146|NCT00961233|1243324|P2|NOT COMPLETED|Overall Study||1
508147|NCT00961233|1243325|P1|NOT COMPLETED|Overall Study||2
508148|NCT00961233|1243324|P2|COMPLETED|Overall Study||11
508149|NCT00961233|1243325|P1|COMPLETED|Overall Study||11
508150|NCT00961233|1243324|P2|STARTED|Overall Study||12
508151|NCT00961233|1243325|P1|STARTED|Overall Study||13
508152|NCT00961220|1243333|P1|NOT COMPLETED|Overall Study||7
508153|NCT00961220|1243333|P1|COMPLETED|Overall Study||10
508154|NCT00961220|1243333|P1|STARTED|Overall Study||17
508155|NCT00961181|1243349|P1|NOT COMPLETED|Overall Study||5
508156|NCT00961181|1243349|P1|COMPLETED|Overall Study||76
508157|NCT00961181|1243349|P1|STARTED|Overall Study||81
508158|NCT00961116|1243362|P2|NOT COMPLETED|Second Intervention||0
508159|NCT00961116|1243363|P1|NOT COMPLETED|Second Intervention||0
508160|NCT00961116|1243362|P2|COMPLETED|Second Intervention||24
508161|NCT00961116|1243363|P1|COMPLETED|Second Intervention||25
508162|NCT00961116|1243362|P2|STARTED|Second Intervention||24
508163|NCT00961116|1243363|P1|STARTED|Second Intervention||25
508164|NCT00961116|1243362|P2|NOT COMPLETED|Washout Period of 7 Days||3
508165|NCT00961116|1243363|P1|NOT COMPLETED|Washout Period of 7 Days||2
508166|NCT00961116|1243362|P2|COMPLETED|Washout Period of 7 Days||24
508167|NCT00961116|1243363|P1|COMPLETED|Washout Period of 7 Days||25
508168|NCT00961116|1243362|P2|STARTED|Washout Period of 7 Days||27
508169|NCT00961116|1243363|P1|STARTED|Washout Period of 7 Days||27
508170|NCT00961116|1243362|P2|NOT COMPLETED|First Intervention||0
508171|NCT00961116|1243363|P1|NOT COMPLETED|First Intervention||0
508172|NCT00961116|1243362|P2|COMPLETED|First Intervention||27
508173|NCT00961116|1243363|P1|COMPLETED|First Intervention||27
508174|NCT00961116|1243362|P2|STARTED|First Intervention||27
508175|NCT00961116|1243363|P1|STARTED|First Intervention||27
508176|NCT00961051|1243375|P2|NOT COMPLETED|Overall Study||14
508177|NCT00961051|1243376|P1|NOT COMPLETED|Overall Study||12
508178|NCT00961051|1243375|P2|COMPLETED|Overall Study||79
508179|NCT00961051|1243376|P1|COMPLETED|Overall Study||165
508180|NCT00961051|1243375|P2|STARTED|Overall Study||93
508181|NCT00961051|1243376|P1|STARTED|Overall Study||177
508182|NCT00960999|1243386|P2|NOT COMPLETED|Overall Study||2
508183|NCT00960999|1243387|P1|NOT COMPLETED|Overall Study||8
508184|NCT00960999|1243386|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|45
508185|NCT00960999|1243387|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|39
508186|NCT00960999|1243386|P2|STARTED|Overall Study||47
508187|NCT00960999|1243387|P1|STARTED|Overall Study||47
508188|NCT00960986|1243397|P4|NOT COMPLETED|Period 3 (7-week Therapy Period)||25
508189|NCT00960986|1243398|P3|NOT COMPLETED|Period 3 (7-week Therapy Period)||20
508190|NCT00960986|1243399|P2|NOT COMPLETED|Period 3 (7-week Therapy Period)||23
508191|NCT00960986|1243400|P1|NOT COMPLETED|Period 3 (7-week Therapy Period)||30
508192|NCT00960986|1243397|P4|COMPLETED|Period 3 (7-week Therapy Period)||36
508193|NCT00960986|1243398|P3|COMPLETED|Period 3 (7-week Therapy Period)||39
508194|NCT00960986|1243399|P2|COMPLETED|Period 3 (7-week Therapy Period)||36
508195|NCT00960986|1243400|P1|COMPLETED|Period 3 (7-week Therapy Period)||26
508196|NCT00960986|1243397|P4|STARTED|Period 3 (7-week Therapy Period)||61
508197|NCT00960986|1243398|P3|STARTED|Period 3 (7-week Therapy Period)||59
508198|NCT00960986|1243399|P2|STARTED|Period 3 (7-week Therapy Period)||59
508199|NCT00960986|1243400|P1|STARTED|Period 3 (7-week Therapy Period)||56
508200|NCT00960986|1243397|P4|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
508201|NCT00960986|1243398|P3|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
508202|NCT00960986|1243399|P2|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
508203|NCT00960986|1243400|P1|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
508204|NCT00960986|1243397|P4|COMPLETED|Period 2 (1-week Initial Dosing Period)||61
508205|NCT00960986|1243398|P3|COMPLETED|Period 2 (1-week Initial Dosing Period)||59
508206|NCT00960986|1243399|P2|COMPLETED|Period 2 (1-week Initial Dosing Period)||59
508207|NCT00960986|1243400|P1|COMPLETED|Period 2 (1-week Initial Dosing Period)||56
508208|NCT00960986|1243397|P4|STARTED|Period 2 (1-week Initial Dosing Period)||61
508209|NCT00960986|1243398|P3|STARTED|Period 2 (1-week Initial Dosing Period)||59
508210|NCT00960986|1243399|P2|STARTED|Period 2 (1-week Initial Dosing Period)||59
508211|NCT00960986|1243400|P1|STARTED|Period 2 (1-week Initial Dosing Period)||56
508212|NCT00960986|1243397|P4|NOT COMPLETED|Period 1 (Screening and Washout)||3
508213|NCT00960986|1243398|P3|NOT COMPLETED|Period 1 (Screening and Washout)||4
508214|NCT00960986|1243399|P2|NOT COMPLETED|Period 1 (Screening and Washout)||4
508215|NCT00960986|1243400|P1|NOT COMPLETED|Period 1 (Screening and Washout)||3
508216|NCT00960986|1243397|P4|COMPLETED|Period 1 (Screening and Washout)||61
508217|NCT00960986|1243398|P3|COMPLETED|Period 1 (Screening and Washout)||59
508218|NCT00960986|1243399|P2|COMPLETED|Period 1 (Screening and Washout)||59
508219|NCT00960986|1243400|P1|COMPLETED|Period 1 (Screening and Washout)||56
508220|NCT00960986|1243397|P4|STARTED|Period 1 (Screening and Washout)||64
508221|NCT00960986|1243398|P3|STARTED|Period 1 (Screening and Washout)||63
508222|NCT00960986|1243399|P2|STARTED|Period 1 (Screening and Washout)||63
508223|NCT00960986|1243400|P1|STARTED|Period 1 (Screening and Washout)||59
508224|NCT00960934|1243476|P6|NOT COMPLETED|Overall Study||64
508225|NCT00960934|1243477|P5|NOT COMPLETED|Overall Study||64
508226|NCT00960934|1243478|P4|NOT COMPLETED|Overall Study||64
508227|NCT00960934|1243479|P3|NOT COMPLETED|Overall Study||64
508228|NCT00960934|1243480|P2|NOT COMPLETED|Overall Study||63
508229|NCT00960934|1243481|P1|NOT COMPLETED|Overall Study||64
508230|NCT00960934|1243476|P6|COMPLETED|Overall Study||0
508231|NCT00960934|1243477|P5|COMPLETED|Overall Study||0
508232|NCT00960934|1243478|P4|COMPLETED|Overall Study||0
508233|NCT00960934|1243479|P3|COMPLETED|Overall Study||0
508234|NCT00960934|1243480|P2|COMPLETED|Overall Study||0
508235|NCT00960934|1243481|P1|COMPLETED|Overall Study||0
508236|NCT00960934|1243476|P6|Number Treated|Overall Study|1 participant was randomized but not treated|63
508237|NCT00960934|1243477|P5|Number Treated|Overall Study|1 participant was randomized but not treated|63
508238|NCT00960934|1243478|P4|Number Treated|Overall Study||64
508239|NCT00960934|1243479|P3|Number Treated|Overall Study||64
508240|NCT00960934|1243480|P2|Number Treated|Overall Study|1 participant was randomized but not treated|62
508241|NCT00960934|1243481|P1|Number Treated|Overall Study||64
508242|NCT00960934|1243476|P6|STARTED|Overall Study||64
508243|NCT00960934|1243477|P5|STARTED|Overall Study||64
508244|NCT00960934|1243478|P4|STARTED|Overall Study||64
508245|NCT00960934|1243479|P3|STARTED|Overall Study||64
508246|NCT00960934|1243480|P2|STARTED|Overall Study||63
508247|NCT00960934|1243481|P1|STARTED|Overall Study||64
508248|NCT00960869|1243593|P2|NOT COMPLETED|Overall Study||62
508249|NCT00960869|1243594|P1|NOT COMPLETED|Overall Study||53
508250|NCT00960869|1243593|P2|COMPLETED|Overall Study||198
508251|NCT00960869|1243594|P1|COMPLETED|Overall Study||206
508252|NCT00960869|1243593|P2|Safety Popluation|Overall Study|3 rand to PA32540 took EC-ASA 325mg/3 rand to EC-ASA 325mg took PA32540 counted by actual treatment.|259
508253|NCT00960869|1243594|P1|Safety Popluation|Overall Study|3 rand to PA32540 took EC-ASA 325mg/3 rand to EC-ASA 325mg took PA32540 counted by actual treatment.|257
508254|NCT00960869|1243593|P2|Intent-to-Treat Population (ITT)|Overall Study||260
508255|NCT00960869|1243594|P1|Intent-to-Treat Population (ITT)|Overall Study||259
508256|NCT00960869|1243593|P2|STARTED|Overall Study||260
508257|NCT00960869|1243594|P1|STARTED|Overall Study||259
508258|NCT00960856|1243608|P4|NOT COMPLETED|Period IV||0
508259|NCT00960856|1243609|P3|NOT COMPLETED|Period IV||0
508260|NCT00960856|1243610|P2|NOT COMPLETED|Period IV||0
508261|NCT00960856|1243611|P1|NOT COMPLETED|Period IV||0
508262|NCT00960856|1243608|P4|COMPLETED|Period IV||9
508263|NCT00960856|1243609|P3|COMPLETED|Period IV||8
508264|NCT00960856|1243610|P2|COMPLETED|Period IV||7
508265|NCT00960856|1243611|P1|COMPLETED|Period IV||10
508266|NCT00960856|1243608|P4|STARTED|Period IV||9
508267|NCT00960856|1243609|P3|STARTED|Period IV||8
508268|NCT00960856|1243610|P2|STARTED|Period IV||7
508269|NCT00960856|1243611|P1|STARTED|Period IV||10
508270|NCT00960856|1243608|P4|NOT COMPLETED|Washout Period of 7 Days||0
508271|NCT00960856|1243609|P3|NOT COMPLETED|Washout Period of 7 Days||1
508272|NCT00960856|1243610|P2|NOT COMPLETED|Washout Period of 7 Days||0
508273|NCT00960856|1243611|P1|NOT COMPLETED|Washout Period of 7 Days||0
508274|NCT00960856|1243608|P4|COMPLETED|Washout Period of 7 Days||9
508275|NCT00960856|1243609|P3|COMPLETED|Washout Period of 7 Days||8
508276|NCT00960856|1243610|P2|COMPLETED|Washout Period of 7 Days||7
508277|NCT00960856|1243611|P1|COMPLETED|Washout Period of 7 Days||10
508278|NCT00960856|1243608|P4|STARTED|Washout Period of 7 Days||9
508279|NCT00960856|1243609|P3|STARTED|Washout Period of 7 Days||9
508280|NCT00960856|1243610|P2|STARTED|Washout Period of 7 Days||7
508281|NCT00960856|1243611|P1|STARTED|Washout Period of 7 Days||10
508282|NCT00960856|1243608|P4|NOT COMPLETED|Period III||0
508283|NCT00960856|1243609|P3|NOT COMPLETED|Period III||0
508284|NCT00960856|1243610|P2|NOT COMPLETED|Period III||0
508285|NCT00960856|1243611|P1|NOT COMPLETED|Period III||0
508286|NCT00960856|1243608|P4|COMPLETED|Period III||9
508287|NCT00960856|1243609|P3|COMPLETED|Period III||9
508288|NCT00960856|1243610|P2|COMPLETED|Period III||7
508289|NCT00960856|1243611|P1|COMPLETED|Period III||10
508290|NCT00960856|1243608|P4|STARTED|Period III||9
508291|NCT00960856|1243609|P3|STARTED|Period III||9
508292|NCT00960856|1243610|P2|STARTED|Period III||7
508293|NCT00960856|1243611|P1|STARTED|Period III||10
508294|NCT00960856|1243608|P4|NOT COMPLETED|Washout Period of 7 Days||0
508295|NCT00960856|1243609|P3|NOT COMPLETED|Washout Period of 7 Days||0
508296|NCT00960856|1243610|P2|NOT COMPLETED|Washout Period of 7 Days||0
508297|NCT00960856|1243611|P1|NOT COMPLETED|Washout Period of 7 Days||0
508298|NCT00960856|1243608|P4|COMPLETED|Washout Period of 7 Days||9
508299|NCT00960856|1243609|P3|COMPLETED|Washout Period of 7 Days||9
508300|NCT00960856|1243610|P2|COMPLETED|Washout Period of 7 Days||7
508301|NCT00960856|1243611|P1|COMPLETED|Washout Period of 7 Days||10
508302|NCT00960856|1243608|P4|STARTED|Washout Period of 7 Days||9
508303|NCT00960856|1243609|P3|STARTED|Washout Period of 7 Days||9
508304|NCT00960856|1243610|P2|STARTED|Washout Period of 7 Days||7
508305|NCT00960856|1243611|P1|STARTED|Washout Period of 7 Days||10
508306|NCT00960856|1243608|P4|NOT COMPLETED|Period II||0
508307|NCT00960856|1243609|P3|NOT COMPLETED|Period II||0
508308|NCT00960856|1243610|P2|NOT COMPLETED|Period II||0
508309|NCT00960856|1243611|P1|NOT COMPLETED|Period II||0
508310|NCT00960856|1243608|P4|COMPLETED|Period II||9
508311|NCT00960856|1243609|P3|COMPLETED|Period II||9
508312|NCT00960856|1243610|P2|COMPLETED|Period II||7
508313|NCT00960856|1243611|P1|COMPLETED|Period II||10
508314|NCT00960856|1243608|P4|STARTED|Period II||9
508315|NCT00960856|1243609|P3|STARTED|Period II||9
508316|NCT00960856|1243610|P2|STARTED|Period II||7
508317|NCT00960856|1243611|P1|STARTED|Period II||10
508318|NCT00960856|1243608|P4|NOT COMPLETED|Washout Period of 7 Days||0
508319|NCT00960856|1243609|P3|NOT COMPLETED|Washout Period of 7 Days||0
508320|NCT00960856|1243610|P2|NOT COMPLETED|Washout Period of 7 Days||2
508321|NCT00960856|1243611|P1|NOT COMPLETED|Washout Period of 7 Days||0
508322|NCT00960856|1243608|P4|COMPLETED|Washout Period of 7 Days||9
508323|NCT00960856|1243609|P3|COMPLETED|Washout Period of 7 Days||9
508324|NCT00960856|1243610|P2|COMPLETED|Washout Period of 7 Days|personal reasons|7
508325|NCT00960856|1243611|P1|COMPLETED|Washout Period of 7 Days||10
508326|NCT00960856|1243608|P4|STARTED|Washout Period of 7 Days||9
508327|NCT00960856|1243609|P3|STARTED|Washout Period of 7 Days||9
508328|NCT00960856|1243610|P2|STARTED|Washout Period of 7 Days||9
508329|NCT00960856|1243611|P1|STARTED|Washout Period of 7 Days||10
508330|NCT00960856|1243608|P4|NOT COMPLETED|Period I||0
508331|NCT00960856|1243609|P3|NOT COMPLETED|Period I||0
508332|NCT00960856|1243610|P2|NOT COMPLETED|Period I||0
508333|NCT00960856|1243611|P1|NOT COMPLETED|Period I||0
508334|NCT00960856|1243608|P4|COMPLETED|Period I||9
508335|NCT00960856|1243609|P3|COMPLETED|Period I||9
508336|NCT00960856|1243610|P2|COMPLETED|Period I||9
508337|NCT00960856|1243611|P1|COMPLETED|Period I||10
508338|NCT00960856|1243608|P4|STARTED|Period I||9
508339|NCT00960856|1243609|P3|STARTED|Period I||9
508340|NCT00960856|1243610|P2|STARTED|Period I||9
508341|NCT00960856|1243611|P1|STARTED|Period I||10
508342|NCT00960843|1243631|P2|NOT COMPLETED|Overall Study||5
508343|NCT00960843|1243632|P1|NOT COMPLETED|Overall Study||2
508344|NCT00960843|1243631|P2|COMPLETED|Overall Study||21
508345|NCT00960843|1243632|P1|COMPLETED|Overall Study||23
508346|NCT00960843|1243631|P2|STARTED|Overall Study||26
508347|NCT00960843|1243632|P1|STARTED|Overall Study||25
508348|NCT00960687|1243642|P2|NOT COMPLETED|Second Intervention||0
508349|NCT00960687|1243643|P1|NOT COMPLETED|Second Intervention||0
508350|NCT00960687|1243642|P2|COMPLETED|Second Intervention||24
508351|NCT00960687|1243643|P1|COMPLETED|Second Intervention||23
508352|NCT00960687|1243642|P2|STARTED|Second Intervention||24
508353|NCT00960687|1243643|P1|STARTED|Second Intervention||23
508354|NCT00960687|1243642|P2|NOT COMPLETED|Washout Period of 7 Days||3
508355|NCT00960687|1243643|P1|NOT COMPLETED|Washout Period of 7 Days||4
508356|NCT00960687|1243642|P2|COMPLETED|Washout Period of 7 Days|two subjects withdrew due to adverse events and one subject withdrew for personal reasons.|24
508357|NCT00960687|1243643|P1|COMPLETED|Washout Period of 7 Days|three subjects withdrew due to adverse events and one subject withdrew for personal reasons.|23
508358|NCT00960687|1243642|P2|STARTED|Washout Period of 7 Days||27
508359|NCT00960687|1243643|P1|STARTED|Washout Period of 7 Days||27
508360|NCT00960687|1243642|P2|NOT COMPLETED|First Intervention||0
508361|NCT00960687|1243643|P1|NOT COMPLETED|First Intervention||0
508362|NCT00960687|1243642|P2|COMPLETED|First Intervention||27
508363|NCT00960687|1243643|P1|COMPLETED|First Intervention||27
508364|NCT00960687|1243642|P2|STARTED|First Intervention||27
508365|NCT00960687|1243643|P1|STARTED|First Intervention||27
508366|NCT00960661|1243655|P3|NOT COMPLETED|Interventional Phase||46
508367|NCT00960661|1243656|P2|NOT COMPLETED|Interventional Phase||52
508368|NCT00960661|1243657|P1|NOT COMPLETED|Interventional Phase||0
508369|NCT00960661|1243655|P3|COMPLETED|Interventional Phase||275
508370|NCT00960661|1243656|P2|COMPLETED|Interventional Phase||264
508371|NCT00960661|1243657|P1|COMPLETED|Interventional Phase||0
508372|NCT00960661|1243655|P3|Per Protocol Population|Interventional Phase|all randomized participants who completed study and had no violations|263
508373|NCT00960661|1243656|P2|Per Protocol Population|Interventional Phase|all randomized participants who completed study and had no violations|247
508374|NCT00960661|1243657|P1|Per Protocol Population|Interventional Phase||0
508375|NCT00960661|1243655|P3|Intent to Treat Population|Interventional Phase|all randomized participants who took at least one dose of study drug|312
508376|NCT00960661|1243656|P2|Intent to Treat Population|Interventional Phase|all randomized participants who took at least one dose of study drug|315
508377|NCT00960661|1243657|P1|Intent to Treat Population|Interventional Phase||0
508378|NCT00960661|1243655|P3|STARTED|Interventional Phase||321
508379|NCT00960661|1243656|P2|STARTED|Interventional Phase||316
508380|NCT00960661|1243657|P1|STARTED|Interventional Phase||0
508381|NCT00960661|1243655|P3|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0
508382|NCT00960661|1243656|P2|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0
508383|NCT00960661|1243657|P1|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||399
508384|NCT00960661|1243655|P3|COMPLETED|Basal Insulin Optimization Phase (BIO)||0
508385|NCT00960661|1243656|P2|COMPLETED|Basal Insulin Optimization Phase (BIO)||0
508386|NCT00960661|1243657|P1|COMPLETED|Basal Insulin Optimization Phase (BIO)||637
508387|NCT00960661|1243655|P3|STARTED|Basal Insulin Optimization Phase (BIO)||0
508388|NCT00960661|1243656|P2|STARTED|Basal Insulin Optimization Phase (BIO)||0
508389|NCT00960661|1243657|P1|STARTED|Basal Insulin Optimization Phase (BIO)||1036
508390|NCT00960622|1243689|P2|NOT COMPLETED|Overall Study||3
508391|NCT00960622|1243690|P1|NOT COMPLETED|Overall Study||0
508392|NCT00960622|1243689|P2|COMPLETED|Overall Study||7
508393|NCT00960622|1243690|P1|COMPLETED|Overall Study||10
508394|NCT00960622|1243689|P2|STARTED|Overall Study||10
508395|NCT00960622|1243690|P1|STARTED|Overall Study||10
508396|NCT00960570|1243696|P1|NOT COMPLETED|Efavirenz and Fenofibric Acid||0
508397|NCT00960570|1243696|P1|COMPLETED|Efavirenz and Fenofibric Acid||25
508398|NCT00960570|1243696|P1|STARTED|Efavirenz and Fenofibric Acid||25
508399|NCT00960570|1243696|P1|NOT COMPLETED|1 Day Period Between Dosing||3
508400|NCT00960570|1243696|P1|COMPLETED|1 Day Period Between Dosing||25
508401|NCT00960570|1243696|P1|STARTED|1 Day Period Between Dosing||28
508402|NCT00960570|1243696|P1|NOT COMPLETED|Fenofibric Acid Alone||0
508403|NCT00960570|1243696|P1|COMPLETED|Fenofibric Acid Alone||28
508404|NCT00960570|1243696|P1|STARTED|Fenofibric Acid Alone||28
508405|NCT00960570|1243696|P1|NOT COMPLETED|21 Day Washout Period||2
508406|NCT00960570|1243696|P1|COMPLETED|21 Day Washout Period||28
508407|NCT00960570|1243696|P1|STARTED|21 Day Washout Period||30
508408|NCT00960570|1243696|P1|NOT COMPLETED|Efavirenz Alone||0
508409|NCT00960570|1243696|P1|COMPLETED|Efavirenz Alone||30
508410|NCT00960570|1243696|P1|STARTED|Efavirenz Alone||30
508411|NCT00960531|1243717|P10|NOT COMPLETED|Overall Study||1
508412|NCT00960531|1243718|P9|NOT COMPLETED|Overall Study||14
508413|NCT00960531|1243719|P8|NOT COMPLETED|Overall Study||4
508414|NCT00960531|1243720|P7|NOT COMPLETED|Overall Study||24
508415|NCT00960531|1243721|P6|NOT COMPLETED|Overall Study||3
508416|NCT00960531|1243722|P5|NOT COMPLETED|Overall Study||2
508417|NCT00960531|1243723|P4|NOT COMPLETED|Overall Study||8
508418|NCT00960531|1243724|P3|NOT COMPLETED|Overall Study||26
508419|NCT00960531|1243725|P2|NOT COMPLETED|Overall Study||1
508420|NCT00960531|1243726|P1|NOT COMPLETED|Overall Study||10
508421|NCT00960531|1243717|P10|COMPLETED|Overall Study|Completed study|3
508422|NCT00960531|1243718|P9|COMPLETED|Overall Study|Completed study|2
508423|NCT00960531|1243719|P8|COMPLETED|Overall Study|Completed study|2
508424|NCT00960531|1243720|P7|COMPLETED|Overall Study|Completed study|3
508425|NCT00960531|1243721|P6|COMPLETED|Overall Study|Completed study|6
508426|NCT00960531|1243722|P5|COMPLETED|Overall Study|Completed study|3
508427|NCT00960531|1243723|P4|COMPLETED|Overall Study|Completed study|17
508428|NCT00960531|1243724|P3|COMPLETED|Overall Study|Completed study|15
508429|NCT00960531|1243725|P2|COMPLETED|Overall Study|Completed study|5
508430|NCT00960531|1243726|P1|COMPLETED|Overall Study|Completed study|11
508431|NCT00960531|1243717|P10|Completed Treatment|Overall Study||4
508432|NCT00960531|1243718|P9|Completed Treatment|Overall Study||2
508433|NCT00960531|1243719|P8|Completed Treatment|Overall Study||3
508434|NCT00960531|1243720|P7|Completed Treatment|Overall Study||4
508435|NCT00960531|1243721|P6|Completed Treatment|Overall Study||7
508436|NCT00960531|1243722|P5|Completed Treatment|Overall Study||3
508437|NCT00960531|1243723|P4|Completed Treatment|Overall Study||17
508438|NCT00960531|1243724|P3|Completed Treatment|Overall Study||15
508439|NCT00960531|1243725|P2|Completed Treatment|Overall Study||5
508440|NCT00960531|1243726|P1|Completed Treatment|Overall Study||12
508441|NCT00960531|1243717|P10|Treated|Overall Study||4
508442|NCT00960531|1243718|P9|Treated|Overall Study||16
508443|NCT00960531|1243719|P8|Treated|Overall Study||6
508444|NCT00960531|1243720|P7|Treated|Overall Study||27
508445|NCT00960531|1243721|P6|Treated|Overall Study||9
508446|NCT00960531|1243722|P5|Treated|Overall Study||5
508447|NCT00960531|1243723|P4|Treated|Overall Study||24
508448|NCT00960531|1243724|P3|Treated|Overall Study||41
508449|NCT00960531|1243725|P2|Treated|Overall Study||6
508450|NCT00960531|1243726|P1|Treated|Overall Study||21
508451|NCT00960531|1243717|P10|STARTED|Overall Study|Started=Randomized|4
508452|NCT00960531|1243718|P9|STARTED|Overall Study|Started=Randomized|16
508453|NCT00960531|1243719|P8|STARTED|Overall Study|Started=Randomized|6
508454|NCT00960531|1243720|P7|STARTED|Overall Study|Started=Randomized|27
508455|NCT00960531|1243721|P6|STARTED|Overall Study|Started=Randomized|9
508456|NCT00960531|1243722|P5|STARTED|Overall Study|Started=Randomized|5
508457|NCT00960531|1243723|P4|STARTED|Overall Study|Started=Randomized.|25
508458|NCT00960531|1243724|P3|STARTED|Overall Study|Started=Randomized|41
508459|NCT00960531|1243725|P2|STARTED|Overall Study|Started=Randomized|6
508460|NCT00960531|1243726|P1|STARTED|Overall Study|Started=Randomized|21
508461|NCT00960440|1243774|P4|NOT COMPLETED|Overall Study||18
508462|NCT00960440|1243775|P3|NOT COMPLETED|Overall Study||13
508463|NCT00960440|1243776|P2|NOT COMPLETED|Overall Study||31
508464|NCT00960440|1243777|P1|NOT COMPLETED|Overall Study||26
508465|NCT00960440|1243774|P4|COMPLETED|Overall Study||48
508466|NCT00960440|1243775|P3|COMPLETED|Overall Study||53
508467|NCT00960440|1243776|P2|COMPLETED|Overall Study||103
508468|NCT00960440|1243777|P1|COMPLETED|Overall Study||107
508469|NCT00960440|1243774|P4|STARTED|Overall Study||66
508470|NCT00960440|1243775|P3|STARTED|Overall Study||66
508471|NCT00960440|1243776|P2|STARTED|Overall Study||134
508472|NCT00960440|1243777|P1|STARTED|Overall Study||133
508473|NCT00960375|1243949|P2|NOT COMPLETED|Overall Study||22
508474|NCT00960375|1243950|P1|NOT COMPLETED|Overall Study||20
508475|NCT00960375|1243949|P2|COMPLETED|Overall Study||65
508476|NCT00960375|1243950|P1|COMPLETED|Overall Study||72
508477|NCT00960375|1243949|P2|STARTED|Overall Study||87
508478|NCT00960375|1243950|P1|STARTED|Overall Study||92
508479|NCT00960323|1243958|P1|NOT COMPLETED|Colchicine and Atorvastatin||0
508480|NCT00960323|1243958|P1|COMPLETED|Colchicine and Atorvastatin||23
508481|NCT00960323|1243958|P1|STARTED|Colchicine and Atorvastatin||23
508482|NCT00960323|1243958|P1|NOT COMPLETED|Atorvastatin Alone||1
508483|NCT00960323|1243958|P1|COMPLETED|Atorvastatin Alone||23
508484|NCT00960323|1243958|P1|STARTED|Atorvastatin Alone||24
508485|NCT00960323|1243958|P1|NOT COMPLETED|14 Day Washout Period||0
508486|NCT00960323|1243958|P1|COMPLETED|14 Day Washout Period||24
508487|NCT00960323|1243958|P1|STARTED|14 Day Washout Period||24
508488|NCT00960323|1243958|P1|NOT COMPLETED|Colchicine Alone||0
508489|NCT00960323|1243958|P1|COMPLETED|Colchicine Alone||24
508490|NCT00960323|1243958|P1|STARTED|Colchicine Alone||24
508491|NCT00960297|1243969|P1|NOT COMPLETED|Overall Study||3
508492|NCT00960297|1243969|P1|COMPLETED|Overall Study||1
508493|NCT00960297|1243969|P1|STARTED|Overall Study||4
508494|NCT00960206|1243976|P3|NOT COMPLETED|Overall Study||12
508495|NCT00960206|1243977|P2|NOT COMPLETED|Overall Study||27
508496|NCT00960206|1243978|P1|NOT COMPLETED|Overall Study||40
508497|NCT00960206|1243976|P3|COMPLETED|Overall Study||77
508498|NCT00960206|1243977|P2|COMPLETED|Overall Study||158
508499|NCT00960206|1243978|P1|COMPLETED|Overall Study||150
508500|NCT00960206|1243976|P3|STARTED|Overall Study||89
508501|NCT00960206|1243977|P2|STARTED|Overall Study||185
508502|NCT00960206|1243978|P1|STARTED|Overall Study||190
508503|NCT00960193|1243996|P1|NOT COMPLETED|Colchicine With Seville Orange Juice||0
508504|NCT00960193|1243996|P1|COMPLETED|Colchicine With Seville Orange Juice||23
508505|NCT00960193|1243996|P1|STARTED|Colchicine With Seville Orange Juice||23
508506|NCT00960193|1243996|P1|NOT COMPLETED|Seville Orange Juice Alone||0
508507|NCT00960193|1243996|P1|COMPLETED|Seville Orange Juice Alone||23
508508|NCT00960193|1243996|P1|STARTED|Seville Orange Juice Alone||23
508509|NCT00960193|1243996|P1|NOT COMPLETED|14 Day Washout Period||1
508510|NCT00960193|1243996|P1|COMPLETED|14 Day Washout Period||23
508511|NCT00960193|1243996|P1|STARTED|14 Day Washout Period||24
508512|NCT00960193|1243996|P1|NOT COMPLETED|Colchicine Alone||0
508513|NCT00960193|1243996|P1|COMPLETED|Colchicine Alone||24
508514|NCT00960193|1243996|P1|STARTED|Colchicine Alone||24
508515|NCT00960154|1244009|P2|NOT COMPLETED|Overall Study||25
508516|NCT00960154|1244010|P1|NOT COMPLETED|Overall Study||25
508517|NCT00960154|1244009|P2|COMPLETED|Overall Study||0
508518|NCT00960154|1244010|P1|COMPLETED|Overall Study||0
508519|NCT00960154|1244009|P2|STARTED|Overall Study||25
508520|NCT00960154|1244010|P1|STARTED|Overall Study||25
508521|NCT00960141|1244021|P3|NOT COMPLETED|Overall Study||7
508522|NCT00960141|1244022|P2|NOT COMPLETED|Overall Study||17
508523|NCT00960141|1244023|P1|NOT COMPLETED|Overall Study||10
508524|NCT00960141|1244021|P3|COMPLETED|Overall Study||163
508525|NCT00960141|1244022|P2|COMPLETED|Overall Study||309
508526|NCT00960141|1244023|P1|COMPLETED|Overall Study||323
508527|NCT00960141|1244021|P3|STARTED|Overall Study||170
508528|NCT00960141|1244022|P2|STARTED|Overall Study||326
508529|NCT00960141|1244023|P1|STARTED|Overall Study||333
508530|NCT00960115|1244048|P2|NOT COMPLETED|Overall Study||15
508531|NCT00960115|1244049|P1|NOT COMPLETED|Overall Study||19
508532|NCT00960115|1244048|P2|COMPLETED|Overall Study||43
508533|NCT00960115|1244049|P1|COMPLETED|Overall Study||95
508534|NCT00960115|1244048|P2|STARTED|Overall Study||58
508535|NCT00960115|1244049|P1|STARTED|Overall Study||114
508536|NCT00960076|1244063|P2|NOT COMPLETED|Overall Study||25
508537|NCT00960076|1244064|P1|NOT COMPLETED|Overall Study||8
508538|NCT00960076|1244063|P2|COMPLETED|Overall Study|Completing 18 weeks of treatment|119
508539|NCT00960076|1244064|P1|COMPLETED|Overall Study|Completing 18 weeks of treatment|130
508540|NCT00960076|1244063|P2|STARTED|Overall Study|Randomized and treated|144
508541|NCT00960076|1244064|P1|STARTED|Overall Study|Randomized and treated|138
508542|NCT00960063|1244079|P3|NOT COMPLETED|Overall Study||3
508543|NCT00960063|1244080|P2|NOT COMPLETED|Overall Study||0
508544|NCT00960063|1244081|P1|NOT COMPLETED|Overall Study||1
508545|NCT00960063|1244079|P3|COMPLETED|Overall Study||0
508546|NCT00960063|1244080|P2|COMPLETED|Overall Study||0
508547|NCT00960063|1244081|P1|COMPLETED|Overall Study||0
508548|NCT00960063|1244079|P3|STARTED|Overall Study||3
508549|NCT00960063|1244080|P2|STARTED|Overall Study||0
508550|NCT00960063|1244081|P1|STARTED|Overall Study||1
508551|NCT00959985|1244123|P4|NOT COMPLETED|Overall Study||0
508552|NCT00959985|1244124|P3|NOT COMPLETED|Overall Study||0
508553|NCT00959985|1244125|P2|NOT COMPLETED|Overall Study||0
508554|NCT00959985|1244126|P1|NOT COMPLETED|Overall Study||0
508555|NCT00959985|1244123|P4|COMPLETED|Overall Study||4
508556|NCT00959985|1244124|P3|COMPLETED|Overall Study||4
508557|NCT00959985|1244125|P2|COMPLETED|Overall Study||7
508558|NCT00959985|1244126|P1|COMPLETED|Overall Study||8
508559|NCT00959985|1244123|P4|STARTED|Overall Study||4
508560|NCT00959985|1244124|P3|STARTED|Overall Study||4
508561|NCT00959985|1244125|P2|STARTED|Overall Study||7
508562|NCT00959985|1244126|P1|STARTED|Overall Study||8
508563|NCT00959946|1244172|P8|NOT COMPLETED|Overall Study||2
508564|NCT00959946|1244173|P7|NOT COMPLETED|Overall Study||2
508565|NCT00959946|1244174|P6|NOT COMPLETED|Overall Study||9
508566|NCT00959946|1244175|P5|NOT COMPLETED|Overall Study||4
508567|NCT00959946|1244176|P4|NOT COMPLETED|Overall Study||5
508568|NCT00959946|1244177|P3|NOT COMPLETED|Overall Study||4
508569|NCT00959946|1244178|P2|NOT COMPLETED|Overall Study||4
508570|NCT00959946|1244179|P1|NOT COMPLETED|Overall Study||2
508571|NCT00959946|1244172|P8|COMPLETED|Overall Study||0
508572|NCT00959946|1244173|P7|COMPLETED|Overall Study||0
508573|NCT00959946|1244174|P6|COMPLETED|Overall Study||0
508574|NCT00959946|1244175|P5|COMPLETED|Overall Study||0
508575|NCT00959946|1244176|P4|COMPLETED|Overall Study||0
508576|NCT00959946|1244177|P3|COMPLETED|Overall Study||0
508577|NCT00959946|1244178|P2|COMPLETED|Overall Study||0
508578|NCT00959946|1244179|P1|COMPLETED|Overall Study||0
508579|NCT00959946|1244172|P8|STARTED|Overall Study||2
508580|NCT00959946|1244173|P7|STARTED|Overall Study||2
508581|NCT00959946|1244174|P6|STARTED|Overall Study||9
508582|NCT00959946|1244175|P5|STARTED|Overall Study||4
508583|NCT00959946|1244176|P4|STARTED|Overall Study||5
508584|NCT00959946|1244177|P3|STARTED|Overall Study||4
508585|NCT00959946|1244178|P2|STARTED|Overall Study||4
508586|NCT00959946|1244179|P1|STARTED|Overall Study||2
508587|NCT00959920|1244232|P2|NOT COMPLETED|Overall Study||1
508588|NCT00959920|1244233|P1|NOT COMPLETED|Overall Study||0
508589|NCT00959920|1244232|P2|COMPLETED|Overall Study||66
508590|NCT00959920|1244233|P1|COMPLETED|Overall Study||72
508591|NCT00959920|1244232|P2|STARTED|Overall Study||67
508592|NCT00959920|1244233|P1|STARTED|Overall Study||72
508593|NCT00959907|1244243|P2|NOT COMPLETED|Overall Study||1
508594|NCT00959907|1244244|P1|NOT COMPLETED|Overall Study||3
508595|NCT00959907|1244243|P2|COMPLETED|Overall Study||28
508596|NCT00959907|1244244|P1|COMPLETED|Overall Study||27
508597|NCT00959907|1244243|P2|STARTED|Overall Study||29
508598|NCT00959907|1244244|P1|STARTED|Overall Study||30
508599|NCT00959894|1244254|P1|NOT COMPLETED|Overall Study||16
508600|NCT00959894|1244254|P1|COMPLETED|Overall Study||63
508601|NCT00959894|1244254|P1|STARTED|Overall Study|One (1) additional subject became ineligible on the day of entry and never started study medication.|79
508602|NCT00959764|1244285|P3|NOT COMPLETED|Overall Study||36
508603|NCT00959764|1244286|P2|NOT COMPLETED|Overall Study||57
508604|NCT00959764|1244287|P1|NOT COMPLETED|Overall Study||95
508605|NCT00959764|1244285|P3|COMPLETED|Overall Study||73
508606|NCT00959764|1244286|P2|COMPLETED|Overall Study||128
508607|NCT00959764|1244287|P1|COMPLETED|Overall Study||176
508608|NCT00959764|1244285|P3|STARTED|Overall Study||109
508609|NCT00959764|1244286|P2|STARTED|Overall Study||185
508610|NCT00959764|1244287|P1|STARTED|Overall Study||271
508611|NCT00959751|1244303|P2|NOT COMPLETED|Overall Study||12
508612|NCT00959751|1244304|P1|NOT COMPLETED|Overall Study||9
508613|NCT00959751|1244303|P2|COMPLETED|Overall Study||86
508614|NCT00959751|1244304|P1|COMPLETED|Overall Study||88
508615|NCT00959751|1244303|P2|STARTED|Overall Study||98
508616|NCT00959751|1244304|P1|STARTED|Overall Study||97
508617|NCT00959699|1244326|P2|NOT COMPLETED|Follow-up Period||6
508618|NCT00959699|1244327|P1|NOT COMPLETED|Follow-up Period||6
508619|NCT00959699|1244326|P2|COMPLETED|Follow-up Period||56
508620|NCT00959699|1244327|P1|COMPLETED|Follow-up Period||27
508621|NCT00959699|1244326|P2|STARTED|Follow-up Period|2 participants didn't enter Follow-up; participants discontinuing treatment could enter Follow-up.|62
508622|NCT00959699|1244327|P1|STARTED|Follow-up Period|1 participant didn't enter Follow-up; participants discontinuing treatment could enter Follow-up.|33
508623|NCT00959699|1244326|P2|NOT COMPLETED|Treatment Period||25
508624|NCT00959699|1244327|P1|NOT COMPLETED|Treatment Period||23
508625|NCT00959699|1244326|P2|COMPLETED|Treatment Period||40
508626|NCT00959699|1244327|P1|COMPLETED|Treatment Period|At TW24, 4 participants not achieving undetectable HCV-RNA crossed-over and received boceprevir.|11
508627|NCT00959699|1244326|P2|Treated|Treatment Period||64
508628|NCT00959699|1244327|P1|Treated|Treatment Period||34
508629|NCT00959699|1244326|P2|STARTED|Treatment Period||65
508630|NCT00959699|1244327|P1|STARTED|Treatment Period||34
508631|NCT00959660|1244348|P4|NOT COMPLETED|Overall Study||3
508632|NCT00959660|1244349|P3|NOT COMPLETED|Overall Study||3
508633|NCT00959660|1244350|P2|NOT COMPLETED|Overall Study||0
508634|NCT00959660|1244351|P1|NOT COMPLETED|Overall Study||2
508635|NCT00959660|1244348|P4|COMPLETED|Overall Study||22
508636|NCT00959660|1244349|P3|COMPLETED|Overall Study||22
508637|NCT00959660|1244350|P2|COMPLETED|Overall Study||24
508638|NCT00959660|1244351|P1|COMPLETED|Overall Study||24
508639|NCT00959660|1244348|P4|STARTED|Overall Study||25
508640|NCT00959660|1244349|P3|STARTED|Overall Study||25
508641|NCT00959660|1244350|P2|STARTED|Overall Study||24
508642|NCT00959660|1244351|P1|STARTED|Overall Study||26
508643|NCT00959647|1244373|P1|NOT COMPLETED|Overall Study||19
508644|NCT00959647|1244373|P1|COMPLETED|Overall Study||0
508645|NCT00959647|1244373|P1|STARTED|Overall Study||19
508646|NCT00959374|1244378|P1|NOT COMPLETED|Overall Study||23
508647|NCT00959374|1244378|P1|COMPLETED|Overall Study||218
508648|NCT00959374|1244378|P1|STARTED|Overall Study|Of the 241 enrolled subjects, 229 were randomized and treated|241
508649|NCT00959192|1244392|P4|NOT COMPLETED|Overall Study||1
508650|NCT00959192|1244393|P3|NOT COMPLETED|Overall Study||3
508651|NCT00959192|1244394|P2|NOT COMPLETED|Overall Study||1
508652|NCT00959192|1244395|P1|NOT COMPLETED|Overall Study||2
508653|NCT00959192|1244392|P4|COMPLETED|Overall Study||7
508654|NCT00959192|1244393|P3|COMPLETED|Overall Study||6
508655|NCT00959192|1244394|P2|COMPLETED|Overall Study||8
508656|NCT00959192|1244395|P1|COMPLETED|Overall Study||4
508657|NCT00959192|1244392|P4|STARTED|Overall Study||8
508658|NCT00959192|1244393|P3|STARTED|Overall Study||9
508659|NCT00959192|1244394|P2|STARTED|Overall Study||9
508660|NCT00959192|1244395|P1|STARTED|Overall Study||6
508661|NCT00959049|1244443|P6|NOT COMPLETED|Overall Study||1
508662|NCT00959049|1244444|P5|NOT COMPLETED|Overall Study||9
508663|NCT00959049|1244445|P4|NOT COMPLETED|Overall Study||11
508664|NCT00959049|1244446|P3|NOT COMPLETED|Overall Study||1
508665|NCT00959049|1244447|P2|NOT COMPLETED|Overall Study||7
508666|NCT00959049|1244448|P1|NOT COMPLETED|Overall Study||18
508667|NCT00959049|1244443|P6|COMPLETED|Overall Study||249
508668|NCT00959049|1244444|P5|COMPLETED|Overall Study||248
508669|NCT00959049|1244445|P4|COMPLETED|Overall Study||217
508670|NCT00959049|1244446|P3|COMPLETED|Overall Study||253
508671|NCT00959049|1244447|P2|COMPLETED|Overall Study||247
508672|NCT00959049|1244448|P1|COMPLETED|Overall Study||213
508673|NCT00959049|1244443|P6|STARTED|Overall Study||250
508674|NCT00959049|1244444|P5|STARTED|Overall Study||257
508675|NCT00959049|1244445|P4|STARTED|Overall Study||228
508676|NCT00959049|1244446|P3|STARTED|Overall Study||254
508677|NCT00959049|1244447|P2|STARTED|Overall Study||254
508678|NCT00959049|1244448|P1|STARTED|Overall Study||231
508679|NCT00958919|1244498|P2|NOT COMPLETED|Second Intervention||0
508680|NCT00958919|1244499|P1|NOT COMPLETED|Second Intervention||0
508681|NCT00958919|1244498|P2|COMPLETED|Second Intervention||7
508682|NCT00958919|1244499|P1|COMPLETED|Second Intervention||7
508683|NCT00958919|1244498|P2|STARTED|Second Intervention||7
508684|NCT00958919|1244499|P1|STARTED|Second Intervention||7
508685|NCT00958919|1244498|P2|NOT COMPLETED|First Intervention||0
508686|NCT00958919|1244499|P1|NOT COMPLETED|First Intervention||0
508687|NCT00958919|1244498|P2|COMPLETED|First Intervention||7
508688|NCT00958919|1244499|P1|COMPLETED|First Intervention||7
508689|NCT00958919|1244498|P2|STARTED|First Intervention||7
508690|NCT00958919|1244499|P1|STARTED|First Intervention||7
508691|NCT00958893|1244513|P1|NOT COMPLETED|Overall Study||4
508692|NCT00958893|1244513|P1|COMPLETED|Overall Study||0
508693|NCT00958893|1244513|P1|STARTED|Overall Study||4
508694|NCT00958880|1244519|P2|NOT COMPLETED|Overall Study||2
508695|NCT00958880|1244520|P1|NOT COMPLETED|Overall Study||2
508696|NCT00958880|1244519|P2|COMPLETED|Overall Study||18
508697|NCT00958880|1244520|P1|COMPLETED|Overall Study||18
508698|NCT00958880|1244519|P2|STARTED|Overall Study||20
508699|NCT00958880|1244520|P1|STARTED|Overall Study||20
508700|NCT00958841|1244528|P1|NOT COMPLETED|Overall Study||96
508701|NCT00958841|1244528|P1|COMPLETED|Overall Study|Completed = Completed extension|22
508702|NCT00958841|1244528|P1|Entered in Extension|Overall Study||63
508703|NCT00958841|1244528|P1|Completed Month 6 (M6)|Overall Study||90
508704|NCT00958841|1244528|P1|STARTED|Overall Study||118
508705|NCT00958828|1244546|P2|NOT COMPLETED|Period 2, 1 Week of Wear||1
508706|NCT00958828|1244547|P1|NOT COMPLETED|Period 2, 1 Week of Wear||0
508707|NCT00958828|1244546|P2|COMPLETED|Period 2, 1 Week of Wear||87
508708|NCT00958828|1244547|P1|COMPLETED|Period 2, 1 Week of Wear||89
508709|NCT00958828|1244546|P2|STARTED|Period 2, 1 Week of Wear||88
508710|NCT00958828|1244547|P1|STARTED|Period 2, 1 Week of Wear||89
508711|NCT00958828|1244546|P2|NOT COMPLETED|Period 1, 1 Week of Wear||1
508712|NCT00958828|1244547|P1|NOT COMPLETED|Period 1, 1 Week of Wear||0
508713|NCT00958828|1244546|P2|COMPLETED|Period 1, 1 Week of Wear||88
508714|NCT00958828|1244547|P1|COMPLETED|Period 1, 1 Week of Wear||89
508715|NCT00958828|1244546|P2|STARTED|Period 1, 1 Week of Wear||89
508716|NCT00958828|1244547|P1|STARTED|Period 1, 1 Week of Wear||89
508717|NCT00958789|1244553|P1|NOT COMPLETED|Overall Study||50
508718|NCT00958789|1244553|P1|COMPLETED|Overall Study|Participant status at the 2 year primary outcome interval determined Completed/Not Completed counts.|131
508719|NCT00958789|1244553|P1|STARTED|Overall Study||181
508720|NCT00958776|1244560|P2|NOT COMPLETED|Overall Study||29
508721|NCT00958776|1244561|P1|NOT COMPLETED|Overall Study||16
508722|NCT00958776|1244560|P2|COMPLETED|Overall Study||239
508723|NCT00958776|1244561|P1|COMPLETED|Overall Study||121
508724|NCT00958776|1244560|P2|STARTED|Overall Study||268
508725|NCT00958776|1244561|P1|STARTED|Overall Study||137
508726|NCT00958724|1244591|P1|NOT COMPLETED|Overall Study||6
508727|NCT00958724|1244591|P1|COMPLETED|Overall Study||0
508728|NCT00958724|1244591|P1|STARTED|Overall Study||6
508729|NCT00958581|1244604|P3|NOT COMPLETED|Overall Study||0
508730|NCT00958581|1244605|P2|NOT COMPLETED|Overall Study||0
508731|NCT00958581|1244606|P1|NOT COMPLETED|Overall Study||0
508732|NCT00958581|1244604|P3|COMPLETED|Overall Study||55
508733|NCT00958581|1244605|P2|COMPLETED|Overall Study||61
508734|NCT00958581|1244606|P1|COMPLETED|Overall Study||61
508735|NCT00958581|1244604|P3|STARTED|Overall Study||55
508736|NCT00958581|1244605|P2|STARTED|Overall Study||61
508737|NCT00958581|1244606|P1|STARTED|Overall Study||61
508738|NCT00958568|1244620|P4|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||106
508739|NCT00958568|1244621|P3|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||82
508740|NCT00958568|1244622|P2|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
508741|NCT00958568|1244623|P1|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
508742|NCT00958568|1244620|P4|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||117
508743|NCT00958568|1244621|P3|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||139
508744|NCT00958568|1244622|P2|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
508745|NCT00958568|1244623|P1|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
508746|NCT00958568|1244620|P4|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||223
508747|NCT00958568|1244621|P3|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||221
508748|NCT00958568|1244622|P2|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0
508749|NCT00958568|1244623|P1|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0
508750|NCT00958568|1244620|P4|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
508751|NCT00958568|1244621|P3|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
508752|NCT00958568|1244622|P2|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||211
508753|NCT00958568|1244623|P1|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
508754|NCT00958568|1244620|P4|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
508755|NCT00958568|1244621|P3|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
508756|NCT00958568|1244622|P2|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||444
508757|NCT00958568|1244623|P1|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
508758|NCT00958568|1244620|P4|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
508759|NCT00958568|1244621|P3|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
508760|NCT00958568|1244622|P2|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||655
508761|NCT00958568|1244623|P1|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
508762|NCT00958568|1244620|P4|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
508763|NCT00958568|1244621|P3|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
508764|NCT00958568|1244622|P2|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
508765|NCT00958568|1244623|P1|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||237
508766|NCT00958568|1244620|P4|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
508767|NCT00958568|1244621|P3|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
508768|NCT00958568|1244622|P2|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
508769|NCT00958568|1244623|P1|COMPLETED|SPII (Wk 0-8, Acute Open-label)||655
508770|NCT00958568|1244620|P4|STARTED|SPII (Wk 0-8, Acute Open-label)||0
508771|NCT00958568|1244621|P3|STARTED|SPII (Wk 0-8, Acute Open-label)||0
508772|NCT00958568|1244622|P2|STARTED|SPII (Wk 0-8, Acute Open-label)||0
508773|NCT00958568|1244623|P1|STARTED|SPII (Wk 0-8, Acute Open-label)||892
508774|NCT00958477|1244708|P4|NOT COMPLETED|Overall Study||0
508775|NCT00958477|1244709|P3|NOT COMPLETED|Overall Study||0
508776|NCT00958477|1244710|P2|NOT COMPLETED|Overall Study||0
508777|NCT00958477|1244711|P1|NOT COMPLETED|Overall Study||0
508778|NCT00958477|1244708|P4|COMPLETED|Overall Study||6
508779|NCT00958477|1244709|P3|COMPLETED|Overall Study||6
508780|NCT00958477|1244710|P2|COMPLETED|Overall Study||6
508781|NCT00958477|1244711|P1|COMPLETED|Overall Study||8
508782|NCT00958477|1244708|P4|STARTED|Overall Study||6
508783|NCT00958477|1244709|P3|STARTED|Overall Study||6
508784|NCT00958477|1244710|P2|STARTED|Overall Study||6
508785|NCT00958477|1244711|P1|STARTED|Overall Study||8
508786|NCT00958438|1244860|P3|NOT COMPLETED|Overall Study||6
508787|NCT00958438|1244861|P2|NOT COMPLETED|Overall Study||10
508788|NCT00958438|1244862|P1|NOT COMPLETED|Overall Study||10
508789|NCT00958438|1244860|P3|COMPLETED|Overall Study||78
508790|NCT00958438|1244861|P2|COMPLETED|Overall Study||72
508791|NCT00958438|1244862|P1|COMPLETED|Overall Study||72
508792|NCT00958438|1244860|P3|STARTED|Overall Study||84
508793|NCT00958438|1244861|P2|STARTED|Overall Study||82
508794|NCT00958438|1244862|P1|STARTED|Overall Study||82
508795|NCT00958360|1244887|P2|NOT COMPLETED|Overall Study||10
508796|NCT00958360|1244888|P1|NOT COMPLETED|Overall Study||11
508797|NCT00958360|1244887|P2|COMPLETED|Overall Study||150
508798|NCT00958360|1244888|P1|COMPLETED|Overall Study||152
508799|NCT00958360|1244887|P2|STARTED|Overall Study||160
508800|NCT00958360|1244888|P1|STARTED|Overall Study||163
508801|NCT00958347|1244902|P1|NOT COMPLETED|Overall Study||226
508802|NCT00958347|1244902|P1|COMPLETED|Overall Study|11 revisions total, one was a bilateral participant with the other hip counted as not completed.|0
508803|NCT00958347|1244902|P1|STARTED|Overall Study||226
508804|NCT00958334|1244909|P3|NOT COMPLETED|Overall Study||13
508805|NCT00958334|1244910|P2|NOT COMPLETED|Overall Study||17
508806|NCT00958334|1244911|P1|NOT COMPLETED|Overall Study||14
508807|NCT00958334|1244909|P3|COMPLETED|Overall Study||8
508808|NCT00958334|1244910|P2|COMPLETED|Overall Study||5
508809|NCT00958334|1244911|P1|COMPLETED|Overall Study||8
508810|NCT00958334|1244909|P3|STARTED|Overall Study||21
508811|NCT00958334|1244910|P2|STARTED|Overall Study||22
508812|NCT00958334|1244911|P1|STARTED|Overall Study||22
508813|NCT00958308|1244922|P3|NOT COMPLETED|Overall Study||0
508814|NCT00958308|1244923|P2|NOT COMPLETED|Overall Study||0
508815|NCT00958308|1244924|P1|NOT COMPLETED|Overall Study||0
508816|NCT00958308|1244922|P3|COMPLETED|Overall Study||86
508817|NCT00958308|1244923|P2|COMPLETED|Overall Study||85
508818|NCT00958308|1244924|P1|COMPLETED|Overall Study||84
508819|NCT00958308|1244922|P3|STARTED|Overall Study||86
508820|NCT00958308|1244923|P2|STARTED|Overall Study||85
508821|NCT00958308|1244924|P1|STARTED|Overall Study||84
508822|NCT00958282|1244934|P2|NOT COMPLETED|Overall Study||6
508823|NCT00958282|1244935|P1|NOT COMPLETED|Overall Study||10
508824|NCT00958282|1244934|P2|COMPLETED|Overall Study||15
508825|NCT00958282|1244935|P1|COMPLETED|Overall Study||12
508826|NCT00958282|1244934|P2|STARTED|Overall Study||21
508827|NCT00958282|1244935|P1|STARTED|Overall Study||22
508828|NCT00958256|1244943|P1|NOT COMPLETED|Overall Study||3
508829|NCT00958256|1244943|P1|COMPLETED|Overall Study||18
508830|NCT00958256|1244943|P1|STARTED|Overall Study||21
508831|NCT00958243|1244953|P6|NOT COMPLETED|Overall Study||10
508832|NCT00958243|1244954|P5|NOT COMPLETED|Overall Study||9
508833|NCT00958243|1244955|P4|NOT COMPLETED|Overall Study||3
508834|NCT00958243|1244956|P3|NOT COMPLETED|Overall Study||14
508835|NCT00958243|1244957|P2|NOT COMPLETED|Overall Study||6
508836|NCT00958243|1244958|P1|NOT COMPLETED|Overall Study||2
508837|NCT00958243|1244953|P6|COMPLETED|Overall Study||99
508838|NCT00958243|1244954|P5|COMPLETED|Overall Study||100
508839|NCT00958243|1244955|P4|COMPLETED|Overall Study||25
508840|NCT00958243|1244956|P3|COMPLETED|Overall Study||82
508841|NCT00958243|1244957|P2|COMPLETED|Overall Study||99
508842|NCT00958243|1244958|P1|COMPLETED|Overall Study||24
508843|NCT00958243|1244953|P6|STARTED|Overall Study||109
508844|NCT00958243|1244954|P5|STARTED|Overall Study||109
508845|NCT00958243|1244955|P4|STARTED|Overall Study||28
508846|NCT00958243|1244956|P3|STARTED|Overall Study||96
508847|NCT00958243|1244957|P2|STARTED|Overall Study||105
508848|NCT00958243|1244958|P1|STARTED|Overall Study||26
508849|NCT00958217|1245016|P2|NOT COMPLETED|Overall Study||25
508850|NCT00958217|1245017|P1|NOT COMPLETED|Overall Study||24
508851|NCT00958217|1245016|P2|COMPLETED|Overall Study|Participants were assessed quarterly for one year following end of treatment|37
508852|NCT00958217|1245017|P1|COMPLETED|Overall Study|Participants were assessed quarterly for one year following end of treatment|37
508853|NCT00958217|1245016|P2|End of Treatment|Overall Study|Participants had a maximum of 16 weeks to complete 12 individual psychotherapy sessions|57
508854|NCT00958217|1245017|P1|End of Treatment|Overall Study|Participants had a maximum of 16 weeks to complete 12 individual psychotherapy sessions|56
508855|NCT00958217|1245016|P2|STARTED|Overall Study||62
508856|NCT00958217|1245017|P1|STARTED|Overall Study||61
508857|NCT00958191|1245028|P1|NOT COMPLETED|Overall Study||111
508858|NCT00958191|1245028|P1|COMPLETED|Overall Study||110
508859|NCT00958191|1245028|P1|STARTED|Overall Study||221
508860|NCT00958165|1245043|P1|NOT COMPLETED|Overall Study||14
508861|NCT00958165|1245043|P1|COMPLETED|Overall Study|Of the 72 treated participants, 67 completed follow-up and were evaluable for effectiveness.|67
508862|NCT00958165|1245043|P1|Treated|Overall Study||72
508863|NCT00958165|1245043|P1|STARTED|Overall Study|81 enrolled participants resulted in 72 eligible participants that were treated.|81
508864|NCT00958126|1245055|P8|NOT COMPLETED|Overall Study||0
508865|NCT00958126|1245056|P7|NOT COMPLETED|Overall Study||1
508866|NCT00958126|1245057|P6|NOT COMPLETED|Overall Study||1
508867|NCT00958126|1245058|P5|NOT COMPLETED|Overall Study||0
508868|NCT00958126|1245059|P4|NOT COMPLETED|Overall Study||11
508869|NCT00958126|1245060|P3|NOT COMPLETED|Overall Study||10
508870|NCT00958126|1245061|P2|NOT COMPLETED|Overall Study||9
508871|NCT00958126|1245062|P1|NOT COMPLETED|Overall Study||1
508872|NCT00958126|1245055|P8|COMPLETED|Overall Study||202
508873|NCT00958126|1245056|P7|COMPLETED|Overall Study||199
508874|NCT00958126|1245057|P6|COMPLETED|Overall Study||202
508875|NCT00958126|1245058|P5|COMPLETED|Overall Study||50
508876|NCT00958126|1245059|P4|COMPLETED|Overall Study||192
508877|NCT00958126|1245060|P3|COMPLETED|Overall Study||191
508878|NCT00958126|1245061|P2|COMPLETED|Overall Study||196
508879|NCT00958126|1245062|P1|COMPLETED|Overall Study||48
508880|NCT00958126|1245055|P8|STARTED|Overall Study||202
508881|NCT00958126|1245056|P7|STARTED|Overall Study||200
508882|NCT00958126|1245057|P6|STARTED|Overall Study||203
508883|NCT00958126|1245058|P5|STARTED|Overall Study||50
508884|NCT00958126|1245059|P4|STARTED|Overall Study||203
508885|NCT00958126|1245060|P3|STARTED|Overall Study||201
508886|NCT00958126|1245061|P2|STARTED|Overall Study||205
508887|NCT00958126|1245062|P1|STARTED|Overall Study||49
508888|NCT00958074|1245134|P2|NOT COMPLETED|Overall Study||1
508889|NCT00958074|1245135|P1|NOT COMPLETED|Overall Study||0
508890|NCT00958074|1245134|P2|COMPLETED|Overall Study||6
508891|NCT00958074|1245135|P1|COMPLETED|Overall Study||4
508892|NCT00958074|1245134|P2|STARTED|Overall Study||7
508893|NCT00958074|1245135|P1|STARTED|Overall Study||4
508894|NCT00958035|1245143|P2|NOT COMPLETED|Overall Study||4
508895|NCT00958035|1245144|P1|NOT COMPLETED|Overall Study||3
508896|NCT00958035|1245143|P2|COMPLETED|Overall Study||39
508897|NCT00958035|1245144|P1|COMPLETED|Overall Study||43
508898|NCT00958035|1245143|P2|STARTED|Overall Study||43
508899|NCT00958035|1245144|P1|STARTED|Overall Study||46
508900|NCT00958009|1245150|P1|NOT COMPLETED|Overall Study||2
508901|NCT00958009|1245150|P1|COMPLETED|Overall Study||107
508902|NCT00958009|1245150|P1|STARTED|Overall Study||109
508903|NCT00957996|1245157|P2|NOT COMPLETED|Overall Study||28
508904|NCT00957996|1245158|P1|NOT COMPLETED|Overall Study||26
508905|NCT00957996|1245157|P2|COMPLETED|Overall Study||89
508906|NCT00957996|1245158|P1|COMPLETED|Overall Study||91
508907|NCT00957996|1245157|P2|STARTED|Overall Study||117
508908|NCT00957996|1245158|P1|STARTED|Overall Study||117
508909|NCT00957944|1245190|P2|NOT COMPLETED|Second Intervention- 24 Hours||0
508910|NCT00957944|1245191|P1|NOT COMPLETED|Second Intervention- 24 Hours||0
508911|NCT00957944|1245190|P2|COMPLETED|Second Intervention- 24 Hours||19
508912|NCT00957944|1245191|P1|COMPLETED|Second Intervention- 24 Hours||20
508913|NCT00957944|1245190|P2|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours|One subject that fullfilled predefined criteria for patch adhesiveness was excluded from the PKS|18
508914|NCT00957944|1245191|P1|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours||20
508915|NCT00957944|1245190|P2|STARTED|Second Intervention- 24 Hours||19
508916|NCT00957944|1245191|P1|STARTED|Second Intervention- 24 Hours||20
508917|NCT00957944|1245190|P2|NOT COMPLETED|Washout Period of at Least 5 Days||0
508918|NCT00957944|1245191|P1|NOT COMPLETED|Washout Period of at Least 5 Days||0
508919|NCT00957944|1245190|P2|COMPLETED|Washout Period of at Least 5 Days||19
508920|NCT00957944|1245191|P1|COMPLETED|Washout Period of at Least 5 Days||20
508921|NCT00957944|1245190|P2|STARTED|Washout Period of at Least 5 Days||19
508922|NCT00957944|1245191|P1|STARTED|Washout Period of at Least 5 Days||20
508923|NCT00957944|1245190|P2|NOT COMPLETED|First Intervention- 24 Hours||1
508924|NCT00957944|1245191|P1|NOT COMPLETED|First Intervention- 24 Hours||0
508925|NCT00957944|1245190|P2|COMPLETED|First Intervention- 24 Hours||19
508926|NCT00957944|1245191|P1|COMPLETED|First Intervention- 24 Hours||20
508927|NCT00957944|1245190|P2|STARTED|First Intervention- 24 Hours||20
508928|NCT00957944|1245191|P1|STARTED|First Intervention- 24 Hours||20
508929|NCT00957905|1245227|P2|NOT COMPLETED|Part B||4
508930|NCT00957905|1245228|P1|NOT COMPLETED|Part B||0
508931|NCT00957905|1245227|P2|COMPLETED|Part B||25
508932|NCT00957905|1245228|P1|COMPLETED|Part B||0
508933|NCT00957905|1245227|P2|STARTED|Part B||29
508934|NCT00957905|1245228|P1|STARTED|Part B||0
508935|NCT00957905|1245227|P2|NOT COMPLETED|Part A||0
508936|NCT00957905|1245228|P1|NOT COMPLETED|Part A||0
508937|NCT00957905|1245227|P2|COMPLETED|Part A||0
508938|NCT00957905|1245228|P1|COMPLETED|Part A||7
508939|NCT00957905|1245227|P2|STARTED|Part A||0
508940|NCT00957905|1245228|P1|STARTED|Part A||7
508941|NCT00957801|1245238|P4|NOT COMPLETED|Overall Study||1
508942|NCT00957801|1245239|P3|NOT COMPLETED|Overall Study||0
508943|NCT00957801|1245240|P2|NOT COMPLETED|Overall Study||0
508944|NCT00957801|1245241|P1|NOT COMPLETED|Overall Study||0
508945|NCT00957801|1245238|P4|COMPLETED|Overall Study||7
508946|NCT00957801|1245239|P3|COMPLETED|Overall Study||7
508947|NCT00957801|1245240|P2|COMPLETED|Overall Study||7
508948|NCT00957801|1245241|P1|COMPLETED|Overall Study||7
508949|NCT00957801|1245238|P4|STARTED|Overall Study||8
508950|NCT00957801|1245239|P3|STARTED|Overall Study||7
508951|NCT00957801|1245240|P2|STARTED|Overall Study||7
508952|NCT00957801|1245241|P1|STARTED|Overall Study||7
508953|NCT00957723|1245407|P1|NOT COMPLETED|Overall Study||121
508954|NCT00957723|1245407|P1|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2yr primary outcome interval.|298
508955|NCT00957723|1245407|P1|STARTED|Overall Study||419
508956|NCT00957684|1245422|P5|NOT COMPLETED|PART II||75
508957|NCT00957684|1245423|P4|NOT COMPLETED|PART II||0
508958|NCT00957684|1245424|P3|NOT COMPLETED|PART II||0
508959|NCT00957684|1245425|P2|NOT COMPLETED|PART II||0
508960|NCT00957684|1245426|P1|NOT COMPLETED|PART II||0
508961|NCT00957684|1245422|P5|COMPLETED|PART II||239
508962|NCT00957684|1245423|P4|COMPLETED|PART II||0
508963|NCT00957684|1245424|P3|COMPLETED|PART II||0
508964|NCT00957684|1245425|P2|COMPLETED|PART II||0
508965|NCT00957684|1245426|P1|COMPLETED|PART II||0
508966|NCT00957684|1245422|P5|Patients Entered Part II|PART II||314
508967|NCT00957684|1245423|P4|Patients Entered Part II|PART II||0
508968|NCT00957684|1245424|P3|Patients Entered Part II|PART II||0
508969|NCT00957684|1245425|P2|Patients Entered Part II|PART II||0
508970|NCT00957684|1245426|P1|Patients Entered Part II|PART II||0
508971|NCT00957684|1245422|P5|STARTED|PART II||314
508972|NCT00957684|1245423|P4|STARTED|PART II||0
508973|NCT00957684|1245424|P3|STARTED|PART II||0
508974|NCT00957684|1245425|P2|STARTED|PART II||0
508975|NCT00957684|1245426|P1|STARTED|PART II||0
508976|NCT00957684|1245422|P5|NOT COMPLETED|PART I||0
508977|NCT00957684|1245423|P4|NOT COMPLETED|PART I||18
508978|NCT00957684|1245424|P3|NOT COMPLETED|PART I||10
508979|NCT00957684|1245425|P2|NOT COMPLETED|PART I||13
508980|NCT00957684|1245426|P1|NOT COMPLETED|PART I||31
508981|NCT00957684|1245422|P5|COMPLETED|PART I||0
508982|NCT00957684|1245423|P4|COMPLETED|PART I||84
508983|NCT00957684|1245424|P3|COMPLETED|PART I||90
508984|NCT00957684|1245425|P2|COMPLETED|PART I||85
508985|NCT00957684|1245426|P1|COMPLETED|PART I||71
508986|NCT00957684|1245422|P5|Per-protocol (PP)Population|PART I||0
508987|NCT00957684|1245423|P4|Per-protocol (PP)Population|PART I||91
508988|NCT00957684|1245424|P3|Per-protocol (PP)Population|PART I||94
508989|NCT00957684|1245425|P2|Per-protocol (PP)Population|PART I||86
508990|NCT00957684|1245426|P1|Per-protocol (PP)Population|PART I||72
508991|NCT00957684|1245422|P5|Intention-to-treat (ITT) Population|PART I||0
508992|NCT00957684|1245423|P4|Intention-to-treat (ITT) Population|PART I||102
508993|NCT00957684|1245424|P3|Intention-to-treat (ITT) Population|PART I||99
508994|NCT00957684|1245425|P2|Intention-to-treat (ITT) Population|PART I||98
508995|NCT00957684|1245426|P1|Intention-to-treat (ITT) Population|PART I||98
508996|NCT00957684|1245422|P5|Randomised (Safety Population)|PART I||0
508997|NCT00957684|1245423|P4|Randomised (Safety Population)|PART I||102
508998|NCT00957684|1245424|P3|Randomised (Safety Population)|PART I||100
508999|NCT00957684|1245425|P2|Randomised (Safety Population)|PART I||98
509000|NCT00957684|1245426|P1|Randomised (Safety Population)|PART I||102
509001|NCT00957684|1245422|P5|STARTED|PART I||0
509002|NCT00957684|1245423|P4|STARTED|PART I||102
509003|NCT00957684|1245424|P3|STARTED|PART I||100
509004|NCT00957684|1245425|P2|STARTED|PART I||98
509005|NCT00957684|1245426|P1|STARTED|PART I||102
509009|NCT00957658|1245493|P1|NOT COMPLETED|Overall Study||65
509010|NCT00957658|1245493|P1|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2yr primary outcome interval.|169
509011|NCT00957658|1245493|P1|STARTED|Overall Study||234
509012|NCT00957593|1245508|P2|NOT COMPLETED|Overall Study||0
509013|NCT00957593|1245509|P1|NOT COMPLETED|Overall Study||0
509014|NCT00957593|1245508|P2|COMPLETED|Overall Study||125
509015|NCT00957593|1245509|P1|COMPLETED|Overall Study||127
509016|NCT00957593|1245508|P2|STARTED|Overall Study||125
509017|NCT00957593|1245509|P1|STARTED|Overall Study||127
509018|NCT00957580|1245518|P3|NOT COMPLETED|Overall Study||0
509019|NCT00957580|1245519|P2|NOT COMPLETED|Overall Study||2
509020|NCT00957580|1245520|P1|NOT COMPLETED|Overall Study||0
509021|NCT00957580|1245518|P3|COMPLETED|Overall Study||15
509022|NCT00957580|1245519|P2|COMPLETED|Overall Study||31
509023|NCT00957580|1245520|P1|COMPLETED|Overall Study||33
509024|NCT00957580|1245518|P3|Treated|Overall Study||15
509025|NCT00957580|1245519|P2|Treated|Overall Study||32
509026|NCT00957580|1245520|P1|Treated|Overall Study||33
509027|NCT00957580|1245518|P3|STARTED|Overall Study||15
509028|NCT00957580|1245519|P2|STARTED|Overall Study||33
509029|NCT00957580|1245520|P1|STARTED|Overall Study||33
509030|NCT00957528|1245667|P3|NOT COMPLETED|Overall Study||1
509031|NCT00957528|1245668|P2|NOT COMPLETED|Overall Study||1
509032|NCT00957528|1245669|P1|NOT COMPLETED|Overall Study||0
509033|NCT00957528|1245667|P3|COMPLETED|Overall Study||8
509034|NCT00957528|1245668|P2|COMPLETED|Overall Study||8
509035|NCT00957528|1245669|P1|COMPLETED|Overall Study||8
509036|NCT00957528|1245667|P3|STARTED|Overall Study||9
509037|NCT00957528|1245668|P2|STARTED|Overall Study||9
509038|NCT00957528|1245669|P1|STARTED|Overall Study||8
509039|NCT00957424|1245692|P1|NOT COMPLETED|Overall Study||23
509040|NCT00957424|1245692|P1|COMPLETED|Overall Study||44
509041|NCT00957424|1245692|P1|Follow-up #2|Overall Study||50
509042|NCT00957424|1245692|P1|Follow-up #1|Overall Study||59
509043|NCT00957424|1245692|P1|STARTED|Overall Study||67
509044|NCT00957372|1245702|P4|NOT COMPLETED|PART II||44
509045|NCT00957372|1245703|P3|NOT COMPLETED|PART II||0
509046|NCT00957372|1245704|P2|NOT COMPLETED|PART II||0
509047|NCT00957372|1245705|P1|NOT COMPLETED|PART II||0
509048|NCT00957372|1245702|P4|COMPLETED|PART II||150
509049|NCT00957372|1245703|P3|COMPLETED|PART II||0
509050|NCT00957372|1245704|P2|COMPLETED|PART II||0
509051|NCT00957372|1245705|P1|COMPLETED|PART II||0
509052|NCT00957372|1245702|P4|Per-Protocol Population|PART II||108
509053|NCT00957372|1245703|P3|Per-Protocol Population|PART II||0
509054|NCT00957372|1245704|P2|Per-Protocol Population|PART II||0
509055|NCT00957372|1245705|P1|Per-Protocol Population|PART II||0
509056|NCT00957372|1245702|P4|Intention-to-treat (ITT) Population|PART II||191
509057|NCT00957372|1245703|P3|Intention-to-treat (ITT) Population|PART II||0
509058|NCT00957372|1245704|P2|Intention-to-treat (ITT) Population|PART II||0
509059|NCT00957372|1245705|P1|Intention-to-treat (ITT) Population|PART II||0
509060|NCT00957372|1245702|P4|Safety Population|PART II||194
509061|NCT00957372|1245703|P3|Safety Population|PART II||0
509062|NCT00957372|1245704|P2|Safety Population|PART II||0
509063|NCT00957372|1245705|P1|Safety Population|PART II||0
509064|NCT00957372|1245702|P4|STARTED|PART II||194
509065|NCT00957372|1245703|P3|STARTED|PART II||0
509066|NCT00957372|1245704|P2|STARTED|PART II||0
509067|NCT00957372|1245705|P1|STARTED|PART II||0
509068|NCT00957372|1245702|P4|NOT COMPLETED|PART I||0
509069|NCT00957372|1245703|P3|NOT COMPLETED|PART I||1
509070|NCT00957372|1245704|P2|NOT COMPLETED|PART I||0
509071|NCT00957372|1245705|P1|NOT COMPLETED|PART I||0
509072|NCT00957372|1245702|P4|COMPLETED|PART I||0
509073|NCT00957372|1245703|P3|COMPLETED|PART I||87
509074|NCT00957372|1245704|P2|COMPLETED|PART I||85
509075|NCT00957372|1245705|P1|COMPLETED|PART I||80
509076|NCT00957372|1245702|P4|Randomized But Not Treated|PART I||0
509077|NCT00957372|1245703|P3|Randomized But Not Treated|PART I||1
509078|NCT00957372|1245704|P2|Randomized But Not Treated|PART I||0
509079|NCT00957372|1245705|P1|Randomized But Not Treated|PART I||0
509080|NCT00957372|1245702|P4|Per-Protocol Population|PART I||0
509081|NCT00957372|1245703|P3|Per-Protocol Population|PART I||51
509082|NCT00957372|1245704|P2|Per-Protocol Population|PART I||47
509083|NCT00957372|1245705|P1|Per-Protocol Population|PART I||35
509084|NCT00957372|1245702|P4|Intention-to-Treat Population|PART I||0
509085|NCT00957372|1245703|P3|Intention-to-Treat Population|PART I||84
509086|NCT00957372|1245704|P2|Intention-to-Treat Population|PART I||84
509087|NCT00957372|1245705|P1|Intention-to-Treat Population|PART I||77
509088|NCT00957372|1245702|P4|Safety Population|PART I||0
509089|NCT00957372|1245703|P3|Safety Population|PART I||87
509090|NCT00957372|1245704|P2|Safety Population|PART I||85
509091|NCT00957372|1245705|P1|Safety Population|PART I||80
509092|NCT00957372|1245702|P4|STARTED|PART I||0
509093|NCT00957372|1245703|P3|STARTED|PART I||88
509094|NCT00957372|1245704|P2|STARTED|PART I||85
509095|NCT00957372|1245705|P1|STARTED|PART I||80
509096|NCT00957333|1245721|P1|NOT COMPLETED|Overall Study||0
509097|NCT00957333|1245721|P1|COMPLETED|Overall Study||44
509098|NCT00957333|1245721|P1|STARTED|Overall Study||44
509099|NCT00957268|1245730|P5|NOT COMPLETED|Overall Study||0
509100|NCT00957268|1245731|P4|NOT COMPLETED|Overall Study||0
509101|NCT00957268|1245732|P3|NOT COMPLETED|Overall Study||1
509102|NCT00957268|1245733|P2|NOT COMPLETED|Overall Study||0
509103|NCT00957268|1245734|P1|NOT COMPLETED|Overall Study||0
509104|NCT00957268|1245730|P5|COMPLETED|Overall Study||22
509105|NCT00957268|1245731|P4|COMPLETED|Overall Study||7
509106|NCT00957268|1245732|P3|COMPLETED|Overall Study||7
509107|NCT00957268|1245733|P2|COMPLETED|Overall Study||4
509108|NCT00957268|1245734|P1|COMPLETED|Overall Study||5
509109|NCT00957268|1245730|P5|STARTED|Overall Study||22
509110|NCT00957268|1245731|P4|STARTED|Overall Study||7
509111|NCT00957268|1245732|P3|STARTED|Overall Study||8
509112|NCT00957268|1245733|P2|STARTED|Overall Study||4
509113|NCT00957268|1245734|P1|STARTED|Overall Study||5
509114|NCT00957242|1245798|P2|NOT COMPLETED|Overall Study||0
509115|NCT00957242|1245799|P1|NOT COMPLETED|Overall Study||0
509116|NCT00957242|1245798|P2|COMPLETED|Overall Study||72
509117|NCT00957242|1245799|P1|COMPLETED|Overall Study||73
509118|NCT00957242|1245798|P2|STARTED|Overall Study||72
509119|NCT00957242|1245799|P1|STARTED|Overall Study||73
509120|NCT00957047|1245831|P5|NOT COMPLETED|PART II||102
509121|NCT00957047|1245832|P4|NOT COMPLETED|PART II||0
509122|NCT00957047|1245833|P3|NOT COMPLETED|PART II||0
509123|NCT00957047|1245834|P2|NOT COMPLETED|PART II||0
509124|NCT00957047|1245835|P1|NOT COMPLETED|PART II||0
509125|NCT00957047|1245831|P5|COMPLETED|PART II||223
509126|NCT00957047|1245832|P4|COMPLETED|PART II||0
509127|NCT00957047|1245833|P3|COMPLETED|PART II||0
509128|NCT00957047|1245834|P2|COMPLETED|PART II||0
509129|NCT00957047|1245835|P1|COMPLETED|PART II||0
509130|NCT00957047|1245831|P5|Terminated Prematurely|PART II|Terminated Prematurely during 1-year Open-Label Period|102
509131|NCT00957047|1245832|P4|Terminated Prematurely|PART II||0
509132|NCT00957047|1245833|P3|Terminated Prematurely|PART II||0
509133|NCT00957047|1245834|P2|Terminated Prematurely|PART II||0
509134|NCT00957047|1245835|P1|Terminated Prematurely|PART II||0
509135|NCT00957047|1245831|P5|STARTED|PART II|325 patients who completed Part I were enrolled in Part II.|325
509136|NCT00957047|1245832|P4|STARTED|PART II||0
509137|NCT00957047|1245833|P3|STARTED|PART II||0
509138|NCT00957047|1245834|P2|STARTED|PART II||0
509139|NCT00957047|1245835|P1|STARTED|PART II||0
509140|NCT00957047|1245831|P5|NOT COMPLETED|PART I||0
509141|NCT00957047|1245832|P4|NOT COMPLETED|PART I||30
509142|NCT00957047|1245833|P3|NOT COMPLETED|PART I||21
509143|NCT00957047|1245834|P2|NOT COMPLETED|PART I||13
509144|NCT00957047|1245835|P1|NOT COMPLETED|PART I||6
509145|NCT00957047|1245831|P5|COMPLETED|PART I||0
509146|NCT00957047|1245832|P4|COMPLETED|PART I||68
509147|NCT00957047|1245833|P3|COMPLETED|PART I||80
509148|NCT00957047|1245834|P2|COMPLETED|PART I||83
509149|NCT00957047|1245835|P1|COMPLETED|PART I||94
509150|NCT00957047|1245831|P5|Per-Protocol Population|PART I||0
509151|NCT00957047|1245832|P4|Per-Protocol Population|PART I||54
509152|NCT00957047|1245833|P3|Per-Protocol Population|PART I||75
509153|NCT00957047|1245834|P2|Per-Protocol Population|PART I||70
509154|NCT00957047|1245835|P1|Per-Protocol Population|PART I||81
509155|NCT00957047|1245831|P5|Intention-to-treat (ITT) Population|PART I||0
509156|NCT00957047|1245832|P4|Intention-to-treat (ITT) Population|PART I||97
509157|NCT00957047|1245833|P3|Intention-to-treat (ITT) Population|PART I||100
509158|NCT00957047|1245834|P2|Intention-to-treat (ITT) Population|PART I||96
509159|NCT00957047|1245835|P1|Intention-to-treat (ITT) Population|PART I||100
509160|NCT00957047|1245831|P5|Randomized/Safety Population|PART I||0
509161|NCT00957047|1245832|P4|Randomized/Safety Population|PART I||98
509162|NCT00957047|1245833|P3|Randomized/Safety Population|PART I||101
509163|NCT00957047|1245834|P2|Randomized/Safety Population|PART I||96
509164|NCT00957047|1245835|P1|Randomized/Safety Population|PART I||100
509165|NCT00957047|1245831|P5|STARTED|PART I||0
509166|NCT00957047|1245832|P4|STARTED|PART I||98
509167|NCT00957047|1245833|P3|STARTED|PART I||101
509168|NCT00957047|1245834|P2|STARTED|PART I||96
509169|NCT00957047|1245835|P1|STARTED|PART I||100
509170|NCT00957034|1245856|P3|NOT COMPLETED|Overall Study||6
509171|NCT00957034|1245857|P2|NOT COMPLETED|Overall Study||4
509172|NCT00957034|1245858|P1|NOT COMPLETED|Overall Study||6
509173|NCT00957034|1245856|P3|COMPLETED|Overall Study||1
509174|NCT00957034|1245857|P2|COMPLETED|Overall Study||0
509175|NCT00957034|1245858|P1|COMPLETED|Overall Study||0
509176|NCT00957034|1245856|P3|STARTED|Overall Study||7
509177|NCT00957034|1245857|P2|STARTED|Overall Study||4
509178|NCT00957034|1245858|P1|STARTED|Overall Study||6
509179|NCT00957021|1245881|P1|NOT COMPLETED|Overall Study||117
509180|NCT00957021|1245881|P1|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2 yr primary outcome interval.|237
509181|NCT00957021|1245881|P1|STARTED|Overall Study||354
509182|NCT00957008|1245894|P4|NOT COMPLETED|Overall Study||24
509183|NCT00957008|1245895|P3|NOT COMPLETED|Overall Study||17
509184|NCT00957008|1245896|P2|NOT COMPLETED|Overall Study||12
509185|NCT00957008|1245897|P1|NOT COMPLETED|Overall Study||21
509186|NCT00957008|1245894|P4|COMPLETED|Overall Study||26
509187|NCT00957008|1245895|P3|COMPLETED|Overall Study||32
509188|NCT00957008|1245896|P2|COMPLETED|Overall Study||37
509189|NCT00957008|1245897|P1|COMPLETED|Overall Study||28
509190|NCT00957008|1245894|P4|STARTED|Overall Study||50
509191|NCT00957008|1245895|P3|STARTED|Overall Study||49
509192|NCT00957008|1245896|P2|STARTED|Overall Study||49
509193|NCT00957008|1245897|P1|STARTED|Overall Study||49
509194|NCT00956943|1245925|P2|NOT COMPLETED|Overall Study||10
509195|NCT00956943|1245926|P1|NOT COMPLETED|Overall Study||9
509196|NCT00956943|1245925|P2|COMPLETED|Overall Study||34
509197|NCT00956943|1245926|P1|COMPLETED|Overall Study||34
509198|NCT00956943|1245925|P2|Baseline|Overall Study||44
509199|NCT00956943|1245926|P1|Baseline|Overall Study||43
509200|NCT00956943|1245925|P2|STARTED|Overall Study||44
509201|NCT00956943|1245926|P1|STARTED|Overall Study||43
509202|NCT00956839|1245937|P3|NOT COMPLETED|Overall Study||3
509203|NCT00956839|1245938|P2|NOT COMPLETED|Overall Study||0
509204|NCT00956839|1245939|P1|NOT COMPLETED|Overall Study||3
509205|NCT00956839|1245937|P3|COMPLETED|Overall Study||10
509206|NCT00956839|1245938|P2|COMPLETED|Overall Study||13
509207|NCT00956839|1245939|P1|COMPLETED|Overall Study||11
509208|NCT00956839|1245937|P3|STARTED|Overall Study||13
509209|NCT00956839|1245938|P2|STARTED|Overall Study||13
509210|NCT00956839|1245939|P1|STARTED|Overall Study||14
509211|NCT00956813|1245952|P2|NOT COMPLETED|Continuation Phase||0
509212|NCT00956813|1245953|P1|NOT COMPLETED|Continuation Phase||0
509213|NCT00956813|1245952|P2|COMPLETED|Continuation Phase||0
509214|NCT00956813|1245953|P1|COMPLETED|Continuation Phase||80
509215|NCT00956813|1245952|P2|STARTED|Continuation Phase||0
509216|NCT00956813|1245953|P1|STARTED|Continuation Phase||80
509217|NCT00956813|1245952|P2|NOT COMPLETED|Flaxseed and Placebo||5
509218|NCT00956813|1245953|P1|NOT COMPLETED|Flaxseed and Placebo||8
509219|NCT00956813|1245952|P2|COMPLETED|Flaxseed and Placebo||100
509220|NCT00956813|1245953|P1|COMPLETED|Flaxseed and Placebo||97
509221|NCT00956813|1245952|P2|STARTED|Flaxseed and Placebo||105
509222|NCT00956813|1245953|P1|STARTED|Flaxseed and Placebo||105
509223|NCT00956761|1245968|P1|NOT COMPLETED|Overall Study||0
509224|NCT00956761|1245968|P1|COMPLETED|Overall Study||63
509225|NCT00956761|1245968|P1|STARTED|Overall Study||63
509226|NCT00956709|1245977|P2|NOT COMPLETED|Overall Study||0
509227|NCT00956709|1245978|P1|NOT COMPLETED|Overall Study||0
509228|NCT00956709|1245977|P2|COMPLETED|Overall Study||19
509229|NCT00956709|1245978|P1|COMPLETED|Overall Study||16
509230|NCT00956709|1245977|P2|STARTED|Overall Study||19
509231|NCT00956709|1245978|P1|STARTED|Overall Study||16
509232|NCT00956657|1245990|P2|NOT COMPLETED|Overall Study||0
509233|NCT00956657|1245991|P1|NOT COMPLETED|Overall Study||0
509234|NCT00956657|1245990|P2|COMPLETED|Overall Study||13
509235|NCT00956657|1245991|P1|COMPLETED|Overall Study||18
509236|NCT00956657|1245990|P2|STARTED|Overall Study||13
509237|NCT00956657|1245991|P1|STARTED|Overall Study||18
509238|NCT00956631|1245997|P1|NOT COMPLETED|Overall Study||16
509239|NCT00956631|1245997|P1|COMPLETED|Overall Study||62
509240|NCT00956631|1245997|P1|STARTED|Overall Study||78
509241|NCT00956592|1246005|P2|NOT COMPLETED|Overall Study||3
509242|NCT00956592|1246006|P1|NOT COMPLETED|Overall Study||1
509243|NCT00956592|1246005|P2|COMPLETED|Overall Study||147
509244|NCT00956592|1246006|P1|COMPLETED|Overall Study||149
509245|NCT00956592|1246005|P2|STARTED|Overall Study||150
509246|NCT00956592|1246006|P1|STARTED|Overall Study||150
509247|NCT00956540|1246026|P4|NOT COMPLETED|Overall Study||4
509248|NCT00956540|1246027|P3|NOT COMPLETED|Overall Study||3
509249|NCT00956540|1246028|P2|NOT COMPLETED|Overall Study||4
509250|NCT00956540|1246029|P1|NOT COMPLETED|Overall Study||3
509251|NCT00956540|1246026|P4|COMPLETED|Overall Study||41
509252|NCT00956540|1246027|P3|COMPLETED|Overall Study||43
509253|NCT00956540|1246028|P2|COMPLETED|Overall Study||46
509254|NCT00956540|1246029|P1|COMPLETED|Overall Study||51
509255|NCT00956540|1246026|P4|STARTED|Overall Study||45
509256|NCT00956540|1246027|P3|STARTED|Overall Study||46
509257|NCT00956540|1246028|P2|STARTED|Overall Study||50
509258|NCT00956540|1246029|P1|STARTED|Overall Study||54
509259|NCT00956293|1246041|P3|NOT COMPLETED|Follow-up Period||0
509260|NCT00956293|1246042|P2|NOT COMPLETED|Follow-up Period||32
509261|NCT00956293|1246043|P1|NOT COMPLETED|Follow-up Period||20
509262|NCT00956293|1246041|P3|COMPLETED|Follow-up Period||0
509263|NCT00956293|1246042|P2|COMPLETED|Follow-up Period||0
509264|NCT00956293|1246043|P1|COMPLETED|Follow-up Period||0
509265|NCT00956293|1246041|P3|STARTED|Follow-up Period||0
509266|NCT00956293|1246042|P2|STARTED|Follow-up Period||32
509267|NCT00956293|1246043|P1|STARTED|Follow-up Period||20
509268|NCT00956293|1246041|P3|NOT COMPLETED|Main Period (Randomization)||0
509269|NCT00956293|1246042|P2|NOT COMPLETED|Main Period (Randomization)||27
509270|NCT00956293|1246043|P1|NOT COMPLETED|Main Period (Randomization)||1
509271|NCT00956293|1246041|P3|COMPLETED|Main Period (Randomization)||0
509272|NCT00956293|1246042|P2|COMPLETED|Main Period (Randomization)||26
509273|NCT00956293|1246043|P1|COMPLETED|Main Period (Randomization)||23
509274|NCT00956293|1246041|P3|Randomized Safety Set|Main Period (Randomization)||0
509275|NCT00956293|1246042|P2|Randomized Safety Set|Main Period (Randomization)||51
509276|NCT00956293|1246043|P1|Randomized Safety Set|Main Period (Randomization)||24
509277|NCT00956293|1246041|P3|Full Analysis Set|Main Period (Randomization)||0
509278|NCT00956293|1246042|P2|Full Analysis Set|Main Period (Randomization)|Two participants, randomized to this arm, did not receive everolimus.|51
509279|NCT00956293|1246043|P1|Full Analysis Set|Main Period (Randomization)||24
509280|NCT00956293|1246041|P3|STARTED|Main Period (Randomization)||0
509281|NCT00956293|1246042|P2|STARTED|Main Period (Randomization)||53
509282|NCT00956293|1246043|P1|STARTED|Main Period (Randomization)||24
509283|NCT00956293|1246041|P3|NOT COMPLETED|Main Period (Pre-randomization)||130
509284|NCT00956293|1246042|P2|NOT COMPLETED|Main Period (Pre-randomization)||0
509285|NCT00956293|1246043|P1|NOT COMPLETED|Main Period (Pre-randomization)||0
509286|NCT00956293|1246041|P3|COMPLETED|Main Period (Pre-randomization)||77
509287|NCT00956293|1246042|P2|COMPLETED|Main Period (Pre-randomization)||0
509288|NCT00956293|1246043|P1|COMPLETED|Main Period (Pre-randomization)||0
509289|NCT00956293|1246041|P3|Enrolled Safety Set|Main Period (Pre-randomization)||203
509290|NCT00956293|1246042|P2|Enrolled Safety Set|Main Period (Pre-randomization)||0
509291|NCT00956293|1246043|P1|Enrolled Safety Set|Main Period (Pre-randomization)||0
509292|NCT00956293|1246041|P3|STARTED|Main Period (Pre-randomization)||207
509293|NCT00956293|1246042|P2|STARTED|Main Period (Pre-randomization)||0
509294|NCT00956293|1246043|P1|STARTED|Main Period (Pre-randomization)||0
509295|NCT00956254|1246067|P1|NOT COMPLETED|Overall Study||0
509296|NCT00956254|1246067|P1|COMPLETED|Overall Study||18
509297|NCT00956254|1246067|P1|STARTED|Overall Study||18
509298|NCT00956085|1246077|P1|NOT COMPLETED|Overall Study||0
509299|NCT00956085|1246077|P1|COMPLETED|Overall Study||12
509300|NCT00956085|1246077|P1|STARTED|Overall Study||12
509301|NCT00956020|1246081|P1|NOT COMPLETED|Overall Study||0
509302|NCT00956020|1246081|P1|COMPLETED|Overall Study||4
509303|NCT00956020|1246081|P1|STARTED|Overall Study||4
509304|NCT00955968|1246098|P2|NOT COMPLETED|Overall Study||126
509305|NCT00955968|1246099|P1|NOT COMPLETED|Overall Study||137
509306|NCT00955968|1246098|P2|COMPLETED|Overall Study||699
509307|NCT00955968|1246099|P1|COMPLETED|Overall Study||691
509308|NCT00955968|1246098|P2|STARTED|Overall Study||825
509309|NCT00955968|1246099|P1|STARTED|Overall Study||828
509310|NCT00955955|1246133|P3|NOT COMPLETED|Overall Study||0
509311|NCT00955955|1246134|P2|NOT COMPLETED|Overall Study||0
509312|NCT00955955|1246135|P1|NOT COMPLETED|Overall Study||2
509313|NCT00955955|1246133|P3|COMPLETED|Overall Study||28
509314|NCT00955955|1246134|P2|COMPLETED|Overall Study||28
509315|NCT00955955|1246135|P1|COMPLETED|Overall Study||17
509316|NCT00955955|1246133|P3|STARTED|Overall Study||28
509317|NCT00955955|1246134|P2|STARTED|Overall Study||28
509318|NCT00955955|1246135|P1|STARTED|Overall Study||19
509319|NCT00955916|1246149|P1|NOT COMPLETED|Overall Study||0
509320|NCT00955916|1246149|P1|COMPLETED|Overall Study||38
509321|NCT00955916|1246149|P1|STARTED|Overall Study||38
509322|NCT00955903|1246158|P3|NOT COMPLETED|Overall Study||7
509323|NCT00955903|1246159|P2|NOT COMPLETED|Overall Study||3
509324|NCT00955903|1246160|P1|NOT COMPLETED|Overall Study||6
509325|NCT00955903|1246158|P3|COMPLETED|Overall Study||48
509326|NCT00955903|1246159|P2|COMPLETED|Overall Study||51
509327|NCT00955903|1246160|P1|COMPLETED|Overall Study||49
509328|NCT00955903|1246158|P3|STARTED|Overall Study||55
509329|NCT00955903|1246159|P2|STARTED|Overall Study||54
509330|NCT00955903|1246160|P1|STARTED|Overall Study||55
509331|NCT00955877|1246177|P3|NOT COMPLETED|Overall Study||0
509332|NCT00955877|1246178|P2|NOT COMPLETED|Overall Study||0
509333|NCT00955877|1246179|P1|NOT COMPLETED|Overall Study||0
509334|NCT00955877|1246177|P3|COMPLETED|Overall Study||7
509335|NCT00955877|1246178|P2|COMPLETED|Overall Study||0
509336|NCT00955877|1246179|P1|COMPLETED|Overall Study||6
509337|NCT00955877|1246177|P3|STARTED|Overall Study||7
509338|NCT00955877|1246178|P2|STARTED|Overall Study|No patients were enrolled because analysis of previous arm wasn't completed.|0
509339|NCT00955877|1246179|P1|STARTED|Overall Study|Drug manufacturer ceased producing the drug prior to completion of 10 enrolled in this arm.|6
509340|NCT00955825|1246219|P2|NOT COMPLETED|Overall Study||17
509341|NCT00955825|1246220|P1|NOT COMPLETED|Overall Study||26
509342|NCT00955825|1246219|P2|COMPLETED|Overall Study||223
509343|NCT00955825|1246220|P1|COMPLETED|Overall Study||207
509344|NCT00955825|1246219|P2|STARTED|Overall Study||240
509345|NCT00955825|1246220|P1|STARTED|Overall Study||233
509346|NCT00955747|1246228|P2|NOT COMPLETED|Overall Study||69
509347|NCT00955747|1246229|P1|NOT COMPLETED|Overall Study||69
509348|NCT00955747|1246228|P2|COMPLETED|Overall Study||172
509349|NCT00955747|1246229|P1|COMPLETED|Overall Study||184
509350|NCT00955747|1246228|P2|STARTED|Overall Study||241
509351|NCT00955747|1246229|P1|STARTED|Overall Study||253
509352|NCT00955721|1246237|P2|NOT COMPLETED|Overall Study||0
509353|NCT00955721|1246238|P1|NOT COMPLETED|Overall Study||3
509354|NCT00955721|1246237|P2|COMPLETED|Overall Study||0
509355|NCT00955721|1246238|P1|COMPLETED|Overall Study||6
509356|NCT00955721|1246237|P2|STARTED|Overall Study||0
509357|NCT00955721|1246238|P1|STARTED|Overall Study||9
509358|NCT00955617|1246248|P2|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3
509359|NCT00955617|1246249|P1|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3
509360|NCT00955617|1246248|P2|COMPLETED|Second MRA (Between Day 1 and Day 51)||7
509361|NCT00955617|1246249|P1|COMPLETED|Second MRA (Between Day 1 and Day 51)||7
509362|NCT00955617|1246248|P2|STARTED|Second MRA (Between Day 1 and Day 51)||10
509363|NCT00955617|1246249|P1|STARTED|Second MRA (Between Day 1 and Day 51)||10
509364|NCT00955617|1246248|P2|NOT COMPLETED|First MRA (Between Day0 and Day21)||0
509365|NCT00955617|1246249|P1|NOT COMPLETED|First MRA (Between Day0 and Day21)||0
509366|NCT00955617|1246248|P2|COMPLETED|First MRA (Between Day0 and Day21)||10
509367|NCT00955617|1246249|P1|COMPLETED|First MRA (Between Day0 and Day21)||10
509368|NCT00955617|1246248|P2|STARTED|First MRA (Between Day0 and Day21)||10
509369|NCT00955617|1246249|P1|STARTED|First MRA (Between Day0 and Day21)||10
509370|NCT00955513|1246262|P3|NOT COMPLETED|Overall Study||3
509371|NCT00955513|1246263|P2|NOT COMPLETED|Overall Study||2
509372|NCT00955513|1246264|P1|NOT COMPLETED|Overall Study||1
509373|NCT00955513|1246262|P3|COMPLETED|Overall Study||79
509374|NCT00955513|1246263|P2|COMPLETED|Overall Study||78
509375|NCT00955513|1246264|P1|COMPLETED|Overall Study||79
509376|NCT00955513|1246262|P3|STARTED|Overall Study||82
509377|NCT00955513|1246263|P2|STARTED|Overall Study||80
509378|NCT00955513|1246264|P1|STARTED|Overall Study||80
509379|NCT00955487|1246274|P6|NOT COMPLETED|Overall Study||0
509380|NCT00955487|1246275|P5|NOT COMPLETED|Overall Study||0
509381|NCT00955487|1246276|P4|NOT COMPLETED|Overall Study||0
509382|NCT00955487|1246277|P3|NOT COMPLETED|Overall Study||0
509383|NCT00955487|1246278|P2|NOT COMPLETED|Overall Study||0
509384|NCT00955487|1246279|P1|NOT COMPLETED|Overall Study||0
509385|NCT00955487|1246274|P6|COMPLETED|Overall Study||35
509386|NCT00955487|1246275|P5|COMPLETED|Overall Study||32
509387|NCT00955487|1246276|P4|COMPLETED|Overall Study||21
509388|NCT00955487|1246277|P3|COMPLETED|Overall Study||17
509389|NCT00955487|1246278|P2|COMPLETED|Overall Study||9
509390|NCT00955487|1246279|P1|COMPLETED|Overall Study||10
509391|NCT00955487|1246274|P6|STARTED|Overall Study||35
509392|NCT00955487|1246275|P5|STARTED|Overall Study||32
509393|NCT00955487|1246276|P4|STARTED|Overall Study||21
509394|NCT00955487|1246277|P3|STARTED|Overall Study||17
509395|NCT00955487|1246278|P2|STARTED|Overall Study||9
509396|NCT00955487|1246279|P1|STARTED|Overall Study||10
509397|NCT00955474|1246313|P2|NOT COMPLETED|Overall Study||5
509398|NCT00955474|1246314|P1|NOT COMPLETED|Overall Study||7
509399|NCT00955474|1246313|P2|COMPLETED|Overall Study||8
509400|NCT00955474|1246314|P1|COMPLETED|Overall Study||5
509401|NCT00955474|1246313|P2|STARTED|Overall Study||13
509402|NCT00955474|1246314|P1|STARTED|Overall Study||12
509403|NCT00955357|1246350|P2|NOT COMPLETED|Maintenance Phase||45
509404|NCT00955357|1246351|P1|NOT COMPLETED|Maintenance Phase||12
509405|NCT00955357|1246350|P2|COMPLETED|Maintenance Phase||249
509406|NCT00955357|1246351|P1|COMPLETED|Maintenance Phase||68
509407|NCT00955357|1246350|P2|STARTED|Maintenance Phase||294
509408|NCT00955357|1246351|P1|STARTED|Maintenance Phase||80
509409|NCT00955357|1246350|P2|NOT COMPLETED|Titration Phase||66
509410|NCT00955357|1246351|P1|NOT COMPLETED|Titration Phase||16
509411|NCT00955357|1246350|P2|COMPLETED|Titration Phase||294
509412|NCT00955357|1246351|P1|COMPLETED|Titration Phase||80
509413|NCT00955357|1246350|P2|STARTED|Titration Phase||360
509414|NCT00955357|1246351|P1|STARTED|Titration Phase||96
509415|NCT00955305|1246359|P2|NOT COMPLETED|Overall Study||87
509416|NCT00955305|1246360|P1|NOT COMPLETED|Overall Study||88
509417|NCT00955305|1246359|P2|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
509418|NCT00955305|1246360|P1|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
509419|NCT00955305|1246359|P2|Eligible and Treated|Overall Study||75
509420|NCT00955305|1246360|P1|Eligible and Treated|Overall Study||78
509421|NCT00955305|1246359|P2|Treated|Overall Study||82
509422|NCT00955305|1246360|P1|Treated|Overall Study||83
509423|NCT00955305|1246359|P2|STARTED|Overall Study||87
509424|NCT00955305|1246360|P1|STARTED|Overall Study||88
509425|NCT00955279|1246373|P3|NOT COMPLETED|Overall Study||8
509426|NCT00955279|1246374|P2|NOT COMPLETED|Overall Study||4
509427|NCT00955279|1246375|P1|NOT COMPLETED|Overall Study||3
509428|NCT00955279|1246373|P3|COMPLETED|Overall Study||52
509429|NCT00955279|1246374|P2|COMPLETED|Overall Study||51
509430|NCT00955279|1246375|P1|COMPLETED|Overall Study||55
509431|NCT00955279|1246373|P3|STARTED|Overall Study||60
509432|NCT00955279|1246374|P2|STARTED|Overall Study||55
509433|NCT00955279|1246375|P1|STARTED|Overall Study||58
509434|NCT00955266|1246397|P2|NOT COMPLETED|Overall Study||0
509435|NCT00955266|1246398|P1|NOT COMPLETED|Overall Study||0
509436|NCT00955266|1246397|P2|COMPLETED|Overall Study||4
509437|NCT00955266|1246398|P1|COMPLETED|Overall Study||4
509438|NCT00955266|1246397|P2|STARTED|Overall Study||4
509439|NCT00955266|1246398|P1|STARTED|Overall Study||4
509440|NCT00955110|1246412|P1|NOT COMPLETED|Treatment Phase||6
509441|NCT00955110|1246412|P1|COMPLETED|Treatment Phase||35
509442|NCT00955110|1246412|P1|Oxycodone CR 60 mg|Treatment Phase||40
509443|NCT00955110|1246412|P1|Oxycodone CR 30 mg|Treatment Phase||40
509444|NCT00955110|1246412|P1|Oxymorphone ER 30 mg|Treatment Phase||38
509445|NCT00955110|1246412|P1|Oxymorphone ER 15 mg|Treatment Phase||37
509446|NCT00955110|1246412|P1|Placebo|Treatment Phase||38
509447|NCT00955110|1246412|P1|STARTED|Treatment Phase||41
509448|NCT00955110|1246412|P1|NOT COMPLETED|Qualification Phase||24
509449|NCT00955110|1246412|P1|COMPLETED|Qualification Phase||54
509450|NCT00955110|1246412|P1|STARTED|Qualification Phase||78
509451|NCT00955032|1246426|P2|NOT COMPLETED|Overall Study||0
509452|NCT00955032|1246427|P1|NOT COMPLETED|Overall Study||0
509453|NCT00955032|1246426|P2|COMPLETED|Overall Study||8
509454|NCT00955032|1246427|P1|COMPLETED|Overall Study||16
509455|NCT00955032|1246426|P2|STARTED|Overall Study||8
509456|NCT00955032|1246427|P1|STARTED|Overall Study||16
509457|NCT00954993|1246447|P1|NOT COMPLETED|Period 2||0
509458|NCT00954993|1246447|P1|COMPLETED|Period 2||3
509459|NCT00954993|1246447|P1|STARTED|Period 2||3
509460|NCT00954993|1246447|P1|NOT COMPLETED|Washout||0
509461|NCT00954993|1246447|P1|COMPLETED|Washout||3
509462|NCT00954993|1246447|P1|STARTED|Washout||3
509463|NCT00954993|1246447|P1|NOT COMPLETED|Period 1||0
509464|NCT00954993|1246447|P1|COMPLETED|Period 1||3
509465|NCT00954993|1246447|P1|STARTED|Period 1||3
509466|NCT00954941|1246459|P2|NOT COMPLETED|Overall Study||7
509467|NCT00954941|1246460|P1|NOT COMPLETED|Overall Study||8
509468|NCT00954941|1246459|P2|COMPLETED|Overall Study||41
509469|NCT00954941|1246460|P1|COMPLETED|Overall Study||42
509470|NCT00954941|1246459|P2|STARTED|Overall Study||48
509471|NCT00954941|1246460|P1|STARTED|Overall Study||50
509472|NCT00954915|1246468|P1|NOT COMPLETED|Overall Study||0
509473|NCT00954915|1246468|P1|COMPLETED|Overall Study||1
509474|NCT00954915|1246468|P1|STARTED|Overall Study||1
509475|NCT00954824|1246472|P1|NOT COMPLETED|Overall Study||50
509476|NCT00954824|1246472|P1|COMPLETED|Overall Study||50
509477|NCT00954824|1246472|P1|STARTED|Overall Study||100
509478|NCT00954733|1246476|P1|NOT COMPLETED|Overall Study||1
509479|NCT00954733|1246476|P1|COMPLETED|Overall Study||39
509480|NCT00954733|1246476|P1|STARTED|Overall Study||40
509481|NCT00954707|1246480|P1|NOT COMPLETED|Overall Study||167
509482|NCT00954707|1246480|P1|COMPLETED|Overall Study|2342 Subjects completed 12-month Phase 1 follow-up; 167 subjects didn't complete the Phase 1.|2342
509483|NCT00954707|1246480|P1|STARTED|Overall Study||2509
509484|NCT00954681|1246496|P1|NOT COMPLETED|Overall Study||5
509485|NCT00954681|1246496|P1|COMPLETED|Overall Study||10
509486|NCT00954681|1246496|P1|STARTED|Overall Study||15
509487|NCT00954538|1246502|P6|NOT COMPLETED|Part III||0
509488|NCT00954538|1246503|P5|NOT COMPLETED|Part III||1
509489|NCT00954538|1246504|P4|NOT COMPLETED|Part III||0
509490|NCT00954538|1246505|P3|NOT COMPLETED|Part III||0
509491|NCT00954538|1246506|P2|NOT COMPLETED|Part III||0
509492|NCT00954538|1246507|P1|NOT COMPLETED|Part III||0
509493|NCT00954538|1246502|P6|COMPLETED|Part III||2
509494|NCT00954538|1246503|P5|COMPLETED|Part III|The subject who did not complete received 1 dose of study drug|5
509495|NCT00954538|1246504|P4|COMPLETED|Part III||4
509496|NCT00954538|1246505|P3|COMPLETED|Part III||0
509497|NCT00954538|1246506|P2|COMPLETED|Part III||0
509498|NCT00954538|1246507|P1|COMPLETED|Part III||0
509499|NCT00954538|1246502|P6|STARTED|Part III|These subjects did not participate in Part I and did participate in Part II and III|2
509500|NCT00954538|1246503|P5|STARTED|Part III|These subjects did not participate in Part I or II|6
509501|NCT00954538|1246504|P4|STARTED|Part III|These subjects did not participate in Part I or II|4
509502|NCT00954538|1246505|P3|STARTED|Part III||0
509503|NCT00954538|1246506|P2|STARTED|Part III||0
509504|NCT00954538|1246507|P1|STARTED|Part III||0
509505|NCT00954538|1246502|P6|NOT COMPLETED|Part II||0
509506|NCT00954538|1246503|P5|NOT COMPLETED|Part II||0
509507|NCT00954538|1246504|P4|NOT COMPLETED|Part II||0
509508|NCT00954538|1246505|P3|NOT COMPLETED|Part II||0
509509|NCT00954538|1246506|P2|NOT COMPLETED|Part II||0
509510|NCT00954538|1246507|P1|NOT COMPLETED|Part II||0
509511|NCT00954538|1246502|P6|COMPLETED|Part II||2
509512|NCT00954538|1246503|P5|COMPLETED|Part II||0
509513|NCT00954538|1246504|P4|COMPLETED|Part II||0
509514|NCT00954538|1246505|P3|COMPLETED|Part II||3
509515|NCT00954538|1246506|P2|COMPLETED|Part II||1
509516|NCT00954538|1246507|P1|COMPLETED|Part II||0
509517|NCT00954538|1246502|P6|STARTED|Part II|These subjects did not participate in Part I and did participate in Part II and III|2
509518|NCT00954538|1246503|P5|STARTED|Part II||0
509519|NCT00954538|1246504|P4|STARTED|Part II||0
509520|NCT00954538|1246505|P3|STARTED|Part II|These subjects did not participate in Part I or III|3
509521|NCT00954538|1246506|P2|STARTED|Part II|This subject did not participate in Part I or III|1
509522|NCT00954538|1246507|P1|STARTED|Part II||0
509523|NCT00954538|1246502|P6|NOT COMPLETED|Part I||0
509524|NCT00954538|1246503|P5|NOT COMPLETED|Part I||0
509525|NCT00954538|1246504|P4|NOT COMPLETED|Part I||0
509526|NCT00954538|1246505|P3|NOT COMPLETED|Part I||0
509527|NCT00954538|1246506|P2|NOT COMPLETED|Part I||0
509528|NCT00954538|1246507|P1|NOT COMPLETED|Part I||0
509529|NCT00954538|1246502|P6|COMPLETED|Part I||0
509530|NCT00954538|1246503|P5|COMPLETED|Part I||0
509531|NCT00954538|1246504|P4|COMPLETED|Part I||0
509532|NCT00954538|1246505|P3|COMPLETED|Part I||0
509533|NCT00954538|1246506|P2|COMPLETED|Part I||0
509534|NCT00954538|1246507|P1|COMPLETED|Part I||3
509535|NCT00954538|1246502|P6|STARTED|Part I||0
509536|NCT00954538|1246503|P5|STARTED|Part I||0
509537|NCT00954538|1246504|P4|STARTED|Part I||0
509538|NCT00954538|1246505|P3|STARTED|Part I||0
509539|NCT00954538|1246506|P2|STARTED|Part I||0
509540|NCT00954538|1246507|P1|STARTED|Part I|These subjects did not participate in Part II or III|3
509541|NCT00954512|1246524|P6|NOT COMPLETED|Overall Study||4
509542|NCT00954512|1246525|P5|NOT COMPLETED|Overall Study||4
509543|NCT00954512|1246526|P4|NOT COMPLETED|Overall Study||2
509544|NCT00954512|1246527|P3|NOT COMPLETED|Overall Study||0
509545|NCT00954512|1246528|P2|NOT COMPLETED|Overall Study||3
509546|NCT00954512|1246529|P1|NOT COMPLETED|Overall Study||2
509547|NCT00954512|1246524|P6|COMPLETED|Overall Study||0
509548|NCT00954512|1246525|P5|COMPLETED|Overall Study||0
509549|NCT00954512|1246526|P4|COMPLETED|Overall Study||0
509550|NCT00954512|1246527|P3|COMPLETED|Overall Study||0
509551|NCT00954512|1246528|P2|COMPLETED|Overall Study||0
509552|NCT00954512|1246529|P1|COMPLETED|Overall Study||0
509553|NCT00954512|1246524|P6|STARTED|Overall Study||4
509554|NCT00954512|1246525|P5|STARTED|Overall Study||4
509555|NCT00954512|1246526|P4|STARTED|Overall Study||2
509556|NCT00954512|1246527|P3|STARTED|Overall Study||0
509557|NCT00954512|1246528|P2|STARTED|Overall Study||3
509558|NCT00954512|1246529|P1|STARTED|Overall Study||2
509559|NCT00954447|1246550|P2|NOT COMPLETED|Overall Study||88
509560|NCT00954447|1246551|P1|NOT COMPLETED|Overall Study||110
509561|NCT00954447|1246550|P2|COMPLETED|Overall Study||543
509562|NCT00954447|1246551|P1|COMPLETED|Overall Study||520
509563|NCT00954447|1246550|P2|STARTED|Overall Study||631
509564|NCT00954447|1246551|P1|STARTED|Overall Study||630
509565|NCT00954421|1246587|P1|NOT COMPLETED|VIM=ON VO=OFF at 6 Months||1
509566|NCT00954421|1246587|P1|COMPLETED|VIM=ON VO=OFF at 6 Months||11
509567|NCT00954421|1246587|P1|STARTED|VIM=ON VO=OFF at 6 Months||12
509568|NCT00954421|1246587|P1|NOT COMPLETED|VIM=OFF VO=ON at 6 Months||0
509569|NCT00954421|1246587|P1|COMPLETED|VIM=OFF VO=ON at 6 Months||12
509570|NCT00954421|1246587|P1|STARTED|VIM=OFF VO=ON at 6 Months||12
509571|NCT00954421|1246587|P1|NOT COMPLETED|VIM=OFF VO=OFF at 6 Months||0
509572|NCT00954421|1246587|P1|COMPLETED|VIM=OFF VO=OFF at 6 Months||12
509573|NCT00954421|1246587|P1|STARTED|VIM=OFF VO=OFF at 6 Months||12
509574|NCT00954421|1246587|P1|NOT COMPLETED|VIM=ON VO=ON at 6 Months||0
509575|NCT00954421|1246587|P1|COMPLETED|VIM=ON VO=ON at 6 Months||12
509576|NCT00954421|1246587|P1|STARTED|VIM=ON VO=ON at 6 Months|This is the point of evaluation: Order of assessment was random for periods 4-7|12
509577|NCT00954421|1246587|P1|NOT COMPLETED|6 Months of DBS||1
509578|NCT00954421|1246587|P1|COMPLETED|6 Months of DBS||12
509579|NCT00954421|1246587|P1|STARTED|6 Months of DBS||13
509580|NCT00954421|1246587|P1|NOT COMPLETED|Baseline||0
509581|NCT00954421|1246587|P1|COMPLETED|Baseline||13
509582|NCT00954421|1246587|P1|STARTED|Baseline||13
509583|NCT00954421|1246587|P1|NOT COMPLETED|Screening||3
509584|NCT00954421|1246587|P1|COMPLETED|Screening||13
509585|NCT00954421|1246587|P1|STARTED|Screening||16
509586|NCT00954356|1246595|P2|NOT COMPLETED|Overall Study||0
509587|NCT00954356|1246596|P1|NOT COMPLETED|Overall Study||0
509588|NCT00954356|1246595|P2|COMPLETED|Overall Study||20
509589|NCT00954356|1246596|P1|COMPLETED|Overall Study||41
509590|NCT00954356|1246595|P2|STARTED|Overall Study||20
509591|NCT00954356|1246596|P1|STARTED|Overall Study||41
509592|NCT00954187|1246626|P2|NOT COMPLETED|Overall Study||0
509593|NCT00954187|1246627|P1|NOT COMPLETED|Overall Study||0
509594|NCT00954187|1246626|P2|COMPLETED|Overall Study||0
509595|NCT00954187|1246627|P1|COMPLETED|Overall Study||0
509596|NCT00954187|1246626|P2|STARTED|Overall Study|No subjects were assigned treatment and no study procedures were performed|0
509597|NCT00954187|1246627|P1|STARTED|Overall Study|No subjects were assigned treatment and no study procedures were performed|0
509598|NCT00954122|1246633|P1|NOT COMPLETED|Overall Study||7
509599|NCT00954122|1246633|P1|COMPLETED|Overall Study||28
509600|NCT00954122|1246633|P1|STARTED|Overall Study||35
509601|NCT00954109|1246643|P1|NOT COMPLETED|Overall Study||0
509602|NCT00954109|1246643|P1|COMPLETED|Overall Study||11
509603|NCT00954109|1246643|P1|STARTED|Overall Study||11
509604|NCT00953927|1246650|P2|NOT COMPLETED|Overall Study||95
509605|NCT00953927|1246651|P1|NOT COMPLETED|Overall Study||105
509606|NCT00953927|1246650|P2|COMPLETED|Overall Study||1303
509607|NCT00953927|1246651|P1|COMPLETED|Overall Study||1294
509608|NCT00953927|1246650|P2|STARTED|Overall Study||1398
509609|NCT00953927|1246651|P1|STARTED|Overall Study||1399
509610|NCT00953862|1246669|P1|NOT COMPLETED|Overall Study||6
509611|NCT00953862|1246669|P1|COMPLETED|Overall Study||12
509612|NCT00953862|1246669|P1|STARTED|Overall Study||18
509613|NCT00953849|1246679|P4|NOT COMPLETED|Overall Study||0
509614|NCT00953849|1246680|P3|NOT COMPLETED|Overall Study||0
509615|NCT00953849|1246681|P2|NOT COMPLETED|Overall Study||0
509616|NCT00953849|1246682|P1|NOT COMPLETED|Overall Study||0
509617|NCT00953849|1246679|P4|COMPLETED|Overall Study||5
509618|NCT00953849|1246680|P3|COMPLETED|Overall Study||4
509619|NCT00953849|1246681|P2|COMPLETED|Overall Study||6
509620|NCT00953849|1246682|P1|COMPLETED|Overall Study||6
509621|NCT00953849|1246679|P4|STARTED|Overall Study||5
509622|NCT00953849|1246680|P3|STARTED|Overall Study||4
509623|NCT00953849|1246681|P2|STARTED|Overall Study||6
509624|NCT00953849|1246682|P1|STARTED|Overall Study||6
509625|NCT00953745|1246706|P2|NOT COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
509626|NCT00953745|1246707|P1|NOT COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
509627|NCT00953745|1246706|P2|COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
509628|NCT00953745|1246707|P1|COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||17
509629|NCT00953745|1246706|P2|STARTED|ARP Phase: 6 Weeks Escitalopram + ARP||0
509630|NCT00953745|1246707|P1|STARTED|ARP Phase: 6 Weeks Escitalopram + ARP||17
509631|NCT00953745|1246706|P2|NOT COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||0
509632|NCT00953745|1246707|P1|NOT COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||1
509633|NCT00953745|1246706|P2|COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||0
509634|NCT00953745|1246707|P1|COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||17
509635|NCT00953745|1246706|P2|STARTED|Phase 2: 2 Weeks Escitalopram + Placebo||0
509636|NCT00953745|1246707|P1|STARTED|Phase 2: 2 Weeks Escitalopram + Placebo||18
509637|NCT00953745|1246706|P2|NOT COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||0
509638|NCT00953745|1246707|P1|NOT COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||13
509639|NCT00953745|1246706|P2|COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||6
509640|NCT00953745|1246707|P1|COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||24
509641|NCT00953745|1246706|P2|STARTED|Phase 1: 8 Weeks Escitalopram + Placebo||6
509642|NCT00953745|1246707|P1|STARTED|Phase 1: 8 Weeks Escitalopram + Placebo||37
509643|NCT00953719|1246717|P2|NOT COMPLETED|Overall Study||5
509644|NCT00953719|1246718|P1|NOT COMPLETED|Overall Study||19
509645|NCT00953719|1246717|P2|COMPLETED|Overall Study||69
509646|NCT00953719|1246718|P1|COMPLETED|Overall Study||150
509647|NCT00953719|1246717|P2|STARTED|Overall Study||74
509648|NCT00953719|1246718|P1|STARTED|Overall Study||169
509649|NCT00953706|1246740|P4|NOT COMPLETED|Part B (96-Week Open-Label Extension)||33
509650|NCT00953706|1246741|P3|NOT COMPLETED|Part B (96-Week Open-Label Extension)||5
509651|NCT00953706|1246742|P2|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0
509652|NCT00953706|1246743|P1|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0
509653|NCT00953706|1246740|P4|COMPLETED|Part B (96-Week Open-Label Extension)||0
509654|NCT00953706|1246741|P3|COMPLETED|Part B (96-Week Open-Label Extension)||0
509655|NCT00953706|1246742|P2|COMPLETED|Part B (96-Week Open-Label Extension)||0
509656|NCT00953706|1246743|P1|COMPLETED|Part B (96-Week Open-Label Extension)||0
509657|NCT00953706|1246740|P4|STARTED|Part B (96-Week Open-Label Extension)||33
509658|NCT00953706|1246741|P3|STARTED|Part B (96-Week Open-Label Extension)||5
509659|NCT00953706|1246742|P2|STARTED|Part B (96-Week Open-Label Extension)||0
509660|NCT00953706|1246743|P1|STARTED|Part B (96-Week Open-Label Extension)||0
509661|NCT00953706|1246740|P4|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0
509662|NCT00953706|1246741|P3|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0
509663|NCT00953706|1246742|P2|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||8
509664|NCT00953706|1246743|P1|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||2
509665|NCT00953706|1246740|P4|COMPLETED|Part A (16-Week Double-Blind Treatment)||0
509666|NCT00953706|1246741|P3|COMPLETED|Part A (16-Week Double-Blind Treatment)||0
509667|NCT00953706|1246742|P2|COMPLETED|Part A (16-Week Double-Blind Treatment)|Only 33 participants continued in Part B.|104
509668|NCT00953706|1246743|P1|COMPLETED|Part A (16-Week Double-Blind Treatment)|Only 5 participants continued in Part B.|26
509669|NCT00953706|1246740|P4|STARTED|Part A (16-Week Double-Blind Treatment)||0
509670|NCT00953706|1246741|P3|STARTED|Part A (16-Week Double-Blind Treatment)||0
509671|NCT00953706|1246742|P2|STARTED|Part A (16-Week Double-Blind Treatment)|All subjects who received at least 1 dose of study drug (ivacaftor)|112
509672|NCT00953706|1246743|P1|STARTED|Part A (16-Week Double-Blind Treatment)|All subjects who received at least 1 dose of study drug (placebo)|28
509673|NCT00953680|1246775|P2|NOT COMPLETED|Period 2||0
509674|NCT00953680|1246776|P1|NOT COMPLETED|Period 2||0
509675|NCT00953680|1246775|P2|COMPLETED|Period 2||38
509676|NCT00953680|1246776|P1|COMPLETED|Period 2||38
509677|NCT00953680|1246775|P2|STARTED|Period 2||38
509678|NCT00953680|1246776|P1|STARTED|Period 2||38
509679|NCT00953680|1246775|P2|NOT COMPLETED|Period 1||1
509680|NCT00953680|1246776|P1|NOT COMPLETED|Period 1||0
509681|NCT00953680|1246775|P2|COMPLETED|Period 1||38
509682|NCT00953680|1246776|P1|COMPLETED|Period 1||38
509683|NCT00953680|1246775|P2|STARTED|Period 1||39
509684|NCT00953680|1246776|P1|STARTED|Period 1||38
509685|NCT00953667|1246788|P1|NOT COMPLETED|Overall Study||123
509686|NCT00953667|1246788|P1|COMPLETED|Overall Study||277
509687|NCT00953667|1246788|P1|STARTED|Overall Study||400
509688|NCT00953654|1246796|P3|NOT COMPLETED|Overall Study||0
509689|NCT00953654|1246797|P2|NOT COMPLETED|Overall Study||0
509690|NCT00953654|1246798|P1|NOT COMPLETED|Overall Study||0
509691|NCT00953654|1246796|P3|COMPLETED|Overall Study||10
509692|NCT00953654|1246797|P2|COMPLETED|Overall Study||10
509693|NCT00953654|1246798|P1|COMPLETED|Overall Study||10
509694|NCT00953654|1246796|P3|STARTED|Overall Study||10
509695|NCT00953654|1246797|P2|STARTED|Overall Study||10
509696|NCT00953654|1246798|P1|STARTED|Overall Study||10
509697|NCT00953615|1246809|P1|NOT COMPLETED|Overall Study||1
509698|NCT00953615|1246809|P1|COMPLETED|Overall Study||0
509699|NCT00953615|1246809|P1|STARTED|Overall Study||1
509700|NCT00953524|1246820|P4|NOT COMPLETED|Overall Study||8
509701|NCT00953524|1246821|P3|NOT COMPLETED|Overall Study||14
509702|NCT00953524|1246822|P2|NOT COMPLETED|Overall Study||15
509703|NCT00953524|1246823|P1|NOT COMPLETED|Overall Study||22
509704|NCT00953524|1246820|P4|COMPLETED|Overall Study||91
509705|NCT00953524|1246821|P3|COMPLETED|Overall Study||233
509706|NCT00953524|1246822|P2|COMPLETED|Overall Study||239
509707|NCT00953524|1246823|P1|COMPLETED|Overall Study||227
509708|NCT00953524|1246820|P4|STARTED|Overall Study||99
509709|NCT00953524|1246821|P3|STARTED|Overall Study||247
509710|NCT00953524|1246822|P2|STARTED|Overall Study||254
509711|NCT00953524|1246823|P1|STARTED|Overall Study||249
509712|NCT00953407|1246866|P5|NOT COMPLETED|Overall Study||1
509713|NCT00953407|1246867|P4|NOT COMPLETED|Overall Study||2
509714|NCT00953407|1246868|P3|NOT COMPLETED|Overall Study||1
509715|NCT00953407|1246869|P2|NOT COMPLETED|Overall Study||1
509716|NCT00953407|1246870|P1|NOT COMPLETED|Overall Study||1
509717|NCT00953407|1246866|P5|COMPLETED|Overall Study||23
509718|NCT00953407|1246867|P4|COMPLETED|Overall Study||23
509719|NCT00953407|1246868|P3|COMPLETED|Overall Study||25
509720|NCT00953407|1246869|P2|COMPLETED|Overall Study||24
509721|NCT00953407|1246870|P1|COMPLETED|Overall Study||25
509722|NCT00953407|1246866|P5|STARTED|Overall Study||24
509723|NCT00953407|1246867|P4|STARTED|Overall Study||25
509724|NCT00953407|1246868|P3|STARTED|Overall Study||26
509725|NCT00953407|1246869|P2|STARTED|Overall Study||25
509726|NCT00953407|1246870|P1|STARTED|Overall Study||26
509727|NCT00953329|1246882|P1|NOT COMPLETED|Overall Study||1
509728|NCT00953329|1246882|P1|COMPLETED|Overall Study||0
509729|NCT00953329|1246882|P1|STARTED|Overall Study||1
509730|NCT00953290|1246886|P1|NOT COMPLETED|Overall Study||0
509731|NCT00953290|1246886|P1|COMPLETED|Overall Study||4
509732|NCT00953290|1246886|P1|STARTED|Overall Study||4
509733|NCT00953225|1246895|P2|NOT COMPLETED|Overall Study||0
509734|NCT00953225|1246896|P1|NOT COMPLETED|Overall Study||2
509735|NCT00953225|1246895|P2|COMPLETED|Overall Study||37
509736|NCT00953225|1246896|P1|COMPLETED|Overall Study||44
509737|NCT00953225|1246895|P2|STARTED|Overall Study||37
509738|NCT00953225|1246896|P1|STARTED|Overall Study||46
509739|NCT00953212|1246908|P4|NOT COMPLETED|Overall Study||0
509740|NCT00953212|1246909|P3|NOT COMPLETED|Overall Study||0
509741|NCT00953212|1246910|P2|NOT COMPLETED|Overall Study||0
509742|NCT00953212|1246911|P1|NOT COMPLETED|Overall Study||0
509743|NCT00953212|1246908|P4|COMPLETED|Overall Study||76
509744|NCT00953212|1246909|P3|COMPLETED|Overall Study||78
509745|NCT00953212|1246910|P2|COMPLETED|Overall Study||74
509746|NCT00953212|1246911|P1|COMPLETED|Overall Study||76
509747|NCT00953212|1246908|P4|STARTED|Overall Study||76
509748|NCT00953212|1246909|P3|STARTED|Overall Study||78
509749|NCT00953212|1246910|P2|STARTED|Overall Study||74
509750|NCT00953212|1246911|P1|STARTED|Overall Study||76
509751|NCT00953199|1246967|P2|NOT COMPLETED|Overall Study||0
509752|NCT00953199|1246968|P1|NOT COMPLETED|Overall Study||0
509753|NCT00953199|1246967|P2|COMPLETED|Overall Study||252
509754|NCT00953199|1246968|P1|COMPLETED|Overall Study||254
509755|NCT00953199|1246967|P2|STARTED|Overall Study||252
509756|NCT00953199|1246968|P1|STARTED|Overall Study||254
509757|NCT00953173|1246976|P1|NOT COMPLETED|Overall Study||282
509758|NCT00953173|1246976|P1|COMPLETED|Overall Study||389
509759|NCT00953173|1246976|P1|STARTED|Overall Study||671
509760|NCT00953160|1246980|P1|NOT COMPLETED|Overall Study||27
509761|NCT00953160|1246980|P1|COMPLETED|Overall Study||49
509762|NCT00953160|1246980|P1|STARTED|Overall Study||76
509763|NCT00953147|1246989|P3|NOT COMPLETED|Overall Study||42
509764|NCT00953147|1246990|P2|NOT COMPLETED|Overall Study||66
509765|NCT00953147|1246991|P1|NOT COMPLETED|Overall Study||37
509766|NCT00953147|1246989|P3|COMPLETED|Overall Study||265
509767|NCT00953147|1246990|P2|COMPLETED|Overall Study||439
509768|NCT00953147|1246991|P1|COMPLETED|Overall Study||261
509769|NCT00953147|1246989|P3|STARTED|Overall Study||307
509770|NCT00953147|1246990|P2|STARTED|Overall Study||505
509771|NCT00953147|1246991|P1|STARTED|Overall Study||298
509772|NCT00953121|1247041|P3|NOT COMPLETED|Overall Study||0
509773|NCT00953121|1247042|P2|NOT COMPLETED|Overall Study||0
509774|NCT00953121|1247043|P1|NOT COMPLETED|Overall Study||0
509775|NCT00953121|1247041|P3|COMPLETED|Overall Study||25
509776|NCT00953121|1247042|P2|COMPLETED|Overall Study||39
509777|NCT00953121|1247043|P1|COMPLETED|Overall Study||40
509778|NCT00953121|1247041|P3|STARTED|Overall Study||25
509779|NCT00953121|1247042|P2|STARTED|Overall Study||39
509780|NCT00953121|1247043|P1|STARTED|Overall Study||40
509781|NCT00953056|1247069|P6|NOT COMPLETED|Overall Study||4
509782|NCT00953056|1247070|P5|NOT COMPLETED|Overall Study||2
509783|NCT00953056|1247071|P4|NOT COMPLETED|Overall Study||0
509784|NCT00953056|1247072|P3|NOT COMPLETED|Overall Study||0
509785|NCT00953056|1247073|P2|NOT COMPLETED|Overall Study||0
509786|NCT00953056|1247074|P1|NOT COMPLETED|Overall Study||0
509787|NCT00953056|1247069|P6|COMPLETED|Overall Study||20
509788|NCT00953056|1247070|P5|COMPLETED|Overall Study|One participant received placebo at the second dose in error, but completed the study.|22
509789|NCT00953056|1247071|P4|COMPLETED|Overall Study||24
509790|NCT00953056|1247072|P3|COMPLETED|Overall Study||24
509791|NCT00953056|1247073|P2|COMPLETED|Overall Study||24
509792|NCT00953056|1247074|P1|COMPLETED|Overall Study||24
509793|NCT00953056|1247069|P6|STARTED|Overall Study||24
509794|NCT00953056|1247070|P5|STARTED|Overall Study||24
509795|NCT00953056|1247071|P4|STARTED|Overall Study||24
509796|NCT00953056|1247072|P3|STARTED|Overall Study||24
509797|NCT00953056|1247073|P2|STARTED|Overall Study||24
509798|NCT00953056|1247074|P1|STARTED|Overall Study||24
509799|NCT00953043|1247098|P2|NOT COMPLETED|Overall Study||2
509800|NCT00953043|1247099|P1|NOT COMPLETED|Overall Study||4
509801|NCT00953043|1247098|P2|COMPLETED|Overall Study||28
509802|NCT00953043|1247099|P1|COMPLETED|Overall Study||26
509803|NCT00953043|1247098|P2|STARTED|Overall Study||30
509804|NCT00953043|1247099|P1|STARTED|Overall Study||30
509805|NCT00953017|1247123|P4|NOT COMPLETED|Overall Study||5
509806|NCT00953017|1247124|P3|NOT COMPLETED|Overall Study||6
509807|NCT00953017|1247125|P2|NOT COMPLETED|Overall Study||6
509808|NCT00953017|1247126|P1|NOT COMPLETED|Overall Study||5
509809|NCT00953017|1247123|P4|COMPLETED|Overall Study||101
509810|NCT00953017|1247124|P3|COMPLETED|Overall Study||100
509811|NCT00953017|1247125|P2|COMPLETED|Overall Study||101
509812|NCT00953017|1247126|P1|COMPLETED|Overall Study||101
509813|NCT00953017|1247123|P4|STARTED|Overall Study||106
509814|NCT00953017|1247124|P3|STARTED|Overall Study||106
509815|NCT00953017|1247125|P2|STARTED|Overall Study||107
509816|NCT00953017|1247126|P1|STARTED|Overall Study||106
509817|NCT00952848|1247148|P1|NOT COMPLETED|Overall Study||4
509818|NCT00952848|1247148|P1|COMPLETED|Overall Study||14
509819|NCT00952848|1247148|P1|STARTED|Overall Study||18
509820|NCT00952822|1247155|P4|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
509821|NCT00952822|1247156|P3|NOT COMPLETED|2nd Pharmacokinetic Evaluation||1
509822|NCT00952822|1247157|P2|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
509823|NCT00952822|1247158|P1|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
509824|NCT00952822|1247155|P4|COMPLETED|2nd Pharmacokinetic Evaluation||4
509825|NCT00952822|1247156|P3|COMPLETED|2nd Pharmacokinetic Evaluation||10
509826|NCT00952822|1247157|P2|COMPLETED|2nd Pharmacokinetic Evaluation||17
509827|NCT00952822|1247158|P1|COMPLETED|2nd Pharmacokinetic Evaluation||9
509828|NCT00952822|1247155|P4|STARTED|2nd Pharmacokinetic Evaluation||4
509829|NCT00952822|1247156|P3|STARTED|2nd Pharmacokinetic Evaluation||11
509830|NCT00952822|1247157|P2|STARTED|2nd Pharmacokinetic Evaluation||17
509831|NCT00952822|1247158|P1|STARTED|2nd Pharmacokinetic Evaluation||9
509832|NCT00952822|1247155|P4|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
509833|NCT00952822|1247156|P3|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
509834|NCT00952822|1247157|P2|NOT COMPLETED|1st Pharmacokinetic Evaluation||1
509835|NCT00952822|1247158|P1|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
509836|NCT00952822|1247155|P4|COMPLETED|1st Pharmacokinetic Evaluation||4
509837|NCT00952822|1247156|P3|COMPLETED|1st Pharmacokinetic Evaluation||11
509838|NCT00952822|1247157|P2|COMPLETED|1st Pharmacokinetic Evaluation||17
509839|NCT00952822|1247158|P1|COMPLETED|1st Pharmacokinetic Evaluation||9
509840|NCT00952822|1247155|P4|STARTED|1st Pharmacokinetic Evaluation||4
509841|NCT00952822|1247156|P3|STARTED|1st Pharmacokinetic Evaluation||11
509842|NCT00952822|1247157|P2|STARTED|1st Pharmacokinetic Evaluation||18
509843|NCT00952822|1247158|P1|STARTED|1st Pharmacokinetic Evaluation||9
509844|NCT00952731|1247190|P2|NOT COMPLETED|Overall Study||0
509845|NCT00952731|1247191|P1|NOT COMPLETED|Overall Study||1
509846|NCT00952731|1247190|P2|COMPLETED|Overall Study||14
509847|NCT00952731|1247191|P1|COMPLETED|Overall Study||12
509848|NCT00952731|1247190|P2|Follow-up|Overall Study||14
509849|NCT00952731|1247191|P1|Follow-up|Overall Study||12
509850|NCT00952731|1247190|P2|Surgery|Overall Study||14
509851|NCT00952731|1247191|P1|Surgery|Overall Study||12
509852|NCT00952731|1247190|P2|Treatment & Pre-Surgery|Overall Study||14
509853|NCT00952731|1247191|P1|Treatment & Pre-Surgery|Overall Study||12
509854|NCT00952731|1247190|P2|Randomization|Overall Study||14
509855|NCT00952731|1247191|P1|Randomization|Overall Study||13
509856|NCT00952731|1247190|P2|STARTED|Overall Study||14
509857|NCT00952731|1247191|P1|STARTED|Overall Study||13
509858|NCT00952705|1247210|P3|NOT COMPLETED|Overall Study||10
509859|NCT00952705|1247211|P2|NOT COMPLETED|Overall Study||10
509860|NCT00952705|1247212|P1|NOT COMPLETED|Overall Study||33
509861|NCT00952705|1247210|P3|COMPLETED|Overall Study||288
509862|NCT00952705|1247211|P2|COMPLETED|Overall Study||290
509863|NCT00952705|1247212|P1|COMPLETED|Overall Study||1169
509864|NCT00952705|1247210|P3|STARTED|Overall Study||298
509865|NCT00952705|1247211|P2|STARTED|Overall Study||300
509866|NCT00952705|1247212|P1|STARTED|Overall Study|Three not treated with Q/LAIV-BFS (1 treated with FluMist/B/Yamagata; 2 withdrew prior to dosing).|1202
509867|NCT00952653|1247274|P1|NOT COMPLETED|Period 2: Coadministration DVS SR, MDZ||0
509868|NCT00952653|1247274|P1|COMPLETED|Period 2: Coadministration DVS SR, MDZ||28
509869|NCT00952653|1247274|P1|STARTED|Period 2: Coadministration DVS SR, MDZ||28
509870|NCT00952653|1247274|P1|NOT COMPLETED|Period 1: MDZ Alone||0
509871|NCT00952653|1247274|P1|COMPLETED|Period 1: MDZ Alone||28
509872|NCT00952653|1247274|P1|STARTED|Period 1: MDZ Alone||28
509873|NCT00952614|1247299|P1|NOT COMPLETED|Overall Study||7
509874|NCT00952614|1247299|P1|COMPLETED|Overall Study|3 subjects died from unrelated causes, 3 were lost to follow-up & 1 had both eyes included in study.|23
509875|NCT00952614|1247299|P1|Participants Started Treatment|Overall Study|29 subjects signed consent; 1 agreed for both eyes to enroll. 30 eyes rec'd drug delivery implant|30
509876|NCT00952614|1247299|P1|STARTED|Overall Study||30
509877|NCT00952588|1247306|P2|NOT COMPLETED|Overall Study||24
509878|NCT00952588|1247307|P1|NOT COMPLETED|Overall Study||36
509879|NCT00952588|1247306|P2|COMPLETED|Overall Study||2
509880|NCT00952588|1247307|P1|COMPLETED|Overall Study||12
509881|NCT00952588|1247306|P2|STARTED|Overall Study||26
509882|NCT00952588|1247307|P1|STARTED|Overall Study||48
509883|NCT00952523|1247325|P1|NOT COMPLETED|Overall Study||7
509884|NCT00952523|1247325|P1|COMPLETED|Overall Study||155
509885|NCT00952523|1247325|P1|STARTED|Overall Study||162
509886|NCT00952484|1247334|P3|NOT COMPLETED|Overall Study||0
509887|NCT00952484|1247335|P2|NOT COMPLETED|Overall Study||1
509888|NCT00952484|1247336|P1|NOT COMPLETED|Overall Study||0
509889|NCT00952484|1247334|P3|COMPLETED|Overall Study||16
509890|NCT00952484|1247335|P2|COMPLETED|Overall Study||6
509891|NCT00952484|1247336|P1|COMPLETED|Overall Study||6
509892|NCT00952484|1247334|P3|STARTED|Overall Study||16
509893|NCT00952484|1247335|P2|STARTED|Overall Study||7
509894|NCT00952484|1247336|P1|STARTED|Overall Study||6
509895|NCT00952419|1247363|P3|NOT COMPLETED|Overall Study||0
509896|NCT00952419|1247364|P2|NOT COMPLETED|Overall Study||10
509897|NCT00952419|1247365|P1|NOT COMPLETED|Overall Study||6
509898|NCT00952419|1247363|P3|COMPLETED|Overall Study||51
509899|NCT00952419|1247364|P2|COMPLETED|Overall Study||198
509900|NCT00952419|1247365|P1|COMPLETED|Overall Study||209
509901|NCT00952419|1247363|P3|STARTED|Overall Study||51
509902|NCT00952419|1247364|P2|STARTED|Overall Study||208
509903|NCT00952419|1247365|P1|STARTED|Overall Study||215
509904|NCT00952393|1247397|P1|NOT COMPLETED|Overall Study||0
509905|NCT00952393|1247397|P1|COMPLETED|Overall Study||10
509906|NCT00952393|1247397|P1|STARTED|Overall Study|10|10
509907|NCT00952367|1247401|P1|NOT COMPLETED|Overall Study||6
509908|NCT00952367|1247401|P1|COMPLETED|Overall Study||3635
509909|NCT00952367|1247401|P1|STARTED|Overall Study||3641
509910|NCT00952341|1247416|P2|NOT COMPLETED|Cycle 2||12
509911|NCT00952341|1247417|P1|NOT COMPLETED|Cycle 2||9
509912|NCT00952341|1247416|P2|COMPLETED|Cycle 2||118
509913|NCT00952341|1247417|P1|COMPLETED|Cycle 2||101
509914|NCT00952341|1247416|P2|STARTED|Cycle 2||130
509915|NCT00952341|1247417|P1|STARTED|Cycle 2||110
509916|NCT00952341|1247416|P2|NOT COMPLETED|Cycle 1||13
509917|NCT00952341|1247417|P1|NOT COMPLETED|Cycle 1||20
509918|NCT00952341|1247416|P2|COMPLETED|Cycle 1||199
509919|NCT00952341|1247417|P1|COMPLETED|Cycle 1||189
509920|NCT00952341|1247416|P2|STARTED|Cycle 1||212
509921|NCT00952341|1247417|P1|STARTED|Cycle 1||209
509922|NCT00952289|1247439|P2|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||54
509923|NCT00952289|1247440|P1|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||0
509924|NCT00952289|1247439|P2|COMPLETED|Patients Who Crossed Over to Ruxolitinib|Number of cross over subjects who were still in the study as of 25 JAN 2013|57
509925|NCT00952289|1247440|P1|COMPLETED|Patients Who Crossed Over to Ruxolitinib||0
509926|NCT00952289|1247439|P2|STARTED|Patients Who Crossed Over to Ruxolitinib||111
509927|NCT00952289|1247440|P1|STARTED|Patients Who Crossed Over to Ruxolitinib||0
509928|NCT00952289|1247439|P2|NOT COMPLETED|All Participants||40
509929|NCT00952289|1247440|P1|NOT COMPLETED|All Participants||21
509930|NCT00952289|1247439|P2|COMPLETED|All Participants|Includes patients in the study as of 2 November 2010 (78) + those who crossed over to Ruxolitinib.|114
509931|NCT00952289|1247440|P1|COMPLETED|All Participants|Represents the number of patients who were still in the study as of 02 November 2010|134
509932|NCT00952289|1247439|P2|Safety Population|All Participants|Randomized patients who are documented to have received at least 1 dose of study medication.|151
509933|NCT00952289|1247440|P1|Safety Population|All Participants||155
509934|NCT00952289|1247439|P2|STARTED|All Participants||154
509935|NCT00952289|1247440|P1|STARTED|All Participants||155
509936|NCT00952276|1247469|P5|NOT COMPLETED|Overall Study||0
509937|NCT00952276|1247470|P4|NOT COMPLETED|Overall Study||1
509938|NCT00952276|1247471|P3|NOT COMPLETED|Overall Study||0
509939|NCT00952276|1247472|P2|NOT COMPLETED|Overall Study||0
509940|NCT00952276|1247473|P1|NOT COMPLETED|Overall Study||1
509941|NCT00952276|1247469|P5|COMPLETED|Overall Study||63
509942|NCT00952276|1247470|P4|COMPLETED|Overall Study||120
509943|NCT00952276|1247471|P3|COMPLETED|Overall Study||122
509944|NCT00952276|1247472|P2|COMPLETED|Overall Study||115
509945|NCT00952276|1247473|P1|COMPLETED|Overall Study||126
509946|NCT00952276|1247469|P5|STARTED|Overall Study||63
509947|NCT00952276|1247470|P4|STARTED|Overall Study||121
509948|NCT00952276|1247471|P3|STARTED|Overall Study||122
509949|NCT00952276|1247472|P2|STARTED|Overall Study||115
509950|NCT00952276|1247473|P1|STARTED|Overall Study||127
509951|NCT00952211|1247522|P2|NOT COMPLETED|Overall Study||0
509952|NCT00952211|1247523|P1|NOT COMPLETED|Overall Study||0
509953|NCT00952211|1247522|P2|COMPLETED|Overall Study||0
509954|NCT00952211|1247523|P1|COMPLETED|Overall Study||3
509955|NCT00952211|1247522|P2|STARTED|Overall Study||0
509956|NCT00952211|1247523|P1|STARTED|Overall Study||3
509957|NCT00952133|1247533|P2|NOT COMPLETED|Overall Study||0
509958|NCT00952133|1247534|P1|NOT COMPLETED|Overall Study||0
509959|NCT00952133|1247533|P2|COMPLETED|Overall Study||59
509960|NCT00952133|1247534|P1|COMPLETED|Overall Study||59
509961|NCT00952133|1247533|P2|STARTED|Overall Study||59
509962|NCT00952133|1247534|P1|STARTED|Overall Study||59
509963|NCT00952120|1247545|P3|NOT COMPLETED|Overall Study||0
509964|NCT00952120|1247546|P2|NOT COMPLETED|Overall Study||0
509965|NCT00952120|1247547|P1|NOT COMPLETED|Overall Study||0
509966|NCT00952120|1247545|P3|COMPLETED|Overall Study||5
509967|NCT00952120|1247546|P2|COMPLETED|Overall Study||47
509968|NCT00952120|1247547|P1|COMPLETED|Overall Study||52
509969|NCT00952120|1247545|P3|STARTED|Overall Study||5
509970|NCT00952120|1247546|P2|STARTED|Overall Study||47
509971|NCT00952120|1247547|P1|STARTED|Overall Study||52
509972|NCT00952081|1247555|P1|NOT COMPLETED|Overall Study||0
509973|NCT00952081|1247555|P1|COMPLETED|Overall Study||22
509974|NCT00952081|1247555|P1|STARTED|Overall Study||22
509975|NCT00952068|1247559|P1|NOT COMPLETED|Overall Study||7
509976|NCT00952068|1247559|P1|COMPLETED|Overall Study||40
509977|NCT00952068|1247559|P1|STARTED|Overall Study||47
509978|NCT00951912|1247570|P3|NOT COMPLETED|Overall Study||2
509979|NCT00951912|1247571|P2|NOT COMPLETED|Overall Study||5
509980|NCT00951912|1247572|P1|NOT COMPLETED|Overall Study||7
509981|NCT00951912|1247570|P3|COMPLETED|Overall Study||54
509982|NCT00951912|1247571|P2|COMPLETED|Overall Study||50
509983|NCT00951912|1247572|P1|COMPLETED|Overall Study||47
509984|NCT00951912|1247570|P3|STARTED|Overall Study||56
509985|NCT00951912|1247571|P2|STARTED|Overall Study||55
509986|NCT00951912|1247572|P1|STARTED|Overall Study||54
509987|NCT00951899|1247624|P2|NOT COMPLETED|Overall Study||0
509988|NCT00951899|1247625|P1|NOT COMPLETED|Overall Study||0
509989|NCT00951899|1247624|P2|COMPLETED|Overall Study||19
509990|NCT00951899|1247625|P1|COMPLETED|Overall Study||19
509991|NCT00951899|1247624|P2|STARTED|Overall Study||19
509992|NCT00951899|1247625|P1|STARTED|Overall Study||19
509993|NCT00951821|1247649|P2|NOT COMPLETED|Overall Study||0
509994|NCT00951821|1247650|P1|NOT COMPLETED|Overall Study||0
509995|NCT00951821|1247649|P2|COMPLETED|Overall Study||8
509996|NCT00951821|1247650|P1|COMPLETED|Overall Study||16
509997|NCT00951821|1247649|P2|STARTED|Overall Study||8
509998|NCT00951821|1247650|P1|STARTED|Overall Study||16
509999|NCT00951808|1247658|P3|NOT COMPLETED|Overall Study||4
510000|NCT00951808|1247659|P2|NOT COMPLETED|Overall Study||0
510001|NCT00951808|1247660|P1|NOT COMPLETED|Overall Study||0
510002|NCT00951808|1247658|P3|COMPLETED|Overall Study|Four subjects withdrew from the study.|223
510003|NCT00951808|1247659|P2|COMPLETED|Overall Study||6
510004|NCT00951808|1247660|P1|COMPLETED|Overall Study||4
510005|NCT00951808|1247658|P3|STARTED|Overall Study||227
510006|NCT00951808|1247659|P2|STARTED|Overall Study||6
510007|NCT00951808|1247660|P1|STARTED|Overall Study||4
510008|NCT00951665|1247672|P6|NOT COMPLETED|Phase 2a||7
510009|NCT00951665|1247673|P5|NOT COMPLETED|Phase 2a||12
510010|NCT00951665|1247674|P4|NOT COMPLETED|Phase 2a||0
510011|NCT00951665|1247675|P3|NOT COMPLETED|Phase 2a||0
510012|NCT00951665|1247676|P2|NOT COMPLETED|Phase 2a||0
510013|NCT00951665|1247677|P1|NOT COMPLETED|Phase 2a||0
510014|NCT00951665|1247672|P6|COMPLETED|Phase 2a||15
510015|NCT00951665|1247673|P5|COMPLETED|Phase 2a||10
510016|NCT00951665|1247674|P4|COMPLETED|Phase 2a||0
510017|NCT00951665|1247675|P3|COMPLETED|Phase 2a||0
510018|NCT00951665|1247676|P2|COMPLETED|Phase 2a||0
510019|NCT00951665|1247677|P1|COMPLETED|Phase 2a||0
510020|NCT00951665|1247672|P6|STARTED|Phase 2a||22
510021|NCT00951665|1247673|P5|STARTED|Phase 2a||22
510022|NCT00951665|1247674|P4|STARTED|Phase 2a||0
510023|NCT00951665|1247675|P3|STARTED|Phase 2a||0
510024|NCT00951665|1247676|P2|STARTED|Phase 2a||0
510025|NCT00951665|1247677|P1|STARTED|Phase 2a||0
510026|NCT00951665|1247672|P6|NOT COMPLETED|Phase 1b||0
510027|NCT00951665|1247673|P5|NOT COMPLETED|Phase 1b||0
510028|NCT00951665|1247674|P4|NOT COMPLETED|Phase 1b||1
510029|NCT00951665|1247675|P3|NOT COMPLETED|Phase 1b||17
510030|NCT00951665|1247676|P2|NOT COMPLETED|Phase 1b||4
510031|NCT00951665|1247677|P1|NOT COMPLETED|Phase 1b||22
510032|NCT00951665|1247672|P6|COMPLETED|Phase 1b||0
510033|NCT00951665|1247673|P5|COMPLETED|Phase 1b||0
510034|NCT00951665|1247674|P4|COMPLETED|Phase 1b||2
510035|NCT00951665|1247675|P3|COMPLETED|Phase 1b||4
510036|NCT00951665|1247676|P2|COMPLETED|Phase 1b||6
510037|NCT00951665|1247677|P1|COMPLETED|Phase 1b||7
510038|NCT00951665|1247672|P6|Started Treatment|Phase 1b||0
510039|NCT00951665|1247673|P5|Started Treatment|Phase 1b||0
510040|NCT00951665|1247674|P4|Started Treatment|Phase 1b||3
510041|NCT00951665|1247675|P3|Started Treatment|Phase 1b||21
510042|NCT00951665|1247676|P2|Started Treatment|Phase 1b||10
510043|NCT00951665|1247677|P1|Started Treatment|Phase 1b||26
510044|NCT00951665|1247672|P6|STARTED|Phase 1b||0
510045|NCT00951665|1247673|P5|STARTED|Phase 1b||0
510046|NCT00951665|1247674|P4|STARTED|Phase 1b||3
510047|NCT00951665|1247675|P3|STARTED|Phase 1b||21
510048|NCT00951665|1247676|P2|STARTED|Phase 1b||10
510049|NCT00951665|1247677|P1|STARTED|Phase 1b||29
510050|NCT00951561|1247778|P4|NOT COMPLETED|Overall Study||1
510051|NCT00951561|1247779|P3|NOT COMPLETED|Overall Study||3
510052|NCT00951561|1247780|P2|NOT COMPLETED|Overall Study||0
510053|NCT00951561|1247781|P1|NOT COMPLETED|Overall Study||0
510054|NCT00951561|1247778|P4|COMPLETED|Overall Study|1 subject dropped after period 2|26
510055|NCT00951561|1247779|P3|COMPLETED|Overall Study|3 subjects dropped after period 2|18
510056|NCT00951561|1247780|P2|COMPLETED|Overall Study||29
510057|NCT00951561|1247781|P1|COMPLETED|Overall Study||25
510058|NCT00951561|1247778|P4|STARTED|Overall Study||27
510059|NCT00951561|1247779|P3|STARTED|Overall Study|1 subject used Vipon periods 1 & 2 instead of Ibuprofen period 2.|21
510060|NCT00951561|1247780|P2|STARTED|Overall Study||29
510061|NCT00951561|1247781|P1|STARTED|Overall Study|Randomized Vipon or Ibuprofen period 1, crossover period 2, randomized period 3, crossover period 4|25
510062|NCT00951509|1247786|P1|NOT COMPLETED|Overall Study||2
510063|NCT00951509|1247786|P1|COMPLETED|Overall Study||29
510064|NCT00951509|1247786|P1|Driving Condition 5|Overall Study||30
510065|NCT00951509|1247786|P1|Driving Condition 4|Overall Study||28
510066|NCT00951509|1247786|P1|Driving Condition 3|Overall Study||25
510067|NCT00951509|1247786|P1|Driving Condition 2|Overall Study||29
510068|NCT00951509|1247786|P1|Driving Condition 1|Overall Study||29
510069|NCT00951509|1247786|P1|STARTED|Overall Study||31
510070|NCT00951496|1247797|P3|NOT COMPLETED|Overall Study||13
510071|NCT00951496|1247798|P2|NOT COMPLETED|Overall Study||8
510072|NCT00951496|1247799|P1|NOT COMPLETED|Overall Study||10
510073|NCT00951496|1247797|P3|COMPLETED|Overall Study||508
510074|NCT00951496|1247798|P2|COMPLETED|Overall Study||510
510075|NCT00951496|1247799|P1|COMPLETED|Overall Study||511
510076|NCT00951496|1247797|P3|STARTED|Overall Study||521
510077|NCT00951496|1247798|P2|STARTED|Overall Study||518
510078|NCT00951496|1247799|P1|STARTED|Overall Study||521
510079|NCT00951483|1247827|P2|NOT COMPLETED|Overall Study||0
510080|NCT00951483|1247828|P1|NOT COMPLETED|Overall Study||19
510081|NCT00951483|1247827|P2|COMPLETED|Overall Study||44
510082|NCT00951483|1247828|P1|COMPLETED|Overall Study||28
510083|NCT00951483|1247827|P2|STARTED|Overall Study||44
510084|NCT00951483|1247828|P1|STARTED|Overall Study||47
510085|NCT00951379|1247848|P2|NOT COMPLETED|Overall Study||2
510086|NCT00951379|1247849|P1|NOT COMPLETED|Overall Study||6
510087|NCT00951379|1247848|P2|COMPLETED|Overall Study||23
510088|NCT00951379|1247849|P1|COMPLETED|Overall Study||21
510089|NCT00951379|1247848|P2|STARTED|Overall Study||25
510090|NCT00951379|1247849|P1|STARTED|Overall Study||27
510091|NCT00951275|1247891|P1|NOT COMPLETED|Overall Study||13
510092|NCT00951275|1247891|P1|COMPLETED|Overall Study||92
510093|NCT00951275|1247891|P1|STARTED|Overall Study||105
510094|NCT00951171|1247923|P2|NOT COMPLETED|Overall Study||0
510095|NCT00951171|1247924|P1|NOT COMPLETED|Overall Study||2
510096|NCT00951171|1247923|P2|COMPLETED|Overall Study|2 of the cervical occlusion group transferred to standard group because of pain during attempted IUI|55
510097|NCT00951171|1247924|P1|COMPLETED|Overall Study||38
510098|NCT00951171|1247923|P2|Pregnancy|Overall Study||7
510099|NCT00951171|1247924|P1|Pregnancy|Overall Study||1
510100|NCT00951171|1247923|P2|STARTED|Overall Study||55
510101|NCT00951171|1247924|P1|STARTED|Overall Study||40
510102|NCT00951093|1247930|P1|NOT COMPLETED|6 Months After GBP||0
510103|NCT00951093|1247930|P1|COMPLETED|6 Months After GBP||53
510104|NCT00951093|1247930|P1|STARTED|6 Months After GBP||53
510105|NCT00951093|1247930|P1|NOT COMPLETED|Before GBP||0
510106|NCT00951093|1247930|P1|COMPLETED|Before GBP||53
510107|NCT00951093|1247930|P1|STARTED|Before GBP||53
510108|NCT00951015|1247958|P5|NOT COMPLETED|Open-label Phase||50
510109|NCT00951015|1247959|P4|NOT COMPLETED|Open-label Phase||0
510110|NCT00951015|1247960|P3|NOT COMPLETED|Open-label Phase||0
510111|NCT00951015|1247961|P2|NOT COMPLETED|Open-label Phase||0
510112|NCT00951015|1247962|P1|NOT COMPLETED|Open-label Phase||0
510113|NCT00951015|1247958|P5|COMPLETED|Open-label Phase||88
510114|NCT00951015|1247959|P4|COMPLETED|Open-label Phase||0
510115|NCT00951015|1247960|P3|COMPLETED|Open-label Phase||0
510116|NCT00951015|1247961|P2|COMPLETED|Open-label Phase||0
510117|NCT00951015|1247962|P1|COMPLETED|Open-label Phase||0
510118|NCT00951015|1247958|P5|STARTED|Open-label Phase||138
510119|NCT00951015|1247959|P4|STARTED|Open-label Phase||0
510120|NCT00951015|1247960|P3|STARTED|Open-label Phase||0
510121|NCT00951015|1247961|P2|STARTED|Open-label Phase||0
510122|NCT00951015|1247962|P1|STARTED|Open-label Phase||0
510123|NCT00951015|1247958|P5|NOT COMPLETED|Randomization Phase 96 Week||0
510124|NCT00951015|1247959|P4|NOT COMPLETED|Randomization Phase 96 Week||10
510125|NCT00951015|1247960|P3|NOT COMPLETED|Randomization Phase 96 Week||5
510126|NCT00951015|1247961|P2|NOT COMPLETED|Randomization Phase 96 Week||7
510127|NCT00951015|1247962|P1|NOT COMPLETED|Randomization Phase 96 Week||5
510128|NCT00951015|1247958|P5|COMPLETED|Randomization Phase 96 Week||0
510129|NCT00951015|1247959|P4|COMPLETED|Randomization Phase 96 Week||40
510130|NCT00951015|1247960|P3|COMPLETED|Randomization Phase 96 Week||46
510131|NCT00951015|1247961|P2|COMPLETED|Randomization Phase 96 Week||44
510132|NCT00951015|1247962|P1|COMPLETED|Randomization Phase 96 Week||48
510133|NCT00951015|1247958|P5|STARTED|Randomization Phase 96 Week||0
510134|NCT00951015|1247959|P4|STARTED|Randomization Phase 96 Week||50
510135|NCT00951015|1247960|P3|STARTED|Randomization Phase 96 Week||51
510136|NCT00951015|1247961|P2|STARTED|Randomization Phase 96 Week||51
510137|NCT00951015|1247962|P1|STARTED|Randomization Phase 96 Week||53
510138|NCT00950963|1248059|P2|NOT COMPLETED|Overall Study||24
510139|NCT00950963|1248060|P1|NOT COMPLETED|Overall Study||29
510140|NCT00950963|1248059|P2|COMPLETED|Overall Study||357
510141|NCT00950963|1248060|P1|COMPLETED|Overall Study||352
510142|NCT00950963|1248059|P2|STARTED|Overall Study|Patients were randomized from a diabetes registry and were followed as intent to treat|381
510143|NCT00950963|1248060|P1|STARTED|Overall Study|Patients were randomized from a diabetes registry and were followed as intent to treat|381
510144|NCT00950937|1248076|P2|NOT COMPLETED|Overall Study||0
510145|NCT00950937|1248077|P1|NOT COMPLETED|Overall Study||0
510146|NCT00950937|1248076|P2|COMPLETED|Overall Study||14
510147|NCT00950937|1248077|P1|COMPLETED|Overall Study||14
510148|NCT00950937|1248076|P2|STARTED|Overall Study||14
510149|NCT00950937|1248077|P1|STARTED|Overall Study||14
510150|NCT00950911|1248095|P2|NOT COMPLETED|Overall Study||15
510151|NCT00950911|1248096|P1|NOT COMPLETED|Overall Study||12
510152|NCT00950911|1248095|P2|COMPLETED|Overall Study||3
510153|NCT00950911|1248096|P1|COMPLETED|Overall Study||5
510154|NCT00950911|1248095|P2|STARTED|Overall Study||18
510155|NCT00950911|1248096|P1|STARTED|Overall Study||17
510156|NCT00950872|1248102|P1|NOT COMPLETED|Overall Study||3
510157|NCT00950872|1248102|P1|COMPLETED|Overall Study||26
510158|NCT00950872|1248102|P1|STARTED|Overall Study||29
510159|NCT00950859|1248111|P2|NOT COMPLETED|Overall Study||10
510160|NCT00950859|1248112|P1|NOT COMPLETED|Overall Study||16
510161|NCT00950859|1248111|P2|COMPLETED|Overall Study||14
510162|NCT00950859|1248112|P1|COMPLETED|Overall Study||11
510163|NCT00950859|1248111|P2|STARTED|Overall Study||24
510164|NCT00950859|1248112|P1|STARTED|Overall Study||27
510165|NCT00950833|1248155|P3|NOT COMPLETED|Overall Study||0
510166|NCT00950833|1248156|P2|NOT COMPLETED|Overall Study||0
510167|NCT00950833|1248157|P1|NOT COMPLETED|Overall Study||0
510168|NCT00950833|1248155|P3|COMPLETED|Overall Study||223
510169|NCT00950833|1248156|P2|COMPLETED|Overall Study||108
510170|NCT00950833|1248157|P1|COMPLETED|Overall Study||112
510171|NCT00950833|1248155|P3|STARTED|Overall Study||223
510172|NCT00950833|1248156|P2|STARTED|Overall Study||108
510173|NCT00950833|1248157|P1|STARTED|Overall Study||112
510174|NCT00950807|1248211|P10|NOT COMPLETED|Treatment Period 3||1
510175|NCT00950807|1248212|P9|NOT COMPLETED|Treatment Period 3||0
510176|NCT00950807|1248213|P8|NOT COMPLETED|Treatment Period 3||1
510177|NCT00950807|1248214|P7|NOT COMPLETED|Treatment Period 3||1
510178|NCT00950807|1248215|P6|NOT COMPLETED|Treatment Period 3||0
510179|NCT00950807|1248216|P5|NOT COMPLETED|Treatment Period 3||0
510180|NCT00950807|1248217|P4|NOT COMPLETED|Treatment Period 3||0
510181|NCT00950807|1248218|P3|NOT COMPLETED|Treatment Period 3||0
510182|NCT00950807|1248219|P2|NOT COMPLETED|Treatment Period 3||0
510183|NCT00950807|1248220|P1|NOT COMPLETED|Treatment Period 3||1
510184|NCT00950807|1248211|P10|COMPLETED|Treatment Period 3||10
510185|NCT00950807|1248212|P9|COMPLETED|Treatment Period 3||9
510186|NCT00950807|1248213|P8|COMPLETED|Treatment Period 3||9
510187|NCT00950807|1248214|P7|COMPLETED|Treatment Period 3||11
510188|NCT00950807|1248215|P6|COMPLETED|Treatment Period 3||9
510189|NCT00950807|1248216|P5|COMPLETED|Treatment Period 3||12
510190|NCT00950807|1248217|P4|COMPLETED|Treatment Period 3||11
510191|NCT00950807|1248218|P3|COMPLETED|Treatment Period 3||10
510192|NCT00950807|1248219|P2|COMPLETED|Treatment Period 3||9
510193|NCT00950807|1248220|P1|COMPLETED|Treatment Period 3||45
510194|NCT00950807|1248211|P10|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|11
510195|NCT00950807|1248212|P9|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
510196|NCT00950807|1248213|P8|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|10
510197|NCT00950807|1248214|P7|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|12
510198|NCT00950807|1248215|P6|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
510199|NCT00950807|1248216|P5|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|12
510200|NCT00950807|1248217|P4|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|11
510201|NCT00950807|1248218|P3|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|10
510202|NCT00950807|1248219|P2|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
510203|NCT00950807|1248220|P1|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|46
510204|NCT00950807|1248211|P10|NOT COMPLETED|Washout Period 2||0
510205|NCT00950807|1248212|P9|NOT COMPLETED|Washout Period 2||0
510206|NCT00950807|1248213|P8|NOT COMPLETED|Washout Period 2||1
510207|NCT00950807|1248214|P7|NOT COMPLETED|Washout Period 2||1
510208|NCT00950807|1248215|P6|NOT COMPLETED|Washout Period 2||0
510209|NCT00950807|1248216|P5|NOT COMPLETED|Washout Period 2||1
510210|NCT00950807|1248217|P4|NOT COMPLETED|Washout Period 2||1
510211|NCT00950807|1248218|P3|NOT COMPLETED|Washout Period 2||0
510212|NCT00950807|1248219|P2|NOT COMPLETED|Washout Period 2||1
510213|NCT00950807|1248220|P1|NOT COMPLETED|Washout Period 2||4
510214|NCT00950807|1248211|P10|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
510215|NCT00950807|1248212|P9|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
510216|NCT00950807|1248213|P8|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|9
510217|NCT00950807|1248214|P7|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|8
510218|NCT00950807|1248215|P6|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|9
510219|NCT00950807|1248216|P5|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|12
510220|NCT00950807|1248217|P4|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
510221|NCT00950807|1248218|P3|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|10
510222|NCT00950807|1248219|P2|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
510223|NCT00950807|1248220|P1|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|47
510224|NCT00950807|1248211|P10|STARTED|Washout Period 2||11
510225|NCT00950807|1248212|P9|STARTED|Washout Period 2||11
510226|NCT00950807|1248213|P8|STARTED|Washout Period 2||10
510227|NCT00950807|1248214|P7|STARTED|Washout Period 2||9
510228|NCT00950807|1248215|P6|STARTED|Washout Period 2||9
510229|NCT00950807|1248216|P5|STARTED|Washout Period 2||13
510230|NCT00950807|1248217|P4|STARTED|Washout Period 2||12
510231|NCT00950807|1248218|P3|STARTED|Washout Period 2||10
510232|NCT00950807|1248219|P2|STARTED|Washout Period 2||12
510233|NCT00950807|1248220|P1|STARTED|Washout Period 2||51
510234|NCT00950807|1248211|P10|NOT COMPLETED|Treatment Period 2||0
510235|NCT00950807|1248212|P9|NOT COMPLETED|Treatment Period 2||0
510236|NCT00950807|1248213|P8|NOT COMPLETED|Treatment Period 2||3
510237|NCT00950807|1248214|P7|NOT COMPLETED|Treatment Period 2||1
510238|NCT00950807|1248215|P6|NOT COMPLETED|Treatment Period 2||1
510239|NCT00950807|1248216|P5|NOT COMPLETED|Treatment Period 2||0
510240|NCT00950807|1248217|P4|NOT COMPLETED|Treatment Period 2||1
510241|NCT00950807|1248218|P3|NOT COMPLETED|Treatment Period 2||0
510242|NCT00950807|1248219|P2|NOT COMPLETED|Treatment Period 2||1
510243|NCT00950807|1248220|P1|NOT COMPLETED|Treatment Period 2||2
510244|NCT00950807|1248211|P10|COMPLETED|Treatment Period 2||11
510245|NCT00950807|1248212|P9|COMPLETED|Treatment Period 2||11
510246|NCT00950807|1248213|P8|COMPLETED|Treatment Period 2||10
510247|NCT00950807|1248214|P7|COMPLETED|Treatment Period 2||9
510248|NCT00950807|1248215|P6|COMPLETED|Treatment Period 2||9
510249|NCT00950807|1248216|P5|COMPLETED|Treatment Period 2||13
510250|NCT00950807|1248217|P4|COMPLETED|Treatment Period 2||12
510251|NCT00950807|1248218|P3|COMPLETED|Treatment Period 2||10
510252|NCT00950807|1248219|P2|COMPLETED|Treatment Period 2||12
510253|NCT00950807|1248220|P1|COMPLETED|Treatment Period 2||51
510254|NCT00950807|1248211|P10|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|11
510255|NCT00950807|1248212|P9|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|11
510256|NCT00950807|1248213|P8|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
510257|NCT00950807|1248214|P7|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
510258|NCT00950807|1248215|P6|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
510259|NCT00950807|1248216|P5|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
510260|NCT00950807|1248217|P4|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
510261|NCT00950807|1248218|P3|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
510262|NCT00950807|1248219|P2|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
510263|NCT00950807|1248220|P1|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|53
510264|NCT00950807|1248211|P10|NOT COMPLETED|Washout Period 1||0
510265|NCT00950807|1248212|P9|NOT COMPLETED|Washout Period 1||1
510266|NCT00950807|1248213|P8|NOT COMPLETED|Washout Period 1||1
510267|NCT00950807|1248214|P7|NOT COMPLETED|Washout Period 1||2
510268|NCT00950807|1248215|P6|NOT COMPLETED|Washout Period 1||0
510269|NCT00950807|1248216|P5|NOT COMPLETED|Washout Period 1||1
510270|NCT00950807|1248217|P4|NOT COMPLETED|Washout Period 1||1
510271|NCT00950807|1248218|P3|NOT COMPLETED|Washout Period 1||0
510272|NCT00950807|1248219|P2|NOT COMPLETED|Washout Period 1||0
510273|NCT00950807|1248220|P1|NOT COMPLETED|Washout Period 1||5
510274|NCT00950807|1248211|P10|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
510275|NCT00950807|1248212|P9|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
510276|NCT00950807|1248213|P8|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
510277|NCT00950807|1248214|P7|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|10
510278|NCT00950807|1248215|P6|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
510279|NCT00950807|1248216|P5|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
510280|NCT00950807|1248217|P4|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
510281|NCT00950807|1248218|P3|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
510282|NCT00950807|1248219|P2|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
510283|NCT00950807|1248220|P1|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|51
510284|NCT00950807|1248211|P10|STARTED|Washout Period 1||13
510285|NCT00950807|1248212|P9|STARTED|Washout Period 1||12
510286|NCT00950807|1248213|P8|STARTED|Washout Period 1||14
510287|NCT00950807|1248214|P7|STARTED|Washout Period 1||12
510288|NCT00950807|1248215|P6|STARTED|Washout Period 1||11
510289|NCT00950807|1248216|P5|STARTED|Washout Period 1||12
510290|NCT00950807|1248217|P4|STARTED|Washout Period 1||12
510291|NCT00950807|1248218|P3|STARTED|Washout Period 1||13
510292|NCT00950807|1248219|P2|STARTED|Washout Period 1||13
510293|NCT00950807|1248220|P1|STARTED|Washout Period 1||56
510294|NCT00950807|1248211|P10|NOT COMPLETED|Treatment Period 1||0
510295|NCT00950807|1248212|P9|NOT COMPLETED|Treatment Period 1||1
510296|NCT00950807|1248213|P8|NOT COMPLETED|Treatment Period 1||0
510297|NCT00950807|1248214|P7|NOT COMPLETED|Treatment Period 1||0
510298|NCT00950807|1248215|P6|NOT COMPLETED|Treatment Period 1||2
510299|NCT00950807|1248216|P5|NOT COMPLETED|Treatment Period 1||1
510300|NCT00950807|1248217|P4|NOT COMPLETED|Treatment Period 1||0
510301|NCT00950807|1248218|P3|NOT COMPLETED|Treatment Period 1||1
510302|NCT00950807|1248219|P2|NOT COMPLETED|Treatment Period 1||0
510303|NCT00950807|1248220|P1|NOT COMPLETED|Treatment Period 1||3
510304|NCT00950807|1248211|P10|COMPLETED|Treatment Period 1||13
510305|NCT00950807|1248212|P9|COMPLETED|Treatment Period 1||12
510306|NCT00950807|1248213|P8|COMPLETED|Treatment Period 1||14
510307|NCT00950807|1248214|P7|COMPLETED|Treatment Period 1||12
510308|NCT00950807|1248215|P6|COMPLETED|Treatment Period 1||11
510309|NCT00950807|1248216|P5|COMPLETED|Treatment Period 1||12
510310|NCT00950807|1248217|P4|COMPLETED|Treatment Period 1||12
510311|NCT00950807|1248218|P3|COMPLETED|Treatment Period 1||13
510312|NCT00950807|1248219|P2|COMPLETED|Treatment Period 1||13
510313|NCT00950807|1248220|P1|COMPLETED|Treatment Period 1||56
510314|NCT00950807|1248211|P10|STARTED|Treatment Period 1||13
510315|NCT00950807|1248212|P9|STARTED|Treatment Period 1||13
510316|NCT00950807|1248213|P8|STARTED|Treatment Period 1||14
510317|NCT00950807|1248214|P7|STARTED|Treatment Period 1||12
510318|NCT00950807|1248215|P6|STARTED|Treatment Period 1||13
510319|NCT00950807|1248216|P5|STARTED|Treatment Period 1||13
510320|NCT00950807|1248217|P4|STARTED|Treatment Period 1||12
510321|NCT00950807|1248218|P3|STARTED|Treatment Period 1||14
510322|NCT00950807|1248219|P2|STARTED|Treatment Period 1||13
510323|NCT00950807|1248220|P1|STARTED|Treatment Period 1||59
510324|NCT00950755|1248262|P1|NOT COMPLETED|Long-Term Follow-Up||9
510325|NCT00950755|1248262|P1|COMPLETED|Long-Term Follow-Up||9
510326|NCT00950755|1248262|P1|STARTED|Long-Term Follow-Up|18 of the 41 participants withdrawing from Study BEX104505 enrolled in the LTFU study.|18
510327|NCT00950755|1248262|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||41
510328|NCT00950755|1248262|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
510329|NCT00950755|1248262|P1|STARTED|Dosimetric and Therapeutic Treatment||41
510330|NCT00950742|1248288|P2|NOT COMPLETED|Overall Study||2
510331|NCT00950742|1248289|P1|NOT COMPLETED|Overall Study||16
510332|NCT00950742|1248288|P2|COMPLETED|Overall Study||0
510333|NCT00950742|1248289|P1|COMPLETED|Overall Study||0
510334|NCT00950742|1248288|P2|STARTED|Overall Study|entered and treated|2
510335|NCT00950742|1248289|P1|STARTED|Overall Study|entered and treated|16
510336|NCT00950729|1248305|P1|NOT COMPLETED|Driving With Aircast||0
510337|NCT00950729|1248305|P1|COMPLETED|Driving With Aircast||48
510338|NCT00950729|1248305|P1|STARTED|Driving With Aircast||48
510339|NCT00950729|1248305|P1|NOT COMPLETED|Driving With Plaster Cast||0
510340|NCT00950729|1248305|P1|COMPLETED|Driving With Plaster Cast||48
510341|NCT00950729|1248305|P1|STARTED|Driving With Plaster Cast||48
510342|NCT00950729|1248305|P1|NOT COMPLETED|Driving With Running Shoes||0
510343|NCT00950729|1248305|P1|COMPLETED|Driving With Running Shoes|June 2007|48
510344|NCT00950729|1248305|P1|STARTED|Driving With Running Shoes|March 2007|48
510345|NCT00950690|1248310|P1|NOT COMPLETED|Overall Study||244
510346|NCT00950690|1248310|P1|COMPLETED|Overall Study||1105
510347|NCT00950690|1248310|P1|STARTED|Overall Study||1349
510348|NCT00950664|1248317|P2|NOT COMPLETED|Second Intervention||48
510349|NCT00950664|1248318|P1|NOT COMPLETED|Second Intervention||46
510350|NCT00950664|1248317|P2|COMPLETED|Second Intervention||0
510351|NCT00950664|1248318|P1|COMPLETED|Second Intervention||0
510352|NCT00950664|1248317|P2|STARTED|Second Intervention||48
510353|NCT00950664|1248318|P1|STARTED|Second Intervention||46
510354|NCT00950664|1248317|P2|NOT COMPLETED|Washout Period of 4 Weeks||0
510355|NCT00950664|1248318|P1|NOT COMPLETED|Washout Period of 4 Weeks||0
510356|NCT00950664|1248317|P2|COMPLETED|Washout Period of 4 Weeks||48
510357|NCT00950664|1248318|P1|COMPLETED|Washout Period of 4 Weeks||46
510358|NCT00950664|1248317|P2|STARTED|Washout Period of 4 Weeks||48
510359|NCT00950664|1248318|P1|STARTED|Washout Period of 4 Weeks||46
510360|NCT00950664|1248317|P2|NOT COMPLETED|First Intervention||5
510361|NCT00950664|1248318|P1|NOT COMPLETED|First Intervention||3
510362|NCT00950664|1248317|P2|COMPLETED|First Intervention||48
510363|NCT00950664|1248318|P1|COMPLETED|First Intervention||46
510364|NCT00950664|1248317|P2|STARTED|First Intervention||53
510365|NCT00950664|1248318|P1|STARTED|First Intervention||49
510366|NCT00950651|1248338|P2|NOT COMPLETED|Overall Study||35
510367|NCT00950651|1248339|P1|NOT COMPLETED|Overall Study||31
510368|NCT00950651|1248338|P2|COMPLETED|Overall Study||181
510369|NCT00950651|1248339|P1|COMPLETED|Overall Study||184
510370|NCT00950651|1248338|P2|STARTED|Overall Study|216 patients randomized but one never took study medication|216
510371|NCT00950651|1248339|P1|STARTED|Overall Study||215
510372|NCT00950612|1248387|P2|NOT COMPLETED|Overall Study||0
510373|NCT00950612|1248388|P1|NOT COMPLETED|Overall Study||0
510374|NCT00950612|1248387|P2|COMPLETED|Overall Study||20
510375|NCT00950612|1248388|P1|COMPLETED|Overall Study||40
510376|NCT00950612|1248387|P2|STARTED|Overall Study||20
510377|NCT00950612|1248388|P1|STARTED|Overall Study||40
510378|NCT00950599|1248432|P10|NOT COMPLETED|Follow-Up Period||2
510379|NCT00950599|1248433|P9|NOT COMPLETED|Follow-Up Period||13
510380|NCT00950599|1248434|P8|NOT COMPLETED|Follow-Up Period||0
510381|NCT00950599|1248435|P7|NOT COMPLETED|Follow-Up Period||0
510382|NCT00950599|1248436|P6|NOT COMPLETED|Follow-Up Period||0
510383|NCT00950599|1248437|P5|NOT COMPLETED|Follow-Up Period||0
510384|NCT00950599|1248438|P4|NOT COMPLETED|Follow-Up Period||0
510385|NCT00950599|1248439|P3|NOT COMPLETED|Follow-Up Period||0
510386|NCT00950599|1248440|P2|NOT COMPLETED|Follow-Up Period||0
510387|NCT00950599|1248441|P1|NOT COMPLETED|Follow-Up Period||0
510388|NCT00950599|1248432|P10|COMPLETED|Follow-Up Period||78
510389|NCT00950599|1248433|P9|COMPLETED|Follow-Up Period||296
510390|NCT00950599|1248434|P8|COMPLETED|Follow-Up Period||0
510391|NCT00950599|1248435|P7|COMPLETED|Follow-Up Period||0
510392|NCT00950599|1248436|P6|COMPLETED|Follow-Up Period||0
510393|NCT00950599|1248437|P5|COMPLETED|Follow-Up Period||0
510394|NCT00950599|1248438|P4|COMPLETED|Follow-Up Period||0
510395|NCT00950599|1248439|P3|COMPLETED|Follow-Up Period||0
510396|NCT00950599|1248440|P2|COMPLETED|Follow-Up Period||0
510397|NCT00950599|1248441|P1|COMPLETED|Follow-Up Period||0
510398|NCT00950599|1248432|P10|STARTED|Follow-Up Period|those completing double blind period (DB) + those rescued/discontinued from DB due to hyperglycemia|80
510399|NCT00950599|1248433|P9|STARTED|Follow-Up Period|those completing double blind period (DB) + those rescued/discontinued from DB due to hyperglycemia|309
510400|NCT00950599|1248434|P8|STARTED|Follow-Up Period||0
510401|NCT00950599|1248435|P7|STARTED|Follow-Up Period||0
510402|NCT00950599|1248436|P6|STARTED|Follow-Up Period||0
510403|NCT00950599|1248437|P5|STARTED|Follow-Up Period||0
510404|NCT00950599|1248438|P4|STARTED|Follow-Up Period||0
510405|NCT00950599|1248439|P3|STARTED|Follow-Up Period||0
510406|NCT00950599|1248440|P2|STARTED|Follow-Up Period||0
510407|NCT00950599|1248441|P1|STARTED|Follow-Up Period||0
510408|NCT00950599|1248432|P10|NOT COMPLETED|Double-Blind Treatment Period||0
510409|NCT00950599|1248433|P9|NOT COMPLETED|Double-Blind Treatment Period||0
510410|NCT00950599|1248434|P8|NOT COMPLETED|Double-Blind Treatment Period||6
510411|NCT00950599|1248435|P7|NOT COMPLETED|Double-Blind Treatment Period||0
510412|NCT00950599|1248436|P6|NOT COMPLETED|Double-Blind Treatment Period||12
510413|NCT00950599|1248437|P5|NOT COMPLETED|Double-Blind Treatment Period||7
510414|NCT00950599|1248438|P4|NOT COMPLETED|Double-Blind Treatment Period||11
510415|NCT00950599|1248439|P3|NOT COMPLETED|Double-Blind Treatment Period||9
510416|NCT00950599|1248440|P2|NOT COMPLETED|Double-Blind Treatment Period||10
510417|NCT00950599|1248441|P1|NOT COMPLETED|Double-Blind Treatment Period||7
510418|NCT00950599|1248432|P10|COMPLETED|Double-Blind Treatment Period||0
510419|NCT00950599|1248433|P9|COMPLETED|Double-Blind Treatment Period||0
510420|NCT00950599|1248434|P8|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|35
510421|NCT00950599|1248435|P7|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|44
510422|NCT00950599|1248436|P6|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|55
510423|NCT00950599|1248437|P5|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|45
510424|NCT00950599|1248438|P4|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|43
510425|NCT00950599|1248439|P3|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|54
510426|NCT00950599|1248440|P2|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|37
510427|NCT00950599|1248441|P1|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|48
510428|NCT00950599|1248432|P10|STARTED|Double-Blind Treatment Period||0
510429|NCT00950599|1248433|P9|STARTED|Double-Blind Treatment Period||0
510430|NCT00950599|1248434|P8|STARTED|Double-Blind Treatment Period||41
510431|NCT00950599|1248435|P7|STARTED|Double-Blind Treatment Period||44
510432|NCT00950599|1248436|P6|STARTED|Double-Blind Treatment Period||67
510433|NCT00950599|1248437|P5|STARTED|Double-Blind Treatment Period||52
510434|NCT00950599|1248438|P4|STARTED|Double-Blind Treatment Period||54
510435|NCT00950599|1248439|P3|STARTED|Double-Blind Treatment Period||63
510436|NCT00950599|1248440|P2|STARTED|Double-Blind Treatment Period||47
510437|NCT00950599|1248441|P1|STARTED|Double-Blind Treatment Period||55
510438|NCT00950352|1249005|P2|NOT COMPLETED|Overall Study||11
510439|NCT00950352|1249006|P1|NOT COMPLETED|Overall Study||42
510440|NCT00950352|1249005|P2|COMPLETED|Overall Study||21
510441|NCT00950352|1249006|P1|COMPLETED|Overall Study||30
510442|NCT00950352|1249005|P2|STARTED|Overall Study||32
510443|NCT00950352|1249006|P1|STARTED|Overall Study||72
510444|NCT00950300|1249014|P2|NOT COMPLETED|SFU Period||78
510445|NCT00950300|1249015|P1|NOT COMPLETED|SFU Period||78
510446|NCT00950300|1249014|P2|COMPLETED|SFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|45
510447|NCT00950300|1249015|P1|COMPLETED|SFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|40
510448|NCT00950300|1249014|P2|STARTED|SFU Period|Participants could withdraw from the study entirely or advance directly to the SFU Period.|123
510449|NCT00950300|1249015|P1|STARTED|SFU Period|Participants could withdraw from the study entirely or advance directly to the SFU Period.|118
510450|NCT00950300|1249014|P2|NOT COMPLETED|TFFU Period||107
510451|NCT00950300|1249015|P1|NOT COMPLETED|TFFU Period||100
510452|NCT00950300|1249014|P2|COMPLETED|TFFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|161
510453|NCT00950300|1249015|P1|COMPLETED|TFFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|165
510454|NCT00950300|1249014|P2|STARTED|TFFU Period|Participants could withdraw from the study entirely or advance directly to the TFFU or SFU Period.|268
510455|NCT00950300|1249015|P1|STARTED|TFFU Period|Participants could withdraw from the study entirely or advance directly to the TFFU or SFU Period.|265
510456|NCT00950300|1249014|P2|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42
510457|NCT00950300|1249015|P1|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42
510458|NCT00950300|1249014|P2|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||255
510459|NCT00950300|1249015|P1|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||257
510460|NCT00950300|1249014|P2|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||274
510461|NCT00950300|1249015|P1|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||277
510462|NCT00950300|1249014|P2|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||273
510463|NCT00950300|1249015|P1|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||277
510464|NCT00950300|1249014|P2|Received Neoadjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||297
510465|NCT00950300|1249015|P1|Received Neoadjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||298
510466|NCT00950300|1249014|P2|STARTED|Neoadjuvant/Adjuvant Treatment Periods||297
510467|NCT00950300|1249015|P1|STARTED|Neoadjuvant/Adjuvant Treatment Periods||299
510468|NCT00950235|1249064|P2|NOT COMPLETED|Overall Study||4
510469|NCT00950235|1249065|P1|NOT COMPLETED|Overall Study||2
510470|NCT00950235|1249064|P2|COMPLETED|Overall Study||54
510471|NCT00950235|1249065|P1|COMPLETED|Overall Study||58
510472|NCT00950235|1249064|P2|STARTED|Overall Study||58
510473|NCT00950235|1249065|P1|STARTED|Overall Study||60
510474|NCT00950183|1249075|P1|NOT COMPLETED|Overall Study||36
510475|NCT00950183|1249075|P1|COMPLETED|Overall Study||0
510476|NCT00950183|1249075|P1|STARTED|Overall Study||36
510477|NCT00949975|1249087|P4|NOT COMPLETED|Overall Study||28
510478|NCT00949975|1249088|P3|NOT COMPLETED|Overall Study||19
510479|NCT00949975|1249089|P2|NOT COMPLETED|Overall Study||29
510480|NCT00949975|1249090|P1|NOT COMPLETED|Overall Study||27
510481|NCT00949975|1249087|P4|COMPLETED|Overall Study||190
510482|NCT00949975|1249088|P3|COMPLETED|Overall Study||183
510483|NCT00949975|1249089|P2|COMPLETED|Overall Study||177
510484|NCT00949975|1249090|P1|COMPLETED|Overall Study||185
510485|NCT00949975|1249087|P4|STARTED|Overall Study||218
510486|NCT00949975|1249088|P3|STARTED|Overall Study||202
510487|NCT00949975|1249089|P2|STARTED|Overall Study||206
510488|NCT00949975|1249090|P1|STARTED|Overall Study||212
510489|NCT00949910|1249208|P1|NOT COMPLETED|Overall Study||6576
510490|NCT00949910|1249208|P1|COMPLETED|Overall Study||10
510491|NCT00949910|1249208|P1|STARTED|Overall Study||6586
510492|NCT00949884|1249221|P3|NOT COMPLETED|Overall Study||58
510493|NCT00949884|1249222|P2|NOT COMPLETED|Overall Study||15
510494|NCT00949884|1249223|P1|NOT COMPLETED|Overall Study||50
510495|NCT00949884|1249221|P3|COMPLETED|Overall Study||411
510496|NCT00949884|1249222|P2|COMPLETED|Overall Study||37
510497|NCT00949884|1249223|P1|COMPLETED|Overall Study||370
510498|NCT00949884|1249221|P3|STARTED|Overall Study||469
510499|NCT00949884|1249222|P2|STARTED|Overall Study||52
510500|NCT00949884|1249223|P1|STARTED|Overall Study||420
510501|NCT00949715|1249278|P2|NOT COMPLETED|Overall Study||0
510502|NCT00949715|1249279|P1|NOT COMPLETED|Overall Study||4
510503|NCT00949715|1249278|P2|COMPLETED|Overall Study||33
510504|NCT00949715|1249279|P1|COMPLETED|Overall Study||28
510505|NCT00949715|1249278|P2|STARTED|Overall Study||33
510506|NCT00949715|1249279|P1|STARTED|Overall Study||32
510507|NCT00949702|1249290|P1|NOT COMPLETED|Overall Study||48
510508|NCT00949702|1249290|P1|COMPLETED|Overall Study||84
510509|NCT00949702|1249290|P1|STARTED|Overall Study||132
510510|NCT00949650|1249307|P2|NOT COMPLETED|Overall Study||115
510511|NCT00949650|1249308|P1|NOT COMPLETED|Overall Study||230
510512|NCT00949650|1249307|P2|COMPLETED|Overall Study||0
510513|NCT00949650|1249308|P1|COMPLETED|Overall Study|On treatment at the cut-off date 17MAR2017.|0
510514|NCT00949650|1249307|P2|STARTED|Overall Study|Treated patients.|115
510515|NCT00949650|1249308|P1|STARTED|Overall Study|Treated patients.|230
510516|NCT00949533|1249346|P2|NOT COMPLETED|Overall Study||1
510517|NCT00949533|1249347|P1|NOT COMPLETED|Overall Study||0
510518|NCT00949533|1249346|P2|COMPLETED|Overall Study||17
510519|NCT00949533|1249347|P1|COMPLETED|Overall Study||19
510520|NCT00949533|1249346|P2|STARTED|Overall Study||18
510521|NCT00949533|1249347|P1|STARTED|Overall Study||19
510522|NCT00949234|1249359|P1|NOT COMPLETED|Overall Study||42
510523|NCT00949234|1249359|P1|COMPLETED|Overall Study||225
510524|NCT00949234|1249359|P1|STARTED|Overall Study||267
510525|NCT00949117|1249365|P2|NOT COMPLETED|Overall Study||5
510526|NCT00949117|1249366|P1|NOT COMPLETED|Overall Study||3
510527|NCT00949117|1249365|P2|COMPLETED|Overall Study||0
510528|NCT00949117|1249366|P1|COMPLETED|Overall Study||1
510529|NCT00949117|1249365|P2|STARTED|Overall Study||5
510530|NCT00949117|1249366|P1|STARTED|Overall Study||4
510531|NCT00949078|1249382|P2|NOT COMPLETED|Overall Study||0
510532|NCT00949078|1249383|P1|NOT COMPLETED|Overall Study||0
510533|NCT00949078|1249382|P2|COMPLETED|Overall Study||9
510534|NCT00949078|1249383|P1|COMPLETED|Overall Study||5
510535|NCT00949078|1249382|P2|STARTED|Overall Study||9
510536|NCT00949078|1249383|P1|STARTED|Overall Study||5
510537|NCT00948896|1249413|P8|NOT COMPLETED|24 Months of Age to 36 Months of Age||0
510538|NCT00948896|1249414|P7|NOT COMPLETED|24 Months of Age to 36 Months of Age||0
510539|NCT00948896|1249415|P6|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
510540|NCT00948896|1249416|P5|NOT COMPLETED|24 Months of Age to 36 Months of Age||1
510541|NCT00948896|1249417|P4|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
510542|NCT00948896|1249418|P3|NOT COMPLETED|24 Months of Age to 36 Months of Age||5
510543|NCT00948896|1249419|P2|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
510544|NCT00948896|1249420|P1|NOT COMPLETED|24 Months of Age to 36 Months of Age||3
510545|NCT00948896|1249413|P8|COMPLETED|24 Months of Age to 36 Months of Age||45
510546|NCT00948896|1249414|P7|COMPLETED|24 Months of Age to 36 Months of Age||43
510547|NCT00948896|1249415|P6|COMPLETED|24 Months of Age to 36 Months of Age||40
510548|NCT00948896|1249416|P5|COMPLETED|24 Months of Age to 36 Months of Age||43
510549|NCT00948896|1249417|P4|COMPLETED|24 Months of Age to 36 Months of Age||85
510550|NCT00948896|1249418|P3|COMPLETED|24 Months of Age to 36 Months of Age||85
510551|NCT00948896|1249419|P2|COMPLETED|24 Months of Age to 36 Months of Age||83
510552|NCT00948896|1249420|P1|COMPLETED|24 Months of Age to 36 Months of Age||87
510553|NCT00948896|1249413|P8|STARTED|24 Months of Age to 36 Months of Age||45
510554|NCT00948896|1249414|P7|STARTED|24 Months of Age to 36 Months of Age||43
510555|NCT00948896|1249415|P6|STARTED|24 Months of Age to 36 Months of Age||42
510556|NCT00948896|1249416|P5|STARTED|24 Months of Age to 36 Months of Age||44
510557|NCT00948896|1249417|P4|STARTED|24 Months of Age to 36 Months of Age||87
510558|NCT00948896|1249418|P3|STARTED|24 Months of Age to 36 Months of Age||90
510559|NCT00948896|1249419|P2|STARTED|24 Months of Age to 36 Months of Age||85
510560|NCT00948896|1249420|P1|STARTED|24 Months of Age to 36 Months of Age||90
510561|NCT00948896|1249413|P8|NOT COMPLETED|Randomization to 24 Months of Age||2
510562|NCT00948896|1249414|P7|NOT COMPLETED|Randomization to 24 Months of Age||4
510563|NCT00948896|1249415|P6|NOT COMPLETED|Randomization to 24 Months of Age||4
510564|NCT00948896|1249416|P5|NOT COMPLETED|Randomization to 24 Months of Age||2
510565|NCT00948896|1249417|P4|NOT COMPLETED|Randomization to 24 Months of Age||11
510566|NCT00948896|1249418|P3|NOT COMPLETED|Randomization to 24 Months of Age||9
510567|NCT00948896|1249419|P2|NOT COMPLETED|Randomization to 24 Months of Age||13
510568|NCT00948896|1249420|P1|NOT COMPLETED|Randomization to 24 Months of Age||8
510569|NCT00948896|1249413|P8|COMPLETED|Randomization to 24 Months of Age||45
510570|NCT00948896|1249414|P7|COMPLETED|Randomization to 24 Months of Age||43
510571|NCT00948896|1249415|P6|COMPLETED|Randomization to 24 Months of Age||42
510572|NCT00948896|1249416|P5|COMPLETED|Randomization to 24 Months of Age||44
510573|NCT00948896|1249417|P4|COMPLETED|Randomization to 24 Months of Age||87
510574|NCT00948896|1249418|P3|COMPLETED|Randomization to 24 Months of Age||90
510575|NCT00948896|1249419|P2|COMPLETED|Randomization to 24 Months of Age||85
510576|NCT00948896|1249420|P1|COMPLETED|Randomization to 24 Months of Age||90
510577|NCT00948896|1249413|P8|STARTED|Randomization to 24 Months of Age||47
510578|NCT00948896|1249414|P7|STARTED|Randomization to 24 Months of Age||47
510579|NCT00948896|1249415|P6|STARTED|Randomization to 24 Months of Age||46
510580|NCT00948896|1249416|P5|STARTED|Randomization to 24 Months of Age||46
510581|NCT00948896|1249417|P4|STARTED|Randomization to 24 Months of Age||98
510582|NCT00948896|1249418|P3|STARTED|Randomization to 24 Months of Age||99
510583|NCT00948896|1249419|P2|STARTED|Randomization to 24 Months of Age||98
510584|NCT00948896|1249420|P1|STARTED|Randomization to 24 Months of Age||98
510585|NCT00948857|1249456|P2|NOT COMPLETED|Overall Study||0
510586|NCT00948857|1249457|P1|NOT COMPLETED|Overall Study||1
510587|NCT00948857|1249456|P2|COMPLETED|Overall Study||2
510588|NCT00948857|1249457|P1|COMPLETED|Overall Study|3 completed and 1 dropped out.|2
510589|NCT00948857|1249456|P2|STARTED|Overall Study||2
510590|NCT00948857|1249457|P1|STARTED|Overall Study||3
510591|NCT00948818|1249465|P2|NOT COMPLETED|Overall Study||94
510592|NCT00948818|1249466|P1|NOT COMPLETED|Overall Study||62
510593|NCT00948818|1249465|P2|COMPLETED|Overall Study||312
510594|NCT00948818|1249466|P1|COMPLETED|Overall Study||335
510595|NCT00948818|1249465|P2|STARTED|Overall Study||406
510596|NCT00948818|1249466|P1|STARTED|Overall Study||397
510597|NCT00948792|1249501|P1|NOT COMPLETED|Overall Study||0
510598|NCT00948792|1249501|P1|COMPLETED|Overall Study||21
510599|NCT00948792|1249501|P1|STARTED|Overall Study||21
510600|NCT00948766|1249513|P2|NOT COMPLETED|Extension Study||0
510601|NCT00948766|1249514|P1|NOT COMPLETED|Extension Study||91
510602|NCT00948766|1249513|P2|COMPLETED|Extension Study||0
510603|NCT00948766|1249514|P1|COMPLETED|Extension Study||306
510604|NCT00948766|1249513|P2|Exposed to Study Medication|Extension Study||0
510605|NCT00948766|1249514|P1|Exposed to Study Medication|Extension Study||396
510606|NCT00948766|1249513|P2|STARTED|Extension Study|No patients received this treatment in the extension study.|0
510607|NCT00948766|1249514|P1|STARTED|Extension Study|397 of the 463 patients who completed the core study entered the extension study.|397
510608|NCT00948766|1249513|P2|NOT COMPLETED|Core Study||126
510609|NCT00948766|1249514|P1|NOT COMPLETED|Core Study||127
510610|NCT00948766|1249513|P2|COMPLETED|Core Study||234
510611|NCT00948766|1249514|P1|COMPLETED|Core Study||229
510612|NCT00948766|1249513|P2|Exposed to Study Medication|Core Study||359
510613|NCT00948766|1249514|P1|Exposed to Study Medication|Core Study||355
510614|NCT00948766|1249513|P2|STARTED|Core Study||360
510615|NCT00948766|1249514|P1|STARTED|Core Study||356
510616|NCT00948688|1249530|P2|NOT COMPLETED|Period 2: 100 mg Vorinostat||1
510617|NCT00948688|1249531|P1|NOT COMPLETED|Period 2: 100 mg Vorinostat||0
510618|NCT00948688|1249530|P2|COMPLETED|Period 2: 100 mg Vorinostat||5
510619|NCT00948688|1249531|P1|COMPLETED|Period 2: 100 mg Vorinostat||0
510620|NCT00948688|1249530|P2|STARTED|Period 2: 100 mg Vorinostat||6
510621|NCT00948688|1249531|P1|STARTED|Period 2: 100 mg Vorinostat||0
510622|NCT00948688|1249530|P2|NOT COMPLETED|Period 1: 200 mg Vorinostat||0
510623|NCT00948688|1249531|P1|NOT COMPLETED|Period 1: 200 mg Vorinostat||2
510624|NCT00948688|1249530|P2|COMPLETED|Period 1: 200 mg Vorinostat||0
510625|NCT00948688|1249531|P1|COMPLETED|Period 1: 200 mg Vorinostat||2
510626|NCT00948688|1249530|P2|STARTED|Period 1: 200 mg Vorinostat||0
510627|NCT00948688|1249531|P1|STARTED|Period 1: 200 mg Vorinostat||4
510634|NCT00948610|1249562|P2|NOT COMPLETED|Overall Study||1
510635|NCT00948610|1249563|P1|NOT COMPLETED|Overall Study||1
510636|NCT00948610|1249562|P2|COMPLETED|Overall Study||9
510637|NCT00948610|1249563|P1|COMPLETED|Overall Study||9
510638|NCT00948610|1249562|P2|STARTED|Overall Study||10
510639|NCT00948610|1249563|P1|STARTED|Overall Study||10
510640|NCT00948506|1249573|P2|NOT COMPLETED|Overall Study||1
510641|NCT00948506|1249574|P1|NOT COMPLETED|Overall Study||3
510642|NCT00948506|1249573|P2|COMPLETED|Overall Study||8
510643|NCT00948506|1249574|P1|COMPLETED|Overall Study||8
510644|NCT00948506|1249573|P2|STARTED|Overall Study||9
510645|NCT00948506|1249574|P1|STARTED|Overall Study||11
510646|NCT00948441|1249585|P2|NOT COMPLETED|Overall Study||4
510647|NCT00948441|1249586|P1|NOT COMPLETED|Overall Study||1
510648|NCT00948441|1249585|P2|COMPLETED|Overall Study||4
510649|NCT00948441|1249586|P1|COMPLETED|Overall Study||7
510650|NCT00948441|1249585|P2|STARTED|Overall Study||8
510651|NCT00948441|1249586|P1|STARTED|Overall Study||8
510652|NCT00948389|1249599|P5|NOT COMPLETED|Overall Study||1
510653|NCT00948389|1249600|P4|NOT COMPLETED|Overall Study||9
510654|NCT00948389|1249601|P3|NOT COMPLETED|Overall Study||7
510655|NCT00948389|1249602|P2|NOT COMPLETED|Overall Study||3
510656|NCT00948389|1249603|P1|NOT COMPLETED|Overall Study||6
510657|NCT00948389|1249599|P5|COMPLETED|Overall Study||0
510658|NCT00948389|1249600|P4|COMPLETED|Overall Study||0
510659|NCT00948389|1249601|P3|COMPLETED|Overall Study||0
510660|NCT00948389|1249602|P2|COMPLETED|Overall Study||0
510661|NCT00948389|1249603|P1|COMPLETED|Overall Study||0
510662|NCT00948389|1249599|P5|STARTED|Overall Study||1
510663|NCT00948389|1249600|P4|STARTED|Overall Study||9
510664|NCT00948389|1249601|P3|STARTED|Overall Study||7
510665|NCT00948389|1249602|P2|STARTED|Overall Study||3
510666|NCT00948389|1249603|P1|STARTED|Overall Study||6
510667|NCT00948246|1249640|P1|NOT COMPLETED|Overall Study||24
510668|NCT00948246|1249640|P1|COMPLETED|Overall Study||86
510669|NCT00948246|1249640|P1|STARTED|Overall Study||110
510670|NCT00948155|1249649|P2|NOT COMPLETED|Second Intervention 21 Days||3
510671|NCT00948155|1249650|P1|NOT COMPLETED|Second Intervention 21 Days||2
510672|NCT00948155|1249649|P2|COMPLETED|Second Intervention 21 Days||8
510673|NCT00948155|1249650|P1|COMPLETED|Second Intervention 21 Days||9
510674|NCT00948155|1249649|P2|STARTED|Second Intervention 21 Days||11
510675|NCT00948155|1249650|P1|STARTED|Second Intervention 21 Days||11
510676|NCT00948155|1249649|P2|NOT COMPLETED|Washout 14 Days||2
510677|NCT00948155|1249650|P1|NOT COMPLETED|Washout 14 Days||1
510678|NCT00948155|1249649|P2|COMPLETED|Washout 14 Days||11
510679|NCT00948155|1249650|P1|COMPLETED|Washout 14 Days||11
510680|NCT00948155|1249649|P2|STARTED|Washout 14 Days||13
510681|NCT00948155|1249650|P1|STARTED|Washout 14 Days||12
510682|NCT00948155|1249649|P2|NOT COMPLETED|First Intervention 21 Days||2
510683|NCT00948155|1249650|P1|NOT COMPLETED|First Intervention 21 Days||2
510684|NCT00948155|1249649|P2|COMPLETED|First Intervention 21 Days||13
510685|NCT00948155|1249650|P1|COMPLETED|First Intervention 21 Days||12
510686|NCT00948155|1249649|P2|STARTED|First Intervention 21 Days||15
510687|NCT00948155|1249650|P1|STARTED|First Intervention 21 Days||14
510688|NCT00948090|1249672|P4|NOT COMPLETED|Overall Study||11
510689|NCT00948090|1249673|P3|NOT COMPLETED|Overall Study||56
510690|NCT00948090|1249674|P2|NOT COMPLETED|Overall Study||1
510691|NCT00948090|1249675|P1|NOT COMPLETED|Overall Study||43
510692|NCT00948090|1249672|P4|COMPLETED|Overall Study||7
510693|NCT00948090|1249673|P3|COMPLETED|Overall Study||67
510694|NCT00948090|1249674|P2|COMPLETED|Overall Study||0
510695|NCT00948090|1249675|P1|COMPLETED|Overall Study||22
510696|NCT00948090|1249672|P4|STARTED|Overall Study||18
510697|NCT00948090|1249673|P3|STARTED|Overall Study||123
510698|NCT00948090|1249674|P2|STARTED|Overall Study||1
510699|NCT00948090|1249675|P1|STARTED|Overall Study||65
510700|NCT00948064|1249697|P3|NOT COMPLETED|Phase II||1
510701|NCT00948064|1249698|P2|NOT COMPLETED|Phase II||1
510702|NCT00948064|1249699|P1|NOT COMPLETED|Phase II||0
510703|NCT00948064|1249697|P3|COMPLETED|Phase II||26
510704|NCT00948064|1249698|P2|COMPLETED|Phase II||51
510705|NCT00948064|1249699|P1|COMPLETED|Phase II||0
510706|NCT00948064|1249697|P3|STARTED|Phase II||27
510707|NCT00948064|1249698|P2|STARTED|Phase II||52
510708|NCT00948064|1249699|P1|STARTED|Phase II||0
510709|NCT00948064|1249697|P3|NOT COMPLETED|Phase I||0
510710|NCT00948064|1249698|P2|NOT COMPLETED|Phase I||0
510711|NCT00948064|1249699|P1|NOT COMPLETED|Phase I||1
510712|NCT00948064|1249697|P3|COMPLETED|Phase I||0
510713|NCT00948064|1249698|P2|COMPLETED|Phase I||0
510714|NCT00948064|1249699|P1|COMPLETED|Phase I||30
510715|NCT00948064|1249697|P3|STARTED|Phase I||0
510716|NCT00948064|1249698|P2|STARTED|Phase I||0
510717|NCT00948064|1249699|P1|STARTED|Phase I||31
510718|NCT00947882|1249714|P4|NOT COMPLETED|Overall Study||82
510719|NCT00947882|1249715|P3|NOT COMPLETED|Overall Study||79
510720|NCT00947882|1249716|P2|NOT COMPLETED|Overall Study||77
510721|NCT00947882|1249717|P1|NOT COMPLETED|Overall Study||74
510722|NCT00947882|1249714|P4|COMPLETED|Overall Study||20
510723|NCT00947882|1249715|P3|COMPLETED|Overall Study||22
510724|NCT00947882|1249716|P2|COMPLETED|Overall Study||24
510725|NCT00947882|1249717|P1|COMPLETED|Overall Study|End of Trial, Month 12: Patients who had completed the 12-month period when the trial was stopped.|26
510726|NCT00947882|1249714|P4|Visit 12, Month 6|Overall Study||95
510727|NCT00947882|1249715|P3|Visit 12, Month 6|Overall Study||90
510728|NCT00947882|1249716|P2|Visit 12, Month 6|Overall Study||91
510729|NCT00947882|1249717|P1|Visit 12, Month 6|Overall Study|The trial was stopped when all patients had completed Visit 12, scheduled 6 months after the dosing.|93
510730|NCT00947882|1249714|P4|Safety Analysis Set|Overall Study||105
510731|NCT00947882|1249715|P3|Safety Analysis Set|Overall Study||100
510732|NCT00947882|1249716|P2|Safety Analysis Set|Overall Study||101
510733|NCT00947882|1249717|P1|Safety Analysis Set|Overall Study|Safety Analysis Set: Received a dose of Investigational Medicinal Product (IMP).|98
510734|NCT00947882|1249714|P4|Actual Treatment|Overall Study||105
510735|NCT00947882|1249715|P3|Actual Treatment|Overall Study|1 patient randomised to 20 mg degarelix received 30 mg degarelix|100
510736|NCT00947882|1249716|P2|Actual Treatment|Overall Study||101
510737|NCT00947882|1249717|P1|Actual Treatment|Overall Study|2 placebo patients received 30 mg degarelix|98
510738|NCT00947882|1249714|P4|Full Analysis Set (FAS)|Overall Study||102
510739|NCT00947882|1249715|P3|Full Analysis Set (FAS)|Overall Study|1 patient received 20 mg degarelix but had no post-baseline IPSS value and was excluded from the FAS|100
510740|NCT00947882|1249716|P2|Full Analysis Set (FAS)|Overall Study||101
510741|NCT00947882|1249717|P1|Full Analysis Set (FAS)|Overall Study|FAS: Received a dose of IMP and completed at least one post-baseline IPSS questionnaire.|100
510742|NCT00947882|1249714|P4|STARTED|Overall Study||102
510743|NCT00947882|1249715|P3|STARTED|Overall Study||101
510744|NCT00947882|1249716|P2|STARTED|Overall Study||101
510745|NCT00947882|1249717|P1|STARTED|Overall Study|Started: Randomised.|100
510746|NCT00947856|1249745|P2|NOT COMPLETED|Follow-up Period||23
510747|NCT00947856|1249746|P1|NOT COMPLETED|Follow-up Period||51
510748|NCT00947856|1249745|P2|COMPLETED|Follow-up Period|Completed survival follow-up due to death|9
510749|NCT00947856|1249746|P1|COMPLETED|Follow-up Period||27
510750|NCT00947856|1249745|P2|STARTED|Follow-up Period|All participants were followed after treatment; thus, number started will not match number completed|32
510751|NCT00947856|1249746|P1|STARTED|Follow-up Period||78
510752|NCT00947856|1249745|P2|NOT COMPLETED|Treatment Period||32
510753|NCT00947856|1249746|P1|NOT COMPLETED|Treatment Period||78
510754|NCT00947856|1249745|P2|COMPLETED|Treatment Period|Patients treated until disease progression, unacceptable toxicity or study closure|0
510755|NCT00947856|1249746|P1|COMPLETED|Treatment Period||0
510756|NCT00947856|1249745|P2|STARTED|Treatment Period|Two patients in extension arm re-enrolled in retreatment arm and are represented in both arms|32
510757|NCT00947856|1249746|P1|STARTED|Treatment Period||78
510758|NCT00947791|1249775|P2|NOT COMPLETED|Overall Study||0
510759|NCT00947791|1249776|P1|NOT COMPLETED|Overall Study||0
510760|NCT00947791|1249775|P2|COMPLETED|Overall Study||1
510761|NCT00947791|1249776|P1|COMPLETED|Overall Study||0
510762|NCT00947791|1249775|P2|STARTED|Overall Study||1
510763|NCT00947791|1249776|P1|STARTED|Overall Study||0
510764|NCT00947765|1249794|P2|NOT COMPLETED|Overall Study||0
510765|NCT00947765|1249795|P1|NOT COMPLETED|Overall Study||0
510766|NCT00947765|1249794|P2|COMPLETED|Overall Study||30
510767|NCT00947765|1249795|P1|COMPLETED|Overall Study||30
510768|NCT00947765|1249794|P2|STARTED|Overall Study||30
510769|NCT00947765|1249795|P1|STARTED|Overall Study||30
510770|NCT00947752|1249817|P2|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0
510771|NCT00947752|1249818|P1|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0
510772|NCT00947752|1249817|P2|COMPLETED|Crossover to 2nd 14-day Treatment Period||76
510773|NCT00947752|1249818|P1|COMPLETED|Crossover to 2nd 14-day Treatment Period||71
510774|NCT00947752|1249817|P2|STARTED|Crossover to 2nd 14-day Treatment Period||76
510775|NCT00947752|1249818|P1|STARTED|Crossover to 2nd 14-day Treatment Period||71
510776|NCT00947752|1249817|P2|NOT COMPLETED|1st 14-day Treatment Period||0
510777|NCT00947752|1249818|P1|NOT COMPLETED|1st 14-day Treatment Period||0
510778|NCT00947752|1249817|P2|COMPLETED|1st 14-day Treatment Period||71
510779|NCT00947752|1249818|P1|COMPLETED|1st 14-day Treatment Period||76
510780|NCT00947752|1249817|P2|STARTED|1st 14-day Treatment Period||71
510781|NCT00947752|1249818|P1|STARTED|1st 14-day Treatment Period||76
510782|NCT00947752|1249817|P2|NOT COMPLETED|7-Day Run-in Treatment Period||0
510783|NCT00947752|1249818|P1|NOT COMPLETED|7-Day Run-in Treatment Period||0
510784|NCT00947752|1249817|P2|COMPLETED|7-Day Run-in Treatment Period||0
510785|NCT00947752|1249818|P1|COMPLETED|7-Day Run-in Treatment Period||147
510786|NCT00947752|1249817|P2|STARTED|7-Day Run-in Treatment Period||0
510787|NCT00947752|1249818|P1|STARTED|7-Day Run-in Treatment Period|All subjects started with a daily does of F1 for 7 days|147
510788|NCT00947661|1249828|P2|NOT COMPLETED|Overall Study||15
510789|NCT00947661|1249829|P1|NOT COMPLETED|Overall Study||13
510790|NCT00947661|1249828|P2|COMPLETED|Overall Study||274
510791|NCT00947661|1249829|P1|COMPLETED|Overall Study||276
510792|NCT00947661|1249828|P2|STARTED|Overall Study||289
510793|NCT00947661|1249829|P1|STARTED|Overall Study||289
510794|NCT00947544|1249835|P2|NOT COMPLETED|Safety-Extension Period (12 Months)||0
510795|NCT00947544|1249836|P1|NOT COMPLETED|Safety-Extension Period (12 Months)||1
510796|NCT00947544|1249835|P2|COMPLETED|Safety-Extension Period (12 Months)||6
510797|NCT00947544|1249836|P1|COMPLETED|Safety-Extension Period (12 Months)||10
510798|NCT00947544|1249835|P2|STARTED|Safety-Extension Period (12 Months)|New participants were enrolled due to DSMB approval.|6
510799|NCT00947544|1249836|P1|STARTED|Safety-Extension Period (12 Months)||11
510800|NCT00947544|1249835|P2|NOT COMPLETED|Switch-Over Period (2 Weeks)||0
510801|NCT00947544|1249836|P1|NOT COMPLETED|Switch-Over Period (2 Weeks)||0
510802|NCT00947544|1249835|P2|COMPLETED|Switch-Over Period (2 Weeks)||0
510803|NCT00947544|1249836|P1|COMPLETED|Switch-Over Period (2 Weeks)||11
510804|NCT00947544|1249835|P2|STARTED|Switch-Over Period (2 Weeks)||0
510805|NCT00947544|1249836|P1|STARTED|Switch-Over Period (2 Weeks)||11
510806|NCT00947531|1249862|P2|NOT COMPLETED|Overall Study||11
510807|NCT00947531|1249863|P1|NOT COMPLETED|Overall Study||14
510808|NCT00947531|1249862|P2|COMPLETED|Overall Study||110
510809|NCT00947531|1249863|P1|COMPLETED|Overall Study||107
510810|NCT00947531|1249862|P2|STARTED|Overall Study||121
510811|NCT00947531|1249863|P1|STARTED|Overall Study||121
510812|NCT00947518|1249872|P3|NOT COMPLETED|Overall Study||0
510813|NCT00947518|1249873|P2|NOT COMPLETED|Overall Study||0
510814|NCT00947518|1249874|P1|NOT COMPLETED|Overall Study||0
510815|NCT00947518|1249872|P3|COMPLETED|Overall Study||20
510816|NCT00947518|1249873|P2|COMPLETED|Overall Study||20
510817|NCT00947518|1249874|P1|COMPLETED|Overall Study||20
510818|NCT00947518|1249872|P3|STARTED|Overall Study||20
510819|NCT00947518|1249873|P2|STARTED|Overall Study||20
510820|NCT00947518|1249874|P1|STARTED|Overall Study||20
510821|NCT00947505|1249890|P2|NOT COMPLETED|Overall Study||2
510822|NCT00947505|1249891|P1|NOT COMPLETED|Overall Study||9
510823|NCT00947505|1249890|P2|COMPLETED|Overall Study||14
510824|NCT00947505|1249891|P1|COMPLETED|Overall Study||24
510825|NCT00947505|1249890|P2|STARTED|Overall Study||16
510826|NCT00947505|1249891|P1|STARTED|Overall Study||33
510827|NCT00947427|1249899|P2|NOT COMPLETED|Overall Study||4
510828|NCT00947427|1249900|P1|NOT COMPLETED|Overall Study||1
510829|NCT00947427|1249899|P2|COMPLETED|Overall Study||45
510830|NCT00947427|1249900|P1|COMPLETED|Overall Study||21
510831|NCT00947427|1249899|P2|STARTED|Overall Study|2 participants discontinued prior to any study drug administration|49
510832|NCT00947427|1249900|P1|STARTED|Overall Study||22
510833|NCT00947349|1249910|P4|NOT COMPLETED|Overall Study Standard of Care||2
510834|NCT00947349|1249911|P3|NOT COMPLETED|Overall Study Standard of Care||2
510835|NCT00947349|1249912|P2|NOT COMPLETED|Overall Study Standard of Care||0
510836|NCT00947349|1249913|P1|NOT COMPLETED|Overall Study Standard of Care||0
510837|NCT00947349|1249910|P4|COMPLETED|Overall Study Standard of Care||4
510838|NCT00947349|1249911|P3|COMPLETED|Overall Study Standard of Care||4
510839|NCT00947349|1249912|P2|COMPLETED|Overall Study Standard of Care||5
510840|NCT00947349|1249913|P1|COMPLETED|Overall Study Standard of Care||4
510841|NCT00947349|1249910|P4|STARTED|Overall Study Standard of Care||6
510842|NCT00947349|1249911|P3|STARTED|Overall Study Standard of Care||6
510843|NCT00947349|1249912|P2|STARTED|Overall Study Standard of Care||5
510844|NCT00947349|1249913|P1|STARTED|Overall Study Standard of Care||4
510845|NCT00947349|1249910|P4|NOT COMPLETED|Triple Treatment Combination Period||0
510846|NCT00947349|1249911|P3|NOT COMPLETED|Triple Treatment Combination Period||0
510847|NCT00947349|1249912|P2|NOT COMPLETED|Triple Treatment Combination Period||1
510848|NCT00947349|1249913|P1|NOT COMPLETED|Triple Treatment Combination Period||0
510849|NCT00947349|1249910|P4|COMPLETED|Triple Treatment Combination Period||6
510850|NCT00947349|1249911|P3|COMPLETED|Triple Treatment Combination Period||6
510851|NCT00947349|1249912|P2|COMPLETED|Triple Treatment Combination Period||5
510852|NCT00947349|1249913|P1|COMPLETED|Triple Treatment Combination Period||4
510853|NCT00947349|1249910|P4|STARTED|Triple Treatment Combination Period||6
510854|NCT00947349|1249911|P3|STARTED|Triple Treatment Combination Period||6
510855|NCT00947349|1249912|P2|STARTED|Triple Treatment Combination Period||6
510856|NCT00947349|1249913|P1|STARTED|Triple Treatment Combination Period||4
510857|NCT00947310|1250048|P3|NOT COMPLETED|Overall Study||0
510858|NCT00947310|1250049|P2|NOT COMPLETED|Overall Study||0
510859|NCT00947310|1250050|P1|NOT COMPLETED|Overall Study||0
510860|NCT00947310|1250048|P3|COMPLETED|Overall Study||486
510861|NCT00947310|1250049|P2|COMPLETED|Overall Study||500
510862|NCT00947310|1250050|P1|COMPLETED|Overall Study||514
510863|NCT00947310|1250048|P3|STARTED|Overall Study||486
510864|NCT00947310|1250049|P2|STARTED|Overall Study||500
510865|NCT00947310|1250050|P1|STARTED|Overall Study||514
510866|NCT00947297|1250064|P1|NOT COMPLETED|Overall Study||7
510867|NCT00947297|1250064|P1|COMPLETED|Overall Study||53
510868|NCT00947297|1250064|P1|STARTED|Overall Study||60
510869|NCT00947284|1250071|P2|NOT COMPLETED|Overall Study||3
510870|NCT00947284|1250072|P1|NOT COMPLETED|Overall Study||0
510871|NCT00947284|1250071|P2|COMPLETED|Overall Study||0
510872|NCT00947284|1250072|P1|COMPLETED|Overall Study||0
510873|NCT00947284|1250071|P2|STARTED|Overall Study||3
510874|NCT00947284|1250072|P1|STARTED|Overall Study||0
510875|NCT00947271|1250080|P4|NOT COMPLETED|12 Months Post Intervention||62
510876|NCT00947271|1250081|P3|NOT COMPLETED|12 Months Post Intervention||59
510877|NCT00947271|1250082|P2|NOT COMPLETED|12 Months Post Intervention||60
510878|NCT00947271|1250083|P1|NOT COMPLETED|12 Months Post Intervention||71
510879|NCT00947271|1250080|P4|COMPLETED|12 Months Post Intervention||188
510880|NCT00947271|1250081|P3|COMPLETED|12 Months Post Intervention||195
510881|NCT00947271|1250082|P2|COMPLETED|12 Months Post Intervention||192
510882|NCT00947271|1250083|P1|COMPLETED|12 Months Post Intervention||183
510883|NCT00947271|1250080|P4|STARTED|12 Months Post Intervention||250
510884|NCT00947271|1250081|P3|STARTED|12 Months Post Intervention||254
510885|NCT00947271|1250082|P2|STARTED|12 Months Post Intervention||252
510886|NCT00947271|1250083|P1|STARTED|12 Months Post Intervention||254
510887|NCT00947271|1250080|P4|NOT COMPLETED|9 Months Post Intervention||59
510888|NCT00947271|1250081|P3|NOT COMPLETED|9 Months Post Intervention||61
510889|NCT00947271|1250082|P2|NOT COMPLETED|9 Months Post Intervention||60
510890|NCT00947271|1250083|P1|NOT COMPLETED|9 Months Post Intervention||70
510891|NCT00947271|1250080|P4|COMPLETED|9 Months Post Intervention||191
510892|NCT00947271|1250081|P3|COMPLETED|9 Months Post Intervention||193
510893|NCT00947271|1250082|P2|COMPLETED|9 Months Post Intervention||192
510894|NCT00947271|1250083|P1|COMPLETED|9 Months Post Intervention||184
510895|NCT00947271|1250080|P4|STARTED|9 Months Post Intervention||250
510896|NCT00947271|1250081|P3|STARTED|9 Months Post Intervention||254
510897|NCT00947271|1250082|P2|STARTED|9 Months Post Intervention||252
510898|NCT00947271|1250083|P1|STARTED|9 Months Post Intervention||254
510899|NCT00947271|1250080|P4|NOT COMPLETED|6 Months Post Intervention||54
510900|NCT00947271|1250081|P3|NOT COMPLETED|6 Months Post Intervention||58
510901|NCT00947271|1250082|P2|NOT COMPLETED|6 Months Post Intervention||53
510902|NCT00947271|1250083|P1|NOT COMPLETED|6 Months Post Intervention||55
510903|NCT00947271|1250080|P4|COMPLETED|6 Months Post Intervention||196
510904|NCT00947271|1250081|P3|COMPLETED|6 Months Post Intervention||196
510905|NCT00947271|1250082|P2|COMPLETED|6 Months Post Intervention||199
510906|NCT00947271|1250083|P1|COMPLETED|6 Months Post Intervention||199
510907|NCT00947271|1250080|P4|STARTED|6 Months Post Intervention||250
510908|NCT00947271|1250081|P3|STARTED|6 Months Post Intervention||254
510909|NCT00947271|1250082|P2|STARTED|6 Months Post Intervention||252
510910|NCT00947271|1250083|P1|STARTED|6 Months Post Intervention||254
510911|NCT00947271|1250080|P4|NOT COMPLETED|3 Months Post Intervention||44
510912|NCT00947271|1250081|P3|NOT COMPLETED|3 Months Post Intervention||36
510913|NCT00947271|1250082|P2|NOT COMPLETED|3 Months Post Intervention||48
510914|NCT00947271|1250083|P1|NOT COMPLETED|3 Months Post Intervention||52
510915|NCT00947271|1250080|P4|COMPLETED|3 Months Post Intervention||206
510916|NCT00947271|1250081|P3|COMPLETED|3 Months Post Intervention||218
510917|NCT00947271|1250082|P2|COMPLETED|3 Months Post Intervention||204
510918|NCT00947271|1250083|P1|COMPLETED|3 Months Post Intervention||202
510919|NCT00947271|1250080|P4|STARTED|3 Months Post Intervention||250
510920|NCT00947271|1250081|P3|STARTED|3 Months Post Intervention||254
510921|NCT00947271|1250082|P2|STARTED|3 Months Post Intervention||252
510922|NCT00947271|1250083|P1|STARTED|3 Months Post Intervention||254
510923|NCT00947219|1250112|P3|NOT COMPLETED|Overall Study||4
510924|NCT00947219|1250113|P2|NOT COMPLETED|Overall Study||4
510925|NCT00947219|1250114|P1|NOT COMPLETED|Overall Study||6
510926|NCT00947219|1250112|P3|COMPLETED|Overall Study||22
510927|NCT00947219|1250113|P2|COMPLETED|Overall Study||21
510928|NCT00947219|1250114|P1|COMPLETED|Overall Study||22
510929|NCT00947219|1250112|P3|STARTED|Overall Study||26
510930|NCT00947219|1250113|P2|STARTED|Overall Study||25
510931|NCT00947219|1250114|P1|STARTED|Overall Study||28
510932|NCT00947167|1250122|P1|NOT COMPLETED|Erlotinib Added to Pertuzumab||0
510933|NCT00947167|1250122|P1|COMPLETED|Erlotinib Added to Pertuzumab||3
510934|NCT00947167|1250122|P1|STARTED|Erlotinib Added to Pertuzumab||3
510935|NCT00947167|1250122|P1|NOT COMPLETED|Pertuzumab Alone||0
510936|NCT00947167|1250122|P1|COMPLETED|Pertuzumab Alone||4
510937|NCT00947167|1250122|P1|STARTED|Pertuzumab Alone||4
510938|NCT00947154|1250127|P1|NOT COMPLETED|Overall Study||1
510939|NCT00947154|1250127|P1|COMPLETED|Overall Study||11
510940|NCT00947154|1250127|P1|STARTED|Overall Study||12
510941|NCT00947115|1250137|P3|NOT COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||15
510942|NCT00947115|1250138|P2|NOT COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||22
510943|NCT00947115|1250139|P1|NOT COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||17
510944|NCT00947115|1250137|P3|COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||156
510945|NCT00947115|1250138|P2|COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||172
510946|NCT00947115|1250139|P1|COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||142
510947|NCT00947115|1250137|P3|STARTED|Year 0 (Month 0) - Year 10 (Month 120)||171
510948|NCT00947115|1250138|P2|STARTED|Year 0 (Month 0) - Year 10 (Month 120)||194
510949|NCT00947115|1250139|P1|STARTED|Year 0 (Month 0) - Year 10 (Month 120)||159
510950|NCT00947115|1250137|P3|NOT COMPLETED|Year 10 (Month 120)||0
510951|NCT00947115|1250138|P2|NOT COMPLETED|Year 10 (Month 120)||0
510952|NCT00947115|1250139|P1|NOT COMPLETED|Year 10 (Month 120)||0
510953|NCT00947115|1250137|P3|COMPLETED|Year 10 (Month 120)||156
510954|NCT00947115|1250138|P2|COMPLETED|Year 10 (Month 120)||172
510955|NCT00947115|1250139|P1|COMPLETED|Year 10 (Month 120)||142
510956|NCT00947115|1250137|P3|STARTED|Year 10 (Month 120)||156
510957|NCT00947115|1250138|P2|STARTED|Year 10 (Month 120)||172
510958|NCT00947115|1250139|P1|STARTED|Year 10 (Month 120)||142
510959|NCT00947115|1250137|P3|NOT COMPLETED|Year 9 (Month 108)||0
510960|NCT00947115|1250138|P2|NOT COMPLETED|Year 9 (Month 108)||0
510961|NCT00947115|1250139|P1|NOT COMPLETED|Year 9 (Month 108)||0
510962|NCT00947115|1250137|P3|COMPLETED|Year 9 (Month 108)||157
510963|NCT00947115|1250138|P2|COMPLETED|Year 9 (Month 108)||180
510964|NCT00947115|1250139|P1|COMPLETED|Year 9 (Month 108)||146
510965|NCT00947115|1250137|P3|STARTED|Year 9 (Month 108)||157
510966|NCT00947115|1250138|P2|STARTED|Year 9 (Month 108)||180
510967|NCT00947115|1250139|P1|STARTED|Year 9 (Month 108)||146
510968|NCT00947115|1250137|P3|NOT COMPLETED|Year 8 (Month 96)||0
510969|NCT00947115|1250138|P2|NOT COMPLETED|Year 8 (Month 96)||0
510970|NCT00947115|1250139|P1|NOT COMPLETED|Year 8 (Month 96)||0
510971|NCT00947115|1250137|P3|COMPLETED|Year 8 (Month 96)||141
510972|NCT00947115|1250138|P2|COMPLETED|Year 8 (Month 96)||152
510973|NCT00947115|1250139|P1|COMPLETED|Year 8 (Month 96)||137
510974|NCT00947115|1250137|P3|STARTED|Year 8 (Month 96)||141
510975|NCT00947115|1250138|P2|STARTED|Year 8 (Month 96)||152
510976|NCT00947115|1250139|P1|STARTED|Year 8 (Month 96)||137
510977|NCT00947115|1250137|P3|NOT COMPLETED|Year 7 (Month 84)||0
510978|NCT00947115|1250138|P2|NOT COMPLETED|Year 7 (Month 84)||0
510979|NCT00947115|1250139|P1|NOT COMPLETED|Year 7 (Month 84)||0
510980|NCT00947115|1250137|P3|COMPLETED|Year 7 (Month 84)||160
510981|NCT00947115|1250138|P2|COMPLETED|Year 7 (Month 84)||165
510982|NCT00947115|1250139|P1|COMPLETED|Year 7 (Month 84)||149
510983|NCT00947115|1250137|P3|STARTED|Year 7 (Month 84)||160
510984|NCT00947115|1250138|P2|STARTED|Year 7 (Month 84)||165
510985|NCT00947115|1250139|P1|STARTED|Year 7 (Month 84)||149
510986|NCT00947115|1250137|P3|NOT COMPLETED|Year 6 (Month 72)||0
510987|NCT00947115|1250138|P2|NOT COMPLETED|Year 6 (Month 72)||0
510988|NCT00947115|1250139|P1|NOT COMPLETED|Year 6 (Month 72)||0
510989|NCT00947115|1250137|P3|COMPLETED|Year 6 (Month 72)||164
510990|NCT00947115|1250138|P2|COMPLETED|Year 6 (Month 72)||177
510991|NCT00947115|1250139|P1|COMPLETED|Year 6 (Month 72)||147
510992|NCT00947115|1250137|P3|STARTED|Year 6 (Month 72)||164
510993|NCT00947115|1250138|P2|STARTED|Year 6 (Month 72)||177
510994|NCT00947115|1250139|P1|STARTED|Year 6 (Month 72)||147
510995|NCT00947115|1250137|P3|NOT COMPLETED|Year 5 (Month 60)||0
510996|NCT00947115|1250138|P2|NOT COMPLETED|Year 5 (Month 60)||0
510997|NCT00947115|1250139|P1|NOT COMPLETED|Year 5 (Month 60)||0
510998|NCT00947115|1250137|P3|COMPLETED|Year 5 (Month 60)||170
510999|NCT00947115|1250138|P2|COMPLETED|Year 5 (Month 60)||184
511000|NCT00947115|1250139|P1|COMPLETED|Year 5 (Month 60)||153
511001|NCT00947115|1250137|P3|STARTED|Year 5 (Month 60)||170
511002|NCT00947115|1250138|P2|STARTED|Year 5 (Month 60)||184
511003|NCT00947115|1250139|P1|STARTED|Year 5 (Month 60)||153
511004|NCT00947011|1250201|P1|NOT COMPLETED|Overall Study||12
511005|NCT00947011|1250201|P1|COMPLETED|Overall Study||0
511006|NCT00947011|1250201|P1|STARTED|Overall Study||12
511007|NCT00946998|1250211|P2|NOT COMPLETED|Overall Study||3
511008|NCT00946998|1250212|P1|NOT COMPLETED|Overall Study||5
511009|NCT00946998|1250211|P2|COMPLETED|Overall Study||96
511010|NCT00946998|1250212|P1|COMPLETED|Overall Study||97
511011|NCT00946998|1250211|P2|Received Treatment as Randomized|Overall Study||99
511012|NCT00946998|1250212|P1|Received Treatment as Randomized|Overall Study||102
511013|NCT00946998|1250211|P2|STARTED|Overall Study||99
511014|NCT00946998|1250212|P1|STARTED|Overall Study||102
511015|NCT00946985|1250226|P1|NOT COMPLETED|Relapse Prevention Phase (24 Months)||2
511016|NCT00946985|1250226|P1|COMPLETED|Relapse Prevention Phase (24 Months)||0
511017|NCT00946985|1250226|P1|STARTED|Relapse Prevention Phase (24 Months)|Both randomized patients were discontinued when the sponsor terminated the trial early.|2
511018|NCT00946985|1250226|P1|NOT COMPLETED|Stabilization Phase (25 Weeks)||160
511019|NCT00946985|1250226|P1|COMPLETED|Stabilization Phase (25 Weeks)||2
511020|NCT00946985|1250226|P1|STARTED|Stabilization Phase (25 Weeks)||162
511021|NCT00946920|1250232|P2|NOT COMPLETED|Overall Study||44
511022|NCT00946920|1250233|P1|NOT COMPLETED|Overall Study||110
511023|NCT00946920|1250232|P2|COMPLETED|Overall Study||239
511024|NCT00946920|1250233|P1|COMPLETED|Overall Study||455
511025|NCT00946920|1250232|P2|Full Analysis Set (FAS)|Overall Study|Received at least one dose of goserelin and had at least one post-dosing efficacy assessment.|282
511026|NCT00946920|1250233|P1|Full Analysis Set (FAS)|Overall Study|Received at least one dose of degarelix and had at least one post-dosing efficacy assessment.|565
511027|NCT00946920|1250232|P2|STARTED|Overall Study|Received at least one dose of goserelin acetate.|283
511028|NCT00946920|1250233|P1|STARTED|Overall Study|Received at least one dose of degarelix.|565
511029|NCT00946881|1250248|P1|NOT COMPLETED|Retreatment||1
511030|NCT00946881|1250248|P1|COMPLETED|Retreatment||7
511031|NCT00946881|1250248|P1|STARTED|Retreatment|This part concerns the number of patients who were retreated ,not the same number as previous period|8
511032|NCT00946881|1250248|P1|NOT COMPLETED|First Treatment||2
511033|NCT00946881|1250248|P1|COMPLETED|First Treatment||28
511034|NCT00946881|1250248|P1|STARTED|First Treatment||30
511035|NCT00946530|1250281|P4|NOT COMPLETED|Overall Study||4
511036|NCT00946530|1250282|P3|NOT COMPLETED|Overall Study||1
511037|NCT00946530|1250283|P2|NOT COMPLETED|Overall Study||4
511038|NCT00946530|1250284|P1|NOT COMPLETED|Overall Study||1
511039|NCT00946530|1250281|P4|COMPLETED|Overall Study|23 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|23
511040|NCT00946530|1250282|P3|COMPLETED|Overall Study|31 dyads consisting of 1 AD patient and 1 caregiver completed the Bright Light Arm|31
511041|NCT00946530|1250283|P2|COMPLETED|Overall Study|23 dyads consisting of 1 AD patient and 1 caregiver completed to the Dim Light (Control) arm|23
511042|NCT00946530|1250284|P1|COMPLETED|Overall Study|31 dyads consisting of 1 AD patient and 1 caregiver completed the Bright Light Arm|31
511043|NCT00946530|1250281|P4|STARTED|Overall Study|27 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|27
511044|NCT00946530|1250282|P3|STARTED|Overall Study|32 dyads consisting of 1 AD patient and 1 caregiver were assigned the Bright Light Arm|32
511045|NCT00946530|1250283|P2|STARTED|Overall Study|27 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|27
511046|NCT00946530|1250284|P1|STARTED|Overall Study|32 dyads consisting of 1 AD patient and 1 caregiver were assigned the Bright Light Arm|32
511047|NCT00946478|1250300|P2|NOT COMPLETED|Overall Study||0
511048|NCT00946478|1250301|P1|NOT COMPLETED|Overall Study||0
511049|NCT00946478|1250300|P2|COMPLETED|Overall Study||20
511050|NCT00946478|1250301|P1|COMPLETED|Overall Study||20
511051|NCT00946478|1250300|P2|STARTED|Overall Study||20
511052|NCT00946478|1250301|P1|STARTED|Overall Study||20
511053|NCT00946348|1250309|P2|NOT COMPLETED|Overall Study||0
511054|NCT00946348|1250310|P1|NOT COMPLETED|Overall Study||0
511055|NCT00946348|1250309|P2|COMPLETED|Overall Study||6
511056|NCT00946348|1250310|P1|COMPLETED|Overall Study||6
511057|NCT00946348|1250309|P2|STARTED|Overall Study||6
511058|NCT00946348|1250310|P1|STARTED|Overall Study||6
511059|NCT00946322|1250316|P1|NOT COMPLETED|Post-treatment||2
511060|NCT00946322|1250316|P1|COMPLETED|Post-treatment||9
511061|NCT00946322|1250316|P1|STARTED|Post-treatment||11
511062|NCT00946322|1250316|P1|NOT COMPLETED|Pre-treatment||1
511063|NCT00946322|1250316|P1|COMPLETED|Pre-treatment||11
511064|NCT00946322|1250316|P1|STARTED|Pre-treatment||12
511065|NCT00946309|1250329|P2|NOT COMPLETED|Overall Study||4
511066|NCT00946309|1250330|P1|NOT COMPLETED|Overall Study||1
511067|NCT00946309|1250329|P2|COMPLETED|Overall Study||19
511068|NCT00946309|1250330|P1|COMPLETED|Overall Study||21
511069|NCT00946309|1250329|P2|STARTED|Overall Study||23
511070|NCT00946309|1250330|P1|STARTED|Overall Study||22
511071|NCT00946296|1250348|P2|NOT COMPLETED|Overall Study||0
511072|NCT00946296|1250349|P1|NOT COMPLETED|Overall Study||3
511073|NCT00946296|1250348|P2|COMPLETED|Overall Study||15
511074|NCT00946296|1250349|P1|COMPLETED|Overall Study||18
511075|NCT00946296|1250348|P2|STARTED|Overall Study||15
511076|NCT00946296|1250349|P1|STARTED|Overall Study||21
511077|NCT00946114|1250357|P2|NOT COMPLETED|Overall Study||2
511078|NCT00946114|1250358|P1|NOT COMPLETED|Overall Study||8
511079|NCT00946114|1250357|P2|COMPLETED|Overall Study||10
511080|NCT00946114|1250358|P1|COMPLETED|Overall Study||12
511081|NCT00946114|1250357|P2|STARTED|Overall Study||12
511082|NCT00946114|1250358|P1|STARTED|Overall Study||20
511083|NCT00946101|1250366|P2|NOT COMPLETED|Overall Study||2
511084|NCT00946101|1250367|P1|NOT COMPLETED|Overall Study||4
511085|NCT00946101|1250366|P2|COMPLETED|Overall Study||63
511086|NCT00946101|1250367|P1|COMPLETED|Overall Study||257
511087|NCT00946101|1250366|P2|Day 15 Post Dose 2|Overall Study||63
511088|NCT00946101|1250367|P1|Day 15 Post Dose 2|Overall Study||254
511089|NCT00946101|1250366|P2|Day 15 Post Dose 1|Overall Study||64
511090|NCT00946101|1250367|P1|Day 15 Post Dose 1|Overall Study||260
511091|NCT00946101|1250366|P2|STARTED|Overall Study||65
511092|NCT00946101|1250367|P1|STARTED|Overall Study|Intent to Treat population, enrolled and randomized|261
511093|NCT00946088|1250433|P2|NOT COMPLETED|Overall Study||1
511094|NCT00946088|1250434|P1|NOT COMPLETED|Overall Study||0
511095|NCT00946088|1250433|P2|COMPLETED|Overall Study|At least one dose administered and pre-term birth status known.|2
511096|NCT00946088|1250434|P1|COMPLETED|Overall Study|At least one dose administered and pre-term birth status known.|4
511097|NCT00946088|1250433|P2|STARTED|Overall Study||3
511098|NCT00946088|1250434|P1|STARTED|Overall Study||4
511099|NCT00945958|1250456|P1|NOT COMPLETED|Overall Study||12
511100|NCT00945958|1250456|P1|COMPLETED|Overall Study||149
511101|NCT00945958|1250456|P1|STARTED|Overall Study||161
511102|NCT00945945|1250463|P2|NOT COMPLETED|Overall Study||55
511103|NCT00945945|1250464|P1|NOT COMPLETED|Overall Study||36
511104|NCT00945945|1250463|P2|COMPLETED|Overall Study||162
511105|NCT00945945|1250464|P1|COMPLETED|Overall Study||171
511106|NCT00945945|1250463|P2|STARTED|Overall Study||217
511107|NCT00945945|1250464|P1|STARTED|Overall Study||207
511108|NCT00945906|1250490|P1|NOT COMPLETED|Overall Study||7
511109|NCT00945906|1250490|P1|COMPLETED|Overall Study||54
511110|NCT00945906|1250490|P1|STARTED|Overall Study||61
511111|NCT00945893|1250501|P2|NOT COMPLETED|Overall Study||10
511112|NCT00945893|1250502|P1|NOT COMPLETED|Overall Study||3
511113|NCT00945893|1250501|P2|COMPLETED|Overall Study||230
511114|NCT00945893|1250502|P1|COMPLETED|Overall Study||57
511115|NCT00945893|1250501|P2|Day 15 Post Dose 2|Overall Study||226
511116|NCT00945893|1250502|P1|Day 15 Post Dose 2|Overall Study||54
511117|NCT00945893|1250501|P2|Day 15 Post Dose 1|Overall Study||238
511118|NCT00945893|1250502|P1|Day 15 Post Dose 1|Overall Study||60
511119|NCT00945893|1250501|P2|STARTED|Overall Study||240
511120|NCT00945893|1250502|P1|STARTED|Overall Study||60
511121|NCT00945854|1250568|P2|NOT COMPLETED|Overall Study||4
511122|NCT00945854|1250569|P1|NOT COMPLETED|Overall Study||2
511123|NCT00945854|1250568|P2|COMPLETED|Overall Study||26
511124|NCT00945854|1250569|P1|COMPLETED|Overall Study||28
511125|NCT00945854|1250568|P2|STARTED|Overall Study||30
511126|NCT00945854|1250569|P1|STARTED|Overall Study||30
511127|NCT00945815|1250579|P1|NOT COMPLETED|Overall Study||8
511128|NCT00945815|1250579|P1|COMPLETED|Overall Study||27
511129|NCT00945815|1250579|P1|Eligible and Began Protocol Therapy|Overall Study||31
511130|NCT00945815|1250579|P1|Eligible|Overall Study||32
511131|NCT00945815|1250579|P1|STARTED|Overall Study||35
511132|NCT00945750|1250590|P6|NOT COMPLETED|Period III||0
511133|NCT00945750|1250591|P5|NOT COMPLETED|Period III||0
511134|NCT00945750|1250592|P4|NOT COMPLETED|Period III||0
511135|NCT00945750|1250593|P3|NOT COMPLETED|Period III||0
511136|NCT00945750|1250594|P2|NOT COMPLETED|Period III||0
511137|NCT00945750|1250595|P1|NOT COMPLETED|Period III||0
511138|NCT00945750|1250590|P6|COMPLETED|Period III||5
511139|NCT00945750|1250591|P5|COMPLETED|Period III||5
511140|NCT00945750|1250592|P4|COMPLETED|Period III||5
511141|NCT00945750|1250593|P3|COMPLETED|Period III||5
511142|NCT00945750|1250594|P2|COMPLETED|Period III||5
511143|NCT00945750|1250595|P1|COMPLETED|Period III||5
511144|NCT00945750|1250590|P6|STARTED|Period III||5
511145|NCT00945750|1250591|P5|STARTED|Period III||5
511146|NCT00945750|1250592|P4|STARTED|Period III||5
511147|NCT00945750|1250593|P3|STARTED|Period III||5
511148|NCT00945750|1250594|P2|STARTED|Period III||5
511149|NCT00945750|1250595|P1|STARTED|Period III||5
511150|NCT00945750|1250590|P6|NOT COMPLETED|Period II||0
511151|NCT00945750|1250591|P5|NOT COMPLETED|Period II||0
511152|NCT00945750|1250592|P4|NOT COMPLETED|Period II||0
511153|NCT00945750|1250593|P3|NOT COMPLETED|Period II||0
511154|NCT00945750|1250594|P2|NOT COMPLETED|Period II||0
511155|NCT00945750|1250595|P1|NOT COMPLETED|Period II||0
511156|NCT00945750|1250590|P6|COMPLETED|Period II||5
511157|NCT00945750|1250591|P5|COMPLETED|Period II||5
511158|NCT00945750|1250592|P4|COMPLETED|Period II||5
511159|NCT00945750|1250593|P3|COMPLETED|Period II||5
511160|NCT00945750|1250594|P2|COMPLETED|Period II||5
511161|NCT00945750|1250595|P1|COMPLETED|Period II||5
511162|NCT00945750|1250590|P6|STARTED|Period II||5
511163|NCT00945750|1250591|P5|STARTED|Period II||5
511164|NCT00945750|1250592|P4|STARTED|Period II||5
511165|NCT00945750|1250593|P3|STARTED|Period II||5
511166|NCT00945750|1250594|P2|STARTED|Period II||5
511167|NCT00945750|1250595|P1|STARTED|Period II||5
511168|NCT00945750|1250590|P6|NOT COMPLETED|Period I||0
511169|NCT00945750|1250591|P5|NOT COMPLETED|Period I||0
511170|NCT00945750|1250592|P4|NOT COMPLETED|Period I||0
511171|NCT00945750|1250593|P3|NOT COMPLETED|Period I||0
511172|NCT00945750|1250594|P2|NOT COMPLETED|Period I||0
511173|NCT00945750|1250595|P1|NOT COMPLETED|Period I||0
511174|NCT00945750|1250590|P6|COMPLETED|Period I||5
511175|NCT00945750|1250591|P5|COMPLETED|Period I||5
511176|NCT00945750|1250592|P4|COMPLETED|Period I||5
511177|NCT00945750|1250593|P3|COMPLETED|Period I||5
511178|NCT00945750|1250594|P2|COMPLETED|Period I||5
511179|NCT00945750|1250595|P1|COMPLETED|Period I||5
511180|NCT00945750|1250590|P6|STARTED|Period I||5
511181|NCT00945750|1250591|P5|STARTED|Period I||5
511182|NCT00945750|1250592|P4|STARTED|Period I||5
511183|NCT00945750|1250593|P3|STARTED|Period I||5
511184|NCT00945750|1250594|P2|STARTED|Period I||5
511185|NCT00945750|1250595|P1|STARTED|Period I||5
511186|NCT00945555|1250608|P1|NOT COMPLETED|Overall Study||28
511187|NCT00945555|1250608|P1|COMPLETED|Overall Study||236
511188|NCT00945555|1250608|P1|STARTED|Overall Study||264
511189|NCT00945477|1250619|P1|NOT COMPLETED|Overall Study||6
511190|NCT00945477|1250619|P1|COMPLETED|Overall Study||5
511191|NCT00945477|1250619|P1|STARTED|Overall Study||11
511192|NCT00945334|1250626|P2|NOT COMPLETED|Overall Study||3
511193|NCT00945334|1250627|P1|NOT COMPLETED|Overall Study||3
511194|NCT00945334|1250626|P2|COMPLETED|Overall Study||15
511195|NCT00945334|1250627|P1|COMPLETED|Overall Study||16
511196|NCT00945334|1250626|P2|STARTED|Overall Study||18
511197|NCT00945334|1250627|P1|STARTED|Overall Study||19
511198|NCT00945321|1250635|P6|NOT COMPLETED|Period 4||1
511199|NCT00945321|1250636|P5|NOT COMPLETED|Period 4||0
511200|NCT00945321|1250637|P4|NOT COMPLETED|Period 4||0
511201|NCT00945321|1250638|P3|NOT COMPLETED|Period 4||0
511202|NCT00945321|1250639|P2|NOT COMPLETED|Period 4||0
511203|NCT00945321|1250640|P1|NOT COMPLETED|Period 4||0
511204|NCT00945321|1250635|P6|COMPLETED|Period 4||6
511205|NCT00945321|1250636|P5|COMPLETED|Period 4||6
511206|NCT00945321|1250637|P4|COMPLETED|Period 4||7
511207|NCT00945321|1250638|P3|COMPLETED|Period 4||7
511208|NCT00945321|1250639|P2|COMPLETED|Period 4||7
511209|NCT00945321|1250640|P1|COMPLETED|Period 4||7
511210|NCT00945321|1250635|P6|STARTED|Period 4||7
511211|NCT00945321|1250636|P5|STARTED|Period 4||6
511212|NCT00945321|1250637|P4|STARTED|Period 4||7
511213|NCT00945321|1250638|P3|STARTED|Period 4||7
511214|NCT00945321|1250639|P2|STARTED|Period 4||7
511215|NCT00945321|1250640|P1|STARTED|Period 4||7
511216|NCT00945321|1250635|P6|NOT COMPLETED|Period 3||0
511217|NCT00945321|1250636|P5|NOT COMPLETED|Period 3||0
511218|NCT00945321|1250637|P4|NOT COMPLETED|Period 3||0
511219|NCT00945321|1250638|P3|NOT COMPLETED|Period 3||0
511220|NCT00945321|1250639|P2|NOT COMPLETED|Period 3||0
511221|NCT00945321|1250640|P1|NOT COMPLETED|Period 3||0
511222|NCT00945321|1250635|P6|COMPLETED|Period 3||7
511223|NCT00945321|1250636|P5|COMPLETED|Period 3||6
511224|NCT00945321|1250637|P4|COMPLETED|Period 3||7
511225|NCT00945321|1250638|P3|COMPLETED|Period 3||7
511226|NCT00945321|1250639|P2|COMPLETED|Period 3||7
511227|NCT00945321|1250640|P1|COMPLETED|Period 3||7
511228|NCT00945321|1250635|P6|STARTED|Period 3||7
511229|NCT00945321|1250636|P5|STARTED|Period 3||6
511230|NCT00945321|1250637|P4|STARTED|Period 3||7
511231|NCT00945321|1250638|P3|STARTED|Period 3||7
511232|NCT00945321|1250639|P2|STARTED|Period 3||7
511233|NCT00945321|1250640|P1|STARTED|Period 3||7
511234|NCT00945321|1250635|P6|NOT COMPLETED|Period 2||0
511235|NCT00945321|1250636|P5|NOT COMPLETED|Period 2||0
511236|NCT00945321|1250637|P4|NOT COMPLETED|Period 2||0
511237|NCT00945321|1250638|P3|NOT COMPLETED|Period 2||0
511238|NCT00945321|1250639|P2|NOT COMPLETED|Period 2||0
511239|NCT00945321|1250640|P1|NOT COMPLETED|Period 2||0
511240|NCT00945321|1250635|P6|COMPLETED|Period 2||7
511241|NCT00945321|1250636|P5|COMPLETED|Period 2||6
511242|NCT00945321|1250637|P4|COMPLETED|Period 2||7
511243|NCT00945321|1250638|P3|COMPLETED|Period 2||7
511244|NCT00945321|1250639|P2|COMPLETED|Period 2||7
511245|NCT00945321|1250640|P1|COMPLETED|Period 2||7
511246|NCT00945321|1250635|P6|STARTED|Period 2||7
511247|NCT00945321|1250636|P5|STARTED|Period 2||6
511248|NCT00945321|1250637|P4|STARTED|Period 2||7
511249|NCT00945321|1250638|P3|STARTED|Period 2||7
511250|NCT00945321|1250639|P2|STARTED|Period 2||7
511251|NCT00945321|1250640|P1|STARTED|Period 2||7
511252|NCT00945321|1250635|P6|NOT COMPLETED|Period 1||0
511253|NCT00945321|1250636|P5|NOT COMPLETED|Period 1||1
511254|NCT00945321|1250637|P4|NOT COMPLETED|Period 1||0
511255|NCT00945321|1250638|P3|NOT COMPLETED|Period 1||0
511256|NCT00945321|1250639|P2|NOT COMPLETED|Period 1||0
511257|NCT00945321|1250640|P1|NOT COMPLETED|Period 1||0
511258|NCT00945321|1250635|P6|COMPLETED|Period 1||7
511259|NCT00945321|1250636|P5|COMPLETED|Period 1||6
511260|NCT00945321|1250637|P4|COMPLETED|Period 1||7
511261|NCT00945321|1250638|P3|COMPLETED|Period 1||7
511262|NCT00945321|1250639|P2|COMPLETED|Period 1||7
511263|NCT00945321|1250640|P1|COMPLETED|Period 1||7
511264|NCT00945321|1250635|P6|STARTED|Period 1||7
511265|NCT00945321|1250636|P5|STARTED|Period 1||7
511266|NCT00945321|1250637|P4|STARTED|Period 1||7
511267|NCT00945321|1250638|P3|STARTED|Period 1||7
511268|NCT00945321|1250639|P2|STARTED|Period 1||7
511269|NCT00945321|1250640|P1|STARTED|Period 1||7
511270|NCT00945295|1250662|P2|NOT COMPLETED|Overall Study||2
511271|NCT00945295|1250663|P1|NOT COMPLETED|Overall Study||0
511272|NCT00945295|1250662|P2|COMPLETED|Overall Study||14
511273|NCT00945295|1250663|P1|COMPLETED|Overall Study||15
511274|NCT00945295|1250662|P2|STARTED|Overall Study||16
511275|NCT00945295|1250663|P1|STARTED|Overall Study||15
511276|NCT00945256|1250676|P5|NOT COMPLETED|Overall Study||1
511277|NCT00945256|1250677|P4|NOT COMPLETED|Overall Study||9
511278|NCT00945256|1250678|P3|NOT COMPLETED|Overall Study||8
511279|NCT00945256|1250679|P2|NOT COMPLETED|Overall Study||2
511280|NCT00945256|1250680|P1|NOT COMPLETED|Overall Study||4
511281|NCT00945256|1250676|P5|COMPLETED|Overall Study||7
511282|NCT00945256|1250677|P4|COMPLETED|Overall Study||7
511283|NCT00945256|1250678|P3|COMPLETED|Overall Study||7
511284|NCT00945256|1250679|P2|COMPLETED|Overall Study||8
511285|NCT00945256|1250680|P1|COMPLETED|Overall Study||9
511286|NCT00945256|1250676|P5|STARTED|Overall Study||8
511287|NCT00945256|1250677|P4|STARTED|Overall Study||16
511288|NCT00945256|1250678|P3|STARTED|Overall Study||15
511289|NCT00945256|1250679|P2|STARTED|Overall Study||10
511290|NCT00945256|1250680|P1|STARTED|Overall Study||13
511291|NCT00945243|1250692|P1|NOT COMPLETED|Overall Study||3
511292|NCT00945243|1250692|P1|COMPLETED|Overall Study||8
511293|NCT00945243|1250692|P1|STARTED|Overall Study|Enrolled and Treated Per Protocol|11
511294|NCT00945139|1250698|P1|NOT COMPLETED|Overall Study||0
511295|NCT00945139|1250698|P1|COMPLETED|Overall Study||46
511296|NCT00945139|1250698|P1|STARTED|Overall Study||46
511297|NCT00945100|1250709|P2|NOT COMPLETED|Post-10 Week Primary Outcome||7
511298|NCT00945100|1250710|P1|NOT COMPLETED|Post-10 Week Primary Outcome||4
511299|NCT00945100|1250709|P2|COMPLETED|Post-10 Week Primary Outcome||56
511300|NCT00945100|1250710|P1|COMPLETED|Post-10 Week Primary Outcome||51
511301|NCT00945100|1250709|P2|STARTED|Post-10 Week Primary Outcome|20 participants were not eligible for Post 10 week Primary Outcome phase|63
511302|NCT00945100|1250710|P1|STARTED|Post-10 Week Primary Outcome|27 participants were not eligible for Post 10 week Primary Outcome phase|55
511303|NCT00945100|1250709|P2|NOT COMPLETED|10-week Primary Outcome||3
511304|NCT00945100|1250710|P1|NOT COMPLETED|10-week Primary Outcome||1
511305|NCT00945100|1250709|P2|COMPLETED|10-week Primary Outcome||83
511306|NCT00945100|1250710|P1|COMPLETED|10-week Primary Outcome||82
511307|NCT00945100|1250709|P2|Completed, Not Eligible|10-week Primary Outcome|Not Eligible for Post-10 week phase|20
511308|NCT00945100|1250710|P1|Completed, Not Eligible|10-week Primary Outcome|Not Eligible for Post-10 week phase|27
511309|NCT00945100|1250709|P2|Completed, Eligible|10-week Primary Outcome|Eligible for Post-10 week phase|63
511310|NCT00945100|1250710|P1|Completed, Eligible|10-week Primary Outcome|Eligible for Post-10 week phase|55
511311|NCT00945100|1250709|P2|STARTED|10-week Primary Outcome||86
511312|NCT00945100|1250710|P1|STARTED|10-week Primary Outcome||83
511313|NCT00945035|1250774|P2|NOT COMPLETED|Period 2||0
511314|NCT00945035|1250775|P1|NOT COMPLETED|Period 2||0
511315|NCT00945035|1250774|P2|COMPLETED|Period 2||18
511316|NCT00945035|1250775|P1|COMPLETED|Period 2||18
511317|NCT00945035|1250774|P2|STARTED|Period 2||18
511318|NCT00945035|1250775|P1|STARTED|Period 2||18
511319|NCT00945035|1250774|P2|NOT COMPLETED|Period 1||0
511320|NCT00945035|1250775|P1|NOT COMPLETED|Period 1||0
511321|NCT00945035|1250774|P2|COMPLETED|Period 1||18
511322|NCT00945035|1250775|P1|COMPLETED|Period 1||18
511323|NCT00945035|1250774|P2|STARTED|Period 1||18
511324|NCT00945035|1250775|P1|STARTED|Period 1||18
511325|NCT00944749|1250783|P1|NOT COMPLETED|Overall Study||1
511326|NCT00944749|1250783|P1|COMPLETED|Overall Study||22
511327|NCT00944749|1250783|P1|STARTED|Overall Study||23
511328|NCT00944710|1250790|P2|NOT COMPLETED|Additional Post 10-week Primary Outcome||11
511329|NCT00944710|1250791|P1|NOT COMPLETED|Additional Post 10-week Primary Outcome||17
511330|NCT00944710|1250790|P2|COMPLETED|Additional Post 10-week Primary Outcome||22
511331|NCT00944710|1250791|P1|COMPLETED|Additional Post 10-week Primary Outcome||23
511332|NCT00944710|1250790|P2|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||26
511333|NCT00944710|1250791|P1|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||24
511334|NCT00944710|1250790|P2|STARTED|Additional Post 10-week Primary Outcome||33
511335|NCT00944710|1250791|P1|STARTED|Additional Post 10-week Primary Outcome||40
511336|NCT00944710|1250790|P2|NOT COMPLETED|12-week Visit (Off-treatment)||0
511337|NCT00944710|1250791|P1|NOT COMPLETED|12-week Visit (Off-treatment)||0
511338|NCT00944710|1250790|P2|COMPLETED|12-week Visit (Off-treatment)||33
511339|NCT00944710|1250791|P1|COMPLETED|12-week Visit (Off-treatment)||40
511340|NCT00944710|1250790|P2|STARTED|12-week Visit (Off-treatment)||33
511341|NCT00944710|1250791|P1|STARTED|12-week Visit (Off-treatment)||40
511342|NCT00944710|1250790|P2|NOT COMPLETED|10-week Primary Outcome||0
511343|NCT00944710|1250791|P1|NOT COMPLETED|10-week Primary Outcome||0
511344|NCT00944710|1250790|P2|COMPLETED|10-week Primary Outcome||33
511345|NCT00944710|1250791|P1|COMPLETED|10-week Primary Outcome||40
511346|NCT00944710|1250790|P2|STARTED|10-week Primary Outcome||33
511347|NCT00944710|1250791|P1|STARTED|10-week Primary Outcome||40
511348|NCT00944697|1250849|P2|NOT COMPLETED|Overall Study||5
511349|NCT00944697|1250850|P1|NOT COMPLETED|Overall Study||2
511350|NCT00944697|1250849|P2|COMPLETED|Overall Study||43
511351|NCT00944697|1250850|P1|COMPLETED|Overall Study||48
511352|NCT00944697|1250849|P2|STARTED|Overall Study||48
511353|NCT00944697|1250850|P1|STARTED|Overall Study||50
511354|NCT00944671|1250862|P6|NOT COMPLETED|Period III||0
511355|NCT00944671|1250863|P5|NOT COMPLETED|Period III||0
511356|NCT00944671|1250864|P4|NOT COMPLETED|Period III||0
511357|NCT00944671|1250865|P3|NOT COMPLETED|Period III||0
511358|NCT00944671|1250866|P2|NOT COMPLETED|Period III||0
511359|NCT00944671|1250867|P1|NOT COMPLETED|Period III||0
511360|NCT00944671|1250862|P6|COMPLETED|Period III||4
511361|NCT00944671|1250863|P5|COMPLETED|Period III||4
511362|NCT00944671|1250864|P4|COMPLETED|Period III||4
511363|NCT00944671|1250865|P3|COMPLETED|Period III||4
511364|NCT00944671|1250866|P2|COMPLETED|Period III||4
511365|NCT00944671|1250867|P1|COMPLETED|Period III||4
511366|NCT00944671|1250862|P6|STARTED|Period III||4
511367|NCT00944671|1250863|P5|STARTED|Period III||4
511368|NCT00944671|1250864|P4|STARTED|Period III||4
511369|NCT00944671|1250865|P3|STARTED|Period III||4
511370|NCT00944671|1250866|P2|STARTED|Period III||4
511371|NCT00944671|1250867|P1|STARTED|Period III||4
511372|NCT00944671|1250862|P6|NOT COMPLETED|Period II||0
511373|NCT00944671|1250863|P5|NOT COMPLETED|Period II||0
511374|NCT00944671|1250864|P4|NOT COMPLETED|Period II||0
511375|NCT00944671|1250865|P3|NOT COMPLETED|Period II||0
511376|NCT00944671|1250866|P2|NOT COMPLETED|Period II||0
511377|NCT00944671|1250867|P1|NOT COMPLETED|Period II||0
511378|NCT00944671|1250862|P6|COMPLETED|Period II||4
511379|NCT00944671|1250863|P5|COMPLETED|Period II||4
511380|NCT00944671|1250864|P4|COMPLETED|Period II||4
511381|NCT00944671|1250865|P3|COMPLETED|Period II||4
511382|NCT00944671|1250866|P2|COMPLETED|Period II||4
511383|NCT00944671|1250867|P1|COMPLETED|Period II||4
511384|NCT00944671|1250862|P6|STARTED|Period II||4
511385|NCT00944671|1250863|P5|STARTED|Period II||4
511386|NCT00944671|1250864|P4|STARTED|Period II||4
511387|NCT00944671|1250865|P3|STARTED|Period II||4
511388|NCT00944671|1250866|P2|STARTED|Period II||4
511389|NCT00944671|1250867|P1|STARTED|Period II||4
511390|NCT00944671|1250862|P6|NOT COMPLETED|Period I||0
511391|NCT00944671|1250863|P5|NOT COMPLETED|Period I||0
511392|NCT00944671|1250864|P4|NOT COMPLETED|Period I||0
511393|NCT00944671|1250865|P3|NOT COMPLETED|Period I||0
511394|NCT00944671|1250866|P2|NOT COMPLETED|Period I||0
511395|NCT00944671|1250867|P1|NOT COMPLETED|Period I||0
511396|NCT00944671|1250862|P6|COMPLETED|Period I||4
511397|NCT00944671|1250863|P5|COMPLETED|Period I||4
511398|NCT00944671|1250864|P4|COMPLETED|Period I||4
511399|NCT00944671|1250865|P3|COMPLETED|Period I||4
511400|NCT00944671|1250866|P2|COMPLETED|Period I||4
511401|NCT00944671|1250867|P1|COMPLETED|Period I||4
511402|NCT00944671|1250862|P6|STARTED|Period I||4
511403|NCT00944671|1250863|P5|STARTED|Period I||4
511404|NCT00944671|1250864|P4|STARTED|Period I||4
511405|NCT00944671|1250865|P3|STARTED|Period I||4
511406|NCT00944671|1250866|P2|STARTED|Period I||4
511407|NCT00944671|1250867|P1|STARTED|Period I||4
511408|NCT00944645|1250880|P2|NOT COMPLETED|Period 2||9
511409|NCT00944645|1250881|P1|NOT COMPLETED|Period 2||8
511410|NCT00944645|1250880|P2|COMPLETED|Period 2||85
511411|NCT00944645|1250881|P1|COMPLETED|Period 2||86
511412|NCT00944645|1250880|P2|STARTED|Period 2||94
511413|NCT00944645|1250881|P1|STARTED|Period 2||94
511414|NCT00944645|1250880|P2|NOT COMPLETED|Period 1||0
511415|NCT00944645|1250881|P1|NOT COMPLETED|Period 1||0
511416|NCT00944645|1250880|P2|COMPLETED|Period 1||94
511417|NCT00944645|1250881|P1|COMPLETED|Period 1||94
511418|NCT00944645|1250880|P2|STARTED|Period 1||94
511419|NCT00944645|1250881|P1|STARTED|Period 1||94
511420|NCT00944554|1250895|P2|NOT COMPLETED|Overall Study||29
511421|NCT00944554|1250896|P1|NOT COMPLETED|Overall Study||28
511422|NCT00944554|1250895|P2|COMPLETED|Overall Study||25
511423|NCT00944554|1250896|P1|COMPLETED|Overall Study||22
511424|NCT00944554|1250895|P2|STARTED|Overall Study||54
511425|NCT00944554|1250896|P1|STARTED|Overall Study||50
511426|NCT00944450|1250902|P2|NOT COMPLETED|Period 2||0
511427|NCT00944450|1250903|P1|NOT COMPLETED|Period 2||0
511428|NCT00944450|1250902|P2|COMPLETED|Period 2||6
511429|NCT00944450|1250903|P1|COMPLETED|Period 2||6
511430|NCT00944450|1250902|P2|STARTED|Period 2||6
511431|NCT00944450|1250903|P1|STARTED|Period 2||6
511432|NCT00944450|1250902|P2|NOT COMPLETED|Period 1||0
511433|NCT00944450|1250903|P1|NOT COMPLETED|Period 1||0
511434|NCT00944450|1250902|P2|COMPLETED|Period 1||6
511435|NCT00944450|1250903|P1|COMPLETED|Period 1||6
511436|NCT00944450|1250902|P2|STARTED|Period 1||6
511437|NCT00944450|1250903|P1|STARTED|Period 1||6
511438|NCT00944229|1250911|P1|NOT COMPLETED|Overall Study||25
511439|NCT00944229|1250911|P1|COMPLETED|Overall Study||33
511440|NCT00944229|1250911|P1|STARTED|Overall Study||58
511441|NCT00944125|1250917|P2|NOT COMPLETED|6 Months to Study Completion||2
511442|NCT00944125|1250918|P1|NOT COMPLETED|6 Months to Study Completion||0
511443|NCT00944125|1250917|P2|COMPLETED|6 Months to Study Completion||18
511444|NCT00944125|1250918|P1|COMPLETED|6 Months to Study Completion||19
511445|NCT00944125|1250917|P2|STARTED|6 Months to Study Completion||20
511446|NCT00944125|1250918|P1|STARTED|6 Months to Study Completion||19
511447|NCT00944125|1250917|P2|NOT COMPLETED|3 to 6 Months||2
511448|NCT00944125|1250918|P1|NOT COMPLETED|3 to 6 Months||0
511449|NCT00944125|1250917|P2|COMPLETED|3 to 6 Months||20
511450|NCT00944125|1250918|P1|COMPLETED|3 to 6 Months||19
511451|NCT00944125|1250917|P2|STARTED|3 to 6 Months||22
511452|NCT00944125|1250918|P1|STARTED|3 to 6 Months||19
511453|NCT00944125|1250917|P2|NOT COMPLETED|Baseline to 3 Months||0
511454|NCT00944125|1250918|P1|NOT COMPLETED|Baseline to 3 Months||0
511455|NCT00944125|1250917|P2|COMPLETED|Baseline to 3 Months||22
511456|NCT00944125|1250918|P1|COMPLETED|Baseline to 3 Months||19
511457|NCT00944125|1250917|P2|STARTED|Baseline to 3 Months||22
511458|NCT00944125|1250918|P1|STARTED|Baseline to 3 Months||19
511459|NCT00944073|1250926|P2|NOT COMPLETED|Overall Study||4
511460|NCT00944073|1250927|P1|NOT COMPLETED|Overall Study||5
511461|NCT00944073|1250926|P2|COMPLETED|Overall Study||287
511462|NCT00944073|1250927|P1|COMPLETED|Overall Study||287
511463|NCT00944073|1250926|P2|STARTED|Overall Study||291
511464|NCT00944073|1250927|P1|STARTED|Overall Study||292
511465|NCT00944047|1251005|P1|NOT COMPLETED|Overall Study||5
511466|NCT00944047|1251005|P1|COMPLETED|Overall Study||27
511467|NCT00944047|1251005|P1|STARTED|Overall Study||32
511468|NCT00944034|1251021|P12|NOT COMPLETED|Overall Study||4
511469|NCT00944034|1251022|P11|NOT COMPLETED|Overall Study||1
511470|NCT00944034|1251023|P10|NOT COMPLETED|Overall Study||10
511471|NCT00944034|1251024|P9|NOT COMPLETED|Overall Study||10
511472|NCT00944034|1251025|P8|NOT COMPLETED|Overall Study||5
511473|NCT00944034|1251026|P7|NOT COMPLETED|Overall Study||4
511474|NCT00944034|1251027|P6|NOT COMPLETED|Overall Study||20
511475|NCT00944034|1251028|P5|NOT COMPLETED|Overall Study||14
511476|NCT00944034|1251029|P4|NOT COMPLETED|Overall Study||4
511477|NCT00944034|1251030|P3|NOT COMPLETED|Overall Study||9
511478|NCT00944034|1251031|P2|NOT COMPLETED|Overall Study||7
511479|NCT00944034|1251032|P1|NOT COMPLETED|Overall Study||5
511480|NCT00944034|1251021|P12|COMPLETED|Overall Study||52
511481|NCT00944034|1251022|P11|COMPLETED|Overall Study||50
511482|NCT00944034|1251023|P10|COMPLETED|Overall Study||236
511483|NCT00944034|1251024|P9|COMPLETED|Overall Study||63
511484|NCT00944034|1251025|P8|COMPLETED|Overall Study||73
511485|NCT00944034|1251026|P7|COMPLETED|Overall Study||102
511486|NCT00944034|1251027|P6|COMPLETED|Overall Study||123
511487|NCT00944034|1251028|P5|COMPLETED|Overall Study||150
511488|NCT00944034|1251029|P4|COMPLETED|Overall Study||170
511489|NCT00944034|1251030|P3|COMPLETED|Overall Study||143
511490|NCT00944034|1251031|P2|COMPLETED|Overall Study||150
511491|NCT00944034|1251032|P1|COMPLETED|Overall Study||183
511492|NCT00944034|1251021|P12|STARTED|Overall Study||56
511493|NCT00944034|1251022|P11|STARTED|Overall Study||51
511494|NCT00944034|1251023|P10|STARTED|Overall Study||246
511495|NCT00944034|1251024|P9|STARTED|Overall Study||73
511496|NCT00944034|1251025|P8|STARTED|Overall Study||78
511497|NCT00944034|1251026|P7|STARTED|Overall Study||106
511498|NCT00944034|1251027|P6|STARTED|Overall Study||143
511499|NCT00944034|1251028|P5|STARTED|Overall Study||164
511500|NCT00944034|1251029|P4|STARTED|Overall Study||174
511501|NCT00944034|1251030|P3|STARTED|Overall Study||152
511502|NCT00944034|1251031|P2|STARTED|Overall Study||157
511503|NCT00944034|1251032|P1|STARTED|Overall Study||188
511504|NCT00944021|1251102|P5|NOT COMPLETED|Overall Study||0
511505|NCT00944021|1251103|P4|NOT COMPLETED|Overall Study||0
511506|NCT00944021|1251104|P3|NOT COMPLETED|Overall Study||0
511507|NCT00944021|1251105|P2|NOT COMPLETED|Overall Study||0
511508|NCT00944021|1251106|P1|NOT COMPLETED|Overall Study||1
511509|NCT00944021|1251102|P5|COMPLETED|Overall Study||8
511510|NCT00944021|1251103|P4|COMPLETED|Overall Study||16
511511|NCT00944021|1251104|P3|COMPLETED|Overall Study||15
511512|NCT00944021|1251105|P2|COMPLETED|Overall Study||15
511513|NCT00944021|1251106|P1|COMPLETED|Overall Study||14
511514|NCT00944021|1251102|P5|STARTED|Overall Study||8
511515|NCT00944021|1251103|P4|STARTED|Overall Study||16
511516|NCT00944021|1251104|P3|STARTED|Overall Study||15
511517|NCT00944021|1251105|P2|STARTED|Overall Study||15
511518|NCT00944021|1251106|P1|STARTED|Overall Study||15
511519|NCT00943917|1251178|P15|NOT COMPLETED|Stage II Continuation||4
511520|NCT00943917|1251179|P14|NOT COMPLETED|Stage II Continuation||3
511521|NCT00943917|1251180|P13|NOT COMPLETED|Stage II Continuation||3
511522|NCT00943917|1251181|P12|NOT COMPLETED|Stage II Continuation||2
511523|NCT00943917|1251182|P11|NOT COMPLETED|Stage II Continuation||0
511524|NCT00943917|1251183|P10|NOT COMPLETED|Stage II Continuation||1
511525|NCT00943917|1251184|P9|NOT COMPLETED|Stage II Continuation||0
511526|NCT00943917|1251185|P8|NOT COMPLETED|Stage II Continuation||0
511527|NCT00943917|1251186|P7|NOT COMPLETED|Stage II Continuation||0
511528|NCT00943917|1251187|P6|NOT COMPLETED|Stage II Continuation||0
511529|NCT00943917|1251188|P5|NOT COMPLETED|Stage II Continuation||0
511530|NCT00943917|1251189|P4|NOT COMPLETED|Stage II Continuation||0
511531|NCT00943917|1251190|P3|NOT COMPLETED|Stage II Continuation||0
511532|NCT00943917|1251191|P2|NOT COMPLETED|Stage II Continuation||0
511533|NCT00943917|1251192|P1|NOT COMPLETED|Stage II Continuation||0
511534|NCT00943917|1251178|P15|COMPLETED|Stage II Continuation||8
511535|NCT00943917|1251179|P14|COMPLETED|Stage II Continuation||12
511536|NCT00943917|1251180|P13|COMPLETED|Stage II Continuation||13
511537|NCT00943917|1251181|P12|COMPLETED|Stage II Continuation||11
511538|NCT00943917|1251182|P11|COMPLETED|Stage II Continuation||15
511539|NCT00943917|1251183|P10|COMPLETED|Stage II Continuation||14
511540|NCT00943917|1251184|P9|COMPLETED|Stage II Continuation||0
511541|NCT00943917|1251185|P8|COMPLETED|Stage II Continuation||0
511542|NCT00943917|1251186|P7|COMPLETED|Stage II Continuation||0
511543|NCT00943917|1251187|P6|COMPLETED|Stage II Continuation||0
511544|NCT00943917|1251188|P5|COMPLETED|Stage II Continuation||0
511545|NCT00943917|1251189|P4|COMPLETED|Stage II Continuation||0
511546|NCT00943917|1251190|P3|COMPLETED|Stage II Continuation||0
511547|NCT00943917|1251191|P2|COMPLETED|Stage II Continuation||0
511548|NCT00943917|1251192|P1|COMPLETED|Stage II Continuation||0
511549|NCT00943917|1251178|P15|STARTED|Stage II Continuation||12
511550|NCT00943917|1251179|P14|STARTED|Stage II Continuation||15
511551|NCT00943917|1251180|P13|STARTED|Stage II Continuation||16
511552|NCT00943917|1251181|P12|STARTED|Stage II Continuation||13
511553|NCT00943917|1251182|P11|STARTED|Stage II Continuation||15
511554|NCT00943917|1251183|P10|STARTED|Stage II Continuation||15
511555|NCT00943917|1251184|P9|STARTED|Stage II Continuation||0
511556|NCT00943917|1251185|P8|STARTED|Stage II Continuation||0
511557|NCT00943917|1251186|P7|STARTED|Stage II Continuation||0
511558|NCT00943917|1251187|P6|STARTED|Stage II Continuation||0
511559|NCT00943917|1251188|P5|STARTED|Stage II Continuation||0
511560|NCT00943917|1251189|P4|STARTED|Stage II Continuation||0
511561|NCT00943917|1251190|P3|STARTED|Stage II Continuation||0
511562|NCT00943917|1251191|P2|STARTED|Stage II Continuation||0
511563|NCT00943917|1251192|P1|STARTED|Stage II Continuation||0
511564|NCT00943917|1251178|P15|NOT COMPLETED|Stage II||0
511565|NCT00943917|1251179|P14|NOT COMPLETED|Stage II||0
511566|NCT00943917|1251180|P13|NOT COMPLETED|Stage II||0
511567|NCT00943917|1251181|P12|NOT COMPLETED|Stage II||0
511568|NCT00943917|1251182|P11|NOT COMPLETED|Stage II||0
511569|NCT00943917|1251183|P10|NOT COMPLETED|Stage II||0
511570|NCT00943917|1251184|P9|NOT COMPLETED|Stage II||1
511571|NCT00943917|1251185|P8|NOT COMPLETED|Stage II||0
511572|NCT00943917|1251186|P7|NOT COMPLETED|Stage II||3
511573|NCT00943917|1251187|P6|NOT COMPLETED|Stage II||3
511574|NCT00943917|1251188|P5|NOT COMPLETED|Stage II||0
511575|NCT00943917|1251189|P4|NOT COMPLETED|Stage II||0
511576|NCT00943917|1251190|P3|NOT COMPLETED|Stage II||0
511577|NCT00943917|1251191|P2|NOT COMPLETED|Stage II||0
511578|NCT00943917|1251192|P1|NOT COMPLETED|Stage II||0
511579|NCT00943917|1251178|P15|COMPLETED|Stage II||0
511580|NCT00943917|1251179|P14|COMPLETED|Stage II||0
511581|NCT00943917|1251180|P13|COMPLETED|Stage II||0
511582|NCT00943917|1251181|P12|COMPLETED|Stage II||0
511583|NCT00943917|1251182|P11|COMPLETED|Stage II||0
511584|NCT00943917|1251183|P10|COMPLETED|Stage II||0
511585|NCT00943917|1251184|P9|COMPLETED|Stage II||20
511586|NCT00943917|1251185|P8|COMPLETED|Stage II||23
511587|NCT00943917|1251186|P7|COMPLETED|Stage II||20
511588|NCT00943917|1251187|P6|COMPLETED|Stage II||20
511589|NCT00943917|1251188|P5|COMPLETED|Stage II||21
511590|NCT00943917|1251189|P4|COMPLETED|Stage II||20
511591|NCT00943917|1251190|P3|COMPLETED|Stage II||0
511592|NCT00943917|1251191|P2|COMPLETED|Stage II||0
511593|NCT00943917|1251192|P1|COMPLETED|Stage II||0
511594|NCT00943917|1251178|P15|STARTED|Stage II||0
511595|NCT00943917|1251179|P14|STARTED|Stage II||0
511596|NCT00943917|1251180|P13|STARTED|Stage II||0
511597|NCT00943917|1251181|P12|STARTED|Stage II||0
511598|NCT00943917|1251182|P11|STARTED|Stage II||0
511599|NCT00943917|1251183|P10|STARTED|Stage II||0
511600|NCT00943917|1251184|P9|STARTED|Stage II||21
511601|NCT00943917|1251185|P8|STARTED|Stage II||23
511602|NCT00943917|1251186|P7|STARTED|Stage II||23
511603|NCT00943917|1251187|P6|STARTED|Stage II||23
511604|NCT00943917|1251188|P5|STARTED|Stage II||21
511605|NCT00943917|1251189|P4|STARTED|Stage II||20
511606|NCT00943917|1251190|P3|STARTED|Stage II||0
511607|NCT00943917|1251191|P2|STARTED|Stage II||0
511608|NCT00943917|1251192|P1|STARTED|Stage II||0
511609|NCT00943917|1251178|P15|NOT COMPLETED|Stage I||0
511610|NCT00943917|1251179|P14|NOT COMPLETED|Stage I||0
511611|NCT00943917|1251180|P13|NOT COMPLETED|Stage I||0
511612|NCT00943917|1251181|P12|NOT COMPLETED|Stage I||0
511613|NCT00943917|1251182|P11|NOT COMPLETED|Stage I||0
511614|NCT00943917|1251183|P10|NOT COMPLETED|Stage I||0
511615|NCT00943917|1251184|P9|NOT COMPLETED|Stage I||0
511616|NCT00943917|1251185|P8|NOT COMPLETED|Stage I||0
511617|NCT00943917|1251186|P7|NOT COMPLETED|Stage I||0
511618|NCT00943917|1251187|P6|NOT COMPLETED|Stage I||0
511619|NCT00943917|1251188|P5|NOT COMPLETED|Stage I||0
511620|NCT00943917|1251189|P4|NOT COMPLETED|Stage I||0
511621|NCT00943917|1251190|P3|NOT COMPLETED|Stage I||6
511622|NCT00943917|1251191|P2|NOT COMPLETED|Stage I||3
511623|NCT00943917|1251192|P1|NOT COMPLETED|Stage I||4
511624|NCT00943917|1251178|P15|COMPLETED|Stage I||0
511625|NCT00943917|1251179|P14|COMPLETED|Stage I||0
511626|NCT00943917|1251180|P13|COMPLETED|Stage I||0
511627|NCT00943917|1251181|P12|COMPLETED|Stage I||0
511628|NCT00943917|1251182|P11|COMPLETED|Stage I||0
511629|NCT00943917|1251183|P10|COMPLETED|Stage I||0
511630|NCT00943917|1251184|P9|COMPLETED|Stage I||0
511631|NCT00943917|1251185|P8|COMPLETED|Stage I||0
511632|NCT00943917|1251186|P7|COMPLETED|Stage I||0
511633|NCT00943917|1251187|P6|COMPLETED|Stage I||0
511634|NCT00943917|1251188|P5|COMPLETED|Stage I||0
511635|NCT00943917|1251189|P4|COMPLETED|Stage I||0
511636|NCT00943917|1251190|P3|COMPLETED|Stage I||47
511637|NCT00943917|1251191|P2|COMPLETED|Stage I||48
511638|NCT00943917|1251192|P1|COMPLETED|Stage I||47
511639|NCT00943917|1251178|P15|STARTED|Stage I||0
511640|NCT00943917|1251179|P14|STARTED|Stage I||0
511641|NCT00943917|1251180|P13|STARTED|Stage I||0
511642|NCT00943917|1251181|P12|STARTED|Stage I||0
511643|NCT00943917|1251182|P11|STARTED|Stage I||0
511644|NCT00943917|1251183|P10|STARTED|Stage I||0
511645|NCT00943917|1251184|P9|STARTED|Stage I||0
511646|NCT00943917|1251185|P8|STARTED|Stage I||0
511647|NCT00943917|1251186|P7|STARTED|Stage I||0
511648|NCT00943917|1251187|P6|STARTED|Stage I||0
511649|NCT00943917|1251188|P5|STARTED|Stage I||0
511650|NCT00943917|1251189|P4|STARTED|Stage I||0
511651|NCT00943917|1251190|P3|STARTED|Stage I||53
511652|NCT00943917|1251191|P2|STARTED|Stage I||51
511653|NCT00943917|1251192|P1|STARTED|Stage I||51
511654|NCT00943878|1251243|P4|NOT COMPLETED|Overall Study||2
511655|NCT00943878|1251244|P3|NOT COMPLETED|Overall Study||6
511656|NCT00943878|1251245|P2|NOT COMPLETED|Overall Study||2
511657|NCT00943878|1251246|P1|NOT COMPLETED|Overall Study||2
511658|NCT00943878|1251243|P4|COMPLETED|Overall Study||198
511659|NCT00943878|1251244|P3|COMPLETED|Overall Study||197
511660|NCT00943878|1251245|P2|COMPLETED|Overall Study||198
511661|NCT00943878|1251246|P1|COMPLETED|Overall Study||200
511662|NCT00943878|1251243|P4|STARTED|Overall Study||200
511663|NCT00943878|1251244|P3|STARTED|Overall Study||203
511664|NCT00943878|1251245|P2|STARTED|Overall Study||200
511665|NCT00943878|1251246|P1|STARTED|Overall Study||202
511666|NCT00943852|1251368|P10|NOT COMPLETED|Fifth Period of Treatment Intervention||0
511667|NCT00943852|1251369|P9|NOT COMPLETED|Fifth Period of Treatment Intervention||0
511668|NCT00943852|1251370|P8|NOT COMPLETED|Fifth Period of Treatment Intervention||0
511669|NCT00943852|1251371|P7|NOT COMPLETED|Fifth Period of Treatment Intervention||0
511670|NCT00943852|1251372|P6|NOT COMPLETED|Fifth Period of Treatment Intervention||0
511671|NCT00943852|1251373|P5|NOT COMPLETED|Fifth Period of Treatment Intervention||0
511672|NCT00943852|1251374|P4|NOT COMPLETED|Fifth Period of Treatment Intervention||0
511673|NCT00943852|1251375|P3|NOT COMPLETED|Fifth Period of Treatment Intervention||0
511674|NCT00943852|1251376|P2|NOT COMPLETED|Fifth Period of Treatment Intervention||0
511675|NCT00943852|1251377|P1|NOT COMPLETED|Fifth Period of Treatment Intervention||0
511676|NCT00943852|1251368|P10|COMPLETED|Fifth Period of Treatment Intervention||1
511677|NCT00943852|1251369|P9|COMPLETED|Fifth Period of Treatment Intervention||1
511678|NCT00943852|1251370|P8|COMPLETED|Fifth Period of Treatment Intervention||0
511679|NCT00943852|1251371|P7|COMPLETED|Fifth Period of Treatment Intervention||0
511680|NCT00943852|1251372|P6|COMPLETED|Fifth Period of Treatment Intervention||0
511681|NCT00943852|1251373|P5|COMPLETED|Fifth Period of Treatment Intervention||1
511682|NCT00943852|1251374|P4|COMPLETED|Fifth Period of Treatment Intervention||0
511683|NCT00943852|1251375|P3|COMPLETED|Fifth Period of Treatment Intervention||0
511684|NCT00943852|1251376|P2|COMPLETED|Fifth Period of Treatment Intervention||1
511685|NCT00943852|1251377|P1|COMPLETED|Fifth Period of Treatment Intervention||1
511686|NCT00943852|1251368|P10|STARTED|Fifth Period of Treatment Intervention||1
511687|NCT00943852|1251369|P9|STARTED|Fifth Period of Treatment Intervention||1
511688|NCT00943852|1251370|P8|STARTED|Fifth Period of Treatment Intervention||0
511689|NCT00943852|1251371|P7|STARTED|Fifth Period of Treatment Intervention||0
511690|NCT00943852|1251372|P6|STARTED|Fifth Period of Treatment Intervention||0
511691|NCT00943852|1251373|P5|STARTED|Fifth Period of Treatment Intervention||1
511692|NCT00943852|1251374|P4|STARTED|Fifth Period of Treatment Intervention||0
511693|NCT00943852|1251375|P3|STARTED|Fifth Period of Treatment Intervention||0
511694|NCT00943852|1251376|P2|STARTED|Fifth Period of Treatment Intervention||1
511695|NCT00943852|1251377|P1|STARTED|Fifth Period of Treatment Intervention||1
511696|NCT00943852|1251368|P10|NOT COMPLETED|Washout Period After Period 4 Treatment||0
511697|NCT00943852|1251369|P9|NOT COMPLETED|Washout Period After Period 4 Treatment||0
511698|NCT00943852|1251370|P8|NOT COMPLETED|Washout Period After Period 4 Treatment||1
511699|NCT00943852|1251371|P7|NOT COMPLETED|Washout Period After Period 4 Treatment||1
511700|NCT00943852|1251372|P6|NOT COMPLETED|Washout Period After Period 4 Treatment||0
511701|NCT00943852|1251373|P5|NOT COMPLETED|Washout Period After Period 4 Treatment||0
511702|NCT00943852|1251374|P4|NOT COMPLETED|Washout Period After Period 4 Treatment||1
511703|NCT00943852|1251375|P3|NOT COMPLETED|Washout Period After Period 4 Treatment||1
511704|NCT00943852|1251376|P2|NOT COMPLETED|Washout Period After Period 4 Treatment||0
511705|NCT00943852|1251377|P1|NOT COMPLETED|Washout Period After Period 4 Treatment||1
511706|NCT00943852|1251368|P10|COMPLETED|Washout Period After Period 4 Treatment||1
511707|NCT00943852|1251369|P9|COMPLETED|Washout Period After Period 4 Treatment||1
511708|NCT00943852|1251370|P8|COMPLETED|Washout Period After Period 4 Treatment||0
511709|NCT00943852|1251371|P7|COMPLETED|Washout Period After Period 4 Treatment||0
511710|NCT00943852|1251372|P6|COMPLETED|Washout Period After Period 4 Treatment||0
511711|NCT00943852|1251373|P5|COMPLETED|Washout Period After Period 4 Treatment||1
511712|NCT00943852|1251374|P4|COMPLETED|Washout Period After Period 4 Treatment||0
511713|NCT00943852|1251375|P3|COMPLETED|Washout Period After Period 4 Treatment||0
511714|NCT00943852|1251376|P2|COMPLETED|Washout Period After Period 4 Treatment||1
511715|NCT00943852|1251377|P1|COMPLETED|Washout Period After Period 4 Treatment||1
511716|NCT00943852|1251368|P10|STARTED|Washout Period After Period 4 Treatment||1
511717|NCT00943852|1251369|P9|STARTED|Washout Period After Period 4 Treatment||1
511718|NCT00943852|1251370|P8|STARTED|Washout Period After Period 4 Treatment||1
511719|NCT00943852|1251371|P7|STARTED|Washout Period After Period 4 Treatment||1
511720|NCT00943852|1251372|P6|STARTED|Washout Period After Period 4 Treatment||0
511721|NCT00943852|1251373|P5|STARTED|Washout Period After Period 4 Treatment||1
511722|NCT00943852|1251374|P4|STARTED|Washout Period After Period 4 Treatment||1
511723|NCT00943852|1251375|P3|STARTED|Washout Period After Period 4 Treatment||1
511724|NCT00943852|1251376|P2|STARTED|Washout Period After Period 4 Treatment||1
511725|NCT00943852|1251377|P1|STARTED|Washout Period After Period 4 Treatment||2
511726|NCT00943852|1251368|P10|NOT COMPLETED|Fourth Period of Treatment Intervention||0
511727|NCT00943852|1251369|P9|NOT COMPLETED|Fourth Period of Treatment Intervention||0
511728|NCT00943852|1251370|P8|NOT COMPLETED|Fourth Period of Treatment Intervention||0
511729|NCT00943852|1251371|P7|NOT COMPLETED|Fourth Period of Treatment Intervention||0
511730|NCT00943852|1251372|P6|NOT COMPLETED|Fourth Period of Treatment Intervention||0
511731|NCT00943852|1251373|P5|NOT COMPLETED|Fourth Period of Treatment Intervention||0
511732|NCT00943852|1251374|P4|NOT COMPLETED|Fourth Period of Treatment Intervention||0
511733|NCT00943852|1251375|P3|NOT COMPLETED|Fourth Period of Treatment Intervention||0
511734|NCT00943852|1251376|P2|NOT COMPLETED|Fourth Period of Treatment Intervention||0
511735|NCT00943852|1251377|P1|NOT COMPLETED|Fourth Period of Treatment Intervention||0
511736|NCT00943852|1251368|P10|COMPLETED|Fourth Period of Treatment Intervention||1
511737|NCT00943852|1251369|P9|COMPLETED|Fourth Period of Treatment Intervention||1
511738|NCT00943852|1251370|P8|COMPLETED|Fourth Period of Treatment Intervention||1
511739|NCT00943852|1251371|P7|COMPLETED|Fourth Period of Treatment Intervention||1
511740|NCT00943852|1251372|P6|COMPLETED|Fourth Period of Treatment Intervention||0
511741|NCT00943852|1251373|P5|COMPLETED|Fourth Period of Treatment Intervention||1
511742|NCT00943852|1251374|P4|COMPLETED|Fourth Period of Treatment Intervention||1
511743|NCT00943852|1251375|P3|COMPLETED|Fourth Period of Treatment Intervention||1
511744|NCT00943852|1251376|P2|COMPLETED|Fourth Period of Treatment Intervention||1
511745|NCT00943852|1251377|P1|COMPLETED|Fourth Period of Treatment Intervention||2
511746|NCT00943852|1251368|P10|STARTED|Fourth Period of Treatment Intervention||1
511747|NCT00943852|1251369|P9|STARTED|Fourth Period of Treatment Intervention||1
511748|NCT00943852|1251370|P8|STARTED|Fourth Period of Treatment Intervention||1
511749|NCT00943852|1251371|P7|STARTED|Fourth Period of Treatment Intervention||1
511750|NCT00943852|1251372|P6|STARTED|Fourth Period of Treatment Intervention||0
511751|NCT00943852|1251373|P5|STARTED|Fourth Period of Treatment Intervention||1
511752|NCT00943852|1251374|P4|STARTED|Fourth Period of Treatment Intervention||1
511753|NCT00943852|1251375|P3|STARTED|Fourth Period of Treatment Intervention||1
511754|NCT00943852|1251376|P2|STARTED|Fourth Period of Treatment Intervention||1
511755|NCT00943852|1251377|P1|STARTED|Fourth Period of Treatment Intervention||2
511756|NCT00943852|1251368|P10|NOT COMPLETED|Washout Period After Period 3 Treatment||0
511757|NCT00943852|1251369|P9|NOT COMPLETED|Washout Period After Period 3 Treatment||0
511758|NCT00943852|1251370|P8|NOT COMPLETED|Washout Period After Period 3 Treatment||0
511759|NCT00943852|1251371|P7|NOT COMPLETED|Washout Period After Period 3 Treatment||1
511760|NCT00943852|1251372|P6|NOT COMPLETED|Washout Period After Period 3 Treatment||0
511761|NCT00943852|1251373|P5|NOT COMPLETED|Washout Period After Period 3 Treatment||0
511762|NCT00943852|1251374|P4|NOT COMPLETED|Washout Period After Period 3 Treatment||0
511763|NCT00943852|1251375|P3|NOT COMPLETED|Washout Period After Period 3 Treatment||0
511764|NCT00943852|1251376|P2|NOT COMPLETED|Washout Period After Period 3 Treatment||0
511765|NCT00943852|1251377|P1|NOT COMPLETED|Washout Period After Period 3 Treatment||0
511766|NCT00943852|1251368|P10|COMPLETED|Washout Period After Period 3 Treatment||1
511767|NCT00943852|1251369|P9|COMPLETED|Washout Period After Period 3 Treatment||1
511768|NCT00943852|1251370|P8|COMPLETED|Washout Period After Period 3 Treatment||1
511769|NCT00943852|1251371|P7|COMPLETED|Washout Period After Period 3 Treatment||1
511770|NCT00943852|1251372|P6|COMPLETED|Washout Period After Period 3 Treatment||0
511771|NCT00943852|1251373|P5|COMPLETED|Washout Period After Period 3 Treatment||1
511772|NCT00943852|1251374|P4|COMPLETED|Washout Period After Period 3 Treatment||1
511773|NCT00943852|1251375|P3|COMPLETED|Washout Period After Period 3 Treatment||1
511774|NCT00943852|1251376|P2|COMPLETED|Washout Period After Period 3 Treatment||1
511775|NCT00943852|1251377|P1|COMPLETED|Washout Period After Period 3 Treatment||2
511776|NCT00943852|1251368|P10|STARTED|Washout Period After Period 3 Treatment||1
511777|NCT00943852|1251369|P9|STARTED|Washout Period After Period 3 Treatment||1
511778|NCT00943852|1251370|P8|STARTED|Washout Period After Period 3 Treatment||1
511779|NCT00943852|1251371|P7|STARTED|Washout Period After Period 3 Treatment||2
511780|NCT00943852|1251372|P6|STARTED|Washout Period After Period 3 Treatment||0
511781|NCT00943852|1251373|P5|STARTED|Washout Period After Period 3 Treatment||1
511782|NCT00943852|1251374|P4|STARTED|Washout Period After Period 3 Treatment||1
511783|NCT00943852|1251375|P3|STARTED|Washout Period After Period 3 Treatment||1
511784|NCT00943852|1251376|P2|STARTED|Washout Period After Period 3 Treatment||1
511785|NCT00943852|1251377|P1|STARTED|Washout Period After Period 3 Treatment||2
511786|NCT00943852|1251368|P10|NOT COMPLETED|Third Period of Treatment Intervention||0
511787|NCT00943852|1251369|P9|NOT COMPLETED|Third Period of Treatment Intervention||0
511788|NCT00943852|1251370|P8|NOT COMPLETED|Third Period of Treatment Intervention||0
511789|NCT00943852|1251371|P7|NOT COMPLETED|Third Period of Treatment Intervention||0
511790|NCT00943852|1251372|P6|NOT COMPLETED|Third Period of Treatment Intervention||0
511791|NCT00943852|1251373|P5|NOT COMPLETED|Third Period of Treatment Intervention||0
511792|NCT00943852|1251374|P4|NOT COMPLETED|Third Period of Treatment Intervention||0
511793|NCT00943852|1251375|P3|NOT COMPLETED|Third Period of Treatment Intervention||0
511794|NCT00943852|1251376|P2|NOT COMPLETED|Third Period of Treatment Intervention||0
511795|NCT00943852|1251377|P1|NOT COMPLETED|Third Period of Treatment Intervention||0
511796|NCT00943852|1251368|P10|COMPLETED|Third Period of Treatment Intervention||1
511797|NCT00943852|1251369|P9|COMPLETED|Third Period of Treatment Intervention||1
511798|NCT00943852|1251370|P8|COMPLETED|Third Period of Treatment Intervention||1
511799|NCT00943852|1251371|P7|COMPLETED|Third Period of Treatment Intervention||2
511800|NCT00943852|1251372|P6|COMPLETED|Third Period of Treatment Intervention||0
511801|NCT00943852|1251373|P5|COMPLETED|Third Period of Treatment Intervention||1
511802|NCT00943852|1251374|P4|COMPLETED|Third Period of Treatment Intervention||1
511803|NCT00943852|1251375|P3|COMPLETED|Third Period of Treatment Intervention||1
511804|NCT00943852|1251376|P2|COMPLETED|Third Period of Treatment Intervention||1
511805|NCT00943852|1251377|P1|COMPLETED|Third Period of Treatment Intervention||2
511806|NCT00943852|1251368|P10|STARTED|Third Period of Treatment Intervention||1
511807|NCT00943852|1251369|P9|STARTED|Third Period of Treatment Intervention||1
511808|NCT00943852|1251370|P8|STARTED|Third Period of Treatment Intervention||1
511809|NCT00943852|1251371|P7|STARTED|Third Period of Treatment Intervention||2
511810|NCT00943852|1251372|P6|STARTED|Third Period of Treatment Intervention||0
511811|NCT00943852|1251373|P5|STARTED|Third Period of Treatment Intervention||1
511812|NCT00943852|1251374|P4|STARTED|Third Period of Treatment Intervention||1
511813|NCT00943852|1251375|P3|STARTED|Third Period of Treatment Intervention||1
511814|NCT00943852|1251376|P2|STARTED|Third Period of Treatment Intervention||1
511815|NCT00943852|1251377|P1|STARTED|Third Period of Treatment Intervention||2
511816|NCT00943852|1251368|P10|NOT COMPLETED|Washout Period After Period 2 Treatment||0
511817|NCT00943852|1251369|P9|NOT COMPLETED|Washout Period After Period 2 Treatment||0
511818|NCT00943852|1251370|P8|NOT COMPLETED|Washout Period After Period 2 Treatment||0
511819|NCT00943852|1251371|P7|NOT COMPLETED|Washout Period After Period 2 Treatment||0
511820|NCT00943852|1251372|P6|NOT COMPLETED|Washout Period After Period 2 Treatment||1
511821|NCT00943852|1251373|P5|NOT COMPLETED|Washout Period After Period 2 Treatment||0
511822|NCT00943852|1251374|P4|NOT COMPLETED|Washout Period After Period 2 Treatment||0
511823|NCT00943852|1251375|P3|NOT COMPLETED|Washout Period After Period 2 Treatment||0
511824|NCT00943852|1251376|P2|NOT COMPLETED|Washout Period After Period 2 Treatment||0
511825|NCT00943852|1251377|P1|NOT COMPLETED|Washout Period After Period 2 Treatment||0
511826|NCT00943852|1251368|P10|COMPLETED|Washout Period After Period 2 Treatment||1
511827|NCT00943852|1251369|P9|COMPLETED|Washout Period After Period 2 Treatment||1
511828|NCT00943852|1251370|P8|COMPLETED|Washout Period After Period 2 Treatment||1
511829|NCT00943852|1251371|P7|COMPLETED|Washout Period After Period 2 Treatment||2
511830|NCT00943852|1251372|P6|COMPLETED|Washout Period After Period 2 Treatment||0
511831|NCT00943852|1251373|P5|COMPLETED|Washout Period After Period 2 Treatment||1
511832|NCT00943852|1251374|P4|COMPLETED|Washout Period After Period 2 Treatment||1
511833|NCT00943852|1251375|P3|COMPLETED|Washout Period After Period 2 Treatment||1
511834|NCT00943852|1251376|P2|COMPLETED|Washout Period After Period 2 Treatment||1
511835|NCT00943852|1251377|P1|COMPLETED|Washout Period After Period 2 Treatment||2
511836|NCT00943852|1251368|P10|STARTED|Washout Period After Period 2 Treatment||1
511837|NCT00943852|1251369|P9|STARTED|Washout Period After Period 2 Treatment||1
511838|NCT00943852|1251370|P8|STARTED|Washout Period After Period 2 Treatment||1
511839|NCT00943852|1251371|P7|STARTED|Washout Period After Period 2 Treatment||2
511840|NCT00943852|1251372|P6|STARTED|Washout Period After Period 2 Treatment||1
511841|NCT00943852|1251373|P5|STARTED|Washout Period After Period 2 Treatment||1
511842|NCT00943852|1251374|P4|STARTED|Washout Period After Period 2 Treatment||1
511843|NCT00943852|1251375|P3|STARTED|Washout Period After Period 2 Treatment||1
511844|NCT00943852|1251376|P2|STARTED|Washout Period After Period 2 Treatment||1
511845|NCT00943852|1251377|P1|STARTED|Washout Period After Period 2 Treatment||2
511846|NCT00943852|1251368|P10|NOT COMPLETED|Second Period of Treatment Intervention||0
511847|NCT00943852|1251369|P9|NOT COMPLETED|Second Period of Treatment Intervention||0
511848|NCT00943852|1251370|P8|NOT COMPLETED|Second Period of Treatment Intervention||0
511849|NCT00943852|1251371|P7|NOT COMPLETED|Second Period of Treatment Intervention||0
511850|NCT00943852|1251372|P6|NOT COMPLETED|Second Period of Treatment Intervention||0
511851|NCT00943852|1251373|P5|NOT COMPLETED|Second Period of Treatment Intervention||0
511852|NCT00943852|1251374|P4|NOT COMPLETED|Second Period of Treatment Intervention||0
511853|NCT00943852|1251375|P3|NOT COMPLETED|Second Period of Treatment Intervention||0
511854|NCT00943852|1251376|P2|NOT COMPLETED|Second Period of Treatment Intervention||0
511855|NCT00943852|1251377|P1|NOT COMPLETED|Second Period of Treatment Intervention||0
511856|NCT00943852|1251368|P10|COMPLETED|Second Period of Treatment Intervention||1
511857|NCT00943852|1251369|P9|COMPLETED|Second Period of Treatment Intervention||1
511858|NCT00943852|1251370|P8|COMPLETED|Second Period of Treatment Intervention||1
511859|NCT00943852|1251371|P7|COMPLETED|Second Period of Treatment Intervention||2
511860|NCT00943852|1251372|P6|COMPLETED|Second Period of Treatment Intervention||1
511861|NCT00943852|1251373|P5|COMPLETED|Second Period of Treatment Intervention||1
511862|NCT00943852|1251374|P4|COMPLETED|Second Period of Treatment Intervention||1
511863|NCT00943852|1251375|P3|COMPLETED|Second Period of Treatment Intervention||1
511864|NCT00943852|1251376|P2|COMPLETED|Second Period of Treatment Intervention||1
511865|NCT00943852|1251377|P1|COMPLETED|Second Period of Treatment Intervention||2
511866|NCT00943852|1251368|P10|STARTED|Second Period of Treatment Intervention||1
511867|NCT00943852|1251369|P9|STARTED|Second Period of Treatment Intervention||1
511868|NCT00943852|1251370|P8|STARTED|Second Period of Treatment Intervention||1
511869|NCT00943852|1251371|P7|STARTED|Second Period of Treatment Intervention||2
511870|NCT00943852|1251372|P6|STARTED|Second Period of Treatment Intervention||1
511871|NCT00943852|1251373|P5|STARTED|Second Period of Treatment Intervention||1
511872|NCT00943852|1251374|P4|STARTED|Second Period of Treatment Intervention||1
511873|NCT00943852|1251375|P3|STARTED|Second Period of Treatment Intervention||1
511874|NCT00943852|1251376|P2|STARTED|Second Period of Treatment Intervention||1
511875|NCT00943852|1251377|P1|STARTED|Second Period of Treatment Intervention||2
511876|NCT00943852|1251368|P10|NOT COMPLETED|Washout Period After Period 1 Treatment||0
511877|NCT00943852|1251369|P9|NOT COMPLETED|Washout Period After Period 1 Treatment||0
511878|NCT00943852|1251370|P8|NOT COMPLETED|Washout Period After Period 1 Treatment||0
511879|NCT00943852|1251371|P7|NOT COMPLETED|Washout Period After Period 1 Treatment||0
511880|NCT00943852|1251372|P6|NOT COMPLETED|Washout Period After Period 1 Treatment||0
511881|NCT00943852|1251373|P5|NOT COMPLETED|Washout Period After Period 1 Treatment||0
511882|NCT00943852|1251374|P4|NOT COMPLETED|Washout Period After Period 1 Treatment||1
511883|NCT00943852|1251375|P3|NOT COMPLETED|Washout Period After Period 1 Treatment||0
511884|NCT00943852|1251376|P2|NOT COMPLETED|Washout Period After Period 1 Treatment||0
511885|NCT00943852|1251377|P1|NOT COMPLETED|Washout Period After Period 1 Treatment||0
511886|NCT00943852|1251368|P10|COMPLETED|Washout Period After Period 1 Treatment||1
511887|NCT00943852|1251369|P9|COMPLETED|Washout Period After Period 1 Treatment||1
511888|NCT00943852|1251370|P8|COMPLETED|Washout Period After Period 1 Treatment||1
511889|NCT00943852|1251371|P7|COMPLETED|Washout Period After Period 1 Treatment||2
511890|NCT00943852|1251372|P6|COMPLETED|Washout Period After Period 1 Treatment||1
511891|NCT00943852|1251373|P5|COMPLETED|Washout Period After Period 1 Treatment||1
511892|NCT00943852|1251374|P4|COMPLETED|Washout Period After Period 1 Treatment||1
511893|NCT00943852|1251375|P3|COMPLETED|Washout Period After Period 1 Treatment||1
511894|NCT00943852|1251376|P2|COMPLETED|Washout Period After Period 1 Treatment||1
511895|NCT00943852|1251377|P1|COMPLETED|Washout Period After Period 1 Treatment||2
511896|NCT00943852|1251368|P10|STARTED|Washout Period After Period 1 Treatment||1
511897|NCT00943852|1251369|P9|STARTED|Washout Period After Period 1 Treatment||1
511898|NCT00943852|1251370|P8|STARTED|Washout Period After Period 1 Treatment||1
511899|NCT00943852|1251371|P7|STARTED|Washout Period After Period 1 Treatment||2
511900|NCT00943852|1251372|P6|STARTED|Washout Period After Period 1 Treatment||1
511901|NCT00943852|1251373|P5|STARTED|Washout Period After Period 1 Treatment||1
511902|NCT00943852|1251374|P4|STARTED|Washout Period After Period 1 Treatment||2
511903|NCT00943852|1251375|P3|STARTED|Washout Period After Period 1 Treatment||1
511904|NCT00943852|1251376|P2|STARTED|Washout Period After Period 1 Treatment||1
511905|NCT00943852|1251377|P1|STARTED|Washout Period After Period 1 Treatment||2
511906|NCT00943852|1251368|P10|NOT COMPLETED|First Period of Treatment Intervention||0
511907|NCT00943852|1251369|P9|NOT COMPLETED|First Period of Treatment Intervention||0
511908|NCT00943852|1251370|P8|NOT COMPLETED|First Period of Treatment Intervention||0
511909|NCT00943852|1251371|P7|NOT COMPLETED|First Period of Treatment Intervention||0
511910|NCT00943852|1251372|P6|NOT COMPLETED|First Period of Treatment Intervention||0
511911|NCT00943852|1251373|P5|NOT COMPLETED|First Period of Treatment Intervention||0
511912|NCT00943852|1251374|P4|NOT COMPLETED|First Period of Treatment Intervention||0
511913|NCT00943852|1251375|P3|NOT COMPLETED|First Period of Treatment Intervention||0
511914|NCT00943852|1251376|P2|NOT COMPLETED|First Period of Treatment Intervention||0
511915|NCT00943852|1251377|P1|NOT COMPLETED|First Period of Treatment Intervention||0
511916|NCT00943852|1251368|P10|COMPLETED|First Period of Treatment Intervention||1
511917|NCT00943852|1251369|P9|COMPLETED|First Period of Treatment Intervention||1
511918|NCT00943852|1251370|P8|COMPLETED|First Period of Treatment Intervention||1
511919|NCT00943852|1251371|P7|COMPLETED|First Period of Treatment Intervention||2
511920|NCT00943852|1251372|P6|COMPLETED|First Period of Treatment Intervention||1
511921|NCT00943852|1251373|P5|COMPLETED|First Period of Treatment Intervention||1
511922|NCT00943852|1251374|P4|COMPLETED|First Period of Treatment Intervention||2
511923|NCT00943852|1251375|P3|COMPLETED|First Period of Treatment Intervention||1
511924|NCT00943852|1251376|P2|COMPLETED|First Period of Treatment Intervention||1
511925|NCT00943852|1251377|P1|COMPLETED|First Period of Treatment Intervention||2
511926|NCT00943852|1251368|P10|STARTED|First Period of Treatment Intervention||1
511927|NCT00943852|1251369|P9|STARTED|First Period of Treatment Intervention||1
511928|NCT00943852|1251370|P8|STARTED|First Period of Treatment Intervention||1
511929|NCT00943852|1251371|P7|STARTED|First Period of Treatment Intervention||2
511930|NCT00943852|1251372|P6|STARTED|First Period of Treatment Intervention||1
511931|NCT00943852|1251373|P5|STARTED|First Period of Treatment Intervention||1
511932|NCT00943852|1251374|P4|STARTED|First Period of Treatment Intervention||2
511933|NCT00943852|1251375|P3|STARTED|First Period of Treatment Intervention||1
511934|NCT00943852|1251376|P2|STARTED|First Period of Treatment Intervention||1
511935|NCT00943852|1251377|P1|STARTED|First Period of Treatment Intervention||2
511936|NCT00943826|1251390|P2|NOT COMPLETED|After Primary Overall Survival Analysis||20
511937|NCT00943826|1251391|P1|NOT COMPLETED|After Primary Overall Survival Analysis||27
511938|NCT00943826|1251390|P2|COMPLETED|After Primary Overall Survival Analysis||0
511939|NCT00943826|1251391|P1|COMPLETED|After Primary Overall Survival Analysis||0
511940|NCT00943826|1251390|P2|STARTED|After Primary Overall Survival Analysis|Some who completed previous period had discontinued, progressed, or died prior to this period.|20
511941|NCT00943826|1251391|P1|STARTED|After Primary Overall Survival Analysis|Some who completed previous period had discontinued, progressed, or died prior to this period.|27
511942|NCT00943826|1251390|P2|NOT COMPLETED|Monotherapy Phase||16
511943|NCT00943826|1251391|P1|NOT COMPLETED|Monotherapy Phase||65
511944|NCT00943826|1251390|P2|COMPLETED|Monotherapy Phase||143
511945|NCT00943826|1251391|P1|COMPLETED|Monotherapy Phase||204
511946|NCT00943826|1251390|P2|STARTED|Monotherapy Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|159
511947|NCT00943826|1251391|P1|STARTED|Monotherapy Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|269
511948|NCT00943826|1251390|P2|NOT COMPLETED|Maintenance Phase||39
511949|NCT00943826|1251391|P1|NOT COMPLETED|Maintenance Phase||43
511950|NCT00943826|1251390|P2|COMPLETED|Maintenance Phase||331
511951|NCT00943826|1251391|P1|COMPLETED|Maintenance Phase||353
511952|NCT00943826|1251390|P2|STARTED|Maintenance Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|370
511953|NCT00943826|1251391|P1|STARTED|Maintenance Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|396
511954|NCT00943826|1251390|P2|NOT COMPLETED|Concurrent Phase||42
511955|NCT00943826|1251391|P1|NOT COMPLETED|Concurrent Phase||61
511956|NCT00943826|1251390|P2|COMPLETED|Concurrent Phase||421
511957|NCT00943826|1251391|P1|COMPLETED|Concurrent Phase||397
511958|NCT00943826|1251390|P2|Treated|Concurrent Phase||459
511959|NCT00943826|1251391|P1|Treated|Concurrent Phase||452
511960|NCT00943826|1251390|P2|STARTED|Concurrent Phase||463
511961|NCT00943826|1251391|P1|STARTED|Concurrent Phase||458
511962|NCT00943787|1251409|P1|NOT COMPLETED|Overall Study||7
511963|NCT00943787|1251409|P1|COMPLETED|Overall Study||34
511964|NCT00943787|1251409|P1|STARTED|Overall Study||41
511965|NCT00943761|1251416|P2|NOT COMPLETED|Overall Study||1
511966|NCT00943761|1251417|P1|NOT COMPLETED|Overall Study||4
511967|NCT00943761|1251416|P2|COMPLETED|Overall Study||23
511968|NCT00943761|1251417|P1|COMPLETED|Overall Study||17
511969|NCT00943761|1251416|P2|STARTED|Overall Study||24
511970|NCT00943761|1251417|P1|STARTED|Overall Study||21
511971|NCT00943735|1251429|P1|NOT COMPLETED|Overall Study||32
511972|NCT00943735|1251429|P1|COMPLETED|Overall Study||742
511973|NCT00943735|1251429|P1|Per Protocol Population|Overall Study||500
511974|NCT00943735|1251429|P1|STARTED|Overall Study||774
511975|NCT00943722|1251467|P5|NOT COMPLETED|Overall Study||22
511976|NCT00943722|1251468|P4|NOT COMPLETED|Overall Study||22
511977|NCT00943722|1251469|P3|NOT COMPLETED|Overall Study||13
511978|NCT00943722|1251470|P2|NOT COMPLETED|Overall Study||22
511979|NCT00943722|1251471|P1|NOT COMPLETED|Overall Study||25
511980|NCT00943722|1251467|P5|COMPLETED|Overall Study|Includes 4 participants for whom completion status is unknown|448
511981|NCT00943722|1251468|P4|COMPLETED|Overall Study||647
511982|NCT00943722|1251469|P3|COMPLETED|Overall Study||631
511983|NCT00943722|1251470|P2|COMPLETED|Overall Study||621
511984|NCT00943722|1251471|P1|COMPLETED|Overall Study||623
511985|NCT00943722|1251467|P5|Vaccination 3|Overall Study||455
511986|NCT00943722|1251468|P4|Vaccination 3|Overall Study||653
511987|NCT00943722|1251469|P3|Vaccination 3|Overall Study||637
511988|NCT00943722|1251470|P2|Vaccination 3|Overall Study||627
511989|NCT00943722|1251471|P1|Vaccination 3|Overall Study||635
511990|NCT00943722|1251467|P5|Vaccination 2|Overall Study||462
511991|NCT00943722|1251468|P4|Vaccination 2|Overall Study||658
511992|NCT00943722|1251469|P3|Vaccination 2|Overall Study||638
511993|NCT00943722|1251470|P2|Vaccination 2|Overall Study||633
511994|NCT00943722|1251471|P1|Vaccination 2|Overall Study||637
511995|NCT00943722|1251467|P5|Vaccination 1|Overall Study||468
511996|NCT00943722|1251468|P4|Vaccination 1|Overall Study||666
511997|NCT00943722|1251469|P3|Vaccination 1|Overall Study||644
511998|NCT00943722|1251470|P2|Vaccination 1|Overall Study||642
511999|NCT00943722|1251471|P1|Vaccination 1|Overall Study||646
512000|NCT00943722|1251467|P5|STARTED|Overall Study||470
512001|NCT00943722|1251468|P4|STARTED|Overall Study||669
512002|NCT00943722|1251469|P3|STARTED|Overall Study||644
512003|NCT00943722|1251470|P2|STARTED|Overall Study||643
512004|NCT00943722|1251471|P1|STARTED|Overall Study||648
512005|NCT00943683|1251501|P2|NOT COMPLETED|Overall Study||6
512006|NCT00943683|1251502|P1|NOT COMPLETED|Overall Study||7
512007|NCT00943683|1251501|P2|COMPLETED|Overall Study||169
512008|NCT00943683|1251502|P1|COMPLETED|Overall Study||74
512009|NCT00943683|1251501|P2|STARTED|Overall Study||175
512010|NCT00943683|1251502|P1|STARTED|Overall Study||81
512011|NCT00943670|1251508|P1|NOT COMPLETED|Trastuzumab Emtansine + Pertuzumab||18
512012|NCT00943670|1251508|P1|COMPLETED|Trastuzumab Emtansine + Pertuzumab|Completed treatment defined as receiving a total of 17 cycles of therapy in both treatment periods.|2
512013|NCT00943670|1251508|P1|STARTED|Trastuzumab Emtansine + Pertuzumab|Patients with early progressive disease who elected to receive T-DM1 and pertuzumab.|20
512014|NCT00943670|1251508|P1|NOT COMPLETED|Single-agent Trastuzumab Emtansine||42
512015|NCT00943670|1251508|P1|COMPLETED|Single-agent Trastuzumab Emtansine|Completed single-agent treatment defined as receiving 17 cycles of trastuzumab emtansine therapy.|9
512016|NCT00943670|1251508|P1|Treated|Single-agent Trastuzumab Emtansine||51
512017|NCT00943670|1251508|P1|STARTED|Single-agent Trastuzumab Emtansine||51
512018|NCT00943631|1251544|P2|NOT COMPLETED|Overall Study||2
512019|NCT00943631|1251545|P1|NOT COMPLETED|Overall Study||4
512020|NCT00943631|1251544|P2|COMPLETED|Overall Study||202
512021|NCT00943631|1251545|P1|COMPLETED|Overall Study||198
512022|NCT00943631|1251544|P2|STARTED|Overall Study||204
512023|NCT00943631|1251545|P1|STARTED|Overall Study||202
512024|NCT00943605|1251597|P2|NOT COMPLETED|Overall Study||30
512025|NCT00943605|1251598|P1|NOT COMPLETED|Overall Study||30
512026|NCT00943605|1251597|P2|COMPLETED|Overall Study||0
512027|NCT00943605|1251598|P1|COMPLETED|Overall Study||0
512028|NCT00943605|1251597|P2|STARTED|Overall Study|There were 10 total subjects (5/group) who were retrospectively unenrolled for deviations.|30
512029|NCT00943605|1251598|P1|STARTED|Overall Study|There were 10 total subjects (5/group) who were retrospectively unenrolled for deviations.|30
512030|NCT00943592|1251608|P1|NOT COMPLETED|Overall Study||3
512031|NCT00943592|1251608|P1|COMPLETED|Overall Study|None of the three deaths were attributed to the conditioning regimen|79
512032|NCT00943592|1251608|P1|Maximum Tolerated Dose|Overall Study|74 patients received the Maximum Tolerated Dose|74
512033|NCT00943592|1251608|P1|STARTED|Overall Study||82
512034|NCT00943579|1251621|P2|NOT COMPLETED|Overall Study||5
512035|NCT00943579|1251622|P1|NOT COMPLETED|Overall Study||6
512036|NCT00943579|1251621|P2|COMPLETED|Overall Study||15
512037|NCT00943579|1251622|P1|COMPLETED|Overall Study||15
512038|NCT00943579|1251621|P2|STARTED|Overall Study||20
512039|NCT00943579|1251622|P1|STARTED|Overall Study||21
512040|NCT00943488|1251643|P2|NOT COMPLETED|Overall Study||2
512041|NCT00943488|1251644|P1|NOT COMPLETED|Overall Study||1
512042|NCT00943488|1251643|P2|COMPLETED|Overall Study||202
512043|NCT00943488|1251644|P1|COMPLETED|Overall Study||203
512044|NCT00943488|1251643|P2|STARTED|Overall Study||204
512045|NCT00943488|1251644|P1|STARTED|Overall Study||204
512058|NCT00943397|1251723|P2|NOT COMPLETED|Overall Study||72
512059|NCT00943397|1251724|P1|NOT COMPLETED|Overall Study||15
512060|NCT00943397|1251723|P2|COMPLETED|Overall Study|Site terminated - Merck administrative decision (52); Patient moved (1); Discontinued for other (3)|86
512061|NCT00943397|1251724|P1|COMPLETED|Overall Study|Site terminated - Merck administrative decision (11); Discontinued for other (1)|17
512062|NCT00943397|1251723|P2|STARTED|Overall Study||158
512063|NCT00943397|1251724|P1|STARTED|Overall Study||32
512064|NCT00943384|1251730|P1|NOT COMPLETED|Overall Study||49
512065|NCT00943384|1251730|P1|COMPLETED|Overall Study|evaluated at the Month 24 visit with complete or partial data|55
512066|NCT00943384|1251730|P1|Treated on Protocol|Overall Study|5 subjects were treated off protocol due to intraoperative decisions made by the surgeon|76
512067|NCT00943384|1251730|P1|Treated|Overall Study|81 subjects were eligible and willing to participate in the study and were treated|81
512068|NCT00943384|1251730|P1|STARTED|Overall Study|104 subjects consented and underwent additional screening to determine eligibility to participate|104
512069|NCT00943306|1251744|P1|NOT COMPLETED|Overall Study||3
512070|NCT00943306|1251744|P1|COMPLETED|Overall Study||16
512071|NCT00943306|1251744|P1|STARTED|Overall Study||19
512072|NCT00943202|1251805|P4|NOT COMPLETED|Overall Study||1
512073|NCT00943202|1251806|P3|NOT COMPLETED|Overall Study||0
512074|NCT00943202|1251807|P2|NOT COMPLETED|Overall Study||2
512075|NCT00943202|1251808|P1|NOT COMPLETED|Overall Study||1
512076|NCT00943202|1251805|P4|COMPLETED|Overall Study||131
512077|NCT00943202|1251806|P3|COMPLETED|Overall Study||133
512078|NCT00943202|1251807|P2|COMPLETED|Overall Study||131
512079|NCT00943202|1251808|P1|COMPLETED|Overall Study||132
512080|NCT00943202|1251805|P4|STARTED|Overall Study||132
512081|NCT00943202|1251806|P3|STARTED|Overall Study||133
512082|NCT00943202|1251807|P2|STARTED|Overall Study||133
512083|NCT00943202|1251808|P1|STARTED|Overall Study||133
512084|NCT00943150|1252024|P2|NOT COMPLETED|Overall Study||0
512085|NCT00943150|1252025|P1|NOT COMPLETED|Overall Study||0
512086|NCT00943150|1252024|P2|COMPLETED|Overall Study||10
512087|NCT00943150|1252025|P1|COMPLETED|Overall Study||10
512088|NCT00943150|1252024|P2|STARTED|Overall Study||10
512089|NCT00943150|1252025|P1|STARTED|Overall Study||10
512090|NCT00943124|1252046|P2|NOT COMPLETED|Period 2||0
512091|NCT00943124|1252047|P1|NOT COMPLETED|Period 2||0
512092|NCT00943124|1252046|P2|COMPLETED|Period 2||108
512093|NCT00943124|1252047|P1|COMPLETED|Period 2||108
512094|NCT00943124|1252046|P2|STARTED|Period 2||108
512095|NCT00943124|1252047|P1|STARTED|Period 2||108
512096|NCT00943124|1252046|P2|NOT COMPLETED|Period 1||2
512097|NCT00943124|1252047|P1|NOT COMPLETED|Period 1||2
512098|NCT00943124|1252046|P2|COMPLETED|Period 1||108
512099|NCT00943124|1252047|P1|COMPLETED|Period 1||108
512100|NCT00943124|1252046|P2|STARTED|Period 1||110
512101|NCT00943124|1252047|P1|STARTED|Period 1||110
512102|NCT00943111|1252069|P3|NOT COMPLETED|5 Years Long-term Treatment Period||75
512103|NCT00943111|1252070|P2|NOT COMPLETED|5 Years Long-term Treatment Period||0
512104|NCT00943111|1252071|P1|NOT COMPLETED|5 Years Long-term Treatment Period||0
512105|NCT00943111|1252069|P3|COMPLETED|5 Years Long-term Treatment Period||77
512106|NCT00943111|1252070|P2|COMPLETED|5 Years Long-term Treatment Period||0
512107|NCT00943111|1252071|P1|COMPLETED|5 Years Long-term Treatment Period||0
512108|NCT00943111|1252069|P3|STARTED|5 Years Long-term Treatment Period|Participants from both the arms of PAP who completed PAP and remained on-study|152
512109|NCT00943111|1252070|P2|STARTED|5 Years Long-term Treatment Period||0
512110|NCT00943111|1252071|P1|STARTED|5 Years Long-term Treatment Period||0
512111|NCT00943111|1252069|P3|NOT COMPLETED|52-Weeks Primary Analysis Period||0
512112|NCT00943111|1252070|P2|NOT COMPLETED|52-Weeks Primary Analysis Period||2
512113|NCT00943111|1252071|P1|NOT COMPLETED|52-Weeks Primary Analysis Period||2
512114|NCT00943111|1252069|P3|COMPLETED|52-Weeks Primary Analysis Period||0
512115|NCT00943111|1252070|P2|COMPLETED|52-Weeks Primary Analysis Period||52
512116|NCT00943111|1252071|P1|COMPLETED|52-Weeks Primary Analysis Period||104
512117|NCT00943111|1252069|P3|Treated|52-Weeks Primary Analysis Period||0
512118|NCT00943111|1252070|P2|Treated|52-Weeks Primary Analysis Period||53
512119|NCT00943111|1252071|P1|Treated|52-Weeks Primary Analysis Period||106
512120|NCT00943111|1252069|P3|STARTED|52-Weeks Primary Analysis Period||0
512121|NCT00943111|1252070|P2|STARTED|52-Weeks Primary Analysis Period||54
512122|NCT00943111|1252071|P1|STARTED|52-Weeks Primary Analysis Period||106
512123|NCT00943098|1252104|P2|NOT COMPLETED|Overall Study||0
512124|NCT00943098|1252105|P1|NOT COMPLETED|Overall Study||0
512125|NCT00943098|1252104|P2|COMPLETED|Overall Study||72
512126|NCT00943098|1252105|P1|COMPLETED|Overall Study||70
512127|NCT00943098|1252104|P2|STARTED|Overall Study|1 patient was excluded from the ITT and therefore the baseline population is 71|72
512128|NCT00943098|1252105|P1|STARTED|Overall Study||70
512129|NCT00943072|1252139|P2|NOT COMPLETED|Overall Study||14
512130|NCT00943072|1252140|P1|NOT COMPLETED|Overall Study||5
512131|NCT00943072|1252139|P2|COMPLETED|Overall Study|60 Participants completed Week 24, From FAS; 50 Participants completed up to Week 100, From SAF|60
512132|NCT00943072|1252140|P1|COMPLETED|Overall Study|110 Participants completed Week 24, From FAS; 102 Participants completed up to Week 100, From SAF|110
512133|NCT00943072|1252139|P2|Full Analysis Set (FAS) Population|Overall Study||73
512134|NCT00943072|1252140|P1|Full Analysis Set (FAS) Population|Overall Study|FAS population used for analysis of Primary and Secondary Outcome Measures|114
512135|NCT00943072|1252139|P2|Participants Received Treatment|Overall Study||74
512136|NCT00943072|1252140|P1|Participants Received Treatment|Overall Study|Safety population (SAF)|114
512137|NCT00943072|1252139|P2|STARTED|Overall Study||74
512138|NCT00943072|1252140|P1|STARTED|Overall Study||115
512139|NCT00942994|1252158|P2|NOT COMPLETED|Overall Study||19
512140|NCT00942994|1252159|P1|NOT COMPLETED|Overall Study||16
512141|NCT00942994|1252158|P2|COMPLETED|Overall Study||190
512142|NCT00942994|1252159|P1|COMPLETED|Overall Study||187
512143|NCT00942994|1252158|P2|STARTED|Overall Study||209
512144|NCT00942994|1252159|P1|STARTED|Overall Study||203
512145|NCT00942968|1252175|P1|NOT COMPLETED|Overall Study||229
512146|NCT00942968|1252175|P1|COMPLETED|Overall Study||109
512147|NCT00942968|1252175|P1|Treated|Overall Study||334
512148|NCT00942968|1252175|P1|STARTED|Overall Study||338
512149|NCT00942903|1252196|P1|NOT COMPLETED|Overall Study||0
512150|NCT00942903|1252196|P1|COMPLETED|Overall Study||20
512151|NCT00942903|1252196|P1|STARTED|Overall Study||20
512152|NCT00942890|1252203|P2|NOT COMPLETED|Overall Study||0
512153|NCT00942890|1252204|P1|NOT COMPLETED|Overall Study||0
512154|NCT00942890|1252203|P2|COMPLETED|Overall Study||23
512155|NCT00942890|1252204|P1|COMPLETED|Overall Study||21
512156|NCT00942890|1252203|P2|STARTED|Overall Study||23
512157|NCT00942890|1252204|P1|STARTED|Overall Study||21
512158|NCT00942851|1252226|P2|NOT COMPLETED|Overall Study||1
512159|NCT00942851|1252227|P1|NOT COMPLETED|Overall Study||0
512160|NCT00942851|1252226|P2|COMPLETED|Overall Study||11
512161|NCT00942851|1252227|P1|COMPLETED|Overall Study||12
512162|NCT00942851|1252226|P2|STARTED|Overall Study||12
512163|NCT00942851|1252227|P1|STARTED|Overall Study||12
512164|NCT00942825|1252239|P2|NOT COMPLETED|Overall Study||0
512165|NCT00942825|1252240|P1|NOT COMPLETED|Overall Study||0
512166|NCT00942825|1252239|P2|COMPLETED|Overall Study||98
512167|NCT00942825|1252240|P1|COMPLETED|Overall Study||97
512168|NCT00942825|1252239|P2|STARTED|Overall Study||98
512169|NCT00942825|1252240|P1|STARTED|Overall Study||97
512170|NCT00942786|1252246|P1|NOT COMPLETED|Overall Study||0
512171|NCT00942786|1252246|P1|COMPLETED|Overall Study|date of last follow-up|297
512172|NCT00942786|1252246|P1|STARTED|Overall Study||297
512173|NCT00942734|1252253|P1|NOT COMPLETED|Overall Study||8
512174|NCT00942734|1252253|P1|COMPLETED|Overall Study||35
512175|NCT00942734|1252253|P1|STARTED|Overall Study||43
512176|NCT00942604|1252259|P2|NOT COMPLETED|Overall Study||4
512177|NCT00942604|1252260|P1|NOT COMPLETED|Overall Study||2
512178|NCT00942604|1252259|P2|COMPLETED|Overall Study||99
512179|NCT00942604|1252260|P1|COMPLETED|Overall Study||98
512180|NCT00942604|1252259|P2|STARTED|Overall Study||103
512181|NCT00942604|1252260|P1|STARTED|Overall Study||100
512182|NCT00942448|1252272|P4|NOT COMPLETED|Overall Study||0
512183|NCT00942448|1252273|P3|NOT COMPLETED|Overall Study||0
512184|NCT00942448|1252274|P2|NOT COMPLETED|Overall Study||0
512185|NCT00942448|1252275|P1|NOT COMPLETED|Overall Study||0
512186|NCT00942448|1252272|P4|COMPLETED|Overall Study||75
512187|NCT00942448|1252273|P3|COMPLETED|Overall Study||78
512188|NCT00942448|1252274|P2|COMPLETED|Overall Study||76
512189|NCT00942448|1252275|P1|COMPLETED|Overall Study||77
512190|NCT00942448|1252272|P4|STARTED|Overall Study||75
512191|NCT00942448|1252273|P3|STARTED|Overall Study||78
512192|NCT00942448|1252274|P2|STARTED|Overall Study||76
512193|NCT00942448|1252275|P1|STARTED|Overall Study||77
512194|NCT00942422|1252337|P1|NOT COMPLETED|Overall Study||3
512195|NCT00942422|1252337|P1|COMPLETED|Overall Study||5
512196|NCT00942422|1252337|P1|STARTED|Overall Study||8
512197|NCT00942409|1252341|P1|NOT COMPLETED|Overall Study||3
512198|NCT00942409|1252341|P1|COMPLETED|Overall Study||2
512199|NCT00942409|1252341|P1|STARTED|Overall Study||5
512200|NCT00942266|1252347|P2|NOT COMPLETED|Overall Study||15
512201|NCT00942266|1252348|P1|NOT COMPLETED|Overall Study||43
512202|NCT00942266|1252347|P2|COMPLETED|Overall Study||0
512203|NCT00942266|1252348|P1|COMPLETED|Overall Study||0
512204|NCT00942266|1252347|P2|STARTED|Overall Study||15
512205|NCT00942266|1252348|P1|STARTED|Overall Study||43
512206|NCT00942188|1252370|P4|NOT COMPLETED|Overall Study||4
512207|NCT00942188|1252371|P3|NOT COMPLETED|Overall Study||9
512208|NCT00942188|1252372|P2|NOT COMPLETED|Overall Study||10
512209|NCT00942188|1252373|P1|NOT COMPLETED|Overall Study||4
512210|NCT00942188|1252370|P4|COMPLETED|Overall Study||23
512211|NCT00942188|1252371|P3|COMPLETED|Overall Study||18
512212|NCT00942188|1252372|P2|COMPLETED|Overall Study||16
512213|NCT00942188|1252373|P1|COMPLETED|Overall Study||22
512214|NCT00942188|1252370|P4|STARTED|Overall Study||27
512215|NCT00942188|1252371|P3|STARTED|Overall Study||27
512216|NCT00942188|1252372|P2|STARTED|Overall Study||26
512217|NCT00942188|1252373|P1|STARTED|Overall Study||26
512218|NCT00942175|1252412|P4|NOT COMPLETED|Overall Study||2
512219|NCT00942175|1252413|P3|NOT COMPLETED|Overall Study||2
512220|NCT00942175|1252414|P2|NOT COMPLETED|Overall Study||4
512221|NCT00942175|1252415|P1|NOT COMPLETED|Overall Study||2
512222|NCT00942175|1252412|P4|COMPLETED|Overall Study||38
512223|NCT00942175|1252413|P3|COMPLETED|Overall Study||38
512224|NCT00942175|1252414|P2|COMPLETED|Overall Study||36
512225|NCT00942175|1252415|P1|COMPLETED|Overall Study||38
512226|NCT00942175|1252412|P4|STARTED|Overall Study||40
512227|NCT00942175|1252413|P3|STARTED|Overall Study||40
512228|NCT00942175|1252414|P2|STARTED|Overall Study||40
512229|NCT00942175|1252415|P1|STARTED|Overall Study||40
512230|NCT00942149|1252465|P1|NOT COMPLETED|Overall Study||0
512231|NCT00942149|1252465|P1|COMPLETED|Overall Study||20
512232|NCT00942149|1252465|P1|STARTED|Overall Study||20
512233|NCT00942084|1252469|P1|NOT COMPLETED|Overall Study||2
512234|NCT00942084|1252469|P1|COMPLETED|Overall Study|There were 2 infant deaths. None determined to be related to study drug.|30
512235|NCT00942084|1252469|P1|STARTED|Overall Study||32
512236|NCT00941993|1252478|P1|NOT COMPLETED|Overall Study||0
512237|NCT00941993|1252478|P1|COMPLETED|Overall Study||109
512238|NCT00941993|1252478|P1|STARTED|Overall Study||109
512239|NCT00941928|1252486|P1|NOT COMPLETED|Overall Study||2
512240|NCT00941928|1252486|P1|COMPLETED|Overall Study||0
512241|NCT00941928|1252486|P1|STARTED|Overall Study||2
512242|NCT00941889|1252492|P2|NOT COMPLETED|Overall Study||12
512243|NCT00941889|1252493|P1|NOT COMPLETED|Overall Study||12
512244|NCT00941889|1252492|P2|COMPLETED|Overall Study||3
512245|NCT00941889|1252493|P1|COMPLETED|Overall Study||5
512246|NCT00941889|1252492|P2|STARTED|Overall Study||15
512247|NCT00941889|1252493|P1|STARTED|Overall Study||17
512248|NCT00941863|1252504|P5|NOT COMPLETED|Continued After PCD||19
512249|NCT00941863|1252505|P4|NOT COMPLETED|Continued After PCD||0
512250|NCT00941863|1252506|P3|NOT COMPLETED|Continued After PCD||0
512251|NCT00941863|1252507|P2|NOT COMPLETED|Continued After PCD||0
512252|NCT00941863|1252508|P1|NOT COMPLETED|Continued After PCD||0
512253|NCT00941863|1252504|P5|COMPLETED|Continued After PCD||6
512254|NCT00941863|1252505|P4|COMPLETED|Continued After PCD||0
512255|NCT00941863|1252506|P3|COMPLETED|Continued After PCD||0
512256|NCT00941863|1252507|P2|COMPLETED|Continued After PCD||0
512257|NCT00941863|1252508|P1|COMPLETED|Continued After PCD||0
512258|NCT00941863|1252504|P5|STARTED|Continued After PCD|25 of 119 participants from the Expansion Phase, were still on the treatment as of 31 May 2005.|25
512259|NCT00941863|1252505|P4|STARTED|Continued After PCD||0
512260|NCT00941863|1252506|P3|STARTED|Continued After PCD||0
512261|NCT00941863|1252507|P2|STARTED|Continued After PCD||0
512262|NCT00941863|1252508|P1|STARTED|Continued After PCD||0
512263|NCT00941863|1252504|P5|NOT COMPLETED|Until Primary Completion Date (PCD)||94
512264|NCT00941863|1252505|P4|NOT COMPLETED|Until Primary Completion Date (PCD)||17
512265|NCT00941863|1252506|P3|NOT COMPLETED|Until Primary Completion Date (PCD)||12
512266|NCT00941863|1252507|P2|NOT COMPLETED|Until Primary Completion Date (PCD)||3
512267|NCT00941863|1252508|P1|NOT COMPLETED|Until Primary Completion Date (PCD)||7
512268|NCT00941863|1252504|P5|COMPLETED|Until Primary Completion Date (PCD)||25
512269|NCT00941863|1252505|P4|COMPLETED|Until Primary Completion Date (PCD)||0
512270|NCT00941863|1252506|P3|COMPLETED|Until Primary Completion Date (PCD)||0
512271|NCT00941863|1252507|P2|COMPLETED|Until Primary Completion Date (PCD)||0
512272|NCT00941863|1252508|P1|COMPLETED|Until Primary Completion Date (PCD)||0
512273|NCT00941863|1252504|P5|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||94
512274|NCT00941863|1252505|P4|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||17
512275|NCT00941863|1252506|P3|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||12
512276|NCT00941863|1252507|P2|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||3
512277|NCT00941863|1252508|P1|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||7
512278|NCT00941863|1252504|P5|STARTED|Until Primary Completion Date (PCD)||119
512279|NCT00941863|1252505|P4|STARTED|Until Primary Completion Date (PCD)||17
512280|NCT00941863|1252506|P3|STARTED|Until Primary Completion Date (PCD)||12
512281|NCT00941863|1252507|P2|STARTED|Until Primary Completion Date (PCD)||3
512282|NCT00941863|1252508|P1|STARTED|Until Primary Completion Date (PCD)||7
512283|NCT00941798|1252535|P2|NOT COMPLETED|Overall Study||185
512284|NCT00941798|1252536|P1|NOT COMPLETED|Overall Study||194
512285|NCT00941798|1252535|P2|COMPLETED|Overall Study||578
512286|NCT00941798|1252536|P1|COMPLETED|Overall Study||561
512287|NCT00941798|1252535|P2|Full Analysis Set|Overall Study||759
512288|NCT00941798|1252536|P1|Full Analysis Set|Overall Study||749
512289|NCT00941798|1252535|P2|STARTED|Overall Study||763
512290|NCT00941798|1252536|P1|STARTED|Overall Study||755
512291|NCT00941733|1252566|P2|NOT COMPLETED|Overall Study||28
512292|NCT00941733|1252567|P1|NOT COMPLETED|Overall Study||74
512293|NCT00941733|1252566|P2|COMPLETED|Overall Study|1 year follow-up|91
512294|NCT00941733|1252567|P1|COMPLETED|Overall Study|1 year follow-up|165
512295|NCT00941733|1252566|P2|STARTED|Overall Study||119
512296|NCT00941733|1252567|P1|STARTED|Overall Study||239
512297|NCT00941720|1252607|P1|NOT COMPLETED|Overall Study||14
512298|NCT00941720|1252607|P1|COMPLETED|Overall Study||57
512299|NCT00941720|1252607|P1|STARTED|Overall Study||71
512300|NCT00941681|1252616|P3|NOT COMPLETED|Overall Study||0
512301|NCT00941681|1252617|P2|NOT COMPLETED|Overall Study||1
512302|NCT00941681|1252618|P1|NOT COMPLETED|Overall Study||0
512303|NCT00941681|1252616|P3|COMPLETED|Overall Study||12
512304|NCT00941681|1252617|P2|COMPLETED|Overall Study||10
512305|NCT00941681|1252618|P1|COMPLETED|Overall Study||12
512306|NCT00941681|1252616|P3|STARTED|Overall Study||12
512307|NCT00941681|1252617|P2|STARTED|Overall Study||11
512308|NCT00941681|1252618|P1|STARTED|Overall Study||12
512309|NCT00941668|1252643|P2|NOT COMPLETED|Overall Study||25
512310|NCT00941668|1252644|P1|NOT COMPLETED|Overall Study||24
512311|NCT00941668|1252643|P2|COMPLETED|Overall Study||0
512312|NCT00941668|1252644|P1|COMPLETED|Overall Study||0
512313|NCT00941668|1252643|P2|STARTED|Overall Study||25
512314|NCT00941668|1252644|P1|STARTED|Overall Study||24
512315|NCT00941655|1252654|P2|NOT COMPLETED|Overall Study||5
512316|NCT00941655|1252655|P1|NOT COMPLETED|Overall Study||5
512317|NCT00941655|1252654|P2|COMPLETED|Overall Study||2
512318|NCT00941655|1252655|P1|COMPLETED|Overall Study||3
512319|NCT00941655|1252654|P2|STARTED|Overall Study||7
512320|NCT00941655|1252655|P1|STARTED|Overall Study||8
512321|NCT00941603|1252680|P6|NOT COMPLETED|Overall Study||3
512322|NCT00941603|1252681|P5|NOT COMPLETED|Overall Study||4
512323|NCT00941603|1252682|P4|NOT COMPLETED|Overall Study||4
512324|NCT00941603|1252683|P3|NOT COMPLETED|Overall Study||5
512325|NCT00941603|1252684|P2|NOT COMPLETED|Overall Study||16
512326|NCT00941603|1252685|P1|NOT COMPLETED|Overall Study||11
512327|NCT00941603|1252680|P6|COMPLETED|Overall Study||94
512328|NCT00941603|1252681|P5|COMPLETED|Overall Study||101
512329|NCT00941603|1252682|P4|COMPLETED|Overall Study||100
512330|NCT00941603|1252683|P3|COMPLETED|Overall Study||99
512331|NCT00941603|1252684|P2|COMPLETED|Overall Study||89
512332|NCT00941603|1252685|P1|COMPLETED|Overall Study||93
512333|NCT00941603|1252680|P6|STARTED|Overall Study||97
512334|NCT00941603|1252681|P5|STARTED|Overall Study||105
512335|NCT00941603|1252682|P4|STARTED|Overall Study||104
512336|NCT00941603|1252683|P3|STARTED|Overall Study||104
512337|NCT00941603|1252684|P2|STARTED|Overall Study||105
512338|NCT00941603|1252685|P1|STARTED|Overall Study||104
512339|NCT00941330|1252707|P2|NOT COMPLETED|Overall Study||2
512340|NCT00941330|1252708|P1|NOT COMPLETED|Overall Study||1
512341|NCT00941330|1252707|P2|COMPLETED|Overall Study||9
512342|NCT00941330|1252708|P1|COMPLETED|Overall Study||14
512343|NCT00941330|1252707|P2|STARTED|Overall Study||11
512344|NCT00941330|1252708|P1|STARTED|Overall Study||15
512345|NCT00941304|1252721|P5|NOT COMPLETED|Overall Study||0
512346|NCT00941304|1252722|P4|NOT COMPLETED|Overall Study||0
512347|NCT00941304|1252723|P3|NOT COMPLETED|Overall Study||0
512348|NCT00941304|1252724|P2|NOT COMPLETED|Overall Study||0
512349|NCT00941304|1252725|P1|NOT COMPLETED|Overall Study||1
512350|NCT00941304|1252721|P5|COMPLETED|Overall Study||31
512351|NCT00941304|1252722|P4|COMPLETED|Overall Study||30
512352|NCT00941304|1252723|P3|COMPLETED|Overall Study||31
512353|NCT00941304|1252724|P2|COMPLETED|Overall Study||30
512354|NCT00941304|1252725|P1|COMPLETED|Overall Study||30
512355|NCT00941304|1252721|P5|STARTED|Overall Study||31
512356|NCT00941304|1252722|P4|STARTED|Overall Study||30
512357|NCT00941304|1252723|P3|STARTED|Overall Study||31
512358|NCT00941304|1252724|P2|STARTED|Overall Study||30
512359|NCT00941304|1252725|P1|STARTED|Overall Study||31
512360|NCT00941070|1252787|P1|NOT COMPLETED|Overall Study||1
512361|NCT00941070|1252787|P1|COMPLETED|Overall Study||25
512362|NCT00941070|1252787|P1|STARTED|Overall Study||26
512363|NCT00941031|1252807|P7|NOT COMPLETED|Maintenance Period||43
512364|NCT00941031|1252808|P6|NOT COMPLETED|Maintenance Period||6
512365|NCT00941031|1252809|P5|NOT COMPLETED|Maintenance Period||9
512366|NCT00941031|1252810|P4|NOT COMPLETED|Maintenance Period||0
512367|NCT00941031|1252811|P3|NOT COMPLETED|Maintenance Period||0
512368|NCT00941031|1252812|P2|NOT COMPLETED|Maintenance Period||0
512369|NCT00941031|1252813|P1|NOT COMPLETED|Maintenance Period||0
512370|NCT00941031|1252807|P7|COMPLETED|Maintenance Period||204
512371|NCT00941031|1252808|P6|COMPLETED|Maintenance Period||61
512372|NCT00941031|1252809|P5|COMPLETED|Maintenance Period||56
512373|NCT00941031|1252810|P4|COMPLETED|Maintenance Period|Non Responders treated with an open label regimen.|0
512374|NCT00941031|1252811|P3|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
512375|NCT00941031|1252812|P2|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
512376|NCT00941031|1252813|P1|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
512377|NCT00941031|1252807|P7|STARTED|Maintenance Period|Non Responders treated with an open label regimen.|247
512378|NCT00941031|1252808|P6|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|67
512379|NCT00941031|1252809|P5|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|65
512380|NCT00941031|1252810|P4|STARTED|Maintenance Period|Non Responders treated with an open label regimen.|0
512381|NCT00941031|1252811|P3|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
512382|NCT00941031|1252812|P2|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
512383|NCT00941031|1252813|P1|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
512384|NCT00941031|1252807|P7|NOT COMPLETED|Induction Period||0
512385|NCT00941031|1252808|P6|NOT COMPLETED|Induction Period||0
512386|NCT00941031|1252809|P5|NOT COMPLETED|Induction Period||0
512387|NCT00941031|1252810|P4|NOT COMPLETED|Induction Period||9
512388|NCT00941031|1252811|P3|NOT COMPLETED|Induction Period||6
512389|NCT00941031|1252812|P2|NOT COMPLETED|Induction Period||4
512390|NCT00941031|1252813|P1|NOT COMPLETED|Induction Period||5
512391|NCT00941031|1252807|P7|COMPLETED|Induction Period||0
512392|NCT00941031|1252808|P6|COMPLETED|Induction Period||0
512393|NCT00941031|1252809|P5|COMPLETED|Induction Period||0
512394|NCT00941031|1252810|P4|COMPLETED|Induction Period||58
512395|NCT00941031|1252811|P3|COMPLETED|Induction Period||127
512396|NCT00941031|1252812|P2|COMPLETED|Induction Period||134
512397|NCT00941031|1252813|P1|COMPLETED|Induction Period||61
512398|NCT00941031|1252807|P7|STARTED|Induction Period||0
512399|NCT00941031|1252808|P6|STARTED|Induction Period||0
512400|NCT00941031|1252809|P5|STARTED|Induction Period||0
512401|NCT00941031|1252810|P4|STARTED|Induction Period||67
512402|NCT00941031|1252811|P3|STARTED|Induction Period||133
512403|NCT00941031|1252812|P2|STARTED|Induction Period||138
512404|NCT00941031|1252813|P1|STARTED|Induction Period||66
512405|NCT00940992|1252839|P3|NOT COMPLETED|Overall Study||2
512406|NCT00940992|1252840|P2|NOT COMPLETED|Overall Study||2
512407|NCT00940992|1252841|P1|NOT COMPLETED|Overall Study||4
512408|NCT00940992|1252839|P3|COMPLETED|Overall Study||28
512409|NCT00940992|1252840|P2|COMPLETED|Overall Study||28
512410|NCT00940992|1252841|P1|COMPLETED|Overall Study||28
512411|NCT00940992|1252839|P3|STARTED|Overall Study||30
512412|NCT00940992|1252840|P2|STARTED|Overall Study||30
512413|NCT00940992|1252841|P1|STARTED|Overall Study||32
512414|NCT00940927|1252852|P1|NOT COMPLETED|Overall Study||0
512415|NCT00940927|1252852|P1|COMPLETED|Overall Study||81
512416|NCT00940927|1252852|P1|STARTED|Overall Study||81
512417|NCT00940901|1252859|P2|NOT COMPLETED|Week 9-16 (Phase 2)||3
512418|NCT00940901|1252860|P1|NOT COMPLETED|Week 9-16 (Phase 2)||2
512419|NCT00940901|1252859|P2|COMPLETED|Week 9-16 (Phase 2)||4
512420|NCT00940901|1252860|P1|COMPLETED|Week 9-16 (Phase 2)||4
512421|NCT00940901|1252859|P2|STARTED|Week 9-16 (Phase 2)||7
512422|NCT00940901|1252860|P1|STARTED|Week 9-16 (Phase 2)||6
512423|NCT00940901|1252859|P2|NOT COMPLETED|Weeks 1-8 (Phase 1)||0
512424|NCT00940901|1252860|P1|NOT COMPLETED|Weeks 1-8 (Phase 1)||0
512425|NCT00940901|1252859|P2|COMPLETED|Weeks 1-8 (Phase 1)||7
512426|NCT00940901|1252860|P1|COMPLETED|Weeks 1-8 (Phase 1)||6
512427|NCT00940901|1252859|P2|STARTED|Weeks 1-8 (Phase 1)||7
512428|NCT00940901|1252860|P1|STARTED|Weeks 1-8 (Phase 1)||6
512429|NCT00940888|1252870|P1|NOT COMPLETED|Overall Study||835
512430|NCT00940888|1252870|P1|COMPLETED|Overall Study|Subjects that completed the 60 month follow up visit|866
512431|NCT00940888|1252870|P1|STARTED|Overall Study|Total number of subjects consented|1701
512432|NCT00940875|1252877|P2|NOT COMPLETED|Post-Study Treatment||3
512433|NCT00940875|1252878|P1|NOT COMPLETED|Post-Study Treatment||0
512434|NCT00940875|1252877|P2|COMPLETED|Post-Study Treatment||1
512435|NCT00940875|1252878|P1|COMPLETED|Post-Study Treatment||0
512436|NCT00940875|1252877|P2|STARTED|Post-Study Treatment||4
512437|NCT00940875|1252878|P1|STARTED|Post-Study Treatment||0
512438|NCT00940875|1252877|P2|NOT COMPLETED|Treatment Phase||19
512439|NCT00940875|1252878|P1|NOT COMPLETED|Treatment Phase||26
512440|NCT00940875|1252877|P2|COMPLETED|Treatment Phase||4
512441|NCT00940875|1252878|P1|COMPLETED|Treatment Phase||5
512442|NCT00940875|1252877|P2|STARTED|Treatment Phase|3 participants randomized to G+E arm received only gemcitabine and were analyzed in Gemcitabine arm|23
512443|NCT00940875|1252878|P1|STARTED|Treatment Phase|Disposition analysis includes 3 participants randomized to G+E but received only gemcitabine|31
512444|NCT00940823|1252898|P2|NOT COMPLETED|Overall Study||32
512445|NCT00940823|1252899|P1|NOT COMPLETED|Overall Study||35
512446|NCT00940823|1252898|P2|COMPLETED|Overall Study||82
512447|NCT00940823|1252899|P1|COMPLETED|Overall Study||89
512448|NCT00940823|1252898|P2|STARTED|Overall Study||114
512449|NCT00940823|1252899|P1|STARTED|Overall Study||124
512450|NCT00940589|1252917|P2|NOT COMPLETED|Overall Study||5
512451|NCT00940589|1252918|P1|NOT COMPLETED|Overall Study||8
512452|NCT00940589|1252917|P2|COMPLETED|Overall Study||29
512453|NCT00940589|1252918|P1|COMPLETED|Overall Study||31
512454|NCT00940589|1252917|P2|STARTED|Overall Study||34
512455|NCT00940589|1252918|P1|STARTED|Overall Study||39
512456|NCT00940576|1252928|P2|NOT COMPLETED|Overall Study||0
512457|NCT00940576|1252929|P1|NOT COMPLETED|Overall Study||0
512458|NCT00940576|1252928|P2|COMPLETED|Overall Study||9
512459|NCT00940576|1252929|P1|COMPLETED|Overall Study||8
512460|NCT00940576|1252928|P2|STARTED|Overall Study||9
512461|NCT00940576|1252929|P1|STARTED|Overall Study||8
512462|NCT00940537|1252938|P2|NOT COMPLETED|Overall Study||0
512463|NCT00940537|1252939|P1|NOT COMPLETED|Overall Study||0
512464|NCT00940537|1252938|P2|COMPLETED|Overall Study||9
512465|NCT00940537|1252939|P1|COMPLETED|Overall Study||5
512466|NCT00940537|1252938|P2|STARTED|Overall Study||9
512467|NCT00940537|1252939|P1|STARTED|Overall Study||5
512468|NCT00940485|1252950|P2|NOT COMPLETED|Overall Study||7
512469|NCT00940485|1252951|P1|NOT COMPLETED|Overall Study||15
512470|NCT00940485|1252950|P2|COMPLETED|Overall Study||93
512471|NCT00940485|1252951|P1|COMPLETED|Overall Study||82
512472|NCT00940485|1252950|P2|STARTED|Overall Study||100
512473|NCT00940485|1252951|P1|STARTED|Overall Study||97
512474|NCT00940446|1252977|P2|NOT COMPLETED|Overall Study||0
512475|NCT00940446|1252978|P1|NOT COMPLETED|Overall Study||0
512476|NCT00940446|1252977|P2|COMPLETED|Overall Study||30
512477|NCT00940446|1252978|P1|COMPLETED|Overall Study||30
512478|NCT00940446|1252977|P2|STARTED|Overall Study||30
512479|NCT00940446|1252978|P1|STARTED|Overall Study||30
512480|NCT00940290|1252990|P4|NOT COMPLETED|Overall Study||0
512481|NCT00940290|1252991|P3|NOT COMPLETED|Overall Study||0
512482|NCT00940290|1252992|P2|NOT COMPLETED|Overall Study||0
512483|NCT00940290|1252993|P1|NOT COMPLETED|Overall Study||0
512484|NCT00940290|1252990|P4|COMPLETED|Overall Study||54
512485|NCT00940290|1252991|P3|COMPLETED|Overall Study||55
512486|NCT00940290|1252992|P2|COMPLETED|Overall Study||53
512487|NCT00940290|1252993|P1|COMPLETED|Overall Study||54
512488|NCT00940290|1252990|P4|STARTED|Overall Study||54
512489|NCT00940290|1252991|P3|STARTED|Overall Study||55
512490|NCT00940290|1252992|P2|STARTED|Overall Study||53
512491|NCT00940290|1252993|P1|STARTED|Overall Study||54
512492|NCT00940108|1253007|P4|NOT COMPLETED|Overall Study||5
512493|NCT00940108|1253008|P3|NOT COMPLETED|Overall Study||3
512494|NCT00940108|1253009|P2|NOT COMPLETED|Overall Study||9
512495|NCT00940108|1253010|P1|NOT COMPLETED|Overall Study||5
512496|NCT00940108|1253007|P4|COMPLETED|Overall Study||99
512497|NCT00940108|1253008|P3|COMPLETED|Overall Study||100
512498|NCT00940108|1253009|P2|COMPLETED|Overall Study||71
512499|NCT00940108|1253010|P1|COMPLETED|Overall Study||77
512500|NCT00940108|1253007|P4|STARTED|Overall Study||104
512501|NCT00940108|1253008|P3|STARTED|Overall Study||103
512502|NCT00940108|1253009|P2|STARTED|Overall Study||80
512503|NCT00940108|1253010|P1|STARTED|Overall Study||82
512504|NCT00940017|1253060|P1|NOT COMPLETED|Overall Study||4
512505|NCT00940017|1253060|P1|COMPLETED|Overall Study||20
512506|NCT00940017|1253060|P1|Subjects Treated|Overall Study||21
512507|NCT00940017|1253060|P1|STARTED|Overall Study||24
512508|NCT00939991|1253081|P2|NOT COMPLETED|Overall Study||0
512509|NCT00939991|1253082|P1|NOT COMPLETED|Overall Study||0
512510|NCT00939991|1253081|P2|COMPLETED|Overall Study||39
512511|NCT00939991|1253082|P1|COMPLETED|Overall Study||9
512512|NCT00939991|1253081|P2|STARTED|Overall Study||39
512513|NCT00939991|1253082|P1|STARTED|Overall Study||9
512514|NCT00939952|1253092|P1|NOT COMPLETED|Overall Study||0
512515|NCT00939952|1253092|P1|COMPLETED|Overall Study||7
512516|NCT00939952|1253092|P1|STARTED|Overall Study||7
512517|NCT00939900|1253104|P2|NOT COMPLETED|Overall Study||7
512518|NCT00939900|1253105|P1|NOT COMPLETED|Overall Study||2
512519|NCT00939900|1253104|P2|COMPLETED|Overall Study||48
512520|NCT00939900|1253105|P1|COMPLETED|Overall Study||53
512521|NCT00939900|1253104|P2|STARTED|Overall Study||55
512522|NCT00939900|1253105|P1|STARTED|Overall Study||55
512523|NCT00939874|1253111|P1|NOT COMPLETED|Overall Study||20
512524|NCT00939874|1253111|P1|COMPLETED|Overall Study||32
512525|NCT00939874|1253111|P1|Completed Week 48|Overall Study||37
512526|NCT00939874|1253111|P1|STARTED|Overall Study||52
512527|NCT00939809|1253116|P1|NOT COMPLETED|Overall Study||3
512528|NCT00939809|1253116|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|28
512529|NCT00939809|1253116|P1|STARTED|Overall Study||31
512530|NCT00939796|1253125|P1|NOT COMPLETED|Overall Study||0
512531|NCT00939796|1253125|P1|COMPLETED|Overall Study||16
512532|NCT00939796|1253125|P1|STARTED|Overall Study||16
512533|NCT00939783|1253131|P1|NOT COMPLETED|Overall Study||649
512534|NCT00939783|1253131|P1|COMPLETED|Overall Study||0
512535|NCT00939783|1253131|P1|Treated|Overall Study||648
512536|NCT00939783|1253131|P1|STARTED|Overall Study||649
512537|NCT00939731|1253138|P2|NOT COMPLETED|Second Intervention Period||0
512538|NCT00939731|1253139|P1|NOT COMPLETED|Second Intervention Period||0
512539|NCT00939731|1253138|P2|COMPLETED|Second Intervention Period||12
512540|NCT00939731|1253139|P1|COMPLETED|Second Intervention Period||12
512541|NCT00939731|1253138|P2|STARTED|Second Intervention Period||12
512542|NCT00939731|1253139|P1|STARTED|Second Intervention Period||12
512543|NCT00939731|1253138|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
512544|NCT00939731|1253139|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
512545|NCT00939731|1253138|P2|COMPLETED|Washout Period (at Least 14 Days)||12
512546|NCT00939731|1253139|P1|COMPLETED|Washout Period (at Least 14 Days)||12
512547|NCT00939731|1253138|P2|STARTED|Washout Period (at Least 14 Days)||12
512548|NCT00939731|1253139|P1|STARTED|Washout Period (at Least 14 Days)||12
512549|NCT00939731|1253138|P2|NOT COMPLETED|First Intervention Period||0
512550|NCT00939731|1253139|P1|NOT COMPLETED|First Intervention Period||0
512551|NCT00939731|1253138|P2|COMPLETED|First Intervention Period||12
512552|NCT00939731|1253139|P1|COMPLETED|First Intervention Period||12
512553|NCT00939731|1253138|P2|STARTED|First Intervention Period||12
512554|NCT00939731|1253139|P1|STARTED|First Intervention Period||12
512555|NCT00939705|1253159|P2|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0
512556|NCT00939705|1253160|P1|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0
512557|NCT00939705|1253159|P2|COMPLETED|Period 3 - Second Intervent - 5 Days||9
512558|NCT00939705|1253160|P1|COMPLETED|Period 3 - Second Intervent - 5 Days||9
512559|NCT00939705|1253159|P2|STARTED|Period 3 - Second Intervent - 5 Days||9
512560|NCT00939705|1253160|P1|STARTED|Period 3 - Second Intervent - 5 Days||9
512561|NCT00939705|1253159|P2|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0
512562|NCT00939705|1253160|P1|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0
512563|NCT00939705|1253159|P2|COMPLETED|Period 2 - Washout Period - 21 Days||9
512564|NCT00939705|1253160|P1|COMPLETED|Period 2 - Washout Period - 21 Days||9
512565|NCT00939705|1253159|P2|STARTED|Period 2 - Washout Period - 21 Days||9
512566|NCT00939705|1253160|P1|STARTED|Period 2 - Washout Period - 21 Days||9
512567|NCT00939705|1253159|P2|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
512568|NCT00939705|1253160|P1|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
512569|NCT00939705|1253159|P2|COMPLETED|Period 1 - First Intervention - 5 Days||9
512570|NCT00939705|1253160|P1|COMPLETED|Period 1 - First Intervention - 5 Days||9
512571|NCT00939705|1253159|P2|STARTED|Period 1 - First Intervention - 5 Days||9
512572|NCT00939705|1253160|P1|STARTED|Period 1 - First Intervention - 5 Days||9
512573|NCT00939692|1253172|P2|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||1
512574|NCT00939692|1253173|P1|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||0
512575|NCT00939692|1253172|P2|COMPLETED|Period 2 - Second Intervent - 5 Days||12
512576|NCT00939692|1253173|P1|COMPLETED|Period 2 - Second Intervent - 5 Days||12
512577|NCT00939692|1253172|P2|STARTED|Period 2 - Second Intervent - 5 Days||13
512578|NCT00939692|1253173|P1|STARTED|Period 2 - Second Intervent - 5 Days||12
512579|NCT00939692|1253172|P2|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
512580|NCT00939692|1253173|P1|NOT COMPLETED|Period 1 - First Intervention - 5 Days||1
512581|NCT00939692|1253172|P2|COMPLETED|Period 1 - First Intervention - 5 Days||13
512582|NCT00939692|1253173|P1|COMPLETED|Period 1 - First Intervention - 5 Days||12
512583|NCT00939692|1253172|P2|STARTED|Period 1 - First Intervention - 5 Days||13
512584|NCT00939692|1253173|P1|STARTED|Period 1 - First Intervention - 5 Days||13
512585|NCT00939627|1253185|P3|NOT COMPLETED|Overall Study||0
512586|NCT00939627|1253186|P2|NOT COMPLETED|Overall Study||28
512587|NCT00939627|1253187|P1|NOT COMPLETED|Overall Study||27
512588|NCT00939627|1253185|P3|COMPLETED|Overall Study||0
512589|NCT00939627|1253186|P2|COMPLETED|Overall Study||0
512590|NCT00939627|1253187|P1|COMPLETED|Overall Study||0
512591|NCT00939627|1253185|P3|STARTED|Overall Study||0
512592|NCT00939627|1253186|P2|STARTED|Overall Study||28
512593|NCT00939627|1253187|P1|STARTED|Overall Study||27
512594|NCT00939562|1253205|P2|NOT COMPLETED|Period 2||0
512595|NCT00939562|1253206|P1|NOT COMPLETED|Period 2||0
512596|NCT00939562|1253205|P2|COMPLETED|Period 2||12
512597|NCT00939562|1253206|P1|COMPLETED|Period 2||12
512598|NCT00939562|1253205|P2|STARTED|Period 2||12
512599|NCT00939562|1253206|P1|STARTED|Period 2||12
512600|NCT00939562|1253205|P2|NOT COMPLETED|Period 1||0
512601|NCT00939562|1253206|P1|NOT COMPLETED|Period 1||0
512602|NCT00939562|1253205|P2|COMPLETED|Period 1||12
512603|NCT00939562|1253206|P1|COMPLETED|Period 1||12
512604|NCT00939562|1253205|P2|STARTED|Period 1||12
512605|NCT00939562|1253206|P1|STARTED|Period 1||12
512606|NCT00939536|1253216|P2|NOT COMPLETED|Second Intervention||0
512607|NCT00939536|1253217|P1|NOT COMPLETED|Second Intervention||0
512608|NCT00939536|1253216|P2|COMPLETED|Second Intervention||12
512609|NCT00939536|1253217|P1|COMPLETED|Second Intervention||12
512610|NCT00939536|1253216|P2|STARTED|Second Intervention||12
512611|NCT00939536|1253217|P1|STARTED|Second Intervention||12
512612|NCT00939536|1253216|P2|NOT COMPLETED|First Intervention||0
512613|NCT00939536|1253217|P1|NOT COMPLETED|First Intervention||0
512614|NCT00939536|1253216|P2|COMPLETED|First Intervention||12
512615|NCT00939536|1253217|P1|COMPLETED|First Intervention||12
512616|NCT00939536|1253216|P2|STARTED|First Intervention||12
512617|NCT00939536|1253217|P1|STARTED|First Intervention||12
512618|NCT00939510|1253227|P1|NOT COMPLETED|Overall Study||1
512619|NCT00939510|1253227|P1|COMPLETED|Overall Study||31
512620|NCT00939510|1253227|P1|STARTED|Overall Study||32
512621|NCT00939484|1253236|P3|NOT COMPLETED|Overall Study||3
512622|NCT00939484|1253237|P2|NOT COMPLETED|Overall Study||20
512623|NCT00939484|1253238|P1|NOT COMPLETED|Overall Study||8
512624|NCT00939484|1253236|P3|COMPLETED|Overall Study||0
512625|NCT00939484|1253237|P2|COMPLETED|Overall Study||0
512626|NCT00939484|1253238|P1|COMPLETED|Overall Study||0
512627|NCT00939484|1253236|P3|STARTED|Overall Study||3
512628|NCT00939484|1253237|P2|STARTED|Overall Study||20
512629|NCT00939484|1253238|P1|STARTED|Overall Study||8
512630|NCT00939471|1253251|P1|NOT COMPLETED|Overall Study||11
512631|NCT00939471|1253251|P1|COMPLETED|Overall Study||33
512632|NCT00939471|1253251|P1|STARTED|Overall Study||44
512633|NCT00939393|1253264|P2|NOT COMPLETED|Overall Study||0
512634|NCT00939393|1253265|P1|NOT COMPLETED|Overall Study||4
512635|NCT00939393|1253264|P2|COMPLETED|Overall Study||35
512636|NCT00939393|1253265|P1|COMPLETED|Overall Study||33
512637|NCT00939393|1253264|P2|STARTED|Overall Study||35
512638|NCT00939393|1253265|P1|STARTED|Overall Study||37
512639|NCT00939367|1253285|P2|NOT COMPLETED|Second Intervention||0
512640|NCT00939367|1253286|P1|NOT COMPLETED|Second Intervention||0
512641|NCT00939367|1253285|P2|COMPLETED|Second Intervention||15
512642|NCT00939367|1253286|P1|COMPLETED|Second Intervention||15
512643|NCT00939367|1253285|P2|STARTED|Second Intervention||15
512644|NCT00939367|1253286|P1|STARTED|Second Intervention||15
512645|NCT00939367|1253285|P2|NOT COMPLETED|First Intervention||0
512646|NCT00939367|1253286|P1|NOT COMPLETED|First Intervention||0
512647|NCT00939367|1253285|P2|COMPLETED|First Intervention||15
512648|NCT00939367|1253286|P1|COMPLETED|First Intervention||15
512649|NCT00939367|1253285|P2|STARTED|First Intervention||15
512650|NCT00939367|1253286|P1|STARTED|First Intervention||15
512651|NCT00939341|1253296|P1|NOT COMPLETED|Overall Study||66
512652|NCT00939341|1253296|P1|COMPLETED|Overall Study|862 participants entered into the 12-week treatment,66 discontinued, 796 completed the treatment.|796
512653|NCT00939341|1253296|P1|STARTED|Overall Study|1022 participants were enrolled. There were 160 screen failures, 862 proceeded to treatment period.|862
512654|NCT00939211|1253316|P1|NOT COMPLETED|Placebo||0
512655|NCT00939211|1253316|P1|COMPLETED|Placebo||28
512656|NCT00939211|1253316|P1|STARTED|Placebo||28
512657|NCT00939211|1253316|P1|NOT COMPLETED|Spiriva 18 Mcg First, Then Placebo||0
512658|NCT00939211|1253316|P1|COMPLETED|Spiriva 18 Mcg First, Then Placebo||28
512659|NCT00939211|1253316|P1|STARTED|Spiriva 18 Mcg First, Then Placebo||28
512660|NCT00939211|1253316|P1|NOT COMPLETED|AZD9164 1200 Mcg First, Then Placebo||0
512661|NCT00939211|1253316|P1|COMPLETED|AZD9164 1200 Mcg First, Then Placebo||28
512662|NCT00939211|1253316|P1|STARTED|AZD9164 1200 Mcg First, Then Placebo||28
512663|NCT00939211|1253316|P1|NOT COMPLETED|AZD9164 400 Mcg First, Then Placebo||0
512664|NCT00939211|1253316|P1|COMPLETED|AZD9164 400 Mcg First, Then Placebo||28
512665|NCT00939211|1253316|P1|STARTED|AZD9164 400 Mcg First, Then Placebo||28
512666|NCT00939211|1253316|P1|NOT COMPLETED|AZD9164 100 Mcg First, Then Placebo||0
512667|NCT00939211|1253316|P1|COMPLETED|AZD9164 100 Mcg First, Then Placebo||28
512668|NCT00939211|1253316|P1|STARTED|AZD9164 100 Mcg First, Then Placebo|Cross-over study|28
512669|NCT00939185|1253378|P1|NOT COMPLETED|Overall Study||25
512670|NCT00939185|1253378|P1|COMPLETED|Overall Study||375
512671|NCT00939185|1253378|P1|Received Treatment|Overall Study||390
512672|NCT00939185|1253378|P1|STARTED|Overall Study||400
512673|NCT00939159|1253385|P1|NOT COMPLETED|Overall Study||0
512674|NCT00939159|1253385|P1|COMPLETED|Overall Study||13
512675|NCT00939159|1253385|P1|STARTED|Overall Study||13
512676|NCT00939120|1253391|P2|NOT COMPLETED|Overall Study||5
512677|NCT00939120|1253392|P1|NOT COMPLETED|Overall Study||8
512678|NCT00939120|1253391|P2|COMPLETED|Overall Study||18
512679|NCT00939120|1253392|P1|COMPLETED|Overall Study||15
512680|NCT00939120|1253391|P2|STARTED|Overall Study||23
512681|NCT00939120|1253392|P1|STARTED|Overall Study||23
512682|NCT00939107|1253416|P2|NOT COMPLETED|Overall Study||12
512683|NCT00939107|1253417|P1|NOT COMPLETED|Overall Study||14
512684|NCT00939107|1253416|P2|COMPLETED|Overall Study||163
512685|NCT00939107|1253417|P1|COMPLETED|Overall Study||161
512686|NCT00939107|1253416|P2|12 Months Follow-up|Overall Study||163
512687|NCT00939107|1253417|P1|12 Months Follow-up|Overall Study||161
512688|NCT00939107|1253416|P2|STARTED|Overall Study||175
512689|NCT00939107|1253417|P1|STARTED|Overall Study||175
512690|NCT00939094|1253431|P2|NOT COMPLETED|Overall Study||10
512691|NCT00939094|1253432|P1|NOT COMPLETED|Overall Study||14
512692|NCT00939094|1253431|P2|COMPLETED|Overall Study||35
512693|NCT00939094|1253432|P1|COMPLETED|Overall Study||28
512694|NCT00939094|1253431|P2|STARTED|Overall Study||45
512695|NCT00939094|1253432|P1|STARTED|Overall Study||42
512696|NCT00939055|1253454|P2|NOT COMPLETED|Overall Study||0
512697|NCT00939055|1253455|P1|NOT COMPLETED|Overall Study||4
512698|NCT00939055|1253454|P2|COMPLETED|Overall Study||39
512699|NCT00939055|1253455|P1|COMPLETED|Overall Study||69
512700|NCT00939055|1253454|P2|STARTED|Overall Study||39
512701|NCT00939055|1253455|P1|STARTED|Overall Study||73
512702|NCT00939029|1253465|P2|NOT COMPLETED|Overall Study||12
512703|NCT00939029|1253466|P1|NOT COMPLETED|Overall Study||6
512704|NCT00939029|1253465|P2|COMPLETED|Overall Study||15
512705|NCT00939029|1253466|P1|COMPLETED|Overall Study||19
512706|NCT00939029|1253465|P2|STARTED|Overall Study||27
512707|NCT00939029|1253466|P1|STARTED|Overall Study||25
512708|NCT00939003|1253478|P2|NOT COMPLETED|Open-label Treatment Period||29
512709|NCT00939003|1253479|P1|NOT COMPLETED|Open-label Treatment Period||29
512710|NCT00939003|1253478|P2|COMPLETED|Open-label Treatment Period||62
512711|NCT00939003|1253479|P1|COMPLETED|Open-label Treatment Period||66
512712|NCT00939003|1253478|P2|STARTED|Open-label Treatment Period||91
512713|NCT00939003|1253479|P1|STARTED|Open-label Treatment Period||95
512714|NCT00939003|1253478|P2|NOT COMPLETED|Double-blind Treatment Period||4
512715|NCT00939003|1253479|P1|NOT COMPLETED|Double-blind Treatment Period||2
512716|NCT00939003|1253478|P2|COMPLETED|Double-blind Treatment Period||91
512717|NCT00939003|1253479|P1|COMPLETED|Double-blind Treatment Period||95
512718|NCT00939003|1253478|P2|STARTED|Double-blind Treatment Period||95
512719|NCT00939003|1253479|P1|STARTED|Double-blind Treatment Period||97
512720|NCT00938964|1253516|P2|NOT COMPLETED|Overall Study||28
512721|NCT00938964|1253517|P1|NOT COMPLETED|Overall Study||30
512722|NCT00938964|1253516|P2|COMPLETED|Overall Study||209
512723|NCT00938964|1253517|P1|COMPLETED|Overall Study||211
512724|NCT00938964|1253516|P2|STARTED|Overall Study||237
512725|NCT00938964|1253517|P1|STARTED|Overall Study||241
512726|NCT00938886|1253581|P2|NOT COMPLETED|Overall Study||10
512727|NCT00938886|1253582|P1|NOT COMPLETED|Overall Study||7
512728|NCT00938886|1253581|P2|COMPLETED|Overall Study||65
512729|NCT00938886|1253582|P1|COMPLETED|Overall Study||68
512730|NCT00938886|1253581|P2|Attended 1 Counseling Session|Overall Study||70
512731|NCT00938886|1253582|P1|Attended 1 Counseling Session|Overall Study||70
512732|NCT00938886|1253581|P2|STARTED|Overall Study||75
512733|NCT00938886|1253582|P1|STARTED|Overall Study||75
512734|NCT00938860|1253592|P2|NOT COMPLETED|Overall Study||17
512735|NCT00938860|1253593|P1|NOT COMPLETED|Overall Study||25
512736|NCT00938860|1253592|P2|COMPLETED|Overall Study||25
512737|NCT00938860|1253593|P1|COMPLETED|Overall Study||25
512738|NCT00938860|1253592|P2|Efficacy Population|Overall Study||41
512739|NCT00938860|1253593|P1|Efficacy Population|Overall Study||40
512740|NCT00938860|1253592|P2|STARTED|Overall Study||42
512741|NCT00938860|1253593|P1|STARTED|Overall Study|Intent-to-Treat (ITT) population. ITT population consisted of all randomized patients|50
512742|NCT00938782|1253617|P2|NOT COMPLETED|Overall Study||0
512743|NCT00938782|1253618|P1|NOT COMPLETED|Overall Study||0
512744|NCT00938782|1253617|P2|COMPLETED|Overall Study|Upon discharge from PACU|35
512745|NCT00938782|1253618|P1|COMPLETED|Overall Study|Upon discharge from PACU|32
512746|NCT00938782|1253617|P2|STARTED|Overall Study|Monitoring started pre-induction of anesthesia|35
512747|NCT00938782|1253618|P1|STARTED|Overall Study|Pre-induction of anesthesia|32
512748|NCT00938717|1253626|P2|NOT COMPLETED|Overall Study||108
512749|NCT00938717|1253627|P1|NOT COMPLETED|Overall Study||98
512750|NCT00938717|1253626|P2|COMPLETED|Overall Study||294
512751|NCT00938717|1253627|P1|COMPLETED|Overall Study||305
512752|NCT00938717|1253626|P2|STARTED|Overall Study||402
512753|NCT00938717|1253627|P1|STARTED|Overall Study||403
512754|NCT00938704|1253661|P2|NOT COMPLETED|Overall Study||0
512755|NCT00938704|1253662|P1|NOT COMPLETED|Overall Study||0
512756|NCT00938704|1253661|P2|COMPLETED|Overall Study||37
512757|NCT00938704|1253662|P1|COMPLETED|Overall Study||33
512758|NCT00938704|1253661|P2|STARTED|Overall Study||37
512759|NCT00938704|1253662|P1|STARTED|Overall Study||33
512760|NCT00938639|1253678|P2|NOT COMPLETED|Overall Study||4
512761|NCT00938639|1253679|P1|NOT COMPLETED|Overall Study||3
512762|NCT00938639|1253678|P2|COMPLETED|Overall Study||116
512763|NCT00938639|1253679|P1|COMPLETED|Overall Study||117
512764|NCT00938639|1253678|P2|STARTED|Overall Study||120
512765|NCT00938639|1253679|P1|STARTED|Overall Study||120
512766|NCT00938548|1253749|P2|NOT COMPLETED|Overall Study||0
512767|NCT00938548|1253750|P1|NOT COMPLETED|Overall Study||0
512768|NCT00938548|1253749|P2|COMPLETED|Overall Study||35
512769|NCT00938548|1253750|P1|COMPLETED|Overall Study||35
512770|NCT00938548|1253749|P2|STARTED|Overall Study||35
512771|NCT00938548|1253750|P1|STARTED|Overall Study||35
512772|NCT00938470|1253762|P2|NOT COMPLETED|Overall Study||3
512773|NCT00938470|1253763|P1|NOT COMPLETED|Overall Study||7
512774|NCT00938470|1253762|P2|COMPLETED|Overall Study||25
512775|NCT00938470|1253763|P1|COMPLETED|Overall Study||27
512776|NCT00938470|1253762|P2|STARTED|Overall Study||28
512777|NCT00938470|1253763|P1|STARTED|Overall Study||34
512778|NCT00938457|1253777|P1|NOT COMPLETED|Overall Study||0
512779|NCT00938457|1253777|P1|COMPLETED|Overall Study||3
512780|NCT00938457|1253777|P1|STARTED|Overall Study||3
512781|NCT00938431|1253793|P3|NOT COMPLETED|Overall Study||8
512782|NCT00938431|1253794|P2|NOT COMPLETED|Overall Study||9
512783|NCT00938431|1253795|P1|NOT COMPLETED|Overall Study||6
512784|NCT00938431|1253793|P3|COMPLETED|Overall Study||1
512785|NCT00938431|1253794|P2|COMPLETED|Overall Study||14
512786|NCT00938431|1253795|P1|COMPLETED|Overall Study||9
512787|NCT00938431|1253793|P3|STARTED|Overall Study||9
512788|NCT00938431|1253794|P2|STARTED|Overall Study||23
512789|NCT00938431|1253795|P1|STARTED|Overall Study||15
512790|NCT00938392|1253822|P2|NOT COMPLETED|Overall Study||4
512791|NCT00938392|1253823|P1|NOT COMPLETED|Overall Study||2
512792|NCT00938392|1253822|P2|COMPLETED|Overall Study||358
512793|NCT00938392|1253823|P1|COMPLETED|Overall Study||360
512794|NCT00938392|1253822|P2|STARTED|Overall Study||362
512795|NCT00938392|1253823|P1|STARTED|Overall Study||362
512796|NCT00938366|1253849|P2|NOT COMPLETED|Overall Study||0
512797|NCT00938366|1253850|P1|NOT COMPLETED|Overall Study||1
512798|NCT00938366|1253849|P2|COMPLETED|Overall Study||9
512799|NCT00938366|1253850|P1|COMPLETED|Overall Study||8
512800|NCT00938366|1253849|P2|STARTED|Overall Study||9
512801|NCT00938366|1253850|P1|STARTED|Overall Study||9
512802|NCT00938327|1253870|P1|NOT COMPLETED|Overall Study||60
512803|NCT00938327|1253870|P1|COMPLETED|Overall Study||272
512804|NCT00938327|1253870|P1|STARTED|Overall Study||332
512805|NCT00938314|1253881|P4|NOT COMPLETED|Cohort 3||1
512806|NCT00938314|1253882|P3|NOT COMPLETED|Cohort 3||4
512807|NCT00938314|1253883|P2|NOT COMPLETED|Cohort 3||0
512808|NCT00938314|1253884|P1|NOT COMPLETED|Cohort 3||0
512809|NCT00938314|1253881|P4|COMPLETED|Cohort 3||7
512810|NCT00938314|1253882|P3|COMPLETED|Cohort 3||20
512811|NCT00938314|1253883|P2|COMPLETED|Cohort 3||0
512812|NCT00938314|1253884|P1|COMPLETED|Cohort 3||0
512813|NCT00938314|1253881|P4|STARTED|Cohort 3||8
512814|NCT00938314|1253882|P3|STARTED|Cohort 3||24
512815|NCT00938314|1253883|P2|STARTED|Cohort 3||0
512816|NCT00938314|1253884|P1|STARTED|Cohort 3||0
512817|NCT00938314|1253881|P4|NOT COMPLETED|Cohort 2||2
512818|NCT00938314|1253882|P3|NOT COMPLETED|Cohort 2||0
512819|NCT00938314|1253883|P2|NOT COMPLETED|Cohort 2||6
512820|NCT00938314|1253884|P1|NOT COMPLETED|Cohort 2||0
512821|NCT00938314|1253881|P4|COMPLETED|Cohort 2||6
512822|NCT00938314|1253882|P3|COMPLETED|Cohort 2||0
512823|NCT00938314|1253883|P2|COMPLETED|Cohort 2||18
512824|NCT00938314|1253884|P1|COMPLETED|Cohort 2||0
512825|NCT00938314|1253881|P4|STARTED|Cohort 2||8
512826|NCT00938314|1253882|P3|STARTED|Cohort 2||0
512827|NCT00938314|1253883|P2|STARTED|Cohort 2||24
512828|NCT00938314|1253884|P1|STARTED|Cohort 2||0
512829|NCT00938314|1253881|P4|NOT COMPLETED|Cohort 1||2
512830|NCT00938314|1253882|P3|NOT COMPLETED|Cohort 1||0
512831|NCT00938314|1253883|P2|NOT COMPLETED|Cohort 1||0
512832|NCT00938314|1253884|P1|NOT COMPLETED|Cohort 1||2
512833|NCT00938314|1253881|P4|COMPLETED|Cohort 1||6
512834|NCT00938314|1253882|P3|COMPLETED|Cohort 1||0
512835|NCT00938314|1253883|P2|COMPLETED|Cohort 1||0
512836|NCT00938314|1253884|P1|COMPLETED|Cohort 1||22
512837|NCT00938314|1253881|P4|STARTED|Cohort 1||8
512838|NCT00938314|1253882|P3|STARTED|Cohort 1||0
512839|NCT00938314|1253883|P2|STARTED|Cohort 1||0
512840|NCT00938314|1253884|P1|STARTED|Cohort 1||24
512841|NCT00938041|1253938|P1|NOT COMPLETED|Overall Study||27
512842|NCT00938041|1253938|P1|COMPLETED|Overall Study||5
512843|NCT00938041|1253938|P1|STARTED|Overall Study||32
512844|NCT00938015|1253947|P1|NOT COMPLETED|Overall Study||147
512845|NCT00938015|1253947|P1|COMPLETED|Overall Study||156
512846|NCT00938015|1253947|P1|STARTED|Overall Study||303
512847|NCT00937950|1253963|P1|NOT COMPLETED|Overall Study||216
512848|NCT00937950|1253963|P1|COMPLETED|Overall Study||1787
512849|NCT00937950|1253963|P1|STARTED|Overall Study||2003
512850|NCT00937937|1253979|P1|NOT COMPLETED|Overall Study||72
512851|NCT00937937|1253979|P1|COMPLETED|Overall Study||0
512852|NCT00937937|1253979|P1|STARTED|Overall Study||72
512853|NCT00937833|1253988|P2|NOT COMPLETED|Overall Study||17
512854|NCT00937833|1253989|P1|NOT COMPLETED|Overall Study||15
512855|NCT00937833|1253988|P2|COMPLETED|Overall Study||60
512856|NCT00937833|1253989|P1|COMPLETED|Overall Study||58
512857|NCT00937833|1253988|P2|STARTED|Overall Study||77
512858|NCT00937833|1253989|P1|STARTED|Overall Study||73
512859|NCT00937794|1253995|P1|NOT COMPLETED|Overall Study||0
512860|NCT00937794|1253995|P1|COMPLETED|Overall Study||33
512861|NCT00937794|1253995|P1|STARTED|Overall Study||33
512862|NCT00937768|1254002|P2|NOT COMPLETED|Overall Study||8
512863|NCT00937768|1254003|P1|NOT COMPLETED|Overall Study||8
512864|NCT00937768|1254002|P2|COMPLETED|Overall Study||0
512865|NCT00937768|1254003|P1|COMPLETED|Overall Study||0
512866|NCT00937768|1254002|P2|STARTED|Overall Study||8
512867|NCT00937768|1254003|P1|STARTED|Overall Study||8
512868|NCT00937560|1254009|P1|NOT COMPLETED|Maintenance Treatment||18
512869|NCT00937560|1254009|P1|COMPLETED|Maintenance Treatment||150
512870|NCT00937560|1254009|P1|STARTED|Maintenance Treatment||168
512871|NCT00937560|1254009|P1|NOT COMPLETED|Initial Treatment||21
512872|NCT00937560|1254009|P1|COMPLETED|Initial Treatment||168
512873|NCT00937560|1254009|P1|Received Treatment|Initial Treatment||189
512874|NCT00937560|1254009|P1|STARTED|Initial Treatment||189
512875|NCT00937547|1254020|P3|NOT COMPLETED|Overall Study||7
512876|NCT00937547|1254021|P2|NOT COMPLETED|Overall Study||6
512877|NCT00937547|1254022|P1|NOT COMPLETED|Overall Study||1
512878|NCT00937547|1254020|P3|COMPLETED|Overall Study||142
512879|NCT00937547|1254021|P2|COMPLETED|Overall Study||78
512880|NCT00937547|1254022|P1|COMPLETED|Overall Study||95
512881|NCT00937547|1254020|P3|Histological Samples|Overall Study||142
512882|NCT00937547|1254021|P2|Histological Samples|Overall Study||78
512883|NCT00937547|1254022|P1|Histological Samples|Overall Study||95
512884|NCT00937547|1254020|P3|STARTED|Overall Study||149
512885|NCT00937547|1254021|P2|STARTED|Overall Study||84
512886|NCT00937547|1254022|P1|STARTED|Overall Study||96
512887|NCT00937521|1254059|P8|NOT COMPLETED|Booster Phase||2
512888|NCT00937521|1254060|P7|NOT COMPLETED|Booster Phase||5
512889|NCT00937521|1254061|P6|NOT COMPLETED|Booster Phase||5
512890|NCT00937521|1254062|P5|NOT COMPLETED|Booster Phase||5
512891|NCT00937521|1254063|P4|NOT COMPLETED|Booster Phase||3
512892|NCT00937521|1254064|P3|NOT COMPLETED|Booster Phase||5
512893|NCT00937521|1254065|P2|NOT COMPLETED|Booster Phase||2
512894|NCT00937521|1254066|P1|NOT COMPLETED|Booster Phase||3
512895|NCT00937521|1254059|P8|COMPLETED|Booster Phase||159
512896|NCT00937521|1254060|P7|COMPLETED|Booster Phase||160
512897|NCT00937521|1254061|P6|COMPLETED|Booster Phase||160
512898|NCT00937521|1254062|P5|COMPLETED|Booster Phase||163
512899|NCT00937521|1254063|P4|COMPLETED|Booster Phase||167
512900|NCT00937521|1254064|P3|COMPLETED|Booster Phase||164
512901|NCT00937521|1254065|P2|COMPLETED|Booster Phase||161
512902|NCT00937521|1254066|P1|COMPLETED|Booster Phase||152
512903|NCT00937521|1254059|P8|Premature Withdrawal|Booster Phase||2
512904|NCT00937521|1254060|P7|Premature Withdrawal|Booster Phase||5
512905|NCT00937521|1254061|P6|Premature Withdrawal|Booster Phase||5
512906|NCT00937521|1254062|P5|Premature Withdrawal|Booster Phase||5
512907|NCT00937521|1254063|P4|Premature Withdrawal|Booster Phase||3
512908|NCT00937521|1254064|P3|Premature Withdrawal|Booster Phase||5
512909|NCT00937521|1254065|P2|Premature Withdrawal|Booster Phase||2
512910|NCT00937521|1254066|P1|Premature Withdrawal|Booster Phase||3
512911|NCT00937521|1254059|P8|STARTED|Booster Phase||161
512912|NCT00937521|1254060|P7|STARTED|Booster Phase||165
512913|NCT00937521|1254061|P6|STARTED|Booster Phase||165
512914|NCT00937521|1254062|P5|STARTED|Booster Phase||168
512915|NCT00937521|1254063|P4|STARTED|Booster Phase||170
512916|NCT00937521|1254064|P3|STARTED|Booster Phase||169
512917|NCT00937521|1254065|P2|STARTED|Booster Phase||163
512918|NCT00937521|1254066|P1|STARTED|Booster Phase||155
512919|NCT00937521|1254059|P8|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
512920|NCT00937521|1254060|P7|NOT COMPLETED|Overall Study - Prior to Booster Dose||5
512921|NCT00937521|1254061|P6|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
512922|NCT00937521|1254062|P5|NOT COMPLETED|Overall Study - Prior to Booster Dose||3
512923|NCT00937521|1254063|P4|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
512924|NCT00937521|1254064|P3|NOT COMPLETED|Overall Study - Prior to Booster Dose||6
512925|NCT00937521|1254065|P2|NOT COMPLETED|Overall Study - Prior to Booster Dose||5
512926|NCT00937521|1254066|P1|NOT COMPLETED|Overall Study - Prior to Booster Dose||3
512927|NCT00937521|1254059|P8|COMPLETED|Overall Study - Prior to Booster Dose||183
512928|NCT00937521|1254060|P7|COMPLETED|Overall Study - Prior to Booster Dose||181
512929|NCT00937521|1254061|P6|COMPLETED|Overall Study - Prior to Booster Dose||187
512930|NCT00937521|1254062|P5|COMPLETED|Overall Study - Prior to Booster Dose||188
512931|NCT00937521|1254063|P4|COMPLETED|Overall Study - Prior to Booster Dose||187
512932|NCT00937521|1254064|P3|COMPLETED|Overall Study - Prior to Booster Dose||186
512933|NCT00937521|1254065|P2|COMPLETED|Overall Study - Prior to Booster Dose||185
512934|NCT00937521|1254066|P1|COMPLETED|Overall Study - Prior to Booster Dose||185
512935|NCT00937521|1254059|P8|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
512936|NCT00937521|1254060|P7|Premature Withdrawal|Overall Study - Prior to Booster Dose||5
512937|NCT00937521|1254061|P6|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
512938|NCT00937521|1254062|P5|Premature Withdrawal|Overall Study - Prior to Booster Dose||3
512939|NCT00937521|1254063|P4|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
512940|NCT00937521|1254064|P3|Premature Withdrawal|Overall Study - Prior to Booster Dose||6
512941|NCT00937521|1254065|P2|Premature Withdrawal|Overall Study - Prior to Booster Dose||5
512942|NCT00937521|1254066|P1|Premature Withdrawal|Overall Study - Prior to Booster Dose||3
512943|NCT00937521|1254059|P8|STARTED|Overall Study - Prior to Booster Dose||184
512944|NCT00937521|1254060|P7|STARTED|Overall Study - Prior to Booster Dose||186
512945|NCT00937521|1254061|P6|STARTED|Overall Study - Prior to Booster Dose||188
512946|NCT00937521|1254062|P5|STARTED|Overall Study - Prior to Booster Dose||191
512947|NCT00937521|1254063|P4|STARTED|Overall Study - Prior to Booster Dose||188
512948|NCT00937521|1254064|P3|STARTED|Overall Study - Prior to Booster Dose||192
512949|NCT00937521|1254065|P2|STARTED|Overall Study - Prior to Booster Dose||190
512950|NCT00937521|1254066|P1|STARTED|Overall Study - Prior to Booster Dose||188
512951|NCT00937495|1254172|P1|NOT COMPLETED|Overall Study||2
512952|NCT00937495|1254172|P1|COMPLETED|Overall Study||14
512953|NCT00937495|1254172|P1|STARTED|Overall Study||16
512954|NCT00937391|1254180|P1|NOT COMPLETED|Stage 2||1
512955|NCT00937391|1254180|P1|COMPLETED|Stage 2|The number completed includes participants within the FAS and Per Protocol Set (PPS)|33
512956|NCT00937391|1254180|P1|Treated|Stage 2|Valid for Full Analysis Set; participants administered correct Magnevist dose based on body weight|34
512957|NCT00937391|1254180|P1|STARTED|Stage 2|Stage 1 and Stage 2 are independent each enrolling a different set of participants|34
512958|NCT00937391|1254180|P1|NOT COMPLETED|Stage 1||0
512959|NCT00937391|1254180|P1|COMPLETED|Stage 1||20
512960|NCT00937391|1254180|P1|Treated|Stage 1|Valid for Full Analysis Set (FAS); includes all participants administered Magnevist Injection|20
512961|NCT00937391|1254180|P1|STARTED|Stage 1||20
512962|NCT00937326|1254236|P5|NOT COMPLETED|Overall Study||5
512963|NCT00937326|1254237|P4|NOT COMPLETED|Overall Study||5
512964|NCT00937326|1254238|P3|NOT COMPLETED|Overall Study||4
512965|NCT00937326|1254239|P2|NOT COMPLETED|Overall Study||7
512966|NCT00937326|1254240|P1|NOT COMPLETED|Overall Study||3
512967|NCT00937326|1254236|P5|COMPLETED|Overall Study||40
512968|NCT00937326|1254237|P4|COMPLETED|Overall Study||40
512969|NCT00937326|1254238|P3|COMPLETED|Overall Study||42
512970|NCT00937326|1254239|P2|COMPLETED|Overall Study||38
512971|NCT00937326|1254240|P1|COMPLETED|Overall Study||43
512972|NCT00937326|1254236|P5|STARTED|Overall Study||45
512973|NCT00937326|1254237|P4|STARTED|Overall Study||45
512974|NCT00937326|1254238|P3|STARTED|Overall Study||46
512975|NCT00937326|1254239|P2|STARTED|Overall Study||45
512976|NCT00937326|1254240|P1|STARTED|Overall Study||46
512977|NCT00937235|1254468|P2|NOT COMPLETED|Overall Study||0
512978|NCT00937235|1254469|P1|NOT COMPLETED|Overall Study||0
512979|NCT00937235|1254468|P2|COMPLETED|Overall Study||70
512980|NCT00937235|1254469|P1|COMPLETED|Overall Study||72
512981|NCT00937235|1254468|P2|STARTED|Overall Study||70
512982|NCT00937235|1254469|P1|STARTED|Overall Study||72
512983|NCT00937157|1254489|P1|NOT COMPLETED|Overall Study||4
512984|NCT00937157|1254489|P1|COMPLETED|Overall Study||8
512985|NCT00937157|1254489|P1|STARTED|Overall Study||12
512986|NCT00937118|1254493|P1|NOT COMPLETED|Overall Study||0
512987|NCT00937118|1254493|P1|COMPLETED|Overall Study||41
512988|NCT00937118|1254493|P1|STARTED|Overall Study||41
512989|NCT00937105|1254502|P2|NOT COMPLETED|Overall Study||39
512990|NCT00937105|1254503|P1|NOT COMPLETED|Overall Study||40
512991|NCT00937105|1254502|P2|COMPLETED|Overall Study||70
512992|NCT00937105|1254503|P1|COMPLETED|Overall Study||69
512993|NCT00937105|1254502|P2|STARTED|Overall Study||109
512994|NCT00937105|1254503|P1|STARTED|Overall Study||109
512995|NCT00937040|1254520|P2|NOT COMPLETED|Overall Study||37
512996|NCT00937040|1254521|P1|NOT COMPLETED|Overall Study||41
512997|NCT00937040|1254520|P2|COMPLETED|Overall Study||141
512998|NCT00937040|1254521|P1|COMPLETED|Overall Study||138
512999|NCT00937040|1254520|P2|STARTED|Overall Study||178
513000|NCT00937040|1254521|P1|STARTED|Overall Study||179
513001|NCT00936975|1254563|P1|NOT COMPLETED|Overall Study||6
513002|NCT00936975|1254563|P1|COMPLETED|Overall Study||12
513003|NCT00936975|1254563|P1|STARTED|Overall Study||18
513004|NCT00936910|1254572|P1|NOT COMPLETED|Overall Study||3
513005|NCT00936910|1254572|P1|COMPLETED|Overall Study|The primary endpt. of 2 (-) cultures within 5 d of lock therapy was met for 10 patients|10
513006|NCT00936910|1254572|P1|STARTED|Overall Study||13
513007|NCT00936897|1254581|P2|NOT COMPLETED|Overall Study||60
513008|NCT00936897|1254582|P1|NOT COMPLETED|Overall Study||19
513009|NCT00936897|1254581|P2|COMPLETED|Overall Study||356
513010|NCT00936897|1254582|P1|COMPLETED|Overall Study||398
513011|NCT00936897|1254581|P2|STARTED|Overall Study|Randomized|416
513012|NCT00936897|1254582|P1|STARTED|Overall Study|Randomized|417
513013|NCT00936741|1254594|P1|NOT COMPLETED|Overall Study||9
513014|NCT00936741|1254594|P1|COMPLETED|Overall Study||21
513015|NCT00936741|1254594|P1|STARTED|Overall Study||30
513016|NCT00936715|1254599|P1|NOT COMPLETED|Overall Study||6
513017|NCT00936715|1254599|P1|COMPLETED|Overall Study||18
513018|NCT00936715|1254599|P1|STARTED|Overall Study||24
513019|NCT00936702|1254603|P1|NOT COMPLETED|Overall Study||46
513020|NCT00936702|1254603|P1|COMPLETED|Overall Study||0
513021|NCT00936702|1254603|P1|STARTED|Overall Study||46
513022|NCT00936663|1254613|P2|NOT COMPLETED|Overall Study||0
513023|NCT00936663|1254614|P1|NOT COMPLETED|Overall Study||0
513024|NCT00936663|1254613|P2|COMPLETED|Overall Study||2
513025|NCT00936663|1254614|P1|COMPLETED|Overall Study||1
513026|NCT00936663|1254613|P2|STARTED|Overall Study||2
513027|NCT00936663|1254614|P1|STARTED|Overall Study||1
513028|NCT00936598|1254636|P2|NOT COMPLETED|Overall Study||0
513029|NCT00936598|1254637|P1|NOT COMPLETED|Overall Study||2
513030|NCT00936598|1254636|P2|COMPLETED|Overall Study||1
513031|NCT00936598|1254637|P1|COMPLETED|Overall Study||2
513032|NCT00936598|1254636|P2|STARTED|Overall Study||1
513033|NCT00936598|1254637|P1|STARTED|Overall Study||4
513034|NCT00936585|1254647|P1|NOT COMPLETED|Overall Study||0
513035|NCT00936585|1254647|P1|COMPLETED|Overall Study||2
513036|NCT00936585|1254647|P1|STARTED|Overall Study||2
513037|NCT00936481|1254653|P2|NOT COMPLETED|Overall Study||0
513038|NCT00936481|1254654|P1|NOT COMPLETED|Overall Study||0
513039|NCT00936481|1254653|P2|COMPLETED|Overall Study||17
513040|NCT00936481|1254654|P1|COMPLETED|Overall Study||17
513041|NCT00936481|1254653|P2|STARTED|Overall Study||17
513042|NCT00936481|1254654|P1|STARTED|Overall Study||17
513043|NCT00936455|1254664|P2|NOT COMPLETED|Overall Study||0
513044|NCT00936455|1254665|P1|NOT COMPLETED|Overall Study||0
513045|NCT00936455|1254664|P2|COMPLETED|Overall Study||38
513046|NCT00936455|1254665|P1|COMPLETED|Overall Study||37
513047|NCT00936455|1254664|P2|STARTED|Overall Study||38
513048|NCT00936455|1254665|P1|STARTED|Overall Study||37
513049|NCT00936377|1254680|P3|NOT COMPLETED|Overall Study||0
513050|NCT00936377|1254681|P2|NOT COMPLETED|Overall Study||0
513051|NCT00936377|1254682|P1|NOT COMPLETED|Overall Study||0
513052|NCT00936377|1254680|P3|COMPLETED|Overall Study||8
513053|NCT00936377|1254681|P2|COMPLETED|Overall Study||8
513054|NCT00936377|1254682|P1|COMPLETED|Overall Study||8
513055|NCT00936377|1254680|P3|STARTED|Overall Study||8
513056|NCT00936377|1254681|P2|STARTED|Overall Study||8
513057|NCT00936377|1254682|P1|STARTED|Overall Study||8
513058|NCT00936351|1254713|P2|NOT COMPLETED|Overall Study||2
513059|NCT00936351|1254714|P1|NOT COMPLETED|Overall Study||3
513060|NCT00936351|1254713|P2|COMPLETED|Overall Study||14
513061|NCT00936351|1254714|P1|COMPLETED|Overall Study||15
513062|NCT00936351|1254713|P2|STARTED|Overall Study||16
513063|NCT00936351|1254714|P1|STARTED|Overall Study||18
513064|NCT00936221|1254726|P2|NOT COMPLETED|Overall Study||1
513065|NCT00936221|1254727|P1|NOT COMPLETED|Overall Study||1
513066|NCT00936221|1254726|P2|COMPLETED|Overall Study|10 patients ongoing at data cutoff + 35 patients who had died.|45
513067|NCT00936221|1254727|P1|COMPLETED|Overall Study|13 patients ongoing cutoff + 31 patients who had died.|44
513068|NCT00936221|1254726|P2|Received Treatment|Overall Study||45
513069|NCT00936221|1254727|P1|Received Treatment|Overall Study||44
513070|NCT00936221|1254726|P2|STARTED|Overall Study||46
513071|NCT00936221|1254727|P1|STARTED|Overall Study||45
513072|NCT00936208|1254741|P2|NOT COMPLETED|Overall Study||22
513073|NCT00936208|1254742|P1|NOT COMPLETED|Overall Study||37
513074|NCT00936208|1254741|P2|COMPLETED|Overall Study||1574
513075|NCT00936208|1254742|P1|COMPLETED|Overall Study||1462
513076|NCT00936208|1254741|P2|STARTED|Overall Study||1596
513077|NCT00936208|1254742|P1|STARTED|Overall Study||1499
513078|NCT00936117|1254760|P1|NOT COMPLETED|Overall Study||10
513079|NCT00936117|1254760|P1|COMPLETED|Overall Study|Completed 42 days on study drug|10
513080|NCT00936117|1254760|P1|STARTED|Overall Study||20
513081|NCT00936065|1254768|P3|NOT COMPLETED|Overall Study||7
513082|NCT00936065|1254769|P2|NOT COMPLETED|Overall Study||4
513083|NCT00936065|1254770|P1|NOT COMPLETED|Overall Study||4
513084|NCT00936065|1254768|P3|COMPLETED|Overall Study||12
513085|NCT00936065|1254769|P2|COMPLETED|Overall Study||16
513086|NCT00936065|1254770|P1|COMPLETED|Overall Study||17
513087|NCT00936065|1254768|P3|Study Assessments Performed|Overall Study||18
513088|NCT00936065|1254769|P2|Study Assessments Performed|Overall Study||19
513089|NCT00936065|1254770|P1|Study Assessments Performed|Overall Study||21
513090|NCT00936065|1254768|P3|Received Treatment|Overall Study||18
513091|NCT00936065|1254769|P2|Received Treatment|Overall Study||20
513092|NCT00936065|1254770|P1|Received Treatment|Overall Study||21
513093|NCT00936065|1254768|P3|STARTED|Overall Study||19
513094|NCT00936065|1254769|P2|STARTED|Overall Study||20
513095|NCT00936065|1254770|P1|STARTED|Overall Study||21
513096|NCT00935883|1254876|P2|NOT COMPLETED|Follow-Up Period||0
513097|NCT00935883|1254877|P1|NOT COMPLETED|Follow-Up Period||0
513098|NCT00935883|1254876|P2|COMPLETED|Follow-Up Period||38
513099|NCT00935883|1254877|P1|COMPLETED|Follow-Up Period||19
513100|NCT00935883|1254876|P2|STARTED|Follow-Up Period||38
513101|NCT00935883|1254877|P1|STARTED|Follow-Up Period||19
513102|NCT00935883|1254876|P2|NOT COMPLETED|Treatment Period||2
513103|NCT00935883|1254877|P1|NOT COMPLETED|Treatment Period||1
513104|NCT00935883|1254876|P2|COMPLETED|Treatment Period||38
513105|NCT00935883|1254877|P1|COMPLETED|Treatment Period||19
513106|NCT00935883|1254876|P2|STARTED|Treatment Period||40
513107|NCT00935883|1254877|P1|STARTED|Treatment Period||20
513108|NCT00935857|1254891|P2|NOT COMPLETED|Overall Study||0
513109|NCT00935857|1254892|P1|NOT COMPLETED|Overall Study||0
513110|NCT00935857|1254891|P2|COMPLETED|Overall Study||16
513111|NCT00935857|1254892|P1|COMPLETED|Overall Study||14
513112|NCT00935857|1254891|P2|STARTED|Overall Study||16
513113|NCT00935857|1254892|P1|STARTED|Overall Study||14
513114|NCT00935818|1254904|P2|NOT COMPLETED|Overall Study||100
513115|NCT00935818|1254905|P1|NOT COMPLETED|Overall Study||91
513116|NCT00935818|1254904|P2|COMPLETED|Overall Study||157
513117|NCT00935818|1254905|P1|COMPLETED|Overall Study||158
513118|NCT00935818|1254904|P2|End of Medication Phase|Overall Study||184
513119|NCT00935818|1254905|P1|End of Medication Phase|Overall Study||182
513120|NCT00935818|1254904|P2|STARTED|Overall Study||257
513121|NCT00935818|1254905|P1|STARTED|Overall Study||249
513122|NCT00935792|1254926|P3|NOT COMPLETED|Overall Study||0
513123|NCT00935792|1254927|P2|NOT COMPLETED|Overall Study||3
513124|NCT00935792|1254928|P1|NOT COMPLETED|Overall Study||1
513125|NCT00935792|1254926|P3|COMPLETED|Overall Study||12
513126|NCT00935792|1254927|P2|COMPLETED|Overall Study||6
513127|NCT00935792|1254928|P1|COMPLETED|Overall Study||6
513128|NCT00935792|1254926|P3|STARTED|Overall Study||12
513129|NCT00935792|1254927|P2|STARTED|Overall Study||9
513130|NCT00935792|1254928|P1|STARTED|Overall Study||7
513131|NCT00935766|1254945|P2|NOT COMPLETED|Overall Study||7
513132|NCT00935766|1254946|P1|NOT COMPLETED|Overall Study||7
513133|NCT00935766|1254945|P2|COMPLETED|Overall Study||27
513134|NCT00935766|1254946|P1|COMPLETED|Overall Study||35
513135|NCT00935766|1254945|P2|STARTED|Overall Study||34
513136|NCT00935766|1254946|P1|STARTED|Overall Study||42
513137|NCT00935701|1254956|P1|NOT COMPLETED|Overall Study||1
513138|NCT00935701|1254956|P1|COMPLETED|Overall Study||9
513139|NCT00935701|1254956|P1|Transition Acupressure to Acupuncture|Overall Study||9
513140|NCT00935701|1254956|P1|STARTED|Overall Study||10
513141|NCT00935649|1254963|P1|NOT COMPLETED|Overall Study||5
513142|NCT00935649|1254963|P1|COMPLETED|Overall Study||134
513143|NCT00935649|1254963|P1|STARTED|Overall Study||139
513144|NCT00935584|1254973|P2|NOT COMPLETED|Overall Study||4
513145|NCT00935584|1254974|P1|NOT COMPLETED|Overall Study||49
513146|NCT00935584|1254973|P2|COMPLETED|Overall Study||19
513147|NCT00935584|1254974|P1|COMPLETED|Overall Study||77
513148|NCT00935584|1254973|P2|STARTED|Overall Study||23
513149|NCT00935584|1254974|P1|STARTED|Overall Study|Out of 128 participants consented, 2 patients had no data collected, as the clinic was cancelled.|126
513150|NCT00935532|1254986|P2|NOT COMPLETED|Overall Study||11
513151|NCT00935532|1254987|P1|NOT COMPLETED|Overall Study||22
513152|NCT00935532|1254986|P2|COMPLETED|Overall Study||201
513153|NCT00935532|1254987|P1|COMPLETED|Overall Study||193
513154|NCT00935532|1254986|P2|STARTED|Overall Study||212
513155|NCT00935532|1254987|P1|STARTED|Overall Study||215
513156|NCT00935493|1255016|P3|NOT COMPLETED|Overall Study||1
513157|NCT00935493|1255017|P2|NOT COMPLETED|Overall Study||2
513158|NCT00935493|1255018|P1|NOT COMPLETED|Overall Study||1
513159|NCT00935493|1255016|P3|COMPLETED|Overall Study||40
513160|NCT00935493|1255017|P2|COMPLETED|Overall Study||39
513161|NCT00935493|1255018|P1|COMPLETED|Overall Study||40
513162|NCT00935493|1255016|P3|STARTED|Overall Study||41
513163|NCT00935493|1255017|P2|STARTED|Overall Study||41
513164|NCT00935493|1255018|P1|STARTED|Overall Study||41
513165|NCT00935311|1255035|P3|NOT COMPLETED|Overall Study||0
513166|NCT00935311|1255036|P2|NOT COMPLETED|Overall Study||0
513167|NCT00935311|1255037|P1|NOT COMPLETED|Overall Study||0
513168|NCT00935311|1255035|P3|COMPLETED|Overall Study||40
513169|NCT00935311|1255036|P2|COMPLETED|Overall Study||39
513170|NCT00935311|1255037|P1|COMPLETED|Overall Study||43
513171|NCT00935311|1255035|P3|STARTED|Overall Study||40
513172|NCT00935311|1255036|P2|STARTED|Overall Study||39
513173|NCT00935311|1255037|P1|STARTED|Overall Study||43
513174|NCT00935272|1255056|P2|NOT COMPLETED|Overall Study||6
513175|NCT00935272|1255057|P1|NOT COMPLETED|Overall Study||19
513176|NCT00935272|1255056|P2|COMPLETED|Overall Study||39
513177|NCT00935272|1255057|P1|COMPLETED|Overall Study||116
513178|NCT00935272|1255056|P2|STARTED|Overall Study||45
513179|NCT00935272|1255057|P1|STARTED|Overall Study||135
513180|NCT00935259|1255066|P2|NOT COMPLETED|Period 2||0
513181|NCT00935259|1255067|P1|NOT COMPLETED|Period 2||0
513182|NCT00935259|1255066|P2|COMPLETED|Period 2||14
513183|NCT00935259|1255067|P1|COMPLETED|Period 2||15
513184|NCT00935259|1255066|P2|STARTED|Period 2||14
513185|NCT00935259|1255067|P1|STARTED|Period 2||15
513186|NCT00935259|1255066|P2|NOT COMPLETED|Period 1||1
513187|NCT00935259|1255067|P1|NOT COMPLETED|Period 1||1
513188|NCT00935259|1255066|P2|COMPLETED|Period 1||14
513189|NCT00935259|1255067|P1|COMPLETED|Period 1||15
513190|NCT00935259|1255066|P2|STARTED|Period 1||15
513191|NCT00935259|1255067|P1|STARTED|Period 1||16
513192|NCT00935220|1255081|P1|NOT COMPLETED|Overall Study||2
513193|NCT00935220|1255081|P1|COMPLETED|Overall Study||39
513194|NCT00935220|1255081|P1|STARTED|Overall Study||41
513195|NCT00935064|1255095|P2|NOT COMPLETED|Overall Study||0
513196|NCT00935064|1255096|P1|NOT COMPLETED|Overall Study||0
513197|NCT00935064|1255095|P2|COMPLETED|Overall Study||30
513198|NCT00935064|1255096|P1|COMPLETED|Overall Study||30
513199|NCT00935064|1255095|P2|STARTED|Overall Study||30
513200|NCT00935064|1255096|P1|STARTED|Overall Study||30
513201|NCT00934947|1255112|P2|NOT COMPLETED|Overall Study||2
513202|NCT00934947|1255113|P1|NOT COMPLETED|Overall Study||0
513203|NCT00934947|1255112|P2|COMPLETED|Overall Study||20
513204|NCT00934947|1255113|P1|COMPLETED|Overall Study||23
513205|NCT00934947|1255112|P2|STARTED|Overall Study||22
513206|NCT00934947|1255113|P1|STARTED|Overall Study||23
513207|NCT00934921|1255127|P2|NOT COMPLETED|Second Intervention||0
513208|NCT00934921|1255128|P1|NOT COMPLETED|Second Intervention||0
513209|NCT00934921|1255127|P2|COMPLETED|Second Intervention||12
513210|NCT00934921|1255128|P1|COMPLETED|Second Intervention||12
513211|NCT00934921|1255127|P2|STARTED|Second Intervention||12
513212|NCT00934921|1255128|P1|STARTED|Second Intervention||12
513213|NCT00934921|1255127|P2|NOT COMPLETED|First Intervention||0
513214|NCT00934921|1255128|P1|NOT COMPLETED|First Intervention||0
513215|NCT00934921|1255127|P2|COMPLETED|First Intervention||12
513216|NCT00934921|1255128|P1|COMPLETED|First Intervention||12
513217|NCT00934921|1255127|P2|STARTED|First Intervention||12
513218|NCT00934921|1255128|P1|STARTED|First Intervention||12
513219|NCT00934856|1255142|P6|NOT COMPLETED|Extension Part||5
513220|NCT00934856|1255143|P5|NOT COMPLETED|Extension Part||4
513221|NCT00934856|1255144|P4|NOT COMPLETED|Extension Part||2
513222|NCT00934856|1255145|P3|NOT COMPLETED|Extension Part||0
513223|NCT00934856|1255146|P2|NOT COMPLETED|Extension Part||0
513224|NCT00934856|1255147|P1|NOT COMPLETED|Extension Part||0
513225|NCT00934856|1255142|P6|COMPLETED|Extension Part||19
513226|NCT00934856|1255143|P5|COMPLETED|Extension Part||24
513227|NCT00934856|1255144|P4|COMPLETED|Extension Part||2
513228|NCT00934856|1255145|P3|COMPLETED|Extension Part||0
513229|NCT00934856|1255146|P2|COMPLETED|Extension Part||0
513230|NCT00934856|1255147|P1|COMPLETED|Extension Part||0
513231|NCT00934856|1255142|P6|STARTED|Extension Part|New participants were enrolled in the extension part.|24
513232|NCT00934856|1255143|P5|STARTED|Extension Part|New participants were enrolled in the extension part.|28
513233|NCT00934856|1255144|P4|STARTED|Extension Part|New participants were enrolled in the extension part.|4
513234|NCT00934856|1255145|P3|STARTED|Extension Part||0
513235|NCT00934856|1255146|P2|STARTED|Extension Part||0
513236|NCT00934856|1255147|P1|STARTED|Extension Part||0
513237|NCT00934856|1255142|P6|NOT COMPLETED|Feasibility Part||3
513238|NCT00934856|1255143|P5|NOT COMPLETED|Feasibility Part||0
513239|NCT00934856|1255144|P4|NOT COMPLETED|Feasibility Part||5
513240|NCT00934856|1255145|P3|NOT COMPLETED|Feasibility Part||3
513241|NCT00934856|1255146|P2|NOT COMPLETED|Feasibility Part||5
513242|NCT00934856|1255147|P1|NOT COMPLETED|Feasibility Part||5
513243|NCT00934856|1255142|P6|COMPLETED|Feasibility Part||6
513244|NCT00934856|1255143|P5|COMPLETED|Feasibility Part||12
513245|NCT00934856|1255144|P4|COMPLETED|Feasibility Part||1
513246|NCT00934856|1255145|P3|COMPLETED|Feasibility Part||0
513247|NCT00934856|1255146|P2|COMPLETED|Feasibility Part||1
513248|NCT00934856|1255147|P1|COMPLETED|Feasibility Part||1
513249|NCT00934856|1255142|P6|STARTED|Feasibility Part||9
513250|NCT00934856|1255143|P5|STARTED|Feasibility Part||12
513251|NCT00934856|1255144|P4|STARTED|Feasibility Part||6
513252|NCT00934856|1255145|P3|STARTED|Feasibility Part||3
513253|NCT00934856|1255146|P2|STARTED|Feasibility Part||6
513254|NCT00934856|1255147|P1|STARTED|Feasibility Part||6
513255|NCT00934843|1255245|P2|NOT COMPLETED|Overall Study||1
513256|NCT00934843|1255246|P1|NOT COMPLETED|Overall Study||0
513257|NCT00934843|1255245|P2|COMPLETED|Overall Study|1 subject discontinued intervention, surgery plan changed and did not require CPB|39
513258|NCT00934843|1255246|P1|COMPLETED|Overall Study||37
513259|NCT00934843|1255245|P2|STARTED|Overall Study||40
513260|NCT00934843|1255246|P1|STARTED|Overall Study||37
513261|NCT00934791|1255262|P2|NOT COMPLETED|Overall Study||0
513262|NCT00934791|1255263|P1|NOT COMPLETED|Overall Study||1
513263|NCT00934791|1255262|P2|COMPLETED|Overall Study||0
513264|NCT00934791|1255263|P1|COMPLETED|Overall Study||0
513265|NCT00934791|1255262|P2|STARTED|Overall Study||0
513266|NCT00934791|1255263|P1|STARTED|Overall Study||1
513267|NCT00934661|1255271|P2|NOT COMPLETED|Overall Study||0
513268|NCT00934661|1255272|P1|NOT COMPLETED|Overall Study||1
513269|NCT00934661|1255271|P2|COMPLETED|Overall Study||20
513270|NCT00934661|1255272|P1|COMPLETED|Overall Study||19
513271|NCT00934661|1255271|P2|STARTED|Overall Study||20
513272|NCT00934661|1255272|P1|STARTED|Overall Study||20
513273|NCT00934648|1255292|P1|NOT COMPLETED|Overall Study||9
513274|NCT00934648|1255292|P1|COMPLETED|Overall Study||6
513275|NCT00934648|1255292|P1|STARTED|Overall Study||15
513276|NCT00934635|1255308|P9|NOT COMPLETED|Overall Study||0
513277|NCT00934635|1255309|P8|NOT COMPLETED|Overall Study||0
513278|NCT00934635|1255310|P7|NOT COMPLETED|Overall Study||0
513279|NCT00934635|1255311|P6|NOT COMPLETED|Overall Study||0
513280|NCT00934635|1255312|P5|NOT COMPLETED|Overall Study||0
513281|NCT00934635|1255313|P4|NOT COMPLETED|Overall Study||0
513282|NCT00934635|1255314|P3|NOT COMPLETED|Overall Study||0
513283|NCT00934635|1255315|P2|NOT COMPLETED|Overall Study||0
513284|NCT00934635|1255316|P1|NOT COMPLETED|Overall Study||0
513285|NCT00934635|1255308|P9|COMPLETED|Overall Study||1
513286|NCT00934635|1255309|P8|COMPLETED|Overall Study||0
513287|NCT00934635|1255310|P7|COMPLETED|Overall Study||0
513288|NCT00934635|1255311|P6|COMPLETED|Overall Study||0
513289|NCT00934635|1255312|P5|COMPLETED|Overall Study||0
513290|NCT00934635|1255313|P4|COMPLETED|Overall Study||0
513291|NCT00934635|1255314|P3|COMPLETED|Overall Study||0
513292|NCT00934635|1255315|P2|COMPLETED|Overall Study||1
513293|NCT00934635|1255316|P1|COMPLETED|Overall Study||0
513294|NCT00934635|1255308|P9|STARTED|Overall Study||1
513295|NCT00934635|1255309|P8|STARTED|Overall Study||0
513296|NCT00934635|1255310|P7|STARTED|Overall Study||0
513297|NCT00934635|1255311|P6|STARTED|Overall Study||0
513298|NCT00934635|1255312|P5|STARTED|Overall Study||0
513299|NCT00934635|1255313|P4|STARTED|Overall Study||0
513300|NCT00934635|1255314|P3|STARTED|Overall Study||0
513301|NCT00934635|1255315|P2|STARTED|Overall Study||1
513302|NCT00934635|1255316|P1|STARTED|Overall Study||0
513303|NCT00934622|1255336|P1|NOT COMPLETED|Overall Study||8
513304|NCT00934622|1255336|P1|COMPLETED|Overall Study||68
513305|NCT00934622|1255336|P1|STARTED|Overall Study||76
513306|NCT00934596|1255343|P2|NOT COMPLETED|Overall Study||0
513307|NCT00934596|1255344|P1|NOT COMPLETED|Overall Study||0
513308|NCT00934596|1255343|P2|COMPLETED|Overall Study||10
513309|NCT00934596|1255344|P1|COMPLETED|Overall Study||10
513310|NCT00934596|1255343|P2|STARTED|Overall Study||10
513311|NCT00934596|1255344|P1|STARTED|Overall Study|Twenty patients were prospectively randomly assigned to the two arms|10
513312|NCT00934544|1255374|P2|NOT COMPLETED|Overall Study||42
513313|NCT00934544|1255375|P1|NOT COMPLETED|Overall Study||55
513314|NCT00934544|1255374|P2|COMPLETED|Overall Study|Participants ongoing in the randomized treatment phase for the BAT group|31
513315|NCT00934544|1255375|P1|COMPLETED|Overall Study|Participants ongoing in the randomized treatment phase for INC424/INCB018424 group|91
513316|NCT00934544|1255374|P2|STARTED|Overall Study||73
513317|NCT00934544|1255375|P1|STARTED|Overall Study||146
513318|NCT00934440|1255389|P1|NOT COMPLETED|Overall Study||1
513319|NCT00934440|1255389|P1|COMPLETED|Overall Study||10
513320|NCT00934440|1255389|P1|STARTED|Overall Study||11
513321|NCT00934375|1255396|P2|NOT COMPLETED|Overall Study||22
513322|NCT00934375|1255397|P1|NOT COMPLETED|Overall Study||13
513323|NCT00934375|1255396|P2|COMPLETED|Overall Study||55
513324|NCT00934375|1255397|P1|COMPLETED|Overall Study||55
513325|NCT00934375|1255396|P2|STARTED|Overall Study||77
513326|NCT00934375|1255397|P1|STARTED|Overall Study||68
513327|NCT00934362|1255405|P2|NOT COMPLETED|Overall Study||0
513328|NCT00934362|1255406|P1|NOT COMPLETED|Overall Study||1
513329|NCT00934362|1255405|P2|COMPLETED|Overall Study||8
513330|NCT00934362|1255406|P1|COMPLETED|Overall Study||7
513331|NCT00934362|1255405|P2|STARTED|Overall Study||8
513332|NCT00934362|1255406|P1|STARTED|Overall Study||8
513333|NCT00934180|1255416|P2|NOT COMPLETED|Second Intervention||0
513334|NCT00934180|1255417|P1|NOT COMPLETED|Second Intervention||0
513335|NCT00934180|1255416|P2|COMPLETED|Second Intervention||12
513336|NCT00934180|1255417|P1|COMPLETED|Second Intervention||12
513337|NCT00934180|1255416|P2|STARTED|Second Intervention||12
513338|NCT00934180|1255417|P1|STARTED|Second Intervention||12
513339|NCT00934180|1255416|P2|NOT COMPLETED|First Intervention||0
513340|NCT00934180|1255417|P1|NOT COMPLETED|First Intervention||0
513341|NCT00934180|1255416|P2|COMPLETED|First Intervention||12
513342|NCT00934180|1255417|P1|COMPLETED|First Intervention||12
513343|NCT00934180|1255416|P2|STARTED|First Intervention||12
513344|NCT00934180|1255417|P1|STARTED|First Intervention||12
513345|NCT00934141|1255429|P4|NOT COMPLETED|Overall Study||3
513346|NCT00934141|1255430|P3|NOT COMPLETED|Overall Study||0
513347|NCT00934141|1255431|P2|NOT COMPLETED|Overall Study||3
513348|NCT00934141|1255432|P1|NOT COMPLETED|Overall Study||4
513349|NCT00934141|1255429|P4|COMPLETED|Overall Study||51
513350|NCT00934141|1255430|P3|COMPLETED|Overall Study||48
513351|NCT00934141|1255431|P2|COMPLETED|Overall Study||47
513352|NCT00934141|1255432|P1|COMPLETED|Overall Study||45
513353|NCT00934141|1255429|P4|STARTED|Overall Study||54
513354|NCT00934141|1255430|P3|STARTED|Overall Study||48
513355|NCT00934141|1255431|P2|STARTED|Overall Study||50
513356|NCT00934141|1255432|P1|STARTED|Overall Study||49
513357|NCT00934128|1255456|P2|NOT COMPLETED|Second Intervention (2 Hours)||3
513358|NCT00934128|1255457|P1|NOT COMPLETED|Second Intervention (2 Hours)||0
513359|NCT00934128|1255456|P2|COMPLETED|Second Intervention (2 Hours)||5
513360|NCT00934128|1255457|P1|COMPLETED|Second Intervention (2 Hours)||3
513361|NCT00934128|1255456|P2|STARTED|Second Intervention (2 Hours)||8
513362|NCT00934128|1255457|P1|STARTED|Second Intervention (2 Hours)||3
513363|NCT00934128|1255456|P2|NOT COMPLETED|Washout Period (1 Hour)||5
513364|NCT00934128|1255457|P1|NOT COMPLETED|Washout Period (1 Hour)||7
513365|NCT00934128|1255456|P2|COMPLETED|Washout Period (1 Hour)||8
513366|NCT00934128|1255457|P1|COMPLETED|Washout Period (1 Hour)||3
513367|NCT00934128|1255456|P2|STARTED|Washout Period (1 Hour)||13
513368|NCT00934128|1255457|P1|STARTED|Washout Period (1 Hour)||10
513369|NCT00934128|1255456|P2|NOT COMPLETED|First Intervention (2 Hours)||2
513370|NCT00934128|1255457|P1|NOT COMPLETED|First Intervention (2 Hours)||5
513371|NCT00934128|1255456|P2|COMPLETED|First Intervention (2 Hours)||13
513372|NCT00934128|1255457|P1|COMPLETED|First Intervention (2 Hours)||10
513373|NCT00934128|1255456|P2|STARTED|First Intervention (2 Hours)||15
513374|NCT00934128|1255457|P1|STARTED|First Intervention (2 Hours)||15
513375|NCT00934102|1255465|P3|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
513376|NCT00934102|1255466|P2|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
513377|NCT00934102|1255467|P1|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
513378|NCT00934102|1255465|P3|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
513379|NCT00934102|1255466|P2|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
513380|NCT00934102|1255467|P1|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
513381|NCT00934102|1255465|P3|STARTED|Period 2, 7 Days/6 Nights of Wear||15
513382|NCT00934102|1255466|P2|STARTED|Period 2, 7 Days/6 Nights of Wear||15
513383|NCT00934102|1255467|P1|STARTED|Period 2, 7 Days/6 Nights of Wear||15
513384|NCT00934102|1255465|P3|NOT COMPLETED|Period 1, One Night of Wear||0
513385|NCT00934102|1255466|P2|NOT COMPLETED|Period 1, One Night of Wear||0
513386|NCT00934102|1255467|P1|NOT COMPLETED|Period 1, One Night of Wear||1
513387|NCT00934102|1255465|P3|COMPLETED|Period 1, One Night of Wear||15
513388|NCT00934102|1255466|P2|COMPLETED|Period 1, One Night of Wear||15
513389|NCT00934102|1255467|P1|COMPLETED|Period 1, One Night of Wear||15
513390|NCT00934102|1255465|P3|STARTED|Period 1, One Night of Wear||15
513391|NCT00934102|1255466|P2|STARTED|Period 1, One Night of Wear||15
513392|NCT00934102|1255467|P1|STARTED|Period 1, One Night of Wear||16
513393|NCT00934050|1255481|P6|NOT COMPLETED|Enrolled After 15 Dec 2009||4
513394|NCT00934050|1255482|P5|NOT COMPLETED|Enrolled After 15 Dec 2009||7
513395|NCT00934050|1255483|P4|NOT COMPLETED|Enrolled After 15 Dec 2009||0
513396|NCT00934050|1255484|P3|NOT COMPLETED|Enrolled After 15 Dec 2009||0
513397|NCT00934050|1255485|P2|NOT COMPLETED|Enrolled After 15 Dec 2009||0
513398|NCT00934050|1255486|P1|NOT COMPLETED|Enrolled After 15 Dec 2009||0
513399|NCT00934050|1255481|P6|COMPLETED|Enrolled After 15 Dec 2009||23
513400|NCT00934050|1255482|P5|COMPLETED|Enrolled After 15 Dec 2009||19
513401|NCT00934050|1255483|P4|COMPLETED|Enrolled After 15 Dec 2009||0
513402|NCT00934050|1255484|P3|COMPLETED|Enrolled After 15 Dec 2009||0
513403|NCT00934050|1255485|P2|COMPLETED|Enrolled After 15 Dec 2009||0
513404|NCT00934050|1255486|P1|COMPLETED|Enrolled After 15 Dec 2009||0
513405|NCT00934050|1255481|P6|STARTED|Enrolled After 15 Dec 2009||27
513406|NCT00934050|1255482|P5|STARTED|Enrolled After 15 Dec 2009||26
513407|NCT00934050|1255483|P4|STARTED|Enrolled After 15 Dec 2009||0
513408|NCT00934050|1255484|P3|STARTED|Enrolled After 15 Dec 2009||0
513409|NCT00934050|1255485|P2|STARTED|Enrolled After 15 Dec 2009||0
513410|NCT00934050|1255486|P1|STARTED|Enrolled After 15 Dec 2009||0
513411|NCT00934050|1255481|P6|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0
513412|NCT00934050|1255482|P5|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0
513413|NCT00934050|1255483|P4|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||14
513414|NCT00934050|1255484|P3|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
513415|NCT00934050|1255485|P2|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
513416|NCT00934050|1255486|P1|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
513417|NCT00934050|1255481|P6|COMPLETED|Enrolled Prior to 15 Dec 2009||0
513418|NCT00934050|1255482|P5|COMPLETED|Enrolled Prior to 15 Dec 2009||0
513419|NCT00934050|1255483|P4|COMPLETED|Enrolled Prior to 15 Dec 2009||0
513420|NCT00934050|1255484|P3|COMPLETED|Enrolled Prior to 15 Dec 2009||0
513421|NCT00934050|1255485|P2|COMPLETED|Enrolled Prior to 15 Dec 2009||0
513422|NCT00934050|1255486|P1|COMPLETED|Enrolled Prior to 15 Dec 2009||0
513423|NCT00934050|1255481|P6|STARTED|Enrolled Prior to 15 Dec 2009||0
513424|NCT00934050|1255482|P5|STARTED|Enrolled Prior to 15 Dec 2009||0
513425|NCT00934050|1255483|P4|STARTED|Enrolled Prior to 15 Dec 2009||14
513426|NCT00934050|1255484|P3|STARTED|Enrolled Prior to 15 Dec 2009||12
513427|NCT00934050|1255485|P2|STARTED|Enrolled Prior to 15 Dec 2009||12
513428|NCT00934050|1255486|P1|STARTED|Enrolled Prior to 15 Dec 2009||12
513429|NCT00933933|1255501|P3|NOT COMPLETED|Pediatric From 2 to 21 Years||0
513430|NCT00933933|1255502|P2|NOT COMPLETED|Pediatric From 2 to 21 Years||0
513431|NCT00933933|1255503|P1|NOT COMPLETED|Pediatric From 2 to 21 Years||0
513432|NCT00933933|1255501|P3|COMPLETED|Pediatric From 2 to 21 Years|Specimens from individuals 16-21 years included reactivity for general population or pregnant women|0
513433|NCT00933933|1255502|P2|COMPLETED|Pediatric From 2 to 21 Years||64
513434|NCT00933933|1255503|P1|COMPLETED|Pediatric From 2 to 21 Years||588
513435|NCT00933933|1255501|P3|STARTED|Pediatric From 2 to 21 Years|Specimens from individuals 16-21 years included reactivity for general population or pregnant women.|0
513436|NCT00933933|1255502|P2|STARTED|Pediatric From 2 to 21 Years||64
513437|NCT00933933|1255503|P1|STARTED|Pediatric From 2 to 21 Years||588
513438|NCT00933933|1255501|P3|NOT COMPLETED|Pregnant Females Between 16-44 Years||0
513439|NCT00933933|1255502|P2|NOT COMPLETED|Pregnant Females Between 16-44 Years||2
513440|NCT00933933|1255503|P1|NOT COMPLETED|Pregnant Females Between 16-44 Years||0
513441|NCT00933933|1255501|P3|COMPLETED|Pregnant Females Between 16-44 Years||203
513442|NCT00933933|1255502|P2|COMPLETED|Pregnant Females Between 16-44 Years||65
513443|NCT00933933|1255503|P1|COMPLETED|Pregnant Females Between 16-44 Years||448
513444|NCT00933933|1255501|P3|STARTED|Pregnant Females Between 16-44 Years||203
513445|NCT00933933|1255502|P2|STARTED|Pregnant Females Between 16-44 Years||67
513446|NCT00933933|1255503|P1|STARTED|Pregnant Females Between 16-44 Years||448
513447|NCT00933933|1255501|P3|NOT COMPLETED|General Population From 16 to 89 Years||0
513448|NCT00933933|1255502|P2|NOT COMPLETED|General Population From 16 to 89 Years||20
513449|NCT00933933|1255503|P1|NOT COMPLETED|General Population From 16 to 89 Years||0
513450|NCT00933933|1255501|P3|COMPLETED|General Population From 16 to 89 Years||1206
513451|NCT00933933|1255502|P2|COMPLETED|General Population From 16 to 89 Years||1267
513452|NCT00933933|1255503|P1|COMPLETED|General Population From 16 to 89 Years||6164
513453|NCT00933933|1255501|P3|STARTED|General Population From 16 to 89 Years||1206
513454|NCT00933933|1255502|P2|STARTED|General Population From 16 to 89 Years||1287
513455|NCT00933933|1255503|P1|STARTED|General Population From 16 to 89 Years||6164
513456|NCT00933686|1255521|P2|NOT COMPLETED|Overall Study||11
513457|NCT00933686|1255522|P1|NOT COMPLETED|Overall Study||10
513458|NCT00933686|1255521|P2|COMPLETED|Overall Study||47
513459|NCT00933686|1255522|P1|COMPLETED|Overall Study||45
513460|NCT00933686|1255521|P2|STARTED|Overall Study||58
513461|NCT00933686|1255522|P1|STARTED|Overall Study||55
513462|NCT00933608|1255542|P2|NOT COMPLETED|Overall Study||2
513463|NCT00933608|1255543|P1|NOT COMPLETED|Overall Study||5
513464|NCT00933608|1255542|P2|COMPLETED|Overall Study||8
513465|NCT00933608|1255543|P1|COMPLETED|Overall Study||2
513466|NCT00933608|1255542|P2|STARTED|Overall Study||10
513467|NCT00933608|1255543|P1|STARTED|Overall Study||7
513468|NCT00933543|1255551|P2|NOT COMPLETED|Overall Study||7
513469|NCT00933543|1255552|P1|NOT COMPLETED|Overall Study||3
513470|NCT00933543|1255551|P2|COMPLETED|Overall Study||46
513471|NCT00933543|1255552|P1|COMPLETED|Overall Study||51
513472|NCT00933543|1255551|P2|STARTED|Overall Study||53
513473|NCT00933543|1255552|P1|STARTED|Overall Study||54
513474|NCT00933491|1255610|P2|NOT COMPLETED|Overall Study||0
513475|NCT00933491|1255611|P1|NOT COMPLETED|Overall Study||0
513476|NCT00933491|1255610|P2|COMPLETED|Overall Study||18
513477|NCT00933491|1255611|P1|COMPLETED|Overall Study||14
513478|NCT00933491|1255610|P2|STARTED|Overall Study||18
513479|NCT00933491|1255611|P1|STARTED|Overall Study||14
513480|NCT00933335|1255621|P2|NOT COMPLETED|Overall Study||16
513481|NCT00933335|1255622|P1|NOT COMPLETED|Overall Study||2
513482|NCT00933335|1255621|P2|COMPLETED|Overall Study||20
513483|NCT00933335|1255622|P1|COMPLETED|Overall Study||0
513484|NCT00933335|1255621|P2|STARTED|Overall Study|35/36 participants who received 3 cycles of fludarabine later received a DD and TD of TST/I 131 TST.|36
513485|NCT00933335|1255622|P1|STARTED|Overall Study||2
513486|NCT00933270|1255692|P1|NOT COMPLETED|Overall Study||87
513487|NCT00933270|1255692|P1|COMPLETED|Overall Study||177
513488|NCT00933270|1255692|P1|STARTED|Overall Study|ITT population|264
513489|NCT00933244|1255786|P3|NOT COMPLETED|Overall Study||3
513490|NCT00933244|1255787|P2|NOT COMPLETED|Overall Study||1
513491|NCT00933244|1255788|P1|NOT COMPLETED|Overall Study||5
513492|NCT00933244|1255786|P3|COMPLETED|Overall Study||73
513493|NCT00933244|1255787|P2|COMPLETED|Overall Study||74
513494|NCT00933244|1255788|P1|COMPLETED|Overall Study||74
513495|NCT00933244|1255786|P3|STARTED|Overall Study||76
513496|NCT00933244|1255787|P2|STARTED|Overall Study||75
513497|NCT00933244|1255788|P1|STARTED|Overall Study||79
513498|NCT00933166|1255805|P1|NOT COMPLETED|Overall Study||18
513499|NCT00933166|1255805|P1|COMPLETED|Overall Study||151
513500|NCT00933166|1255805|P1|STARTED|Overall Study||169
513501|NCT00932893|1255811|P2|NOT COMPLETED|Overall Study||170
513502|NCT00932893|1255812|P1|NOT COMPLETED|Overall Study||133
513503|NCT00932893|1255811|P2|COMPLETED|Overall Study||4
513504|NCT00932893|1255812|P1|COMPLETED|Overall Study||40
513505|NCT00932893|1255811|P2|Treated|Overall Study||171
513506|NCT00932893|1255812|P1|Treated|Overall Study||172
513507|NCT00932893|1255811|P2|STARTED|Overall Study||174
513508|NCT00932893|1255812|P1|STARTED|Overall Study||173
513509|NCT00932828|1255843|P1|NOT COMPLETED|Overall Study||5
513510|NCT00932828|1255843|P1|COMPLETED|Overall Study|5 subjects who did not complete the protocol were considered in an ITT analysis.|32
513511|NCT00932828|1255843|P1|STARTED|Overall Study||37
513512|NCT00932659|1255849|P1|NOT COMPLETED|Overall Study||0
513513|NCT00932659|1255849|P1|COMPLETED|Overall Study||8
513514|NCT00932659|1255849|P1|STARTED|Overall Study||8
513515|NCT00932646|1255854|P4|NOT COMPLETED|Overall Study||1
513516|NCT00932646|1255855|P3|NOT COMPLETED|Overall Study||4
513517|NCT00932646|1255856|P2|NOT COMPLETED|Overall Study||3
513518|NCT00932646|1255857|P1|NOT COMPLETED|Overall Study||5
513519|NCT00932646|1255854|P4|COMPLETED|Overall Study||24
513520|NCT00932646|1255855|P3|COMPLETED|Overall Study||21
513521|NCT00932646|1255856|P2|COMPLETED|Overall Study||22
513522|NCT00932646|1255857|P1|COMPLETED|Overall Study||20
513523|NCT00932646|1255854|P4|STARTED|Overall Study||25
513524|NCT00932646|1255855|P3|STARTED|Overall Study||25
513525|NCT00932646|1255856|P2|STARTED|Overall Study||25
513526|NCT00932646|1255857|P1|STARTED|Overall Study||25
513527|NCT00932620|1255913|P2|NOT COMPLETED|Overall Study||0
513528|NCT00932620|1255914|P1|NOT COMPLETED|Overall Study||0
513529|NCT00932620|1255913|P2|COMPLETED|Overall Study||50
513530|NCT00932620|1255914|P1|COMPLETED|Overall Study||50
513531|NCT00932620|1255913|P2|STARTED|Overall Study||50
513532|NCT00932620|1255914|P1|STARTED|Overall Study||50
513533|NCT00932477|1255922|P6|NOT COMPLETED|Treatment 3||0
513534|NCT00932477|1255923|P5|NOT COMPLETED|Treatment 3||0
513535|NCT00932477|1255924|P4|NOT COMPLETED|Treatment 3||0
513536|NCT00932477|1255925|P3|NOT COMPLETED|Treatment 3||0
513537|NCT00932477|1255926|P2|NOT COMPLETED|Treatment 3||0
513538|NCT00932477|1255927|P1|NOT COMPLETED|Treatment 3||0
513539|NCT00932477|1255922|P6|COMPLETED|Treatment 3||8
513540|NCT00932477|1255923|P5|COMPLETED|Treatment 3||8
513541|NCT00932477|1255924|P4|COMPLETED|Treatment 3||7
513542|NCT00932477|1255925|P3|COMPLETED|Treatment 3||9
513543|NCT00932477|1255926|P2|COMPLETED|Treatment 3||8
513544|NCT00932477|1255927|P1|COMPLETED|Treatment 3||7
513545|NCT00932477|1255922|P6|STARTED|Treatment 3||8
513546|NCT00932477|1255923|P5|STARTED|Treatment 3||8
513547|NCT00932477|1255924|P4|STARTED|Treatment 3||7
513548|NCT00932477|1255925|P3|STARTED|Treatment 3||9
513549|NCT00932477|1255926|P2|STARTED|Treatment 3||8
513550|NCT00932477|1255927|P1|STARTED|Treatment 3||7
513551|NCT00932477|1255922|P6|NOT COMPLETED|Treatment 2||0
513552|NCT00932477|1255923|P5|NOT COMPLETED|Treatment 2||0
513553|NCT00932477|1255924|P4|NOT COMPLETED|Treatment 2||0
513554|NCT00932477|1255925|P3|NOT COMPLETED|Treatment 2||0
513555|NCT00932477|1255926|P2|NOT COMPLETED|Treatment 2||0
513556|NCT00932477|1255927|P1|NOT COMPLETED|Treatment 2||0
513557|NCT00932477|1255922|P6|COMPLETED|Treatment 2||8
513558|NCT00932477|1255923|P5|COMPLETED|Treatment 2||8
513559|NCT00932477|1255924|P4|COMPLETED|Treatment 2||7
513560|NCT00932477|1255925|P3|COMPLETED|Treatment 2||9
513561|NCT00932477|1255926|P2|COMPLETED|Treatment 2||8
513562|NCT00932477|1255927|P1|COMPLETED|Treatment 2||7
513563|NCT00932477|1255922|P6|STARTED|Treatment 2||8
513564|NCT00932477|1255923|P5|STARTED|Treatment 2||8
513565|NCT00932477|1255924|P4|STARTED|Treatment 2||7
513566|NCT00932477|1255925|P3|STARTED|Treatment 2||9
513567|NCT00932477|1255926|P2|STARTED|Treatment 2||8
513568|NCT00932477|1255927|P1|STARTED|Treatment 2||7
513569|NCT00932477|1255922|P6|NOT COMPLETED|Treatment 1||0
513570|NCT00932477|1255923|P5|NOT COMPLETED|Treatment 1||0
513571|NCT00932477|1255924|P4|NOT COMPLETED|Treatment 1||0
513572|NCT00932477|1255925|P3|NOT COMPLETED|Treatment 1||0
513573|NCT00932477|1255926|P2|NOT COMPLETED|Treatment 1||0
513574|NCT00932477|1255927|P1|NOT COMPLETED|Treatment 1||0
513575|NCT00932477|1255922|P6|COMPLETED|Treatment 1||8
513576|NCT00932477|1255923|P5|COMPLETED|Treatment 1||8
513577|NCT00932477|1255924|P4|COMPLETED|Treatment 1||7
513578|NCT00932477|1255925|P3|COMPLETED|Treatment 1||9
513579|NCT00932477|1255926|P2|COMPLETED|Treatment 1||8
513580|NCT00932477|1255927|P1|COMPLETED|Treatment 1||7
513581|NCT00932477|1255922|P6|STARTED|Treatment 1||8
513582|NCT00932477|1255923|P5|STARTED|Treatment 1||8
513583|NCT00932477|1255924|P4|STARTED|Treatment 1||7
513584|NCT00932477|1255925|P3|STARTED|Treatment 1||9
513585|NCT00932477|1255926|P2|STARTED|Treatment 1||8
513586|NCT00932477|1255927|P1|STARTED|Treatment 1||7
513587|NCT00932451|1255944|P1|NOT COMPLETED|Overall Study||822
513588|NCT00932451|1255944|P1|COMPLETED|Overall Study||244
513589|NCT00932451|1255944|P1|STARTED|Overall Study||1066
513590|NCT00932425|1255968|P2|NOT COMPLETED|Overall Study||2
513591|NCT00932425|1255969|P1|NOT COMPLETED|Overall Study||0
513592|NCT00932425|1255968|P2|COMPLETED|Overall Study||18
513593|NCT00932425|1255969|P1|COMPLETED|Overall Study||20
513594|NCT00932425|1255968|P2|STARTED|Overall Study||20
513595|NCT00932425|1255969|P1|STARTED|Overall Study||20
513596|NCT00932399|1255984|P2|NOT COMPLETED|Overall Study||0
513597|NCT00932399|1255985|P1|NOT COMPLETED|Overall Study||0
513598|NCT00932399|1255984|P2|COMPLETED|Overall Study||3790
513599|NCT00932399|1255985|P1|COMPLETED|Overall Study||759
513600|NCT00932399|1255984|P2|STARTED|Overall Study||3790
513601|NCT00932399|1255985|P1|STARTED|Overall Study||759
513602|NCT00932373|1256002|P11|NOT COMPLETED|Overall Study||3
513603|NCT00932373|1256003|P10|NOT COMPLETED|Overall Study||13
513604|NCT00932373|1256004|P9|NOT COMPLETED|Overall Study||2
513605|NCT00932373|1256005|P8|NOT COMPLETED|Overall Study||3
513606|NCT00932373|1256006|P7|NOT COMPLETED|Overall Study||1
513607|NCT00932373|1256007|P6|NOT COMPLETED|Overall Study||3
513608|NCT00932373|1256008|P5|NOT COMPLETED|Overall Study||14
513609|NCT00932373|1256009|P4|NOT COMPLETED|Overall Study||0
513610|NCT00932373|1256010|P3|NOT COMPLETED|Overall Study||1
513611|NCT00932373|1256011|P2|NOT COMPLETED|Overall Study||1
513612|NCT00932373|1256012|P1|NOT COMPLETED|Overall Study||3
513613|NCT00932373|1256002|P11|COMPLETED|Overall Study||0
513614|NCT00932373|1256003|P10|COMPLETED|Overall Study||3
513615|NCT00932373|1256004|P9|COMPLETED|Overall Study||1
513616|NCT00932373|1256005|P8|COMPLETED|Overall Study||0
513617|NCT00932373|1256006|P7|COMPLETED|Overall Study||2
513618|NCT00932373|1256007|P6|COMPLETED|Overall Study||0
513619|NCT00932373|1256008|P5|COMPLETED|Overall Study||1
513620|NCT00932373|1256009|P4|COMPLETED|Overall Study||1
513621|NCT00932373|1256010|P3|COMPLETED|Overall Study||0
513622|NCT00932373|1256011|P2|COMPLETED|Overall Study||0
513623|NCT00932373|1256012|P1|COMPLETED|Overall Study||0
513624|NCT00932373|1256002|P11|STARTED|Overall Study||3
513625|NCT00932373|1256003|P10|STARTED|Overall Study||16
513626|NCT00932373|1256004|P9|STARTED|Overall Study||3
513627|NCT00932373|1256005|P8|STARTED|Overall Study||3
513628|NCT00932373|1256006|P7|STARTED|Overall Study||3
513629|NCT00932373|1256007|P6|STARTED|Overall Study||3
513630|NCT00932373|1256008|P5|STARTED|Overall Study||15
513631|NCT00932373|1256009|P4|STARTED|Overall Study||1
513632|NCT00932373|1256010|P3|STARTED|Overall Study||1
513633|NCT00932373|1256011|P2|STARTED|Overall Study||1
513634|NCT00932373|1256012|P1|STARTED|Overall Study||3
513635|NCT00932321|1256114|P2|NOT COMPLETED|Overall Study||46
513636|NCT00932321|1256115|P1|NOT COMPLETED|Overall Study||171
513637|NCT00932321|1256114|P2|COMPLETED|Overall Study||141
513638|NCT00932321|1256115|P1|COMPLETED|Overall Study||580
513639|NCT00932321|1256114|P2|MITT Population|Overall Study||181
513640|NCT00932321|1256115|P1|MITT Population|Overall Study||705
513641|NCT00932321|1256114|P2|STARTED|Overall Study||187
513642|NCT00932321|1256115|P1|STARTED|Overall Study||751
513643|NCT00932282|1256125|P2|NOT COMPLETED|OIT Maintenance Phase||2
513644|NCT00932282|1256126|P1|NOT COMPLETED|OIT Maintenance Phase||1
513645|NCT00932282|1256125|P2|COMPLETED|OIT Maintenance Phase||2
513646|NCT00932282|1256126|P1|COMPLETED|OIT Maintenance Phase||4
513647|NCT00932282|1256125|P2|STARTED|OIT Maintenance Phase||4
513648|NCT00932282|1256126|P1|STARTED|OIT Maintenance Phase||5
513649|NCT00932282|1256125|P2|NOT COMPLETED|Biweekly OIT Buildup Phase||1
513650|NCT00932282|1256126|P1|NOT COMPLETED|Biweekly OIT Buildup Phase||1
513651|NCT00932282|1256125|P2|COMPLETED|Biweekly OIT Buildup Phase||4
513652|NCT00932282|1256126|P1|COMPLETED|Biweekly OIT Buildup Phase||5
513653|NCT00932282|1256125|P2|STARTED|Biweekly OIT Buildup Phase||5
513654|NCT00932282|1256126|P1|STARTED|Biweekly OIT Buildup Phase||6
513655|NCT00932282|1256125|P2|NOT COMPLETED|Modified OIT Rush Desensitization Phase||0
513656|NCT00932282|1256126|P1|NOT COMPLETED|Modified OIT Rush Desensitization Phase||0
513657|NCT00932282|1256125|P2|COMPLETED|Modified OIT Rush Desensitization Phase||5
513658|NCT00932282|1256126|P1|COMPLETED|Modified OIT Rush Desensitization Phase||6
513659|NCT00932282|1256125|P2|STARTED|Modified OIT Rush Desensitization Phase||5
513660|NCT00932282|1256126|P1|STARTED|Modified OIT Rush Desensitization Phase||6
513661|NCT00932282|1256125|P2|NOT COMPLETED|Pre-OIT Anti-IgE Therapy Phase||1
513662|NCT00932282|1256126|P1|NOT COMPLETED|Pre-OIT Anti-IgE Therapy Phase||1
513663|NCT00932282|1256125|P2|COMPLETED|Pre-OIT Anti-IgE Therapy Phase||5
513664|NCT00932282|1256126|P1|COMPLETED|Pre-OIT Anti-IgE Therapy Phase||6
513665|NCT00932282|1256125|P2|STARTED|Pre-OIT Anti-IgE Therapy Phase||6
513666|NCT00932282|1256126|P1|STARTED|Pre-OIT Anti-IgE Therapy Phase||7
513667|NCT00932165|1256140|P1|NOT COMPLETED|Overall Study||1
513668|NCT00932165|1256140|P1|COMPLETED|Overall Study||450
513669|NCT00932165|1256140|P1|STARTED|Overall Study||451
513670|NCT00932152|1256153|P2|NOT COMPLETED|Overall Study||2
513671|NCT00932152|1256154|P1|NOT COMPLETED|Overall Study||1
513672|NCT00932152|1256153|P2|COMPLETED|Overall Study||0
513673|NCT00932152|1256154|P1|COMPLETED|Overall Study||0
513674|NCT00932152|1256153|P2|STARTED|Overall Study||2
513675|NCT00932152|1256154|P1|STARTED|Overall Study||1
513676|NCT00932126|1256164|P8|NOT COMPLETED|Overall Study||10
513677|NCT00932126|1256165|P7|NOT COMPLETED|Overall Study||5
513678|NCT00932126|1256166|P6|NOT COMPLETED|Overall Study||3
513679|NCT00932126|1256167|P5|NOT COMPLETED|Overall Study||5
513680|NCT00932126|1256168|P4|NOT COMPLETED|Overall Study||3
513681|NCT00932126|1256169|P3|NOT COMPLETED|Overall Study||3
513682|NCT00932126|1256170|P2|NOT COMPLETED|Overall Study||3
513683|NCT00932126|1256171|P1|NOT COMPLETED|Overall Study||3
513684|NCT00932126|1256164|P8|COMPLETED|Overall Study||0
513685|NCT00932126|1256165|P7|COMPLETED|Overall Study||0
513686|NCT00932126|1256166|P6|COMPLETED|Overall Study||0
513687|NCT00932126|1256167|P5|COMPLETED|Overall Study||0
513688|NCT00932126|1256168|P4|COMPLETED|Overall Study||0
513689|NCT00932126|1256169|P3|COMPLETED|Overall Study||0
513690|NCT00932126|1256170|P2|COMPLETED|Overall Study||0
513691|NCT00932126|1256171|P1|COMPLETED|Overall Study||0
513692|NCT00932126|1256164|P8|STARTED|Overall Study||10
513693|NCT00932126|1256165|P7|STARTED|Overall Study||5
513694|NCT00932126|1256166|P6|STARTED|Overall Study||3
513695|NCT00932126|1256167|P5|STARTED|Overall Study||5
513696|NCT00932126|1256168|P4|STARTED|Overall Study||3
513697|NCT00932126|1256169|P3|STARTED|Overall Study||3
513698|NCT00932126|1256170|P2|STARTED|Overall Study||3
513699|NCT00932126|1256171|P1|STARTED|Overall Study||3
513700|NCT00932113|1256209|P2|NOT COMPLETED|Overall Study||0
513701|NCT00932113|1256210|P1|NOT COMPLETED|Overall Study||1
513702|NCT00932113|1256209|P2|COMPLETED|Overall Study||15
513703|NCT00932113|1256210|P1|COMPLETED|Overall Study||14
513704|NCT00932113|1256209|P2|STARTED|Overall Study||15
513705|NCT00932113|1256210|P1|STARTED|Overall Study||15
513706|NCT00932035|1256228|P2|NOT COMPLETED|Overall Study||0
513707|NCT00932035|1256229|P1|NOT COMPLETED|Overall Study||0
513708|NCT00932035|1256228|P2|COMPLETED|Overall Study||21
513709|NCT00932035|1256229|P1|COMPLETED|Overall Study||18
513710|NCT00932035|1256228|P2|STARTED|Overall Study||21
513711|NCT00932035|1256229|P1|STARTED|Overall Study||18
513712|NCT00932022|1256241|P2|NOT COMPLETED|Overall Study||4
513713|NCT00932022|1256242|P1|NOT COMPLETED|Overall Study||5
513714|NCT00932022|1256241|P2|COMPLETED|Overall Study||59
513715|NCT00932022|1256242|P1|COMPLETED|Overall Study||59
513716|NCT00932022|1256241|P2|STARTED|Overall Study||63
513717|NCT00932022|1256242|P1|STARTED|Overall Study||64
513718|NCT00931996|1256256|P1|NOT COMPLETED|Overall Study||7
513719|NCT00931996|1256256|P1|COMPLETED|Overall Study||5
513720|NCT00931996|1256256|P1|STARTED|Overall Study||12
513721|NCT00931918|1256262|P2|NOT COMPLETED|Overall Study||17
513722|NCT00931918|1256263|P1|NOT COMPLETED|Overall Study||17
513723|NCT00931918|1256262|P2|COMPLETED|Overall Study|Completed the maximum of 6 cycles.|86
513724|NCT00931918|1256263|P1|COMPLETED|Overall Study|Completed the maximum of 6 cycles.|86
513725|NCT00931918|1256262|P2|Safety Population: Received Study Drug|Overall Study||101
513726|NCT00931918|1256263|P1|Safety Population: Received Study Drug|Overall Study||100
513727|NCT00931918|1256262|P2|STARTED|Overall Study||103
513728|NCT00931918|1256263|P1|STARTED|Overall Study||103
513729|NCT00931879|1256289|P2|NOT COMPLETED|Overall Study||3
513730|NCT00931879|1256290|P1|NOT COMPLETED|Overall Study||3
513731|NCT00931879|1256289|P2|COMPLETED|Overall Study||19
513732|NCT00931879|1256290|P1|COMPLETED|Overall Study||19
513733|NCT00931879|1256289|P2|STARTED|Overall Study||22
513734|NCT00931879|1256290|P1|STARTED|Overall Study||22
513735|NCT00931801|1256315|P3|NOT COMPLETED|Overall Study||4
513736|NCT00931801|1256316|P2|NOT COMPLETED|Overall Study||1
513737|NCT00931801|1256317|P1|NOT COMPLETED|Overall Study||1
513738|NCT00931801|1256315|P3|COMPLETED|Overall Study||10
513739|NCT00931801|1256316|P2|COMPLETED|Overall Study||14
513740|NCT00931801|1256317|P1|COMPLETED|Overall Study||13
513741|NCT00931801|1256315|P3|STARTED|Overall Study||14
513742|NCT00931801|1256316|P2|STARTED|Overall Study||15
513743|NCT00931801|1256317|P1|STARTED|Overall Study||14
513744|NCT00931723|1256340|P2|NOT COMPLETED|Overall Study||39
513745|NCT00931723|1256341|P1|NOT COMPLETED|Overall Study||26
513746|NCT00931723|1256340|P2|COMPLETED|Overall Study||144
513747|NCT00931723|1256341|P1|COMPLETED|Overall Study||147
513748|NCT00931723|1256340|P2|STARTED|Overall Study||183
513749|NCT00931723|1256341|P1|STARTED|Overall Study||173
513750|NCT00931710|1256389|P2|NOT COMPLETED|Overall Study||38
513751|NCT00931710|1256390|P1|NOT COMPLETED|Overall Study||34
513752|NCT00931710|1256389|P2|COMPLETED|Overall Study||209
513753|NCT00931710|1256390|P1|COMPLETED|Overall Study||207
513754|NCT00931710|1256389|P2|STARTED|Overall Study||247
513755|NCT00931710|1256390|P1|STARTED|Overall Study||241
513756|NCT00931632|1256408|P2|NOT COMPLETED|Overall Study||18
513757|NCT00931632|1256409|P1|NOT COMPLETED|Overall Study||21
513758|NCT00931632|1256408|P2|COMPLETED|Overall Study|Completed at 36 weeks Postmenstrual Age (PMA)|204
513759|NCT00931632|1256409|P1|COMPLETED|Overall Study|Completed at 36 weeks Postmenstrual Age (PMA)|208
513760|NCT00931632|1256408|P2|STARTED|Overall Study|Randomized|222
513761|NCT00931632|1256409|P1|STARTED|Overall Study|Randomized|229
513762|NCT00931528|1256431|P2|NOT COMPLETED|Overall Study||60
513763|NCT00931528|1256432|P1|NOT COMPLETED|Overall Study||41
513764|NCT00931528|1256431|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|61
513765|NCT00931528|1256432|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|80
513766|NCT00931528|1256431|P2|STARTED|Overall Study||121
513767|NCT00931528|1256432|P1|STARTED|Overall Study||121
513768|NCT00931515|1256452|P2|NOT COMPLETED|Overall Study||5
513769|NCT00931515|1256453|P1|NOT COMPLETED|Overall Study||2
513770|NCT00931515|1256452|P2|COMPLETED|Overall Study||10
513771|NCT00931515|1256453|P1|COMPLETED|Overall Study||13
513772|NCT00931515|1256452|P2|STARTED|Overall Study||15
513773|NCT00931515|1256453|P1|STARTED|Overall Study||15
513774|NCT00931489|1256464|P5|NOT COMPLETED|Overall Study||0
513775|NCT00931489|1256465|P4|NOT COMPLETED|Overall Study||0
513776|NCT00931489|1256466|P3|NOT COMPLETED|Overall Study||0
513777|NCT00931489|1256467|P2|NOT COMPLETED|Overall Study||0
513778|NCT00931489|1256468|P1|NOT COMPLETED|Overall Study||0
513779|NCT00931489|1256464|P5|COMPLETED|Overall Study||7
513780|NCT00931489|1256465|P4|COMPLETED|Overall Study||39
513781|NCT00931489|1256466|P3|COMPLETED|Overall Study|3 subjects enrolled in Group 1 (responders) were moved to Group 3 (non-responders)|5
513782|NCT00931489|1256467|P2|COMPLETED|Overall Study||40
513783|NCT00931489|1256468|P1|COMPLETED|Overall Study||40
513784|NCT00931489|1256464|P5|STARTED|Overall Study||7
513785|NCT00931489|1256465|P4|STARTED|Overall Study||39
513786|NCT00931489|1256466|P3|STARTED|Overall Study||5
513787|NCT00931489|1256467|P2|STARTED|Overall Study||40
513788|NCT00931489|1256468|P1|STARTED|Overall Study||40
513789|NCT00931463|1256483|P2|NOT COMPLETED|Overall Study||5
513790|NCT00931463|1256484|P1|NOT COMPLETED|Overall Study||17
513791|NCT00931463|1256483|P2|COMPLETED|Overall Study||265
513792|NCT00931463|1256484|P1|COMPLETED|Overall Study||254
513793|NCT00931463|1256483|P2|STARTED|Overall Study||270
513794|NCT00931463|1256484|P1|STARTED|Overall Study||271
513795|NCT00931411|1256500|P2|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||1
513796|NCT00931411|1256501|P1|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||0
513797|NCT00931411|1256500|P2|COMPLETED|After Crossover - 14 Days (up to Day 56)||34
513798|NCT00931411|1256501|P1|COMPLETED|After Crossover - 14 Days (up to Day 56)||31
513799|NCT00931411|1256500|P2|STARTED|After Crossover - 14 Days (up to Day 56)||35
513800|NCT00931411|1256501|P1|STARTED|After Crossover - 14 Days (up to Day 56)||31
513801|NCT00931411|1256500|P2|NOT COMPLETED|First Intervention - 42 Days||3
513802|NCT00931411|1256501|P1|NOT COMPLETED|First Intervention - 42 Days||4
513803|NCT00931411|1256500|P2|COMPLETED|First Intervention - 42 Days||35
513804|NCT00931411|1256501|P1|COMPLETED|First Intervention - 42 Days||31
513805|NCT00931411|1256500|P2|STARTED|First Intervention - 42 Days||38
513806|NCT00931411|1256501|P1|STARTED|First Intervention - 42 Days||35
513807|NCT00931385|1256522|P4|NOT COMPLETED|Overall Study||5
513808|NCT00931385|1256523|P3|NOT COMPLETED|Overall Study||1
513809|NCT00931385|1256524|P2|NOT COMPLETED|Overall Study||2
513810|NCT00931385|1256525|P1|NOT COMPLETED|Overall Study||2
513811|NCT00931385|1256522|P4|COMPLETED|Overall Study||21
513812|NCT00931385|1256523|P3|COMPLETED|Overall Study||24
513813|NCT00931385|1256524|P2|COMPLETED|Overall Study||21
513814|NCT00931385|1256525|P1|COMPLETED|Overall Study||23
513815|NCT00931385|1256522|P4|STARTED|Overall Study||26
513816|NCT00931385|1256523|P3|STARTED|Overall Study||25
513817|NCT00931385|1256524|P2|STARTED|Overall Study||23
513818|NCT00931385|1256525|P1|STARTED|Overall Study||25
513819|NCT00931359|1256581|P2|NOT COMPLETED|Overall Study||13
513820|NCT00931359|1256582|P1|NOT COMPLETED|Overall Study||6
513821|NCT00931359|1256581|P2|COMPLETED|Overall Study||68
513822|NCT00931359|1256582|P1|COMPLETED|Overall Study||33
513823|NCT00931359|1256581|P2|STARTED|Overall Study||81
513824|NCT00931359|1256582|P1|STARTED|Overall Study||39
513825|NCT00931307|1256594|P1|NOT COMPLETED|Overall Study||13
513826|NCT00931307|1256594|P1|COMPLETED|Overall Study||9
513827|NCT00931307|1256594|P1|STARTED|Overall Study||22
513828|NCT00931268|1256598|P1|NOT COMPLETED|Overall Study||6
513829|NCT00931268|1256598|P1|COMPLETED|Overall Study||4
513830|NCT00931268|1256598|P1|STARTED|Overall Study||10
513831|NCT00931255|1256610|P2|NOT COMPLETED|Overall Study||3
513832|NCT00931255|1256611|P1|NOT COMPLETED|Overall Study||2
513833|NCT00931255|1256610|P2|COMPLETED|Overall Study||12
513834|NCT00931255|1256611|P1|COMPLETED|Overall Study||15
513835|NCT00931255|1256610|P2|STARTED|Overall Study||15
513836|NCT00931255|1256611|P1|STARTED|Overall Study||17
513837|NCT00931242|1256635|P2|NOT COMPLETED|Overall Study||2
513838|NCT00931242|1256636|P1|NOT COMPLETED|Overall Study||5
513839|NCT00931242|1256635|P2|COMPLETED|Overall Study||0
513840|NCT00931242|1256636|P1|COMPLETED|Overall Study||5
513841|NCT00931242|1256635|P2|STARTED|Overall Study||2
513842|NCT00931242|1256636|P1|STARTED|Overall Study||10
513843|NCT00931164|1256642|P1|NOT COMPLETED|Overall Study||0
513844|NCT00931164|1256642|P1|COMPLETED|Overall Study||6
513845|NCT00931164|1256642|P1|STARTED|Overall Study||6
513846|NCT00930982|1256648|P2|NOT COMPLETED|Overall Study||29
513847|NCT00930982|1256649|P1|NOT COMPLETED|Overall Study||21
513848|NCT00930982|1256648|P2|COMPLETED|Overall Study||35
513849|NCT00930982|1256649|P1|COMPLETED|Overall Study||39
513850|NCT00930982|1256648|P2|STARTED|Overall Study||64
513851|NCT00930982|1256649|P1|STARTED|Overall Study||60
513852|NCT00930969|1256683|P1|NOT COMPLETED|Overall Study||38
513853|NCT00930969|1256683|P1|COMPLETED|Overall Study||137
513854|NCT00930969|1256683|P1|STARTED|Overall Study||175
513855|NCT00930930|1256693|P2|NOT COMPLETED|Overall Study||9
513856|NCT00930930|1256694|P1|NOT COMPLETED|Overall Study||21
513857|NCT00930930|1256693|P2|COMPLETED|Overall Study||40
513858|NCT00930930|1256694|P1|COMPLETED|Overall Study||75
513859|NCT00930930|1256693|P2|STARTED|Overall Study||49
513860|NCT00930930|1256694|P1|STARTED|Overall Study||96
513861|NCT00930813|1256708|P2|NOT COMPLETED|Overall Study||14
513862|NCT00930813|1256709|P1|NOT COMPLETED|Overall Study||8
513863|NCT00930813|1256708|P2|COMPLETED|Overall Study||38
513864|NCT00930813|1256709|P1|COMPLETED|Overall Study||41
513865|NCT00930813|1256708|P2|STARTED|Overall Study||52
513866|NCT00930813|1256709|P1|STARTED|Overall Study||49
513867|NCT00930787|1256719|P2|NOT COMPLETED|Overall Study||0
513868|NCT00930787|1256720|P1|NOT COMPLETED|Overall Study||0
513869|NCT00930787|1256719|P2|COMPLETED|Overall Study||9
513870|NCT00930787|1256720|P1|COMPLETED|Overall Study||14
513871|NCT00930787|1256719|P2|STARTED|Overall Study||9
513872|NCT00930787|1256720|P1|STARTED|Overall Study||14
513873|NCT00930774|1256730|P4|NOT COMPLETED|Overall Study||0
513874|NCT00930774|1256731|P3|NOT COMPLETED|Overall Study||2
513875|NCT00930774|1256732|P2|NOT COMPLETED|Overall Study||9
513876|NCT00930774|1256733|P1|NOT COMPLETED|Overall Study||1
513877|NCT00930774|1256730|P4|COMPLETED|Overall Study||25
513878|NCT00930774|1256731|P3|COMPLETED|Overall Study||22
513879|NCT00930774|1256732|P2|COMPLETED|Overall Study||16
513880|NCT00930774|1256733|P1|COMPLETED|Overall Study||24
513881|NCT00930774|1256730|P4|STARTED|Overall Study||25
513882|NCT00930774|1256731|P3|STARTED|Overall Study||24
513883|NCT00930774|1256732|P2|STARTED|Overall Study||25
513884|NCT00930774|1256733|P1|STARTED|Overall Study||25
513885|NCT00930761|1256773|P2|NOT COMPLETED|Overall Study||3
513886|NCT00930761|1256774|P1|NOT COMPLETED|Overall Study||4
513887|NCT00930761|1256773|P2|COMPLETED|Overall Study||48
513888|NCT00930761|1256774|P1|COMPLETED|Overall Study||46
513889|NCT00930761|1256773|P2|STARTED|Overall Study||51
513890|NCT00930761|1256774|P1|STARTED|Overall Study||50
513891|NCT00930722|1256786|P1|NOT COMPLETED|Overall Study||27
513892|NCT00930722|1256786|P1|COMPLETED|Overall Study||302
513893|NCT00930722|1256786|P1|STARTED|Overall Study||329
513894|NCT00930644|1256801|P1|NOT COMPLETED|Overall Study||23
513895|NCT00930644|1256801|P1|COMPLETED|Overall Study||65
513896|NCT00930644|1256801|P1|STARTED|Overall Study||88
513897|NCT00930553|1256814|P1|NOT COMPLETED|Overall Study||223
513898|NCT00930553|1256814|P1|COMPLETED|Overall Study||1091
513899|NCT00930553|1256814|P1|Participants Entered From CAMMS324|Overall Study||685
513900|NCT00930553|1256814|P1|Participants Entered From CAMMS323|Overall Study||488
513901|NCT00930553|1256814|P1|Participants Entered From CAMMS223|Overall Study||141
513902|NCT00930553|1256814|P1|STARTED|Overall Study||1314
513903|NCT00930293|1256882|P2|NOT COMPLETED|Overall Study||7
513904|NCT00930293|1256883|P1|NOT COMPLETED|Overall Study||7
513905|NCT00930293|1256882|P2|COMPLETED|Overall Study||19
513906|NCT00930293|1256883|P1|COMPLETED|Overall Study||17
513907|NCT00930293|1256882|P2|STARTED|Overall Study||26
513908|NCT00930293|1256883|P1|STARTED|Overall Study||24
513909|NCT00930176|1256891|P1|NOT COMPLETED|Overall Study||1
513910|NCT00930176|1256891|P1|COMPLETED|Overall Study||15
513911|NCT00930176|1256891|P1|STARTED|Overall Study||16
513912|NCT00929981|1256896|P1|NOT COMPLETED|Overall Study||0
513913|NCT00929981|1256896|P1|COMPLETED|Overall Study||80
513914|NCT00929981|1256896|P1|STARTED|Overall Study||80
513915|NCT00929864|1256908|P2|NOT COMPLETED|Overall Study||83
513916|NCT00929864|1256909|P1|NOT COMPLETED|Overall Study||66
513917|NCT00929864|1256908|P2|COMPLETED|Overall Study||245
513918|NCT00929864|1256909|P1|COMPLETED|Overall Study||252
513919|NCT00929864|1256908|P2|STARTED|Overall Study||328
513920|NCT00929864|1256909|P1|STARTED|Overall Study||318
513921|NCT00929773|1256929|P2|NOT COMPLETED|Overall Study||0
513922|NCT00929773|1256930|P1|NOT COMPLETED|Overall Study||0
513923|NCT00929773|1256929|P2|COMPLETED|Overall Study||50
513924|NCT00929773|1256930|P1|COMPLETED|Overall Study||50
513925|NCT00929773|1256929|P2|STARTED|Overall Study||50
513926|NCT00929773|1256930|P1|STARTED|Overall Study||50
513927|NCT00929734|1256948|P2|NOT COMPLETED|Overall Study||3
513928|NCT00929734|1256949|P1|NOT COMPLETED|Overall Study||2
513929|NCT00929734|1256948|P2|COMPLETED|Overall Study||47
513930|NCT00929734|1256949|P1|COMPLETED|Overall Study||47
513931|NCT00929734|1256948|P2|STARTED|Overall Study||50
513932|NCT00929734|1256949|P1|STARTED|Overall Study||49
513933|NCT00929708|1256966|P5|NOT COMPLETED|Overall Study||6
513934|NCT00929708|1256967|P4|NOT COMPLETED|Overall Study||6
513935|NCT00929708|1256968|P3|NOT COMPLETED|Overall Study||3
513936|NCT00929708|1256969|P2|NOT COMPLETED|Overall Study||3
513937|NCT00929708|1256970|P1|NOT COMPLETED|Overall Study||4
513938|NCT00929708|1256966|P5|COMPLETED|Overall Study||57
513939|NCT00929708|1256967|P4|COMPLETED|Overall Study||61
513940|NCT00929708|1256968|P3|COMPLETED|Overall Study||62
513941|NCT00929708|1256969|P2|COMPLETED|Overall Study||66
513942|NCT00929708|1256970|P1|COMPLETED|Overall Study||61
513943|NCT00929708|1256966|P5|STARTED|Overall Study||63
513944|NCT00929708|1256967|P4|STARTED|Overall Study||67
513945|NCT00929708|1256968|P3|STARTED|Overall Study||65
513946|NCT00929708|1256969|P2|STARTED|Overall Study||69
513947|NCT00929708|1256970|P1|STARTED|Overall Study||65
513948|NCT00929695|1257024|P2|NOT COMPLETED|Overall Study||6
513949|NCT00929695|1257025|P1|NOT COMPLETED|Overall Study||8
513950|NCT00929695|1257024|P2|COMPLETED|Overall Study||77
513951|NCT00929695|1257025|P1|COMPLETED|Overall Study||73
513952|NCT00929695|1257024|P2|STARTED|Overall Study||83
513953|NCT00929695|1257025|P1|STARTED|Overall Study||81
513954|NCT00929669|1257055|P1|NOT COMPLETED|Overall Study||1
513955|NCT00929669|1257055|P1|COMPLETED|Overall Study||1
513956|NCT00929669|1257055|P1|STARTED|Overall Study||2
513957|NCT00929656|1257062|P2|NOT COMPLETED|Overall Study||1
513958|NCT00929656|1257063|P1|NOT COMPLETED|Overall Study||0
513959|NCT00929656|1257062|P2|COMPLETED|Overall Study||8
513960|NCT00929656|1257063|P1|COMPLETED|Overall Study||13
513961|NCT00929656|1257062|P2|STARTED|Overall Study||9
513962|NCT00929656|1257063|P1|STARTED|Overall Study||13
513963|NCT00929643|1257077|P1|NOT COMPLETED|Overall Study||2
513964|NCT00929643|1257077|P1|COMPLETED|Overall Study||201
513965|NCT00929643|1257077|P1|STARTED|Overall Study||203
513966|NCT00929578|1257086|P1|NOT COMPLETED|Overall Study||0
513967|NCT00929578|1257086|P1|COMPLETED|Overall Study||15
513968|NCT00929578|1257086|P1|STARTED|Overall Study||15
513969|NCT00929526|1257099|P2|NOT COMPLETED|Overall Study||29
513970|NCT00929526|1257100|P1|NOT COMPLETED|Overall Study||17
513971|NCT00929526|1257099|P2|COMPLETED|Overall Study||348
513972|NCT00929526|1257100|P1|COMPLETED|Overall Study||358
513973|NCT00929526|1257099|P2|STARTED|Overall Study||377
513974|NCT00929526|1257100|P1|STARTED|Overall Study||375
513975|NCT00929500|1257136|P2|NOT COMPLETED|Overall Study||0
513976|NCT00929500|1257137|P1|NOT COMPLETED|Overall Study||4
513977|NCT00929500|1257136|P2|COMPLETED|Overall Study||4
513978|NCT00929500|1257137|P1|COMPLETED|Overall Study||4
513979|NCT00929500|1257136|P2|STARTED|Overall Study||4
513980|NCT00929500|1257137|P1|STARTED|Overall Study||8
513981|NCT00929474|1257151|P2|NOT COMPLETED|Overall Study||9
513982|NCT00929474|1257152|P1|NOT COMPLETED|Overall Study||8
513983|NCT00929474|1257151|P2|COMPLETED|Overall Study||0
513984|NCT00929474|1257152|P1|COMPLETED|Overall Study||0
513985|NCT00929474|1257151|P2|STARTED|Overall Study||9
513986|NCT00929474|1257152|P1|STARTED|Overall Study||8
513987|NCT00929383|1257158|P1|NOT COMPLETED|Overall Study||15
513988|NCT00929383|1257158|P1|COMPLETED|Overall Study||67
513989|NCT00929383|1257158|P1|STARTED|Overall Study||82
513990|NCT00929357|1257168|P2|NOT COMPLETED|Overall Study||0
513991|NCT00929357|1257169|P1|NOT COMPLETED|Overall Study||0
513992|NCT00929357|1257168|P2|COMPLETED|Overall Study||64
513993|NCT00929357|1257169|P1|COMPLETED|Overall Study||92
513994|NCT00929357|1257168|P2|STARTED|Overall Study||64
513995|NCT00929357|1257169|P1|STARTED|Overall Study||92
513996|NCT00929344|1257192|P3|NOT COMPLETED|Overall Study||21
513997|NCT00929344|1257193|P2|NOT COMPLETED|Overall Study||13
513998|NCT00929344|1257194|P1|NOT COMPLETED|Overall Study||22
513999|NCT00929344|1257192|P3|COMPLETED|Overall Study||29
514000|NCT00929344|1257193|P2|COMPLETED|Overall Study||37
514001|NCT00929344|1257194|P1|COMPLETED|Overall Study||28
514002|NCT00929344|1257192|P3|STARTED|Overall Study||50
514003|NCT00929344|1257193|P2|STARTED|Overall Study||50
514004|NCT00929344|1257194|P1|STARTED|Overall Study||50
514005|NCT00929331|1257210|P2|NOT COMPLETED|Overall Study||0
514006|NCT00929331|1257211|P1|NOT COMPLETED|Overall Study||0
514007|NCT00929331|1257210|P2|COMPLETED|Overall Study||55
514008|NCT00929331|1257211|P1|COMPLETED|Overall Study||55
514009|NCT00929331|1257210|P2|STARTED|Overall Study||55
514010|NCT00929331|1257211|P1|STARTED|Overall Study||55
514011|NCT00929305|1257245|P2|NOT COMPLETED|Overall Study||0
514012|NCT00929305|1257246|P1|NOT COMPLETED|Overall Study||0
514013|NCT00929305|1257245|P2|COMPLETED|Overall Study||43
514014|NCT00929305|1257246|P1|COMPLETED|Overall Study||43
514015|NCT00929305|1257245|P2|STARTED|Overall Study||43
514016|NCT00929305|1257246|P1|STARTED|Overall Study||43
514017|NCT00929240|1257254|P3|NOT COMPLETED|Maintenance Phase||91
514018|NCT00929240|1257255|P2|NOT COMPLETED|Maintenance Phase||94
514019|NCT00929240|1257256|P1|NOT COMPLETED|Maintenance Phase||0
514020|NCT00929240|1257254|P3|COMPLETED|Maintenance Phase||0
514021|NCT00929240|1257255|P2|COMPLETED|Maintenance Phase||0
514022|NCT00929240|1257256|P1|COMPLETED|Maintenance Phase||0
514023|NCT00929240|1257254|P3|STARTED|Maintenance Phase||91
514024|NCT00929240|1257255|P2|STARTED|Maintenance Phase||94
514025|NCT00929240|1257256|P1|STARTED|Maintenance Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|0
514026|NCT00929240|1257254|P3|NOT COMPLETED|Initial Treatment Phase||0
514027|NCT00929240|1257255|P2|NOT COMPLETED|Initial Treatment Phase||0
514028|NCT00929240|1257256|P1|NOT COMPLETED|Initial Treatment Phase||99
514029|NCT00929240|1257254|P3|COMPLETED|Initial Treatment Phase||0
514030|NCT00929240|1257255|P2|COMPLETED|Initial Treatment Phase||0
514031|NCT00929240|1257256|P1|COMPLETED|Initial Treatment Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|185
514032|NCT00929240|1257254|P3|STARTED|Initial Treatment Phase||0
514033|NCT00929240|1257255|P2|STARTED|Initial Treatment Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|0
514034|NCT00929240|1257256|P1|STARTED|Initial Treatment Phase|Includes only the participants that received Initial Phase Treatment.|284
514035|NCT00929201|1257283|P2|NOT COMPLETED|Period 2||0
514036|NCT00929201|1257284|P1|NOT COMPLETED|Period 2||0
514037|NCT00929201|1257283|P2|COMPLETED|Period 2||30
514038|NCT00929201|1257284|P1|COMPLETED|Period 2||30
514039|NCT00929201|1257283|P2|STARTED|Period 2||30
514040|NCT00929201|1257284|P1|STARTED|Period 2||30
514041|NCT00929201|1257283|P2|NOT COMPLETED|7-day Washout||0
514042|NCT00929201|1257284|P1|NOT COMPLETED|7-day Washout||0
514043|NCT00929201|1257283|P2|COMPLETED|7-day Washout||30
514044|NCT00929201|1257284|P1|COMPLETED|7-day Washout||30
514045|NCT00929201|1257283|P2|STARTED|7-day Washout||30
514046|NCT00929201|1257284|P1|STARTED|7-day Washout||30
514047|NCT00929201|1257283|P2|NOT COMPLETED|Period 1||1
514048|NCT00929201|1257284|P1|NOT COMPLETED|Period 1||0
514049|NCT00929201|1257283|P2|COMPLETED|Period 1||30
514050|NCT00929201|1257284|P1|COMPLETED|Period 1||30
514051|NCT00929201|1257283|P2|STARTED|Period 1||31
514052|NCT00929201|1257284|P1|STARTED|Period 1||30
514053|NCT00929162|1257294|P2|NOT COMPLETED|Overall Study||42
514054|NCT00929162|1257295|P1|NOT COMPLETED|Overall Study||48
514055|NCT00929162|1257294|P2|COMPLETED|Overall Study||19
514056|NCT00929162|1257295|P1|COMPLETED|Overall Study||11
514057|NCT00929162|1257294|P2|Patients Who Received Treatment|Overall Study||58
514058|NCT00929162|1257295|P1|Patients Who Received Treatment|Overall Study||58
514059|NCT00929162|1257294|P2|STARTED|Overall Study||61
514060|NCT00929162|1257295|P1|STARTED|Overall Study||59
514061|NCT00929110|1257308|P3|NOT COMPLETED|Overall Study||62
514062|NCT00929110|1257309|P2|NOT COMPLETED|Overall Study||76
514063|NCT00929110|1257310|P1|NOT COMPLETED|Overall Study||118
514064|NCT00929110|1257308|P3|COMPLETED|Overall Study||206
514065|NCT00929110|1257309|P2|COMPLETED|Overall Study||193
514066|NCT00929110|1257310|P1|COMPLETED|Overall Study||411
514067|NCT00929110|1257308|P3|STARTED|Overall Study||268
514068|NCT00929110|1257309|P2|STARTED|Overall Study||269
514069|NCT00929110|1257310|P1|STARTED|Overall Study||529
514070|NCT00929071|1257375|P1|NOT COMPLETED|Overall Study||0
514071|NCT00929071|1257375|P1|COMPLETED|Overall Study||10
514072|NCT00929071|1257375|P1|STARTED|Overall Study||10
514073|NCT00928954|1257382|P2|NOT COMPLETED|Overall Study||0
514074|NCT00928954|1257383|P1|NOT COMPLETED|Overall Study||0
514075|NCT00928954|1257382|P2|COMPLETED|Overall Study||6
514076|NCT00928954|1257383|P1|COMPLETED|Overall Study||4
514077|NCT00928954|1257382|P2|STARTED|Overall Study||6
514078|NCT00928954|1257383|P1|STARTED|Overall Study||4
514079|NCT00928889|1257393|P2|NOT COMPLETED|Overall Study||2
514080|NCT00928889|1257394|P1|NOT COMPLETED|Overall Study||5
514081|NCT00928889|1257393|P2|COMPLETED|Overall Study||78
514082|NCT00928889|1257394|P1|COMPLETED|Overall Study||75
514083|NCT00928889|1257393|P2|STARTED|Overall Study||80
514084|NCT00928889|1257394|P1|STARTED|Overall Study||80
514085|NCT00928772|1257421|P3|NOT COMPLETED|Overall Study||0
514086|NCT00928772|1257422|P2|NOT COMPLETED|Overall Study||0
514087|NCT00928772|1257423|P1|NOT COMPLETED|Overall Study||0
514088|NCT00928772|1257421|P3|COMPLETED|Overall Study||38
514089|NCT00928772|1257422|P2|COMPLETED|Overall Study||38
514090|NCT00928772|1257423|P1|COMPLETED|Overall Study||39
514091|NCT00928772|1257421|P3|STARTED|Overall Study||38
514092|NCT00928772|1257422|P2|STARTED|Overall Study||38
514093|NCT00928772|1257423|P1|STARTED|Overall Study||39
514094|NCT00928746|1257440|P1|NOT COMPLETED|Overall Study||6
514095|NCT00928746|1257440|P1|COMPLETED|Overall Study||136
514096|NCT00928746|1257440|P1|STARTED|Overall Study||142
514097|NCT00928720|1257463|P3|NOT COMPLETED|Overall Study||3
514098|NCT00928720|1257464|P2|NOT COMPLETED|Overall Study||6
514099|NCT00928720|1257465|P1|NOT COMPLETED|Overall Study||2
514100|NCT00928720|1257463|P3|COMPLETED|Overall Study||15
514101|NCT00928720|1257464|P2|COMPLETED|Overall Study||14
514102|NCT00928720|1257465|P1|COMPLETED|Overall Study||17
514103|NCT00928720|1257463|P3|STARTED|Overall Study||18
514104|NCT00928720|1257464|P2|STARTED|Overall Study||20
514105|NCT00928720|1257465|P1|STARTED|Overall Study||19
514106|NCT00928694|1257488|P2|NOT COMPLETED|Second Intervention||0
514107|NCT00928694|1257489|P1|NOT COMPLETED|Second Intervention||0
514108|NCT00928694|1257488|P2|COMPLETED|Second Intervention||7
514109|NCT00928694|1257489|P1|COMPLETED|Second Intervention||7
514110|NCT00928694|1257488|P2|STARTED|Second Intervention||7
514111|NCT00928694|1257489|P1|STARTED|Second Intervention||7
514112|NCT00928694|1257488|P2|NOT COMPLETED|First Intervention||0
514113|NCT00928694|1257489|P1|NOT COMPLETED|First Intervention||0
514114|NCT00928694|1257488|P2|COMPLETED|First Intervention||7
514115|NCT00928694|1257489|P1|COMPLETED|First Intervention||7
514116|NCT00928694|1257488|P2|STARTED|First Intervention||7
514117|NCT00928694|1257489|P1|STARTED|First Intervention||7
514118|NCT00928668|1257497|P5|NOT COMPLETED|Overall Study||1
514119|NCT00928668|1257498|P4|NOT COMPLETED|Overall Study||1
514120|NCT00928668|1257499|P3|NOT COMPLETED|Overall Study||1
514121|NCT00928668|1257500|P2|NOT COMPLETED|Overall Study||1
514122|NCT00928668|1257501|P1|NOT COMPLETED|Overall Study||1
514123|NCT00928668|1257497|P5|COMPLETED|Overall Study||5
514124|NCT00928668|1257498|P4|COMPLETED|Overall Study||3
514125|NCT00928668|1257499|P3|COMPLETED|Overall Study||6
514126|NCT00928668|1257500|P2|COMPLETED|Overall Study||6
514127|NCT00928668|1257501|P1|COMPLETED|Overall Study||6
514128|NCT00928668|1257497|P5|STARTED|Overall Study||6
514129|NCT00928668|1257498|P4|STARTED|Overall Study||4
514130|NCT00928668|1257499|P3|STARTED|Overall Study||7
514131|NCT00928668|1257500|P2|STARTED|Overall Study||7
514132|NCT00928668|1257501|P1|STARTED|Overall Study||7
514133|NCT00928642|1257543|P1|NOT COMPLETED|Overall Study||0
514134|NCT00928642|1257543|P1|COMPLETED|Overall Study|1 subject withdrew after 1st cycle but before disease assessment. 7 of 8 are evaluable for response|8
514135|NCT00928642|1257543|P1|STARTED|Overall Study||8
514136|NCT00928512|1257557|P5|NOT COMPLETED|Overall Study||15
514137|NCT00928512|1257558|P4|NOT COMPLETED|Overall Study||21
514138|NCT00928512|1257559|P3|NOT COMPLETED|Overall Study||11
514139|NCT00928512|1257560|P2|NOT COMPLETED|Overall Study||6
514140|NCT00928512|1257561|P1|NOT COMPLETED|Overall Study||10
514141|NCT00928512|1257557|P5|COMPLETED|Overall Study||35
514142|NCT00928512|1257558|P4|COMPLETED|Overall Study||33
514143|NCT00928512|1257559|P3|COMPLETED|Overall Study||38
514144|NCT00928512|1257560|P2|COMPLETED|Overall Study||37
514145|NCT00928512|1257561|P1|COMPLETED|Overall Study||31
514146|NCT00928512|1257557|P5|Entered/Continued to Week 20 (All)|Overall Study||45
514147|NCT00928512|1257558|P4|Entered/Continued to Week 20 (All)|Overall Study||45
514148|NCT00928512|1257559|P3|Entered/Continued to Week 20 (All)|Overall Study||46
514149|NCT00928512|1257560|P2|Entered/Continued to Week 20 (All)|Overall Study||43
514150|NCT00928512|1257561|P1|Entered/Continued to Week 20 (All)|Overall Study||37
514151|NCT00928512|1257557|P5|Completed Week 16|Overall Study||45
514152|NCT00928512|1257558|P4|Completed Week 16|Overall Study||48
514153|NCT00928512|1257559|P3|Completed Week 16|Overall Study||47
514154|NCT00928512|1257560|P2|Completed Week 16|Overall Study||43
514155|NCT00928512|1257561|P1|Completed Week 16|Overall Study||38
514156|NCT00928512|1257557|P5|New Groups After Reassignment|Overall Study||0
514157|NCT00928512|1257558|P4|New Groups After Reassignment|Overall Study|2 patients in this group continued at Week 16 but did not receive any study drug at Week 20|18
514158|NCT00928512|1257559|P3|New Groups After Reassignment|Overall Study|1 patient in this group continued at Week 16 but did not receive any study drug at Week 20.|23
514159|NCT00928512|1257560|P2|New Groups After Reassignment|Overall Study||115
514160|NCT00928512|1257561|P1|New Groups After Reassignment|Overall Study|1 patient in this group continued at Week 16 but did not receive any study drug at Week 20.|60
514161|NCT00928512|1257557|P5|Not Reassigned at Week 20 (Responders)|Overall Study||0
514162|NCT00928512|1257558|P4|Not Reassigned at Week 20 (Responders)|Overall Study||18
514163|NCT00928512|1257559|P3|Not Reassigned at Week 20 (Responders)|Overall Study||23
514164|NCT00928512|1257560|P2|Not Reassigned at Week 20 (Responders)|Overall Study||20
514165|NCT00928512|1257561|P1|Not Reassigned at Week 20 (Responders)|Overall Study||37
514166|NCT00928512|1257557|P5|Reassigned at Week 20 (Non-responders)|Overall Study|All placebo patients (responders & non-responders) were reassigned treatment to the 150 mg group.|45
514167|NCT00928512|1257558|P4|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 25 mg group were reassigned treatment to the 150 mg group.|27
514168|NCT00928512|1257559|P3|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 75 mg group were reassigned treatment to the 150 mg group.|23
514169|NCT00928512|1257560|P2|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 150 mg group were reassigned treatment to the 300 mg group.|23
514170|NCT00928512|1257561|P1|Reassigned at Week 20 (Non-responders)|Overall Study|All patients in the 300 mg group at Week 20 remained at this dose in this group.|0
514171|NCT00928512|1257557|P5|Discontinued Prior to Week 16|Overall Study||5
514172|NCT00928512|1257558|P4|Discontinued Prior to Week 16|Overall Study||6
514173|NCT00928512|1257559|P3|Discontinued Prior to Week 16|Overall Study||2
514174|NCT00928512|1257560|P2|Discontinued Prior to Week 16|Overall Study||0
514175|NCT00928512|1257561|P1|Discontinued Prior to Week 16|Overall Study||3
514176|NCT00928512|1257557|P5|STARTED|Overall Study||50
514177|NCT00928512|1257558|P4|STARTED|Overall Study||54
514178|NCT00928512|1257559|P3|STARTED|Overall Study||49
514179|NCT00928512|1257560|P2|STARTED|Overall Study||43
514180|NCT00928512|1257561|P1|STARTED|Overall Study||41
514181|NCT00928486|1257662|P1|NOT COMPLETED|Overall Study||10
514182|NCT00928486|1257662|P1|COMPLETED|Overall Study|Completed = those who continued responding to treatment; upon marketing approval, given lenalidomide|15
514183|NCT00928486|1257662|P1|Efficacy Evaluable (EE)|Overall Study|EE population = given at least 1 dose of study drug, evaluated for efficacy and met eligibility|24
514184|NCT00928486|1257662|P1|STARTED|Overall Study||25
514185|NCT00928434|1257671|P3|NOT COMPLETED|Overall Study||44
514186|NCT00928434|1257672|P2|NOT COMPLETED|Overall Study||14
514187|NCT00928434|1257673|P1|NOT COMPLETED|Overall Study||44
514188|NCT00928434|1257671|P3|COMPLETED|Overall Study||134
514189|NCT00928434|1257672|P2|COMPLETED|Overall Study||36
514190|NCT00928434|1257673|P1|COMPLETED|Overall Study||131
514191|NCT00928434|1257671|P3|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|150
514192|NCT00928434|1257672|P2|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|41
514193|NCT00928434|1257673|P1|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|137
514194|NCT00928434|1257671|P3|STARTED|Overall Study|Full Analysis Set Patients|178
514195|NCT00928434|1257672|P2|STARTED|Overall Study|Full Analysis Set Patients|50
514196|NCT00928434|1257673|P1|STARTED|Overall Study|Full Analysis Set Patients|175
514197|NCT00928421|1257745|P1|NOT COMPLETED|Overall Study||0
514198|NCT00928421|1257745|P1|COMPLETED|Overall Study||16
514199|NCT00928421|1257745|P1|Treated With Study Drug|Overall Study||16
514200|NCT00928421|1257745|P1|STARTED|Overall Study||16
514201|NCT00928408|1257749|P1|NOT COMPLETED|Overall Study||23
514202|NCT00928408|1257749|P1|COMPLETED|Overall Study||282
514203|NCT00928408|1257749|P1|Full Analysis Set|Overall Study|All enrolled participants who fulfilled the study inclusion/exclusion criteria|303
514204|NCT00928408|1257749|P1|STARTED|Overall Study|Number Enrolled|305
514205|NCT00928395|1257778|P1|NOT COMPLETED|Overall Study||21
514206|NCT00928395|1257778|P1|COMPLETED|Overall Study||29
514207|NCT00928395|1257778|P1|STARTED|Overall Study||50
514208|NCT00928304|1257782|P2|NOT COMPLETED|Overall Study||0
514209|NCT00928304|1257783|P1|NOT COMPLETED|Overall Study||0
514210|NCT00928304|1257782|P2|COMPLETED|Overall Study||70
514211|NCT00928304|1257783|P1|COMPLETED|Overall Study||39
514212|NCT00928304|1257782|P2|STARTED|Overall Study||70
514213|NCT00928304|1257783|P1|STARTED|Overall Study||39
514214|NCT00928252|1257795|P1|NOT COMPLETED|Overall Study||3
514215|NCT00928252|1257795|P1|COMPLETED|Overall Study||42
514216|NCT00928252|1257795|P1|STARTED|Overall Study||45
514217|NCT00928187|1257804|P3|NOT COMPLETED|Overall Study||5
514218|NCT00928187|1257805|P2|NOT COMPLETED|Overall Study||6
514219|NCT00928187|1257806|P1|NOT COMPLETED|Overall Study||2
514220|NCT00928187|1257804|P3|COMPLETED|Overall Study||150
514221|NCT00928187|1257805|P2|COMPLETED|Overall Study||141
514222|NCT00928187|1257806|P1|COMPLETED|Overall Study||150
514223|NCT00928187|1257804|P3|Analysed|Overall Study||154
514224|NCT00928187|1257805|P2|Analysed|Overall Study||145
514225|NCT00928187|1257806|P1|Analysed|Overall Study||152
514226|NCT00928187|1257804|P3|STARTED|Overall Study||155
514227|NCT00928187|1257805|P2|STARTED|Overall Study||147
514228|NCT00928187|1257806|P1|STARTED|Overall Study||152
514229|NCT00928174|1257850|P1|NOT COMPLETED|Overall Study||5
514230|NCT00928174|1257850|P1|COMPLETED|Overall Study|3 withdrawn before start of participation|22
514231|NCT00928174|1257850|P1|STARTED|Overall Study||27
514232|NCT00928083|1257857|P9|NOT COMPLETED|Overall Study||0
514233|NCT00928083|1257858|P8|NOT COMPLETED|Overall Study||0
514234|NCT00928083|1257859|P7|NOT COMPLETED|Overall Study||0
514235|NCT00928083|1257860|P6|NOT COMPLETED|Overall Study||0
514236|NCT00928083|1257861|P5|NOT COMPLETED|Overall Study||1
514237|NCT00928083|1257862|P4|NOT COMPLETED|Overall Study||1
514238|NCT00928083|1257863|P3|NOT COMPLETED|Overall Study||0
514239|NCT00928083|1257864|P2|NOT COMPLETED|Overall Study||0
514240|NCT00928083|1257865|P1|NOT COMPLETED|Overall Study||4
514241|NCT00928083|1257857|P9|COMPLETED|Overall Study||6
514242|NCT00928083|1257858|P8|COMPLETED|Overall Study||6
514243|NCT00928083|1257859|P7|COMPLETED|Overall Study||6
514244|NCT00928083|1257860|P6|COMPLETED|Overall Study||6
514245|NCT00928083|1257861|P5|COMPLETED|Overall Study||6
514246|NCT00928083|1257862|P4|COMPLETED|Overall Study||5
514247|NCT00928083|1257863|P3|COMPLETED|Overall Study||8
514248|NCT00928083|1257864|P2|COMPLETED|Overall Study||8
514249|NCT00928083|1257865|P1|COMPLETED|Overall Study||6
514250|NCT00928083|1257857|P9|STARTED|Overall Study||6
514251|NCT00928083|1257858|P8|STARTED|Overall Study||6
514252|NCT00928083|1257859|P7|STARTED|Overall Study||6
514253|NCT00928083|1257860|P6|STARTED|Overall Study||6
514254|NCT00928083|1257861|P5|STARTED|Overall Study||7
514255|NCT00928083|1257862|P4|STARTED|Overall Study||6
514256|NCT00928083|1257863|P3|STARTED|Overall Study||8
514257|NCT00928083|1257864|P2|STARTED|Overall Study||8
514258|NCT00928083|1257865|P1|STARTED|Overall Study||10
514259|NCT00928070|1257976|P2|NOT COMPLETED|Overall Study||57
514260|NCT00928070|1257977|P1|NOT COMPLETED|Overall Study||63
514261|NCT00928070|1257976|P2|COMPLETED|Overall Study||226
514262|NCT00928070|1257977|P1|COMPLETED|Overall Study||220
514263|NCT00928070|1257976|P2|Treated|Overall Study||281
514264|NCT00928070|1257977|P1|Treated|Overall Study||281
514265|NCT00928070|1257976|P2|STARTED|Overall Study||283
514266|NCT00928070|1257977|P1|STARTED|Overall Study||283
514267|NCT00928057|1258035|P2|NOT COMPLETED|Overall Study||4
514268|NCT00928057|1258036|P1|NOT COMPLETED|Overall Study||2
514269|NCT00928057|1258035|P2|COMPLETED|Overall Study||85
514270|NCT00928057|1258036|P1|COMPLETED|Overall Study||82
514271|NCT00928057|1258035|P2|STARTED|Overall Study||89
514272|NCT00928057|1258036|P1|STARTED|Overall Study||84
514273|NCT00928018|1258061|P2|NOT COMPLETED|Overall Study||0
514274|NCT00928018|1258062|P1|NOT COMPLETED|Overall Study||1
514275|NCT00928018|1258061|P2|COMPLETED|Overall Study||73
514276|NCT00928018|1258062|P1|COMPLETED|Overall Study||65
514277|NCT00928018|1258061|P2|STARTED|Overall Study||73
514278|NCT00928018|1258062|P1|STARTED|Overall Study|One Arm A patient withdrew consent, treated as Arm B, but analyzed on Arm A based on intent-to-treat|66
514279|NCT00927992|1258080|P1|NOT COMPLETED|Overall Study||0
514280|NCT00927992|1258080|P1|COMPLETED|Overall Study||11
514281|NCT00927992|1258080|P1|STARTED|Overall Study||11
514282|NCT00927953|1258092|P2|NOT COMPLETED|Overall Study||1
514283|NCT00927953|1258093|P1|NOT COMPLETED|Overall Study||2
514284|NCT00927953|1258092|P2|COMPLETED|Overall Study||6
514285|NCT00927953|1258093|P1|COMPLETED|Overall Study||4
514286|NCT00927953|1258092|P2|STARTED|Overall Study||7
514287|NCT00927953|1258093|P1|STARTED|Overall Study||6
514288|NCT00927940|1258107|P1|NOT COMPLETED|Overall Study||1
514289|NCT00927940|1258107|P1|COMPLETED|Overall Study|A patient died before 30 days follow up. This pasitent is excluded from primary analysis.|99
514290|NCT00927940|1258107|P1|STARTED|Overall Study||100
514291|NCT00927927|1258127|P15|NOT COMPLETED|Overall Study||0
514292|NCT00927927|1258128|P14|NOT COMPLETED|Overall Study||0
514293|NCT00927927|1258129|P13|NOT COMPLETED|Overall Study||0
514294|NCT00927927|1258130|P12|NOT COMPLETED|Overall Study||2
514295|NCT00927927|1258131|P11|NOT COMPLETED|Overall Study||0
514296|NCT00927927|1258132|P10|NOT COMPLETED|Overall Study||0
514297|NCT00927927|1258133|P9|NOT COMPLETED|Overall Study||0
514298|NCT00927927|1258134|P8|NOT COMPLETED|Overall Study||2
514299|NCT00927927|1258135|P7|NOT COMPLETED|Overall Study||0
514300|NCT00927927|1258136|P6|NOT COMPLETED|Overall Study||0
514301|NCT00927927|1258137|P5|NOT COMPLETED|Overall Study||0
514302|NCT00927927|1258138|P4|NOT COMPLETED|Overall Study||0
514303|NCT00927927|1258139|P3|NOT COMPLETED|Overall Study||0
514304|NCT00927927|1258140|P2|NOT COMPLETED|Overall Study||0
514305|NCT00927927|1258141|P1|NOT COMPLETED|Overall Study||0
514306|NCT00927927|1258127|P15|COMPLETED|Overall Study||9
514307|NCT00927927|1258128|P14|COMPLETED|Overall Study||5
514308|NCT00927927|1258129|P13|COMPLETED|Overall Study||5
514309|NCT00927927|1258130|P12|COMPLETED|Overall Study|One subject withdrew consent after being randomised but before receiving any trial product.|4
514310|NCT00927927|1258131|P11|COMPLETED|Overall Study||5
514311|NCT00927927|1258132|P10|COMPLETED|Overall Study||3
514312|NCT00927927|1258133|P9|COMPLETED|Overall Study||8
514313|NCT00927927|1258134|P8|COMPLETED|Overall Study||1
514314|NCT00927927|1258135|P7|COMPLETED|Overall Study||3
514315|NCT00927927|1258136|P6|COMPLETED|Overall Study||3
514316|NCT00927927|1258137|P5|COMPLETED|Overall Study||3
514317|NCT00927927|1258138|P4|COMPLETED|Overall Study||3
514318|NCT00927927|1258139|P3|COMPLETED|Overall Study||3
514319|NCT00927927|1258140|P2|COMPLETED|Overall Study||3
514320|NCT00927927|1258141|P1|COMPLETED|Overall Study||3
514321|NCT00927927|1258127|P15|Exposed|Overall Study||9
514322|NCT00927927|1258128|P14|Exposed|Overall Study||5
514323|NCT00927927|1258129|P13|Exposed|Overall Study||5
514324|NCT00927927|1258130|P12|Exposed|Overall Study||5
514325|NCT00927927|1258131|P11|Exposed|Overall Study||5
514326|NCT00927927|1258132|P10|Exposed|Overall Study||3
514327|NCT00927927|1258133|P9|Exposed|Overall Study||8
514328|NCT00927927|1258134|P8|Exposed|Overall Study||3
514329|NCT00927927|1258135|P7|Exposed|Overall Study||3
514330|NCT00927927|1258136|P6|Exposed|Overall Study||3
514331|NCT00927927|1258137|P5|Exposed|Overall Study||3
514332|NCT00927927|1258138|P4|Exposed|Overall Study||3
514333|NCT00927927|1258139|P3|Exposed|Overall Study||3
514334|NCT00927927|1258140|P2|Exposed|Overall Study||3
514335|NCT00927927|1258141|P1|Exposed|Overall Study||3
514336|NCT00927927|1258127|P15|STARTED|Overall Study||9
514337|NCT00927927|1258128|P14|STARTED|Overall Study||5
514338|NCT00927927|1258129|P13|STARTED|Overall Study||5
514339|NCT00927927|1258130|P12|STARTED|Overall Study||6
514340|NCT00927927|1258131|P11|STARTED|Overall Study||5
514341|NCT00927927|1258132|P10|STARTED|Overall Study||3
514342|NCT00927927|1258133|P9|STARTED|Overall Study||8
514343|NCT00927927|1258134|P8|STARTED|Overall Study||3
514344|NCT00927927|1258135|P7|STARTED|Overall Study||3
514345|NCT00927927|1258136|P6|STARTED|Overall Study||3
514346|NCT00927927|1258137|P5|STARTED|Overall Study||3
514347|NCT00927927|1258138|P4|STARTED|Overall Study||3
514348|NCT00927927|1258139|P3|STARTED|Overall Study||3
514349|NCT00927927|1258140|P2|STARTED|Overall Study||3
514350|NCT00927927|1258141|P1|STARTED|Overall Study||3
514351|NCT00927901|1258188|P4|NOT COMPLETED|Treatment Period 4||1
514352|NCT00927901|1258189|P3|NOT COMPLETED|Treatment Period 4||1
514353|NCT00927901|1258190|P2|NOT COMPLETED|Treatment Period 4||0
514354|NCT00927901|1258191|P1|NOT COMPLETED|Treatment Period 4||0
514355|NCT00927901|1258188|P4|COMPLETED|Treatment Period 4||8
514356|NCT00927901|1258189|P3|COMPLETED|Treatment Period 4||5
514357|NCT00927901|1258190|P2|COMPLETED|Treatment Period 4||7
514358|NCT00927901|1258191|P1|COMPLETED|Treatment Period 4||7
514359|NCT00927901|1258188|P4|STARTED|Treatment Period 4||9
514360|NCT00927901|1258189|P3|STARTED|Treatment Period 4||6
514361|NCT00927901|1258190|P2|STARTED|Treatment Period 4||7
514362|NCT00927901|1258191|P1|STARTED|Treatment Period 4||7
514363|NCT00927901|1258188|P4|NOT COMPLETED|Treatment Period 3||0
514364|NCT00927901|1258189|P3|NOT COMPLETED|Treatment Period 3||0
514365|NCT00927901|1258190|P2|NOT COMPLETED|Treatment Period 3||0
514366|NCT00927901|1258191|P1|NOT COMPLETED|Treatment Period 3||0
514367|NCT00927901|1258188|P4|COMPLETED|Treatment Period 3||9
514368|NCT00927901|1258189|P3|COMPLETED|Treatment Period 3||6
514369|NCT00927901|1258190|P2|COMPLETED|Treatment Period 3||7
514370|NCT00927901|1258191|P1|COMPLETED|Treatment Period 3||7
514371|NCT00927901|1258188|P4|STARTED|Treatment Period 3||9
514372|NCT00927901|1258189|P3|STARTED|Treatment Period 3||6
514373|NCT00927901|1258190|P2|STARTED|Treatment Period 3||7
514374|NCT00927901|1258191|P1|STARTED|Treatment Period 3||7
514375|NCT00927901|1258188|P4|NOT COMPLETED|Treatment Period 2||0
514376|NCT00927901|1258189|P3|NOT COMPLETED|Treatment Period 2||0
514377|NCT00927901|1258190|P2|NOT COMPLETED|Treatment Period 2||0
514378|NCT00927901|1258191|P1|NOT COMPLETED|Treatment Period 2||0
514379|NCT00927901|1258188|P4|COMPLETED|Treatment Period 2||9
514380|NCT00927901|1258189|P3|COMPLETED|Treatment Period 2||6
514381|NCT00927901|1258190|P2|COMPLETED|Treatment Period 2||7
514382|NCT00927901|1258191|P1|COMPLETED|Treatment Period 2||7
514383|NCT00927901|1258188|P4|STARTED|Treatment Period 2||9
514384|NCT00927901|1258189|P3|STARTED|Treatment Period 2||6
514385|NCT00927901|1258190|P2|STARTED|Treatment Period 2||7
514386|NCT00927901|1258191|P1|STARTED|Treatment Period 2||7
514387|NCT00927901|1258188|P4|NOT COMPLETED|Treatment Period 1||0
514388|NCT00927901|1258189|P3|NOT COMPLETED|Treatment Period 1||1
514389|NCT00927901|1258190|P2|NOT COMPLETED|Treatment Period 1||0
514390|NCT00927901|1258191|P1|NOT COMPLETED|Treatment Period 1||0
514391|NCT00927901|1258188|P4|COMPLETED|Treatment Period 1||9
514392|NCT00927901|1258189|P3|COMPLETED|Treatment Period 1||6
514393|NCT00927901|1258190|P2|COMPLETED|Treatment Period 1||7
514394|NCT00927901|1258191|P1|COMPLETED|Treatment Period 1||7
514395|NCT00927901|1258188|P4|STARTED|Treatment Period 1||9
514396|NCT00927901|1258189|P3|STARTED|Treatment Period 1||7
514397|NCT00927901|1258190|P2|STARTED|Treatment Period 1||7
514398|NCT00927901|1258191|P1|STARTED|Treatment Period 1||7
514399|NCT00927888|1258221|P2|NOT COMPLETED|Overall Study||0
514400|NCT00927888|1258222|P1|NOT COMPLETED|Overall Study||0
514401|NCT00927888|1258221|P2|COMPLETED|Overall Study||27
514402|NCT00927888|1258222|P1|COMPLETED|Overall Study||29
514403|NCT00927888|1258221|P2|STARTED|Overall Study||27
514404|NCT00927888|1258222|P1|STARTED|Overall Study||29
514405|NCT00927862|1258232|P2|NOT COMPLETED|Overall Study||45
514406|NCT00927862|1258233|P1|NOT COMPLETED|Overall Study||27
514407|NCT00927862|1258232|P2|COMPLETED|Overall Study||1866
514408|NCT00927862|1258233|P1|COMPLETED|Overall Study|477 patients evaluated in primary analyses and 488 evaluated in secondary analyses.|477
514409|NCT00927862|1258232|P2|STARTED|Overall Study||1911
514410|NCT00927862|1258233|P1|STARTED|Overall Study||504
514411|NCT00927849|1258258|P3|NOT COMPLETED|Overall Study||0
514412|NCT00927849|1258259|P2|NOT COMPLETED|Overall Study||0
514413|NCT00927849|1258260|P1|NOT COMPLETED|Overall Study||0
514414|NCT00927849|1258258|P3|COMPLETED|Overall Study||21
514415|NCT00927849|1258259|P2|COMPLETED|Overall Study||21
514416|NCT00927849|1258260|P1|COMPLETED|Overall Study||21
514417|NCT00927849|1258258|P3|STARTED|Overall Study||21
514418|NCT00927849|1258259|P2|STARTED|Overall Study||21
514419|NCT00927849|1258260|P1|STARTED|Overall Study||21
514420|NCT00927823|1258268|P4|NOT COMPLETED|Continuous Dosing Period||5
514421|NCT00927823|1258269|P3|NOT COMPLETED|Continuous Dosing Period||26
514422|NCT00927823|1258270|P2|NOT COMPLETED|Continuous Dosing Period||3
514423|NCT00927823|1258271|P1|NOT COMPLETED|Continuous Dosing Period||3
514424|NCT00927823|1258268|P4|COMPLETED|Continuous Dosing Period||0
514425|NCT00927823|1258269|P3|COMPLETED|Continuous Dosing Period||0
514426|NCT00927823|1258270|P2|COMPLETED|Continuous Dosing Period||0
514427|NCT00927823|1258271|P1|COMPLETED|Continuous Dosing Period||0
514428|NCT00927823|1258268|P4|Treated|Continuous Dosing Period||5
514429|NCT00927823|1258269|P3|Treated|Continuous Dosing Period||23
514430|NCT00927823|1258270|P2|Treated|Continuous Dosing Period||3
514431|NCT00927823|1258271|P1|Treated|Continuous Dosing Period||3
514432|NCT00927823|1258268|P4|STARTED|Continuous Dosing Period||5
514433|NCT00927823|1258269|P3|STARTED|Continuous Dosing Period||26
514434|NCT00927823|1258270|P2|STARTED|Continuous Dosing Period||3
514435|NCT00927823|1258271|P1|STARTED|Continuous Dosing Period||3
514436|NCT00927823|1258268|P4|NOT COMPLETED|Lead-In Period||0
514437|NCT00927823|1258269|P3|NOT COMPLETED|Lead-In Period||0
514438|NCT00927823|1258270|P2|NOT COMPLETED|Lead-In Period||0
514439|NCT00927823|1258271|P1|NOT COMPLETED|Lead-In Period||0
514440|NCT00927823|1258268|P4|COMPLETED|Lead-In Period||5
514441|NCT00927823|1258269|P3|COMPLETED|Lead-In Period||26
514442|NCT00927823|1258270|P2|COMPLETED|Lead-In Period||3
514443|NCT00927823|1258271|P1|COMPLETED|Lead-In Period||3
514444|NCT00927823|1258268|P4|STARTED|Lead-In Period||5
514445|NCT00927823|1258269|P3|STARTED|Lead-In Period||26
514446|NCT00927823|1258270|P2|STARTED|Lead-In Period||3
514447|NCT00927823|1258271|P1|STARTED|Lead-In Period||3
514448|NCT00927758|1258335|P6|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
514449|NCT00927758|1258336|P5|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
514450|NCT00927758|1258337|P4|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
514451|NCT00927758|1258338|P3|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
514452|NCT00927758|1258339|P2|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
514453|NCT00927758|1258340|P1|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
514454|NCT00927758|1258335|P6|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||2
514455|NCT00927758|1258336|P5|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3
514456|NCT00927758|1258337|P4|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||1
514457|NCT00927758|1258338|P3|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3
514458|NCT00927758|1258339|P2|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4
514459|NCT00927758|1258340|P1|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4
514460|NCT00927758|1258335|P6|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||2
514461|NCT00927758|1258336|P5|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3
514462|NCT00927758|1258337|P4|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||1
514463|NCT00927758|1258338|P3|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3
514464|NCT00927758|1258339|P2|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4
514465|NCT00927758|1258340|P1|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4
514466|NCT00927758|1258335|P6|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
514467|NCT00927758|1258336|P5|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
514468|NCT00927758|1258337|P4|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
514469|NCT00927758|1258338|P3|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
514470|NCT00927758|1258339|P2|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
514471|NCT00927758|1258340|P1|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
514472|NCT00927758|1258335|P6|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||2
514473|NCT00927758|1258336|P5|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3
514474|NCT00927758|1258337|P4|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
514475|NCT00927758|1258338|P3|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3
514476|NCT00927758|1258339|P2|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4
514477|NCT00927758|1258340|P1|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4
514478|NCT00927758|1258335|P6|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||2
514479|NCT00927758|1258336|P5|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3
514480|NCT00927758|1258337|P4|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||1
514481|NCT00927758|1258338|P3|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3
514482|NCT00927758|1258339|P2|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4
514483|NCT00927758|1258340|P1|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4
514484|NCT00927758|1258335|P6|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3
514485|NCT00927758|1258336|P5|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3
514486|NCT00927758|1258337|P4|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||2
514487|NCT00927758|1258338|P3|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
514488|NCT00927758|1258339|P2|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
514489|NCT00927758|1258340|P1|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
514490|NCT00927758|1258335|P6|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1
514491|NCT00927758|1258336|P5|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
514492|NCT00927758|1258337|P4|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1
514493|NCT00927758|1258338|P3|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
514494|NCT00927758|1258339|P2|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
514495|NCT00927758|1258340|P1|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
514496|NCT00927758|1258335|P6|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3
514497|NCT00927758|1258336|P5|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3
514498|NCT00927758|1258337|P4|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||2
514499|NCT00927758|1258338|P3|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
514500|NCT00927758|1258339|P2|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
514501|NCT00927758|1258340|P1|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
514502|NCT00927758|1258335|P6|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3
514503|NCT00927758|1258336|P5|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3
514504|NCT00927758|1258337|P4|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||2
514505|NCT00927758|1258338|P3|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
514506|NCT00927758|1258339|P2|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
514507|NCT00927758|1258340|P1|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
514508|NCT00927758|1258335|P6|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
514509|NCT00927758|1258336|P5|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3
514510|NCT00927758|1258337|P4|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3
514511|NCT00927758|1258338|P3|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
514512|NCT00927758|1258339|P2|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
514513|NCT00927758|1258340|P1|STARTED|Treatment Cycle 1 (Day 1 - Day 7)|"Started  indicates randomized as well as safety set."|4
514514|NCT00927589|1258348|P1|NOT COMPLETED|Overall Study||16
514515|NCT00927589|1258348|P1|COMPLETED|Overall Study|Participants were considered to have completed the study after receiving 3 cycles of treatment.|43
514516|NCT00927589|1258348|P1|STARTED|Overall Study||59
514517|NCT00927576|1258372|P2|NOT COMPLETED|Overall Study||0
514518|NCT00927576|1258373|P1|NOT COMPLETED|Overall Study||0
514519|NCT00927576|1258372|P2|COMPLETED|Overall Study||28
514520|NCT00927576|1258373|P1|COMPLETED|Overall Study||237
514521|NCT00927576|1258372|P2|Cognitive Testing|Overall Study||28
514522|NCT00927576|1258373|P1|Cognitive Testing|Overall Study||237
514523|NCT00927576|1258372|P2|STARTED|Overall Study||28
514524|NCT00927576|1258373|P1|STARTED|Overall Study||237
514525|NCT00927563|1258378|P1|NOT COMPLETED|Overall Study||2
514526|NCT00927563|1258378|P1|COMPLETED|Overall Study||22
514527|NCT00927563|1258378|P1|STARTED|Overall Study||24
514528|NCT00927472|1258386|P2|NOT COMPLETED|Overall Study||22
514529|NCT00927472|1258387|P1|NOT COMPLETED|Overall Study||11
514530|NCT00927472|1258386|P2|COMPLETED|Overall Study||106
514531|NCT00927472|1258387|P1|COMPLETED|Overall Study||115
514532|NCT00927472|1258386|P2|STARTED|Overall Study||128
514533|NCT00927472|1258387|P1|STARTED|Overall Study||126
514534|NCT00927394|1258413|P2|NOT COMPLETED|Overall Study||85
514535|NCT00927394|1258414|P1|NOT COMPLETED|Overall Study||77
514536|NCT00927394|1258413|P2|COMPLETED|Overall Study||483
514537|NCT00927394|1258414|P1|COMPLETED|Overall Study||498
514538|NCT00927394|1258413|P2|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||562
514539|NCT00927394|1258414|P1|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||574
514540|NCT00927394|1258413|P2|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study||323
514541|NCT00927394|1258414|P1|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study|consists of all patients in FAS 2 who had both valid baseline and post-baseline ABPM assessments.|342
514542|NCT00927394|1258413|P2|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study||398
514543|NCT00927394|1258414|P1|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study|FAS 2= all patients randomized to Cohort 2 and who had a valid baseline assessment of 24 hours ABPM.|417
514544|NCT00927394|1258413|P2|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study||164
514721|NCT00926367|1258911|P1|COMPLETED|Overall Study||23
514722|NCT00926367|1258910|P2|STARTED|Overall Study||27
514545|NCT00927394|1258414|P1|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study|FAS 1 includes all patients in Cohort 1 to whom study treatments were given through randomization.|157
514546|NCT00927394|1258413|P2|Combined Safety Set (Cohort 1 and 2)|Overall Study||565
514547|NCT00927394|1258414|P1|Combined Safety Set (Cohort 1 and 2)|Overall Study||574
514548|NCT00927394|1258413|P2|Cohort 2 (Randomized)|Overall Study||403
514549|NCT00927394|1258414|P1|Cohort 2 (Randomized)|Overall Study|Cohort 2 includes patients with specific eligibility criteria mentioned in protocol section|418
514550|NCT00927394|1258413|P2|Cohort 1 (Randomized)|Overall Study||165
514551|NCT00927394|1258414|P1|Cohort 1 (Randomized)|Overall Study|Cohort 1 includes patients with specific eligibility criteria mentioned in protocol section|157
514552|NCT00927394|1258413|P2|STARTED|Overall Study|One patient was randomized in error and was discontinued by site.|568
514553|NCT00927394|1258414|P1|STARTED|Overall Study||575
514554|NCT00927368|1258445|P3|NOT COMPLETED|Overall Study||5
514555|NCT00927368|1258446|P2|NOT COMPLETED|Overall Study||5
514556|NCT00927368|1258447|P1|NOT COMPLETED|Overall Study||6
514557|NCT00927368|1258445|P3|COMPLETED|Overall Study||138
514558|NCT00927368|1258446|P2|COMPLETED|Overall Study||152
514559|NCT00927368|1258447|P1|COMPLETED|Overall Study||147
514560|NCT00927368|1258445|P3|STARTED|Overall Study||143
514561|NCT00927368|1258446|P2|STARTED|Overall Study||157
514562|NCT00927368|1258447|P1|STARTED|Overall Study||153
514563|NCT00927355|1258466|P2|NOT COMPLETED|Overall Study||1
514564|NCT00927355|1258467|P1|NOT COMPLETED|Overall Study||1
514565|NCT00927355|1258466|P2|COMPLETED|Overall Study||4
514566|NCT00927355|1258467|P1|COMPLETED|Overall Study||4
514567|NCT00927355|1258466|P2|STARTED|Overall Study||5
514568|NCT00927355|1258467|P1|STARTED|Overall Study||5
514569|NCT00927264|1258487|P2|NOT COMPLETED|Overall Study||25
514570|NCT00927264|1258488|P1|NOT COMPLETED|Overall Study||56
514571|NCT00927264|1258487|P2|COMPLETED|Overall Study||140
514572|NCT00927264|1258488|P1|COMPLETED|Overall Study||109
514573|NCT00927264|1258487|P2|STARTED|Overall Study||165
514574|NCT00927264|1258488|P1|STARTED|Overall Study||165
514575|NCT00927251|1258502|P1|NOT COMPLETED|Overall Study||8
514576|NCT00927251|1258502|P1|COMPLETED|Overall Study||82
514577|NCT00927251|1258502|P1|STARTED|Overall Study||90
514578|NCT00927186|1258508|P2|NOT COMPLETED|12 - 24 Months Extension Treatment||0
514579|NCT00927186|1258509|P1|NOT COMPLETED|12 - 24 Months Extension Treatment||0
514580|NCT00927186|1258508|P2|COMPLETED|12 - 24 Months Extension Treatment||11
514581|NCT00927186|1258509|P1|COMPLETED|12 - 24 Months Extension Treatment||10
514582|NCT00927186|1258508|P2|STARTED|12 - 24 Months Extension Treatment|Not all participants who completed 12 months of primary study chose to enter 12-month extension.|11
514583|NCT00927186|1258509|P1|STARTED|12 - 24 Months Extension Treatment|Not all participants who completed 12 months of primary study chose to enter 12-month extension.|10
514584|NCT00927186|1258508|P2|NOT COMPLETED|12 Months Primary Study||4
514585|NCT00927186|1258509|P1|NOT COMPLETED|12 Months Primary Study||7
514586|NCT00927186|1258508|P2|COMPLETED|12 Months Primary Study||31
514587|NCT00927186|1258509|P1|COMPLETED|12 Months Primary Study||27
514588|NCT00927186|1258508|P2|Completed 6 Months Double Blind Phase|12 Months Primary Study||31
514589|NCT00927186|1258509|P1|Completed 6 Months Double Blind Phase|12 Months Primary Study||28
514590|NCT00927186|1258508|P2|STARTED|12 Months Primary Study||35
514591|NCT00927186|1258509|P1|STARTED|12 Months Primary Study||34
514592|NCT00927160|1258627|P2|NOT COMPLETED|Overall Study||0
514593|NCT00927160|1258628|P1|NOT COMPLETED|Overall Study||0
514594|NCT00927160|1258627|P2|COMPLETED|Overall Study||173
514595|NCT00927160|1258628|P1|COMPLETED|Overall Study||173
514596|NCT00927160|1258627|P2|STARTED|Overall Study||173
514597|NCT00927160|1258628|P1|STARTED|Overall Study||173
514598|NCT00927095|1258639|P3|NOT COMPLETED|Overall Study||2
514599|NCT00927095|1258640|P2|NOT COMPLETED|Overall Study||4
514600|NCT00927095|1258641|P1|NOT COMPLETED|Overall Study||6
514601|NCT00927095|1258639|P3|COMPLETED|Overall Study||22
514602|NCT00927095|1258640|P2|COMPLETED|Overall Study||17
514603|NCT00927095|1258641|P1|COMPLETED|Overall Study||16
514604|NCT00927095|1258639|P3|STARTED|Overall Study||24
514605|NCT00927095|1258640|P2|STARTED|Overall Study||21
514606|NCT00927095|1258641|P1|STARTED|Overall Study||22
514607|NCT00927082|1258653|P4|NOT COMPLETED|Overall Study||19
514608|NCT00927082|1258654|P3|NOT COMPLETED|Overall Study||22
514609|NCT00927082|1258655|P2|NOT COMPLETED|Overall Study||10
514610|NCT00927082|1258656|P1|NOT COMPLETED|Overall Study||12
514611|NCT00927082|1258653|P4|COMPLETED|Overall Study||78
514612|NCT00927082|1258654|P3|COMPLETED|Overall Study||86
514613|NCT00927082|1258655|P2|COMPLETED|Overall Study||77
514614|NCT00927082|1258656|P1|COMPLETED|Overall Study||79
514615|NCT00927082|1258653|P4|STARTED|Overall Study||97
514616|NCT00927082|1258654|P3|STARTED|Overall Study||108
514617|NCT00927082|1258655|P2|STARTED|Overall Study||87
514618|NCT00927082|1258656|P1|STARTED|Overall Study||91
514619|NCT00927069|1258720|P4|NOT COMPLETED|Week 12 to Week 24||3
514620|NCT00927069|1258721|P3|NOT COMPLETED|Week 12 to Week 24||3
514621|NCT00927069|1258722|P2|NOT COMPLETED|Week 12 to Week 24||0
514622|NCT00927069|1258723|P1|NOT COMPLETED|Week 12 to Week 24||2
514623|NCT00927069|1258720|P4|COMPLETED|Week 12 to Week 24||20
514624|NCT00927069|1258721|P3|COMPLETED|Week 12 to Week 24||28
514625|NCT00927069|1258722|P2|COMPLETED|Week 12 to Week 24||11
514626|NCT00927069|1258723|P1|COMPLETED|Week 12 to Week 24||16
514627|NCT00927069|1258720|P4|STARTED|Week 12 to Week 24|23 Pts. from Group B had a dose incr. since they did not respond to 40mg adalimumab every other week|23
514723|NCT00926367|1258911|P1|STARTED|Overall Study||25
514628|NCT00927069|1258721|P3|STARTED|Week 12 to Week 24|31 Pts. from Group A had a dose incr. since they did not respond to 40mg adalimumab every other week|31
514629|NCT00927069|1258722|P2|STARTED|Week 12 to Week 24|11 patients stayed at the same dose of 40 mg Adalimumab every other week|11
514630|NCT00927069|1258723|P1|STARTED|Week 12 to Week 24|17 patients stayed at the same dose. One patient withdrew at Week 12 and also had no dose increase|18
514631|NCT00927069|1258720|P4|NOT COMPLETED|Week 0 to Week 12||0
514632|NCT00927069|1258721|P3|NOT COMPLETED|Week 0 to Week 12||0
514633|NCT00927069|1258722|P2|NOT COMPLETED|Week 0 to Week 12||1
514634|NCT00927069|1258723|P1|NOT COMPLETED|Week 0 to Week 12||1
514635|NCT00927069|1258720|P4|COMPLETED|Week 0 to Week 12||0
514636|NCT00927069|1258721|P3|COMPLETED|Week 0 to Week 12||0
514637|NCT00927069|1258722|P2|COMPLETED|Week 0 to Week 12||34
514638|NCT00927069|1258723|P1|COMPLETED|Week 0 to Week 12||49
514639|NCT00927069|1258720|P4|STARTED|Week 0 to Week 12||0
514640|NCT00927069|1258721|P3|STARTED|Week 0 to Week 12||0
514641|NCT00927069|1258722|P2|STARTED|Week 0 to Week 12||35
514642|NCT00927069|1258723|P1|STARTED|Week 0 to Week 12||50
514643|NCT00926952|1258733|P1|NOT COMPLETED|Overall Study||0
514644|NCT00926952|1258733|P1|COMPLETED|Overall Study||20
514645|NCT00926952|1258733|P1|STARTED|Overall Study||20
514646|NCT00926887|1258747|P2|NOT COMPLETED|Overall Study||0
514647|NCT00926887|1258748|P1|NOT COMPLETED|Overall Study||0
514648|NCT00926887|1258747|P2|COMPLETED|Overall Study||50
514649|NCT00926887|1258748|P1|COMPLETED|Overall Study||54
514650|NCT00926887|1258747|P2|STARTED|Overall Study||50
514651|NCT00926887|1258748|P1|STARTED|Overall Study||54
514652|NCT00926848|1258760|P2|NOT COMPLETED|Overall Study||0
514653|NCT00926848|1258761|P1|NOT COMPLETED|Overall Study||0
514654|NCT00926848|1258760|P2|COMPLETED|Overall Study||34
514655|NCT00926848|1258761|P1|COMPLETED|Overall Study||34
514656|NCT00926848|1258760|P2|STARTED|Overall Study||34
514657|NCT00926848|1258761|P1|STARTED|Overall Study||34
514658|NCT00926796|1258779|P2|NOT COMPLETED|Overall Study||106
514659|NCT00926796|1258780|P1|NOT COMPLETED|Overall Study||107
514660|NCT00926796|1258779|P2|COMPLETED|Overall Study|Number eligible and in the full analysis set|199
514661|NCT00926796|1258780|P1|COMPLETED|Overall Study|Number eligible and in the full analysis set|202
514662|NCT00926796|1258779|P2|STARTED|Overall Study|Number randomized|305
514663|NCT00926796|1258780|P1|STARTED|Overall Study|Number randomized|309
514664|NCT00926783|1258801|P2|NOT COMPLETED|Overall Study||3
514665|NCT00926783|1258802|P1|NOT COMPLETED|Overall Study||3
514666|NCT00926783|1258801|P2|COMPLETED|Overall Study||38
514667|NCT00926783|1258802|P1|COMPLETED|Overall Study||39
514668|NCT00926783|1258801|P2|STARTED|Overall Study||41
514669|NCT00926783|1258802|P1|STARTED|Overall Study||42
514670|NCT00926588|1258820|P2|NOT COMPLETED|Overall Study||4
514671|NCT00926588|1258821|P1|NOT COMPLETED|Overall Study||8
514672|NCT00926588|1258820|P2|COMPLETED|Overall Study||122
514673|NCT00926588|1258821|P1|COMPLETED|Overall Study||116
514674|NCT00926588|1258820|P2|STARTED|Overall Study||126
514675|NCT00926588|1258821|P1|STARTED|Overall Study||124
514676|NCT00926575|1258829|P2|NOT COMPLETED|Overall Study||17
514677|NCT00926575|1258830|P1|NOT COMPLETED|Overall Study||16
514678|NCT00926575|1258829|P2|COMPLETED|Overall Study||53
514679|NCT00926575|1258830|P1|COMPLETED|Overall Study||54
514680|NCT00926575|1258829|P2|STARTED|Overall Study||70
514681|NCT00926575|1258830|P1|STARTED|Overall Study||70
514682|NCT00926536|1258842|P2|NOT COMPLETED|Overall Study||2
514683|NCT00926536|1258843|P1|NOT COMPLETED|Overall Study||1
514684|NCT00926536|1258842|P2|COMPLETED|Overall Study||41
514685|NCT00926536|1258843|P1|COMPLETED|Overall Study||43
514686|NCT00926536|1258842|P2|STARTED|Overall Study||43
514687|NCT00926536|1258843|P1|STARTED|Overall Study||44
514688|NCT00926497|1258853|P2|NOT COMPLETED|Overall Study||0
514689|NCT00926497|1258854|P1|NOT COMPLETED|Overall Study||0
514690|NCT00926497|1258853|P2|COMPLETED|Overall Study||61
514691|NCT00926497|1258854|P1|COMPLETED|Overall Study||60
514692|NCT00926497|1258853|P2|STARTED|Overall Study||61
514693|NCT00926497|1258854|P1|STARTED|Overall Study||60
514694|NCT00926393|1258864|P2|NOT COMPLETED|Overall Study||3
514695|NCT00926393|1258865|P1|NOT COMPLETED|Overall Study||2
514696|NCT00926393|1258864|P2|COMPLETED|Overall Study||67
514697|NCT00926393|1258865|P1|COMPLETED|Overall Study||67
514698|NCT00926393|1258864|P2|STARTED|Overall Study||70
514699|NCT00926393|1258865|P1|STARTED|Overall Study||69
514718|NCT00926367|1258910|P2|NOT COMPLETED|Overall Study||3
514719|NCT00926367|1258911|P1|NOT COMPLETED|Overall Study||2
514720|NCT00926367|1258910|P2|COMPLETED|Overall Study||24
514724|NCT00926328|1258953|P2|NOT COMPLETED|Overall Study||14
514725|NCT00926328|1258954|P1|NOT COMPLETED|Overall Study||12
514726|NCT00926328|1258953|P2|COMPLETED|Overall Study||46
514727|NCT00926328|1258954|P1|COMPLETED|Overall Study||48
514728|NCT00926328|1258953|P2|STARTED|Overall Study||60
514729|NCT00926328|1258954|P1|STARTED|Overall Study||60
514730|NCT00926289|1258964|P2|NOT COMPLETED|Overall Study||36
514731|NCT00926289|1258965|P1|NOT COMPLETED|Overall Study||25
514732|NCT00926289|1258964|P2|COMPLETED|Overall Study||558
514733|NCT00926289|1258965|P1|COMPLETED|Overall Study||269
514734|NCT00926289|1258964|P2|STARTED|Overall Study|Number of treated patients|594
514735|NCT00926289|1258965|P1|STARTED|Overall Study|Number of treated patients|294
514736|NCT00926263|1259001|P2|NOT COMPLETED|Overall Study||0
514737|NCT00926263|1259002|P1|NOT COMPLETED|Overall Study||0
514738|NCT00926263|1259001|P2|COMPLETED|Overall Study||12
514739|NCT00926263|1259002|P1|COMPLETED|Overall Study||16
514740|NCT00926263|1259001|P2|STARTED|Overall Study||12
514741|NCT00926263|1259002|P1|STARTED|Overall Study||16
514742|NCT00926211|1259033|P1|NOT COMPLETED|Overall Study||1
514743|NCT00926211|1259033|P1|COMPLETED|Overall Study||35
514744|NCT00926211|1259033|P1|STARTED|Overall Study|One additional subject was not randomized and did not receive the treatment procedure.|36
514745|NCT00926185|1259044|P4|NOT COMPLETED|Overall Study||10
514746|NCT00926185|1259045|P3|NOT COMPLETED|Overall Study||10
514747|NCT00926185|1259046|P2|NOT COMPLETED|Overall Study||6
514748|NCT00926185|1259047|P1|NOT COMPLETED|Overall Study||3
514749|NCT00926185|1259044|P4|COMPLETED|Overall Study||48
514750|NCT00926185|1259045|P3|COMPLETED|Overall Study||48
514751|NCT00926185|1259046|P2|COMPLETED|Overall Study||51
514752|NCT00926185|1259047|P1|COMPLETED|Overall Study||54
514753|NCT00926185|1259044|P4|STARTED|Overall Study||58
514754|NCT00926185|1259045|P3|STARTED|Overall Study||58
514755|NCT00926185|1259046|P2|STARTED|Overall Study||57
514756|NCT00926185|1259047|P1|STARTED|Overall Study||57
514757|NCT00926029|1259064|P3|NOT COMPLETED|Overall Study||1
514758|NCT00926029|1259065|P2|NOT COMPLETED|Overall Study||1
514759|NCT00926029|1259066|P1|NOT COMPLETED|Overall Study||2
514760|NCT00926029|1259064|P3|COMPLETED|Overall Study||33
514761|NCT00926029|1259065|P2|COMPLETED|Overall Study||33
514762|NCT00926029|1259066|P1|COMPLETED|Overall Study||32
514763|NCT00926029|1259064|P3|STARTED|Overall Study||34
514764|NCT00926029|1259065|P2|STARTED|Overall Study||34
514765|NCT00926029|1259066|P1|STARTED|Overall Study||34
514766|NCT00925990|1259079|P2|NOT COMPLETED|Overall Study||11
514767|NCT00925990|1259080|P1|NOT COMPLETED|Overall Study||5
514768|NCT00925990|1259079|P2|COMPLETED|Overall Study||24
514769|NCT00925990|1259080|P1|COMPLETED|Overall Study||30
514770|NCT00925990|1259079|P2|STARTED|Overall Study||35
514771|NCT00925990|1259080|P1|STARTED|Overall Study||35
514772|NCT00925938|1259091|P3|NOT COMPLETED|Overall Study||0
514773|NCT00925938|1259092|P2|NOT COMPLETED|Overall Study||0
514774|NCT00925938|1259093|P1|NOT COMPLETED|Overall Study||0
514775|NCT00925938|1259091|P3|COMPLETED|Overall Study||17
514776|NCT00925938|1259092|P2|COMPLETED|Overall Study||25
514777|NCT00925938|1259093|P1|COMPLETED|Overall Study||9
514778|NCT00925938|1259091|P3|STARTED|Overall Study||17
514779|NCT00925938|1259092|P2|STARTED|Overall Study||25
514780|NCT00925938|1259093|P1|STARTED|Overall Study||9
514781|NCT00925899|1259115|P2|NOT COMPLETED|Part 2||12
514782|NCT00925899|1259116|P1|NOT COMPLETED|Part 2||6
514783|NCT00925899|1259115|P2|COMPLETED|Part 2||9
514784|NCT00925899|1259116|P1|COMPLETED|Part 2||9
514785|NCT00925899|1259115|P2|STARTED|Part 2|Nine patients withdrew because they did not wish to continue in the study|21
514786|NCT00925899|1259116|P1|STARTED|Part 2|All patients received the same intervention in the second part of the study (20 mg melatonin)|15
514787|NCT00925899|1259115|P2|NOT COMPLETED|Part 1||11
514788|NCT00925899|1259116|P1|NOT COMPLETED|Part 1||11
514789|NCT00925899|1259115|P2|COMPLETED|Part 1||27
514790|NCT00925899|1259116|P1|COMPLETED|Part 1||23
514791|NCT00925899|1259115|P2|STARTED|Part 1||38
514792|NCT00925899|1259116|P1|STARTED|Part 1||34
514793|NCT00925782|1259134|P2|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0
514794|NCT00925782|1259135|P1|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0
514795|NCT00925782|1259134|P2|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12
514796|NCT00925782|1259135|P1|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12
514797|NCT00925782|1259134|P2|STARTED|Follow-up(Day +1 to Date of Engraftment)||12
514798|NCT00925782|1259135|P1|STARTED|Follow-up(Day +1 to Date of Engraftment)||12
514799|NCT00925782|1259134|P2|NOT COMPLETED|Study Period (Day -3 to Day 0)||0
514800|NCT00925782|1259135|P1|NOT COMPLETED|Study Period (Day -3 to Day 0)||0
514801|NCT00925782|1259134|P2|COMPLETED|Study Period (Day -3 to Day 0)||12
514802|NCT00925782|1259135|P1|COMPLETED|Study Period (Day -3 to Day 0)||12
514803|NCT00925782|1259134|P2|STARTED|Study Period (Day -3 to Day 0)||12
514804|NCT00925782|1259135|P1|STARTED|Study Period (Day -3 to Day 0)||12
514805|NCT00925782|1259134|P2|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0
514806|NCT00925782|1259135|P1|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0
514807|NCT00925782|1259134|P2|COMPLETED|Pretreatment (Day -30 to Day -3)||12
514808|NCT00925782|1259135|P1|COMPLETED|Pretreatment (Day -30 to Day -3)||12
514809|NCT00925782|1259134|P2|STARTED|Pretreatment (Day -30 to Day -3)||12
514810|NCT00925782|1259135|P1|STARTED|Pretreatment (Day -30 to Day -3)||12
514811|NCT00925769|1259144|P6|NOT COMPLETED|Overall Study||3
514812|NCT00925769|1259145|P5|NOT COMPLETED|Overall Study||3
514813|NCT00925769|1259146|P4|NOT COMPLETED|Overall Study||6
514814|NCT00925769|1259147|P3|NOT COMPLETED|Overall Study||6
514815|NCT00925769|1259148|P2|NOT COMPLETED|Overall Study||6
514816|NCT00925769|1259149|P1|NOT COMPLETED|Overall Study||6
514817|NCT00925769|1259144|P6|COMPLETED|Overall Study||0
514818|NCT00925769|1259145|P5|COMPLETED|Overall Study||0
514819|NCT00925769|1259146|P4|COMPLETED|Overall Study||0
514820|NCT00925769|1259147|P3|COMPLETED|Overall Study||0
514821|NCT00925769|1259148|P2|COMPLETED|Overall Study||0
514822|NCT00925769|1259149|P1|COMPLETED|Overall Study||0
514823|NCT00925769|1259144|P6|STARTED|Overall Study||3
514824|NCT00925769|1259145|P5|STARTED|Overall Study||3
514825|NCT00925769|1259146|P4|STARTED|Overall Study||6
514826|NCT00925769|1259147|P3|STARTED|Overall Study||6
514827|NCT00925769|1259148|P2|STARTED|Overall Study||6
514828|NCT00925769|1259149|P1|STARTED|Overall Study||6
514829|NCT00925704|1259217|P6|NOT COMPLETED|Third Intervention||1
514830|NCT00925704|1259218|P5|NOT COMPLETED|Third Intervention||0
514831|NCT00925704|1259219|P4|NOT COMPLETED|Third Intervention||0
514832|NCT00925704|1259220|P3|NOT COMPLETED|Third Intervention||0
514833|NCT00925704|1259221|P2|NOT COMPLETED|Third Intervention||0
514834|NCT00925704|1259222|P1|NOT COMPLETED|Third Intervention||0
514835|NCT00925704|1259217|P6|COMPLETED|Third Intervention||6
514836|NCT00925704|1259218|P5|COMPLETED|Third Intervention||5
514837|NCT00925704|1259219|P4|COMPLETED|Third Intervention||6
514838|NCT00925704|1259220|P3|COMPLETED|Third Intervention||7
514839|NCT00925704|1259221|P2|COMPLETED|Third Intervention||7
514840|NCT00925704|1259222|P1|COMPLETED|Third Intervention||5
514841|NCT00925704|1259217|P6|STARTED|Third Intervention||7
514842|NCT00925704|1259218|P5|STARTED|Third Intervention||5
514843|NCT00925704|1259219|P4|STARTED|Third Intervention||6
514844|NCT00925704|1259220|P3|STARTED|Third Intervention||7
514845|NCT00925704|1259221|P2|STARTED|Third Intervention||7
514846|NCT00925704|1259222|P1|STARTED|Third Intervention||5
514847|NCT00925704|1259217|P6|NOT COMPLETED|Washout||0
514848|NCT00925704|1259218|P5|NOT COMPLETED|Washout||0
514849|NCT00925704|1259219|P4|NOT COMPLETED|Washout||0
514850|NCT00925704|1259220|P3|NOT COMPLETED|Washout||0
514851|NCT00925704|1259221|P2|NOT COMPLETED|Washout||0
514852|NCT00925704|1259222|P1|NOT COMPLETED|Washout||0
514853|NCT00925704|1259217|P6|COMPLETED|Washout||7
514854|NCT00925704|1259218|P5|COMPLETED|Washout||5
514855|NCT00925704|1259219|P4|COMPLETED|Washout||6
514856|NCT00925704|1259220|P3|COMPLETED|Washout||7
514857|NCT00925704|1259221|P2|COMPLETED|Washout||7
514858|NCT00925704|1259222|P1|COMPLETED|Washout||5
514859|NCT00925704|1259217|P6|STARTED|Washout||7
514860|NCT00925704|1259218|P5|STARTED|Washout||5
514861|NCT00925704|1259219|P4|STARTED|Washout||6
514862|NCT00925704|1259220|P3|STARTED|Washout||7
514863|NCT00925704|1259221|P2|STARTED|Washout||7
514864|NCT00925704|1259222|P1|STARTED|Washout||5
514865|NCT00925704|1259217|P6|NOT COMPLETED|Second Intervention||0
514866|NCT00925704|1259218|P5|NOT COMPLETED|Second Intervention||1
514867|NCT00925704|1259219|P4|NOT COMPLETED|Second Intervention||0
514868|NCT00925704|1259220|P3|NOT COMPLETED|Second Intervention||0
514869|NCT00925704|1259221|P2|NOT COMPLETED|Second Intervention||0
514870|NCT00925704|1259222|P1|NOT COMPLETED|Second Intervention||1
514871|NCT00925704|1259217|P6|COMPLETED|Second Intervention||7
514872|NCT00925704|1259218|P5|COMPLETED|Second Intervention||5
514873|NCT00925704|1259219|P4|COMPLETED|Second Intervention||6
514874|NCT00925704|1259220|P3|COMPLETED|Second Intervention||7
514875|NCT00925704|1259221|P2|COMPLETED|Second Intervention||7
514876|NCT00925704|1259222|P1|COMPLETED|Second Intervention||5
514877|NCT00925704|1259217|P6|STARTED|Second Intervention||7
514878|NCT00925704|1259218|P5|STARTED|Second Intervention||6
514879|NCT00925704|1259219|P4|STARTED|Second Intervention||6
514880|NCT00925704|1259220|P3|STARTED|Second Intervention||7
514881|NCT00925704|1259221|P2|STARTED|Second Intervention||7
514882|NCT00925704|1259222|P1|STARTED|Second Intervention||6
514883|NCT00925704|1259217|P6|NOT COMPLETED|Washout||0
514884|NCT00925704|1259218|P5|NOT COMPLETED|Washout||0
514885|NCT00925704|1259219|P4|NOT COMPLETED|Washout||0
514886|NCT00925704|1259220|P3|NOT COMPLETED|Washout||0
514887|NCT00925704|1259221|P2|NOT COMPLETED|Washout||0
514888|NCT00925704|1259222|P1|NOT COMPLETED|Washout||0
514889|NCT00925704|1259217|P6|COMPLETED|Washout||7
514890|NCT00925704|1259218|P5|COMPLETED|Washout||6
514891|NCT00925704|1259219|P4|COMPLETED|Washout||6
514892|NCT00925704|1259220|P3|COMPLETED|Washout||7
514893|NCT00925704|1259221|P2|COMPLETED|Washout||7
514894|NCT00925704|1259222|P1|COMPLETED|Washout||6
514895|NCT00925704|1259217|P6|STARTED|Washout||7
514896|NCT00925704|1259218|P5|STARTED|Washout||6
514897|NCT00925704|1259219|P4|STARTED|Washout||6
514898|NCT00925704|1259220|P3|STARTED|Washout||7
514899|NCT00925704|1259221|P2|STARTED|Washout||7
514900|NCT00925704|1259222|P1|STARTED|Washout||6
514901|NCT00925704|1259217|P6|NOT COMPLETED|First Intervention||0
514902|NCT00925704|1259218|P5|NOT COMPLETED|First Intervention||1
514903|NCT00925704|1259219|P4|NOT COMPLETED|First Intervention||1
514904|NCT00925704|1259220|P3|NOT COMPLETED|First Intervention||0
514905|NCT00925704|1259221|P2|NOT COMPLETED|First Intervention||0
514906|NCT00925704|1259222|P1|NOT COMPLETED|First Intervention||0
514907|NCT00925704|1259217|P6|COMPLETED|First Intervention||7
514908|NCT00925704|1259218|P5|COMPLETED|First Intervention||6
514909|NCT00925704|1259219|P4|COMPLETED|First Intervention||6
514910|NCT00925704|1259220|P3|COMPLETED|First Intervention||7
514911|NCT00925704|1259221|P2|COMPLETED|First Intervention||7
514912|NCT00925704|1259222|P1|COMPLETED|First Intervention||6
514913|NCT00925704|1259217|P6|STARTED|First Intervention||7
514914|NCT00925704|1259218|P5|STARTED|First Intervention||7
514915|NCT00925704|1259219|P4|STARTED|First Intervention||7
514916|NCT00925704|1259220|P3|STARTED|First Intervention||7
514917|NCT00925704|1259221|P2|STARTED|First Intervention||7
514918|NCT00925704|1259222|P1|STARTED|First Intervention||6
514919|NCT00925600|1259235|P2|NOT COMPLETED|Overall Study||28
514920|NCT00925600|1259236|P1|NOT COMPLETED|Overall Study||32
514921|NCT00925600|1259235|P2|COMPLETED|Overall Study||355
514922|NCT00925600|1259236|P1|COMPLETED|Overall Study||354
514923|NCT00925600|1259235|P2|Received Treatment|Overall Study||382
514924|NCT00925600|1259236|P1|Received Treatment|Overall Study|Three participants received at least 1 dose of denosumab in error|383
514925|NCT00925600|1259235|P2|STARTED|Overall Study||383
514926|NCT00925600|1259236|P1|STARTED|Overall Study||386
514927|NCT00925587|1259258|P2|NOT COMPLETED|Overall Study||25
514928|NCT00925587|1259259|P1|NOT COMPLETED|Overall Study||36
514929|NCT00925587|1259258|P2|COMPLETED|Overall Study||155
514930|NCT00925587|1259259|P1|COMPLETED|Overall Study||142
514931|NCT00925587|1259258|P2|STARTED|Overall Study||180
514932|NCT00925587|1259259|P1|STARTED|Overall Study||178
514933|NCT00925548|1259373|P2|NOT COMPLETED|Overall Study||5
514934|NCT00925548|1259374|P1|NOT COMPLETED|Overall Study||10
514935|NCT00925548|1259373|P2|COMPLETED|Overall Study||0
514936|NCT00925548|1259374|P1|COMPLETED|Overall Study||1
514937|NCT00925548|1259373|P2|STARTED|Overall Study||5
514938|NCT00925548|1259374|P1|STARTED|Overall Study||11
514939|NCT00925522|1259400|P1|NOT COMPLETED|Overall Study||0
514940|NCT00925522|1259400|P1|COMPLETED|Overall Study||20
514941|NCT00925522|1259400|P1|STARTED|Overall Study||20
514942|NCT00925353|1259404|P1|NOT COMPLETED|Overall Study||3
514943|NCT00925353|1259404|P1|COMPLETED|Overall Study||10
514944|NCT00925353|1259404|P1|STARTED|Overall Study||13
514945|NCT00925288|1259410|P2|NOT COMPLETED|Overall Study||7
514946|NCT00925288|1259411|P1|NOT COMPLETED|Overall Study||9
514947|NCT00925288|1259410|P2|COMPLETED|Overall Study||93
514948|NCT00925288|1259411|P1|COMPLETED|Overall Study||91
514949|NCT00925288|1259410|P2|STARTED|Overall Study||100
514950|NCT00925288|1259411|P1|STARTED|Overall Study||100
514951|NCT00925132|1259423|P5|NOT COMPLETED|Overall Study||5
514952|NCT00925132|1259424|P4|NOT COMPLETED|Overall Study||0
514953|NCT00925132|1259425|P3|NOT COMPLETED|Overall Study||0
514954|NCT00925132|1259426|P2|NOT COMPLETED|Overall Study||0
514955|NCT00925132|1259427|P1|NOT COMPLETED|Overall Study||2
514956|NCT00925132|1259423|P5|COMPLETED|Overall Study||17
514957|NCT00925132|1259424|P4|COMPLETED|Overall Study||4
514958|NCT00925132|1259425|P3|COMPLETED|Overall Study||4
514959|NCT00925132|1259426|P2|COMPLETED|Overall Study||4
514960|NCT00925132|1259427|P1|COMPLETED|Overall Study||3
514961|NCT00925132|1259423|P5|STARTED|Overall Study||22
514962|NCT00925132|1259424|P4|STARTED|Overall Study||4
514963|NCT00925132|1259425|P3|STARTED|Overall Study||4
514964|NCT00925132|1259426|P2|STARTED|Overall Study||4
514965|NCT00925132|1259427|P1|STARTED|Overall Study||5
514966|NCT00925119|1259433|P1|NOT COMPLETED|Overall Study||12
514967|NCT00925119|1259433|P1|COMPLETED|Overall Study||19
514968|NCT00925119|1259433|P1|STARTED|Overall Study||31
514969|NCT00925015|1259446|P3|NOT COMPLETED|Overall Study||6
514970|NCT00925015|1259447|P2|NOT COMPLETED|Overall Study||6
514971|NCT00925015|1259448|P1|NOT COMPLETED|Overall Study||8
514972|NCT00925015|1259446|P3|COMPLETED|Overall Study||0
514973|NCT00925015|1259447|P2|COMPLETED|Overall Study||0
514974|NCT00925015|1259448|P1|COMPLETED|Overall Study||0
514975|NCT00925015|1259446|P3|STARTED|Overall Study||6
514976|NCT00925015|1259447|P2|STARTED|Overall Study||6
514977|NCT00925015|1259448|P1|STARTED|Overall Study||8
514978|NCT00924950|1259504|P1|NOT COMPLETED|Overall Study||2
514979|NCT00924950|1259504|P1|COMPLETED|Overall Study||28
514980|NCT00924950|1259504|P1|STARTED|Overall Study||30
514981|NCT00924898|1259509|P1|NOT COMPLETED|Overall Study||2
514982|NCT00924898|1259509|P1|COMPLETED|Overall Study||90
514983|NCT00924898|1259509|P1|STARTED|Overall Study||92
514984|NCT00924833|1259521|P3|NOT COMPLETED|Overall Study||0
514985|NCT00924833|1259522|P2|NOT COMPLETED|Overall Study||0
514986|NCT00924833|1259523|P1|NOT COMPLETED|Overall Study||0
514987|NCT00924833|1259521|P3|COMPLETED|Overall Study|1 subject was excluded from the analysis for medical problems unrelated to the study.|9
514988|NCT00924833|1259522|P2|COMPLETED|Overall Study|1 subject was excluded from the analysis for incomplete data.|9
514989|NCT00924833|1259523|P1|COMPLETED|Overall Study|7 subjects analyzed (2 were excluded for poor cardiopulmonary exercise stress test quality).|9
514990|NCT00924833|1259521|P3|STARTED|Overall Study||9
514991|NCT00924833|1259522|P2|STARTED|Overall Study||9
514992|NCT00924833|1259523|P1|STARTED|Overall Study||9
514993|NCT00924807|1259537|P1|NOT COMPLETED|Overall Study||0
514994|NCT00924807|1259537|P1|COMPLETED|Overall Study||4
514995|NCT00924807|1259537|P1|STARTED|Overall Study||4
514996|NCT00924781|1259545|P2|NOT COMPLETED|Overall Study||10
514997|NCT00924781|1259546|P1|NOT COMPLETED|Overall Study||12
514998|NCT00924781|1259545|P2|COMPLETED|Overall Study||9
514999|NCT00924781|1259546|P1|COMPLETED|Overall Study||8
515000|NCT00924781|1259545|P2|STARTED|Overall Study||19
515001|NCT00924781|1259546|P1|STARTED|Overall Study||20
515002|NCT00924729|1259580|P2|NOT COMPLETED|Overall Study||0
515003|NCT00924729|1259581|P1|NOT COMPLETED|Overall Study||2
515004|NCT00924729|1259580|P2|COMPLETED|Overall Study||25
515005|NCT00924729|1259581|P1|COMPLETED|Overall Study||23
515006|NCT00924729|1259580|P2|STARTED|Overall Study||25
515007|NCT00924729|1259581|P1|STARTED|Overall Study||25
515008|NCT00924651|1259591|P2|NOT COMPLETED|Overall Study||25
515009|NCT00924651|1259592|P1|NOT COMPLETED|Overall Study||25
515010|NCT00924651|1259591|P2|COMPLETED|Overall Study||312
515011|NCT00924651|1259592|P1|COMPLETED|Overall Study||331
515012|NCT00924651|1259591|P2|STARTED|Overall Study||337
515013|NCT00924651|1259592|P1|STARTED|Overall Study||356
515014|NCT00924638|1259600|P2|NOT COMPLETED|Overall Study||13
515015|NCT00924638|1259601|P1|NOT COMPLETED|Overall Study||12
515016|NCT00924638|1259600|P2|COMPLETED|Overall Study|Completed 6 months of follow-up|207
515017|NCT00924638|1259601|P1|COMPLETED|Overall Study|Completed 6 months of follow-up|209
515018|NCT00924638|1259600|P2|STARTED|Overall Study|Randomized to Control Arm|220
515019|NCT00924638|1259601|P1|STARTED|Overall Study|Randomized to Continuous Monitoring Arm|221
515020|NCT00924560|1259623|P3|NOT COMPLETED|Overall Study||83
515021|NCT00924560|1259624|P2|NOT COMPLETED|Overall Study||208
515022|NCT00924560|1259625|P1|NOT COMPLETED|Overall Study||211
515023|NCT00924560|1259623|P3|COMPLETED|Overall Study||372
515024|NCT00924560|1259624|P2|COMPLETED|Overall Study||240
515025|NCT00924560|1259625|P1|COMPLETED|Overall Study||247
515026|NCT00924560|1259623|P3|Received Treatment|Overall Study||0
515027|NCT00924560|1259624|P2|Received Treatment|Overall Study|Excludes 9 participants from one site that was closed due to audit findings.|411
515028|NCT00924560|1259625|P1|Received Treatment|Overall Study|Excludes 7 participants at 1 site that was closed. One participant received 28-day OC in error.|422
515029|NCT00924560|1259623|P3|STARTED|Overall Study||455
515030|NCT00924560|1259624|P2|STARTED|Overall Study||448
515031|NCT00924560|1259625|P1|STARTED|Overall Study||458
515032|NCT00924508|1259669|P1|NOT COMPLETED|Overall Study||3
515033|NCT00924508|1259669|P1|COMPLETED|Overall Study||20
515034|NCT00924508|1259669|P1|STARTED|Overall Study||23
515035|NCT00924482|1259676|P1|NOT COMPLETED|Overall Study||0
515036|NCT00924482|1259676|P1|COMPLETED|Overall Study||261
515037|NCT00924482|1259676|P1|STARTED|Overall Study||261
515038|NCT00924469|1259683|P2|NOT COMPLETED|Overall Study||2
515039|NCT00924469|1259684|P1|NOT COMPLETED|Overall Study||2
515040|NCT00924469|1259683|P2|COMPLETED|Overall Study||26
515041|NCT00924469|1259684|P1|COMPLETED|Overall Study||28
515042|NCT00924469|1259683|P2|STARTED|Overall Study||28
515043|NCT00924469|1259684|P1|STARTED|Overall Study||30
515044|NCT00924443|1259706|P1|NOT COMPLETED|Overall Study||3
515045|NCT00924443|1259706|P1|COMPLETED|Overall Study||66
515046|NCT00924443|1259706|P1|Full Analysis Set (Received Study Drug)|Overall Study||66
515047|NCT00924443|1259706|P1|STARTED|Overall Study||69
515048|NCT00924404|1259716|P2|NOT COMPLETED|Overall Study||4
515049|NCT00924404|1259717|P1|NOT COMPLETED|Overall Study||6
515050|NCT00924404|1259716|P2|COMPLETED|Overall Study||22
515051|NCT00924404|1259717|P1|COMPLETED|Overall Study||21
515052|NCT00924404|1259716|P2|STARTED|Overall Study||26
515053|NCT00924404|1259717|P1|STARTED|Overall Study||27
515054|NCT00924352|1259725|P2|NOT COMPLETED|Overall Study||0
515055|NCT00924352|1259726|P1|NOT COMPLETED|Overall Study||0
515056|NCT00924352|1259725|P2|COMPLETED|Overall Study||44
515057|NCT00924352|1259726|P1|COMPLETED|Overall Study||12
515058|NCT00924352|1259725|P2|STARTED|Overall Study||44
515059|NCT00924352|1259726|P1|STARTED|Overall Study||12
515060|NCT00924313|1259739|P1|NOT COMPLETED|Overall Study||1
515061|NCT00924313|1259739|P1|COMPLETED|Overall Study||39
515062|NCT00924313|1259739|P1|STARTED|Overall Study||40
515063|NCT00924287|1259751|P1|NOT COMPLETED|Overall Study||1
515064|NCT00924287|1259751|P1|COMPLETED|Overall Study||0
515065|NCT00924287|1259751|P1|STARTED|Overall Study||1
515066|NCT00924209|1259757|P1|NOT COMPLETED|Overall Study||0
515067|NCT00924209|1259757|P1|COMPLETED|Overall Study||7
515068|NCT00924209|1259757|P1|STARTED|Overall Study||7
515069|NCT00924170|1259764|P2|NOT COMPLETED|Overall Study||8
515070|NCT00924170|1259765|P1|NOT COMPLETED|Overall Study||7
515071|NCT00924170|1259764|P2|COMPLETED|Overall Study||0
515072|NCT00924170|1259765|P1|COMPLETED|Overall Study||3
515073|NCT00924170|1259764|P2|STARTED|Overall Study||8
515074|NCT00924170|1259765|P1|STARTED|Overall Study||10
515075|NCT00924118|1259805|P2|NOT COMPLETED|Overall Study||0
515076|NCT00924118|1259806|P1|NOT COMPLETED|Overall Study||0
515077|NCT00924118|1259805|P2|COMPLETED|Overall Study||15
515078|NCT00924118|1259806|P1|COMPLETED|Overall Study||15
515079|NCT00924118|1259805|P2|STARTED|Overall Study||15
515080|NCT00924118|1259806|P1|STARTED|Overall Study||15
515081|NCT00924066|1259814|P1|NOT COMPLETED|Overall Study||0
515082|NCT00924066|1259814|P1|COMPLETED|Overall Study||41
515083|NCT00924066|1259814|P1|STARTED|Overall Study||41
515084|NCT00924053|1259823|P4|NOT COMPLETED|Overall Study||0
515085|NCT00924053|1259824|P3|NOT COMPLETED|Overall Study||0
515086|NCT00924053|1259825|P2|NOT COMPLETED|Overall Study||0
515087|NCT00924053|1259826|P1|NOT COMPLETED|Overall Study||0
515088|NCT00924053|1259823|P4|COMPLETED|Overall Study||6
515089|NCT00924053|1259824|P3|COMPLETED|Overall Study||6
515090|NCT00924053|1259825|P2|COMPLETED|Overall Study||6
515091|NCT00924053|1259826|P1|COMPLETED|Overall Study||6
515092|NCT00924053|1259823|P4|STARTED|Overall Study||6
515093|NCT00924053|1259824|P3|STARTED|Overall Study||6
515094|NCT00924053|1259825|P2|STARTED|Overall Study||6
515095|NCT00924053|1259826|P1|STARTED|Overall Study||6
515096|NCT00924040|1259872|P1|NOT COMPLETED|Overall Study||0
515097|NCT00924040|1259872|P1|COMPLETED|Overall Study||1
515098|NCT00924040|1259872|P1|STARTED|Overall Study||1
515099|NCT00924001|1259884|P1|NOT COMPLETED|Overall Study||0
515100|NCT00924001|1259884|P1|COMPLETED|Overall Study||1
515101|NCT00924001|1259884|P1|STARTED|Overall Study||1
515102|NCT00923975|1259890|P1|NOT COMPLETED|Overall Study||1
515103|NCT00923975|1259890|P1|COMPLETED|Overall Study|One subject did not meet inclusion criteria; the data was not used in analysis.|50
515104|NCT00923975|1259890|P1|STARTED|Overall Study||51
515105|NCT00923949|1259897|P1|NOT COMPLETED|Overall Study||0
515106|NCT00923949|1259897|P1|COMPLETED|Overall Study||1
515107|NCT00923949|1259897|P1|STARTED|Overall Study||1
515108|NCT00923936|1259909|P2|NOT COMPLETED|Overall Study||3
515109|NCT00923936|1259910|P1|NOT COMPLETED|Overall Study||8
515110|NCT00923936|1259909|P2|COMPLETED|Overall Study||3
515111|NCT00923936|1259910|P1|COMPLETED|Overall Study||2
515112|NCT00923936|1259909|P2|STARTED|Overall Study||6
515113|NCT00923936|1259910|P1|STARTED|Overall Study||10
515114|NCT00923910|1259926|P2|NOT COMPLETED|Period 2||0
515115|NCT00923910|1259927|P1|NOT COMPLETED|Period 2||0
515116|NCT00923910|1259926|P2|COMPLETED|Period 2||5
515117|NCT00923910|1259927|P1|COMPLETED|Period 2||5
515118|NCT00923910|1259926|P2|STARTED|Period 2||5
515119|NCT00923910|1259927|P1|STARTED|Period 2||5
515120|NCT00923910|1259926|P2|NOT COMPLETED|Period 1||0
515121|NCT00923910|1259927|P1|NOT COMPLETED|Period 1||0
515122|NCT00923910|1259926|P2|COMPLETED|Period 1||5
515123|NCT00923910|1259927|P1|COMPLETED|Period 1||5
515124|NCT00923910|1259926|P2|STARTED|Period 1||5
515125|NCT00923910|1259927|P1|STARTED|Period 1||5
515126|NCT00923845|1259939|P2|NOT COMPLETED|Allogeneic Stem Cell Therapy||0
515127|NCT00923845|1259940|P1|NOT COMPLETED|Allogeneic Stem Cell Therapy||0
515128|NCT00923845|1259939|P2|COMPLETED|Allogeneic Stem Cell Therapy||10
515129|NCT00923845|1259940|P1|COMPLETED|Allogeneic Stem Cell Therapy||0
515130|NCT00923845|1259939|P2|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||6
515131|NCT00923845|1259940|P1|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||0
515132|NCT00923845|1259939|P2|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||8
515133|NCT00923845|1259940|P1|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||0
515134|NCT00923845|1259939|P2|STARTED|Allogeneic Stem Cell Therapy||10
515135|NCT00923845|1259940|P1|STARTED|Allogeneic Stem Cell Therapy||0
515136|NCT00923845|1259939|P2|NOT COMPLETED|Induction Therapy||2
515137|NCT00923845|1259940|P1|NOT COMPLETED|Induction Therapy||0
515138|NCT00923845|1259939|P2|COMPLETED|Induction Therapy||10
515139|NCT00923845|1259940|P1|COMPLETED|Induction Therapy||0
515140|NCT00923845|1259939|P2|STARTED|Induction Therapy||12
515141|NCT00923845|1259940|P1|STARTED|Induction Therapy||0
515142|NCT00923845|1259939|P2|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
515143|NCT00923845|1259940|P1|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
515144|NCT00923845|1259939|P2|COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
515145|NCT00923845|1259940|P1|COMPLETED|Donor Hematopoietic Stem Cell Harvest||13
515146|NCT00923845|1259939|P2|STARTED|Donor Hematopoietic Stem Cell Harvest||0
515147|NCT00923845|1259940|P1|STARTED|Donor Hematopoietic Stem Cell Harvest||13
515148|NCT00923845|1259939|P2|NOT COMPLETED|Donor Lymphocyte Harvest||0
515149|NCT00923845|1259940|P1|NOT COMPLETED|Donor Lymphocyte Harvest||0
515150|NCT00923845|1259939|P2|COMPLETED|Donor Lymphocyte Harvest||0
515151|NCT00923845|1259940|P1|COMPLETED|Donor Lymphocyte Harvest||13
515152|NCT00923845|1259939|P2|STARTED|Donor Lymphocyte Harvest||0
515153|NCT00923845|1259940|P1|STARTED|Donor Lymphocyte Harvest||13
515154|NCT00923481|1259961|P1|NOT COMPLETED|Overall Study||0
515155|NCT00923481|1259961|P1|COMPLETED|Overall Study||37
515156|NCT00923481|1259961|P1|STARTED|Overall Study||37
515157|NCT00923364|1259966|P2|NOT COMPLETED|Overall Study||0
515158|NCT00923364|1259967|P1|NOT COMPLETED|Overall Study||4
515159|NCT00923364|1259966|P2|COMPLETED|Overall Study||5
515160|NCT00923364|1259967|P1|COMPLETED|Overall Study||10
515161|NCT00923364|1259966|P2|STARTED|Overall Study||5
515162|NCT00923364|1259967|P1|STARTED|Overall Study||14
515163|NCT00923351|1259979|P3|NOT COMPLETED|Overall Study||12
515164|NCT00923351|1259980|P2|NOT COMPLETED|Overall Study||0
515165|NCT00923351|1259981|P1|NOT COMPLETED|Overall Study||0
515166|NCT00923351|1259979|P3|COMPLETED|Overall Study||0
515167|NCT00923351|1259980|P2|COMPLETED|Overall Study||26
515168|NCT00923351|1259981|P1|COMPLETED|Overall Study||6
515169|NCT00923351|1259979|P3|STARTED|Overall Study||12
515170|NCT00923351|1259980|P2|STARTED|Overall Study||26
515171|NCT00923351|1259981|P1|STARTED|Overall Study||6
515172|NCT00923273|1259996|P5|NOT COMPLETED|Phase II Treatment Period||0
515173|NCT00923273|1259997|P4|NOT COMPLETED|Phase II Treatment Period||7
515174|NCT00923273|1259998|P3|NOT COMPLETED|Phase II Treatment Period||0
515175|NCT00923273|1259999|P2|NOT COMPLETED|Phase II Treatment Period||0
515176|NCT00923273|1260000|P1|NOT COMPLETED|Phase II Treatment Period||0
515177|NCT00923273|1259996|P5|COMPLETED|Phase II Treatment Period||0
515178|NCT00923273|1259997|P4|COMPLETED|Phase II Treatment Period||20
515179|NCT00923273|1259998|P3|COMPLETED|Phase II Treatment Period||0
515180|NCT00923273|1259999|P2|COMPLETED|Phase II Treatment Period||0
515181|NCT00923273|1260000|P1|COMPLETED|Phase II Treatment Period||0
515182|NCT00923273|1259996|P5|STARTED|Phase II Treatment Period||0
515266|NCT00923091|1260266|P11|STARTED|Period VI (Open-Label)||0
515183|NCT00923273|1259997|P4|STARTED|Phase II Treatment Period|Includes 8 subjects with prior peme;12 subjects who were peme naive; 7 subjects rolled over from phI|27
515184|NCT00923273|1259998|P3|STARTED|Phase II Treatment Period||0
515185|NCT00923273|1259999|P2|STARTED|Phase II Treatment Period||0
515186|NCT00923273|1260000|P1|STARTED|Phase II Treatment Period|The phase II portion will utilize the MTD from the phase I portion.|0
515187|NCT00923273|1259996|P5|NOT COMPLETED|Phase I Treatment Period||0
515188|NCT00923273|1259997|P4|NOT COMPLETED|Phase I Treatment Period||0
515189|NCT00923273|1259998|P3|NOT COMPLETED|Phase I Treatment Period||0
515190|NCT00923273|1259999|P2|NOT COMPLETED|Phase I Treatment Period||0
515191|NCT00923273|1260000|P1|NOT COMPLETED|Phase I Treatment Period||0
515192|NCT00923273|1259996|P5|COMPLETED|Phase I Treatment Period||5
515193|NCT00923273|1259997|P4|COMPLETED|Phase I Treatment Period||7
515194|NCT00923273|1259998|P3|COMPLETED|Phase I Treatment Period||3
515195|NCT00923273|1259999|P2|COMPLETED|Phase I Treatment Period||3
515196|NCT00923273|1260000|P1|COMPLETED|Phase I Treatment Period||4
515197|NCT00923273|1259996|P5|STARTED|Phase I Treatment Period|5 subjects peme naive.|5
515198|NCT00923273|1259997|P4|STARTED|Phase I Treatment Period|3 subjects initially enrolled and 4 subjects added after dose level 5; peme naive.|7
515199|NCT00923273|1259998|P3|STARTED|Phase I Treatment Period|3 subjects peme naive.|3
515200|NCT00923273|1259999|P2|STARTED|Phase I Treatment Period|3 subjects peme naive.|3
515201|NCT00923273|1260000|P1|STARTED|Phase I Treatment Period|The phase I portion will establish the maximum tolerated dose. 4 subjects peme naive.|4
515202|NCT00923260|1260025|P2|NOT COMPLETED|Overall Study||1
515203|NCT00923260|1260026|P1|NOT COMPLETED|Overall Study||1
515204|NCT00923260|1260025|P2|COMPLETED|Overall Study|Patient didn't complete the follow-up period after surgery|11
515205|NCT00923260|1260026|P1|COMPLETED|Overall Study|Patient didn't complete the follow-up period after surgery|11
515206|NCT00923260|1260025|P2|STARTED|Overall Study||12
515207|NCT00923260|1260026|P1|STARTED|Overall Study||12
515208|NCT00923247|1260160|P2|NOT COMPLETED|Overall Study||0
515209|NCT00923247|1260161|P1|NOT COMPLETED|Overall Study||0
515210|NCT00923247|1260160|P2|COMPLETED|Overall Study||1
515211|NCT00923247|1260161|P1|COMPLETED|Overall Study||21
515212|NCT00923247|1260160|P2|STARTED|Overall Study||1
515213|NCT00923247|1260161|P1|STARTED|Overall Study||21
515214|NCT00923195|1260189|P2|NOT COMPLETED|Overall Study||1
515215|NCT00923195|1260190|P1|NOT COMPLETED|Overall Study||0
515216|NCT00923195|1260189|P2|COMPLETED|Overall Study||1
515217|NCT00923195|1260190|P1|COMPLETED|Overall Study||2
515218|NCT00923195|1260189|P2|STARTED|Overall Study||2
515219|NCT00923195|1260190|P1|STARTED|Overall Study||2
515220|NCT00923156|1260201|P3|NOT COMPLETED|Overall Study||3
515221|NCT00923156|1260202|P2|NOT COMPLETED|Overall Study||4
515222|NCT00923156|1260203|P1|NOT COMPLETED|Overall Study||0
515223|NCT00923156|1260201|P3|COMPLETED|Overall Study||38
515224|NCT00923156|1260202|P2|COMPLETED|Overall Study||38
515225|NCT00923156|1260203|P1|COMPLETED|Overall Study||40
515226|NCT00923156|1260201|P3|STARTED|Overall Study||41
515227|NCT00923156|1260202|P2|STARTED|Overall Study||42
515228|NCT00923156|1260203|P1|STARTED|Overall Study|"Started indicates randomized, safety and pharmacodynamic population"|40
515229|NCT00923130|1260229|P1|NOT COMPLETED|Overall Study||25
515230|NCT00923130|1260229|P1|COMPLETED|Overall Study||5
515231|NCT00923130|1260229|P1|STARTED|Overall Study||30
515232|NCT00923117|1260247|P2|NOT COMPLETED|Overall Study||0
515233|NCT00923117|1260248|P1|NOT COMPLETED|Overall Study||0
515234|NCT00923117|1260247|P2|COMPLETED|Overall Study||43
515235|NCT00923117|1260248|P1|COMPLETED|Overall Study||44
515236|NCT00923117|1260247|P2|STARTED|Overall Study||43
515237|NCT00923117|1260248|P1|STARTED|Overall Study||44
515238|NCT00923091|1260264|P13|NOT COMPLETED|Period VI (Open-Label)||0
515239|NCT00923091|1260265|P12|NOT COMPLETED|Period VI (Open-Label)||0
515240|NCT00923091|1260266|P11|NOT COMPLETED|Period VI (Open-Label)||0
515241|NCT00923091|1260267|P10|NOT COMPLETED|Period VI (Open-Label)||0
515242|NCT00923091|1260268|P9|NOT COMPLETED|Period VI (Open-Label)||0
515243|NCT00923091|1260269|P8|NOT COMPLETED|Period VI (Open-Label)||0
515244|NCT00923091|1260270|P7|NOT COMPLETED|Period VI (Open-Label)||0
515245|NCT00923091|1260271|P6|NOT COMPLETED|Period VI (Open-Label)||0
515246|NCT00923091|1260272|P5|NOT COMPLETED|Period VI (Open-Label)||7
515247|NCT00923091|1260273|P4|NOT COMPLETED|Period VI (Open-Label)||3
515248|NCT00923091|1260274|P3|NOT COMPLETED|Period VI (Open-Label)||13
515249|NCT00923091|1260275|P2|NOT COMPLETED|Period VI (Open-Label)||8
515250|NCT00923091|1260276|P1|NOT COMPLETED|Period VI (Open-Label)||39
515251|NCT00923091|1260264|P13|COMPLETED|Period VI (Open-Label)||0
515252|NCT00923091|1260265|P12|COMPLETED|Period VI (Open-Label)||0
515253|NCT00923091|1260266|P11|COMPLETED|Period VI (Open-Label)||0
515254|NCT00923091|1260267|P10|COMPLETED|Period VI (Open-Label)||0
515255|NCT00923091|1260268|P9|COMPLETED|Period VI (Open-Label)||0
515256|NCT00923091|1260269|P8|COMPLETED|Period VI (Open-Label)||0
515257|NCT00923091|1260270|P7|COMPLETED|Period VI (Open-Label)||0
515258|NCT00923091|1260271|P6|COMPLETED|Period VI (Open-Label)||0
515259|NCT00923091|1260272|P5|COMPLETED|Period VI (Open-Label)||157
515260|NCT00923091|1260273|P4|COMPLETED|Period VI (Open-Label)||143
515261|NCT00923091|1260274|P3|COMPLETED|Period VI (Open-Label)||467
515262|NCT00923091|1260275|P2|COMPLETED|Period VI (Open-Label)||264
515263|NCT00923091|1260276|P1|COMPLETED|Period VI (Open-Label)||1408
515264|NCT00923091|1260264|P13|STARTED|Period VI (Open-Label)||0
515265|NCT00923091|1260265|P12|STARTED|Period VI (Open-Label)||0
515267|NCT00923091|1260267|P10|STARTED|Period VI (Open-Label)||0
515268|NCT00923091|1260268|P9|STARTED|Period VI (Open-Label)||0
515269|NCT00923091|1260269|P8|STARTED|Period VI (Open-Label)||0
515270|NCT00923091|1260270|P7|STARTED|Period VI (Open-Label)||0
515271|NCT00923091|1260271|P6|STARTED|Period VI (Open-Label)||0
515272|NCT00923091|1260272|P5|STARTED|Period VI (Open-Label)||164
515273|NCT00923091|1260273|P4|STARTED|Period VI (Open-Label)||146
515274|NCT00923091|1260274|P3|STARTED|Period VI (Open-Label)||480
515275|NCT00923091|1260275|P2|STARTED|Period VI (Open-Label)||272
515276|NCT00923091|1260276|P1|STARTED|Period VI (Open-Label)|1837 from Period III+2 from Period IV + 670 from Period 5 = 2509|1447
515277|NCT00923091|1260264|P13|NOT COMPLETED|Period V (Double -Blind)||2
515278|NCT00923091|1260265|P12|NOT COMPLETED|Period V (Double -Blind)||0
515279|NCT00923091|1260266|P11|NOT COMPLETED|Period V (Double -Blind)||1
515280|NCT00923091|1260267|P10|NOT COMPLETED|Period V (Double -Blind)||0
515281|NCT00923091|1260268|P9|NOT COMPLETED|Period V (Double -Blind)||1
515282|NCT00923091|1260269|P8|NOT COMPLETED|Period V (Double -Blind)||0
515283|NCT00923091|1260270|P7|NOT COMPLETED|Period V (Double -Blind)||0
515284|NCT00923091|1260271|P6|NOT COMPLETED|Period V (Double -Blind)||0
515285|NCT00923091|1260272|P5|NOT COMPLETED|Period V (Double -Blind)||0
515286|NCT00923091|1260273|P4|NOT COMPLETED|Period V (Double -Blind)||0
515287|NCT00923091|1260274|P3|NOT COMPLETED|Period V (Double -Blind)||0
515288|NCT00923091|1260275|P2|NOT COMPLETED|Period V (Double -Blind)||0
515289|NCT00923091|1260276|P1|NOT COMPLETED|Period V (Double -Blind)||0
515290|NCT00923091|1260264|P13|COMPLETED|Period V (Double -Blind)||73
515291|NCT00923091|1260265|P12|COMPLETED|Period V (Double -Blind)||151
515292|NCT00923091|1260266|P11|COMPLETED|Period V (Double -Blind)||193
515293|NCT00923091|1260267|P10|COMPLETED|Period V (Double -Blind)||119
515294|NCT00923091|1260268|P9|COMPLETED|Period V (Double -Blind)||134
515295|NCT00923091|1260269|P8|COMPLETED|Period V (Double -Blind)||0
515296|NCT00923091|1260270|P7|COMPLETED|Period V (Double -Blind)||0
515297|NCT00923091|1260271|P6|COMPLETED|Period V (Double -Blind)||0
515298|NCT00923091|1260272|P5|COMPLETED|Period V (Double -Blind)||0
515299|NCT00923091|1260273|P4|COMPLETED|Period V (Double -Blind)||0
515300|NCT00923091|1260274|P3|COMPLETED|Period V (Double -Blind)||0
515301|NCT00923091|1260275|P2|COMPLETED|Period V (Double -Blind)||0
515302|NCT00923091|1260276|P1|COMPLETED|Period V (Double -Blind)||0
515303|NCT00923091|1260264|P13|STARTED|Period V (Double -Blind)||75
515304|NCT00923091|1260265|P12|STARTED|Period V (Double -Blind)||151
515305|NCT00923091|1260266|P11|STARTED|Period V (Double -Blind)||194
515306|NCT00923091|1260267|P10|STARTED|Period V (Double -Blind)||119
515307|NCT00923091|1260268|P9|STARTED|Period V (Double -Blind)||135
515308|NCT00923091|1260269|P8|STARTED|Period V (Double -Blind)||0
515309|NCT00923091|1260270|P7|STARTED|Period V (Double -Blind)||0
515310|NCT00923091|1260271|P6|STARTED|Period V (Double -Blind)||0
515311|NCT00923091|1260272|P5|STARTED|Period V (Double -Blind)||0
515312|NCT00923091|1260273|P4|STARTED|Period V (Double -Blind)||0
515313|NCT00923091|1260274|P3|STARTED|Period V (Double -Blind)||0
515314|NCT00923091|1260275|P2|STARTED|Period V (Double -Blind)||0
515315|NCT00923091|1260276|P1|STARTED|Period V (Double -Blind)|677 completed Period 4. 1 did not continue and 2 erroneously responders were not counted = 674|0
515316|NCT00923091|1260264|P13|NOT COMPLETED|Period IV (Double-Blind)||0
515317|NCT00923091|1260265|P12|NOT COMPLETED|Period IV (Double-Blind)||0
515318|NCT00923091|1260266|P11|NOT COMPLETED|Period IV (Double-Blind)||0
515319|NCT00923091|1260267|P10|NOT COMPLETED|Period IV (Double-Blind)||0
515320|NCT00923091|1260268|P9|NOT COMPLETED|Period IV (Double-Blind)||0
515321|NCT00923091|1260269|P8|NOT COMPLETED|Period IV (Double-Blind)||0
515322|NCT00923091|1260270|P7|NOT COMPLETED|Period IV (Double-Blind)||0
515323|NCT00923091|1260271|P6|NOT COMPLETED|Period IV (Double-Blind)||0
515324|NCT00923091|1260272|P5|NOT COMPLETED|Period IV (Double-Blind)||0
515325|NCT00923091|1260273|P4|NOT COMPLETED|Period IV (Double-Blind)||0
515326|NCT00923091|1260274|P3|NOT COMPLETED|Period IV (Double-Blind)||0
515327|NCT00923091|1260275|P2|NOT COMPLETED|Period IV (Double-Blind)||2
515328|NCT00923091|1260276|P1|NOT COMPLETED|Period IV (Double-Blind)||2
515329|NCT00923091|1260264|P13|COMPLETED|Period IV (Double-Blind)||0
515330|NCT00923091|1260265|P12|COMPLETED|Period IV (Double-Blind)||0
515331|NCT00923091|1260266|P11|COMPLETED|Period IV (Double-Blind)||0
515332|NCT00923091|1260267|P10|COMPLETED|Period IV (Double-Blind)||0
515333|NCT00923091|1260268|P9|COMPLETED|Period IV (Double-Blind)||0
515334|NCT00923091|1260269|P8|COMPLETED|Period IV (Double-Blind)||0
515335|NCT00923091|1260270|P7|COMPLETED|Period IV (Double-Blind)||0
515336|NCT00923091|1260271|P6|COMPLETED|Period IV (Double-Blind)||0
515337|NCT00923091|1260272|P5|COMPLETED|Period IV (Double-Blind)||0
515338|NCT00923091|1260273|P4|COMPLETED|Period IV (Double-Blind)||0
515339|NCT00923091|1260274|P3|COMPLETED|Period IV (Double-Blind)||0
515340|NCT00923091|1260275|P2|COMPLETED|Period IV (Double-Blind)||451
515341|NCT00923091|1260276|P1|COMPLETED|Period IV (Double-Blind)||226
515342|NCT00923091|1260264|P13|STARTED|Period IV (Double-Blind)||0
515343|NCT00923091|1260265|P12|STARTED|Period IV (Double-Blind)||0
515344|NCT00923091|1260266|P11|STARTED|Period IV (Double-Blind)||0
515345|NCT00923091|1260267|P10|STARTED|Period IV (Double-Blind)||0
515346|NCT00923091|1260268|P9|STARTED|Period IV (Double-Blind)||0
515347|NCT00923091|1260269|P8|STARTED|Period IV (Double-Blind)||0
515348|NCT00923091|1260270|P7|STARTED|Period IV (Double-Blind)||0
515349|NCT00923091|1260271|P6|STARTED|Period IV (Double-Blind)||0
515350|NCT00923091|1260272|P5|STARTED|Period IV (Double-Blind)||0
515351|NCT00923091|1260273|P4|STARTED|Period IV (Double-Blind)||0
515352|NCT00923091|1260274|P3|STARTED|Period IV (Double-Blind)||0
515353|NCT00923091|1260275|P2|STARTED|Period IV (Double-Blind)||453
515354|NCT00923091|1260276|P1|STARTED|Period IV (Double-Blind)|2 did not continue in the study and 1837 responders went directly to Period VI. 228+453+2+1837=2520|228
515355|NCT00923091|1260264|P13|NOT COMPLETED|Period III (Single-Blind)||0
515356|NCT00923091|1260265|P12|NOT COMPLETED|Period III (Single-Blind)||0
515357|NCT00923091|1260266|P11|NOT COMPLETED|Period III (Single-Blind)||0
515358|NCT00923091|1260267|P10|NOT COMPLETED|Period III (Single-Blind)||0
515359|NCT00923091|1260268|P9|NOT COMPLETED|Period III (Single-Blind)||0
515360|NCT00923091|1260269|P8|NOT COMPLETED|Period III (Single-Blind)||0
515361|NCT00923091|1260270|P7|NOT COMPLETED|Period III (Single-Blind)||0
515362|NCT00923091|1260271|P6|NOT COMPLETED|Period III (Single-Blind)||0
515363|NCT00923091|1260272|P5|NOT COMPLETED|Period III (Single-Blind)||0
515364|NCT00923091|1260273|P4|NOT COMPLETED|Period III (Single-Blind)||0
515365|NCT00923091|1260274|P3|NOT COMPLETED|Period III (Single-Blind)||0
515366|NCT00923091|1260275|P2|NOT COMPLETED|Period III (Single-Blind)||0
515367|NCT00923091|1260276|P1|NOT COMPLETED|Period III (Single-Blind)||20
515368|NCT00923091|1260264|P13|COMPLETED|Period III (Single-Blind)||0
515369|NCT00923091|1260265|P12|COMPLETED|Period III (Single-Blind)||0
515370|NCT00923091|1260266|P11|COMPLETED|Period III (Single-Blind)||0
515371|NCT00923091|1260267|P10|COMPLETED|Period III (Single-Blind)||0
515372|NCT00923091|1260268|P9|COMPLETED|Period III (Single-Blind)||0
515373|NCT00923091|1260269|P8|COMPLETED|Period III (Single-Blind)||0
515374|NCT00923091|1260270|P7|COMPLETED|Period III (Single-Blind)||0
515375|NCT00923091|1260271|P6|COMPLETED|Period III (Single-Blind)||0
515376|NCT00923091|1260272|P5|COMPLETED|Period III (Single-Blind)||0
515377|NCT00923091|1260273|P4|COMPLETED|Period III (Single-Blind)||0
515378|NCT00923091|1260274|P3|COMPLETED|Period III (Single-Blind)||0
515379|NCT00923091|1260275|P2|COMPLETED|Period III (Single-Blind)||0
515380|NCT00923091|1260276|P1|COMPLETED|Period III (Single-Blind)||2520
515381|NCT00923091|1260264|P13|STARTED|Period III (Single-Blind)||0
515382|NCT00923091|1260265|P12|STARTED|Period III (Single-Blind)||0
515383|NCT00923091|1260266|P11|STARTED|Period III (Single-Blind)||0
515384|NCT00923091|1260267|P10|STARTED|Period III (Single-Blind)||0
515385|NCT00923091|1260268|P9|STARTED|Period III (Single-Blind)||0
515386|NCT00923091|1260269|P8|STARTED|Period III (Single-Blind)||0
515387|NCT00923091|1260270|P7|STARTED|Period III (Single-Blind)||0
515388|NCT00923091|1260271|P6|STARTED|Period III (Single-Blind)||0
515389|NCT00923091|1260272|P5|STARTED|Period III (Single-Blind)||0
515390|NCT00923091|1260273|P4|STARTED|Period III (Single-Blind)||0
515391|NCT00923091|1260274|P3|STARTED|Period III (Single-Blind)||0
515392|NCT00923091|1260275|P2|STARTED|Period III (Single-Blind)||0
515393|NCT00923091|1260276|P1|STARTED|Period III (Single-Blind)|2543 completed Period 2. Three decided not to continue in the study=2540.|2540
515394|NCT00923091|1260264|P13|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
515395|NCT00923091|1260265|P12|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
515396|NCT00923091|1260266|P11|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
515397|NCT00923091|1260267|P10|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
515398|NCT00923091|1260268|P9|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
515399|NCT00923091|1260269|P8|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||25
515400|NCT00923091|1260270|P7|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||18
515401|NCT00923091|1260271|P6|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||15
515402|NCT00923091|1260272|P5|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||21
515403|NCT00923091|1260273|P4|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||27
515404|NCT00923091|1260274|P3|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||13
515405|NCT00923091|1260275|P2|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||11
515406|NCT00923091|1260276|P1|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||16
515407|NCT00923091|1260264|P13|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
515408|NCT00923091|1260265|P12|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
515409|NCT00923091|1260266|P11|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
515410|NCT00923091|1260267|P10|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
515411|NCT00923091|1260268|P9|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
515412|NCT00923091|1260269|P8|COMPLETED|PeriodI-II (Randomized, Double-Blind)||311
515413|NCT00923091|1260270|P7|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319
515414|NCT00923091|1260271|P6|COMPLETED|PeriodI-II (Randomized, Double-Blind)||322
515415|NCT00923091|1260272|P5|COMPLETED|PeriodI-II (Randomized, Double-Blind)||315
515416|NCT00923091|1260273|P4|COMPLETED|PeriodI-II (Randomized, Double-Blind)||309
515417|NCT00923091|1260274|P3|COMPLETED|PeriodI-II (Randomized, Double-Blind)||323
515418|NCT00923091|1260275|P2|COMPLETED|PeriodI-II (Randomized, Double-Blind)||325
515419|NCT00923091|1260276|P1|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319
515420|NCT00923091|1260264|P13|STARTED|PeriodI-II (Randomized, Double-Blind)||0
515421|NCT00923091|1260265|P12|STARTED|PeriodI-II (Randomized, Double-Blind)||0
515422|NCT00923091|1260266|P11|STARTED|PeriodI-II (Randomized, Double-Blind)||0
515423|NCT00923091|1260267|P10|STARTED|PeriodI-II (Randomized, Double-Blind)||0
515424|NCT00923091|1260268|P9|STARTED|PeriodI-II (Randomized, Double-Blind)||0
515425|NCT00923091|1260269|P8|STARTED|PeriodI-II (Randomized, Double-Blind)||336
515426|NCT00923091|1260270|P7|STARTED|PeriodI-II (Randomized, Double-Blind)||337
515427|NCT00923091|1260271|P6|STARTED|PeriodI-II (Randomized, Double-Blind)||337
515428|NCT00923091|1260272|P5|STARTED|PeriodI-II (Randomized, Double-Blind)||336
515429|NCT00923091|1260273|P4|STARTED|PeriodI-II (Randomized, Double-Blind)||336
515430|NCT00923091|1260274|P3|STARTED|PeriodI-II (Randomized, Double-Blind)||336
515431|NCT00923091|1260275|P2|STARTED|PeriodI-II (Randomized, Double-Blind)||336
515432|NCT00923091|1260276|P1|STARTED|PeriodI-II (Randomized, Double-Blind)||335
515433|NCT00923078|1260326|P3|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
515434|NCT00923078|1260327|P2|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
515435|NCT00923078|1260328|P1|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
515436|NCT00923078|1260326|P3|COMPLETED|Second Intervention (Weeks 5-8)||0
515437|NCT00923078|1260327|P2|COMPLETED|Second Intervention (Weeks 5-8)||19
515438|NCT00923078|1260328|P1|COMPLETED|Second Intervention (Weeks 5-8)||19
515439|NCT00923078|1260326|P3|STARTED|Second Intervention (Weeks 5-8)|Healthy Comparison sample subjects completed only a single test session (baseline)|0
515440|NCT00923078|1260327|P2|STARTED|Second Intervention (Weeks 5-8)||19
515441|NCT00923078|1260328|P1|STARTED|Second Intervention (Weeks 5-8)||19
515442|NCT00923078|1260326|P3|NOT COMPLETED|First Intervention (Weeks 1-4)||20
515443|NCT00923078|1260327|P2|NOT COMPLETED|First Intervention (Weeks 1-4)||1
515444|NCT00923078|1260328|P1|NOT COMPLETED|First Intervention (Weeks 1-4)||1
515445|NCT00923078|1260326|P3|COMPLETED|First Intervention (Weeks 1-4)||0
515446|NCT00923078|1260327|P2|COMPLETED|First Intervention (Weeks 1-4)||19
515447|NCT00923078|1260328|P1|COMPLETED|First Intervention (Weeks 1-4)||19
515448|NCT00923078|1260326|P3|STARTED|First Intervention (Weeks 1-4)||20
515449|NCT00923078|1260327|P2|STARTED|First Intervention (Weeks 1-4)||20
515450|NCT00923078|1260328|P1|STARTED|First Intervention (Weeks 1-4)||20
515451|NCT00922987|1260347|P1|NOT COMPLETED|Overall Study||4
515452|NCT00922987|1260347|P1|COMPLETED|Overall Study||277
515453|NCT00922987|1260347|P1|STARTED|Overall Study||281
515454|NCT00922935|1260362|P3|NOT COMPLETED|Overall Study||0
515455|NCT00922935|1260363|P2|NOT COMPLETED|Overall Study||5
515456|NCT00922935|1260364|P1|NOT COMPLETED|Overall Study||1
515457|NCT00922935|1260362|P3|COMPLETED|Overall Study||10
515458|NCT00922935|1260363|P2|COMPLETED|Overall Study||11
515459|NCT00922935|1260364|P1|COMPLETED|Overall Study||9
515460|NCT00922935|1260362|P3|STARTED|Overall Study||10
515461|NCT00922935|1260363|P2|STARTED|Overall Study||16
515462|NCT00922935|1260364|P1|STARTED|Overall Study||10
515463|NCT00922779|1260372|P1|NOT COMPLETED|Overall Study||2327
515464|NCT00922779|1260372|P1|COMPLETED|Overall Study||4334
515465|NCT00922779|1260372|P1|STARTED|Overall Study||6661
515466|NCT00922766|1260379|P1|NOT COMPLETED|Overall Study||7
515467|NCT00922766|1260379|P1|COMPLETED|Overall Study||610
515468|NCT00922766|1260379|P1|STARTED|Overall Study||617
515469|NCT00922701|1260388|P1|NOT COMPLETED|Overall Study||0
515470|NCT00922701|1260388|P1|COMPLETED|Overall Study||4
515471|NCT00922701|1260388|P1|STARTED|Overall Study||4
515472|NCT00922636|1260397|P5|NOT COMPLETED|Overall Study||16
515473|NCT00922636|1260398|P4|NOT COMPLETED|Overall Study||17
515474|NCT00922636|1260399|P3|NOT COMPLETED|Overall Study||20
515475|NCT00922636|1260400|P2|NOT COMPLETED|Overall Study||16
515476|NCT00922636|1260401|P1|NOT COMPLETED|Overall Study||7
515477|NCT00922636|1260397|P5|COMPLETED|Overall Study||59
515478|NCT00922636|1260398|P4|COMPLETED|Overall Study||58
515479|NCT00922636|1260399|P3|COMPLETED|Overall Study||56
515480|NCT00922636|1260400|P2|COMPLETED|Overall Study||62
515481|NCT00922636|1260401|P1|COMPLETED|Overall Study||29
515482|NCT00922636|1260397|P5|Entered Optional Taper Phase|Overall Study||12
515483|NCT00922636|1260398|P4|Entered Optional Taper Phase|Overall Study||7
515484|NCT00922636|1260399|P3|Entered Optional Taper Phase|Overall Study||15
515485|NCT00922636|1260400|P2|Entered Optional Taper Phase|Overall Study||10
515486|NCT00922636|1260401|P1|Entered Optional Taper Phase|Overall Study||4
515487|NCT00922636|1260397|P5|STARTED|Overall Study||75
515488|NCT00922636|1260398|P4|STARTED|Overall Study||75
515489|NCT00922636|1260399|P3|STARTED|Overall Study||76
515490|NCT00922636|1260400|P2|STARTED|Overall Study||78
515491|NCT00922636|1260401|P1|STARTED|Overall Study||36
515492|NCT00922623|1260548|P1|NOT COMPLETED|Overall Study||5
515493|NCT00922623|1260548|P1|COMPLETED|Overall Study||88
515494|NCT00922623|1260548|P1|STARTED|Overall Study||93
515495|NCT00922480|1260556|P2|NOT COMPLETED|Extension Study||3
515496|NCT00922480|1260557|P1|NOT COMPLETED|Extension Study||5
515497|NCT00922480|1260556|P2|COMPLETED|Extension Study||82
515498|NCT00922480|1260557|P1|COMPLETED|Extension Study||68
515499|NCT00922480|1260556|P2|STARTED|Extension Study||85
515500|NCT00922480|1260557|P1|STARTED|Extension Study||73
515501|NCT00922480|1260556|P2|NOT COMPLETED|Main Study||29
515502|NCT00922480|1260557|P1|NOT COMPLETED|Main Study||37
515503|NCT00922480|1260556|P2|COMPLETED|Main Study||226
515504|NCT00922480|1260557|P1|COMPLETED|Main Study||213
515505|NCT00922480|1260556|P2|STARTED|Main Study||255
515506|NCT00922480|1260557|P1|STARTED|Main Study||250
515507|NCT00922441|1260568|P3|NOT COMPLETED|Overall Study||3
515508|NCT00922441|1260569|P2|NOT COMPLETED|Overall Study||0
515509|NCT00922441|1260570|P1|NOT COMPLETED|Overall Study||0
515510|NCT00922441|1260568|P3|COMPLETED|Overall Study||29
515511|NCT00922441|1260569|P2|COMPLETED|Overall Study||30
515512|NCT00922441|1260570|P1|COMPLETED|Overall Study||30
515513|NCT00922441|1260568|P3|STARTED|Overall Study||32
515514|NCT00922441|1260569|P2|STARTED|Overall Study||30
515515|NCT00922441|1260570|P1|STARTED|Overall Study||30
515516|NCT00922428|1260578|P1|NOT COMPLETED|Overall Study||15
515517|NCT00922428|1260578|P1|COMPLETED|Overall Study|for 11 participants no gender was given|1374
515518|NCT00922428|1260578|P1|STARTED|Overall Study|13 patients were completely not analysed, 2 not for demographic or efficacy but for safety|1389
515519|NCT00922272|1260607|P2|NOT COMPLETED|Double-blind Phase||6
515520|NCT00922272|1260608|P1|NOT COMPLETED|Double-blind Phase||7
515521|NCT00922272|1260607|P2|COMPLETED|Double-blind Phase||29
515522|NCT00922272|1260608|P1|COMPLETED|Double-blind Phase||27
515523|NCT00922272|1260607|P2|STARTED|Double-blind Phase||35
515524|NCT00922272|1260608|P1|STARTED|Double-blind Phase||34
515525|NCT00922272|1260607|P2|NOT COMPLETED|Open-label Phase||0
515526|NCT00922272|1260608|P1|NOT COMPLETED|Open-label Phase||23
515527|NCT00922272|1260607|P2|COMPLETED|Open-label Phase||0
515528|NCT00922272|1260608|P1|COMPLETED|Open-label Phase||69
515529|NCT00922272|1260607|P2|STARTED|Open-label Phase||0
515530|NCT00922272|1260608|P1|STARTED|Open-label Phase||92
515531|NCT00922233|1260664|P1|NOT COMPLETED|Overall Study||4
515532|NCT00922233|1260664|P1|COMPLETED|Overall Study||68
515533|NCT00922233|1260664|P1|STARTED|Overall Study||72
515534|NCT00922207|1260673|P3|NOT COMPLETED|Overall Study||4
515535|NCT00922207|1260674|P2|NOT COMPLETED|Overall Study||7
515536|NCT00922207|1260675|P1|NOT COMPLETED|Overall Study||6
515537|NCT00922207|1260673|P3|COMPLETED|Overall Study||90
515538|NCT00922207|1260674|P2|COMPLETED|Overall Study||88
515539|NCT00922207|1260675|P1|COMPLETED|Overall Study||85
515540|NCT00922207|1260673|P3|STARTED|Overall Study||94
515541|NCT00922207|1260674|P2|STARTED|Overall Study||95
515542|NCT00922207|1260675|P1|STARTED|Overall Study||91
515543|NCT00922194|1260701|P1|NOT COMPLETED|Metformin for 12 Months or More||0
515544|NCT00922194|1260701|P1|COMPLETED|Metformin for 12 Months or More||102
515545|NCT00922194|1260701|P1|STARTED|Metformin for 12 Months or More|Gradually increasing dose of Extended Release Metformin|102
515546|NCT00922194|1260701|P1|NOT COMPLETED|Metformin in Maximum Tolerated Dose||0
515547|NCT00922194|1260701|P1|COMPLETED|Metformin in Maximum Tolerated Dose|June 2009|102
515548|NCT00922194|1260701|P1|STARTED|Metformin in Maximum Tolerated Dose|February 2006|102
515549|NCT00922116|1260711|P1|NOT COMPLETED|Overall Study||15
515550|NCT00922116|1260711|P1|COMPLETED|Overall Study||176
515551|NCT00922116|1260711|P1|STARTED|Overall Study||191
515552|NCT00921947|1260722|P2|NOT COMPLETED|Day 28||0
515553|NCT00921947|1260723|P1|NOT COMPLETED|Day 28||0
515554|NCT00921947|1260722|P2|COMPLETED|Day 28||30
515555|NCT00921947|1260723|P1|COMPLETED|Day 28||28
515556|NCT00921947|1260722|P2|STARTED|Day 28||30
515557|NCT00921947|1260723|P1|STARTED|Day 28|2 subjects were lost to follow-up and did not receive the 2nd vaccination of 1.0 ug i.m.|28
515558|NCT00921947|1260722|P2|NOT COMPLETED|Day 0||0
515559|NCT00921947|1260723|P1|NOT COMPLETED|Day 0||0
515560|NCT00921947|1260722|P2|COMPLETED|Day 0||30
515561|NCT00921947|1260723|P1|COMPLETED|Day 0||30
515562|NCT00921947|1260722|P2|STARTED|Day 0||30
515563|NCT00921947|1260723|P1|STARTED|Day 0||30
515564|NCT00921934|1260733|P1|NOT COMPLETED|Overall Study||0
515565|NCT00921934|1260733|P1|COMPLETED|Overall Study||68
515566|NCT00921934|1260733|P1|STARTED|Overall Study||68
515567|NCT00921895|1260737|P1|NOT COMPLETED|Overall Study||0
515568|NCT00921895|1260737|P1|COMPLETED|Overall Study||128
515569|NCT00921895|1260737|P1|STARTED|Overall Study||128
515570|NCT00921687|1260744|P2|NOT COMPLETED|Overall Study||0
515571|NCT00921687|1260745|P1|NOT COMPLETED|Overall Study||0
515572|NCT00921687|1260744|P2|COMPLETED|Overall Study||363
515573|NCT00921687|1260745|P1|COMPLETED|Overall Study||418
515574|NCT00921687|1260744|P2|STARTED|Overall Study||363
515575|NCT00921687|1260745|P1|STARTED|Overall Study|eligible patients seen in clinic between 1/1/09 and 1/1/10|418
515576|NCT00921557|1260756|P3|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||1
515577|NCT00921557|1260757|P2|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||1
515578|NCT00921557|1260758|P1|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||3
515579|NCT00921557|1260756|P3|COMPLETED|Weeks 96-144 (Off Study Treatment)||16
515580|NCT00921557|1260757|P2|COMPLETED|Weeks 96-144 (Off Study Treatment)||15
515581|NCT00921557|1260758|P1|COMPLETED|Weeks 96-144 (Off Study Treatment)||12
515582|NCT00921557|1260756|P3|STARTED|Weeks 96-144 (Off Study Treatment)||17
515583|NCT00921557|1260757|P2|STARTED|Weeks 96-144 (Off Study Treatment)||16
515584|NCT00921557|1260758|P1|STARTED|Weeks 96-144 (Off Study Treatment)||15
515585|NCT00921557|1260756|P3|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||1
515586|NCT00921557|1260757|P2|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||1
515587|NCT00921557|1260758|P1|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||0
515588|NCT00921557|1260756|P3|COMPLETED|Weeks 48-96 (on Study Treatment)||17
515589|NCT00921557|1260757|P2|COMPLETED|Weeks 48-96 (on Study Treatment)||16
515590|NCT00921557|1260758|P1|COMPLETED|Weeks 48-96 (on Study Treatment)||15
515591|NCT00921557|1260756|P3|STARTED|Weeks 48-96 (on Study Treatment)||18
515592|NCT00921557|1260757|P2|STARTED|Weeks 48-96 (on Study Treatment)||17
515593|NCT00921557|1260758|P1|STARTED|Weeks 48-96 (on Study Treatment)||15
515594|NCT00921557|1260756|P3|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||0
515595|NCT00921557|1260757|P2|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||0
515596|NCT00921557|1260758|P1|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||2
515597|NCT00921557|1260756|P3|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|18
515598|NCT00921557|1260757|P2|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|17
515599|NCT00921557|1260758|P1|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|15
515600|NCT00921557|1260756|P3|STARTED|Weeks 0-48 (on Study Treatment)||18
515601|NCT00921557|1260757|P2|STARTED|Weeks 0-48 (on Study Treatment)||17
515602|NCT00921557|1260758|P1|STARTED|Weeks 0-48 (on Study Treatment)||17
515603|NCT00921518|1260818|P2|NOT COMPLETED|Overall Study||0
515604|NCT00921518|1260819|P1|NOT COMPLETED|Overall Study||0
515605|NCT00921518|1260818|P2|COMPLETED|Overall Study||44
515606|NCT00921518|1260819|P1|COMPLETED|Overall Study||48
515607|NCT00921518|1260818|P2|STARTED|Overall Study||44
515608|NCT00921518|1260819|P1|STARTED|Overall Study||48
515609|NCT00921310|1260827|P3|NOT COMPLETED|Overall Study||0
515610|NCT00921310|1260828|P2|NOT COMPLETED|Overall Study||0
515611|NCT00921310|1260829|P1|NOT COMPLETED|Overall Study||0
515612|NCT00921310|1260827|P3|COMPLETED|Overall Study||4
515613|NCT00921310|1260828|P2|COMPLETED|Overall Study||6
515614|NCT00921310|1260829|P1|COMPLETED|Overall Study||2
515615|NCT00921310|1260827|P3|STARTED|Overall Study||4
515616|NCT00921310|1260828|P2|STARTED|Overall Study||6
515617|NCT00921310|1260829|P1|STARTED|Overall Study||2
515618|NCT00921115|1260854|P1|NOT COMPLETED|Overall Study||0
515619|NCT00921115|1260854|P1|COMPLETED|Overall Study||42
515620|NCT00921115|1260854|P1|STARTED|Overall Study||42
515621|NCT00921024|1260860|P2|NOT COMPLETED|Overall Study||3
515622|NCT00921024|1260861|P1|NOT COMPLETED|Overall Study||4
515623|NCT00921024|1260860|P2|COMPLETED|Overall Study||39
515624|NCT00921024|1260861|P1|COMPLETED|Overall Study||81
515625|NCT00921024|1260860|P2|STARTED|Overall Study||42
515626|NCT00921024|1260861|P1|STARTED|Overall Study||85
515627|NCT00920907|1260871|P2|NOT COMPLETED|Maintenance Period||13
515628|NCT00920907|1260872|P1|NOT COMPLETED|Maintenance Period||12
515629|NCT00920907|1260871|P2|COMPLETED|Maintenance Period|2 participants who entered Maintenance Period did not receive study drug during the period.|2
515630|NCT00920907|1260872|P1|COMPLETED|Maintenance Period|All participants who entered Maintenance were treated with study drug.|3
515631|NCT00920907|1260871|P2|STARTED|Maintenance Period|1 patient completed Induction phase but discontinued the study prior to start of maintenance phase.|15
515632|NCT00920907|1260872|P1|STARTED|Maintenance Period||15
515633|NCT00920907|1260871|P2|NOT COMPLETED|Induction Period||22
515634|NCT00920907|1260872|P1|NOT COMPLETED|Induction Period||22
515635|NCT00920907|1260871|P2|COMPLETED|Induction Period||16
515636|NCT00920907|1260872|P1|COMPLETED|Induction Period||15
515637|NCT00920907|1260871|P2|STARTED|Induction Period||38
515638|NCT00920907|1260872|P1|STARTED|Induction Period||37
515639|NCT00920855|1260913|P3|NOT COMPLETED|Overall Study||22
515640|NCT00920855|1260914|P2|NOT COMPLETED|Overall Study||3
515641|NCT00920855|1260915|P1|NOT COMPLETED|Overall Study||5
515642|NCT00920855|1260913|P3|COMPLETED|Overall Study|completed eight cycles of treatment|9
515643|NCT00920855|1260914|P2|COMPLETED|Overall Study|completed eight cycles of treatment|1
515644|NCT00920855|1260915|P1|COMPLETED|Overall Study|completed eight cycles of treatment|0
515645|NCT00920855|1260913|P3|Safety and Efficacy Populations|Overall Study||31
515646|NCT00920855|1260914|P2|Safety and Efficacy Populations|Overall Study||4
515647|NCT00920855|1260915|P1|Safety and Efficacy Populations|Overall Study||5
515648|NCT00920855|1260913|P3|STARTED|Overall Study||31
515649|NCT00920855|1260914|P2|STARTED|Overall Study||4
515650|NCT00920855|1260915|P1|STARTED|Overall Study||5
515651|NCT00920829|1260941|P4|NOT COMPLETED|Available for Analysis||11
515652|NCT00920829|1260942|P3|NOT COMPLETED|Available for Analysis||10
515653|NCT00920829|1260943|P2|NOT COMPLETED|Available for Analysis||11
515654|NCT00920829|1260944|P1|NOT COMPLETED|Available for Analysis||8
515655|NCT00920829|1260941|P4|COMPLETED|Available for Analysis||24
515656|NCT00920829|1260942|P3|COMPLETED|Available for Analysis||28
515657|NCT00920829|1260943|P2|COMPLETED|Available for Analysis||27
515658|NCT00920829|1260944|P1|COMPLETED|Available for Analysis||27
515659|NCT00920829|1260941|P4|STARTED|Available for Analysis||35
515660|NCT00920829|1260942|P3|STARTED|Available for Analysis||38
515661|NCT00920829|1260943|P2|STARTED|Available for Analysis||38
515662|NCT00920829|1260944|P1|STARTED|Available for Analysis||35
515663|NCT00920829|1260941|P4|NOT COMPLETED|Allocation||2
515664|NCT00920829|1260942|P3|NOT COMPLETED|Allocation||0
515665|NCT00920829|1260943|P2|NOT COMPLETED|Allocation||1
515666|NCT00920829|1260944|P1|NOT COMPLETED|Allocation||3
515667|NCT00920829|1260941|P4|COMPLETED|Allocation||35
515668|NCT00920829|1260942|P3|COMPLETED|Allocation||38
515669|NCT00920829|1260943|P2|COMPLETED|Allocation||38
515670|NCT00920829|1260944|P1|COMPLETED|Allocation||35
515671|NCT00920829|1260941|P4|STARTED|Allocation||37
515672|NCT00920829|1260942|P3|STARTED|Allocation||38
515673|NCT00920829|1260943|P2|STARTED|Allocation||39
515674|NCT00920829|1260944|P1|STARTED|Allocation||38
515675|NCT00920816|1260958|P4|NOT COMPLETED|Overall Study||69
515676|NCT00920816|1260959|P3|NOT COMPLETED|Overall Study||135
515677|NCT00920816|1260960|P2|NOT COMPLETED|Overall Study||96
515678|NCT00920816|1260961|P1|NOT COMPLETED|Overall Study||192
515679|NCT00920816|1260958|P4|COMPLETED|Overall Study||0
515680|NCT00920816|1260959|P3|COMPLETED|Overall Study||0
515681|NCT00920816|1260960|P2|COMPLETED|Overall Study||0
515682|NCT00920816|1260961|P1|COMPLETED|Overall Study||0
515683|NCT00920816|1260958|P4|Treated|Overall Study||69
515684|NCT00920816|1260959|P3|Treated|Overall Study||135
515685|NCT00920816|1260960|P2|Treated|Overall Study||96
515686|NCT00920816|1260961|P1|Treated|Overall Study||189
515687|NCT00920816|1260958|P4|STARTED|Overall Study||69
515688|NCT00920816|1260959|P3|STARTED|Overall Study||135
515689|NCT00920816|1260960|P2|STARTED|Overall Study||96
515690|NCT00920816|1260961|P1|STARTED|Overall Study||192
515691|NCT00920790|1260999|P1|NOT COMPLETED|Overall Study||14
515692|NCT00920790|1260999|P1|COMPLETED|Overall Study||13
515693|NCT00920790|1260999|P1|STARTED|Overall Study||27
515694|NCT00920699|1261011|P3|NOT COMPLETED|Overall Study||4
515695|NCT00920699|1261012|P2|NOT COMPLETED|Overall Study||1
515696|NCT00920699|1261013|P1|NOT COMPLETED|Overall Study||2
515697|NCT00920699|1261011|P3|COMPLETED|Overall Study||28
515698|NCT00920699|1261012|P2|COMPLETED|Overall Study||29
515699|NCT00920699|1261013|P1|COMPLETED|Overall Study||27
515700|NCT00920699|1261011|P3|STARTED|Overall Study||32
515701|NCT00920699|1261012|P2|STARTED|Overall Study||30
515702|NCT00920699|1261013|P1|STARTED|Overall Study||29
515703|NCT00920686|1261030|P3|NOT COMPLETED|Overall Study||13
515704|NCT00920686|1261031|P2|NOT COMPLETED|Overall Study||22
515705|NCT00920686|1261032|P1|NOT COMPLETED|Overall Study||19
515706|NCT00920686|1261030|P3|COMPLETED|Overall Study||62
515707|NCT00920686|1261031|P2|COMPLETED|Overall Study||60
515708|NCT00920686|1261032|P1|COMPLETED|Overall Study||63
515709|NCT00920686|1261030|P3|STARTED|Overall Study||75
515710|NCT00920686|1261031|P2|STARTED|Overall Study||82
515711|NCT00920686|1261032|P1|STARTED|Overall Study||82
515712|NCT00920647|1261056|P4|NOT COMPLETED|Overall Study||0
515713|NCT00920647|1261057|P3|NOT COMPLETED|Overall Study||0
515714|NCT00920647|1261058|P2|NOT COMPLETED|Overall Study||0
515715|NCT00920647|1261059|P1|NOT COMPLETED|Overall Study||0
515716|NCT00920647|1261056|P4|COMPLETED|Overall Study||4
515717|NCT00920647|1261057|P3|COMPLETED|Overall Study||4
515718|NCT00920647|1261058|P2|COMPLETED|Overall Study||4
515719|NCT00920647|1261059|P1|COMPLETED|Overall Study||4
515720|NCT00920647|1261056|P4|STARTED|Overall Study||4
515721|NCT00920647|1261057|P3|STARTED|Overall Study||4
515722|NCT00920647|1261058|P2|STARTED|Overall Study||4
515723|NCT00920647|1261059|P1|STARTED|Overall Study||4
515724|NCT00920621|1261111|P4|NOT COMPLETED|Overall Study||35
515725|NCT00920621|1261112|P3|NOT COMPLETED|Overall Study||35
515726|NCT00920621|1261113|P2|NOT COMPLETED|Overall Study||45
515727|NCT00920621|1261114|P1|NOT COMPLETED|Overall Study||54
515728|NCT00920621|1261111|P4|COMPLETED|Overall Study||401
515729|NCT00920621|1261112|P3|COMPLETED|Overall Study||405
515730|NCT00920621|1261113|P2|COMPLETED|Overall Study||391
515731|NCT00920621|1261114|P1|COMPLETED|Overall Study||386
515732|NCT00920621|1261111|P4|STARTED|Overall Study||436
515733|NCT00920621|1261112|P3|STARTED|Overall Study||440
515734|NCT00920621|1261113|P2|STARTED|Overall Study||436
515735|NCT00920621|1261114|P1|STARTED|Overall Study||440
515736|NCT00920439|1261138|P1|NOT COMPLETED|Overall Study||0
515737|NCT00920439|1261138|P1|COMPLETED|Overall Study||25
515738|NCT00920439|1261138|P1|STARTED|Overall Study||25
515739|NCT00920426|1261148|P4|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
515740|NCT00920426|1261149|P3|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
515741|NCT00920426|1261150|P2|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
515742|NCT00920426|1261151|P1|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
515743|NCT00920426|1261148|P4|COMPLETED|ITZ112929: Optimized Therapy (OT)||8
515744|NCT00920426|1261149|P3|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
515745|NCT00920426|1261150|P2|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
515746|NCT00920426|1261151|P1|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
515747|NCT00920426|1261148|P4|STARTED|ITZ112929: Optimized Therapy (OT)|Out of 9 participants receiving randomized regimen, 8 participants continued to receive OT.|8
515748|NCT00920426|1261149|P3|STARTED|ITZ112929: Optimized Therapy (OT)||0
515749|NCT00920426|1261150|P2|STARTED|ITZ112929: Optimized Therapy (OT)||0
515750|NCT00920426|1261151|P1|STARTED|ITZ112929: Optimized Therapy (OT)||0
515751|NCT00920426|1261148|P4|NOT COMPLETED|ITZ112929: Randomized Regimen||0
515752|NCT00920426|1261149|P3|NOT COMPLETED|ITZ112929: Randomized Regimen||0
515753|NCT00920426|1261150|P2|NOT COMPLETED|ITZ112929: Randomized Regimen||0
515754|NCT00920426|1261151|P1|NOT COMPLETED|ITZ112929: Randomized Regimen||0
515755|NCT00920426|1261148|P4|COMPLETED|ITZ112929: Randomized Regimen||0
515756|NCT00920426|1261149|P3|COMPLETED|ITZ112929: Randomized Regimen||2
515757|NCT00920426|1261150|P2|COMPLETED|ITZ112929: Randomized Regimen||7
515758|NCT00920426|1261151|P1|COMPLETED|ITZ112929: Randomized Regimen||0
515759|NCT00920426|1261148|P4|STARTED|ITZ112929: Randomized Regimen||0
515760|NCT00920426|1261149|P3|STARTED|ITZ112929: Randomized Regimen||2
515761|NCT00920426|1261150|P2|STARTED|ITZ112929: Randomized Regimen||7
515762|NCT00920426|1261151|P1|STARTED|ITZ112929: Randomized Regimen||0
515763|NCT00920426|1261148|P4|NOT COMPLETED|ITZ111451||0
515764|NCT00920426|1261149|P3|NOT COMPLETED|ITZ111451||0
515765|NCT00920426|1261150|P2|NOT COMPLETED|ITZ111451||0
515766|NCT00920426|1261151|P1|NOT COMPLETED|ITZ111451||1
515767|NCT00920426|1261148|P4|COMPLETED|ITZ111451||0
515768|NCT00920426|1261149|P3|COMPLETED|ITZ111451||0
515769|NCT00920426|1261150|P2|COMPLETED|ITZ111451||0
515770|NCT00920426|1261151|P1|COMPLETED|ITZ111451||7
515771|NCT00920426|1261148|P4|STARTED|ITZ111451||0
515772|NCT00920426|1261149|P3|STARTED|ITZ111451||0
515773|NCT00920426|1261150|P2|STARTED|ITZ111451||0
515774|NCT00920426|1261151|P1|STARTED|ITZ111451||8
515775|NCT00920374|1261220|P2|NOT COMPLETED|Overall Study||0
515776|NCT00920374|1261221|P1|NOT COMPLETED|Overall Study||0
515777|NCT00920374|1261220|P2|COMPLETED|Overall Study||57
515778|NCT00920374|1261221|P1|COMPLETED|Overall Study||61
515779|NCT00920374|1261220|P2|STARTED|Overall Study||57
515780|NCT00920374|1261221|P1|STARTED|Overall Study||61
515781|NCT00920309|1261247|P2|NOT COMPLETED|Overall Study||0
515782|NCT00920309|1261248|P1|NOT COMPLETED|Overall Study||0
515783|NCT00920309|1261247|P2|COMPLETED|Overall Study||7
515784|NCT00920309|1261248|P1|COMPLETED|Overall Study||14
515785|NCT00920309|1261247|P2|STARTED|Overall Study||7
515786|NCT00920309|1261248|P1|STARTED|Overall Study||14
515787|NCT00920231|1261258|P2|NOT COMPLETED|Overall Study||0
515788|NCT00920231|1261259|P1|NOT COMPLETED|Overall Study||0
515789|NCT00920231|1261258|P2|COMPLETED|Overall Study||8
515790|NCT00920231|1261259|P1|COMPLETED|Overall Study||8
515791|NCT00920231|1261258|P2|STARTED|Overall Study||8
515792|NCT00920231|1261259|P1|STARTED|Overall Study||8
515793|NCT00920218|1261271|P4|NOT COMPLETED|Overall Study||7
515794|NCT00920218|1261272|P3|NOT COMPLETED|Overall Study||8
515795|NCT00920218|1261273|P2|NOT COMPLETED|Overall Study||5
515796|NCT00920218|1261274|P1|NOT COMPLETED|Overall Study||2
515797|NCT00920218|1261271|P4|COMPLETED|Overall Study||23
515798|NCT00920218|1261272|P3|COMPLETED|Overall Study||23
515799|NCT00920218|1261273|P2|COMPLETED|Overall Study||24
515800|NCT00920218|1261274|P1|COMPLETED|Overall Study||28
515801|NCT00920218|1261271|P4|STARTED|Overall Study||30
515802|NCT00920218|1261272|P3|STARTED|Overall Study||31
515803|NCT00920218|1261273|P2|STARTED|Overall Study||29
515804|NCT00920218|1261274|P1|STARTED|Overall Study||30
515805|NCT00920140|1261377|P5|NOT COMPLETED|Phase 2||11
515806|NCT00920140|1261378|P4|NOT COMPLETED|Phase 2||22
515807|NCT00920140|1261379|P3|NOT COMPLETED|Phase 2||50
515808|NCT00920140|1261380|P2|NOT COMPLETED|Phase 2||0
515809|NCT00920140|1261381|P1|NOT COMPLETED|Phase 2||0
515810|NCT00920140|1261377|P5|COMPLETED|Phase 2||0
515811|NCT00920140|1261378|P4|COMPLETED|Phase 2||0
515812|NCT00920140|1261379|P3|COMPLETED|Phase 2||0
515813|NCT00920140|1261380|P2|COMPLETED|Phase 2||0
515814|NCT00920140|1261381|P1|COMPLETED|Phase 2||0
515815|NCT00920140|1261377|P5|STARTED|Phase 2||11
515816|NCT00920140|1261378|P4|STARTED|Phase 2||22
515817|NCT00920140|1261379|P3|STARTED|Phase 2||50
515818|NCT00920140|1261380|P2|STARTED|Phase 2||0
515819|NCT00920140|1261381|P1|STARTED|Phase 2||0
515820|NCT00920140|1261377|P5|NOT COMPLETED|Phase 1 (Dose Escalation)||0
515821|NCT00920140|1261378|P4|NOT COMPLETED|Phase 1 (Dose Escalation)||0
515822|NCT00920140|1261379|P3|NOT COMPLETED|Phase 1 (Dose Escalation)||0
515823|NCT00920140|1261380|P2|NOT COMPLETED|Phase 1 (Dose Escalation)||9
515824|NCT00920140|1261381|P1|NOT COMPLETED|Phase 1 (Dose Escalation)||5
515825|NCT00920140|1261377|P5|COMPLETED|Phase 1 (Dose Escalation)||0
515826|NCT00920140|1261378|P4|COMPLETED|Phase 1 (Dose Escalation)||0
515827|NCT00920140|1261379|P3|COMPLETED|Phase 1 (Dose Escalation)||0
515828|NCT00920140|1261380|P2|COMPLETED|Phase 1 (Dose Escalation)||0
515829|NCT00920140|1261381|P1|COMPLETED|Phase 1 (Dose Escalation)||0
515830|NCT00920140|1261377|P5|STARTED|Phase 1 (Dose Escalation)||0
515831|NCT00920140|1261378|P4|STARTED|Phase 1 (Dose Escalation)||0
515832|NCT00920140|1261379|P3|STARTED|Phase 1 (Dose Escalation)||0
515833|NCT00920140|1261380|P2|STARTED|Phase 1 (Dose Escalation)||9
515834|NCT00920140|1261381|P1|STARTED|Phase 1 (Dose Escalation)||5
515835|NCT00920075|1261419|P1|NOT COMPLETED|Post Study, 11 Pts Responded||0
515836|NCT00920075|1261419|P1|COMPLETED|Post Study, 11 Pts Responded||11
515837|NCT00920075|1261419|P1|STARTED|Post Study, 11 Pts Responded||11
515838|NCT00920075|1261419|P1|NOT COMPLETED|Last Study,25 Pts Invited,11 Responded||0
515839|NCT00920075|1261419|P1|COMPLETED|Last Study,25 Pts Invited,11 Responded||11
515840|NCT00920075|1261419|P1|STARTED|Last Study,25 Pts Invited,11 Responded||11
515841|NCT00920023|1261425|P1|NOT COMPLETED|Overall Study||0
515842|NCT00920023|1261425|P1|COMPLETED|Overall Study||15
515843|NCT00920023|1261425|P1|STARTED|Overall Study||15
515844|NCT00919932|1261432|P2|NOT COMPLETED|Overall Study||0
515845|NCT00919932|1261433|P1|NOT COMPLETED|Overall Study||0
515846|NCT00919932|1261432|P2|COMPLETED|Overall Study||5
515847|NCT00919932|1261433|P1|COMPLETED|Overall Study||4
515848|NCT00919932|1261432|P2|STARTED|Overall Study||5
515849|NCT00919932|1261433|P1|STARTED|Overall Study||4
515850|NCT00919893|1261443|P2|NOT COMPLETED|Overall Study||9
515851|NCT00919893|1261444|P1|NOT COMPLETED|Overall Study||19
515852|NCT00919893|1261443|P2|COMPLETED|Overall Study||60
515853|NCT00919893|1261444|P1|COMPLETED|Overall Study||51
515854|NCT00919893|1261443|P2|STARTED|Overall Study||69
515855|NCT00919893|1261444|P1|STARTED|Overall Study||70
515856|NCT00919867|1261456|P6|NOT COMPLETED|Third Intervention||0
515857|NCT00919867|1261457|P5|NOT COMPLETED|Third Intervention||0
515858|NCT00919867|1261458|P4|NOT COMPLETED|Third Intervention||0
515859|NCT00919867|1261459|P3|NOT COMPLETED|Third Intervention||0
515860|NCT00919867|1261460|P2|NOT COMPLETED|Third Intervention||0
515861|NCT00919867|1261461|P1|NOT COMPLETED|Third Intervention||0
515862|NCT00919867|1261456|P6|COMPLETED|Third Intervention||6
515863|NCT00919867|1261457|P5|COMPLETED|Third Intervention||7
515864|NCT00919867|1261458|P4|COMPLETED|Third Intervention||7
515865|NCT00919867|1261459|P3|COMPLETED|Third Intervention||6
515866|NCT00919867|1261460|P2|COMPLETED|Third Intervention||7
515867|NCT00919867|1261461|P1|COMPLETED|Third Intervention||7
515868|NCT00919867|1261456|P6|STARTED|Third Intervention||6
515869|NCT00919867|1261457|P5|STARTED|Third Intervention||7
515870|NCT00919867|1261458|P4|STARTED|Third Intervention||7
515871|NCT00919867|1261459|P3|STARTED|Third Intervention||6
515872|NCT00919867|1261460|P2|STARTED|Third Intervention||7
515873|NCT00919867|1261461|P1|STARTED|Third Intervention||7
515874|NCT00919867|1261456|P6|NOT COMPLETED|Washout||0
515875|NCT00919867|1261457|P5|NOT COMPLETED|Washout||0
515876|NCT00919867|1261458|P4|NOT COMPLETED|Washout||0
515877|NCT00919867|1261459|P3|NOT COMPLETED|Washout||0
515878|NCT00919867|1261460|P2|NOT COMPLETED|Washout||0
515879|NCT00919867|1261461|P1|NOT COMPLETED|Washout||0
515880|NCT00919867|1261456|P6|COMPLETED|Washout||6
515881|NCT00919867|1261457|P5|COMPLETED|Washout||7
515882|NCT00919867|1261458|P4|COMPLETED|Washout||7
515883|NCT00919867|1261459|P3|COMPLETED|Washout||6
515884|NCT00919867|1261460|P2|COMPLETED|Washout||7
515885|NCT00919867|1261461|P1|COMPLETED|Washout||7
515886|NCT00919867|1261456|P6|STARTED|Washout||6
515887|NCT00919867|1261457|P5|STARTED|Washout||7
515888|NCT00919867|1261458|P4|STARTED|Washout||7
515889|NCT00919867|1261459|P3|STARTED|Washout||6
515890|NCT00919867|1261460|P2|STARTED|Washout||7
515891|NCT00919867|1261461|P1|STARTED|Washout||7
515892|NCT00919867|1261456|P6|NOT COMPLETED|Second Intervention||0
515893|NCT00919867|1261457|P5|NOT COMPLETED|Second Intervention||0
515894|NCT00919867|1261458|P4|NOT COMPLETED|Second Intervention||0
515895|NCT00919867|1261459|P3|NOT COMPLETED|Second Intervention||0
515896|NCT00919867|1261460|P2|NOT COMPLETED|Second Intervention||0
515897|NCT00919867|1261461|P1|NOT COMPLETED|Second Intervention||0
515898|NCT00919867|1261456|P6|COMPLETED|Second Intervention||6
515899|NCT00919867|1261457|P5|COMPLETED|Second Intervention||7
515900|NCT00919867|1261458|P4|COMPLETED|Second Intervention||7
515901|NCT00919867|1261459|P3|COMPLETED|Second Intervention||6
515902|NCT00919867|1261460|P2|COMPLETED|Second Intervention||7
515903|NCT00919867|1261461|P1|COMPLETED|Second Intervention||7
515904|NCT00919867|1261456|P6|STARTED|Second Intervention||6
515905|NCT00919867|1261457|P5|STARTED|Second Intervention||7
515906|NCT00919867|1261458|P4|STARTED|Second Intervention||7
515907|NCT00919867|1261459|P3|STARTED|Second Intervention||6
515908|NCT00919867|1261460|P2|STARTED|Second Intervention||7
515909|NCT00919867|1261461|P1|STARTED|Second Intervention||7
515910|NCT00919867|1261456|P6|NOT COMPLETED|Washout||0
515911|NCT00919867|1261457|P5|NOT COMPLETED|Washout||0
515912|NCT00919867|1261458|P4|NOT COMPLETED|Washout||0
515913|NCT00919867|1261459|P3|NOT COMPLETED|Washout||0
515914|NCT00919867|1261460|P2|NOT COMPLETED|Washout||0
515915|NCT00919867|1261461|P1|NOT COMPLETED|Washout||0
515916|NCT00919867|1261456|P6|COMPLETED|Washout||6
515917|NCT00919867|1261457|P5|COMPLETED|Washout||7
515918|NCT00919867|1261458|P4|COMPLETED|Washout||7
515919|NCT00919867|1261459|P3|COMPLETED|Washout||6
515920|NCT00919867|1261460|P2|COMPLETED|Washout||7
515921|NCT00919867|1261461|P1|COMPLETED|Washout||7
515922|NCT00919867|1261456|P6|STARTED|Washout||6
515923|NCT00919867|1261457|P5|STARTED|Washout||7
515924|NCT00919867|1261458|P4|STARTED|Washout||7
515925|NCT00919867|1261459|P3|STARTED|Washout||6
515926|NCT00919867|1261460|P2|STARTED|Washout||7
515927|NCT00919867|1261461|P1|STARTED|Washout||7
515928|NCT00919867|1261456|P6|NOT COMPLETED|First Intervention||1
515929|NCT00919867|1261457|P5|NOT COMPLETED|First Intervention||0
515930|NCT00919867|1261458|P4|NOT COMPLETED|First Intervention||0
515931|NCT00919867|1261459|P3|NOT COMPLETED|First Intervention||1
515932|NCT00919867|1261460|P2|NOT COMPLETED|First Intervention||0
515933|NCT00919867|1261461|P1|NOT COMPLETED|First Intervention||0
515934|NCT00919867|1261456|P6|COMPLETED|First Intervention||6
515935|NCT00919867|1261457|P5|COMPLETED|First Intervention||7
515936|NCT00919867|1261458|P4|COMPLETED|First Intervention||7
515937|NCT00919867|1261459|P3|COMPLETED|First Intervention||6
515938|NCT00919867|1261460|P2|COMPLETED|First Intervention||7
515939|NCT00919867|1261461|P1|COMPLETED|First Intervention||7
515940|NCT00919867|1261456|P6|STARTED|First Intervention||7
515941|NCT00919867|1261457|P5|STARTED|First Intervention||7
515942|NCT00919867|1261458|P4|STARTED|First Intervention||7
515943|NCT00919867|1261459|P3|STARTED|First Intervention||7
515944|NCT00919867|1261460|P2|STARTED|First Intervention||7
515945|NCT00919867|1261461|P1|STARTED|First Intervention||7
515946|NCT00919854|1261482|P1|NOT COMPLETED|Overall Study||1
515947|NCT00919854|1261482|P1|COMPLETED|Overall Study|'Completed' represents the patients that are ongoing at the time of cut-off for the Week 24 analysis|20
515948|NCT00919854|1261482|P1|STARTED|Overall Study||21
515949|NCT00919802|1261491|P2|NOT COMPLETED|Second Intervention - (24 Hours)||0
515950|NCT00919802|1261492|P1|NOT COMPLETED|Second Intervention - (24 Hours)||0
515951|NCT00919802|1261491|P2|COMPLETED|Second Intervention - (24 Hours)||13
515952|NCT00919802|1261492|P1|COMPLETED|Second Intervention - (24 Hours)||12
515953|NCT00919802|1261491|P2|STARTED|Second Intervention - (24 Hours)||13
515954|NCT00919802|1261492|P1|STARTED|Second Intervention - (24 Hours)||12
515955|NCT00919802|1261491|P2|NOT COMPLETED|First Intervention - (24 Hours)||0
515956|NCT00919802|1261492|P1|NOT COMPLETED|First Intervention - (24 Hours)||0
515957|NCT00919802|1261491|P2|COMPLETED|First Intervention - (24 Hours)||13
515958|NCT00919802|1261492|P1|COMPLETED|First Intervention - (24 Hours)||12
515959|NCT00919802|1261491|P2|STARTED|First Intervention - (24 Hours)||13
515960|NCT00919802|1261492|P1|STARTED|First Intervention - (24 Hours)||12
515961|NCT00919763|1261502|P2|NOT COMPLETED|Overall Study||4
515962|NCT00919763|1261503|P1|NOT COMPLETED|Overall Study||12
515963|NCT00919763|1261502|P2|COMPLETED|Overall Study||45
515964|NCT00919763|1261503|P1|COMPLETED|Overall Study||41
515965|NCT00919763|1261502|P2|STARTED|Overall Study||49
515966|NCT00919763|1261503|P1|STARTED|Overall Study||53
515967|NCT00919724|1261511|P2|NOT COMPLETED|Overall Study||0
515968|NCT00919724|1261512|P1|NOT COMPLETED|Overall Study||0
515969|NCT00919724|1261511|P2|COMPLETED|Overall Study||44
515970|NCT00919724|1261512|P1|COMPLETED|Overall Study||45
515971|NCT00919724|1261511|P2|STARTED|Overall Study||44
515972|NCT00919724|1261512|P1|STARTED|Overall Study||45
515973|NCT00919711|1261520|P2|NOT COMPLETED|Overall Study||13
515974|NCT00919711|1261521|P1|NOT COMPLETED|Overall Study||33
515975|NCT00919711|1261520|P2|COMPLETED|Overall Study||422
515976|NCT00919711|1261521|P1|COMPLETED|Overall Study||402
515977|NCT00919711|1261520|P2|STARTED|Overall Study||435
515978|NCT00919711|1261521|P1|STARTED|Overall Study||435
515979|NCT00919633|1261537|P4|NOT COMPLETED|Overall Study||21
515980|NCT00919633|1261538|P3|NOT COMPLETED|Overall Study||23
515981|NCT00919633|1261539|P2|NOT COMPLETED|Overall Study||15
515982|NCT00919633|1261540|P1|NOT COMPLETED|Overall Study||22
515983|NCT00919633|1261537|P4|COMPLETED|Overall Study||5
515984|NCT00919633|1261538|P3|COMPLETED|Overall Study||4
515985|NCT00919633|1261539|P2|COMPLETED|Overall Study||10
515986|NCT00919633|1261540|P1|COMPLETED|Overall Study||6
515987|NCT00919633|1261537|P4|STARTED|Overall Study||26
515988|NCT00919633|1261538|P3|STARTED|Overall Study||27
515989|NCT00919633|1261539|P2|STARTED|Overall Study||25
515990|NCT00919633|1261540|P1|STARTED|Overall Study||28
515991|NCT00919191|1261558|P1|NOT COMPLETED|Overall Study||0
515992|NCT00919191|1261558|P1|COMPLETED|Overall Study||26
515993|NCT00919191|1261558|P1|STARTED|Overall Study||26
515994|NCT00919126|1261568|P3|NOT COMPLETED|Overall Study||1
515995|NCT00919126|1261569|P2|NOT COMPLETED|Overall Study||5
515996|NCT00919126|1261570|P1|NOT COMPLETED|Overall Study||1
515997|NCT00919126|1261568|P3|COMPLETED|Overall Study||32
515998|NCT00919126|1261569|P2|COMPLETED|Overall Study||32
515999|NCT00919126|1261570|P1|COMPLETED|Overall Study||31
516000|NCT00919126|1261568|P3|STARTED|Overall Study||33
516001|NCT00919126|1261569|P2|STARTED|Overall Study||37
516002|NCT00919126|1261570|P1|STARTED|Overall Study||32
516003|NCT00919113|1261616|P2|NOT COMPLETED|Overall Study||8
516004|NCT00919113|1261617|P1|NOT COMPLETED|Overall Study||9
516005|NCT00919113|1261616|P2|COMPLETED|Overall Study||40
516006|NCT00919113|1261617|P1|COMPLETED|Overall Study||41
516007|NCT00919113|1261616|P2|Received Placebo|Overall Study|One subject was misrandomized. Actual treatment was used for Demographic and Safety analysis.|49
516008|NCT00919113|1261617|P1|Received Placebo|Overall Study||0
516009|NCT00919113|1261616|P2|Received Uracyst|Overall Study||0
516010|NCT00919113|1261617|P1|Received Uracyst|Overall Study|One subject was misrandomized. Actual treatment was used for Demographic and Safety analysis.|49
516011|NCT00919113|1261616|P2|STARTED|Overall Study||48
516012|NCT00919113|1261617|P1|STARTED|Overall Study||50
516013|NCT00919061|1261625|P1|NOT COMPLETED|Overall Study||2
516014|NCT00919061|1261625|P1|COMPLETED|Overall Study||37
516015|NCT00919061|1261625|P1|STARTED|Overall Study||39
516016|NCT00919035|1261630|P1|NOT COMPLETED|Overall Study||0
516017|NCT00919035|1261630|P1|COMPLETED|Overall Study||21
516018|NCT00919035|1261630|P1|STARTED|Overall Study||21
516019|NCT00918957|1261638|P2|NOT COMPLETED|Overall Study||0
516020|NCT00918957|1261639|P1|NOT COMPLETED|Overall Study||3
516021|NCT00918957|1261638|P2|COMPLETED|Overall Study||30
516022|NCT00918957|1261639|P1|COMPLETED|Overall Study||29
516023|NCT00918957|1261638|P2|STARTED|Overall Study||30
516024|NCT00918957|1261639|P1|STARTED|Overall Study||32
516025|NCT00918931|1261666|P1|NOT COMPLETED|Overall Study||0
516026|NCT00918931|1261666|P1|COMPLETED|Overall Study||3
516027|NCT00918931|1261666|P1|STARTED|Overall Study||3
516028|NCT00918879|1261672|P2|NOT COMPLETED|Overall Study||6
516029|NCT00918879|1261673|P1|NOT COMPLETED|Overall Study||6
516030|NCT00918879|1261672|P2|COMPLETED|Overall Study|Completed 24 weeks of treatment|100
516031|NCT00918879|1261673|P1|COMPLETED|Overall Study|Completed 24 weeks of treatment|101
516032|NCT00918879|1261672|P2|STARTED|Overall Study|Randomized and treated|106
516033|NCT00918879|1261673|P1|STARTED|Overall Study|Randomized and treated|107
516034|NCT00918866|1261687|P2|NOT COMPLETED|Overall Study||0
516035|NCT00918866|1261688|P1|NOT COMPLETED|Overall Study||0
516036|NCT00918866|1261687|P2|COMPLETED|Overall Study||16
516037|NCT00918866|1261688|P1|COMPLETED|Overall Study||16
516038|NCT00918866|1261687|P2|STARTED|Overall Study||16
516039|NCT00918866|1261688|P1|STARTED|Overall Study||16
516040|NCT00918749|1261705|P3|NOT COMPLETED|Overall Study||7
516041|NCT00918749|1261706|P2|NOT COMPLETED|Overall Study||3
516042|NCT00918749|1261707|P1|NOT COMPLETED|Overall Study||7
516043|NCT00918749|1261705|P3|COMPLETED|Overall Study||62
516044|NCT00918749|1261706|P2|COMPLETED|Overall Study||63
516045|NCT00918749|1261707|P1|COMPLETED|Overall Study||63
516046|NCT00918749|1261705|P3|ITT (Intent to Treat) Population|Overall Study||69
516047|NCT00918749|1261706|P2|ITT (Intent to Treat) Population|Overall Study||66
516048|NCT00918749|1261707|P1|ITT (Intent to Treat) Population|Overall Study|One subject took no study drug and was not included in ITT Population|69
516049|NCT00918749|1261705|P3|STARTED|Overall Study||69
516050|NCT00918749|1261706|P2|STARTED|Overall Study||66
516051|NCT00918749|1261707|P1|STARTED|Overall Study||70
516052|NCT00918736|1261739|P1|NOT COMPLETED|Overall Study||4
516053|NCT00918736|1261739|P1|COMPLETED|Overall Study|October, 2008|46
516054|NCT00918736|1261739|P1|STARTED|Overall Study|October, 2007|50
516055|NCT00918723|1261743|P1|NOT COMPLETED|Overall Study||0
516056|NCT00918723|1261743|P1|COMPLETED|Overall Study||40
516057|NCT00918723|1261743|P1|STARTED|Overall Study||40
516058|NCT00918684|1261752|P1|NOT COMPLETED|Treatment Phase||25
516059|NCT00918684|1261752|P1|COMPLETED|Treatment Phase||65
516060|NCT00918684|1261752|P1|STARTED|Treatment Phase||90
516061|NCT00918684|1261752|P1|NOT COMPLETED|Two Week Drug Washout and Placebo Phase||16
516062|NCT00918684|1261752|P1|COMPLETED|Two Week Drug Washout and Placebo Phase||90
516063|NCT00918684|1261752|P1|STARTED|Two Week Drug Washout and Placebo Phase||106
516064|NCT00918671|1261758|P1|NOT COMPLETED|Overall Study||0
516065|NCT00918671|1261758|P1|COMPLETED|Overall Study||60
516066|NCT00918671|1261758|P1|STARTED|Overall Study||60
516067|NCT00918645|1261763|P1|NOT COMPLETED|Overall Study||1
516068|NCT00918645|1261763|P1|COMPLETED|Overall Study||12
516069|NCT00918645|1261763|P1|STARTED|Overall Study||13
516070|NCT00918580|1261769|P1|NOT COMPLETED|After 6-month FU to 1-year FU||60
516071|NCT00918580|1261769|P1|COMPLETED|After 6-month FU to 1-year FU||87
516072|NCT00918580|1261769|P1|Continued After 6-Month FU|After 6-month FU to 1-year FU||89
516073|NCT00918580|1261769|P1|STARTED|After 6-month FU to 1-year FU||147
516074|NCT00918580|1261769|P1|NOT COMPLETED|Up to 6-month Follow-up(FU)||11
516075|NCT00918580|1261769|P1|COMPLETED|Up to 6-month Follow-up(FU)|Completed include 1 participant:withdrew before Dose 2 (protocol violation) but completed 6-month FU|147
516076|NCT00918580|1261769|P1|Vaccinated Dose 2|Up to 6-month Follow-up(FU)||146
516077|NCT00918580|1261769|P1|Vaccinated Dose 1|Up to 6-month Follow-up(FU)||158
516078|NCT00918580|1261769|P1|STARTED|Up to 6-month Follow-up(FU)||158
516079|NCT00918385|1261789|P2|NOT COMPLETED|Combination Nilutamide and Dasatinib||8
516080|NCT00918385|1261790|P1|NOT COMPLETED|Combination Nilutamide and Dasatinib||6
516081|NCT00918385|1261789|P2|COMPLETED|Combination Nilutamide and Dasatinib||3
516082|NCT00918385|1261790|P1|COMPLETED|Combination Nilutamide and Dasatinib||6
516083|NCT00918385|1261789|P2|STARTED|Combination Nilutamide and Dasatinib||11
516084|NCT00918385|1261790|P1|STARTED|Combination Nilutamide and Dasatinib||12
516085|NCT00918385|1261789|P2|NOT COMPLETED|Monotherapy||6
516086|NCT00918385|1261790|P1|NOT COMPLETED|Monotherapy||2
516087|NCT00918385|1261789|P2|COMPLETED|Monotherapy|Completed = received treatment until first disease progression on single agent.|11
516088|NCT00918385|1261790|P1|COMPLETED|Monotherapy|Completed = received treatment until first disease progression on single agent.|12
516089|NCT00918385|1261789|P2|STARTED|Monotherapy||17
516090|NCT00918385|1261790|P1|STARTED|Monotherapy||14
516091|NCT00918346|1261799|P2|NOT COMPLETED|Post Study Period||0
516092|NCT00918346|1261800|P1|NOT COMPLETED|Post Study Period||0
516093|NCT00918346|1261799|P2|COMPLETED|Post Study Period||21
516094|NCT00918346|1261800|P1|COMPLETED|Post Study Period||21
516095|NCT00918346|1261799|P2|STARTED|Post Study Period||21
516096|NCT00918346|1261800|P1|STARTED|Post Study Period||21
516097|NCT00918346|1261799|P2|NOT COMPLETED|Second Treatment Period (4 Weeks)||0
516098|NCT00918346|1261800|P1|NOT COMPLETED|Second Treatment Period (4 Weeks)||0
516099|NCT00918346|1261799|P2|COMPLETED|Second Treatment Period (4 Weeks)||21
516100|NCT00918346|1261800|P1|COMPLETED|Second Treatment Period (4 Weeks)||21
516101|NCT00918346|1261799|P2|STARTED|Second Treatment Period (4 Weeks)||21
516102|NCT00918346|1261800|P1|STARTED|Second Treatment Period (4 Weeks)||21
516103|NCT00918346|1261799|P2|NOT COMPLETED|Washout (at Least 4 Weeks)||0
516104|NCT00918346|1261800|P1|NOT COMPLETED|Washout (at Least 4 Weeks)||0
516105|NCT00918346|1261799|P2|COMPLETED|Washout (at Least 4 Weeks)||21
516106|NCT00918346|1261800|P1|COMPLETED|Washout (at Least 4 Weeks)||21
516107|NCT00918346|1261799|P2|STARTED|Washout (at Least 4 Weeks)||21
516108|NCT00918346|1261800|P1|STARTED|Washout (at Least 4 Weeks)||21
516109|NCT00918346|1261799|P2|NOT COMPLETED|First Treatment Period (4 Weeks)||1
516110|NCT00918346|1261800|P1|NOT COMPLETED|First Treatment Period (4 Weeks)||0
516111|NCT00918346|1261799|P2|COMPLETED|First Treatment Period (4 Weeks)|A patient completed the first treatment period but discontinued thereafter (did not start washout).|21
516112|NCT00918346|1261800|P1|COMPLETED|First Treatment Period (4 Weeks)||21
516113|NCT00918346|1261799|P2|STARTED|First Treatment Period (4 Weeks)||22
516114|NCT00918346|1261800|P1|STARTED|First Treatment Period (4 Weeks)||21
516115|NCT00918333|1261816|P2|NOT COMPLETED|Overall Study||5
516116|NCT00918333|1261817|P1|NOT COMPLETED|Overall Study||3
516117|NCT00918333|1261816|P2|COMPLETED|Overall Study||93
516118|NCT00918333|1261817|P1|COMPLETED|Overall Study||23
516119|NCT00918333|1261816|P2|STARTED|Overall Study||98
516120|NCT00918333|1261817|P1|STARTED|Overall Study||26
516121|NCT00918281|1261837|P1|NOT COMPLETED|Overall Study||29
516122|NCT00918281|1261837|P1|COMPLETED|Overall Study||41
516123|NCT00918281|1261837|P1|STARTED|Overall Study||70
516124|NCT00918255|1261847|P3|NOT COMPLETED|Overall Study||5
516125|NCT00918255|1261848|P2|NOT COMPLETED|Overall Study||0
516126|NCT00918255|1261849|P1|NOT COMPLETED|Overall Study||6
516127|NCT00918255|1261847|P3|COMPLETED|Overall Study||46
516128|NCT00918255|1261848|P2|COMPLETED|Overall Study||52
516129|NCT00918255|1261849|P1|COMPLETED|Overall Study||45
516130|NCT00918255|1261847|P3|STARTED|Overall Study||51
516131|NCT00918255|1261848|P2|STARTED|Overall Study||52
516132|NCT00918255|1261849|P1|STARTED|Overall Study||51
516133|NCT00918203|1261877|P3|NOT COMPLETED|Crossover to Olaratumab Monotherapy||3
516134|NCT00918203|1261878|P2|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
516135|NCT00918203|1261879|P1|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
516136|NCT00918203|1261877|P3|COMPLETED|Crossover to Olaratumab Monotherapy||14
516137|NCT00918203|1261878|P2|COMPLETED|Crossover to Olaratumab Monotherapy||0
516138|NCT00918203|1261879|P1|COMPLETED|Crossover to Olaratumab Monotherapy||0
516139|NCT00918203|1261877|P3|STARTED|Crossover to Olaratumab Monotherapy|16 participants crossed over to olaratumab after PD and 1 participant of symptomatic deterioration.|17
516140|NCT00918203|1261878|P2|STARTED|Crossover to Olaratumab Monotherapy||0
516141|NCT00918203|1261879|P1|STARTED|Crossover to Olaratumab Monotherapy||0
516142|NCT00918203|1261877|P3|NOT COMPLETED|Treatment With or Without Olaratumab||0
516143|NCT00918203|1261878|P2|NOT COMPLETED|Treatment With or Without Olaratumab||14
516144|NCT00918203|1261879|P1|NOT COMPLETED|Treatment With or Without Olaratumab||7
516145|NCT00918203|1261877|P3|COMPLETED|Treatment With or Without Olaratumab||0
516146|NCT00918203|1261878|P2|COMPLETED|Treatment With or Without Olaratumab||53
516147|NCT00918203|1261879|P1|COMPLETED|Treatment With or Without Olaratumab||63
516148|NCT00918203|1261877|P3|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||0
516149|NCT00918203|1261878|P2|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||64
516150|NCT00918203|1261879|P1|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||67
516151|NCT00918203|1261877|P3|STARTED|Treatment With or Without Olaratumab||0
516152|NCT00918203|1261878|P2|STARTED|Treatment With or Without Olaratumab||67
516153|NCT00918203|1261879|P1|STARTED|Treatment With or Without Olaratumab||70
516154|NCT00918138|1261910|P2|NOT COMPLETED|Overall Study||1
516155|NCT00918138|1261911|P1|NOT COMPLETED|Overall Study||2
516156|NCT00918138|1261910|P2|COMPLETED|Overall Study||46
516157|NCT00918138|1261911|P1|COMPLETED|Overall Study||44
516158|NCT00918138|1261910|P2|STARTED|Overall Study||47
516159|NCT00918138|1261911|P1|STARTED|Overall Study||46
516160|NCT00918125|1261927|P2|NOT COMPLETED|Overall Study||0
516161|NCT00918125|1261928|P1|NOT COMPLETED|Overall Study||0
516162|NCT00918125|1261927|P2|COMPLETED|Overall Study||39
516163|NCT00918125|1261928|P1|COMPLETED|Overall Study||20
516164|NCT00918125|1261927|P2|STARTED|Overall Study||39
516165|NCT00918125|1261928|P1|STARTED|Overall Study||20
516166|NCT00917865|1261939|P1|NOT COMPLETED|Overall Study||0
516167|NCT00917865|1261939|P1|COMPLETED|Overall Study||11
516168|NCT00917865|1261939|P1|STARTED|Overall Study||11
516169|NCT00917852|1261950|P1|NOT COMPLETED|Overall Study||6
516170|NCT00917852|1261950|P1|COMPLETED|Overall Study||45
516171|NCT00917852|1261950|P1|STARTED|Overall Study||51
516172|NCT00917735|1261957|P2|NOT COMPLETED|Overall Study||63
516173|NCT00917735|1261958|P1|NOT COMPLETED|Overall Study||75
516174|NCT00917735|1261957|P2|COMPLETED|Overall Study||474
516175|NCT00917735|1261958|P1|COMPLETED|Overall Study||463
516176|NCT00917735|1261957|P2|STARTED|Overall Study||537
516177|NCT00917735|1261958|P1|STARTED|Overall Study||538
516178|NCT00917644|1261968|P2|NOT COMPLETED|Period 2: Second Intervention||0
516179|NCT00917644|1261969|P1|NOT COMPLETED|Period 2: Second Intervention||1
516180|NCT00917644|1261968|P2|COMPLETED|Period 2: Second Intervention|Total number of subjects completed Ref drug = 73.|37
516181|NCT00917644|1261969|P1|COMPLETED|Period 2: Second Intervention|Total number of subjects completed Test drug = 74.|36
516182|NCT00917644|1261968|P2|STARTED|Period 2: Second Intervention|Washout: Reference drug (Ref) 1st, completed = 37; 2nd period: Ref drug 2nd, completed = 36.|37
516183|NCT00917644|1261969|P1|STARTED|Period 2: Second Intervention|Washout: Test drug 1st, completed = 37; 2nd period: Test drug 2nd, completed = 37.|37
516184|NCT00917644|1261968|P2|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||0
516185|NCT00917644|1261969|P1|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||2
516186|NCT00917644|1261968|P2|COMPLETED|Period: Washout Period of > = 2 Weeks||37
516187|NCT00917644|1261969|P1|COMPLETED|Period: Washout Period of > = 2 Weeks||37
516188|NCT00917644|1261968|P2|STARTED|Period: Washout Period of > = 2 Weeks||37
516189|NCT00917644|1261969|P1|STARTED|Period: Washout Period of > = 2 Weeks||39
516190|NCT00917644|1261968|P2|NOT COMPLETED|Period 1: First Intervention||0
516191|NCT00917644|1261969|P1|NOT COMPLETED|Period 1: First Intervention||0
516192|NCT00917644|1261968|P2|COMPLETED|Period 1: First Intervention||37
516193|NCT00917644|1261969|P1|COMPLETED|Period 1: First Intervention||39
516194|NCT00917644|1261968|P2|STARTED|Period 1: First Intervention||37
516195|NCT00917644|1261969|P1|STARTED|Period 1: First Intervention||39
516196|NCT00917579|1261983|P2|NOT COMPLETED|Period 2: 2nd Intervention||0
516197|NCT00917579|1261984|P1|NOT COMPLETED|Period 2: 2nd Intervention||0
516198|NCT00917579|1261983|P2|COMPLETED|Period 2: 2nd Intervention||37
516199|NCT00917579|1261984|P1|COMPLETED|Period 2: 2nd Intervention||37
516200|NCT00917579|1261983|P2|STARTED|Period 2: 2nd Intervention||37
516201|NCT00917579|1261984|P1|STARTED|Period 2: 2nd Intervention||37
516202|NCT00917579|1261983|P2|NOT COMPLETED|Washout >= 2 Weeks||0
516203|NCT00917579|1261984|P1|NOT COMPLETED|Washout >= 2 Weeks||2
516204|NCT00917579|1261983|P2|COMPLETED|Washout >= 2 Weeks||37
516205|NCT00917579|1261984|P1|COMPLETED|Washout >= 2 Weeks||37
516206|NCT00917579|1261983|P2|STARTED|Washout >= 2 Weeks||37
516207|NCT00917579|1261984|P1|STARTED|Washout >= 2 Weeks||39
516208|NCT00917579|1261983|P2|NOT COMPLETED|Period 1: 1st Intervention||0
516209|NCT00917579|1261984|P1|NOT COMPLETED|Period 1: 1st Intervention||0
516210|NCT00917579|1261983|P2|COMPLETED|Period 1: 1st Intervention||37
516211|NCT00917579|1261984|P1|COMPLETED|Period 1: 1st Intervention||39
516212|NCT00917579|1261983|P2|STARTED|Period 1: 1st Intervention||37
516213|NCT00917579|1261984|P1|STARTED|Period 1: 1st Intervention||39
516214|NCT00917501|1262000|P2|NOT COMPLETED|Overall Study||5
516215|NCT00917501|1262001|P1|NOT COMPLETED|Overall Study||8
516216|NCT00917501|1262000|P2|COMPLETED|Overall Study||21
516217|NCT00917501|1262001|P1|COMPLETED|Overall Study||21
516218|NCT00917501|1262000|P2|STARTED|Overall Study||26
516219|NCT00917501|1262001|P1|STARTED|Overall Study||29
516220|NCT00917384|1262009|P2|NOT COMPLETED|Overall Study||4
516221|NCT00917384|1262010|P1|NOT COMPLETED|Overall Study||14
516222|NCT00917384|1262009|P2|COMPLETED|Overall Study||113
516223|NCT00917384|1262010|P1|COMPLETED|Overall Study||224
516224|NCT00917384|1262009|P2|Received at Least 1 Dose of Study Drug|Overall Study||115
516225|NCT00917384|1262010|P1|Received at Least 1 Dose of Study Drug|Overall Study||236
516226|NCT00917384|1262009|P2|STARTED|Overall Study||117
516227|NCT00917384|1262010|P1|STARTED|Overall Study||238
516228|NCT00917267|1262034|P2|NOT COMPLETED|Overall Study||79
516229|NCT00917267|1262035|P1|NOT COMPLETED|Overall Study||39
516230|NCT00917267|1262034|P2|COMPLETED|Overall Study||266
516231|NCT00917267|1262035|P1|COMPLETED|Overall Study||307
516232|NCT00917267|1262034|P2|Intent to Treat (ITT)|Overall Study||338
516233|NCT00917267|1262035|P1|Intent to Treat (ITT)|Overall Study||340
516234|NCT00917267|1262034|P2|STARTED|Overall Study||345
516235|NCT00917267|1262035|P1|STARTED|Overall Study||346
516236|NCT00917124|1262063|P2|NOT COMPLETED|Overall Study||6
516237|NCT00917124|1262064|P1|NOT COMPLETED|Overall Study||4
516238|NCT00917124|1262063|P2|COMPLETED|Overall Study||94
516239|NCT00917124|1262064|P1|COMPLETED|Overall Study||96
516240|NCT00917124|1262063|P2|STARTED|Overall Study||100
516241|NCT00917124|1262064|P1|STARTED|Overall Study||100
516242|NCT00916929|1262074|P2|NOT COMPLETED|Overall Study||29
516243|NCT00916929|1262075|P1|NOT COMPLETED|Overall Study||10
516244|NCT00916929|1262074|P2|COMPLETED|Overall Study||53
516245|NCT00916929|1262075|P1|COMPLETED|Overall Study||70
516246|NCT00916929|1262074|P2|STARTED|Overall Study||82
516247|NCT00916929|1262075|P1|STARTED|Overall Study||80
516248|NCT00916721|1262085|P2|NOT COMPLETED|Overall Study||10
516249|NCT00916721|1262086|P1|NOT COMPLETED|Overall Study||10
516250|NCT00916721|1262085|P2|COMPLETED|Overall Study||29
516251|NCT00916721|1262086|P1|COMPLETED|Overall Study||25
516252|NCT00916721|1262085|P2|STARTED|Overall Study||39
516253|NCT00916721|1262086|P1|STARTED|Overall Study||35
516254|NCT00916643|1262098|P1|NOT COMPLETED|Overall Study||0
516255|NCT00916643|1262098|P1|COMPLETED|Overall Study||113
516256|NCT00916643|1262098|P1|STARTED|Overall Study||113
516257|NCT00916617|1262109|P4|NOT COMPLETED|Overall Study||7
516258|NCT00916617|1262110|P3|NOT COMPLETED|Overall Study||10
516259|NCT00916617|1262111|P2|NOT COMPLETED|Overall Study||21
516260|NCT00916617|1262112|P1|NOT COMPLETED|Overall Study||23
516261|NCT00916617|1262109|P4|COMPLETED|Overall Study||0
516262|NCT00916617|1262110|P3|COMPLETED|Overall Study||0
516263|NCT00916617|1262111|P2|COMPLETED|Overall Study||0
516264|NCT00916617|1262112|P1|COMPLETED|Overall Study||1
516265|NCT00916617|1262109|P4|STARTED|Overall Study||7
516266|NCT00916617|1262110|P3|STARTED|Overall Study||10
516267|NCT00916617|1262111|P2|STARTED|Overall Study||21
516268|NCT00916617|1262112|P1|STARTED|Overall Study||24
516269|NCT00916578|1262126|P1|NOT COMPLETED|Overall Study||7
516270|NCT00916578|1262126|P1|COMPLETED|Overall Study||26
516271|NCT00916578|1262126|P1|STARTED|Overall Study||33
516272|NCT00916539|1262132|P2|NOT COMPLETED|Overall Study||0
516273|NCT00916539|1262133|P1|NOT COMPLETED|Overall Study||0
516274|NCT00916539|1262132|P2|COMPLETED|Overall Study||31
516275|NCT00916539|1262133|P1|COMPLETED|Overall Study||31
516276|NCT00916539|1262132|P2|STARTED|Overall Study||31
516277|NCT00916539|1262133|P1|STARTED|Overall Study||31
516278|NCT00916383|1262155|P1|NOT COMPLETED|Overall Study||3
516279|NCT00916383|1262155|P1|COMPLETED|Overall Study||46
516280|NCT00916383|1262155|P1|STARTED|Overall Study||49
516281|NCT00916370|1262183|P2|NOT COMPLETED|Overall Study||2
516282|NCT00916370|1262184|P1|NOT COMPLETED|Overall Study||5
516283|NCT00916370|1262183|P2|COMPLETED|Overall Study||102
516284|NCT00916370|1262184|P1|COMPLETED|Overall Study||396
516285|NCT00916370|1262183|P2|STARTED|Overall Study||104
516286|NCT00916370|1262184|P1|STARTED|Overall Study||401
516287|NCT00916357|1262358|P6|NOT COMPLETED|Period 3||0
516288|NCT00916357|1262359|P5|NOT COMPLETED|Period 3||0
516289|NCT00916357|1262360|P4|NOT COMPLETED|Period 3||0
516290|NCT00916357|1262361|P3|NOT COMPLETED|Period 3||0
516291|NCT00916357|1262362|P2|NOT COMPLETED|Period 3||0
516292|NCT00916357|1262363|P1|NOT COMPLETED|Period 3||0
516293|NCT00916357|1262358|P6|COMPLETED|Period 3||4
516294|NCT00916357|1262359|P5|COMPLETED|Period 3||3
516295|NCT00916357|1262360|P4|COMPLETED|Period 3||3
516296|NCT00916357|1262361|P3|COMPLETED|Period 3||4
516297|NCT00916357|1262362|P2|COMPLETED|Period 3||4
516298|NCT00916357|1262363|P1|COMPLETED|Period 3||3
516299|NCT00916357|1262358|P6|STARTED|Period 3||4
516300|NCT00916357|1262359|P5|STARTED|Period 3||3
516301|NCT00916357|1262360|P4|STARTED|Period 3||3
516302|NCT00916357|1262361|P3|STARTED|Period 3||4
516303|NCT00916357|1262362|P2|STARTED|Period 3||4
516304|NCT00916357|1262363|P1|STARTED|Period 3||3
516305|NCT00916357|1262358|P6|NOT COMPLETED|Washout (3 to 14 Days)||0
516306|NCT00916357|1262359|P5|NOT COMPLETED|Washout (3 to 14 Days)||0
516307|NCT00916357|1262360|P4|NOT COMPLETED|Washout (3 to 14 Days)||0
516308|NCT00916357|1262361|P3|NOT COMPLETED|Washout (3 to 14 Days)||0
516309|NCT00916357|1262362|P2|NOT COMPLETED|Washout (3 to 14 Days)||0
516310|NCT00916357|1262363|P1|NOT COMPLETED|Washout (3 to 14 Days)||0
516311|NCT00916357|1262358|P6|COMPLETED|Washout (3 to 14 Days)||4
516312|NCT00916357|1262359|P5|COMPLETED|Washout (3 to 14 Days)||3
516313|NCT00916357|1262360|P4|COMPLETED|Washout (3 to 14 Days)||3
516314|NCT00916357|1262361|P3|COMPLETED|Washout (3 to 14 Days)||4
516315|NCT00916357|1262362|P2|COMPLETED|Washout (3 to 14 Days)||4
516316|NCT00916357|1262363|P1|COMPLETED|Washout (3 to 14 Days)||3
516317|NCT00916357|1262358|P6|STARTED|Washout (3 to 14 Days)||4
516318|NCT00916357|1262359|P5|STARTED|Washout (3 to 14 Days)||3
516319|NCT00916357|1262360|P4|STARTED|Washout (3 to 14 Days)||3
516320|NCT00916357|1262361|P3|STARTED|Washout (3 to 14 Days)||4
516321|NCT00916357|1262362|P2|STARTED|Washout (3 to 14 Days)||4
516322|NCT00916357|1262363|P1|STARTED|Washout (3 to 14 Days)||3
516323|NCT00916357|1262358|P6|NOT COMPLETED|Period 2||0
516324|NCT00916357|1262359|P5|NOT COMPLETED|Period 2||0
516325|NCT00916357|1262360|P4|NOT COMPLETED|Period 2||1
516326|NCT00916357|1262361|P3|NOT COMPLETED|Period 2||0
516327|NCT00916357|1262362|P2|NOT COMPLETED|Period 2||0
516328|NCT00916357|1262363|P1|NOT COMPLETED|Period 2||0
516329|NCT00916357|1262358|P6|COMPLETED|Period 2||4
516330|NCT00916357|1262359|P5|COMPLETED|Period 2||3
516331|NCT00916357|1262360|P4|COMPLETED|Period 2||3
516332|NCT00916357|1262361|P3|COMPLETED|Period 2||4
516333|NCT00916357|1262362|P2|COMPLETED|Period 2||4
516334|NCT00916357|1262363|P1|COMPLETED|Period 2||3
516335|NCT00916357|1262358|P6|STARTED|Period 2||4
516336|NCT00916357|1262359|P5|STARTED|Period 2||3
516337|NCT00916357|1262360|P4|STARTED|Period 2||4
516338|NCT00916357|1262361|P3|STARTED|Period 2||4
516339|NCT00916357|1262362|P2|STARTED|Period 2||4
516340|NCT00916357|1262363|P1|STARTED|Period 2||3
516341|NCT00916357|1262358|P6|NOT COMPLETED|Washout (3 to 14 Days)||0
516342|NCT00916357|1262359|P5|NOT COMPLETED|Washout (3 to 14 Days)||0
516343|NCT00916357|1262360|P4|NOT COMPLETED|Washout (3 to 14 Days)||0
516344|NCT00916357|1262361|P3|NOT COMPLETED|Washout (3 to 14 Days)||0
516345|NCT00916357|1262362|P2|NOT COMPLETED|Washout (3 to 14 Days)||0
516346|NCT00916357|1262363|P1|NOT COMPLETED|Washout (3 to 14 Days)||0
516347|NCT00916357|1262358|P6|COMPLETED|Washout (3 to 14 Days)||4
516348|NCT00916357|1262359|P5|COMPLETED|Washout (3 to 14 Days)||3
516349|NCT00916357|1262360|P4|COMPLETED|Washout (3 to 14 Days)||4
516350|NCT00916357|1262361|P3|COMPLETED|Washout (3 to 14 Days)||4
516351|NCT00916357|1262362|P2|COMPLETED|Washout (3 to 14 Days)||4
516352|NCT00916357|1262363|P1|COMPLETED|Washout (3 to 14 Days)||3
516353|NCT00916357|1262358|P6|STARTED|Washout (3 to 14 Days)||4
516354|NCT00916357|1262359|P5|STARTED|Washout (3 to 14 Days)||3
516355|NCT00916357|1262360|P4|STARTED|Washout (3 to 14 Days)||4
516356|NCT00916357|1262361|P3|STARTED|Washout (3 to 14 Days)||4
516357|NCT00916357|1262362|P2|STARTED|Washout (3 to 14 Days)||4
516358|NCT00916357|1262363|P1|STARTED|Washout (3 to 14 Days)||3
516359|NCT00916357|1262358|P6|NOT COMPLETED|Period 1||0
516360|NCT00916357|1262359|P5|NOT COMPLETED|Period 1||0
516361|NCT00916357|1262360|P4|NOT COMPLETED|Period 1||0
516362|NCT00916357|1262361|P3|NOT COMPLETED|Period 1||0
516363|NCT00916357|1262362|P2|NOT COMPLETED|Period 1||0
516364|NCT00916357|1262363|P1|NOT COMPLETED|Period 1||1
516365|NCT00916357|1262358|P6|COMPLETED|Period 1||4
516366|NCT00916357|1262359|P5|COMPLETED|Period 1||3
516367|NCT00916357|1262360|P4|COMPLETED|Period 1||4
516368|NCT00916357|1262361|P3|COMPLETED|Period 1||4
516369|NCT00916357|1262362|P2|COMPLETED|Period 1||4
516370|NCT00916357|1262363|P1|COMPLETED|Period 1||3
516371|NCT00916357|1262358|P6|Received at Least 1 Dose of Study Drug|Period 1||4
516372|NCT00916357|1262359|P5|Received at Least 1 Dose of Study Drug|Period 1||3
516373|NCT00916357|1262360|P4|Received at Least 1 Dose of Study Drug|Period 1||4
516374|NCT00916357|1262361|P3|Received at Least 1 Dose of Study Drug|Period 1||4
516375|NCT00916357|1262362|P2|Received at Least 1 Dose of Study Drug|Period 1||4
516376|NCT00916357|1262363|P1|Received at Least 1 Dose of Study Drug|Period 1||4
516377|NCT00916357|1262358|P6|STARTED|Period 1||4
516378|NCT00916357|1262359|P5|STARTED|Period 1||3
516379|NCT00916357|1262360|P4|STARTED|Period 1||4
516380|NCT00916357|1262361|P3|STARTED|Period 1||4
516381|NCT00916357|1262362|P2|STARTED|Period 1||4
516382|NCT00916357|1262363|P1|STARTED|Period 1||4
516383|NCT00916344|1262401|P1|NOT COMPLETED|Overall Study||8
516384|NCT00916344|1262401|P1|COMPLETED|Overall Study||167
516385|NCT00916344|1262401|P1|STARTED|Overall Study||175
516386|NCT00916305|1262408|P2|NOT COMPLETED|Overall Study||28
516387|NCT00916305|1262409|P1|NOT COMPLETED|Overall Study||21
516388|NCT00916305|1262408|P2|COMPLETED|Overall Study||9
516389|NCT00916305|1262409|P1|COMPLETED|Overall Study||7
516390|NCT00916305|1262408|P2|STARTED|Overall Study||37
516391|NCT00916305|1262409|P1|STARTED|Overall Study||28
516392|NCT00916279|1262417|P1|NOT COMPLETED|Overall Study||4
516393|NCT00916279|1262417|P1|COMPLETED|Overall Study||37
516394|NCT00916279|1262417|P1|24 Months|Overall Study||37
516395|NCT00916279|1262417|P1|6 Months|Overall Study||41
516396|NCT00916279|1262417|P1|30 Days|Overall Study||41
516397|NCT00916279|1262417|P1|STARTED|Overall Study||41
516398|NCT00916136|1262427|P2|NOT COMPLETED|Overall Study||0
516399|NCT00916136|1262428|P1|NOT COMPLETED|Overall Study||0
516400|NCT00916136|1262427|P2|COMPLETED|Overall Study||29
516401|NCT00916136|1262428|P1|COMPLETED|Overall Study||37
516402|NCT00916136|1262427|P2|STARTED|Overall Study||29
516403|NCT00916136|1262428|P1|STARTED|Overall Study||37
516404|NCT00916032|1262436|P2|NOT COMPLETED|Overall Study||0
516405|NCT00916032|1262437|P1|NOT COMPLETED|Overall Study||0
516406|NCT00916032|1262436|P2|COMPLETED|Overall Study||11
516407|NCT00916032|1262437|P1|COMPLETED|Overall Study||12
516408|NCT00916032|1262436|P2|STARTED|Overall Study||11
516409|NCT00916032|1262437|P1|STARTED|Overall Study||12
516410|NCT00916006|1262479|P2|NOT COMPLETED|Overall Study||7
516411|NCT00916006|1262480|P1|NOT COMPLETED|Overall Study||3
516412|NCT00916006|1262479|P2|COMPLETED|Overall Study||127
516413|NCT00916006|1262480|P1|COMPLETED|Overall Study||132
516414|NCT00916006|1262479|P2|STARTED|Overall Study||134
516415|NCT00916006|1262480|P1|STARTED|Overall Study||135
516416|NCT00915902|1262490|P2|NOT COMPLETED|2nd Treatment Period||1
516417|NCT00915902|1262491|P1|NOT COMPLETED|2nd Treatment Period||0
516418|NCT00915902|1262490|P2|COMPLETED|2nd Treatment Period||20
516419|NCT00915902|1262491|P1|COMPLETED|2nd Treatment Period||19
516420|NCT00915902|1262490|P2|STARTED|2nd Treatment Period||21
516421|NCT00915902|1262491|P1|STARTED|2nd Treatment Period||19
516422|NCT00915902|1262490|P2|NOT COMPLETED|Washout (4 Weeks)||1
516423|NCT00915902|1262491|P1|NOT COMPLETED|Washout (4 Weeks)||0
516424|NCT00915902|1262490|P2|COMPLETED|Washout (4 Weeks)||21
516425|NCT00915902|1262491|P1|COMPLETED|Washout (4 Weeks)||19
516426|NCT00915902|1262490|P2|STARTED|Washout (4 Weeks)||22
516427|NCT00915902|1262491|P1|STARTED|Washout (4 Weeks)||19
516428|NCT00915902|1262490|P2|NOT COMPLETED|1st Treatment Period||0
516429|NCT00915902|1262491|P1|NOT COMPLETED|1st Treatment Period||1
516430|NCT00915902|1262490|P2|COMPLETED|1st Treatment Period||22
516431|NCT00915902|1262491|P1|COMPLETED|1st Treatment Period||19
516432|NCT00915902|1262490|P2|STARTED|1st Treatment Period||22
516433|NCT00915902|1262491|P1|STARTED|1st Treatment Period||20
516434|NCT00915876|1262501|P2|NOT COMPLETED|Overall Study||1
516435|NCT00915876|1262502|P1|NOT COMPLETED|Overall Study||0
516436|NCT00915876|1262501|P2|COMPLETED|Overall Study||20
516437|NCT00915876|1262502|P1|COMPLETED|Overall Study||20
516438|NCT00915876|1262501|P2|Moving Beyond First Dose|Overall Study||20
516439|NCT00915876|1262502|P1|Moving Beyond First Dose|Overall Study||20
516440|NCT00915876|1262501|P2|STARTED|Overall Study||21
516441|NCT00915876|1262502|P1|STARTED|Overall Study||20
516442|NCT00915798|1262512|P4|NOT COMPLETED|Overall Study||0
516443|NCT00915798|1262513|P3|NOT COMPLETED|Overall Study||0
516444|NCT00915798|1262514|P2|NOT COMPLETED|Overall Study||0
516445|NCT00915798|1262515|P1|NOT COMPLETED|Overall Study||0
516446|NCT00915798|1262512|P4|COMPLETED|Overall Study||26
516447|NCT00915798|1262513|P3|COMPLETED|Overall Study||23
516448|NCT00915798|1262514|P2|COMPLETED|Overall Study||21
516449|NCT00915798|1262515|P1|COMPLETED|Overall Study||19
516450|NCT00915798|1262512|P4|STARTED|Overall Study||26
516451|NCT00915798|1262513|P3|STARTED|Overall Study||23
516452|NCT00915798|1262514|P2|STARTED|Overall Study||21
516453|NCT00915798|1262515|P1|STARTED|Overall Study||19
516454|NCT00915772|1262538|P3|NOT COMPLETED|Overall Study||29
516455|NCT00915772|1262539|P2|NOT COMPLETED|Overall Study||46
516456|NCT00915772|1262540|P1|NOT COMPLETED|Overall Study||36
516457|NCT00915772|1262538|P3|COMPLETED|Overall Study||142
516458|NCT00915772|1262539|P2|COMPLETED|Overall Study||179
516459|NCT00915772|1262540|P1|COMPLETED|Overall Study||134
516460|NCT00915772|1262538|P3|STARTED|Overall Study||171
516461|NCT00915772|1262539|P2|STARTED|Overall Study||225
516462|NCT00915772|1262540|P1|STARTED|Overall Study||170
516463|NCT00915759|1262585|P1|NOT COMPLETED|Overall Study||0
516464|NCT00915759|1262585|P1|COMPLETED|Overall Study|number of participants|40
516465|NCT00915759|1262585|P1|STARTED|Overall Study|number of participants|40
516466|NCT00915655|1262595|P1|NOT COMPLETED|Overall Study||0
516467|NCT00915655|1262595|P1|COMPLETED|Overall Study|'Completed' represents patients who have not discontinued at time of cut-off for Week 24 analysis|12
516468|NCT00915655|1262595|P1|STARTED|Overall Study||12
516469|NCT00915603|1262602|P2|NOT COMPLETED|Overall Study||55
516470|NCT00915603|1262603|P1|NOT COMPLETED|Overall Study||56
516471|NCT00915603|1262602|P2|COMPLETED|Overall Study||0
516472|NCT00915603|1262603|P1|COMPLETED|Overall Study||0
516473|NCT00915603|1262602|P2|STARTED|Overall Study|One patient enrolled/randomized but did not start treatment|55
516474|NCT00915603|1262603|P1|STARTED|Overall Study|One patient enrolled/randomized but did not start treatment|56
516475|NCT00915590|1262619|P2|NOT COMPLETED|Overall Study||1
516476|NCT00915590|1262620|P1|NOT COMPLETED|Overall Study||2
516477|NCT00915590|1262619|P2|COMPLETED|Overall Study||4
516478|NCT00915590|1262620|P1|COMPLETED|Overall Study||3
516479|NCT00915590|1262619|P2|STARTED|Overall Study||5
516480|NCT00915590|1262620|P1|STARTED|Overall Study||5
516481|NCT00915551|1262639|P2|NOT COMPLETED|Overall Study||1
516482|NCT00915551|1262640|P1|NOT COMPLETED|Overall Study||0
516483|NCT00915551|1262639|P2|COMPLETED|Overall Study||135
516484|NCT00915551|1262640|P1|COMPLETED|Overall Study||142
516485|NCT00915551|1262639|P2|STARTED|Overall Study||136
516486|NCT00915551|1262640|P1|STARTED|Overall Study||142
516487|NCT00915525|1262650|P2|NOT COMPLETED|Overall Study||135
516488|NCT00915525|1262651|P1|NOT COMPLETED|Overall Study||265
516489|NCT00915525|1262650|P2|COMPLETED|Overall Study||151
516490|NCT00915525|1262651|P1|COMPLETED|Overall Study||278
516491|NCT00915525|1262650|P2|STARTED|Overall Study||286
516492|NCT00915525|1262651|P1|STARTED|Overall Study||543
516493|NCT00915499|1262754|P2|NOT COMPLETED|Overall Study||2
516494|NCT00915499|1262755|P1|NOT COMPLETED|Overall Study||4
516495|NCT00915499|1262754|P2|COMPLETED|Overall Study||31
516496|NCT00915499|1262755|P1|COMPLETED|Overall Study||29
516497|NCT00915499|1262754|P2|STARTED|Overall Study||33
516498|NCT00915499|1262755|P1|STARTED|Overall Study||33
516499|NCT00915473|1262765|P2|NOT COMPLETED|4-week Follow Up||5
516500|NCT00915473|1262766|P1|NOT COMPLETED|4-week Follow Up||1
516501|NCT00915473|1262765|P2|COMPLETED|4-week Follow Up||30
516502|NCT00915473|1262766|P1|COMPLETED|4-week Follow Up||33
516503|NCT00915473|1262765|P2|STARTED|4-week Follow Up||35
516504|NCT00915473|1262766|P1|STARTED|4-week Follow Up||34
516505|NCT00915473|1262765|P2|NOT COMPLETED|Injection||0
516506|NCT00915473|1262766|P1|NOT COMPLETED|Injection||0
516507|NCT00915473|1262765|P2|COMPLETED|Injection||35
516508|NCT00915473|1262766|P1|COMPLETED|Injection||34
516509|NCT00915473|1262765|P2|STARTED|Injection||35
516510|NCT00915473|1262766|P1|STARTED|Injection||34
516511|NCT00915473|1262765|P2|NOT COMPLETED|Screening||0
516512|NCT00915473|1262766|P1|NOT COMPLETED|Screening||1
516513|NCT00915473|1262765|P2|COMPLETED|Screening||35
516514|NCT00915473|1262766|P1|COMPLETED|Screening||34
516515|NCT00915473|1262765|P2|STARTED|Screening||35
516516|NCT00915473|1262766|P1|STARTED|Screening||35
516517|NCT00915356|1262783|P5|NOT COMPLETED|Overall Study||0
516518|NCT00915356|1262784|P4|NOT COMPLETED|Overall Study||0
516519|NCT00915356|1262785|P3|NOT COMPLETED|Overall Study||0
516520|NCT00915356|1262786|P2|NOT COMPLETED|Overall Study||0
516521|NCT00915356|1262787|P1|NOT COMPLETED|Overall Study||1
516522|NCT00915356|1262783|P5|COMPLETED|Overall Study||43
516523|NCT00915356|1262784|P4|COMPLETED|Overall Study||12
516524|NCT00915356|1262785|P3|COMPLETED|Overall Study||45
516525|NCT00915356|1262786|P2|COMPLETED|Overall Study||45
516526|NCT00915356|1262787|P1|COMPLETED|Overall Study||25
516527|NCT00915356|1262783|P5|STARTED|Overall Study||43
516528|NCT00915356|1262784|P4|STARTED|Overall Study||12
516529|NCT00915356|1262785|P3|STARTED|Overall Study||45
516530|NCT00915356|1262786|P2|STARTED|Overall Study||45
516531|NCT00915356|1262787|P1|STARTED|Overall Study||26
516532|NCT00915343|1262849|P3|NOT COMPLETED|Part B - Open Label Period||2
516533|NCT00915343|1262850|P2|NOT COMPLETED|Part B - Open Label Period||0
516534|NCT00915343|1262851|P1|NOT COMPLETED|Part B - Open Label Period||0
516535|NCT00915343|1262849|P3|COMPLETED|Part B - Open Label Period||57
516536|NCT00915343|1262850|P2|COMPLETED|Part B - Open Label Period||0
516537|NCT00915343|1262851|P1|COMPLETED|Part B - Open Label Period||0
516538|NCT00915343|1262849|P3|STARTED|Part B - Open Label Period||59
516539|NCT00915343|1262850|P2|STARTED|Part B - Open Label Period||0
516540|NCT00915343|1262851|P1|STARTED|Part B - Open Label Period||0
516541|NCT00915343|1262849|P3|NOT COMPLETED|Part A - Second Intervention Period||0
516542|NCT00915343|1262850|P2|NOT COMPLETED|Part A - Second Intervention Period||0
516543|NCT00915343|1262851|P1|NOT COMPLETED|Part A - Second Intervention Period||0
516544|NCT00915343|1262849|P3|COMPLETED|Part A - Second Intervention Period||0
516545|NCT00915343|1262850|P2|COMPLETED|Part A - Second Intervention Period||32
516546|NCT00915343|1262851|P1|COMPLETED|Part A - Second Intervention Period||32
516547|NCT00915343|1262849|P3|STARTED|Part A - Second Intervention Period||0
516548|NCT00915343|1262850|P2|STARTED|Part A - Second Intervention Period||32
516549|NCT00915343|1262851|P1|STARTED|Part A - Second Intervention Period||32
516550|NCT00915343|1262849|P3|NOT COMPLETED|Part A - First Intervention Period||0
516551|NCT00915343|1262850|P2|NOT COMPLETED|Part A - First Intervention Period||0
516552|NCT00915343|1262851|P1|NOT COMPLETED|Part A - First Intervention Period||0
516553|NCT00915343|1262849|P3|COMPLETED|Part A - First Intervention Period||0
516554|NCT00915343|1262850|P2|COMPLETED|Part A - First Intervention Period||32
516555|NCT00915343|1262851|P1|COMPLETED|Part A - First Intervention Period||32
516556|NCT00915343|1262849|P3|STARTED|Part A - First Intervention Period||0
516557|NCT00915343|1262850|P2|STARTED|Part A - First Intervention Period||32
516558|NCT00915343|1262851|P1|STARTED|Part A - First Intervention Period||32
516559|NCT00915278|1262936|P6|NOT COMPLETED|Overall Study||8
516560|NCT00915278|1262937|P5|NOT COMPLETED|Overall Study||2
516561|NCT00915278|1262938|P4|NOT COMPLETED|Overall Study||3
516562|NCT00915278|1262939|P3|NOT COMPLETED|Overall Study||1
516563|NCT00915278|1262940|P2|NOT COMPLETED|Overall Study||3
516564|NCT00915278|1262941|P1|NOT COMPLETED|Overall Study||5
516565|NCT00915278|1262936|P6|COMPLETED|Overall Study||1
516566|NCT00915278|1262937|P5|COMPLETED|Overall Study||1
516567|NCT00915278|1262938|P4|COMPLETED|Overall Study||2
516568|NCT00915278|1262939|P3|COMPLETED|Overall Study||2
516569|NCT00915278|1262940|P2|COMPLETED|Overall Study||2
516570|NCT00915278|1262941|P1|COMPLETED|Overall Study||3
516571|NCT00915278|1262936|P6|STARTED|Overall Study||9
516572|NCT00915278|1262937|P5|STARTED|Overall Study||3
516573|NCT00915278|1262938|P4|STARTED|Overall Study||5
516574|NCT00915278|1262939|P3|STARTED|Overall Study||3
516575|NCT00915278|1262940|P2|STARTED|Overall Study||5
516576|NCT00915278|1262941|P1|STARTED|Overall Study||8
516577|NCT00915148|1263087|P1|NOT COMPLETED|Overall Study||0
516578|NCT00915148|1263087|P1|COMPLETED|Overall Study|August 2010|110
516579|NCT00915148|1263087|P1|STARTED|Overall Study|October 2009|110
516580|NCT00915018|1263094|P2|NOT COMPLETED|Overall Study||207
516581|NCT00915018|1263095|P1|NOT COMPLETED|Overall Study||215
516582|NCT00915018|1263094|P2|COMPLETED|Overall Study||30
516583|NCT00915018|1263095|P1|COMPLETED|Overall Study||27
516584|NCT00915018|1263094|P2|Received Treatment|Overall Study||234
516585|NCT00915018|1263095|P1|Received Treatment|Overall Study||240
516586|NCT00915018|1263094|P2|STARTED|Overall Study||237
516587|NCT00915018|1263095|P1|STARTED|Overall Study||242
516588|NCT00914966|1263109|P1|NOT COMPLETED|Step 3: 2500 Units||0
516589|NCT00914966|1263109|P1|COMPLETED|Step 3: 2500 Units||12
516590|NCT00914966|1263109|P1|STARTED|Step 3: 2500 Units||12
516591|NCT00914966|1263109|P1|NOT COMPLETED|Step 2: 2000 Units||1
516592|NCT00914966|1263109|P1|COMPLETED|Step 2: 2000 Units||12
516593|NCT00914966|1263109|P1|STARTED|Step 2: 2000 Units||13
516594|NCT00914966|1263109|P1|NOT COMPLETED|Step 1: 1500 Units||2
516595|NCT00914966|1263109|P1|COMPLETED|Step 1: 1500 Units|5/18 subjects completing Step 1 (1500 Units) entered the 3 month follow-up and did not dose escalate|18
516596|NCT00914966|1263109|P1|STARTED|Step 1: 1500 Units||20
516597|NCT00914927|1263128|P7|NOT COMPLETED|Overall Study||0
516598|NCT00914927|1263129|P6|NOT COMPLETED|Overall Study||0
516599|NCT00914927|1263130|P5|NOT COMPLETED|Overall Study||2
516600|NCT00914927|1263131|P4|NOT COMPLETED|Overall Study||2
516601|NCT00914927|1263132|P3|NOT COMPLETED|Overall Study||0
516602|NCT00914927|1263133|P2|NOT COMPLETED|Overall Study||2
516603|NCT00914927|1263134|P1|NOT COMPLETED|Overall Study||2
516604|NCT00914927|1263128|P7|COMPLETED|Overall Study||21
516605|NCT00914927|1263129|P6|COMPLETED|Overall Study||21
516606|NCT00914927|1263130|P5|COMPLETED|Overall Study||19
516607|NCT00914927|1263131|P4|COMPLETED|Overall Study||14
516608|NCT00914927|1263132|P3|COMPLETED|Overall Study||17
516609|NCT00914927|1263133|P2|COMPLETED|Overall Study||14
516610|NCT00914927|1263134|P1|COMPLETED|Overall Study||16
516611|NCT00914927|1263128|P7|STARTED|Overall Study||21
516612|NCT00914927|1263129|P6|STARTED|Overall Study||21
516613|NCT00914927|1263130|P5|STARTED|Overall Study||21
516614|NCT00914927|1263131|P4|STARTED|Overall Study||16
516615|NCT00914927|1263132|P3|STARTED|Overall Study||17
516616|NCT00914927|1263133|P2|STARTED|Overall Study||16
516617|NCT00914927|1263134|P1|STARTED|Overall Study||18
516618|NCT00914862|1263183|P5|NOT COMPLETED|Overall Study||0
516619|NCT00914862|1263184|P4|NOT COMPLETED|Overall Study||0
516620|NCT00914862|1263185|P3|NOT COMPLETED|Overall Study||0
516621|NCT00914862|1263186|P2|NOT COMPLETED|Overall Study||0
516622|NCT00914862|1263187|P1|NOT COMPLETED|Overall Study||0
516623|NCT00914862|1263183|P5|COMPLETED|Overall Study||28
516624|NCT00914862|1263184|P4|COMPLETED|Overall Study||8
516625|NCT00914862|1263185|P3|COMPLETED|Overall Study||8
516626|NCT00914862|1263186|P2|COMPLETED|Overall Study||6
516627|NCT00914862|1263187|P1|COMPLETED|Overall Study||6
516628|NCT00914862|1263183|P5|STARTED|Overall Study||28
516629|NCT00914862|1263184|P4|STARTED|Overall Study||8
516630|NCT00914862|1263185|P3|STARTED|Overall Study||8
516631|NCT00914862|1263186|P2|STARTED|Overall Study||6
516632|NCT00914862|1263187|P1|STARTED|Overall Study||6
516633|NCT00914849|1263261|P2|NOT COMPLETED|Overall Study||1
516634|NCT00914849|1263262|P1|NOT COMPLETED|Overall Study||1
516635|NCT00914849|1263261|P2|COMPLETED|Overall Study||33
516636|NCT00914849|1263262|P1|COMPLETED|Overall Study||33
516637|NCT00914849|1263261|P2|STARTED|Overall Study||34
516638|NCT00914849|1263262|P1|STARTED|Overall Study||34
516639|NCT00914810|1263296|P2|NOT COMPLETED|Overall Study||1
516640|NCT00914810|1263297|P1|NOT COMPLETED|Overall Study||2
516641|NCT00914810|1263296|P2|COMPLETED|Overall Study||18
516642|NCT00914810|1263297|P1|COMPLETED|Overall Study||18
516643|NCT00914810|1263296|P2|STARTED|Overall Study||19
516644|NCT00914810|1263297|P1|STARTED|Overall Study||20
516645|NCT00914589|1263308|P3|NOT COMPLETED|Overall Study||12
516646|NCT00914589|1263309|P2|NOT COMPLETED|Overall Study||16
516647|NCT00914589|1263310|P1|NOT COMPLETED|Overall Study||25
516648|NCT00914589|1263308|P3|COMPLETED|Overall Study||126
516649|NCT00914589|1263309|P2|COMPLETED|Overall Study||127
516650|NCT00914589|1263310|P1|COMPLETED|Overall Study||103
516651|NCT00914589|1263308|P3|STARTED|Overall Study||138
516652|NCT00914589|1263309|P2|STARTED|Overall Study||143
516653|NCT00914589|1263310|P1|STARTED|Overall Study||128
516654|NCT00914485|1263330|P1|NOT COMPLETED|Overall Study||0
516655|NCT00914485|1263330|P1|COMPLETED|Overall Study||369
516656|NCT00914485|1263330|P1|STARTED|Overall Study||369
516657|NCT00914459|1263336|P2|NOT COMPLETED|Overall Study||1
516658|NCT00914459|1263337|P1|NOT COMPLETED|Overall Study||1
516659|NCT00914459|1263336|P2|COMPLETED|Overall Study||18
516660|NCT00914459|1263337|P1|COMPLETED|Overall Study||17
516661|NCT00914459|1263336|P2|STARTED|Overall Study||19
516662|NCT00914459|1263337|P1|STARTED|Overall Study||18
516663|NCT00914316|1263367|P4|NOT COMPLETED|Phase 2||0
516664|NCT00914316|1263368|P3|NOT COMPLETED|Phase 2||1
516665|NCT00914316|1263369|P2|NOT COMPLETED|Phase 2||0
516666|NCT00914316|1263370|P1|NOT COMPLETED|Phase 2||1
516667|NCT00914316|1263367|P4|COMPLETED|Phase 2||6
516668|NCT00914316|1263368|P3|COMPLETED|Phase 2||2
516669|NCT00914316|1263369|P2|COMPLETED|Phase 2||4
516670|NCT00914316|1263370|P1|COMPLETED|Phase 2||1
516671|NCT00914316|1263367|P4|STARTED|Phase 2||6
516672|NCT00914316|1263368|P3|STARTED|Phase 2||3
516673|NCT00914316|1263369|P2|STARTED|Phase 2||4
516674|NCT00914316|1263370|P1|STARTED|Phase 2||2
516675|NCT00914316|1263367|P4|NOT COMPLETED|Phase 1||2
516676|NCT00914316|1263368|P3|NOT COMPLETED|Phase 1||5
516677|NCT00914316|1263369|P2|NOT COMPLETED|Phase 1||2
516678|NCT00914316|1263370|P1|NOT COMPLETED|Phase 1||5
516679|NCT00914316|1263367|P4|COMPLETED|Phase 1||6
516680|NCT00914316|1263368|P3|COMPLETED|Phase 1||3
516681|NCT00914316|1263369|P2|COMPLETED|Phase 1||4
516682|NCT00914316|1263370|P1|COMPLETED|Phase 1||2
516683|NCT00914316|1263367|P4|STARTED|Phase 1||8
516684|NCT00914316|1263368|P3|STARTED|Phase 1||8
516685|NCT00914316|1263369|P2|STARTED|Phase 1||6
516686|NCT00914316|1263370|P1|STARTED|Phase 1||7
516687|NCT00914186|1263388|P4|NOT COMPLETED|Overall Study||10
516688|NCT00914186|1263389|P3|NOT COMPLETED|Overall Study||2
516689|NCT00914186|1263390|P2|NOT COMPLETED|Overall Study||2
516690|NCT00914186|1263391|P1|NOT COMPLETED|Overall Study||3
516691|NCT00914186|1263388|P4|COMPLETED|Overall Study||20
516692|NCT00914186|1263389|P3|COMPLETED|Overall Study||29
516693|NCT00914186|1263390|P2|COMPLETED|Overall Study||28
516694|NCT00914186|1263391|P1|COMPLETED|Overall Study||28
516695|NCT00914186|1263388|P4|STARTED|Overall Study||30
516696|NCT00914186|1263389|P3|STARTED|Overall Study||31
516697|NCT00914186|1263390|P2|STARTED|Overall Study||30
516698|NCT00914186|1263391|P1|STARTED|Overall Study||31
516699|NCT00914069|1263425|P2|NOT COMPLETED|Overall Study||0
516700|NCT00914069|1263426|P1|NOT COMPLETED|Overall Study||0
516701|NCT00914069|1263425|P2|COMPLETED|Overall Study||88
516702|NCT00914069|1263426|P1|COMPLETED|Overall Study||84
516703|NCT00914069|1263425|P2|STARTED|Overall Study||88
516704|NCT00914069|1263426|P1|STARTED|Overall Study||84
516705|NCT00913913|1263440|P1|NOT COMPLETED|Overall Study||8
516706|NCT00913913|1263440|P1|COMPLETED|Overall Study||0
516707|NCT00913913|1263440|P1|STARTED|Overall Study||8
516708|NCT00913835|1263449|P2|NOT COMPLETED|Lip Dox: Olaratumab Monotherapy||3
516709|NCT00913835|1263450|P1|NOT COMPLETED|Lip Dox: Olaratumab Monotherapy||0
516710|NCT00913835|1263449|P2|COMPLETED|Lip Dox: Olaratumab Monotherapy||25
516711|NCT00913835|1263450|P1|COMPLETED|Lip Dox: Olaratumab Monotherapy||0
516712|NCT00913835|1263449|P2|Received at Least 1 Dose of Study Drug|Lip Dox: Olaratumab Monotherapy||28
516713|NCT00913835|1263450|P1|Received at Least 1 Dose of Study Drug|Lip Dox: Olaratumab Monotherapy||0
516714|NCT00913835|1263449|P2|STARTED|Lip Dox: Olaratumab Monotherapy||28
516715|NCT00913835|1263450|P1|STARTED|Lip Dox: Olaratumab Monotherapy||0
516716|NCT00913835|1263449|P2|NOT COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||7
516717|NCT00913835|1263450|P1|NOT COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||8
516718|NCT00913835|1263449|P2|COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||55
516719|NCT00913835|1263450|P1|COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||55
516720|NCT00913835|1263449|P2|Received Any Study Drug|Olara+Lip Dox and Lip Dox Monotherapy||61
516721|NCT00913835|1263450|P1|Received Any Study Drug|Olara+Lip Dox and Lip Dox Monotherapy||62
516722|NCT00913835|1263449|P2|STARTED|Olara+Lip Dox and Lip Dox Monotherapy||62
516723|NCT00913835|1263450|P1|STARTED|Olara+Lip Dox and Lip Dox Monotherapy||63
516724|NCT00913770|1263489|P3|NOT COMPLETED|Overall Study||21
516725|NCT00913770|1263490|P2|NOT COMPLETED|Overall Study||29
516726|NCT00913770|1263491|P1|NOT COMPLETED|Overall Study||35
516727|NCT00913770|1263489|P3|COMPLETED|Overall Study||93
516728|NCT00913770|1263490|P2|COMPLETED|Overall Study||82
516729|NCT00913770|1263491|P1|COMPLETED|Overall Study||69
516730|NCT00913770|1263489|P3|STARTED|Overall Study||114
516731|NCT00913770|1263490|P2|STARTED|Overall Study||111
516732|NCT00913770|1263491|P1|STARTED|Overall Study||104
516733|NCT00913744|1263504|P2|NOT COMPLETED|Overall Study||1
516734|NCT00913744|1263505|P1|NOT COMPLETED|Overall Study||5
516735|NCT00913744|1263504|P2|COMPLETED|Overall Study||24
516736|NCT00913744|1263505|P1|COMPLETED|Overall Study||70
516737|NCT00913744|1263504|P2|STARTED|Overall Study||25
516738|NCT00913744|1263505|P1|STARTED|Overall Study||75
516739|NCT00913692|1263511|P1|NOT COMPLETED|Treatment Phase 2 (5 Months)||0
516740|NCT00913692|1263511|P1|COMPLETED|Treatment Phase 2 (5 Months)||1
516741|NCT00913692|1263511|P1|STARTED|Treatment Phase 2 (5 Months)||1
516742|NCT00913692|1263511|P1|NOT COMPLETED|Washout (2 Weeks)||0
516743|NCT00913692|1263511|P1|COMPLETED|Washout (2 Weeks)||1
516744|NCT00913692|1263511|P1|STARTED|Washout (2 Weeks)||1
516745|NCT00913692|1263511|P1|NOT COMPLETED|Treatment Phase 1 (5 Months)||1
516746|NCT00913692|1263511|P1|COMPLETED|Treatment Phase 1 (5 Months)||1
516747|NCT00913692|1263511|P1|STARTED|Treatment Phase 1 (5 Months)||2
516748|NCT00913692|1263511|P1|NOT COMPLETED|Screening (4 Months)||9
516749|NCT00913692|1263511|P1|COMPLETED|Screening (4 Months)||2
516750|NCT00913692|1263511|P1|STARTED|Screening (4 Months)||11
516751|NCT00913627|1263525|P4|NOT COMPLETED|Overall Study||0
516752|NCT00913627|1263526|P3|NOT COMPLETED|Overall Study||0
516753|NCT00913627|1263527|P2|NOT COMPLETED|Overall Study||0
516754|NCT00913627|1263528|P1|NOT COMPLETED|Overall Study||0
516755|NCT00913627|1263525|P4|COMPLETED|Overall Study||58
516756|NCT00913627|1263526|P3|COMPLETED|Overall Study||56
516757|NCT00913627|1263527|P2|COMPLETED|Overall Study||53
516758|NCT00913627|1263528|P1|COMPLETED|Overall Study||29
516759|NCT00913627|1263525|P4|STARTED|Overall Study||58
516760|NCT00913627|1263526|P3|STARTED|Overall Study||56
516761|NCT00913627|1263527|P2|STARTED|Overall Study||53
516762|NCT00913627|1263528|P1|STARTED|Overall Study||29
516763|NCT00913523|1263605|P3|NOT COMPLETED|Overall Study||14
516764|NCT00913523|1263606|P2|NOT COMPLETED|Overall Study||16
516765|NCT00913523|1263607|P1|NOT COMPLETED|Overall Study||18
516766|NCT00913523|1263605|P3|COMPLETED|Overall Study||147
516767|NCT00913523|1263606|P2|COMPLETED|Overall Study||143
516768|NCT00913523|1263607|P1|COMPLETED|Overall Study||144
516769|NCT00913523|1263605|P3|STARTED|Overall Study||161
516770|NCT00913523|1263606|P2|STARTED|Overall Study||159
516771|NCT00913523|1263607|P1|STARTED|Overall Study||162
516772|NCT00913510|1263632|P2|NOT COMPLETED|Overall Study||4
516773|NCT00913510|1263633|P1|NOT COMPLETED|Overall Study||8
516774|NCT00913510|1263632|P2|COMPLETED|Overall Study||3
516775|NCT00913510|1263633|P1|COMPLETED|Overall Study||5
516776|NCT00913510|1263632|P2|STARTED|Overall Study||7
516777|NCT00913510|1263633|P1|STARTED|Overall Study||13
516778|NCT00913458|1263639|P7|NOT COMPLETED|Phase 3||8
516779|NCT00913458|1263640|P6|NOT COMPLETED|Phase 3||18
516780|NCT00913458|1263641|P5|NOT COMPLETED|Phase 3||22
516781|NCT00913458|1263642|P4|NOT COMPLETED|Phase 3||0
516782|NCT00913458|1263643|P3|NOT COMPLETED|Phase 3||0
516783|NCT00913458|1263644|P2|NOT COMPLETED|Phase 3||0
516784|NCT00913458|1263645|P1|NOT COMPLETED|Phase 3||0
516785|NCT00913458|1263639|P7|COMPLETED|Phase 3||24
516786|NCT00913458|1263640|P6|COMPLETED|Phase 3||28
516787|NCT00913458|1263641|P5|COMPLETED|Phase 3||31
516788|NCT00913458|1263642|P4|COMPLETED|Phase 3||0
516789|NCT00913458|1263643|P3|COMPLETED|Phase 3||0
516790|NCT00913458|1263644|P2|COMPLETED|Phase 3||0
516791|NCT00913458|1263645|P1|COMPLETED|Phase 3|This arm is part of Phase 1 of the study.|0
516792|NCT00913458|1263639|P7|STARTED|Phase 3|Participants who completed Phase 2 study|32
516793|NCT00913458|1263640|P6|STARTED|Phase 3|Participants who completed Phase 2 study|46
516794|NCT00913458|1263641|P5|STARTED|Phase 3|Participants who completed Phase 2 study|53
516795|NCT00913458|1263642|P4|STARTED|Phase 3||0
516796|NCT00913458|1263643|P3|STARTED|Phase 3||0
516797|NCT00913458|1263644|P2|STARTED|Phase 3||0
516798|NCT00913458|1263645|P1|STARTED|Phase 3|This arm is part of Phase 1 of the study.|0
516799|NCT00913458|1263639|P7|NOT COMPLETED|Phase 2||0
516800|NCT00913458|1263640|P6|NOT COMPLETED|Phase 2||0
516801|NCT00913458|1263641|P5|NOT COMPLETED|Phase 2||0
516802|NCT00913458|1263642|P4|NOT COMPLETED|Phase 2||33
516803|NCT00913458|1263643|P3|NOT COMPLETED|Phase 2||19
516804|NCT00913458|1263644|P2|NOT COMPLETED|Phase 2||10
516805|NCT00913458|1263645|P1|NOT COMPLETED|Phase 2||0
516806|NCT00913458|1263639|P7|COMPLETED|Phase 2||0
516807|NCT00913458|1263640|P6|COMPLETED|Phase 2||0
516808|NCT00913458|1263641|P5|COMPLETED|Phase 2||0
516809|NCT00913458|1263642|P4|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|32
516810|NCT00913458|1263643|P3|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|46
516811|NCT00913458|1263644|P2|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|53
516812|NCT00913458|1263645|P1|COMPLETED|Phase 2|This arm is part of Phase 1 of the study.|0
516813|NCT00913458|1263639|P7|STARTED|Phase 2||0
516814|NCT00913458|1263640|P6|STARTED|Phase 2||0
516815|NCT00913458|1263641|P5|STARTED|Phase 2||0
516816|NCT00913458|1263642|P4|STARTED|Phase 2||65
516817|NCT00913458|1263643|P3|STARTED|Phase 2||65
516818|NCT00913458|1263644|P2|STARTED|Phase 2||63
516819|NCT00913458|1263645|P1|STARTED|Phase 2|This arm is part of Phase 1 of the study.|0
516820|NCT00913458|1263639|P7|NOT COMPLETED|Phase 1||0
516821|NCT00913458|1263640|P6|NOT COMPLETED|Phase 1||0
516822|NCT00913458|1263641|P5|NOT COMPLETED|Phase 1||0
516823|NCT00913458|1263642|P4|NOT COMPLETED|Phase 1||0
516824|NCT00913458|1263643|P3|NOT COMPLETED|Phase 1||0
516825|NCT00913458|1263644|P2|NOT COMPLETED|Phase 1||0
516826|NCT00913458|1263645|P1|NOT COMPLETED|Phase 1||112
516827|NCT00913458|1263639|P7|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
516828|NCT00913458|1263640|P6|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
516829|NCT00913458|1263641|P5|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
516830|NCT00913458|1263642|P4|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
516831|NCT00913458|1263643|P3|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
516832|NCT00913458|1263644|P2|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
516833|NCT00913458|1263645|P1|COMPLETED|Phase 1|194 continued to Phase 2 but 1 was randomized in error leaving 193 in the phase 2 analysis.|194
516834|NCT00913458|1263639|P7|STARTED|Phase 1|This arm is part of Phase 3 study|0
516835|NCT00913458|1263640|P6|STARTED|Phase 1|This arm is part of Phase 3 study|0
516836|NCT00913458|1263641|P5|STARTED|Phase 1|This arm is part of Phase 3 study|0
516837|NCT00913458|1263642|P4|STARTED|Phase 1|This arm is part of Phase 2 study|0
516838|NCT00913458|1263643|P3|STARTED|Phase 1|This arm is part of Phase 2 study|0
516839|NCT00913458|1263644|P2|STARTED|Phase 1|This arm is part of Phase 2 study|0
516840|NCT00913458|1263645|P1|STARTED|Phase 1||306
516841|NCT00913380|1263738|P2|NOT COMPLETED|Clinical Outcomes||6
516842|NCT00913380|1263739|P1|NOT COMPLETED|Clinical Outcomes||6
516843|NCT00913380|1263738|P2|COMPLETED|Clinical Outcomes||441
516844|NCT00913380|1263739|P1|COMPLETED|Clinical Outcomes||438
516845|NCT00913380|1263738|P2|STARTED|Clinical Outcomes||447
516846|NCT00913380|1263739|P1|STARTED|Clinical Outcomes||444
516847|NCT00913380|1263738|P2|NOT COMPLETED|CT Examination||0
516848|NCT00913380|1263739|P1|NOT COMPLETED|CT Examination||0
516849|NCT00913380|1263738|P2|COMPLETED|CT Examination||447
516850|NCT00913380|1263739|P1|COMPLETED|CT Examination||444
516851|NCT00913380|1263738|P2|STARTED|CT Examination||447
516852|NCT00913380|1263739|P1|STARTED|CT Examination||444
516853|NCT00913263|1263765|P1|NOT COMPLETED|Overall Study||0
516854|NCT00913263|1263765|P1|COMPLETED|Overall Study||24
516855|NCT00913263|1263765|P1|STARTED|Overall Study||24
516856|NCT00913133|1263774|P1|NOT COMPLETED|Overall Study||0
516857|NCT00913133|1263774|P1|COMPLETED|Overall Study||516
516858|NCT00913133|1263774|P1|STARTED|Overall Study||516
516859|NCT00913081|1263779|P1|NOT COMPLETED|Placebo + Niacin 500 mg (1day)||0
516860|NCT00913081|1263779|P1|COMPLETED|Placebo + Niacin 500 mg (1day)||17
516861|NCT00913081|1263779|P1|STARTED|Placebo + Niacin 500 mg (1day)||17
516862|NCT00913081|1263779|P1|NOT COMPLETED|Washout #3 (7days)||0
516863|NCT00913081|1263779|P1|COMPLETED|Washout #3 (7days)||17
516864|NCT00913081|1263779|P1|STARTED|Washout #3 (7days)||17
516865|NCT00913081|1263779|P1|NOT COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||0
516866|NCT00913081|1263779|P1|COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||17
516867|NCT00913081|1263779|P1|STARTED|Quercetin 2000 mg + Niacin 500 mg (1day)||17
516868|NCT00913081|1263779|P1|NOT COMPLETED|Washout #2 (7 Days)||0
516869|NCT00913081|1263779|P1|COMPLETED|Washout #2 (7 Days)||17
516870|NCT00913081|1263779|P1|STARTED|Washout #2 (7 Days)||17
516871|NCT00913081|1263779|P1|NOT COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||0
516872|NCT00913081|1263779|P1|COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||17
516873|NCT00913081|1263779|P1|STARTED|Quercetin 1000 mg + Niacin 500 mg (1day)||17
516874|NCT00913081|1263779|P1|NOT COMPLETED|Washout #1 (7 Days)||0
516875|NCT00913081|1263779|P1|COMPLETED|Washout #1 (7 Days)||17
516876|NCT00913081|1263779|P1|STARTED|Washout #1 (7 Days)||17
516877|NCT00913081|1263779|P1|NOT COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||0
516878|NCT00913081|1263779|P1|COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||17
516879|NCT00913081|1263779|P1|STARTED|Quercetin 500 mg + Niacin 500 mg (1day)||17
516880|NCT00913003|1263791|P2|NOT COMPLETED|Overall Study||0
516881|NCT00913003|1263792|P1|NOT COMPLETED|Overall Study||0
516882|NCT00913003|1263791|P2|COMPLETED|Overall Study||11
516883|NCT00913003|1263792|P1|COMPLETED|Overall Study||11
516884|NCT00913003|1263791|P2|STARTED|Overall Study||11
516885|NCT00913003|1263792|P1|STARTED|Overall Study||11
516886|NCT00912964|1263805|P3|NOT COMPLETED|Overall Study||54
516887|NCT00912964|1263806|P2|NOT COMPLETED|Overall Study||46
516888|NCT00912964|1263807|P1|NOT COMPLETED|Overall Study||66
516889|NCT00912964|1263805|P3|COMPLETED|Overall Study||386
516890|NCT00912964|1263806|P2|COMPLETED|Overall Study||387
516891|NCT00912964|1263807|P1|COMPLETED|Overall Study||367
516892|NCT00912964|1263805|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|257
516893|NCT00912964|1263806|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|254
516894|NCT00912964|1263807|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|262
516895|NCT00912964|1263805|P3|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|426
516896|NCT00912964|1263806|P2|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|410
516897|NCT00912964|1263807|P1|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|415
516898|NCT00912964|1263805|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|440
516899|NCT00912964|1263806|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|432
516900|NCT00912964|1263807|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|433
516901|NCT00912964|1263805|P3|STARTED|Overall Study||440
516902|NCT00912964|1263806|P2|STARTED|Overall Study||433
516903|NCT00912964|1263807|P1|STARTED|Overall Study||433
516904|NCT00912925|1263931|P2|NOT COMPLETED|Overall Study||0
516905|NCT00912925|1263932|P1|NOT COMPLETED|Overall Study||0
516906|NCT00912925|1263931|P2|COMPLETED|Overall Study||22
516907|NCT00912925|1263932|P1|COMPLETED|Overall Study||23
516908|NCT00912925|1263931|P2|STARTED|Overall Study||22
516909|NCT00912925|1263932|P1|STARTED|Overall Study||23
516910|NCT00912912|1263950|P1|NOT COMPLETED|Overall Study||4
516911|NCT00912912|1263950|P1|COMPLETED|Overall Study||1
516912|NCT00912912|1263950|P1|STARTED|Overall Study||5
516913|NCT00912808|1263956|P2|NOT COMPLETED|Second Intervention (6 Weeks)||1
516914|NCT00912808|1263957|P1|NOT COMPLETED|Second Intervention (6 Weeks)||1
516915|NCT00912808|1263956|P2|COMPLETED|Second Intervention (6 Weeks)||9
516916|NCT00912808|1263957|P1|COMPLETED|Second Intervention (6 Weeks)||8
516917|NCT00912808|1263956|P2|Received Intervention|Second Intervention (6 Weeks)||10
516918|NCT00912808|1263957|P1|Received Intervention|Second Intervention (6 Weeks)||9
516919|NCT00912808|1263956|P2|STARTED|Second Intervention (6 Weeks)||10
516920|NCT00912808|1263957|P1|STARTED|Second Intervention (6 Weeks)||9
516921|NCT00912808|1263956|P2|NOT COMPLETED|Washout||1
516922|NCT00912808|1263957|P1|NOT COMPLETED|Washout||0
516923|NCT00912808|1263956|P2|COMPLETED|Washout||10
516924|NCT00912808|1263957|P1|COMPLETED|Washout||9
516925|NCT00912808|1263956|P2|STARTED|Washout||11
516926|NCT00912808|1263957|P1|STARTED|Washout||9
516927|NCT00912808|1263956|P2|NOT COMPLETED|First Intervention (6 Weeks)||1
516928|NCT00912808|1263957|P1|NOT COMPLETED|First Intervention (6 Weeks)||2
516929|NCT00912808|1263956|P2|COMPLETED|First Intervention (6 Weeks)||11
516930|NCT00912808|1263957|P1|COMPLETED|First Intervention (6 Weeks)||9
516931|NCT00912808|1263956|P2|Received Intervention|First Intervention (6 Weeks)||12
516932|NCT00912808|1263957|P1|Received Intervention|First Intervention (6 Weeks)||11
516933|NCT00912808|1263956|P2|STARTED|First Intervention (6 Weeks)||12
516934|NCT00912808|1263957|P1|STARTED|First Intervention (6 Weeks)||11
516935|NCT00912795|1263967|P2|NOT COMPLETED|Overall Study||58
516936|NCT00912795|1263968|P1|NOT COMPLETED|Overall Study||47
516937|NCT00912795|1263967|P2|COMPLETED|Overall Study||17
516938|NCT00912795|1263968|P1|COMPLETED|Overall Study||29
516939|NCT00912795|1263967|P2|STARTED|Overall Study||75
516940|NCT00912795|1263968|P1|STARTED|Overall Study||76
516941|NCT00912782|1263982|P2|NOT COMPLETED|Overall Study||5
516942|NCT00912782|1263983|P1|NOT COMPLETED|Overall Study||3
516943|NCT00912782|1263982|P2|COMPLETED|Overall Study||20
516944|NCT00912782|1263983|P1|COMPLETED|Overall Study||24
516945|NCT00912782|1263982|P2|STARTED|Overall Study||25
516946|NCT00912782|1263983|P1|STARTED|Overall Study||27
516947|NCT00912743|1263993|P2|NOT COMPLETED|Overall Study||20
516948|NCT00912743|1263994|P1|NOT COMPLETED|Overall Study||13
516949|NCT00912743|1263993|P2|COMPLETED|Overall Study||0
516950|NCT00912743|1263994|P1|COMPLETED|Overall Study||0
516951|NCT00912743|1263993|P2|STARTED|Overall Study||20
516952|NCT00912743|1263994|P1|STARTED|Overall Study||13
516953|NCT00912509|1264006|P2|NOT COMPLETED|Overall Study||3
516954|NCT00912509|1264007|P1|NOT COMPLETED|Overall Study||5
516955|NCT00912509|1264006|P2|COMPLETED|Overall Study||7
516956|NCT00912509|1264007|P1|COMPLETED|Overall Study||15
516957|NCT00912509|1264006|P2|STARTED|Overall Study||10
516958|NCT00912509|1264007|P1|STARTED|Overall Study||20
516959|NCT00912405|1264015|P1|NOT COMPLETED|Overall Study||5
516960|NCT00912405|1264015|P1|COMPLETED|Overall Study||45
516961|NCT00912405|1264015|P1|STARTED|Overall Study||50
516962|NCT00912301|1264025|P3|NOT COMPLETED|Overall Study||0
516963|NCT00912301|1264026|P2|NOT COMPLETED|Overall Study||0
516964|NCT00912301|1264027|P1|NOT COMPLETED|Overall Study||0
516965|NCT00912301|1264025|P3|COMPLETED|Overall Study||13
516966|NCT00912301|1264026|P2|COMPLETED|Overall Study||12
516967|NCT00912301|1264027|P1|COMPLETED|Overall Study||11
516968|NCT00912301|1264025|P3|STARTED|Overall Study||13
516969|NCT00912301|1264026|P2|STARTED|Overall Study||12
516970|NCT00912301|1264027|P1|STARTED|Overall Study||11
516971|NCT00912288|1264049|P2|NOT COMPLETED|Overall Study||40
516972|NCT00912288|1264050|P1|NOT COMPLETED|Overall Study||41
516973|NCT00912288|1264049|P2|COMPLETED|Overall Study||2
516974|NCT00912288|1264050|P1|COMPLETED|Overall Study||3
516975|NCT00912288|1264049|P2|STARTED|Overall Study||42
516976|NCT00912288|1264050|P1|STARTED|Overall Study||44
516977|NCT00912223|1264072|P1|NOT COMPLETED|Overall Study||3
516978|NCT00912223|1264072|P1|COMPLETED|Overall Study||62
516979|NCT00912223|1264072|P1|STARTED|Overall Study||65
516980|NCT00912158|1264091|P3|NOT COMPLETED|Overall Study||0
516981|NCT00912158|1264092|P2|NOT COMPLETED|Overall Study||0
516982|NCT00912158|1264093|P1|NOT COMPLETED|Overall Study||0
516983|NCT00912158|1264091|P3|COMPLETED|Overall Study||41
516984|NCT00912158|1264092|P2|COMPLETED|Overall Study||44
516985|NCT00912158|1264093|P1|COMPLETED|Overall Study||44
516986|NCT00912158|1264091|P3|STARTED|Overall Study||41
516987|NCT00912158|1264092|P2|STARTED|Overall Study||44
516988|NCT00912158|1264093|P1|STARTED|Overall Study||44
516989|NCT00912093|1264103|P5|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
516990|NCT00912093|1264104|P4|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
516991|NCT00912093|1264105|P3|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
516992|NCT00912093|1264106|P2|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
516993|NCT00912093|1264107|P1|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
516994|NCT00912093|1264103|P5|COMPLETED|The Open Label Extension (OLE) Phase||4
516995|NCT00912093|1264104|P4|COMPLETED|The Open Label Extension (OLE) Phase||2
516996|NCT00912093|1264105|P3|COMPLETED|The Open Label Extension (OLE) Phase||3
516997|NCT00912093|1264106|P2|COMPLETED|The Open Label Extension (OLE) Phase||35
516998|NCT00912093|1264107|P1|COMPLETED|The Open Label Extension (OLE) Phase||38
516999|NCT00912093|1264103|P5|STARTED|The Open Label Extension (OLE) Phase||4
517000|NCT00912093|1264104|P4|STARTED|The Open Label Extension (OLE) Phase||2
517001|NCT00912093|1264105|P3|STARTED|The Open Label Extension (OLE) Phase||3
517002|NCT00912093|1264106|P2|STARTED|The Open Label Extension (OLE) Phase||35
517003|NCT00912093|1264107|P1|STARTED|The Open Label Extension (OLE) Phase||38
517004|NCT00912093|1264103|P5|NOT COMPLETED|The Controlled Phase||1
517005|NCT00912093|1264104|P4|NOT COMPLETED|The Controlled Phase||0
517006|NCT00912093|1264105|P3|NOT COMPLETED|The Controlled Phase||0
517007|NCT00912093|1264106|P2|NOT COMPLETED|The Controlled Phase||2
517008|NCT00912093|1264107|P1|NOT COMPLETED|The Controlled Phase||0
517009|NCT00912093|1264103|P5|COMPLETED|The Controlled Phase||4
517010|NCT00912093|1264104|P4|COMPLETED|The Controlled Phase||2
517011|NCT00912093|1264105|P3|COMPLETED|The Controlled Phase||3
517012|NCT00912093|1264106|P2|COMPLETED|The Controlled Phase||43
517013|NCT00912093|1264107|P1|COMPLETED|The Controlled Phase||43
517014|NCT00912093|1264103|P5|STARTED|The Controlled Phase||5
517015|NCT00912093|1264104|P4|STARTED|The Controlled Phase||2
517016|NCT00912093|1264105|P3|STARTED|The Controlled Phase||3
517017|NCT00912093|1264106|P2|STARTED|The Controlled Phase||45
517018|NCT00912093|1264107|P1|STARTED|The Controlled Phase||43
517019|NCT00912028|1264126|P5|NOT COMPLETED|Overall Study||3
517020|NCT00912028|1264127|P4|NOT COMPLETED|Overall Study||1
517021|NCT00912028|1264128|P3|NOT COMPLETED|Overall Study||0
517022|NCT00912028|1264129|P2|NOT COMPLETED|Overall Study||3
517023|NCT00912028|1264130|P1|NOT COMPLETED|Overall Study||5
517024|NCT00912028|1264126|P5|COMPLETED|Overall Study||0
517025|NCT00912028|1264127|P4|COMPLETED|Overall Study||16
517026|NCT00912028|1264128|P3|COMPLETED|Overall Study||13
517027|NCT00912028|1264129|P2|COMPLETED|Overall Study||0
517028|NCT00912028|1264130|P1|COMPLETED|Overall Study||30
517029|NCT00912028|1264126|P5|STARTED|Overall Study||3
517030|NCT00912028|1264127|P4|STARTED|Overall Study||17
517031|NCT00912028|1264128|P3|STARTED|Overall Study||13
517032|NCT00912028|1264129|P2|STARTED|Overall Study||3
517033|NCT00912028|1264130|P1|STARTED|Overall Study||35
517034|NCT00912015|1264159|P4|NOT COMPLETED|Overall Study||2
517035|NCT00912015|1264160|P3|NOT COMPLETED|Overall Study||3
517036|NCT00912015|1264161|P2|NOT COMPLETED|Overall Study||8
517037|NCT00912015|1264162|P1|NOT COMPLETED|Overall Study||16
517038|NCT00912015|1264159|P4|COMPLETED|Overall Study||0
517039|NCT00912015|1264160|P3|COMPLETED|Overall Study||22
517040|NCT00912015|1264161|P2|COMPLETED|Overall Study||62
517041|NCT00912015|1264162|P1|COMPLETED|Overall Study||125
517128|NCT00911625|1264340|P2|NOT COMPLETED|Overall Study||0
517042|NCT00912015|1264159|P4|STARTED|Overall Study|Two patients took 100 mg against instructions in protocol that the minimum daily dose was 200 mg.|2
517043|NCT00912015|1264160|P3|STARTED|Overall Study|Dose at which a patient spent the longest time.|25
517044|NCT00912015|1264161|P2|STARTED|Overall Study|Dose at which a patient spent the longest time.|70
517045|NCT00912015|1264162|P1|STARTED|Overall Study|Dose at which a patient spent the longest time.|141
517046|NCT00912002|1264172|P1|NOT COMPLETED|Overall Study||0
517047|NCT00912002|1264172|P1|COMPLETED|Overall Study||6
517048|NCT00912002|1264172|P1|STARTED|Overall Study||6
517049|NCT00911989|1264178|P1|NOT COMPLETED|Overall Study||1
517050|NCT00911989|1264178|P1|COMPLETED|Overall Study||3
517051|NCT00911989|1264178|P1|STARTED|Overall Study||4
517052|NCT00911937|1264184|P2|NOT COMPLETED|Overall Study||95
517053|NCT00911937|1264185|P1|NOT COMPLETED|Overall Study||87
517054|NCT00911937|1264184|P2|COMPLETED|Overall Study||381
517055|NCT00911937|1264185|P1|COMPLETED|Overall Study||400
517056|NCT00911937|1264184|P2|Treated|Overall Study||463
517057|NCT00911937|1264185|P1|Treated|Overall Study||474
517058|NCT00911937|1264184|P2|STARTED|Overall Study||476
517059|NCT00911937|1264185|P1|STARTED|Overall Study||487
517060|NCT00911898|1264245|P1|NOT COMPLETED|Overall Study||0
517061|NCT00911898|1264245|P1|COMPLETED|Overall Study||20
517062|NCT00911898|1264245|P1|STARTED|Overall Study||20
517063|NCT00911859|1264252|P3|NOT COMPLETED|Follow-up Period||41
517064|NCT00911859|1264253|P2|NOT COMPLETED|Follow-up Period||46
517065|NCT00911859|1264254|P1|NOT COMPLETED|Follow-up Period||11
517066|NCT00911859|1264252|P3|COMPLETED|Follow-up Period||11
517067|NCT00911859|1264253|P2|COMPLETED|Follow-up Period||7
517068|NCT00911859|1264254|P1|COMPLETED|Follow-up Period||1
517069|NCT00911859|1264252|P3|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|52
517070|NCT00911859|1264253|P2|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|53
517071|NCT00911859|1264254|P1|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|12
517072|NCT00911859|1264252|P3|NOT COMPLETED|Maintainance Period||21
517073|NCT00911859|1264253|P2|NOT COMPLETED|Maintainance Period||0
517074|NCT00911859|1264254|P1|NOT COMPLETED|Maintainance Period||0
517075|NCT00911859|1264252|P3|COMPLETED|Maintainance Period||0
517076|NCT00911859|1264253|P2|COMPLETED|Maintainance Period||0
517077|NCT00911859|1264254|P1|COMPLETED|Maintainance Period||0
517078|NCT00911859|1264252|P3|STARTED|Maintainance Period|Participants who received siltuximab only during the 18-month maintenance period|21
517079|NCT00911859|1264253|P2|STARTED|Maintainance Period||0
517080|NCT00911859|1264254|P1|STARTED|Maintainance Period||0
517081|NCT00911859|1264252|P3|NOT COMPLETED|Treatment Period||25
517082|NCT00911859|1264253|P2|NOT COMPLETED|Treatment Period||21
517083|NCT00911859|1264254|P1|NOT COMPLETED|Treatment Period||8
517084|NCT00911859|1264252|P3|COMPLETED|Treatment Period||27
517085|NCT00911859|1264253|P2|COMPLETED|Treatment Period||33
517086|NCT00911859|1264254|P1|COMPLETED|Treatment Period||4
517087|NCT00911859|1264252|P3|Received Treatment|Treatment Period||52
517088|NCT00911859|1264253|P2|Received Treatment|Treatment Period||53
517089|NCT00911859|1264254|P1|Received Treatment|Treatment Period||12
517090|NCT00911859|1264252|P3|STARTED|Treatment Period||52
517091|NCT00911859|1264253|P2|STARTED|Treatment Period||54
517092|NCT00911859|1264254|P1|STARTED|Treatment Period||12
517093|NCT00911820|1264280|P2|NOT COMPLETED|Overall Study||43
517094|NCT00911820|1264281|P1|NOT COMPLETED|Overall Study||45
517095|NCT00911820|1264280|P2|COMPLETED|Overall Study||0
517096|NCT00911820|1264281|P1|COMPLETED|Overall Study||0
517097|NCT00911820|1264280|P2|Treated|Overall Study|Randomized patients not treated: withdrew consent (n=2)|41
517098|NCT00911820|1264281|P1|Treated|Overall Study|Randomized patients not treated: unable to confirm pathology (n=1)|44
517099|NCT00911820|1264280|P2|STARTED|Overall Study||43
517100|NCT00911820|1264281|P1|STARTED|Overall Study||45
517101|NCT00911807|1264298|P3|NOT COMPLETED|Overall Study||23
517102|NCT00911807|1264299|P2|NOT COMPLETED|Overall Study||18
517103|NCT00911807|1264300|P1|NOT COMPLETED|Overall Study||17
517104|NCT00911807|1264298|P3|COMPLETED|Overall Study||52
517105|NCT00911807|1264299|P2|COMPLETED|Overall Study||52
517106|NCT00911807|1264300|P1|COMPLETED|Overall Study||55
517107|NCT00911807|1264298|P3|STARTED|Overall Study||75
517108|NCT00911807|1264299|P2|STARTED|Overall Study||70
517109|NCT00911807|1264300|P1|STARTED|Overall Study||72
517110|NCT00911768|1264310|P2|NOT COMPLETED|Overall Study||4
517111|NCT00911768|1264311|P1|NOT COMPLETED|Overall Study||6
517112|NCT00911768|1264310|P2|COMPLETED|Overall Study||46
517113|NCT00911768|1264311|P1|COMPLETED|Overall Study||44
517114|NCT00911768|1264310|P2|STARTED|Overall Study||50
517115|NCT00911768|1264311|P1|STARTED|Overall Study||50
517116|NCT00911742|1264323|P2|NOT COMPLETED|Treatment Phase II||0
517117|NCT00911742|1264324|P1|NOT COMPLETED|Treatment Phase II||0
517118|NCT00911742|1264323|P2|COMPLETED|Treatment Phase II||13
517119|NCT00911742|1264324|P1|COMPLETED|Treatment Phase II||13
517120|NCT00911742|1264323|P2|STARTED|Treatment Phase II||13
517121|NCT00911742|1264324|P1|STARTED|Treatment Phase II||13
517122|NCT00911742|1264323|P2|NOT COMPLETED|Treatment Phase I||0
517123|NCT00911742|1264324|P1|NOT COMPLETED|Treatment Phase I||0
517124|NCT00911742|1264323|P2|COMPLETED|Treatment Phase I||13
517125|NCT00911742|1264324|P1|COMPLETED|Treatment Phase I||13
517126|NCT00911742|1264323|P2|STARTED|Treatment Phase I||13
517127|NCT00911742|1264324|P1|STARTED|Treatment Phase I||13
517129|NCT00911625|1264341|P1|NOT COMPLETED|Overall Study||7
517130|NCT00911625|1264340|P2|COMPLETED|Overall Study||57
517131|NCT00911625|1264341|P1|COMPLETED|Overall Study||50
517132|NCT00911625|1264340|P2|STARTED|Overall Study||57
517133|NCT00911625|1264341|P1|STARTED|Overall Study||57
517134|NCT00911612|1264351|P2|NOT COMPLETED|Overall Study||0
517135|NCT00911612|1264352|P1|NOT COMPLETED|Overall Study||0
517136|NCT00911612|1264351|P2|COMPLETED|Overall Study||12
517137|NCT00911612|1264352|P1|COMPLETED|Overall Study||12
517138|NCT00911612|1264351|P2|STARTED|Overall Study||12
517139|NCT00911612|1264352|P1|STARTED|Overall Study||12
517140|NCT00911547|1264370|P4|NOT COMPLETED|Overall Study||16
517141|NCT00911547|1264371|P3|NOT COMPLETED|Overall Study||22
517142|NCT00911547|1264372|P2|NOT COMPLETED|Overall Study||42
517143|NCT00911547|1264373|P1|NOT COMPLETED|Overall Study||11
517144|NCT00911547|1264370|P4|COMPLETED|Overall Study||177
517145|NCT00911547|1264371|P3|COMPLETED|Overall Study||178
517146|NCT00911547|1264372|P2|COMPLETED|Overall Study||159
517147|NCT00911547|1264373|P1|COMPLETED|Overall Study||37
517148|NCT00911547|1264370|P4|STARTED|Overall Study|Efficacy analyses were over the 16 weeks of treatment.|193
517149|NCT00911547|1264371|P3|STARTED|Overall Study|Efficacy analyses were over the 16 weeks of treatment.|200
517150|NCT00911547|1264372|P2|STARTED|Overall Study|Efficacy in last 10 wks to minimize confounding effect of beclo in 1st 4 wks & allow beclo washout.|201
517151|NCT00911547|1264373|P1|STARTED|Overall Study|Efficacy in last 10 wks to minimize confounding effect of beclo in 1st 4 wks & allow beclo washout.|48
517152|NCT00911534|1264401|P2|NOT COMPLETED|Overall Study||16
517153|NCT00911534|1264402|P1|NOT COMPLETED|Overall Study||15
517154|NCT00911534|1264401|P2|COMPLETED|Overall Study||137
517155|NCT00911534|1264402|P1|COMPLETED|Overall Study||132
517156|NCT00911534|1264401|P2|STARTED|Overall Study|Randomized (treated)|153
517157|NCT00911534|1264402|P1|STARTED|Overall Study|Randomized (treated)|147
517158|NCT00911495|1264414|P1|NOT COMPLETED|Overall Study||1
517159|NCT00911495|1264414|P1|COMPLETED|Overall Study||14
517160|NCT00911495|1264414|P1|STARTED|Overall Study||15
517161|NCT00911443|1264427|P5|NOT COMPLETED|Overall Study||0
517162|NCT00911443|1264428|P4|NOT COMPLETED|Overall Study||0
517163|NCT00911443|1264429|P3|NOT COMPLETED|Overall Study||0
517164|NCT00911443|1264430|P2|NOT COMPLETED|Overall Study||0
517165|NCT00911443|1264431|P1|NOT COMPLETED|Overall Study||0
517166|NCT00911443|1264427|P5|COMPLETED|Overall Study||97
517167|NCT00911443|1264428|P4|COMPLETED|Overall Study||99
517168|NCT00911443|1264429|P3|COMPLETED|Overall Study||98
517169|NCT00911443|1264430|P2|COMPLETED|Overall Study||97
517170|NCT00911443|1264431|P1|COMPLETED|Overall Study||97
517171|NCT00911443|1264427|P5|STARTED|Overall Study||97
517172|NCT00911443|1264428|P4|STARTED|Overall Study||99
517173|NCT00911443|1264429|P3|STARTED|Overall Study||98
517174|NCT00911443|1264430|P2|STARTED|Overall Study||97
517175|NCT00911443|1264431|P1|STARTED|Overall Study||97
517176|NCT00911326|1264448|P1|NOT COMPLETED|Overall Study||16
517177|NCT00911326|1264448|P1|COMPLETED|Overall Study||85
517178|NCT00911326|1264448|P1|STARTED|Overall Study||101
517179|NCT00911300|1264457|P2|NOT COMPLETED|Overall Study||43
517180|NCT00911300|1264458|P1|NOT COMPLETED|Overall Study||35
517181|NCT00911300|1264457|P2|COMPLETED|Overall Study||131
517182|NCT00911300|1264458|P1|COMPLETED|Overall Study||140
517183|NCT00911300|1264457|P2|STARTED|Overall Study||174
517184|NCT00911300|1264458|P1|STARTED|Overall Study||175
517185|NCT00911274|1264484|P2|NOT COMPLETED|Period 2||0
517186|NCT00911274|1264485|P1|NOT COMPLETED|Period 2||0
517187|NCT00911274|1264484|P2|COMPLETED|Period 2||26
517188|NCT00911274|1264485|P1|COMPLETED|Period 2||27
517189|NCT00911274|1264484|P2|STARTED|Period 2||26
517190|NCT00911274|1264485|P1|STARTED|Period 2||27
517191|NCT00911274|1264484|P2|NOT COMPLETED|Period 1||0
517192|NCT00911274|1264485|P1|NOT COMPLETED|Period 1||0
517193|NCT00911274|1264484|P2|COMPLETED|Period 1||26
517194|NCT00911274|1264485|P1|COMPLETED|Period 1||27
517195|NCT00911274|1264484|P2|STARTED|Period 1||26
517196|NCT00911274|1264485|P1|STARTED|Period 1||27
517197|NCT00911170|1264495|P2|NOT COMPLETED|Long Term Follow-Up||422
517198|NCT00911170|1264496|P1|NOT COMPLETED|Long Term Follow-Up||423
517199|NCT00911170|1264495|P2|COMPLETED|Long Term Follow-Up|As of the data cut-off date of 8 June 2012|0
517200|NCT00911170|1264496|P1|COMPLETED|Long Term Follow-Up|As of the data cut-off date of 8 June 2012|0
517201|NCT00911170|1264495|P2|STARTED|Long Term Follow-Up|Participants who received treatment in the Treatment Period|422
517202|NCT00911170|1264496|P1|STARTED|Long Term Follow-Up|Participants who received treatment in the Treatment Period|423
517203|NCT00911170|1264495|P2|NOT COMPLETED|Treatment Period||37
517204|NCT00911170|1264496|P1|NOT COMPLETED|Treatment Period||27
517205|NCT00911170|1264495|P2|COMPLETED|Treatment Period|Completed 4 cycles of treatment including chemotherapy, bevacizumab and investigational product.|386
517206|NCT00911170|1264496|P1|COMPLETED|Treatment Period|Completed 4 cycles of treatment including chemotherapy, bevacizumab and investigational product.|397
517207|NCT00911170|1264495|P2|Received Investigational Product|Treatment Period||419
517208|NCT00911170|1264496|P1|Received Investigational Product|Treatment Period|Includes one participant who received pegfilgrastim in error.|422
517209|NCT00911170|1264495|P2|Received Bevacizumab|Treatment Period||420
517210|NCT00911170|1264496|P1|Received Bevacizumab|Treatment Period||423
517211|NCT00911170|1264495|P2|Received Chemotherapy|Treatment Period|Primary Analysis Set|422
517212|NCT00911170|1264496|P1|Received Chemotherapy|Treatment Period|Primary Analysis Set|423
517213|NCT00911170|1264495|P2|STARTED|Treatment Period||423
517214|NCT00911170|1264496|P1|STARTED|Treatment Period||424
517215|NCT00911157|1264520|P2|NOT COMPLETED|Overall Study||2
517216|NCT00911157|1264521|P1|NOT COMPLETED|Overall Study||7
517217|NCT00911157|1264520|P2|COMPLETED|Overall Study||8
517218|NCT00911157|1264521|P1|COMPLETED|Overall Study||22
517219|NCT00911157|1264520|P2|STARTED|Overall Study||10
517220|NCT00911157|1264521|P1|STARTED|Overall Study||29
517221|NCT00911144|1264537|P2|NOT COMPLETED|Overall Study||5
517222|NCT00911144|1264538|P1|NOT COMPLETED|Overall Study||16
517223|NCT00911144|1264537|P2|COMPLETED|Overall Study||108
517224|NCT00911144|1264538|P1|COMPLETED|Overall Study||319
517225|NCT00911144|1264537|P2|STARTED|Overall Study||113
517226|NCT00911144|1264538|P1|STARTED|Overall Study||335
517227|NCT00910988|1264566|P4|NOT COMPLETED|Overall Study||0
517228|NCT00910988|1264567|P3|NOT COMPLETED|Overall Study||3
517229|NCT00910988|1264568|P2|NOT COMPLETED|Overall Study||4
517230|NCT00910988|1264569|P1|NOT COMPLETED|Overall Study||2
517231|NCT00910988|1264566|P4|COMPLETED|Overall Study||6
517232|NCT00910988|1264567|P3|COMPLETED|Overall Study||5
517233|NCT00910988|1264568|P2|COMPLETED|Overall Study||12
517234|NCT00910988|1264569|P1|COMPLETED|Overall Study||14
517235|NCT00910988|1264566|P4|STARTED|Overall Study||6
517236|NCT00910988|1264567|P3|STARTED|Overall Study||8
517237|NCT00910988|1264568|P2|STARTED|Overall Study||16
517238|NCT00910988|1264569|P1|STARTED|Overall Study||16
517239|NCT00910962|1264614|P3|NOT COMPLETED|Overall Study||76
517240|NCT00910962|1264615|P2|NOT COMPLETED|Overall Study||78
517241|NCT00910962|1264616|P1|NOT COMPLETED|Overall Study||43
517242|NCT00910962|1264614|P3|COMPLETED|Overall Study||116
517243|NCT00910962|1264615|P2|COMPLETED|Overall Study||121
517244|NCT00910962|1264616|P1|COMPLETED|Overall Study||92
517245|NCT00910962|1264614|P3|STARTED|Overall Study||192
517246|NCT00910962|1264615|P2|STARTED|Overall Study||199
517247|NCT00910962|1264616|P1|STARTED|Overall Study||135
517248|NCT00910910|1264708|P2|NOT COMPLETED|Overall Study||224
517249|NCT00910910|1264709|P1|NOT COMPLETED|Overall Study||225
517250|NCT00910910|1264708|P2|COMPLETED|Overall Study|Completed includes participants who are continuing with ongoing treatment|1
517251|NCT00910910|1264709|P1|COMPLETED|Overall Study|Completed includes participants who are continuing with ongoing treatment|0
517252|NCT00910910|1264708|P2|Safety Population|Overall Study|All randomized participants who received at least 1 dose of the either lenalidomide or chlorambucil|223
517253|NCT00910910|1264709|P1|Safety Population|Overall Study|All randomized participants who received at least 1 dose of the either lenalidomide or chlorambucil|224
517254|NCT00910910|1264708|P2|STARTED|Overall Study||225
517255|NCT00910910|1264709|P1|STARTED|Overall Study||225
517256|NCT00910871|1264743|P1|NOT COMPLETED|Overall Study||54
517257|NCT00910871|1264743|P1|COMPLETED|Overall Study||179
517258|NCT00910871|1264743|P1|STARTED|Overall Study||233
517259|NCT00910858|1264751|P3|NOT COMPLETED|Combined Treatment Phase||4
517260|NCT00910858|1264752|P2|NOT COMPLETED|Combined Treatment Phase||10
517261|NCT00910858|1264753|P1|NOT COMPLETED|Combined Treatment Phase||9
517262|NCT00910858|1264751|P3|COMPLETED|Combined Treatment Phase||0
517263|NCT00910858|1264752|P2|COMPLETED|Combined Treatment Phase||0
517264|NCT00910858|1264753|P1|COMPLETED|Combined Treatment Phase||0
517265|NCT00910858|1264751|P3|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|4
517266|NCT00910858|1264752|P2|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|10
517267|NCT00910858|1264753|P1|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|9
517268|NCT00910858|1264751|P3|NOT COMPLETED|Monotherapy Phase||7
517269|NCT00910858|1264752|P2|NOT COMPLETED|Monotherapy Phase||15
517270|NCT00910858|1264753|P1|NOT COMPLETED|Monotherapy Phase||17
517271|NCT00910858|1264751|P3|COMPLETED|Monotherapy Phase||0
517272|NCT00910858|1264752|P2|COMPLETED|Monotherapy Phase||0
517273|NCT00910858|1264753|P1|COMPLETED|Monotherapy Phase||0
517274|NCT00910858|1264751|P3|Pharmacokinetic Population|Monotherapy Phase||7
517275|NCT00910858|1264752|P2|Pharmacokinetic Population|Monotherapy Phase|Patients in the 15 mg Non-del 5q group were not included in the pharmacokinetic assessment.|0
517276|NCT00910858|1264753|P1|Pharmacokinetic Population|Monotherapy Phase||17
517277|NCT00910858|1264751|P3|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|7
517278|NCT00910858|1264752|P2|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|15
517279|NCT00910858|1264753|P1|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|17
517280|NCT00910858|1264751|P3|STARTED|Monotherapy Phase|Includes 3 participants from the PK Phase and 4 newly enrolled participants.|7
517281|NCT00910858|1264752|P2|STARTED|Monotherapy Phase|All 15 participants were newly enrolled into the Monotherapy Phase.|15
517282|NCT00910858|1264753|P1|STARTED|Monotherapy Phase|Includes 8 participants from the PK Phase and 9 newly enrolled participants.|17
517283|NCT00910858|1264751|P3|NOT COMPLETED|Pharmacokinetic Phase||0
517284|NCT00910858|1264752|P2|NOT COMPLETED|Pharmacokinetic Phase||0
517285|NCT00910858|1264753|P1|NOT COMPLETED|Pharmacokinetic Phase||1
517286|NCT00910858|1264751|P3|COMPLETED|Pharmacokinetic Phase||3
517287|NCT00910858|1264752|P2|COMPLETED|Pharmacokinetic Phase||0
517288|NCT00910858|1264753|P1|COMPLETED|Pharmacokinetic Phase||8
517289|NCT00910858|1264751|P3|STARTED|Pharmacokinetic Phase||3
517290|NCT00910858|1264752|P2|STARTED|Pharmacokinetic Phase||0
517291|NCT00910858|1264753|P1|STARTED|Pharmacokinetic Phase||9
517292|NCT00910845|1264778|P2|NOT COMPLETED|Treatment Cycle 2||9
517293|NCT00910845|1264779|P1|NOT COMPLETED|Treatment Cycle 2||5
517294|NCT00910845|1264778|P2|COMPLETED|Treatment Cycle 2||203
517295|NCT00910845|1264779|P1|COMPLETED|Treatment Cycle 2||136
517296|NCT00910845|1264778|P2|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|212
517297|NCT00910845|1264779|P1|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|141
517298|NCT00910845|1264778|P2|NOT COMPLETED|Treatment Cycle 1||34
517299|NCT00910845|1264779|P1|NOT COMPLETED|Treatment Cycle 1||31
517300|NCT00910845|1264778|P2|COMPLETED|Treatment Cycle 1||243
517301|NCT00910845|1264779|P1|COMPLETED|Treatment Cycle 1||249
517302|NCT00910845|1264778|P2|STARTED|Treatment Cycle 1||277
517303|NCT00910845|1264779|P1|STARTED|Treatment Cycle 1||280
517304|NCT00910728|1264798|P9|NOT COMPLETED|Overall Study||3
517305|NCT00910728|1264799|P8|NOT COMPLETED|Overall Study||3
517306|NCT00910728|1264800|P7|NOT COMPLETED|Overall Study||6
517307|NCT00910728|1264801|P6|NOT COMPLETED|Overall Study||1
517308|NCT00910728|1264802|P5|NOT COMPLETED|Overall Study||5
517309|NCT00910728|1264803|P4|NOT COMPLETED|Overall Study||3
517310|NCT00910728|1264804|P3|NOT COMPLETED|Overall Study||3
517311|NCT00910728|1264805|P2|NOT COMPLETED|Overall Study||3
517312|NCT00910728|1264806|P1|NOT COMPLETED|Overall Study||6
517313|NCT00910728|1264798|P9|COMPLETED|Overall Study||0
517314|NCT00910728|1264799|P8|COMPLETED|Overall Study||1
517315|NCT00910728|1264800|P7|COMPLETED|Overall Study||0
517316|NCT00910728|1264801|P6|COMPLETED|Overall Study||0
517317|NCT00910728|1264802|P5|COMPLETED|Overall Study||1
517318|NCT00910728|1264803|P4|COMPLETED|Overall Study||0
517319|NCT00910728|1264804|P3|COMPLETED|Overall Study||0
517320|NCT00910728|1264805|P2|COMPLETED|Overall Study||0
517321|NCT00910728|1264806|P1|COMPLETED|Overall Study||0
517322|NCT00910728|1264798|P9|STARTED|Overall Study||3
517323|NCT00910728|1264799|P8|STARTED|Overall Study||4
517324|NCT00910728|1264800|P7|STARTED|Overall Study||6
517325|NCT00910728|1264801|P6|STARTED|Overall Study||1
517326|NCT00910728|1264802|P5|STARTED|Overall Study||6
517327|NCT00910728|1264803|P4|STARTED|Overall Study||3
517328|NCT00910728|1264804|P3|STARTED|Overall Study||3
517329|NCT00910728|1264805|P2|STARTED|Overall Study||3
517330|NCT00910728|1264806|P1|STARTED|Overall Study||6
517331|NCT00910715|1264928|P3|NOT COMPLETED|Overall Study||0
517332|NCT00910715|1264929|P2|NOT COMPLETED|Overall Study||26
517333|NCT00910715|1264930|P1|NOT COMPLETED|Overall Study||22
517334|NCT00910715|1264928|P3|COMPLETED|Overall Study||81
517335|NCT00910715|1264929|P2|COMPLETED|Overall Study||91
517336|NCT00910715|1264930|P1|COMPLETED|Overall Study||86
517337|NCT00910715|1264928|P3|STARTED|Overall Study||81
517338|NCT00910715|1264929|P2|STARTED|Overall Study||117
517339|NCT00910715|1264930|P1|STARTED|Overall Study||108
517340|NCT00910689|1264944|P4|NOT COMPLETED|Months 11- 16: Evaluation Period II||6
517341|NCT00910689|1264945|P3|NOT COMPLETED|Months 11- 16: Evaluation Period II||7
517342|NCT00910689|1264946|P2|NOT COMPLETED|Months 11- 16: Evaluation Period II||10
517343|NCT00910689|1264947|P1|NOT COMPLETED|Months 11- 16: Evaluation Period II||10
517344|NCT00910689|1264944|P4|COMPLETED|Months 11- 16: Evaluation Period II||35
517345|NCT00910689|1264945|P3|COMPLETED|Months 11- 16: Evaluation Period II||28
517346|NCT00910689|1264946|P2|COMPLETED|Months 11- 16: Evaluation Period II||25
517347|NCT00910689|1264947|P1|COMPLETED|Months 11- 16: Evaluation Period II||30
517348|NCT00910689|1264944|P4|STARTED|Months 11- 16: Evaluation Period II||41
517349|NCT00910689|1264945|P3|STARTED|Months 11- 16: Evaluation Period II||35
517350|NCT00910689|1264946|P2|STARTED|Months 11- 16: Evaluation Period II||35
517351|NCT00910689|1264947|P1|STARTED|Months 11- 16: Evaluation Period II||40
517352|NCT00910689|1264944|P4|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
517353|NCT00910689|1264945|P3|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
517354|NCT00910689|1264946|P2|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
517355|NCT00910689|1264947|P1|NOT COMPLETED|Months 5 - 10: Evaluation Period I||4
517356|NCT00910689|1264944|P4|COMPLETED|Months 5 - 10: Evaluation Period I||41
517357|NCT00910689|1264945|P3|COMPLETED|Months 5 - 10: Evaluation Period I||35
517358|NCT00910689|1264946|P2|COMPLETED|Months 5 - 10: Evaluation Period I||35
517359|NCT00910689|1264947|P1|COMPLETED|Months 5 - 10: Evaluation Period I||40
517360|NCT00910689|1264944|P4|STARTED|Months 5 - 10: Evaluation Period I||48
517361|NCT00910689|1264945|P3|STARTED|Months 5 - 10: Evaluation Period I||42
517362|NCT00910689|1264946|P2|STARTED|Months 5 - 10: Evaluation Period I||42
517363|NCT00910689|1264947|P1|STARTED|Months 5 - 10: Evaluation Period I||44
517364|NCT00910689|1264944|P4|NOT COMPLETED|Month 2- 4: Treatment Period||11
517365|NCT00910689|1264945|P3|NOT COMPLETED|Month 2- 4: Treatment Period||8
517366|NCT00910689|1264946|P2|NOT COMPLETED|Month 2- 4: Treatment Period||10
517367|NCT00910689|1264947|P1|NOT COMPLETED|Month 2- 4: Treatment Period||9
517368|NCT00910689|1264944|P4|COMPLETED|Month 2- 4: Treatment Period||48
517369|NCT00910689|1264945|P3|COMPLETED|Month 2- 4: Treatment Period||42
517370|NCT00910689|1264946|P2|COMPLETED|Month 2- 4: Treatment Period||42
517371|NCT00910689|1264947|P1|COMPLETED|Month 2- 4: Treatment Period||44
517372|NCT00910689|1264944|P4|STARTED|Month 2- 4: Treatment Period||59
517373|NCT00910689|1264945|P3|STARTED|Month 2- 4: Treatment Period||50
517374|NCT00910689|1264946|P2|STARTED|Month 2- 4: Treatment Period||52
517375|NCT00910689|1264947|P1|STARTED|Month 2- 4: Treatment Period||53
517376|NCT00910689|1264944|P4|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||10
517377|NCT00910689|1264945|P3|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||5
517378|NCT00910689|1264946|P2|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||1
517379|NCT00910689|1264947|P1|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||2
517380|NCT00910689|1264944|P4|COMPLETED|Month 1: Optimal Acute Therapy Run in||59
517381|NCT00910689|1264945|P3|COMPLETED|Month 1: Optimal Acute Therapy Run in||50
517382|NCT00910689|1264946|P2|COMPLETED|Month 1: Optimal Acute Therapy Run in||52
517383|NCT00910689|1264947|P1|COMPLETED|Month 1: Optimal Acute Therapy Run in||53
517384|NCT00910689|1264944|P4|STARTED|Month 1: Optimal Acute Therapy Run in||69
517385|NCT00910689|1264945|P3|STARTED|Month 1: Optimal Acute Therapy Run in||55
517386|NCT00910689|1264946|P2|STARTED|Month 1: Optimal Acute Therapy Run in||53
517387|NCT00910689|1264947|P1|STARTED|Month 1: Optimal Acute Therapy Run in||55
517388|NCT00910663|1264979|P2|NOT COMPLETED|Period 2||0
517389|NCT00910663|1264980|P1|NOT COMPLETED|Period 2||0
517390|NCT00910663|1264979|P2|COMPLETED|Period 2||29
517391|NCT00910663|1264980|P1|COMPLETED|Period 2||30
517392|NCT00910663|1264979|P2|STARTED|Period 2||29
517393|NCT00910663|1264980|P1|STARTED|Period 2||30
517394|NCT00910663|1264979|P2|NOT COMPLETED|Period 1||1
517395|NCT00910663|1264980|P1|NOT COMPLETED|Period 1||0
517396|NCT00910663|1264979|P2|COMPLETED|Period 1||29
517397|NCT00910663|1264980|P1|COMPLETED|Period 1||30
517398|NCT00910663|1264979|P2|STARTED|Period 1||30
517399|NCT00910663|1264980|P1|STARTED|Period 1||30
517400|NCT00910624|1264994|P4|NOT COMPLETED|Follow-Up Phase||0
517401|NCT00910624|1264995|P3|NOT COMPLETED|Follow-Up Phase||4
517402|NCT00910624|1264996|P2|NOT COMPLETED|Follow-Up Phase||4
517403|NCT00910624|1264997|P1|NOT COMPLETED|Follow-Up Phase||6
517404|NCT00910624|1264994|P4|COMPLETED|Follow-Up Phase||2
517405|NCT00910624|1264995|P3|COMPLETED|Follow-Up Phase||25
517406|NCT00910624|1264996|P2|COMPLETED|Follow-Up Phase||76
517407|NCT00910624|1264997|P1|COMPLETED|Follow-Up Phase||42
517408|NCT00910624|1264994|P4|STARTED|Follow-Up Phase||2
517409|NCT00910624|1264995|P3|STARTED|Follow-Up Phase||29
517410|NCT00910624|1264996|P2|STARTED|Follow-Up Phase||80
517411|NCT00910624|1264997|P1|STARTED|Follow-Up Phase||48
517412|NCT00910624|1264994|P4|NOT COMPLETED|Treatment Phase||0
517413|NCT00910624|1264995|P3|NOT COMPLETED|Treatment Phase||9
517414|NCT00910624|1264996|P2|NOT COMPLETED|Treatment Phase||21
517415|NCT00910624|1264997|P1|NOT COMPLETED|Treatment Phase||30
517416|NCT00910624|1264994|P4|COMPLETED|Treatment Phase||2
517417|NCT00910624|1264995|P3|COMPLETED|Treatment Phase||20
517418|NCT00910624|1264996|P2|COMPLETED|Treatment Phase||64
517419|NCT00910624|1264997|P1|COMPLETED|Treatment Phase||22
517420|NCT00910624|1264994|P4|STARTED|Treatment Phase||2
517421|NCT00910624|1264995|P3|STARTED|Treatment Phase||29
517422|NCT00910624|1264996|P2|STARTED|Treatment Phase||85
517423|NCT00910624|1264997|P1|STARTED|Treatment Phase||52
517424|NCT00910520|1265011|P2|NOT COMPLETED|Treatment Cycle 2||8
517425|NCT00910520|1265012|P1|NOT COMPLETED|Treatment Cycle 2||7
517426|NCT00910520|1265011|P2|COMPLETED|Treatment Cycle 2||215
517427|NCT00910520|1265012|P1|COMPLETED|Treatment Cycle 2||156
517428|NCT00910520|1265011|P2|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|223
517429|NCT00910520|1265012|P1|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|163
517430|NCT00910520|1265011|P2|NOT COMPLETED|Treatment Cycle 1||24
517431|NCT00910520|1265012|P1|NOT COMPLETED|Treatment Cycle 1||20
517432|NCT00910520|1265011|P2|COMPLETED|Treatment Cycle 1||247
517433|NCT00910520|1265012|P1|COMPLETED|Treatment Cycle 1||257
517434|NCT00910520|1265011|P2|STARTED|Treatment Cycle 1||271
517435|NCT00910520|1265012|P1|STARTED|Treatment Cycle 1||277
517436|NCT00910299|1265024|P2|NOT COMPLETED|Overall Study||74
517437|NCT00910299|1265025|P1|NOT COMPLETED|Overall Study||76
517438|NCT00910299|1265024|P2|COMPLETED|Overall Study|1 participant died of sepsis while on study drug and was considered a “protocol completer.”|137
517439|NCT00910299|1265025|P1|COMPLETED|Overall Study||136
517440|NCT00910299|1265024|P2|Received at Least 1 Dose of Study Drug|Overall Study||210
517441|NCT00910299|1265025|P1|Received at Least 1 Dose of Study Drug|Overall Study||210
517442|NCT00910299|1265024|P2|STARTED|Overall Study||211
517443|NCT00910299|1265025|P1|STARTED|Overall Study||212
517444|NCT00910273|1265037|P2|NOT COMPLETED|Overall Study||13
517445|NCT00910273|1265038|P1|NOT COMPLETED|Overall Study||18
517446|NCT00910273|1265037|P2|COMPLETED|Overall Study||3
517447|NCT00910273|1265038|P1|COMPLETED|Overall Study||0
517448|NCT00910273|1265037|P2|STARTED|Overall Study||16
517449|NCT00910273|1265038|P1|STARTED|Overall Study||18
517450|NCT00910091|1265090|P2|NOT COMPLETED|Treatment and Survival||4
517451|NCT00910091|1265091|P1|NOT COMPLETED|Treatment and Survival||4
517452|NCT00910091|1265090|P2|COMPLETED|Treatment and Survival||31
517453|NCT00910091|1265091|P1|COMPLETED|Treatment and Survival||32
517454|NCT00910091|1265090|P2|STARTED|Treatment and Survival||35
517455|NCT00910091|1265091|P1|STARTED|Treatment and Survival||36
517456|NCT00910091|1265090|P2|NOT COMPLETED|Pre-assignment||2
517457|NCT00910091|1265091|P1|NOT COMPLETED|Pre-assignment||0
517458|NCT00910091|1265090|P2|COMPLETED|Pre-assignment||35
517459|NCT00910091|1265091|P1|COMPLETED|Pre-assignment||36
517460|NCT00910091|1265090|P2|STARTED|Pre-assignment||37
517461|NCT00910091|1265091|P1|STARTED|Pre-assignment||36
517462|NCT00910039|1265119|P1|NOT COMPLETED|Overall Study||1
517463|NCT00910039|1265119|P1|COMPLETED|Overall Study||13
517464|NCT00910039|1265119|P1|STARTED|Overall Study||14
517465|NCT00910000|1265136|P6|NOT COMPLETED|Overall Study||1
517466|NCT00910000|1265137|P5|NOT COMPLETED|Overall Study||1
517467|NCT00910000|1265138|P4|NOT COMPLETED|Overall Study||2
517468|NCT00910000|1265139|P3|NOT COMPLETED|Overall Study||3
517469|NCT00910000|1265140|P2|NOT COMPLETED|Overall Study||3
517470|NCT00910000|1265141|P1|NOT COMPLETED|Overall Study||0
517471|NCT00910000|1265136|P6|COMPLETED|Overall Study||0
517472|NCT00910000|1265137|P5|COMPLETED|Overall Study||2
517473|NCT00910000|1265138|P4|COMPLETED|Overall Study||0
517474|NCT00910000|1265139|P3|COMPLETED|Overall Study||0
517475|NCT00910000|1265140|P2|COMPLETED|Overall Study||0
517476|NCT00910000|1265141|P1|COMPLETED|Overall Study||3
517477|NCT00910000|1265136|P6|STARTED|Overall Study||1
517478|NCT00910000|1265137|P5|STARTED|Overall Study||3
517479|NCT00910000|1265138|P4|STARTED|Overall Study||2
517480|NCT00910000|1265139|P3|STARTED|Overall Study||3
517481|NCT00910000|1265140|P2|STARTED|Overall Study||3
517482|NCT00910000|1265141|P1|STARTED|Overall Study||3
517483|NCT00909870|1265159|P2|NOT COMPLETED|Overall Study||27
517484|NCT00909870|1265160|P1|NOT COMPLETED|Overall Study||23
517485|NCT00909870|1265159|P2|COMPLETED|Overall Study||236
517486|NCT00909870|1265160|P1|COMPLETED|Overall Study||251
517487|NCT00909870|1265159|P2|STARTED|Overall Study||263
517488|NCT00909870|1265160|P1|STARTED|Overall Study||274
517489|NCT00909857|1265172|P2|NOT COMPLETED|Overall Study||45
517490|NCT00909857|1265173|P1|NOT COMPLETED|Overall Study||36
517491|NCT00909857|1265172|P2|COMPLETED|Overall Study||209
517492|NCT00909857|1265173|P1|COMPLETED|Overall Study||217
517493|NCT00909857|1265172|P2|Treated|Overall Study||230
517494|NCT00909857|1265173|P1|Treated|Overall Study||234
517495|NCT00909857|1265172|P2|STARTED|Overall Study||254
517496|NCT00909857|1265173|P1|STARTED|Overall Study||253
517497|NCT00909844|1265313|P1|NOT COMPLETED|Overall Study||4
517498|NCT00909844|1265313|P1|COMPLETED|Overall Study||31
517499|NCT00909844|1265313|P1|STARTED|Overall Study||35
517500|NCT00909792|1265331|P2|NOT COMPLETED|Period 2||1
517501|NCT00909792|1265332|P1|NOT COMPLETED|Period 2||1
517502|NCT00909792|1265331|P2|COMPLETED|Period 2||124
517503|NCT00909792|1265332|P1|COMPLETED|Period 2||128
517504|NCT00909792|1265331|P2|STARTED|Period 2|Two discontinuations between P1 & P2: 1 for fail inc/exc criteria; 1 for lack of efficacy.|125
517505|NCT00909792|1265332|P1|STARTED|Period 2|One participant discontinued between Period 1 and Period 2 due to lack of efficacy.|129
517506|NCT00909792|1265331|P2|NOT COMPLETED|Period 1||1
517507|NCT00909792|1265332|P1|NOT COMPLETED|Period 1||0
517508|NCT00909792|1265331|P2|COMPLETED|Period 1||127
517509|NCT00909792|1265332|P1|COMPLETED|Period 1||130
517510|NCT00909792|1265331|P2|STARTED|Period 1||128
517511|NCT00909792|1265332|P1|STARTED|Period 1||130
517512|NCT00909779|1265340|P2|NOT COMPLETED|Overall Study||165
517513|NCT00909779|1265341|P1|NOT COMPLETED|Overall Study||210
517514|NCT00909779|1265340|P2|COMPLETED|Overall Study|All subjects but 42 were followed for 12 months/until death (whichever was earlier).|255
517515|NCT00909779|1265341|P1|COMPLETED|Overall Study|All subjects but 47 were followed for 12 months/until death (whichever was earlier).|211
517516|NCT00909779|1265340|P2|STARTED|Overall Study||420
517517|NCT00909779|1265341|P1|STARTED|Overall Study||421
517518|NCT00909753|1265365|P2|NOT COMPLETED|Period: Second Intervention||0
517519|NCT00909753|1265366|P1|NOT COMPLETED|Period: Second Intervention||1
517520|NCT00909753|1265365|P2|COMPLETED|Period: Second Intervention||43
517521|NCT00909753|1265366|P1|COMPLETED|Period: Second Intervention||43
517522|NCT00909753|1265365|P2|STARTED|Period: Second Intervention||43
517523|NCT00909753|1265366|P1|STARTED|Period: Second Intervention||44
517524|NCT00909753|1265365|P2|NOT COMPLETED|Period: Washout of 28 Days||3
517525|NCT00909753|1265366|P1|NOT COMPLETED|Period: Washout of 28 Days||2
517526|NCT00909753|1265365|P2|COMPLETED|Period: Washout of 28 Days||43
517527|NCT00909753|1265366|P1|COMPLETED|Period: Washout of 28 Days||44
517528|NCT00909753|1265365|P2|STARTED|Period: Washout of 28 Days||46
517529|NCT00909753|1265366|P1|STARTED|Period: Washout of 28 Days||46
517530|NCT00909753|1265365|P2|NOT COMPLETED|Period: First Intervention||0
517531|NCT00909753|1265366|P1|NOT COMPLETED|Period: First Intervention||0
517532|NCT00909753|1265365|P2|COMPLETED|Period: First Intervention||46
517533|NCT00909753|1265366|P1|COMPLETED|Period: First Intervention||46
517534|NCT00909753|1265365|P2|STARTED|Period: First Intervention||46
517535|NCT00909753|1265366|P1|STARTED|Period: First Intervention||46
517536|NCT00909727|1265386|P2|NOT COMPLETED|Overall Study||0
517537|NCT00909727|1265387|P1|NOT COMPLETED|Overall Study||4
517538|NCT00909727|1265386|P2|COMPLETED|Overall Study|Completed Treatment and Extension Periods (through Week 48)|26
517539|NCT00909727|1265387|P1|COMPLETED|Overall Study|Completed Treatment and Extension Periods (through Week 48)|22
517540|NCT00909727|1265386|P2|Completed Treatment Period, Week 24|Overall Study||26
517541|NCT00909727|1265387|P1|Completed Treatment Period, Week 24|Overall Study||23
517542|NCT00909727|1265386|P2|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (ivacaftor)|26
517543|NCT00909727|1265387|P1|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (placebo)|26
517544|NCT00909649|1265403|P2|NOT COMPLETED|Overall Study||0
517545|NCT00909649|1265404|P1|NOT COMPLETED|Overall Study||0
517546|NCT00909649|1265403|P2|COMPLETED|Overall Study||25
517547|NCT00909649|1265404|P1|COMPLETED|Overall Study||25
517548|NCT00909649|1265403|P2|STARTED|Overall Study||25
517549|NCT00909649|1265404|P1|STARTED|Overall Study||25
517550|NCT00909610|1265410|P2|NOT COMPLETED|Period: Second Intervention||0
517551|NCT00909610|1265411|P1|NOT COMPLETED|Period: Second Intervention||1
517552|NCT00909610|1265410|P2|COMPLETED|Period: Second Intervention||33
517553|NCT00909610|1265411|P1|COMPLETED|Period: Second Intervention||36
517554|NCT00909610|1265410|P2|STARTED|Period: Second Intervention||33
517555|NCT00909610|1265411|P1|STARTED|Period: Second Intervention||37
517556|NCT00909610|1265410|P2|NOT COMPLETED|Period: Washout of 28 Days||6
517557|NCT00909610|1265411|P1|NOT COMPLETED|Period: Washout of 28 Days||3
517558|NCT00909610|1265410|P2|COMPLETED|Period: Washout of 28 Days||33
517559|NCT00909610|1265411|P1|COMPLETED|Period: Washout of 28 Days||37
517560|NCT00909610|1265410|P2|STARTED|Period: Washout of 28 Days||39
517561|NCT00909610|1265411|P1|STARTED|Period: Washout of 28 Days||40
517562|NCT00909610|1265410|P2|NOT COMPLETED|Period: First Intervention||1
517563|NCT00909610|1265411|P1|NOT COMPLETED|Period: First Intervention||0
517564|NCT00909610|1265410|P2|COMPLETED|Period: First Intervention||39
517565|NCT00909610|1265411|P1|COMPLETED|Period: First Intervention||40
517566|NCT00909610|1265410|P2|STARTED|Period: First Intervention||40
517567|NCT00909610|1265411|P1|STARTED|Period: First Intervention||40
517568|NCT00909545|1265433|P4|NOT COMPLETED|Overall Study||5
517569|NCT00909545|1265434|P3|NOT COMPLETED|Overall Study||1
517570|NCT00909545|1265435|P2|NOT COMPLETED|Overall Study||1
517571|NCT00909545|1265436|P1|NOT COMPLETED|Overall Study||1
517572|NCT00909545|1265433|P4|COMPLETED|Overall Study||19
517573|NCT00909545|1265434|P3|COMPLETED|Overall Study||25
517574|NCT00909545|1265435|P2|COMPLETED|Overall Study||22
517575|NCT00909545|1265436|P1|COMPLETED|Overall Study||25
517576|NCT00909545|1265433|P4|STARTED|Overall Study||24
517577|NCT00909545|1265434|P3|STARTED|Overall Study||26
517578|NCT00909545|1265435|P2|STARTED|Overall Study||23
517579|NCT00909545|1265436|P1|STARTED|Overall Study||26
517580|NCT00909532|1265572|P2|NOT COMPLETED|Overall Study||6
517581|NCT00909532|1265573|P1|NOT COMPLETED|Overall Study||10
517582|NCT00909532|1265572|P2|COMPLETED|Overall Study|Completed Treatment and Extension Periods (Through Week 48)|77
517583|NCT00909532|1265573|P1|COMPLETED|Overall Study|Completed Treatment and Extension Periods (Through Week 48)|68
517584|NCT00909532|1265572|P2|Completed Treatment Period, Week 24|Overall Study||80
517585|NCT00909532|1265573|P1|Completed Treatment Period, Week 24|Overall Study||71
517586|NCT00909532|1265572|P2|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (ivacaftor).|83
517587|NCT00909532|1265573|P1|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (placebo).|78
517588|NCT00909480|1265591|P2|NOT COMPLETED|Overall Study||41
517589|NCT00909480|1265592|P1|NOT COMPLETED|Overall Study||38
517590|NCT00909480|1265591|P2|COMPLETED|Overall Study||188
517591|NCT00909480|1265592|P1|COMPLETED|Overall Study||190
517592|NCT00909480|1265591|P2|Exposed|Overall Study|2 subjects withdrew before exposure to trial insulin|227
517593|NCT00909480|1265592|P1|Exposed|Overall Study|2 subjects withdrew before exposure to trial insulin|226
517594|NCT00909480|1265591|P2|STARTED|Overall Study||229
517595|NCT00909480|1265592|P1|STARTED|Overall Study||228
517596|NCT00909428|1265627|P3|NOT COMPLETED|Overall Study||9
517597|NCT00909428|1265628|P2|NOT COMPLETED|Overall Study||10
517598|NCT00909428|1265629|P1|NOT COMPLETED|Overall Study||13
517599|NCT00909428|1265627|P3|COMPLETED|Overall Study||0
517600|NCT00909428|1265628|P2|COMPLETED|Overall Study||5
517601|NCT00909428|1265629|P1|COMPLETED|Overall Study||5
517602|NCT00909428|1265627|P3|STARTED|Overall Study||9
517603|NCT00909428|1265628|P2|STARTED|Overall Study||15
517604|NCT00909428|1265629|P1|STARTED|Overall Study||18
517605|NCT00909389|1265636|P1|NOT COMPLETED|Overall Study||133
517606|NCT00909389|1265636|P1|COMPLETED|Overall Study||4615
517607|NCT00909389|1265636|P1|STARTED|Overall Study||4748
517608|NCT00909324|1265642|P2|NOT COMPLETED|Overall Study||0
517609|NCT00909324|1265643|P1|NOT COMPLETED|Overall Study||0
517610|NCT00909324|1265642|P2|COMPLETED|Overall Study||90
517611|NCT00909324|1265643|P1|COMPLETED|Overall Study||72
517612|NCT00909324|1265642|P2|STARTED|Overall Study||90
517613|NCT00909324|1265643|P1|STARTED|Overall Study||72
517614|NCT00909220|1265655|P2|NOT COMPLETED|Overall Study||0
517615|NCT00909220|1265656|P1|NOT COMPLETED|Overall Study||0
517616|NCT00909220|1265655|P2|COMPLETED|Overall Study||36
517617|NCT00909220|1265656|P1|COMPLETED|Overall Study||41
517618|NCT00909220|1265655|P2|Submission for Publication|Overall Study||36
517619|NCT00909220|1265656|P1|Submission for Publication|Overall Study||41
517620|NCT00909220|1265655|P2|Data Analyses|Overall Study||36
517621|NCT00909220|1265656|P1|Data Analyses|Overall Study||41
517622|NCT00909220|1265655|P2|Data Entry|Overall Study||36
517623|NCT00909220|1265656|P1|Data Entry|Overall Study||41
517624|NCT00909220|1265655|P2|STARTED|Overall Study|Started enrolling participants May 2009|36
517625|NCT00909220|1265656|P1|STARTED|Overall Study|Started enrolling participants May 2009|41
517626|NCT00909181|1265670|P3|NOT COMPLETED|Overall Study||33
517627|NCT00909181|1265671|P2|NOT COMPLETED|Overall Study||18
517628|NCT00909181|1265672|P1|NOT COMPLETED|Overall Study||39
517629|NCT00909181|1265670|P3|COMPLETED|Overall Study||169
517630|NCT00909181|1265671|P2|COMPLETED|Overall Study||196
517631|NCT00909181|1265672|P1|COMPLETED|Overall Study||171
517632|NCT00909181|1265670|P3|STARTED|Overall Study||202
517633|NCT00909181|1265671|P2|STARTED|Overall Study||214
517634|NCT00909181|1265672|P1|STARTED|Overall Study||210
517635|NCT00909155|1265683|P3|NOT COMPLETED|Overall Study||7
517636|NCT00909155|1265684|P2|NOT COMPLETED|Overall Study||5
517637|NCT00909155|1265685|P1|NOT COMPLETED|Overall Study||3
517638|NCT00909155|1265683|P3|COMPLETED|Overall Study||14
517639|NCT00909155|1265684|P2|COMPLETED|Overall Study||9
517640|NCT00909155|1265685|P1|COMPLETED|Overall Study||12
517641|NCT00909155|1265683|P3|STARTED|Overall Study||21
517642|NCT00909155|1265684|P2|STARTED|Overall Study||14
517643|NCT00909155|1265685|P1|STARTED|Overall Study||15
517644|NCT00909064|1265693|P1|NOT COMPLETED|Overall Study||0
517645|NCT00909064|1265693|P1|COMPLETED|Overall Study||114
517646|NCT00909064|1265693|P1|STARTED|Overall Study||114
517647|NCT00909038|1265699|P1|NOT COMPLETED|Overall Study||417
517648|NCT00909038|1265699|P1|COMPLETED|Overall Study||1994
517649|NCT00909038|1265699|P1|STARTED|Overall Study||2411
517650|NCT00908960|1265711|P3|NOT COMPLETED|Overall Study||2
517651|NCT00908960|1265712|P2|NOT COMPLETED|Overall Study||1
517652|NCT00908960|1265713|P1|NOT COMPLETED|Overall Study||1
517653|NCT00908960|1265711|P3|COMPLETED|Overall Study||32
517654|NCT00908960|1265712|P2|COMPLETED|Overall Study||11
517655|NCT00908960|1265713|P1|COMPLETED|Overall Study||23
517656|NCT00908960|1265711|P3|Evaluable|Overall Study||32
517657|NCT00908960|1265712|P2|Evaluable|Overall Study||11
517658|NCT00908960|1265713|P1|Evaluable|Overall Study||23
517659|NCT00908960|1265711|P3|STARTED|Overall Study||34
517660|NCT00908960|1265712|P2|STARTED|Overall Study||12
517661|NCT00908960|1265713|P1|STARTED|Overall Study||24
517662|NCT00908908|1265727|P1|NOT COMPLETED|Overall Study||0
517663|NCT00908908|1265727|P1|COMPLETED|Overall Study||6
517664|NCT00908908|1265727|P1|Physician Decision|Overall Study||0
517665|NCT00908908|1265727|P1|Administrative/Other|Overall Study||0
517666|NCT00908908|1265727|P1|Withdrawl by Subject|Overall Study||0
517667|NCT00908908|1265727|P1|Adverse Event|Overall Study||0
517668|NCT00908908|1265727|P1|STARTED|Overall Study||6
517669|NCT00908895|1265735|P2|NOT COMPLETED|Overall Study||6
517670|NCT00908895|1265736|P1|NOT COMPLETED|Overall Study||4
517671|NCT00908895|1265735|P2|COMPLETED|Overall Study||57
517672|NCT00908895|1265736|P1|COMPLETED|Overall Study||53
517673|NCT00908895|1265735|P2|STARTED|Overall Study||63
517674|NCT00908895|1265736|P1|STARTED|Overall Study||57
517675|NCT00908882|1265746|P2|NOT COMPLETED|Overall Study||30
517676|NCT00908882|1265747|P1|NOT COMPLETED|Overall Study||28
517677|NCT00908882|1265746|P2|COMPLETED|Overall Study||59
517678|NCT00908882|1265747|P1|COMPLETED|Overall Study||61
517679|NCT00908882|1265746|P2|STARTED|Overall Study||89
517680|NCT00908882|1265747|P1|STARTED|Overall Study||89
517681|NCT00908687|1265777|P6|NOT COMPLETED|Overall Study||6
517682|NCT00908687|1265778|P5|NOT COMPLETED|Overall Study||4
517683|NCT00908687|1265779|P4|NOT COMPLETED|Overall Study||3
517684|NCT00908687|1265780|P3|NOT COMPLETED|Overall Study||3
517685|NCT00908687|1265781|P2|NOT COMPLETED|Overall Study||1
517686|NCT00908687|1265782|P1|NOT COMPLETED|Overall Study||1
517687|NCT00908687|1265777|P6|COMPLETED|Overall Study||94
517688|NCT00908687|1265778|P5|COMPLETED|Overall Study||94
517689|NCT00908687|1265779|P4|COMPLETED|Overall Study||47
517690|NCT00908687|1265780|P3|COMPLETED|Overall Study||99
517691|NCT00908687|1265781|P2|COMPLETED|Overall Study||99
517692|NCT00908687|1265782|P1|COMPLETED|Overall Study||49
517693|NCT00908687|1265777|P6|STARTED|Overall Study||100
517694|NCT00908687|1265778|P5|STARTED|Overall Study||98
517695|NCT00908687|1265779|P4|STARTED|Overall Study||50
517696|NCT00908687|1265780|P3|STARTED|Overall Study||102
517697|NCT00908687|1265781|P2|STARTED|Overall Study||100
517698|NCT00908687|1265782|P1|STARTED|Overall Study||50
517699|NCT00908648|1265798|P2|NOT COMPLETED|Overall Study||0
517700|NCT00908648|1265799|P1|NOT COMPLETED|Overall Study||0
517701|NCT00908648|1265798|P2|COMPLETED|Overall Study||103
517702|NCT00908648|1265799|P1|COMPLETED|Overall Study||108
517703|NCT00908648|1265798|P2|STARTED|Overall Study||103
517704|NCT00908648|1265799|P1|STARTED|Overall Study||108
517705|NCT00908596|1265809|P4|NOT COMPLETED|Overall Study||37
517706|NCT00908596|1265810|P3|NOT COMPLETED|Overall Study||74
517707|NCT00908596|1265811|P2|NOT COMPLETED|Overall Study||13
517708|NCT00908596|1265812|P1|NOT COMPLETED|Overall Study||47
517709|NCT00908596|1265809|P4|COMPLETED|Overall Study||48
517710|NCT00908596|1265810|P3|COMPLETED|Overall Study||119
517711|NCT00908596|1265811|P2|COMPLETED|Overall Study||19
517712|NCT00908596|1265812|P1|COMPLETED|Overall Study||0
517713|NCT00908596|1265809|P4|STARTED|Overall Study||85
517714|NCT00908596|1265810|P3|STARTED|Overall Study||193
517715|NCT00908596|1265811|P2|STARTED|Overall Study||32
517716|NCT00908596|1265812|P1|STARTED|Overall Study||47
517717|NCT00908583|1265842|P1|NOT COMPLETED|Phase 5||3
517718|NCT00908583|1265842|P1|COMPLETED|Phase 5||2
517719|NCT00908583|1265842|P1|STARTED|Phase 5||5
517720|NCT00908583|1265842|P1|NOT COMPLETED|Phase 4||2
517721|NCT00908583|1265842|P1|COMPLETED|Phase 4||3
517722|NCT00908583|1265842|P1|STARTED|Phase 4||5
517723|NCT00908583|1265842|P1|NOT COMPLETED|Phase 3||2
517724|NCT00908583|1265842|P1|COMPLETED|Phase 3||8
517725|NCT00908583|1265842|P1|STARTED|Phase 3||10
517726|NCT00908583|1265842|P1|NOT COMPLETED|Phase 2||2
517727|NCT00908583|1265842|P1|COMPLETED|Phase 2||10
517728|NCT00908583|1265842|P1|STARTED|Phase 2||12
517729|NCT00908583|1265842|P1|NOT COMPLETED|Phase 1||5
517730|NCT00908583|1265842|P1|COMPLETED|Phase 1||15
517731|NCT00908583|1265842|P1|STARTED|Phase 1||20
517732|NCT00908388|1265860|P1|NOT COMPLETED|Overall Study||10
517733|NCT00908388|1265860|P1|COMPLETED|Overall Study||40
517734|NCT00908388|1265860|P1|STARTED|Overall Study||50
517735|NCT00908375|1265870|P2|NOT COMPLETED|Overall Study||10
517736|NCT00908375|1265871|P1|NOT COMPLETED|Overall Study||10
517737|NCT00908375|1265870|P2|COMPLETED|Overall Study||9
517738|NCT00908375|1265871|P1|COMPLETED|Overall Study||10
517739|NCT00908375|1265870|P2|STARTED|Overall Study||19
517740|NCT00908375|1265871|P1|STARTED|Overall Study||20
517741|NCT00908349|1265881|P1|NOT COMPLETED|Overall Study||35
517742|NCT00908349|1265881|P1|COMPLETED|Overall Study||179
517743|NCT00908349|1265881|P1|STARTED|Overall Study||214
517744|NCT00908310|1265885|P1|NOT COMPLETED|Overall Study||60
517745|NCT00908310|1265885|P1|COMPLETED|Overall Study||153
517746|NCT00908310|1265885|P1|STARTED|Overall Study||213
517747|NCT00908232|1265889|P4|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||0
517748|NCT00908232|1265890|P3|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||1
517749|NCT00908232|1265891|P2|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||3
517750|NCT00908232|1265892|P1|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||35
517751|NCT00908232|1265889|P4|COMPLETED|Randomization (Cycle 5) to Cycle 8||4
517752|NCT00908232|1265890|P3|COMPLETED|Randomization (Cycle 5) to Cycle 8||7
517753|NCT00908232|1265891|P2|COMPLETED|Randomization (Cycle 5) to Cycle 8||4
517754|NCT00908232|1265892|P1|COMPLETED|Randomization (Cycle 5) to Cycle 8||63
517755|NCT00908232|1265889|P4|STARTED|Randomization (Cycle 5) to Cycle 8||4
517756|NCT00908232|1265890|P3|STARTED|Randomization (Cycle 5) to Cycle 8||8
517757|NCT00908232|1265891|P2|STARTED|Randomization (Cycle 5) to Cycle 8||7
517758|NCT00908232|1265892|P1|STARTED|Randomization (Cycle 5) to Cycle 8|Responding patients (not randomized) who received 4 more cycles of VD|98
517759|NCT00908232|1265889|P4|NOT COMPLETED|Cycle 1 to 4||0
517760|NCT00908232|1265890|P3|NOT COMPLETED|Cycle 1 to 4||0
517761|NCT00908232|1265891|P2|NOT COMPLETED|Cycle 1 to 4||0
517762|NCT00908232|1265892|P1|NOT COMPLETED|Cycle 1 to 4||28
517763|NCT00908232|1265889|P4|COMPLETED|Cycle 1 to 4||0
517764|NCT00908232|1265890|P3|COMPLETED|Cycle 1 to 4||0
517765|NCT00908232|1265891|P2|COMPLETED|Cycle 1 to 4||0
517766|NCT00908232|1265892|P1|COMPLETED|Cycle 1 to 4|Of those completed, 120 subjects were assessed for response, 117 w/ Response or SD continued.|135
517767|NCT00908232|1265889|P4|STARTED|Cycle 1 to 4||0
517768|NCT00908232|1265890|P3|STARTED|Cycle 1 to 4||0
517769|NCT00908232|1265891|P2|STARTED|Cycle 1 to 4||0
517770|NCT00908232|1265892|P1|STARTED|Cycle 1 to 4|All participants started VD treatment for 4 cycles prior to local site response assessments|163
517771|NCT00908141|1265910|P2|NOT COMPLETED|Overall Study||1
517772|NCT00908141|1265911|P1|NOT COMPLETED|Overall Study||0
517773|NCT00908141|1265910|P2|COMPLETED|Overall Study||8
517774|NCT00908141|1265911|P1|COMPLETED|Overall Study||8
517775|NCT00908141|1265910|P2|STARTED|Overall Study||9
517776|NCT00908141|1265911|P1|STARTED|Overall Study||8
517777|NCT00908128|1265919|P2|NOT COMPLETED|Period 4||0
517778|NCT00908128|1265920|P1|NOT COMPLETED|Period 4||0
517779|NCT00908128|1265919|P2|COMPLETED|Period 4||19
517780|NCT00908128|1265920|P1|COMPLETED|Period 4||20
517781|NCT00908128|1265919|P2|STARTED|Period 4|One subject withdrew prior to Period 4 dosing due to adverse events|19
517782|NCT00908128|1265920|P1|STARTED|Period 4||20
517783|NCT00908128|1265919|P2|NOT COMPLETED|Period 3||0
517784|NCT00908128|1265920|P1|NOT COMPLETED|Period 3||0
517785|NCT00908128|1265919|P2|COMPLETED|Period 3||20
517786|NCT00908128|1265920|P1|COMPLETED|Period 3||20
517787|NCT00908128|1265919|P2|STARTED|Period 3||20
517788|NCT00908128|1265920|P1|STARTED|Period 3||20
517789|NCT00908128|1265919|P2|NOT COMPLETED|Period 2||0
517790|NCT00908128|1265920|P1|NOT COMPLETED|Period 2||0
517791|NCT00908128|1265919|P2|COMPLETED|Period 2||20
517792|NCT00908128|1265920|P1|COMPLETED|Period 2||20
517793|NCT00908128|1265919|P2|STARTED|Period 2||20
517794|NCT00908128|1265920|P1|STARTED|Period 2||20
517795|NCT00908128|1265919|P2|NOT COMPLETED|Period 1||0
517796|NCT00908128|1265920|P1|NOT COMPLETED|Period 1||0
517797|NCT00908128|1265919|P2|COMPLETED|Period 1||20
517798|NCT00908128|1265920|P1|COMPLETED|Period 1||20
517799|NCT00908128|1265919|P2|STARTED|Period 1||20
517800|NCT00908128|1265920|P1|STARTED|Period 1||20
517801|NCT00908115|1265928|P1|NOT COMPLETED|Overall Study||14
517802|NCT00908115|1265928|P1|COMPLETED|Overall Study||1244
517803|NCT00908115|1265928|P1|STARTED|Overall Study||1258
517804|NCT00908076|1265936|P2|NOT COMPLETED|Overall Study||1
517805|NCT00908076|1265937|P1|NOT COMPLETED|Overall Study||1
517806|NCT00908076|1265936|P2|COMPLETED|Overall Study||26
517807|NCT00908076|1265937|P1|COMPLETED|Overall Study||26
517808|NCT00908076|1265936|P2|STARTED|Overall Study||27
517809|NCT00908076|1265937|P1|STARTED|Overall Study||27
517810|NCT00908037|1265950|P12|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3
517811|NCT00908037|1265951|P11|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||4
517812|NCT00908037|1265952|P10|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3
517813|NCT00908037|1265953|P9|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
517814|NCT00908037|1265954|P8|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
517815|NCT00908037|1265955|P7|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
517816|NCT00908037|1265956|P6|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
517817|NCT00908037|1265957|P5|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
517818|NCT00908037|1265958|P4|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
517819|NCT00908037|1265959|P3|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
517820|NCT00908037|1265960|P2|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
517821|NCT00908037|1265961|P1|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
517822|NCT00908037|1265950|P12|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||12
517823|NCT00908037|1265951|P11|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)|Two participants were randomized but did not receive treatment.|24
517824|NCT00908037|1265952|P10|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||21
517825|NCT00908037|1265953|P9|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
517826|NCT00908037|1265954|P8|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
517827|NCT00908037|1265955|P7|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
517828|NCT00908037|1265956|P6|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
517829|NCT00908037|1265957|P5|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
517830|NCT00908037|1265958|P4|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
517831|NCT00908037|1265959|P3|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
517832|NCT00908037|1265960|P2|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
517833|NCT00908037|1265961|P1|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
517834|NCT00908037|1265950|P12|STARTED|Part 2/3(Eltrombopag Open-Label Period)||15
517835|NCT00908037|1265951|P11|STARTED|Part 2/3(Eltrombopag Open-Label Period)|Two participants were randomized but did not receive treatment.|28
517836|NCT00908037|1265952|P10|STARTED|Part 2/3(Eltrombopag Open-Label Period)||24
517837|NCT00908037|1265953|P9|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
517838|NCT00908037|1265954|P8|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
517839|NCT00908037|1265955|P7|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
517840|NCT00908037|1265956|P6|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
517841|NCT00908037|1265957|P5|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
517842|NCT00908037|1265958|P4|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
517843|NCT00908037|1265959|P3|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
517844|NCT00908037|1265960|P2|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
517845|NCT00908037|1265961|P1|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
517846|NCT00908037|1265950|P12|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
517847|NCT00908037|1265951|P11|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
517848|NCT00908037|1265952|P10|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
517849|NCT00908037|1265953|P9|NOT COMPLETED|Part 2 (7 Week Randomized Period)||5
517850|NCT00908037|1265954|P8|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
517851|NCT00908037|1265955|P7|NOT COMPLETED|Part 2 (7 Week Randomized Period)||4
517852|NCT00908037|1265956|P6|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
517853|NCT00908037|1265957|P5|NOT COMPLETED|Part 2 (7 Week Randomized Period)||3
517854|NCT00908037|1265958|P4|NOT COMPLETED|Part 2 (7 Week Randomized Period)||1
517855|NCT00908037|1265959|P3|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
517856|NCT00908037|1265960|P2|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
517857|NCT00908037|1265961|P1|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
517858|NCT00908037|1265950|P12|COMPLETED|Part 2 (7 Week Randomized Period)||0
517859|NCT00908037|1265951|P11|COMPLETED|Part 2 (7 Week Randomized Period)||0
517860|NCT00908037|1265952|P10|COMPLETED|Part 2 (7 Week Randomized Period)||0
517861|NCT00908037|1265953|P9|COMPLETED|Part 2 (7 Week Randomized Period)||5
517862|NCT00908037|1265954|P8|COMPLETED|Part 2 (7 Week Randomized Period)||5
517863|NCT00908037|1265955|P7|COMPLETED|Part 2 (7 Week Randomized Period)||15
517864|NCT00908037|1265956|P6|COMPLETED|Part 2 (7 Week Randomized Period)||9
517865|NCT00908037|1265957|P5|COMPLETED|Part 2 (7 Week Randomized Period)||13
517866|NCT00908037|1265958|P4|COMPLETED|Part 2 (7 Week Randomized Period)||7
517867|NCT00908037|1265959|P3|COMPLETED|Part 2 (7 Week Randomized Period)||0
517868|NCT00908037|1265960|P2|COMPLETED|Part 2 (7 Week Randomized Period)||0
517869|NCT00908037|1265961|P1|COMPLETED|Part 2 (7 Week Randomized Period)||0
517870|NCT00908037|1265950|P12|STARTED|Part 2 (7 Week Randomized Period)||0
517871|NCT00908037|1265951|P11|STARTED|Part 2 (7 Week Randomized Period)||0
517872|NCT00908037|1265952|P10|STARTED|Part 2 (7 Week Randomized Period)||0
517873|NCT00908037|1265953|P9|STARTED|Part 2 (7 Week Randomized Period)||10
517874|NCT00908037|1265954|P8|STARTED|Part 2 (7 Week Randomized Period)||5
517875|NCT00908037|1265955|P7|STARTED|Part 2 (7 Week Randomized Period)||19
517876|NCT00908037|1265956|P6|STARTED|Part 2 (7 Week Randomized Period)||9
517877|NCT00908037|1265957|P5|STARTED|Part 2 (7 Week Randomized Period)||16
517878|NCT00908037|1265958|P4|STARTED|Part 2 (7 Week Randomized Period)||8
517879|NCT00908037|1265959|P3|STARTED|Part 2 (7 Week Randomized Period)||0
517880|NCT00908037|1265960|P2|STARTED|Part 2 (7 Week Randomized Period)||0
517881|NCT00908037|1265961|P1|STARTED|Part 2 (7 Week Randomized Period)||0
517882|NCT00908037|1265950|P12|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
517883|NCT00908037|1265951|P11|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
517884|NCT00908037|1265952|P10|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
517885|NCT00908037|1265953|P9|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
517886|NCT00908037|1265954|P8|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
517887|NCT00908037|1265955|P7|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
517888|NCT00908037|1265956|P6|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
517889|NCT00908037|1265957|P5|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
517890|NCT00908037|1265958|P4|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
517891|NCT00908037|1265959|P3|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
517892|NCT00908037|1265960|P2|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
517893|NCT00908037|1265961|P1|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
517894|NCT00908037|1265950|P12|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
517895|NCT00908037|1265951|P11|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
517896|NCT00908037|1265952|P10|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
517897|NCT00908037|1265953|P9|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
517898|NCT00908037|1265954|P8|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
517899|NCT00908037|1265955|P7|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
517900|NCT00908037|1265956|P6|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
517901|NCT00908037|1265957|P5|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
517902|NCT00908037|1265958|P4|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
517903|NCT00908037|1265959|P3|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
517904|NCT00908037|1265960|P2|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
517905|NCT00908037|1265961|P1|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
517906|NCT00908037|1265950|P12|STARTED|Part1 (24 Week Dose-Finding Period)||0
517907|NCT00908037|1265951|P11|STARTED|Part1 (24 Week Dose-Finding Period)||0
517908|NCT00908037|1265952|P10|STARTED|Part1 (24 Week Dose-Finding Period)||0
517909|NCT00908037|1265953|P9|STARTED|Part1 (24 Week Dose-Finding Period)||0
517910|NCT00908037|1265954|P8|STARTED|Part1 (24 Week Dose-Finding Period)||0
517911|NCT00908037|1265955|P7|STARTED|Part1 (24 Week Dose-Finding Period)||0
517912|NCT00908037|1265956|P6|STARTED|Part1 (24 Week Dose-Finding Period)||0
517913|NCT00908037|1265957|P5|STARTED|Part1 (24 Week Dose-Finding Period)||0
517914|NCT00908037|1265958|P4|STARTED|Part1 (24 Week Dose-Finding Period)||0
517915|NCT00908037|1265959|P3|STARTED|Part1 (24 Week Dose-Finding Period)||5
517916|NCT00908037|1265960|P2|STARTED|Part1 (24 Week Dose-Finding Period)||5
517917|NCT00908037|1265961|P1|STARTED|Part1 (24 Week Dose-Finding Period)||5
517918|NCT00908011|1266110|P2|NOT COMPLETED|Overall Study||2
517919|NCT00908011|1266111|P1|NOT COMPLETED|Overall Study||2
517920|NCT00908011|1266110|P2|COMPLETED|Overall Study||18
517921|NCT00908011|1266111|P1|COMPLETED|Overall Study||21
517922|NCT00908011|1266110|P2|STARTED|Overall Study||20
517923|NCT00908011|1266111|P1|STARTED|Overall Study||23
517924|NCT00907907|1266119|P2|NOT COMPLETED|Period 4||0
517925|NCT00907907|1266120|P1|NOT COMPLETED|Period 4||0
517926|NCT00907907|1266119|P2|COMPLETED|Period 4||18
517927|NCT00907907|1266120|P1|COMPLETED|Period 4||19
517928|NCT00907907|1266119|P2|STARTED|Period 4|two subjects were withdrawn prior to Period 4 dosing|18
517929|NCT00907907|1266120|P1|STARTED|Period 4|one subject withdrew prior to Period 4 dosing|19
517930|NCT00907907|1266119|P2|NOT COMPLETED|Period 3||0
517931|NCT00907907|1266120|P1|NOT COMPLETED|Period 3||0
517932|NCT00907907|1266119|P2|COMPLETED|Period 3||20
517933|NCT00907907|1266120|P1|COMPLETED|Period 3||20
517934|NCT00907907|1266119|P2|STARTED|Period 3||20
517935|NCT00907907|1266120|P1|STARTED|Period 3||20
517936|NCT00907907|1266119|P2|NOT COMPLETED|Period 2||0
517937|NCT00907907|1266120|P1|NOT COMPLETED|Period 2||0
517938|NCT00907907|1266119|P2|COMPLETED|Period 2||20
517939|NCT00907907|1266120|P1|COMPLETED|Period 2||20
517940|NCT00907907|1266119|P2|STARTED|Period 2||20
517941|NCT00907907|1266120|P1|STARTED|Period 2||20
517942|NCT00907907|1266119|P2|NOT COMPLETED|Period 1||0
517943|NCT00907907|1266120|P1|NOT COMPLETED|Period 1||0
517944|NCT00907907|1266119|P2|COMPLETED|Period 1||20
517945|NCT00907907|1266120|P1|COMPLETED|Period 1||20
517946|NCT00907907|1266119|P2|STARTED|Period 1||20
517947|NCT00907907|1266120|P1|STARTED|Period 1||20
517948|NCT00907881|1266128|P1|NOT COMPLETED|Overall Study||85
517949|NCT00907881|1266128|P1|COMPLETED|Overall Study||984
517950|NCT00907881|1266128|P1|STARTED|Overall Study||1069
517951|NCT00907803|1266138|P3|NOT COMPLETED|Overall Study||0
517952|NCT00907803|1266139|P2|NOT COMPLETED|Overall Study||3
517953|NCT00907803|1266140|P1|NOT COMPLETED|Overall Study||3
517954|NCT00907803|1266138|P3|COMPLETED|Overall Study||16
517955|NCT00907803|1266139|P2|COMPLETED|Overall Study||43
517956|NCT00907803|1266140|P1|COMPLETED|Overall Study||42
517957|NCT00907803|1266138|P3|STARTED|Overall Study||16
517958|NCT00907803|1266139|P2|STARTED|Overall Study||46
517959|NCT00907803|1266140|P1|STARTED|Overall Study||45
517960|NCT00907777|1266171|P2|NOT COMPLETED|Overall Study||1
517961|NCT00907777|1266172|P1|NOT COMPLETED|Overall Study||0
517962|NCT00907777|1266171|P2|COMPLETED|Overall Study||26
517963|NCT00907777|1266172|P1|COMPLETED|Overall Study||25
517964|NCT00907777|1266171|P2|STARTED|Overall Study||27
517965|NCT00907777|1266172|P1|STARTED|Overall Study||25
517966|NCT00907738|1266199|P5|NOT COMPLETED|Overall Study||2
517967|NCT00907738|1266200|P4|NOT COMPLETED|Overall Study||4
517968|NCT00907738|1266201|P3|NOT COMPLETED|Overall Study||7
517969|NCT00907738|1266202|P2|NOT COMPLETED|Overall Study||1
517970|NCT00907738|1266203|P1|NOT COMPLETED|Overall Study||13
517971|NCT00907738|1266199|P5|COMPLETED|Overall Study||0
517972|NCT00907738|1266200|P4|COMPLETED|Overall Study||0
517973|NCT00907738|1266201|P3|COMPLETED|Overall Study||0
517974|NCT00907738|1266202|P2|COMPLETED|Overall Study||0
517975|NCT00907738|1266203|P1|COMPLETED|Overall Study||0
517976|NCT00907738|1266199|P5|STARTED|Overall Study||2
517977|NCT00907738|1266200|P4|STARTED|Overall Study||4
517978|NCT00907738|1266201|P3|STARTED|Overall Study||7
517979|NCT00907738|1266202|P2|STARTED|Overall Study||1
517980|NCT00907738|1266203|P1|STARTED|Overall Study||13
517981|NCT00907621|1266221|P2|NOT COMPLETED|Overall Study||4
517982|NCT00907621|1266222|P1|NOT COMPLETED|Overall Study||7
517983|NCT00907621|1266221|P2|COMPLETED|Overall Study||41
517984|NCT00907621|1266222|P1|COMPLETED|Overall Study||38
517985|NCT00907621|1266221|P2|STARTED|Overall Study||45
517986|NCT00907621|1266222|P1|STARTED|Overall Study||45
517987|NCT00907517|1266235|P5|NOT COMPLETED|Overall Study||5
517988|NCT00907517|1266236|P4|NOT COMPLETED|Overall Study||4
517989|NCT00907517|1266237|P3|NOT COMPLETED|Overall Study||4
517990|NCT00907517|1266238|P2|NOT COMPLETED|Overall Study||3
517991|NCT00907517|1266239|P1|NOT COMPLETED|Overall Study||3
517992|NCT00907517|1266235|P5|COMPLETED|Overall Study||1
517993|NCT00907517|1266236|P4|COMPLETED|Overall Study||2
517994|NCT00907517|1266237|P3|COMPLETED|Overall Study||2
517995|NCT00907517|1266238|P2|COMPLETED|Overall Study||0
517996|NCT00907517|1266239|P1|COMPLETED|Overall Study||0
517997|NCT00907517|1266235|P5|STARTED|Overall Study||6
517998|NCT00907517|1266236|P4|STARTED|Overall Study||6
517999|NCT00907517|1266237|P3|STARTED|Overall Study||6
518000|NCT00907517|1266238|P2|STARTED|Overall Study||3
518001|NCT00907517|1266239|P1|STARTED|Overall Study||3
518002|NCT00907478|1266264|P3|NOT COMPLETED|Overall Study||22
518003|NCT00907478|1266265|P2|NOT COMPLETED|Overall Study||17
518004|NCT00907478|1266266|P1|NOT COMPLETED|Overall Study||27
518005|NCT00907478|1266264|P3|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|47
518006|NCT00907478|1266265|P2|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|33
518007|NCT00907478|1266266|P1|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|23
518008|NCT00907478|1266264|P3|STARTED|Overall Study||69
518009|NCT00907478|1266265|P2|STARTED|Overall Study||50
518010|NCT00907478|1266266|P1|STARTED|Overall Study||50
518011|NCT00907426|1266297|P3|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||7
518012|NCT00907426|1266298|P2|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||3
518013|NCT00907426|1266299|P1|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||11
518014|NCT00907426|1266297|P3|COMPLETED|Treatment Period 2 (6 to 12 Months)||77
518015|NCT00907426|1266298|P2|COMPLETED|Treatment Period 2 (6 to 12 Months)||52
518016|NCT00907426|1266299|P1|COMPLETED|Treatment Period 2 (6 to 12 Months)||184
518017|NCT00907426|1266297|P3|STARTED|Treatment Period 2 (6 to 12 Months)||84
518018|NCT00907426|1266298|P2|STARTED|Treatment Period 2 (6 to 12 Months)||55
518019|NCT00907426|1266299|P1|STARTED|Treatment Period 2 (6 to 12 Months)||195
518020|NCT00907426|1266297|P3|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||9
518021|NCT00907426|1266298|P2|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||5
518022|NCT00907426|1266299|P1|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||20
518023|NCT00907426|1266297|P3|COMPLETED|Treatment Period 1 (0 to 6 Months)||84
518024|NCT00907426|1266298|P2|COMPLETED|Treatment Period 1 (0 to 6 Months)||55
518025|NCT00907426|1266299|P1|COMPLETED|Treatment Period 1 (0 to 6 Months)||195
518026|NCT00907426|1266297|P3|STARTED|Treatment Period 1 (0 to 6 Months)||93
518027|NCT00907426|1266298|P2|STARTED|Treatment Period 1 (0 to 6 Months)||60
518028|NCT00907426|1266299|P1|STARTED|Treatment Period 1 (0 to 6 Months)||215
518029|NCT00907374|1266316|P2|NOT COMPLETED|Overall Study||2
518030|NCT00907374|1266317|P1|NOT COMPLETED|Overall Study||2
518031|NCT00907374|1266316|P2|COMPLETED|Overall Study||11
518032|NCT00907374|1266317|P1|COMPLETED|Overall Study||12
518033|NCT00907374|1266316|P2|STARTED|Overall Study||13
518034|NCT00907374|1266317|P1|STARTED|Overall Study||14
518035|NCT00907335|1266331|P2|NOT COMPLETED|Overall Study||1
518036|NCT00907335|1266332|P1|NOT COMPLETED|Overall Study||8
518037|NCT00907335|1266331|P2|COMPLETED|Overall Study||54
518038|NCT00907335|1266332|P1|COMPLETED|Overall Study||47
518039|NCT00907335|1266331|P2|STARTED|Overall Study||55
518040|NCT00907335|1266332|P1|STARTED|Overall Study||55
518041|NCT00907257|1266350|P2|NOT COMPLETED|Overall Study||12
518042|NCT00907257|1266351|P1|NOT COMPLETED|Overall Study||13
518043|NCT00907257|1266350|P2|COMPLETED|Overall Study||112
518044|NCT00907257|1266351|P1|COMPLETED|Overall Study||110
518045|NCT00907257|1266350|P2|STARTED|Overall Study||124
518046|NCT00907257|1266351|P1|STARTED|Overall Study||123
518047|NCT00907218|1266361|P1|NOT COMPLETED|Overall Study||0
518048|NCT00907218|1266361|P1|COMPLETED|Overall Study||2
518049|NCT00907218|1266361|P1|STARTED|Overall Study||2
518050|NCT00907153|1266373|P2|NOT COMPLETED|Overall Study||4
518051|NCT00907153|1266374|P1|NOT COMPLETED|Overall Study||2
518052|NCT00907153|1266373|P2|COMPLETED|Overall Study||11
518053|NCT00907153|1266374|P1|COMPLETED|Overall Study||11
518054|NCT00907153|1266373|P2|STARTED|Overall Study||15
518055|NCT00907153|1266374|P1|STARTED|Overall Study||13
518056|NCT00907101|1266416|P1|NOT COMPLETED|Overall Study||0
518057|NCT00907101|1266416|P1|COMPLETED|Overall Study||30
518058|NCT00907101|1266416|P1|STARTED|Overall Study||30
518059|NCT00907088|1266426|P2|NOT COMPLETED|Overall Study||30
518060|NCT00907088|1266427|P1|NOT COMPLETED|Overall Study||20
518061|NCT00907088|1266426|P2|COMPLETED|Overall Study||99
518062|NCT00907088|1266427|P1|COMPLETED|Overall Study||102
518063|NCT00907088|1266426|P2|STARTED|Overall Study||129
518064|NCT00907088|1266427|P1|STARTED|Overall Study||122
518065|NCT00906971|1266435|P2|NOT COMPLETED|Overall Study||3
518066|NCT00906971|1266436|P1|NOT COMPLETED|Overall Study||8
518067|NCT00906971|1266435|P2|COMPLETED|Overall Study||33
518068|NCT00906971|1266436|P1|COMPLETED|Overall Study||28
518069|NCT00906971|1266435|P2|STARTED|Overall Study||36
518070|NCT00906971|1266436|P1|STARTED|Overall Study||36
518071|NCT00906945|1266449|P6|NOT COMPLETED|Overall Study||2
518072|NCT00906945|1266450|P5|NOT COMPLETED|Overall Study||1
518073|NCT00906945|1266451|P4|NOT COMPLETED|Overall Study||1
518074|NCT00906945|1266452|P3|NOT COMPLETED|Overall Study||0
518075|NCT00906945|1266453|P2|NOT COMPLETED|Overall Study||0
518076|NCT00906945|1266454|P1|NOT COMPLETED|Overall Study||0
518077|NCT00906945|1266449|P6|COMPLETED|Overall Study||14
518078|NCT00906945|1266450|P5|COMPLETED|Overall Study||6
518079|NCT00906945|1266451|P4|COMPLETED|Overall Study||6
518080|NCT00906945|1266452|P3|COMPLETED|Overall Study||3
518081|NCT00906945|1266453|P2|COMPLETED|Overall Study||3
518082|NCT00906945|1266454|P1|COMPLETED|Overall Study||3
518083|NCT00906945|1266449|P6|STARTED|Overall Study||16
518084|NCT00906945|1266450|P5|STARTED|Overall Study||7
518085|NCT00906945|1266451|P4|STARTED|Overall Study||7
518086|NCT00906945|1266452|P3|STARTED|Overall Study||3
518087|NCT00906945|1266453|P2|STARTED|Overall Study||3
518088|NCT00906945|1266454|P1|STARTED|Overall Study||3
518089|NCT00906789|1266481|P1|NOT COMPLETED|Overall Study||0
518090|NCT00906789|1266481|P1|COMPLETED|Overall Study||15
518091|NCT00906789|1266481|P1|STARTED|Overall Study|Radiologists served as own control. Total enrollment is 15 radiologists.|15
518092|NCT00906776|1266491|P2|NOT COMPLETED|Overall Study||0
518093|NCT00906776|1266492|P1|NOT COMPLETED|Overall Study||0
518094|NCT00906776|1266491|P2|COMPLETED|Overall Study||8
518095|NCT00906776|1266492|P1|COMPLETED|Overall Study||11
518096|NCT00906776|1266491|P2|STARTED|Overall Study||8
518097|NCT00906776|1266492|P1|STARTED|Overall Study||11
518098|NCT00906698|1266514|P6|NOT COMPLETED|Overall Study||5
518099|NCT00906698|1266515|P5|NOT COMPLETED|Overall Study||18
518100|NCT00906698|1266516|P4|NOT COMPLETED|Overall Study||4
518101|NCT00906698|1266517|P3|NOT COMPLETED|Overall Study||6
518102|NCT00906698|1266518|P2|NOT COMPLETED|Overall Study||19
518103|NCT00906698|1266519|P1|NOT COMPLETED|Overall Study||3
518104|NCT00906698|1266514|P6|COMPLETED|Overall Study||0
518105|NCT00906698|1266515|P5|COMPLETED|Overall Study||0
518106|NCT00906698|1266516|P4|COMPLETED|Overall Study||0
518107|NCT00906698|1266517|P3|COMPLETED|Overall Study||0
518108|NCT00906698|1266518|P2|COMPLETED|Overall Study||0
518109|NCT00906698|1266519|P1|COMPLETED|Overall Study||0
518110|NCT00906698|1266514|P6|STARTED|Overall Study||5
518111|NCT00906698|1266515|P5|STARTED|Overall Study||18
518112|NCT00906698|1266516|P4|STARTED|Overall Study||4
518113|NCT00906698|1266517|P3|STARTED|Overall Study||6
518114|NCT00906698|1266518|P2|STARTED|Overall Study||19
518115|NCT00906698|1266519|P1|STARTED|Overall Study||3
518116|NCT00906503|1266601|P1|NOT COMPLETED|Overall Study||0
518117|NCT00906503|1266601|P1|COMPLETED|Overall Study||9
518118|NCT00906503|1266601|P1|STARTED|Overall Study||9
518119|NCT00906425|1266607|P2|NOT COMPLETED|Overall Study||72
518120|NCT00906425|1266608|P1|NOT COMPLETED|Overall Study||73
518121|NCT00906425|1266607|P2|COMPLETED|Overall Study|Clinical Trial expected to be completed in 2013|0
518122|NCT00906425|1266608|P1|COMPLETED|Overall Study|Clinical Trial expected to be completed in 2013|0
518123|NCT00906425|1266607|P2|2 Year|Overall Study|ITT population|58
518124|NCT00906425|1266608|P1|2 Year|Overall Study|ITT population|62
518125|NCT00906425|1266607|P2|1 Year|Overall Study|ITT population|60
518126|NCT00906425|1266608|P1|1 Year|Overall Study|ITT population|67
518127|NCT00906425|1266607|P2|6 Months|Overall Study|ITT population|64
518128|NCT00906425|1266608|P1|6 Months|Overall Study|ITT population|69
518129|NCT00906425|1266607|P2|STARTED|Overall Study||72
518130|NCT00906425|1266608|P1|STARTED|Overall Study||73
518131|NCT00906399|1266621|P7|NOT COMPLETED|Year 2||29
518132|NCT00906399|1266622|P6|NOT COMPLETED|Year 2||47
518133|NCT00906399|1266623|P5|NOT COMPLETED|Year 2||35
518134|NCT00906399|1266624|P4|NOT COMPLETED|Year 2||30
518135|NCT00906399|1266625|P3|NOT COMPLETED|Year 2||0
518136|NCT00906399|1266626|P2|NOT COMPLETED|Year 2||0
518137|NCT00906399|1266627|P1|NOT COMPLETED|Year 2||0
518138|NCT00906399|1266621|P7|COMPLETED|Year 2||409
518139|NCT00906399|1266622|P6|COMPLETED|Year 2||391
518140|NCT00906399|1266623|P5|COMPLETED|Year 2||193
518141|NCT00906399|1266624|P4|COMPLETED|Year 2||198
518142|NCT00906399|1266625|P3|COMPLETED|Year 2||0
518143|NCT00906399|1266626|P2|COMPLETED|Year 2||0
518144|NCT00906399|1266627|P1|COMPLETED|Year 2||0
518145|NCT00906399|1266621|P7|Completed Year 2 Study Treatment|Year 2||411
518146|NCT00906399|1266622|P6|Completed Year 2 Study Treatment|Year 2||391
518147|NCT00906399|1266623|P5|Completed Year 2 Study Treatment|Year 2||196
518148|NCT00906399|1266624|P4|Completed Year 2 Study Treatment|Year 2||200
518149|NCT00906399|1266625|P3|Completed Year 2 Study Treatment|Year 2||0
518150|NCT00906399|1266626|P2|Completed Year 2 Study Treatment|Year 2||0
518151|NCT00906399|1266627|P1|Completed Year 2 Study Treatment|Year 2||0
518152|NCT00906399|1266621|P7|STARTED|Year 2||438
518153|NCT00906399|1266622|P6|STARTED|Year 2||438
518154|NCT00906399|1266623|P5|STARTED|Year 2||228
518155|NCT00906399|1266624|P4|STARTED|Year 2||228
518156|NCT00906399|1266625|P3|STARTED|Year 2||0
518157|NCT00906399|1266626|P2|STARTED|Year 2||0
518158|NCT00906399|1266627|P1|STARTED|Year 2||0
518159|NCT00906399|1266621|P7|NOT COMPLETED|Year 1||0
518160|NCT00906399|1266622|P6|NOT COMPLETED|Year 1||0
518161|NCT00906399|1266623|P5|NOT COMPLETED|Year 1||0
518162|NCT00906399|1266624|P4|NOT COMPLETED|Year 1||0
518163|NCT00906399|1266625|P3|NOT COMPLETED|Year 1||76
518164|NCT00906399|1266626|P2|NOT COMPLETED|Year 1||63
518165|NCT00906399|1266627|P1|NOT COMPLETED|Year 1||44
518166|NCT00906399|1266621|P7|COMPLETED|Year 1||0
518167|NCT00906399|1266622|P6|COMPLETED|Year 1||0
518168|NCT00906399|1266623|P5|COMPLETED|Year 1||0
518169|NCT00906399|1266624|P4|COMPLETED|Year 1||0
518170|NCT00906399|1266625|P3|COMPLETED|Year 1|1 participant discontinued treatment before end of study period but remained to complete follow-up.|439
518171|NCT00906399|1266626|P2|COMPLETED|Year 1||438
518172|NCT00906399|1266627|P1|COMPLETED|Year 1||456
518173|NCT00906399|1266621|P7|Completed Year 1 Study Treatment|Year 1||0
518174|NCT00906399|1266622|P6|Completed Year 1 Study Treatment|Year 1||0
518175|NCT00906399|1266623|P5|Completed Year 1 Study Treatment|Year 1||0
518176|NCT00906399|1266624|P4|Completed Year 1 Study Treatment|Year 1||0
518177|NCT00906399|1266625|P3|Completed Year 1 Study Treatment|Year 1||438
518178|NCT00906399|1266626|P2|Completed Year 1 Study Treatment|Year 1||438
518179|NCT00906399|1266627|P1|Completed Year 1 Study Treatment|Year 1||456
518180|NCT00906399|1266621|P7|STARTED|Year 1||0
518181|NCT00906399|1266622|P6|STARTED|Year 1||0
518182|NCT00906399|1266623|P5|STARTED|Year 1||0
518183|NCT00906399|1266624|P4|STARTED|Year 1||0
518184|NCT00906399|1266625|P3|STARTED|Year 1||515
518185|NCT00906399|1266626|P2|STARTED|Year 1||501
518186|NCT00906399|1266627|P1|STARTED|Year 1||500
518187|NCT00906373|1266650|P2|NOT COMPLETED|Overall Study||8
518188|NCT00906373|1266651|P1|NOT COMPLETED|Overall Study||0
518189|NCT00906373|1266650|P2|COMPLETED|Overall Study||33
518190|NCT00906373|1266651|P1|COMPLETED|Overall Study||6
518191|NCT00906373|1266650|P2|Received Any Amount of Study Drug|Overall Study||41
518192|NCT00906373|1266651|P1|Received Any Amount of Study Drug|Overall Study||6
518193|NCT00906373|1266650|P2|STARTED|Overall Study||41
518194|NCT00906373|1266651|P1|STARTED|Overall Study||6
518195|NCT00906347|1266690|P2|NOT COMPLETED|Received Study Drug||31
518196|NCT00906347|1266691|P1|NOT COMPLETED|Received Study Drug||40
518197|NCT00906347|1266690|P2|COMPLETED|Received Study Drug||143
518198|NCT00906347|1266691|P1|COMPLETED|Received Study Drug||136
518199|NCT00906347|1266690|P2|STARTED|Received Study Drug||174
518200|NCT00906347|1266691|P1|STARTED|Received Study Drug||176
518201|NCT00906347|1266690|P2|NOT COMPLETED|Randomized||0
518202|NCT00906347|1266691|P1|NOT COMPLETED|Randomized||0
518203|NCT00906347|1266690|P2|COMPLETED|Randomized||174
518204|NCT00906347|1266691|P1|COMPLETED|Randomized||176
518205|NCT00906347|1266690|P2|STARTED|Randomized||174
518206|NCT00906347|1266691|P1|STARTED|Randomized||176
518207|NCT00906282|1266711|P1|NOT COMPLETED|Surgical Resection||0
518208|NCT00906282|1266711|P1|COMPLETED|Surgical Resection||27
518209|NCT00906282|1266711|P1|STARTED|Surgical Resection||27
518210|NCT00906282|1266711|P1|NOT COMPLETED|Preoperative Chemotherapy||19
518211|NCT00906282|1266711|P1|COMPLETED|Preoperative Chemotherapy|2 of 27 patients completed less than 4 cycles and were deemed surgical candidates.|27
518212|NCT00906282|1266711|P1|STARTED|Preoperative Chemotherapy||46
518213|NCT00906243|1266719|P1|NOT COMPLETED|Overall Study||0
518214|NCT00906243|1266719|P1|COMPLETED|Overall Study||6
518215|NCT00906243|1266719|P1|STARTED|Overall Study||6
518216|NCT00906204|1266725|P2|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||3
518217|NCT00906204|1266726|P1|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||2
518218|NCT00906204|1266725|P2|COMPLETED|Secondary Endpoints (Long-term Safety)||48
518219|NCT00906204|1266726|P1|COMPLETED|Secondary Endpoints (Long-term Safety)||41
518220|NCT00906204|1266725|P2|STARTED|Secondary Endpoints (Long-term Safety)||51
518221|NCT00906204|1266726|P1|STARTED|Secondary Endpoints (Long-term Safety)||43
518222|NCT00906204|1266725|P2|NOT COMPLETED|Primary Endpoint (Early Safety)||1
518223|NCT00906204|1266726|P1|NOT COMPLETED|Primary Endpoint (Early Safety)||2
518224|NCT00906204|1266725|P2|COMPLETED|Primary Endpoint (Early Safety)||51
518225|NCT00906204|1266726|P1|COMPLETED|Primary Endpoint (Early Safety)||43
518226|NCT00906204|1266725|P2|STARTED|Primary Endpoint (Early Safety)||52
518227|NCT00906204|1266726|P1|STARTED|Primary Endpoint (Early Safety)||45
518228|NCT00906178|1266744|P2|NOT COMPLETED|Overall Study||16
518229|NCT00906178|1266745|P1|NOT COMPLETED|Overall Study||15
518230|NCT00906178|1266744|P2|COMPLETED|Overall Study||167
518231|NCT00906178|1266745|P1|COMPLETED|Overall Study||168
518232|NCT00906178|1266744|P2|STARTED|Overall Study||183
518233|NCT00906178|1266745|P1|STARTED|Overall Study||183
518234|NCT00906087|1266757|P1|NOT COMPLETED|Final Washout Period 4 Weeks||0
518235|NCT00906087|1266757|P1|COMPLETED|Final Washout Period 4 Weeks||12
518236|NCT00906087|1266757|P1|STARTED|Final Washout Period 4 Weeks||12
518237|NCT00906087|1266757|P1|NOT COMPLETED|Cosopt Treatment 6 Weeks||0
518238|NCT00906087|1266757|P1|COMPLETED|Cosopt Treatment 6 Weeks||12
518239|NCT00906087|1266757|P1|STARTED|Cosopt Treatment 6 Weeks||12
518240|NCT00906087|1266757|P1|NOT COMPLETED|Initial Washout||2
518241|NCT00906087|1266757|P1|COMPLETED|Initial Washout||12
518242|NCT00906087|1266757|P1|Completed Washout and Continue Protocol|Initial Washout||12
518243|NCT00906087|1266757|P1|Begin Washout|Initial Washout||13
518244|NCT00906087|1266757|P1|Completed Screening|Initial Washout||14
518245|NCT00906087|1266757|P1|STARTED|Initial Washout||14
518246|NCT00906074|1266766|P2|NOT COMPLETED|Overall Study||0
518247|NCT00906074|1266767|P1|NOT COMPLETED|Overall Study||0
518248|NCT00906074|1266766|P2|COMPLETED|Overall Study||90
518249|NCT00906074|1266767|P1|COMPLETED|Overall Study||90
518250|NCT00906074|1266766|P2|STARTED|Overall Study||90
518251|NCT00906074|1266767|P1|STARTED|Overall Study||90
518252|NCT00906035|1266794|P3|NOT COMPLETED|Overall Study||0
518253|NCT00906035|1266795|P2|NOT COMPLETED|Overall Study||3
518254|NCT00906035|1266796|P1|NOT COMPLETED|Overall Study||2
518255|NCT00906035|1266794|P3|COMPLETED|Overall Study||8
518256|NCT00906035|1266795|P2|COMPLETED|Overall Study|2 subjects Withdrew after Visit 1 and 1 subject Withdrew shortly after Visit 1due to an AE|6
518257|NCT00906035|1266796|P1|COMPLETED|Overall Study|One Drop-Out; SAE day before Visit 1 and One subject Withrew prior to visit 1|6
518258|NCT00906035|1266794|P3|STARTED|Overall Study||8
518259|NCT00906035|1266795|P2|STARTED|Overall Study||9
518260|NCT00906035|1266796|P1|STARTED|Overall Study||8
518261|NCT00905840|1266810|P1|NOT COMPLETED|Overall Study||16
518262|NCT00905840|1266810|P1|COMPLETED|Overall Study||75
518263|NCT00905840|1266810|P1|STARTED|Overall Study||91
518264|NCT00905827|1266822|P3|NOT COMPLETED|Overall Study||0
518265|NCT00905827|1266823|P2|NOT COMPLETED|Overall Study||0
518266|NCT00905827|1266824|P1|NOT COMPLETED|Overall Study||0
518267|NCT00905827|1266822|P3|COMPLETED|Overall Study||73
518268|NCT00905827|1266823|P2|COMPLETED|Overall Study||69
518269|NCT00905827|1266824|P1|COMPLETED|Overall Study||70
518270|NCT00905827|1266822|P3|STARTED|Overall Study||73
518271|NCT00905827|1266823|P2|STARTED|Overall Study||69
518272|NCT00905827|1266824|P1|STARTED|Overall Study||70
518273|NCT00905632|1266841|P7|NOT COMPLETED|Overall Study||4
518274|NCT00905632|1266842|P6|NOT COMPLETED|Overall Study||1
518275|NCT00905632|1266843|P5|NOT COMPLETED|Overall Study||0
518276|NCT00905632|1266844|P4|NOT COMPLETED|Overall Study||0
518277|NCT00905632|1266845|P3|NOT COMPLETED|Overall Study||0
518278|NCT00905632|1266846|P2|NOT COMPLETED|Overall Study||0
518279|NCT00905632|1266847|P1|NOT COMPLETED|Overall Study||0
518280|NCT00905632|1266841|P7|COMPLETED|Overall Study||7
518281|NCT00905632|1266842|P6|COMPLETED|Overall Study||8
518282|NCT00905632|1266843|P5|COMPLETED|Overall Study||10
518283|NCT00905632|1266844|P4|COMPLETED|Overall Study||6
518284|NCT00905632|1266845|P3|COMPLETED|Overall Study||7
518285|NCT00905632|1266846|P2|COMPLETED|Overall Study||6
518286|NCT00905632|1266847|P1|COMPLETED|Overall Study||8
518287|NCT00905632|1266841|P7|STARTED|Overall Study||11
518288|NCT00905632|1266842|P6|STARTED|Overall Study||9
518289|NCT00905632|1266843|P5|STARTED|Overall Study||10
518290|NCT00905632|1266844|P4|STARTED|Overall Study||6
518291|NCT00905632|1266845|P3|STARTED|Overall Study||7
518292|NCT00905632|1266846|P2|STARTED|Overall Study||6
518293|NCT00905632|1266847|P1|STARTED|Overall Study||8
518294|NCT00905606|1266985|P2|NOT COMPLETED|Period 2||0
518295|NCT00905606|1266986|P1|NOT COMPLETED|Period 2||0
518296|NCT00905606|1266985|P2|COMPLETED|Period 2||14
518297|NCT00905606|1266986|P1|COMPLETED|Period 2||14
518298|NCT00905606|1266985|P2|STARTED|Period 2||14
518299|NCT00905606|1266986|P1|STARTED|Period 2||14
518300|NCT00905606|1266985|P2|NOT COMPLETED|Washout||0
518301|NCT00905606|1266986|P1|NOT COMPLETED|Washout||1
518302|NCT00905606|1266985|P2|COMPLETED|Washout||14
518303|NCT00905606|1266986|P1|COMPLETED|Washout||14
518304|NCT00905606|1266985|P2|STARTED|Washout||14
518305|NCT00905606|1266986|P1|STARTED|Washout||15
518306|NCT00905606|1266985|P2|NOT COMPLETED|Period 1||1
518307|NCT00905606|1266986|P1|NOT COMPLETED|Period 1||0
518308|NCT00905606|1266985|P2|COMPLETED|Period 1||14
518309|NCT00905606|1266986|P1|COMPLETED|Period 1||15
518310|NCT00905606|1266985|P2|STARTED|Period 1||15
518311|NCT00905606|1266986|P1|STARTED|Period 1||15
518312|NCT00905580|1266996|P2|NOT COMPLETED|Overall Study||3
518313|NCT00905580|1266997|P1|NOT COMPLETED|Overall Study||2
518314|NCT00905580|1266996|P2|COMPLETED|Overall Study||47
518315|NCT00905580|1266997|P1|COMPLETED|Overall Study||47
518316|NCT00905580|1266996|P2|STARTED|Overall Study||50
518317|NCT00905580|1266997|P1|STARTED|Overall Study||49
518318|NCT00905567|1267011|P2|NOT COMPLETED|Period 2||0
518319|NCT00905567|1267012|P1|NOT COMPLETED|Period 2||0
518320|NCT00905567|1267011|P2|COMPLETED|Period 2||11
518321|NCT00905567|1267012|P1|COMPLETED|Period 2||12
518322|NCT00905567|1267011|P2|STARTED|Period 2||11
518323|NCT00905567|1267012|P1|STARTED|Period 2||12
518324|NCT00905567|1267011|P2|NOT COMPLETED|Washout||1
518325|NCT00905567|1267012|P1|NOT COMPLETED|Washout||0
518326|NCT00905567|1267011|P2|COMPLETED|Washout||11
518327|NCT00905567|1267012|P1|COMPLETED|Washout||12
518328|NCT00905567|1267011|P2|STARTED|Washout||12
518329|NCT00905567|1267012|P1|STARTED|Washout||12
518330|NCT00905567|1267011|P2|NOT COMPLETED|Period 1||0
518331|NCT00905567|1267012|P1|NOT COMPLETED|Period 1||0
518332|NCT00905567|1267011|P2|COMPLETED|Period 1||12
518333|NCT00905567|1267012|P1|COMPLETED|Period 1||12
518334|NCT00905567|1267011|P2|STARTED|Period 1||12
518335|NCT00905567|1267012|P1|STARTED|Period 1||12
518336|NCT00905554|1267022|P2|NOT COMPLETED|Overall Study||0
518337|NCT00905554|1267023|P1|NOT COMPLETED|Overall Study||0
518338|NCT00905554|1267022|P2|COMPLETED|Overall Study||114
518339|NCT00905554|1267023|P1|COMPLETED|Overall Study||116
518340|NCT00905554|1267022|P2|STARTED|Overall Study||114
518341|NCT00905554|1267023|P1|STARTED|Overall Study||116
518342|NCT00905515|1267034|P3|NOT COMPLETED|Overall Study||2
518343|NCT00905515|1267035|P2|NOT COMPLETED|Overall Study||0
518344|NCT00905515|1267036|P1|NOT COMPLETED|Overall Study||2
518345|NCT00905515|1267034|P3|COMPLETED|Overall Study||20
518346|NCT00905515|1267035|P2|COMPLETED|Overall Study||20
518347|NCT00905515|1267036|P1|COMPLETED|Overall Study||19
518348|NCT00905515|1267034|P3|STARTED|Overall Study||22
518349|NCT00905515|1267035|P2|STARTED|Overall Study||20
518350|NCT00905515|1267036|P1|STARTED|Overall Study||21
518351|NCT00905489|1267044|P1|NOT COMPLETED|Optional Extension Phase (OEP)||1
518352|NCT00905489|1267044|P1|COMPLETED|Optional Extension Phase (OEP)||39
518353|NCT00905489|1267044|P1|STARTED|Optional Extension Phase (OEP)|Includes only subjects who chose to continue trt with nevirapine XR after completing the PK phase.|40
518354|NCT00905489|1267044|P1|NOT COMPLETED|Pharmaco-kinetic (PK) Phase||5
518355|NCT00905489|1267044|P1|COMPLETED|Pharmaco-kinetic (PK) Phase||80
518356|NCT00905489|1267044|P1|STARTED|Pharmaco-kinetic (PK) Phase||85
518357|NCT00905437|1267093|P2|NOT COMPLETED|Overall Study||10
518358|NCT00905437|1267094|P1|NOT COMPLETED|Overall Study||8
518359|NCT00905437|1267093|P2|COMPLETED|Overall Study||27
518360|NCT00905437|1267094|P1|COMPLETED|Overall Study||27
518361|NCT00905437|1267093|P2|STARTED|Overall Study||37
518362|NCT00905437|1267094|P1|STARTED|Overall Study||35
518363|NCT00905424|1267114|P2|NOT COMPLETED|Overall Study||9
518364|NCT00905424|1267115|P1|NOT COMPLETED|Overall Study||11
518365|NCT00905424|1267114|P2|COMPLETED|Overall Study||79
518366|NCT00905424|1267115|P1|COMPLETED|Overall Study||78
518367|NCT00905424|1267114|P2|STARTED|Overall Study||88
518368|NCT00905424|1267115|P1|STARTED|Overall Study||89
518369|NCT00905359|1267157|P2|NOT COMPLETED|Overall Study||16
518370|NCT00905359|1267158|P1|NOT COMPLETED|Overall Study||24
518371|NCT00905359|1267157|P2|COMPLETED|Overall Study||65
518372|NCT00905359|1267158|P1|COMPLETED|Overall Study||58
518373|NCT00905359|1267157|P2|24 Months Follow up|Overall Study||65
518374|NCT00905359|1267158|P1|24 Months Follow up|Overall Study||58
518375|NCT00905359|1267157|P2|12 Months Follow up|Overall Study||72
518376|NCT00905359|1267158|P1|12 Months Follow up|Overall Study||68
518377|NCT00905359|1267157|P2|STARTED|Overall Study||81
518378|NCT00905359|1267158|P1|STARTED|Overall Study||82
518379|NCT00905346|1267194|P2|NOT COMPLETED|Period 2||0
518380|NCT00905346|1267195|P1|NOT COMPLETED|Period 2||0
518381|NCT00905346|1267194|P2|COMPLETED|Period 2||11
518382|NCT00905346|1267195|P1|COMPLETED|Period 2||10
518383|NCT00905346|1267194|P2|STARTED|Period 2|one subject withdrew prior to Pd. 2 dosing|11
518384|NCT00905346|1267195|P1|STARTED|Period 2|one subject withdrew prior to Pd. 2 dosing|10
518385|NCT00905346|1267194|P2|NOT COMPLETED|Period 1||0
518386|NCT00905346|1267195|P1|NOT COMPLETED|Period 1||1
518387|NCT00905346|1267194|P2|COMPLETED|Period 1||12
518388|NCT00905346|1267195|P1|COMPLETED|Period 1||11
518389|NCT00905346|1267194|P2|STARTED|Period 1||12
518390|NCT00905346|1267195|P1|STARTED|Period 1||12
518391|NCT00905307|1267209|P6|NOT COMPLETED|Overall Study||42
518392|NCT00905307|1267210|P5|NOT COMPLETED|Overall Study||16
518393|NCT00905307|1267211|P4|NOT COMPLETED|Overall Study||37
518394|NCT00905307|1267212|P3|NOT COMPLETED|Overall Study||37
518395|NCT00905307|1267213|P2|NOT COMPLETED|Overall Study||37
518396|NCT00905307|1267214|P1|NOT COMPLETED|Overall Study||22
518397|NCT00905307|1267209|P6|COMPLETED|Overall Study||53
518398|NCT00905307|1267210|P5|COMPLETED|Overall Study||34
518399|NCT00905307|1267211|P4|COMPLETED|Overall Study||56
518400|NCT00905307|1267212|P3|COMPLETED|Overall Study||53
518401|NCT00905307|1267213|P2|COMPLETED|Overall Study||52
518402|NCT00905307|1267214|P1|COMPLETED|Overall Study||20
518403|NCT00905307|1267209|P6|STARTED|Overall Study||95
518404|NCT00905307|1267210|P5|STARTED|Overall Study||50
518405|NCT00905307|1267211|P4|STARTED|Overall Study||93
518406|NCT00905307|1267212|P3|STARTED|Overall Study||90
518407|NCT00905307|1267213|P2|STARTED|Overall Study||89
518408|NCT00905307|1267214|P1|STARTED|Overall Study||42
518409|NCT00905268|1267274|P4|NOT COMPLETED|Overall Study||2
518410|NCT00905268|1267275|P3|NOT COMPLETED|Overall Study||0
518411|NCT00905268|1267276|P2|NOT COMPLETED|Overall Study||1
518412|NCT00905268|1267277|P1|NOT COMPLETED|Overall Study||4
518413|NCT00905268|1267274|P4|COMPLETED|Overall Study||57
518414|NCT00905268|1267275|P3|COMPLETED|Overall Study||59
518415|NCT00905268|1267276|P2|COMPLETED|Overall Study||56
518416|NCT00905268|1267277|P1|COMPLETED|Overall Study||53
518417|NCT00905268|1267274|P4|STARTED|Overall Study||59
518418|NCT00905268|1267275|P3|STARTED|Overall Study||59
518419|NCT00905268|1267276|P2|STARTED|Overall Study||57
518420|NCT00905268|1267277|P1|STARTED|Overall Study||57
518421|NCT00905255|1267309|P2|NOT COMPLETED|Overall Study||9
518422|NCT00905255|1267310|P1|NOT COMPLETED|Overall Study||13
518423|NCT00905255|1267309|P2|COMPLETED|Overall Study||27
518424|NCT00905255|1267310|P1|COMPLETED|Overall Study||20
518425|NCT00905255|1267309|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||36
518426|NCT00905255|1267310|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|33
518427|NCT00905255|1267309|P2|Safety Population|Overall Study||36
518428|NCT00905255|1267310|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|33
518429|NCT00905255|1267309|P2|STARTED|Overall Study||36
518430|NCT00905255|1267310|P1|STARTED|Overall Study|Randomized.|33
518431|NCT00905164|1267328|P2|NOT COMPLETED|Period 2||0
518432|NCT00905164|1267329|P1|NOT COMPLETED|Period 2||0
518433|NCT00905164|1267328|P2|COMPLETED|Period 2||11
518434|NCT00905164|1267329|P1|COMPLETED|Period 2||12
518435|NCT00905164|1267328|P2|STARTED|Period 2||11
518436|NCT00905164|1267329|P1|STARTED|Period 2||12
518437|NCT00905164|1267328|P2|NOT COMPLETED|Period 1||1
518438|NCT00905164|1267329|P1|NOT COMPLETED|Period 1||0
518439|NCT00905164|1267328|P2|COMPLETED|Period 1||11
518440|NCT00905164|1267329|P1|COMPLETED|Period 1||12
518441|NCT00905164|1267328|P2|STARTED|Period 1||12
518442|NCT00905164|1267329|P1|STARTED|Period 1||12
518443|NCT00905151|1267337|P1|NOT COMPLETED|Overall Study||6
518444|NCT00905151|1267337|P1|COMPLETED|Overall Study||200
518445|NCT00905151|1267337|P1|STARTED|Overall Study||206
518446|NCT00905125|1267343|P2|NOT COMPLETED|Overall Study||3
518447|NCT00905125|1267344|P1|NOT COMPLETED|Overall Study||4
518448|NCT00905125|1267343|P2|COMPLETED|Overall Study||53
518449|NCT00905125|1267344|P1|COMPLETED|Overall Study||42
518450|NCT00905125|1267343|P2|STARTED|Overall Study||56
518451|NCT00905125|1267344|P1|STARTED|Overall Study||46
518452|NCT00905034|1267376|P1|NOT COMPLETED|Overall Study||1
518453|NCT00905034|1267376|P1|COMPLETED|Overall Study||36
518454|NCT00905034|1267376|P1|STARTED|Overall Study||37
518455|NCT00905021|1267380|P1|NOT COMPLETED|Overall Study||2
518456|NCT00905021|1267380|P1|COMPLETED|Overall Study|2 patients were off study due to AE.|2
518457|NCT00905021|1267380|P1|STARTED|Overall Study||4
518458|NCT00904995|1267387|P2|NOT COMPLETED|Overall Study||0
518459|NCT00904995|1267388|P1|NOT COMPLETED|Overall Study||0
518460|NCT00904995|1267387|P2|COMPLETED|Overall Study||11
518461|NCT00904995|1267388|P1|COMPLETED|Overall Study||10
518462|NCT00904995|1267387|P2|STARTED|Overall Study||11
518463|NCT00904995|1267388|P1|STARTED|Overall Study||10
518464|NCT00904982|1267398|P4|NOT COMPLETED|Overall Study||0
518465|NCT00904982|1267399|P3|NOT COMPLETED|Overall Study||0
518466|NCT00904982|1267400|P2|NOT COMPLETED|Overall Study||0
518467|NCT00904982|1267401|P1|NOT COMPLETED|Overall Study||2
518468|NCT00904982|1267398|P4|COMPLETED|Overall Study||68
518469|NCT00904982|1267399|P3|COMPLETED|Overall Study||67
518470|NCT00904982|1267400|P2|COMPLETED|Overall Study||67
518471|NCT00904982|1267401|P1|COMPLETED|Overall Study||66
518472|NCT00904982|1267398|P4|STARTED|Overall Study||68
518473|NCT00904982|1267399|P3|STARTED|Overall Study||67
518474|NCT00904982|1267400|P2|STARTED|Overall Study||67
518475|NCT00904982|1267401|P1|STARTED|Overall Study||68
518476|NCT00904969|1267411|P1|NOT COMPLETED|Overall Study||19
518477|NCT00904969|1267411|P1|COMPLETED|Overall Study|# of Implanted Subjects Who Completed the Study|31
518478|NCT00904969|1267411|P1|STARTED|Overall Study|Number of patients with an attempted implant; 1 subject with procedure aborted|50
518479|NCT00904943|1267463|P2|NOT COMPLETED|Period 2||0
518480|NCT00904943|1267464|P1|NOT COMPLETED|Period 2||0
518481|NCT00904943|1267463|P2|COMPLETED|Period 2||8
518482|NCT00904943|1267464|P1|COMPLETED|Period 2||9
518483|NCT00904943|1267463|P2|STARTED|Period 2|one subject was withdrawn prior to Pd. 2 dosing|8
518484|NCT00904943|1267464|P1|STARTED|Period 2||9
518485|NCT00904943|1267463|P2|NOT COMPLETED|Period 1||0
518486|NCT00904943|1267464|P1|NOT COMPLETED|Period 1||0
518487|NCT00904943|1267463|P2|COMPLETED|Period 1||9
518488|NCT00904943|1267464|P1|COMPLETED|Period 1||9
518489|NCT00904943|1267463|P2|STARTED|Period 1||9
518490|NCT00904943|1267464|P1|STARTED|Period 1||9
518491|NCT00904917|1267476|P4|NOT COMPLETED|Overall Study||2
518492|NCT00904917|1267477|P3|NOT COMPLETED|Overall Study||2
518493|NCT00904917|1267478|P2|NOT COMPLETED|Overall Study||2
518494|NCT00904917|1267479|P1|NOT COMPLETED|Overall Study||2
518495|NCT00904917|1267476|P4|COMPLETED|Overall Study||6
518496|NCT00904917|1267477|P3|COMPLETED|Overall Study||6
518497|NCT00904917|1267478|P2|COMPLETED|Overall Study||9
518498|NCT00904917|1267479|P1|COMPLETED|Overall Study||5
518499|NCT00904917|1267476|P4|STARTED|Overall Study||8
518500|NCT00904917|1267477|P3|STARTED|Overall Study||8
518501|NCT00904917|1267478|P2|STARTED|Overall Study||11
518502|NCT00904917|1267479|P1|STARTED|Overall Study||7
518503|NCT00904839|1267497|P3|NOT COMPLETED|Overall Study||15
518504|NCT00904839|1267498|P2|NOT COMPLETED|Overall Study||18
518505|NCT00904839|1267499|P1|NOT COMPLETED|Overall Study||1
518506|NCT00904839|1267497|P3|COMPLETED|Overall Study||27
518507|NCT00904839|1267498|P2|COMPLETED|Overall Study||64
518508|NCT00904839|1267499|P1|COMPLETED|Overall Study||3
518509|NCT00904839|1267497|P3|STARTED|Overall Study|Randomised|42
518510|NCT00904839|1267498|P2|STARTED|Overall Study|11 patients were randomised to Maximum Tolerable Dose analysis set.|82
518511|NCT00904839|1267499|P1|STARTED|Overall Study|All 4 patients were randomised to Maximum Tolerable Dose analysis set.|4
518512|NCT00904826|1267533|P1|NOT COMPLETED|Overall Study||0
518513|NCT00904826|1267533|P1|COMPLETED|Overall Study||14
518514|NCT00904826|1267533|P1|STARTED|Overall Study||14
518515|NCT00904748|1267545|P6|NOT COMPLETED|Overall Study||0
518516|NCT00904748|1267546|P5|NOT COMPLETED|Overall Study||1
518517|NCT00904748|1267547|P4|NOT COMPLETED|Overall Study||2
518518|NCT00904748|1267548|P3|NOT COMPLETED|Overall Study||1
518519|NCT00904748|1267549|P2|NOT COMPLETED|Overall Study||1
518520|NCT00904748|1267550|P1|NOT COMPLETED|Overall Study||1
518521|NCT00904748|1267545|P6|COMPLETED|Overall Study||8
518522|NCT00904748|1267546|P5|COMPLETED|Overall Study||7
518523|NCT00904748|1267547|P4|COMPLETED|Overall Study||6
518524|NCT00904748|1267548|P3|COMPLETED|Overall Study||7
518525|NCT00904748|1267549|P2|COMPLETED|Overall Study||7
518526|NCT00904748|1267550|P1|COMPLETED|Overall Study||7
518527|NCT00904748|1267545|P6|Received Treatment|Overall Study||8
518528|NCT00904748|1267546|P5|Received Treatment|Overall Study||7
518529|NCT00904748|1267547|P4|Received Treatment|Overall Study||8
518530|NCT00904748|1267548|P3|Received Treatment|Overall Study||8
518531|NCT00904748|1267549|P2|Received Treatment|Overall Study||8
518532|NCT00904748|1267550|P1|Received Treatment|Overall Study||8
518533|NCT00904748|1267545|P6|STARTED|Overall Study||8
518534|NCT00904748|1267546|P5|STARTED|Overall Study|1 participant randomized to this sequence discontinued prior to receipt of study medication.|8
518535|NCT00904748|1267547|P4|STARTED|Overall Study||8
518536|NCT00904748|1267548|P3|STARTED|Overall Study||8
518537|NCT00904748|1267549|P2|STARTED|Overall Study||8
518538|NCT00904748|1267550|P1|STARTED|Overall Study||8
518539|NCT00904722|1267574|P1|NOT COMPLETED|Overall Study||1
518540|NCT00904722|1267574|P1|COMPLETED|Overall Study||29
518541|NCT00904722|1267574|P1|STARTED|Overall Study||30
518542|NCT00904670|1267579|P2|NOT COMPLETED|Second Intervention Period||0
518543|NCT00904670|1267580|P1|NOT COMPLETED|Second Intervention Period||0
518544|NCT00904670|1267579|P2|COMPLETED|Second Intervention Period||22
518545|NCT00904670|1267580|P1|COMPLETED|Second Intervention Period||17
518546|NCT00904670|1267579|P2|STARTED|Second Intervention Period||22
518547|NCT00904670|1267580|P1|STARTED|Second Intervention Period||17
518548|NCT00904670|1267579|P2|NOT COMPLETED|First Intervention Period||0
518549|NCT00904670|1267580|P1|NOT COMPLETED|First Intervention Period||0
518550|NCT00904670|1267579|P2|COMPLETED|First Intervention Period||22
518551|NCT00904670|1267580|P1|COMPLETED|First Intervention Period||17
518552|NCT00904670|1267579|P2|STARTED|First Intervention Period||22
518553|NCT00904670|1267580|P1|STARTED|First Intervention Period||17
518554|NCT00904670|1267579|P2|NOT COMPLETED|Open Label Phase||0
518555|NCT00904670|1267580|P1|NOT COMPLETED|Open Label Phase||6
518556|NCT00904670|1267579|P2|COMPLETED|Open Label Phase||22
518557|NCT00904670|1267580|P1|COMPLETED|Open Label Phase||17
518558|NCT00904670|1267579|P2|STARTED|Open Label Phase||22
518559|NCT00904670|1267580|P1|STARTED|Open Label Phase||23
518560|NCT00904618|1267601|P1|NOT COMPLETED|Overall Study||0
518561|NCT00904618|1267601|P1|COMPLETED|Overall Study||48
518562|NCT00904618|1267601|P1|STARTED|Overall Study||48
518563|NCT00904488|1267611|P2|NOT COMPLETED|Overall Study||0
518564|NCT00904488|1267612|P1|NOT COMPLETED|Overall Study||0
518565|NCT00904488|1267611|P2|COMPLETED|Overall Study||6
518566|NCT00904488|1267612|P1|COMPLETED|Overall Study||5
518567|NCT00904488|1267611|P2|STARTED|Overall Study||6
518568|NCT00904488|1267612|P1|STARTED|Overall Study||5
518569|NCT00904423|1267642|P1|NOT COMPLETED|Overall Study||0
518570|NCT00904423|1267642|P1|COMPLETED|Overall Study||8
518571|NCT00904423|1267642|P1|STARTED|Overall Study||8
518572|NCT00904371|1267650|P1|NOT COMPLETED|Overall Study||9
518573|NCT00904371|1267650|P1|COMPLETED|Overall Study||202
518574|NCT00904371|1267650|P1|STARTED|Overall Study||211
518575|NCT00904215|1267664|P1|NOT COMPLETED|Overall Study||135
518576|NCT00904215|1267664|P1|COMPLETED|Overall Study||960
518577|NCT00904215|1267664|P1|STARTED|Overall Study||1095
518578|NCT00904189|1267671|P1|NOT COMPLETED|Overall Study||0
518579|NCT00904189|1267671|P1|COMPLETED|Overall Study||2
518580|NCT00904189|1267671|P1|STARTED|Overall Study||2
518581|NCT00904150|1267678|P2|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0
518582|NCT00904150|1267679|P1|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0
518583|NCT00904150|1267678|P2|COMPLETED|Blood Samples (RNA): Luteal Phase||30
518584|NCT00904150|1267679|P1|COMPLETED|Blood Samples (RNA): Luteal Phase||34
518585|NCT00904150|1267678|P2|STARTED|Blood Samples (RNA): Luteal Phase||30
518586|NCT00904150|1267679|P1|STARTED|Blood Samples (RNA): Luteal Phase||34
518587|NCT00904150|1267678|P2|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0
518588|NCT00904150|1267679|P1|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0
518589|NCT00904150|1267678|P2|COMPLETED|Blood Samples (RNA): Follicular Phase||32
518590|NCT00904150|1267679|P1|COMPLETED|Blood Samples (RNA): Follicular Phase||37
518591|NCT00904150|1267678|P2|STARTED|Blood Samples (RNA): Follicular Phase||32
518592|NCT00904150|1267679|P1|STARTED|Blood Samples (RNA): Follicular Phase||37
518593|NCT00904150|1267678|P2|NOT COMPLETED|Saliva Samples (DNA)||145
518594|NCT00904150|1267679|P1|NOT COMPLETED|Saliva Samples (DNA)||3
518595|NCT00904150|1267678|P2|COMPLETED|Saliva Samples (DNA)||155
518596|NCT00904150|1267679|P1|COMPLETED|Saliva Samples (DNA)||282
518597|NCT00904150|1267678|P2|STARTED|Saliva Samples (DNA)||300
518598|NCT00904150|1267679|P1|STARTED|Saliva Samples (DNA)||285
518599|NCT00904007|1267699|P2|NOT COMPLETED|Overall Study||0
518600|NCT00904007|1267700|P1|NOT COMPLETED|Overall Study||0
518601|NCT00904007|1267699|P2|COMPLETED|Overall Study||56
518602|NCT00904007|1267700|P1|COMPLETED|Overall Study||55
518603|NCT00904007|1267699|P2|STARTED|Overall Study||56
518604|NCT00904007|1267700|P1|STARTED|Overall Study||55
518605|NCT00903968|1267708|P8|NOT COMPLETED|Overall Study||33
518606|NCT00903968|1267709|P7|NOT COMPLETED|Overall Study||3
518607|NCT00903968|1267710|P6|NOT COMPLETED|Overall Study||6
518608|NCT00903968|1267711|P5|NOT COMPLETED|Overall Study||4
518609|NCT00903968|1267712|P4|NOT COMPLETED|Overall Study||3
518610|NCT00903968|1267713|P3|NOT COMPLETED|Overall Study||3
518611|NCT00903968|1267714|P2|NOT COMPLETED|Overall Study||3
518612|NCT00903968|1267715|P1|NOT COMPLETED|Overall Study||3
518613|NCT00903968|1267708|P8|COMPLETED|Overall Study||0
518614|NCT00903968|1267709|P7|COMPLETED|Overall Study||0
518615|NCT00903968|1267710|P6|COMPLETED|Overall Study||0
518616|NCT00903968|1267711|P5|COMPLETED|Overall Study||0
518617|NCT00903968|1267712|P4|COMPLETED|Overall Study||0
518618|NCT00903968|1267713|P3|COMPLETED|Overall Study||0
518619|NCT00903968|1267714|P2|COMPLETED|Overall Study||0
518620|NCT00903968|1267715|P1|COMPLETED|Overall Study||0
518621|NCT00903968|1267708|P8|STARTED|Overall Study||33
518622|NCT00903968|1267709|P7|STARTED|Overall Study||3
518623|NCT00903968|1267710|P6|STARTED|Overall Study||6
518624|NCT00903968|1267711|P5|STARTED|Overall Study||4
518625|NCT00903968|1267712|P4|STARTED|Overall Study||3
518626|NCT00903968|1267713|P3|STARTED|Overall Study||3
518627|NCT00903968|1267714|P2|STARTED|Overall Study||3
518628|NCT00903968|1267715|P1|STARTED|Overall Study||3
518629|NCT00903929|1267745|P4|NOT COMPLETED|Overall Study||3
518630|NCT00903929|1267746|P3|NOT COMPLETED|Overall Study||1
518631|NCT00903929|1267747|P2|NOT COMPLETED|Overall Study||0
518632|NCT00903929|1267748|P1|NOT COMPLETED|Overall Study||0
518633|NCT00903929|1267745|P4|COMPLETED|Overall Study||6
518634|NCT00903929|1267746|P3|COMPLETED|Overall Study||3
518635|NCT00903929|1267747|P2|COMPLETED|Overall Study||3
518636|NCT00903929|1267748|P1|COMPLETED|Overall Study||3
518637|NCT00903929|1267745|P4|STARTED|Overall Study|Participants who did not complete the study were replaced with additional participants.|9
518638|NCT00903929|1267746|P3|STARTED|Overall Study|Participants who did not complete the study were replaced with additional participants.|4
518639|NCT00903929|1267747|P2|STARTED|Overall Study||3
518640|NCT00903929|1267748|P1|STARTED|Overall Study||3
518641|NCT00903877|1267754|P1|NOT COMPLETED|Overall Study||43
518642|NCT00903877|1267754|P1|COMPLETED|Overall Study||8
518643|NCT00903877|1267754|P1|STARTED|Overall Study||51
518644|NCT00903695|1267760|P2|NOT COMPLETED|Overall Study||0
518645|NCT00903695|1267761|P1|NOT COMPLETED|Overall Study||2
518646|NCT00903695|1267760|P2|COMPLETED|Overall Study||2
518647|NCT00903695|1267761|P1|COMPLETED|Overall Study||6
518648|NCT00903695|1267760|P2|STARTED|Overall Study||2
518649|NCT00903695|1267761|P1|STARTED|Overall Study||8
518650|NCT00903682|1267783|P2|NOT COMPLETED|Overall Study||15
518651|NCT00903682|1267784|P1|NOT COMPLETED|Overall Study||16
518652|NCT00903682|1267783|P2|COMPLETED|Overall Study||63
518653|NCT00903682|1267784|P1|COMPLETED|Overall Study||63
518654|NCT00903682|1267783|P2|STARTED|Overall Study||78
518655|NCT00903682|1267784|P1|STARTED|Overall Study||79
518656|NCT00903630|1267805|P3|NOT COMPLETED|Phase 2||1
518657|NCT00903630|1267806|P2|NOT COMPLETED|Phase 2||0
518658|NCT00903630|1267807|P1|NOT COMPLETED|Phase 2||0
518659|NCT00903630|1267805|P3|COMPLETED|Phase 2|One participant was removed from the study after 2 weeks of treatment due to skin toxicity.|3
518660|NCT00903630|1267806|P2|COMPLETED|Phase 2||0
518661|NCT00903630|1267807|P1|COMPLETED|Phase 2||6
518662|NCT00903630|1267805|P3|STARTED|Phase 2||4
518663|NCT00903630|1267806|P2|STARTED|Phase 2||0
518664|NCT00903630|1267807|P1|STARTED|Phase 2||6
518665|NCT00903630|1267805|P3|NOT COMPLETED|Phase l||0
518666|NCT00903630|1267806|P2|NOT COMPLETED|Phase l||0
518667|NCT00903630|1267807|P1|NOT COMPLETED|Phase l||0
518668|NCT00903630|1267805|P3|COMPLETED|Phase l||0
518669|NCT00903630|1267806|P2|COMPLETED|Phase l||5
518670|NCT00903630|1267807|P1|COMPLETED|Phase l||6
518671|NCT00903630|1267805|P3|STARTED|Phase l||0
518672|NCT00903630|1267806|P2|STARTED|Phase l||5
518673|NCT00903630|1267807|P1|STARTED|Phase l||6
518674|NCT00903617|1267825|P4|NOT COMPLETED|Overall Study||1
518675|NCT00903617|1267826|P3|NOT COMPLETED|Overall Study||5
518676|NCT00903617|1267827|P2|NOT COMPLETED|Overall Study||5
518677|NCT00903617|1267828|P1|NOT COMPLETED|Overall Study||3
518678|NCT00903617|1267825|P4|COMPLETED|Overall Study||20
518679|NCT00903617|1267826|P3|COMPLETED|Overall Study||15
518680|NCT00903617|1267827|P2|COMPLETED|Overall Study||15
518681|NCT00903617|1267828|P1|COMPLETED|Overall Study||16
518682|NCT00903617|1267825|P4|STARTED|Overall Study||21
518683|NCT00903617|1267826|P3|STARTED|Overall Study||20
518684|NCT00903617|1267827|P2|STARTED|Overall Study||20
518685|NCT00903617|1267828|P1|STARTED|Overall Study||19
518686|NCT00903448|1267922|P2|NOT COMPLETED|Period 3: 5 Days||0
518687|NCT00903448|1267923|P1|NOT COMPLETED|Period 3: 5 Days||0
518688|NCT00903448|1267922|P2|COMPLETED|Period 3: 5 Days||20
518689|NCT00903448|1267923|P1|COMPLETED|Period 3: 5 Days||20
518690|NCT00903448|1267922|P2|STARTED|Period 3: 5 Days||20
518691|NCT00903448|1267923|P1|STARTED|Period 3: 5 Days||20
518692|NCT00903448|1267922|P2|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0
518693|NCT00903448|1267923|P1|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0
518694|NCT00903448|1267922|P2|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20
518695|NCT00903448|1267923|P1|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20
518696|NCT00903448|1267922|P2|STARTED|Period 2: 5 Days Then 10 Day Washout||20
518697|NCT00903448|1267923|P1|STARTED|Period 2: 5 Days Then 10 Day Washout||20
518698|NCT00903448|1267922|P2|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0
518699|NCT00903448|1267923|P1|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0
518700|NCT00903448|1267922|P2|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20
518701|NCT00903448|1267923|P1|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20
518702|NCT00903448|1267922|P2|STARTED|Period 1: 5 Days Then 10 Day Washout||20
518703|NCT00903448|1267923|P1|STARTED|Period 1: 5 Days Then 10 Day Washout||20
518704|NCT00903409|1267931|P2|NOT COMPLETED|Overall Study||27
518705|NCT00903409|1267932|P1|NOT COMPLETED|Overall Study||26
518706|NCT00903409|1267931|P2|COMPLETED|Overall Study||73
518707|NCT00903409|1267932|P1|COMPLETED|Overall Study||62
518708|NCT00903409|1267931|P2|STARTED|Overall Study||100
518709|NCT00903409|1267932|P1|STARTED|Overall Study||88
518710|NCT00903396|1267950|P4|NOT COMPLETED|Overall Study||0
518711|NCT00903396|1267951|P3|NOT COMPLETED|Overall Study||0
518712|NCT00903396|1267952|P2|NOT COMPLETED|Overall Study||0
518713|NCT00903396|1267953|P1|NOT COMPLETED|Overall Study||0
518714|NCT00903396|1267950|P4|COMPLETED|Overall Study||1
518715|NCT00903396|1267951|P3|COMPLETED|Overall Study||3
518716|NCT00903396|1267952|P2|COMPLETED|Overall Study||1
518717|NCT00903396|1267953|P1|COMPLETED|Overall Study||2
518718|NCT00903396|1267950|P4|STARTED|Overall Study||1
518719|NCT00903396|1267951|P3|STARTED|Overall Study||3
518720|NCT00903396|1267952|P2|STARTED|Overall Study||1
518721|NCT00903396|1267953|P1|STARTED|Overall Study||2
518722|NCT00903383|1267983|P4|NOT COMPLETED|Overall Study||5
518723|NCT00903383|1267984|P3|NOT COMPLETED|Overall Study||3
518724|NCT00903383|1267985|P2|NOT COMPLETED|Overall Study||6
518725|NCT00903383|1267986|P1|NOT COMPLETED|Overall Study||7
518726|NCT00903383|1267983|P4|COMPLETED|Overall Study||44
518727|NCT00903383|1267984|P3|COMPLETED|Overall Study||47
518728|NCT00903383|1267985|P2|COMPLETED|Overall Study||48
518729|NCT00903383|1267986|P1|COMPLETED|Overall Study||48
518730|NCT00903383|1267983|P4|STARTED|Overall Study||49
518731|NCT00903383|1267984|P3|STARTED|Overall Study||50
518732|NCT00903383|1267985|P2|STARTED|Overall Study||54
518733|NCT00903383|1267986|P1|STARTED|Overall Study||55
518734|NCT00903370|1268018|P2|NOT COMPLETED|Overall Study||24
518735|NCT00903370|1268019|P1|NOT COMPLETED|Overall Study||28
518736|NCT00903370|1268018|P2|COMPLETED|Overall Study||109
518737|NCT00903370|1268019|P1|COMPLETED|Overall Study||99
518738|NCT00903370|1268018|P2|STARTED|Overall Study||133
518739|NCT00903370|1268019|P1|STARTED|Overall Study||127
518740|NCT00903357|1268027|P2|NOT COMPLETED|Second Intervention||0
518741|NCT00903357|1268028|P1|NOT COMPLETED|Second Intervention||1
518742|NCT00903357|1268027|P2|COMPLETED|Second Intervention||22
518743|NCT00903357|1268028|P1|COMPLETED|Second Intervention||21
518744|NCT00903357|1268027|P2|STARTED|Second Intervention||22
518745|NCT00903357|1268028|P1|STARTED|Second Intervention||22
518746|NCT00903357|1268027|P2|NOT COMPLETED|Wash Out Period of 2 Weeks||1
518747|NCT00903357|1268028|P1|NOT COMPLETED|Wash Out Period of 2 Weeks||0
518748|NCT00903357|1268027|P2|COMPLETED|Wash Out Period of 2 Weeks||22
518749|NCT00903357|1268028|P1|COMPLETED|Wash Out Period of 2 Weeks||22
518750|NCT00903357|1268027|P2|STARTED|Wash Out Period of 2 Weeks||23
518751|NCT00903357|1268028|P1|STARTED|Wash Out Period of 2 Weeks||22
518752|NCT00903357|1268027|P2|NOT COMPLETED|First Intervention||4
518753|NCT00903357|1268028|P1|NOT COMPLETED|First Intervention||5
518754|NCT00903357|1268027|P2|COMPLETED|First Intervention||23
518755|NCT00903357|1268028|P1|COMPLETED|First Intervention||22
518756|NCT00903357|1268027|P2|STARTED|First Intervention||27
518757|NCT00903357|1268028|P1|STARTED|First Intervention||27
518758|NCT00903344|1268040|P2|NOT COMPLETED|Overall Study||3
518759|NCT00903344|1268041|P1|NOT COMPLETED|Overall Study||5
518760|NCT00903344|1268040|P2|COMPLETED|Overall Study||7
518761|NCT00903344|1268041|P1|COMPLETED|Overall Study||7
518762|NCT00903344|1268040|P2|6 Month Visit|Overall Study||10
518763|NCT00903344|1268041|P1|6 Month Visit|Overall Study||9
518764|NCT00903344|1268040|P2|3 Month Visit|Overall Study||10
518765|NCT00903344|1268041|P1|3 Month Visit|Overall Study||10
518766|NCT00903344|1268040|P2|STARTED|Overall Study||10
518767|NCT00903344|1268041|P1|STARTED|Overall Study||12
518768|NCT00903331|1268059|P2|NOT COMPLETED|Overall Study||18
518769|NCT00903331|1268060|P1|NOT COMPLETED|Overall Study||5
518770|NCT00903331|1268059|P2|COMPLETED|Overall Study||101
518771|NCT00903331|1268060|P1|COMPLETED|Overall Study||54
518772|NCT00903331|1268059|P2|STARTED|Overall Study||119
518773|NCT00903331|1268060|P1|STARTED|Overall Study||59
518774|NCT00903201|1268071|P3|NOT COMPLETED|Overall Study||2
518775|NCT00903201|1268072|P2|NOT COMPLETED|Overall Study||6
518776|NCT00903201|1268073|P1|NOT COMPLETED|Overall Study||5
518777|NCT00903201|1268071|P3|COMPLETED|Overall Study||39
518778|NCT00903201|1268072|P2|COMPLETED|Overall Study||38
518779|NCT00903201|1268073|P1|COMPLETED|Overall Study||56
518780|NCT00903201|1268071|P3|STARTED|Overall Study||41
518781|NCT00903201|1268072|P2|STARTED|Overall Study||44
518782|NCT00903201|1268073|P1|STARTED|Overall Study||61
518783|NCT00903175|1268131|P2|NOT COMPLETED|Period 2 - Second Line||36
518784|NCT00903175|1268132|P1|NOT COMPLETED|Period 2 - Second Line||49
518785|NCT00903175|1268131|P2|COMPLETED|Period 2 - Second Line|Completed = Disease progression - (completed 2L)|80
518786|NCT00903175|1268132|P1|COMPLETED|Period 2 - Second Line|Completed = Disease progression - (completed 2L)|79
518787|NCT00903175|1268131|P2|STARTED|Period 2 - Second Line|130 from Sunitinib 1L planned to enter 2L period and cross over to everolimus but only 116 did.|116
518788|NCT00903175|1268132|P1|STARTED|Period 2 - Second Line|139 from everolimus 1L planned to enter 2L period and cross over to sunitinib but only 128 did.|128
518789|NCT00903175|1268131|P2|NOT COMPLETED|Period 1 - First Line||89
518790|NCT00903175|1268132|P1|NOT COMPLETED|Period 1 - First Line||77
518791|NCT00903175|1268131|P2|COMPLETED|Period 1 - First Line|Completed = Disease progression (completed 1L)|142
518792|NCT00903175|1268132|P1|COMPLETED|Period 1 - First Line|Completed = Disease progression (completed 1L)|161
518793|NCT00903175|1268131|P2|STARTED|Period 1 - First Line||231
518794|NCT00903175|1268132|P1|STARTED|Period 1 - First Line||238
518795|NCT00903162|1268162|P1|NOT COMPLETED|Overall Study||4
518796|NCT00903162|1268162|P1|COMPLETED|Overall Study||12
518797|NCT00903162|1268162|P1|STARTED|Overall Study||16
518798|NCT00903032|1268170|P2|NOT COMPLETED|Overall Study||5
518799|NCT00903032|1268171|P1|NOT COMPLETED|Overall Study||7
518800|NCT00903032|1268170|P2|COMPLETED|Overall Study||119
518801|NCT00903032|1268171|P1|COMPLETED|Overall Study||122
518802|NCT00903032|1268170|P2|STARTED|Overall Study||124
518803|NCT00903032|1268171|P1|STARTED|Overall Study||129
518804|NCT00903006|1268181|P4|NOT COMPLETED|Overall Study||0
518805|NCT00903006|1268182|P3|NOT COMPLETED|Overall Study||1
518806|NCT00903006|1268183|P2|NOT COMPLETED|Overall Study||3
518807|NCT00903006|1268184|P1|NOT COMPLETED|Overall Study||2
518808|NCT00903006|1268181|P4|COMPLETED|Overall Study||0
518809|NCT00903006|1268182|P3|COMPLETED|Overall Study||0
518810|NCT00903006|1268183|P2|COMPLETED|Overall Study||0
518811|NCT00903006|1268184|P1|COMPLETED|Overall Study||0
518812|NCT00903006|1268181|P4|STARTED|Overall Study|Zero participants started due to smaller sample size.|0
518813|NCT00903006|1268182|P3|STARTED|Overall Study||1
518814|NCT00903006|1268183|P2|STARTED|Overall Study||3
518815|NCT00903006|1268184|P1|STARTED|Overall Study||2
518816|NCT00902850|1268196|P2|NOT COMPLETED|Overall Study||2
518817|NCT00902850|1268197|P1|NOT COMPLETED|Overall Study||2
518818|NCT00902850|1268196|P2|COMPLETED|Overall Study||12
518819|NCT00902850|1268197|P1|COMPLETED|Overall Study||12
518820|NCT00902850|1268196|P2|STARTED|Overall Study||14
518821|NCT00902850|1268197|P1|STARTED|Overall Study||14
518822|NCT00902746|1268203|P1|NOT COMPLETED|Overall Study||36
518823|NCT00902746|1268203|P1|COMPLETED|Overall Study||113
518824|NCT00902746|1268203|P1|Transfer to Step 2|Overall Study||133
518825|NCT00902746|1268203|P1|Initiation of Study Drug Administration|Overall Study||148
518826|NCT00902746|1268203|P1|STARTED|Overall Study||149
518827|NCT00902668|1268208|P1|NOT COMPLETED|Overall Study||3
518828|NCT00902668|1268208|P1|COMPLETED|Overall Study||0
518829|NCT00902668|1268208|P1|STARTED|Overall Study||3
518830|NCT00902564|1268212|P1|NOT COMPLETED|Overall Study||2
518831|NCT00902564|1268212|P1|COMPLETED|Overall Study||28
518832|NCT00902564|1268212|P1|STARTED|Overall Study||30
518833|NCT00902538|1268227|P6|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||1
518834|NCT00902538|1268228|P5|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||2
518835|NCT00902538|1268229|P4|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||9
518836|NCT00902538|1268230|P3|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
518837|NCT00902538|1268231|P2|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
518838|NCT00902538|1268232|P1|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
518839|NCT00902538|1268227|P6|COMPLETED|4-Randomized Double-blind 2 Treatments||196
518840|NCT00902538|1268228|P5|COMPLETED|4-Randomized Double-blind 2 Treatments||95
518841|NCT00902538|1268229|P4|COMPLETED|4-Randomized Double-blind 2 Treatments||458
518842|NCT00902538|1268230|P3|COMPLETED|4-Randomized Double-blind 2 Treatments||0
518843|NCT00902538|1268231|P2|COMPLETED|4-Randomized Double-blind 2 Treatments||0
518844|NCT00902538|1268232|P1|COMPLETED|4-Randomized Double-blind 2 Treatments||0
518845|NCT00902538|1268227|P6|STARTED|4-Randomized Double-blind 2 Treatments||197
518846|NCT00902538|1268228|P5|STARTED|4-Randomized Double-blind 2 Treatments|Period 3 non-responders were randomized to OLM 40-AML 10-HCTZ 12.5 or 25 in a 2:1 ratio|97
518847|NCT00902538|1268229|P4|STARTED|4-Randomized Double-blind 2 Treatments|Period 3 responders were continued on OLM 40-AML 10-HCTZ 12.5|467
518848|NCT00902538|1268230|P3|STARTED|4-Randomized Double-blind 2 Treatments||0
518849|NCT00902538|1268231|P2|STARTED|4-Randomized Double-blind 2 Treatments||0
518850|NCT00902538|1268232|P1|STARTED|4-Randomized Double-blind 2 Treatments||0
518851|NCT00902538|1268227|P6|NOT COMPLETED|3-Single-blind, Single Treatment||0
518852|NCT00902538|1268228|P5|NOT COMPLETED|3-Single-blind, Single Treatment||0
518853|NCT00902538|1268229|P4|NOT COMPLETED|3-Single-blind, Single Treatment||0
518854|NCT00902538|1268230|P3|NOT COMPLETED|3-Single-blind, Single Treatment||0
518855|NCT00902538|1268231|P2|NOT COMPLETED|3-Single-blind, Single Treatment||15
518856|NCT00902538|1268232|P1|NOT COMPLETED|3-Single-blind, Single Treatment||0
518857|NCT00902538|1268227|P6|COMPLETED|3-Single-blind, Single Treatment||0
518858|NCT00902538|1268228|P5|COMPLETED|3-Single-blind, Single Treatment||0
518859|NCT00902538|1268229|P4|COMPLETED|3-Single-blind, Single Treatment||0
518860|NCT00902538|1268230|P3|COMPLETED|3-Single-blind, Single Treatment||0
518861|NCT00902538|1268231|P2|COMPLETED|3-Single-blind, Single Treatment||767
518862|NCT00902538|1268232|P1|COMPLETED|3-Single-blind, Single Treatment||0
518863|NCT00902538|1268227|P6|STARTED|3-Single-blind, Single Treatment||0
518864|NCT00902538|1268228|P5|STARTED|3-Single-blind, Single Treatment||0
518865|NCT00902538|1268229|P4|STARTED|3-Single-blind, Single Treatment||0
518866|NCT00902538|1268230|P3|STARTED|3-Single-blind, Single Treatment||0
518867|NCT00902538|1268231|P2|STARTED|3-Single-blind, Single Treatment|Number starting is < total completing previous arm since 3 subjects did not receive at least 1 dose.|782
518868|NCT00902538|1268232|P1|STARTED|3-Single-blind, Single Treatment||0
518869|NCT00902538|1268227|P6|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
518870|NCT00902538|1268228|P5|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
518871|NCT00902538|1268229|P4|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
518872|NCT00902538|1268230|P3|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||8
518873|NCT00902538|1268231|P2|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||6
518874|NCT00902538|1268232|P1|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||9
518875|NCT00902538|1268227|P6|COMPLETED|2-Randomized Double-blind 3 Treatments||0
518876|NCT00902538|1268228|P5|COMPLETED|2-Randomized Double-blind 3 Treatments||0
518877|NCT00902538|1268229|P4|COMPLETED|2-Randomized Double-blind 3 Treatments||0
518878|NCT00902538|1268230|P3|COMPLETED|2-Randomized Double-blind 3 Treatments||262
518879|NCT00902538|1268231|P2|COMPLETED|2-Randomized Double-blind 3 Treatments||263
518880|NCT00902538|1268232|P1|COMPLETED|2-Randomized Double-blind 3 Treatments||260
518881|NCT00902538|1268227|P6|STARTED|2-Randomized Double-blind 3 Treatments||0
518882|NCT00902538|1268228|P5|STARTED|2-Randomized Double-blind 3 Treatments||0
518883|NCT00902538|1268229|P4|STARTED|2-Randomized Double-blind 3 Treatments||0
518884|NCT00902538|1268230|P3|STARTED|2-Randomized Double-blind 3 Treatments||270
518885|NCT00902538|1268231|P2|STARTED|2-Randomized Double-blind 3 Treatments||269
518886|NCT00902538|1268232|P1|STARTED|2-Randomized Double-blind 3 Treatments|Only 808 began Period 2 because the others finishing Period 1 did not meet the entry criteria.|269
518887|NCT00902538|1268227|P6|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
518888|NCT00902538|1268228|P5|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
518889|NCT00902538|1268229|P4|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
518890|NCT00902538|1268230|P3|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
518891|NCT00902538|1268231|P2|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
518892|NCT00902538|1268232|P1|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||118
518893|NCT00902538|1268227|P6|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
518894|NCT00902538|1268228|P5|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
518895|NCT00902538|1268229|P4|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
518896|NCT00902538|1268230|P3|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
518897|NCT00902538|1268231|P2|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
518898|NCT00902538|1268232|P1|COMPLETED|1-Single-blind, Run-in, Single-Treatment||2086
518899|NCT00902538|1268227|P6|STARTED|1-Single-blind, Run-in, Single-Treatment||0
518900|NCT00902538|1268228|P5|STARTED|1-Single-blind, Run-in, Single-Treatment||0
518901|NCT00902538|1268229|P4|STARTED|1-Single-blind, Run-in, Single-Treatment||0
518902|NCT00902538|1268230|P3|STARTED|1-Single-blind, Run-in, Single-Treatment||0
518903|NCT00902538|1268231|P2|STARTED|1-Single-blind, Run-in, Single-Treatment||0
518904|NCT00902538|1268232|P1|STARTED|1-Single-blind, Run-in, Single-Treatment||2204
518905|NCT00902330|1268264|P2|NOT COMPLETED|Overall Study||5
518906|NCT00902330|1268265|P1|NOT COMPLETED|Overall Study||4
518907|NCT00902330|1268264|P2|COMPLETED|Overall Study||75
518908|NCT00902330|1268265|P1|COMPLETED|Overall Study||77
518909|NCT00902330|1268264|P2|STARTED|Overall Study||80
518910|NCT00902330|1268265|P1|STARTED|Overall Study||81
518911|NCT00902304|1268302|P3|NOT COMPLETED|Overall Study||110
518912|NCT00902304|1268303|P2|NOT COMPLETED|Overall Study||71
518913|NCT00902304|1268304|P1|NOT COMPLETED|Overall Study||58
518914|NCT00902304|1268302|P3|COMPLETED|Overall Study||568
518915|NCT00902304|1268303|P2|COMPLETED|Overall Study||289
518916|NCT00902304|1268304|P1|COMPLETED|Overall Study||466
518917|NCT00902304|1268302|P3|STARTED|Overall Study||678
518918|NCT00902304|1268303|P2|STARTED|Overall Study||360
518919|NCT00902304|1268304|P1|STARTED|Overall Study||524
518920|NCT00902278|1268354|P5|NOT COMPLETED|Overall Study||2
518921|NCT00902278|1268355|P4|NOT COMPLETED|Overall Study||0
518922|NCT00902278|1268356|P3|NOT COMPLETED|Overall Study||5
518923|NCT00902278|1268357|P2|NOT COMPLETED|Overall Study||2
518924|NCT00902278|1268358|P1|NOT COMPLETED|Overall Study||4
518925|NCT00902278|1268354|P5|COMPLETED|Overall Study||35
518926|NCT00902278|1268355|P4|COMPLETED|Overall Study||12
518927|NCT00902278|1268356|P3|COMPLETED|Overall Study||49
518928|NCT00902278|1268357|P2|COMPLETED|Overall Study||34
518929|NCT00902278|1268358|P1|COMPLETED|Overall Study||50
518930|NCT00902278|1268354|P5|STARTED|Overall Study||37
518931|NCT00902278|1268355|P4|STARTED|Overall Study||12
518932|NCT00902278|1268356|P3|STARTED|Overall Study||54
518933|NCT00902278|1268357|P2|STARTED|Overall Study||36
518934|NCT00902278|1268358|P1|STARTED|Overall Study||54
518935|NCT00902265|1268375|P1|NOT COMPLETED|Overall Study||6
518936|NCT00902265|1268375|P1|COMPLETED|Overall Study||132
518937|NCT00902265|1268375|P1|Participants Who Received Treatment|Overall Study||137
518938|NCT00902265|1268375|P1|STARTED|Overall Study||138
518939|NCT00902226|1268387|P1|NOT COMPLETED|Overall Study||0
518940|NCT00902226|1268387|P1|COMPLETED|Overall Study||30
518941|NCT00902226|1268387|P1|STARTED|Overall Study||30
518942|NCT00902174|1268399|P2|NOT COMPLETED|Overall Study||18
518943|NCT00902174|1268400|P1|NOT COMPLETED|Overall Study||34
518944|NCT00902174|1268399|P2|COMPLETED|Overall Study||81
518945|NCT00902174|1268400|P1|COMPLETED|Overall Study||69
518946|NCT00902174|1268399|P2|STARTED|Overall Study||99
518947|NCT00902174|1268400|P1|STARTED|Overall Study||103
518948|NCT00902161|1268438|P3|NOT COMPLETED|Period 2||0
518949|NCT00902161|1268439|P2|NOT COMPLETED|Period 2||0
518950|NCT00902161|1268440|P1|NOT COMPLETED|Period 2||0
518951|NCT00902161|1268438|P3|COMPLETED|Period 2||0
518952|NCT00902161|1268439|P2|COMPLETED|Period 2||9
518953|NCT00902161|1268440|P1|COMPLETED|Period 2|2 participants discontinued and were replaced; 1 due to protocol deviation and 1 withdrew consent|8
518954|NCT00902161|1268438|P3|STARTED|Period 2||0
518955|NCT00902161|1268439|P2|STARTED|Period 2||9
518956|NCT00902161|1268440|P1|STARTED|Period 2||8
518957|NCT00902161|1268438|P3|NOT COMPLETED|Post-clamp Washout||0
518958|NCT00902161|1268439|P2|NOT COMPLETED|Post-clamp Washout||0
518959|NCT00902161|1268440|P1|NOT COMPLETED|Post-clamp Washout||0
518960|NCT00902161|1268438|P3|COMPLETED|Post-clamp Washout|2 participants discontinued washout and were replaced; 1 due to an AE and 1 due to lack of efficacy|22
518961|NCT00902161|1268439|P2|COMPLETED|Post-clamp Washout||0
518962|NCT00902161|1268440|P1|COMPLETED|Post-clamp Washout||0
518963|NCT00902161|1268438|P3|STARTED|Post-clamp Washout||22
518964|NCT00902161|1268439|P2|STARTED|Post-clamp Washout||0
518965|NCT00902161|1268440|P1|STARTED|Post-clamp Washout||0
518966|NCT00902161|1268438|P3|NOT COMPLETED|Period 1||0
518967|NCT00902161|1268439|P2|NOT COMPLETED|Period 1||0
518968|NCT00902161|1268440|P1|NOT COMPLETED|Period 1||0
518969|NCT00902161|1268438|P3|COMPLETED|Period 1||0
518970|NCT00902161|1268439|P2|COMPLETED|Period 1||10
518971|NCT00902161|1268440|P1|COMPLETED|Period 1||12
518972|NCT00902161|1268438|P3|STARTED|Period 1||0
518973|NCT00902161|1268439|P2|STARTED|Period 1||10
518974|NCT00902161|1268440|P1|STARTED|Period 1||12
518975|NCT00902161|1268438|P3|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
518976|NCT00902161|1268439|P2|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
518977|NCT00902161|1268440|P1|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
518978|NCT00902161|1268438|P3|COMPLETED|Pre-study Washout/Propanolol Run-in||22
518979|NCT00902161|1268439|P2|COMPLETED|Pre-study Washout/Propanolol Run-in||0
518980|NCT00902161|1268440|P1|COMPLETED|Pre-study Washout/Propanolol Run-in||0
518981|NCT00902161|1268438|P3|STARTED|Pre-study Washout/Propanolol Run-in||22
518982|NCT00902161|1268439|P2|STARTED|Pre-study Washout/Propanolol Run-in||0
518983|NCT00902161|1268440|P1|STARTED|Pre-study Washout/Propanolol Run-in||0
518984|NCT00901901|1268457|P2|NOT COMPLETED|Follow-up Period||259
518985|NCT00901901|1268458|P1|NOT COMPLETED|Follow-up Period||246
518986|NCT00901901|1268457|P2|COMPLETED|Follow-up Period|These participants are ongoing.|65
518987|NCT00901901|1268458|P1|COMPLETED|Follow-up Period|These participants are ongoing.|76
518988|NCT00901901|1268457|P2|STARTED|Follow-up Period||324
518989|NCT00901901|1268458|P1|STARTED|Follow-up Period||322
518990|NCT00901901|1268457|P2|NOT COMPLETED|Treatment Period||168
518991|NCT00901901|1268458|P1|NOT COMPLETED|Treatment Period||157
518992|NCT00901901|1268457|P2|COMPLETED|Treatment Period|17 of these participants are ongoing|190
518993|NCT00901901|1268458|P1|COMPLETED|Treatment Period|19 of these participants are ongoing|205
518994|NCT00901901|1268457|P2|Participants Received Treatment|Treatment Period||355
518995|NCT00901901|1268458|P1|Participants Received Treatment|Treatment Period||362
518996|NCT00901901|1268457|P2|STARTED|Treatment Period||358
518997|NCT00901901|1268458|P1|STARTED|Treatment Period||362
518998|NCT00901628|1268480|P2|NOT COMPLETED|Overall Study||10
518999|NCT00901628|1268481|P1|NOT COMPLETED|Overall Study||4
519000|NCT00901628|1268480|P2|COMPLETED|Overall Study||42
519001|NCT00901628|1268481|P1|COMPLETED|Overall Study||45
519002|NCT00901628|1268480|P2|STARTED|Overall Study||52
519003|NCT00901628|1268481|P1|STARTED|Overall Study||49
519004|NCT00901576|1268503|P6|NOT COMPLETED|Third Intervention||0
519005|NCT00901576|1268504|P5|NOT COMPLETED|Third Intervention||0
519006|NCT00901576|1268505|P4|NOT COMPLETED|Third Intervention||0
519007|NCT00901576|1268506|P3|NOT COMPLETED|Third Intervention||0
519008|NCT00901576|1268507|P2|NOT COMPLETED|Third Intervention||0
519009|NCT00901576|1268508|P1|NOT COMPLETED|Third Intervention||0
519010|NCT00901576|1268503|P6|COMPLETED|Third Intervention||5
519011|NCT00901576|1268504|P5|COMPLETED|Third Intervention||6
519012|NCT00901576|1268505|P4|COMPLETED|Third Intervention||5
519013|NCT00901576|1268506|P3|COMPLETED|Third Intervention||7
519014|NCT00901576|1268507|P2|COMPLETED|Third Intervention||7
519015|NCT00901576|1268508|P1|COMPLETED|Third Intervention||5
519016|NCT00901576|1268503|P6|STARTED|Third Intervention||5
519017|NCT00901576|1268504|P5|STARTED|Third Intervention||6
519018|NCT00901576|1268505|P4|STARTED|Third Intervention||5
519019|NCT00901576|1268506|P3|STARTED|Third Intervention||7
519020|NCT00901576|1268507|P2|STARTED|Third Intervention||7
519021|NCT00901576|1268508|P1|STARTED|Third Intervention||5
519022|NCT00901576|1268503|P6|NOT COMPLETED|Washout||0
519023|NCT00901576|1268504|P5|NOT COMPLETED|Washout||0
519024|NCT00901576|1268505|P4|NOT COMPLETED|Washout||0
519025|NCT00901576|1268506|P3|NOT COMPLETED|Washout||0
519026|NCT00901576|1268507|P2|NOT COMPLETED|Washout||0
519027|NCT00901576|1268508|P1|NOT COMPLETED|Washout||0
519028|NCT00901576|1268503|P6|COMPLETED|Washout||5
519029|NCT00901576|1268504|P5|COMPLETED|Washout||6
519030|NCT00901576|1268505|P4|COMPLETED|Washout||5
519031|NCT00901576|1268506|P3|COMPLETED|Washout||7
519032|NCT00901576|1268507|P2|COMPLETED|Washout||7
519033|NCT00901576|1268508|P1|COMPLETED|Washout||5
519034|NCT00901576|1268503|P6|STARTED|Washout||5
519035|NCT00901576|1268504|P5|STARTED|Washout||6
519036|NCT00901576|1268505|P4|STARTED|Washout||5
519037|NCT00901576|1268506|P3|STARTED|Washout||7
519038|NCT00901576|1268507|P2|STARTED|Washout||7
519039|NCT00901576|1268508|P1|STARTED|Washout||5
519040|NCT00901576|1268503|P6|NOT COMPLETED|Second Intervention||1
519041|NCT00901576|1268504|P5|NOT COMPLETED|Second Intervention||0
519042|NCT00901576|1268505|P4|NOT COMPLETED|Second Intervention||1
519043|NCT00901576|1268506|P3|NOT COMPLETED|Second Intervention||0
519044|NCT00901576|1268507|P2|NOT COMPLETED|Second Intervention||0
519045|NCT00901576|1268508|P1|NOT COMPLETED|Second Intervention||1
519046|NCT00901576|1268503|P6|COMPLETED|Second Intervention||5
519047|NCT00901576|1268504|P5|COMPLETED|Second Intervention||6
519048|NCT00901576|1268505|P4|COMPLETED|Second Intervention||5
519049|NCT00901576|1268506|P3|COMPLETED|Second Intervention||7
519050|NCT00901576|1268507|P2|COMPLETED|Second Intervention||7
519051|NCT00901576|1268508|P1|COMPLETED|Second Intervention||5
519052|NCT00901576|1268503|P6|STARTED|Second Intervention||6
519053|NCT00901576|1268504|P5|STARTED|Second Intervention||6
519054|NCT00901576|1268505|P4|STARTED|Second Intervention||6
519055|NCT00901576|1268506|P3|STARTED|Second Intervention||7
519056|NCT00901576|1268507|P2|STARTED|Second Intervention||7
519057|NCT00901576|1268508|P1|STARTED|Second Intervention||6
519058|NCT00901576|1268503|P6|NOT COMPLETED|Washout||0
519059|NCT00901576|1268504|P5|NOT COMPLETED|Washout||0
519060|NCT00901576|1268505|P4|NOT COMPLETED|Washout||0
519061|NCT00901576|1268506|P3|NOT COMPLETED|Washout||0
519062|NCT00901576|1268507|P2|NOT COMPLETED|Washout||0
519063|NCT00901576|1268508|P1|NOT COMPLETED|Washout||0
519064|NCT00901576|1268503|P6|COMPLETED|Washout||6
519065|NCT00901576|1268504|P5|COMPLETED|Washout||6
519066|NCT00901576|1268505|P4|COMPLETED|Washout||6
519067|NCT00901576|1268506|P3|COMPLETED|Washout||7
519068|NCT00901576|1268507|P2|COMPLETED|Washout||7
519069|NCT00901576|1268508|P1|COMPLETED|Washout||6
519070|NCT00901576|1268503|P6|STARTED|Washout||6
519071|NCT00901576|1268504|P5|STARTED|Washout||6
519072|NCT00901576|1268505|P4|STARTED|Washout||6
519073|NCT00901576|1268506|P3|STARTED|Washout||7
519074|NCT00901576|1268507|P2|STARTED|Washout||7
519075|NCT00901576|1268508|P1|STARTED|Washout||6
519076|NCT00901576|1268503|P6|NOT COMPLETED|First Intervention||0
519077|NCT00901576|1268504|P5|NOT COMPLETED|First Intervention||0
519078|NCT00901576|1268505|P4|NOT COMPLETED|First Intervention||0
519079|NCT00901576|1268506|P3|NOT COMPLETED|First Intervention||0
519080|NCT00901576|1268507|P2|NOT COMPLETED|First Intervention||0
519081|NCT00901576|1268508|P1|NOT COMPLETED|First Intervention||0
519082|NCT00901576|1268503|P6|COMPLETED|First Intervention||6
519083|NCT00901576|1268504|P5|COMPLETED|First Intervention||6
519084|NCT00901576|1268505|P4|COMPLETED|First Intervention||6
519085|NCT00901576|1268506|P3|COMPLETED|First Intervention||7
519086|NCT00901576|1268507|P2|COMPLETED|First Intervention||7
519087|NCT00901576|1268508|P1|COMPLETED|First Intervention||6
519088|NCT00901576|1268503|P6|STARTED|First Intervention||6
519089|NCT00901576|1268504|P5|STARTED|First Intervention||6
519090|NCT00901576|1268505|P4|STARTED|First Intervention||6
519091|NCT00901576|1268506|P3|STARTED|First Intervention||7
519092|NCT00901576|1268507|P2|STARTED|First Intervention||7
519093|NCT00901576|1268508|P1|STARTED|First Intervention||6
519094|NCT00901459|1268529|P1|NOT COMPLETED|Overall Study||6
519095|NCT00901459|1268529|P1|COMPLETED|Overall Study||15
519096|NCT00901459|1268529|P1|STARTED|Overall Study||21
519097|NCT00901342|1268540|P1|NOT COMPLETED|Overall Study||15
519098|NCT00901342|1268540|P1|COMPLETED|Overall Study|89 subjects completed the study completion visit|89
519099|NCT00901342|1268540|P1|Received at Least 1 Infusion|Overall Study||98
519100|NCT00901342|1268540|P1|STARTED|Overall Study||104
519101|NCT00901316|1268546|P2|NOT COMPLETED|Overall Study||0
519102|NCT00901316|1268547|P1|NOT COMPLETED|Overall Study||0
519103|NCT00901316|1268546|P2|COMPLETED|Overall Study||495
519104|NCT00901316|1268547|P1|COMPLETED|Overall Study||492
519105|NCT00901316|1268546|P2|STARTED|Overall Study||495
519106|NCT00901316|1268547|P1|STARTED|Overall Study||492
519107|NCT00901225|1268553|P1|NOT COMPLETED|Overall Study||1
519108|NCT00901225|1268553|P1|COMPLETED|Overall Study||20
519109|NCT00901225|1268553|P1|STARTED|Overall Study||21
519110|NCT00901186|1268564|P2|NOT COMPLETED|Overall Study||11
519111|NCT00901186|1268565|P1|NOT COMPLETED|Overall Study||9
519112|NCT00901186|1268564|P2|COMPLETED|Overall Study||32
519113|NCT00901186|1268565|P1|COMPLETED|Overall Study||31
519114|NCT00901186|1268564|P2|Intent to Treat|Overall Study|Five treated participants did not have at least a baseline and one post-treatment BCVA.|38
519115|NCT00901186|1268565|P1|Intent to Treat|Overall Study|Four treated participants did not have at least a baseline and one post-treatment BCVA.|35
519116|NCT00901186|1268564|P2|Safety Set|Overall Study||43
519117|NCT00901186|1268565|P1|Safety Set|Overall Study|One participant did not receive one intravitreal RFB002 injection.|39
519118|NCT00901186|1268564|P2|STARTED|Overall Study||43
519119|NCT00901186|1268565|P1|STARTED|Overall Study||40
519120|NCT00901017|1268581|P1|NOT COMPLETED|Overall Study||0
519121|NCT00901017|1268581|P1|COMPLETED|Overall Study||14
519122|NCT00901017|1268581|P1|STARTED|Overall Study||14
519123|NCT00900822|1268595|P1|NOT COMPLETED|12 Months Clinical Evaluation||0
519124|NCT00900822|1268595|P1|COMPLETED|12 Months Clinical Evaluation||11
519125|NCT00900822|1268595|P1|STARTED|12 Months Clinical Evaluation||11
519126|NCT00900822|1268595|P1|NOT COMPLETED|9 Months Histological Evaluation||0
519127|NCT00900822|1268595|P1|COMPLETED|9 Months Histological Evaluation||11
519128|NCT00900822|1268595|P1|STARTED|9 Months Histological Evaluation||11
519129|NCT00900796|1268605|P1|NOT COMPLETED|Phase 2||5
519130|NCT00900796|1268605|P1|COMPLETED|Phase 2||6
519131|NCT00900796|1268605|P1|STARTED|Phase 2||11
519132|NCT00900796|1268605|P1|NOT COMPLETED|Between Phase 1 and Phase 2||110
519133|NCT00900796|1268605|P1|COMPLETED|Between Phase 1 and Phase 2||11
519134|NCT00900796|1268605|P1|STARTED|Between Phase 1 and Phase 2||121
519135|NCT00900796|1268605|P1|NOT COMPLETED|Phase 1||11
519136|NCT00900796|1268605|P1|COMPLETED|Phase 1||121
519137|NCT00900796|1268605|P1|STARTED|Phase 1||132
519138|NCT00900757|1268615|P1|NOT COMPLETED|Overall Study||19
519139|NCT00900757|1268615|P1|COMPLETED|Overall Study||38
519140|NCT00900757|1268615|P1|STARTED|Overall Study||57
519141|NCT00900731|1268625|P2|NOT COMPLETED|Overall Study||61
519142|NCT00900731|1268626|P1|NOT COMPLETED|Overall Study||60
519143|NCT00900731|1268625|P2|COMPLETED|Overall Study||740
519144|NCT00900731|1268626|P1|COMPLETED|Overall Study||737
519145|NCT00900731|1268625|P2|Safety Set: Received Study Drug|Overall Study||799
519146|NCT00900731|1268626|P1|Safety Set: Received Study Drug|Overall Study||794
519147|NCT00900731|1268625|P2|STARTED|Overall Study||801
519148|NCT00900731|1268626|P1|STARTED|Overall Study|Randomized participants|797
519149|NCT00900666|1268648|P2|NOT COMPLETED|Overall Study||0
519150|NCT00900666|1268649|P1|NOT COMPLETED|Overall Study||0
519151|NCT00900666|1268648|P2|COMPLETED|Overall Study||9
519152|NCT00900666|1268649|P1|COMPLETED|Overall Study||10
519153|NCT00900666|1268648|P2|STARTED|Overall Study||9
519154|NCT00900666|1268649|P1|STARTED|Overall Study||10
519155|NCT00900627|1268663|P6|NOT COMPLETED|Overall Study||26
519156|NCT00900627|1268664|P5|NOT COMPLETED|Overall Study||29
519157|NCT00900627|1268665|P4|NOT COMPLETED|Overall Study||6
519158|NCT00900627|1268666|P3|NOT COMPLETED|Overall Study||6
519159|NCT00900627|1268667|P2|NOT COMPLETED|Overall Study||2
519160|NCT00900627|1268668|P1|NOT COMPLETED|Overall Study||6
519161|NCT00900627|1268663|P6|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|70
519162|NCT00900627|1268664|P5|COMPLETED|Overall Study|No set completion, pts were to remain in study until withdrawn|65
519163|NCT00900627|1268665|P4|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
519164|NCT00900627|1268666|P3|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
519165|NCT00900627|1268667|P2|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
519166|NCT00900627|1268668|P1|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
519167|NCT00900627|1268663|P6|STARTED|Overall Study|The values under 'Not Completed' are based on the time of the primary analysis|96
519168|NCT00900627|1268664|P5|STARTED|Overall Study|The values under 'Not Completed' are based on the time of the primary analysis|94
519169|NCT00900627|1268665|P4|STARTED|Overall Study||6
519170|NCT00900627|1268666|P3|STARTED|Overall Study||6
519171|NCT00900627|1268667|P2|STARTED|Overall Study||2
519172|NCT00900627|1268668|P1|STARTED|Overall Study||6
519173|NCT00900601|1268686|P1|NOT COMPLETED|Overall Study||1
519174|NCT00900601|1268686|P1|COMPLETED|Overall Study||8
519175|NCT00900601|1268686|P1|STARTED|Overall Study||9
519176|NCT00900237|1268694|P2|NOT COMPLETED|Overall Study||0
519177|NCT00900237|1268695|P1|NOT COMPLETED|Overall Study||0
519178|NCT00900237|1268694|P2|COMPLETED|Overall Study||7
519179|NCT00900237|1268695|P1|COMPLETED|Overall Study||7
519180|NCT00900237|1268694|P2|STARTED|Overall Study||7
519181|NCT00900237|1268695|P1|STARTED|Overall Study||7
519182|NCT00900159|1268705|P2|NOT COMPLETED|Second Intervention||0
519183|NCT00900159|1268706|P1|NOT COMPLETED|Second Intervention||1
519184|NCT00900159|1268705|P2|COMPLETED|Second Intervention||13
519185|NCT00900159|1268706|P1|COMPLETED|Second Intervention||10
519186|NCT00900159|1268705|P2|STARTED|Second Intervention||13
519187|NCT00900159|1268706|P1|STARTED|Second Intervention||11
519188|NCT00900159|1268705|P2|NOT COMPLETED|Washout||0
519189|NCT00900159|1268706|P1|NOT COMPLETED|Washout||0
519190|NCT00900159|1268705|P2|COMPLETED|Washout||13
519191|NCT00900159|1268706|P1|COMPLETED|Washout||11
519192|NCT00900159|1268705|P2|STARTED|Washout||13
519193|NCT00900159|1268706|P1|STARTED|Washout||11
519194|NCT00900159|1268705|P2|NOT COMPLETED|First Intervention||0
519195|NCT00900159|1268706|P1|NOT COMPLETED|First Intervention||0
519196|NCT00900159|1268705|P2|COMPLETED|First Intervention||13
519197|NCT00900159|1268706|P1|COMPLETED|First Intervention||11
519198|NCT00900159|1268705|P2|STARTED|First Intervention||13
519199|NCT00900159|1268706|P1|STARTED|First Intervention||11
519200|NCT00900146|1268725|P5|NOT COMPLETED|Intermediate: Period III||167
519201|NCT00900146|1268726|P4|NOT COMPLETED|Intermediate: Period III||90
519202|NCT00900146|1268727|P3|NOT COMPLETED|Intermediate: Period III||84
519203|NCT00900146|1268728|P2|NOT COMPLETED|Intermediate: Period III||93
519204|NCT00900146|1268729|P1|NOT COMPLETED|Intermediate: Period III||87
519205|NCT00900146|1268725|P5|COMPLETED|Intermediate: Period III||0
519206|NCT00900146|1268726|P4|COMPLETED|Intermediate: Period III||0
519207|NCT00900146|1268727|P3|COMPLETED|Intermediate: Period III||0
519208|NCT00900146|1268728|P2|COMPLETED|Intermediate: Period III||0
519209|NCT00900146|1268729|P1|COMPLETED|Intermediate: Period III||0
519210|NCT00900146|1268725|P5|Safety Set|Intermediate: Period III||166
519211|NCT00900146|1268726|P4|Safety Set|Intermediate: Period III||90
519212|NCT00900146|1268727|P3|Safety Set|Intermediate: Period III||84
519213|NCT00900146|1268728|P2|Safety Set|Intermediate: Period III||92
519214|NCT00900146|1268729|P1|Safety Set|Intermediate: Period III||86
519215|NCT00900146|1268725|P5|STARTED|Intermediate: Period III||167
519216|NCT00900146|1268726|P4|STARTED|Intermediate: Period III||90
519217|NCT00900146|1268727|P3|STARTED|Intermediate: Period III||84
519218|NCT00900146|1268728|P2|STARTED|Intermediate: Period III||93
519219|NCT00900146|1268729|P1|STARTED|Intermediate: Period III||87
519220|NCT00900146|1268725|P5|NOT COMPLETED|Dose Finding: Period II (4 Months)||12
519221|NCT00900146|1268726|P4|NOT COMPLETED|Dose Finding: Period II (4 Months)||2
519222|NCT00900146|1268727|P3|NOT COMPLETED|Dose Finding: Period II (4 Months)||5
519223|NCT00900146|1268728|P2|NOT COMPLETED|Dose Finding: Period II (4 Months)||2
519224|NCT00900146|1268729|P1|NOT COMPLETED|Dose Finding: Period II (4 Months)||5
519225|NCT00900146|1268725|P5|COMPLETED|Dose Finding: Period II (4 Months)|Placebo also included 1 patient with no study completion page.|167
519226|NCT00900146|1268726|P4|COMPLETED|Dose Finding: Period II (4 Months)||90
519227|NCT00900146|1268727|P3|COMPLETED|Dose Finding: Period II (4 Months)||87
519228|NCT00900146|1268728|P2|COMPLETED|Dose Finding: Period II (4 Months)||93
519229|NCT00900146|1268729|P1|COMPLETED|Dose Finding: Period II (4 Months)||88
519230|NCT00900146|1268725|P5|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||179
519231|NCT00900146|1268726|P4|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92
519232|NCT00900146|1268727|P3|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92
519233|NCT00900146|1268728|P2|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||95
519234|NCT00900146|1268729|P1|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||93
519235|NCT00900146|1268725|P5|STARTED|Dose Finding: Period II (4 Months)||179
519236|NCT00900146|1268726|P4|STARTED|Dose Finding: Period II (4 Months)||92
519237|NCT00900146|1268727|P3|STARTED|Dose Finding: Period II (4 Months)||92
519238|NCT00900146|1268728|P2|STARTED|Dose Finding: Period II (4 Months)||95
519239|NCT00900146|1268729|P1|STARTED|Dose Finding: Period II (4 Months)||93
519240|NCT00900029|1268846|P5|NOT COMPLETED|Overall Study||6
519241|NCT00900029|1268847|P4|NOT COMPLETED|Overall Study||7
519242|NCT00900029|1268848|P3|NOT COMPLETED|Overall Study||3
519243|NCT00900029|1268849|P2|NOT COMPLETED|Overall Study||4
519244|NCT00900029|1268850|P1|NOT COMPLETED|Overall Study||3
519245|NCT00900029|1268846|P5|COMPLETED|Overall Study||38
519246|NCT00900029|1268847|P4|COMPLETED|Overall Study||35
519247|NCT00900029|1268848|P3|COMPLETED|Overall Study||38
519248|NCT00900029|1268849|P2|COMPLETED|Overall Study||37
519249|NCT00900029|1268850|P1|COMPLETED|Overall Study||35
519250|NCT00900029|1268846|P5|STARTED|Overall Study||44
519251|NCT00900029|1268847|P4|STARTED|Overall Study||42
519252|NCT00900029|1268848|P3|STARTED|Overall Study||41
519253|NCT00900029|1268849|P2|STARTED|Overall Study||41
519254|NCT00900029|1268850|P1|STARTED|Overall Study||38
519255|NCT00899847|1268867|P1|NOT COMPLETED|Overall Study||2
519256|NCT00899847|1268867|P1|COMPLETED|Overall Study||7
519257|NCT00899847|1268867|P1|STARTED|Overall Study||9
519258|NCT00899717|1268880|P2|NOT COMPLETED|Overall Study||0
519259|NCT00899717|1268881|P1|NOT COMPLETED|Overall Study||0
519260|NCT00899717|1268880|P2|COMPLETED|Overall Study||11
519261|NCT00899717|1268881|P1|COMPLETED|Overall Study||10
519262|NCT00899717|1268880|P2|STARTED|Overall Study||11
519263|NCT00899717|1268881|P1|STARTED|Overall Study||10
519264|NCT00899678|1268898|P3|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||28
519265|NCT00899678|1268899|P2|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||25
519266|NCT00899678|1268900|P1|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||0
519267|NCT00899678|1268898|P3|COMPLETED|Maintenance Period (Weeks 8 to 62)||7
519268|NCT00899678|1268899|P2|COMPLETED|Maintenance Period (Weeks 8 to 62)||12
519269|NCT00899678|1268900|P1|COMPLETED|Maintenance Period (Weeks 8 to 62)||0
519270|NCT00899678|1268898|P3|STARTED|Maintenance Period (Weeks 8 to 62)||35
519271|NCT00899678|1268899|P2|STARTED|Maintenance Period (Weeks 8 to 62)||37
519272|NCT00899678|1268900|P1|STARTED|Maintenance Period (Weeks 8 to 62)|Induction only includes subjects that discontinued before Maintenance Period.|0
519273|NCT00899678|1268898|P3|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0
519274|NCT00899678|1268899|P2|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0
519275|NCT00899678|1268900|P1|NOT COMPLETED|Induction Period (Weeks 0 to 6)||25
519276|NCT00899678|1268898|P3|COMPLETED|Induction Period (Weeks 0 to 6)||35
519277|NCT00899678|1268899|P2|COMPLETED|Induction Period (Weeks 0 to 6)||37
519278|NCT00899678|1268900|P1|COMPLETED|Induction Period (Weeks 0 to 6)|2 subjects completed the Induction Phase, but discontinued prior to receiving any Maintenance doses.|2
519279|NCT00899678|1268898|P3|STARTED|Induction Period (Weeks 0 to 6)||35
519280|NCT00899678|1268899|P2|STARTED|Induction Period (Weeks 0 to 6)||37
519281|NCT00899678|1268900|P1|STARTED|Induction Period (Weeks 0 to 6)|Induction only includes subjects that discontinued before Maintenance Period.|27
519282|NCT00899600|1268930|P2|NOT COMPLETED|Overall Study||0
519283|NCT00899600|1268931|P1|NOT COMPLETED|Overall Study||0
519284|NCT00899600|1268930|P2|COMPLETED|Overall Study||52
519285|NCT00899600|1268931|P1|COMPLETED|Overall Study||50
519286|NCT00899600|1268930|P2|STARTED|Overall Study||52
519287|NCT00899600|1268931|P1|STARTED|Overall Study||50
519288|NCT00899574|1268937|P1|NOT COMPLETED|Overall Study||0
519289|NCT00899574|1268937|P1|COMPLETED|Overall Study||10
519290|NCT00899574|1268937|P1|STARTED|Overall Study||10
519291|NCT00899470|1268942|P4|NOT COMPLETED|Fourth Therapy||0
519292|NCT00899470|1268943|P3|NOT COMPLETED|Fourth Therapy||0
519293|NCT00899470|1268944|P2|NOT COMPLETED|Fourth Therapy||0
519294|NCT00899470|1268945|P1|NOT COMPLETED|Fourth Therapy||0
519295|NCT00899470|1268942|P4|COMPLETED|Fourth Therapy||6
519296|NCT00899470|1268943|P3|COMPLETED|Fourth Therapy||6
519297|NCT00899470|1268944|P2|COMPLETED|Fourth Therapy||6
519298|NCT00899470|1268945|P1|COMPLETED|Fourth Therapy||6
519299|NCT00899470|1268942|P4|STARTED|Fourth Therapy||6
519300|NCT00899470|1268943|P3|STARTED|Fourth Therapy||6
519301|NCT00899470|1268944|P2|STARTED|Fourth Therapy||6
519302|NCT00899470|1268945|P1|STARTED|Fourth Therapy||6
519303|NCT00899470|1268942|P4|NOT COMPLETED|Third Washout||0
519304|NCT00899470|1268943|P3|NOT COMPLETED|Third Washout||0
519305|NCT00899470|1268944|P2|NOT COMPLETED|Third Washout||0
519306|NCT00899470|1268945|P1|NOT COMPLETED|Third Washout||0
519307|NCT00899470|1268942|P4|COMPLETED|Third Washout||6
519308|NCT00899470|1268943|P3|COMPLETED|Third Washout||6
519309|NCT00899470|1268944|P2|COMPLETED|Third Washout||6
519310|NCT00899470|1268945|P1|COMPLETED|Third Washout||6
519311|NCT00899470|1268942|P4|STARTED|Third Washout||6
519312|NCT00899470|1268943|P3|STARTED|Third Washout||6
519313|NCT00899470|1268944|P2|STARTED|Third Washout||6
519314|NCT00899470|1268945|P1|STARTED|Third Washout||6
519315|NCT00899470|1268942|P4|NOT COMPLETED|Third Therapy||0
519316|NCT00899470|1268943|P3|NOT COMPLETED|Third Therapy||0
519317|NCT00899470|1268944|P2|NOT COMPLETED|Third Therapy||0
519318|NCT00899470|1268945|P1|NOT COMPLETED|Third Therapy||0
519319|NCT00899470|1268942|P4|COMPLETED|Third Therapy||6
519320|NCT00899470|1268943|P3|COMPLETED|Third Therapy||6
519321|NCT00899470|1268944|P2|COMPLETED|Third Therapy||6
519322|NCT00899470|1268945|P1|COMPLETED|Third Therapy||6
519323|NCT00899470|1268942|P4|STARTED|Third Therapy||6
519324|NCT00899470|1268943|P3|STARTED|Third Therapy||6
519325|NCT00899470|1268944|P2|STARTED|Third Therapy||6
519326|NCT00899470|1268945|P1|STARTED|Third Therapy||6
519327|NCT00899470|1268942|P4|NOT COMPLETED|Second Washout||0
519328|NCT00899470|1268943|P3|NOT COMPLETED|Second Washout||0
519329|NCT00899470|1268944|P2|NOT COMPLETED|Second Washout||0
519330|NCT00899470|1268945|P1|NOT COMPLETED|Second Washout||0
519331|NCT00899470|1268942|P4|COMPLETED|Second Washout||6
519332|NCT00899470|1268943|P3|COMPLETED|Second Washout||6
519333|NCT00899470|1268944|P2|COMPLETED|Second Washout||6
519334|NCT00899470|1268945|P1|COMPLETED|Second Washout||6
519335|NCT00899470|1268942|P4|STARTED|Second Washout||6
519336|NCT00899470|1268943|P3|STARTED|Second Washout||6
519337|NCT00899470|1268944|P2|STARTED|Second Washout||6
519338|NCT00899470|1268945|P1|STARTED|Second Washout||6
519339|NCT00899470|1268942|P4|NOT COMPLETED|Second Therapy||0
519340|NCT00899470|1268943|P3|NOT COMPLETED|Second Therapy||0
519341|NCT00899470|1268944|P2|NOT COMPLETED|Second Therapy||0
519342|NCT00899470|1268945|P1|NOT COMPLETED|Second Therapy||0
519343|NCT00899470|1268942|P4|COMPLETED|Second Therapy||6
519344|NCT00899470|1268943|P3|COMPLETED|Second Therapy||6
519345|NCT00899470|1268944|P2|COMPLETED|Second Therapy||6
519346|NCT00899470|1268945|P1|COMPLETED|Second Therapy||6
519347|NCT00899470|1268942|P4|STARTED|Second Therapy||6
519348|NCT00899470|1268943|P3|STARTED|Second Therapy||6
519349|NCT00899470|1268944|P2|STARTED|Second Therapy||6
519350|NCT00899470|1268945|P1|STARTED|Second Therapy||6
519351|NCT00899470|1268942|P4|NOT COMPLETED|First Washout Period||0
519352|NCT00899470|1268943|P3|NOT COMPLETED|First Washout Period||0
519353|NCT00899470|1268944|P2|NOT COMPLETED|First Washout Period||0
519354|NCT00899470|1268945|P1|NOT COMPLETED|First Washout Period||0
519355|NCT00899470|1268942|P4|COMPLETED|First Washout Period||6
519356|NCT00899470|1268943|P3|COMPLETED|First Washout Period||6
519357|NCT00899470|1268944|P2|COMPLETED|First Washout Period||6
519358|NCT00899470|1268945|P1|COMPLETED|First Washout Period||6
519359|NCT00899470|1268942|P4|STARTED|First Washout Period||6
519360|NCT00899470|1268943|P3|STARTED|First Washout Period||6
519361|NCT00899470|1268944|P2|STARTED|First Washout Period||6
519362|NCT00899470|1268945|P1|STARTED|First Washout Period||6
519363|NCT00899470|1268942|P4|NOT COMPLETED|First Therapy||0
519364|NCT00899470|1268943|P3|NOT COMPLETED|First Therapy||0
519365|NCT00899470|1268944|P2|NOT COMPLETED|First Therapy||0
519366|NCT00899470|1268945|P1|NOT COMPLETED|First Therapy||0
519367|NCT00899470|1268942|P4|COMPLETED|First Therapy||6
519368|NCT00899470|1268943|P3|COMPLETED|First Therapy||6
519369|NCT00899470|1268944|P2|COMPLETED|First Therapy||6
519370|NCT00899470|1268945|P1|COMPLETED|First Therapy||6
519371|NCT00899470|1268942|P4|STARTED|First Therapy||6
519372|NCT00899470|1268943|P3|STARTED|First Therapy||6
519373|NCT00899470|1268944|P2|STARTED|First Therapy||6
519374|NCT00899470|1268945|P1|STARTED|First Therapy||6
519375|NCT00899392|1269023|P2|NOT COMPLETED|Overall Study||24
519376|NCT00899392|1269024|P1|NOT COMPLETED|Overall Study||21
519377|NCT00899392|1269023|P2|COMPLETED|Overall Study|Subjects:PerVariableStudied Consent:47-EAC 50-FBC Anxiety:60-EAC 3-FBC Satisfaction:63-EAC 67-FBC|50
519378|NCT00899392|1269024|P1|COMPLETED|Overall Study|Subjects:PerVariableStudied Consent:47-EAC 50-FBC Anxiety:60-EAC 3-FBC Satisfaction:63-EAC 67-FBC|47
519379|NCT00899392|1269023|P2|STARTED|Overall Study||74
519380|NCT00899392|1269024|P1|STARTED|Overall Study||68
519381|NCT00899379|1269041|P5|NOT COMPLETED|Overall Study||31
519382|NCT00899379|1269042|P4|NOT COMPLETED|Overall Study||37
519383|NCT00899379|1269043|P3|NOT COMPLETED|Overall Study||29
519384|NCT00899379|1269044|P2|NOT COMPLETED|Overall Study||29
519385|NCT00899379|1269045|P1|NOT COMPLETED|Overall Study||34
519386|NCT00899379|1269041|P5|COMPLETED|Overall Study|Patients who took study drug and completed the study|63
519387|NCT00899379|1269042|P4|COMPLETED|Overall Study|Patients who took study drug and completed the study|57
519388|NCT00899379|1269043|P3|COMPLETED|Overall Study|Patients who took study drug and completed the study|66
519389|NCT00899379|1269044|P2|COMPLETED|Overall Study|Patients who took study drug and completed the study|66
519390|NCT00899379|1269045|P1|COMPLETED|Overall Study|Patients who took study drug and completed the study|61
519391|NCT00899379|1269041|P5|Patients Not Treated|Overall Study|Patients who did not take study drug|13
519392|NCT00899379|1269042|P4|Patients Not Treated|Overall Study|Patients who did not take study drug|17
519393|NCT00899379|1269043|P3|Patients Not Treated|Overall Study|Patients who did not take study drug|11
519394|NCT00899379|1269044|P2|Patients Not Treated|Overall Study|Patients who did not take study drug|13
519395|NCT00899379|1269045|P1|Patients Not Treated|Overall Study|Patients who did not take study drug|12
519396|NCT00899379|1269041|P5|Patients Treated|Overall Study|Patients who took study drug|81
519397|NCT00899379|1269042|P4|Patients Treated|Overall Study|Patients who took study drug|77
519398|NCT00899379|1269043|P3|Patients Treated|Overall Study|Patients who took study drug|84
519399|NCT00899379|1269044|P2|Patients Treated|Overall Study|Patients who took study drug|82
519400|NCT00899379|1269045|P1|Patients Treated|Overall Study|Patients who took study drug|83
519401|NCT00899379|1269041|P5|STARTED|Overall Study|Patients who were allocated study drug|94
519402|NCT00899379|1269042|P4|STARTED|Overall Study|Patients who were allocated study drug|94
519403|NCT00899379|1269043|P3|STARTED|Overall Study|Patients who were allocated study drug|95
519404|NCT00899379|1269044|P2|STARTED|Overall Study|Patients who were allocated study drug|95
519405|NCT00899379|1269045|P1|STARTED|Overall Study|Patients who were allocated study drug|95
519406|NCT00899353|1269057|P1|NOT COMPLETED|Overall Study||5
519407|NCT00899353|1269057|P1|COMPLETED|Overall Study||11
519408|NCT00899353|1269057|P1|STARTED|Overall Study||16
519409|NCT00898937|1269081|P3|NOT COMPLETED|Overall Study||0
519410|NCT00898937|1269082|P2|NOT COMPLETED|Overall Study||0
519411|NCT00898937|1269083|P1|NOT COMPLETED|Overall Study||0
519412|NCT00898937|1269081|P3|COMPLETED|Overall Study||9
519413|NCT00898937|1269082|P2|COMPLETED|Overall Study||21
519414|NCT00898937|1269083|P1|COMPLETED|Overall Study||25
519415|NCT00898937|1269081|P3|STARTED|Overall Study||9
519416|NCT00898937|1269082|P2|STARTED|Overall Study||21
519417|NCT00898937|1269083|P1|STARTED|Overall Study||25
519418|NCT00898807|1269093|P2|NOT COMPLETED|Overall Study||9
519419|NCT00898807|1269094|P1|NOT COMPLETED|Overall Study||8
519420|NCT00898807|1269093|P2|COMPLETED|Overall Study||83
519421|NCT00898807|1269094|P1|COMPLETED|Overall Study||86
519422|NCT00898807|1269093|P2|STARTED|Overall Study||92
519423|NCT00898807|1269094|P1|STARTED|Overall Study||94
519424|NCT00898677|1269110|P4|NOT COMPLETED|Overall Study||19
519425|NCT00898677|1269111|P3|NOT COMPLETED|Overall Study||72
519426|NCT00898677|1269112|P2|NOT COMPLETED|Overall Study||69
519427|NCT00898677|1269113|P1|NOT COMPLETED|Overall Study||17
519428|NCT00898677|1269110|P4|COMPLETED|Overall Study||159
519429|NCT00898677|1269111|P3|COMPLETED|Overall Study||383
519430|NCT00898677|1269112|P2|COMPLETED|Overall Study||386
519431|NCT00898677|1269113|P1|COMPLETED|Overall Study||163
519432|NCT00898677|1269110|P4|Patients Treated|Overall Study|Patients Not Treated: 18|160
519433|NCT00898677|1269111|P3|Patients Treated|Overall Study|Patients Not Treated: 67|388
519434|NCT00898677|1269112|P2|Patients Treated|Overall Study|Patients Not Treated: 68|387
519435|NCT00898677|1269113|P1|Patients Treated|Overall Study|Patients Not Treated: 16|164
519436|NCT00898677|1269110|P4|STARTED|Overall Study||178
519437|NCT00898677|1269111|P3|STARTED|Overall Study||455
519438|NCT00898677|1269112|P2|STARTED|Overall Study||455
519439|NCT00898677|1269113|P1|STARTED|Overall Study||180
519440|NCT00898560|1269139|P1|NOT COMPLETED|Overall Study||1
519441|NCT00898560|1269139|P1|COMPLETED|Overall Study||19
519442|NCT00898560|1269139|P1|STARTED|Overall Study||20
519443|NCT00898443|1269151|P2|NOT COMPLETED|Overall Study||0
519444|NCT00898443|1269152|P1|NOT COMPLETED|Overall Study||1
519445|NCT00898443|1269151|P2|COMPLETED|Overall Study||8
519446|NCT00898443|1269152|P1|COMPLETED|Overall Study||9
519447|NCT00898443|1269151|P2|STARTED|Overall Study||8
519448|NCT00898443|1269152|P1|STARTED|Overall Study||10
519449|NCT00898222|1269160|P1|NOT COMPLETED|Overall Study||0
519450|NCT00898222|1269160|P1|COMPLETED|Overall Study||4
519451|NCT00898222|1269160|P1|STARTED|Overall Study||4
519452|NCT00897949|1269167|P3|NOT COMPLETED|Overall Study||69
519453|NCT00897949|1269168|P2|NOT COMPLETED|Overall Study||103
519454|NCT00897949|1269169|P1|NOT COMPLETED|Overall Study||104
519455|NCT00897949|1269167|P3|COMPLETED|Overall Study|Patients who took study drug and completed the study|301
519456|NCT00897949|1269168|P2|COMPLETED|Overall Study|Patients who took study drug and completed the study|446
519457|NCT00897949|1269169|P1|COMPLETED|Overall Study|Patients who took study drug and completed the study|450
519458|NCT00897949|1269167|P3|Patients Treated|Overall Study|Patients who took study drug|304
519459|NCT00897949|1269168|P2|Patients Treated|Overall Study|Patients who took study drug|456
519460|NCT00897949|1269169|P1|Patients Treated|Overall Study|Patients who took study drug|458
519461|NCT00897949|1269167|P3|STARTED|Overall Study|Patients who were allocated study drug|370
519462|NCT00897949|1269168|P2|STARTED|Overall Study|Patients who were allocated study drug|549
519463|NCT00897949|1269169|P1|STARTED|Overall Study|Patients who were allocated study drug|554
519464|NCT00897910|1269192|P1|NOT COMPLETED|Overall Study||0
519465|NCT00897910|1269192|P1|COMPLETED|Overall Study|None of the blood samples were analyzed due to lack of funding. No tissue sample was collected|6
519466|NCT00897910|1269192|P1|STARTED|Overall Study|None of the blood samples were analyzed due to lack of funding. No tissue sample was collected.|6
519467|NCT00897897|1269196|P1|NOT COMPLETED|Overall Study||0
519468|NCT00897897|1269196|P1|COMPLETED|Overall Study||33
519469|NCT00897897|1269196|P1|STARTED|Overall Study||33
519470|NCT00897715|1269203|P2|NOT COMPLETED|Overall Study||1
519471|NCT00897715|1269204|P1|NOT COMPLETED|Overall Study||2
519472|NCT00897715|1269203|P2|COMPLETED|Overall Study||6
519473|NCT00897715|1269204|P1|COMPLETED|Overall Study||6
519474|NCT00897715|1269203|P2|STARTED|Overall Study||7
519475|NCT00897715|1269204|P1|STARTED|Overall Study||8
519476|NCT00897676|1269212|P2|NOT COMPLETED|Intervention 2(6 Hours)||0
519477|NCT00897676|1269213|P1|NOT COMPLETED|Intervention 2(6 Hours)||0
519478|NCT00897676|1269212|P2|COMPLETED|Intervention 2(6 Hours)||7
519479|NCT00897676|1269213|P1|COMPLETED|Intervention 2(6 Hours)||9
519480|NCT00897676|1269212|P2|STARTED|Intervention 2(6 Hours)||7
519481|NCT00897676|1269213|P1|STARTED|Intervention 2(6 Hours)||9
519482|NCT00897676|1269212|P2|NOT COMPLETED|Intervention 1(6 Hours)||0
519483|NCT00897676|1269213|P1|NOT COMPLETED|Intervention 1(6 Hours)||0
519484|NCT00897676|1269212|P2|COMPLETED|Intervention 1(6 Hours)||7
519485|NCT00897676|1269213|P1|COMPLETED|Intervention 1(6 Hours)||9
519486|NCT00897676|1269212|P2|STARTED|Intervention 1(6 Hours)||7
519487|NCT00897676|1269213|P1|STARTED|Intervention 1(6 Hours)||9
519488|NCT00897390|1269229|P1|NOT COMPLETED|Overall Study||6
519489|NCT00897390|1269229|P1|COMPLETED|Overall Study||18
519490|NCT00897390|1269229|P1|STARTED|Overall Study||24
519491|NCT00897104|1269319|P3|NOT COMPLETED|Overall Study||8
519492|NCT00897104|1269320|P2|NOT COMPLETED|Overall Study||71
519493|NCT00897104|1269321|P1|NOT COMPLETED|Overall Study||64
519494|NCT00897104|1269319|P3|COMPLETED|Overall Study|Participants who took study drug and completed the study|79
519495|NCT00897104|1269320|P2|COMPLETED|Overall Study|Participants who took study drug and completed the study|357
519496|NCT00897104|1269321|P1|COMPLETED|Overall Study|Participants who took study drug and completed the study|354
519497|NCT00897104|1269319|P3|Participants Not Treated|Overall Study|Participants who did not take study drug|7
519498|NCT00897104|1269320|P2|Participants Not Treated|Overall Study|Participants who did not take study drug|71
519591|NCT00895895|1269719|P1|NOT COMPLETED|Period 2||56
519499|NCT00897104|1269321|P1|Participants Not Treated|Overall Study|Participants who did not take study drug|63
519500|NCT00897104|1269319|P3|Participants Treated|Overall Study|Participants who took study drug|80
519501|NCT00897104|1269320|P2|Participants Treated|Overall Study|Participants who took study drug|357
519502|NCT00897104|1269321|P1|Participants Treated|Overall Study|Participants who took study drug|355
519503|NCT00897104|1269319|P3|STARTED|Overall Study|Participants who were allocated study drug|87
519504|NCT00897104|1269320|P2|STARTED|Overall Study|Participants who were allocated study drug|428
519505|NCT00897104|1269321|P1|STARTED|Overall Study|Participants who were allocated study drug|418
519506|NCT00896779|1269349|P2|NOT COMPLETED|Overall Study||1
519507|NCT00896779|1269350|P1|NOT COMPLETED|Overall Study||0
519508|NCT00896779|1269349|P2|COMPLETED|Overall Study||11
519509|NCT00896779|1269350|P1|COMPLETED|Overall Study||8
519510|NCT00896779|1269349|P2|STARTED|Overall Study||12
519511|NCT00896779|1269350|P1|STARTED|Overall Study||8
519512|NCT00896649|1269356|P1|NOT COMPLETED|Overall Study||5
519513|NCT00896649|1269356|P1|COMPLETED|Overall Study||188
519514|NCT00896649|1269356|P1|STARTED|Overall Study||193
519515|NCT00896454|1269361|P1|NOT COMPLETED|Overall Study||33
519516|NCT00896454|1269361|P1|COMPLETED|Overall Study||0
519517|NCT00896454|1269361|P1|STARTED|Overall Study||33
519518|NCT00896441|1269375|P2|NOT COMPLETED|Overall Study||0
519519|NCT00896441|1269376|P1|NOT COMPLETED|Overall Study||2
519520|NCT00896441|1269375|P2|COMPLETED|Overall Study||9
519521|NCT00896441|1269376|P1|COMPLETED|Overall Study||15
519522|NCT00896441|1269375|P2|STARTED|Overall Study||9
519523|NCT00896441|1269376|P1|STARTED|Overall Study||17
519524|NCT00896389|1269383|P1|NOT COMPLETED|HCTZ High Dose||0
519525|NCT00896389|1269383|P1|COMPLETED|HCTZ High Dose||25
519526|NCT00896389|1269383|P1|STARTED|HCTZ High Dose||25
519527|NCT00896389|1269383|P1|NOT COMPLETED|HCTZ Low Dose||0
519528|NCT00896389|1269383|P1|COMPLETED|HCTZ Low Dose||28
519529|NCT00896389|1269383|P1|STARTED|HCTZ Low Dose|Only subjects with SBP > 120 mmHg and agreeable to the HCTZ protocol continued to the next period.|28
519530|NCT00896389|1269383|P1|NOT COMPLETED|Salt Loading||0
519531|NCT00896389|1269383|P1|COMPLETED|Salt Loading||124
519532|NCT00896389|1269383|P1|STARTED|Salt Loading||124
519533|NCT00896363|1269400|P3|NOT COMPLETED|Overall Study||8
519534|NCT00896363|1269401|P2|NOT COMPLETED|Overall Study||11
519535|NCT00896363|1269402|P1|NOT COMPLETED|Overall Study||6
519536|NCT00896363|1269400|P3|COMPLETED|Overall Study||24
519537|NCT00896363|1269401|P2|COMPLETED|Overall Study||25
519538|NCT00896363|1269402|P1|COMPLETED|Overall Study||25
519539|NCT00896363|1269400|P3|STARTED|Overall Study||32
519540|NCT00896363|1269401|P2|STARTED|Overall Study||36
519541|NCT00896363|1269402|P1|STARTED|Overall Study||31
519542|NCT00896337|1269454|P1|NOT COMPLETED|Overall Study||25
519543|NCT00896337|1269454|P1|COMPLETED|Overall Study||100
519544|NCT00896337|1269454|P1|STARTED|Overall Study||125
519545|NCT00896233|1269521|P1|NOT COMPLETED|Overall Study||1
519546|NCT00896233|1269521|P1|COMPLETED|Overall Study||9
519547|NCT00896233|1269521|P1|STARTED|Overall Study||10
519548|NCT00896168|1269534|P2|NOT COMPLETED|Overall Study||19
519549|NCT00896168|1269535|P1|NOT COMPLETED|Overall Study||14
519550|NCT00896168|1269534|P2|COMPLETED|Overall Study||111
519551|NCT00896168|1269535|P1|COMPLETED|Overall Study||90
519552|NCT00896168|1269534|P2|STARTED|Overall Study||130
519553|NCT00896168|1269535|P1|STARTED|Overall Study||104
519554|NCT00896064|1269565|P2|NOT COMPLETED|Overall Study||0
519555|NCT00896064|1269566|P1|NOT COMPLETED|Overall Study||0
519556|NCT00896064|1269565|P2|COMPLETED|Overall Study||21
519557|NCT00896064|1269566|P1|COMPLETED|Overall Study||22
519558|NCT00896064|1269565|P2|STARTED|Overall Study||21
519559|NCT00896064|1269566|P1|STARTED|Overall Study||22
519560|NCT00896051|1269596|P2|NOT COMPLETED|Overall Study||9
519561|NCT00896051|1269597|P1|NOT COMPLETED|Overall Study||10
519562|NCT00896051|1269596|P2|COMPLETED|Overall Study||16
519563|NCT00896051|1269597|P1|COMPLETED|Overall Study||15
519564|NCT00896051|1269596|P2|STARTED|Overall Study||25
519565|NCT00896051|1269597|P1|STARTED|Overall Study||25
519566|NCT00896038|1269639|P2|NOT COMPLETED|Overall Study||1
519567|NCT00896038|1269640|P1|NOT COMPLETED|Overall Study||4
519568|NCT00896038|1269639|P2|COMPLETED|Overall Study||27
519569|NCT00896038|1269640|P1|COMPLETED|Overall Study||26
519570|NCT00896038|1269639|P2|STARTED|Overall Study||28
519571|NCT00896038|1269640|P1|STARTED|Overall Study||30
519572|NCT00896025|1269678|P1|NOT COMPLETED|Overall Study||0
519573|NCT00896025|1269678|P1|COMPLETED|Overall Study||8
519574|NCT00896025|1269678|P1|STARTED|Overall Study||8
519575|NCT00895947|1269684|P2|NOT COMPLETED|Overall Study||10
519576|NCT00895947|1269685|P1|NOT COMPLETED|Overall Study||12
519577|NCT00895947|1269684|P2|COMPLETED|Overall Study||90
519578|NCT00895947|1269685|P1|COMPLETED|Overall Study||88
519579|NCT00895947|1269684|P2|STARTED|Overall Study||100
519580|NCT00895947|1269685|P1|STARTED|Overall Study||100
519581|NCT00895934|1269703|P2|NOT COMPLETED|Overall Study||25
519582|NCT00895934|1269704|P1|NOT COMPLETED|Overall Study||6
519583|NCT00895934|1269703|P2|COMPLETED|Overall Study||18
519584|NCT00895934|1269704|P1|COMPLETED|Overall Study||4
519585|NCT00895934|1269703|P2|STARTED|Overall Study||43
519586|NCT00895934|1269704|P1|STARTED|Overall Study||10
519587|NCT00895895|1269715|P5|NOT COMPLETED|Period 2||49
519588|NCT00895895|1269716|P4|NOT COMPLETED|Period 2||54
519589|NCT00895895|1269717|P3|NOT COMPLETED|Period 2||49
519590|NCT00895895|1269718|P2|NOT COMPLETED|Period 2||53
519592|NCT00895895|1269715|P5|COMPLETED|Period 2||35
519593|NCT00895895|1269716|P4|COMPLETED|Period 2||37
519594|NCT00895895|1269717|P3|COMPLETED|Period 2||33
519595|NCT00895895|1269718|P2|COMPLETED|Period 2||31
519596|NCT00895895|1269719|P1|COMPLETED|Period 2||30
519597|NCT00895895|1269715|P5|STARTED|Period 2||84
519598|NCT00895895|1269716|P4|STARTED|Period 2||91
519599|NCT00895895|1269717|P3|STARTED|Period 2||82
519600|NCT00895895|1269718|P2|STARTED|Period 2||84
519601|NCT00895895|1269719|P1|STARTED|Period 2||86
519602|NCT00895895|1269715|P5|NOT COMPLETED|After Period 1, Prior to Period 2||2
519603|NCT00895895|1269716|P4|NOT COMPLETED|After Period 1, Prior to Period 2||0
519604|NCT00895895|1269717|P3|NOT COMPLETED|After Period 1, Prior to Period 2||2
519605|NCT00895895|1269718|P2|NOT COMPLETED|After Period 1, Prior to Period 2||0
519606|NCT00895895|1269719|P1|NOT COMPLETED|After Period 1, Prior to Period 2||0
519607|NCT00895895|1269715|P5|COMPLETED|After Period 1, Prior to Period 2||84
519608|NCT00895895|1269716|P4|COMPLETED|After Period 1, Prior to Period 2||91
519609|NCT00895895|1269717|P3|COMPLETED|After Period 1, Prior to Period 2||82
519610|NCT00895895|1269718|P2|COMPLETED|After Period 1, Prior to Period 2||84
519611|NCT00895895|1269719|P1|COMPLETED|After Period 1, Prior to Period 2||86
519612|NCT00895895|1269715|P5|STARTED|After Period 1, Prior to Period 2||86
519613|NCT00895895|1269716|P4|STARTED|After Period 1, Prior to Period 2||91
519614|NCT00895895|1269717|P3|STARTED|After Period 1, Prior to Period 2||84
519615|NCT00895895|1269718|P2|STARTED|After Period 1, Prior to Period 2||84
519616|NCT00895895|1269719|P1|STARTED|After Period 1, Prior to Period 2||86
519617|NCT00895895|1269715|P5|NOT COMPLETED|Period 1||20
519618|NCT00895895|1269716|P4|NOT COMPLETED|Period 1||13
519619|NCT00895895|1269717|P3|NOT COMPLETED|Period 1||20
519620|NCT00895895|1269718|P2|NOT COMPLETED|Period 1||21
519621|NCT00895895|1269719|P1|NOT COMPLETED|Period 1||21
519622|NCT00895895|1269715|P5|COMPLETED|Period 1||86
519623|NCT00895895|1269716|P4|COMPLETED|Period 1||91
519624|NCT00895895|1269717|P3|COMPLETED|Period 1||84
519625|NCT00895895|1269718|P2|COMPLETED|Period 1||84
519626|NCT00895895|1269719|P1|COMPLETED|Period 1||86
519627|NCT00895895|1269715|P5|Randomized But Not Treated|Period 1||2
519628|NCT00895895|1269716|P4|Randomized But Not Treated|Period 1||1
519629|NCT00895895|1269717|P3|Randomized But Not Treated|Period 1||1
519630|NCT00895895|1269718|P2|Randomized But Not Treated|Period 1||3
519631|NCT00895895|1269719|P1|Randomized But Not Treated|Period 1||1
519632|NCT00895895|1269715|P5|STARTED|Period 1||106
519633|NCT00895895|1269716|P4|STARTED|Period 1||104
519634|NCT00895895|1269717|P3|STARTED|Period 1||104
519635|NCT00895895|1269718|P2|STARTED|Period 1||105
519636|NCT00895895|1269719|P1|STARTED|Period 1||107
519637|NCT00895843|1269833|P2|NOT COMPLETED|Overall Study||12
519638|NCT00895843|1269834|P1|NOT COMPLETED|Overall Study||12
519639|NCT00895843|1269833|P2|COMPLETED|Overall Study||50
519640|NCT00895843|1269834|P1|COMPLETED|Overall Study||48
519641|NCT00895843|1269833|P2|STARTED|Overall Study||62
519642|NCT00895843|1269834|P1|STARTED|Overall Study||60
519643|NCT00895830|1269845|P5|NOT COMPLETED|Overall Study||0
519644|NCT00895830|1269846|P4|NOT COMPLETED|Overall Study||0
519645|NCT00895830|1269847|P3|NOT COMPLETED|Overall Study||0
519646|NCT00895830|1269848|P2|NOT COMPLETED|Overall Study||0
519647|NCT00895830|1269849|P1|NOT COMPLETED|Overall Study||0
519648|NCT00895830|1269845|P5|COMPLETED|Overall Study||55
519649|NCT00895830|1269846|P4|COMPLETED|Overall Study||52
519650|NCT00895830|1269847|P3|COMPLETED|Overall Study||49
519651|NCT00895830|1269848|P2|COMPLETED|Overall Study||50
519652|NCT00895830|1269849|P1|COMPLETED|Overall Study||51
519653|NCT00895830|1269845|P5|STARTED|Overall Study||55
519654|NCT00895830|1269846|P4|STARTED|Overall Study||52
519655|NCT00895830|1269847|P3|STARTED|Overall Study||49
519656|NCT00895830|1269848|P2|STARTED|Overall Study||50
519657|NCT00895830|1269849|P1|STARTED|Overall Study||51
519658|NCT00895817|1269863|P2|NOT COMPLETED|Overall Study||0
519659|NCT00895817|1269864|P1|NOT COMPLETED|Overall Study||0
519660|NCT00895817|1269863|P2|COMPLETED|Overall Study||21
519661|NCT00895817|1269864|P1|COMPLETED|Overall Study||21
519662|NCT00895817|1269863|P2|STARTED|Overall Study||21
519663|NCT00895817|1269864|P1|STARTED|Overall Study||21
519664|NCT00895752|1269870|P1|NOT COMPLETED|Overall Study||0
519665|NCT00895752|1269870|P1|COMPLETED|Overall Study||6
519666|NCT00895752|1269870|P1|STARTED|Overall Study||6
519667|NCT00895661|1269881|P1|NOT COMPLETED|Overall Study||3
519668|NCT00895661|1269881|P1|COMPLETED|Overall Study||37
519669|NCT00895661|1269881|P1|STARTED|Overall Study||40
519670|NCT00895622|1269891|P3|NOT COMPLETED|Overall Study||4
519671|NCT00895622|1269892|P2|NOT COMPLETED|Overall Study||4
519672|NCT00895622|1269893|P1|NOT COMPLETED|Overall Study||5
519673|NCT00895622|1269891|P3|COMPLETED|Overall Study||53
519674|NCT00895622|1269892|P2|COMPLETED|Overall Study||52
519675|NCT00895622|1269893|P1|COMPLETED|Overall Study||60
519676|NCT00895622|1269891|P3|STARTED|Overall Study||57
519677|NCT00895622|1269892|P2|STARTED|Overall Study||56
519678|NCT00895622|1269893|P1|STARTED|Overall Study||65
519679|NCT00895583|1269916|P2|NOT COMPLETED|Overall Study||12
519680|NCT00895583|1269917|P1|NOT COMPLETED|Overall Study||44
519681|NCT00895583|1269916|P2|COMPLETED|Overall Study||111
519682|NCT00895583|1269917|P1|COMPLETED|Overall Study||87
519683|NCT00895583|1269916|P2|STARTED|Overall Study||123
519684|NCT00895583|1269917|P1|STARTED|Overall Study||131
519685|NCT00895531|1269997|P2|NOT COMPLETED|Overall Study||0
519686|NCT00895531|1269998|P1|NOT COMPLETED|Overall Study||0
519687|NCT00895531|1269997|P2|COMPLETED|Overall Study||37
519688|NCT00895531|1269998|P1|COMPLETED|Overall Study||38
519689|NCT00895531|1269997|P2|STARTED|Overall Study||37
519690|NCT00895531|1269998|P1|STARTED|Overall Study||38
519691|NCT00895453|1270007|P3|NOT COMPLETED|Overall Study||23
519692|NCT00895453|1270008|P2|NOT COMPLETED|Overall Study||25
519693|NCT00895453|1270009|P1|NOT COMPLETED|Overall Study||25
519694|NCT00895453|1270007|P3|COMPLETED|Overall Study||23
519695|NCT00895453|1270008|P2|COMPLETED|Overall Study||25
519696|NCT00895453|1270009|P1|COMPLETED|Overall Study||23
519697|NCT00895453|1270007|P3|STARTED|Overall Study||46
519698|NCT00895453|1270008|P2|STARTED|Overall Study||50
519699|NCT00895453|1270009|P1|STARTED|Overall Study||48
519700|NCT00895310|1270017|P1|NOT COMPLETED|Overall Study||1
519701|NCT00895310|1270017|P1|COMPLETED|Overall Study||29
519702|NCT00895310|1270017|P1|STARTED|Overall Study||30
519703|NCT00895284|1270026|P2|NOT COMPLETED|Overall Study||0
519704|NCT00895284|1270027|P1|NOT COMPLETED|Overall Study||0
519705|NCT00895284|1270026|P2|COMPLETED|Overall Study||0
519706|NCT00895284|1270027|P1|COMPLETED|Overall Study||3
519707|NCT00895284|1270026|P2|STARTED|Overall Study||0
519708|NCT00895284|1270027|P1|STARTED|Overall Study||3
519709|NCT00895245|1270033|P1|NOT COMPLETED|Overall Study||6
519710|NCT00895245|1270033|P1|COMPLETED|Overall Study||0
519711|NCT00895245|1270033|P1|STARTED|Overall Study||6
519712|NCT00895232|1270043|P3|NOT COMPLETED|Overall Study||5
519713|NCT00895232|1270044|P2|NOT COMPLETED|Overall Study||4
519714|NCT00895232|1270045|P1|NOT COMPLETED|Overall Study||3
519715|NCT00895232|1270043|P3|COMPLETED|Overall Study||3
519716|NCT00895232|1270044|P2|COMPLETED|Overall Study||2
519717|NCT00895232|1270045|P1|COMPLETED|Overall Study||4
519718|NCT00895232|1270043|P3|STARTED|Overall Study||8
519719|NCT00895232|1270044|P2|STARTED|Overall Study||6
519720|NCT00895232|1270045|P1|STARTED|Overall Study||7
519721|NCT00895193|1270063|P4|NOT COMPLETED|Overall Study||0
519722|NCT00895193|1270064|P3|NOT COMPLETED|Overall Study||0
519723|NCT00895193|1270065|P2|NOT COMPLETED|Overall Study||0
519724|NCT00895193|1270066|P1|NOT COMPLETED|Overall Study||0
519725|NCT00895193|1270063|P4|COMPLETED|Overall Study||25
519726|NCT00895193|1270064|P3|COMPLETED|Overall Study||25
519727|NCT00895193|1270065|P2|COMPLETED|Overall Study||25
519728|NCT00895193|1270066|P1|COMPLETED|Overall Study||25
519729|NCT00895193|1270063|P4|STARTED|Overall Study||25
519730|NCT00895193|1270064|P3|STARTED|Overall Study||25
519731|NCT00895193|1270065|P2|STARTED|Overall Study||25
519732|NCT00895193|1270066|P1|STARTED|Overall Study||25
519733|NCT00895180|1270090|P2|NOT COMPLETED|Overall Study||0
519734|NCT00895180|1270091|P1|NOT COMPLETED|Overall Study||0
519735|NCT00895180|1270090|P2|COMPLETED|Overall Study||40
519736|NCT00895180|1270091|P1|COMPLETED|Overall Study||40
519737|NCT00895180|1270090|P2|Received at Least 1 Dose of Study Drug|Overall Study||40
519738|NCT00895180|1270091|P1|Received at Least 1 Dose of Study Drug|Overall Study||40
519739|NCT00895180|1270090|P2|STARTED|Overall Study||40
519740|NCT00895180|1270091|P1|STARTED|Overall Study||40
519741|NCT00895011|1270112|P3|NOT COMPLETED|Overall Study||8
519742|NCT00895011|1270113|P2|NOT COMPLETED|Overall Study||14
519743|NCT00895011|1270114|P1|NOT COMPLETED|Overall Study||24
519744|NCT00895011|1270112|P3|COMPLETED|Overall Study||91
519745|NCT00895011|1270113|P2|COMPLETED|Overall Study||85
519746|NCT00895011|1270114|P1|COMPLETED|Overall Study||76
519747|NCT00895011|1270112|P3|STARTED|Overall Study||99
519748|NCT00895011|1270113|P2|STARTED|Overall Study||99
519749|NCT00895011|1270114|P1|STARTED|Overall Study||100
519750|NCT00894933|1270128|P1|NOT COMPLETED|Overall Study||4
519751|NCT00894933|1270128|P1|COMPLETED|Overall Study||29
519752|NCT00894933|1270128|P1|STARTED|Overall Study||33
519753|NCT00894803|1270146|P2|NOT COMPLETED|Overall Study||5
519754|NCT00894803|1270147|P1|NOT COMPLETED|Overall Study||20
519755|NCT00894803|1270146|P2|COMPLETED|Overall Study||20
519756|NCT00894803|1270147|P1|COMPLETED|Overall Study||81
519757|NCT00894803|1270146|P2|STARTED|Overall Study||25
519758|NCT00894803|1270147|P1|STARTED|Overall Study||101
519759|NCT00894790|1270183|P2|NOT COMPLETED|Overall Study||2
519760|NCT00894790|1270184|P1|NOT COMPLETED|Overall Study||1
519761|NCT00894790|1270183|P2|COMPLETED|Overall Study||2
519762|NCT00894790|1270184|P1|COMPLETED|Overall Study||3
519763|NCT00894790|1270183|P2|STARTED|Overall Study||4
519764|NCT00894790|1270184|P1|STARTED|Overall Study||4
519765|NCT00894699|1270208|P2|NOT COMPLETED|Overall Study||0
519766|NCT00894699|1270209|P1|NOT COMPLETED|Overall Study||0
519767|NCT00894699|1270208|P2|COMPLETED|Overall Study||19
519768|NCT00894699|1270209|P1|COMPLETED|Overall Study||21
519769|NCT00894699|1270208|P2|STARTED|Overall Study||19
519770|NCT00894699|1270209|P1|STARTED|Overall Study||21
519771|NCT00894647|1270217|P2|NOT COMPLETED|Overall Study||14
519772|NCT00894647|1270218|P1|NOT COMPLETED|Overall Study||10
519773|NCT00894647|1270217|P2|COMPLETED|Overall Study||112
519774|NCT00894647|1270218|P1|COMPLETED|Overall Study||111
519775|NCT00894647|1270217|P2|STARTED|Overall Study||126
519776|NCT00894647|1270218|P1|STARTED|Overall Study||121
519777|NCT00894556|1270231|P4|NOT COMPLETED|Treatment Phase||0
519778|NCT00894556|1270232|P3|NOT COMPLETED|Treatment Phase||1
519779|NCT00894556|1270233|P2|NOT COMPLETED|Treatment Phase||4
519780|NCT00894556|1270234|P1|NOT COMPLETED|Treatment Phase||4
519781|NCT00894556|1270231|P4|COMPLETED|Treatment Phase||0
519782|NCT00894556|1270232|P3|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|35
519783|NCT00894556|1270233|P2|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|32
519784|NCT00894556|1270234|P1|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|33
519785|NCT00894556|1270231|P4|STARTED|Treatment Phase||0
519786|NCT00894556|1270232|P3|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|36
519787|NCT00894556|1270233|P2|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|36
519788|NCT00894556|1270234|P1|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|37
519789|NCT00894556|1270231|P4|NOT COMPLETED|Baseline Phase||85
519790|NCT00894556|1270232|P3|NOT COMPLETED|Baseline Phase||0
519791|NCT00894556|1270233|P2|NOT COMPLETED|Baseline Phase||0
519792|NCT00894556|1270234|P1|NOT COMPLETED|Baseline Phase||0
519793|NCT00894556|1270231|P4|COMPLETED|Baseline Phase||109
519794|NCT00894556|1270232|P3|COMPLETED|Baseline Phase||0
519795|NCT00894556|1270233|P2|COMPLETED|Baseline Phase||0
519796|NCT00894556|1270234|P1|COMPLETED|Baseline Phase||0
519797|NCT00894556|1270231|P4|STARTED|Baseline Phase||194
519798|NCT00894556|1270232|P3|STARTED|Baseline Phase||0
519799|NCT00894556|1270233|P2|STARTED|Baseline Phase||0
519800|NCT00894556|1270234|P1|STARTED|Baseline Phase||0
519801|NCT00894543|1270245|P2|NOT COMPLETED|Week 4 to Week 8||2
519802|NCT00894543|1270246|P1|NOT COMPLETED|Week 4 to Week 8||4
519803|NCT00894543|1270245|P2|COMPLETED|Week 4 to Week 8||97
519804|NCT00894543|1270246|P1|COMPLETED|Week 4 to Week 8||97
519805|NCT00894543|1270245|P2|STARTED|Week 4 to Week 8||99
519806|NCT00894543|1270246|P1|STARTED|Week 4 to Week 8||101
519807|NCT00894543|1270245|P2|NOT COMPLETED|Baseline to Week 4||2
519808|NCT00894543|1270246|P1|NOT COMPLETED|Baseline to Week 4||3
519809|NCT00894543|1270245|P2|COMPLETED|Baseline to Week 4||99
519810|NCT00894543|1270246|P1|COMPLETED|Baseline to Week 4||101
519811|NCT00894543|1270245|P2|STARTED|Baseline to Week 4||101
519812|NCT00894543|1270246|P1|STARTED|Baseline to Week 4||104
519813|NCT00894543|1270245|P2|NOT COMPLETED|Baseline||0
519814|NCT00894543|1270246|P1|NOT COMPLETED|Baseline||0
519815|NCT00894543|1270245|P2|COMPLETED|Baseline||101
519816|NCT00894543|1270246|P1|COMPLETED|Baseline||104
519817|NCT00894543|1270245|P2|STARTED|Baseline||101
519818|NCT00894543|1270246|P1|STARTED|Baseline||104
519819|NCT00894517|1270270|P2|NOT COMPLETED|Overall Study||5
519820|NCT00894517|1270271|P1|NOT COMPLETED|Overall Study||2
519821|NCT00894517|1270270|P2|COMPLETED|Overall Study||26
519822|NCT00894517|1270271|P1|COMPLETED|Overall Study||28
519823|NCT00894517|1270270|P2|STARTED|Overall Study||31
519824|NCT00894517|1270271|P1|STARTED|Overall Study||30
519825|NCT00894504|1270285|P1|NOT COMPLETED|Overall Study||71
519826|NCT00894504|1270285|P1|COMPLETED|Overall Study||0
519827|NCT00894504|1270285|P1|STARTED|Overall Study||71
519828|NCT00894465|1270301|P2|NOT COMPLETED|Overall Study||0
519829|NCT00894465|1270302|P1|NOT COMPLETED|Overall Study||0
519830|NCT00894465|1270301|P2|COMPLETED|Overall Study||22
519831|NCT00894465|1270302|P1|COMPLETED|Overall Study||22
519832|NCT00894465|1270301|P2|STARTED|Overall Study||22
519833|NCT00894465|1270302|P1|STARTED|Overall Study||22
519834|NCT00894387|1270312|P2|NOT COMPLETED|Overall Study||175
519835|NCT00894387|1270313|P1|NOT COMPLETED|Overall Study||175
519836|NCT00894387|1270312|P2|COMPLETED|Overall Study||643
519837|NCT00894387|1270313|P1|COMPLETED|Overall Study|"Completed indicates patients whose treatment duration completed as per protocol"|646
519838|NCT00894387|1270312|P2|Completed Secondary Efficacy Phase (12m)|Overall Study||640
519839|NCT00894387|1270313|P1|Completed Secondary Efficacy Phase (12m)|Overall Study||654
519840|NCT00894387|1270312|P2|Completed Primary Efficacy Phase (6 m)|Overall Study||707
519841|NCT00894387|1270313|P1|Completed Primary Efficacy Phase (6 m)|Overall Study||717
519842|NCT00894387|1270312|P2|Full Analysis Set|Overall Study||807
519843|NCT00894387|1270313|P1|Full Analysis Set|Overall Study||808
519844|NCT00894387|1270312|P2|Safety Set|Overall Study||810
519845|NCT00894387|1270313|P1|Safety Set|Overall Study||808
519846|NCT00894387|1270312|P2|STARTED|Overall Study||818
519847|NCT00894387|1270313|P1|STARTED|Overall Study|"Started indicates all randomized patients"|821
519848|NCT00894361|1270333|P2|NOT COMPLETED|Overall Study||64
519849|NCT00894361|1270334|P1|NOT COMPLETED|Overall Study||24
519850|NCT00894361|1270333|P2|COMPLETED|Overall Study||136
519851|NCT00894361|1270334|P1|COMPLETED|Overall Study||176
519852|NCT00894361|1270333|P2|STARTED|Overall Study||200
519853|NCT00894361|1270334|P1|STARTED|Overall Study||200
519854|NCT00894322|1270343|P3|NOT COMPLETED|Overall Study||0
519855|NCT00894322|1270344|P2|NOT COMPLETED|Overall Study||0
519856|NCT00894322|1270345|P1|NOT COMPLETED|Overall Study||1
519857|NCT00894322|1270343|P3|COMPLETED|Overall Study||12
519858|NCT00894322|1270344|P2|COMPLETED|Overall Study||23
519859|NCT00894322|1270345|P1|COMPLETED|Overall Study||29
519860|NCT00894322|1270343|P3|STARTED|Overall Study||12
519861|NCT00894322|1270344|P2|STARTED|Overall Study||23
519862|NCT00894322|1270345|P1|STARTED|Overall Study||30
519863|NCT00894244|1270384|P1|NOT COMPLETED|Overall Study||1
519864|NCT00894244|1270384|P1|COMPLETED|Overall Study||24
519865|NCT00894244|1270384|P1|STARTED|Overall Study||25
519866|NCT00894166|1270396|P8|NOT COMPLETED|Overall Study||34
519867|NCT00894166|1270397|P7|NOT COMPLETED|Overall Study||16
519868|NCT00894166|1270398|P6|NOT COMPLETED|Overall Study||16
519869|NCT00894166|1270399|P5|NOT COMPLETED|Overall Study||24
519870|NCT00894166|1270400|P4|NOT COMPLETED|Overall Study||69
519871|NCT00894166|1270401|P3|NOT COMPLETED|Overall Study||62
519872|NCT00894166|1270402|P2|NOT COMPLETED|Overall Study||63
519873|NCT00894166|1270403|P1|NOT COMPLETED|Overall Study||61
519874|NCT00894166|1270396|P8|COMPLETED|Overall Study||0
519875|NCT00894166|1270397|P7|COMPLETED|Overall Study||19
519876|NCT00894166|1270398|P6|COMPLETED|Overall Study||20
519877|NCT00894166|1270399|P5|COMPLETED|Overall Study||10
519878|NCT00894166|1270400|P4|COMPLETED|Overall Study||45
519879|NCT00894166|1270401|P3|COMPLETED|Overall Study||50
519880|NCT00894166|1270402|P2|COMPLETED|Overall Study||46
519881|NCT00894166|1270403|P1|COMPLETED|Overall Study||71
519882|NCT00894166|1270396|P8|STARTED|Overall Study||34
519883|NCT00894166|1270397|P7|STARTED|Overall Study||35
519884|NCT00894166|1270398|P6|STARTED|Overall Study||36
519885|NCT00894166|1270399|P5|STARTED|Overall Study||34
519886|NCT00894166|1270400|P4|STARTED|Overall Study||114
519887|NCT00894166|1270401|P3|STARTED|Overall Study||112
519888|NCT00894166|1270402|P2|STARTED|Overall Study||109
519889|NCT00894166|1270403|P1|STARTED|Overall Study||132
519890|NCT00894127|1270433|P1|NOT COMPLETED|Overall Study||0
519891|NCT00894127|1270433|P1|COMPLETED|Overall Study||128
519892|NCT00894127|1270433|P1|STARTED|Overall Study||128
519893|NCT00893997|1270437|P1|NOT COMPLETED|Overall Study||0
519894|NCT00893997|1270437|P1|COMPLETED|Overall Study||10
519895|NCT00893997|1270437|P1|STARTED|Overall Study||10
519896|NCT00893971|1270442|P1|NOT COMPLETED|Overall Study||3
519897|NCT00893971|1270442|P1|COMPLETED|Overall Study||13
519898|NCT00893971|1270442|P1|GP MDI (PT001) + FF MDI (PT005)|Overall Study||16
519899|NCT00893971|1270442|P1|Placebo + FF MDI (PT005)|Overall Study||13
519900|NCT00893971|1270442|P1|Placebo + GFF MDI (PT003)|Overall Study||15
519901|NCT00893971|1270442|P1|Placebo + GP MDI (PT001)|Overall Study||15
519902|NCT00893971|1270442|P1|STARTED|Overall Study||16
519903|NCT00893789|1270560|P4|NOT COMPLETED|Overall Study||13
519904|NCT00893789|1270561|P3|NOT COMPLETED|Overall Study||7
519905|NCT00893789|1270562|P2|NOT COMPLETED|Overall Study||4
519906|NCT00893789|1270563|P1|NOT COMPLETED|Overall Study||6
519907|NCT00893789|1270560|P4|COMPLETED|Overall Study||16
519908|NCT00893789|1270561|P3|COMPLETED|Overall Study||22
519909|NCT00893789|1270562|P2|COMPLETED|Overall Study||26
519910|NCT00893789|1270563|P1|COMPLETED|Overall Study||23
519911|NCT00893789|1270560|P4|Full Analysis Set (FAS)|Overall Study||27
519912|NCT00893789|1270561|P3|Full Analysis Set (FAS)|Overall Study||28
519913|NCT00893789|1270562|P2|Full Analysis Set (FAS)|Overall Study||29
519914|NCT00893789|1270563|P1|Full Analysis Set (FAS)|Overall Study|FAS = participants in the safety analysis set with ≥1 postbaseline primary efficacy assessment.|29
519915|NCT00893789|1270560|P4|Safety Analysis Set (SAS)|Overall Study||29
519916|NCT00893789|1270561|P3|Safety Analysis Set (SAS)|Overall Study||29
519917|NCT00893789|1270562|P2|Safety Analysis Set (SAS)|Overall Study||30
519918|NCT00893789|1270563|P1|Safety Analysis Set (SAS)|Overall Study|SAS = all participants who received 1 or more doses of study drug.|29
519919|NCT00893789|1270560|P4|STARTED|Overall Study||29
519920|NCT00893789|1270561|P3|STARTED|Overall Study||29
519921|NCT00893789|1270562|P2|STARTED|Overall Study||30
519922|NCT00893789|1270563|P1|STARTED|Overall Study||29
519923|NCT00893763|1270647|P2|NOT COMPLETED|Overall Study||110
519924|NCT00893763|1270648|P1|NOT COMPLETED|Overall Study||110
519925|NCT00893763|1270647|P2|COMPLETED|Overall Study||47
519926|NCT00893763|1270648|P1|COMPLETED|Overall Study||47
519927|NCT00893763|1270647|P2|STARTED|Overall Study||157
519928|NCT00893763|1270648|P1|STARTED|Overall Study||157
519929|NCT00893737|1270656|P1|NOT COMPLETED|Overall Study||12
519930|NCT00893737|1270656|P1|COMPLETED|Overall Study||135
519931|NCT00893737|1270656|P1|STARTED|Overall Study||147
519932|NCT00893464|1270670|P8|NOT COMPLETED|Overall Study||2
519933|NCT00893464|1270671|P7|NOT COMPLETED|Overall Study||2
519934|NCT00893464|1270672|P6|NOT COMPLETED|Overall Study||0
519935|NCT00893464|1270673|P5|NOT COMPLETED|Overall Study||0
519936|NCT00893464|1270674|P4|NOT COMPLETED|Overall Study||0
519937|NCT00893464|1270675|P3|NOT COMPLETED|Overall Study||0
519938|NCT00893464|1270676|P2|NOT COMPLETED|Overall Study||0
519939|NCT00893464|1270677|P1|NOT COMPLETED|Overall Study||0
519940|NCT00893464|1270670|P8|COMPLETED|Overall Study||3
519941|NCT00893464|1270671|P7|COMPLETED|Overall Study||8
519942|NCT00893464|1270672|P6|COMPLETED|Overall Study||7
519943|NCT00893464|1270673|P5|COMPLETED|Overall Study||4
519944|NCT00893464|1270674|P4|COMPLETED|Overall Study||1
519945|NCT00893464|1270675|P3|COMPLETED|Overall Study||1
519946|NCT00893464|1270676|P2|COMPLETED|Overall Study||1
519947|NCT00893464|1270677|P1|COMPLETED|Overall Study||1
519948|NCT00893464|1270670|P8|STARTED|Overall Study||5
519949|NCT00893464|1270671|P7|STARTED|Overall Study||10
519950|NCT00893464|1270672|P6|STARTED|Overall Study||7
519951|NCT00893464|1270673|P5|STARTED|Overall Study||4
519952|NCT00893464|1270674|P4|STARTED|Overall Study||1
519953|NCT00893464|1270675|P3|STARTED|Overall Study||1
519954|NCT00893464|1270676|P2|STARTED|Overall Study||1
519955|NCT00893464|1270677|P1|STARTED|Overall Study||1
519956|NCT00893152|1270795|P2|NOT COMPLETED|Overall Study||0
519957|NCT00893152|1270796|P1|NOT COMPLETED|Overall Study||0
519958|NCT00893152|1270795|P2|COMPLETED|Overall Study||36
519959|NCT00893152|1270796|P1|COMPLETED|Overall Study||47
519960|NCT00893152|1270795|P2|STARTED|Overall Study||36
519961|NCT00893152|1270796|P1|STARTED|Overall Study||47
519962|NCT00893113|1270804|P2|NOT COMPLETED|Overall Study||16
519963|NCT00893113|1270805|P1|NOT COMPLETED|Overall Study||13
519964|NCT00893113|1270804|P2|COMPLETED|Overall Study||22
519965|NCT00893113|1270805|P1|COMPLETED|Overall Study||23
519966|NCT00893113|1270804|P2|STARTED|Overall Study||38
519967|NCT00893113|1270805|P1|STARTED|Overall Study||36
519968|NCT00893074|1270815|P1|NOT COMPLETED|Overall Study||11
519969|NCT00893074|1270815|P1|COMPLETED|Overall Study||13
519970|NCT00893074|1270815|P1|STARTED|Overall Study||24
519971|NCT00892957|1270835|P2|NOT COMPLETED|Postoperative Day 30 Assessment||0
519972|NCT00892957|1270836|P1|NOT COMPLETED|Postoperative Day 30 Assessment||0
519973|NCT00892957|1270835|P2|COMPLETED|Postoperative Day 30 Assessment||66
519974|NCT00892957|1270836|P1|COMPLETED|Postoperative Day 30 Assessment||70
519975|NCT00892957|1270835|P2|STARTED|Postoperative Day 30 Assessment||66
519976|NCT00892957|1270836|P1|STARTED|Postoperative Day 30 Assessment|Two participants missed postoperative Day 14 assessment, both returned for Day 30 postop assessment|70
519977|NCT00892957|1270835|P2|NOT COMPLETED|Postoperative Day 14 Assessment||0
519978|NCT00892957|1270836|P1|NOT COMPLETED|Postoperative Day 14 Assessment||0
519979|NCT00892957|1270835|P2|COMPLETED|Postoperative Day 14 Assessment||66
519980|NCT00892957|1270836|P1|COMPLETED|Postoperative Day 14 Assessment||68
519981|NCT00892957|1270835|P2|STARTED|Postoperative Day 14 Assessment||66
519982|NCT00892957|1270836|P1|STARTED|Postoperative Day 14 Assessment|Two participants missed postoperative Day 14 assessment, both returned for Day 30 postop assessment|68
519983|NCT00892957|1270835|P2|NOT COMPLETED|Between Postoperative Day 1 and Day 14||4
519984|NCT00892957|1270836|P1|NOT COMPLETED|Between Postoperative Day 1 and Day 14||0
519985|NCT00892957|1270835|P2|COMPLETED|Between Postoperative Day 1 and Day 14||66
519986|NCT00892957|1270836|P1|COMPLETED|Between Postoperative Day 1 and Day 14||70
519987|NCT00892957|1270835|P2|STARTED|Between Postoperative Day 1 and Day 14||70
519988|NCT00892957|1270836|P1|STARTED|Between Postoperative Day 1 and Day 14||70
519989|NCT00892957|1270835|P2|NOT COMPLETED|Postoperative Day 1 Assessment||0
519990|NCT00892957|1270836|P1|NOT COMPLETED|Postoperative Day 1 Assessment||0
519991|NCT00892957|1270835|P2|COMPLETED|Postoperative Day 1 Assessment||70
519992|NCT00892957|1270836|P1|COMPLETED|Postoperative Day 1 Assessment||70
519993|NCT00892957|1270835|P2|STARTED|Postoperative Day 1 Assessment||70
519994|NCT00892957|1270836|P1|STARTED|Postoperative Day 1 Assessment||70
519995|NCT00892957|1270835|P2|NOT COMPLETED|Intraoperative Day 0||0
519996|NCT00892957|1270836|P1|NOT COMPLETED|Intraoperative Day 0||0
519997|NCT00892957|1270835|P2|COMPLETED|Intraoperative Day 0||70
519998|NCT00892957|1270836|P1|COMPLETED|Intraoperative Day 0||70
519999|NCT00892957|1270835|P2|STARTED|Intraoperative Day 0||70
520000|NCT00892957|1270836|P1|STARTED|Intraoperative Day 0||70
520001|NCT00892775|1270924|P2|NOT COMPLETED|Overall Study||1
520002|NCT00892775|1270925|P1|NOT COMPLETED|Overall Study||5
520003|NCT00892775|1270924|P2|COMPLETED|Overall Study||165
520004|NCT00892775|1270925|P1|COMPLETED|Overall Study||327
520005|NCT00892775|1270924|P2|STARTED|Overall Study||166
520006|NCT00892775|1270925|P1|STARTED|Overall Study||332
520007|NCT00892723|1270952|P3|NOT COMPLETED|Overall Study||2
520008|NCT00892723|1270953|P2|NOT COMPLETED|Overall Study||4
520009|NCT00892723|1270954|P1|NOT COMPLETED|Overall Study||2
520010|NCT00892723|1270952|P3|COMPLETED|Overall Study||17
520011|NCT00892723|1270953|P2|COMPLETED|Overall Study||15
520012|NCT00892723|1270954|P1|COMPLETED|Overall Study||19
520013|NCT00892723|1270952|P3|STARTED|Overall Study||19
520014|NCT00892723|1270953|P2|STARTED|Overall Study||19
520015|NCT00892723|1270954|P1|STARTED|Overall Study||21
520016|NCT00892710|1270998|P3|NOT COMPLETED|Overall Study||55
520017|NCT00892710|1270999|P2|NOT COMPLETED|Overall Study||59
520018|NCT00892710|1271000|P1|NOT COMPLETED|Overall Study||48
520019|NCT00892710|1270998|P3|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
520020|NCT00892710|1270999|P2|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
520021|NCT00892710|1271000|P1|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
520022|NCT00892710|1270998|P3|STARTED|Overall Study||55
520023|NCT00892710|1270999|P2|STARTED|Overall Study||59
520024|NCT00892710|1271000|P1|STARTED|Overall Study||48
520025|NCT00892697|1271023|P1|NOT COMPLETED|Overall Study||0
520026|NCT00892697|1271023|P1|COMPLETED|Overall Study||15
520027|NCT00892697|1271023|P1|STARTED|Overall Study||15
520028|NCT00892606|1271030|P2|NOT COMPLETED|Overall Study||4
520029|NCT00892606|1271031|P1|NOT COMPLETED|Overall Study||5
520030|NCT00892606|1271030|P2|COMPLETED|Overall Study||33
520031|NCT00892606|1271031|P1|COMPLETED|Overall Study||33
520032|NCT00892606|1271030|P2|STARTED|Overall Study||37
520033|NCT00892606|1271031|P1|STARTED|Overall Study||38
520034|NCT00892437|1271043|P2|NOT COMPLETED|Open-Label Extension Phase||4
520035|NCT00892437|1271044|P1|NOT COMPLETED|Open-Label Extension Phase||12
520036|NCT00892437|1271043|P2|COMPLETED|Open-Label Extension Phase||15
520037|NCT00892437|1271044|P1|COMPLETED|Open-Label Extension Phase||32
520038|NCT00892437|1271043|P2|STARTED|Open-Label Extension Phase|5 participants completed the randomized phase but did not enter the open-label extension phase.|19
520039|NCT00892437|1271044|P1|STARTED|Open-Label Extension Phase|1 participant completed the randomized phase but did not enter the open-label extension phase.|44
520040|NCT00892437|1271043|P2|NOT COMPLETED|Randomized Phase||5
520041|NCT00892437|1271044|P1|NOT COMPLETED|Randomized Phase||11
520042|NCT00892437|1271043|P2|COMPLETED|Randomized Phase||24
520043|NCT00892437|1271044|P1|COMPLETED|Randomized Phase||45
520044|NCT00892437|1271043|P2|Randomized and Treated|Randomized Phase||29
520045|NCT00892437|1271044|P1|Randomized and Treated|Randomized Phase||50
520046|NCT00892437|1271043|P2|STARTED|Randomized Phase||29
520047|NCT00892437|1271044|P1|STARTED|Randomized Phase||56
520048|NCT00892281|1271063|P2|NOT COMPLETED|Overall Study||37
520049|NCT00892281|1271064|P1|NOT COMPLETED|Overall Study||267
520050|NCT00892281|1271063|P2|COMPLETED|Overall Study||187
520051|NCT00892281|1271064|P1|COMPLETED|Overall Study||930
520052|NCT00892281|1271063|P2|STARTED|Overall Study||224
520053|NCT00892281|1271064|P1|STARTED|Overall Study||1197
520054|NCT00892177|1271077|P6|NOT COMPLETED|Phase II||2
520055|NCT00892177|1271078|P5|NOT COMPLETED|Phase II||5
520056|NCT00892177|1271079|P4|NOT COMPLETED|Phase II||0
520057|NCT00892177|1271080|P3|NOT COMPLETED|Phase II||0
520058|NCT00892177|1271081|P2|NOT COMPLETED|Phase II||0
520059|NCT00892177|1271082|P1|NOT COMPLETED|Phase II||0
520060|NCT00892177|1271077|P6|COMPLETED|Phase II||38
520061|NCT00892177|1271078|P5|COMPLETED|Phase II||83
520062|NCT00892177|1271079|P4|COMPLETED|Phase II||0
520063|NCT00892177|1271080|P3|COMPLETED|Phase II||0
520064|NCT00892177|1271081|P2|COMPLETED|Phase II||0
520065|NCT00892177|1271082|P1|COMPLETED|Phase II||0
520066|NCT00892177|1271077|P6|STARTED|Phase II||40
520067|NCT00892177|1271078|P5|STARTED|Phase II||88
520068|NCT00892177|1271079|P4|STARTED|Phase II||0
520069|NCT00892177|1271080|P3|STARTED|Phase II||0
520070|NCT00892177|1271081|P2|STARTED|Phase II||0
520071|NCT00892177|1271082|P1|STARTED|Phase II||0
520072|NCT00892177|1271077|P6|NOT COMPLETED|Phase I: Dose Level 3||0
520073|NCT00892177|1271078|P5|NOT COMPLETED|Phase I: Dose Level 3||0
520074|NCT00892177|1271079|P4|NOT COMPLETED|Phase I: Dose Level 3||0
520075|NCT00892177|1271080|P3|NOT COMPLETED|Phase I: Dose Level 3||0
520076|NCT00892177|1271081|P2|NOT COMPLETED|Phase I: Dose Level 3||0
520077|NCT00892177|1271082|P1|NOT COMPLETED|Phase I: Dose Level 3||0
520078|NCT00892177|1271077|P6|COMPLETED|Phase I: Dose Level 3||0
520079|NCT00892177|1271078|P5|COMPLETED|Phase I: Dose Level 3||0
520080|NCT00892177|1271079|P4|COMPLETED|Phase I: Dose Level 3||6
520081|NCT00892177|1271080|P3|COMPLETED|Phase I: Dose Level 3||0
520082|NCT00892177|1271081|P2|COMPLETED|Phase I: Dose Level 3||0
520083|NCT00892177|1271082|P1|COMPLETED|Phase I: Dose Level 3||0
520084|NCT00892177|1271077|P6|STARTED|Phase I: Dose Level 3||0
520085|NCT00892177|1271078|P5|STARTED|Phase I: Dose Level 3||0
520086|NCT00892177|1271079|P4|STARTED|Phase I: Dose Level 3||6
520087|NCT00892177|1271080|P3|STARTED|Phase I: Dose Level 3||0
520088|NCT00892177|1271081|P2|STARTED|Phase I: Dose Level 3||0
520089|NCT00892177|1271082|P1|STARTED|Phase I: Dose Level 3||0
520090|NCT00892177|1271077|P6|NOT COMPLETED|Phase I: Dose Level 2||0
520091|NCT00892177|1271078|P5|NOT COMPLETED|Phase I: Dose Level 2||0
520092|NCT00892177|1271079|P4|NOT COMPLETED|Phase I: Dose Level 2||0
520093|NCT00892177|1271080|P3|NOT COMPLETED|Phase I: Dose Level 2||0
520094|NCT00892177|1271081|P2|NOT COMPLETED|Phase I: Dose Level 2||0
520095|NCT00892177|1271082|P1|NOT COMPLETED|Phase I: Dose Level 2||0
520096|NCT00892177|1271077|P6|COMPLETED|Phase I: Dose Level 2||0
520097|NCT00892177|1271078|P5|COMPLETED|Phase I: Dose Level 2||0
520098|NCT00892177|1271079|P4|COMPLETED|Phase I: Dose Level 2||0
520099|NCT00892177|1271080|P3|COMPLETED|Phase I: Dose Level 2||3
520100|NCT00892177|1271081|P2|COMPLETED|Phase I: Dose Level 2||0
520101|NCT00892177|1271082|P1|COMPLETED|Phase I: Dose Level 2||0
520102|NCT00892177|1271077|P6|STARTED|Phase I: Dose Level 2||0
520103|NCT00892177|1271078|P5|STARTED|Phase I: Dose Level 2||0
520104|NCT00892177|1271079|P4|STARTED|Phase I: Dose Level 2||0
520105|NCT00892177|1271080|P3|STARTED|Phase I: Dose Level 2||3
520106|NCT00892177|1271081|P2|STARTED|Phase I: Dose Level 2||0
520107|NCT00892177|1271082|P1|STARTED|Phase I: Dose Level 2||0
520108|NCT00892177|1271077|P6|NOT COMPLETED|Phase I: Dose Level 1||0
520109|NCT00892177|1271078|P5|NOT COMPLETED|Phase I: Dose Level 1||0
520110|NCT00892177|1271079|P4|NOT COMPLETED|Phase I: Dose Level 1||0
520111|NCT00892177|1271080|P3|NOT COMPLETED|Phase I: Dose Level 1||0
520112|NCT00892177|1271081|P2|NOT COMPLETED|Phase I: Dose Level 1||0
520113|NCT00892177|1271082|P1|NOT COMPLETED|Phase I: Dose Level 1||0
520114|NCT00892177|1271077|P6|COMPLETED|Phase I: Dose Level 1||0
520115|NCT00892177|1271078|P5|COMPLETED|Phase I: Dose Level 1||0
520116|NCT00892177|1271079|P4|COMPLETED|Phase I: Dose Level 1||0
520117|NCT00892177|1271080|P3|COMPLETED|Phase I: Dose Level 1||0
520118|NCT00892177|1271081|P2|COMPLETED|Phase I: Dose Level 1||4
520119|NCT00892177|1271082|P1|COMPLETED|Phase I: Dose Level 1||0
520120|NCT00892177|1271077|P6|STARTED|Phase I: Dose Level 1||0
520121|NCT00892177|1271078|P5|STARTED|Phase I: Dose Level 1||0
520122|NCT00892177|1271079|P4|STARTED|Phase I: Dose Level 1||0
520123|NCT00892177|1271080|P3|STARTED|Phase I: Dose Level 1||0
520124|NCT00892177|1271081|P2|STARTED|Phase I: Dose Level 1||4
520125|NCT00892177|1271082|P1|STARTED|Phase I: Dose Level 1||0
520126|NCT00892177|1271077|P6|NOT COMPLETED|Phase I: Dose Level 0||0
520127|NCT00892177|1271078|P5|NOT COMPLETED|Phase I: Dose Level 0||0
520128|NCT00892177|1271079|P4|NOT COMPLETED|Phase I: Dose Level 0||0
520129|NCT00892177|1271080|P3|NOT COMPLETED|Phase I: Dose Level 0||0
520130|NCT00892177|1271081|P2|NOT COMPLETED|Phase I: Dose Level 0||0
520131|NCT00892177|1271082|P1|NOT COMPLETED|Phase I: Dose Level 0||0
520132|NCT00892177|1271077|P6|COMPLETED|Phase I: Dose Level 0||0
520133|NCT00892177|1271078|P5|COMPLETED|Phase I: Dose Level 0||0
520134|NCT00892177|1271079|P4|COMPLETED|Phase I: Dose Level 0||0
520135|NCT00892177|1271080|P3|COMPLETED|Phase I: Dose Level 0||0
520136|NCT00892177|1271081|P2|COMPLETED|Phase I: Dose Level 0||0
520137|NCT00892177|1271082|P1|COMPLETED|Phase I: Dose Level 0||3
520138|NCT00892177|1271077|P6|STARTED|Phase I: Dose Level 0||0
520139|NCT00892177|1271078|P5|STARTED|Phase I: Dose Level 0||0
520140|NCT00892177|1271079|P4|STARTED|Phase I: Dose Level 0||0
520141|NCT00892177|1271080|P3|STARTED|Phase I: Dose Level 0||0
520142|NCT00892177|1271081|P2|STARTED|Phase I: Dose Level 0||0
520143|NCT00892177|1271082|P1|STARTED|Phase I: Dose Level 0||3
520144|NCT00892151|1271107|P1|NOT COMPLETED|Overall Study||1
520145|NCT00892151|1271107|P1|COMPLETED|Overall Study||50
520146|NCT00892151|1271107|P1|STARTED|Overall Study||51
520147|NCT00892099|1271116|P3|NOT COMPLETED|Overall Study||7
520148|NCT00892099|1271117|P2|NOT COMPLETED|Overall Study||1
520149|NCT00892099|1271118|P1|NOT COMPLETED|Overall Study||5
520150|NCT00892099|1271116|P3|COMPLETED|Overall Study||29
520151|NCT00892099|1271117|P2|COMPLETED|Overall Study||32
520152|NCT00892099|1271118|P1|COMPLETED|Overall Study||31
520153|NCT00892099|1271116|P3|STARTED|Overall Study||36
520154|NCT00892099|1271117|P2|STARTED|Overall Study||33
520155|NCT00892099|1271118|P1|STARTED|Overall Study||36
520156|NCT00892047|1271143|P2|NOT COMPLETED|Overall Study||7
520157|NCT00892047|1271144|P1|NOT COMPLETED|Overall Study||4
520158|NCT00892047|1271143|P2|COMPLETED|Overall Study||83
520159|NCT00892047|1271144|P1|COMPLETED|Overall Study||87
520160|NCT00892047|1271143|P2|STARTED|Overall Study||90
520161|NCT00892047|1271144|P1|STARTED|Overall Study||91
520162|NCT00892008|1271160|P1|NOT COMPLETED|Overall Study||565
520163|NCT00892008|1271160|P1|COMPLETED|Overall Study||1713
520164|NCT00892008|1271160|P1|STARTED|Overall Study||2278
520165|NCT00891995|1271176|P2|NOT COMPLETED|Overall Study||0
520166|NCT00891995|1271177|P1|NOT COMPLETED|Overall Study||0
520167|NCT00891995|1271176|P2|COMPLETED|Overall Study||21
520168|NCT00891995|1271177|P1|COMPLETED|Overall Study||50
520169|NCT00891995|1271176|P2|STARTED|Overall Study||21
520170|NCT00891995|1271177|P1|STARTED|Overall Study||50
520171|NCT00891982|1271201|P2|NOT COMPLETED|Overall Study||1
520172|NCT00891982|1271202|P1|NOT COMPLETED|Overall Study||2
520173|NCT00891982|1271201|P2|COMPLETED|Overall Study||30
520174|NCT00891982|1271202|P1|COMPLETED|Overall Study||28
520175|NCT00891982|1271201|P2|STARTED|Overall Study||31
520176|NCT00891982|1271202|P1|STARTED|Overall Study||30
520177|NCT00891930|1271246|P1|NOT COMPLETED|Part 2: Panitumumab + Ganitumab||31
520178|NCT00891930|1271246|P1|COMPLETED|Part 2: Panitumumab + Ganitumab||5
520179|NCT00891930|1271246|P1|STARTED|Part 2: Panitumumab + Ganitumab||36
520180|NCT00891930|1271246|P1|NOT COMPLETED|Part 1: Panitumumab +Irinotecan||40
520181|NCT00891930|1271246|P1|COMPLETED|Part 1: Panitumumab +Irinotecan||36
520182|NCT00891930|1271246|P1|Received Treatment|Part 1: Panitumumab +Irinotecan||74
520183|NCT00891930|1271246|P1|STARTED|Part 1: Panitumumab +Irinotecan||76
520184|NCT00891904|1271267|P1|NOT COMPLETED|Overall Study||2
520185|NCT00891904|1271267|P1|COMPLETED|Overall Study||0
520186|NCT00891904|1271267|P1|STARTED|Overall Study||2
520187|NCT00891839|1271274|P1|NOT COMPLETED|Overall Study||7
520188|NCT00891839|1271274|P1|COMPLETED|Overall Study|completed treatment|38
520189|NCT00891839|1271274|P1|STARTED|Overall Study||45
520190|NCT00891813|1271283|P1|NOT COMPLETED|Overall Study||12
520191|NCT00891813|1271283|P1|COMPLETED|Overall Study||88
520192|NCT00891813|1271283|P1|STARTED|Overall Study||100
520193|NCT00891774|1271289|P1|NOT COMPLETED|Overall Study||14
520194|NCT00891774|1271289|P1|COMPLETED|Overall Study||158
520195|NCT00891774|1271289|P1|STARTED|Overall Study||172
520196|NCT00891735|1271297|P4|NOT COMPLETED|Overall Study||15
520197|NCT00891735|1271298|P3|NOT COMPLETED|Overall Study||12
520198|NCT00891735|1271299|P2|NOT COMPLETED|Overall Study||16
520199|NCT00891735|1271300|P1|NOT COMPLETED|Overall Study||17
520200|NCT00891735|1271297|P4|COMPLETED|Overall Study||258
520201|NCT00891735|1271298|P3|COMPLETED|Overall Study||263
520202|NCT00891735|1271299|P2|COMPLETED|Overall Study||258
520203|NCT00891735|1271300|P1|COMPLETED|Overall Study||258
520204|NCT00891735|1271297|P4|STARTED|Overall Study||273
520205|NCT00891735|1271298|P3|STARTED|Overall Study||275
520206|NCT00891735|1271299|P2|STARTED|Overall Study||274
520207|NCT00891735|1271300|P1|STARTED|Overall Study||275
520208|NCT00891657|1271340|P2|NOT COMPLETED|Overall Study||1
520209|NCT00891657|1271341|P1|NOT COMPLETED|Overall Study||1
520210|NCT00891657|1271340|P2|COMPLETED|Overall Study||5
520211|NCT00891657|1271341|P1|COMPLETED|Overall Study||8
520212|NCT00891657|1271340|P2|STARTED|Overall Study||6
520213|NCT00891657|1271341|P1|STARTED|Overall Study||9
520214|NCT00891618|1271353|P1|NOT COMPLETED|Overall Study||1
520215|NCT00891618|1271353|P1|COMPLETED|Overall Study||20
520216|NCT00891618|1271353|P1|STARTED|Overall Study||21
520217|NCT00891527|1271357|P1|NOT COMPLETED|Overall Study||2
520218|NCT00891527|1271357|P1|COMPLETED|Overall Study||48
520219|NCT00891527|1271357|P1|STARTED|Overall Study||50
520220|NCT00891462|1271366|P3|NOT COMPLETED|Overall Study||24
520221|NCT00891462|1271367|P2|NOT COMPLETED|Overall Study||33
520222|NCT00891462|1271368|P1|NOT COMPLETED|Overall Study||37
520223|NCT00891462|1271366|P3|COMPLETED|Overall Study||166
520224|NCT00891462|1271367|P2|COMPLETED|Overall Study||152
520225|NCT00891462|1271368|P1|COMPLETED|Overall Study||149
520226|NCT00891462|1271366|P3|STARTED|Overall Study||190
520227|NCT00891462|1271367|P2|STARTED|Overall Study||185
520228|NCT00891462|1271368|P1|STARTED|Overall Study||186
520229|NCT00891436|1271381|P2|NOT COMPLETED|Overall Study||0
520230|NCT00891436|1271382|P1|NOT COMPLETED|Overall Study||0
520231|NCT00891436|1271381|P2|COMPLETED|Overall Study||10
520232|NCT00891436|1271382|P1|COMPLETED|Overall Study||10
520233|NCT00891436|1271381|P2|STARTED|Overall Study||10
520234|NCT00891436|1271382|P1|STARTED|Overall Study||10
520235|NCT00891371|1271390|P1|NOT COMPLETED|Treatment||9
520236|NCT00891371|1271390|P1|COMPLETED|Treatment||27
520237|NCT00891371|1271390|P1|STARTED|Treatment||36
520238|NCT00891371|1271390|P1|NOT COMPLETED|Pre-assignment||6
520239|NCT00891371|1271390|P1|COMPLETED|Pre-assignment||36
520240|NCT00891371|1271390|P1|STARTED|Pre-assignment||42
520241|NCT00891319|1271401|P2|NOT COMPLETED|Overall Study||0
520242|NCT00891319|1271402|P1|NOT COMPLETED|Overall Study||8
520243|NCT00891319|1271401|P2|COMPLETED|Overall Study||40
520244|NCT00891319|1271402|P1|COMPLETED|Overall Study||32
520245|NCT00891319|1271401|P2|STARTED|Overall Study||40
520246|NCT00891319|1271402|P1|STARTED|Overall Study||40
520247|NCT00891293|1271412|P1|NOT COMPLETED|Overall Study||84
520248|NCT00891293|1271412|P1|COMPLETED|Overall Study||9
520249|NCT00891293|1271412|P1|STARTED|Overall Study|93 participants were enrolled; baseline data are provided for 89 participants (Safety Population).|93
520250|NCT00891228|1271427|P3|NOT COMPLETED|Overall Study||15
520251|NCT00891228|1271428|P2|NOT COMPLETED|Overall Study||13
520252|NCT00891228|1271429|P1|NOT COMPLETED|Overall Study||11
520253|NCT00891228|1271427|P3|COMPLETED|Overall Study||19
520254|NCT00891228|1271428|P2|COMPLETED|Overall Study||20
520255|NCT00891228|1271429|P1|COMPLETED|Overall Study||21
520256|NCT00891228|1271427|P3|STARTED|Overall Study||34
520257|NCT00891228|1271428|P2|STARTED|Overall Study||33
520258|NCT00891228|1271429|P1|STARTED|Overall Study||32
520259|NCT00891202|1271451|P4|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||5
520260|NCT00891202|1271452|P3|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||7
520261|NCT00891202|1271453|P2|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
520262|NCT00891202|1271454|P1|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
520263|NCT00891202|1271451|P4|COMPLETED|LTTP (Post-Week 39 up to Week 312)||15
520264|NCT00891202|1271452|P3|COMPLETED|LTTP (Post-Week 39 up to Week 312)||12
520265|NCT00891202|1271453|P2|COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
520266|NCT00891202|1271454|P1|COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
520267|NCT00891202|1271451|P4|STARTED|LTTP (Post-Week 39 up to Week 312)||20
520268|NCT00891202|1271452|P3|STARTED|LTTP (Post-Week 39 up to Week 312)||19
520269|NCT00891202|1271453|P2|STARTED|LTTP (Post-Week 39 up to Week 312)||0
520270|NCT00891202|1271454|P1|STARTED|LTTP (Post-Week 39 up to Week 312)||0
520271|NCT00891202|1271451|P4|NOT COMPLETED|PAP (Up To Week 39)||0
520272|NCT00891202|1271452|P3|NOT COMPLETED|PAP (Up To Week 39)||0
520273|NCT00891202|1271453|P2|NOT COMPLETED|PAP (Up To Week 39)||0
520274|NCT00891202|1271454|P1|NOT COMPLETED|PAP (Up To Week 39)||1
520275|NCT00891202|1271451|P4|COMPLETED|PAP (Up To Week 39)||0
520276|NCT00891202|1271452|P3|COMPLETED|PAP (Up To Week 39)||0
520277|NCT00891202|1271453|P2|COMPLETED|PAP (Up To Week 39)||20
520278|NCT00891202|1271454|P1|COMPLETED|PAP (Up To Week 39)||19
520279|NCT00891202|1271451|P4|STARTED|PAP (Up To Week 39)||0
520280|NCT00891202|1271452|P3|STARTED|PAP (Up To Week 39)||0
520281|NCT00891202|1271453|P2|STARTED|PAP (Up To Week 39)||20
520282|NCT00891202|1271454|P1|STARTED|PAP (Up To Week 39)||20
520283|NCT00891176|1271480|P4|NOT COMPLETED|At 6 Years of Age||0
520284|NCT00891176|1271481|P3|NOT COMPLETED|At 6 Years of Age||0
520285|NCT00891176|1271482|P2|NOT COMPLETED|At 6 Years of Age||0
520286|NCT00891176|1271483|P1|NOT COMPLETED|At 6 Years of Age||0
520287|NCT00891176|1271480|P4|COMPLETED|At 6 Years of Age||135
520288|NCT00891176|1271481|P3|COMPLETED|At 6 Years of Age||135
520289|NCT00891176|1271482|P2|COMPLETED|At 6 Years of Age||138
520290|NCT00891176|1271483|P1|COMPLETED|At 6 Years of Age||131
520291|NCT00891176|1271480|P4|STARTED|At 6 Years of Age||135
520292|NCT00891176|1271481|P3|STARTED|At 6 Years of Age||135
520293|NCT00891176|1271482|P2|STARTED|At 6 Years of Age||138
520294|NCT00891176|1271483|P1|STARTED|At 6 Years of Age||131
520295|NCT00891176|1271480|P4|NOT COMPLETED|At 4 Years of Age||0
520296|NCT00891176|1271481|P3|NOT COMPLETED|At 4 Years of Age||0
520297|NCT00891176|1271482|P2|NOT COMPLETED|At 4 Years of Age||0
520298|NCT00891176|1271483|P1|NOT COMPLETED|At 4 Years of Age||0
520299|NCT00891176|1271480|P4|COMPLETED|At 4 Years of Age||137
520300|NCT00891176|1271481|P3|COMPLETED|At 4 Years of Age||142
520301|NCT00891176|1271482|P2|COMPLETED|At 4 Years of Age||142
520302|NCT00891176|1271483|P1|COMPLETED|At 4 Years of Age||140
520303|NCT00891176|1271480|P4|STARTED|At 4 Years of Age||137
520304|NCT00891176|1271481|P3|STARTED|At 4 Years of Age||142
520305|NCT00891176|1271482|P2|STARTED|At 4 Years of Age||142
520306|NCT00891176|1271483|P1|STARTED|At 4 Years of Age||140
520307|NCT00891176|1271480|P4|NOT COMPLETED|At 3 Years of Age||0
520308|NCT00891176|1271481|P3|NOT COMPLETED|At 3 Years of Age||0
520309|NCT00891176|1271482|P2|NOT COMPLETED|At 3 Years of Age||0
520310|NCT00891176|1271483|P1|NOT COMPLETED|At 3 Years of Age||0
520311|NCT00891176|1271480|P4|COMPLETED|At 3 Years of Age||141
520312|NCT00891176|1271481|P3|COMPLETED|At 3 Years of Age||149
520313|NCT00891176|1271482|P2|COMPLETED|At 3 Years of Age||147
520314|NCT00891176|1271483|P1|COMPLETED|At 3 Years of Age||144
520315|NCT00891176|1271480|P4|STARTED|At 3 Years of Age||141
520316|NCT00891176|1271481|P3|STARTED|At 3 Years of Age||149
520317|NCT00891176|1271482|P2|STARTED|At 3 Years of Age||147
520318|NCT00891176|1271483|P1|STARTED|At 3 Years of Age||144
520319|NCT00891046|1271630|P5|NOT COMPLETED|Overall Study||39
520320|NCT00891046|1271631|P4|NOT COMPLETED|Overall Study||3
520321|NCT00891046|1271632|P3|NOT COMPLETED|Overall Study||23
520322|NCT00891046|1271633|P2|NOT COMPLETED|Overall Study||9
520323|NCT00891046|1271634|P1|NOT COMPLETED|Overall Study||12
520324|NCT00891046|1271630|P5|COMPLETED|Overall Study||84
520325|NCT00891046|1271631|P4|COMPLETED|Overall Study||8
520326|NCT00891046|1271632|P3|COMPLETED|Overall Study||17
520327|NCT00891046|1271633|P2|COMPLETED|Overall Study||54
520328|NCT00891046|1271634|P1|COMPLETED|Overall Study||21
520329|NCT00891046|1271630|P5|STARTED|Overall Study||123
520330|NCT00891046|1271631|P4|STARTED|Overall Study||11
520331|NCT00891046|1271632|P3|STARTED|Overall Study||40
520332|NCT00891046|1271633|P2|STARTED|Overall Study||63
520333|NCT00891046|1271634|P1|STARTED|Overall Study||33
520334|NCT00891020|1271710|P3|NOT COMPLETED|Long-term Extension Period||23
520335|NCT00891020|1271711|P2|NOT COMPLETED|Long-term Extension Period||24
520336|NCT00891020|1271712|P1|NOT COMPLETED|Long-term Extension Period||6
520337|NCT00891020|1271710|P3|COMPLETED|Long-term Extension Period||170
520338|NCT00891020|1271711|P2|COMPLETED|Long-term Extension Period||172
520339|NCT00891020|1271712|P1|COMPLETED|Long-term Extension Period||49
520340|NCT00891020|1271710|P3|STARTED|Long-term Extension Period||193
520341|NCT00891020|1271711|P2|STARTED|Long-term Extension Period||196
520342|NCT00891020|1271712|P1|STARTED|Long-term Extension Period||55
520343|NCT00891020|1271710|P3|NOT COMPLETED|24 Week Treatment Period||58
520344|NCT00891020|1271711|P2|NOT COMPLETED|24 Week Treatment Period||60
520345|NCT00891020|1271712|P1|NOT COMPLETED|24 Week Treatment Period||37
520346|NCT00891020|1271710|P3|COMPLETED|24 Week Treatment Period||302
520347|NCT00891020|1271711|P2|COMPLETED|24 Week Treatment Period||303
520348|NCT00891020|1271712|P1|COMPLETED|24 Week Treatment Period||126
520349|NCT00891020|1271710|P3|Safety Set|24 Week Treatment Period|28 patients from Monotherapy arm received DMARD, included in 8 mg/kg +DMARD arm for safety.|381
520350|NCT00891020|1271711|P2|Safety Set|24 Week Treatment Period|1 patient from Monotherapy arm and 1 from 8 mg/kg +DMARD, included in 4 mg/kg +DMARD arm for safety.|364
520351|NCT00891020|1271712|P1|Safety Set|24 Week Treatment Period|4 patients from 8 mg/kg +DMARD arm did not receive DMARD, included in Monotherapy arm for safety.|138
520352|NCT00891020|1271710|P3|Intent-to-Treat (ITT)|24 Week Treatment Period||358
520353|NCT00891020|1271711|P2|Intent-to-Treat (ITT)|24 Week Treatment Period||362
520354|NCT00891020|1271712|P1|Intent-to-Treat (ITT)|24 Week Treatment Period||163
520355|NCT00891020|1271710|P3|STARTED|24 Week Treatment Period||360
520356|NCT00891020|1271711|P2|STARTED|24 Week Treatment Period||363
520357|NCT00891020|1271712|P1|STARTED|24 Week Treatment Period||163
520358|NCT00890981|1271745|P2|NOT COMPLETED|Overall Study||0
520359|NCT00890981|1271746|P1|NOT COMPLETED|Overall Study||0
520360|NCT00890981|1271745|P2|COMPLETED|Overall Study||40
520361|NCT00890981|1271746|P1|COMPLETED|Overall Study||39
520362|NCT00890981|1271745|P2|STARTED|Overall Study||40
520363|NCT00890981|1271746|P1|STARTED|Overall Study||39
520364|NCT00890929|1271776|P1|NOT COMPLETED|Overall Study||6
520365|NCT00890929|1271776|P1|COMPLETED|Overall Study||39
520366|NCT00890929|1271776|P1|Initiated Treatment|Overall Study||43
520367|NCT00890929|1271776|P1|Consented & Enrolled|Overall Study||45
520368|NCT00890929|1271776|P1|STARTED|Overall Study||45
520369|NCT00890916|1271788|P1|NOT COMPLETED|"Rehab - NP Off"||0
520370|NCT00890916|1271788|P1|COMPLETED|"Rehab - NP Off"||10
520371|NCT00890916|1271788|P1|"Grasp Release Pre-Test OFF"|"Rehab - NP Off"||10
520372|NCT00890916|1271788|P1|STARTED|"Rehab - NP Off"||10
520373|NCT00890916|1271788|P1|NOT COMPLETED|"Rehab - Neuroprosthesis (NP) On"||0
520374|NCT00890916|1271788|P1|COMPLETED|"Rehab - Neuroprosthesis (NP) On"||10
520375|NCT00890916|1271788|P1|"Grasp Release Pre-Test ON"|"Rehab - Neuroprosthesis (NP) On"||10
520376|NCT00890916|1271788|P1|STARTED|"Rehab - Neuroprosthesis (NP) On"|First Implanted Stimulator-Telemeter (IST-12) Implant.|10
520377|NCT00890825|1271794|P2|NOT COMPLETED|Overall Study||14
520378|NCT00890825|1271795|P1|NOT COMPLETED|Overall Study||14
520379|NCT00890825|1271794|P2|COMPLETED|Overall Study||29
520380|NCT00890825|1271795|P1|COMPLETED|Overall Study||30
520381|NCT00890825|1271794|P2|STARTED|Overall Study|A patient randomized to this arm was excluded from the safety population for not receiving treatment|43
520382|NCT00890825|1271795|P1|STARTED|Overall Study||44
520383|NCT00890721|1271815|P2|NOT COMPLETED|Overall Study||1
520384|NCT00890721|1271816|P1|NOT COMPLETED|Overall Study||1
520385|NCT00890721|1271815|P2|COMPLETED|Overall Study||93
520386|NCT00890721|1271816|P1|COMPLETED|Overall Study||94
520387|NCT00890721|1271815|P2|STARTED|Overall Study||94
520388|NCT00890721|1271816|P1|STARTED|Overall Study||95
520389|NCT00890695|1271824|P2|NOT COMPLETED|Overall Study||0
520390|NCT00890695|1271825|P1|NOT COMPLETED|Overall Study||1
520391|NCT00890695|1271824|P2|COMPLETED|Overall Study||33
520392|NCT00890695|1271825|P1|COMPLETED|Overall Study||31
520393|NCT00890695|1271824|P2|STARTED|Overall Study||33
520394|NCT00890695|1271825|P1|STARTED|Overall Study||32
520395|NCT00890682|1271843|P2|NOT COMPLETED|Overall Study||2
520396|NCT00890682|1271844|P1|NOT COMPLETED|Overall Study||4
520397|NCT00890682|1271843|P2|COMPLETED|Overall Study||94
520398|NCT00890682|1271844|P1|COMPLETED|Overall Study||93
520399|NCT00890682|1271843|P2|STARTED|Overall Study||96
520400|NCT00890682|1271844|P1|STARTED|Overall Study||97
520401|NCT00890656|1271850|P1|NOT COMPLETED|Overall Study||0
520402|NCT00890656|1271850|P1|COMPLETED|Overall Study||90
520403|NCT00890656|1271850|P1|STARTED|Overall Study||90
520404|NCT00890591|1271854|P1|NOT COMPLETED|Overall Study||20
520405|NCT00890591|1271854|P1|COMPLETED|Overall Study||124
520406|NCT00890591|1271854|P1|STARTED|Overall Study||144
520407|NCT00890552|1271860|P1|NOT COMPLETED|On-treatment||10
520408|NCT00890552|1271860|P1|COMPLETED|On-treatment||14
520409|NCT00890552|1271860|P1|STARTED|On-treatment||24
520410|NCT00890552|1271860|P1|NOT COMPLETED|Enrollment and Pre-treatment||1
520411|NCT00890552|1271860|P1|COMPLETED|Enrollment and Pre-treatment||24
520412|NCT00890552|1271860|P1|STARTED|Enrollment and Pre-treatment||25
520413|NCT00890409|1271869|P2|NOT COMPLETED|Overall Study||21
520414|NCT00890409|1271870|P1|NOT COMPLETED|Overall Study||20
520415|NCT00890409|1271869|P2|COMPLETED|Overall Study||119
520416|NCT00890409|1271870|P1|COMPLETED|Overall Study||96
520417|NCT00890409|1271869|P2|STARTED|Overall Study||140
520418|NCT00890409|1271870|P1|STARTED|Overall Study||116
520419|NCT00890201|1271880|P2|NOT COMPLETED|Overall Study||56
520420|NCT00890201|1271881|P1|NOT COMPLETED|Overall Study||5
520421|NCT00890201|1271880|P2|COMPLETED|Overall Study|103 patients without acute cholecystitis or common bile duct stones|103
520422|NCT00890201|1271881|P1|COMPLETED|Overall Study|33 patients with gastric cancer and without gallstone disease|33
520423|NCT00890201|1271880|P2|STARTED|Overall Study|41 patients with acute cholecystitis and 15 patients with common bile duct stones|159
520424|NCT00890201|1271881|P1|STARTED|Overall Study|5 patients with gastric cancer and gallstone disease|38
520425|NCT00890097|1271890|P3|NOT COMPLETED|Overall Study||77
520426|NCT00890097|1271891|P2|NOT COMPLETED|Overall Study||86
520427|NCT00890097|1271892|P1|NOT COMPLETED|Overall Study||68
520428|NCT00890097|1271890|P3|COMPLETED|Overall Study||184
520429|NCT00890097|1271891|P2|COMPLETED|Overall Study||173
520430|NCT00890097|1271892|P1|COMPLETED|Overall Study||184
520431|NCT00890097|1271890|P3|STARTED|Overall Study||261
520432|NCT00890097|1271891|P2|STARTED|Overall Study||259
520433|NCT00890097|1271892|P1|STARTED|Overall Study||252
520434|NCT00890084|1271900|P1|NOT COMPLETED|Overall Study||142
520435|NCT00890084|1271900|P1|COMPLETED|Overall Study||2771
520436|NCT00890084|1271900|P1|STARTED|Overall Study||2913
520437|NCT00889928|1271911|P1|NOT COMPLETED|Overall Study||0
520438|NCT00889928|1271911|P1|COMPLETED|Overall Study||7
520439|NCT00889928|1271911|P1|STARTED|Overall Study||7
520440|NCT00889915|1271919|P4|NOT COMPLETED|Overall Study||8
520441|NCT00889915|1271920|P3|NOT COMPLETED|Overall Study||13
520442|NCT00889915|1271921|P2|NOT COMPLETED|Overall Study||5
520443|NCT00889915|1271922|P1|NOT COMPLETED|Overall Study||2
520444|NCT00889915|1271919|P4|COMPLETED|Overall Study||40
520445|NCT00889915|1271920|P3|COMPLETED|Overall Study||54
520446|NCT00889915|1271921|P2|COMPLETED|Overall Study||71
520447|NCT00889915|1271922|P1|COMPLETED|Overall Study||35
520448|NCT00889915|1271919|P4|STARTED|Overall Study||48
520449|NCT00889915|1271920|P3|STARTED|Overall Study||67
520450|NCT00889915|1271921|P2|STARTED|Overall Study||76
520451|NCT00889915|1271922|P1|STARTED|Overall Study||37
520452|NCT00889863|1271940|P2|NOT COMPLETED|Part II: Randomized Double Blind||26
520453|NCT00889863|1271941|P1|NOT COMPLETED|Part II: Randomized Double Blind||11
520454|NCT00889863|1271940|P2|COMPLETED|Part II: Randomized Double Blind||24
520455|NCT00889863|1271941|P1|COMPLETED|Part II: Randomized Double Blind||39
520456|NCT00889863|1271940|P2|STARTED|Part II: Randomized Double Blind||50
520457|NCT00889863|1271941|P1|STARTED|Part II: Randomized Double Blind||50
520458|NCT00889863|1271940|P2|NOT COMPLETED|Part I: Open Label||0
520459|NCT00889863|1271941|P1|NOT COMPLETED|Part I: Open Label||77
520460|NCT00889863|1271940|P2|COMPLETED|Part I: Open Label||0
520461|NCT00889863|1271941|P1|COMPLETED|Part I: Open Label||100
520462|NCT00889863|1271940|P2|Entered Part 1d|Part I: Open Label||0
520463|NCT00889863|1271941|P1|Entered Part 1d|Part I: Open Label||103
520464|NCT00889863|1271940|P2|Entered Part Ic|Part I: Open Label||0
520465|NCT00889863|1271941|P1|Entered Part Ic|Part I: Open Label|Patients steroid free at study entry entered Part Id directly and did not participate in Part Ic.|92
520466|NCT00889863|1271940|P2|Entered Part Ib|Part I: Open Label||0
520467|NCT00889863|1271941|P1|Entered Part Ib|Part I: Open Label||142
520468|NCT00889863|1271940|P2|Entered Part Ia|Part I: Open Label||0
520469|NCT00889863|1271941|P1|Entered Part Ia|Part I: Open Label||145
520470|NCT00889863|1271940|P2|STARTED|Part I: Open Label|No participants received placebo in Part I.|0
520471|NCT00889863|1271941|P1|STARTED|Part I: Open Label||177
520472|NCT00889824|1271963|P1|NOT COMPLETED|Overall Study||0
520473|NCT00889824|1271963|P1|COMPLETED|Overall Study||5
520474|NCT00889824|1271963|P1|STARTED|Overall Study||5
520475|NCT00889720|1271967|P1|NOT COMPLETED|Overall Study||8
520476|NCT00889720|1271967|P1|COMPLETED|Overall Study||8
520477|NCT00889720|1271967|P1|Surgical Population|Overall Study||12
520478|NCT00889720|1271967|P1|STARTED|Overall Study||16
520479|NCT00889707|1271994|P2|NOT COMPLETED|Overall Study||10
520480|NCT00889707|1271995|P1|NOT COMPLETED|Overall Study||7
520481|NCT00889707|1271994|P2|COMPLETED|Overall Study||21
520482|NCT00889707|1271995|P1|COMPLETED|Overall Study||54
520483|NCT00889707|1271994|P2|STARTED|Overall Study||31
520484|NCT00889707|1271995|P1|STARTED|Overall Study||61
520485|NCT00889681|1272003|P1|NOT COMPLETED|Overall Study||3
520486|NCT00889681|1272003|P1|COMPLETED|Overall Study||78
520487|NCT00889681|1272003|P1|Received Treatment|Overall Study||78
520488|NCT00889681|1272003|P1|STARTED|Overall Study||81
520489|NCT00889603|1272010|P1|NOT COMPLETED|Overall Study||37
520490|NCT00889603|1272010|P1|COMPLETED|Overall Study||333
520491|NCT00889603|1272010|P1|STARTED|Overall Study||370
520492|NCT00889512|1272025|P2|NOT COMPLETED|Overall Study||0
520493|NCT00889512|1272026|P1|NOT COMPLETED|Overall Study||0
520494|NCT00889512|1272025|P2|COMPLETED|Overall Study||9
520495|NCT00889512|1272026|P1|COMPLETED|Overall Study||5
520496|NCT00889512|1272025|P2|STARTED|Overall Study||9
520497|NCT00889512|1272026|P1|STARTED|Overall Study||5
520498|NCT00889421|1272032|P1|NOT COMPLETED|Overall Study||3
520499|NCT00889421|1272032|P1|COMPLETED|Overall Study||0
520500|NCT00889421|1272032|P1|STARTED|Overall Study||3
520501|NCT00889330|1272042|P2|NOT COMPLETED|Overall Study||0
520502|NCT00889330|1272043|P1|NOT COMPLETED|Overall Study||0
520503|NCT00889330|1272042|P2|COMPLETED|Overall Study||30
520504|NCT00889330|1272043|P1|COMPLETED|Overall Study||30
520505|NCT00889330|1272042|P2|STARTED|Overall Study||30
520506|NCT00889330|1272043|P1|STARTED|Overall Study||30
520507|NCT00889265|1272073|P1|NOT COMPLETED|Overall Study||7
520508|NCT00889265|1272073|P1|COMPLETED|Overall Study||44
520509|NCT00889265|1272073|P1|STARTED|Overall Study|Date Enrollment Started: 07/21/2009 Date Enrollment Completed: 02/15/2011 Total enrolled: 51|51
520510|NCT00889252|1272080|P2|NOT COMPLETED|Overall Study||4
520511|NCT00889252|1272081|P1|NOT COMPLETED|Overall Study||7
520512|NCT00889252|1272080|P2|COMPLETED|Overall Study||78
520513|NCT00889252|1272081|P1|COMPLETED|Overall Study||161
520514|NCT00889252|1272080|P2|STARTED|Overall Study||82
520515|NCT00889252|1272081|P1|STARTED|Overall Study||168
520516|NCT00889200|1272123|P1|NOT COMPLETED|Overall Study||0
520517|NCT00889200|1272123|P1|COMPLETED|Overall Study||12
520518|NCT00889200|1272123|P1|STARTED|Overall Study||12
520519|NCT00889187|1272127|P4|NOT COMPLETED|Overall Study||0
520520|NCT00889187|1272128|P3|NOT COMPLETED|Overall Study||0
520521|NCT00889187|1272129|P2|NOT COMPLETED|Overall Study||0
520522|NCT00889187|1272130|P1|NOT COMPLETED|Overall Study||0
520523|NCT00889187|1272127|P4|COMPLETED|Overall Study||0
520524|NCT00889187|1272128|P3|COMPLETED|Overall Study||4
520525|NCT00889187|1272129|P2|COMPLETED|Overall Study||3
520526|NCT00889187|1272130|P1|COMPLETED|Overall Study||3
520527|NCT00889187|1272127|P4|STARTED|Overall Study||0
520528|NCT00889187|1272128|P3|STARTED|Overall Study||4
520529|NCT00889187|1272129|P2|STARTED|Overall Study||3
520530|NCT00889187|1272130|P1|STARTED|Overall Study||3
520531|NCT00888979|1272145|P1|NOT COMPLETED|Overall Study||4
520532|NCT00888979|1272145|P1|COMPLETED|Overall Study||6
520533|NCT00888979|1272145|P1|Received the Inhaler/Counseling|Overall Study||8
520534|NCT00888979|1272145|P1|STARTED|Overall Study||10
520535|NCT00888940|1272153|P2|NOT COMPLETED|Overall Study||21
520536|NCT00888940|1272154|P1|NOT COMPLETED|Overall Study||28
520537|NCT00888940|1272153|P2|COMPLETED|Overall Study||101
520538|NCT00888940|1272154|P1|COMPLETED|Overall Study||92
520539|NCT00888940|1272153|P2|Completed Therapy|Overall Study||106
520540|NCT00888940|1272154|P1|Completed Therapy|Overall Study||107
520541|NCT00888940|1272153|P2|STARTED|Overall Study||122
520542|NCT00888940|1272154|P1|STARTED|Overall Study||120
520543|NCT00888849|1272164|P2|NOT COMPLETED|Overall Study||9
520544|NCT00888849|1272165|P1|NOT COMPLETED|Overall Study||5
520545|NCT00888849|1272164|P2|COMPLETED|Overall Study||129
520546|NCT00888849|1272165|P1|COMPLETED|Overall Study||137
520547|NCT00888849|1272164|P2|STARTED|Overall Study||138
520548|NCT00888849|1272165|P1|STARTED|Overall Study||142
520549|NCT00888654|1272175|P1|NOT COMPLETED|Overall Study||10
520550|NCT00888654|1272175|P1|COMPLETED|Overall Study||31
520551|NCT00888654|1272175|P1|STARTED|Overall Study||41
520552|NCT00888628|1272181|P1|NOT COMPLETED|Overall Study||3
520553|NCT00888628|1272181|P1|COMPLETED|Overall Study||4
520554|NCT00888628|1272181|P1|Transplanted|Overall Study||4
520555|NCT00888628|1272181|P1|Withdrawn|Overall Study||1
520556|NCT00888628|1272181|P1|Screen Failure|Overall Study||2
520557|NCT00888628|1272181|P1|Enrolled|Overall Study||7
520558|NCT00888628|1272181|P1|STARTED|Overall Study||7
520559|NCT00888459|1272195|P2|NOT COMPLETED|Overall Study||0
520560|NCT00888459|1272196|P1|NOT COMPLETED|Overall Study||0
520561|NCT00888459|1272195|P2|COMPLETED|Overall Study||30
520562|NCT00888459|1272196|P1|COMPLETED|Overall Study||30
520563|NCT00888459|1272195|P2|STARTED|Overall Study||30
520564|NCT00888459|1272196|P1|STARTED|Overall Study||30
520565|NCT00888433|1272204|P2|NOT COMPLETED|Overall Study||3
520566|NCT00888433|1272205|P1|NOT COMPLETED|Overall Study||3
520567|NCT00888433|1272204|P2|COMPLETED|Overall Study||51
520568|NCT00888433|1272205|P1|COMPLETED|Overall Study||49
520569|NCT00888433|1272204|P2|STARTED|Overall Study||54
520570|NCT00888433|1272205|P1|STARTED|Overall Study||52
520571|NCT00888381|1272213|P2|NOT COMPLETED|Overall Study||1
520572|NCT00888381|1272214|P1|NOT COMPLETED|Overall Study||0
520573|NCT00888381|1272213|P2|COMPLETED|Overall Study||59
520574|NCT00888381|1272214|P1|COMPLETED|Overall Study||60
520575|NCT00888381|1272213|P2|STARTED|Overall Study||60
520576|NCT00888381|1272214|P1|STARTED|Overall Study||60
520577|NCT00888355|1272234|P4|NOT COMPLETED|Overall Study||10
520578|NCT00888355|1272235|P3|NOT COMPLETED|Overall Study||12
520579|NCT00888355|1272236|P2|NOT COMPLETED|Overall Study||9
520580|NCT00888355|1272237|P1|NOT COMPLETED|Overall Study||22
520581|NCT00888355|1272234|P4|COMPLETED|Overall Study||96
520582|NCT00888355|1272235|P3|COMPLETED|Overall Study||94
520583|NCT00888355|1272236|P2|COMPLETED|Overall Study||99
520584|NCT00888355|1272237|P1|COMPLETED|Overall Study||86
520585|NCT00888355|1272234|P4|STARTED|Overall Study||106
520586|NCT00888355|1272235|P3|STARTED|Overall Study||106
520587|NCT00888355|1272236|P2|STARTED|Overall Study||108
520588|NCT00888355|1272237|P1|STARTED|Overall Study||108
520589|NCT00888329|1272293|P2|NOT COMPLETED|Overall Study||9
520590|NCT00888329|1272294|P1|NOT COMPLETED|Overall Study||6
520591|NCT00888329|1272293|P2|COMPLETED|Overall Study||122
520592|NCT00888329|1272294|P1|COMPLETED|Overall Study||119
520593|NCT00888329|1272293|P2|STARTED|Overall Study||131
520594|NCT00888329|1272294|P1|STARTED|Overall Study||125
520595|NCT00888238|1272300|P3|NOT COMPLETED|Third Period of Treatment Intervention||0
520596|NCT00888238|1272301|P2|NOT COMPLETED|Third Period of Treatment Intervention||0
520597|NCT00888238|1272302|P1|NOT COMPLETED|Third Period of Treatment Intervention||0
520598|NCT00888238|1272300|P3|COMPLETED|Third Period of Treatment Intervention||3
520599|NCT00888238|1272301|P2|COMPLETED|Third Period of Treatment Intervention||4
520600|NCT00888238|1272302|P1|COMPLETED|Third Period of Treatment Intervention||4
520601|NCT00888238|1272300|P3|STARTED|Third Period of Treatment Intervention||3
520602|NCT00888238|1272301|P2|STARTED|Third Period of Treatment Intervention||4
520603|NCT00888238|1272302|P1|STARTED|Third Period of Treatment Intervention||4
520604|NCT00888238|1272300|P3|NOT COMPLETED|Washout Period After Period 2||1
520605|NCT00888238|1272301|P2|NOT COMPLETED|Washout Period After Period 2||0
520606|NCT00888238|1272302|P1|NOT COMPLETED|Washout Period After Period 2||0
520607|NCT00888238|1272300|P3|COMPLETED|Washout Period After Period 2||3
520608|NCT00888238|1272301|P2|COMPLETED|Washout Period After Period 2||4
520609|NCT00888238|1272302|P1|COMPLETED|Washout Period After Period 2||4
520610|NCT00888238|1272300|P3|STARTED|Washout Period After Period 2||4
520611|NCT00888238|1272301|P2|STARTED|Washout Period After Period 2||4
520612|NCT00888238|1272302|P1|STARTED|Washout Period After Period 2||4
520613|NCT00888238|1272300|P3|NOT COMPLETED|Second Period of Treatment Intervention||0
520614|NCT00888238|1272301|P2|NOT COMPLETED|Second Period of Treatment Intervention||0
520615|NCT00888238|1272302|P1|NOT COMPLETED|Second Period of Treatment Intervention||0
520616|NCT00888238|1272300|P3|COMPLETED|Second Period of Treatment Intervention||4
520617|NCT00888238|1272301|P2|COMPLETED|Second Period of Treatment Intervention||4
520618|NCT00888238|1272302|P1|COMPLETED|Second Period of Treatment Intervention||4
520619|NCT00888238|1272300|P3|STARTED|Second Period of Treatment Intervention||4
520620|NCT00888238|1272301|P2|STARTED|Second Period of Treatment Intervention||4
520621|NCT00888238|1272302|P1|STARTED|Second Period of Treatment Intervention||4
520622|NCT00888238|1272300|P3|NOT COMPLETED|Washout Period After Period 1||0
520623|NCT00888238|1272301|P2|NOT COMPLETED|Washout Period After Period 1||0
520624|NCT00888238|1272302|P1|NOT COMPLETED|Washout Period After Period 1||0
520625|NCT00888238|1272300|P3|COMPLETED|Washout Period After Period 1||4
520626|NCT00888238|1272301|P2|COMPLETED|Washout Period After Period 1||4
520627|NCT00888238|1272302|P1|COMPLETED|Washout Period After Period 1||4
520628|NCT00888238|1272300|P3|STARTED|Washout Period After Period 1||4
520629|NCT00888238|1272301|P2|STARTED|Washout Period After Period 1||4
520630|NCT00888238|1272302|P1|STARTED|Washout Period After Period 1||4
520631|NCT00888238|1272300|P3|NOT COMPLETED|First Period of Treatment Intervention||0
520632|NCT00888238|1272301|P2|NOT COMPLETED|First Period of Treatment Intervention||0
520633|NCT00888238|1272302|P1|NOT COMPLETED|First Period of Treatment Intervention||0
520634|NCT00888238|1272300|P3|COMPLETED|First Period of Treatment Intervention||4
520635|NCT00888238|1272301|P2|COMPLETED|First Period of Treatment Intervention||4
520636|NCT00888238|1272302|P1|COMPLETED|First Period of Treatment Intervention||4
520637|NCT00888238|1272300|P3|STARTED|First Period of Treatment Intervention||4
520638|NCT00888238|1272301|P2|STARTED|First Period of Treatment Intervention||4
520639|NCT00888238|1272302|P1|STARTED|First Period of Treatment Intervention||4
520640|NCT00888173|1272310|P1|NOT COMPLETED|Overall Study||2
520641|NCT00888173|1272310|P1|COMPLETED|Overall Study||43
520642|NCT00888173|1272310|P1|STARTED|Overall Study||45
520643|NCT00888134|1272318|P1|NOT COMPLETED|Follow-up||1
520644|NCT00888134|1272318|P1|COMPLETED|Follow-up|23 died; 3 were lost-to-follow-up|26
520645|NCT00888134|1272318|P1|STARTED|Follow-up||27
520646|NCT00888134|1272318|P1|NOT COMPLETED|Treatment With Study Drug||1
520647|NCT00888134|1272318|P1|COMPLETED|Treatment With Study Drug|21 had progressive disease; 5 had unacceptable toxicity; 1 finished treatment|27
520648|NCT00888134|1272318|P1|STARTED|Treatment With Study Drug||28
520649|NCT00887978|1272328|P2|NOT COMPLETED|Overall Study||15
520650|NCT00887978|1272329|P1|NOT COMPLETED|Overall Study||25
520651|NCT00887978|1272328|P2|COMPLETED|Overall Study||138
520652|NCT00887978|1272329|P1|COMPLETED|Overall Study||132
520653|NCT00887978|1272328|P2|STARTED|Overall Study||153
520654|NCT00887978|1272329|P1|STARTED|Overall Study||157
520655|NCT00887965|1272365|P1|NOT COMPLETED|Overall Study||0
520656|NCT00887965|1272365|P1|COMPLETED|Overall Study||15
520657|NCT00887965|1272365|P1|STARTED|Overall Study||15
520658|NCT00887913|1272395|P1|NOT COMPLETED|Overall Study||6
520659|NCT00887913|1272395|P1|COMPLETED|Overall Study||63
520660|NCT00887913|1272395|P1|STARTED|Overall Study||69
520661|NCT00887822|1272403|P2|NOT COMPLETED|Overall Study||102
520662|NCT00887822|1272404|P1|NOT COMPLETED|Overall Study||97
520663|NCT00887822|1272403|P2|COMPLETED|Overall Study||0
520664|NCT00887822|1272404|P1|COMPLETED|Overall Study||3
520665|NCT00887822|1272403|P2|Treated (Safety Population)|Overall Study||101
520666|NCT00887822|1272404|P1|Treated (Safety Population)|Overall Study||100
520667|NCT00887822|1272403|P2|STARTED|Overall Study||102
520668|NCT00887822|1272404|P1|STARTED|Overall Study||100
520669|NCT00887809|1272436|P2|NOT COMPLETED|Overall Study||0
520670|NCT00887809|1272437|P1|NOT COMPLETED|Overall Study||4
520671|NCT00887809|1272436|P2|COMPLETED|Overall Study||10
520672|NCT00887809|1272437|P1|COMPLETED|Overall Study||33
520673|NCT00887809|1272436|P2|STARTED|Overall Study||10
520674|NCT00887809|1272437|P1|STARTED|Overall Study||37
520675|NCT00887744|1272443|P1|NOT COMPLETED|Overall Study||34
520676|NCT00887744|1272443|P1|COMPLETED|Overall Study||128
520677|NCT00887744|1272443|P1|STARTED|Overall Study|162 patients signed an informed consent but only 157 patients were treated with the Aperius.|162
520678|NCT00887679|1272452|P1|NOT COMPLETED|Overall Study||10
520679|NCT00887679|1272452|P1|COMPLETED|Overall Study|20 subjects completed the study.|20
520680|NCT00887679|1272452|P1|STARTED|Overall Study||30
520681|NCT00887653|1272461|P1|NOT COMPLETED|Overall Study||0
520682|NCT00887653|1272461|P1|COMPLETED|Overall Study||20
520683|NCT00887653|1272461|P1|STARTED|Overall Study||20
520684|NCT00887640|1272467|P1|NOT COMPLETED|Overall Study||0
520685|NCT00887640|1272467|P1|COMPLETED|Overall Study||11
520686|NCT00887640|1272467|P1|STARTED|Overall Study||11
520687|NCT00887588|1272482|P2|NOT COMPLETED|Extension Period||5
520688|NCT00887588|1272483|P1|NOT COMPLETED|Extension Period||6
520689|NCT00887588|1272482|P2|COMPLETED|Extension Period||120
520690|NCT00887588|1272483|P1|COMPLETED|Extension Period||121
520691|NCT00887588|1272482|P2|Arterial Stiffness Set|Extension Period||94
520692|NCT00887588|1272483|P1|Arterial Stiffness Set|Extension Period||86
520693|NCT00887588|1272482|P2|STARTED|Extension Period||125
520694|NCT00887588|1272483|P1|STARTED|Extension Period||127
520695|NCT00887588|1272482|P2|NOT COMPLETED|Core Period||21
520696|NCT00887588|1272483|P1|NOT COMPLETED|Core Period||19
520697|NCT00887588|1272482|P2|COMPLETED|Core Period||131
520698|NCT00887588|1272483|P1|COMPLETED|Core Period||130
520699|NCT00887588|1272482|P2|Arterial Stiffness Set|Core Period||94
520700|NCT00887588|1272483|P1|Arterial Stiffness Set|Core Period||86
520701|NCT00887588|1272482|P2|Full Analysis Set|Core Period||146
520702|NCT00887588|1272483|P1|Full Analysis Set|Core Period||148
520703|NCT00887588|1272482|P2|Extension Efficacy Set|Core Period||125
520704|NCT00887588|1272483|P1|Extension Efficacy Set|Core Period||127
520705|NCT00887588|1272482|P2|STARTED|Core Period||152
520706|NCT00887588|1272483|P1|STARTED|Core Period||149
520707|NCT00887575|1272535|P3|NOT COMPLETED|Phase II - Maintenance Therapy||0
520708|NCT00887575|1272536|P2|NOT COMPLETED|Phase II - Maintenance Therapy||0
520709|NCT00887575|1272537|P1|NOT COMPLETED|Phase II - Maintenance Therapy||2
520710|NCT00887575|1272535|P3|COMPLETED|Phase II - Maintenance Therapy||0
520711|NCT00887575|1272536|P2|COMPLETED|Phase II - Maintenance Therapy||0
520712|NCT00887575|1272537|P1|COMPLETED|Phase II - Maintenance Therapy||6
520713|NCT00887575|1272535|P3|STARTED|Phase II - Maintenance Therapy||0
520714|NCT00887575|1272536|P2|STARTED|Phase II - Maintenance Therapy||0
520715|NCT00887575|1272537|P1|STARTED|Phase II - Maintenance Therapy|Pts who completed 6 cycles of Neoadjuvant Therapy & underwent surgery were eligible for maintenance|8
520716|NCT00887575|1272535|P3|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0
520717|NCT00887575|1272536|P2|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0
520718|NCT00887575|1272537|P1|NOT COMPLETED|Phase II - Neoadjuvant Therapy||25
520719|NCT00887575|1272535|P3|COMPLETED|Phase II - Neoadjuvant Therapy||0
520720|NCT00887575|1272536|P2|COMPLETED|Phase II - Neoadjuvant Therapy||0
520721|NCT00887575|1272537|P1|COMPLETED|Phase II - Neoadjuvant Therapy||16
520722|NCT00887575|1272535|P3|STARTED|Phase II - Neoadjuvant Therapy||0
520723|NCT00887575|1272536|P2|STARTED|Phase II - Neoadjuvant Therapy||0
520724|NCT00887575|1272537|P1|STARTED|Phase II - Neoadjuvant Therapy|Includes patients treated at MTD during Phase I, 39 additional patients enrolled, 4 were not treated|41
520725|NCT00887575|1272535|P3|NOT COMPLETED|Phase I||3
520726|NCT00887575|1272536|P2|NOT COMPLETED|Phase I||6
520727|NCT00887575|1272537|P1|NOT COMPLETED|Phase I||0
520728|NCT00887575|1272535|P3|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
520729|NCT00887575|1272536|P2|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
520730|NCT00887575|1272537|P1|COMPLETED|Phase I||6
520731|NCT00887575|1272535|P3|STARTED|Phase I||3
520732|NCT00887575|1272536|P2|STARTED|Phase I||6
520733|NCT00887575|1272537|P1|STARTED|Phase I||6
520734|NCT00887562|1272548|P3|NOT COMPLETED|Overall Study||1
520735|NCT00887562|1272549|P2|NOT COMPLETED|Overall Study||2
520736|NCT00887562|1272550|P1|NOT COMPLETED|Overall Study||3
520737|NCT00887562|1272548|P3|COMPLETED|Overall Study||7
520738|NCT00887562|1272549|P2|COMPLETED|Overall Study||7
520739|NCT00887562|1272550|P1|COMPLETED|Overall Study||7
520740|NCT00887562|1272548|P3|STARTED|Overall Study||8
520741|NCT00887562|1272549|P2|STARTED|Overall Study||9
520742|NCT00887562|1272550|P1|STARTED|Overall Study||10
520743|NCT00887549|1272564|P1|NOT COMPLETED|Maintenance Therapy||43
520744|NCT00887549|1272564|P1|COMPLETED|Maintenance Therapy||0
520745|NCT00887549|1272564|P1|STARTED|Maintenance Therapy||43
520746|NCT00887549|1272564|P1|NOT COMPLETED|Induction Therapy||27
520747|NCT00887549|1272564|P1|COMPLETED|Induction Therapy||43
520748|NCT00887549|1272564|P1|STARTED|Induction Therapy||70
520749|NCT00887510|1272573|P2|NOT COMPLETED|Overall Study||0
520750|NCT00887510|1272574|P1|NOT COMPLETED|Overall Study||0
520751|NCT00887510|1272573|P2|COMPLETED|Overall Study||12
520752|NCT00887510|1272574|P1|COMPLETED|Overall Study||12
520753|NCT00887510|1272573|P2|STARTED|Overall Study||12
520754|NCT00887510|1272574|P1|STARTED|Overall Study||12
520755|NCT00887484|1272582|P1|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||3
520756|NCT00887484|1272582|P1|COMPLETED|Full Face Treatment (Weeks 5 and 8)||45
520757|NCT00887484|1272582|P1|STARTED|Full Face Treatment (Weeks 5 and 8)||48
520838|NCT00887224|1272775|P2|NOT COMPLETED|OL Taper Phase / OL Follow Up||0
520758|NCT00887484|1272582|P1|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0
520759|NCT00887484|1272582|P1|COMPLETED|Split Face Treatment (Weeks 1 and 2)||48
520760|NCT00887484|1272582|P1|STARTED|Split Face Treatment (Weeks 1 and 2)||48
520761|NCT00887471|1272648|P2|NOT COMPLETED|Overall Study||0
520762|NCT00887471|1272649|P1|NOT COMPLETED|Overall Study||0
520763|NCT00887471|1272648|P2|COMPLETED|Overall Study||15
520764|NCT00887471|1272649|P1|COMPLETED|Overall Study||15
520765|NCT00887471|1272648|P2|STARTED|Overall Study||15
520766|NCT00887471|1272649|P1|STARTED|Overall Study||15
520767|NCT00887458|1272659|P2|NOT COMPLETED|Overall Study||4
520768|NCT00887458|1272660|P1|NOT COMPLETED|Overall Study||0
520769|NCT00887458|1272659|P2|COMPLETED|Overall Study||25
520770|NCT00887458|1272660|P1|COMPLETED|Overall Study||17
520771|NCT00887458|1272659|P2|STARTED|Overall Study||29
520772|NCT00887458|1272660|P1|STARTED|Overall Study||17
520773|NCT00887354|1272670|P2|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||6
520774|NCT00887354|1272671|P1|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||3
520775|NCT00887354|1272670|P2|COMPLETED|Open Label Phase (Week 26 to Week 78)||59
520776|NCT00887354|1272671|P1|COMPLETED|Open Label Phase (Week 26 to Week 78)||57
520777|NCT00887354|1272670|P2|STARTED|Open Label Phase (Week 26 to Week 78)||65
520778|NCT00887354|1272671|P1|STARTED|Open Label Phase (Week 26 to Week 78)||60
520779|NCT00887354|1272670|P2|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||48
520780|NCT00887354|1272671|P1|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||51
520781|NCT00887354|1272670|P2|COMPLETED|Treatment Phase (Week 0 to Week 26)||65
520782|NCT00887354|1272671|P1|COMPLETED|Treatment Phase (Week 0 to Week 26)||60
520783|NCT00887354|1272670|P2|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||85
520784|NCT00887354|1272671|P1|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||86
520785|NCT00887354|1272670|P2|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||110
520786|NCT00887354|1272671|P1|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||106
520787|NCT00887354|1272670|P2|STARTED|Treatment Phase (Week 0 to Week 26)||113
520788|NCT00887354|1272671|P1|STARTED|Treatment Phase (Week 0 to Week 26)||111
520789|NCT00887341|1272691|P2|NOT COMPLETED|Overall Study||3
520790|NCT00887341|1272692|P1|NOT COMPLETED|Overall Study||2
520791|NCT00887341|1272691|P2|COMPLETED|Overall Study||36
520792|NCT00887341|1272692|P1|COMPLETED|Overall Study||35
520793|NCT00887341|1272691|P2|STARTED|Overall Study||39
520794|NCT00887341|1272692|P1|STARTED|Overall Study||37
520795|NCT00887315|1272728|P2|NOT COMPLETED|Overall Study||4
520796|NCT00887315|1272729|P1|NOT COMPLETED|Overall Study||7
520797|NCT00887315|1272728|P2|COMPLETED|Overall Study||0
520798|NCT00887315|1272729|P1|COMPLETED|Overall Study||0
520799|NCT00887315|1272728|P2|STARTED|Overall Study||4
520800|NCT00887315|1272729|P1|STARTED|Overall Study||7
520801|NCT00887289|1272737|P1|NOT COMPLETED|Overall Study||95
520802|NCT00887289|1272737|P1|COMPLETED|Overall Study||1409
520803|NCT00887289|1272737|P1|STARTED|Overall Study||1504
520804|NCT00887250|1272749|P3|NOT COMPLETED|Overall Study||13
520805|NCT00887250|1272750|P2|NOT COMPLETED|Overall Study||12
520806|NCT00887250|1272751|P1|NOT COMPLETED|Overall Study||18
520807|NCT00887250|1272749|P3|COMPLETED|Overall Study||110
520808|NCT00887250|1272750|P2|COMPLETED|Overall Study||115
520809|NCT00887250|1272751|P1|COMPLETED|Overall Study||98
520810|NCT00887250|1272749|P3|STARTED|Overall Study||123
520811|NCT00887250|1272750|P2|STARTED|Overall Study||127
520812|NCT00887250|1272751|P1|STARTED|Overall Study||116
520813|NCT00887224|1272774|P3|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||30
520814|NCT00887224|1272775|P2|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||41
520815|NCT00887224|1272776|P1|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||0
520816|NCT00887224|1272774|P3|COMPLETED|DB Taper Phase / Post Study Follow Up||235
520817|NCT00887224|1272775|P2|COMPLETED|DB Taper Phase / Post Study Follow Up||226
520818|NCT00887224|1272776|P1|COMPLETED|DB Taper Phase / Post Study Follow Up||0
520819|NCT00887224|1272774|P3|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||30
520820|NCT00887224|1272775|P2|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up|DBp could have discontinued at anytime during DB taper period or Follow-up (7 days after last dose).|41
520821|NCT00887224|1272776|P1|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||0
520822|NCT00887224|1272774|P3|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||7
520823|NCT00887224|1272775|P2|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||9
520824|NCT00887224|1272776|P1|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||0
520825|NCT00887224|1272774|P3|STARTED|DB Taper Phase / Post Study Follow Up||265
520826|NCT00887224|1272775|P2|STARTED|DB Taper Phase / Post Study Follow Up|Double-blind participants (DBp) could have entered 7-day taper period at any time during DB phase.|267
520827|NCT00887224|1272776|P1|STARTED|DB Taper Phase / Post Study Follow Up||0
520828|NCT00887224|1272774|P3|NOT COMPLETED|Double-blind (DB) Phase||62
520829|NCT00887224|1272775|P2|NOT COMPLETED|Double-blind (DB) Phase||100
520830|NCT00887224|1272776|P1|NOT COMPLETED|Double-blind (DB) Phase||0
520831|NCT00887224|1272774|P3|COMPLETED|Double-blind (DB) Phase||210
520832|NCT00887224|1272775|P2|COMPLETED|Double-blind (DB) Phase||176
520833|NCT00887224|1272776|P1|COMPLETED|Double-blind (DB) Phase||0
520834|NCT00887224|1272774|P3|STARTED|Double-blind (DB) Phase||272
520835|NCT00887224|1272775|P2|STARTED|Double-blind (DB) Phase|2 participants randomized in error to DB, then entered OL Taper; counted in OL Taper and DB phases.|276
520836|NCT00887224|1272776|P1|STARTED|Double-blind (DB) Phase||0
520837|NCT00887224|1272774|P3|NOT COMPLETED|OL Taper Phase / OL Follow Up||0
520839|NCT00887224|1272776|P1|NOT COMPLETED|OL Taper Phase / OL Follow Up||144
520840|NCT00887224|1272774|P3|COMPLETED|OL Taper Phase / OL Follow Up||0
520841|NCT00887224|1272775|P2|COMPLETED|OL Taper Phase / OL Follow Up||0
520842|NCT00887224|1272776|P1|COMPLETED|OL Taper Phase / OL Follow Up||163
520843|NCT00887224|1272774|P3|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0
520844|NCT00887224|1272775|P2|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0
520845|NCT00887224|1272776|P1|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up|Could have discontinued at any time during OL taper phase or OL Follow-up (7 days after last dose).|144
520846|NCT00887224|1272774|P3|STARTED|OL Taper Phase / OL Follow Up||0
520847|NCT00887224|1272775|P2|STARTED|OL Taper Phase / OL Follow Up||0
520848|NCT00887224|1272776|P1|STARTED|OL Taper Phase / OL Follow Up|Could have entered 7-day taper period at any time during either the OLR phase or OLS phase.|307
520849|NCT00887224|1272774|P3|NOT COMPLETED|Between OLS and DB Phases||0
520850|NCT00887224|1272775|P2|NOT COMPLETED|Between OLS and DB Phases||0
520851|NCT00887224|1272776|P1|NOT COMPLETED|Between OLS and DB Phases||28
520852|NCT00887224|1272774|P3|COMPLETED|Between OLS and DB Phases||0
520853|NCT00887224|1272775|P2|COMPLETED|Between OLS and DB Phases||0
520854|NCT00887224|1272776|P1|COMPLETED|Between OLS and DB Phases||548
520855|NCT00887224|1272774|P3|STARTED|Between OLS and DB Phases||0
520856|NCT00887224|1272775|P2|STARTED|Between OLS and DB Phases||0
520857|NCT00887224|1272776|P1|STARTED|Between OLS and DB Phases||576
520858|NCT00887224|1272774|P3|NOT COMPLETED|Open-label Stability (OLS) Phase||0
520859|NCT00887224|1272775|P2|NOT COMPLETED|Open-label Stability (OLS) Phase||0
520860|NCT00887224|1272776|P1|NOT COMPLETED|Open-label Stability (OLS) Phase||83
520861|NCT00887224|1272774|P3|COMPLETED|Open-label Stability (OLS) Phase||0
520862|NCT00887224|1272775|P2|COMPLETED|Open-label Stability (OLS) Phase||0
520863|NCT00887224|1272776|P1|COMPLETED|Open-label Stability (OLS) Phase||576
520864|NCT00887224|1272774|P3|STARTED|Open-label Stability (OLS) Phase||0
520865|NCT00887224|1272775|P2|STARTED|Open-label Stability (OLS) Phase||0
520866|NCT00887224|1272776|P1|STARTED|Open-label Stability (OLS) Phase||659
520867|NCT00887224|1272774|P3|NOT COMPLETED|Between OLR and OLS Phases||0
520868|NCT00887224|1272775|P2|NOT COMPLETED|Between OLR and OLS Phases||0
520869|NCT00887224|1272776|P1|NOT COMPLETED|Between OLR and OLS Phases||93
520870|NCT00887224|1272774|P3|COMPLETED|Between OLR and OLS Phases||0
520871|NCT00887224|1272775|P2|COMPLETED|Between OLR and OLS Phases||0
520872|NCT00887224|1272776|P1|COMPLETED|Between OLR and OLS Phases||659
520873|NCT00887224|1272774|P3|STARTED|Between OLR and OLS Phases||0
520874|NCT00887224|1272775|P2|STARTED|Between OLR and OLS Phases||0
520875|NCT00887224|1272776|P1|STARTED|Between OLR and OLS Phases||752
520876|NCT00887224|1272774|P3|NOT COMPLETED|Open-label Response (OLR) Phase||0
520877|NCT00887224|1272775|P2|NOT COMPLETED|Open-label Response (OLR) Phase||0
520878|NCT00887224|1272776|P1|NOT COMPLETED|Open-label Response (OLR) Phase||122
520879|NCT00887224|1272774|P3|COMPLETED|Open-label Response (OLR) Phase||0
520880|NCT00887224|1272775|P2|COMPLETED|Open-label Response (OLR) Phase||0
520881|NCT00887224|1272776|P1|COMPLETED|Open-label Response (OLR) Phase||752
520882|NCT00887224|1272774|P3|STARTED|Open-label Response (OLR) Phase||0
520883|NCT00887224|1272775|P2|STARTED|Open-label Response (OLR) Phase||0
520884|NCT00887224|1272776|P1|STARTED|Open-label Response (OLR) Phase||874
520885|NCT00887198|1272803|P3|NOT COMPLETED|Cross Over (Placebo to AA)||93
520886|NCT00887198|1272804|P2|NOT COMPLETED|Cross Over (Placebo to AA)||0
520887|NCT00887198|1272805|P1|NOT COMPLETED|Cross Over (Placebo to AA)||0
520888|NCT00887198|1272803|P3|COMPLETED|Cross Over (Placebo to AA)||0
520889|NCT00887198|1272804|P2|COMPLETED|Cross Over (Placebo to AA)||0
520890|NCT00887198|1272805|P1|COMPLETED|Cross Over (Placebo to AA)||0
520891|NCT00887198|1272803|P3|STARTED|Cross Over (Placebo to AA)|93= 51 participants(crossed over under amendment 3)+42 participants (crossed over under amendment 4)|93
520892|NCT00887198|1272804|P2|STARTED|Cross Over (Placebo to AA)||0
520893|NCT00887198|1272805|P1|STARTED|Cross Over (Placebo to AA)||0
520894|NCT00887198|1272803|P3|NOT COMPLETED|Randomized Period||0
520895|NCT00887198|1272804|P2|NOT COMPLETED|Randomized Period||542
520896|NCT00887198|1272805|P1|NOT COMPLETED|Randomized Period||546
520897|NCT00887198|1272803|P3|COMPLETED|Randomized Period||0
520898|NCT00887198|1272804|P2|COMPLETED|Randomized Period||0
520899|NCT00887198|1272805|P1|COMPLETED|Randomized Period||0
520900|NCT00887198|1272803|P3|Treated|Randomized Period||0
520901|NCT00887198|1272804|P2|Treated|Randomized Period||540
520902|NCT00887198|1272805|P1|Treated|Randomized Period||542
520903|NCT00887198|1272803|P3|STARTED|Randomized Period||0
520904|NCT00887198|1272804|P2|STARTED|Randomized Period||542
520905|NCT00887198|1272805|P1|STARTED|Randomized Period||546
520906|NCT00887159|1272836|P3|NOT COMPLETED|Overall Study||56
520907|NCT00887159|1272837|P2|NOT COMPLETED|Overall Study||56
520908|NCT00887159|1272838|P1|NOT COMPLETED|Overall Study||29
520909|NCT00887159|1272836|P3|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicity.|0
520910|NCT00887159|1272837|P2|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicity.|0
520911|NCT00887159|1272838|P1|COMPLETED|Overall Study||27
520912|NCT00887159|1272836|P3|Eligible/Treated Pts With CTCs Results|Overall Study||38
520913|NCT00887159|1272837|P2|Eligible/Treated Pts With CTCs Results|Overall Study||42
520914|NCT00887159|1272838|P1|Eligible/Treated Pts With CTCs Results|Overall Study||40
520915|NCT00887159|1272836|P3|Eligible and Treated Patients|Overall Study||52
520916|NCT00887159|1272837|P2|Eligible and Treated Patients|Overall Study||52
520917|NCT00887159|1272838|P1|Eligible and Treated Patients|Overall Study||48
520918|NCT00887159|1272836|P3|Patients Who Started Assigned Treatment|Overall Study||52
520919|NCT00887159|1272837|P2|Patients Who Started Assigned Treatment|Overall Study||53
520920|NCT00887159|1272838|P1|Patients Who Started Assigned Treatment|Overall Study||53
520921|NCT00887159|1272836|P3|STARTED|Overall Study||56
520922|NCT00887159|1272837|P2|STARTED|Overall Study||56
520923|NCT00887159|1272838|P1|STARTED|Overall Study||56
520924|NCT00886938|1272854|P1|NOT COMPLETED|Overall Study||2
520925|NCT00886938|1272854|P1|COMPLETED|Overall Study||10
520926|NCT00886938|1272854|P1|STARTED|Overall Study||12
520927|NCT00886899|1272858|P1|NOT COMPLETED|Overall Study||0
520928|NCT00886899|1272858|P1|COMPLETED|Overall Study||147
520929|NCT00886899|1272858|P1|STARTED|Overall Study||147
520930|NCT00886834|1272867|P2|NOT COMPLETED|Overall Study||3
520931|NCT00886834|1272868|P1|NOT COMPLETED|Overall Study||0
520932|NCT00886834|1272867|P2|COMPLETED|Overall Study||51
520933|NCT00886834|1272868|P1|COMPLETED|Overall Study||54
520934|NCT00886834|1272867|P2|STARTED|Overall Study||54
520935|NCT00886834|1272868|P1|STARTED|Overall Study||54
520936|NCT00886821|1272890|P14|NOT COMPLETED|Stage 2||1
520937|NCT00886821|1272891|P13|NOT COMPLETED|Stage 2||5
520938|NCT00886821|1272892|P12|NOT COMPLETED|Stage 2||1
520939|NCT00886821|1272893|P11|NOT COMPLETED|Stage 2||0
520940|NCT00886821|1272894|P10|NOT COMPLETED|Stage 2||0
520941|NCT00886821|1272895|P9|NOT COMPLETED|Stage 2||0
520942|NCT00886821|1272896|P8|NOT COMPLETED|Stage 2||0
520943|NCT00886821|1272897|P7|NOT COMPLETED|Stage 2||0
520944|NCT00886821|1272898|P6|NOT COMPLETED|Stage 2||0
520945|NCT00886821|1272899|P5|NOT COMPLETED|Stage 2||0
520946|NCT00886821|1272900|P4|NOT COMPLETED|Stage 2||0
520947|NCT00886821|1272901|P3|NOT COMPLETED|Stage 2||0
520948|NCT00886821|1272902|P2|NOT COMPLETED|Stage 2||0
520949|NCT00886821|1272903|P1|NOT COMPLETED|Stage 2||0
520950|NCT00886821|1272890|P14|COMPLETED|Stage 2||8
520951|NCT00886821|1272891|P13|COMPLETED|Stage 2||8
520952|NCT00886821|1272892|P12|COMPLETED|Stage 2||8
520953|NCT00886821|1272893|P11|COMPLETED|Stage 2||9
520954|NCT00886821|1272894|P10|COMPLETED|Stage 2||0
520955|NCT00886821|1272895|P9|COMPLETED|Stage 2||0
520956|NCT00886821|1272896|P8|COMPLETED|Stage 2||0
520957|NCT00886821|1272897|P7|COMPLETED|Stage 2||0
520958|NCT00886821|1272898|P6|COMPLETED|Stage 2||0
520959|NCT00886821|1272899|P5|COMPLETED|Stage 2||0
520960|NCT00886821|1272900|P4|COMPLETED|Stage 2||0
520961|NCT00886821|1272901|P3|COMPLETED|Stage 2||0
520962|NCT00886821|1272902|P2|COMPLETED|Stage 2||0
520963|NCT00886821|1272903|P1|COMPLETED|Stage 2||0
520964|NCT00886821|1272890|P14|STARTED|Stage 2||9
520965|NCT00886821|1272891|P13|STARTED|Stage 2||13
520966|NCT00886821|1272892|P12|STARTED|Stage 2||9
520967|NCT00886821|1272893|P11|STARTED|Stage 2||9
520968|NCT00886821|1272894|P10|STARTED|Stage 2||0
520969|NCT00886821|1272895|P9|STARTED|Stage 2||0
520970|NCT00886821|1272896|P8|STARTED|Stage 2||0
520971|NCT00886821|1272897|P7|STARTED|Stage 2||0
520972|NCT00886821|1272898|P6|STARTED|Stage 2||0
520973|NCT00886821|1272899|P5|STARTED|Stage 2||0
520974|NCT00886821|1272900|P4|STARTED|Stage 2||0
520975|NCT00886821|1272901|P3|STARTED|Stage 2||0
520976|NCT00886821|1272902|P2|STARTED|Stage 2||0
520977|NCT00886821|1272903|P1|STARTED|Stage 2||0
520978|NCT00886821|1272890|P14|NOT COMPLETED|Stage 1||0
520979|NCT00886821|1272891|P13|NOT COMPLETED|Stage 1||0
520980|NCT00886821|1272892|P12|NOT COMPLETED|Stage 1||0
520981|NCT00886821|1272893|P11|NOT COMPLETED|Stage 1||0
520982|NCT00886821|1272894|P10|NOT COMPLETED|Stage 1||0
520983|NCT00886821|1272895|P9|NOT COMPLETED|Stage 1||0
520984|NCT00886821|1272896|P8|NOT COMPLETED|Stage 1||0
520985|NCT00886821|1272897|P7|NOT COMPLETED|Stage 1||0
520986|NCT00886821|1272898|P6|NOT COMPLETED|Stage 1||0
520987|NCT00886821|1272899|P5|NOT COMPLETED|Stage 1||0
520988|NCT00886821|1272900|P4|NOT COMPLETED|Stage 1||0
520989|NCT00886821|1272901|P3|NOT COMPLETED|Stage 1||0
520990|NCT00886821|1272902|P2|NOT COMPLETED|Stage 1||0
520991|NCT00886821|1272903|P1|NOT COMPLETED|Stage 1||0
520992|NCT00886821|1272890|P14|COMPLETED|Stage 1||0
520993|NCT00886821|1272891|P13|COMPLETED|Stage 1||0
520994|NCT00886821|1272892|P12|COMPLETED|Stage 1||0
520995|NCT00886821|1272893|P11|COMPLETED|Stage 1||0
520996|NCT00886821|1272894|P10|COMPLETED|Stage 1||18
520997|NCT00886821|1272895|P9|COMPLETED|Stage 1||6
520998|NCT00886821|1272896|P8|COMPLETED|Stage 1||6
520999|NCT00886821|1272897|P7|COMPLETED|Stage 1||6
521000|NCT00886821|1272898|P6|COMPLETED|Stage 1||6
521001|NCT00886821|1272899|P5|COMPLETED|Stage 1||6
521002|NCT00886821|1272900|P4|COMPLETED|Stage 1||7
521003|NCT00886821|1272901|P3|COMPLETED|Stage 1||6
521004|NCT00886821|1272902|P2|COMPLETED|Stage 1||6
521005|NCT00886821|1272903|P1|COMPLETED|Stage 1||7
521006|NCT00886821|1272890|P14|STARTED|Stage 1||0
521007|NCT00886821|1272891|P13|STARTED|Stage 1||0
521008|NCT00886821|1272892|P12|STARTED|Stage 1||0
521009|NCT00886821|1272893|P11|STARTED|Stage 1||0
521010|NCT00886821|1272894|P10|STARTED|Stage 1||18
521011|NCT00886821|1272895|P9|STARTED|Stage 1||6
521012|NCT00886821|1272896|P8|STARTED|Stage 1||6
521013|NCT00886821|1272897|P7|STARTED|Stage 1||6
521014|NCT00886821|1272898|P6|STARTED|Stage 1||6
521015|NCT00886821|1272899|P5|STARTED|Stage 1||6
521016|NCT00886821|1272900|P4|STARTED|Stage 1||7
521017|NCT00886821|1272901|P3|STARTED|Stage 1||6
521018|NCT00886821|1272902|P2|STARTED|Stage 1||6
521019|NCT00886821|1272903|P1|STARTED|Stage 1||7
521020|NCT00886795|1273128|P1|NOT COMPLETED|Overall Study||1
521021|NCT00886795|1273128|P1|COMPLETED|Overall Study||3
521022|NCT00886795|1273128|P1|STARTED|Overall Study||4
521023|NCT00886769|1273135|P2|NOT COMPLETED|Overall Study||37
521024|NCT00886769|1273136|P1|NOT COMPLETED|Overall Study||6
521025|NCT00886769|1273135|P2|COMPLETED|Overall Study||4
521026|NCT00886769|1273136|P1|COMPLETED|Overall Study||37
521027|NCT00886769|1273135|P2|STARTED|Overall Study||41
521028|NCT00886769|1273136|P1|STARTED|Overall Study||43
521029|NCT00886743|1273160|P1|NOT COMPLETED|Overall Study||4
521030|NCT00886743|1273160|P1|COMPLETED|Overall Study||15
521031|NCT00886743|1273160|P1|STARTED|Overall Study|Received treatment|19
521032|NCT00886704|1273170|P2|NOT COMPLETED|Overall Study||0
521033|NCT00886704|1273171|P1|NOT COMPLETED|Overall Study||0
521034|NCT00886704|1273170|P2|COMPLETED|Overall Study||10
521035|NCT00886704|1273171|P1|COMPLETED|Overall Study||40
521036|NCT00886704|1273170|P2|STARTED|Overall Study||10
521037|NCT00886704|1273171|P1|STARTED|Overall Study||40
521038|NCT00886639|1273179|P1|NOT COMPLETED|Overall Study||16
521039|NCT00886639|1273179|P1|COMPLETED|Overall Study||111
521040|NCT00886639|1273179|P1|STARTED|Overall Study||127
521041|NCT00886626|1273183|P2|NOT COMPLETED|Period 2 (90 Days)||0
521042|NCT00886626|1273184|P1|NOT COMPLETED|Period 2 (90 Days)||0
521043|NCT00886626|1273183|P2|COMPLETED|Period 2 (90 Days)||6
521044|NCT00886626|1273184|P1|COMPLETED|Period 2 (90 Days)||5
521045|NCT00886626|1273183|P2|STARTED|Period 2 (90 Days)||6
521046|NCT00886626|1273184|P1|STARTED|Period 2 (90 Days)||5
521047|NCT00886626|1273183|P2|NOT COMPLETED|Period 1 (90 Days)||0
521048|NCT00886626|1273184|P1|NOT COMPLETED|Period 1 (90 Days)||1
521049|NCT00886626|1273183|P2|COMPLETED|Period 1 (90 Days)||6
521050|NCT00886626|1273184|P1|COMPLETED|Period 1 (90 Days)||5
521051|NCT00886626|1273183|P2|STARTED|Period 1 (90 Days)||6
521052|NCT00886626|1273184|P1|STARTED|Period 1 (90 Days)||6
521053|NCT00886613|1273193|P3|NOT COMPLETED|Overall Study||3
521054|NCT00886613|1273194|P2|NOT COMPLETED|Overall Study||0
521055|NCT00886613|1273195|P1|NOT COMPLETED|Overall Study||2
521056|NCT00886613|1273193|P3|COMPLETED|Overall Study||37
521057|NCT00886613|1273194|P2|COMPLETED|Overall Study||39
521058|NCT00886613|1273195|P1|COMPLETED|Overall Study||39
521059|NCT00886613|1273193|P3|STARTED|Overall Study||40
521060|NCT00886613|1273194|P2|STARTED|Overall Study||39
521061|NCT00886613|1273195|P1|STARTED|Overall Study||41
521062|NCT00886600|1273217|P4|NOT COMPLETED|Combination Therapy Period||0
521063|NCT00886600|1273218|P3|NOT COMPLETED|Combination Therapy Period||2
521064|NCT00886600|1273219|P2|NOT COMPLETED|Combination Therapy Period||0
521065|NCT00886600|1273220|P1|NOT COMPLETED|Combination Therapy Period||0
521066|NCT00886600|1273217|P4|COMPLETED|Combination Therapy Period||23
521067|NCT00886600|1273218|P3|COMPLETED|Combination Therapy Period||19
521068|NCT00886600|1273219|P2|COMPLETED|Combination Therapy Period||21
521069|NCT00886600|1273220|P1|COMPLETED|Combination Therapy Period||28
521070|NCT00886600|1273217|P4|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 5-(SiDBP <85); 1-(SiDBP ≥85)|23
521071|NCT00886600|1273218|P3|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 7-(SiDBP <85); 1-(SiDBP ≥85)|21
521072|NCT00886600|1273219|P2|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 4-(SiDBP <85); 3-(SiDBP ≥85)|21
521073|NCT00886600|1273220|P1|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 2-(Sitting Diastolic Blood Pressure (SiDBP) <85)|28
521074|NCT00886600|1273217|P4|NOT COMPLETED|Double-blind Monotherapy||2
521075|NCT00886600|1273218|P3|NOT COMPLETED|Double-blind Monotherapy||1
521076|NCT00886600|1273219|P2|NOT COMPLETED|Double-blind Monotherapy||1
521077|NCT00886600|1273220|P1|NOT COMPLETED|Double-blind Monotherapy||2
521078|NCT00886600|1273217|P4|COMPLETED|Double-blind Monotherapy||29
521079|NCT00886600|1273218|P3|COMPLETED|Double-blind Monotherapy||29
521080|NCT00886600|1273219|P2|COMPLETED|Double-blind Monotherapy|1 pt discontinued after Wk 4 due to AE starting in placebo baseline and continuing into double-blind|28
521081|NCT00886600|1273220|P1|COMPLETED|Double-blind Monotherapy||30
521082|NCT00886600|1273217|P4|STARTED|Double-blind Monotherapy||31
521083|NCT00886600|1273218|P3|STARTED|Double-blind Monotherapy||30
521084|NCT00886600|1273219|P2|STARTED|Double-blind Monotherapy||29
521085|NCT00886600|1273220|P1|STARTED|Double-blind Monotherapy||32
521086|NCT00886587|1273244|P2|NOT COMPLETED|Overall Study||2
521087|NCT00886587|1273245|P1|NOT COMPLETED|Overall Study||4
521088|NCT00886587|1273244|P2|COMPLETED|Overall Study||39
521089|NCT00886587|1273245|P1|COMPLETED|Overall Study||37
521090|NCT00886587|1273244|P2|STARTED|Overall Study||41
521091|NCT00886587|1273245|P1|STARTED|Overall Study||41
521092|NCT00886483|1273259|P2|NOT COMPLETED|Overall Study||3
521093|NCT00886483|1273260|P1|NOT COMPLETED|Overall Study||2
521094|NCT00886483|1273259|P2|COMPLETED|Overall Study||10
521095|NCT00886483|1273260|P1|COMPLETED|Overall Study||24
521096|NCT00886483|1273259|P2|Completed 20 Treatments|Overall Study||11
521097|NCT00886483|1273260|P1|Completed 20 Treatments|Overall Study||25
521098|NCT00886483|1273259|P2|STARTED|Overall Study||13
521099|NCT00886483|1273260|P1|STARTED|Overall Study||26
521100|NCT00886340|1273278|P2|NOT COMPLETED|Overall Study||7
521101|NCT00886340|1273279|P1|NOT COMPLETED|Overall Study||0
521102|NCT00886340|1273278|P2|COMPLETED|Overall Study||24
521103|NCT00886340|1273279|P1|COMPLETED|Overall Study||27
521104|NCT00886340|1273278|P2|STARTED|Overall Study||31
521105|NCT00886340|1273279|P1|STARTED|Overall Study||27
521106|NCT00886288|1273287|P2|NOT COMPLETED|Overall Study||227
521107|NCT00886288|1273288|P1|NOT COMPLETED|Overall Study||743
521108|NCT00886288|1273287|P2|COMPLETED|Overall Study||457
521109|NCT00886288|1273288|P1|COMPLETED|Overall Study||1284
521110|NCT00886288|1273287|P2|STARTED|Overall Study|Baseline Population|684
521111|NCT00886288|1273288|P1|STARTED|Overall Study|Baseline Population|2027
521112|NCT00886145|1273304|P1|NOT COMPLETED|Overall Study||0
521113|NCT00886145|1273304|P1|COMPLETED|Overall Study||1
521114|NCT00886145|1273304|P1|STARTED|Overall Study||1
521115|NCT00886119|1273310|P2|NOT COMPLETED|Period 2||0
521116|NCT00886119|1273311|P1|NOT COMPLETED|Period 2||0
521117|NCT00886119|1273310|P2|COMPLETED|Period 2||22
521118|NCT00886119|1273311|P1|COMPLETED|Period 2||23
521119|NCT00886119|1273310|P2|STARTED|Period 2||22
521120|NCT00886119|1273311|P1|STARTED|Period 2||23
521121|NCT00886119|1273310|P2|NOT COMPLETED|Period 1||0
521122|NCT00886119|1273311|P1|NOT COMPLETED|Period 1||1
521123|NCT00886119|1273310|P2|COMPLETED|Period 1||22
521124|NCT00886119|1273311|P1|COMPLETED|Period 1||23
521125|NCT00886119|1273310|P2|STARTED|Period 1||22
521126|NCT00886119|1273311|P1|STARTED|Period 1||24
521127|NCT00886015|1273319|P2|NOT COMPLETED|Overall Study||2
521128|NCT00886015|1273320|P1|NOT COMPLETED|Overall Study||0
521129|NCT00886015|1273319|P2|COMPLETED|Overall Study|1669 eyes; 956 participants|1669
521130|NCT00886015|1273320|P1|COMPLETED|Overall Study|1674 eyes; 960 participants|1674
521131|NCT00886015|1273319|P2|STARTED|Overall Study|1671 eyes; 957 participants|1671
521132|NCT00886015|1273320|P1|STARTED|Overall Study|1674 eyes; 960 participants|1674
521133|NCT00885846|1273339|P3|NOT COMPLETED|Overall Study||2
521134|NCT00885846|1273340|P2|NOT COMPLETED|Overall Study||5
521135|NCT00885846|1273341|P1|NOT COMPLETED|Overall Study||2
521136|NCT00885846|1273339|P3|COMPLETED|Overall Study|Cohort 1 = 4 Cohort 2 = 6|8
521137|NCT00885846|1273340|P2|COMPLETED|Overall Study|Cohort 1 = 1 Cohort 2 = 5|6
521138|NCT00885846|1273341|P1|COMPLETED|Overall Study|Cohort 1 = 3 Cohort 2 = 6|9
521139|NCT00885846|1273339|P3|STARTED|Overall Study|Cohort 1 = 4 Cohort 2 = 6|10
521140|NCT00885846|1273340|P2|STARTED|Overall Study|Cohort 1 = 6 Cohort 2 = 5|11
521141|NCT00885846|1273341|P1|STARTED|Overall Study|Cohort 1 = 5 Cohort 2 = 6|11
521142|NCT00885768|1273349|P1|NOT COMPLETED|Overall Study||0
521143|NCT00885768|1273349|P1|COMPLETED|Overall Study|all patients with including criteria completed the study|146
521144|NCT00885768|1273349|P1|STARTED|Overall Study|all patients with coronary artery stenosis on angiography entered the study|146
521145|NCT00885755|1273356|P3|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0
521146|NCT00885755|1273357|P2|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0
521147|NCT00885755|1273358|P1|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||5
521148|NCT00885755|1273356|P3|COMPLETED|Part II: Trastuzumab + Capecitabine.||0
521149|NCT00885755|1273357|P2|COMPLETED|Part II: Trastuzumab + Capecitabine.||1
521150|NCT00885755|1273358|P1|COMPLETED|Part II: Trastuzumab + Capecitabine.||8
521151|NCT00885755|1273356|P3|STARTED|Part II: Trastuzumab + Capecitabine.||0
521152|NCT00885755|1273357|P2|STARTED|Part II: Trastuzumab + Capecitabine.||1
521153|NCT00885755|1273358|P1|STARTED|Part II: Trastuzumab + Capecitabine.||13
521154|NCT00885755|1273356|P3|NOT COMPLETED|Part I: Trastuzumab+Taxane||1
521155|NCT00885755|1273357|P2|NOT COMPLETED|Part I: Trastuzumab+Taxane||0
521156|NCT00885755|1273358|P1|NOT COMPLETED|Part I: Trastuzumab+Taxane||18
521157|NCT00885755|1273356|P3|COMPLETED|Part I: Trastuzumab+Taxane||0
521158|NCT00885755|1273357|P2|COMPLETED|Part I: Trastuzumab+Taxane||1
521159|NCT00885755|1273358|P1|COMPLETED|Part I: Trastuzumab+Taxane||13
521160|NCT00885755|1273356|P3|STARTED|Part I: Trastuzumab+Taxane||1
521161|NCT00885755|1273357|P2|STARTED|Part I: Trastuzumab+Taxane||1
521162|NCT00885755|1273358|P1|STARTED|Part I: Trastuzumab+Taxane||31
521163|NCT00885742|1273383|P1|NOT COMPLETED|Overall Study||0
521164|NCT00885742|1273383|P1|COMPLETED|Overall Study||41
521165|NCT00885742|1273383|P1|STARTED|Overall Study||41
521166|NCT00885703|1273401|P7|NOT COMPLETED|Overall Study||6
521167|NCT00885703|1273402|P6|NOT COMPLETED|Overall Study||13
521168|NCT00885703|1273403|P5|NOT COMPLETED|Overall Study||12
521169|NCT00885703|1273404|P4|NOT COMPLETED|Overall Study||9
521170|NCT00885703|1273405|P3|NOT COMPLETED|Overall Study||11
521171|NCT00885703|1273406|P2|NOT COMPLETED|Overall Study||10
521172|NCT00885703|1273407|P1|NOT COMPLETED|Overall Study||10
521173|NCT00885703|1273401|P7|COMPLETED|Overall Study||18
521174|NCT00885703|1273402|P6|COMPLETED|Overall Study||11
521175|NCT00885703|1273403|P5|COMPLETED|Overall Study||12
521176|NCT00885703|1273404|P4|COMPLETED|Overall Study||15
521177|NCT00885703|1273405|P3|COMPLETED|Overall Study||13
521178|NCT00885703|1273406|P2|COMPLETED|Overall Study||16
521179|NCT00885703|1273407|P1|COMPLETED|Overall Study||12
521180|NCT00885703|1273401|P7|STARTED|Overall Study||24
521181|NCT00885703|1273402|P6|STARTED|Overall Study||24
521182|NCT00885703|1273403|P5|STARTED|Overall Study||24
521183|NCT00885703|1273404|P4|STARTED|Overall Study||24
521184|NCT00885703|1273405|P3|STARTED|Overall Study||24
521185|NCT00885703|1273406|P2|STARTED|Overall Study||26
521186|NCT00885703|1273407|P1|STARTED|Overall Study||22
521187|NCT00885677|1273465|P2|NOT COMPLETED|Overall Study||178
521188|NCT00885677|1273466|P1|NOT COMPLETED|Overall Study||183
521189|NCT00885677|1273465|P2|COMPLETED|Overall Study||277
521190|NCT00885677|1273466|P1|COMPLETED|Overall Study||279
521191|NCT00885677|1273465|P2|Intention To Treat|Overall Study||428
521192|NCT00885677|1273466|P1|Intention To Treat|Overall Study||437
521193|NCT00885677|1273465|P2|STARTED|Overall Study||455
521194|NCT00885677|1273466|P1|STARTED|Overall Study||462
521195|NCT00885638|1273474|P2|NOT COMPLETED|Overall Study||0
521196|NCT00885638|1273475|P1|NOT COMPLETED|Overall Study||0
521197|NCT00885638|1273474|P2|COMPLETED|Overall Study||6
521198|NCT00885638|1273475|P1|COMPLETED|Overall Study||6
521199|NCT00885638|1273474|P2|STARTED|Overall Study||6
521200|NCT00885638|1273475|P1|STARTED|Overall Study||6
521201|NCT00885534|1273482|P1|NOT COMPLETED|Overall Study||1
521202|NCT00885534|1273482|P1|COMPLETED|Overall Study||6
521203|NCT00885534|1273482|P1|STARTED|Overall Study||7
521204|NCT00885482|1273486|P1|NOT COMPLETED|Overall Study||4
521205|NCT00885482|1273486|P1|COMPLETED|Overall Study||36
521206|NCT00885482|1273486|P1|STARTED|Overall Study||40
521207|NCT00885378|1273492|P2|NOT COMPLETED|Overall Study||8
521208|NCT00885378|1273493|P1|NOT COMPLETED|Overall Study||8
521209|NCT00885378|1273492|P2|COMPLETED|Overall Study||78
521210|NCT00885378|1273493|P1|COMPLETED|Overall Study||66
521211|NCT00885378|1273492|P2|STARTED|Overall Study|Number randomized.|86
521212|NCT00885378|1273493|P1|STARTED|Overall Study|Number randomized.|74
521213|NCT00885365|1273523|P2|NOT COMPLETED|4 Weeks OFF Treatment||0
521214|NCT00885365|1273524|P1|NOT COMPLETED|4 Weeks OFF Treatment||0
521215|NCT00885365|1273523|P2|COMPLETED|4 Weeks OFF Treatment||159
521216|NCT00885365|1273524|P1|COMPLETED|4 Weeks OFF Treatment||155
521217|NCT00885365|1273523|P2|STARTED|4 Weeks OFF Treatment||159
521218|NCT00885365|1273524|P1|STARTED|4 Weeks OFF Treatment||155
521219|NCT00885365|1273523|P2|NOT COMPLETED|4 Weeks ON Treatment||6
521220|NCT00885365|1273524|P1|NOT COMPLETED|4 Weeks ON Treatment||4
521221|NCT00885365|1273523|P2|COMPLETED|4 Weeks ON Treatment||159
521222|NCT00885365|1273524|P1|COMPLETED|4 Weeks ON Treatment||155
521223|NCT00885365|1273523|P2|Safety Population|4 Weeks ON Treatment|Six participants randomized to TOBI were administered Bramitob|168
521224|NCT00885365|1273524|P1|Safety Population|4 Weeks ON Treatment|Nine participants randomized to Bramitob were administered TOBI.|156
521225|NCT00885365|1273523|P2|Intent-to-Treat Population|4 Weeks ON Treatment||163
521226|NCT00885365|1273524|P1|Intent-to-Treat Population|4 Weeks ON Treatment|Participants who took 1 dose of study medication and had baseline and at least 1 post-treatment FEV1|158
521227|NCT00885365|1273523|P2|STARTED|4 Weeks ON Treatment||165
521228|NCT00885365|1273524|P1|STARTED|4 Weeks ON Treatment||159
521229|NCT00885352|1273560|P2|NOT COMPLETED|Overall Study||20
521230|NCT00885352|1273561|P1|NOT COMPLETED|Overall Study||8
521231|NCT00885352|1273560|P2|COMPLETED|Overall Study||136
521232|NCT00885352|1273561|P1|COMPLETED|Overall Study||149
521233|NCT00885352|1273560|P2|STARTED|Overall Study||156
521234|NCT00885352|1273561|P1|STARTED|Overall Study||157
521235|NCT00885170|1273573|P2|NOT COMPLETED|Overall Study||23
521236|NCT00885170|1273574|P1|NOT COMPLETED|Overall Study||38
521237|NCT00885170|1273573|P2|COMPLETED|Overall Study||99
521238|NCT00885170|1273574|P1|COMPLETED|Overall Study||86
521239|NCT00885170|1273573|P2|Treated|Overall Study||121
521240|NCT00885170|1273574|P1|Treated|Overall Study||122
521241|NCT00885170|1273573|P2|STARTED|Overall Study||122
521242|NCT00885170|1273574|P1|STARTED|Overall Study||124
521243|NCT00885118|1273633|P5|NOT COMPLETED|Overall Study||1
521244|NCT00885118|1273634|P4|NOT COMPLETED|Overall Study||0
521245|NCT00885118|1273635|P3|NOT COMPLETED|Overall Study||1
521246|NCT00885118|1273636|P2|NOT COMPLETED|Overall Study||0
521247|NCT00885118|1273637|P1|NOT COMPLETED|Overall Study||1
521248|NCT00885118|1273633|P5|COMPLETED|Overall Study||18
521249|NCT00885118|1273634|P4|COMPLETED|Overall Study||20
521250|NCT00885118|1273635|P3|COMPLETED|Overall Study||20
521251|NCT00885118|1273636|P2|COMPLETED|Overall Study||19
521252|NCT00885118|1273637|P1|COMPLETED|Overall Study||20
521253|NCT00885118|1273633|P5|STARTED|Overall Study||19
521254|NCT00885118|1273634|P4|STARTED|Overall Study||20
521255|NCT00885118|1273635|P3|STARTED|Overall Study||21
521256|NCT00885118|1273636|P2|STARTED|Overall Study||19
521257|NCT00885118|1273637|P1|STARTED|Overall Study||21
521258|NCT00885105|1273776|P2|NOT COMPLETED|Overall Study||10
521259|NCT00885105|1273777|P1|NOT COMPLETED|Overall Study||1
521260|NCT00885105|1273776|P2|COMPLETED|Overall Study||120
521261|NCT00885105|1273777|P1|COMPLETED|Overall Study||111
521262|NCT00885105|1273776|P2|STARTED|Overall Study||130
521263|NCT00885105|1273777|P1|STARTED|Overall Study||112
521264|NCT00885092|1273795|P2|NOT COMPLETED|Period 2, 7 Days||0
521265|NCT00885092|1273796|P1|NOT COMPLETED|Period 2, 7 Days||0
521266|NCT00885092|1273795|P2|COMPLETED|Period 2, 7 Days||20
521267|NCT00885092|1273796|P1|COMPLETED|Period 2, 7 Days||20
521268|NCT00885092|1273795|P2|STARTED|Period 2, 7 Days||20
521269|NCT00885092|1273796|P1|STARTED|Period 2, 7 Days||20
521270|NCT00885092|1273795|P2|NOT COMPLETED|Period 1, 7 Days||0
521271|NCT00885092|1273796|P1|NOT COMPLETED|Period 1, 7 Days||0
521272|NCT00885092|1273795|P2|COMPLETED|Period 1, 7 Days||20
521273|NCT00885092|1273796|P1|COMPLETED|Period 1, 7 Days||20
521274|NCT00885092|1273795|P2|STARTED|Period 1, 7 Days||20
521275|NCT00885092|1273796|P1|STARTED|Period 1, 7 Days||20
521276|NCT00885079|1273808|P2|NOT COMPLETED|Overall Study||4
521277|NCT00885079|1273809|P1|NOT COMPLETED|Overall Study||2
521278|NCT00885079|1273808|P2|COMPLETED|Overall Study||91
521279|NCT00885079|1273809|P1|COMPLETED|Overall Study||91
521280|NCT00885079|1273808|P2|STARTED|Overall Study||95
521281|NCT00885079|1273809|P1|STARTED|Overall Study||93
521282|NCT00884949|1273817|P1|NOT COMPLETED|Continuation Period||0
521283|NCT00884949|1273817|P1|COMPLETED|Continuation Period||18
521284|NCT00884949|1273817|P1|STARTED|Continuation Period||18
521285|NCT00884949|1273817|P1|NOT COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||0
521286|NCT00884949|1273817|P1|COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||18
521287|NCT00884949|1273817|P1|STARTED|Weeks 25-36: 2.0 mg/kg/Week||18
521288|NCT00884949|1273817|P1|NOT COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||0
521289|NCT00884949|1273817|P1|COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||18
521290|NCT00884949|1273817|P1|STARTED|Weeks 13-24: 1.0 mg/kg/Week||18
521291|NCT00884949|1273817|P1|NOT COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||2
521292|NCT00884949|1273817|P1|COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||18
521293|NCT00884949|1273817|P1|STARTED|Weeks 1-12: 0.1 mg/kg/Week||20
521294|NCT00884910|1273834|P1|NOT COMPLETED|Overall Study||1
521295|NCT00884910|1273834|P1|COMPLETED|Overall Study|patient diagnosed with primary pulmonary tumor during study|32
521296|NCT00884910|1273834|P1|STARTED|Overall Study||33
521297|NCT00884897|1273841|P2|NOT COMPLETED|Overall Study||0
521298|NCT00884897|1273842|P1|NOT COMPLETED|Overall Study||0
521299|NCT00884897|1273841|P2|COMPLETED|Overall Study||15
521300|NCT00884897|1273842|P1|COMPLETED|Overall Study||13
521301|NCT00884897|1273841|P2|STARTED|Overall Study||15
521302|NCT00884897|1273842|P1|STARTED|Overall Study||13
521303|NCT00884832|1273852|P2|NOT COMPLETED|Overall Study||1
521304|NCT00884832|1273853|P1|NOT COMPLETED|Overall Study||0
521305|NCT00884832|1273852|P2|COMPLETED|Overall Study||21
521306|NCT00884832|1273853|P1|COMPLETED|Overall Study||22
521307|NCT00884832|1273852|P2|STARTED|Overall Study||22
521308|NCT00884832|1273853|P1|STARTED|Overall Study||22
521309|NCT00884806|1273883|P1|NOT COMPLETED|Overall Study||0
521310|NCT00884806|1273883|P1|COMPLETED|Overall Study||110
521311|NCT00884806|1273883|P1|STARTED|Overall Study||110
521312|NCT00884793|1273888|P1|NOT COMPLETED|Overall Study||1
521313|NCT00884793|1273888|P1|COMPLETED|Overall Study||7
521314|NCT00884793|1273888|P1|STARTED|Overall Study||8
521315|NCT00884754|1273897|P2|NOT COMPLETED|Overall Study||0
521316|NCT00884754|1273898|P1|NOT COMPLETED|Overall Study||0
521317|NCT00884754|1273897|P2|COMPLETED|Overall Study||30
521318|NCT00884754|1273898|P1|COMPLETED|Overall Study||30
521319|NCT00884754|1273897|P2|STARTED|Overall Study||30
521320|NCT00884754|1273898|P1|STARTED|Overall Study||30
521321|NCT00884741|1273907|P4|NOT COMPLETED|Randomization||8
521322|NCT00884741|1273908|P3|NOT COMPLETED|Randomization||8
521323|NCT00884741|1273909|P2|NOT COMPLETED|Randomization||0
521324|NCT00884741|1273910|P1|NOT COMPLETED|Randomization||0
521325|NCT00884741|1273907|P4|COMPLETED|Randomization|Patients with data available for the primary analysis are considered to have completed the study.|312
521326|NCT00884741|1273908|P3|COMPLETED|Randomization|Patients with data available for the primary analysis are considered to have completed the study.|309
521327|NCT00884741|1273909|P2|COMPLETED|Randomization||0
521328|NCT00884741|1273910|P1|COMPLETED|Randomization||0
521329|NCT00884741|1273907|P4|STARTED|Randomization|These patients completed the previous period on the Step 2 Registration arm.|320
521330|NCT00884741|1273908|P3|STARTED|Randomization|These patients completed the previous period on the Step 2 Registration arm.|317
521331|NCT00884741|1273909|P2|STARTED|Randomization|Step 2 Registration Arm goes to a randomized arm.|0
521332|NCT00884741|1273910|P1|STARTED|Randomization||0
521333|NCT00884741|1273907|P4|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
521334|NCT00884741|1273908|P3|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
521335|NCT00884741|1273909|P2|NOT COMPLETED|Step 2 Registration: Tissue Analysis||29
521336|NCT00884741|1273910|P1|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
521337|NCT00884741|1273907|P4|COMPLETED|Step 2 Registration: Tissue Analysis||0
521338|NCT00884741|1273908|P3|COMPLETED|Step 2 Registration: Tissue Analysis||0
521339|NCT00884741|1273909|P2|COMPLETED|Step 2 Registration: Tissue Analysis||637
521340|NCT00884741|1273910|P1|COMPLETED|Step 2 Registration: Tissue Analysis||0
521341|NCT00884741|1273907|P4|STARTED|Step 2 Registration: Tissue Analysis||0
521342|NCT00884741|1273908|P3|STARTED|Step 2 Registration: Tissue Analysis||0
521343|NCT00884741|1273909|P2|STARTED|Step 2 Registration: Tissue Analysis|These patients completed the previous period on the Step 1 Registration arm.|666
521344|NCT00884741|1273910|P1|STARTED|Step 2 Registration: Tissue Analysis|Step 1 Registration Arm goes to Step 2 Registration Arm|0
521345|NCT00884741|1273907|P4|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
521346|NCT00884741|1273908|P3|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
521347|NCT00884741|1273909|P2|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
521348|NCT00884741|1273910|P1|NOT COMPLETED|Step 1 Registration: Tissue Screening||312
521349|NCT00884741|1273907|P4|COMPLETED|Step 1 Registration: Tissue Screening||0
521350|NCT00884741|1273908|P3|COMPLETED|Step 1 Registration: Tissue Screening||0
521351|NCT00884741|1273909|P2|COMPLETED|Step 1 Registration: Tissue Screening||0
521352|NCT00884741|1273910|P1|COMPLETED|Step 1 Registration: Tissue Screening||666
521353|NCT00884741|1273907|P4|STARTED|Step 1 Registration: Tissue Screening||0
521354|NCT00884741|1273908|P3|STARTED|Step 1 Registration: Tissue Screening||0
521355|NCT00884741|1273909|P2|STARTED|Step 1 Registration: Tissue Screening||0
521356|NCT00884741|1273910|P1|STARTED|Step 1 Registration: Tissue Screening||978
521357|NCT00884611|1273921|P1|NOT COMPLETED|Overall Study||1
521358|NCT00884611|1273921|P1|COMPLETED|Overall Study||19
521359|NCT00884611|1273921|P1|Enrolled, Not Treated|Overall Study||1
521360|NCT00884611|1273921|P1|STARTED|Overall Study||20
521361|NCT00884585|1273945|P2|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||0
521362|NCT00884585|1273946|P1|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||3
521363|NCT00884585|1273945|P2|COMPLETED|Open-Label Maintenance (Months 9-12)||0
521364|NCT00884585|1273946|P1|COMPLETED|Open-Label Maintenance (Months 9-12)||144
521365|NCT00884585|1273945|P2|STARTED|Open-Label Maintenance (Months 9-12)||0
521366|NCT00884585|1273946|P1|STARTED|Open-Label Maintenance (Months 9-12)||147
521367|NCT00884585|1273945|P2|NOT COMPLETED|Open-Label Phase (Months 3-9)||0
521368|NCT00884585|1273946|P1|NOT COMPLETED|Open-Label Phase (Months 3-9)||15
521369|NCT00884585|1273945|P2|COMPLETED|Open-Label Phase (Months 3-9)||0
521370|NCT00884585|1273946|P1|COMPLETED|Open-Label Phase (Months 3-9)||147
521371|NCT00884585|1273945|P2|STARTED|Open-Label Phase (Months 3-9)|All placebo patients who completed the double-masked phase received COS in the open-label phase.|0
521372|NCT00884585|1273946|P1|STARTED|Open-Label Phase (Months 3-9)|All patients who completed the double-masked phase received COS in the open-label phase.|162
521373|NCT00884585|1273945|P2|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||4
521374|NCT00884585|1273946|P1|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||10
521375|NCT00884585|1273945|P2|COMPLETED|Double-Masked Phase (Day 1-Month 3)|All placebo patients who completed the double-masked phase received COS in the open-label phase.|83
521376|NCT00884585|1273946|P1|COMPLETED|Double-Masked Phase (Day 1-Month 3)||79
521377|NCT00884585|1273945|P2|STARTED|Double-Masked Phase (Day 1-Month 3)||87
521378|NCT00884585|1273946|P1|STARTED|Double-Masked Phase (Day 1-Month 3)||89
521379|NCT00884390|1273960|P2|NOT COMPLETED|Overall Study||8
521380|NCT00884390|1273961|P1|NOT COMPLETED|Overall Study||23
521381|NCT00884390|1273960|P2|COMPLETED|Overall Study||54
521382|NCT00884390|1273961|P1|COMPLETED|Overall Study||123
521383|NCT00884390|1273960|P2|STARTED|Overall Study||62
521384|NCT00884390|1273961|P1|STARTED|Overall Study||146
521385|NCT00884377|1273979|P2|NOT COMPLETED|Overall Study||1
521386|NCT00884377|1273980|P1|NOT COMPLETED|Overall Study||2
521387|NCT00884377|1273979|P2|COMPLETED|Overall Study||27
521388|NCT00884377|1273980|P1|COMPLETED|Overall Study|1 received full course of therapy,withdrew consent before completion of the 12 month follow up|26
521389|NCT00884377|1273979|P2|STARTED|Overall Study|1 was not treated due to concerns arising from the location of cutaneous leishmaniasis lesion|28
521390|NCT00884377|1273980|P1|STARTED|Overall Study|1 not treated because infecting parasite could not be confirmed as L. major on rapid PCR testing,|28
521391|NCT00884325|1274002|P2|NOT COMPLETED|Overall Study||4
521392|NCT00884325|1274003|P1|NOT COMPLETED|Overall Study||3
521393|NCT00884325|1274002|P2|COMPLETED|Overall Study||16
521394|NCT00884325|1274003|P1|COMPLETED|Overall Study||17
521395|NCT00884325|1274002|P2|STARTED|Overall Study||20
521396|NCT00884325|1274003|P1|STARTED|Overall Study||20
521397|NCT00884312|1274013|P2|NOT COMPLETED|Overall Study||25
521398|NCT00884312|1274014|P1|NOT COMPLETED|Overall Study||2
521399|NCT00884312|1274013|P2|COMPLETED|Overall Study||67
521400|NCT00884312|1274014|P1|COMPLETED|Overall Study||7
521401|NCT00884312|1274013|P2|Received Treatment|Overall Study||91
521402|NCT00884312|1274014|P1|Received Treatment|Overall Study||9
521403|NCT00884312|1274013|P2|STARTED|Overall Study||92
521404|NCT00884312|1274014|P1|STARTED|Overall Study||9
521405|NCT00884286|1274030|P2|NOT COMPLETED|Overall Study||33
521406|NCT00884286|1274031|P1|NOT COMPLETED|Overall Study||32
521407|NCT00884286|1274030|P2|COMPLETED|Overall Study||0
521408|NCT00884286|1274031|P1|COMPLETED|Overall Study||2
521409|NCT00884286|1274030|P2|STARTED|Overall Study||33
521410|NCT00884286|1274031|P1|STARTED|Overall Study||34
521411|NCT00884273|1274045|P2|NOT COMPLETED|Overall Study||5
521412|NCT00884273|1274046|P1|NOT COMPLETED|Overall Study||2
521413|NCT00884273|1274045|P2|COMPLETED|Overall Study||93
521414|NCT00884273|1274046|P1|COMPLETED|Overall Study||82
521415|NCT00884273|1274045|P2|Safety Analysis Set|Overall Study||98
521416|NCT00884273|1274046|P1|Safety Analysis Set|Overall Study||84
521417|NCT00884273|1274045|P2|Per Protocol (PP) Analysis Set|Overall Study||92
521418|NCT00884273|1274046|P1|Per Protocol (PP) Analysis Set|Overall Study||81
521419|NCT00884273|1274045|P2|Full Analysis Set (FAS)|Overall Study|One participant did not have any post-dose efficacy assessment and was excluded from the FAS.|97
521420|NCT00884273|1274046|P1|Full Analysis Set (FAS)|Overall Study|Two participants did not have any post-dose efficacy assessment and were excluded from the FAS.|82
521421|NCT00884273|1274045|P2|STARTED|Overall Study|ITT population.|98
521422|NCT00884273|1274046|P1|STARTED|Overall Study|Intention-to-treat (ITT) population.|84
521423|NCT00884221|1274072|P2|NOT COMPLETED|Overall Study||32
521424|NCT00884221|1274073|P1|NOT COMPLETED|Overall Study||34
521425|NCT00884221|1274072|P2|COMPLETED|Overall Study||343
521426|NCT00884221|1274073|P1|COMPLETED|Overall Study||340
521427|NCT00884221|1274072|P2|STARTED|Overall Study||375
521428|NCT00884221|1274073|P1|STARTED|Overall Study||374
521429|NCT00884117|1274109|P1|NOT COMPLETED|Overall Study||249
521430|NCT00884117|1274109|P1|COMPLETED|Overall Study|Defined as Day 6 visit for those enrolled before Amendment D; thereafter defined as Day 10 visit.|4312
521431|NCT00884117|1274109|P1|STARTED|Overall Study||4561
521432|NCT00884065|1274153|P2|NOT COMPLETED|Overall Study||0
521433|NCT00884065|1274154|P1|NOT COMPLETED|Overall Study||0
521434|NCT00884065|1274153|P2|COMPLETED|Overall Study||25
521435|NCT00884065|1274154|P1|COMPLETED|Overall Study||25
521436|NCT00884065|1274153|P2|STARTED|Overall Study||25
521437|NCT00884065|1274154|P1|STARTED|Overall Study||25
521438|NCT00884039|1274172|P2|NOT COMPLETED|Overall Study||1
521439|NCT00884039|1274173|P1|NOT COMPLETED|Overall Study||2
521440|NCT00884039|1274172|P2|COMPLETED|Overall Study||1
521441|NCT00884039|1274173|P1|COMPLETED|Overall Study||3
521442|NCT00884039|1274172|P2|STARTED|Overall Study||2
521443|NCT00884039|1274173|P1|STARTED|Overall Study||5
521444|NCT00883779|1274181|P2|NOT COMPLETED|Off-study Phase||202
521445|NCT00883779|1274182|P1|NOT COMPLETED|Off-study Phase||209
521446|NCT00883779|1274181|P2|COMPLETED|Off-study Phase||0
521447|NCT00883779|1274182|P1|COMPLETED|Off-study Phase||0
521448|NCT00883779|1274181|P2|STARTED|Off-study Phase||202
521449|NCT00883779|1274182|P1|STARTED|Off-study Phase||209
521450|NCT00883779|1274181|P2|NOT COMPLETED|Post-Study Treatment Phase||135
521451|NCT00883779|1274182|P1|NOT COMPLETED|Post-Study Treatment Phase||112
521452|NCT00883779|1274181|P2|COMPLETED|Post-Study Treatment Phase||0
521453|NCT00883779|1274182|P1|COMPLETED|Post-Study Treatment Phase||0
521454|NCT00883779|1274181|P2|STARTED|Post-Study Treatment Phase||135
521455|NCT00883779|1274182|P1|STARTED|Post-Study Treatment Phase||112
521456|NCT00883779|1274181|P2|NOT COMPLETED|Primary Study Treatment Phase||86
521457|NCT00883779|1274182|P1|NOT COMPLETED|Primary Study Treatment Phase||105
521458|NCT00883779|1274181|P2|COMPLETED|Primary Study Treatment Phase||140
521459|NCT00883779|1274182|P1|COMPLETED|Primary Study Treatment Phase||120
521460|NCT00883779|1274181|P2|STARTED|Primary Study Treatment Phase||226
521461|NCT00883779|1274182|P1|STARTED|Primary Study Treatment Phase||225
521462|NCT00883753|1274218|P1|NOT COMPLETED|Overall Study||107
521463|NCT00883753|1274218|P1|COMPLETED|Overall Study||827
521464|NCT00883753|1274218|P1|STARTED|Overall Study||934
521465|NCT00883740|1274258|P2|NOT COMPLETED|Second Intervention||1
521466|NCT00883740|1274259|P1|NOT COMPLETED|Second Intervention||1
521467|NCT00883740|1274258|P2|COMPLETED|Second Intervention||50
521468|NCT00883740|1274259|P1|COMPLETED|Second Intervention||52
521469|NCT00883740|1274258|P2|STARTED|Second Intervention||51
521470|NCT00883740|1274259|P1|STARTED|Second Intervention|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|53
521471|NCT00883740|1274258|P2|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0
521472|NCT00883740|1274259|P1|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0
521473|NCT00883740|1274258|P2|COMPLETED|Taper and Washout Period (2 Weeks)||51
521474|NCT00883740|1274259|P1|COMPLETED|Taper and Washout Period (2 Weeks)||54
521475|NCT00883740|1274258|P2|STARTED|Taper and Washout Period (2 Weeks)||51
521476|NCT00883740|1274259|P1|STARTED|Taper and Washout Period (2 Weeks)|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|54
521477|NCT00883740|1274258|P2|NOT COMPLETED|First Intervention||8
521478|NCT00883740|1274259|P1|NOT COMPLETED|First Intervention||7
521479|NCT00883740|1274258|P2|COMPLETED|First Intervention||51
521480|NCT00883740|1274259|P1|COMPLETED|First Intervention|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|53
521481|NCT00883740|1274258|P2|STARTED|First Intervention||59
521482|NCT00883740|1274259|P1|STARTED|First Intervention||60
521483|NCT00883675|1274299|P1|NOT COMPLETED|Overall Study||0
521484|NCT00883675|1274299|P1|COMPLETED|Overall Study||133
521485|NCT00883675|1274299|P1|STARTED|Overall Study||133
521486|NCT00883558|1274303|P3|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||1
521487|NCT00883558|1274304|P2|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
521488|NCT00883558|1274305|P1|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
521489|NCT00883558|1274303|P3|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||22
521490|NCT00883558|1274304|P2|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||19
521491|NCT00883558|1274305|P1|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
521492|NCT00883558|1274303|P3|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||23
521493|NCT00883558|1274304|P2|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||19
521494|NCT00883558|1274305|P1|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||0
521495|NCT00883558|1274303|P3|STARTED|Second Treatment Cycle (Weeks 16 to 28)||23
521496|NCT00883558|1274304|P2|STARTED|Second Treatment Cycle (Weeks 16 to 28)||19
521497|NCT00883558|1274305|P1|STARTED|Second Treatment Cycle (Weeks 16 to 28)||0
521498|NCT00883558|1274303|P3|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||1
521499|NCT00883558|1274304|P2|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||3
521500|NCT00883558|1274305|P1|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0
521501|NCT00883558|1274303|P3|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||23
521502|NCT00883558|1274304|P2|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||19
521503|NCT00883558|1274305|P1|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0
521504|NCT00883558|1274303|P3|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||24
521505|NCT00883558|1274304|P2|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||22
521506|NCT00883558|1274305|P1|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||0
521507|NCT00883558|1274303|P3|STARTED|First Treatment Cycle (Weeks 4 to 16)||24
521508|NCT00883558|1274304|P2|STARTED|First Treatment Cycle (Weeks 4 to 16)||22
521509|NCT00883558|1274305|P1|STARTED|First Treatment Cycle (Weeks 4 to 16)||0
521510|NCT00883558|1274303|P3|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0
521511|NCT00883558|1274304|P2|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0
521512|NCT00883558|1274305|P1|NOT COMPLETED|Titration Period (Weeks 0 to 4)||2
521513|NCT00883558|1274303|P3|COMPLETED|Titration Period (Weeks 0 to 4)||0
521514|NCT00883558|1274304|P2|COMPLETED|Titration Period (Weeks 0 to 4)||0
521515|NCT00883558|1274305|P1|COMPLETED|Titration Period (Weeks 0 to 4)||46
521516|NCT00883558|1274303|P3|STARTED|Titration Period (Weeks 0 to 4)||0
521517|NCT00883558|1274304|P2|STARTED|Titration Period (Weeks 0 to 4)||0
521518|NCT00883558|1274305|P1|STARTED|Titration Period (Weeks 0 to 4)||48
521519|NCT00883493|1274317|P2|NOT COMPLETED|Overall Study||50
521520|NCT00883493|1274318|P1|NOT COMPLETED|Overall Study||46
521521|NCT00883493|1274317|P2|COMPLETED|Overall Study||159
521522|NCT00883493|1274318|P1|COMPLETED|Overall Study||166
521523|NCT00883493|1274317|P2|Per Protocol Analysis Population|Overall Study||155
521524|NCT00883493|1274318|P1|Per Protocol Analysis Population|Overall Study||162
521525|NCT00883493|1274317|P2|Intention To Treat Analysis Population|Overall Study||195
521526|NCT00883493|1274318|P1|Intention To Treat Analysis Population|Overall Study||204
521527|NCT00883493|1274317|P2|STARTED|Overall Study||209
521528|NCT00883493|1274318|P1|STARTED|Overall Study||212
521529|NCT00883389|1274342|P1|NOT COMPLETED|Overall Study||0
521530|NCT00883389|1274342|P1|COMPLETED|Overall Study||26
521531|NCT00883389|1274342|P1|STARTED|Overall Study||26
521532|NCT00883337|1274349|P3|NOT COMPLETED|Extension Treatment Period||19
521533|NCT00883337|1274350|P2|NOT COMPLETED|Extension Treatment Period||23
521534|NCT00883337|1274351|P1|NOT COMPLETED|Extension Treatment Period||28
521535|NCT00883337|1274349|P3|COMPLETED|Extension Treatment Period||40
521536|NCT00883337|1274350|P2|COMPLETED|Extension Treatment Period||66
521537|NCT00883337|1274351|P1|COMPLETED|Extension Treatment Period||61
521538|NCT00883337|1274349|P3|STARTED|Extension Treatment Period|12 participants completed the core period but didn't enter the extension period.|59
521539|NCT00883337|1274350|P2|STARTED|Extension Treatment Period||89
521540|NCT00883337|1274351|P1|STARTED|Extension Treatment Period||89
521541|NCT00883337|1274349|P3|NOT COMPLETED|Core Treatment Period||33
521542|NCT00883337|1274350|P2|NOT COMPLETED|Core Treatment Period||22
521543|NCT00883337|1274351|P1|NOT COMPLETED|Core Treatment Period||20
521544|NCT00883337|1274349|P3|COMPLETED|Core Treatment Period||71
521545|NCT00883337|1274350|P2|COMPLETED|Core Treatment Period||89
521546|NCT00883337|1274351|P1|COMPLETED|Core Treatment Period||89
521547|NCT00883337|1274349|P3|Treated|Core Treatment Period|3 participants refused treatment with Rebif®|101
521548|NCT00883337|1274350|P2|Treated|Core Treatment Period|One participant received teriflunomide 7 mg instead of teriflunomide 14 mg|111
521549|NCT00883337|1274351|P1|Treated|Core Treatment Period||109
521550|NCT00883337|1274349|P3|STARTED|Core Treatment Period||104
521551|NCT00883337|1274350|P2|STARTED|Core Treatment Period||111
521552|NCT00883337|1274351|P1|STARTED|Core Treatment Period||109
521553|NCT00883246|1274383|P1|NOT COMPLETED|Overall Study||173
521554|NCT00883246|1274383|P1|COMPLETED|Overall Study||626
521555|NCT00883246|1274383|P1|STARTED|Overall Study||799
521556|NCT00883233|1274405|P4|NOT COMPLETED|Overall Study||5
521557|NCT00883233|1274406|P3|NOT COMPLETED|Overall Study||4
521558|NCT00883233|1274407|P2|NOT COMPLETED|Overall Study||4
521559|NCT00883233|1274408|P1|NOT COMPLETED|Overall Study||5
521560|NCT00883233|1274405|P4|COMPLETED|Overall Study||25
521561|NCT00883233|1274406|P3|COMPLETED|Overall Study||25
521562|NCT00883233|1274407|P2|COMPLETED|Overall Study||28
521563|NCT00883233|1274408|P1|COMPLETED|Overall Study||27
521564|NCT00883233|1274405|P4|STARTED|Overall Study||30
521565|NCT00883233|1274406|P3|STARTED|Overall Study||29
521566|NCT00883233|1274407|P2|STARTED|Overall Study||32
521567|NCT00883233|1274408|P1|STARTED|Overall Study||32
521568|NCT00883181|1274418|P1|NOT COMPLETED|Overall Study||278
521569|NCT00883181|1274418|P1|COMPLETED|Overall Study|Completed planned chemotherapy|1069
521570|NCT00883181|1274418|P1|STARTED|Overall Study|Full analysis set|1347
521571|NCT00883168|1274631|P4|NOT COMPLETED|Overall Study||15
521572|NCT00883168|1274632|P3|NOT COMPLETED|Overall Study||19
521573|NCT00883168|1274633|P2|NOT COMPLETED|Overall Study||15
521574|NCT00883168|1274634|P1|NOT COMPLETED|Overall Study||14
521575|NCT00883168|1274631|P4|COMPLETED|Overall Study||433
521576|NCT00883168|1274632|P3|COMPLETED|Overall Study||431
521577|NCT00883168|1274633|P2|COMPLETED|Overall Study||430
521578|NCT00883168|1274634|P1|COMPLETED|Overall Study||434
521579|NCT00883168|1274631|P4|STARTED|Overall Study||448
521580|NCT00883168|1274632|P3|STARTED|Overall Study||450
521581|NCT00883168|1274633|P2|STARTED|Overall Study||445
521582|NCT00883168|1274634|P1|STARTED|Overall Study||448
521583|NCT00883129|1274654|P2|NOT COMPLETED|Overall Study||36
521584|NCT00883129|1274655|P1|NOT COMPLETED|Overall Study||20
521585|NCT00883129|1274654|P2|COMPLETED|Overall Study|53 subjects provided a 24 month outcome, 16 of whom had prematurely withdrawn from drug treatment.|37
521586|NCT00883129|1274655|P1|COMPLETED|Overall Study|53 subjects provided a 24 month outcome, 4 of whom had prematurely withdrawn from drug treatment.|49
521587|NCT00883129|1274654|P2|STARTED|Overall Study||73
521588|NCT00883129|1274655|P1|STARTED|Overall Study||69
521589|NCT00883116|1274679|P2|NOT COMPLETED|Overall Study||219
521590|NCT00883116|1274680|P1|NOT COMPLETED|Overall Study||209
521591|NCT00883116|1274679|P2|COMPLETED|Overall Study||29
521592|NCT00883116|1274680|P1|COMPLETED|Overall Study||39
521593|NCT00883116|1274679|P2|Received Treatment|Overall Study||239
521594|NCT00883116|1274680|P1|Received Treatment|Overall Study||248
521595|NCT00883116|1274679|P2|STARTED|Overall Study||248
521596|NCT00883116|1274680|P1|STARTED|Overall Study||248
521597|NCT00883103|1274695|P2|NOT COMPLETED|Overall Study||0
521598|NCT00883103|1274696|P1|NOT COMPLETED|Overall Study||0
521599|NCT00883103|1274695|P2|COMPLETED|Overall Study||68
521600|NCT00883103|1274696|P1|COMPLETED|Overall Study||69
521601|NCT00883103|1274695|P2|STARTED|Overall Study||68
521602|NCT00883103|1274696|P1|STARTED|Overall Study||69
521603|NCT00883090|1274702|P1|NOT COMPLETED|Overall Study||2
521604|NCT00883090|1274702|P1|COMPLETED|Overall Study||13
521605|NCT00883090|1274702|P1|STARTED|Overall Study|Of the 15 participants started, 14 were administered FXIII|15
521606|NCT00882921|1274717|P1|NOT COMPLETED|Overall Study||11
521607|NCT00882921|1274717|P1|COMPLETED|Overall Study||15
521608|NCT00882921|1274717|P1|STARTED|Overall Study||26
521609|NCT00882908|1274727|P5|NOT COMPLETED|Overall Study||6
521610|NCT00882908|1274728|P4|NOT COMPLETED|Overall Study||7
521611|NCT00882908|1274729|P3|NOT COMPLETED|Overall Study||7
521612|NCT00882908|1274730|P2|NOT COMPLETED|Overall Study||6
521613|NCT00882908|1274731|P1|NOT COMPLETED|Overall Study||3
521614|NCT00882908|1274727|P5|COMPLETED|Overall Study||71
521615|NCT00882908|1274728|P4|COMPLETED|Overall Study||72
521616|NCT00882908|1274729|P3|COMPLETED|Overall Study||70
521617|NCT00882908|1274730|P2|COMPLETED|Overall Study||69
521618|NCT00882908|1274731|P1|COMPLETED|Overall Study||75
521619|NCT00882908|1274727|P5|STARTED|Overall Study||77
521620|NCT00882908|1274728|P4|STARTED|Overall Study||79
521621|NCT00882908|1274729|P3|STARTED|Overall Study||77
521622|NCT00882908|1274730|P2|STARTED|Overall Study||75
521623|NCT00882908|1274731|P1|STARTED|Overall Study||78
521624|NCT00882778|1274806|P1|NOT COMPLETED|Overall Study||0
521625|NCT00882778|1274806|P1|COMPLETED|Overall Study||86
521626|NCT00882778|1274806|P1|STARTED|Overall Study||86
521627|NCT00882713|1274837|P1|NOT COMPLETED|Overall Study||22
521628|NCT00882713|1274837|P1|COMPLETED|Overall Study||172
521629|NCT00882713|1274837|P1|STARTED|Overall Study||194
521630|NCT00882687|1274863|P4|NOT COMPLETED|Overall Study||2
521631|NCT00882687|1274864|P3|NOT COMPLETED|Overall Study||3
521632|NCT00882687|1274865|P2|NOT COMPLETED|Overall Study||2
521633|NCT00882687|1274866|P1|NOT COMPLETED|Overall Study||2
521634|NCT00882687|1274863|P4|COMPLETED|Overall Study||13
521635|NCT00882687|1274864|P3|COMPLETED|Overall Study||12
521636|NCT00882687|1274865|P2|COMPLETED|Overall Study||13
521637|NCT00882687|1274866|P1|COMPLETED|Overall Study||13
521638|NCT00882687|1274863|P4|STARTED|Overall Study||15
521639|NCT00882687|1274864|P3|STARTED|Overall Study||15
521640|NCT00882687|1274865|P2|STARTED|Overall Study||15
521641|NCT00882687|1274866|P1|STARTED|Overall Study||15
521642|NCT00882661|1274899|P2|NOT COMPLETED|Treatment||26
521643|NCT00882661|1274900|P1|NOT COMPLETED|Treatment||10
521644|NCT00882661|1274899|P2|COMPLETED|Treatment||114
521645|NCT00882661|1274900|P1|COMPLETED|Treatment||141
521646|NCT00882661|1274899|P2|STARTED|Treatment||140
521647|NCT00882661|1274900|P1|STARTED|Treatment||151
521648|NCT00882661|1274899|P2|NOT COMPLETED|Investigational Training||0
521649|NCT00882661|1274900|P1|NOT COMPLETED|Investigational Training||10
521650|NCT00882661|1274899|P2|COMPLETED|Investigational Training||0
521651|NCT00882661|1274900|P1|COMPLETED|Investigational Training||79
521652|NCT00882661|1274899|P2|STARTED|Investigational Training||0
521653|NCT00882661|1274900|P1|STARTED|Investigational Training||89
521654|NCT00882583|1274930|P2|NOT COMPLETED|Overall Study||1
521655|NCT00882583|1274931|P1|NOT COMPLETED|Overall Study||1
521656|NCT00882583|1274930|P2|COMPLETED|Overall Study||11
521657|NCT00882583|1274931|P1|COMPLETED|Overall Study||6
521658|NCT00882583|1274930|P2|STARTED|Overall Study||12
521659|NCT00882583|1274931|P1|STARTED|Overall Study||7
521660|NCT00882557|1274939|P2|NOT COMPLETED|Overall Study||1
521661|NCT00882557|1274940|P1|NOT COMPLETED|Overall Study||2
521662|NCT00882557|1274939|P2|COMPLETED|Overall Study||7
521663|NCT00882557|1274940|P1|COMPLETED|Overall Study||6
521664|NCT00882557|1274939|P2|Completed Dose 2|Overall Study||7
521665|NCT00882557|1274940|P1|Completed Dose 2|Overall Study||6
521666|NCT00882557|1274939|P2|Completed Dose 1|Overall Study||7
521667|NCT00882557|1274940|P1|Completed Dose 1|Overall Study||8
521668|NCT00882557|1274939|P2|STARTED|Overall Study||8
521669|NCT00882557|1274940|P1|STARTED|Overall Study||8
521670|NCT00882518|1274960|P2|NOT COMPLETED|Overall Study||44
521671|NCT00882518|1274961|P1|NOT COMPLETED|Overall Study||38
521672|NCT00882518|1274960|P2|COMPLETED|Overall Study||148
521673|NCT00882518|1274961|P1|COMPLETED|Overall Study||158
521674|NCT00882518|1274960|P2|STARTED|Overall Study||192
521675|NCT00882518|1274961|P1|STARTED|Overall Study||196
521676|NCT00882440|1274990|P7|NOT COMPLETED|Overall Study||4
521677|NCT00882440|1274991|P6|NOT COMPLETED|Overall Study||7
521678|NCT00882440|1274992|P5|NOT COMPLETED|Overall Study||10
521679|NCT00882440|1274993|P4|NOT COMPLETED|Overall Study||3
521680|NCT00882440|1274994|P3|NOT COMPLETED|Overall Study||7
521681|NCT00882440|1274995|P2|NOT COMPLETED|Overall Study||8
521682|NCT00882440|1274996|P1|NOT COMPLETED|Overall Study||11
521683|NCT00882440|1274990|P7|COMPLETED|Overall Study||79
521684|NCT00882440|1274991|P6|COMPLETED|Overall Study||77
521685|NCT00882440|1274992|P5|COMPLETED|Overall Study||80
521686|NCT00882440|1274993|P4|COMPLETED|Overall Study||76
521687|NCT00882440|1274994|P3|COMPLETED|Overall Study||75
521688|NCT00882440|1274995|P2|COMPLETED|Overall Study||72
521689|NCT00882440|1274996|P1|COMPLETED|Overall Study||67
521690|NCT00882440|1274990|P7|STARTED|Overall Study||83
521691|NCT00882440|1274991|P6|STARTED|Overall Study||84
521692|NCT00882440|1274992|P5|STARTED|Overall Study||90
521693|NCT00882440|1274993|P4|STARTED|Overall Study||79
521694|NCT00882440|1274994|P3|STARTED|Overall Study||82
521695|NCT00882440|1274995|P2|STARTED|Overall Study||80
521696|NCT00882440|1274996|P1|STARTED|Overall Study||78
521697|NCT00882362|1275021|P2|NOT COMPLETED|Overall Study||23
521698|NCT00882362|1275022|P1|NOT COMPLETED|Overall Study||49
521699|NCT00882362|1275021|P2|COMPLETED|Overall Study||10
521700|NCT00882362|1275022|P1|COMPLETED|Overall Study||73
521701|NCT00882362|1275021|P2|STARTED|Overall Study||33
521702|NCT00882362|1275022|P1|STARTED|Overall Study||122
521703|NCT00882310|1275028|P1|NOT COMPLETED|Overall Study||22
521704|NCT00882310|1275028|P1|COMPLETED|Overall Study||15
521705|NCT00882310|1275028|P1|STARTED|Overall Study||37
521706|NCT00882206|1275034|P1|NOT COMPLETED|Overall Study||0
521707|NCT00882206|1275034|P1|COMPLETED|Overall Study||13
521708|NCT00882206|1275034|P1|STARTED|Overall Study||13
521709|NCT00882102|1275041|P1|NOT COMPLETED|Overall Study||0
521710|NCT00882102|1275041|P1|COMPLETED|Overall Study||40
521711|NCT00882102|1275041|P1|STARTED|Overall Study||40
521712|NCT00881959|1275047|P2|NOT COMPLETED|Overall Study||4
521713|NCT00881959|1275048|P1|NOT COMPLETED|Overall Study||2
521714|NCT00881959|1275047|P2|COMPLETED|Overall Study||38
521715|NCT00881959|1275048|P1|COMPLETED|Overall Study||36
521716|NCT00881959|1275047|P2|STARTED|Overall Study||42
521717|NCT00881959|1275048|P1|STARTED|Overall Study||38
521718|NCT00881894|1275056|P2|NOT COMPLETED|Overall Study||3
521719|NCT00881894|1275057|P1|NOT COMPLETED|Overall Study||1
521720|NCT00881894|1275056|P2|COMPLETED|Overall Study||23
521721|NCT00881894|1275057|P1|COMPLETED|Overall Study||25
521722|NCT00881894|1275056|P2|Pharmacokinetic Set (PKS)|Overall Study|Patients with an insufficient patch adhesiveness were excluded from the PKS.|21
521723|NCT00881894|1275057|P1|Pharmacokinetic Set (PKS)|Overall Study|Patients with an insufficient patch adhesiveness were excluded from the PKS.|23
521724|NCT00881894|1275056|P2|STARTED|Overall Study||26
521725|NCT00881894|1275057|P1|STARTED|Overall Study||26
521726|NCT00881868|1275089|P2|NOT COMPLETED|Overall Study||2
521727|NCT00881868|1275090|P1|NOT COMPLETED|Overall Study||8
521728|NCT00881868|1275089|P2|COMPLETED|Overall Study||38
521729|NCT00881868|1275090|P1|COMPLETED|Overall Study||33
521730|NCT00881868|1275089|P2|STARTED|Overall Study||40
521731|NCT00881868|1275090|P1|STARTED|Overall Study||41
521732|NCT00881751|1275104|P2|NOT COMPLETED|Overall Study||5
521733|NCT00881751|1275105|P1|NOT COMPLETED|Overall Study||0
521734|NCT00881751|1275104|P2|COMPLETED|Overall Study||43
521735|NCT00881751|1275105|P1|COMPLETED|Overall Study||47
521736|NCT00881751|1275104|P2|STARTED|Overall Study||48
521737|NCT00881751|1275105|P1|STARTED|Overall Study||47
521738|NCT00881712|1275120|P3|NOT COMPLETED|Overall Study||0
521739|NCT00881712|1275121|P2|NOT COMPLETED|Overall Study||0
521740|NCT00881712|1275122|P1|NOT COMPLETED|Overall Study||2
521741|NCT00881712|1275120|P3|COMPLETED|Overall Study||0
521742|NCT00881712|1275121|P2|COMPLETED|Overall Study||0
521743|NCT00881712|1275122|P1|COMPLETED|Overall Study||13
521744|NCT00881712|1275120|P3|STARTED|Overall Study|This arm was non-randomized and no enrolled patients fit the inclusion criteria for this group.|0
521745|NCT00881712|1275121|P2|STARTED|Overall Study|This arm was non-randomized and no enrolled patients fit the inclusion criteria for this group.|0
521746|NCT00881712|1275122|P1|STARTED|Overall Study||15
521747|NCT00881647|1275144|P2|NOT COMPLETED|Overall Study||1
521748|NCT00881647|1275145|P1|NOT COMPLETED|Overall Study||2
521749|NCT00881647|1275144|P2|COMPLETED|Overall Study||15
521750|NCT00881647|1275145|P1|COMPLETED|Overall Study||27
521751|NCT00881647|1275144|P2|STARTED|Overall Study||16
521752|NCT00881647|1275145|P1|STARTED|Overall Study||29
521753|NCT00881621|1275155|P1|NOT COMPLETED|Overall Study||34
521754|NCT00881621|1275155|P1|COMPLETED|Overall Study||17
521755|NCT00881621|1275155|P1|STARTED|Overall Study||51
521756|NCT00881608|1275167|P1|NOT COMPLETED|Overall Study||11
521757|NCT00881608|1275167|P1|COMPLETED|Overall Study||0
521758|NCT00881608|1275167|P1|STARTED|Overall Study||11
521759|NCT00881530|1275190|P6|NOT COMPLETED|Overall Study||5
521760|NCT00881530|1275191|P5|NOT COMPLETED|Overall Study||14
521761|NCT00881530|1275192|P4|NOT COMPLETED|Overall Study||9
521762|NCT00881530|1275193|P3|NOT COMPLETED|Overall Study||5
521763|NCT00881530|1275194|P2|NOT COMPLETED|Overall Study||5
521764|NCT00881530|1275195|P1|NOT COMPLETED|Overall Study||14
521765|NCT00881530|1275190|P6|COMPLETED|Overall Study||51
521766|NCT00881530|1275191|P5|COMPLETED|Overall Study||152
521767|NCT00881530|1275192|P4|COMPLETED|Overall Study||157
521768|NCT00881530|1275193|P3|COMPLETED|Overall Study||51
521769|NCT00881530|1275194|P2|COMPLETED|Overall Study||104
521770|NCT00881530|1275195|P1|COMPLETED|Overall Study||92
521771|NCT00881530|1275190|P6|STARTED|Overall Study||56
521772|NCT00881530|1275191|P5|STARTED|Overall Study||166
521773|NCT00881530|1275192|P4|STARTED|Overall Study||166
521774|NCT00881530|1275193|P3|STARTED|Overall Study||56
521775|NCT00881530|1275194|P2|STARTED|Overall Study||109
521776|NCT00881530|1275195|P1|STARTED|Overall Study||106
521777|NCT00881504|1275251|P1|NOT COMPLETED|Overall Study||1
521778|NCT00881504|1275251|P1|COMPLETED|Overall Study||8
521779|NCT00881504|1275251|P1|STARTED|Overall Study||9
521780|NCT00881465|1275258|P2|NOT COMPLETED|Overall Study||0
521781|NCT00881465|1275259|P1|NOT COMPLETED|Overall Study||2
521782|NCT00881465|1275258|P2|COMPLETED|Overall Study||15
521783|NCT00881465|1275259|P1|COMPLETED|Overall Study||14
521784|NCT00881465|1275258|P2|STARTED|Overall Study||15
521785|NCT00881465|1275259|P1|STARTED|Overall Study||16
521786|NCT00881335|1275271|P2|NOT COMPLETED|Overall Study||2
521787|NCT00881335|1275272|P1|NOT COMPLETED|Overall Study||3
521788|NCT00881335|1275271|P2|COMPLETED|Overall Study|2 participants did not complete the period|28
521789|NCT00881335|1275272|P1|COMPLETED|Overall Study|3 participants did not complete the period|27
521790|NCT00881335|1275271|P2|STARTED|Overall Study||30
521791|NCT00881335|1275272|P1|STARTED|Overall Study||30
521792|NCT00881205|1275292|P2|NOT COMPLETED|Overall Study||7
521793|NCT00881205|1275293|P1|NOT COMPLETED|Overall Study||11
521794|NCT00881205|1275292|P2|COMPLETED|Overall Study||34
521795|NCT00881205|1275293|P1|COMPLETED|Overall Study||34
521796|NCT00881205|1275292|P2|STARTED|Overall Study||41
521797|NCT00881205|1275293|P1|STARTED|Overall Study||45
521798|NCT00880919|1275303|P3|NOT COMPLETED|Overall Study||6
521799|NCT00880919|1275304|P2|NOT COMPLETED|Overall Study||14
521800|NCT00880919|1275305|P1|NOT COMPLETED|Overall Study||15
521801|NCT00880919|1275303|P3|COMPLETED|Overall Study||23
521802|NCT00880919|1275304|P2|COMPLETED|Overall Study||19
521803|NCT00880919|1275305|P1|COMPLETED|Overall Study||18
521804|NCT00880919|1275303|P3|STARTED|Overall Study||29
521805|NCT00880919|1275304|P2|STARTED|Overall Study||33
521806|NCT00880919|1275305|P1|STARTED|Overall Study||33
521807|NCT00880906|1275339|P2|NOT COMPLETED|Overall Study||7
521808|NCT00880906|1275340|P1|NOT COMPLETED|Overall Study||12
521809|NCT00880906|1275339|P2|COMPLETED|Overall Study||14
521810|NCT00880906|1275340|P1|COMPLETED|Overall Study||17
521811|NCT00880906|1275339|P2|STARTED|Overall Study||21
521812|NCT00880906|1275340|P1|STARTED|Overall Study||29
521813|NCT00880763|1275352|P4|NOT COMPLETED|Extension Period (Part 2)||3
521814|NCT00880763|1275353|P3|NOT COMPLETED|Extension Period (Part 2)||3
521815|NCT00880763|1275354|P2|NOT COMPLETED|Extension Period (Part 2)||3
521816|NCT00880763|1275355|P1|NOT COMPLETED|Extension Period (Part 2)||0
521817|NCT00880763|1275352|P4|COMPLETED|Extension Period (Part 2)||19
521818|NCT00880763|1275353|P3|COMPLETED|Extension Period (Part 2)||20
521819|NCT00880763|1275354|P2|COMPLETED|Extension Period (Part 2)||19
521820|NCT00880763|1275355|P1|COMPLETED|Extension Period (Part 2)||23
521821|NCT00880763|1275352|P4|STARTED|Extension Period (Part 2)||22
521822|NCT00880763|1275353|P3|STARTED|Extension Period (Part 2)||23
521823|NCT00880763|1275354|P2|STARTED|Extension Period (Part 2)||22
521824|NCT00880763|1275355|P1|STARTED|Extension Period (Part 2)||23
521825|NCT00880763|1275352|P4|NOT COMPLETED|Initial Treatment Period (Part 1)||0
521826|NCT00880763|1275353|P3|NOT COMPLETED|Initial Treatment Period (Part 1)||0
521827|NCT00880763|1275354|P2|NOT COMPLETED|Initial Treatment Period (Part 1)||0
521828|NCT00880763|1275355|P1|NOT COMPLETED|Initial Treatment Period (Part 1)||0
521829|NCT00880763|1275352|P4|COMPLETED|Initial Treatment Period (Part 1)||22
521830|NCT00880763|1275353|P3|COMPLETED|Initial Treatment Period (Part 1)||23
521831|NCT00880763|1275354|P2|COMPLETED|Initial Treatment Period (Part 1)||22
521832|NCT00880763|1275355|P1|COMPLETED|Initial Treatment Period (Part 1)||23
521833|NCT00880763|1275352|P4|STARTED|Initial Treatment Period (Part 1)||22
521834|NCT00880763|1275353|P3|STARTED|Initial Treatment Period (Part 1)||23
521835|NCT00880763|1275354|P2|STARTED|Initial Treatment Period (Part 1)||22
521836|NCT00880763|1275355|P1|STARTED|Initial Treatment Period (Part 1)||23
521837|NCT00880750|1275387|P2|NOT COMPLETED|Second Intervention||2
521838|NCT00880750|1275388|P1|NOT COMPLETED|Second Intervention||4
521839|NCT00880750|1275387|P2|COMPLETED|Second Intervention||30
521840|NCT00880750|1275388|P1|COMPLETED|Second Intervention||26
521841|NCT00880750|1275387|P2|STARTED|Second Intervention||32
521842|NCT00880750|1275388|P1|STARTED|Second Intervention||30
521843|NCT00880750|1275387|P2|NOT COMPLETED|Washout Period||0
521844|NCT00880750|1275388|P1|NOT COMPLETED|Washout Period||0
521845|NCT00880750|1275387|P2|COMPLETED|Washout Period||32
521846|NCT00880750|1275388|P1|COMPLETED|Washout Period||30
521847|NCT00880750|1275387|P2|STARTED|Washout Period||32
521848|NCT00880750|1275388|P1|STARTED|Washout Period||30
521849|NCT00880750|1275387|P2|NOT COMPLETED|First Intervention||1
521850|NCT00880750|1275388|P1|NOT COMPLETED|First Intervention||9
521851|NCT00880750|1275387|P2|COMPLETED|First Intervention||32
521852|NCT00880750|1275388|P1|COMPLETED|First Intervention||30
521853|NCT00880750|1275387|P2|STARTED|First Intervention||33
521854|NCT00880750|1275388|P1|STARTED|First Intervention||39
521855|NCT00880698|1275406|P4|NOT COMPLETED|Overall Study||3
521856|NCT00880698|1275407|P3|NOT COMPLETED|Overall Study||1
521857|NCT00880698|1275408|P2|NOT COMPLETED|Overall Study||3
521858|NCT00880698|1275409|P1|NOT COMPLETED|Overall Study||1
521859|NCT00880698|1275406|P4|COMPLETED|Overall Study||36
521860|NCT00880698|1275407|P3|COMPLETED|Overall Study||36
521861|NCT00880698|1275408|P2|COMPLETED|Overall Study||61
521862|NCT00880698|1275409|P1|COMPLETED|Overall Study||61
521863|NCT00880698|1275406|P4|STARTED|Overall Study||39
521864|NCT00880698|1275407|P3|STARTED|Overall Study||37
521865|NCT00880698|1275408|P2|STARTED|Overall Study||64
521866|NCT00880698|1275409|P1|STARTED|Overall Study||62
521867|NCT00880685|1275435|P1|NOT COMPLETED|Memantine 30mg||0
521868|NCT00880685|1275435|P1|COMPLETED|Memantine 30mg||9
521869|NCT00880685|1275435|P1|STARTED|Memantine 30mg||9
521870|NCT00880685|1275435|P1|NOT COMPLETED|Memantine 20mg||1
521871|NCT00880685|1275435|P1|COMPLETED|Memantine 20mg||9
521872|NCT00880685|1275435|P1|STARTED|Memantine 20mg||10
521873|NCT00880685|1275435|P1|NOT COMPLETED|Memantine 10mg||2
521874|NCT00880685|1275435|P1|COMPLETED|Memantine 10mg||10
521875|NCT00880685|1275435|P1|STARTED|Memantine 10mg||12
521876|NCT00880620|1275447|P4|NOT COMPLETED|Overall Study||24
521877|NCT00880620|1275448|P3|NOT COMPLETED|Overall Study||21
521878|NCT00880620|1275449|P2|NOT COMPLETED|Overall Study||15
521879|NCT00880620|1275450|P1|NOT COMPLETED|Overall Study||21
521880|NCT00880620|1275447|P4|COMPLETED|Overall Study||74
521881|NCT00880620|1275448|P3|COMPLETED|Overall Study||83
521882|NCT00880620|1275449|P2|COMPLETED|Overall Study||72
521883|NCT00880620|1275450|P1|COMPLETED|Overall Study||71
521884|NCT00880620|1275447|P4|Week 23|Overall Study||74
521885|NCT00880620|1275448|P3|Week 23|Overall Study||85
521886|NCT00880620|1275449|P2|Week 23|Overall Study||72
521887|NCT00880620|1275450|P1|Week 23|Overall Study||71
521888|NCT00880620|1275447|P4|Week 16|Overall Study||74
521889|NCT00880620|1275448|P3|Week 16|Overall Study||87
521890|NCT00880620|1275449|P2|Week 16|Overall Study||73
521891|NCT00880620|1275450|P1|Week 16|Overall Study||74
521892|NCT00880620|1275447|P4|Week 9|Overall Study||78
521893|NCT00880620|1275448|P3|Week 9|Overall Study||88
521894|NCT00880620|1275449|P2|Week 9|Overall Study||73
521895|NCT00880620|1275450|P1|Week 9|Overall Study||80
521896|NCT00880620|1275447|P4|Week 4|Overall Study||86
521897|NCT00880620|1275448|P3|Week 4|Overall Study||94
521898|NCT00880620|1275449|P2|Week 4|Overall Study||79
521899|NCT00880620|1275450|P1|Week 4|Overall Study||88
521900|NCT00880620|1275447|P4|STARTED|Overall Study||98
521901|NCT00880620|1275448|P3|STARTED|Overall Study||104
521902|NCT00880620|1275449|P2|STARTED|Overall Study||87
521903|NCT00880620|1275450|P1|STARTED|Overall Study||92
521904|NCT00880581|1275464|P1|NOT COMPLETED|Cycle 2 Re-treatment||0
521905|NCT00880581|1275464|P1|COMPLETED|Cycle 2 Re-treatment||24
521906|NCT00880581|1275464|P1|STARTED|Cycle 2 Re-treatment|6 subjects with progessive disease were not treated and evaluated in Cycle 2|24
521907|NCT00880581|1275464|P1|NOT COMPLETED|Cycle 1||0
521908|NCT00880581|1275464|P1|COMPLETED|Cycle 1||30
521909|NCT00880581|1275464|P1|STARTED|Cycle 1||30
521910|NCT00880568|1275478|P9|NOT COMPLETED|Overall Study||3
521911|NCT00880568|1275479|P8|NOT COMPLETED|Overall Study||2
521912|NCT00880568|1275480|P7|NOT COMPLETED|Overall Study||6
521913|NCT00880568|1275481|P6|NOT COMPLETED|Overall Study||3
521914|NCT00880568|1275482|P5|NOT COMPLETED|Overall Study||3
521915|NCT00880568|1275483|P4|NOT COMPLETED|Overall Study||1
521916|NCT00880568|1275484|P3|NOT COMPLETED|Overall Study||3
521917|NCT00880568|1275485|P2|NOT COMPLETED|Overall Study||3
521918|NCT00880568|1275486|P1|NOT COMPLETED|Overall Study||3
521919|NCT00880568|1275478|P9|COMPLETED|Overall Study||0
521920|NCT00880568|1275479|P8|COMPLETED|Overall Study||0
521921|NCT00880568|1275480|P7|COMPLETED|Overall Study||0
521922|NCT00880568|1275481|P6|COMPLETED|Overall Study||0
521923|NCT00880568|1275482|P5|COMPLETED|Overall Study||0
521924|NCT00880568|1275483|P4|COMPLETED|Overall Study||0
521925|NCT00880568|1275484|P3|COMPLETED|Overall Study||0
521926|NCT00880568|1275485|P2|COMPLETED|Overall Study||0
521927|NCT00880568|1275486|P1|COMPLETED|Overall Study||0
521928|NCT00880568|1275478|P9|STARTED|Overall Study||3
521929|NCT00880568|1275479|P8|STARTED|Overall Study||2
521930|NCT00880568|1275480|P7|STARTED|Overall Study||6
521931|NCT00880568|1275481|P6|STARTED|Overall Study||3
521932|NCT00880568|1275482|P5|STARTED|Overall Study||3
521933|NCT00880568|1275483|P4|STARTED|Overall Study||1
521934|NCT00880568|1275484|P3|STARTED|Overall Study||3
521935|NCT00880568|1275485|P2|STARTED|Overall Study||3
521936|NCT00880568|1275486|P1|STARTED|Overall Study||3
521937|NCT00880555|1275532|P6|NOT COMPLETED|Overall Study||1
521938|NCT00880555|1275533|P5|NOT COMPLETED|Overall Study||1
521939|NCT00880555|1275534|P4|NOT COMPLETED|Overall Study||2
521940|NCT00880555|1275535|P3|NOT COMPLETED|Overall Study||5
521941|NCT00880555|1275536|P2|NOT COMPLETED|Overall Study||17
521942|NCT00880555|1275537|P1|NOT COMPLETED|Overall Study||10
521943|NCT00880555|1275532|P6|COMPLETED|Overall Study||0
521944|NCT00880555|1275533|P5|COMPLETED|Overall Study||0
521945|NCT00880555|1275534|P4|COMPLETED|Overall Study||0
521946|NCT00880555|1275535|P3|COMPLETED|Overall Study||6
521947|NCT00880555|1275536|P2|COMPLETED|Overall Study||23
521948|NCT00880555|1275537|P1|COMPLETED|Overall Study||13
521949|NCT00880555|1275532|P6|STARTED|Overall Study||1
521950|NCT00880555|1275533|P5|STARTED|Overall Study||1
521951|NCT00880555|1275534|P4|STARTED|Overall Study||2
521952|NCT00880555|1275535|P3|STARTED|Overall Study||11
521953|NCT00880555|1275536|P2|STARTED|Overall Study||40
521954|NCT00880555|1275537|P1|STARTED|Overall Study||23
521955|NCT00880542|1275548|P1|NOT COMPLETED|Follow-up Period||0
521956|NCT00880542|1275548|P1|COMPLETED|Follow-up Period||7
521957|NCT00880542|1275548|P1|STARTED|Follow-up Period|All 7 patients who started the treatment period completed the follow-up period.|7
521958|NCT00880542|1275548|P1|NOT COMPLETED|Continued Treatment Period||0
521959|NCT00880542|1275548|P1|COMPLETED|Continued Treatment Period||0
521960|NCT00880542|1275548|P1|STARTED|Continued Treatment Period|None of the 3 subjects from previous period met study criteria for continuation of therapy.|0
521961|NCT00880542|1275548|P1|NOT COMPLETED|Post Surgical Evaluation||0
521962|NCT00880542|1275548|P1|COMPLETED|Post Surgical Evaluation|none of the 3 subjects met study criteria for continuation of therapy.|3
521963|NCT00880542|1275548|P1|STARTED|Post Surgical Evaluation||3
521964|NCT00880542|1275548|P1|NOT COMPLETED|REP: Surgical Resection||1
521965|NCT00880542|1275548|P1|COMPLETED|REP: Surgical Resection||3
521966|NCT00880542|1275548|P1|STARTED|REP: Surgical Resection||4
521967|NCT00880542|1275548|P1|NOT COMPLETED|Response Evaluation Period(REP): PET/CT||0
521968|NCT00880542|1275548|P1|COMPLETED|Response Evaluation Period(REP): PET/CT||4
521969|NCT00880542|1275548|P1|STARTED|Response Evaluation Period(REP): PET/CT||4
521970|NCT00880542|1275548|P1|NOT COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||3
521971|NCT00880542|1275548|P1|COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||4
521972|NCT00880542|1275548|P1|STARTED|Treatment Period (Sorafenib+Ifosfamide)||7
521973|NCT00880425|1275553|P2|NOT COMPLETED|Overall Study||0
521974|NCT00880425|1275554|P1|NOT COMPLETED|Overall Study||0
521975|NCT00880425|1275553|P2|COMPLETED|Overall Study||27
521976|NCT00880425|1275554|P1|COMPLETED|Overall Study||18
521977|NCT00880425|1275553|P2|STARTED|Overall Study||27
521978|NCT00880425|1275554|P1|STARTED|Overall Study||18
521979|NCT00880399|1275565|P3|NOT COMPLETED|Overall Study||26
521980|NCT00880399|1275566|P2|NOT COMPLETED|Overall Study||29
521981|NCT00880399|1275567|P1|NOT COMPLETED|Overall Study||31
521982|NCT00880399|1275565|P3|COMPLETED|Overall Study||81
521983|NCT00880399|1275566|P2|COMPLETED|Overall Study||84
521984|NCT00880399|1275567|P1|COMPLETED|Overall Study||77
521985|NCT00880399|1275565|P3|STARTED|Overall Study||107
521986|NCT00880399|1275566|P2|STARTED|Overall Study||113
521987|NCT00880399|1275567|P1|STARTED|Overall Study||108
521988|NCT00880360|1275623|P1|NOT COMPLETED|Overall Study||0
521989|NCT00880360|1275623|P1|COMPLETED|Overall Study||19
521990|NCT00880360|1275623|P1|STARTED|Overall Study||19
521991|NCT00880334|1275630|P2|NOT COMPLETED|Overall Study||3
521992|NCT00880334|1275631|P1|NOT COMPLETED|Overall Study||4
521993|NCT00880334|1275630|P2|COMPLETED|Overall Study||72
521994|NCT00880334|1275631|P1|COMPLETED|Overall Study||70
521995|NCT00880334|1275630|P2|Eligible & Treated|Overall Study||72
521996|NCT00880334|1275631|P1|Eligible & Treated|Overall Study||70
521997|NCT00880334|1275630|P2|STARTED|Overall Study||75
521998|NCT00880334|1275631|P1|STARTED|Overall Study||74
521999|NCT00880269|1275647|P2|NOT COMPLETED|Overall Study||27
522000|NCT00880269|1275648|P1|NOT COMPLETED|Overall Study||32
522001|NCT00880269|1275647|P2|COMPLETED|Overall Study||0
522002|NCT00880269|1275648|P1|COMPLETED|Overall Study||0
522003|NCT00880269|1275647|P2|Discontinued Treatment|Overall Study||27
522004|NCT00880269|1275648|P1|Discontinued Treatment|Overall Study||32
522005|NCT00880269|1275647|P2|STARTED|Overall Study||27
522006|NCT00880269|1275648|P1|STARTED|Overall Study||32
522007|NCT00880256|1275664|P1|NOT COMPLETED|Overall Study||28
522008|NCT00880256|1275664|P1|COMPLETED|Overall Study||65
522009|NCT00880256|1275664|P1|STARTED|Overall Study||93
522010|NCT00880230|1275669|P1|NOT COMPLETED|Overall Study||7
522011|NCT00880230|1275669|P1|COMPLETED|Overall Study||134
522012|NCT00880230|1275669|P1|STARTED|Overall Study||141
522013|NCT00880191|1275691|P2|NOT COMPLETED|Overall Study||8
522014|NCT00880191|1275692|P1|NOT COMPLETED|Overall Study||13
522015|NCT00880191|1275691|P2|COMPLETED|Overall Study||198
522016|NCT00880191|1275692|P1|COMPLETED|Overall Study||194
522017|NCT00880191|1275691|P2|Available for Primary Endpoint Analysis|Overall Study||206
522018|NCT00880191|1275692|P1|Available for Primary Endpoint Analysis|Overall Study||207
522019|NCT00880191|1275691|P2|STARTED|Overall Study||206
522020|NCT00880191|1275692|P1|STARTED|Overall Study||207
522021|NCT00880165|1275712|P2|NOT COMPLETED|Overall Study||50
522022|NCT00880165|1275713|P1|NOT COMPLETED|Overall Study||62
522023|NCT00880165|1275712|P2|COMPLETED|Overall Study||98
522024|NCT00880165|1275713|P1|COMPLETED|Overall Study||86
522025|NCT00880165|1275712|P2|STARTED|Overall Study||148
522026|NCT00880165|1275713|P1|STARTED|Overall Study||148
522027|NCT00880100|1275723|P1|NOT COMPLETED|Treatment Phase With Ultrase® MT12||3
522028|NCT00880100|1275723|P1|COMPLETED|Treatment Phase With Ultrase® MT12||45
522029|NCT00880100|1275723|P1|STARTED|Treatment Phase With Ultrase® MT12||48
522030|NCT00880100|1275723|P1|NOT COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||1
522031|NCT00880100|1275723|P1|COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||48
522032|NCT00880100|1275723|P1|STARTED|Baseline Phase-Usual Pancreatic Enzymes||49
522033|NCT00880087|1275736|P2|NOT COMPLETED|Overall Study||2
522034|NCT00880087|1275737|P1|NOT COMPLETED|Overall Study||0
522035|NCT00880087|1275736|P2|COMPLETED|Overall Study|Of 161 with 1-year vital status, 158 had received Therapeutic Normothermia, 3 received no treatment.|161
522036|NCT00880087|1275737|P1|COMPLETED|Overall Study|1-year vital status available for all 166 Started patients.|166
522037|NCT00880087|1275736|P2|STARTED|Overall Study|Among the 163 Started, 160 received Therapeutic Normothermia and 3 received no treatment.|163
522038|NCT00880087|1275737|P1|STARTED|Overall Study|Among the 166 Started, 161 received Therapeutic Hypothermia and 5 received no treatment.|166
522039|NCT00880048|1275752|P3|NOT COMPLETED|Overall Study||35
522040|NCT00880048|1275753|P2|NOT COMPLETED|Overall Study||33
522041|NCT00880048|1275754|P1|NOT COMPLETED|Overall Study||28
522042|NCT00880048|1275752|P3|COMPLETED|Overall Study||77
522043|NCT00880048|1275753|P2|COMPLETED|Overall Study||82
522044|NCT00880048|1275754|P1|COMPLETED|Overall Study||88
522045|NCT00880048|1275752|P3|STARTED|Overall Study||112
522046|NCT00880048|1275753|P2|STARTED|Overall Study||115
522047|NCT00880048|1275754|P1|STARTED|Overall Study||116
522048|NCT00880022|1275812|P2|NOT COMPLETED|Overall Study||3
522049|NCT00880022|1275813|P1|NOT COMPLETED|Overall Study||2
522050|NCT00880022|1275812|P2|COMPLETED|Overall Study||21
522051|NCT00880022|1275813|P1|COMPLETED|Overall Study||21
522052|NCT00880022|1275812|P2|STARTED|Overall Study||24
522053|NCT00880022|1275813|P1|STARTED|Overall Study||23
522054|NCT00880009|1275821|P1|NOT COMPLETED|Overall Study||16
522055|NCT00880009|1275821|P1|COMPLETED|Overall Study||0
522056|NCT00880009|1275821|P1|STARTED|Overall Study||16
522057|NCT00879996|1275845|P2|NOT COMPLETED|Overall Study||13
522058|NCT00879996|1275846|P1|NOT COMPLETED|Overall Study||15
522059|NCT00879996|1275845|P2|COMPLETED|Overall Study||13
522060|NCT00879996|1275846|P1|COMPLETED|Overall Study||13
522061|NCT00879996|1275845|P2|STARTED|Overall Study||26
522062|NCT00879996|1275846|P1|STARTED|Overall Study||28
522063|NCT00879970|1275861|P5|NOT COMPLETED|Period 2 Vitamin D Randomization||7
522064|NCT00879970|1275862|P4|NOT COMPLETED|Period 2 Vitamin D Randomization||4
522065|NCT00879970|1275863|P3|NOT COMPLETED|Period 2 Vitamin D Randomization||0
522066|NCT00879970|1275864|P2|NOT COMPLETED|Period 2 Vitamin D Randomization||0
522067|NCT00879970|1275865|P1|NOT COMPLETED|Period 2 Vitamin D Randomization||0
522068|NCT00879970|1275861|P5|COMPLETED|Period 2 Vitamin D Randomization||600
522069|NCT00879970|1275862|P4|COMPLETED|Period 2 Vitamin D Randomization||610
522070|NCT00879970|1275863|P3|COMPLETED|Period 2 Vitamin D Randomization||0
522071|NCT00879970|1275864|P2|COMPLETED|Period 2 Vitamin D Randomization||0
522072|NCT00879970|1275865|P1|COMPLETED|Period 2 Vitamin D Randomization||0
522073|NCT00879970|1275861|P5|STARTED|Period 2 Vitamin D Randomization||607
522074|NCT00879970|1275862|P4|STARTED|Period 2 Vitamin D Randomization||614
522075|NCT00879970|1275863|P3|STARTED|Period 2 Vitamin D Randomization||0
522076|NCT00879970|1275864|P2|STARTED|Period 2 Vitamin D Randomization||0
522077|NCT00879970|1275865|P1|STARTED|Period 2 Vitamin D Randomization||0
522078|NCT00879970|1275861|P5|NOT COMPLETED|Period 1 TZD Randomization||0
522079|NCT00879970|1275862|P4|NOT COMPLETED|Period 1 TZD Randomization||0
522080|NCT00879970|1275863|P3|NOT COMPLETED|Period 1 TZD Randomization||6
522081|NCT00879970|1275864|P2|NOT COMPLETED|Period 1 TZD Randomization||4
522082|NCT00879970|1275865|P1|NOT COMPLETED|Period 1 TZD Randomization||8
522083|NCT00879970|1275861|P5|COMPLETED|Period 1 TZD Randomization||0
522084|NCT00879970|1275862|P4|COMPLETED|Period 1 TZD Randomization||0
522085|NCT00879970|1275863|P3|COMPLETED|Period 1 TZD Randomization||393
522086|NCT00879970|1275864|P2|COMPLETED|Period 1 TZD Randomization||388
522087|NCT00879970|1275865|P1|COMPLETED|Period 1 TZD Randomization||533
522088|NCT00879970|1275861|P5|STARTED|Period 1 TZD Randomization||0
522089|NCT00879970|1275862|P4|STARTED|Period 1 TZD Randomization||0
522090|NCT00879970|1275863|P3|STARTED|Period 1 TZD Randomization||399
522091|NCT00879970|1275864|P2|STARTED|Period 1 TZD Randomization||392
522092|NCT00879970|1275865|P1|STARTED|Period 1 TZD Randomization||541
522093|NCT00879879|1275947|P1|NOT COMPLETED|Overall Study||3
522094|NCT00879879|1275947|P1|COMPLETED|Overall Study||17
522095|NCT00879879|1275947|P1|STARTED|Overall Study||20
522096|NCT00879814|1275955|P4|NOT COMPLETED|Overall Study||5
522097|NCT00879814|1275956|P3|NOT COMPLETED|Overall Study||3
522098|NCT00879814|1275957|P2|NOT COMPLETED|Overall Study||2
522099|NCT00879814|1275958|P1|NOT COMPLETED|Overall Study||4
522100|NCT00879814|1275955|P4|COMPLETED|Overall Study||7
522101|NCT00879814|1275956|P3|COMPLETED|Overall Study||9
522102|NCT00879814|1275957|P2|COMPLETED|Overall Study||10
522103|NCT00879814|1275958|P1|COMPLETED|Overall Study||8
522104|NCT00879814|1275955|P4|STARTED|Overall Study||12
522105|NCT00879814|1275956|P3|STARTED|Overall Study||12
522106|NCT00879814|1275957|P2|STARTED|Overall Study||12
522107|NCT00879814|1275958|P1|STARTED|Overall Study||12
522108|NCT00879775|1276066|P2|NOT COMPLETED|Overall Study||1
522109|NCT00879775|1276067|P1|NOT COMPLETED|Overall Study||2
522110|NCT00879775|1276066|P2|COMPLETED|Overall Study||20
522111|NCT00879775|1276067|P1|COMPLETED|Overall Study||18
522112|NCT00879775|1276066|P2|STARTED|Overall Study||21
522113|NCT00879775|1276067|P1|STARTED|Overall Study||20
522114|NCT00879710|1276083|P4|NOT COMPLETED|Phase 2 6 Weeks||0
522115|NCT00879710|1276084|P3|NOT COMPLETED|Phase 2 6 Weeks||0
522116|NCT00879710|1276085|P2|NOT COMPLETED|Phase 2 6 Weeks||0
522117|NCT00879710|1276086|P1|NOT COMPLETED|Phase 2 6 Weeks||0
522118|NCT00879710|1276083|P4|COMPLETED|Phase 2 6 Weeks||13
522119|NCT00879710|1276084|P3|COMPLETED|Phase 2 6 Weeks||10
522120|NCT00879710|1276085|P2|COMPLETED|Phase 2 6 Weeks||14
522121|NCT00879710|1276086|P1|COMPLETED|Phase 2 6 Weeks||10
522122|NCT00879710|1276083|P4|STARTED|Phase 2 6 Weeks||13
522123|NCT00879710|1276084|P3|STARTED|Phase 2 6 Weeks||10
522124|NCT00879710|1276085|P2|STARTED|Phase 2 6 Weeks||14
522125|NCT00879710|1276086|P1|STARTED|Phase 2 6 Weeks||10
522126|NCT00879710|1276083|P4|NOT COMPLETED|Wash Out Period of 4 Weeks||0
522127|NCT00879710|1276084|P3|NOT COMPLETED|Wash Out Period of 4 Weeks||0
522128|NCT00879710|1276085|P2|NOT COMPLETED|Wash Out Period of 4 Weeks||0
522129|NCT00879710|1276086|P1|NOT COMPLETED|Wash Out Period of 4 Weeks||0
522130|NCT00879710|1276083|P4|COMPLETED|Wash Out Period of 4 Weeks||13
522131|NCT00879710|1276084|P3|COMPLETED|Wash Out Period of 4 Weeks||10
522132|NCT00879710|1276085|P2|COMPLETED|Wash Out Period of 4 Weeks||14
522133|NCT00879710|1276086|P1|COMPLETED|Wash Out Period of 4 Weeks||10
522134|NCT00879710|1276083|P4|STARTED|Wash Out Period of 4 Weeks||13
522135|NCT00879710|1276084|P3|STARTED|Wash Out Period of 4 Weeks|The person who did not complete ezetimibe arm came back to complete simvastatin arm.|10
522136|NCT00879710|1276085|P2|STARTED|Wash Out Period of 4 Weeks||14
522137|NCT00879710|1276086|P1|STARTED|Wash Out Period of 4 Weeks||10
522138|NCT00879710|1276083|P4|NOT COMPLETED|Phase 1 - 6 Weeks||4
522139|NCT00879710|1276084|P3|NOT COMPLETED|Phase 1 - 6 Weeks||2
522140|NCT00879710|1276085|P2|NOT COMPLETED|Phase 1 - 6 Weeks||3
522141|NCT00879710|1276086|P1|NOT COMPLETED|Phase 1 - 6 Weeks||2
522142|NCT00879710|1276083|P4|COMPLETED|Phase 1 - 6 Weeks||13
522143|NCT00879710|1276084|P3|COMPLETED|Phase 1 - 6 Weeks||9
522144|NCT00879710|1276085|P2|COMPLETED|Phase 1 - 6 Weeks||14
522145|NCT00879710|1276086|P1|COMPLETED|Phase 1 - 6 Weeks||10
522146|NCT00879710|1276083|P4|STARTED|Phase 1 - 6 Weeks|Started with ezetimibe 10 mg as the starting drug|17
522147|NCT00879710|1276084|P3|STARTED|Phase 1 - 6 Weeks|Started with ezetimibe 10 mg as the starting drug|11
522148|NCT00879710|1276085|P2|STARTED|Phase 1 - 6 Weeks|Started with simvastatin 40 mg as the starting drug|17
522149|NCT00879710|1276086|P1|STARTED|Phase 1 - 6 Weeks|Started with simvastatin 40 mg as the starting drug|12
522150|NCT00879697|1276096|P2|NOT COMPLETED|Overall Study||2
522151|NCT00879697|1276097|P1|NOT COMPLETED|Overall Study||2
522152|NCT00879697|1276096|P2|COMPLETED|Overall Study|Two patients did not finish the trial|15
522153|NCT00879697|1276097|P1|COMPLETED|Overall Study|Two patients did not finish the trial|15
522154|NCT00879697|1276096|P2|STARTED|Overall Study|Seventeen patients achieved inclusion and exclusion criteria|17
522155|NCT00879697|1276097|P1|STARTED|Overall Study|Seventeen patients achieved inclusion and exclusion criteria|17
522156|NCT00879684|1276103|P7|NOT COMPLETED|Stage 2: Expanded Cohort||13
522157|NCT00879684|1276104|P6|NOT COMPLETED|Stage 2: Expanded Cohort||0
522158|NCT00879684|1276105|P5|NOT COMPLETED|Stage 2: Expanded Cohort||0
522159|NCT00879684|1276106|P4|NOT COMPLETED|Stage 2: Expanded Cohort||0
522160|NCT00879684|1276107|P3|NOT COMPLETED|Stage 2: Expanded Cohort||0
522161|NCT00879684|1276108|P2|NOT COMPLETED|Stage 2: Expanded Cohort||0
522162|NCT00879684|1276109|P1|NOT COMPLETED|Stage 2: Expanded Cohort||0
522163|NCT00879684|1276103|P7|COMPLETED|Stage 2: Expanded Cohort||0
522164|NCT00879684|1276104|P6|COMPLETED|Stage 2: Expanded Cohort||0
522165|NCT00879684|1276105|P5|COMPLETED|Stage 2: Expanded Cohort||0
522166|NCT00879684|1276106|P4|COMPLETED|Stage 2: Expanded Cohort||0
522167|NCT00879684|1276107|P3|COMPLETED|Stage 2: Expanded Cohort||0
522168|NCT00879684|1276108|P2|COMPLETED|Stage 2: Expanded Cohort||0
522169|NCT00879684|1276109|P1|COMPLETED|Stage 2: Expanded Cohort||0
522170|NCT00879684|1276103|P7|STARTED|Stage 2: Expanded Cohort||13
522171|NCT00879684|1276104|P6|STARTED|Stage 2: Expanded Cohort||0
522172|NCT00879684|1276105|P5|STARTED|Stage 2: Expanded Cohort||0
522173|NCT00879684|1276106|P4|STARTED|Stage 2: Expanded Cohort||0
522174|NCT00879684|1276107|P3|STARTED|Stage 2: Expanded Cohort||0
522175|NCT00879684|1276108|P2|STARTED|Stage 2: Expanded Cohort||0
522176|NCT00879684|1276109|P1|STARTED|Stage 2: Expanded Cohort||0
522177|NCT00879684|1276103|P7|NOT COMPLETED|Stage 1: Dose Escalation||0
522178|NCT00879684|1276104|P6|NOT COMPLETED|Stage 1: Dose Escalation||3
522179|NCT00879684|1276105|P5|NOT COMPLETED|Stage 1: Dose Escalation||3
522180|NCT00879684|1276106|P4|NOT COMPLETED|Stage 1: Dose Escalation||6
522181|NCT00879684|1276107|P3|NOT COMPLETED|Stage 1: Dose Escalation||3
522182|NCT00879684|1276108|P2|NOT COMPLETED|Stage 1: Dose Escalation||3
522183|NCT00879684|1276109|P1|NOT COMPLETED|Stage 1: Dose Escalation||3
522184|NCT00879684|1276103|P7|COMPLETED|Stage 1: Dose Escalation||0
522185|NCT00879684|1276104|P6|COMPLETED|Stage 1: Dose Escalation||0
522186|NCT00879684|1276105|P5|COMPLETED|Stage 1: Dose Escalation||0
522187|NCT00879684|1276106|P4|COMPLETED|Stage 1: Dose Escalation||0
522188|NCT00879684|1276107|P3|COMPLETED|Stage 1: Dose Escalation||0
522189|NCT00879684|1276108|P2|COMPLETED|Stage 1: Dose Escalation||0
522190|NCT00879684|1276109|P1|COMPLETED|Stage 1: Dose Escalation||0
522191|NCT00879684|1276103|P7|STARTED|Stage 1: Dose Escalation||0
522192|NCT00879684|1276104|P6|STARTED|Stage 1: Dose Escalation||3
522193|NCT00879684|1276105|P5|STARTED|Stage 1: Dose Escalation||3
522194|NCT00879684|1276106|P4|STARTED|Stage 1: Dose Escalation||6
522195|NCT00879684|1276107|P3|STARTED|Stage 1: Dose Escalation||3
522196|NCT00879684|1276108|P2|STARTED|Stage 1: Dose Escalation||3
522197|NCT00879684|1276109|P1|STARTED|Stage 1: Dose Escalation||3
522198|NCT00879645|1276175|P4|NOT COMPLETED|Overall Study||0
522199|NCT00879645|1276176|P3|NOT COMPLETED|Overall Study||0
522200|NCT00879645|1276177|P2|NOT COMPLETED|Overall Study||0
522201|NCT00879645|1276178|P1|NOT COMPLETED|Overall Study||1
522202|NCT00879645|1276175|P4|COMPLETED|Overall Study||7
522203|NCT00879645|1276176|P3|COMPLETED|Overall Study||6
522204|NCT00879645|1276177|P2|COMPLETED|Overall Study||6
522205|NCT00879645|1276178|P1|COMPLETED|Overall Study||8
522206|NCT00879645|1276175|P4|STARTED|Overall Study||7
522207|NCT00879645|1276176|P3|STARTED|Overall Study||6
522208|NCT00879645|1276177|P2|STARTED|Overall Study||6
522209|NCT00879645|1276178|P1|STARTED|Overall Study||9
522210|NCT00879619|1276196|P1|NOT COMPLETED|Overall Study||0
522211|NCT00879619|1276196|P1|COMPLETED|Overall Study||4
522212|NCT00879619|1276196|P1|STARTED|Overall Study||4
522213|NCT00879411|1276205|P1|NOT COMPLETED|Overall Study||162
522214|NCT00879411|1276205|P1|COMPLETED|Overall Study||539
522215|NCT00879411|1276205|P1|STARTED|Overall Study||701
522216|NCT00879398|1276211|P1|NOT COMPLETED|Overall Study||675
522217|NCT00879398|1276211|P1|COMPLETED|Overall Study||2434
522218|NCT00879398|1276211|P1|STARTED|Overall Study||3109
522219|NCT00879359|1276221|P1|NOT COMPLETED|Overall Study||0
522220|NCT00879359|1276221|P1|COMPLETED|Overall Study||15
522221|NCT00879359|1276221|P1|STARTED|Overall Study||15
522222|NCT00879333|1276229|P2|NOT COMPLETED|Overall Study||217
522223|NCT00879333|1276230|P1|NOT COMPLETED|Overall Study||428
522224|NCT00879333|1276229|P2|COMPLETED|Overall Study||0
522225|NCT00879333|1276230|P1|COMPLETED|Overall Study|Completed=Patients Still on Treatment; At data cutoff final analysis, 11 patients were on treatment|11
522226|NCT00879333|1276229|P2|Discontinued Study Treatment|Overall Study||217
522227|NCT00879333|1276230|P1|Discontinued Study Treatment|Overall Study||428
522228|NCT00879333|1276229|P2|STARTED|Overall Study||217
522229|NCT00879333|1276230|P1|STARTED|Overall Study||439
522230|NCT00879255|1276250|P2|NOT COMPLETED|Overall Study||19
522231|NCT00879255|1276251|P1|NOT COMPLETED|Overall Study||16
522232|NCT00879255|1276250|P2|COMPLETED|Overall Study|Completed 6-mo follow-up|45
522233|NCT00879255|1276251|P1|COMPLETED|Overall Study|Completed 6-mo follow-up|45
522234|NCT00879255|1276250|P2|Completed 3-mo Follow-up|Overall Study||49
522235|NCT00879255|1276251|P1|Completed 3-mo Follow-up|Overall Study||48
522236|NCT00879255|1276250|P2|Completed Posttreatment Follow-up|Overall Study||55
522237|NCT00879255|1276251|P1|Completed Posttreatment Follow-up|Overall Study||50
522238|NCT00879255|1276250|P2|Received Allocated Intervention:|Overall Study||56
522239|NCT00879255|1276251|P1|Received Allocated Intervention:|Overall Study||51
522240|NCT00879255|1276250|P2|STARTED|Overall Study||64
522241|NCT00879255|1276251|P1|STARTED|Overall Study||61
522242|NCT00879229|1276263|P2|NOT COMPLETED|Overall Study||14
522243|NCT00879229|1276264|P1|NOT COMPLETED|Overall Study||22
522244|NCT00879229|1276263|P2|COMPLETED|Overall Study||1
522245|NCT00879229|1276264|P1|COMPLETED|Overall Study||3
522246|NCT00879229|1276263|P2|STARTED|Overall Study||15
522247|NCT00879229|1276264|P1|STARTED|Overall Study||25
522248|NCT00879190|1276290|P2|NOT COMPLETED|Overall Study||0
522249|NCT00879190|1276291|P1|NOT COMPLETED|Overall Study||0
522250|NCT00879190|1276290|P2|COMPLETED|Overall Study||49
522251|NCT00879190|1276291|P1|COMPLETED|Overall Study||43
522252|NCT00879190|1276290|P2|STARTED|Overall Study||49
522253|NCT00879190|1276291|P1|STARTED|Overall Study||43
522254|NCT00879034|1276301|P1|NOT COMPLETED|Overall Study||0
522255|NCT00879034|1276301|P1|COMPLETED|Overall Study||5
522256|NCT00879034|1276301|P1|Received Treatment|Overall Study||4
522257|NCT00879034|1276301|P1|STARTED|Overall Study||5
522258|NCT00878995|1276312|P2|NOT COMPLETED|Midpoint Study - Post Study||0
522259|NCT00878995|1276313|P1|NOT COMPLETED|Midpoint Study - Post Study||0
522260|NCT00878995|1276312|P2|COMPLETED|Midpoint Study - Post Study||10
522261|NCT00878995|1276313|P1|COMPLETED|Midpoint Study - Post Study||12
522262|NCT00878995|1276312|P2|STARTED|Midpoint Study - Post Study||10
522263|NCT00878995|1276313|P1|STARTED|Midpoint Study - Post Study||12
522264|NCT00878995|1276312|P2|NOT COMPLETED|Baseline Study - Midpoint Study||2
522265|NCT00878995|1276313|P1|NOT COMPLETED|Baseline Study - Midpoint Study||0
522266|NCT00878995|1276312|P2|COMPLETED|Baseline Study - Midpoint Study|2 subjects dropped after the baseline study. They decided to seek treatment closer to home.|10
522267|NCT00878995|1276313|P1|COMPLETED|Baseline Study - Midpoint Study||12
522268|NCT00878995|1276312|P2|Baseline Study|Baseline Study - Midpoint Study||12
522269|NCT00878995|1276313|P1|Baseline Study|Baseline Study - Midpoint Study||12
522270|NCT00878995|1276312|P2|STARTED|Baseline Study - Midpoint Study||12
522271|NCT00878995|1276313|P1|STARTED|Baseline Study - Midpoint Study||12
522272|NCT00878969|1276414|P3|NOT COMPLETED|Overall Study||11
522273|NCT00878969|1276415|P2|NOT COMPLETED|Overall Study||15
522274|NCT00878969|1276416|P1|NOT COMPLETED|Overall Study||15
522275|NCT00878969|1276414|P3|COMPLETED|Overall Study||15
522276|NCT00878969|1276415|P2|COMPLETED|Overall Study||12
522277|NCT00878969|1276416|P1|COMPLETED|Overall Study||10
522278|NCT00878969|1276414|P3|STARTED|Overall Study||26
522279|NCT00878969|1276415|P2|STARTED|Overall Study||27
522280|NCT00878969|1276416|P1|STARTED|Overall Study||25
522281|NCT00878878|1276426|P2|NOT COMPLETED|Overall Study||0
522282|NCT00878878|1276427|P1|NOT COMPLETED|Overall Study||0
522283|NCT00878878|1276426|P2|COMPLETED|Overall Study||15
522284|NCT00878878|1276427|P1|COMPLETED|Overall Study||15
522285|NCT00878878|1276426|P2|STARTED|Overall Study||15
522286|NCT00878878|1276427|P1|STARTED|Overall Study||15
522287|NCT00878826|1276440|P3|NOT COMPLETED|Overall Study||0
522288|NCT00878826|1276441|P2|NOT COMPLETED|Overall Study||0
522289|NCT00878826|1276442|P1|NOT COMPLETED|Overall Study||0
522290|NCT00878826|1276440|P3|COMPLETED|Overall Study||2
522291|NCT00878826|1276441|P2|COMPLETED|Overall Study||6
522292|NCT00878826|1276442|P1|COMPLETED|Overall Study||3
522293|NCT00878826|1276440|P3|STARTED|Overall Study||2
522294|NCT00878826|1276441|P2|STARTED|Overall Study||6
522295|NCT00878826|1276442|P1|STARTED|Overall Study||3
522296|NCT00878800|1276464|P5|NOT COMPLETED|Overall Study||16
522297|NCT00878800|1276465|P4|NOT COMPLETED|Overall Study||6
522298|NCT00878800|1276466|P3|NOT COMPLETED|Overall Study||9
522299|NCT00878800|1276467|P2|NOT COMPLETED|Overall Study||7
522300|NCT00878800|1276468|P1|NOT COMPLETED|Overall Study||3
522301|NCT00878800|1276464|P5|COMPLETED|Overall Study|Mean number of cycles administered: 6.4|0
522302|NCT00878800|1276465|P4|COMPLETED|Overall Study|Mean number of cycles administered: 5.3|0
522303|NCT00878800|1276466|P3|COMPLETED|Overall Study|Mean number of cycles administered: 3.0|0
522304|NCT00878800|1276467|P2|COMPLETED|Overall Study|Mean number of cycles administered: 4.6|0
522305|NCT00878800|1276468|P1|COMPLETED|Overall Study|Mean number of cycles administered: 4.0|0
522306|NCT00878800|1276464|P5|STARTED|Overall Study||16
522307|NCT00878800|1276465|P4|STARTED|Overall Study||6
522308|NCT00878800|1276466|P3|STARTED|Overall Study||9
522309|NCT00878800|1276467|P2|STARTED|Overall Study||7
522310|NCT00878800|1276468|P1|STARTED|Overall Study||3
522311|NCT00878722|1276503|P8|NOT COMPLETED|Overall Study||7
522312|NCT00878722|1276504|P7|NOT COMPLETED|Overall Study||6
522313|NCT00878722|1276505|P6|NOT COMPLETED|Overall Study||2
522314|NCT00878722|1276506|P5|NOT COMPLETED|Overall Study||7
522315|NCT00878722|1276507|P4|NOT COMPLETED|Overall Study||9
522316|NCT00878722|1276508|P3|NOT COMPLETED|Overall Study||3
522317|NCT00878722|1276509|P2|NOT COMPLETED|Overall Study||3
522318|NCT00878722|1276510|P1|NOT COMPLETED|Overall Study||3
522319|NCT00878722|1276503|P8|COMPLETED|Overall Study||0
522320|NCT00878722|1276504|P7|COMPLETED|Overall Study||0
522321|NCT00878722|1276505|P6|COMPLETED|Overall Study||1
522322|NCT00878722|1276506|P5|COMPLETED|Overall Study||0
522323|NCT00878722|1276507|P4|COMPLETED|Overall Study||0
522324|NCT00878722|1276508|P3|COMPLETED|Overall Study||0
522325|NCT00878722|1276509|P2|COMPLETED|Overall Study||0
522326|NCT00878722|1276510|P1|COMPLETED|Overall Study||0
522327|NCT00878722|1276503|P8|STARTED|Overall Study||7
522328|NCT00878722|1276504|P7|STARTED|Overall Study||6
522329|NCT00878722|1276505|P6|STARTED|Overall Study||3
522330|NCT00878722|1276506|P5|STARTED|Overall Study||7
522331|NCT00878722|1276507|P4|STARTED|Overall Study||9
522332|NCT00878722|1276508|P3|STARTED|Overall Study||3
522333|NCT00878722|1276509|P2|STARTED|Overall Study||3
522334|NCT00878722|1276510|P1|STARTED|Overall Study||3
522335|NCT00878709|1276595|P2|NOT COMPLETED|Overall Study||237
522336|NCT00878709|1276596|P1|NOT COMPLETED|Overall Study||325
522337|NCT00878709|1276595|P2|COMPLETED|Overall Study||1183
522338|NCT00878709|1276596|P1|COMPLETED|Overall Study||1095
522339|NCT00878709|1276595|P2|STARTED|Overall Study||1420
522340|NCT00878709|1276596|P1|STARTED|Overall Study||1420
522341|NCT00878644|1276622|P2|NOT COMPLETED|Overall Study||4
522342|NCT00878644|1276623|P1|NOT COMPLETED|Overall Study||4
522343|NCT00878644|1276622|P2|COMPLETED|Overall Study||136
522344|NCT00878644|1276623|P1|COMPLETED|Overall Study||151
522345|NCT00878644|1276622|P2|STARTED|Overall Study||140
522346|NCT00878644|1276623|P1|STARTED|Overall Study||155
522347|NCT00878605|1276639|P4|NOT COMPLETED|Overall Study||3
522348|NCT00878605|1276640|P3|NOT COMPLETED|Overall Study||1
522349|NCT00878605|1276641|P2|NOT COMPLETED|Overall Study||3
522350|NCT00878605|1276642|P1|NOT COMPLETED|Overall Study||3
522351|NCT00878605|1276639|P4|COMPLETED|Overall Study||6
522352|NCT00878605|1276640|P3|COMPLETED|Overall Study||8
522353|NCT00878605|1276641|P2|COMPLETED|Overall Study||7
522354|NCT00878605|1276642|P1|COMPLETED|Overall Study||7
522355|NCT00878605|1276639|P4|STARTED|Overall Study||9
522356|NCT00878605|1276640|P3|STARTED|Overall Study||9
522357|NCT00878605|1276641|P2|STARTED|Overall Study||10
522358|NCT00878605|1276642|P1|STARTED|Overall Study||10
522359|NCT00878553|1276656|P5|NOT COMPLETED|PK Study||0
522360|NCT00878553|1276657|P4|NOT COMPLETED|PK Study||1
522361|NCT00878553|1276658|P3|NOT COMPLETED|PK Study||0
522362|NCT00878553|1276659|P2|NOT COMPLETED|PK Study||0
522363|NCT00878553|1276660|P1|NOT COMPLETED|PK Study||0
522364|NCT00878553|1276656|P5|COMPLETED|PK Study||15
522365|NCT00878553|1276657|P4|COMPLETED|PK Study|One patient withdrew consent after completing the Sleep Substudy and prior to starting PK substudy.|13
522366|NCT00878553|1276658|P3|COMPLETED|PK Study||17
522367|NCT00878553|1276659|P2|COMPLETED|PK Study||16
522368|NCT00878553|1276660|P1|COMPLETED|PK Study|A total of 61 randomized patients completed this parallel group, single dose PK substudy.|0
522369|NCT00878553|1276656|P5|STARTED|PK Study|During the PK period, 15 randomized participants received one bedtime dose of 20mg SKP-1041.|15
522370|NCT00878553|1276657|P4|STARTED|PK Study|During the PK period, 14 participants were randomized to receive one bedtime dose of 15mg SKP-1041.|14
522371|NCT00878553|1276658|P3|STARTED|PK Study|During the PK period, 17 randomized participants received one bedtime dose of 10mg SKP-1041.|17
522372|NCT00878553|1276659|P2|STARTED|PK Study|During the PK period, 16 randomized participants received one bedtime dose of SKP-1041 placebo.|16
522373|NCT00878553|1276660|P1|STARTED|PK Study|A total of 62 randomized patients started this parallel group, single dose PK substudy.|0
522374|NCT00878553|1276656|P5|NOT COMPLETED|Sleep Study||0
522375|NCT00878553|1276657|P4|NOT COMPLETED|Sleep Study||0
522376|NCT00878553|1276658|P3|NOT COMPLETED|Sleep Study||0
522377|NCT00878553|1276659|P2|NOT COMPLETED|Sleep Study||0
522378|NCT00878553|1276660|P1|NOT COMPLETED|Sleep Study||5
522379|NCT00878553|1276656|P5|COMPLETED|Sleep Study||0
522380|NCT00878553|1276657|P4|COMPLETED|Sleep Study||0
522381|NCT00878553|1276658|P3|COMPLETED|Sleep Study||0
522382|NCT00878553|1276659|P2|COMPLETED|Sleep Study||0
522383|NCT00878553|1276660|P1|COMPLETED|Sleep Study|5 patient withdraws result in greater than 5 lost patient data across groups due to CROSSOVER design|62
522384|NCT00878553|1276656|P5|Number of Patients Receiving 20mg|Sleep Study||0
522385|NCT00878553|1276657|P4|Number of Patients Receiving 20mg|Sleep Study||0
522386|NCT00878553|1276658|P3|Number of Patients Receiving 20mg|Sleep Study||0
522387|NCT00878553|1276659|P2|Number of Patients Receiving 20mg|Sleep Study||0
522388|NCT00878553|1276660|P1|Number of Patients Receiving 20mg|Sleep Study||65
522389|NCT00878553|1276656|P5|Number of Patients Receiving 15mg|Sleep Study||0
522390|NCT00878553|1276657|P4|Number of Patients Receiving 15mg|Sleep Study||0
522391|NCT00878553|1276658|P3|Number of Patients Receiving 15mg|Sleep Study||0
522392|NCT00878553|1276659|P2|Number of Patients Receiving 15mg|Sleep Study||0
522393|NCT00878553|1276660|P1|Number of Patients Receiving 15mg|Sleep Study||65
522394|NCT00878553|1276656|P5|Number of Patients Receiving 10mg|Sleep Study||0
522395|NCT00878553|1276657|P4|Number of Patients Receiving 10mg|Sleep Study||0
522396|NCT00878553|1276658|P3|Number of Patients Receiving 10mg|Sleep Study||0
522397|NCT00878553|1276659|P2|Number of Patients Receiving 10mg|Sleep Study||0
522398|NCT00878553|1276660|P1|Number of Patients Receiving 10mg|Sleep Study||65
522399|NCT00878553|1276656|P5|Number of Patients Receiving Placebo|Sleep Study||0
522400|NCT00878553|1276657|P4|Number of Patients Receiving Placebo|Sleep Study||0
522401|NCT00878553|1276658|P3|Number of Patients Receiving Placebo|Sleep Study||0
522402|NCT00878553|1276659|P2|Number of Patients Receiving Placebo|Sleep Study||0
522403|NCT00878553|1276660|P1|Number of Patients Receiving Placebo|Sleep Study||66
522404|NCT00878553|1276656|P5|STARTED|Sleep Study||0
522405|NCT00878553|1276657|P4|STARTED|Sleep Study||0
522406|NCT00878553|1276658|P3|STARTED|Sleep Study||0
522407|NCT00878553|1276659|P2|STARTED|Sleep Study||0
522408|NCT00878553|1276660|P1|STARTED|Sleep Study|This Intention to Treat population includes all randomized patients; one dropped prior to treatment.|67
522409|NCT00878501|1276719|P3|NOT COMPLETED|Overall Study||8
522410|NCT00878501|1276720|P2|NOT COMPLETED|Overall Study||7
522411|NCT00878501|1276721|P1|NOT COMPLETED|Overall Study||17
522412|NCT00878501|1276719|P3|COMPLETED|Overall Study||85
522413|NCT00878501|1276720|P2|COMPLETED|Overall Study||37
522414|NCT00878501|1276721|P1|COMPLETED|Overall Study||87
522415|NCT00878501|1276719|P3|Interim Analysis|Overall Study||81
522416|NCT00878501|1276720|P2|Interim Analysis|Overall Study||37
522417|NCT00878501|1276721|P1|Interim Analysis|Overall Study||83
522418|NCT00878501|1276719|P3|STARTED|Overall Study||93
522419|NCT00878501|1276720|P2|STARTED|Overall Study||44
522420|NCT00878501|1276721|P1|STARTED|Overall Study|One of these patients did not receive study drug since incorrectly enrolled (mis-randomisation)|104
522421|NCT00878436|1276740|P2|NOT COMPLETED|Overall Study||24
522422|NCT00878436|1276741|P1|NOT COMPLETED|Overall Study||23
522423|NCT00878436|1276740|P2|COMPLETED|Overall Study||0
522424|NCT00878436|1276741|P1|COMPLETED|Overall Study||5
522425|NCT00878436|1276740|P2|6 Months|Overall Study||0
522426|NCT00878436|1276741|P1|6 Months|Overall Study||8
522427|NCT00878436|1276740|P2|Completed 2 Cycles|Overall Study||20
522428|NCT00878436|1276741|P1|Completed 2 Cycles|Overall Study||21
522429|NCT00878436|1276740|P2|STARTED|Overall Study||24
522430|NCT00878436|1276741|P1|STARTED|Overall Study||28
522431|NCT00878228|1276755|P2|NOT COMPLETED|Overall Study||12
522432|NCT00878228|1276756|P1|NOT COMPLETED|Overall Study||10
522433|NCT00878228|1276755|P2|COMPLETED|Overall Study||37
522434|NCT00878228|1276756|P1|COMPLETED|Overall Study||39
522435|NCT00878228|1276755|P2|STARTED|Overall Study||49
522436|NCT00878228|1276756|P1|STARTED|Overall Study||49
522437|NCT00878215|1276770|P4|NOT COMPLETED|Overall Study||0
522438|NCT00878215|1276771|P3|NOT COMPLETED|Overall Study||0
522439|NCT00878215|1276772|P2|NOT COMPLETED|Overall Study||10
522440|NCT00878215|1276773|P1|NOT COMPLETED|Overall Study||0
522441|NCT00878215|1276770|P4|COMPLETED|Overall Study||0
522442|NCT00878215|1276771|P3|COMPLETED|Overall Study||0
522443|NCT00878215|1276772|P2|COMPLETED|Overall Study||9
522444|NCT00878215|1276773|P1|COMPLETED|Overall Study||21
522445|NCT00878215|1276770|P4|STARTED|Overall Study|Phase 4 not performed because the liver imaging system became commercially available|0
522446|NCT00878215|1276771|P3|STARTED|Overall Study|Phase 3 not performed because the liver imaging system became commercially available|0
522447|NCT00878215|1276772|P2|STARTED|Overall Study||19
522448|NCT00878215|1276773|P1|STARTED|Overall Study||21
522449|NCT00877929|1276785|P2|NOT COMPLETED|Overall Study||35
522450|NCT00877929|1276786|P1|NOT COMPLETED|Overall Study||20
522451|NCT00877929|1276785|P2|COMPLETED|Overall Study||319
522452|NCT00877929|1276786|P1|COMPLETED|Overall Study||332
522453|NCT00877929|1276785|P2|STARTED|Overall Study||354
522454|NCT00877929|1276786|P1|STARTED|Overall Study||352
522455|NCT00877890|1276874|P2|NOT COMPLETED|Overall Study||30
522456|NCT00877890|1276875|P1|NOT COMPLETED|Overall Study||20
522457|NCT00877890|1276874|P2|COMPLETED|Overall Study||95
522458|NCT00877890|1276875|P1|COMPLETED|Overall Study||109
522459|NCT00877890|1276874|P2|Intent to Treat (ITT)|Overall Study||123
522460|NCT00877890|1276875|P1|Intent to Treat (ITT)|Overall Study||129
522461|NCT00877890|1276874|P2|STARTED|Overall Study||125
522462|NCT00877890|1276875|P1|STARTED|Overall Study||129
522463|NCT00877877|1276909|P1|NOT COMPLETED|Year 10||0
522464|NCT00877877|1276909|P1|COMPLETED|Year 10||495
522465|NCT00877877|1276909|P1|STARTED|Year 10||495
522466|NCT00877877|1276909|P1|NOT COMPLETED|Year 9||0
522467|NCT00877877|1276909|P1|COMPLETED|Year 9||507
522468|NCT00877877|1276909|P1|STARTED|Year 9||507
522469|NCT00877877|1276909|P1|NOT COMPLETED|Year 8||0
522470|NCT00877877|1276909|P1|COMPLETED|Year 8||522
522471|NCT00877877|1276909|P1|STARTED|Year 8||522
522472|NCT00877877|1276909|P1|NOT COMPLETED|Year 7||0
522473|NCT00877877|1276909|P1|COMPLETED|Year 7||523
522474|NCT00877877|1276909|P1|STARTED|Year 7||523
522475|NCT00877877|1276909|P1|NOT COMPLETED|Year 6||0
522476|NCT00877877|1276909|P1|COMPLETED|Year 6||529
522477|NCT00877877|1276909|P1|STARTED|Year 6||529
522478|NCT00877877|1276909|P1|NOT COMPLETED|Year 5||0
522479|NCT00877877|1276909|P1|COMPLETED|Year 5||397
522480|NCT00877877|1276909|P1|STARTED|Year 5||397
522481|NCT00877799|1276940|P5|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||1
522482|NCT00877799|1276941|P4|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||2
522483|NCT00877799|1276942|P3|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
522484|NCT00877799|1276943|P2|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
522485|NCT00877799|1276944|P1|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
522486|NCT00877799|1276940|P5|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||19
522487|NCT00877799|1276941|P4|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||24
522488|NCT00877799|1276942|P3|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
522489|NCT00877799|1276943|P2|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
522490|NCT00877799|1276944|P1|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
522491|NCT00877799|1276940|P5|STARTED|Cohort 2: Immediately Post-op (Day 0)||20
522492|NCT00877799|1276941|P4|STARTED|Cohort 2: Immediately Post-op (Day 0)||26
522493|NCT00877799|1276942|P3|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
522494|NCT00877799|1276943|P2|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
522495|NCT00877799|1276944|P1|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
522496|NCT00877799|1276940|P5|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
522497|NCT00877799|1276941|P4|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
522498|NCT00877799|1276942|P3|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3
522589|NCT00877032|1277076|P6|Treated|Overall Study||6
522499|NCT00877799|1276943|P2|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||5
522500|NCT00877799|1276944|P1|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3
522501|NCT00877799|1276940|P5|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
522502|NCT00877799|1276941|P4|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
522503|NCT00877799|1276942|P3|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||18
522504|NCT00877799|1276943|P2|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||17
522505|NCT00877799|1276944|P1|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||22
522506|NCT00877799|1276940|P5|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0
522507|NCT00877799|1276941|P4|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0
522508|NCT00877799|1276942|P3|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||21
522509|NCT00877799|1276943|P2|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||22
522510|NCT00877799|1276944|P1|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||25
522511|NCT00877773|1276959|P1|NOT COMPLETED|Overall Study||44
522512|NCT00877773|1276959|P1|COMPLETED|Overall Study|No participant reached to first restaging.|0
522513|NCT00877773|1276959|P1|STARTED|Overall Study||44
522514|NCT00877604|1276965|P2|NOT COMPLETED|Overall Study||3
522515|NCT00877604|1276966|P1|NOT COMPLETED|Overall Study||2
522516|NCT00877604|1276965|P2|COMPLETED|Overall Study||14
522517|NCT00877604|1276966|P1|COMPLETED|Overall Study||15
522518|NCT00877604|1276965|P2|STARTED|Overall Study||17
522519|NCT00877604|1276966|P1|STARTED|Overall Study||17
522520|NCT00877487|1276972|P2|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||47
522521|NCT00877487|1276973|P1|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||6
522522|NCT00877487|1276972|P2|COMPLETED|Double-blind Randomized Withdrawal Phase||13
522523|NCT00877487|1276973|P1|COMPLETED|Double-blind Randomized Withdrawal Phase||50
522524|NCT00877487|1276972|P2|STARTED|Double-blind Randomized Withdrawal Phase||60
522525|NCT00877487|1276973|P1|STARTED|Double-blind Randomized Withdrawal Phase||56
522526|NCT00877487|1276972|P2|NOT COMPLETED|Open-label Treatment Phase||0
522527|NCT00877487|1276973|P1|NOT COMPLETED|Open-label Treatment Phase||7
522528|NCT00877487|1276972|P2|COMPLETED|Open-label Treatment Phase||0
522529|NCT00877487|1276973|P1|COMPLETED|Open-label Treatment Phase||116
522530|NCT00877487|1276972|P2|STARTED|Open-label Treatment Phase||0
522531|NCT00877487|1276973|P1|STARTED|Open-label Treatment Phase||123
522532|NCT00877448|1276990|P7|NOT COMPLETED|Overall Study||0
522533|NCT00877448|1276991|P6|NOT COMPLETED|Overall Study||1
522534|NCT00877448|1276992|P5|NOT COMPLETED|Overall Study||0
522535|NCT00877448|1276993|P4|NOT COMPLETED|Overall Study||1
522536|NCT00877448|1276994|P3|NOT COMPLETED|Overall Study||0
522537|NCT00877448|1276995|P2|NOT COMPLETED|Overall Study||1
522538|NCT00877448|1276996|P1|NOT COMPLETED|Overall Study||0
522539|NCT00877448|1276990|P7|COMPLETED|Overall Study||3
522540|NCT00877448|1276991|P6|COMPLETED|Overall Study||9
522541|NCT00877448|1276992|P5|COMPLETED|Overall Study||10
522542|NCT00877448|1276993|P4|COMPLETED|Overall Study||9
522543|NCT00877448|1276994|P3|COMPLETED|Overall Study||10
522544|NCT00877448|1276995|P2|COMPLETED|Overall Study||9
522545|NCT00877448|1276996|P1|COMPLETED|Overall Study||10
522546|NCT00877448|1276990|P7|STARTED|Overall Study||3
522547|NCT00877448|1276991|P6|STARTED|Overall Study||10
522548|NCT00877448|1276992|P5|STARTED|Overall Study||10
522549|NCT00877448|1276993|P4|STARTED|Overall Study||10
522550|NCT00877448|1276994|P3|STARTED|Overall Study||10
522551|NCT00877448|1276995|P2|STARTED|Overall Study||10
522552|NCT00877448|1276996|P1|STARTED|Overall Study||10
522553|NCT00877383|1277021|P2|NOT COMPLETED|Overall Study||37
522554|NCT00877383|1277022|P1|NOT COMPLETED|Overall Study||29
522555|NCT00877383|1277021|P2|COMPLETED|Overall Study||533
522556|NCT00877383|1277022|P1|COMPLETED|Overall Study||543
522557|NCT00877383|1277021|P2|STARTED|Overall Study||570
522558|NCT00877383|1277022|P1|STARTED|Overall Study||572
522559|NCT00877370|1277038|P1|NOT COMPLETED|Overall Study||0
522560|NCT00877370|1277038|P1|COMPLETED|Overall Study||8
522561|NCT00877370|1277038|P1|STARTED|Overall Study||8
522562|NCT00877071|1277042|P1|NOT COMPLETED|Overall Study||2
522563|NCT00877071|1277042|P1|COMPLETED|Overall Study||0
522564|NCT00877071|1277042|P1|STARTED|Overall Study||2
522565|NCT00877058|1277052|P3|NOT COMPLETED|Overall Study||39
522566|NCT00877058|1277053|P2|NOT COMPLETED|Overall Study||40
522567|NCT00877058|1277054|P1|NOT COMPLETED|Overall Study||37
522568|NCT00877058|1277052|P3|COMPLETED|Overall Study||75
522569|NCT00877058|1277053|P2|COMPLETED|Overall Study||131
522570|NCT00877058|1277054|P1|COMPLETED|Overall Study||137
522571|NCT00877058|1277052|P3|STARTED|Overall Study||114
522572|NCT00877058|1277053|P2|STARTED|Overall Study||171
522573|NCT00877058|1277054|P1|STARTED|Overall Study||174
522574|NCT00877032|1277075|P7|NOT COMPLETED|Overall Study||2
522575|NCT00877032|1277076|P6|NOT COMPLETED|Overall Study||0
522576|NCT00877032|1277077|P5|NOT COMPLETED|Overall Study||0
522577|NCT00877032|1277078|P4|NOT COMPLETED|Overall Study||1
522578|NCT00877032|1277079|P3|NOT COMPLETED|Overall Study||0
522579|NCT00877032|1277080|P2|NOT COMPLETED|Overall Study||0
522580|NCT00877032|1277081|P1|NOT COMPLETED|Overall Study||0
522581|NCT00877032|1277075|P7|COMPLETED|Overall Study||18
522582|NCT00877032|1277076|P6|COMPLETED|Overall Study||6
522583|NCT00877032|1277077|P5|COMPLETED|Overall Study||6
522584|NCT00877032|1277078|P4|COMPLETED|Overall Study||6
522585|NCT00877032|1277079|P3|COMPLETED|Overall Study||6
522586|NCT00877032|1277080|P2|COMPLETED|Overall Study||6
522587|NCT00877032|1277081|P1|COMPLETED|Overall Study||6
522588|NCT00877032|1277075|P7|Treated|Overall Study||18
522590|NCT00877032|1277077|P5|Treated|Overall Study||6
522591|NCT00877032|1277078|P4|Treated|Overall Study||6
522592|NCT00877032|1277079|P3|Treated|Overall Study||6
522593|NCT00877032|1277080|P2|Treated|Overall Study||6
522594|NCT00877032|1277081|P1|Treated|Overall Study||6
522595|NCT00877032|1277075|P7|STARTED|Overall Study||20
522596|NCT00877032|1277076|P6|STARTED|Overall Study||6
522597|NCT00877032|1277077|P5|STARTED|Overall Study||6
522598|NCT00877032|1277078|P4|STARTED|Overall Study||7
522599|NCT00877032|1277079|P3|STARTED|Overall Study||6
522600|NCT00877032|1277080|P2|STARTED|Overall Study||6
522601|NCT00877032|1277081|P1|STARTED|Overall Study||6
522602|NCT00877006|1277182|P2|NOT COMPLETED|Long-Term Follow-up Period||55
522603|NCT00877006|1277183|P1|NOT COMPLETED|Long-Term Follow-up Period||53
522604|NCT00877006|1277182|P2|COMPLETED|Long-Term Follow-up Period||154
522605|NCT00877006|1277183|P1|COMPLETED|Long-Term Follow-up Period||157
522606|NCT00877006|1277182|P2|STARTED|Long-Term Follow-up Period||209
522607|NCT00877006|1277183|P1|STARTED|Long-Term Follow-up Period||210
522608|NCT00877006|1277182|P2|NOT COMPLETED|Treatment Period||27
522609|NCT00877006|1277183|P1|NOT COMPLETED|Treatment Period||25
522610|NCT00877006|1277182|P2|COMPLETED|Treatment Period||196
522611|NCT00877006|1277183|P1|COMPLETED|Treatment Period||199
522612|NCT00877006|1277182|P2|STARTED|Treatment Period||223
522613|NCT00877006|1277183|P1|STARTED|Treatment Period||224
522614|NCT00876928|1277223|P2|NOT COMPLETED|Overall Study||5
522615|NCT00876928|1277224|P1|NOT COMPLETED|Overall Study||3
522616|NCT00876928|1277223|P2|COMPLETED|Overall Study||56
522617|NCT00876928|1277224|P1|COMPLETED|Overall Study||53
522618|NCT00876928|1277223|P2|STARTED|Overall Study||61
522619|NCT00876928|1277224|P1|STARTED|Overall Study||56
522620|NCT00876915|1277235|P3|NOT COMPLETED|Overall Study||0
522621|NCT00876915|1277236|P2|NOT COMPLETED|Overall Study||14
522622|NCT00876915|1277237|P1|NOT COMPLETED|Overall Study||19
522623|NCT00876915|1277235|P3|COMPLETED|Overall Study||101
522624|NCT00876915|1277236|P2|COMPLETED|Overall Study||34
522625|NCT00876915|1277237|P1|COMPLETED|Overall Study||31
522626|NCT00876915|1277235|P3|Week 8|Overall Study||0
522627|NCT00876915|1277236|P2|Week 8|Overall Study||36
522628|NCT00876915|1277237|P1|Week 8|Overall Study||33
522629|NCT00876915|1277235|P3|Week 4|Overall Study||0
522630|NCT00876915|1277236|P2|Week 4|Overall Study||45
522631|NCT00876915|1277237|P1|Week 4|Overall Study||38
522632|NCT00876915|1277235|P3|STARTED|Overall Study||101
522633|NCT00876915|1277236|P2|STARTED|Overall Study||48
522634|NCT00876915|1277237|P1|STARTED|Overall Study||50
522635|NCT00876733|1277261|P4|NOT COMPLETED|Overall Study||7
522636|NCT00876733|1277262|P3|NOT COMPLETED|Overall Study||30
522637|NCT00876733|1277263|P2|NOT COMPLETED|Overall Study||42
522638|NCT00876733|1277264|P1|NOT COMPLETED|Overall Study||91
522639|NCT00876733|1277261|P4|COMPLETED|Overall Study||14
522640|NCT00876733|1277262|P3|COMPLETED|Overall Study||63
522641|NCT00876733|1277263|P2|COMPLETED|Overall Study||161
522642|NCT00876733|1277264|P1|COMPLETED|Overall Study||197
522643|NCT00876733|1277261|P4|STARTED|Overall Study||21
522644|NCT00876733|1277262|P3|STARTED|Overall Study||93
522645|NCT00876733|1277263|P2|STARTED|Overall Study||203
522646|NCT00876733|1277264|P1|STARTED|Overall Study||288
522647|NCT00876694|1277372|P2|NOT COMPLETED|Overall Study||12
522648|NCT00876694|1277373|P1|NOT COMPLETED|Overall Study||21
522649|NCT00876694|1277372|P2|COMPLETED|Overall Study||49
522650|NCT00876694|1277373|P1|COMPLETED|Overall Study||104
522651|NCT00876694|1277372|P2|STARTED|Overall Study||61
522652|NCT00876694|1277373|P1|STARTED|Overall Study||125
522653|NCT00876460|1277399|P8|NOT COMPLETED|Mono Therapy Phase||3
522654|NCT00876460|1277400|P7|NOT COMPLETED|Mono Therapy Phase||1
522655|NCT00876460|1277401|P6|NOT COMPLETED|Mono Therapy Phase||0
522656|NCT00876460|1277402|P5|NOT COMPLETED|Mono Therapy Phase||2
522657|NCT00876460|1277403|P4|NOT COMPLETED|Mono Therapy Phase||1
522658|NCT00876460|1277404|P3|NOT COMPLETED|Mono Therapy Phase||0
522659|NCT00876460|1277405|P2|NOT COMPLETED|Mono Therapy Phase||1
522660|NCT00876460|1277406|P1|NOT COMPLETED|Mono Therapy Phase||0
522661|NCT00876460|1277399|P8|COMPLETED|Mono Therapy Phase||0
522662|NCT00876460|1277400|P7|COMPLETED|Mono Therapy Phase||0
522663|NCT00876460|1277401|P6|COMPLETED|Mono Therapy Phase||0
522664|NCT00876460|1277402|P5|COMPLETED|Mono Therapy Phase||0
522665|NCT00876460|1277403|P4|COMPLETED|Mono Therapy Phase||0
522666|NCT00876460|1277404|P3|COMPLETED|Mono Therapy Phase||0
522667|NCT00876460|1277405|P2|COMPLETED|Mono Therapy Phase||0
522668|NCT00876460|1277406|P1|COMPLETED|Mono Therapy Phase||0
522669|NCT00876460|1277399|P8|STARTED|Mono Therapy Phase|Three patients started mono therapy phase after discontinued from combination therapy phase.|3
522670|NCT00876460|1277400|P7|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
522671|NCT00876460|1277401|P6|STARTED|Mono Therapy Phase||0
522672|NCT00876460|1277402|P5|STARTED|Mono Therapy Phase|Two patients started mono therapy phase after discontinued from combination therapy phase.|2
522673|NCT00876460|1277403|P4|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
522674|NCT00876460|1277404|P3|STARTED|Mono Therapy Phase||0
522675|NCT00876460|1277405|P2|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
522676|NCT00876460|1277406|P1|STARTED|Mono Therapy Phase||0
522677|NCT00876460|1277399|P8|NOT COMPLETED|Combination Therapy Phase||6
522678|NCT00876460|1277400|P7|NOT COMPLETED|Combination Therapy Phase||8
522679|NCT00876460|1277401|P6|NOT COMPLETED|Combination Therapy Phase||3
522680|NCT00876460|1277402|P5|NOT COMPLETED|Combination Therapy Phase||7
522681|NCT00876460|1277403|P4|NOT COMPLETED|Combination Therapy Phase||6
522682|NCT00876460|1277404|P3|NOT COMPLETED|Combination Therapy Phase||3
522683|NCT00876460|1277405|P2|NOT COMPLETED|Combination Therapy Phase||7
522684|NCT00876460|1277406|P1|NOT COMPLETED|Combination Therapy Phase||3
522685|NCT00876460|1277399|P8|COMPLETED|Combination Therapy Phase||0
522686|NCT00876460|1277400|P7|COMPLETED|Combination Therapy Phase||0
522687|NCT00876460|1277401|P6|COMPLETED|Combination Therapy Phase||0
522688|NCT00876460|1277402|P5|COMPLETED|Combination Therapy Phase||0
522689|NCT00876460|1277403|P4|COMPLETED|Combination Therapy Phase||0
522690|NCT00876460|1277404|P3|COMPLETED|Combination Therapy Phase||0
522691|NCT00876460|1277405|P2|COMPLETED|Combination Therapy Phase||0
522692|NCT00876460|1277406|P1|COMPLETED|Combination Therapy Phase||0
522693|NCT00876460|1277399|P8|STARTED|Combination Therapy Phase||6
522694|NCT00876460|1277400|P7|STARTED|Combination Therapy Phase||8
522695|NCT00876460|1277401|P6|STARTED|Combination Therapy Phase||3
522696|NCT00876460|1277402|P5|STARTED|Combination Therapy Phase||7
522697|NCT00876460|1277403|P4|STARTED|Combination Therapy Phase||6
522698|NCT00876460|1277404|P3|STARTED|Combination Therapy Phase||3
522699|NCT00876460|1277405|P2|STARTED|Combination Therapy Phase||7
522700|NCT00876460|1277406|P1|STARTED|Combination Therapy Phase||3
522701|NCT00876447|1277478|P2|NOT COMPLETED|Overall Study||81
522702|NCT00876447|1277479|P1|NOT COMPLETED|Overall Study||80
522703|NCT00876447|1277478|P2|COMPLETED|Overall Study||122
522704|NCT00876447|1277479|P1|COMPLETED|Overall Study||105
522705|NCT00876447|1277478|P2|STARTED|Overall Study||203
522706|NCT00876447|1277479|P1|STARTED|Overall Study||185
522707|NCT00876343|1277540|P3|NOT COMPLETED|Overall Study||12
522708|NCT00876343|1277541|P2|NOT COMPLETED|Overall Study||17
522709|NCT00876343|1277542|P1|NOT COMPLETED|Overall Study||17
522710|NCT00876343|1277540|P3|COMPLETED|Overall Study||183
522711|NCT00876343|1277541|P2|COMPLETED|Overall Study||180
522712|NCT00876343|1277542|P1|COMPLETED|Overall Study||177
522713|NCT00876343|1277540|P3|STARTED|Overall Study||195
522714|NCT00876343|1277541|P2|STARTED|Overall Study||197
522715|NCT00876343|1277542|P1|STARTED|Overall Study||194
522716|NCT00876265|1277556|P1|NOT COMPLETED|Overall Study||12
522717|NCT00876265|1277556|P1|COMPLETED|Overall Study||106
522718|NCT00876265|1277556|P1|STARTED|Overall Study||118
522719|NCT00876018|1277565|P3|NOT COMPLETED|Overall Study||3
522720|NCT00876018|1277566|P2|NOT COMPLETED|Overall Study||5
522721|NCT00876018|1277567|P1|NOT COMPLETED|Overall Study||5
522722|NCT00876018|1277565|P3|COMPLETED|Overall Study||97
522723|NCT00876018|1277566|P2|COMPLETED|Overall Study||95
522724|NCT00876018|1277567|P1|COMPLETED|Overall Study||95
522725|NCT00876018|1277565|P3|STARTED|Overall Study||100
522726|NCT00876018|1277566|P2|STARTED|Overall Study||100
522727|NCT00876018|1277567|P1|STARTED|Overall Study||100
522728|NCT00875979|1277622|P2|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||47
522729|NCT00875979|1277623|P1|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0
522730|NCT00875979|1277622|P2|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||11
522731|NCT00875979|1277623|P1|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0
522732|NCT00875979|1277622|P2|STARTED|Dose Expansion Phase - 3.6 mg/kg||58
522733|NCT00875979|1277623|P1|STARTED|Dose Expansion Phase - 3.6 mg/kg||0
522734|NCT00875979|1277622|P2|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||6
522735|NCT00875979|1277623|P1|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
522736|NCT00875979|1277622|P2|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
522737|NCT00875979|1277623|P1|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
522738|NCT00875979|1277622|P2|STARTED|Dose Escalation Phase - 3.6 mg/kg||6
522739|NCT00875979|1277623|P1|STARTED|Dose Escalation Phase - 3.6 mg/kg||0
522740|NCT00875979|1277622|P2|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
522741|NCT00875979|1277623|P1|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||3
522742|NCT00875979|1277622|P2|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
522743|NCT00875979|1277623|P1|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
522744|NCT00875979|1277622|P2|STARTED|Dose Escalation Phase - 3.0 mg/kg||0
522745|NCT00875979|1277623|P1|STARTED|Dose Escalation Phase - 3.0 mg/kg||3
522746|NCT00875836|1277635|P2|NOT COMPLETED|Overall Study||40
522747|NCT00875836|1277636|P1|NOT COMPLETED|Overall Study||43
522748|NCT00875836|1277635|P2|COMPLETED|Overall Study||47
522749|NCT00875836|1277636|P1|COMPLETED|Overall Study||45
522750|NCT00875836|1277635|P2|STARTED|Overall Study||87
522751|NCT00875836|1277636|P1|STARTED|Overall Study||88
522752|NCT00875810|1277646|P1|NOT COMPLETED|Overall Study||46
522753|NCT00875810|1277646|P1|COMPLETED|Overall Study||148
522754|NCT00875810|1277646|P1|24 Months Follow up|Overall Study||148
522755|NCT00875810|1277646|P1|12 Months Follow up|Overall Study||112
522756|NCT00875810|1277646|P1|6 Months Follow up|Overall Study||80
522757|NCT00875810|1277646|P1|3 Months Follow up|Overall Study||175
522758|NCT00875810|1277646|P1|Discharged|Overall Study||177
522759|NCT00875810|1277646|P1|Implanted|Overall Study||190
522760|NCT00875810|1277646|P1|STARTED|Overall Study||194
522761|NCT00875797|1277655|P2|NOT COMPLETED|Overall Study||3
522762|NCT00875797|1277656|P1|NOT COMPLETED|Overall Study||6
522763|NCT00875797|1277655|P2|COMPLETED|Overall Study||42
522764|NCT00875797|1277656|P1|COMPLETED|Overall Study||39
522765|NCT00875797|1277655|P2|STARTED|Overall Study||45
522766|NCT00875797|1277656|P1|STARTED|Overall Study||45
522767|NCT00875706|1277669|P3|NOT COMPLETED|Overall Study||0
522768|NCT00875706|1277670|P2|NOT COMPLETED|Overall Study||0
522769|NCT00875706|1277671|P1|NOT COMPLETED|Overall Study||1
522770|NCT00875706|1277669|P3|COMPLETED|Overall Study||13
522771|NCT00875706|1277670|P2|COMPLETED|Overall Study||24
522772|NCT00875706|1277671|P1|COMPLETED|Overall Study||7
522773|NCT00875706|1277669|P3|STARTED|Overall Study||13
522774|NCT00875706|1277670|P2|STARTED|Overall Study||24
522775|NCT00875706|1277671|P1|STARTED|Overall Study||8
522776|NCT00875615|1277688|P1|NOT COMPLETED|Overall Study||1
522777|NCT00875615|1277688|P1|COMPLETED|Overall Study||10
522778|NCT00875615|1277688|P1|STARTED|Overall Study||11
522779|NCT00875589|1277695|P2|NOT COMPLETED|Overall Study||0
522780|NCT00875589|1277696|P1|NOT COMPLETED|Overall Study||0
522781|NCT00875589|1277695|P2|COMPLETED|Overall Study||11
522782|NCT00875589|1277696|P1|COMPLETED|Overall Study||15
522783|NCT00875589|1277695|P2|STARTED|Overall Study||11
522784|NCT00875589|1277696|P1|STARTED|Overall Study||15
522785|NCT00875563|1277702|P1|NOT COMPLETED|Overall Study||24
522786|NCT00875563|1277702|P1|COMPLETED|Overall Study||18
522787|NCT00875563|1277702|P1|STARTED|Overall Study||42
522788|NCT00875550|1277708|P2|NOT COMPLETED|Overall Study||10
522789|NCT00875550|1277709|P1|NOT COMPLETED|Overall Study||12
522790|NCT00875550|1277708|P2|COMPLETED|Overall Study||76
522791|NCT00875550|1277709|P1|COMPLETED|Overall Study||77
522792|NCT00875550|1277708|P2|STARTED|Overall Study||86
522793|NCT00875550|1277709|P1|STARTED|Overall Study||89
522794|NCT00875485|1277727|P2|NOT COMPLETED|Challenge Dose Epoch||0
522795|NCT00875485|1277728|P1|NOT COMPLETED|Challenge Dose Epoch||1
522796|NCT00875485|1277727|P2|COMPLETED|Challenge Dose Epoch||11
522797|NCT00875485|1277728|P1|COMPLETED|Challenge Dose Epoch||7
522798|NCT00875485|1277727|P2|STARTED|Challenge Dose Epoch||11
522799|NCT00875485|1277728|P1|STARTED|Challenge Dose Epoch||8
522800|NCT00875485|1277727|P2|NOT COMPLETED|Year 15||0
522801|NCT00875485|1277728|P1|NOT COMPLETED|Year 15||0
522802|NCT00875485|1277727|P2|COMPLETED|Year 15||111
522803|NCT00875485|1277728|P1|COMPLETED|Year 15||98
522804|NCT00875485|1277727|P2|STARTED|Year 15||111
522805|NCT00875485|1277728|P1|STARTED|Year 15||98
522806|NCT00875485|1277727|P2|NOT COMPLETED|Year 14||0
522807|NCT00875485|1277728|P1|NOT COMPLETED|Year 14||0
522808|NCT00875485|1277727|P2|COMPLETED|Year 14||113
522809|NCT00875485|1277728|P1|COMPLETED|Year 14||100
522810|NCT00875485|1277727|P2|STARTED|Year 14||113
522811|NCT00875485|1277728|P1|STARTED|Year 14||100
522812|NCT00875485|1277727|P2|NOT COMPLETED|Year 13||0
522813|NCT00875485|1277728|P1|NOT COMPLETED|Year 13||0
522814|NCT00875485|1277727|P2|COMPLETED|Year 13||113
522815|NCT00875485|1277728|P1|COMPLETED|Year 13||102
522816|NCT00875485|1277727|P2|STARTED|Year 13||113
522817|NCT00875485|1277728|P1|STARTED|Year 13||102
522818|NCT00875485|1277727|P2|NOT COMPLETED|Year 12||0
522819|NCT00875485|1277728|P1|NOT COMPLETED|Year 12||0
522820|NCT00875485|1277727|P2|COMPLETED|Year 12||109
522821|NCT00875485|1277728|P1|COMPLETED|Year 12||101
522822|NCT00875485|1277727|P2|STARTED|Year 12||109
522823|NCT00875485|1277728|P1|STARTED|Year 12||101
522824|NCT00875485|1277727|P2|NOT COMPLETED|Year 11||0
522825|NCT00875485|1277728|P1|NOT COMPLETED|Year 11||0
522826|NCT00875485|1277727|P2|COMPLETED|Year 11||111
522827|NCT00875485|1277728|P1|COMPLETED|Year 11||99
522828|NCT00875485|1277727|P2|STARTED|Year 11||111
522829|NCT00875485|1277728|P1|STARTED|Year 11||99
522830|NCT00875433|1277768|P1|NOT COMPLETED|Overall Study||60
522831|NCT00875433|1277768|P1|COMPLETED|Overall Study||0
522832|NCT00875433|1277768|P1|STARTED|Overall Study|Treated|60
522833|NCT00875420|1277798|P5|NOT COMPLETED|Overall Study||2
522834|NCT00875420|1277799|P4|NOT COMPLETED|Overall Study||2
522835|NCT00875420|1277800|P3|NOT COMPLETED|Overall Study||3
522836|NCT00875420|1277801|P2|NOT COMPLETED|Overall Study||2
522837|NCT00875420|1277802|P1|NOT COMPLETED|Overall Study||2
522838|NCT00875420|1277798|P5|COMPLETED|Overall Study||17
522839|NCT00875420|1277799|P4|COMPLETED|Overall Study||16
522840|NCT00875420|1277800|P3|COMPLETED|Overall Study||18
522841|NCT00875420|1277801|P2|COMPLETED|Overall Study||18
522842|NCT00875420|1277802|P1|COMPLETED|Overall Study||20
522843|NCT00875420|1277798|P5|STARTED|Overall Study||19
522844|NCT00875420|1277799|P4|STARTED|Overall Study||18
522845|NCT00875420|1277800|P3|STARTED|Overall Study||21
522846|NCT00875420|1277801|P2|STARTED|Overall Study||20
522847|NCT00875420|1277802|P1|STARTED|Overall Study||22
522848|NCT00875394|1277832|P3|NOT COMPLETED|Overall Study||0
522849|NCT00875394|1277833|P2|NOT COMPLETED|Overall Study||0
522850|NCT00875394|1277834|P1|NOT COMPLETED|Overall Study||0
522851|NCT00875394|1277832|P3|COMPLETED|Overall Study||9
522852|NCT00875394|1277833|P2|COMPLETED|Overall Study||23
522853|NCT00875394|1277834|P1|COMPLETED|Overall Study||36
522854|NCT00875394|1277832|P3|STARTED|Overall Study||9
522855|NCT00875394|1277833|P2|STARTED|Overall Study||23
522856|NCT00875394|1277834|P1|STARTED|Overall Study||36
522857|NCT00875329|1277842|P1|NOT COMPLETED|Overall Study||0
522858|NCT00875329|1277842|P1|COMPLETED|Overall Study||97
522859|NCT00875329|1277842|P1|STARTED|Overall Study||97
522860|NCT00875212|1277846|P1|NOT COMPLETED|CaGP and Fluoride Dentifrice||0
522861|NCT00875212|1277846|P1|COMPLETED|CaGP and Fluoride Dentifrice||12
522862|NCT00875212|1277846|P1|STARTED|CaGP and Fluoride Dentifrice||12
522863|NCT00875212|1277846|P1|NOT COMPLETED|Fluoride Only Dentifrice||0
522864|NCT00875212|1277846|P1|COMPLETED|Fluoride Only Dentifrice||12
522865|NCT00875212|1277846|P1|STARTED|Fluoride Only Dentifrice||12
522866|NCT00875212|1277846|P1|NOT COMPLETED|CaGP Only Dentifrice||0
522867|NCT00875212|1277846|P1|COMPLETED|CaGP Only Dentifrice||12
522868|NCT00875212|1277846|P1|STARTED|CaGP Only Dentifrice||12
522869|NCT00875212|1277846|P1|NOT COMPLETED|Placebo Dentifrice||0
522870|NCT00875212|1277846|P1|COMPLETED|Placebo Dentifrice|all participants completed this group|12
522871|NCT00875212|1277846|P1|STARTED|Placebo Dentifrice||12
522872|NCT00875017|1277863|P6|NOT COMPLETED|Fourth Intervention||1
522873|NCT00875017|1277864|P5|NOT COMPLETED|Fourth Intervention||0
522874|NCT00875017|1277865|P4|NOT COMPLETED|Fourth Intervention||0
522875|NCT00875017|1277866|P3|NOT COMPLETED|Fourth Intervention||0
522876|NCT00875017|1277867|P2|NOT COMPLETED|Fourth Intervention||0
522877|NCT00875017|1277868|P1|NOT COMPLETED|Fourth Intervention||0
522878|NCT00875017|1277863|P6|COMPLETED|Fourth Intervention||4
522879|NCT00875017|1277864|P5|COMPLETED|Fourth Intervention||3
522880|NCT00875017|1277865|P4|COMPLETED|Fourth Intervention||4
522881|NCT00875017|1277866|P3|COMPLETED|Fourth Intervention||2
522882|NCT00875017|1277867|P2|COMPLETED|Fourth Intervention||3
522883|NCT00875017|1277868|P1|COMPLETED|Fourth Intervention||3
522884|NCT00875017|1277863|P6|STARTED|Fourth Intervention||5
522885|NCT00875017|1277864|P5|STARTED|Fourth Intervention||3
522886|NCT00875017|1277865|P4|STARTED|Fourth Intervention||4
522887|NCT00875017|1277866|P3|STARTED|Fourth Intervention||2
522888|NCT00875017|1277867|P2|STARTED|Fourth Intervention||3
522889|NCT00875017|1277868|P1|STARTED|Fourth Intervention||3
522890|NCT00875017|1277863|P6|NOT COMPLETED|Washout||0
522891|NCT00875017|1277864|P5|NOT COMPLETED|Washout||1
522892|NCT00875017|1277865|P4|NOT COMPLETED|Washout||0
522893|NCT00875017|1277866|P3|NOT COMPLETED|Washout||0
522894|NCT00875017|1277867|P2|NOT COMPLETED|Washout||0
522895|NCT00875017|1277868|P1|NOT COMPLETED|Washout||0
522896|NCT00875017|1277863|P6|COMPLETED|Washout||5
522897|NCT00875017|1277864|P5|COMPLETED|Washout||3
522898|NCT00875017|1277865|P4|COMPLETED|Washout||4
522899|NCT00875017|1277866|P3|COMPLETED|Washout||2
522900|NCT00875017|1277867|P2|COMPLETED|Washout||3
522901|NCT00875017|1277868|P1|COMPLETED|Washout||3
522902|NCT00875017|1277863|P6|STARTED|Washout||5
522903|NCT00875017|1277864|P5|STARTED|Washout||4
522904|NCT00875017|1277865|P4|STARTED|Washout||4
522905|NCT00875017|1277866|P3|STARTED|Washout||2
522906|NCT00875017|1277867|P2|STARTED|Washout||3
522907|NCT00875017|1277868|P1|STARTED|Washout||3
522908|NCT00875017|1277863|P6|NOT COMPLETED|Third Intervention||0
522909|NCT00875017|1277864|P5|NOT COMPLETED|Third Intervention||0
522910|NCT00875017|1277865|P4|NOT COMPLETED|Third Intervention||0
522911|NCT00875017|1277866|P3|NOT COMPLETED|Third Intervention||1
522912|NCT00875017|1277867|P2|NOT COMPLETED|Third Intervention||1
522913|NCT00875017|1277868|P1|NOT COMPLETED|Third Intervention||0
522914|NCT00875017|1277863|P6|COMPLETED|Third Intervention||5
522915|NCT00875017|1277864|P5|COMPLETED|Third Intervention||4
522916|NCT00875017|1277865|P4|COMPLETED|Third Intervention||4
522917|NCT00875017|1277866|P3|COMPLETED|Third Intervention||2
522918|NCT00875017|1277867|P2|COMPLETED|Third Intervention||3
522919|NCT00875017|1277868|P1|COMPLETED|Third Intervention||3
522920|NCT00875017|1277863|P6|STARTED|Third Intervention||5
522921|NCT00875017|1277864|P5|STARTED|Third Intervention||4
522922|NCT00875017|1277865|P4|STARTED|Third Intervention||4
522923|NCT00875017|1277866|P3|STARTED|Third Intervention||3
522924|NCT00875017|1277867|P2|STARTED|Third Intervention||4
522925|NCT00875017|1277868|P1|STARTED|Third Intervention||3
522926|NCT00875017|1277863|P6|NOT COMPLETED|Washout||0
522927|NCT00875017|1277864|P5|NOT COMPLETED|Washout||0
522928|NCT00875017|1277865|P4|NOT COMPLETED|Washout||0
522929|NCT00875017|1277866|P3|NOT COMPLETED|Washout||0
522930|NCT00875017|1277867|P2|NOT COMPLETED|Washout||1
522931|NCT00875017|1277868|P1|NOT COMPLETED|Washout||0
522932|NCT00875017|1277863|P6|COMPLETED|Washout||5
522933|NCT00875017|1277864|P5|COMPLETED|Washout||4
522934|NCT00875017|1277865|P4|COMPLETED|Washout||4
522935|NCT00875017|1277866|P3|COMPLETED|Washout||3
522936|NCT00875017|1277867|P2|COMPLETED|Washout||4
522937|NCT00875017|1277868|P1|COMPLETED|Washout||3
522938|NCT00875017|1277863|P6|STARTED|Washout||5
522939|NCT00875017|1277864|P5|STARTED|Washout||4
522940|NCT00875017|1277865|P4|STARTED|Washout||4
522941|NCT00875017|1277866|P3|STARTED|Washout||3
522942|NCT00875017|1277867|P2|STARTED|Washout||5
522943|NCT00875017|1277868|P1|STARTED|Washout||3
522944|NCT00875017|1277863|P6|NOT COMPLETED|Second Intervention||0
522945|NCT00875017|1277864|P5|NOT COMPLETED|Second Intervention||0
522946|NCT00875017|1277865|P4|NOT COMPLETED|Second Intervention||1
522947|NCT00875017|1277866|P3|NOT COMPLETED|Second Intervention||0
522948|NCT00875017|1277867|P2|NOT COMPLETED|Second Intervention||0
522949|NCT00875017|1277868|P1|NOT COMPLETED|Second Intervention||0
522950|NCT00875017|1277863|P6|COMPLETED|Second Intervention||5
522951|NCT00875017|1277864|P5|COMPLETED|Second Intervention||4
522952|NCT00875017|1277865|P4|COMPLETED|Second Intervention||4
522953|NCT00875017|1277866|P3|COMPLETED|Second Intervention||3
522954|NCT00875017|1277867|P2|COMPLETED|Second Intervention||5
522955|NCT00875017|1277868|P1|COMPLETED|Second Intervention||3
522956|NCT00875017|1277863|P6|STARTED|Second Intervention||5
522957|NCT00875017|1277864|P5|STARTED|Second Intervention||4
522958|NCT00875017|1277865|P4|STARTED|Second Intervention||5
522959|NCT00875017|1277866|P3|STARTED|Second Intervention||3
522960|NCT00875017|1277867|P2|STARTED|Second Intervention||5
522961|NCT00875017|1277868|P1|STARTED|Second Intervention||3
522962|NCT00875017|1277863|P6|NOT COMPLETED|Washout||0
522963|NCT00875017|1277864|P5|NOT COMPLETED|Washout||0
522964|NCT00875017|1277865|P4|NOT COMPLETED|Washout||0
522965|NCT00875017|1277866|P3|NOT COMPLETED|Washout||1
522966|NCT00875017|1277867|P2|NOT COMPLETED|Washout||0
522967|NCT00875017|1277868|P1|NOT COMPLETED|Washout||0
522968|NCT00875017|1277863|P6|COMPLETED|Washout||5
522969|NCT00875017|1277864|P5|COMPLETED|Washout||4
522970|NCT00875017|1277865|P4|COMPLETED|Washout||5
522971|NCT00875017|1277866|P3|COMPLETED|Washout||3
522972|NCT00875017|1277867|P2|COMPLETED|Washout||5
522973|NCT00875017|1277868|P1|COMPLETED|Washout||3
522974|NCT00875017|1277863|P6|STARTED|Washout||5
522975|NCT00875017|1277864|P5|STARTED|Washout||4
522976|NCT00875017|1277865|P4|STARTED|Washout||5
522977|NCT00875017|1277866|P3|STARTED|Washout||4
522978|NCT00875017|1277867|P2|STARTED|Washout||5
522979|NCT00875017|1277868|P1|STARTED|Washout||3
522980|NCT00875017|1277863|P6|NOT COMPLETED|First Intervention||0
522981|NCT00875017|1277864|P5|NOT COMPLETED|First Intervention||1
522982|NCT00875017|1277865|P4|NOT COMPLETED|First Intervention||1
522983|NCT00875017|1277866|P3|NOT COMPLETED|First Intervention||1
522984|NCT00875017|1277867|P2|NOT COMPLETED|First Intervention||0
522985|NCT00875017|1277868|P1|NOT COMPLETED|First Intervention||2
522986|NCT00875017|1277863|P6|COMPLETED|First Intervention||5
522987|NCT00875017|1277864|P5|COMPLETED|First Intervention||4
522988|NCT00875017|1277865|P4|COMPLETED|First Intervention||5
522989|NCT00875017|1277866|P3|COMPLETED|First Intervention||4
522990|NCT00875017|1277867|P2|COMPLETED|First Intervention||5
522991|NCT00875017|1277868|P1|COMPLETED|First Intervention||3
522992|NCT00875017|1277863|P6|STARTED|First Intervention||5
522993|NCT00875017|1277864|P5|STARTED|First Intervention||5
522994|NCT00875017|1277865|P4|STARTED|First Intervention||6
522995|NCT00875017|1277866|P3|STARTED|First Intervention||5
522996|NCT00875017|1277867|P2|STARTED|First Intervention||5
522997|NCT00875017|1277868|P1|STARTED|First Intervention||5
522998|NCT00874939|1277882|P1|NOT COMPLETED|Overall Study||4
522999|NCT00874939|1277882|P1|COMPLETED|Overall Study||0
523000|NCT00874939|1277882|P1|Treated|Overall Study||0
523001|NCT00874939|1277882|P1|STARTED|Overall Study||4
523002|NCT00874887|1277898|P2|NOT COMPLETED|Overall Study||0
523003|NCT00874887|1277899|P1|NOT COMPLETED|Overall Study||0
523004|NCT00874887|1277898|P2|COMPLETED|Overall Study||34
523005|NCT00874887|1277899|P1|COMPLETED|Overall Study||32
523006|NCT00874887|1277898|P2|STARTED|Overall Study||34
523007|NCT00874887|1277899|P1|STARTED|Overall Study||32
523008|NCT00874848|1277915|P2|NOT COMPLETED|Overall Study||28
523009|NCT00874848|1277916|P1|NOT COMPLETED|Overall Study||59
523010|NCT00874848|1277915|P2|COMPLETED|Overall Study|Pts who completed 18 tx cycles without progressive disease were defined as completing treatment.|1
523011|NCT00874848|1277916|P1|COMPLETED|Overall Study|Pts who completed 18 tx cycles without progressive disease were defined as completing treatment.|0
523012|NCT00874848|1277915|P2|Discontinued|Overall Study||28
523013|NCT00874848|1277916|P1|Discontinued|Overall Study||59
523014|NCT00874848|1277915|P2|STARTED|Overall Study||29
523015|NCT00874848|1277916|P1|STARTED|Overall Study||59
523016|NCT00874822|1277932|P1|NOT COMPLETED|Overall Study||8
523017|NCT00874822|1277932|P1|COMPLETED|Overall Study||208
523018|NCT00874822|1277932|P1|STARTED|Overall Study||216
523019|NCT00874770|1277940|P4|NOT COMPLETED|Overall Study||5
523020|NCT00874770|1277941|P3|NOT COMPLETED|Overall Study||4
523021|NCT00874770|1277942|P2|NOT COMPLETED|Overall Study||1
523022|NCT00874770|1277943|P1|NOT COMPLETED|Overall Study||5
523023|NCT00874770|1277940|P4|COMPLETED|Overall Study||7
523024|NCT00874770|1277941|P3|COMPLETED|Overall Study||8
523025|NCT00874770|1277942|P2|COMPLETED|Overall Study||11
523026|NCT00874770|1277943|P1|COMPLETED|Overall Study||7
523027|NCT00874770|1277940|P4|STARTED|Overall Study||12
523028|NCT00874770|1277941|P3|STARTED|Overall Study||12
523029|NCT00874770|1277942|P2|STARTED|Overall Study||12
523030|NCT00874770|1277943|P1|STARTED|Overall Study||12
523031|NCT00874549|1277981|P4|NOT COMPLETED|Overall Study||2
523032|NCT00874549|1277982|P3|NOT COMPLETED|Overall Study||4
523033|NCT00874549|1277983|P2|NOT COMPLETED|Overall Study||1
523034|NCT00874549|1277984|P1|NOT COMPLETED|Overall Study||1
523035|NCT00874549|1277981|P4|COMPLETED|Overall Study||56
523036|NCT00874549|1277982|P3|COMPLETED|Overall Study||47
523037|NCT00874549|1277983|P2|COMPLETED|Overall Study||55
523038|NCT00874549|1277984|P1|COMPLETED|Overall Study||50
523039|NCT00874549|1277981|P4|STARTED|Overall Study||58
523040|NCT00874549|1277982|P3|STARTED|Overall Study||51
523041|NCT00874549|1277983|P2|STARTED|Overall Study||56
523042|NCT00874549|1277984|P1|STARTED|Overall Study||51
523043|NCT00874510|1278052|P2|NOT COMPLETED|Year 2||0
523044|NCT00874510|1278053|P1|NOT COMPLETED|Year 2||0
523045|NCT00874510|1278052|P2|COMPLETED|Year 2||87
523046|NCT00874510|1278053|P1|COMPLETED|Year 2||92
523047|NCT00874510|1278052|P2|STARTED|Year 2||87
523048|NCT00874510|1278053|P1|STARTED|Year 2||92
523049|NCT00874510|1278052|P2|NOT COMPLETED|Year 1||0
523050|NCT00874510|1278053|P1|NOT COMPLETED|Year 1||0
523051|NCT00874510|1278052|P2|COMPLETED|Year 1||85
523052|NCT00874510|1278053|P1|COMPLETED|Year 1||88
523053|NCT00874510|1278052|P2|STARTED|Year 1||85
523054|NCT00874510|1278053|P1|STARTED|Year 1||88
523055|NCT00874497|1278061|P2|NOT COMPLETED|Overall Study||18
523056|NCT00874497|1278062|P1|NOT COMPLETED|Overall Study||28
523057|NCT00874497|1278061|P2|COMPLETED|Overall Study||15
523058|NCT00874497|1278062|P1|COMPLETED|Overall Study||23
523059|NCT00874497|1278061|P2|STARTED|Overall Study|This is the number of participants who were treated and were considered as safety population.|33
523060|NCT00874497|1278062|P1|STARTED|Overall Study|This is the number of participants who were treated and were considered as safety population.|51
523061|NCT00874276|1278102|P2|NOT COMPLETED|Overall Study||1
523062|NCT00874276|1278103|P1|NOT COMPLETED|Overall Study||1
523063|NCT00874276|1278102|P2|COMPLETED|Overall Study||7
523064|NCT00874276|1278103|P1|COMPLETED|Overall Study||5
523065|NCT00874276|1278102|P2|STARTED|Overall Study||8
523066|NCT00874276|1278103|P1|STARTED|Overall Study||6
523067|NCT00874250|1278111|P1|NOT COMPLETED|Overall Study||51
523068|NCT00874250|1278111|P1|COMPLETED|Overall Study||0
523069|NCT00874250|1278111|P1|STARTED|Overall Study||51
523070|NCT00874120|1278125|P2|NOT COMPLETED|Second Intervention||0
523071|NCT00874120|1278126|P1|NOT COMPLETED|Second Intervention||2
523072|NCT00874120|1278125|P2|COMPLETED|Second Intervention||56
523073|NCT00874120|1278126|P1|COMPLETED|Second Intervention||50
523074|NCT00874120|1278125|P2|STARTED|Second Intervention||56
523075|NCT00874120|1278126|P1|STARTED|Second Intervention||52
523076|NCT00874120|1278125|P2|NOT COMPLETED|Wash-out Period||0
523077|NCT00874120|1278126|P1|NOT COMPLETED|Wash-out Period||0
523078|NCT00874120|1278125|P2|COMPLETED|Wash-out Period||56
523079|NCT00874120|1278126|P1|COMPLETED|Wash-out Period||52
523080|NCT00874120|1278125|P2|STARTED|Wash-out Period||56
523081|NCT00874120|1278126|P1|STARTED|Wash-out Period||52
523082|NCT00874120|1278125|P2|NOT COMPLETED|First Intervention||2
523083|NCT00874120|1278126|P1|NOT COMPLETED|First Intervention||6
523084|NCT00874120|1278125|P2|COMPLETED|First Intervention||56
523085|NCT00874120|1278126|P1|COMPLETED|First Intervention||52
523086|NCT00874120|1278125|P2|STARTED|First Intervention||58
523087|NCT00874120|1278126|P1|STARTED|First Intervention||58
523088|NCT00874094|1278132|P1|NOT COMPLETED|Overall Study||0
523089|NCT00874094|1278132|P1|COMPLETED|Overall Study||15
523090|NCT00874094|1278132|P1|STARTED|Overall Study||15
523091|NCT00874029|1278139|P1|NOT COMPLETED|Overall Study||21
523092|NCT00874029|1278139|P1|COMPLETED|Overall Study||116
523093|NCT00874029|1278139|P1|STARTED|Overall Study||137
523094|NCT00873912|1278155|P2|NOT COMPLETED|Overall Study||0
523095|NCT00873912|1278156|P1|NOT COMPLETED|Overall Study||3
523096|NCT00873912|1278155|P2|COMPLETED|Overall Study||60
523097|NCT00873912|1278156|P1|COMPLETED|Overall Study||237
523098|NCT00873912|1278155|P2|STARTED|Overall Study||60
523099|NCT00873912|1278156|P1|STARTED|Overall Study||240
523100|NCT00873873|1278174|P4|NOT COMPLETED|Overall Study||0
523101|NCT00873873|1278175|P3|NOT COMPLETED|Overall Study||0
523102|NCT00873873|1278176|P2|NOT COMPLETED|Overall Study||0
523103|NCT00873873|1278177|P1|NOT COMPLETED|Overall Study||0
523104|NCT00873873|1278174|P4|COMPLETED|Overall Study||18
523105|NCT00873873|1278175|P3|COMPLETED|Overall Study||9
523106|NCT00873873|1278176|P2|COMPLETED|Overall Study||8
523107|NCT00873873|1278177|P1|COMPLETED|Overall Study||20
523108|NCT00873873|1278174|P4|STARTED|Overall Study||18
523109|NCT00873873|1278175|P3|STARTED|Overall Study||9
523110|NCT00873873|1278176|P2|STARTED|Overall Study||8
523111|NCT00873873|1278177|P1|STARTED|Overall Study||20
523112|NCT00873860|1278195|P4|NOT COMPLETED|Overall Study||1
523113|NCT00873860|1278196|P3|NOT COMPLETED|Overall Study||3
523114|NCT00873860|1278197|P2|NOT COMPLETED|Overall Study||0
523115|NCT00873860|1278198|P1|NOT COMPLETED|Overall Study||4
523116|NCT00873860|1278195|P4|COMPLETED|Overall Study||47
523117|NCT00873860|1278196|P3|COMPLETED|Overall Study||48
523118|NCT00873860|1278197|P2|COMPLETED|Overall Study||47
523119|NCT00873860|1278198|P1|COMPLETED|Overall Study||44
523120|NCT00873860|1278195|P4|Treated|Overall Study||48
523121|NCT00873860|1278196|P3|Treated|Overall Study||51
523122|NCT00873860|1278197|P2|Treated|Overall Study||47
523123|NCT00873860|1278198|P1|Treated|Overall Study||47
523124|NCT00873860|1278195|P4|STARTED|Overall Study||48
523125|NCT00873860|1278196|P3|STARTED|Overall Study||51
523126|NCT00873860|1278197|P2|STARTED|Overall Study||47
523127|NCT00873860|1278198|P1|STARTED|Overall Study||48
523128|NCT00873821|1278269|P2|NOT COMPLETED|Overall Study||0
523129|NCT00873821|1278270|P1|NOT COMPLETED|Overall Study||0
523130|NCT00873821|1278269|P2|COMPLETED|Overall Study||22
523131|NCT00873821|1278270|P1|COMPLETED|Overall Study||22
523132|NCT00873821|1278269|P2|STARTED|Overall Study||22
523133|NCT00873821|1278270|P1|STARTED|Overall Study||22
523134|NCT00873782|1278280|P1|NOT COMPLETED|Overall Study||0
523135|NCT00873782|1278280|P1|COMPLETED|Overall Study||16
523136|NCT00873782|1278280|P1|STARTED|Overall Study||16
523137|NCT00873730|1278286|P2|NOT COMPLETED|Overall Study||5
523138|NCT00873730|1278287|P1|NOT COMPLETED|Overall Study||6
523139|NCT00873730|1278286|P2|COMPLETED|Overall Study||49
523140|NCT00873730|1278287|P1|COMPLETED|Overall Study||48
523141|NCT00873730|1278286|P2|STARTED|Overall Study||54
523142|NCT00873730|1278287|P1|STARTED|Overall Study||54
523143|NCT00873457|1278323|P1|NOT COMPLETED|Overall Study||0
523144|NCT00873457|1278323|P1|COMPLETED|Overall Study||16
523145|NCT00873457|1278323|P1|STARTED|Overall Study||16
523146|NCT00873366|1278330|P1|NOT COMPLETED|Overall Study||6
523147|NCT00873366|1278330|P1|COMPLETED|Overall Study||71
523148|NCT00873366|1278330|P1|STARTED|Overall Study||77
523149|NCT00873327|1278349|P1|NOT COMPLETED|Overall Study||0
523150|NCT00873327|1278349|P1|COMPLETED|Overall Study||32
523151|NCT00873327|1278349|P1|STARTED|Overall Study||32
523152|NCT00873119|1278355|P2|NOT COMPLETED|Overall Study||26
523153|NCT00873119|1278356|P1|NOT COMPLETED|Overall Study||44
523154|NCT00873119|1278355|P2|COMPLETED|Overall Study||19
523155|NCT00873119|1278356|P1|COMPLETED|Overall Study|Of 42 patients treated with belinostat, 23 patients received 6 or more treatment cycles.|0
523156|NCT00873119|1278355|P2|STARTED|Overall Study||45
523157|NCT00873119|1278356|P1|STARTED|Overall Study||44
523158|NCT00873093|1278377|P5|NOT COMPLETED|Overall Study||2
523159|NCT00873093|1278378|P4|NOT COMPLETED|Overall Study||11
523160|NCT00873093|1278379|P3|NOT COMPLETED|Overall Study||16
523161|NCT00873093|1278380|P2|NOT COMPLETED|Overall Study||27
523162|NCT00873093|1278381|P1|NOT COMPLETED|Overall Study||1
523163|NCT00873093|1278377|P5|COMPLETED|Overall Study||8
523164|NCT00873093|1278378|P4|COMPLETED|Overall Study||12
523165|NCT00873093|1278379|P3|COMPLETED|Overall Study||33
523166|NCT00873093|1278380|P2|COMPLETED|Overall Study||35
523167|NCT00873093|1278381|P1|COMPLETED|Overall Study||3
523168|NCT00873093|1278377|P5|STARTED|Overall Study||10
523169|NCT00873093|1278378|P4|STARTED|Overall Study||23
523170|NCT00873093|1278379|P3|STARTED|Overall Study||49
523171|NCT00873093|1278380|P2|STARTED|Overall Study||62
523172|NCT00873093|1278381|P1|STARTED|Overall Study||4
523173|NCT00873041|1278438|P3|NOT COMPLETED|Extension Study||2
523174|NCT00873041|1278439|P2|NOT COMPLETED|Extension Study||0
523175|NCT00873041|1278440|P1|NOT COMPLETED|Extension Study||1
523176|NCT00873041|1278438|P3|COMPLETED|Extension Study||46
523177|NCT00873041|1278439|P2|COMPLETED|Extension Study||44
523178|NCT00873041|1278440|P1|COMPLETED|Extension Study||40
523179|NCT00873041|1278438|P3|STARTED|Extension Study||48
523180|NCT00873041|1278439|P2|STARTED|Extension Study||44
523181|NCT00873041|1278440|P1|STARTED|Extension Study||41
523182|NCT00873041|1278438|P3|NOT COMPLETED|Core Study||5
523183|NCT00873041|1278439|P2|NOT COMPLETED|Core Study||6
523184|NCT00873041|1278440|P1|NOT COMPLETED|Core Study||7
523185|NCT00873041|1278438|P3|COMPLETED|Core Study||51
523186|NCT00873041|1278439|P2|COMPLETED|Core Study||49
523187|NCT00873041|1278440|P1|COMPLETED|Core Study||48
523188|NCT00873041|1278438|P3|STARTED|Core Study||56
523189|NCT00873041|1278439|P2|STARTED|Core Study||55
523190|NCT00873041|1278440|P1|STARTED|Core Study||55
523191|NCT00873015|1278498|P4|NOT COMPLETED|Overall Study||0
523192|NCT00873015|1278499|P3|NOT COMPLETED|Overall Study||0
523193|NCT00873015|1278500|P2|NOT COMPLETED|Overall Study||1
523194|NCT00873015|1278501|P1|NOT COMPLETED|Overall Study||0
523195|NCT00873015|1278498|P4|COMPLETED|Overall Study||3
523196|NCT00873015|1278499|P3|COMPLETED|Overall Study||3
523197|NCT00873015|1278500|P2|COMPLETED|Overall Study||3
523198|NCT00873015|1278501|P1|COMPLETED|Overall Study||9
523199|NCT00873015|1278498|P4|STARTED|Overall Study||3
523200|NCT00873015|1278499|P3|STARTED|Overall Study||3
523201|NCT00873015|1278500|P2|STARTED|Overall Study||4
523202|NCT00873015|1278501|P1|STARTED|Overall Study||9
523203|NCT00872989|1278510|P2|NOT COMPLETED|Overall Study||63
523204|NCT00872989|1278511|P1|NOT COMPLETED|Overall Study||65
523205|NCT00872989|1278510|P2|COMPLETED|Overall Study||0
523206|NCT00872989|1278511|P1|COMPLETED|Overall Study||1
523207|NCT00872989|1278510|P2|STARTED|Overall Study||63
523208|NCT00872989|1278511|P1|STARTED|Overall Study||66
523209|NCT00872898|1278530|P2|NOT COMPLETED|Part Two - Double Blind||6
523210|NCT00872898|1278531|P1|NOT COMPLETED|Part Two - Double Blind||11
523211|NCT00872898|1278530|P2|COMPLETED|Part Two - Double Blind||54
523212|NCT00872898|1278531|P1|COMPLETED|Part Two - Double Blind||50
523213|NCT00872898|1278530|P2|STARTED|Part Two - Double Blind||60
523214|NCT00872898|1278531|P1|STARTED|Part Two - Double Blind||61
523215|NCT00872898|1278530|P2|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0
523216|NCT00872898|1278531|P1|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0
523217|NCT00872898|1278530|P2|COMPLETED|Part One - Open Label, Pharmacokinetics||4
523218|NCT00872898|1278531|P1|COMPLETED|Part One - Open Label, Pharmacokinetics||0
523219|NCT00872898|1278530|P2|STARTED|Part One - Open Label, Pharmacokinetics||4
523220|NCT00872898|1278531|P1|STARTED|Part One - Open Label, Pharmacokinetics||0
523221|NCT00872833|1278565|P2|NOT COMPLETED|Overall Study||0
523222|NCT00872833|1278566|P1|NOT COMPLETED|Overall Study||0
523223|NCT00872833|1278565|P2|COMPLETED|Overall Study||17
523224|NCT00872833|1278566|P1|COMPLETED|Overall Study||15
523225|NCT00872833|1278565|P2|STARTED|Overall Study||17
523226|NCT00872833|1278566|P1|STARTED|Overall Study||15
523227|NCT00872729|1278575|P1|NOT COMPLETED|Overall Study||0
523228|NCT00872729|1278575|P1|COMPLETED|Overall Study||9
523229|NCT00872729|1278575|P1|STARTED|Overall Study||9
523230|NCT00872599|1278605|P2|NOT COMPLETED|Second Drug During High Salt Intake||0
523231|NCT00872599|1278606|P1|NOT COMPLETED|Second Drug During High Salt Intake||0
523232|NCT00872599|1278605|P2|COMPLETED|Second Drug During High Salt Intake||16
523233|NCT00872599|1278606|P1|COMPLETED|Second Drug During High Salt Intake||15
523234|NCT00872599|1278605|P2|STARTED|Second Drug During High Salt Intake||16
523235|NCT00872599|1278606|P1|STARTED|Second Drug During High Salt Intake||15
523236|NCT00872599|1278605|P2|NOT COMPLETED|Second Washout Period||1
523237|NCT00872599|1278606|P1|NOT COMPLETED|Second Washout Period||1
523238|NCT00872599|1278605|P2|COMPLETED|Second Washout Period||16
523239|NCT00872599|1278606|P1|COMPLETED|Second Washout Period||15
523240|NCT00872599|1278605|P2|STARTED|Second Washout Period||17
523241|NCT00872599|1278606|P1|STARTED|Second Washout Period||16
523242|NCT00872599|1278605|P2|NOT COMPLETED|First Drug During High Salt Intake||0
523243|NCT00872599|1278606|P1|NOT COMPLETED|First Drug During High Salt Intake||0
523244|NCT00872599|1278605|P2|COMPLETED|First Drug During High Salt Intake||17
523245|NCT00872599|1278606|P1|COMPLETED|First Drug During High Salt Intake||16
523246|NCT00872599|1278605|P2|STARTED|First Drug During High Salt Intake||17
523247|NCT00872599|1278606|P1|STARTED|First Drug During High Salt Intake||16
523248|NCT00872599|1278605|P2|NOT COMPLETED|First Washout Period After Low Salt||0
523249|NCT00872599|1278606|P1|NOT COMPLETED|First Washout Period After Low Salt||0
523250|NCT00872599|1278605|P2|COMPLETED|First Washout Period After Low Salt||17
523251|NCT00872599|1278606|P1|COMPLETED|First Washout Period After Low Salt||16
523252|NCT00872599|1278605|P2|STARTED|First Washout Period After Low Salt||17
523253|NCT00872599|1278606|P1|STARTED|First Washout Period After Low Salt||16
523254|NCT00872534|1278616|P2|NOT COMPLETED|Overall Study||3
523255|NCT00872534|1278617|P1|NOT COMPLETED|Overall Study||3
523256|NCT00872534|1278616|P2|COMPLETED|Overall Study||101
523257|NCT00872534|1278617|P1|COMPLETED|Overall Study||97
523258|NCT00872534|1278616|P2|STARTED|Overall Study||104
523259|NCT00872534|1278617|P1|STARTED|Overall Study||100
523260|NCT00872521|1278626|P3|NOT COMPLETED|Secondary Endpoint Analysis||1
523261|NCT00872521|1278627|P2|NOT COMPLETED|Secondary Endpoint Analysis||2
523262|NCT00872521|1278628|P1|NOT COMPLETED|Secondary Endpoint Analysis||0
523263|NCT00872521|1278626|P3|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|7
523264|NCT00872521|1278627|P2|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|58
523265|NCT00872521|1278628|P1|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|20
523266|NCT00872521|1278626|P3|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|8
523267|NCT00872521|1278627|P2|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|60
523268|NCT00872521|1278628|P1|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|20
523269|NCT00872521|1278626|P3|NOT COMPLETED|Completed 3-month Follow up||0
523270|NCT00872521|1278627|P2|NOT COMPLETED|Completed 3-month Follow up||3
523271|NCT00872521|1278628|P1|NOT COMPLETED|Completed 3-month Follow up||0
523272|NCT00872521|1278626|P3|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|8
523273|NCT00872521|1278627|P2|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|60
523274|NCT00872521|1278628|P1|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|20
523275|NCT00872521|1278626|P3|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|8
523276|NCT00872521|1278627|P2|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|63
523277|NCT00872521|1278628|P1|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|20
523278|NCT00872521|1278626|P3|NOT COMPLETED|Primary Endpoint Analysis||1
523279|NCT00872521|1278627|P2|NOT COMPLETED|Primary Endpoint Analysis||5
523280|NCT00872521|1278628|P1|NOT COMPLETED|Primary Endpoint Analysis||1
523281|NCT00872521|1278626|P3|COMPLETED|Primary Endpoint Analysis|participants analyzed|8
523282|NCT00872521|1278627|P2|COMPLETED|Primary Endpoint Analysis|participants analyzed|63
523283|NCT00872521|1278628|P1|COMPLETED|Primary Endpoint Analysis|participants analyzed|20
523284|NCT00872521|1278626|P3|STARTED|Primary Endpoint Analysis|Completed PAD induction|9
523285|NCT00872521|1278627|P2|STARTED|Primary Endpoint Analysis|Completed PAD induction|68
523286|NCT00872521|1278628|P1|STARTED|Primary Endpoint Analysis|Completed PAD induction|21
523287|NCT00872521|1278626|P3|NOT COMPLETED|Completed PAD Induction||0
523288|NCT00872521|1278627|P2|NOT COMPLETED|Completed PAD Induction||4
523289|NCT00872521|1278628|P1|NOT COMPLETED|Completed PAD Induction||5
523290|NCT00872521|1278626|P3|COMPLETED|Completed PAD Induction|Completed PAD induction|9
523291|NCT00872521|1278627|P2|COMPLETED|Completed PAD Induction|Completed PAD induction|68
523292|NCT00872521|1278628|P1|COMPLETED|Completed PAD Induction|Completed PAD induction|21
523293|NCT00872521|1278626|P3|STARTED|Completed PAD Induction|Received allocated treatment|9
523294|NCT00872521|1278627|P2|STARTED|Completed PAD Induction|Received allocated treatment|72
523295|NCT00872521|1278628|P1|STARTED|Completed PAD Induction|Received allocated treatment|26
523296|NCT00872430|1278676|P2|NOT COMPLETED|Second Intervention||0
523297|NCT00872430|1278677|P1|NOT COMPLETED|Second Intervention||0
523298|NCT00872430|1278676|P2|COMPLETED|Second Intervention||10
523299|NCT00872430|1278677|P1|COMPLETED|Second Intervention||10
523300|NCT00872430|1278676|P2|STARTED|Second Intervention||10
523301|NCT00872430|1278677|P1|STARTED|Second Intervention||10
523302|NCT00872430|1278676|P2|NOT COMPLETED|Washout Period||0
523303|NCT00872430|1278677|P1|NOT COMPLETED|Washout Period||0
523304|NCT00872430|1278676|P2|COMPLETED|Washout Period||10
523305|NCT00872430|1278677|P1|COMPLETED|Washout Period||10
523306|NCT00872430|1278676|P2|STARTED|Washout Period||10
523307|NCT00872430|1278677|P1|STARTED|Washout Period||10
523308|NCT00872430|1278676|P2|NOT COMPLETED|First Intervention||0
523309|NCT00872430|1278677|P1|NOT COMPLETED|First Intervention||0
523310|NCT00872430|1278676|P2|COMPLETED|First Intervention||10
523311|NCT00872430|1278677|P1|COMPLETED|First Intervention||10
523312|NCT00872430|1278676|P2|STARTED|First Intervention||10
523313|NCT00872430|1278677|P1|STARTED|First Intervention||10
523314|NCT00872339|1278686|P3|NOT COMPLETED|Overall Study||0
523315|NCT00872339|1278687|P2|NOT COMPLETED|Overall Study||0
523316|NCT00872339|1278688|P1|NOT COMPLETED|Overall Study||0
523317|NCT00872339|1278686|P3|COMPLETED|Overall Study||37
523318|NCT00872339|1278687|P2|COMPLETED|Overall Study||14
523319|NCT00872339|1278688|P1|COMPLETED|Overall Study||201
523320|NCT00872339|1278686|P3|STARTED|Overall Study||37
523321|NCT00872339|1278687|P2|STARTED|Overall Study||14
523322|NCT00872339|1278688|P1|STARTED|Overall Study||201
523323|NCT00872170|1278699|P2|NOT COMPLETED|Overall Study||0
523324|NCT00872170|1278700|P1|NOT COMPLETED|Overall Study||1
523325|NCT00872170|1278699|P2|COMPLETED|Overall Study||13
523326|NCT00872170|1278700|P1|COMPLETED|Overall Study|One patient withdrew from study at week 2.|13
523327|NCT00872170|1278699|P2|STARTED|Overall Study||13
523328|NCT00872170|1278700|P1|STARTED|Overall Study||14
523329|NCT00872079|1278715|P1|NOT COMPLETED|Overall Study||0
523330|NCT00872079|1278715|P1|COMPLETED|Overall Study||175
523331|NCT00872079|1278715|P1|STARTED|Overall Study||175
523332|NCT00872027|1278721|P2|NOT COMPLETED|Overall Study||0
523333|NCT00872027|1278722|P1|NOT COMPLETED|Overall Study||0
523334|NCT00872027|1278721|P2|COMPLETED|Overall Study||8
523335|NCT00872027|1278722|P1|COMPLETED|Overall Study||7
523336|NCT00872027|1278721|P2|STARTED|Overall Study||8
523337|NCT00872027|1278722|P1|STARTED|Overall Study||7
523338|NCT00872001|1278730|P2|NOT COMPLETED|Overall Study||131
523339|NCT00872001|1278731|P1|NOT COMPLETED|Overall Study||136
523340|NCT00872001|1278730|P2|COMPLETED|Overall Study||1413
523341|NCT00872001|1278731|P1|COMPLETED|Overall Study||1400
523342|NCT00872001|1278730|P2|STARTED|Overall Study||1544
523343|NCT00872001|1278731|P1|STARTED|Overall Study||1536
523344|NCT00871975|1278739|P1|NOT COMPLETED|Overall Study||22
523345|NCT00871975|1278739|P1|COMPLETED|Overall Study||133
523346|NCT00871975|1278739|P1|STARTED|Overall Study||155
523347|NCT00871871|1278745|P4|NOT COMPLETED|Part II||4
523348|NCT00871871|1278746|P3|NOT COMPLETED|Part II||4
523349|NCT00871871|1278747|P2|NOT COMPLETED|Part II||0
523350|NCT00871871|1278748|P1|NOT COMPLETED|Part II||0
523351|NCT00871871|1278745|P4|COMPLETED|Part II||11
523352|NCT00871871|1278746|P3|COMPLETED|Part II||9
523353|NCT00871871|1278747|P2|COMPLETED|Part II||0
523354|NCT00871871|1278748|P1|COMPLETED|Part II||0
523355|NCT00871871|1278745|P4|STARTED|Part II||15
523356|NCT00871871|1278746|P3|STARTED|Part II||13
523357|NCT00871871|1278747|P2|STARTED|Part II||0
523358|NCT00871871|1278748|P1|STARTED|Part II||0
523359|NCT00871871|1278745|P4|NOT COMPLETED|Part I||0
523360|NCT00871871|1278746|P3|NOT COMPLETED|Part I||0
523361|NCT00871871|1278747|P2|NOT COMPLETED|Part I||3
523362|NCT00871871|1278748|P1|NOT COMPLETED|Part I||3
523363|NCT00871871|1278745|P4|COMPLETED|Part I||0
523364|NCT00871871|1278746|P3|COMPLETED|Part I||0
523365|NCT00871871|1278747|P2|COMPLETED|Part I||15
523366|NCT00871871|1278748|P1|COMPLETED|Part I||15
523367|NCT00871871|1278745|P4|STARTED|Part I||0
523368|NCT00871871|1278746|P3|STARTED|Part I||0
523369|NCT00871871|1278747|P2|STARTED|Part I||18
523370|NCT00871871|1278748|P1|STARTED|Part I||18
523371|NCT00871819|1278768|P1|NOT COMPLETED|Overall Study||0
523372|NCT00871819|1278768|P1|COMPLETED|Overall Study||20
523373|NCT00871819|1278768|P1|STARTED|Overall Study||20
523374|NCT00871780|1278772|P1|NOT COMPLETED|Overall Study||27
523375|NCT00871780|1278772|P1|COMPLETED|Overall Study||197
523376|NCT00871780|1278772|P1|Efficacy Analysis Population|Overall Study|participants who had ≥1 infusion of natalizumab and completed at least 1 on-treatment evaluation|215
523377|NCT00871780|1278772|P1|Safety Analysis Population|Overall Study|participants who had ≥1 infusion of natalizumab during the study|218
523378|NCT00871780|1278772|P1|STARTED|Overall Study|number enrolled|224
523379|NCT00871741|1278792|P2|NOT COMPLETED|Overall Study||7
523380|NCT00871741|1278793|P1|NOT COMPLETED|Overall Study||9
523381|NCT00871741|1278792|P2|COMPLETED|Overall Study||0
523382|NCT00871741|1278793|P1|COMPLETED|Overall Study||0
523383|NCT00871741|1278792|P2|STARTED|Overall Study||7
523384|NCT00871741|1278793|P1|STARTED|Overall Study||9
523385|NCT00871728|1278807|P1|NOT COMPLETED|Overall Study||20
523386|NCT00871728|1278807|P1|COMPLETED|Overall Study||112
523387|NCT00871728|1278807|P1|Treated|Overall Study||130
523388|NCT00871728|1278807|P1|STARTED|Overall Study||132
523389|NCT00871715|1278820|P3|NOT COMPLETED|Overall Study||26
523390|NCT00871715|1278821|P2|NOT COMPLETED|Overall Study||16
523391|NCT00871715|1278822|P1|NOT COMPLETED|Overall Study||15
523392|NCT00871715|1278820|P3|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|96
523393|NCT00871715|1278821|P2|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|104
523394|NCT00871715|1278822|P1|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|104
523395|NCT00871715|1278820|P3|6-mo Follow-up|Overall Study||112
523396|NCT00871715|1278821|P2|6-mo Follow-up|Overall Study||113
523397|NCT00871715|1278822|P1|6-mo Follow-up|Overall Study||110
523398|NCT00871715|1278820|P3|Post-Intervention|Overall Study||115
523399|NCT00871715|1278821|P2|Post-Intervention|Overall Study||115
523400|NCT00871715|1278822|P1|Post-Intervention|Overall Study||112
523401|NCT00871715|1278820|P3|STARTED|Overall Study||122
523402|NCT00871715|1278821|P2|STARTED|Overall Study||120
523403|NCT00871715|1278822|P1|STARTED|Overall Study||119
523404|NCT00871689|1278840|P1|NOT COMPLETED|Overall Study||0
523405|NCT00871689|1278840|P1|COMPLETED|Overall Study||2
523406|NCT00871689|1278840|P1|STARTED|Overall Study||2
523407|NCT00871624|1278853|P2|NOT COMPLETED|Overall Study||1
523408|NCT00871624|1278854|P1|NOT COMPLETED|Overall Study||2
523409|NCT00871624|1278853|P2|COMPLETED|Overall Study||17
523410|NCT00871624|1278854|P1|COMPLETED|Overall Study||16
523411|NCT00871624|1278853|P2|STARTED|Overall Study||18
523412|NCT00871624|1278854|P1|STARTED|Overall Study||18
523413|NCT00871572|1278866|P4|NOT COMPLETED|Overall Study||7
523414|NCT00871572|1278867|P3|NOT COMPLETED|Overall Study||4
523415|NCT00871572|1278868|P2|NOT COMPLETED|Overall Study||6
523416|NCT00871572|1278869|P1|NOT COMPLETED|Overall Study||2
523417|NCT00871572|1278866|P4|COMPLETED|Overall Study||19
523418|NCT00871572|1278867|P3|COMPLETED|Overall Study||30
523419|NCT00871572|1278868|P2|COMPLETED|Overall Study||11
523420|NCT00871572|1278869|P1|COMPLETED|Overall Study||8
523421|NCT00871572|1278866|P4|Received at Least 1 Dose of Study Drug|Overall Study||25
523422|NCT00871572|1278867|P3|Received at Least 1 Dose of Study Drug|Overall Study||34
523423|NCT00871572|1278868|P2|Received at Least 1 Dose of Study Drug|Overall Study||17
523424|NCT00871572|1278869|P1|Received at Least 1 Dose of Study Drug|Overall Study||9
523425|NCT00871572|1278866|P4|≥1 Post Baseline Value by Assigned Group|Overall Study||25
523426|NCT00871572|1278867|P3|≥1 Post Baseline Value by Assigned Group|Overall Study||34
523427|NCT00871572|1278868|P2|≥1 Post Baseline Value by Assigned Group|Overall Study||17
523428|NCT00871572|1278869|P1|≥1 Post Baseline Value by Assigned Group|Overall Study||9
523429|NCT00871572|1278866|P4|STARTED|Overall Study||26
523430|NCT00871572|1278867|P3|STARTED|Overall Study||34
523431|NCT00871572|1278868|P2|STARTED|Overall Study||17
523432|NCT00871572|1278869|P1|STARTED|Overall Study||10
523433|NCT00871494|1278939|P1|NOT COMPLETED|Overall Study||14
523434|NCT00871494|1278939|P1|COMPLETED|Overall Study||62
523435|NCT00871494|1278939|P1|STARTED|Overall Study||76
523436|NCT00871429|1278946|P1|NOT COMPLETED|Overall Study||24
523437|NCT00871429|1278946|P1|COMPLETED|Overall Study||75
523438|NCT00871429|1278946|P1|STARTED|Overall Study||99
523439|NCT00871403|1278957|P3|NOT COMPLETED|Monotherapy Treatment Phase||1
523440|NCT00871403|1278958|P2|NOT COMPLETED|Monotherapy Treatment Phase||13
523441|NCT00871403|1278959|P1|NOT COMPLETED|Monotherapy Treatment Phase||0
523442|NCT00871403|1278957|P3|COMPLETED|Monotherapy Treatment Phase||0
523443|NCT00871403|1278958|P2|COMPLETED|Monotherapy Treatment Phase||0
523444|NCT00871403|1278959|P1|COMPLETED|Monotherapy Treatment Phase||0
523445|NCT00871403|1278957|P3|STARTED|Monotherapy Treatment Phase||1
523446|NCT00871403|1278958|P2|STARTED|Monotherapy Treatment Phase||13
523447|NCT00871403|1278959|P1|STARTED|Monotherapy Treatment Phase||0
523448|NCT00871403|1278957|P3|NOT COMPLETED|Combination Treatment Phase||12
523449|NCT00871403|1278958|P2|NOT COMPLETED|Combination Treatment Phase||49
523450|NCT00871403|1278959|P1|NOT COMPLETED|Combination Treatment Phase||9
523451|NCT00871403|1278957|P3|COMPLETED|Combination Treatment Phase|These participants completed combination treatment|23
523452|NCT00871403|1278958|P2|COMPLETED|Combination Treatment Phase|These participants completed combination treatment|13
523453|NCT00871403|1278959|P1|COMPLETED|Combination Treatment Phase|No particiapants completed Combination Treatement.|0
523454|NCT00871403|1278957|P3|STARTED|Combination Treatment Phase||35
523455|NCT00871403|1278958|P2|STARTED|Combination Treatment Phase||62
523456|NCT00871403|1278959|P1|STARTED|Combination Treatment Phase||9
523457|NCT00871377|1278972|P6|NOT COMPLETED|Third Intervention (10 Weeks)||0
523458|NCT00871377|1278973|P5|NOT COMPLETED|Third Intervention (10 Weeks)||0
523459|NCT00871377|1278974|P4|NOT COMPLETED|Third Intervention (10 Weeks)||1
523460|NCT00871377|1278975|P3|NOT COMPLETED|Third Intervention (10 Weeks)||0
523461|NCT00871377|1278976|P2|NOT COMPLETED|Third Intervention (10 Weeks)||0
523462|NCT00871377|1278977|P1|NOT COMPLETED|Third Intervention (10 Weeks)||0
523463|NCT00871377|1278972|P6|COMPLETED|Third Intervention (10 Weeks)||3
523464|NCT00871377|1278973|P5|COMPLETED|Third Intervention (10 Weeks)||4
523465|NCT00871377|1278974|P4|COMPLETED|Third Intervention (10 Weeks)||3
523466|NCT00871377|1278975|P3|COMPLETED|Third Intervention (10 Weeks)||3
523467|NCT00871377|1278976|P2|COMPLETED|Third Intervention (10 Weeks)||4
523468|NCT00871377|1278977|P1|COMPLETED|Third Intervention (10 Weeks)||2
523469|NCT00871377|1278972|P6|STARTED|Third Intervention (10 Weeks)||3
523470|NCT00871377|1278973|P5|STARTED|Third Intervention (10 Weeks)||4
523471|NCT00871377|1278974|P4|STARTED|Third Intervention (10 Weeks)||4
523472|NCT00871377|1278975|P3|STARTED|Third Intervention (10 Weeks)||3
523473|NCT00871377|1278976|P2|STARTED|Third Intervention (10 Weeks)||4
523474|NCT00871377|1278977|P1|STARTED|Third Intervention (10 Weeks)||2
523475|NCT00871377|1278972|P6|NOT COMPLETED|Washout (6 Weeks)||1
523476|NCT00871377|1278973|P5|NOT COMPLETED|Washout (6 Weeks)||0
523477|NCT00871377|1278974|P4|NOT COMPLETED|Washout (6 Weeks)||0
523478|NCT00871377|1278975|P3|NOT COMPLETED|Washout (6 Weeks)||0
523479|NCT00871377|1278976|P2|NOT COMPLETED|Washout (6 Weeks)||0
523480|NCT00871377|1278977|P1|NOT COMPLETED|Washout (6 Weeks)||0
523481|NCT00871377|1278972|P6|COMPLETED|Washout (6 Weeks)||3
523482|NCT00871377|1278973|P5|COMPLETED|Washout (6 Weeks)||4
523483|NCT00871377|1278974|P4|COMPLETED|Washout (6 Weeks)||4
523484|NCT00871377|1278975|P3|COMPLETED|Washout (6 Weeks)||3
523485|NCT00871377|1278976|P2|COMPLETED|Washout (6 Weeks)||4
523486|NCT00871377|1278977|P1|COMPLETED|Washout (6 Weeks)||2
523487|NCT00871377|1278972|P6|STARTED|Washout (6 Weeks)||4
523488|NCT00871377|1278973|P5|STARTED|Washout (6 Weeks)||4
523489|NCT00871377|1278974|P4|STARTED|Washout (6 Weeks)||4
523490|NCT00871377|1278975|P3|STARTED|Washout (6 Weeks)||3
523491|NCT00871377|1278976|P2|STARTED|Washout (6 Weeks)||4
523492|NCT00871377|1278977|P1|STARTED|Washout (6 Weeks)||2
523493|NCT00871377|1278972|P6|NOT COMPLETED|Second Intervention (10 Weeks)||0
523494|NCT00871377|1278973|P5|NOT COMPLETED|Second Intervention (10 Weeks)||0
523495|NCT00871377|1278974|P4|NOT COMPLETED|Second Intervention (10 Weeks)||0
523496|NCT00871377|1278975|P3|NOT COMPLETED|Second Intervention (10 Weeks)||0
523497|NCT00871377|1278976|P2|NOT COMPLETED|Second Intervention (10 Weeks)||0
523498|NCT00871377|1278977|P1|NOT COMPLETED|Second Intervention (10 Weeks)||0
523499|NCT00871377|1278972|P6|COMPLETED|Second Intervention (10 Weeks)||4
523500|NCT00871377|1278973|P5|COMPLETED|Second Intervention (10 Weeks)||4
523501|NCT00871377|1278974|P4|COMPLETED|Second Intervention (10 Weeks)||4
523502|NCT00871377|1278975|P3|COMPLETED|Second Intervention (10 Weeks)||3
523503|NCT00871377|1278976|P2|COMPLETED|Second Intervention (10 Weeks)||4
523504|NCT00871377|1278977|P1|COMPLETED|Second Intervention (10 Weeks)||2
523505|NCT00871377|1278972|P6|STARTED|Second Intervention (10 Weeks)||4
523506|NCT00871377|1278973|P5|STARTED|Second Intervention (10 Weeks)||4
523507|NCT00871377|1278974|P4|STARTED|Second Intervention (10 Weeks)||4
523508|NCT00871377|1278975|P3|STARTED|Second Intervention (10 Weeks)||3
523509|NCT00871377|1278976|P2|STARTED|Second Intervention (10 Weeks)||4
523510|NCT00871377|1278977|P1|STARTED|Second Intervention (10 Weeks)||2
523511|NCT00871377|1278972|P6|NOT COMPLETED|Washout (6 Weeks)||0
523512|NCT00871377|1278973|P5|NOT COMPLETED|Washout (6 Weeks)||0
523513|NCT00871377|1278974|P4|NOT COMPLETED|Washout (6 Weeks)||0
523514|NCT00871377|1278975|P3|NOT COMPLETED|Washout (6 Weeks)||0
523515|NCT00871377|1278976|P2|NOT COMPLETED|Washout (6 Weeks)||0
523516|NCT00871377|1278977|P1|NOT COMPLETED|Washout (6 Weeks)||1
523517|NCT00871377|1278972|P6|COMPLETED|Washout (6 Weeks)||4
523518|NCT00871377|1278973|P5|COMPLETED|Washout (6 Weeks)||4
523519|NCT00871377|1278974|P4|COMPLETED|Washout (6 Weeks)||4
523520|NCT00871377|1278975|P3|COMPLETED|Washout (6 Weeks)||3
523521|NCT00871377|1278976|P2|COMPLETED|Washout (6 Weeks)||4
523522|NCT00871377|1278977|P1|COMPLETED|Washout (6 Weeks)||2
523523|NCT00871377|1278972|P6|STARTED|Washout (6 Weeks)||4
523524|NCT00871377|1278973|P5|STARTED|Washout (6 Weeks)||4
523525|NCT00871377|1278974|P4|STARTED|Washout (6 Weeks)||4
523526|NCT00871377|1278975|P3|STARTED|Washout (6 Weeks)||3
523527|NCT00871377|1278976|P2|STARTED|Washout (6 Weeks)||4
523528|NCT00871377|1278977|P1|STARTED|Washout (6 Weeks)||3
523529|NCT00871377|1278972|P6|NOT COMPLETED|First Intervention (10 Weeks)||1
523530|NCT00871377|1278973|P5|NOT COMPLETED|First Intervention (10 Weeks)||0
523531|NCT00871377|1278974|P4|NOT COMPLETED|First Intervention (10 Weeks)||0
523532|NCT00871377|1278975|P3|NOT COMPLETED|First Intervention (10 Weeks)||1
523533|NCT00871377|1278976|P2|NOT COMPLETED|First Intervention (10 Weeks)||0
523534|NCT00871377|1278977|P1|NOT COMPLETED|First Intervention (10 Weeks)||0
523535|NCT00871377|1278972|P6|COMPLETED|First Intervention (10 Weeks)||4
523536|NCT00871377|1278973|P5|COMPLETED|First Intervention (10 Weeks)||4
523537|NCT00871377|1278974|P4|COMPLETED|First Intervention (10 Weeks)||4
523538|NCT00871377|1278975|P3|COMPLETED|First Intervention (10 Weeks)||3
523539|NCT00871377|1278976|P2|COMPLETED|First Intervention (10 Weeks)||4
523540|NCT00871377|1278977|P1|COMPLETED|First Intervention (10 Weeks)||3
523541|NCT00871377|1278972|P6|STARTED|First Intervention (10 Weeks)||5
523542|NCT00871377|1278973|P5|STARTED|First Intervention (10 Weeks)||4
523543|NCT00871377|1278974|P4|STARTED|First Intervention (10 Weeks)||4
523544|NCT00871377|1278975|P3|STARTED|First Intervention (10 Weeks)||4
523545|NCT00871377|1278976|P2|STARTED|First Intervention (10 Weeks)||4
523546|NCT00871377|1278977|P1|STARTED|First Intervention (10 Weeks)||3
523547|NCT00871351|1278988|P3|NOT COMPLETED|Overall Study||0
523548|NCT00871351|1278989|P2|NOT COMPLETED|Overall Study||1
523549|NCT00871351|1278990|P1|NOT COMPLETED|Overall Study||4
523550|NCT00871351|1278988|P3|COMPLETED|Overall Study||32
523551|NCT00871351|1278989|P2|COMPLETED|Overall Study||45
523552|NCT00871351|1278990|P1|COMPLETED|Overall Study||43
523553|NCT00871351|1278988|P3|STARTED|Overall Study||32
523554|NCT00871351|1278989|P2|STARTED|Overall Study||46
523555|NCT00871351|1278990|P1|STARTED|Overall Study||47
523556|NCT00871338|1279012|P2|NOT COMPLETED|After Booster||0
523557|NCT00871338|1279013|P1|NOT COMPLETED|After Booster||0
523558|NCT00871338|1279012|P2|COMPLETED|After Booster||135
523559|NCT00871338|1279013|P1|COMPLETED|After Booster||139
523560|NCT00871338|1279012|P2|STARTED|After Booster||135
523561|NCT00871338|1279013|P1|STARTED|After Booster||139
523562|NCT00871338|1279012|P2|NOT COMPLETED|Prior to Booster||3
523563|NCT00871338|1279013|P1|NOT COMPLETED|Prior to Booster||2
523564|NCT00871338|1279012|P2|COMPLETED|Prior to Booster||139
523565|NCT00871338|1279013|P1|COMPLETED|Prior to Booster||140
523566|NCT00871338|1279012|P2|STARTED|Prior to Booster||142
523567|NCT00871338|1279013|P1|STARTED|Prior to Booster||142
523568|NCT00871286|1279093|P2|NOT COMPLETED|Overall Study||6
523569|NCT00871286|1279094|P1|NOT COMPLETED|Overall Study||0
523570|NCT00871286|1279093|P2|COMPLETED|Overall Study||14
523571|NCT00871286|1279094|P1|COMPLETED|Overall Study||20
523572|NCT00871286|1279093|P2|STARTED|Overall Study||20
523573|NCT00871286|1279094|P1|STARTED|Overall Study||20
523574|NCT00871234|1279102|P1|NOT COMPLETED|Overall Study||5
523575|NCT00871234|1279102|P1|COMPLETED|Overall Study||23
523576|NCT00871234|1279102|P1|STARTED|Overall Study||28
523577|NCT00871169|1279106|P1|NOT COMPLETED|Overall Study||3
523578|NCT00871169|1279106|P1|COMPLETED|Overall Study||58
523579|NCT00871169|1279106|P1|STARTED|Overall Study||61
523580|NCT00871143|1279113|P2|NOT COMPLETED|Overall Study||0
523581|NCT00871143|1279114|P1|NOT COMPLETED|Overall Study||0
523582|NCT00871143|1279113|P2|COMPLETED|Overall Study||25
523583|NCT00871143|1279114|P1|COMPLETED|Overall Study||21
523584|NCT00871143|1279113|P2|STARTED|Overall Study||25
523585|NCT00871143|1279114|P1|STARTED|Overall Study||21
523586|NCT00871117|1279134|P2|NOT COMPLETED|Overall Study||10
523587|NCT00871117|1279135|P1|NOT COMPLETED|Overall Study||5
523588|NCT00871117|1279134|P2|COMPLETED|Overall Study||227
523589|NCT00871117|1279135|P1|COMPLETED|Overall Study||234
523590|NCT00871117|1279134|P2|STARTED|Overall Study||237
523591|NCT00871117|1279135|P1|STARTED|Overall Study||239
523592|NCT00871000|1279167|P2|NOT COMPLETED|Overall Study||0
523593|NCT00871000|1279168|P1|NOT COMPLETED|Overall Study||1
523594|NCT00871000|1279167|P2|COMPLETED|Overall Study||152
523595|NCT00871000|1279168|P1|COMPLETED|Overall Study||150
523596|NCT00871000|1279167|P2|STARTED|Overall Study||152
523597|NCT00871000|1279168|P1|STARTED|Overall Study||151
523598|NCT00870896|1279210|P1|NOT COMPLETED|Overall Study||0
523599|NCT00870896|1279210|P1|COMPLETED|Overall Study||5
523600|NCT00870896|1279210|P1|STARTED|Overall Study||5
523601|NCT00870870|1279220|P4|NOT COMPLETED|Overall Study||5
523602|NCT00870870|1279221|P3|NOT COMPLETED|Overall Study||3
523603|NCT00870870|1279222|P2|NOT COMPLETED|Overall Study||1
523604|NCT00870870|1279223|P1|NOT COMPLETED|Overall Study||0
523605|NCT00870870|1279220|P4|COMPLETED|Overall Study||20
523606|NCT00870870|1279221|P3|COMPLETED|Overall Study||26
523607|NCT00870870|1279222|P2|COMPLETED|Overall Study||5
523608|NCT00870870|1279223|P1|COMPLETED|Overall Study||4
523609|NCT00870870|1279220|P4|STARTED|Overall Study||25
523610|NCT00870870|1279221|P3|STARTED|Overall Study||29
523611|NCT00870870|1279222|P2|STARTED|Overall Study||6
523612|NCT00870870|1279223|P1|STARTED|Overall Study||4
523613|NCT00870740|1279267|P6|NOT COMPLETED|Overall Study||17
523614|NCT00870740|1279268|P5|NOT COMPLETED|Overall Study||11
523615|NCT00870740|1279269|P4|NOT COMPLETED|Overall Study||12
523616|NCT00870740|1279270|P3|NOT COMPLETED|Overall Study||10
523617|NCT00870740|1279271|P2|NOT COMPLETED|Overall Study||9
523618|NCT00870740|1279272|P1|NOT COMPLETED|Overall Study||12
523619|NCT00870740|1279267|P6|COMPLETED|Overall Study||70
523620|NCT00870740|1279268|P5|COMPLETED|Overall Study||77
523621|NCT00870740|1279269|P4|COMPLETED|Overall Study||74
523622|NCT00870740|1279270|P3|COMPLETED|Overall Study||76
523623|NCT00870740|1279271|P2|COMPLETED|Overall Study||75
523624|NCT00870740|1279272|P1|COMPLETED|Overall Study||74
523625|NCT00870740|1279267|P6|STARTED|Overall Study|number randomized and dosed|87
523626|NCT00870740|1279268|P5|STARTED|Overall Study|number randomized and dosed|88
523627|NCT00870740|1279269|P4|STARTED|Overall Study|number randomized and dosed|86
523628|NCT00870740|1279270|P3|STARTED|Overall Study|number randomized and dosed|86
523629|NCT00870740|1279271|P2|STARTED|Overall Study|number randomized and dosed|84
523630|NCT00870740|1279272|P1|STARTED|Overall Study|number randomized and dosed|86
523631|NCT00870688|1279346|P1|NOT COMPLETED|Overall Study||4
523632|NCT00870688|1279346|P1|COMPLETED|Overall Study||78
523633|NCT00870688|1279346|P1|STARTED|Overall Study||82
523634|NCT00870584|1279351|P2|NOT COMPLETED|Overall Study||13
523635|NCT00870584|1279352|P1|NOT COMPLETED|Overall Study||16
523636|NCT00870584|1279351|P2|COMPLETED|Overall Study||122
523637|NCT00870584|1279352|P1|COMPLETED|Overall Study||120
523638|NCT00870584|1279351|P2|STARTED|Overall Study||135
523639|NCT00870584|1279352|P1|STARTED|Overall Study||136
523640|NCT00870545|1279360|P1|NOT COMPLETED|Overall Study||17
523641|NCT00870545|1279360|P1|COMPLETED|Overall Study||69
523642|NCT00870545|1279360|P1|STARTED|Overall Study||86
523643|NCT00870467|1279371|P6|NOT COMPLETED|Open-label||3
523644|NCT00870467|1279372|P5|NOT COMPLETED|Open-label||5
523645|NCT00870467|1279373|P4|NOT COMPLETED|Open-label||7
523646|NCT00870467|1279374|P3|NOT COMPLETED|Open-label||13
523647|NCT00870467|1279375|P2|NOT COMPLETED|Open-label||0
523648|NCT00870467|1279376|P1|NOT COMPLETED|Open-label||0
523649|NCT00870467|1279371|P6|COMPLETED|Open-label||21
523650|NCT00870467|1279372|P5|COMPLETED|Open-label||5
523651|NCT00870467|1279373|P4|COMPLETED|Open-label||120
523652|NCT00870467|1279374|P3|COMPLETED|Open-label||132
523653|NCT00870467|1279375|P2|COMPLETED|Open-label||0
523654|NCT00870467|1279376|P1|COMPLETED|Open-label||0
523655|NCT00870467|1279371|P6|STARTED|Open-label||24
523656|NCT00870467|1279372|P5|STARTED|Open-label||10
523657|NCT00870467|1279373|P4|STARTED|Open-label||127
523658|NCT00870467|1279374|P3|STARTED|Open-label||145
523659|NCT00870467|1279375|P2|STARTED|Open-label||0
523660|NCT00870467|1279376|P1|STARTED|Open-label||0
523661|NCT00870467|1279371|P6|NOT COMPLETED|Double-blind||0
523662|NCT00870467|1279372|P5|NOT COMPLETED|Double-blind||0
523663|NCT00870467|1279373|P4|NOT COMPLETED|Double-blind||0
523664|NCT00870467|1279374|P3|NOT COMPLETED|Double-blind||0
523665|NCT00870467|1279375|P2|NOT COMPLETED|Double-blind||12
523666|NCT00870467|1279376|P1|NOT COMPLETED|Double-blind||16
523667|NCT00870467|1279371|P6|COMPLETED|Double-blind||0
523668|NCT00870467|1279372|P5|COMPLETED|Double-blind||0
523669|NCT00870467|1279373|P4|COMPLETED|Double-blind||0
523670|NCT00870467|1279374|P3|COMPLETED|Double-blind||0
523671|NCT00870467|1279375|P2|COMPLETED|Double-blind|24 participants who completed 26 weeks received open-label adalimumab 40 mg eow as rescue therapy|151
523672|NCT00870467|1279376|P1|COMPLETED|Double-blind|10 participants who completed 26 weeks received open-label adalimumab 40 mg eow as rescue therapy|155
523673|NCT00870467|1279371|P6|STARTED|Double-blind||0
523674|NCT00870467|1279372|P5|STARTED|Double-blind||0
523675|NCT00870467|1279373|P4|STARTED|Double-blind||0
523676|NCT00870467|1279374|P3|STARTED|Double-blind||0
523677|NCT00870467|1279375|P2|STARTED|Double-blind||163
523678|NCT00870467|1279376|P1|STARTED|Double-blind||171
523679|NCT00870363|1279424|P4|NOT COMPLETED|Overall Study||0
523680|NCT00870363|1279425|P3|NOT COMPLETED|Overall Study||3
523681|NCT00870363|1279426|P2|NOT COMPLETED|Overall Study||3
523682|NCT00870363|1279427|P1|NOT COMPLETED|Overall Study||0
523683|NCT00870363|1279424|P4|COMPLETED|Overall Study||12
523684|NCT00870363|1279425|P3|COMPLETED|Overall Study||8
523685|NCT00870363|1279426|P2|COMPLETED|Overall Study||8
523686|NCT00870363|1279427|P1|COMPLETED|Overall Study||10
523687|NCT00870363|1279424|P4|STARTED|Overall Study||12
523688|NCT00870363|1279425|P3|STARTED|Overall Study||11
523689|NCT00870363|1279426|P2|STARTED|Overall Study||11
523690|NCT00870363|1279427|P1|STARTED|Overall Study||10
523691|NCT00870194|1279463|P2|NOT COMPLETED|Overall Study||14
523692|NCT00870194|1279464|P1|NOT COMPLETED|Overall Study||26
523693|NCT00870194|1279463|P2|COMPLETED|Overall Study||114
523694|NCT00870194|1279464|P1|COMPLETED|Overall Study||101
523695|NCT00870194|1279463|P2|Per Protocol Set|Overall Study||111
523696|NCT00870194|1279464|P1|Per Protocol Set|Overall Study||97
523697|NCT00870194|1279463|P2|STARTED|Overall Study||128
523698|NCT00870194|1279464|P1|STARTED|Overall Study||127
523699|NCT00870103|1279502|P1|NOT COMPLETED|Overall Study||4
523700|NCT00870103|1279502|P1|COMPLETED|Overall Study||60
523701|NCT00870103|1279502|P1|STARTED|Overall Study||64
523702|NCT00869999|1279507|P1|NOT COMPLETED|Overall Study||2
523703|NCT00869999|1279507|P1|COMPLETED|Overall Study||24
523704|NCT00869999|1279507|P1|STARTED|Overall Study||26
523705|NCT00869960|1279513|P1|NOT COMPLETED|Overall Study||2
523706|NCT00869960|1279513|P1|COMPLETED|Overall Study||22
523707|NCT00869960|1279513|P1|STARTED|Overall Study||24
523708|NCT00869947|1279526|P2|NOT COMPLETED|Overall Study||0
523709|NCT00869947|1279527|P1|NOT COMPLETED|Overall Study||0
523710|NCT00869947|1279526|P2|COMPLETED|Overall Study||8
523711|NCT00869947|1279527|P1|COMPLETED|Overall Study||8
523712|NCT00869947|1279526|P2|STARTED|Overall Study||8
523713|NCT00869947|1279527|P1|STARTED|Overall Study||8
523714|NCT00869791|1279540|P2|NOT COMPLETED|Period 2 Treatment for 7 Days||0
523715|NCT00869791|1279541|P1|NOT COMPLETED|Period 2 Treatment for 7 Days||0
523716|NCT00869791|1279540|P2|COMPLETED|Period 2 Treatment for 7 Days||13
523717|NCT00869791|1279541|P1|COMPLETED|Period 2 Treatment for 7 Days||14
523718|NCT00869791|1279540|P2|STARTED|Period 2 Treatment for 7 Days||13
523719|NCT00869791|1279541|P1|STARTED|Period 2 Treatment for 7 Days||14
523720|NCT00869791|1279540|P2|NOT COMPLETED|Period 1 Treatment for 7 Days||0
523721|NCT00869791|1279541|P1|NOT COMPLETED|Period 1 Treatment for 7 Days||0
523722|NCT00869791|1279540|P2|COMPLETED|Period 1 Treatment for 7 Days||13
523723|NCT00869791|1279541|P1|COMPLETED|Period 1 Treatment for 7 Days||14
523724|NCT00869791|1279540|P2|STARTED|Period 1 Treatment for 7 Days||13
523725|NCT00869791|1279541|P1|STARTED|Period 1 Treatment for 7 Days||14
523726|NCT00869778|1279562|P3|NOT COMPLETED|Overall Study||10
523727|NCT00869778|1279563|P2|NOT COMPLETED|Overall Study||7
523728|NCT00869778|1279564|P1|NOT COMPLETED|Overall Study||12
523729|NCT00869778|1279562|P3|COMPLETED|Overall Study||110
523730|NCT00869778|1279563|P2|COMPLETED|Overall Study||113
523731|NCT00869778|1279564|P1|COMPLETED|Overall Study||108
523732|NCT00869778|1279562|P3|STARTED|Overall Study||120
523733|NCT00869778|1279563|P2|STARTED|Overall Study||120
523734|NCT00869778|1279564|P1|STARTED|Overall Study||120
523735|NCT00869622|1279601|P2|NOT COMPLETED|Overall Study||14
523736|NCT00869622|1279602|P1|NOT COMPLETED|Overall Study||13
523737|NCT00869622|1279601|P2|COMPLETED|Overall Study||26
523738|NCT00869622|1279602|P1|COMPLETED|Overall Study||27
523739|NCT00869622|1279601|P2|STARTED|Overall Study||40
523740|NCT00869622|1279602|P1|STARTED|Overall Study||40
523741|NCT00869609|1279612|P2|NOT COMPLETED|Overall Study||3
523742|NCT00869609|1279613|P1|NOT COMPLETED|Overall Study||6
523743|NCT00869609|1279612|P2|COMPLETED|Overall Study||26
523744|NCT00869609|1279613|P1|COMPLETED|Overall Study||25
523745|NCT00869609|1279612|P2|STARTED|Overall Study||29
523746|NCT00869609|1279613|P1|STARTED|Overall Study||31
523747|NCT00869557|1279639|P2|NOT COMPLETED|Extension Phase||3
523748|NCT00869557|1279640|P1|NOT COMPLETED|Extension Phase||10
523749|NCT00869557|1279639|P2|COMPLETED|Extension Phase||11
523750|NCT00869557|1279640|P1|COMPLETED|Extension Phase||35
523751|NCT00869557|1279639|P2|STARTED|Extension Phase|Seven participants completing randomized Atripla treatment did not enter open-label extension phase.|14
523752|NCT00869557|1279640|P1|STARTED|Extension Phase||45
523753|NCT00869557|1279639|P2|NOT COMPLETED|Randomized Phase||2
523754|NCT00869557|1279640|P1|NOT COMPLETED|Randomized Phase||3
523755|NCT00869557|1279639|P2|COMPLETED|Randomized Phase||21
523756|NCT00869557|1279640|P1|COMPLETED|Randomized Phase||45
523757|NCT00869557|1279639|P2|STARTED|Randomized Phase||23
523758|NCT00869557|1279640|P1|STARTED|Randomized Phase||48
523759|NCT00869518|1279659|P2|NOT COMPLETED|Overall Study||1
523760|NCT00869518|1279660|P1|NOT COMPLETED|Overall Study||1
523761|NCT00869518|1279659|P2|COMPLETED|Overall Study||5
523762|NCT00869518|1279660|P1|COMPLETED|Overall Study||5
523763|NCT00869518|1279659|P2|STARTED|Overall Study||6
523764|NCT00869518|1279660|P1|STARTED|Overall Study||6
523765|NCT00869414|1279672|P3|NOT COMPLETED|Overall Study||0
523766|NCT00869414|1279673|P2|NOT COMPLETED|Overall Study||0
523767|NCT00869414|1279674|P1|NOT COMPLETED|Overall Study||0
523768|NCT00869414|1279672|P3|COMPLETED|Overall Study||0
523769|NCT00869414|1279673|P2|COMPLETED|Overall Study||0
523770|NCT00869414|1279674|P1|COMPLETED|Overall Study||0
523771|NCT00869414|1279672|P3|STARTED|Overall Study||0
523772|NCT00869414|1279673|P2|STARTED|Overall Study||0
523773|NCT00869414|1279674|P1|STARTED|Overall Study||0
523774|NCT00869401|1279688|P5|NOT COMPLETED|Overall Study||3
523775|NCT00869401|1279689|P4|NOT COMPLETED|Overall Study||5
523776|NCT00869401|1279690|P3|NOT COMPLETED|Overall Study||0
523777|NCT00869401|1279691|P2|NOT COMPLETED|Overall Study||0
523778|NCT00869401|1279692|P1|NOT COMPLETED|Overall Study||0
523779|NCT00869401|1279688|P5|COMPLETED|Overall Study||63
523780|NCT00869401|1279689|P4|COMPLETED|Overall Study||133
523781|NCT00869401|1279690|P3|COMPLETED|Overall Study||7
523782|NCT00869401|1279691|P2|COMPLETED|Overall Study||3
523783|NCT00869401|1279692|P1|COMPLETED|Overall Study||3
523784|NCT00869401|1279688|P5|STARTED|Overall Study||66
523785|NCT00869401|1279689|P4|STARTED|Overall Study||138
523786|NCT00869401|1279690|P3|STARTED|Overall Study||7
523787|NCT00869401|1279691|P2|STARTED|Overall Study||3
523788|NCT00869401|1279692|P1|STARTED|Overall Study||3
523789|NCT00869375|1279710|P2|NOT COMPLETED|Overall Study||0
523790|NCT00869375|1279711|P1|NOT COMPLETED|Overall Study||0
523791|NCT00869375|1279710|P2|COMPLETED|Overall Study||3
523792|NCT00869375|1279711|P1|COMPLETED|Overall Study||3
523793|NCT00869375|1279710|P2|STARTED|Overall Study||3
523794|NCT00869375|1279711|P1|STARTED|Overall Study||3
523795|NCT00869362|1279721|P2|NOT COMPLETED|Overall Study||5
523796|NCT00869362|1279722|P1|NOT COMPLETED|Overall Study||1
523797|NCT00869362|1279721|P2|COMPLETED|Overall Study||11
523798|NCT00869362|1279722|P1|COMPLETED|Overall Study||14
523799|NCT00869362|1279721|P2|STARTED|Overall Study||16
523800|NCT00869362|1279722|P1|STARTED|Overall Study||15
523801|NCT00869349|1279732|P2|NOT COMPLETED|Overall Study||4
523802|NCT00869349|1279733|P1|NOT COMPLETED|Overall Study||7
523803|NCT00869349|1279732|P2|COMPLETED|Overall Study||36
523804|NCT00869349|1279733|P1|COMPLETED|Overall Study||32
523805|NCT00869349|1279732|P2|STARTED|Overall Study||40
523806|NCT00869349|1279733|P1|STARTED|Overall Study||39
523807|NCT00869323|1279743|P1|NOT COMPLETED|Maintenance Therapy||1
523808|NCT00869323|1279743|P1|COMPLETED|Maintenance Therapy||1
523809|NCT00869323|1279743|P1|STARTED|Maintenance Therapy|One participant removed from study after completing induction therapy due to progressive disease.|2
523810|NCT00869323|1279743|P1|NOT COMPLETED|Induction Therapy||0
523811|NCT00869323|1279743|P1|COMPLETED|Induction Therapy||3
523812|NCT00869323|1279743|P1|STARTED|Induction Therapy||3
523813|NCT00869258|1279751|P1|NOT COMPLETED|Overall Study||1
523814|NCT00869258|1279751|P1|COMPLETED|Overall Study||31
523815|NCT00869258|1279751|P1|STARTED|Overall Study||32
523816|NCT00869167|1279757|P2|NOT COMPLETED|Overall Study||1
523817|NCT00869167|1279758|P1|NOT COMPLETED|Overall Study||0
523818|NCT00869167|1279757|P2|COMPLETED|Overall Study||0
523819|NCT00869167|1279758|P1|COMPLETED|Overall Study||2
523820|NCT00869167|1279757|P2|STARTED|Overall Study||1
523821|NCT00869167|1279758|P1|STARTED|Overall Study||2
523822|NCT00869141|1279774|P2|NOT COMPLETED|Overall Study||0
523823|NCT00869141|1279775|P1|NOT COMPLETED|Overall Study||0
523824|NCT00869141|1279774|P2|COMPLETED|Overall Study||26
523825|NCT00869141|1279775|P1|COMPLETED|Overall Study||26
523826|NCT00869141|1279774|P2|STARTED|Overall Study||26
523827|NCT00869141|1279775|P1|STARTED|Overall Study||26
523828|NCT00869128|1279785|P2|NOT COMPLETED|Overall Study||6
523829|NCT00869128|1279786|P1|NOT COMPLETED|Overall Study||6
523830|NCT00869128|1279785|P2|COMPLETED|Overall Study||12
523831|NCT00869128|1279786|P1|COMPLETED|Overall Study||12
523832|NCT00869128|1279785|P2|STARTED|Overall Study||18
523833|NCT00869128|1279786|P1|STARTED|Overall Study||18
523834|NCT00869089|1279790|P1|NOT COMPLETED|Overall Study||3
523835|NCT00869089|1279790|P1|COMPLETED|Overall Study||2
523836|NCT00869089|1279790|P1|STARTED|Overall Study||5
523837|NCT00869050|1279794|P1|NOT COMPLETED|Overall Study||3
523838|NCT00869050|1279794|P1|COMPLETED|Overall Study||38
523839|NCT00869050|1279794|P1|STARTED|Overall Study||41
523840|NCT00868998|1279799|P1|NOT COMPLETED|Overall Study||5
523841|NCT00868998|1279799|P1|COMPLETED|Overall Study||0
523842|NCT00868998|1279799|P1|STARTED|Overall Study||5
523843|NCT00868959|1279804|P1|NOT COMPLETED|Overall Study||258
523844|NCT00868959|1279804|P1|COMPLETED|Overall Study||559
523845|NCT00868959|1279804|P1|STARTED|Overall Study|817 represents total number of subjects who provided informed consent.|817
523846|NCT00868790|1279810|P14|NOT COMPLETED|Post-study||0
523847|NCT00868790|1279811|P13|NOT COMPLETED|Post-study||0
523848|NCT00868790|1279812|P12|NOT COMPLETED|Post-study||0
523849|NCT00868790|1279813|P11|NOT COMPLETED|Post-study||0
523850|NCT00868790|1279814|P10|NOT COMPLETED|Post-study||1
523851|NCT00868790|1279815|P9|NOT COMPLETED|Post-study||0
523852|NCT00868790|1279816|P8|NOT COMPLETED|Post-study||2
523853|NCT00868790|1279817|P7|NOT COMPLETED|Post-study||0
523854|NCT00868790|1279818|P6|NOT COMPLETED|Post-study||0
523855|NCT00868790|1279819|P5|NOT COMPLETED|Post-study||1
523856|NCT00868790|1279820|P4|NOT COMPLETED|Post-study||0
523857|NCT00868790|1279821|P3|NOT COMPLETED|Post-study||0
523858|NCT00868790|1279822|P2|NOT COMPLETED|Post-study||0
523859|NCT00868790|1279823|P1|NOT COMPLETED|Post-study||0
523860|NCT00868790|1279810|P14|COMPLETED|Post-study||7
523861|NCT00868790|1279811|P13|COMPLETED|Post-study||6
523862|NCT00868790|1279812|P12|COMPLETED|Post-study||3
523863|NCT00868790|1279813|P11|COMPLETED|Post-study||5
523864|NCT00868790|1279814|P10|COMPLETED|Post-study||1
523865|NCT00868790|1279815|P9|COMPLETED|Post-study||6
523866|NCT00868790|1279816|P8|COMPLETED|Post-study||12
523867|NCT00868790|1279817|P7|COMPLETED|Post-study||4
523868|NCT00868790|1279818|P6|COMPLETED|Post-study||1
523869|NCT00868790|1279819|P5|COMPLETED|Post-study||17
523870|NCT00868790|1279820|P4|COMPLETED|Post-study||3
523871|NCT00868790|1279821|P3|COMPLETED|Post-study||3
523872|NCT00868790|1279822|P2|COMPLETED|Post-study||6
523873|NCT00868790|1279823|P1|COMPLETED|Post-study||7
523874|NCT00868790|1279810|P14|STARTED|Post-study||7
523875|NCT00868790|1279811|P13|STARTED|Post-study||6
523876|NCT00868790|1279812|P12|STARTED|Post-study||3
523877|NCT00868790|1279813|P11|STARTED|Post-study||5
523878|NCT00868790|1279814|P10|STARTED|Post-study||2
523879|NCT00868790|1279815|P9|STARTED|Post-study||6
523880|NCT00868790|1279816|P8|STARTED|Post-study||14
523881|NCT00868790|1279817|P7|STARTED|Post-study||4
523882|NCT00868790|1279818|P6|STARTED|Post-study||1
523883|NCT00868790|1279819|P5|STARTED|Post-study||18
523884|NCT00868790|1279820|P4|STARTED|Post-study||3
523885|NCT00868790|1279821|P3|STARTED|Post-study||3
523886|NCT00868790|1279822|P2|STARTED|Post-study||6
523887|NCT00868790|1279823|P1|STARTED|Post-study||7
523888|NCT00868790|1279810|P14|NOT COMPLETED|Period 4||1
523889|NCT00868790|1279811|P13|NOT COMPLETED|Period 4||1
523890|NCT00868790|1279812|P12|NOT COMPLETED|Period 4||1
523891|NCT00868790|1279813|P11|NOT COMPLETED|Period 4||3
523892|NCT00868790|1279814|P10|NOT COMPLETED|Period 4||0
523893|NCT00868790|1279815|P9|NOT COMPLETED|Period 4||2
523894|NCT00868790|1279816|P8|NOT COMPLETED|Period 4||3
523895|NCT00868790|1279817|P7|NOT COMPLETED|Period 4||0
523896|NCT00868790|1279818|P6|NOT COMPLETED|Period 4||0
523897|NCT00868790|1279819|P5|NOT COMPLETED|Period 4||0
523898|NCT00868790|1279820|P4|NOT COMPLETED|Period 4||0
523899|NCT00868790|1279821|P3|NOT COMPLETED|Period 4||1
523900|NCT00868790|1279822|P2|NOT COMPLETED|Period 4||0
523901|NCT00868790|1279823|P1|NOT COMPLETED|Period 4||2
523902|NCT00868790|1279810|P14|COMPLETED|Period 4||7
523903|NCT00868790|1279811|P13|COMPLETED|Period 4||6
523904|NCT00868790|1279812|P12|COMPLETED|Period 4||3
523905|NCT00868790|1279813|P11|COMPLETED|Period 4||5
523906|NCT00868790|1279814|P10|COMPLETED|Period 4||2
523907|NCT00868790|1279815|P9|COMPLETED|Period 4||6
523908|NCT00868790|1279816|P8|COMPLETED|Period 4||14
523909|NCT00868790|1279817|P7|COMPLETED|Period 4||4
523910|NCT00868790|1279818|P6|COMPLETED|Period 4||1
523911|NCT00868790|1279819|P5|COMPLETED|Period 4||18
523912|NCT00868790|1279820|P4|COMPLETED|Period 4||3
523913|NCT00868790|1279821|P3|COMPLETED|Period 4|One non-completion due to abnormal alanine aminotransferase/aspartate aminotransferase (ALT/AST)|3
523914|NCT00868790|1279822|P2|COMPLETED|Period 4||6
523915|NCT00868790|1279823|P1|COMPLETED|Period 4||7
523916|NCT00868790|1279810|P14|STARTED|Period 4||8
523917|NCT00868790|1279811|P13|STARTED|Period 4||7
523918|NCT00868790|1279812|P12|STARTED|Period 4||4
523919|NCT00868790|1279813|P11|STARTED|Period 4||8
523920|NCT00868790|1279814|P10|STARTED|Period 4||2
523921|NCT00868790|1279815|P9|STARTED|Period 4||8
523922|NCT00868790|1279816|P8|STARTED|Period 4||17
523923|NCT00868790|1279817|P7|STARTED|Period 4||4
523924|NCT00868790|1279818|P6|STARTED|Period 4||1
523925|NCT00868790|1279819|P5|STARTED|Period 4||18
523926|NCT00868790|1279820|P4|STARTED|Period 4||3
523927|NCT00868790|1279821|P3|STARTED|Period 4||4
523928|NCT00868790|1279822|P2|STARTED|Period 4||6
523929|NCT00868790|1279823|P1|STARTED|Period 4||9
523930|NCT00868790|1279810|P14|NOT COMPLETED|Period 3||0
523931|NCT00868790|1279811|P13|NOT COMPLETED|Period 3||0
523932|NCT00868790|1279812|P12|NOT COMPLETED|Period 3||0
523933|NCT00868790|1279813|P11|NOT COMPLETED|Period 3||1
523934|NCT00868790|1279814|P10|NOT COMPLETED|Period 3||1
523935|NCT00868790|1279815|P9|NOT COMPLETED|Period 3||0
523936|NCT00868790|1279816|P8|NOT COMPLETED|Period 3||0
523937|NCT00868790|1279817|P7|NOT COMPLETED|Period 3||0
523938|NCT00868790|1279818|P6|NOT COMPLETED|Period 3||0
523939|NCT00868790|1279819|P5|NOT COMPLETED|Period 3||0
523940|NCT00868790|1279820|P4|NOT COMPLETED|Period 3||1
523941|NCT00868790|1279821|P3|NOT COMPLETED|Period 3||0
523942|NCT00868790|1279822|P2|NOT COMPLETED|Period 3||0
523943|NCT00868790|1279823|P1|NOT COMPLETED|Period 3||0
523944|NCT00868790|1279810|P14|COMPLETED|Period 3||8
523945|NCT00868790|1279811|P13|COMPLETED|Period 3||7
523946|NCT00868790|1279812|P12|COMPLETED|Period 3||4
523947|NCT00868790|1279813|P11|COMPLETED|Period 3||8
523948|NCT00868790|1279814|P10|COMPLETED|Period 3||2
523949|NCT00868790|1279815|P9|COMPLETED|Period 3||8
523950|NCT00868790|1279816|P8|COMPLETED|Period 3||17
523951|NCT00868790|1279817|P7|COMPLETED|Period 3||4
523952|NCT00868790|1279818|P6|COMPLETED|Period 3||1
523953|NCT00868790|1279819|P5|COMPLETED|Period 3||18
523954|NCT00868790|1279820|P4|COMPLETED|Period 3||3
523955|NCT00868790|1279821|P3|COMPLETED|Period 3||4
523956|NCT00868790|1279822|P2|COMPLETED|Period 3||6
523957|NCT00868790|1279823|P1|COMPLETED|Period 3||9
523958|NCT00868790|1279810|P14|STARTED|Period 3||8
523959|NCT00868790|1279811|P13|STARTED|Period 3||7
523960|NCT00868790|1279812|P12|STARTED|Period 3||4
523961|NCT00868790|1279813|P11|STARTED|Period 3||9
523962|NCT00868790|1279814|P10|STARTED|Period 3||3
523963|NCT00868790|1279815|P9|STARTED|Period 3||8
523964|NCT00868790|1279816|P8|STARTED|Period 3||17
523965|NCT00868790|1279817|P7|STARTED|Period 3||4
523966|NCT00868790|1279818|P6|STARTED|Period 3||1
523967|NCT00868790|1279819|P5|STARTED|Period 3||18
523968|NCT00868790|1279820|P4|STARTED|Period 3||4
523969|NCT00868790|1279821|P3|STARTED|Period 3||4
523970|NCT00868790|1279822|P2|STARTED|Period 3||6
523971|NCT00868790|1279823|P1|STARTED|Period 3||9
523972|NCT00868790|1279810|P14|NOT COMPLETED|Period 2||1
523973|NCT00868790|1279811|P13|NOT COMPLETED|Period 2||0
523974|NCT00868790|1279812|P12|NOT COMPLETED|Period 2||0
523975|NCT00868790|1279813|P11|NOT COMPLETED|Period 2||0
523976|NCT00868790|1279814|P10|NOT COMPLETED|Period 2||0
523977|NCT00868790|1279815|P9|NOT COMPLETED|Period 2||2
523978|NCT00868790|1279816|P8|NOT COMPLETED|Period 2||0
523979|NCT00868790|1279817|P7|NOT COMPLETED|Period 2||0
523980|NCT00868790|1279818|P6|NOT COMPLETED|Period 2||1
523981|NCT00868790|1279819|P5|NOT COMPLETED|Period 2||0
523982|NCT00868790|1279820|P4|NOT COMPLETED|Period 2||0
523983|NCT00868790|1279821|P3|NOT COMPLETED|Period 2||0
523984|NCT00868790|1279822|P2|NOT COMPLETED|Period 2||1
523985|NCT00868790|1279823|P1|NOT COMPLETED|Period 2||0
523986|NCT00868790|1279810|P14|COMPLETED|Period 2||8
523987|NCT00868790|1279811|P13|COMPLETED|Period 2||7
523988|NCT00868790|1279812|P12|COMPLETED|Period 2||4
523989|NCT00868790|1279813|P11|COMPLETED|Period 2||9
523990|NCT00868790|1279814|P10|COMPLETED|Period 2||3
523991|NCT00868790|1279815|P9|COMPLETED|Period 2||8
523992|NCT00868790|1279816|P8|COMPLETED|Period 2||17
523993|NCT00868790|1279817|P7|COMPLETED|Period 2||4
523994|NCT00868790|1279818|P6|COMPLETED|Period 2||1
523995|NCT00868790|1279819|P5|COMPLETED|Period 2||18
523996|NCT00868790|1279820|P4|COMPLETED|Period 2||4
523997|NCT00868790|1279821|P3|COMPLETED|Period 2||4
523998|NCT00868790|1279822|P2|COMPLETED|Period 2||6
523999|NCT00868790|1279823|P1|COMPLETED|Period 2||9
524000|NCT00868790|1279810|P14|STARTED|Period 2||9
524001|NCT00868790|1279811|P13|STARTED|Period 2||7
524002|NCT00868790|1279812|P12|STARTED|Period 2||4
524003|NCT00868790|1279813|P11|STARTED|Period 2||9
524004|NCT00868790|1279814|P10|STARTED|Period 2||3
524005|NCT00868790|1279815|P9|STARTED|Period 2||10
524006|NCT00868790|1279816|P8|STARTED|Period 2||17
524007|NCT00868790|1279817|P7|STARTED|Period 2||4
524008|NCT00868790|1279818|P6|STARTED|Period 2||2
524009|NCT00868790|1279819|P5|STARTED|Period 2||18
524010|NCT00868790|1279820|P4|STARTED|Period 2||4
524011|NCT00868790|1279821|P3|STARTED|Period 2||4
524012|NCT00868790|1279822|P2|STARTED|Period 2||7
524013|NCT00868790|1279823|P1|STARTED|Period 2||9
524014|NCT00868790|1279810|P14|NOT COMPLETED|Period 1||2
524015|NCT00868790|1279811|P13|NOT COMPLETED|Period 1||0
524016|NCT00868790|1279812|P12|NOT COMPLETED|Period 1||0
524017|NCT00868790|1279813|P11|NOT COMPLETED|Period 1||0
524018|NCT00868790|1279814|P10|NOT COMPLETED|Period 1||0
524019|NCT00868790|1279815|P9|NOT COMPLETED|Period 1||1
524020|NCT00868790|1279816|P8|NOT COMPLETED|Period 1||3
524021|NCT00868790|1279817|P7|NOT COMPLETED|Period 1||0
524022|NCT00868790|1279818|P6|NOT COMPLETED|Period 1||1
524023|NCT00868790|1279819|P5|NOT COMPLETED|Period 1||1
524024|NCT00868790|1279820|P4|NOT COMPLETED|Period 1||0
524025|NCT00868790|1279821|P3|NOT COMPLETED|Period 1||0
524026|NCT00868790|1279822|P2|NOT COMPLETED|Period 1||1
524027|NCT00868790|1279823|P1|NOT COMPLETED|Period 1||2
524028|NCT00868790|1279810|P14|COMPLETED|Period 1||9
524029|NCT00868790|1279811|P13|COMPLETED|Period 1||7
524030|NCT00868790|1279812|P12|COMPLETED|Period 1||4
524031|NCT00868790|1279813|P11|COMPLETED|Period 1||9
524032|NCT00868790|1279814|P10|COMPLETED|Period 1||3
524033|NCT00868790|1279815|P9|COMPLETED|Period 1||10
524034|NCT00868790|1279816|P8|COMPLETED|Period 1||17
524035|NCT00868790|1279817|P7|COMPLETED|Period 1||4
524036|NCT00868790|1279818|P6|COMPLETED|Period 1||2
524037|NCT00868790|1279819|P5|COMPLETED|Period 1||18
524038|NCT00868790|1279820|P4|COMPLETED|Period 1||4
524039|NCT00868790|1279821|P3|COMPLETED|Period 1||4
524040|NCT00868790|1279822|P2|COMPLETED|Period 1||7
524041|NCT00868790|1279823|P1|COMPLETED|Period 1||9
524042|NCT00868790|1279810|P14|STARTED|Period 1||11
524043|NCT00868790|1279811|P13|STARTED|Period 1||7
524044|NCT00868790|1279812|P12|STARTED|Period 1||4
524045|NCT00868790|1279813|P11|STARTED|Period 1||9
524046|NCT00868790|1279814|P10|STARTED|Period 1||3
524047|NCT00868790|1279815|P9|STARTED|Period 1||11
524048|NCT00868790|1279816|P8|STARTED|Period 1||20
524049|NCT00868790|1279817|P7|STARTED|Period 1||4
524050|NCT00868790|1279818|P6|STARTED|Period 1||3
524051|NCT00868790|1279819|P5|STARTED|Period 1||19
524052|NCT00868790|1279820|P4|STARTED|Period 1||4
524053|NCT00868790|1279821|P3|STARTED|Period 1||4
524054|NCT00868790|1279822|P2|STARTED|Period 1||8
524055|NCT00868790|1279823|P1|STARTED|Period 1||11
524056|NCT00868751|1279860|P1|NOT COMPLETED|Overall Study||1
524057|NCT00868751|1279860|P1|COMPLETED|Overall Study||0
524058|NCT00868751|1279860|P1|STARTED|Overall Study||1
524059|NCT00868712|1279871|P3|NOT COMPLETED|Overall Study||0
524060|NCT00868712|1279872|P2|NOT COMPLETED|Overall Study||0
524061|NCT00868712|1279873|P1|NOT COMPLETED|Overall Study||0
524062|NCT00868712|1279871|P3|COMPLETED|Overall Study||28
524063|NCT00868712|1279872|P2|COMPLETED|Overall Study||11
524064|NCT00868712|1279873|P1|COMPLETED|Overall Study||31
524065|NCT00868712|1279871|P3|STARTED|Overall Study||28
524066|NCT00868712|1279872|P2|STARTED|Overall Study||11
524067|NCT00868712|1279873|P1|STARTED|Overall Study||31
524068|NCT00868699|1279887|P3|NOT COMPLETED|Overall Study||43
524069|NCT00868699|1279888|P2|NOT COMPLETED|Overall Study||45
524070|NCT00868699|1279889|P1|NOT COMPLETED|Overall Study||43
524071|NCT00868699|1279887|P3|COMPLETED|Overall Study||123
524072|NCT00868699|1279888|P2|COMPLETED|Overall Study||124
524073|NCT00868699|1279889|P1|COMPLETED|Overall Study||127
524074|NCT00868699|1279887|P3|Safety Population|Overall Study||164
524075|NCT00868699|1279888|P2|Safety Population|Overall Study||167
524076|NCT00868699|1279889|P1|Safety Population|Overall Study||168
524077|NCT00868699|1279887|P3|Intent-to-Treat Population|Overall Study||161
524078|NCT00868699|1279888|P2|Intent-to-Treat Population|Overall Study||162
524079|NCT00868699|1279889|P1|Intent-to-Treat Population|Overall Study||162
524080|NCT00868699|1279887|P3|STARTED|Overall Study||166
524081|NCT00868699|1279888|P2|STARTED|Overall Study||169
524082|NCT00868699|1279889|P1|STARTED|Overall Study||170
524083|NCT00868608|1279906|P3|NOT COMPLETED|Overall Study||5
524084|NCT00868608|1279907|P2|NOT COMPLETED|Overall Study||3
524085|NCT00868608|1279908|P1|NOT COMPLETED|Overall Study||23
524086|NCT00868608|1279906|P3|COMPLETED|Overall Study||0
524087|NCT00868608|1279907|P2|COMPLETED|Overall Study||1
524088|NCT00868608|1279908|P1|COMPLETED|Overall Study||49
524089|NCT00868608|1279906|P3|STARTED|Overall Study||5
524090|NCT00868608|1279907|P2|STARTED|Overall Study||4
524091|NCT00868608|1279908|P1|STARTED|Overall Study||72
524092|NCT00868530|1279932|P1|NOT COMPLETED|Overall Study||4
524093|NCT00868530|1279932|P1|COMPLETED|Overall Study||49
524094|NCT00868530|1279932|P1|STARTED|Overall Study||53
524095|NCT00868517|1279947|P3|NOT COMPLETED|Overall Study||2
524096|NCT00868517|1279948|P2|NOT COMPLETED|Overall Study||4
524097|NCT00868517|1279949|P1|NOT COMPLETED|Overall Study||4
524098|NCT00868517|1279947|P3|COMPLETED|Overall Study||9
524099|NCT00868517|1279948|P2|COMPLETED|Overall Study||8
524100|NCT00868517|1279949|P1|COMPLETED|Overall Study||8
524101|NCT00868517|1279947|P3|STARTED|Overall Study||11
524102|NCT00868517|1279948|P2|STARTED|Overall Study||12
524103|NCT00868517|1279949|P1|STARTED|Overall Study||12
524104|NCT00868452|1279974|P2|NOT COMPLETED|Overall Study||29
524105|NCT00868452|1279975|P1|NOT COMPLETED|Overall Study||40
524106|NCT00868452|1279974|P2|COMPLETED|Overall Study||136
524107|NCT00868452|1279975|P1|COMPLETED|Overall Study||143
524108|NCT00868452|1279974|P2|STARTED|Overall Study||165
524109|NCT00868452|1279975|P1|STARTED|Overall Study||183
524110|NCT00868439|1279987|P2|NOT COMPLETED|Overall Study||9
524111|NCT00868439|1279988|P1|NOT COMPLETED|Overall Study||8
524112|NCT00868439|1279987|P2|COMPLETED|Overall Study||40
524113|NCT00868439|1279988|P1|COMPLETED|Overall Study||48
524114|NCT00868439|1279987|P2|STARTED|Overall Study||49
524115|NCT00868439|1279988|P1|STARTED|Overall Study||56
524116|NCT00868374|1280006|P2|NOT COMPLETED|Overall Study||7
524117|NCT00868374|1280007|P1|NOT COMPLETED|Overall Study||7
524118|NCT00868374|1280006|P2|COMPLETED|Overall Study||4
524119|NCT00868374|1280007|P1|COMPLETED|Overall Study||5
524120|NCT00868374|1280006|P2|STARTED|Overall Study||11
524121|NCT00868374|1280007|P1|STARTED|Overall Study||12
524122|NCT00868348|1280015|P2|NOT COMPLETED|Overall Study||0
524123|NCT00868348|1280016|P1|NOT COMPLETED|Overall Study||0
524124|NCT00868348|1280015|P2|COMPLETED|Overall Study||30
524125|NCT00868348|1280016|P1|COMPLETED|Overall Study||30
524126|NCT00868348|1280015|P2|STARTED|Overall Study||30
524127|NCT00868348|1280016|P1|STARTED|Overall Study||30
524128|NCT00868309|1280034|P2|NOT COMPLETED|Overall Study||0
524129|NCT00868309|1280035|P1|NOT COMPLETED|Overall Study||0
524130|NCT00868309|1280034|P2|COMPLETED|Overall Study||6
524131|NCT00868309|1280035|P1|COMPLETED|Overall Study||6
524132|NCT00868309|1280034|P2|STARTED|Overall Study||6
524133|NCT00868309|1280035|P1|STARTED|Overall Study||6
524134|NCT00868296|1280045|P2|NOT COMPLETED|Overall Study||3
524135|NCT00868296|1280046|P1|NOT COMPLETED|Overall Study||0
524136|NCT00868296|1280045|P2|COMPLETED|Overall Study||43
524137|NCT00868296|1280046|P1|COMPLETED|Overall Study||12
524138|NCT00868296|1280045|P2|STARTED|Overall Study||46
524139|NCT00868296|1280046|P1|STARTED|Overall Study||12
524140|NCT00868231|1280054|P6|NOT COMPLETED|Treatment Period 3||0
524141|NCT00868231|1280055|P5|NOT COMPLETED|Treatment Period 3||0
524142|NCT00868231|1280056|P4|NOT COMPLETED|Treatment Period 3||0
524143|NCT00868231|1280057|P3|NOT COMPLETED|Treatment Period 3||1
524144|NCT00868231|1280058|P2|NOT COMPLETED|Treatment Period 3||0
524145|NCT00868231|1280059|P1|NOT COMPLETED|Treatment Period 3||0
524146|NCT00868231|1280054|P6|COMPLETED|Treatment Period 3||5
524147|NCT00868231|1280055|P5|COMPLETED|Treatment Period 3||4
524148|NCT00868231|1280056|P4|COMPLETED|Treatment Period 3||5
524149|NCT00868231|1280057|P3|COMPLETED|Treatment Period 3||4
524150|NCT00868231|1280058|P2|COMPLETED|Treatment Period 3||5
524151|NCT00868231|1280059|P1|COMPLETED|Treatment Period 3||4
524152|NCT00868231|1280054|P6|STARTED|Treatment Period 3||5
524153|NCT00868231|1280055|P5|STARTED|Treatment Period 3||4
524154|NCT00868231|1280056|P4|STARTED|Treatment Period 3||5
524155|NCT00868231|1280057|P3|STARTED|Treatment Period 3||5
524156|NCT00868231|1280058|P2|STARTED|Treatment Period 3||5
524157|NCT00868231|1280059|P1|STARTED|Treatment Period 3||4
524158|NCT00868231|1280054|P6|NOT COMPLETED|Treatment Period 2||0
524159|NCT00868231|1280055|P5|NOT COMPLETED|Treatment Period 2||0
524160|NCT00868231|1280056|P4|NOT COMPLETED|Treatment Period 2||0
524161|NCT00868231|1280057|P3|NOT COMPLETED|Treatment Period 2||0
524162|NCT00868231|1280058|P2|NOT COMPLETED|Treatment Period 2||0
524163|NCT00868231|1280059|P1|NOT COMPLETED|Treatment Period 2||1
524164|NCT00868231|1280054|P6|COMPLETED|Treatment Period 2||5
524165|NCT00868231|1280055|P5|COMPLETED|Treatment Period 2||4
524166|NCT00868231|1280056|P4|COMPLETED|Treatment Period 2||5
524167|NCT00868231|1280057|P3|COMPLETED|Treatment Period 2||5
524168|NCT00868231|1280058|P2|COMPLETED|Treatment Period 2||5
524169|NCT00868231|1280059|P1|COMPLETED|Treatment Period 2||4
524170|NCT00868231|1280054|P6|STARTED|Treatment Period 2||5
524171|NCT00868231|1280055|P5|STARTED|Treatment Period 2||4
524172|NCT00868231|1280056|P4|STARTED|Treatment Period 2||5
524173|NCT00868231|1280057|P3|STARTED|Treatment Period 2||5
524174|NCT00868231|1280058|P2|STARTED|Treatment Period 2||5
524175|NCT00868231|1280059|P1|STARTED|Treatment Period 2||5
524176|NCT00868231|1280054|P6|NOT COMPLETED|Treatment Period 1||0
524177|NCT00868231|1280055|P5|NOT COMPLETED|Treatment Period 1||1
524178|NCT00868231|1280056|P4|NOT COMPLETED|Treatment Period 1||0
524179|NCT00868231|1280057|P3|NOT COMPLETED|Treatment Period 1||0
524180|NCT00868231|1280058|P2|NOT COMPLETED|Treatment Period 1||0
524181|NCT00868231|1280059|P1|NOT COMPLETED|Treatment Period 1||0
524182|NCT00868231|1280054|P6|COMPLETED|Treatment Period 1||5
524183|NCT00868231|1280055|P5|COMPLETED|Treatment Period 1||4
524184|NCT00868231|1280056|P4|COMPLETED|Treatment Period 1||5
524185|NCT00868231|1280057|P3|COMPLETED|Treatment Period 1||5
524186|NCT00868231|1280058|P2|COMPLETED|Treatment Period 1||5
524187|NCT00868231|1280059|P1|COMPLETED|Treatment Period 1||5
524188|NCT00868231|1280054|P6|STARTED|Treatment Period 1||5
524189|NCT00868231|1280055|P5|STARTED|Treatment Period 1||5
524190|NCT00868231|1280056|P4|STARTED|Treatment Period 1||5
524191|NCT00868231|1280057|P3|STARTED|Treatment Period 1||5
524192|NCT00868231|1280058|P2|STARTED|Treatment Period 1||5
524193|NCT00868231|1280059|P1|STARTED|Treatment Period 1||5
524194|NCT00868218|1280104|P4|NOT COMPLETED|Overall Study||0
524195|NCT00868218|1280105|P3|NOT COMPLETED|Overall Study||0
524196|NCT00868218|1280106|P2|NOT COMPLETED|Overall Study||0
524197|NCT00868218|1280107|P1|NOT COMPLETED|Overall Study||0
524198|NCT00868218|1280104|P4|COMPLETED|Overall Study||15
524199|NCT00868218|1280105|P3|COMPLETED|Overall Study||15
524200|NCT00868218|1280106|P2|COMPLETED|Overall Study||15
524201|NCT00868218|1280107|P1|COMPLETED|Overall Study||15
524202|NCT00868218|1280104|P4|STARTED|Overall Study||15
524203|NCT00868218|1280105|P3|STARTED|Overall Study||15
524204|NCT00868218|1280106|P2|STARTED|Overall Study||15
524205|NCT00868218|1280107|P1|STARTED|Overall Study||15
524206|NCT00868192|1280125|P1|NOT COMPLETED|Overall Study||4
524207|NCT00868192|1280125|P1|COMPLETED|Overall Study||34
524208|NCT00868192|1280125|P1|STARTED|Overall Study||38
524209|NCT00868140|1280142|P2|NOT COMPLETED|Overall Study||0
524210|NCT00868140|1280143|P1|NOT COMPLETED|Overall Study||0
524211|NCT00868140|1280142|P2|COMPLETED|Overall Study||25
524212|NCT00868140|1280143|P1|COMPLETED|Overall Study||26
524213|NCT00868140|1280142|P2|STARTED|Overall Study||25
524214|NCT00868140|1280143|P1|STARTED|Overall Study||26
524215|NCT00868101|1280161|P2|NOT COMPLETED|Overall Study||0
524216|NCT00868101|1280162|P1|NOT COMPLETED|Overall Study||0
524217|NCT00868101|1280161|P2|COMPLETED|Overall Study||10
524218|NCT00868101|1280162|P1|COMPLETED|Overall Study||12
524219|NCT00868101|1280161|P2|STARTED|Overall Study||10
524220|NCT00868101|1280162|P1|STARTED|Overall Study||12
524221|NCT00867659|1280174|P1|NOT COMPLETED|Overall Study||0
524222|NCT00867659|1280174|P1|COMPLETED|Overall Study|January 2010|20
524223|NCT00867659|1280174|P1|STARTED|Overall Study|October 2009|20
524224|NCT00867568|1280179|P1|NOT COMPLETED|Overall Study||15
524225|NCT00867568|1280179|P1|COMPLETED|Overall Study||3
524226|NCT00867568|1280179|P1|STARTED|Overall Study||18
524227|NCT00867529|1280188|P1|NOT COMPLETED|Overall Study||0
524228|NCT00867529|1280188|P1|COMPLETED|Overall Study||63
524229|NCT00867529|1280188|P1|STARTED|Overall Study||63
524230|NCT00867503|1280196|P1|NOT COMPLETED|Overall Study||1
524231|NCT00867503|1280196|P1|COMPLETED|Overall Study||9
524232|NCT00867503|1280196|P1|STARTED|Overall Study||10
524233|NCT00867490|1280202|P1|NOT COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||0
524234|NCT00867490|1280202|P1|COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||61
524235|NCT00867490|1280202|P1|STARTED|Phase 3 - Aliskiren+HCTZ+Amlodipine|The first 60 patients with systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg entered this phase.|61
524236|NCT00867490|1280202|P1|NOT COMPLETED|Phase 2 - Aliskiren+HCTZ||3
524237|NCT00867490|1280202|P1|COMPLETED|Phase 2 - Aliskiren+HCTZ||120
524238|NCT00867490|1280202|P1|STARTED|Phase 2 - Aliskiren+HCTZ|Only patients with mean sitting diastolic BP ≥ 90 mmHg at the end of Phase 1 entered this phase.|123
524239|NCT00867490|1280202|P1|NOT COMPLETED|Phase 1 - Candesartan+HCTZ||10
524240|NCT00867490|1280202|P1|COMPLETED|Phase 1 - Candesartan+HCTZ||176
524241|NCT00867490|1280202|P1|STARTED|Phase 1 - Candesartan+HCTZ||186
524242|NCT00867451|1280221|P2|NOT COMPLETED|Overall Study||0
524243|NCT00867451|1280222|P1|NOT COMPLETED|Overall Study||0
524244|NCT00867451|1280221|P2|COMPLETED|Overall Study||4
524245|NCT00867451|1280222|P1|COMPLETED|Overall Study||4
524246|NCT00867451|1280221|P2|STARTED|Overall Study||4
524247|NCT00867451|1280222|P1|STARTED|Overall Study||4
524248|NCT00867360|1280244|P2|NOT COMPLETED|Overall Study||1
524249|NCT00867360|1280245|P1|NOT COMPLETED|Overall Study||1
524250|NCT00867360|1280244|P2|COMPLETED|Overall Study||5
524251|NCT00867360|1280245|P1|COMPLETED|Overall Study||3
524252|NCT00867360|1280244|P2|STARTED|Overall Study||6
524253|NCT00867360|1280245|P1|STARTED|Overall Study||4
524254|NCT00867321|1280258|P6|NOT COMPLETED|Overall Study||0
524255|NCT00867321|1280259|P5|NOT COMPLETED|Overall Study||0
524256|NCT00867321|1280260|P4|NOT COMPLETED|Overall Study||0
524257|NCT00867321|1280261|P3|NOT COMPLETED|Overall Study||0
524258|NCT00867321|1280262|P2|NOT COMPLETED|Overall Study||1
524259|NCT00867321|1280263|P1|NOT COMPLETED|Overall Study||0
524260|NCT00867321|1280258|P6|COMPLETED|Overall Study||3
524261|NCT00867321|1280259|P5|COMPLETED|Overall Study||5
524262|NCT00867321|1280260|P4|COMPLETED|Overall Study||6
524263|NCT00867321|1280261|P3|COMPLETED|Overall Study||3
524264|NCT00867321|1280262|P2|COMPLETED|Overall Study||2
524265|NCT00867321|1280263|P1|COMPLETED|Overall Study||4
524266|NCT00867321|1280258|P6|STARTED|Overall Study||3
524267|NCT00867321|1280259|P5|STARTED|Overall Study||5
524268|NCT00867321|1280260|P4|STARTED|Overall Study||6
524269|NCT00867321|1280261|P3|STARTED|Overall Study||3
524270|NCT00867321|1280262|P2|STARTED|Overall Study||3
524271|NCT00867321|1280263|P1|STARTED|Overall Study||4
524272|NCT00867217|1280283|P2|NOT COMPLETED|Overall Study||10
524273|NCT00867217|1280284|P1|NOT COMPLETED|Overall Study||3
524274|NCT00867217|1280283|P2|COMPLETED|Overall Study||70
524275|NCT00867217|1280284|P1|COMPLETED|Overall Study||77
524276|NCT00867217|1280283|P2|STARTED|Overall Study||80
524277|NCT00867217|1280284|P1|STARTED|Overall Study||80
524278|NCT00867165|1280292|P2|NOT COMPLETED|Overall Study||0
524279|NCT00867165|1280293|P1|NOT COMPLETED|Overall Study||4
524280|NCT00867165|1280292|P2|COMPLETED|Overall Study||45
524281|NCT00867165|1280293|P1|COMPLETED|Overall Study||89
524282|NCT00867165|1280292|P2|STARTED|Overall Study||45
524283|NCT00867165|1280293|P1|STARTED|Overall Study||93
524284|NCT00867139|1280398|P3|NOT COMPLETED|Overall Study||1
524285|NCT00867139|1280399|P2|NOT COMPLETED|Overall Study||0
524286|NCT00867139|1280400|P1|NOT COMPLETED|Overall Study||0
524287|NCT00867139|1280398|P3|COMPLETED|Overall Study|One open-labeled patient withdrew on day 5.|3
524288|NCT00867139|1280399|P2|COMPLETED|Overall Study||1
524289|NCT00867139|1280400|P1|COMPLETED|Overall Study||2
524290|NCT00867139|1280398|P3|STARTED|Overall Study||4
524291|NCT00867139|1280399|P2|STARTED|Overall Study||1
524292|NCT00867139|1280400|P1|STARTED|Overall Study||2
524293|NCT00867113|1280441|P1|NOT COMPLETED|Post Treatment After Survival Follow-up||11
524294|NCT00867113|1280441|P1|COMPLETED|Post Treatment After Survival Follow-up||57
524295|NCT00867113|1280441|P1|STARTED|Post Treatment After Survival Follow-up||68
524296|NCT00867113|1280441|P1|NOT COMPLETED|Treatment Period||45
524297|NCT00867113|1280441|P1|COMPLETED|Treatment Period||46
524298|NCT00867113|1280441|P1|Full Analysis Set (FAS)|Treatment Period||91
524299|NCT00867113|1280441|P1|Safety Set|Treatment Period||91
524300|NCT00867113|1280441|P1|STARTED|Treatment Period||91
524301|NCT00867087|1280448|P1|NOT COMPLETED|Overall Study||42
524302|NCT00867087|1280448|P1|COMPLETED|Overall Study||21
524303|NCT00867087|1280448|P1|STARTED|Overall Study||63
524304|NCT00867035|1280464|P2|NOT COMPLETED|Baseline to 1 Week||0
524305|NCT00867035|1280465|P1|NOT COMPLETED|Baseline to 1 Week||1
524306|NCT00867035|1280464|P2|COMPLETED|Baseline to 1 Week||8
524307|NCT00867035|1280465|P1|COMPLETED|Baseline to 1 Week||11
524308|NCT00867035|1280464|P2|STARTED|Baseline to 1 Week||8
524309|NCT00867035|1280465|P1|STARTED|Baseline to 1 Week||12
524310|NCT00867035|1280464|P2|NOT COMPLETED|Baseline to 4 Hours||0
524311|NCT00867035|1280465|P1|NOT COMPLETED|Baseline to 4 Hours||0
524312|NCT00867035|1280464|P2|COMPLETED|Baseline to 4 Hours||8
524313|NCT00867035|1280465|P1|COMPLETED|Baseline to 4 Hours||12
524314|NCT00867035|1280464|P2|STARTED|Baseline to 4 Hours||8
524315|NCT00867035|1280465|P1|STARTED|Baseline to 4 Hours||12
524316|NCT00867035|1280464|P2|NOT COMPLETED|Baseline to 2 Hours||0
524317|NCT00867035|1280465|P1|NOT COMPLETED|Baseline to 2 Hours||0
524318|NCT00867035|1280464|P2|COMPLETED|Baseline to 2 Hours||8
524319|NCT00867035|1280465|P1|COMPLETED|Baseline to 2 Hours||12
524320|NCT00867035|1280464|P2|STARTED|Baseline to 2 Hours||8
524321|NCT00867035|1280465|P1|STARTED|Baseline to 2 Hours||12
524322|NCT00867035|1280464|P2|NOT COMPLETED|Baseline to 1 Hour||1
524323|NCT00867035|1280465|P1|NOT COMPLETED|Baseline to 1 Hour||1
524324|NCT00867035|1280464|P2|COMPLETED|Baseline to 1 Hour||8
524325|NCT00867035|1280465|P1|COMPLETED|Baseline to 1 Hour||12
524326|NCT00867035|1280464|P2|STARTED|Baseline to 1 Hour||9
524327|NCT00867035|1280465|P1|STARTED|Baseline to 1 Hour||13
524328|NCT00867009|1280491|P1|NOT COMPLETED|Maintenance Period||4
524329|NCT00867009|1280491|P1|COMPLETED|Maintenance Period|Participant was considered completed if they had PD, death, or stopped receiving study drug.|47
524330|NCT00867009|1280491|P1|STARTED|Maintenance Period||51
524331|NCT00867009|1280491|P1|NOT COMPLETED|Induction Period||62
524332|NCT00867009|1280491|P1|COMPLETED|Induction Period|Participants continued on the study in the Maintenance Period.|51
524333|NCT00867009|1280491|P1|Protocol Qualified (PQ) Population|Induction Period|Stage IIIB/IV NS-NSCLC, no concurrent chemotherapy, measurable disease, ≥1 dose study drug.|109
524334|NCT00867009|1280491|P1|Received at Least 1 Dose of Study Drug|Induction Period||113
524335|NCT00867009|1280491|P1|STARTED|Induction Period|Participants with Stage IIIB/IV non-squamous (NS) non-small cell lung cancer (NSCLC)|113
524336|NCT00866918|1280500|P2|NOT COMPLETED|Overall Study||12
524337|NCT00866918|1280501|P1|NOT COMPLETED|Overall Study||16
524338|NCT00866918|1280500|P2|COMPLETED|Overall Study||27
524339|NCT00866918|1280501|P1|COMPLETED|Overall Study||53
524340|NCT00866918|1280500|P2|STARTED|Overall Study||39
524341|NCT00866918|1280501|P1|STARTED|Overall Study||69
524342|NCT00866905|1280513|P1|NOT COMPLETED|Overall Study||33
524343|NCT00866905|1280513|P1|COMPLETED|Overall Study||135
524344|NCT00866905|1280513|P1|STARTED|Overall Study||168
524345|NCT00866814|1280518|P1|NOT COMPLETED|Overall Study||20
524346|NCT00866814|1280518|P1|COMPLETED|Overall Study||99
524347|NCT00866814|1280518|P1|STARTED|Overall Study||119
524348|NCT00866788|1280531|P4|NOT COMPLETED|Overall Study||5
524349|NCT00866788|1280532|P3|NOT COMPLETED|Overall Study||2
524350|NCT00866788|1280533|P2|NOT COMPLETED|Overall Study||6
524351|NCT00866788|1280534|P1|NOT COMPLETED|Overall Study||6
524352|NCT00866788|1280531|P4|COMPLETED|Overall Study||16
524353|NCT00866788|1280532|P3|COMPLETED|Overall Study||23
524354|NCT00866788|1280533|P2|COMPLETED|Overall Study||17
524355|NCT00866788|1280534|P1|COMPLETED|Overall Study||15
524356|NCT00866788|1280531|P4|STARTED|Overall Study||21
524357|NCT00866788|1280532|P3|STARTED|Overall Study||25
524358|NCT00866788|1280533|P2|STARTED|Overall Study||23
524359|NCT00866788|1280534|P1|STARTED|Overall Study||21
524360|NCT00866775|1280582|P2|NOT COMPLETED|Overall Study||52
524361|NCT00866775|1280583|P1|NOT COMPLETED|Overall Study||36
524362|NCT00866775|1280582|P2|COMPLETED|Overall Study||76
524363|NCT00866775|1280583|P1|COMPLETED|Overall Study||29
524364|NCT00866775|1280582|P2|STARTED|Overall Study||128
524365|NCT00866775|1280583|P1|STARTED|Overall Study||65
524366|NCT00866723|1280619|P1|NOT COMPLETED|Overall Study||5
524367|NCT00866723|1280619|P1|COMPLETED|Overall Study||0
524368|NCT00866723|1280619|P1|STARTED|Overall Study||5
524369|NCT00866697|1280626|P2|NOT COMPLETED|Overall Study||377
524370|NCT00866697|1280627|P1|NOT COMPLETED|Overall Study||373
524371|NCT00866697|1280626|P2|COMPLETED|Overall Study||95
524372|NCT00866697|1280627|P1|COMPLETED|Overall Study||95
524373|NCT00866697|1280626|P2|Ongoing|Overall Study||312
524374|NCT00866697|1280627|P1|Ongoing|Overall Study||335
524375|NCT00866697|1280626|P2|STARTED|Overall Study||472
524376|NCT00866697|1280627|P1|STARTED|Overall Study||468
524377|NCT00866658|1280671|P2|NOT COMPLETED|Overall Study||21
524378|NCT00866658|1280672|P1|NOT COMPLETED|Overall Study||13
524379|NCT00866658|1280671|P2|COMPLETED|Overall Study||133
524380|NCT00866658|1280672|P1|COMPLETED|Overall Study||144
524381|NCT00866658|1280671|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||154
524382|NCT00866658|1280672|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|157
524383|NCT00866658|1280671|P2|Safety Population|Overall Study||154
524384|NCT00866658|1280672|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|157
524385|NCT00866658|1280671|P2|STARTED|Overall Study||154
524386|NCT00866658|1280672|P1|STARTED|Overall Study|Randomized.|157
524387|NCT00866606|1280700|P1|NOT COMPLETED|Overall Study||4
524388|NCT00866606|1280700|P1|COMPLETED|Overall Study||31
524389|NCT00866606|1280700|P1|STARTED|Overall Study||35
524390|NCT00866359|1280714|P4|NOT COMPLETED|Observational Follow-Up Phase||0
524391|NCT00866359|1280715|P3|NOT COMPLETED|Observational Follow-Up Phase||0
524392|NCT00866359|1280716|P2|NOT COMPLETED|Observational Follow-Up Phase||0
524393|NCT00866359|1280717|P1|NOT COMPLETED|Observational Follow-Up Phase||0
524394|NCT00866359|1280714|P4|COMPLETED|Observational Follow-Up Phase||54
524395|NCT00866359|1280715|P3|COMPLETED|Observational Follow-Up Phase||54
524396|NCT00866359|1280716|P2|COMPLETED|Observational Follow-Up Phase||0
524397|NCT00866359|1280717|P1|COMPLETED|Observational Follow-Up Phase||0
524398|NCT00866359|1280714|P4|STARTED|Observational Follow-Up Phase|Includes those who entered the follow-up phase from both the placebo controlled or extension phase.|54
524399|NCT00866359|1280715|P3|STARTED|Observational Follow-Up Phase|Includes those who entered the follow-up phase from both the placebo controlled or extension phase.|54
524400|NCT00866359|1280716|P2|STARTED|Observational Follow-Up Phase||0
524401|NCT00866359|1280717|P1|STARTED|Observational Follow-Up Phase||0
524402|NCT00866359|1280714|P4|NOT COMPLETED|Extension Phase (Day 86 to 169)||3
524403|NCT00866359|1280715|P3|NOT COMPLETED|Extension Phase (Day 86 to 169)||1
524404|NCT00866359|1280716|P2|NOT COMPLETED|Extension Phase (Day 86 to 169)||0
524405|NCT00866359|1280717|P1|NOT COMPLETED|Extension Phase (Day 86 to 169)||0
524406|NCT00866359|1280714|P4|COMPLETED|Extension Phase (Day 86 to 169)||47
524407|NCT00866359|1280715|P3|COMPLETED|Extension Phase (Day 86 to 169)||44
524408|NCT00866359|1280716|P2|COMPLETED|Extension Phase (Day 86 to 169)||0
524409|NCT00866359|1280717|P1|COMPLETED|Extension Phase (Day 86 to 169)||0
524410|NCT00866359|1280714|P4|STARTED|Extension Phase (Day 86 to 169)||50
524411|NCT00866359|1280715|P3|STARTED|Extension Phase (Day 86 to 169)||45
524412|NCT00866359|1280716|P2|STARTED|Extension Phase (Day 86 to 169)||0
524413|NCT00866359|1280717|P1|STARTED|Extension Phase (Day 86 to 169)||0
524414|NCT00866359|1280714|P4|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0
524415|NCT00866359|1280715|P3|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0
524416|NCT00866359|1280716|P2|NOT COMPLETED|Treatment Phase (Days 1 to 85)||5
524417|NCT00866359|1280717|P1|NOT COMPLETED|Treatment Phase (Days 1 to 85)||11
524418|NCT00866359|1280714|P4|COMPLETED|Treatment Phase (Days 1 to 85)||0
524419|NCT00866359|1280715|P3|COMPLETED|Treatment Phase (Days 1 to 85)||0
524420|NCT00866359|1280716|P2|COMPLETED|Treatment Phase (Days 1 to 85)||50
524421|NCT00866359|1280717|P1|COMPLETED|Treatment Phase (Days 1 to 85)||45
524422|NCT00866359|1280714|P4|STARTED|Treatment Phase (Days 1 to 85)||0
524423|NCT00866359|1280715|P3|STARTED|Treatment Phase (Days 1 to 85)||0
524424|NCT00866359|1280716|P2|STARTED|Treatment Phase (Days 1 to 85)||55
524425|NCT00866359|1280717|P1|STARTED|Treatment Phase (Days 1 to 85)||56
524426|NCT00866320|1280770|P1|NOT COMPLETED|Overall Study||6
524427|NCT00866320|1280770|P1|COMPLETED|Overall Study|All patients that received treatment were analyzed.|43
524428|NCT00866320|1280770|P1|STARTED|Overall Study||49
524429|NCT00866307|1280777|P3|NOT COMPLETED|Consolidation/Maintenance||16
524430|NCT00866307|1280778|P2|NOT COMPLETED|Consolidation/Maintenance||9
524431|NCT00866307|1280779|P1|NOT COMPLETED|Consolidation/Maintenance||0
524432|NCT00866307|1280777|P3|COMPLETED|Consolidation/Maintenance||14
524433|NCT00866307|1280778|P2|COMPLETED|Consolidation/Maintenance||45
524434|NCT00866307|1280779|P1|COMPLETED|Consolidation/Maintenance||0
524435|NCT00866307|1280777|P3|STARTED|Consolidation/Maintenance||30
524436|NCT00866307|1280778|P2|STARTED|Consolidation/Maintenance||54
524437|NCT00866307|1280779|P1|STARTED|Consolidation/Maintenance||0
524438|NCT00866307|1280777|P3|NOT COMPLETED|Induction||0
524439|NCT00866307|1280778|P2|NOT COMPLETED|Induction||0
524440|NCT00866307|1280779|P1|NOT COMPLETED|Induction||20
524441|NCT00866307|1280777|P3|COMPLETED|Induction||0
524442|NCT00866307|1280778|P2|COMPLETED|Induction||0
524443|NCT00866307|1280779|P1|COMPLETED|Induction||84
524444|NCT00866307|1280777|P3|STARTED|Induction||0
524445|NCT00866307|1280778|P2|STARTED|Induction||0
524446|NCT00866307|1280779|P1|STARTED|Induction||104
524447|NCT00866294|1280789|P3|NOT COMPLETED|Overall Study||11
524448|NCT00866294|1280790|P2|NOT COMPLETED|Overall Study||20
524449|NCT00866294|1280791|P1|NOT COMPLETED|Overall Study||33
524450|NCT00866294|1280789|P3|COMPLETED|Overall Study||72
524451|NCT00866294|1280790|P2|COMPLETED|Overall Study||141
524452|NCT00866294|1280791|P1|COMPLETED|Overall Study||139
524453|NCT00866294|1280789|P3|STARTED|Overall Study||83
524454|NCT00866294|1280790|P2|STARTED|Overall Study||161
524455|NCT00866294|1280791|P1|STARTED|Overall Study||172
524456|NCT00866281|1280820|P2|NOT COMPLETED|Overall Study||15
524457|NCT00866281|1280821|P1|NOT COMPLETED|Overall Study||7
524458|NCT00866281|1280820|P2|COMPLETED|Overall Study||0
524459|NCT00866281|1280821|P1|COMPLETED|Overall Study||0
524460|NCT00866281|1280820|P2|STARTED|Overall Study||15
524461|NCT00866281|1280821|P1|STARTED|Overall Study||7
524462|NCT00866177|1280837|P1|NOT COMPLETED|Overall Study||152
524463|NCT00866177|1280837|P1|COMPLETED|Overall Study||15
524464|NCT00866177|1280837|P1|STARTED|Overall Study||167
524465|NCT00866047|1280841|P1|NOT COMPLETED|Follow-up Period||5
524466|NCT00866047|1280841|P1|COMPLETED|Follow-up Period|Completed survival follow-up due to death [25] or study completion [28]|53
524467|NCT00866047|1280841|P1|STARTED|Follow-up Period|All participants were to be followed after treatment|58
524468|NCT00866047|1280841|P1|NOT COMPLETED|Treatment Period||48
524469|NCT00866047|1280841|P1|COMPLETED|Treatment Period|Number who completed 16 cycles of treatment|10
524470|NCT00866047|1280841|P1|STARTED|Treatment Period||58
524471|NCT00866034|1280859|P2|NOT COMPLETED|Overall Study||8
524472|NCT00866034|1280860|P1|NOT COMPLETED|Overall Study||16
524473|NCT00866034|1280859|P2|COMPLETED|Overall Study||301
524474|NCT00866034|1280860|P1|COMPLETED|Overall Study||292
524475|NCT00866034|1280859|P2|STARTED|Overall Study||309
524476|NCT00866034|1280860|P1|STARTED|Overall Study||308
524477|NCT00865904|1280873|P5|NOT COMPLETED|Overall Study||1
524478|NCT00865904|1280874|P4|NOT COMPLETED|Overall Study||1
524479|NCT00865904|1280875|P3|NOT COMPLETED|Overall Study||0
524480|NCT00865904|1280876|P2|NOT COMPLETED|Overall Study||0
524481|NCT00865904|1280877|P1|NOT COMPLETED|Overall Study||2
524482|NCT00865904|1280873|P5|COMPLETED|Overall Study|Completed 14-day follow-up.|19
524483|NCT00865904|1280874|P4|COMPLETED|Overall Study|Completed 14-day follow-up.|17
524484|NCT00865904|1280875|P3|COMPLETED|Overall Study|Completed 14-day follow-up.|18
524485|NCT00865904|1280876|P2|COMPLETED|Overall Study|Completed 14-day follow-up.|18
524486|NCT00865904|1280877|P1|COMPLETED|Overall Study|Completed 14-day follow-up.|17
524487|NCT00865904|1280873|P5|STARTED|Overall Study|Randomized.|20
524488|NCT00865904|1280874|P4|STARTED|Overall Study|Randomized.|18
524489|NCT00865904|1280875|P3|STARTED|Overall Study|Randomized.|18
524490|NCT00865904|1280876|P2|STARTED|Overall Study|Randomized.|18
524491|NCT00865904|1280877|P1|STARTED|Overall Study|Randomized.|19
524492|NCT00865709|1280934|P2|NOT COMPLETED|Long Term Follow-up||49
524493|NCT00865709|1280935|P1|NOT COMPLETED|Long Term Follow-up||46
524494|NCT00865709|1280934|P2|COMPLETED|Long Term Follow-up||33
524495|NCT00865709|1280935|P1|COMPLETED|Long Term Follow-up||24
524496|NCT00865709|1280934|P2|STARTED|Long Term Follow-up||82
524497|NCT00865709|1280935|P1|STARTED|Long Term Follow-up||70
524498|NCT00865709|1280934|P2|NOT COMPLETED|Active Follow-up||1
524499|NCT00865709|1280935|P1|NOT COMPLETED|Active Follow-up||8
524500|NCT00865709|1280934|P2|COMPLETED|Active Follow-up||15
524501|NCT00865709|1280935|P1|COMPLETED|Active Follow-up||17
524502|NCT00865709|1280934|P2|STARTED|Active Follow-up||16
524503|NCT00865709|1280935|P1|STARTED|Active Follow-up||25
524504|NCT00865709|1280934|P2|NOT COMPLETED|Treatment||18
524505|NCT00865709|1280935|P1|NOT COMPLETED|Treatment||30
524506|NCT00865709|1280934|P2|COMPLETED|Treatment|Patients who continued treatment at data cut-off or discontinued treatment due to PD or death|83
524507|NCT00865709|1280935|P1|COMPLETED|Treatment|Patients who continued treatment at data cut-off or discontinued treatment due to PD or death|67
524508|NCT00865709|1280934|P2|Received Treatment|Treatment|Safety population|101
524509|NCT00865709|1280935|P1|Received Treatment|Treatment|Safety population|97
524510|NCT00865709|1280934|P2|STARTED|Treatment||101
524511|NCT00865709|1280935|P1|STARTED|Treatment||97
524512|NCT00865514|1280951|P1|NOT COMPLETED|Overall Study||2
524513|NCT00865514|1280951|P1|COMPLETED|Overall Study||0
524514|NCT00865514|1280951|P1|STARTED|Overall Study||2
524515|NCT00865345|1280956|P1|NOT COMPLETED|Overall Study||2
524516|NCT00865345|1280956|P1|COMPLETED|Overall Study||61
524517|NCT00865345|1280956|P1|STARTED|Overall Study||63
524518|NCT00865306|1280963|P2|NOT COMPLETED|One-Year Follow-Up||0
524519|NCT00865306|1280964|P1|NOT COMPLETED|One-Year Follow-Up||0
524520|NCT00865306|1280963|P2|COMPLETED|One-Year Follow-Up||15
524521|NCT00865306|1280964|P1|COMPLETED|One-Year Follow-Up||29
524522|NCT00865306|1280963|P2|STARTED|One-Year Follow-Up|Only controls who opted for CBT after the waitlist (n=17) were included. 2 were lost (15 included).|15
524523|NCT00865306|1280964|P1|STARTED|One-Year Follow-Up||29
524524|NCT00865306|1280963|P2|NOT COMPLETED|Controlled Trial||2
524525|NCT00865306|1280964|P1|NOT COMPLETED|Controlled Trial||5
524526|NCT00865306|1280963|P2|COMPLETED|Controlled Trial||28
524527|NCT00865306|1280964|P1|COMPLETED|Controlled Trial||29
524528|NCT00865306|1280963|P2|STARTED|Controlled Trial||30
524529|NCT00865306|1280964|P1|STARTED|Controlled Trial|35 assigned to CBT. One child in trial had 0 anxiety disorders, so we excluded her from analysis.|34
524530|NCT00865202|1280976|P2|NOT COMPLETED|Overall Study||0
524531|NCT00865202|1280977|P1|NOT COMPLETED|Overall Study||0
524532|NCT00865202|1280976|P2|COMPLETED|Overall Study||149
524533|NCT00865202|1280977|P1|COMPLETED|Overall Study||152
524534|NCT00865202|1280976|P2|STARTED|Overall Study||149
524535|NCT00865202|1280977|P1|STARTED|Overall Study||152
524536|NCT00865189|1280993|P2|NOT COMPLETED|Overall Study||19
524537|NCT00865189|1280994|P1|NOT COMPLETED|Overall Study||12
524538|NCT00865189|1280993|P2|COMPLETED|Overall Study||26
524539|NCT00865189|1280994|P1|COMPLETED|Overall Study||34
524540|NCT00865189|1280993|P2|STARTED|Overall Study||45
524541|NCT00865189|1280994|P1|STARTED|Overall Study||46
524542|NCT00865124|1281022|P3|NOT COMPLETED|Overall Study||0
524543|NCT00865124|1281023|P2|NOT COMPLETED|Overall Study||1
524544|NCT00865124|1281024|P1|NOT COMPLETED|Overall Study||4
524545|NCT00865124|1281022|P3|COMPLETED|Overall Study||17
524546|NCT00865124|1281023|P2|COMPLETED|Overall Study||24
524547|NCT00865124|1281024|P1|COMPLETED|Overall Study||23
524548|NCT00865124|1281022|P3|STARTED|Overall Study||17
524549|NCT00865124|1281023|P2|STARTED|Overall Study||25
524550|NCT00865124|1281024|P1|STARTED|Overall Study||27
524551|NCT00865098|1281041|P1|NOT COMPLETED|Overall Study||1
524552|NCT00865098|1281041|P1|COMPLETED|Overall Study|Discontinued from the study due to progressive disease, after completing planned treatment schedule|21
524553|NCT00865098|1281041|P1|STARTED|Overall Study||22
524554|NCT00865046|1281053|P3|NOT COMPLETED|Overall Study||1
524555|NCT00865046|1281054|P2|NOT COMPLETED|Overall Study||5
524556|NCT00865046|1281055|P1|NOT COMPLETED|Overall Study||6
524557|NCT00865046|1281053|P3|COMPLETED|Overall Study||62
524558|NCT00865046|1281054|P2|COMPLETED|Overall Study||59
524559|NCT00865046|1281055|P1|COMPLETED|Overall Study||57
524560|NCT00865046|1281053|P3|STARTED|Overall Study||63
524561|NCT00865046|1281054|P2|STARTED|Overall Study||64
524562|NCT00865046|1281055|P1|STARTED|Overall Study||63
524563|NCT00865020|1281065|P2|NOT COMPLETED|Overall Study||51
524564|NCT00865020|1281066|P1|NOT COMPLETED|Overall Study||49
524565|NCT00865020|1281065|P2|COMPLETED|Overall Study||357
524566|NCT00865020|1281066|P1|COMPLETED|Overall Study||365
524567|NCT00865020|1281065|P2|STARTED|Overall Study||408
524568|NCT00865020|1281066|P1|STARTED|Overall Study||414
524569|NCT00864916|1281082|P2|NOT COMPLETED|Overall Study||4
524570|NCT00864916|1281083|P1|NOT COMPLETED|Overall Study||6
524571|NCT00864916|1281082|P2|COMPLETED|Overall Study||5
524572|NCT00864916|1281083|P1|COMPLETED|Overall Study||4
524573|NCT00864916|1281082|P2|STARTED|Overall Study||9
524574|NCT00864916|1281083|P1|STARTED|Overall Study||10
524575|NCT00864851|1281092|P3|NOT COMPLETED|Overall Study||0
524576|NCT00864851|1281093|P2|NOT COMPLETED|Overall Study||1
524577|NCT00864851|1281094|P1|NOT COMPLETED|Overall Study||3
524578|NCT00864851|1281092|P3|COMPLETED|Overall Study||5
524579|NCT00864851|1281093|P2|COMPLETED|Overall Study||18
524580|NCT00864851|1281094|P1|COMPLETED|Overall Study||17
524581|NCT00864851|1281092|P3|STARTED|Overall Study||5
524582|NCT00864851|1281093|P2|STARTED|Overall Study||19
524583|NCT00864851|1281094|P1|STARTED|Overall Study||20
524584|NCT00864708|1281128|P1|NOT COMPLETED|Overall Study||0
524585|NCT00864708|1281128|P1|COMPLETED|Overall Study||1
524586|NCT00864708|1281128|P1|STARTED|Overall Study||1
524587|NCT00864682|1281140|P3|NOT COMPLETED|Overall Study||2
524588|NCT00864682|1281141|P2|NOT COMPLETED|Overall Study||1
524589|NCT00864682|1281142|P1|NOT COMPLETED|Overall Study||2
524590|NCT00864682|1281140|P3|COMPLETED|Overall Study||51
524591|NCT00864682|1281141|P2|COMPLETED|Overall Study||50
524592|NCT00864682|1281142|P1|COMPLETED|Overall Study||50
524593|NCT00864682|1281140|P3|STARTED|Overall Study||53
524594|NCT00864682|1281141|P2|STARTED|Overall Study||51
524595|NCT00864682|1281142|P1|STARTED|Overall Study||52
524596|NCT00864539|1281162|P6|NOT COMPLETED|Overall Study||14
524597|NCT00864539|1281163|P5|NOT COMPLETED|Overall Study||22
524598|NCT00864539|1281164|P4|NOT COMPLETED|Overall Study||7
524599|NCT00864539|1281165|P3|NOT COMPLETED|Overall Study||10
524600|NCT00864539|1281166|P2|NOT COMPLETED|Overall Study||23
524601|NCT00864539|1281167|P1|NOT COMPLETED|Overall Study||9
524602|NCT00864539|1281162|P6|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|71
524603|NCT00864539|1281163|P5|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|81
524604|NCT00864539|1281164|P4|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|89
524605|NCT00864539|1281165|P3|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|92
524606|NCT00864539|1281166|P2|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|72
524607|NCT00864539|1281167|P1|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|95
524608|NCT00864539|1281162|P6|STARTED|Overall Study||85
524609|NCT00864539|1281163|P5|STARTED|Overall Study||103
524610|NCT00864539|1281164|P4|STARTED|Overall Study||96
524611|NCT00864539|1281165|P3|STARTED|Overall Study||102
524612|NCT00864539|1281166|P2|STARTED|Overall Study||95
524613|NCT00864539|1281167|P1|STARTED|Overall Study||104
524614|NCT00864513|1281181|P1|NOT COMPLETED|Overall Study||3
524615|NCT00864513|1281181|P1|COMPLETED|Overall Study||12
524616|NCT00864513|1281181|P1|STARTED|Overall Study||15
524617|NCT00864383|1281191|P3|NOT COMPLETED|Modified Intent to Treat||85
524618|NCT00864383|1281192|P2|NOT COMPLETED|Modified Intent to Treat||87
524619|NCT00864383|1281193|P1|NOT COMPLETED|Modified Intent to Treat||85
524620|NCT00864383|1281191|P3|COMPLETED|Modified Intent to Treat||551
524621|NCT00864383|1281192|P2|COMPLETED|Modified Intent to Treat||568
524622|NCT00864383|1281193|P1|COMPLETED|Modified Intent to Treat||555
524623|NCT00864383|1281191|P3|STARTED|Modified Intent to Treat||636
524624|NCT00864383|1281192|P2|STARTED|Modified Intent to Treat||655
524625|NCT00864383|1281193|P1|STARTED|Modified Intent to Treat||640
524626|NCT00864383|1281191|P3|NOT COMPLETED|Per- Protocol||112
524627|NCT00864383|1281192|P2|NOT COMPLETED|Per- Protocol||141
524628|NCT00864383|1281193|P1|NOT COMPLETED|Per- Protocol||130
524629|NCT00864383|1281191|P3|COMPLETED|Per- Protocol||524
524630|NCT00864383|1281192|P2|COMPLETED|Per- Protocol||514
524631|NCT00864383|1281193|P1|COMPLETED|Per- Protocol||510
524632|NCT00864383|1281191|P3|STARTED|Per- Protocol||636
524633|NCT00864383|1281192|P2|STARTED|Per- Protocol||655
524634|NCT00864383|1281193|P1|STARTED|Per- Protocol||640
524635|NCT00864253|1281227|P2|NOT COMPLETED|Overall Study||58
524636|NCT00864253|1281228|P1|NOT COMPLETED|Overall Study||99
524637|NCT00864253|1281227|P2|COMPLETED|Overall Study|Completed = defined as discontinuation due to progressive disease|207
524638|NCT00864253|1281228|P1|COMPLETED|Overall Study|Completed = defined as discontinuation due to progressive disease|165
524639|NCT00864253|1281227|P2|Treated|Overall Study||258
524640|NCT00864253|1281228|P1|Treated|Overall Study||257
524641|NCT00864253|1281227|P2|STARTED|Overall Study||265
524642|NCT00864253|1281228|P1|STARTED|Overall Study||264
524643|NCT00864227|1281258|P1|NOT COMPLETED|Overall Study||4
524644|NCT00864227|1281258|P1|COMPLETED|Overall Study||50
524645|NCT00864227|1281258|P1|STARTED|Overall Study||54
524646|NCT00864123|1281275|P2|NOT COMPLETED|Overall Study||0
524647|NCT00864123|1281276|P1|NOT COMPLETED|Overall Study||0
524648|NCT00864123|1281275|P2|COMPLETED|Overall Study||15
524649|NCT00864123|1281276|P1|COMPLETED|Overall Study||15
524650|NCT00864123|1281275|P2|STARTED|Overall Study||15
524651|NCT00864123|1281276|P1|STARTED|Overall Study||15
524652|NCT00864084|1281286|P1|NOT COMPLETED|Overall Study||3
524653|NCT00864084|1281286|P1|COMPLETED|Overall Study||11
524654|NCT00864084|1281286|P1|STARTED|Overall Study||14
524655|NCT00864032|1281309|P3|NOT COMPLETED|Overall Study||0
524656|NCT00864032|1281310|P2|NOT COMPLETED|Overall Study||0
524657|NCT00864032|1281311|P1|NOT COMPLETED|Overall Study||0
524658|NCT00864032|1281309|P3|COMPLETED|Overall Study||0
524659|NCT00864032|1281310|P2|COMPLETED|Overall Study||5
524660|NCT00864032|1281311|P1|COMPLETED|Overall Study||3
524661|NCT00864032|1281309|P3|STARTED|Overall Study||0
524662|NCT00864032|1281310|P2|STARTED|Overall Study||5
524663|NCT00864032|1281311|P1|STARTED|Overall Study||3
524664|NCT00863798|1281320|P3|NOT COMPLETED|Overall Study||25
524665|NCT00863798|1281321|P2|NOT COMPLETED|Overall Study||30
524666|NCT00863798|1281322|P1|NOT COMPLETED|Overall Study||32
524667|NCT00863798|1281320|P3|COMPLETED|Overall Study||202
524668|NCT00863798|1281321|P2|COMPLETED|Overall Study||198
524669|NCT00863798|1281322|P1|COMPLETED|Overall Study||195
524670|NCT00863798|1281320|P3|Treated|Overall Study||224
524671|NCT00863798|1281321|P2|Treated|Overall Study||226
524672|NCT00863798|1281322|P1|Treated|Overall Study||223
524673|NCT00863798|1281320|P3|STARTED|Overall Study||227
524674|NCT00863798|1281321|P2|STARTED|Overall Study||228
524675|NCT00863798|1281322|P1|STARTED|Overall Study||227
524676|NCT00863746|1281374|P2|NOT COMPLETED|Survival Follow up||280
524677|NCT00863746|1281375|P1|NOT COMPLETED|Survival Follow up||253
524678|NCT00863746|1281374|P2|COMPLETED|Survival Follow up||51
524679|NCT00863746|1281375|P1|COMPLETED|Survival Follow up||45
524680|NCT00863746|1281374|P2|STARTED|Survival Follow up|331 patients of 339 patients (=353 randomized - 14 death) entered the survival follow-up.|331
524681|NCT00863746|1281375|P1|STARTED|Survival Follow up|298 patients of 317 patients (= 346 randomized - 29 deaths) entered the survival follow-up|298
524682|NCT00863746|1281374|P2|NOT COMPLETED|Treatment||35
524683|NCT00863746|1281375|P1|NOT COMPLETED|Treatment||71
524684|NCT00863746|1281374|P2|COMPLETED|Treatment||318
524685|NCT00863746|1281375|P1|COMPLETED|Treatment||279
524686|NCT00863746|1281374|P2|Participants Received Treatment|Treatment|Safety population|351
524687|NCT00863746|1281375|P1|Participants Received Treatment|Treatment|Safety population|346
524688|NCT00863746|1281374|P2|STARTED|Treatment||353
524689|NCT00863746|1281375|P1|STARTED|Treatment||350
524690|NCT00863707|1281401|P2|NOT COMPLETED|Overall Study||3
524691|NCT00863707|1281402|P1|NOT COMPLETED|Overall Study||4
524692|NCT00863707|1281401|P2|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|334
524693|NCT00863707|1281402|P1|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|170
524694|NCT00863707|1281401|P2|STARTED|Overall Study||337
524695|NCT00863707|1281402|P1|STARTED|Overall Study||174
524696|NCT00863655|1281410|P2|NOT COMPLETED|Overall Study||239
524697|NCT00863655|1281411|P1|NOT COMPLETED|Overall Study||485
524698|NCT00863655|1281410|P2|COMPLETED|Overall Study|Completed means discontinued the treatment period.|0
524699|NCT00863655|1281411|P1|COMPLETED|Overall Study|Completed means discontinued the treatment period.|0
524700|NCT00863655|1281410|P2|STARTED|Overall Study||239
524701|NCT00863655|1281411|P1|STARTED|Overall Study||485
524702|NCT00863551|1281438|P1|NOT COMPLETED|Overall Study||0
524703|NCT00863551|1281438|P1|COMPLETED|Overall Study||12
524704|NCT00863551|1281438|P1|STARTED|Overall Study||12
524705|NCT00863512|1281448|P2|NOT COMPLETED|Overall Study||0
524706|NCT00863512|1281449|P1|NOT COMPLETED|Overall Study||14
524707|NCT00863512|1281448|P2|COMPLETED|Overall Study||17
524708|NCT00863512|1281449|P1|COMPLETED|Overall Study||3
524709|NCT00863512|1281448|P2|STARTED|Overall Study||17
524710|NCT00863512|1281449|P1|STARTED|Overall Study||17
524711|NCT00863434|1281455|P1|NOT COMPLETED|Overall Study||0
524712|NCT00863434|1281455|P1|COMPLETED|Overall Study||2
524713|NCT00863434|1281455|P1|STARTED|Overall Study||2
524714|NCT00863356|1281461|P1|NOT COMPLETED|Overall Study||0
524715|NCT00863356|1281461|P1|COMPLETED|Overall Study||20
524716|NCT00863356|1281461|P1|STARTED|Overall Study||20
524717|NCT00863343|1281467|P2|NOT COMPLETED|Overall Study||0
524718|NCT00863343|1281468|P1|NOT COMPLETED|Overall Study||0
524719|NCT00863343|1281467|P2|COMPLETED|Overall Study||374
524720|NCT00863343|1281468|P1|COMPLETED|Overall Study||17
524721|NCT00863343|1281467|P2|STARTED|Overall Study||374
524722|NCT00863343|1281468|P1|STARTED|Overall Study||17
524723|NCT00863330|1281480|P1|NOT COMPLETED|Overall Study||6
524724|NCT00863330|1281480|P1|COMPLETED|Overall Study||0
524725|NCT00863330|1281480|P1|STARTED|Overall Study||6
524726|NCT00863317|1281486|P2|NOT COMPLETED|Overall Study||9
524727|NCT00863317|1281487|P1|NOT COMPLETED|Overall Study||8
524728|NCT00863317|1281486|P2|COMPLETED|Overall Study||64
524729|NCT00863317|1281487|P1|COMPLETED|Overall Study||60
524730|NCT00863317|1281486|P2|STARTED|Overall Study||73
524731|NCT00863317|1281487|P1|STARTED|Overall Study||68
524732|NCT00863265|1281493|P6|NOT COMPLETED|Overall Study||0
524733|NCT00863265|1281494|P5|NOT COMPLETED|Overall Study||1
524734|NCT00863265|1281495|P4|NOT COMPLETED|Overall Study||0
524735|NCT00863265|1281496|P3|NOT COMPLETED|Overall Study||0
524736|NCT00863265|1281497|P2|NOT COMPLETED|Overall Study||0
524737|NCT00863265|1281498|P1|NOT COMPLETED|Overall Study||0
524738|NCT00863265|1281493|P6|COMPLETED|Overall Study||3
524739|NCT00863265|1281494|P5|COMPLETED|Overall Study||3
524740|NCT00863265|1281495|P4|COMPLETED|Overall Study||4
524741|NCT00863265|1281496|P3|COMPLETED|Overall Study||4
524742|NCT00863265|1281497|P2|COMPLETED|Overall Study||3
524743|NCT00863265|1281498|P1|COMPLETED|Overall Study||4
524744|NCT00863265|1281493|P6|STARTED|Overall Study||3
524745|NCT00863265|1281494|P5|STARTED|Overall Study||4
524746|NCT00863265|1281495|P4|STARTED|Overall Study||4
524747|NCT00863265|1281496|P3|STARTED|Overall Study||4
524748|NCT00863265|1281497|P2|STARTED|Overall Study||3
524749|NCT00863265|1281498|P1|STARTED|Overall Study||4
524750|NCT00863109|1281512|P1|NOT COMPLETED|Follow-up Period||11
524751|NCT00863109|1281512|P1|COMPLETED|Follow-up Period||48
524752|NCT00863109|1281512|P1|STARTED|Follow-up Period|Follow-up performed on 53 who completed Treatment Period plus 6 who discontinued treatment|59
524753|NCT00863109|1281512|P1|NOT COMPLETED|Treatment Period||77
524754|NCT00863109|1281512|P1|COMPLETED|Treatment Period||53
524755|NCT00863109|1281512|P1|STARTED|Treatment Period||130
524756|NCT00863057|1281529|P4|NOT COMPLETED|Period 4 (Weeks 16-20)||0
524757|NCT00863057|1281530|P3|NOT COMPLETED|Period 4 (Weeks 16-20)||0
524758|NCT00863057|1281531|P2|NOT COMPLETED|Period 4 (Weeks 16-20)||0
524759|NCT00863057|1281532|P1|NOT COMPLETED|Period 4 (Weeks 16-20)||0
524760|NCT00863057|1281529|P4|COMPLETED|Period 4 (Weeks 16-20)||2
524761|NCT00863057|1281530|P3|COMPLETED|Period 4 (Weeks 16-20)||2
524762|NCT00863057|1281531|P2|COMPLETED|Period 4 (Weeks 16-20)||1
524763|NCT00863057|1281532|P1|COMPLETED|Period 4 (Weeks 16-20)||3
524764|NCT00863057|1281529|P4|STARTED|Period 4 (Weeks 16-20)||2
524765|NCT00863057|1281530|P3|STARTED|Period 4 (Weeks 16-20)||2
524766|NCT00863057|1281531|P2|STARTED|Period 4 (Weeks 16-20)||1
524767|NCT00863057|1281532|P1|STARTED|Period 4 (Weeks 16-20)||3
524768|NCT00863057|1281529|P4|NOT COMPLETED|Period 3 (Weeks 11-15)||0
524769|NCT00863057|1281530|P3|NOT COMPLETED|Period 3 (Weeks 11-15)||0
524770|NCT00863057|1281531|P2|NOT COMPLETED|Period 3 (Weeks 11-15)||0
524771|NCT00863057|1281532|P1|NOT COMPLETED|Period 3 (Weeks 11-15)||0
524772|NCT00863057|1281529|P4|COMPLETED|Period 3 (Weeks 11-15)||2
524773|NCT00863057|1281530|P3|COMPLETED|Period 3 (Weeks 11-15)||2
524774|NCT00863057|1281531|P2|COMPLETED|Period 3 (Weeks 11-15)||1
524775|NCT00863057|1281532|P1|COMPLETED|Period 3 (Weeks 11-15)||3
524776|NCT00863057|1281529|P4|STARTED|Period 3 (Weeks 11-15)||2
524777|NCT00863057|1281530|P3|STARTED|Period 3 (Weeks 11-15)||2
524778|NCT00863057|1281531|P2|STARTED|Period 3 (Weeks 11-15)||1
524779|NCT00863057|1281532|P1|STARTED|Period 3 (Weeks 11-15)||3
524780|NCT00863057|1281529|P4|NOT COMPLETED|Period 2 (Weeks 6-10)||1
524781|NCT00863057|1281530|P3|NOT COMPLETED|Period 2 (Weeks 6-10)||1
524782|NCT00863057|1281531|P2|NOT COMPLETED|Period 2 (Weeks 6-10)||1
524783|NCT00863057|1281532|P1|NOT COMPLETED|Period 2 (Weeks 6-10)||0
524784|NCT00863057|1281529|P4|COMPLETED|Period 2 (Weeks 6-10)||2
524785|NCT00863057|1281530|P3|COMPLETED|Period 2 (Weeks 6-10)||2
524786|NCT00863057|1281531|P2|COMPLETED|Period 2 (Weeks 6-10)||1
524787|NCT00863057|1281532|P1|COMPLETED|Period 2 (Weeks 6-10)||3
524788|NCT00863057|1281529|P4|STARTED|Period 2 (Weeks 6-10)||3
524789|NCT00863057|1281530|P3|STARTED|Period 2 (Weeks 6-10)||3
524790|NCT00863057|1281531|P2|STARTED|Period 2 (Weeks 6-10)||2
524791|NCT00863057|1281532|P1|STARTED|Period 2 (Weeks 6-10)||3
524792|NCT00863057|1281529|P4|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1
524793|NCT00863057|1281530|P3|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||0
524794|NCT00863057|1281531|P2|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||2
524795|NCT00863057|1281532|P1|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1
524796|NCT00863057|1281529|P4|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
524797|NCT00863057|1281530|P3|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
524798|NCT00863057|1281531|P2|COMPLETED|Milestones Period 1 (Weeks 0-5)||2
524799|NCT00863057|1281532|P1|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
524800|NCT00863057|1281529|P4|STARTED|Milestones Period 1 (Weeks 0-5)||4
524801|NCT00863057|1281530|P3|STARTED|Milestones Period 1 (Weeks 0-5)||3
524802|NCT00863057|1281531|P2|STARTED|Milestones Period 1 (Weeks 0-5)||4
524803|NCT00863057|1281532|P1|STARTED|Milestones Period 1 (Weeks 0-5)||4
524804|NCT00862979|1281582|P2|NOT COMPLETED|Overall Study||7
524805|NCT00862979|1281583|P1|NOT COMPLETED|Overall Study||8
524806|NCT00862979|1281582|P2|COMPLETED|Overall Study||71
524807|NCT00862979|1281583|P1|COMPLETED|Overall Study||76
524808|NCT00862979|1281582|P2|Full Analysis Set (FAS)|Overall Study||71
524809|NCT00862979|1281583|P1|Full Analysis Set (FAS)|Overall Study||74
524810|NCT00862979|1281582|P2|STARTED|Overall Study||78
524811|NCT00862979|1281583|P1|STARTED|Overall Study||84
524812|NCT00862940|1281601|P2|NOT COMPLETED|Overall Study||30
524813|NCT00862940|1281602|P1|NOT COMPLETED|Overall Study||30
524814|NCT00862940|1281601|P2|COMPLETED|Overall Study||114
524815|NCT00862940|1281602|P1|COMPLETED|Overall Study||103
524816|NCT00862940|1281601|P2|STARTED|Overall Study||144
524817|NCT00862940|1281602|P1|STARTED|Overall Study||133
524818|NCT00862849|1281614|P6|NOT COMPLETED|Intervention 6||0
524819|NCT00862849|1281615|P5|NOT COMPLETED|Intervention 6||0
524820|NCT00862849|1281616|P4|NOT COMPLETED|Intervention 6||0
524821|NCT00862849|1281617|P3|NOT COMPLETED|Intervention 6||0
524822|NCT00862849|1281618|P2|NOT COMPLETED|Intervention 6||0
524823|NCT00862849|1281619|P1|NOT COMPLETED|Intervention 6||0
524824|NCT00862849|1281614|P6|COMPLETED|Intervention 6||3
524825|NCT00862849|1281615|P5|COMPLETED|Intervention 6||4
524826|NCT00862849|1281616|P4|COMPLETED|Intervention 6||4
524827|NCT00862849|1281617|P3|COMPLETED|Intervention 6||3
524828|NCT00862849|1281618|P2|COMPLETED|Intervention 6||3
524829|NCT00862849|1281619|P1|COMPLETED|Intervention 6||3
524830|NCT00862849|1281614|P6|STARTED|Intervention 6||3
524831|NCT00862849|1281615|P5|STARTED|Intervention 6||4
524832|NCT00862849|1281616|P4|STARTED|Intervention 6||4
524833|NCT00862849|1281617|P3|STARTED|Intervention 6||3
524834|NCT00862849|1281618|P2|STARTED|Intervention 6||3
524835|NCT00862849|1281619|P1|STARTED|Intervention 6||3
524836|NCT00862849|1281614|P6|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
524837|NCT00862849|1281615|P5|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
524838|NCT00862849|1281616|P4|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
524839|NCT00862849|1281617|P3|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
524840|NCT00862849|1281618|P2|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
524841|NCT00862849|1281619|P1|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
524842|NCT00862849|1281614|P6|COMPLETED|Washout 5 (3 to 14 Days)||3
524843|NCT00862849|1281615|P5|COMPLETED|Washout 5 (3 to 14 Days)||4
524844|NCT00862849|1281616|P4|COMPLETED|Washout 5 (3 to 14 Days)||4
524845|NCT00862849|1281617|P3|COMPLETED|Washout 5 (3 to 14 Days)||3
524846|NCT00862849|1281618|P2|COMPLETED|Washout 5 (3 to 14 Days)||3
524847|NCT00862849|1281619|P1|COMPLETED|Washout 5 (3 to 14 Days)||3
524848|NCT00862849|1281614|P6|STARTED|Washout 5 (3 to 14 Days)||3
524849|NCT00862849|1281615|P5|STARTED|Washout 5 (3 to 14 Days)||4
524850|NCT00862849|1281616|P4|STARTED|Washout 5 (3 to 14 Days)||4
524851|NCT00862849|1281617|P3|STARTED|Washout 5 (3 to 14 Days)||3
524852|NCT00862849|1281618|P2|STARTED|Washout 5 (3 to 14 Days)||3
524853|NCT00862849|1281619|P1|STARTED|Washout 5 (3 to 14 Days)||3
524854|NCT00862849|1281614|P6|NOT COMPLETED|Intervention 5||0
524855|NCT00862849|1281615|P5|NOT COMPLETED|Intervention 5||0
524856|NCT00862849|1281616|P4|NOT COMPLETED|Intervention 5||0
524857|NCT00862849|1281617|P3|NOT COMPLETED|Intervention 5||0
524858|NCT00862849|1281618|P2|NOT COMPLETED|Intervention 5||0
524859|NCT00862849|1281619|P1|NOT COMPLETED|Intervention 5||0
524860|NCT00862849|1281614|P6|COMPLETED|Intervention 5||3
524861|NCT00862849|1281615|P5|COMPLETED|Intervention 5||4
524862|NCT00862849|1281616|P4|COMPLETED|Intervention 5||4
524863|NCT00862849|1281617|P3|COMPLETED|Intervention 5||3
524864|NCT00862849|1281618|P2|COMPLETED|Intervention 5||3
524865|NCT00862849|1281619|P1|COMPLETED|Intervention 5||3
524866|NCT00862849|1281614|P6|STARTED|Intervention 5||3
524867|NCT00862849|1281615|P5|STARTED|Intervention 5||4
524868|NCT00862849|1281616|P4|STARTED|Intervention 5||4
524869|NCT00862849|1281617|P3|STARTED|Intervention 5||3
524870|NCT00862849|1281618|P2|STARTED|Intervention 5||3
524871|NCT00862849|1281619|P1|STARTED|Intervention 5||3
524872|NCT00862849|1281614|P6|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
524873|NCT00862849|1281615|P5|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
524874|NCT00862849|1281616|P4|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
524875|NCT00862849|1281617|P3|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
524876|NCT00862849|1281618|P2|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
524877|NCT00862849|1281619|P1|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
524878|NCT00862849|1281614|P6|COMPLETED|Washout 4 (3 to 14 Days)||3
524879|NCT00862849|1281615|P5|COMPLETED|Washout 4 (3 to 14 Days)||4
524880|NCT00862849|1281616|P4|COMPLETED|Washout 4 (3 to 14 Days)||4
524881|NCT00862849|1281617|P3|COMPLETED|Washout 4 (3 to 14 Days)||3
524882|NCT00862849|1281618|P2|COMPLETED|Washout 4 (3 to 14 Days)||3
524883|NCT00862849|1281619|P1|COMPLETED|Washout 4 (3 to 14 Days)||3
524884|NCT00862849|1281614|P6|STARTED|Washout 4 (3 to 14 Days)||3
524885|NCT00862849|1281615|P5|STARTED|Washout 4 (3 to 14 Days)||4
524886|NCT00862849|1281616|P4|STARTED|Washout 4 (3 to 14 Days)||4
524887|NCT00862849|1281617|P3|STARTED|Washout 4 (3 to 14 Days)||3
524888|NCT00862849|1281618|P2|STARTED|Washout 4 (3 to 14 Days)||3
524889|NCT00862849|1281619|P1|STARTED|Washout 4 (3 to 14 Days)||3
524890|NCT00862849|1281614|P6|NOT COMPLETED|Intervention 4||0
524891|NCT00862849|1281615|P5|NOT COMPLETED|Intervention 4||0
524892|NCT00862849|1281616|P4|NOT COMPLETED|Intervention 4||0
524893|NCT00862849|1281617|P3|NOT COMPLETED|Intervention 4||0
524894|NCT00862849|1281618|P2|NOT COMPLETED|Intervention 4||0
524895|NCT00862849|1281619|P1|NOT COMPLETED|Intervention 4||0
524896|NCT00862849|1281614|P6|COMPLETED|Intervention 4||3
524897|NCT00862849|1281615|P5|COMPLETED|Intervention 4||4
524898|NCT00862849|1281616|P4|COMPLETED|Intervention 4||4
524899|NCT00862849|1281617|P3|COMPLETED|Intervention 4||3
524900|NCT00862849|1281618|P2|COMPLETED|Intervention 4||3
524901|NCT00862849|1281619|P1|COMPLETED|Intervention 4||3
524902|NCT00862849|1281614|P6|STARTED|Intervention 4||3
524903|NCT00862849|1281615|P5|STARTED|Intervention 4||4
524904|NCT00862849|1281616|P4|STARTED|Intervention 4||4
524905|NCT00862849|1281617|P3|STARTED|Intervention 4||3
524906|NCT00862849|1281618|P2|STARTED|Intervention 4||3
524907|NCT00862849|1281619|P1|STARTED|Intervention 4||3
524908|NCT00862849|1281614|P6|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
524909|NCT00862849|1281615|P5|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
524910|NCT00862849|1281616|P4|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
524911|NCT00862849|1281617|P3|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
524912|NCT00862849|1281618|P2|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
524913|NCT00862849|1281619|P1|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
524914|NCT00862849|1281614|P6|COMPLETED|Washout 3 (3 to 14 Days)||3
524915|NCT00862849|1281615|P5|COMPLETED|Washout 3 (3 to 14 Days)||4
524916|NCT00862849|1281616|P4|COMPLETED|Washout 3 (3 to 14 Days)||4
524917|NCT00862849|1281617|P3|COMPLETED|Washout 3 (3 to 14 Days)||3
524918|NCT00862849|1281618|P2|COMPLETED|Washout 3 (3 to 14 Days)||3
524919|NCT00862849|1281619|P1|COMPLETED|Washout 3 (3 to 14 Days)||3
524920|NCT00862849|1281614|P6|STARTED|Washout 3 (3 to 14 Days)||3
524921|NCT00862849|1281615|P5|STARTED|Washout 3 (3 to 14 Days)||4
524922|NCT00862849|1281616|P4|STARTED|Washout 3 (3 to 14 Days)||4
524923|NCT00862849|1281617|P3|STARTED|Washout 3 (3 to 14 Days)||3
524924|NCT00862849|1281618|P2|STARTED|Washout 3 (3 to 14 Days)||3
524925|NCT00862849|1281619|P1|STARTED|Washout 3 (3 to 14 Days)||3
524926|NCT00862849|1281614|P6|NOT COMPLETED|Intervention 3||0
524927|NCT00862849|1281615|P5|NOT COMPLETED|Intervention 3||0
524928|NCT00862849|1281616|P4|NOT COMPLETED|Intervention 3||0
524929|NCT00862849|1281617|P3|NOT COMPLETED|Intervention 3||0
524930|NCT00862849|1281618|P2|NOT COMPLETED|Intervention 3||0
524931|NCT00862849|1281619|P1|NOT COMPLETED|Intervention 3||0
524932|NCT00862849|1281614|P6|COMPLETED|Intervention 3||3
524933|NCT00862849|1281615|P5|COMPLETED|Intervention 3||4
524934|NCT00862849|1281616|P4|COMPLETED|Intervention 3||4
524935|NCT00862849|1281617|P3|COMPLETED|Intervention 3||3
524936|NCT00862849|1281618|P2|COMPLETED|Intervention 3||3
524937|NCT00862849|1281619|P1|COMPLETED|Intervention 3||3
524938|NCT00862849|1281614|P6|STARTED|Intervention 3||3
524939|NCT00862849|1281615|P5|STARTED|Intervention 3||4
524940|NCT00862849|1281616|P4|STARTED|Intervention 3||4
524941|NCT00862849|1281617|P3|STARTED|Intervention 3||3
524942|NCT00862849|1281618|P2|STARTED|Intervention 3||3
524943|NCT00862849|1281619|P1|STARTED|Intervention 3||3
524944|NCT00862849|1281614|P6|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
524945|NCT00862849|1281615|P5|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
524946|NCT00862849|1281616|P4|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
524947|NCT00862849|1281617|P3|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
524948|NCT00862849|1281618|P2|NOT COMPLETED|Washout 2 (3 to 14 Days)||1
524949|NCT00862849|1281619|P1|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
524950|NCT00862849|1281614|P6|COMPLETED|Washout 2 (3 to 14 Days)||3
524951|NCT00862849|1281615|P5|COMPLETED|Washout 2 (3 to 14 Days)||4
524952|NCT00862849|1281616|P4|COMPLETED|Washout 2 (3 to 14 Days)||4
524953|NCT00862849|1281617|P3|COMPLETED|Washout 2 (3 to 14 Days)||3
524954|NCT00862849|1281618|P2|COMPLETED|Washout 2 (3 to 14 Days)||3
524955|NCT00862849|1281619|P1|COMPLETED|Washout 2 (3 to 14 Days)||3
524956|NCT00862849|1281614|P6|STARTED|Washout 2 (3 to 14 Days)||3
524957|NCT00862849|1281615|P5|STARTED|Washout 2 (3 to 14 Days)||4
524958|NCT00862849|1281616|P4|STARTED|Washout 2 (3 to 14 Days)||4
524959|NCT00862849|1281617|P3|STARTED|Washout 2 (3 to 14 Days)||3
524960|NCT00862849|1281618|P2|STARTED|Washout 2 (3 to 14 Days)||4
524961|NCT00862849|1281619|P1|STARTED|Washout 2 (3 to 14 Days)||3
524962|NCT00862849|1281614|P6|NOT COMPLETED|Intervention 2||0
524963|NCT00862849|1281615|P5|NOT COMPLETED|Intervention 2||0
524964|NCT00862849|1281616|P4|NOT COMPLETED|Intervention 2||0
524965|NCT00862849|1281617|P3|NOT COMPLETED|Intervention 2||0
524966|NCT00862849|1281618|P2|NOT COMPLETED|Intervention 2||0
524967|NCT00862849|1281619|P1|NOT COMPLETED|Intervention 2||0
524968|NCT00862849|1281614|P6|COMPLETED|Intervention 2||3
524969|NCT00862849|1281615|P5|COMPLETED|Intervention 2||4
524970|NCT00862849|1281616|P4|COMPLETED|Intervention 2||4
524971|NCT00862849|1281617|P3|COMPLETED|Intervention 2||3
524972|NCT00862849|1281618|P2|COMPLETED|Intervention 2||4
524973|NCT00862849|1281619|P1|COMPLETED|Intervention 2||3
524974|NCT00862849|1281614|P6|STARTED|Intervention 2||3
524975|NCT00862849|1281615|P5|STARTED|Intervention 2||4
524976|NCT00862849|1281616|P4|STARTED|Intervention 2||4
524977|NCT00862849|1281617|P3|STARTED|Intervention 2||3
524978|NCT00862849|1281618|P2|STARTED|Intervention 2||4
524979|NCT00862849|1281619|P1|STARTED|Intervention 2||3
524980|NCT00862849|1281614|P6|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
524981|NCT00862849|1281615|P5|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
524982|NCT00862849|1281616|P4|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
524983|NCT00862849|1281617|P3|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
524984|NCT00862849|1281618|P2|NOT COMPLETED|Washout 1 (3 to 14 Days)||1
524985|NCT00862849|1281619|P1|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
524986|NCT00862849|1281614|P6|COMPLETED|Washout 1 (3 to 14 Days)||3
524987|NCT00862849|1281615|P5|COMPLETED|Washout 1 (3 to 14 Days)||4
524988|NCT00862849|1281616|P4|COMPLETED|Washout 1 (3 to 14 Days)||4
524989|NCT00862849|1281617|P3|COMPLETED|Washout 1 (3 to 14 Days)||3
524990|NCT00862849|1281618|P2|COMPLETED|Washout 1 (3 to 14 Days)||4
524991|NCT00862849|1281619|P1|COMPLETED|Washout 1 (3 to 14 Days)||3
524992|NCT00862849|1281614|P6|STARTED|Washout 1 (3 to 14 Days)||3
524993|NCT00862849|1281615|P5|STARTED|Washout 1 (3 to 14 Days)||4
524994|NCT00862849|1281616|P4|STARTED|Washout 1 (3 to 14 Days)||4
524995|NCT00862849|1281617|P3|STARTED|Washout 1 (3 to 14 Days)||3
524996|NCT00862849|1281618|P2|STARTED|Washout 1 (3 to 14 Days)||5
524997|NCT00862849|1281619|P1|STARTED|Washout 1 (3 to 14 Days)||3
524998|NCT00862849|1281614|P6|NOT COMPLETED|Intervention 1||0
524999|NCT00862849|1281615|P5|NOT COMPLETED|Intervention 1||0
525000|NCT00862849|1281616|P4|NOT COMPLETED|Intervention 1||0
525001|NCT00862849|1281617|P3|NOT COMPLETED|Intervention 1||0
525002|NCT00862849|1281618|P2|NOT COMPLETED|Intervention 1||0
525003|NCT00862849|1281619|P1|NOT COMPLETED|Intervention 1||0
525004|NCT00862849|1281614|P6|COMPLETED|Intervention 1||3
525005|NCT00862849|1281615|P5|COMPLETED|Intervention 1||4
525006|NCT00862849|1281616|P4|COMPLETED|Intervention 1||4
525007|NCT00862849|1281617|P3|COMPLETED|Intervention 1||3
525008|NCT00862849|1281618|P2|COMPLETED|Intervention 1||5
525009|NCT00862849|1281619|P1|COMPLETED|Intervention 1||3
525010|NCT00862849|1281614|P6|Received at Least One Dose of Study Drug|Intervention 1||3
525011|NCT00862849|1281615|P5|Received at Least One Dose of Study Drug|Intervention 1||4
525012|NCT00862849|1281616|P4|Received at Least One Dose of Study Drug|Intervention 1||4
525013|NCT00862849|1281617|P3|Received at Least One Dose of Study Drug|Intervention 1||3
525014|NCT00862849|1281618|P2|Received at Least One Dose of Study Drug|Intervention 1||5
525015|NCT00862849|1281619|P1|Received at Least One Dose of Study Drug|Intervention 1||3
525016|NCT00862849|1281614|P6|STARTED|Intervention 1||3
525017|NCT00862849|1281615|P5|STARTED|Intervention 1||4
525018|NCT00862849|1281616|P4|STARTED|Intervention 1||4
525019|NCT00862849|1281617|P3|STARTED|Intervention 1||3
525020|NCT00862849|1281618|P2|STARTED|Intervention 1||5
525021|NCT00862849|1281619|P1|STARTED|Intervention 1||3
525022|NCT00862836|1281642|P1|NOT COMPLETED|Overall Study||1
525023|NCT00862836|1281642|P1|COMPLETED|Overall Study||14
525024|NCT00862836|1281642|P1|Evaluable for Activity (Tumour Response)|Overall Study||10
525025|NCT00862836|1281642|P1|Evaluable for Safety/Toxicity|Overall Study|1 patient withdrew consent before first cycle|14
525026|NCT00862836|1281642|P1|STARTED|Overall Study||15
525027|NCT00862823|1281653|P2|NOT COMPLETED|Second Intervention||0
525028|NCT00862823|1281654|P1|NOT COMPLETED|Second Intervention||0
525029|NCT00862823|1281653|P2|COMPLETED|Second Intervention||9
525030|NCT00862823|1281654|P1|COMPLETED|Second Intervention||5
525031|NCT00862823|1281653|P2|STARTED|Second Intervention||9
525032|NCT00862823|1281654|P1|STARTED|Second Intervention||5
525033|NCT00862823|1281653|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
525034|NCT00862823|1281654|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
525035|NCT00862823|1281653|P2|COMPLETED|Washout Period of 2 Weeks||9
525036|NCT00862823|1281654|P1|COMPLETED|Washout Period of 2 Weeks||5
525037|NCT00862823|1281653|P2|STARTED|Washout Period of 2 Weeks||9
525038|NCT00862823|1281654|P1|STARTED|Washout Period of 2 Weeks||5
525039|NCT00862823|1281653|P2|NOT COMPLETED|First Intervention||1
525040|NCT00862823|1281654|P1|NOT COMPLETED|First Intervention||1
525041|NCT00862823|1281653|P2|COMPLETED|First Intervention||9
525042|NCT00862823|1281654|P1|COMPLETED|First Intervention||5
525043|NCT00862823|1281653|P2|STARTED|First Intervention||10
525044|NCT00862823|1281654|P1|STARTED|First Intervention||6
525045|NCT00862810|1281663|P2|NOT COMPLETED|Overall Study||4
525046|NCT00862810|1281664|P1|NOT COMPLETED|Overall Study||4
525047|NCT00862810|1281663|P2|COMPLETED|Overall Study||35
525048|NCT00862810|1281664|P1|COMPLETED|Overall Study||29
525049|NCT00862810|1281663|P2|STARTED|Overall Study||39
525050|NCT00862810|1281664|P1|STARTED|Overall Study||33
525051|NCT00862784|1281670|P1|NOT COMPLETED|Overall Study||0
525052|NCT00862784|1281670|P1|COMPLETED|Overall Study||48
525053|NCT00862784|1281670|P1|Received Any Amount of Study Drug|Overall Study||48
525054|NCT00862784|1281670|P1|STARTED|Overall Study||48
525055|NCT00862745|1281692|P2|NOT COMPLETED|Open-label Follow-up||49
525056|NCT00862745|1281693|P1|NOT COMPLETED|Open-label Follow-up||39
525057|NCT00862745|1281692|P2|COMPLETED|Open-label Follow-up||225
525058|NCT00862745|1281693|P1|COMPLETED|Open-label Follow-up||229
525059|NCT00862745|1281692|P2|STARTED|Open-label Follow-up|10 participants elected not to enter the open-label portion of the study after completing the RCT.|274
525060|NCT00862745|1281693|P1|STARTED|Open-label Follow-up|19 participants elected not to enter the open-label portion of the study after completing the RCT.|268
525061|NCT00862745|1281692|P2|NOT COMPLETED|Randomized Control Trial||39
525062|NCT00862745|1281693|P1|NOT COMPLETED|Randomized Control Trial||38
525063|NCT00862745|1281692|P2|COMPLETED|Randomized Control Trial||284
525064|NCT00862745|1281693|P1|COMPLETED|Randomized Control Trial||284
525065|NCT00862745|1281692|P2|STARTED|Randomized Control Trial||323
525066|NCT00862745|1281693|P1|STARTED|Randomized Control Trial||322
525067|NCT00862719|1281703|P4|NOT COMPLETED|Overall Study||1
525068|NCT00862719|1281704|P3|NOT COMPLETED|Overall Study||4
525069|NCT00862719|1281705|P2|NOT COMPLETED|Overall Study||6
525070|NCT00862719|1281706|P1|NOT COMPLETED|Overall Study||10
525071|NCT00862719|1281703|P4|COMPLETED|Overall Study||0
525072|NCT00862719|1281704|P3|COMPLETED|Overall Study||0
525073|NCT00862719|1281705|P2|COMPLETED|Overall Study||1
525074|NCT00862719|1281706|P1|COMPLETED|Overall Study||7
525075|NCT00862719|1281703|P4|STARTED|Overall Study||1
525076|NCT00862719|1281704|P3|STARTED|Overall Study||4
525077|NCT00862719|1281705|P2|STARTED|Overall Study||7
525078|NCT00862719|1281706|P1|STARTED|Overall Study||17
525079|NCT00862654|1281729|P4|NOT COMPLETED|Overall Study||6
525080|NCT00862654|1281730|P3|NOT COMPLETED|Overall Study||6
525081|NCT00862654|1281731|P2|NOT COMPLETED|Overall Study||8
525082|NCT00862654|1281732|P1|NOT COMPLETED|Overall Study||6
525083|NCT00862654|1281729|P4|COMPLETED|Overall Study||74
525084|NCT00862654|1281730|P3|COMPLETED|Overall Study||76
525085|NCT00862654|1281731|P2|COMPLETED|Overall Study||74
525086|NCT00862654|1281732|P1|COMPLETED|Overall Study||76
525087|NCT00862654|1281729|P4|STARTED|Overall Study||80
525088|NCT00862654|1281730|P3|STARTED|Overall Study||82
525089|NCT00862654|1281731|P2|STARTED|Overall Study||82
525090|NCT00862654|1281732|P1|STARTED|Overall Study||82
525091|NCT00862641|1281746|P4|NOT COMPLETED|Overall Study||4
525092|NCT00862641|1281747|P3|NOT COMPLETED|Overall Study||1
525093|NCT00862641|1281748|P2|NOT COMPLETED|Overall Study||4
525094|NCT00862641|1281749|P1|NOT COMPLETED|Overall Study||1
525095|NCT00862641|1281746|P4|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|316
525096|NCT00862641|1281747|P3|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|151
525097|NCT00862641|1281748|P2|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|356
525098|NCT00862641|1281749|P1|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|176
525099|NCT00862641|1281746|P4|STARTED|Overall Study||320
525100|NCT00862641|1281747|P3|STARTED|Overall Study||152
525101|NCT00862641|1281748|P2|STARTED|Overall Study||360
525102|NCT00862641|1281749|P1|STARTED|Overall Study||177
525103|NCT00862563|1281795|P4|NOT COMPLETED|Overall Study||5
525104|NCT00862563|1281796|P3|NOT COMPLETED|Overall Study||6
525105|NCT00862563|1281797|P2|NOT COMPLETED|Overall Study||4
525106|NCT00862563|1281798|P1|NOT COMPLETED|Overall Study||4
525107|NCT00862563|1281795|P4|COMPLETED|Overall Study||19
525108|NCT00862563|1281796|P3|COMPLETED|Overall Study||15
525109|NCT00862563|1281797|P2|COMPLETED|Overall Study||17
525110|NCT00862563|1281798|P1|COMPLETED|Overall Study||15
525111|NCT00862563|1281795|P4|STARTED|Overall Study||24
525112|NCT00862563|1281796|P3|STARTED|Overall Study||21
525113|NCT00862563|1281797|P2|STARTED|Overall Study||21
525114|NCT00862563|1281798|P1|STARTED|Overall Study||19
525115|NCT00862537|1281836|P1|NOT COMPLETED|Overall Study||7
525116|NCT00862537|1281836|P1|COMPLETED|Overall Study||11
525117|NCT00862537|1281836|P1|STARTED|Overall Study||18
525118|NCT00862459|1281843|P3|NOT COMPLETED|Overall Study||6
525119|NCT00862459|1281844|P2|NOT COMPLETED|Overall Study||8
525120|NCT00862459|1281845|P1|NOT COMPLETED|Overall Study||6
525121|NCT00862459|1281843|P3|COMPLETED|Overall Study||66
525122|NCT00862459|1281844|P2|COMPLETED|Overall Study||85
525123|NCT00862459|1281845|P1|COMPLETED|Overall Study||66
525124|NCT00862459|1281843|P3|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 68 received Gadobutrol and 69 received OptiMARK|69
525125|NCT00862459|1281844|P2|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 90 received Gadobutrol and 88 received OptiMARK|90
525126|NCT00862459|1281845|P1|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 67 received Gadobutrol and 70 received OptiMARK|70
525127|NCT00862459|1281843|P3|STARTED|Overall Study||72
525128|NCT00862459|1281844|P2|STARTED|Overall Study||93
525129|NCT00862459|1281845|P1|STARTED|Overall Study||72
525130|NCT00862277|1281992|P3|NOT COMPLETED|Overall Study||5
525131|NCT00862277|1281993|P2|NOT COMPLETED|Overall Study||2
525132|NCT00862277|1281994|P1|NOT COMPLETED|Overall Study||1
525133|NCT00862277|1281992|P3|COMPLETED|Overall Study||100
525134|NCT00862277|1281993|P2|COMPLETED|Overall Study||94
525135|NCT00862277|1281994|P1|COMPLETED|Overall Study||560
525136|NCT00862277|1281992|P3|STARTED|Overall Study||105
525137|NCT00862277|1281993|P2|STARTED|Overall Study||96
525138|NCT00862277|1281994|P1|STARTED|Overall Study||561
525139|NCT00862251|1282008|P3|NOT COMPLETED|Overall Study||9
525140|NCT00862251|1282009|P2|NOT COMPLETED|Overall Study||5
525141|NCT00862251|1282010|P1|NOT COMPLETED|Overall Study||19
525142|NCT00862251|1282008|P3|COMPLETED|Overall Study||315
525143|NCT00862251|1282009|P2|COMPLETED|Overall Study||157
525144|NCT00862251|1282010|P1|COMPLETED|Overall Study||303
525145|NCT00862251|1282008|P3|STARTED|Overall Study||324
525146|NCT00862251|1282009|P2|STARTED|Overall Study||162
525147|NCT00862251|1282010|P1|STARTED|Overall Study||322
525148|NCT00862186|1282063|P1|NOT COMPLETED|Overall Study||0
525149|NCT00862186|1282063|P1|COMPLETED|Overall Study||15
525150|NCT00862186|1282063|P1|STARTED|Overall Study||15
525151|NCT00862134|1282070|P2|NOT COMPLETED|Overall Study||12
525152|NCT00862134|1282071|P1|NOT COMPLETED|Overall Study||11
525153|NCT00862134|1282070|P2|COMPLETED|Overall Study||11
525154|NCT00862134|1282071|P1|COMPLETED|Overall Study||8
525155|NCT00862134|1282070|P2|STARTED|Overall Study||23
525156|NCT00862134|1282071|P1|STARTED|Overall Study||19
525157|NCT00862121|1282083|P2|NOT COMPLETED|Overall Study||8
525158|NCT00862121|1282084|P1|NOT COMPLETED|Overall Study||1
525159|NCT00862121|1282083|P2|COMPLETED|Overall Study||4
525160|NCT00862121|1282084|P1|COMPLETED|Overall Study||7
525161|NCT00862121|1282083|P2|Safety Analysis Set|Overall Study||11
525162|NCT00862121|1282084|P1|Safety Analysis Set|Overall Study|The participant with no evaluable post-baseline CDAI score was included in the Safety Analysis Set.|8
525163|NCT00862121|1282083|P2|Full Analysis Set (FAS)|Overall Study|One participant randomised in error (no IMP taken).|11
525164|NCT00862121|1282084|P1|Full Analysis Set (FAS)|Overall Study|One participant had no evaluable post-baseline CDAI score.|7
525165|NCT00862121|1282083|P2|STARTED|Overall Study|Randomised, intent-to-treat (ITT)|12
525166|NCT00862121|1282084|P1|STARTED|Overall Study||8
525167|NCT00862082|1282102|P2|NOT COMPLETED|Overall Study||1
525168|NCT00862082|1282103|P1|NOT COMPLETED|Overall Study||5
525169|NCT00862082|1282102|P2|COMPLETED|Overall Study||5
525170|NCT00862082|1282103|P1|COMPLETED|Overall Study||3
525171|NCT00862082|1282102|P2|STARTED|Overall Study||6
525172|NCT00862082|1282103|P1|STARTED|Overall Study||8
525173|NCT00861913|1282146|P1|NOT COMPLETED|Overall Study||0
525174|NCT00861913|1282146|P1|COMPLETED|Overall Study||13
525175|NCT00861913|1282146|P1|STARTED|Overall Study||13
525176|NCT00861757|1282158|P4|NOT COMPLETED|Overall Study||9
525177|NCT00861757|1282159|P3|NOT COMPLETED|Overall Study||18
525178|NCT00861757|1282160|P2|NOT COMPLETED|Overall Study||15
525179|NCT00861757|1282161|P1|NOT COMPLETED|Overall Study||9
525180|NCT00861757|1282158|P4|COMPLETED|Overall Study||143
525181|NCT00861757|1282159|P3|COMPLETED|Overall Study||137
525182|NCT00861757|1282160|P2|COMPLETED|Overall Study||136
525183|NCT00861757|1282161|P1|COMPLETED|Overall Study||145
525184|NCT00861757|1282158|P4|STARTED|Overall Study||152
525185|NCT00861757|1282159|P3|STARTED|Overall Study||155
525186|NCT00861757|1282160|P2|STARTED|Overall Study||151
525187|NCT00861757|1282161|P1|STARTED|Overall Study||154
525188|NCT00861744|1282219|P4|NOT COMPLETED|Overall Study||33
525189|NCT00861744|1282220|P3|NOT COMPLETED|Overall Study||24
525190|NCT00861744|1282221|P2|NOT COMPLETED|Overall Study||29
525191|NCT00861744|1282222|P1|NOT COMPLETED|Overall Study||17
525192|NCT00861744|1282219|P4|COMPLETED|Overall Study||275
525193|NCT00861744|1282220|P3|COMPLETED|Overall Study||280
525194|NCT00861744|1282221|P2|COMPLETED|Overall Study||275
525195|NCT00861744|1282222|P1|COMPLETED|Overall Study||287
525196|NCT00861744|1282219|P4|STARTED|Overall Study||308
525197|NCT00861744|1282220|P3|STARTED|Overall Study||304
525198|NCT00861744|1282221|P2|STARTED|Overall Study||304
525199|NCT00861744|1282222|P1|STARTED|Overall Study||304
525200|NCT00861705|1282404|P4|NOT COMPLETED|Overall Study||1
525201|NCT00861705|1282405|P3|NOT COMPLETED|Overall Study||0
525202|NCT00861705|1282406|P2|NOT COMPLETED|Overall Study||3
525203|NCT00861705|1282407|P1|NOT COMPLETED|Overall Study||7
525204|NCT00861705|1282404|P4|COMPLETED|Overall Study||112
525205|NCT00861705|1282405|P3|COMPLETED|Overall Study||113
525206|NCT00861705|1282406|P2|COMPLETED|Overall Study||110
525207|NCT00861705|1282407|P1|COMPLETED|Overall Study||108
525208|NCT00861705|1282404|P4|STARTED|Overall Study||113
525209|NCT00861705|1282405|P3|STARTED|Overall Study||113
525210|NCT00861705|1282406|P2|STARTED|Overall Study||113
525211|NCT00861705|1282407|P1|STARTED|Overall Study||115
525212|NCT00861692|1282423|P1|NOT COMPLETED|Overall Study||6
525213|NCT00861692|1282423|P1|COMPLETED|Overall Study||14
525214|NCT00861692|1282423|P1|STARTED|Overall Study||20
525215|NCT00861614|1282435|P2|NOT COMPLETED|Overall Study||368
525216|NCT00861614|1282436|P1|NOT COMPLETED|Overall Study||371
525217|NCT00861614|1282435|P2|COMPLETED|Overall Study||28
525218|NCT00861614|1282436|P1|COMPLETED|Overall Study||22
525219|NCT00861614|1282435|P2|STARTED|Overall Study||396
525220|NCT00861614|1282436|P1|STARTED|Overall Study||393
525221|NCT00861601|1282469|P3|NOT COMPLETED|Overall Study||0
525222|NCT00861601|1282470|P2|NOT COMPLETED|Overall Study||0
525223|NCT00861601|1282471|P1|NOT COMPLETED|Overall Study||0
525224|NCT00861601|1282469|P3|COMPLETED|Overall Study||12
525225|NCT00861601|1282470|P2|COMPLETED|Overall Study||14
525226|NCT00861601|1282471|P1|COMPLETED|Overall Study||12
525227|NCT00861601|1282469|P3|STARTED|Overall Study||12
525228|NCT00861601|1282470|P2|STARTED|Overall Study||14
525229|NCT00861601|1282471|P1|STARTED|Overall Study||12
525230|NCT00861471|1282521|P1|NOT COMPLETED|Overall Study||9
525231|NCT00861471|1282521|P1|COMPLETED|Overall Study||3
525232|NCT00861471|1282521|P1|STARTED|Overall Study||12
525233|NCT00861341|1282529|P1|NOT COMPLETED|Overall Study||2
525234|NCT00861341|1282529|P1|COMPLETED|Overall Study||38
525235|NCT00861341|1282529|P1|STARTED|Overall Study||40
525236|NCT00861263|1282534|P1|NOT COMPLETED|Overall Study||0
525237|NCT00861263|1282534|P1|COMPLETED|Overall Study||193
525238|NCT00861263|1282534|P1|STARTED|Overall Study||193
525239|NCT00861198|1282538|P1|NOT COMPLETED|Overall Study||5
525240|NCT00861198|1282538|P1|COMPLETED|Overall Study||70
525241|NCT00861198|1282538|P1|STARTED|Overall Study||75
525242|NCT00861146|1282544|P2|NOT COMPLETED|Overall Study||8
525243|NCT00861146|1282545|P1|NOT COMPLETED|Overall Study||20
525244|NCT00861146|1282544|P2|COMPLETED|Overall Study||38
525245|NCT00861146|1282545|P1|COMPLETED|Overall Study||85
525246|NCT00861146|1282544|P2|Week 13 Assessment|Overall Study||38
525247|NCT00861146|1282545|P1|Week 13 Assessment|Overall Study||85
525248|NCT00861146|1282544|P2|Week 2 Assessment|Overall Study||45
525249|NCT00861146|1282545|P1|Week 2 Assessment|Overall Study||97
525250|NCT00861146|1282544|P2|STARTED|Overall Study||46
525251|NCT00861146|1282545|P1|STARTED|Overall Study||105
525252|NCT00860951|1282555|P1|NOT COMPLETED|Overall Study||7
525253|NCT00860951|1282555|P1|COMPLETED|Overall Study||22
525254|NCT00860951|1282555|P1|STARTED|Overall Study||29
525255|NCT00860847|1282563|P2|NOT COMPLETED|Overall Study||5
525256|NCT00860847|1282564|P1|NOT COMPLETED|Overall Study||4
525257|NCT00860847|1282563|P2|COMPLETED|Overall Study||28
525258|NCT00860847|1282564|P1|COMPLETED|Overall Study||28
525259|NCT00860847|1282563|P2|STARTED|Overall Study||33
525260|NCT00860847|1282564|P1|STARTED|Overall Study||32
525261|NCT00860795|1282572|P2|NOT COMPLETED|Overall Study||0
525262|NCT00860795|1282573|P1|NOT COMPLETED|Overall Study||0
525263|NCT00860795|1282572|P2|COMPLETED|Overall Study||10
525264|NCT00860795|1282573|P1|COMPLETED|Overall Study|One participant discontinued study medication on day 5, but completed safety evaluations|10
525265|NCT00860795|1282572|P2|Number to Complete Study Medication|Overall Study||10
525266|NCT00860795|1282573|P1|Number to Complete Study Medication|Overall Study||9
525267|NCT00860795|1282572|P2|STARTED|Overall Study||10
525268|NCT00860795|1282573|P1|STARTED|Overall Study||10
525269|NCT00860743|1282597|P2|NOT COMPLETED|Overall Study||0
525270|NCT00860743|1282598|P1|NOT COMPLETED|Overall Study||3
525271|NCT00860743|1282597|P2|COMPLETED|Overall Study||23
525272|NCT00860743|1282598|P1|COMPLETED|Overall Study||37
525273|NCT00860743|1282597|P2|STARTED|Overall Study||23
525274|NCT00860743|1282598|P1|STARTED|Overall Study||40
525275|NCT00860535|1282604|P1|NOT COMPLETED|Overall Study||1
525276|NCT00860535|1282604|P1|COMPLETED|Overall Study||8
525277|NCT00860535|1282604|P1|DISCONTINUED|Overall Study|Participant did not meet inclusion criteria and did not complete the study.|1
525278|NCT00860535|1282604|P1|STARTED|Overall Study||9
525279|NCT00860470|1282611|P2|NOT COMPLETED|Overall Study||59
525280|NCT00860470|1282612|P1|NOT COMPLETED|Overall Study||48
525281|NCT00860470|1282611|P2|COMPLETED|Overall Study||22346
525282|NCT00860470|1282612|P1|COMPLETED|Overall Study||22114
525283|NCT00860470|1282611|P2|STARTED|Overall Study||22405
525284|NCT00860470|1282612|P1|STARTED|Overall Study||22162
525285|NCT00860457|1282636|P1|NOT COMPLETED|Overall Study||11
525286|NCT00860457|1282636|P1|COMPLETED|Overall Study||11
525287|NCT00860457|1282636|P1|STARTED|Overall Study||22
525288|NCT00860405|1282642|P2|NOT COMPLETED|Overall Study||4
525289|NCT00860405|1282643|P1|NOT COMPLETED|Overall Study||5
525290|NCT00860405|1282642|P2|COMPLETED|Overall Study||26
525291|NCT00860405|1282643|P1|COMPLETED|Overall Study|completed overall study|26
525292|NCT00860405|1282642|P2|Day 28 Follow-up Performed|Overall Study||29
525293|NCT00860405|1282643|P1|Day 28 Follow-up Performed|Overall Study||31
525294|NCT00860405|1282642|P2|Completed Treatment|Overall Study||29
525295|NCT00860405|1282643|P1|Completed Treatment|Overall Study||31
525296|NCT00860405|1282642|P2|STARTED|Overall Study||30
525297|NCT00860405|1282643|P1|STARTED|Overall Study||31
525298|NCT00860314|1282667|P2|NOT COMPLETED|Overall Study||0
525299|NCT00860314|1282668|P1|NOT COMPLETED|Overall Study||0
525300|NCT00860314|1282667|P2|COMPLETED|Overall Study||48
525301|NCT00860314|1282668|P1|COMPLETED|Overall Study||48
525302|NCT00860314|1282667|P2|STARTED|Overall Study||48
525303|NCT00860314|1282668|P1|STARTED|Overall Study||48
525304|NCT00860262|1282683|P3|NOT COMPLETED|Overall Study||18
525305|NCT00860262|1282684|P2|NOT COMPLETED|Overall Study||22
525306|NCT00860262|1282685|P1|NOT COMPLETED|Overall Study||20
525307|NCT00860262|1282683|P3|COMPLETED|Overall Study||202
525308|NCT00860262|1282684|P2|COMPLETED|Overall Study||195
525309|NCT00860262|1282685|P1|COMPLETED|Overall Study||401
525310|NCT00860262|1282683|P3|STARTED|Overall Study||220
525311|NCT00860262|1282684|P2|STARTED|Overall Study||217
525312|NCT00860262|1282685|P1|STARTED|Overall Study||421
525313|NCT00860249|1282798|P3|NOT COMPLETED|Overall Study||21
525314|NCT00860249|1282799|P2|NOT COMPLETED|Overall Study||18
525315|NCT00860249|1282800|P1|NOT COMPLETED|Overall Study||21
525316|NCT00860249|1282798|P3|COMPLETED|Overall Study||0
525317|NCT00860249|1282799|P2|COMPLETED|Overall Study||0
525318|NCT00860249|1282800|P1|COMPLETED|Overall Study||0
525319|NCT00860249|1282798|P3|STARTED|Overall Study||21
525320|NCT00860249|1282799|P2|STARTED|Overall Study||18
525321|NCT00860249|1282800|P1|STARTED|Overall Study||21
525322|NCT00860171|1282811|P1|NOT COMPLETED|Overall Study||0
525323|NCT00860171|1282811|P1|COMPLETED|Overall Study||16
525324|NCT00860171|1282811|P1|STARTED|Overall Study||16
525325|NCT00860158|1282818|P1|NOT COMPLETED|Overall Study||1
525326|NCT00860158|1282818|P1|COMPLETED|Overall Study||0
525327|NCT00860158|1282818|P1|STARTED|Overall Study||1
525328|NCT00860067|1282830|P3|NOT COMPLETED|Overall Study||9
525329|NCT00860067|1282831|P2|NOT COMPLETED|Overall Study||9
525330|NCT00860067|1282832|P1|NOT COMPLETED|Overall Study||51
525331|NCT00860067|1282830|P3|COMPLETED|Overall Study||292
525332|NCT00860067|1282831|P2|COMPLETED|Overall Study||290
525333|NCT00860067|1282832|P1|COMPLETED|Overall Study||1149
525334|NCT00860067|1282830|P3|STARTED|Overall Study||301
525335|NCT00860067|1282831|P2|STARTED|Overall Study||299
525336|NCT00860067|1282832|P1|STARTED|Overall Study||1200
525337|NCT00860028|1282892|P2|NOT COMPLETED|Smoking Cessation Phase||2
525338|NCT00860028|1282893|P1|NOT COMPLETED|Smoking Cessation Phase||0
525339|NCT00860028|1282892|P2|COMPLETED|Smoking Cessation Phase||12
525340|NCT00860028|1282893|P1|COMPLETED|Smoking Cessation Phase||13
525341|NCT00860028|1282892|P2|STARTED|Smoking Cessation Phase||14
525342|NCT00860028|1282893|P1|STARTED|Smoking Cessation Phase||13
525343|NCT00860028|1282892|P2|NOT COMPLETED|Placebo Controlled Pretreatment Period||1
525344|NCT00860028|1282893|P1|NOT COMPLETED|Placebo Controlled Pretreatment Period||2
525345|NCT00860028|1282892|P2|COMPLETED|Placebo Controlled Pretreatment Period||14
525346|NCT00860028|1282893|P1|COMPLETED|Placebo Controlled Pretreatment Period||13
525347|NCT00860028|1282892|P2|STARTED|Placebo Controlled Pretreatment Period||15
525348|NCT00860028|1282893|P1|STARTED|Placebo Controlled Pretreatment Period||15
525349|NCT00859950|1282905|P2|NOT COMPLETED|Overall Study||0
525350|NCT00859950|1282906|P1|NOT COMPLETED|Overall Study||0
525351|NCT00859950|1282905|P2|COMPLETED|Overall Study||21
525352|NCT00859950|1282906|P1|COMPLETED|Overall Study||49
525353|NCT00859950|1282905|P2|STARTED|Overall Study||21
525354|NCT00859950|1282906|P1|STARTED|Overall Study||49
525355|NCT00859937|1282914|P2|NOT COMPLETED|Overall Study||0
525356|NCT00859937|1282915|P1|NOT COMPLETED|Overall Study||1
525357|NCT00859937|1282914|P2|COMPLETED|Overall Study||14
525358|NCT00859937|1282915|P1|COMPLETED|Overall Study||40
525359|NCT00859937|1282914|P2|STARTED|Overall Study||14
525360|NCT00859937|1282915|P1|STARTED|Overall Study||41
525361|NCT00859898|1282930|P3|NOT COMPLETED|Overall Study||27
525362|NCT00859898|1282931|P2|NOT COMPLETED|Overall Study||31
525363|NCT00859898|1282932|P1|NOT COMPLETED|Overall Study||28
525364|NCT00859898|1282930|P3|COMPLETED|Overall Study||181
525365|NCT00859898|1282931|P2|COMPLETED|Overall Study||188
525366|NCT00859898|1282932|P1|COMPLETED|Overall Study||183
525367|NCT00859898|1282930|P3|STARTED|Overall Study||208
525368|NCT00859898|1282931|P2|STARTED|Overall Study||219
525369|NCT00859898|1282932|P1|STARTED|Overall Study||211
525370|NCT00859833|1282973|P1|NOT COMPLETED|Overall Study||0
525371|NCT00859833|1282973|P1|COMPLETED|Overall Study||30
525372|NCT00859833|1282973|P1|STARTED|Overall Study||30
525373|NCT00859651|1282980|P2|NOT COMPLETED|Overall Study||0
525374|NCT00859651|1282981|P1|NOT COMPLETED|Overall Study||0
525375|NCT00859651|1282980|P2|COMPLETED|Overall Study||22
525376|NCT00859651|1282981|P1|COMPLETED|Overall Study||18
525377|NCT00859651|1282980|P2|STARTED|Overall Study||22
525378|NCT00859651|1282981|P1|STARTED|Overall Study||18
525379|NCT00859638|1282991|P2|NOT COMPLETED|Overall Study||4
525380|NCT00859638|1282992|P1|NOT COMPLETED|Overall Study||10
525381|NCT00859638|1282991|P2|COMPLETED|Overall Study||55
525382|NCT00859638|1282992|P1|COMPLETED|Overall Study||55
525383|NCT00859638|1282991|P2|STARTED|Overall Study||59
525384|NCT00859638|1282992|P1|STARTED|Overall Study||65
525385|NCT00859586|1282998|P1|NOT COMPLETED|Overall Study||4
525386|NCT00859586|1282998|P1|COMPLETED|Overall Study||4
525387|NCT00859586|1282998|P1|STARTED|Overall Study||8
525388|NCT00859573|1283004|P2|NOT COMPLETED|Overall Study||2
525389|NCT00859573|1283005|P1|NOT COMPLETED|Overall Study||5
525390|NCT00859573|1283004|P2|COMPLETED|Overall Study||1
525391|NCT00859573|1283005|P1|COMPLETED|Overall Study||1
525392|NCT00859573|1283004|P2|STARTED|Overall Study||3
525393|NCT00859573|1283005|P1|STARTED|Overall Study||6
525394|NCT00859547|1283011|P1|NOT COMPLETED|Overall Study||2
525395|NCT00859547|1283011|P1|COMPLETED|Overall Study||28
525396|NCT00859547|1283011|P1|STARTED|Overall Study||30
525397|NCT00859521|1283024|P2|NOT COMPLETED|Second Intervention||0
525398|NCT00859521|1283025|P1|NOT COMPLETED|Second Intervention||0
525399|NCT00859521|1283024|P2|COMPLETED|Second Intervention||14
525400|NCT00859521|1283025|P1|COMPLETED|Second Intervention||15
525401|NCT00859521|1283024|P2|STARTED|Second Intervention||14
525402|NCT00859521|1283025|P1|STARTED|Second Intervention||15
525403|NCT00859521|1283024|P2|NOT COMPLETED|Washout||1
525404|NCT00859521|1283025|P1|NOT COMPLETED|Washout||0
525405|NCT00859521|1283024|P2|COMPLETED|Washout||14
525406|NCT00859521|1283025|P1|COMPLETED|Washout||15
525407|NCT00859521|1283024|P2|STARTED|Washout||15
525408|NCT00859521|1283025|P1|STARTED|Washout||15
525409|NCT00859521|1283024|P2|NOT COMPLETED|First Intervention||0
525410|NCT00859521|1283025|P1|NOT COMPLETED|First Intervention||0
525411|NCT00859521|1283024|P2|COMPLETED|First Intervention||15
525412|NCT00859521|1283025|P1|COMPLETED|First Intervention||15
525413|NCT00859521|1283024|P2|STARTED|First Intervention||15
525414|NCT00859521|1283025|P1|STARTED|First Intervention||15
525415|NCT00859508|1283035|P2|NOT COMPLETED|Overall Study||0
525416|NCT00859508|1283036|P1|NOT COMPLETED|Overall Study||6
525417|NCT00859508|1283035|P2|COMPLETED|Overall Study||37
525418|NCT00859508|1283036|P1|COMPLETED|Overall Study||62
525419|NCT00859508|1283035|P2|STARTED|Overall Study||37
525420|NCT00859508|1283036|P1|STARTED|Overall Study||68
525421|NCT00859469|1283042|P1|NOT COMPLETED|Overall Study||28
525422|NCT00859469|1283042|P1|COMPLETED|Overall Study||1
525423|NCT00859469|1283042|P1|6 Cycles|Overall Study||16
525424|NCT00859469|1283042|P1|STARTED|Overall Study||29
525425|NCT00859430|1283050|P2|NOT COMPLETED|Second Intervention||0
525426|NCT00859430|1283051|P1|NOT COMPLETED|Second Intervention||0
525427|NCT00859430|1283050|P2|COMPLETED|Second Intervention||10
525428|NCT00859430|1283051|P1|COMPLETED|Second Intervention||11
525429|NCT00859430|1283050|P2|STARTED|Second Intervention||10
525430|NCT00859430|1283051|P1|STARTED|Second Intervention||11
525431|NCT00859430|1283050|P2|NOT COMPLETED|First Intervention||1
525432|NCT00859430|1283051|P1|NOT COMPLETED|First Intervention||0
525433|NCT00859430|1283050|P2|COMPLETED|First Intervention||10
525434|NCT00859430|1283051|P1|COMPLETED|First Intervention||11
525435|NCT00859430|1283050|P2|STARTED|First Intervention||11
525436|NCT00859430|1283051|P1|STARTED|First Intervention||11
525437|NCT00859339|1283059|P1|NOT COMPLETED|Overall Study||0
525438|NCT00859339|1283059|P1|COMPLETED|Overall Study||9
525439|NCT00859339|1283059|P1|STARTED|Overall Study||9
525440|NCT00859313|1283067|P1|NOT COMPLETED|Overall Study||4
525441|NCT00859313|1283067|P1|COMPLETED|Overall Study||26
525442|NCT00859313|1283067|P1|STARTED|Overall Study||30
525443|NCT00859222|1283074|P5|NOT COMPLETED|Overall Study||15
525444|NCT00859222|1283075|P4|NOT COMPLETED|Overall Study||24
525445|NCT00859222|1283076|P3|NOT COMPLETED|Overall Study||6
525446|NCT00859222|1283077|P2|NOT COMPLETED|Overall Study||3
525447|NCT00859222|1283078|P1|NOT COMPLETED|Overall Study||3
525448|NCT00859222|1283074|P5|COMPLETED|Overall Study||0
525449|NCT00859222|1283075|P4|COMPLETED|Overall Study||0
525450|NCT00859222|1283076|P3|COMPLETED|Overall Study||0
525451|NCT00859222|1283077|P2|COMPLETED|Overall Study||0
525452|NCT00859222|1283078|P1|COMPLETED|Overall Study||0
525453|NCT00859222|1283074|P5|STARTED|Overall Study||15
525454|NCT00859222|1283075|P4|STARTED|Overall Study||24
525455|NCT00859222|1283076|P3|STARTED|Overall Study||6
525456|NCT00859222|1283077|P2|STARTED|Overall Study||3
525457|NCT00859222|1283078|P1|STARTED|Overall Study||3
525458|NCT00859131|1283105|P2|NOT COMPLETED|Overall Study||0
525459|NCT00859131|1283106|P1|NOT COMPLETED|Overall Study||0
525460|NCT00859131|1283105|P2|COMPLETED|Overall Study||98
525461|NCT00859131|1283106|P1|COMPLETED|Overall Study||102
525462|NCT00859131|1283105|P2|STARTED|Overall Study||98
525463|NCT00859131|1283106|P1|STARTED|Overall Study||102
525464|NCT00859053|1283128|P4|NOT COMPLETED|Overall Study||0
525465|NCT00859053|1283129|P3|NOT COMPLETED|Overall Study||0
525466|NCT00859053|1283130|P2|NOT COMPLETED|Overall Study||0
525467|NCT00859053|1283131|P1|NOT COMPLETED|Overall Study||0
525468|NCT00859053|1283128|P4|COMPLETED|Overall Study||12
525469|NCT00859053|1283129|P3|COMPLETED|Overall Study||6
525470|NCT00859053|1283130|P2|COMPLETED|Overall Study||6
525471|NCT00859053|1283131|P1|COMPLETED|Overall Study||6
525472|NCT00859053|1283128|P4|STARTED|Overall Study||12
525473|NCT00859053|1283129|P3|STARTED|Overall Study||6
525474|NCT00859053|1283130|P2|STARTED|Overall Study||6
525475|NCT00859053|1283131|P1|STARTED|Overall Study||6
525476|NCT00859040|1283175|P2|NOT COMPLETED|Overall Study||0
525477|NCT00859040|1283176|P1|NOT COMPLETED|Overall Study||0
525478|NCT00859040|1283175|P2|COMPLETED|Overall Study||16
525479|NCT00859040|1283176|P1|COMPLETED|Overall Study||18
525480|NCT00859040|1283175|P2|STARTED|Overall Study||16
525481|NCT00859040|1283176|P1|STARTED|Overall Study||18
525482|NCT00859027|1283191|P2|NOT COMPLETED|Overall Study||5
525483|NCT00859027|1283192|P1|NOT COMPLETED|Overall Study||5
525484|NCT00859027|1283191|P2|COMPLETED|Overall Study||20
525485|NCT00859027|1283192|P1|COMPLETED|Overall Study||20
525486|NCT00859027|1283191|P2|STARTED|Overall Study||25
525487|NCT00859027|1283192|P1|STARTED|Overall Study||25
525488|NCT00859014|1283200|P1|NOT COMPLETED|Overall Study||5
525489|NCT00859014|1283200|P1|COMPLETED|Overall Study||20
525490|NCT00859014|1283200|P1|STARTED|Overall Study||25
525491|NCT00858962|1283205|P1|NOT COMPLETED|Overall Study||0
525492|NCT00858962|1283205|P1|COMPLETED|Overall Study||12
525493|NCT00858962|1283205|P1|STARTED|Overall Study||12
525494|NCT00858858|1283209|P1|NOT COMPLETED|Overall Study||18
525495|NCT00858858|1283209|P1|COMPLETED|Overall Study||42
525496|NCT00858858|1283209|P1|STARTED|Overall Study||60
525497|NCT00858845|1283215|P2|NOT COMPLETED|Overall Study||1
525498|NCT00858845|1283216|P1|NOT COMPLETED|Overall Study||0
525499|NCT00858845|1283215|P2|COMPLETED|Overall Study||5
525500|NCT00858845|1283216|P1|COMPLETED|Overall Study||5
525501|NCT00858845|1283215|P2|STARTED|Overall Study||6
525502|NCT00858845|1283216|P1|STARTED|Overall Study||5
525503|NCT00858832|1283228|P2|NOT COMPLETED|Overall Study||1
525504|NCT00858832|1283229|P1|NOT COMPLETED|Overall Study||1
525505|NCT00858832|1283228|P2|COMPLETED|Overall Study||22
525506|NCT00858832|1283229|P1|COMPLETED|Overall Study||20
525507|NCT00858832|1283228|P2|STARTED|Overall Study||23
525508|NCT00858832|1283229|P1|STARTED|Overall Study|study terminated early due to enrollment deficiencies|21
525509|NCT00858780|1283235|P5|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||2
525510|NCT00858780|1283236|P4|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
525511|NCT00858780|1283237|P3|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
525512|NCT00858780|1283238|P2|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
525513|NCT00858780|1283239|P1|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
525514|NCT00858780|1283235|P5|COMPLETED|OL Re-Treatment (Failure to Week 48)||41
525515|NCT00858780|1283236|P4|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
525516|NCT00858780|1283237|P3|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
525517|NCT00858780|1283238|P2|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
525518|NCT00858780|1283239|P1|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
525519|NCT00858780|1283235|P5|STARTED|OL Re-Treatment (Failure to Week 48)|43 participants showed treatment failure in Period 2 and entered in Period 3.|43
525520|NCT00858780|1283236|P4|STARTED|OL Re-Treatment (Failure to Week 48)||0
525521|NCT00858780|1283237|P3|STARTED|OL Re-Treatment (Failure to Week 48)||0
525522|NCT00858780|1283238|P2|STARTED|OL Re-Treatment (Failure to Week 48)||0
525523|NCT00858780|1283239|P1|STARTED|OL Re-Treatment (Failure to Week 48)||0
525524|NCT00858780|1283235|P5|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
525525|NCT00858780|1283236|P4|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||1
525526|NCT00858780|1283237|P3|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2
525527|NCT00858780|1283238|P2|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2
525528|NCT00858780|1283239|P1|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
525529|NCT00858780|1283235|P5|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
525530|NCT00858780|1283236|P4|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||22
525531|NCT00858780|1283237|P3|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||25
525532|NCT00858780|1283238|P2|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||21
525533|NCT00858780|1283239|P1|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
525534|NCT00858780|1283235|P5|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0
525535|NCT00858780|1283236|P4|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23
525536|NCT00858780|1283237|P3|STARTED|Double-Blind (Week 0 to Failure/Week 48)||27
525537|NCT00858780|1283238|P2|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23
525538|NCT00858780|1283239|P1|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0
525539|NCT00858780|1283235|P5|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
525540|NCT00858780|1283236|P4|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
525541|NCT00858780|1283237|P3|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
525542|NCT00858780|1283238|P2|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
525543|NCT00858780|1283239|P1|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||18
525544|NCT00858780|1283235|P5|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
525545|NCT00858780|1283236|P4|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
525546|NCT00858780|1283237|P3|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
525547|NCT00858780|1283238|P2|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
525548|NCT00858780|1283239|P1|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||73
525549|NCT00858780|1283235|P5|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
525550|NCT00858780|1283236|P4|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
525551|NCT00858780|1283237|P3|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
525552|NCT00858780|1283238|P2|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
525553|NCT00858780|1283239|P1|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||91
525554|NCT00858702|1283314|P2|NOT COMPLETED|Overall Study||2
525555|NCT00858702|1283315|P1|NOT COMPLETED|Overall Study||5
525556|NCT00858702|1283314|P2|COMPLETED|Overall Study||50
525557|NCT00858702|1283315|P1|COMPLETED|Overall Study||48
525558|NCT00858702|1283314|P2|STARTED|Overall Study||52
525559|NCT00858702|1283315|P1|STARTED|Overall Study||53
525560|NCT00858689|1283323|P1|NOT COMPLETED|Overall Study||1
525561|NCT00858689|1283323|P1|COMPLETED|Overall Study||19
525562|NCT00858689|1283323|P1|STARTED|Overall Study||20
525563|NCT00858637|1283330|P6|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
525564|NCT00858637|1283331|P5|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
525565|NCT00858637|1283332|P4|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
525566|NCT00858637|1283333|P3|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
525567|NCT00858637|1283334|P2|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
525568|NCT00858637|1283335|P1|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
525569|NCT00858637|1283330|P6|COMPLETED|Placebo-controlled Withdrawal Phase||58
525570|NCT00858637|1283331|P5|COMPLETED|Placebo-controlled Withdrawal Phase||55
525571|NCT00858637|1283332|P4|COMPLETED|Placebo-controlled Withdrawal Phase||0
525572|NCT00858637|1283333|P3|COMPLETED|Placebo-controlled Withdrawal Phase||53
525573|NCT00858637|1283334|P2|COMPLETED|Placebo-controlled Withdrawal Phase||49
525574|NCT00858637|1283335|P1|COMPLETED|Placebo-controlled Withdrawal Phase||0
525575|NCT00858637|1283330|P6|STARTED|Placebo-controlled Withdrawal Phase||59
525576|NCT00858637|1283331|P5|STARTED|Placebo-controlled Withdrawal Phase||56
525577|NCT00858637|1283332|P4|STARTED|Placebo-controlled Withdrawal Phase||0
525578|NCT00858637|1283333|P3|STARTED|Placebo-controlled Withdrawal Phase||54
525579|NCT00858637|1283334|P2|STARTED|Placebo-controlled Withdrawal Phase||49
525580|NCT00858637|1283335|P1|STARTED|Placebo-controlled Withdrawal Phase||0
525581|NCT00858637|1283330|P6|NOT COMPLETED|Active Comparison Phase||0
525582|NCT00858637|1283331|P5|NOT COMPLETED|Active Comparison Phase||0
525583|NCT00858637|1283332|P4|NOT COMPLETED|Active Comparison Phase||18
525584|NCT00858637|1283333|P3|NOT COMPLETED|Active Comparison Phase||0
525585|NCT00858637|1283334|P2|NOT COMPLETED|Active Comparison Phase||0
525586|NCT00858637|1283335|P1|NOT COMPLETED|Active Comparison Phase||24
525587|NCT00858637|1283330|P6|COMPLETED|Active Comparison Phase||0
525588|NCT00858637|1283331|P5|COMPLETED|Active Comparison Phase||0
525589|NCT00858637|1283332|P4|COMPLETED|Active Comparison Phase||115
525590|NCT00858637|1283333|P3|COMPLETED|Active Comparison Phase||0
525591|NCT00858637|1283334|P2|COMPLETED|Active Comparison Phase||0
525592|NCT00858637|1283335|P1|COMPLETED|Active Comparison Phase||103
525593|NCT00858637|1283330|P6|STARTED|Active Comparison Phase||0
525594|NCT00858637|1283331|P5|STARTED|Active Comparison Phase||0
525595|NCT00858637|1283332|P4|STARTED|Active Comparison Phase||133
525596|NCT00858637|1283333|P3|STARTED|Active Comparison Phase||0
525597|NCT00858637|1283334|P2|STARTED|Active Comparison Phase||0
525598|NCT00858637|1283335|P1|STARTED|Active Comparison Phase||127
525599|NCT00858507|1283347|P2|NOT COMPLETED|Overall Study||15
525600|NCT00858507|1283348|P1|NOT COMPLETED|Overall Study||22
525601|NCT00858507|1283347|P2|COMPLETED|Overall Study||101
525602|NCT00858507|1283348|P1|COMPLETED|Overall Study||83
525603|NCT00858507|1283347|P2|STARTED|Overall Study||116
525604|NCT00858507|1283348|P1|STARTED|Overall Study||105
525605|NCT00858494|1283354|P1|NOT COMPLETED|Overall Study||4
525606|NCT00858494|1283354|P1|COMPLETED|Overall Study|2 participants dropped out before giving study medication. Symptoms resolved without a dose in 2.|45
525607|NCT00858494|1283354|P1|STARTED|Overall Study||49
525608|NCT00858468|1283361|P2|NOT COMPLETED|Overall Study||0
525609|NCT00858468|1283362|P1|NOT COMPLETED|Overall Study||0
525610|NCT00858468|1283361|P2|COMPLETED|Overall Study||192
525611|NCT00858468|1283362|P1|COMPLETED|Overall Study||201
525612|NCT00858468|1283361|P2|STARTED|Overall Study||192
525613|NCT00858468|1283362|P1|STARTED|Overall Study|1 enrolled participant was not vaccinated and removed from analysis|201
525614|NCT00858442|1283376|P2|NOT COMPLETED|Compression:Start to Finish||3
525615|NCT00858442|1283377|P1|NOT COMPLETED|Compression:Start to Finish||1
525616|NCT00858442|1283376|P2|COMPLETED|Compression:Start to Finish||20
525617|NCT00858442|1283377|P1|COMPLETED|Compression:Start to Finish||20
525618|NCT00858442|1283376|P2|STARTED|Compression:Start to Finish||23
525619|NCT00858442|1283377|P1|STARTED|Compression:Start to Finish||21
525620|NCT00858442|1283376|P2|NOT COMPLETED|From Surgery to Start Compression;||0
525621|NCT00858442|1283377|P1|NOT COMPLETED|From Surgery to Start Compression;||0
525622|NCT00858442|1283376|P2|COMPLETED|From Surgery to Start Compression;||23
525623|NCT00858442|1283377|P1|COMPLETED|From Surgery to Start Compression;||21
525624|NCT00858442|1283376|P2|STARTED|From Surgery to Start Compression;||23
525625|NCT00858442|1283377|P1|STARTED|From Surgery to Start Compression;||21
525626|NCT00858403|1283387|P1|NOT COMPLETED|Overall Study||5
525627|NCT00858403|1283387|P1|COMPLETED|Overall Study||2
525628|NCT00858403|1283387|P1|STARTED|Overall Study||7
525629|NCT00858390|1283399|P2|NOT COMPLETED|Overall Study||0
525630|NCT00858390|1283400|P1|NOT COMPLETED|Overall Study||0
525631|NCT00858390|1283399|P2|COMPLETED|Overall Study||18
525632|NCT00858390|1283400|P1|COMPLETED|Overall Study||18
525633|NCT00858390|1283399|P2|STARTED|Overall Study||18
525634|NCT00858390|1283400|P1|STARTED|Overall Study||18
525635|NCT00858247|1283408|P2|NOT COMPLETED|Week 12 Follow-up||1
525636|NCT00858247|1283409|P1|NOT COMPLETED|Week 12 Follow-up||0
525637|NCT00858247|1283408|P2|COMPLETED|Week 12 Follow-up||23
525638|NCT00858247|1283409|P1|COMPLETED|Week 12 Follow-up||23
525639|NCT00858247|1283408|P2|STARTED|Week 12 Follow-up||24
525640|NCT00858247|1283409|P1|STARTED|Week 12 Follow-up||23
525641|NCT00858247|1283408|P2|NOT COMPLETED|Baseline Assessment||2
525642|NCT00858247|1283409|P1|NOT COMPLETED|Baseline Assessment||2
525643|NCT00858247|1283408|P2|COMPLETED|Baseline Assessment||24
525644|NCT00858247|1283409|P1|COMPLETED|Baseline Assessment||23
525645|NCT00858247|1283408|P2|STARTED|Baseline Assessment||26
525646|NCT00858247|1283409|P1|STARTED|Baseline Assessment||25
525647|NCT00858208|1283425|P1|NOT COMPLETED|Overall Study||79
525648|NCT00858208|1283425|P1|COMPLETED|Overall Study||6
525649|NCT00858208|1283425|P1|STARTED|Overall Study||85
525650|NCT00858143|1283442|P1|NOT COMPLETED|Overall Study||50
525651|NCT00858143|1283442|P1|COMPLETED|Overall Study||261
525652|NCT00858143|1283442|P1|STARTED|Overall Study|Baseline|311
525653|NCT00858130|1283491|P1|NOT COMPLETED|Overall Study||0
525654|NCT00858130|1283491|P1|COMPLETED|Overall Study||12
525655|NCT00858130|1283491|P1|STARTED|Overall Study||12
525656|NCT00858013|1283501|P2|NOT COMPLETED|Overall Study||19
525657|NCT00858013|1283502|P1|NOT COMPLETED|Overall Study||22
525658|NCT00858013|1283501|P2|COMPLETED|Overall Study||23
525659|NCT00858013|1283502|P1|COMPLETED|Overall Study||24
525660|NCT00858013|1283501|P2|STARTED|Overall Study||42
525661|NCT00858013|1283502|P1|STARTED|Overall Study||46
525662|NCT00857961|1283516|P1|NOT COMPLETED|Overall Study||0
525663|NCT00857961|1283516|P1|COMPLETED|Overall Study||21
525664|NCT00857961|1283516|P1|STARTED|Overall Study||21
525665|NCT00857948|1283554|P4|NOT COMPLETED|Overall Study||0
525666|NCT00857948|1283555|P3|NOT COMPLETED|Overall Study||1
525667|NCT00857948|1283556|P2|NOT COMPLETED|Overall Study||0
525668|NCT00857948|1283557|P1|NOT COMPLETED|Overall Study||3
525669|NCT00857948|1283554|P4|COMPLETED|Overall Study||23
525670|NCT00857948|1283555|P3|COMPLETED|Overall Study||18
525671|NCT00857948|1283556|P2|COMPLETED|Overall Study||18
525672|NCT00857948|1283557|P1|COMPLETED|Overall Study||15
525673|NCT00857948|1283554|P4|STARTED|Overall Study||23
525674|NCT00857948|1283555|P3|STARTED|Overall Study||19
525675|NCT00857948|1283556|P2|STARTED|Overall Study||18
525676|NCT00857948|1283557|P1|STARTED|Overall Study||18
525677|NCT00857896|1283579|P1|NOT COMPLETED|Week 5 to Week 8||0
525678|NCT00857896|1283579|P1|COMPLETED|Week 5 to Week 8||20
525679|NCT00857896|1283579|P1|STARTED|Week 5 to Week 8||20
525680|NCT00857896|1283579|P1|NOT COMPLETED|Baseline to Week 4||1
525681|NCT00857896|1283579|P1|COMPLETED|Baseline to Week 4||20
525682|NCT00857896|1283579|P1|STARTED|Baseline to Week 4||21
525683|NCT00857857|1283591|P1|NOT COMPLETED|Overall Study||0
525684|NCT00857857|1283591|P1|COMPLETED|Overall Study||24
525685|NCT00857857|1283591|P1|STARTED|Overall Study||24
525686|NCT00857818|1283735|P2|NOT COMPLETED|Overall Study||8
525687|NCT00857818|1283736|P1|NOT COMPLETED|Overall Study||11
525688|NCT00857818|1283735|P2|COMPLETED|Overall Study||6
525689|NCT00857818|1283736|P1|COMPLETED|Overall Study||3
525690|NCT00857818|1283735|P2|Received Treatment|Overall Study||12
525691|NCT00857818|1283736|P1|Received Treatment|Overall Study||14
525692|NCT00857818|1283735|P2|STARTED|Overall Study||14
525693|NCT00857818|1283736|P1|STARTED|Overall Study||14
525694|NCT00857792|1283764|P1|NOT COMPLETED|Overall Study||12
525695|NCT00857792|1283764|P1|COMPLETED|Overall Study||108
525696|NCT00857792|1283764|P1|STARTED|Overall Study||120
525697|NCT00857766|1283770|P2|NOT COMPLETED|Overall Study||30
525698|NCT00857766|1283771|P1|NOT COMPLETED|Overall Study||31
525699|NCT00857766|1283770|P2|COMPLETED|Overall Study||96
525700|NCT00857766|1283771|P1|COMPLETED|Overall Study||92
525701|NCT00857766|1283770|P2|STARTED|Overall Study||126
525702|NCT00857766|1283771|P1|STARTED|Overall Study||123
525703|NCT00857714|1283781|P1|NOT COMPLETED|Overall Study||0
525704|NCT00857714|1283781|P1|COMPLETED|Overall Study||1
525705|NCT00857714|1283781|P1|STARTED|Overall Study||1
525706|NCT00857649|1283788|P2|NOT COMPLETED|Overall Study||32
525707|NCT00857649|1283789|P1|NOT COMPLETED|Overall Study||31
525708|NCT00857649|1283788|P2|COMPLETED|Overall Study||155
525709|NCT00857649|1283789|P1|COMPLETED|Overall Study||151
525710|NCT00857649|1283788|P2|STARTED|Overall Study||187
525711|NCT00857649|1283789|P1|STARTED|Overall Study||182
525712|NCT00857623|1283805|P2|NOT COMPLETED|Overall Study||10
525713|NCT00857623|1283806|P1|NOT COMPLETED|Overall Study||14
525714|NCT00857623|1283805|P2|COMPLETED|Overall Study||55
525715|NCT00857623|1283806|P1|COMPLETED|Overall Study||48
525716|NCT00857623|1283805|P2|STARTED|Overall Study||65
525717|NCT00857623|1283806|P1|STARTED|Overall Study||62
525718|NCT00857584|1283830|P2|NOT COMPLETED|Overall Study||5
525719|NCT00857584|1283831|P1|NOT COMPLETED|Overall Study||4
525720|NCT00857584|1283830|P2|COMPLETED|Overall Study||8
525721|NCT00857584|1283831|P1|COMPLETED|Overall Study||10
525722|NCT00857584|1283830|P2|Week 8|Overall Study||8
525723|NCT00857584|1283831|P1|Week 8|Overall Study||10
525724|NCT00857584|1283830|P2|Week 4|Overall Study||9
525725|NCT00857584|1283831|P1|Week 4|Overall Study||11
525726|NCT00857584|1283830|P2|Week 2|Overall Study||11
525727|NCT00857584|1283831|P1|Week 2|Overall Study||14
525728|NCT00857584|1283830|P2|Week 1|Overall Study||13
525729|NCT00857584|1283831|P1|Week 1|Overall Study||14
525730|NCT00857584|1283830|P2|STARTED|Overall Study||13
525731|NCT00857584|1283831|P1|STARTED|Overall Study||14
525732|NCT00857545|1283873|P2|NOT COMPLETED|Overall Study||0
525733|NCT00857545|1283874|P1|NOT COMPLETED|Overall Study||0
525734|NCT00857545|1283873|P2|COMPLETED|Overall Study||85
525735|NCT00857545|1283874|P1|COMPLETED|Overall Study|Enrolled and randomized participants.|86
525736|NCT00857545|1283873|P2|STARTED|Overall Study||85
525737|NCT00857545|1283874|P1|STARTED|Overall Study||86
525738|NCT00857532|1283884|P1|NOT COMPLETED|Overall Study||0
525739|NCT00857532|1283884|P1|COMPLETED|Overall Study||31
525740|NCT00857532|1283884|P1|STARTED|Overall Study||31
525741|NCT00857506|1283895|P3|NOT COMPLETED|Overall Study||18
525742|NCT00857506|1283896|P2|NOT COMPLETED|Overall Study||15
525743|NCT00857506|1283897|P1|NOT COMPLETED|Overall Study||15
525744|NCT00857506|1283895|P3|COMPLETED|Overall Study||51
525745|NCT00857506|1283896|P2|COMPLETED|Overall Study||37
525746|NCT00857506|1283897|P1|COMPLETED|Overall Study||16
525747|NCT00857506|1283895|P3|STARTED|Overall Study||69
525748|NCT00857506|1283896|P2|STARTED|Overall Study||52
525749|NCT00857506|1283897|P1|STARTED|Overall Study||31
525750|NCT00857454|1283923|P1|NOT COMPLETED|Overall Study||20
525751|NCT00857454|1283923|P1|COMPLETED|Overall Study||51
525752|NCT00857454|1283923|P1|STARTED|Overall Study||71
525753|NCT00857415|1283936|P2|NOT COMPLETED|Overall Study||0
525754|NCT00857415|1283937|P1|NOT COMPLETED|Overall Study||117
525755|NCT00857415|1283936|P2|COMPLETED|Overall Study||74
525756|NCT00857415|1283937|P1|COMPLETED|Overall Study||35
525757|NCT00857415|1283936|P2|Deceased Within One Year of AV-45 Scan|Overall Study|Subjects in the specificity cohort were not followed to autopsy|0
525758|NCT00857415|1283937|P1|Deceased Within One Year of AV-45 Scan|Overall Study||37
525759|NCT00857415|1283936|P2|STARTED|Overall Study||74
525760|NCT00857415|1283937|P1|STARTED|Overall Study||152
525761|NCT00857311|1283948|P4|NOT COMPLETED|Overall Study||0
525762|NCT00857311|1283949|P3|NOT COMPLETED|Overall Study||0
525763|NCT00857311|1283950|P2|NOT COMPLETED|Overall Study||0
525764|NCT00857311|1283951|P1|NOT COMPLETED|Overall Study||1
525765|NCT00857311|1283948|P4|COMPLETED|Overall Study||0
525766|NCT00857311|1283949|P3|COMPLETED|Overall Study||8
525767|NCT00857311|1283950|P2|COMPLETED|Overall Study||0
525768|NCT00857311|1283951|P1|COMPLETED|Overall Study||8
525769|NCT00857311|1283948|P4|STARTED|Overall Study||0
525770|NCT00857311|1283949|P3|STARTED|Overall Study||8
525771|NCT00857311|1283950|P2|STARTED|Overall Study||0
525772|NCT00857311|1283951|P1|STARTED|Overall Study||9
525773|NCT00857285|1283963|P2|NOT COMPLETED|Overall Study||6
525774|NCT00857285|1283964|P1|NOT COMPLETED|Overall Study||12
525775|NCT00857285|1283963|P2|COMPLETED|Overall Study||59
525776|NCT00857285|1283964|P1|COMPLETED|Overall Study||53
525777|NCT00857285|1283963|P2|STARTED|Overall Study||65
525778|NCT00857285|1283964|P1|STARTED|Overall Study||65
525779|NCT00857272|1283970|P2|NOT COMPLETED|Overall Study||9
525780|NCT00857272|1283971|P1|NOT COMPLETED|Overall Study||9
525781|NCT00857272|1283970|P2|COMPLETED|Overall Study||145
525782|NCT00857272|1283971|P1|COMPLETED|Overall Study||145
525783|NCT00857272|1283970|P2|STARTED|Overall Study|Includes 7 non-ITT patients that withdrew consent|154
525784|NCT00857272|1283971|P1|STARTED|Overall Study|Includes 6 non-ITT patients that withdrew consent|154
525785|NCT00857259|1283980|P3|NOT COMPLETED|Overall Study||1
525786|NCT00857259|1283981|P2|NOT COMPLETED|Overall Study||0
525787|NCT00857259|1283982|P1|NOT COMPLETED|Overall Study||1
525788|NCT00857259|1283980|P3|COMPLETED|Overall Study||6
525789|NCT00857259|1283981|P2|COMPLETED|Overall Study||1
525790|NCT00857259|1283982|P1|COMPLETED|Overall Study||7
525791|NCT00857259|1283980|P3|STARTED|Overall Study||7
525792|NCT00857259|1283981|P2|STARTED|Overall Study||1
525793|NCT00857259|1283982|P1|STARTED|Overall Study||8
525794|NCT00857246|1283992|P1|NOT COMPLETED|ChemoRT||3
525795|NCT00857246|1283992|P1|COMPLETED|ChemoRT||12
525796|NCT00857246|1283992|P1|STARTED|ChemoRT|6 did not start adjuvant therapy due to disease-related complications or patient withdrawal.|15
525797|NCT00857246|1283992|P1|NOT COMPLETED|Surgery (Curative)||6
525798|NCT00857246|1283992|P1|COMPLETED|Surgery (Curative)||21
525799|NCT00857246|1283992|P1|STARTED|Surgery (Curative)||27
525800|NCT00857246|1283992|P1|NOT COMPLETED|Induction Regimen||3
525801|NCT00857246|1283992|P1|COMPLETED|Induction Regimen||27
525802|NCT00857246|1283992|P1|STARTED|Induction Regimen||30
525803|NCT00857233|1284002|P1|NOT COMPLETED|Overall Study||55
525804|NCT00857233|1284002|P1|COMPLETED|Overall Study||242
525805|NCT00857233|1284002|P1|STARTED|Overall Study||297
525806|NCT00857220|1284011|P1|NOT COMPLETED|Overall Study||183
525807|NCT00857220|1284011|P1|COMPLETED|Overall Study||121
525808|NCT00857220|1284011|P1|STARTED|Overall Study||304
525809|NCT00856986|1284033|P5|NOT COMPLETED|Extension Period, Weeks 26-52||0
525810|NCT00856986|1284034|P4|NOT COMPLETED|Extension Period, Weeks 26-52||0
525811|NCT00856986|1284035|P3|NOT COMPLETED|Extension Period, Weeks 26-52||38
525812|NCT00856986|1284036|P2|NOT COMPLETED|Extension Period, Weeks 26-52||14
525813|NCT00856986|1284037|P1|NOT COMPLETED|Extension Period, Weeks 26-52||19
525814|NCT00856986|1284033|P5|COMPLETED|Extension Period, Weeks 26-52||0
525815|NCT00856986|1284034|P4|COMPLETED|Extension Period, Weeks 26-52||0
525816|NCT00856986|1284035|P3|COMPLETED|Extension Period, Weeks 26-52||432
525817|NCT00856986|1284036|P2|COMPLETED|Extension Period, Weeks 26-52||130
525818|NCT00856986|1284037|P1|COMPLETED|Extension Period, Weeks 26-52||108
525819|NCT00856986|1284033|P5|Enrolled in Extension|Extension Period, Weeks 26-52||0
525820|NCT00856986|1284034|P4|Enrolled in Extension|Extension Period, Weeks 26-52||0
525821|NCT00856986|1284035|P3|Enrolled in Extension|Extension Period, Weeks 26-52||461
525822|NCT00856986|1284036|P2|Enrolled in Extension|Extension Period, Weeks 26-52||140
525823|NCT00856986|1284037|P1|Enrolled in Extension|Extension Period, Weeks 26-52||122
525824|NCT00856986|1284033|P5|STARTED|Extension Period, Weeks 26-52||0
525825|NCT00856986|1284034|P4|STARTED|Extension Period, Weeks 26-52||0
525826|NCT00856986|1284035|P3|STARTED|Extension Period, Weeks 26-52|Subjects with HbA1c ≥8.0% who accepted intensification with detemir = 7 (Intensified Group)|470
525827|NCT00856986|1284036|P2|STARTED|Extension Period, Weeks 26-52||144
525828|NCT00856986|1284037|P1|STARTED|Extension Period, Weeks 26-52|Subjects with HbA1c ≥8.0% who accepted intensification with detemir = 17 (Intensified Group)|127
525829|NCT00856986|1284033|P5|NOT COMPLETED|Main Period, Weeks 0-26||0
525830|NCT00856986|1284034|P4|NOT COMPLETED|Main Period, Weeks 0-26||0
525831|NCT00856986|1284035|P3|NOT COMPLETED|Main Period, Weeks 0-26||28
525832|NCT00856986|1284036|P2|NOT COMPLETED|Main Period, Weeks 0-26||18
525833|NCT00856986|1284037|P1|NOT COMPLETED|Main Period, Weeks 0-26||34
525834|NCT00856986|1284033|P5|COMPLETED|Main Period, Weeks 0-26||0
525835|NCT00856986|1284034|P4|COMPLETED|Main Period, Weeks 0-26||0
525836|NCT00856986|1284035|P3|COMPLETED|Main Period, Weeks 0-26||470
525837|NCT00856986|1284036|P2|COMPLETED|Main Period, Weeks 0-26||144
525838|NCT00856986|1284037|P1|COMPLETED|Main Period, Weeks 0-26||127
525839|NCT00856986|1284033|P5|STARTED|Main Period, Weeks 0-26||0
525840|NCT00856986|1284034|P4|STARTED|Main Period, Weeks 0-26||0
525841|NCT00856986|1284035|P3|STARTED|Main Period, Weeks 0-26||498
525842|NCT00856986|1284036|P2|STARTED|Main Period, Weeks 0-26||162
525843|NCT00856986|1284037|P1|STARTED|Main Period, Weeks 0-26||161
525844|NCT00856986|1284033|P5|NOT COMPLETED|Run-in Period, Weeks -12-0||0
525845|NCT00856986|1284034|P4|NOT COMPLETED|Run-in Period, Weeks -12-0||167
525846|NCT00856986|1284035|P3|NOT COMPLETED|Run-in Period, Weeks -12-0||0
525847|NCT00856986|1284036|P2|NOT COMPLETED|Run-in Period, Weeks -12-0||0
525848|NCT00856986|1284037|P1|NOT COMPLETED|Run-in Period, Weeks -12-0||0
525849|NCT00856986|1284033|P5|COMPLETED|Run-in Period, Weeks -12-0||0
525850|NCT00856986|1284034|P4|COMPLETED|Run-in Period, Weeks -12-0|Subjects who withdrew during run-in and before randomisation were Early Withdrawals|0
525851|NCT00856986|1284035|P3|COMPLETED|Run-in Period, Weeks -12-0||498
525852|NCT00856986|1284036|P2|COMPLETED|Run-in Period, Weeks -12-0||162
525853|NCT00856986|1284037|P1|COMPLETED|Run-in Period, Weeks -12-0||161
525854|NCT00856986|1284033|P5|STARTED|Run-in Period, Weeks -12-0||0
525855|NCT00856986|1284034|P4|STARTED|Run-in Period, Weeks -12-0||167
525856|NCT00856986|1284035|P3|STARTED|Run-in Period, Weeks -12-0||498
525857|NCT00856986|1284036|P2|STARTED|Run-in Period, Weeks -12-0||162
525858|NCT00856986|1284037|P1|STARTED|Run-in Period, Weeks -12-0||161
525859|NCT00856973|1284207|P3|NOT COMPLETED|Overall Study||38
525860|NCT00856973|1284208|P2|NOT COMPLETED|Overall Study||41
525861|NCT00856973|1284209|P1|NOT COMPLETED|Overall Study||36
525862|NCT00856973|1284207|P3|COMPLETED|Overall Study||123
525863|NCT00856973|1284208|P2|COMPLETED|Overall Study||122
525864|NCT00856973|1284209|P1|COMPLETED|Overall Study||126
525865|NCT00856973|1284207|P3|STARTED|Overall Study||161
525866|NCT00856973|1284208|P2|STARTED|Overall Study||163
525867|NCT00856973|1284209|P1|STARTED|Overall Study||162
525868|NCT00856934|1284277|P3|NOT COMPLETED|Overall Study||0
525869|NCT00856934|1284278|P2|NOT COMPLETED|Overall Study||0
525870|NCT00856934|1284279|P1|NOT COMPLETED|Overall Study||0
525871|NCT00856934|1284277|P3|COMPLETED|Overall Study||15
525872|NCT00856934|1284278|P2|COMPLETED|Overall Study||15
525873|NCT00856934|1284279|P1|COMPLETED|Overall Study||15
525874|NCT00856934|1284277|P3|STARTED|Overall Study||15
525875|NCT00856934|1284278|P2|STARTED|Overall Study||15
525876|NCT00856934|1284279|P1|STARTED|Overall Study||15
525877|NCT00856908|1284289|P2|NOT COMPLETED|Overall Study||0
525878|NCT00856908|1284290|P1|NOT COMPLETED|Overall Study||1
525879|NCT00856908|1284289|P2|COMPLETED|Overall Study||5
525880|NCT00856908|1284290|P1|COMPLETED|Overall Study||14
525881|NCT00856908|1284289|P2|STARTED|Overall Study||5
525882|NCT00856908|1284290|P1|STARTED|Overall Study||15
525883|NCT00856843|1284317|P2|NOT COMPLETED|Overall Study||5
525884|NCT00856843|1284318|P1|NOT COMPLETED|Overall Study||2
525885|NCT00856843|1284317|P2|COMPLETED|Overall Study||63
525886|NCT00856843|1284318|P1|COMPLETED|Overall Study||66
525887|NCT00856843|1284317|P2|STARTED|Overall Study||68
525888|NCT00856843|1284318|P1|STARTED|Overall Study||68
525889|NCT00856830|1284354|P4|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
525890|NCT00856830|1284355|P3|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
525891|NCT00856830|1284356|P2|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
525892|NCT00856830|1284357|P1|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
525893|NCT00856830|1284354|P4|COMPLETED|Regimen - B (Carboplatin & Etoposide)||12
525894|NCT00856830|1284355|P3|COMPLETED|Regimen - B (Carboplatin & Etoposide)||6
525895|NCT00856830|1284356|P2|COMPLETED|Regimen - B (Carboplatin & Etoposide)||6
525896|NCT00856830|1284357|P1|COMPLETED|Regimen - B (Carboplatin & Etoposide)||3
525897|NCT00856830|1284354|P4|STARTED|Regimen - B (Carboplatin & Etoposide)||12
525898|NCT00856830|1284355|P3|STARTED|Regimen - B (Carboplatin & Etoposide)||6
525899|NCT00856830|1284356|P2|STARTED|Regimen - B (Carboplatin & Etoposide)||6
525900|NCT00856830|1284357|P1|STARTED|Regimen - B (Carboplatin & Etoposide)||3
525901|NCT00856830|1284354|P4|NOT COMPLETED|Irinotecan & Bendamustine||3
525902|NCT00856830|1284355|P3|NOT COMPLETED|Irinotecan & Bendamustine||0
525903|NCT00856830|1284356|P2|NOT COMPLETED|Irinotecan & Bendamustine||0
525904|NCT00856830|1284357|P1|NOT COMPLETED|Irinotecan & Bendamustine||0
525905|NCT00856830|1284354|P4|COMPLETED|Irinotecan & Bendamustine||12
525906|NCT00856830|1284355|P3|COMPLETED|Irinotecan & Bendamustine||6
525907|NCT00856830|1284356|P2|COMPLETED|Irinotecan & Bendamustine||6
525908|NCT00856830|1284357|P1|COMPLETED|Irinotecan & Bendamustine||3
525909|NCT00856830|1284354|P4|Maximum Tolerated Dose|Irinotecan & Bendamustine||12
525910|NCT00856830|1284355|P3|Maximum Tolerated Dose|Irinotecan & Bendamustine||6
525911|NCT00856830|1284356|P2|Maximum Tolerated Dose|Irinotecan & Bendamustine||6
525912|NCT00856830|1284357|P1|Maximum Tolerated Dose|Irinotecan & Bendamustine||3
525913|NCT00856830|1284354|P4|STARTED|Irinotecan & Bendamustine||15
525914|NCT00856830|1284355|P3|STARTED|Irinotecan & Bendamustine||6
525915|NCT00856830|1284356|P2|STARTED|Irinotecan & Bendamustine||6
525916|NCT00856830|1284357|P1|STARTED|Irinotecan & Bendamustine||3
525917|NCT00856791|1284363|P1|NOT COMPLETED|Overall Study||0
525918|NCT00856791|1284363|P1|COMPLETED|Overall Study||1
525919|NCT00856791|1284363|P1|STARTED|Overall Study||1
525920|NCT00856778|1284368|P1|NOT COMPLETED|Overall Study||24
525921|NCT00856778|1284368|P1|COMPLETED|Overall Study||74
525922|NCT00856778|1284368|P1|STARTED|Overall Study||98
525923|NCT00856739|1284387|P3|NOT COMPLETED|Overall Study||0
525924|NCT00856739|1284388|P2|NOT COMPLETED|Overall Study||0
525925|NCT00856739|1284389|P1|NOT COMPLETED|Overall Study||0
525926|NCT00856739|1284387|P3|COMPLETED|Overall Study||55
525927|NCT00856739|1284388|P2|COMPLETED|Overall Study||52
525928|NCT00856739|1284389|P1|COMPLETED|Overall Study||70
525929|NCT00856739|1284387|P3|STARTED|Overall Study||55
525930|NCT00856739|1284388|P2|STARTED|Overall Study||52
525931|NCT00856739|1284389|P1|STARTED|Overall Study||70
525932|NCT00856726|1284400|P1|NOT COMPLETED|Overall Study||0
525933|NCT00856726|1284400|P1|COMPLETED|Overall Study||26
525934|NCT00856726|1284400|P1|STARTED|Overall Study||26
525935|NCT00856661|1284411|P2|NOT COMPLETED|Overall Study||29
525936|NCT00856661|1284412|P1|NOT COMPLETED|Overall Study||27
525937|NCT00856661|1284411|P2|COMPLETED|Overall Study||106
525938|NCT00856661|1284412|P1|COMPLETED|Overall Study||108
525939|NCT00856661|1284411|P2|Randomized Not Treated|Overall Study||4
525940|NCT00856661|1284412|P1|Randomized Not Treated|Overall Study||9
525941|NCT00856661|1284411|P2|Treated|Overall Study||131
525942|NCT00856661|1284412|P1|Treated|Overall Study||126
525943|NCT00856661|1284411|P2|STARTED|Overall Study|Randomised|135
525944|NCT00856661|1284412|P1|STARTED|Overall Study|Randomised|135
525945|NCT00856635|1284426|P2|NOT COMPLETED|Overall Study||8
525946|NCT00856635|1284427|P1|NOT COMPLETED|Overall Study||10
525947|NCT00856635|1284426|P2|COMPLETED|Overall Study||14
525948|NCT00856635|1284427|P1|COMPLETED|Overall Study||12
525949|NCT00856635|1284426|P2|Received Study Drug|Overall Study||20
525950|NCT00856635|1284427|P1|Received Study Drug|Overall Study||20
525951|NCT00856635|1284426|P2|STARTED|Overall Study||22
525952|NCT00856635|1284427|P1|STARTED|Overall Study||22
525953|NCT00856609|1284437|P2|NOT COMPLETED|Overall Study||0
525954|NCT00856609|1284438|P1|NOT COMPLETED|Overall Study||1
525955|NCT00856609|1284437|P2|COMPLETED|Overall Study||39
525956|NCT00856609|1284438|P1|COMPLETED|Overall Study||40
525957|NCT00856609|1284437|P2|STARTED|Overall Study||39
525958|NCT00856609|1284438|P1|STARTED|Overall Study||41
525959|NCT00856583|1284450|P2|NOT COMPLETED|Overall Study||2597
525960|NCT00856583|1284451|P1|NOT COMPLETED|Overall Study||3137
525961|NCT00856583|1284450|P2|COMPLETED|Overall Study|Patients who were still on study drug at the time of study closure|2307
525962|NCT00856583|1284451|P1|COMPLETED|Overall Study|Patients who were still on study drug at the time of study closure|1768
525963|NCT00856583|1284450|P2|STARTED|Overall Study|Patients treated|4904
525964|NCT00856583|1284451|P1|STARTED|Overall Study|Patients treated|4905
525965|NCT00856557|1284481|P2|NOT COMPLETED|Overall Study||16
525966|NCT00856557|1284482|P1|NOT COMPLETED|Overall Study||12
525967|NCT00856557|1284481|P2|COMPLETED|Overall Study||60
525968|NCT00856557|1284482|P1|COMPLETED|Overall Study||50
525969|NCT00856557|1284481|P2|With Patients With Contextual Flags|Overall Study||60
525970|NCT00856557|1284482|P1|With Patients With Contextual Flags|Overall Study||50
525971|NCT00856557|1284481|P2|Tested With Standardized Patients|Overall Study||76
525972|NCT00856557|1284482|P1|Tested With Standardized Patients|Overall Study||62
525973|NCT00856557|1284481|P2|Received Intervention/Control|Overall Study||76
525974|NCT00856557|1284482|P1|Received Intervention/Control|Overall Study||62
525975|NCT00856557|1284481|P2|STARTED|Overall Study||76
525976|NCT00856557|1284482|P1|STARTED|Overall Study||62
525977|NCT00856544|1284496|P4|NOT COMPLETED|Overall Study||13
525978|NCT00856544|1284497|P3|NOT COMPLETED|Overall Study||8
525979|NCT00856544|1284498|P2|NOT COMPLETED|Overall Study||66
525980|NCT00856544|1284499|P1|NOT COMPLETED|Overall Study||57
525981|NCT00856544|1284496|P4|COMPLETED|Overall Study||67
525982|NCT00856544|1284497|P3|COMPLETED|Overall Study||71
525983|NCT00856544|1284498|P2|COMPLETED|Overall Study||252
525984|NCT00856544|1284499|P1|COMPLETED|Overall Study||261
525985|NCT00856544|1284496|P4|Treated|Overall Study||80
525986|NCT00856544|1284497|P3|Treated|Overall Study||79
525987|NCT00856544|1284498|P2|Treated|Overall Study||318
525988|NCT00856544|1284499|P1|Treated|Overall Study||315
525989|NCT00856544|1284496|P4|STARTED|Overall Study||80
525990|NCT00856544|1284497|P3|STARTED|Overall Study||79
525991|NCT00856544|1284498|P2|STARTED|Overall Study||318
525992|NCT00856544|1284499|P1|STARTED|Overall Study||318
525993|NCT00856518|1284678|P2|NOT COMPLETED|Overall Study||2
525994|NCT00856518|1284679|P1|NOT COMPLETED|Overall Study||4
525995|NCT00856518|1284678|P2|COMPLETED|Overall Study||16
525996|NCT00856518|1284679|P1|COMPLETED|Overall Study||20
525997|NCT00856518|1284678|P2|STARTED|Overall Study||18
525998|NCT00856518|1284679|P1|STARTED|Overall Study||24
525999|NCT00856492|1284692|P3|NOT COMPLETED|Overall Study||2
526000|NCT00856492|1284693|P2|NOT COMPLETED|Overall Study||1
526001|NCT00856492|1284694|P1|NOT COMPLETED|Overall Study||1
526002|NCT00856492|1284692|P3|COMPLETED|Overall Study||51
526003|NCT00856492|1284693|P2|COMPLETED|Overall Study||62
526004|NCT00856492|1284694|P1|COMPLETED|Overall Study||98
526005|NCT00856492|1284692|P3|Toxicity Eval|Overall Study||51
526006|NCT00856492|1284693|P2|Toxicity Eval|Overall Study||60
526007|NCT00856492|1284694|P1|Toxicity Eval|Overall Study||96
526008|NCT00856492|1284692|P3|STARTED|Overall Study||53
526009|NCT00856492|1284693|P2|STARTED|Overall Study||63
526010|NCT00856492|1284694|P1|STARTED|Overall Study||99
526011|NCT00856414|1284708|P1|NOT COMPLETED|Overall Study||0
526012|NCT00856414|1284708|P1|COMPLETED|Overall Study||45
526013|NCT00856414|1284708|P1|STARTED|Overall Study||45
526014|NCT00856388|1284716|P1|NOT COMPLETED|Overall Study||1
526015|NCT00856388|1284716|P1|COMPLETED|Overall Study||61
526016|NCT00856388|1284716|P1|STARTED|Overall Study||62
526017|NCT00856349|1284727|P1|NOT COMPLETED|Overall Study||1021
526018|NCT00856349|1284727|P1|COMPLETED|Overall Study||3111
526019|NCT00856349|1284727|P1|24 Month Follow-up|Overall Study||1698
526020|NCT00856349|1284727|P1|18 Month Follow-up|Overall Study||2467
526021|NCT00856349|1284727|P1|12 Month Follow-up|Overall Study||3228
526022|NCT00856349|1284727|P1|STARTED|Overall Study||4132
526023|NCT00856323|1284736|P1|NOT COMPLETED|Overall Study||2
526024|NCT00856323|1284736|P1|COMPLETED|Overall Study||51
526025|NCT00856323|1284736|P1|STARTED|Overall Study||53
526026|NCT00856297|1284748|P5|NOT COMPLETED|Overall Study||0
526027|NCT00856297|1284749|P4|NOT COMPLETED|Overall Study||0
526028|NCT00856297|1284750|P3|NOT COMPLETED|Overall Study||0
526029|NCT00856297|1284751|P2|NOT COMPLETED|Overall Study||0
526030|NCT00856297|1284752|P1|NOT COMPLETED|Overall Study||2
526031|NCT00856297|1284748|P5|COMPLETED|Overall Study||31
526032|NCT00856297|1284749|P4|COMPLETED|Overall Study||44
526033|NCT00856297|1284750|P3|COMPLETED|Overall Study||107
526034|NCT00856297|1284751|P2|COMPLETED|Overall Study||76
526035|NCT00856297|1284752|P1|COMPLETED|Overall Study||129
526036|NCT00856297|1284748|P5|STARTED|Overall Study||31
526037|NCT00856297|1284749|P4|STARTED|Overall Study||44
526038|NCT00856297|1284750|P3|STARTED|Overall Study||107
526039|NCT00856297|1284751|P2|STARTED|Overall Study||76
526040|NCT00856297|1284752|P1|STARTED|Overall Study||131
526041|NCT00856284|1284785|P3|NOT COMPLETED|Overall Study||447
526042|NCT00856284|1284786|P2|NOT COMPLETED|Overall Study||392
526043|NCT00856284|1284787|P1|NOT COMPLETED|Overall Study||408
526044|NCT00856284|1284785|P3|COMPLETED|Overall Study||427
526045|NCT00856284|1284786|P2|COMPLETED|Overall Study||493
526046|NCT00856284|1284787|P1|COMPLETED|Overall Study||472
526047|NCT00856284|1284785|P3|Received Study Drug|Overall Study||869
526048|NCT00856284|1284786|P2|Received Study Drug|Overall Study||878
526049|NCT00856284|1284787|P1|Received Study Drug|Overall Study||873
526050|NCT00856284|1284785|P3|STARTED|Overall Study||874
526051|NCT00856284|1284786|P2|STARTED|Overall Study||885
526052|NCT00856284|1284787|P1|STARTED|Overall Study||880
526053|NCT00856245|1284813|P1|NOT COMPLETED|Overall Study||5
526054|NCT00856245|1284813|P1|COMPLETED|Overall Study||14
526055|NCT00856245|1284813|P1|STARTED|Overall Study||19
526056|NCT00856232|1284821|P3|NOT COMPLETED|Overall Study||0
526057|NCT00856232|1284822|P2|NOT COMPLETED|Overall Study||0
526058|NCT00856232|1284823|P1|NOT COMPLETED|Overall Study||0
526059|NCT00856232|1284821|P3|COMPLETED|Overall Study||36
526060|NCT00856232|1284822|P2|COMPLETED|Overall Study||29
526061|NCT00856232|1284823|P1|COMPLETED|Overall Study||26
526062|NCT00856232|1284821|P3|STARTED|Overall Study||36
526063|NCT00856232|1284822|P2|STARTED|Overall Study||29
526064|NCT00856232|1284823|P1|STARTED|Overall Study||26
526065|NCT00856206|1284836|P2|NOT COMPLETED|Overall Study||161
526066|NCT00856206|1284837|P1|NOT COMPLETED|Overall Study||54
526067|NCT00856206|1284836|P2|COMPLETED|Overall Study||824
526068|NCT00856206|1284837|P1|COMPLETED|Overall Study||276
526069|NCT00856206|1284836|P2|STARTED|Overall Study||985
526070|NCT00856206|1284837|P1|STARTED|Overall Study||330
526071|NCT00856193|1284851|P2|NOT COMPLETED|Period 2||2
526072|NCT00856193|1284852|P1|NOT COMPLETED|Period 2||0
526073|NCT00856193|1284851|P2|COMPLETED|Period 2||15
526074|NCT00856193|1284852|P1|COMPLETED|Period 2||16
526075|NCT00856193|1284851|P2|STARTED|Period 2||17
526076|NCT00856193|1284852|P1|STARTED|Period 2||16
526077|NCT00856193|1284851|P2|NOT COMPLETED|Period 1||0
526078|NCT00856193|1284852|P1|NOT COMPLETED|Period 1||0
526079|NCT00856193|1284851|P2|COMPLETED|Period 1||17
526080|NCT00856193|1284852|P1|COMPLETED|Period 1||16
526081|NCT00856193|1284851|P2|STARTED|Period 1||17
526082|NCT00856193|1284852|P1|STARTED|Period 1||16
526083|NCT00856180|1284864|P1|NOT COMPLETED|Overall Study||20
526084|NCT00856180|1284864|P1|COMPLETED|Overall Study||0
526085|NCT00856180|1284864|P1|STARTED|Overall Study||20
526086|NCT00856050|1284873|P1|NOT COMPLETED|Overall Study||0
526087|NCT00856050|1284873|P1|COMPLETED|Overall Study||26
526088|NCT00856050|1284873|P1|STARTED|Overall Study||26
526089|NCT00856024|1284877|P1|NOT COMPLETED|Overall Study||0
526090|NCT00856024|1284877|P1|COMPLETED|Overall Study||902
526091|NCT00856024|1284877|P1|STARTED|Overall Study||902
526092|NCT00855959|1284889|P1|NOT COMPLETED|Overall Study||9
526093|NCT00855959|1284889|P1|COMPLETED|Overall Study||99
526094|NCT00855959|1284889|P1|Patients Who Received Pulmicort Respules|Overall Study||105
526095|NCT00855959|1284889|P1|STARTED|Overall Study||108
526096|NCT00855933|1284906|P2|NOT COMPLETED|Overall Study||1
526097|NCT00855933|1284907|P1|NOT COMPLETED|Overall Study||0
526098|NCT00855933|1284906|P2|COMPLETED|Overall Study||29
526099|NCT00855933|1284907|P1|COMPLETED|Overall Study||30
526100|NCT00855933|1284906|P2|STARTED|Overall Study||30
526101|NCT00855933|1284907|P1|STARTED|Overall Study||30
526102|NCT00855920|1284916|P3|NOT COMPLETED|Overall Study||11
526103|NCT00855920|1284917|P2|NOT COMPLETED|Overall Study||9
526104|NCT00855920|1284918|P1|NOT COMPLETED|Overall Study||8
526105|NCT00855920|1284916|P3|COMPLETED|Overall Study||64
526106|NCT00855920|1284917|P2|COMPLETED|Overall Study||65
526107|NCT00855920|1284918|P1|COMPLETED|Overall Study||68
526108|NCT00855920|1284916|P3|Safety Population|Overall Study||75
526109|NCT00855920|1284917|P2|Safety Population|Overall Study|1 participant from Rilonacept+Indomethacin arm received Placebo (for Rilonacept)+Indomethacin|73
526110|NCT00855920|1284918|P1|Safety Population|Overall Study|1 participant from Rilonacept+Indomethacin arm received Placebo (for Rilonacept)+Indomethacin|77
526111|NCT00855920|1284916|P3|STARTED|Overall Study||75
526112|NCT00855920|1284917|P2|STARTED|Overall Study||74
526113|NCT00855920|1284918|P1|STARTED|Overall Study||76
526114|NCT00855894|1284935|P1|NOT COMPLETED|Overall Study||33
526115|NCT00855894|1284935|P1|COMPLETED|Overall Study||8
526116|NCT00855894|1284935|P1|STARTED|Overall Study||41
526117|NCT00855868|1284945|P2|NOT COMPLETED|Overall Study||1
526118|NCT00855868|1284946|P1|NOT COMPLETED|Overall Study||1
526119|NCT00855868|1284945|P2|COMPLETED|Overall Study||14
526120|NCT00855868|1284946|P1|COMPLETED|Overall Study||12
526121|NCT00855868|1284945|P2|STARTED|Overall Study||15
526122|NCT00855868|1284946|P1|STARTED|Overall Study||13
526123|NCT00855842|1284952|P1|NOT COMPLETED|Overall Study||0
526124|NCT00855842|1284952|P1|COMPLETED|Overall Study||4
526125|NCT00855842|1284952|P1|STARTED|Overall Study||4
526126|NCT00855816|1284958|P2|NOT COMPLETED|Overall Study||21
526127|NCT00855816|1284959|P1|NOT COMPLETED|Overall Study||26
526128|NCT00855816|1284958|P2|COMPLETED|Overall Study||12
526129|NCT00855816|1284959|P1|COMPLETED|Overall Study||21
526130|NCT00855816|1284958|P2|STARTED|Overall Study||33
526131|NCT00855816|1284959|P1|STARTED|Overall Study||47
526132|NCT00855738|1284965|P1|NOT COMPLETED|Overall Study||5
526133|NCT00855738|1284965|P1|COMPLETED|Overall Study||106
526134|NCT00855738|1284965|P1|At Least 1 Dose and 1 Endpoint|Overall Study|Received at least 1 dose of study drug and had data for at least 1 efficacy endpoint.|108
526135|NCT00855738|1284965|P1|STARTED|Overall Study||111
526136|NCT00855595|1284993|P2|NOT COMPLETED|Overall Study||7
526137|NCT00855595|1284994|P1|NOT COMPLETED|Overall Study||6
526138|NCT00855595|1284993|P2|COMPLETED|Overall Study||94
526139|NCT00855595|1284994|P1|COMPLETED|Overall Study||100
526140|NCT00855595|1284993|P2|STARTED|Overall Study||101
526141|NCT00855595|1284994|P1|STARTED|Overall Study||106
526142|NCT00855582|1285033|P3|NOT COMPLETED|Overall Study||30
526143|NCT00855582|1285034|P2|NOT COMPLETED|Overall Study||24
526144|NCT00855582|1285035|P1|NOT COMPLETED|Overall Study||26
526145|NCT00855582|1285033|P3|COMPLETED|Overall Study||170
526146|NCT00855582|1285034|P2|COMPLETED|Overall Study||184
526147|NCT00855582|1285035|P1|COMPLETED|Overall Study||172
526148|NCT00855582|1285033|P3|STARTED|Overall Study||200
526149|NCT00855582|1285034|P2|STARTED|Overall Study||208
526150|NCT00855582|1285035|P1|STARTED|Overall Study||198
526151|NCT00855465|1285124|P2|NOT COMPLETED|Follow-up Period (FUP)||2
526152|NCT00855465|1285125|P1|NOT COMPLETED|Follow-up Period (FUP)||8
526153|NCT00855465|1285124|P2|COMPLETED|Follow-up Period (FUP)||2
526154|NCT00855465|1285125|P1|COMPLETED|Follow-up Period (FUP)||9
526155|NCT00855465|1285124|P2|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|4
526156|NCT00855465|1285125|P1|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|17
526157|NCT00855465|1285124|P2|NOT COMPLETED|Treatment Period||5
526158|NCT00855465|1285125|P1|NOT COMPLETED|Treatment Period||14
526159|NCT00855465|1285124|P2|COMPLETED|Treatment Period||83
526160|NCT00855465|1285125|P1|COMPLETED|Treatment Period||160
526161|NCT00855465|1285124|P2|Participants Received Treatment|Treatment Period||88
526162|NCT00855465|1285125|P1|Participants Received Treatment|Treatment Period|1 subject randomized but not treated|173
526163|NCT00855465|1285124|P2|STARTED|Treatment Period||88
526164|NCT00855465|1285125|P1|STARTED|Treatment Period||174
526165|NCT00855439|1285215|P2|NOT COMPLETED|Overall Study||0
526166|NCT00855439|1285216|P1|NOT COMPLETED|Overall Study||3
526167|NCT00855439|1285215|P2|COMPLETED|Overall Study||24
526168|NCT00855439|1285216|P1|COMPLETED|Overall Study||19
526169|NCT00855439|1285215|P2|STARTED|Overall Study||24
526170|NCT00855439|1285216|P1|STARTED|Overall Study||22
526171|NCT00855413|1285228|P1|NOT COMPLETED|Overall Study||0
526172|NCT00855413|1285228|P1|COMPLETED|Overall Study||15
526173|NCT00855413|1285228|P1|STARTED|Overall Study||15
526174|NCT00855335|1285274|P5|NOT COMPLETED|Overall Study||1
526175|NCT00855335|1285275|P4|NOT COMPLETED|Overall Study||7
526176|NCT00855335|1285276|P3|NOT COMPLETED|Overall Study||5
526177|NCT00855335|1285277|P2|NOT COMPLETED|Overall Study||2
526178|NCT00855335|1285278|P1|NOT COMPLETED|Overall Study||5
526179|NCT00855335|1285274|P5|COMPLETED|Overall Study||6
526180|NCT00855335|1285275|P4|COMPLETED|Overall Study||12
526181|NCT00855335|1285276|P3|COMPLETED|Overall Study||10
526182|NCT00855335|1285277|P2|COMPLETED|Overall Study||15
526183|NCT00855335|1285278|P1|COMPLETED|Overall Study||12
526184|NCT00855335|1285274|P5|STARTED|Overall Study||7
526185|NCT00855335|1285275|P4|STARTED|Overall Study||19
526186|NCT00855335|1285276|P3|STARTED|Overall Study||15
526187|NCT00855335|1285277|P2|STARTED|Overall Study||17
526188|NCT00855335|1285278|P1|STARTED|Overall Study||17
526189|NCT00855309|1285365|P2|NOT COMPLETED|Overall Study||0
526190|NCT00855309|1285366|P1|NOT COMPLETED|Overall Study||1
526191|NCT00855309|1285365|P2|COMPLETED|Overall Study||55
526192|NCT00855309|1285366|P1|COMPLETED|Overall Study||56
526193|NCT00855309|1285365|P2|STARTED|Overall Study||55
526194|NCT00855309|1285366|P1|STARTED|Overall Study||57
526195|NCT00855218|1285374|P2|NOT COMPLETED|Overall Study||153
526196|NCT00855218|1285375|P1|NOT COMPLETED|Overall Study||154
526197|NCT00855218|1285374|P2|COMPLETED|Overall Study||0
526198|NCT00855218|1285375|P1|COMPLETED|Overall Study||0
526199|NCT00855218|1285374|P2|Participants Received Treatment|Overall Study||151
526200|NCT00855218|1285375|P1|Participants Received Treatment|Overall Study||153
526201|NCT00855218|1285374|P2|STARTED|Overall Study||153
526202|NCT00855218|1285375|P1|STARTED|Overall Study||154
526203|NCT00855166|1285393|P2|NOT COMPLETED|Overall Study||8
526204|NCT00855166|1285394|P1|NOT COMPLETED|Overall Study||5
526205|NCT00855166|1285393|P2|COMPLETED|Overall Study||83
526206|NCT00855166|1285394|P1|COMPLETED|Overall Study||86
526207|NCT00855166|1285393|P2|STARTED|Overall Study|Of the 91 randomized participants only 89 were included in the full analysis set.|91
526208|NCT00855166|1285394|P1|STARTED|Overall Study||91
526209|NCT00855062|1285414|P2|NOT COMPLETED|Step2||6
526210|NCT00855062|1285415|P1|NOT COMPLETED|Step2||6
526211|NCT00855062|1285414|P2|COMPLETED|Step2||15
526212|NCT00855062|1285415|P1|COMPLETED|Step2||13
526213|NCT00855062|1285414|P2|STARTED|Step2|26 participants completed STEP1; however, only 21 out of the 26 decided to enroll in STEP2.|21
526214|NCT00855062|1285415|P1|STARTED|Step2|26 participants completed STEP1; however, only 19 out of the 26 decided to enroll in STEP2.|19
526215|NCT00855062|1285414|P2|NOT COMPLETED|Step1||11
526216|NCT00855062|1285415|P1|NOT COMPLETED|Step1||10
526217|NCT00855062|1285414|P2|COMPLETED|Step1||26
526218|NCT00855062|1285415|P1|COMPLETED|Step1||26
526219|NCT00855062|1285414|P2|STARTED|Step1||37
526220|NCT00855062|1285415|P1|STARTED|Step1||36
526221|NCT00855010|1285441|P2|NOT COMPLETED|Overall Study||1
526222|NCT00855010|1285442|P1|NOT COMPLETED|Overall Study||4
526223|NCT00855010|1285441|P2|COMPLETED|Overall Study||18
526224|NCT00855010|1285442|P1|COMPLETED|Overall Study||19
526225|NCT00855010|1285441|P2|STARTED|Overall Study||19
526226|NCT00855010|1285442|P1|STARTED|Overall Study||23
526227|NCT00854906|1285464|P1|NOT COMPLETED|Overall Study||1
526228|NCT00854906|1285464|P1|COMPLETED|Overall Study|There were 26 participants in this group. One person was excluded be causes of no ocular history.|25
526229|NCT00854906|1285464|P1|STARTED|Overall Study|There were 26 participants whose eyes were measured in the KTBUT group.|26
526230|NCT00854724|1285473|P2|NOT COMPLETED|Second Intervention||1
526231|NCT00854724|1285474|P1|NOT COMPLETED|Second Intervention||1
526232|NCT00854724|1285473|P2|COMPLETED|Second Intervention||5
526233|NCT00854724|1285474|P1|COMPLETED|Second Intervention||5
526234|NCT00854724|1285473|P2|STARTED|Second Intervention||6
526235|NCT00854724|1285474|P1|STARTED|Second Intervention||6
526236|NCT00854724|1285473|P2|NOT COMPLETED|Washout||1
526237|NCT00854724|1285474|P1|NOT COMPLETED|Washout||1
526238|NCT00854724|1285473|P2|COMPLETED|Washout||6
526239|NCT00854724|1285474|P1|COMPLETED|Washout||6
526240|NCT00854724|1285473|P2|STARTED|Washout||7
526241|NCT00854724|1285474|P1|STARTED|Washout||7
526242|NCT00854724|1285473|P2|NOT COMPLETED|First Intervention||1
526243|NCT00854724|1285474|P1|NOT COMPLETED|First Intervention||1
526244|NCT00854724|1285473|P2|COMPLETED|First Intervention||7
526245|NCT00854724|1285474|P1|COMPLETED|First Intervention||7
526246|NCT00854724|1285473|P2|STARTED|First Intervention||8
526247|NCT00854724|1285474|P1|STARTED|First Intervention||8
526248|NCT00854620|1285480|P1|NOT COMPLETED|Overall Study||1
526249|NCT00854620|1285480|P1|COMPLETED|Overall Study||8
526250|NCT00854620|1285480|P1|STARTED|Overall Study||9
526251|NCT00854607|1285484|P1|NOT COMPLETED|2 Weeks After Start Anti-fungal Therapy||65
526252|NCT00854607|1285484|P1|COMPLETED|2 Weeks After Start Anti-fungal Therapy||51
526253|NCT00854607|1285484|P1|STARTED|2 Weeks After Start Anti-fungal Therapy||116
526254|NCT00854607|1285484|P1|NOT COMPLETED|Enrollment||0
526255|NCT00854607|1285484|P1|COMPLETED|Enrollment||116
526256|NCT00854607|1285484|P1|STARTED|Enrollment||116
526257|NCT00854594|1285519|P2|NOT COMPLETED|Overall Study||0
526258|NCT00854594|1285520|P1|NOT COMPLETED|Overall Study||0
526259|NCT00854594|1285519|P2|COMPLETED|Overall Study||69
526260|NCT00854594|1285520|P1|COMPLETED|Overall Study||48
526261|NCT00854594|1285519|P2|STARTED|Overall Study|9 sites randomized to intervention, providers completed surveys before and/or after study period|69
526262|NCT00854594|1285520|P1|STARTED|Overall Study|9 sites randomized to control arm, providers completed surveys before and/or after study period|48
526263|NCT00854581|1285532|P1|NOT COMPLETED|Part 2 Maintenance (Up to 12 Months)||3
526264|NCT00854581|1285532|P1|COMPLETED|Part 2 Maintenance (Up to 12 Months)||2
526265|NCT00854581|1285532|P1|STARTED|Part 2 Maintenance (Up to 12 Months)||5
526266|NCT00854581|1285532|P1|NOT COMPLETED|Part 1 Maintenance (Up to Day 60)||2
526267|NCT00854581|1285532|P1|COMPLETED|Part 1 Maintenance (Up to Day 60)||5
526268|NCT00854581|1285532|P1|STARTED|Part 1 Maintenance (Up to Day 60)||7
526269|NCT00854581|1285532|P1|NOT COMPLETED|Induction (Up to Day 21)||6
526270|NCT00854581|1285532|P1|COMPLETED|Induction (Up to Day 21)||7
526271|NCT00854581|1285532|P1|STARTED|Induction (Up to Day 21)||13
526272|NCT00854373|1285547|P2|NOT COMPLETED|Overall Study||4
526273|NCT00854373|1285548|P1|NOT COMPLETED|Overall Study||2
526274|NCT00854373|1285547|P2|COMPLETED|Overall Study||89
526275|NCT00854373|1285548|P1|COMPLETED|Overall Study||93
526276|NCT00854373|1285547|P2|STARTED|Overall Study||93
526277|NCT00854373|1285548|P1|STARTED|Overall Study||95
526278|NCT00854360|1285562|P4|NOT COMPLETED|Overall Study||10
526279|NCT00854360|1285563|P3|NOT COMPLETED|Overall Study||2
526280|NCT00854360|1285564|P2|NOT COMPLETED|Overall Study||3
526281|NCT00854360|1285565|P1|NOT COMPLETED|Overall Study||2
526282|NCT00854360|1285562|P4|COMPLETED|Overall Study||114
526283|NCT00854360|1285563|P3|COMPLETED|Overall Study||120
526284|NCT00854360|1285564|P2|COMPLETED|Overall Study|One patient discontinued due to both an AE and study medication discontinuation.|120
526285|NCT00854360|1285565|P1|COMPLETED|Overall Study||116
526286|NCT00854360|1285562|P4|Intent to Treat / Safety Population|Overall Study|One patient did not receive any double-blind study medication.|123
526287|NCT00854360|1285563|P3|Intent to Treat / Safety Population|Overall Study||122
526288|NCT00854360|1285564|P2|Intent to Treat / Safety Population|Overall Study||123
526289|NCT00854360|1285565|P1|Intent to Treat / Safety Population|Overall Study||118
526290|NCT00854360|1285562|P4|STARTED|Overall Study||124
526291|NCT00854360|1285563|P3|STARTED|Overall Study||122
526292|NCT00854360|1285564|P2|STARTED|Overall Study||123
526293|NCT00854360|1285565|P1|STARTED|Overall Study||118
526294|NCT00854308|1285597|P2|NOT COMPLETED|Overall Study||67
526295|NCT00854308|1285598|P1|NOT COMPLETED|Overall Study||62
526296|NCT00854308|1285597|P2|COMPLETED|Overall Study||1
526297|NCT00854308|1285598|P1|COMPLETED|Overall Study|Completed participants in both arms were still receiving study drug when analyses were performed.|7
526298|NCT00854308|1285597|P2|Received Study Drug|Overall Study||67
526299|NCT00854308|1285598|P1|Received Study Drug|Overall Study||69
526300|NCT00854308|1285597|P2|STARTED|Overall Study||68
526301|NCT00854308|1285598|P1|STARTED|Overall Study||69
526302|NCT00854113|1285623|P11|NOT COMPLETED|Overall Study||0
526303|NCT00854113|1285624|P10|NOT COMPLETED|Overall Study||0
526304|NCT00854113|1285625|P9|NOT COMPLETED|Overall Study||1
526305|NCT00854113|1285626|P8|NOT COMPLETED|Overall Study||3
526306|NCT00854113|1285627|P7|NOT COMPLETED|Overall Study||0
526307|NCT00854113|1285628|P6|NOT COMPLETED|Overall Study||0
526308|NCT00854113|1285629|P5|NOT COMPLETED|Overall Study||0
526309|NCT00854113|1285630|P4|NOT COMPLETED|Overall Study||0
526310|NCT00854113|1285631|P3|NOT COMPLETED|Overall Study||0
526311|NCT00854113|1285632|P2|NOT COMPLETED|Overall Study||0
526312|NCT00854113|1285633|P1|NOT COMPLETED|Overall Study||0
526313|NCT00854113|1285623|P11|COMPLETED|Overall Study||6
526314|NCT00854113|1285624|P10|COMPLETED|Overall Study||8
526315|NCT00854113|1285625|P9|COMPLETED|Overall Study||7
526316|NCT00854113|1285626|P8|COMPLETED|Overall Study||5
526317|NCT00854113|1285627|P7|COMPLETED|Overall Study||12
526318|NCT00854113|1285628|P6|COMPLETED|Overall Study||6
526319|NCT00854113|1285629|P5|COMPLETED|Overall Study||6
526320|NCT00854113|1285630|P4|COMPLETED|Overall Study||6
526321|NCT00854113|1285631|P3|COMPLETED|Overall Study||6
526322|NCT00854113|1285632|P2|COMPLETED|Overall Study||6
526323|NCT00854113|1285633|P1|COMPLETED|Overall Study||6
526324|NCT00854113|1285623|P11|STARTED|Overall Study||6
526325|NCT00854113|1285624|P10|STARTED|Overall Study||8
526326|NCT00854113|1285625|P9|STARTED|Overall Study||8
526327|NCT00854113|1285626|P8|STARTED|Overall Study||8
526328|NCT00854113|1285627|P7|STARTED|Overall Study||12
526329|NCT00854113|1285628|P6|STARTED|Overall Study||6
526330|NCT00854113|1285629|P5|STARTED|Overall Study||6
526331|NCT00854113|1285630|P4|STARTED|Overall Study||6
526332|NCT00854113|1285631|P3|STARTED|Overall Study||6
526333|NCT00854113|1285632|P2|STARTED|Overall Study||6
526334|NCT00854113|1285633|P1|STARTED|Overall Study||6
526335|NCT00854087|1285736|P2|NOT COMPLETED|Overall Study||19
526336|NCT00854087|1285737|P1|NOT COMPLETED|Overall Study||19
526337|NCT00854087|1285736|P2|COMPLETED|Overall Study||40
526338|NCT00854087|1285737|P1|COMPLETED|Overall Study||40
526339|NCT00854087|1285736|P2|STARTED|Overall Study||59
526340|NCT00854087|1285737|P1|STARTED|Overall Study||59
526341|NCT00853996|1285743|P1|NOT COMPLETED|Overall Study||0
526342|NCT00853996|1285743|P1|COMPLETED|Overall Study||25
526343|NCT00853996|1285743|P1|STARTED|Overall Study||25
526344|NCT00853970|1285755|P2|NOT COMPLETED|Overall Study||3
526345|NCT00853970|1285756|P1|NOT COMPLETED|Overall Study||6
526346|NCT00853970|1285755|P2|COMPLETED|Overall Study||144
526347|NCT00853970|1285756|P1|COMPLETED|Overall Study||146
526348|NCT00853970|1285755|P2|STARTED|Overall Study||147
526349|NCT00853970|1285756|P1|STARTED|Overall Study||152
526350|NCT00853957|1285766|P2|NOT COMPLETED|Overall Study||19
526351|NCT00853957|1285767|P1|NOT COMPLETED|Overall Study||14
526352|NCT00853957|1285766|P2|COMPLETED|Overall Study||204
526353|NCT00853957|1285767|P1|COMPLETED|Overall Study||206
526354|NCT00853957|1285766|P2|STARTED|Overall Study||223
526355|NCT00853957|1285767|P1|STARTED|Overall Study||220
526356|NCT00853905|1285785|P2|NOT COMPLETED|Overall Study||4
526357|NCT00853905|1285786|P1|NOT COMPLETED|Overall Study||2
526358|NCT00853905|1285785|P2|COMPLETED|Overall Study||36
526359|NCT00853905|1285786|P1|COMPLETED|Overall Study||35
526360|NCT00853905|1285785|P2|STARTED|Overall Study||40
526361|NCT00853905|1285786|P1|STARTED|Overall Study||37
526362|NCT00853840|1285792|P2|NOT COMPLETED|Period 2||0
526363|NCT00853840|1285793|P1|NOT COMPLETED|Period 2||0
526364|NCT00853840|1285792|P2|COMPLETED|Period 2||9
526365|NCT00853840|1285793|P1|COMPLETED|Period 2||9
526366|NCT00853840|1285792|P2|Vardenafil or Placebo (Day 3)|Period 2|Administered 1 hour post Maraviroc dosing|9
526367|NCT00853840|1285793|P1|Vardenafil or Placebo (Day 3)|Period 2|Administered 1 hour post Maraviroc dosing|9
526368|NCT00853840|1285792|P2|Maraviroc (Days 1 - 3)|Period 2||9
526369|NCT00853840|1285793|P1|Maraviroc (Days 1 - 3)|Period 2||9
526370|NCT00853840|1285792|P2|STARTED|Period 2||9
526371|NCT00853840|1285793|P1|STARTED|Period 2||9
526372|NCT00853840|1285792|P2|NOT COMPLETED|Period 1||0
526373|NCT00853840|1285793|P1|NOT COMPLETED|Period 1||0
526374|NCT00853840|1285792|P2|COMPLETED|Period 1||9
526375|NCT00853840|1285793|P1|COMPLETED|Period 1||9
526376|NCT00853840|1285792|P2|Vardenafil or Placebo (Day 4)|Period 1|Administered 1 hour post Maraviroc dosing|9
526377|NCT00853840|1285793|P1|Vardenafil or Placebo (Day 4)|Period 1|Administered 1 hour post Maraviroc dosing|9
526378|NCT00853840|1285792|P2|Maraviroc (Days 1 - 4)|Period 1||9
526379|NCT00853840|1285793|P1|Maraviroc (Days 1 - 4)|Period 1||9
526380|NCT00853840|1285792|P2|STARTED|Period 1||9
526381|NCT00853840|1285793|P1|STARTED|Period 1||9
526382|NCT00853827|1285810|P2|NOT COMPLETED|Double Blind Period (103 Weeks)||109
526383|NCT00853827|1285811|P1|NOT COMPLETED|Double Blind Period (103 Weeks)||104
526384|NCT00853827|1285810|P2|COMPLETED|Double Blind Period (103 Weeks)||199
526385|NCT00853827|1285811|P1|COMPLETED|Double Blind Period (103 Weeks)||201
526386|NCT00853827|1285810|P2|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||233
526387|NCT00853827|1285811|P1|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||225
526388|NCT00853827|1285810|P2|STARTED|Double Blind Period (103 Weeks)||308
526389|NCT00853827|1285811|P1|STARTED|Double Blind Period (103 Weeks)|"Started indicates number of patients in randomized set, full analysis set (FAS) and safety set."|305
526390|NCT00853827|1285810|P2|NOT COMPLETED|Single Blind Period (1 Week)||0
526391|NCT00853827|1285811|P1|NOT COMPLETED|Single Blind Period (1 Week)||39
526392|NCT00853827|1285810|P2|COMPLETED|Single Blind Period (1 Week)||0
526393|NCT00853827|1285811|P1|COMPLETED|Single Blind Period (1 Week)|Completed patients in single blind period|613
526489|NCT00853307|1286324|P2|COMPLETED|Overall Study||20
526394|NCT00853827|1285810|P2|STARTED|Single Blind Period (1 Week)|This arm was only used in double blind period|0
526395|NCT00853827|1285811|P1|STARTED|Single Blind Period (1 Week)|Enrolled patients in single blind|652
526396|NCT00853762|1285827|P4|NOT COMPLETED|Overall Study||22
526397|NCT00853762|1285828|P3|NOT COMPLETED|Overall Study||17
526398|NCT00853762|1285829|P2|NOT COMPLETED|Overall Study||19
526399|NCT00853762|1285830|P1|NOT COMPLETED|Overall Study||16
526400|NCT00853762|1285827|P4|COMPLETED|Overall Study||0
526401|NCT00853762|1285828|P3|COMPLETED|Overall Study||0
526402|NCT00853762|1285829|P2|COMPLETED|Overall Study||0
526403|NCT00853762|1285830|P1|COMPLETED|Overall Study||0
526404|NCT00853762|1285827|P4|STARTED|Overall Study||22
526405|NCT00853762|1285828|P3|STARTED|Overall Study||17
526406|NCT00853762|1285829|P2|STARTED|Overall Study||19
526407|NCT00853762|1285830|P1|STARTED|Overall Study||16
526408|NCT00853749|1285898|P2|NOT COMPLETED|Overall Study||1
526409|NCT00853749|1285899|P1|NOT COMPLETED|Overall Study||0
526410|NCT00853749|1285898|P2|COMPLETED|Overall Study||38
526411|NCT00853749|1285899|P1|COMPLETED|Overall Study||50
526412|NCT00853749|1285898|P2|Vaccinated|Overall Study||39
526413|NCT00853749|1285899|P1|Vaccinated|Overall Study||50
526414|NCT00853749|1285898|P2|STARTED|Overall Study||39
526415|NCT00853749|1285899|P1|STARTED|Overall Study||50
526416|NCT00853723|1285920|P3|NOT COMPLETED|Overall Study||2
526417|NCT00853723|1285921|P2|NOT COMPLETED|Overall Study||7
526418|NCT00853723|1285922|P1|NOT COMPLETED|Overall Study||6
526419|NCT00853723|1285920|P3|COMPLETED|Overall Study||33
526420|NCT00853723|1285921|P2|COMPLETED|Overall Study||28
526421|NCT00853723|1285922|P1|COMPLETED|Overall Study||29
526422|NCT00853723|1285920|P3|STARTED|Overall Study||35
526423|NCT00853723|1285921|P2|STARTED|Overall Study||35
526424|NCT00853723|1285922|P1|STARTED|Overall Study||35
526425|NCT00853658|1285969|P3|NOT COMPLETED|Overall Study||815
526426|NCT00853658|1285970|P2|NOT COMPLETED|Overall Study||832
526427|NCT00853658|1285971|P1|NOT COMPLETED|Overall Study||787
526428|NCT00853658|1285969|P3|COMPLETED|Overall Study||1539
526429|NCT00853658|1285970|P2|COMPLETED|Overall Study||1524
526430|NCT00853658|1285971|P1|COMPLETED|Overall Study||1567
526431|NCT00853658|1285969|P3|Safety Set|Overall Study||2345
526432|NCT00853658|1285970|P2|Safety Set|Overall Study||2348
526433|NCT00853658|1285971|P1|Safety Set|Overall Study||2347
526434|NCT00853658|1285969|P3|Full Analysis Set (FAS)|Overall Study||2336
526435|NCT00853658|1285970|P2|Full Analysis Set (FAS)|Overall Study||2340
526436|NCT00853658|1285971|P1|Full Analysis Set (FAS)|Overall Study||2340
526437|NCT00853658|1285969|P3|STARTED|Overall Study||2354
526438|NCT00853658|1285970|P2|STARTED|Overall Study||2356
526439|NCT00853658|1285971|P1|STARTED|Overall Study||2354
526440|NCT00853606|1285985|P1|NOT COMPLETED|Overall Study||220
526441|NCT00853606|1285985|P1|COMPLETED|Overall Study||492
526442|NCT00853606|1285985|P1|STARTED|Overall Study||712
526443|NCT00853593|1285991|P1|NOT COMPLETED|Overall Study||45
526444|NCT00853593|1285991|P1|COMPLETED|Overall Study||152
526445|NCT00853593|1285991|P1|Model 4396 Lead Attempted|Overall Study||164
526446|NCT00853593|1285991|P1|Implant Attempted|Overall Study||193
526447|NCT00853593|1285991|P1|STARTED|Overall Study||197
526448|NCT00853580|1286018|P2|NOT COMPLETED|Overall Study||16
526449|NCT00853580|1286019|P1|NOT COMPLETED|Overall Study||7
526450|NCT00853580|1286018|P2|COMPLETED|Overall Study||56
526451|NCT00853580|1286019|P1|COMPLETED|Overall Study||67
526452|NCT00853580|1286018|P2|STARTED|Overall Study||72
526453|NCT00853580|1286019|P1|STARTED|Overall Study||74
526454|NCT00853567|1286066|P1|NOT COMPLETED|Overall Study||71
526455|NCT00853567|1286066|P1|COMPLETED|Overall Study||0
526456|NCT00853567|1286066|P1|STARTED|Overall Study||71
526457|NCT00853489|1286076|P2|NOT COMPLETED|Overall Study||2
526458|NCT00853489|1286077|P1|NOT COMPLETED|Overall Study||5
526459|NCT00853489|1286076|P2|COMPLETED|Overall Study||12
526460|NCT00853489|1286077|P1|COMPLETED|Overall Study||11
526461|NCT00853489|1286076|P2|STARTED|Overall Study||14
526462|NCT00853489|1286077|P1|STARTED|Overall Study||16
526463|NCT00853385|1286092|P5|NOT COMPLETED|Overall Study||42
526464|NCT00853385|1286093|P4|NOT COMPLETED|Overall Study||13
526465|NCT00853385|1286094|P3|NOT COMPLETED|Overall Study||9
526466|NCT00853385|1286095|P2|NOT COMPLETED|Overall Study||43
526467|NCT00853385|1286096|P1|NOT COMPLETED|Overall Study||54
526468|NCT00853385|1286092|P5|COMPLETED|Overall Study||162
526469|NCT00853385|1286093|P4|COMPLETED|Overall Study||39
526470|NCT00853385|1286094|P3|COMPLETED|Overall Study||47
526471|NCT00853385|1286095|P2|COMPLETED|Overall Study||158
526472|NCT00853385|1286096|P1|COMPLETED|Overall Study||150
526473|NCT00853385|1286092|P5|STARTED|Overall Study||204
526474|NCT00853385|1286093|P4|STARTED|Overall Study||52
526475|NCT00853385|1286094|P3|STARTED|Overall Study||56
526476|NCT00853385|1286095|P2|STARTED|Overall Study||201
526477|NCT00853385|1286096|P1|STARTED|Overall Study||204
526478|NCT00853333|1286312|P3|NOT COMPLETED|Overall Study||0
526479|NCT00853333|1286313|P2|NOT COMPLETED|Overall Study||0
526480|NCT00853333|1286314|P1|NOT COMPLETED|Overall Study||0
526481|NCT00853333|1286312|P3|COMPLETED|Overall Study||31
526482|NCT00853333|1286313|P2|COMPLETED|Overall Study||27
526483|NCT00853333|1286314|P1|COMPLETED|Overall Study||28
526484|NCT00853333|1286312|P3|STARTED|Overall Study||31
526485|NCT00853333|1286313|P2|STARTED|Overall Study||27
526486|NCT00853333|1286314|P1|STARTED|Overall Study||28
526487|NCT00853307|1286324|P2|NOT COMPLETED|Overall Study||5
526488|NCT00853307|1286325|P1|NOT COMPLETED|Overall Study||2
526490|NCT00853307|1286325|P1|COMPLETED|Overall Study|Completed = participants who completed the study treatment.|4
526491|NCT00853307|1286324|P2|STARTED|Overall Study||25
526492|NCT00853307|1286325|P1|STARTED|Overall Study||6
526493|NCT00853242|1286352|P7|NOT COMPLETED|Overall Study||5
526494|NCT00853242|1286353|P6|NOT COMPLETED|Overall Study||2
526495|NCT00853242|1286354|P5|NOT COMPLETED|Overall Study||4
526496|NCT00853242|1286355|P4|NOT COMPLETED|Overall Study||4
526497|NCT00853242|1286356|P3|NOT COMPLETED|Overall Study||3
526498|NCT00853242|1286357|P2|NOT COMPLETED|Overall Study||3
526499|NCT00853242|1286358|P1|NOT COMPLETED|Overall Study||3
526500|NCT00853242|1286352|P7|COMPLETED|Overall Study||44
526501|NCT00853242|1286353|P6|COMPLETED|Overall Study||49
526502|NCT00853242|1286354|P5|COMPLETED|Overall Study||46
526503|NCT00853242|1286355|P4|COMPLETED|Overall Study||46
526504|NCT00853242|1286356|P3|COMPLETED|Overall Study||46
526505|NCT00853242|1286357|P2|COMPLETED|Overall Study||47
526506|NCT00853242|1286358|P1|COMPLETED|Overall Study||47
526507|NCT00853242|1286352|P7|Treated|Overall Study||48
526508|NCT00853242|1286353|P6|Treated|Overall Study||51
526509|NCT00853242|1286354|P5|Treated|Overall Study||50
526510|NCT00853242|1286355|P4|Treated|Overall Study||50
526511|NCT00853242|1286356|P3|Treated|Overall Study||48
526512|NCT00853242|1286357|P2|Treated|Overall Study||49
526513|NCT00853242|1286358|P1|Treated|Overall Study||50
526514|NCT00853242|1286352|P7|STARTED|Overall Study||49
526515|NCT00853242|1286353|P6|STARTED|Overall Study||51
526516|NCT00853242|1286354|P5|STARTED|Overall Study||50
526517|NCT00853242|1286355|P4|STARTED|Overall Study||50
526518|NCT00853242|1286356|P3|STARTED|Overall Study||49
526519|NCT00853242|1286357|P2|STARTED|Overall Study||50
526520|NCT00853242|1286358|P1|STARTED|Overall Study||50
526521|NCT00853229|1286400|P2|NOT COMPLETED|Phase 2: Cross Over||0
526522|NCT00853229|1286401|P1|NOT COMPLETED|Phase 2: Cross Over||0
526523|NCT00853229|1286400|P2|COMPLETED|Phase 2: Cross Over||0
526524|NCT00853229|1286401|P1|COMPLETED|Phase 2: Cross Over||0
526525|NCT00853229|1286400|P2|STARTED|Phase 2: Cross Over||0
526526|NCT00853229|1286401|P1|STARTED|Phase 2: Cross Over||0
526527|NCT00853229|1286400|P2|NOT COMPLETED|Phase 1: Initial Intervention||8
526528|NCT00853229|1286401|P1|NOT COMPLETED|Phase 1: Initial Intervention||8
526529|NCT00853229|1286400|P2|COMPLETED|Phase 1: Initial Intervention||0
526530|NCT00853229|1286401|P1|COMPLETED|Phase 1: Initial Intervention||0
526531|NCT00853229|1286400|P2|STARTED|Phase 1: Initial Intervention||8
526532|NCT00853229|1286401|P1|STARTED|Phase 1: Initial Intervention||8
526533|NCT00853151|1286411|P4|NOT COMPLETED|Overall Study||3
526534|NCT00853151|1286412|P3|NOT COMPLETED|Overall Study||8
526535|NCT00853151|1286413|P2|NOT COMPLETED|Overall Study||13
526536|NCT00853151|1286414|P1|NOT COMPLETED|Overall Study||10
526537|NCT00853151|1286411|P4|COMPLETED|Overall Study||15
526538|NCT00853151|1286412|P3|COMPLETED|Overall Study||30
526539|NCT00853151|1286413|P2|COMPLETED|Overall Study||24
526540|NCT00853151|1286414|P1|COMPLETED|Overall Study||28
526541|NCT00853151|1286411|P4|STARTED|Overall Study||18
526542|NCT00853151|1286412|P3|STARTED|Overall Study||38
526543|NCT00853151|1286413|P2|STARTED|Overall Study||37
526544|NCT00853151|1286414|P1|STARTED|Overall Study||38
526545|NCT00853112|1286563|P7|NOT COMPLETED|Overall Study||1
526546|NCT00853112|1286564|P6|NOT COMPLETED|Overall Study||0
526547|NCT00853112|1286565|P5|NOT COMPLETED|Overall Study||0
526548|NCT00853112|1286566|P4|NOT COMPLETED|Overall Study||2
526549|NCT00853112|1286567|P3|NOT COMPLETED|Overall Study||0
526550|NCT00853112|1286568|P2|NOT COMPLETED|Overall Study||1
526551|NCT00853112|1286569|P1|NOT COMPLETED|Overall Study||0
526552|NCT00853112|1286563|P7|COMPLETED|Overall Study||6
526553|NCT00853112|1286564|P6|COMPLETED|Overall Study||7
526554|NCT00853112|1286565|P5|COMPLETED|Overall Study||6
526555|NCT00853112|1286566|P4|COMPLETED|Overall Study||6
526556|NCT00853112|1286567|P3|COMPLETED|Overall Study||7
526557|NCT00853112|1286568|P2|COMPLETED|Overall Study||6
526558|NCT00853112|1286569|P1|COMPLETED|Overall Study||6
526559|NCT00853112|1286563|P7|Treated|Overall Study||6
526560|NCT00853112|1286564|P6|Treated|Overall Study||7
526561|NCT00853112|1286565|P5|Treated|Overall Study||6
526562|NCT00853112|1286566|P4|Treated|Overall Study||6
526563|NCT00853112|1286567|P3|Treated|Overall Study||7
526564|NCT00853112|1286568|P2|Treated|Overall Study||6
526565|NCT00853112|1286569|P1|Treated|Overall Study||6
526566|NCT00853112|1286563|P7|STARTED|Overall Study||7
526567|NCT00853112|1286564|P6|STARTED|Overall Study||7
526568|NCT00853112|1286565|P5|STARTED|Overall Study||6
526569|NCT00853112|1286566|P4|STARTED|Overall Study||8
526570|NCT00853112|1286567|P3|STARTED|Overall Study||7
526571|NCT00853112|1286568|P2|STARTED|Overall Study||7
526572|NCT00853112|1286569|P1|STARTED|Overall Study||6
526573|NCT00853099|1286679|P4|NOT COMPLETED|Double-blind + Open-label Periods||147
526574|NCT00853099|1286680|P3|NOT COMPLETED|Double-blind + Open-label Periods||0
526575|NCT00853099|1286681|P2|NOT COMPLETED|Double-blind + Open-label Periods||0
526576|NCT00853099|1286682|P1|NOT COMPLETED|Double-blind + Open-label Periods||0
526577|NCT00853099|1286679|P4|COMPLETED|Double-blind + Open-label Periods||119
526578|NCT00853099|1286680|P3|COMPLETED|Double-blind + Open-label Periods||0
526579|NCT00853099|1286681|P2|COMPLETED|Double-blind + Open-label Periods||0
526580|NCT00853099|1286682|P1|COMPLETED|Double-blind + Open-label Periods||0
526672|NCT00852644|1286918|P2|COMPLETED|Overall Study||3
526673|NCT00852644|1286919|P1|COMPLETED|Overall Study||3
526581|NCT00853099|1286679|P4|STARTED|Double-blind + Open-label Periods|7 participants randomized to placebo did not receive any adalimumab; 1 participant was excluded.|266
526582|NCT00853099|1286680|P3|STARTED|Double-blind + Open-label Periods||0
526583|NCT00853099|1286681|P2|STARTED|Double-blind + Open-label Periods||0
526584|NCT00853099|1286682|P1|STARTED|Double-blind + Open-label Periods||0
526585|NCT00853099|1286679|P4|NOT COMPLETED|Double-blind Period||0
526586|NCT00853099|1286680|P3|NOT COMPLETED|Double-blind Period||31
526587|NCT00853099|1286681|P2|NOT COMPLETED|Double-blind Period||29
526588|NCT00853099|1286682|P1|NOT COMPLETED|Double-blind Period||23
526589|NCT00853099|1286679|P4|COMPLETED|Double-blind Period||0
526590|NCT00853099|1286680|P3|COMPLETED|Double-blind Period|Participants who completed Week 52.|60
526591|NCT00853099|1286681|P2|COMPLETED|Double-blind Period|Participants who completed Week 52.|58
526592|NCT00853099|1286682|P1|COMPLETED|Double-blind Period|Participants who completed Week 52.|73
526593|NCT00853099|1286679|P4|Completed Week 8|Double-blind Period||0
526594|NCT00853099|1286680|P3|Completed Week 8|Double-blind Period||86
526595|NCT00853099|1286681|P2|Completed Week 8|Double-blind Period||85
526596|NCT00853099|1286682|P1|Completed Week 8|Double-blind Period||92
526597|NCT00853099|1286679|P4|Treated|Double-blind Period||0
526598|NCT00853099|1286680|P3|Treated|Double-blind Period|1 participant, incorrectly treated with open-label (rescue) study drug at Week 0, was excluded.|90
526599|NCT00853099|1286681|P2|Treated|Double-blind Period||87
526600|NCT00853099|1286682|P1|Treated|Double-blind Period||96
526601|NCT00853099|1286679|P4|STARTED|Double-blind Period||0
526602|NCT00853099|1286680|P3|STARTED|Double-blind Period||91
526603|NCT00853099|1286681|P2|STARTED|Double-blind Period||87
526604|NCT00853099|1286682|P1|STARTED|Double-blind Period||96
526605|NCT00853073|1286724|P2|NOT COMPLETED|Overall Study||2
526606|NCT00853073|1286725|P1|NOT COMPLETED|Overall Study||3
526607|NCT00853073|1286724|P2|COMPLETED|Overall Study||29
526608|NCT00853073|1286725|P1|COMPLETED|Overall Study||29
526609|NCT00853073|1286724|P2|STARTED|Overall Study||31
526610|NCT00853073|1286725|P1|STARTED|Overall Study||32
526611|NCT00853021|1286733|P1|NOT COMPLETED|Overall Study||5
526612|NCT00853021|1286733|P1|COMPLETED|Overall Study||21
526613|NCT00853021|1286733|P1|STARTED|Overall Study||26
526614|NCT00852995|1286745|P5|NOT COMPLETED|Overall Study||4
526615|NCT00852995|1286746|P4|NOT COMPLETED|Overall Study||5
526616|NCT00852995|1286747|P3|NOT COMPLETED|Overall Study||5
526617|NCT00852995|1286748|P2|NOT COMPLETED|Overall Study||1
526618|NCT00852995|1286749|P1|NOT COMPLETED|Overall Study||8
526619|NCT00852995|1286745|P5|COMPLETED|Overall Study||46
526620|NCT00852995|1286746|P4|COMPLETED|Overall Study||40
526621|NCT00852995|1286747|P3|COMPLETED|Overall Study||39
526622|NCT00852995|1286748|P2|COMPLETED|Overall Study||42
526623|NCT00852995|1286749|P1|COMPLETED|Overall Study||38
526624|NCT00852995|1286745|P5|STARTED|Overall Study||50
526625|NCT00852995|1286746|P4|STARTED|Overall Study||45
526626|NCT00852995|1286747|P3|STARTED|Overall Study||44
526627|NCT00852995|1286748|P2|STARTED|Overall Study||43
526628|NCT00852995|1286749|P1|STARTED|Overall Study||46
526629|NCT00852969|1286793|P2|NOT COMPLETED|Overall Study||2
526630|NCT00852969|1286794|P1|NOT COMPLETED|Overall Study||0
526631|NCT00852969|1286793|P2|COMPLETED|Overall Study||13
526632|NCT00852969|1286794|P1|COMPLETED|Overall Study||15
526633|NCT00852969|1286793|P2|STARTED|Overall Study||15
526634|NCT00852969|1286794|P1|STARTED|Overall Study||15
526635|NCT00852930|1286805|P3|NOT COMPLETED|Overall Study||2
526636|NCT00852930|1286806|P2|NOT COMPLETED|Overall Study||1
526637|NCT00852930|1286807|P1|NOT COMPLETED|Overall Study||1
526638|NCT00852930|1286805|P3|COMPLETED|Overall Study||15
526639|NCT00852930|1286806|P2|COMPLETED|Overall Study||16
526640|NCT00852930|1286807|P1|COMPLETED|Overall Study||15
526641|NCT00852930|1286805|P3|STARTED|Overall Study||17
526642|NCT00852930|1286806|P2|STARTED|Overall Study||17
526643|NCT00852930|1286807|P1|STARTED|Overall Study||16
526644|NCT00852917|1286828|P4|NOT COMPLETED|Overall Study||93
526645|NCT00852917|1286829|P3|NOT COMPLETED|Overall Study||58
526646|NCT00852917|1286830|P2|NOT COMPLETED|Overall Study||46
526647|NCT00852917|1286831|P1|NOT COMPLETED|Overall Study||44
526648|NCT00852917|1286828|P4|COMPLETED|Overall Study||134
526649|NCT00852917|1286829|P3|COMPLETED|Overall Study||50
526650|NCT00852917|1286830|P2|COMPLETED|Overall Study||65
526651|NCT00852917|1286831|P1|COMPLETED|Overall Study||62
526652|NCT00852917|1286828|P4|STARTED|Overall Study||227
526653|NCT00852917|1286829|P3|STARTED|Overall Study||108
526654|NCT00852917|1286830|P2|STARTED|Overall Study||111
526655|NCT00852917|1286831|P1|STARTED|Overall Study||106
526656|NCT00852761|1286871|P2|NOT COMPLETED|Overall Study||0
526657|NCT00852761|1286872|P1|NOT COMPLETED|Overall Study||0
526658|NCT00852761|1286871|P2|COMPLETED|Overall Study||17
526659|NCT00852761|1286872|P1|COMPLETED|Overall Study||17
526660|NCT00852761|1286871|P2|STARTED|Overall Study||17
526661|NCT00852761|1286872|P1|STARTED|Overall Study||17
526662|NCT00852644|1286914|P6|NOT COMPLETED|Overall Study||0
526663|NCT00852644|1286915|P5|NOT COMPLETED|Overall Study||0
526664|NCT00852644|1286916|P4|NOT COMPLETED|Overall Study||0
526665|NCT00852644|1286917|P3|NOT COMPLETED|Overall Study||0
526666|NCT00852644|1286918|P2|NOT COMPLETED|Overall Study||0
526667|NCT00852644|1286919|P1|NOT COMPLETED|Overall Study||0
526668|NCT00852644|1286914|P6|COMPLETED|Overall Study||0
526669|NCT00852644|1286915|P5|COMPLETED|Overall Study||0
526670|NCT00852644|1286916|P4|COMPLETED|Overall Study||3
526671|NCT00852644|1286917|P3|COMPLETED|Overall Study||0
526674|NCT00852644|1286914|P6|STARTED|Overall Study||0
526675|NCT00852644|1286915|P5|STARTED|Overall Study||0
526676|NCT00852644|1286916|P4|STARTED|Overall Study||3
526677|NCT00852644|1286917|P3|STARTED|Overall Study||0
526678|NCT00852644|1286918|P2|STARTED|Overall Study||3
526679|NCT00852644|1286919|P1|STARTED|Overall Study||3
526680|NCT00852631|1286940|P1|NOT COMPLETED|Overall Study||11
526681|NCT00852631|1286940|P1|COMPLETED|Overall Study||17
526682|NCT00852631|1286940|P1|STARTED|Overall Study||28
526683|NCT00852592|1286948|P2|NOT COMPLETED|Overall Study||4
526684|NCT00852592|1286949|P1|NOT COMPLETED|Overall Study||3
526685|NCT00852592|1286948|P2|COMPLETED|Overall Study||19
526686|NCT00852592|1286949|P1|COMPLETED|Overall Study||20
526687|NCT00852592|1286948|P2|STARTED|Overall Study||23
526688|NCT00852592|1286949|P1|STARTED|Overall Study||23
526689|NCT00852540|1286959|P2|NOT COMPLETED|Overall Study||18
526690|NCT00852540|1286960|P1|NOT COMPLETED|Overall Study||36
526691|NCT00852540|1286959|P2|COMPLETED|Overall Study||122
526692|NCT00852540|1286960|P1|COMPLETED|Overall Study||234
526693|NCT00852540|1286959|P2|STARTED|Overall Study||140
526694|NCT00852540|1286960|P1|STARTED|Overall Study||270
526695|NCT00852527|1286986|P2|NOT COMPLETED|Overall Study||0
526696|NCT00852527|1286987|P1|NOT COMPLETED|Overall Study||0
526697|NCT00852527|1286986|P2|COMPLETED|Overall Study||242
526698|NCT00852527|1286987|P1|COMPLETED|Overall Study||196
526699|NCT00852527|1286986|P2|STARTED|Overall Study||242
526700|NCT00852527|1286987|P1|STARTED|Overall Study||196
526701|NCT00852475|1286994|P2|NOT COMPLETED|Overall Study||4
526702|NCT00852475|1286995|P1|NOT COMPLETED|Overall Study||3
526703|NCT00852475|1286994|P2|COMPLETED|Overall Study||16
526704|NCT00852475|1286995|P1|COMPLETED|Overall Study||23
526705|NCT00852475|1286994|P2|STARTED|Overall Study||20
526706|NCT00852475|1286995|P1|STARTED|Overall Study||26
526707|NCT00852397|1287006|P3|NOT COMPLETED|Overall Study||14
526708|NCT00852397|1287007|P2|NOT COMPLETED|Overall Study||8
526709|NCT00852397|1287008|P1|NOT COMPLETED|Overall Study||11
526710|NCT00852397|1287006|P3|COMPLETED|Overall Study||36
526711|NCT00852397|1287007|P2|COMPLETED|Overall Study||41
526712|NCT00852397|1287008|P1|COMPLETED|Overall Study||41
526713|NCT00852397|1287006|P3|Treated Participants|Overall Study||49
526714|NCT00852397|1287007|P2|Treated Participants|Overall Study||49
526715|NCT00852397|1287008|P1|Treated Participants|Overall Study||51
526716|NCT00852397|1287006|P3|STARTED|Overall Study||50
526717|NCT00852397|1287007|P2|STARTED|Overall Study||49
526718|NCT00852397|1287008|P1|STARTED|Overall Study||52
526719|NCT00852241|1287037|P1|NOT COMPLETED|Overall Study||18
526720|NCT00852241|1287037|P1|COMPLETED|Overall Study||0
526721|NCT00852241|1287037|P1|STARTED|Overall Study||18
526722|NCT00852137|1287043|P2|NOT COMPLETED|Overall Study||0
526723|NCT00852137|1287044|P1|NOT COMPLETED|Overall Study||0
526724|NCT00852137|1287043|P2|COMPLETED|Overall Study||3
526725|NCT00852137|1287044|P1|COMPLETED|Overall Study||13
526726|NCT00852137|1287043|P2|STARTED|Overall Study||3
526727|NCT00852137|1287044|P1|STARTED|Overall Study||13
526728|NCT00852124|1287066|P2|NOT COMPLETED|Overall Study||0
526729|NCT00852124|1287067|P1|NOT COMPLETED|Overall Study||0
526730|NCT00852124|1287066|P2|COMPLETED|Overall Study||0
526731|NCT00852124|1287067|P1|COMPLETED|Overall Study||3
526732|NCT00852124|1287066|P2|STARTED|Overall Study||0
526733|NCT00852124|1287067|P1|STARTED|Overall Study||3
526734|NCT00851903|1287072|P1|NOT COMPLETED|Overall Study||2
526735|NCT00851903|1287072|P1|COMPLETED|Overall Study||110
526736|NCT00851903|1287072|P1|Modified Intent-To-Treat Population|Overall Study|mITT population: patients treated by combination with at least 1 on-treatment efficacy measure|111
526737|NCT00851903|1287072|P1|Treated by Combination|Overall Study|patients treated with at least one dose of insulin glargine AND one dose of sitagliptin|111
526738|NCT00851903|1287072|P1|Safety Population|Overall Study|patients treated with at least one dose of insulin glargine OR one dose of sitagliptin|112
526739|NCT00851903|1287072|P1|STARTED|Overall Study||112
526740|NCT00851890|1287086|P4|NOT COMPLETED|Overall Study||1
526741|NCT00851890|1287087|P3|NOT COMPLETED|Overall Study||0
526742|NCT00851890|1287088|P2|NOT COMPLETED|Overall Study||1
526743|NCT00851890|1287089|P1|NOT COMPLETED|Overall Study||0
526744|NCT00851890|1287086|P4|COMPLETED|Overall Study||5
526745|NCT00851890|1287087|P3|COMPLETED|Overall Study||8
526746|NCT00851890|1287088|P2|COMPLETED|Overall Study||7
526747|NCT00851890|1287089|P1|COMPLETED|Overall Study||8
526748|NCT00851890|1287086|P4|STARTED|Overall Study||6
526749|NCT00851890|1287087|P3|STARTED|Overall Study||8
526750|NCT00851890|1287088|P2|STARTED|Overall Study||8
526751|NCT00851890|1287089|P1|STARTED|Overall Study||8
526752|NCT00851799|1287149|P3|NOT COMPLETED|Overall Study||24
526753|NCT00851799|1287150|P2|NOT COMPLETED|Overall Study||13
526754|NCT00851799|1287151|P1|NOT COMPLETED|Overall Study||16
526755|NCT00851799|1287149|P3|COMPLETED|Overall Study||89
526756|NCT00851799|1287150|P2|COMPLETED|Overall Study||93
526757|NCT00851799|1287151|P1|COMPLETED|Overall Study||93
526758|NCT00851799|1287149|P3|STARTED|Overall Study||113
526759|NCT00851799|1287150|P2|STARTED|Overall Study||106
526760|NCT00851799|1287151|P1|STARTED|Overall Study||109
526761|NCT00851786|1287239|P2|NOT COMPLETED|Overall Study||2
526762|NCT00851786|1287240|P1|NOT COMPLETED|Overall Study||5
526763|NCT00851786|1287239|P2|COMPLETED|Overall Study||97
526764|NCT00851786|1287240|P1|COMPLETED|Overall Study||291
526765|NCT00851786|1287239|P2|STARTED|Overall Study|Two subjects (one found ineligible and one withdrew consent) were off study with no vaccine.|99
526766|NCT00851786|1287240|P1|STARTED|Overall Study|One subject cannot adhere to protocol requirement and was off study with no vaccine.|296
526767|NCT00851747|1287253|P3|NOT COMPLETED|Overall Study||6
526768|NCT00851747|1287254|P2|NOT COMPLETED|Overall Study||6
526769|NCT00851747|1287255|P1|NOT COMPLETED|Overall Study||6
526770|NCT00851747|1287253|P3|COMPLETED|Overall Study||0
526771|NCT00851747|1287254|P2|COMPLETED|Overall Study||0
526772|NCT00851747|1287255|P1|COMPLETED|Overall Study||0
526773|NCT00851747|1287253|P3|STARTED|Overall Study||6
526774|NCT00851747|1287254|P2|STARTED|Overall Study||6
526775|NCT00851747|1287255|P1|STARTED|Overall Study||6
526776|NCT00851721|1287264|P2|NOT COMPLETED|Overall Study||1
526777|NCT00851721|1287265|P1|NOT COMPLETED|Overall Study||2
526778|NCT00851721|1287264|P2|COMPLETED|Overall Study||16
526779|NCT00851721|1287265|P1|COMPLETED|Overall Study||17
526780|NCT00851721|1287264|P2|STARTED|Overall Study||17
526781|NCT00851721|1287265|P1|STARTED|Overall Study||19
526782|NCT00851682|1287355|P2|NOT COMPLETED|Overall Study||0
526783|NCT00851682|1287356|P1|NOT COMPLETED|Overall Study||5
526784|NCT00851682|1287355|P2|COMPLETED|Overall Study||5
526785|NCT00851682|1287356|P1|COMPLETED|Overall Study||55
526786|NCT00851682|1287355|P2|STARTED|Overall Study||5
526787|NCT00851682|1287356|P1|STARTED|Overall Study||60
526788|NCT00851643|1287370|P6|NOT COMPLETED|Extension Study (Up to 36 Months)||1
526789|NCT00851643|1287371|P5|NOT COMPLETED|Extension Study (Up to 36 Months)||2
526790|NCT00851643|1287372|P4|NOT COMPLETED|Extension Study (Up to 36 Months)||2
526791|NCT00851643|1287373|P3|NOT COMPLETED|Extension Study (Up to 36 Months)||5
526792|NCT00851643|1287374|P2|NOT COMPLETED|Extension Study (Up to 36 Months)||4
526793|NCT00851643|1287375|P1|NOT COMPLETED|Extension Study (Up to 36 Months)||4
526794|NCT00851643|1287370|P6|COMPLETED|Extension Study (Up to 36 Months)||14
526795|NCT00851643|1287371|P5|COMPLETED|Extension Study (Up to 36 Months)||19
526796|NCT00851643|1287372|P4|COMPLETED|Extension Study (Up to 36 Months)||5
526797|NCT00851643|1287373|P3|COMPLETED|Extension Study (Up to 36 Months)||14
526798|NCT00851643|1287374|P2|COMPLETED|Extension Study (Up to 36 Months)||15
526799|NCT00851643|1287375|P1|COMPLETED|Extension Study (Up to 36 Months)||6
526800|NCT00851643|1287370|P6|STARTED|Extension Study (Up to 36 Months)||15
526801|NCT00851643|1287371|P5|STARTED|Extension Study (Up to 36 Months)||21
526802|NCT00851643|1287372|P4|STARTED|Extension Study (Up to 36 Months)||7
526803|NCT00851643|1287373|P3|STARTED|Extension Study (Up to 36 Months)||19
526804|NCT00851643|1287374|P2|STARTED|Extension Study (Up to 36 Months)||19
526805|NCT00851643|1287375|P1|STARTED|Extension Study (Up to 36 Months)||10
526806|NCT00851643|1287370|P6|NOT COMPLETED|Base Study (Up to 12 Months)||1
526807|NCT00851643|1287371|P5|NOT COMPLETED|Base Study (Up to 12 Months)||0
526808|NCT00851643|1287372|P4|NOT COMPLETED|Base Study (Up to 12 Months)||0
526809|NCT00851643|1287373|P3|NOT COMPLETED|Base Study (Up to 12 Months)||0
526810|NCT00851643|1287374|P2|NOT COMPLETED|Base Study (Up to 12 Months)||0
526811|NCT00851643|1287375|P1|NOT COMPLETED|Base Study (Up to 12 Months)||1
526812|NCT00851643|1287370|P6|COMPLETED|Base Study (Up to 12 Months)||29
526813|NCT00851643|1287371|P5|COMPLETED|Base Study (Up to 12 Months)||30
526814|NCT00851643|1287372|P4|COMPLETED|Base Study (Up to 12 Months)||15
526815|NCT00851643|1287373|P3|COMPLETED|Base Study (Up to 12 Months)||30
526816|NCT00851643|1287374|P2|COMPLETED|Base Study (Up to 12 Months)||30
526817|NCT00851643|1287375|P1|COMPLETED|Base Study (Up to 12 Months)||14
526818|NCT00851643|1287370|P6|STARTED|Base Study (Up to 12 Months)||30
526819|NCT00851643|1287371|P5|STARTED|Base Study (Up to 12 Months)||30
526820|NCT00851643|1287372|P4|STARTED|Base Study (Up to 12 Months)||15
526821|NCT00851643|1287373|P3|STARTED|Base Study (Up to 12 Months)||30
526822|NCT00851643|1287374|P2|STARTED|Base Study (Up to 12 Months)||30
526823|NCT00851643|1287375|P1|STARTED|Base Study (Up to 12 Months)||15
526824|NCT00851630|1287396|P2|NOT COMPLETED|Overall Study||2
526825|NCT00851630|1287397|P1|NOT COMPLETED|Overall Study||2
526826|NCT00851630|1287396|P2|COMPLETED|Overall Study||33
526827|NCT00851630|1287397|P1|COMPLETED|Overall Study||33
526828|NCT00851630|1287396|P2|STARTED|Overall Study||35
526829|NCT00851630|1287397|P1|STARTED|Overall Study||35
526830|NCT00851591|1287411|P2|NOT COMPLETED|Overall Study||0
526831|NCT00851591|1287412|P1|NOT COMPLETED|Overall Study||2
526832|NCT00851591|1287411|P2|COMPLETED|Overall Study||1
526833|NCT00851591|1287412|P1|COMPLETED|Overall Study||0
526834|NCT00851591|1287411|P2|STARTED|Overall Study|One received treatment.|1
526835|NCT00851591|1287412|P1|STARTED|Overall Study|These 2 participants did not receive treatment.|2
526836|NCT00851552|1287418|P1|NOT COMPLETED|Overall Study||7
526837|NCT00851552|1287418|P1|COMPLETED|Overall Study||2
526838|NCT00851552|1287418|P1|STARTED|Overall Study||9
526839|NCT00851409|1287423|P1|NOT COMPLETED|Overall Study||0
526840|NCT00851409|1287423|P1|COMPLETED|Overall Study||25
526841|NCT00851409|1287423|P1|STARTED|Overall Study||25
526842|NCT00851318|1287432|P4|NOT COMPLETED|Overall Study||19
526843|NCT00851318|1287433|P3|NOT COMPLETED|Overall Study||21
526844|NCT00851318|1287434|P2|NOT COMPLETED|Overall Study||5
526845|NCT00851318|1287435|P1|NOT COMPLETED|Overall Study||30
526846|NCT00851318|1287432|P4|COMPLETED|Overall Study||73
526847|NCT00851318|1287433|P3|COMPLETED|Overall Study||72
526848|NCT00851318|1287434|P2|COMPLETED|Overall Study||14
526849|NCT00851318|1287435|P1|COMPLETED|Overall Study||51
526850|NCT00851318|1287432|P4|Completed Week 52|Overall Study||85
526851|NCT00851318|1287433|P3|Completed Week 52|Overall Study||87
526852|NCT00851318|1287434|P2|Completed Week 52|Overall Study||16
526853|NCT00851318|1287435|P1|Completed Week 52|Overall Study||64
526854|NCT00851318|1287432|P4|Completed Week 24|Overall Study||87
526855|NCT00851318|1287433|P3|Completed Week 24|Overall Study||90
526856|NCT00851318|1287434|P2|Completed Week 24|Overall Study||17
526857|NCT00851318|1287435|P1|Completed Week 24|Overall Study||69
526858|NCT00851318|1287432|P4|STARTED|Overall Study||92
526859|NCT00851318|1287433|P3|STARTED|Overall Study||93
526860|NCT00851318|1287434|P2|STARTED|Overall Study||19
526861|NCT00851318|1287435|P1|STARTED|Overall Study||81
526862|NCT00851279|1287465|P1|NOT COMPLETED|Overall Study||0
526863|NCT00851279|1287465|P1|COMPLETED|Overall Study||53
526864|NCT00851279|1287465|P1|STARTED|Overall Study||53
526865|NCT00851253|1287471|P2|NOT COMPLETED|Overall Study||0
526866|NCT00851253|1287472|P1|NOT COMPLETED|Overall Study||1
526867|NCT00851253|1287471|P2|COMPLETED|Overall Study||10
526868|NCT00851253|1287472|P1|COMPLETED|Overall Study||1
526869|NCT00851253|1287471|P2|STARTED|Overall Study||10
526870|NCT00851253|1287472|P1|STARTED|Overall Study||2
526871|NCT00851084|1287482|P2|NOT COMPLETED|Overall Study||119
526872|NCT00851084|1287483|P1|NOT COMPLETED|Overall Study||117
526873|NCT00851084|1287482|P2|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria.|0
526874|NCT00851084|1287483|P1|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria.|0
526875|NCT00851084|1287482|P2|STARTED|Overall Study||119
526876|NCT00851084|1287483|P1|STARTED|Overall Study||117
526877|NCT00851006|1287499|P2|NOT COMPLETED|Overall Study||0
526878|NCT00851006|1287500|P1|NOT COMPLETED|Overall Study||0
526879|NCT00851006|1287499|P2|COMPLETED|Overall Study||6
526880|NCT00851006|1287500|P1|COMPLETED|Overall Study||7
526881|NCT00851006|1287499|P2|STARTED|Overall Study||6
526882|NCT00851006|1287500|P1|STARTED|Overall Study||7
526883|NCT00850993|1287511|P4|NOT COMPLETED|Overall Study||0
526884|NCT00850993|1287512|P3|NOT COMPLETED|Overall Study||0
526885|NCT00850993|1287513|P2|NOT COMPLETED|Overall Study||1
526886|NCT00850993|1287514|P1|NOT COMPLETED|Overall Study||0
526887|NCT00850993|1287511|P4|COMPLETED|Overall Study||8
526888|NCT00850993|1287512|P3|COMPLETED|Overall Study||18
526889|NCT00850993|1287513|P2|COMPLETED|Overall Study||16
526890|NCT00850993|1287514|P1|COMPLETED|Overall Study||15
526891|NCT00850993|1287511|P4|STARTED|Overall Study||8
526892|NCT00850993|1287512|P3|STARTED|Overall Study||18
526893|NCT00850993|1287513|P2|STARTED|Overall Study||17
526894|NCT00850993|1287514|P1|STARTED|Overall Study||15
526895|NCT00850889|1287528|P1|NOT COMPLETED|Overall Study||0
526896|NCT00850889|1287528|P1|COMPLETED|Overall Study||32
526897|NCT00850889|1287528|P1|STARTED|Overall Study||32
526898|NCT00850759|1287543|P4|NOT COMPLETED|Overall Study||3
526899|NCT00850759|1287544|P3|NOT COMPLETED|Overall Study||5
526900|NCT00850759|1287545|P2|NOT COMPLETED|Overall Study||5
526901|NCT00850759|1287546|P1|NOT COMPLETED|Overall Study||7
526902|NCT00850759|1287543|P4|COMPLETED|Overall Study||55
526903|NCT00850759|1287544|P3|COMPLETED|Overall Study||52
526904|NCT00850759|1287545|P2|COMPLETED|Overall Study||52
526905|NCT00850759|1287546|P1|COMPLETED|Overall Study||52
526906|NCT00850759|1287543|P4|STARTED|Overall Study||58
526907|NCT00850759|1287544|P3|STARTED|Overall Study||57
526908|NCT00850759|1287545|P2|STARTED|Overall Study||57
526909|NCT00850759|1287546|P1|STARTED|Overall Study||59
526910|NCT00850720|1287556|P1|NOT COMPLETED|Overall Study||0
526911|NCT00850720|1287556|P1|COMPLETED|Overall Study||0
526912|NCT00850720|1287556|P1|STARTED|Overall Study||0
526913|NCT00850642|1287562|P2|NOT COMPLETED|Overall Study||0
526914|NCT00850642|1287563|P1|NOT COMPLETED|Overall Study||0
526915|NCT00850642|1287562|P2|COMPLETED|Overall Study||4
526916|NCT00850642|1287563|P1|COMPLETED|Overall Study||3
526917|NCT00850642|1287562|P2|STARTED|Overall Study||4
526918|NCT00850642|1287563|P1|STARTED|Overall Study||3
526919|NCT00850603|1287601|P5|NOT COMPLETED|Overall Study||0
526920|NCT00850603|1287602|P4|NOT COMPLETED|Overall Study||0
526921|NCT00850603|1287603|P3|NOT COMPLETED|Overall Study||0
526922|NCT00850603|1287604|P2|NOT COMPLETED|Overall Study||0
526923|NCT00850603|1287605|P1|NOT COMPLETED|Overall Study||0
526924|NCT00850603|1287601|P5|COMPLETED|Overall Study||34
526925|NCT00850603|1287602|P4|COMPLETED|Overall Study||34
526926|NCT00850603|1287603|P3|COMPLETED|Overall Study||34
526927|NCT00850603|1287604|P2|COMPLETED|Overall Study||34
526928|NCT00850603|1287605|P1|COMPLETED|Overall Study||34
526929|NCT00850603|1287601|P5|STARTED|Overall Study||34
526930|NCT00850603|1287602|P4|STARTED|Overall Study||34
526931|NCT00850603|1287603|P3|STARTED|Overall Study||34
526932|NCT00850603|1287604|P2|STARTED|Overall Study||34
526933|NCT00850603|1287605|P1|STARTED|Overall Study||34
526934|NCT00850564|1287627|P1|NOT COMPLETED|Overall Study||2
526935|NCT00850564|1287627|P1|COMPLETED|Overall Study||13
526936|NCT00850564|1287627|P1|STARTED|Overall Study||15
526937|NCT00850538|1287632|P1|NOT COMPLETED|Overall Study||41
526938|NCT00850538|1287632|P1|COMPLETED|Overall Study||60
526939|NCT00850538|1287632|P1|STARTED|Overall Study||101
526940|NCT00850499|1287638|P2|NOT COMPLETED|Overall Study||2
526941|NCT00850499|1287639|P1|NOT COMPLETED|Overall Study||3
526942|NCT00850499|1287638|P2|COMPLETED|Overall Study||6
526943|NCT00850499|1287639|P1|COMPLETED|Overall Study||1
526944|NCT00850499|1287638|P2|STARTED|Overall Study||8
526945|NCT00850499|1287639|P1|STARTED|Overall Study||4
526946|NCT00850460|1287649|P2|NOT COMPLETED|Overall Study||4
526947|NCT00850460|1287650|P1|NOT COMPLETED|Overall Study||4
526948|NCT00850460|1287649|P2|COMPLETED|Overall Study||3
526949|NCT00850460|1287650|P1|COMPLETED|Overall Study||3
526950|NCT00850460|1287649|P2|Completion - Week 8|Overall Study||3
526951|NCT00850460|1287650|P1|Completion - Week 8|Overall Study||3
526952|NCT00850460|1287649|P2|Started - Week 0|Overall Study||7
526953|NCT00850460|1287650|P1|Started - Week 0|Overall Study||7
526954|NCT00850460|1287649|P2|STARTED|Overall Study||7
526955|NCT00850460|1287650|P1|STARTED|Overall Study||7
526956|NCT00850421|1287658|P1|NOT COMPLETED|Overall Study||17
526957|NCT00850421|1287658|P1|COMPLETED|Overall Study||18
526958|NCT00850421|1287658|P1|STARTED|Overall Study||35
526959|NCT00850395|1287662|P1|NOT COMPLETED|Overall Study||10
526960|NCT00850395|1287662|P1|COMPLETED|Overall Study||69
526961|NCT00850395|1287662|P1|STARTED|Overall Study||79
526962|NCT00850343|1287682|P4|NOT COMPLETED|Overall Study||13
526963|NCT00850343|1287683|P3|NOT COMPLETED|Overall Study||14
526964|NCT00850343|1287684|P2|NOT COMPLETED|Overall Study||3
526965|NCT00850343|1287685|P1|NOT COMPLETED|Overall Study||46
526966|NCT00850343|1287682|P4|COMPLETED|Overall Study||30
526967|NCT00850343|1287683|P3|COMPLETED|Overall Study||29
526968|NCT00850343|1287684|P2|COMPLETED|Overall Study||9
526969|NCT00850343|1287685|P1|COMPLETED|Overall Study||64
526970|NCT00850343|1287682|P4|Completed Week 52|Overall Study||37
526971|NCT00850343|1287683|P3|Completed Week 52|Overall Study||37
526972|NCT00850343|1287684|P2|Completed Week 52|Overall Study||11
526973|NCT00850343|1287685|P1|Completed Week 52|Overall Study||88
526974|NCT00850343|1287682|P4|Completed Week 24|Overall Study||39
526975|NCT00850343|1287683|P3|Completed Week 24|Overall Study||39
526976|NCT00850343|1287684|P2|Completed Week 24|Overall Study||12
526977|NCT00850343|1287685|P1|Completed Week 24|Overall Study||94
526978|NCT00850343|1287682|P4|STARTED|Overall Study||43
526979|NCT00850343|1287683|P3|STARTED|Overall Study||43
526980|NCT00850343|1287684|P2|STARTED|Overall Study||12
526981|NCT00850343|1287685|P1|STARTED|Overall Study||110
526982|NCT00850200|1287715|P1|NOT COMPLETED|Overall Study||1
526983|NCT00850200|1287715|P1|COMPLETED|Overall Study||19
526984|NCT00850200|1287715|P1|STARTED|Overall Study||20
526985|NCT00850174|1287723|P2|NOT COMPLETED|Second Intervention||0
526986|NCT00850174|1287724|P1|NOT COMPLETED|Second Intervention||1
526987|NCT00850174|1287723|P2|COMPLETED|Second Intervention||28
526988|NCT00850174|1287724|P1|COMPLETED|Second Intervention||29
526989|NCT00850174|1287723|P2|STARTED|Second Intervention||28
526990|NCT00850174|1287724|P1|STARTED|Second Intervention||30
526991|NCT00850174|1287723|P2|NOT COMPLETED|Washout: One Week||2
526992|NCT00850174|1287724|P1|NOT COMPLETED|Washout: One Week||0
526993|NCT00850174|1287723|P2|COMPLETED|Washout: One Week||28
526994|NCT00850174|1287724|P1|COMPLETED|Washout: One Week||30
526995|NCT00850174|1287723|P2|STARTED|Washout: One Week||30
526996|NCT00850174|1287724|P1|STARTED|Washout: One Week||30
526997|NCT00850174|1287723|P2|NOT COMPLETED|First Intervention||0
526998|NCT00850174|1287724|P1|NOT COMPLETED|First Intervention||0
526999|NCT00850174|1287723|P2|COMPLETED|First Intervention||30
527000|NCT00850174|1287724|P1|COMPLETED|First Intervention||30
527001|NCT00850174|1287723|P2|STARTED|First Intervention||30
527002|NCT00850174|1287724|P1|STARTED|First Intervention||30
527003|NCT00850135|1287738|P1|NOT COMPLETED|Overall Study||1
527004|NCT00850135|1287738|P1|COMPLETED|Overall Study||56
527005|NCT00850135|1287738|P1|STARTED|Overall Study||57
527006|NCT00850096|1287746|P2|NOT COMPLETED|Overall Study||2
527007|NCT00850096|1287747|P1|NOT COMPLETED|Overall Study||3
527008|NCT00850096|1287746|P2|COMPLETED|Overall Study||45
527009|NCT00850096|1287747|P1|COMPLETED|Overall Study||44
527010|NCT00850096|1287746|P2|STARTED|Overall Study||47
527011|NCT00850096|1287747|P1|STARTED|Overall Study||47
527012|NCT00850070|1287757|P2|NOT COMPLETED|Overall Study||1
527013|NCT00850070|1287758|P1|NOT COMPLETED|Overall Study||3
527014|NCT00850070|1287757|P2|COMPLETED|Overall Study||22
527015|NCT00850070|1287758|P1|COMPLETED|Overall Study||20
527016|NCT00850070|1287757|P2|STARTED|Overall Study||23
527017|NCT00850070|1287758|P1|STARTED|Overall Study||23
527018|NCT00850031|1287782|P1|NOT COMPLETED|Overall Study||17
527019|NCT00850031|1287782|P1|COMPLETED|Overall Study||101
527020|NCT00850031|1287782|P1|STARTED|Overall Study||118
527021|NCT00849940|1287787|P1|NOT COMPLETED|Overall Study||4
527022|NCT00849940|1287787|P1|COMPLETED|Overall Study||68
527023|NCT00849940|1287787|P1|STARTED|Overall Study||72
527024|NCT00849901|1287798|P3|NOT COMPLETED|Extension Phase||17
527025|NCT00849901|1287799|P2|NOT COMPLETED|Extension Phase||26
527026|NCT00849901|1287800|P1|NOT COMPLETED|Extension Phase||27
527027|NCT00849901|1287798|P3|COMPLETED|Extension Phase||69
527028|NCT00849901|1287799|P2|COMPLETED|Extension Phase||65
527029|NCT00849901|1287800|P1|COMPLETED|Extension Phase||56
527030|NCT00849901|1287798|P3|STARTED|Extension Phase||86
527031|NCT00849901|1287799|P2|STARTED|Extension Phase||91
527032|NCT00849901|1287800|P1|STARTED|Extension Phase||83
527033|NCT00849901|1287798|P3|NOT COMPLETED|Acute Treatment Phase||16
527034|NCT00849901|1287799|P2|NOT COMPLETED|Acute Treatment Phase||26
527035|NCT00849901|1287800|P1|NOT COMPLETED|Acute Treatment Phase||30
527036|NCT00849901|1287798|P3|COMPLETED|Acute Treatment Phase|1 didn't enter extension phase.|87
527037|NCT00849901|1287799|P2|COMPLETED|Acute Treatment Phase||91
527038|NCT00849901|1287800|P1|COMPLETED|Acute Treatment Phase|4 didn't enter extension phase.|87
527039|NCT00849901|1287798|P3|STARTED|Acute Treatment Phase||103
527040|NCT00849901|1287799|P2|STARTED|Acute Treatment Phase||117
527041|NCT00849901|1287800|P1|STARTED|Acute Treatment Phase||117
527042|NCT00849875|1287847|P1|NOT COMPLETED|Overall Study||47
527043|NCT00849875|1287847|P1|COMPLETED|Overall Study||1
527044|NCT00849875|1287847|P1|STARTED|Overall Study||48
527045|NCT00849862|1287929|P2|NOT COMPLETED|Second Intervention||0
527046|NCT00849862|1287930|P1|NOT COMPLETED|Second Intervention||0
527047|NCT00849862|1287929|P2|COMPLETED|Second Intervention||11
527048|NCT00849862|1287930|P1|COMPLETED|Second Intervention||11
527049|NCT00849862|1287929|P2|STARTED|Second Intervention||11
527050|NCT00849862|1287930|P1|STARTED|Second Intervention||11
527051|NCT00849862|1287929|P2|NOT COMPLETED|Washout: 7 Days||0
527052|NCT00849862|1287930|P1|NOT COMPLETED|Washout: 7 Days||0
527053|NCT00849862|1287929|P2|COMPLETED|Washout: 7 Days||11
527054|NCT00849862|1287930|P1|COMPLETED|Washout: 7 Days||11
527055|NCT00849862|1287929|P2|STARTED|Washout: 7 Days||11
527056|NCT00849862|1287930|P1|STARTED|Washout: 7 Days||11
527057|NCT00849862|1287929|P2|NOT COMPLETED|First Intervention||0
527058|NCT00849862|1287930|P1|NOT COMPLETED|First Intervention||0
527059|NCT00849862|1287929|P2|COMPLETED|First Intervention||11
527060|NCT00849862|1287930|P1|COMPLETED|First Intervention||11
527061|NCT00849862|1287929|P2|STARTED|First Intervention||11
527062|NCT00849862|1287930|P1|STARTED|First Intervention||11
527063|NCT00849810|1287938|P1|NOT COMPLETED|Overall Study||0
527064|NCT00849810|1287938|P1|COMPLETED|Overall Study||1
527065|NCT00849810|1287938|P1|STARTED|Overall Study||1
527066|NCT00849797|1287944|P2|NOT COMPLETED|Second Intervention||0
527067|NCT00849797|1287945|P1|NOT COMPLETED|Second Intervention||0
527068|NCT00849797|1287944|P2|COMPLETED|Second Intervention||57
527069|NCT00849797|1287945|P1|COMPLETED|Second Intervention||59
527070|NCT00849797|1287944|P2|STARTED|Second Intervention||57
527071|NCT00849797|1287945|P1|STARTED|Second Intervention||59
527072|NCT00849797|1287944|P2|NOT COMPLETED|Washout: One Week||2
527073|NCT00849797|1287945|P1|NOT COMPLETED|Washout: One Week||0
527074|NCT00849797|1287944|P2|COMPLETED|Washout: One Week||57
527075|NCT00849797|1287945|P1|COMPLETED|Washout: One Week||59
527076|NCT00849797|1287944|P2|STARTED|Washout: One Week||59
527077|NCT00849797|1287945|P1|STARTED|Washout: One Week||59
527078|NCT00849797|1287944|P2|NOT COMPLETED|First Intervention||1
527079|NCT00849797|1287945|P1|NOT COMPLETED|First Intervention||1
527080|NCT00849797|1287944|P2|COMPLETED|First Intervention||59
527081|NCT00849797|1287945|P1|COMPLETED|First Intervention||59
527082|NCT00849797|1287944|P2|STARTED|First Intervention||60
527083|NCT00849797|1287945|P1|STARTED|First Intervention||60
527084|NCT00849693|1287963|P4|NOT COMPLETED|Extension Phase||38
527085|NCT00849693|1287964|P3|NOT COMPLETED|Extension Phase||35
527086|NCT00849693|1287965|P2|NOT COMPLETED|Extension Phase||30
527087|NCT00849693|1287966|P1|NOT COMPLETED|Extension Phase||30
527088|NCT00849693|1287963|P4|COMPLETED|Extension Phase||44
527089|NCT00849693|1287964|P3|COMPLETED|Extension Phase||49
527090|NCT00849693|1287965|P2|COMPLETED|Extension Phase||50
527091|NCT00849693|1287966|P1|COMPLETED|Extension Phase||43
527092|NCT00849693|1287963|P4|STARTED|Extension Phase||82
527093|NCT00849693|1287964|P3|STARTED|Extension Phase||84
527094|NCT00849693|1287965|P2|STARTED|Extension Phase||80
527095|NCT00849693|1287966|P1|STARTED|Extension Phase||73
527096|NCT00849693|1287963|P4|NOT COMPLETED|Acute Treatment Phase||37
527097|NCT00849693|1287964|P3|NOT COMPLETED|Acute Treatment Phase||33
527098|NCT00849693|1287965|P2|NOT COMPLETED|Acute Treatment Phase||35
527099|NCT00849693|1287966|P1|NOT COMPLETED|Acute Treatment Phase||33
527100|NCT00849693|1287963|P4|COMPLETED|Acute Treatment Phase|3 didn't enter extension phase|85
527101|NCT00849693|1287964|P3|COMPLETED|Acute Treatment Phase||84
527102|NCT00849693|1287965|P2|COMPLETED|Acute Treatment Phase|1 didn't enter extension phase|81
527103|NCT00849693|1287966|P1|COMPLETED|Acute Treatment Phase|2 didn't enter extension phase.|75
527104|NCT00849693|1287963|P4|STARTED|Acute Treatment Phase||122
527105|NCT00849693|1287964|P3|STARTED|Acute Treatment Phase||117
527106|NCT00849693|1287965|P2|STARTED|Acute Treatment Phase||116
527107|NCT00849693|1287966|P1|STARTED|Acute Treatment Phase||108
527108|NCT00849680|1288033|P8|NOT COMPLETED|Overall Study||8
527109|NCT00849680|1288034|P7|NOT COMPLETED|Overall Study||17
527110|NCT00849680|1288035|P6|NOT COMPLETED|Overall Study||15
527111|NCT00849680|1288036|P5|NOT COMPLETED|Overall Study||10
527112|NCT00849680|1288037|P4|NOT COMPLETED|Overall Study||14
527113|NCT00849680|1288038|P3|NOT COMPLETED|Overall Study||15
527114|NCT00849680|1288039|P2|NOT COMPLETED|Overall Study||3
527115|NCT00849680|1288040|P1|NOT COMPLETED|Overall Study||11
527116|NCT00849680|1288033|P8|COMPLETED|Overall Study||23
527117|NCT00849680|1288034|P7|COMPLETED|Overall Study||61
527118|NCT00849680|1288035|P6|COMPLETED|Overall Study||27
527119|NCT00849680|1288036|P5|COMPLETED|Overall Study||32
527120|NCT00849680|1288037|P4|COMPLETED|Overall Study||28
527121|NCT00849680|1288038|P3|COMPLETED|Overall Study||27
527122|NCT00849680|1288039|P2|COMPLETED|Overall Study||10
527123|NCT00849680|1288040|P1|COMPLETED|Overall Study||16
527124|NCT00849680|1288033|P8|STARTED|Overall Study||31
527125|NCT00849680|1288034|P7|STARTED|Overall Study||78
527126|NCT00849680|1288035|P6|STARTED|Overall Study||42
527127|NCT00849680|1288036|P5|STARTED|Overall Study||42
527128|NCT00849680|1288037|P4|STARTED|Overall Study||42
527129|NCT00849680|1288038|P3|STARTED|Overall Study||42
527130|NCT00849680|1288039|P2|STARTED|Overall Study||13
527131|NCT00849680|1288040|P1|STARTED|Overall Study||27
527132|NCT00849524|1288082|P1|NOT COMPLETED|Overall Study||3
527133|NCT00849524|1288082|P1|COMPLETED|Overall Study||3
527134|NCT00849524|1288082|P1|STARTED|Overall Study||6
527135|NCT00849485|1288090|P2|NOT COMPLETED|Second Intervention||0
527136|NCT00849485|1288091|P1|NOT COMPLETED|Second Intervention||0
527137|NCT00849485|1288090|P2|COMPLETED|Second Intervention||11
527138|NCT00849485|1288091|P1|COMPLETED|Second Intervention||11
527139|NCT00849485|1288090|P2|STARTED|Second Intervention||11
527140|NCT00849485|1288091|P1|STARTED|Second Intervention||11
527141|NCT00849485|1288090|P2|NOT COMPLETED|Washout: 7 Days||0
527142|NCT00849485|1288091|P1|NOT COMPLETED|Washout: 7 Days||0
527143|NCT00849485|1288090|P2|COMPLETED|Washout: 7 Days||11
527144|NCT00849485|1288091|P1|COMPLETED|Washout: 7 Days||11
527145|NCT00849485|1288090|P2|STARTED|Washout: 7 Days||11
527146|NCT00849485|1288091|P1|STARTED|Washout: 7 Days||11
527147|NCT00849485|1288090|P2|NOT COMPLETED|First Intervention||0
527148|NCT00849485|1288091|P1|NOT COMPLETED|First Intervention||0
527149|NCT00849485|1288090|P2|COMPLETED|First Intervention||11
527150|NCT00849485|1288091|P1|COMPLETED|First Intervention||11
527151|NCT00849485|1288090|P2|STARTED|First Intervention||11
527152|NCT00849485|1288091|P1|STARTED|First Intervention||11
527153|NCT00849472|1288099|P1|NOT COMPLETED|Pazopanib Postsurgery Treatment||26
527154|NCT00849472|1288099|P1|COMPLETED|Pazopanib Postsurgery Treatment||16
527155|NCT00849472|1288099|P1|STARTED|Pazopanib Postsurgery Treatment|36 participants completed PPT; 7 participants who discontinued PPT resumed treatment postsurgery.|42
527156|NCT00849472|1288099|P1|NOT COMPLETED|Pazopanib Presurgery Treatment (PPT)||58
527157|NCT00849472|1288099|P1|COMPLETED|Pazopanib Presurgery Treatment (PPT)||36
527158|NCT00849472|1288099|P1|STARTED|Pazopanib Presurgery Treatment (PPT)||94
527159|NCT00849472|1288099|P1|NOT COMPLETED|Weekly Paclitaxel||16
527160|NCT00849472|1288099|P1|COMPLETED|Weekly Paclitaxel||78
527161|NCT00849472|1288099|P1|STARTED|Weekly Paclitaxel|One par. was deemed ineligible after completing AC therapy and did not start paclitaxel+pazopanib.|94
527162|NCT00849472|1288099|P1|NOT COMPLETED|Doxorubicin and Cyclophosphamide (AC)||6
527163|NCT00849472|1288099|P1|COMPLETED|Doxorubicin and Cyclophosphamide (AC)||95
527164|NCT00849472|1288099|P1|STARTED|Doxorubicin and Cyclophosphamide (AC)||101
527165|NCT00849381|1288113|P1|NOT COMPLETED|Overall Study||145
527166|NCT00849381|1288113|P1|COMPLETED|Overall Study|Out of the subjects who completed, 167 were enrolled at the center having compliance issues.|1092
527167|NCT00849381|1288113|P1|STARTED|Overall Study|Out of the subjects who started, 243 were enrolled at the center having compliance issues.|1237
527168|NCT00849290|1288119|P1|NOT COMPLETED|Overall Study||55
527169|NCT00849290|1288119|P1|COMPLETED|Overall Study||58
527170|NCT00849290|1288119|P1|STARTED|Overall Study||113
527171|NCT00849251|1288123|P2|NOT COMPLETED|Overall Study||1
527172|NCT00849251|1288124|P1|NOT COMPLETED|Overall Study||1
527173|NCT00849251|1288123|P2|COMPLETED|Overall Study||24
527174|NCT00849251|1288124|P1|COMPLETED|Overall Study||5
527175|NCT00849251|1288123|P2|STARTED|Overall Study||25
527176|NCT00849251|1288124|P1|STARTED|Overall Study||6
527177|NCT00849212|1288130|P1|NOT COMPLETED|Overall Study||7
527178|NCT00849212|1288130|P1|COMPLETED|Overall Study||23
527179|NCT00849212|1288130|P1|STARTED|Overall Study||30
527180|NCT00849186|1288135|P1|NOT COMPLETED|Overall Study||10
527181|NCT00849186|1288135|P1|COMPLETED|Overall Study||16
527182|NCT00849186|1288135|P1|STARTED|Overall Study||26
527183|NCT00849147|1288141|P1|NOT COMPLETED|Overall Study||5
527184|NCT00849147|1288141|P1|COMPLETED|Overall Study||50
527185|NCT00849147|1288141|P1|STARTED|Overall Study||55
527186|NCT00849121|1288158|P2|NOT COMPLETED|Overall Study||0
527187|NCT00849121|1288159|P1|NOT COMPLETED|Overall Study||0
527188|NCT00849121|1288158|P2|COMPLETED|Overall Study||9
527189|NCT00849121|1288159|P1|COMPLETED|Overall Study||8
527190|NCT00849121|1288158|P2|STARTED|Overall Study||9
527191|NCT00849121|1288159|P1|STARTED|Overall Study||8
527192|NCT00849108|1288174|P2|NOT COMPLETED|Cohort 2 Efficacy||10
527193|NCT00849108|1288175|P1|NOT COMPLETED|Cohort 2 Efficacy||0
527194|NCT00849108|1288174|P2|COMPLETED|Cohort 2 Efficacy||133
527195|NCT00849108|1288175|P1|COMPLETED|Cohort 2 Efficacy||0
527196|NCT00849108|1288174|P2|STARTED|Cohort 2 Efficacy||143
527197|NCT00849108|1288175|P1|STARTED|Cohort 2 Efficacy|Cohort 1 subjects did not participate in period 2: efficacy|0
527198|NCT00849108|1288174|P2|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0
527199|NCT00849108|1288175|P1|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||1
527200|NCT00849108|1288174|P2|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0
527201|NCT00849108|1288175|P1|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||32
527202|NCT00849108|1288174|P2|STARTED|Cohort 1 Dose Ranging and Dose Interval|Cohort 2(Pharm Stress) subjects did not participate in dose range, dose frequency|0
527203|NCT00849108|1288175|P1|STARTED|Cohort 1 Dose Ranging and Dose Interval||33
527204|NCT00849056|1288185|P2|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||25
527205|NCT00849056|1288186|P1|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||27
527206|NCT00849056|1288185|P2|COMPLETED|Follow-up Period (FUP) (8 Weeks)||124
527207|NCT00849056|1288186|P1|COMPLETED|Follow-up Period (FUP) (8 Weeks)||122
527208|NCT00849056|1288185|P2|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. One par. did not participate in the FUP.|149
527209|NCT00849056|1288186|P1|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Two par. did not participate in the FUP.|149
527210|NCT00849056|1288185|P2|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||50
527211|NCT00849056|1288186|P1|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||63
527212|NCT00849056|1288185|P2|COMPLETED|Treatment Period (TP) (156 Weeks)||100
527213|NCT00849056|1288186|P1|COMPLETED|Treatment Period (TP) (156 Weeks)||88
527214|NCT00849056|1288185|P2|STARTED|Treatment Period (TP) (156 Weeks)||150
527215|NCT00849056|1288186|P1|STARTED|Treatment Period (TP) (156 Weeks)||151
527216|NCT00849017|1288211|P3|NOT COMPLETED|Follow-up Period (8 Weeks)||25
527217|NCT00849017|1288212|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||18
527218|NCT00849017|1288213|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||25
527219|NCT00849017|1288211|P3|COMPLETED|Follow-up Period (8 Weeks)||74
527220|NCT00849017|1288212|P2|COMPLETED|Follow-up Period (8 Weeks)||83
527221|NCT00849017|1288213|P1|COMPLETED|Follow-up Period (8 Weeks)||76
527222|NCT00849017|1288211|P3|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|99
527223|NCT00849017|1288212|P2|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
527224|NCT00849017|1288213|P1|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
527225|NCT00849017|1288211|P3|NOT COMPLETED|Treatment Period (156 Weeks)||42
527226|NCT00849017|1288212|P2|NOT COMPLETED|Treatment Period (156 Weeks)||33
527227|NCT00849017|1288213|P1|NOT COMPLETED|Treatment Period (156 Weeks)||43
527228|NCT00849017|1288211|P3|COMPLETED|Treatment Period (156 Weeks)||57
527229|NCT00849017|1288212|P2|COMPLETED|Treatment Period (156 Weeks)||68
527230|NCT00849017|1288213|P1|COMPLETED|Treatment Period (156 Weeks)||58
527231|NCT00849017|1288211|P3|STARTED|Treatment Period (156 Weeks)||99
527232|NCT00849017|1288212|P2|STARTED|Treatment Period (156 Weeks)||101
527233|NCT00849017|1288213|P1|STARTED|Treatment Period (156 Weeks)||101
527234|NCT00848965|1288256|P1|NOT COMPLETED|Overall Study||2
527235|NCT00848965|1288256|P1|COMPLETED|Overall Study||57
527236|NCT00848965|1288256|P1|STARTED|Overall Study||59
527237|NCT00848926|1288298|P1|NOT COMPLETED|Follow-up Period||12
527238|NCT00848926|1288298|P1|COMPLETED|Follow-up Period|Completed survival follow-up due to death [57] or study termination by sponsor [33]|90
527239|NCT00848926|1288298|P1|STARTED|Follow-up Period|All participants were to be followed after treatment|102
527240|NCT00848926|1288298|P1|NOT COMPLETED|Treatment Period||84
527241|NCT00848926|1288298|P1|COMPLETED|Treatment Period|Number who completed 16 cycles of treatment|18
527242|NCT00848926|1288298|P1|STARTED|Treatment Period||102
527243|NCT00848783|1288317|P3|NOT COMPLETED|Overall Study||0
527244|NCT00848783|1288318|P2|NOT COMPLETED|Overall Study||2
527245|NCT00848783|1288319|P1|NOT COMPLETED|Overall Study||3
527246|NCT00848783|1288317|P3|COMPLETED|Overall Study||1
527247|NCT00848783|1288318|P2|COMPLETED|Overall Study||1
527248|NCT00848783|1288319|P1|COMPLETED|Overall Study||1
527249|NCT00848783|1288317|P3|STARTED|Overall Study||1
527250|NCT00848783|1288318|P2|STARTED|Overall Study||3
527251|NCT00848783|1288319|P1|STARTED|Overall Study||4
527252|NCT00848744|1288328|P1|NOT COMPLETED|Overall Study||0
527253|NCT00848744|1288328|P1|COMPLETED|Overall Study||10
527254|NCT00848744|1288328|P1|STARTED|Overall Study||10
527255|NCT00848549|1288337|P2|NOT COMPLETED|E2090-E044-314 (Extension Study)||24
527256|NCT00848549|1288338|P1|NOT COMPLETED|E2090-E044-314 (Extension Study)||17
527257|NCT00848549|1288337|P2|COMPLETED|E2090-E044-314 (Extension Study)||134
527258|NCT00848549|1288338|P1|COMPLETED|E2090-E044-314 (Extension Study)||120
527259|NCT00848549|1288337|P2|STARTED|E2090-E044-314 (Extension Study)||158
527260|NCT00848549|1288338|P1|STARTED|E2090-E044-314 (Extension Study)||137
527261|NCT00848549|1288337|P2|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||34
527262|NCT00848549|1288338|P1|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||24
527263|NCT00848549|1288337|P2|COMPLETED|E2090-E044-310 (Base Study) Transition||158
527264|NCT00848549|1288338|P1|COMPLETED|E2090-E044-310 (Base Study) Transition||137
527265|NCT00848549|1288337|P2|STARTED|E2090-E044-310 (Base Study) Transition||192
527266|NCT00848549|1288338|P1|STARTED|E2090-E044-310 (Base Study) Transition||161
527267|NCT00848549|1288337|P2|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||109
527268|NCT00848549|1288338|P1|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||121
527269|NCT00848549|1288337|P2|COMPLETED|E2090-E044-310 (Base Study) Disposition||192
527270|NCT00848549|1288338|P1|COMPLETED|E2090-E044-310 (Base Study) Disposition||161
527271|NCT00848549|1288337|P2|STARTED|E2090-E044-310 (Base Study) Disposition||301
527272|NCT00848549|1288338|P1|STARTED|E2090-E044-310 (Base Study) Disposition||282
527273|NCT00848536|1288356|P2|NOT COMPLETED|Overall Study||7
527274|NCT00848536|1288357|P1|NOT COMPLETED|Overall Study||4
527275|NCT00848536|1288356|P2|COMPLETED|Overall Study||179
527276|NCT00848536|1288357|P1|COMPLETED|Overall Study||181
527277|NCT00848536|1288356|P2|STARTED|Overall Study||186
527278|NCT00848536|1288357|P1|STARTED|Overall Study||185
527279|NCT00848510|1288371|P4|NOT COMPLETED|Overall Study||0
527280|NCT00848510|1288372|P3|NOT COMPLETED|Overall Study||0
527281|NCT00848510|1288373|P2|NOT COMPLETED|Overall Study||0
527282|NCT00848510|1288374|P1|NOT COMPLETED|Overall Study||0
527283|NCT00848510|1288371|P4|COMPLETED|Overall Study||10
527284|NCT00848510|1288372|P3|COMPLETED|Overall Study||8
527285|NCT00848510|1288373|P2|COMPLETED|Overall Study||13
527286|NCT00848510|1288374|P1|COMPLETED|Overall Study||10
527287|NCT00848510|1288371|P4|STARTED|Overall Study||10
527288|NCT00848510|1288372|P3|STARTED|Overall Study||8
527289|NCT00848510|1288373|P2|STARTED|Overall Study||13
527290|NCT00848510|1288374|P1|STARTED|Overall Study||10
527291|NCT00848497|1288422|P2|NOT COMPLETED|Overall Study||1
527292|NCT00848497|1288423|P1|NOT COMPLETED|Overall Study||2
527293|NCT00848497|1288422|P2|COMPLETED|Overall Study||0
527294|NCT00848497|1288423|P1|COMPLETED|Overall Study||0
527295|NCT00848497|1288422|P2|STARTED|Overall Study|Completed Visit 4|1
527296|NCT00848497|1288423|P1|STARTED|Overall Study||2
527297|NCT00848484|1288437|P2|NOT COMPLETED|Second Intervention (Treatment Period 2)||1
527298|NCT00848484|1288438|P1|NOT COMPLETED|Second Intervention (Treatment Period 2)||0
527299|NCT00848484|1288437|P2|COMPLETED|Second Intervention (Treatment Period 2)||20
527300|NCT00848484|1288438|P1|COMPLETED|Second Intervention (Treatment Period 2)||25
527301|NCT00848484|1288437|P2|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0
527302|NCT00848484|1288438|P1|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0
527303|NCT00848484|1288437|P2|STARTED|Second Intervention (Treatment Period 2)||21
527304|NCT00848484|1288438|P1|STARTED|Second Intervention (Treatment Period 2)||25
527305|NCT00848484|1288437|P2|NOT COMPLETED|Washout Period of Two Weeks||3
527306|NCT00848484|1288438|P1|NOT COMPLETED|Washout Period of Two Weeks||0
527307|NCT00848484|1288437|P2|COMPLETED|Washout Period of Two Weeks||21
527308|NCT00848484|1288438|P1|COMPLETED|Washout Period of Two Weeks||25
527309|NCT00848484|1288437|P2|STARTED|Washout Period of Two Weeks||24
527310|NCT00848484|1288438|P1|STARTED|Washout Period of Two Weeks||25
527311|NCT00848484|1288437|P2|NOT COMPLETED|First Intervention (Treatment Period 1)||3
527312|NCT00848484|1288438|P1|NOT COMPLETED|First Intervention (Treatment Period 1)||2
527313|NCT00848484|1288437|P2|COMPLETED|First Intervention (Treatment Period 1)||24
527314|NCT00848484|1288438|P1|COMPLETED|First Intervention (Treatment Period 1)||25
527315|NCT00848484|1288437|P2|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||1
527316|NCT00848484|1288438|P1|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||2
527317|NCT00848484|1288437|P2|STARTED|First Intervention (Treatment Period 1)||27
527318|NCT00848484|1288438|P1|STARTED|First Intervention (Treatment Period 1)||27
527319|NCT00848367|1288456|P2|NOT COMPLETED|Overall Study||9
527320|NCT00848367|1288457|P1|NOT COMPLETED|Overall Study||9
527321|NCT00848367|1288456|P2|COMPLETED|Overall Study||41
527322|NCT00848367|1288457|P1|COMPLETED|Overall Study||43
527323|NCT00848367|1288456|P2|STARTED|Overall Study||50
527324|NCT00848367|1288457|P1|STARTED|Overall Study||52
527325|NCT00848354|1288467|P2|NOT COMPLETED|Phase 2 Year 2||7
527326|NCT00848354|1288468|P1|NOT COMPLETED|Phase 2 Year 2||23
527327|NCT00848354|1288467|P2|COMPLETED|Phase 2 Year 2||113
527328|NCT00848354|1288468|P1|COMPLETED|Phase 2 Year 2||218
527329|NCT00848354|1288467|P2|STARTED|Phase 2 Year 2|Randomized Phase 1 treatment assignment.|120
527330|NCT00848354|1288468|P1|STARTED|Phase 2 Year 2|"Randomized Phase 1 treatment assignment.~1 participant discontinued between Year 1 and Year 2."|241
527331|NCT00848354|1288467|P2|NOT COMPLETED|Phase 2 Year 1||6
527332|NCT00848354|1288468|P1|NOT COMPLETED|Phase 2 Year 1||18
527333|NCT00848354|1288467|P2|COMPLETED|Phase 2 Year 1||120
527334|NCT00848354|1288468|P1|COMPLETED|Phase 2 Year 1||242
527335|NCT00848354|1288467|P2|STARTED|Phase 2 Year 1|Randomized Phase 1 treatment assignment. 3 participants discontinued between Phase 1 and Phase 2.|126
527336|NCT00848354|1288468|P1|STARTED|Phase 2 Year 1|Randomized Phase 1 treatment assignment. 9 participants discontinued between Phase 1 and Phase 2.|260
527337|NCT00848354|1288467|P2|NOT COMPLETED|Phase 1||14
527338|NCT00848354|1288468|P1|NOT COMPLETED|Phase 1||12
527339|NCT00848354|1288467|P2|COMPLETED|Phase 1||129
527340|NCT00848354|1288468|P1|COMPLETED|Phase 1||269
527341|NCT00848354|1288467|P2|STARTED|Phase 1||143
527342|NCT00848354|1288468|P1|STARTED|Phase 1|One participant was randomized to the Etanercept + Methotrexate group but received SSZ in error.|281
527343|NCT00848250|1288620|P2|NOT COMPLETED|Overall Study||1
527344|NCT00848250|1288621|P1|NOT COMPLETED|Overall Study||0
527345|NCT00848250|1288620|P2|COMPLETED|Overall Study||9
527346|NCT00848250|1288621|P1|COMPLETED|Overall Study||11
527347|NCT00848250|1288620|P2|STARTED|Overall Study||10
527348|NCT00848250|1288621|P1|STARTED|Overall Study||11
527349|NCT00848237|1288639|P1|NOT COMPLETED|Overall Study||539
527350|NCT00848237|1288639|P1|COMPLETED|Overall Study||4982
527351|NCT00848237|1288639|P1|STARTED|Overall Study||5521
527352|NCT00848211|1288652|P4|NOT COMPLETED|Overall Study||0
527353|NCT00848211|1288653|P3|NOT COMPLETED|Overall Study||1
527354|NCT00848211|1288654|P2|NOT COMPLETED|Overall Study||1
527355|NCT00848211|1288655|P1|NOT COMPLETED|Overall Study||0
527356|NCT00848211|1288652|P4|COMPLETED|Overall Study||5
527357|NCT00848211|1288653|P3|COMPLETED|Overall Study||5
527358|NCT00848211|1288654|P2|COMPLETED|Overall Study||6
527359|NCT00848211|1288655|P1|COMPLETED|Overall Study||6
527360|NCT00848211|1288652|P4|STARTED|Overall Study||5
527361|NCT00848211|1288653|P3|STARTED|Overall Study||6
527362|NCT00848211|1288654|P2|STARTED|Overall Study||7
527363|NCT00848211|1288655|P1|STARTED|Overall Study||6
527364|NCT00848198|1288673|P1|NOT COMPLETED|Overall Study||15
527365|NCT00848198|1288673|P1|COMPLETED|Overall Study||299
527366|NCT00848198|1288673|P1|STARTED|Overall Study||314
527367|NCT00848185|1288714|P3|NOT COMPLETED|Overall Study||0
527368|NCT00848185|1288715|P2|NOT COMPLETED|Overall Study||0
527369|NCT00848185|1288716|P1|NOT COMPLETED|Overall Study||0
527370|NCT00848185|1288714|P3|COMPLETED|Overall Study||32
527371|NCT00848185|1288715|P2|COMPLETED|Overall Study||32
527372|NCT00848185|1288716|P1|COMPLETED|Overall Study||32
527373|NCT00848185|1288714|P3|STARTED|Overall Study||32
527374|NCT00848185|1288715|P2|STARTED|Overall Study||32
527375|NCT00848185|1288716|P1|STARTED|Overall Study||32
527376|NCT00848172|1288726|P2|NOT COMPLETED|Visit 3 - Follow Up||0
527377|NCT00848172|1288727|P1|NOT COMPLETED|Visit 3 - Follow Up||0
527378|NCT00848172|1288726|P2|COMPLETED|Visit 3 - Follow Up||8
527379|NCT00848172|1288727|P1|COMPLETED|Visit 3 - Follow Up||10
527380|NCT00848172|1288726|P2|STARTED|Visit 3 - Follow Up||8
527381|NCT00848172|1288727|P1|STARTED|Visit 3 - Follow Up||10
527382|NCT00848172|1288726|P2|NOT COMPLETED|Visit 2 - Drug Administration||1
527383|NCT00848172|1288727|P1|NOT COMPLETED|Visit 2 - Drug Administration||0
527384|NCT00848172|1288726|P2|COMPLETED|Visit 2 - Drug Administration||8
527385|NCT00848172|1288727|P1|COMPLETED|Visit 2 - Drug Administration||10
527386|NCT00848172|1288726|P2|STARTED|Visit 2 - Drug Administration||9
527387|NCT00848172|1288727|P1|STARTED|Visit 2 - Drug Administration||10
527388|NCT00848120|1288738|P1|NOT COMPLETED|Overall Study||1
527389|NCT00848120|1288738|P1|COMPLETED|Overall Study||28
527390|NCT00848120|1288738|P1|STARTED|Overall Study||29
527391|NCT00848107|1288750|P1|NOT COMPLETED|Overall Study||21
527392|NCT00848107|1288750|P1|COMPLETED|Overall Study||94
527393|NCT00848107|1288750|P1|STARTED|Overall Study||115
527394|NCT00848081|1288760|P2|NOT COMPLETED|Overall Study||18
527395|NCT00848081|1288761|P1|NOT COMPLETED|Overall Study||20
527396|NCT00848081|1288760|P2|COMPLETED|Overall Study||140
527397|NCT00848081|1288761|P1|COMPLETED|Overall Study||140
527398|NCT00848081|1288760|P2|STARTED|Overall Study||158
527399|NCT00848081|1288761|P1|STARTED|Overall Study||160
527400|NCT00848042|1288778|P3|NOT COMPLETED|Overall Study||0
527401|NCT00848042|1288779|P2|NOT COMPLETED|Overall Study||2
527402|NCT00848042|1288780|P1|NOT COMPLETED|Overall Study||4
527403|NCT00848042|1288778|P3|COMPLETED|Overall Study||1
527404|NCT00848042|1288779|P2|COMPLETED|Overall Study||3
527405|NCT00848042|1288780|P1|COMPLETED|Overall Study||1
527406|NCT00848042|1288778|P3|Month 6|Overall Study||1
527407|NCT00848042|1288779|P2|Month 6|Overall Study||3
527408|NCT00848042|1288780|P1|Month 6|Overall Study||1
527409|NCT00848042|1288778|P3|Month 5|Overall Study||1
527410|NCT00848042|1288779|P2|Month 5|Overall Study||3
527411|NCT00848042|1288780|P1|Month 5|Overall Study||1
527412|NCT00848042|1288778|P3|Month 4|Overall Study||1
527413|NCT00848042|1288779|P2|Month 4|Overall Study||4
527414|NCT00848042|1288780|P1|Month 4|Overall Study||1
527415|NCT00848042|1288778|P3|Month 3|Overall Study||1
527416|NCT00848042|1288779|P2|Month 3|Overall Study||4
527417|NCT00848042|1288780|P1|Month 3|Overall Study||1
527418|NCT00848042|1288778|P3|Month 2|Overall Study||1
527419|NCT00848042|1288779|P2|Month 2|Overall Study||5
527420|NCT00848042|1288780|P1|Month 2|Overall Study||1
527421|NCT00848042|1288778|P3|Month 1|Overall Study||1
527422|NCT00848042|1288779|P2|Month 1|Overall Study||5
527423|NCT00848042|1288780|P1|Month 1|Overall Study||4
527424|NCT00848042|1288778|P3|Day 15|Overall Study||1
527425|NCT00848042|1288779|P2|Day 15|Overall Study||5
527426|NCT00848042|1288780|P1|Day 15|Overall Study||4
527427|NCT00848042|1288778|P3|Day 8|Overall Study||1
527428|NCT00848042|1288779|P2|Day 8|Overall Study||5
527429|NCT00848042|1288780|P1|Day 8|Overall Study||5
527430|NCT00848042|1288778|P3|Day 3|Overall Study||1
527431|NCT00848042|1288779|P2|Day 3|Overall Study||5
527432|NCT00848042|1288780|P1|Day 3|Overall Study||5
527433|NCT00848042|1288778|P3|Day 2|Overall Study||1
527434|NCT00848042|1288779|P2|Day 2|Overall Study||5
527435|NCT00848042|1288780|P1|Day 2|Overall Study||5
527436|NCT00848042|1288778|P3|Day 1|Overall Study||1
527437|NCT00848042|1288779|P2|Day 1|Overall Study||5
527438|NCT00848042|1288780|P1|Day 1|Overall Study||5
527439|NCT00848042|1288778|P3|STARTED|Overall Study||1
527440|NCT00848042|1288779|P2|STARTED|Overall Study||5
527441|NCT00848042|1288780|P1|STARTED|Overall Study||5
527442|NCT00848016|1288791|P1|NOT COMPLETED|Overall Study||0
527443|NCT00848016|1288791|P1|COMPLETED|Overall Study||29
527444|NCT00848016|1288791|P1|STARTED|Overall Study||29
527445|NCT00847912|1288799|P2|NOT COMPLETED|Overall Study||13
527446|NCT00847912|1288800|P1|NOT COMPLETED|Overall Study||9
527447|NCT00847912|1288799|P2|COMPLETED|Overall Study||464
527448|NCT00847912|1288800|P1|COMPLETED|Overall Study||468
527449|NCT00847912|1288799|P2|STARTED|Overall Study||477
527450|NCT00847912|1288800|P1|STARTED|Overall Study||477
527451|NCT00847886|1288810|P2|NOT COMPLETED|Overall Study||1
527452|NCT00847886|1288811|P1|NOT COMPLETED|Overall Study||0
527453|NCT00847886|1288810|P2|COMPLETED|Overall Study||3
527454|NCT00847886|1288811|P1|COMPLETED|Overall Study||12
527455|NCT00847886|1288810|P2|STARTED|Overall Study||4
527456|NCT00847886|1288811|P1|STARTED|Overall Study||12
527457|NCT00847808|1288837|P1|NOT COMPLETED|Overall Study||15
527458|NCT00847808|1288837|P1|COMPLETED|Overall Study||163
527459|NCT00847808|1288837|P1|STARTED|Overall Study||178
527460|NCT00847704|1288854|P1|NOT COMPLETED|Overall Study||1
527461|NCT00847704|1288854|P1|COMPLETED|Overall Study||2
527462|NCT00847704|1288854|P1|STARTED|Overall Study||3
527463|NCT00847665|1288865|P2|NOT COMPLETED|Overall Study||0
527464|NCT00847665|1288866|P1|NOT COMPLETED|Overall Study||1
527465|NCT00847665|1288865|P2|COMPLETED|Overall Study||165
527466|NCT00847665|1288866|P1|COMPLETED|Overall Study||164
527467|NCT00847665|1288865|P2|STARTED|Overall Study||165
527468|NCT00847665|1288866|P1|STARTED|Overall Study||165
527469|NCT00847626|1288889|P11|NOT COMPLETED|Overall Study||20
527470|NCT00847626|1288890|P10|NOT COMPLETED|Overall Study||14
527471|NCT00847626|1288891|P9|NOT COMPLETED|Overall Study||14
527472|NCT00847626|1288892|P8|NOT COMPLETED|Overall Study||19
527473|NCT00847626|1288893|P7|NOT COMPLETED|Overall Study||22
527474|NCT00847626|1288894|P6|NOT COMPLETED|Overall Study||37
527475|NCT00847626|1288895|P5|NOT COMPLETED|Overall Study||28
527476|NCT00847626|1288896|P4|NOT COMPLETED|Overall Study||31
527477|NCT00847626|1288897|P3|NOT COMPLETED|Overall Study||16
527478|NCT00847626|1288898|P2|NOT COMPLETED|Overall Study||23
527479|NCT00847626|1288899|P1|NOT COMPLETED|Overall Study||21
527480|NCT00847626|1288889|P11|COMPLETED|Overall Study||142
527481|NCT00847626|1288890|P10|COMPLETED|Overall Study||139
527482|NCT00847626|1288891|P9|COMPLETED|Overall Study||141
527483|NCT00847626|1288892|P8|COMPLETED|Overall Study||141
527484|NCT00847626|1288893|P7|COMPLETED|Overall Study||135
527485|NCT00847626|1288894|P6|COMPLETED|Overall Study||125
527486|NCT00847626|1288895|P5|COMPLETED|Overall Study||125
527487|NCT00847626|1288896|P4|COMPLETED|Overall Study||125
527488|NCT00847626|1288897|P3|COMPLETED|Overall Study||131
527489|NCT00847626|1288898|P2|COMPLETED|Overall Study||131
527490|NCT00847626|1288899|P1|COMPLETED|Overall Study||135
527491|NCT00847626|1288889|P11|STARTED|Overall Study||162
527492|NCT00847626|1288890|P10|STARTED|Overall Study||153
527493|NCT00847626|1288891|P9|STARTED|Overall Study||155
527494|NCT00847626|1288892|P8|STARTED|Overall Study|Includes participant who was treated with double-blind study medication but not randomized.|160
527495|NCT00847626|1288893|P7|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|157
527496|NCT00847626|1288894|P6|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|162
527497|NCT00847626|1288895|P5|STARTED|Overall Study||153
527498|NCT00847626|1288896|P4|STARTED|Overall Study||156
527499|NCT00847626|1288897|P3|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|147
527500|NCT00847626|1288898|P2|STARTED|Overall Study||154
527501|NCT00847626|1288899|P1|STARTED|Overall Study||156
527502|NCT00847613|1289098|P4|NOT COMPLETED|Overall Study||79
527503|NCT00847613|1289099|P3|NOT COMPLETED|Overall Study||81
527504|NCT00847613|1289100|P2|NOT COMPLETED|Overall Study||319
527505|NCT00847613|1289101|P1|NOT COMPLETED|Overall Study||321
527506|NCT00847613|1289098|P4|COMPLETED|Overall Study||0
527507|NCT00847613|1289099|P3|COMPLETED|Overall Study||0
527508|NCT00847613|1289100|P2|COMPLETED|Overall Study||0
527509|NCT00847613|1289101|P1|COMPLETED|Overall Study||0
527510|NCT00847613|1289098|P4|Treated|Overall Study||79
527511|NCT00847613|1289099|P3|Treated|Overall Study||81
527512|NCT00847613|1289100|P2|Treated|Overall Study||316
527513|NCT00847613|1289101|P1|Treated|Overall Study||321
527514|NCT00847613|1289098|P4|STARTED|Overall Study||79
527515|NCT00847613|1289099|P3|STARTED|Overall Study||81
527516|NCT00847613|1289100|P2|STARTED|Overall Study||319
527517|NCT00847613|1289101|P1|STARTED|Overall Study||321
527518|NCT00847587|1289341|P2|NOT COMPLETED|Overall Study||0
527519|NCT00847587|1289342|P1|NOT COMPLETED|Overall Study||1
527520|NCT00847587|1289341|P2|COMPLETED|Overall Study||34
527521|NCT00847587|1289342|P1|COMPLETED|Overall Study|Patient declined study after randomization.|34
527522|NCT00847587|1289341|P2|STARTED|Overall Study||34
527523|NCT00847587|1289342|P1|STARTED|Overall Study||35
527524|NCT00847561|1289352|P2|NOT COMPLETED|Overall Study||4
527525|NCT00847561|1289353|P1|NOT COMPLETED|Overall Study||13
527526|NCT00847561|1289352|P2|COMPLETED|Overall Study||62
527527|NCT00847561|1289353|P1|COMPLETED|Overall Study||57
527528|NCT00847561|1289352|P2|STARTED|Overall Study||66
527529|NCT00847561|1289353|P1|STARTED|Overall Study||70
527530|NCT00847535|1289359|P3|NOT COMPLETED|Overall Study||1
527531|NCT00847535|1289360|P2|NOT COMPLETED|Overall Study||2
527532|NCT00847535|1289361|P1|NOT COMPLETED|Overall Study||2
527533|NCT00847535|1289359|P3|COMPLETED|Overall Study||15
527534|NCT00847535|1289360|P2|COMPLETED|Overall Study||22
527535|NCT00847535|1289361|P1|COMPLETED|Overall Study||22
527536|NCT00847535|1289359|P3|200 Million AMDC|Overall Study||8
527537|NCT00847535|1289360|P2|200 Million AMDC|Overall Study||0
527538|NCT00847535|1289361|P1|200 Million AMDC|Overall Study||0
527539|NCT00847535|1289359|P3|100 Million AMDC|Overall Study||8
527540|NCT00847535|1289360|P2|100 Million AMDC|Overall Study||8
527541|NCT00847535|1289361|P1|100 Million AMDC|Overall Study||8
527542|NCT00847535|1289359|P3|50 Million AMDC|Overall Study||0
527543|NCT00847535|1289360|P2|50 Million AMDC|Overall Study||8
527544|NCT00847535|1289361|P1|50 Million AMDC|Overall Study||8
527545|NCT00847535|1289359|P3|10 Million AMDC|Overall Study||0
527546|NCT00847535|1289360|P2|10 Million AMDC|Overall Study||8
527547|NCT00847535|1289361|P1|10 Million AMDC|Overall Study||8
527548|NCT00847535|1289359|P3|STARTED|Overall Study||16
527549|NCT00847535|1289360|P2|STARTED|Overall Study||24
527550|NCT00847535|1289361|P1|STARTED|Overall Study||24
527551|NCT00847522|1289369|P1|NOT COMPLETED|Overall Study||0
527552|NCT00847522|1289369|P1|COMPLETED|Overall Study||90
527553|NCT00847522|1289369|P1|Phase II|Overall Study||80
527554|NCT00847522|1289369|P1|Phase I|Overall Study||10
527555|NCT00847522|1289369|P1|STARTED|Overall Study||90
527556|NCT00847509|1289374|P1|NOT COMPLETED|Overall Study||11
527557|NCT00847509|1289374|P1|COMPLETED|Overall Study||38
527558|NCT00847509|1289374|P1|STARTED|Overall Study||49
527559|NCT00847405|1289380|P2|NOT COMPLETED|Second Intervention||0
527560|NCT00847405|1289381|P1|NOT COMPLETED|Second Intervention||0
527561|NCT00847405|1289380|P2|COMPLETED|Second Intervention||13
527562|NCT00847405|1289381|P1|COMPLETED|Second Intervention||13
527563|NCT00847405|1289380|P2|STARTED|Second Intervention||13
527564|NCT00847405|1289381|P1|STARTED|Second Intervention||13
527565|NCT00847405|1289380|P2|NOT COMPLETED|Washout of 7 Days||0
527566|NCT00847405|1289381|P1|NOT COMPLETED|Washout of 7 Days||1
527567|NCT00847405|1289380|P2|COMPLETED|Washout of 7 Days||13
527568|NCT00847405|1289381|P1|COMPLETED|Washout of 7 Days||13
527569|NCT00847405|1289380|P2|STARTED|Washout of 7 Days||13
527570|NCT00847405|1289381|P1|STARTED|Washout of 7 Days||14
527571|NCT00847405|1289380|P2|NOT COMPLETED|First Intervention||1
527572|NCT00847405|1289381|P1|NOT COMPLETED|First Intervention||0
527573|NCT00847405|1289380|P2|COMPLETED|First Intervention||13
527574|NCT00847405|1289381|P1|COMPLETED|First Intervention||14
527575|NCT00847405|1289380|P2|STARTED|First Intervention||14
527576|NCT00847405|1289381|P1|STARTED|First Intervention||14
527577|NCT00847301|1289389|P1|NOT COMPLETED|Overall Study||54
527578|NCT00847301|1289389|P1|COMPLETED|Overall Study||374
527579|NCT00847301|1289389|P1|STARTED|Overall Study||428
527580|NCT00847288|1289399|P2|NOT COMPLETED|Overall Study||47
527581|NCT00847288|1289400|P1|NOT COMPLETED|Overall Study||30
527582|NCT00847288|1289399|P2|COMPLETED|Overall Study||780
527583|NCT00847288|1289400|P1|COMPLETED|Overall Study||811
527584|NCT00847288|1289399|P2|STARTED|Overall Study||827
527585|NCT00847288|1289400|P1|STARTED|Overall Study||841
527586|NCT00847210|1289414|P2|NOT COMPLETED|Overall Study||0
527587|NCT00847210|1289415|P1|NOT COMPLETED|Overall Study||0
527588|NCT00847210|1289414|P2|COMPLETED|Overall Study||18
527589|NCT00847210|1289415|P1|COMPLETED|Overall Study||18
527590|NCT00847210|1289414|P2|STARTED|Overall Study||18
527591|NCT00847210|1289415|P1|STARTED|Overall Study||18
527592|NCT00847197|1289437|P2|NOT COMPLETED|Overall Study||5
527593|NCT00847197|1289438|P1|NOT COMPLETED|Overall Study||24
527594|NCT00847197|1289437|P2|COMPLETED|Overall Study||70
527595|NCT00847197|1289438|P1|COMPLETED|Overall Study||92
527596|NCT00847197|1289437|P2|STARTED|Overall Study||75
527597|NCT00847197|1289438|P1|STARTED|Overall Study||116
527598|NCT00847145|1289456|P8|NOT COMPLETED|Overall Study||4
527599|NCT00847145|1289457|P7|NOT COMPLETED|Overall Study||9
527600|NCT00847145|1289458|P6|NOT COMPLETED|Overall Study||4
527601|NCT00847145|1289459|P5|NOT COMPLETED|Overall Study||6
527602|NCT00847145|1289460|P4|NOT COMPLETED|Overall Study||1
527603|NCT00847145|1289461|P3|NOT COMPLETED|Overall Study||11
527604|NCT00847145|1289462|P2|NOT COMPLETED|Overall Study||6
527605|NCT00847145|1289463|P1|NOT COMPLETED|Overall Study||6
527606|NCT00847145|1289456|P8|COMPLETED|Overall Study||136
527607|NCT00847145|1289457|P7|COMPLETED|Overall Study||143
527608|NCT00847145|1289458|P6|COMPLETED|Overall Study||152
527609|NCT00847145|1289459|P5|COMPLETED|Overall Study||131
527610|NCT00847145|1289460|P4|COMPLETED|Overall Study||116
527611|NCT00847145|1289461|P3|COMPLETED|Overall Study||274
527612|NCT00847145|1289462|P2|COMPLETED|Overall Study||627
527613|NCT00847145|1289463|P1|COMPLETED|Overall Study||623
527614|NCT00847145|1289456|P8|STARTED|Overall Study||140
527615|NCT00847145|1289457|P7|STARTED|Overall Study||152
527616|NCT00847145|1289458|P6|STARTED|Overall Study||156
527617|NCT00847145|1289459|P5|STARTED|Overall Study||137
527618|NCT00847145|1289460|P4|STARTED|Overall Study||117
527619|NCT00847145|1289461|P3|STARTED|Overall Study||285
527620|NCT00847145|1289462|P2|STARTED|Overall Study||633
527621|NCT00847145|1289463|P1|STARTED|Overall Study||629
527622|NCT00847132|1289513|P2|NOT COMPLETED|Overall Study||1
527623|NCT00847132|1289514|P1|NOT COMPLETED|Overall Study||1
527624|NCT00847132|1289513|P2|COMPLETED|Overall Study||84
527625|NCT00847132|1289514|P1|COMPLETED|Overall Study||89
527626|NCT00847132|1289513|P2|STARTED|Overall Study||85
527627|NCT00847132|1289514|P1|STARTED|Overall Study||90
527628|NCT00847015|1289522|P1|NOT COMPLETED|Overall Study||3
527629|NCT00847015|1289522|P1|COMPLETED|Overall Study||15
527630|NCT00847015|1289522|P1|STARTED|Overall Study||18
527631|NCT00847002|1289530|P2|NOT COMPLETED|Overall Study||0
527632|NCT00847002|1289531|P1|NOT COMPLETED|Overall Study||0
527633|NCT00847002|1289530|P2|COMPLETED|Overall Study||4
527634|NCT00847002|1289531|P1|COMPLETED|Overall Study||4
527635|NCT00847002|1289530|P2|STARTED|Overall Study||4
527636|NCT00847002|1289531|P1|STARTED|Overall Study||4
527637|NCT00846885|1289541|P2|NOT COMPLETED|Second Intervention||0
527638|NCT00846885|1289542|P1|NOT COMPLETED|Second Intervention||0
527639|NCT00846885|1289541|P2|COMPLETED|Second Intervention||14
527640|NCT00846885|1289542|P1|COMPLETED|Second Intervention||14
527641|NCT00846885|1289541|P2|STARTED|Second Intervention||14
527642|NCT00846885|1289542|P1|STARTED|Second Intervention||14
527643|NCT00846885|1289541|P2|NOT COMPLETED|Washout of 7 Days||0
527644|NCT00846885|1289542|P1|NOT COMPLETED|Washout of 7 Days||0
527645|NCT00846885|1289541|P2|COMPLETED|Washout of 7 Days||14
527646|NCT00846885|1289542|P1|COMPLETED|Washout of 7 Days||14
527647|NCT00846885|1289541|P2|STARTED|Washout of 7 Days||14
527648|NCT00846885|1289542|P1|STARTED|Washout of 7 Days||14
527649|NCT00846885|1289541|P2|NOT COMPLETED|First Intervention||0
527650|NCT00846885|1289542|P1|NOT COMPLETED|First Intervention||0
527651|NCT00846885|1289541|P2|COMPLETED|First Intervention||14
527652|NCT00846885|1289542|P1|COMPLETED|First Intervention||14
527653|NCT00846885|1289541|P2|STARTED|First Intervention||14
527654|NCT00846885|1289542|P1|STARTED|First Intervention||14
527655|NCT00846846|1289550|P1|NOT COMPLETED|Overall Study||75
527656|NCT00846846|1289550|P1|COMPLETED|Overall Study|Study ongoing but not recruiting participants.|943
527657|NCT00846846|1289550|P1|STARTED|Overall Study||1018
527658|NCT00846807|1289555|P1|NOT COMPLETED|Overall Study||632
527659|NCT00846807|1289555|P1|COMPLETED|Overall Study|Completed treatment.|4660
527660|NCT00846807|1289555|P1|STARTED|Overall Study|Entered and treated.|5292
527661|NCT00846768|1289563|P4|NOT COMPLETED|Overall Study||0
527662|NCT00846768|1289564|P3|NOT COMPLETED|Overall Study||0
527663|NCT00846768|1289565|P2|NOT COMPLETED|Overall Study||1
527664|NCT00846768|1289566|P1|NOT COMPLETED|Overall Study||0
527665|NCT00846768|1289563|P4|COMPLETED|Overall Study||12
527666|NCT00846768|1289564|P3|COMPLETED|Overall Study||12
527667|NCT00846768|1289565|P2|COMPLETED|Overall Study||11
527668|NCT00846768|1289566|P1|COMPLETED|Overall Study||11
527669|NCT00846768|1289563|P4|STARTED|Overall Study||12
527670|NCT00846768|1289564|P3|STARTED|Overall Study||12
527671|NCT00846768|1289565|P2|STARTED|Overall Study||12
527672|NCT00846768|1289566|P1|STARTED|Overall Study||11
527673|NCT00846651|1289638|P2|NOT COMPLETED|Overall Study||4
527674|NCT00846651|1289639|P1|NOT COMPLETED|Overall Study||4
527675|NCT00846651|1289638|P2|COMPLETED|Overall Study||37
527676|NCT00846651|1289639|P1|COMPLETED|Overall Study||37
527677|NCT00846651|1289638|P2|STARTED|Overall Study||41
527678|NCT00846651|1289639|P1|STARTED|Overall Study||41
527679|NCT00846586|1289657|P2|NOT COMPLETED|Overall Study||35
527680|NCT00846586|1289658|P1|NOT COMPLETED|Overall Study||39
527681|NCT00846586|1289657|P2|COMPLETED|Overall Study||529
527682|NCT00846586|1289658|P1|COMPLETED|Overall Study||531
527683|NCT00846586|1289657|P2|Received Study Drug|Overall Study|Three patients were not exposed to study treatment in this group.|561
527684|NCT00846586|1289658|P1|Received Study Drug|Overall Study||570
527685|NCT00846586|1289657|P2|STARTED|Overall Study||564
527686|NCT00846586|1289658|P1|STARTED|Overall Study||570
527687|NCT00846573|1289677|P4|NOT COMPLETED|Overall Study||0
527688|NCT00846573|1289678|P3|NOT COMPLETED|Overall Study||0
527689|NCT00846573|1289679|P2|NOT COMPLETED|Overall Study||0
527690|NCT00846573|1289680|P1|NOT COMPLETED|Overall Study||0
527691|NCT00846573|1289677|P4|COMPLETED|Overall Study||0
527692|NCT00846573|1289678|P3|COMPLETED|Overall Study||7
527693|NCT00846573|1289679|P2|COMPLETED|Overall Study||2
527694|NCT00846573|1289680|P1|COMPLETED|Overall Study||5
527695|NCT00846573|1289677|P4|STARTED|Overall Study||0
527696|NCT00846573|1289678|P3|STARTED|Overall Study||7
527697|NCT00846573|1289679|P2|STARTED|Overall Study||2
527698|NCT00846573|1289680|P1|STARTED|Overall Study||5
527699|NCT00846547|1289688|P1|NOT COMPLETED|Overall Study||7
527700|NCT00846547|1289688|P1|COMPLETED|Overall Study||25
527701|NCT00846547|1289688|P1|STARTED|Overall Study||32
527702|NCT00846521|1289692|P1|NOT COMPLETED|Overall Study||11
527703|NCT00846521|1289692|P1|COMPLETED|Overall Study||12
527704|NCT00846521|1289692|P1|STARTED|Overall Study||23
527705|NCT00846495|1289699|P2|NOT COMPLETED|Overall Study||3
527706|NCT00846495|1289700|P1|NOT COMPLETED|Overall Study||8
527707|NCT00846495|1289699|P2|COMPLETED|Overall Study||24
527708|NCT00846495|1289700|P1|COMPLETED|Overall Study||20
527709|NCT00846495|1289699|P2|STARTED|Overall Study||27
527710|NCT00846495|1289700|P1|STARTED|Overall Study||28
527711|NCT00846391|1289723|P3|NOT COMPLETED|Overall Study||3
527712|NCT00846391|1289724|P2|NOT COMPLETED|Overall Study||2
527713|NCT00846391|1289725|P1|NOT COMPLETED|Overall Study||1
527714|NCT00846391|1289723|P3|COMPLETED|Overall Study||3
527715|NCT00846391|1289724|P2|COMPLETED|Overall Study||2
527716|NCT00846391|1289725|P1|COMPLETED|Overall Study||3
527717|NCT00846391|1289723|P3|STARTED|Overall Study||6
527718|NCT00846391|1289724|P2|STARTED|Overall Study||4
527719|NCT00846391|1289725|P1|STARTED|Overall Study||4
527720|NCT00846365|1289736|P3|NOT COMPLETED|Overall Study||33
527721|NCT00846365|1289737|P2|NOT COMPLETED|Overall Study||49
527722|NCT00846365|1289738|P1|NOT COMPLETED|Overall Study||55
527723|NCT00846365|1289736|P3|COMPLETED|Overall Study||323
527724|NCT00846365|1289737|P2|COMPLETED|Overall Study||308
527725|NCT00846365|1289738|P1|COMPLETED|Overall Study||317
527726|NCT00846365|1289736|P3|STARTED|Overall Study||356
527727|NCT00846365|1289737|P2|STARTED|Overall Study||357
527728|NCT00846365|1289738|P1|STARTED|Overall Study||372
527729|NCT00846287|1289793|P2|NOT COMPLETED|Overall Study||5
527730|NCT00846287|1289794|P1|NOT COMPLETED|Overall Study||10
527731|NCT00846287|1289793|P2|COMPLETED|Overall Study||10
527732|NCT00846287|1289794|P1|COMPLETED|Overall Study||6
527733|NCT00846287|1289793|P2|STARTED|Overall Study||15
527734|NCT00846287|1289794|P1|STARTED|Overall Study||16
527735|NCT00846066|1289804|P2|NOT COMPLETED|Overall Study||0
527736|NCT00846066|1289805|P1|NOT COMPLETED|Overall Study||0
527737|NCT00846066|1289804|P2|COMPLETED|Overall Study||29
527738|NCT00846066|1289805|P1|COMPLETED|Overall Study||27
527739|NCT00846066|1289804|P2|STARTED|Overall Study||29
527740|NCT00846066|1289805|P1|STARTED|Overall Study||27
527741|NCT00846027|1289817|P1|NOT COMPLETED|Overall Study||90
527742|NCT00846027|1289817|P1|COMPLETED|Overall Study||0
527743|NCT00846027|1289817|P1|Received Treatment|Overall Study||83
527744|NCT00846027|1289817|P1|STARTED|Overall Study||90
527745|NCT00845975|1289826|P2|NOT COMPLETED|Overall Study||0
527746|NCT00845975|1289827|P1|NOT COMPLETED|Overall Study||0
527747|NCT00845975|1289826|P2|COMPLETED|Overall Study||9
527748|NCT00845975|1289827|P1|COMPLETED|Overall Study||9
527749|NCT00845975|1289826|P2|STARTED|Overall Study||9
527750|NCT00845975|1289827|P1|STARTED|Overall Study||9
527751|NCT00845897|1289840|P3|NOT COMPLETED|Overall Study||3
527752|NCT00845897|1289841|P2|NOT COMPLETED|Overall Study||5
527753|NCT00845897|1289842|P1|NOT COMPLETED|Overall Study||2
527754|NCT00845897|1289840|P3|COMPLETED|Overall Study||2
527755|NCT00845897|1289841|P2|COMPLETED|Overall Study||2
527756|NCT00845897|1289842|P1|COMPLETED|Overall Study||3
527757|NCT00845897|1289840|P3|STARTED|Overall Study||5
527758|NCT00845897|1289841|P2|STARTED|Overall Study||7
527759|NCT00845897|1289842|P1|STARTED|Overall Study||5
527760|NCT00845858|1289856|P3|NOT COMPLETED|Overall Study||8
527761|NCT00845858|1289857|P2|NOT COMPLETED|Overall Study||12
527762|NCT00845858|1289858|P1|NOT COMPLETED|Overall Study||8
527763|NCT00845858|1289856|P3|COMPLETED|Overall Study||87
527764|NCT00845858|1289857|P2|COMPLETED|Overall Study||84
527765|NCT00845858|1289858|P1|COMPLETED|Overall Study||88
527766|NCT00845858|1289856|P3|STARTED|Overall Study||95
527767|NCT00845858|1289857|P2|STARTED|Overall Study|"95 subjects received allocated intervention.~1 subject was not eligible and was not dosed."|96
527768|NCT00845858|1289858|P1|STARTED|Overall Study|"95 subjects received allocated intervention.~1 subject withdrew consent and was not dosed."|96
527769|NCT00845845|1289871|P2|NOT COMPLETED|Overall Study||4
527770|NCT00845845|1289872|P1|NOT COMPLETED|Overall Study||0
527771|NCT00845845|1289871|P2|COMPLETED|Overall Study||2
527772|NCT00845845|1289872|P1|COMPLETED|Overall Study||3
527773|NCT00845845|1289871|P2|STARTED|Overall Study||6
527774|NCT00845845|1289872|P1|STARTED|Overall Study||3
527775|NCT00845832|1289883|P3|NOT COMPLETED|Extended Safety Follow-Up||7
527776|NCT00845832|1289884|P2|NOT COMPLETED|Extended Safety Follow-Up||0
527777|NCT00845832|1289885|P1|NOT COMPLETED|Extended Safety Follow-Up||0
527778|NCT00845832|1289883|P3|COMPLETED|Extended Safety Follow-Up||0
527779|NCT00845832|1289884|P2|COMPLETED|Extended Safety Follow-Up||5
527780|NCT00845832|1289885|P1|COMPLETED|Extended Safety Follow-Up||2
527781|NCT00845832|1289883|P3|STARTED|Extended Safety Follow-Up|Only participants who remained B cell depleted required extended safety follow-up.|7
527782|NCT00845832|1289884|P2|STARTED|Extended Safety Follow-Up|Only participants who remained B cell depleted required extended safety follow-up.|5
527783|NCT00845832|1289885|P1|STARTED|Extended Safety Follow-Up||2
527784|NCT00845832|1289883|P3|NOT COMPLETED|Safety Follow-Up||0
527785|NCT00845832|1289884|P2|NOT COMPLETED|Safety Follow-Up||0
527786|NCT00845832|1289885|P1|NOT COMPLETED|Safety Follow-Up||1
527787|NCT00845832|1289883|P3|COMPLETED|Safety Follow-Up||12
527788|NCT00845832|1289884|P2|COMPLETED|Safety Follow-Up|One participant from this group was re-assigned to TCZ (4 mg/kg) group.|9
527789|NCT00845832|1289885|P1|COMPLETED|Safety Follow-Up||2
527790|NCT00845832|1289883|P3|STARTED|Safety Follow-Up|One participant each from the placebo and TCZ (2 mg/kg) groups were re-assigned to this group.|12
527791|NCT00845832|1289884|P2|STARTED|Safety Follow-Up|All participants who withdrew from study were asked to return for safety follow-up.|9
527792|NCT00845832|1289885|P1|STARTED|Safety Follow-Up|One participant from this group was re-assigned to TCZ (4 mg/kg) group.|3
527793|NCT00845832|1289883|P3|NOT COMPLETED|Treatment Period||0
527794|NCT00845832|1289884|P2|NOT COMPLETED|Treatment Period||3
527795|NCT00845832|1289885|P1|NOT COMPLETED|Treatment Period||1
527796|NCT00845832|1289883|P3|COMPLETED|Treatment Period||10
527797|NCT00845832|1289884|P2|COMPLETED|Treatment Period||7
527798|NCT00845832|1289885|P1|COMPLETED|Treatment Period||3
527799|NCT00845832|1289883|P3|STARTED|Treatment Period||10
527800|NCT00845832|1289884|P2|STARTED|Treatment Period||10
527801|NCT00845832|1289885|P1|STARTED|Treatment Period||4
527802|NCT00845728|1289931|P2|NOT COMPLETED|Overall Study||342
527803|NCT00845728|1289932|P1|NOT COMPLETED|Overall Study||386
527804|NCT00845728|1289931|P2|COMPLETED|Overall Study||1379
527805|NCT00845728|1289932|P1|COMPLETED|Overall Study||1337
527806|NCT00845728|1289931|P2|Exposed|Overall Study||1718
527807|NCT00845728|1289932|P1|Exposed|Overall Study||1721
527808|NCT00845728|1289931|P2|STARTED|Overall Study||1721
527809|NCT00845728|1289932|P1|STARTED|Overall Study||1723
527810|NCT00845702|1289940|P1|NOT COMPLETED|Dotarem MRA||0
527811|NCT00845702|1289940|P1|COMPLETED|Dotarem MRA||32
527812|NCT00845702|1289940|P1|STARTED|Dotarem MRA||32
527813|NCT00845702|1289940|P1|NOT COMPLETED|TOF MRA||1
527814|NCT00845702|1289940|P1|COMPLETED|TOF MRA|One patient did not perform study MRA procedures.|32
527815|NCT00845702|1289940|P1|STARTED|TOF MRA||33
527816|NCT00845676|1289946|P1|NOT COMPLETED|Overall Study||2
527817|NCT00845676|1289946|P1|COMPLETED|Overall Study||19
527818|NCT00845676|1289946|P1|STARTED|Overall Study||21
527819|NCT00845663|1289952|P2|NOT COMPLETED|Overall Study||0
527820|NCT00845663|1289953|P1|NOT COMPLETED|Overall Study||0
527821|NCT00845663|1289952|P2|COMPLETED|Overall Study||49
527822|NCT00845663|1289953|P1|COMPLETED|Overall Study||49
527823|NCT00845663|1289952|P2|STARTED|Overall Study||49
527824|NCT00845663|1289953|P1|STARTED|Overall Study||49
527825|NCT00845650|1290007|P6|NOT COMPLETED|Overall Study||2
527826|NCT00845650|1290008|P5|NOT COMPLETED|Overall Study||3
527827|NCT00845650|1290009|P4|NOT COMPLETED|Overall Study||1
527828|NCT00845650|1290010|P3|NOT COMPLETED|Overall Study||3
527829|NCT00845650|1290011|P2|NOT COMPLETED|Overall Study||0
527830|NCT00845650|1290012|P1|NOT COMPLETED|Overall Study||1
527831|NCT00845650|1290007|P6|COMPLETED|Overall Study||15
527832|NCT00845650|1290008|P5|COMPLETED|Overall Study||28
527833|NCT00845650|1290009|P4|COMPLETED|Overall Study||13
527834|NCT00845650|1290010|P3|COMPLETED|Overall Study||28
527835|NCT00845650|1290011|P2|COMPLETED|Overall Study||5
527836|NCT00845650|1290012|P1|COMPLETED|Overall Study||30
527837|NCT00845650|1290007|P6|STARTED|Overall Study|1 subject not dosed|17
527838|NCT00845650|1290008|P5|STARTED|Overall Study|2 subjects not dosed|31
527839|NCT00845650|1290009|P4|STARTED|Overall Study||14
527840|NCT00845650|1290010|P3|STARTED|Overall Study||31
527841|NCT00845650|1290011|P2|STARTED|Overall Study||5
527842|NCT00845650|1290012|P1|STARTED|Overall Study|1 subject not dosed|31
527843|NCT00845507|1290049|P2|NOT COMPLETED|Overall Study||1
527844|NCT00845507|1290050|P1|NOT COMPLETED|Overall Study||2
527845|NCT00845507|1290049|P2|COMPLETED|Overall Study||29
527846|NCT00845507|1290050|P1|COMPLETED|Overall Study||22
527847|NCT00845507|1290049|P2|STARTED|Overall Study||30
527848|NCT00845507|1290050|P1|STARTED|Overall Study||24
527849|NCT00845481|1290058|P1|NOT COMPLETED|Overall Study||0
527850|NCT00845481|1290058|P1|COMPLETED|Overall Study||24
527851|NCT00845481|1290058|P1|STARTED|Overall Study||24
527852|NCT00845429|1290070|P3|NOT COMPLETED|Overall Study||20
527853|NCT00845429|1290071|P2|NOT COMPLETED|Overall Study||15
527854|NCT00845429|1290072|P1|NOT COMPLETED|Overall Study||14
527855|NCT00845429|1290070|P3|COMPLETED|Overall Study||224
527856|NCT00845429|1290071|P2|COMPLETED|Overall Study||226
527857|NCT00845429|1290072|P1|COMPLETED|Overall Study||230
527858|NCT00845429|1290070|P3|STARTED|Overall Study||244
527859|NCT00845429|1290071|P2|STARTED|Overall Study||241
527860|NCT00845429|1290072|P1|STARTED|Overall Study||244
527861|NCT00845195|1290091|P2|NOT COMPLETED|Overall Study||0
527862|NCT00845195|1290092|P1|NOT COMPLETED|Overall Study||0
527863|NCT00845195|1290091|P2|COMPLETED|Overall Study||75
527864|NCT00845195|1290092|P1|COMPLETED|Overall Study||75
527865|NCT00845195|1290091|P2|STARTED|Overall Study||75
527866|NCT00845195|1290092|P1|STARTED|Overall Study||75
527867|NCT00845182|1290107|P3|NOT COMPLETED|Overall Study||6
527868|NCT00845182|1290108|P2|NOT COMPLETED|Overall Study||4
527869|NCT00845182|1290109|P1|NOT COMPLETED|Overall Study||3
527870|NCT00845182|1290107|P3|COMPLETED|Overall Study||9
527871|NCT00845182|1290108|P2|COMPLETED|Overall Study||11
527872|NCT00845182|1290109|P1|COMPLETED|Overall Study||10
527873|NCT00845182|1290107|P3|STARTED|Overall Study||15
527874|NCT00845182|1290108|P2|STARTED|Overall Study||15
527875|NCT00845182|1290109|P1|STARTED|Overall Study||13
527876|NCT00845130|1290123|P2|NOT COMPLETED|Overall Study||3
527877|NCT00845130|1290124|P1|NOT COMPLETED|Overall Study||4
527878|NCT00845130|1290123|P2|COMPLETED|Overall Study||19
527879|NCT00845130|1290124|P1|COMPLETED|Overall Study||16
527880|NCT00845130|1290123|P2|STARTED|Overall Study||22
527881|NCT00845130|1290124|P1|STARTED|Overall Study||20
527882|NCT00845065|1290134|P2|NOT COMPLETED|Overall Study||55
527883|NCT00845065|1290135|P1|NOT COMPLETED|Overall Study||47
527884|NCT00845065|1290134|P2|COMPLETED|Overall Study||79
527885|NCT00845065|1290135|P1|COMPLETED|Overall Study||20
527886|NCT00845065|1290134|P2|STARTED|Overall Study||134
527887|NCT00845065|1290135|P1|STARTED|Overall Study||67
527888|NCT00845039|1290151|P2|NOT COMPLETED|Overall Study||0
527889|NCT00845039|1290152|P1|NOT COMPLETED|Overall Study||0
527890|NCT00845039|1290151|P2|COMPLETED|Overall Study||2
527891|NCT00845039|1290152|P1|COMPLETED|Overall Study||2
527892|NCT00845039|1290151|P2|Received at Least 1 Dose of Study Drug|Overall Study||2
527893|NCT00845039|1290152|P1|Received at Least 1 Dose of Study Drug|Overall Study||2
527894|NCT00845039|1290151|P2|STARTED|Overall Study||2
527895|NCT00845039|1290152|P1|STARTED|Overall Study||2
527896|NCT00845000|1290179|P6|NOT COMPLETED|Period 3||0
527897|NCT00845000|1290180|P5|NOT COMPLETED|Period 3||0
527898|NCT00845000|1290181|P4|NOT COMPLETED|Period 3||0
527899|NCT00845000|1290182|P3|NOT COMPLETED|Period 3||0
527900|NCT00845000|1290183|P2|NOT COMPLETED|Period 3||0
527901|NCT00845000|1290184|P1|NOT COMPLETED|Period 3||0
527902|NCT00845000|1290179|P6|COMPLETED|Period 3||2
527903|NCT00845000|1290180|P5|COMPLETED|Period 3||2
527904|NCT00845000|1290181|P4|COMPLETED|Period 3||2
527905|NCT00845000|1290182|P3|COMPLETED|Period 3||2
527906|NCT00845000|1290183|P2|COMPLETED|Period 3||2
527907|NCT00845000|1290184|P1|COMPLETED|Period 3||2
527908|NCT00845000|1290179|P6|STARTED|Period 3||2
527909|NCT00845000|1290180|P5|STARTED|Period 3||2
527910|NCT00845000|1290181|P4|STARTED|Period 3||2
527911|NCT00845000|1290182|P3|STARTED|Period 3||2
527912|NCT00845000|1290183|P2|STARTED|Period 3||2
527913|NCT00845000|1290184|P1|STARTED|Period 3||2
527914|NCT00845000|1290179|P6|NOT COMPLETED|Period 2||0
527915|NCT00845000|1290180|P5|NOT COMPLETED|Period 2||0
527916|NCT00845000|1290181|P4|NOT COMPLETED|Period 2||0
527917|NCT00845000|1290182|P3|NOT COMPLETED|Period 2||0
527918|NCT00845000|1290183|P2|NOT COMPLETED|Period 2||0
527919|NCT00845000|1290184|P1|NOT COMPLETED|Period 2||0
527920|NCT00845000|1290179|P6|COMPLETED|Period 2||2
527921|NCT00845000|1290180|P5|COMPLETED|Period 2||2
527922|NCT00845000|1290181|P4|COMPLETED|Period 2||2
527923|NCT00845000|1290182|P3|COMPLETED|Period 2||2
527924|NCT00845000|1290183|P2|COMPLETED|Period 2||2
527925|NCT00845000|1290184|P1|COMPLETED|Period 2||2
527926|NCT00845000|1290179|P6|STARTED|Period 2||2
527927|NCT00845000|1290180|P5|STARTED|Period 2||2
527928|NCT00845000|1290181|P4|STARTED|Period 2||2
527929|NCT00845000|1290182|P3|STARTED|Period 2||2
527930|NCT00845000|1290183|P2|STARTED|Period 2||2
527931|NCT00845000|1290184|P1|STARTED|Period 2||2
527932|NCT00845000|1290179|P6|NOT COMPLETED|Period 1||0
527933|NCT00845000|1290180|P5|NOT COMPLETED|Period 1||0
527934|NCT00845000|1290181|P4|NOT COMPLETED|Period 1||0
527935|NCT00845000|1290182|P3|NOT COMPLETED|Period 1||0
527936|NCT00845000|1290183|P2|NOT COMPLETED|Period 1||0
527937|NCT00845000|1290184|P1|NOT COMPLETED|Period 1||0
527938|NCT00845000|1290179|P6|COMPLETED|Period 1||2
527939|NCT00845000|1290180|P5|COMPLETED|Period 1||2
527940|NCT00845000|1290181|P4|COMPLETED|Period 1||2
527941|NCT00845000|1290182|P3|COMPLETED|Period 1||2
527942|NCT00845000|1290183|P2|COMPLETED|Period 1||2
527943|NCT00845000|1290184|P1|COMPLETED|Period 1||2
527944|NCT00845000|1290179|P6|STARTED|Period 1||2
527945|NCT00845000|1290180|P5|STARTED|Period 1||2
527946|NCT00845000|1290181|P4|STARTED|Period 1||2
527947|NCT00845000|1290182|P3|STARTED|Period 1||2
527948|NCT00845000|1290183|P2|STARTED|Period 1||2
527949|NCT00845000|1290184|P1|STARTED|Period 1||2
527950|NCT00844896|1290203|P2|NOT COMPLETED|Overall Study||17
527951|NCT00844896|1290204|P1|NOT COMPLETED|Overall Study||12
527952|NCT00844896|1290203|P2|COMPLETED|Overall Study||11
527953|NCT00844896|1290204|P1|COMPLETED|Overall Study||17
527954|NCT00844896|1290203|P2|STARTED|Overall Study||28
527955|NCT00844896|1290204|P1|STARTED|Overall Study||29
527956|NCT00844883|1290226|P1|NOT COMPLETED|Overall Study||4
527957|NCT00844883|1290226|P1|COMPLETED|Overall Study||46
527958|NCT00844883|1290226|P1|Patients Who Received TACE|Overall Study|2 patients withdrawn at Week 1 prior to TACE for intolerance to sorafenib|48
527959|NCT00844883|1290226|P1|STARTED|Overall Study||50
527960|NCT00844857|1290238|P2|NOT COMPLETED|Overall Study||37
527961|NCT00844857|1290239|P1|NOT COMPLETED|Overall Study||78
527962|NCT00844857|1290238|P2|COMPLETED|Overall Study||60
527963|NCT00844857|1290239|P1|COMPLETED|Overall Study||116
527964|NCT00844857|1290238|P2|Population Analyzed|Overall Study|randomized participants who took at least 1 dose of study drug excluding 2 GCP noncompliant sites.|85
527965|NCT00844857|1290239|P1|Population Analyzed|Overall Study|Randomized participants who took at least 1 dose of study drug excluding 2 GCP noncompliant sites.|170
527966|NCT00844857|1290238|P2|STARTED|Overall Study||97
527967|NCT00844857|1290239|P1|STARTED|Overall Study||194
527968|NCT00844844|1290283|P1|NOT COMPLETED|Post Treatment Period||1
527969|NCT00844844|1290283|P1|COMPLETED|Post Treatment Period||5
527970|NCT00844844|1290283|P1|STARTED|Post Treatment Period||6
527971|NCT00844844|1290283|P1|NOT COMPLETED|Extension Treatment Period||2
527972|NCT00844844|1290283|P1|COMPLETED|Extension Treatment Period||11
527973|NCT00844844|1290283|P1|STARTED|Extension Treatment Period||13
527974|NCT00844844|1290283|P1|NOT COMPLETED|Treatment Period (26 Weeks)||2
527975|NCT00844844|1290283|P1|COMPLETED|Treatment Period (26 Weeks)||15
527976|NCT00844844|1290283|P1|STARTED|Treatment Period (26 Weeks)||17
527977|NCT00844844|1290283|P1|NOT COMPLETED|Screening Period||0
527978|NCT00844844|1290283|P1|COMPLETED|Screening Period||17
527979|NCT00844844|1290283|P1|STARTED|Screening Period||17
527980|NCT00844831|1290297|P1|NOT COMPLETED|Overall Study||6
527981|NCT00844831|1290297|P1|COMPLETED|Overall Study||19
527982|NCT00844831|1290297|P1|STARTED|Overall Study||25
527983|NCT00844805|1290307|P4|NOT COMPLETED|Follow-Up Phase||9
527984|NCT00844805|1290308|P3|NOT COMPLETED|Follow-Up Phase||9
527985|NCT00844805|1290309|P2|NOT COMPLETED|Follow-Up Phase||0
527986|NCT00844805|1290310|P1|NOT COMPLETED|Follow-Up Phase||0
527987|NCT00844805|1290307|P4|COMPLETED|Follow-Up Phase||32
527988|NCT00844805|1290308|P3|COMPLETED|Follow-Up Phase||32
527989|NCT00844805|1290309|P2|COMPLETED|Follow-Up Phase||0
527990|NCT00844805|1290310|P1|COMPLETED|Follow-Up Phase||0
527991|NCT00844805|1290307|P4|STARTED|Follow-Up Phase|Participants who met partial remission criteria at the end of treatment entered the Follow-Up Phase.|41
527992|NCT00844805|1290308|P3|STARTED|Follow-Up Phase|Participants who met partial remission criteria at the end of treatment entered the Follow-Up Phase.|41
527993|NCT00844805|1290309|P2|STARTED|Follow-Up Phase||0
527994|NCT00844805|1290310|P1|STARTED|Follow-Up Phase||0
527995|NCT00844805|1290307|P4|NOT COMPLETED|Treatment Phase||0
527996|NCT00844805|1290308|P3|NOT COMPLETED|Treatment Phase||0
527997|NCT00844805|1290309|P2|NOT COMPLETED|Treatment Phase||7
527998|NCT00844805|1290310|P1|NOT COMPLETED|Treatment Phase||10
527999|NCT00844805|1290307|P4|COMPLETED|Treatment Phase||0
528000|NCT00844805|1290308|P3|COMPLETED|Treatment Phase||0
528001|NCT00844805|1290309|P2|COMPLETED|Treatment Phase||45
528002|NCT00844805|1290310|P1|COMPLETED|Treatment Phase||96
528003|NCT00844805|1290307|P4|STARTED|Treatment Phase||0
528004|NCT00844805|1290308|P3|STARTED|Treatment Phase||0
528005|NCT00844805|1290309|P2|STARTED|Treatment Phase||52
528006|NCT00844805|1290310|P1|STARTED|Treatment Phase||106
528007|NCT00844753|1290354|P4|NOT COMPLETED|Overall Study||11
528008|NCT00844753|1290355|P3|NOT COMPLETED|Overall Study||7
528009|NCT00844753|1290356|P2|NOT COMPLETED|Overall Study||3
528010|NCT00844753|1290357|P1|NOT COMPLETED|Overall Study||8
528011|NCT00844753|1290354|P4|COMPLETED|Overall Study||21
528012|NCT00844753|1290355|P3|COMPLETED|Overall Study||25
528013|NCT00844753|1290356|P2|COMPLETED|Overall Study||29
528014|NCT00844753|1290357|P1|COMPLETED|Overall Study||24
528015|NCT00844753|1290354|P4|STARTED|Overall Study||32
528016|NCT00844753|1290355|P3|STARTED|Overall Study||32
528017|NCT00844753|1290356|P2|STARTED|Overall Study||32
528018|NCT00844753|1290357|P1|STARTED|Overall Study||32
528019|NCT00844714|1290369|P1|NOT COMPLETED|Overall Study||0
528020|NCT00844714|1290369|P1|COMPLETED|Overall Study||20
528021|NCT00844714|1290369|P1|STARTED|Overall Study||20
528022|NCT00844649|1290375|P2|NOT COMPLETED|Overall Study||418
528023|NCT00844649|1290376|P1|NOT COMPLETED|Overall Study||405
528024|NCT00844649|1290375|P2|COMPLETED|Overall Study|Completed = participants remaining on treatment at the time of the data cut off 17 Sept 2012|12
528025|NCT00844649|1290376|P1|COMPLETED|Overall Study|Completed = participants remaining on treatment at the time of the data cut off 17 Sept 2012|26
528026|NCT00844649|1290375|P2|Treated Population|Overall Study|Treated population = all randomized patients who received at least one dose of study drug|402
528027|NCT00844649|1290376|P1|Treated Population|Overall Study|Treated population = all randomized patients who received at least one dose of study drug|421
528028|NCT00844649|1290375|P2|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|430
528029|NCT00844649|1290376|P1|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|431
528030|NCT00844597|1290400|P6|NOT COMPLETED|Overall Study||0
528031|NCT00844597|1290401|P5|NOT COMPLETED|Overall Study||0
528032|NCT00844597|1290402|P4|NOT COMPLETED|Overall Study||1
528033|NCT00844597|1290403|P3|NOT COMPLETED|Overall Study||0
528034|NCT00844597|1290404|P2|NOT COMPLETED|Overall Study||0
528035|NCT00844597|1290405|P1|NOT COMPLETED|Overall Study||0
528036|NCT00844597|1290400|P6|COMPLETED|Overall Study||4
528037|NCT00844597|1290401|P5|COMPLETED|Overall Study||4
528038|NCT00844597|1290402|P4|COMPLETED|Overall Study||2
528039|NCT00844597|1290403|P3|COMPLETED|Overall Study||2
528040|NCT00844597|1290404|P2|COMPLETED|Overall Study||2
528041|NCT00844597|1290405|P1|COMPLETED|Overall Study||4
528042|NCT00844597|1290400|P6|STARTED|Overall Study||4
528043|NCT00844597|1290401|P5|STARTED|Overall Study||4
528044|NCT00844597|1290402|P4|STARTED|Overall Study||3
528045|NCT00844597|1290403|P3|STARTED|Overall Study||2
528046|NCT00844597|1290404|P2|STARTED|Overall Study||2
528047|NCT00844597|1290405|P1|STARTED|Overall Study||4
528048|NCT00844558|1290425|P2|NOT COMPLETED|Overall Study||4
528049|NCT00844558|1290426|P1|NOT COMPLETED|Overall Study||12
528050|NCT00844558|1290425|P2|COMPLETED|Overall Study||18
528051|NCT00844558|1290426|P1|COMPLETED|Overall Study||24
528052|NCT00844558|1290425|P2|12 Month Visit|Overall Study|-Discontinued intervention (n=0)|18
528053|NCT00844558|1290426|P1|12 Month Visit|Overall Study|Discontinued intervention (n=4)|24
528054|NCT00844558|1290425|P2|6 Month Visit|Overall Study|-Discontinued intervention (n=1)|18
528055|NCT00844558|1290426|P1|6 Month Visit|Overall Study|Discontinued intervention (n=1)|28
528056|NCT00844558|1290425|P2|3 Month Visit|Overall Study|"Lost to follow-up (n=1)~Discontinued Intervention (n=1)"|19
528057|NCT00844558|1290426|P1|3 Month Visit|Overall Study|Discontinued intervention (n=4)|29
528058|NCT00844558|1290425|P2|Received Allocated Intervention|Overall Study||21
528059|NCT00844558|1290426|P1|Received Allocated Intervention|Overall Study||33
528060|NCT00844558|1290425|P2|STARTED|Overall Study|"Received allocated intervention (n=21)~Did not receive allocated intervention (n=1)"|22
528061|NCT00844558|1290426|P1|STARTED|Overall Study|"Received allocated intervention (n=33)~Did not receive allocated intervention (n=3)"|36
528062|NCT00844545|1290442|P1|NOT COMPLETED|Post Treatment Period||1
528063|NCT00844545|1290442|P1|COMPLETED|Post Treatment Period||5
528064|NCT00844545|1290442|P1|STARTED|Post Treatment Period||6
528065|NCT00844545|1290442|P1|NOT COMPLETED|Extension Treatment Period||2
528066|NCT00844545|1290442|P1|COMPLETED|Extension Treatment Period||11
528067|NCT00844545|1290442|P1|STARTED|Extension Treatment Period||13
528068|NCT00844545|1290442|P1|NOT COMPLETED|Treatment Period (26 Weeks)||2
528069|NCT00844545|1290442|P1|COMPLETED|Treatment Period (26 Weeks)||15
528070|NCT00844545|1290442|P1|STARTED|Treatment Period (26 Weeks)||17
528071|NCT00844545|1290442|P1|NOT COMPLETED|Screening Period||0
528072|NCT00844545|1290442|P1|COMPLETED|Screening Period||17
528073|NCT00844545|1290442|P1|STARTED|Screening Period||17
528074|NCT00844532|1290456|P1|NOT COMPLETED|Overall Study||39
528075|NCT00844532|1290456|P1|COMPLETED|Overall Study||112
528076|NCT00844532|1290456|P1|STARTED|Overall Study||151
528077|NCT00844519|1290542|P2|NOT COMPLETED|Overall Study||1
528078|NCT00844519|1290543|P1|NOT COMPLETED|Overall Study||2
528079|NCT00844519|1290542|P2|COMPLETED|Overall Study||25
528080|NCT00844519|1290543|P1|COMPLETED|Overall Study||24
528081|NCT00844519|1290542|P2|STARTED|Overall Study||26
528082|NCT00844519|1290543|P1|STARTED|Overall Study||26
528083|NCT00844480|1290551|P2|NOT COMPLETED|Overall Study||3
528084|NCT00844480|1290552|P1|NOT COMPLETED|Overall Study||2
528085|NCT00844480|1290551|P2|COMPLETED|Overall Study||6
528086|NCT00844480|1290552|P1|COMPLETED|Overall Study||6
528087|NCT00844480|1290551|P2|STARTED|Overall Study||9
528088|NCT00844480|1290552|P1|STARTED|Overall Study||8
528089|NCT00844428|1290560|P1|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1
528090|NCT00844428|1290560|P1|COMPLETED|Post Treatment Period (Patients Who Disc||4
528091|NCT00844428|1290560|P1|STARTED|Post Treatment Period (Patients Who Disc||5
528092|NCT00844428|1290560|P1|NOT COMPLETED|Extension Treatment Period||1
528093|NCT00844428|1290560|P1|COMPLETED|Extension Treatment Period||18
528094|NCT00844428|1290560|P1|STARTED|Extension Treatment Period||19
528095|NCT00844428|1290560|P1|NOT COMPLETED|Treatment Period (26 Weeks)||0
528096|NCT00844428|1290560|P1|COMPLETED|Treatment Period (26 Weeks)||20
528097|NCT00844428|1290560|P1|STARTED|Treatment Period (26 Weeks)||20
528098|NCT00844428|1290560|P1|NOT COMPLETED|Observation Period (8 Weeks)||0
528099|NCT00844428|1290560|P1|COMPLETED|Observation Period (8 Weeks)||20
528100|NCT00844428|1290560|P1|STARTED|Observation Period (8 Weeks)||20
528101|NCT00844428|1290560|P1|NOT COMPLETED|Screening Period||3
528102|NCT00844428|1290560|P1|COMPLETED|Screening Period||20
528103|NCT00844428|1290560|P1|STARTED|Screening Period||23
528104|NCT00844415|1290576|P1|NOT COMPLETED|Overall Study||1
528105|NCT00844415|1290576|P1|COMPLETED|Overall Study|Completed.|8
528106|NCT00844415|1290576|P1|Pat. Received Single Dose 75mg|Overall Study||1
528107|NCT00844415|1290576|P1|Pat. Received 125mg Followed by 150mg|Overall Study||2
528108|NCT00844415|1290576|P1|Pat. Received 100mg Followed by 125mg|Overall Study||3
528109|NCT00844415|1290576|P1|Pat. Received 75mg Followed by 100mg|Overall Study||3
528110|NCT00844415|1290576|P1|STARTED|Overall Study|Entered and treated.|9
528111|NCT00844376|1290590|P2|NOT COMPLETED|Period 2: Second Intervention||0
528112|NCT00844376|1290591|P1|NOT COMPLETED|Period 2: Second Intervention||0
528113|NCT00844376|1290590|P2|COMPLETED|Period 2: Second Intervention||6
528114|NCT00844376|1290591|P1|COMPLETED|Period 2: Second Intervention|Total subjects administered Test drug = 12; total subjects administered Reference drug = 11.|5
528115|NCT00844376|1290590|P2|STARTED|Period 2: Second Intervention||6
528116|NCT00844376|1290591|P1|STARTED|Period 2: Second Intervention||5
528117|NCT00844376|1290590|P2|NOT COMPLETED|Period 1: First Intervention||0
528118|NCT00844376|1290591|P1|NOT COMPLETED|Period 1: First Intervention||1
528119|NCT00844376|1290590|P2|COMPLETED|Period 1: First Intervention||6
528120|NCT00844376|1290591|P1|COMPLETED|Period 1: First Intervention||5
528121|NCT00844376|1290590|P2|STARTED|Period 1: First Intervention||6
528122|NCT00844376|1290591|P1|STARTED|Period 1: First Intervention||6
528123|NCT00844298|1290609|P1|NOT COMPLETED|Overall Study||0
528124|NCT00844298|1290609|P1|COMPLETED|Overall Study||91
528125|NCT00844298|1290609|P1|STARTED|Overall Study||91
528126|NCT00844194|1290615|P2|NOT COMPLETED|Overall Study||8
528127|NCT00844194|1290616|P1|NOT COMPLETED|Overall Study||25
528128|NCT00844194|1290615|P2|COMPLETED|Overall Study||22
528129|NCT00844194|1290616|P1|COMPLETED|Overall Study||53
528130|NCT00844194|1290615|P2|STARTED|Overall Study||30
528131|NCT00844194|1290616|P1|STARTED|Overall Study||78
528132|NCT00844090|1290822|P2|NOT COMPLETED|Overall Study||8
528133|NCT00844090|1290823|P1|NOT COMPLETED|Overall Study||6
528134|NCT00844090|1290822|P2|COMPLETED|Overall Study||46
528135|NCT00844090|1290823|P1|COMPLETED|Overall Study||46
528136|NCT00844090|1290822|P2|STARTED|Overall Study||54
528137|NCT00844090|1290823|P1|STARTED|Overall Study||52
528138|NCT00844051|1290831|P2|NOT COMPLETED|Overall Study||0
528139|NCT00844051|1290832|P1|NOT COMPLETED|Overall Study||0
528140|NCT00844051|1290831|P2|COMPLETED|Overall Study||2368
528141|NCT00844051|1290832|P1|COMPLETED|Overall Study||2087
528142|NCT00844051|1290831|P2|STARTED|Overall Study||2368
528143|NCT00844051|1290832|P1|STARTED|Overall Study||2087
528144|NCT00843986|1290842|P2|NOT COMPLETED|Overall Study||1
528145|NCT00843986|1290843|P1|NOT COMPLETED|Overall Study||1
528146|NCT00843986|1290842|P2|COMPLETED|Overall Study||5
528147|NCT00843986|1290843|P1|COMPLETED|Overall Study||2
528148|NCT00843986|1290842|P2|Completed Treatment (Infusion)|Overall Study||6
528149|NCT00843986|1290843|P1|Completed Treatment (Infusion)|Overall Study||2
528150|NCT00843986|1290842|P2|STARTED|Overall Study||6
528151|NCT00843986|1290843|P1|STARTED|Overall Study||3
528152|NCT00843843|1290871|P2|NOT COMPLETED|Overall Study||2
528153|NCT00843843|1290872|P1|NOT COMPLETED|Overall Study||2
528154|NCT00843843|1290871|P2|COMPLETED|Overall Study||6
528155|NCT00843843|1290872|P1|COMPLETED|Overall Study||6
528156|NCT00843843|1290871|P2|STARTED|Overall Study||8
528157|NCT00843843|1290872|P1|STARTED|Overall Study||8
528158|NCT00843830|1290880|P1|NOT COMPLETED|Overall Study||0
528159|NCT00843830|1290880|P1|COMPLETED|Overall Study||4
528160|NCT00843830|1290880|P1|STARTED|Overall Study||4
528161|NCT00843778|1290885|P1|NOT COMPLETED|Overall Study||35
528162|NCT00843778|1290885|P1|COMPLETED|Overall Study||96
528163|NCT00843778|1290885|P1|STARTED|Overall Study||131
528164|NCT00843713|1290920|P2|NOT COMPLETED|Overall Study||0
528165|NCT00843713|1290921|P1|NOT COMPLETED|Overall Study||0
528166|NCT00843713|1290920|P2|COMPLETED|Overall Study||26
528167|NCT00843713|1290921|P1|COMPLETED|Overall Study||30
528168|NCT00843713|1290920|P2|STARTED|Overall Study||26
528169|NCT00843713|1290921|P1|STARTED|Overall Study||30
528170|NCT00843635|1290930|P3|NOT COMPLETED|Overall Study||0
528171|NCT00843635|1290931|P2|NOT COMPLETED|Overall Study||2
528172|NCT00843635|1290932|P1|NOT COMPLETED|Overall Study||2
528173|NCT00843635|1290930|P3|COMPLETED|Overall Study||5
528174|NCT00843635|1290931|P2|COMPLETED|Overall Study||13
528175|NCT00843635|1290932|P1|COMPLETED|Overall Study||13
528176|NCT00843635|1290930|P3|STARTED|Overall Study||5
528177|NCT00843635|1290931|P2|STARTED|Overall Study||15
528178|NCT00843635|1290932|P1|STARTED|Overall Study||15
528179|NCT00843622|1290952|P2|NOT COMPLETED|Overall Study||55
528180|NCT00843622|1290953|P1|NOT COMPLETED|Overall Study||43
528181|NCT00843622|1290952|P2|COMPLETED|Overall Study||70
528182|NCT00843622|1290953|P1|COMPLETED|Overall Study||82
528183|NCT00843622|1290952|P2|STARTED|Overall Study||125
528184|NCT00843622|1290953|P1|STARTED|Overall Study||125
528185|NCT00843518|1290961|P2|NOT COMPLETED|Period 3 (Single-blind Washout)||0
528186|NCT00843518|1290962|P1|NOT COMPLETED|Period 3 (Single-blind Washout)||0
528187|NCT00843518|1290961|P2|COMPLETED|Period 3 (Single-blind Washout)||49
528188|NCT00843518|1290962|P1|COMPLETED|Period 3 (Single-blind Washout)||42
528189|NCT00843518|1290961|P2|STARTED|Period 3 (Single-blind Washout)||49
528190|NCT00843518|1290962|P1|STARTED|Period 3 (Single-blind Washout)|1 LY451395 participant completed double-blind treatment, but did not enter washout period.|42
528191|NCT00843518|1290961|P2|NOT COMPLETED|Period 2 (Double-blind Treatment)||20
528192|NCT00843518|1290962|P1|NOT COMPLETED|Period 2 (Double-blind Treatment)||20
528193|NCT00843518|1290961|P2|COMPLETED|Period 2 (Double-blind Treatment)||49
528194|NCT00843518|1290962|P1|COMPLETED|Period 2 (Double-blind Treatment)||43
528195|NCT00843518|1290961|P2|STARTED|Period 2 (Double-blind Treatment)||69
528196|NCT00843518|1290962|P1|STARTED|Period 2 (Double-blind Treatment)||63
528197|NCT00843492|1290992|P2|NOT COMPLETED|Overall Study||14
528198|NCT00843492|1290993|P1|NOT COMPLETED|Overall Study||8
528199|NCT00843492|1290992|P2|COMPLETED|Overall Study||607
528200|NCT00843492|1290993|P1|COMPLETED|Overall Study||614
528201|NCT00843492|1290992|P2|STARTED|Overall Study||621
528202|NCT00843492|1290993|P1|STARTED|Overall Study||622
528203|NCT00843479|1291013|P2|NOT COMPLETED|Overall Study||0
528204|NCT00843479|1291014|P1|NOT COMPLETED|Overall Study||0
528205|NCT00843479|1291013|P2|COMPLETED|Overall Study||12
528206|NCT00843479|1291014|P1|COMPLETED|Overall Study||12
528207|NCT00843479|1291013|P2|STARTED|Overall Study||12
528208|NCT00843479|1291014|P1|STARTED|Overall Study||12
528209|NCT00843466|1291032|P2|NOT COMPLETED|Overall Study||0
528210|NCT00843466|1291033|P1|NOT COMPLETED|Overall Study||0
528211|NCT00843466|1291032|P2|COMPLETED|Overall Study||18
528212|NCT00843466|1291033|P1|COMPLETED|Overall Study||24
528213|NCT00843466|1291032|P2|STARTED|Overall Study||18
528214|NCT00843466|1291033|P1|STARTED|Overall Study||24
528215|NCT00843349|1291043|P4|NOT COMPLETED|Overall Study||1
528216|NCT00843349|1291044|P3|NOT COMPLETED|Overall Study||0
528217|NCT00843349|1291045|P2|NOT COMPLETED|Overall Study||0
528218|NCT00843349|1291046|P1|NOT COMPLETED|Overall Study||3
528219|NCT00843349|1291043|P4|COMPLETED|Overall Study||10
528220|NCT00843349|1291044|P3|COMPLETED|Overall Study||10
528221|NCT00843349|1291045|P2|COMPLETED|Overall Study||11
528222|NCT00843349|1291046|P1|COMPLETED|Overall Study||8
528223|NCT00843349|1291043|P4|STARTED|Overall Study||11
528224|NCT00843349|1291044|P3|STARTED|Overall Study||10
528225|NCT00843349|1291045|P2|STARTED|Overall Study||11
528226|NCT00843349|1291046|P1|STARTED|Overall Study||11
528227|NCT00843310|1291060|P1|NOT COMPLETED|Overall Study||7
528228|NCT00843310|1291060|P1|COMPLETED|Overall Study||1
528229|NCT00843310|1291060|P1|STARTED|Overall Study||8
528230|NCT00843284|1291064|P1|NOT COMPLETED|Overall Study||72
528231|NCT00843284|1291064|P1|COMPLETED|Overall Study||619
528232|NCT00843284|1291064|P1|STARTED|Overall Study||691
528233|NCT00843193|1291074|P2|NOT COMPLETED|Overall Study||11
528234|NCT00843193|1291075|P1|NOT COMPLETED|Overall Study||8
528235|NCT00843193|1291074|P2|COMPLETED|Overall Study||88
528236|NCT00843193|1291075|P1|COMPLETED|Overall Study||91
528237|NCT00843193|1291074|P2|STARTED|Overall Study||99
528238|NCT00843193|1291075|P1|STARTED|Overall Study||99
528239|NCT00843180|1291111|P2|NOT COMPLETED|Overall Study||0
528240|NCT00843180|1291112|P1|NOT COMPLETED|Overall Study||0
528241|NCT00843180|1291111|P2|COMPLETED|Overall Study||7
528242|NCT00843180|1291112|P1|COMPLETED|Overall Study||16
528243|NCT00843180|1291111|P2|STARTED|Overall Study||7
528244|NCT00843180|1291112|P1|STARTED|Overall Study||16
528245|NCT00843167|1291126|P2|NOT COMPLETED|Follow-up||0
528246|NCT00843167|1291127|P1|NOT COMPLETED|Follow-up||0
528247|NCT00843167|1291126|P2|COMPLETED|Follow-up||24
528248|NCT00843167|1291127|P1|COMPLETED|Follow-up||24
528249|NCT00843167|1291126|P2|Completed Final Visit|Follow-up||24
528250|NCT00843167|1291127|P1|Completed Final Visit|Follow-up||24
528251|NCT00843167|1291126|P2|STARTED|Follow-up||24
528252|NCT00843167|1291127|P1|STARTED|Follow-up||24
528253|NCT00843167|1291126|P2|NOT COMPLETED|Treatment Period||8
528254|NCT00843167|1291127|P1|NOT COMPLETED|Treatment Period||3
528255|NCT00843167|1291126|P2|COMPLETED|Treatment Period||19
528256|NCT00843167|1291127|P1|COMPLETED|Treatment Period||24
528257|NCT00843167|1291126|P2|STARTED|Treatment Period||27
528258|NCT00843167|1291127|P1|STARTED|Treatment Period||27
528259|NCT00843115|1291140|P1|NOT COMPLETED|Overall Study||66
528260|NCT00843115|1291140|P1|COMPLETED|Overall Study||304
528261|NCT00843115|1291140|P1|STARTED|Overall Study||370
528262|NCT00843050|1291186|P1|NOT COMPLETED|Overall Study||13
528263|NCT00843050|1291186|P1|COMPLETED|Overall Study||0
528264|NCT00843050|1291186|P1|STARTED|Overall Study||13
528265|NCT00843024|1291196|P6|NOT COMPLETED|Double-blind Treatment Phase||25
528266|NCT00843024|1291197|P5|NOT COMPLETED|Double-blind Treatment Phase||20
528267|NCT00843024|1291198|P4|NOT COMPLETED|Double-blind Treatment Phase||23
528268|NCT00843024|1291199|P3|NOT COMPLETED|Double-blind Treatment Phase||31
528269|NCT00843024|1291200|P2|NOT COMPLETED|Double-blind Treatment Phase||0
528270|NCT00843024|1291201|P1|NOT COMPLETED|Double-blind Treatment Phase||0
528271|NCT00843024|1291196|P6|COMPLETED|Double-blind Treatment Phase||152
528272|NCT00843024|1291197|P5|COMPLETED|Double-blind Treatment Phase||97
528273|NCT00843024|1291198|P4|COMPLETED|Double-blind Treatment Phase||96
528274|NCT00843024|1291199|P3|COMPLETED|Double-blind Treatment Phase||145
528275|NCT00843024|1291200|P2|COMPLETED|Double-blind Treatment Phase||0
528276|NCT00843024|1291201|P1|COMPLETED|Double-blind Treatment Phase||0
528277|NCT00843024|1291196|P6|STARTED|Double-blind Treatment Phase||177
528278|NCT00843024|1291197|P5|STARTED|Double-blind Treatment Phase||117
528279|NCT00843024|1291198|P4|STARTED|Double-blind Treatment Phase||119
528280|NCT00843024|1291199|P3|STARTED|Double-blind Treatment Phase||176
528281|NCT00843024|1291200|P2|STARTED|Double-blind Treatment Phase||0
528282|NCT00843024|1291201|P1|STARTED|Double-blind Treatment Phase||0
528283|NCT00843024|1291196|P6|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
528284|NCT00843024|1291197|P5|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
528285|NCT00843024|1291198|P4|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
528286|NCT00843024|1291199|P3|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
528287|NCT00843024|1291200|P2|NOT COMPLETED|Single-blind Placebo Run-In Phase||136
528288|NCT00843024|1291201|P1|NOT COMPLETED|Single-blind Placebo Run-In Phase||140
528289|NCT00843024|1291196|P6|COMPLETED|Single-blind Placebo Run-In Phase||0
528290|NCT00843024|1291197|P5|COMPLETED|Single-blind Placebo Run-In Phase||0
528291|NCT00843024|1291198|P4|COMPLETED|Single-blind Placebo Run-In Phase||0
528292|NCT00843024|1291199|P3|COMPLETED|Single-blind Placebo Run-In Phase||0
528293|NCT00843024|1291200|P2|COMPLETED|Single-blind Placebo Run-In Phase||321
528294|NCT00843024|1291201|P1|COMPLETED|Single-blind Placebo Run-In Phase||268
528295|NCT00843024|1291196|P6|STARTED|Single-blind Placebo Run-In Phase||0
528296|NCT00843024|1291197|P5|STARTED|Single-blind Placebo Run-In Phase||0
528297|NCT00843024|1291198|P4|STARTED|Single-blind Placebo Run-In Phase||0
528298|NCT00843024|1291199|P3|STARTED|Single-blind Placebo Run-In Phase||0
528299|NCT00843024|1291200|P2|STARTED|Single-blind Placebo Run-In Phase||457
528300|NCT00843024|1291201|P1|STARTED|Single-blind Placebo Run-In Phase||408
528301|NCT00842985|1291266|P1|NOT COMPLETED|Fourth Intervention||0
528302|NCT00842985|1291266|P1|COMPLETED|Fourth Intervention||15
528303|NCT00842985|1291266|P1|STARTED|Fourth Intervention||15
528304|NCT00842985|1291266|P1|NOT COMPLETED|Washout Period of GE 4 Days||0
528305|NCT00842985|1291266|P1|COMPLETED|Washout Period of GE 4 Days||15
528306|NCT00842985|1291266|P1|STARTED|Washout Period of GE 4 Days||15
528307|NCT00842985|1291266|P1|NOT COMPLETED|Third Intervention||0
528308|NCT00842985|1291266|P1|COMPLETED|Third Intervention||15
528309|NCT00842985|1291266|P1|STARTED|Third Intervention||15
528310|NCT00842985|1291266|P1|NOT COMPLETED|Washout Period of GE 4 Days||2
528311|NCT00842985|1291266|P1|COMPLETED|Washout Period of GE 4 Days||15
528312|NCT00842985|1291266|P1|STARTED|Washout Period of GE 4 Days||17
528313|NCT00842985|1291266|P1|NOT COMPLETED|Second Intervention||1
528314|NCT00842985|1291266|P1|COMPLETED|Second Intervention||17
528315|NCT00842985|1291266|P1|STARTED|Second Intervention||18
528316|NCT00842985|1291266|P1|NOT COMPLETED|Washout Period of GE 4 Days||2
528317|NCT00842985|1291266|P1|COMPLETED|Washout Period of GE 4 Days||18
528318|NCT00842985|1291266|P1|STARTED|Washout Period of GE 4 Days||20
528319|NCT00842985|1291266|P1|NOT COMPLETED|First Intervention||6
528320|NCT00842985|1291266|P1|COMPLETED|First Intervention|Completed 1st Intervention|20
528321|NCT00842985|1291266|P1|STARTED|First Intervention|Signed Consent|26
528322|NCT00842985|1291266|P1|NOT COMPLETED|Screening||27
528323|NCT00842985|1291266|P1|COMPLETED|Screening||26
528324|NCT00842985|1291266|P1|STARTED|Screening||53
528325|NCT00842946|1291275|P2|NOT COMPLETED|Overall Study||5
528326|NCT00842946|1291276|P1|NOT COMPLETED|Overall Study||5
528327|NCT00842946|1291275|P2|COMPLETED|Overall Study||19
528328|NCT00842946|1291276|P1|COMPLETED|Overall Study||16
528329|NCT00842946|1291275|P2|STARTED|Overall Study||24
528330|NCT00842946|1291276|P1|STARTED|Overall Study||21
528331|NCT00842829|1291284|P3|NOT COMPLETED|Continuation Period||61
528332|NCT00842829|1291285|P2|NOT COMPLETED|Continuation Period||0
528333|NCT00842829|1291286|P1|NOT COMPLETED|Continuation Period||0
528334|NCT00842829|1291284|P3|COMPLETED|Continuation Period||27
528335|NCT00842829|1291285|P2|COMPLETED|Continuation Period||0
528336|NCT00842829|1291286|P1|COMPLETED|Continuation Period||0
528337|NCT00842829|1291284|P3|Continuation Safety Analysis Set|Continuation Period|Received at least one dose of study drug|87
528338|NCT00842829|1291285|P2|Continuation Safety Analysis Set|Continuation Period||0
528339|NCT00842829|1291286|P1|Continuation Safety Analysis Set|Continuation Period||0
528340|NCT00842829|1291284|P3|STARTED|Continuation Period|Eligible for Continuation Period|88
528341|NCT00842829|1291285|P2|STARTED|Continuation Period||0
528342|NCT00842829|1291286|P1|STARTED|Continuation Period||0
528343|NCT00842829|1291284|P3|NOT COMPLETED|Treatment Period||63
528344|NCT00842829|1291285|P2|NOT COMPLETED|Treatment Period||0
528345|NCT00842829|1291286|P1|NOT COMPLETED|Treatment Period||0
528346|NCT00842829|1291284|P3|COMPLETED|Treatment Period||218
528347|NCT00842829|1291285|P2|COMPLETED|Treatment Period||0
528348|NCT00842829|1291286|P1|COMPLETED|Treatment Period||0
528349|NCT00842829|1291284|P3|Safety Analysis Set|Treatment Period|Received at least one dose of study drug|223
528350|NCT00842829|1291285|P2|Safety Analysis Set|Treatment Period||0
528351|NCT00842829|1291286|P1|Safety Analysis Set|Treatment Period||0
528352|NCT00842829|1291284|P3|STARTED|Treatment Period||281
528353|NCT00842829|1291285|P2|STARTED|Treatment Period||0
528354|NCT00842829|1291286|P1|STARTED|Treatment Period||0
528355|NCT00842829|1291284|P3|NOT COMPLETED|Dose Titration Period||0
528356|NCT00842829|1291285|P2|NOT COMPLETED|Dose Titration Period||23
528357|NCT00842829|1291286|P1|NOT COMPLETED|Dose Titration Period||26
528358|NCT00842829|1291284|P3|COMPLETED|Dose Titration Period||0
528359|NCT00842829|1291285|P2|COMPLETED|Dose Titration Period||151
528360|NCT00842829|1291286|P1|COMPLETED|Dose Titration Period||130
528361|NCT00842829|1291284|P3|Titration Safety Analysis Set|Dose Titration Period||0
528362|NCT00842829|1291285|P2|Titration Safety Analysis Set|Dose Titration Period|Received at least one dose of study drug|167
528363|NCT00842829|1291286|P1|Titration Safety Analysis Set|Dose Titration Period|Received at least one dose of study drug|145
528364|NCT00842829|1291284|P3|STARTED|Dose Titration Period||0
528365|NCT00842829|1291285|P2|STARTED|Dose Titration Period||174
528366|NCT00842829|1291286|P1|STARTED|Dose Titration Period||156
528367|NCT00842751|1291320|P1|NOT COMPLETED|Overall Study||0
528368|NCT00842751|1291320|P1|COMPLETED|Overall Study||11
528369|NCT00842751|1291320|P1|STARTED|Overall Study||11
528370|NCT00842712|1291341|P7|NOT COMPLETED|Randomized Part||6
528371|NCT00842712|1291342|P6|NOT COMPLETED|Randomized Part||1
528372|NCT00842712|1291343|P5|NOT COMPLETED|Randomized Part||0
528373|NCT00842712|1291344|P4|NOT COMPLETED|Randomized Part||0
528374|NCT00842712|1291345|P3|NOT COMPLETED|Randomized Part||0
528375|NCT00842712|1291346|P2|NOT COMPLETED|Randomized Part||0
528376|NCT00842712|1291347|P1|NOT COMPLETED|Randomized Part||0
528377|NCT00842712|1291341|P7|COMPLETED|Randomized Part||78
528378|NCT00842712|1291342|P6|COMPLETED|Randomized Part||50
528379|NCT00842712|1291343|P5|COMPLETED|Randomized Part||85
528380|NCT00842712|1291344|P4|COMPLETED|Randomized Part||0
528381|NCT00842712|1291345|P3|COMPLETED|Randomized Part||0
528382|NCT00842712|1291346|P2|COMPLETED|Randomized Part||0
528383|NCT00842712|1291347|P1|COMPLETED|Randomized Part||0
528384|NCT00842712|1291341|P7|Treated|Randomized Part||80
528385|NCT00842712|1291342|P6|Treated|Randomized Part||50
528386|NCT00842712|1291343|P5|Treated|Randomized Part||85
528387|NCT00842712|1291344|P4|Treated|Randomized Part||0
528388|NCT00842712|1291345|P3|Treated|Randomized Part||0
528389|NCT00842712|1291346|P2|Treated|Randomized Part||0
528390|NCT00842712|1291347|P1|Treated|Randomized Part||0
528391|NCT00842712|1291341|P7|STARTED|Randomized Part||84
528392|NCT00842712|1291342|P6|STARTED|Randomized Part||51
528393|NCT00842712|1291343|P5|STARTED|Randomized Part||85
528394|NCT00842712|1291344|P4|STARTED|Randomized Part||0
528395|NCT00842712|1291345|P3|STARTED|Randomized Part||0
528396|NCT00842712|1291346|P2|STARTED|Randomized Part||0
528397|NCT00842712|1291347|P1|STARTED|Randomized Part||0
528398|NCT00842712|1291341|P7|NOT COMPLETED|Safety Run-in Part||0
528399|NCT00842712|1291342|P6|NOT COMPLETED|Safety Run-in Part||0
528400|NCT00842712|1291343|P5|NOT COMPLETED|Safety Run-in Part||0
528401|NCT00842712|1291344|P4|NOT COMPLETED|Safety Run-in Part||1
528402|NCT00842712|1291345|P3|NOT COMPLETED|Safety Run-in Part||0
528403|NCT00842712|1291346|P2|NOT COMPLETED|Safety Run-in Part||2
528404|NCT00842712|1291347|P1|NOT COMPLETED|Safety Run-in Part||3
528405|NCT00842712|1291341|P7|COMPLETED|Safety Run-in Part||0
528406|NCT00842712|1291342|P6|COMPLETED|Safety Run-in Part||0
528407|NCT00842712|1291343|P5|COMPLETED|Safety Run-in Part||0
528408|NCT00842712|1291344|P4|COMPLETED|Safety Run-in Part||2
528409|NCT00842712|1291345|P3|COMPLETED|Safety Run-in Part||3
528410|NCT00842712|1291346|P2|COMPLETED|Safety Run-in Part||1
528411|NCT00842712|1291347|P1|COMPLETED|Safety Run-in Part||0
528412|NCT00842712|1291341|P7|STARTED|Safety Run-in Part||0
528413|NCT00842712|1291342|P6|STARTED|Safety Run-in Part||0
528414|NCT00842712|1291343|P5|STARTED|Safety Run-in Part||0
528415|NCT00842712|1291344|P4|STARTED|Safety Run-in Part||3
528416|NCT00842712|1291345|P3|STARTED|Safety Run-in Part||3
528417|NCT00842712|1291346|P2|STARTED|Safety Run-in Part||3
528418|NCT00842712|1291347|P1|STARTED|Safety Run-in Part||3
528419|NCT00842608|1291379|P4|NOT COMPLETED|Overall Study||0
528420|NCT00842608|1291380|P3|NOT COMPLETED|Overall Study||0
528421|NCT00842608|1291381|P2|NOT COMPLETED|Overall Study||0
528422|NCT00842608|1291382|P1|NOT COMPLETED|Overall Study||0
528423|NCT00842608|1291379|P4|COMPLETED|Overall Study||100
528424|NCT00842608|1291380|P3|COMPLETED|Overall Study||99
528425|NCT00842608|1291381|P2|COMPLETED|Overall Study||176
528426|NCT00842608|1291382|P1|COMPLETED|Overall Study||170
528427|NCT00842608|1291379|P4|STARTED|Overall Study||100
528428|NCT00842608|1291380|P3|STARTED|Overall Study||99
528429|NCT00842608|1291381|P2|STARTED|Overall Study||176
528430|NCT00842608|1291382|P1|STARTED|Overall Study||170
528431|NCT00842543|1291404|P4|NOT COMPLETED|Overall Study||4
528432|NCT00842543|1291405|P3|NOT COMPLETED|Overall Study||3
528433|NCT00842543|1291406|P2|NOT COMPLETED|Overall Study||0
528434|NCT00842543|1291407|P1|NOT COMPLETED|Overall Study||2
528435|NCT00842543|1291404|P4|COMPLETED|Overall Study||4
528436|NCT00842543|1291405|P3|COMPLETED|Overall Study||10
528437|NCT00842543|1291406|P2|COMPLETED|Overall Study||5
528438|NCT00842543|1291407|P1|COMPLETED|Overall Study||11
528439|NCT00842543|1291404|P4|STARTED|Overall Study||8
528440|NCT00842543|1291405|P3|STARTED|Overall Study||13
528441|NCT00842543|1291406|P2|STARTED|Overall Study||5
528442|NCT00842543|1291407|P1|STARTED|Overall Study||13
528443|NCT00842361|1291421|P2|NOT COMPLETED|Overall Study||2
528444|NCT00842361|1291422|P1|NOT COMPLETED|Overall Study||1
528445|NCT00842361|1291421|P2|COMPLETED|Overall Study||31
528446|NCT00842361|1291422|P1|COMPLETED|Overall Study||32
528447|NCT00842361|1291421|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|32
528448|NCT00842361|1291422|P1|Exposed|Overall Study||33
528449|NCT00842361|1291421|P2|STARTED|Overall Study||33
528450|NCT00842361|1291422|P1|STARTED|Overall Study||33
528451|NCT00842348|1291442|P2|NOT COMPLETED|Study 729||38
528452|NCT00842348|1291443|P1|NOT COMPLETED|Study 729||26
528453|NCT00842348|1291442|P2|COMPLETED|Study 729|Enrolled in Study 729 and received at least one dose of open label lanreotide Autogel.|9
528454|NCT00842348|1291443|P1|COMPLETED|Study 729|Enrolled in Study 729 and received at least one dose of open label lanreotide Autogel.|16
528455|NCT00842348|1291442|P2|STARTED|Study 729||47
528456|NCT00842348|1291443|P1|STARTED|Study 729||42
528457|NCT00842348|1291442|P2|NOT COMPLETED|Patients Randomised in Study 726||56
528458|NCT00842348|1291443|P1|NOT COMPLETED|Patients Randomised in Study 726||59
528459|NCT00842348|1291442|P2|COMPLETED|Patients Randomised in Study 726|15 patients had stable disease and 32 patients had progressive disease.|47
528460|NCT00842348|1291443|P1|COMPLETED|Patients Randomised in Study 726|41 patients had stable disease and 1 patient had progressive disease.|42
528461|NCT00842348|1291442|P2|STARTED|Patients Randomised in Study 726||103
528462|NCT00842348|1291443|P1|STARTED|Patients Randomised in Study 726||101
528463|NCT00842335|1291453|P1|NOT COMPLETED|Overall Study||0
528464|NCT00842335|1291453|P1|COMPLETED|Overall Study||18
528465|NCT00842335|1291453|P1|STARTED|Overall Study||18
528466|NCT00842296|1291460|P1|NOT COMPLETED|Overall Study||0
528467|NCT00842296|1291460|P1|COMPLETED|Overall Study||326
528468|NCT00842296|1291460|P1|STARTED|Overall Study||326
528469|NCT00842257|1291486|P1|NOT COMPLETED|Overall Study||1
528470|NCT00842257|1291486|P1|COMPLETED|Overall Study||19
528471|NCT00842257|1291486|P1|STARTED|Overall Study||20
528472|NCT00842244|1291493|P1|NOT COMPLETED|Overall Study||21
528473|NCT00842244|1291493|P1|COMPLETED|Overall Study||1
528474|NCT00842244|1291493|P1|STARTED|Overall Study||22
528475|NCT00842231|1291512|P1|NOT COMPLETED|Overall Study||0
528476|NCT00842231|1291512|P1|COMPLETED|Overall Study||40
528477|NCT00842231|1291512|P1|STARTED|Overall Study||40
528478|NCT00842153|1291520|P2|NOT COMPLETED|Overall Study||3
528479|NCT00842153|1291521|P1|NOT COMPLETED|Overall Study||1
528480|NCT00842153|1291520|P2|COMPLETED|Overall Study||27
528481|NCT00842153|1291521|P1|COMPLETED|Overall Study||27
528482|NCT00842153|1291520|P2|STARTED|Overall Study||30
528483|NCT00842153|1291521|P1|STARTED|Overall Study||28
528484|NCT00842075|1291561|P2|NOT COMPLETED|Overall Study||0
528485|NCT00842075|1291562|P1|NOT COMPLETED|Overall Study||0
528486|NCT00842075|1291561|P2|COMPLETED|Overall Study||5
528487|NCT00842075|1291562|P1|COMPLETED|Overall Study||5
528488|NCT00842075|1291561|P2|STARTED|Overall Study||5
528489|NCT00842075|1291562|P1|STARTED|Overall Study||5
528490|NCT00842023|1291572|P2|NOT COMPLETED|Overall Study||0
528491|NCT00842023|1291573|P1|NOT COMPLETED|Overall Study||0
528492|NCT00842023|1291572|P2|COMPLETED|Overall Study||44
528493|NCT00842023|1291573|P1|COMPLETED|Overall Study||45
528494|NCT00842023|1291572|P2|STARTED|Overall Study||44
528495|NCT00842023|1291573|P1|STARTED|Overall Study||45
528496|NCT00841971|1291585|P2|NOT COMPLETED|Overall Study||1
528497|NCT00841971|1291586|P1|NOT COMPLETED|Overall Study||2
528498|NCT00841971|1291585|P2|COMPLETED|Overall Study||99
528499|NCT00841971|1291586|P1|COMPLETED|Overall Study||98
528500|NCT00841971|1291585|P2|STARTED|Overall Study||100
528501|NCT00841971|1291586|P1|STARTED|Overall Study||100
528502|NCT00841906|1291596|P2|NOT COMPLETED|Overall Study||0
528503|NCT00841906|1291597|P1|NOT COMPLETED|Overall Study||2
528504|NCT00841906|1291596|P2|COMPLETED|Overall Study||15
528505|NCT00841906|1291597|P1|COMPLETED|Overall Study||15
528506|NCT00841906|1291596|P2|STARTED|Overall Study||15
528507|NCT00841906|1291597|P1|STARTED|Overall Study||17
528508|NCT00841815|1291611|P2|NOT COMPLETED|Period 2||0
528509|NCT00841815|1291612|P1|NOT COMPLETED|Period 2||0
528510|NCT00841815|1291611|P2|COMPLETED|Period 2||13
528511|NCT00841815|1291612|P1|COMPLETED|Period 2||14
528512|NCT00841815|1291611|P2|STARTED|Period 2||13
528513|NCT00841815|1291612|P1|STARTED|Period 2||14
528514|NCT00841815|1291611|P2|NOT COMPLETED|Washout||1
528515|NCT00841815|1291612|P1|NOT COMPLETED|Washout||0
528516|NCT00841815|1291611|P2|COMPLETED|Washout||13
528517|NCT00841815|1291612|P1|COMPLETED|Washout||14
528518|NCT00841815|1291611|P2|STARTED|Washout||14
528519|NCT00841815|1291612|P1|STARTED|Washout||14
528520|NCT00841815|1291611|P2|NOT COMPLETED|Period 1||0
528521|NCT00841815|1291612|P1|NOT COMPLETED|Period 1||0
528522|NCT00841815|1291611|P2|COMPLETED|Period 1||14
528523|NCT00841815|1291612|P1|COMPLETED|Period 1||14
528524|NCT00841815|1291611|P2|STARTED|Period 1||14
528525|NCT00841815|1291612|P1|STARTED|Period 1||14
528526|NCT00841776|1291622|P2|NOT COMPLETED|Overall Study||3
528527|NCT00841776|1291623|P1|NOT COMPLETED|Overall Study||2
528528|NCT00841776|1291622|P2|COMPLETED|Overall Study||24
528529|NCT00841776|1291623|P1|COMPLETED|Overall Study||25
528530|NCT00841776|1291622|P2|STARTED|Overall Study||27
528531|NCT00841776|1291623|P1|STARTED|Overall Study||27
528532|NCT00841763|1291641|P4|NOT COMPLETED|Overall Study||3
528533|NCT00841763|1291642|P3|NOT COMPLETED|Overall Study||8
528534|NCT00841763|1291643|P2|NOT COMPLETED|Overall Study||57
528535|NCT00841763|1291644|P1|NOT COMPLETED|Overall Study||162
528536|NCT00841763|1291641|P4|COMPLETED|Overall Study||53
528537|NCT00841763|1291642|P3|COMPLETED|Overall Study||211
528538|NCT00841763|1291643|P2|COMPLETED|Overall Study||624
528539|NCT00841763|1291644|P1|COMPLETED|Overall Study||2529
528540|NCT00841763|1291641|P4|STARTED|Overall Study||56
528541|NCT00841763|1291642|P3|STARTED|Overall Study||219
528542|NCT00841763|1291643|P2|STARTED|Overall Study||681
528543|NCT00841763|1291644|P1|STARTED|Overall Study||2691
528544|NCT00841698|1291706|P2|NOT COMPLETED|Second Intervention||0
528545|NCT00841698|1291707|P1|NOT COMPLETED|Second Intervention||0
528546|NCT00841698|1291706|P2|COMPLETED|Second Intervention||25
528547|NCT00841698|1291707|P1|COMPLETED|Second Intervention||24
528548|NCT00841698|1291706|P2|STARTED|Second Intervention||25
528549|NCT00841698|1291707|P1|STARTED|Second Intervention||24
528550|NCT00841698|1291706|P2|NOT COMPLETED|Washout: 2 Weeks||0
528551|NCT00841698|1291707|P1|NOT COMPLETED|Washout: 2 Weeks||0
528552|NCT00841698|1291706|P2|COMPLETED|Washout: 2 Weeks||25
528553|NCT00841698|1291707|P1|COMPLETED|Washout: 2 Weeks||24
528554|NCT00841698|1291706|P2|STARTED|Washout: 2 Weeks||25
528555|NCT00841698|1291707|P1|STARTED|Washout: 2 Weeks||24
528556|NCT00841698|1291706|P2|NOT COMPLETED|First Intervention||0
528557|NCT00841698|1291707|P1|NOT COMPLETED|First Intervention||1
528558|NCT00841698|1291706|P2|COMPLETED|First Intervention||25
528559|NCT00841698|1291707|P1|COMPLETED|First Intervention||24
528560|NCT00841698|1291706|P2|STARTED|First Intervention||25
528561|NCT00841698|1291707|P1|STARTED|First Intervention||25
528562|NCT00841672|1291717|P2|NOT COMPLETED|Overall Study||32
528563|NCT00841672|1291718|P1|NOT COMPLETED|Overall Study||20
528564|NCT00841672|1291717|P2|COMPLETED|Overall Study||209
528565|NCT00841672|1291718|P1|COMPLETED|Overall Study||224
528566|NCT00841672|1291717|P2|STARTED|Overall Study||241
528567|NCT00841672|1291718|P1|STARTED|Overall Study|One patient was mis-randomized and was not treated in the double-blind treatment period.|244
528568|NCT00841659|1291734|P2|NOT COMPLETED|Second Intervention||0
528569|NCT00841659|1291735|P1|NOT COMPLETED|Second Intervention||0
528570|NCT00841659|1291734|P2|COMPLETED|Second Intervention||12
528571|NCT00841659|1291735|P1|COMPLETED|Second Intervention||11
528572|NCT00841659|1291734|P2|STARTED|Second Intervention||12
528573|NCT00841659|1291735|P1|STARTED|Second Intervention||11
528574|NCT00841659|1291734|P2|NOT COMPLETED|Washout: 2 Weeks||0
528575|NCT00841659|1291735|P1|NOT COMPLETED|Washout: 2 Weeks||1
528576|NCT00841659|1291734|P2|COMPLETED|Washout: 2 Weeks||12
528577|NCT00841659|1291735|P1|COMPLETED|Washout: 2 Weeks||11
528578|NCT00841659|1291734|P2|STARTED|Washout: 2 Weeks||12
528579|NCT00841659|1291735|P1|STARTED|Washout: 2 Weeks||12
528580|NCT00841659|1291734|P2|NOT COMPLETED|First Intervention||0
528581|NCT00841659|1291735|P1|NOT COMPLETED|First Intervention||0
528582|NCT00841659|1291734|P2|COMPLETED|First Intervention||12
528583|NCT00841659|1291735|P1|COMPLETED|First Intervention||12
528584|NCT00841659|1291734|P2|STARTED|First Intervention||12
528585|NCT00841659|1291735|P1|STARTED|First Intervention||12
528586|NCT00841555|1291746|P3|NOT COMPLETED|Overall Study||0
528587|NCT00841555|1291747|P2|NOT COMPLETED|Overall Study||0
528588|NCT00841555|1291748|P1|NOT COMPLETED|Overall Study||0
528589|NCT00841555|1291746|P3|COMPLETED|Overall Study||3
528590|NCT00841555|1291747|P2|COMPLETED|Overall Study||3
528591|NCT00841555|1291748|P1|COMPLETED|Overall Study||3
528592|NCT00841555|1291746|P3|STARTED|Overall Study||3
528593|NCT00841555|1291747|P2|STARTED|Overall Study||3
528594|NCT00841555|1291748|P1|STARTED|Overall Study||3
528595|NCT00841542|1291758|P2|NOT COMPLETED|Period 2||0
528596|NCT00841542|1291759|P1|NOT COMPLETED|Period 2||0
528597|NCT00841542|1291758|P2|COMPLETED|Period 2||14
528598|NCT00841542|1291759|P1|COMPLETED|Period 2||13
528599|NCT00841542|1291758|P2|STARTED|Period 2||14
528600|NCT00841542|1291759|P1|STARTED|Period 2||13
528601|NCT00841542|1291758|P2|NOT COMPLETED|Period 1||0
528602|NCT00841542|1291759|P1|NOT COMPLETED|Period 1||1
528603|NCT00841542|1291758|P2|COMPLETED|Period 1||14
528604|NCT00841542|1291759|P1|COMPLETED|Period 1||13
528605|NCT00841542|1291758|P2|STARTED|Period 1||14
528606|NCT00841542|1291759|P1|STARTED|Period 1||14
528607|NCT00841412|1291767|P2|NOT COMPLETED|Overall Study||30
528608|NCT00841412|1291768|P1|NOT COMPLETED|Overall Study||40
528609|NCT00841412|1291767|P2|COMPLETED|Overall Study||50
528610|NCT00841412|1291768|P1|COMPLETED|Overall Study|130 residents completed all study phases across both groups, including follow-up.|80
528611|NCT00841412|1291767|P2|STARTED|Overall Study|80 residents were in the delayed intervention group, but all residents received intervention.|80
528612|NCT00841412|1291768|P1|STARTED|Overall Study|200 of 222 consented residents completed baseline assessments across both groups.|120
528613|NCT00841321|1291774|P2|NOT COMPLETED|Overall Study||3
528614|NCT00841321|1291775|P1|NOT COMPLETED|Overall Study||1
528615|NCT00841321|1291774|P2|COMPLETED|Overall Study||58
528616|NCT00841321|1291775|P1|COMPLETED|Overall Study||58
528617|NCT00841321|1291774|P2|STARTED|Overall Study||61
528618|NCT00841321|1291775|P1|STARTED|Overall Study||59
528619|NCT00841269|1291789|P2|NOT COMPLETED|Overall Study||9
528620|NCT00841269|1291790|P1|NOT COMPLETED|Overall Study||8
528621|NCT00841269|1291789|P2|COMPLETED|Overall Study||13
528622|NCT00841269|1291790|P1|COMPLETED|Overall Study||12
528623|NCT00841269|1291789|P2|STARTED|Overall Study||22
528624|NCT00841269|1291790|P1|STARTED|Overall Study||20
528625|NCT00841204|1291801|P2|NOT COMPLETED|Overall Study||0
528626|NCT00841204|1291802|P1|NOT COMPLETED|Overall Study||0
528627|NCT00841204|1291801|P2|COMPLETED|Overall Study||25
528628|NCT00841204|1291802|P1|COMPLETED|Overall Study||25
528629|NCT00841204|1291801|P2|STARTED|Overall Study||25
528630|NCT00841204|1291802|P1|STARTED|Overall Study||25
528631|NCT00841087|1291824|P2|NOT COMPLETED|Overall Study||0
528632|NCT00841087|1291825|P1|NOT COMPLETED|Overall Study||0
528633|NCT00841087|1291824|P2|COMPLETED|Overall Study||32
528634|NCT00841087|1291825|P1|COMPLETED|Overall Study||33
528635|NCT00841087|1291824|P2|STARTED|Overall Study||32
528636|NCT00841087|1291825|P1|STARTED|Overall Study||33
528637|NCT00841035|1291843|P1|NOT COMPLETED|Phase 2 of Overall Study||0
528638|NCT00841035|1291843|P1|COMPLETED|Phase 2 of Overall Study||6
528639|NCT00841035|1291843|P1|STARTED|Phase 2 of Overall Study||6
528640|NCT00841035|1291843|P1|NOT COMPLETED|Phase 1 Overall Study||13
528641|NCT00841035|1291843|P1|COMPLETED|Phase 1 Overall Study||6
528642|NCT00841035|1291843|P1|STARTED|Phase 1 Overall Study|2 phase enrollment,1st phase enrolled with cancer by fine needle aspiration in endoscopic ultrasound|19
528643|NCT00840996|1291850|P2|NOT COMPLETED|Overall Study||0
528644|NCT00840996|1291851|P1|NOT COMPLETED|Overall Study||1
528645|NCT00840996|1291850|P2|COMPLETED|Overall Study||58
528646|NCT00840996|1291851|P1|COMPLETED|Overall Study||57
528647|NCT00840996|1291850|P2|STARTED|Overall Study||58
528648|NCT00840996|1291851|P1|STARTED|Overall Study||58
528649|NCT00840879|1291871|P2|NOT COMPLETED|Second Intervention||0
528650|NCT00840879|1291872|P1|NOT COMPLETED|Second Intervention||1
528651|NCT00840879|1291871|P2|COMPLETED|Second Intervention||14
528652|NCT00840879|1291872|P1|COMPLETED|Second Intervention||13
528653|NCT00840879|1291871|P2|STARTED|Second Intervention||14
528654|NCT00840879|1291872|P1|STARTED|Second Intervention||14
528655|NCT00840879|1291871|P2|NOT COMPLETED|Washout: 14 Days||0
528656|NCT00840879|1291872|P1|NOT COMPLETED|Washout: 14 Days||0
528657|NCT00840879|1291871|P2|COMPLETED|Washout: 14 Days||14
528658|NCT00840879|1291872|P1|COMPLETED|Washout: 14 Days||14
528659|NCT00840879|1291871|P2|STARTED|Washout: 14 Days||14
528660|NCT00840879|1291872|P1|STARTED|Washout: 14 Days||14
528661|NCT00840879|1291871|P2|NOT COMPLETED|First Intervention||0
528662|NCT00840879|1291872|P1|NOT COMPLETED|First Intervention||0
528663|NCT00840879|1291871|P2|COMPLETED|First Intervention||14
528664|NCT00840879|1291872|P1|COMPLETED|First Intervention||14
528665|NCT00840879|1291871|P2|STARTED|First Intervention||14
528666|NCT00840879|1291872|P1|STARTED|First Intervention||14
528667|NCT00840866|1291882|P2|NOT COMPLETED|Second Intervention||0
528668|NCT00840866|1291883|P1|NOT COMPLETED|Second Intervention||0
528669|NCT00840866|1291882|P2|COMPLETED|Second Intervention||19
528670|NCT00840866|1291883|P1|COMPLETED|Second Intervention||20
528671|NCT00840866|1291882|P2|STARTED|Second Intervention||19
528672|NCT00840866|1291883|P1|STARTED|Second Intervention||20
528673|NCT00840866|1291882|P2|NOT COMPLETED|Washout of 7 Days||0
528674|NCT00840866|1291883|P1|NOT COMPLETED|Washout of 7 Days||0
528675|NCT00840866|1291882|P2|COMPLETED|Washout of 7 Days||19
528676|NCT00840866|1291883|P1|COMPLETED|Washout of 7 Days||20
528677|NCT00840866|1291882|P2|STARTED|Washout of 7 Days||19
528678|NCT00840866|1291883|P1|STARTED|Washout of 7 Days||20
528679|NCT00840866|1291882|P2|NOT COMPLETED|First Intervention||0
528680|NCT00840866|1291883|P1|NOT COMPLETED|First Intervention||0
528681|NCT00840866|1291882|P2|COMPLETED|First Intervention||19
528682|NCT00840866|1291883|P1|COMPLETED|First Intervention||20
528683|NCT00840866|1291882|P2|STARTED|First Intervention||19
528684|NCT00840866|1291883|P1|STARTED|First Intervention||20
528685|NCT00840840|1291893|P2|NOT COMPLETED|Period 2||0
528686|NCT00840840|1291894|P1|NOT COMPLETED|Period 2||0
528687|NCT00840840|1291893|P2|COMPLETED|Period 2||24
528688|NCT00840840|1291894|P1|COMPLETED|Period 2||23
528689|NCT00840840|1291893|P2|STARTED|Period 2||24
528690|NCT00840840|1291894|P1|STARTED|Period 2|One subject was withdrawn due to AE after Period 1|23
528691|NCT00840840|1291893|P2|NOT COMPLETED|Period 1||0
528692|NCT00840840|1291894|P1|NOT COMPLETED|Period 1||0
528693|NCT00840840|1291893|P2|COMPLETED|Period 1||24
528694|NCT00840840|1291894|P1|COMPLETED|Period 1||24
528695|NCT00840840|1291893|P2|STARTED|Period 1||24
528696|NCT00840840|1291894|P1|STARTED|Period 1||24
528697|NCT00840658|1291912|P4|NOT COMPLETED|Overall Study||4
528698|NCT00840658|1291913|P3|NOT COMPLETED|Overall Study||5
528699|NCT00840658|1291914|P2|NOT COMPLETED|Overall Study||3
528700|NCT00840658|1291915|P1|NOT COMPLETED|Overall Study||5
528701|NCT00840658|1291912|P4|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|142
528702|NCT00840658|1291913|P3|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|143
528703|NCT00840658|1291914|P2|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|143
528704|NCT00840658|1291915|P1|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|139
528705|NCT00840658|1291912|P4|STARTED|Overall Study||146
528706|NCT00840658|1291913|P3|STARTED|Overall Study||148
528707|NCT00840658|1291914|P2|STARTED|Overall Study||146
528708|NCT00840658|1291915|P1|STARTED|Overall Study||144
528709|NCT00840632|1291927|P2|NOT COMPLETED|Second Intervention||0
528710|NCT00840632|1291928|P1|NOT COMPLETED|Second Intervention||0
528711|NCT00840632|1291927|P2|COMPLETED|Second Intervention||18
528712|NCT00840632|1291928|P1|COMPLETED|Second Intervention||19
528713|NCT00840632|1291927|P2|STARTED|Second Intervention||18
528714|NCT00840632|1291928|P1|STARTED|Second Intervention||19
528715|NCT00840632|1291927|P2|NOT COMPLETED|Washout||1
528716|NCT00840632|1291928|P1|NOT COMPLETED|Washout||1
528717|NCT00840632|1291927|P2|COMPLETED|Washout||18
528718|NCT00840632|1291928|P1|COMPLETED|Washout||19
528719|NCT00840632|1291927|P2|STARTED|Washout||19
528720|NCT00840632|1291928|P1|STARTED|Washout||20
528721|NCT00840632|1291927|P2|NOT COMPLETED|First Intervention||1
528722|NCT00840632|1291928|P1|NOT COMPLETED|First Intervention||0
528723|NCT00840632|1291927|P2|COMPLETED|First Intervention||19
528724|NCT00840632|1291928|P1|COMPLETED|First Intervention||20
528725|NCT00840632|1291927|P2|STARTED|First Intervention||20
528726|NCT00840632|1291928|P1|STARTED|First Intervention||20
528727|NCT00840476|1291944|P2|NOT COMPLETED|Second Intervention||0
528728|NCT00840476|1291945|P1|NOT COMPLETED|Second Intervention||0
528729|NCT00840476|1291944|P2|COMPLETED|Second Intervention||14
528730|NCT00840476|1291945|P1|COMPLETED|Second Intervention||14
528731|NCT00840476|1291944|P2|STARTED|Second Intervention||14
528732|NCT00840476|1291945|P1|STARTED|Second Intervention||14
528733|NCT00840476|1291944|P2|NOT COMPLETED|Washout: 14 Days||0
528734|NCT00840476|1291945|P1|NOT COMPLETED|Washout: 14 Days||0
528735|NCT00840476|1291944|P2|COMPLETED|Washout: 14 Days||14
528736|NCT00840476|1291945|P1|COMPLETED|Washout: 14 Days||14
528737|NCT00840476|1291944|P2|STARTED|Washout: 14 Days||14
528738|NCT00840476|1291945|P1|STARTED|Washout: 14 Days||14
528739|NCT00840476|1291944|P2|NOT COMPLETED|First Intervention||0
528740|NCT00840476|1291945|P1|NOT COMPLETED|First Intervention||0
528741|NCT00840476|1291944|P2|COMPLETED|First Intervention||14
528742|NCT00840476|1291945|P1|COMPLETED|First Intervention||14
528743|NCT00840476|1291944|P2|STARTED|First Intervention||14
528744|NCT00840476|1291945|P1|STARTED|First Intervention||14
528745|NCT00840450|1291953|P1|NOT COMPLETED|Overall Study||3
528746|NCT00840450|1291953|P1|COMPLETED|Overall Study||9
528747|NCT00840450|1291953|P1|STARTED|Overall Study||12
528748|NCT00840411|1291961|P2|NOT COMPLETED|Second Intervention||0
528749|NCT00840411|1291962|P1|NOT COMPLETED|Second Intervention||0
528750|NCT00840411|1291961|P2|COMPLETED|Second Intervention||33
528751|NCT00840411|1291962|P1|COMPLETED|Second Intervention||31
528752|NCT00840411|1291961|P2|STARTED|Second Intervention||33
528753|NCT00840411|1291962|P1|STARTED|Second Intervention||31
528754|NCT00840411|1291961|P2|NOT COMPLETED|Washout||0
528755|NCT00840411|1291962|P1|NOT COMPLETED|Washout||1
528756|NCT00840411|1291961|P2|COMPLETED|Washout||33
528757|NCT00840411|1291962|P1|COMPLETED|Washout||31
528758|NCT00840411|1291961|P2|STARTED|Washout||33
528759|NCT00840411|1291962|P1|STARTED|Washout||32
528760|NCT00840411|1291961|P2|NOT COMPLETED|First Intervention||0
528761|NCT00840411|1291962|P1|NOT COMPLETED|First Intervention||1
528762|NCT00840411|1291961|P2|COMPLETED|First Intervention||33
528763|NCT00840411|1291962|P1|COMPLETED|First Intervention||32
528764|NCT00840411|1291961|P2|STARTED|First Intervention||33
528765|NCT00840411|1291962|P1|STARTED|First Intervention||33
528766|NCT00840307|1291970|P1|NOT COMPLETED|Overall Study||4
528767|NCT00840307|1291970|P1|COMPLETED|Overall Study||16
528768|NCT00840307|1291970|P1|STARTED|Overall Study||20
528769|NCT00840294|1291976|P2|NOT COMPLETED|Overall Study||5
528770|NCT00840294|1291977|P1|NOT COMPLETED|Overall Study||3
528771|NCT00840294|1291976|P2|COMPLETED|Overall Study|These are the subjects included in the baseline, outcomes, and adverse events tables|38
528772|NCT00840294|1291977|P1|COMPLETED|Overall Study|These are the subjects included in the baseline, outcomes, and adverse events tables|39
528773|NCT00840294|1291976|P2|STARTED|Overall Study||43
528774|NCT00840294|1291977|P1|STARTED|Overall Study||42
528775|NCT00840281|1291987|P2|NOT COMPLETED|Second Intervention||0
528776|NCT00840281|1291988|P1|NOT COMPLETED|Second Intervention||0
528777|NCT00840281|1291987|P2|COMPLETED|Second Intervention||19
528778|NCT00840281|1291988|P1|COMPLETED|Second Intervention||19
528779|NCT00840281|1291987|P2|STARTED|Second Intervention||19
528780|NCT00840281|1291988|P1|STARTED|Second Intervention||19
528781|NCT00840281|1291987|P2|NOT COMPLETED|Washout of 7 Days||0
528782|NCT00840281|1291988|P1|NOT COMPLETED|Washout of 7 Days||0
528783|NCT00840281|1291987|P2|COMPLETED|Washout of 7 Days||19
528784|NCT00840281|1291988|P1|COMPLETED|Washout of 7 Days||19
528785|NCT00840281|1291987|P2|STARTED|Washout of 7 Days||19
528786|NCT00840281|1291988|P1|STARTED|Washout of 7 Days||19
528787|NCT00840281|1291987|P2|NOT COMPLETED|First Intervention||0
528788|NCT00840281|1291988|P1|NOT COMPLETED|First Intervention||0
528789|NCT00840281|1291987|P2|COMPLETED|First Intervention||19
528790|NCT00840281|1291988|P1|COMPLETED|First Intervention||19
528791|NCT00840281|1291987|P2|STARTED|First Intervention||19
528792|NCT00840281|1291988|P1|STARTED|First Intervention||19
528793|NCT00840216|1291998|P2|NOT COMPLETED|Second Intervention||0
528794|NCT00840216|1291999|P1|NOT COMPLETED|Second Intervention||0
528795|NCT00840216|1291998|P2|COMPLETED|Second Intervention||11
528796|NCT00840216|1291999|P1|COMPLETED|Second Intervention||10
528797|NCT00840216|1291998|P2|STARTED|Second Intervention||11
528798|NCT00840216|1291999|P1|STARTED|Second Intervention||10
528799|NCT00840216|1291998|P2|NOT COMPLETED|Washout: 7 Days||0
528800|NCT00840216|1291999|P1|NOT COMPLETED|Washout: 7 Days||1
528801|NCT00840216|1291998|P2|COMPLETED|Washout: 7 Days||11
528802|NCT00840216|1291999|P1|COMPLETED|Washout: 7 Days||10
528803|NCT00840216|1291998|P2|STARTED|Washout: 7 Days||11
528804|NCT00840216|1291999|P1|STARTED|Washout: 7 Days||11
528805|NCT00840216|1291998|P2|NOT COMPLETED|First Intervention||0
528806|NCT00840216|1291999|P1|NOT COMPLETED|First Intervention||0
528807|NCT00840216|1291998|P2|COMPLETED|First Intervention||11
528808|NCT00840216|1291999|P1|COMPLETED|First Intervention||11
528809|NCT00840216|1291998|P2|STARTED|First Intervention||11
528810|NCT00840216|1291999|P1|STARTED|First Intervention||11
528811|NCT00840203|1292009|P2|NOT COMPLETED|Second Intervention||0
528812|NCT00840203|1292010|P1|NOT COMPLETED|Second Intervention||0
528813|NCT00840203|1292009|P2|COMPLETED|Second Intervention||34
528814|NCT00840203|1292010|P1|COMPLETED|Second Intervention||35
528815|NCT00840203|1292009|P2|STARTED|Second Intervention||34
528816|NCT00840203|1292010|P1|STARTED|Second Intervention||35
528817|NCT00840203|1292009|P2|NOT COMPLETED|Washout||0
528818|NCT00840203|1292010|P1|NOT COMPLETED|Washout||1
528819|NCT00840203|1292009|P2|COMPLETED|Washout||34
528820|NCT00840203|1292010|P1|COMPLETED|Washout||35
528821|NCT00840203|1292009|P2|STARTED|Washout||34
528822|NCT00840203|1292010|P1|STARTED|Washout||36
528823|NCT00840203|1292009|P2|NOT COMPLETED|First Intervention||1
528824|NCT00840203|1292010|P1|NOT COMPLETED|First Intervention||1
528825|NCT00840203|1292009|P2|COMPLETED|First Intervention||34
528826|NCT00840203|1292010|P1|COMPLETED|First Intervention||36
528827|NCT00840203|1292009|P2|STARTED|First Intervention||35
528828|NCT00840203|1292010|P1|STARTED|First Intervention||37
528829|NCT00840099|1292026|P2|NOT COMPLETED|Period 2||0
528830|NCT00840099|1292027|P1|NOT COMPLETED|Period 2||0
528831|NCT00840099|1292026|P2|COMPLETED|Period 2||24
528832|NCT00840099|1292027|P1|COMPLETED|Period 2||21
528833|NCT00840099|1292026|P2|STARTED|Period 2||24
528834|NCT00840099|1292027|P1|STARTED|Period 2|3 subjects were dismissed from study prior to period 2 dosing|21
528835|NCT00840099|1292026|P2|NOT COMPLETED|Period 1||0
528836|NCT00840099|1292027|P1|NOT COMPLETED|Period 1||0
528837|NCT00840099|1292026|P2|COMPLETED|Period 1||24
528838|NCT00840099|1292027|P1|COMPLETED|Period 1||24
528839|NCT00840099|1292026|P2|STARTED|Period 1||24
528840|NCT00840099|1292027|P1|STARTED|Period 1||24
528841|NCT00840086|1292041|P1|NOT COMPLETED|Overall Study||4
528842|NCT00840086|1292041|P1|COMPLETED|Overall Study||146
528843|NCT00840086|1292041|P1|STARTED|Overall Study||150
528844|NCT00840073|1292050|P2|NOT COMPLETED|Second Intervention||1
528845|NCT00840073|1292051|P1|NOT COMPLETED|Second Intervention||1
528846|NCT00840073|1292050|P2|COMPLETED|Second Intervention||24
528847|NCT00840073|1292051|P1|COMPLETED|Second Intervention||24
528848|NCT00840073|1292050|P2|STARTED|Second Intervention||25
528849|NCT00840073|1292051|P1|STARTED|Second Intervention||25
528850|NCT00840073|1292050|P2|NOT COMPLETED|First Intervention||0
528851|NCT00840073|1292051|P1|NOT COMPLETED|First Intervention||0
528852|NCT00840073|1292050|P2|COMPLETED|First Intervention||25
528853|NCT00840073|1292051|P1|COMPLETED|First Intervention||25
528854|NCT00840073|1292050|P2|STARTED|First Intervention||25
528855|NCT00840073|1292051|P1|STARTED|First Intervention||25
528856|NCT00840060|1292065|P2|NOT COMPLETED|Overall Study||1
528857|NCT00840060|1292066|P1|NOT COMPLETED|Overall Study||1
528858|NCT00840060|1292065|P2|COMPLETED|Overall Study||19
528859|NCT00840060|1292066|P1|COMPLETED|Overall Study||19
528860|NCT00840060|1292065|P2|STARTED|Overall Study||20
528861|NCT00840060|1292066|P1|STARTED|Overall Study||20
528862|NCT00840034|1292076|P2|NOT COMPLETED|Taper Phase||2
528863|NCT00840034|1292077|P1|NOT COMPLETED|Taper Phase||3
528864|NCT00840034|1292076|P2|COMPLETED|Taper Phase||80
528865|NCT00840034|1292077|P1|COMPLETED|Taper Phase||87
528866|NCT00840034|1292076|P2|STARTED|Taper Phase|Completed Acute Treatment (AT) or discontinued ≥4 weeks of AT and chose to participate in Taper.|82
528867|NCT00840034|1292077|P1|STARTED|Taper Phase|Completed Acute Treatment (AT) or discontinued ≥4 weeks of AT and chose to participate in Taper.|90
528868|NCT00840034|1292076|P2|NOT COMPLETED|Acute Treatment Phase||36
528869|NCT00840034|1292077|P1|NOT COMPLETED|Acute Treatment Phase||21
528870|NCT00840034|1292076|P2|COMPLETED|Acute Treatment Phase||80
528871|NCT00840034|1292077|P1|COMPLETED|Acute Treatment Phase||90
528872|NCT00840034|1292076|P2|STARTED|Acute Treatment Phase||116
528873|NCT00840034|1292077|P1|STARTED|Acute Treatment Phase||111
528874|NCT00839982|1292113|P4|NOT COMPLETED|Overall Study||0
528875|NCT00839982|1292114|P3|NOT COMPLETED|Overall Study||0
528876|NCT00839982|1292115|P2|NOT COMPLETED|Overall Study||0
528877|NCT00839982|1292116|P1|NOT COMPLETED|Overall Study||0
528878|NCT00839982|1292113|P4|COMPLETED|Overall Study||3
528879|NCT00839982|1292114|P3|COMPLETED|Overall Study||2
528880|NCT00839982|1292115|P2|COMPLETED|Overall Study||26
528881|NCT00839982|1292116|P1|COMPLETED|Overall Study||4
528882|NCT00839982|1292113|P4|STARTED|Overall Study||3
528883|NCT00839982|1292114|P3|STARTED|Overall Study||2
528884|NCT00839982|1292115|P2|STARTED|Overall Study||26
528885|NCT00839982|1292116|P1|STARTED|Overall Study||4
528886|NCT00839956|1292130|P1|NOT COMPLETED|Overall Study||12
528887|NCT00839956|1292130|P1|COMPLETED|Overall Study||19
528888|NCT00839956|1292130|P1|STARTED|Overall Study||31
528889|NCT00839930|1292139|P2|NOT COMPLETED|Second Intervention||0
528890|NCT00839930|1292140|P1|NOT COMPLETED|Second Intervention||0
528891|NCT00839930|1292139|P2|COMPLETED|Second Intervention||15
528892|NCT00839930|1292140|P1|COMPLETED|Second Intervention||15
528893|NCT00839930|1292139|P2|STARTED|Second Intervention||15
528894|NCT00839930|1292140|P1|STARTED|Second Intervention||15
528895|NCT00839930|1292139|P2|NOT COMPLETED|Washout: 7 Days||0
528896|NCT00839930|1292140|P1|NOT COMPLETED|Washout: 7 Days||0
528897|NCT00839930|1292139|P2|COMPLETED|Washout: 7 Days||15
528898|NCT00839930|1292140|P1|COMPLETED|Washout: 7 Days||15
528899|NCT00839930|1292139|P2|STARTED|Washout: 7 Days||15
528900|NCT00839930|1292140|P1|STARTED|Washout: 7 Days||15
528901|NCT00839930|1292139|P2|NOT COMPLETED|First Intervention||0
528902|NCT00839930|1292140|P1|NOT COMPLETED|First Intervention||0
528903|NCT00839930|1292139|P2|COMPLETED|First Intervention||15
528904|NCT00839930|1292140|P1|COMPLETED|First Intervention||15
528905|NCT00839930|1292139|P2|STARTED|First Intervention||15
528906|NCT00839930|1292140|P1|STARTED|First Intervention||15
528907|NCT00839917|1292150|P2|NOT COMPLETED|Overall Study||1
528908|NCT00839917|1292151|P1|NOT COMPLETED|Overall Study||1
528909|NCT00839917|1292150|P2|COMPLETED|Overall Study|Study completers were randomized participants who received study vaccination and had follow-up data|16
528910|NCT00839917|1292151|P1|COMPLETED|Overall Study|Study completers were randomized participants who received study vaccination and had follow-up data|12
528911|NCT00839917|1292150|P2|STARTED|Overall Study||17
528912|NCT00839917|1292151|P1|STARTED|Overall Study||13
528913|NCT00839800|1292189|P2|NOT COMPLETED|Overall Study||110
528914|NCT00839800|1292190|P1|NOT COMPLETED|Overall Study||93
528915|NCT00839800|1292189|P2|COMPLETED|Overall Study||932
528916|NCT00839800|1292190|P1|COMPLETED|Overall Study||956
528917|NCT00839800|1292189|P2|STARTED|Overall Study||1042
528918|NCT00839800|1292190|P1|STARTED|Overall Study||1049
528919|NCT00839540|1292223|P3|NOT COMPLETED|Overall Study||0
528920|NCT00839540|1292224|P2|NOT COMPLETED|Overall Study||0
528921|NCT00839540|1292225|P1|NOT COMPLETED|Overall Study||0
528922|NCT00839540|1292223|P3|COMPLETED|Overall Study||5
528923|NCT00839540|1292224|P2|COMPLETED|Overall Study||8
528924|NCT00839540|1292225|P1|COMPLETED|Overall Study||8
528925|NCT00839540|1292223|P3|STARTED|Overall Study||5
528926|NCT00839540|1292224|P2|STARTED|Overall Study||8
528927|NCT00839540|1292225|P1|STARTED|Overall Study||8
528928|NCT00839527|1292236|P3|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||62
528929|NCT00839527|1292237|P2|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||56
528930|NCT00839527|1292238|P1|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||28
528931|NCT00839527|1292236|P3|COMPLETED|Follow-up Period (FUP) (8 Weeks)||204
528932|NCT00839527|1292237|P2|COMPLETED|Follow-up Period (FUP) (8 Weeks)||217
528933|NCT00839527|1292238|P1|COMPLETED|Follow-up Period (FUP) (8 Weeks)||86
528934|NCT00839527|1292236|P3|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Five par. did not participate in the FUP.|266
528935|NCT00839527|1292237|P2|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Four par. did not participate in the FUP.|273
528936|NCT00839527|1292238|P1|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. One par. did not participate in the FUP.|114
528937|NCT00839527|1292236|P3|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||119
528938|NCT00839527|1292237|P2|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||118
528939|NCT00839527|1292238|P1|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||60
528940|NCT00839527|1292236|P3|COMPLETED|Treatment Period (TP) (156 Weeks)||152
528941|NCT00839527|1292237|P2|COMPLETED|Treatment Period (TP) (156 Weeks)||159
528942|NCT00839527|1292238|P1|COMPLETED|Treatment Period (TP) (156 Weeks)||55
528943|NCT00839527|1292236|P3|STARTED|Treatment Period (TP) (156 Weeks)||271
528944|NCT00839527|1292237|P2|STARTED|Treatment Period (TP) (156 Weeks)||277
528945|NCT00839527|1292238|P1|STARTED|Treatment Period (TP) (156 Weeks)||115
528946|NCT00839436|1292273|P3|NOT COMPLETED|Overall Study||1
528947|NCT00839436|1292274|P2|NOT COMPLETED|Overall Study||1
528948|NCT00839436|1292275|P1|NOT COMPLETED|Overall Study||1
528949|NCT00839436|1292273|P3|COMPLETED|Overall Study||0
528950|NCT00839436|1292274|P2|COMPLETED|Overall Study||4
528951|NCT00839436|1292275|P1|COMPLETED|Overall Study||2
528952|NCT00839436|1292273|P3|STARTED|Overall Study||1
528953|NCT00839436|1292274|P2|STARTED|Overall Study||5
528954|NCT00839436|1292275|P1|STARTED|Overall Study||3
528955|NCT00839423|1292287|P4|NOT COMPLETED|Overall Study||20
528956|NCT00839423|1292288|P3|NOT COMPLETED|Overall Study||18
528957|NCT00839423|1292289|P2|NOT COMPLETED|Overall Study||10
528958|NCT00839423|1292290|P1|NOT COMPLETED|Overall Study||18
528959|NCT00839423|1292287|P4|COMPLETED|Overall Study||93
528960|NCT00839423|1292288|P3|COMPLETED|Overall Study||82
528961|NCT00839423|1292289|P2|COMPLETED|Overall Study||98
528962|NCT00839423|1292290|P1|COMPLETED|Overall Study||87
528963|NCT00839423|1292287|P4|STARTED|Overall Study||113
528964|NCT00839423|1292288|P3|STARTED|Overall Study||100
528965|NCT00839423|1292289|P2|STARTED|Overall Study||108
528966|NCT00839423|1292290|P1|STARTED|Overall Study||105
528967|NCT00839332|1292331|P3|NOT COMPLETED|Phase 2||39
528968|NCT00839332|1292332|P2|NOT COMPLETED|Phase 2||68
528969|NCT00839332|1292333|P1|NOT COMPLETED|Phase 2||0
528970|NCT00839332|1292331|P3|COMPLETED|Phase 2||0
528971|NCT00839332|1292332|P2|COMPLETED|Phase 2||0
528972|NCT00839332|1292333|P1|COMPLETED|Phase 2||0
528973|NCT00839332|1292331|P3|Received at Least 1 Dose of Study Drug|Phase 2||34
528974|NCT00839332|1292332|P2|Received at Least 1 Dose of Study Drug|Phase 2||65
528975|NCT00839332|1292333|P1|Received at Least 1 Dose of Study Drug|Phase 2||0
528976|NCT00839332|1292331|P3|STARTED|Phase 2||39
528977|NCT00839332|1292332|P2|STARTED|Phase 2||68
528978|NCT00839332|1292333|P1|STARTED|Phase 2|Participants in Phase 1 did not participate in Phase 2.|0
528979|NCT00839332|1292331|P3|NOT COMPLETED|Phase 1||0
528980|NCT00839332|1292332|P2|NOT COMPLETED|Phase 1||0
528981|NCT00839332|1292333|P1|NOT COMPLETED|Phase 1||50
528982|NCT00839332|1292331|P3|COMPLETED|Phase 1||0
528983|NCT00839332|1292332|P2|COMPLETED|Phase 1||0
528984|NCT00839332|1292333|P1|COMPLETED|Phase 1||0
528985|NCT00839332|1292331|P3|Received at Least 1 Dose of Study Drug|Phase 1||0
528986|NCT00839332|1292332|P2|Received at Least 1 Dose of Study Drug|Phase 1||0
528987|NCT00839332|1292333|P1|Received at Least 1 Dose of Study Drug|Phase 1||50
528988|NCT00839332|1292331|P3|STARTED|Phase 1|Participants in Phase 2 did not participate in Phase 1.|0
528989|NCT00839332|1292332|P2|STARTED|Phase 1|Participants in Phase 2 did not participate in Phase 1.|0
528990|NCT00839332|1292333|P1|STARTED|Phase 1||50
528991|NCT00839319|1292361|P5|NOT COMPLETED|Overall Study||0
528992|NCT00839319|1292362|P4|NOT COMPLETED|Overall Study||3
528993|NCT00839319|1292363|P3|NOT COMPLETED|Overall Study||3
528994|NCT00839319|1292364|P2|NOT COMPLETED|Overall Study||1
528995|NCT00839319|1292365|P1|NOT COMPLETED|Overall Study||2
528996|NCT00839319|1292361|P5|COMPLETED|Overall Study||8
528997|NCT00839319|1292362|P4|COMPLETED|Overall Study|1 withdrawn by investigator for syncopal reaction , 2 excluded from analysis (low serum LH)|5
528998|NCT00839319|1292363|P3|COMPLETED|Overall Study|1 dropped out after Day 1 visit, 2 excluded from analysis (low serum LH)|5
528999|NCT00839319|1292364|P2|COMPLETED|Overall Study|1 excluded from analysis (low serum LH)|7
529000|NCT00839319|1292365|P1|COMPLETED|Overall Study|1 withdrew consent prior to procedures; 1 excluded from analysis (low serum LH)|6
529001|NCT00839319|1292361|P5|STARTED|Overall Study||8
529002|NCT00839319|1292362|P4|STARTED|Overall Study||8
529003|NCT00839319|1292363|P3|STARTED|Overall Study||8
529004|NCT00839319|1292364|P2|STARTED|Overall Study||8
529005|NCT00839319|1292365|P1|STARTED|Overall Study||8
529006|NCT00839306|1292394|P2|NOT COMPLETED|Overall Study||43
529007|NCT00839306|1292395|P1|NOT COMPLETED|Overall Study||25
529008|NCT00839306|1292394|P2|COMPLETED|Overall Study||134
529009|NCT00839306|1292395|P1|COMPLETED|Overall Study||35
529010|NCT00839306|1292394|P2|STARTED|Overall Study|Treated|177
529011|NCT00839306|1292395|P1|STARTED|Overall Study|Treated|60
529012|NCT00839241|1292405|P2|NOT COMPLETED|Overall Study||17
529013|NCT00839241|1292406|P1|NOT COMPLETED|Overall Study||5
529014|NCT00839241|1292405|P2|COMPLETED|Overall Study||8
529015|NCT00839241|1292406|P1|COMPLETED|Overall Study||15
529016|NCT00839241|1292405|P2|STARTED|Overall Study||25
529017|NCT00839241|1292406|P1|STARTED|Overall Study||20
529018|NCT00839098|1292493|P3|NOT COMPLETED|Overall Study||7
529019|NCT00839098|1292494|P2|NOT COMPLETED|Overall Study||1
529020|NCT00839098|1292495|P1|NOT COMPLETED|Overall Study||2
529021|NCT00839098|1292493|P3|COMPLETED|Overall Study||6
529022|NCT00839098|1292494|P2|COMPLETED|Overall Study||11
529023|NCT00839098|1292495|P1|COMPLETED|Overall Study||1
529024|NCT00839098|1292493|P3|STARTED|Overall Study||13
529025|NCT00839098|1292494|P2|STARTED|Overall Study||12
529026|NCT00839098|1292495|P1|STARTED|Overall Study||3
529027|NCT00839072|1292521|P2|NOT COMPLETED|Second Intervention Period||0
529028|NCT00839072|1292522|P1|NOT COMPLETED|Second Intervention Period||1
529029|NCT00839072|1292521|P2|COMPLETED|Second Intervention Period||11
529030|NCT00839072|1292522|P1|COMPLETED|Second Intervention Period||9
529031|NCT00839072|1292521|P2|STARTED|Second Intervention Period||11
529032|NCT00839072|1292522|P1|STARTED|Second Intervention Period||10
529033|NCT00839072|1292521|P2|NOT COMPLETED|Washout Period of 7 Days||0
529034|NCT00839072|1292522|P1|NOT COMPLETED|Washout Period of 7 Days||0
529035|NCT00839072|1292521|P2|COMPLETED|Washout Period of 7 Days||11
529036|NCT00839072|1292522|P1|COMPLETED|Washout Period of 7 Days||10
529037|NCT00839072|1292521|P2|STARTED|Washout Period of 7 Days||11
529038|NCT00839072|1292522|P1|STARTED|Washout Period of 7 Days||10
529039|NCT00839072|1292521|P2|NOT COMPLETED|First Intervention Period||1
529040|NCT00839072|1292522|P1|NOT COMPLETED|First Intervention Period||2
529041|NCT00839072|1292521|P2|COMPLETED|First Intervention Period||11
529042|NCT00839072|1292522|P1|COMPLETED|First Intervention Period||10
529043|NCT00839072|1292521|P2|STARTED|First Intervention Period||12
529044|NCT00839072|1292522|P1|STARTED|First Intervention Period||12
529045|NCT00838981|1292542|P4|NOT COMPLETED|Day 4 to Week 11||7
529046|NCT00838981|1292543|P3|NOT COMPLETED|Day 4 to Week 11||11
529047|NCT00838981|1292544|P2|NOT COMPLETED|Day 4 to Week 11||8
529048|NCT00838981|1292545|P1|NOT COMPLETED|Day 4 to Week 11||7
529049|NCT00838981|1292542|P4|COMPLETED|Day 4 to Week 11||12
529050|NCT00838981|1292543|P3|COMPLETED|Day 4 to Week 11||16
529051|NCT00838981|1292544|P2|COMPLETED|Day 4 to Week 11||11
529052|NCT00838981|1292545|P1|COMPLETED|Day 4 to Week 11||19
529053|NCT00838981|1292542|P4|Completed Main Treatment on 400mg|Day 4 to Week 11||14
529054|NCT00838981|1292543|P3|Completed Main Treatment on 400mg|Day 4 to Week 11||17
529055|NCT00838981|1292544|P2|Completed Main Treatment on 400mg|Day 4 to Week 11||13
529056|NCT00838981|1292545|P1|Completed Main Treatment on 400mg|Day 4 to Week 11||22
529057|NCT00838981|1292542|P4|STARTED|Day 4 to Week 11||19
529058|NCT00838981|1292543|P3|STARTED|Day 4 to Week 11||27
529059|NCT00838981|1292544|P2|STARTED|Day 4 to Week 11||19
529060|NCT00838981|1292545|P1|STARTED|Day 4 to Week 11||26
529061|NCT00838981|1292542|P4|NOT COMPLETED|Week 1 Days 1-3||0
529062|NCT00838981|1292543|P3|NOT COMPLETED|Week 1 Days 1-3||0
529063|NCT00838981|1292544|P2|NOT COMPLETED|Week 1 Days 1-3||0
529064|NCT00838981|1292545|P1|NOT COMPLETED|Week 1 Days 1-3||0
529065|NCT00838981|1292542|P4|COMPLETED|Week 1 Days 1-3||19
529066|NCT00838981|1292543|P3|COMPLETED|Week 1 Days 1-3||27
529067|NCT00838981|1292544|P2|COMPLETED|Week 1 Days 1-3||19
529068|NCT00838981|1292545|P1|COMPLETED|Week 1 Days 1-3||26
529069|NCT00838981|1292542|P4|STARTED|Week 1 Days 1-3||19
529070|NCT00838981|1292543|P3|STARTED|Week 1 Days 1-3||27
529071|NCT00838981|1292544|P2|STARTED|Week 1 Days 1-3||19
529072|NCT00838981|1292545|P1|STARTED|Week 1 Days 1-3||26
529073|NCT00838929|1292566|P3|NOT COMPLETED|Overall Study||1
529074|NCT00838929|1292567|P2|NOT COMPLETED|Overall Study||3
529075|NCT00838929|1292568|P1|NOT COMPLETED|Overall Study||0
529076|NCT00838929|1292566|P3|COMPLETED|Overall Study||5
529077|NCT00838929|1292567|P2|COMPLETED|Overall Study||5
529078|NCT00838929|1292568|P1|COMPLETED|Overall Study||3
529079|NCT00838929|1292566|P3|STARTED|Overall Study||6
529080|NCT00838929|1292567|P2|STARTED|Overall Study||8
529081|NCT00838929|1292568|P1|STARTED|Overall Study||3
529082|NCT00838916|1292576|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||51
529083|NCT00838916|1292577|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||96
529084|NCT00838916|1292576|P2|COMPLETED|Follow-up Period (8 Weeks)||190
529085|NCT00838916|1292577|P1|COMPLETED|Follow-up Period (8 Weeks)||408
529086|NCT00838916|1292576|P2|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|241
529087|NCT00838916|1292577|P1|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|504
529088|NCT00838916|1292576|P2|NOT COMPLETED|Treatment Period (156 Weeks)||77
529089|NCT00838916|1292577|P1|NOT COMPLETED|Treatment Period (156 Weeks)||196
529090|NCT00838916|1292576|P2|COMPLETED|Treatment Period (156 Weeks)||164
529091|NCT00838916|1292577|P1|COMPLETED|Treatment Period (156 Weeks)||308
529092|NCT00838916|1292576|P2|STARTED|Treatment Period (156 Weeks)||241
529093|NCT00838916|1292577|P1|STARTED|Treatment Period (156 Weeks)||504
529094|NCT00838903|1292606|P4|NOT COMPLETED|Follow-up Period (8 Weeks)||58
529095|NCT00838903|1292607|P3|NOT COMPLETED|Follow-up Period (8 Weeks)||64
529096|NCT00838903|1292608|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||65
529097|NCT00838903|1292609|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||26
529098|NCT00838903|1292606|P4|COMPLETED|Follow-up Period (8 Weeks)||244
529099|NCT00838903|1292607|P3|COMPLETED|Follow-up Period (8 Weeks)||243
529100|NCT00838903|1292608|P2|COMPLETED|Follow-up Period (8 Weeks)||237
529101|NCT00838903|1292609|P1|COMPLETED|Follow-up Period (8 Weeks)||75
529102|NCT00838903|1292606|P4|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|302
529103|NCT00838903|1292607|P3|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|307
529104|NCT00838903|1292608|P2|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|302
529105|NCT00838903|1292609|P1|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
529106|NCT00838903|1292606|P4|NOT COMPLETED|Treatment Period (156 Weeks)||110
529107|NCT00838903|1292607|P3|NOT COMPLETED|Treatment Period (156 Weeks)||116
529108|NCT00838903|1292608|P2|NOT COMPLETED|Treatment Period (156 Weeks)||112
529109|NCT00838903|1292609|P1|NOT COMPLETED|Treatment Period (156 Weeks)||46
529110|NCT00838903|1292606|P4|COMPLETED|Treatment Period (156 Weeks)||192
529111|NCT00838903|1292607|P3|COMPLETED|Treatment Period (156 Weeks)||191
529112|NCT00838903|1292608|P2|COMPLETED|Treatment Period (156 Weeks)||190
529113|NCT00838903|1292609|P1|COMPLETED|Treatment Period (156 Weeks)||55
529114|NCT00838903|1292606|P4|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
529115|NCT00838903|1292607|P3|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
529116|NCT00838903|1292608|P2|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
529117|NCT00838903|1292609|P1|Missing Active Treatment Status|Treatment Period (156 Weeks)||1
529118|NCT00838903|1292606|P4|STARTED|Treatment Period (156 Weeks)||302
529119|NCT00838903|1292607|P3|STARTED|Treatment Period (156 Weeks)||307
529120|NCT00838903|1292608|P2|STARTED|Treatment Period (156 Weeks)||302
529121|NCT00838903|1292609|P1|STARTED|Treatment Period (156 Weeks)||101
529122|NCT00838682|1292653|P2|NOT COMPLETED|Overall Study||19
529123|NCT00838682|1292654|P1|NOT COMPLETED|Overall Study||25
529124|NCT00838682|1292653|P2|COMPLETED|Overall Study||33
529125|NCT00838682|1292654|P1|COMPLETED|Overall Study||29
529126|NCT00838682|1292653|P2|STARTED|Overall Study||52
529127|NCT00838682|1292654|P1|STARTED|Overall Study||54
529128|NCT00838630|1292672|P2|NOT COMPLETED|Second Intervention||0
529129|NCT00838630|1292673|P1|NOT COMPLETED|Second Intervention||0
529130|NCT00838630|1292672|P2|COMPLETED|Second Intervention||18
529131|NCT00838630|1292673|P1|COMPLETED|Second Intervention||16
529132|NCT00838630|1292672|P2|STARTED|Second Intervention||18
529133|NCT00838630|1292673|P1|STARTED|Second Intervention||16
529134|NCT00838630|1292672|P2|NOT COMPLETED|Washout: 7 Days||0
529135|NCT00838630|1292673|P1|NOT COMPLETED|Washout: 7 Days||1
529136|NCT00838630|1292672|P2|COMPLETED|Washout: 7 Days||18
529137|NCT00838630|1292673|P1|COMPLETED|Washout: 7 Days||16
529138|NCT00838630|1292672|P2|STARTED|Washout: 7 Days||18
529139|NCT00838630|1292673|P1|STARTED|Washout: 7 Days||17
529140|NCT00838630|1292672|P2|NOT COMPLETED|First Intervention||0
529141|NCT00838630|1292673|P1|NOT COMPLETED|First Intervention||1
529142|NCT00838630|1292672|P2|COMPLETED|First Intervention||18
529143|NCT00838630|1292673|P1|COMPLETED|First Intervention||17
529144|NCT00838630|1292672|P2|STARTED|First Intervention||18
529145|NCT00838630|1292673|P1|STARTED|First Intervention||18
529146|NCT00838578|1292681|P1|NOT COMPLETED|Overall Study||2
529147|NCT00838578|1292681|P1|COMPLETED|Overall Study||63
529148|NCT00838578|1292681|P1|STARTED|Overall Study|In this Ph 1/2 study, 65 subjects were enrolled; 2 were protocol violators, so only 63 treated.|65
529149|NCT00838539|1292701|P12|NOT COMPLETED|Overall Study||4
529150|NCT00838539|1292702|P11|NOT COMPLETED|Overall Study||5
529151|NCT00838539|1292703|P10|NOT COMPLETED|Overall Study||8
529152|NCT00838539|1292704|P9|NOT COMPLETED|Overall Study||5
529153|NCT00838539|1292705|P8|NOT COMPLETED|Overall Study||6
529154|NCT00838539|1292706|P7|NOT COMPLETED|Overall Study||5
529155|NCT00838539|1292707|P6|NOT COMPLETED|Overall Study||4
529156|NCT00838539|1292708|P5|NOT COMPLETED|Overall Study||6
529157|NCT00838539|1292709|P4|NOT COMPLETED|Overall Study||4
529158|NCT00838539|1292710|P3|NOT COMPLETED|Overall Study||5
529159|NCT00838539|1292711|P2|NOT COMPLETED|Overall Study||6
529160|NCT00838539|1292712|P1|NOT COMPLETED|Overall Study||3
529161|NCT00838539|1292701|P12|COMPLETED|Overall Study||0
529162|NCT00838539|1292702|P11|COMPLETED|Overall Study||0
529163|NCT00838539|1292703|P10|COMPLETED|Overall Study||0
529164|NCT00838539|1292704|P9|COMPLETED|Overall Study||0
529165|NCT00838539|1292705|P8|COMPLETED|Overall Study||0
529166|NCT00838539|1292706|P7|COMPLETED|Overall Study||2
529167|NCT00838539|1292707|P6|COMPLETED|Overall Study||0
529168|NCT00838539|1292708|P5|COMPLETED|Overall Study||0
529169|NCT00838539|1292709|P4|COMPLETED|Overall Study||0
529170|NCT00838539|1292710|P3|COMPLETED|Overall Study||0
529171|NCT00838539|1292711|P2|COMPLETED|Overall Study||0
529172|NCT00838539|1292712|P1|COMPLETED|Overall Study||0
529173|NCT00838539|1292701|P12|Received Treatment|Overall Study||4
529174|NCT00838539|1292702|P11|Received Treatment|Overall Study||5
529175|NCT00838539|1292703|P10|Received Treatment|Overall Study||8
529176|NCT00838539|1292704|P9|Received Treatment|Overall Study||5
529177|NCT00838539|1292705|P8|Received Treatment|Overall Study||6
529178|NCT00838539|1292706|P7|Received Treatment|Overall Study||7
529179|NCT00838539|1292707|P6|Received Treatment|Overall Study||4
529180|NCT00838539|1292708|P5|Received Treatment|Overall Study||4
529181|NCT00838539|1292709|P4|Received Treatment|Overall Study||4
529182|NCT00838539|1292710|P3|Received Treatment|Overall Study||5
529183|NCT00838539|1292711|P2|Received Treatment|Overall Study||5
529184|NCT00838539|1292712|P1|Received Treatment|Overall Study||3
529185|NCT00838539|1292701|P12|STARTED|Overall Study||4
529186|NCT00838539|1292702|P11|STARTED|Overall Study||5
529187|NCT00838539|1292703|P10|STARTED|Overall Study||8
529188|NCT00838539|1292704|P9|STARTED|Overall Study||5
529189|NCT00838539|1292705|P8|STARTED|Overall Study||6
529190|NCT00838539|1292706|P7|STARTED|Overall Study||7
529191|NCT00838539|1292707|P6|STARTED|Overall Study||4
529192|NCT00838539|1292708|P5|STARTED|Overall Study||6
529193|NCT00838539|1292709|P4|STARTED|Overall Study||4
529194|NCT00838539|1292710|P3|STARTED|Overall Study||5
529195|NCT00838539|1292711|P2|STARTED|Overall Study||6
529196|NCT00838539|1292712|P1|STARTED|Overall Study||3
529197|NCT00838526|1292750|P2|NOT COMPLETED|Overall Study||39
529198|NCT00838526|1292751|P1|NOT COMPLETED|Overall Study||24
529199|NCT00838526|1292750|P2|COMPLETED|Overall Study||137
529200|NCT00838526|1292751|P1|COMPLETED|Overall Study||35
529201|NCT00838526|1292750|P2|STARTED|Overall Study|Treated|176
529202|NCT00838526|1292751|P1|STARTED|Overall Study|Treated|59
529203|NCT00838513|1292759|P1|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1
529204|NCT00838513|1292759|P1|COMPLETED|Post Treatment Period (Patients Who Disc||4
529205|NCT00838513|1292759|P1|STARTED|Post Treatment Period (Patients Who Disc||5
529206|NCT00838513|1292759|P1|NOT COMPLETED|Extension Treatment Period||1
529207|NCT00838513|1292759|P1|COMPLETED|Extension Treatment Period||18
529208|NCT00838513|1292759|P1|STARTED|Extension Treatment Period||19
529209|NCT00838513|1292759|P1|NOT COMPLETED|Treatment Period (26 Weeks)||0
529210|NCT00838513|1292759|P1|COMPLETED|Treatment Period (26 Weeks)||20
529211|NCT00838513|1292759|P1|STARTED|Treatment Period (26 Weeks)||20
529212|NCT00838513|1292759|P1|NOT COMPLETED|Observation Period (8 Weeks)||0
529213|NCT00838513|1292759|P1|COMPLETED|Observation Period (8 Weeks)||20
529214|NCT00838513|1292759|P1|STARTED|Observation Period (8 Weeks)||20
529215|NCT00838513|1292759|P1|NOT COMPLETED|Screening Period||3
529216|NCT00838513|1292759|P1|COMPLETED|Screening Period||20
529217|NCT00838513|1292759|P1|STARTED|Screening Period||23
529218|NCT00838331|1292775|P1|NOT COMPLETED|Aged Blood Transfusion||9
529219|NCT00838331|1292775|P1|COMPLETED|Aged Blood Transfusion||8
529220|NCT00838331|1292775|P1|STARTED|Aged Blood Transfusion||17
529221|NCT00838331|1292775|P1|NOT COMPLETED|Fresh Blood Transfusion||0
529222|NCT00838331|1292775|P1|COMPLETED|Fresh Blood Transfusion||17
529223|NCT00838331|1292775|P1|STARTED|Fresh Blood Transfusion||17
529224|NCT00838279|1292781|P2|NOT COMPLETED|Second Intervention||0
529225|NCT00838279|1292782|P1|NOT COMPLETED|Second Intervention||0
529226|NCT00838279|1292781|P2|COMPLETED|Second Intervention||15
529227|NCT00838279|1292782|P1|COMPLETED|Second Intervention||15
529228|NCT00838279|1292781|P2|STARTED|Second Intervention||15
529229|NCT00838279|1292782|P1|STARTED|Second Intervention||15
529230|NCT00838279|1292781|P2|NOT COMPLETED|Washout||1
529231|NCT00838279|1292782|P1|NOT COMPLETED|Washout||1
529232|NCT00838279|1292781|P2|COMPLETED|Washout||15
529233|NCT00838279|1292782|P1|COMPLETED|Washout||15
529234|NCT00838279|1292781|P2|STARTED|Washout||16
529235|NCT00838279|1292782|P1|STARTED|Washout||16
529236|NCT00838279|1292781|P2|NOT COMPLETED|First Intervention||0
529237|NCT00838279|1292782|P1|NOT COMPLETED|First Intervention||0
529238|NCT00838279|1292781|P2|COMPLETED|First Intervention||16
529239|NCT00838279|1292782|P1|COMPLETED|First Intervention||16
529240|NCT00838279|1292781|P2|STARTED|First Intervention||16
529241|NCT00838279|1292782|P1|STARTED|First Intervention||16
529242|NCT00838201|1292792|P2|NOT COMPLETED|Overall Study||53
529243|NCT00838201|1292793|P1|NOT COMPLETED|Overall Study||42
529244|NCT00838201|1292792|P2|COMPLETED|Overall Study||145
529245|NCT00838201|1292793|P1|COMPLETED|Overall Study||144
529246|NCT00838201|1292792|P2|STARTED|Overall Study||198
529247|NCT00838201|1292793|P1|STARTED|Overall Study||186
529248|NCT00838162|1292803|P4|NOT COMPLETED|Overall Study||0
529249|NCT00838162|1292804|P3|NOT COMPLETED|Overall Study||0
529250|NCT00838162|1292805|P2|NOT COMPLETED|Overall Study||0
529251|NCT00838162|1292806|P1|NOT COMPLETED|Overall Study||0
529252|NCT00838162|1292803|P4|COMPLETED|Overall Study||8
529253|NCT00838162|1292804|P3|COMPLETED|Overall Study||8
529254|NCT00838162|1292805|P2|COMPLETED|Overall Study||8
529255|NCT00838162|1292806|P1|COMPLETED|Overall Study||9
529256|NCT00838162|1292803|P4|STARTED|Overall Study||8
529257|NCT00838162|1292804|P3|STARTED|Overall Study||8
529258|NCT00838162|1292805|P2|STARTED|Overall Study||8
529259|NCT00838162|1292806|P1|STARTED|Overall Study||9
529260|NCT00838136|1292850|P2|NOT COMPLETED|Second Intervention||1
529261|NCT00838136|1292851|P1|NOT COMPLETED|Second Intervention||0
529262|NCT00838136|1292850|P2|COMPLETED|Second Intervention||15
529263|NCT00838136|1292851|P1|COMPLETED|Second Intervention||16
529264|NCT00838136|1292850|P2|STARTED|Second Intervention||16
529265|NCT00838136|1292851|P1|STARTED|Second Intervention||16
529266|NCT00838136|1292850|P2|NOT COMPLETED|First Intervention||0
529267|NCT00838136|1292851|P1|NOT COMPLETED|First Intervention||0
529268|NCT00838136|1292850|P2|COMPLETED|First Intervention||16
529269|NCT00838136|1292851|P1|COMPLETED|First Intervention||16
529270|NCT00838136|1292850|P2|STARTED|First Intervention||16
529271|NCT00838136|1292851|P1|STARTED|First Intervention||16
529272|NCT00838110|1292861|P4|NOT COMPLETED|Overall Study||18
529273|NCT00838110|1292862|P3|NOT COMPLETED|Overall Study||17
529274|NCT00838110|1292863|P2|NOT COMPLETED|Overall Study||22
529275|NCT00838110|1292864|P1|NOT COMPLETED|Overall Study||22
529276|NCT00838110|1292861|P4|COMPLETED|Overall Study||226
529277|NCT00838110|1292862|P3|COMPLETED|Overall Study||226
529278|NCT00838110|1292863|P2|COMPLETED|Overall Study||106
529279|NCT00838110|1292864|P1|COMPLETED|Overall Study||105
529280|NCT00838110|1292861|P4|Treated|Overall Study||244
529281|NCT00838110|1292862|P3|Treated|Overall Study||243
529282|NCT00838110|1292863|P2|Treated|Overall Study||127
529283|NCT00838110|1292864|P1|Treated|Overall Study||127
529284|NCT00838110|1292861|P4|STARTED|Overall Study||244
529285|NCT00838110|1292862|P3|STARTED|Overall Study||243
529286|NCT00838110|1292863|P2|STARTED|Overall Study||128
529287|NCT00838110|1292864|P1|STARTED|Overall Study||127
529288|NCT00838097|1292884|P1|NOT COMPLETED|Overall Study||176
529289|NCT00838097|1292884|P1|COMPLETED|Overall Study||145
529290|NCT00838097|1292884|P1|Received Darbepoetin Alfa|Overall Study||319
529291|NCT00838097|1292884|P1|STARTED|Overall Study||321
529292|NCT00837967|1292892|P2|NOT COMPLETED|Second Intervention||0
529293|NCT00837967|1292893|P1|NOT COMPLETED|Second Intervention||0
529294|NCT00837967|1292892|P2|COMPLETED|Second Intervention||12
529295|NCT00837967|1292893|P1|COMPLETED|Second Intervention||11
529296|NCT00837967|1292892|P2|STARTED|Second Intervention||12
529297|NCT00837967|1292893|P1|STARTED|Second Intervention||11
529298|NCT00837967|1292892|P2|NOT COMPLETED|Washout Period of 7 - 14 Days||0
529299|NCT00837967|1292893|P1|NOT COMPLETED|Washout Period of 7 - 14 Days||2
529300|NCT00837967|1292892|P2|COMPLETED|Washout Period of 7 - 14 Days||12
529301|NCT00837967|1292893|P1|COMPLETED|Washout Period of 7 - 14 Days||11
529302|NCT00837967|1292892|P2|STARTED|Washout Period of 7 - 14 Days||12
529303|NCT00837967|1292893|P1|STARTED|Washout Period of 7 - 14 Days||13
529304|NCT00837967|1292892|P2|NOT COMPLETED|First Intervention||0
529305|NCT00837967|1292893|P1|NOT COMPLETED|First Intervention||0
529306|NCT00837967|1292892|P2|COMPLETED|First Intervention||12
529307|NCT00837967|1292893|P1|COMPLETED|First Intervention||13
529308|NCT00837967|1292892|P2|STARTED|First Intervention||12
529309|NCT00837967|1292893|P1|STARTED|First Intervention||13
529310|NCT00837876|1292909|P1|NOT COMPLETED|Overall Study||37
529311|NCT00837876|1292909|P1|COMPLETED|Overall Study||0
529312|NCT00837876|1292909|P1|STARTED|Overall Study||37
529313|NCT00837824|1292918|P2|NOT COMPLETED|Overall Study||0
529314|NCT00837824|1292919|P1|NOT COMPLETED|Overall Study||0
529315|NCT00837824|1292918|P2|COMPLETED|Overall Study||9
529316|NCT00837824|1292919|P1|COMPLETED|Overall Study||11
529317|NCT00837824|1292918|P2|STARTED|Overall Study||9
529318|NCT00837824|1292919|P1|STARTED|Overall Study||11
529319|NCT00837811|1292931|P3|NOT COMPLETED|Overall Study||1
529320|NCT00837811|1292932|P2|NOT COMPLETED|Overall Study||34
529321|NCT00837811|1292933|P1|NOT COMPLETED|Overall Study||7
529322|NCT00837811|1292931|P3|COMPLETED|Overall Study||0
529323|NCT00837811|1292932|P2|COMPLETED|Overall Study||87
529324|NCT00837811|1292933|P1|COMPLETED|Overall Study||53
529325|NCT00837811|1292931|P3|Included in Efficacy Analyses|Overall Study||1
529326|NCT00837811|1292932|P2|Included in Efficacy Analyses|Overall Study|Excludes participant from site with Good Clinical Practice (GCP) violations.|120
529327|NCT00837811|1292933|P1|Included in Efficacy Analyses|Overall Study||59
529328|NCT00837811|1292931|P3|Had at Least 1 Efficacy Assessment|Overall Study||1
529329|NCT00837811|1292932|P2|Had at Least 1 Efficacy Assessment|Overall Study||121
529330|NCT00837811|1292933|P1|Had at Least 1 Efficacy Assessment|Overall Study||59
529331|NCT00837811|1292931|P3|Received Any Amount of Study Drug|Overall Study||1
529332|NCT00837811|1292932|P2|Received Any Amount of Study Drug|Overall Study||121
529333|NCT00837811|1292933|P1|Received Any Amount of Study Drug|Overall Study||60
529334|NCT00837811|1292931|P3|STARTED|Overall Study||1
529335|NCT00837811|1292932|P2|STARTED|Overall Study||121
529336|NCT00837811|1292933|P1|STARTED|Overall Study||60
529337|NCT00837759|1293018|P1|NOT COMPLETED|Overall Study||4
529338|NCT00837759|1293018|P1|COMPLETED|Overall Study||3
529339|NCT00837759|1293018|P1|STARTED|Overall Study||7
529340|NCT00837616|1293029|P2|NOT COMPLETED|Overall Study||1
529341|NCT00837616|1293030|P1|NOT COMPLETED|Overall Study||0
529342|NCT00837616|1293029|P2|COMPLETED|Overall Study||20
529343|NCT00837616|1293030|P1|COMPLETED|Overall Study||20
529344|NCT00837616|1293029|P2|STARTED|Overall Study||21
529345|NCT00837616|1293030|P1|STARTED|Overall Study||20
529346|NCT00837577|1293056|P2|NOT COMPLETED|Open-label Period||9
529347|NCT00837577|1293057|P1|NOT COMPLETED|Open-label Period||8
529348|NCT00837577|1293056|P2|COMPLETED|Open-label Period||54
529349|NCT00837577|1293057|P1|COMPLETED|Open-label Period||60
529350|NCT00837577|1293056|P2|STARTED|Open-label Period||63
529351|NCT00837577|1293057|P1|STARTED|Open-label Period||68
529352|NCT00837577|1293056|P2|NOT COMPLETED|Double-blind Period||0
529353|NCT00837577|1293057|P1|NOT COMPLETED|Double-blind Period||2
529354|NCT00837577|1293056|P2|COMPLETED|Double-blind Period||63
529355|NCT00837577|1293057|P1|COMPLETED|Double-blind Period||68
529356|NCT00837577|1293056|P2|STARTED|Double-blind Period||63
529357|NCT00837577|1293057|P1|STARTED|Double-blind Period||70
529358|NCT00837512|1293068|P2|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0
529359|NCT00837512|1293069|P1|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0
529360|NCT00837512|1293068|P2|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8
529361|NCT00837512|1293069|P1|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8
529445|NCT00836927|1293211|P5|STARTED|Overall Study||1
529362|NCT00837512|1293068|P2|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8
529363|NCT00837512|1293069|P1|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8
529364|NCT00837512|1293068|P2|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0
529365|NCT00837512|1293069|P1|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0
529366|NCT00837512|1293068|P2|COMPLETED|Both Arms: Washout (7-28 Days)||8
529367|NCT00837512|1293069|P1|COMPLETED|Both Arms: Washout (7-28 Days)||8
529368|NCT00837512|1293068|P2|STARTED|Both Arms: Washout (7-28 Days)||8
529369|NCT00837512|1293069|P1|STARTED|Both Arms: Washout (7-28 Days)||8
529370|NCT00837512|1293068|P2|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0
529371|NCT00837512|1293069|P1|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0
529372|NCT00837512|1293068|P2|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8
529373|NCT00837512|1293069|P1|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8
529374|NCT00837512|1293068|P2|STARTED|First Intervention (6hrs) - RANDOMIZED||8
529375|NCT00837512|1293069|P1|STARTED|First Intervention (6hrs) - RANDOMIZED||8
529376|NCT00837486|1293077|P2|NOT COMPLETED|Long-term Follow-up Phase - Open Label||0
529377|NCT00837486|1293078|P1|NOT COMPLETED|Long-term Follow-up Phase - Open Label||5
529378|NCT00837486|1293077|P2|COMPLETED|Long-term Follow-up Phase - Open Label||0
529379|NCT00837486|1293078|P1|COMPLETED|Long-term Follow-up Phase - Open Label||24
529380|NCT00837486|1293077|P2|STARTED|Long-term Follow-up Phase - Open Label||0
529381|NCT00837486|1293078|P1|STARTED|Long-term Follow-up Phase - Open Label|All subjects received open-label stimulation during this phase.|29
529382|NCT00837486|1293077|P2|NOT COMPLETED|Blinded-treatment Phase||0
529383|NCT00837486|1293078|P1|NOT COMPLETED|Blinded-treatment Phase||1
529384|NCT00837486|1293077|P2|COMPLETED|Blinded-treatment Phase||14
529385|NCT00837486|1293078|P1|COMPLETED|Blinded-treatment Phase|One subject did not receive the allocated intervention.|15
529386|NCT00837486|1293077|P2|STARTED|Blinded-treatment Phase||14
529387|NCT00837486|1293078|P1|STARTED|Blinded-treatment Phase||16
529388|NCT00837473|1293090|P1|NOT COMPLETED|Overall Study||3
529389|NCT00837473|1293090|P1|COMPLETED|Overall Study||12
529390|NCT00837473|1293090|P1|STARTED|Overall Study||15
529391|NCT00837447|1293103|P1|NOT COMPLETED|Overall Study||0
529392|NCT00837447|1293103|P1|COMPLETED|Overall Study|Each of the 54 pts received a Nexgen CR on one side and a Nexgen CR-Flex on the contralateral side.|54
529393|NCT00837447|1293103|P1|STARTED|Overall Study|Each of the 54 pts received a Nexgen CR on one side and a Nexgen CR-Flex on the contralateral side.|54
529394|NCT00837434|1293110|P2|NOT COMPLETED|Overall Study||1
529395|NCT00837434|1293111|P1|NOT COMPLETED|Overall Study||9
529396|NCT00837434|1293110|P2|COMPLETED|Overall Study||19
529397|NCT00837434|1293111|P1|COMPLETED|Overall Study||34
529398|NCT00837434|1293110|P2|STARTED|Overall Study||20
529399|NCT00837434|1293111|P1|STARTED|Overall Study||43
529400|NCT00837330|1293131|P2|NOT COMPLETED|Overall Study||3
529401|NCT00837330|1293132|P1|NOT COMPLETED|Overall Study||1
529402|NCT00837330|1293131|P2|COMPLETED|Overall Study||7
529403|NCT00837330|1293132|P1|COMPLETED|Overall Study||9
529404|NCT00837330|1293131|P2|STARTED|Overall Study||10
529405|NCT00837330|1293132|P1|STARTED|Overall Study||10
529406|NCT00837252|1293138|P1|NOT COMPLETED|Overall Study||0
529407|NCT00837252|1293138|P1|COMPLETED|Overall Study||5
529408|NCT00837252|1293138|P1|STARTED|Overall Study||5
529409|NCT00837213|1293155|P2|NOT COMPLETED|Overall Study||5
529410|NCT00837213|1293156|P1|NOT COMPLETED|Overall Study||6
529411|NCT00837213|1293155|P2|COMPLETED|Overall Study||12
529412|NCT00837213|1293156|P1|COMPLETED|Overall Study||10
529413|NCT00837213|1293155|P2|STARTED|Overall Study||17
529414|NCT00837213|1293156|P1|STARTED|Overall Study||16
529415|NCT00837200|1293176|P1|NOT COMPLETED|Overall Study||0
529416|NCT00837200|1293176|P1|COMPLETED|Overall Study||13
529417|NCT00837200|1293176|P1|STARTED|Overall Study||13
529418|NCT00837161|1293182|P1|NOT COMPLETED|Overall Study||2
529419|NCT00837161|1293182|P1|COMPLETED|Overall Study||9
529420|NCT00837161|1293182|P1|STARTED|Overall Study||11
529421|NCT00837148|1293190|P1|NOT COMPLETED|Overall Study||2
529422|NCT00837148|1293190|P1|COMPLETED|Overall Study||35
529423|NCT00837148|1293190|P1|STARTED|Overall Study||37
529424|NCT00837031|1293194|P1|NOT COMPLETED|Overall Study||0
529425|NCT00837031|1293194|P1|COMPLETED|Overall Study||72
529426|NCT00837031|1293194|P1|STARTED|Overall Study||72
529427|NCT00836953|1293200|P1|NOT COMPLETED|Overall Study||2
529428|NCT00836953|1293200|P1|COMPLETED|Overall Study||31
529429|NCT00836953|1293200|P1|STARTED|Overall Study||33
529430|NCT00836927|1293211|P5|NOT COMPLETED|Overall Study||1
529431|NCT00836927|1293212|P4|NOT COMPLETED|Overall Study||1
529432|NCT00836927|1293213|P3|NOT COMPLETED|Overall Study||1
529433|NCT00836927|1293214|P2|NOT COMPLETED|Overall Study||1
529434|NCT00836927|1293215|P1|NOT COMPLETED|Overall Study||3
529435|NCT00836927|1293211|P5|COMPLETED|Overall Study||0
529436|NCT00836927|1293212|P4|COMPLETED|Overall Study||0
529437|NCT00836927|1293213|P3|COMPLETED|Overall Study||0
529438|NCT00836927|1293214|P2|COMPLETED|Overall Study||0
529439|NCT00836927|1293215|P1|COMPLETED|Overall Study||0
529440|NCT00836927|1293211|P5|Completed Dosing Through 03 Apr 2017|Overall Study||0
529441|NCT00836927|1293212|P4|Completed Dosing Through 03 Apr 2017|Overall Study||0
529442|NCT00836927|1293213|P3|Completed Dosing Through 03 Apr 2017|Overall Study|Participant continues to receive study drug past the data cut-off date of 03 Apr 2017|1
529443|NCT00836927|1293214|P2|Completed Dosing Through 03 Apr 2017|Overall Study|Participant continues to receive study drug past the data cut-off date of 03 Apr 2017|1
529444|NCT00836927|1293215|P1|Completed Dosing Through 03 Apr 2017|Overall Study||0
529446|NCT00836927|1293212|P4|STARTED|Overall Study||1
529447|NCT00836927|1293213|P3|STARTED|Overall Study|One participant received ridaforolimus 3 mg IV infusion before being switched to the oral tablet.|1
529448|NCT00836927|1293214|P2|STARTED|Overall Study||1
529449|NCT00836927|1293215|P1|STARTED|Overall Study||3
529450|NCT00836901|1293249|P2|NOT COMPLETED|Second Intervention||0
529451|NCT00836901|1293250|P1|NOT COMPLETED|Second Intervention||0
529452|NCT00836901|1293249|P2|COMPLETED|Second Intervention||28
529453|NCT00836901|1293250|P1|COMPLETED|Second Intervention||23
529454|NCT00836901|1293249|P2|STARTED|Second Intervention||28
529455|NCT00836901|1293250|P1|STARTED|Second Intervention||23
529456|NCT00836901|1293249|P2|NOT COMPLETED|First Intervention||0
529457|NCT00836901|1293250|P1|NOT COMPLETED|First Intervention||1
529458|NCT00836901|1293249|P2|COMPLETED|First Intervention||28
529459|NCT00836901|1293250|P1|COMPLETED|First Intervention||23
529460|NCT00836901|1293249|P2|STARTED|First Intervention||28
529461|NCT00836901|1293250|P1|STARTED|First Intervention||24
529462|NCT00836875|1293266|P2|NOT COMPLETED|Overall Study||3
529463|NCT00836875|1293267|P1|NOT COMPLETED|Overall Study||3
529464|NCT00836875|1293266|P2|COMPLETED|Overall Study||17
529465|NCT00836875|1293267|P1|COMPLETED|Overall Study||8
529466|NCT00836875|1293266|P2|STARTED|Overall Study||20
529467|NCT00836875|1293267|P1|STARTED|Overall Study||11
529468|NCT00836810|1293283|P2|NOT COMPLETED|Overall Study||0
529469|NCT00836810|1293284|P1|NOT COMPLETED|Overall Study||1
529470|NCT00836810|1293283|P2|COMPLETED|Overall Study||6
529471|NCT00836810|1293284|P1|COMPLETED|Overall Study|1 patient was subsequently diagnosed with SLE and, per protocol, was not included.|4
529472|NCT00836810|1293283|P2|STARTED|Overall Study||6
529473|NCT00836810|1293284|P1|STARTED|Overall Study||5
529474|NCT00836745|1293300|P1|NOT COMPLETED|Overall Study||21
529475|NCT00836745|1293300|P1|COMPLETED|Overall Study||15
529476|NCT00836745|1293300|P1|STARTED|Overall Study||36
529477|NCT00836719|1293307|P1|NOT COMPLETED|Overall Study||0
529478|NCT00836719|1293307|P1|COMPLETED|Overall Study||10
529479|NCT00836719|1293307|P1|STARTED|Overall Study||10
529480|NCT00836706|1293314|P2|NOT COMPLETED|Second Intervention||0
529481|NCT00836706|1293315|P1|NOT COMPLETED|Second Intervention||0
529482|NCT00836706|1293314|P2|COMPLETED|Second Intervention||11
529483|NCT00836706|1293315|P1|COMPLETED|Second Intervention||11
529484|NCT00836706|1293314|P2|STARTED|Second Intervention||11
529485|NCT00836706|1293315|P1|STARTED|Second Intervention||11
529486|NCT00836706|1293314|P2|NOT COMPLETED|Washout: 7 Days||1
529487|NCT00836706|1293315|P1|NOT COMPLETED|Washout: 7 Days||0
529488|NCT00836706|1293314|P2|COMPLETED|Washout: 7 Days||11
529489|NCT00836706|1293315|P1|COMPLETED|Washout: 7 Days||11
529490|NCT00836706|1293314|P2|STARTED|Washout: 7 Days||12
529491|NCT00836706|1293315|P1|STARTED|Washout: 7 Days||11
529492|NCT00836706|1293314|P2|NOT COMPLETED|First Intervention||0
529493|NCT00836706|1293315|P1|NOT COMPLETED|First Intervention||0
529494|NCT00836706|1293314|P2|COMPLETED|First Intervention||12
529495|NCT00836706|1293315|P1|COMPLETED|First Intervention||11
529496|NCT00836706|1293314|P2|STARTED|First Intervention||12
529497|NCT00836706|1293315|P1|STARTED|First Intervention||11
529498|NCT00836693|1293325|P2|NOT COMPLETED|Overall Study||6
529499|NCT00836693|1293326|P1|NOT COMPLETED|Overall Study||17
529500|NCT00836693|1293325|P2|COMPLETED|Overall Study||64
529501|NCT00836693|1293326|P1|COMPLETED|Overall Study||130
529502|NCT00836693|1293325|P2|STARTED|Overall Study||70
529503|NCT00836693|1293326|P1|STARTED|Overall Study||147
529504|NCT00836641|1293368|P2|NOT COMPLETED|Overall Study||0
529505|NCT00836641|1293369|P1|NOT COMPLETED|Overall Study||0
529506|NCT00836641|1293368|P2|COMPLETED|Overall Study||34
529507|NCT00836641|1293369|P1|COMPLETED|Overall Study||36
529508|NCT00836641|1293368|P2|STARTED|Overall Study||34
529509|NCT00836641|1293369|P1|STARTED|Overall Study||36
529510|NCT00836498|1293378|P2|NOT COMPLETED|Overall Study||1
529511|NCT00836498|1293379|P1|NOT COMPLETED|Overall Study||4
529512|NCT00836498|1293378|P2|COMPLETED|Overall Study||21
529513|NCT00836498|1293379|P1|COMPLETED|Overall Study|Participant who discontinued the study vaccination due to AE completed the 180-day safety follow-up.|40
529514|NCT00836498|1293378|P2|STARTED|Overall Study||22
529515|NCT00836498|1293379|P1|STARTED|Overall Study||44
529516|NCT00836472|1293411|P2|NOT COMPLETED|Second Intervention||0
529517|NCT00836472|1293412|P1|NOT COMPLETED|Second Intervention||0
529518|NCT00836472|1293411|P2|COMPLETED|Second Intervention||27
529519|NCT00836472|1293412|P1|COMPLETED|Second Intervention||28
529520|NCT00836472|1293411|P2|STARTED|Second Intervention||27
529521|NCT00836472|1293412|P1|STARTED|Second Intervention||28
529522|NCT00836472|1293411|P2|NOT COMPLETED|Washout||3
529523|NCT00836472|1293412|P1|NOT COMPLETED|Washout||2
529524|NCT00836472|1293411|P2|COMPLETED|Washout||27
529525|NCT00836472|1293412|P1|COMPLETED|Washout||28
529526|NCT00836472|1293411|P2|STARTED|Washout||30
529527|NCT00836472|1293412|P1|STARTED|Washout||30
529528|NCT00836472|1293411|P2|NOT COMPLETED|First Intervention||0
529529|NCT00836472|1293412|P1|NOT COMPLETED|First Intervention||0
529530|NCT00836472|1293411|P2|COMPLETED|First Intervention||30
529531|NCT00836472|1293412|P1|COMPLETED|First Intervention||30
529532|NCT00836472|1293411|P2|STARTED|First Intervention||30
529533|NCT00836472|1293412|P1|STARTED|First Intervention||30
529534|NCT00836433|1293428|P2|NOT COMPLETED|Overall Study||7
529535|NCT00836433|1293429|P1|NOT COMPLETED|Overall Study||12
529536|NCT00836433|1293428|P2|COMPLETED|Overall Study||321
529537|NCT00836433|1293429|P1|COMPLETED|Overall Study||349
529538|NCT00836433|1293428|P2|STARTED|Overall Study||328
529539|NCT00836433|1293429|P1|STARTED|Overall Study||361
529540|NCT00836407|1293439|P2|NOT COMPLETED|Overall Study||8
529541|NCT00836407|1293440|P1|NOT COMPLETED|Overall Study||11
529542|NCT00836407|1293439|P2|COMPLETED|Overall Study||7
529543|NCT00836407|1293440|P1|COMPLETED|Overall Study||4
529544|NCT00836407|1293439|P2|STARTED|Overall Study||15
529545|NCT00836407|1293440|P1|STARTED|Overall Study||15
529546|NCT00836355|1293452|P4|NOT COMPLETED|Overall Study||0
529547|NCT00836355|1293453|P3|NOT COMPLETED|Overall Study||0
529548|NCT00836355|1293454|P2|NOT COMPLETED|Overall Study||0
529549|NCT00836355|1293455|P1|NOT COMPLETED|Overall Study||0
529550|NCT00836355|1293452|P4|COMPLETED|Overall Study||2
529551|NCT00836355|1293453|P3|COMPLETED|Overall Study||0
529552|NCT00836355|1293454|P2|COMPLETED|Overall Study||4
529553|NCT00836355|1293455|P1|COMPLETED|Overall Study||0
529554|NCT00836355|1293452|P4|STARTED|Overall Study||2
529555|NCT00836355|1293453|P3|STARTED|Overall Study||0
529556|NCT00836355|1293454|P2|STARTED|Overall Study||4
529557|NCT00836355|1293455|P1|STARTED|Overall Study||0
529558|NCT00836342|1293476|P3|NOT COMPLETED|Overall Study||0
529559|NCT00836342|1293477|P2|NOT COMPLETED|Overall Study||0
529560|NCT00836342|1293478|P1|NOT COMPLETED|Overall Study||0
529561|NCT00836342|1293476|P3|COMPLETED|Overall Study||36
529562|NCT00836342|1293477|P2|COMPLETED|Overall Study||23
529563|NCT00836342|1293478|P1|COMPLETED|Overall Study||22
529564|NCT00836342|1293476|P3|STARTED|Overall Study||36
529565|NCT00836342|1293477|P2|STARTED|Overall Study||23
529566|NCT00836342|1293478|P1|STARTED|Overall Study||22
529567|NCT00836277|1293489|P1|NOT COMPLETED|Overall Study||6
529568|NCT00836277|1293489|P1|COMPLETED|Overall Study||18
529569|NCT00836277|1293489|P1|STARTED|Overall Study||24
529570|NCT00836095|1293499|P2|NOT COMPLETED|Overall Study||3
529571|NCT00836095|1293500|P1|NOT COMPLETED|Overall Study||0
529572|NCT00836095|1293499|P2|COMPLETED|Overall Study||27
529573|NCT00836095|1293500|P1|COMPLETED|Overall Study||22
529574|NCT00836095|1293499|P2|STARTED|Overall Study||30
529575|NCT00836095|1293500|P1|STARTED|Overall Study||22
529576|NCT00836056|1293510|P2|NOT COMPLETED|Second Intervention||0
529577|NCT00836056|1293511|P1|NOT COMPLETED|Second Intervention||0
529578|NCT00836056|1293510|P2|COMPLETED|Second Intervention||12
529579|NCT00836056|1293511|P1|COMPLETED|Second Intervention||11
529580|NCT00836056|1293510|P2|STARTED|Second Intervention||12
529581|NCT00836056|1293511|P1|STARTED|Second Intervention||11
529582|NCT00836056|1293510|P2|NOT COMPLETED|Washout: 7 Days||0
529583|NCT00836056|1293511|P1|NOT COMPLETED|Washout: 7 Days||0
529584|NCT00836056|1293510|P2|COMPLETED|Washout: 7 Days||12
529585|NCT00836056|1293511|P1|COMPLETED|Washout: 7 Days||11
529586|NCT00836056|1293510|P2|STARTED|Washout: 7 Days||12
529587|NCT00836056|1293511|P1|STARTED|Washout: 7 Days||11
529588|NCT00836056|1293510|P2|NOT COMPLETED|First Intervention||0
529589|NCT00836056|1293511|P1|NOT COMPLETED|First Intervention||1
529590|NCT00836056|1293510|P2|COMPLETED|First Intervention||12
529591|NCT00836056|1293511|P1|COMPLETED|First Intervention||11
529592|NCT00836056|1293510|P2|STARTED|First Intervention||12
529593|NCT00836056|1293511|P1|STARTED|First Intervention||12
529594|NCT00836017|1293519|P1|NOT COMPLETED|Overall Study||544
529595|NCT00836017|1293519|P1|COMPLETED|Overall Study||502
529596|NCT00836017|1293519|P1|STARTED|Overall Study||1046
529597|NCT00836004|1293529|P2|NOT COMPLETED|Second Intervention||0
529598|NCT00836004|1293530|P1|NOT COMPLETED|Second Intervention||0
529599|NCT00836004|1293529|P2|COMPLETED|Second Intervention||12
529600|NCT00836004|1293530|P1|COMPLETED|Second Intervention||12
529601|NCT00836004|1293529|P2|STARTED|Second Intervention||12
529602|NCT00836004|1293530|P1|STARTED|Second Intervention||12
529603|NCT00836004|1293529|P2|NOT COMPLETED|Washout: 7 Days||0
529604|NCT00836004|1293530|P1|NOT COMPLETED|Washout: 7 Days||0
529605|NCT00836004|1293529|P2|COMPLETED|Washout: 7 Days||12
529606|NCT00836004|1293530|P1|COMPLETED|Washout: 7 Days||12
529607|NCT00836004|1293529|P2|STARTED|Washout: 7 Days||12
529608|NCT00836004|1293530|P1|STARTED|Washout: 7 Days||12
529609|NCT00836004|1293529|P2|NOT COMPLETED|First Intervention||0
529610|NCT00836004|1293530|P1|NOT COMPLETED|First Intervention||0
529611|NCT00836004|1293529|P2|COMPLETED|First Intervention||12
529612|NCT00836004|1293530|P1|COMPLETED|First Intervention||12
529613|NCT00836004|1293529|P2|STARTED|First Intervention||12
529614|NCT00836004|1293530|P1|STARTED|First Intervention||12
529615|NCT00835991|1293540|P2|NOT COMPLETED|Second Intervention||0
529616|NCT00835991|1293541|P1|NOT COMPLETED|Second Intervention||0
529617|NCT00835991|1293540|P2|COMPLETED|Second Intervention||26
529618|NCT00835991|1293541|P1|COMPLETED|Second Intervention||27
529619|NCT00835991|1293540|P2|STARTED|Second Intervention||26
529620|NCT00835991|1293541|P1|STARTED|Second Intervention||27
529621|NCT00835991|1293540|P2|NOT COMPLETED|Washout||3
529622|NCT00835991|1293541|P1|NOT COMPLETED|Washout||3
529623|NCT00835991|1293540|P2|COMPLETED|Washout||26
529624|NCT00835991|1293541|P1|COMPLETED|Washout||27
529625|NCT00835991|1293540|P2|STARTED|Washout||29
529626|NCT00835991|1293541|P1|STARTED|Washout||30
529627|NCT00835991|1293540|P2|NOT COMPLETED|First Intervention||1
529628|NCT00835991|1293541|P1|NOT COMPLETED|First Intervention||0
529629|NCT00835991|1293540|P2|COMPLETED|First Intervention||29
529630|NCT00835991|1293541|P1|COMPLETED|First Intervention||30
529631|NCT00835991|1293540|P2|STARTED|First Intervention||30
529632|NCT00835991|1293541|P1|STARTED|First Intervention||30
529633|NCT00835978|1293559|P4|NOT COMPLETED|Overall Study||10
529634|NCT00835978|1293560|P3|NOT COMPLETED|Overall Study||91
529635|NCT00835978|1293561|P2|NOT COMPLETED|Overall Study||56
529636|NCT00835978|1293562|P1|NOT COMPLETED|Overall Study||56
529637|NCT00835978|1293559|P4|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
529638|NCT00835978|1293560|P3|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
529639|NCT00835978|1293561|P2|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
529640|NCT00835978|1293562|P1|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
529641|NCT00835978|1293559|P4|Treated|Overall Study||10
529642|NCT00835978|1293560|P3|Treated|Overall Study||91
529643|NCT00835978|1293561|P2|Treated|Overall Study||56
529644|NCT00835978|1293562|P1|Treated|Overall Study||56
529645|NCT00835978|1293559|P4|STARTED|Overall Study||10
529646|NCT00835978|1293560|P3|STARTED|Overall Study||91
529647|NCT00835978|1293561|P2|STARTED|Overall Study||56
529648|NCT00835978|1293562|P1|STARTED|Overall Study||56
529649|NCT00835926|1293622|P2|NOT COMPLETED|Overall Study||0
529650|NCT00835926|1293623|P1|NOT COMPLETED|Overall Study||0
529651|NCT00835926|1293622|P2|COMPLETED|Overall Study||60
529652|NCT00835926|1293623|P1|COMPLETED|Overall Study||61
529653|NCT00835926|1293622|P2|STARTED|Overall Study||60
529654|NCT00835926|1293623|P1|STARTED|Overall Study||61
529655|NCT00835900|1293637|P2|NOT COMPLETED|Overall Study||6
529656|NCT00835900|1293638|P1|NOT COMPLETED|Overall Study||5
529657|NCT00835900|1293637|P2|COMPLETED|Overall Study||22
529658|NCT00835900|1293638|P1|COMPLETED|Overall Study||27
529659|NCT00835900|1293637|P2|STARTED|Overall Study||28
529660|NCT00835900|1293638|P1|STARTED|Overall Study||32
529661|NCT00835861|1293648|P2|NOT COMPLETED|Overall Study||2
529662|NCT00835861|1293649|P1|NOT COMPLETED|Overall Study||1
529663|NCT00835861|1293648|P2|COMPLETED|Overall Study||14
529664|NCT00835861|1293649|P1|COMPLETED|Overall Study||14
529665|NCT00835861|1293648|P2|STARTED|Overall Study||16
529666|NCT00835861|1293649|P1|STARTED|Overall Study||15
529667|NCT00835796|1293673|P2|NOT COMPLETED|Second Intervention||0
529668|NCT00835796|1293674|P1|NOT COMPLETED|Second Intervention||0
529669|NCT00835796|1293673|P2|COMPLETED|Second Intervention||9
529670|NCT00835796|1293674|P1|COMPLETED|Second Intervention||10
529671|NCT00835796|1293673|P2|STARTED|Second Intervention||9
529672|NCT00835796|1293674|P1|STARTED|Second Intervention||10
529673|NCT00835796|1293673|P2|NOT COMPLETED|Washout||0
529674|NCT00835796|1293674|P1|NOT COMPLETED|Washout||0
529675|NCT00835796|1293673|P2|COMPLETED|Washout||9
529676|NCT00835796|1293674|P1|COMPLETED|Washout||10
529677|NCT00835796|1293673|P2|STARTED|Washout||9
529678|NCT00835796|1293674|P1|STARTED|Washout||10
529679|NCT00835796|1293673|P2|NOT COMPLETED|First Intervention||1
529680|NCT00835796|1293674|P1|NOT COMPLETED|First Intervention||0
529681|NCT00835796|1293673|P2|COMPLETED|First Intervention||9
529682|NCT00835796|1293674|P1|COMPLETED|First Intervention||10
529683|NCT00835796|1293673|P2|STARTED|First Intervention||10
529684|NCT00835796|1293674|P1|STARTED|First Intervention||10
529685|NCT00835731|1293684|P2|NOT COMPLETED|Overall Study||1
529686|NCT00835731|1293685|P1|NOT COMPLETED|Overall Study||2
529687|NCT00835731|1293684|P2|COMPLETED|Overall Study||60
529688|NCT00835731|1293685|P1|COMPLETED|Overall Study||62
529689|NCT00835731|1293684|P2|STARTED|Overall Study||61
529690|NCT00835731|1293685|P1|STARTED|Overall Study||64
529691|NCT00835705|1293705|P2|NOT COMPLETED|Second Intervention||0
529692|NCT00835705|1293706|P1|NOT COMPLETED|Second Intervention||1
529693|NCT00835705|1293705|P2|COMPLETED|Second Intervention||28
529694|NCT00835705|1293706|P1|COMPLETED|Second Intervention||22
529695|NCT00835705|1293705|P2|STARTED|Second Intervention||28
529696|NCT00835705|1293706|P1|STARTED|Second Intervention||23
529697|NCT00835705|1293705|P2|NOT COMPLETED|First Intervention||0
529698|NCT00835705|1293706|P1|NOT COMPLETED|First Intervention||1
529699|NCT00835705|1293705|P2|COMPLETED|First Intervention||28
529700|NCT00835705|1293706|P1|COMPLETED|First Intervention||23
529701|NCT00835705|1293705|P2|STARTED|First Intervention||28
529702|NCT00835705|1293706|P1|STARTED|First Intervention||24
529703|NCT00835692|1293722|P2|NOT COMPLETED|Second Intervention||0
529704|NCT00835692|1293723|P1|NOT COMPLETED|Second Intervention||0
529705|NCT00835692|1293722|P2|COMPLETED|Second Intervention||28
529706|NCT00835692|1293723|P1|COMPLETED|Second Intervention||27
529707|NCT00835692|1293722|P2|STARTED|Second Intervention||28
529708|NCT00835692|1293723|P1|STARTED|Second Intervention||27
529709|NCT00835692|1293722|P2|NOT COMPLETED|Washout||0
529710|NCT00835692|1293723|P1|NOT COMPLETED|Washout||0
529711|NCT00835692|1293722|P2|COMPLETED|Washout||28
529712|NCT00835692|1293723|P1|COMPLETED|Washout||27
529713|NCT00835692|1293722|P2|STARTED|Washout||28
529714|NCT00835692|1293723|P1|STARTED|Washout||27
529715|NCT00835692|1293722|P2|NOT COMPLETED|First Intervention||0
529716|NCT00835692|1293723|P1|NOT COMPLETED|First Intervention||1
529717|NCT00835692|1293722|P2|COMPLETED|First Intervention||28
529718|NCT00835692|1293723|P1|COMPLETED|First Intervention||27
529719|NCT00835692|1293722|P2|STARTED|First Intervention||28
529720|NCT00835692|1293723|P1|STARTED|First Intervention||28
529721|NCT00835679|1293735|P4|NOT COMPLETED|Overall Study||0
529722|NCT00835679|1293736|P3|NOT COMPLETED|Overall Study||0
529723|NCT00835679|1293737|P2|NOT COMPLETED|Overall Study||0
529724|NCT00835679|1293738|P1|NOT COMPLETED|Overall Study||1
529725|NCT00835679|1293735|P4|COMPLETED|Overall Study||0
529726|NCT00835679|1293736|P3|COMPLETED|Overall Study||0
529727|NCT00835679|1293737|P2|COMPLETED|Overall Study||0
529728|NCT00835679|1293738|P1|COMPLETED|Overall Study||8
529729|NCT00835679|1293735|P4|STARTED|Overall Study||0
529730|NCT00835679|1293736|P3|STARTED|Overall Study||0
529731|NCT00835679|1293737|P2|STARTED|Overall Study|This study closed prematurely, thus no patients went on Cohort B, C or D.|0
529732|NCT00835679|1293738|P1|STARTED|Overall Study||9
529733|NCT00835666|1293762|P2|NOT COMPLETED|Second Intervention||0
529734|NCT00835666|1293763|P1|NOT COMPLETED|Second Intervention||0
529735|NCT00835666|1293762|P2|COMPLETED|Second Intervention||16
529736|NCT00835666|1293763|P1|COMPLETED|Second Intervention||14
529737|NCT00835666|1293762|P2|STARTED|Second Intervention||16
529738|NCT00835666|1293763|P1|STARTED|Second Intervention||14
529739|NCT00835666|1293762|P2|NOT COMPLETED|Washout||0
529740|NCT00835666|1293763|P1|NOT COMPLETED|Washout||2
529741|NCT00835666|1293762|P2|COMPLETED|Washout||16
529742|NCT00835666|1293763|P1|COMPLETED|Washout||14
529743|NCT00835666|1293762|P2|STARTED|Washout||16
529744|NCT00835666|1293763|P1|STARTED|Washout||16
529745|NCT00835666|1293762|P2|NOT COMPLETED|First Intervention||0
529746|NCT00835666|1293763|P1|NOT COMPLETED|First Intervention||0
529747|NCT00835666|1293762|P2|COMPLETED|First Intervention||16
529748|NCT00835666|1293763|P1|COMPLETED|First Intervention||16
529749|NCT00835666|1293762|P2|STARTED|First Intervention||16
529750|NCT00835666|1293763|P1|STARTED|First Intervention||16
529751|NCT00835640|1293773|P2|NOT COMPLETED|Second Intervention||0
529752|NCT00835640|1293774|P1|NOT COMPLETED|Second Intervention||1
529753|NCT00835640|1293773|P2|COMPLETED|Second Intervention||12
529754|NCT00835640|1293774|P1|COMPLETED|Second Intervention||11
529755|NCT00835640|1293773|P2|STARTED|Second Intervention||12
529756|NCT00835640|1293774|P1|STARTED|Second Intervention||12
529757|NCT00835640|1293773|P2|NOT COMPLETED|Washout of 7 Days||0
529758|NCT00835640|1293774|P1|NOT COMPLETED|Washout of 7 Days||0
529759|NCT00835640|1293773|P2|COMPLETED|Washout of 7 Days||12
529760|NCT00835640|1293774|P1|COMPLETED|Washout of 7 Days||12
529761|NCT00835640|1293773|P2|STARTED|Washout of 7 Days||12
529762|NCT00835640|1293774|P1|STARTED|Washout of 7 Days||12
529763|NCT00835640|1293773|P2|NOT COMPLETED|First Intervention||0
529764|NCT00835640|1293774|P1|NOT COMPLETED|First Intervention||0
529765|NCT00835640|1293773|P2|COMPLETED|First Intervention||12
529766|NCT00835640|1293774|P1|COMPLETED|First Intervention||12
529767|NCT00835640|1293773|P2|STARTED|First Intervention||12
529768|NCT00835640|1293774|P1|STARTED|First Intervention||12
529769|NCT00835614|1293784|P2|NOT COMPLETED|Second Intervention||0
529770|NCT00835614|1293785|P1|NOT COMPLETED|Second Intervention||0
529771|NCT00835614|1293784|P2|COMPLETED|Second Intervention||13
529772|NCT00835614|1293785|P1|COMPLETED|Second Intervention||13
529773|NCT00835614|1293784|P2|STARTED|Second Intervention||13
529774|NCT00835614|1293785|P1|STARTED|Second Intervention||13
529775|NCT00835614|1293784|P2|NOT COMPLETED|Washout of 7 Days||0
529776|NCT00835614|1293785|P1|NOT COMPLETED|Washout of 7 Days||0
529777|NCT00835614|1293784|P2|COMPLETED|Washout of 7 Days||13
529778|NCT00835614|1293785|P1|COMPLETED|Washout of 7 Days||13
529779|NCT00835614|1293784|P2|STARTED|Washout of 7 Days||13
529780|NCT00835614|1293785|P1|STARTED|Washout of 7 Days||13
529781|NCT00835614|1293784|P2|NOT COMPLETED|First Intervention||0
529782|NCT00835614|1293785|P1|NOT COMPLETED|First Intervention||0
529783|NCT00835614|1293784|P2|COMPLETED|First Intervention||13
529784|NCT00835614|1293785|P1|COMPLETED|First Intervention||13
529785|NCT00835614|1293784|P2|STARTED|First Intervention||13
529786|NCT00835614|1293785|P1|STARTED|First Intervention||13
529787|NCT00835588|1293795|P2|NOT COMPLETED|Second Intervention||0
529788|NCT00835588|1293796|P1|NOT COMPLETED|Second Intervention||0
529789|NCT00835588|1293795|P2|COMPLETED|Second Intervention||50
529790|NCT00835588|1293796|P1|COMPLETED|Second Intervention||50
529791|NCT00835588|1293795|P2|STARTED|Second Intervention||50
529792|NCT00835588|1293796|P1|STARTED|Second Intervention||50
529793|NCT00835588|1293795|P2|NOT COMPLETED|Washout: 5 Days||0
529794|NCT00835588|1293796|P1|NOT COMPLETED|Washout: 5 Days||0
529795|NCT00835588|1293795|P2|COMPLETED|Washout: 5 Days||50
529796|NCT00835588|1293796|P1|COMPLETED|Washout: 5 Days||50
529797|NCT00835588|1293795|P2|STARTED|Washout: 5 Days||50
529798|NCT00835588|1293796|P1|STARTED|Washout: 5 Days||50
529799|NCT00835588|1293795|P2|NOT COMPLETED|First Intervention||0
529800|NCT00835588|1293796|P1|NOT COMPLETED|First Intervention||0
529801|NCT00835588|1293795|P2|COMPLETED|First Intervention||50
529802|NCT00835588|1293796|P1|COMPLETED|First Intervention||50
529803|NCT00835588|1293795|P2|STARTED|First Intervention||50
529804|NCT00835588|1293796|P1|STARTED|First Intervention||50
529805|NCT00835575|1293806|P2|NOT COMPLETED|Second Intervention||0
529806|NCT00835575|1293807|P1|NOT COMPLETED|Second Intervention||0
529807|NCT00835575|1293806|P2|COMPLETED|Second Intervention||16
529808|NCT00835575|1293807|P1|COMPLETED|Second Intervention||15
529809|NCT00835575|1293806|P2|STARTED|Second Intervention||16
529810|NCT00835575|1293807|P1|STARTED|Second Intervention||15
529811|NCT00835575|1293806|P2|NOT COMPLETED|Washout of 14 Days||0
529812|NCT00835575|1293807|P1|NOT COMPLETED|Washout of 14 Days||1
529813|NCT00835575|1293806|P2|COMPLETED|Washout of 14 Days||16
529814|NCT00835575|1293807|P1|COMPLETED|Washout of 14 Days||15
529815|NCT00835575|1293806|P2|STARTED|Washout of 14 Days||16
529816|NCT00835575|1293807|P1|STARTED|Washout of 14 Days||16
529817|NCT00835575|1293806|P2|NOT COMPLETED|First Intervention||0
529818|NCT00835575|1293807|P1|NOT COMPLETED|First Intervention||0
529819|NCT00835575|1293806|P2|COMPLETED|First Intervention||16
529820|NCT00835575|1293807|P1|COMPLETED|First Intervention||16
529821|NCT00835575|1293806|P2|STARTED|First Intervention||16
529822|NCT00835575|1293807|P1|STARTED|First Intervention||16
529823|NCT00835549|1293817|P2|NOT COMPLETED|Second Intervention||0
529824|NCT00835549|1293818|P1|NOT COMPLETED|Second Intervention||0
529825|NCT00835549|1293817|P2|COMPLETED|Second Intervention||16
529826|NCT00835549|1293818|P1|COMPLETED|Second Intervention||14
529827|NCT00835549|1293817|P2|STARTED|Second Intervention||16
529828|NCT00835549|1293818|P1|STARTED|Second Intervention||14
529829|NCT00835549|1293817|P2|NOT COMPLETED|Washout of 7 Days||0
529830|NCT00835549|1293818|P1|NOT COMPLETED|Washout of 7 Days||2
529831|NCT00835549|1293817|P2|COMPLETED|Washout of 7 Days||16
529832|NCT00835549|1293818|P1|COMPLETED|Washout of 7 Days||14
529833|NCT00835549|1293817|P2|STARTED|Washout of 7 Days||16
529834|NCT00835549|1293818|P1|STARTED|Washout of 7 Days||16
529835|NCT00835549|1293817|P2|NOT COMPLETED|First Intervention||0
529836|NCT00835549|1293818|P1|NOT COMPLETED|First Intervention||0
529837|NCT00835549|1293817|P2|COMPLETED|First Intervention||16
529838|NCT00835549|1293818|P1|COMPLETED|First Intervention||16
529839|NCT00835549|1293817|P2|STARTED|First Intervention||16
529840|NCT00835549|1293818|P1|STARTED|First Intervention||16
529841|NCT00835536|1293828|P2|NOT COMPLETED|Second Intervention||0
529842|NCT00835536|1293829|P1|NOT COMPLETED|Second Intervention||0
529843|NCT00835536|1293828|P2|COMPLETED|Second Intervention||14
529844|NCT00835536|1293829|P1|COMPLETED|Second Intervention||12
529845|NCT00835536|1293828|P2|STARTED|Second Intervention||14
529846|NCT00835536|1293829|P1|STARTED|Second Intervention||12
529847|NCT00835536|1293828|P2|NOT COMPLETED|Washout of 5 Weeks||0
529848|NCT00835536|1293829|P1|NOT COMPLETED|Washout of 5 Weeks||1
529849|NCT00835536|1293828|P2|COMPLETED|Washout of 5 Weeks||14
529850|NCT00835536|1293829|P1|COMPLETED|Washout of 5 Weeks||12
529851|NCT00835536|1293828|P2|STARTED|Washout of 5 Weeks||14
529852|NCT00835536|1293829|P1|STARTED|Washout of 5 Weeks||13
529853|NCT00835536|1293828|P2|NOT COMPLETED|First Intervention||0
529854|NCT00835536|1293829|P1|NOT COMPLETED|First Intervention||0
529855|NCT00835536|1293828|P2|COMPLETED|First Intervention||14
529856|NCT00835536|1293829|P1|COMPLETED|First Intervention||13
529857|NCT00835536|1293828|P2|STARTED|First Intervention||14
529858|NCT00835536|1293829|P1|STARTED|First Intervention||13
529859|NCT00835510|1293838|P3|NOT COMPLETED|Overall Study||38
529860|NCT00835510|1293839|P2|NOT COMPLETED|Overall Study||69
529861|NCT00835510|1293840|P1|NOT COMPLETED|Overall Study||76
529862|NCT00835510|1293838|P3|COMPLETED|Overall Study||70
529863|NCT00835510|1293839|P2|COMPLETED|Overall Study||152
529864|NCT00835510|1293840|P1|COMPLETED|Overall Study||143
529865|NCT00835510|1293838|P3|Positive Fungal Culture|Overall Study||71
529866|NCT00835510|1293839|P2|Positive Fungal Culture|Overall Study||155
529867|NCT00835510|1293840|P1|Positive Fungal Culture|Overall Study||149
529868|NCT00835510|1293838|P3|STARTED|Overall Study||108
529869|NCT00835510|1293839|P2|STARTED|Overall Study||221
529870|NCT00835510|1293840|P1|STARTED|Overall Study||219
529871|NCT00835497|1293862|P2|NOT COMPLETED|Second Intervention||0
529872|NCT00835497|1293863|P1|NOT COMPLETED|Second Intervention||0
529873|NCT00835497|1293862|P2|COMPLETED|Second Intervention||20
529874|NCT00835497|1293863|P1|COMPLETED|Second Intervention||20
529875|NCT00835497|1293862|P2|STARTED|Second Intervention||20
529876|NCT00835497|1293863|P1|STARTED|Second Intervention||20
529877|NCT00835497|1293862|P2|NOT COMPLETED|Washout: 7 Days||0
529878|NCT00835497|1293863|P1|NOT COMPLETED|Washout: 7 Days||0
529879|NCT00835497|1293862|P2|COMPLETED|Washout: 7 Days||20
529880|NCT00835497|1293863|P1|COMPLETED|Washout: 7 Days||20
529881|NCT00835497|1293862|P2|STARTED|Washout: 7 Days||20
529882|NCT00835497|1293863|P1|STARTED|Washout: 7 Days||20
529883|NCT00835497|1293862|P2|NOT COMPLETED|First Intervention||0
529884|NCT00835497|1293863|P1|NOT COMPLETED|First Intervention||0
529885|NCT00835497|1293862|P2|COMPLETED|First Intervention||20
529886|NCT00835497|1293863|P1|COMPLETED|First Intervention||20
529887|NCT00835497|1293862|P2|STARTED|First Intervention||20
529888|NCT00835497|1293863|P1|STARTED|First Intervention||20
529889|NCT00835484|1293879|P2|NOT COMPLETED|Second Intervention||0
529890|NCT00835484|1293880|P1|NOT COMPLETED|Second Intervention||0
529891|NCT00835484|1293879|P2|COMPLETED|Second Intervention||16
529892|NCT00835484|1293880|P1|COMPLETED|Second Intervention||16
529893|NCT00835484|1293879|P2|STARTED|Second Intervention||16
529894|NCT00835484|1293880|P1|STARTED|Second Intervention||16
529895|NCT00835484|1293879|P2|NOT COMPLETED|Washout of 7 Days||0
529896|NCT00835484|1293880|P1|NOT COMPLETED|Washout of 7 Days||0
529897|NCT00835484|1293879|P2|COMPLETED|Washout of 7 Days||16
529898|NCT00835484|1293880|P1|COMPLETED|Washout of 7 Days||16
529899|NCT00835484|1293879|P2|STARTED|Washout of 7 Days||16
529900|NCT00835484|1293880|P1|STARTED|Washout of 7 Days||16
529901|NCT00835484|1293879|P2|NOT COMPLETED|First Intervention||0
529902|NCT00835484|1293880|P1|NOT COMPLETED|First Intervention||0
529903|NCT00835484|1293879|P2|COMPLETED|First Intervention||16
529904|NCT00835484|1293880|P1|COMPLETED|First Intervention||16
529905|NCT00835484|1293879|P2|STARTED|First Intervention||16
529906|NCT00835484|1293880|P1|STARTED|First Intervention||16
529907|NCT00835406|1293890|P2|NOT COMPLETED|Period: Second Intervention||0
529908|NCT00835406|1293891|P1|NOT COMPLETED|Period: Second Intervention||0
529909|NCT00835406|1293890|P2|COMPLETED|Period: Second Intervention||67
529910|NCT00835406|1293891|P1|COMPLETED|Period: Second Intervention||68
529911|NCT00835406|1293890|P2|STARTED|Period: Second Intervention||67
529912|NCT00835406|1293891|P1|STARTED|Period: Second Intervention||68
529913|NCT00835406|1293890|P2|NOT COMPLETED|Period: Washout of 7 Days||2
529914|NCT00835406|1293891|P1|NOT COMPLETED|Period: Washout of 7 Days||0
529915|NCT00835406|1293890|P2|COMPLETED|Period: Washout of 7 Days||67
529916|NCT00835406|1293891|P1|COMPLETED|Period: Washout of 7 Days||68
529917|NCT00835406|1293890|P2|STARTED|Period: Washout of 7 Days||69
529918|NCT00835406|1293891|P1|STARTED|Period: Washout of 7 Days||68
529919|NCT00835406|1293890|P2|NOT COMPLETED|Period: First Intervention||1
529920|NCT00835406|1293891|P1|NOT COMPLETED|Period: First Intervention||2
529921|NCT00835406|1293890|P2|COMPLETED|Period: First Intervention||69
529922|NCT00835406|1293891|P1|COMPLETED|Period: First Intervention||68
529923|NCT00835406|1293890|P2|STARTED|Period: First Intervention||70
529924|NCT00835406|1293891|P1|STARTED|Period: First Intervention||70
529925|NCT00835380|1293897|P1|NOT COMPLETED|Overall Study||2
529926|NCT00835380|1293897|P1|COMPLETED|Overall Study||78
529927|NCT00835380|1293897|P1|STARTED|Overall Study||80
529928|NCT00835367|1293904|P2|NOT COMPLETED|Second Intervention||1
529929|NCT00835367|1293905|P1|NOT COMPLETED|Second Intervention||1
529930|NCT00835367|1293904|P2|COMPLETED|Second Intervention||33
529931|NCT00835367|1293905|P1|COMPLETED|Second Intervention||30
529932|NCT00835367|1293904|P2|STARTED|Second Intervention||34
529933|NCT00835367|1293905|P1|STARTED|Second Intervention||31
529934|NCT00835367|1293904|P2|NOT COMPLETED|Washout||0
529935|NCT00835367|1293905|P1|NOT COMPLETED|Washout||3
529936|NCT00835367|1293904|P2|COMPLETED|Washout||34
529937|NCT00835367|1293905|P1|COMPLETED|Washout||31
529938|NCT00835367|1293904|P2|STARTED|Washout||34
529939|NCT00835367|1293905|P1|STARTED|Washout||34
529940|NCT00835367|1293904|P2|NOT COMPLETED|First Intervention||0
529941|NCT00835367|1293905|P1|NOT COMPLETED|First Intervention||0
529942|NCT00835367|1293904|P2|COMPLETED|First Intervention||34
529943|NCT00835367|1293905|P1|COMPLETED|First Intervention||34
529944|NCT00835367|1293904|P2|STARTED|First Intervention||34
529945|NCT00835367|1293905|P1|STARTED|First Intervention||34
529946|NCT00835354|1293927|P2|NOT COMPLETED|Second Intervention||0
529947|NCT00835354|1293928|P1|NOT COMPLETED|Second Intervention||0
529948|NCT00835354|1293927|P2|COMPLETED|Second Intervention||12
529949|NCT00835354|1293928|P1|COMPLETED|Second Intervention||13
529950|NCT00835354|1293927|P2|STARTED|Second Intervention||12
529951|NCT00835354|1293928|P1|STARTED|Second Intervention||13
529952|NCT00835354|1293927|P2|NOT COMPLETED|Washout of 7 Days||0
529953|NCT00835354|1293928|P1|NOT COMPLETED|Washout of 7 Days||0
529954|NCT00835354|1293927|P2|COMPLETED|Washout of 7 Days||12
529955|NCT00835354|1293928|P1|COMPLETED|Washout of 7 Days||13
529956|NCT00835354|1293927|P2|STARTED|Washout of 7 Days||12
529957|NCT00835354|1293928|P1|STARTED|Washout of 7 Days||13
529958|NCT00835354|1293927|P2|NOT COMPLETED|First Intervention||1
529959|NCT00835354|1293928|P1|NOT COMPLETED|First Intervention||0
529960|NCT00835354|1293927|P2|COMPLETED|First Intervention||12
529961|NCT00835354|1293928|P1|COMPLETED|First Intervention||13
529962|NCT00835354|1293927|P2|STARTED|First Intervention||13
529963|NCT00835354|1293928|P1|STARTED|First Intervention||13
529964|NCT00835341|1293938|P2|NOT COMPLETED|Overall Study||12
529965|NCT00835341|1293939|P1|NOT COMPLETED|Overall Study||3
529966|NCT00835341|1293938|P2|COMPLETED|Overall Study||46
529967|NCT00835341|1293939|P1|COMPLETED|Overall Study||32
529968|NCT00835341|1293938|P2|STARTED|Overall Study||58
529969|NCT00835341|1293939|P1|STARTED|Overall Study||35
529970|NCT00835276|1293947|P2|NOT COMPLETED|Second Intervention||0
529971|NCT00835276|1293948|P1|NOT COMPLETED|Second Intervention||0
529972|NCT00835276|1293947|P2|COMPLETED|Second Intervention||24
529973|NCT00835276|1293948|P1|COMPLETED|Second Intervention||24
529974|NCT00835276|1293947|P2|STARTED|Second Intervention||24
529975|NCT00835276|1293948|P1|STARTED|Second Intervention||24
529976|NCT00835276|1293947|P2|NOT COMPLETED|Washout of 7 Days||0
529977|NCT00835276|1293948|P1|NOT COMPLETED|Washout of 7 Days||0
529978|NCT00835276|1293947|P2|COMPLETED|Washout of 7 Days||24
529979|NCT00835276|1293948|P1|COMPLETED|Washout of 7 Days||24
529980|NCT00835276|1293947|P2|STARTED|Washout of 7 Days||24
529981|NCT00835276|1293948|P1|STARTED|Washout of 7 Days||24
529982|NCT00835276|1293947|P2|NOT COMPLETED|First Intervention||0
529983|NCT00835276|1293948|P1|NOT COMPLETED|First Intervention||0
529984|NCT00835276|1293947|P2|COMPLETED|First Intervention||24
529985|NCT00835276|1293948|P1|COMPLETED|First Intervention||24
529986|NCT00835276|1293947|P2|STARTED|First Intervention||24
529987|NCT00835276|1293948|P1|STARTED|First Intervention||24
529988|NCT00835263|1293958|P2|NOT COMPLETED|Second Intervention||0
529989|NCT00835263|1293959|P1|NOT COMPLETED|Second Intervention||1
529990|NCT00835263|1293958|P2|COMPLETED|Second Intervention||16
529991|NCT00835263|1293959|P1|COMPLETED|Second Intervention||15
529992|NCT00835263|1293958|P2|STARTED|Second Intervention||16
529993|NCT00835263|1293959|P1|STARTED|Second Intervention||16
529994|NCT00835263|1293958|P2|NOT COMPLETED|First Intervention||0
529995|NCT00835263|1293959|P1|NOT COMPLETED|First Intervention||0
529996|NCT00835263|1293958|P2|COMPLETED|First Intervention||16
529997|NCT00835263|1293959|P1|COMPLETED|First Intervention||16
529998|NCT00835263|1293958|P2|STARTED|First Intervention||16
529999|NCT00835263|1293959|P1|STARTED|First Intervention||16
530000|NCT00835237|1293969|P2|NOT COMPLETED|Overall Study||0
530001|NCT00835237|1293970|P1|NOT COMPLETED|Overall Study||6
530002|NCT00835237|1293969|P2|COMPLETED|Overall Study||445
530003|NCT00835237|1293970|P1|COMPLETED|Overall Study||881
530004|NCT00835237|1293969|P2|STARTED|Overall Study||445
530005|NCT00835237|1293970|P1|STARTED|Overall Study||887
530006|NCT00835224|1293994|P1|NOT COMPLETED|Overall Study||10
530007|NCT00835224|1293994|P1|COMPLETED|Overall Study||24
530008|NCT00835224|1293994|P1|STARTED|Overall Study||34
530009|NCT00835211|1294010|P2|NOT COMPLETED|Second Intervention||0
530010|NCT00835211|1294011|P1|NOT COMPLETED|Second Intervention||0
530011|NCT00835211|1294010|P2|COMPLETED|Second Intervention||22
530012|NCT00835211|1294011|P1|COMPLETED|Second Intervention||21
530013|NCT00835211|1294010|P2|STARTED|Second Intervention||22
530014|NCT00835211|1294011|P1|STARTED|Second Intervention||21
530015|NCT00835211|1294010|P2|NOT COMPLETED|Washout: 7 Days||1
530016|NCT00835211|1294011|P1|NOT COMPLETED|Washout: 7 Days||3
530017|NCT00835211|1294010|P2|COMPLETED|Washout: 7 Days||22
530018|NCT00835211|1294011|P1|COMPLETED|Washout: 7 Days||21
530019|NCT00835211|1294010|P2|STARTED|Washout: 7 Days||23
530020|NCT00835211|1294011|P1|STARTED|Washout: 7 Days||24
530021|NCT00835211|1294010|P2|NOT COMPLETED|First Intervention||1
530022|NCT00835211|1294011|P1|NOT COMPLETED|First Intervention||0
530023|NCT00835211|1294010|P2|COMPLETED|First Intervention||23
530024|NCT00835211|1294011|P1|COMPLETED|First Intervention||24
530025|NCT00835211|1294010|P2|STARTED|First Intervention||24
530026|NCT00835211|1294011|P1|STARTED|First Intervention||24
530027|NCT00835198|1294021|P2|NOT COMPLETED|Overall Study||7
530028|NCT00835198|1294022|P1|NOT COMPLETED|Overall Study||8
530029|NCT00835198|1294021|P2|COMPLETED|Overall Study||74
530030|NCT00835198|1294022|P1|COMPLETED|Overall Study||74
530031|NCT00835198|1294021|P2|STARTED|Overall Study||81
530032|NCT00835198|1294022|P1|STARTED|Overall Study||82
530033|NCT00835185|1294034|P1|NOT COMPLETED|Overall Study||0
530034|NCT00835185|1294034|P1|COMPLETED|Overall Study||44
530035|NCT00835185|1294034|P1|Received at Least 1 Dose of Study Drug|Overall Study||44
530036|NCT00835185|1294034|P1|STARTED|Overall Study||44
530037|NCT00835172|1294057|P2|NOT COMPLETED|Second Intervention||0
530038|NCT00835172|1294058|P1|NOT COMPLETED|Second Intervention||0
530039|NCT00835172|1294057|P2|COMPLETED|Second Intervention||15
530040|NCT00835172|1294058|P1|COMPLETED|Second Intervention||16
530041|NCT00835172|1294057|P2|STARTED|Second Intervention||15
530042|NCT00835172|1294058|P1|STARTED|Second Intervention||16
530043|NCT00835172|1294057|P2|NOT COMPLETED|Washout||1
530044|NCT00835172|1294058|P1|NOT COMPLETED|Washout||0
530045|NCT00835172|1294057|P2|COMPLETED|Washout||15
530046|NCT00835172|1294058|P1|COMPLETED|Washout||16
530047|NCT00835172|1294057|P2|STARTED|Washout||16
530048|NCT00835172|1294058|P1|STARTED|Washout||16
530049|NCT00835172|1294057|P2|NOT COMPLETED|First Intervention||0
530050|NCT00835172|1294058|P1|NOT COMPLETED|First Intervention||0
530051|NCT00835172|1294057|P2|COMPLETED|First Intervention||16
530052|NCT00835172|1294058|P1|COMPLETED|First Intervention||16
530053|NCT00835172|1294057|P2|STARTED|First Intervention||16
530054|NCT00835172|1294058|P1|STARTED|First Intervention||16
530055|NCT00835159|1294068|P2|NOT COMPLETED|Overall Study||0
530056|NCT00835159|1294069|P1|NOT COMPLETED|Overall Study||0
530057|NCT00835159|1294068|P2|COMPLETED|Overall Study||17
530058|NCT00835159|1294069|P1|COMPLETED|Overall Study||11
530059|NCT00835159|1294068|P2|STARTED|Overall Study||17
530060|NCT00835159|1294069|P1|STARTED|Overall Study||11
530061|NCT00835146|1294077|P2|NOT COMPLETED|Second Intervention||0
530062|NCT00835146|1294078|P1|NOT COMPLETED|Second Intervention||0
530063|NCT00835146|1294077|P2|COMPLETED|Second Intervention||14
530064|NCT00835146|1294078|P1|COMPLETED|Second Intervention||14
530065|NCT00835146|1294077|P2|STARTED|Second Intervention||14
530066|NCT00835146|1294078|P1|STARTED|Second Intervention||14
530067|NCT00835146|1294077|P2|NOT COMPLETED|Washout of 5 Weeks||0
530068|NCT00835146|1294078|P1|NOT COMPLETED|Washout of 5 Weeks||0
530069|NCT00835146|1294077|P2|COMPLETED|Washout of 5 Weeks||14
530070|NCT00835146|1294078|P1|COMPLETED|Washout of 5 Weeks||14
530071|NCT00835146|1294077|P2|STARTED|Washout of 5 Weeks||14
530072|NCT00835146|1294078|P1|STARTED|Washout of 5 Weeks||14
530073|NCT00835146|1294077|P2|NOT COMPLETED|First Intervention||0
530074|NCT00835146|1294078|P1|NOT COMPLETED|First Intervention||0
530075|NCT00835146|1294077|P2|COMPLETED|First Intervention||14
530076|NCT00835146|1294078|P1|COMPLETED|First Intervention||14
530077|NCT00835146|1294077|P2|STARTED|First Intervention||14
530078|NCT00835146|1294078|P1|STARTED|First Intervention||14
530079|NCT00835120|1294084|P1|NOT COMPLETED|Overall Study||8
530080|NCT00835120|1294084|P1|COMPLETED|Overall Study||26
530081|NCT00835120|1294084|P1|STARTED|Overall Study||34
530082|NCT00835081|1294094|P2|NOT COMPLETED|Second Intervention||0
530083|NCT00835081|1294095|P1|NOT COMPLETED|Second Intervention||0
530084|NCT00835081|1294094|P2|COMPLETED|Second Intervention||13
530085|NCT00835081|1294095|P1|COMPLETED|Second Intervention||12
530086|NCT00835081|1294094|P2|STARTED|Second Intervention||13
530087|NCT00835081|1294095|P1|STARTED|Second Intervention||12
530088|NCT00835081|1294094|P2|NOT COMPLETED|Washout of 7 Days||0
530089|NCT00835081|1294095|P1|NOT COMPLETED|Washout of 7 Days||1
530090|NCT00835081|1294094|P2|COMPLETED|Washout of 7 Days||13
530091|NCT00835081|1294095|P1|COMPLETED|Washout of 7 Days||12
530092|NCT00835081|1294094|P2|STARTED|Washout of 7 Days||13
530093|NCT00835081|1294095|P1|STARTED|Washout of 7 Days||13
530094|NCT00835081|1294094|P2|NOT COMPLETED|First Intervention||0
530095|NCT00835081|1294095|P1|NOT COMPLETED|First Intervention||0
530096|NCT00835081|1294094|P2|COMPLETED|First Intervention||13
530097|NCT00835081|1294095|P1|COMPLETED|First Intervention||13
530098|NCT00835081|1294094|P2|STARTED|First Intervention||13
530099|NCT00835081|1294095|P1|STARTED|First Intervention||13
530100|NCT00835068|1294105|P2|NOT COMPLETED|Overall Study||1
530101|NCT00835068|1294106|P1|NOT COMPLETED|Overall Study||10
530102|NCT00835068|1294105|P2|COMPLETED|Overall Study||0
530103|NCT00835068|1294106|P1|COMPLETED|Overall Study||47
530104|NCT00835068|1294105|P2|STARTED|Overall Study||1
530105|NCT00835068|1294106|P1|STARTED|Overall Study||57
530106|NCT00835042|1294126|P2|NOT COMPLETED|Second Intervention||0
530107|NCT00835042|1294127|P1|NOT COMPLETED|Second Intervention||0
530108|NCT00835042|1294126|P2|COMPLETED|Second Intervention||24
530109|NCT00835042|1294127|P1|COMPLETED|Second Intervention||26
530110|NCT00835042|1294126|P2|STARTED|Second Intervention||24
530111|NCT00835042|1294127|P1|STARTED|Second Intervention||26
530112|NCT00835042|1294126|P2|NOT COMPLETED|Washout of 21 Days||2
530113|NCT00835042|1294127|P1|NOT COMPLETED|Washout of 21 Days||0
530114|NCT00835042|1294126|P2|COMPLETED|Washout of 21 Days||24
530115|NCT00835042|1294127|P1|COMPLETED|Washout of 21 Days||26
530116|NCT00835042|1294126|P2|STARTED|Washout of 21 Days||26
530117|NCT00835042|1294127|P1|STARTED|Washout of 21 Days||26
530118|NCT00835042|1294126|P2|NOT COMPLETED|First Intervention||2
530119|NCT00835042|1294127|P1|NOT COMPLETED|First Intervention||4
530120|NCT00835042|1294126|P2|COMPLETED|First Intervention||26
530121|NCT00835042|1294127|P1|COMPLETED|First Intervention||26
530122|NCT00835042|1294126|P2|STARTED|First Intervention||28
530123|NCT00835042|1294127|P1|STARTED|First Intervention||30
530124|NCT00835003|1294149|P2|NOT COMPLETED|Overall Study||0
530125|NCT00835003|1294150|P1|NOT COMPLETED|Overall Study||0
530126|NCT00835003|1294149|P2|COMPLETED|Overall Study||638
530127|NCT00835003|1294150|P1|COMPLETED|Overall Study||636
530128|NCT00835003|1294149|P2|STARTED|Overall Study||638
530129|NCT00835003|1294150|P1|STARTED|Overall Study||636
530130|NCT00834990|1294158|P2|NOT COMPLETED|Second Intervention||0
530131|NCT00834990|1294159|P1|NOT COMPLETED|Second Intervention||0
530132|NCT00834990|1294158|P2|COMPLETED|Second Intervention||11
530133|NCT00834990|1294159|P1|COMPLETED|Second Intervention||12
530134|NCT00834990|1294158|P2|STARTED|Second Intervention||11
530135|NCT00834990|1294159|P1|STARTED|Second Intervention||12
530136|NCT00834990|1294158|P2|NOT COMPLETED|Washout of 7 Days||0
530137|NCT00834990|1294159|P1|NOT COMPLETED|Washout of 7 Days||0
530138|NCT00834990|1294158|P2|COMPLETED|Washout of 7 Days||11
530139|NCT00834990|1294159|P1|COMPLETED|Washout of 7 Days||12
530140|NCT00834990|1294158|P2|STARTED|Washout of 7 Days||11
530141|NCT00834990|1294159|P1|STARTED|Washout of 7 Days||12
530142|NCT00834990|1294158|P2|NOT COMPLETED|First Intervention||0
530143|NCT00834990|1294159|P1|NOT COMPLETED|First Intervention||0
530144|NCT00834990|1294158|P2|COMPLETED|First Intervention||11
530145|NCT00834990|1294159|P1|COMPLETED|First Intervention||12
530146|NCT00834990|1294158|P2|STARTED|First Intervention||11
530147|NCT00834990|1294159|P1|STARTED|First Intervention||12
530148|NCT00834977|1294169|P2|NOT COMPLETED|Second Intervention||0
530149|NCT00834977|1294170|P1|NOT COMPLETED|Second Intervention||0
530150|NCT00834977|1294169|P2|COMPLETED|Second Intervention||24
530151|NCT00834977|1294170|P1|COMPLETED|Second Intervention||24
530152|NCT00834977|1294169|P2|STARTED|Second Intervention||24
530153|NCT00834977|1294170|P1|STARTED|Second Intervention||24
530154|NCT00834977|1294169|P2|NOT COMPLETED|First Intervention||0
530155|NCT00834977|1294170|P1|NOT COMPLETED|First Intervention||0
530156|NCT00834977|1294169|P2|COMPLETED|First Intervention||24
530157|NCT00834977|1294170|P1|COMPLETED|First Intervention||24
530158|NCT00834977|1294169|P2|STARTED|First Intervention||24
530159|NCT00834977|1294170|P1|STARTED|First Intervention||24
530160|NCT00834964|1294192|P2|NOT COMPLETED|Second Intervention||0
530161|NCT00834964|1294193|P1|NOT COMPLETED|Second Intervention||0
530162|NCT00834964|1294192|P2|COMPLETED|Second Intervention||15
530163|NCT00834964|1294193|P1|COMPLETED|Second Intervention||15
530164|NCT00834964|1294192|P2|STARTED|Second Intervention||15
530165|NCT00834964|1294193|P1|STARTED|Second Intervention||15
530166|NCT00834964|1294192|P2|NOT COMPLETED|Washout: 7 Days||0
530167|NCT00834964|1294193|P1|NOT COMPLETED|Washout: 7 Days||0
530168|NCT00834964|1294192|P2|COMPLETED|Washout: 7 Days||15
530169|NCT00834964|1294193|P1|COMPLETED|Washout: 7 Days||15
530170|NCT00834964|1294192|P2|STARTED|Washout: 7 Days||15
530171|NCT00834964|1294193|P1|STARTED|Washout: 7 Days||15
530172|NCT00834964|1294192|P2|NOT COMPLETED|First Intervention||0
530173|NCT00834964|1294193|P1|NOT COMPLETED|First Intervention||0
530174|NCT00834964|1294192|P2|COMPLETED|First Intervention||15
530175|NCT00834964|1294193|P1|COMPLETED|First Intervention||15
530176|NCT00834964|1294192|P2|STARTED|First Intervention||15
530177|NCT00834964|1294193|P1|STARTED|First Intervention||15
530178|NCT00834912|1294213|P6|NOT COMPLETED|Treatment Period 3||0
530179|NCT00834912|1294214|P5|NOT COMPLETED|Treatment Period 3||0
530180|NCT00834912|1294215|P4|NOT COMPLETED|Treatment Period 3||0
530181|NCT00834912|1294216|P3|NOT COMPLETED|Treatment Period 3||0
530182|NCT00834912|1294217|P2|NOT COMPLETED|Treatment Period 3||0
530183|NCT00834912|1294218|P1|NOT COMPLETED|Treatment Period 3||0
530184|NCT00834912|1294213|P6|COMPLETED|Treatment Period 3||6
530185|NCT00834912|1294214|P5|COMPLETED|Treatment Period 3||5
530186|NCT00834912|1294215|P4|COMPLETED|Treatment Period 3||5
530187|NCT00834912|1294216|P3|COMPLETED|Treatment Period 3||5
530188|NCT00834912|1294217|P2|COMPLETED|Treatment Period 3||5
530189|NCT00834912|1294218|P1|COMPLETED|Treatment Period 3||6
530190|NCT00834912|1294213|P6|STARTED|Treatment Period 3||6
530191|NCT00834912|1294214|P5|STARTED|Treatment Period 3||5
530192|NCT00834912|1294215|P4|STARTED|Treatment Period 3||5
530193|NCT00834912|1294216|P3|STARTED|Treatment Period 3||5
530194|NCT00834912|1294217|P2|STARTED|Treatment Period 3||5
530195|NCT00834912|1294218|P1|STARTED|Treatment Period 3||6
530196|NCT00834912|1294213|P6|NOT COMPLETED|Treatment Period 2||0
530197|NCT00834912|1294214|P5|NOT COMPLETED|Treatment Period 2||1
530198|NCT00834912|1294215|P4|NOT COMPLETED|Treatment Period 2||0
530199|NCT00834912|1294216|P3|NOT COMPLETED|Treatment Period 2||1
530200|NCT00834912|1294217|P2|NOT COMPLETED|Treatment Period 2||0
530201|NCT00834912|1294218|P1|NOT COMPLETED|Treatment Period 2||0
530202|NCT00834912|1294213|P6|COMPLETED|Treatment Period 2||6
530203|NCT00834912|1294214|P5|COMPLETED|Treatment Period 2|One subject completed treatment period 2 but did not enter treatment period 3|5
530204|NCT00834912|1294215|P4|COMPLETED|Treatment Period 2||5
530205|NCT00834912|1294216|P3|COMPLETED|Treatment Period 2|One subject completed treatment period 2 but did not enter treatment period 3|5
530206|NCT00834912|1294217|P2|COMPLETED|Treatment Period 2||5
530207|NCT00834912|1294218|P1|COMPLETED|Treatment Period 2||6
530208|NCT00834912|1294213|P6|STARTED|Treatment Period 2||6
530209|NCT00834912|1294214|P5|STARTED|Treatment Period 2||6
530210|NCT00834912|1294215|P4|STARTED|Treatment Period 2||5
530211|NCT00834912|1294216|P3|STARTED|Treatment Period 2||6
530212|NCT00834912|1294217|P2|STARTED|Treatment Period 2||5
530213|NCT00834912|1294218|P1|STARTED|Treatment Period 2||6
530214|NCT00834912|1294213|P6|NOT COMPLETED|Treatment Period 1||0
530215|NCT00834912|1294214|P5|NOT COMPLETED|Treatment Period 1||0
530216|NCT00834912|1294215|P4|NOT COMPLETED|Treatment Period 1||1
530217|NCT00834912|1294216|P3|NOT COMPLETED|Treatment Period 1||0
530218|NCT00834912|1294217|P2|NOT COMPLETED|Treatment Period 1||1
530219|NCT00834912|1294218|P1|NOT COMPLETED|Treatment Period 1||0
530220|NCT00834912|1294213|P6|COMPLETED|Treatment Period 1||6
530221|NCT00834912|1294214|P5|COMPLETED|Treatment Period 1||6
530222|NCT00834912|1294215|P4|COMPLETED|Treatment Period 1|One subject completed all of treatment period 1 assessments but did not enter treatment period 2|5
530223|NCT00834912|1294216|P3|COMPLETED|Treatment Period 1||6
530224|NCT00834912|1294217|P2|COMPLETED|Treatment Period 1|One subject completed all of treatment period 1 assessments but did not enter treatment period 2|5
530225|NCT00834912|1294218|P1|COMPLETED|Treatment Period 1||6
530226|NCT00834912|1294213|P6|STARTED|Treatment Period 1||6
530227|NCT00834912|1294214|P5|STARTED|Treatment Period 1||6
530228|NCT00834912|1294215|P4|STARTED|Treatment Period 1||6
530229|NCT00834912|1294216|P3|STARTED|Treatment Period 1||6
530230|NCT00834912|1294217|P2|STARTED|Treatment Period 1||6
530231|NCT00834912|1294218|P1|STARTED|Treatment Period 1||6
530232|NCT00834899|1294240|P2|NOT COMPLETED|Overall Study||1
530233|NCT00834899|1294241|P1|NOT COMPLETED|Overall Study||1
530234|NCT00834899|1294240|P2|COMPLETED|Overall Study|One patient was withdrawn early because she did not meet eligibility criteria.|3
530235|NCT00834899|1294241|P1|COMPLETED|Overall Study|One patient withdrew consent following completion of the study drug infusion.|8
530236|NCT00834899|1294240|P2|STARTED|Overall Study||4
530237|NCT00834899|1294241|P1|STARTED|Overall Study||9
530238|NCT00834886|1294257|P4|NOT COMPLETED|Overall Study||0
530239|NCT00834886|1294258|P3|NOT COMPLETED|Overall Study||1
530240|NCT00834886|1294259|P2|NOT COMPLETED|Overall Study||1
530241|NCT00834886|1294260|P1|NOT COMPLETED|Overall Study||0
530242|NCT00834886|1294257|P4|COMPLETED|Overall Study||10
530243|NCT00834886|1294258|P3|COMPLETED|Overall Study||9
530244|NCT00834886|1294259|P2|COMPLETED|Overall Study||9
530245|NCT00834886|1294260|P1|COMPLETED|Overall Study||10
530246|NCT00834886|1294257|P4|STARTED|Overall Study||10
530247|NCT00834886|1294258|P3|STARTED|Overall Study||10
530248|NCT00834886|1294259|P2|STARTED|Overall Study||10
530249|NCT00834886|1294260|P1|STARTED|Overall Study||10
530250|NCT00834873|1294280|P2|NOT COMPLETED|Second Intervention||0
530251|NCT00834873|1294281|P1|NOT COMPLETED|Second Intervention||0
530252|NCT00834873|1294280|P2|COMPLETED|Second Intervention||11
530253|NCT00834873|1294281|P1|COMPLETED|Second Intervention||12
530254|NCT00834873|1294280|P2|STARTED|Second Intervention||11
530255|NCT00834873|1294281|P1|STARTED|Second Intervention||12
530256|NCT00834873|1294280|P2|NOT COMPLETED|Washout: 7 Days||0
530257|NCT00834873|1294281|P1|NOT COMPLETED|Washout: 7 Days||0
530258|NCT00834873|1294280|P2|COMPLETED|Washout: 7 Days||11
530259|NCT00834873|1294281|P1|COMPLETED|Washout: 7 Days||12
530260|NCT00834873|1294280|P2|STARTED|Washout: 7 Days||11
530261|NCT00834873|1294281|P1|STARTED|Washout: 7 Days||12
530262|NCT00834873|1294280|P2|NOT COMPLETED|First Intervention||1
530263|NCT00834873|1294281|P1|NOT COMPLETED|First Intervention||0
530264|NCT00834873|1294280|P2|COMPLETED|First Intervention||11
530265|NCT00834873|1294281|P1|COMPLETED|First Intervention||12
530266|NCT00834873|1294280|P2|STARTED|First Intervention||12
530267|NCT00834873|1294281|P1|STARTED|First Intervention||12
530268|NCT00834834|1294291|P2|NOT COMPLETED|Overall Study||3
530269|NCT00834834|1294292|P1|NOT COMPLETED|Overall Study||4
530270|NCT00834834|1294291|P2|COMPLETED|Overall Study||39
530271|NCT00834834|1294292|P1|COMPLETED|Overall Study||38
530272|NCT00834834|1294291|P2|STARTED|Overall Study||42
530273|NCT00834834|1294292|P1|STARTED|Overall Study||42
530274|NCT00834808|1294303|P3|NOT COMPLETED|Treatment Period 3 (Day 15)||0
530275|NCT00834808|1294304|P2|NOT COMPLETED|Treatment Period 3 (Day 15)||0
530276|NCT00834808|1294305|P1|NOT COMPLETED|Treatment Period 3 (Day 15)||0
530277|NCT00834808|1294303|P3|COMPLETED|Treatment Period 3 (Day 15)||9
530278|NCT00834808|1294304|P2|COMPLETED|Treatment Period 3 (Day 15)||9
530279|NCT00834808|1294305|P1|COMPLETED|Treatment Period 3 (Day 15)||9
530280|NCT00834808|1294303|P3|STARTED|Treatment Period 3 (Day 15)||9
530281|NCT00834808|1294304|P2|STARTED|Treatment Period 3 (Day 15)||9
530282|NCT00834808|1294305|P1|STARTED|Treatment Period 3 (Day 15)||9
530283|NCT00834808|1294303|P3|NOT COMPLETED|Treatment Period 2 (Day 8)||0
530284|NCT00834808|1294304|P2|NOT COMPLETED|Treatment Period 2 (Day 8)||0
530285|NCT00834808|1294305|P1|NOT COMPLETED|Treatment Period 2 (Day 8)||0
530286|NCT00834808|1294303|P3|COMPLETED|Treatment Period 2 (Day 8)||9
530287|NCT00834808|1294304|P2|COMPLETED|Treatment Period 2 (Day 8)||9
530288|NCT00834808|1294305|P1|COMPLETED|Treatment Period 2 (Day 8)||9
530289|NCT00834808|1294303|P3|STARTED|Treatment Period 2 (Day 8)||9
530290|NCT00834808|1294304|P2|STARTED|Treatment Period 2 (Day 8)||9
530291|NCT00834808|1294305|P1|STARTED|Treatment Period 2 (Day 8)||9
530292|NCT00834808|1294303|P3|NOT COMPLETED|Treatment Period 1 (Day 1)||0
530293|NCT00834808|1294304|P2|NOT COMPLETED|Treatment Period 1 (Day 1)||0
530294|NCT00834808|1294305|P1|NOT COMPLETED|Treatment Period 1 (Day 1)||0
530295|NCT00834808|1294303|P3|COMPLETED|Treatment Period 1 (Day 1)||9
530296|NCT00834808|1294304|P2|COMPLETED|Treatment Period 1 (Day 1)||9
530297|NCT00834808|1294305|P1|COMPLETED|Treatment Period 1 (Day 1)||9
530298|NCT00834808|1294303|P3|STARTED|Treatment Period 1 (Day 1)||9
530299|NCT00834808|1294304|P2|STARTED|Treatment Period 1 (Day 1)||9
530300|NCT00834808|1294305|P1|STARTED|Treatment Period 1 (Day 1)||9
530301|NCT00834795|1294327|P2|NOT COMPLETED|Second Intervention||0
530302|NCT00834795|1294328|P1|NOT COMPLETED|Second Intervention||1
530303|NCT00834795|1294327|P2|COMPLETED|Second Intervention||17
530304|NCT00834795|1294328|P1|COMPLETED|Second Intervention||17
530305|NCT00834795|1294327|P2|STARTED|Second Intervention||17
530306|NCT00834795|1294328|P1|STARTED|Second Intervention||18
530307|NCT00834795|1294327|P2|NOT COMPLETED|Washout: 7 Days||1
530308|NCT00834795|1294328|P1|NOT COMPLETED|Washout: 7 Days||0
530309|NCT00834795|1294327|P2|COMPLETED|Washout: 7 Days||17
530310|NCT00834795|1294328|P1|COMPLETED|Washout: 7 Days||18
530311|NCT00834795|1294327|P2|STARTED|Washout: 7 Days||18
530312|NCT00834795|1294328|P1|STARTED|Washout: 7 Days||18
530313|NCT00834795|1294327|P2|NOT COMPLETED|First Intervention||0
530314|NCT00834795|1294328|P1|NOT COMPLETED|First Intervention||0
530315|NCT00834795|1294327|P2|COMPLETED|First Intervention||18
530316|NCT00834795|1294328|P1|COMPLETED|First Intervention||18
530317|NCT00834795|1294327|P2|STARTED|First Intervention||18
530318|NCT00834795|1294328|P1|STARTED|First Intervention||18
530319|NCT00834756|1294338|P2|NOT COMPLETED|Second Intervention||0
530320|NCT00834756|1294339|P1|NOT COMPLETED|Second Intervention||0
530321|NCT00834756|1294338|P2|COMPLETED|Second Intervention||18
530322|NCT00834756|1294339|P1|COMPLETED|Second Intervention||16
530323|NCT00834756|1294338|P2|STARTED|Second Intervention||18
530324|NCT00834756|1294339|P1|STARTED|Second Intervention||16
530325|NCT00834756|1294338|P2|NOT COMPLETED|Washout: 21 Days||0
530326|NCT00834756|1294339|P1|NOT COMPLETED|Washout: 21 Days||1
530327|NCT00834756|1294338|P2|COMPLETED|Washout: 21 Days||18
530328|NCT00834756|1294339|P1|COMPLETED|Washout: 21 Days||16
530329|NCT00834756|1294338|P2|STARTED|Washout: 21 Days||18
530330|NCT00834756|1294339|P1|STARTED|Washout: 21 Days||17
530331|NCT00834756|1294338|P2|NOT COMPLETED|First Intervention||0
530332|NCT00834756|1294339|P1|NOT COMPLETED|First Intervention||1
530333|NCT00834756|1294338|P2|COMPLETED|First Intervention||18
530334|NCT00834756|1294339|P1|COMPLETED|First Intervention||17
530335|NCT00834756|1294338|P2|STARTED|First Intervention||18
530336|NCT00834756|1294339|P1|STARTED|First Intervention||18
530337|NCT00834743|1294349|P2|NOT COMPLETED|Second Intervention||0
530338|NCT00834743|1294350|P1|NOT COMPLETED|Second Intervention||1
530339|NCT00834743|1294349|P2|COMPLETED|Second Intervention||16
530340|NCT00834743|1294350|P1|COMPLETED|Second Intervention||15
530341|NCT00834743|1294349|P2|STARTED|Second Intervention||16
530342|NCT00834743|1294350|P1|STARTED|Second Intervention||16
530343|NCT00834743|1294349|P2|NOT COMPLETED|Washout of 7 Days||0
530344|NCT00834743|1294350|P1|NOT COMPLETED|Washout of 7 Days||0
530345|NCT00834743|1294349|P2|COMPLETED|Washout of 7 Days||16
530346|NCT00834743|1294350|P1|COMPLETED|Washout of 7 Days||16
530347|NCT00834743|1294349|P2|STARTED|Washout of 7 Days||16
530348|NCT00834743|1294350|P1|STARTED|Washout of 7 Days||16
530349|NCT00834743|1294349|P2|NOT COMPLETED|First Intervention||0
530350|NCT00834743|1294350|P1|NOT COMPLETED|First Intervention||0
530351|NCT00834743|1294349|P2|COMPLETED|First Intervention||16
530352|NCT00834743|1294350|P1|COMPLETED|First Intervention||16
530353|NCT00834743|1294349|P2|STARTED|First Intervention||16
530354|NCT00834743|1294350|P1|STARTED|First Intervention||16
530355|NCT00834717|1294360|P2|NOT COMPLETED|Second Intervention||0
530356|NCT00834717|1294361|P1|NOT COMPLETED|Second Intervention||0
530357|NCT00834717|1294360|P2|COMPLETED|Second Intervention||19
530358|NCT00834717|1294361|P1|COMPLETED|Second Intervention||19
530359|NCT00834717|1294360|P2|STARTED|Second Intervention||19
530360|NCT00834717|1294361|P1|STARTED|Second Intervention||19
530361|NCT00834717|1294360|P2|NOT COMPLETED|First Intervention||1
530362|NCT00834717|1294361|P1|NOT COMPLETED|First Intervention||1
530363|NCT00834717|1294360|P2|COMPLETED|First Intervention||19
530364|NCT00834717|1294361|P1|COMPLETED|First Intervention||19
530365|NCT00834717|1294360|P2|STARTED|First Intervention||20
530366|NCT00834717|1294361|P1|STARTED|First Intervention||20
530367|NCT00834678|1294369|P1|NOT COMPLETED|Overall Study||0
530368|NCT00834678|1294369|P1|COMPLETED|Overall Study||11
530369|NCT00834678|1294369|P1|STARTED|Overall Study||11
530370|NCT00834652|1294383|P2|NOT COMPLETED|Overall Study||40
530371|NCT00834652|1294384|P1|NOT COMPLETED|Overall Study||38
530372|NCT00834652|1294383|P2|COMPLETED|Overall Study||62
530373|NCT00834652|1294384|P1|COMPLETED|Overall Study||66
530374|NCT00834652|1294383|P2|STARTED|Overall Study||102
530375|NCT00834652|1294384|P1|STARTED|Overall Study||104
530376|NCT00834639|1294392|P2|NOT COMPLETED|Second Intervention||2
530377|NCT00834639|1294393|P1|NOT COMPLETED|Second Intervention||0
530378|NCT00834639|1294392|P2|COMPLETED|Second Intervention||10
530379|NCT00834639|1294393|P1|COMPLETED|Second Intervention||12
530380|NCT00834639|1294392|P2|STARTED|Second Intervention||12
530381|NCT00834639|1294393|P1|STARTED|Second Intervention||12
530382|NCT00834639|1294392|P2|NOT COMPLETED|Washout of 7 Days||0
530383|NCT00834639|1294393|P1|NOT COMPLETED|Washout of 7 Days||0
530384|NCT00834639|1294392|P2|COMPLETED|Washout of 7 Days||12
530385|NCT00834639|1294393|P1|COMPLETED|Washout of 7 Days||12
530386|NCT00834639|1294392|P2|STARTED|Washout of 7 Days||12
530387|NCT00834639|1294393|P1|STARTED|Washout of 7 Days||12
530388|NCT00834639|1294392|P2|NOT COMPLETED|First Intervention||0
530389|NCT00834639|1294393|P1|NOT COMPLETED|First Intervention||0
530390|NCT00834639|1294392|P2|COMPLETED|First Intervention||12
530391|NCT00834639|1294393|P1|COMPLETED|First Intervention||12
530392|NCT00834639|1294392|P2|STARTED|First Intervention||12
530393|NCT00834639|1294393|P1|STARTED|First Intervention||12
530394|NCT00834626|1294401|P1|NOT COMPLETED|Overall Study||0
530395|NCT00834626|1294401|P1|COMPLETED|Overall Study||30
530396|NCT00834626|1294401|P1|1 Year Follow-up|Overall Study||30
530397|NCT00834626|1294401|P1|STARTED|Overall Study||30
530398|NCT00834613|1294410|P2|NOT COMPLETED|Second Intervention||0
530399|NCT00834613|1294411|P1|NOT COMPLETED|Second Intervention||0
530400|NCT00834613|1294410|P2|COMPLETED|Second Intervention||16
530401|NCT00834613|1294411|P1|COMPLETED|Second Intervention||15
530402|NCT00834613|1294410|P2|STARTED|Second Intervention||16
530403|NCT00834613|1294411|P1|STARTED|Second Intervention||15
530404|NCT00834613|1294410|P2|NOT COMPLETED|Washout of 7 Days||0
530405|NCT00834613|1294411|P1|NOT COMPLETED|Washout of 7 Days||0
530406|NCT00834613|1294410|P2|COMPLETED|Washout of 7 Days||16
530407|NCT00834613|1294411|P1|COMPLETED|Washout of 7 Days||15
530408|NCT00834613|1294410|P2|STARTED|Washout of 7 Days||16
530409|NCT00834613|1294411|P1|STARTED|Washout of 7 Days||15
530410|NCT00834613|1294410|P2|NOT COMPLETED|First Intervention||0
530411|NCT00834613|1294411|P1|NOT COMPLETED|First Intervention||1
530412|NCT00834613|1294410|P2|COMPLETED|First Intervention||16
530413|NCT00834613|1294411|P1|COMPLETED|First Intervention||15
530414|NCT00834613|1294410|P2|STARTED|First Intervention||16
530415|NCT00834613|1294411|P1|STARTED|First Intervention||16
530416|NCT00834587|1294421|P2|NOT COMPLETED|Second Intervention||0
530417|NCT00834587|1294422|P1|NOT COMPLETED|Second Intervention||0
530418|NCT00834587|1294421|P2|COMPLETED|Second Intervention||20
530419|NCT00834587|1294422|P1|COMPLETED|Second Intervention||19
530420|NCT00834587|1294421|P2|STARTED|Second Intervention||20
530421|NCT00834587|1294422|P1|STARTED|Second Intervention||19
530422|NCT00834587|1294421|P2|NOT COMPLETED|Washout: 7 Days||0
530423|NCT00834587|1294422|P1|NOT COMPLETED|Washout: 7 Days||1
530424|NCT00834587|1294421|P2|COMPLETED|Washout: 7 Days||20
530425|NCT00834587|1294422|P1|COMPLETED|Washout: 7 Days||19
530426|NCT00834587|1294421|P2|STARTED|Washout: 7 Days||20
530427|NCT00834587|1294422|P1|STARTED|Washout: 7 Days||20
530428|NCT00834587|1294421|P2|NOT COMPLETED|First Intervention||0
530429|NCT00834587|1294422|P1|NOT COMPLETED|First Intervention||0
530430|NCT00834587|1294421|P2|COMPLETED|First Intervention||20
530431|NCT00834587|1294422|P1|COMPLETED|First Intervention||20
530432|NCT00834587|1294421|P2|STARTED|First Intervention||20
530433|NCT00834587|1294422|P1|STARTED|First Intervention||20
530434|NCT00834574|1294438|P2|NOT COMPLETED|Second Intervention||0
530435|NCT00834574|1294439|P1|NOT COMPLETED|Second Intervention||0
530436|NCT00834574|1294438|P2|COMPLETED|Second Intervention||16
530437|NCT00834574|1294439|P1|COMPLETED|Second Intervention||16
530438|NCT00834574|1294438|P2|STARTED|Second Intervention||16
530439|NCT00834574|1294439|P1|STARTED|Second Intervention||16
530440|NCT00834574|1294438|P2|NOT COMPLETED|Washout of 7 Days||0
530441|NCT00834574|1294439|P1|NOT COMPLETED|Washout of 7 Days||0
530442|NCT00834574|1294438|P2|COMPLETED|Washout of 7 Days||16
530443|NCT00834574|1294439|P1|COMPLETED|Washout of 7 Days||16
530444|NCT00834574|1294438|P2|STARTED|Washout of 7 Days||16
530445|NCT00834574|1294439|P1|STARTED|Washout of 7 Days||16
530446|NCT00834574|1294438|P2|NOT COMPLETED|First Intervention||0
530447|NCT00834574|1294439|P1|NOT COMPLETED|First Intervention||0
530448|NCT00834574|1294438|P2|COMPLETED|First Intervention||16
530449|NCT00834574|1294439|P1|COMPLETED|First Intervention||16
530450|NCT00834574|1294438|P2|STARTED|First Intervention||16
530451|NCT00834574|1294439|P1|STARTED|First Intervention||16
530452|NCT00834561|1294449|P2|NOT COMPLETED|Second Intervention||0
530453|NCT00834561|1294450|P1|NOT COMPLETED|Second Intervention||0
530454|NCT00834561|1294449|P2|COMPLETED|Second Intervention||16
530455|NCT00834561|1294450|P1|COMPLETED|Second Intervention||16
530456|NCT00834561|1294449|P2|STARTED|Second Intervention||16
530457|NCT00834561|1294450|P1|STARTED|Second Intervention||16
530458|NCT00834561|1294449|P2|NOT COMPLETED|First Intervention||0
530459|NCT00834561|1294450|P1|NOT COMPLETED|First Intervention||0
530460|NCT00834561|1294449|P2|COMPLETED|First Intervention||16
530461|NCT00834561|1294450|P1|COMPLETED|First Intervention||16
530462|NCT00834561|1294449|P2|STARTED|First Intervention||16
530463|NCT00834561|1294450|P1|STARTED|First Intervention||16
530464|NCT00834535|1294460|P2|NOT COMPLETED|Second Intervention||0
530465|NCT00834535|1294461|P1|NOT COMPLETED|Second Intervention||0
530466|NCT00834535|1294460|P2|COMPLETED|Second Intervention||16
530467|NCT00834535|1294461|P1|COMPLETED|Second Intervention||16
530468|NCT00834535|1294460|P2|STARTED|Second Intervention||16
530469|NCT00834535|1294461|P1|STARTED|Second Intervention||16
530470|NCT00834535|1294460|P2|NOT COMPLETED|Washout of 7 Days||0
530471|NCT00834535|1294461|P1|NOT COMPLETED|Washout of 7 Days||0
530472|NCT00834535|1294460|P2|COMPLETED|Washout of 7 Days||16
530473|NCT00834535|1294461|P1|COMPLETED|Washout of 7 Days||16
530474|NCT00834535|1294460|P2|STARTED|Washout of 7 Days||16
530475|NCT00834535|1294461|P1|STARTED|Washout of 7 Days||16
530476|NCT00834535|1294460|P2|NOT COMPLETED|First Intervention||0
530477|NCT00834535|1294461|P1|NOT COMPLETED|First Intervention||0
530478|NCT00834535|1294460|P2|COMPLETED|First Intervention||16
530479|NCT00834535|1294461|P1|COMPLETED|First Intervention||16
530480|NCT00834535|1294460|P2|STARTED|First Intervention||16
530481|NCT00834535|1294461|P1|STARTED|First Intervention||16
530482|NCT00834522|1294471|P2|NOT COMPLETED|Second Intervention||0
530483|NCT00834522|1294472|P1|NOT COMPLETED|Second Intervention||0
530484|NCT00834522|1294471|P2|COMPLETED|Second Intervention||39
530485|NCT00834522|1294472|P1|COMPLETED|Second Intervention||37
530486|NCT00834522|1294471|P2|STARTED|Second Intervention||39
530487|NCT00834522|1294472|P1|STARTED|Second Intervention||37
530488|NCT00834522|1294471|P2|NOT COMPLETED|Washout||1
530489|NCT00834522|1294472|P1|NOT COMPLETED|Washout||3
530490|NCT00834522|1294471|P2|COMPLETED|Washout||39
530491|NCT00834522|1294472|P1|COMPLETED|Washout||37
530492|NCT00834522|1294471|P2|STARTED|Washout||40
530493|NCT00834522|1294472|P1|STARTED|Washout||40
530494|NCT00834522|1294471|P2|NOT COMPLETED|First Intervention||0
530495|NCT00834522|1294472|P1|NOT COMPLETED|First Intervention||0
530496|NCT00834522|1294471|P2|COMPLETED|First Intervention||40
530497|NCT00834522|1294472|P1|COMPLETED|First Intervention||40
530498|NCT00834522|1294471|P2|STARTED|First Intervention||40
530499|NCT00834522|1294472|P1|STARTED|First Intervention||40
530500|NCT00834483|1294482|P2|NOT COMPLETED|Overall Study||0
530501|NCT00834483|1294483|P1|NOT COMPLETED|Overall Study||0
530502|NCT00834483|1294482|P2|COMPLETED|Overall Study||29
530503|NCT00834483|1294483|P1|COMPLETED|Overall Study||31
530504|NCT00834483|1294482|P2|STARTED|Overall Study||29
530505|NCT00834483|1294483|P1|STARTED|Overall Study||31
530506|NCT00834444|1294495|P2|NOT COMPLETED|Second Intervention||0
530507|NCT00834444|1294496|P1|NOT COMPLETED|Second Intervention||1
530508|NCT00834444|1294495|P2|COMPLETED|Second Intervention||16
530509|NCT00834444|1294496|P1|COMPLETED|Second Intervention||16
530510|NCT00834444|1294495|P2|STARTED|Second Intervention||16
530511|NCT00834444|1294496|P1|STARTED|Second Intervention||17
530512|NCT00834444|1294495|P2|NOT COMPLETED|Washout of 7 Days||1
530513|NCT00834444|1294496|P1|NOT COMPLETED|Washout of 7 Days||0
530514|NCT00834444|1294495|P2|COMPLETED|Washout of 7 Days||16
530515|NCT00834444|1294496|P1|COMPLETED|Washout of 7 Days||17
530516|NCT00834444|1294495|P2|STARTED|Washout of 7 Days||17
530517|NCT00834444|1294496|P1|STARTED|Washout of 7 Days||17
530518|NCT00834444|1294495|P2|NOT COMPLETED|First Intervention||1
530519|NCT00834444|1294496|P1|NOT COMPLETED|First Intervention||1
530520|NCT00834444|1294495|P2|COMPLETED|First Intervention||17
530521|NCT00834444|1294496|P1|COMPLETED|First Intervention||17
530522|NCT00834444|1294495|P2|STARTED|First Intervention||18
530523|NCT00834444|1294496|P1|STARTED|First Intervention||18
530524|NCT00834431|1294506|P2|NOT COMPLETED|Second Intervention||0
530525|NCT00834431|1294507|P1|NOT COMPLETED|Second Intervention||0
530526|NCT00834431|1294506|P2|COMPLETED|Second Intervention||16
530527|NCT00834431|1294507|P1|COMPLETED|Second Intervention||18
530528|NCT00834431|1294506|P2|STARTED|Second Intervention||16
530529|NCT00834431|1294507|P1|STARTED|Second Intervention||18
530530|NCT00834431|1294506|P2|NOT COMPLETED|Washout of 7 Days||1
530531|NCT00834431|1294507|P1|NOT COMPLETED|Washout of 7 Days||0
530532|NCT00834431|1294506|P2|COMPLETED|Washout of 7 Days||16
530533|NCT00834431|1294507|P1|COMPLETED|Washout of 7 Days||18
530534|NCT00834431|1294506|P2|STARTED|Washout of 7 Days||17
530535|NCT00834431|1294507|P1|STARTED|Washout of 7 Days||18
530536|NCT00834431|1294506|P2|NOT COMPLETED|First Intervention||1
530537|NCT00834431|1294507|P1|NOT COMPLETED|First Intervention||0
530538|NCT00834431|1294506|P2|COMPLETED|First Intervention||17
530539|NCT00834431|1294507|P1|COMPLETED|First Intervention||18
530540|NCT00834431|1294506|P2|STARTED|First Intervention||18
530541|NCT00834431|1294507|P1|STARTED|First Intervention||18
530542|NCT00834418|1294517|P2|NOT COMPLETED|Overall Study||2
530543|NCT00834418|1294518|P1|NOT COMPLETED|Overall Study||0
530544|NCT00834418|1294517|P2|COMPLETED|Overall Study||40
530545|NCT00834418|1294518|P1|COMPLETED|Overall Study||42
530546|NCT00834418|1294517|P2|STARTED|Overall Study||42
530547|NCT00834418|1294518|P1|STARTED|Overall Study||42
530548|NCT00834405|1294526|P2|NOT COMPLETED|Overall Study||0
530549|NCT00834405|1294527|P1|NOT COMPLETED|Overall Study||0
530550|NCT00834405|1294526|P2|COMPLETED|Overall Study||17
530551|NCT00834405|1294527|P1|COMPLETED|Overall Study||20
530552|NCT00834405|1294526|P2|STARTED|Overall Study||17
530553|NCT00834405|1294527|P1|STARTED|Overall Study||20
530554|NCT00834366|1294535|P2|NOT COMPLETED|Treatment Period 2||0
530555|NCT00834366|1294536|P1|NOT COMPLETED|Treatment Period 2||0
530556|NCT00834366|1294535|P2|COMPLETED|Treatment Period 2||12
530557|NCT00834366|1294536|P1|COMPLETED|Treatment Period 2||12
530558|NCT00834366|1294535|P2|STARTED|Treatment Period 2||12
530559|NCT00834366|1294536|P1|STARTED|Treatment Period 2||12
530560|NCT00834366|1294535|P2|NOT COMPLETED|Treatment Period 1||1
530561|NCT00834366|1294536|P1|NOT COMPLETED|Treatment Period 1||1
530562|NCT00834366|1294535|P2|COMPLETED|Treatment Period 1||12
530563|NCT00834366|1294536|P1|COMPLETED|Treatment Period 1||12
530564|NCT00834366|1294535|P2|STARTED|Treatment Period 1||13
530565|NCT00834366|1294536|P1|STARTED|Treatment Period 1||13
530566|NCT00834340|1294552|P2|NOT COMPLETED|Second Intervention||0
530567|NCT00834340|1294553|P1|NOT COMPLETED|Second Intervention||0
530568|NCT00834340|1294552|P2|COMPLETED|Second Intervention||16
530569|NCT00834340|1294553|P1|COMPLETED|Second Intervention||14
530570|NCT00834340|1294552|P2|STARTED|Second Intervention||16
530571|NCT00834340|1294553|P1|STARTED|Second Intervention||14
530572|NCT00834340|1294552|P2|NOT COMPLETED|Washout||0
530573|NCT00834340|1294553|P1|NOT COMPLETED|Washout||2
530574|NCT00834340|1294552|P2|COMPLETED|Washout||16
530575|NCT00834340|1294553|P1|COMPLETED|Washout||14
530576|NCT00834340|1294552|P2|STARTED|Washout||16
530577|NCT00834340|1294553|P1|STARTED|Washout||16
530578|NCT00834340|1294552|P2|NOT COMPLETED|First Intervention||0
530579|NCT00834340|1294553|P1|NOT COMPLETED|First Intervention||0
530580|NCT00834340|1294552|P2|COMPLETED|First Intervention||16
530581|NCT00834340|1294553|P1|COMPLETED|First Intervention||16
530582|NCT00834340|1294552|P2|STARTED|First Intervention||16
530583|NCT00834340|1294553|P1|STARTED|First Intervention||16
530584|NCT00834288|1294563|P2|NOT COMPLETED|Treatment Phase II||0
530585|NCT00834288|1294564|P1|NOT COMPLETED|Treatment Phase II||0
530586|NCT00834288|1294563|P2|COMPLETED|Treatment Phase II||13
530587|NCT00834288|1294564|P1|COMPLETED|Treatment Phase II||13
530588|NCT00834288|1294563|P2|STARTED|Treatment Phase II||13
530589|NCT00834288|1294564|P1|STARTED|Treatment Phase II||13
530590|NCT00834288|1294563|P2|NOT COMPLETED|Treatment Phase I||0
530591|NCT00834288|1294564|P1|NOT COMPLETED|Treatment Phase I||0
530592|NCT00834288|1294563|P2|COMPLETED|Treatment Phase I||13
530593|NCT00834288|1294564|P1|COMPLETED|Treatment Phase I||13
530594|NCT00834288|1294563|P2|STARTED|Treatment Phase I||13
530595|NCT00834288|1294564|P1|STARTED|Treatment Phase I||13
530596|NCT00834275|1294586|P2|NOT COMPLETED|Second Intervention||0
530597|NCT00834275|1294587|P1|NOT COMPLETED|Second Intervention||0
530598|NCT00834275|1294586|P2|COMPLETED|Second Intervention||13
530599|NCT00834275|1294587|P1|COMPLETED|Second Intervention||13
530600|NCT00834275|1294586|P2|STARTED|Second Intervention||13
530601|NCT00834275|1294587|P1|STARTED|Second Intervention||13
530602|NCT00834275|1294586|P2|NOT COMPLETED|Washout of 7 Days||0
530603|NCT00834275|1294587|P1|NOT COMPLETED|Washout of 7 Days||0
530604|NCT00834275|1294586|P2|COMPLETED|Washout of 7 Days||13
530605|NCT00834275|1294587|P1|COMPLETED|Washout of 7 Days||13
530606|NCT00834275|1294586|P2|STARTED|Washout of 7 Days||13
530607|NCT00834275|1294587|P1|STARTED|Washout of 7 Days||13
530608|NCT00834275|1294586|P2|NOT COMPLETED|First Intervention||0
530609|NCT00834275|1294587|P1|NOT COMPLETED|First Intervention||0
530610|NCT00834275|1294586|P2|COMPLETED|First Intervention||13
530611|NCT00834275|1294587|P1|COMPLETED|First Intervention||13
530612|NCT00834275|1294586|P2|STARTED|First Intervention||13
530613|NCT00834275|1294587|P1|STARTED|First Intervention||13
530614|NCT00834249|1294597|P2|NOT COMPLETED|Second Intervention||0
530615|NCT00834249|1294598|P1|NOT COMPLETED|Second Intervention||1
530616|NCT00834249|1294597|P2|COMPLETED|Second Intervention||8
530617|NCT00834249|1294598|P1|COMPLETED|Second Intervention||7
530618|NCT00834249|1294597|P2|STARTED|Second Intervention||8
530619|NCT00834249|1294598|P1|STARTED|Second Intervention||8
530620|NCT00834249|1294597|P2|NOT COMPLETED|Washout: 7 Days||1
530621|NCT00834249|1294598|P1|NOT COMPLETED|Washout: 7 Days||1
530622|NCT00834249|1294597|P2|COMPLETED|Washout: 7 Days||8
530623|NCT00834249|1294598|P1|COMPLETED|Washout: 7 Days||8
530624|NCT00834249|1294597|P2|STARTED|Washout: 7 Days||9
530625|NCT00834249|1294598|P1|STARTED|Washout: 7 Days||9
530626|NCT00834249|1294597|P2|NOT COMPLETED|First Intervention||0
530627|NCT00834249|1294598|P1|NOT COMPLETED|First Intervention||0
530628|NCT00834249|1294597|P2|COMPLETED|First Intervention||9
530629|NCT00834249|1294598|P1|COMPLETED|First Intervention||9
530630|NCT00834249|1294597|P2|STARTED|First Intervention||9
530631|NCT00834249|1294598|P1|STARTED|First Intervention||9
530632|NCT00834236|1294614|P2|NOT COMPLETED|Overall Study||0
530633|NCT00834236|1294615|P1|NOT COMPLETED|Overall Study||0
530634|NCT00834236|1294614|P2|COMPLETED|Overall Study||47
530635|NCT00834236|1294615|P1|COMPLETED|Overall Study||29
530636|NCT00834236|1294614|P2|STARTED|Overall Study||47
530637|NCT00834236|1294615|P1|STARTED|Overall Study||29
530638|NCT00834210|1294623|P2|NOT COMPLETED|Overall Study||8
530639|NCT00834210|1294624|P1|NOT COMPLETED|Overall Study||3
530640|NCT00834210|1294623|P2|COMPLETED|Overall Study||77
530641|NCT00834210|1294624|P1|COMPLETED|Overall Study||83
530642|NCT00834210|1294623|P2|STARTED|Overall Study||85
530643|NCT00834210|1294624|P1|STARTED|Overall Study||86
530644|NCT00834197|1294638|P2|NOT COMPLETED|Second Intervention||0
530645|NCT00834197|1294639|P1|NOT COMPLETED|Second Intervention||0
530646|NCT00834197|1294638|P2|COMPLETED|Second Intervention||16
530647|NCT00834197|1294639|P1|COMPLETED|Second Intervention||16
530648|NCT00834197|1294638|P2|STARTED|Second Intervention||16
530649|NCT00834197|1294639|P1|STARTED|Second Intervention||16
530650|NCT00834197|1294638|P2|NOT COMPLETED|Washout of 14 Days||0
530651|NCT00834197|1294639|P1|NOT COMPLETED|Washout of 14 Days||0
530652|NCT00834197|1294638|P2|COMPLETED|Washout of 14 Days||16
530653|NCT00834197|1294639|P1|COMPLETED|Washout of 14 Days||16
530654|NCT00834197|1294638|P2|STARTED|Washout of 14 Days||16
530655|NCT00834197|1294639|P1|STARTED|Washout of 14 Days||16
530656|NCT00834197|1294638|P2|NOT COMPLETED|First Intervention||0
530657|NCT00834197|1294639|P1|NOT COMPLETED|First Intervention||0
530658|NCT00834197|1294638|P2|COMPLETED|First Intervention||16
530659|NCT00834197|1294639|P1|COMPLETED|First Intervention||16
530660|NCT00834197|1294638|P2|STARTED|First Intervention||16
530661|NCT00834197|1294639|P1|STARTED|First Intervention||16
530662|NCT00834171|1294649|P2|NOT COMPLETED|Overall Study||0
530663|NCT00834171|1294650|P1|NOT COMPLETED|Overall Study||0
530664|NCT00834171|1294649|P2|COMPLETED|Overall Study||7
530665|NCT00834171|1294650|P1|COMPLETED|Overall Study||43
530666|NCT00834171|1294649|P2|STARTED|Overall Study||7
530667|NCT00834171|1294650|P1|STARTED|Overall Study||43
530668|NCT00834132|1294658|P2|NOT COMPLETED|Second Intervention||0
530669|NCT00834132|1294659|P1|NOT COMPLETED|Second Intervention||0
530670|NCT00834132|1294658|P2|COMPLETED|Second Intervention||12
530671|NCT00834132|1294659|P1|COMPLETED|Second Intervention||12
530672|NCT00834132|1294658|P2|STARTED|Second Intervention||12
530673|NCT00834132|1294659|P1|STARTED|Second Intervention||12
530674|NCT00834132|1294658|P2|NOT COMPLETED|Washout: 21 Days||0
530675|NCT00834132|1294659|P1|NOT COMPLETED|Washout: 21 Days||0
530676|NCT00834132|1294658|P2|COMPLETED|Washout: 21 Days||12
530677|NCT00834132|1294659|P1|COMPLETED|Washout: 21 Days||12
530678|NCT00834132|1294658|P2|STARTED|Washout: 21 Days||12
530679|NCT00834132|1294659|P1|STARTED|Washout: 21 Days||12
530680|NCT00834132|1294658|P2|NOT COMPLETED|First Intervention||0
530681|NCT00834132|1294659|P1|NOT COMPLETED|First Intervention||0
530682|NCT00834132|1294658|P2|COMPLETED|First Intervention||12
530683|NCT00834132|1294659|P1|COMPLETED|First Intervention||12
530684|NCT00834132|1294658|P2|STARTED|First Intervention||12
530685|NCT00834132|1294659|P1|STARTED|First Intervention||12
530686|NCT00834106|1294669|P2|NOT COMPLETED|Extension Study (Month 42 to Month 90)||74
530687|NCT00834106|1294670|P1|NOT COMPLETED|Extension Study (Month 42 to Month 90)||96
530688|NCT00834106|1294669|P2|COMPLETED|Extension Study (Month 42 to Month 90)||1294
530689|NCT00834106|1294670|P1|COMPLETED|Extension Study (Month 42 to Month 90)||1308
530690|NCT00834106|1294669|P2|STARTED|Extension Study (Month 42 to Month 90)|Some participants missed the Month 30 visit but returned for the Month 42 visit|1368
530691|NCT00834106|1294670|P1|STARTED|Extension Study (Month 42 to Month 90)|Some participants missed the Month 30 visit but returned for the Month 42 visit|1404
530692|NCT00834106|1294669|P2|NOT COMPLETED|Base Study (Day 1 to Month 30)||145
530693|NCT00834106|1294670|P1|NOT COMPLETED|Base Study (Day 1 to Month 30)||102
530694|NCT00834106|1294669|P2|COMPLETED|Base Study (Day 1 to Month 30)|Completed Month 30 follow-up|1358
530695|NCT00834106|1294670|P1|COMPLETED|Base Study (Day 1 to Month 30)|Completed Month 30 follow-up|1401
530696|NCT00834106|1294669|P2|Completed Vaccinations|Base Study (Day 1 to Month 30)||1463
530697|NCT00834106|1294670|P1|Completed Vaccinations|Base Study (Day 1 to Month 30)||1473
530698|NCT00834106|1294669|P2|Vaccinated|Base Study (Day 1 to Month 30)||1503
530699|NCT00834106|1294670|P1|Vaccinated|Base Study (Day 1 to Month 30)||1503
530700|NCT00834106|1294669|P2|STARTED|Base Study (Day 1 to Month 30)|Randomized participants|1503
530701|NCT00834106|1294670|P1|STARTED|Base Study (Day 1 to Month 30)|Randomized participants|1503
530702|NCT00834080|1294694|P1|NOT COMPLETED|Overall Study||23
530703|NCT00834080|1294694|P1|COMPLETED|Overall Study||15
530704|NCT00834080|1294694|P1|STARTED|Overall Study||38
530705|NCT00834067|1294700|P2|NOT COMPLETED|Second Intervention||0
530706|NCT00834067|1294701|P1|NOT COMPLETED|Second Intervention||0
530707|NCT00834067|1294700|P2|COMPLETED|Second Intervention||29
530708|NCT00834067|1294701|P1|COMPLETED|Second Intervention||30
530709|NCT00834067|1294700|P2|STARTED|Second Intervention||29
530710|NCT00834067|1294701|P1|STARTED|Second Intervention||30
530711|NCT00834067|1294700|P2|NOT COMPLETED|Washout of 21 Days||1
530712|NCT00834067|1294701|P1|NOT COMPLETED|Washout of 21 Days||0
530713|NCT00834067|1294700|P2|COMPLETED|Washout of 21 Days||29
530714|NCT00834067|1294701|P1|COMPLETED|Washout of 21 Days||30
530715|NCT00834067|1294700|P2|STARTED|Washout of 21 Days||30
530716|NCT00834067|1294701|P1|STARTED|Washout of 21 Days||30
530717|NCT00834067|1294700|P2|NOT COMPLETED|First Intervention||0
530718|NCT00834067|1294701|P1|NOT COMPLETED|First Intervention||0
530719|NCT00834067|1294700|P2|COMPLETED|First Intervention||30
530720|NCT00834067|1294701|P1|COMPLETED|First Intervention||30
530721|NCT00834067|1294700|P2|STARTED|First Intervention||30
530722|NCT00834067|1294701|P1|STARTED|First Intervention||30
530723|NCT00834041|1294723|P2|NOT COMPLETED|Overall Study||1
530724|NCT00834041|1294724|P1|NOT COMPLETED|Overall Study||1
530725|NCT00834041|1294723|P2|COMPLETED|Overall Study||19
530726|NCT00834041|1294724|P1|COMPLETED|Overall Study||18
530727|NCT00834041|1294723|P2|STARTED|Overall Study||20
530728|NCT00834041|1294724|P1|STARTED|Overall Study||19
530729|NCT00833989|1294742|P4|NOT COMPLETED|Overall Study||2
530730|NCT00833989|1294743|P3|NOT COMPLETED|Overall Study||1
530731|NCT00833989|1294744|P2|NOT COMPLETED|Overall Study||0
530732|NCT00833989|1294745|P1|NOT COMPLETED|Overall Study||3
530733|NCT00833989|1294742|P4|COMPLETED|Overall Study||6
530734|NCT00833989|1294743|P3|COMPLETED|Overall Study||8
530735|NCT00833989|1294744|P2|COMPLETED|Overall Study||8
530736|NCT00833989|1294745|P1|COMPLETED|Overall Study||14
530737|NCT00833989|1294742|P4|STARTED|Overall Study||8
530738|NCT00833989|1294743|P3|STARTED|Overall Study||9
530739|NCT00833989|1294744|P2|STARTED|Overall Study||8
530740|NCT00833989|1294745|P1|STARTED|Overall Study||17
530741|NCT00833976|1294849|P1|NOT COMPLETED|Overall Study||51
530742|NCT00833976|1294849|P1|COMPLETED|Overall Study||14
530743|NCT00833976|1294849|P1|STARTED|Overall Study||65
530744|NCT00833937|1294857|P2|NOT COMPLETED|Second Intervention||0
530745|NCT00833937|1294858|P1|NOT COMPLETED|Second Intervention||0
530746|NCT00833937|1294857|P2|COMPLETED|Second Intervention||12
530747|NCT00833937|1294858|P1|COMPLETED|Second Intervention||11
530748|NCT00833937|1294857|P2|STARTED|Second Intervention||12
530749|NCT00833937|1294858|P1|STARTED|Second Intervention||11
530750|NCT00833937|1294857|P2|NOT COMPLETED|Washout||0
530751|NCT00833937|1294858|P1|NOT COMPLETED|Washout||1
530752|NCT00833937|1294857|P2|COMPLETED|Washout||12
530753|NCT00833937|1294858|P1|COMPLETED|Washout||11
530754|NCT00833937|1294857|P2|STARTED|Washout||12
530755|NCT00833937|1294858|P1|STARTED|Washout||12
530756|NCT00833937|1294857|P2|NOT COMPLETED|First Intervention||0
530757|NCT00833937|1294858|P1|NOT COMPLETED|First Intervention||0
530758|NCT00833937|1294857|P2|COMPLETED|First Intervention||12
530759|NCT00833937|1294858|P1|COMPLETED|First Intervention||12
530760|NCT00833937|1294857|P2|STARTED|First Intervention||12
530761|NCT00833937|1294858|P1|STARTED|First Intervention||12
530762|NCT00833924|1294866|P1|NOT COMPLETED|Overall Study||109
530763|NCT00833924|1294866|P1|COMPLETED|Overall Study||11
530764|NCT00833924|1294866|P1|12-month|Overall Study||113
530765|NCT00833924|1294866|P1|30-day|Overall Study||120
530766|NCT00833924|1294866|P1|STARTED|Overall Study||120
530767|NCT00833911|1294871|P1|NOT COMPLETED|Maintenance Phase II||10
530768|NCT00833911|1294871|P1|COMPLETED|Maintenance Phase II||166
530769|NCT00833911|1294871|P1|STARTED|Maintenance Phase II|97 patients chose not to continue into Maintenance Phase II|176
530770|NCT00833911|1294871|P1|NOT COMPLETED|Maintenance Phase I||98
530771|NCT00833911|1294871|P1|COMPLETED|Maintenance Phase I||273
530772|NCT00833911|1294871|P1|STARTED|Maintenance Phase I||371
530773|NCT00833911|1294871|P1|NOT COMPLETED|Titration||21
530774|NCT00833911|1294871|P1|COMPLETED|Titration||371
530775|NCT00833911|1294871|P1|STARTED|Titration||392
530776|NCT00833898|1294881|P2|NOT COMPLETED|Overall Study||36
530777|NCT00833898|1294882|P1|NOT COMPLETED|Overall Study||40
530778|NCT00833898|1294881|P2|COMPLETED|Overall Study||38
530779|NCT00833898|1294882|P1|COMPLETED|Overall Study||34
530780|NCT00833898|1294881|P2|Month 12 (Post Transplantation)|Overall Study||50
530781|NCT00833898|1294882|P1|Month 12 (Post Transplantation)|Overall Study||50
530782|NCT00833898|1294881|P2|Month 6 (Post Transplantation)|Overall Study||54
530783|NCT00833898|1294882|P1|Month 6 (Post Transplantation)|Overall Study||59
530784|NCT00833898|1294881|P2|Month 3 (Post Transplantation)|Overall Study||64
530785|NCT00833898|1294882|P1|Month 3 (Post Transplantation)|Overall Study||66
530786|NCT00833898|1294881|P2|Month 1 (Post Transplantation)|Overall Study||74
530787|NCT00833898|1294882|P1|Month 1 (Post Transplantation)|Overall Study||72
530788|NCT00833898|1294881|P2|STARTED|Overall Study||74
530789|NCT00833898|1294882|P1|STARTED|Overall Study||74
530790|NCT00833859|1294928|P1|NOT COMPLETED|Overall Study||0
530791|NCT00833859|1294928|P1|COMPLETED|Overall Study||2
530792|NCT00833859|1294928|P1|STARTED|Overall Study||2
530793|NCT00833833|1294941|P6|NOT COMPLETED|Phase 2 (as of 01 April 2011)||61
530794|NCT00833833|1294942|P5|NOT COMPLETED|Phase 2 (as of 01 April 2011)||55
530795|NCT00833833|1294943|P4|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
530796|NCT00833833|1294944|P3|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
530797|NCT00833833|1294945|P2|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
530798|NCT00833833|1294946|P1|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
530799|NCT00833833|1294941|P6|COMPLETED|Phase 2 (as of 01 April 2011)|Confirmed progressive disease|47
530800|NCT00833833|1294942|P5|COMPLETED|Phase 2 (as of 01 April 2011)|Confirmed progressive disease|58
530801|NCT00833833|1294943|P4|COMPLETED|Phase 2 (as of 01 April 2011)||0
530802|NCT00833833|1294944|P3|COMPLETED|Phase 2 (as of 01 April 2011)||0
530803|NCT00833833|1294945|P2|COMPLETED|Phase 2 (as of 01 April 2011)||0
530804|NCT00833833|1294946|P1|COMPLETED|Phase 2 (as of 01 April 2011)||0
530805|NCT00833833|1294941|P6|Safety Population|Phase 2 (as of 01 April 2011)||107
530806|NCT00833833|1294942|P5|Safety Population|Phase 2 (as of 01 April 2011)||112
530807|NCT00833833|1294943|P4|Safety Population|Phase 2 (as of 01 April 2011)||0
530808|NCT00833833|1294944|P3|Safety Population|Phase 2 (as of 01 April 2011)||0
530809|NCT00833833|1294945|P2|Safety Population|Phase 2 (as of 01 April 2011)||0
530810|NCT00833833|1294946|P1|Safety Population|Phase 2 (as of 01 April 2011)||0
530811|NCT00833833|1294941|P6|STARTED|Phase 2 (as of 01 April 2011)||108
530812|NCT00833833|1294942|P5|STARTED|Phase 2 (as of 01 April 2011)||113
530813|NCT00833833|1294943|P4|STARTED|Phase 2 (as of 01 April 2011)||0
530814|NCT00833833|1294944|P3|STARTED|Phase 2 (as of 01 April 2011)||0
530815|NCT00833833|1294945|P2|STARTED|Phase 2 (as of 01 April 2011)||0
530816|NCT00833833|1294946|P1|STARTED|Phase 2 (as of 01 April 2011)||0
530817|NCT00833833|1294941|P6|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0
530818|NCT00833833|1294942|P5|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0
530819|NCT00833833|1294943|P4|NOT COMPLETED|Phase 1 (as of 01 April 2011)||6
530820|NCT00833833|1294944|P3|NOT COMPLETED|Phase 1 (as of 01 April 2011)||9
530821|NCT00833833|1294945|P2|NOT COMPLETED|Phase 1 (as of 01 April 2011)||5
530822|NCT00833833|1294946|P1|NOT COMPLETED|Phase 1 (as of 01 April 2011)||4
530823|NCT00833833|1294941|P6|COMPLETED|Phase 1 (as of 01 April 2011)||0
530824|NCT00833833|1294942|P5|COMPLETED|Phase 1 (as of 01 April 2011)||0
530825|NCT00833833|1294943|P4|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|4
530826|NCT00833833|1294944|P3|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|5
530827|NCT00833833|1294945|P2|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|3
530828|NCT00833833|1294946|P1|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|2
530829|NCT00833833|1294941|P6|STARTED|Phase 1 (as of 01 April 2011)||0
530830|NCT00833833|1294942|P5|STARTED|Phase 1 (as of 01 April 2011)||0
530831|NCT00833833|1294943|P4|STARTED|Phase 1 (as of 01 April 2011)||10
530832|NCT00833833|1294944|P3|STARTED|Phase 1 (as of 01 April 2011)||14
530833|NCT00833833|1294945|P2|STARTED|Phase 1 (as of 01 April 2011)||8
530834|NCT00833833|1294946|P1|STARTED|Phase 1 (as of 01 April 2011)||6
530835|NCT00833794|1294986|P2|NOT COMPLETED|Double-blind Phase||49
530836|NCT00833794|1294987|P1|NOT COMPLETED|Double-blind Phase||106
530837|NCT00833794|1294986|P2|COMPLETED|Double-blind Phase||165
530838|NCT00833794|1294987|P1|COMPLETED|Double-blind Phase||326
530839|NCT00833794|1294986|P2|STARTED|Double-blind Phase|Of the 646 patients who completed the Open-Label phase, 214 were randomized to Placebo|214
530840|NCT00833794|1294987|P1|STARTED|Double-blind Phase|Of the 646 patients who completed the Open-Label phase, 432 were randomized to Tramadol Once A Day|432
530841|NCT00833794|1294986|P2|NOT COMPLETED|Open-label Phase||0
530842|NCT00833794|1294987|P1|NOT COMPLETED|Open-label Phase||382
530843|NCT00833794|1294986|P2|COMPLETED|Open-label Phase||0
530844|NCT00833794|1294987|P1|COMPLETED|Open-label Phase|Randomized in double-blind phase|646
530845|NCT00833794|1294986|P2|Received Open-Label Treatment|Open-label Phase||0
530846|NCT00833794|1294987|P1|Received Open-Label Treatment|Open-label Phase||1023
530847|NCT00833794|1294986|P2|Entered run-in Period|Open-label Phase||0
530848|NCT00833794|1294987|P1|Entered run-in Period|Open-label Phase||1027
530849|NCT00833794|1294986|P2|STARTED|Open-label Phase|No Placebo arm during open-label phase.|0
530850|NCT00833794|1294987|P1|STARTED|Open-label Phase|Enrolled. Population described in the baseline characteristics is 1023 patients (Open-Label safety).|1028
530851|NCT00833781|1295015|P2|NOT COMPLETED|Overall Study||0
530852|NCT00833781|1295016|P1|NOT COMPLETED|Overall Study||0
530853|NCT00833781|1295015|P2|COMPLETED|Overall Study||5
530854|NCT00833781|1295016|P1|COMPLETED|Overall Study||10
530855|NCT00833781|1295015|P2|STARTED|Overall Study||5
530856|NCT00833781|1295016|P1|STARTED|Overall Study||10
530857|NCT00833755|1295031|P4|NOT COMPLETED|Overall Study||6
530858|NCT00833755|1295032|P3|NOT COMPLETED|Overall Study||2
530859|NCT00833755|1295033|P2|NOT COMPLETED|Overall Study||5
530860|NCT00833755|1295034|P1|NOT COMPLETED|Overall Study||4
530861|NCT00833755|1295031|P4|COMPLETED|Overall Study||17
530862|NCT00833755|1295032|P3|COMPLETED|Overall Study||20
530863|NCT00833755|1295033|P2|COMPLETED|Overall Study||13
530864|NCT00833755|1295034|P1|COMPLETED|Overall Study||12
530865|NCT00833755|1295031|P4|STARTED|Overall Study||23
530866|NCT00833755|1295032|P3|STARTED|Overall Study||22
530867|NCT00833755|1295033|P2|STARTED|Overall Study||18
530868|NCT00833755|1295034|P1|STARTED|Overall Study||16
530869|NCT00833703|1295054|P2|NOT COMPLETED|Overall Study||1
530870|NCT00833703|1295055|P1|NOT COMPLETED|Overall Study||0
530871|NCT00833703|1295054|P2|COMPLETED|Overall Study|Completed follow-up|25
530872|NCT00833703|1295055|P1|COMPLETED|Overall Study|Completed follow-up|23
530873|NCT00833703|1295054|P2|Completed Treatment|Overall Study||24
530874|NCT00833703|1295055|P1|Completed Treatment|Overall Study||22
530875|NCT00833703|1295054|P2|Treated|Overall Study||26
530876|NCT00833703|1295055|P1|Treated|Overall Study||23
530877|NCT00833703|1295054|P2|STARTED|Overall Study|Included|26
530878|NCT00833703|1295055|P1|STARTED|Overall Study|Included|23
530879|NCT00833690|1295068|P3|NOT COMPLETED|Overall Study||0
530880|NCT00833690|1295069|P2|NOT COMPLETED|Overall Study||2
530881|NCT00833690|1295070|P1|NOT COMPLETED|Overall Study||4
530882|NCT00833690|1295068|P3|COMPLETED|Overall Study||26
530883|NCT00833690|1295069|P2|COMPLETED|Overall Study||22
530884|NCT00833690|1295070|P1|COMPLETED|Overall Study||21
530885|NCT00833690|1295068|P3|STARTED|Overall Study||26
530886|NCT00833690|1295069|P2|STARTED|Overall Study||24
530887|NCT00833690|1295070|P1|STARTED|Overall Study||25
530888|NCT00833664|1295194|P2|NOT COMPLETED|Second Intervention||0
530889|NCT00833664|1295195|P1|NOT COMPLETED|Second Intervention||0
530890|NCT00833664|1295194|P2|COMPLETED|Second Intervention||11
530891|NCT00833664|1295195|P1|COMPLETED|Second Intervention||10
530892|NCT00833664|1295194|P2|STARTED|Second Intervention||11
530893|NCT00833664|1295195|P1|STARTED|Second Intervention||10
530894|NCT00833664|1295194|P2|NOT COMPLETED|Washout: 14 Days||0
530895|NCT00833664|1295195|P1|NOT COMPLETED|Washout: 14 Days||1
530896|NCT00833664|1295194|P2|COMPLETED|Washout: 14 Days||11
530897|NCT00833664|1295195|P1|COMPLETED|Washout: 14 Days||10
530898|NCT00833664|1295194|P2|STARTED|Washout: 14 Days||11
530899|NCT00833664|1295195|P1|STARTED|Washout: 14 Days||11
530900|NCT00833664|1295194|P2|NOT COMPLETED|First Intervention||0
530901|NCT00833664|1295195|P1|NOT COMPLETED|First Intervention||0
530902|NCT00833664|1295194|P2|COMPLETED|First Intervention||11
530903|NCT00833664|1295195|P1|COMPLETED|First Intervention||11
530904|NCT00833664|1295194|P2|STARTED|First Intervention||11
530905|NCT00833664|1295195|P1|STARTED|First Intervention||11
530906|NCT00833638|1295206|P3|NOT COMPLETED|Phase 3: Open-label Extension Phase||2
530907|NCT00833638|1295207|P2|NOT COMPLETED|Phase 3: Open-label Extension Phase||3
530908|NCT00833638|1295208|P1|NOT COMPLETED|Phase 3: Open-label Extension Phase||1
530909|NCT00833638|1295206|P3|COMPLETED|Phase 3: Open-label Extension Phase||122
530910|NCT00833638|1295207|P2|COMPLETED|Phase 3: Open-label Extension Phase||105
530911|NCT00833638|1295208|P1|COMPLETED|Phase 3: Open-label Extension Phase||110
530912|NCT00833638|1295206|P3|STARTED|Phase 3: Open-label Extension Phase||124
530913|NCT00833638|1295207|P2|STARTED|Phase 3: Open-label Extension Phase||108
530914|NCT00833638|1295208|P1|STARTED|Phase 3: Open-label Extension Phase||111
530915|NCT00833638|1295206|P3|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||9
530916|NCT00833638|1295207|P2|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10
530917|NCT00833638|1295208|P1|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10
530918|NCT00833638|1295206|P3|COMPLETED|Phase 2: Double-blind Treatment Phase||124
530919|NCT00833638|1295207|P2|COMPLETED|Phase 2: Double-blind Treatment Phase||108
530920|NCT00833638|1295208|P1|COMPLETED|Phase 2: Double-blind Treatment Phase||111
530921|NCT00833638|1295206|P3|STARTED|Phase 2: Double-blind Treatment Phase||133
530922|NCT00833638|1295207|P2|STARTED|Phase 2: Double-blind Treatment Phase||118
530923|NCT00833638|1295208|P1|STARTED|Phase 2: Double-blind Treatment Phase||121
530924|NCT00833586|1295250|P2|NOT COMPLETED|Second Intervention||0
530925|NCT00833586|1295251|P1|NOT COMPLETED|Second Intervention||0
530926|NCT00833586|1295250|P2|COMPLETED|Second Intervention||14
530927|NCT00833586|1295251|P1|COMPLETED|Second Intervention||14
530928|NCT00833586|1295250|P2|STARTED|Second Intervention||14
530929|NCT00833586|1295251|P1|STARTED|Second Intervention||14
530930|NCT00833586|1295250|P2|NOT COMPLETED|Washout: 14 Days||0
530931|NCT00833586|1295251|P1|NOT COMPLETED|Washout: 14 Days||0
530932|NCT00833586|1295250|P2|COMPLETED|Washout: 14 Days||14
530933|NCT00833586|1295251|P1|COMPLETED|Washout: 14 Days||14
530934|NCT00833586|1295250|P2|STARTED|Washout: 14 Days||14
530935|NCT00833586|1295251|P1|STARTED|Washout: 14 Days||14
530936|NCT00833586|1295250|P2|NOT COMPLETED|First Intervention||0
530937|NCT00833586|1295251|P1|NOT COMPLETED|First Intervention||0
530938|NCT00833586|1295250|P2|COMPLETED|First Intervention||14
530939|NCT00833586|1295251|P1|COMPLETED|First Intervention||14
530940|NCT00833586|1295250|P2|STARTED|First Intervention||14
530941|NCT00833586|1295251|P1|STARTED|First Intervention||14
530942|NCT00833560|1295259|P1|NOT COMPLETED|Overall Study||42
530943|NCT00833560|1295259|P1|COMPLETED|Overall Study||353
530944|NCT00833560|1295259|P1|STARTED|Overall Study||395
530945|NCT00833547|1295268|P2|NOT COMPLETED|Overall Study||2
530946|NCT00833547|1295269|P1|NOT COMPLETED|Overall Study||2
530947|NCT00833547|1295268|P2|COMPLETED|Overall Study||10
530948|NCT00833547|1295269|P1|COMPLETED|Overall Study||11
530949|NCT00833547|1295268|P2|STARTED|Overall Study||12
530950|NCT00833547|1295269|P1|STARTED|Overall Study||13
530951|NCT00833521|1295279|P2|NOT COMPLETED|Second Intervention||0
530952|NCT00833521|1295280|P1|NOT COMPLETED|Second Intervention||0
530953|NCT00833521|1295279|P2|COMPLETED|Second Intervention||19
530954|NCT00833521|1295280|P1|COMPLETED|Second Intervention||19
530955|NCT00833521|1295279|P2|STARTED|Second Intervention||19
530956|NCT00833521|1295280|P1|STARTED|Second Intervention||19
530957|NCT00833521|1295279|P2|NOT COMPLETED|First Intervention||0
530958|NCT00833521|1295280|P1|NOT COMPLETED|First Intervention||0
530959|NCT00833521|1295279|P2|COMPLETED|First Intervention||19
530960|NCT00833521|1295280|P1|COMPLETED|First Intervention||19
530961|NCT00833521|1295279|P2|STARTED|First Intervention||19
530962|NCT00833521|1295280|P1|STARTED|First Intervention||19
530963|NCT00833482|1295290|P6|NOT COMPLETED|Days 21-30||0
530964|NCT00833482|1295291|P5|NOT COMPLETED|Days 21-30||1
530965|NCT00833482|1295292|P4|NOT COMPLETED|Days 21-30||0
530966|NCT00833482|1295293|P3|NOT COMPLETED|Days 21-30||1
530967|NCT00833482|1295294|P2|NOT COMPLETED|Days 21-30||0
530968|NCT00833482|1295295|P1|NOT COMPLETED|Days 21-30||0
530969|NCT00833482|1295290|P6|COMPLETED|Days 21-30||0
530970|NCT00833482|1295291|P5|COMPLETED|Days 21-30||7
530971|NCT00833482|1295292|P4|COMPLETED|Days 21-30||0
530972|NCT00833482|1295293|P3|COMPLETED|Days 21-30||20
530973|NCT00833482|1295294|P2|COMPLETED|Days 21-30||0
530974|NCT00833482|1295295|P1|COMPLETED|Days 21-30||0
530975|NCT00833482|1295290|P6|STARTED|Days 21-30||0
530976|NCT00833482|1295291|P5|STARTED|Days 21-30||8
530977|NCT00833482|1295292|P4|STARTED|Days 21-30||0
530978|NCT00833482|1295293|P3|STARTED|Days 21-30||21
530979|NCT00833482|1295294|P2|STARTED|Days 21-30||0
530980|NCT00833482|1295295|P1|STARTED|Days 21-30||0
530981|NCT00833482|1295290|P6|NOT COMPLETED|Days 11-20||0
530982|NCT00833482|1295291|P5|NOT COMPLETED|Days 11-20||0
530983|NCT00833482|1295292|P4|NOT COMPLETED|Days 11-20||0
530984|NCT00833482|1295293|P3|NOT COMPLETED|Days 11-20||0
530985|NCT00833482|1295294|P2|NOT COMPLETED|Days 11-20||3
530986|NCT00833482|1295295|P1|NOT COMPLETED|Days 11-20||0
530987|NCT00833482|1295290|P6|COMPLETED|Days 11-20||8
530988|NCT00833482|1295291|P5|COMPLETED|Days 11-20||0
530989|NCT00833482|1295292|P4|COMPLETED|Days 11-20||0
530990|NCT00833482|1295293|P3|COMPLETED|Days 11-20||0
530991|NCT00833482|1295294|P2|COMPLETED|Days 11-20||21
530992|NCT00833482|1295295|P1|COMPLETED|Days 11-20||0
530993|NCT00833482|1295290|P6|STARTED|Days 11-20|Participants who received treatment.|8
530994|NCT00833482|1295291|P5|STARTED|Days 11-20||0
530995|NCT00833482|1295292|P4|STARTED|Days 11-20||0
530996|NCT00833482|1295293|P3|STARTED|Days 11-20||0
530997|NCT00833482|1295294|P2|STARTED|Days 11-20|Participants who received treatment.|24
530998|NCT00833482|1295295|P1|STARTED|Days 11-20||0
530999|NCT00833482|1295290|P6|NOT COMPLETED|Days 1-3||0
531000|NCT00833482|1295291|P5|NOT COMPLETED|Days 1-3||0
531001|NCT00833482|1295292|P4|NOT COMPLETED|Days 1-3||0
531002|NCT00833482|1295293|P3|NOT COMPLETED|Days 1-3||0
531003|NCT00833482|1295294|P2|NOT COMPLETED|Days 1-3||0
531004|NCT00833482|1295295|P1|NOT COMPLETED|Days 1-3||0
531005|NCT00833482|1295290|P6|COMPLETED|Days 1-3||0
531006|NCT00833482|1295291|P5|COMPLETED|Days 1-3||0
531007|NCT00833482|1295292|P4|COMPLETED|Days 1-3||8
531008|NCT00833482|1295293|P3|COMPLETED|Days 1-3||0
531009|NCT00833482|1295294|P2|COMPLETED|Days 1-3||0
531010|NCT00833482|1295295|P1|COMPLETED|Days 1-3||24
531011|NCT00833482|1295290|P6|STARTED|Days 1-3||0
531012|NCT00833482|1295291|P5|STARTED|Days 1-3||0
531013|NCT00833482|1295292|P4|STARTED|Days 1-3||8
531014|NCT00833482|1295293|P3|STARTED|Days 1-3||0
531015|NCT00833482|1295294|P2|STARTED|Days 1-3|Participants who received treatment|0
531016|NCT00833482|1295295|P1|STARTED|Days 1-3|Participants who received treatment|24
531017|NCT00833469|1295351|P1|NOT COMPLETED|Overall Study||2
531018|NCT00833469|1295351|P1|COMPLETED|Overall Study||3
531019|NCT00833469|1295351|P1|STARTED|Overall Study||5
531020|NCT00833443|1295359|P2|NOT COMPLETED|Overall Study||28
531021|NCT00833443|1295360|P1|NOT COMPLETED|Overall Study||20
531022|NCT00833443|1295359|P2|COMPLETED|Overall Study||15
531023|NCT00833443|1295360|P1|COMPLETED|Overall Study||21
531024|NCT00833443|1295359|P2|STARTED|Overall Study||43
531025|NCT00833443|1295360|P1|STARTED|Overall Study||41
531026|NCT00833417|1295374|P2|NOT COMPLETED|Overall Study||71
531027|NCT00833417|1295375|P1|NOT COMPLETED|Overall Study||33
531028|NCT00833417|1295374|P2|COMPLETED|Overall Study||0
531029|NCT00833417|1295375|P1|COMPLETED|Overall Study||0
531030|NCT00833417|1295374|P2|STARTED|Overall Study||71
531031|NCT00833417|1295375|P1|STARTED|Overall Study||33
531032|NCT00833365|1295390|P2|NOT COMPLETED|Overall Study||0
531033|NCT00833365|1295391|P1|NOT COMPLETED|Overall Study||0
531034|NCT00833365|1295390|P2|COMPLETED|Overall Study||6
531035|NCT00833365|1295391|P1|COMPLETED|Overall Study||9
531036|NCT00833365|1295390|P2|STARTED|Overall Study||6
531037|NCT00833365|1295391|P1|STARTED|Overall Study||9
531038|NCT00833248|1295401|P2|NOT COMPLETED|Overall Study||3
531039|NCT00833248|1295402|P1|NOT COMPLETED|Overall Study||4
531040|NCT00833248|1295401|P2|COMPLETED|Overall Study||62
531041|NCT00833248|1295402|P1|COMPLETED|Overall Study||177
531042|NCT00833248|1295401|P2|Safety Analysis Set|Overall Study||64
531043|NCT00833248|1295402|P1|Safety Analysis Set|Overall Study||181
531044|NCT00833248|1295401|P2|Per Protocol (PP) Analysis Set|Overall Study||57
531045|NCT00833248|1295402|P1|Per Protocol (PP) Analysis Set|Overall Study||164
531046|NCT00833248|1295401|P2|Full Analysis Set (FAS)|Overall Study||64
531047|NCT00833248|1295402|P1|Full Analysis Set (FAS)|Overall Study||180
531048|NCT00833248|1295401|P2|STARTED|Overall Study||65
531049|NCT00833248|1295402|P1|STARTED|Overall Study||181
531050|NCT00833092|1295426|P2|NOT COMPLETED|Overall Study||7
531051|NCT00833092|1295427|P1|NOT COMPLETED|Overall Study||4
531052|NCT00833092|1295426|P2|COMPLETED|Overall Study||50
531053|NCT00833092|1295427|P1|COMPLETED|Overall Study||50
531054|NCT00833092|1295426|P2|STARTED|Overall Study||57
531055|NCT00833092|1295427|P1|STARTED|Overall Study||54
531056|NCT00833053|1295435|P2|NOT COMPLETED|Overall Study||3
531057|NCT00833053|1295436|P1|NOT COMPLETED|Overall Study||9
531058|NCT00833053|1295435|P2|COMPLETED|Overall Study||17
531059|NCT00833053|1295436|P1|COMPLETED|Overall Study||10
531060|NCT00833053|1295435|P2|STARTED|Overall Study||20
531061|NCT00833053|1295436|P1|STARTED|Overall Study||19
531062|NCT00833040|1295454|P6|NOT COMPLETED|Overall Study||1
531063|NCT00833040|1295455|P5|NOT COMPLETED|Overall Study||0
531064|NCT00833040|1295456|P4|NOT COMPLETED|Overall Study||0
531065|NCT00833040|1295457|P3|NOT COMPLETED|Overall Study||0
531066|NCT00833040|1295458|P2|NOT COMPLETED|Overall Study||0
531067|NCT00833040|1295459|P1|NOT COMPLETED|Overall Study||0
531068|NCT00833040|1295454|P6|COMPLETED|Overall Study||4
531069|NCT00833040|1295455|P5|COMPLETED|Overall Study||5
531070|NCT00833040|1295456|P4|COMPLETED|Overall Study||6
531071|NCT00833040|1295457|P3|COMPLETED|Overall Study||6
531072|NCT00833040|1295458|P2|COMPLETED|Overall Study||6
531073|NCT00833040|1295459|P1|COMPLETED|Overall Study||6
531074|NCT00833040|1295454|P6|STARTED|Overall Study||5
531075|NCT00833040|1295455|P5|STARTED|Overall Study||5
531076|NCT00833040|1295456|P4|STARTED|Overall Study||6
531077|NCT00833040|1295457|P3|STARTED|Overall Study||6
531078|NCT00833040|1295458|P2|STARTED|Overall Study||6
531079|NCT00833040|1295459|P1|STARTED|Overall Study||6
531080|NCT00833027|1295464|P1|NOT COMPLETED|Overall Study||211
531081|NCT00833027|1295464|P1|COMPLETED|Overall Study||397
531082|NCT00833027|1295464|P1|STARTED|Overall Study||608
531083|NCT00832975|1295469|P1|NOT COMPLETED|Overall Study||39
531084|NCT00832975|1295469|P1|COMPLETED|Overall Study||118
531085|NCT00832975|1295469|P1|STARTED|Overall Study||157
531089|NCT00832819|1295483|P3|NOT COMPLETED|Overall Study||1
531090|NCT00832819|1295484|P2|NOT COMPLETED|Overall Study||1
531091|NCT00832819|1295485|P1|NOT COMPLETED|Overall Study||0
531092|NCT00832819|1295483|P3|COMPLETED|Overall Study||15
531093|NCT00832819|1295484|P2|COMPLETED|Overall Study||5
531094|NCT00832819|1295485|P1|COMPLETED|Overall Study||6
531095|NCT00832819|1295483|P3|STARTED|Overall Study||16
531096|NCT00832819|1295484|P2|STARTED|Overall Study||6
531097|NCT00832819|1295485|P1|STARTED|Overall Study||6
531098|NCT00832780|1295491|P1|NOT COMPLETED|Overall Study||25
531099|NCT00832780|1295491|P1|COMPLETED|Overall Study||19
531100|NCT00832780|1295491|P1|STARTED|Overall Study||44
531101|NCT00832767|1295501|P2|NOT COMPLETED|Overall Study||18
531102|NCT00832767|1295502|P1|NOT COMPLETED|Overall Study||22
531103|NCT00832767|1295501|P2|COMPLETED|Overall Study||63
531104|NCT00832767|1295502|P1|COMPLETED|Overall Study||99
531105|NCT00832767|1295501|P2|STARTED|Overall Study||81
531106|NCT00832767|1295502|P1|STARTED|Overall Study||121
531107|NCT00832650|1295533|P3|NOT COMPLETED|Overall Study||1
531108|NCT00832650|1295534|P2|NOT COMPLETED|Overall Study||0
531109|NCT00832650|1295535|P1|NOT COMPLETED|Overall Study||0
531110|NCT00832650|1295533|P3|COMPLETED|Overall Study||22
531111|NCT00832650|1295534|P2|COMPLETED|Overall Study||12
531112|NCT00832650|1295535|P1|COMPLETED|Overall Study||25
531113|NCT00832650|1295533|P3|Treated|Overall Study||22
531114|NCT00832650|1295534|P2|Treated|Overall Study||12
531115|NCT00832650|1295535|P1|Treated|Overall Study||25
531116|NCT00832650|1295533|P3|STARTED|Overall Study||23
531117|NCT00832650|1295534|P2|STARTED|Overall Study||12
531118|NCT00832650|1295535|P1|STARTED|Overall Study||25
531122|NCT00832624|1295575|P1|NOT COMPLETED|Overall Study||10
531123|NCT00832624|1295575|P1|COMPLETED|Overall Study||0
531124|NCT00832624|1295575|P1|STARTED|Overall Study||10
531125|NCT00832598|1295579|P1|NOT COMPLETED|Overall Study||0
531126|NCT00832598|1295579|P1|COMPLETED|Overall Study||13
531127|NCT00832598|1295579|P1|STARTED|Overall Study||13
531128|NCT00832585|1295585|P1|NOT COMPLETED|Overall Study||2
531129|NCT00832585|1295585|P1|COMPLETED|Overall Study|Only three subjects completed all of the visits for the study as per protocol.|3
531130|NCT00832585|1295585|P1|STARTED|Overall Study|Eight subjects were screened but only 5 started the study and received study drug.|5
531131|NCT00832572|1295592|P2|NOT COMPLETED|Period 2||0
531132|NCT00832572|1295593|P1|NOT COMPLETED|Period 2||0
531133|NCT00832572|1295592|P2|COMPLETED|Period 2||2
531134|NCT00832572|1295593|P1|COMPLETED|Period 2||3
531135|NCT00832572|1295592|P2|STARTED|Period 2||2
531136|NCT00832572|1295593|P1|STARTED|Period 2||3
531137|NCT00832572|1295592|P2|NOT COMPLETED|Period 1||0
531138|NCT00832572|1295593|P1|NOT COMPLETED|Period 1||0
531139|NCT00832572|1295592|P2|COMPLETED|Period 1||2
531140|NCT00832572|1295593|P1|COMPLETED|Period 1||3
531141|NCT00832572|1295592|P2|STARTED|Period 1||2
531142|NCT00832572|1295593|P1|STARTED|Period 1||3
531143|NCT00832520|1295605|P1|NOT COMPLETED|Overall Study||0
531144|NCT00832520|1295605|P1|COMPLETED|Overall Study||13
531145|NCT00832520|1295605|P1|STARTED|Overall Study||13
531146|NCT00832455|1295610|P1|NOT COMPLETED|Overall Study||72
531147|NCT00832455|1295610|P1|COMPLETED|Overall Study||373
531148|NCT00832455|1295610|P1|Week 12|Overall Study||373
531149|NCT00832455|1295610|P1|Week 8 (Optional)|Overall Study||247
531150|NCT00832455|1295610|P1|Week 4|Overall Study||411
531151|NCT00832455|1295610|P1|Baseline|Overall Study|420 –patients that received at least one dose of study medication and had 1 follow-up visit (ITT)|420
531152|NCT00832455|1295610|P1|STARTED|Overall Study|445 – number of patients that signed the informed consent form (Safety population)|445
531153|NCT00832416|1295634|P4|NOT COMPLETED|Overall Study||83
531154|NCT00832416|1295635|P3|NOT COMPLETED|Overall Study||61
531155|NCT00832416|1295636|P2|NOT COMPLETED|Overall Study||53
531156|NCT00832416|1295637|P1|NOT COMPLETED|Overall Study||46
531157|NCT00832416|1295634|P4|COMPLETED|Overall Study||144
531158|NCT00832416|1295635|P3|COMPLETED|Overall Study||54
531159|NCT00832416|1295636|P2|COMPLETED|Overall Study||60
531160|NCT00832416|1295637|P1|COMPLETED|Overall Study||64
531161|NCT00832416|1295634|P4|STARTED|Overall Study||227
531162|NCT00832416|1295635|P3|STARTED|Overall Study||115
531163|NCT00832416|1295636|P2|STARTED|Overall Study||113
531164|NCT00832416|1295637|P1|STARTED|Overall Study||110
531165|NCT00832390|1295678|P3|NOT COMPLETED|Overall Study||0
531166|NCT00832390|1295679|P2|NOT COMPLETED|Overall Study||0
531167|NCT00832390|1295680|P1|NOT COMPLETED|Overall Study||0
531168|NCT00832390|1295678|P3|COMPLETED|Overall Study||1
531169|NCT00832390|1295679|P2|COMPLETED|Overall Study||16
531170|NCT00832390|1295680|P1|COMPLETED|Overall Study||12
531171|NCT00832390|1295678|P3|STARTED|Overall Study||1
531172|NCT00832390|1295679|P2|STARTED|Overall Study||16
531173|NCT00832390|1295680|P1|STARTED|Overall Study||12
531174|NCT00832377|1295688|P1|NOT COMPLETED|Overall Study||1
531175|NCT00832377|1295688|P1|COMPLETED|Overall Study||36
531176|NCT00832377|1295688|P1|STARTED|Overall Study||37
531177|NCT00832338|1295695|P1|NOT COMPLETED|Overall Study||0
531178|NCT00832338|1295695|P1|COMPLETED|Overall Study||23
531179|NCT00832338|1295695|P1|STARTED|Overall Study||23
531180|NCT00832299|1295699|P1|NOT COMPLETED|Overall Study||0
531181|NCT00832299|1295699|P1|COMPLETED|Overall Study||2
531182|NCT00832299|1295699|P1|STARTED|Overall Study||2
531183|NCT00832260|1295704|P1|NOT COMPLETED|Overall Study||0
531184|NCT00832260|1295704|P1|COMPLETED|Overall Study||70
531185|NCT00832260|1295704|P1|STARTED|Overall Study||70
531186|NCT00832130|1295711|P2|NOT COMPLETED|Overall Study||0
531187|NCT00832130|1295712|P1|NOT COMPLETED|Overall Study||0
531188|NCT00832130|1295711|P2|COMPLETED|Overall Study||70
531189|NCT00832130|1295712|P1|COMPLETED|Overall Study||69
531190|NCT00832130|1295711|P2|STARTED|Overall Study||70
531191|NCT00832130|1295712|P1|STARTED|Overall Study||69
531192|NCT00832117|1295734|P1|NOT COMPLETED|Overall Study||12
531193|NCT00832117|1295734|P1|COMPLETED|Overall Study||17
531194|NCT00832117|1295734|P1|STARTED|Overall Study||29
531195|NCT00832091|1295753|P2|NOT COMPLETED|Overall Study||2
531196|NCT00832091|1295754|P1|NOT COMPLETED|Overall Study||5
531197|NCT00832091|1295753|P2|COMPLETED|Overall Study||53
531198|NCT00832091|1295754|P1|COMPLETED|Overall Study||12
531199|NCT00832091|1295753|P2|STARTED|Overall Study||55
531200|NCT00832091|1295754|P1|STARTED|Overall Study||17
531201|NCT00832078|1295762|P2|NOT COMPLETED|Test Day 2 - 2 Period||0
531202|NCT00832078|1295763|P1|NOT COMPLETED|Test Day 2 - 2 Period||1
531203|NCT00832078|1295762|P2|COMPLETED|Test Day 2 - 2 Period||10
531204|NCT00832078|1295763|P1|COMPLETED|Test Day 2 - 2 Period||12
531205|NCT00832078|1295762|P2|STARTED|Test Day 2 - 2 Period||10
531206|NCT00832078|1295763|P1|STARTED|Test Day 2 - 2 Period||13
531207|NCT00832078|1295762|P2|NOT COMPLETED|Test Day 2 - 1 Period||0
531208|NCT00832078|1295763|P1|NOT COMPLETED|Test Day 2 - 1 Period||0
531209|NCT00832078|1295762|P2|COMPLETED|Test Day 2 - 1 Period||10
531210|NCT00832078|1295763|P1|COMPLETED|Test Day 2 - 1 Period||13
531211|NCT00832078|1295762|P2|STARTED|Test Day 2 - 1 Period||10
531212|NCT00832078|1295763|P1|STARTED|Test Day 2 - 1 Period||13
531213|NCT00832078|1295762|P2|NOT COMPLETED|Test Day 1-2 Period||2
531214|NCT00832078|1295763|P1|NOT COMPLETED|Test Day 1-2 Period||0
531215|NCT00832078|1295762|P2|COMPLETED|Test Day 1-2 Period||10
531216|NCT00832078|1295763|P1|COMPLETED|Test Day 1-2 Period||13
531217|NCT00832078|1295762|P2|STARTED|Test Day 1-2 Period||12
531218|NCT00832078|1295763|P1|STARTED|Test Day 1-2 Period||13
531219|NCT00832078|1295762|P2|NOT COMPLETED|Test Day 1- 1 Period||0
531220|NCT00832078|1295763|P1|NOT COMPLETED|Test Day 1- 1 Period||0
531221|NCT00832078|1295762|P2|COMPLETED|Test Day 1- 1 Period||12
531222|NCT00832078|1295763|P1|COMPLETED|Test Day 1- 1 Period||13
531223|NCT00832078|1295762|P2|STARTED|Test Day 1- 1 Period||12
531224|NCT00832078|1295763|P1|STARTED|Test Day 1- 1 Period||13
531225|NCT00832000|1295769|P2|NOT COMPLETED|Overall Study||1
531226|NCT00832000|1295770|P1|NOT COMPLETED|Overall Study||6
531227|NCT00832000|1295769|P2|COMPLETED|Overall Study||29
531228|NCT00832000|1295770|P1|COMPLETED|Overall Study||23
531229|NCT00832000|1295769|P2|Crossed Over to Opposite Intervention|Overall Study|Mexiletine 200 mg orally three times daily|29
531230|NCT00832000|1295770|P1|Crossed Over to Opposite Intervention|Overall Study|Placebo|25
531231|NCT00832000|1295769|P2|STARTED|Overall Study|Placebo|30
531232|NCT00832000|1295770|P1|STARTED|Overall Study|Mexiletine 200 mg orally three times daily|29
531233|NCT00831987|1295808|P2|NOT COMPLETED|Overall Study||0
531234|NCT00831987|1295809|P1|NOT COMPLETED|Overall Study||0
531235|NCT00831987|1295808|P2|COMPLETED|Overall Study||60
531236|NCT00831987|1295809|P1|COMPLETED|Overall Study||60
531237|NCT00831987|1295808|P2|STARTED|Overall Study||60
531238|NCT00831987|1295809|P1|STARTED|Overall Study||60
531239|NCT00831844|1295831|P10|NOT COMPLETED|Overall Study||0
531240|NCT00831844|1295832|P9|NOT COMPLETED|Overall Study||9
531241|NCT00831844|1295833|P8|NOT COMPLETED|Overall Study||10
531242|NCT00831844|1295834|P7|NOT COMPLETED|Overall Study||10
531243|NCT00831844|1295835|P6|NOT COMPLETED|Overall Study||19
531244|NCT00831844|1295836|P5|NOT COMPLETED|Overall Study||14
531245|NCT00831844|1295837|P4|NOT COMPLETED|Overall Study||10
531246|NCT00831844|1295838|P3|NOT COMPLETED|Overall Study||20
531247|NCT00831844|1295839|P2|NOT COMPLETED|Overall Study||12
531248|NCT00831844|1295840|P1|NOT COMPLETED|Overall Study||10
531249|NCT00831844|1295831|P10|COMPLETED|Overall Study||0
531250|NCT00831844|1295832|P9|COMPLETED|Overall Study||0
531251|NCT00831844|1295833|P8|COMPLETED|Overall Study||0
531252|NCT00831844|1295834|P7|COMPLETED|Overall Study||0
531253|NCT00831844|1295835|P6|COMPLETED|Overall Study||1
531254|NCT00831844|1295836|P5|COMPLETED|Overall Study||0
531255|NCT00831844|1295837|P4|COMPLETED|Overall Study||0
531256|NCT00831844|1295838|P3|COMPLETED|Overall Study||1
531257|NCT00831844|1295839|P2|COMPLETED|Overall Study||0
531258|NCT00831844|1295840|P1|COMPLETED|Overall Study||0
531259|NCT00831844|1295831|P10|STARTED|Overall Study||0
531260|NCT00831844|1295832|P9|STARTED|Overall Study||9
531261|NCT00831844|1295833|P8|STARTED|Overall Study||10
531262|NCT00831844|1295834|P7|STARTED|Overall Study||10
531263|NCT00831844|1295835|P6|STARTED|Overall Study||20
531264|NCT00831844|1295836|P5|STARTED|Overall Study||14
531265|NCT00831844|1295837|P4|STARTED|Overall Study||10
531266|NCT00831844|1295838|P3|STARTED|Overall Study||21
531267|NCT00831844|1295839|P2|STARTED|Overall Study||12
531268|NCT00831844|1295840|P1|STARTED|Overall Study||10
531269|NCT00831779|1295864|P2|NOT COMPLETED|Overall Study||1
531270|NCT00831779|1295865|P1|NOT COMPLETED|Overall Study||1
531271|NCT00831779|1295864|P2|COMPLETED|Overall Study||22
531272|NCT00831779|1295865|P1|COMPLETED|Overall Study||20
531273|NCT00831779|1295864|P2|STARTED|Overall Study||23
531274|NCT00831779|1295865|P1|STARTED|Overall Study||21
531275|NCT00831766|1295875|P2|NOT COMPLETED|Overall Study||0
531276|NCT00831766|1295876|P1|NOT COMPLETED|Overall Study||0
531277|NCT00831766|1295875|P2|COMPLETED|Overall Study||28
531278|NCT00831766|1295876|P1|COMPLETED|Overall Study||23
531279|NCT00831766|1295875|P2|STARTED|Overall Study||28
531280|NCT00831766|1295876|P1|STARTED|Overall Study||23
531281|NCT00831753|1295887|P2|NOT COMPLETED|Overall Study||0
531282|NCT00831753|1295888|P1|NOT COMPLETED|Overall Study||0
531283|NCT00831753|1295887|P2|COMPLETED|Overall Study||131
531284|NCT00831753|1295888|P1|COMPLETED|Overall Study||132
531285|NCT00831753|1295887|P2|STARTED|Overall Study||131
531286|NCT00831753|1295888|P1|STARTED|Overall Study||132
531287|NCT00831701|1295902|P2|NOT COMPLETED|Overall Study||5
531288|NCT00831701|1295903|P1|NOT COMPLETED|Overall Study||5
531289|NCT00831701|1295902|P2|COMPLETED|Overall Study||45
531290|NCT00831701|1295903|P1|COMPLETED|Overall Study||45
531291|NCT00831701|1295902|P2|STARTED|Overall Study||50
531292|NCT00831701|1295903|P1|STARTED|Overall Study||50
531293|NCT00831675|1295919|P2|NOT COMPLETED|Overall Study||0
531294|NCT00831675|1295920|P1|NOT COMPLETED|Overall Study||0
531295|NCT00831675|1295919|P2|COMPLETED|Overall Study||18
531296|NCT00831675|1295920|P1|COMPLETED|Overall Study||12
531297|NCT00831675|1295919|P2|STARTED|Overall Study||18
531298|NCT00831675|1295920|P1|STARTED|Overall Study||12
531299|NCT00831493|1295932|P1|NOT COMPLETED|Overall Study||1
531300|NCT00831493|1295932|P1|COMPLETED|Overall Study||2
531301|NCT00831493|1295932|P1|STARTED|Overall Study||3
531302|NCT00831480|1295936|P1|NOT COMPLETED|Overall Study||2
531303|NCT00831480|1295936|P1|COMPLETED|Overall Study||7
531304|NCT00831480|1295936|P1|STARTED|Overall Study||9
531305|NCT00831441|1295942|P2|NOT COMPLETED|Follow Up (30 Days)||174
531306|NCT00831441|1295943|P1|NOT COMPLETED|Follow Up (30 Days)||133
531307|NCT00831441|1295942|P2|COMPLETED|Follow Up (30 Days)||3355
531308|NCT00831441|1295943|P1|COMPLETED|Follow Up (30 Days)||3375
531309|NCT00831441|1295942|P2|STARTED|Follow Up (30 Days)|3529 participants entered the follow up period.|3529
531310|NCT00831441|1295943|P1|STARTED|Follow Up (30 Days)|3508 participants entered the follow up period.|3508
531311|NCT00831441|1295942|P2|NOT COMPLETED|Randomized||3705
531312|NCT00831441|1295943|P1|NOT COMPLETED|Randomized||3687
531313|NCT00831441|1295942|P2|COMPLETED|Randomized||0
531314|NCT00831441|1295943|P1|COMPLETED|Randomized||0
531315|NCT00831441|1295942|P2|Treated|Randomized||3672
531316|NCT00831441|1295943|P1|Treated|Randomized||3643
531317|NCT00831441|1295942|P2|STARTED|Randomized||3705
531318|NCT00831441|1295943|P1|STARTED|Randomized||3687
531319|NCT00831428|1295971|P1|NOT COMPLETED|Overall Study||0
531320|NCT00831428|1295971|P1|COMPLETED|Overall Study||97
531321|NCT00831428|1295971|P1|STARTED|Overall Study||97
531322|NCT00831415|1295975|P1|NOT COMPLETED|Overall Study||75
531323|NCT00831415|1295975|P1|COMPLETED|Overall Study|In addition to Completers for Study includes 2 participants who discontinued after on-therapy period|229
531324|NCT00831415|1295975|P1|"Study Completers"|Overall Study|Defined as participants whose conclusion of study participation status was “study completed.”|227
531325|NCT00831415|1295975|P1|"Completers for Exposure"|Overall Study|Participants with ≥ 301 days of exposure to study drug and completed study day 308 evaluations.|227
531326|NCT00831415|1295975|P1|STARTED|Overall Study||304
531327|NCT00831389|1295984|P2|NOT COMPLETED|Overall Study||1
531328|NCT00831389|1295985|P1|NOT COMPLETED|Overall Study||0
531329|NCT00831389|1295984|P2|COMPLETED|Overall Study||6
531330|NCT00831389|1295985|P1|COMPLETED|Overall Study||6
531331|NCT00831389|1295984|P2|STARTED|Overall Study||7
531332|NCT00831389|1295985|P1|STARTED|Overall Study||6
531333|NCT00831311|1296011|P2|NOT COMPLETED|Overall Study||8
531334|NCT00831311|1296012|P1|NOT COMPLETED|Overall Study||12
531335|NCT00831311|1296011|P2|COMPLETED|Overall Study||304
531336|NCT00831311|1296012|P1|COMPLETED|Overall Study||300
531337|NCT00831311|1296011|P2|STARTED|Overall Study||312
531338|NCT00831311|1296012|P1|STARTED|Overall Study||312
531339|NCT00831272|1296034|P4|NOT COMPLETED|Overall Study||10
531340|NCT00831272|1296035|P3|NOT COMPLETED|Overall Study||10
531341|NCT00831272|1296036|P2|NOT COMPLETED|Overall Study||7
531342|NCT00831272|1296037|P1|NOT COMPLETED|Overall Study||8
531343|NCT00831272|1296034|P4|COMPLETED|Overall Study||56
531344|NCT00831272|1296035|P3|COMPLETED|Overall Study||63
531345|NCT00831272|1296036|P2|COMPLETED|Overall Study||37
531346|NCT00831272|1296037|P1|COMPLETED|Overall Study||30
531347|NCT00831272|1296034|P4|STARTED|Overall Study||66
531348|NCT00831272|1296035|P3|STARTED|Overall Study||73
531349|NCT00831272|1296036|P2|STARTED|Overall Study||44
531350|NCT00831272|1296037|P1|STARTED|Overall Study||38
531351|NCT00831233|1296049|P2|NOT COMPLETED|Overall Study||1
531352|NCT00831233|1296050|P1|NOT COMPLETED|Overall Study||3
531353|NCT00831233|1296049|P2|COMPLETED|Overall Study||12
531354|NCT00831233|1296050|P1|COMPLETED|Overall Study||26
531355|NCT00831233|1296049|P2|Per Protocol (PP) Analysis Set|Overall Study||11
531356|NCT00831233|1296050|P1|Per Protocol (PP) Analysis Set|Overall Study||26
531357|NCT00831233|1296049|P2|Full Analysis Set (FAS)|Overall Study||13
531358|NCT00831233|1296050|P1|Full Analysis Set (FAS)|Overall Study|2 participants were randomised but never treated.|27
531359|NCT00831233|1296049|P2|STARTED|Overall Study|ITT population.|13
531360|NCT00831233|1296050|P1|STARTED|Overall Study|Intention-to-treat (ITT) population.|29
531361|NCT00831181|1296074|P1|NOT COMPLETED|Overall Study||12
531362|NCT00831181|1296074|P1|COMPLETED|Overall Study||15
531363|NCT00831181|1296074|P1|STARTED|Overall Study||27
531364|NCT00831129|1296087|P2|NOT COMPLETED|Overall Study||10
531365|NCT00831129|1296088|P1|NOT COMPLETED|Overall Study||0
531366|NCT00831129|1296087|P2|COMPLETED|Overall Study||23
531367|NCT00831129|1296088|P1|COMPLETED|Overall Study||20
531368|NCT00831129|1296087|P2|STARTED|Overall Study||33
531369|NCT00831129|1296088|P1|STARTED|Overall Study||20
531370|NCT00830960|1296130|P6|NOT COMPLETED|Overall Study||37
531371|NCT00830960|1296131|P5|NOT COMPLETED|Overall Study||32
531372|NCT00830960|1296132|P4|NOT COMPLETED|Overall Study||32
531373|NCT00830960|1296133|P3|NOT COMPLETED|Overall Study||29
531374|NCT00830960|1296134|P2|NOT COMPLETED|Overall Study||28
531375|NCT00830960|1296135|P1|NOT COMPLETED|Overall Study||33
531376|NCT00830960|1296130|P6|COMPLETED|Overall Study||63
531377|NCT00830960|1296131|P5|COMPLETED|Overall Study|6 participants not completed due to death; 1 additional death occurred after study discontinuation.|64
531378|NCT00830960|1296132|P4|COMPLETED|Overall Study||106
531379|NCT00830960|1296133|P3|COMPLETED|Overall Study||108
531380|NCT00830960|1296134|P2|COMPLETED|Overall Study||96
531381|NCT00830960|1296135|P1|COMPLETED|Overall Study||91
531382|NCT00830960|1296130|P6|Received at Least 1 Dose of Study Drug|Overall Study||93
531383|NCT00830960|1296131|P5|Received at Least 1 Dose of Study Drug|Overall Study||91
531384|NCT00830960|1296132|P4|Received at Least 1 Dose of Study Drug|Overall Study||135
531385|NCT00830960|1296133|P3|Received at Least 1 Dose of Study Drug|Overall Study||133
531386|NCT00830960|1296134|P2|Received at Least 1 Dose of Study Drug|Overall Study||122
531387|NCT00830960|1296135|P1|Received at Least 1 Dose of Study Drug|Overall Study|Baseline Characteristics (below) include those who received ≥1 dose study drug, not all who STARTED.|117
531388|NCT00830960|1296130|P6|STARTED|Overall Study|Total 720 participants were randomized; 1 was not included in a cohort as baseline weight missing.|100
531389|NCT00830960|1296131|P5|STARTED|Overall Study||96
531390|NCT00830960|1296132|P4|STARTED|Overall Study||138
531391|NCT00830960|1296133|P3|STARTED|Overall Study||137
531392|NCT00830960|1296134|P2|STARTED|Overall Study||124
531393|NCT00830960|1296135|P1|STARTED|Overall Study|"Number of participants STARTED equals the number of participants randomized."|124
531394|NCT00830947|1296251|P2|NOT COMPLETED|Overall Study||4
531395|NCT00830947|1296252|P1|NOT COMPLETED|Overall Study||4
531396|NCT00830947|1296251|P2|COMPLETED|Overall Study||18
531397|NCT00830947|1296252|P1|COMPLETED|Overall Study||19
531398|NCT00830947|1296251|P2|STARTED|Overall Study||22
531399|NCT00830947|1296252|P1|STARTED|Overall Study||23
531400|NCT00830804|1296258|P1|NOT COMPLETED|Overall Study||15
531401|NCT00830804|1296258|P1|COMPLETED|Overall Study||97
531402|NCT00830804|1296258|P1|STARTED|Overall Study|113 subjects enrolled. One subject never started study treatment and was excluded in all analysis.|112
531403|NCT00830791|1296284|P6|NOT COMPLETED|Overall Study||0
531404|NCT00830791|1296285|P5|NOT COMPLETED|Overall Study||0
531405|NCT00830791|1296286|P4|NOT COMPLETED|Overall Study||0
531406|NCT00830791|1296287|P3|NOT COMPLETED|Overall Study||0
531407|NCT00830791|1296288|P2|NOT COMPLETED|Overall Study||0
531408|NCT00830791|1296289|P1|NOT COMPLETED|Overall Study||0
531409|NCT00830791|1296284|P6|COMPLETED|Overall Study||0
531410|NCT00830791|1296285|P5|COMPLETED|Overall Study||0
531411|NCT00830791|1296286|P4|COMPLETED|Overall Study||8
531412|NCT00830791|1296287|P3|COMPLETED|Overall Study||8
531413|NCT00830791|1296288|P2|COMPLETED|Overall Study||8
531414|NCT00830791|1296289|P1|COMPLETED|Overall Study||8
531415|NCT00830791|1296284|P6|STARTED|Overall Study||0
531416|NCT00830791|1296285|P5|STARTED|Overall Study||0
531417|NCT00830791|1296286|P4|STARTED|Overall Study||8
531418|NCT00830791|1296287|P3|STARTED|Overall Study||8
531419|NCT00830791|1296288|P2|STARTED|Overall Study||8
531420|NCT00830791|1296289|P1|STARTED|Overall Study||8
531421|NCT00830765|1296338|P2|NOT COMPLETED|Overall Study||2
531422|NCT00830765|1296339|P1|NOT COMPLETED|Overall Study||3
531423|NCT00830765|1296338|P2|COMPLETED|Overall Study||69
531424|NCT00830765|1296339|P1|COMPLETED|Overall Study||70
531425|NCT00830765|1296338|P2|STARTED|Overall Study||71
531426|NCT00830765|1296339|P1|STARTED|Overall Study||73
531427|NCT00830596|1296348|P3|NOT COMPLETED|Overall Study||6
531428|NCT00830596|1296349|P2|NOT COMPLETED|Overall Study||2
531429|NCT00830596|1296350|P1|NOT COMPLETED|Overall Study||2
531430|NCT00830596|1296348|P3|COMPLETED|Overall Study||67
531431|NCT00830596|1296349|P2|COMPLETED|Overall Study||72
531432|NCT00830596|1296350|P1|COMPLETED|Overall Study||72
531433|NCT00830596|1296348|P3|STARTED|Overall Study||73
531434|NCT00830596|1296349|P2|STARTED|Overall Study||74
531435|NCT00830596|1296350|P1|STARTED|Overall Study||74
531436|NCT00830518|1296372|P2|NOT COMPLETED|Overall Study||11
531437|NCT00830518|1296373|P1|NOT COMPLETED|Overall Study||46
531438|NCT00830518|1296372|P2|COMPLETED|Overall Study||0
531439|NCT00830518|1296373|P1|COMPLETED|Overall Study|Completed = participants who completed study treatment.|0
531440|NCT00830518|1296372|P2|STARTED|Overall Study||11
531441|NCT00830518|1296373|P1|STARTED|Overall Study||46
531442|NCT00830440|1296392|P2|NOT COMPLETED|Overall Study||0
531443|NCT00830440|1296393|P1|NOT COMPLETED|Overall Study||8
531444|NCT00830440|1296392|P2|COMPLETED|Overall Study||11
531445|NCT00830440|1296393|P1|COMPLETED|Overall Study||24
531446|NCT00830440|1296392|P2|Completed 24 Week Follow up|Overall Study||0
531447|NCT00830440|1296393|P1|Completed 24 Week Follow up|Overall Study||3
531448|NCT00830440|1296392|P2|Completed 16 Week Follow up|Overall Study||0
531449|NCT00830440|1296393|P1|Completed 16 Week Follow up|Overall Study||4
531450|NCT00830440|1296392|P2|Completed 12 Week Follow up|Overall Study||11
531451|NCT00830440|1296393|P1|Completed 12 Week Follow up|Overall Study||24
531452|NCT00830440|1296392|P2|Received Device|Overall Study||0
531453|NCT00830440|1296393|P1|Received Device|Overall Study||26
531454|NCT00830440|1296392|P2|STARTED|Overall Study||11
531455|NCT00830440|1296393|P1|STARTED|Overall Study||32
531456|NCT00830388|1296403|P1|NOT COMPLETED|Overall Study||0
531457|NCT00830388|1296403|P1|COMPLETED|Overall Study||11
531458|NCT00830388|1296403|P1|STARTED|Overall Study||11
531459|NCT00830375|1296408|P1|NOT COMPLETED|Overall Study||1
531460|NCT00830375|1296408|P1|COMPLETED|Overall Study||9
531461|NCT00830375|1296408|P1|STARTED|Overall Study||10
531462|NCT00830362|1296414|P2|NOT COMPLETED|Overall Study||4
531463|NCT00830362|1296415|P1|NOT COMPLETED|Overall Study||4
531464|NCT00830362|1296414|P2|COMPLETED|Overall Study|The enrolled subjects that completed all 3 testing sessions (were not lost to follow-up).|20
531465|NCT00830362|1296415|P1|COMPLETED|Overall Study|The enrolled subjects that completed all 3 testing sessions (were not lost to follow-up).|23
531466|NCT00830362|1296414|P2|Completed Sessions 1 and 2|Overall Study|Received palcebo and completed both Test and Retrieval sessions (Session 1 and 2).|24
531467|NCT00830362|1296415|P1|Completed Sessions 1 and 2|Overall Study|Received propranolol and completed both Test and Retrieval sessions (Session 1 and 2).|26
531468|NCT00830362|1296414|P2|STARTED|Overall Study|They received Propranolol and completed Test Session (Session 1). One subject left after day 1.|24
531469|NCT00830362|1296415|P1|STARTED|Overall Study|They received Propranolol and completed Test Session (Session 1). One subject left after day 1.|27
531470|NCT00830336|1296423|P2|NOT COMPLETED|Second Intervention||0
531471|NCT00830336|1296424|P1|NOT COMPLETED|Second Intervention||0
531472|NCT00830336|1296423|P2|COMPLETED|Second Intervention||40
531473|NCT00830336|1296424|P1|COMPLETED|Second Intervention||39
531474|NCT00830336|1296423|P2|STARTED|Second Intervention||40
531475|NCT00830336|1296424|P1|STARTED|Second Intervention||39
531476|NCT00830336|1296423|P2|NOT COMPLETED|Washout: 21 Days||0
531477|NCT00830336|1296424|P1|NOT COMPLETED|Washout: 21 Days||1
531478|NCT00830336|1296423|P2|COMPLETED|Washout: 21 Days||40
531479|NCT00830336|1296424|P1|COMPLETED|Washout: 21 Days||39
531480|NCT00830336|1296423|P2|STARTED|Washout: 21 Days||40
531481|NCT00830336|1296424|P1|STARTED|Washout: 21 Days||40
531482|NCT00830336|1296423|P2|NOT COMPLETED|First Intervention||0
531483|NCT00830336|1296424|P1|NOT COMPLETED|First Intervention||0
531484|NCT00830336|1296423|P2|COMPLETED|First Intervention||40
531485|NCT00830336|1296424|P1|COMPLETED|First Intervention||40
531486|NCT00830336|1296423|P2|STARTED|First Intervention||40
531487|NCT00830336|1296424|P1|STARTED|First Intervention||40
531488|NCT00830310|1296432|P1|NOT COMPLETED|Overall Study||13
531489|NCT00830310|1296432|P1|COMPLETED|Overall Study||30
531490|NCT00830310|1296432|P1|STARTED|Overall Study||43
531491|NCT00830284|1296444|P1|NOT COMPLETED|Overall Study||2
531492|NCT00830284|1296444|P1|COMPLETED|Overall Study||10
531493|NCT00830284|1296444|P1|STARTED|Overall Study|The study was started in our Medical Surgical ICU October of 2008.|12
531494|NCT00830258|1296451|P2|NOT COMPLETED|Second Intervention||0
531495|NCT00830258|1296452|P1|NOT COMPLETED|Second Intervention||0
531496|NCT00830258|1296451|P2|COMPLETED|Second Intervention||30
531497|NCT00830258|1296452|P1|COMPLETED|Second Intervention||28
531498|NCT00830258|1296451|P2|STARTED|Second Intervention||30
531499|NCT00830258|1296452|P1|STARTED|Second Intervention||28
531500|NCT00830258|1296451|P2|NOT COMPLETED|Washout: 7 Days||0
531501|NCT00830258|1296452|P1|NOT COMPLETED|Washout: 7 Days||1
531502|NCT00830258|1296451|P2|COMPLETED|Washout: 7 Days||30
531503|NCT00830258|1296452|P1|COMPLETED|Washout: 7 Days||28
531504|NCT00830258|1296451|P2|STARTED|Washout: 7 Days||30
531505|NCT00830258|1296452|P1|STARTED|Washout: 7 Days||29
531506|NCT00830258|1296451|P2|NOT COMPLETED|First Intervention||0
531507|NCT00830258|1296452|P1|NOT COMPLETED|First Intervention||1
531508|NCT00830258|1296451|P2|COMPLETED|First Intervention||30
531509|NCT00830258|1296452|P1|COMPLETED|First Intervention||29
531510|NCT00830258|1296451|P2|STARTED|First Intervention||30
531511|NCT00830258|1296452|P1|STARTED|First Intervention||30
531512|NCT00830232|1296462|P2|NOT COMPLETED|Overall Study||0
531513|NCT00830232|1296463|P1|NOT COMPLETED|Overall Study||0
531514|NCT00830232|1296462|P2|COMPLETED|Overall Study||20
531515|NCT00830232|1296463|P1|COMPLETED|Overall Study||20
531516|NCT00830232|1296462|P2|STARTED|Overall Study||20
531517|NCT00830232|1296463|P1|STARTED|Overall Study||20
531518|NCT00830219|1296471|P2|NOT COMPLETED|Second Intervention||0
531519|NCT00830219|1296472|P1|NOT COMPLETED|Second Intervention||0
531520|NCT00830219|1296471|P2|COMPLETED|Second Intervention||22
531521|NCT00830219|1296472|P1|COMPLETED|Second Intervention||22
531522|NCT00830219|1296471|P2|STARTED|Second Intervention||22
531523|NCT00830219|1296472|P1|STARTED|Second Intervention||22
531524|NCT00830219|1296471|P2|NOT COMPLETED|Washout of 7 Days||1
531525|NCT00830219|1296472|P1|NOT COMPLETED|Washout of 7 Days||1
531526|NCT00830219|1296471|P2|COMPLETED|Washout of 7 Days||22
531527|NCT00830219|1296472|P1|COMPLETED|Washout of 7 Days||22
531528|NCT00830219|1296471|P2|STARTED|Washout of 7 Days||23
531529|NCT00830219|1296472|P1|STARTED|Washout of 7 Days||23
531530|NCT00830219|1296471|P2|NOT COMPLETED|First Intervention||0
531531|NCT00830219|1296472|P1|NOT COMPLETED|First Intervention||0
531532|NCT00830219|1296471|P2|COMPLETED|First Intervention||23
531533|NCT00830219|1296472|P1|COMPLETED|First Intervention||23
531534|NCT00830219|1296471|P2|STARTED|First Intervention||23
531535|NCT00830219|1296472|P1|STARTED|First Intervention||23
531536|NCT00830206|1296482|P2|NOT COMPLETED|Second Intervention||0
531537|NCT00830206|1296483|P1|NOT COMPLETED|Second Intervention||0
531538|NCT00830206|1296482|P2|COMPLETED|Second Intervention||39
531539|NCT00830206|1296483|P1|COMPLETED|Second Intervention||39
531540|NCT00830206|1296482|P2|STARTED|Second Intervention||39
531541|NCT00830206|1296483|P1|STARTED|Second Intervention||39
531542|NCT00830206|1296482|P2|NOT COMPLETED|Washout: 21 Days||1
531543|NCT00830206|1296483|P1|NOT COMPLETED|Washout: 21 Days||1
531544|NCT00830206|1296482|P2|COMPLETED|Washout: 21 Days||39
531545|NCT00830206|1296483|P1|COMPLETED|Washout: 21 Days||39
531546|NCT00830206|1296482|P2|STARTED|Washout: 21 Days||40
531547|NCT00830206|1296483|P1|STARTED|Washout: 21 Days||40
531548|NCT00830206|1296482|P2|NOT COMPLETED|First Intervention||0
531549|NCT00830206|1296483|P1|NOT COMPLETED|First Intervention||0
531550|NCT00830206|1296482|P2|COMPLETED|First Intervention||40
531551|NCT00830206|1296483|P1|COMPLETED|First Intervention||40
531552|NCT00830206|1296482|P2|STARTED|First Intervention||40
531553|NCT00830206|1296483|P1|STARTED|First Intervention||40
531554|NCT00830167|1296493|P2|NOT COMPLETED|Overall Study||43
531555|NCT00830167|1296494|P1|NOT COMPLETED|Overall Study||40
531556|NCT00830167|1296493|P2|COMPLETED|Overall Study||207
531557|NCT00830167|1296494|P1|COMPLETED|Overall Study||208
531558|NCT00830167|1296493|P2|STARTED|Overall Study|Treated|250
531559|NCT00830167|1296494|P1|STARTED|Overall Study|Treated|248
531560|NCT00830128|1296564|P1|NOT COMPLETED|Overall Study||19
531561|NCT00830128|1296564|P1|COMPLETED|Overall Study||87
531562|NCT00830128|1296564|P1|STARTED|Overall Study||106
531563|NCT00830115|1296579|P1|NOT COMPLETED|Overall Study||3
531564|NCT00830115|1296579|P1|COMPLETED|Overall Study||1042
531565|NCT00830115|1296579|P1|STARTED|Overall Study||1045
531566|NCT00830076|1296595|P1|NOT COMPLETED|Placebo Sitagliptin + Placebo Metformin||0
531567|NCT00830076|1296595|P1|COMPLETED|Placebo Sitagliptin + Placebo Metformin||18
531568|NCT00830076|1296595|P1|STARTED|Placebo Sitagliptin + Placebo Metformin||18
531569|NCT00830076|1296595|P1|NOT COMPLETED|7-day Washout||0
531570|NCT00830076|1296595|P1|COMPLETED|7-day Washout||18
531571|NCT00830076|1296595|P1|STARTED|7-day Washout||18
531572|NCT00830076|1296595|P1|NOT COMPLETED|Sitagliptin + Metformin||0
531573|NCT00830076|1296595|P1|COMPLETED|Sitagliptin + Metformin||18
531574|NCT00830076|1296595|P1|STARTED|Sitagliptin + Metformin||18
531575|NCT00830076|1296595|P1|NOT COMPLETED|7-day Washout||0
531576|NCT00830076|1296595|P1|COMPLETED|7-day Washout||18
531577|NCT00830076|1296595|P1|STARTED|7-day Washout||18
531578|NCT00830076|1296595|P1|NOT COMPLETED|Metformin + Placebo Sitagliptin||0
531579|NCT00830076|1296595|P1|COMPLETED|Metformin + Placebo Sitagliptin||18
531580|NCT00830076|1296595|P1|STARTED|Metformin + Placebo Sitagliptin||18
531581|NCT00830076|1296595|P1|NOT COMPLETED|7-day Washout||0
531582|NCT00830076|1296595|P1|COMPLETED|7-day Washout||18
531583|NCT00830076|1296595|P1|STARTED|7-day Washout||18
531584|NCT00830076|1296595|P1|NOT COMPLETED|Sitagliptin + Placebo Metformin||0
531585|NCT00830076|1296595|P1|COMPLETED|Sitagliptin + Placebo Metformin||18
531586|NCT00830076|1296595|P1|STARTED|Sitagliptin + Placebo Metformin||18
531587|NCT00830037|1296606|P2|NOT COMPLETED|Overall Study||19
531588|NCT00830037|1296607|P1|NOT COMPLETED|Overall Study||18
531589|NCT00830037|1296606|P2|COMPLETED|Overall Study||50
531590|NCT00830037|1296607|P1|COMPLETED|Overall Study||49
531591|NCT00830037|1296606|P2|STARTED|Overall Study||69
531592|NCT00830037|1296607|P1|STARTED|Overall Study||67
531593|NCT00830024|1296617|P2|NOT COMPLETED|Second Intervention||0
531594|NCT00830024|1296618|P1|NOT COMPLETED|Second Intervention||0
531595|NCT00830024|1296617|P2|COMPLETED|Second Intervention||18
531596|NCT00830024|1296618|P1|COMPLETED|Second Intervention||17
531597|NCT00830024|1296617|P2|STARTED|Second Intervention||18
531598|NCT00830024|1296618|P1|STARTED|Second Intervention||17
531599|NCT00830024|1296617|P2|NOT COMPLETED|Washout: 7 Days||0
531600|NCT00830024|1296618|P1|NOT COMPLETED|Washout: 7 Days||1
531601|NCT00830024|1296617|P2|COMPLETED|Washout: 7 Days||18
531602|NCT00830024|1296618|P1|COMPLETED|Washout: 7 Days||17
531603|NCT00830024|1296617|P2|STARTED|Washout: 7 Days||18
531604|NCT00830024|1296618|P1|STARTED|Washout: 7 Days||18
531605|NCT00830024|1296617|P2|NOT COMPLETED|First Intervention||0
531606|NCT00830024|1296618|P1|NOT COMPLETED|First Intervention||0
531607|NCT00830024|1296617|P2|COMPLETED|First Intervention||18
531608|NCT00830024|1296618|P1|COMPLETED|First Intervention||18
531609|NCT00830024|1296617|P2|STARTED|First Intervention||18
531610|NCT00830024|1296618|P1|STARTED|First Intervention||18
531611|NCT00829998|1296628|P2|NOT COMPLETED|Second Intervention||0
531612|NCT00829998|1296629|P1|NOT COMPLETED|Second Intervention||0
531613|NCT00829998|1296628|P2|COMPLETED|Second Intervention||19
531614|NCT00829998|1296629|P1|COMPLETED|Second Intervention||21
531615|NCT00829998|1296628|P2|STARTED|Second Intervention||19
531616|NCT00829998|1296629|P1|STARTED|Second Intervention||21
531617|NCT00829998|1296628|P2|NOT COMPLETED|Washout||1
531618|NCT00829998|1296629|P1|NOT COMPLETED|Washout||0
531619|NCT00829998|1296628|P2|COMPLETED|Washout||19
531620|NCT00829998|1296629|P1|COMPLETED|Washout||21
531621|NCT00829998|1296628|P2|STARTED|Washout||20
531622|NCT00829998|1296629|P1|STARTED|Washout||21
531623|NCT00829998|1296628|P2|NOT COMPLETED|First Intervention||0
531624|NCT00829998|1296629|P1|NOT COMPLETED|First Intervention||0
531625|NCT00829998|1296628|P2|COMPLETED|First Intervention||20
531626|NCT00829998|1296629|P1|COMPLETED|First Intervention||21
531627|NCT00829998|1296628|P2|STARTED|First Intervention||20
531628|NCT00829998|1296629|P1|STARTED|First Intervention||21
531629|NCT00829985|1296639|P2|NOT COMPLETED|Overall Study||4
531630|NCT00829985|1296640|P1|NOT COMPLETED|Overall Study||9
531631|NCT00829985|1296639|P2|COMPLETED|Overall Study||22
531632|NCT00829985|1296640|P1|COMPLETED|Overall Study||19
531633|NCT00829985|1296639|P2|STARTED|Overall Study||26
531634|NCT00829985|1296640|P1|STARTED|Overall Study||28
531635|NCT00829933|1296658|P4|NOT COMPLETED|Overall Study||14
531636|NCT00829933|1296659|P3|NOT COMPLETED|Overall Study||13
531637|NCT00829933|1296660|P2|NOT COMPLETED|Overall Study||13
531638|NCT00829933|1296661|P1|NOT COMPLETED|Overall Study||14
531639|NCT00829933|1296658|P4|COMPLETED|Overall Study||120
531640|NCT00829933|1296659|P3|COMPLETED|Overall Study||119
531641|NCT00829933|1296660|P2|COMPLETED|Overall Study||122
531642|NCT00829933|1296661|P1|COMPLETED|Overall Study||121
531643|NCT00829933|1296658|P4|Baseline Analysis Population|Overall Study||129
531644|NCT00829933|1296659|P3|Baseline Analysis Population|Overall Study||131
531645|NCT00829933|1296660|P2|Baseline Analysis Population|Overall Study||134
531646|NCT00829933|1296661|P1|Baseline Analysis Population|Overall Study||131
531647|NCT00829933|1296658|P4|STARTED|Overall Study||134
531648|NCT00829933|1296659|P3|STARTED|Overall Study||132
531649|NCT00829933|1296660|P2|STARTED|Overall Study||135
531650|NCT00829933|1296661|P1|STARTED|Overall Study||135
531651|NCT00829868|1296673|P2|NOT COMPLETED|Second Intervention||0
531652|NCT00829868|1296674|P1|NOT COMPLETED|Second Intervention||0
531653|NCT00829868|1296673|P2|COMPLETED|Second Intervention||21
531654|NCT00829868|1296674|P1|COMPLETED|Second Intervention||20
531655|NCT00829868|1296673|P2|STARTED|Second Intervention||21
531656|NCT00829868|1296674|P1|STARTED|Second Intervention||20
531657|NCT00829868|1296673|P2|NOT COMPLETED|Washout||0
531658|NCT00829868|1296674|P1|NOT COMPLETED|Washout||1
531659|NCT00829868|1296673|P2|COMPLETED|Washout||21
531660|NCT00829868|1296674|P1|COMPLETED|Washout||20
531661|NCT00829868|1296673|P2|STARTED|Washout||21
531662|NCT00829868|1296674|P1|STARTED|Washout||21
531663|NCT00829868|1296673|P2|NOT COMPLETED|First Intervention||0
531664|NCT00829868|1296674|P1|NOT COMPLETED|First Intervention||0
531665|NCT00829868|1296673|P2|COMPLETED|First Intervention||21
531666|NCT00829868|1296674|P1|COMPLETED|First Intervention||21
531667|NCT00829868|1296673|P2|STARTED|First Intervention||21
531668|NCT00829868|1296674|P1|STARTED|First Intervention||21
531669|NCT00829829|1296685|P3|NOT COMPLETED|Overall Study||11
531670|NCT00829829|1296686|P2|NOT COMPLETED|Overall Study||16
531671|NCT00829829|1296687|P1|NOT COMPLETED|Overall Study||22
531672|NCT00829829|1296685|P3|COMPLETED|Overall Study||70
531673|NCT00829829|1296686|P2|COMPLETED|Overall Study||64
531674|NCT00829829|1296687|P1|COMPLETED|Overall Study||58
531675|NCT00829829|1296685|P3|Treated|Overall Study||81
531676|NCT00829829|1296686|P2|Treated|Overall Study||80
531677|NCT00829829|1296687|P1|Treated|Overall Study||79
531678|NCT00829829|1296685|P3|STARTED|Overall Study||81
531679|NCT00829829|1296686|P2|STARTED|Overall Study||80
531680|NCT00829829|1296687|P1|STARTED|Overall Study||80
531681|NCT00829790|1296712|P2|NOT COMPLETED|Second Intervention||0
531682|NCT00829790|1296713|P1|NOT COMPLETED|Second Intervention||0
531683|NCT00829790|1296712|P2|COMPLETED|Second Intervention||14
531684|NCT00829790|1296713|P1|COMPLETED|Second Intervention||15
531685|NCT00829790|1296712|P2|STARTED|Second Intervention||14
531686|NCT00829790|1296713|P1|STARTED|Second Intervention||15
531687|NCT00829790|1296712|P2|NOT COMPLETED|Washout of 14 Days||1
531688|NCT00829790|1296713|P1|NOT COMPLETED|Washout of 14 Days||0
531689|NCT00829790|1296712|P2|COMPLETED|Washout of 14 Days||14
531690|NCT00829790|1296713|P1|COMPLETED|Washout of 14 Days||15
531691|NCT00829790|1296712|P2|STARTED|Washout of 14 Days||15
531692|NCT00829790|1296713|P1|STARTED|Washout of 14 Days||15
531693|NCT00829790|1296712|P2|NOT COMPLETED|First Intervention||0
531694|NCT00829790|1296713|P1|NOT COMPLETED|First Intervention||0
531695|NCT00829790|1296712|P2|COMPLETED|First Intervention||15
531696|NCT00829790|1296713|P1|COMPLETED|First Intervention||15
531697|NCT00829790|1296712|P2|STARTED|First Intervention||15
531698|NCT00829790|1296713|P1|STARTED|First Intervention||15
531699|NCT00829764|1296723|P2|NOT COMPLETED|Second Intervention||0
531700|NCT00829764|1296724|P1|NOT COMPLETED|Second Intervention||0
531701|NCT00829764|1296723|P2|COMPLETED|Second Intervention||14
531702|NCT00829764|1296724|P1|COMPLETED|Second Intervention||13
531703|NCT00829764|1296723|P2|STARTED|Second Intervention||14
531704|NCT00829764|1296724|P1|STARTED|Second Intervention||13
531705|NCT00829764|1296723|P2|NOT COMPLETED|Washout of 14 Days||0
531706|NCT00829764|1296724|P1|NOT COMPLETED|Washout of 14 Days||0
531707|NCT00829764|1296723|P2|COMPLETED|Washout of 14 Days||14
531708|NCT00829764|1296724|P1|COMPLETED|Washout of 14 Days||13
531709|NCT00829764|1296723|P2|STARTED|Washout of 14 Days||14
531710|NCT00829764|1296724|P1|STARTED|Washout of 14 Days||13
531711|NCT00829764|1296723|P2|NOT COMPLETED|First Intervention||1
531712|NCT00829764|1296724|P1|NOT COMPLETED|First Intervention||2
531713|NCT00829764|1296723|P2|COMPLETED|First Intervention||14
531714|NCT00829764|1296724|P1|COMPLETED|First Intervention||13
531715|NCT00829764|1296723|P2|STARTED|First Intervention||15
531716|NCT00829764|1296724|P1|STARTED|First Intervention||15
531717|NCT00829738|1296732|P1|NOT COMPLETED|Overall Study||8
531718|NCT00829738|1296732|P1|COMPLETED|Overall Study||4180
531719|NCT00829738|1296732|P1|STARTED|Overall Study||4188
531720|NCT00829712|1296750|P2|NOT COMPLETED|Second Intervention||0
531721|NCT00829712|1296751|P1|NOT COMPLETED|Second Intervention||0
531722|NCT00829712|1296750|P2|COMPLETED|Second Intervention||11
531723|NCT00829712|1296751|P1|COMPLETED|Second Intervention||12
531724|NCT00829712|1296750|P2|STARTED|Second Intervention||11
531725|NCT00829712|1296751|P1|STARTED|Second Intervention||12
531726|NCT00829712|1296750|P2|NOT COMPLETED|Washout of 7 Days||1
531727|NCT00829712|1296751|P1|NOT COMPLETED|Washout of 7 Days||0
531728|NCT00829712|1296750|P2|COMPLETED|Washout of 7 Days||11
531729|NCT00829712|1296751|P1|COMPLETED|Washout of 7 Days||12
531730|NCT00829712|1296750|P2|STARTED|Washout of 7 Days||12
531731|NCT00829712|1296751|P1|STARTED|Washout of 7 Days||12
531732|NCT00829712|1296750|P2|NOT COMPLETED|First Intervention||0
531733|NCT00829712|1296751|P1|NOT COMPLETED|First Intervention||0
531734|NCT00829712|1296750|P2|COMPLETED|First Intervention||12
531735|NCT00829712|1296751|P1|COMPLETED|First Intervention||12
531736|NCT00829712|1296750|P2|STARTED|First Intervention||12
531737|NCT00829712|1296751|P1|STARTED|First Intervention||12
531738|NCT00829686|1296761|P2|NOT COMPLETED|Overall Study||0
531739|NCT00829686|1296762|P1|NOT COMPLETED|Overall Study||0
531740|NCT00829686|1296761|P2|COMPLETED|Overall Study||18
531741|NCT00829686|1296762|P1|COMPLETED|Overall Study||13
531742|NCT00829686|1296761|P2|STARTED|Overall Study||18
531743|NCT00829686|1296762|P1|STARTED|Overall Study||13
531744|NCT00829673|1296770|P2|NOT COMPLETED|Second Intervention||0
531745|NCT00829673|1296771|P1|NOT COMPLETED|Second Intervention||0
531746|NCT00829673|1296770|P2|COMPLETED|Second Intervention||12
531747|NCT00829673|1296771|P1|COMPLETED|Second Intervention||11
531748|NCT00829673|1296770|P2|STARTED|Second Intervention||12
531749|NCT00829673|1296771|P1|STARTED|Second Intervention||11
531750|NCT00829673|1296770|P2|NOT COMPLETED|Washout of 7 Days||0
531751|NCT00829673|1296771|P1|NOT COMPLETED|Washout of 7 Days||1
531752|NCT00829673|1296770|P2|COMPLETED|Washout of 7 Days||12
531753|NCT00829673|1296771|P1|COMPLETED|Washout of 7 Days||11
531754|NCT00829673|1296770|P2|STARTED|Washout of 7 Days||12
531755|NCT00829673|1296771|P1|STARTED|Washout of 7 Days||12
531756|NCT00829673|1296770|P2|NOT COMPLETED|First Intervention||0
531757|NCT00829673|1296771|P1|NOT COMPLETED|First Intervention||0
531758|NCT00829673|1296770|P2|COMPLETED|First Intervention||12
531759|NCT00829673|1296771|P1|COMPLETED|First Intervention||12
531760|NCT00829673|1296770|P2|STARTED|First Intervention||12
531761|NCT00829673|1296771|P1|STARTED|First Intervention||12
531762|NCT00829621|1296781|P2|NOT COMPLETED|Overall Study||4
531763|NCT00829621|1296782|P1|NOT COMPLETED|Overall Study||4
531764|NCT00829621|1296781|P2|COMPLETED|Overall Study||8
531765|NCT00829621|1296782|P1|COMPLETED|Overall Study||4
531766|NCT00829621|1296781|P2|STARTED|Overall Study||12
531767|NCT00829621|1296782|P1|STARTED|Overall Study||8
531768|NCT00829530|1296790|P2|NOT COMPLETED|Second Intervention||0
531769|NCT00829530|1296791|P1|NOT COMPLETED|Second Intervention||1
531770|NCT00829530|1296790|P2|COMPLETED|Second Intervention||18
531771|NCT00829530|1296791|P1|COMPLETED|Second Intervention||19
531772|NCT00829530|1296790|P2|STARTED|Second Intervention||18
531773|NCT00829530|1296791|P1|STARTED|Second Intervention||20
531774|NCT00829530|1296790|P2|NOT COMPLETED|Washout of 42 Days||0
531775|NCT00829530|1296791|P1|NOT COMPLETED|Washout of 42 Days||0
531776|NCT00829530|1296790|P2|COMPLETED|Washout of 42 Days||18
531777|NCT00829530|1296791|P1|COMPLETED|Washout of 42 Days||20
531778|NCT00829530|1296790|P2|STARTED|Washout of 42 Days||18
531779|NCT00829530|1296791|P1|STARTED|Washout of 42 Days||20
531780|NCT00829530|1296790|P2|NOT COMPLETED|First Intervention||2
531781|NCT00829530|1296791|P1|NOT COMPLETED|First Intervention||0
531782|NCT00829530|1296790|P2|COMPLETED|First Intervention||18
531783|NCT00829530|1296791|P1|COMPLETED|First Intervention||20
531784|NCT00829530|1296790|P2|STARTED|First Intervention||20
531785|NCT00829530|1296791|P1|STARTED|First Intervention||20
531786|NCT00829504|1296805|P2|NOT COMPLETED|Second Intervention||0
531787|NCT00829504|1296806|P1|NOT COMPLETED|Second Intervention||1
531788|NCT00829504|1296805|P2|COMPLETED|Second Intervention||22
531789|NCT00829504|1296806|P1|COMPLETED|Second Intervention||19
531790|NCT00829504|1296805|P2|STARTED|Second Intervention||22
531791|NCT00829504|1296806|P1|STARTED|Second Intervention||20
531792|NCT00829504|1296805|P2|NOT COMPLETED|Washout of 7 Days||0
531793|NCT00829504|1296806|P1|NOT COMPLETED|Washout of 7 Days||1
531794|NCT00829504|1296805|P2|COMPLETED|Washout of 7 Days||22
531795|NCT00829504|1296806|P1|COMPLETED|Washout of 7 Days||20
531796|NCT00829504|1296805|P2|STARTED|Washout of 7 Days||22
531797|NCT00829504|1296806|P1|STARTED|Washout of 7 Days||21
531798|NCT00829504|1296805|P2|NOT COMPLETED|First Intervention||0
531799|NCT00829504|1296806|P1|NOT COMPLETED|First Intervention||1
531800|NCT00829504|1296805|P2|COMPLETED|First Intervention||22
531801|NCT00829504|1296806|P1|COMPLETED|First Intervention||21
531802|NCT00829504|1296805|P2|STARTED|First Intervention||22
531803|NCT00829504|1296806|P1|STARTED|First Intervention||22
531804|NCT00829452|1296816|P2|NOT COMPLETED|Second Intervention||1
531805|NCT00829452|1296817|P1|NOT COMPLETED|Second Intervention||0
531806|NCT00829452|1296816|P2|COMPLETED|Second Intervention||17
531807|NCT00829452|1296817|P1|COMPLETED|Second Intervention||20
531808|NCT00829452|1296816|P2|STARTED|Second Intervention||18
531809|NCT00829452|1296817|P1|STARTED|Second Intervention||20
531810|NCT00829452|1296816|P2|NOT COMPLETED|Washout of 42 Days||1
531811|NCT00829452|1296817|P1|NOT COMPLETED|Washout of 42 Days||0
531812|NCT00829452|1296816|P2|COMPLETED|Washout of 42 Days||18
531813|NCT00829452|1296817|P1|COMPLETED|Washout of 42 Days||20
531814|NCT00829452|1296816|P2|STARTED|Washout of 42 Days||19
531815|NCT00829452|1296817|P1|STARTED|Washout of 42 Days||20
531816|NCT00829452|1296816|P2|NOT COMPLETED|First Intervention||1
531817|NCT00829452|1296817|P1|NOT COMPLETED|First Intervention||0
531818|NCT00829452|1296816|P2|COMPLETED|First Intervention||19
531819|NCT00829452|1296817|P1|COMPLETED|First Intervention||20
531820|NCT00829452|1296816|P2|STARTED|First Intervention||20
531821|NCT00829452|1296817|P1|STARTED|First Intervention||20
531822|NCT00829439|1296829|P4|NOT COMPLETED|Overall Study||0
531823|NCT00829439|1296830|P3|NOT COMPLETED|Overall Study||1
531824|NCT00829439|1296831|P2|NOT COMPLETED|Overall Study||0
531825|NCT00829439|1296832|P1|NOT COMPLETED|Overall Study||0
531826|NCT00829439|1296829|P4|COMPLETED|Overall Study||4
531827|NCT00829439|1296830|P3|COMPLETED|Overall Study||5
531828|NCT00829439|1296831|P2|COMPLETED|Overall Study||3
531829|NCT00829439|1296832|P1|COMPLETED|Overall Study||3
531830|NCT00829439|1296829|P4|STARTED|Overall Study||4
531831|NCT00829439|1296830|P3|STARTED|Overall Study||6
531832|NCT00829439|1296831|P2|STARTED|Overall Study||3
531833|NCT00829439|1296832|P1|STARTED|Overall Study||3
531834|NCT00829426|1296838|P2|NOT COMPLETED|Second Intervention||0
531835|NCT00829426|1296839|P1|NOT COMPLETED|Second Intervention||0
531836|NCT00829426|1296838|P2|COMPLETED|Second Intervention||16
531837|NCT00829426|1296839|P1|COMPLETED|Second Intervention||15
531838|NCT00829426|1296838|P2|STARTED|Second Intervention||16
531839|NCT00829426|1296839|P1|STARTED|Second Intervention||15
531840|NCT00829426|1296838|P2|NOT COMPLETED|Washout: 7 Days||0
531841|NCT00829426|1296839|P1|NOT COMPLETED|Washout: 7 Days||1
531842|NCT00829426|1296838|P2|COMPLETED|Washout: 7 Days||16
531843|NCT00829426|1296839|P1|COMPLETED|Washout: 7 Days||15
531844|NCT00829426|1296838|P2|STARTED|Washout: 7 Days||16
531845|NCT00829426|1296839|P1|STARTED|Washout: 7 Days||16
531846|NCT00829426|1296838|P2|NOT COMPLETED|First Intervention||0
531847|NCT00829426|1296839|P1|NOT COMPLETED|First Intervention||0
531848|NCT00829426|1296838|P2|COMPLETED|First Intervention||16
531849|NCT00829426|1296839|P1|COMPLETED|First Intervention||16
531850|NCT00829426|1296838|P2|STARTED|First Intervention||16
531851|NCT00829426|1296839|P1|STARTED|First Intervention||16
531852|NCT00829387|1296849|P2|NOT COMPLETED|Overall Study||3
531853|NCT00829387|1296850|P1|NOT COMPLETED|Overall Study||3
531854|NCT00829387|1296849|P2|COMPLETED|Overall Study||21
531855|NCT00829387|1296850|P1|COMPLETED|Overall Study||20
531856|NCT00829387|1296849|P2|STARTED|Overall Study||24
531857|NCT00829387|1296850|P1|STARTED|Overall Study||23
531858|NCT00829309|1296868|P2|NOT COMPLETED|Second Intervention||0
531859|NCT00829309|1296869|P1|NOT COMPLETED|Second Intervention||0
531860|NCT00829309|1296868|P2|COMPLETED|Second Intervention||8
531861|NCT00829309|1296869|P1|COMPLETED|Second Intervention||7
531862|NCT00829309|1296868|P2|STARTED|Second Intervention||8
531863|NCT00829309|1296869|P1|STARTED|Second Intervention||7
531864|NCT00829309|1296868|P2|NOT COMPLETED|Washout: 7 Days||0
531865|NCT00829309|1296869|P1|NOT COMPLETED|Washout: 7 Days||1
531866|NCT00829309|1296868|P2|COMPLETED|Washout: 7 Days||8
531867|NCT00829309|1296869|P1|COMPLETED|Washout: 7 Days||7
531868|NCT00829309|1296868|P2|STARTED|Washout: 7 Days||8
531869|NCT00829309|1296869|P1|STARTED|Washout: 7 Days||8
531870|NCT00829309|1296868|P2|NOT COMPLETED|First Intervention||0
531871|NCT00829309|1296869|P1|NOT COMPLETED|First Intervention||0
531872|NCT00829309|1296868|P2|COMPLETED|First Intervention||8
531873|NCT00829309|1296869|P1|COMPLETED|First Intervention||8
531874|NCT00829309|1296868|P2|STARTED|First Intervention||8
531875|NCT00829309|1296869|P1|STARTED|First Intervention||8
531876|NCT00829296|1296879|P2|NOT COMPLETED|Overall Study||4
531877|NCT00829296|1296880|P1|NOT COMPLETED|Overall Study||5
531878|NCT00829296|1296879|P2|COMPLETED|Overall Study||32
531879|NCT00829296|1296880|P1|COMPLETED|Overall Study||29
531880|NCT00829296|1296879|P2|STARTED|Overall Study||36
531881|NCT00829296|1296880|P1|STARTED|Overall Study||34
531882|NCT00829283|1296894|P2|NOT COMPLETED|Overall Study||25
531883|NCT00829283|1296895|P1|NOT COMPLETED|Overall Study||7
531884|NCT00829283|1296894|P2|COMPLETED|Overall Study||127
531885|NCT00829283|1296895|P1|COMPLETED|Overall Study||32
531886|NCT00829283|1296894|P2|STARTED|Overall Study||152
531887|NCT00829283|1296895|P1|STARTED|Overall Study||39
531888|NCT00829244|1296905|P2|NOT COMPLETED|Overall Study||21
531889|NCT00829244|1296906|P1|NOT COMPLETED|Overall Study||14
531890|NCT00829244|1296905|P2|COMPLETED|Overall Study||83
531891|NCT00829244|1296906|P1|COMPLETED|Overall Study||82
531892|NCT00829244|1296905|P2|STARTED|Overall Study||104
531893|NCT00829244|1296906|P1|STARTED|Overall Study||96
531894|NCT00829179|1296936|P1|NOT COMPLETED|Overall Study||1
531895|NCT00829179|1296936|P1|COMPLETED|Overall Study||19
531896|NCT00829179|1296936|P1|STARTED|Overall Study||20
531897|NCT00829166|1296942|P2|NOT COMPLETED|Overall Study||496
531898|NCT00829166|1296943|P1|NOT COMPLETED|Overall Study||495
531899|NCT00829166|1296942|P2|COMPLETED|Overall Study||0
531900|NCT00829166|1296943|P1|COMPLETED|Overall Study||0
531901|NCT00829166|1296942|P2|Treated|Overall Study||488
531902|NCT00829166|1296943|P1|Treated|Overall Study||490
531903|NCT00829166|1296942|P2|STARTED|Overall Study||496
531904|NCT00829166|1296943|P1|STARTED|Overall Study||495
531905|NCT00829049|1296984|P2|NOT COMPLETED|Overall Study||20
531906|NCT00829049|1296985|P1|NOT COMPLETED|Overall Study||17
531907|NCT00829049|1296984|P2|COMPLETED|Overall Study||68
531908|NCT00829049|1296985|P1|COMPLETED|Overall Study||60
531909|NCT00829049|1296984|P2|STARTED|Overall Study||88
531910|NCT00829049|1296985|P1|STARTED|Overall Study||77
531911|NCT00829036|1296997|P1|NOT COMPLETED|Overall Study||0
531912|NCT00829036|1296997|P1|COMPLETED|Overall Study||24
531913|NCT00829036|1296997|P1|STARTED|Overall Study||24
531914|NCT00829010|1297006|P5|NOT COMPLETED|Overall Study||2
531915|NCT00829010|1297007|P4|NOT COMPLETED|Overall Study||8
531916|NCT00829010|1297008|P3|NOT COMPLETED|Overall Study||3
531917|NCT00829010|1297009|P2|NOT COMPLETED|Overall Study||9
531918|NCT00829010|1297010|P1|NOT COMPLETED|Overall Study||10
531919|NCT00829010|1297006|P5|COMPLETED|Overall Study||98
531920|NCT00829010|1297007|P4|COMPLETED|Overall Study||92
531921|NCT00829010|1297008|P3|COMPLETED|Overall Study||97
531922|NCT00829010|1297009|P2|COMPLETED|Overall Study||92
531923|NCT00829010|1297010|P1|COMPLETED|Overall Study||73
531924|NCT00829010|1297006|P5|STARTED|Overall Study||100
531925|NCT00829010|1297007|P4|STARTED|Overall Study||100
531926|NCT00829010|1297008|P3|STARTED|Overall Study||100
531927|NCT00829010|1297009|P2|STARTED|Overall Study||101
531928|NCT00829010|1297010|P1|STARTED|Overall Study||83
531929|NCT00828984|1297175|P3|NOT COMPLETED|Overall Study||9
531930|NCT00828984|1297176|P2|NOT COMPLETED|Overall Study||16
531931|NCT00828984|1297177|P1|NOT COMPLETED|Overall Study||14
531932|NCT00828984|1297175|P3|COMPLETED|Overall Study||19
531933|NCT00828984|1297176|P2|COMPLETED|Overall Study||15
531934|NCT00828984|1297177|P1|COMPLETED|Overall Study||14
531935|NCT00828984|1297175|P3|Post Intervention Follow-Up|Overall Study||19
531936|NCT00828984|1297176|P2|Post Intervention Follow-Up|Overall Study||16
531937|NCT00828984|1297177|P1|Post Intervention Follow-Up|Overall Study||15
531938|NCT00828984|1297175|P3|Flexible Sigmoidoscopy|Overall Study||19
531939|NCT00828984|1297176|P2|Flexible Sigmoidoscopy|Overall Study||19
531940|NCT00828984|1297177|P1|Flexible Sigmoidoscopy|Overall Study||20
531941|NCT00828984|1297175|P3|Treatment|Overall Study||24
531942|NCT00828984|1297176|P2|Treatment|Overall Study||26
531943|NCT00828984|1297177|P1|Treatment|Overall Study||24
531944|NCT00828984|1297175|P3|Randomization|Overall Study||28
531945|NCT00828984|1297176|P2|Randomization|Overall Study||31
531946|NCT00828984|1297177|P1|Randomization|Overall Study||28
531947|NCT00828984|1297175|P3|STARTED|Overall Study||28
531948|NCT00828984|1297176|P2|STARTED|Overall Study||31
531949|NCT00828984|1297177|P1|STARTED|Overall Study||28
531950|NCT00828945|1297200|P1|NOT COMPLETED|Overall Study||41
531951|NCT00828945|1297200|P1|COMPLETED|Overall Study||216
531952|NCT00828945|1297200|P1|STARTED|Overall Study||257
531953|NCT00828841|1297217|P3|NOT COMPLETED|Overall Study||4
531954|NCT00828841|1297218|P2|NOT COMPLETED|Overall Study||4
531955|NCT00828841|1297219|P1|NOT COMPLETED|Overall Study||4
531956|NCT00828841|1297217|P3|COMPLETED|Overall Study||126
531957|NCT00828841|1297218|P2|COMPLETED|Overall Study||232
531958|NCT00828841|1297219|P1|COMPLETED|Overall Study||231
531959|NCT00828841|1297217|P3|STARTED|Overall Study||130
531960|NCT00828841|1297218|P2|STARTED|Overall Study||236
531961|NCT00828841|1297219|P1|STARTED|Overall Study||235
531962|NCT00828750|1297232|P1|NOT COMPLETED|Overall Study||4
531963|NCT00828750|1297232|P1|COMPLETED|Overall Study||15
531964|NCT00828750|1297232|P1|STARTED|Overall Study||19
531965|NCT00828711|1297246|P3|NOT COMPLETED|Overall Study||0
531966|NCT00828711|1297247|P2|NOT COMPLETED|Overall Study||0
531967|NCT00828711|1297248|P1|NOT COMPLETED|Overall Study||1
531968|NCT00828711|1297246|P3|COMPLETED|Overall Study||131
531969|NCT00828711|1297247|P2|COMPLETED|Overall Study||125
531970|NCT00828711|1297248|P1|COMPLETED|Overall Study||117
531971|NCT00828711|1297246|P3|STARTED|Overall Study||131
531972|NCT00828711|1297247|P2|STARTED|Overall Study||125
531973|NCT00828711|1297248|P1|STARTED|Overall Study||118
531974|NCT00828568|1297280|P3|NOT COMPLETED|Treated - Received at Least One Dose||5
531975|NCT00828568|1297281|P2|NOT COMPLETED|Treated - Received at Least One Dose||29
531976|NCT00828568|1297282|P1|NOT COMPLETED|Treated - Received at Least One Dose||30
531977|NCT00828568|1297280|P3|COMPLETED|Treated - Received at Least One Dose||55
531978|NCT00828568|1297281|P2|COMPLETED|Treated - Received at Least One Dose||150
531979|NCT00828568|1297282|P1|COMPLETED|Treated - Received at Least One Dose||153
531980|NCT00828568|1297280|P3|STARTED|Treated - Received at Least One Dose||60
531981|NCT00828568|1297281|P2|STARTED|Treated - Received at Least One Dose||179
531982|NCT00828568|1297282|P1|STARTED|Treated - Received at Least One Dose||183
531983|NCT00828568|1297280|P3|NOT COMPLETED|Randomized||2
531984|NCT00828568|1297281|P2|NOT COMPLETED|Randomized||0
531985|NCT00828568|1297282|P1|NOT COMPLETED|Randomized||1
531986|NCT00828568|1297280|P3|COMPLETED|Randomized||60
531987|NCT00828568|1297281|P2|COMPLETED|Randomized||179
531988|NCT00828568|1297282|P1|COMPLETED|Randomized||183
531989|NCT00828568|1297280|P3|STARTED|Randomized||62
531990|NCT00828568|1297281|P2|STARTED|Randomized||179
531991|NCT00828568|1297282|P1|STARTED|Randomized||184
531992|NCT00828542|1297297|P2|NOT COMPLETED|Overall Study||3
531993|NCT00828542|1297298|P1|NOT COMPLETED|Overall Study||3
531994|NCT00828542|1297297|P2|COMPLETED|Overall Study||20
531995|NCT00828542|1297298|P1|COMPLETED|Overall Study||20
531996|NCT00828542|1297297|P2|STARTED|Overall Study||23
531997|NCT00828542|1297298|P1|STARTED|Overall Study||23
531998|NCT00828516|1297304|P1|NOT COMPLETED|Clinical Phase: Series 2||0
531999|NCT00828516|1297304|P1|COMPLETED|Clinical Phase: Series 2||30
532000|NCT00828516|1297304|P1|STARTED|Clinical Phase: Series 2||30
532001|NCT00828516|1297304|P1|NOT COMPLETED|Clinical Phase: Series 1||2
532002|NCT00828516|1297304|P1|COMPLETED|Clinical Phase: Series 1||33
532003|NCT00828516|1297304|P1|STARTED|Clinical Phase: Series 1||35
532004|NCT00828464|1297309|P1|NOT COMPLETED|Overall Study||1
532005|NCT00828464|1297309|P1|COMPLETED|Overall Study||29
532006|NCT00828464|1297309|P1|STARTED|Overall Study||30
532007|NCT00828451|1297326|P1|NOT COMPLETED|Overall Study||11
532008|NCT00828451|1297326|P1|COMPLETED|Overall Study||18
532009|NCT00828451|1297326|P1|STARTED|Overall Study||29
532010|NCT00828412|1297334|P2|NOT COMPLETED|Overall Study||2
532011|NCT00828412|1297335|P1|NOT COMPLETED|Overall Study||9
532012|NCT00828412|1297334|P2|COMPLETED|Overall Study||48
532013|NCT00828412|1297335|P1|COMPLETED|Overall Study||41
532014|NCT00828412|1297334|P2|STARTED|Overall Study||50
532015|NCT00828412|1297335|P1|STARTED|Overall Study||50
532016|NCT00828347|1297343|P2|NOT COMPLETED|Overall Study||0
532017|NCT00828347|1297344|P1|NOT COMPLETED|Overall Study||0
532018|NCT00828347|1297343|P2|COMPLETED|Overall Study||11
532019|NCT00828347|1297344|P1|COMPLETED|Overall Study||12
532020|NCT00828347|1297343|P2|STARTED|Overall Study||11
532021|NCT00828347|1297344|P1|STARTED|Overall Study||12
532022|NCT00828321|1297352|P2|NOT COMPLETED|Second Intervention||1
532023|NCT00828321|1297353|P1|NOT COMPLETED|Second Intervention||0
532024|NCT00828321|1297352|P2|COMPLETED|Second Intervention||19
532025|NCT00828321|1297353|P1|COMPLETED|Second Intervention||18
532026|NCT00828321|1297352|P2|STARTED|Second Intervention||20
532027|NCT00828321|1297353|P1|STARTED|Second Intervention||18
532028|NCT00828321|1297352|P2|NOT COMPLETED|Washout of 42 Days||0
532029|NCT00828321|1297353|P1|NOT COMPLETED|Washout of 42 Days||2
532030|NCT00828321|1297352|P2|COMPLETED|Washout of 42 Days||20
532031|NCT00828321|1297353|P1|COMPLETED|Washout of 42 Days||18
532032|NCT00828321|1297352|P2|STARTED|Washout of 42 Days||20
532033|NCT00828321|1297353|P1|STARTED|Washout of 42 Days||20
532034|NCT00828321|1297352|P2|NOT COMPLETED|First Intervention||0
532035|NCT00828321|1297353|P1|NOT COMPLETED|First Intervention||0
532036|NCT00828321|1297352|P2|COMPLETED|First Intervention||20
532037|NCT00828321|1297353|P1|COMPLETED|First Intervention||20
532038|NCT00828321|1297352|P2|STARTED|First Intervention||20
532039|NCT00828321|1297353|P1|STARTED|First Intervention||20
532040|NCT00828308|1297365|P1|NOT COMPLETED|Overall Study||0
532041|NCT00828308|1297365|P1|COMPLETED|Overall Study||16
532042|NCT00828308|1297365|P1|STARTED|Overall Study||16
532043|NCT00828295|1297371|P2|NOT COMPLETED|Overall Study||0
532044|NCT00828295|1297372|P1|NOT COMPLETED|Overall Study||0
532045|NCT00828295|1297371|P2|COMPLETED|Overall Study||75
532046|NCT00828295|1297372|P1|COMPLETED|Overall Study||75
532047|NCT00828295|1297371|P2|STARTED|Overall Study||75
532048|NCT00828295|1297372|P1|STARTED|Overall Study||75
532049|NCT00828204|1297382|P2|NOT COMPLETED|Extension Study||3
532050|NCT00828204|1297383|P1|NOT COMPLETED|Extension Study||0
532051|NCT00828204|1297382|P2|COMPLETED|Extension Study||61
532052|NCT00828204|1297383|P1|COMPLETED|Extension Study||0
532053|NCT00828204|1297382|P2|STARTED|Extension Study|Participation in Extension Study was optional for Main Subset participants completing Main Study.|64
532054|NCT00828204|1297383|P1|STARTED|Extension Study|Participation in the Extension Study was not offered to Initial Subset after completing Main Study.|0
532055|NCT00828204|1297382|P2|NOT COMPLETED|Main Study: After Study Restart||3
532056|NCT00828204|1297383|P1|NOT COMPLETED|Main Study: After Study Restart||0
532057|NCT00828204|1297382|P2|COMPLETED|Main Study: After Study Restart||71
532058|NCT00828204|1297383|P1|COMPLETED|Main Study: After Study Restart||0
532059|NCT00828204|1297382|P2|Continued With Autoinjector Injections|Main Study: After Study Restart||72
532060|NCT00828204|1297383|P1|Continued With Autoinjector Injections|Main Study: After Study Restart||0
532061|NCT00828204|1297382|P2|Completed Manual Injection|Main Study: After Study Restart||74
532062|NCT00828204|1297383|P1|Completed Manual Injection|Main Study: After Study Restart||0
532063|NCT00828204|1297382|P2|STARTED|Main Study: After Study Restart|After a protocol amendment, the Main Subset participants were enrolled.|74
532064|NCT00828204|1297383|P1|STARTED|Main Study: After Study Restart|Initial Subset participants did not continue after the study was suspended.|0
532065|NCT00828204|1297382|P2|NOT COMPLETED|Main Study: Prior to Study Suspension||0
532066|NCT00828204|1297383|P1|NOT COMPLETED|Main Study: Prior to Study Suspension||14
532067|NCT00828204|1297382|P2|COMPLETED|Main Study: Prior to Study Suspension||0
532068|NCT00828204|1297383|P1|COMPLETED|Main Study: Prior to Study Suspension||7
532069|NCT00828204|1297382|P2|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||0
532070|NCT00828204|1297383|P1|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||19
532071|NCT00828204|1297382|P2|Completed Manual Injection|Main Study: Prior to Study Suspension||0
532072|NCT00828204|1297383|P1|Completed Manual Injection|Main Study: Prior to Study Suspension||21
532073|NCT00828204|1297382|P2|STARTED|Main Study: Prior to Study Suspension|Main Subset was not enrolled until after study suspension (period 2, below).|0
532074|NCT00828204|1297383|P1|STARTED|Main Study: Prior to Study Suspension||21
532075|NCT00828191|1297402|P2|NOT COMPLETED|Overall Study||10
532076|NCT00828191|1297403|P1|NOT COMPLETED|Overall Study||8
532077|NCT00828191|1297402|P2|COMPLETED|Overall Study|Patients with at least one embryo transferred.|390
532078|NCT00828191|1297403|P1|COMPLETED|Overall Study|Patients with at least one embryo transferred.|392
532079|NCT00828191|1297402|P2|STARTED|Overall Study|Randomized patients|400
532080|NCT00828191|1297403|P1|STARTED|Overall Study|Randomized patients|400
532081|NCT00828178|1297415|P2|NOT COMPLETED|Overall Study||2
532082|NCT00828178|1297416|P1|NOT COMPLETED|Overall Study||0
532083|NCT00828178|1297415|P2|COMPLETED|Overall Study|Two patients did not complete the study.|43
532084|NCT00828178|1297416|P1|COMPLETED|Overall Study||42
532085|NCT00828178|1297415|P2|STARTED|Overall Study|Eighty seven participants were randomized.|45
532086|NCT00828178|1297416|P1|STARTED|Overall Study||42
532087|NCT00828139|1297430|P4|NOT COMPLETED|Overall Study||51
532088|NCT00828139|1297431|P3|NOT COMPLETED|Overall Study||55
532089|NCT00828139|1297432|P2|NOT COMPLETED|Overall Study||41
532090|NCT00828139|1297433|P1|NOT COMPLETED|Overall Study||41
532091|NCT00828139|1297430|P4|COMPLETED|Overall Study||0
532092|NCT00828139|1297431|P3|COMPLETED|Overall Study||0
532093|NCT00828139|1297432|P2|COMPLETED|Overall Study||0
532094|NCT00828139|1297433|P1|COMPLETED|Overall Study||1
532095|NCT00828139|1297430|P4|STARTED|Overall Study||51
532096|NCT00828139|1297431|P3|STARTED|Overall Study||55
532097|NCT00828139|1297432|P2|STARTED|Overall Study||41
532098|NCT00828139|1297433|P1|STARTED|Overall Study||42
532099|NCT00828113|1297453|P2|NOT COMPLETED|Overall Study||31
532100|NCT00828113|1297454|P1|NOT COMPLETED|Overall Study||30
532101|NCT00828113|1297453|P2|COMPLETED|Overall Study||20
532102|NCT00828113|1297454|P1|COMPLETED|Overall Study||20
532103|NCT00828113|1297453|P2|STARTED|Overall Study||51
532104|NCT00828113|1297454|P1|STARTED|Overall Study||50
532105|NCT00828074|1297462|P3|NOT COMPLETED|Overall Study||0
532106|NCT00828074|1297463|P2|NOT COMPLETED|Overall Study||0
532107|NCT00828074|1297464|P1|NOT COMPLETED|Overall Study||0
532108|NCT00828074|1297462|P3|COMPLETED|Overall Study||35
532109|NCT00828074|1297463|P2|COMPLETED|Overall Study||5
532110|NCT00828074|1297464|P1|COMPLETED|Overall Study||6
532111|NCT00828074|1297462|P3|STARTED|Overall Study||35
532112|NCT00828074|1297463|P2|STARTED|Overall Study||5
532113|NCT00828074|1297464|P1|STARTED|Overall Study||6
532114|NCT00828061|1297476|P6|NOT COMPLETED|Period 3||0
532115|NCT00828061|1297477|P5|NOT COMPLETED|Period 3||0
532116|NCT00828061|1297478|P4|NOT COMPLETED|Period 3||0
532117|NCT00828061|1297479|P3|NOT COMPLETED|Period 3||0
532118|NCT00828061|1297480|P2|NOT COMPLETED|Period 3||0
532119|NCT00828061|1297481|P1|NOT COMPLETED|Period 3||0
532120|NCT00828061|1297476|P6|COMPLETED|Period 3||3
532121|NCT00828061|1297477|P5|COMPLETED|Period 3||3
532122|NCT00828061|1297478|P4|COMPLETED|Period 3||3
532123|NCT00828061|1297479|P3|COMPLETED|Period 3||3
532124|NCT00828061|1297480|P2|COMPLETED|Period 3||3
532125|NCT00828061|1297481|P1|COMPLETED|Period 3||4
532126|NCT00828061|1297476|P6|STARTED|Period 3||3
532127|NCT00828061|1297477|P5|STARTED|Period 3||3
532128|NCT00828061|1297478|P4|STARTED|Period 3||3
532129|NCT00828061|1297479|P3|STARTED|Period 3||3
532130|NCT00828061|1297480|P2|STARTED|Period 3||3
532131|NCT00828061|1297481|P1|STARTED|Period 3||4
532132|NCT00828061|1297476|P6|NOT COMPLETED|Period 2||0
532133|NCT00828061|1297477|P5|NOT COMPLETED|Period 2||0
532134|NCT00828061|1297478|P4|NOT COMPLETED|Period 2||0
532135|NCT00828061|1297479|P3|NOT COMPLETED|Period 2||0
532136|NCT00828061|1297480|P2|NOT COMPLETED|Period 2||0
532137|NCT00828061|1297481|P1|NOT COMPLETED|Period 2||0
532138|NCT00828061|1297476|P6|COMPLETED|Period 2||3
532139|NCT00828061|1297477|P5|COMPLETED|Period 2||3
532140|NCT00828061|1297478|P4|COMPLETED|Period 2||3
532141|NCT00828061|1297479|P3|COMPLETED|Period 2||3
532142|NCT00828061|1297480|P2|COMPLETED|Period 2||3
532143|NCT00828061|1297481|P1|COMPLETED|Period 2||4
532144|NCT00828061|1297476|P6|STARTED|Period 2||3
532145|NCT00828061|1297477|P5|STARTED|Period 2||3
532146|NCT00828061|1297478|P4|STARTED|Period 2||3
532147|NCT00828061|1297479|P3|STARTED|Period 2||3
532148|NCT00828061|1297480|P2|STARTED|Period 2||3
532149|NCT00828061|1297481|P1|STARTED|Period 2||4
532150|NCT00828061|1297476|P6|NOT COMPLETED|Period 1||0
532151|NCT00828061|1297477|P5|NOT COMPLETED|Period 1||0
532152|NCT00828061|1297478|P4|NOT COMPLETED|Period 1||0
532153|NCT00828061|1297479|P3|NOT COMPLETED|Period 1||0
532154|NCT00828061|1297480|P2|NOT COMPLETED|Period 1||0
532155|NCT00828061|1297481|P1|NOT COMPLETED|Period 1||0
532156|NCT00828061|1297476|P6|COMPLETED|Period 1||3
532157|NCT00828061|1297477|P5|COMPLETED|Period 1||3
532158|NCT00828061|1297478|P4|COMPLETED|Period 1||3
532159|NCT00828061|1297479|P3|COMPLETED|Period 1||3
532160|NCT00828061|1297480|P2|COMPLETED|Period 1||3
532161|NCT00828061|1297481|P1|COMPLETED|Period 1||4
532162|NCT00828061|1297476|P6|STARTED|Period 1||3
532163|NCT00828061|1297477|P5|STARTED|Period 1||3
532164|NCT00828061|1297478|P4|STARTED|Period 1||3
532165|NCT00828061|1297479|P3|STARTED|Period 1||3
532166|NCT00828061|1297480|P2|STARTED|Period 1||3
532167|NCT00828061|1297481|P1|STARTED|Period 1||4
532168|NCT00827983|1297494|P2|NOT COMPLETED|Overall Study||16
532169|NCT00827983|1297495|P1|NOT COMPLETED|Overall Study||18
532170|NCT00827983|1297494|P2|COMPLETED|Overall Study|patients who performed the pregnancy test|328
532171|NCT00827983|1297495|P1|COMPLETED|Overall Study|patients who performed the pregnancy test|321
532172|NCT00827983|1297494|P2|STARTED|Overall Study|all randomised patients|344
532173|NCT00827983|1297495|P1|STARTED|Overall Study|All randomised patients|339
532174|NCT00827944|1297507|P2|NOT COMPLETED|Overall Study||59
532175|NCT00827944|1297508|P1|NOT COMPLETED|Overall Study||63
532176|NCT00827944|1297507|P2|COMPLETED|Overall Study||240
532177|NCT00827944|1297508|P1|COMPLETED|Overall Study||241
532178|NCT00827944|1297507|P2|STARTED|Overall Study||299
532179|NCT00827944|1297508|P1|STARTED|Overall Study||304
532180|NCT00827931|1297528|P2|NOT COMPLETED|Overall Study||6
532181|NCT00827931|1297529|P1|NOT COMPLETED|Overall Study||6
532182|NCT00827931|1297528|P2|COMPLETED|Overall Study||39
532183|NCT00827931|1297529|P1|COMPLETED|Overall Study||43
532184|NCT00827931|1297528|P2|STARTED|Overall Study||45
532185|NCT00827931|1297529|P1|STARTED|Overall Study||49
532186|NCT00827918|1297550|P3|NOT COMPLETED|Overall Study||21
532187|NCT00827918|1297551|P2|NOT COMPLETED|Overall Study||9
532188|NCT00827918|1297552|P1|NOT COMPLETED|Overall Study||28
532189|NCT00827918|1297550|P3|COMPLETED|Overall Study||62
532190|NCT00827918|1297551|P2|COMPLETED|Overall Study||38
532191|NCT00827918|1297552|P1|COMPLETED|Overall Study||58
532192|NCT00827918|1297550|P3|STARTED|Overall Study||83
532193|NCT00827918|1297551|P2|STARTED|Overall Study||47
532194|NCT00827918|1297552|P1|STARTED|Overall Study||86
532195|NCT00827827|1297580|P2|NOT COMPLETED|Overall Study||0
532196|NCT00827827|1297581|P1|NOT COMPLETED|Overall Study||8
532197|NCT00827827|1297580|P2|COMPLETED|Overall Study||16
532198|NCT00827827|1297581|P1|COMPLETED|Overall Study||14
532199|NCT00827827|1297580|P2|STARTED|Overall Study||16
532200|NCT00827827|1297581|P1|STARTED|Overall Study||22
532201|NCT00827632|1297625|P2|NOT COMPLETED|Overall Study||23
532202|NCT00827632|1297626|P1|NOT COMPLETED|Overall Study||22
532203|NCT00827632|1297625|P2|COMPLETED|Overall Study||75
532204|NCT00827632|1297626|P1|COMPLETED|Overall Study||106
532205|NCT00827632|1297625|P2|STARTED|Overall Study||98
532206|NCT00827632|1297626|P1|STARTED|Overall Study||128
532207|NCT00827606|1297634|P2|NOT COMPLETED|Overall Study||38
532208|NCT00827606|1297635|P1|NOT COMPLETED|Overall Study||27
532209|NCT00827606|1297634|P2|COMPLETED|Overall Study||94
532210|NCT00827606|1297635|P1|COMPLETED|Overall Study||112
532211|NCT00827606|1297634|P2|STARTED|Overall Study||132
532212|NCT00827606|1297635|P1|STARTED|Overall Study||139
532213|NCT00827567|1297696|P1|NOT COMPLETED|Overall Study||4
532214|NCT00827567|1297696|P1|COMPLETED|Overall Study|2 screen failures, 4 withdrew from study to go on to other therapies|0
532215|NCT00827567|1297696|P1|STARTED|Overall Study||4
532216|NCT00827541|1297702|P2|NOT COMPLETED|Overall Study||11
532217|NCT00827541|1297703|P1|NOT COMPLETED|Overall Study||4
532218|NCT00827541|1297702|P2|COMPLETED|Overall Study||85
532219|NCT00827541|1297703|P1|COMPLETED|Overall Study||15
532220|NCT00827541|1297702|P2|STARTED|Overall Study||96
532221|NCT00827541|1297703|P1|STARTED|Overall Study||19
532222|NCT00827502|1297715|P1|NOT COMPLETED|Overall Study||21
532223|NCT00827502|1297715|P1|COMPLETED|Overall Study||400
532224|NCT00827502|1297715|P1|Received Treatment (Number Treated)|Overall Study||410
532225|NCT00827502|1297715|P1|STARTED|Overall Study||421
532226|NCT00827372|1297721|P1|NOT COMPLETED|Overall Study||8
532227|NCT00827372|1297721|P1|COMPLETED|Overall Study||2
532228|NCT00827372|1297721|P1|STARTED|Overall Study||10
532229|NCT00827255|1297729|P1|NOT COMPLETED|Overall Study||0
532230|NCT00827255|1297729|P1|COMPLETED|Overall Study||35
532231|NCT00827255|1297729|P1|STARTED|Overall Study||35
532232|NCT00827242|1297736|P2|NOT COMPLETED|Overall Study||12
532233|NCT00827242|1297737|P1|NOT COMPLETED|Overall Study||13
532234|NCT00827242|1297736|P2|COMPLETED|Overall Study||152
532235|NCT00827242|1297737|P1|COMPLETED|Overall Study||148
532236|NCT00827242|1297736|P2|STARTED|Overall Study||164
532237|NCT00827242|1297737|P1|STARTED|Overall Study||161
532238|NCT00827112|1297775|P2|NOT COMPLETED|Overall Study||12
532239|NCT00827112|1297776|P1|NOT COMPLETED|Overall Study||15
532240|NCT00827112|1297775|P2|COMPLETED|Overall Study||52
532241|NCT00827112|1297776|P1|COMPLETED|Overall Study||50
532242|NCT00827112|1297775|P2|Treated|Overall Study||61
532243|NCT00827112|1297776|P1|Treated|Overall Study||60
532244|NCT00827112|1297775|P2|STARTED|Overall Study||64
532245|NCT00827112|1297776|P1|STARTED|Overall Study||65
532246|NCT00827099|1297809|P1|NOT COMPLETED|Overall Study||0
532247|NCT00827099|1297809|P1|COMPLETED|Overall Study||5
532248|NCT00827099|1297809|P1|STARTED|Overall Study||5
532249|NCT00827073|1297820|P2|NOT COMPLETED|Overall Study||0
532250|NCT00827073|1297821|P1|NOT COMPLETED|Overall Study||0
532251|NCT00827073|1297820|P2|COMPLETED|Overall Study||20
532252|NCT00827073|1297821|P1|COMPLETED|Overall Study||20
532253|NCT00827073|1297820|P2|STARTED|Overall Study||20
532254|NCT00827073|1297821|P1|STARTED|Overall Study||20
532255|NCT00826943|1297829|P6|NOT COMPLETED|Overall Study||0
532256|NCT00826943|1297830|P5|NOT COMPLETED|Overall Study||1
532257|NCT00826943|1297831|P4|NOT COMPLETED|Overall Study||0
532258|NCT00826943|1297832|P3|NOT COMPLETED|Overall Study||0
532259|NCT00826943|1297833|P2|NOT COMPLETED|Overall Study||0
532260|NCT00826943|1297834|P1|NOT COMPLETED|Overall Study||0
532261|NCT00826943|1297829|P6|COMPLETED|Overall Study||2
532262|NCT00826943|1297830|P5|COMPLETED|Overall Study||6
532263|NCT00826943|1297831|P4|COMPLETED|Overall Study||5
532264|NCT00826943|1297832|P3|COMPLETED|Overall Study||4
532265|NCT00826943|1297833|P2|COMPLETED|Overall Study||6
532266|NCT00826943|1297834|P1|COMPLETED|Overall Study||6
532267|NCT00826943|1297829|P6|STARTED|Overall Study||2
532268|NCT00826943|1297830|P5|STARTED|Overall Study||7
532269|NCT00826943|1297831|P4|STARTED|Overall Study||5
532270|NCT00826943|1297832|P3|STARTED|Overall Study||4
532271|NCT00826943|1297833|P2|STARTED|Overall Study||6
532272|NCT00826943|1297834|P1|STARTED|Overall Study||6
532273|NCT00826800|1297848|P1|NOT COMPLETED|Overall Study||0
532274|NCT00826800|1297848|P1|COMPLETED|Overall Study||2
532275|NCT00826800|1297848|P1|STARTED|Overall Study||2
532276|NCT00826748|1297855|P3|NOT COMPLETED|Overall Study||4
532277|NCT00826748|1297856|P2|NOT COMPLETED|Overall Study||0
532278|NCT00826748|1297857|P1|NOT COMPLETED|Overall Study||0
532279|NCT00826748|1297855|P3|COMPLETED|Overall Study||8
532280|NCT00826748|1297856|P2|COMPLETED|Overall Study||4
532281|NCT00826748|1297857|P1|COMPLETED|Overall Study||6
532282|NCT00826748|1297855|P3|STARTED|Overall Study||12
532283|NCT00826748|1297856|P2|STARTED|Overall Study||4
532284|NCT00826748|1297857|P1|STARTED|Overall Study||6
532285|NCT00826618|1297865|P1|NOT COMPLETED|Overall Study||1
532286|NCT00826618|1297865|P1|COMPLETED|Overall Study||5
532287|NCT00826618|1297865|P1|STARTED|Overall Study||6
532288|NCT00826540|1297869|P1|NOT COMPLETED|Overall Study||4
532289|NCT00826540|1297869|P1|COMPLETED|Overall Study||79
532290|NCT00826540|1297869|P1|STARTED|Overall Study||83
532291|NCT00826449|1297875|P1|NOT COMPLETED|Overall Study||5
532292|NCT00826449|1297875|P1|COMPLETED|Overall Study||42
532293|NCT00826449|1297875|P1|Phase II|Overall Study||35
532294|NCT00826449|1297875|P1|Phase I|Overall Study||12
532295|NCT00826449|1297875|P1|STARTED|Overall Study||47
532296|NCT00826280|1297884|P3|NOT COMPLETED|Overall Study||46
532297|NCT00826280|1297885|P2|NOT COMPLETED|Overall Study||46
532298|NCT00826280|1297886|P1|NOT COMPLETED|Overall Study||48
532299|NCT00826280|1297884|P3|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|71
532300|NCT00826280|1297885|P2|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|70
532301|NCT00826280|1297886|P1|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|66
532302|NCT00826280|1297884|P3|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|72
532303|NCT00826280|1297885|P2|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|71
532304|NCT00826280|1297886|P1|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|66
532305|NCT00826280|1297884|P3|Safety Analysis Set|Overall Study|SAF was all randomized subjects who received at least one dose of regadenoson|116
532306|NCT00826280|1297885|P2|Safety Analysis Set|Overall Study|SAF was all randomized subjects who received at least one dose of regadenoson|116
532307|NCT00826280|1297886|P1|Safety Analysis Set|Overall Study|Safety Analysis Set (SAF) was all randomized subjects who received at least one dose of regadenoson|113
532308|NCT00826280|1297884|P3|STARTED|Overall Study||117
532309|NCT00826280|1297885|P2|STARTED|Overall Study||116
532310|NCT00826280|1297886|P1|STARTED|Overall Study||114
532311|NCT00826267|1297915|P3|NOT COMPLETED|Overall Study||0
532312|NCT00826267|1297916|P2|NOT COMPLETED|Overall Study||0
532313|NCT00826267|1297917|P1|NOT COMPLETED|Overall Study||1
532314|NCT00826267|1297915|P3|COMPLETED|Overall Study||11
532315|NCT00826267|1297916|P2|COMPLETED|Overall Study||8
532316|NCT00826267|1297917|P1|COMPLETED|Overall Study||9
532317|NCT00826267|1297915|P3|STARTED|Overall Study||11
532318|NCT00826267|1297916|P2|STARTED|Overall Study||8
532319|NCT00826267|1297917|P1|STARTED|Overall Study||10
532320|NCT00826228|1297935|P1|NOT COMPLETED|Overall Study||1
532321|NCT00826228|1297935|P1|COMPLETED|Overall Study||11
532322|NCT00826228|1297935|P1|STARTED|Overall Study||12
532323|NCT00826202|1297942|P2|NOT COMPLETED|Overall Study||13
532324|NCT00826202|1297943|P1|NOT COMPLETED|Overall Study||10
532325|NCT00826202|1297942|P2|COMPLETED|Overall Study||11
532326|NCT00826202|1297943|P1|COMPLETED|Overall Study||10
532327|NCT00826202|1297942|P2|Completed Visit 4 (1st Efficacy Visit)|Overall Study||20
532328|NCT00826202|1297943|P1|Completed Visit 4 (1st Efficacy Visit)|Overall Study||15
532329|NCT00826202|1297942|P2|STARTED|Overall Study||24
532330|NCT00826202|1297943|P1|STARTED|Overall Study||20
532331|NCT00826176|1297957|P2|NOT COMPLETED|Overall Study||0
532332|NCT00826176|1297958|P1|NOT COMPLETED|Overall Study||13
532333|NCT00826176|1297957|P2|COMPLETED|Overall Study|treated and completed|36
532334|NCT00826176|1297958|P1|COMPLETED|Overall Study|treated and completed|115
532335|NCT00826176|1297957|P2|STARTED|Overall Study|enrolled|36
532336|NCT00826176|1297958|P1|STARTED|Overall Study|enrolled|128
532337|NCT00826111|1297970|P2|NOT COMPLETED|Overall Study||2
532338|NCT00826111|1297971|P1|NOT COMPLETED|Overall Study||7
532339|NCT00826111|1297970|P2|COMPLETED|Overall Study||3
532340|NCT00826111|1297971|P1|COMPLETED|Overall Study||7
532341|NCT00826111|1297970|P2|STARTED|Overall Study||5
532342|NCT00826111|1297971|P1|STARTED|Overall Study||14
532343|NCT00826007|1297995|P2|NOT COMPLETED|Overall Study||0
532344|NCT00826007|1297996|P1|NOT COMPLETED|Overall Study||0
532345|NCT00826007|1297995|P2|COMPLETED|Overall Study||279
532346|NCT00826007|1297996|P1|COMPLETED|Overall Study|Retrospective review|308
532347|NCT00826007|1297995|P2|STARTED|Overall Study||279
532348|NCT00826007|1297996|P1|STARTED|Overall Study|Retrospective review|308
532349|NCT00825994|1298001|P1|NOT COMPLETED|Overall Study||5
532350|NCT00825994|1298001|P1|COMPLETED|Overall Study||19
532351|NCT00825994|1298001|P1|STARTED|Overall Study||24
532352|NCT00825916|1298009|P3|NOT COMPLETED|Overall Study||1
532353|NCT00825916|1298010|P2|NOT COMPLETED|Overall Study||2
532354|NCT00825916|1298011|P1|NOT COMPLETED|Overall Study||4
532355|NCT00825916|1298009|P3|COMPLETED|Overall Study||19
532356|NCT00825916|1298010|P2|COMPLETED|Overall Study||18
532357|NCT00825916|1298011|P1|COMPLETED|Overall Study||15
532358|NCT00825916|1298009|P3|STARTED|Overall Study||20
532359|NCT00825916|1298010|P2|STARTED|Overall Study||20
532360|NCT00825916|1298011|P1|STARTED|Overall Study||19
532361|NCT00825825|1298052|P6|NOT COMPLETED|Third Medication Period (14 Days)||2
532362|NCT00825825|1298053|P5|NOT COMPLETED|Third Medication Period (14 Days)||0
532363|NCT00825825|1298054|P4|NOT COMPLETED|Third Medication Period (14 Days)||0
532364|NCT00825825|1298055|P3|NOT COMPLETED|Third Medication Period (14 Days)||0
532365|NCT00825825|1298056|P2|NOT COMPLETED|Third Medication Period (14 Days)||2
532366|NCT00825825|1298057|P1|NOT COMPLETED|Third Medication Period (14 Days)||0
532367|NCT00825825|1298052|P6|COMPLETED|Third Medication Period (14 Days)||1
532368|NCT00825825|1298053|P5|COMPLETED|Third Medication Period (14 Days)||3
532369|NCT00825825|1298054|P4|COMPLETED|Third Medication Period (14 Days)||3
532370|NCT00825825|1298055|P3|COMPLETED|Third Medication Period (14 Days)||2
532371|NCT00825825|1298056|P2|COMPLETED|Third Medication Period (14 Days)||2
532372|NCT00825825|1298057|P1|COMPLETED|Third Medication Period (14 Days)||1
532373|NCT00825825|1298052|P6|STARTED|Third Medication Period (14 Days)||3
532374|NCT00825825|1298053|P5|STARTED|Third Medication Period (14 Days)||3
532375|NCT00825825|1298054|P4|STARTED|Third Medication Period (14 Days)||3
532376|NCT00825825|1298055|P3|STARTED|Third Medication Period (14 Days)||2
532377|NCT00825825|1298056|P2|STARTED|Third Medication Period (14 Days)||4
532378|NCT00825825|1298057|P1|STARTED|Third Medication Period (14 Days)||1
532379|NCT00825825|1298052|P6|NOT COMPLETED|Second Washout Period (14 Days)||0
532380|NCT00825825|1298053|P5|NOT COMPLETED|Second Washout Period (14 Days)||0
532381|NCT00825825|1298054|P4|NOT COMPLETED|Second Washout Period (14 Days)||0
532382|NCT00825825|1298055|P3|NOT COMPLETED|Second Washout Period (14 Days)||0
532383|NCT00825825|1298056|P2|NOT COMPLETED|Second Washout Period (14 Days)||0
532384|NCT00825825|1298057|P1|NOT COMPLETED|Second Washout Period (14 Days)||0
532385|NCT00825825|1298052|P6|COMPLETED|Second Washout Period (14 Days)||3
532386|NCT00825825|1298053|P5|COMPLETED|Second Washout Period (14 Days)||3
532387|NCT00825825|1298054|P4|COMPLETED|Second Washout Period (14 Days)||3
532388|NCT00825825|1298055|P3|COMPLETED|Second Washout Period (14 Days)||2
532389|NCT00825825|1298056|P2|COMPLETED|Second Washout Period (14 Days)||4
532390|NCT00825825|1298057|P1|COMPLETED|Second Washout Period (14 Days)||1
532391|NCT00825825|1298052|P6|STARTED|Second Washout Period (14 Days)||3
532392|NCT00825825|1298053|P5|STARTED|Second Washout Period (14 Days)||3
532393|NCT00825825|1298054|P4|STARTED|Second Washout Period (14 Days)||3
532394|NCT00825825|1298055|P3|STARTED|Second Washout Period (14 Days)||2
532395|NCT00825825|1298056|P2|STARTED|Second Washout Period (14 Days)||4
532396|NCT00825825|1298057|P1|STARTED|Second Washout Period (14 Days)||1
532397|NCT00825825|1298052|P6|NOT COMPLETED|Second Medication Period (14 Days)||0
532398|NCT00825825|1298053|P5|NOT COMPLETED|Second Medication Period (14 Days)||1
532399|NCT00825825|1298054|P4|NOT COMPLETED|Second Medication Period (14 Days)||2
532400|NCT00825825|1298055|P3|NOT COMPLETED|Second Medication Period (14 Days)||0
532401|NCT00825825|1298056|P2|NOT COMPLETED|Second Medication Period (14 Days)||0
532402|NCT00825825|1298057|P1|NOT COMPLETED|Second Medication Period (14 Days)||2
532403|NCT00825825|1298052|P6|COMPLETED|Second Medication Period (14 Days)||3
532404|NCT00825825|1298053|P5|COMPLETED|Second Medication Period (14 Days)||3
532405|NCT00825825|1298054|P4|COMPLETED|Second Medication Period (14 Days)||3
532406|NCT00825825|1298055|P3|COMPLETED|Second Medication Period (14 Days)||2
532407|NCT00825825|1298056|P2|COMPLETED|Second Medication Period (14 Days)||4
532408|NCT00825825|1298057|P1|COMPLETED|Second Medication Period (14 Days)||1
532409|NCT00825825|1298052|P6|STARTED|Second Medication Period (14 Days)||3
532410|NCT00825825|1298053|P5|STARTED|Second Medication Period (14 Days)||4
532411|NCT00825825|1298054|P4|STARTED|Second Medication Period (14 Days)||5
532412|NCT00825825|1298055|P3|STARTED|Second Medication Period (14 Days)||2
532413|NCT00825825|1298056|P2|STARTED|Second Medication Period (14 Days)||4
532414|NCT00825825|1298057|P1|STARTED|Second Medication Period (14 Days)||3
532415|NCT00825825|1298052|P6|NOT COMPLETED|First Washout Period (14 Days)||0
532416|NCT00825825|1298053|P5|NOT COMPLETED|First Washout Period (14 Days)||0
532417|NCT00825825|1298054|P4|NOT COMPLETED|First Washout Period (14 Days)||0
532418|NCT00825825|1298055|P3|NOT COMPLETED|First Washout Period (14 Days)||0
532419|NCT00825825|1298056|P2|NOT COMPLETED|First Washout Period (14 Days)||0
532420|NCT00825825|1298057|P1|NOT COMPLETED|First Washout Period (14 Days)||0
532421|NCT00825825|1298052|P6|COMPLETED|First Washout Period (14 Days)||3
532422|NCT00825825|1298053|P5|COMPLETED|First Washout Period (14 Days)||4
532423|NCT00825825|1298054|P4|COMPLETED|First Washout Period (14 Days)||5
532424|NCT00825825|1298055|P3|COMPLETED|First Washout Period (14 Days)||2
532425|NCT00825825|1298056|P2|COMPLETED|First Washout Period (14 Days)||4
532426|NCT00825825|1298057|P1|COMPLETED|First Washout Period (14 Days)||3
532427|NCT00825825|1298052|P6|STARTED|First Washout Period (14 Days)||3
532428|NCT00825825|1298053|P5|STARTED|First Washout Period (14 Days)||4
532429|NCT00825825|1298054|P4|STARTED|First Washout Period (14 Days)||5
532430|NCT00825825|1298055|P3|STARTED|First Washout Period (14 Days)||2
532431|NCT00825825|1298056|P2|STARTED|First Washout Period (14 Days)||4
532432|NCT00825825|1298057|P1|STARTED|First Washout Period (14 Days)||3
532433|NCT00825825|1298052|P6|NOT COMPLETED|First Medication Period (14 Days)||2
532434|NCT00825825|1298053|P5|NOT COMPLETED|First Medication Period (14 Days)||0
532435|NCT00825825|1298054|P4|NOT COMPLETED|First Medication Period (14 Days)||0
532436|NCT00825825|1298055|P3|NOT COMPLETED|First Medication Period (14 Days)||1
532437|NCT00825825|1298056|P2|NOT COMPLETED|First Medication Period (14 Days)||0
532438|NCT00825825|1298057|P1|NOT COMPLETED|First Medication Period (14 Days)||3
532439|NCT00825825|1298052|P6|COMPLETED|First Medication Period (14 Days)||3
532440|NCT00825825|1298053|P5|COMPLETED|First Medication Period (14 Days)||4
532441|NCT00825825|1298054|P4|COMPLETED|First Medication Period (14 Days)||5
532442|NCT00825825|1298055|P3|COMPLETED|First Medication Period (14 Days)||2
532443|NCT00825825|1298056|P2|COMPLETED|First Medication Period (14 Days)||4
532444|NCT00825825|1298057|P1|COMPLETED|First Medication Period (14 Days)||3
532445|NCT00825825|1298052|P6|STARTED|First Medication Period (14 Days)||5
532446|NCT00825825|1298053|P5|STARTED|First Medication Period (14 Days)||4
532447|NCT00825825|1298054|P4|STARTED|First Medication Period (14 Days)||5
532448|NCT00825825|1298055|P3|STARTED|First Medication Period (14 Days)||3
532449|NCT00825825|1298056|P2|STARTED|First Medication Period (14 Days)||4
532450|NCT00825825|1298057|P1|STARTED|First Medication Period (14 Days)||6
532451|NCT00825812|1298073|P4|NOT COMPLETED|Overall Study||10
532452|NCT00825812|1298074|P3|NOT COMPLETED|Overall Study||6
532453|NCT00825812|1298075|P2|NOT COMPLETED|Overall Study||1
532454|NCT00825812|1298076|P1|NOT COMPLETED|Overall Study||0
532455|NCT00825812|1298073|P4|COMPLETED|Overall Study||111
532456|NCT00825812|1298074|P3|COMPLETED|Overall Study||120
532457|NCT00825812|1298075|P2|COMPLETED|Overall Study||31
532458|NCT00825812|1298076|P1|COMPLETED|Overall Study||29
532459|NCT00825812|1298073|P4|TREATED|Overall Study||111
532460|NCT00825812|1298074|P3|TREATED|Overall Study||120
532461|NCT00825812|1298075|P2|TREATED|Overall Study||31
532462|NCT00825812|1298076|P1|TREATED|Overall Study||29
532463|NCT00825812|1298073|P4|STARTED|Overall Study||121
532464|NCT00825812|1298074|P3|STARTED|Overall Study||126
532465|NCT00825812|1298075|P2|STARTED|Overall Study||32
532466|NCT00825812|1298076|P1|STARTED|Overall Study||29
532467|NCT00825786|1298092|P2|NOT COMPLETED|Overall Study||0
532468|NCT00825786|1298093|P1|NOT COMPLETED|Overall Study||0
532469|NCT00825786|1298092|P2|COMPLETED|Overall Study||51
532470|NCT00825786|1298093|P1|COMPLETED|Overall Study||52
532471|NCT00825786|1298092|P2|STARTED|Overall Study||51
532472|NCT00825786|1298093|P1|STARTED|Overall Study||52
532473|NCT00825734|1298111|P3|NOT COMPLETED|Phase II||76
532474|NCT00825734|1298112|P2|NOT COMPLETED|Phase II||0
532475|NCT00825734|1298113|P1|NOT COMPLETED|Phase II||0
532476|NCT00825734|1298111|P3|COMPLETED|Phase II||0
532477|NCT00825734|1298112|P2|COMPLETED|Phase II||0
532478|NCT00825734|1298113|P1|COMPLETED|Phase II||0
532479|NCT00825734|1298111|P3|STARTED|Phase II|Includes patients treated at MTD during Phase I and 73 additional patients enrolled for Phase II|76
532480|NCT00825734|1298112|P2|STARTED|Phase II||0
532481|NCT00825734|1298113|P1|STARTED|Phase II||0
532482|NCT00825734|1298111|P3|NOT COMPLETED|Phase I||0
532483|NCT00825734|1298112|P2|NOT COMPLETED|Phase I||3
532484|NCT00825734|1298113|P1|NOT COMPLETED|Phase I||4
532485|NCT00825734|1298111|P3|COMPLETED|Phase I||3
532486|NCT00825734|1298112|P2|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
532487|NCT00825734|1298113|P1|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
532488|NCT00825734|1298111|P3|STARTED|Phase I||3
532489|NCT00825734|1298112|P2|STARTED|Phase I||3
532490|NCT00825734|1298113|P1|STARTED|Phase I||4
532491|NCT00825682|1298123|P2|NOT COMPLETED|Overall Study||5
532492|NCT00825682|1298124|P1|NOT COMPLETED|Overall Study||13
532493|NCT00825682|1298123|P2|COMPLETED|Overall Study||20
532494|NCT00825682|1298124|P1|COMPLETED|Overall Study||34
532495|NCT00825682|1298123|P2|STARTED|Overall Study||25
532496|NCT00825682|1298124|P1|STARTED|Overall Study||47
532497|NCT00825630|1298138|P4|NOT COMPLETED|Overall Study||0
532498|NCT00825630|1298139|P3|NOT COMPLETED|Overall Study||0
532499|NCT00825630|1298140|P2|NOT COMPLETED|Overall Study||0
532500|NCT00825630|1298141|P1|NOT COMPLETED|Overall Study||0
532501|NCT00825630|1298138|P4|COMPLETED|Overall Study||13
532502|NCT00825630|1298139|P3|COMPLETED|Overall Study||19
532503|NCT00825630|1298140|P2|COMPLETED|Overall Study||62
532504|NCT00825630|1298141|P1|COMPLETED|Overall Study||29
532505|NCT00825630|1298138|P4|STARTED|Overall Study||13
532506|NCT00825630|1298139|P3|STARTED|Overall Study||19
532507|NCT00825630|1298140|P2|STARTED|Overall Study||62
532508|NCT00825630|1298141|P1|STARTED|Overall Study||29
532509|NCT00825565|1298151|P1|NOT COMPLETED|Overall Study||0
532510|NCT00825565|1298151|P1|COMPLETED|Overall Study||8
532511|NCT00825565|1298151|P1|STARTED|Overall Study||8
532512|NCT00825500|1298164|P3|NOT COMPLETED|Overall Study||0
532513|NCT00825500|1298165|P2|NOT COMPLETED|Overall Study||0
532514|NCT00825500|1298166|P1|NOT COMPLETED|Overall Study||0
532515|NCT00825500|1298164|P3|COMPLETED|Overall Study||120
532516|NCT00825500|1298165|P2|COMPLETED|Overall Study||121
532517|NCT00825500|1298166|P1|COMPLETED|Overall Study||125
532518|NCT00825500|1298164|P3|STARTED|Overall Study||120
532519|NCT00825500|1298165|P2|STARTED|Overall Study||121
532520|NCT00825500|1298166|P1|STARTED|Overall Study||125
532521|NCT00825370|1298179|P2|NOT COMPLETED|Overall Study||0
532522|NCT00825370|1298180|P1|NOT COMPLETED|Overall Study||0
532523|NCT00825370|1298179|P2|COMPLETED|Overall Study||175
532524|NCT00825370|1298180|P1|COMPLETED|Overall Study||175
532525|NCT00825370|1298179|P2|STARTED|Overall Study||175
532526|NCT00825370|1298180|P1|STARTED|Overall Study||175
532527|NCT00825344|1298194|P2|NOT COMPLETED|Overall Study||1
532528|NCT00825344|1298195|P1|NOT COMPLETED|Overall Study||1
532529|NCT00825344|1298194|P2|COMPLETED|Overall Study||42
532530|NCT00825344|1298195|P1|COMPLETED|Overall Study||33
532531|NCT00825344|1298194|P2|STARTED|Overall Study||43
532532|NCT00825344|1298195|P1|STARTED|Overall Study||34
532533|NCT00825318|1298205|P1|NOT COMPLETED|Overall Study||1
532534|NCT00825318|1298205|P1|COMPLETED|Overall Study||12
532535|NCT00825318|1298205|P1|STARTED|Overall Study||13
532536|NCT00825305|1298215|P2|NOT COMPLETED|Overall Study||23
532537|NCT00825305|1298216|P1|NOT COMPLETED|Overall Study||17
532538|NCT00825305|1298215|P2|COMPLETED|Overall Study||252
532539|NCT00825305|1298216|P1|COMPLETED|Overall Study||533
532540|NCT00825305|1298215|P2|STARTED|Overall Study||275
532541|NCT00825305|1298216|P1|STARTED|Overall Study||550
532542|NCT00825266|1298230|P2|NOT COMPLETED|Overall Study||0
532543|NCT00825266|1298231|P1|NOT COMPLETED|Overall Study||0
532544|NCT00825266|1298230|P2|COMPLETED|Overall Study||1
532545|NCT00825266|1298231|P1|COMPLETED|Overall Study||1
532546|NCT00825266|1298230|P2|STARTED|Overall Study||1
532547|NCT00825266|1298231|P1|STARTED|Overall Study||1
532548|NCT00825227|1298243|P2|NOT COMPLETED|Overall Study||0
532549|NCT00825227|1298244|P1|NOT COMPLETED|Overall Study||0
532550|NCT00825227|1298243|P2|COMPLETED|Overall Study||4
532551|NCT00825227|1298244|P1|COMPLETED|Overall Study||6
532552|NCT00825227|1298243|P2|STARTED|Overall Study||4
532553|NCT00825227|1298244|P1|STARTED|Overall Study||6
532554|NCT00825175|1298256|P2|NOT COMPLETED|Overall Study||5
532555|NCT00825175|1298257|P1|NOT COMPLETED|Overall Study||0
532556|NCT00825175|1298256|P2|COMPLETED|Overall Study||7
532557|NCT00825175|1298257|P1|COMPLETED|Overall Study||10
532558|NCT00825175|1298256|P2|STARTED|Overall Study||12
532559|NCT00825175|1298257|P1|STARTED|Overall Study||10
532560|NCT00825162|1298266|P3|NOT COMPLETED|Overall Study||6
532561|NCT00825162|1298267|P2|NOT COMPLETED|Overall Study||21
532562|NCT00825162|1298268|P1|NOT COMPLETED|Overall Study||28
532563|NCT00825162|1298266|P3|COMPLETED|Overall Study||396
532564|NCT00825162|1298267|P2|COMPLETED|Overall Study||859
532565|NCT00825162|1298268|P1|COMPLETED|Overall Study||682
532566|NCT00825162|1298266|P3|STARTED|Overall Study||402
532567|NCT00825162|1298267|P2|STARTED|Overall Study||880
532568|NCT00825162|1298268|P1|STARTED|Overall Study||710
532569|NCT00824993|1298294|P2|NOT COMPLETED|Overall Study||17
532570|NCT00824993|1298295|P1|NOT COMPLETED|Overall Study||14
532571|NCT00824993|1298294|P2|COMPLETED|Overall Study||22
532572|NCT00824993|1298295|P1|COMPLETED|Overall Study||25
532573|NCT00824993|1298294|P2|6 Month Follow up|Overall Study||27
532574|NCT00824993|1298295|P1|6 Month Follow up|Overall Study||33
532575|NCT00824993|1298294|P2|STARTED|Overall Study||39
532576|NCT00824993|1298295|P1|STARTED|Overall Study||39
532577|NCT00824850|1298303|P2|NOT COMPLETED|Overall Study||1
532578|NCT00824850|1298304|P1|NOT COMPLETED|Overall Study||0
532579|NCT00824850|1298303|P2|COMPLETED|Overall Study||36
532580|NCT00824850|1298304|P1|COMPLETED|Overall Study||38
532581|NCT00824850|1298303|P2|Received Vaccination 13vPnC|Overall Study||36
532582|NCT00824850|1298304|P1|Received Vaccination 13vPnC|Overall Study||38
532583|NCT00824850|1298303|P2|STARTED|Overall Study||37
532584|NCT00824850|1298304|P1|STARTED|Overall Study||38
532585|NCT00824824|1298350|P2|NOT COMPLETED|Overall Study||0
532586|NCT00824824|1298351|P1|NOT COMPLETED|Overall Study||0
532587|NCT00824824|1298350|P2|COMPLETED|Overall Study||3
532588|NCT00824824|1298351|P1|COMPLETED|Overall Study||4
532589|NCT00824824|1298350|P2|STARTED|Overall Study||3
532590|NCT00824824|1298351|P1|STARTED|Overall Study||4
532591|NCT00824772|1298357|P1|NOT COMPLETED|Overall Study||8
532592|NCT00824772|1298357|P1|COMPLETED|Overall Study||196
532593|NCT00824772|1298357|P1|STARTED|Overall Study||204
532594|NCT00824746|1298362|P1|NOT COMPLETED|Overall Study||0
532595|NCT00824746|1298362|P1|COMPLETED|Overall Study||23
532596|NCT00824746|1298362|P1|STARTED|Overall Study||23
532597|NCT00824733|1298368|P1|NOT COMPLETED|Overall Study||0
532598|NCT00824733|1298368|P1|COMPLETED|Overall Study||6
532599|NCT00824733|1298368|P1|STARTED|Overall Study||6
532600|NCT00824720|1298377|P3|NOT COMPLETED|Overall Study||1
532601|NCT00824720|1298378|P2|NOT COMPLETED|Overall Study||1
532602|NCT00824720|1298379|P1|NOT COMPLETED|Overall Study||3
532603|NCT00824720|1298377|P3|COMPLETED|Overall Study||19
532604|NCT00824720|1298378|P2|COMPLETED|Overall Study||15
532605|NCT00824720|1298379|P1|COMPLETED|Overall Study||16
532606|NCT00824720|1298377|P3|STARTED|Overall Study||20
532607|NCT00824720|1298378|P2|STARTED|Overall Study|1 subject in the low dose group did not receive device - unable to insert.|16
532608|NCT00824720|1298379|P1|STARTED|Overall Study|3 subjects in the high dose group did not receive device - unable to insert.|19
532609|NCT00824655|1298395|P2|NOT COMPLETED|Toddler Dose (12 Months of Age)||0
532610|NCT00824655|1298396|P1|NOT COMPLETED|Toddler Dose (12 Months of Age)||2
532611|NCT00824655|1298395|P2|COMPLETED|Toddler Dose (12 Months of Age)||116
532612|NCT00824655|1298396|P1|COMPLETED|Toddler Dose (12 Months of Age)||116
532613|NCT00824655|1298395|P2|STARTED|Toddler Dose (12 Months of Age)||116
532614|NCT00824655|1298396|P1|STARTED|Toddler Dose (12 Months of Age)||118
532615|NCT00824655|1298395|P2|NOT COMPLETED|After Infant Dose (6 Months of Age)||0
532616|NCT00824655|1298396|P1|NOT COMPLETED|After Infant Dose (6 Months of Age)||0
532617|NCT00824655|1298395|P2|COMPLETED|After Infant Dose (6 Months of Age)||0
532618|NCT00824655|1298396|P1|COMPLETED|After Infant Dose (6 Months of Age)||118
532619|NCT00824655|1298395|P2|STARTED|After Infant Dose (6 Months of Age)||0
532620|NCT00824655|1298396|P1|STARTED|After Infant Dose (6 Months of Age)||118
532621|NCT00824655|1298395|P2|NOT COMPLETED|Infant Series (5 Months of Age)||0
532622|NCT00824655|1298396|P1|NOT COMPLETED|Infant Series (5 Months of Age)||0
532623|NCT00824655|1298395|P2|COMPLETED|Infant Series (5 Months of Age)||0
532624|NCT00824655|1298396|P1|COMPLETED|Infant Series (5 Months of Age)||118
532625|NCT00824655|1298395|P2|STARTED|Infant Series (5 Months of Age)||0
532626|NCT00824655|1298396|P1|STARTED|Infant Series (5 Months of Age)||118
532627|NCT00824616|1298416|P2|NOT COMPLETED|Overall Study||7
532628|NCT00824616|1298417|P1|NOT COMPLETED|Overall Study||6
532629|NCT00824616|1298416|P2|COMPLETED|Overall Study||27
532630|NCT00824616|1298417|P1|COMPLETED|Overall Study||28
532631|NCT00824616|1298416|P2|STARTED|Overall Study||34
532632|NCT00824616|1298417|P1|STARTED|Overall Study||34
532633|NCT00824564|1298427|P2|NOT COMPLETED|Overall Study||10
532634|NCT00824564|1298428|P1|NOT COMPLETED|Overall Study||8
532635|NCT00824564|1298427|P2|COMPLETED|Overall Study||30
532636|NCT00824564|1298428|P1|COMPLETED|Overall Study||34
532637|NCT00824564|1298427|P2|Treated|Overall Study||40
532638|NCT00824564|1298428|P1|Treated|Overall Study||41
532639|NCT00824564|1298427|P2|STARTED|Overall Study||40
532640|NCT00824564|1298428|P1|STARTED|Overall Study||42
532641|NCT00824538|1298446|P1|NOT COMPLETED|Overall Study||2
532642|NCT00824538|1298446|P1|COMPLETED|Overall Study||11
532643|NCT00824538|1298446|P1|STARTED|Overall Study|13 patients entered the study|13
532644|NCT00824512|1298456|P2|NOT COMPLETED|Overall Study||0
532645|NCT00824512|1298457|P1|NOT COMPLETED|Overall Study||0
532646|NCT00824512|1298456|P2|COMPLETED|Overall Study||11
532647|NCT00824512|1298457|P1|COMPLETED|Overall Study||11
532648|NCT00824512|1298456|P2|STARTED|Overall Study||11
532649|NCT00824512|1298457|P1|STARTED|Overall Study||11
532650|NCT00824473|1298507|P2|NOT COMPLETED|Overall Study||13
532651|NCT00824473|1298508|P1|NOT COMPLETED|Overall Study||15
532652|NCT00824473|1298507|P2|COMPLETED|Overall Study||238
532653|NCT00824473|1298508|P1|COMPLETED|Overall Study||240
532654|NCT00824473|1298507|P2|STARTED|Overall Study||251
532655|NCT00824473|1298508|P1|STARTED|Overall Study|1 subject was randomized in error|255
532656|NCT00824460|1298530|P6|NOT COMPLETED|Overall Study||8
532657|NCT00824460|1298531|P5|NOT COMPLETED|Overall Study||9
532658|NCT00824460|1298532|P4|NOT COMPLETED|Overall Study||12
532659|NCT00824460|1298533|P3|NOT COMPLETED|Overall Study||5
532660|NCT00824460|1298534|P2|NOT COMPLETED|Overall Study||9
532661|NCT00824460|1298535|P1|NOT COMPLETED|Overall Study||8
532662|NCT00824460|1298530|P6|COMPLETED|Overall Study||18
532663|NCT00824460|1298531|P5|COMPLETED|Overall Study||15
532664|NCT00824460|1298532|P4|COMPLETED|Overall Study||15
532665|NCT00824460|1298533|P3|COMPLETED|Overall Study||20
532666|NCT00824460|1298534|P2|COMPLETED|Overall Study||17
532667|NCT00824460|1298535|P1|COMPLETED|Overall Study||18
532668|NCT00824460|1298530|P6|STARTED|Overall Study||26
532669|NCT00824460|1298531|P5|STARTED|Overall Study||24
532670|NCT00824460|1298532|P4|STARTED|Overall Study||27
532671|NCT00824460|1298533|P3|STARTED|Overall Study||25
532672|NCT00824460|1298534|P2|STARTED|Overall Study||26
532673|NCT00824460|1298535|P1|STARTED|Overall Study||26
532674|NCT00824434|1298567|P1|NOT COMPLETED|Overall Study||0
532675|NCT00824434|1298567|P1|COMPLETED|Overall Study||100
532676|NCT00824434|1298567|P1|STARTED|Overall Study||100
532677|NCT00824421|1298589|P3|NOT COMPLETED|Overall Study||14
532678|NCT00824421|1298590|P2|NOT COMPLETED|Overall Study||22
532679|NCT00824421|1298591|P1|NOT COMPLETED|Overall Study||17
532680|NCT00824421|1298589|P3|COMPLETED|Overall Study||49
532681|NCT00824421|1298590|P2|COMPLETED|Overall Study||44
532682|NCT00824421|1298591|P1|COMPLETED|Overall Study||49
532683|NCT00824421|1298589|P3|Treated|Overall Study||63
532684|NCT00824421|1298590|P2|Treated|Overall Study||65
532685|NCT00824421|1298591|P1|Treated|Overall Study||65
532686|NCT00824421|1298589|P3|STARTED|Overall Study||63
532687|NCT00824421|1298590|P2|STARTED|Overall Study||66
532688|NCT00824421|1298591|P1|STARTED|Overall Study||66
532689|NCT00824408|1298642|P5|NOT COMPLETED|Randomized Phase||46
532690|NCT00824408|1298643|P4|NOT COMPLETED|Randomized Phase||46
532691|NCT00824408|1298644|P3|NOT COMPLETED|Randomized Phase||36
532692|NCT00824408|1298645|P2|NOT COMPLETED|Randomized Phase||0
532693|NCT00824408|1298646|P1|NOT COMPLETED|Randomized Phase||0
532694|NCT00824408|1298642|P5|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
532695|NCT00824408|1298643|P4|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
532696|NCT00824408|1298644|P3|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
532697|NCT00824408|1298645|P2|COMPLETED|Randomized Phase||0
532698|NCT00824408|1298646|P1|COMPLETED|Randomized Phase||0
532699|NCT00824408|1298642|P5|STARTED|Randomized Phase||47
532700|NCT00824408|1298643|P4|STARTED|Randomized Phase||47
532701|NCT00824408|1298644|P3|STARTED|Randomized Phase||37
532702|NCT00824408|1298645|P2|STARTED|Randomized Phase||0
532703|NCT00824408|1298646|P1|STARTED|Randomized Phase||0
532704|NCT00824408|1298642|P5|NOT COMPLETED|Run-in Phase||0
532705|NCT00824408|1298643|P4|NOT COMPLETED|Run-in Phase||0
532706|NCT00824408|1298644|P3|NOT COMPLETED|Run-in Phase||0
532707|NCT00824408|1298645|P2|NOT COMPLETED|Run-in Phase||6
532708|NCT00824408|1298646|P1|NOT COMPLETED|Run-in Phase||6
532709|NCT00824408|1298642|P5|COMPLETED|Run-in Phase||0
532710|NCT00824408|1298643|P4|COMPLETED|Run-in Phase||0
532711|NCT00824408|1298644|P3|COMPLETED|Run-in Phase||0
532712|NCT00824408|1298645|P2|COMPLETED|Run-in Phase||0
532713|NCT00824408|1298646|P1|COMPLETED|Run-in Phase||0
532714|NCT00824408|1298642|P5|STARTED|Run-in Phase||0
532715|NCT00824408|1298643|P4|STARTED|Run-in Phase||0
532716|NCT00824408|1298644|P3|STARTED|Run-in Phase||0
532717|NCT00824408|1298645|P2|STARTED|Run-in Phase||6
532718|NCT00824408|1298646|P1|STARTED|Run-in Phase||6
532719|NCT00824382|1298698|P4|NOT COMPLETED|Overall Study||5
532720|NCT00824382|1298699|P3|NOT COMPLETED|Overall Study||3
532721|NCT00824382|1298700|P2|NOT COMPLETED|Overall Study||2
532722|NCT00824382|1298701|P1|NOT COMPLETED|Overall Study||5
532723|NCT00824382|1298698|P4|COMPLETED|Overall Study||81
532724|NCT00824382|1298699|P3|COMPLETED|Overall Study||76
532725|NCT00824382|1298700|P2|COMPLETED|Overall Study||82
532726|NCT00824382|1298701|P1|COMPLETED|Overall Study||74
532727|NCT00824382|1298698|P4|STARTED|Overall Study||86
532728|NCT00824382|1298699|P3|STARTED|Overall Study||79
532729|NCT00824382|1298700|P2|STARTED|Overall Study||84
532730|NCT00824382|1298701|P1|STARTED|Overall Study||79
532731|NCT00824369|1298777|P6|NOT COMPLETED|Overall Study||1
532732|NCT00824369|1298778|P5|NOT COMPLETED|Overall Study||1
532733|NCT00824369|1298779|P4|NOT COMPLETED|Overall Study||2
532734|NCT00824369|1298780|P3|NOT COMPLETED|Overall Study||1
532735|NCT00824369|1298781|P2|NOT COMPLETED|Overall Study||0
532736|NCT00824369|1298782|P1|NOT COMPLETED|Overall Study||1
532737|NCT00824369|1298777|P6|COMPLETED|Overall Study||16
532738|NCT00824369|1298778|P5|COMPLETED|Overall Study||11
532739|NCT00824369|1298779|P4|COMPLETED|Overall Study||9
532740|NCT00824369|1298780|P3|COMPLETED|Overall Study||2
532741|NCT00824369|1298781|P2|COMPLETED|Overall Study||4
532742|NCT00824369|1298782|P1|COMPLETED|Overall Study||4
532743|NCT00824369|1298777|P6|STARTED|Overall Study||17
532744|NCT00824369|1298778|P5|STARTED|Overall Study||12
532745|NCT00824369|1298779|P4|STARTED|Overall Study||11
532746|NCT00824369|1298780|P3|STARTED|Overall Study||3
532747|NCT00824369|1298781|P2|STARTED|Overall Study||4
532748|NCT00824369|1298782|P1|STARTED|Overall Study||5
532749|NCT00824291|1298822|P2|NOT COMPLETED|Overall Study||35
532750|NCT00824291|1298823|P1|NOT COMPLETED|Overall Study||54
532751|NCT00824291|1298822|P2|COMPLETED|Overall Study||107
532752|NCT00824291|1298823|P1|COMPLETED|Overall Study||231
532753|NCT00824291|1298822|P2|STARTED|Overall Study||142
532754|NCT00824291|1298823|P1|STARTED|Overall Study||285
532755|NCT00824265|1298845|P2|NOT COMPLETED|Overall Study||80
532756|NCT00824265|1298846|P1|NOT COMPLETED|Overall Study||64
532757|NCT00824265|1298845|P2|COMPLETED|Overall Study||102
532758|NCT00824265|1298846|P1|COMPLETED|Overall Study||119
532759|NCT00824265|1298845|P2|STARTED|Overall Study||182
532760|NCT00824265|1298846|P1|STARTED|Overall Study||183
532761|NCT00824161|1298905|P1|NOT COMPLETED|Overall Study||2
532762|NCT00824161|1298905|P1|COMPLETED|Overall Study||26
532763|NCT00824161|1298905|P1|STARTED|Overall Study||28
532764|NCT00824070|1298914|P3|NOT COMPLETED|Overall Study||0
532765|NCT00824070|1298915|P2|NOT COMPLETED|Overall Study||0
532766|NCT00824070|1298916|P1|NOT COMPLETED|Overall Study||0
532767|NCT00824070|1298914|P3|COMPLETED|Overall Study||36
532768|NCT00824070|1298915|P2|COMPLETED|Overall Study||35
532769|NCT00824070|1298916|P1|COMPLETED|Overall Study||34
532770|NCT00824070|1298914|P3|STARTED|Overall Study||36
532771|NCT00824070|1298915|P2|STARTED|Overall Study||35
532772|NCT00824070|1298916|P1|STARTED|Overall Study||34
532773|NCT00824044|1298926|P2|NOT COMPLETED|Overall Study||6
532774|NCT00824044|1298927|P1|NOT COMPLETED|Overall Study||9
532775|NCT00824044|1298926|P2|COMPLETED|Overall Study||10
532776|NCT00824044|1298927|P1|COMPLETED|Overall Study||14
532777|NCT00824044|1298926|P2|STARTED|Overall Study||16
532778|NCT00824044|1298927|P1|STARTED|Overall Study||23
532779|NCT00824005|1298971|P2|NOT COMPLETED|Overall Study||2
532780|NCT00824005|1298972|P1|NOT COMPLETED|Overall Study||0
532781|NCT00824005|1298971|P2|COMPLETED|Overall Study||59
532782|NCT00824005|1298972|P1|COMPLETED|Overall Study||31
532783|NCT00824005|1298971|P2|STARTED|Overall Study||61
532784|NCT00824005|1298972|P1|STARTED|Overall Study||31
532785|NCT00823979|1299007|P3|NOT COMPLETED|Overall Study||24
532786|NCT00823979|1299008|P2|NOT COMPLETED|Overall Study||32
532787|NCT00823979|1299009|P1|NOT COMPLETED|Overall Study||29
532788|NCT00823979|1299007|P3|COMPLETED|Overall Study||11
532789|NCT00823979|1299008|P2|COMPLETED|Overall Study||3
532790|NCT00823979|1299009|P1|COMPLETED|Overall Study||6
532791|NCT00823979|1299007|P3|Treated|Overall Study||34
532792|NCT00823979|1299008|P2|Treated|Overall Study||32
532793|NCT00823979|1299009|P1|Treated|Overall Study||31
532794|NCT00823979|1299007|P3|STARTED|Overall Study||35
532795|NCT00823979|1299008|P2|STARTED|Overall Study||35
532796|NCT00823979|1299009|P1|STARTED|Overall Study||35
532797|NCT00823966|1299047|P1|NOT COMPLETED|Overall Study||0
532798|NCT00823966|1299047|P1|COMPLETED|Overall Study||3
532799|NCT00823966|1299047|P1|STARTED|Overall Study||3
532800|NCT00823901|1299054|P2|NOT COMPLETED|Overall Study||2
532801|NCT00823901|1299055|P1|NOT COMPLETED|Overall Study||4
532802|NCT00823901|1299054|P2|COMPLETED|Overall Study|Discontinued intervention (n=1) Only baseline completed (n=1)|38
532896|NCT00823043|1299428|P1|STARTED|Overall Study||64
532803|NCT00823901|1299055|P1|COMPLETED|Overall Study|Discontinued intervention (n=2) Only baseline completed (n=2)|39
532804|NCT00823901|1299054|P2|STARTED|Overall Study|Randomized to placebo gel|40
532805|NCT00823901|1299055|P1|STARTED|Overall Study|Randomized to clindamycin/tretinoin gel|43
532806|NCT00823836|1299063|P2|NOT COMPLETED|Long-term Phase||5
532807|NCT00823836|1299064|P1|NOT COMPLETED|Long-term Phase||5
532808|NCT00823836|1299063|P2|COMPLETED|Long-term Phase||79
532809|NCT00823836|1299064|P1|COMPLETED|Long-term Phase||68
532810|NCT00823836|1299063|P2|STARTED|Long-term Phase||84
532811|NCT00823836|1299064|P1|STARTED|Long-term Phase||73
532812|NCT00823836|1299063|P2|NOT COMPLETED|NV and PR/XR Switching Phases||29
532813|NCT00823836|1299064|P1|NOT COMPLETED|NV and PR/XR Switching Phases||32
532814|NCT00823836|1299063|P2|COMPLETED|NV and PR/XR Switching Phases||117
532815|NCT00823836|1299064|P1|COMPLETED|NV and PR/XR Switching Phases||124
532816|NCT00823836|1299063|P2|STARTED|NV and PR/XR Switching Phases||146
532817|NCT00823836|1299064|P1|STARTED|NV and PR/XR Switching Phases||156
532818|NCT00823823|1299170|P2|NOT COMPLETED|Overall Study||6
532819|NCT00823823|1299171|P1|NOT COMPLETED|Overall Study||8
532820|NCT00823823|1299170|P2|COMPLETED|Overall Study||101
532821|NCT00823823|1299171|P1|COMPLETED|Overall Study||101
532822|NCT00823823|1299170|P2|STARTED|Overall Study||107
532823|NCT00823823|1299171|P1|STARTED|Overall Study||109
532824|NCT00823797|1299181|P2|NOT COMPLETED|Overall Study||0
532825|NCT00823797|1299182|P1|NOT COMPLETED|Overall Study||0
532826|NCT00823797|1299181|P2|COMPLETED|Overall Study||16
532827|NCT00823797|1299182|P1|COMPLETED|Overall Study||29
532828|NCT00823797|1299181|P2|STARTED|Overall Study||16
532829|NCT00823797|1299182|P1|STARTED|Overall Study||29
532830|NCT00823719|1299195|P2|NOT COMPLETED|Overall Study||11
532831|NCT00823719|1299196|P1|NOT COMPLETED|Overall Study||6
532832|NCT00823719|1299195|P2|COMPLETED|Overall Study||24
532833|NCT00823719|1299196|P1|COMPLETED|Overall Study||20
532834|NCT00823719|1299195|P2|STARTED|Overall Study||35
532835|NCT00823719|1299196|P1|STARTED|Overall Study||26
532836|NCT00823615|1299249|P2|NOT COMPLETED|Period 2||2
532837|NCT00823615|1299250|P1|NOT COMPLETED|Period 2||3
532838|NCT00823615|1299249|P2|COMPLETED|Period 2||17
532839|NCT00823615|1299250|P1|COMPLETED|Period 2||16
532840|NCT00823615|1299249|P2|STARTED|Period 2||19
532841|NCT00823615|1299250|P1|STARTED|Period 2||19
532842|NCT00823615|1299249|P2|NOT COMPLETED|Period 1||0
532843|NCT00823615|1299250|P1|NOT COMPLETED|Period 1||0
532844|NCT00823615|1299249|P2|COMPLETED|Period 1||19
532845|NCT00823615|1299250|P1|COMPLETED|Period 1||19
532846|NCT00823615|1299249|P2|STARTED|Period 1||19
532847|NCT00823615|1299250|P1|STARTED|Period 1||19
532848|NCT00823472|1299260|P2|NOT COMPLETED|Overall Study||28
532849|NCT00823472|1299261|P1|NOT COMPLETED|Overall Study||24
532850|NCT00823472|1299260|P2|COMPLETED|Overall Study||39
532851|NCT00823472|1299261|P1|COMPLETED|Overall Study||56
532852|NCT00823472|1299260|P2|STARTED|Overall Study||67
532853|NCT00823472|1299261|P1|STARTED|Overall Study||80
532854|NCT00823303|1299271|P2|NOT COMPLETED|Overall Study||11
532855|NCT00823303|1299272|P1|NOT COMPLETED|Overall Study||9
532856|NCT00823303|1299271|P2|COMPLETED|Overall Study||45
532857|NCT00823303|1299272|P1|COMPLETED|Overall Study||45
532858|NCT00823303|1299271|P2|STARTED|Overall Study||56
532859|NCT00823303|1299272|P1|STARTED|Overall Study||54
532860|NCT00823264|1299280|P2|NOT COMPLETED|Overall Study||0
532861|NCT00823264|1299281|P1|NOT COMPLETED|Overall Study||2
532862|NCT00823264|1299280|P2|COMPLETED|Overall Study||7
532863|NCT00823264|1299281|P1|COMPLETED|Overall Study||8
532864|NCT00823264|1299280|P2|STARTED|Overall Study||7
532865|NCT00823264|1299281|P1|STARTED|Overall Study||10
532866|NCT00823212|1299289|P2|NOT COMPLETED|Overall Study||33
532867|NCT00823212|1299290|P1|NOT COMPLETED|Overall Study||35
532868|NCT00823212|1299289|P2|COMPLETED|Overall Study|12-month follow-up|735
532869|NCT00823212|1299290|P1|COMPLETED|Overall Study|12-month follow-up|727
532870|NCT00823212|1299289|P2|STARTED|Overall Study||768
532871|NCT00823212|1299290|P1|STARTED|Overall Study||762
532872|NCT00823199|1299372|P1|NOT COMPLETED|Overall Study||2
532873|NCT00823199|1299372|P1|COMPLETED|Overall Study||8
532874|NCT00823199|1299372|P1|STARTED|Overall Study||10
532875|NCT00823095|1299378|P1|NOT COMPLETED|Overall Study||0
532876|NCT00823095|1299378|P1|COMPLETED|Overall Study||7
532877|NCT00823095|1299378|P1|STARTED|Overall Study||7
532878|NCT00823082|1299385|P2|NOT COMPLETED|Overall Study||1
532879|NCT00823082|1299386|P1|NOT COMPLETED|Overall Study||0
532880|NCT00823082|1299385|P2|COMPLETED|Overall Study||99
532881|NCT00823082|1299386|P1|COMPLETED|Overall Study||100
532882|NCT00823082|1299385|P2|Intent-to-Treat/Per Protocol Populations|Overall Study||94
532883|NCT00823082|1299386|P1|Intent-to-Treat/Per Protocol Populations|Overall Study||100
532884|NCT00823082|1299385|P2|Safety Population|Overall Study||99
532885|NCT00823082|1299386|P1|Safety Population|Overall Study||100
532886|NCT00823082|1299385|P2|STARTED|Overall Study||100
532887|NCT00823082|1299386|P1|STARTED|Overall Study||100
532888|NCT00823069|1299420|P1|NOT COMPLETED|Overall Study||0
532889|NCT00823069|1299420|P1|COMPLETED|Overall Study||60
532890|NCT00823069|1299420|P1|STARTED|Overall Study||60
532891|NCT00823043|1299427|P2|NOT COMPLETED|Overall Study||0
532892|NCT00823043|1299428|P1|NOT COMPLETED|Overall Study||0
532893|NCT00823043|1299427|P2|COMPLETED|Overall Study||39
532894|NCT00823043|1299428|P1|COMPLETED|Overall Study||64
532895|NCT00823043|1299427|P2|STARTED|Overall Study||39
532897|NCT00822926|1299441|P2|NOT COMPLETED|Second Injection Visit||1
532898|NCT00822926|1299442|P1|NOT COMPLETED|Second Injection Visit||1
532899|NCT00822926|1299441|P2|COMPLETED|Second Injection Visit||2
532900|NCT00822926|1299442|P1|COMPLETED|Second Injection Visit||1
532901|NCT00822926|1299441|P2|STARTED|Second Injection Visit||3
532902|NCT00822926|1299442|P1|STARTED|Second Injection Visit||2
532903|NCT00822926|1299441|P2|NOT COMPLETED|Washout (Varies Based on Scheduling)||0
532904|NCT00822926|1299442|P1|NOT COMPLETED|Washout (Varies Based on Scheduling)||0
532905|NCT00822926|1299441|P2|COMPLETED|Washout (Varies Based on Scheduling)||3
532906|NCT00822926|1299442|P1|COMPLETED|Washout (Varies Based on Scheduling)||2
532907|NCT00822926|1299441|P2|STARTED|Washout (Varies Based on Scheduling)||3
532908|NCT00822926|1299442|P1|STARTED|Washout (Varies Based on Scheduling)||2
532909|NCT00822926|1299441|P2|NOT COMPLETED|First Injection Visit||0
532910|NCT00822926|1299442|P1|NOT COMPLETED|First Injection Visit||0
532911|NCT00822926|1299441|P2|COMPLETED|First Injection Visit||3
532912|NCT00822926|1299442|P1|COMPLETED|First Injection Visit||2
532913|NCT00822926|1299441|P2|STARTED|First Injection Visit||3
532914|NCT00822926|1299442|P1|STARTED|First Injection Visit||2
532915|NCT00822900|1299456|P2|NOT COMPLETED|Overall Study||93
532916|NCT00822900|1299457|P1|NOT COMPLETED|Overall Study||108
532917|NCT00822900|1299456|P2|COMPLETED|Overall Study||347
532918|NCT00822900|1299457|P1|COMPLETED|Overall Study||334
532919|NCT00822900|1299456|P2|STARTED|Overall Study||440
532920|NCT00822900|1299457|P1|STARTED|Overall Study||442
532921|NCT00822770|1299485|P1|NOT COMPLETED|Overall Study||0
532922|NCT00822770|1299485|P1|COMPLETED|Overall Study||47
532923|NCT00822770|1299485|P1|STARTED|Overall Study||47
532924|NCT00822757|1299491|P2|NOT COMPLETED|Overall Study||0
532925|NCT00822757|1299492|P1|NOT COMPLETED|Overall Study||0
532926|NCT00822757|1299491|P2|COMPLETED|Overall Study||10
532927|NCT00822757|1299492|P1|COMPLETED|Overall Study||41
532928|NCT00822757|1299491|P2|STARTED|Overall Study||10
532929|NCT00822757|1299492|P1|STARTED|Overall Study||41
532930|NCT00822692|1299504|P2|NOT COMPLETED|Overall Study||25
532931|NCT00822692|1299505|P1|NOT COMPLETED|Overall Study||17
532932|NCT00822692|1299504|P2|COMPLETED|Overall Study|June 1 , 2009|51
532933|NCT00822692|1299505|P1|COMPLETED|Overall Study|June 1, 2009|46
532934|NCT00822692|1299504|P2|STARTED|Overall Study|July 1, 2008|76
532935|NCT00822692|1299505|P1|STARTED|Overall Study|July 1, 2008|63
532936|NCT00822679|1299513|P2|NOT COMPLETED|Overall Study||0
532937|NCT00822679|1299514|P1|NOT COMPLETED|Overall Study||0
532938|NCT00822679|1299513|P2|COMPLETED|Overall Study||0
532939|NCT00822679|1299514|P1|COMPLETED|Overall Study||0
532940|NCT00822679|1299513|P2|STARTED|Overall Study||0
532941|NCT00822679|1299514|P1|STARTED|Overall Study||0
532942|NCT00822588|1299522|P2|NOT COMPLETED|Overall Study||4
532943|NCT00822588|1299523|P1|NOT COMPLETED|Overall Study||7
532944|NCT00822588|1299522|P2|COMPLETED|Overall Study|APT/ITT analysis set|110
532945|NCT00822588|1299523|P1|COMPLETED|Overall Study|APT/ITT analysis set|106
532946|NCT00822588|1299522|P2|STARTED|Overall Study|4 participants excluded before surgery. No baseline data available|114
532947|NCT00822588|1299523|P1|STARTED|Overall Study|7 participants excluded before surgery. No baseline data available|113
532948|NCT00822523|1299532|P3|NOT COMPLETED|Overall Study||0
532949|NCT00822523|1299533|P2|NOT COMPLETED|Overall Study||0
532950|NCT00822523|1299534|P1|NOT COMPLETED|Overall Study||0
532951|NCT00822523|1299532|P3|COMPLETED|Overall Study||4
532952|NCT00822523|1299533|P2|COMPLETED|Overall Study||4
532953|NCT00822523|1299534|P1|COMPLETED|Overall Study||5
532954|NCT00822523|1299532|P3|STARTED|Overall Study||4
532955|NCT00822523|1299533|P2|STARTED|Overall Study||4
532956|NCT00822523|1299534|P1|STARTED|Overall Study||5
532957|NCT00822510|1299580|P2|NOT COMPLETED|Overall Study||5
532958|NCT00822510|1299581|P1|NOT COMPLETED|Overall Study||3
532959|NCT00822510|1299580|P2|COMPLETED|Overall Study||36
532960|NCT00822510|1299581|P1|COMPLETED|Overall Study||35
532961|NCT00822510|1299580|P2|STARTED|Overall Study||41
532962|NCT00822510|1299581|P1|STARTED|Overall Study||38
532963|NCT00822354|1299601|P2|NOT COMPLETED|Second Intervention (28 Days)||0
532964|NCT00822354|1299602|P1|NOT COMPLETED|Second Intervention (28 Days)||1
532965|NCT00822354|1299601|P2|COMPLETED|Second Intervention (28 Days)||5
532966|NCT00822354|1299602|P1|COMPLETED|Second Intervention (28 Days)||3
532967|NCT00822354|1299601|P2|STARTED|Second Intervention (28 Days)||5
532968|NCT00822354|1299602|P1|STARTED|Second Intervention (28 Days)||4
532969|NCT00822354|1299601|P2|NOT COMPLETED|Washout (7 Days)||0
532970|NCT00822354|1299602|P1|NOT COMPLETED|Washout (7 Days)||0
532971|NCT00822354|1299601|P2|COMPLETED|Washout (7 Days)||5
532972|NCT00822354|1299602|P1|COMPLETED|Washout (7 Days)||4
532973|NCT00822354|1299601|P2|STARTED|Washout (7 Days)||5
532974|NCT00822354|1299602|P1|STARTED|Washout (7 Days)||4
532975|NCT00822354|1299601|P2|NOT COMPLETED|First Intervention (28 Days)||0
532976|NCT00822354|1299602|P1|NOT COMPLETED|First Intervention (28 Days)||1
532977|NCT00822354|1299601|P2|COMPLETED|First Intervention (28 Days)||5
532978|NCT00822354|1299602|P1|COMPLETED|First Intervention (28 Days)||4
532979|NCT00822354|1299601|P2|STARTED|First Intervention (28 Days)||5
532980|NCT00822354|1299602|P1|STARTED|First Intervention (28 Days)||5
532981|NCT00822328|1299632|P2|NOT COMPLETED|Overall Study||0
532982|NCT00822328|1299633|P1|NOT COMPLETED|Overall Study||0
532983|NCT00822328|1299632|P2|COMPLETED|Overall Study||12
532984|NCT00822328|1299633|P1|COMPLETED|Overall Study||12
532985|NCT00822328|1299632|P2|STARTED|Overall Study||12
532986|NCT00822328|1299633|P1|STARTED|Overall Study||12
532987|NCT00822237|1299643|P2|NOT COMPLETED|Dose 2 Vaccination||11
532988|NCT00822237|1299644|P1|NOT COMPLETED|Dose 2 Vaccination||4
532989|NCT00822237|1299643|P2|COMPLETED|Dose 2 Vaccination||262
532990|NCT00822237|1299644|P1|COMPLETED|Dose 2 Vaccination||270
532991|NCT00822237|1299643|P2|STARTED|Dose 2 Vaccination|Number who received second dose|273
532992|NCT00822237|1299644|P1|STARTED|Dose 2 Vaccination|Number who received second dose|274
532993|NCT00822237|1299643|P2|NOT COMPLETED|Dose 1 Vaccination||26
532994|NCT00822237|1299644|P1|NOT COMPLETED|Dose 1 Vaccination||25
532995|NCT00822237|1299643|P2|COMPLETED|Dose 1 Vaccination||273
532996|NCT00822237|1299644|P1|COMPLETED|Dose 1 Vaccination||274
532997|NCT00822237|1299643|P2|STARTED|Dose 1 Vaccination|Number randomized|299
532998|NCT00822237|1299644|P1|STARTED|Dose 1 Vaccination|Number randomized|299
532999|NCT00822185|1299654|P5|NOT COMPLETED|Overall Study||0
533000|NCT00822185|1299655|P4|NOT COMPLETED|Overall Study||0
533001|NCT00822185|1299656|P3|NOT COMPLETED|Overall Study||0
533002|NCT00822185|1299657|P2|NOT COMPLETED|Overall Study||0
533003|NCT00822185|1299658|P1|NOT COMPLETED|Overall Study||0
533004|NCT00822185|1299654|P5|COMPLETED|Overall Study||8
533005|NCT00822185|1299655|P4|COMPLETED|Overall Study||6
533006|NCT00822185|1299656|P3|COMPLETED|Overall Study||6
533007|NCT00822185|1299657|P2|COMPLETED|Overall Study||6
533008|NCT00822185|1299658|P1|COMPLETED|Overall Study||6
533009|NCT00822185|1299654|P5|STARTED|Overall Study||8
533010|NCT00822185|1299655|P4|STARTED|Overall Study||6
533011|NCT00822185|1299656|P3|STARTED|Overall Study||6
533012|NCT00822185|1299657|P2|STARTED|Overall Study||6
533013|NCT00822185|1299658|P1|STARTED|Overall Study||6
533014|NCT00822172|1299725|P2|NOT COMPLETED|Overall Study||19
533015|NCT00822172|1299726|P1|NOT COMPLETED|Overall Study||15
533016|NCT00822172|1299725|P2|COMPLETED|Overall Study||64
533017|NCT00822172|1299726|P1|COMPLETED|Overall Study||65
533018|NCT00822172|1299725|P2|STARTED|Overall Study||83
533019|NCT00822172|1299726|P1|STARTED|Overall Study||80
533020|NCT00822120|1299734|P6|NOT COMPLETED|PET-directed Therapy||0
533021|NCT00822120|1299735|P5|NOT COMPLETED|PET-directed Therapy||0
533022|NCT00822120|1299736|P4|NOT COMPLETED|PET-directed Therapy||10
533023|NCT00822120|1299737|P3|NOT COMPLETED|PET-directed Therapy||0
533024|NCT00822120|1299738|P2|NOT COMPLETED|PET-directed Therapy||0
533025|NCT00822120|1299739|P1|NOT COMPLETED|PET-directed Therapy||0
533026|NCT00822120|1299734|P6|COMPLETED|PET-directed Therapy||1
533027|NCT00822120|1299735|P5|COMPLETED|PET-directed Therapy||10
533028|NCT00822120|1299736|P4|COMPLETED|PET-directed Therapy||45
533029|NCT00822120|1299737|P3|COMPLETED|PET-directed Therapy||270
533030|NCT00822120|1299738|P2|COMPLETED|PET-directed Therapy||0
533031|NCT00822120|1299739|P1|COMPLETED|PET-directed Therapy||0
533032|NCT00822120|1299734|P6|Eligibile and Evaluable Patients|PET-directed Therapy||1
533033|NCT00822120|1299735|P5|Eligibile and Evaluable Patients|PET-directed Therapy||10
533034|NCT00822120|1299736|P4|Eligibile and Evaluable Patients|PET-directed Therapy||55
533035|NCT00822120|1299737|P3|Eligibile and Evaluable Patients|PET-directed Therapy||270
533036|NCT00822120|1299738|P2|Eligibile and Evaluable Patients|PET-directed Therapy||0
533037|NCT00822120|1299739|P1|Eligibile and Evaluable Patients|PET-directed Therapy||0
533038|NCT00822120|1299734|P6|STARTED|PET-directed Therapy||1
533039|NCT00822120|1299735|P5|STARTED|PET-directed Therapy||10
533040|NCT00822120|1299736|P4|STARTED|PET-directed Therapy||55
533041|NCT00822120|1299737|P3|STARTED|PET-directed Therapy||270
533042|NCT00822120|1299738|P2|STARTED|PET-directed Therapy||0
533043|NCT00822120|1299739|P1|STARTED|PET-directed Therapy||0
533044|NCT00822120|1299734|P6|NOT COMPLETED|Initial Registration||0
533045|NCT00822120|1299735|P5|NOT COMPLETED|Initial Registration||0
533046|NCT00822120|1299736|P4|NOT COMPLETED|Initial Registration||0
533047|NCT00822120|1299737|P3|NOT COMPLETED|Initial Registration||0
533048|NCT00822120|1299738|P2|NOT COMPLETED|Initial Registration||1
533049|NCT00822120|1299739|P1|NOT COMPLETED|Initial Registration||26
533050|NCT00822120|1299734|P6|COMPLETED|Initial Registration||0
533051|NCT00822120|1299735|P5|COMPLETED|Initial Registration||0
533052|NCT00822120|1299736|P4|COMPLETED|Initial Registration||0
533053|NCT00822120|1299737|P3|COMPLETED|Initial Registration||0
533054|NCT00822120|1299738|P2|COMPLETED|Initial Registration||12
533055|NCT00822120|1299739|P1|COMPLETED|Initial Registration||332
533056|NCT00822120|1299734|P6|Eligible and Evaluable Patients|Initial Registration||0
533057|NCT00822120|1299735|P5|Eligible and Evaluable Patients|Initial Registration||0
533058|NCT00822120|1299736|P4|Eligible and Evaluable Patients|Initial Registration||0
533059|NCT00822120|1299737|P3|Eligible and Evaluable Patients|Initial Registration||0
533060|NCT00822120|1299738|P2|Eligible and Evaluable Patients|Initial Registration||12
533061|NCT00822120|1299739|P1|Eligible and Evaluable Patients|Initial Registration||336
533062|NCT00822120|1299734|P6|STARTED|Initial Registration||0
533063|NCT00822120|1299735|P5|STARTED|Initial Registration||0
533064|NCT00822120|1299736|P4|STARTED|Initial Registration||0
533065|NCT00822120|1299737|P3|STARTED|Initial Registration||0
533066|NCT00822120|1299738|P2|STARTED|Initial Registration||13
533067|NCT00822120|1299739|P1|STARTED|Initial Registration||358
533068|NCT00822094|1299764|P2|NOT COMPLETED|Overall Study||25
533069|NCT00822094|1299765|P1|NOT COMPLETED|Overall Study||44
533070|NCT00822094|1299764|P2|COMPLETED|Overall Study||20
533071|NCT00822094|1299765|P1|COMPLETED|Overall Study||37
533072|NCT00822094|1299764|P2|STARTED|Overall Study||45
533073|NCT00822094|1299765|P1|STARTED|Overall Study||81
533074|NCT00821964|1299781|P1|NOT COMPLETED|Overall Study||6
533075|NCT00821964|1299781|P1|COMPLETED|Overall Study||9
533076|NCT00821964|1299781|P1|Evaluable for Pathologic Response|Overall Study||7
533077|NCT00821964|1299781|P1|Evaluable for Clinical Response|Overall Study||14
533078|NCT00821964|1299781|P1|STARTED|Overall Study||15
533079|NCT00821951|1299790|P1|NOT COMPLETED|Overall Study||5
533080|NCT00821951|1299790|P1|COMPLETED|Overall Study||12
533081|NCT00821951|1299790|P1|STARTED|Overall Study||17
533082|NCT00821886|1299794|P1|NOT COMPLETED|Overall Study||9
533083|NCT00821886|1299794|P1|COMPLETED|Overall Study||49
533084|NCT00821886|1299794|P1|STARTED|Overall Study|Two patients were enrolled, but subsequently found to be ineligible|58
533085|NCT00821873|1299801|P1|NOT COMPLETED|Overall Study||4
533086|NCT00821873|1299801|P1|COMPLETED|Overall Study||5
533087|NCT00821873|1299801|P1|STARTED|Overall Study||9
533088|NCT00821821|1299808|P3|NOT COMPLETED|Overall Study||0
533089|NCT00821821|1299809|P2|NOT COMPLETED|Overall Study||0
533090|NCT00821821|1299810|P1|NOT COMPLETED|Overall Study||0
533091|NCT00821821|1299808|P3|COMPLETED|Overall Study||11
533092|NCT00821821|1299809|P2|COMPLETED|Overall Study||13
533093|NCT00821821|1299810|P1|COMPLETED|Overall Study||12
533094|NCT00821821|1299808|P3|STARTED|Overall Study||11
533095|NCT00821821|1299809|P2|STARTED|Overall Study||13
533096|NCT00821821|1299810|P1|STARTED|Overall Study||12
533097|NCT00821678|1299822|P2|NOT COMPLETED|Overall Study||14
533098|NCT00821678|1299823|P1|NOT COMPLETED|Overall Study||21
533099|NCT00821678|1299822|P2|COMPLETED|Overall Study||118
533100|NCT00821678|1299823|P1|COMPLETED|Overall Study||112
533101|NCT00821678|1299822|P2|STARTED|Overall Study||132
533102|NCT00821678|1299823|P1|STARTED|Overall Study||133
533103|NCT00821587|1299841|P2|NOT COMPLETED|Overall Study||1
533104|NCT00821587|1299842|P1|NOT COMPLETED|Overall Study||0
533105|NCT00821587|1299841|P2|COMPLETED|Overall Study||18
533106|NCT00821587|1299842|P1|COMPLETED|Overall Study||20
533107|NCT00821587|1299841|P2|STARTED|Overall Study||19
533108|NCT00821587|1299842|P1|STARTED|Overall Study||20
533109|NCT00821509|1299851|P3|NOT COMPLETED|Overall Study||34
533110|NCT00821509|1299852|P2|NOT COMPLETED|Overall Study||11
533111|NCT00821509|1299853|P1|NOT COMPLETED|Overall Study||12
533112|NCT00821509|1299851|P3|COMPLETED|Overall Study|This is a result of 50 lost-to-follow-up and 16 new recruits|190
533113|NCT00821509|1299852|P2|COMPLETED|Overall Study|This is a result of 57 lost-to-follow-up and 46 new recruits|191
533114|NCT00821509|1299853|P1|COMPLETED|Overall Study|This is a result of 56 lost-to-follow-up and 44 new recruits|245
533115|NCT00821509|1299851|P3|STARTED|Overall Study||224
533116|NCT00821509|1299852|P2|STARTED|Overall Study||202
533117|NCT00821509|1299853|P1|STARTED|Overall Study||257
533118|NCT00821431|1299866|P2|NOT COMPLETED|Overall Study||5
533119|NCT00821431|1299867|P1|NOT COMPLETED|Overall Study||15
533120|NCT00821431|1299866|P2|COMPLETED|Overall Study||47
533121|NCT00821431|1299867|P1|COMPLETED|Overall Study||23
533122|NCT00821431|1299866|P2|STARTED|Overall Study||52
533123|NCT00821431|1299867|P1|STARTED|Overall Study||38
533124|NCT00821327|1299875|P1|NOT COMPLETED|Overall Study||35
533125|NCT00821327|1299875|P1|COMPLETED|Overall Study||1
533126|NCT00821327|1299875|P1|STARTED|Overall Study||36
533127|NCT00821236|1299884|P1|NOT COMPLETED|Overall Study||3
533128|NCT00821236|1299884|P1|COMPLETED|Overall Study||37
533129|NCT00821236|1299884|P1|STARTED|Overall Study||40
533130|NCT00821184|1299900|P2|NOT COMPLETED|Overall Study||0
533131|NCT00821184|1299901|P1|NOT COMPLETED|Overall Study||0
533132|NCT00821184|1299900|P2|COMPLETED|Overall Study||6
533133|NCT00821184|1299901|P1|COMPLETED|Overall Study||6
533134|NCT00821184|1299900|P2|STARTED|Overall Study||6
533135|NCT00821184|1299901|P1|STARTED|Overall Study||6
533136|NCT00821119|1299911|P2|NOT COMPLETED|Overall Study||0
533137|NCT00821119|1299912|P1|NOT COMPLETED|Overall Study||0
533138|NCT00821119|1299911|P2|COMPLETED|Overall Study||100
533139|NCT00821119|1299912|P1|COMPLETED|Overall Study||100
533140|NCT00821119|1299911|P2|STARTED|Overall Study||100
533141|NCT00821119|1299912|P1|STARTED|Overall Study||100
533142|NCT00821093|1299924|P2|NOT COMPLETED|Overall Study||40
533143|NCT00821093|1299925|P1|NOT COMPLETED|Overall Study||49
533144|NCT00821093|1299924|P2|COMPLETED|Overall Study||523
533145|NCT00821093|1299925|P1|COMPLETED|Overall Study||511
533146|NCT00821093|1299924|P2|Exposed to Drug|Overall Study||562
533147|NCT00821093|1299925|P1|Exposed to Drug|Overall Study||559
533148|NCT00821093|1299924|P2|STARTED|Overall Study||563
533149|NCT00821093|1299925|P1|STARTED|Overall Study||560
533150|NCT00821041|1299935|P2|NOT COMPLETED|Overall Study||0
533151|NCT00821041|1299936|P1|NOT COMPLETED|Overall Study||0
533152|NCT00821041|1299935|P2|COMPLETED|Overall Study||59
533153|NCT00821041|1299936|P1|COMPLETED|Overall Study||59
533154|NCT00821041|1299935|P2|STARTED|Overall Study||59
533155|NCT00821041|1299936|P1|STARTED|Overall Study||59
533156|NCT00820898|1299944|P1|NOT COMPLETED|Overall Study||1
533157|NCT00820898|1299944|P1|COMPLETED|Overall Study||23
533158|NCT00820898|1299944|P1|STARTED|Overall Study||24
533159|NCT00820872|1299954|P1|NOT COMPLETED|Overall Study||0
533160|NCT00820872|1299954|P1|COMPLETED|Overall Study||30
533161|NCT00820872|1299954|P1|STARTED|Overall Study||30
533162|NCT00820755|1299958|P3|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45
533163|NCT00820755|1299959|P2|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45
533164|NCT00820755|1299960|P1|NOT COMPLETED|Period 2: Maintenance Therapy Phase||0
533165|NCT00820755|1299958|P3|COMPLETED|Period 2: Maintenance Therapy Phase||109
533166|NCT00820755|1299959|P2|COMPLETED|Period 2: Maintenance Therapy Phase||112
533167|NCT00820755|1299960|P1|COMPLETED|Period 2: Maintenance Therapy Phase||0
533168|NCT00820755|1299958|P3|STARTED|Period 2: Maintenance Therapy Phase||154
533169|NCT00820755|1299959|P2|STARTED|Period 2: Maintenance Therapy Phase||157
533170|NCT00820755|1299960|P1|STARTED|Period 2: Maintenance Therapy Phase||0
533171|NCT00820755|1299958|P3|NOT COMPLETED|Period 1: Combination Therapy Phase||0
533172|NCT00820755|1299959|P2|NOT COMPLETED|Period 1: Combination Therapy Phase||0
533173|NCT00820755|1299960|P1|NOT COMPLETED|Period 1: Combination Therapy Phase||270
533174|NCT00820755|1299958|P3|COMPLETED|Period 1: Combination Therapy Phase||0
533175|NCT00820755|1299959|P2|COMPLETED|Period 1: Combination Therapy Phase||0
533176|NCT00820755|1299960|P1|COMPLETED|Period 1: Combination Therapy Phase|2 of 313 participants excluded from maintenance phase analysis (reason: not eligible)|313
533177|NCT00820755|1299958|P3|STARTED|Period 1: Combination Therapy Phase||0
533178|NCT00820755|1299959|P2|STARTED|Period 1: Combination Therapy Phase||0
533179|NCT00820755|1299960|P1|STARTED|Period 1: Combination Therapy Phase||583
533180|NCT00820664|1299984|P3|NOT COMPLETED|Overall Study||0
533181|NCT00820664|1299985|P2|NOT COMPLETED|Overall Study||0
533182|NCT00820664|1299986|P1|NOT COMPLETED|Overall Study||0
533183|NCT00820664|1299984|P3|COMPLETED|Overall Study||9
533184|NCT00820664|1299985|P2|COMPLETED|Overall Study||11
533185|NCT00820664|1299986|P1|COMPLETED|Overall Study||9
533186|NCT00820664|1299984|P3|STARTED|Overall Study||9
533187|NCT00820664|1299985|P2|STARTED|Overall Study||11
533188|NCT00820664|1299986|P1|STARTED|Overall Study||9
533189|NCT00820612|1299996|P2|NOT COMPLETED|Overall Study||0
533190|NCT00820612|1299997|P1|NOT COMPLETED|Overall Study||0
533191|NCT00820612|1299996|P2|COMPLETED|Overall Study||295
533192|NCT00820612|1299997|P1|COMPLETED|Overall Study||307
533193|NCT00820612|1299996|P2|STARTED|Overall Study||295
533194|NCT00820612|1299997|P1|STARTED|Overall Study||307
533195|NCT00820573|1300007|P4|NOT COMPLETED|Overall Study||0
533196|NCT00820573|1300008|P3|NOT COMPLETED|Overall Study||0
533197|NCT00820573|1300009|P2|NOT COMPLETED|Overall Study||0
533198|NCT00820573|1300010|P1|NOT COMPLETED|Overall Study||0
533199|NCT00820573|1300007|P4|COMPLETED|Overall Study||4
533200|NCT00820573|1300008|P3|COMPLETED|Overall Study||4
533201|NCT00820573|1300009|P2|COMPLETED|Overall Study||4
533202|NCT00820573|1300010|P1|COMPLETED|Overall Study||4
533203|NCT00820573|1300007|P4|STARTED|Overall Study||4
533204|NCT00820573|1300008|P3|STARTED|Overall Study||4
533205|NCT00820573|1300009|P2|STARTED|Overall Study||4
533206|NCT00820573|1300010|P1|STARTED|Overall Study||4
533207|NCT00820534|1300034|P2|NOT COMPLETED|Overall Study||0
533208|NCT00820534|1300035|P1|NOT COMPLETED|Overall Study||0
533209|NCT00820534|1300034|P2|COMPLETED|Overall Study||62
533210|NCT00820534|1300035|P1|COMPLETED|Overall Study||64
533211|NCT00820534|1300034|P2|STARTED|Overall Study||62
533212|NCT00820534|1300035|P1|STARTED|Overall Study||64
533213|NCT00820443|1300043|P1|NOT COMPLETED|24 Month||43
533214|NCT00820443|1300043|P1|COMPLETED|24 Month||202
533215|NCT00820443|1300043|P1|STARTED|24 Month||245
533216|NCT00820443|1300043|P1|NOT COMPLETED|12 Month||24
533217|NCT00820443|1300043|P1|COMPLETED|12 Month||226
533218|NCT00820443|1300043|P1|STARTED|12 Month||250
533219|NCT00820443|1300043|P1|NOT COMPLETED|6 Month||20
533220|NCT00820443|1300043|P1|COMPLETED|6 Month||233
533221|NCT00820443|1300043|P1|STARTED|6 Month||253
533222|NCT00820443|1300043|P1|NOT COMPLETED|3 Month||9
533223|NCT00820443|1300043|P1|COMPLETED|3 Month||244
533224|NCT00820443|1300043|P1|STARTED|3 Month||253
533225|NCT00820443|1300043|P1|NOT COMPLETED|Immediately||5
533226|NCT00820443|1300043|P1|COMPLETED|Immediately||248
533227|NCT00820443|1300043|P1|STARTED|Immediately||253
533228|NCT00820443|1300043|P1|NOT COMPLETED|Op||0
533229|NCT00820443|1300043|P1|COMPLETED|Op||253
533230|NCT00820443|1300043|P1|STARTED|Op||253
533231|NCT00820443|1300043|P1|NOT COMPLETED|Pre-Op||0
533232|NCT00820443|1300043|P1|COMPLETED|Pre-Op||253
533233|NCT00820443|1300043|P1|STARTED|Pre-Op||253
533234|NCT00820248|1300053|P2|NOT COMPLETED|Overall Study||1
533235|NCT00820248|1300054|P1|NOT COMPLETED|Overall Study||4
533236|NCT00820248|1300053|P2|COMPLETED|Overall Study||159
533237|NCT00820248|1300054|P1|COMPLETED|Overall Study||156
533238|NCT00820248|1300053|P2|Received Protocol Treatment|Overall Study||159
533239|NCT00820248|1300054|P1|Received Protocol Treatment|Overall Study||156
533240|NCT00820248|1300053|P2|STARTED|Overall Study||160
533241|NCT00820248|1300054|P1|STARTED|Overall Study||160
533242|NCT00820222|1300064|P2|NOT COMPLETED|Overall Study||211
533243|NCT00820222|1300065|P1|NOT COMPLETED|Overall Study||201
533244|NCT00820222|1300064|P2|COMPLETED|Overall Study||58
533245|NCT00820222|1300065|P1|COMPLETED|Overall Study||70
533246|NCT00820222|1300064|P2|Ongoing|Overall Study||191
533247|NCT00820222|1300065|P1|Ongoing|Overall Study||185
533248|NCT00820222|1300064|P2|STARTED|Overall Study||269
533249|NCT00820222|1300065|P1|STARTED|Overall Study||271
533250|NCT00819910|1300095|P4|NOT COMPLETED|Overall Study||1
533251|NCT00819910|1300096|P3|NOT COMPLETED|Overall Study||3
533252|NCT00819910|1300097|P2|NOT COMPLETED|Overall Study||1
533253|NCT00819910|1300098|P1|NOT COMPLETED|Overall Study||2
533254|NCT00819910|1300095|P4|COMPLETED|Overall Study||10
533255|NCT00819910|1300096|P3|COMPLETED|Overall Study||7
533256|NCT00819910|1300097|P2|COMPLETED|Overall Study||9
533257|NCT00819910|1300098|P1|COMPLETED|Overall Study||8
533258|NCT00819910|1300095|P4|STARTED|Overall Study||11
533259|NCT00819910|1300096|P3|STARTED|Overall Study||10
533260|NCT00819910|1300097|P2|STARTED|Overall Study||10
533261|NCT00819910|1300098|P1|STARTED|Overall Study||10
533262|NCT00819832|1300130|P6|NOT COMPLETED|Overall Study||0
533263|NCT00819832|1300131|P5|NOT COMPLETED|Overall Study||0
533264|NCT00819832|1300132|P4|NOT COMPLETED|Overall Study||0
533265|NCT00819832|1300133|P3|NOT COMPLETED|Overall Study||0
533266|NCT00819832|1300134|P2|NOT COMPLETED|Overall Study||0
533267|NCT00819832|1300135|P1|NOT COMPLETED|Overall Study||3
533268|NCT00819832|1300130|P6|COMPLETED|Overall Study||0
533269|NCT00819832|1300131|P5|COMPLETED|Overall Study||0
533270|NCT00819832|1300132|P4|COMPLETED|Overall Study||0
533271|NCT00819832|1300133|P3|COMPLETED|Overall Study||0
533272|NCT00819832|1300134|P2|COMPLETED|Overall Study||0
533273|NCT00819832|1300135|P1|COMPLETED|Overall Study||0
533274|NCT00819832|1300130|P6|STARTED|Overall Study||0
533275|NCT00819832|1300131|P5|STARTED|Overall Study||0
533276|NCT00819832|1300132|P4|STARTED|Overall Study||0
533277|NCT00819832|1300133|P3|STARTED|Overall Study||0
533278|NCT00819832|1300134|P2|STARTED|Overall Study||0
533279|NCT00819832|1300135|P1|STARTED|Overall Study|No patient data analysis.|3
533280|NCT00819780|1300151|P2|NOT COMPLETED|Overall Study||21
533281|NCT00819780|1300152|P1|NOT COMPLETED|Overall Study||28
533282|NCT00819780|1300151|P2|COMPLETED|Overall Study|Indicates participants who ended study treatment|122
533283|NCT00819780|1300152|P1|COMPLETED|Overall Study|Indicates participants who ended study treatment|114
533284|NCT00819780|1300151|P2|Received Study Treatment|Overall Study||139
533285|NCT00819780|1300152|P1|Received Study Treatment|Overall Study||139
533286|NCT00819780|1300151|P2|STARTED|Overall Study||143
533287|NCT00819780|1300152|P1|STARTED|Overall Study||142
533288|NCT00819767|1300186|P2|NOT COMPLETED|Overall Study||2
533289|NCT00819767|1300187|P1|NOT COMPLETED|Overall Study||1
533290|NCT00819767|1300186|P2|COMPLETED|Overall Study||33
533291|NCT00819767|1300187|P1|COMPLETED|Overall Study||32
533292|NCT00819767|1300186|P2|STARTED|Overall Study||35
533293|NCT00819767|1300187|P1|STARTED|Overall Study||33
533294|NCT00819741|1300199|P2|NOT COMPLETED|Overall Study||14
533295|NCT00819741|1300200|P1|NOT COMPLETED|Overall Study||22
533296|NCT00819741|1300199|P2|COMPLETED|Overall Study||201
533297|NCT00819741|1300200|P1|COMPLETED|Overall Study||196
533298|NCT00819741|1300199|P2|Exposed to Drug|Overall Study|One subject after randomisation was not exposed to the treatment due to non-compliance|214
533299|NCT00819741|1300200|P1|Exposed to Drug|Overall Study||218
533300|NCT00819741|1300199|P2|STARTED|Overall Study||215
533301|NCT00819741|1300200|P1|STARTED|Overall Study||218
533302|NCT00819637|1300237|P3|NOT COMPLETED|Overall Study||0
533303|NCT00819637|1300238|P2|NOT COMPLETED|Overall Study||0
533304|NCT00819637|1300239|P1|NOT COMPLETED|Overall Study||0
533305|NCT00819637|1300237|P3|COMPLETED|Overall Study||0
533306|NCT00819637|1300238|P2|COMPLETED|Overall Study||0
533307|NCT00819637|1300239|P1|COMPLETED|Overall Study||2
533308|NCT00819637|1300237|P3|STARTED|Overall Study||0
533309|NCT00819637|1300238|P2|STARTED|Overall Study||0
533310|NCT00819637|1300239|P1|STARTED|Overall Study||2
533311|NCT00819585|1300254|P7|NOT COMPLETED|Overall Study||13
533312|NCT00819585|1300255|P6|NOT COMPLETED|Overall Study||2
533313|NCT00819585|1300256|P5|NOT COMPLETED|Overall Study||3
533314|NCT00819585|1300257|P4|NOT COMPLETED|Overall Study||5
533315|NCT00819585|1300258|P3|NOT COMPLETED|Overall Study||6
533316|NCT00819585|1300259|P2|NOT COMPLETED|Overall Study||6
533317|NCT00819585|1300260|P1|NOT COMPLETED|Overall Study||6
533318|NCT00819585|1300254|P7|COMPLETED|Overall Study||95
533319|NCT00819585|1300255|P6|COMPLETED|Overall Study||52
533320|NCT00819585|1300256|P5|COMPLETED|Overall Study||50
533321|NCT00819585|1300257|P4|COMPLETED|Overall Study||49
533322|NCT00819585|1300258|P3|COMPLETED|Overall Study||48
533323|NCT00819585|1300259|P2|COMPLETED|Overall Study||48
533324|NCT00819585|1300260|P1|COMPLETED|Overall Study||49
533325|NCT00819585|1300254|P7|Safety Population|Overall Study||108
533326|NCT00819585|1300255|P6|Safety Population|Overall Study|A pt. who was randomized to repeated dose regimen, found as HIV +ve, didn't take any study drug.|53
533327|NCT00819585|1300256|P5|Safety Population|Overall Study||53
533328|NCT00819585|1300257|P4|Safety Population|Overall Study||54
533329|NCT00819585|1300258|P3|Safety Population|Overall Study||54
533330|NCT00819585|1300259|P2|Safety Population|Overall Study||54
533331|NCT00819585|1300260|P1|Safety Population|Overall Study||55
533332|NCT00819585|1300254|P7|STARTED|Overall Study||108
533333|NCT00819585|1300255|P6|STARTED|Overall Study||54
533334|NCT00819585|1300256|P5|STARTED|Overall Study||53
533335|NCT00819585|1300257|P4|STARTED|Overall Study||54
533336|NCT00819585|1300258|P3|STARTED|Overall Study||54
533337|NCT00819585|1300259|P2|STARTED|Overall Study||54
533338|NCT00819585|1300260|P1|STARTED|Overall Study|"Started indicates randomized as well as full analysis set."|55
533339|NCT00819507|1300317|P1|NOT COMPLETED|Overall Study||0
533340|NCT00819507|1300317|P1|COMPLETED|Overall Study||25
533341|NCT00819507|1300317|P1|STARTED|Overall Study||25
533342|NCT00819403|1300324|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
533343|NCT00819403|1300325|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
533344|NCT00819403|1300324|P2|COMPLETED|Second Intervention (6 Weeks)||8
533345|NCT00819403|1300325|P1|COMPLETED|Second Intervention (6 Weeks)||7
533346|NCT00819403|1300324|P2|STARTED|Second Intervention (6 Weeks)||8
533347|NCT00819403|1300325|P1|STARTED|Second Intervention (6 Weeks)||7
533348|NCT00819403|1300324|P2|NOT COMPLETED|Washout (14 Days)||0
533349|NCT00819403|1300325|P1|NOT COMPLETED|Washout (14 Days)||0
533350|NCT00819403|1300324|P2|COMPLETED|Washout (14 Days)||8
533351|NCT00819403|1300325|P1|COMPLETED|Washout (14 Days)||7
533352|NCT00819403|1300324|P2|STARTED|Washout (14 Days)||8
533353|NCT00819403|1300325|P1|STARTED|Washout (14 Days)||7
533354|NCT00819403|1300324|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
533355|NCT00819403|1300325|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
533356|NCT00819403|1300324|P2|COMPLETED|First Intervention (6 Weeks)||8
533357|NCT00819403|1300325|P1|COMPLETED|First Intervention (6 Weeks)||7
533358|NCT00819403|1300324|P2|STARTED|First Intervention (6 Weeks)||8
533359|NCT00819403|1300325|P1|STARTED|First Intervention (6 Weeks)||7
533360|NCT00819390|1300337|P4|NOT COMPLETED|Overall Study||0
533361|NCT00819390|1300338|P3|NOT COMPLETED|Overall Study||1
533362|NCT00819390|1300339|P2|NOT COMPLETED|Overall Study||1
533363|NCT00819390|1300340|P1|NOT COMPLETED|Overall Study||3
533364|NCT00819390|1300337|P4|COMPLETED|Overall Study||19
533365|NCT00819390|1300338|P3|COMPLETED|Overall Study||17
533366|NCT00819390|1300339|P2|COMPLETED|Overall Study||16
533367|NCT00819390|1300340|P1|COMPLETED|Overall Study||13
533368|NCT00819390|1300337|P4|STARTED|Overall Study||19
533369|NCT00819390|1300338|P3|STARTED|Overall Study||18
533370|NCT00819390|1300339|P2|STARTED|Overall Study||17
533371|NCT00819390|1300340|P1|STARTED|Overall Study||16
533372|NCT00819286|1300452|P2|NOT COMPLETED|Overall Study||25
533373|NCT00819286|1300453|P1|NOT COMPLETED|Overall Study||14
533374|NCT00819286|1300452|P2|COMPLETED|Overall Study||45
533375|NCT00819286|1300453|P1|COMPLETED|Overall Study||56
533376|NCT00819286|1300452|P2|STARTED|Overall Study||70
533377|NCT00819286|1300453|P1|STARTED|Overall Study||70
533378|NCT00819260|1300461|P1|NOT COMPLETED|Overall Study||0
533379|NCT00819260|1300461|P1|COMPLETED|Overall Study||31
533380|NCT00819260|1300461|P1|STARTED|Overall Study||31
533381|NCT00819247|1300476|P3|NOT COMPLETED|Overall Study||14
533382|NCT00819247|1300477|P2|NOT COMPLETED|Overall Study||16
533383|NCT00819247|1300478|P1|NOT COMPLETED|Overall Study||11
533384|NCT00819247|1300476|P3|COMPLETED|Overall Study||26
533385|NCT00819247|1300477|P2|COMPLETED|Overall Study||30
533386|NCT00819247|1300478|P1|COMPLETED|Overall Study||32
533387|NCT00819247|1300476|P3|Per Protocol Population|Overall Study|One participant - baseline testosterone outside normal range.|38
533388|NCT00819247|1300477|P2|Per Protocol Population|Overall Study|Two participants - prohibited drugs|44
533389|NCT00819247|1300478|P1|Per Protocol Population|Overall Study|One participant- baseline testosterone outside normal range. Three participants- prohibited drugs.|38
533390|NCT00819247|1300476|P3|Intent-to-treat Population|Overall Study|One randomised participant withdrew at Day 1.|39
533391|NCT00819247|1300477|P2|Intent-to-treat Population|Overall Study||46
533392|NCT00819247|1300478|P1|Intent-to-treat Population|Overall Study|One randomised participant withdrew at Day 1.|42
533393|NCT00819247|1300476|P3|Randomized|Overall Study||40
533394|NCT00819247|1300477|P2|Randomized|Overall Study||46
533395|NCT00819247|1300478|P1|Randomized|Overall Study||43
533396|NCT00819247|1300476|P3|STARTED|Overall Study||40
533397|NCT00819247|1300477|P2|STARTED|Overall Study||46
533398|NCT00819247|1300478|P1|STARTED|Overall Study||43
533399|NCT00819234|1300504|P10|NOT COMPLETED|Overall Study||7
533400|NCT00819234|1300505|P9|NOT COMPLETED|Overall Study||6
533401|NCT00819234|1300506|P8|NOT COMPLETED|Overall Study||9
533402|NCT00819234|1300507|P7|NOT COMPLETED|Overall Study||5
533403|NCT00819234|1300508|P6|NOT COMPLETED|Overall Study||7
533404|NCT00819234|1300509|P5|NOT COMPLETED|Overall Study||1
533405|NCT00819234|1300510|P4|NOT COMPLETED|Overall Study||6
533406|NCT00819234|1300511|P3|NOT COMPLETED|Overall Study||8
533407|NCT00819234|1300512|P2|NOT COMPLETED|Overall Study||15
533408|NCT00819234|1300513|P1|NOT COMPLETED|Overall Study||10
533409|NCT00819234|1300504|P10|COMPLETED|Overall Study||30
533410|NCT00819234|1300505|P9|COMPLETED|Overall Study||31
533411|NCT00819234|1300506|P8|COMPLETED|Overall Study||20
533412|NCT00819234|1300507|P7|COMPLETED|Overall Study||8
533413|NCT00819234|1300508|P6|COMPLETED|Overall Study||7
533414|NCT00819234|1300509|P5|COMPLETED|Overall Study||12
533415|NCT00819234|1300510|P4|COMPLETED|Overall Study||22
533416|NCT00819234|1300511|P3|COMPLETED|Overall Study||28
533417|NCT00819234|1300512|P2|COMPLETED|Overall Study||20
533418|NCT00819234|1300513|P1|COMPLETED|Overall Study||21
533419|NCT00819234|1300504|P10|STARTED|Overall Study||37
533420|NCT00819234|1300505|P9|STARTED|Overall Study||37
533421|NCT00819234|1300506|P8|STARTED|Overall Study||29
533422|NCT00819234|1300507|P7|STARTED|Overall Study||13
533423|NCT00819234|1300508|P6|STARTED|Overall Study||14
533424|NCT00819234|1300509|P5|STARTED|Overall Study||13
533425|NCT00819234|1300510|P4|STARTED|Overall Study||28
533426|NCT00819234|1300511|P3|STARTED|Overall Study||36
533427|NCT00819234|1300512|P2|STARTED|Overall Study||35
533428|NCT00819234|1300513|P1|STARTED|Overall Study||31
533429|NCT00819182|1300674|P3|NOT COMPLETED|Overall Study||1
533430|NCT00819182|1300675|P2|NOT COMPLETED|Overall Study||8
533431|NCT00819182|1300676|P1|NOT COMPLETED|Overall Study||13
533432|NCT00819182|1300674|P3|COMPLETED|Overall Study||43
533433|NCT00819182|1300675|P2|COMPLETED|Overall Study||78
533434|NCT00819182|1300676|P1|COMPLETED|Overall Study||75
533435|NCT00819182|1300674|P3|Week 16 Visit|Overall Study||43
533436|NCT00819182|1300675|P2|Week 16 Visit|Overall Study||78
533437|NCT00819182|1300676|P1|Week 16 Visit|Overall Study||75
533610|NCT00818454|1301392|P1|STARTED|Treatment Period 3||0
533438|NCT00819182|1300674|P3|STARTED|Overall Study|Consented participants allocated to this arm.|44
533439|NCT00819182|1300675|P2|STARTED|Overall Study|Consented participants allocated to this arm.|86
533440|NCT00819182|1300676|P1|STARTED|Overall Study|Consented participants allocated to this arm.|88
533441|NCT00819156|1300712|P6|NOT COMPLETED|Overall Study||8
533442|NCT00819156|1300713|P5|NOT COMPLETED|Overall Study||6
533443|NCT00819156|1300714|P4|NOT COMPLETED|Overall Study||2
533444|NCT00819156|1300715|P3|NOT COMPLETED|Overall Study||6
533445|NCT00819156|1300716|P2|NOT COMPLETED|Overall Study||10
533446|NCT00819156|1300717|P1|NOT COMPLETED|Overall Study||10
533447|NCT00819156|1300712|P6|COMPLETED|Overall Study||23
533448|NCT00819156|1300713|P5|COMPLETED|Overall Study||27
533449|NCT00819156|1300714|P4|COMPLETED|Overall Study||28
533450|NCT00819156|1300715|P3|COMPLETED|Overall Study||26
533451|NCT00819156|1300716|P2|COMPLETED|Overall Study||23
533452|NCT00819156|1300717|P1|COMPLETED|Overall Study||20
533453|NCT00819156|1300712|P6|Randomised and Treated (ITT Population)|Overall Study||30
533454|NCT00819156|1300713|P5|Randomised and Treated (ITT Population)|Overall Study||33
533455|NCT00819156|1300714|P4|Randomised and Treated (ITT Population)|Overall Study||30
533456|NCT00819156|1300715|P3|Randomised and Treated (ITT Population)|Overall Study||32
533457|NCT00819156|1300716|P2|Randomised and Treated (ITT Population)|Overall Study||32
533458|NCT00819156|1300717|P1|Randomised and Treated (ITT Population)|Overall Study||30
533459|NCT00819156|1300712|P6|STARTED|Overall Study||31
533460|NCT00819156|1300713|P5|STARTED|Overall Study||33
533461|NCT00819156|1300714|P4|STARTED|Overall Study||30
533462|NCT00819156|1300715|P3|STARTED|Overall Study||32
533463|NCT00819156|1300716|P2|STARTED|Overall Study||33
533464|NCT00819156|1300717|P1|STARTED|Overall Study||30
533465|NCT00819091|1300807|P2|NOT COMPLETED|Overall Study||10
533466|NCT00819091|1300808|P1|NOT COMPLETED|Overall Study||7
533467|NCT00819091|1300807|P2|COMPLETED|Overall Study||151
533468|NCT00819091|1300808|P1|COMPLETED|Overall Study||77
533469|NCT00819091|1300807|P2|STARTED|Overall Study||161
533470|NCT00819091|1300808|P1|STARTED|Overall Study||84
533471|NCT00819052|1300834|P2|NOT COMPLETED|Overall Study||14
533472|NCT00819052|1300835|P1|NOT COMPLETED|Overall Study||6
533473|NCT00819052|1300834|P2|COMPLETED|Overall Study||281
533474|NCT00819052|1300835|P1|COMPLETED|Overall Study||142
533475|NCT00819052|1300834|P2|STARTED|Overall Study||295
533476|NCT00819052|1300835|P1|STARTED|Overall Study||148
533477|NCT00819039|1300950|P3|NOT COMPLETED|Overall Study||1
533478|NCT00819039|1300951|P2|NOT COMPLETED|Overall Study||0
533479|NCT00819039|1300952|P1|NOT COMPLETED|Overall Study||2
533480|NCT00819039|1300950|P3|COMPLETED|Overall Study||24
533481|NCT00819039|1300951|P2|COMPLETED|Overall Study||27
533482|NCT00819039|1300952|P1|COMPLETED|Overall Study||44
533483|NCT00819039|1300950|P3|STARTED|Overall Study||25
533484|NCT00819039|1300951|P2|STARTED|Overall Study||27
533485|NCT00819039|1300952|P1|STARTED|Overall Study||46
533486|NCT00819013|1300982|P4|NOT COMPLETED|Overall Study||4
533487|NCT00819013|1300983|P3|NOT COMPLETED|Overall Study||5
533488|NCT00819013|1300984|P2|NOT COMPLETED|Overall Study||1
533489|NCT00819013|1300985|P1|NOT COMPLETED|Overall Study||3
533490|NCT00819013|1300982|P4|COMPLETED|Overall Study||17
533491|NCT00819013|1300983|P3|COMPLETED|Overall Study||16
533492|NCT00819013|1300984|P2|COMPLETED|Overall Study||22
533493|NCT00819013|1300985|P1|COMPLETED|Overall Study||19
533494|NCT00819013|1300982|P4|STARTED|Overall Study||21
533495|NCT00819013|1300983|P3|STARTED|Overall Study||21
533496|NCT00819013|1300984|P2|STARTED|Overall Study||23
533497|NCT00819013|1300985|P1|STARTED|Overall Study||22
533498|NCT00818961|1301035|P1|NOT COMPLETED|Overall Study||0
533499|NCT00818961|1301035|P1|COMPLETED|Overall Study||36
533500|NCT00818961|1301035|P1|STARTED|Overall Study||36
533501|NCT00818883|1301051|P2|NOT COMPLETED|Overall Study||46
533502|NCT00818883|1301052|P1|NOT COMPLETED|Overall Study||51
533503|NCT00818883|1301051|P2|COMPLETED|Overall Study||260
533504|NCT00818883|1301052|P1|COMPLETED|Overall Study||252
533505|NCT00818883|1301051|P2|STARTED|Overall Study||306
533506|NCT00818883|1301052|P1|STARTED|Overall Study||303
533507|NCT00818805|1301086|P2|NOT COMPLETED|Second Intervention||0
533508|NCT00818805|1301087|P1|NOT COMPLETED|Second Intervention||0
533509|NCT00818805|1301086|P2|COMPLETED|Second Intervention||25
533510|NCT00818805|1301087|P1|COMPLETED|Second Intervention||25
533511|NCT00818805|1301086|P2|STARTED|Second Intervention||25
533512|NCT00818805|1301087|P1|STARTED|Second Intervention||25
533513|NCT00818805|1301086|P2|NOT COMPLETED|First Intervention||0
533514|NCT00818805|1301087|P1|NOT COMPLETED|First Intervention||0
533515|NCT00818805|1301086|P2|COMPLETED|First Intervention||25
533516|NCT00818805|1301087|P1|COMPLETED|First Intervention||25
533517|NCT00818805|1301086|P2|STARTED|First Intervention||25
533518|NCT00818805|1301087|P1|STARTED|First Intervention||25
533519|NCT00818779|1301099|P2|NOT COMPLETED|Overall Study||1
533520|NCT00818779|1301100|P1|NOT COMPLETED|Overall Study||6
533521|NCT00818779|1301099|P2|COMPLETED|Overall Study||15
533522|NCT00818779|1301100|P1|COMPLETED|Overall Study||16
533523|NCT00818779|1301099|P2|STARTED|Overall Study||16
533524|NCT00818779|1301100|P1|STARTED|Overall Study||22
533525|NCT00818766|1301116|P2|NOT COMPLETED|Overall Study||10
533526|NCT00818766|1301117|P1|NOT COMPLETED|Overall Study||15
533527|NCT00818766|1301116|P2|COMPLETED|Overall Study||116
533528|NCT00818766|1301117|P1|COMPLETED|Overall Study||110
533611|NCT00818454|1301389|P4|NOT COMPLETED|Treatment Period 2||0
533529|NCT00818766|1301116|P2|Intent-to-Treat Population|Overall Study|2 participants were randomized twice but only counted once (per first randomization).|124
533530|NCT00818766|1301117|P1|Intent-to-Treat Population|Overall Study|1 participant was randomized twice but only counted once (per first randomization).|121
533531|NCT00818766|1301116|P2|Received Allocated Intervention|Overall Study||126
533532|NCT00818766|1301117|P1|Received Allocated Intervention|Overall Study|1 withdrew consent, 1 had active infection and 1 was given open-label antibiotic after surgery.|122
533533|NCT00818766|1301116|P2|STARTED|Overall Study||126
533534|NCT00818766|1301117|P1|STARTED|Overall Study||125
533535|NCT00818753|1301146|P3|NOT COMPLETED|Overall Study||1
533536|NCT00818753|1301147|P2|NOT COMPLETED|Overall Study||0
533537|NCT00818753|1301148|P1|NOT COMPLETED|Overall Study||3
533538|NCT00818753|1301146|P3|COMPLETED|Overall Study||9
533539|NCT00818753|1301147|P2|COMPLETED|Overall Study||21
533540|NCT00818753|1301148|P1|COMPLETED|Overall Study||19
533541|NCT00818753|1301146|P3|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|10
533542|NCT00818753|1301147|P2|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|21
533543|NCT00818753|1301148|P1|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|22
533544|NCT00818662|1301172|P4|NOT COMPLETED|Overall Study||16
533545|NCT00818662|1301173|P3|NOT COMPLETED|Overall Study||9
533546|NCT00818662|1301174|P2|NOT COMPLETED|Overall Study||33
533547|NCT00818662|1301175|P1|NOT COMPLETED|Overall Study||23
533548|NCT00818662|1301172|P4|COMPLETED|Overall Study||47
533549|NCT00818662|1301173|P3|COMPLETED|Overall Study||49
533550|NCT00818662|1301174|P2|COMPLETED|Overall Study||102
533551|NCT00818662|1301175|P1|COMPLETED|Overall Study||104
533552|NCT00818662|1301172|P4|STARTED|Overall Study||63
533553|NCT00818662|1301173|P3|STARTED|Overall Study||58
533554|NCT00818662|1301174|P2|STARTED|Overall Study||135
533555|NCT00818662|1301175|P1|STARTED|Overall Study||127
533556|NCT00818649|1301261|P1|NOT COMPLETED|Overall Study||4
533557|NCT00818649|1301261|P1|COMPLETED|Overall Study||12
533558|NCT00818649|1301261|P1|STARTED|Overall Study||16
533559|NCT00818623|1301275|P8|NOT COMPLETED|Overall Study||1
533560|NCT00818623|1301276|P7|NOT COMPLETED|Overall Study||4
533561|NCT00818623|1301277|P6|NOT COMPLETED|Overall Study||3
533562|NCT00818623|1301278|P5|NOT COMPLETED|Overall Study||4
533563|NCT00818623|1301279|P4|NOT COMPLETED|Overall Study||5
533564|NCT00818623|1301280|P3|NOT COMPLETED|Overall Study||4
533565|NCT00818623|1301281|P2|NOT COMPLETED|Overall Study||4
533566|NCT00818623|1301282|P1|NOT COMPLETED|Overall Study||2
533567|NCT00818623|1301275|P8|COMPLETED|Overall Study||26
533568|NCT00818623|1301276|P7|COMPLETED|Overall Study||23
533569|NCT00818623|1301277|P6|COMPLETED|Overall Study||21
533570|NCT00818623|1301278|P5|COMPLETED|Overall Study||23
533571|NCT00818623|1301279|P4|COMPLETED|Overall Study||19
533572|NCT00818623|1301280|P3|COMPLETED|Overall Study||9
533573|NCT00818623|1301281|P2|COMPLETED|Overall Study||8
533574|NCT00818623|1301282|P1|COMPLETED|Overall Study||24
533575|NCT00818623|1301275|P8|Intent-to-treat (ITT) Population|Overall Study||27
533576|NCT00818623|1301276|P7|Intent-to-treat (ITT) Population|Overall Study|Three participants in this group were randomized but never received any treatment.|24
533577|NCT00818623|1301277|P6|Intent-to-treat (ITT) Population|Overall Study||24
533578|NCT00818623|1301278|P5|Intent-to-treat (ITT) Population|Overall Study|Three participants in this group were randomized but never received any treatment.|24
533579|NCT00818623|1301279|P4|Intent-to-treat (ITT) Population|Overall Study||24
533580|NCT00818623|1301280|P3|Intent-to-treat (ITT) Population|Overall Study|One participant in this group was randomized but never received any treatment.|12
533581|NCT00818623|1301281|P2|Intent-to-treat (ITT) Population|Overall Study||12
533582|NCT00818623|1301282|P1|Intent-to-treat (ITT) Population|Overall Study|One participant in this group was randomized but never received any treatment.|25
533583|NCT00818623|1301275|P8|STARTED|Overall Study||27
533584|NCT00818623|1301276|P7|STARTED|Overall Study||27
533585|NCT00818623|1301277|P6|STARTED|Overall Study||24
533586|NCT00818623|1301278|P5|STARTED|Overall Study||27
533587|NCT00818623|1301279|P4|STARTED|Overall Study||24
533588|NCT00818623|1301280|P3|STARTED|Overall Study||13
533589|NCT00818623|1301281|P2|STARTED|Overall Study||12
533590|NCT00818623|1301282|P1|STARTED|Overall Study||26
533591|NCT00818519|1301358|P2|NOT COMPLETED|Overall Study||19
533592|NCT00818519|1301359|P1|NOT COMPLETED|Overall Study||14
533593|NCT00818519|1301358|P2|COMPLETED|Overall Study||71
533594|NCT00818519|1301359|P1|COMPLETED|Overall Study||75
533595|NCT00818519|1301358|P2|Participants Received Treatment|Overall Study|= Baseline|86
533596|NCT00818519|1301359|P1|Participants Received Treatment|Overall Study|= Baseline|87
533597|NCT00818519|1301358|P2|STARTED|Overall Study|4 excluded from FAS because study drug intake unknown or never administered|90
533598|NCT00818519|1301359|P1|STARTED|Overall Study|2 excluded from FAS because study drug intake unknown or never administered|89
533599|NCT00818454|1301389|P4|NOT COMPLETED|Treatment Period 3||1
533600|NCT00818454|1301390|P3|NOT COMPLETED|Treatment Period 3||0
533601|NCT00818454|1301391|P2|NOT COMPLETED|Treatment Period 3||0
533602|NCT00818454|1301392|P1|NOT COMPLETED|Treatment Period 3||0
533603|NCT00818454|1301389|P4|COMPLETED|Treatment Period 3||138
533604|NCT00818454|1301390|P3|COMPLETED|Treatment Period 3||26
533605|NCT00818454|1301391|P2|COMPLETED|Treatment Period 3||0
533606|NCT00818454|1301392|P1|COMPLETED|Treatment Period 3||0
533607|NCT00818454|1301389|P4|STARTED|Treatment Period 3||139
533608|NCT00818454|1301390|P3|STARTED|Treatment Period 3||26
533609|NCT00818454|1301391|P2|STARTED|Treatment Period 3||0
533612|NCT00818454|1301390|P3|NOT COMPLETED|Treatment Period 2||0
533613|NCT00818454|1301391|P2|NOT COMPLETED|Treatment Period 2||1
533614|NCT00818454|1301392|P1|NOT COMPLETED|Treatment Period 2||2
533615|NCT00818454|1301389|P4|COMPLETED|Treatment Period 2||0
533616|NCT00818454|1301390|P3|COMPLETED|Treatment Period 2||0
533617|NCT00818454|1301391|P2|COMPLETED|Treatment Period 2||106
533618|NCT00818454|1301392|P1|COMPLETED|Treatment Period 2||106
533619|NCT00818454|1301389|P4|STARTED|Treatment Period 2||0
533620|NCT00818454|1301390|P3|STARTED|Treatment Period 2||0
533621|NCT00818454|1301391|P2|STARTED|Treatment Period 2||107
533622|NCT00818454|1301392|P1|STARTED|Treatment Period 2||108
533623|NCT00818454|1301389|P4|NOT COMPLETED|Washout Period of 1 Week||0
533624|NCT00818454|1301390|P3|NOT COMPLETED|Washout Period of 1 Week||0
533625|NCT00818454|1301391|P2|NOT COMPLETED|Washout Period of 1 Week||3
533626|NCT00818454|1301392|P1|NOT COMPLETED|Washout Period of 1 Week||4
533627|NCT00818454|1301389|P4|COMPLETED|Washout Period of 1 Week||0
533628|NCT00818454|1301390|P3|COMPLETED|Washout Period of 1 Week||0
533629|NCT00818454|1301391|P2|COMPLETED|Washout Period of 1 Week||107
533630|NCT00818454|1301392|P1|COMPLETED|Washout Period of 1 Week||108
533631|NCT00818454|1301389|P4|STARTED|Washout Period of 1 Week||0
533632|NCT00818454|1301390|P3|STARTED|Washout Period of 1 Week||0
533633|NCT00818454|1301391|P2|STARTED|Washout Period of 1 Week||110
533634|NCT00818454|1301392|P1|STARTED|Washout Period of 1 Week||112
533635|NCT00818454|1301389|P4|NOT COMPLETED|Treatment Period 1||0
533636|NCT00818454|1301390|P3|NOT COMPLETED|Treatment Period 1||0
533637|NCT00818454|1301391|P2|NOT COMPLETED|Treatment Period 1||1
533638|NCT00818454|1301392|P1|NOT COMPLETED|Treatment Period 1||3
533639|NCT00818454|1301389|P4|COMPLETED|Treatment Period 1||0
533640|NCT00818454|1301390|P3|COMPLETED|Treatment Period 1||0
533641|NCT00818454|1301391|P2|COMPLETED|Treatment Period 1||110
533642|NCT00818454|1301392|P1|COMPLETED|Treatment Period 1||112
533643|NCT00818454|1301389|P4|STARTED|Treatment Period 1||0
533644|NCT00818454|1301390|P3|STARTED|Treatment Period 1||0
533645|NCT00818454|1301391|P2|STARTED|Treatment Period 1||111
533646|NCT00818454|1301392|P1|STARTED|Treatment Period 1||115
533647|NCT00818441|1301420|P2|NOT COMPLETED|Overall Study||30
533648|NCT00818441|1301421|P1|NOT COMPLETED|Overall Study||89
533649|NCT00818441|1301420|P2|COMPLETED|Overall Study||0
533650|NCT00818441|1301421|P1|COMPLETED|Overall Study||0
533651|NCT00818441|1301420|P2|STARTED|Overall Study||30
533652|NCT00818441|1301421|P1|STARTED|Overall Study||89
533653|NCT00818389|1301443|P2|NOT COMPLETED|Overall Study||6
533654|NCT00818389|1301444|P1|NOT COMPLETED|Overall Study||4
533655|NCT00818389|1301443|P2|COMPLETED|Overall Study|6 subjects terminated study early before 1st interim analysis. Study terminated early for futility.|38
533656|NCT00818389|1301444|P1|COMPLETED|Overall Study|4 subjects terminated study early before 1st interim analysis. Study terminated early for futility.|36
533657|NCT00818389|1301443|P2|STARTED|Overall Study||44
533658|NCT00818389|1301444|P1|STARTED|Overall Study||40
533659|NCT00818337|1301454|P1|NOT COMPLETED|Overall Study||0
533660|NCT00818337|1301454|P1|COMPLETED|Overall Study||36
533661|NCT00818337|1301454|P1|STARTED|Overall Study||36
533662|NCT00818324|1301459|P1|NOT COMPLETED|Overall Study||27
533663|NCT00818324|1301459|P1|COMPLETED|Overall Study||127
533664|NCT00818324|1301459|P1|STARTED|Overall Study||154
533665|NCT00818272|1301464|P1|NOT COMPLETED|Overall Study||74
533666|NCT00818272|1301464|P1|COMPLETED|Overall Study||74
533667|NCT00818272|1301464|P1|STARTED|Overall Study||148
533668|NCT00818259|1301479|P9|NOT COMPLETED|Part V||0
533669|NCT00818259|1301480|P8|NOT COMPLETED|Part V||1
533670|NCT00818259|1301481|P7|NOT COMPLETED|Part V||0
533671|NCT00818259|1301482|P6|NOT COMPLETED|Part V||0
533672|NCT00818259|1301483|P5|NOT COMPLETED|Part V||0
533673|NCT00818259|1301484|P4|NOT COMPLETED|Part V||0
533674|NCT00818259|1301485|P3|NOT COMPLETED|Part V||0
533675|NCT00818259|1301486|P2|NOT COMPLETED|Part V||0
533676|NCT00818259|1301487|P1|NOT COMPLETED|Part V||0
533677|NCT00818259|1301479|P9|COMPLETED|Part V||6
533678|NCT00818259|1301480|P8|COMPLETED|Part V||16
533679|NCT00818259|1301481|P7|COMPLETED|Part V||0
533680|NCT00818259|1301482|P6|COMPLETED|Part V||0
533681|NCT00818259|1301483|P5|COMPLETED|Part V||0
533682|NCT00818259|1301484|P4|COMPLETED|Part V||0
533683|NCT00818259|1301485|P3|COMPLETED|Part V||0
533684|NCT00818259|1301486|P2|COMPLETED|Part V||0
533685|NCT00818259|1301487|P1|COMPLETED|Part V||0
533686|NCT00818259|1301479|P9|STARTED|Part V|Newly enrolled participants|6
533687|NCT00818259|1301480|P8|STARTED|Part V|Participants continuing from Part IV|17
533688|NCT00818259|1301481|P7|STARTED|Part V||0
533689|NCT00818259|1301482|P6|STARTED|Part V||0
533690|NCT00818259|1301483|P5|STARTED|Part V||0
533691|NCT00818259|1301484|P4|STARTED|Part V||0
533692|NCT00818259|1301485|P3|STARTED|Part V||0
533693|NCT00818259|1301486|P2|STARTED|Part V||0
533694|NCT00818259|1301487|P1|STARTED|Part V||0
533695|NCT00818259|1301479|P9|NOT COMPLETED|Part IV||0
533696|NCT00818259|1301480|P8|NOT COMPLETED|Part IV||0
533697|NCT00818259|1301481|P7|NOT COMPLETED|Part IV||0
533698|NCT00818259|1301482|P6|NOT COMPLETED|Part IV||1
533699|NCT00818259|1301483|P5|NOT COMPLETED|Part IV||0
533700|NCT00818259|1301484|P4|NOT COMPLETED|Part IV||0
533701|NCT00818259|1301485|P3|NOT COMPLETED|Part IV||0
533702|NCT00818259|1301486|P2|NOT COMPLETED|Part IV||0
533703|NCT00818259|1301487|P1|NOT COMPLETED|Part IV||0
533704|NCT00818259|1301479|P9|COMPLETED|Part IV||0
533705|NCT00818259|1301480|P8|COMPLETED|Part IV||0
533706|NCT00818259|1301481|P7|COMPLETED|Part IV||5
533707|NCT00818259|1301482|P6|COMPLETED|Part IV||14
533708|NCT00818259|1301483|P5|COMPLETED|Part IV||0
533709|NCT00818259|1301484|P4|COMPLETED|Part IV||0
533710|NCT00818259|1301485|P3|COMPLETED|Part IV||0
533711|NCT00818259|1301486|P2|COMPLETED|Part IV||0
533712|NCT00818259|1301487|P1|COMPLETED|Part IV||0
533713|NCT00818259|1301479|P9|STARTED|Part IV||0
533714|NCT00818259|1301480|P8|STARTED|Part IV||0
533715|NCT00818259|1301481|P7|STARTED|Part IV|Newly enrolled participants|5
533716|NCT00818259|1301482|P6|STARTED|Part IV|Participants continuing from Part III|15
533717|NCT00818259|1301483|P5|STARTED|Part IV||0
533718|NCT00818259|1301484|P4|STARTED|Part IV||0
533719|NCT00818259|1301485|P3|STARTED|Part IV||0
533720|NCT00818259|1301486|P2|STARTED|Part IV||0
533721|NCT00818259|1301487|P1|STARTED|Part IV||0
533722|NCT00818259|1301479|P9|NOT COMPLETED|Part III||0
533723|NCT00818259|1301480|P8|NOT COMPLETED|Part III||0
533724|NCT00818259|1301481|P7|NOT COMPLETED|Part III||0
533725|NCT00818259|1301482|P6|NOT COMPLETED|Part III||0
533726|NCT00818259|1301483|P5|NOT COMPLETED|Part III||0
533727|NCT00818259|1301484|P4|NOT COMPLETED|Part III||0
533728|NCT00818259|1301485|P3|NOT COMPLETED|Part III||0
533729|NCT00818259|1301486|P2|NOT COMPLETED|Part III||0
533730|NCT00818259|1301487|P1|NOT COMPLETED|Part III||0
533731|NCT00818259|1301479|P9|COMPLETED|Part III||0
533732|NCT00818259|1301480|P8|COMPLETED|Part III||0
533733|NCT00818259|1301481|P7|COMPLETED|Part III||0
533734|NCT00818259|1301482|P6|COMPLETED|Part III||0
533735|NCT00818259|1301483|P5|COMPLETED|Part III||19
533736|NCT00818259|1301484|P4|COMPLETED|Part III||0
533737|NCT00818259|1301485|P3|COMPLETED|Part III||0
533738|NCT00818259|1301486|P2|COMPLETED|Part III||0
533739|NCT00818259|1301487|P1|COMPLETED|Part III||0
533740|NCT00818259|1301479|P9|STARTED|Part III||0
533741|NCT00818259|1301480|P8|STARTED|Part III||0
533742|NCT00818259|1301481|P7|STARTED|Part III||0
533743|NCT00818259|1301482|P6|STARTED|Part III||0
533744|NCT00818259|1301483|P5|STARTED|Part III|Newly enrolled participants|19
533745|NCT00818259|1301484|P4|STARTED|Part III||0
533746|NCT00818259|1301485|P3|STARTED|Part III||0
533747|NCT00818259|1301486|P2|STARTED|Part III||0
533748|NCT00818259|1301487|P1|STARTED|Part III||0
533749|NCT00818259|1301479|P9|NOT COMPLETED|Part II||0
533750|NCT00818259|1301480|P8|NOT COMPLETED|Part II||0
533751|NCT00818259|1301481|P7|NOT COMPLETED|Part II||0
533752|NCT00818259|1301482|P6|NOT COMPLETED|Part II||0
533753|NCT00818259|1301483|P5|NOT COMPLETED|Part II||0
533754|NCT00818259|1301484|P4|NOT COMPLETED|Part II||2
533755|NCT00818259|1301485|P3|NOT COMPLETED|Part II||1
533756|NCT00818259|1301486|P2|NOT COMPLETED|Part II||0
533757|NCT00818259|1301487|P1|NOT COMPLETED|Part II||0
533758|NCT00818259|1301479|P9|COMPLETED|Part II||0
533759|NCT00818259|1301480|P8|COMPLETED|Part II||0
533760|NCT00818259|1301481|P7|COMPLETED|Part II||0
533761|NCT00818259|1301482|P6|COMPLETED|Part II||0
533762|NCT00818259|1301483|P5|COMPLETED|Part II||0
533763|NCT00818259|1301484|P4|COMPLETED|Part II||18
533764|NCT00818259|1301485|P3|COMPLETED|Part II||18
533765|NCT00818259|1301486|P2|COMPLETED|Part II||0
533766|NCT00818259|1301487|P1|COMPLETED|Part II||0
533767|NCT00818259|1301479|P9|Treated|Part II||0
533768|NCT00818259|1301480|P8|Treated|Part II||0
533769|NCT00818259|1301481|P7|Treated|Part II||0
533770|NCT00818259|1301482|P6|Treated|Part II||0
533771|NCT00818259|1301483|P5|Treated|Part II||0
533772|NCT00818259|1301484|P4|Treated|Part II||19
533773|NCT00818259|1301485|P3|Treated|Part II||19
533774|NCT00818259|1301486|P2|Treated|Part II||0
533775|NCT00818259|1301487|P1|Treated|Part II||0
533776|NCT00818259|1301479|P9|STARTED|Part II||0
533777|NCT00818259|1301480|P8|STARTED|Part II||0
533778|NCT00818259|1301481|P7|STARTED|Part II||0
533779|NCT00818259|1301482|P6|STARTED|Part II||0
533780|NCT00818259|1301483|P5|STARTED|Part II||0
533781|NCT00818259|1301484|P4|STARTED|Part II|Newly enrolled participants|20
533782|NCT00818259|1301485|P3|STARTED|Part II|Newly enrolled participants|19
533783|NCT00818259|1301486|P2|STARTED|Part II||0
533784|NCT00818259|1301487|P1|STARTED|Part II||0
533785|NCT00818259|1301479|P9|NOT COMPLETED|Part I||0
533786|NCT00818259|1301480|P8|NOT COMPLETED|Part I||0
533787|NCT00818259|1301481|P7|NOT COMPLETED|Part I||0
533788|NCT00818259|1301482|P6|NOT COMPLETED|Part I||0
533789|NCT00818259|1301483|P5|NOT COMPLETED|Part I||0
533790|NCT00818259|1301484|P4|NOT COMPLETED|Part I||0
533791|NCT00818259|1301485|P3|NOT COMPLETED|Part I||0
533792|NCT00818259|1301486|P2|NOT COMPLETED|Part I||0
533793|NCT00818259|1301487|P1|NOT COMPLETED|Part I||1
533794|NCT00818259|1301479|P9|COMPLETED|Part I||0
533795|NCT00818259|1301480|P8|COMPLETED|Part I||0
533796|NCT00818259|1301481|P7|COMPLETED|Part I||0
533797|NCT00818259|1301482|P6|COMPLETED|Part I||0
533798|NCT00818259|1301483|P5|COMPLETED|Part I||0
533799|NCT00818259|1301484|P4|COMPLETED|Part I||0
533800|NCT00818259|1301485|P3|COMPLETED|Part I||0
533801|NCT00818259|1301486|P2|COMPLETED|Part I||11
533802|NCT00818259|1301487|P1|COMPLETED|Part I||11
533803|NCT00818259|1301479|P9|STARTED|Part I||0
533804|NCT00818259|1301480|P8|STARTED|Part I||0
533805|NCT00818259|1301481|P7|STARTED|Part I||0
533806|NCT00818259|1301482|P6|STARTED|Part I||0
533807|NCT00818259|1301483|P5|STARTED|Part I||0
533808|NCT00818259|1301484|P4|STARTED|Part I||0
533809|NCT00818259|1301485|P3|STARTED|Part I||0
533810|NCT00818259|1301486|P2|STARTED|Part I|Newly enrolled participants|11
533811|NCT00818259|1301487|P1|STARTED|Part I|Newly enrolled participants|12
533812|NCT00818259|1301479|P9|NOT COMPLETED|Randomization||0
533813|NCT00818259|1301480|P8|NOT COMPLETED|Randomization||0
533814|NCT00818259|1301481|P7|NOT COMPLETED|Randomization||0
533815|NCT00818259|1301482|P6|NOT COMPLETED|Randomization||0
533816|NCT00818259|1301483|P5|NOT COMPLETED|Randomization||0
533817|NCT00818259|1301484|P4|NOT COMPLETED|Randomization||0
533818|NCT00818259|1301485|P3|NOT COMPLETED|Randomization||0
533819|NCT00818259|1301486|P2|NOT COMPLETED|Randomization||0
533820|NCT00818259|1301487|P1|NOT COMPLETED|Randomization||0
533821|NCT00818259|1301479|P9|COMPLETED|Randomization||6
533822|NCT00818259|1301480|P8|COMPLETED|Randomization||0
533823|NCT00818259|1301481|P7|COMPLETED|Randomization||5
533824|NCT00818259|1301482|P6|COMPLETED|Randomization||0
533825|NCT00818259|1301483|P5|COMPLETED|Randomization||19
533826|NCT00818259|1301484|P4|COMPLETED|Randomization||20
533827|NCT00818259|1301485|P3|COMPLETED|Randomization||19
533828|NCT00818259|1301486|P2|COMPLETED|Randomization||11
533829|NCT00818259|1301487|P1|COMPLETED|Randomization||12
533830|NCT00818259|1301479|P9|STARTED|Randomization||6
533831|NCT00818259|1301480|P8|STARTED|Randomization||0
533832|NCT00818259|1301481|P7|STARTED|Randomization||5
533833|NCT00818259|1301482|P6|STARTED|Randomization||0
533834|NCT00818259|1301483|P5|STARTED|Randomization||19
533835|NCT00818259|1301484|P4|STARTED|Randomization||20
533836|NCT00818259|1301485|P3|STARTED|Randomization||19
533837|NCT00818259|1301486|P2|STARTED|Randomization||11
533838|NCT00818259|1301487|P1|STARTED|Randomization||12
533839|NCT00818246|1301559|P1|NOT COMPLETED|Overall Study||5
533840|NCT00818246|1301559|P1|COMPLETED|Overall Study|split-face study|35
533841|NCT00818246|1301559|P1|STARTED|Overall Study||40
533842|NCT00818207|1301568|P2|NOT COMPLETED|Overall Study||267
533843|NCT00818207|1301569|P1|NOT COMPLETED|Overall Study||222
533844|NCT00818207|1301568|P2|COMPLETED|Overall Study||417
533845|NCT00818207|1301569|P1|COMPLETED|Overall Study||474
533846|NCT00818207|1301568|P2|STARTED|Overall Study||684
533847|NCT00818207|1301569|P1|STARTED|Overall Study||696
533848|NCT00818168|1301583|P1|NOT COMPLETED|Overall Study||70
533849|NCT00818168|1301583|P1|COMPLETED|Overall Study|Includes 78 participants whose completer/non-completer status was not reported (missing)|250
533850|NCT00818168|1301583|P1|STARTED|Overall Study||320
533851|NCT00818116|1301591|P1|NOT COMPLETED|Overall Study||0
533852|NCT00818116|1301591|P1|COMPLETED|Overall Study||34
533853|NCT00818116|1301591|P1|STARTED|Overall Study||34
533854|NCT00817999|1301597|P2|NOT COMPLETED|No Grapefruit Juice||0
533855|NCT00817999|1301598|P1|NOT COMPLETED|No Grapefruit Juice||0
533856|NCT00817999|1301597|P2|COMPLETED|No Grapefruit Juice||17
533857|NCT00817999|1301598|P1|COMPLETED|No Grapefruit Juice||15
533858|NCT00817999|1301597|P2|STARTED|No Grapefruit Juice||17
533859|NCT00817999|1301598|P1|STARTED|No Grapefruit Juice||15
533860|NCT00817999|1301597|P2|NOT COMPLETED|Grapefruit Juice||0
533861|NCT00817999|1301598|P1|NOT COMPLETED|Grapefruit Juice||0
533862|NCT00817999|1301597|P2|COMPLETED|Grapefruit Juice||17
533863|NCT00817999|1301598|P1|COMPLETED|Grapefruit Juice||15
533864|NCT00817999|1301597|P2|STARTED|Grapefruit Juice||17
533865|NCT00817999|1301598|P1|STARTED|Grapefruit Juice||15
533866|NCT00817843|1301606|P2|NOT COMPLETED|Second Period (6 Weeks)||1
533867|NCT00817843|1301607|P1|NOT COMPLETED|Second Period (6 Weeks)||0
533868|NCT00817843|1301606|P2|COMPLETED|Second Period (6 Weeks)||44
533869|NCT00817843|1301607|P1|COMPLETED|Second Period (6 Weeks)|All patients with >=1 postrandomization dose and measurement were analyzed|41
533870|NCT00817843|1301606|P2|STARTED|Second Period (6 Weeks)||45
533871|NCT00817843|1301607|P1|STARTED|Second Period (6 Weeks)||41
533872|NCT00817843|1301606|P2|NOT COMPLETED|Washout Period (6 Weeks)||1
533873|NCT00817843|1301607|P1|NOT COMPLETED|Washout Period (6 Weeks)||1
533874|NCT00817843|1301606|P2|COMPLETED|Washout Period (6 Weeks)||45
533875|NCT00817843|1301607|P1|COMPLETED|Washout Period (6 Weeks)||41
533876|NCT00817843|1301606|P2|STARTED|Washout Period (6 Weeks)||46
533877|NCT00817843|1301607|P1|STARTED|Washout Period (6 Weeks)||42
533878|NCT00817843|1301606|P2|NOT COMPLETED|First Period (6 Weeks)||4
533879|NCT00817843|1301607|P1|NOT COMPLETED|First Period (6 Weeks)||8
533880|NCT00817843|1301606|P2|COMPLETED|First Period (6 Weeks)||46
533881|NCT00817843|1301607|P1|COMPLETED|First Period (6 Weeks)|All patients with >=1 postrandomization dose and measurement were analyzed|42
533882|NCT00817843|1301606|P2|STARTED|First Period (6 Weeks)||50
533883|NCT00817843|1301607|P1|STARTED|First Period (6 Weeks)||50
533884|NCT00817804|1301614|P2|NOT COMPLETED|Overall Study||0
533885|NCT00817804|1301615|P1|NOT COMPLETED|Overall Study||0
533886|NCT00817804|1301614|P2|COMPLETED|Overall Study||2
533887|NCT00817804|1301615|P1|COMPLETED|Overall Study||1
533888|NCT00817804|1301614|P2|STARTED|Overall Study||2
533889|NCT00817804|1301615|P1|STARTED|Overall Study||1
533890|NCT00817778|1301623|P2|NOT COMPLETED|Overall Study||3
533891|NCT00817778|1301624|P1|NOT COMPLETED|Overall Study||3
533892|NCT00817778|1301623|P2|COMPLETED|Overall Study||5
533893|NCT00817778|1301624|P1|COMPLETED|Overall Study||16
533894|NCT00817778|1301623|P2|STARTED|Overall Study||8
533895|NCT00817778|1301624|P1|STARTED|Overall Study||19
533896|NCT00817596|1301649|P1|NOT COMPLETED|Overall Study||48
533897|NCT00817596|1301649|P1|COMPLETED|Overall Study||62
533898|NCT00817596|1301649|P1|STARTED|Overall Study||110
533899|NCT00817531|1301653|P1|NOT COMPLETED|Overall Study||2
533900|NCT00817531|1301653|P1|COMPLETED|Overall Study|20 out of 22 patients finished study treatment. 2 patients stopped the treatment after the 1st week.|20
533901|NCT00817531|1301653|P1|STARTED|Overall Study|22 patients were eligible for this study and started the treatment.|22
533902|NCT00817479|1301659|P2|NOT COMPLETED|Overall Study||1
533903|NCT00817479|1301660|P1|NOT COMPLETED|Overall Study||1
533904|NCT00817479|1301659|P2|COMPLETED|Overall Study||13
533905|NCT00817479|1301660|P1|COMPLETED|Overall Study||5
533906|NCT00817479|1301659|P2|STARTED|Overall Study||14
533907|NCT00817479|1301660|P1|STARTED|Overall Study||6
533908|NCT00817336|1301670|P2|NOT COMPLETED|Overall Study||1
533909|NCT00817336|1301671|P1|NOT COMPLETED|Overall Study||1
533910|NCT00817336|1301670|P2|COMPLETED|Overall Study||7
533911|NCT00817336|1301671|P1|COMPLETED|Overall Study||7
533912|NCT00817336|1301670|P2|STARTED|Overall Study||8
533913|NCT00817336|1301671|P1|STARTED|Overall Study||8
533914|NCT00817219|1301682|P1|NOT COMPLETED|Overall Study||0
533915|NCT00817219|1301682|P1|COMPLETED|Overall Study||33
533916|NCT00817219|1301682|P1|STARTED|Overall Study||33
533917|NCT00817206|1301697|P2|NOT COMPLETED|Overall Study||9
533918|NCT00817206|1301698|P1|NOT COMPLETED|Overall Study||21
533919|NCT00817206|1301697|P2|COMPLETED|Overall Study||154
533920|NCT00817206|1301698|P1|COMPLETED|Overall Study||142
533921|NCT00817206|1301697|P2|STARTED|Overall Study||163
533922|NCT00817206|1301698|P1|STARTED|Overall Study||163
533923|NCT00817063|1301706|P2|NOT COMPLETED|Overall Study||170
533924|NCT00817063|1301707|P1|NOT COMPLETED|Overall Study||137
533925|NCT00817063|1301706|P2|COMPLETED|Overall Study||128
533926|NCT00817063|1301707|P1|COMPLETED|Overall Study||161
533927|NCT00817063|1301706|P2|STARTED|Overall Study||298
533928|NCT00817063|1301707|P1|STARTED|Overall Study||298
533929|NCT00816907|1301751|P2|NOT COMPLETED|Overall Study||17
533930|NCT00816907|1301752|P1|NOT COMPLETED|Overall Study||13
533931|NCT00816907|1301751|P2|COMPLETED|Overall Study||58
533932|NCT00816907|1301752|P1|COMPLETED|Overall Study||58
533933|NCT00816907|1301751|P2|STARTED|Overall Study||75
533934|NCT00816907|1301752|P1|STARTED|Overall Study||71
533935|NCT00816829|1301774|P2|NOT COMPLETED|Overall Study||0
533936|NCT00816829|1301775|P1|NOT COMPLETED|Overall Study||0
533937|NCT00816829|1301774|P2|COMPLETED|Overall Study||18
533938|NCT00816829|1301775|P1|COMPLETED|Overall Study||16
533939|NCT00816829|1301774|P2|STARTED|Overall Study||18
533940|NCT00816829|1301775|P1|STARTED|Overall Study||16
533941|NCT00816777|1301801|P2|NOT COMPLETED|Overall Study||0
533942|NCT00816777|1301802|P1|NOT COMPLETED|Overall Study||0
533943|NCT00816777|1301801|P2|COMPLETED|Overall Study||2
533944|NCT00816777|1301802|P1|COMPLETED|Overall Study||2
533945|NCT00816777|1301801|P2|STARTED|Overall Study||2
533946|NCT00816777|1301802|P1|STARTED|Overall Study||2
533947|NCT00816595|1301810|P2|NOT COMPLETED|Overall Study||0
533948|NCT00816595|1301811|P1|NOT COMPLETED|Overall Study||2
533949|NCT00816595|1301810|P2|COMPLETED|Overall Study||33
533950|NCT00816595|1301811|P1|COMPLETED|Overall Study||33
533951|NCT00816595|1301810|P2|STARTED|Overall Study||33
533952|NCT00816595|1301811|P1|STARTED|Overall Study||35
533953|NCT00816556|1301824|P3|NOT COMPLETED|Overall Study||3
533954|NCT00816556|1301825|P2|NOT COMPLETED|Overall Study||2
533955|NCT00816556|1301826|P1|NOT COMPLETED|Overall Study||2
533956|NCT00816556|1301824|P3|COMPLETED|Overall Study||19
533957|NCT00816556|1301825|P2|COMPLETED|Overall Study||19
533958|NCT00816556|1301826|P1|COMPLETED|Overall Study||18
533959|NCT00816556|1301824|P3|STARTED|Overall Study||22
533960|NCT00816556|1301825|P2|STARTED|Overall Study||21
533961|NCT00816556|1301826|P1|STARTED|Overall Study||20
533962|NCT00816400|1301849|P9|NOT COMPLETED|Overall Study||6
533963|NCT00816400|1301850|P8|NOT COMPLETED|Overall Study||5
533964|NCT00816400|1301851|P7|NOT COMPLETED|Overall Study||2
533965|NCT00816400|1301852|P6|NOT COMPLETED|Overall Study||3
533966|NCT00816400|1301853|P5|NOT COMPLETED|Overall Study||2
533967|NCT00816400|1301854|P4|NOT COMPLETED|Overall Study||3
533968|NCT00816400|1301855|P3|NOT COMPLETED|Overall Study||5
533969|NCT00816400|1301856|P2|NOT COMPLETED|Overall Study||3
533970|NCT00816400|1301857|P1|NOT COMPLETED|Overall Study||2
533971|NCT00816400|1301849|P9|COMPLETED|Overall Study||0
533972|NCT00816400|1301850|P8|COMPLETED|Overall Study||1
533973|NCT00816400|1301851|P7|COMPLETED|Overall Study||1
533974|NCT00816400|1301852|P6|COMPLETED|Overall Study||0
533975|NCT00816400|1301853|P5|COMPLETED|Overall Study||1
533976|NCT00816400|1301854|P4|COMPLETED|Overall Study||0
533977|NCT00816400|1301855|P3|COMPLETED|Overall Study||0
533978|NCT00816400|1301856|P2|COMPLETED|Overall Study||0
533979|NCT00816400|1301857|P1|COMPLETED|Overall Study||1
533980|NCT00816400|1301849|P9|STARTED|Overall Study||6
533981|NCT00816400|1301850|P8|STARTED|Overall Study||6
533982|NCT00816400|1301851|P7|STARTED|Overall Study||3
533983|NCT00816400|1301852|P6|STARTED|Overall Study||3
533984|NCT00816400|1301853|P5|STARTED|Overall Study||3
533985|NCT00816400|1301854|P4|STARTED|Overall Study||3
533986|NCT00816400|1301855|P3|STARTED|Overall Study||5
533987|NCT00816400|1301856|P2|STARTED|Overall Study||3
533988|NCT00816400|1301857|P1|STARTED|Overall Study||3
533989|NCT00816348|1302041|P1|NOT COMPLETED|Overall Study||0
533990|NCT00816348|1302041|P1|COMPLETED|Overall Study||15
533991|NCT00816348|1302041|P1|STARTED|Overall Study||15
533992|NCT00816166|1302047|P2|NOT COMPLETED|Overall Study||12
533993|NCT00816166|1302048|P1|NOT COMPLETED|Overall Study||10
533994|NCT00816166|1302047|P2|COMPLETED|Overall Study||41
533995|NCT00816166|1302048|P1|COMPLETED|Overall Study||49
533996|NCT00816166|1302047|P2|ITT Population (Met Eligibility)|Overall Study||53
533997|NCT00816166|1302048|P1|ITT Population (Met Eligibility)|Overall Study|Of 59 randomized to Stent Arm, 1 subject failed to meet eligibility and was excluded from the ITT|58
533998|NCT00816166|1302047|P2|STARTED|Overall Study|Of 53 randomized to Medical Therapy Arm, 9 were treated with Stent+Medical Therapy|53
533999|NCT00816166|1302048|P1|STARTED|Overall Study|Of 59 randomized to Stent Arm, 4 were treated with Medical Therapy Only|59
534000|NCT00816101|1302057|P3|NOT COMPLETED|Overall Study||0
534001|NCT00816101|1302058|P2|NOT COMPLETED|Overall Study||0
534002|NCT00816101|1302059|P1|NOT COMPLETED|Overall Study||0
534003|NCT00816101|1302057|P3|COMPLETED|Overall Study||5
534004|NCT00816101|1302058|P2|COMPLETED|Overall Study||8
534005|NCT00816101|1302059|P1|COMPLETED|Overall Study||13
534006|NCT00816101|1302057|P3|STARTED|Overall Study||5
534007|NCT00816101|1302058|P2|STARTED|Overall Study||8
534008|NCT00816101|1302059|P1|STARTED|Overall Study||13
534009|NCT00816062|1302073|P1|NOT COMPLETED|Overall Study||127
534010|NCT00816062|1302073|P1|COMPLETED|Overall Study||133
534011|NCT00816062|1302073|P1|STARTED|Overall Study||260
534012|NCT00816036|1302080|P2|NOT COMPLETED|Overall Study||108
534013|NCT00816036|1302081|P1|NOT COMPLETED|Overall Study||176
534014|NCT00816036|1302080|P2|COMPLETED|Overall Study||287
534015|NCT00816036|1302081|P1|COMPLETED|Overall Study||327
534016|NCT00816036|1302080|P2|STARTED|Overall Study||395
534017|NCT00816036|1302081|P1|STARTED|Overall Study||503
534018|NCT00816023|1302095|P4|NOT COMPLETED|Overall Study||12
534019|NCT00816023|1302096|P3|NOT COMPLETED|Overall Study||9
534020|NCT00816023|1302097|P2|NOT COMPLETED|Overall Study||6
534021|NCT00816023|1302098|P1|NOT COMPLETED|Overall Study||9
534022|NCT00816023|1302095|P4|COMPLETED|Overall Study||62
534023|NCT00816023|1302096|P3|COMPLETED|Overall Study||60
534024|NCT00816023|1302097|P2|COMPLETED|Overall Study||56
534025|NCT00816023|1302098|P1|COMPLETED|Overall Study||62
534026|NCT00816023|1302095|P4|Completed Therapy|Overall Study||63
534027|NCT00816023|1302096|P3|Completed Therapy|Overall Study||61
534028|NCT00816023|1302097|P2|Completed Therapy|Overall Study||59
534029|NCT00816023|1302098|P1|Completed Therapy|Overall Study||65
534030|NCT00816023|1302095|P4|STARTED|Overall Study||74
534031|NCT00816023|1302096|P3|STARTED|Overall Study||69
534032|NCT00816023|1302097|P2|STARTED|Overall Study||62
534033|NCT00816023|1302098|P1|STARTED|Overall Study||71
534034|NCT00815919|1302112|P1|NOT COMPLETED|Overall Study||4
534035|NCT00815919|1302112|P1|COMPLETED|Overall Study||18
534036|NCT00815919|1302112|P1|STARTED|Overall Study||22
534037|NCT00815776|1302123|P3|NOT COMPLETED|Overall Study||6
534038|NCT00815776|1302124|P2|NOT COMPLETED|Overall Study||8
534039|NCT00815776|1302125|P1|NOT COMPLETED|Overall Study||8
534040|NCT00815776|1302123|P3|COMPLETED|Overall Study||22
534041|NCT00815776|1302124|P2|COMPLETED|Overall Study||56
534042|NCT00815776|1302125|P1|COMPLETED|Overall Study||52
534043|NCT00815776|1302123|P3|STARTED|Overall Study||28
534044|NCT00815776|1302124|P2|STARTED|Overall Study||64
534045|NCT00815776|1302125|P1|STARTED|Overall Study||60
534046|NCT00815698|1302141|P2|NOT COMPLETED|Overall Study||0
534047|NCT00815698|1302142|P1|NOT COMPLETED|Overall Study||0
534048|NCT00815698|1302141|P2|COMPLETED|Overall Study||171
534049|NCT00815698|1302142|P1|COMPLETED|Overall Study||163
534050|NCT00815698|1302141|P2|STARTED|Overall Study||171
534051|NCT00815698|1302142|P1|STARTED|Overall Study||163
534052|NCT00815685|1302150|P1|NOT COMPLETED|Overall Study||22
534053|NCT00815685|1302150|P1|COMPLETED|Overall Study|Complete pre and post-treatment serum samples were available for 14 participants.|14
534054|NCT00815685|1302150|P1|STARTED|Overall Study||36
534055|NCT00815659|1302155|P1|NOT COMPLETED|Overall Study||23
534056|NCT00815659|1302155|P1|COMPLETED|Overall Study||74
534057|NCT00815659|1302155|P1|STARTED|Overall Study||97
534058|NCT00815633|1302198|P1|NOT COMPLETED|Overall Study||1
534059|NCT00815633|1302198|P1|COMPLETED|Overall Study||0
534060|NCT00815633|1302198|P1|STARTED|Overall Study||1
534061|NCT00815516|1302205|P2|NOT COMPLETED|Overall Study||1
534062|NCT00815516|1302206|P1|NOT COMPLETED|Overall Study||4
534063|NCT00815516|1302205|P2|COMPLETED|Overall Study||9
534064|NCT00815516|1302206|P1|COMPLETED|Overall Study||16
534065|NCT00815516|1302205|P2|STARTED|Overall Study||10
534066|NCT00815516|1302206|P1|STARTED|Overall Study||20
534067|NCT00815490|1302237|P2|NOT COMPLETED|Overall Study||0
534068|NCT00815490|1302238|P1|NOT COMPLETED|Overall Study||0
534069|NCT00815490|1302237|P2|COMPLETED|Overall Study||9
534070|NCT00815490|1302238|P1|COMPLETED|Overall Study||9
534071|NCT00815490|1302237|P2|STARTED|Overall Study||9
534072|NCT00815490|1302238|P1|STARTED|Overall Study||9
534073|NCT00815360|1302246|P2|NOT COMPLETED|Overall Study||0
534074|NCT00815360|1302247|P1|NOT COMPLETED|Overall Study||0
534075|NCT00815360|1302246|P2|COMPLETED|Overall Study||11
534076|NCT00815360|1302247|P1|COMPLETED|Overall Study||11
534077|NCT00815360|1302246|P2|STARTED|Overall Study||11
534078|NCT00815360|1302247|P1|STARTED|Overall Study||11
534079|NCT00815347|1302255|P1|NOT COMPLETED|Overall Study||4
534080|NCT00815347|1302255|P1|COMPLETED|Overall Study||7
534081|NCT00815347|1302255|P1|STARTED|Overall Study||11
534082|NCT00815308|1302271|P1|NOT COMPLETED|Overall Study||10
534083|NCT00815308|1302271|P1|COMPLETED|Overall Study||45
534084|NCT00815308|1302271|P1|STARTED|Overall Study||55
534085|NCT00815295|1302280|P3|NOT COMPLETED|Overall Study||3
534086|NCT00815295|1302281|P2|NOT COMPLETED|Overall Study||1
534087|NCT00815295|1302282|P1|NOT COMPLETED|Overall Study||0
534088|NCT00815295|1302280|P3|COMPLETED|Overall Study||9
534089|NCT00815295|1302281|P2|COMPLETED|Overall Study||7
534090|NCT00815295|1302282|P1|COMPLETED|Overall Study||8
534091|NCT00815295|1302280|P3|STARTED|Overall Study||12
534092|NCT00815295|1302281|P2|STARTED|Overall Study||8
534093|NCT00815295|1302282|P1|STARTED|Overall Study||8
534094|NCT00815191|1302294|P2|NOT COMPLETED|Overall Study||1
534095|NCT00815191|1302295|P1|NOT COMPLETED|Overall Study||1
534096|NCT00815191|1302294|P2|COMPLETED|Overall Study||34
534097|NCT00815191|1302295|P1|COMPLETED|Overall Study||37
534098|NCT00815191|1302294|P2|STARTED|Overall Study||35
534099|NCT00815191|1302295|P1|STARTED|Overall Study||38
534100|NCT00815087|1302303|P2|NOT COMPLETED|Overall Study||0
534101|NCT00815087|1302304|P1|NOT COMPLETED|Overall Study||0
534102|NCT00815087|1302303|P2|COMPLETED|Overall Study||10
534103|NCT00815087|1302304|P1|COMPLETED|Overall Study||10
534104|NCT00815087|1302303|P2|STARTED|Overall Study||10
534105|NCT00815087|1302304|P1|STARTED|Overall Study||10
534106|NCT00815035|1302312|P3|NOT COMPLETED|Open Label Extension Phase||6
534107|NCT00815035|1302313|P2|NOT COMPLETED|Open Label Extension Phase||0
534108|NCT00815035|1302314|P1|NOT COMPLETED|Open Label Extension Phase||0
534109|NCT00815035|1302312|P3|COMPLETED|Open Label Extension Phase||9
534110|NCT00815035|1302313|P2|COMPLETED|Open Label Extension Phase||0
534111|NCT00815035|1302314|P1|COMPLETED|Open Label Extension Phase||0
534112|NCT00815035|1302312|P3|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|15
534113|NCT00815035|1302313|P2|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|0
534114|NCT00815035|1302314|P1|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|0
534115|NCT00815035|1302312|P3|NOT COMPLETED|Blinded Phase||0
534116|NCT00815035|1302313|P2|NOT COMPLETED|Blinded Phase||0
534117|NCT00815035|1302314|P1|NOT COMPLETED|Blinded Phase||1
534118|NCT00815035|1302312|P3|COMPLETED|Blinded Phase||0
534119|NCT00815035|1302313|P2|COMPLETED|Blinded Phase||6
534120|NCT00815035|1302314|P1|COMPLETED|Blinded Phase||9
534121|NCT00815035|1302312|P3|STARTED|Blinded Phase||0
534122|NCT00815035|1302313|P2|STARTED|Blinded Phase||6
534123|NCT00815035|1302314|P1|STARTED|Blinded Phase||10
534124|NCT00814983|1302332|P2|NOT COMPLETED|Overall Study||0
534125|NCT00814983|1302333|P1|NOT COMPLETED|Overall Study||3
534126|NCT00814983|1302332|P2|COMPLETED|Overall Study||0
534127|NCT00814983|1302333|P1|COMPLETED|Overall Study||12
534128|NCT00814983|1302332|P2|STARTED|Overall Study||0
534129|NCT00814983|1302333|P1|STARTED|Overall Study||15
534130|NCT00814970|1302343|P1|NOT COMPLETED|Overall Study||50
534131|NCT00814970|1302343|P1|COMPLETED|Overall Study||146
534132|NCT00814970|1302343|P1|STARTED|Overall Study||196
534133|NCT00814892|1302364|P1|NOT COMPLETED|Overall Study||2
534134|NCT00814892|1302364|P1|COMPLETED|Overall Study||0
534135|NCT00814892|1302364|P1|STARTED|Overall Study||2
534136|NCT00814879|1302376|P2|NOT COMPLETED|By Week 48||3
534137|NCT00814879|1302377|P1|NOT COMPLETED|By Week 48||2
534138|NCT00814879|1302376|P2|COMPLETED|By Week 48||26
534139|NCT00814879|1302377|P1|COMPLETED|By Week 48||25
534140|NCT00814879|1302376|P2|STARTED|By Week 48||29
534141|NCT00814879|1302377|P1|STARTED|By Week 48||27
534142|NCT00814879|1302376|P2|NOT COMPLETED|By Week 24||1
534143|NCT00814879|1302377|P1|NOT COMPLETED|By Week 24||1
534144|NCT00814879|1302376|P2|COMPLETED|By Week 24||29
534145|NCT00814879|1302377|P1|COMPLETED|By Week 24||27
534146|NCT00814879|1302376|P2|STARTED|By Week 24||30
534147|NCT00814879|1302377|P1|STARTED|By Week 24||28
534148|NCT00814801|1302396|P3|NOT COMPLETED|Overall Study||43
534149|NCT00814801|1302397|P2|NOT COMPLETED|Overall Study||38
534150|NCT00814801|1302398|P1|NOT COMPLETED|Overall Study||34
534151|NCT00814801|1302396|P3|COMPLETED|Overall Study||151
534152|NCT00814801|1302397|P2|COMPLETED|Overall Study||154
534153|NCT00814801|1302398|P1|COMPLETED|Overall Study||160
534154|NCT00814801|1302396|P3|STARTED|Overall Study||194
534155|NCT00814801|1302397|P2|STARTED|Overall Study||192
534156|NCT00814801|1302398|P1|STARTED|Overall Study||194
534157|NCT00814788|1302418|P1|NOT COMPLETED|Overall Study||0
534158|NCT00814788|1302418|P1|COMPLETED|Overall Study||24
534159|NCT00814788|1302418|P1|STARTED|Overall Study||24
534160|NCT00814775|1302426|P2|NOT COMPLETED|Overall Study||0
534161|NCT00814775|1302427|P1|NOT COMPLETED|Overall Study||0
534162|NCT00814775|1302426|P2|COMPLETED|Overall Study||20
534163|NCT00814775|1302427|P1|COMPLETED|Overall Study||23
534164|NCT00814775|1302426|P2|STARTED|Overall Study||20
534165|NCT00814775|1302427|P1|STARTED|Overall Study||23
534166|NCT00814710|1302437|P2|NOT COMPLETED|Overall Study||3
534167|NCT00814710|1302438|P1|NOT COMPLETED|Overall Study||8
534168|NCT00814710|1302437|P2|COMPLETED|Overall Study||117
534169|NCT00814710|1302438|P1|COMPLETED|Overall Study||232
534170|NCT00814710|1302437|P2|STARTED|Overall Study||120
534171|NCT00814710|1302438|P1|STARTED|Overall Study||240
534172|NCT00814697|1302476|P1|NOT COMPLETED|Overall Study||0
534173|NCT00814697|1302476|P1|COMPLETED|Overall Study||12
534174|NCT00814697|1302476|P1|STARTED|Overall Study||12
534175|NCT00814671|1302483|P3|NOT COMPLETED|Overall Study||2
534176|NCT00814671|1302484|P2|NOT COMPLETED|Overall Study||4
534177|NCT00814671|1302485|P1|NOT COMPLETED|Overall Study||7
534178|NCT00814671|1302483|P3|COMPLETED|Overall Study||49
534179|NCT00814671|1302484|P2|COMPLETED|Overall Study||44
534180|NCT00814671|1302485|P1|COMPLETED|Overall Study||47
534181|NCT00814671|1302483|P3|STARTED|Overall Study||51
534182|NCT00814671|1302484|P2|STARTED|Overall Study||48
534183|NCT00814671|1302485|P1|STARTED|Overall Study||54
534184|NCT00814658|1302506|P2|NOT COMPLETED|Overall Study||4
534185|NCT00814658|1302507|P1|NOT COMPLETED|Overall Study||4
534186|NCT00814658|1302506|P2|COMPLETED|Overall Study||8
534187|NCT00814658|1302507|P1|COMPLETED|Overall Study||5
534188|NCT00814658|1302506|P2|STARTED|Overall Study||12
534189|NCT00814658|1302507|P1|STARTED|Overall Study||9
534190|NCT00814632|1302573|P1|NOT COMPLETED|Overall Study||2
534191|NCT00814632|1302573|P1|COMPLETED|Overall Study|Two subjects withdrew early due to lack of efficacy.|7
534192|NCT00814632|1302573|P1|STARTED|Overall Study|Ten were allocated to treatment intervention however one was not treated due to lactose allergy.|9
534193|NCT00814580|1302579|P2|NOT COMPLETED|Overall Study||47
534194|NCT00814580|1302580|P1|NOT COMPLETED|Overall Study||31
534195|NCT00814580|1302579|P2|COMPLETED|Overall Study||141
534196|NCT00814580|1302580|P1|COMPLETED|Overall Study||163
534197|NCT00814580|1302579|P2|STARTED|Overall Study||188
534198|NCT00814580|1302580|P1|STARTED|Overall Study||194
534199|NCT00814502|1302710|P2|NOT COMPLETED|Overall Study||2
534200|NCT00814502|1302711|P1|NOT COMPLETED|Overall Study||1
534201|NCT00814502|1302710|P2|COMPLETED|Overall Study||7
534202|NCT00814502|1302711|P1|COMPLETED|Overall Study||7
534203|NCT00814502|1302710|P2|STARTED|Overall Study||9
534204|NCT00814502|1302711|P1|STARTED|Overall Study||8
534205|NCT00814489|1302724|P3|NOT COMPLETED|Overall Study||1
534206|NCT00814489|1302725|P2|NOT COMPLETED|Overall Study||0
534207|NCT00814489|1302726|P1|NOT COMPLETED|Overall Study||2
534208|NCT00814489|1302724|P3|COMPLETED|Overall Study||7
534209|NCT00814489|1302725|P2|COMPLETED|Overall Study||17
534210|NCT00814489|1302726|P1|COMPLETED|Overall Study||13
534211|NCT00814489|1302724|P3|STARTED|Overall Study||8
534212|NCT00814489|1302725|P2|STARTED|Overall Study||17
534213|NCT00814489|1302726|P1|STARTED|Overall Study||15
534214|NCT00814463|1302758|P1|NOT COMPLETED|Overall Study||1
534215|NCT00814463|1302758|P1|COMPLETED|Overall Study||0
534216|NCT00814463|1302758|P1|STARTED|Overall Study||1
534217|NCT00814346|1302764|P2|NOT COMPLETED|Open Phase (17 Months)||0
534218|NCT00814346|1302765|P1|NOT COMPLETED|Open Phase (17 Months)||10
534219|NCT00814346|1302764|P2|COMPLETED|Open Phase (17 Months)||0
534220|NCT00814346|1302765|P1|COMPLETED|Open Phase (17 Months)||31
534221|NCT00814346|1302764|P2|AD|Open Phase (17 Months)||0
534222|NCT00814346|1302765|P1|AD|Open Phase (17 Months)|Open period was not proposed to AD subjects.|0
534223|NCT00814346|1302764|P2|MC|Open Phase (17 Months)||0
534224|NCT00814346|1302765|P1|MC|Open Phase (17 Months)||20
534225|NCT00814346|1302764|P2|CNE|Open Phase (17 Months)||0
534226|NCT00814346|1302765|P1|CNE|Open Phase (17 Months)||21
534227|NCT00814346|1302764|P2|STARTED|Open Phase (17 Months)|This was an open period, without placebo arm, the number of subject on placebo is 0.|0
534228|NCT00814346|1302765|P1|STARTED|Open Phase (17 Months)|Open period was treated with EGB761®. 41 subjects accepted follow-up open period(21 in CNE,20 in MC)|41
534229|NCT00814346|1302764|P2|NOT COMPLETED|Double-blind Phase (4 Weeks)||3
534230|NCT00814346|1302765|P1|NOT COMPLETED|Double-blind Phase (4 Weeks)||0
534231|NCT00814346|1302764|P2|COMPLETED|Double-blind Phase (4 Weeks)||23
534232|NCT00814346|1302765|P1|COMPLETED|Double-blind Phase (4 Weeks)||23
534233|NCT00814346|1302764|P2|AD|Double-blind Phase (4 Weeks)||2
534234|NCT00814346|1302765|P1|AD|Double-blind Phase (4 Weeks)||3
534235|NCT00814346|1302764|P2|MC|Double-blind Phase (4 Weeks)||11
534236|NCT00814346|1302765|P1|MC|Double-blind Phase (4 Weeks)||10
534237|NCT00814346|1302764|P2|CNE|Double-blind Phase (4 Weeks)||13
534238|NCT00814346|1302765|P1|CNE|Double-blind Phase (4 Weeks)||10
534239|NCT00814346|1302764|P2|STARTED|Double-blind Phase (4 Weeks)||26
534240|NCT00814346|1302765|P1|STARTED|Double-blind Phase (4 Weeks)||23
534241|NCT00814333|1302831|P2|NOT COMPLETED|Treatment Period||0
534242|NCT00814333|1302832|P1|NOT COMPLETED|Treatment Period||0
534243|NCT00814333|1302831|P2|COMPLETED|Treatment Period||0
534244|NCT00814333|1302832|P1|COMPLETED|Treatment Period||0
534245|NCT00814333|1302831|P2|STARTED|Treatment Period||0
534246|NCT00814333|1302832|P1|STARTED|Treatment Period||0
534247|NCT00814333|1302831|P2|NOT COMPLETED|Enrollment||0
534248|NCT00814333|1302832|P1|NOT COMPLETED|Enrollment||1
534249|NCT00814333|1302831|P2|COMPLETED|Enrollment||0
534250|NCT00814333|1302832|P1|COMPLETED|Enrollment||0
534251|NCT00814333|1302831|P2|STARTED|Enrollment||0
534252|NCT00814333|1302832|P1|STARTED|Enrollment||1
534253|NCT00814320|1302840|P2|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||10
534254|NCT00814320|1302841|P1|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||3
534255|NCT00814320|1302840|P2|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)|Three participants who switched to safety follow-up remained in the study.|60
534256|NCT00814320|1302841|P1|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||8
534257|NCT00814320|1302840|P2|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||70
534258|NCT00814320|1302841|P1|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||11
534259|NCT00814320|1302840|P2|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||0
534260|NCT00814320|1302841|P1|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||2
534261|NCT00814320|1302840|P2|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||70
534262|NCT00814320|1302841|P1|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||11
534263|NCT00814320|1302840|P2|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||70
534264|NCT00814320|1302841|P1|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||13
534265|NCT00814320|1302840|P2|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||1
534266|NCT00814320|1302841|P1|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||0
534267|NCT00814320|1302840|P2|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||70
534268|NCT00814320|1302841|P1|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13
534269|NCT00814320|1302840|P2|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||71
534270|NCT00814320|1302841|P1|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13
534271|NCT00814320|1302840|P2|NOT COMPLETED|Epoch 1 (IV Treatment)||2
534272|NCT00814320|1302841|P1|NOT COMPLETED|Epoch 1 (IV Treatment)||1
534273|NCT00814320|1302840|P2|COMPLETED|Epoch 1 (IV Treatment)||71
534274|NCT00814320|1302841|P1|COMPLETED|Epoch 1 (IV Treatment)||13
534275|NCT00814320|1302840|P2|STARTED|Epoch 1 (IV Treatment)||73
534276|NCT00814320|1302841|P1|STARTED|Epoch 1 (IV Treatment)||14
534277|NCT00814307|1302973|P4|NOT COMPLETED|Overall Study||10
534278|NCT00814307|1302974|P3|NOT COMPLETED|Overall Study||7
534279|NCT00814307|1302975|P2|NOT COMPLETED|Overall Study||27
534280|NCT00814307|1302976|P1|NOT COMPLETED|Overall Study||12
534281|NCT00814307|1302973|P4|COMPLETED|Overall Study||51
534282|NCT00814307|1302974|P3|COMPLETED|Overall Study||54
534283|NCT00814307|1302975|P2|COMPLETED|Overall Study||218
534284|NCT00814307|1302976|P1|COMPLETED|Overall Study||232
534285|NCT00814307|1302973|P4|Treated|Overall Study||61
534286|NCT00814307|1302974|P3|Treated|Overall Study||61
534287|NCT00814307|1302975|P2|Treated|Overall Study||245
534288|NCT00814307|1302976|P1|Treated|Overall Study||243
534289|NCT00814307|1302973|P4|STARTED|Overall Study||61
534290|NCT00814307|1302974|P3|STARTED|Overall Study||61
534291|NCT00814307|1302975|P2|STARTED|Overall Study||245
534292|NCT00814307|1302976|P1|STARTED|Overall Study||244
534293|NCT00814255|1303141|P3|NOT COMPLETED|Overall Study||1
534294|NCT00814255|1303142|P2|NOT COMPLETED|Overall Study||0
534295|NCT00814255|1303143|P1|NOT COMPLETED|Overall Study||1
534296|NCT00814255|1303141|P3|COMPLETED|Overall Study||7
534297|NCT00814255|1303142|P2|COMPLETED|Overall Study||7
534298|NCT00814255|1303143|P1|COMPLETED|Overall Study||7
534299|NCT00814255|1303141|P3|STARTED|Overall Study||8
534300|NCT00814255|1303142|P2|STARTED|Overall Study||7
534301|NCT00814255|1303143|P1|STARTED|Overall Study||8
534302|NCT00814177|1303165|P2|NOT COMPLETED|Overall Study||0
534303|NCT00814177|1303166|P1|NOT COMPLETED|Overall Study||0
534304|NCT00814177|1303165|P2|COMPLETED|Overall Study||80
534305|NCT00814177|1303166|P1|COMPLETED|Overall Study||80
534306|NCT00814177|1303165|P2|STARTED|Overall Study||80
534307|NCT00814177|1303166|P1|STARTED|Overall Study||80
534308|NCT00814164|1303172|P1|NOT COMPLETED|Overall Study||19
534309|NCT00814164|1303172|P1|COMPLETED|Overall Study||2
534310|NCT00814164|1303172|P1|STARTED|Overall Study||21
534311|NCT00814138|1303185|P2|NOT COMPLETED|Overall Study||7
534312|NCT00814138|1303186|P1|NOT COMPLETED|Overall Study||1
534313|NCT00814138|1303185|P2|COMPLETED|Overall Study||18
534314|NCT00814138|1303186|P1|COMPLETED|Overall Study||24
534315|NCT00814138|1303185|P2|STARTED|Overall Study||25
534316|NCT00814138|1303186|P1|STARTED|Overall Study||25
534317|NCT00813995|1303206|P2|NOT COMPLETED|Overall Study||16
534318|NCT00813995|1303207|P1|NOT COMPLETED|Overall Study||23
534319|NCT00813995|1303206|P2|COMPLETED|Overall Study||182
534320|NCT00813995|1303207|P1|COMPLETED|Overall Study||174
534321|NCT00813995|1303206|P2|STARTED|Overall Study||198
534322|NCT00813995|1303207|P1|STARTED|Overall Study||197
534323|NCT00813982|1303221|P1|NOT COMPLETED|Overall Study||0
534324|NCT00813982|1303221|P1|COMPLETED|Overall Study||59
534325|NCT00813982|1303221|P1|STARTED|Overall Study||59
534326|NCT00813943|1303230|P3|NOT COMPLETED|Overall Study||3
534327|NCT00813943|1303231|P2|NOT COMPLETED|Overall Study||5
534328|NCT00813943|1303232|P1|NOT COMPLETED|Overall Study||5
534329|NCT00813943|1303230|P3|COMPLETED|Overall Study||86
534330|NCT00813943|1303231|P2|COMPLETED|Overall Study||83
534331|NCT00813943|1303232|P1|COMPLETED|Overall Study||83
534332|NCT00813943|1303230|P3|STARTED|Overall Study||89
534333|NCT00813943|1303231|P2|STARTED|Overall Study||88
534334|NCT00813943|1303232|P1|STARTED|Overall Study||88
534335|NCT00813917|1303262|P2|NOT COMPLETED|Overall Study||6
534336|NCT00813917|1303263|P1|NOT COMPLETED|Overall Study||6
534337|NCT00813917|1303262|P2|COMPLETED|Overall Study||32
534338|NCT00813917|1303263|P1|COMPLETED|Overall Study||32
534339|NCT00813917|1303262|P2|STARTED|Overall Study||38
534340|NCT00813917|1303263|P1|STARTED|Overall Study||38
534341|NCT00813904|1303269|P1|NOT COMPLETED|Overall Study||1
534342|NCT00813904|1303269|P1|COMPLETED|Overall Study||30
534343|NCT00813904|1303269|P1|STARTED|Overall Study||31
534344|NCT00813813|1303277|P2|NOT COMPLETED|Overall Study||9
534345|NCT00813813|1303278|P1|NOT COMPLETED|Overall Study||3
534346|NCT00813813|1303277|P2|COMPLETED|Overall Study||16
534347|NCT00813813|1303278|P1|COMPLETED|Overall Study||4
534348|NCT00813813|1303277|P2|STARTED|Overall Study||25
534349|NCT00813813|1303278|P1|STARTED|Overall Study||7
534350|NCT00813800|1303294|P1|NOT COMPLETED|Overall Study||6
534351|NCT00813800|1303294|P1|COMPLETED|Overall Study||5
534352|NCT00813800|1303294|P1|STARTED|Overall Study||11
534353|NCT00813761|1303302|P4|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||5
534354|NCT00813761|1303303|P3|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9
534355|NCT00813761|1303304|P2|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9
534356|NCT00813761|1303305|P1|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||16
534357|NCT00813761|1303302|P4|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||100
534358|NCT00813761|1303303|P3|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||94
534359|NCT00813761|1303304|P2|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||91
534360|NCT00813761|1303305|P1|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||101
534361|NCT00813761|1303302|P4|STARTED|Phase 2 (4 Weeks to 24 Weeks)||105
534362|NCT00813761|1303303|P3|STARTED|Phase 2 (4 Weeks to 24 Weeks)||103
534363|NCT00813761|1303304|P2|STARTED|Phase 2 (4 Weeks to 24 Weeks)||100
534364|NCT00813761|1303305|P1|STARTED|Phase 2 (4 Weeks to 24 Weeks)||117
534365|NCT00813761|1303302|P4|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||2
534366|NCT00813761|1303303|P3|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||12
534367|NCT00813761|1303304|P2|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||3
534368|NCT00813761|1303305|P1|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||4
534369|NCT00813761|1303302|P4|COMPLETED|Phase 1 (Baseline to 4 Weeks)||105
534370|NCT00813761|1303303|P3|COMPLETED|Phase 1 (Baseline to 4 Weeks)||103
534371|NCT00813761|1303304|P2|COMPLETED|Phase 1 (Baseline to 4 Weeks)||100
534372|NCT00813761|1303305|P1|COMPLETED|Phase 1 (Baseline to 4 Weeks)||117
534373|NCT00813761|1303302|P4|STARTED|Phase 1 (Baseline to 4 Weeks)||107
534374|NCT00813761|1303303|P3|STARTED|Phase 1 (Baseline to 4 Weeks)||115
534375|NCT00813761|1303304|P2|STARTED|Phase 1 (Baseline to 4 Weeks)||103
534376|NCT00813761|1303305|P1|STARTED|Phase 1 (Baseline to 4 Weeks)||121
534377|NCT00813748|1303355|P2|NOT COMPLETED|Skin Test Substudy||1
534378|NCT00813748|1303356|P1|NOT COMPLETED|Skin Test Substudy||0
534379|NCT00813748|1303355|P2|COMPLETED|Skin Test Substudy||7
534380|NCT00813748|1303356|P1|COMPLETED|Skin Test Substudy||3
534381|NCT00813748|1303355|P2|STARTED|Skin Test Substudy|Included participants who discontinued omalizumab for at least 16 weeks but not more than 18 months.|8
534382|NCT00813748|1303356|P1|STARTED|Skin Test Substudy|Included participants who discontinued omalizumab for at least 16 weeks but not more than 18 months.|3
534383|NCT00813748|1303355|P2|NOT COMPLETED|Main Observational Study||0
534384|NCT00813748|1303356|P1|NOT COMPLETED|Main Observational Study||0
534385|NCT00813748|1303355|P2|COMPLETED|Main Observational Study||88
534386|NCT00813748|1303356|P1|COMPLETED|Main Observational Study||30
534387|NCT00813748|1303355|P2|STARTED|Main Observational Study||88
534388|NCT00813748|1303356|P1|STARTED|Main Observational Study||30
534389|NCT00813709|1303385|P6|NOT COMPLETED|Open Label Period||11
534390|NCT00813709|1303386|P5|NOT COMPLETED|Open Label Period||10
534391|NCT00813709|1303387|P4|NOT COMPLETED|Open Label Period||20
534392|NCT00813709|1303388|P3|NOT COMPLETED|Open Label Period||0
534393|NCT00813709|1303389|P2|NOT COMPLETED|Open Label Period||0
534394|NCT00813709|1303390|P1|NOT COMPLETED|Open Label Period||0
534395|NCT00813709|1303385|P6|COMPLETED|Open Label Period||35
534396|NCT00813709|1303386|P5|COMPLETED|Open Label Period||41
534397|NCT00813709|1303387|P4|COMPLETED|Open Label Period||38
534398|NCT00813709|1303388|P3|COMPLETED|Open Label Period||0
534399|NCT00813709|1303389|P2|COMPLETED|Open Label Period||0
534400|NCT00813709|1303390|P1|COMPLETED|Open Label Period||0
534401|NCT00813709|1303385|P6|Treated|Open Label Period||45
534402|NCT00813709|1303386|P5|Treated|Open Label Period||51
534403|NCT00813709|1303387|P4|Treated|Open Label Period||57
534404|NCT00813709|1303388|P3|Treated|Open Label Period||0
534405|NCT00813709|1303389|P2|Treated|Open Label Period||0
534406|NCT00813709|1303390|P1|Treated|Open Label Period||0
534407|NCT00813709|1303385|P6|STARTED|Open Label Period|28 participants in OL period initially + 18 participants from DB converted to CDMS during the study|46
534408|NCT00813709|1303386|P5|STARTED|Open Label Period|25 participants in OL period initially + 26 participants from DB converted to CDMS during the study|51
534409|NCT00813709|1303387|P4|STARTED|Open Label Period|49 participants in OL period initially + 9 participants from DB converted to CDMS during the study|58
534410|NCT00813709|1303388|P3|STARTED|Open Label Period||0
534411|NCT00813709|1303389|P2|STARTED|Open Label Period||0
534412|NCT00813709|1303390|P1|STARTED|Open Label Period||0
534413|NCT00813709|1303385|P6|NOT COMPLETED|Double Blind Period||0
534414|NCT00813709|1303386|P5|NOT COMPLETED|Double Blind Period||0
534415|NCT00813709|1303387|P4|NOT COMPLETED|Double Blind Period||0
534416|NCT00813709|1303388|P3|NOT COMPLETED|Double Blind Period||31
534417|NCT00813709|1303389|P2|NOT COMPLETED|Double Blind Period||41
534418|NCT00813709|1303390|P1|NOT COMPLETED|Double Blind Period||31
534419|NCT00813709|1303385|P6|COMPLETED|Double Blind Period||0
534420|NCT00813709|1303386|P5|COMPLETED|Double Blind Period||0
534421|NCT00813709|1303387|P4|COMPLETED|Double Blind Period||0
534422|NCT00813709|1303388|P3|COMPLETED|Double Blind Period||68
534423|NCT00813709|1303389|P2|COMPLETED|Double Blind Period||76
534424|NCT00813709|1303390|P1|COMPLETED|Double Blind Period||53
534425|NCT00813709|1303385|P6|Treated|Double Blind Period||0
534426|NCT00813709|1303386|P5|Treated|Double Blind Period||0
534427|NCT00813709|1303387|P4|Treated|Double Blind Period||0
534428|NCT00813709|1303388|P3|Treated|Double Blind Period||98
534429|NCT00813709|1303389|P2|Treated|Double Blind Period||114
534430|NCT00813709|1303390|P1|Treated|Double Blind Period||83
534431|NCT00813709|1303385|P6|STARTED|Double Blind Period||0
534432|NCT00813709|1303386|P5|STARTED|Double Blind Period||0
534433|NCT00813709|1303387|P4|STARTED|Double Blind Period||0
534434|NCT00813709|1303388|P3|STARTED|Double Blind Period||99
534435|NCT00813709|1303389|P2|STARTED|Double Blind Period||117
534436|NCT00813709|1303390|P1|STARTED|Double Blind Period||84
534437|NCT00813592|1303470|P1|NOT COMPLETED|Overall Study||2
534438|NCT00813592|1303470|P1|COMPLETED|Overall Study||0
534439|NCT00813592|1303470|P1|Response Assessment|Overall Study|One patient met the response assessment.|1
534440|NCT00813592|1303470|P1|Treated|Overall Study|Two patients were treated.|2
534441|NCT00813592|1303470|P1|STARTED|Overall Study||2
534442|NCT00813488|1303479|P2|NOT COMPLETED|Open-label Extension||7
534443|NCT00813488|1303480|P1|NOT COMPLETED|Open-label Extension||12
534444|NCT00813488|1303479|P2|COMPLETED|Open-label Extension|This group received standard of care (including immediate-release oxycodone)|59
534445|NCT00813488|1303480|P1|COMPLETED|Open-label Extension|This group received FBT open--label|53
534446|NCT00813488|1303479|P2|STARTED|Open-label Extension|Patients completing double-blind periods were randomized to FBT or standard of care for open-label|66
534447|NCT00813488|1303480|P1|STARTED|Open-label Extension|Patients completing double-blind periods were randomized to FBT or standard of care for open-label|65
534448|NCT00813488|1303479|P2|NOT COMPLETED|Double-blind Treatment Period 2||1
534449|NCT00813488|1303480|P1|NOT COMPLETED|Double-blind Treatment Period 2||5
534450|NCT00813488|1303479|P2|COMPLETED|Double-blind Treatment Period 2||65
534451|NCT00813488|1303480|P1|COMPLETED|Double-blind Treatment Period 2||66
534452|NCT00813488|1303479|P2|STARTED|Double-blind Treatment Period 2||66
534453|NCT00813488|1303480|P1|STARTED|Double-blind Treatment Period 2||71
534454|NCT00813488|1303479|P2|NOT COMPLETED|Double-blind Treatment Period 1||5
534455|NCT00813488|1303480|P1|NOT COMPLETED|Double-blind Treatment Period 1||1
534456|NCT00813488|1303479|P2|COMPLETED|Double-blind Treatment Period 1||66
534457|NCT00813488|1303480|P1|COMPLETED|Double-blind Treatment Period 1||71
534458|NCT00813488|1303479|P2|STARTED|Double-blind Treatment Period 1|After titration subjects were re-randomized to these two treatment arms|71
534459|NCT00813488|1303480|P1|STARTED|Double-blind Treatment Period 1|After titration subjects were re-randomized to these two treatment arms|72
534460|NCT00813488|1303479|P2|NOT COMPLETED|Titration Period 2||10
534461|NCT00813488|1303480|P1|NOT COMPLETED|Titration Period 2||16
534462|NCT00813488|1303479|P2|COMPLETED|Titration Period 2||79
534463|NCT00813488|1303480|P1|COMPLETED|Titration Period 2||64
534464|NCT00813488|1303479|P2|STARTED|Titration Period 2||89
534465|NCT00813488|1303480|P1|STARTED|Titration Period 2||80
534466|NCT00813488|1303479|P2|NOT COMPLETED|Titration Period 1||17
534467|NCT00813488|1303480|P1|NOT COMPLETED|Titration Period 1||27
534468|NCT00813488|1303479|P2|COMPLETED|Titration Period 1||89
534469|NCT00813488|1303480|P1|COMPLETED|Titration Period 1||80
534470|NCT00813488|1303479|P2|STARTED|Titration Period 1||106
534471|NCT00813488|1303480|P1|STARTED|Titration Period 1||107
534472|NCT00813319|1303578|P2|NOT COMPLETED|Overall Study||0
534473|NCT00813319|1303579|P1|NOT COMPLETED|Overall Study||0
534474|NCT00813319|1303578|P2|COMPLETED|Overall Study|104 out of 108 have complete follow-up data, there were 4 missing charts 7 months post-randomization|108
534475|NCT00813319|1303579|P1|COMPLETED|Overall Study|100 out of 108 have complete follow-up data, there were 8 missing charts 7 months post-randomization|108
534476|NCT00813319|1303578|P2|STARTED|Overall Study||108
534477|NCT00813319|1303579|P1|STARTED|Overall Study||108
534478|NCT00813176|1303591|P2|NOT COMPLETED|Overall Study||0
534479|NCT00813176|1303592|P1|NOT COMPLETED|Overall Study||0
534480|NCT00813176|1303591|P2|COMPLETED|Overall Study||25
534481|NCT00813176|1303592|P1|COMPLETED|Overall Study||25
534482|NCT00813176|1303591|P2|STARTED|Overall Study||25
534483|NCT00813176|1303592|P1|STARTED|Overall Study||25
534484|NCT00813150|1303610|P2|NOT COMPLETED|Long Term Follow-up||31
534485|NCT00813150|1303611|P1|NOT COMPLETED|Long Term Follow-up||24
534486|NCT00813150|1303610|P2|COMPLETED|Long Term Follow-up|Number of participants who completed follow-up phase|0
534487|NCT00813150|1303611|P1|COMPLETED|Long Term Follow-up|Number of participants who completed follow-up phase|2
534488|NCT00813150|1303610|P2|STARTED|Long Term Follow-up|Number of participants who entered follow-up phase|31
534489|NCT00813150|1303611|P1|STARTED|Long Term Follow-up|Number of participants who entered follow-up phase|26
534490|NCT00813150|1303610|P2|NOT COMPLETED|Treatment Period||32
534491|NCT00813150|1303611|P1|NOT COMPLETED|Treatment Period||32
534492|NCT00813150|1303610|P2|COMPLETED|Treatment Period|Participants who completed 8 cycles of treatment|15
534493|NCT00813150|1303611|P1|COMPLETED|Treatment Period|Participants who completed 8 cycles of treatment|14
534494|NCT00813150|1303610|P2|Intent-to-treat Participants|Treatment Period||47
534495|NCT00813150|1303611|P1|Intent-to-treat Participants|Treatment Period||43
534496|NCT00813150|1303610|P2|STARTED|Treatment Period|Number of randomized and treated participants|47
534497|NCT00813150|1303611|P1|STARTED|Treatment Period|Number of randomized and treated participants|46
534498|NCT00813111|1303625|P2|NOT COMPLETED|Overall Study||0
534499|NCT00813111|1303626|P1|NOT COMPLETED|Overall Study||2
534500|NCT00813111|1303625|P2|COMPLETED|Overall Study||70
534501|NCT00813111|1303626|P1|COMPLETED|Overall Study||64
534502|NCT00813111|1303625|P2|STARTED|Overall Study||70
534503|NCT00813111|1303626|P1|STARTED|Overall Study||66
534504|NCT00813098|1303635|P3|NOT COMPLETED|Overall Study||2
534505|NCT00813098|1303636|P2|NOT COMPLETED|Overall Study||8
534506|NCT00813098|1303637|P1|NOT COMPLETED|Overall Study||3
534507|NCT00813098|1303635|P3|COMPLETED|Overall Study||50
534508|NCT00813098|1303636|P2|COMPLETED|Overall Study||46
534509|NCT00813098|1303637|P1|COMPLETED|Overall Study||46
534510|NCT00813098|1303635|P3|STARTED|Overall Study||52
534511|NCT00813098|1303636|P2|STARTED|Overall Study||54
534512|NCT00813098|1303637|P1|STARTED|Overall Study||49
534513|NCT00812981|1303662|P2|NOT COMPLETED|Overall Study||1
534514|NCT00812981|1303663|P1|NOT COMPLETED|Overall Study||0
534515|NCT00812981|1303662|P2|COMPLETED|Overall Study||159
534516|NCT00812981|1303663|P1|COMPLETED|Overall Study||160
534517|NCT00812981|1303662|P2|STARTED|Overall Study||160
534518|NCT00812981|1303663|P1|STARTED|Overall Study||160
534519|NCT00812968|1303701|P1|NOT COMPLETED|Overall Study||11
534520|NCT00812968|1303701|P1|COMPLETED|Overall Study||0
534521|NCT00812968|1303701|P1|STARTED|Overall Study||11
534522|NCT00812955|1303736|P4|NOT COMPLETED|Overall Study||8
534523|NCT00812955|1303737|P3|NOT COMPLETED|Overall Study||6
534524|NCT00812955|1303738|P2|NOT COMPLETED|Overall Study||7
534525|NCT00812955|1303739|P1|NOT COMPLETED|Overall Study||10
534526|NCT00812955|1303736|P4|COMPLETED|Overall Study||110
534527|NCT00812955|1303737|P3|COMPLETED|Overall Study||113
534528|NCT00812955|1303738|P2|COMPLETED|Overall Study||111
534529|NCT00812955|1303739|P1|COMPLETED|Overall Study||109
534530|NCT00812955|1303736|P4|STARTED|Overall Study||118
534531|NCT00812955|1303737|P3|STARTED|Overall Study||119
534532|NCT00812955|1303738|P2|STARTED|Overall Study||118
534533|NCT00812955|1303739|P1|STARTED|Overall Study||119
534534|NCT00812929|1303759|P10|NOT COMPLETED|Treatment Period 5||0
534535|NCT00812929|1303760|P9|NOT COMPLETED|Treatment Period 5||0
534536|NCT00812929|1303761|P8|NOT COMPLETED|Treatment Period 5||0
534537|NCT00812929|1303762|P7|NOT COMPLETED|Treatment Period 5||0
534538|NCT00812929|1303763|P6|NOT COMPLETED|Treatment Period 5||0
534539|NCT00812929|1303764|P5|NOT COMPLETED|Treatment Period 5||0
534540|NCT00812929|1303765|P4|NOT COMPLETED|Treatment Period 5||0
534541|NCT00812929|1303766|P3|NOT COMPLETED|Treatment Period 5||0
534542|NCT00812929|1303767|P2|NOT COMPLETED|Treatment Period 5||0
534543|NCT00812929|1303768|P1|NOT COMPLETED|Treatment Period 5||0
534544|NCT00812929|1303759|P10|COMPLETED|Treatment Period 5||4
534545|NCT00812929|1303760|P9|COMPLETED|Treatment Period 5||4
534546|NCT00812929|1303761|P8|COMPLETED|Treatment Period 5||5
534547|NCT00812929|1303762|P7|COMPLETED|Treatment Period 5||5
534548|NCT00812929|1303763|P6|COMPLETED|Treatment Period 5||4
534549|NCT00812929|1303764|P5|COMPLETED|Treatment Period 5||5
534550|NCT00812929|1303765|P4|COMPLETED|Treatment Period 5||4
534551|NCT00812929|1303766|P3|COMPLETED|Treatment Period 5||4
534552|NCT00812929|1303767|P2|COMPLETED|Treatment Period 5||4
534553|NCT00812929|1303768|P1|COMPLETED|Treatment Period 5||5
534554|NCT00812929|1303759|P10|STARTED|Treatment Period 5||4
534555|NCT00812929|1303760|P9|STARTED|Treatment Period 5||4
534556|NCT00812929|1303761|P8|STARTED|Treatment Period 5||5
534557|NCT00812929|1303762|P7|STARTED|Treatment Period 5||5
534558|NCT00812929|1303763|P6|STARTED|Treatment Period 5||4
534559|NCT00812929|1303764|P5|STARTED|Treatment Period 5||5
534560|NCT00812929|1303765|P4|STARTED|Treatment Period 5||4
534561|NCT00812929|1303766|P3|STARTED|Treatment Period 5||4
534562|NCT00812929|1303767|P2|STARTED|Treatment Period 5||4
534563|NCT00812929|1303768|P1|STARTED|Treatment Period 5||5
534564|NCT00812929|1303759|P10|NOT COMPLETED|Washout Period 4 (7 Days)||0
534565|NCT00812929|1303760|P9|NOT COMPLETED|Washout Period 4 (7 Days)||0
534566|NCT00812929|1303761|P8|NOT COMPLETED|Washout Period 4 (7 Days)||0
534567|NCT00812929|1303762|P7|NOT COMPLETED|Washout Period 4 (7 Days)||0
534568|NCT00812929|1303763|P6|NOT COMPLETED|Washout Period 4 (7 Days)||0
534569|NCT00812929|1303764|P5|NOT COMPLETED|Washout Period 4 (7 Days)||0
534570|NCT00812929|1303765|P4|NOT COMPLETED|Washout Period 4 (7 Days)||0
534571|NCT00812929|1303766|P3|NOT COMPLETED|Washout Period 4 (7 Days)||0
534572|NCT00812929|1303767|P2|NOT COMPLETED|Washout Period 4 (7 Days)||0
534573|NCT00812929|1303768|P1|NOT COMPLETED|Washout Period 4 (7 Days)||0
534574|NCT00812929|1303759|P10|COMPLETED|Washout Period 4 (7 Days)||4
534575|NCT00812929|1303760|P9|COMPLETED|Washout Period 4 (7 Days)||4
534576|NCT00812929|1303761|P8|COMPLETED|Washout Period 4 (7 Days)||5
534577|NCT00812929|1303762|P7|COMPLETED|Washout Period 4 (7 Days)||5
534578|NCT00812929|1303763|P6|COMPLETED|Washout Period 4 (7 Days)||4
534579|NCT00812929|1303764|P5|COMPLETED|Washout Period 4 (7 Days)||5
534580|NCT00812929|1303765|P4|COMPLETED|Washout Period 4 (7 Days)||4
534581|NCT00812929|1303766|P3|COMPLETED|Washout Period 4 (7 Days)||4
534582|NCT00812929|1303767|P2|COMPLETED|Washout Period 4 (7 Days)||4
534583|NCT00812929|1303768|P1|COMPLETED|Washout Period 4 (7 Days)||5
534584|NCT00812929|1303759|P10|STARTED|Washout Period 4 (7 Days)||4
534585|NCT00812929|1303760|P9|STARTED|Washout Period 4 (7 Days)||4
534586|NCT00812929|1303761|P8|STARTED|Washout Period 4 (7 Days)||5
534587|NCT00812929|1303762|P7|STARTED|Washout Period 4 (7 Days)||5
534588|NCT00812929|1303763|P6|STARTED|Washout Period 4 (7 Days)||4
534589|NCT00812929|1303764|P5|STARTED|Washout Period 4 (7 Days)||5
534590|NCT00812929|1303765|P4|STARTED|Washout Period 4 (7 Days)||4
534591|NCT00812929|1303766|P3|STARTED|Washout Period 4 (7 Days)||4
534592|NCT00812929|1303767|P2|STARTED|Washout Period 4 (7 Days)||4
534593|NCT00812929|1303768|P1|STARTED|Washout Period 4 (7 Days)||5
534594|NCT00812929|1303759|P10|NOT COMPLETED|Treatment Period 4||0
534595|NCT00812929|1303760|P9|NOT COMPLETED|Treatment Period 4||0
534596|NCT00812929|1303761|P8|NOT COMPLETED|Treatment Period 4||0
534597|NCT00812929|1303762|P7|NOT COMPLETED|Treatment Period 4||0
534598|NCT00812929|1303763|P6|NOT COMPLETED|Treatment Period 4||0
534599|NCT00812929|1303764|P5|NOT COMPLETED|Treatment Period 4||0
534600|NCT00812929|1303765|P4|NOT COMPLETED|Treatment Period 4||0
534601|NCT00812929|1303766|P3|NOT COMPLETED|Treatment Period 4||0
534602|NCT00812929|1303767|P2|NOT COMPLETED|Treatment Period 4||0
534603|NCT00812929|1303768|P1|NOT COMPLETED|Treatment Period 4||0
534604|NCT00812929|1303759|P10|COMPLETED|Treatment Period 4||4
534605|NCT00812929|1303760|P9|COMPLETED|Treatment Period 4||4
534606|NCT00812929|1303761|P8|COMPLETED|Treatment Period 4||5
534607|NCT00812929|1303762|P7|COMPLETED|Treatment Period 4||5
534608|NCT00812929|1303763|P6|COMPLETED|Treatment Period 4||4
534609|NCT00812929|1303764|P5|COMPLETED|Treatment Period 4||5
534610|NCT00812929|1303765|P4|COMPLETED|Treatment Period 4||4
534611|NCT00812929|1303766|P3|COMPLETED|Treatment Period 4||4
534612|NCT00812929|1303767|P2|COMPLETED|Treatment Period 4||4
534613|NCT00812929|1303768|P1|COMPLETED|Treatment Period 4||5
534614|NCT00812929|1303759|P10|STARTED|Treatment Period 4||4
534615|NCT00812929|1303760|P9|STARTED|Treatment Period 4||4
534616|NCT00812929|1303761|P8|STARTED|Treatment Period 4||5
534617|NCT00812929|1303762|P7|STARTED|Treatment Period 4||5
534618|NCT00812929|1303763|P6|STARTED|Treatment Period 4||4
534619|NCT00812929|1303764|P5|STARTED|Treatment Period 4||5
534620|NCT00812929|1303765|P4|STARTED|Treatment Period 4||4
534621|NCT00812929|1303766|P3|STARTED|Treatment Period 4||4
534622|NCT00812929|1303767|P2|STARTED|Treatment Period 4||4
534623|NCT00812929|1303768|P1|STARTED|Treatment Period 4||5
534624|NCT00812929|1303759|P10|NOT COMPLETED|Washout Period 3 (7 Days)||0
534625|NCT00812929|1303760|P9|NOT COMPLETED|Washout Period 3 (7 Days)||0
534626|NCT00812929|1303761|P8|NOT COMPLETED|Washout Period 3 (7 Days)||0
534627|NCT00812929|1303762|P7|NOT COMPLETED|Washout Period 3 (7 Days)||0
534628|NCT00812929|1303763|P6|NOT COMPLETED|Washout Period 3 (7 Days)||1
534629|NCT00812929|1303764|P5|NOT COMPLETED|Washout Period 3 (7 Days)||0
534630|NCT00812929|1303765|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
534631|NCT00812929|1303766|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
534632|NCT00812929|1303767|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
534633|NCT00812929|1303768|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
534634|NCT00812929|1303759|P10|COMPLETED|Washout Period 3 (7 Days)||4
534635|NCT00812929|1303760|P9|COMPLETED|Washout Period 3 (7 Days)||4
534636|NCT00812929|1303761|P8|COMPLETED|Washout Period 3 (7 Days)||5
534637|NCT00812929|1303762|P7|COMPLETED|Washout Period 3 (7 Days)||5
534638|NCT00812929|1303763|P6|COMPLETED|Washout Period 3 (7 Days)||4
534639|NCT00812929|1303764|P5|COMPLETED|Washout Period 3 (7 Days)||5
534640|NCT00812929|1303765|P4|COMPLETED|Washout Period 3 (7 Days)||4
534641|NCT00812929|1303766|P3|COMPLETED|Washout Period 3 (7 Days)||4
534642|NCT00812929|1303767|P2|COMPLETED|Washout Period 3 (7 Days)||4
534643|NCT00812929|1303768|P1|COMPLETED|Washout Period 3 (7 Days)||5
534644|NCT00812929|1303759|P10|STARTED|Washout Period 3 (7 Days)||4
534645|NCT00812929|1303760|P9|STARTED|Washout Period 3 (7 Days)||4
534646|NCT00812929|1303761|P8|STARTED|Washout Period 3 (7 Days)||5
534647|NCT00812929|1303762|P7|STARTED|Washout Period 3 (7 Days)||5
534648|NCT00812929|1303763|P6|STARTED|Washout Period 3 (7 Days)||5
534649|NCT00812929|1303764|P5|STARTED|Washout Period 3 (7 Days)||5
534650|NCT00812929|1303765|P4|STARTED|Washout Period 3 (7 Days)||4
534651|NCT00812929|1303766|P3|STARTED|Washout Period 3 (7 Days)||4
534652|NCT00812929|1303767|P2|STARTED|Washout Period 3 (7 Days)||4
534653|NCT00812929|1303768|P1|STARTED|Washout Period 3 (7 Days)||5
534654|NCT00812929|1303759|P10|NOT COMPLETED|Treatment Period 3||0
534655|NCT00812929|1303760|P9|NOT COMPLETED|Treatment Period 3||0
534656|NCT00812929|1303761|P8|NOT COMPLETED|Treatment Period 3||0
534657|NCT00812929|1303762|P7|NOT COMPLETED|Treatment Period 3||0
534658|NCT00812929|1303763|P6|NOT COMPLETED|Treatment Period 3||0
534659|NCT00812929|1303764|P5|NOT COMPLETED|Treatment Period 3||0
534660|NCT00812929|1303765|P4|NOT COMPLETED|Treatment Period 3||0
534661|NCT00812929|1303766|P3|NOT COMPLETED|Treatment Period 3||0
534662|NCT00812929|1303767|P2|NOT COMPLETED|Treatment Period 3||0
534663|NCT00812929|1303768|P1|NOT COMPLETED|Treatment Period 3||0
534664|NCT00812929|1303759|P10|COMPLETED|Treatment Period 3||4
534665|NCT00812929|1303760|P9|COMPLETED|Treatment Period 3||4
534666|NCT00812929|1303761|P8|COMPLETED|Treatment Period 3||5
534667|NCT00812929|1303762|P7|COMPLETED|Treatment Period 3||5
534668|NCT00812929|1303763|P6|COMPLETED|Treatment Period 3||5
534669|NCT00812929|1303764|P5|COMPLETED|Treatment Period 3||5
534670|NCT00812929|1303765|P4|COMPLETED|Treatment Period 3||4
534671|NCT00812929|1303766|P3|COMPLETED|Treatment Period 3||4
534672|NCT00812929|1303767|P2|COMPLETED|Treatment Period 3||4
534673|NCT00812929|1303768|P1|COMPLETED|Treatment Period 3||5
534674|NCT00812929|1303759|P10|STARTED|Treatment Period 3||4
534675|NCT00812929|1303760|P9|STARTED|Treatment Period 3||4
534676|NCT00812929|1303761|P8|STARTED|Treatment Period 3||5
534677|NCT00812929|1303762|P7|STARTED|Treatment Period 3||5
534678|NCT00812929|1303763|P6|STARTED|Treatment Period 3||5
534679|NCT00812929|1303764|P5|STARTED|Treatment Period 3||5
534680|NCT00812929|1303765|P4|STARTED|Treatment Period 3||4
534681|NCT00812929|1303766|P3|STARTED|Treatment Period 3||4
534682|NCT00812929|1303767|P2|STARTED|Treatment Period 3||4
534683|NCT00812929|1303768|P1|STARTED|Treatment Period 3||5
534684|NCT00812929|1303759|P10|NOT COMPLETED|Washout Period 2 (7 Days)||1
534685|NCT00812929|1303760|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
534686|NCT00812929|1303761|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
534687|NCT00812929|1303762|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
534688|NCT00812929|1303763|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
534689|NCT00812929|1303764|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
534690|NCT00812929|1303765|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
534691|NCT00812929|1303766|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
534692|NCT00812929|1303767|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
534693|NCT00812929|1303768|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
534694|NCT00812929|1303759|P10|COMPLETED|Washout Period 2 (7 Days)||4
534695|NCT00812929|1303760|P9|COMPLETED|Washout Period 2 (7 Days)||4
534696|NCT00812929|1303761|P8|COMPLETED|Washout Period 2 (7 Days)||5
534697|NCT00812929|1303762|P7|COMPLETED|Washout Period 2 (7 Days)||5
534698|NCT00812929|1303763|P6|COMPLETED|Washout Period 2 (7 Days)||5
534699|NCT00812929|1303764|P5|COMPLETED|Washout Period 2 (7 Days)||5
534700|NCT00812929|1303765|P4|COMPLETED|Washout Period 2 (7 Days)||4
534701|NCT00812929|1303766|P3|COMPLETED|Washout Period 2 (7 Days)||4
534702|NCT00812929|1303767|P2|COMPLETED|Washout Period 2 (7 Days)||4
534703|NCT00812929|1303768|P1|COMPLETED|Washout Period 2 (7 Days)||5
534704|NCT00812929|1303759|P10|STARTED|Washout Period 2 (7 Days)||5
534705|NCT00812929|1303760|P9|STARTED|Washout Period 2 (7 Days)||4
534706|NCT00812929|1303761|P8|STARTED|Washout Period 2 (7 Days)||5
534707|NCT00812929|1303762|P7|STARTED|Washout Period 2 (7 Days)||5
534708|NCT00812929|1303763|P6|STARTED|Washout Period 2 (7 Days)||5
534709|NCT00812929|1303764|P5|STARTED|Washout Period 2 (7 Days)||5
534710|NCT00812929|1303765|P4|STARTED|Washout Period 2 (7 Days)||4
534711|NCT00812929|1303766|P3|STARTED|Washout Period 2 (7 Days)||4
534712|NCT00812929|1303767|P2|STARTED|Washout Period 2 (7 Days)||4
534713|NCT00812929|1303768|P1|STARTED|Washout Period 2 (7 Days)||5
534714|NCT00812929|1303759|P10|NOT COMPLETED|Treatment Period 2||0
534715|NCT00812929|1303760|P9|NOT COMPLETED|Treatment Period 2||0
534716|NCT00812929|1303761|P8|NOT COMPLETED|Treatment Period 2||0
534717|NCT00812929|1303762|P7|NOT COMPLETED|Treatment Period 2||0
534718|NCT00812929|1303763|P6|NOT COMPLETED|Treatment Period 2||0
534719|NCT00812929|1303764|P5|NOT COMPLETED|Treatment Period 2||0
534720|NCT00812929|1303765|P4|NOT COMPLETED|Treatment Period 2||0
534721|NCT00812929|1303766|P3|NOT COMPLETED|Treatment Period 2||0
534722|NCT00812929|1303767|P2|NOT COMPLETED|Treatment Period 2||0
534723|NCT00812929|1303768|P1|NOT COMPLETED|Treatment Period 2||0
534724|NCT00812929|1303759|P10|COMPLETED|Treatment Period 2||5
534725|NCT00812929|1303760|P9|COMPLETED|Treatment Period 2||4
534726|NCT00812929|1303761|P8|COMPLETED|Treatment Period 2||5
534727|NCT00812929|1303762|P7|COMPLETED|Treatment Period 2||5
534728|NCT00812929|1303763|P6|COMPLETED|Treatment Period 2||5
534729|NCT00812929|1303764|P5|COMPLETED|Treatment Period 2||5
534730|NCT00812929|1303765|P4|COMPLETED|Treatment Period 2||4
534731|NCT00812929|1303766|P3|COMPLETED|Treatment Period 2||4
534732|NCT00812929|1303767|P2|COMPLETED|Treatment Period 2||4
534733|NCT00812929|1303768|P1|COMPLETED|Treatment Period 2||5
534734|NCT00812929|1303759|P10|STARTED|Treatment Period 2||5
534735|NCT00812929|1303760|P9|STARTED|Treatment Period 2||4
534736|NCT00812929|1303761|P8|STARTED|Treatment Period 2||5
534737|NCT00812929|1303762|P7|STARTED|Treatment Period 2||5
534738|NCT00812929|1303763|P6|STARTED|Treatment Period 2||5
534739|NCT00812929|1303764|P5|STARTED|Treatment Period 2||5
534740|NCT00812929|1303765|P4|STARTED|Treatment Period 2||4
534741|NCT00812929|1303766|P3|STARTED|Treatment Period 2||4
534742|NCT00812929|1303767|P2|STARTED|Treatment Period 2||4
534743|NCT00812929|1303768|P1|STARTED|Treatment Period 2||5
534744|NCT00812929|1303759|P10|NOT COMPLETED|Washout Period 1 (7 Days)||0
534745|NCT00812929|1303760|P9|NOT COMPLETED|Washout Period 1 (7 Days)||0
534746|NCT00812929|1303761|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
534747|NCT00812929|1303762|P7|NOT COMPLETED|Washout Period 1 (7 Days)||0
534748|NCT00812929|1303763|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
534749|NCT00812929|1303764|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
534750|NCT00812929|1303765|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
534751|NCT00812929|1303766|P3|NOT COMPLETED|Washout Period 1 (7 Days)||1
534752|NCT00812929|1303767|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
534753|NCT00812929|1303768|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
534754|NCT00812929|1303759|P10|COMPLETED|Washout Period 1 (7 Days)||5
534755|NCT00812929|1303760|P9|COMPLETED|Washout Period 1 (7 Days)||4
534756|NCT00812929|1303761|P8|COMPLETED|Washout Period 1 (7 Days)||5
534757|NCT00812929|1303762|P7|COMPLETED|Washout Period 1 (7 Days)||5
534758|NCT00812929|1303763|P6|COMPLETED|Washout Period 1 (7 Days)||5
534759|NCT00812929|1303764|P5|COMPLETED|Washout Period 1 (7 Days)||5
534760|NCT00812929|1303765|P4|COMPLETED|Washout Period 1 (7 Days)||4
534761|NCT00812929|1303766|P3|COMPLETED|Washout Period 1 (7 Days)||4
534762|NCT00812929|1303767|P2|COMPLETED|Washout Period 1 (7 Days)||4
534763|NCT00812929|1303768|P1|COMPLETED|Washout Period 1 (7 Days)||5
534764|NCT00812929|1303759|P10|STARTED|Washout Period 1 (7 Days)||5
534765|NCT00812929|1303760|P9|STARTED|Washout Period 1 (7 Days)||4
534766|NCT00812929|1303761|P8|STARTED|Washout Period 1 (7 Days)||5
534767|NCT00812929|1303762|P7|STARTED|Washout Period 1 (7 Days)||5
534768|NCT00812929|1303763|P6|STARTED|Washout Period 1 (7 Days)||5
534769|NCT00812929|1303764|P5|STARTED|Washout Period 1 (7 Days)||5
534770|NCT00812929|1303765|P4|STARTED|Washout Period 1 (7 Days)||4
534771|NCT00812929|1303766|P3|STARTED|Washout Period 1 (7 Days)||5
534772|NCT00812929|1303767|P2|STARTED|Washout Period 1 (7 Days)||4
534773|NCT00812929|1303768|P1|STARTED|Washout Period 1 (7 Days)||5
534774|NCT00812929|1303759|P10|NOT COMPLETED|Treatment Period 1||0
534775|NCT00812929|1303760|P9|NOT COMPLETED|Treatment Period 1||0
534776|NCT00812929|1303761|P8|NOT COMPLETED|Treatment Period 1||0
534777|NCT00812929|1303762|P7|NOT COMPLETED|Treatment Period 1||0
534778|NCT00812929|1303763|P6|NOT COMPLETED|Treatment Period 1||0
534779|NCT00812929|1303764|P5|NOT COMPLETED|Treatment Period 1||0
534780|NCT00812929|1303765|P4|NOT COMPLETED|Treatment Period 1||0
534781|NCT00812929|1303766|P3|NOT COMPLETED|Treatment Period 1||0
534782|NCT00812929|1303767|P2|NOT COMPLETED|Treatment Period 1||0
534783|NCT00812929|1303768|P1|NOT COMPLETED|Treatment Period 1||0
534784|NCT00812929|1303759|P10|COMPLETED|Treatment Period 1||5
534785|NCT00812929|1303760|P9|COMPLETED|Treatment Period 1||4
534786|NCT00812929|1303761|P8|COMPLETED|Treatment Period 1||5
534787|NCT00812929|1303762|P7|COMPLETED|Treatment Period 1||5
534788|NCT00812929|1303763|P6|COMPLETED|Treatment Period 1||5
534789|NCT00812929|1303764|P5|COMPLETED|Treatment Period 1||5
534790|NCT00812929|1303765|P4|COMPLETED|Treatment Period 1||4
534791|NCT00812929|1303766|P3|COMPLETED|Treatment Period 1||5
534792|NCT00812929|1303767|P2|COMPLETED|Treatment Period 1||4
534793|NCT00812929|1303768|P1|COMPLETED|Treatment Period 1||5
534794|NCT00812929|1303759|P10|STARTED|Treatment Period 1||5
534795|NCT00812929|1303760|P9|STARTED|Treatment Period 1||4
534796|NCT00812929|1303761|P8|STARTED|Treatment Period 1||5
534797|NCT00812929|1303762|P7|STARTED|Treatment Period 1||5
534798|NCT00812929|1303763|P6|STARTED|Treatment Period 1||5
534799|NCT00812929|1303764|P5|STARTED|Treatment Period 1||5
534800|NCT00812929|1303765|P4|STARTED|Treatment Period 1||4
534801|NCT00812929|1303766|P3|STARTED|Treatment Period 1||5
534802|NCT00812929|1303767|P2|STARTED|Treatment Period 1||4
534803|NCT00812929|1303768|P1|STARTED|Treatment Period 1||5
534804|NCT00812916|1303884|P1|NOT COMPLETED|Overall Study||3
534805|NCT00812916|1303884|P1|COMPLETED|Overall Study||203
534806|NCT00812916|1303884|P1|CFAE - Guided Ablation|Overall Study||203
534807|NCT00812916|1303884|P1|Data Available|Overall Study||205
534808|NCT00812916|1303884|P1|STARTED|Overall Study|206 enrolled (consented)|206
534809|NCT00812877|1303895|P2|NOT COMPLETED|Overall Study||51
534810|NCT00812877|1303896|P1|NOT COMPLETED|Overall Study||37
534811|NCT00812877|1303895|P2|COMPLETED|Overall Study||130
534812|NCT00812877|1303896|P1|COMPLETED|Overall Study||158
534813|NCT00812877|1303895|P2|STARTED|Overall Study||181
534814|NCT00812877|1303896|P1|STARTED|Overall Study||195
534815|NCT00812812|1303906|P2|NOT COMPLETED|Overall Study||4
534816|NCT00812812|1303907|P1|NOT COMPLETED|Overall Study||3
534817|NCT00812812|1303906|P2|COMPLETED|Overall Study||25
534818|NCT00812812|1303907|P1|COMPLETED|Overall Study||24
534819|NCT00812812|1303906|P2|STARTED|Overall Study||29
534820|NCT00812812|1303907|P1|STARTED|Overall Study||27
534821|NCT00812708|1303920|P1|NOT COMPLETED|Overall Study||8
534822|NCT00812708|1303920|P1|COMPLETED|Overall Study||64
534823|NCT00812708|1303920|P1|Taken to Surgery for Device Implantation|Overall Study|2 patients could not be implanted because of intraoperative complications.|66
534824|NCT00812708|1303920|P1|STARTED|Overall Study|6 patients withdrew from the study before being taken to the operating room.|72
534825|NCT00812604|1303931|P2|NOT COMPLETED|Overall Study||5
534826|NCT00812604|1303932|P1|NOT COMPLETED|Overall Study||5
534827|NCT00812604|1303931|P2|COMPLETED|Overall Study||22
534828|NCT00812604|1303932|P1|COMPLETED|Overall Study||23
534829|NCT00812604|1303931|P2|STARTED|Overall Study||27
534830|NCT00812604|1303932|P1|STARTED|Overall Study||28
534831|NCT00812565|1303948|P8|NOT COMPLETED|Overall Study||1
534832|NCT00812565|1303949|P7|NOT COMPLETED|Overall Study||0
534833|NCT00812565|1303950|P6|NOT COMPLETED|Overall Study||1
534834|NCT00812565|1303951|P5|NOT COMPLETED|Overall Study||1
534835|NCT00812565|1303952|P4|NOT COMPLETED|Overall Study||2
534836|NCT00812565|1303953|P3|NOT COMPLETED|Overall Study||0
534837|NCT00812565|1303954|P2|NOT COMPLETED|Overall Study||1
534838|NCT00812565|1303955|P1|NOT COMPLETED|Overall Study||3
534839|NCT00812565|1303948|P8|COMPLETED|Overall Study||6
534840|NCT00812565|1303949|P7|COMPLETED|Overall Study||8
534841|NCT00812565|1303950|P6|COMPLETED|Overall Study||6
534842|NCT00812565|1303951|P5|COMPLETED|Overall Study||6
534843|NCT00812565|1303952|P4|COMPLETED|Overall Study||5
534844|NCT00812565|1303953|P3|COMPLETED|Overall Study||7
534845|NCT00812565|1303954|P2|COMPLETED|Overall Study||6
534846|NCT00812565|1303955|P1|COMPLETED|Overall Study||5
534847|NCT00812565|1303948|P8|STARTED|Overall Study||7
534848|NCT00812565|1303949|P7|STARTED|Overall Study||8
534849|NCT00812565|1303950|P6|STARTED|Overall Study||7
534850|NCT00812565|1303951|P5|STARTED|Overall Study||7
534851|NCT00812565|1303952|P4|STARTED|Overall Study||7
534852|NCT00812565|1303953|P3|STARTED|Overall Study||7
534853|NCT00812565|1303954|P2|STARTED|Overall Study||7
534854|NCT00812565|1303955|P1|STARTED|Overall Study||8
534855|NCT00812487|1304079|P2|NOT COMPLETED|Overall Study||3
534856|NCT00812487|1304080|P1|NOT COMPLETED|Overall Study||6
534857|NCT00812487|1304079|P2|COMPLETED|Overall Study||39
534858|NCT00812487|1304080|P1|COMPLETED|Overall Study||26
534859|NCT00812487|1304079|P2|STARTED|Overall Study||42
534860|NCT00812487|1304080|P1|STARTED|Overall Study||32
534861|NCT00812461|1304106|P2|NOT COMPLETED|All Treated Patients||147
534862|NCT00812461|1304107|P1|NOT COMPLETED|All Treated Patients||132
534863|NCT00812461|1304106|P2|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|194
534864|NCT00812461|1304107|P1|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|205
534865|NCT00812461|1304106|P2|STARTED|All Treated Patients||341
534866|NCT00812461|1304107|P1|STARTED|All Treated Patients||337
534867|NCT00812461|1304106|P2|NOT COMPLETED|All Randomised Patients||17
534868|NCT00812461|1304107|P1|NOT COMPLETED|All Randomised Patients||23
534869|NCT00812461|1304106|P2|COMPLETED|All Randomised Patients||341
534870|NCT00812461|1304107|P1|COMPLETED|All Randomised Patients||337
534871|NCT00812461|1304106|P2|STARTED|All Randomised Patients||358
534872|NCT00812461|1304107|P1|STARTED|All Randomised Patients||360
534873|NCT00812331|1304130|P5|NOT COMPLETED|Overall Study||0
534874|NCT00812331|1304131|P4|NOT COMPLETED|Overall Study||0
534875|NCT00812331|1304132|P3|NOT COMPLETED|Overall Study||0
534876|NCT00812331|1304133|P2|NOT COMPLETED|Overall Study||0
534877|NCT00812331|1304134|P1|NOT COMPLETED|Overall Study||1
534878|NCT00812331|1304130|P5|COMPLETED|Overall Study||8
534879|NCT00812331|1304131|P4|COMPLETED|Overall Study||7
534880|NCT00812331|1304132|P3|COMPLETED|Overall Study||8
534881|NCT00812331|1304133|P2|COMPLETED|Overall Study||8
534882|NCT00812331|1304134|P1|COMPLETED|Overall Study||5
534883|NCT00812331|1304130|P5|STARTED|Overall Study||8
534884|NCT00812331|1304131|P4|STARTED|Overall Study||7
534885|NCT00812331|1304132|P3|STARTED|Overall Study||8
534886|NCT00812331|1304133|P2|STARTED|Overall Study||8
534887|NCT00812331|1304134|P1|STARTED|Overall Study||6
534888|NCT00812253|1304209|P2|NOT COMPLETED|Overall Study||3
534889|NCT00812253|1304210|P1|NOT COMPLETED|Overall Study||6
534890|NCT00812253|1304209|P2|COMPLETED|Overall Study||39
534891|NCT00812253|1304210|P1|COMPLETED|Overall Study||26
534892|NCT00812253|1304209|P2|STARTED|Overall Study||42
534893|NCT00812253|1304210|P1|STARTED|Overall Study||32
534894|NCT00812110|1304226|P1|NOT COMPLETED|Overall Study||0
534895|NCT00812110|1304226|P1|COMPLETED|Overall Study||292
534896|NCT00812110|1304226|P1|STARTED|Overall Study||292
534897|NCT00812097|1304235|P4|NOT COMPLETED|Overall Study||35
534898|NCT00812097|1304236|P3|NOT COMPLETED|Overall Study||57
534899|NCT00812097|1304237|P2|NOT COMPLETED|Overall Study||89
534900|NCT00812097|1304238|P1|NOT COMPLETED|Overall Study||245
534901|NCT00812097|1304235|P4|COMPLETED|Overall Study||34
534902|NCT00812097|1304236|P3|COMPLETED|Overall Study||67
534903|NCT00812097|1304237|P2|COMPLETED|Overall Study||101
534904|NCT00812097|1304238|P1|COMPLETED|Overall Study||327
534905|NCT00812097|1304235|P4|STARTED|Overall Study||69
534906|NCT00812097|1304236|P3|STARTED|Overall Study||124
534907|NCT00812097|1304237|P2|STARTED|Overall Study||190
534908|NCT00812097|1304238|P1|STARTED|Overall Study||572
534909|NCT00812006|1304267|P3|NOT COMPLETED|Overall Study||6
534910|NCT00812006|1304268|P2|NOT COMPLETED|Overall Study||3
534911|NCT00812006|1304269|P1|NOT COMPLETED|Overall Study||6
534912|NCT00812006|1304267|P3|COMPLETED|Overall Study||30
534913|NCT00812006|1304268|P2|COMPLETED|Overall Study||33
534914|NCT00812006|1304269|P1|COMPLETED|Overall Study||30
534915|NCT00812006|1304267|P3|STARTED|Overall Study||36
534916|NCT00812006|1304268|P2|STARTED|Overall Study||36
534917|NCT00812006|1304269|P1|STARTED|Overall Study||36
534918|NCT00811954|1304286|P3|NOT COMPLETED|Overall Study||101
534919|NCT00811954|1304287|P2|NOT COMPLETED|Overall Study||72
534920|NCT00811954|1304288|P1|NOT COMPLETED|Overall Study||89
534921|NCT00811954|1304286|P3|COMPLETED|Overall Study||500
534922|NCT00811954|1304287|P2|COMPLETED|Overall Study||531
534923|NCT00811954|1304288|P1|COMPLETED|Overall Study||516
534924|NCT00811954|1304286|P3|STARTED|Overall Study||601
534925|NCT00811954|1304287|P2|STARTED|Overall Study||603
534926|NCT00811954|1304288|P1|STARTED|Overall Study||605
534927|NCT00811941|1304352|P2|NOT COMPLETED|All Treated Patients||191
534928|NCT00811941|1304353|P1|NOT COMPLETED|All Treated Patients||52
534929|NCT00811941|1304352|P2|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|310
534930|NCT00811941|1304353|P1|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|112
534931|NCT00811941|1304352|P2|STARTED|All Treated Patients||501
534932|NCT00811941|1304353|P1|STARTED|All Treated Patients||164
534933|NCT00811941|1304352|P2|NOT COMPLETED|All Randomised Patients||8
534934|NCT00811941|1304353|P1|NOT COMPLETED|All Randomised Patients||2
534935|NCT00811941|1304352|P2|COMPLETED|All Randomised Patients||501
534936|NCT00811941|1304353|P1|COMPLETED|All Randomised Patients||164
534937|NCT00811941|1304352|P2|STARTED|All Randomised Patients||509
534938|NCT00811941|1304353|P1|STARTED|All Randomised Patients||166
534939|NCT00811928|1304391|P2|NOT COMPLETED|Overall Study||33
534940|NCT00811928|1304392|P1|NOT COMPLETED|Overall Study||39
534941|NCT00811928|1304391|P2|COMPLETED|Overall Study||90
534942|NCT00811928|1304392|P1|COMPLETED|Overall Study||90
534943|NCT00811928|1304391|P2|STARTED|Overall Study||123
534944|NCT00811928|1304392|P1|STARTED|Overall Study||129
534945|NCT00811850|1304410|P1|NOT COMPLETED|Treatment Period 3: Combigan® or Cosopt®||0
534946|NCT00811850|1304410|P1|COMPLETED|Treatment Period 3: Combigan® or Cosopt®||15
534947|NCT00811850|1304410|P1|STARTED|Treatment Period 3: Combigan® or Cosopt®||15
534948|NCT00811850|1304410|P1|NOT COMPLETED|Treatment Period 2: Wash Out||0
534949|NCT00811850|1304410|P1|COMPLETED|Treatment Period 2: Wash Out||15
534950|NCT00811850|1304410|P1|STARTED|Treatment Period 2: Wash Out||15
534951|NCT00811850|1304410|P1|NOT COMPLETED|Treatment Period 1: Combigan® or Cosopt®||0
534952|NCT00811850|1304410|P1|COMPLETED|Treatment Period 1: Combigan® or Cosopt®||15
534953|NCT00811850|1304410|P1|STARTED|Treatment Period 1: Combigan® or Cosopt®||15
534954|NCT00811798|1304430|P1|NOT COMPLETED|Overall Study||0
534955|NCT00811798|1304430|P1|COMPLETED|Overall Study||92
534956|NCT00811798|1304430|P1|STARTED|Overall Study||92
534957|NCT00811733|1304436|P2|NOT COMPLETED|Overall Study||10
534958|NCT00811733|1304437|P1|NOT COMPLETED|Overall Study||11
534959|NCT00811733|1304436|P2|COMPLETED|Overall Study||12
534960|NCT00811733|1304437|P1|COMPLETED|Overall Study||4
534961|NCT00811733|1304436|P2|STARTED|Overall Study||22
534962|NCT00811733|1304437|P1|STARTED|Overall Study||15
534963|NCT00811720|1304485|P2|NOT COMPLETED|All Treated Patients||164
534964|NCT00811720|1304486|P1|NOT COMPLETED|All Treated Patients||96
534965|NCT00811720|1304485|P2|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|138
534966|NCT00811720|1304486|P1|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|200
534967|NCT00811720|1304485|P2|STARTED|All Treated Patients||302
534968|NCT00811720|1304486|P1|STARTED|All Treated Patients||296
534969|NCT00811720|1304485|P2|NOT COMPLETED|All Randomised Patients||4
534970|NCT00811720|1304486|P1|NOT COMPLETED|All Randomised Patients||2
534971|NCT00811720|1304485|P2|COMPLETED|All Randomised Patients||302
534972|NCT00811720|1304486|P1|COMPLETED|All Randomised Patients||296
534973|NCT00811720|1304485|P2|STARTED|All Randomised Patients||306
534974|NCT00811720|1304486|P1|STARTED|All Randomised Patients||298
534975|NCT00811655|1304504|P1|NOT COMPLETED|Overall Study||1
534976|NCT00811655|1304504|P1|COMPLETED|Overall Study||5
534977|NCT00811655|1304504|P1|STARTED|Overall Study||6
534978|NCT00811642|1304516|P1|NOT COMPLETED|Overall Study||15
534979|NCT00811642|1304516|P1|COMPLETED|Overall Study|The Per Protocol Set (PPS) includes the 47 participants who completed the study per protocol.|47
534980|NCT00811642|1304516|P1|STARTED|Overall Study|63 participants were screened and enrolled; 62 participants from Safety Set (SS) started study drug.|62
534981|NCT00811590|1304526|P1|NOT COMPLETED|Overall Study||0
534982|NCT00811590|1304526|P1|COMPLETED|Overall Study||3
534983|NCT00811590|1304526|P1|STARTED|Overall Study||3
534984|NCT00811577|1304532|P2|NOT COMPLETED|Overall Study||1
534985|NCT00811577|1304533|P1|NOT COMPLETED|Overall Study||10
534986|NCT00811577|1304532|P2|COMPLETED|Overall Study||23
534987|NCT00811577|1304533|P1|COMPLETED|Overall Study||116
534988|NCT00811577|1304532|P2|STARTED|Overall Study||24
534989|NCT00811577|1304533|P1|STARTED|Overall Study||126
534990|NCT00811564|1304584|P2|NOT COMPLETED|Overall Study||2
534991|NCT00811564|1304585|P1|NOT COMPLETED|Overall Study||9
534992|NCT00811564|1304584|P2|COMPLETED|Overall Study||73
534993|NCT00811564|1304585|P1|COMPLETED|Overall Study||64
534994|NCT00811564|1304584|P2|STARTED|Overall Study||75
534995|NCT00811564|1304585|P1|STARTED|Overall Study||73
534996|NCT00811473|1304593|P2|NOT COMPLETED|Overall Study||26
534997|NCT00811473|1304594|P1|NOT COMPLETED|Overall Study||23
534998|NCT00811473|1304593|P2|COMPLETED|Overall Study||74
534999|NCT00811473|1304594|P1|COMPLETED|Overall Study||70
535000|NCT00811473|1304593|P2|STARTED|Overall Study||100
535001|NCT00811473|1304594|P1|STARTED|Overall Study||93
535002|NCT00811434|1304610|P2|NOT COMPLETED|Second Intervention||0
535003|NCT00811434|1304611|P1|NOT COMPLETED|Second Intervention||0
535004|NCT00811434|1304610|P2|COMPLETED|Second Intervention||5
535005|NCT00811434|1304611|P1|COMPLETED|Second Intervention||4
535006|NCT00811434|1304610|P2|STARTED|Second Intervention||5
535007|NCT00811434|1304611|P1|STARTED|Second Intervention||4
535008|NCT00811434|1304610|P2|NOT COMPLETED|Washout (1 Month)||0
535009|NCT00811434|1304611|P1|NOT COMPLETED|Washout (1 Month)||0
535010|NCT00811434|1304610|P2|COMPLETED|Washout (1 Month)||5
535011|NCT00811434|1304611|P1|COMPLETED|Washout (1 Month)||4
535012|NCT00811434|1304610|P2|STARTED|Washout (1 Month)||5
535013|NCT00811434|1304611|P1|STARTED|Washout (1 Month)||4
535014|NCT00811434|1304610|P2|NOT COMPLETED|First Intervention||0
535015|NCT00811434|1304611|P1|NOT COMPLETED|First Intervention||3
535016|NCT00811434|1304610|P2|COMPLETED|First Intervention||5
535017|NCT00811434|1304611|P1|COMPLETED|First Intervention||4
535018|NCT00811434|1304610|P2|STARTED|First Intervention||5
535019|NCT00811434|1304611|P1|STARTED|First Intervention||7
535020|NCT00811395|1304625|P6|NOT COMPLETED|Extension Treatment||2
535021|NCT00811395|1304626|P5|NOT COMPLETED|Extension Treatment||0
535022|NCT00811395|1304627|P4|NOT COMPLETED|Extension Treatment||3
535023|NCT00811395|1304628|P3|NOT COMPLETED|Extension Treatment||3
535024|NCT00811395|1304629|P2|NOT COMPLETED|Extension Treatment||6
535025|NCT00811395|1304630|P1|NOT COMPLETED|Extension Treatment||2
535026|NCT00811395|1304625|P6|COMPLETED|Extension Treatment|completed 48-week treatment|27
535027|NCT00811395|1304626|P5|COMPLETED|Extension Treatment|completed 48-week treatment|30
535028|NCT00811395|1304627|P4|COMPLETED|Extension Treatment|completed 48-week treatment|34
535029|NCT00811395|1304628|P3|COMPLETED|Extension Treatment|completed 48-week treatment|24
535030|NCT00811395|1304629|P2|COMPLETED|Extension Treatment|completed 48-week treatment|22
535031|NCT00811395|1304630|P1|COMPLETED|Extension Treatment|completed 48-week treatment|29
535032|NCT00811395|1304625|P6|STARTED|Extension Treatment|continued initial treatment|29
535033|NCT00811395|1304626|P5|STARTED|Extension Treatment|continued initial treatment|30
535034|NCT00811395|1304627|P4|STARTED|Extension Treatment|continued initial treatment|37
535035|NCT00811395|1304628|P3|STARTED|Extension Treatment|continued initial treatment|27
535036|NCT00811395|1304629|P2|STARTED|Extension Treatment|continued initial treatment|28
535037|NCT00811395|1304630|P1|STARTED|Extension Treatment|continued initial treatment|31
535038|NCT00811395|1304625|P6|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||6
535039|NCT00811395|1304626|P5|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||5
535040|NCT00811395|1304627|P4|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2
535041|NCT00811395|1304628|P3|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2
535042|NCT00811395|1304629|P2|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||4
535043|NCT00811395|1304630|P1|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||3
535044|NCT00811395|1304625|P6|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|35
535045|NCT00811395|1304626|P5|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|37
535046|NCT00811395|1304627|P4|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|38
535047|NCT00811395|1304628|P3|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|36
535048|NCT00811395|1304629|P2|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|33
535049|NCT00811395|1304630|P1|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|38
535050|NCT00811395|1304625|P6|STARTED|Initial Treatment (PDY6045 or PDY6046)||41
535051|NCT00811395|1304626|P5|STARTED|Initial Treatment (PDY6045 or PDY6046)||42
535052|NCT00811395|1304627|P4|STARTED|Initial Treatment (PDY6045 or PDY6046)||40
535053|NCT00811395|1304628|P3|STARTED|Initial Treatment (PDY6045 or PDY6046)||38
535054|NCT00811395|1304629|P2|STARTED|Initial Treatment (PDY6045 or PDY6046)|One participant received 7 mg instead of 14 mg as per randomization|37
535055|NCT00811395|1304630|P1|STARTED|Initial Treatment (PDY6045 or PDY6046)||41
535056|NCT00811382|1304694|P2|NOT COMPLETED|Overall Study||0
535057|NCT00811382|1304695|P1|NOT COMPLETED|Overall Study||0
535058|NCT00811382|1304694|P2|COMPLETED|Overall Study||75
535059|NCT00811382|1304695|P1|COMPLETED|Overall Study||88
535060|NCT00811382|1304694|P2|STARTED|Overall Study||75
535061|NCT00811382|1304695|P1|STARTED|Overall Study||88
535062|NCT00811317|1304707|P1|NOT COMPLETED|Overall Study||0
535063|NCT00811317|1304707|P1|COMPLETED|Overall Study||11
535064|NCT00811317|1304707|P1|STARTED|Overall Study||11
535065|NCT00811252|1304736|P3|NOT COMPLETED|Overall Study||23
535066|NCT00811252|1304737|P2|NOT COMPLETED|Overall Study||20
535067|NCT00811252|1304738|P1|NOT COMPLETED|Overall Study||17
535068|NCT00811252|1304736|P3|COMPLETED|Overall Study||128
535069|NCT00811252|1304737|P2|COMPLETED|Overall Study||136
535070|NCT00811252|1304738|P1|COMPLETED|Overall Study||128
535071|NCT00811252|1304736|P3|STARTED|Overall Study||151
535072|NCT00811252|1304737|P2|STARTED|Overall Study||156
535073|NCT00811252|1304738|P1|STARTED|Overall Study||145
535074|NCT00811174|1304782|P1|NOT COMPLETED|Overall Study||3
535075|NCT00811174|1304782|P1|COMPLETED|Overall Study||2
535076|NCT00811174|1304782|P1|STARTED|Overall Study||5
535077|NCT00811135|1304793|P1|NOT COMPLETED|Overall Study||88
535078|NCT00811135|1304793|P1|COMPLETED|Overall Study||0
535079|NCT00811135|1304793|P1|STARTED|Overall Study||88
535080|NCT00811070|1304811|P6|NOT COMPLETED|Overall Study||1
535081|NCT00811070|1304812|P5|NOT COMPLETED|Overall Study||5
535082|NCT00811070|1304813|P4|NOT COMPLETED|Overall Study||2
535083|NCT00811070|1304814|P3|NOT COMPLETED|Overall Study||0
535084|NCT00811070|1304815|P2|NOT COMPLETED|Overall Study||1
535085|NCT00811070|1304816|P1|NOT COMPLETED|Overall Study||1
535086|NCT00811070|1304811|P6|COMPLETED|Overall Study||10
535087|NCT00811070|1304812|P5|COMPLETED|Overall Study||2
535088|NCT00811070|1304813|P4|COMPLETED|Overall Study||26
535089|NCT00811070|1304814|P3|COMPLETED|Overall Study||3
535090|NCT00811070|1304815|P2|COMPLETED|Overall Study||6
535091|NCT00811070|1304816|P1|COMPLETED|Overall Study||6
535092|NCT00811070|1304811|P6|STARTED|Overall Study||11
535093|NCT00811070|1304812|P5|STARTED|Overall Study||7
535094|NCT00811070|1304813|P4|STARTED|Overall Study||28
535095|NCT00811070|1304814|P3|STARTED|Overall Study||3
535096|NCT00811070|1304815|P2|STARTED|Overall Study||7
535097|NCT00811070|1304816|P1|STARTED|Overall Study||7
535098|NCT00811057|1304876|P3|NOT COMPLETED|Overall Study||10
535099|NCT00811057|1304877|P2|NOT COMPLETED|Overall Study||10
535100|NCT00811057|1304878|P1|NOT COMPLETED|Overall Study||5
535101|NCT00811057|1304876|P3|COMPLETED|Overall Study||87
535102|NCT00811057|1304877|P2|COMPLETED|Overall Study||104
535103|NCT00811057|1304878|P1|COMPLETED|Overall Study||85
535104|NCT00811057|1304876|P3|STARTED|Overall Study||97
535105|NCT00811057|1304877|P2|STARTED|Overall Study||114
535106|NCT00811057|1304878|P1|STARTED|Overall Study||90
535107|NCT00811018|1304889|P1|NOT COMPLETED|Overall Study||968
535108|NCT00811018|1304889|P1|COMPLETED|Overall Study||224
535109|NCT00811018|1304889|P1|STARTED|Overall Study||1192
535110|NCT00810901|1304907|P2|NOT COMPLETED|Overall Study||58
535111|NCT00810901|1304908|P1|NOT COMPLETED|Overall Study||88
535112|NCT00810901|1304907|P2|COMPLETED|Overall Study||118
535113|NCT00810901|1304908|P1|COMPLETED|Overall Study||165
535114|NCT00810901|1304907|P2|6-month Follow-up|Overall Study||122
535115|NCT00810901|1304908|P1|6-month Follow-up|Overall Study||181
535116|NCT00810901|1304907|P2|1-month Follow up|Overall Study||146
535117|NCT00810901|1304908|P1|1-month Follow up|Overall Study||242
535118|NCT00810901|1304907|P2|STARTED|Overall Study||176
535119|NCT00810901|1304908|P1|STARTED|Overall Study||253
535120|NCT00810888|1304919|P3|NOT COMPLETED|Overall Study||0
535121|NCT00810888|1304920|P2|NOT COMPLETED|Overall Study||0
535122|NCT00810888|1304921|P1|NOT COMPLETED|Overall Study||0
535123|NCT00810888|1304919|P3|COMPLETED|Overall Study||73
535124|NCT00810888|1304920|P2|COMPLETED|Overall Study||9
535125|NCT00810888|1304921|P1|COMPLETED|Overall Study||10
535126|NCT00810888|1304919|P3|STARTED|Overall Study||73
535127|NCT00810888|1304920|P2|STARTED|Overall Study||9
535128|NCT00810888|1304921|P1|STARTED|Overall Study||10
535129|NCT00810810|1304954|P4|NOT COMPLETED|Overall Study||13
535130|NCT00810810|1304955|P3|NOT COMPLETED|Overall Study||11
535131|NCT00810810|1304956|P2|NOT COMPLETED|Overall Study||11
535132|NCT00810810|1304957|P1|NOT COMPLETED|Overall Study||0
535133|NCT00810810|1304954|P4|COMPLETED|Overall Study||38
535134|NCT00810810|1304955|P3|COMPLETED|Overall Study||45
535135|NCT00810810|1304956|P2|COMPLETED|Overall Study||38
535136|NCT00810810|1304957|P1|COMPLETED|Overall Study||124
535137|NCT00810810|1304954|P4|STARTED|Overall Study||51
535138|NCT00810810|1304955|P3|STARTED|Overall Study||56
535139|NCT00810810|1304956|P2|STARTED|Overall Study||49
535140|NCT00810810|1304957|P1|STARTED|Overall Study||124
535141|NCT00810771|1304974|P3|NOT COMPLETED|Overall Study||0
535142|NCT00810771|1304975|P2|NOT COMPLETED|Overall Study||0
535143|NCT00810771|1304976|P1|NOT COMPLETED|Overall Study||0
535144|NCT00810771|1304974|P3|COMPLETED|Overall Study||84
535145|NCT00810771|1304975|P2|COMPLETED|Overall Study||234
535146|NCT00810771|1304976|P1|COMPLETED|Overall Study||232
535147|NCT00810771|1304974|P3|STARTED|Overall Study||84
535148|NCT00810771|1304975|P2|STARTED|Overall Study||234
535149|NCT00810771|1304976|P1|STARTED|Overall Study||232
535150|NCT00810719|1304996|P1|NOT COMPLETED|Overall Study||0
535151|NCT00810719|1304996|P1|COMPLETED|Overall Study||30
535152|NCT00810719|1304996|P1|STARTED|Overall Study||30
535153|NCT00810693|1305005|P3|NOT COMPLETED|Follow-up Period (FUP)||4
535154|NCT00810693|1305006|P2|NOT COMPLETED|Follow-up Period (FUP)||3
535155|NCT00810693|1305007|P1|NOT COMPLETED|Follow-up Period (FUP)||8
535156|NCT00810693|1305005|P3|COMPLETED|Follow-up Period (FUP)||12
535157|NCT00810693|1305006|P2|COMPLETED|Follow-up Period (FUP)||4
535158|NCT00810693|1305007|P1|COMPLETED|Follow-up Period (FUP)||15
535159|NCT00810693|1305005|P3|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|16
535160|NCT00810693|1305006|P2|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|7
535161|NCT00810693|1305007|P1|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|23
535162|NCT00810693|1305005|P3|NOT COMPLETED|Treatment Period||16
535163|NCT00810693|1305006|P2|NOT COMPLETED|Treatment Period||7
535164|NCT00810693|1305007|P1|NOT COMPLETED|Treatment Period||17
535165|NCT00810693|1305005|P3|COMPLETED|Treatment Period||111
535166|NCT00810693|1305006|P2|COMPLETED|Treatment Period||57
535167|NCT00810693|1305007|P1|COMPLETED|Treatment Period||237
535168|NCT00810693|1305005|P3|Participants Received Treatment|Treatment Period||126
535169|NCT00810693|1305006|P2|Participants Received Treatment|Treatment Period||63
535170|NCT00810693|1305007|P1|Participants Received Treatment|Treatment Period||254
535171|NCT00810693|1305005|P3|STARTED|Treatment Period|1 randomized but not treated|127
535172|NCT00810693|1305006|P2|STARTED|Treatment Period|1 randomized but not treated|64
535173|NCT00810693|1305007|P1|STARTED|Treatment Period||254
535174|NCT00810641|1305039|P3|NOT COMPLETED|Overall Study||2
535175|NCT00810641|1305040|P2|NOT COMPLETED|Overall Study||1
535176|NCT00810641|1305041|P1|NOT COMPLETED|Overall Study||0
535177|NCT00810641|1305039|P3|COMPLETED|Overall Study||49
535178|NCT00810641|1305040|P2|COMPLETED|Overall Study||53
535179|NCT00810641|1305041|P1|COMPLETED|Overall Study||52
535180|NCT00810641|1305039|P3|STARTED|Overall Study||51
535181|NCT00810641|1305040|P2|STARTED|Overall Study||54
535182|NCT00810641|1305041|P1|STARTED|Overall Study||52
535183|NCT00810602|1305049|P2|NOT COMPLETED|Overall Study||3
535184|NCT00810602|1305050|P1|NOT COMPLETED|Overall Study||8
535185|NCT00810602|1305049|P2|COMPLETED|Overall Study||31
535186|NCT00810602|1305050|P1|COMPLETED|Overall Study||19
535187|NCT00810602|1305049|P2|STARTED|Overall Study||34
535188|NCT00810602|1305050|P1|STARTED|Overall Study||27
535189|NCT00810576|1305057|P1|NOT COMPLETED|Overall Study||0
535190|NCT00810576|1305057|P1|COMPLETED|Overall Study||1
535191|NCT00810576|1305057|P1|STARTED|Overall Study||1
535192|NCT00810511|1305063|P2|NOT COMPLETED|Overall Study||4
535193|NCT00810511|1305064|P1|NOT COMPLETED|Overall Study||10
535194|NCT00810511|1305063|P2|COMPLETED|Overall Study||102
535195|NCT00810511|1305064|P1|COMPLETED|Overall Study||97
535196|NCT00810511|1305063|P2|STARTED|Overall Study||106
535197|NCT00810511|1305064|P1|STARTED|Overall Study||107
535198|NCT00810394|1305070|P1|NOT COMPLETED|Overall Study||3
535199|NCT00810394|1305070|P1|COMPLETED|Overall Study||47
535200|NCT00810394|1305070|P1|Cycle 3 400mg Twice Daily|Overall Study||5
535201|NCT00810394|1305070|P1|Cycle 3 800 mg Twice Daily|Overall Study||4
535202|NCT00810394|1305070|P1|Cycle 2 400mg Once Daily|Overall Study||22
535203|NCT00810394|1305070|P1|Cycle 2 600mg Twice Daily|Overall Study||13
535204|NCT00810394|1305070|P1|STARTED|Overall Study||50
535205|NCT00810368|1305078|P2|NOT COMPLETED|Overall Study||2
535206|NCT00810368|1305079|P1|NOT COMPLETED|Overall Study||6
535207|NCT00810368|1305078|P2|COMPLETED|Overall Study||13
535208|NCT00810368|1305079|P1|COMPLETED|Overall Study||12
535209|NCT00810368|1305078|P2|STARTED|Overall Study||15
535210|NCT00810368|1305079|P1|STARTED|Overall Study||18
535211|NCT00810355|1305100|P3|NOT COMPLETED|Overall Study||11
535212|NCT00810355|1305101|P2|NOT COMPLETED|Overall Study||17
535213|NCT00810355|1305102|P1|NOT COMPLETED|Overall Study||14
535214|NCT00810355|1305100|P3|COMPLETED|Overall Study||14
535215|NCT00810355|1305101|P2|COMPLETED|Overall Study||8
535216|NCT00810355|1305102|P1|COMPLETED|Overall Study||11
535217|NCT00810355|1305100|P3|STARTED|Overall Study||25
535218|NCT00810355|1305101|P2|STARTED|Overall Study||25
535219|NCT00810355|1305102|P1|STARTED|Overall Study||25
535220|NCT00810342|1305118|P2|NOT COMPLETED|12-month Followup||11
535221|NCT00810342|1305119|P1|NOT COMPLETED|12-month Followup||12
535222|NCT00810342|1305118|P2|COMPLETED|12-month Followup||136
535223|NCT00810342|1305119|P1|COMPLETED|12-month Followup||113
535224|NCT00810342|1305118|P2|STARTED|12-month Followup||147
535225|NCT00810342|1305119|P1|STARTED|12-month Followup||125
535226|NCT00810342|1305118|P2|NOT COMPLETED|6-month Follow-up||8
535227|NCT00810342|1305119|P1|NOT COMPLETED|6-month Follow-up||24
535228|NCT00810342|1305118|P2|COMPLETED|6-month Follow-up||147
535229|NCT00810342|1305119|P1|COMPLETED|6-month Follow-up||125
535230|NCT00810342|1305118|P2|STARTED|6-month Follow-up||155
535231|NCT00810342|1305119|P1|STARTED|6-month Follow-up||149
535232|NCT00810342|1305118|P2|NOT COMPLETED|Month 1 Follow-up||2
535233|NCT00810342|1305119|P1|NOT COMPLETED|Month 1 Follow-up||5
535234|NCT00810342|1305118|P2|COMPLETED|Month 1 Follow-up||155
535235|NCT00810342|1305119|P1|COMPLETED|Month 1 Follow-up||149
535236|NCT00810342|1305118|P2|STARTED|Month 1 Follow-up||157
535237|NCT00810342|1305119|P1|STARTED|Month 1 Follow-up||154
535238|NCT00810303|1305127|P1|NOT COMPLETED|Ezetimibe and Efavirenz - Day 21-30||0
535239|NCT00810303|1305127|P1|COMPLETED|Ezetimibe and Efavirenz - Day 21-30||12
535240|NCT00810303|1305127|P1|STARTED|Ezetimibe and Efavirenz - Day 21-30||12
535241|NCT00810303|1305127|P1|NOT COMPLETED|Ezetimibe and Efavirenz - Day 16-20||0
535242|NCT00810303|1305127|P1|COMPLETED|Ezetimibe and Efavirenz - Day 16-20||12
535243|NCT00810303|1305127|P1|STARTED|Ezetimibe and Efavirenz - Day 16-20||12
535244|NCT00810303|1305127|P1|NOT COMPLETED|Ezetimibe Alone - Day 6-15||0
535245|NCT00810303|1305127|P1|COMPLETED|Ezetimibe Alone - Day 6-15||12
535246|NCT00810303|1305127|P1|STARTED|Ezetimibe Alone - Day 6-15||12
535247|NCT00810303|1305127|P1|NOT COMPLETED|Efavirenz Alone - Day 1-5||0
535248|NCT00810303|1305127|P1|COMPLETED|Efavirenz Alone - Day 1-5||12
535249|NCT00810303|1305127|P1|STARTED|Efavirenz Alone - Day 1-5||12
535250|NCT00810277|1305152|P1|NOT COMPLETED|Overall Study||1
535251|NCT00810277|1305152|P1|COMPLETED|Overall Study||13
535252|NCT00810277|1305152|P1|STARTED|Overall Study||14
535253|NCT00810199|1305167|P2|NOT COMPLETED|Overall Study||82
535254|NCT00810199|1305168|P1|NOT COMPLETED|Overall Study||59
535255|NCT00810199|1305167|P2|COMPLETED|Overall Study|Completed=Completed Treatment|195
535256|NCT00810199|1305168|P1|COMPLETED|Overall Study||220
535257|NCT00810199|1305167|P2|Completed Week 104|Overall Study||201
535258|NCT00810199|1305168|P1|Completed Week 104|Overall Study||222
535259|NCT00810199|1305167|P2|Completed Week 52|Overall Study||229
535260|NCT00810199|1305168|P1|Completed Week 52|Overall Study||243
535261|NCT00810199|1305167|P2|Completed Week 24|Overall Study||250
535262|NCT00810199|1305168|P1|Completed Week 24|Overall Study||259
535263|NCT00810199|1305167|P2|Received Study Drug|Overall Study||276
535264|NCT00810199|1305168|P1|Received Study Drug|Overall Study||277
535265|NCT00810199|1305167|P2|STARTED|Overall Study||277
535266|NCT00810199|1305168|P1|STARTED|Overall Study||279
535267|NCT00810108|1305246|P2|NOT COMPLETED|Overall Study||0
535268|NCT00810108|1305247|P1|NOT COMPLETED|Overall Study||1
535269|NCT00810108|1305246|P2|COMPLETED|Overall Study||7
535270|NCT00810108|1305247|P1|COMPLETED|Overall Study||5
535271|NCT00810108|1305246|P2|STARTED|Overall Study||7
535272|NCT00810108|1305247|P1|STARTED|Overall Study||6
535273|NCT00810095|1305252|P1|NOT COMPLETED|Overall Study||0
535274|NCT00810095|1305252|P1|COMPLETED|Overall Study||40
535275|NCT00810095|1305252|P1|STARTED|Overall Study||40
535276|NCT00810082|1305261|P2|NOT COMPLETED|Overall Study||4
535277|NCT00810082|1305262|P1|NOT COMPLETED|Overall Study||0
535278|NCT00810082|1305261|P2|COMPLETED|Overall Study||27
535279|NCT00810082|1305262|P1|COMPLETED|Overall Study||34
535280|NCT00810082|1305261|P2|STARTED|Overall Study||31
535281|NCT00810082|1305262|P1|STARTED|Overall Study||34
535282|NCT00810069|1305270|P3|NOT COMPLETED|Double-Blind Period II||72
535283|NCT00810069|1305271|P2|NOT COMPLETED|Double-Blind Period II||56
535284|NCT00810069|1305272|P1|NOT COMPLETED|Double-Blind Period II||0
535285|NCT00810069|1305270|P3|COMPLETED|Double-Blind Period II||212
535286|NCT00810069|1305271|P2|COMPLETED|Double-Blind Period II||226
535287|NCT00810069|1305272|P1|COMPLETED|Double-Blind Period II||0
535288|NCT00810069|1305270|P3|STARTED|Double-Blind Period II|At Week 8 - delayed intervention divided by response to treatment (nonresponders or responders).|284
535289|NCT00810069|1305271|P2|STARTED|Double-Blind Period II||282
535290|NCT00810069|1305272|P1|STARTED|Double-Blind Period II||0
535291|NCT00810069|1305270|P3|NOT COMPLETED|Lead-in Period I||0
535292|NCT00810069|1305271|P2|NOT COMPLETED|Lead-in Period I||0
535293|NCT00810069|1305272|P1|NOT COMPLETED|Lead-in Period I||274
535294|NCT00810069|1305270|P3|COMPLETED|Lead-in Period I||0
535295|NCT00810069|1305271|P2|COMPLETED|Lead-in Period I||0
535296|NCT00810069|1305272|P1|COMPLETED|Lead-in Period I||566
535297|NCT00810069|1305270|P3|STARTED|Lead-in Period I||0
535298|NCT00810069|1305271|P2|STARTED|Lead-in Period I||0
535299|NCT00810069|1305272|P1|STARTED|Lead-in Period I||840
535300|NCT00810043|1305317|P3|NOT COMPLETED|Overall Study||8
535301|NCT00810043|1305318|P2|NOT COMPLETED|Overall Study||1
535302|NCT00810043|1305319|P1|NOT COMPLETED|Overall Study||4
535303|NCT00810043|1305317|P3|COMPLETED|Overall Study||0
535304|NCT00810043|1305318|P2|COMPLETED|Overall Study||54
535305|NCT00810043|1305319|P1|COMPLETED|Overall Study||53
535306|NCT00810043|1305317|P3|STARTED|Overall Study||8
535307|NCT00810043|1305318|P2|STARTED|Overall Study||55
535308|NCT00810043|1305319|P1|STARTED|Overall Study||57
535309|NCT00809965|1305341|P3|NOT COMPLETED|Overall Study||844
535310|NCT00809965|1305342|P2|NOT COMPLETED|Overall Study||775
535311|NCT00809965|1305343|P1|NOT COMPLETED|Overall Study||783
535312|NCT00809965|1305341|P3|COMPLETED|Overall Study||4332
535313|NCT00809965|1305342|P2|COMPLETED|Overall Study||4399
535314|NCT00809965|1305343|P1|COMPLETED|Overall Study||4393
535315|NCT00809965|1305341|P3|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5115
535316|NCT00809965|1305342|P2|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5114
535317|NCT00809965|1305343|P1|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5113
535318|NCT00809965|1305341|P3|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5110
535319|NCT00809965|1305342|P2|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5115
535320|NCT00809965|1305343|P1|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5125
535321|NCT00809965|1305341|P3|STARTED|Overall Study||5176
535322|NCT00809965|1305342|P2|STARTED|Overall Study||5174
535323|NCT00809965|1305343|P1|STARTED|Overall Study||5176
535324|NCT00809926|1305365|P2|NOT COMPLETED|Overall Study||23
535325|NCT00809926|1305366|P1|NOT COMPLETED|Overall Study||31
535326|NCT00809926|1305365|P2|COMPLETED|Overall Study||196
535327|NCT00809926|1305366|P1|COMPLETED|Overall Study||201
535328|NCT00809926|1305365|P2|STARTED|Overall Study||219
535329|NCT00809926|1305366|P1|STARTED|Overall Study||232
535330|NCT00809848|1305395|P5|NOT COMPLETED|Overall Study||3
535331|NCT00809848|1305396|P4|NOT COMPLETED|Overall Study||1
535332|NCT00809848|1305397|P3|NOT COMPLETED|Overall Study||0
535333|NCT00809848|1305398|P2|NOT COMPLETED|Overall Study||0
535334|NCT00809848|1305399|P1|NOT COMPLETED|Overall Study||0
535335|NCT00809848|1305395|P5|COMPLETED|Overall Study||34
535336|NCT00809848|1305396|P4|COMPLETED|Overall Study||30
535337|NCT00809848|1305397|P3|COMPLETED|Overall Study||34
535338|NCT00809848|1305398|P2|COMPLETED|Overall Study||34
535339|NCT00809848|1305399|P1|COMPLETED|Overall Study||36
535340|NCT00809848|1305395|P5|STARTED|Overall Study||37
535341|NCT00809848|1305396|P4|STARTED|Overall Study||31
535342|NCT00809848|1305397|P3|STARTED|Overall Study||34
535343|NCT00809848|1305398|P2|STARTED|Overall Study||34
535344|NCT00809848|1305399|P1|STARTED|Overall Study||36
535345|NCT00809835|1305420|P4|NOT COMPLETED|Overall Study||2
535346|NCT00809835|1305421|P3|NOT COMPLETED|Overall Study||11
535347|NCT00809835|1305422|P2|NOT COMPLETED|Overall Study||7
535348|NCT00809835|1305423|P1|NOT COMPLETED|Overall Study||8
535349|NCT00809835|1305420|P4|COMPLETED|Overall Study||25
535350|NCT00809835|1305421|P3|COMPLETED|Overall Study||27
535351|NCT00809835|1305422|P2|COMPLETED|Overall Study||20
535352|NCT00809835|1305423|P1|COMPLETED|Overall Study||20
535353|NCT00809835|1305420|P4|STARTED|Overall Study||27
535354|NCT00809835|1305421|P3|STARTED|Overall Study||38
535355|NCT00809835|1305422|P2|STARTED|Overall Study||27
535356|NCT00809835|1305423|P1|STARTED|Overall Study||28
535357|NCT00809809|1305443|P2|NOT COMPLETED|Overall Study||2
535358|NCT00809809|1305444|P1|NOT COMPLETED|Overall Study||3
535359|NCT00809809|1305443|P2|COMPLETED|Overall Study|2 dropped from the study when it was discovered they met the exclusion criteria|77
535360|NCT00809809|1305444|P1|COMPLETED|Overall Study|3 dropped from the study when it was discovered they met the exclusion criteria|75
535361|NCT00809809|1305443|P2|STARTED|Overall Study||79
535362|NCT00809809|1305444|P1|STARTED|Overall Study||78
535363|NCT00809757|1305453|P3|NOT COMPLETED|Overall Study||11
535364|NCT00809757|1305454|P2|NOT COMPLETED|Overall Study||5
535365|NCT00809757|1305455|P1|NOT COMPLETED|Overall Study||6
535366|NCT00809757|1305453|P3|COMPLETED|Overall Study||53
535367|NCT00809757|1305454|P2|COMPLETED|Overall Study||60
535368|NCT00809757|1305455|P1|COMPLETED|Overall Study||62
535369|NCT00809757|1305453|P3|STARTED|Overall Study||64
535370|NCT00809757|1305454|P2|STARTED|Overall Study||65
535371|NCT00809757|1305455|P1|STARTED|Overall Study||68
535372|NCT00809614|1305540|P2|NOT COMPLETED|Overall Study||4
535373|NCT00809614|1305541|P1|NOT COMPLETED|Overall Study||3
535374|NCT00809614|1305540|P2|COMPLETED|Overall Study||10
535375|NCT00809614|1305541|P1|COMPLETED|Overall Study||25
535376|NCT00809614|1305540|P2|Pharmacodynamic (PD) Set|Overall Study||13
535377|NCT00809614|1305541|P1|Pharmacodynamic (PD) Set|Overall Study||24
535378|NCT00809614|1305540|P2|Pharmacokinetic Safety Set|Overall Study||14
535379|NCT00809614|1305541|P1|Pharmacokinetic Safety Set|Overall Study||27
535380|NCT00809614|1305540|P2|STARTED|Overall Study||14
535381|NCT00809614|1305541|P1|STARTED|Overall Study||28
535382|NCT00809523|1305571|P2|NOT COMPLETED|Overall Study||4
535383|NCT00809523|1305572|P1|NOT COMPLETED|Overall Study||7
535384|NCT00809523|1305571|P2|COMPLETED|Overall Study||48
535385|NCT00809523|1305572|P1|COMPLETED|Overall Study||47
535386|NCT00809523|1305571|P2|STARTED|Overall Study||52
535387|NCT00809523|1305572|P1|STARTED|Overall Study||54
535388|NCT00809471|1305585|P3|NOT COMPLETED|Overall Study||17
535389|NCT00809471|1305586|P2|NOT COMPLETED|Overall Study||20
535390|NCT00809471|1305587|P1|NOT COMPLETED|Overall Study||20
535391|NCT00809471|1305585|P3|COMPLETED|Overall Study||114
535392|NCT00809471|1305586|P2|COMPLETED|Overall Study||109
535393|NCT00809471|1305587|P1|COMPLETED|Overall Study||110
535394|NCT00809471|1305585|P3|STARTED|Overall Study||131
535395|NCT00809471|1305586|P2|STARTED|Overall Study||129
535396|NCT00809471|1305587|P1|STARTED|Overall Study||130
535397|NCT00809458|1305603|P2|NOT COMPLETED|Overall Study||1
535398|NCT00809458|1305604|P1|NOT COMPLETED|Overall Study||1
535399|NCT00809458|1305603|P2|COMPLETED|Overall Study||5
535400|NCT00809458|1305604|P1|COMPLETED|Overall Study||8
535401|NCT00809458|1305603|P2|STARTED|Overall Study||6
535402|NCT00809458|1305604|P1|STARTED|Overall Study||9
535403|NCT00809445|1305617|P3|NOT COMPLETED|6 Month Follow-up||24
535404|NCT00809445|1305618|P2|NOT COMPLETED|6 Month Follow-up||23
535405|NCT00809445|1305619|P1|NOT COMPLETED|6 Month Follow-up||24
535406|NCT00809445|1305617|P3|COMPLETED|6 Month Follow-up||395
535407|NCT00809445|1305618|P2|COMPLETED|6 Month Follow-up||410
535408|NCT00809445|1305619|P1|COMPLETED|6 Month Follow-up||405
535409|NCT00809445|1305617|P3|STARTED|6 Month Follow-up||419
535410|NCT00809445|1305618|P2|STARTED|6 Month Follow-up||433
535411|NCT00809445|1305619|P1|STARTED|6 Month Follow-up||429
535412|NCT00809445|1305617|P3|NOT COMPLETED|1 Month Follow-up||4
535413|NCT00809445|1305618|P2|NOT COMPLETED|1 Month Follow-up||4
535414|NCT00809445|1305619|P1|NOT COMPLETED|1 Month Follow-up||2
535415|NCT00809445|1305617|P3|COMPLETED|1 Month Follow-up||415
535416|NCT00809445|1305618|P2|COMPLETED|1 Month Follow-up||429
535417|NCT00809445|1305619|P1|COMPLETED|1 Month Follow-up||427
535418|NCT00809445|1305617|P3|STARTED|1 Month Follow-up||419
535419|NCT00809445|1305618|P2|STARTED|1 Month Follow-up||433
535420|NCT00809445|1305619|P1|STARTED|1 Month Follow-up||429
535421|NCT00809328|1305636|P1|NOT COMPLETED|Overall Study||29
535422|NCT00809328|1305636|P1|COMPLETED|Overall Study||73
535423|NCT00809328|1305636|P1|STARTED|Overall Study||102
535424|NCT00809276|1305644|P1|NOT COMPLETED|Overall Study||0
535425|NCT00809276|1305644|P1|COMPLETED|Overall Study||92
535426|NCT00809276|1305644|P1|STARTED|Overall Study||92
535427|NCT00809185|1305648|P1|NOT COMPLETED|Overall Study||0
535428|NCT00809185|1305648|P1|COMPLETED|Overall Study||7
535429|NCT00809185|1305648|P1|STARTED|Overall Study||7
535430|NCT00809159|1305656|P6|NOT COMPLETED|Part 1 and 2||3
535431|NCT00809159|1305657|P5|NOT COMPLETED|Part 1 and 2||6
535432|NCT00809159|1305658|P4|NOT COMPLETED|Part 1 and 2||5
535433|NCT00809159|1305659|P3|NOT COMPLETED|Part 1 and 2||10
535434|NCT00809159|1305660|P2|NOT COMPLETED|Part 1 and 2||0
535435|NCT00809159|1305661|P1|NOT COMPLETED|Part 1 and 2||0
535436|NCT00809159|1305656|P6|COMPLETED|Part 1 and 2||3
535437|NCT00809159|1305657|P5|COMPLETED|Part 1 and 2||6
535438|NCT00809159|1305658|P4|COMPLETED|Part 1 and 2||7
535439|NCT00809159|1305659|P3|COMPLETED|Part 1 and 2||20
535440|NCT00809159|1305660|P2|COMPLETED|Part 1 and 2||0
535441|NCT00809159|1305661|P1|COMPLETED|Part 1 and 2||0
535442|NCT00809159|1305656|P6|PD Analysis Set|Part 1 and 2||6
535443|NCT00809159|1305657|P5|PD Analysis Set|Part 1 and 2||12
535444|NCT00809159|1305658|P4|PD Analysis Set|Part 1 and 2||12
535445|NCT00809159|1305659|P3|PD Analysis Set|Part 1 and 2||28
535446|NCT00809159|1305660|P2|PD Analysis Set|Part 1 and 2||0
535447|NCT00809159|1305661|P1|PD Analysis Set|Part 1 and 2||0
535448|NCT00809159|1305656|P6|PK Analysis Set|Part 1 and 2||6
535449|NCT00809159|1305657|P5|PK Analysis Set|Part 1 and 2||12
535450|NCT00809159|1305658|P4|PK Analysis Set|Part 1 and 2||12
535451|NCT00809159|1305659|P3|PK Analysis Set|Part 1 and 2||30
535452|NCT00809159|1305660|P2|PK Analysis Set|Part 1 and 2||0
535453|NCT00809159|1305661|P1|PK Analysis Set|Part 1 and 2||0
535454|NCT00809159|1305656|P6|STARTED|Part 1 and 2||6
535455|NCT00809159|1305657|P5|STARTED|Part 1 and 2||12
535456|NCT00809159|1305658|P4|STARTED|Part 1 and 2||12
535457|NCT00809159|1305659|P3|STARTED|Part 1 and 2||30
535458|NCT00809159|1305660|P2|STARTED|Part 1 and 2||0
535459|NCT00809159|1305661|P1|STARTED|Part 1 and 2||0
535460|NCT00809159|1305656|P6|NOT COMPLETED|Part 1||0
535461|NCT00809159|1305657|P5|NOT COMPLETED|Part 1||0
535462|NCT00809159|1305658|P4|NOT COMPLETED|Part 1||0
535463|NCT00809159|1305659|P3|NOT COMPLETED|Part 1||0
535464|NCT00809159|1305660|P2|NOT COMPLETED|Part 1||3
535465|NCT00809159|1305661|P1|NOT COMPLETED|Part 1||8
535466|NCT00809159|1305656|P6|COMPLETED|Part 1||0
535467|NCT00809159|1305657|P5|COMPLETED|Part 1||0
535468|NCT00809159|1305658|P4|COMPLETED|Part 1||0
535469|NCT00809159|1305659|P3|COMPLETED|Part 1||0
535470|NCT00809159|1305660|P2|COMPLETED|Part 1||3
535471|NCT00809159|1305661|P1|COMPLETED|Part 1||16
535472|NCT00809159|1305656|P6|PD Analysis Set|Part 1||0
535473|NCT00809159|1305657|P5|PD Analysis Set|Part 1||0
535474|NCT00809159|1305658|P4|PD Analysis Set|Part 1||0
535475|NCT00809159|1305659|P3|PD Analysis Set|Part 1||0
535476|NCT00809159|1305660|P2|PD Analysis Set|Part 1||6
535477|NCT00809159|1305661|P1|PD Analysis Set|Part 1||23
535478|NCT00809159|1305656|P6|PK Analysis Set|Part 1||0
535479|NCT00809159|1305657|P5|PK Analysis Set|Part 1||0
535480|NCT00809159|1305658|P4|PK Analysis Set|Part 1||0
535481|NCT00809159|1305659|P3|PK Analysis Set|Part 1||0
535482|NCT00809159|1305660|P2|PK Analysis Set|Part 1||6
535483|NCT00809159|1305661|P1|PK Analysis Set|Part 1||24
535484|NCT00809159|1305656|P6|STARTED|Part 1||0
535485|NCT00809159|1305657|P5|STARTED|Part 1||0
535486|NCT00809159|1305658|P4|STARTED|Part 1||0
535487|NCT00809159|1305659|P3|STARTED|Part 1||0
535488|NCT00809159|1305660|P2|STARTED|Part 1||6
535489|NCT00809159|1305661|P1|STARTED|Part 1||24
535490|NCT00809146|1305727|P2|NOT COMPLETED|Overall Study||0
535491|NCT00809146|1305728|P1|NOT COMPLETED|Overall Study||0
535492|NCT00809146|1305727|P2|COMPLETED|Overall Study||445
535493|NCT00809146|1305728|P1|COMPLETED|Overall Study||448
535494|NCT00809146|1305727|P2|STARTED|Overall Study||445
535495|NCT00809146|1305728|P1|STARTED|Overall Study||448
535496|NCT00809133|1305766|P14|NOT COMPLETED|Overall Study||7
535497|NCT00809133|1305767|P13|NOT COMPLETED|Overall Study||5
535498|NCT00809133|1305768|P12|NOT COMPLETED|Overall Study||8
535499|NCT00809133|1305769|P11|NOT COMPLETED|Overall Study||6
535500|NCT00809133|1305770|P10|NOT COMPLETED|Overall Study||9
535501|NCT00809133|1305771|P9|NOT COMPLETED|Overall Study||3
535502|NCT00809133|1305772|P8|NOT COMPLETED|Overall Study||8
535503|NCT00809133|1305773|P7|NOT COMPLETED|Overall Study||6
535504|NCT00809133|1305774|P6|NOT COMPLETED|Overall Study||7
535505|NCT00809133|1305775|P5|NOT COMPLETED|Overall Study||5
535506|NCT00809133|1305776|P4|NOT COMPLETED|Overall Study||3
535507|NCT00809133|1305777|P3|NOT COMPLETED|Overall Study||6
535508|NCT00809133|1305778|P2|NOT COMPLETED|Overall Study||7
535509|NCT00809133|1305779|P1|NOT COMPLETED|Overall Study||3
535510|NCT00809133|1305766|P14|COMPLETED|Overall Study||0
535511|NCT00809133|1305767|P13|COMPLETED|Overall Study||0
535512|NCT00809133|1305768|P12|COMPLETED|Overall Study||0
535513|NCT00809133|1305769|P11|COMPLETED|Overall Study||0
535514|NCT00809133|1305770|P10|COMPLETED|Overall Study||0
535515|NCT00809133|1305771|P9|COMPLETED|Overall Study||0
535516|NCT00809133|1305772|P8|COMPLETED|Overall Study||0
535517|NCT00809133|1305773|P7|COMPLETED|Overall Study||0
535518|NCT00809133|1305774|P6|COMPLETED|Overall Study||0
535519|NCT00809133|1305775|P5|COMPLETED|Overall Study||0
535520|NCT00809133|1305776|P4|COMPLETED|Overall Study||0
535521|NCT00809133|1305777|P3|COMPLETED|Overall Study||0
535522|NCT00809133|1305778|P2|COMPLETED|Overall Study||0
535523|NCT00809133|1305779|P1|COMPLETED|Overall Study||0
535524|NCT00809133|1305766|P14|STARTED|Overall Study||7
535525|NCT00809133|1305767|P13|STARTED|Overall Study||5
535526|NCT00809133|1305768|P12|STARTED|Overall Study||8
535527|NCT00809133|1305769|P11|STARTED|Overall Study||6
535528|NCT00809133|1305770|P10|STARTED|Overall Study||9
535529|NCT00809133|1305771|P9|STARTED|Overall Study||3
535530|NCT00809133|1305772|P8|STARTED|Overall Study||8
535531|NCT00809133|1305773|P7|STARTED|Overall Study||6
535532|NCT00809133|1305774|P6|STARTED|Overall Study||7
535533|NCT00809133|1305775|P5|STARTED|Overall Study||5
535534|NCT00809133|1305776|P4|STARTED|Overall Study||3
535535|NCT00809133|1305777|P3|STARTED|Overall Study||6
535536|NCT00809133|1305778|P2|STARTED|Overall Study||7
535537|NCT00809133|1305779|P1|STARTED|Overall Study||3
535538|NCT00809094|1305933|P2|NOT COMPLETED|Overall Study||1
535539|NCT00809094|1305934|P1|NOT COMPLETED|Overall Study||0
535540|NCT00809094|1305933|P2|COMPLETED|Overall Study||33
535541|NCT00809094|1305934|P1|COMPLETED|Overall Study||36
535542|NCT00809094|1305933|P2|STARTED|Overall Study||34
535543|NCT00809094|1305934|P1|STARTED|Overall Study||36
535544|NCT00809055|1305954|P2|NOT COMPLETED|Overall Study||7
535545|NCT00809055|1305955|P1|NOT COMPLETED|Overall Study||9
535546|NCT00809055|1305954|P2|COMPLETED|Overall Study||30
535547|NCT00809055|1305955|P1|COMPLETED|Overall Study||28
535548|NCT00809055|1305954|P2|STARTED|Overall Study||37
535549|NCT00809055|1305955|P1|STARTED|Overall Study||37
535550|NCT00808899|1305979|P1|NOT COMPLETED|Overall Study||4
535551|NCT00808899|1305979|P1|COMPLETED|Overall Study||0
535552|NCT00808899|1305979|P1|STARTED|Overall Study||4
535553|NCT00808834|1305983|P2|NOT COMPLETED|Period 2||0
535554|NCT00808834|1305984|P1|NOT COMPLETED|Period 2||0
535555|NCT00808834|1305983|P2|COMPLETED|Period 2||99
535556|NCT00808834|1305984|P1|COMPLETED|Period 2||97
535557|NCT00808834|1305983|P2|STARTED|Period 2||99
535558|NCT00808834|1305984|P1|STARTED|Period 2||97
535559|NCT00808834|1305983|P2|NOT COMPLETED|Period 1||0
535560|NCT00808834|1305984|P1|NOT COMPLETED|Period 1||0
535561|NCT00808834|1305983|P2|COMPLETED|Period 1||99
535562|NCT00808834|1305984|P1|COMPLETED|Period 1||97
535563|NCT00808834|1305983|P2|STARTED|Period 1||99
535564|NCT00808834|1305984|P1|STARTED|Period 1||97
535565|NCT00808808|1305993|P3|NOT COMPLETED|Overall Study||2557
535566|NCT00808808|1305994|P2|NOT COMPLETED|Overall Study||2437
535567|NCT00808808|1305995|P1|NOT COMPLETED|Overall Study||2817
535568|NCT00808808|1305993|P3|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1830
535569|NCT00808808|1305994|P2|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1320
535570|NCT00808808|1305995|P1|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1261
535571|NCT00808808|1305993|P3|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|2132
535572|NCT00808808|1305994|P2|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|1489
535573|NCT00808808|1305995|P1|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|1392
535574|NCT00808808|1305993|P3|STARTED|Overall Study|Started includes all employees at participating sites.|4387
535575|NCT00808808|1305994|P2|STARTED|Overall Study|Started includes all employees at participating sites|3757
535576|NCT00808808|1305995|P1|STARTED|Overall Study|Started includes all employees at participating sites.|4078
535577|NCT00808769|1306021|P2|NOT COMPLETED|Second Intervention||0
535578|NCT00808769|1306022|P1|NOT COMPLETED|Second Intervention||0
535579|NCT00808769|1306021|P2|COMPLETED|Second Intervention||15
535580|NCT00808769|1306022|P1|COMPLETED|Second Intervention||15
535581|NCT00808769|1306021|P2|STARTED|Second Intervention||15
535582|NCT00808769|1306022|P1|STARTED|Second Intervention||15
535583|NCT00808769|1306021|P2|NOT COMPLETED|First Intervention||0
535584|NCT00808769|1306022|P1|NOT COMPLETED|First Intervention||0
535585|NCT00808769|1306021|P2|COMPLETED|First Intervention||15
535586|NCT00808769|1306022|P1|COMPLETED|First Intervention||15
535587|NCT00808769|1306021|P2|STARTED|First Intervention||15
535588|NCT00808769|1306022|P1|STARTED|First Intervention||15
535589|NCT00808665|1306030|P2|NOT COMPLETED|Overall Study||3
535590|NCT00808665|1306031|P1|NOT COMPLETED|Overall Study||6
535591|NCT00808665|1306030|P2|COMPLETED|Overall Study||29
535592|NCT00808665|1306031|P1|COMPLETED|Overall Study||25
535593|NCT00808665|1306030|P2|Completed Post Operative Doses|Overall Study||29
535594|NCT00808665|1306031|P1|Completed Post Operative Doses|Overall Study||25
535595|NCT00808665|1306030|P2|Completed Intra-operative Dose|Overall Study||32
535596|NCT00808665|1306031|P1|Completed Intra-operative Dose|Overall Study||26
535597|NCT00808665|1306030|P2|Medication Started|Overall Study||32
535598|NCT00808665|1306031|P1|Medication Started|Overall Study||30
535599|NCT00808665|1306030|P2|STARTED|Overall Study||32
535600|NCT00808665|1306031|P1|STARTED|Overall Study||31
535601|NCT00808639|1306037|P1|NOT COMPLETED|Overall Study||1
535602|NCT00808639|1306037|P1|COMPLETED|Overall Study|One patient went off treatment due to disease progression before surgery.|38
535603|NCT00808639|1306037|P1|STARTED|Overall Study||39
535604|NCT00808509|1306045|P2|NOT COMPLETED|Observation Phase||0
535605|NCT00808509|1306046|P1|NOT COMPLETED|Observation Phase||0
535606|NCT00808509|1306045|P2|COMPLETED|Observation Phase||15
535607|NCT00808509|1306046|P1|COMPLETED|Observation Phase||16
535608|NCT00808509|1306045|P2|STARTED|Observation Phase|The observation phase was open to all participants|15
535609|NCT00808509|1306046|P1|STARTED|Observation Phase|The observation phase was open to all participants|16
535610|NCT00808509|1306045|P2|NOT COMPLETED|Randomized Phase||5
535611|NCT00808509|1306046|P1|NOT COMPLETED|Randomized Phase||2
535612|NCT00808509|1306045|P2|COMPLETED|Randomized Phase|Includes participants who received rescue therapy & follow-up for 12 weeks|11
535613|NCT00808509|1306046|P1|COMPLETED|Randomized Phase||15
535614|NCT00808509|1306045|P2|Received Rescue Therapy|Randomized Phase||9
535615|NCT00808509|1306046|P1|Received Rescue Therapy|Randomized Phase||0
535616|NCT00808509|1306045|P2|STARTED|Randomized Phase||16
535617|NCT00808509|1306046|P1|STARTED|Randomized Phase||17
535618|NCT00808483|1306144|P2|NOT COMPLETED|From 5 Months to 12 Months||0
535619|NCT00808483|1306145|P1|NOT COMPLETED|From 5 Months to 12 Months||1
535620|NCT00808483|1306144|P2|COMPLETED|From 5 Months to 12 Months||32
535621|NCT00808483|1306145|P1|COMPLETED|From 5 Months to 12 Months||32
535622|NCT00808483|1306144|P2|STARTED|From 5 Months to 12 Months||32
535623|NCT00808483|1306145|P1|STARTED|From 5 Months to 12 Months||33
535624|NCT00808483|1306144|P2|NOT COMPLETED|From 3 to 5 Months After Surgery||1
535625|NCT00808483|1306145|P1|NOT COMPLETED|From 3 to 5 Months After Surgery||2
535626|NCT00808483|1306144|P2|COMPLETED|From 3 to 5 Months After Surgery||32
535627|NCT00808483|1306145|P1|COMPLETED|From 3 to 5 Months After Surgery||33
535628|NCT00808483|1306144|P2|STARTED|From 3 to 5 Months After Surgery||33
535629|NCT00808483|1306145|P1|STARTED|From 3 to 5 Months After Surgery||35
535630|NCT00808470|1306167|P2|NOT COMPLETED|Overall Study||0
535631|NCT00808470|1306168|P1|NOT COMPLETED|Overall Study||2
535632|NCT00808470|1306167|P2|COMPLETED|Overall Study||35
535633|NCT00808470|1306168|P1|COMPLETED|Overall Study||35
535634|NCT00808470|1306167|P2|STARTED|Overall Study||35
535635|NCT00808470|1306168|P1|STARTED|Overall Study||37
535636|NCT00808444|1306182|P2|NOT COMPLETED|Overall Study||1
535637|NCT00808444|1306183|P1|NOT COMPLETED|Overall Study||1
535638|NCT00808444|1306182|P2|COMPLETED|Overall Study||232
535639|NCT00808444|1306183|P1|COMPLETED|Overall Study||232
535640|NCT00808444|1306182|P2|STARTED|Overall Study||233
535641|NCT00808444|1306183|P1|STARTED|Overall Study||233
535642|NCT00808405|1306223|P2|NOT COMPLETED|Overall Study||0
535643|NCT00808405|1306224|P1|NOT COMPLETED|Overall Study||0
535644|NCT00808405|1306223|P2|COMPLETED|Overall Study||27
535645|NCT00808405|1306224|P1|COMPLETED|Overall Study||61
535646|NCT00808405|1306223|P2|STARTED|Overall Study||27
535647|NCT00808405|1306224|P1|STARTED|Overall Study||61
535648|NCT00808340|1306232|P6|NOT COMPLETED|Third Intervention||0
535649|NCT00808340|1306233|P5|NOT COMPLETED|Third Intervention||0
535650|NCT00808340|1306234|P4|NOT COMPLETED|Third Intervention||0
535651|NCT00808340|1306235|P3|NOT COMPLETED|Third Intervention||0
535652|NCT00808340|1306236|P2|NOT COMPLETED|Third Intervention||0
535653|NCT00808340|1306237|P1|NOT COMPLETED|Third Intervention||0
535654|NCT00808340|1306232|P6|COMPLETED|Third Intervention||6
535655|NCT00808340|1306233|P5|COMPLETED|Third Intervention||5
535656|NCT00808340|1306234|P4|COMPLETED|Third Intervention||3
535657|NCT00808340|1306235|P3|COMPLETED|Third Intervention||7
535658|NCT00808340|1306236|P2|COMPLETED|Third Intervention||9
535659|NCT00808340|1306237|P1|COMPLETED|Third Intervention||4
535660|NCT00808340|1306232|P6|STARTED|Third Intervention||6
535661|NCT00808340|1306233|P5|STARTED|Third Intervention||5
535662|NCT00808340|1306234|P4|STARTED|Third Intervention||3
535663|NCT00808340|1306235|P3|STARTED|Third Intervention||7
535664|NCT00808340|1306236|P2|STARTED|Third Intervention||9
535665|NCT00808340|1306237|P1|STARTED|Third Intervention||4
535666|NCT00808340|1306232|P6|NOT COMPLETED|Second Intervention||0
535667|NCT00808340|1306233|P5|NOT COMPLETED|Second Intervention||0
535668|NCT00808340|1306234|P4|NOT COMPLETED|Second Intervention||0
535669|NCT00808340|1306235|P3|NOT COMPLETED|Second Intervention||0
535670|NCT00808340|1306236|P2|NOT COMPLETED|Second Intervention||0
535671|NCT00808340|1306237|P1|NOT COMPLETED|Second Intervention||0
535672|NCT00808340|1306232|P6|COMPLETED|Second Intervention||6
535673|NCT00808340|1306233|P5|COMPLETED|Second Intervention||5
535674|NCT00808340|1306234|P4|COMPLETED|Second Intervention||3
535675|NCT00808340|1306235|P3|COMPLETED|Second Intervention||7
535676|NCT00808340|1306236|P2|COMPLETED|Second Intervention||9
535677|NCT00808340|1306237|P1|COMPLETED|Second Intervention||4
535678|NCT00808340|1306232|P6|STARTED|Second Intervention||6
535679|NCT00808340|1306233|P5|STARTED|Second Intervention||5
535680|NCT00808340|1306234|P4|STARTED|Second Intervention||3
535681|NCT00808340|1306235|P3|STARTED|Second Intervention||7
535682|NCT00808340|1306236|P2|STARTED|Second Intervention||9
535683|NCT00808340|1306237|P1|STARTED|Second Intervention||4
535684|NCT00808340|1306232|P6|NOT COMPLETED|First Intervention||0
535685|NCT00808340|1306233|P5|NOT COMPLETED|First Intervention||0
535686|NCT00808340|1306234|P4|NOT COMPLETED|First Intervention||0
535687|NCT00808340|1306235|P3|NOT COMPLETED|First Intervention||0
535688|NCT00808340|1306236|P2|NOT COMPLETED|First Intervention||0
535689|NCT00808340|1306237|P1|NOT COMPLETED|First Intervention||0
535690|NCT00808340|1306232|P6|COMPLETED|First Intervention||6
535691|NCT00808340|1306233|P5|COMPLETED|First Intervention||5
535692|NCT00808340|1306234|P4|COMPLETED|First Intervention||3
535693|NCT00808340|1306235|P3|COMPLETED|First Intervention||7
535694|NCT00808340|1306236|P2|COMPLETED|First Intervention||9
535695|NCT00808340|1306237|P1|COMPLETED|First Intervention||4
535696|NCT00808340|1306232|P6|STARTED|First Intervention||6
535697|NCT00808340|1306233|P5|STARTED|First Intervention||5
535698|NCT00808340|1306234|P4|STARTED|First Intervention||3
535699|NCT00808340|1306235|P3|STARTED|First Intervention||7
535700|NCT00808340|1306236|P2|STARTED|First Intervention||9
535701|NCT00808340|1306237|P1|STARTED|First Intervention||4
535702|NCT00808249|1306258|P4|NOT COMPLETED|Overall Study||16
535703|NCT00808249|1306259|P3|NOT COMPLETED|Overall Study||22
535704|NCT00808249|1306260|P2|NOT COMPLETED|Overall Study||15
535705|NCT00808249|1306261|P1|NOT COMPLETED|Overall Study||17
535706|NCT00808249|1306258|P4|COMPLETED|Overall Study||90
535707|NCT00808249|1306259|P3|COMPLETED|Overall Study||83
535708|NCT00808249|1306260|P2|COMPLETED|Overall Study||91
535709|NCT00808249|1306261|P1|COMPLETED|Overall Study||90
535710|NCT00808249|1306258|P4|STARTED|Overall Study||106
535711|NCT00808249|1306259|P3|STARTED|Overall Study||105
535712|NCT00808249|1306260|P2|STARTED|Overall Study||106
535713|NCT00808249|1306261|P1|STARTED|Overall Study||107
535714|NCT00808236|1306289|P2|NOT COMPLETED|Overall Study||91
535715|NCT00808236|1306290|P1|NOT COMPLETED|Overall Study||82
535716|NCT00808236|1306289|P2|COMPLETED|Overall Study||13
535717|NCT00808236|1306290|P1|COMPLETED|Overall Study||14
535718|NCT00808236|1306289|P2|Admitted to Hospital|Overall Study|Died during transport to hospital(1)|42
535719|NCT00808236|1306290|P1|Admitted to Hospital|Overall Study|Died during transport to hospital(2); DNAR determination was made at hospital(1)|30
535720|NCT00808236|1306289|P2|Achieved ROSC|Overall Study||43
535721|NCT00808236|1306290|P1|Achieved ROSC|Overall Study||33
535722|NCT00808236|1306289|P2|Included in Analysis|Overall Study|Crossed over & withdrawn (1); Lost to Follow-Up: taken to non-participating hospital (1)|99
535723|NCT00808236|1306290|P1|Included in Analysis|Overall Study|Lost to Follow-Up: taken to non-participating hospital (1)|83
535724|NCT00808236|1306289|P2|Met Eligibility Criteria|Overall Study|Pre-defined exclusions: Terminal(1); Asphyxia(1), In-hospital(1)|101
535725|NCT00808236|1306290|P1|Met Eligibility Criteria|Overall Study|Pre-defined exclusions: DNAR(4); had pulse(2); CVA(2); Drug OD(2); On home oxygen(1); Unwitnessed(1)|84
535726|NCT00808236|1306289|P2|STARTED|Overall Study||104
535727|NCT00808236|1306290|P1|STARTED|Overall Study||96
535728|NCT00808132|1306323|P5|NOT COMPLETED|Overall Study||100
535729|NCT00808132|1306324|P4|NOT COMPLETED|Overall Study||69
535730|NCT00808132|1306325|P3|NOT COMPLETED|Overall Study||54
535731|NCT00808132|1306326|P2|NOT COMPLETED|Overall Study||88
535732|NCT00808132|1306327|P1|NOT COMPLETED|Overall Study||98
535733|NCT00808132|1306323|P5|COMPLETED|Overall Study||383
535734|NCT00808132|1306324|P4|COMPLETED|Overall Study||159
535735|NCT00808132|1306325|P3|COMPLETED|Overall Study||185
535736|NCT00808132|1306326|P2|COMPLETED|Overall Study||393
535737|NCT00808132|1306327|P1|COMPLETED|Overall Study||357
535738|NCT00808132|1306323|P5|Treated|Overall Study||474
535739|NCT00808132|1306324|P4|Treated|Overall Study||220
535740|NCT00808132|1306325|P3|Treated|Overall Study||230
535741|NCT00808132|1306326|P2|Treated|Overall Study||474
535742|NCT00808132|1306327|P1|Treated|Overall Study||445
535743|NCT00808132|1306323|P5|STARTED|Overall Study||483
535744|NCT00808132|1306324|P4|STARTED|Overall Study||228
535745|NCT00808132|1306325|P3|STARTED|Overall Study||239
535746|NCT00808132|1306326|P2|STARTED|Overall Study||481
535747|NCT00808132|1306327|P1|STARTED|Overall Study||455
535748|NCT00808080|1306399|P1|NOT COMPLETED|Overall Study||6
535749|NCT00808080|1306399|P1|COMPLETED|Overall Study||0
535750|NCT00808080|1306399|P1|STARTED|Overall Study||6
535751|NCT00808067|1306405|P2|NOT COMPLETED|Overall Study||518
535752|NCT00808067|1306406|P1|NOT COMPLETED|Overall Study||481
535753|NCT00808067|1306405|P2|COMPLETED|Overall Study||2438
535754|NCT00808067|1306406|P1|COMPLETED|Overall Study||2446
535755|NCT00808067|1306405|P2|STARTED|Overall Study|Number of patients which are treated.|2956
535756|NCT00808067|1306406|P1|STARTED|Overall Study|Number of patients which are treated.|2927
535757|NCT00808028|1306442|P4|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||23
535758|NCT00808028|1306443|P3|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||29
535759|NCT00808028|1306444|P2|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||0
535760|NCT00808028|1306445|P1|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||11
535761|NCT00808028|1306442|P4|COMPLETED|Stage 2 (Followed up to 48 Months )||128
535762|NCT00808028|1306443|P3|COMPLETED|Stage 2 (Followed up to 48 Months )||141
535763|NCT00808028|1306444|P2|COMPLETED|Stage 2 (Followed up to 48 Months )||0
535764|NCT00808028|1306445|P1|COMPLETED|Stage 2 (Followed up to 48 Months )|Out of 511 completed participants in Stage 1, 89 did not enter Stage 2|69
535765|NCT00808028|1306442|P4|STARTED|Stage 2 (Followed up to 48 Months )||151
535766|NCT00808028|1306443|P3|STARTED|Stage 2 (Followed up to 48 Months )||170
535767|NCT00808028|1306444|P2|STARTED|Stage 2 (Followed up to 48 Months )||0
535768|NCT00808028|1306445|P1|STARTED|Stage 2 (Followed up to 48 Months )|Out of 511 completed participants in Stage 1, 89 did not enter Stage 2|80
535769|NCT00808028|1306442|P4|NOT COMPLETED|Stage 1 (6 Months)||15
535770|NCT00808028|1306443|P3|NOT COMPLETED|Stage 1 (6 Months)||7
535771|NCT00808028|1306444|P2|NOT COMPLETED|Stage 1 (6 Months)||1
535772|NCT00808028|1306445|P1|NOT COMPLETED|Stage 1 (6 Months)||5
535773|NCT00808028|1306442|P4|COMPLETED|Stage 1 (6 Months)||183
535774|NCT00808028|1306443|P3|COMPLETED|Stage 1 (6 Months)||191
535775|NCT00808028|1306444|P2|COMPLETED|Stage 1 (6 Months)|Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2|21
535776|NCT00808028|1306445|P1|COMPLETED|Stage 1 (6 Months)||116
535777|NCT00808028|1306442|P4|STARTED|Stage 1 (6 Months)||198
535778|NCT00808028|1306443|P3|STARTED|Stage 1 (6 Months)||198
535779|NCT00808028|1306444|P2|STARTED|Stage 1 (6 Months)|Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2|22
535780|NCT00808028|1306445|P1|STARTED|Stage 1 (6 Months)||121
535781|NCT00808015|1306481|P1|NOT COMPLETED|Overall Study||344
535782|NCT00808015|1306481|P1|COMPLETED|Overall Study||1033
535783|NCT00808015|1306481|P1|Treated|Overall Study||1373
535784|NCT00808015|1306481|P1|STARTED|Overall Study||1377
535785|NCT00807989|1306495|P2|NOT COMPLETED|Overall Study||2
535786|NCT00807989|1306496|P1|NOT COMPLETED|Overall Study||3
535787|NCT00807989|1306495|P2|COMPLETED|Overall Study||98
535788|NCT00807989|1306496|P1|COMPLETED|Overall Study||104
535789|NCT00807989|1306495|P2|STARTED|Overall Study||100
535790|NCT00807989|1306496|P1|STARTED|Overall Study||107
535791|NCT00807937|1306510|P4|NOT COMPLETED|Overall Study||15
535792|NCT00807937|1306511|P3|NOT COMPLETED|Overall Study||14
535793|NCT00807937|1306512|P2|NOT COMPLETED|Overall Study||25
535794|NCT00807937|1306513|P1|NOT COMPLETED|Overall Study||27
535795|NCT00807937|1306510|P4|COMPLETED|Overall Study||77
535796|NCT00807937|1306511|P3|COMPLETED|Overall Study||78
535797|NCT00807937|1306512|P2|COMPLETED|Overall Study||67
535798|NCT00807937|1306513|P1|COMPLETED|Overall Study||66
535799|NCT00807937|1306510|P4|STARTED|Overall Study||92
535800|NCT00807937|1306511|P3|STARTED|Overall Study||92
535801|NCT00807937|1306512|P2|STARTED|Overall Study||92
535802|NCT00807937|1306513|P1|STARTED|Overall Study||93
535803|NCT00807885|1306548|P9|NOT COMPLETED|Overall Study||0
535804|NCT00807885|1306549|P8|NOT COMPLETED|Overall Study||0
535805|NCT00807885|1306550|P7|NOT COMPLETED|Overall Study||0
535806|NCT00807885|1306551|P6|NOT COMPLETED|Overall Study||1
535807|NCT00807885|1306552|P5|NOT COMPLETED|Overall Study||0
535808|NCT00807885|1306553|P4|NOT COMPLETED|Overall Study||0
535809|NCT00807885|1306554|P3|NOT COMPLETED|Overall Study||0
535810|NCT00807885|1306555|P2|NOT COMPLETED|Overall Study||0
535811|NCT00807885|1306556|P1|NOT COMPLETED|Overall Study||0
535812|NCT00807885|1306548|P9|COMPLETED|Overall Study||11
535813|NCT00807885|1306549|P8|COMPLETED|Overall Study||11
535814|NCT00807885|1306550|P7|COMPLETED|Overall Study||12
535815|NCT00807885|1306551|P6|COMPLETED|Overall Study|Subject completed treatment, but lost to follow-up|11
535816|NCT00807885|1306552|P5|COMPLETED|Overall Study||12
535817|NCT00807885|1306553|P4|COMPLETED|Overall Study||10
535818|NCT00807885|1306554|P3|COMPLETED|Overall Study||11
535819|NCT00807885|1306555|P2|COMPLETED|Overall Study||11
535820|NCT00807885|1306556|P1|COMPLETED|Overall Study||10
535821|NCT00807885|1306548|P9|STARTED|Overall Study||11
535822|NCT00807885|1306549|P8|STARTED|Overall Study||11
535823|NCT00807885|1306550|P7|STARTED|Overall Study||12
535824|NCT00807885|1306551|P6|STARTED|Overall Study||12
535825|NCT00807885|1306552|P5|STARTED|Overall Study||12
535826|NCT00807885|1306553|P4|STARTED|Overall Study||10
535827|NCT00807885|1306554|P3|STARTED|Overall Study||11
535828|NCT00807885|1306555|P2|STARTED|Overall Study||11
535829|NCT00807885|1306556|P1|STARTED|Overall Study||10
535830|NCT00807846|1306605|P2|NOT COMPLETED|Overall Study||4
535831|NCT00807846|1306606|P1|NOT COMPLETED|Overall Study||12
535832|NCT00807846|1306605|P2|COMPLETED|Overall Study||94
535833|NCT00807846|1306606|P1|COMPLETED|Overall Study||88
535834|NCT00807846|1306605|P2|STARTED|Overall Study||98
535835|NCT00807846|1306606|P1|STARTED|Overall Study||100
535836|NCT00807768|1306640|P2|NOT COMPLETED|Overall Study||0
535837|NCT00807768|1306641|P1|NOT COMPLETED|Overall Study||0
535838|NCT00807768|1306640|P2|COMPLETED|Overall Study||300
535839|NCT00807768|1306641|P1|COMPLETED|Overall Study||301
535840|NCT00807768|1306640|P2|STARTED|Overall Study||300
535841|NCT00807768|1306641|P1|STARTED|Overall Study||301
535842|NCT00807664|1306659|P2|NOT COMPLETED|Overall Study||19
535843|NCT00807664|1306660|P1|NOT COMPLETED|Overall Study||11
535844|NCT00807664|1306659|P2|COMPLETED|Overall Study||75
535845|NCT00807664|1306660|P1|COMPLETED|Overall Study||77
535846|NCT00807664|1306659|P2|STARTED|Overall Study||94
535847|NCT00807664|1306660|P1|STARTED|Overall Study||88
535848|NCT00807573|1306670|P1|NOT COMPLETED|Overall Study||2
535849|NCT00807573|1306670|P1|COMPLETED|Overall Study||42
535850|NCT00807573|1306670|P1|STARTED|Overall Study||44
535851|NCT00807560|1306676|P2|NOT COMPLETED|Overall Study||0
535852|NCT00807560|1306677|P1|NOT COMPLETED|Overall Study||0
535853|NCT00807560|1306676|P2|COMPLETED|Overall Study||39
535854|NCT00807560|1306677|P1|COMPLETED|Overall Study||38
535855|NCT00807560|1306676|P2|STARTED|Overall Study||39
535856|NCT00807560|1306677|P1|STARTED|Overall Study||38
535857|NCT00807495|1306716|P5|NOT COMPLETED|Overall Study||5
535858|NCT00807495|1306717|P4|NOT COMPLETED|Overall Study||1
535859|NCT00807495|1306718|P3|NOT COMPLETED|Overall Study||4
535860|NCT00807495|1306719|P2|NOT COMPLETED|Overall Study||6
535861|NCT00807495|1306720|P1|NOT COMPLETED|Overall Study||8
535862|NCT00807495|1306716|P5|COMPLETED|Overall Study||2
535863|NCT00807495|1306717|P4|COMPLETED|Overall Study||0
535864|NCT00807495|1306718|P3|COMPLETED|Overall Study||1
535865|NCT00807495|1306719|P2|COMPLETED|Overall Study||7
535866|NCT00807495|1306720|P1|COMPLETED|Overall Study|Completed = participants who completed the study treatment to PD or symptomatic deterioration.|14
535867|NCT00807495|1306716|P5|STARTED|Overall Study|An ATL participant had late on-study biopsy and was in DLBL, reducing ATL participants from 8 to 7.|7
535868|NCT00807495|1306717|P4|STARTED|Overall Study||1
535869|NCT00807495|1306718|P3|STARTED|Overall Study||5
535870|NCT00807495|1306719|P2|STARTED|Overall Study||13
535871|NCT00807495|1306720|P1|STARTED|Overall Study||22
535872|NCT00807456|1306762|P1|NOT COMPLETED|Overall Study||0
535873|NCT00807456|1306762|P1|COMPLETED|Overall Study||65
535874|NCT00807456|1306762|P1|STARTED|Overall Study||65
535875|NCT00807365|1306766|P1|NOT COMPLETED|Overall Study||5
535876|NCT00807365|1306766|P1|COMPLETED|Overall Study||0
535877|NCT00807365|1306766|P1|STARTED|Overall Study||5
535878|NCT00807248|1306774|P4|NOT COMPLETED|Overall Study||14
535879|NCT00807248|1306775|P3|NOT COMPLETED|Overall Study||18
535880|NCT00807248|1306776|P2|NOT COMPLETED|Overall Study||12
535881|NCT00807248|1306777|P1|NOT COMPLETED|Overall Study||21
535882|NCT00807248|1306774|P4|COMPLETED|Overall Study||126
535883|NCT00807248|1306775|P3|COMPLETED|Overall Study||121
535884|NCT00807248|1306776|P2|COMPLETED|Overall Study||128
535885|NCT00807248|1306777|P1|COMPLETED|Overall Study||50
535886|NCT00807248|1306774|P4|STARTED|Overall Study||140
535887|NCT00807248|1306775|P3|STARTED|Overall Study||139
535888|NCT00807248|1306776|P2|STARTED|Overall Study||140
535889|NCT00807248|1306777|P1|STARTED|Overall Study||71
535890|NCT00807235|1306821|P2|NOT COMPLETED|Overall Study||0
535891|NCT00807235|1306822|P1|NOT COMPLETED|Overall Study||1
535892|NCT00807235|1306821|P2|COMPLETED|Overall Study||6
535893|NCT00807235|1306822|P1|COMPLETED|Overall Study||10
535894|NCT00807235|1306821|P2|STARTED|Overall Study||6
535895|NCT00807235|1306822|P1|STARTED|Overall Study||11
535896|NCT00807209|1306855|P3|NOT COMPLETED|Overall Study||0
535897|NCT00807209|1306856|P2|NOT COMPLETED|Overall Study||0
535898|NCT00807209|1306857|P1|NOT COMPLETED|Overall Study||0
535899|NCT00807209|1306855|P3|COMPLETED|Overall Study||1
535900|NCT00807209|1306856|P2|COMPLETED|Overall Study||1
535901|NCT00807209|1306857|P1|COMPLETED|Overall Study||1
535902|NCT00807209|1306855|P3|STARTED|Overall Study||1
535903|NCT00807209|1306856|P2|STARTED|Overall Study||1
535904|NCT00807209|1306857|P1|STARTED|Overall Study||1
535905|NCT00807092|1306867|P2|NOT COMPLETED|Overall Study||4
535906|NCT00807092|1306868|P1|NOT COMPLETED|Overall Study||1
535907|NCT00807092|1306867|P2|COMPLETED|Overall Study||69
535908|NCT00807092|1306868|P1|COMPLETED|Overall Study||71
535909|NCT00807092|1306867|P2|Exposed to Drug|Overall Study||73
535910|NCT00807092|1306868|P1|Exposed to Drug|Overall Study|Subject was randomised, but not exposed to any trial drug|71
535911|NCT00807092|1306867|P2|STARTED|Overall Study||73
535912|NCT00807092|1306868|P1|STARTED|Overall Study||72
535913|NCT00807040|1306898|P2|NOT COMPLETED|Overall Study||41
535914|NCT00807040|1306899|P1|NOT COMPLETED|Overall Study||36
535915|NCT00807040|1306898|P2|COMPLETED|Overall Study||84
535916|NCT00807040|1306899|P1|COMPLETED|Overall Study||90
535917|NCT00807040|1306898|P2|STARTED|Overall Study||125
535918|NCT00807040|1306899|P1|STARTED|Overall Study||126
535919|NCT00807014|1306909|P2|NOT COMPLETED|Overall Study||27
535920|NCT00807014|1306910|P1|NOT COMPLETED|Overall Study||27
535921|NCT00807014|1306909|P2|COMPLETED|Overall Study||58
535922|NCT00807014|1306910|P1|COMPLETED|Overall Study||56
535923|NCT00807014|1306909|P2|STARTED|Overall Study||85
535924|NCT00807014|1306910|P1|STARTED|Overall Study||83
535925|NCT00807001|1306941|P5|NOT COMPLETED|Overall Study||0
535926|NCT00807001|1306942|P4|NOT COMPLETED|Overall Study||0
535927|NCT00807001|1306943|P3|NOT COMPLETED|Overall Study||0
535928|NCT00807001|1306944|P2|NOT COMPLETED|Overall Study||1
535929|NCT00807001|1306945|P1|NOT COMPLETED|Overall Study||0
535930|NCT00807001|1306941|P5|COMPLETED|Overall Study||9
535931|NCT00807001|1306942|P4|COMPLETED|Overall Study||8
535932|NCT00807001|1306943|P3|COMPLETED|Overall Study||8
535933|NCT00807001|1306944|P2|COMPLETED|Overall Study||7
535934|NCT00807001|1306945|P1|COMPLETED|Overall Study||8
535935|NCT00807001|1306941|P5|STARTED|Overall Study||9
535936|NCT00807001|1306942|P4|STARTED|Overall Study||8
535937|NCT00807001|1306943|P3|STARTED|Overall Study||8
535938|NCT00807001|1306944|P2|STARTED|Overall Study||8
535939|NCT00807001|1306945|P1|STARTED|Overall Study|For all groups, number of subjects who received at least one dose of study drug.|8
535940|NCT00806988|1306964|P2|NOT COMPLETED|Overall Study||43
535941|NCT00806988|1306965|P1|NOT COMPLETED|Overall Study||27
535942|NCT00806988|1306964|P2|COMPLETED|Overall Study||108
535943|NCT00806988|1306965|P1|COMPLETED|Overall Study||123
535944|NCT00806988|1306964|P2|STARTED|Overall Study||151
535945|NCT00806988|1306965|P1|STARTED|Overall Study||150
535946|NCT00806819|1306975|P2|NOT COMPLETED|Overall Study||358
535947|NCT00806819|1306976|P1|NOT COMPLETED|Overall Study||346
535948|NCT00806819|1306975|P2|COMPLETED|Overall Study|On-treatment at analysis DBL date (15 February 2013)|2
535949|NCT00806819|1306976|P1|COMPLETED|Overall Study|On-treatment at analysis DBL date (15 February 2013)|7
535950|NCT00806819|1306975|P2|STARTED|Overall Study|randomised patients|360
535951|NCT00806819|1306976|P1|STARTED|Overall Study|randomised patients|353
535952|NCT00806676|1307011|P3|NOT COMPLETED|Overall Study||6
535953|NCT00806676|1307012|P2|NOT COMPLETED|Overall Study||0
535954|NCT00806676|1307013|P1|NOT COMPLETED|Overall Study||4
535955|NCT00806676|1307011|P3|COMPLETED|Overall Study||23
535956|NCT00806676|1307012|P2|COMPLETED|Overall Study||9
535957|NCT00806676|1307013|P1|COMPLETED|Overall Study||25
535958|NCT00806676|1307011|P3|STARTED|Overall Study||29
535959|NCT00806676|1307012|P2|STARTED|Overall Study||9
535960|NCT00806676|1307013|P1|STARTED|Overall Study||29
535961|NCT00806624|1307045|P3|NOT COMPLETED|Overall Study||6
535962|NCT00806624|1307046|P2|NOT COMPLETED|Overall Study||12
535963|NCT00806624|1307047|P1|NOT COMPLETED|Overall Study||9
535964|NCT00806624|1307045|P3|COMPLETED|Overall Study||69
535965|NCT00806624|1307046|P2|COMPLETED|Overall Study||68
535966|NCT00806624|1307047|P1|COMPLETED|Overall Study||70
535967|NCT00806624|1307045|P3|STARTED|Overall Study||75
535968|NCT00806624|1307046|P2|STARTED|Overall Study||80
535969|NCT00806624|1307047|P1|STARTED|Overall Study||79
535970|NCT00806598|1307055|P1|NOT COMPLETED|Overall Study||0
535971|NCT00806598|1307055|P1|COMPLETED|Overall Study||48
535972|NCT00806598|1307055|P1|STARTED|Overall Study||48
535973|NCT00806585|1307064|P5|NOT COMPLETED|Overall Study||31
535974|NCT00806585|1307065|P4|NOT COMPLETED|Overall Study||15
535975|NCT00806585|1307066|P3|NOT COMPLETED|Overall Study||32
535976|NCT00806585|1307067|P2|NOT COMPLETED|Overall Study||31
535977|NCT00806585|1307068|P1|NOT COMPLETED|Overall Study||32
535978|NCT00806585|1307064|P5|COMPLETED|Overall Study||106
535979|NCT00806585|1307065|P4|COMPLETED|Overall Study||56
535980|NCT00806585|1307066|P3|COMPLETED|Overall Study||109
535981|NCT00806585|1307067|P2|COMPLETED|Overall Study||103
535982|NCT00806585|1307068|P1|COMPLETED|Overall Study||105
535983|NCT00806585|1307064|P5|STARTED|Overall Study||137
535984|NCT00806585|1307065|P4|STARTED|Overall Study||71
535985|NCT00806585|1307066|P3|STARTED|Overall Study||141
535986|NCT00806585|1307067|P2|STARTED|Overall Study||134
535987|NCT00806585|1307068|P1|STARTED|Overall Study||137
535988|NCT00806546|1307100|P1|NOT COMPLETED|Overall Study||307
535989|NCT00806546|1307100|P1|COMPLETED|Overall Study||207
535990|NCT00806546|1307100|P1|STARTED|Overall Study|35 subjects were enrolled but did not treat for a total of 479 subjects in the safety population|514
535991|NCT00806494|1307104|P1|NOT COMPLETED|Overall Study||80
535992|NCT00806494|1307104|P1|COMPLETED|Overall Study||251
535993|NCT00806494|1307104|P1|STARTED|Overall Study||331
535994|NCT00806442|1307128|P2|NOT COMPLETED|Overall Study||7
535995|NCT00806442|1307129|P1|NOT COMPLETED|Overall Study||4
535996|NCT00806442|1307128|P2|COMPLETED|Overall Study||14
535997|NCT00806442|1307129|P1|COMPLETED|Overall Study||14
535998|NCT00806442|1307128|P2|Second Intervention (3 Wks)|Overall Study||14
535999|NCT00806442|1307129|P1|Second Intervention (3 Wks)|Overall Study||15
536000|NCT00806442|1307128|P2|Washout (3 Wks)|Overall Study||14
536001|NCT00806442|1307129|P1|Washout (3 Wks)|Overall Study||15
536002|NCT00806442|1307128|P2|First Intervention (3 Wks)|Overall Study||21
536003|NCT00806442|1307129|P1|First Intervention (3 Wks)|Overall Study||18
536004|NCT00806442|1307128|P2|STARTED|Overall Study||21
536005|NCT00806442|1307129|P1|STARTED|Overall Study||18
536006|NCT00806416|1307151|P4|NOT COMPLETED|Period 2 - Part II||0
536007|NCT00806416|1307152|P3|NOT COMPLETED|Period 2 - Part II||0
536008|NCT00806416|1307153|P2|NOT COMPLETED|Period 2 - Part II||0
536009|NCT00806416|1307154|P1|NOT COMPLETED|Period 2 - Part II||0
536010|NCT00806416|1307151|P4|COMPLETED|Period 2 - Part II||14
536011|NCT00806416|1307152|P3|COMPLETED|Period 2 - Part II||14
536012|NCT00806416|1307153|P2|COMPLETED|Period 2 - Part II||0
536013|NCT00806416|1307154|P1|COMPLETED|Period 2 - Part II||0
536014|NCT00806416|1307151|P4|STARTED|Period 2 - Part II||14
536015|NCT00806416|1307152|P3|STARTED|Period 2 - Part II||14
536016|NCT00806416|1307153|P2|STARTED|Period 2 - Part II||0
536017|NCT00806416|1307154|P1|STARTED|Period 2 - Part II||0
536018|NCT00806416|1307151|P4|NOT COMPLETED|Period 1 - Part II||2
536019|NCT00806416|1307152|P3|NOT COMPLETED|Period 1 - Part II||0
536020|NCT00806416|1307153|P2|NOT COMPLETED|Period 1 - Part II||0
536021|NCT00806416|1307154|P1|NOT COMPLETED|Period 1 - Part II||0
536022|NCT00806416|1307151|P4|COMPLETED|Period 1 - Part II||14
536023|NCT00806416|1307152|P3|COMPLETED|Period 1 - Part II||14
536024|NCT00806416|1307153|P2|COMPLETED|Period 1 - Part II||0
536025|NCT00806416|1307154|P1|COMPLETED|Period 1 - Part II||0
536026|NCT00806416|1307151|P4|STARTED|Period 1 - Part II||16
536027|NCT00806416|1307152|P3|STARTED|Period 1 - Part II||14
536028|NCT00806416|1307153|P2|STARTED|Period 1 - Part II||0
536029|NCT00806416|1307154|P1|STARTED|Period 1 - Part II||0
536030|NCT00806416|1307151|P4|NOT COMPLETED|Period 2 - Part I||0
536031|NCT00806416|1307152|P3|NOT COMPLETED|Period 2 - Part I||0
536032|NCT00806416|1307153|P2|NOT COMPLETED|Period 2 - Part I||0
536033|NCT00806416|1307154|P1|NOT COMPLETED|Period 2 - Part I||0
536034|NCT00806416|1307151|P4|COMPLETED|Period 2 - Part I||0
536035|NCT00806416|1307152|P3|COMPLETED|Period 2 - Part I||0
536036|NCT00806416|1307153|P2|COMPLETED|Period 2 - Part I||103
536037|NCT00806416|1307154|P1|COMPLETED|Period 2 - Part I||104
536038|NCT00806416|1307151|P4|STARTED|Period 2 - Part I||0
536039|NCT00806416|1307152|P3|STARTED|Period 2 - Part I||0
536040|NCT00806416|1307153|P2|STARTED|Period 2 - Part I||103
536041|NCT00806416|1307154|P1|STARTED|Period 2 - Part I||104
536042|NCT00806416|1307151|P4|NOT COMPLETED|Period 1 - Part I||0
536043|NCT00806416|1307152|P3|NOT COMPLETED|Period 1 - Part I||0
536044|NCT00806416|1307153|P2|NOT COMPLETED|Period 1 - Part I||4
536045|NCT00806416|1307154|P1|NOT COMPLETED|Period 1 - Part I||3
536046|NCT00806416|1307151|P4|COMPLETED|Period 1 - Part I||0
536047|NCT00806416|1307152|P3|COMPLETED|Period 1 - Part I||0
536048|NCT00806416|1307153|P2|COMPLETED|Period 1 - Part I||103
536049|NCT00806416|1307154|P1|COMPLETED|Period 1 - Part I||104
536050|NCT00806416|1307151|P4|STARTED|Period 1 - Part I||0
536051|NCT00806416|1307152|P3|STARTED|Period 1 - Part I||0
536052|NCT00806416|1307153|P2|STARTED|Period 1 - Part I||107
536053|NCT00806416|1307154|P1|STARTED|Period 1 - Part I||107
536054|NCT00806403|1307167|P2|NOT COMPLETED|Overall Study||3
536055|NCT00806403|1307168|P1|NOT COMPLETED|Overall Study||4
536056|NCT00806403|1307167|P2|COMPLETED|Overall Study||98
536057|NCT00806403|1307168|P1|COMPLETED|Overall Study||100
536058|NCT00806403|1307167|P2|STARTED|Overall Study||101
536059|NCT00806403|1307168|P1|STARTED|Overall Study||104
536060|NCT00806390|1307182|P2|NOT COMPLETED|Overall Study||0
536061|NCT00806390|1307183|P1|NOT COMPLETED|Overall Study||0
536062|NCT00806390|1307182|P2|COMPLETED|Overall Study||8
536063|NCT00806390|1307183|P1|COMPLETED|Overall Study||7
536064|NCT00806390|1307182|P2|STARTED|Overall Study||8
536065|NCT00806390|1307183|P1|STARTED|Overall Study||7
536066|NCT00806351|1307191|P2|NOT COMPLETED|Overall Study||4
536067|NCT00806351|1307192|P1|NOT COMPLETED|Overall Study||5
536068|NCT00806351|1307191|P2|COMPLETED|Overall Study||2
536069|NCT00806351|1307192|P1|COMPLETED|Overall Study||10
536070|NCT00806351|1307191|P2|STARTED|Overall Study||6
536071|NCT00806351|1307192|P1|STARTED|Overall Study||15
536072|NCT00806260|1307229|P6|NOT COMPLETED|Period 3||0
536073|NCT00806260|1307230|P5|NOT COMPLETED|Period 3||0
536074|NCT00806260|1307231|P4|NOT COMPLETED|Period 3||0
536075|NCT00806260|1307232|P3|NOT COMPLETED|Period 3||1
536076|NCT00806260|1307233|P2|NOT COMPLETED|Period 3||1
536077|NCT00806260|1307234|P1|NOT COMPLETED|Period 3||1
536078|NCT00806260|1307229|P6|COMPLETED|Period 3||0
536079|NCT00806260|1307230|P5|COMPLETED|Period 3||0
536080|NCT00806260|1307231|P4|COMPLETED|Period 3||12
536081|NCT00806260|1307232|P3|COMPLETED|Period 3||5
536082|NCT00806260|1307233|P2|COMPLETED|Period 3||7
536083|NCT00806260|1307234|P1|COMPLETED|Period 3||12
536084|NCT00806260|1307229|P6|STARTED|Period 3||0
536085|NCT00806260|1307230|P5|STARTED|Period 3||0
536086|NCT00806260|1307231|P4|STARTED|Period 3||12
536087|NCT00806260|1307232|P3|STARTED|Period 3||6
536088|NCT00806260|1307233|P2|STARTED|Period 3||8
536089|NCT00806260|1307234|P1|STARTED|Period 3||13
536090|NCT00806260|1307229|P6|NOT COMPLETED|Period 2||0
536091|NCT00806260|1307230|P5|NOT COMPLETED|Period 2||0
536092|NCT00806260|1307231|P4|NOT COMPLETED|Period 2||2
536093|NCT00806260|1307232|P3|NOT COMPLETED|Period 2||2
536094|NCT00806260|1307233|P2|NOT COMPLETED|Period 2||0
536095|NCT00806260|1307234|P1|NOT COMPLETED|Period 2||2
536096|NCT00806260|1307229|P6|COMPLETED|Period 2||0
536097|NCT00806260|1307230|P5|COMPLETED|Period 2||0
536098|NCT00806260|1307231|P4|COMPLETED|Period 2||12
536099|NCT00806260|1307232|P3|COMPLETED|Period 2||6
536100|NCT00806260|1307233|P2|COMPLETED|Period 2||8
536101|NCT00806260|1307234|P1|COMPLETED|Period 2||13
536102|NCT00806260|1307229|P6|STARTED|Period 2||0
536103|NCT00806260|1307230|P5|STARTED|Period 2||0
536104|NCT00806260|1307231|P4|STARTED|Period 2||14
536105|NCT00806260|1307232|P3|STARTED|Period 2||8
536106|NCT00806260|1307233|P2|STARTED|Period 2||8
536107|NCT00806260|1307234|P1|STARTED|Period 2||15
536108|NCT00806260|1307229|P6|NOT COMPLETED|Period 1 (1 Day)||0
536109|NCT00806260|1307230|P5|NOT COMPLETED|Period 1 (1 Day)||3
536110|NCT00806260|1307231|P4|NOT COMPLETED|Period 1 (1 Day)||0
536111|NCT00806260|1307232|P3|NOT COMPLETED|Period 1 (1 Day)||0
536112|NCT00806260|1307233|P2|NOT COMPLETED|Period 1 (1 Day)||0
536113|NCT00806260|1307234|P1|NOT COMPLETED|Period 1 (1 Day)||0
536114|NCT00806260|1307229|P6|COMPLETED|Period 1 (1 Day)|did not move onto Periods 2 and 3 due to adjusted design of study|17
536115|NCT00806260|1307230|P5|COMPLETED|Period 1 (1 Day)|did not move onto Periods 2 and 3 due to adjusted design of study|15
536116|NCT00806260|1307231|P4|COMPLETED|Period 1 (1 Day)||14
536117|NCT00806260|1307232|P3|COMPLETED|Period 1 (1 Day)||8
536118|NCT00806260|1307233|P2|COMPLETED|Period 1 (1 Day)||8
536119|NCT00806260|1307234|P1|COMPLETED|Period 1 (1 Day)||15
536120|NCT00806260|1307229|P6|STARTED|Period 1 (1 Day)||17
536121|NCT00806260|1307230|P5|STARTED|Period 1 (1 Day)||18
536122|NCT00806260|1307231|P4|STARTED|Period 1 (1 Day)||14
536123|NCT00806260|1307232|P3|STARTED|Period 1 (1 Day)||8
536124|NCT00806260|1307233|P2|STARTED|Period 1 (1 Day)||8
536125|NCT00806260|1307234|P1|STARTED|Period 1 (1 Day)||15
536126|NCT00806234|1307249|P3|NOT COMPLETED|Overall Study||12
536127|NCT00806234|1307250|P2|NOT COMPLETED|Overall Study||12
536128|NCT00806234|1307251|P1|NOT COMPLETED|Overall Study||13
536129|NCT00806234|1307249|P3|COMPLETED|Overall Study||37
536130|NCT00806234|1307250|P2|COMPLETED|Overall Study||19
536131|NCT00806234|1307251|P1|COMPLETED|Overall Study||34
536132|NCT00806234|1307249|P3|STARTED|Overall Study||49
536133|NCT00806234|1307250|P2|STARTED|Overall Study||31
536134|NCT00806234|1307251|P1|STARTED|Overall Study||47
536135|NCT00806221|1307268|P1|NOT COMPLETED|Overall Study||2
536136|NCT00806221|1307268|P1|COMPLETED|Overall Study||20
536137|NCT00806221|1307268|P1|STARTED|Overall Study||22
536138|NCT00806195|1307279|P4|NOT COMPLETED|Overall Study||106
536139|NCT00806195|1307280|P3|NOT COMPLETED|Overall Study||270
536140|NCT00806195|1307281|P2|NOT COMPLETED|Overall Study||162
536141|NCT00806195|1307282|P1|NOT COMPLETED|Overall Study||514
536142|NCT00806195|1307279|P4|COMPLETED|Overall Study||383
536143|NCT00806195|1307280|P3|COMPLETED|Overall Study||1139
536144|NCT00806195|1307281|P2|COMPLETED|Overall Study||1321
536145|NCT00806195|1307282|P1|COMPLETED|Overall Study||3849
536146|NCT00806195|1307279|P4|STARTED|Overall Study||489
536147|NCT00806195|1307280|P3|STARTED|Overall Study||1409
536148|NCT00806195|1307281|P2|STARTED|Overall Study||1483
536149|NCT00806195|1307282|P1|STARTED|Overall Study||4363
536150|NCT00806078|1307296|P2|NOT COMPLETED|Second Intervention||0
536151|NCT00806078|1307297|P1|NOT COMPLETED|Second Intervention||0
536152|NCT00806078|1307296|P2|COMPLETED|Second Intervention||9
536153|NCT00806078|1307297|P1|COMPLETED|Second Intervention||9
536154|NCT00806078|1307296|P2|STARTED|Second Intervention||9
536155|NCT00806078|1307297|P1|STARTED|Second Intervention||9
536156|NCT00806078|1307296|P2|NOT COMPLETED|7 Day Washout Period||0
536157|NCT00806078|1307297|P1|NOT COMPLETED|7 Day Washout Period||0
536158|NCT00806078|1307296|P2|COMPLETED|7 Day Washout Period||9
536159|NCT00806078|1307297|P1|COMPLETED|7 Day Washout Period||9
536160|NCT00806078|1307296|P2|STARTED|7 Day Washout Period||9
536161|NCT00806078|1307297|P1|STARTED|7 Day Washout Period||9
536162|NCT00806078|1307296|P2|NOT COMPLETED|First Intervention||0
536163|NCT00806078|1307297|P1|NOT COMPLETED|First Intervention||0
536164|NCT00806078|1307296|P2|COMPLETED|First Intervention||9
536165|NCT00806078|1307297|P1|COMPLETED|First Intervention||9
536166|NCT00806078|1307296|P2|STARTED|First Intervention||9
536167|NCT00806078|1307297|P1|STARTED|First Intervention||9
536168|NCT00806026|1307313|P6|NOT COMPLETED|Overall Study||32
536169|NCT00806026|1307314|P5|NOT COMPLETED|Overall Study||30
536170|NCT00806026|1307315|P4|NOT COMPLETED|Overall Study||29
536171|NCT00806026|1307316|P3|NOT COMPLETED|Overall Study||93
536172|NCT00806026|1307317|P2|NOT COMPLETED|Overall Study||101
536173|NCT00806026|1307318|P1|NOT COMPLETED|Overall Study||92
536174|NCT00806026|1307313|P6|COMPLETED|Overall Study||29
536175|NCT00806026|1307314|P5|COMPLETED|Overall Study||29
536176|NCT00806026|1307315|P4|COMPLETED|Overall Study||32
536177|NCT00806026|1307316|P3|COMPLETED|Overall Study||89
536178|NCT00806026|1307317|P2|COMPLETED|Overall Study||82
536179|NCT00806026|1307318|P1|COMPLETED|Overall Study||93
536180|NCT00806026|1307313|P6|Treated|Overall Study||61
536181|NCT00806026|1307314|P5|Treated|Overall Study||59
536182|NCT00806026|1307315|P4|Treated|Overall Study||59
536183|NCT00806026|1307316|P3|Treated|Overall Study||180
536184|NCT00806026|1307317|P2|Treated|Overall Study||178
536185|NCT00806026|1307318|P1|Treated|Overall Study||182
536186|NCT00806026|1307313|P6|STARTED|Overall Study||61
536187|NCT00806026|1307314|P5|STARTED|Overall Study||59
536188|NCT00806026|1307315|P4|STARTED|Overall Study||61
536189|NCT00806026|1307316|P3|STARTED|Overall Study||182
536190|NCT00806026|1307317|P2|STARTED|Overall Study||183
536191|NCT00806026|1307318|P1|STARTED|Overall Study||185
536192|NCT00805961|1307413|P1|NOT COMPLETED|Maintenance Treatment||34
536193|NCT00805961|1307413|P1|COMPLETED|Maintenance Treatment||23
536194|NCT00805961|1307413|P1|STARTED|Maintenance Treatment||57
536195|NCT00805961|1307413|P1|NOT COMPLETED|Treatment-Free Interval||7
536196|NCT00805961|1307413|P1|COMPLETED|Treatment-Free Interval||57
536197|NCT00805961|1307413|P1|STARTED|Treatment-Free Interval||64
536198|NCT00805961|1307413|P1|NOT COMPLETED|Modality Therapy||4
536199|NCT00805961|1307413|P1|COMPLETED|Modality Therapy||64
536200|NCT00805961|1307413|P1|STARTED|Modality Therapy||68
536201|NCT00805935|1307423|P4|NOT COMPLETED|Overall Study||11
536202|NCT00805935|1307424|P3|NOT COMPLETED|Overall Study||15
536203|NCT00805935|1307425|P2|NOT COMPLETED|Overall Study||19
536204|NCT00805935|1307426|P1|NOT COMPLETED|Overall Study||13
536205|NCT00805935|1307423|P4|COMPLETED|Overall Study||19
536206|NCT00805935|1307424|P3|COMPLETED|Overall Study||13
536207|NCT00805935|1307425|P2|COMPLETED|Overall Study||8
536208|NCT00805935|1307426|P1|COMPLETED|Overall Study||12
536209|NCT00805935|1307423|P4|STARTED|Overall Study||30
536210|NCT00805935|1307424|P3|STARTED|Overall Study||28
536211|NCT00805935|1307425|P2|STARTED|Overall Study||27
536212|NCT00805935|1307426|P1|STARTED|Overall Study||25
536213|NCT00805870|1307480|P2|NOT COMPLETED|Overall Study||0
536214|NCT00805870|1307481|P1|NOT COMPLETED|Overall Study||0
536215|NCT00805870|1307480|P2|COMPLETED|Overall Study||10
536216|NCT00805870|1307481|P1|COMPLETED|Overall Study||10
536217|NCT00805870|1307480|P2|STARTED|Overall Study||10
536218|NCT00805870|1307481|P1|STARTED|Overall Study||10
536219|NCT00805792|1307493|P1|NOT COMPLETED|Overall Study||5
536220|NCT00805792|1307493|P1|COMPLETED|Overall Study||28
536221|NCT00805792|1307493|P1|STARTED|Overall Study||33
536222|NCT00805766|1307501|P1|NOT COMPLETED|Increased Dose Period||13
536223|NCT00805766|1307501|P1|COMPLETED|Increased Dose Period||26
536224|NCT00805766|1307501|P1|STARTED|Increased Dose Period||39
536225|NCT00805766|1307501|P1|NOT COMPLETED|Screening Period||6
536226|NCT00805766|1307501|P1|COMPLETED|Screening Period||39
536227|NCT00805766|1307501|P1|STARTED|Screening Period||45
536228|NCT00805740|1307515|P2|NOT COMPLETED|Overall Study||4
536229|NCT00805740|1307516|P1|NOT COMPLETED|Overall Study||11
536230|NCT00805740|1307515|P2|COMPLETED|Overall Study||9
536231|NCT00805740|1307516|P1|COMPLETED|Overall Study||17
536232|NCT00805740|1307515|P2|Treated|Overall Study||13
536233|NCT00805740|1307516|P1|Treated|Overall Study||26
536234|NCT00805740|1307515|P2|STARTED|Overall Study||13
536235|NCT00805740|1307516|P1|STARTED|Overall Study||28
536236|NCT00805675|1307541|P3|NOT COMPLETED|Overall Study||1
536237|NCT00805675|1307542|P2|NOT COMPLETED|Overall Study||0
536238|NCT00805675|1307543|P1|NOT COMPLETED|Overall Study||0
536239|NCT00805675|1307541|P3|COMPLETED|Overall Study||15
536240|NCT00805675|1307542|P2|COMPLETED|Overall Study||14
536241|NCT00805675|1307543|P1|COMPLETED|Overall Study||16
536242|NCT00805675|1307541|P3|STARTED|Overall Study||16
536243|NCT00805675|1307542|P2|STARTED|Overall Study||14
536244|NCT00805675|1307543|P1|STARTED|Overall Study||16
536245|NCT00805545|1307577|P2|NOT COMPLETED|Overall Study||3
536246|NCT00805545|1307578|P1|NOT COMPLETED|Overall Study||6
536247|NCT00805545|1307577|P2|COMPLETED|Overall Study||197
536248|NCT00805545|1307578|P1|COMPLETED|Overall Study||194
536249|NCT00805545|1307577|P2|STARTED|Overall Study||200
536250|NCT00805545|1307578|P1|STARTED|Overall Study||200
536251|NCT00805493|1307587|P3|NOT COMPLETED|Overall Study||1
536252|NCT00805493|1307588|P2|NOT COMPLETED|Overall Study||0
536253|NCT00805493|1307589|P1|NOT COMPLETED|Overall Study||2
536254|NCT00805493|1307587|P3|COMPLETED|Overall Study||0
536255|NCT00805493|1307588|P2|COMPLETED|Overall Study||2
536256|NCT00805493|1307589|P1|COMPLETED|Overall Study||1
536257|NCT00805493|1307587|P3|STARTED|Overall Study||1
536258|NCT00805493|1307588|P2|STARTED|Overall Study||2
536259|NCT00805493|1307589|P1|STARTED|Overall Study||3
536260|NCT00805480|1307604|P4|NOT COMPLETED|Overall Study||5
536261|NCT00805480|1307605|P3|NOT COMPLETED|Overall Study||12
536262|NCT00805480|1307606|P2|NOT COMPLETED|Overall Study||7
536263|NCT00805480|1307607|P1|NOT COMPLETED|Overall Study||14
536264|NCT00805480|1307604|P4|COMPLETED|Overall Study||5
536265|NCT00805480|1307605|P3|COMPLETED|Overall Study||19
536266|NCT00805480|1307606|P2|COMPLETED|Overall Study||22
536267|NCT00805480|1307607|P1|COMPLETED|Overall Study||16
536268|NCT00805480|1307604|P4|Pharmacodynamic Analysis Set|Overall Study||10
536269|NCT00805480|1307605|P3|Pharmacodynamic Analysis Set|Overall Study||29
536270|NCT00805480|1307606|P2|Pharmacodynamic Analysis Set|Overall Study||25
536271|NCT00805480|1307607|P1|Pharmacodynamic Analysis Set|Overall Study||30
536272|NCT00805480|1307604|P4|STARTED|Overall Study||10
536273|NCT00805480|1307605|P3|STARTED|Overall Study||31
536274|NCT00805480|1307606|P2|STARTED|Overall Study||29
536275|NCT00805480|1307607|P1|STARTED|Overall Study||30
536276|NCT00805467|1307636|P4|NOT COMPLETED|Overall Study||237
536277|NCT00805467|1307637|P3|NOT COMPLETED|Overall Study||103
536278|NCT00805467|1307638|P2|NOT COMPLETED|Overall Study||34
536279|NCT00805467|1307639|P1|NOT COMPLETED|Overall Study||0
536280|NCT00805467|1307636|P4|COMPLETED|Overall Study|Ongoing when study terminated|144
536281|NCT00805467|1307637|P3|COMPLETED|Overall Study|Ongoing when study terminated|80
536282|NCT00805467|1307638|P2|COMPLETED|Overall Study|Ongoing when study terminated|25
536283|NCT00805467|1307639|P1|COMPLETED|Overall Study|Ongoing when study terminated|1
536284|NCT00805467|1307636|P4|Enrolled But Did Not Receive Treatment|Overall Study||0
536285|NCT00805467|1307637|P3|Enrolled But Did Not Receive Treatment|Overall Study||0
536286|NCT00805467|1307638|P2|Enrolled But Did Not Receive Treatment|Overall Study||0
536287|NCT00805467|1307639|P1|Enrolled But Did Not Receive Treatment|Overall Study||0
536288|NCT00805467|1307636|P4|STARTED|Overall Study|Patients who received treatment|381
536289|NCT00805467|1307637|P3|STARTED|Overall Study|Patients who received treatment|183
536290|NCT00805467|1307638|P2|STARTED|Overall Study|Patients who received treatment|59
536291|NCT00805467|1307639|P1|STARTED|Overall Study|Patients who received treatment|1
536292|NCT00805441|1307659|P2|NOT COMPLETED|Overall Study||36
536293|NCT00805441|1307660|P1|NOT COMPLETED|Overall Study||34
536294|NCT00805441|1307659|P2|COMPLETED|Overall Study||60
536295|NCT00805441|1307660|P1|COMPLETED|Overall Study||60
536296|NCT00805441|1307659|P2|Full Analysis Set (FAS)|Overall Study|All randomized participants who received ≥1 dose study drug and contributed to post-baseline data.|91
536297|NCT00805441|1307660|P1|Full Analysis Set (FAS)|Overall Study|All randomized participants who received ≥1 dose study drug and contributed to post-baseline data.|92
536298|NCT00805441|1307659|P2|STARTED|Overall Study||96
536299|NCT00805441|1307660|P1|STARTED|Overall Study||94
536300|NCT00805389|1307695|P5|NOT COMPLETED|Overall Study||13
536301|NCT00805389|1307696|P4|NOT COMPLETED|Overall Study||17
536302|NCT00805389|1307697|P3|NOT COMPLETED|Overall Study||12
536303|NCT00805389|1307698|P2|NOT COMPLETED|Overall Study||5
536304|NCT00805389|1307699|P1|NOT COMPLETED|Overall Study||7
536305|NCT00805389|1307695|P5|COMPLETED|Overall Study||129
536306|NCT00805389|1307696|P4|COMPLETED|Overall Study||128
536307|NCT00805389|1307697|P3|COMPLETED|Overall Study||129
536308|NCT00805389|1307698|P2|COMPLETED|Overall Study||137
536309|NCT00805389|1307699|P1|COMPLETED|Overall Study||136
536310|NCT00805389|1307695|P5|STARTED|Overall Study||142
536311|NCT00805389|1307696|P4|STARTED|Overall Study||145
536312|NCT00805389|1307697|P3|STARTED|Overall Study||141
536313|NCT00805389|1307698|P2|STARTED|Overall Study||142
536314|NCT00805389|1307699|P1|STARTED|Overall Study||143
536315|NCT00805285|1307941|P1|NOT COMPLETED|Overall Study||1
536316|NCT00805285|1307941|P1|COMPLETED|Overall Study||0
536317|NCT00805285|1307941|P1|STARTED|Overall Study||1
536318|NCT00805194|1307951|P2|NOT COMPLETED|Overall Study||654
536319|NCT00805194|1307952|P1|NOT COMPLETED|Overall Study||649
536320|NCT00805194|1307951|P2|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 February 2013).|5
536321|NCT00805194|1307952|P1|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 February 2013)|6
536322|NCT00805194|1307951|P2|STARTED|Overall Study|randomised patients|659
536323|NCT00805194|1307952|P1|STARTED|Overall Study|randomised patients|655
536324|NCT00805142|1307986|P2|NOT COMPLETED|Maintenance Period||2
536325|NCT00805142|1307987|P1|NOT COMPLETED|Maintenance Period||0
536326|NCT00805142|1307986|P2|COMPLETED|Maintenance Period||30
536327|NCT00805142|1307987|P1|COMPLETED|Maintenance Period||30
536328|NCT00805142|1307986|P2|STARTED|Maintenance Period||32
536329|NCT00805142|1307987|P1|STARTED|Maintenance Period||30
536330|NCT00805142|1307986|P2|NOT COMPLETED|Titration Period||10
536331|NCT00805142|1307987|P1|NOT COMPLETED|Titration Period||6
536332|NCT00805142|1307986|P2|COMPLETED|Titration Period||32
536333|NCT00805142|1307987|P1|COMPLETED|Titration Period||30
536334|NCT00805142|1307986|P2|STARTED|Titration Period||42
536335|NCT00805142|1307987|P1|STARTED|Titration Period||36
536336|NCT00805038|1308013|P2|NOT COMPLETED|Overall Study||0
536337|NCT00805038|1308014|P1|NOT COMPLETED|Overall Study||0
536338|NCT00805038|1308013|P2|COMPLETED|Overall Study||92
536339|NCT00805038|1308014|P1|COMPLETED|Overall Study||75
536340|NCT00805038|1308013|P2|STARTED|Overall Study||92
536341|NCT00805038|1308014|P1|STARTED|Overall Study||75
536342|NCT00805025|1308020|P1|NOT COMPLETED|Overall Study||49
536343|NCT00805025|1308020|P1|COMPLETED|Overall Study||82
536344|NCT00805025|1308020|P1|Enrolled and Treated|Overall Study||89
536345|NCT00805025|1308020|P1|STARTED|Overall Study||131
536346|NCT00804999|1308030|P4|NOT COMPLETED|Overall Study||0
536347|NCT00804999|1308031|P3|NOT COMPLETED|Overall Study||0
536348|NCT00804999|1308032|P2|NOT COMPLETED|Overall Study||0
536349|NCT00804999|1308033|P1|NOT COMPLETED|Overall Study||0
536350|NCT00804999|1308030|P4|COMPLETED|Overall Study||10
536351|NCT00804999|1308031|P3|COMPLETED|Overall Study||14
536352|NCT00804999|1308032|P2|COMPLETED|Overall Study||12
536353|NCT00804999|1308033|P1|COMPLETED|Overall Study||15
536354|NCT00804999|1308030|P4|STARTED|Overall Study||10
536355|NCT00804999|1308031|P3|STARTED|Overall Study||14
536356|NCT00804999|1308032|P2|STARTED|Overall Study||12
536357|NCT00804999|1308033|P1|STARTED|Overall Study||15
536358|NCT00804986|1308049|P6|NOT COMPLETED|Overall Study||10
536359|NCT00804986|1308050|P5|NOT COMPLETED|Overall Study||9
536360|NCT00804986|1308051|P4|NOT COMPLETED|Overall Study||8
536361|NCT00804986|1308052|P3|NOT COMPLETED|Overall Study||2
536362|NCT00804986|1308053|P2|NOT COMPLETED|Overall Study||8
536363|NCT00804986|1308054|P1|NOT COMPLETED|Overall Study||1
536364|NCT00804986|1308049|P6|COMPLETED|Overall Study||31
536365|NCT00804986|1308050|P5|COMPLETED|Overall Study||34
536366|NCT00804986|1308051|P4|COMPLETED|Overall Study||34
536367|NCT00804986|1308052|P3|COMPLETED|Overall Study||40
536368|NCT00804986|1308053|P2|COMPLETED|Overall Study||35
536369|NCT00804986|1308054|P1|COMPLETED|Overall Study||35
536370|NCT00804986|1308049|P6|STARTED|Overall Study||41
536371|NCT00804986|1308050|P5|STARTED|Overall Study||43
536372|NCT00804986|1308051|P4|STARTED|Overall Study||42
536373|NCT00804986|1308052|P3|STARTED|Overall Study||42
536374|NCT00804986|1308053|P2|STARTED|Overall Study||43
536375|NCT00804986|1308054|P1|STARTED|Overall Study||36
536376|NCT00804908|1308149|P3|NOT COMPLETED|Overall Study||114
536377|NCT00804908|1308150|P2|NOT COMPLETED|Overall Study||116
536378|NCT00804908|1308151|P1|NOT COMPLETED|Overall Study||115
536379|NCT00804908|1308149|P3|COMPLETED|Overall Study||1
536380|NCT00804908|1308150|P2|COMPLETED|Overall Study||0
536381|NCT00804908|1308151|P1|COMPLETED|Overall Study||0
536382|NCT00804908|1308149|P3|STARTED|Overall Study||115
536383|NCT00804908|1308150|P2|STARTED|Overall Study||116
536384|NCT00804908|1308151|P1|STARTED|Overall Study||115
536385|NCT00804843|1308182|P2|NOT COMPLETED|Overall Study||7
536386|NCT00804843|1308183|P1|NOT COMPLETED|Overall Study||10
536387|NCT00804843|1308182|P2|COMPLETED|Overall Study||43
536388|NCT00804843|1308183|P1|COMPLETED|Overall Study||40
536389|NCT00804843|1308182|P2|STARTED|Overall Study||50
536390|NCT00804843|1308183|P1|STARTED|Overall Study||50
536391|NCT00804713|1308193|P1|NOT COMPLETED|Overall Study||0
536392|NCT00804713|1308193|P1|COMPLETED|Overall Study||1978
536393|NCT00804713|1308193|P1|STARTED|Overall Study||1978
536394|NCT00804687|1308201|P6|NOT COMPLETED|Period 5: Treatment Period||0
536395|NCT00804687|1308202|P5|NOT COMPLETED|Period 5: Treatment Period||1
536396|NCT00804687|1308203|P4|NOT COMPLETED|Period 5: Treatment Period||0
536397|NCT00804687|1308204|P3|NOT COMPLETED|Period 5: Treatment Period||1
536398|NCT00804687|1308205|P2|NOT COMPLETED|Period 5: Treatment Period||0
536399|NCT00804687|1308206|P1|NOT COMPLETED|Period 5: Treatment Period||1
536400|NCT00804687|1308201|P6|COMPLETED|Period 5: Treatment Period||8
536401|NCT00804687|1308202|P5|COMPLETED|Period 5: Treatment Period||8
536402|NCT00804687|1308203|P4|COMPLETED|Period 5: Treatment Period||8
536403|NCT00804687|1308204|P3|COMPLETED|Period 5: Treatment Period||8
536404|NCT00804687|1308205|P2|COMPLETED|Period 5: Treatment Period||9
536405|NCT00804687|1308206|P1|COMPLETED|Period 5: Treatment Period||8
536406|NCT00804687|1308201|P6|STARTED|Period 5: Treatment Period||8
536407|NCT00804687|1308202|P5|STARTED|Period 5: Treatment Period||9
536408|NCT00804687|1308203|P4|STARTED|Period 5: Treatment Period||8
536409|NCT00804687|1308204|P3|STARTED|Period 5: Treatment Period||9
536410|NCT00804687|1308205|P2|STARTED|Period 5: Treatment Period||9
536411|NCT00804687|1308206|P1|STARTED|Period 5: Treatment Period||9
536412|NCT00804687|1308201|P6|NOT COMPLETED|Period 4: Washout Period||0
536413|NCT00804687|1308202|P5|NOT COMPLETED|Period 4: Washout Period||0
536414|NCT00804687|1308203|P4|NOT COMPLETED|Period 4: Washout Period||0
536415|NCT00804687|1308204|P3|NOT COMPLETED|Period 4: Washout Period||0
536416|NCT00804687|1308205|P2|NOT COMPLETED|Period 4: Washout Period||0
536417|NCT00804687|1308206|P1|NOT COMPLETED|Period 4: Washout Period||0
536418|NCT00804687|1308201|P6|COMPLETED|Period 4: Washout Period||8
536419|NCT00804687|1308202|P5|COMPLETED|Period 4: Washout Period||9
536420|NCT00804687|1308203|P4|COMPLETED|Period 4: Washout Period||8
536421|NCT00804687|1308204|P3|COMPLETED|Period 4: Washout Period||9
536422|NCT00804687|1308205|P2|COMPLETED|Period 4: Washout Period||9
536423|NCT00804687|1308206|P1|COMPLETED|Period 4: Washout Period||9
536424|NCT00804687|1308201|P6|STARTED|Period 4: Washout Period||8
536425|NCT00804687|1308202|P5|STARTED|Period 4: Washout Period||9
536426|NCT00804687|1308203|P4|STARTED|Period 4: Washout Period||8
536427|NCT00804687|1308204|P3|STARTED|Period 4: Washout Period||9
536428|NCT00804687|1308205|P2|STARTED|Period 4: Washout Period||9
536429|NCT00804687|1308206|P1|STARTED|Period 4: Washout Period||9
536430|NCT00804687|1308201|P6|NOT COMPLETED|Period 3: Treatment Period||0
536431|NCT00804687|1308202|P5|NOT COMPLETED|Period 3: Treatment Period||0
536432|NCT00804687|1308203|P4|NOT COMPLETED|Period 3: Treatment Period||1
536433|NCT00804687|1308204|P3|NOT COMPLETED|Period 3: Treatment Period||0
536434|NCT00804687|1308205|P2|NOT COMPLETED|Period 3: Treatment Period||0
536435|NCT00804687|1308206|P1|NOT COMPLETED|Period 3: Treatment Period||0
536436|NCT00804687|1308201|P6|COMPLETED|Period 3: Treatment Period||8
536437|NCT00804687|1308202|P5|COMPLETED|Period 3: Treatment Period||9
536438|NCT00804687|1308203|P4|COMPLETED|Period 3: Treatment Period||8
536439|NCT00804687|1308204|P3|COMPLETED|Period 3: Treatment Period||9
536440|NCT00804687|1308205|P2|COMPLETED|Period 3: Treatment Period||9
536441|NCT00804687|1308206|P1|COMPLETED|Period 3: Treatment Period||9
536442|NCT00804687|1308201|P6|STARTED|Period 3: Treatment Period||8
536443|NCT00804687|1308202|P5|STARTED|Period 3: Treatment Period||9
536444|NCT00804687|1308203|P4|STARTED|Period 3: Treatment Period||9
536445|NCT00804687|1308204|P3|STARTED|Period 3: Treatment Period||9
536446|NCT00804687|1308205|P2|STARTED|Period 3: Treatment Period||9
536447|NCT00804687|1308206|P1|STARTED|Period 3: Treatment Period||9
536448|NCT00804687|1308201|P6|NOT COMPLETED|Period 2: Washout Period||0
536449|NCT00804687|1308202|P5|NOT COMPLETED|Period 2: Washout Period||0
536450|NCT00804687|1308203|P4|NOT COMPLETED|Period 2: Washout Period||0
536451|NCT00804687|1308204|P3|NOT COMPLETED|Period 2: Washout Period||0
536452|NCT00804687|1308205|P2|NOT COMPLETED|Period 2: Washout Period||0
536453|NCT00804687|1308206|P1|NOT COMPLETED|Period 2: Washout Period||0
536454|NCT00804687|1308201|P6|COMPLETED|Period 2: Washout Period||8
536455|NCT00804687|1308202|P5|COMPLETED|Period 2: Washout Period||9
536456|NCT00804687|1308203|P4|COMPLETED|Period 2: Washout Period||9
536457|NCT00804687|1308204|P3|COMPLETED|Period 2: Washout Period||9
536458|NCT00804687|1308205|P2|COMPLETED|Period 2: Washout Period||9
536459|NCT00804687|1308206|P1|COMPLETED|Period 2: Washout Period||9
536460|NCT00804687|1308201|P6|STARTED|Period 2: Washout Period||8
536461|NCT00804687|1308202|P5|STARTED|Period 2: Washout Period||9
536462|NCT00804687|1308203|P4|STARTED|Period 2: Washout Period||9
536463|NCT00804687|1308204|P3|STARTED|Period 2: Washout Period||9
536464|NCT00804687|1308205|P2|STARTED|Period 2: Washout Period||9
536465|NCT00804687|1308206|P1|STARTED|Period 2: Washout Period||9
536466|NCT00804687|1308201|P6|NOT COMPLETED|Period 1: Treatment Period||0
536467|NCT00804687|1308202|P5|NOT COMPLETED|Period 1: Treatment Period||0
536468|NCT00804687|1308203|P4|NOT COMPLETED|Period 1: Treatment Period||0
536469|NCT00804687|1308204|P3|NOT COMPLETED|Period 1: Treatment Period||0
536470|NCT00804687|1308205|P2|NOT COMPLETED|Period 1: Treatment Period||0
536471|NCT00804687|1308206|P1|NOT COMPLETED|Period 1: Treatment Period||0
536472|NCT00804687|1308201|P6|COMPLETED|Period 1: Treatment Period||8
536473|NCT00804687|1308202|P5|COMPLETED|Period 1: Treatment Period||9
536474|NCT00804687|1308203|P4|COMPLETED|Period 1: Treatment Period||9
536475|NCT00804687|1308204|P3|COMPLETED|Period 1: Treatment Period||9
536476|NCT00804687|1308205|P2|COMPLETED|Period 1: Treatment Period||9
536477|NCT00804687|1308206|P1|COMPLETED|Period 1: Treatment Period||9
536478|NCT00804687|1308201|P6|STARTED|Period 1: Treatment Period||8
536479|NCT00804687|1308202|P5|STARTED|Period 1: Treatment Period||9
536480|NCT00804687|1308203|P4|STARTED|Period 1: Treatment Period||9
536481|NCT00804687|1308204|P3|STARTED|Period 1: Treatment Period||9
536482|NCT00804687|1308205|P2|STARTED|Period 1: Treatment Period||9
536483|NCT00804687|1308206|P1|STARTED|Period 1: Treatment Period||9
536484|NCT00804648|1308223|P6|NOT COMPLETED|Third Invervention||0
536485|NCT00804648|1308224|P5|NOT COMPLETED|Third Invervention||0
536486|NCT00804648|1308225|P4|NOT COMPLETED|Third Invervention||0
536487|NCT00804648|1308226|P3|NOT COMPLETED|Third Invervention||0
536488|NCT00804648|1308227|P2|NOT COMPLETED|Third Invervention||0
536489|NCT00804648|1308228|P1|NOT COMPLETED|Third Invervention||0
536490|NCT00804648|1308223|P6|COMPLETED|Third Invervention||8
536491|NCT00804648|1308224|P5|COMPLETED|Third Invervention||4
536492|NCT00804648|1308225|P4|COMPLETED|Third Invervention||4
536493|NCT00804648|1308226|P3|COMPLETED|Third Invervention||6
536494|NCT00804648|1308227|P2|COMPLETED|Third Invervention||5
536495|NCT00804648|1308228|P1|COMPLETED|Third Invervention||3
536496|NCT00804648|1308223|P6|STARTED|Third Invervention||8
536497|NCT00804648|1308224|P5|STARTED|Third Invervention||4
536498|NCT00804648|1308225|P4|STARTED|Third Invervention||4
536499|NCT00804648|1308226|P3|STARTED|Third Invervention||6
536500|NCT00804648|1308227|P2|STARTED|Third Invervention||5
536501|NCT00804648|1308228|P1|STARTED|Third Invervention||3
536502|NCT00804648|1308223|P6|NOT COMPLETED|Second Intervention||0
536503|NCT00804648|1308224|P5|NOT COMPLETED|Second Intervention||0
536504|NCT00804648|1308225|P4|NOT COMPLETED|Second Intervention||0
536505|NCT00804648|1308226|P3|NOT COMPLETED|Second Intervention||0
536506|NCT00804648|1308227|P2|NOT COMPLETED|Second Intervention||0
536507|NCT00804648|1308228|P1|NOT COMPLETED|Second Intervention||0
536508|NCT00804648|1308223|P6|COMPLETED|Second Intervention||8
536509|NCT00804648|1308224|P5|COMPLETED|Second Intervention||4
536510|NCT00804648|1308225|P4|COMPLETED|Second Intervention||4
536511|NCT00804648|1308226|P3|COMPLETED|Second Intervention||6
536512|NCT00804648|1308227|P2|COMPLETED|Second Intervention||5
536513|NCT00804648|1308228|P1|COMPLETED|Second Intervention||3
536514|NCT00804648|1308223|P6|STARTED|Second Intervention||8
536515|NCT00804648|1308224|P5|STARTED|Second Intervention||4
536516|NCT00804648|1308225|P4|STARTED|Second Intervention||4
536517|NCT00804648|1308226|P3|STARTED|Second Intervention||6
536518|NCT00804648|1308227|P2|STARTED|Second Intervention||5
536519|NCT00804648|1308228|P1|STARTED|Second Intervention||3
536520|NCT00804648|1308223|P6|NOT COMPLETED|First Intervention||0
536521|NCT00804648|1308224|P5|NOT COMPLETED|First Intervention||0
536522|NCT00804648|1308225|P4|NOT COMPLETED|First Intervention||0
536523|NCT00804648|1308226|P3|NOT COMPLETED|First Intervention||0
536524|NCT00804648|1308227|P2|NOT COMPLETED|First Intervention||0
536525|NCT00804648|1308228|P1|NOT COMPLETED|First Intervention||0
536526|NCT00804648|1308223|P6|COMPLETED|First Intervention||8
536527|NCT00804648|1308224|P5|COMPLETED|First Intervention||4
536528|NCT00804648|1308225|P4|COMPLETED|First Intervention||4
536529|NCT00804648|1308226|P3|COMPLETED|First Intervention||6
536530|NCT00804648|1308227|P2|COMPLETED|First Intervention||5
536531|NCT00804648|1308228|P1|COMPLETED|First Intervention||3
536532|NCT00804648|1308223|P6|STARTED|First Intervention||8
536533|NCT00804648|1308224|P5|STARTED|First Intervention||4
536534|NCT00804648|1308225|P4|STARTED|First Intervention||4
536535|NCT00804648|1308226|P3|STARTED|First Intervention||6
536536|NCT00804648|1308227|P2|STARTED|First Intervention||5
536537|NCT00804648|1308228|P1|STARTED|First Intervention||3
536538|NCT00804609|1308271|P2|NOT COMPLETED|Overall Study||1
536539|NCT00804609|1308272|P1|NOT COMPLETED|Overall Study||0
536540|NCT00804609|1308271|P2|COMPLETED|Overall Study||14
536541|NCT00804609|1308272|P1|COMPLETED|Overall Study||15
536542|NCT00804609|1308271|P2|STARTED|Overall Study||15
536543|NCT00804609|1308272|P1|STARTED|Overall Study||15
536544|NCT00804596|1308278|P1|NOT COMPLETED|Overall Study||0
536545|NCT00804596|1308278|P1|COMPLETED|Overall Study||74
536546|NCT00804596|1308278|P1|STARTED|Overall Study||74
536547|NCT00804570|1308285|P2|NOT COMPLETED|Overall Study||94
536548|NCT00804570|1308286|P1|NOT COMPLETED|Overall Study||72
536549|NCT00804570|1308285|P2|COMPLETED|Overall Study||94
536550|NCT00804570|1308286|P1|COMPLETED|Overall Study||115
536551|NCT00804570|1308285|P2|STARTED|Overall Study||188
536552|NCT00804570|1308286|P1|STARTED|Overall Study||187
536553|NCT00804193|1308345|P3|NOT COMPLETED|Overall Study||32
536554|NCT00804193|1308346|P2|NOT COMPLETED|Overall Study||44
536555|NCT00804193|1308347|P1|NOT COMPLETED|Overall Study||39
536556|NCT00804193|1308345|P3|COMPLETED|Overall Study||77
536557|NCT00804193|1308346|P2|COMPLETED|Overall Study||180
536558|NCT00804193|1308347|P1|COMPLETED|Overall Study||181
536559|NCT00804193|1308345|P3|STARTED|Overall Study||109
536560|NCT00804193|1308346|P2|STARTED|Overall Study||224
536561|NCT00804193|1308347|P1|STARTED|Overall Study||220
536562|NCT00803959|1308363|P2|NOT COMPLETED|Overall Study||51
536563|NCT00803959|1308364|P1|NOT COMPLETED|Overall Study||56
536564|NCT00803959|1308363|P2|COMPLETED|Overall Study|Because it is a non-inferiority trial, the PP analysis was the main analysis (n=264).|264
536565|NCT00803959|1308364|P1|COMPLETED|Overall Study|Because it is a non-inferiority trial, the PP analysis was the main analysis (n=259).|259
536566|NCT00803959|1308363|P2|ITT Analysis With Primary Outcome Data|Overall Study||272
536567|NCT00803959|1308364|P1|ITT Analysis With Primary Outcome Data|Overall Study||266
536568|NCT00803959|1308363|P2|STARTED|Overall Study||315
536569|NCT00803959|1308364|P1|STARTED|Overall Study||315
536570|NCT00803790|1308396|P4|NOT COMPLETED|Period 2||1
536571|NCT00803790|1308397|P3|NOT COMPLETED|Period 2||1
536572|NCT00803790|1308398|P2|NOT COMPLETED|Period 2||0
536573|NCT00803790|1308399|P1|NOT COMPLETED|Period 2||2
536574|NCT00803790|1308396|P4|COMPLETED|Period 2||30
536575|NCT00803790|1308397|P3|COMPLETED|Period 2||30
536576|NCT00803790|1308398|P2|COMPLETED|Period 2||114
536577|NCT00803790|1308399|P1|COMPLETED|Period 2||114
536578|NCT00803790|1308396|P4|STARTED|Period 2||31
536579|NCT00803790|1308397|P3|STARTED|Period 2||31
536580|NCT00803790|1308398|P2|STARTED|Period 2||114
536581|NCT00803790|1308399|P1|STARTED|Period 2||116
536582|NCT00803790|1308396|P4|NOT COMPLETED|Period 1||4
536583|NCT00803790|1308397|P3|NOT COMPLETED|Period 1||1
536584|NCT00803790|1308398|P2|NOT COMPLETED|Period 1||12
536585|NCT00803790|1308399|P1|NOT COMPLETED|Period 1||9
536586|NCT00803790|1308396|P4|COMPLETED|Period 1||31
536587|NCT00803790|1308397|P3|COMPLETED|Period 1||31
536588|NCT00803790|1308398|P2|COMPLETED|Period 1||114
536589|NCT00803790|1308399|P1|COMPLETED|Period 1||116
536590|NCT00803790|1308396|P4|STARTED|Period 1||35
536591|NCT00803790|1308397|P3|STARTED|Period 1||32
536592|NCT00803790|1308398|P2|STARTED|Period 1||126
536593|NCT00803790|1308399|P1|STARTED|Period 1||125
536594|NCT00803777|1308410|P1|NOT COMPLETED|Overall Study||0
536595|NCT00803777|1308410|P1|COMPLETED|Overall Study||147
536596|NCT00803777|1308410|P1|STARTED|Overall Study||147
536597|NCT00803751|1308420|P2|NOT COMPLETED|Overall Study||0
536598|NCT00803751|1308421|P1|NOT COMPLETED|Overall Study||0
536599|NCT00803751|1308420|P2|COMPLETED|Overall Study||23
536600|NCT00803751|1308421|P1|COMPLETED|Overall Study||26
536601|NCT00803751|1308420|P2|STARTED|Overall Study||23
536602|NCT00803751|1308421|P1|STARTED|Overall Study||26
536603|NCT00803738|1308439|P2|NOT COMPLETED|Overall Study||110
536604|NCT00803738|1308440|P1|NOT COMPLETED|Overall Study||94
536605|NCT00803738|1308439|P2|COMPLETED|Overall Study||176
536606|NCT00803738|1308440|P1|COMPLETED|Overall Study||192
536607|NCT00803738|1308439|P2|STARTED|Overall Study||286
536608|NCT00803738|1308440|P1|STARTED|Overall Study||286
536609|NCT00803712|1308452|P2|NOT COMPLETED|Overall Study||27
536610|NCT00803712|1308453|P1|NOT COMPLETED|Overall Study||36
536611|NCT00803712|1308452|P2|COMPLETED|Overall Study|128 participants randomized to the control group completed the study|128
536612|NCT00803712|1308453|P1|COMPLETED|Overall Study|118 participants randomized to the cinacalcet group completed the study|118
536613|NCT00803712|1308452|P2|Safety Analysis Set|Overall Study|Randomized to the control group|154
536614|NCT00803712|1308453|P1|Safety Analysis Set|Overall Study|Rz'ed to cinacalcet and received at least 1 dose, or to control but received cinacalcet throughout|155
536615|NCT00803712|1308452|P2|Full Analysis Set|Overall Study|151 participants randomized and had at least one PTH concentration available after study day 1.|151
536616|NCT00803712|1308453|P1|Full Analysis Set|Overall Study|153 participants randomized and had at least one PTH concentration available after study day 1.|153
536617|NCT00803712|1308452|P2|STARTED|Overall Study|155 participants were randomized to the control group|155
536618|NCT00803712|1308453|P1|STARTED|Overall Study|154 participants were randomized to the cinacalcet group|154
536619|NCT00803686|1308521|P4|NOT COMPLETED|Part 2, Period 3||0
536620|NCT00803686|1308522|P3|NOT COMPLETED|Part 2, Period 3||0
536621|NCT00803686|1308523|P2|NOT COMPLETED|Part 2, Period 3||0
536622|NCT00803686|1308524|P1|NOT COMPLETED|Part 2, Period 3||0
536623|NCT00803686|1308521|P4|COMPLETED|Part 2, Period 3|All who started this period completed|4
536624|NCT00803686|1308522|P3|COMPLETED|Part 2, Period 3|All who started this period completed|5
536625|NCT00803686|1308523|P2|COMPLETED|Part 2, Period 3|No subjects were treated in this period.|0
536626|NCT00803686|1308524|P1|COMPLETED|Part 2, Period 3|No subjects were treated in this period|0
536627|NCT00803686|1308521|P4|STARTED|Part 2, Period 3|Of the 6 eligible, 2 elected not to continue into Period 3.|4
536628|NCT00803686|1308522|P3|STARTED|Part 2, Period 3|Of the 6 eligible, 1 elected not to continue into Period 3.|5
536629|NCT00803686|1308523|P2|STARTED|Part 2, Period 3|No subjects were treated in this period.|0
536630|NCT00803686|1308524|P1|STARTED|Part 2, Period 3|No subjects were treated in this period|0
536631|NCT00803686|1308521|P4|NOT COMPLETED|Part 1, Period 2||0
536632|NCT00803686|1308522|P3|NOT COMPLETED|Part 1, Period 2||0
536633|NCT00803686|1308523|P2|NOT COMPLETED|Part 1, Period 2||0
536634|NCT00803686|1308524|P1|NOT COMPLETED|Part 1, Period 2||0
536635|NCT00803686|1308521|P4|COMPLETED|Part 1, Period 2|No subjects treated.|0
536636|NCT00803686|1308522|P3|COMPLETED|Part 1, Period 2|No subjects treated.|0
536637|NCT00803686|1308523|P2|COMPLETED|Part 1, Period 2||6
536638|NCT00803686|1308524|P1|COMPLETED|Part 1, Period 2||6
536639|NCT00803686|1308521|P4|STARTED|Part 1, Period 2|No subjects were to be treated until after Periods 1 and 2.|0
536640|NCT00803686|1308522|P3|STARTED|Part 1, Period 2|No subjects were to be treated until after Periods 1 and 2.|0
536641|NCT00803686|1308523|P2|STARTED|Part 1, Period 2||6
536642|NCT00803686|1308524|P1|STARTED|Part 1, Period 2||6
536643|NCT00803686|1308521|P4|NOT COMPLETED|Part 1, Period 1||0
536644|NCT00803686|1308522|P3|NOT COMPLETED|Part 1, Period 1||0
536645|NCT00803686|1308523|P2|NOT COMPLETED|Part 1, Period 1||0
536646|NCT00803686|1308524|P1|NOT COMPLETED|Part 1, Period 1||0
536647|NCT00803686|1308521|P4|COMPLETED|Part 1, Period 1||0
536648|NCT00803686|1308522|P3|COMPLETED|Part 1, Period 1||0
536649|NCT00803686|1308523|P2|COMPLETED|Part 1, Period 1||6
536650|NCT00803686|1308524|P1|COMPLETED|Part 1, Period 1||6
536651|NCT00803686|1308521|P4|STARTED|Part 1, Period 1||0
536652|NCT00803686|1308522|P3|STARTED|Part 1, Period 1||0
536653|NCT00803686|1308523|P2|STARTED|Part 1, Period 1||6
536654|NCT00803686|1308524|P1|STARTED|Part 1, Period 1||6
536655|NCT00803647|1308542|P1|NOT COMPLETED|Overall Study||0
536656|NCT00803647|1308542|P1|COMPLETED|Overall Study||20
536657|NCT00803647|1308542|P1|STARTED|Overall Study||20
536658|NCT00803634|1308552|P2|NOT COMPLETED|Overall Study||5
536659|NCT00803634|1308553|P1|NOT COMPLETED|Overall Study||6
536660|NCT00803634|1308552|P2|COMPLETED|Overall Study|All patients dosed with SOC antihypertensive therapy [Safety population]|48
536661|NCT00803634|1308553|P1|COMPLETED|Overall Study|All patients dosed with clevidipine [Safety population]|45
536662|NCT00803634|1308552|P2|mITT (Dosed & Have Confirmed AHF)|Overall Study|All patients dosed with SOC antihypertensive therapy and confirmed to have AHF [mITT population]|41
536663|NCT00803634|1308553|P1|mITT (Dosed & Have Confirmed AHF)|Overall Study|All patients dosed with clevidipine and confirmed to have AHF [mITT population]|44
536664|NCT00803634|1308552|P2|STARTED|Overall Study|All patients dosed with SOC antihypertensive therapy [Safety population]|53
536665|NCT00803634|1308553|P1|STARTED|Overall Study|All patients dosed with clevidipine [Safety population]|51
536666|NCT00803595|1308582|P3|NOT COMPLETED|Overall Study||16
536667|NCT00803595|1308583|P2|NOT COMPLETED|Overall Study||8
536668|NCT00803595|1308584|P1|NOT COMPLETED|Overall Study||15
536669|NCT00803595|1308582|P3|COMPLETED|Overall Study||322
536670|NCT00803595|1308583|P2|COMPLETED|Overall Study||319
536671|NCT00803595|1308584|P1|COMPLETED|Overall Study||322
536672|NCT00803595|1308582|P3|STARTED|Overall Study||338
536673|NCT00803595|1308583|P2|STARTED|Overall Study||327
536674|NCT00803595|1308584|P1|STARTED|Overall Study||337
536675|NCT00803543|1308597|P2|NOT COMPLETED|Overall Study||12
536676|NCT00803543|1308598|P1|NOT COMPLETED|Overall Study||24
536677|NCT00803543|1308597|P2|COMPLETED|Overall Study||22
536678|NCT00803543|1308598|P1|COMPLETED|Overall Study||45
536679|NCT00803543|1308597|P2|STARTED|Overall Study||34
536680|NCT00803543|1308598|P1|STARTED|Overall Study||69
536681|NCT00803517|1308612|P2|NOT COMPLETED|Overall Study||0
536682|NCT00803517|1308613|P1|NOT COMPLETED|Overall Study||0
536683|NCT00803517|1308612|P2|COMPLETED|Overall Study||12
536684|NCT00803517|1308613|P1|COMPLETED|Overall Study||12
536685|NCT00803517|1308612|P2|STARTED|Overall Study||12
536686|NCT00803517|1308613|P1|STARTED|Overall Study||12
536687|NCT00803452|1308621|P2|NOT COMPLETED|Overall Study||5
536688|NCT00803452|1308622|P1|NOT COMPLETED|Overall Study||0
536689|NCT00803452|1308621|P2|COMPLETED|Overall Study||17
536690|NCT00803452|1308622|P1|COMPLETED|Overall Study||9
536691|NCT00803452|1308621|P2|STARTED|Overall Study||22
536692|NCT00803452|1308622|P1|STARTED|Overall Study||9
536693|NCT00803413|1308632|P4|NOT COMPLETED|Overall Period||0
536694|NCT00803413|1308633|P3|NOT COMPLETED|Overall Period||0
536695|NCT00803413|1308634|P2|NOT COMPLETED|Overall Period||0
536696|NCT00803413|1308635|P1|NOT COMPLETED|Overall Period||0
536697|NCT00803413|1308632|P4|COMPLETED|Overall Period||30
536698|NCT00803413|1308633|P3|COMPLETED|Overall Period||29
536699|NCT00803413|1308634|P2|COMPLETED|Overall Period||32
536700|NCT00803413|1308635|P1|COMPLETED|Overall Period||28
536701|NCT00803413|1308632|P4|STARTED|Overall Period||30
536702|NCT00803413|1308633|P3|STARTED|Overall Period||29
536703|NCT00803413|1308634|P2|STARTED|Overall Period||32
536704|NCT00803413|1308635|P1|STARTED|Overall Period||28
536705|NCT00803400|1308647|P2|NOT COMPLETED|Overall Study||24
536706|NCT00803400|1308648|P1|NOT COMPLETED|Overall Study||20
536707|NCT00803400|1308647|P2|COMPLETED|Overall Study||51
536708|NCT00803400|1308648|P1|COMPLETED|Overall Study||55
536709|NCT00803400|1308647|P2|STARTED|Overall Study||75
536710|NCT00803400|1308648|P1|STARTED|Overall Study||75
536711|NCT00803361|1308660|P2|NOT COMPLETED|Overall Study||28
536712|NCT00803361|1308661|P1|NOT COMPLETED|Overall Study||26
536713|NCT00803361|1308660|P2|COMPLETED|Overall Study||74
536714|NCT00803361|1308661|P1|COMPLETED|Overall Study||82
536715|NCT00803361|1308660|P2|STARTED|Overall Study||102
536716|NCT00803361|1308661|P1|STARTED|Overall Study||108
536717|NCT00803283|1308681|P2|NOT COMPLETED|Overall Study||0
536718|NCT00803283|1308682|P1|NOT COMPLETED|Overall Study||0
536719|NCT00803283|1308681|P2|COMPLETED|Overall Study||1
536720|NCT00803283|1308682|P1|COMPLETED|Overall Study||1
536721|NCT00803283|1308681|P2|STARTED|Overall Study||1
536722|NCT00803283|1308682|P1|STARTED|Overall Study||1
536723|NCT00803270|1308708|P2|NOT COMPLETED|Overall Study||2
536724|NCT00803270|1308709|P1|NOT COMPLETED|Overall Study||1
536725|NCT00803270|1308708|P2|COMPLETED|Overall Study||12
536726|NCT00803270|1308709|P1|COMPLETED|Overall Study||12
536727|NCT00803270|1308708|P2|STARTED|Overall Study||14
536728|NCT00803270|1308709|P1|STARTED|Overall Study||13
536729|NCT00803244|1308719|P2|NOT COMPLETED|Overall Study||15
536730|NCT00803244|1308720|P1|NOT COMPLETED|Overall Study||7
536731|NCT00803244|1308719|P2|COMPLETED|Overall Study||178
536732|NCT00803244|1308720|P1|COMPLETED|Overall Study||181
536733|NCT00803244|1308719|P2|STARTED|Overall Study||193
536734|NCT00803244|1308720|P1|STARTED|Overall Study||188
536735|NCT00803179|1308728|P1|NOT COMPLETED|Overall Study||3
536736|NCT00803179|1308728|P1|COMPLETED|Overall Study||2
536737|NCT00803179|1308728|P1|STARTED|Overall Study||5
536738|NCT00803114|1308734|P2|NOT COMPLETED|Overall Study||0
536739|NCT00803114|1308735|P1|NOT COMPLETED|Overall Study||0
536740|NCT00803114|1308734|P2|COMPLETED|Overall Study||115
536741|NCT00803114|1308735|P1|COMPLETED|Overall Study||113
536742|NCT00803114|1308734|P2|STARTED|Overall Study||115
536743|NCT00803114|1308735|P1|STARTED|Overall Study||113
536744|NCT00803101|1308747|P2|NOT COMPLETED|Overall Study||22
536745|NCT00803101|1308748|P1|NOT COMPLETED|Overall Study||18
536746|NCT00803101|1308747|P2|COMPLETED|Overall Study||66
536747|NCT00803101|1308748|P1|COMPLETED|Overall Study||70
536748|NCT00803101|1308747|P2|STARTED|Overall Study||88
536749|NCT00803101|1308748|P1|STARTED|Overall Study||88
536750|NCT00803062|1308770|P4|NOT COMPLETED|Overall Study||0
536751|NCT00803062|1308771|P3|NOT COMPLETED|Overall Study||0
536752|NCT00803062|1308772|P2|NOT COMPLETED|Overall Study||0
536753|NCT00803062|1308773|P1|NOT COMPLETED|Overall Study||0
536754|NCT00803062|1308770|P4|COMPLETED|Overall Study||112
536755|NCT00803062|1308771|P3|COMPLETED|Overall Study||111
536756|NCT00803062|1308772|P2|COMPLETED|Overall Study||115
536757|NCT00803062|1308773|P1|COMPLETED|Overall Study||114
536758|NCT00803062|1308770|P4|STARTED|Overall Study||112
536759|NCT00803062|1308771|P3|STARTED|Overall Study||111
536760|NCT00803062|1308772|P2|STARTED|Overall Study||115
536761|NCT00803062|1308773|P1|STARTED|Overall Study||114
536762|NCT00803049|1308799|P4|NOT COMPLETED|Overall Study||102
536763|NCT00803049|1308800|P3|NOT COMPLETED|Overall Study||44
536764|NCT00803049|1308801|P2|NOT COMPLETED|Overall Study||118
536765|NCT00803049|1308802|P1|NOT COMPLETED|Overall Study||61
536766|NCT00803049|1308799|P4|COMPLETED|Overall Study||151
536767|NCT00803049|1308800|P3|COMPLETED|Overall Study||64
536768|NCT00803049|1308801|P2|COMPLETED|Overall Study||134
536769|NCT00803049|1308802|P1|COMPLETED|Overall Study||68
536770|NCT00803049|1308799|P4|Safety Population|Overall Study|1 participant received Teriflunomide 7 mg and analysed in Teriflunomide 7 mg/7 mg arm|250
536771|NCT00803049|1308800|P3|Safety Population|Overall Study|1 participant received Teriflunomide 7 mg and analysed in Teriflunomide 7 mg/7 mg arm|107
536772|NCT00803049|1308801|P2|Safety Population|Overall Study|Included 1 participant from Placebo/Teriflunomide 14 mg and 1 from Teriflunomide14 mg/14 mg arm|254
536773|NCT00803049|1308802|P1|Safety Population|Overall Study||129
536774|NCT00803049|1308799|P4|Treated|Overall Study||251
536775|NCT00803049|1308800|P3|Treated|Overall Study||108
536776|NCT00803049|1308801|P2|Treated|Overall Study||252
536777|NCT00803049|1308802|P1|Treated|Overall Study||129
536778|NCT00803049|1308799|P4|STARTED|Overall Study|Randomized in extension study|253
536779|NCT00803049|1308800|P3|STARTED|Overall Study|Randomized in extension study|108
536780|NCT00803049|1308801|P2|STARTED|Overall Study|Randomized in extension study|252
536781|NCT00803049|1308802|P1|STARTED|Overall Study|Randomized in extension study|129
536782|NCT00803023|1308836|P4|NOT COMPLETED|Overall Study||8
536783|NCT00803023|1308837|P3|NOT COMPLETED|Overall Study||11
536784|NCT00803023|1308838|P2|NOT COMPLETED|Overall Study||8
536785|NCT00803023|1308839|P1|NOT COMPLETED|Overall Study||5
536786|NCT00803023|1308836|P4|COMPLETED|Overall Study||25
536787|NCT00803023|1308837|P3|COMPLETED|Overall Study||20
536788|NCT00803023|1308838|P2|COMPLETED|Overall Study||25
536789|NCT00803023|1308839|P1|COMPLETED|Overall Study||27
536790|NCT00803023|1308836|P4|STARTED|Overall Study||33
536791|NCT00803023|1308837|P3|STARTED|Overall Study||31
536792|NCT00803023|1308838|P2|STARTED|Overall Study||33
536793|NCT00803023|1308839|P1|STARTED|Overall Study||32
536794|NCT00803010|1308851|P2|NOT COMPLETED|Overall Study||0
536795|NCT00803010|1308852|P1|NOT COMPLETED|Overall Study||0
536796|NCT00803010|1308851|P2|COMPLETED|Overall Study||37
536797|NCT00803010|1308852|P1|COMPLETED|Overall Study||37
536798|NCT00803010|1308851|P2|STARTED|Overall Study||37
536799|NCT00803010|1308852|P1|STARTED|Overall Study||37
536800|NCT00802997|1308864|P2|NOT COMPLETED|6 Month to 9 Months||0
536801|NCT00802997|1308865|P1|NOT COMPLETED|6 Month to 9 Months||2
536802|NCT00802997|1308864|P2|COMPLETED|6 Month to 9 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
536803|NCT00802997|1308865|P1|COMPLETED|6 Month to 9 Months||25
536804|NCT00802997|1308864|P2|STARTED|6 Month to 9 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
536805|NCT00802997|1308865|P1|STARTED|6 Month to 9 Months||27
536806|NCT00802997|1308864|P2|NOT COMPLETED|3 Months to 6 Months||0
536807|NCT00802997|1308865|P1|NOT COMPLETED|3 Months to 6 Months||7
536808|NCT00802997|1308864|P2|COMPLETED|3 Months to 6 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
536809|NCT00802997|1308865|P1|COMPLETED|3 Months to 6 Months||27
536810|NCT00802997|1308864|P2|STARTED|3 Months to 6 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
536811|NCT00802997|1308865|P1|STARTED|3 Months to 6 Months||34
536812|NCT00802997|1308864|P2|NOT COMPLETED|Baseline to 3 Months||0
536813|NCT00802997|1308865|P1|NOT COMPLETED|Baseline to 3 Months||0
536814|NCT00802997|1308864|P2|COMPLETED|Baseline to 3 Months||17
536815|NCT00802997|1308865|P1|COMPLETED|Baseline to 3 Months||34
536816|NCT00802997|1308864|P2|STARTED|Baseline to 3 Months||17
536817|NCT00802997|1308865|P1|STARTED|Baseline to 3 Months||34
536818|NCT00802919|1308877|P2|NOT COMPLETED|Overall Study||1
536819|NCT00802919|1308878|P1|NOT COMPLETED|Overall Study||3
536820|NCT00802919|1308877|P2|COMPLETED|Overall Study||45
536821|NCT00802919|1308878|P1|COMPLETED|Overall Study||42
536822|NCT00802919|1308877|P2|STARTED|Overall Study||46
536823|NCT00802919|1308878|P1|STARTED|Overall Study||45
536824|NCT00802893|1308890|P1|NOT COMPLETED|Overall Study||3
536825|NCT00802893|1308890|P1|COMPLETED|Overall Study||0
536826|NCT00802893|1308890|P1|STARTED|Overall Study||3
536827|NCT00802880|1308895|P1|NOT COMPLETED|Overall Study||0
536828|NCT00802880|1308895|P1|COMPLETED|Overall Study||80
536829|NCT00802880|1308895|P1|STARTED|Overall Study||80
536830|NCT00802867|1308914|P1|NOT COMPLETED|Overall Study||13
536831|NCT00802867|1308914|P1|COMPLETED|Overall Study||976
536832|NCT00802867|1308914|P1|STARTED|Overall Study||989
536833|NCT00802854|1308922|P1|NOT COMPLETED|Overall Study||0
536834|NCT00802854|1308922|P1|COMPLETED|Overall Study||244
536835|NCT00802854|1308922|P1|STARTED|Overall Study||244
536836|NCT00802841|1308937|P2|NOT COMPLETED|Overall Study||95
536837|NCT00802841|1308938|P1|NOT COMPLETED|Overall Study||96
536838|NCT00802841|1308937|P2|COMPLETED|Overall Study||0
536839|NCT00802841|1308938|P1|COMPLETED|Overall Study||0
536840|NCT00802841|1308937|P2|Cross-over Set|Overall Study||56
536841|NCT00802841|1308938|P1|Cross-over Set|Overall Study||13
536842|NCT00802841|1308937|P2|Safety Set|Overall Study||93
536843|NCT00802841|1308938|P1|Safety Set|Overall Study||96
536844|NCT00802841|1308937|P2|Full Analysis Set|Overall Study||95
536845|NCT00802841|1308938|P1|Full Analysis Set|Overall Study||96
536846|NCT00802841|1308937|P2|STARTED|Overall Study||95
536847|NCT00802841|1308938|P1|STARTED|Overall Study||96
536848|NCT00802737|1308963|P3|NOT COMPLETED|Overall Study||1
536849|NCT00802737|1308964|P2|NOT COMPLETED|Overall Study||11
536850|NCT00802737|1308965|P1|NOT COMPLETED|Overall Study||17
536851|NCT00802737|1308963|P3|COMPLETED|Overall Study||0
536852|NCT00802737|1308964|P2|COMPLETED|Overall Study||0
536853|NCT00802737|1308965|P1|COMPLETED|Overall Study||0
536854|NCT00802737|1308963|P3|STARTED|Overall Study||1
536855|NCT00802737|1308964|P2|STARTED|Overall Study||11
536856|NCT00802737|1308965|P1|STARTED|Overall Study||17
536857|NCT00802685|1309013|P2|NOT COMPLETED|Overall Study||0
536858|NCT00802685|1309014|P1|NOT COMPLETED|Overall Study||0
536859|NCT00802685|1309013|P2|COMPLETED|Overall Study||51
536860|NCT00802685|1309014|P1|COMPLETED|Overall Study||54
536861|NCT00802685|1309013|P2|STARTED|Overall Study||51
536862|NCT00802685|1309014|P1|STARTED|Overall Study||54
536863|NCT00802672|1309025|P3|NOT COMPLETED|Overall Study||34
536864|NCT00802672|1309026|P2|NOT COMPLETED|Overall Study||52
536865|NCT00802672|1309027|P1|NOT COMPLETED|Overall Study||68
536866|NCT00802672|1309025|P3|COMPLETED|Overall Study||77
536867|NCT00802672|1309026|P2|COMPLETED|Overall Study||174
536868|NCT00802672|1309027|P1|COMPLETED|Overall Study||156
536869|NCT00802672|1309025|P3|STARTED|Overall Study||111
536870|NCT00802672|1309026|P2|STARTED|Overall Study||226
536871|NCT00802672|1309027|P1|STARTED|Overall Study||224
536872|NCT00802659|1309045|P4|NOT COMPLETED|Overall Study||0
536873|NCT00802659|1309046|P3|NOT COMPLETED|Overall Study||0
536874|NCT00802659|1309047|P2|NOT COMPLETED|Overall Study||1
536875|NCT00802659|1309048|P1|NOT COMPLETED|Overall Study||0
536876|NCT00802659|1309045|P4|COMPLETED|Overall Study||0
536877|NCT00802659|1309046|P3|COMPLETED|Overall Study||0
536878|NCT00802659|1309047|P2|COMPLETED|Overall Study||1
536879|NCT00802659|1309048|P1|COMPLETED|Overall Study||0
536880|NCT00802659|1309045|P4|STARTED|Overall Study||0
536881|NCT00802659|1309046|P3|STARTED|Overall Study||0
536882|NCT00802659|1309047|P2|STARTED|Overall Study||2
536883|NCT00802659|1309048|P1|STARTED|Overall Study||0
536884|NCT00802633|1309076|P2|NOT COMPLETED|Overall Study||0
536885|NCT00802633|1309077|P1|NOT COMPLETED|Overall Study||0
536886|NCT00802633|1309076|P2|COMPLETED|Overall Study||40
536887|NCT00802633|1309077|P1|COMPLETED|Overall Study||40
536888|NCT00802633|1309076|P2|STARTED|Overall Study||40
536889|NCT00802633|1309077|P1|STARTED|Overall Study||40
536890|NCT00802529|1309087|P2|NOT COMPLETED|Overall Study||1
536891|NCT00802529|1309088|P1|NOT COMPLETED|Overall Study||0
536892|NCT00802529|1309087|P2|COMPLETED|Overall Study||29
536893|NCT00802529|1309088|P1|COMPLETED|Overall Study|2 patients crossed-over to gentamicin after steroids failed to control vertigo (as per protocol).|30
536894|NCT00802529|1309087|P2|STARTED|Overall Study||30
536895|NCT00802529|1309088|P1|STARTED|Overall Study||30
536896|NCT00802503|1309100|P2|NOT COMPLETED|Overall Study||20
536897|NCT00802503|1309101|P1|NOT COMPLETED|Overall Study||10
536898|NCT00802503|1309100|P2|COMPLETED|Overall Study||133
536899|NCT00802503|1309101|P1|COMPLETED|Overall Study||142
536900|NCT00802503|1309100|P2|STARTED|Overall Study||153
536901|NCT00802503|1309101|P1|STARTED|Overall Study||152
536902|NCT00802464|1309127|P4|NOT COMPLETED|Month 8 - Month 14||0
536903|NCT00802464|1309128|P3|NOT COMPLETED|Month 8 - Month 14||1
536904|NCT00802464|1309129|P2|NOT COMPLETED|Month 8 - Month 14||2
536905|NCT00802464|1309130|P1|NOT COMPLETED|Month 8 - Month 14||1
536906|NCT00802464|1309127|P4|COMPLETED|Month 8 - Month 14||126
536907|NCT00802464|1309128|P3|COMPLETED|Month 8 - Month 14||129
536908|NCT00802464|1309129|P2|COMPLETED|Month 8 - Month 14||63
536909|NCT00802464|1309130|P1|COMPLETED|Month 8 - Month 14||33
536910|NCT00802464|1309127|P4|STARTED|Month 8 - Month 14||126
536911|NCT00802464|1309128|P3|STARTED|Month 8 - Month 14||130
536912|NCT00802464|1309129|P2|STARTED|Month 8 - Month 14||65
536913|NCT00802464|1309130|P1|STARTED|Month 8 - Month 14||34
536914|NCT00802464|1309127|P4|NOT COMPLETED|Month 0 - Month 8||9
536915|NCT00802464|1309128|P3|NOT COMPLETED|Month 0 - Month 8||7
536916|NCT00802464|1309129|P2|NOT COMPLETED|Month 0 - Month 8||3
536917|NCT00802464|1309130|P1|NOT COMPLETED|Month 0 - Month 8||0
536918|NCT00802464|1309127|P4|COMPLETED|Month 0 - Month 8||141
536919|NCT00802464|1309128|P3|COMPLETED|Month 0 - Month 8||142
536920|NCT00802464|1309129|P2|COMPLETED|Month 0 - Month 8||70
536921|NCT00802464|1309130|P1|COMPLETED|Month 0 - Month 8||38
536922|NCT00802464|1309127|P4|STARTED|Month 0 - Month 8||150
536923|NCT00802464|1309128|P3|STARTED|Month 0 - Month 8||149
536924|NCT00802464|1309129|P2|STARTED|Month 0 - Month 8||73
536925|NCT00802464|1309130|P1|STARTED|Month 0 - Month 8||38
536926|NCT00802438|1309216|P1|NOT COMPLETED|Overall Study||28
536927|NCT00802438|1309216|P1|COMPLETED|Overall Study||10
536928|NCT00802438|1309216|P1|STARTED|Overall Study||38
536929|NCT00802412|1309223|P2|NOT COMPLETED|Overall Study||1
536930|NCT00802412|1309224|P1|NOT COMPLETED|Overall Study||2
536931|NCT00802412|1309223|P2|COMPLETED|Overall Study||66
536932|NCT00802412|1309224|P1|COMPLETED|Overall Study||63
536933|NCT00802412|1309223|P2|STARTED|Overall Study||67
536934|NCT00802412|1309224|P1|STARTED|Overall Study||65
536935|NCT00802360|1309236|P4|NOT COMPLETED|Overall Study||22
536936|NCT00802360|1309237|P3|NOT COMPLETED|Overall Study||25
536937|NCT00802360|1309238|P2|NOT COMPLETED|Overall Study||26
536938|NCT00802360|1309239|P1|NOT COMPLETED|Overall Study||24
536939|NCT00802360|1309236|P4|COMPLETED|Overall Study||17
536940|NCT00802360|1309237|P3|COMPLETED|Overall Study||17
536941|NCT00802360|1309238|P2|COMPLETED|Overall Study||16
536942|NCT00802360|1309239|P1|COMPLETED|Overall Study||18
536943|NCT00802360|1309236|P4|STARTED|Overall Study||39
536944|NCT00802360|1309237|P3|STARTED|Overall Study||42
536945|NCT00802360|1309238|P2|STARTED|Overall Study||42
536946|NCT00802360|1309239|P1|STARTED|Overall Study||42
536947|NCT00802204|1309281|P2|NOT COMPLETED|Overall Study||1
536948|NCT00802204|1309282|P1|NOT COMPLETED|Overall Study||1
536949|NCT00802204|1309281|P2|COMPLETED|Overall Study||18
536950|NCT00802204|1309282|P1|COMPLETED|Overall Study||8
536951|NCT00802204|1309281|P2|STARTED|Overall Study||19
536952|NCT00802204|1309282|P1|STARTED|Overall Study||9
536953|NCT00802178|1309306|P1|NOT COMPLETED|Overall Study||113
536954|NCT00802178|1309306|P1|COMPLETED|Overall Study||2335
536955|NCT00802178|1309306|P1|STARTED|Overall Study||2448
536956|NCT00802100|1309316|P3|NOT COMPLETED|Overall Study||4
536957|NCT00802100|1309317|P2|NOT COMPLETED|Overall Study||7
536958|NCT00802100|1309318|P1|NOT COMPLETED|Overall Study||6
536959|NCT00802100|1309316|P3|COMPLETED|Overall Study||2
536960|NCT00802100|1309317|P2|COMPLETED|Overall Study||2
536961|NCT00802100|1309318|P1|COMPLETED|Overall Study||0
536962|NCT00802100|1309316|P3|STARTED|Overall Study||6
536963|NCT00802100|1309317|P2|STARTED|Overall Study||9
536964|NCT00802100|1309318|P1|STARTED|Overall Study||6
536965|NCT00802074|1309333|P6|NOT COMPLETED|Overall Study||0
536966|NCT00802074|1309334|P5|NOT COMPLETED|Overall Study||0
536967|NCT00802074|1309335|P4|NOT COMPLETED|Overall Study||0
536968|NCT00802074|1309336|P3|NOT COMPLETED|Overall Study||1
536969|NCT00802074|1309337|P2|NOT COMPLETED|Overall Study||1
536970|NCT00802074|1309338|P1|NOT COMPLETED|Overall Study||2
536971|NCT00802074|1309333|P6|COMPLETED|Overall Study||7
536972|NCT00802074|1309334|P5|COMPLETED|Overall Study||7
536973|NCT00802074|1309335|P4|COMPLETED|Overall Study||7
536974|NCT00802074|1309336|P3|COMPLETED|Overall Study||6
536975|NCT00802074|1309337|P2|COMPLETED|Overall Study||7
536976|NCT00802074|1309338|P1|COMPLETED|Overall Study||7
536977|NCT00802074|1309333|P6|STARTED|Overall Study||7
536978|NCT00802074|1309334|P5|STARTED|Overall Study||7
536979|NCT00802074|1309335|P4|STARTED|Overall Study||7
536980|NCT00802074|1309336|P3|STARTED|Overall Study||7
536981|NCT00802074|1309337|P2|STARTED|Overall Study||8
536982|NCT00802074|1309338|P1|STARTED|Overall Study||9
536983|NCT00801983|1309372|P2|NOT COMPLETED|Period 2||1
536984|NCT00801983|1309373|P1|NOT COMPLETED|Period 2||2
536985|NCT00801983|1309372|P2|COMPLETED|Period 2||32
536986|NCT00801983|1309373|P1|COMPLETED|Period 2||38
536987|NCT00801983|1309372|P2|STARTED|Period 2||33
536988|NCT00801983|1309373|P1|STARTED|Period 2||40
536989|NCT00801983|1309372|P2|NOT COMPLETED|Period 1||8
536990|NCT00801983|1309373|P1|NOT COMPLETED|Period 1||4
536991|NCT00801983|1309372|P2|COMPLETED|Period 1||33
536992|NCT00801983|1309373|P1|COMPLETED|Period 1||40
536993|NCT00801983|1309372|P2|STARTED|Period 1||41
536994|NCT00801983|1309373|P1|STARTED|Period 1||44
536995|NCT00801892|1309381|P2|NOT COMPLETED|Sham Crossover Period||2
536996|NCT00801892|1309382|P1|NOT COMPLETED|Sham Crossover Period||0
536997|NCT00801892|1309381|P2|COMPLETED|Sham Crossover Period||5
536998|NCT00801892|1309382|P1|COMPLETED|Sham Crossover Period||0
536999|NCT00801892|1309381|P2|STARTED|Sham Crossover Period||7
537000|NCT00801892|1309382|P1|STARTED|Sham Crossover Period||0
537001|NCT00801892|1309381|P2|NOT COMPLETED|Main Study Period||1
537002|NCT00801892|1309382|P1|NOT COMPLETED|Main Study Period||0
537003|NCT00801892|1309381|P2|COMPLETED|Main Study Period||10
537004|NCT00801892|1309382|P1|COMPLETED|Main Study Period||12
537005|NCT00801892|1309381|P2|STARTED|Main Study Period||11
537006|NCT00801892|1309382|P1|STARTED|Main Study Period||12
537007|NCT00801827|1309398|P1|NOT COMPLETED|Overall Study||0
537008|NCT00801827|1309398|P1|COMPLETED|Overall Study||5
537009|NCT00801827|1309398|P1|STARTED|Overall Study|2 others consented but due to scheduling did not complete|5
537010|NCT00801801|1309402|P1|NOT COMPLETED|Overall Study||0
537011|NCT00801801|1309402|P1|COMPLETED|Overall Study||5
537012|NCT00801801|1309402|P1|STARTED|Overall Study||5
537013|NCT00801684|1309407|P1|NOT COMPLETED|Overall Study||0
537014|NCT00801684|1309407|P1|COMPLETED|Overall Study||24
537015|NCT00801684|1309407|P1|STARTED|Overall Study||24
537016|NCT00801632|1309429|P1|NOT COMPLETED|Overall Study||1
537017|NCT00801632|1309429|P1|COMPLETED|Overall Study||4
537018|NCT00801632|1309429|P1|STARTED|Overall Study||5
537019|NCT00801242|1309440|P1|NOT COMPLETED|Overall Study||52
537020|NCT00801242|1309440|P1|COMPLETED|Overall Study|42, 10, and 0 participants withdrew during Cycles 1, 2, and 3 (i.e. 168 completed the trial).|168
537021|NCT00801242|1309440|P1|Started Cycle 3|Overall Study||2
537022|NCT00801242|1309440|P1|Started Cycle 2|Overall Study||35
537023|NCT00801242|1309440|P1|FAS, Off-treatment Cycle 1|Overall Study|Completed 7 months induction period and were enrolled in the off-treatment period of cycle 1.|191
537024|NCT00801242|1309440|P1|Full Analysis Set (FAS), Cycle 1|Overall Study|Randomized participants who received ≥1 dose and had ≥1 efficacy assessment.|213
537025|NCT00801242|1309440|P1|Safety Analysis Set|Overall Study|Randomized participants who received ≥1 dose of degarelix.|216
537026|NCT00801242|1309440|P1|STARTED|Overall Study|Randomized participants.|220
537027|NCT00801229|1309453|P2|NOT COMPLETED|Received Study Drug/Placebo||4
537028|NCT00801229|1309454|P1|NOT COMPLETED|Received Study Drug/Placebo||4
537029|NCT00801229|1309453|P2|COMPLETED|Received Study Drug/Placebo||30
537030|NCT00801229|1309454|P1|COMPLETED|Received Study Drug/Placebo||31
537031|NCT00801229|1309453|P2|STARTED|Received Study Drug/Placebo||34
537032|NCT00801229|1309454|P1|STARTED|Received Study Drug/Placebo||35
537033|NCT00801229|1309453|P2|NOT COMPLETED|Signed Consent||3
537034|NCT00801229|1309454|P1|NOT COMPLETED|Signed Consent||3
537035|NCT00801229|1309453|P2|COMPLETED|Signed Consent||34
537036|NCT00801229|1309454|P1|COMPLETED|Signed Consent||35
537037|NCT00801229|1309453|P2|STARTED|Signed Consent||37
537038|NCT00801229|1309454|P1|STARTED|Signed Consent||38
537039|NCT00801138|1309464|P4|NOT COMPLETED|Overall Study||0
537040|NCT00801138|1309465|P3|NOT COMPLETED|Overall Study||0
537041|NCT00801138|1309466|P2|NOT COMPLETED|Overall Study||0
537042|NCT00801138|1309467|P1|NOT COMPLETED|Overall Study||0
537043|NCT00801138|1309464|P4|COMPLETED|Overall Study||54
537044|NCT00801138|1309465|P3|COMPLETED|Overall Study||54
537045|NCT00801138|1309466|P2|COMPLETED|Overall Study||56
537046|NCT00801138|1309467|P1|COMPLETED|Overall Study||54
537047|NCT00801138|1309464|P4|STARTED|Overall Study||54
537048|NCT00801138|1309465|P3|STARTED|Overall Study||54
537049|NCT00801138|1309466|P2|STARTED|Overall Study||56
537050|NCT00801138|1309467|P1|STARTED|Overall Study||54
537051|NCT00801099|1309489|P1|NOT COMPLETED|Overall Study||101
537052|NCT00801099|1309489|P1|COMPLETED|Overall Study||175
537053|NCT00801099|1309489|P1|STARTED|Overall Study||276
537054|NCT00800982|1309495|P2|NOT COMPLETED|Overall Study||3
537055|NCT00800982|1309496|P1|NOT COMPLETED|Overall Study||2
537056|NCT00800982|1309495|P2|COMPLETED|Overall Study||12
537057|NCT00800982|1309496|P1|COMPLETED|Overall Study||13
537058|NCT00800982|1309495|P2|STARTED|Overall Study||15
537059|NCT00800982|1309496|P1|STARTED|Overall Study||15
537060|NCT00800865|1309504|P2|NOT COMPLETED|Overall Study||0
537061|NCT00800865|1309505|P1|NOT COMPLETED|Overall Study||0
537062|NCT00800865|1309504|P2|COMPLETED|Overall Study||16
537063|NCT00800865|1309505|P1|COMPLETED|Overall Study||15
537064|NCT00800865|1309504|P2|STARTED|Overall Study||16
537065|NCT00800865|1309505|P1|STARTED|Overall Study||15
537066|NCT00800839|1309513|P1|NOT COMPLETED|Overall Study||7
537067|NCT00800839|1309513|P1|COMPLETED|Overall Study||49
537068|NCT00800839|1309513|P1|STARTED|Overall Study||56
537069|NCT00800735|1309522|P1|NOT COMPLETED|Overall Study||14
537070|NCT00800735|1309522|P1|COMPLETED|Overall Study||16
537071|NCT00800735|1309522|P1|STARTED|Overall Study||30
537072|NCT00800683|1309528|P2|NOT COMPLETED|Overall Study||19
537073|NCT00800683|1309529|P1|NOT COMPLETED|Overall Study||17
537074|NCT00800683|1309528|P2|COMPLETED|Overall Study|Number who completed treatment|49
537075|NCT00800683|1309529|P1|COMPLETED|Overall Study|Number who completed treatment|48
537076|NCT00800683|1309528|P2|STARTED|Overall Study|Number who started treatment|68
537077|NCT00800683|1309529|P1|STARTED|Overall Study|Number who started treatment|65
537078|NCT00800540|1309575|P2|NOT COMPLETED|Period 2: 6 Weeks||1
537079|NCT00800540|1309576|P1|NOT COMPLETED|Period 2: 6 Weeks||0
537080|NCT00800540|1309575|P2|COMPLETED|Period 2: 6 Weeks||16
537081|NCT00800540|1309576|P1|COMPLETED|Period 2: 6 Weeks||16
537082|NCT00800540|1309575|P2|STARTED|Period 2: 6 Weeks||17
537083|NCT00800540|1309576|P1|STARTED|Period 2: 6 Weeks||16
537084|NCT00800540|1309575|P2|NOT COMPLETED|Washout: 4 Weeks||0
537085|NCT00800540|1309576|P1|NOT COMPLETED|Washout: 4 Weeks||0
537086|NCT00800540|1309575|P2|COMPLETED|Washout: 4 Weeks||17
537087|NCT00800540|1309576|P1|COMPLETED|Washout: 4 Weeks||16
537088|NCT00800540|1309575|P2|STARTED|Washout: 4 Weeks||17
537089|NCT00800540|1309576|P1|STARTED|Washout: 4 Weeks||16
537090|NCT00800540|1309575|P2|NOT COMPLETED|Period One: 6 Weeks||1
537091|NCT00800540|1309576|P1|NOT COMPLETED|Period One: 6 Weeks||1
537092|NCT00800540|1309575|P2|COMPLETED|Period One: 6 Weeks||17
537093|NCT00800540|1309576|P1|COMPLETED|Period One: 6 Weeks||16
537094|NCT00800540|1309575|P2|STARTED|Period One: 6 Weeks||18
537095|NCT00800540|1309576|P1|STARTED|Period One: 6 Weeks||17
537096|NCT00800436|1309611|P7|NOT COMPLETED|Overall Study||0
537097|NCT00800436|1309612|P6|NOT COMPLETED|Overall Study||0
537098|NCT00800436|1309613|P5|NOT COMPLETED|Overall Study||0
537099|NCT00800436|1309614|P4|NOT COMPLETED|Overall Study||1
537100|NCT00800436|1309615|P3|NOT COMPLETED|Overall Study||1
537101|NCT00800436|1309616|P2|NOT COMPLETED|Overall Study||0
537102|NCT00800436|1309617|P1|NOT COMPLETED|Overall Study||0
537103|NCT00800436|1309611|P7|COMPLETED|Overall Study||20
537104|NCT00800436|1309612|P6|COMPLETED|Overall Study||20
537105|NCT00800436|1309613|P5|COMPLETED|Overall Study||6
537106|NCT00800436|1309614|P4|COMPLETED|Overall Study||5
537107|NCT00800436|1309615|P3|COMPLETED|Overall Study||5
537108|NCT00800436|1309616|P2|COMPLETED|Overall Study||6
537109|NCT00800436|1309617|P1|COMPLETED|Overall Study||6
537110|NCT00800436|1309611|P7|STARTED|Overall Study||20
537111|NCT00800436|1309612|P6|STARTED|Overall Study||20
537112|NCT00800436|1309613|P5|STARTED|Overall Study||6
537113|NCT00800436|1309614|P4|STARTED|Overall Study||6
537114|NCT00800436|1309615|P3|STARTED|Overall Study||6
537115|NCT00800436|1309616|P2|STARTED|Overall Study||6
537116|NCT00800436|1309617|P1|STARTED|Overall Study||6
537117|NCT00800384|1309663|P2|NOT COMPLETED|Overall Study||43
537118|NCT00800384|1309664|P1|NOT COMPLETED|Overall Study||41
537119|NCT00800384|1309663|P2|COMPLETED|Overall Study||1210
537120|NCT00800384|1309664|P1|COMPLETED|Overall Study||1206
537121|NCT00800384|1309663|P2|STARTED|Overall Study||1253
537122|NCT00800384|1309664|P1|STARTED|Overall Study||1247
537123|NCT00800345|1309672|P1|NOT COMPLETED|Overall Study||0
537124|NCT00800345|1309672|P1|COMPLETED|Overall Study||33
537125|NCT00800345|1309672|P1|STARTED|Overall Study||33
537126|NCT00800254|1309679|P2|NOT COMPLETED|Overall Study||6
537127|NCT00800254|1309680|P1|NOT COMPLETED|Overall Study||5
537128|NCT00800254|1309679|P2|COMPLETED|Overall Study||25
537129|NCT00800254|1309680|P1|COMPLETED|Overall Study||30
537130|NCT00800254|1309679|P2|3.5 Weeks Post-operatively|Overall Study||31
537131|NCT00800254|1309680|P1|3.5 Weeks Post-operatively|Overall Study||31
537132|NCT00800254|1309679|P2|STARTED|Overall Study||31
537133|NCT00800254|1309680|P1|STARTED|Overall Study||35
537134|NCT00800202|1309702|P2|NOT COMPLETED|Overall Study||24
537135|NCT00800202|1309703|P1|NOT COMPLETED|Overall Study||67
537136|NCT00800202|1309702|P2|COMPLETED|Overall Study||0
537137|NCT00800202|1309703|P1|COMPLETED|Overall Study||0
537138|NCT00800202|1309702|P2|STARTED|Overall Study||24
537139|NCT00800202|1309703|P1|STARTED|Overall Study||67
537140|NCT00799903|1309723|P2|NOT COMPLETED|Overall Study||278
537141|NCT00799903|1309724|P1|NOT COMPLETED|Overall Study||273
537142|NCT00799903|1309723|P2|COMPLETED|Overall Study||7646
537143|NCT00799903|1309724|P1|COMPLETED|Overall Study||7631
537144|NCT00799903|1309723|P2|STARTED|Overall Study||7924
537145|NCT00799903|1309724|P1|STARTED|Overall Study||7904
537146|NCT00799825|1309744|P1|NOT COMPLETED|Overall Study||48
537147|NCT00799825|1309744|P1|COMPLETED|Overall Study||296
537148|NCT00799825|1309744|P1|STARTED|Overall Study||344
537149|NCT00799773|1309752|P2|NOT COMPLETED|Overall Study||0
537150|NCT00799773|1309753|P1|NOT COMPLETED|Overall Study||0
537151|NCT00799773|1309752|P2|COMPLETED|Overall Study||1
537152|NCT00799773|1309753|P1|COMPLETED|Overall Study||2
537153|NCT00799773|1309752|P2|STARTED|Overall Study||1
537154|NCT00799773|1309753|P1|STARTED|Overall Study||2
537155|NCT00799708|1309784|P3|NOT COMPLETED|Overall Study||0
537156|NCT00799708|1309785|P2|NOT COMPLETED|Overall Study||0
537157|NCT00799708|1309786|P1|NOT COMPLETED|Overall Study||1
537158|NCT00799708|1309784|P3|COMPLETED|Overall Study||11
537159|NCT00799708|1309785|P2|COMPLETED|Overall Study||6
537160|NCT00799708|1309786|P1|COMPLETED|Overall Study||9
537161|NCT00799708|1309784|P3|STARTED|Overall Study||11
537162|NCT00799708|1309785|P2|STARTED|Overall Study||6
537163|NCT00799708|1309786|P1|STARTED|Overall Study||10
537164|NCT00799643|1309798|P2|NOT COMPLETED|Overall Study||27
537165|NCT00799643|1309799|P1|NOT COMPLETED|Overall Study||25
537166|NCT00799643|1309798|P2|COMPLETED|Overall Study||119
537167|NCT00799643|1309799|P1|COMPLETED|Overall Study||115
537168|NCT00799643|1309798|P2|STARTED|Overall Study||146
537169|NCT00799643|1309799|P1|STARTED|Overall Study||140
537170|NCT00799617|1309809|P2|NOT COMPLETED|Anemia Trial||3
537171|NCT00799617|1309810|P1|NOT COMPLETED|Anemia Trial||3
537172|NCT00799617|1309809|P2|COMPLETED|Anemia Trial||32
537173|NCT00799617|1309810|P1|COMPLETED|Anemia Trial||24
537174|NCT00799617|1309809|P2|STARTED|Anemia Trial||35
537175|NCT00799617|1309810|P1|STARTED|Anemia Trial||27
537176|NCT00799617|1309809|P2|NOT COMPLETED|Cognitive Function Trial||1
537177|NCT00799617|1309810|P1|NOT COMPLETED|Cognitive Function Trial||0
537178|NCT00799617|1309809|P2|COMPLETED|Cognitive Function Trial||245
537179|NCT00799617|1309810|P1|COMPLETED|Cognitive Function Trial||247
537180|NCT00799617|1309809|P2|STARTED|Cognitive Function Trial||246
537181|NCT00799617|1309810|P1|STARTED|Cognitive Function Trial||247
537182|NCT00799617|1309809|P2|NOT COMPLETED|Bone Trial||16
537183|NCT00799617|1309810|P1|NOT COMPLETED|Bone Trial||6
537184|NCT00799617|1309809|P2|COMPLETED|Bone Trial||85
537185|NCT00799617|1309810|P1|COMPLETED|Bone Trial||104
537186|NCT00799617|1309809|P2|STARTED|Bone Trial||101
537187|NCT00799617|1309810|P1|STARTED|Bone Trial||110
537188|NCT00799617|1309809|P2|NOT COMPLETED|Cardiovascular Trial||17
537189|NCT00799617|1309810|P1|NOT COMPLETED|Cardiovascular Trial||15
537190|NCT00799617|1309809|P2|COMPLETED|Cardiovascular Trial||65
537191|NCT00799617|1309810|P1|COMPLETED|Cardiovascular Trial||73
537192|NCT00799617|1309809|P2|STARTED|Cardiovascular Trial||82
537193|NCT00799617|1309810|P1|STARTED|Cardiovascular Trial||88
537194|NCT00799617|1309809|P2|NOT COMPLETED|Vitality Trial||22
537195|NCT00799617|1309810|P1|NOT COMPLETED|Vitality Trial||7
537196|NCT00799617|1309809|P2|COMPLETED|Vitality Trial||216
537197|NCT00799617|1309810|P1|COMPLETED|Vitality Trial||229
537198|NCT00799617|1309809|P2|STARTED|Vitality Trial||238
537199|NCT00799617|1309810|P1|STARTED|Vitality Trial||236
537200|NCT00799617|1309809|P2|NOT COMPLETED|Physical Function Trial||11
537201|NCT00799617|1309810|P1|NOT COMPLETED|Physical Function Trial||6
537202|NCT00799617|1309809|P2|COMPLETED|Physical Function Trial||185
537203|NCT00799617|1309810|P1|COMPLETED|Physical Function Trial||185
537204|NCT00799617|1309809|P2|STARTED|Physical Function Trial||196
537205|NCT00799617|1309810|P1|STARTED|Physical Function Trial||191
537206|NCT00799617|1309809|P2|NOT COMPLETED|Sexual Funtion Trial||21
537207|NCT00799617|1309810|P1|NOT COMPLETED|Sexual Funtion Trial||16
537208|NCT00799617|1309809|P2|COMPLETED|Sexual Funtion Trial||215
537209|NCT00799617|1309810|P1|COMPLETED|Sexual Funtion Trial||218
537210|NCT00799617|1309809|P2|STARTED|Sexual Funtion Trial||236
537211|NCT00799617|1309810|P1|STARTED|Sexual Funtion Trial||234
537212|NCT00799617|1309809|P2|NOT COMPLETED|Main Testosterone Trial||21
537213|NCT00799617|1309810|P1|NOT COMPLETED|Main Testosterone Trial||19
537214|NCT00799617|1309809|P2|COMPLETED|Main Testosterone Trial||374
537215|NCT00799617|1309810|P1|COMPLETED|Main Testosterone Trial|Participants qualified for 1 of the 3 main trials (sexual function, physical function, vitality).|376
537216|NCT00799617|1309809|P2|STARTED|Main Testosterone Trial||395
537217|NCT00799617|1309810|P1|STARTED|Main Testosterone Trial||395
537218|NCT00799604|1309891|P3|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
537219|NCT00799604|1309892|P2|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
537220|NCT00799604|1309893|P1|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
537221|NCT00799604|1309891|P3|COMPLETED|Bolus 2 (With Anesthesia)||3
537222|NCT00799604|1309892|P2|COMPLETED|Bolus 2 (With Anesthesia)||12
537223|NCT00799604|1309893|P1|COMPLETED|Bolus 2 (With Anesthesia)||6
537224|NCT00799604|1309891|P3|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|3
537225|NCT00799604|1309892|P2|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|12
537226|NCT00799604|1309893|P1|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|6
537227|NCT00799604|1309891|P3|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
537228|NCT00799604|1309892|P2|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
537229|NCT00799604|1309893|P1|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
537230|NCT00799604|1309891|P3|COMPLETED|Bolus 1 (Pre-anesthesia)||10
537231|NCT00799604|1309892|P2|COMPLETED|Bolus 1 (Pre-anesthesia)||10
537232|NCT00799604|1309893|P1|COMPLETED|Bolus 1 (Pre-anesthesia)||10
537233|NCT00799604|1309891|P3|STARTED|Bolus 1 (Pre-anesthesia)||10
537234|NCT00799604|1309892|P2|STARTED|Bolus 1 (Pre-anesthesia)||10
537235|NCT00799604|1309893|P1|STARTED|Bolus 1 (Pre-anesthesia)||10
537236|NCT00799591|1309917|P1|NOT COMPLETED|Overall Study||66
537237|NCT00799591|1309917|P1|COMPLETED|Overall Study||90
537238|NCT00799591|1309917|P1|STARTED|Overall Study||156
537239|NCT00799578|1309928|P1|NOT COMPLETED|Overall Study||2
537240|NCT00799578|1309928|P1|COMPLETED|Overall Study||11
537241|NCT00799578|1309928|P1|STARTED|Overall Study||13
537242|NCT00799487|1309935|P3|NOT COMPLETED|Double-Blind Assessment Period||2
537243|NCT00799487|1309936|P2|NOT COMPLETED|Double-Blind Assessment Period||1
537244|NCT00799487|1309937|P1|NOT COMPLETED|Double-Blind Assessment Period||0
537245|NCT00799487|1309935|P3|COMPLETED|Double-Blind Assessment Period||32
537246|NCT00799487|1309936|P2|COMPLETED|Double-Blind Assessment Period||33
537247|NCT00799487|1309937|P1|COMPLETED|Double-Blind Assessment Period||0
537248|NCT00799487|1309935|P3|STARTED|Double-Blind Assessment Period||34
537249|NCT00799487|1309936|P2|STARTED|Double-Blind Assessment Period||34
537250|NCT00799487|1309937|P1|STARTED|Double-Blind Assessment Period||0
537251|NCT00799487|1309935|P3|NOT COMPLETED|Dose Adjustment Period||0
537252|NCT00799487|1309936|P2|NOT COMPLETED|Dose Adjustment Period||0
537253|NCT00799487|1309937|P1|NOT COMPLETED|Dose Adjustment Period||21
537254|NCT00799487|1309935|P3|COMPLETED|Dose Adjustment Period||34
537255|NCT00799487|1309936|P2|COMPLETED|Dose Adjustment Period||34
537256|NCT00799487|1309937|P1|COMPLETED|Dose Adjustment Period||0
537257|NCT00799487|1309935|P3|STARTED|Dose Adjustment Period||34
537258|NCT00799487|1309936|P2|STARTED|Dose Adjustment Period||34
537259|NCT00799487|1309937|P1|STARTED|Dose Adjustment Period||21
537260|NCT00799474|1310017|P1|NOT COMPLETED|Overall Study||0
537261|NCT00799474|1310017|P1|COMPLETED|Overall Study||609
537262|NCT00799474|1310017|P1|STARTED|Overall Study||609
537263|NCT00799435|1310025|P2|NOT COMPLETED|Overall Study||0
537264|NCT00799435|1310026|P1|NOT COMPLETED|Overall Study||0
537265|NCT00799435|1310025|P2|COMPLETED|Overall Study||1
537266|NCT00799435|1310026|P1|COMPLETED|Overall Study||1
537267|NCT00799435|1310025|P2|STARTED|Overall Study||1
537268|NCT00799435|1310026|P1|STARTED|Overall Study||1
537269|NCT00799422|1310032|P6|NOT COMPLETED|Third Week of Wear||0
537270|NCT00799422|1310033|P5|NOT COMPLETED|Third Week of Wear||0
537271|NCT00799422|1310034|P4|NOT COMPLETED|Third Week of Wear||0
537272|NCT00799422|1310035|P3|NOT COMPLETED|Third Week of Wear||0
537273|NCT00799422|1310036|P2|NOT COMPLETED|Third Week of Wear||0
537274|NCT00799422|1310037|P1|NOT COMPLETED|Third Week of Wear||0
537275|NCT00799422|1310032|P6|COMPLETED|Third Week of Wear||4
537276|NCT00799422|1310033|P5|COMPLETED|Third Week of Wear||4
537277|NCT00799422|1310034|P4|COMPLETED|Third Week of Wear||3
537278|NCT00799422|1310035|P3|COMPLETED|Third Week of Wear||3
537279|NCT00799422|1310036|P2|COMPLETED|Third Week of Wear||4
537280|NCT00799422|1310037|P1|COMPLETED|Third Week of Wear||4
537281|NCT00799422|1310032|P6|STARTED|Third Week of Wear||4
537282|NCT00799422|1310033|P5|STARTED|Third Week of Wear||4
537283|NCT00799422|1310034|P4|STARTED|Third Week of Wear||3
537284|NCT00799422|1310035|P3|STARTED|Third Week of Wear||3
537285|NCT00799422|1310036|P2|STARTED|Third Week of Wear||4
537286|NCT00799422|1310037|P1|STARTED|Third Week of Wear||4
537287|NCT00799422|1310032|P6|NOT COMPLETED|Second Week of Wear||0
537288|NCT00799422|1310033|P5|NOT COMPLETED|Second Week of Wear||0
537289|NCT00799422|1310034|P4|NOT COMPLETED|Second Week of Wear||0
537290|NCT00799422|1310035|P3|NOT COMPLETED|Second Week of Wear||0
537291|NCT00799422|1310036|P2|NOT COMPLETED|Second Week of Wear||0
537292|NCT00799422|1310037|P1|NOT COMPLETED|Second Week of Wear||0
537293|NCT00799422|1310032|P6|COMPLETED|Second Week of Wear||4
537294|NCT00799422|1310033|P5|COMPLETED|Second Week of Wear||4
537295|NCT00799422|1310034|P4|COMPLETED|Second Week of Wear||3
537296|NCT00799422|1310035|P3|COMPLETED|Second Week of Wear||3
537297|NCT00799422|1310036|P2|COMPLETED|Second Week of Wear||4
537298|NCT00799422|1310037|P1|COMPLETED|Second Week of Wear||4
537299|NCT00799422|1310032|P6|STARTED|Second Week of Wear|One subject discontinued between First and Second 3 weeks (adverse event)|4
537300|NCT00799422|1310033|P5|STARTED|Second Week of Wear||4
537394|NCT00798590|1310293|P2|COMPLETED|Overall Study||0
537301|NCT00799422|1310034|P4|STARTED|Second Week of Wear|One subject discontinued between First and Second 3 weeks (adverse event)|3
537302|NCT00799422|1310035|P3|STARTED|Second Week of Wear||3
537303|NCT00799422|1310036|P2|STARTED|Second Week of Wear||4
537304|NCT00799422|1310037|P1|STARTED|Second Week of Wear||4
537305|NCT00799422|1310032|P6|NOT COMPLETED|First Week of Wear||0
537306|NCT00799422|1310033|P5|NOT COMPLETED|First Week of Wear||0
537307|NCT00799422|1310034|P4|NOT COMPLETED|First Week of Wear||1
537308|NCT00799422|1310035|P3|NOT COMPLETED|First Week of Wear||1
537309|NCT00799422|1310036|P2|NOT COMPLETED|First Week of Wear||0
537310|NCT00799422|1310037|P1|NOT COMPLETED|First Week of Wear||0
537311|NCT00799422|1310032|P6|COMPLETED|First Week of Wear||5
537312|NCT00799422|1310033|P5|COMPLETED|First Week of Wear||4
537313|NCT00799422|1310034|P4|COMPLETED|First Week of Wear||4
537314|NCT00799422|1310035|P3|COMPLETED|First Week of Wear||3
537315|NCT00799422|1310036|P2|COMPLETED|First Week of Wear||4
537316|NCT00799422|1310037|P1|COMPLETED|First Week of Wear||4
537317|NCT00799422|1310032|P6|STARTED|First Week of Wear||5
537318|NCT00799422|1310033|P5|STARTED|First Week of Wear||4
537319|NCT00799422|1310034|P4|STARTED|First Week of Wear||5
537320|NCT00799422|1310035|P3|STARTED|First Week of Wear||4
537321|NCT00799422|1310036|P2|STARTED|First Week of Wear||4
537322|NCT00799422|1310037|P1|STARTED|First Week of Wear||4
537323|NCT00799409|1310054|P3|NOT COMPLETED|Overall Study||0
537324|NCT00799409|1310055|P2|NOT COMPLETED|Overall Study||0
537325|NCT00799409|1310056|P1|NOT COMPLETED|Overall Study||7
537326|NCT00799409|1310054|P3|COMPLETED|Overall Study||35
537327|NCT00799409|1310055|P2|COMPLETED|Overall Study||36
537328|NCT00799409|1310056|P1|COMPLETED|Overall Study||0
537329|NCT00799409|1310054|P3|STARTED|Overall Study||35
537330|NCT00799409|1310055|P2|STARTED|Overall Study||36
537331|NCT00799409|1310056|P1|STARTED|Overall Study||7
537332|NCT00799396|1310136|P1|NOT COMPLETED|Clopidogrel Plus Aspirin||6
537333|NCT00799396|1310136|P1|COMPLETED|Clopidogrel Plus Aspirin||663
537334|NCT00799396|1310136|P1|STARTED|Clopidogrel Plus Aspirin||669
537335|NCT00799396|1310136|P1|NOT COMPLETED|Clopidogrel Treatment||13
537336|NCT00799396|1310136|P1|COMPLETED|Clopidogrel Treatment||669
537337|NCT00799396|1310136|P1|STARTED|Clopidogrel Treatment||682
537338|NCT00799383|1310143|P2|NOT COMPLETED|Overall Study||6
537339|NCT00799383|1310144|P1|NOT COMPLETED|Overall Study||3
537340|NCT00799383|1310143|P2|COMPLETED|Overall Study||18
537341|NCT00799383|1310144|P1|COMPLETED|Overall Study||20
537342|NCT00799383|1310143|P2|STARTED|Overall Study||24
537343|NCT00799383|1310144|P1|STARTED|Overall Study||23
537344|NCT00799292|1310166|P2|NOT COMPLETED|Overall Study||0
537345|NCT00799292|1310167|P1|NOT COMPLETED|Overall Study||0
537346|NCT00799292|1310166|P2|COMPLETED|Overall Study||29
537347|NCT00799292|1310167|P1|COMPLETED|Overall Study||29
537348|NCT00799292|1310166|P2|STARTED|Overall Study||29
537349|NCT00799292|1310167|P1|STARTED|Overall Study||29
537350|NCT00799227|1310171|P1|NOT COMPLETED|Overall Study||3
537351|NCT00799227|1310171|P1|COMPLETED|Overall Study||53
537352|NCT00799227|1310171|P1|STARTED|Overall Study||56
537353|NCT00798967|1310180|P2|NOT COMPLETED|Overall Study||4
537354|NCT00798967|1310181|P1|NOT COMPLETED|Overall Study||4
537355|NCT00798967|1310180|P2|COMPLETED|Overall Study||39
537356|NCT00798967|1310181|P1|COMPLETED|Overall Study||39
537357|NCT00798967|1310180|P2|Discontinued During Dosing Period|Overall Study||4
537358|NCT00798967|1310181|P1|Discontinued During Dosing Period|Overall Study||4
537359|NCT00798967|1310180|P2|STARTED|Overall Study||43
537360|NCT00798967|1310181|P1|STARTED|Overall Study||43
537361|NCT00798889|1310189|P1|NOT COMPLETED|Overall Study||314
537362|NCT00798889|1310189|P1|COMPLETED|Overall Study||0
537363|NCT00798889|1310189|P1|Treated|Overall Study||311
537364|NCT00798889|1310189|P1|STARTED|Overall Study||314
537365|NCT00798759|1310195|P2|NOT COMPLETED|Overall Study||13
537366|NCT00798759|1310196|P1|NOT COMPLETED|Overall Study||8
537367|NCT00798759|1310195|P2|COMPLETED|Overall Study||106
537368|NCT00798759|1310196|P1|COMPLETED|Overall Study||109
537369|NCT00798759|1310195|P2|STARTED|Overall Study||119
537370|NCT00798759|1310196|P1|STARTED|Overall Study||117
537371|NCT00798720|1310204|P1|NOT COMPLETED|Overall Study||0
537372|NCT00798720|1310204|P1|COMPLETED|Overall Study||18
537373|NCT00798720|1310204|P1|STARTED|Overall Study||18
537374|NCT00798707|1310214|P3|NOT COMPLETED|Overall Study||22
537375|NCT00798707|1310215|P2|NOT COMPLETED|Overall Study||33
537376|NCT00798707|1310216|P1|NOT COMPLETED|Overall Study||26
537377|NCT00798707|1310214|P3|COMPLETED|Overall Study||215
537378|NCT00798707|1310215|P2|COMPLETED|Overall Study||204
537379|NCT00798707|1310216|P1|COMPLETED|Overall Study||209
537380|NCT00798707|1310214|P3|Treated|Overall Study||236
537381|NCT00798707|1310215|P2|Treated|Overall Study||232
537382|NCT00798707|1310216|P1|Treated|Overall Study||231
537383|NCT00798707|1310214|P3|STARTED|Overall Study||237
537384|NCT00798707|1310215|P2|STARTED|Overall Study||237
537385|NCT00798707|1310216|P1|STARTED|Overall Study||235
537386|NCT00798655|1310266|P1|NOT COMPLETED|Overall Study||2
537387|NCT00798655|1310266|P1|COMPLETED|Overall Study||44
537388|NCT00798655|1310266|P1|STARTED|Overall Study||46
537389|NCT00798603|1310271|P1|NOT COMPLETED|Overall Study||35
537390|NCT00798603|1310271|P1|COMPLETED|Overall Study||27
537391|NCT00798603|1310271|P1|STARTED|Overall Study||62
537392|NCT00798590|1310293|P2|NOT COMPLETED|Overall Study||8
537393|NCT00798590|1310294|P1|NOT COMPLETED|Overall Study||11
537395|NCT00798590|1310294|P1|COMPLETED|Overall Study||0
537396|NCT00798590|1310293|P2|STARTED|Overall Study||8
537397|NCT00798590|1310294|P1|STARTED|Overall Study||11
537398|NCT00798577|1310304|P2|NOT COMPLETED|Overall Study||0
537399|NCT00798577|1310305|P1|NOT COMPLETED|Overall Study||0
537400|NCT00798577|1310304|P2|COMPLETED|Overall Study||7
537401|NCT00798577|1310305|P1|COMPLETED|Overall Study||17
537402|NCT00798577|1310304|P2|STARTED|Overall Study||7
537403|NCT00798577|1310305|P1|STARTED|Overall Study||17
537404|NCT00798486|1310319|P1|NOT COMPLETED|Overall Study||0
537405|NCT00798486|1310319|P1|COMPLETED|Overall Study||110
537406|NCT00798486|1310319|P1|STARTED|Overall Study||110
537407|NCT00798434|1310328|P2|NOT COMPLETED|Open-Label||32
537408|NCT00798434|1310329|P1|NOT COMPLETED|Open-Label||42
537409|NCT00798434|1310328|P2|COMPLETED|Open-Label||282
537410|NCT00798434|1310329|P1|COMPLETED|Open-Label||299
537411|NCT00798434|1310328|P2|Received Treatment|Open-Label||313
537412|NCT00798434|1310329|P1|Received Treatment|Open-Label||341
537413|NCT00798434|1310328|P2|STARTED|Open-Label||314
537414|NCT00798434|1310329|P1|STARTED|Open-Label||341
537415|NCT00798434|1310328|P2|NOT COMPLETED|Double-Blind||84
537416|NCT00798434|1310329|P1|NOT COMPLETED|Double-Blind||55
537417|NCT00798434|1310328|P2|COMPLETED|Double-Blind||314
537418|NCT00798434|1310329|P1|COMPLETED|Double-Blind||341
537419|NCT00798434|1310328|P2|Received Treatment|Double-Blind||392
537420|NCT00798434|1310329|P1|Received Treatment|Double-Blind||393
537421|NCT00798434|1310328|P2|STARTED|Double-Blind||398
537422|NCT00798434|1310329|P1|STARTED|Double-Blind||396
537423|NCT00798369|1310415|P6|NOT COMPLETED|Overall Study||3
537424|NCT00798369|1310416|P5|NOT COMPLETED|Overall Study||1
537425|NCT00798369|1310417|P4|NOT COMPLETED|Overall Study||1
537426|NCT00798369|1310418|P3|NOT COMPLETED|Overall Study||2
537427|NCT00798369|1310419|P2|NOT COMPLETED|Overall Study||1
537428|NCT00798369|1310420|P1|NOT COMPLETED|Overall Study||1
537429|NCT00798369|1310415|P6|COMPLETED|Overall Study||54
537430|NCT00798369|1310416|P5|COMPLETED|Overall Study||27
537431|NCT00798369|1310417|P4|COMPLETED|Overall Study||28
537432|NCT00798369|1310418|P3|COMPLETED|Overall Study||27
537433|NCT00798369|1310419|P2|COMPLETED|Overall Study||28
537434|NCT00798369|1310420|P1|COMPLETED|Overall Study||27
537435|NCT00798369|1310415|P6|STARTED|Overall Study||57
537436|NCT00798369|1310416|P5|STARTED|Overall Study||28
537437|NCT00798369|1310417|P4|STARTED|Overall Study||29
537438|NCT00798369|1310418|P3|STARTED|Overall Study||29
537439|NCT00798369|1310419|P2|STARTED|Overall Study||29
537440|NCT00798369|1310420|P1|STARTED|Overall Study||28
537441|NCT00798317|1310467|P2|NOT COMPLETED|Overall Study||7
537442|NCT00798317|1310468|P1|NOT COMPLETED|Overall Study||10
537443|NCT00798317|1310467|P2|COMPLETED|Overall Study||74
537444|NCT00798317|1310468|P1|COMPLETED|Overall Study||235
537445|NCT00798317|1310467|P2|STARTED|Overall Study||81
537446|NCT00798317|1310468|P1|STARTED|Overall Study||245
537447|NCT00798304|1310479|P3|NOT COMPLETED|Overall Study||10
537448|NCT00798304|1310480|P2|NOT COMPLETED|Overall Study||22
537449|NCT00798304|1310481|P1|NOT COMPLETED|Overall Study||14
537450|NCT00798304|1310479|P3|COMPLETED|Overall Study||0
537451|NCT00798304|1310480|P2|COMPLETED|Overall Study||0
537452|NCT00798304|1310481|P1|COMPLETED|Overall Study||0
537453|NCT00798304|1310479|P3|STARTED|Overall Study||10
537454|NCT00798304|1310480|P2|STARTED|Overall Study||22
537455|NCT00798304|1310481|P1|STARTED|Overall Study||14
537456|NCT00798161|1310514|P7|NOT COMPLETED|Overall Study||10
537457|NCT00798161|1310515|P6|NOT COMPLETED|Overall Study||11
537458|NCT00798161|1310516|P5|NOT COMPLETED|Overall Study||16
537459|NCT00798161|1310517|P4|NOT COMPLETED|Overall Study||21
537460|NCT00798161|1310518|P3|NOT COMPLETED|Overall Study||21
537461|NCT00798161|1310519|P2|NOT COMPLETED|Overall Study||17
537462|NCT00798161|1310520|P1|NOT COMPLETED|Overall Study||18
537463|NCT00798161|1310514|P7|COMPLETED|Overall Study||56
537464|NCT00798161|1310515|P6|COMPLETED|Overall Study||132
537465|NCT00798161|1310516|P5|COMPLETED|Overall Study||127
537466|NCT00798161|1310517|P4|COMPLETED|Overall Study||121
537467|NCT00798161|1310518|P3|COMPLETED|Overall Study||126
537468|NCT00798161|1310519|P2|COMPLETED|Overall Study||127
537469|NCT00798161|1310520|P1|COMPLETED|Overall Study||54
537470|NCT00798161|1310514|P7|STARTED|Overall Study||66
537471|NCT00798161|1310515|P6|STARTED|Overall Study||143
537472|NCT00798161|1310516|P5|STARTED|Overall Study||143
537473|NCT00798161|1310517|P4|STARTED|Overall Study||142
537474|NCT00798161|1310518|P3|STARTED|Overall Study||147
537475|NCT00798161|1310519|P2|STARTED|Overall Study||144
537476|NCT00798161|1310520|P1|STARTED|Overall Study||72
537477|NCT00798135|1310627|P1|NOT COMPLETED|Overall Study||13
537478|NCT00798135|1310627|P1|COMPLETED|Overall Study||0
537479|NCT00798135|1310627|P1|STARTED|Overall Study||13
537480|NCT00798096|1310633|P1|NOT COMPLETED|Overall Study||2
537481|NCT00798096|1310633|P1|COMPLETED|Overall Study|Completion of Study is defined as a minimum of 8 weeks of treatment or early disease progression|16
537482|NCT00798096|1310633|P1|STARTED|Overall Study|Treatment with 200 mg bid, oral Fostamatanib until disease progression, toxicity or withdrawal|18
537483|NCT00798018|1310644|P4|NOT COMPLETED|Overall Study||0
537484|NCT00798018|1310645|P3|NOT COMPLETED|Overall Study||0
537485|NCT00798018|1310646|P2|NOT COMPLETED|Overall Study||0
537486|NCT00798018|1310647|P1|NOT COMPLETED|Overall Study||0
537487|NCT00798018|1310644|P4|COMPLETED|Overall Study||25
537488|NCT00798018|1310645|P3|COMPLETED|Overall Study||25
537489|NCT00798018|1310646|P2|COMPLETED|Overall Study||25
537490|NCT00798018|1310647|P1|COMPLETED|Overall Study||25
537491|NCT00798018|1310644|P4|STARTED|Overall Study||25
537492|NCT00798018|1310645|P3|STARTED|Overall Study||25
537493|NCT00798018|1310646|P2|STARTED|Overall Study||25
537494|NCT00798018|1310647|P1|STARTED|Overall Study||25
537495|NCT00797966|1310661|P6|NOT COMPLETED|Phase A+||28
537496|NCT00797966|1310662|P5|NOT COMPLETED|Phase A+||0
537497|NCT00797966|1310663|P4|NOT COMPLETED|Phase A+||0
537498|NCT00797966|1310664|P3|NOT COMPLETED|Phase A+||0
537499|NCT00797966|1310665|P2|NOT COMPLETED|Phase A+||0
537500|NCT00797966|1310666|P1|NOT COMPLETED|Phase A+||0
537501|NCT00797966|1310661|P6|COMPLETED|Phase A+||207
537502|NCT00797966|1310662|P5|COMPLETED|Phase A+||0
537503|NCT00797966|1310663|P4|COMPLETED|Phase A+||0
537504|NCT00797966|1310664|P3|COMPLETED|Phase A+||0
537505|NCT00797966|1310665|P2|COMPLETED|Phase A+||0
537506|NCT00797966|1310666|P1|COMPLETED|Phase A+||0
537507|NCT00797966|1310661|P6|STARTED|Phase A+||235
537508|NCT00797966|1310662|P5|STARTED|Phase A+||0
537509|NCT00797966|1310663|P4|STARTED|Phase A+||0
537510|NCT00797966|1310664|P3|STARTED|Phase A+||0
537511|NCT00797966|1310665|P2|STARTED|Phase A+||0
537512|NCT00797966|1310666|P1|STARTED|Phase A+||0
537513|NCT00797966|1310661|P6|NOT COMPLETED|Phase B||0
537514|NCT00797966|1310662|P5|NOT COMPLETED|Phase B||0
537515|NCT00797966|1310663|P4|NOT COMPLETED|Phase B||16
537516|NCT00797966|1310664|P3|NOT COMPLETED|Phase B||21
537517|NCT00797966|1310665|P2|NOT COMPLETED|Phase B||18
537518|NCT00797966|1310666|P1|NOT COMPLETED|Phase B||11
537519|NCT00797966|1310661|P6|COMPLETED|Phase B||0
537520|NCT00797966|1310662|P5|COMPLETED|Phase B||0
537521|NCT00797966|1310663|P4|COMPLETED|Phase B||110
537522|NCT00797966|1310664|P3|COMPLETED|Phase B||100
537523|NCT00797966|1310665|P2|COMPLETED|Phase B||102
537524|NCT00797966|1310666|P1|COMPLETED|Phase B||51
537525|NCT00797966|1310661|P6|STARTED|Phase B||0
537526|NCT00797966|1310662|P5|STARTED|Phase B||0
537527|NCT00797966|1310663|P4|STARTED|Phase B|Randomized participants.|126
537528|NCT00797966|1310664|P3|STARTED|Phase B|Randomized participants.|121
537529|NCT00797966|1310665|P2|STARTED|Phase B|Randomized participants.|120
537530|NCT00797966|1310666|P1|STARTED|Phase B|Randomized participants.|62
537531|NCT00797966|1310661|P6|NOT COMPLETED|Phase A||0
537532|NCT00797966|1310662|P5|NOT COMPLETED|Phase A||185
537533|NCT00797966|1310663|P4|NOT COMPLETED|Phase A||0
537534|NCT00797966|1310664|P3|NOT COMPLETED|Phase A||0
537535|NCT00797966|1310665|P2|NOT COMPLETED|Phase A||0
537536|NCT00797966|1310666|P1|NOT COMPLETED|Phase A||0
537537|NCT00797966|1310661|P6|COMPLETED|Phase A||0
537538|NCT00797966|1310662|P5|COMPLETED|Phase A||664
537539|NCT00797966|1310663|P4|COMPLETED|Phase A||0
537540|NCT00797966|1310664|P3|COMPLETED|Phase A||0
537541|NCT00797966|1310665|P2|COMPLETED|Phase A||0
537542|NCT00797966|1310666|P1|COMPLETED|Phase A||0
537543|NCT00797966|1310661|P6|STARTED|Phase A||0
537544|NCT00797966|1310662|P5|STARTED|Phase A|850 participants entered Phase A; 849 participants were treated.|849
537545|NCT00797966|1310663|P4|STARTED|Phase A||0
537546|NCT00797966|1310664|P3|STARTED|Phase A||0
537547|NCT00797966|1310665|P2|STARTED|Phase A||0
537548|NCT00797966|1310666|P1|STARTED|Phase A||0
537549|NCT00797862|1310731|P3|NOT COMPLETED|Overall Study||86
537550|NCT00797862|1310732|P2|NOT COMPLETED|Overall Study||68
537551|NCT00797862|1310733|P1|NOT COMPLETED|Overall Study||124
537552|NCT00797862|1310731|P3|COMPLETED|Overall Study||230
537553|NCT00797862|1310732|P2|COMPLETED|Overall Study||250
537554|NCT00797862|1310733|P1|COMPLETED|Overall Study||496
537555|NCT00797862|1310731|P3|Entered Double-Blind Treatment (FAS)|Overall Study||315
537556|NCT00797862|1310732|P2|Entered Double-Blind Treatment (FAS)|Overall Study||315
537557|NCT00797862|1310733|P1|Entered Double-Blind Treatment (FAS)|Overall Study||617
537558|NCT00797862|1310731|P3|STARTED|Overall Study|1 participant was mis-randomized and discontinued. Only 315 participants received study drug.|316
537559|NCT00797862|1310732|P2|STARTED|Overall Study|3 participants were mis-randomized and discontinued. Only 315 participants received study drug.|318
537560|NCT00797862|1310733|P1|STARTED|Overall Study|3 participants were mis-randomized and discontinued. Only 617 participants received study drug.|620
537561|NCT00797823|1310762|P3|NOT COMPLETED|Second Period (Crossover)||0
537562|NCT00797823|1310763|P2|NOT COMPLETED|Second Period (Crossover)||0
537563|NCT00797823|1310764|P1|NOT COMPLETED|Second Period (Crossover)||0
537564|NCT00797823|1310762|P3|COMPLETED|Second Period (Crossover)||0
537565|NCT00797823|1310763|P2|COMPLETED|Second Period (Crossover)||4
537566|NCT00797823|1310764|P1|COMPLETED|Second Period (Crossover)||3
537567|NCT00797823|1310762|P3|STARTED|Second Period (Crossover)||0
537568|NCT00797823|1310763|P2|STARTED|Second Period (Crossover)||4
537569|NCT00797823|1310764|P1|STARTED|Second Period (Crossover)||3
537570|NCT00797823|1310762|P3|NOT COMPLETED|First Period (Initial Randomization)||0
537571|NCT00797823|1310763|P2|NOT COMPLETED|First Period (Initial Randomization)||0
537572|NCT00797823|1310764|P1|NOT COMPLETED|First Period (Initial Randomization)||1
537573|NCT00797823|1310762|P3|COMPLETED|First Period (Initial Randomization)||0
537574|NCT00797823|1310763|P2|COMPLETED|First Period (Initial Randomization)||4
537575|NCT00797823|1310764|P1|COMPLETED|First Period (Initial Randomization)||3
537576|NCT00797823|1310762|P3|STARTED|First Period (Initial Randomization)|Pilot studies only performed during initial period.|0
537577|NCT00797823|1310763|P2|STARTED|First Period (Initial Randomization)||4
537578|NCT00797823|1310764|P1|STARTED|First Period (Initial Randomization)||4
537579|NCT00797823|1310762|P3|NOT COMPLETED|Pilot Studies||0
537580|NCT00797823|1310763|P2|NOT COMPLETED|Pilot Studies||0
537581|NCT00797823|1310764|P1|NOT COMPLETED|Pilot Studies||0
537582|NCT00797823|1310762|P3|COMPLETED|Pilot Studies||6
537583|NCT00797823|1310763|P2|COMPLETED|Pilot Studies||0
537584|NCT00797823|1310764|P1|COMPLETED|Pilot Studies||0
537585|NCT00797823|1310762|P3|STARTED|Pilot Studies||6
537586|NCT00797823|1310763|P2|STARTED|Pilot Studies|Not involved in pilot studies|0
537587|NCT00797823|1310764|P1|STARTED|Pilot Studies|Not involved in pilot studies|0
537588|NCT00797797|1310775|P2|NOT COMPLETED|Overall Study||43
537589|NCT00797797|1310776|P1|NOT COMPLETED|Overall Study||55
537590|NCT00797797|1310775|P2|COMPLETED|Overall Study||141
537591|NCT00797797|1310776|P1|COMPLETED|Overall Study||123
537592|NCT00797797|1310775|P2|STARTED|Overall Study||184
537593|NCT00797797|1310776|P1|STARTED|Overall Study|Two patients took no background stable dose of pregabalin after randomization and are not included.|178
537594|NCT00797732|1310786|P3|NOT COMPLETED|Overall Study||154
537595|NCT00797732|1310787|P2|NOT COMPLETED|Overall Study||3
537596|NCT00797732|1310788|P1|NOT COMPLETED|Overall Study||5
537597|NCT00797732|1310786|P3|COMPLETED|Overall Study||0
537598|NCT00797732|1310787|P2|COMPLETED|Overall Study||18
537599|NCT00797732|1310788|P1|COMPLETED|Overall Study||16
537600|NCT00797732|1310786|P3|Evaluable at 12 Months|Overall Study||0
537601|NCT00797732|1310787|P2|Evaluable at 12 Months|Overall Study||18
537602|NCT00797732|1310788|P1|Evaluable at 12 Months|Overall Study||17
537603|NCT00797732|1310786|P3|Evaluable at 20 Weeks|Overall Study||0
537604|NCT00797732|1310787|P2|Evaluable at 20 Weeks|Overall Study||18
537605|NCT00797732|1310788|P1|Evaluable at 20 Weeks|Overall Study||17
537606|NCT00797732|1310786|P3|Evaluable at Baseline|Overall Study||0
537607|NCT00797732|1310787|P2|Evaluable at Baseline|Overall Study||18
537608|NCT00797732|1310788|P1|Evaluable at Baseline|Overall Study||18
537609|NCT00797732|1310786|P3|STARTED|Overall Study||154
537610|NCT00797732|1310787|P2|STARTED|Overall Study||21
537611|NCT00797732|1310788|P1|STARTED|Overall Study||21
537612|NCT00797667|1310803|P3|NOT COMPLETED|Overall Study||127
537613|NCT00797667|1310804|P2|NOT COMPLETED|Overall Study||259
537614|NCT00797667|1310805|P1|NOT COMPLETED|Overall Study||260
537615|NCT00797667|1310803|P3|COMPLETED|Overall Study||4
537616|NCT00797667|1310804|P2|COMPLETED|Overall Study||5
537617|NCT00797667|1310805|P1|COMPLETED|Overall Study||5
537618|NCT00797667|1310803|P3|Treated|Overall Study||130
537619|NCT00797667|1310804|P2|Treated|Overall Study||263
537620|NCT00797667|1310805|P1|Treated|Overall Study||263
537621|NCT00797667|1310803|P3|STARTED|Overall Study||131
537622|NCT00797667|1310804|P2|STARTED|Overall Study||264
537623|NCT00797667|1310805|P1|STARTED|Overall Study||265
537624|NCT00797563|1310831|P1|NOT COMPLETED|Overall Study||1
537625|NCT00797563|1310831|P1|COMPLETED|Overall Study||101
537626|NCT00797563|1310831|P1|STARTED|Overall Study|number of subjects|102
537627|NCT00797511|1310837|P1|NOT COMPLETED|Overall Study||1
537628|NCT00797511|1310837|P1|COMPLETED|Overall Study||131
537629|NCT00797511|1310837|P1|STARTED|Overall Study||132
537630|NCT00797459|1310845|P1|NOT COMPLETED|Overall Study||0
537631|NCT00797459|1310845|P1|COMPLETED|Overall Study||60
537632|NCT00797459|1310845|P1|STARTED|Overall Study||60
537633|NCT00797316|1310855|P2|NOT COMPLETED|Overall Study||32
537634|NCT00797316|1310856|P1|NOT COMPLETED|Overall Study||23
537635|NCT00797316|1310855|P2|COMPLETED|Overall Study||233
537636|NCT00797316|1310856|P1|COMPLETED|Overall Study||244
537637|NCT00797316|1310855|P2|STARTED|Overall Study||265
537638|NCT00797316|1310856|P1|STARTED|Overall Study||267
537639|NCT00797277|1310872|P2|NOT COMPLETED|Overall Study||0
537640|NCT00797277|1310873|P1|NOT COMPLETED|Overall Study||0
537641|NCT00797277|1310872|P2|COMPLETED|Overall Study||30
537642|NCT00797277|1310873|P1|COMPLETED|Overall Study||37
537643|NCT00797277|1310872|P2|STARTED|Overall Study||30
537644|NCT00797277|1310873|P1|STARTED|Overall Study||37
537645|NCT00797212|1310881|P1|NOT COMPLETED|Overall Study||0
537646|NCT00797212|1310881|P1|COMPLETED|Overall Study||50
537647|NCT00797212|1310881|P1|STARTED|Overall Study||50
537648|NCT00797108|1310890|P3|NOT COMPLETED|Overall Study||6
537649|NCT00797108|1310891|P2|NOT COMPLETED|Overall Study||2
537650|NCT00797108|1310892|P1|NOT COMPLETED|Overall Study||4
537651|NCT00797108|1310890|P3|COMPLETED|Overall Study||6
537652|NCT00797108|1310891|P2|COMPLETED|Overall Study||9
537653|NCT00797108|1310892|P1|COMPLETED|Overall Study||8
537654|NCT00797108|1310890|P3|Treated|Overall Study||12
537655|NCT00797108|1310891|P2|Treated|Overall Study||11
537656|NCT00797108|1310892|P1|Treated|Overall Study||10
537657|NCT00797108|1310890|P3|STARTED|Overall Study||12
537658|NCT00797108|1310891|P2|STARTED|Overall Study||11
537659|NCT00797108|1310892|P1|STARTED|Overall Study||12
537660|NCT00796991|1310927|P3|NOT COMPLETED|Overall Study||14
537661|NCT00796991|1310928|P2|NOT COMPLETED|Overall Study||12
537662|NCT00796991|1310929|P1|NOT COMPLETED|Overall Study||15
537663|NCT00796991|1310927|P3|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|6
537664|NCT00796991|1310928|P2|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|7
537665|NCT00796991|1310929|P1|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|5
537666|NCT00796991|1310927|P3|STARTED|Overall Study||20
537667|NCT00796991|1310928|P2|STARTED|Overall Study||19
537668|NCT00796991|1310929|P1|STARTED|Overall Study||20
537669|NCT00796926|1311029|P2|NOT COMPLETED|Overall Study||0
537670|NCT00796926|1311030|P1|NOT COMPLETED|Overall Study||1
537671|NCT00796926|1311029|P2|COMPLETED|Overall Study||15
537672|NCT00796926|1311030|P1|COMPLETED|Overall Study||14
537673|NCT00796926|1311029|P2|STARTED|Overall Study||15
537674|NCT00796926|1311030|P1|STARTED|Overall Study||15
537675|NCT00796861|1311036|P1|NOT COMPLETED|Overall Study||4
537676|NCT00796861|1311036|P1|COMPLETED|Overall Study||0
537677|NCT00796861|1311036|P1|STARTED|Overall Study||4
537678|NCT00796822|1311042|P2|NOT COMPLETED|Overall Study||0
537679|NCT00796822|1311043|P1|NOT COMPLETED|Overall Study||3
537680|NCT00796822|1311042|P2|COMPLETED|Overall Study||13
537681|NCT00796822|1311043|P1|COMPLETED|Overall Study||10
537682|NCT00796822|1311042|P2|STARTED|Overall Study||13
537683|NCT00796822|1311043|P1|STARTED|Overall Study||13
537684|NCT00796757|1311051|P1|NOT COMPLETED|Overall Study||86
537685|NCT00796757|1311051|P1|COMPLETED|Overall Study||60
537686|NCT00796757|1311051|P1|STARTED|Overall Study||146
537687|NCT00796744|1311066|P3|NOT COMPLETED|Overall Study||1
537688|NCT00796744|1311067|P2|NOT COMPLETED|Overall Study||0
537689|NCT00796744|1311068|P1|NOT COMPLETED|Overall Study||0
537690|NCT00796744|1311066|P3|COMPLETED|Overall Study||27
537691|NCT00796744|1311067|P2|COMPLETED|Overall Study||26
537692|NCT00796744|1311068|P1|COMPLETED|Overall Study||24
537693|NCT00796744|1311066|P3|STARTED|Overall Study||28
537694|NCT00796744|1311067|P2|STARTED|Overall Study||26
537695|NCT00796744|1311068|P1|STARTED|Overall Study||24
537696|NCT00796718|1311085|P1|NOT COMPLETED|Overall Study||9
537697|NCT00796718|1311085|P1|COMPLETED|Overall Study||53
537698|NCT00796718|1311085|P1|STARTED|Overall Study||62
537699|NCT00796705|1311096|P4|NOT COMPLETED|Overall Study||0
537700|NCT00796705|1311097|P3|NOT COMPLETED|Overall Study||0
537701|NCT00796705|1311098|P2|NOT COMPLETED|Overall Study||0
537702|NCT00796705|1311099|P1|NOT COMPLETED|Overall Study||0
537703|NCT00796705|1311096|P4|COMPLETED|Overall Study||2
537704|NCT00796705|1311097|P3|COMPLETED|Overall Study||4
537705|NCT00796705|1311098|P2|COMPLETED|Overall Study||4
537706|NCT00796705|1311099|P1|COMPLETED|Overall Study||3
537707|NCT00796705|1311096|P4|STARTED|Overall Study||2
537708|NCT00796705|1311097|P3|STARTED|Overall Study||4
537709|NCT00796705|1311098|P2|STARTED|Overall Study||4
537710|NCT00796705|1311099|P1|STARTED|Overall Study||3
537711|NCT00796666|1311137|P2|NOT COMPLETED|Overall Study||64
537712|NCT00796666|1311138|P1|NOT COMPLETED|Overall Study||67
537713|NCT00796666|1311137|P2|COMPLETED|Overall Study||0
537714|NCT00796666|1311138|P1|COMPLETED|Overall Study||0
537715|NCT00796666|1311137|P2|Randomized and Not Treated|Overall Study||0
537716|NCT00796666|1311138|P1|Randomized and Not Treated|Overall Study||1
537717|NCT00796666|1311137|P2|Treated|Overall Study||64
537718|NCT00796666|1311138|P1|Treated|Overall Study||66
537719|NCT00796666|1311137|P2|STARTED|Overall Study||64
537720|NCT00796666|1311138|P1|STARTED|Overall Study||67
537721|NCT00796653|1311172|P4|NOT COMPLETED|Overall Study||40
537722|NCT00796653|1311173|P3|NOT COMPLETED|Overall Study||36
537723|NCT00796653|1311174|P2|NOT COMPLETED|Overall Study||37
537724|NCT00796653|1311175|P1|NOT COMPLETED|Overall Study||51
537725|NCT00796653|1311172|P4|COMPLETED|Overall Study||193
537726|NCT00796653|1311173|P3|COMPLETED|Overall Study||198
537727|NCT00796653|1311174|P2|COMPLETED|Overall Study||195
537728|NCT00796653|1311175|P1|COMPLETED|Overall Study||184
537729|NCT00796653|1311172|P4|STARTED|Overall Study||233
537730|NCT00796653|1311173|P3|STARTED|Overall Study||234
537731|NCT00796653|1311174|P2|STARTED|Overall Study||232
537732|NCT00796653|1311175|P1|STARTED|Overall Study||235
537733|NCT00796627|1311443|P2|NOT COMPLETED|Overall Study||0
537734|NCT00796627|1311444|P1|NOT COMPLETED|Overall Study||0
537735|NCT00796627|1311443|P2|COMPLETED|Overall Study||31
537736|NCT00796627|1311444|P1|COMPLETED|Overall Study||10
537737|NCT00796627|1311443|P2|STARTED|Overall Study||31
537738|NCT00796627|1311444|P1|STARTED|Overall Study||10
537739|NCT00796614|1311460|P4|NOT COMPLETED|Overall Study||1
537740|NCT00796614|1311461|P3|NOT COMPLETED|Overall Study||3
537741|NCT00796614|1311462|P2|NOT COMPLETED|Overall Study||4
537742|NCT00796614|1311463|P1|NOT COMPLETED|Overall Study||5
537743|NCT00796614|1311460|P4|COMPLETED|Overall Study||40
537744|NCT00796614|1311461|P3|COMPLETED|Overall Study||36
537745|NCT00796614|1311462|P2|COMPLETED|Overall Study||36
537746|NCT00796614|1311463|P1|COMPLETED|Overall Study||36
537747|NCT00796614|1311460|P4|Not Treated|Overall Study||0
537748|NCT00796614|1311461|P3|Not Treated|Overall Study||1
537749|NCT00796614|1311462|P2|Not Treated|Overall Study||0
537750|NCT00796614|1311463|P1|Not Treated|Overall Study||0
537751|NCT00796614|1311460|P4|STARTED|Overall Study||41
537752|NCT00796614|1311461|P3|STARTED|Overall Study||39
537753|NCT00796614|1311462|P2|STARTED|Overall Study||40
537754|NCT00796614|1311463|P1|STARTED|Overall Study||41
537755|NCT00796549|1311505|P1|NOT COMPLETED|Overall Study||218
537756|NCT00796549|1311505|P1|COMPLETED|Overall Study||0
537757|NCT00796549|1311505|P1|Entered|Overall Study|entered and treated|69
537758|NCT00796549|1311505|P1|STARTED|Overall Study|Excluding duplicate records for 5 patients who were screened twice|218
537759|NCT00796523|1311522|P2|NOT COMPLETED|Overall Study||7
537760|NCT00796523|1311523|P1|NOT COMPLETED|Overall Study||9
537761|NCT00796523|1311522|P2|COMPLETED|Overall Study||17
537762|NCT00796523|1311523|P1|COMPLETED|Overall Study||18
537763|NCT00796523|1311522|P2|STARTED|Overall Study||24
537764|NCT00796523|1311523|P1|STARTED|Overall Study||27
537765|NCT00796510|1311533|P2|NOT COMPLETED|Overall Study||0
537766|NCT00796510|1311534|P1|NOT COMPLETED|Overall Study||3
537767|NCT00796510|1311533|P2|COMPLETED|Overall Study||0
537768|NCT00796510|1311534|P1|COMPLETED|Overall Study||0
537769|NCT00796510|1311533|P2|STARTED|Overall Study||0
537770|NCT00796510|1311534|P1|STARTED|Overall Study||3
537771|NCT00796419|1311546|P2|NOT COMPLETED|Overall Study||1
537772|NCT00796419|1311547|P1|NOT COMPLETED|Overall Study||0
537773|NCT00796419|1311546|P2|COMPLETED|Overall Study||13
537774|NCT00796419|1311547|P1|COMPLETED|Overall Study||13
537775|NCT00796419|1311546|P2|STARTED|Overall Study||14
537776|NCT00796419|1311547|P1|STARTED|Overall Study||13
537777|NCT00796367|1311560|P3|NOT COMPLETED|Overall Study||47
537778|NCT00796367|1311561|P2|NOT COMPLETED|Overall Study||25
537779|NCT00796367|1311562|P1|NOT COMPLETED|Overall Study||30
537780|NCT00796367|1311560|P3|COMPLETED|Overall Study||248
537781|NCT00796367|1311561|P2|COMPLETED|Overall Study||129
537782|NCT00796367|1311562|P1|COMPLETED|Overall Study||197
537783|NCT00796367|1311560|P3|STARTED|Overall Study||295
537784|NCT00796367|1311561|P2|STARTED|Overall Study|one participant signed ICF but withdrew from study prior to first dosing in OB-305|154
537785|NCT00796367|1311562|P1|STARTED|Overall Study||227
537786|NCT00796328|1311573|P1|NOT COMPLETED|Overall Study||6
537787|NCT00796328|1311573|P1|COMPLETED|Overall Study||40
537788|NCT00796328|1311573|P1|STARTED|Overall Study||46
537789|NCT00796315|1311577|P3|NOT COMPLETED|Overall Study||0
537790|NCT00796315|1311578|P2|NOT COMPLETED|Overall Study||1
537791|NCT00796315|1311579|P1|NOT COMPLETED|Overall Study||0
537792|NCT00796315|1311577|P3|COMPLETED|Overall Study||15
537793|NCT00796315|1311578|P2|COMPLETED|Overall Study||16
537794|NCT00796315|1311579|P1|COMPLETED|Overall Study||9
537795|NCT00796315|1311577|P3|STARTED|Overall Study||15
537796|NCT00796315|1311578|P2|STARTED|Overall Study||17
537797|NCT00796315|1311579|P1|STARTED|Overall Study||9
537798|NCT00796302|1311592|P2|NOT COMPLETED|Overall Study||18
537799|NCT00796302|1311593|P1|NOT COMPLETED|Overall Study||13
537800|NCT00796302|1311592|P2|COMPLETED|Overall Study||66
537801|NCT00796302|1311593|P1|COMPLETED|Overall Study||71
537802|NCT00796302|1311592|P2|STARTED|Overall Study||84
537803|NCT00796302|1311593|P1|STARTED|Overall Study||84
537804|NCT00796224|1311607|P2|NOT COMPLETED|Overall Study||1
537805|NCT00796224|1311608|P1|NOT COMPLETED|Overall Study||1
537806|NCT00796224|1311607|P2|COMPLETED|Overall Study||18
537807|NCT00796224|1311608|P1|COMPLETED|Overall Study||18
537808|NCT00796224|1311607|P2|STARTED|Overall Study||19
537809|NCT00796224|1311608|P1|STARTED|Overall Study||19
537810|NCT00796120|1311628|P2|NOT COMPLETED|Overall Study||60
537811|NCT00796120|1311629|P1|NOT COMPLETED|Overall Study||61
537812|NCT00796120|1311628|P2|COMPLETED|Overall Study||0
537813|NCT00796120|1311629|P1|COMPLETED|Overall Study||0
537814|NCT00796120|1311628|P2|Treated|Overall Study||57
537815|NCT00796120|1311629|P1|Treated|Overall Study||61
537816|NCT00796120|1311628|P2|STARTED|Overall Study||60
537817|NCT00796120|1311629|P1|STARTED|Overall Study||61
537818|NCT00796003|1311645|P2|NOT COMPLETED|Overall Study||29
537819|NCT00796003|1311646|P1|NOT COMPLETED|Overall Study||3
537820|NCT00796003|1311645|P2|COMPLETED|Overall Study|Includes 2 participants from Phase I (20 mg/m2) group|7
537821|NCT00796003|1311646|P1|COMPLETED|Overall Study||0
537822|NCT00796003|1311645|P2|Treated|Overall Study|Number of participants treated|34
537823|NCT00796003|1311646|P1|Treated|Overall Study|Number of participants treated|3
537824|NCT00796003|1311645|P2|STARTED|Overall Study|Number of participants enrolled. Includes 6 participants from Phase I (20 mg/m2) group|36
537825|NCT00796003|1311646|P1|STARTED|Overall Study|Number of participants enrolled|3
537826|NCT00795951|1311667|P1|NOT COMPLETED|Overall Study||2
537827|NCT00795951|1311667|P1|COMPLETED|Overall Study||100
537828|NCT00795951|1311667|P1|STARTED|Overall Study||102
537829|NCT00795886|1311704|P1|NOT COMPLETED|Overall Study||10
537830|NCT00795886|1311704|P1|COMPLETED|Overall Study||53
537831|NCT00795886|1311704|P1|STARTED|Overall Study||63
537832|NCT00795821|1311712|P2|NOT COMPLETED|Taper Phase||0
537833|NCT00795821|1311713|P1|NOT COMPLETED|Taper Phase||9
537834|NCT00795821|1311712|P2|COMPLETED|Taper Phase|N=6 participants completed only Acute Taper Phase; N=0 participants entered Extension Taper Phase.|6
537835|NCT00795821|1311713|P1|COMPLETED|Taper Phase|N=231 participants completed Taper Phases: N=3 from Acute Phase; N=228 from Extension Phase.|231
537836|NCT00795821|1311712|P2|STARTED|Taper Phase|N=6 participants entered only Acute Taper Phase.|6
537837|NCT00795821|1311713|P1|STARTED|Taper Phase|N=240 participants entered Taper Phases: N=4 from Acute Phase; N=236 from Extension Phase.|240
537838|NCT00795821|1311712|P2|NOT COMPLETED|Long-term Extension Phase||92
537839|NCT00795821|1311713|P1|NOT COMPLETED|Long-term Extension Phase||90
537840|NCT00795821|1311712|P2|COMPLETED|Long-term Extension Phase||115
537841|NCT00795821|1311713|P1|COMPLETED|Long-term Extension Phase||100
537842|NCT00795821|1311712|P2|STARTED|Long-term Extension Phase|All placebo-treated participants received LY2216684 in the Long-term Extension Phase.|207
537843|NCT00795821|1311713|P1|STARTED|Long-term Extension Phase||190
537844|NCT00795821|1311712|P2|NOT COMPLETED|Acute Treatment Phase||31
537845|NCT00795821|1311713|P1|NOT COMPLETED|Acute Treatment Phase||56
537846|NCT00795821|1311712|P2|COMPLETED|Acute Treatment Phase|7 placebo-treated participants in the Acute Phase chose not to enter the Long-term Extension Phase.|214
537847|NCT00795821|1311713|P1|COMPLETED|Acute Treatment Phase|4 LY-treated participants in the Acute Phase chose not to enter the Long-term Extension Phase.|194
537848|NCT00795821|1311712|P2|STARTED|Acute Treatment Phase||245
537849|NCT00795821|1311713|P1|STARTED|Acute Treatment Phase||250
537850|NCT00795769|1311782|P1|NOT COMPLETED|Overall Study||0
537851|NCT00795769|1311782|P1|COMPLETED|Overall Study||49
537852|NCT00795769|1311782|P1|STARTED|Overall Study||49
537853|NCT00795717|1311788|P2|NOT COMPLETED|Phase II||1
537854|NCT00795717|1311789|P1|NOT COMPLETED|Phase II||0
537855|NCT00795717|1311788|P2|COMPLETED|Phase II||18
537856|NCT00795717|1311789|P1|COMPLETED|Phase II||18
537857|NCT00795717|1311788|P2|STARTED|Phase II||19
537858|NCT00795717|1311789|P1|STARTED|Phase II||18
537859|NCT00795717|1311788|P2|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2
537860|NCT00795717|1311789|P1|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2
537861|NCT00795717|1311788|P2|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||19
537862|NCT00795717|1311789|P1|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||18
537863|NCT00795717|1311788|P2|STARTED|Phase I Followed by Wash Out x 4 Weeks|Randomized to placebo first|21
537864|NCT00795717|1311789|P1|STARTED|Phase I Followed by Wash Out x 4 Weeks|Randomized to treatment first|20
537865|NCT00795704|1311801|P2|NOT COMPLETED|Overall Study||3
537866|NCT00795704|1311802|P1|NOT COMPLETED|Overall Study||4
537867|NCT00795704|1311801|P2|COMPLETED|Overall Study||9
537868|NCT00795704|1311802|P1|COMPLETED|Overall Study||8
537869|NCT00795704|1311801|P2|STARTED|Overall Study||12
537870|NCT00795704|1311802|P1|STARTED|Overall Study||12
537871|NCT00795639|1311814|P2|NOT COMPLETED|Overall Study||26
537872|NCT00795639|1311815|P1|NOT COMPLETED|Overall Study||21
537873|NCT00795639|1311814|P2|COMPLETED|Overall Study||66
537874|NCT00795639|1311815|P1|COMPLETED|Overall Study||70
537875|NCT00795639|1311814|P2|Randomized and Not Treated|Overall Study||1
537876|NCT00795639|1311815|P1|Randomized and Not Treated|Overall Study||0
537877|NCT00795639|1311814|P2|STARTED|Overall Study||92
537878|NCT00795639|1311815|P1|STARTED|Overall Study||91
537879|NCT00795600|1311827|P2|NOT COMPLETED|Overall Study||4
537880|NCT00795600|1311828|P1|NOT COMPLETED|Overall Study||4
537881|NCT00795600|1311827|P2|COMPLETED|Overall Study||31
537882|NCT00795600|1311828|P1|COMPLETED|Overall Study||21
537883|NCT00795600|1311827|P2|Exposed to Drug|Overall Study||35
537884|NCT00795600|1311828|P1|Exposed to Drug|Overall Study|1 patient did not take study medication because the patient withdrew consent|24
537885|NCT00795600|1311827|P2|STARTED|Overall Study||35
537886|NCT00795600|1311828|P1|STARTED|Overall Study||25
537887|NCT00795535|1311948|P1|NOT COMPLETED|Overall Study||20
537888|NCT00795535|1311948|P1|COMPLETED|Overall Study||75
537889|NCT00795535|1311948|P1|STARTED|Overall Study||95
537890|NCT00795509|1311955|P1|NOT COMPLETED|Overall Study||31
537891|NCT00795509|1311955|P1|COMPLETED|Overall Study||343
537892|NCT00795509|1311955|P1|STARTED|Overall Study||374
537893|NCT00795366|1311962|P2|NOT COMPLETED|Overall Study||0
537894|NCT00795366|1311963|P1|NOT COMPLETED|Overall Study||0
537895|NCT00795366|1311962|P2|COMPLETED|Overall Study||54
537896|NCT00795366|1311963|P1|COMPLETED|Overall Study||42
537897|NCT00795366|1311962|P2|STARTED|Overall Study||54
537898|NCT00795366|1311963|P1|STARTED|Overall Study||42
537899|NCT00795340|1311971|P2|NOT COMPLETED|Overall Study||0
537900|NCT00795340|1311972|P1|NOT COMPLETED|Overall Study||7
537901|NCT00795340|1311971|P2|COMPLETED|Overall Study||153
537902|NCT00795340|1311972|P1|COMPLETED|Overall Study||146
537903|NCT00795340|1311971|P2|STARTED|Overall Study||153
537904|NCT00795340|1311972|P1|STARTED|Overall Study||153
537905|NCT00795288|1311984|P2|NOT COMPLETED|Overall Study||0
537906|NCT00795288|1311985|P1|NOT COMPLETED|Overall Study||0
537907|NCT00795288|1311984|P2|COMPLETED|Overall Study||21
537908|NCT00795288|1311985|P1|COMPLETED|Overall Study||21
537909|NCT00795288|1311984|P2|STARTED|Overall Study||21
537910|NCT00795288|1311985|P1|STARTED|Overall Study||21
537911|NCT00795210|1311998|P3|NOT COMPLETED|Overall Study||2
537912|NCT00795210|1311999|P2|NOT COMPLETED|Overall Study||1
537913|NCT00795210|1312000|P1|NOT COMPLETED|Overall Study||0
537914|NCT00795210|1311998|P3|COMPLETED|Overall Study||3
537915|NCT00795210|1311999|P2|COMPLETED|Overall Study||11
537916|NCT00795210|1312000|P1|COMPLETED|Overall Study||8
537917|NCT00795210|1311998|P3|STARTED|Overall Study||5
537918|NCT00795210|1311999|P2|STARTED|Overall Study||12
537919|NCT00795210|1312000|P1|STARTED|Overall Study||8
537920|NCT00795184|1312011|P2|NOT COMPLETED|Overall Study||13
537921|NCT00795184|1312012|P1|NOT COMPLETED|Overall Study||8
537922|NCT00795184|1312011|P2|COMPLETED|Overall Study|44 patients analysable, completed all 3 imaging procedures|44
537923|NCT00795184|1312012|P1|COMPLETED|Overall Study|57 patients analysable, completed all 3 imaging procedures|57
537924|NCT00795184|1312011|P2|STARTED|Overall Study||57
537925|NCT00795184|1312012|P1|STARTED|Overall Study||65
537926|NCT00795145|1312023|P7|NOT COMPLETED|Cohort 2||0
537927|NCT00795145|1312024|P6|NOT COMPLETED|Cohort 2||0
537928|NCT00795145|1312025|P5|NOT COMPLETED|Cohort 2||0
537929|NCT00795145|1312026|P4|NOT COMPLETED|Cohort 2||0
537930|NCT00795145|1312027|P3|NOT COMPLETED|Cohort 2||0
537931|NCT00795145|1312028|P2|NOT COMPLETED|Cohort 2||0
537932|NCT00795145|1312029|P1|NOT COMPLETED|Cohort 2||0
537933|NCT00795145|1312023|P7|COMPLETED|Cohort 2||10
537934|NCT00795145|1312024|P6|COMPLETED|Cohort 2||10
537935|NCT00795145|1312025|P5|COMPLETED|Cohort 2||10
537936|NCT00795145|1312026|P4|COMPLETED|Cohort 2||10
537937|NCT00795145|1312027|P3|COMPLETED|Cohort 2||0
537938|NCT00795145|1312028|P2|COMPLETED|Cohort 2||0
537939|NCT00795145|1312029|P1|COMPLETED|Cohort 2||0
537940|NCT00795145|1312023|P7|STARTED|Cohort 2||10
537941|NCT00795145|1312024|P6|STARTED|Cohort 2||10
537942|NCT00795145|1312025|P5|STARTED|Cohort 2||10
537943|NCT00795145|1312026|P4|STARTED|Cohort 2||10
537944|NCT00795145|1312027|P3|STARTED|Cohort 2||0
537945|NCT00795145|1312028|P2|STARTED|Cohort 2||0
537946|NCT00795145|1312029|P1|STARTED|Cohort 2||0
537947|NCT00795145|1312023|P7|NOT COMPLETED|Cohort 1||0
537948|NCT00795145|1312024|P6|NOT COMPLETED|Cohort 1||0
537949|NCT00795145|1312025|P5|NOT COMPLETED|Cohort 1||0
537950|NCT00795145|1312026|P4|NOT COMPLETED|Cohort 1||0
537951|NCT00795145|1312027|P3|NOT COMPLETED|Cohort 1||0
537952|NCT00795145|1312028|P2|NOT COMPLETED|Cohort 1||0
537953|NCT00795145|1312029|P1|NOT COMPLETED|Cohort 1||0
537954|NCT00795145|1312023|P7|COMPLETED|Cohort 1||0
537955|NCT00795145|1312024|P6|COMPLETED|Cohort 1||0
537956|NCT00795145|1312025|P5|COMPLETED|Cohort 1||0
537957|NCT00795145|1312026|P4|COMPLETED|Cohort 1||0
537958|NCT00795145|1312027|P3|COMPLETED|Cohort 1||3
537959|NCT00795145|1312028|P2|COMPLETED|Cohort 1||3
537960|NCT00795145|1312029|P1|COMPLETED|Cohort 1||3
537961|NCT00795145|1312023|P7|STARTED|Cohort 1||0
537962|NCT00795145|1312024|P6|STARTED|Cohort 1||0
537963|NCT00795145|1312025|P5|STARTED|Cohort 1||0
537964|NCT00795145|1312026|P4|STARTED|Cohort 1||0
537965|NCT00795145|1312027|P3|STARTED|Cohort 1||3
537966|NCT00795145|1312028|P2|STARTED|Cohort 1||3
537967|NCT00795145|1312029|P1|STARTED|Cohort 1||3
537968|NCT00795132|1312073|P1|NOT COMPLETED|Overall Study||3
537969|NCT00795132|1312073|P1|COMPLETED|Overall Study||44
537970|NCT00795132|1312073|P1|STARTED|Overall Study||47
537971|NCT00795002|1312087|P2|NOT COMPLETED|Overall Study||2
537972|NCT00795002|1312088|P1|NOT COMPLETED|Overall Study||2
537973|NCT00795002|1312087|P2|COMPLETED|Overall Study||37
537974|NCT00795002|1312088|P1|COMPLETED|Overall Study||37
537975|NCT00795002|1312087|P2|STARTED|Overall Study||39
537976|NCT00795002|1312088|P1|STARTED|Overall Study||39
537977|NCT00794963|1312096|P2|NOT COMPLETED|Overall Study||4
537978|NCT00794963|1312097|P1|NOT COMPLETED|Overall Study||1
537979|NCT00794963|1312096|P2|COMPLETED|Overall Study||0
537980|NCT00794963|1312097|P1|COMPLETED|Overall Study||3
537981|NCT00794963|1312096|P2|STARTED|Overall Study||4
537982|NCT00794963|1312097|P1|STARTED|Overall Study||4
537983|NCT00794924|1312105|P2|NOT COMPLETED|Overall Study||70
537984|NCT00794924|1312106|P1|NOT COMPLETED|Overall Study||60
537985|NCT00794924|1312105|P2|COMPLETED|Overall Study||101
537986|NCT00794924|1312106|P1|COMPLETED|Overall Study||114
537987|NCT00794924|1312105|P2|STARTED|Overall Study|14 patients refused to start the study|171
537988|NCT00794924|1312106|P1|STARTED|Overall Study|14 patients refused to start the study|174
537989|NCT00794820|1312110|P1|NOT COMPLETED|Overall Study||16
537990|NCT00794820|1312110|P1|COMPLETED|Overall Study||50
537991|NCT00794820|1312110|P1|STARTED|Overall Study||66
537992|NCT00794677|1312118|P2|NOT COMPLETED|Second Intervention||0
537993|NCT00794677|1312119|P1|NOT COMPLETED|Second Intervention||0
537994|NCT00794677|1312118|P2|COMPLETED|Second Intervention||13
537995|NCT00794677|1312119|P1|COMPLETED|Second Intervention||11
537996|NCT00794677|1312118|P2|STARTED|Second Intervention||13
537997|NCT00794677|1312119|P1|STARTED|Second Intervention||11
537998|NCT00794677|1312118|P2|NOT COMPLETED|First Intervention||0
537999|NCT00794677|1312119|P1|NOT COMPLETED|First Intervention||2
538000|NCT00794677|1312118|P2|COMPLETED|First Intervention||13
538001|NCT00794677|1312119|P1|COMPLETED|First Intervention||11
538002|NCT00794677|1312118|P2|STARTED|First Intervention||13
538003|NCT00794677|1312119|P1|STARTED|First Intervention||13
538004|NCT00794664|1312141|P2|NOT COMPLETED|Follow-up Period||5
538005|NCT00794664|1312142|P1|NOT COMPLETED|Follow-up Period||1
538006|NCT00794664|1312141|P2|COMPLETED|Follow-up Period||28
538007|NCT00794664|1312142|P1|COMPLETED|Follow-up Period||15
538008|NCT00794664|1312141|P2|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|33
538009|NCT00794664|1312142|P1|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|16
538010|NCT00794664|1312141|P2|NOT COMPLETED|Treatment Period||12
538011|NCT00794664|1312142|P1|NOT COMPLETED|Treatment Period||1
538012|NCT00794664|1312141|P2|COMPLETED|Treatment Period|6 participants enrolled in open-label extension study NCT00694109|27
538013|NCT00794664|1312142|P1|COMPLETED|Treatment Period|3 participants enrolled in open-label extension study NCT00694109|18
538014|NCT00794664|1312141|P2|STARTED|Treatment Period||39
538015|NCT00794664|1312142|P1|STARTED|Treatment Period||19
538016|NCT00794560|1312190|P4|NOT COMPLETED|Overall Study||4
538017|NCT00794560|1312191|P3|NOT COMPLETED|Overall Study||4
538018|NCT00794560|1312192|P2|NOT COMPLETED|Overall Study||4
538019|NCT00794560|1312193|P1|NOT COMPLETED|Overall Study||3
538020|NCT00794560|1312190|P4|COMPLETED|Overall Study||34
538021|NCT00794560|1312191|P3|COMPLETED|Overall Study||40
538022|NCT00794560|1312192|P2|COMPLETED|Overall Study||32
538023|NCT00794560|1312193|P1|COMPLETED|Overall Study||33
538024|NCT00794560|1312190|P4|STARTED|Overall Study||38
538025|NCT00794560|1312191|P3|STARTED|Overall Study||44
538026|NCT00794560|1312192|P2|STARTED|Overall Study||36
538027|NCT00794560|1312193|P1|STARTED|Overall Study||36
538028|NCT00794547|1312207|P2|NOT COMPLETED|Overall Study||0
538029|NCT00794547|1312208|P1|NOT COMPLETED|Overall Study||0
538030|NCT00794547|1312207|P2|COMPLETED|Overall Study||16
538031|NCT00794547|1312208|P1|COMPLETED|Overall Study||18
538032|NCT00794547|1312207|P2|STARTED|Overall Study||16
538033|NCT00794547|1312208|P1|STARTED|Overall Study||18
538034|NCT00794508|1312216|P1|NOT COMPLETED|Overall Study||0
538035|NCT00794508|1312216|P1|COMPLETED|Overall Study||10
538036|NCT00794508|1312216|P1|STARTED|Overall Study||10
538037|NCT00794469|1312222|P1|NOT COMPLETED|Overall Study||0
538038|NCT00794469|1312222|P1|COMPLETED|Overall Study||21
538039|NCT00794469|1312222|P1|STARTED|Overall Study||21
538040|NCT00794365|1312227|P1|NOT COMPLETED|Overall Study||79
538041|NCT00794365|1312227|P1|COMPLETED|Overall Study||251
538042|NCT00794365|1312227|P1|STARTED|Overall Study||330
538043|NCT00794313|1312233|P3|NOT COMPLETED|Overall Study||0
538044|NCT00794313|1312234|P2|NOT COMPLETED|Overall Study||0
538045|NCT00794313|1312235|P1|NOT COMPLETED|Overall Study||0
538046|NCT00794313|1312233|P3|COMPLETED|Overall Study||1
538047|NCT00794313|1312234|P2|COMPLETED|Overall Study||1
538048|NCT00794313|1312235|P1|COMPLETED|Overall Study||1
538049|NCT00794313|1312233|P3|STARTED|Overall Study||1
538050|NCT00794313|1312234|P2|STARTED|Overall Study||1
538051|NCT00794313|1312235|P1|STARTED|Overall Study||1
538052|NCT00794196|1312248|P2|NOT COMPLETED|Overall Study||23
538053|NCT00794196|1312249|P1|NOT COMPLETED|Overall Study||5
538054|NCT00794196|1312248|P2|COMPLETED|Overall Study||64
538055|NCT00794196|1312249|P1|COMPLETED|Overall Study||87
538056|NCT00794196|1312248|P2|STARTED|Overall Study||87
538057|NCT00794196|1312249|P1|STARTED|Overall Study||92
538058|NCT00794170|1312259|P2|NOT COMPLETED|Overall Study||3
538059|NCT00794170|1312260|P1|NOT COMPLETED|Overall Study||7
538060|NCT00794170|1312259|P2|COMPLETED|Overall Study||152
538061|NCT00794170|1312260|P1|COMPLETED|Overall Study||150
538062|NCT00794170|1312259|P2|STARTED|Overall Study||155
538063|NCT00794170|1312260|P1|STARTED|Overall Study||157
538064|NCT00794157|1312269|P3|NOT COMPLETED|Overall Study||19
538065|NCT00794157|1312270|P2|NOT COMPLETED|Overall Study||10
538066|NCT00794157|1312271|P1|NOT COMPLETED|Overall Study||10
538067|NCT00794157|1312269|P3|COMPLETED|Overall Study||98
538068|NCT00794157|1312270|P2|COMPLETED|Overall Study||106
538069|NCT00794157|1312271|P1|COMPLETED|Overall Study||104
538070|NCT00794157|1312269|P3|STARTED|Overall Study||117
538071|NCT00794157|1312270|P2|STARTED|Overall Study||116
538072|NCT00794157|1312271|P1|STARTED|Overall Study||114
538073|NCT00794144|1312293|P2|NOT COMPLETED|Overall Study||3
538074|NCT00794144|1312294|P1|NOT COMPLETED|Overall Study||3
538075|NCT00794144|1312293|P2|COMPLETED|Overall Study||63
538076|NCT00794144|1312294|P1|COMPLETED|Overall Study||63
538077|NCT00794144|1312293|P2|STARTED|Overall Study||66
538078|NCT00794144|1312294|P1|STARTED|Overall Study||66
538079|NCT00794118|1312300|P1|NOT COMPLETED|Overall Study||27
538080|NCT00794118|1312300|P1|COMPLETED|Overall Study||272
538081|NCT00794118|1312300|P1|STARTED|Overall Study||299
538082|NCT00793910|1312358|P2|NOT COMPLETED|Overall Study||7
538083|NCT00793910|1312359|P1|NOT COMPLETED|Overall Study||5
538084|NCT00793910|1312358|P2|COMPLETED|Overall Study||46
538085|NCT00793910|1312359|P1|COMPLETED|Overall Study||48
538086|NCT00793910|1312358|P2|STARTED|Overall Study||53
538087|NCT00793910|1312359|P1|STARTED|Overall Study||53
538088|NCT00793871|1312373|P1|NOT COMPLETED|Overall Study||60
538089|NCT00793871|1312373|P1|COMPLETED|Overall Study||0
538090|NCT00793871|1312373|P1|Received Treatment|Overall Study||59
538091|NCT00793871|1312373|P1|STARTED|Overall Study||60
538092|NCT00793819|1312387|P2|NOT COMPLETED|Overall Study||9
538093|NCT00793819|1312388|P1|NOT COMPLETED|Overall Study||14
538094|NCT00793819|1312387|P2|COMPLETED|Overall Study||89
538095|NCT00793819|1312388|P1|COMPLETED|Overall Study||97
538096|NCT00793819|1312387|P2|STARTED|Overall Study||98
538097|NCT00793819|1312388|P1|STARTED|Overall Study||111
538098|NCT00793793|1312406|P12|NOT COMPLETED|Overall Study||6
538099|NCT00793793|1312407|P11|NOT COMPLETED|Overall Study||3
538100|NCT00793793|1312408|P10|NOT COMPLETED|Overall Study||9
538101|NCT00793793|1312409|P9|NOT COMPLETED|Overall Study||9
538102|NCT00793793|1312410|P8|NOT COMPLETED|Overall Study||0
538103|NCT00793793|1312411|P7|NOT COMPLETED|Overall Study||4
538104|NCT00793793|1312412|P6|NOT COMPLETED|Overall Study||2
538105|NCT00793793|1312413|P5|NOT COMPLETED|Overall Study||2
538106|NCT00793793|1312414|P4|NOT COMPLETED|Overall Study||3
538107|NCT00793793|1312415|P3|NOT COMPLETED|Overall Study||2
538108|NCT00793793|1312416|P2|NOT COMPLETED|Overall Study||1
538109|NCT00793793|1312417|P1|NOT COMPLETED|Overall Study||0
538110|NCT00793793|1312406|P12|COMPLETED|Overall Study||1
538111|NCT00793793|1312407|P11|COMPLETED|Overall Study||3
538112|NCT00793793|1312408|P10|COMPLETED|Overall Study||6
538113|NCT00793793|1312409|P9|COMPLETED|Overall Study||6
538114|NCT00793793|1312410|P8|COMPLETED|Overall Study||6
538115|NCT00793793|1312411|P7|COMPLETED|Overall Study||3
538116|NCT00793793|1312412|P6|COMPLETED|Overall Study||4
538117|NCT00793793|1312413|P5|COMPLETED|Overall Study||4
538118|NCT00793793|1312414|P4|COMPLETED|Overall Study||4
538119|NCT00793793|1312415|P3|COMPLETED|Overall Study||5
538120|NCT00793793|1312416|P2|COMPLETED|Overall Study||5
538121|NCT00793793|1312417|P1|COMPLETED|Overall Study||8
538122|NCT00793793|1312406|P12|STARTED|Overall Study||7
538123|NCT00793793|1312407|P11|STARTED|Overall Study||6
538124|NCT00793793|1312408|P10|STARTED|Overall Study||15
538125|NCT00793793|1312409|P9|STARTED|Overall Study||15
538126|NCT00793793|1312410|P8|STARTED|Overall Study||6
538127|NCT00793793|1312411|P7|STARTED|Overall Study||7
538128|NCT00793793|1312412|P6|STARTED|Overall Study||6
538129|NCT00793793|1312413|P5|STARTED|Overall Study||6
538130|NCT00793793|1312414|P4|STARTED|Overall Study||7
538131|NCT00793793|1312415|P3|STARTED|Overall Study||7
538132|NCT00793793|1312416|P2|STARTED|Overall Study||6
538133|NCT00793793|1312417|P1|STARTED|Overall Study||8
538134|NCT00793780|1312792|P2|NOT COMPLETED|Overall Study||1
538135|NCT00793780|1312793|P1|NOT COMPLETED|Overall Study||2
538136|NCT00793780|1312792|P2|COMPLETED|Overall Study||11
538137|NCT00793780|1312793|P1|COMPLETED|Overall Study||10
538138|NCT00793780|1312792|P2|Collected Baseline Data|Overall Study||12
538139|NCT00793780|1312793|P1|Collected Baseline Data|Overall Study||11
538140|NCT00793780|1312792|P2|Randomization|Overall Study||12
538141|NCT00793780|1312793|P1|Randomization|Overall Study||12
538142|NCT00793780|1312792|P2|STARTED|Overall Study||12
538143|NCT00793780|1312793|P1|STARTED|Overall Study||12
538144|NCT00793650|1312811|P2|NOT COMPLETED|Overall Study||0
538145|NCT00793650|1312812|P1|NOT COMPLETED|Overall Study||0
538146|NCT00793650|1312811|P2|COMPLETED|Overall Study||20
538147|NCT00793650|1312812|P1|COMPLETED|Overall Study||19
538148|NCT00793650|1312811|P2|STARTED|Overall Study||20
538149|NCT00793650|1312812|P1|STARTED|Overall Study||19
538150|NCT00793624|1312824|P4|NOT COMPLETED|Overall Study||43
538151|NCT00793624|1312825|P3|NOT COMPLETED|Overall Study||39
538152|NCT00793624|1312826|P2|NOT COMPLETED|Overall Study||36
538153|NCT00793624|1312827|P1|NOT COMPLETED|Overall Study||57
538154|NCT00793624|1312824|P4|COMPLETED|Overall Study||184
538155|NCT00793624|1312825|P3|COMPLETED|Overall Study||186
538156|NCT00793624|1312826|P2|COMPLETED|Overall Study||191
538157|NCT00793624|1312827|P1|COMPLETED|Overall Study||168
538158|NCT00793624|1312824|P4|STARTED|Overall Study||227
538159|NCT00793624|1312825|P3|STARTED|Overall Study||225
538160|NCT00793624|1312826|P2|STARTED|Overall Study||227
538161|NCT00793624|1312827|P1|STARTED|Overall Study||225
538162|NCT00793611|1313095|P2|NOT COMPLETED|Overall Study||0
538163|NCT00793611|1313096|P1|NOT COMPLETED|Overall Study||0
538164|NCT00793611|1313095|P2|COMPLETED|Overall Study||10
538165|NCT00793611|1313096|P1|COMPLETED|Overall Study||10
538166|NCT00793611|1313095|P2|STARTED|Overall Study||10
538167|NCT00793611|1313096|P1|STARTED|Overall Study||10
538168|NCT00793585|1313108|P2|NOT COMPLETED|Overall Study||3
538169|NCT00793585|1313109|P1|NOT COMPLETED|Overall Study||2
538170|NCT00793585|1313108|P2|COMPLETED|Overall Study||18
538171|NCT00793585|1313109|P1|COMPLETED|Overall Study||17
538172|NCT00793585|1313108|P2|STARTED|Overall Study||21
538173|NCT00793585|1313109|P1|STARTED|Overall Study||19
538174|NCT00793572|1313117|P1|NOT COMPLETED|Overall Study||0
538175|NCT00793572|1313117|P1|COMPLETED|Overall Study||32
538176|NCT00793572|1313117|P1|STARTED|Overall Study||32
538177|NCT00793546|1313128|P2|NOT COMPLETED|Overall Study||28
538178|NCT00793546|1313129|P1|NOT COMPLETED|Overall Study||14
538179|NCT00793546|1313128|P2|COMPLETED|Overall Study||0
538180|NCT00793546|1313129|P1|COMPLETED|Overall Study||0
538181|NCT00793546|1313128|P2|STARTED|Overall Study||28
538182|NCT00793546|1313129|P1|STARTED|Overall Study||14
538183|NCT00793520|1313159|P2|NOT COMPLETED|Placebo Crossover to Milnacipran||1
538184|NCT00793520|1313160|P1|NOT COMPLETED|Placebo Crossover to Milnacipran||0
538185|NCT00793520|1313159|P2|COMPLETED|Placebo Crossover to Milnacipran||0
538186|NCT00793520|1313160|P1|COMPLETED|Placebo Crossover to Milnacipran||0
538187|NCT00793520|1313159|P2|STARTED|Placebo Crossover to Milnacipran||1
538188|NCT00793520|1313160|P1|STARTED|Placebo Crossover to Milnacipran||0
538189|NCT00793520|1313159|P2|NOT COMPLETED|Milnacipran Crossover to Placebo||0
538190|NCT00793520|1313160|P1|NOT COMPLETED|Milnacipran Crossover to Placebo||1
538191|NCT00793520|1313159|P2|COMPLETED|Milnacipran Crossover to Placebo||0
538192|NCT00793520|1313160|P1|COMPLETED|Milnacipran Crossover to Placebo||0
538193|NCT00793520|1313159|P2|STARTED|Milnacipran Crossover to Placebo||0
538194|NCT00793520|1313160|P1|STARTED|Milnacipran Crossover to Placebo||1
538195|NCT00793455|1313170|P2|NOT COMPLETED|Overall Study||0
538196|NCT00793455|1313171|P1|NOT COMPLETED|Overall Study||0
538197|NCT00793455|1313170|P2|COMPLETED|Overall Study||314
538198|NCT00793455|1313171|P1|COMPLETED|Overall Study||314
538199|NCT00793455|1313170|P2|STARTED|Overall Study||314
538200|NCT00793455|1313171|P1|STARTED|Overall Study||314
538201|NCT00793403|1313179|P1|NOT COMPLETED|Overall Study||73
538202|NCT00793403|1313179|P1|COMPLETED|Overall Study||220
538203|NCT00793403|1313179|P1|STARTED|Overall Study||293
538204|NCT00793325|1313226|P1|NOT COMPLETED|Overall Study||19
538205|NCT00793325|1313226|P1|COMPLETED|Overall Study||890
538206|NCT00793325|1313226|P1|STARTED|Overall Study||909
538207|NCT00793182|1313250|P1|NOT COMPLETED|Overall Study||1
538208|NCT00793182|1313250|P1|COMPLETED|Overall Study||5
538209|NCT00793182|1313250|P1|STARTED|Overall Study||6
538210|NCT00793169|1313254|P1|NOT COMPLETED|Overall Study||0
538211|NCT00793169|1313254|P1|COMPLETED|Overall Study||19
538212|NCT00793169|1313254|P1|STARTED|Overall Study||19
538213|NCT00793104|1313258|P1|NOT COMPLETED|Overall Study||1
538214|NCT00793104|1313258|P1|COMPLETED|Overall Study||9
538215|NCT00793104|1313258|P1|STARTED|Overall Study||10
538216|NCT00792948|1313266|P1|NOT COMPLETED|Overall Study||28
538217|NCT00792948|1313266|P1|COMPLETED|Overall Study|Patients who completed induction/consolidation step|69
538218|NCT00792948|1313266|P1|STARTED|Overall Study|Patients registered to induction/consolidation step|97
538219|NCT00792935|1313277|P2|NOT COMPLETED|Overall Study||3
538220|NCT00792935|1313278|P1|NOT COMPLETED|Overall Study||4
538221|NCT00792935|1313277|P2|COMPLETED|Overall Study||68
538222|NCT00792935|1313278|P1|COMPLETED|Overall Study||68
538223|NCT00792935|1313277|P2|STARTED|Overall Study||71
538224|NCT00792935|1313278|P1|STARTED|Overall Study||72
538225|NCT00792922|1313290|P4|NOT COMPLETED|At 3 Years||0
538226|NCT00792922|1313291|P3|NOT COMPLETED|At 3 Years||0
538227|NCT00792922|1313292|P2|NOT COMPLETED|At 3 Years||0
538228|NCT00792922|1313293|P1|NOT COMPLETED|At 3 Years||0
538229|NCT00792922|1313290|P4|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
538230|NCT00792922|1313291|P3|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
538231|NCT00792922|1313292|P2|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
538232|NCT00792922|1313293|P1|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
538233|NCT00792922|1313290|P4|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
538234|NCT00792922|1313291|P3|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
538235|NCT00792922|1313292|P2|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
538236|NCT00792922|1313293|P1|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
538237|NCT00792922|1313290|P4|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
538238|NCT00792922|1313291|P3|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
538239|NCT00792922|1313292|P2|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
538240|NCT00792922|1313293|P1|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
538241|NCT00792922|1313290|P4|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
538242|NCT00792922|1313291|P3|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
538243|NCT00792922|1313292|P2|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
538244|NCT00792922|1313293|P1|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
538245|NCT00792922|1313290|P4|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|0
538246|NCT00792922|1313291|P3|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|0
538247|NCT00792922|1313292|P2|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|0
538248|NCT00792922|1313293|P1|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|0
538249|NCT00792922|1313290|P4|NOT COMPLETED|At Baseline||0
538250|NCT00792922|1313291|P3|NOT COMPLETED|At Baseline||0
538251|NCT00792922|1313292|P2|NOT COMPLETED|At Baseline||0
538252|NCT00792922|1313293|P1|NOT COMPLETED|At Baseline||0
538253|NCT00792922|1313290|P4|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
538254|NCT00792922|1313291|P3|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
538255|NCT00792922|1313292|P2|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
538256|NCT00792922|1313293|P1|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
538257|NCT00792922|1313290|P4|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
538258|NCT00792922|1313291|P3|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
538259|NCT00792922|1313292|P2|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
538260|NCT00792922|1313293|P1|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
538261|NCT00792922|1313290|P4|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
538262|NCT00792922|1313291|P3|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
538263|NCT00792922|1313292|P2|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
538264|NCT00792922|1313293|P1|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
538265|NCT00792922|1313290|P4|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
538266|NCT00792922|1313291|P3|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
538267|NCT00792922|1313292|P2|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
538268|NCT00792922|1313293|P1|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
538269|NCT00792922|1313290|P4|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
538270|NCT00792922|1313291|P3|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
538271|NCT00792922|1313292|P2|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
538272|NCT00792922|1313293|P1|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
538273|NCT00792909|1313310|P3|NOT COMPLETED|Overall Study||0
538274|NCT00792909|1313311|P2|NOT COMPLETED|Overall Study||1
538275|NCT00792909|1313312|P1|NOT COMPLETED|Overall Study||0
538276|NCT00792909|1313310|P3|COMPLETED|Overall Study||62
538277|NCT00792909|1313311|P2|COMPLETED|Overall Study||58
538278|NCT00792909|1313312|P1|COMPLETED|Overall Study||51
538279|NCT00792909|1313310|P3|STARTED|Overall Study||62
538280|NCT00792909|1313311|P2|STARTED|Overall Study||59
538281|NCT00792909|1313312|P1|STARTED|Overall Study||51
538282|NCT00792805|1313368|P3|NOT COMPLETED|Overall Study||33
538283|NCT00792805|1313369|P2|NOT COMPLETED|Overall Study||26
538284|NCT00792805|1313370|P1|NOT COMPLETED|Overall Study||22
538285|NCT00792805|1313368|P3|COMPLETED|Overall Study||154
538286|NCT00792805|1313369|P2|COMPLETED|Overall Study||162
538287|NCT00792805|1313370|P1|COMPLETED|Overall Study||166
538288|NCT00792805|1313368|P3|Exposed to Study Medication or Placebo|Overall Study|One patient in this group did not receive any study treatment.|186
538289|NCT00792805|1313369|P2|Exposed to Study Medication or Placebo|Overall Study||188
538290|NCT00792805|1313370|P1|Exposed to Study Medication or Placebo|Overall Study|One patient in this group did not receive any study treatment.|187
538291|NCT00792805|1313368|P3|STARTED|Overall Study||187
538292|NCT00792805|1313369|P2|STARTED|Overall Study||188
538293|NCT00792805|1313370|P1|STARTED|Overall Study||188
538294|NCT00792701|1313380|P2|NOT COMPLETED|Overall Study||44
538295|NCT00792701|1313381|P1|NOT COMPLETED|Overall Study||19
538296|NCT00792701|1313380|P2|COMPLETED|Overall Study||22
538297|NCT00792701|1313381|P1|COMPLETED|Overall Study||0
538298|NCT00792701|1313380|P2|Eligible and Analyzable|Overall Study||44
538299|NCT00792701|1313381|P1|Eligible and Analyzable|Overall Study||17
538300|NCT00792701|1313380|P2|Eligible|Overall Study||63
538301|NCT00792701|1313381|P1|Eligible|Overall Study||18
538302|NCT00792701|1313380|P2|STARTED|Overall Study||66
538303|NCT00792701|1313381|P1|STARTED|Overall Study||19
538304|NCT00792688|1313395|P3|NOT COMPLETED|Overall Study||0
538305|NCT00792688|1313396|P2|NOT COMPLETED|Overall Study||0
538306|NCT00792688|1313397|P1|NOT COMPLETED|Overall Study||0
538307|NCT00792688|1313395|P3|COMPLETED|Overall Study||9
538308|NCT00792688|1313396|P2|COMPLETED|Overall Study||8
538309|NCT00792688|1313397|P1|COMPLETED|Overall Study||9
538310|NCT00792688|1313395|P3|STARTED|Overall Study||9
538311|NCT00792688|1313396|P2|STARTED|Overall Study||8
538312|NCT00792688|1313397|P1|STARTED|Overall Study||9
538313|NCT00792636|1313411|P3|NOT COMPLETED|Overall Study||81
538314|NCT00792636|1313412|P2|NOT COMPLETED|Overall Study||81
538315|NCT00792636|1313413|P1|NOT COMPLETED|Overall Study||68
538316|NCT00792636|1313411|P3|COMPLETED|Overall Study||55
538317|NCT00792636|1313412|P2|COMPLETED|Overall Study||55
538318|NCT00792636|1313413|P1|COMPLETED|Overall Study||67
538319|NCT00792636|1313411|P3|STARTED|Overall Study||136
538320|NCT00792636|1313412|P2|STARTED|Overall Study||136
538321|NCT00792636|1313413|P1|STARTED|Overall Study||135
538322|NCT00792623|1313450|P1|NOT COMPLETED|Overall Study||7
538323|NCT00792623|1313450|P1|COMPLETED|Overall Study||22
538324|NCT00792623|1313450|P1|STARTED|Overall Study||29
538325|NCT00792610|1313463|P1|NOT COMPLETED|Overall Study||0
538326|NCT00792610|1313463|P1|COMPLETED|Overall Study||127
538327|NCT00792610|1313463|P1|Youths|Overall Study||127
538328|NCT00792610|1313463|P1|STARTED|Overall Study||127
538329|NCT00792428|1313469|P2|NOT COMPLETED|Overall Study||0
538330|NCT00792428|1313470|P1|NOT COMPLETED|Overall Study||0
538331|NCT00792428|1313469|P2|COMPLETED|Overall Study||10
538332|NCT00792428|1313470|P1|COMPLETED|Overall Study||10
538333|NCT00792428|1313469|P2|STARTED|Overall Study||10
538334|NCT00792428|1313470|P1|STARTED|Overall Study||10
538335|NCT00792298|1313478|P8|NOT COMPLETED|Treatment Period 2||2
538336|NCT00792298|1313479|P7|NOT COMPLETED|Treatment Period 2||1
538337|NCT00792298|1313480|P6|NOT COMPLETED|Treatment Period 2||0
538338|NCT00792298|1313481|P5|NOT COMPLETED|Treatment Period 2||2
538339|NCT00792298|1313482|P4|NOT COMPLETED|Treatment Period 2||2
538340|NCT00792298|1313483|P3|NOT COMPLETED|Treatment Period 2||1
538341|NCT00792298|1313484|P2|NOT COMPLETED|Treatment Period 2||1
538342|NCT00792298|1313485|P1|NOT COMPLETED|Treatment Period 2||1
538343|NCT00792298|1313478|P8|COMPLETED|Treatment Period 2||28
538344|NCT00792298|1313479|P7|COMPLETED|Treatment Period 2||28
538345|NCT00792298|1313480|P6|COMPLETED|Treatment Period 2||27
538346|NCT00792298|1313481|P5|COMPLETED|Treatment Period 2||30
538347|NCT00792298|1313482|P4|COMPLETED|Treatment Period 2||26
538348|NCT00792298|1313483|P3|COMPLETED|Treatment Period 2||30
538349|NCT00792298|1313484|P2|COMPLETED|Treatment Period 2||30
538350|NCT00792298|1313485|P1|COMPLETED|Treatment Period 2||29
538351|NCT00792298|1313478|P8|STARTED|Treatment Period 2||30
538352|NCT00792298|1313479|P7|STARTED|Treatment Period 2||29
538353|NCT00792298|1313480|P6|STARTED|Treatment Period 2||27
538354|NCT00792298|1313481|P5|STARTED|Treatment Period 2||32
538355|NCT00792298|1313482|P4|STARTED|Treatment Period 2||28
538356|NCT00792298|1313483|P3|STARTED|Treatment Period 2||31
538357|NCT00792298|1313484|P2|STARTED|Treatment Period 2||31
538358|NCT00792298|1313485|P1|STARTED|Treatment Period 2||30
538359|NCT00792298|1313478|P8|NOT COMPLETED|Washout||0
538360|NCT00792298|1313479|P7|NOT COMPLETED|Washout||0
538361|NCT00792298|1313480|P6|NOT COMPLETED|Washout||2
538362|NCT00792298|1313481|P5|NOT COMPLETED|Washout||0
538363|NCT00792298|1313482|P4|NOT COMPLETED|Washout||0
538364|NCT00792298|1313483|P3|NOT COMPLETED|Washout||1
538365|NCT00792298|1313484|P2|NOT COMPLETED|Washout||0
538366|NCT00792298|1313485|P1|NOT COMPLETED|Washout||0
538367|NCT00792298|1313478|P8|COMPLETED|Washout||30
538368|NCT00792298|1313479|P7|COMPLETED|Washout||29
538369|NCT00792298|1313480|P6|COMPLETED|Washout||27
538370|NCT00792298|1313481|P5|COMPLETED|Washout||32
538371|NCT00792298|1313482|P4|COMPLETED|Washout||28
538372|NCT00792298|1313483|P3|COMPLETED|Washout||31
538373|NCT00792298|1313484|P2|COMPLETED|Washout||31
538374|NCT00792298|1313485|P1|COMPLETED|Washout||30
538375|NCT00792298|1313478|P8|STARTED|Washout||30
538376|NCT00792298|1313479|P7|STARTED|Washout|2 participants discontinued therapy during Period 1 but entered the Washout as allowed per protocol|29
538377|NCT00792298|1313480|P6|STARTED|Washout||29
538378|NCT00792298|1313481|P5|STARTED|Washout||32
538379|NCT00792298|1313482|P4|STARTED|Washout||28
538380|NCT00792298|1313483|P3|STARTED|Washout|1 participant discontinued therapy during Period 1 but entered the Washout as allowed per protocol|32
538381|NCT00792298|1313484|P2|STARTED|Washout||31
538382|NCT00792298|1313485|P1|STARTED|Washout||30
538383|NCT00792298|1313478|P8|NOT COMPLETED|Treatment Period 1||1
538384|NCT00792298|1313479|P7|NOT COMPLETED|Treatment Period 1||4
538385|NCT00792298|1313480|P6|NOT COMPLETED|Treatment Period 1||3
538386|NCT00792298|1313481|P5|NOT COMPLETED|Treatment Period 1||0
538387|NCT00792298|1313482|P4|NOT COMPLETED|Treatment Period 1||4
538388|NCT00792298|1313483|P3|NOT COMPLETED|Treatment Period 1||2
538389|NCT00792298|1313484|P2|NOT COMPLETED|Treatment Period 1||1
538390|NCT00792298|1313485|P1|NOT COMPLETED|Treatment Period 1||1
538391|NCT00792298|1313478|P8|COMPLETED|Treatment Period 1||30
538392|NCT00792298|1313479|P7|COMPLETED|Treatment Period 1||27
538393|NCT00792298|1313480|P6|COMPLETED|Treatment Period 1||29
538394|NCT00792298|1313481|P5|COMPLETED|Treatment Period 1||32
538395|NCT00792298|1313482|P4|COMPLETED|Treatment Period 1||28
538396|NCT00792298|1313483|P3|COMPLETED|Treatment Period 1||31
538397|NCT00792298|1313484|P2|COMPLETED|Treatment Period 1||31
538398|NCT00792298|1313485|P1|COMPLETED|Treatment Period 1||30
538399|NCT00792298|1313478|P8|STARTED|Treatment Period 1||31
538400|NCT00792298|1313479|P7|STARTED|Treatment Period 1||31
538401|NCT00792298|1313480|P6|STARTED|Treatment Period 1||32
538402|NCT00792298|1313481|P5|STARTED|Treatment Period 1||32
538403|NCT00792298|1313482|P4|STARTED|Treatment Period 1||32
538404|NCT00792298|1313483|P3|STARTED|Treatment Period 1||33
538405|NCT00792298|1313484|P2|STARTED|Treatment Period 1||32
538406|NCT00792298|1313485|P1|STARTED|Treatment Period 1||31
538407|NCT00792259|1313515|P3|NOT COMPLETED|Overall Study||0
538408|NCT00792259|1313516|P2|NOT COMPLETED|Overall Study||0
538409|NCT00792259|1313517|P1|NOT COMPLETED|Overall Study||1
538410|NCT00792259|1313515|P3|COMPLETED|Overall Study||13
538411|NCT00792259|1313516|P2|COMPLETED|Overall Study||20
538412|NCT00792259|1313517|P1|COMPLETED|Overall Study||14
538413|NCT00792259|1313515|P3|STARTED|Overall Study||13
538414|NCT00792259|1313516|P2|STARTED|Overall Study||20
538415|NCT00792259|1313517|P1|STARTED|Overall Study||15
538416|NCT00792116|1313527|P2|NOT COMPLETED|Overall Study||1
538417|NCT00792116|1313528|P1|NOT COMPLETED|Overall Study||1
538418|NCT00792116|1313527|P2|COMPLETED|Overall Study||54
538419|NCT00792116|1313528|P1|COMPLETED|Overall Study||52
538420|NCT00792116|1313527|P2|STARTED|Overall Study||55
538421|NCT00792116|1313528|P1|STARTED|Overall Study||53
538422|NCT00792103|1313538|P1|NOT COMPLETED|Overall Study||133
538423|NCT00792103|1313538|P1|COMPLETED|Overall Study||65
538424|NCT00792103|1313538|P1|STARTED|Overall Study|15 subjects were enrolled but did not treat for a total of 183 subjects in the safety population|198
538425|NCT00791999|1313550|P4|NOT COMPLETED|Overall Study||52
538426|NCT00791999|1313551|P3|NOT COMPLETED|Overall Study||20
538427|NCT00791999|1313552|P2|NOT COMPLETED|Overall Study||16
538428|NCT00791999|1313553|P1|NOT COMPLETED|Overall Study||21
538429|NCT00791999|1313550|P4|COMPLETED|Overall Study||25
538430|NCT00791999|1313551|P3|COMPLETED|Overall Study||65
538431|NCT00791999|1313552|P2|COMPLETED|Overall Study||66
538432|NCT00791999|1313553|P1|COMPLETED|Overall Study||51
538433|NCT00791999|1313550|P4|STARTED|Overall Study||77
538434|NCT00791999|1313551|P3|STARTED|Overall Study||85
538435|NCT00791999|1313552|P2|STARTED|Overall Study||82
538436|NCT00791999|1313553|P1|STARTED|Overall Study||72
538437|NCT00791973|1313569|P2|NOT COMPLETED|Second Intervention (1 Week)||0
538438|NCT00791973|1313570|P1|NOT COMPLETED|Second Intervention (1 Week)||0
538439|NCT00791973|1313569|P2|COMPLETED|Second Intervention (1 Week)||7
538440|NCT00791973|1313570|P1|COMPLETED|Second Intervention (1 Week)||8
538441|NCT00791973|1313569|P2|STARTED|Second Intervention (1 Week)||7
538442|NCT00791973|1313570|P1|STARTED|Second Intervention (1 Week)||8
538443|NCT00791973|1313569|P2|NOT COMPLETED|Washout (1 Week)||0
538444|NCT00791973|1313570|P1|NOT COMPLETED|Washout (1 Week)||0
538445|NCT00791973|1313569|P2|COMPLETED|Washout (1 Week)||7
538446|NCT00791973|1313570|P1|COMPLETED|Washout (1 Week)||8
538447|NCT00791973|1313569|P2|STARTED|Washout (1 Week)||7
538448|NCT00791973|1313570|P1|STARTED|Washout (1 Week)||8
538449|NCT00791973|1313569|P2|NOT COMPLETED|First Intervention (1 Week)||0
538450|NCT00791973|1313570|P1|NOT COMPLETED|First Intervention (1 Week)||0
538451|NCT00791973|1313569|P2|COMPLETED|First Intervention (1 Week)||7
538452|NCT00791973|1313570|P1|COMPLETED|First Intervention (1 Week)||8
538453|NCT00791973|1313569|P2|STARTED|First Intervention (1 Week)||7
538454|NCT00791973|1313570|P1|STARTED|First Intervention (1 Week)||8
538455|NCT00791934|1313578|P1|NOT COMPLETED|Overall Study||15
538456|NCT00791934|1313578|P1|COMPLETED|Overall Study|Follow-up extended to 1 yr. 13 subjects chose not to participate in the extension.|48
538457|NCT00791934|1313578|P1|STARTED|Overall Study||63
538458|NCT00791921|1313588|P2|NOT COMPLETED|Overall Study||96
538459|NCT00791921|1313589|P1|NOT COMPLETED|Overall Study||34
538460|NCT00791921|1313588|P2|COMPLETED|Overall Study||18
538461|NCT00791921|1313589|P1|COMPLETED|Overall Study||82
538462|NCT00791921|1313588|P2|STARTED|Overall Study||114
538463|NCT00791921|1313589|P1|STARTED|Overall Study||116
538464|NCT00791908|1313597|P1|NOT COMPLETED|Overall Study||0
538465|NCT00791908|1313597|P1|COMPLETED|Overall Study||15
538466|NCT00791908|1313597|P1|STARTED|Overall Study||15
538467|NCT00791817|1313607|P2|NOT COMPLETED|2: Single Dose||0
538468|NCT00791817|1313608|P1|NOT COMPLETED|2: Single Dose||0
538469|NCT00791817|1313607|P2|COMPLETED|2: Single Dose||5
538470|NCT00791817|1313608|P1|COMPLETED|2: Single Dose||5
538471|NCT00791817|1313607|P2|STARTED|2: Single Dose||5
538472|NCT00791817|1313608|P1|STARTED|2: Single Dose||5
538473|NCT00791817|1313607|P2|NOT COMPLETED|1: Single Dose Followed by Week Washout||0
538474|NCT00791817|1313608|P1|NOT COMPLETED|1: Single Dose Followed by Week Washout||0
538475|NCT00791817|1313607|P2|COMPLETED|1: Single Dose Followed by Week Washout||5
538476|NCT00791817|1313608|P1|COMPLETED|1: Single Dose Followed by Week Washout||5
538477|NCT00791817|1313607|P2|STARTED|1: Single Dose Followed by Week Washout||5
538478|NCT00791817|1313608|P1|STARTED|1: Single Dose Followed by Week Washout||5
538479|NCT00791778|1313616|P2|NOT COMPLETED|Follow-up||1
538480|NCT00791778|1313617|P1|NOT COMPLETED|Follow-up||5
538481|NCT00791778|1313616|P2|COMPLETED|Follow-up|Includes 78 participants with study follow-up terminated by sponsor and 12 deaths|90
538482|NCT00791778|1313617|P1|COMPLETED|Follow-up|Includes 79 participants with study follow-up terminated by sponsor and 16 deaths|95
538483|NCT00791778|1313616|P2|STARTED|Follow-up||91
538484|NCT00791778|1313617|P1|STARTED|Follow-up||100
538485|NCT00791778|1313616|P2|NOT COMPLETED|Double-blind Treatment||48
538486|NCT00791778|1313617|P1|NOT COMPLETED|Double-blind Treatment||77
538487|NCT00791778|1313616|P2|COMPLETED|Double-blind Treatment|includes: 75 subjects with progression|75
538488|NCT00791778|1313617|P1|COMPLETED|Double-blind Treatment|includes: 42 subjects with progression, 4 subjects transferred to a continuation study|46
538489|NCT00791778|1313616|P2|STARTED|Double-blind Treatment||123
538490|NCT00791778|1313617|P1|STARTED|Double-blind Treatment||123
538491|NCT00791765|1313671|P2|NOT COMPLETED|Weeks 13 to 24||8
538492|NCT00791765|1313672|P1|NOT COMPLETED|Weeks 13 to 24||5
538493|NCT00791765|1313671|P2|COMPLETED|Weeks 13 to 24||49
538494|NCT00791765|1313672|P1|COMPLETED|Weeks 13 to 24||49
538495|NCT00791765|1313671|P2|STARTED|Weeks 13 to 24|1 participant discontinued due to an adverse event after completing 12 weeks.|57
538496|NCT00791765|1313672|P1|STARTED|Weeks 13 to 24||54
538497|NCT00791765|1313671|P2|NOT COMPLETED|Weeks 1 to 12||4
538498|NCT00791765|1313672|P1|NOT COMPLETED|Weeks 1 to 12||8
538499|NCT00791765|1313671|P2|COMPLETED|Weeks 1 to 12||58
538500|NCT00791765|1313672|P1|COMPLETED|Weeks 1 to 12||54
538501|NCT00791765|1313671|P2|Treated|Weeks 1 to 12||59
538502|NCT00791765|1313672|P1|Treated|Weeks 1 to 12||62
538503|NCT00791765|1313671|P2|STARTED|Weeks 1 to 12||62
538504|NCT00791765|1313672|P1|STARTED|Weeks 1 to 12||62
538505|NCT00791700|1313687|P4|NOT COMPLETED|Overall Study||18
538506|NCT00791700|1313688|P3|NOT COMPLETED|Overall Study||4
538507|NCT00791700|1313689|P2|NOT COMPLETED|Overall Study||5
538508|NCT00791700|1313690|P1|NOT COMPLETED|Overall Study||4
538509|NCT00791700|1313687|P4|COMPLETED|Overall Study|Two participants discontinued treatment after the lower bound (days 313 and 314) of Week 48 window.|25
538510|NCT00791700|1313688|P3|COMPLETED|Overall Study||9
538511|NCT00791700|1313689|P2|COMPLETED|Overall Study||26
538512|NCT00791700|1313690|P1|COMPLETED|Overall Study||12
538513|NCT00791700|1313687|P4|STARTED|Overall Study|Please note that the data presented here is Subject Discontinuations Through Week 48.|43
538514|NCT00791700|1313688|P3|STARTED|Overall Study|Please note that the data presented here is Subject Discontinuations Through Week 48.|13
538515|NCT00791700|1313689|P2|STARTED|Overall Study|Please note that the data presented here is Subject Discontinuations Through Week 48.|31
538516|NCT00791700|1313690|P1|STARTED|Overall Study|Please note that the data presented here is Subject Discontinuations Through Week 48.|16
538517|NCT00791661|1313778|P3|NOT COMPLETED|Period 3||0
538518|NCT00791661|1313779|P2|NOT COMPLETED|Period 3||0
538519|NCT00791661|1313780|P1|NOT COMPLETED|Period 3||0
538520|NCT00791661|1313778|P3|COMPLETED|Period 3||6
538521|NCT00791661|1313779|P2|COMPLETED|Period 3||8
538522|NCT00791661|1313780|P1|COMPLETED|Period 3||8
538523|NCT00791661|1313778|P3|Received Matching Placebo to MK-1006|Period 3||1
538524|NCT00791661|1313779|P2|Received Matching Placebo to MK-1006|Period 3||2
538525|NCT00791661|1313780|P1|Received Matching Placebo to MK-1006|Period 3||2
538526|NCT00791661|1313778|P3|Received MK-1006|Period 3||5
538527|NCT00791661|1313779|P2|Received MK-1006|Period 3||6
538528|NCT00791661|1313780|P1|Received MK-1006|Period 3||6
538529|NCT00791661|1313778|P3|STARTED|Period 3||6
538530|NCT00791661|1313779|P2|STARTED|Period 3||8
538531|NCT00791661|1313780|P1|STARTED|Period 3||8
538532|NCT00791661|1313778|P3|NOT COMPLETED|7 Day Wash-out||0
538533|NCT00791661|1313779|P2|NOT COMPLETED|7 Day Wash-out||0
538534|NCT00791661|1313780|P1|NOT COMPLETED|7 Day Wash-out||0
538535|NCT00791661|1313778|P3|COMPLETED|7 Day Wash-out||6
538536|NCT00791661|1313779|P2|COMPLETED|7 Day Wash-out||8
538537|NCT00791661|1313780|P1|COMPLETED|7 Day Wash-out||8
538538|NCT00791661|1313778|P3|STARTED|7 Day Wash-out||6
538539|NCT00791661|1313779|P2|STARTED|7 Day Wash-out||8
538540|NCT00791661|1313780|P1|STARTED|7 Day Wash-out||8
538541|NCT00791661|1313778|P3|NOT COMPLETED|Period 2||0
538542|NCT00791661|1313779|P2|NOT COMPLETED|Period 2||0
538543|NCT00791661|1313780|P1|NOT COMPLETED|Period 2||0
538544|NCT00791661|1313778|P3|COMPLETED|Period 2||6
538545|NCT00791661|1313779|P2|COMPLETED|Period 2||8
538546|NCT00791661|1313780|P1|COMPLETED|Period 2||8
538547|NCT00791661|1313778|P3|Received Matching Placebo to MK-1006|Period 2||2
538548|NCT00791661|1313779|P2|Received Matching Placebo to MK-1006|Period 2||2
538549|NCT00791661|1313780|P1|Received Matching Placebo to MK-1006|Period 2||2
538550|NCT00791661|1313778|P3|Received MK-1006|Period 2||4
538551|NCT00791661|1313779|P2|Received MK-1006|Period 2||6
538552|NCT00791661|1313780|P1|Received MK-1006|Period 2||6
538553|NCT00791661|1313778|P3|STARTED|Period 2||6
538554|NCT00791661|1313779|P2|STARTED|Period 2||8
538555|NCT00791661|1313780|P1|STARTED|Period 2||8
538556|NCT00791661|1313778|P3|NOT COMPLETED|7 Day Wash-out||2
538557|NCT00791661|1313779|P2|NOT COMPLETED|7 Day Wash-out||0
538558|NCT00791661|1313780|P1|NOT COMPLETED|7 Day Wash-out||0
538559|NCT00791661|1313778|P3|COMPLETED|7 Day Wash-out||6
538560|NCT00791661|1313779|P2|COMPLETED|7 Day Wash-out||8
538561|NCT00791661|1313780|P1|COMPLETED|7 Day Wash-out||8
538562|NCT00791661|1313778|P3|STARTED|7 Day Wash-out||8
538563|NCT00791661|1313779|P2|STARTED|7 Day Wash-out||8
538564|NCT00791661|1313780|P1|STARTED|7 Day Wash-out||8
538565|NCT00791661|1313778|P3|NOT COMPLETED|Period 1||0
538566|NCT00791661|1313779|P2|NOT COMPLETED|Period 1||0
538567|NCT00791661|1313780|P1|NOT COMPLETED|Period 1||0
538568|NCT00791661|1313778|P3|COMPLETED|Period 1||8
538569|NCT00791661|1313779|P2|COMPLETED|Period 1||8
538570|NCT00791661|1313780|P1|COMPLETED|Period 1||8
538571|NCT00791661|1313778|P3|Received Matching Placebo to MK-1006|Period 1||2
538572|NCT00791661|1313779|P2|Received Matching Placebo to MK-1006|Period 1||2
538573|NCT00791661|1313780|P1|Received Matching Placebo to MK-1006|Period 1||2
538574|NCT00791661|1313778|P3|Received MK-1006|Period 1||6
538575|NCT00791661|1313779|P2|Received MK-1006|Period 1||6
538576|NCT00791661|1313780|P1|Received MK-1006|Period 1||6
538577|NCT00791661|1313778|P3|STARTED|Period 1||8
538578|NCT00791661|1313779|P2|STARTED|Period 1||8
538579|NCT00791661|1313780|P1|STARTED|Period 1||8
538580|NCT00791648|1313873|P2|NOT COMPLETED|Overall Study||2
538581|NCT00791648|1313874|P1|NOT COMPLETED|Overall Study||0
538582|NCT00791648|1313873|P2|COMPLETED|Overall Study||307
538583|NCT00791648|1313874|P1|COMPLETED|Overall Study||308
538584|NCT00791648|1313873|P2|STARTED|Overall Study||309
538585|NCT00791648|1313874|P1|STARTED|Overall Study||308
538586|NCT00791557|1313890|P1|NOT COMPLETED|Overall Study||1
538587|NCT00791557|1313890|P1|COMPLETED|Overall Study||1
538588|NCT00791557|1313890|P1|STARTED|Overall Study||2
538589|NCT00791518|1313894|P1|NOT COMPLETED|Overall Study||93
538590|NCT00791518|1313894|P1|COMPLETED|Overall Study||991
538591|NCT00791518|1313894|P1|STARTED|Overall Study||1084
538592|NCT00791492|1313922|P2|NOT COMPLETED|Overall Study||3
538593|NCT00791492|1313923|P1|NOT COMPLETED|Overall Study||6
538594|NCT00791492|1313922|P2|COMPLETED|Overall Study||38
538595|NCT00791492|1313923|P1|COMPLETED|Overall Study||39
538596|NCT00791492|1313922|P2|TREATED|Overall Study||41
538597|NCT00791492|1313923|P1|TREATED|Overall Study||44
538598|NCT00791492|1313922|P2|STARTED|Overall Study||41
538599|NCT00791492|1313923|P1|STARTED|Overall Study||45
538600|NCT00791479|1313971|P6|NOT COMPLETED|Overall Study||3
538601|NCT00791479|1313972|P5|NOT COMPLETED|Overall Study||3
538602|NCT00791479|1313973|P4|NOT COMPLETED|Overall Study||4
538603|NCT00791479|1313974|P3|NOT COMPLETED|Overall Study||0
538604|NCT00791479|1313975|P2|NOT COMPLETED|Overall Study||3
538605|NCT00791479|1313976|P1|NOT COMPLETED|Overall Study||2
538606|NCT00791479|1313971|P6|COMPLETED|Overall Study||29
538607|NCT00791479|1313972|P5|COMPLETED|Overall Study||0
538608|NCT00791479|1313973|P4|COMPLETED|Overall Study||25
538609|NCT00791479|1313974|P3|COMPLETED|Overall Study||34
538610|NCT00791479|1313975|P2|COMPLETED|Overall Study||31
538611|NCT00791479|1313976|P1|COMPLETED|Overall Study||33
538612|NCT00791479|1313971|P6|Received at Least One Dose of Study Drug|Overall Study||32
538613|NCT00791479|1313972|P5|Received at Least One Dose of Study Drug|Overall Study||3
538614|NCT00791479|1313973|P4|Received at Least One Dose of Study Drug|Overall Study||29
538615|NCT00791479|1313974|P3|Received at Least One Dose of Study Drug|Overall Study||34
538616|NCT00791479|1313975|P2|Received at Least One Dose of Study Drug|Overall Study||34
538617|NCT00791479|1313976|P1|Received at Least One Dose of Study Drug|Overall Study||35
538618|NCT00791479|1313971|P6|STARTED|Overall Study||32
538619|NCT00791479|1313972|P5|STARTED|Overall Study|3mg LY2189265 discont. Replaced with 1.5mg dose based on dose finding Study H9X-MC-GBCF; NCT00734474|3
538620|NCT00791479|1313973|P4|STARTED|Overall Study||29
538621|NCT00791479|1313974|P3|STARTED|Overall Study||34
538622|NCT00791479|1313975|P2|STARTED|Overall Study||34
538623|NCT00791479|1313976|P1|STARTED|Overall Study||35
538624|NCT00791388|1314075|P5|NOT COMPLETED|Period 4 - 400 mg Dose Group||4
538625|NCT00791388|1314076|P4|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
538626|NCT00791388|1314077|P3|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
538627|NCT00791388|1314078|P2|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
538628|NCT00791388|1314079|P1|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
538629|NCT00791388|1314075|P5|COMPLETED|Period 4 - 400 mg Dose Group||4
538630|NCT00791388|1314076|P4|COMPLETED|Period 4 - 400 mg Dose Group||0
538631|NCT00791388|1314077|P3|COMPLETED|Period 4 - 400 mg Dose Group||0
538632|NCT00791388|1314078|P2|COMPLETED|Period 4 - 400 mg Dose Group||0
538633|NCT00791388|1314079|P1|COMPLETED|Period 4 - 400 mg Dose Group||4
538634|NCT00791388|1314075|P5|STARTED|Period 4 - 400 mg Dose Group||8
538635|NCT00791388|1314076|P4|STARTED|Period 4 - 400 mg Dose Group||0
538636|NCT00791388|1314077|P3|STARTED|Period 4 - 400 mg Dose Group||0
538637|NCT00791388|1314078|P2|STARTED|Period 4 - 400 mg Dose Group||0
538638|NCT00791388|1314079|P1|STARTED|Period 4 - 400 mg Dose Group||4
538639|NCT00791388|1314075|P5|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
538640|NCT00791388|1314076|P4|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
538641|NCT00791388|1314077|P3|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
538642|NCT00791388|1314078|P2|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
538643|NCT00791388|1314079|P1|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
538644|NCT00791388|1314075|P5|COMPLETED|Period 3 - 200 mg Dose Group||0
538645|NCT00791388|1314076|P4|COMPLETED|Period 3 - 200 mg Dose Group||8
538646|NCT00791388|1314077|P3|COMPLETED|Period 3 - 200 mg Dose Group||0
538647|NCT00791388|1314078|P2|COMPLETED|Period 3 - 200 mg Dose Group||0
538648|NCT00791388|1314079|P1|COMPLETED|Period 3 - 200 mg Dose Group||3
538649|NCT00791388|1314075|P5|STARTED|Period 3 - 200 mg Dose Group||0
538650|NCT00791388|1314076|P4|STARTED|Period 3 - 200 mg Dose Group||8
538651|NCT00791388|1314077|P3|STARTED|Period 3 - 200 mg Dose Group||0
538652|NCT00791388|1314078|P2|STARTED|Period 3 - 200 mg Dose Group||0
538653|NCT00791388|1314079|P1|STARTED|Period 3 - 200 mg Dose Group||3
538654|NCT00791388|1314075|P5|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
538655|NCT00791388|1314076|P4|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
538656|NCT00791388|1314077|P3|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
538657|NCT00791388|1314078|P2|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
538658|NCT00791388|1314079|P1|NOT COMPLETED|Period 2 - 100 mg Dose Group||1
538659|NCT00791388|1314075|P5|COMPLETED|Period 2 - 100 mg Dose Group||0
538660|NCT00791388|1314076|P4|COMPLETED|Period 2 - 100 mg Dose Group||0
538661|NCT00791388|1314077|P3|COMPLETED|Period 2 - 100 mg Dose Group||8
538662|NCT00791388|1314078|P2|COMPLETED|Period 2 - 100 mg Dose Group||0
538663|NCT00791388|1314079|P1|COMPLETED|Period 2 - 100 mg Dose Group||2
538664|NCT00791388|1314075|P5|STARTED|Period 2 - 100 mg Dose Group||0
538665|NCT00791388|1314076|P4|STARTED|Period 2 - 100 mg Dose Group||0
538666|NCT00791388|1314077|P3|STARTED|Period 2 - 100 mg Dose Group||8
538667|NCT00791388|1314078|P2|STARTED|Period 2 - 100 mg Dose Group||0
538668|NCT00791388|1314079|P1|STARTED|Period 2 - 100 mg Dose Group||3
538669|NCT00791388|1314075|P5|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
538670|NCT00791388|1314076|P4|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
538671|NCT00791388|1314077|P3|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
538672|NCT00791388|1314078|P2|NOT COMPLETED|Period 1 - 50 mg Dose Group||1
538673|NCT00791388|1314079|P1|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
538674|NCT00791388|1314075|P5|COMPLETED|Period 1 - 50 mg Dose Group||0
538675|NCT00791388|1314076|P4|COMPLETED|Period 1 - 50 mg Dose Group||0
538676|NCT00791388|1314077|P3|COMPLETED|Period 1 - 50 mg Dose Group||0
538677|NCT00791388|1314078|P2|COMPLETED|Period 1 - 50 mg Dose Group||7
538678|NCT00791388|1314079|P1|COMPLETED|Period 1 - 50 mg Dose Group||3
538679|NCT00791388|1314075|P5|STARTED|Period 1 - 50 mg Dose Group||0
538680|NCT00791388|1314076|P4|STARTED|Period 1 - 50 mg Dose Group||0
538681|NCT00791388|1314077|P3|STARTED|Period 1 - 50 mg Dose Group||0
538682|NCT00791388|1314078|P2|STARTED|Period 1 - 50 mg Dose Group||8
538683|NCT00791388|1314079|P1|STARTED|Period 1 - 50 mg Dose Group||3
538684|NCT00791336|1314106|P1|NOT COMPLETED|Overall Study||0
538685|NCT00791336|1314106|P1|COMPLETED|Overall Study||1
538686|NCT00791336|1314106|P1|STARTED|Overall Study||1
538687|NCT00791323|1314114|P2|NOT COMPLETED|Overall Study||0
538688|NCT00791323|1314115|P1|NOT COMPLETED|Overall Study||0
538689|NCT00791323|1314114|P2|COMPLETED|Overall Study||3
538690|NCT00791323|1314115|P1|COMPLETED|Overall Study||6
538691|NCT00791323|1314114|P2|STARTED|Overall Study||3
538692|NCT00791323|1314115|P1|STARTED|Overall Study||6
538693|NCT00791258|1314121|P1|NOT COMPLETED|Overall Study||263
538694|NCT00791258|1314121|P1|COMPLETED|Overall Study||736
538695|NCT00791258|1314121|P1|STARTED|Overall Study||999
538696|NCT00791128|1314183|P1|NOT COMPLETED|Overall Study||9
538697|NCT00791128|1314183|P1|COMPLETED|Overall Study||13
538698|NCT00791128|1314183|P1|STARTED|Overall Study||22
538699|NCT00791102|1314188|P2|NOT COMPLETED|Period 2||0
538700|NCT00791102|1314189|P1|NOT COMPLETED|Period 2||0
538701|NCT00791102|1314188|P2|COMPLETED|Period 2||10
538702|NCT00791102|1314189|P1|COMPLETED|Period 2||10
538703|NCT00791102|1314188|P2|STARTED|Period 2||10
538704|NCT00791102|1314189|P1|STARTED|Period 2||10
538705|NCT00791102|1314188|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
538706|NCT00791102|1314189|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
538707|NCT00791102|1314188|P2|COMPLETED|Washout Period of 2 Weeks||10
538708|NCT00791102|1314189|P1|COMPLETED|Washout Period of 2 Weeks||10
538709|NCT00791102|1314188|P2|STARTED|Washout Period of 2 Weeks||10
538710|NCT00791102|1314189|P1|STARTED|Washout Period of 2 Weeks||10
538711|NCT00791102|1314188|P2|NOT COMPLETED|Period 1||0
538712|NCT00791102|1314189|P1|NOT COMPLETED|Period 1||0
538713|NCT00791102|1314188|P2|COMPLETED|Period 1||10
538714|NCT00791102|1314189|P1|COMPLETED|Period 1||10
538715|NCT00791102|1314188|P2|STARTED|Period 1||10
538716|NCT00791102|1314189|P1|STARTED|Period 1||10
538717|NCT00791089|1314207|P2|NOT COMPLETED|Overall Study||6
538718|NCT00791089|1314208|P1|NOT COMPLETED|Overall Study||6
538719|NCT00791089|1314207|P2|COMPLETED|Overall Study||0
538720|NCT00791089|1314208|P1|COMPLETED|Overall Study||0
538721|NCT00791089|1314207|P2|Six-month Data Collected|Overall Study||5
538722|NCT00791089|1314208|P1|Six-month Data Collected|Overall Study||6
538723|NCT00791089|1314207|P2|Began Actually Taking Fish Oil or Placeb|Overall Study||5
538724|NCT00791089|1314208|P1|Began Actually Taking Fish Oil or Placeb|Overall Study||6
538725|NCT00791089|1314207|P2|STARTED|Overall Study||6
538726|NCT00791089|1314208|P1|STARTED|Overall Study||6
538727|NCT00791076|1314214|P1|NOT COMPLETED|Overall Study||8
538728|NCT00791076|1314214|P1|COMPLETED|Overall Study||0
538729|NCT00791076|1314214|P1|STARTED|Overall Study||8
538730|NCT00791037|1314222|P1|NOT COMPLETED|Overall Study||0
538731|NCT00791037|1314222|P1|COMPLETED|Overall Study||23
538732|NCT00791037|1314222|P1|Skeletal or Bone-only Disease by FDG-PET|Overall Study||1
538733|NCT00791037|1314222|P1|Primary Outcome|Overall Study||19
538734|NCT00791037|1314222|P1|STARTED|Overall Study||23
538735|NCT00790907|1314232|P3|NOT COMPLETED|Overall Study||339
538736|NCT00790907|1314233|P2|NOT COMPLETED|Overall Study||340
538737|NCT00790907|1314234|P1|NOT COMPLETED|Overall Study||455
538738|NCT00790907|1314232|P3|COMPLETED|Overall Study||663
538739|NCT00790907|1314233|P2|COMPLETED|Overall Study||684
538740|NCT00790907|1314234|P1|COMPLETED|Overall Study||754
538741|NCT00790907|1314232|P3|STARTED|Overall Study||1002
538742|NCT00790907|1314233|P2|STARTED|Overall Study||1024
538743|NCT00790907|1314234|P1|STARTED|Overall Study||1209
538744|NCT00790868|1314257|P2|NOT COMPLETED|Overall Study||17
538745|NCT00790868|1314258|P1|NOT COMPLETED|Overall Study||6
538746|NCT00790868|1314257|P2|COMPLETED|Overall Study||75
538747|NCT00790868|1314258|P1|COMPLETED|Overall Study||82
538748|NCT00790868|1314257|P2|STARTED|Overall Study||92
538749|NCT00790868|1314258|P1|STARTED|Overall Study||88
538750|NCT00790855|1314272|P1|NOT COMPLETED|Overall Study||0
538751|NCT00790855|1314272|P1|COMPLETED|Overall Study||25
538752|NCT00790855|1314272|P1|STARTED|Overall Study||25
538753|NCT00790803|1314277|P1|NOT COMPLETED|Overall Study||0
538754|NCT00790803|1314277|P1|COMPLETED|Overall Study||5
538755|NCT00790803|1314277|P1|STARTED|Overall Study||5
538756|NCT00790790|1314288|P3|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
538757|NCT00790790|1314289|P2|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
538758|NCT00790790|1314290|P1|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
538759|NCT00790790|1314288|P3|COMPLETED|Study Period 3: 1-Week Washout Phase||26
538760|NCT00790790|1314289|P2|COMPLETED|Study Period 3: 1-Week Washout Phase||31
538761|NCT00790790|1314290|P1|COMPLETED|Study Period 3: 1-Week Washout Phase||37
538762|NCT00790790|1314288|P3|STARTED|Study Period 3: 1-Week Washout Phase||27
538763|NCT00790790|1314289|P2|STARTED|Study Period 3: 1-Week Washout Phase||32
538764|NCT00790790|1314290|P1|STARTED|Study Period 3: 1-Week Washout Phase||37
538765|NCT00790790|1314288|P3|NOT COMPLETED|Study Period 2: Therapy Phase||21
538766|NCT00790790|1314289|P2|NOT COMPLETED|Study Period 2: Therapy Phase||18
538767|NCT00790790|1314290|P1|NOT COMPLETED|Study Period 2: Therapy Phase||12
538768|NCT00790790|1314288|P3|COMPLETED|Study Period 2: Therapy Phase||27
538769|NCT00790790|1314289|P2|COMPLETED|Study Period 2: Therapy Phase||32
538770|NCT00790790|1314290|P1|COMPLETED|Study Period 2: Therapy Phase||37
538771|NCT00790790|1314288|P3|STARTED|Study Period 2: Therapy Phase||48
538772|NCT00790790|1314289|P2|STARTED|Study Period 2: Therapy Phase||50
538773|NCT00790790|1314290|P1|STARTED|Study Period 2: Therapy Phase||49
538774|NCT00790751|1314367|P4|NOT COMPLETED|Overall Study||21
538775|NCT00790751|1314368|P3|NOT COMPLETED|Overall Study||20
538776|NCT00790751|1314369|P2|NOT COMPLETED|Overall Study||30
538777|NCT00790751|1314370|P1|NOT COMPLETED|Overall Study||25
538778|NCT00790751|1314367|P4|COMPLETED|Overall Study||141
538779|NCT00790751|1314368|P3|COMPLETED|Overall Study||141
538780|NCT00790751|1314369|P2|COMPLETED|Overall Study||131
538781|NCT00790751|1314370|P1|COMPLETED|Overall Study||137
538782|NCT00790751|1314367|P4|STARTED|Overall Study||162
538783|NCT00790751|1314368|P3|STARTED|Overall Study||161
538784|NCT00790751|1314369|P2|STARTED|Overall Study||161
538785|NCT00790751|1314370|P1|STARTED|Overall Study||162
538786|NCT00790738|1314390|P2|NOT COMPLETED|Overall Study||3
538787|NCT00790738|1314391|P1|NOT COMPLETED|Overall Study||2
538788|NCT00790738|1314390|P2|COMPLETED|Overall Study||3
538789|NCT00790738|1314391|P1|COMPLETED|Overall Study||3
538790|NCT00790738|1314390|P2|STARTED|Overall Study||6
538791|NCT00790738|1314391|P1|STARTED|Overall Study||5
538792|NCT00790673|1314405|P4|NOT COMPLETED|Overall Study||0
538793|NCT00790673|1314406|P3|NOT COMPLETED|Overall Study||0
538794|NCT00790673|1314407|P2|NOT COMPLETED|Overall Study||0
538795|NCT00790673|1314408|P1|NOT COMPLETED|Overall Study||0
538796|NCT00790673|1314405|P4|COMPLETED|Overall Study||8
538797|NCT00790673|1314406|P3|COMPLETED|Overall Study||12
538798|NCT00790673|1314407|P2|COMPLETED|Overall Study||6
538799|NCT00790673|1314408|P1|COMPLETED|Overall Study||6
538800|NCT00790673|1314405|P4|STARTED|Overall Study||8
538801|NCT00790673|1314406|P3|STARTED|Overall Study||12
538802|NCT00790673|1314407|P2|STARTED|Overall Study||6
538803|NCT00790673|1314408|P1|STARTED|Overall Study||6
538804|NCT00790647|1314418|P1|NOT COMPLETED|Overall Study||1
538805|NCT00790647|1314418|P1|COMPLETED|Overall Study||9
538806|NCT00790647|1314418|P1|STARTED|Overall Study||10
538807|NCT00790569|1314428|P3|NOT COMPLETED|End of Study (12 Month Interview)||50
538808|NCT00790569|1314429|P2|NOT COMPLETED|End of Study (12 Month Interview)||19
538809|NCT00790569|1314430|P1|NOT COMPLETED|End of Study (12 Month Interview)||66
538810|NCT00790569|1314428|P3|COMPLETED|End of Study (12 Month Interview)||83
538811|NCT00790569|1314429|P2|COMPLETED|End of Study (12 Month Interview)||26
538812|NCT00790569|1314430|P1|COMPLETED|End of Study (12 Month Interview)||71
538813|NCT00790569|1314428|P3|STARTED|End of Study (12 Month Interview)||133
538814|NCT00790569|1314429|P2|STARTED|End of Study (12 Month Interview)||45
538815|NCT00790569|1314430|P1|STARTED|End of Study (12 Month Interview)||137
538816|NCT00790569|1314428|P3|NOT COMPLETED|End of Treatment (6 Month Interview)||26
538817|NCT00790569|1314429|P2|NOT COMPLETED|End of Treatment (6 Month Interview)||10
538818|NCT00790569|1314430|P1|NOT COMPLETED|End of Treatment (6 Month Interview)||22
538819|NCT00790569|1314428|P3|COMPLETED|End of Treatment (6 Month Interview)||107
538820|NCT00790569|1314429|P2|COMPLETED|End of Treatment (6 Month Interview)||35
538821|NCT00790569|1314430|P1|COMPLETED|End of Treatment (6 Month Interview)||115
538822|NCT00790569|1314428|P3|STARTED|End of Treatment (6 Month Interview)||133
538823|NCT00790569|1314429|P2|STARTED|End of Treatment (6 Month Interview)||45
538824|NCT00790569|1314430|P1|STARTED|End of Treatment (6 Month Interview)||137
538825|NCT00790556|1314471|P2|NOT COMPLETED|Treatment Period 2||0
538826|NCT00790556|1314472|P1|NOT COMPLETED|Treatment Period 2||0
538827|NCT00790556|1314471|P2|COMPLETED|Treatment Period 2||6
538828|NCT00790556|1314472|P1|COMPLETED|Treatment Period 2||6
538829|NCT00790556|1314471|P2|STARTED|Treatment Period 2||6
538830|NCT00790556|1314472|P1|STARTED|Treatment Period 2||6
538831|NCT00790556|1314471|P2|NOT COMPLETED|Washout After Period 1||0
538832|NCT00790556|1314472|P1|NOT COMPLETED|Washout After Period 1||0
538833|NCT00790556|1314471|P2|COMPLETED|Washout After Period 1||6
538834|NCT00790556|1314472|P1|COMPLETED|Washout After Period 1||6
538835|NCT00790556|1314471|P2|STARTED|Washout After Period 1||6
538836|NCT00790556|1314472|P1|STARTED|Washout After Period 1||6
538837|NCT00790556|1314471|P2|NOT COMPLETED|Treatment Period 1||0
538838|NCT00790556|1314472|P1|NOT COMPLETED|Treatment Period 1||2
538839|NCT00790556|1314471|P2|COMPLETED|Treatment Period 1||6
538840|NCT00790556|1314472|P1|COMPLETED|Treatment Period 1||6
538841|NCT00790556|1314471|P2|STARTED|Treatment Period 1||6
538842|NCT00790556|1314472|P1|STARTED|Treatment Period 1||8
538843|NCT00790452|1314484|P2|NOT COMPLETED|Overall Study||0
538844|NCT00790452|1314485|P1|NOT COMPLETED|Overall Study||1
538845|NCT00790452|1314484|P2|COMPLETED|Overall Study||0
538846|NCT00790452|1314485|P1|COMPLETED|Overall Study||0
538847|NCT00790452|1314484|P2|STARTED|Overall Study||0
538848|NCT00790452|1314485|P1|STARTED|Overall Study||1
538849|NCT00790400|1314493|P2|NOT COMPLETED|Everolimus Period (Core or Extension)||0
538850|NCT00790400|1314494|P1|NOT COMPLETED|Everolimus Period (Core or Extension)||29
538851|NCT00790400|1314493|P2|COMPLETED|Everolimus Period (Core or Extension)||0
538852|NCT00790400|1314494|P1|COMPLETED|Everolimus Period (Core or Extension)|Treatment duration completed as per protocol|83
538853|NCT00790400|1314493|P2|STARTED|Everolimus Period (Core or Extension)|"Placebo randomized patients who switched to Everolimus are reported in Everolimus arm."|0
538854|NCT00790400|1314494|P1|STARTED|Everolimus Period (Core or Extension)|112 pts had Everolimus during core and/or extension (6 from placebo did not switch to Eve. in ext.)|112
538855|NCT00790400|1314493|P2|NOT COMPLETED|Double-blind Period (Core Phase)||13
538856|NCT00790400|1314494|P1|NOT COMPLETED|Double-blind Period (Core Phase)||7
538857|NCT00790400|1314493|P2|COMPLETED|Double-blind Period (Core Phase)|Completed = 1st received Placebo in the Core phase, switched to Everolimus in Extension phase|26
538858|NCT00790400|1314494|P1|COMPLETED|Double-blind Period (Core Phase)|Completed = Completed the Core phase & moved to Extension phase|72
538859|NCT00790400|1314493|P2|STARTED|Double-blind Period (Core Phase)||39
538860|NCT00790400|1314494|P1|STARTED|Double-blind Period (Core Phase)||79
538861|NCT00790335|1314523|P2|NOT COMPLETED|Overall Study||112
538862|NCT00790335|1314524|P1|NOT COMPLETED|Overall Study||80
538863|NCT00790335|1314523|P2|COMPLETED|Overall Study||243
538864|NCT00790335|1314524|P1|COMPLETED|Overall Study||257
538865|NCT00790335|1314523|P2|STARTED|Overall Study||355
538866|NCT00790335|1314524|P1|STARTED|Overall Study||337
538867|NCT00790296|1314584|P2|NOT COMPLETED|Overall Study||2
538868|NCT00790296|1314585|P1|NOT COMPLETED|Overall Study||1
538869|NCT00790296|1314584|P2|COMPLETED|Overall Study||4
538870|NCT00790296|1314585|P1|COMPLETED|Overall Study||4
538871|NCT00790296|1314584|P2|STARTED|Overall Study||6
538872|NCT00790296|1314585|P1|STARTED|Overall Study||5
538873|NCT00790270|1314594|P3|NOT COMPLETED|Overall Study||0
538874|NCT00790270|1314595|P2|NOT COMPLETED|Overall Study||0
538875|NCT00790270|1314596|P1|NOT COMPLETED|Overall Study||0
538876|NCT00790270|1314594|P3|COMPLETED|Overall Study||20
538877|NCT00790270|1314595|P2|COMPLETED|Overall Study||20
538878|NCT00790270|1314596|P1|COMPLETED|Overall Study||21
538879|NCT00790270|1314594|P3|STARTED|Overall Study||20
538880|NCT00790270|1314595|P2|STARTED|Overall Study||20
538881|NCT00790270|1314596|P1|STARTED|Overall Study||21
538882|NCT00790218|1314607|P3|NOT COMPLETED|Overall Study||0
538883|NCT00790218|1314608|P2|NOT COMPLETED|Overall Study||0
538884|NCT00790218|1314609|P1|NOT COMPLETED|Overall Study||1
538885|NCT00790218|1314607|P3|COMPLETED|Overall Study||7
538886|NCT00790218|1314608|P2|COMPLETED|Overall Study||6
538887|NCT00790218|1314609|P1|COMPLETED|Overall Study||5
538888|NCT00790218|1314607|P3|STARTED|Overall Study||7
538889|NCT00790218|1314608|P2|STARTED|Overall Study||6
538890|NCT00790218|1314609|P1|STARTED|Overall Study||6
538891|NCT00790205|1314619|P2|NOT COMPLETED|Overall Study||434
538892|NCT00790205|1314620|P1|NOT COMPLETED|Overall Study||360
538893|NCT00790205|1314619|P2|COMPLETED|Overall Study||6905
538894|NCT00790205|1314620|P1|COMPLETED|Overall Study||6972
538895|NCT00790205|1314619|P2|Treated|Overall Study||7274
538896|NCT00790205|1314620|P1|Treated|Overall Study||7266
538897|NCT00790205|1314619|P2|STARTED|Overall Study||7339
538898|NCT00790205|1314620|P1|STARTED|Overall Study||7332
538899|NCT00790192|1314664|P4|NOT COMPLETED|Overall Study||48
538900|NCT00790192|1314665|P3|NOT COMPLETED|Overall Study||23
538901|NCT00790192|1314666|P2|NOT COMPLETED|Overall Study||28
538902|NCT00790192|1314667|P1|NOT COMPLETED|Overall Study||36
538903|NCT00790192|1314664|P4|COMPLETED|Overall Study||74
538904|NCT00790192|1314665|P3|COMPLETED|Overall Study||97
538905|NCT00790192|1314666|P2|COMPLETED|Overall Study||93
538906|NCT00790192|1314667|P1|COMPLETED|Overall Study||89
538907|NCT00790192|1314664|P4|STARTED|Overall Study||122
538908|NCT00790192|1314665|P3|STARTED|Overall Study||120
538909|NCT00790192|1314666|P2|STARTED|Overall Study||121
538910|NCT00790192|1314667|P1|STARTED|Overall Study||125
538911|NCT00790062|1314684|P3|NOT COMPLETED|Overall Study||0
538912|NCT00790062|1314685|P2|NOT COMPLETED|Overall Study||0
538913|NCT00790062|1314686|P1|NOT COMPLETED|Overall Study||0
538914|NCT00790062|1314684|P3|COMPLETED|Overall Study||658
538915|NCT00790062|1314685|P2|COMPLETED|Overall Study||481
538916|NCT00790062|1314686|P1|COMPLETED|Overall Study||659
538917|NCT00790062|1314684|P3|STARTED|Overall Study||658
538918|NCT00790062|1314685|P2|STARTED|Overall Study||481
538919|NCT00790062|1314686|P1|STARTED|Overall Study||659
538920|NCT00790036|1314717|P2|NOT COMPLETED|Overall Study||121
538921|NCT00790036|1314718|P1|NOT COMPLETED|Overall Study||195
538922|NCT00790036|1314717|P2|COMPLETED|Overall Study|completed = treatment duration completed as per protocol|249
538923|NCT00790036|1314718|P1|COMPLETED|Overall Study|completed = treatment duration completed as per protocol|177
538924|NCT00790036|1314717|P2|Untreated Participants|Overall Study|not treated due to administrative problems and subject withdrawal of consent.|6
538925|NCT00790036|1314718|P1|Untreated Participants|Overall Study|not treated due to administrative problems, protocol deviation, and subject withdrawal of consent.|4
538926|NCT00790036|1314717|P2|STARTED|Overall Study||370
538927|NCT00790036|1314718|P1|STARTED|Overall Study||372
538928|NCT00790023|1314732|P3|NOT COMPLETED|Overall Study||21
538929|NCT00790023|1314733|P2|NOT COMPLETED|Overall Study||10
538930|NCT00790023|1314734|P1|NOT COMPLETED|Overall Study||11
538931|NCT00790023|1314732|P3|COMPLETED|Overall Study||214
538932|NCT00790023|1314733|P2|COMPLETED|Overall Study||225
538933|NCT00790023|1314734|P1|COMPLETED|Overall Study||226
538934|NCT00790023|1314732|P3|STARTED|Overall Study||235
538935|NCT00790023|1314733|P2|STARTED|Overall Study||235
538936|NCT00790023|1314734|P1|STARTED|Overall Study||237
538937|NCT00789997|1314824|P2|NOT COMPLETED|Overall Study||2
538938|NCT00789997|1314825|P1|NOT COMPLETED|Overall Study||1
538939|NCT00789997|1314824|P2|COMPLETED|Overall Study||38
538940|NCT00789997|1314825|P1|COMPLETED|Overall Study||40
538941|NCT00789997|1314824|P2|STARTED|Overall Study||40
538942|NCT00789997|1314825|P1|STARTED|Overall Study||41
538943|NCT00789958|1314833|P1|NOT COMPLETED|Overall Study||37
538944|NCT00789958|1314833|P1|COMPLETED|Overall Study||68
538945|NCT00789958|1314833|P1|Eligible and Analyzable|Overall Study||79
538946|NCT00789958|1314833|P1|STARTED|Overall Study||105
538947|NCT00789880|1314852|P6|NOT COMPLETED|Overall Study||0
538948|NCT00789880|1314853|P5|NOT COMPLETED|Overall Study||3
538949|NCT00789880|1314854|P4|NOT COMPLETED|Overall Study||1
538950|NCT00789880|1314855|P3|NOT COMPLETED|Overall Study||0
538951|NCT00789880|1314856|P2|NOT COMPLETED|Overall Study||1
538952|NCT00789880|1314857|P1|NOT COMPLETED|Overall Study||1
538953|NCT00789880|1314852|P6|COMPLETED|Overall Study||8
538954|NCT00789880|1314853|P5|COMPLETED|Overall Study||15
538955|NCT00789880|1314854|P4|COMPLETED|Overall Study||15
538956|NCT00789880|1314855|P3|COMPLETED|Overall Study||8
538957|NCT00789880|1314856|P2|COMPLETED|Overall Study||15
538958|NCT00789880|1314857|P1|COMPLETED|Overall Study||15
538959|NCT00789880|1314852|P6|STARTED|Overall Study||8
538960|NCT00789880|1314853|P5|STARTED|Overall Study||18
538961|NCT00789880|1314854|P4|STARTED|Overall Study||16
538962|NCT00789880|1314855|P3|STARTED|Overall Study||8
538963|NCT00789880|1314856|P2|STARTED|Overall Study||16
538964|NCT00789880|1314857|P1|STARTED|Overall Study||16
538965|NCT00789854|1314886|P3|NOT COMPLETED|Overall Study||47
538966|NCT00789854|1314887|P2|NOT COMPLETED|Overall Study||35
538967|NCT00789854|1314888|P1|NOT COMPLETED|Overall Study||49
538968|NCT00789854|1314886|P3|COMPLETED|Overall Study||182
538969|NCT00789854|1314887|P2|COMPLETED|Overall Study||196
538970|NCT00789854|1314888|P1|COMPLETED|Overall Study||179
538971|NCT00789854|1314886|P3|STARTED|Overall Study||229
538972|NCT00789854|1314887|P2|STARTED|Overall Study||231
538973|NCT00789854|1314888|P1|STARTED|Overall Study||228
538974|NCT00789828|1314985|P2|NOT COMPLETED|Open-label Extension Period (4 Years)||0
538975|NCT00789828|1314986|P1|NOT COMPLETED|Open-label Extension Period (4 Years)||29
538976|NCT00789828|1314985|P2|COMPLETED|Open-label Extension Period (4 Years)||0
538977|NCT00789828|1314986|P1|COMPLETED|Open-label Extension Period (4 Years)||82
538978|NCT00789828|1314985|P2|STARTED|Open-label Extension Period (4 Years)|No participant received placebo.|0
538979|NCT00789828|1314986|P1|STARTED|Open-label Extension Period (4 Years)|Of 117 participants only 111 completed the core period and continued in the extension period|111
538980|NCT00789828|1314985|P2|NOT COMPLETED|Core Period (48 Weeks)||6
538981|NCT00789828|1314986|P1|NOT COMPLETED|Core Period (48 Weeks)||0
538982|NCT00789828|1314985|P2|COMPLETED|Core Period (48 Weeks)||33
538983|NCT00789828|1314986|P1|COMPLETED|Core Period (48 Weeks)||78
538984|NCT00789828|1314985|P2|STARTED|Core Period (48 Weeks)||39
538985|NCT00789828|1314986|P1|STARTED|Core Period (48 Weeks)||78
538986|NCT00789815|1315020|P2|NOT COMPLETED|Overall Study||1
538987|NCT00789815|1315021|P1|NOT COMPLETED|Overall Study||7
538988|NCT00789815|1315020|P2|COMPLETED|Overall Study||249
538989|NCT00789815|1315021|P1|COMPLETED|Overall Study||243
538990|NCT00789815|1315020|P2|STARTED|Overall Study||250
538991|NCT00789815|1315021|P1|STARTED|Overall Study||250
538992|NCT00789802|1315044|P3|NOT COMPLETED|Overall Study||6
538993|NCT00789802|1315045|P2|NOT COMPLETED|Overall Study||7
538994|NCT00789802|1315046|P1|NOT COMPLETED|Overall Study||10
538995|NCT00789802|1315044|P3|COMPLETED|Overall Study||37
538996|NCT00789802|1315045|P2|COMPLETED|Overall Study||35
538997|NCT00789802|1315046|P1|COMPLETED|Overall Study||34
538998|NCT00789802|1315044|P3|STARTED|Overall Study||43
538999|NCT00789802|1315045|P2|STARTED|Overall Study||42
539000|NCT00789802|1315046|P1|STARTED|Overall Study||44
539001|NCT00789750|1315065|P2|NOT COMPLETED|Overall Study||60
539002|NCT00789750|1315066|P1|NOT COMPLETED|Overall Study||59
539003|NCT00789750|1315065|P2|COMPLETED|Overall Study||222
539004|NCT00789750|1315066|P1|COMPLETED|Overall Study||221
539005|NCT00789750|1315065|P2|Intent to Treat Set|Overall Study||276
539006|NCT00789750|1315066|P1|Intent to Treat Set|Overall Study||271
539007|NCT00789750|1315065|P2|Safety Set|Overall Study||277
539008|NCT00789750|1315066|P1|Safety Set|Overall Study||274
539009|NCT00789750|1315065|P2|Dropped During run-in Period|Overall Study||5
539010|NCT00789750|1315066|P1|Dropped During run-in Period|Overall Study||6
539011|NCT00789750|1315065|P2|STARTED|Overall Study||282
539012|NCT00789750|1315066|P1|STARTED|Overall Study||280
539013|NCT00789737|1315110|P2|NOT COMPLETED|Overall Study||55
539014|NCT00789737|1315111|P1|NOT COMPLETED|Overall Study||48
539015|NCT00789737|1315110|P2|COMPLETED|Overall Study||126
539016|NCT00789737|1315111|P1|COMPLETED|Overall Study||128
539017|NCT00789737|1315110|P2|STARTED|Overall Study||181
539018|NCT00789737|1315111|P1|STARTED|Overall Study||176
539019|NCT00789724|1315143|P2|NOT COMPLETED|Overall Study||0
539020|NCT00789724|1315144|P1|NOT COMPLETED|Overall Study||0
539021|NCT00789724|1315143|P2|COMPLETED|Overall Study||5
539022|NCT00789724|1315144|P1|COMPLETED|Overall Study||5
539023|NCT00789724|1315143|P2|STARTED|Overall Study||5
539024|NCT00789724|1315144|P1|STARTED|Overall Study||5
539025|NCT00789698|1315154|P4|NOT COMPLETED|Overall Study||52
539026|NCT00789698|1315155|P3|NOT COMPLETED|Overall Study||27
539027|NCT00789698|1315156|P2|NOT COMPLETED|Overall Study||33
539028|NCT00789698|1315157|P1|NOT COMPLETED|Overall Study||40
539029|NCT00789698|1315154|P4|COMPLETED|Overall Study||33
539030|NCT00789698|1315155|P3|COMPLETED|Overall Study||29
539031|NCT00789698|1315156|P2|COMPLETED|Overall Study||46
539032|NCT00789698|1315157|P1|COMPLETED|Overall Study||32
539033|NCT00789698|1315154|P4|STARTED|Overall Study||85
539034|NCT00789698|1315155|P3|STARTED|Overall Study||56
539035|NCT00789698|1315156|P2|STARTED|Overall Study||79
539036|NCT00789698|1315157|P1|STARTED|Overall Study||72
539037|NCT00789685|1315171|P1|NOT COMPLETED|Overall Study||12
539038|NCT00789685|1315171|P1|COMPLETED|Overall Study|Completed the study to Day 28|25
539039|NCT00789685|1315171|P1|STARTED|Overall Study||37
539040|NCT00789672|1315179|P2|NOT COMPLETED|Overall Study||0
539041|NCT00789672|1315180|P1|NOT COMPLETED|Overall Study||0
539042|NCT00789672|1315179|P2|COMPLETED|Overall Study||17
539043|NCT00789672|1315180|P1|COMPLETED|Overall Study||16
539044|NCT00789672|1315179|P2|STARTED|Overall Study||17
539045|NCT00789672|1315180|P1|STARTED|Overall Study||16
539046|NCT00789581|1315212|P2|NOT COMPLETED|Adjuvant Therapy||57
539047|NCT00789581|1315213|P1|NOT COMPLETED|Adjuvant Therapy||40
539048|NCT00789581|1315212|P2|COMPLETED|Adjuvant Therapy||234
539049|NCT00789581|1315213|P1|COMPLETED|Adjuvant Therapy||255
539050|NCT00789581|1315212|P2|STARTED|Adjuvant Therapy||291
539051|NCT00789581|1315213|P1|STARTED|Adjuvant Therapy||295
539052|NCT00789581|1315212|P2|NOT COMPLETED|AC Therapy||17
539053|NCT00789581|1315213|P1|NOT COMPLETED|AC Therapy||11
539054|NCT00789581|1315212|P2|COMPLETED|AC Therapy||291
539055|NCT00789581|1315213|P1|COMPLETED|AC Therapy||295
539056|NCT00789581|1315212|P2|STARTED|AC Therapy||308
539057|NCT00789581|1315213|P1|STARTED|AC Therapy||306
539058|NCT00789555|1315224|P3|NOT COMPLETED|Overall Study||159
539059|NCT00789555|1315225|P2|NOT COMPLETED|Overall Study||139
539060|NCT00789555|1315226|P1|NOT COMPLETED|Overall Study||159
539061|NCT00789555|1315224|P3|COMPLETED|Overall Study||263
539062|NCT00789555|1315225|P2|COMPLETED|Overall Study||278
539063|NCT00789555|1315226|P1|COMPLETED|Overall Study||262
539064|NCT00789555|1315224|P3|STARTED|Overall Study||422
539065|NCT00789555|1315225|P2|STARTED|Overall Study||417
539066|NCT00789555|1315226|P1|STARTED|Overall Study||421
539067|NCT00789529|1315251|P2|NOT COMPLETED|Overall Study||1
539068|NCT00789529|1315252|P1|NOT COMPLETED|Overall Study||1
539069|NCT00789529|1315251|P2|COMPLETED|Overall Study||15
539070|NCT00789529|1315252|P1|COMPLETED|Overall Study||15
539071|NCT00789529|1315251|P2|STARTED|Overall Study||16
539072|NCT00789529|1315252|P1|STARTED|Overall Study||16
539073|NCT00789477|1315265|P5|NOT COMPLETED|Overall Study||7
539074|NCT00789477|1315266|P4|NOT COMPLETED|Overall Study||10
539075|NCT00789477|1315267|P3|NOT COMPLETED|Overall Study||11
539076|NCT00789477|1315268|P2|NOT COMPLETED|Overall Study||6
539077|NCT00789477|1315269|P1|NOT COMPLETED|Overall Study||11
539078|NCT00789477|1315265|P5|COMPLETED|Overall Study||38
539079|NCT00789477|1315266|P4|COMPLETED|Overall Study||34
539080|NCT00789477|1315267|P3|COMPLETED|Overall Study||33
539081|NCT00789477|1315268|P2|COMPLETED|Overall Study||38
539082|NCT00789477|1315269|P1|COMPLETED|Overall Study||33
539083|NCT00789477|1315265|P5|Participants Received Treatment|Overall Study|SAF|45
539084|NCT00789477|1315266|P4|Participants Received Treatment|Overall Study|SAF|42
539085|NCT00789477|1315267|P3|Participants Received Treatment|Overall Study|SAF|44
539086|NCT00789477|1315268|P2|Participants Received Treatment|Overall Study|SAF|44
539087|NCT00789477|1315269|P1|Participants Received Treatment|Overall Study|safety analysis set (SAF)|44
539088|NCT00789477|1315265|P5|STARTED|Overall Study|randomized|45
539089|NCT00789477|1315266|P4|STARTED|Overall Study|randomized|44
539090|NCT00789477|1315267|P3|STARTED|Overall Study|randomized|44
539091|NCT00789477|1315268|P2|STARTED|Overall Study|randomized|44
539092|NCT00789477|1315269|P1|STARTED|Overall Study|randomized|44
539093|NCT00789438|1315304|P3|NOT COMPLETED|Overall Study||0
539094|NCT00789438|1315305|P2|NOT COMPLETED|Overall Study||0
539095|NCT00789438|1315306|P1|NOT COMPLETED|Overall Study||0
539096|NCT00789438|1315304|P3|COMPLETED|Overall Study||28
539097|NCT00789438|1315305|P2|COMPLETED|Overall Study||20
539098|NCT00789438|1315306|P1|COMPLETED|Overall Study||21
539099|NCT00789438|1315304|P3|STARTED|Overall Study||28
539100|NCT00789438|1315305|P2|STARTED|Overall Study||20
539101|NCT00789438|1315306|P1|STARTED|Overall Study||21
539102|NCT00789373|1315314|P3|NOT COMPLETED|Maintenance||180
539103|NCT00789373|1315315|P2|NOT COMPLETED|Maintenance||359
539104|NCT00789373|1315316|P1|NOT COMPLETED|Maintenance||0
539105|NCT00789373|1315314|P3|COMPLETED|Maintenance||0
539106|NCT00789373|1315315|P2|COMPLETED|Maintenance||0
539107|NCT00789373|1315316|P1|COMPLETED|Maintenance||0
539108|NCT00789373|1315314|P3|STARTED|Maintenance||180
539109|NCT00789373|1315315|P2|STARTED|Maintenance||359
539110|NCT00789373|1315316|P1|STARTED|Maintenance||0
539111|NCT00789373|1315314|P3|NOT COMPLETED|Induction||0
539112|NCT00789373|1315315|P2|NOT COMPLETED|Induction||0
539113|NCT00789373|1315316|P1|NOT COMPLETED|Induction||399
539114|NCT00789373|1315314|P3|COMPLETED|Induction||0
539115|NCT00789373|1315315|P2|COMPLETED|Induction||0
539116|NCT00789373|1315316|P1|COMPLETED|Induction|1 patient received maintenance therapy post-induction but was never randomized.|540
539117|NCT00789373|1315314|P3|STARTED|Induction||0
539118|NCT00789373|1315315|P2|STARTED|Induction||0
539119|NCT00789373|1315316|P1|STARTED|Induction||939
539120|NCT00789321|1315343|P2|NOT COMPLETED|Overall Study||1
539121|NCT00789321|1315344|P1|NOT COMPLETED|Overall Study||0
539122|NCT00789321|1315343|P2|COMPLETED|Overall Study||22
539123|NCT00789321|1315344|P1|COMPLETED|Overall Study||24
539124|NCT00789321|1315343|P2|STARTED|Overall Study||23
539125|NCT00789321|1315344|P1|STARTED|Overall Study||24
539126|NCT00789256|1315354|P2|NOT COMPLETED|Overall Study||0
539127|NCT00789256|1315355|P1|NOT COMPLETED|Overall Study||0
539128|NCT00789256|1315354|P2|COMPLETED|Overall Study||12
539129|NCT00789256|1315355|P1|COMPLETED|Overall Study|Strata 1 had 5 responders and continued accrual, but the study was closed due to low accrual.|14
539130|NCT00789256|1315354|P2|STARTED|Overall Study||12
539131|NCT00789256|1315355|P1|STARTED|Overall Study||14
539132|NCT00789191|1315363|P2|NOT COMPLETED|Overall Study||19
539133|NCT00789191|1315364|P1|NOT COMPLETED|Overall Study||14
539134|NCT00789191|1315363|P2|COMPLETED|Overall Study||92
539135|NCT00789191|1315364|P1|COMPLETED|Overall Study||97
539136|NCT00789191|1315363|P2|Exposed|Overall Study|1 non-compliance|110
539137|NCT00789191|1315364|P1|Exposed|Overall Study|2 withdrew informed consent. 1 randomised by mistake. 1 non-compliance|107
539138|NCT00789191|1315363|P2|STARTED|Overall Study||111
539139|NCT00789191|1315364|P1|STARTED|Overall Study||111
539140|NCT00789113|1315392|P1|NOT COMPLETED|Overall Study||0
539141|NCT00789113|1315392|P1|COMPLETED|Overall Study||12
539142|NCT00789113|1315392|P1|STARTED|Overall Study||12
539143|NCT00789074|1315399|P2|NOT COMPLETED|Overall Study||13
539144|NCT00789074|1315400|P1|NOT COMPLETED|Overall Study||11
539145|NCT00789074|1315399|P2|COMPLETED|Overall Study||35
539146|NCT00789074|1315400|P1|COMPLETED|Overall Study||42
539147|NCT00789074|1315399|P2|STARTED|Overall Study||48
539148|NCT00789074|1315400|P1|STARTED|Overall Study||53
539149|NCT00789035|1315421|P5|NOT COMPLETED|Overall Study||6
539150|NCT00789035|1315422|P4|NOT COMPLETED|Overall Study||1
539151|NCT00789035|1315423|P3|NOT COMPLETED|Overall Study||1
539152|NCT00789035|1315424|P2|NOT COMPLETED|Overall Study||7
539153|NCT00789035|1315425|P1|NOT COMPLETED|Overall Study||6
539154|NCT00789035|1315421|P5|COMPLETED|Overall Study||74
539155|NCT00789035|1315422|P4|COMPLETED|Overall Study||81
539156|NCT00789035|1315423|P3|COMPLETED|Overall Study||80
539157|NCT00789035|1315424|P2|COMPLETED|Overall Study||74
539158|NCT00789035|1315425|P1|COMPLETED|Overall Study||76
539159|NCT00789035|1315421|P5|STARTED|Overall Study||80
539160|NCT00789035|1315422|P4|STARTED|Overall Study||82
539161|NCT00789035|1315423|P3|STARTED|Overall Study||81
539162|NCT00789035|1315424|P2|STARTED|Overall Study||81
539163|NCT00789035|1315425|P1|STARTED|Overall Study||82
539164|NCT00788957|1315484|P6|NOT COMPLETED|Part 3||11
539165|NCT00788957|1315485|P5|NOT COMPLETED|Part 3||9
539166|NCT00788957|1315486|P4|NOT COMPLETED|Part 3||0
539167|NCT00788957|1315487|P3|NOT COMPLETED|Part 3||0
539168|NCT00788957|1315488|P2|NOT COMPLETED|Part 3||0
539169|NCT00788957|1315489|P1|NOT COMPLETED|Part 3||0
539170|NCT00788957|1315484|P6|COMPLETED|Part 3|Completed the safety follow-up visit|1
539171|NCT00788957|1315485|P5|COMPLETED|Part 3|Completed the safety follow-up visit|4
539172|NCT00788957|1315486|P4|COMPLETED|Part 3||0
539173|NCT00788957|1315487|P3|COMPLETED|Part 3||0
539174|NCT00788957|1315488|P2|COMPLETED|Part 3||0
539175|NCT00788957|1315489|P1|COMPLETED|Part 3||0
539176|NCT00788957|1315484|P6|STARTED|Part 3||12
539177|NCT00788957|1315485|P5|STARTED|Part 3||13
539178|NCT00788957|1315486|P4|STARTED|Part 3||0
539179|NCT00788957|1315487|P3|STARTED|Part 3||0
539180|NCT00788957|1315488|P2|STARTED|Part 3||0
539181|NCT00788957|1315489|P1|STARTED|Part 3||0
539182|NCT00788957|1315484|P6|NOT COMPLETED|Part 2||0
539183|NCT00788957|1315485|P5|NOT COMPLETED|Part 2||0
539184|NCT00788957|1315486|P4|NOT COMPLETED|Part 2||41
539185|NCT00788957|1315487|P3|NOT COMPLETED|Part 2||44
539186|NCT00788957|1315488|P2|NOT COMPLETED|Part 2||42
539187|NCT00788957|1315489|P1|NOT COMPLETED|Part 2||0
539188|NCT00788957|1315484|P6|COMPLETED|Part 2||0
539189|NCT00788957|1315485|P5|COMPLETED|Part 2||0
539190|NCT00788957|1315486|P4|COMPLETED|Part 2|Completed the safety follow-up visit|5
539191|NCT00788957|1315487|P3|COMPLETED|Part 2|Completed the safety follow-up visit|4
539192|NCT00788957|1315488|P2|COMPLETED|Part 2|Completed the safety follow-up visit at the end of the study|6
539193|NCT00788957|1315489|P1|COMPLETED|Part 2||0
539194|NCT00788957|1315484|P6|STARTED|Part 2||0
539195|NCT00788957|1315485|P5|STARTED|Part 2||0
539196|NCT00788957|1315486|P4|STARTED|Part 2||46
539197|NCT00788957|1315487|P3|STARTED|Part 2||48
539198|NCT00788957|1315488|P2|STARTED|Part 2||48
539199|NCT00788957|1315489|P1|STARTED|Part 2||0
539200|NCT00788957|1315484|P6|NOT COMPLETED|Part 1||0
539201|NCT00788957|1315485|P5|NOT COMPLETED|Part 1||0
539202|NCT00788957|1315486|P4|NOT COMPLETED|Part 1||0
539203|NCT00788957|1315487|P3|NOT COMPLETED|Part 1||0
539204|NCT00788957|1315488|P2|NOT COMPLETED|Part 1||0
539205|NCT00788957|1315489|P1|NOT COMPLETED|Part 1||9
539206|NCT00788957|1315484|P6|COMPLETED|Part 1||0
539207|NCT00788957|1315485|P5|COMPLETED|Part 1||0
539208|NCT00788957|1315486|P4|COMPLETED|Part 1||0
539209|NCT00788957|1315487|P3|COMPLETED|Part 1||0
539210|NCT00788957|1315488|P2|COMPLETED|Part 1||0
539211|NCT00788957|1315489|P1|COMPLETED|Part 1|Completed the safety follow-up visit|2
539212|NCT00788957|1315484|P6|STARTED|Part 1||0
539213|NCT00788957|1315485|P5|STARTED|Part 1||0
539214|NCT00788957|1315486|P4|STARTED|Part 1||0
539215|NCT00788957|1315487|P3|STARTED|Part 1||0
539216|NCT00788957|1315488|P2|STARTED|Part 1||0
539217|NCT00788957|1315489|P1|STARTED|Part 1||11
539218|NCT00788892|1315545|P2|NOT COMPLETED|Overall Study||23
539219|NCT00788892|1315546|P1|NOT COMPLETED|Overall Study||49
539220|NCT00788892|1315545|P2|COMPLETED|Overall Study||18
539221|NCT00788892|1315546|P1|COMPLETED|Overall Study||36
539222|NCT00788892|1315545|P2|STARTED|Overall Study||41
539223|NCT00788892|1315546|P1|STARTED|Overall Study||85
539224|NCT00788775|1315564|P2|NOT COMPLETED|Overall Study||8
539225|NCT00788775|1315565|P1|NOT COMPLETED|Overall Study||10
539226|NCT00788775|1315564|P2|COMPLETED|Overall Study||1
539227|NCT00788775|1315565|P1|COMPLETED|Overall Study||1
539228|NCT00788775|1315564|P2|Treated|Overall Study||8
539229|NCT00788775|1315565|P1|Treated|Overall Study||11
539230|NCT00788775|1315564|P2|STARTED|Overall Study||9
539231|NCT00788775|1315565|P1|STARTED|Overall Study||11
539232|NCT00788710|1315580|P3|NOT COMPLETED|Overall Study||6
539233|NCT00788710|1315581|P2|NOT COMPLETED|Overall Study||8
539234|NCT00788710|1315582|P1|NOT COMPLETED|Overall Study||5
539235|NCT00788710|1315580|P3|COMPLETED|Overall Study||138
539236|NCT00788710|1315581|P2|COMPLETED|Overall Study||134
539237|NCT00788710|1315582|P1|COMPLETED|Overall Study||139
539238|NCT00788710|1315580|P3|STARTED|Overall Study||144
539239|NCT00788710|1315581|P2|STARTED|Overall Study||142
539240|NCT00788710|1315582|P1|STARTED|Overall Study||144
539241|NCT00788697|1315596|P1|NOT COMPLETED|Overall Study||109
539242|NCT00788697|1315596|P1|COMPLETED|Overall Study||240
539243|NCT00788697|1315596|P1|STARTED|Overall Study||349
539244|NCT00788593|1315643|P3|NOT COMPLETED|Second Intervention Period||1
539245|NCT00788593|1315644|P2|NOT COMPLETED|Second Intervention Period||1
539246|NCT00788593|1315645|P1|NOT COMPLETED|Second Intervention Period||0
539247|NCT00788593|1315643|P3|COMPLETED|Second Intervention Period||36
539248|NCT00788593|1315644|P2|COMPLETED|Second Intervention Period||37
539249|NCT00788593|1315645|P1|COMPLETED|Second Intervention Period||0
539250|NCT00788593|1315643|P3|STARTED|Second Intervention Period||37
539251|NCT00788593|1315644|P2|STARTED|Second Intervention Period||38
539252|NCT00788593|1315645|P1|STARTED|Second Intervention Period||0
539253|NCT00788593|1315643|P3|NOT COMPLETED|First Intervention Period||0
539254|NCT00788593|1315644|P2|NOT COMPLETED|First Intervention Period||1
539255|NCT00788593|1315645|P1|NOT COMPLETED|First Intervention Period||0
539256|NCT00788593|1315643|P3|COMPLETED|First Intervention Period||37
539257|NCT00788593|1315644|P2|COMPLETED|First Intervention Period||38
539258|NCT00788593|1315645|P1|COMPLETED|First Intervention Period||0
539259|NCT00788593|1315643|P3|STARTED|First Intervention Period||37
539260|NCT00788593|1315644|P2|STARTED|First Intervention Period||39
539261|NCT00788593|1315645|P1|STARTED|First Intervention Period||0
539262|NCT00788593|1315643|P3|NOT COMPLETED|Placebo Run-in Phase||0
539263|NCT00788593|1315644|P2|NOT COMPLETED|Placebo Run-in Phase||0
539264|NCT00788593|1315645|P1|NOT COMPLETED|Placebo Run-in Phase||6
539265|NCT00788593|1315643|P3|COMPLETED|Placebo Run-in Phase||0
539266|NCT00788593|1315644|P2|COMPLETED|Placebo Run-in Phase||0
539267|NCT00788593|1315645|P1|COMPLETED|Placebo Run-in Phase||76
539268|NCT00788593|1315643|P3|STARTED|Placebo Run-in Phase||0
539269|NCT00788593|1315644|P2|STARTED|Placebo Run-in Phase||0
539270|NCT00788593|1315645|P1|STARTED|Placebo Run-in Phase||82
539271|NCT00788372|1315662|P1|NOT COMPLETED|Period 2 (Week 4 to Week 52)||32
539272|NCT00788372|1315662|P1|COMPLETED|Period 2 (Week 4 to Week 52)||79
539273|NCT00788372|1315662|P1|STARTED|Period 2 (Week 4 to Week 52)||111
539274|NCT00788372|1315662|P1|NOT COMPLETED|Period 1 (up to 4 Weeks)||31
539275|NCT00788372|1315662|P1|COMPLETED|Period 1 (up to 4 Weeks)||111
539276|NCT00788372|1315662|P1|STARTED|Period 1 (up to 4 Weeks)||142
539277|NCT00788255|1315676|P1|NOT COMPLETED|Overall Study||0
539278|NCT00788255|1315676|P1|COMPLETED|Overall Study||25
539279|NCT00788255|1315676|P1|Oxytocin: 0 μU/mL|Overall Study||25
539280|NCT00788255|1315676|P1|Oxytocin Infusion 3: 32.9μU/mL|Overall Study||25
539281|NCT00788255|1315676|P1|Oxytocin Infusion 2: 30.1μU/mL|Overall Study||25
539282|NCT00788255|1315676|P1|Oxytocin Infusion 1: 22.5 μU/mL|Overall Study||25
539283|NCT00788255|1315676|P1|STARTED|Overall Study||25
539284|NCT00788073|1315691|P2|NOT COMPLETED|Placebo Then STX209||1
539285|NCT00788073|1315692|P1|NOT COMPLETED|Placebo Then STX209||2
539286|NCT00788073|1315691|P2|COMPLETED|Placebo Then STX209||29
539287|NCT00788073|1315692|P1|COMPLETED|Placebo Then STX209||27
539288|NCT00788073|1315691|P2|STARTED|Placebo Then STX209||30
539289|NCT00788073|1315692|P1|STARTED|Placebo Then STX209||29
539290|NCT00788073|1315691|P2|NOT COMPLETED|STX209 Then Placebo||3
539291|NCT00788073|1315692|P1|NOT COMPLETED|STX209 Then Placebo||1
539292|NCT00788073|1315691|P2|COMPLETED|STX209 Then Placebo||30
539293|NCT00788073|1315692|P1|COMPLETED|STX209 Then Placebo||29
539294|NCT00788073|1315691|P2|STARTED|STX209 Then Placebo||33
539295|NCT00788073|1315692|P1|STARTED|STX209 Then Placebo||30
539296|NCT00788008|1315702|P2|NOT COMPLETED|Overall Study||0
539297|NCT00788008|1315703|P1|NOT COMPLETED|Overall Study||0
539298|NCT00788008|1315702|P2|COMPLETED|Overall Study||101
539299|NCT00788008|1315703|P1|COMPLETED|Overall Study||98
539300|NCT00788008|1315702|P2|STARTED|Overall Study||101
539301|NCT00788008|1315703|P1|STARTED|Overall Study||98
539302|NCT00787943|1315709|P1|NOT COMPLETED|Overall Study||0
539303|NCT00787943|1315709|P1|COMPLETED|Overall Study||10
539304|NCT00787943|1315709|P1|STARTED|Overall Study||10
539305|NCT00787930|1315717|P1|NOT COMPLETED|Continuation Treatment -- up to 12 Month||3
539306|NCT00787930|1315717|P1|COMPLETED|Continuation Treatment -- up to 12 Month||16
539307|NCT00787930|1315717|P1|STARTED|Continuation Treatment -- up to 12 Month||19
539308|NCT00787930|1315717|P1|NOT COMPLETED|Acute Treatment -- 3 Weeks||0
539309|NCT00787930|1315717|P1|COMPLETED|Acute Treatment -- 3 Weeks||19
539310|NCT00787930|1315717|P1|STARTED|Acute Treatment -- 3 Weeks||19
539311|NCT00787917|1315732|P2|NOT COMPLETED|Open Label||0
539312|NCT00787917|1315733|P1|NOT COMPLETED|Open Label||4
539313|NCT00787917|1315732|P2|COMPLETED|Open Label||0
539314|NCT00787917|1315733|P1|COMPLETED|Open Label||3
539315|NCT00787917|1315732|P2|STARTED|Open Label|"Placebo was not an arm in open label treatment."|0
539316|NCT00787917|1315733|P1|STARTED|Open Label||7
539317|NCT00787917|1315732|P2|NOT COMPLETED|Blinded Treatment||2
539318|NCT00787917|1315733|P1|NOT COMPLETED|Blinded Treatment||5
539319|NCT00787917|1315732|P2|COMPLETED|Blinded Treatment||3
539320|NCT00787917|1315733|P1|COMPLETED|Blinded Treatment||4
539321|NCT00787917|1315732|P2|STARTED|Blinded Treatment||5
539322|NCT00787917|1315733|P1|STARTED|Blinded Treatment||9
539323|NCT00787904|1315752|P2|NOT COMPLETED|Overall Study||0
539324|NCT00787904|1315753|P1|NOT COMPLETED|Overall Study||0
539325|NCT00787904|1315752|P2|COMPLETED|Overall Study||13
539326|NCT00787904|1315753|P1|COMPLETED|Overall Study||6
539327|NCT00787904|1315752|P2|STARTED|Overall Study||13
539328|NCT00787904|1315753|P1|STARTED|Overall Study||6
539329|NCT00787891|1315763|P2|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7
539330|NCT00787891|1315764|P1|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7
539331|NCT00787891|1315763|P2|COMPLETED|Maintenance Double-blind Phase (Part 2)||24
539332|NCT00787891|1315764|P1|COMPLETED|Maintenance Double-blind Phase (Part 2)||26
539333|NCT00787891|1315763|P2|STARTED|Maintenance Double-blind Phase (Part 2)||31
539334|NCT00787891|1315764|P1|STARTED|Maintenance Double-blind Phase (Part 2)||33
539335|NCT00787891|1315763|P2|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||9
539336|NCT00787891|1315764|P1|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||10
539337|NCT00787891|1315763|P2|COMPLETED|Short-term Double-blind Phase (Part 1)||53
539338|NCT00787891|1315764|P1|COMPLETED|Short-term Double-blind Phase (Part 1)||55
539339|NCT00787891|1315763|P2|STARTED|Short-term Double-blind Phase (Part 1)||62
539340|NCT00787891|1315764|P1|STARTED|Short-term Double-blind Phase (Part 1)||65
539341|NCT00787852|1315784|P2|NOT COMPLETED|Overall Study||0
539342|NCT00787852|1315785|P1|NOT COMPLETED|Overall Study||1
539343|NCT00787852|1315784|P2|COMPLETED|Overall Study||5
539344|NCT00787852|1315785|P1|COMPLETED|Overall Study|1 patient withdrew consent prior to starting|5
539345|NCT00787852|1315784|P2|STARTED|Overall Study|The study was terminated prior to enrolled to group 2|5
539346|NCT00787852|1315785|P1|STARTED|Overall Study||6
539347|NCT00787839|1315791|P1|NOT COMPLETED|Overall Study||404
539348|NCT00787839|1315791|P1|COMPLETED|Overall Study||1535
539349|NCT00787839|1315791|P1|Complete GCT, OGTT, A1c, Demographics|Overall Study||1535
539350|NCT00787839|1315791|P1|Completed GCT Screening|Overall Study||1876
539351|NCT00787839|1315791|P1|Consented|Overall Study|consented|1939
539352|NCT00787839|1315791|P1|STARTED|Overall Study||1939
539353|NCT00787800|1315814|P2|NOT COMPLETED|Overall Study||7
539354|NCT00787800|1315815|P1|NOT COMPLETED|Overall Study||3
539355|NCT00787800|1315814|P2|COMPLETED|Overall Study||43
539356|NCT00787800|1315815|P1|COMPLETED|Overall Study||47
539357|NCT00787800|1315814|P2|STARTED|Overall Study||50
539358|NCT00787800|1315815|P1|STARTED|Overall Study||50
539359|NCT00787787|1315831|P1|NOT COMPLETED|Overall Study||7
539360|NCT00787787|1315831|P1|COMPLETED|Overall Study||0
539361|NCT00787787|1315831|P1|STARTED|Overall Study||7
539362|NCT00787761|1315837|P1|NOT COMPLETED|Overall Study||0
539363|NCT00787761|1315837|P1|COMPLETED|Overall Study||24
539364|NCT00787761|1315837|P1|STARTED|Overall Study||24
539365|NCT00787644|1315850|P2|NOT COMPLETED|Overall Study||2
539366|NCT00787644|1315851|P1|NOT COMPLETED|Overall Study||2
539367|NCT00787644|1315850|P2|COMPLETED|Overall Study||9
539368|NCT00787644|1315851|P1|COMPLETED|Overall Study||10
539369|NCT00787644|1315850|P2|STARTED|Overall Study||11
539370|NCT00787644|1315851|P1|STARTED|Overall Study||12
539371|NCT00787618|1315860|P3|NOT COMPLETED|Overall Study||0
539372|NCT00787618|1315861|P2|NOT COMPLETED|Overall Study||0
539373|NCT00787618|1315862|P1|NOT COMPLETED|Overall Study||0
539374|NCT00787618|1315860|P3|COMPLETED|Overall Study||3
539375|NCT00787618|1315861|P2|COMPLETED|Overall Study||0
539376|NCT00787618|1315862|P1|COMPLETED|Overall Study||3
539377|NCT00787618|1315860|P3|STARTED|Overall Study||3
539378|NCT00787618|1315861|P2|STARTED|Overall Study||0
539379|NCT00787618|1315862|P1|STARTED|Overall Study||3
539380|NCT00787605|1315872|P2|NOT COMPLETED|Overall Study||56
539381|NCT00787605|1315873|P1|NOT COMPLETED|Overall Study||46
539382|NCT00787605|1315872|P2|COMPLETED|Overall Study||376
539383|NCT00787605|1315873|P1|COMPLETED|Overall Study||382
539384|NCT00787605|1315872|P2|STARTED|Overall Study||432
539385|NCT00787605|1315873|P1|STARTED|Overall Study||428
539386|NCT00787566|1315892|P3|NOT COMPLETED|Overall Study||0
539387|NCT00787566|1315893|P2|NOT COMPLETED|Overall Study||1
539388|NCT00787566|1315894|P1|NOT COMPLETED|Overall Study||0
539389|NCT00787566|1315892|P3|COMPLETED|Overall Study||22
539390|NCT00787566|1315893|P2|COMPLETED|Overall Study|1 patient withdrew from the study due to an AE related to chemotherapy agent administration.|24
539391|NCT00787566|1315894|P1|COMPLETED|Overall Study||21
539392|NCT00787566|1315892|P3|STARTED|Overall Study||22
539393|NCT00787566|1315893|P2|STARTED|Overall Study||25
539394|NCT00787566|1315894|P1|STARTED|Overall Study||21
539395|NCT00787527|1315902|P1|NOT COMPLETED|Overall Study||3
539396|NCT00787527|1315902|P1|COMPLETED|Overall Study||11
539397|NCT00787527|1315902|P1|STARTED|Overall Study||14
539398|NCT00787332|1315912|P2|NOT COMPLETED|Overall Study||0
539399|NCT00787332|1315913|P1|NOT COMPLETED|Overall Study||0
539400|NCT00787332|1315912|P2|COMPLETED|Overall Study||8
539401|NCT00787332|1315913|P1|COMPLETED|Overall Study||8
539402|NCT00787332|1315912|P2|STARTED|Overall Study||8
539403|NCT00787332|1315913|P1|STARTED|Overall Study||8
539404|NCT00787319|1315919|P1|NOT COMPLETED|Overall Study||63
539405|NCT00787319|1315919|P1|COMPLETED|Overall Study||45
539406|NCT00787319|1315919|P1|STARTED|Overall Study||108
539407|NCT00787267|1315931|P1|NOT COMPLETED|Overall Study||12
539408|NCT00787267|1315931|P1|COMPLETED|Overall Study|Received at least one dose of study drug|25
539409|NCT00787267|1315931|P1|STARTED|Overall Study|Signed a consent form|37
539410|NCT00787254|1315941|P2|NOT COMPLETED|Overall Study||82
539411|NCT00787254|1315942|P1|NOT COMPLETED|Overall Study||76
539412|NCT00787254|1315941|P2|COMPLETED|Overall Study||99
539413|NCT00787254|1315942|P1|COMPLETED|Overall Study||109
539414|NCT00787254|1315941|P2|STARTED|Overall Study||181
539415|NCT00787254|1315942|P1|STARTED|Overall Study||185
539416|NCT00787241|1316045|P3|NOT COMPLETED|Overall Study||0
539417|NCT00787241|1316046|P2|NOT COMPLETED|Overall Study||0
539418|NCT00787241|1316047|P1|NOT COMPLETED|Overall Study||0
539419|NCT00787241|1316045|P3|COMPLETED|Overall Study||41
539420|NCT00787241|1316046|P2|COMPLETED|Overall Study||143
539421|NCT00787241|1316047|P1|COMPLETED|Overall Study||261
539422|NCT00787241|1316045|P3|STARTED|Overall Study||41
539423|NCT00787241|1316046|P2|STARTED|Overall Study||143
539424|NCT00787241|1316047|P1|STARTED|Overall Study||261
539425|NCT00787202|1316066|P5|NOT COMPLETED|Overall Study||4
539426|NCT00787202|1316067|P4|NOT COMPLETED|Overall Study||2
539427|NCT00787202|1316068|P3|NOT COMPLETED|Overall Study||7
539428|NCT00787202|1316069|P2|NOT COMPLETED|Overall Study||11
539429|NCT00787202|1316070|P1|NOT COMPLETED|Overall Study||14
539430|NCT00787202|1316066|P5|COMPLETED|Overall Study||45
539431|NCT00787202|1316067|P4|COMPLETED|Overall Study||31
539432|NCT00787202|1316068|P3|COMPLETED|Overall Study||26
539433|NCT00787202|1316069|P2|COMPLETED|Overall Study||20
539434|NCT00787202|1316070|P1|COMPLETED|Overall Study||35
539435|NCT00787202|1316066|P5|Treated|Overall Study||49
539436|NCT00787202|1316067|P4|Treated|Overall Study||33
539437|NCT00787202|1316068|P3|Treated|Overall Study||33
539438|NCT00787202|1316069|P2|Treated|Overall Study||31
539439|NCT00787202|1316070|P1|Treated|Overall Study||48
539440|NCT00787202|1316066|P5|STARTED|Overall Study||49
539441|NCT00787202|1316067|P4|STARTED|Overall Study||33
539442|NCT00787202|1316068|P3|STARTED|Overall Study||33
539443|NCT00787202|1316069|P2|STARTED|Overall Study||31
539444|NCT00787202|1316070|P1|STARTED|Overall Study||49
539445|NCT00787189|1316123|P2|NOT COMPLETED|Overall Study||2
539446|NCT00787189|1316124|P1|NOT COMPLETED|Overall Study||2
539447|NCT00787189|1316123|P2|COMPLETED|Overall Study|To study end point.|30
539448|NCT00787189|1316124|P1|COMPLETED|Overall Study|To study end point.|30
539449|NCT00787189|1316123|P2|STARTED|Overall Study||32
539450|NCT00787189|1316124|P1|STARTED|Overall Study||32
539451|NCT00787150|1316133|P3|NOT COMPLETED|Overall Study||5
539452|NCT00787150|1316134|P2|NOT COMPLETED|Overall Study||7
539453|NCT00787150|1316135|P1|NOT COMPLETED|Overall Study||9
539454|NCT00787150|1316133|P3|COMPLETED|Overall Study||66
539455|NCT00787150|1316134|P2|COMPLETED|Overall Study||65
539456|NCT00787150|1316135|P1|COMPLETED|Overall Study||66
539457|NCT00787150|1316133|P3|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|71
539458|NCT00787150|1316134|P2|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|72
539459|NCT00787150|1316135|P1|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|75
539460|NCT00787137|1316180|P3|NOT COMPLETED|Overall Study||1
539461|NCT00787137|1316181|P2|NOT COMPLETED|Overall Study||0
539462|NCT00787137|1316182|P1|NOT COMPLETED|Overall Study||0
539463|NCT00787137|1316180|P3|COMPLETED|Overall Study||4
539464|NCT00787137|1316181|P2|COMPLETED|Overall Study||6
539465|NCT00787137|1316182|P1|COMPLETED|Overall Study||6
539466|NCT00787137|1316180|P3|STARTED|Overall Study||5
539467|NCT00787137|1316181|P2|STARTED|Overall Study||6
539468|NCT00787137|1316182|P1|STARTED|Overall Study||6
539469|NCT00787124|1316204|P2|NOT COMPLETED|Overall Study||0
539470|NCT00787124|1316205|P1|NOT COMPLETED|Overall Study||0
539471|NCT00787124|1316204|P2|COMPLETED|Overall Study||4
539472|NCT00787124|1316205|P1|COMPLETED|Overall Study||4
539473|NCT00787124|1316204|P2|STARTED|Overall Study||4
539474|NCT00787124|1316205|P1|STARTED|Overall Study||4
539475|NCT00787020|1316215|P2|NOT COMPLETED|Overall Study||0
539476|NCT00787020|1316216|P1|NOT COMPLETED|Overall Study||0
539477|NCT00787020|1316215|P2|COMPLETED|Overall Study||13
539478|NCT00787020|1316216|P1|COMPLETED|Overall Study||24
539479|NCT00787020|1316215|P2|STARTED|Overall Study||13
539480|NCT00787020|1316216|P1|STARTED|Overall Study||24
539481|NCT00786994|1316230|P4|NOT COMPLETED|Overall Study||6
539482|NCT00786994|1316231|P3|NOT COMPLETED|Overall Study||2
539483|NCT00786994|1316232|P2|NOT COMPLETED|Overall Study||15
539484|NCT00786994|1316233|P1|NOT COMPLETED|Overall Study||10
539485|NCT00786994|1316230|P4|COMPLETED|Overall Study||22
539486|NCT00786994|1316231|P3|COMPLETED|Overall Study||24
539487|NCT00786994|1316232|P2|COMPLETED|Overall Study||39
539488|NCT00786994|1316233|P1|COMPLETED|Overall Study||47
539489|NCT00786994|1316230|P4|ITT|Overall Study||28
539490|NCT00786994|1316231|P3|ITT|Overall Study||25
539491|NCT00786994|1316232|P2|ITT|Overall Study||51
539492|NCT00786994|1316233|P1|ITT|Overall Study||53
539493|NCT00786994|1316230|P4|STARTED|Overall Study||28
539494|NCT00786994|1316231|P3|STARTED|Overall Study||26
539495|NCT00786994|1316232|P2|STARTED|Overall Study||54
539496|NCT00786994|1316233|P1|STARTED|Overall Study||57
539497|NCT00786916|1316245|P3|NOT COMPLETED|Overall Study||0
539498|NCT00786916|1316246|P2|NOT COMPLETED|Overall Study||0
539499|NCT00786916|1316247|P1|NOT COMPLETED|Overall Study||0
539500|NCT00786916|1316245|P3|COMPLETED|Overall Study||34
539501|NCT00786916|1316246|P2|COMPLETED|Overall Study||36
539502|NCT00786916|1316247|P1|COMPLETED|Overall Study||39
539503|NCT00786916|1316245|P3|STARTED|Overall Study||34
539504|NCT00786916|1316246|P2|STARTED|Overall Study||36
539505|NCT00786916|1316247|P1|STARTED|Overall Study||39
539506|NCT00786864|1316257|P2|NOT COMPLETED|Overall Study||1
539507|NCT00786864|1316258|P1|NOT COMPLETED|Overall Study||1
539508|NCT00786864|1316257|P2|COMPLETED|Overall Study|1 child lost to study immediately post-intervention as she left the school|32
539509|NCT00786864|1316258|P1|COMPLETED|Overall Study|1 child excluded at the 3 month follow-up, as he sustained a serious back injury|38
539510|NCT00786864|1316257|P2|STARTED|Overall Study||33
539511|NCT00786864|1316258|P1|STARTED|Overall Study||39
539512|NCT00786838|1316270|P1|NOT COMPLETED|Overall Study||49
539513|NCT00786838|1316270|P1|COMPLETED|Overall Study||26
539514|NCT00786838|1316270|P1|STARTED|Overall Study||75
539515|NCT00786799|1316297|P2|NOT COMPLETED|Overall Study||1
539516|NCT00786799|1316298|P1|NOT COMPLETED|Overall Study||1
539517|NCT00786799|1316297|P2|COMPLETED|Overall Study||12
539518|NCT00786799|1316298|P1|COMPLETED|Overall Study||13
539519|NCT00786799|1316297|P2|STARTED|Overall Study||13
539520|NCT00786799|1316298|P1|STARTED|Overall Study||14
539521|NCT00786682|1316309|P1|NOT COMPLETED|Overall Study||0
539522|NCT00786682|1316309|P1|COMPLETED|Overall Study||11
539523|NCT00786682|1316309|P1|STARTED|Overall Study||11
539524|NCT00786643|1316317|P2|NOT COMPLETED|Overall Study||0
539525|NCT00786643|1316318|P1|NOT COMPLETED|Overall Study||0
539526|NCT00786643|1316317|P2|COMPLETED|Overall Study||28
539527|NCT00786643|1316318|P1|COMPLETED|Overall Study||20
539528|NCT00786643|1316317|P2|STARTED|Overall Study||28
539529|NCT00786643|1316318|P1|STARTED|Overall Study||20
539530|NCT00786565|1316328|P1|NOT COMPLETED|Post Surgery||2
539531|NCT00786565|1316328|P1|COMPLETED|Post Surgery|67 Participants (134 eyes) completed the study.|67
539532|NCT00786565|1316328|P1|STARTED|Post Surgery||69
539533|NCT00786565|1316328|P1|NOT COMPLETED|Enrollment Prior to Surgery||6
539534|NCT00786565|1316328|P1|COMPLETED|Enrollment Prior to Surgery|69 participants - Akreos Advanced Optic Lens in one eye and Akreos Adapt Lens in the fellow eye.|69
539535|NCT00786565|1316328|P1|STARTED|Enrollment Prior to Surgery||75
539536|NCT00786487|1316370|P4|NOT COMPLETED|Overall Study||0
539537|NCT00786487|1316371|P3|NOT COMPLETED|Overall Study||0
539538|NCT00786487|1316372|P2|NOT COMPLETED|Overall Study||0
539539|NCT00786487|1316373|P1|NOT COMPLETED|Overall Study||0
539540|NCT00786487|1316370|P4|COMPLETED|Overall Study||7
539541|NCT00786487|1316371|P3|COMPLETED|Overall Study||9
539542|NCT00786487|1316372|P2|COMPLETED|Overall Study||7
539543|NCT00786487|1316373|P1|COMPLETED|Overall Study||10
539544|NCT00786487|1316370|P4|STARTED|Overall Study||7
539545|NCT00786487|1316371|P3|STARTED|Overall Study||9
539546|NCT00786487|1316372|P2|STARTED|Overall Study||7
539547|NCT00786487|1316373|P1|STARTED|Overall Study||10
539548|NCT00786474|1316385|P2|NOT COMPLETED|Overall Study||43
539549|NCT00786474|1316386|P1|NOT COMPLETED|Overall Study||37
539550|NCT00786474|1316385|P2|COMPLETED|Overall Study||891
539551|NCT00786474|1316386|P1|COMPLETED|Overall Study||913
539552|NCT00786474|1316385|P2|STARTED|Overall Study||934
539553|NCT00786474|1316386|P1|STARTED|Overall Study||950
539554|NCT00786422|1316398|P1|NOT COMPLETED|Follow-up Period||3
539555|NCT00786422|1316398|P1|COMPLETED|Follow-up Period||17
539556|NCT00786422|1316398|P1|STARTED|Follow-up Period|Participants entered follow-up period. No reason documents for those not entering this period|20
539557|NCT00786422|1316398|P1|NOT COMPLETED|Rivaroxaban Treatment||11
539558|NCT00786422|1316398|P1|COMPLETED|Rivaroxaban Treatment||14
539559|NCT00786422|1316398|P1|STARTED|Rivaroxaban Treatment||25
539560|NCT00786409|1316414|P1|NOT COMPLETED|Overall Study||7
539561|NCT00786409|1316414|P1|COMPLETED|Overall Study||20
539562|NCT00786409|1316414|P1|STARTED|Overall Study||27
539563|NCT00786188|1316431|P2|NOT COMPLETED|Overall Study||1
539564|NCT00786188|1316432|P1|NOT COMPLETED|Overall Study||5
539565|NCT00786188|1316431|P2|COMPLETED|Overall Study||51
539566|NCT00786188|1316432|P1|COMPLETED|Overall Study||45
539567|NCT00786188|1316431|P2|STARTED|Overall Study||52
539568|NCT00786188|1316432|P1|STARTED|Overall Study||50
539569|NCT00786032|1316458|P1|NOT COMPLETED|Overall Study||24
539570|NCT00786032|1316458|P1|COMPLETED|Overall Study||3
539571|NCT00786032|1316458|P1|Independent Users|Overall Study|All data analyses were based on the 14 independent users.|14
539572|NCT00786032|1316458|P1|STARTED|Overall Study||27
539573|NCT00785980|1316468|P1|NOT COMPLETED|Quinine Sulfate With Ciprofloxacin||0
539574|NCT00785980|1316468|P1|COMPLETED|Quinine Sulfate With Ciprofloxacin||21
539575|NCT00785980|1316468|P1|STARTED|Quinine Sulfate With Ciprofloxacin||21
539576|NCT00785980|1316468|P1|NOT COMPLETED|Ciprofloxacin Alone||0
539577|NCT00785980|1316468|P1|COMPLETED|Ciprofloxacin Alone||21
539578|NCT00785980|1316468|P1|STARTED|Ciprofloxacin Alone||21
539579|NCT00785980|1316468|P1|NOT COMPLETED|7 Day Washout Period||3
539580|NCT00785980|1316468|P1|COMPLETED|7 Day Washout Period||21
539581|NCT00785980|1316468|P1|STARTED|7 Day Washout Period||24
539582|NCT00785980|1316468|P1|NOT COMPLETED|Quinine Sulfate Alone||0
539583|NCT00785980|1316468|P1|COMPLETED|Quinine Sulfate Alone||24
539584|NCT00785980|1316468|P1|STARTED|Quinine Sulfate Alone||24
539585|NCT00785798|1316479|P1|NOT COMPLETED|Overall Study||1
539586|NCT00785798|1316479|P1|COMPLETED|Overall Study||16
539587|NCT00785798|1316479|P1|STARTED|Overall Study||17
539588|NCT00785785|1316486|P2|NOT COMPLETED|Optional Extension Phase||125
539589|NCT00785785|1316487|P1|NOT COMPLETED|Optional Extension Phase||39
539590|NCT00785785|1316486|P2|COMPLETED|Optional Extension Phase||0
539591|NCT00785785|1316487|P1|COMPLETED|Optional Extension Phase||0
539592|NCT00785785|1316486|P2|STARTED|Optional Extension Phase|crossover extension phase was optional|125
539593|NCT00785785|1316487|P1|STARTED|Optional Extension Phase|crossover extension phase was optional|39
539594|NCT00785785|1316486|P2|NOT COMPLETED|Core Phase up to 36 Months||320
539595|NCT00785785|1316487|P1|NOT COMPLETED|Core Phase up to 36 Months||324
539596|NCT00785785|1316486|P2|COMPLETED|Core Phase up to 36 Months||0
539597|NCT00785785|1316487|P1|COMPLETED|Core Phase up to 36 Months||0
539598|NCT00785785|1316486|P2|STARTED|Core Phase up to 36 Months||320
539599|NCT00785785|1316487|P1|STARTED|Core Phase up to 36 Months||324
539600|NCT00785772|1316495|P1|NOT COMPLETED|Overall Study||0
539601|NCT00785772|1316495|P1|COMPLETED|Overall Study||1
539602|NCT00785772|1316495|P1|STARTED|Overall Study||1
539603|NCT00785707|1316501|P1|NOT COMPLETED|Overall Study||7
539604|NCT00785707|1316501|P1|COMPLETED|Overall Study||24
539605|NCT00785707|1316501|P1|STARTED|Overall Study||31
539606|NCT00785629|1316510|P4|NOT COMPLETED|Overall Study||16
539607|NCT00785629|1316511|P3|NOT COMPLETED|Overall Study||10
539608|NCT00785629|1316512|P2|NOT COMPLETED|Overall Study||5
539609|NCT00785629|1316513|P1|NOT COMPLETED|Overall Study||8
539610|NCT00785629|1316510|P4|COMPLETED|Overall Study|16 not completed|41
539611|NCT00785629|1316511|P3|COMPLETED|Overall Study|10 not completed|18
539612|NCT00785629|1316512|P2|COMPLETED|Overall Study|5 not completed|25
539613|NCT00785629|1316513|P1|COMPLETED|Overall Study|8 not completed|22
539614|NCT00785629|1316510|P4|STARTED|Overall Study||57
539615|NCT00785629|1316511|P3|STARTED|Overall Study||28
539616|NCT00785629|1316512|P2|STARTED|Overall Study||30
539617|NCT00785629|1316513|P1|STARTED|Overall Study||30
539618|NCT00785577|1316526|P5|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
539619|NCT00785577|1316527|P4|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
539620|NCT00785577|1316528|P3|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
539621|NCT00785577|1316529|P2|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
539622|NCT00785577|1316530|P1|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
539623|NCT00785577|1316526|P5|COMPLETED|Study Period 3: 1-Week Washout Phase||26
539624|NCT00785577|1316527|P4|COMPLETED|Study Period 3: 1-Week Washout Phase||35
539625|NCT00785577|1316528|P3|COMPLETED|Study Period 3: 1-Week Washout Phase||25
539626|NCT00785577|1316529|P2|COMPLETED|Study Period 3: 1-Week Washout Phase||36
539627|NCT00785577|1316530|P1|COMPLETED|Study Period 3: 1-Week Washout Phase||78
539628|NCT00785577|1316526|P5|STARTED|Study Period 3: 1-Week Washout Phase||27
539629|NCT00785577|1316527|P4|STARTED|Study Period 3: 1-Week Washout Phase||36
539630|NCT00785577|1316528|P3|STARTED|Study Period 3: 1-Week Washout Phase||25
539631|NCT00785577|1316529|P2|STARTED|Study Period 3: 1-Week Washout Phase||36
539632|NCT00785577|1316530|P1|STARTED|Study Period 3: 1-Week Washout Phase||78
539633|NCT00785577|1316526|P5|NOT COMPLETED|Study Period 2: Therapy Phase||20
539634|NCT00785577|1316527|P4|NOT COMPLETED|Study Period 2: Therapy Phase||13
539635|NCT00785577|1316528|P3|NOT COMPLETED|Study Period 2: Therapy Phase||18
539636|NCT00785577|1316529|P2|NOT COMPLETED|Study Period 2: Therapy Phase||9
539637|NCT00785577|1316530|P1|NOT COMPLETED|Study Period 2: Therapy Phase||11
539638|NCT00785577|1316526|P5|COMPLETED|Study Period 2: Therapy Phase||27
539639|NCT00785577|1316527|P4|COMPLETED|Study Period 2: Therapy Phase||36
539640|NCT00785577|1316528|P3|COMPLETED|Study Period 2: Therapy Phase||25
539641|NCT00785577|1316529|P2|COMPLETED|Study Period 2: Therapy Phase||36
539642|NCT00785577|1316530|P1|COMPLETED|Study Period 2: Therapy Phase||78
539643|NCT00785577|1316526|P5|STARTED|Study Period 2: Therapy Phase||47
539644|NCT00785577|1316527|P4|STARTED|Study Period 2: Therapy Phase||49
539645|NCT00785577|1316528|P3|STARTED|Study Period 2: Therapy Phase||43
539646|NCT00785577|1316529|P2|STARTED|Study Period 2: Therapy Phase||45
539647|NCT00785577|1316530|P1|STARTED|Study Period 2: Therapy Phase||89
539648|NCT00785512|1316668|P2|NOT COMPLETED|Overall Study||4
539649|NCT00785512|1316669|P1|NOT COMPLETED|Overall Study||3
539650|NCT00785512|1316668|P2|COMPLETED|Overall Study||101
539651|NCT00785512|1316669|P1|COMPLETED|Overall Study||99
539652|NCT00785512|1316668|P2|STARTED|Overall Study||105
539653|NCT00785512|1316669|P1|STARTED|Overall Study||102
539654|NCT00785486|1316678|P1|NOT COMPLETED|Midazolam With Qualaquin at Steady State||0
539655|NCT00785486|1316678|P1|COMPLETED|Midazolam With Qualaquin at Steady State||23
539656|NCT00785486|1316678|P1|STARTED|Midazolam With Qualaquin at Steady State||23
539657|NCT00785486|1316678|P1|NOT COMPLETED|Qualaquin Alone at Steady State||0
539658|NCT00785486|1316678|P1|COMPLETED|Qualaquin Alone at Steady State||23
539659|NCT00785486|1316678|P1|STARTED|Qualaquin Alone at Steady State||23
539660|NCT00785486|1316678|P1|NOT COMPLETED|3 Day Washout||0
539661|NCT00785486|1316678|P1|COMPLETED|3 Day Washout||23
539662|NCT00785486|1316678|P1|STARTED|3 Day Washout||23
539663|NCT00785486|1316678|P1|NOT COMPLETED|Midazolam Alone||1
539664|NCT00785486|1316678|P1|COMPLETED|Midazolam Alone|one participant withdrew for personal reasons after first midazolam dose|23
539665|NCT00785486|1316678|P1|STARTED|Midazolam Alone||24
539666|NCT00785356|1316702|P1|NOT COMPLETED|Overall Study||8
539667|NCT00785356|1316702|P1|COMPLETED|Overall Study||0
539668|NCT00785356|1316702|P1|STARTED|Overall Study||8
539669|NCT00785291|1316713|P3|NOT COMPLETED|Overall Study||106
539670|NCT00785291|1316714|P2|NOT COMPLETED|Overall Study||149
539671|NCT00785291|1316715|P1|NOT COMPLETED|Overall Study||136
539672|NCT00785291|1316713|P3|COMPLETED|Overall Study||139
539673|NCT00785291|1316714|P2|COMPLETED|Overall Study||122
539674|NCT00785291|1316715|P1|COMPLETED|Overall Study||147
539675|NCT00785291|1316713|P3|STARTED|Overall Study||245
539676|NCT00785291|1316714|P2|STARTED|Overall Study||271
539677|NCT00785291|1316715|P1|STARTED|Overall Study||283
539678|NCT00785213|1316735|P1|NOT COMPLETED|Rosiglitazone With Quinine Sulfate||1
539679|NCT00785213|1316735|P1|COMPLETED|Rosiglitazone With Quinine Sulfate||18
539680|NCT00785213|1316735|P1|STARTED|Rosiglitazone With Quinine Sulfate||19
539681|NCT00785213|1316735|P1|NOT COMPLETED|Quinine Sulfate Alone||4
539682|NCT00785213|1316735|P1|COMPLETED|Quinine Sulfate Alone||19
539683|NCT00785213|1316735|P1|STARTED|Quinine Sulfate Alone||23
539684|NCT00785213|1316735|P1|NOT COMPLETED|2 Day Washout Period||0
539685|NCT00785213|1316735|P1|COMPLETED|2 Day Washout Period||23
539686|NCT00785213|1316735|P1|STARTED|2 Day Washout Period||23
539687|NCT00785213|1316735|P1|NOT COMPLETED|Rosiglitazone Alone||0
539688|NCT00785213|1316735|P1|COMPLETED|Rosiglitazone Alone||23
539689|NCT00785213|1316735|P1|STARTED|Rosiglitazone Alone||23
539690|NCT00785044|1316746|P1|NOT COMPLETED|Overall Study||496
539691|NCT00785044|1316746|P1|COMPLETED|Overall Study|Data for 471 participants (MBG313) combined with data from MBG311 and MBG312 for efficacy analysis|468
539692|NCT00785044|1316746|P1|Enrolled Participants|Overall Study|Out of 964 from MBG311 and MBG312 HF participants, 471 enrolled into the extension MBG313 study.|471
539693|NCT00785044|1316746|P1|STARTED|Overall Study|Eligible to participate in MBG313|964
539694|NCT00784979|1316751|P1|NOT COMPLETED|Overall Study||6
539695|NCT00784979|1316751|P1|COMPLETED|Overall Study||20
539696|NCT00784979|1316751|P1|STARTED|Overall Study||26
539697|NCT00784927|1316755|P1|NOT COMPLETED|Overall Study||3
539698|NCT00784927|1316755|P1|COMPLETED|Overall Study||33
539699|NCT00784927|1316755|P1|STARTED|Overall Study||36
539700|NCT00784875|1316767|P4|NOT COMPLETED|Period D||1
539701|NCT00784875|1316768|P3|NOT COMPLETED|Period D||6
539702|NCT00784875|1316769|P2|NOT COMPLETED|Period D||4
539703|NCT00784875|1316770|P1|NOT COMPLETED|Period D||5
539704|NCT00784875|1316767|P4|COMPLETED|Period D||87
539705|NCT00784875|1316768|P3|COMPLETED|Period D||88
539706|NCT00784875|1316769|P2|COMPLETED|Period D||85
539707|NCT00784875|1316770|P1|COMPLETED|Period D||86
539708|NCT00784875|1316767|P4|STARTED|Period D||88
539709|NCT00784875|1316768|P3|STARTED|Period D||94
539710|NCT00784875|1316769|P2|STARTED|Period D||89
539711|NCT00784875|1316770|P1|STARTED|Period D||91
539712|NCT00784875|1316767|P4|NOT COMPLETED|Period C||7
539713|NCT00784875|1316768|P3|NOT COMPLETED|Period C||13
539714|NCT00784875|1316769|P2|NOT COMPLETED|Period C||6
539715|NCT00784875|1316770|P1|NOT COMPLETED|Period C||7
539716|NCT00784875|1316767|P4|COMPLETED|Period C||91
539717|NCT00784875|1316768|P3|COMPLETED|Period C||84
539718|NCT00784875|1316769|P2|COMPLETED|Period C||91
539719|NCT00784875|1316770|P1|COMPLETED|Period C||96
539720|NCT00784875|1316767|P4|STARTED|Period C||98
539721|NCT00784875|1316768|P3|STARTED|Period C||97
539722|NCT00784875|1316769|P2|STARTED|Period C||97
539723|NCT00784875|1316770|P1|STARTED|Period C||103
539724|NCT00784875|1316767|P4|NOT COMPLETED|Period B - Efficacy Endpoint||19
539725|NCT00784875|1316768|P3|NOT COMPLETED|Period B - Efficacy Endpoint||21
539726|NCT00784875|1316769|P2|NOT COMPLETED|Period B - Efficacy Endpoint||12
539727|NCT00784875|1316770|P1|NOT COMPLETED|Period B - Efficacy Endpoint||14
539728|NCT00784875|1316767|P4|COMPLETED|Period B - Efficacy Endpoint||98
539729|NCT00784875|1316768|P3|COMPLETED|Period B - Efficacy Endpoint||96
539730|NCT00784875|1316769|P2|COMPLETED|Period B - Efficacy Endpoint||101
539731|NCT00784875|1316770|P1|COMPLETED|Period B - Efficacy Endpoint||100
539732|NCT00784875|1316767|P4|Cohort 2|Period B - Efficacy Endpoint||101
539733|NCT00784875|1316768|P3|Cohort 2|Period B - Efficacy Endpoint||102
539734|NCT00784875|1316769|P2|Cohort 2|Period B - Efficacy Endpoint||102
539735|NCT00784875|1316770|P1|Cohort 2|Period B - Efficacy Endpoint||102
539736|NCT00784875|1316767|P4|STARTED|Period B - Efficacy Endpoint||117
539737|NCT00784875|1316768|P3|STARTED|Period B - Efficacy Endpoint||117
539738|NCT00784875|1316769|P2|STARTED|Period B - Efficacy Endpoint||113
539739|NCT00784875|1316770|P1|STARTED|Period B - Efficacy Endpoint||114
539740|NCT00784875|1316767|P4|NOT COMPLETED|Period A - Baseline||182
539741|NCT00784875|1316768|P3|NOT COMPLETED|Period A - Baseline||0
539742|NCT00784875|1316769|P2|NOT COMPLETED|Period A - Baseline||0
539743|NCT00784875|1316770|P1|NOT COMPLETED|Period A - Baseline||0
539744|NCT00784875|1316767|P4|COMPLETED|Period A - Baseline||461
539745|NCT00784875|1316768|P3|COMPLETED|Period A - Baseline||0
539746|NCT00784875|1316769|P2|COMPLETED|Period A - Baseline||0
539747|NCT00784875|1316770|P1|COMPLETED|Period A - Baseline||0
539748|NCT00784875|1316767|P4|STARTED|Period A - Baseline||643
539749|NCT00784875|1316768|P3|STARTED|Period A - Baseline||0
539750|NCT00784875|1316769|P2|STARTED|Period A - Baseline||0
539751|NCT00784875|1316770|P1|STARTED|Period A - Baseline||0
539752|NCT00784849|1316884|P1|NOT COMPLETED|Overall Study||0
539753|NCT00784849|1316884|P1|COMPLETED|Overall Study||62
539754|NCT00784849|1316884|P1|STARTED|Overall Study||62
539755|NCT00784836|1316890|P1|NOT COMPLETED|Overall Study||3
539756|NCT00784836|1316890|P1|COMPLETED|Overall Study|The study was terminated early by the Sponsor for business reason not related to safety.|0
539757|NCT00784836|1316890|P1|STARTED|Overall Study||3
539758|NCT00784810|1316897|P2|NOT COMPLETED|Overall Study||49
539759|NCT00784810|1316898|P1|NOT COMPLETED|Overall Study||63
539760|NCT00784810|1316897|P2|COMPLETED|Overall Study||74
539761|NCT00784810|1316898|P1|COMPLETED|Overall Study||61
539762|NCT00784810|1316897|P2|STARTED|Overall Study||123
539763|NCT00784810|1316898|P1|STARTED|Overall Study||124
539764|NCT00784784|1316908|P2|NOT COMPLETED|Overall Study||2
539765|NCT00784784|1316909|P1|NOT COMPLETED|Overall Study||2
539766|NCT00784784|1316908|P2|COMPLETED|Overall Study||40
539767|NCT00784784|1316909|P1|COMPLETED|Overall Study||20
539768|NCT00784784|1316908|P2|STARTED|Overall Study||42
539769|NCT00784784|1316909|P1|STARTED|Overall Study||22
539770|NCT00784719|1316924|P7|NOT COMPLETED|Overall Study||5
539771|NCT00784719|1316925|P6|NOT COMPLETED|Overall Study||3
539772|NCT00784719|1316926|P5|NOT COMPLETED|Overall Study||6
539773|NCT00784719|1316927|P4|NOT COMPLETED|Overall Study||0
539774|NCT00784719|1316928|P3|NOT COMPLETED|Overall Study||1
539775|NCT00784719|1316929|P2|NOT COMPLETED|Overall Study||3
539776|NCT00784719|1316930|P1|NOT COMPLETED|Overall Study||3
539777|NCT00784719|1316924|P7|COMPLETED|Overall Study||42
539778|NCT00784719|1316925|P6|COMPLETED|Overall Study||41
539779|NCT00784719|1316926|P5|COMPLETED|Overall Study||42
539780|NCT00784719|1316927|P4|COMPLETED|Overall Study||48
539781|NCT00784719|1316928|P3|COMPLETED|Overall Study||46
539782|NCT00784719|1316929|P2|COMPLETED|Overall Study||43
539783|NCT00784719|1316930|P1|COMPLETED|Overall Study||44
539784|NCT00784719|1316924|P7|STARTED|Overall Study||47
539785|NCT00784719|1316925|P6|STARTED|Overall Study||44
539786|NCT00784719|1316926|P5|STARTED|Overall Study||48
539787|NCT00784719|1316927|P4|STARTED|Overall Study||48
539788|NCT00784719|1316928|P3|STARTED|Overall Study||47
539789|NCT00784719|1316929|P2|STARTED|Overall Study||46
539790|NCT00784719|1316930|P1|STARTED|Overall Study||47
539791|NCT00784654|1317100|P3|NOT COMPLETED|Randomized Withdrawal Period||63
539792|NCT00784654|1317101|P2|NOT COMPLETED|Randomized Withdrawal Period||18
539793|NCT00784654|1317102|P1|NOT COMPLETED|Randomized Withdrawal Period||0
539794|NCT00784654|1317100|P3|COMPLETED|Randomized Withdrawal Period||16
539795|NCT00784654|1317101|P2|COMPLETED|Randomized Withdrawal Period||60
539796|NCT00784654|1317102|P1|COMPLETED|Randomized Withdrawal Period||0
539797|NCT00784654|1317100|P3|STARTED|Randomized Withdrawal Period||79
539798|NCT00784654|1317101|P2|STARTED|Randomized Withdrawal Period||78
539799|NCT00784654|1317102|P1|STARTED|Randomized Withdrawal Period||0
539800|NCT00784654|1317100|P3|NOT COMPLETED|Open-Label Period (Non-Randomized)||0
539801|NCT00784654|1317101|P2|NOT COMPLETED|Open-Label Period (Non-Randomized)||0
539802|NCT00784654|1317102|P1|NOT COMPLETED|Open-Label Period (Non-Randomized)||111
539803|NCT00784654|1317100|P3|COMPLETED|Open-Label Period (Non-Randomized)||0
539804|NCT00784654|1317101|P2|COMPLETED|Open-Label Period (Non-Randomized)||0
539805|NCT00784654|1317102|P1|COMPLETED|Open-Label Period (Non-Randomized)||165
539806|NCT00784654|1317100|P3|STARTED|Open-Label Period (Non-Randomized)||0
539807|NCT00784654|1317101|P2|STARTED|Open-Label Period (Non-Randomized)||0
539808|NCT00784654|1317102|P1|STARTED|Open-Label Period (Non-Randomized)||276
539809|NCT00784563|1317137|P3|NOT COMPLETED|Year 3||3
539810|NCT00784563|1317138|P2|NOT COMPLETED|Year 3||0
539811|NCT00784563|1317139|P1|NOT COMPLETED|Year 3||0
539812|NCT00784563|1317137|P3|COMPLETED|Year 3||14
539813|NCT00784563|1317138|P2|COMPLETED|Year 3||0
539814|NCT00784563|1317139|P1|COMPLETED|Year 3||0
539815|NCT00784563|1317137|P3|STARTED|Year 3||17
539816|NCT00784563|1317138|P2|STARTED|Year 3||0
539817|NCT00784563|1317139|P1|STARTED|Year 3||0
539818|NCT00784563|1317137|P3|NOT COMPLETED|Years 1 & 2||0
539819|NCT00784563|1317138|P2|NOT COMPLETED|Years 1 & 2||5
539820|NCT00784563|1317139|P1|NOT COMPLETED|Years 1 & 2||3
539821|NCT00784563|1317137|P3|COMPLETED|Years 1 & 2||0
539822|NCT00784563|1317138|P2|COMPLETED|Years 1 & 2||17
539823|NCT00784563|1317139|P1|COMPLETED|Years 1 & 2||18
539824|NCT00784563|1317137|P3|STARTED|Years 1 & 2||0
539825|NCT00784563|1317138|P2|STARTED|Years 1 & 2||22
539826|NCT00784563|1317139|P1|STARTED|Years 1 & 2||21
539827|NCT00784550|1317157|P2|NOT COMPLETED|Overall Study||42
539828|NCT00784550|1317158|P1|NOT COMPLETED|Overall Study||36
539829|NCT00784550|1317157|P2|COMPLETED|Overall Study||127
539830|NCT00784550|1317158|P1|COMPLETED|Overall Study||137
539831|NCT00784550|1317157|P2|STARTED|Overall Study||169
539832|NCT00784550|1317158|P1|STARTED|Overall Study||173
539833|NCT00784459|1317176|P2|NOT COMPLETED|Overall Study||2
539834|NCT00784459|1317177|P1|NOT COMPLETED|Overall Study||0
539835|NCT00784459|1317176|P2|COMPLETED|Overall Study||11
539836|NCT00784459|1317177|P1|COMPLETED|Overall Study||11
539837|NCT00784459|1317176|P2|STARTED|Overall Study||13
539838|NCT00784459|1317177|P1|STARTED|Overall Study||11
539839|NCT00784368|1317188|P3|NOT COMPLETED|Overall Study||11
539840|NCT00784368|1317189|P2|NOT COMPLETED|Overall Study||11
539841|NCT00784368|1317190|P1|NOT COMPLETED|Overall Study||8
539842|NCT00784368|1317188|P3|COMPLETED|Overall Study||12
539843|NCT00784368|1317189|P2|COMPLETED|Overall Study||5
539844|NCT00784368|1317190|P1|COMPLETED|Overall Study||8
539845|NCT00784368|1317188|P3|STARTED|Overall Study||23
539846|NCT00784368|1317189|P2|STARTED|Overall Study||16
539847|NCT00784368|1317190|P1|STARTED|Overall Study||16
539848|NCT00784277|1317228|P7|NOT COMPLETED|ER Treatment||15
539849|NCT00784277|1317229|P6|NOT COMPLETED|ER Treatment||24
539850|NCT00784277|1317230|P5|NOT COMPLETED|ER Treatment||9
539851|NCT00784277|1317231|P4|NOT COMPLETED|ER Treatment||0
539852|NCT00784277|1317232|P3|NOT COMPLETED|ER Treatment||0
539853|NCT00784277|1317233|P2|NOT COMPLETED|ER Treatment||0
539854|NCT00784277|1317234|P1|NOT COMPLETED|ER Treatment||0
539855|NCT00784277|1317228|P7|COMPLETED|ER Treatment||76
539856|NCT00784277|1317229|P6|COMPLETED|ER Treatment||226
539857|NCT00784277|1317230|P5|COMPLETED|ER Treatment||113
539858|NCT00784277|1317231|P4|COMPLETED|ER Treatment||0
539859|NCT00784277|1317232|P3|COMPLETED|ER Treatment||0
539860|NCT00784277|1317233|P2|COMPLETED|ER Treatment||0
539861|NCT00784277|1317234|P1|COMPLETED|ER Treatment||0
539862|NCT00784277|1317228|P7|STARTED|ER Treatment|9 participants who had completed IR treatment have not taken any ER treatment.|91
539863|NCT00784277|1317229|P6|STARTED|ER Treatment|10 participants who had completed IR treatment have not taken any ER treatment.|250
539864|NCT00784277|1317230|P5|STARTED|ER Treatment|10 participants who had completed IR treatment have not taken any ER treatment.|122
539865|NCT00784277|1317231|P4|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
539866|NCT00784277|1317232|P3|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
539867|NCT00784277|1317233|P2|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
539868|NCT00784277|1317234|P1|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
539869|NCT00784277|1317228|P7|NOT COMPLETED|IR Treatment||0
539870|NCT00784277|1317229|P6|NOT COMPLETED|IR Treatment||0
539871|NCT00784277|1317230|P5|NOT COMPLETED|IR Treatment||0
539872|NCT00784277|1317231|P4|NOT COMPLETED|IR Treatment||43
539873|NCT00784277|1317232|P3|NOT COMPLETED|IR Treatment||28
539874|NCT00784277|1317233|P2|NOT COMPLETED|IR Treatment||17
539875|NCT00784277|1317234|P1|NOT COMPLETED|IR Treatment||16
539876|NCT00784277|1317228|P7|COMPLETED|IR Treatment||0
539877|NCT00784277|1317229|P6|COMPLETED|IR Treatment||0
539878|NCT00784277|1317230|P5|COMPLETED|IR Treatment||0
539879|NCT00784277|1317231|P4|COMPLETED|IR Treatment||100
539880|NCT00784277|1317232|P3|COMPLETED|IR Treatment||126
539881|NCT00784277|1317233|P2|COMPLETED|IR Treatment||134
539882|NCT00784277|1317234|P1|COMPLETED|IR Treatment||132
539883|NCT00784277|1317228|P7|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
539884|NCT00784277|1317229|P6|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
539885|NCT00784277|1317230|P5|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
539886|NCT00784277|1317231|P4|STARTED|IR Treatment||143
539887|NCT00784277|1317232|P3|STARTED|IR Treatment||154
539888|NCT00784277|1317233|P2|STARTED|IR Treatment||151
539889|NCT00784277|1317234|P1|STARTED|IR Treatment||148
539890|NCT00784238|1317251|P1|NOT COMPLETED|Overall Study||119
539891|NCT00784238|1317251|P1|COMPLETED|Overall Study||170
539892|NCT00784238|1317251|P1|STARTED|Overall Study||289
539893|NCT00784147|1317294|P2|NOT COMPLETED|Overall Study||9
539894|NCT00784147|1317295|P1|NOT COMPLETED|Overall Study||8
539895|NCT00784147|1317294|P2|COMPLETED|Overall Study||45
539896|NCT00784147|1317295|P1|COMPLETED|Overall Study||51
539897|NCT00784147|1317294|P2|STARTED|Overall Study||54
539898|NCT00784147|1317295|P1|STARTED|Overall Study||59
539899|NCT00784134|1317315|P2|NOT COMPLETED|Overall Study||6
539900|NCT00784134|1317316|P1|NOT COMPLETED|Overall Study||3
539901|NCT00784134|1317315|P2|COMPLETED|Overall Study||245
539902|NCT00784134|1317316|P1|COMPLETED|Overall Study||246
539903|NCT00784134|1317315|P2|STARTED|Overall Study||251
539904|NCT00784134|1317316|P1|STARTED|Overall Study||249
539905|NCT00784095|1317415|P3|NOT COMPLETED|Overall Study||1
539906|NCT00784095|1317416|P2|NOT COMPLETED|Overall Study||1
539907|NCT00784095|1317417|P1|NOT COMPLETED|Overall Study||0
539908|NCT00784095|1317415|P3|COMPLETED|Overall Study||11
539909|NCT00784095|1317416|P2|COMPLETED|Overall Study||11
539910|NCT00784095|1317417|P1|COMPLETED|Overall Study||12
539911|NCT00784095|1317415|P3|STARTED|Overall Study||12
539912|NCT00784095|1317416|P2|STARTED|Overall Study||12
539913|NCT00784095|1317417|P1|STARTED|Overall Study||12
539914|NCT00784043|1317439|P2|NOT COMPLETED|Overall Study||6
539915|NCT00784043|1317440|P1|NOT COMPLETED|Overall Study||31
539916|NCT00784043|1317439|P2|COMPLETED|Overall Study||0
539917|NCT00784043|1317440|P1|COMPLETED|Overall Study||0
539918|NCT00784043|1317439|P2|STARTED|Overall Study||6
539919|NCT00784043|1317440|P1|STARTED|Overall Study||31
539920|NCT00784030|1317452|P2|NOT COMPLETED|Overall Study||0
539921|NCT00784030|1317453|P1|NOT COMPLETED|Overall Study||0
539922|NCT00784030|1317452|P2|COMPLETED|Overall Study||10
539923|NCT00784030|1317453|P1|COMPLETED|Overall Study||13
539924|NCT00784030|1317452|P2|STARTED|Overall Study||10
539925|NCT00784030|1317453|P1|STARTED|Overall Study||13
539926|NCT00783965|1317461|P2|NOT COMPLETED|Second Intervention (24 Months)||9
539927|NCT00783965|1317462|P1|NOT COMPLETED|Second Intervention (24 Months)||0
539928|NCT00783965|1317461|P2|COMPLETED|Second Intervention (24 Months)||16
539929|NCT00783965|1317462|P1|COMPLETED|Second Intervention (24 Months)||2
539930|NCT00783965|1317461|P2|STARTED|Second Intervention (24 Months)||25
539931|NCT00783965|1317462|P1|STARTED|Second Intervention (24 Months)||2
539932|NCT00783965|1317461|P2|NOT COMPLETED|First Intervention (12 Months)||4
539933|NCT00783965|1317462|P1|NOT COMPLETED|First Intervention (12 Months)||3
539934|NCT00783965|1317461|P2|COMPLETED|First Intervention (12 Months)||25
539935|NCT00783965|1317462|P1|COMPLETED|First Intervention (12 Months)||2
539936|NCT00783965|1317461|P2|STARTED|First Intervention (12 Months)||29
539937|NCT00783965|1317462|P1|STARTED|First Intervention (12 Months)||5
539938|NCT00783952|1317470|P1|NOT COMPLETED|Overall Study||0
539939|NCT00783952|1317470|P1|COMPLETED|Overall Study||8
539940|NCT00783952|1317470|P1|STARTED|Overall Study||8
539941|NCT00783835|1317475|P1|NOT COMPLETED|Overall Study||10
539942|NCT00783835|1317475|P1|COMPLETED|Overall Study||50
539943|NCT00783835|1317475|P1|STARTED|Overall Study||60
539944|NCT00783796|1317487|P1|NOT COMPLETED|Overall Study||6
539945|NCT00783796|1317487|P1|COMPLETED|Overall Study||144
539946|NCT00783796|1317487|P1|STARTED|Overall Study||150
539947|NCT00783718|1317592|P7|NOT COMPLETED|Maintenance Phase||195
539948|NCT00783718|1317593|P6|NOT COMPLETED|Maintenance Phase||41
539949|NCT00783718|1317594|P5|NOT COMPLETED|Maintenance Phase||45
539950|NCT00783718|1317595|P4|NOT COMPLETED|Maintenance Phase||78
539951|NCT00783718|1317596|P3|NOT COMPLETED|Maintenance Phase||0
539952|NCT00783718|1317597|P2|NOT COMPLETED|Maintenance Phase||0
539953|NCT00783718|1317598|P1|NOT COMPLETED|Maintenance Phase||105
539954|NCT00783718|1317592|P7|COMPLETED|Maintenance Phase||135
539955|NCT00783718|1317593|P6|COMPLETED|Maintenance Phase||84
539956|NCT00783718|1317594|P5|COMPLETED|Maintenance Phase||77
539957|NCT00783718|1317595|P4|COMPLETED|Maintenance Phase||48
539958|NCT00783718|1317596|P3|COMPLETED|Maintenance Phase||0
539959|NCT00783718|1317597|P2|COMPLETED|Maintenance Phase||0
539960|NCT00783718|1317598|P1|COMPLETED|Maintenance Phase||30
539961|NCT00783718|1317592|P7|STARTED|Maintenance Phase||330
539962|NCT00783718|1317593|P6|STARTED|Maintenance Phase||125
539963|NCT00783718|1317594|P5|STARTED|Maintenance Phase||122
539964|NCT00783718|1317595|P4|STARTED|Maintenance Phase||126
539965|NCT00783718|1317596|P3|STARTED|Maintenance Phase||0
539966|NCT00783718|1317597|P2|STARTED|Maintenance Phase||0
539967|NCT00783718|1317598|P1|STARTED|Maintenance Phase||135
539968|NCT00783718|1317592|P7|NOT COMPLETED|Induction Phase||0
539969|NCT00783718|1317593|P6|NOT COMPLETED|Induction Phase||0
539970|NCT00783718|1317594|P5|NOT COMPLETED|Induction Phase||0
539971|NCT00783718|1317595|P4|NOT COMPLETED|Induction Phase||0
539972|NCT00783718|1317596|P3|NOT COMPLETED|Induction Phase||36
539973|NCT00783718|1317597|P2|NOT COMPLETED|Induction Phase||7
539974|NCT00783718|1317598|P1|NOT COMPLETED|Induction Phase||14
539975|NCT00783718|1317592|P7|COMPLETED|Induction Phase||0
539976|NCT00783718|1317593|P6|COMPLETED|Induction Phase||0
539977|NCT00783718|1317594|P5|COMPLETED|Induction Phase||0
539978|NCT00783718|1317595|P4|COMPLETED|Induction Phase||0
539979|NCT00783718|1317596|P3|COMPLETED|Induction Phase||485
539980|NCT00783718|1317597|P2|COMPLETED|Induction Phase||218
539981|NCT00783718|1317598|P1|COMPLETED|Induction Phase||135
539982|NCT00783718|1317592|P7|STARTED|Induction Phase||0
539983|NCT00783718|1317593|P6|STARTED|Induction Phase||0
539984|NCT00783718|1317594|P5|STARTED|Induction Phase||0
539985|NCT00783718|1317595|P4|STARTED|Induction Phase||0
539986|NCT00783718|1317596|P3|STARTED|Induction Phase||521
539987|NCT00783718|1317597|P2|STARTED|Induction Phase||225
539988|NCT00783718|1317598|P1|STARTED|Induction Phase||149
539989|NCT00783705|1317626|P2|NOT COMPLETED|Overall Study||5
539990|NCT00783705|1317627|P1|NOT COMPLETED|Overall Study||6
539991|NCT00783705|1317626|P2|COMPLETED|Overall Study||36
539992|NCT00783705|1317627|P1|COMPLETED|Overall Study||38
539993|NCT00783705|1317626|P2|STARTED|Overall Study||41
539994|NCT00783705|1317627|P1|STARTED|Overall Study||44
539995|NCT00783692|1317674|P7|NOT COMPLETED|Maintenance Phase||249
539996|NCT00783692|1317675|P6|NOT COMPLETED|Maintenance Phase||72
539997|NCT00783692|1317676|P5|NOT COMPLETED|Maintenance Phase||81
539998|NCT00783692|1317677|P4|NOT COMPLETED|Maintenance Phase||89
539999|NCT00783692|1317678|P3|NOT COMPLETED|Maintenance Phase||0
540000|NCT00783692|1317679|P2|NOT COMPLETED|Maintenance Phase||0
540001|NCT00783692|1317680|P1|NOT COMPLETED|Maintenance Phase||95
540002|NCT00783692|1317674|P7|COMPLETED|Maintenance Phase||163
540003|NCT00783692|1317675|P6|COMPLETED|Maintenance Phase||82
540004|NCT00783692|1317676|P5|COMPLETED|Maintenance Phase||73
540005|NCT00783692|1317677|P4|COMPLETED|Maintenance Phase||64
540006|NCT00783692|1317678|P3|COMPLETED|Maintenance Phase||0
540007|NCT00783692|1317679|P2|COMPLETED|Maintenance Phase||0
540008|NCT00783692|1317680|P1|COMPLETED|Maintenance Phase||42
540009|NCT00783692|1317674|P7|STARTED|Maintenance Phase||412
540010|NCT00783692|1317675|P6|STARTED|Maintenance Phase||154
540011|NCT00783692|1317676|P5|STARTED|Maintenance Phase||154
540012|NCT00783692|1317677|P4|STARTED|Maintenance Phase||153
540013|NCT00783692|1317678|P3|STARTED|Maintenance Phase||0
540014|NCT00783692|1317679|P2|STARTED|Maintenance Phase||0
540015|NCT00783692|1317680|P1|STARTED|Maintenance Phase||137
540016|NCT00783692|1317674|P7|NOT COMPLETED|Induction Phase||0
540017|NCT00783692|1317675|P6|NOT COMPLETED|Induction Phase||0
540018|NCT00783692|1317676|P5|NOT COMPLETED|Induction Phase||0
540019|NCT00783692|1317677|P4|NOT COMPLETED|Induction Phase||0
540020|NCT00783692|1317678|P3|NOT COMPLETED|Induction Phase||74
540021|NCT00783692|1317679|P2|NOT COMPLETED|Induction Phase||21
540022|NCT00783692|1317680|P1|NOT COMPLETED|Induction Phase||11
540023|NCT00783692|1317674|P7|COMPLETED|Induction Phase||0
540024|NCT00783692|1317675|P6|COMPLETED|Induction Phase||0
540025|NCT00783692|1317676|P5|COMPLETED|Induction Phase||0
540026|NCT00783692|1317677|P4|COMPLETED|Induction Phase||0
540027|NCT00783692|1317678|P3|COMPLETED|Induction Phase||674
540028|NCT00783692|1317679|P2|COMPLETED|Induction Phase||199
540029|NCT00783692|1317680|P1|COMPLETED|Induction Phase||137
540030|NCT00783692|1317674|P7|Treated|Induction Phase||0
540031|NCT00783692|1317675|P6|Treated|Induction Phase||0
540032|NCT00783692|1317676|P5|Treated|Induction Phase||0
540033|NCT00783692|1317677|P4|Treated|Induction Phase||0
540034|NCT00783692|1317678|P3|Treated|Induction Phase||747
540035|NCT00783692|1317679|P2|Treated|Induction Phase||220
540036|NCT00783692|1317680|P1|Treated|Induction Phase||148
540037|NCT00783692|1317674|P7|STARTED|Induction Phase||0
540038|NCT00783692|1317675|P6|STARTED|Induction Phase||0
540039|NCT00783692|1317676|P5|STARTED|Induction Phase||0
540040|NCT00783692|1317677|P4|STARTED|Induction Phase||0
540041|NCT00783692|1317678|P3|STARTED|Induction Phase||748
540042|NCT00783692|1317679|P2|STARTED|Induction Phase||220
540043|NCT00783692|1317680|P1|STARTED|Induction Phase||148
540044|NCT00783614|1317707|P4|NOT COMPLETED|Overall Study||0
540045|NCT00783614|1317708|P3|NOT COMPLETED|Overall Study||0
540046|NCT00783614|1317709|P2|NOT COMPLETED|Overall Study||0
540047|NCT00783614|1317710|P1|NOT COMPLETED|Overall Study||0
540048|NCT00783614|1317707|P4|COMPLETED|Overall Study||5
540049|NCT00783614|1317708|P3|COMPLETED|Overall Study||5
540050|NCT00783614|1317709|P2|COMPLETED|Overall Study||6
540051|NCT00783614|1317710|P1|COMPLETED|Overall Study||6
540052|NCT00783614|1317707|P4|STARTED|Overall Study||5
540053|NCT00783614|1317708|P3|STARTED|Overall Study||5
540054|NCT00783614|1317709|P2|STARTED|Overall Study||6
540055|NCT00783614|1317710|P1|STARTED|Overall Study||6
540056|NCT00783432|1317726|P2|NOT COMPLETED|Overall Study||78
540057|NCT00783432|1317727|P1|NOT COMPLETED|Overall Study||85
540058|NCT00783432|1317726|P2|COMPLETED|Overall Study||354
540059|NCT00783432|1317727|P1|COMPLETED|Overall Study||345
540060|NCT00783432|1317726|P2|STARTED|Overall Study|This includes 2 subjects that received a randomization number but did not receive study drug|432
540061|NCT00783432|1317727|P1|STARTED|Overall Study|This includes 2 subjects that received a randomization number but did not receive study drug|430
540062|NCT00783302|1317737|P1|NOT COMPLETED|Overall Study||35
540063|NCT00783302|1317737|P1|COMPLETED|Overall Study||850
540064|NCT00783302|1317737|P1|STARTED|Overall Study||885
540065|NCT00783263|1317759|P4|NOT COMPLETED|Overall Study||3
540066|NCT00783263|1317760|P3|NOT COMPLETED|Overall Study||3
540067|NCT00783263|1317761|P2|NOT COMPLETED|Overall Study||2
540068|NCT00783263|1317762|P1|NOT COMPLETED|Overall Study||4
540069|NCT00783263|1317759|P4|COMPLETED|Overall Study||118
540070|NCT00783263|1317760|P3|COMPLETED|Overall Study||119
540071|NCT00783263|1317761|P2|COMPLETED|Overall Study||96
540072|NCT00783263|1317762|P1|COMPLETED|Overall Study||95
540073|NCT00783263|1317759|P4|STARTED|Overall Study||121
540074|NCT00783263|1317760|P3|STARTED|Overall Study||122
540075|NCT00783263|1317761|P2|STARTED|Overall Study||98
540076|NCT00783263|1317762|P1|STARTED|Overall Study||99
540077|NCT00783224|1317792|P4|NOT COMPLETED|Overall Study||2
540078|NCT00783224|1317793|P3|NOT COMPLETED|Overall Study||1
540079|NCT00783224|1317794|P2|NOT COMPLETED|Overall Study||0
540080|NCT00783224|1317795|P1|NOT COMPLETED|Overall Study||0
540081|NCT00783224|1317792|P4|COMPLETED|Overall Study||140
540082|NCT00783224|1317793|P3|COMPLETED|Overall Study||142
540083|NCT00783224|1317794|P2|COMPLETED|Overall Study||34
540084|NCT00783224|1317795|P1|COMPLETED|Overall Study||32
540085|NCT00783224|1317792|P4|STARTED|Overall Study||142
540086|NCT00783224|1317793|P3|STARTED|Overall Study||143
540087|NCT00783224|1317794|P2|STARTED|Overall Study||34
540088|NCT00783224|1317795|P1|STARTED|Overall Study||32
540089|NCT00783198|1317807|P3|NOT COMPLETED|Overall Study||42
540090|NCT00783198|1317808|P2|NOT COMPLETED|Overall Study||43
540091|NCT00783198|1317809|P1|NOT COMPLETED|Overall Study||57
540092|NCT00783198|1317807|P3|COMPLETED|Overall Study||146
540093|NCT00783198|1317808|P2|COMPLETED|Overall Study||144
540094|NCT00783198|1317809|P1|COMPLETED|Overall Study||133
540095|NCT00783198|1317807|P3|STARTED|Overall Study||188
540096|NCT00783198|1317808|P2|STARTED|Overall Study||187
540097|NCT00783198|1317809|P1|STARTED|Overall Study||190
540098|NCT00783094|1317832|P3|NOT COMPLETED|Open-Label Extension Period||30
540099|NCT00783094|1317833|P2|NOT COMPLETED|Open-Label Extension Period||19
540100|NCT00783094|1317834|P1|NOT COMPLETED|Open-Label Extension Period||22
540101|NCT00783094|1317832|P3|COMPLETED|Open-Label Extension Period||101
540102|NCT00783094|1317833|P2|COMPLETED|Open-Label Extension Period||109
540103|NCT00783094|1317834|P1|COMPLETED|Open-Label Extension Period||113
540104|NCT00783094|1317832|P3|STARTED|Open-Label Extension Period||131
540105|NCT00783094|1317833|P2|STARTED|Open-Label Extension Period||128
540106|NCT00783094|1317834|P1|STARTED|Open-Label Extension Period||135
540107|NCT00783094|1317832|P3|NOT COMPLETED|Randomized Double-Blind Treatment Period||9
540108|NCT00783094|1317833|P2|NOT COMPLETED|Randomized Double-Blind Treatment Period||12
540109|NCT00783094|1317834|P1|NOT COMPLETED|Randomized Double-Blind Treatment Period||7
540110|NCT00783094|1317832|P3|COMPLETED|Randomized Double-Blind Treatment Period||131
540111|NCT00783094|1317833|P2|COMPLETED|Randomized Double-Blind Treatment Period||128
540112|NCT00783094|1317834|P1|COMPLETED|Randomized Double-Blind Treatment Period||135
540113|NCT00783094|1317832|P3|STARTED|Randomized Double-Blind Treatment Period||140
540114|NCT00783094|1317833|P2|STARTED|Randomized Double-Blind Treatment Period||140
540115|NCT00783094|1317834|P1|STARTED|Randomized Double-Blind Treatment Period||142
540116|NCT00782834|1317910|P1|NOT COMPLETED|Treatment Phase||1
540117|NCT00782834|1317910|P1|COMPLETED|Treatment Phase||13
540118|NCT00782834|1317910|P1|STARTED|Treatment Phase||14
540119|NCT00782834|1317910|P1|NOT COMPLETED|Screened Patients||1
540120|NCT00782834|1317910|P1|COMPLETED|Screened Patients|1 pt ineligible d/t arrhythmia|14
540121|NCT00782834|1317910|P1|STARTED|Screened Patients||15
540122|NCT00782821|1317919|P4|NOT COMPLETED|Overall Study||2
540123|NCT00782821|1317920|P3|NOT COMPLETED|Overall Study||1
540124|NCT00782821|1317921|P2|NOT COMPLETED|Overall Study||0
540125|NCT00782821|1317922|P1|NOT COMPLETED|Overall Study||0
540126|NCT00782821|1317919|P4|COMPLETED|Overall Study||8
540127|NCT00782821|1317920|P3|COMPLETED|Overall Study||9
540128|NCT00782821|1317921|P2|COMPLETED|Overall Study||10
540129|NCT00782821|1317922|P1|COMPLETED|Overall Study||10
540130|NCT00782821|1317919|P4|STARTED|Overall Study||10
540131|NCT00782821|1317920|P3|STARTED|Overall Study||10
540132|NCT00782821|1317921|P2|STARTED|Overall Study||10
540133|NCT00782821|1317922|P1|STARTED|Overall Study||10
540134|NCT00782795|1317950|P2|NOT COMPLETED|Overall Study||2
540135|NCT00782795|1317951|P1|NOT COMPLETED|Overall Study||1
540136|NCT00782795|1317950|P2|COMPLETED|Overall Study||6
540137|NCT00782795|1317951|P1|COMPLETED|Overall Study||16
540138|NCT00782795|1317950|P2|24 Week Appointment|Overall Study||7
540139|NCT00782795|1317951|P1|24 Week Appointment|Overall Study||16
540140|NCT00782795|1317950|P2|6 Weeks (1st Apptment)|Overall Study||7
540141|NCT00782795|1317951|P1|6 Weeks (1st Apptment)|Overall Study||16
540142|NCT00782795|1317950|P2|STARTED|Overall Study||8
540143|NCT00782795|1317951|P1|STARTED|Overall Study||17
540144|NCT00782756|1317983|P1|NOT COMPLETED|Overall Study||0
540145|NCT00782756|1317983|P1|COMPLETED|Overall Study||40
540146|NCT00782756|1317983|P1|STARTED|Overall Study||40
540147|NCT00782717|1317991|P2|NOT COMPLETED|Overall Study||28
540148|NCT00782717|1317992|P1|NOT COMPLETED|Overall Study||15
540149|NCT00782717|1317991|P2|COMPLETED|Overall Study||102
540150|NCT00782717|1317992|P1|COMPLETED|Overall Study||118
540151|NCT00782717|1317991|P2|STARTED|Overall Study||130
540152|NCT00782717|1317992|P1|STARTED|Overall Study||133
540153|NCT00782639|1318002|P2|NOT COMPLETED|Overall Study||0
540154|NCT00782639|1318003|P1|NOT COMPLETED|Overall Study||0
540155|NCT00782639|1318002|P2|COMPLETED|Overall Study|This study was terminated due to low enrollment.|11
540156|NCT00782639|1318003|P1|COMPLETED|Overall Study|This study was terminated due to low enrollment.|12
540157|NCT00782639|1318002|P2|STARTED|Overall Study||11
540158|NCT00782639|1318003|P1|STARTED|Overall Study||12
540159|NCT00782626|1318019|P1|NOT COMPLETED|Overall Study||7
540160|NCT00782626|1318019|P1|COMPLETED|Overall Study||16
540161|NCT00782626|1318019|P1|STARTED|Overall Study||23
540162|NCT00782509|1318026|P3|NOT COMPLETED|Overall Study||36
540163|NCT00782509|1318027|P2|NOT COMPLETED|Overall Study||24
540164|NCT00782509|1318028|P1|NOT COMPLETED|Overall Study||41
540165|NCT00782509|1318026|P3|COMPLETED|Overall Study||181
540166|NCT00782509|1318027|P2|COMPLETED|Overall Study||185
540167|NCT00782509|1318028|P1|COMPLETED|Overall Study||175
540168|NCT00782509|1318026|P3|STARTED|Overall Study||217
540169|NCT00782509|1318027|P2|STARTED|Overall Study||209
540170|NCT00782509|1318028|P1|STARTED|Overall Study||216
540171|NCT00782496|1318221|P2|NOT COMPLETED|Overall Study||15
540172|NCT00782496|1318222|P1|NOT COMPLETED|Overall Study||14
540173|NCT00782496|1318221|P2|COMPLETED|Overall Study||90
540174|NCT00782496|1318222|P1|COMPLETED|Overall Study||92
540175|NCT00782496|1318221|P2|STARTED|Overall Study||105
540176|NCT00782496|1318222|P1|STARTED|Overall Study||106
540177|NCT00782483|1318229|P1|NOT COMPLETED|Overall Study||6
540178|NCT00782483|1318229|P1|COMPLETED|Overall Study||0
540179|NCT00782483|1318229|P1|STARTED|Overall Study|6 subjects enrolled beginning on 04/27/2009 with last enrollment on 04/13/2010.|6
540180|NCT00782418|1318233|P7|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
540181|NCT00782418|1318234|P6|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
540182|NCT00782418|1318235|P5|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
540183|NCT00782418|1318236|P4|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
540184|NCT00782418|1318237|P3|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
540185|NCT00782418|1318238|P2|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
540186|NCT00782418|1318239|P1|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
540187|NCT00782418|1318233|P7|COMPLETED|Period 2 Procedure/Treatment Groups||4
540188|NCT00782418|1318234|P6|COMPLETED|Period 2 Procedure/Treatment Groups||4
540189|NCT00782418|1318235|P5|COMPLETED|Period 2 Procedure/Treatment Groups||3
540190|NCT00782418|1318236|P4|COMPLETED|Period 2 Procedure/Treatment Groups||1
540191|NCT00782418|1318237|P3|COMPLETED|Period 2 Procedure/Treatment Groups||4
540192|NCT00782418|1318238|P2|COMPLETED|Period 2 Procedure/Treatment Groups||4
540193|NCT00782418|1318239|P1|COMPLETED|Period 2 Procedure/Treatment Groups||3
540194|NCT00782418|1318233|P7|STARTED|Period 2 Procedure/Treatment Groups||4
540195|NCT00782418|1318234|P6|STARTED|Period 2 Procedure/Treatment Groups||4
540196|NCT00782418|1318235|P5|STARTED|Period 2 Procedure/Treatment Groups||3
540197|NCT00782418|1318236|P4|STARTED|Period 2 Procedure/Treatment Groups||1
540198|NCT00782418|1318237|P3|STARTED|Period 2 Procedure/Treatment Groups||4
540199|NCT00782418|1318238|P2|STARTED|Period 2 Procedure/Treatment Groups||4
540200|NCT00782418|1318239|P1|STARTED|Period 2 Procedure/Treatment Groups||3
540201|NCT00782418|1318233|P7|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
540202|NCT00782418|1318234|P6|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1
540203|NCT00782418|1318235|P5|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1
540204|NCT00782418|1318236|P4|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
540205|NCT00782418|1318237|P3|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
540206|NCT00782418|1318238|P2|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
540207|NCT00782418|1318239|P1|NOT COMPLETED|Period 1 Procedure/Treatment Groups||2
540208|NCT00782418|1318233|P7|COMPLETED|Period 1 Procedure/Treatment Groups||4
540209|NCT00782418|1318234|P6|COMPLETED|Period 1 Procedure/Treatment Groups||4
540210|NCT00782418|1318235|P5|COMPLETED|Period 1 Procedure/Treatment Groups||4
540211|NCT00782418|1318236|P4|COMPLETED|Period 1 Procedure/Treatment Groups||2
540212|NCT00782418|1318237|P3|COMPLETED|Period 1 Procedure/Treatment Groups||4
540213|NCT00782418|1318238|P2|COMPLETED|Period 1 Procedure/Treatment Groups||4
540214|NCT00782418|1318239|P1|COMPLETED|Period 1 Procedure/Treatment Groups||1
540215|NCT00782418|1318233|P7|STARTED|Period 1 Procedure/Treatment Groups||4
540216|NCT00782418|1318234|P6|STARTED|Period 1 Procedure/Treatment Groups||5
540217|NCT00782418|1318235|P5|STARTED|Period 1 Procedure/Treatment Groups||5
540218|NCT00782418|1318236|P4|STARTED|Period 1 Procedure/Treatment Groups||2
540219|NCT00782418|1318237|P3|STARTED|Period 1 Procedure/Treatment Groups||4
540220|NCT00782418|1318238|P2|STARTED|Period 1 Procedure/Treatment Groups||4
540221|NCT00782418|1318239|P1|STARTED|Period 1 Procedure/Treatment Groups||3
540222|NCT00782379|1318259|P1|NOT COMPLETED|Overall Study||0
540223|NCT00782379|1318259|P1|COMPLETED|Overall Study||20
540224|NCT00782379|1318259|P1|STARTED|Overall Study||20
540225|NCT00782340|1318276|P3|NOT COMPLETED|Randomized Double Blind||0
540226|NCT00782340|1318277|P2|NOT COMPLETED|Randomized Double Blind||0
540227|NCT00782340|1318278|P1|NOT COMPLETED|Randomized Double Blind||0
540228|NCT00782340|1318276|P3|COMPLETED|Randomized Double Blind||80
540229|NCT00782340|1318277|P2|COMPLETED|Randomized Double Blind||82
540230|NCT00782340|1318278|P1|COMPLETED|Randomized Double Blind||0
540231|NCT00782340|1318276|P3|STARTED|Randomized Double Blind||80
540232|NCT00782340|1318277|P2|STARTED|Randomized Double Blind||82
540233|NCT00782340|1318278|P1|STARTED|Randomized Double Blind||0
540234|NCT00782340|1318276|P3|NOT COMPLETED|Open Label Titration||0
540235|NCT00782340|1318277|P2|NOT COMPLETED|Open Label Titration||0
540236|NCT00782340|1318278|P1|NOT COMPLETED|Open Label Titration||101
540237|NCT00782340|1318276|P3|COMPLETED|Open Label Titration||0
540238|NCT00782340|1318277|P2|COMPLETED|Open Label Titration||0
540239|NCT00782340|1318278|P1|COMPLETED|Open Label Titration||162
540240|NCT00782340|1318276|P3|STARTED|Open Label Titration||0
540241|NCT00782340|1318277|P2|STARTED|Open Label Titration||0
540242|NCT00782340|1318278|P1|STARTED|Open Label Titration||263
540243|NCT00782288|1318304|P3|NOT COMPLETED|Overall Study||0
540244|NCT00782288|1318305|P2|NOT COMPLETED|Overall Study||0
540245|NCT00782288|1318306|P1|NOT COMPLETED|Overall Study||0
540246|NCT00782288|1318304|P3|COMPLETED|Overall Study||8
540247|NCT00782288|1318305|P2|COMPLETED|Overall Study||8
540248|NCT00782288|1318306|P1|COMPLETED|Overall Study||8
540249|NCT00782288|1318304|P3|STARTED|Overall Study||8
540250|NCT00782288|1318305|P2|STARTED|Overall Study||8
540251|NCT00782288|1318306|P1|STARTED|Overall Study||8
540252|NCT00782275|1318348|P1|NOT COMPLETED|Overall Study||41
540253|NCT00782275|1318348|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
540254|NCT00782275|1318348|P1|Prior VEGFR Response Evaluable|Overall Study|One patient was unevaluable and therefore excluded from related subgroup analyses.|39
540255|NCT00782275|1318348|P1|Treated|Overall Study||40
540256|NCT00782275|1318348|P1|STARTED|Overall Study||41
540257|NCT00782210|1318357|P3|NOT COMPLETED|Overall Study||35
540258|NCT00782210|1318358|P2|NOT COMPLETED|Overall Study||35
540259|NCT00782210|1318359|P1|NOT COMPLETED|Overall Study||50
540260|NCT00782210|1318357|P3|COMPLETED|Overall Study||172
540261|NCT00782210|1318358|P2|COMPLETED|Overall Study||173
540262|NCT00782210|1318359|P1|COMPLETED|Overall Study||159
540263|NCT00782210|1318357|P3|STARTED|Overall Study||207
540264|NCT00782210|1318358|P2|STARTED|Overall Study||208
540265|NCT00782210|1318359|P1|STARTED|Overall Study||209
540266|NCT00782184|1318552|P2|NOT COMPLETED|Overall Study||5
540267|NCT00782184|1318553|P1|NOT COMPLETED|Overall Study||4
540268|NCT00782184|1318552|P2|COMPLETED|Overall Study||125
540269|NCT00782184|1318553|P1|COMPLETED|Overall Study||116
540270|NCT00782184|1318552|P2|STARTED|Overall Study||130
540271|NCT00782184|1318553|P1|STARTED|Overall Study||120
540272|NCT00782171|1318590|P2|NOT COMPLETED|Overall Study||19
540273|NCT00782171|1318591|P1|NOT COMPLETED|Overall Study||22
540274|NCT00782171|1318590|P2|COMPLETED|Overall Study||115
540275|NCT00782171|1318591|P1|COMPLETED|Overall Study||124
540276|NCT00782171|1318590|P2|Surgery (Baseline)|Overall Study||128
540277|NCT00782171|1318591|P1|Surgery (Baseline)|Overall Study||138
540278|NCT00782171|1318590|P2|1 Year|Overall Study||120
540279|NCT00782171|1318591|P1|1 Year|Overall Study||131
540280|NCT00782171|1318590|P2|20-23 Weeks|Overall Study||124
540281|NCT00782171|1318591|P1|20-23 Weeks|Overall Study||135
540282|NCT00782171|1318590|P2|STARTED|Overall Study||134
540283|NCT00782171|1318591|P1|STARTED|Overall Study||146
540284|NCT00782067|1318623|P1|NOT COMPLETED|Overall Study||95
540285|NCT00782067|1318623|P1|COMPLETED|Overall Study||21
540286|NCT00782067|1318623|P1|Primary Efficacy Population (PEP)|Overall Study||89
540287|NCT00782067|1318623|P1|Treatment Ongoing|Overall Study||21
540288|NCT00782067|1318623|P1|STARTED|Overall Study||116
540289|NCT00781963|1318633|P3|NOT COMPLETED|Overall Study||2
540290|NCT00781963|1318634|P2|NOT COMPLETED|Overall Study||9
540291|NCT00781963|1318635|P1|NOT COMPLETED|Overall Study||8
540292|NCT00781963|1318633|P3|COMPLETED|Overall Study||51
540293|NCT00781963|1318634|P2|COMPLETED|Overall Study||43
540294|NCT00781963|1318635|P1|COMPLETED|Overall Study||46
540295|NCT00781963|1318633|P3|6-month Follow-up|Overall Study||52
540296|NCT00781963|1318634|P2|6-month Follow-up|Overall Study||44
540297|NCT00781963|1318635|P1|6-month Follow-up|Overall Study||48
540298|NCT00781963|1318633|P3|Post-treatment|Overall Study||53
540299|NCT00781963|1318634|P2|Post-treatment|Overall Study||45
540300|NCT00781963|1318635|P1|Post-treatment|Overall Study||52
540301|NCT00781963|1318633|P3|STARTED|Overall Study||53
540302|NCT00781963|1318634|P2|STARTED|Overall Study||52
540303|NCT00781963|1318635|P1|STARTED|Overall Study||54
540304|NCT00781950|1318645|P2|NOT COMPLETED|Overall Study||13
540305|NCT00781950|1318646|P1|NOT COMPLETED|Overall Study||11
540306|NCT00781950|1318645|P2|COMPLETED|Overall Study||45
540307|NCT00781950|1318646|P1|COMPLETED|Overall Study||41
540308|NCT00781950|1318645|P2|STARTED|Overall Study||58
540309|NCT00781950|1318646|P1|STARTED|Overall Study||52
540310|NCT00781937|1318656|P2|NOT COMPLETED|Follow up Period (Week 56-68)||5
540311|NCT00781937|1318657|P1|NOT COMPLETED|Follow up Period (Week 56-68)||6
540312|NCT00781937|1318656|P2|COMPLETED|Follow up Period (Week 56-68)||141
540313|NCT00781937|1318657|P1|COMPLETED|Follow up Period (Week 56-68)||153
540314|NCT00781937|1318656|P2|STARTED|Follow up Period (Week 56-68)||146
540315|NCT00781937|1318657|P1|STARTED|Follow up Period (Week 56-68)||159
540316|NCT00781937|1318656|P2|NOT COMPLETED|Main Trial Period Through Week 56||64
540317|NCT00781937|1318657|P1|NOT COMPLETED|Main Trial Period Through Week 56||53
540318|NCT00781937|1318656|P2|COMPLETED|Main Trial Period Through Week 56||146
540319|NCT00781937|1318657|P1|COMPLETED|Main Trial Period Through Week 56||159
540320|NCT00781937|1318656|P2|STARTED|Main Trial Period Through Week 56||210
540321|NCT00781937|1318657|P1|STARTED|Main Trial Period Through Week 56||212
540322|NCT00781911|1318715|P2|NOT COMPLETED|Overall Study||8
540323|NCT00781911|1318716|P1|NOT COMPLETED|Overall Study||6
540324|NCT00781911|1318715|P2|COMPLETED|Overall Study||4
540325|NCT00781911|1318716|P1|COMPLETED|Overall Study||25
540326|NCT00781911|1318715|P2|Received at Least 1 Dose of Study Drug|Overall Study||12
540327|NCT00781911|1318716|P1|Received at Least 1 Dose of Study Drug|Overall Study||31
540328|NCT00781911|1318715|P2|STARTED|Overall Study||12
540329|NCT00781911|1318716|P1|STARTED|Overall Study||31
540330|NCT00781898|1318744|P2|NOT COMPLETED|Overall Study||29
540331|NCT00781898|1318745|P1|NOT COMPLETED|Overall Study||34
540332|NCT00781898|1318744|P2|COMPLETED|Overall Study||126
540333|NCT00781898|1318745|P1|COMPLETED|Overall Study||119
540334|NCT00781898|1318744|P2|STARTED|Overall Study||155
540335|NCT00781898|1318745|P1|STARTED|Overall Study||153
540336|NCT00781859|1318753|P2|NOT COMPLETED|Overall Study||9
540337|NCT00781859|1318754|P1|NOT COMPLETED|Overall Study||19
540338|NCT00781859|1318753|P2|COMPLETED|Overall Study||98
540339|NCT00781859|1318754|P1|COMPLETED|Overall Study||200
540340|NCT00781859|1318753|P2|STARTED|Overall Study||107
540341|NCT00781859|1318754|P1|STARTED|Overall Study||219
540342|NCT00781599|1318764|P2|NOT COMPLETED|Overall Study||4
540343|NCT00781599|1318765|P1|NOT COMPLETED|Overall Study||7
540344|NCT00781599|1318764|P2|COMPLETED|Overall Study||32
540345|NCT00781599|1318765|P1|COMPLETED|Overall Study||29
540346|NCT00781599|1318764|P2|STARTED|Overall Study||36
540347|NCT00781599|1318765|P1|STARTED|Overall Study||36
540348|NCT00781508|1318779|P2|NOT COMPLETED|Overall Study||0
540349|NCT00781508|1318780|P1|NOT COMPLETED|Overall Study||0
540350|NCT00781508|1318779|P2|COMPLETED|Overall Study||5
540351|NCT00781508|1318780|P1|COMPLETED|Overall Study||5
540352|NCT00781508|1318779|P2|STARTED|Overall Study|"First Intervention (1 day), Washout (48 hours), Second Intervention (1 day)"|5
540353|NCT00781508|1318780|P1|STARTED|Overall Study|"First Intervention (1 day), Washout (48 hours), Second Intervention (1 day)"|5
540354|NCT00781456|1318790|P2|NOT COMPLETED|Overall Study||16
540355|NCT00781456|1318791|P1|NOT COMPLETED|Overall Study||21
540356|NCT00781456|1318790|P2|COMPLETED|Overall Study||35
540357|NCT00781456|1318791|P1|COMPLETED|Overall Study||37
540358|NCT00781456|1318790|P2|Received Study Drug|Overall Study||49
540359|NCT00781456|1318791|P1|Received Study Drug|Overall Study||57
540360|NCT00781456|1318790|P2|STARTED|Overall Study||51
540361|NCT00781456|1318791|P1|STARTED|Overall Study||58
540362|NCT00781391|1318814|P3|NOT COMPLETED|Overall Study||784
540363|NCT00781391|1318815|P2|NOT COMPLETED|Overall Study||807
540364|NCT00781391|1318816|P1|NOT COMPLETED|Overall Study||879
540365|NCT00781391|1318814|P3|COMPLETED|Overall Study||6250
540366|NCT00781391|1318815|P2|COMPLETED|Overall Study||6228
540367|NCT00781391|1318816|P1|COMPLETED|Overall Study||6157
540368|NCT00781391|1318814|P3|Per Protocol Analysis Set|Overall Study||6982
540369|NCT00781391|1318815|P2|Per Protocol Analysis Set|Overall Study||6995
540370|NCT00781391|1318816|P1|Per Protocol Analysis Set|Overall Study||6993
540371|NCT00781391|1318814|P3|mITT Analysis Set (Received Drug)|Overall Study||7002
540372|NCT00781391|1318815|P2|mITT Analysis Set (Received Drug)|Overall Study||7012
540373|NCT00781391|1318816|P1|mITT Analysis Set (Received Drug)|Overall Study||7012
540374|NCT00781391|1318814|P3|Safety Analysis Set (Received Drug)|Overall Study||7002
540375|NCT00781391|1318815|P2|Safety Analysis Set (Received Drug)|Overall Study||7012
540376|NCT00781391|1318816|P1|Safety Analysis Set (Received Drug)|Overall Study||7012
540377|NCT00781391|1318814|P3|STARTED|Overall Study||7034
540378|NCT00781391|1318815|P2|STARTED|Overall Study||7035
540379|NCT00781391|1318816|P1|STARTED|Overall Study||7036
540380|NCT00781365|1318850|P2|NOT COMPLETED|Overall Study||36
540381|NCT00781365|1318851|P1|NOT COMPLETED|Overall Study||34
540382|NCT00781365|1318850|P2|COMPLETED|Overall Study|completed both 6 and 12 month follow up|186
540383|NCT00781365|1318851|P1|COMPLETED|Overall Study|completed both 6 and 12 month follow up|194
540384|NCT00781365|1318850|P2|STARTED|Overall Study||222
540385|NCT00781365|1318851|P1|STARTED|Overall Study||228
540386|NCT00781326|1318861|P1|NOT COMPLETED|Phase 2||0
540387|NCT00781326|1318861|P1|COMPLETED|Phase 2||0
540388|NCT00781326|1318861|P1|STARTED|Phase 2|Study terminated prior to enrollment into Phase II|0
540389|NCT00781326|1318861|P1|NOT COMPLETED|Phase I||4
540390|NCT00781326|1318861|P1|COMPLETED|Phase I||2
540391|NCT00781326|1318861|P1|STARTED|Phase I|Nine subjects consented; 3 did not meet eligibility criteria. 6 started antidepressant treatment.|6
540392|NCT00781274|1318865|P1|NOT COMPLETED|Overall Study||2
540393|NCT00781274|1318865|P1|COMPLETED|Overall Study||30
540394|NCT00781274|1318865|P1|STARTED|Overall Study||32
540395|NCT00781079|1318871|P2|NOT COMPLETED|Overall Study||17
540396|NCT00781079|1318872|P1|NOT COMPLETED|Overall Study||27
540397|NCT00781079|1318871|P2|COMPLETED|Overall Study||116
540398|NCT00781079|1318872|P1|COMPLETED|Overall Study||122
540399|NCT00781079|1318871|P2|STARTED|Overall Study||133
540400|NCT00781079|1318872|P1|STARTED|Overall Study||149
540401|NCT00780962|1318882|P2|NOT COMPLETED|Overall Study||27
540402|NCT00780962|1318883|P1|NOT COMPLETED|Overall Study||15
540403|NCT00780962|1318882|P2|COMPLETED|Overall Study||172
540404|NCT00780962|1318883|P1|COMPLETED|Overall Study||185
540405|NCT00780962|1318882|P2|Second Blood Draw (Outcome Measurement)|Overall Study||172
540406|NCT00780962|1318883|P1|Second Blood Draw (Outcome Measurement)|Overall Study||185
540407|NCT00780962|1318882|P2|STARTED|Overall Study||199
540408|NCT00780962|1318883|P1|STARTED|Overall Study||200
540409|NCT00780910|1318889|P1|NOT COMPLETED|Overall Study||2
540410|NCT00780910|1318889|P1|COMPLETED|Overall Study||107
540411|NCT00780910|1318889|P1|STARTED|Overall Study||109
540412|NCT00780741|1318895|P2|NOT COMPLETED|Overall Study||10
540413|NCT00780741|1318896|P1|NOT COMPLETED|Overall Study||7
540414|NCT00780741|1318895|P2|COMPLETED|Overall Study|18 months of age (±4 weeks)|71
540415|NCT00780741|1318896|P1|COMPLETED|Overall Study|18 months of age (±4 weeks)|75
540416|NCT00780741|1318895|P2|6-Month Visit|Overall Study|6 months (±2 weeks) timed from randomization|67
540417|NCT00780741|1318896|P1|6-Month Visit|Overall Study|6 months (±2 weeks) timed from randomization|73
540418|NCT00780741|1318895|P2|STARTED|Overall Study|randomized|81
540419|NCT00780741|1318896|P1|STARTED|Overall Study|randomized|82
540420|NCT00780715|1318912|P4|NOT COMPLETED|Overall Study||0
540421|NCT00780715|1318913|P3|NOT COMPLETED|Overall Study||0
540422|NCT00780715|1318914|P2|NOT COMPLETED|Overall Study||0
540423|NCT00780715|1318915|P1|NOT COMPLETED|Overall Study||0
540424|NCT00780715|1318912|P4|COMPLETED|Overall Study||11
540425|NCT00780715|1318913|P3|COMPLETED|Overall Study||6
540426|NCT00780715|1318914|P2|COMPLETED|Overall Study||6
540427|NCT00780715|1318915|P1|COMPLETED|Overall Study||6
540428|NCT00780715|1318912|P4|STARTED|Overall Study||11
540429|NCT00780715|1318913|P3|STARTED|Overall Study||6
540430|NCT00780715|1318914|P2|STARTED|Overall Study||6
540431|NCT00780715|1318915|P1|STARTED|Overall Study||6
540432|NCT00780676|1318930|P5|NOT COMPLETED|Overall Study||0
540433|NCT00780676|1318931|P4|NOT COMPLETED|Overall Study||0
540434|NCT00780676|1318932|P3|NOT COMPLETED|Overall Study||0
540435|NCT00780676|1318933|P2|NOT COMPLETED|Overall Study||0
540436|NCT00780676|1318934|P1|NOT COMPLETED|Overall Study||0
540437|NCT00780676|1318930|P5|COMPLETED|Overall Study||0
540438|NCT00780676|1318931|P4|COMPLETED|Overall Study||0
540439|NCT00780676|1318932|P3|COMPLETED|Overall Study||13
540440|NCT00780676|1318933|P2|COMPLETED|Overall Study||8
540441|NCT00780676|1318934|P1|COMPLETED|Overall Study||9
540442|NCT00780676|1318930|P5|STARTED|Overall Study||0
540443|NCT00780676|1318931|P4|STARTED|Overall Study||0
540444|NCT00780676|1318932|P3|STARTED|Overall Study||13
540445|NCT00780676|1318933|P2|STARTED|Overall Study||8
540446|NCT00780676|1318934|P1|STARTED|Overall Study||9
540447|NCT00780572|1318942|P2|NOT COMPLETED|Overall Study||0
540448|NCT00780572|1318943|P1|NOT COMPLETED|Overall Study||0
540449|NCT00780572|1318942|P2|COMPLETED|Overall Study||298
540450|NCT00780572|1318943|P1|COMPLETED|Overall Study||297
540451|NCT00780572|1318942|P2|STARTED|Overall Study||298
540452|NCT00780572|1318943|P1|STARTED|Overall Study||297
540453|NCT00780481|1318949|P1|NOT COMPLETED|Overall Study||0
540454|NCT00780481|1318949|P1|COMPLETED|Overall Study||13
540455|NCT00780481|1318949|P1|STARTED|Overall Study||13
540456|NCT00780455|1318958|P2|NOT COMPLETED|Overall Study||0
540457|NCT00780455|1318959|P1|NOT COMPLETED|Overall Study||0
540458|NCT00780455|1318958|P2|COMPLETED|Overall Study||2
540459|NCT00780455|1318959|P1|COMPLETED|Overall Study||2
540460|NCT00780455|1318958|P2|STARTED|Overall Study||2
540461|NCT00780455|1318959|P1|STARTED|Overall Study||2
540462|NCT00780416|1318985|P2|NOT COMPLETED|Overall Study||9
540463|NCT00780416|1318986|P1|NOT COMPLETED|Overall Study||12
540464|NCT00780416|1318985|P2|COMPLETED|Overall Study||54
540465|NCT00780416|1318986|P1|COMPLETED|Overall Study||114
540466|NCT00780416|1318985|P2|STARTED|Overall Study||63
540467|NCT00780416|1318986|P1|STARTED|Overall Study||126
540468|NCT00780403|1318992|P2|NOT COMPLETED|Second Intervention||0
540469|NCT00780403|1318993|P1|NOT COMPLETED|Second Intervention||0
540470|NCT00780403|1318992|P2|COMPLETED|Second Intervention||111
540471|NCT00780403|1318993|P1|COMPLETED|Second Intervention||109
540472|NCT00780403|1318992|P2|STARTED|Second Intervention||111
540473|NCT00780403|1318993|P1|STARTED|Second Intervention||109
540474|NCT00780403|1318992|P2|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
540475|NCT00780403|1318993|P1|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
540476|NCT00780403|1318992|P2|COMPLETED|Interval Between Doses (8-10 Minutes)||111
540477|NCT00780403|1318993|P1|COMPLETED|Interval Between Doses (8-10 Minutes)||109
540478|NCT00780403|1318992|P2|STARTED|Interval Between Doses (8-10 Minutes)||111
540479|NCT00780403|1318993|P1|STARTED|Interval Between Doses (8-10 Minutes)||109
540480|NCT00780403|1318992|P2|NOT COMPLETED|First Intervention||0
540481|NCT00780403|1318993|P1|NOT COMPLETED|First Intervention||0
540482|NCT00780403|1318992|P2|COMPLETED|First Intervention||111
540483|NCT00780403|1318993|P1|COMPLETED|First Intervention||109
540484|NCT00780403|1318992|P2|STARTED|First Intervention||111
540485|NCT00780403|1318993|P1|STARTED|First Intervention||109
540486|NCT00780338|1319002|P2|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||5
540487|NCT00780338|1319003|P1|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||13
540488|NCT00780338|1319002|P2|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||159
540489|NCT00780338|1319003|P1|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||156
540490|NCT00780338|1319002|P2|STARTED|Mid to Post (1 Year; 2 Years in Total)||164
540491|NCT00780338|1319003|P1|STARTED|Mid to Post (1 Year; 2 Years in Total)||169
540492|NCT00780338|1319002|P2|NOT COMPLETED|Baseline to Mid (1 Year)||38
540493|NCT00780338|1319003|P1|NOT COMPLETED|Baseline to Mid (1 Year)||5
540494|NCT00780338|1319002|P2|COMPLETED|Baseline to Mid (1 Year)||164
540495|NCT00780338|1319003|P1|COMPLETED|Baseline to Mid (1 Year)||169
540496|NCT00780338|1319002|P2|STARTED|Baseline to Mid (1 Year)||202
540497|NCT00780338|1319003|P1|STARTED|Baseline to Mid (1 Year)||174
540498|NCT00780273|1319031|P1|NOT COMPLETED|Overall Study||2
540499|NCT00780273|1319031|P1|COMPLETED|Overall Study||17
540500|NCT00780273|1319031|P1|STARTED|Overall Study||19
540501|NCT00780208|1319040|P1|NOT COMPLETED|Overall Study||6
540502|NCT00780208|1319040|P1|COMPLETED|Overall Study||8
540503|NCT00780208|1319040|P1|STARTED|Overall Study||14
540504|NCT00780026|1319047|P2|NOT COMPLETED|Overall Study||0
540505|NCT00780026|1319048|P1|NOT COMPLETED|Overall Study||0
540506|NCT00780026|1319047|P2|COMPLETED|Overall Study||44
540507|NCT00780026|1319048|P1|COMPLETED|Overall Study||42
540508|NCT00780026|1319047|P2|STARTED|Overall Study||44
540509|NCT00780026|1319048|P1|STARTED|Overall Study||42
540510|NCT00779909|1319070|P4|NOT COMPLETED|Overall Study||1
540511|NCT00779909|1319071|P3|NOT COMPLETED|Overall Study||0
540512|NCT00779909|1319072|P2|NOT COMPLETED|Overall Study||1
540513|NCT00779909|1319073|P1|NOT COMPLETED|Overall Study||1
540514|NCT00779909|1319070|P4|COMPLETED|Overall Study||7
540515|NCT00779909|1319071|P3|COMPLETED|Overall Study||8
540516|NCT00779909|1319072|P2|COMPLETED|Overall Study||8
540517|NCT00779909|1319073|P1|COMPLETED|Overall Study||9
540518|NCT00779909|1319070|P4|STARTED|Overall Study||8
540519|NCT00779909|1319071|P3|STARTED|Overall Study||8
540520|NCT00779909|1319072|P2|STARTED|Overall Study||9
540521|NCT00779909|1319073|P1|STARTED|Overall Study||10
540522|NCT00779857|1319115|P1|NOT COMPLETED|Overall Study||6
540523|NCT00779857|1319115|P1|COMPLETED|Overall Study|12 Month Post procedure, 64 subjects available for evaluation|64
540524|NCT00779857|1319115|P1|3 Month Post Procedure|Overall Study|3 month follow-up, 65 of the subjects were available for evaluation.|65
540525|NCT00779857|1319115|P1|30 Day Post Procedure|Overall Study|2 missed Visit|68
540526|NCT00779857|1319115|P1|STARTED|Overall Study|70 patients treated|70
540527|NCT00779779|1319120|P1|NOT COMPLETED|Overall Study||24
540528|NCT00779779|1319120|P1|COMPLETED|Overall Study||498
540529|NCT00779779|1319120|P1|STARTED|Overall Study||522
540530|NCT00779766|1319129|P2|NOT COMPLETED|Overall Study||68
540531|NCT00779766|1319130|P1|NOT COMPLETED|Overall Study||85
540532|NCT00779766|1319129|P2|COMPLETED|Overall Study|Among those 2814 subjects, 1408 completed the study and 1406 had an unknown completion status.|2957
540533|NCT00779766|1319130|P1|COMPLETED|Overall Study|Among those 2831 subjects, 1432 completed the study and 1399 had an unknown completion status.|2941
540534|NCT00779766|1319129|P2|STARTED|Overall Study||3025
540535|NCT00779766|1319130|P1|STARTED|Overall Study||3026
540536|NCT00779701|1319208|P1|NOT COMPLETED|Overall Study||0
540537|NCT00779701|1319208|P1|COMPLETED|Overall Study||27
540538|NCT00779701|1319208|P1|STARTED|Overall Study||27
540539|NCT00779675|1319212|P1|NOT COMPLETED|Extended Treatment Period||46
540540|NCT00779675|1319212|P1|COMPLETED|Extended Treatment Period||147
540541|NCT00779675|1319212|P1|STARTED|Extended Treatment Period|Clinical responders during the treatment period could enter the extended treatment period.|193
540542|NCT00779675|1319212|P1|NOT COMPLETED|Treatment Period||332
540543|NCT00779675|1319212|P1|COMPLETED|Treatment Period||328
540544|NCT00779675|1319212|P1|STARTED|Treatment Period|One of the 660 participants did not receive study treatment.|660
540545|NCT00779584|1319240|P9|NOT COMPLETED|Overall Study||2
540546|NCT00779584|1319241|P8|NOT COMPLETED|Overall Study||3
540547|NCT00779584|1319242|P7|NOT COMPLETED|Overall Study||8
540548|NCT00779584|1319243|P6|NOT COMPLETED|Overall Study||6
540549|NCT00779584|1319244|P5|NOT COMPLETED|Overall Study||7
540550|NCT00779584|1319245|P4|NOT COMPLETED|Overall Study||6
540551|NCT00779584|1319246|P3|NOT COMPLETED|Overall Study||7
540552|NCT00779584|1319247|P2|NOT COMPLETED|Overall Study||3
540553|NCT00779584|1319248|P1|NOT COMPLETED|Overall Study||3
540554|NCT00779584|1319240|P9|COMPLETED|Overall Study||0
540555|NCT00779584|1319241|P8|COMPLETED|Overall Study||0
540556|NCT00779584|1319242|P7|COMPLETED|Overall Study||0
540557|NCT00779584|1319243|P6|COMPLETED|Overall Study||0
540558|NCT00779584|1319244|P5|COMPLETED|Overall Study||0
540559|NCT00779584|1319245|P4|COMPLETED|Overall Study||0
540560|NCT00779584|1319246|P3|COMPLETED|Overall Study||0
540561|NCT00779584|1319247|P2|COMPLETED|Overall Study||0
540562|NCT00779584|1319248|P1|COMPLETED|Overall Study||0
540563|NCT00779584|1319240|P9|Treated|Overall Study||2
540564|NCT00779584|1319241|P8|Treated|Overall Study||3
540565|NCT00779584|1319242|P7|Treated|Overall Study||8
540566|NCT00779584|1319243|P6|Treated|Overall Study||4
540567|NCT00779584|1319244|P5|Treated|Overall Study||7
540568|NCT00779584|1319245|P4|Treated|Overall Study||6
540569|NCT00779584|1319246|P3|Treated|Overall Study||7
540570|NCT00779584|1319247|P2|Treated|Overall Study||3
540571|NCT00779584|1319248|P1|Treated|Overall Study||3
540572|NCT00779584|1319240|P9|STARTED|Overall Study||2
540573|NCT00779584|1319241|P8|STARTED|Overall Study||3
540574|NCT00779584|1319242|P7|STARTED|Overall Study||8
540575|NCT00779584|1319243|P6|STARTED|Overall Study||6
540576|NCT00779584|1319244|P5|STARTED|Overall Study||7
540577|NCT00779584|1319245|P4|STARTED|Overall Study||6
540578|NCT00779584|1319246|P3|STARTED|Overall Study||7
540579|NCT00779584|1319247|P2|STARTED|Overall Study||3
540580|NCT00779584|1319248|P1|STARTED|Overall Study||3
540581|NCT00779558|1319324|P2|NOT COMPLETED|Overall Study||7
540582|NCT00779558|1319325|P1|NOT COMPLETED|Overall Study||4
540583|NCT00779558|1319324|P2|COMPLETED|Overall Study||37
540584|NCT00779558|1319325|P1|COMPLETED|Overall Study||53
540585|NCT00779558|1319324|P2|STARTED|Overall Study||44
540586|NCT00779558|1319325|P1|STARTED|Overall Study||57
540587|NCT00779506|1319339|P1|NOT COMPLETED|Overall Study||29
540588|NCT00779506|1319339|P1|COMPLETED|Overall Study||67
540589|NCT00779506|1319339|P1|Withdrawal Treatment|Overall Study||27
540590|NCT00779506|1319339|P1|Treatment Complete|Overall Study||67
540591|NCT00779506|1319339|P1|MITT|Overall Study||89
540592|NCT00779506|1319339|P1|Assigned|Overall Study||94
540593|NCT00779506|1319339|P1|Screen Failed|Overall Study||2
540594|NCT00779506|1319339|P1|Enrolled|Overall Study||96
540595|NCT00779506|1319339|P1|STARTED|Overall Study||96
540596|NCT00779467|1319353|P4|NOT COMPLETED|Overall Study||19
540597|NCT00779467|1319354|P3|NOT COMPLETED|Overall Study||10
540598|NCT00779467|1319355|P2|NOT COMPLETED|Overall Study||5
540599|NCT00779467|1319356|P1|NOT COMPLETED|Overall Study||15
540600|NCT00779467|1319353|P4|COMPLETED|Overall Study||35
540601|NCT00779467|1319354|P3|COMPLETED|Overall Study||38
540602|NCT00779467|1319355|P2|COMPLETED|Overall Study||40
540603|NCT00779467|1319356|P1|COMPLETED|Overall Study||38
540604|NCT00779467|1319353|P4|STARTED|Overall Study||54
540605|NCT00779467|1319354|P3|STARTED|Overall Study||48
540606|NCT00779467|1319355|P2|STARTED|Overall Study||45
540607|NCT00779467|1319356|P1|STARTED|Overall Study||53
540608|NCT00779402|1319396|P2|NOT COMPLETED|Long-term Follow-up||6
540609|NCT00779402|1319397|P1|NOT COMPLETED|Long-term Follow-up||21
540610|NCT00779402|1319396|P2|COMPLETED|Long-term Follow-up||7
540611|NCT00779402|1319397|P1|COMPLETED|Long-term Follow-up||20
540612|NCT00779402|1319396|P2|STARTED|Long-term Follow-up||13
540613|NCT00779402|1319397|P1|STARTED|Long-term Follow-up||41
540614|NCT00779402|1319396|P2|NOT COMPLETED|Surveillance Phase||31
540615|NCT00779402|1319397|P1|NOT COMPLETED|Surveillance Phase||43
540616|NCT00779402|1319396|P2|COMPLETED|Surveillance Phase||13
540617|NCT00779402|1319397|P1|COMPLETED|Surveillance Phase||41
540618|NCT00779402|1319396|P2|STARTED|Surveillance Phase||44
540619|NCT00779402|1319397|P1|STARTED|Surveillance Phase||84
540620|NCT00779402|1319396|P2|NOT COMPLETED|Treatment Phase 1||15
540621|NCT00779402|1319397|P1|NOT COMPLETED|Treatment Phase 1||33
540622|NCT00779402|1319396|P2|COMPLETED|Treatment Phase 1||44
540623|NCT00779402|1319397|P1|COMPLETED|Treatment Phase 1||84
540624|NCT00779402|1319396|P2|Received Booster Infusion|Treatment Phase 1||30
540625|NCT00779402|1319397|P1|Received Booster Infusion|Treatment Phase 1||50
540626|NCT00779402|1319396|P2|Received ≥1 Study Product (Exposure Set)|Treatment Phase 1||59
540627|NCT00779402|1319397|P1|Received ≥1 Study Product (Exposure Set)|Treatment Phase 1||113
540628|NCT00779402|1319396|P2|Received ≥1 Leukapherisis (Safety Set)|Treatment Phase 1||59
540629|NCT00779402|1319397|P1|Received ≥1 Leukapherisis (Safety Set)|Treatment Phase 1||116
540630|NCT00779402|1319396|P2|STARTED|Treatment Phase 1||59
540631|NCT00779402|1319397|P1|STARTED|Treatment Phase 1||117
540632|NCT00779311|1319410|P5|NOT COMPLETED|Overall Study||0
540633|NCT00779311|1319411|P4|NOT COMPLETED|Overall Study||0
540634|NCT00779311|1319412|P3|NOT COMPLETED|Overall Study||0
540635|NCT00779311|1319413|P2|NOT COMPLETED|Overall Study||0
540636|NCT00779311|1319414|P1|NOT COMPLETED|Overall Study||0
540637|NCT00779311|1319410|P5|COMPLETED|Overall Study||0
540638|NCT00779311|1319411|P4|COMPLETED|Overall Study||0
540639|NCT00779311|1319412|P3|COMPLETED|Overall Study||0
540640|NCT00779311|1319413|P2|COMPLETED|Overall Study||0
540641|NCT00779311|1319414|P1|COMPLETED|Overall Study||8
540642|NCT00779311|1319410|P5|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
540643|NCT00779311|1319411|P4|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
540644|NCT00779311|1319412|P3|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
540645|NCT00779311|1319413|P2|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
540646|NCT00779311|1319414|P1|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||6
540647|NCT00779311|1319410|P5|STARTED|Overall Study||0
540648|NCT00779311|1319411|P4|STARTED|Overall Study||0
540649|NCT00779311|1319412|P3|STARTED|Overall Study||0
540650|NCT00779311|1319413|P2|STARTED|Overall Study||0
540651|NCT00779311|1319414|P1|STARTED|Overall Study|2 of 6 patients were not evaluable for DLT assessment and were replaced for a total of 8 enrolled.|8
540652|NCT00779285|1319436|P1|NOT COMPLETED|Overall Study||0
540653|NCT00779285|1319436|P1|COMPLETED|Overall Study||1
540654|NCT00779285|1319436|P1|STARTED|Overall Study||1
540655|NCT00779259|1319440|P1|NOT COMPLETED|Theophylline With Quinine||0
540656|NCT00779259|1319440|P1|COMPLETED|Theophylline With Quinine||22
540657|NCT00779259|1319440|P1|STARTED|Theophylline With Quinine||22
540658|NCT00779259|1319440|P1|NOT COMPLETED|Quinine Alone||2
540659|NCT00779259|1319440|P1|COMPLETED|Quinine Alone||22
540660|NCT00779259|1319440|P1|STARTED|Quinine Alone||24
540661|NCT00779259|1319440|P1|NOT COMPLETED|4 Day Washout Period||0
540662|NCT00779259|1319440|P1|COMPLETED|4 Day Washout Period||24
540663|NCT00779259|1319440|P1|STARTED|4 Day Washout Period||24
540664|NCT00779259|1319440|P1|NOT COMPLETED|Theophylline Alone||0
540665|NCT00779259|1319440|P1|COMPLETED|Theophylline Alone||24
540666|NCT00779259|1319440|P1|STARTED|Theophylline Alone||24
540667|NCT00779246|1319461|P2|NOT COMPLETED|Overall Study||53
540668|NCT00779246|1319462|P1|NOT COMPLETED|Overall Study||33
540669|NCT00779246|1319461|P2|COMPLETED|Overall Study||715
540670|NCT00779246|1319462|P1|COMPLETED|Overall Study||717
540671|NCT00779246|1319461|P2|STARTED|Overall Study||768
540672|NCT00779246|1319462|P1|STARTED|Overall Study||750
540673|NCT00779155|1319474|P2|NOT COMPLETED|Overall Study||0
540674|NCT00779155|1319475|P1|NOT COMPLETED|Overall Study||0
540675|NCT00779155|1319474|P2|COMPLETED|Overall Study||6
540676|NCT00779155|1319475|P1|COMPLETED|Overall Study||6
540677|NCT00779155|1319474|P2|STARTED|Overall Study||6
540678|NCT00779155|1319475|P1|STARTED|Overall Study||6
540679|NCT00779142|1319481|P1|NOT COMPLETED|Overall Study||3
540680|NCT00779142|1319481|P1|COMPLETED|Overall Study|Only 2 patients were actually enrolled.|2
540681|NCT00779142|1319481|P1|STARTED|Overall Study|5 patients signed consent and were screened.|5
540682|NCT00779116|1319487|P2|NOT COMPLETED|Second Intervention||0
540683|NCT00779116|1319488|P1|NOT COMPLETED|Second Intervention||0
540684|NCT00779116|1319487|P2|COMPLETED|Second Intervention||108
540685|NCT00779116|1319488|P1|COMPLETED|Second Intervention||109
540686|NCT00779116|1319487|P2|STARTED|Second Intervention||108
540687|NCT00779116|1319488|P1|STARTED|Second Intervention||109
540688|NCT00779116|1319487|P2|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
540689|NCT00779116|1319488|P1|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
540690|NCT00779116|1319487|P2|COMPLETED|Interval Between Doses (8-10 Minutes)||108
540691|NCT00779116|1319488|P1|COMPLETED|Interval Between Doses (8-10 Minutes)||109
540692|NCT00779116|1319487|P2|STARTED|Interval Between Doses (8-10 Minutes)||108
540693|NCT00779116|1319488|P1|STARTED|Interval Between Doses (8-10 Minutes)||109
540694|NCT00779116|1319487|P2|NOT COMPLETED|First Intervention||0
540695|NCT00779116|1319488|P1|NOT COMPLETED|First Intervention||0
540696|NCT00779116|1319487|P2|COMPLETED|First Intervention||108
540697|NCT00779116|1319488|P1|COMPLETED|First Intervention||109
540698|NCT00779116|1319487|P2|STARTED|First Intervention||108
540699|NCT00779116|1319488|P1|STARTED|First Intervention||109
540700|NCT00779038|1319495|P1|NOT COMPLETED|Overall Study||13
540701|NCT00779038|1319495|P1|COMPLETED|Overall Study||0
540702|NCT00779038|1319495|P1|STARTED|Overall Study||13
540703|NCT00779025|1319504|P1|NOT COMPLETED|Overall Study||1
540704|NCT00779025|1319504|P1|COMPLETED|Overall Study||81
540705|NCT00779025|1319504|P1|STARTED|Overall Study||82
540706|NCT00778999|1319515|P2|NOT COMPLETED|Overall Study||34
540707|NCT00778999|1319516|P1|NOT COMPLETED|Overall Study||28
540708|NCT00778999|1319515|P2|COMPLETED|Overall Study||185
540709|NCT00778999|1319516|P1|COMPLETED|Overall Study||195
540710|NCT00778999|1319515|P2|STARTED|Overall Study||219
540711|NCT00778999|1319516|P1|STARTED|Overall Study||223
540712|NCT00778921|1319525|P3|NOT COMPLETED|Overall Study||28
540713|NCT00778921|1319526|P2|NOT COMPLETED|Overall Study||19
540714|NCT00778921|1319527|P1|NOT COMPLETED|Overall Study||18
540715|NCT00778921|1319525|P3|COMPLETED|Overall Study||255
540716|NCT00778921|1319526|P2|COMPLETED|Overall Study||266
540717|NCT00778921|1319527|P1|COMPLETED|Overall Study||261
540718|NCT00778921|1319525|P3|STARTED|Overall Study||283
540719|NCT00778921|1319526|P2|STARTED|Overall Study||285
540720|NCT00778921|1319527|P1|STARTED|Overall Study||279
540721|NCT00778895|1319544|P3|NOT COMPLETED|ESFU Phase||2
540722|NCT00778895|1319545|P2|NOT COMPLETED|ESFU Phase||12
540723|NCT00778895|1319546|P1|NOT COMPLETED|ESFU Phase||11
540724|NCT00778895|1319544|P3|COMPLETED|ESFU Phase||41
540725|NCT00778895|1319545|P2|COMPLETED|ESFU Phase||155
540726|NCT00778895|1319546|P1|COMPLETED|ESFU Phase||153
540727|NCT00778895|1319544|P3|STARTED|ESFU Phase||43
540728|NCT00778895|1319545|P2|STARTED|ESFU Phase||167
540729|NCT00778895|1319546|P1|STARTED|ESFU Phase||164
540730|NCT00778895|1319544|P3|NOT COMPLETED|Active Phase||0
540731|NCT00778895|1319545|P2|NOT COMPLETED|Active Phase||6
540732|NCT00778895|1319546|P1|NOT COMPLETED|Active Phase||7
540733|NCT00778895|1319544|P3|COMPLETED|Active Phase||43
540734|NCT00778895|1319545|P2|COMPLETED|Active Phase||161
540735|NCT00778895|1319546|P1|COMPLETED|Active Phase||157
540736|NCT00778895|1319544|P3|STARTED|Active Phase||43
540737|NCT00778895|1319545|P2|STARTED|Active Phase||167
540738|NCT00778895|1319546|P1|STARTED|Active Phase||164
540739|NCT00778869|1319584|P1|NOT COMPLETED|Overall Study||0
540740|NCT00778869|1319584|P1|COMPLETED|Overall Study||10
540741|NCT00778869|1319584|P1|STARTED|Overall Study||10
540742|NCT00778830|1319590|P2|NOT COMPLETED|Overall Study||1
540743|NCT00778830|1319591|P1|NOT COMPLETED|Overall Study||0
540744|NCT00778830|1319590|P2|COMPLETED|Overall Study||187
540745|NCT00778830|1319591|P1|COMPLETED|Overall Study||101
540746|NCT00778830|1319590|P2|STARTED|Overall Study||188
540747|NCT00778830|1319591|P1|STARTED|Overall Study||101
540748|NCT00778817|1319603|P1|NOT COMPLETED|Overall Study||4
540749|NCT00778817|1319603|P1|COMPLETED|Overall Study||16
540750|NCT00778817|1319603|P1|STARTED|Overall Study||20
540751|NCT00778648|1319620|P2|NOT COMPLETED|Overall Study||5
540752|NCT00778648|1319621|P1|NOT COMPLETED|Overall Study||9
540753|NCT00778648|1319620|P2|COMPLETED|Overall Study||266
540754|NCT00778648|1319621|P1|COMPLETED|Overall Study||263
540755|NCT00778648|1319620|P2|STARTED|Overall Study||271
540756|NCT00778648|1319621|P1|STARTED|Overall Study||272
540757|NCT00778622|1319630|P3|NOT COMPLETED|Overall Study||15
540758|NCT00778622|1319631|P2|NOT COMPLETED|Overall Study||15
540759|NCT00778622|1319632|P1|NOT COMPLETED|Overall Study||16
540760|NCT00778622|1319630|P3|COMPLETED|Overall Study||109
540761|NCT00778622|1319631|P2|COMPLETED|Overall Study||107
540762|NCT00778622|1319632|P1|COMPLETED|Overall Study||109
540763|NCT00778622|1319630|P3|STARTED|Overall Study||124
540764|NCT00778622|1319631|P2|STARTED|Overall Study||122
540765|NCT00778622|1319632|P1|STARTED|Overall Study||125
540766|NCT00778375|1319685|P1|NOT COMPLETED|Overall Study||3
540767|NCT00778375|1319685|P1|COMPLETED|Overall Study||119
540768|NCT00778375|1319685|P1|STARTED|Overall Study||122
540769|NCT00778336|1319699|P4|NOT COMPLETED|3 Month Follow Up||0
540770|NCT00778336|1319700|P3|NOT COMPLETED|3 Month Follow Up||5
540771|NCT00778336|1319701|P2|NOT COMPLETED|3 Month Follow Up||23
540772|NCT00778336|1319702|P1|NOT COMPLETED|3 Month Follow Up||23
540773|NCT00778336|1319699|P4|COMPLETED|3 Month Follow Up||12
540774|NCT00778336|1319700|P3|COMPLETED|3 Month Follow Up||65
540775|NCT00778336|1319701|P2|COMPLETED|3 Month Follow Up||144
540776|NCT00778336|1319702|P1|COMPLETED|3 Month Follow Up||169
540777|NCT00778336|1319699|P4|STARTED|3 Month Follow Up||12
540778|NCT00778336|1319700|P3|STARTED|3 Month Follow Up||70
540779|NCT00778336|1319701|P2|STARTED|3 Month Follow Up||167
540780|NCT00778336|1319702|P1|STARTED|3 Month Follow Up||192
540781|NCT00778336|1319699|P4|NOT COMPLETED|Index Procedure-Discharge||0
540782|NCT00778336|1319700|P3|NOT COMPLETED|Index Procedure-Discharge||2
540783|NCT00778336|1319701|P2|NOT COMPLETED|Index Procedure-Discharge||3
540784|NCT00778336|1319702|P1|NOT COMPLETED|Index Procedure-Discharge||6
540785|NCT00778336|1319699|P4|COMPLETED|Index Procedure-Discharge||12
540786|NCT00778336|1319700|P3|COMPLETED|Index Procedure-Discharge||70
540787|NCT00778336|1319701|P2|COMPLETED|Index Procedure-Discharge||167
540788|NCT00778336|1319702|P1|COMPLETED|Index Procedure-Discharge||192
540789|NCT00778336|1319699|P4|STARTED|Index Procedure-Discharge||12
540790|NCT00778336|1319700|P3|STARTED|Index Procedure-Discharge||72
540791|NCT00778336|1319701|P2|STARTED|Index Procedure-Discharge||170
540792|NCT00778336|1319702|P1|STARTED|Index Procedure-Discharge||198
540793|NCT00778310|1319722|P2|NOT COMPLETED|Overall Study||0
540794|NCT00778310|1319723|P1|NOT COMPLETED|Overall Study||0
540795|NCT00778310|1319722|P2|COMPLETED|Overall Study||26
540796|NCT00778310|1319723|P1|COMPLETED|Overall Study||17
540797|NCT00778310|1319722|P2|Usable Data|Overall Study||21
540798|NCT00778310|1319723|P1|Usable Data|Overall Study||14
540799|NCT00778310|1319722|P2|STARTED|Overall Study||26
540800|NCT00778310|1319723|P1|STARTED|Overall Study||17
540801|NCT00778258|1319740|P9|NOT COMPLETED|Overall Study||4
540802|NCT00778258|1319741|P8|NOT COMPLETED|Overall Study||15
540803|NCT00778258|1319742|P7|NOT COMPLETED|Overall Study||15
540804|NCT00778258|1319743|P6|NOT COMPLETED|Overall Study||10
540805|NCT00778258|1319744|P5|NOT COMPLETED|Overall Study||0
540806|NCT00778258|1319745|P4|NOT COMPLETED|Overall Study||3
540807|NCT00778258|1319746|P3|NOT COMPLETED|Overall Study||10
540808|NCT00778258|1319747|P2|NOT COMPLETED|Overall Study||2
540809|NCT00778258|1319748|P1|NOT COMPLETED|Overall Study||7
540810|NCT00778258|1319740|P9|COMPLETED|Overall Study||6
540811|NCT00778258|1319741|P8|COMPLETED|Overall Study||26
540812|NCT00778258|1319742|P7|COMPLETED|Overall Study||19
540813|NCT00778258|1319743|P6|COMPLETED|Overall Study||13
540814|NCT00778258|1319744|P5|COMPLETED|Overall Study||6
540815|NCT00778258|1319745|P4|COMPLETED|Overall Study||12
540816|NCT00778258|1319746|P3|COMPLETED|Overall Study||10
540817|NCT00778258|1319747|P2|COMPLETED|Overall Study||3
540818|NCT00778258|1319748|P1|COMPLETED|Overall Study||9
540819|NCT00778258|1319740|P9|STARTED|Overall Study||10
540820|NCT00778258|1319741|P8|STARTED|Overall Study||41
540821|NCT00778258|1319742|P7|STARTED|Overall Study||34
540822|NCT00778258|1319743|P6|STARTED|Overall Study||23
540823|NCT00778258|1319744|P5|STARTED|Overall Study||6
540824|NCT00778258|1319745|P4|STARTED|Overall Study||15
540825|NCT00778258|1319746|P3|STARTED|Overall Study||20
540826|NCT00778258|1319747|P2|STARTED|Overall Study||5
540827|NCT00778258|1319748|P1|STARTED|Overall Study||16
540828|NCT00778167|1319803|P3|NOT COMPLETED|Overall Study||0
540829|NCT00778167|1319804|P2|NOT COMPLETED|Overall Study||0
540830|NCT00778167|1319805|P1|NOT COMPLETED|Overall Study||0
540831|NCT00778167|1319803|P3|COMPLETED|Overall Study||4
540832|NCT00778167|1319804|P2|COMPLETED|Overall Study||8
540833|NCT00778167|1319805|P1|COMPLETED|Overall Study||6
540834|NCT00778167|1319803|P3|STARTED|Overall Study||4
540835|NCT00778167|1319804|P2|STARTED|Overall Study||8
540836|NCT00778167|1319805|P1|STARTED|Overall Study||6
540837|NCT00778102|1319815|P2|NOT COMPLETED|Overall Study||22
540838|NCT00778102|1319816|P1|NOT COMPLETED|Overall Study||21
540839|NCT00778102|1319815|P2|COMPLETED|Overall Study||19
540840|NCT00778102|1319816|P1|COMPLETED|Overall Study||18
540841|NCT00778102|1319815|P2|STARTED|Overall Study||41
540842|NCT00778102|1319816|P1|STARTED|Overall Study||39
540843|NCT00777946|1319851|P3|NOT COMPLETED|Overall Study||16
540844|NCT00777946|1319852|P2|NOT COMPLETED|Overall Study||6
540845|NCT00777946|1319853|P1|NOT COMPLETED|Overall Study||21
540846|NCT00777946|1319851|P3|COMPLETED|Overall Study||244
540847|NCT00777946|1319852|P2|COMPLETED|Overall Study||271
540848|NCT00777946|1319853|P1|COMPLETED|Overall Study||262
540849|NCT00777946|1319851|P3|Safety & Full Analysis Sets|Overall Study||260
540850|NCT00777946|1319852|P2|Safety & Full Analysis Sets|Overall Study||276
540851|NCT00777946|1319853|P1|Safety & Full Analysis Sets|Overall Study||282
540852|NCT00777946|1319851|P3|STARTED|Overall Study||260
540853|NCT00777946|1319852|P2|STARTED|Overall Study|1 patient in the Aliskiren 300 mg/Amlodipine 5 mg group was randomized in error.|277
540854|NCT00777946|1319853|P1|STARTED|Overall Study|1 patient in the Aliskiren 300 mg/Amlodipine 10 mg group was randomized in error.|283
540855|NCT00777855|1319876|P2|NOT COMPLETED|Second Intervention||0
540856|NCT00777855|1319877|P1|NOT COMPLETED|Second Intervention||0
540857|NCT00777855|1319876|P2|COMPLETED|Second Intervention||5
540858|NCT00777855|1319877|P1|COMPLETED|Second Intervention||5
540859|NCT00777855|1319876|P2|STARTED|Second Intervention||5
540860|NCT00777855|1319877|P1|STARTED|Second Intervention||5
540861|NCT00777855|1319876|P2|NOT COMPLETED|Washout Period (>= 14 Days)||0
540862|NCT00777855|1319877|P1|NOT COMPLETED|Washout Period (>= 14 Days)||0
540863|NCT00777855|1319876|P2|COMPLETED|Washout Period (>= 14 Days)||5
540864|NCT00777855|1319877|P1|COMPLETED|Washout Period (>= 14 Days)||5
540865|NCT00777855|1319876|P2|STARTED|Washout Period (>= 14 Days)||5
540866|NCT00777855|1319877|P1|STARTED|Washout Period (>= 14 Days)||5
540867|NCT00777855|1319876|P2|NOT COMPLETED|First Intervention||0
540868|NCT00777855|1319877|P1|NOT COMPLETED|First Intervention||0
540869|NCT00777855|1319876|P2|COMPLETED|First Intervention||5
540870|NCT00777855|1319877|P1|COMPLETED|First Intervention||5
540871|NCT00777855|1319876|P2|STARTED|First Intervention||5
540872|NCT00777855|1319877|P1|STARTED|First Intervention||5
540873|NCT00777803|1319888|P2|NOT COMPLETED|Overall Study||7
540874|NCT00777803|1319889|P1|NOT COMPLETED|Overall Study||15
540875|NCT00777803|1319888|P2|COMPLETED|Overall Study||90
540876|NCT00777803|1319889|P1|COMPLETED|Overall Study||269
540877|NCT00777803|1319888|P2|STARTED|Overall Study||97
540878|NCT00777803|1319889|P1|STARTED|Overall Study||284
540879|NCT00777790|1319924|P3|NOT COMPLETED|Overall Study||0
540880|NCT00777790|1319925|P2|NOT COMPLETED|Overall Study||0
540881|NCT00777790|1319926|P1|NOT COMPLETED|Overall Study||0
540882|NCT00777790|1319924|P3|COMPLETED|Overall Study||88
540883|NCT00777790|1319925|P2|COMPLETED|Overall Study||77
540884|NCT00777790|1319926|P1|COMPLETED|Overall Study||76
540885|NCT00777790|1319924|P3|STARTED|Overall Study||88
540886|NCT00777790|1319925|P2|STARTED|Overall Study||77
540887|NCT00777790|1319926|P1|STARTED|Overall Study||76
540888|NCT00777764|1319936|P2|NOT COMPLETED|Overall Study||1
540889|NCT00777764|1319937|P1|NOT COMPLETED|Overall Study||0
540890|NCT00777764|1319936|P2|COMPLETED|Overall Study||29
540891|NCT00777764|1319937|P1|COMPLETED|Overall Study||30
540892|NCT00777764|1319936|P2|STARTED|Overall Study||30
540893|NCT00777764|1319937|P1|STARTED|Overall Study||30
540894|NCT00777634|1319949|P2|NOT COMPLETED|Overall Study||1
540895|NCT00777634|1319950|P1|NOT COMPLETED|Overall Study||5
540896|NCT00777634|1319949|P2|COMPLETED|Overall Study||133
540897|NCT00777634|1319950|P1|COMPLETED|Overall Study||129
540898|NCT00777634|1319949|P2|STARTED|Overall Study||134
540899|NCT00777634|1319950|P1|STARTED|Overall Study||134
540900|NCT00777608|1319968|P2|NOT COMPLETED|Overall Study||6
540901|NCT00777608|1319969|P1|NOT COMPLETED|Overall Study||4
540902|NCT00777608|1319968|P2|COMPLETED|Overall Study||47
540903|NCT00777608|1319969|P1|COMPLETED|Overall Study||49
540904|NCT00777608|1319968|P2|STARTED|Overall Study||53
540905|NCT00777608|1319969|P1|STARTED|Overall Study||53
540906|NCT00777556|1319979|P1|NOT COMPLETED|Overall Study||66
540907|NCT00777556|1319979|P1|COMPLETED|Overall Study|Completed all 3 follow-up visits|277
540908|NCT00777556|1319979|P1|Used Product|Overall Study||297
540909|NCT00777556|1319979|P1|Safety Population|Overall Study|Participants who used the product; two were given product in error (inappropriately self-selected)|299
540910|NCT00777556|1319979|P1|Dispensed Product|Overall Study||307
540911|NCT00777556|1319979|P1|STARTED|Overall Study|Enrolled; signed informed consent|343
540912|NCT00777335|1319988|P2|NOT COMPLETED|Overall Study||0
540913|NCT00777335|1319989|P1|NOT COMPLETED|Overall Study||0
540914|NCT00777335|1319988|P2|COMPLETED|Overall Study||2
540915|NCT00777335|1319989|P1|COMPLETED|Overall Study||2
540916|NCT00777335|1319988|P2|STARTED|Overall Study||2
540917|NCT00777335|1319989|P1|STARTED|Overall Study||2
540918|NCT00777257|1320000|P3|NOT COMPLETED|Overall Study||9
540919|NCT00777257|1320001|P2|NOT COMPLETED|Overall Study||12
540920|NCT00777257|1320002|P1|NOT COMPLETED|Overall Study||11
540921|NCT00777257|1320000|P3|COMPLETED|Overall Study||442
540922|NCT00777257|1320001|P2|COMPLETED|Overall Study||438
540923|NCT00777257|1320002|P1|COMPLETED|Overall Study||433
540924|NCT00777257|1320000|P3|STARTED|Overall Study||451
540925|NCT00777257|1320001|P2|STARTED|Overall Study||450
540926|NCT00777257|1320002|P1|STARTED|Overall Study||444
540927|NCT00777205|1320021|P2|NOT COMPLETED|Overall Study||71
540928|NCT00777205|1320022|P1|NOT COMPLETED|Overall Study||31
540929|NCT00777205|1320021|P2|COMPLETED|Overall Study||129
540930|NCT00777205|1320022|P1|COMPLETED|Overall Study||212
540931|NCT00777205|1320021|P2|Intervention Interruption|Overall Study|56 participants excluded from main analyses due to 2 mos interruption in study intervention|56
540932|NCT00777205|1320022|P1|Intervention Interruption|Overall Study||0
540933|NCT00777205|1320021|P2|STARTED|Overall Study||200
540934|NCT00777205|1320022|P1|STARTED|Overall Study||243
540935|NCT00777179|1320038|P2|NOT COMPLETED|Overall Study||0
540936|NCT00777179|1320039|P1|NOT COMPLETED|Overall Study||0
540937|NCT00777179|1320038|P2|COMPLETED|Overall Study|All participants' data within ITT set were included for final result.|42
540938|NCT00777179|1320039|P1|COMPLETED|Overall Study|All participants' data within ITT set were included for final result.|75
540939|NCT00777179|1320038|P2|STARTED|Overall Study|Number of participants for intent-to-treat (ITT) set population|42
540940|NCT00777179|1320039|P1|STARTED|Overall Study|Number of participants for intent-to-treat (ITT) set population|75
540941|NCT00777153|1320056|P3|NOT COMPLETED|Overall Study||37
540942|NCT00777153|1320057|P2|NOT COMPLETED|Overall Study||83
540943|NCT00777153|1320058|P1|NOT COMPLETED|Overall Study||90
540944|NCT00777153|1320056|P3|COMPLETED|Overall Study||28
540945|NCT00777153|1320057|P2|COMPLETED|Overall Study||46
540946|NCT00777153|1320058|P1|COMPLETED|Overall Study||41
540947|NCT00777153|1320056|P3|STARTED|Overall Study||65
540948|NCT00777153|1320057|P2|STARTED|Overall Study||129
540949|NCT00777153|1320058|P1|STARTED|Overall Study||131
540950|NCT00777101|1320083|P2|NOT COMPLETED|Overall Study||51
540951|NCT00777101|1320084|P1|NOT COMPLETED|Overall Study||62
540952|NCT00777101|1320083|P2|COMPLETED|Overall Study||65
540953|NCT00777101|1320084|P1|COMPLETED|Overall Study||55
540954|NCT00777101|1320083|P2|Treated|Overall Study||115
540955|NCT00777101|1320084|P1|Treated|Overall Study||116
540956|NCT00777101|1320083|P2|STARTED|Overall Study||116
540957|NCT00777101|1320084|P1|STARTED|Overall Study||117
540958|NCT00777062|1320104|P2|NOT COMPLETED|Overall Study||5
540959|NCT00777062|1320105|P1|NOT COMPLETED|Overall Study||3
540960|NCT00777062|1320104|P2|COMPLETED|Overall Study||36
540961|NCT00777062|1320105|P1|COMPLETED|Overall Study||36
540962|NCT00777062|1320104|P2|STARTED|Overall Study||41
540963|NCT00777062|1320105|P1|STARTED|Overall Study||39
540964|NCT00777049|1320115|P2|NOT COMPLETED|Overall Study||1
540965|NCT00777049|1320116|P1|NOT COMPLETED|Overall Study||1
540966|NCT00777049|1320115|P2|COMPLETED|Overall Study||20
540967|NCT00777049|1320116|P1|COMPLETED|Overall Study||32
540968|NCT00777049|1320115|P2|STARTED|Overall Study||21
540969|NCT00777049|1320116|P1|STARTED|Overall Study||33
540970|NCT00777036|1320125|P3|NOT COMPLETED|Follow-Up||4
540971|NCT00777036|1320126|P2|NOT COMPLETED|Follow-Up||8
540972|NCT00777036|1320127|P1|NOT COMPLETED|Follow-Up||5
540973|NCT00777036|1320125|P3|COMPLETED|Follow-Up|Completed = Still in Follow-up|19
540974|NCT00777036|1320126|P2|COMPLETED|Follow-Up|Completed = Still in Follow-up|5
540975|NCT00777036|1320127|P1|COMPLETED|Follow-Up|Completed = Still in Follow-up|9
540976|NCT00777036|1320125|P3|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|23
540977|NCT00777036|1320126|P2|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|13
540978|NCT00777036|1320127|P1|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|14
540979|NCT00777036|1320125|P3|NOT COMPLETED|On Treatment||23
540980|NCT00777036|1320126|P2|NOT COMPLETED|On Treatment||16
540981|NCT00777036|1320127|P1|NOT COMPLETED|On Treatment||15
540982|NCT00777036|1320125|P3|COMPLETED|On Treatment|Completed = Still on treatment|61
540983|NCT00777036|1320126|P2|COMPLETED|On Treatment|Completed = Still on treatment|1
540984|NCT00777036|1320127|P1|COMPLETED|On Treatment|Completed = Still on treatment|14
540985|NCT00777036|1320125|P3|STARTED|On Treatment||84
540986|NCT00777036|1320126|P2|STARTED|On Treatment||17
540987|NCT00777036|1320127|P1|STARTED|On Treatment||29
540988|NCT00777023|1320223|P3|NOT COMPLETED|Overall Study||37
540989|NCT00777023|1320224|P2|NOT COMPLETED|Overall Study||41
540990|NCT00777023|1320225|P1|NOT COMPLETED|Overall Study||35
540991|NCT00777023|1320223|P3|COMPLETED|Overall Study||146
540992|NCT00777023|1320224|P2|COMPLETED|Overall Study||149
540993|NCT00777023|1320225|P1|COMPLETED|Overall Study||151
540994|NCT00777023|1320223|P3|STARTED|Overall Study|183 patients were randomized, and 183 received study treatment.|183
540995|NCT00777023|1320224|P2|STARTED|Overall Study|190 patients were randomized, and 190 received study treatment.|190
540996|NCT00777023|1320225|P1|STARTED|Overall Study|192 patients were randomized, but only 186 received study treatment.|186
540997|NCT00776997|1320242|P1|NOT COMPLETED|Overall Study||2
540998|NCT00776997|1320242|P1|COMPLETED|Overall Study|98 subjects evaluated at 12-months. Endpoint analysis based on all subjects treated (n=100)|98
540999|NCT00776997|1320242|P1|STARTED|Overall Study||100
541000|NCT00776984|1320251|P2|NOT COMPLETED|Overall Study||21
541001|NCT00776984|1320252|P1|NOT COMPLETED|Overall Study||31
541002|NCT00776984|1320251|P2|COMPLETED|Overall Study||198
541003|NCT00776984|1320252|P1|COMPLETED|Overall Study||203
541004|NCT00776984|1320251|P2|STARTED|Overall Study||219
541005|NCT00776984|1320252|P1|STARTED|Overall Study||234
541006|NCT00776919|1320326|P4|NOT COMPLETED|Overall Study||39
541007|NCT00776919|1320327|P3|NOT COMPLETED|Overall Study||32
541008|NCT00776919|1320328|P2|NOT COMPLETED|Overall Study||33
541009|NCT00776919|1320329|P1|NOT COMPLETED|Overall Study||27
541010|NCT00776919|1320326|P4|COMPLETED|Overall Study||293
541011|NCT00776919|1320327|P3|COMPLETED|Overall Study||296
541012|NCT00776919|1320328|P2|COMPLETED|Overall Study||295
541013|NCT00776919|1320329|P1|COMPLETED|Overall Study||300
541014|NCT00776919|1320326|P4|STARTED|Overall Study||332
541015|NCT00776919|1320327|P3|STARTED|Overall Study||328
541016|NCT00776919|1320328|P2|STARTED|Overall Study||328
541017|NCT00776919|1320329|P1|STARTED|Overall Study||327
541018|NCT00776789|1320393|P2|NOT COMPLETED|Overall Study||3
541019|NCT00776789|1320394|P1|NOT COMPLETED|Overall Study||3
541020|NCT00776789|1320393|P2|COMPLETED|Overall Study||18
541021|NCT00776789|1320394|P1|COMPLETED|Overall Study||17
541022|NCT00776789|1320393|P2|STARTED|Overall Study||21
541023|NCT00776789|1320394|P1|STARTED|Overall Study||20
541024|NCT00776659|1320406|P1|NOT COMPLETED|Overall Study||26
541025|NCT00776659|1320406|P1|COMPLETED|Overall Study||13
541026|NCT00776659|1320406|P1|STARTED|Overall Study||39
541027|NCT00776594|1320418|P2|NOT COMPLETED|Overall Study||2
541028|NCT00776594|1320419|P1|NOT COMPLETED|Overall Study||4
541029|NCT00776594|1320418|P2|COMPLETED|Overall Study||34
541030|NCT00776594|1320419|P1|COMPLETED|Overall Study||62
541031|NCT00776594|1320418|P2|STARTED|Overall Study||36
541032|NCT00776594|1320419|P1|STARTED|Overall Study||66
541033|NCT00776555|1320433|P2|NOT COMPLETED|Overall Study||0
541034|NCT00776555|1320434|P1|NOT COMPLETED|Overall Study||3
541035|NCT00776555|1320433|P2|COMPLETED|Overall Study||0
541036|NCT00776555|1320434|P1|COMPLETED|Overall Study||0
541037|NCT00776555|1320433|P2|STARTED|Overall Study||0
541038|NCT00776555|1320434|P1|STARTED|Overall Study||3
541039|NCT00776295|1320444|P1|NOT COMPLETED|Overall Study||0
541040|NCT00776295|1320444|P1|COMPLETED|Overall Study||2
541041|NCT00776295|1320444|P1|STARTED|Overall Study||2
541042|NCT00776230|1320452|P3|NOT COMPLETED|Overall Study||5
541043|NCT00776230|1320453|P2|NOT COMPLETED|Overall Study||3
541044|NCT00776230|1320454|P1|NOT COMPLETED|Overall Study||3
541045|NCT00776230|1320452|P3|COMPLETED|Overall Study||97
541046|NCT00776230|1320453|P2|COMPLETED|Overall Study||100
541047|NCT00776230|1320454|P1|COMPLETED|Overall Study||96
541048|NCT00776230|1320452|P3|Enrolled and Vaccinated at Day 0|Overall Study||102
541049|NCT00776230|1320453|P2|Enrolled and Vaccinated at Day 0|Overall Study||103
541050|NCT00776230|1320454|P1|Enrolled and Vaccinated at Day 0|Overall Study||98
541051|NCT00776230|1320452|P3|STARTED|Overall Study||102
541052|NCT00776230|1320453|P2|STARTED|Overall Study||103
541053|NCT00776230|1320454|P1|STARTED|Overall Study||99
541054|NCT00776100|1320464|P2|NOT COMPLETED|Overall Study||0
541055|NCT00776100|1320465|P1|NOT COMPLETED|Overall Study||1
541056|NCT00776100|1320464|P2|COMPLETED|Overall Study||1
541057|NCT00776100|1320465|P1|COMPLETED|Overall Study||0
541058|NCT00776100|1320464|P2|STARTED|Overall Study||1
541059|NCT00776100|1320465|P1|STARTED|Overall Study||1
541060|NCT00776009|1320487|P6|NOT COMPLETED|Period 3: Third Intervention||0
541061|NCT00776009|1320488|P5|NOT COMPLETED|Period 3: Third Intervention||0
541062|NCT00776009|1320489|P4|NOT COMPLETED|Period 3: Third Intervention||0
541063|NCT00776009|1320490|P3|NOT COMPLETED|Period 3: Third Intervention||0
541064|NCT00776009|1320491|P2|NOT COMPLETED|Period 3: Third Intervention||0
541065|NCT00776009|1320492|P1|NOT COMPLETED|Period 3: Third Intervention||1
541066|NCT00776009|1320487|P6|COMPLETED|Period 3: Third Intervention||26
541067|NCT00776009|1320488|P5|COMPLETED|Period 3: Third Intervention||26
541068|NCT00776009|1320489|P4|COMPLETED|Period 3: Third Intervention||27
541069|NCT00776009|1320490|P3|COMPLETED|Period 3: Third Intervention||27
541070|NCT00776009|1320491|P2|COMPLETED|Period 3: Third Intervention||27
541071|NCT00776009|1320492|P1|COMPLETED|Period 3: Third Intervention||24
541072|NCT00776009|1320487|P6|STARTED|Period 3: Third Intervention||26
541073|NCT00776009|1320488|P5|STARTED|Period 3: Third Intervention||26
541074|NCT00776009|1320489|P4|STARTED|Period 3: Third Intervention||27
541075|NCT00776009|1320490|P3|STARTED|Period 3: Third Intervention||27
541076|NCT00776009|1320491|P2|STARTED|Period 3: Third Intervention||27
541077|NCT00776009|1320492|P1|STARTED|Period 3: Third Intervention||25
541078|NCT00776009|1320487|P6|NOT COMPLETED|Period 2: Second Intervention||1
541079|NCT00776009|1320488|P5|NOT COMPLETED|Period 2: Second Intervention||0
541080|NCT00776009|1320489|P4|NOT COMPLETED|Period 2: Second Intervention||0
541081|NCT00776009|1320490|P3|NOT COMPLETED|Period 2: Second Intervention||1
541082|NCT00776009|1320491|P2|NOT COMPLETED|Period 2: Second Intervention||0
541083|NCT00776009|1320492|P1|NOT COMPLETED|Period 2: Second Intervention||1
541084|NCT00776009|1320487|P6|COMPLETED|Period 2: Second Intervention||26
541085|NCT00776009|1320488|P5|COMPLETED|Period 2: Second Intervention||26
541086|NCT00776009|1320489|P4|COMPLETED|Period 2: Second Intervention||27
541087|NCT00776009|1320490|P3|COMPLETED|Period 2: Second Intervention||27
541088|NCT00776009|1320491|P2|COMPLETED|Period 2: Second Intervention||27
541089|NCT00776009|1320492|P1|COMPLETED|Period 2: Second Intervention||25
541090|NCT00776009|1320487|P6|STARTED|Period 2: Second Intervention||27
541091|NCT00776009|1320488|P5|STARTED|Period 2: Second Intervention||26
541092|NCT00776009|1320489|P4|STARTED|Period 2: Second Intervention||27
541093|NCT00776009|1320490|P3|STARTED|Period 2: Second Intervention||28
541094|NCT00776009|1320491|P2|STARTED|Period 2: Second Intervention||27
541095|NCT00776009|1320492|P1|STARTED|Period 2: Second Intervention||26
541096|NCT00776009|1320487|P6|NOT COMPLETED|Period 1: First Intervention||0
541097|NCT00776009|1320488|P5|NOT COMPLETED|Period 1: First Intervention||2
541098|NCT00776009|1320489|P4|NOT COMPLETED|Period 1: First Intervention||0
541099|NCT00776009|1320490|P3|NOT COMPLETED|Period 1: First Intervention||1
541100|NCT00776009|1320491|P2|NOT COMPLETED|Period 1: First Intervention||1
541101|NCT00776009|1320492|P1|NOT COMPLETED|Period 1: First Intervention||0
541102|NCT00776009|1320487|P6|COMPLETED|Period 1: First Intervention||27
541103|NCT00776009|1320488|P5|COMPLETED|Period 1: First Intervention||26
541104|NCT00776009|1320489|P4|COMPLETED|Period 1: First Intervention||27
541105|NCT00776009|1320490|P3|COMPLETED|Period 1: First Intervention||28
541106|NCT00776009|1320491|P2|COMPLETED|Period 1: First Intervention||27
541107|NCT00776009|1320492|P1|COMPLETED|Period 1: First Intervention||26
541108|NCT00776009|1320487|P6|STARTED|Period 1: First Intervention||27
541109|NCT00776009|1320488|P5|STARTED|Period 1: First Intervention||28
541110|NCT00776009|1320489|P4|STARTED|Period 1: First Intervention||27
541111|NCT00776009|1320490|P3|STARTED|Period 1: First Intervention||29
541112|NCT00776009|1320491|P2|STARTED|Period 1: First Intervention||28
541113|NCT00776009|1320492|P1|STARTED|Period 1: First Intervention||26
541114|NCT00775983|1320514|P2|NOT COMPLETED|Overall Study||2
541115|NCT00775983|1320515|P1|NOT COMPLETED|Overall Study||1
541116|NCT00775983|1320514|P2|COMPLETED|Overall Study||34
541117|NCT00775983|1320515|P1|COMPLETED|Overall Study||35
541118|NCT00775983|1320514|P2|STARTED|Overall Study||36
541119|NCT00775983|1320515|P1|STARTED|Overall Study||36
541120|NCT00775944|1320527|P4|NOT COMPLETED|Overall Study||16
541121|NCT00775944|1320528|P3|NOT COMPLETED|Overall Study||16
541122|NCT00775944|1320529|P2|NOT COMPLETED|Overall Study||9
541123|NCT00775944|1320530|P1|NOT COMPLETED|Overall Study||15
541124|NCT00775944|1320527|P4|COMPLETED|Overall Study|16 participants withdrew consent|632
541125|NCT00775944|1320528|P3|COMPLETED|Overall Study|16 participants withdrew consent|632
541126|NCT00775944|1320529|P2|COMPLETED|Overall Study|9 participants withdrew consent|638
541127|NCT00775944|1320530|P1|COMPLETED|Overall Study|15 participants withdrew consent|633
541128|NCT00775944|1320527|P4|STARTED|Overall Study||648
541129|NCT00775944|1320528|P3|STARTED|Overall Study||648
541130|NCT00775944|1320529|P2|STARTED|Overall Study||647
541131|NCT00775944|1320530|P1|STARTED|Overall Study||648
541132|NCT00775684|1320559|P3|NOT COMPLETED|Overall Study||3
541133|NCT00775684|1320560|P2|NOT COMPLETED|Overall Study||1
541134|NCT00775684|1320561|P1|NOT COMPLETED|Overall Study||3
541135|NCT00775684|1320559|P3|COMPLETED|Overall Study||14
541136|NCT00775684|1320560|P2|COMPLETED|Overall Study||12
541137|NCT00775684|1320561|P1|COMPLETED|Overall Study||14
541138|NCT00775684|1320559|P3|STARTED|Overall Study||17
541139|NCT00775684|1320560|P2|STARTED|Overall Study||13
541140|NCT00775684|1320561|P1|STARTED|Overall Study||17
541141|NCT00775671|1320583|P2|NOT COMPLETED|Overall Study||0
541142|NCT00775671|1320584|P1|NOT COMPLETED|Overall Study||0
541143|NCT00775671|1320583|P2|COMPLETED|Overall Study||23
541144|NCT00775671|1320584|P1|COMPLETED|Overall Study||23
541145|NCT00775671|1320583|P2|STARTED|Overall Study||23
541146|NCT00775671|1320584|P1|STARTED|Overall Study||23
541147|NCT00775658|1320592|P2|NOT COMPLETED|Second Intervention||0
541148|NCT00775658|1320593|P1|NOT COMPLETED|Second Intervention||0
541149|NCT00775658|1320592|P2|COMPLETED|Second Intervention||11
541150|NCT00775658|1320593|P1|COMPLETED|Second Intervention||10
541151|NCT00775658|1320592|P2|STARTED|Second Intervention||11
541152|NCT00775658|1320593|P1|STARTED|Second Intervention||10
541153|NCT00775658|1320592|P2|NOT COMPLETED|First Intervention||0
541154|NCT00775658|1320593|P1|NOT COMPLETED|First Intervention||0
541155|NCT00775658|1320592|P2|COMPLETED|First Intervention||11
541156|NCT00775658|1320593|P1|COMPLETED|First Intervention||10
541157|NCT00775658|1320592|P2|STARTED|First Intervention||11
541158|NCT00775658|1320593|P1|STARTED|First Intervention||10
541159|NCT00775645|1320603|P2|NOT COMPLETED|Overall Study||20
541160|NCT00775645|1320604|P1|NOT COMPLETED|Overall Study||17
541161|NCT00775645|1320603|P2|COMPLETED|Overall Study||181
541162|NCT00775645|1320604|P1|COMPLETED|Overall Study||191
541163|NCT00775645|1320603|P2|STARTED|Overall Study||201
541164|NCT00775645|1320604|P1|STARTED|Overall Study||208
541165|NCT00775606|1320626|P2|NOT COMPLETED|Overall Study||0
541166|NCT00775606|1320627|P1|NOT COMPLETED|Overall Study||3
541167|NCT00775606|1320626|P2|COMPLETED|Overall Study||5
541168|NCT00775606|1320627|P1|COMPLETED|Overall Study||5
541169|NCT00775606|1320626|P2|STARTED|Overall Study||5
541170|NCT00775606|1320627|P1|STARTED|Overall Study||8
541171|NCT00775593|1320637|P1|NOT COMPLETED|Overall Study||7
541172|NCT00775593|1320637|P1|COMPLETED|Overall Study||53
541173|NCT00775593|1320637|P1|STARTED|Overall Study||60
541174|NCT00775528|1320644|P1|NOT COMPLETED|Overall Study||1
541175|NCT00775528|1320644|P1|COMPLETED|Overall Study||18
541176|NCT00775528|1320644|P1|STARTED|Overall Study|Started means number of patients who consented|19
541177|NCT00775463|1320653|P2|NOT COMPLETED|Overall Study||13
541178|NCT00775463|1320654|P1|NOT COMPLETED|Overall Study||11
541179|NCT00775463|1320653|P2|COMPLETED|Overall Study||59
541180|NCT00775463|1320654|P1|COMPLETED|Overall Study||65
541181|NCT00775463|1320653|P2|STARTED|Overall Study||72
541182|NCT00775463|1320654|P1|STARTED|Overall Study||76
541183|NCT00775450|1320691|P5|NOT COMPLETED|Overall Study||2
541184|NCT00775450|1320692|P4|NOT COMPLETED|Overall Study||0
541185|NCT00775450|1320693|P3|NOT COMPLETED|Overall Study||0
541186|NCT00775450|1320694|P2|NOT COMPLETED|Overall Study||0
541187|NCT00775450|1320695|P1|NOT COMPLETED|Overall Study||3
541188|NCT00775450|1320691|P5|COMPLETED|Overall Study||199
541189|NCT00775450|1320692|P4|COMPLETED|Overall Study||108
541190|NCT00775450|1320693|P3|COMPLETED|Overall Study||105
541191|NCT00775450|1320694|P2|COMPLETED|Overall Study||98
541192|NCT00775450|1320695|P1|COMPLETED|Overall Study||292
541193|NCT00775450|1320691|P5|STARTED|Overall Study||201
541194|NCT00775450|1320692|P4|STARTED|Overall Study||108
541195|NCT00775450|1320693|P3|STARTED|Overall Study||105
541196|NCT00775450|1320694|P2|STARTED|Overall Study||98
541197|NCT00775450|1320695|P1|STARTED|Overall Study||295
541198|NCT00775437|1320722|P1|NOT COMPLETED|Overall Study||6
541199|NCT00775437|1320722|P1|COMPLETED|Overall Study||26
541200|NCT00775437|1320722|P1|STARTED|Overall Study||32
541201|NCT00775411|1320772|P1|NOT COMPLETED|Overall Study||1
541202|NCT00775411|1320772|P1|COMPLETED|Overall Study||43
541203|NCT00775411|1320772|P1|STARTED|Overall Study||44
541204|NCT00775346|1320778|P1|NOT COMPLETED|Overall Study||0
541205|NCT00775346|1320778|P1|COMPLETED|Overall Study||92
541206|NCT00775346|1320778|P1|STARTED|Overall Study||92
541207|NCT00775229|1320784|P2|NOT COMPLETED|Overall Study||2
541208|NCT00775229|1320785|P1|NOT COMPLETED|Overall Study||5
541209|NCT00775229|1320784|P2|COMPLETED|Overall Study||24
541210|NCT00775229|1320785|P1|COMPLETED|Overall Study||20
541211|NCT00775229|1320784|P2|STARTED|Overall Study||26
541212|NCT00775229|1320785|P1|STARTED|Overall Study||25
541213|NCT00775203|1320797|P2|NOT COMPLETED|Overall Study||43
541214|NCT00775203|1320798|P1|NOT COMPLETED|Overall Study||62
541215|NCT00775203|1320797|P2|COMPLETED|Overall Study||163
541216|NCT00775203|1320798|P1|COMPLETED|Overall Study||144
541217|NCT00775203|1320797|P2|Received Study Medication|Overall Study||204
541218|NCT00775203|1320798|P1|Received Study Medication|Overall Study||202
541219|NCT00775203|1320797|P2|STARTED|Overall Study||206
541220|NCT00775203|1320798|P1|STARTED|Overall Study||206
541221|NCT00775190|1320832|P2|NOT COMPLETED|Overall Study||5
541222|NCT00775190|1320833|P1|NOT COMPLETED|Overall Study||4
541223|NCT00775190|1320832|P2|COMPLETED|Overall Study||0
541224|NCT00775190|1320833|P1|COMPLETED|Overall Study||3
541225|NCT00775190|1320832|P2|STARTED|Overall Study||5
541226|NCT00775190|1320833|P1|STARTED|Overall Study||7
541227|NCT00775021|1320855|P2|NOT COMPLETED|Second Intervention||1
541228|NCT00775021|1320856|P1|NOT COMPLETED|Second Intervention||0
541229|NCT00775021|1320855|P2|COMPLETED|Second Intervention||59
541230|NCT00775021|1320856|P1|COMPLETED|Second Intervention||62
541231|NCT00775021|1320855|P2|STARTED|Second Intervention||60
541232|NCT00775021|1320856|P1|STARTED|Second Intervention||62
541233|NCT00775021|1320855|P2|NOT COMPLETED|First Intervention||0
541234|NCT00775021|1320856|P1|NOT COMPLETED|First Intervention||1
541235|NCT00775021|1320855|P2|COMPLETED|First Intervention||60
541236|NCT00775021|1320856|P1|COMPLETED|First Intervention||62
541237|NCT00775021|1320855|P2|STARTED|First Intervention||60
541238|NCT00775021|1320856|P1|STARTED|First Intervention||63
541239|NCT00774995|1320874|P4|NOT COMPLETED|Overall Study||0
541240|NCT00774995|1320875|P3|NOT COMPLETED|Overall Study||1
541241|NCT00774995|1320876|P2|NOT COMPLETED|Overall Study||0
541242|NCT00774995|1320877|P1|NOT COMPLETED|Overall Study||0
541243|NCT00774995|1320874|P4|COMPLETED|Overall Study||16
541244|NCT00774995|1320875|P3|COMPLETED|Overall Study||7
541245|NCT00774995|1320876|P2|COMPLETED|Overall Study||16
541246|NCT00774995|1320877|P1|COMPLETED|Overall Study||9
541247|NCT00774995|1320874|P4|STARTED|Overall Study||16
541248|NCT00774995|1320875|P3|STARTED|Overall Study||8
541249|NCT00774995|1320876|P2|STARTED|Overall Study||16
541250|NCT00774995|1320877|P1|STARTED|Overall Study||9
541251|NCT00774930|1320917|P2|NOT COMPLETED|LTOLE Phase||17
541252|NCT00774930|1320918|P1|NOT COMPLETED|LTOLE Phase||15
541253|NCT00774930|1320917|P2|COMPLETED|LTOLE Phase||8
541254|NCT00774930|1320918|P1|COMPLETED|LTOLE Phase||17
541255|NCT00774930|1320917|P2|STARTED|LTOLE Phase|20 subjects from IOL did not enter LTOLE (12 completed IOL, 8 did not complete IOL).|25
541256|NCT00774930|1320918|P1|STARTED|LTOLE Phase|24 subjects from IOL did not enter LTOLE (11 completed IOL, 13 did not complete IOL).|32
541257|NCT00774930|1320917|P2|NOT COMPLETED|IOL Phase||9
541258|NCT00774930|1320918|P1|NOT COMPLETED|IOL Phase||13
541259|NCT00774930|1320917|P2|COMPLETED|IOL Phase||37
541260|NCT00774930|1320918|P1|COMPLETED|IOL Phase||43
541261|NCT00774930|1320917|P2|STARTED|IOL Phase|Includes 1 subject listed as completing and withdrawing from the DB phase due to brain radiation|46
541262|NCT00774930|1320918|P1|STARTED|IOL Phase||56
541263|NCT00774930|1320917|P2|NOT COMPLETED|DB Phase||22
541264|NCT00774930|1320918|P1|NOT COMPLETED|DB Phase||14
541265|NCT00774930|1320917|P2|COMPLETED|DB Phase|had diary data at least up to day 21 after 4th dose, regardless of missing diary data before day 21.|34
541266|NCT00774930|1320918|P1|COMPLETED|DB Phase|Received 4 DB study injections AND continued to IOL phase OR|45
541267|NCT00774930|1320917|P2|STARTED|DB Phase|One subject was randomised to receive lanreotide Autogel, but erroneously received placebo.|56
541268|NCT00774930|1320918|P1|STARTED|DB Phase|One subject was randomised to receive lanreotide Autogel, but erroneously received placebo.|59
541269|NCT00774852|1320946|P2|NOT COMPLETED|Overall Study||41
541270|NCT00774852|1320947|P1|NOT COMPLETED|Overall Study||45
541271|NCT00774852|1320946|P2|COMPLETED|Overall Study||27
541272|NCT00774852|1320947|P1|COMPLETED|Overall Study||24
541273|NCT00774852|1320946|P2|STARTED|Overall Study||68
541274|NCT00774852|1320947|P1|STARTED|Overall Study||69
541275|NCT00774800|1320995|P1|NOT COMPLETED|Intervention 4||1
541276|NCT00774800|1320995|P1|COMPLETED|Intervention 4||21
541277|NCT00774800|1320995|P1|Received at Least One Dose of Study Drug|Intervention 4||21
541278|NCT00774800|1320995|P1|STARTED|Intervention 4||22
541279|NCT00774800|1320995|P1|NOT COMPLETED|Washout (3 to 10 Days)||0
541280|NCT00774800|1320995|P1|COMPLETED|Washout (3 to 10 Days)||22
541281|NCT00774800|1320995|P1|STARTED|Washout (3 to 10 Days)||22
541282|NCT00774800|1320995|P1|NOT COMPLETED|Intervention 3||0
541283|NCT00774800|1320995|P1|COMPLETED|Intervention 3||22
541284|NCT00774800|1320995|P1|Received at Least One Dose of Study Drug|Intervention 3||22
541285|NCT00774800|1320995|P1|STARTED|Intervention 3||22
541286|NCT00774800|1320995|P1|NOT COMPLETED|Washout (3 to 10 Days)||0
541287|NCT00774800|1320995|P1|COMPLETED|Washout (3 to 10 Days)||22
541288|NCT00774800|1320995|P1|STARTED|Washout (3 to 10 Days)||22
541289|NCT00774800|1320995|P1|NOT COMPLETED|Intervention 2||0
541290|NCT00774800|1320995|P1|COMPLETED|Intervention 2||22
541291|NCT00774800|1320995|P1|Received at Least One Dose of Study Drug|Intervention 2||22
541292|NCT00774800|1320995|P1|STARTED|Intervention 2||22
541293|NCT00774800|1320995|P1|NOT COMPLETED|Washout (3 to 10 Days)||0
541294|NCT00774800|1320995|P1|COMPLETED|Washout (3 to 10 Days)||22
541295|NCT00774800|1320995|P1|STARTED|Washout (3 to 10 Days)||22
541296|NCT00774800|1320995|P1|NOT COMPLETED|Intervention 1||0
541297|NCT00774800|1320995|P1|COMPLETED|Intervention 1||22
541298|NCT00774800|1320995|P1|Received at Least One Dose of Study Drug|Intervention 1||22
541299|NCT00774800|1320995|P1|STARTED|Intervention 1||22
541300|NCT00774787|1321017|P1|NOT COMPLETED|Overall Study||1
541301|NCT00774787|1321017|P1|COMPLETED|Overall Study||26
541302|NCT00774787|1321017|P1|STARTED|Overall Study||27
541303|NCT00774748|1321024|P1|NOT COMPLETED|Overall Study||3
541304|NCT00774748|1321024|P1|COMPLETED|Overall Study||18
541305|NCT00774748|1321024|P1|STARTED|Overall Study||21
541306|NCT00774397|1321039|P7|NOT COMPLETED|Overall Study||30
541307|NCT00774397|1321040|P6|NOT COMPLETED|Overall Study||22
541308|NCT00774397|1321041|P5|NOT COMPLETED|Overall Study||46
541309|NCT00774397|1321042|P4|NOT COMPLETED|Overall Study||17
541310|NCT00774397|1321043|P3|NOT COMPLETED|Overall Study||30
541311|NCT00774397|1321044|P2|NOT COMPLETED|Overall Study||13
541312|NCT00774397|1321045|P1|NOT COMPLETED|Overall Study||14
541313|NCT00774397|1321039|P7|COMPLETED|Overall Study||41
541314|NCT00774397|1321040|P6|COMPLETED|Overall Study||54
541315|NCT00774397|1321041|P5|COMPLETED|Overall Study||97
541316|NCT00774397|1321042|P4|COMPLETED|Overall Study||129
541317|NCT00774397|1321043|P3|COMPLETED|Overall Study||113
541318|NCT00774397|1321044|P2|COMPLETED|Overall Study||56
541319|NCT00774397|1321045|P1|COMPLETED|Overall Study||57
541320|NCT00774397|1321039|P7|STARTED|Overall Study||71
541321|NCT00774397|1321040|P6|STARTED|Overall Study||76
541322|NCT00774397|1321041|P5|STARTED|Overall Study||143
541323|NCT00774397|1321042|P4|STARTED|Overall Study||146
541324|NCT00774397|1321043|P3|STARTED|Overall Study||143
541325|NCT00774397|1321044|P2|STARTED|Overall Study||69
541326|NCT00774397|1321045|P1|STARTED|Overall Study||71
541327|NCT00774306|1321281|P4|NOT COMPLETED|Overall Study||5
541328|NCT00774306|1321282|P3|NOT COMPLETED|Overall Study||8
541329|NCT00774306|1321283|P2|NOT COMPLETED|Overall Study||2
541330|NCT00774306|1321284|P1|NOT COMPLETED|Overall Study||18
541331|NCT00774306|1321281|P4|COMPLETED|Overall Study||2
541332|NCT00774306|1321282|P3|COMPLETED|Overall Study||8
541333|NCT00774306|1321283|P2|COMPLETED|Overall Study||3
541334|NCT00774306|1321284|P1|COMPLETED|Overall Study||6
541335|NCT00774306|1321281|P4|STARTED|Overall Study||7
541336|NCT00774306|1321282|P3|STARTED|Overall Study||16
541337|NCT00774306|1321283|P2|STARTED|Overall Study||5
541338|NCT00774306|1321284|P1|STARTED|Overall Study||24
541339|NCT00774267|1321298|P4|NOT COMPLETED|Overall Study||0
541340|NCT00774267|1321299|P3|NOT COMPLETED|Overall Study||0
541341|NCT00774267|1321300|P2|NOT COMPLETED|Overall Study||0
541342|NCT00774267|1321301|P1|NOT COMPLETED|Overall Study||0
541343|NCT00774267|1321298|P4|COMPLETED|Overall Study||135
541344|NCT00774267|1321299|P3|COMPLETED|Overall Study||129
541345|NCT00774267|1321300|P2|COMPLETED|Overall Study||111
541346|NCT00774267|1321301|P1|COMPLETED|Overall Study||132
541347|NCT00774267|1321298|P4|STARTED|Overall Study||135
541348|NCT00774267|1321299|P3|STARTED|Overall Study||129
541349|NCT00774267|1321300|P2|STARTED|Overall Study||111
541350|NCT00774267|1321301|P1|STARTED|Overall Study||132
541351|NCT00774163|1321313|P2|NOT COMPLETED|Overall Study||0
541352|NCT00774163|1321314|P1|NOT COMPLETED|Overall Study||0
541353|NCT00774163|1321313|P2|COMPLETED|Overall Study||15
541354|NCT00774163|1321314|P1|COMPLETED|Overall Study||30
541355|NCT00774163|1321313|P2|STARTED|Overall Study||15
541356|NCT00774163|1321314|P1|STARTED|Overall Study||30
541357|NCT00774046|1321352|P1|NOT COMPLETED|Autologous Transplant||0
541358|NCT00774046|1321352|P1|COMPLETED|Autologous Transplant||4
541359|NCT00774046|1321352|P1|STARTED|Autologous Transplant|2 patients died in remission and 1 relapsed without having received transplant|4
541360|NCT00774046|1321352|P1|NOT COMPLETED|Stem Cell Mobilization||3
541361|NCT00774046|1321352|P1|COMPLETED|Stem Cell Mobilization||7
541362|NCT00774046|1321352|P1|STARTED|Stem Cell Mobilization|For mobilization, the patient must have had a CR and not been a candidate for allogeneic transplant|10
541363|NCT00774046|1321352|P1|NOT COMPLETED|Induction Therapy||0
541364|NCT00774046|1321352|P1|COMPLETED|Induction Therapy||32
541365|NCT00774046|1321352|P1|STARTED|Induction Therapy||32
541366|NCT00774046|1321352|P1|NOT COMPLETED|Enrollment||28
541367|NCT00774046|1321352|P1|COMPLETED|Enrollment||32
541368|NCT00774046|1321352|P1|STARTED|Enrollment||60
541369|NCT00774046|1321352|P1|NOT COMPLETED|Screening||56
541370|NCT00774046|1321352|P1|COMPLETED|Screening||60
541371|NCT00774046|1321352|P1|STARTED|Screening||116
541372|NCT00773968|1321362|P1|NOT COMPLETED|Overall Study||45
541373|NCT00773968|1321362|P1|COMPLETED|Overall Study||95
541374|NCT00773968|1321362|P1|Treated|Overall Study||111
541375|NCT00773968|1321362|P1|STARTED|Overall Study||140
541376|NCT00773955|1321371|P1|NOT COMPLETED|Overall Study||0
541377|NCT00773955|1321371|P1|COMPLETED|Overall Study||15
541378|NCT00773955|1321371|P1|STARTED|Overall Study||15
541379|NCT00773786|1321378|P2|NOT COMPLETED|Second Intervention (1 Week)||0
541380|NCT00773786|1321379|P1|NOT COMPLETED|Second Intervention (1 Week)||0
541381|NCT00773786|1321378|P2|COMPLETED|Second Intervention (1 Week)||10
541382|NCT00773786|1321379|P1|COMPLETED|Second Intervention (1 Week)||10
541383|NCT00773786|1321378|P2|STARTED|Second Intervention (1 Week)||10
541384|NCT00773786|1321379|P1|STARTED|Second Intervention (1 Week)||10
541385|NCT00773786|1321378|P2|NOT COMPLETED|Washout (1 Week)||0
541386|NCT00773786|1321379|P1|NOT COMPLETED|Washout (1 Week)||0
541387|NCT00773786|1321378|P2|COMPLETED|Washout (1 Week)||10
541388|NCT00773786|1321379|P1|COMPLETED|Washout (1 Week)||10
541389|NCT00773786|1321378|P2|STARTED|Washout (1 Week)||10
541390|NCT00773786|1321379|P1|STARTED|Washout (1 Week)||10
541391|NCT00773786|1321378|P2|NOT COMPLETED|First Intervention (1 Week)||0
541392|NCT00773786|1321379|P1|NOT COMPLETED|First Intervention (1 Week)||0
541393|NCT00773786|1321378|P2|COMPLETED|First Intervention (1 Week)||10
541394|NCT00773786|1321379|P1|COMPLETED|First Intervention (1 Week)||10
541395|NCT00773786|1321378|P2|STARTED|First Intervention (1 Week)||10
541396|NCT00773786|1321379|P1|STARTED|First Intervention (1 Week)||10
541397|NCT00773734|1321393|P6|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
541398|NCT00773734|1321394|P5|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
541399|NCT00773734|1321395|P4|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12
541400|NCT00773734|1321396|P3|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12
541401|NCT00773734|1321397|P2|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
541402|NCT00773734|1321398|P1|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
541403|NCT00773734|1321393|P6|COMPLETED|LTE Period: Week 52 to 6 Years||0
541404|NCT00773734|1321394|P5|COMPLETED|LTE Period: Week 52 to 6 Years||0
541405|NCT00773734|1321395|P4|COMPLETED|LTE Period: Week 52 to 6 Years|Completed = Completed Long Term Extension study|5
541406|NCT00773734|1321396|P3|COMPLETED|LTE Period: Week 52 to 6 Years|Completed = Completed Long Term Extension study|4
541407|NCT00773734|1321397|P2|COMPLETED|LTE Period: Week 52 to 6 Years||0
541408|NCT00773734|1321398|P1|COMPLETED|LTE Period: Week 52 to 6 Years||0
541409|NCT00773734|1321393|P6|STARTED|LTE Period: Week 52 to 6 Years||0
541410|NCT00773734|1321394|P5|STARTED|LTE Period: Week 52 to 6 Years||0
541411|NCT00773734|1321395|P4|STARTED|LTE Period: Week 52 to 6 Years|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|17
541412|NCT00773734|1321396|P3|STARTED|LTE Period: Week 52 to 6 Years|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|16
541413|NCT00773734|1321397|P2|STARTED|LTE Period: Week 52 to 6 Years||0
541414|NCT00773734|1321398|P1|STARTED|LTE Period: Week 52 to 6 Years||0
541415|NCT00773734|1321393|P6|NOT COMPLETED|Extension: Active Treatment Week 24-52||8
541416|NCT00773734|1321394|P5|NOT COMPLETED|Extension: Active Treatment Week 24-52||5
541417|NCT00773734|1321395|P4|NOT COMPLETED|Extension: Active Treatment Week 24-52||10
541418|NCT00773734|1321396|P3|NOT COMPLETED|Extension: Active Treatment Week 24-52||17
541419|NCT00773734|1321397|P2|NOT COMPLETED|Extension: Active Treatment Week 24-52||13
541420|NCT00773734|1321398|P1|NOT COMPLETED|Extension: Active Treatment Week 24-52||0
541421|NCT00773734|1321393|P6|COMPLETED|Extension: Active Treatment Week 24-52||19
541422|NCT00773734|1321394|P5|COMPLETED|Extension: Active Treatment Week 24-52||22
541423|NCT00773734|1321395|P4|COMPLETED|Extension: Active Treatment Week 24-52||48
541424|NCT00773734|1321396|P3|COMPLETED|Extension: Active Treatment Week 24-52||33
541425|NCT00773734|1321397|P2|COMPLETED|Extension: Active Treatment Week 24-52|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|34
541426|NCT00773734|1321398|P1|COMPLETED|Extension: Active Treatment Week 24-52||0
541427|NCT00773734|1321393|P6|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4
541428|NCT00773734|1321394|P5|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4
541429|NCT00773734|1321395|P4|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10
541430|NCT00773734|1321396|P3|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10
541431|NCT00773734|1321397|P2|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||5
541432|NCT00773734|1321398|P1|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||0
541433|NCT00773734|1321393|P6|STARTED|Extension: Active Treatment Week 24-52||27
541434|NCT00773734|1321394|P5|STARTED|Extension: Active Treatment Week 24-52||27
541435|NCT00773734|1321395|P4|STARTED|Extension: Active Treatment Week 24-52||58
541436|NCT00773734|1321396|P3|STARTED|Extension: Active Treatment Week 24-52||50
541437|NCT00773734|1321397|P2|STARTED|Extension: Active Treatment Week 24-52||47
541438|NCT00773734|1321398|P1|STARTED|Extension: Active Treatment Week 24-52||0
541439|NCT00773734|1321393|P6|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||5
541440|NCT00773734|1321394|P5|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||1
541441|NCT00773734|1321395|P4|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||2
541442|NCT00773734|1321396|P3|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||7
541443|NCT00773734|1321397|P2|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||12
541444|NCT00773734|1321398|P1|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||0
541445|NCT00773734|1321393|P6|COMPLETED|Core: Active Treatment Phase Week 16-24||31
541446|NCT00773734|1321394|P5|COMPLETED|Core: Active Treatment Phase Week 16-24||33
541447|NCT00773734|1321395|P4|COMPLETED|Core: Active Treatment Phase Week 16-24||65
541448|NCT00773734|1321396|P3|COMPLETED|Core: Active Treatment Phase Week 16-24||59
541449|NCT00773734|1321397|P2|COMPLETED|Core: Active Treatment Phase Week 16-24||65
541450|NCT00773734|1321398|P1|COMPLETED|Core: Active Treatment Phase Week 16-24||0
541451|NCT00773734|1321393|P6|STARTED|Core: Active Treatment Phase Week 16-24||36
541452|NCT00773734|1321394|P5|STARTED|Core: Active Treatment Phase Week 16-24||34
541453|NCT00773734|1321395|P4|STARTED|Core: Active Treatment Phase Week 16-24|3 participants elected not to continue from previous period|67
541454|NCT00773734|1321396|P3|STARTED|Core: Active Treatment Phase Week 16-24||66
541455|NCT00773734|1321397|P2|STARTED|Core: Active Treatment Phase Week 16-24|2 participants elected not to continue from previous period|77
541456|NCT00773734|1321398|P1|STARTED|Core: Active Treatment Phase Week 16-24|Placebo participants were re-randomized at Week 16 to receive apremilast 20mg or 30mg PO BID.|0
541457|NCT00773734|1321393|P6|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
541458|NCT00773734|1321394|P5|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
541459|NCT00773734|1321395|P4|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||18
541460|NCT00773734|1321396|P3|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||21
541461|NCT00773734|1321397|P2|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||10
541462|NCT00773734|1321398|P1|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||16
541463|NCT00773734|1321393|P6|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
541464|NCT00773734|1321394|P5|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
541465|NCT00773734|1321395|P4|COMPLETED|Core: Placebo Controlled Phase Week 0-16|3 participants completed placebo controlled phase but elected not to continue|70
541466|NCT00773734|1321396|P3|COMPLETED|Core: Placebo Controlled Phase Week 0-16||66
541467|NCT00773734|1321397|P2|COMPLETED|Core: Placebo Controlled Phase Week 0-16|2 participants completed placebo controlled phase but elected not to continue|79
541468|NCT00773734|1321398|P1|COMPLETED|Core: Placebo Controlled Phase Week 0-16|2 participants completed placebo controlled phase but elected not to continue|72
541469|NCT00773734|1321393|P6|STARTED|Core: Placebo Controlled Phase Week 0-16||0
541470|NCT00773734|1321394|P5|STARTED|Core: Placebo Controlled Phase Week 0-16||0
541471|NCT00773734|1321395|P4|STARTED|Core: Placebo Controlled Phase Week 0-16||88
541472|NCT00773734|1321396|P3|STARTED|Core: Placebo Controlled Phase Week 0-16||87
541473|NCT00773734|1321397|P2|STARTED|Core: Placebo Controlled Phase Week 0-16||89
541474|NCT00773734|1321398|P1|STARTED|Core: Placebo Controlled Phase Week 0-16||88
541475|NCT00773474|1321960|P1|NOT COMPLETED|Overall Study||0
541476|NCT00773474|1321960|P1|COMPLETED|Overall Study||29
541477|NCT00773474|1321960|P1|STARTED|Overall Study||29
541478|NCT00773461|1321969|P2|NOT COMPLETED|Overall Study||4
541479|NCT00773461|1321970|P1|NOT COMPLETED|Overall Study||5
541480|NCT00773461|1321969|P2|COMPLETED|Overall Study||135
541481|NCT00773461|1321970|P1|COMPLETED|Overall Study||65
541482|NCT00773461|1321969|P2|STARTED|Overall Study||139
541483|NCT00773461|1321970|P1|STARTED|Overall Study||70
541484|NCT00773422|1322011|P3|NOT COMPLETED|Overall Study||0
541485|NCT00773422|1322012|P2|NOT COMPLETED|Overall Study||0
541486|NCT00773422|1322013|P1|NOT COMPLETED|Overall Study||0
541487|NCT00773422|1322011|P3|COMPLETED|Overall Study||10
541488|NCT00773422|1322012|P2|COMPLETED|Overall Study||9
541489|NCT00773422|1322013|P1|COMPLETED|Overall Study||11
541490|NCT00773422|1322011|P3|STARTED|Overall Study||10
541491|NCT00773422|1322012|P2|STARTED|Overall Study||9
541492|NCT00773422|1322013|P1|STARTED|Overall Study||11
541493|NCT00773383|1322024|P1|NOT COMPLETED|Overall Study||31
541494|NCT00773383|1322024|P1|COMPLETED|Overall Study|this includes at the time of clinical cut-off (2/23/2010) there were 4 patients ongoing|4
541495|NCT00773383|1322024|P1|Received Study Drug|Overall Study||34
541496|NCT00773383|1322024|P1|STARTED|Overall Study||35
541497|NCT00773370|1322046|P2|NOT COMPLETED|Overall Study||10
541498|NCT00773370|1322047|P1|NOT COMPLETED|Overall Study||18
541499|NCT00773370|1322046|P2|COMPLETED|Overall Study||23
541500|NCT00773370|1322047|P1|COMPLETED|Overall Study||25
541501|NCT00773370|1322046|P2|STARTED|Overall Study||33
541502|NCT00773370|1322047|P1|STARTED|Overall Study||43
541503|NCT00773279|1322059|P2|NOT COMPLETED|Period 2||6
541504|NCT00773279|1322060|P1|NOT COMPLETED|Period 2||3
541505|NCT00773279|1322059|P2|COMPLETED|Period 2||111
541506|NCT00773279|1322060|P1|COMPLETED|Period 2||111
541507|NCT00773279|1322059|P2|STARTED|Period 2||117
541508|NCT00773279|1322060|P1|STARTED|Period 2||114
541509|NCT00773279|1322059|P2|NOT COMPLETED|Period 1||4
541510|NCT00773279|1322060|P1|NOT COMPLETED|Period 1||7
541511|NCT00773279|1322059|P2|COMPLETED|Period 1||117
541512|NCT00773279|1322060|P1|COMPLETED|Period 1||114
541513|NCT00773279|1322059|P2|STARTED|Period 1||121
541514|NCT00773279|1322060|P1|STARTED|Period 1||121
541515|NCT00773253|1322081|P2|NOT COMPLETED|Second Intervention (Week 24-48)||0
541516|NCT00773253|1322082|P1|NOT COMPLETED|Second Intervention (Week 24-48)||0
541517|NCT00773253|1322081|P2|COMPLETED|Second Intervention (Week 24-48)||4
541518|NCT00773253|1322082|P1|COMPLETED|Second Intervention (Week 24-48)||5
541519|NCT00773253|1322081|P2|STARTED|Second Intervention (Week 24-48)||4
541520|NCT00773253|1322082|P1|STARTED|Second Intervention (Week 24-48)||5
541521|NCT00773253|1322081|P2|NOT COMPLETED|First Intervention (Week 0-24)||1
541522|NCT00773253|1322082|P1|NOT COMPLETED|First Intervention (Week 0-24)||0
541523|NCT00773253|1322081|P2|COMPLETED|First Intervention (Week 0-24)||4
541524|NCT00773253|1322082|P1|COMPLETED|First Intervention (Week 0-24)||5
541525|NCT00773253|1322081|P2|STARTED|First Intervention (Week 0-24)||5
541526|NCT00773253|1322082|P1|STARTED|First Intervention (Week 0-24)||5
541527|NCT00773136|1322088|P1|NOT COMPLETED|Overall Study||2
541528|NCT00773136|1322088|P1|COMPLETED|Overall Study||19
541529|NCT00773136|1322088|P1|STARTED|Overall Study||21
541530|NCT00773097|1322093|P1|NOT COMPLETED|Overall Study||7
541531|NCT00773097|1322093|P1|COMPLETED|Overall Study||39
541532|NCT00773097|1322093|P1|STARTED|Overall Study||46
541533|NCT00772967|1322099|P6|NOT COMPLETED|Crossover Treatment 3||0
541534|NCT00772967|1322100|P5|NOT COMPLETED|Crossover Treatment 3||1
541535|NCT00772967|1322101|P4|NOT COMPLETED|Crossover Treatment 3||0
541536|NCT00772967|1322102|P3|NOT COMPLETED|Crossover Treatment 3||0
541537|NCT00772967|1322103|P2|NOT COMPLETED|Crossover Treatment 3||0
541538|NCT00772967|1322104|P1|NOT COMPLETED|Crossover Treatment 3||0
541539|NCT00772967|1322099|P6|COMPLETED|Crossover Treatment 3||3
541540|NCT00772967|1322100|P5|COMPLETED|Crossover Treatment 3||3
541541|NCT00772967|1322101|P4|COMPLETED|Crossover Treatment 3||3
541542|NCT00772967|1322102|P3|COMPLETED|Crossover Treatment 3||3
541543|NCT00772967|1322103|P2|COMPLETED|Crossover Treatment 3||4
541544|NCT00772967|1322104|P1|COMPLETED|Crossover Treatment 3||3
541545|NCT00772967|1322099|P6|STARTED|Crossover Treatment 3||3
541546|NCT00772967|1322100|P5|STARTED|Crossover Treatment 3||4
541547|NCT00772967|1322101|P4|STARTED|Crossover Treatment 3||3
541548|NCT00772967|1322102|P3|STARTED|Crossover Treatment 3||3
541549|NCT00772967|1322103|P2|STARTED|Crossover Treatment 3||4
541550|NCT00772967|1322104|P1|STARTED|Crossover Treatment 3||3
541551|NCT00772967|1322099|P6|NOT COMPLETED|Break 2 (4-7 Days)||0
541552|NCT00772967|1322100|P5|NOT COMPLETED|Break 2 (4-7 Days)||0
541553|NCT00772967|1322101|P4|NOT COMPLETED|Break 2 (4-7 Days)||0
541554|NCT00772967|1322102|P3|NOT COMPLETED|Break 2 (4-7 Days)||0
541555|NCT00772967|1322103|P2|NOT COMPLETED|Break 2 (4-7 Days)||0
541556|NCT00772967|1322104|P1|NOT COMPLETED|Break 2 (4-7 Days)||0
541557|NCT00772967|1322099|P6|COMPLETED|Break 2 (4-7 Days)||3
541558|NCT00772967|1322100|P5|COMPLETED|Break 2 (4-7 Days)||4
541559|NCT00772967|1322101|P4|COMPLETED|Break 2 (4-7 Days)||3
541560|NCT00772967|1322102|P3|COMPLETED|Break 2 (4-7 Days)||3
541561|NCT00772967|1322103|P2|COMPLETED|Break 2 (4-7 Days)||4
541562|NCT00772967|1322104|P1|COMPLETED|Break 2 (4-7 Days)||3
541563|NCT00772967|1322099|P6|STARTED|Break 2 (4-7 Days)||3
541564|NCT00772967|1322100|P5|STARTED|Break 2 (4-7 Days)||4
541565|NCT00772967|1322101|P4|STARTED|Break 2 (4-7 Days)||3
541566|NCT00772967|1322102|P3|STARTED|Break 2 (4-7 Days)||3
541567|NCT00772967|1322103|P2|STARTED|Break 2 (4-7 Days)||4
541568|NCT00772967|1322104|P1|STARTED|Break 2 (4-7 Days)||3
541569|NCT00772967|1322099|P6|NOT COMPLETED|Crossover Treatment 2||0
541570|NCT00772967|1322100|P5|NOT COMPLETED|Crossover Treatment 2||0
541571|NCT00772967|1322101|P4|NOT COMPLETED|Crossover Treatment 2||0
541572|NCT00772967|1322102|P3|NOT COMPLETED|Crossover Treatment 2||0
541573|NCT00772967|1322103|P2|NOT COMPLETED|Crossover Treatment 2||0
541574|NCT00772967|1322104|P1|NOT COMPLETED|Crossover Treatment 2||0
541575|NCT00772967|1322099|P6|COMPLETED|Crossover Treatment 2||3
541576|NCT00772967|1322100|P5|COMPLETED|Crossover Treatment 2||4
541577|NCT00772967|1322101|P4|COMPLETED|Crossover Treatment 2||3
541578|NCT00772967|1322102|P3|COMPLETED|Crossover Treatment 2||3
541579|NCT00772967|1322103|P2|COMPLETED|Crossover Treatment 2||4
541580|NCT00772967|1322104|P1|COMPLETED|Crossover Treatment 2||3
541581|NCT00772967|1322099|P6|STARTED|Crossover Treatment 2||3
541582|NCT00772967|1322100|P5|STARTED|Crossover Treatment 2||4
541583|NCT00772967|1322101|P4|STARTED|Crossover Treatment 2||3
541584|NCT00772967|1322102|P3|STARTED|Crossover Treatment 2||3
541585|NCT00772967|1322103|P2|STARTED|Crossover Treatment 2||4
541586|NCT00772967|1322104|P1|STARTED|Crossover Treatment 2||3
541587|NCT00772967|1322099|P6|NOT COMPLETED|Break 1 (4-7 Days)||0
541588|NCT00772967|1322100|P5|NOT COMPLETED|Break 1 (4-7 Days)||0
541589|NCT00772967|1322101|P4|NOT COMPLETED|Break 1 (4-7 Days)||0
541590|NCT00772967|1322102|P3|NOT COMPLETED|Break 1 (4-7 Days)||0
541591|NCT00772967|1322103|P2|NOT COMPLETED|Break 1 (4-7 Days)||1
541592|NCT00772967|1322104|P1|NOT COMPLETED|Break 1 (4-7 Days)||0
541593|NCT00772967|1322099|P6|COMPLETED|Break 1 (4-7 Days)||3
541594|NCT00772967|1322100|P5|COMPLETED|Break 1 (4-7 Days)||4
541595|NCT00772967|1322101|P4|COMPLETED|Break 1 (4-7 Days)||3
541596|NCT00772967|1322102|P3|COMPLETED|Break 1 (4-7 Days)||3
541597|NCT00772967|1322103|P2|COMPLETED|Break 1 (4-7 Days)||4
541598|NCT00772967|1322104|P1|COMPLETED|Break 1 (4-7 Days)||3
541599|NCT00772967|1322099|P6|STARTED|Break 1 (4-7 Days)||3
541600|NCT00772967|1322100|P5|STARTED|Break 1 (4-7 Days)||4
541601|NCT00772967|1322101|P4|STARTED|Break 1 (4-7 Days)||3
541602|NCT00772967|1322102|P3|STARTED|Break 1 (4-7 Days)||3
541603|NCT00772967|1322103|P2|STARTED|Break 1 (4-7 Days)||5
541604|NCT00772967|1322104|P1|STARTED|Break 1 (4-7 Days)||3
541605|NCT00772967|1322099|P6|NOT COMPLETED|Crossover Treatment 1||0
541606|NCT00772967|1322100|P5|NOT COMPLETED|Crossover Treatment 1||0
541607|NCT00772967|1322101|P4|NOT COMPLETED|Crossover Treatment 1||1
541608|NCT00772967|1322102|P3|NOT COMPLETED|Crossover Treatment 1||0
541609|NCT00772967|1322103|P2|NOT COMPLETED|Crossover Treatment 1||0
541610|NCT00772967|1322104|P1|NOT COMPLETED|Crossover Treatment 1||0
541611|NCT00772967|1322099|P6|COMPLETED|Crossover Treatment 1||3
541612|NCT00772967|1322100|P5|COMPLETED|Crossover Treatment 1||4
541613|NCT00772967|1322101|P4|COMPLETED|Crossover Treatment 1|The withdrawal is not included in any outcomes; but is part of the Adverse Event group for placebo|3
541614|NCT00772967|1322102|P3|COMPLETED|Crossover Treatment 1||3
541615|NCT00772967|1322103|P2|COMPLETED|Crossover Treatment 1||5
541616|NCT00772967|1322104|P1|COMPLETED|Crossover Treatment 1||3
541617|NCT00772967|1322099|P6|STARTED|Crossover Treatment 1||3
541618|NCT00772967|1322100|P5|STARTED|Crossover Treatment 1||4
541619|NCT00772967|1322101|P4|STARTED|Crossover Treatment 1||4
541620|NCT00772967|1322102|P3|STARTED|Crossover Treatment 1||3
541621|NCT00772967|1322103|P2|STARTED|Crossover Treatment 1||5
541622|NCT00772967|1322104|P1|STARTED|Crossover Treatment 1||3
541623|NCT00772954|1322124|P3|NOT COMPLETED|Overall Study||1
541624|NCT00772954|1322125|P2|NOT COMPLETED|Overall Study||0
541625|NCT00772954|1322126|P1|NOT COMPLETED|Overall Study||0
541626|NCT00772954|1322124|P3|COMPLETED|Overall Study||11
541627|NCT00772954|1322125|P2|COMPLETED|Overall Study||12
541628|NCT00772954|1322126|P1|COMPLETED|Overall Study||12
541629|NCT00772954|1322124|P3|STARTED|Overall Study||12
541630|NCT00772954|1322125|P2|STARTED|Overall Study||12
541631|NCT00772954|1322126|P1|STARTED|Overall Study||12
541632|NCT00772941|1322134|P1|NOT COMPLETED|Overall Study||682
541633|NCT00772941|1322134|P1|COMPLETED|Overall Study||3257
541634|NCT00772941|1322134|P1|STARTED|Overall Study||3939
541635|NCT00772928|1322165|P2|NOT COMPLETED|Overall Study||41
541636|NCT00772928|1322166|P1|NOT COMPLETED|Overall Study||44
541637|NCT00772928|1322165|P2|COMPLETED|Overall Study||538
541638|NCT00772928|1322166|P1|COMPLETED|Overall Study||543
541639|NCT00772928|1322165|P2|STARTED|Overall Study||579
541640|NCT00772928|1322166|P1|STARTED|Overall Study||587
541641|NCT00772915|1322176|P1|NOT COMPLETED|Overall Study||15
541642|NCT00772915|1322176|P1|COMPLETED|Overall Study||23
541643|NCT00772915|1322176|P1|STARTED|Overall Study||38
541644|NCT00772889|1322183|P3|NOT COMPLETED|Overall Study||16
541645|NCT00772889|1322184|P2|NOT COMPLETED|Overall Study||18
541646|NCT00772889|1322185|P1|NOT COMPLETED|Overall Study||22
541647|NCT00772889|1322183|P3|COMPLETED|Overall Study||187
541648|NCT00772889|1322184|P2|COMPLETED|Overall Study||375
541649|NCT00772889|1322185|P1|COMPLETED|Overall Study||353
541650|NCT00772889|1322183|P3|Completed at Day 21|Overall Study||203
541651|NCT00772889|1322184|P2|Completed at Day 21|Overall Study||390
541652|NCT00772889|1322185|P1|Completed at Day 21|Overall Study||374
541653|NCT00772889|1322183|P3|STARTED|Overall Study||203
541654|NCT00772889|1322184|P2|STARTED|Overall Study||393
541655|NCT00772889|1322185|P1|STARTED|Overall Study||375
541656|NCT00772772|1322238|P1|NOT COMPLETED|Overall Study||0
541657|NCT00772772|1322238|P1|COMPLETED|Overall Study||12
541658|NCT00772772|1322238|P1|STARTED|Overall Study||12
541659|NCT00772707|1322243|P1|NOT COMPLETED|Overall Study||3
541660|NCT00772707|1322243|P1|COMPLETED|Overall Study||111
541661|NCT00772707|1322243|P1|STARTED|Overall Study||114
541662|NCT00772668|1322248|P1|NOT COMPLETED|Overall Study||3
541663|NCT00772668|1322248|P1|COMPLETED|Overall Study||0
541664|NCT00772668|1322248|P1|STARTED|Overall Study||3
541665|NCT00772629|1322257|P2|NOT COMPLETED|Overall Study||0
541666|NCT00772629|1322258|P1|NOT COMPLETED|Overall Study||1
541667|NCT00772629|1322257|P2|COMPLETED|Overall Study||1
541668|NCT00772629|1322258|P1|COMPLETED|Overall Study||16
541669|NCT00772629|1322257|P2|STARTED|Overall Study||1
541670|NCT00772629|1322258|P1|STARTED|Overall Study||17
541671|NCT00772603|1322267|P3|NOT COMPLETED|Overall Study||26
541672|NCT00772603|1322268|P2|NOT COMPLETED|Overall Study||40
541673|NCT00772603|1322269|P1|NOT COMPLETED|Overall Study||52
541674|NCT00772603|1322267|P3|COMPLETED|Overall Study||95
541675|NCT00772603|1322268|P2|COMPLETED|Overall Study||82
541676|NCT00772603|1322269|P1|COMPLETED|Overall Study||71
541677|NCT00772603|1322267|P3|STARTED|Overall Study||121
541678|NCT00772603|1322268|P2|STARTED|Overall Study||122
541679|NCT00772603|1322269|P1|STARTED|Overall Study||123
541680|NCT00772590|1322293|P4|NOT COMPLETED|Overall Study||0
541681|NCT00772590|1322294|P3|NOT COMPLETED|Overall Study||0
541682|NCT00772590|1322295|P2|NOT COMPLETED|Overall Study||0
541683|NCT00772590|1322296|P1|NOT COMPLETED|Overall Study||0
541684|NCT00772590|1322293|P4|COMPLETED|Overall Study||17
541685|NCT00772590|1322294|P3|COMPLETED|Overall Study||18
541686|NCT00772590|1322295|P2|COMPLETED|Overall Study||19
541687|NCT00772590|1322296|P1|COMPLETED|Overall Study||19
541688|NCT00772590|1322293|P4|STARTED|Overall Study||17
541689|NCT00772590|1322294|P3|STARTED|Overall Study||18
541690|NCT00772590|1322295|P2|STARTED|Overall Study||19
541691|NCT00772590|1322296|P1|STARTED|Overall Study||19
541692|NCT00772577|1322308|P2|NOT COMPLETED|Overall Study||23
541693|NCT00772577|1322309|P1|NOT COMPLETED|Overall Study||23
541694|NCT00772577|1322308|P2|COMPLETED|Overall Study||170
541695|NCT00772577|1322309|P1|COMPLETED|Overall Study||170
541696|NCT00772577|1322308|P2|STARTED|Overall Study||193
541697|NCT00772577|1322309|P1|STARTED|Overall Study||193
541698|NCT00772538|1322325|P2|NOT COMPLETED|Overall Study||26
541699|NCT00772538|1322326|P1|NOT COMPLETED|Overall Study||20
541700|NCT00772538|1322325|P2|COMPLETED|Overall Study||211
541701|NCT00772538|1322326|P1|COMPLETED|Overall Study||202
541702|NCT00772538|1322325|P2|STARTED|Overall Study||237
541703|NCT00772538|1322326|P1|STARTED|Overall Study||222
541704|NCT00772447|1322398|P2|NOT COMPLETED|Overall Study||24
541705|NCT00772447|1322399|P1|NOT COMPLETED|Overall Study||20
541706|NCT00772447|1322398|P2|COMPLETED|Overall Study||110
541707|NCT00772447|1322399|P1|COMPLETED|Overall Study||111
541708|NCT00772447|1322398|P2|STARTED|Overall Study||134
541709|NCT00772447|1322399|P1|STARTED|Overall Study||131
541710|NCT00772382|1322427|P1|NOT COMPLETED|Overall Study||55
541711|NCT00772382|1322427|P1|COMPLETED|Overall Study||61
541712|NCT00772382|1322427|P1|STARTED|Overall Study||116
541713|NCT00772369|1322432|P1|NOT COMPLETED|Overall Study||1
541714|NCT00772369|1322432|P1|COMPLETED|Overall Study||3213
541715|NCT00772369|1322432|P1|STARTED|Overall Study||3214
541716|NCT00772304|1322437|P1|NOT COMPLETED|Overall Study||0
541717|NCT00772304|1322437|P1|COMPLETED|Overall Study||102
541718|NCT00772304|1322437|P1|STARTED|Overall Study||102
541719|NCT00772148|1322443|P2|NOT COMPLETED|Maintenance Phase (Week 52)||5
541720|NCT00772148|1322444|P1|NOT COMPLETED|Maintenance Phase (Week 52)||4
541721|NCT00772148|1322443|P2|COMPLETED|Maintenance Phase (Week 52)||18
541722|NCT00772148|1322444|P1|COMPLETED|Maintenance Phase (Week 52)||17
541723|NCT00772148|1322443|P2|STARTED|Maintenance Phase (Week 52)||23
541724|NCT00772148|1322444|P1|STARTED|Maintenance Phase (Week 52)||21
541725|NCT00772148|1322443|P2|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||6
541726|NCT00772148|1322444|P1|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||8
541727|NCT00772148|1322443|P2|COMPLETED|Pharmacokinetic Phase (14 Days)||23
541728|NCT00772148|1322444|P1|COMPLETED|Pharmacokinetic Phase (14 Days)||21
541729|NCT00772148|1322443|P2|STARTED|Pharmacokinetic Phase (14 Days)||29
541730|NCT00772148|1322444|P1|STARTED|Pharmacokinetic Phase (14 Days)||29
541731|NCT00772109|1322464|P4|NOT COMPLETED|Overall Study||31
541732|NCT00772109|1322465|P3|NOT COMPLETED|Overall Study||19
541733|NCT00772109|1322466|P2|NOT COMPLETED|Overall Study||19
541734|NCT00772109|1322467|P1|NOT COMPLETED|Overall Study||21
541735|NCT00772109|1322464|P4|COMPLETED|Overall Study||1397
541736|NCT00772109|1322465|P3|COMPLETED|Overall Study||936
541737|NCT00772109|1322466|P2|COMPLETED|Overall Study||934
541738|NCT00772109|1322467|P1|COMPLETED|Overall Study||935
541739|NCT00772109|1322464|P4|STARTED|Overall Study||1428
541740|NCT00772109|1322465|P3|STARTED|Overall Study||955
541741|NCT00772109|1322466|P2|STARTED|Overall Study||953
541742|NCT00772109|1322467|P1|STARTED|Overall Study||956
541743|NCT00772070|1322491|P2|NOT COMPLETED|Overall Study||10
541744|NCT00772070|1322492|P1|NOT COMPLETED|Overall Study||2
541745|NCT00772070|1322491|P2|COMPLETED|Overall Study||61
541746|NCT00772070|1322492|P1|COMPLETED|Overall Study|Two participants had vaccination errors, they were removed from analysis.|100
541747|NCT00772070|1322491|P2|STARTED|Overall Study||71
541748|NCT00772070|1322492|P1|STARTED|Overall Study||102
541749|NCT00772031|1322504|P2|NOT COMPLETED|Overall Study||43
541750|NCT00772031|1322505|P1|NOT COMPLETED|Overall Study||32
541751|NCT00772031|1322504|P2|COMPLETED|Overall Study||52
541752|NCT00772031|1322505|P1|COMPLETED|Overall Study||64
541753|NCT00772031|1322504|P2|STARTED|Overall Study||95
541754|NCT00772031|1322505|P1|STARTED|Overall Study||96
541755|NCT00772005|1322531|P4|NOT COMPLETED|Overall Study||26
541756|NCT00772005|1322532|P3|NOT COMPLETED|Overall Study||28
541757|NCT00772005|1322533|P2|NOT COMPLETED|Overall Study||30
541758|NCT00772005|1322534|P1|NOT COMPLETED|Overall Study||25
541759|NCT00772005|1322531|P4|COMPLETED|Overall Study||46
541760|NCT00772005|1322532|P3|COMPLETED|Overall Study||44
541761|NCT00772005|1322533|P2|COMPLETED|Overall Study||40
541762|NCT00772005|1322534|P1|COMPLETED|Overall Study||46
541763|NCT00772005|1322531|P4|STARTED|Overall Study|Two patients withdrew before taking any study drug.|72
541764|NCT00772005|1322532|P3|STARTED|Overall Study|One patient withdrew before taking any study drug.|72
541765|NCT00772005|1322533|P2|STARTED|Overall Study|One patient withdrew before taking any study drug.|70
541766|NCT00772005|1322534|P1|STARTED|Overall Study||71
541767|NCT00771953|1323222|P2|NOT COMPLETED|Overall Study||10
541768|NCT00771953|1323223|P1|NOT COMPLETED|Overall Study||10
541769|NCT00771953|1323222|P2|COMPLETED|Overall Study||26
541770|NCT00771953|1323223|P1|COMPLETED|Overall Study||26
541771|NCT00771953|1323222|P2|STARTED|Overall Study||36
541772|NCT00771953|1323223|P1|STARTED|Overall Study||36
541773|NCT00771927|1323233|P2|NOT COMPLETED|Overall Study||237
541774|NCT00771927|1323234|P1|NOT COMPLETED|Overall Study||255
541775|NCT00771927|1323233|P2|COMPLETED|Overall Study||256
541776|NCT00771927|1323234|P1|COMPLETED|Overall Study||256
541777|NCT00771927|1323233|P2|STARTED|Overall Study|Participant Flow and Baseline Characteristics refer to the Safety Set population.|493
541778|NCT00771927|1323234|P1|STARTED|Overall Study|Participant Flow and Baseline Characteristics refer to the Safety Set population.|511
541779|NCT00771914|1323246|P4|NOT COMPLETED|Overall Study||2
541780|NCT00771914|1323247|P3|NOT COMPLETED|Overall Study||0
541781|NCT00771914|1323248|P2|NOT COMPLETED|Overall Study||0
541782|NCT00771914|1323249|P1|NOT COMPLETED|Overall Study||0
541783|NCT00771914|1323246|P4|COMPLETED|Overall Study||6
541784|NCT00771914|1323247|P3|COMPLETED|Overall Study||6
541785|NCT00771914|1323248|P2|COMPLETED|Overall Study||6
541786|NCT00771914|1323249|P1|COMPLETED|Overall Study||7
541787|NCT00771914|1323246|P4|STARTED|Overall Study||8
541788|NCT00771914|1323247|P3|STARTED|Overall Study||6
541789|NCT00771914|1323248|P2|STARTED|Overall Study||6
541790|NCT00771914|1323249|P1|STARTED|Overall Study||7
541791|NCT00771901|1323262|P3|NOT COMPLETED|Overall Study||4
541792|NCT00771901|1323263|P2|NOT COMPLETED|Overall Study||0
541793|NCT00771901|1323264|P1|NOT COMPLETED|Overall Study||0
541794|NCT00771901|1323262|P3|COMPLETED|Overall Study||6
541795|NCT00771901|1323263|P2|COMPLETED|Overall Study||10
541796|NCT00771901|1323264|P1|COMPLETED|Overall Study||10
541797|NCT00771901|1323262|P3|STARTED|Overall Study||10
541798|NCT00771901|1323263|P2|STARTED|Overall Study||10
541799|NCT00771901|1323264|P1|STARTED|Overall Study||10
541800|NCT00771875|1323281|P3|NOT COMPLETED|Overall Study||0
541801|NCT00771875|1323282|P2|NOT COMPLETED|Overall Study||1
541802|NCT00771875|1323283|P1|NOT COMPLETED|Overall Study||0
541803|NCT00771875|1323281|P3|COMPLETED|Overall Study||10
541804|NCT00771875|1323282|P2|COMPLETED|Overall Study||9
541805|NCT00771875|1323283|P1|COMPLETED|Overall Study||10
541806|NCT00771875|1323281|P3|STARTED|Overall Study||10
541807|NCT00771875|1323282|P2|STARTED|Overall Study||10
541808|NCT00771875|1323283|P1|STARTED|Overall Study||10
541809|NCT00771849|1323311|P2|NOT COMPLETED|Overall Study||4
541810|NCT00771849|1323312|P1|NOT COMPLETED|Overall Study||2
541811|NCT00771849|1323311|P2|COMPLETED|Overall Study||47
541812|NCT00771849|1323312|P1|COMPLETED|Overall Study||50
541813|NCT00771849|1323311|P2|STARTED|Overall Study|One subject was not vaccinated|51
541814|NCT00771849|1323312|P1|STARTED|Overall Study||52
541815|NCT00771810|1323323|P3|NOT COMPLETED|Overall Study||7
541816|NCT00771810|1323324|P2|NOT COMPLETED|Overall Study||5
541817|NCT00771810|1323325|P1|NOT COMPLETED|Overall Study||5
541818|NCT00771810|1323323|P3|COMPLETED|Overall Study||6
541819|NCT00771810|1323324|P2|COMPLETED|Overall Study||6
541820|NCT00771810|1323325|P1|COMPLETED|Overall Study||5
541821|NCT00771810|1323323|P3|STARTED|Overall Study||13
541822|NCT00771810|1323324|P2|STARTED|Overall Study||11
541823|NCT00771810|1323325|P1|STARTED|Overall Study||10
541824|NCT00771758|1323363|P3|NOT COMPLETED|Overall Study||2
541825|NCT00771758|1323364|P2|NOT COMPLETED|Overall Study||12
541826|NCT00771758|1323365|P1|NOT COMPLETED|Overall Study||8
541827|NCT00771758|1323363|P3|COMPLETED|Overall Study||19
541828|NCT00771758|1323364|P2|COMPLETED|Overall Study||31
541829|NCT00771758|1323365|P1|COMPLETED|Overall Study||36
541830|NCT00771758|1323363|P3|STARTED|Overall Study||21
541831|NCT00771758|1323364|P2|STARTED|Overall Study||43
541832|NCT00771758|1323365|P1|STARTED|Overall Study||44
541833|NCT00771745|1323515|P2|NOT COMPLETED|Overall Study||0
541834|NCT00771745|1323516|P1|NOT COMPLETED|Overall Study||0
541835|NCT00771745|1323515|P2|COMPLETED|Overall Study||5
541836|NCT00771745|1323516|P1|COMPLETED|Overall Study||6
541837|NCT00771745|1323515|P2|STARTED|Overall Study||5
541838|NCT00771745|1323516|P1|STARTED|Overall Study||6
541839|NCT00771667|1323526|P10|NOT COMPLETED|Maintenance Phase||17
541840|NCT00771667|1323527|P9|NOT COMPLETED|Maintenance Phase||22
541841|NCT00771667|1323528|P8|NOT COMPLETED|Maintenance Phase||5
541842|NCT00771667|1323529|P7|NOT COMPLETED|Maintenance Phase||10
541843|NCT00771667|1323530|P6|NOT COMPLETED|Maintenance Phase||7
541844|NCT00771667|1323531|P5|NOT COMPLETED|Maintenance Phase||2
541845|NCT00771667|1323532|P4|NOT COMPLETED|Maintenance Phase||0
541846|NCT00771667|1323533|P3|NOT COMPLETED|Maintenance Phase||0
541847|NCT00771667|1323534|P2|NOT COMPLETED|Maintenance Phase||0
541848|NCT00771667|1323535|P1|NOT COMPLETED|Maintenance Phase||0
541849|NCT00771667|1323526|P10|COMPLETED|Maintenance Phase||92
541850|NCT00771667|1323527|P9|COMPLETED|Maintenance Phase||88
541851|NCT00771667|1323528|P8|COMPLETED|Maintenance Phase||67
541852|NCT00771667|1323529|P7|COMPLETED|Maintenance Phase||63
541853|NCT00771667|1323530|P6|COMPLETED|Maintenance Phase||78
541854|NCT00771667|1323531|P5|COMPLETED|Maintenance Phase||26
541855|NCT00771667|1323532|P4|COMPLETED|Maintenance Phase||0
541856|NCT00771667|1323533|P3|COMPLETED|Maintenance Phase||0
541857|NCT00771667|1323534|P2|COMPLETED|Maintenance Phase||0
541858|NCT00771667|1323535|P1|COMPLETED|Maintenance Phase||0
541859|NCT00771667|1323526|P10|STARTED|Maintenance Phase||109
541860|NCT00771667|1323527|P9|STARTED|Maintenance Phase||110
541861|NCT00771667|1323528|P8|STARTED|Maintenance Phase||72
541862|NCT00771667|1323529|P7|STARTED|Maintenance Phase||73
541863|NCT00771667|1323530|P6|STARTED|Maintenance Phase||85
541864|NCT00771667|1323531|P5|STARTED|Maintenance Phase||28
541865|NCT00771667|1323532|P4|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
541866|NCT00771667|1323533|P3|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
541867|NCT00771667|1323534|P2|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
541868|NCT00771667|1323535|P1|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
541869|NCT00771667|1323526|P10|NOT COMPLETED|Induction Phase||0
541870|NCT00771667|1323527|P9|NOT COMPLETED|Induction Phase||0
541871|NCT00771667|1323528|P8|NOT COMPLETED|Induction Phase||0
541872|NCT00771667|1323529|P7|NOT COMPLETED|Induction Phase||0
541873|NCT00771667|1323530|P6|NOT COMPLETED|Induction Phase||0
541874|NCT00771667|1323531|P5|NOT COMPLETED|Induction Phase||0
541875|NCT00771667|1323532|P4|NOT COMPLETED|Induction Phase||8
541876|NCT00771667|1323533|P3|NOT COMPLETED|Induction Phase||12
541877|NCT00771667|1323534|P2|NOT COMPLETED|Induction Phase||10
541878|NCT00771667|1323535|P1|NOT COMPLETED|Induction Phase||19
541879|NCT00771667|1323526|P10|COMPLETED|Induction Phase||0
541880|NCT00771667|1323527|P9|COMPLETED|Induction Phase||0
541881|NCT00771667|1323528|P8|COMPLETED|Induction Phase||0
541882|NCT00771667|1323529|P7|COMPLETED|Induction Phase||0
541883|NCT00771667|1323530|P6|COMPLETED|Induction Phase||0
541884|NCT00771667|1323531|P5|COMPLETED|Induction Phase||0
541885|NCT00771667|1323532|P4|COMPLETED|Induction Phase||123
541886|NCT00771667|1323533|P3|COMPLETED|Induction Phase||120
541887|NCT00771667|1323534|P2|COMPLETED|Induction Phase||121
541888|NCT00771667|1323535|P1|COMPLETED|Induction Phase||113
541889|NCT00771667|1323526|P10|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
541890|NCT00771667|1323527|P9|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
541891|NCT00771667|1323528|P8|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
541892|NCT00771667|1323529|P7|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
541893|NCT00771667|1323530|P6|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
541894|NCT00771667|1323531|P5|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
541895|NCT00771667|1323532|P4|STARTED|Induction Phase||131
541896|NCT00771667|1323533|P3|STARTED|Induction Phase||132
541897|NCT00771667|1323534|P2|STARTED|Induction Phase||131
541898|NCT00771667|1323535|P1|STARTED|Induction Phase||132
541899|NCT00771615|1323580|P9|NOT COMPLETED|Overall Study||0
541900|NCT00771615|1323581|P8|NOT COMPLETED|Overall Study||1
541901|NCT00771615|1323582|P7|NOT COMPLETED|Overall Study||1
541902|NCT00771615|1323583|P6|NOT COMPLETED|Overall Study||1
541903|NCT00771615|1323584|P5|NOT COMPLETED|Overall Study||0
541904|NCT00771615|1323585|P4|NOT COMPLETED|Overall Study||1
541905|NCT00771615|1323586|P3|NOT COMPLETED|Overall Study||1
541906|NCT00771615|1323587|P2|NOT COMPLETED|Overall Study||2
541907|NCT00771615|1323588|P1|NOT COMPLETED|Overall Study||1
541908|NCT00771615|1323580|P9|COMPLETED|Overall Study|Up to Day 364|41
541909|NCT00771615|1323581|P8|COMPLETED|Overall Study|Up to Day 364|58
541910|NCT00771615|1323582|P7|COMPLETED|Overall Study|Up to Day 364|45
541911|NCT00771615|1323583|P6|COMPLETED|Overall Study|Up to Day 364|60
541912|NCT00771615|1323584|P5|COMPLETED|Overall Study|Up to Day 364|40
541913|NCT00771615|1323585|P4|COMPLETED|Overall Study|Up to Day 364|59
541914|NCT00771615|1323586|P3|COMPLETED|Overall Study|Up to Day 364|40
541915|NCT00771615|1323587|P2|COMPLETED|Overall Study|Up to Day 364|70
541916|NCT00771615|1323588|P1|COMPLETED|Overall Study|Up to Day 364|48
541917|NCT00771615|1323580|P9|STARTED|Overall Study||41
541918|NCT00771615|1323581|P8|STARTED|Overall Study||59
541919|NCT00771615|1323582|P7|STARTED|Overall Study||46
541920|NCT00771615|1323583|P6|STARTED|Overall Study||61
541921|NCT00771615|1323584|P5|STARTED|Overall Study||40
541922|NCT00771615|1323585|P4|STARTED|Overall Study||60
541923|NCT00771615|1323586|P3|STARTED|Overall Study||41
541924|NCT00771615|1323587|P2|STARTED|Overall Study||72
541925|NCT00771615|1323588|P1|STARTED|Overall Study||49
541926|NCT00771602|1323782|P3|NOT COMPLETED|Overall Study||0
541927|NCT00771602|1323783|P2|NOT COMPLETED|Overall Study||0
541928|NCT00771602|1323784|P1|NOT COMPLETED|Overall Study||0
541929|NCT00771602|1323782|P3|COMPLETED|Overall Study||0
541930|NCT00771602|1323783|P2|COMPLETED|Overall Study||0
541931|NCT00771602|1323784|P1|COMPLETED|Overall Study||1
541932|NCT00771602|1323782|P3|STARTED|Overall Study||0
541933|NCT00771602|1323783|P2|STARTED|Overall Study||0
541934|NCT00771602|1323784|P1|STARTED|Overall Study||1
541935|NCT00771537|1323808|P16|NOT COMPLETED|Overall Study||0
541936|NCT00771537|1323809|P15|NOT COMPLETED|Overall Study||0
541937|NCT00771537|1323810|P14|NOT COMPLETED|Overall Study||0
541938|NCT00771537|1323811|P13|NOT COMPLETED|Overall Study||0
541939|NCT00771537|1323812|P12|NOT COMPLETED|Overall Study||0
541940|NCT00771537|1323813|P11|NOT COMPLETED|Overall Study||0
541941|NCT00771537|1323814|P10|NOT COMPLETED|Overall Study||0
541942|NCT00771537|1323815|P9|NOT COMPLETED|Overall Study||0
541943|NCT00771537|1323816|P8|NOT COMPLETED|Overall Study||0
541944|NCT00771537|1323817|P7|NOT COMPLETED|Overall Study||0
541945|NCT00771537|1323818|P6|NOT COMPLETED|Overall Study||0
541946|NCT00771537|1323819|P5|NOT COMPLETED|Overall Study||0
541947|NCT00771537|1323820|P4|NOT COMPLETED|Overall Study||0
541948|NCT00771537|1323821|P3|NOT COMPLETED|Overall Study||0
541949|NCT00771537|1323822|P2|NOT COMPLETED|Overall Study||0
541950|NCT00771537|1323823|P1|NOT COMPLETED|Overall Study||0
541951|NCT00771537|1323808|P16|COMPLETED|Overall Study||122
541952|NCT00771537|1323809|P15|COMPLETED|Overall Study||124
541953|NCT00771537|1323810|P14|COMPLETED|Overall Study||124
541954|NCT00771537|1323811|P13|COMPLETED|Overall Study||128
541955|NCT00771537|1323812|P12|COMPLETED|Overall Study||137
541956|NCT00771537|1323813|P11|COMPLETED|Overall Study||133
541957|NCT00771537|1323814|P10|COMPLETED|Overall Study||119
541958|NCT00771537|1323815|P9|COMPLETED|Overall Study||115
541959|NCT00771537|1323816|P8|COMPLETED|Overall Study||132
541960|NCT00771537|1323817|P7|COMPLETED|Overall Study||128
541961|NCT00771537|1323818|P6|COMPLETED|Overall Study||118
541962|NCT00771537|1323819|P5|COMPLETED|Overall Study||127
541963|NCT00771537|1323820|P4|COMPLETED|Overall Study||114
541964|NCT00771537|1323821|P3|COMPLETED|Overall Study||151
541965|NCT00771537|1323822|P2|COMPLETED|Overall Study||124
541966|NCT00771537|1323823|P1|COMPLETED|Overall Study||135
541967|NCT00771537|1323808|P16|STARTED|Overall Study||122
541968|NCT00771537|1323809|P15|STARTED|Overall Study||124
541969|NCT00771537|1323810|P14|STARTED|Overall Study||124
541970|NCT00771537|1323811|P13|STARTED|Overall Study||128
541971|NCT00771537|1323812|P12|STARTED|Overall Study||137
541972|NCT00771537|1323813|P11|STARTED|Overall Study||133
541973|NCT00771537|1323814|P10|STARTED|Overall Study||119
541974|NCT00771537|1323815|P9|STARTED|Overall Study||115
541975|NCT00771537|1323816|P8|STARTED|Overall Study||132
541976|NCT00771537|1323817|P7|STARTED|Overall Study||128
541977|NCT00771537|1323818|P6|STARTED|Overall Study||118
541978|NCT00771537|1323819|P5|STARTED|Overall Study||127
541979|NCT00771537|1323820|P4|STARTED|Overall Study||114
541980|NCT00771537|1323821|P3|STARTED|Overall Study||151
541981|NCT00771537|1323822|P2|STARTED|Overall Study||124
541982|NCT00771537|1323823|P1|STARTED|Overall Study||135
541983|NCT00771472|1323849|P2|NOT COMPLETED|Overall Study||4
541984|NCT00771472|1323850|P1|NOT COMPLETED|Overall Study||6
541985|NCT00771472|1323849|P2|COMPLETED|Overall Study||0
541986|NCT00771472|1323850|P1|COMPLETED|Overall Study||0
541987|NCT00771472|1323849|P2|STARTED|Overall Study||4
541988|NCT00771472|1323850|P1|STARTED|Overall Study||6
541989|NCT00771407|1323861|P2|NOT COMPLETED|Overall Study||25
541990|NCT00771407|1323862|P1|NOT COMPLETED|Overall Study||20
541991|NCT00771407|1323861|P2|COMPLETED|Overall Study||35
541992|NCT00771407|1323862|P1|COMPLETED|Overall Study||40
541993|NCT00771407|1323861|P2|STARTED|Overall Study||60
541994|NCT00771407|1323862|P1|STARTED|Overall Study||60
541995|NCT00771316|1323870|P2|NOT COMPLETED|Overall Study||1
541996|NCT00771316|1323871|P1|NOT COMPLETED|Overall Study||2
541997|NCT00771316|1323870|P2|COMPLETED|Overall Study||1
541998|NCT00771316|1323871|P1|COMPLETED|Overall Study||2
541999|NCT00771316|1323870|P2|STARTED|Overall Study||2
542000|NCT00771316|1323871|P1|STARTED|Overall Study||4
542001|NCT00771277|1323881|P1|NOT COMPLETED|Overall Study||0
542002|NCT00771277|1323881|P1|COMPLETED|Overall Study||6
542003|NCT00771277|1323881|P1|STARTED|Overall Study||6
542004|NCT00771264|1323889|P2|NOT COMPLETED|Overall Study||5
542005|NCT00771264|1323890|P1|NOT COMPLETED|Overall Study||7
542006|NCT00771264|1323889|P2|COMPLETED|Overall Study||105
542007|NCT00771264|1323890|P1|COMPLETED|Overall Study||103
542008|NCT00771264|1323889|P2|STARTED|Overall Study||110
542009|NCT00771264|1323890|P1|STARTED|Overall Study||110
542010|NCT00771238|1323898|P2|NOT COMPLETED|Overall Study||0
542011|NCT00771238|1323899|P1|NOT COMPLETED|Overall Study||0
542012|NCT00771238|1323898|P2|COMPLETED|Overall Study||21
542013|NCT00771238|1323899|P1|COMPLETED|Overall Study||31
542014|NCT00771238|1323898|P2|STARTED|Overall Study||21
542015|NCT00771238|1323899|P1|STARTED|Overall Study||31
542016|NCT00771173|1323909|P2|NOT COMPLETED|Overall Study||17
542017|NCT00771173|1323910|P1|NOT COMPLETED|Overall Study||22
542018|NCT00771173|1323909|P2|COMPLETED|Overall Study||112
542019|NCT00771173|1323910|P1|COMPLETED|Overall Study||107
542020|NCT00771173|1323909|P2|STARTED|Overall Study||129
542021|NCT00771173|1323910|P1|STARTED|Overall Study||129
542022|NCT00771056|1323916|P1|NOT COMPLETED|Overall Study||5
542023|NCT00771056|1323916|P1|COMPLETED|Overall Study||18
542024|NCT00771056|1323916|P1|STARTED|Overall Study||23
542025|NCT00770991|1323923|P2|NOT COMPLETED|Overall Study||5
542026|NCT00770991|1323924|P1|NOT COMPLETED|Overall Study||5
542027|NCT00770991|1323923|P2|COMPLETED|Overall Study|7 subjects completed 36 weeks (+/- 10 days)of treatment|7
542028|NCT00770991|1323924|P1|COMPLETED|Overall Study|7 subjects completed 36 weeks (+/- 10 days)of treatment|7
542029|NCT00770991|1323923|P2|STARTED|Overall Study|We anticipated 26-30 subjects with FAP 18 year or olders would need to be enrolled to randomize 18|12
542030|NCT00770991|1323924|P1|STARTED|Overall Study|34 participants enrolled (signed informed consent). 24 subjects were eligible to be randomized.|12
542031|NCT00770965|1323940|P4|NOT COMPLETED|Excluded Set||13
542032|NCT00770965|1323941|P3|NOT COMPLETED|Excluded Set||14
542033|NCT00770965|1323942|P2|NOT COMPLETED|Excluded Set||13
542034|NCT00770965|1323943|P1|NOT COMPLETED|Excluded Set||15
542035|NCT00770965|1323940|P4|COMPLETED|Excluded Set||2
542036|NCT00770965|1323941|P3|COMPLETED|Excluded Set||2
542037|NCT00770965|1323942|P2|COMPLETED|Excluded Set||3
542038|NCT00770965|1323943|P1|COMPLETED|Excluded Set||3
542039|NCT00770965|1323940|P4|STARTED|Excluded Set||15
542040|NCT00770965|1323941|P3|STARTED|Excluded Set||16
542041|NCT00770965|1323942|P2|STARTED|Excluded Set||16
542042|NCT00770965|1323943|P1|STARTED|Excluded Set||18
542043|NCT00770965|1323940|P4|NOT COMPLETED|Safety Set||1
542044|NCT00770965|1323941|P3|NOT COMPLETED|Safety Set||1
542045|NCT00770965|1323942|P2|NOT COMPLETED|Safety Set||0
542046|NCT00770965|1323943|P1|NOT COMPLETED|Safety Set||0
542047|NCT00770965|1323940|P4|COMPLETED|Safety Set||4
542048|NCT00770965|1323941|P3|COMPLETED|Safety Set||3
542049|NCT00770965|1323942|P2|COMPLETED|Safety Set||4
542050|NCT00770965|1323943|P1|COMPLETED|Safety Set||2
542051|NCT00770965|1323940|P4|STARTED|Safety Set||5
542052|NCT00770965|1323941|P3|STARTED|Safety Set||4
542053|NCT00770965|1323942|P2|STARTED|Safety Set||4
542054|NCT00770965|1323943|P1|STARTED|Safety Set||2
542055|NCT00770913|1323964|P3|NOT COMPLETED|Overall Study||13
542056|NCT00770913|1323965|P2|NOT COMPLETED|Overall Study||8
542057|NCT00770913|1323966|P1|NOT COMPLETED|Overall Study||11
542058|NCT00770913|1323964|P3|COMPLETED|Overall Study||100
542059|NCT00770913|1323965|P2|COMPLETED|Overall Study||103
542060|NCT00770913|1323966|P1|COMPLETED|Overall Study||102
542061|NCT00770913|1323964|P3|STARTED|Overall Study||113
542062|NCT00770913|1323965|P2|STARTED|Overall Study||111
542063|NCT00770913|1323966|P1|STARTED|Overall Study||113
542064|NCT00770861|1323976|P2|NOT COMPLETED|Overall Study||16
542065|NCT00770861|1323977|P1|NOT COMPLETED|Overall Study||10
542066|NCT00770861|1323976|P2|COMPLETED|Overall Study||120
542067|NCT00770861|1323977|P1|COMPLETED|Overall Study||131
542068|NCT00770861|1323976|P2|STARTED|Overall Study||136
542069|NCT00770861|1323977|P1|STARTED|Overall Study||141
542070|NCT00770809|1323988|P3|NOT COMPLETED|Overall Study||23
542071|NCT00770809|1323989|P2|NOT COMPLETED|Overall Study||10
542072|NCT00770809|1323990|P1|NOT COMPLETED|Overall Study||17
542073|NCT00770809|1323988|P3|COMPLETED|Overall Study||44
542074|NCT00770809|1323989|P2|COMPLETED|Overall Study||110
542075|NCT00770809|1323990|P1|COMPLETED|Overall Study||101
542076|NCT00770809|1323988|P3|STARTED|Overall Study||67
542077|NCT00770809|1323989|P2|STARTED|Overall Study||120
542078|NCT00770809|1323990|P1|STARTED|Overall Study||118
542079|NCT00770770|1324000|P2|NOT COMPLETED|Overall Study||1
542080|NCT00770770|1324001|P1|NOT COMPLETED|Overall Study||10
542081|NCT00770770|1324000|P2|COMPLETED|Overall Study||5
542082|NCT00770770|1324001|P1|COMPLETED|Overall Study||4
542083|NCT00770770|1324000|P2|STARTED|Overall Study||6
542084|NCT00770770|1324001|P1|STARTED|Overall Study||14
542085|NCT00770757|1324007|P1|NOT COMPLETED|Overall Study||0
542086|NCT00770757|1324007|P1|COMPLETED|Overall Study||13
542087|NCT00770757|1324007|P1|STARTED|Overall Study||13
542088|NCT00770692|1324019|P4|NOT COMPLETED|Overall Study||11
542089|NCT00770692|1324020|P3|NOT COMPLETED|Overall Study||14
542090|NCT00770692|1324021|P2|NOT COMPLETED|Overall Study||9
542091|NCT00770692|1324022|P1|NOT COMPLETED|Overall Study||12
542092|NCT00770692|1324019|P4|COMPLETED|Overall Study||66
542093|NCT00770692|1324020|P3|COMPLETED|Overall Study||70
542094|NCT00770692|1324021|P2|COMPLETED|Overall Study||74
542095|NCT00770692|1324022|P1|COMPLETED|Overall Study||69
542096|NCT00770692|1324019|P4|STARTED|Overall Study||77
542097|NCT00770692|1324020|P3|STARTED|Overall Study||84
542098|NCT00770692|1324021|P2|STARTED|Overall Study||83
542099|NCT00770692|1324022|P1|STARTED|Overall Study|"1 participant whose compliance was unknown, was regarded as a treatment compliance unknown"|81
542100|NCT00770679|1324048|P1|NOT COMPLETED|Overall Study||6
542101|NCT00770679|1324048|P1|COMPLETED|Overall Study||10
542102|NCT00770679|1324048|P1|STARTED|Overall Study||16
542103|NCT00770653|1324056|P2|NOT COMPLETED|Overall Study||29
542104|NCT00770653|1324057|P1|NOT COMPLETED|Overall Study||32
542105|NCT00770653|1324056|P2|COMPLETED|Overall Study||121
542106|NCT00770653|1324057|P1|COMPLETED|Overall Study||123
542107|NCT00770653|1324056|P2|STARTED|Overall Study||150
542108|NCT00770653|1324057|P1|STARTED|Overall Study||155
542109|NCT00770588|1324127|P2|NOT COMPLETED|Overall Study||95
542110|NCT00770588|1324128|P1|NOT COMPLETED|Overall Study||81
542111|NCT00770588|1324127|P2|COMPLETED|Overall Study||53
542112|NCT00770588|1324128|P1|COMPLETED|Overall Study||67
542113|NCT00770588|1324127|P2|STARTED|Overall Study||148
542114|NCT00770588|1324128|P1|STARTED|Overall Study||148
542115|NCT00770562|1324144|P2|NOT COMPLETED|Overall Study||1
542116|NCT00770562|1324145|P1|NOT COMPLETED|Overall Study||1
542117|NCT00770562|1324144|P2|COMPLETED|Overall Study||49
542118|NCT00770562|1324145|P1|COMPLETED|Overall Study||52
542119|NCT00770562|1324144|P2|STARTED|Overall Study||50
542120|NCT00770562|1324145|P1|STARTED|Overall Study||53
542121|NCT00770510|1324156|P1|NOT COMPLETED|Overall Study||5
542122|NCT00770510|1324156|P1|COMPLETED|Overall Study||67
542123|NCT00770510|1324156|P1|STARTED|Overall Study||72
542124|NCT00770484|1324195|P2|NOT COMPLETED|Overall Study||0
542125|NCT00770484|1324196|P1|NOT COMPLETED|Overall Study||1
542126|NCT00770484|1324195|P2|COMPLETED|Overall Study||4
542127|NCT00770484|1324196|P1|COMPLETED|Overall Study||7
542128|NCT00770484|1324195|P2|STARTED|Overall Study||4
542129|NCT00770484|1324196|P1|STARTED|Overall Study||8
542130|NCT00770432|1324204|P2|NOT COMPLETED|Overall Study||7
542131|NCT00770432|1324205|P1|NOT COMPLETED|Overall Study||4
542132|NCT00770432|1324204|P2|COMPLETED|Overall Study||94
542133|NCT00770432|1324205|P1|COMPLETED|Overall Study||98
542134|NCT00770432|1324204|P2|STARTED|Overall Study||101
542135|NCT00770432|1324205|P1|STARTED|Overall Study||102
542136|NCT00770367|1324213|P2|NOT COMPLETED|Second Intervention||0
542137|NCT00770367|1324214|P1|NOT COMPLETED|Second Intervention||2
542138|NCT00770367|1324213|P2|COMPLETED|Second Intervention||15
542139|NCT00770367|1324214|P1|COMPLETED|Second Intervention||16
542140|NCT00770367|1324213|P2|STARTED|Second Intervention||15
542141|NCT00770367|1324214|P1|STARTED|Second Intervention||18
542142|NCT00770367|1324213|P2|NOT COMPLETED|Washout Period of 4 Weeks||1
542143|NCT00770367|1324214|P1|NOT COMPLETED|Washout Period of 4 Weeks||0
542144|NCT00770367|1324213|P2|COMPLETED|Washout Period of 4 Weeks||15
542145|NCT00770367|1324214|P1|COMPLETED|Washout Period of 4 Weeks||18
542146|NCT00770367|1324213|P2|STARTED|Washout Period of 4 Weeks||16
542147|NCT00770367|1324214|P1|STARTED|Washout Period of 4 Weeks||18
542148|NCT00770367|1324213|P2|NOT COMPLETED|First Intervention||2
542149|NCT00770367|1324214|P1|NOT COMPLETED|First Intervention||0
542150|NCT00770367|1324213|P2|COMPLETED|First Intervention||16
542151|NCT00770367|1324214|P1|COMPLETED|First Intervention||18
542152|NCT00770367|1324213|P2|STARTED|First Intervention||18
542153|NCT00770367|1324214|P1|STARTED|First Intervention||18
542154|NCT00770341|1324223|P3|NOT COMPLETED|Overall Study||3
542155|NCT00770341|1324224|P2|NOT COMPLETED|Overall Study||5
542156|NCT00770341|1324225|P1|NOT COMPLETED|Overall Study||12
542157|NCT00770341|1324223|P3|COMPLETED|Overall Study||8
542158|NCT00770341|1324224|P2|COMPLETED|Overall Study||17
542159|NCT00770341|1324225|P1|COMPLETED|Overall Study||77
542160|NCT00770341|1324223|P3|STARTED|Overall Study|Number randomized|11
542161|NCT00770341|1324224|P2|STARTED|Overall Study|Number randomized|22
542162|NCT00770341|1324225|P1|STARTED|Overall Study|Number randomized|89
542163|NCT00770328|1324251|P2|NOT COMPLETED|Overall Study||4
542164|NCT00770328|1324252|P1|NOT COMPLETED|Overall Study||13
542165|NCT00770328|1324251|P2|COMPLETED|Overall Study||11
542166|NCT00770328|1324252|P1|COMPLETED|Overall Study||9
542167|NCT00770328|1324251|P2|STARTED|Overall Study||15
542168|NCT00770328|1324252|P1|STARTED|Overall Study||22
542169|NCT00770315|1324268|P4|NOT COMPLETED|Overall Study||38
542170|NCT00770315|1324269|P3|NOT COMPLETED|Overall Study||57
542171|NCT00770315|1324270|P2|NOT COMPLETED|Overall Study||43
542172|NCT00770315|1324271|P1|NOT COMPLETED|Overall Study||40
542173|NCT00770315|1324268|P4|COMPLETED|Overall Study||160
542174|NCT00770315|1324269|P3|COMPLETED|Overall Study||137
542175|NCT00770315|1324270|P2|COMPLETED|Overall Study||152
542176|NCT00770315|1324271|P1|COMPLETED|Overall Study||157
542177|NCT00770315|1324268|P4|STARTED|Overall Study||198
542178|NCT00770315|1324269|P3|STARTED|Overall Study||194
542179|NCT00770315|1324270|P2|STARTED|Overall Study||195
542180|NCT00770315|1324271|P1|STARTED|Overall Study||197
542181|NCT00770289|1324297|P1|NOT COMPLETED|Overall Study||6
542182|NCT00770289|1324297|P1|COMPLETED|Overall Study||845
542183|NCT00770289|1324297|P1|STARTED|Overall Study||851
542184|NCT00770211|1324308|P2|NOT COMPLETED|Overall Study||2
542185|NCT00770211|1324309|P1|NOT COMPLETED|Overall Study||1
542186|NCT00770211|1324308|P2|COMPLETED|Overall Study||87
542187|NCT00770211|1324309|P1|COMPLETED|Overall Study||181
542188|NCT00770211|1324308|P2|STARTED|Overall Study||89
542189|NCT00770211|1324309|P1|STARTED|Overall Study||182
542190|NCT00770146|1324325|P2|NOT COMPLETED|Follow-up Period||20
542191|NCT00770146|1324326|P1|NOT COMPLETED|Follow-up Period||11
542192|NCT00770146|1324325|P2|COMPLETED|Follow-up Period||85
542193|NCT00770146|1324326|P1|COMPLETED|Follow-up Period||42
542194|NCT00770146|1324325|P2|STARTED|Follow-up Period||105
542195|NCT00770146|1324326|P1|STARTED|Follow-up Period||53
542196|NCT00770146|1324325|P2|NOT COMPLETED|Treatment Period||45
542197|NCT00770146|1324326|P1|NOT COMPLETED|Treatment Period||9
542198|NCT00770146|1324325|P2|COMPLETED|Treatment Period||60
542199|NCT00770146|1324326|P1|COMPLETED|Treatment Period||44
542200|NCT00770146|1324325|P2|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|101
542201|NCT00770146|1324326|P1|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|50
542202|NCT00770146|1324325|P2|Treated|Treatment Period||105
542203|NCT00770146|1324326|P1|Treated|Treatment Period||52
542204|NCT00770146|1324325|P2|STARTED|Treatment Period||105
542205|NCT00770146|1324326|P1|STARTED|Treatment Period||53
542206|NCT00770120|1324370|P1|NOT COMPLETED|Overall Study||61
542207|NCT00770120|1324370|P1|COMPLETED|Overall Study||0
542208|NCT00770120|1324370|P1|Not Analyzable|Overall Study||1
542209|NCT00770120|1324370|P1|Eligible|Overall Study||60
542210|NCT00770120|1324370|P1|STARTED|Overall Study||61
542211|NCT00770029|1324379|P2|NOT COMPLETED|Overall Study||3
542212|NCT00770029|1324380|P1|NOT COMPLETED|Overall Study||6
542213|NCT00770029|1324379|P2|COMPLETED|Overall Study||89
542214|NCT00770029|1324380|P1|COMPLETED|Overall Study||178
542215|NCT00770029|1324379|P2|STARTED|Overall Study||92
542216|NCT00770029|1324380|P1|STARTED|Overall Study||184
542217|NCT00769860|1324396|P2|NOT COMPLETED|Overall Study||0
542218|NCT00769860|1324397|P1|NOT COMPLETED|Overall Study||2
542219|NCT00769860|1324396|P2|COMPLETED|Overall Study||8
542220|NCT00769860|1324397|P1|COMPLETED|Overall Study||14
542221|NCT00769860|1324396|P2|Month 8|Overall Study||8
542222|NCT00769860|1324397|P1|Month 8|Overall Study||14
542223|NCT00769860|1324396|P2|Month 4|Overall Study||8
542224|NCT00769860|1324397|P1|Month 4|Overall Study||16
542225|NCT00769860|1324396|P2|STARTED|Overall Study||8
542226|NCT00769860|1324397|P1|STARTED|Overall Study||16
542227|NCT00769704|1324425|P2|NOT COMPLETED|Overall Study||199
542228|NCT00769704|1324426|P1|NOT COMPLETED|Overall Study||111
542229|NCT00769704|1324425|P2|COMPLETED|Overall Study||97
542230|NCT00769704|1324426|P1|COMPLETED|Overall Study||30
542231|NCT00769704|1324425|P2|Received Treatment|Overall Study||292
542232|NCT00769704|1324426|P1|Received Treatment|Overall Study||127
542233|NCT00769704|1324425|P2|Intent-to-treat Population|Overall Study|Participants who were randomized once to study treatment; excludes 1 participant randomized 3 times|295
542234|NCT00769704|1324426|P1|Intent-to-treat Population|Overall Study|All participants who were randomized once to study treatment|141
542235|NCT00769704|1324425|P2|STARTED|Overall Study||296
542236|NCT00769704|1324426|P1|STARTED|Overall Study||141
542237|NCT00769652|1324446|P2|NOT COMPLETED|Overall Study||0
542238|NCT00769652|1324447|P1|NOT COMPLETED|Overall Study||0
542239|NCT00769652|1324446|P2|COMPLETED|Overall Study||1
542240|NCT00769652|1324447|P1|COMPLETED|Overall Study||6
542241|NCT00769652|1324446|P2|STARTED|Overall Study||1
542242|NCT00769652|1324447|P1|STARTED|Overall Study||6
542243|NCT00769561|1324459|P2|NOT COMPLETED|Overall Study||5
542244|NCT00769561|1324460|P1|NOT COMPLETED|Overall Study||3
542245|NCT00769561|1324459|P2|COMPLETED|Overall Study||24
542246|NCT00769561|1324460|P1|COMPLETED|Overall Study||26
542247|NCT00769561|1324459|P2|STARTED|Overall Study||29
542248|NCT00769561|1324460|P1|STARTED|Overall Study||29
542249|NCT00769314|1324482|P2|NOT COMPLETED|Overall Study||13
542250|NCT00769314|1324483|P1|NOT COMPLETED|Overall Study||17
542251|NCT00769314|1324482|P2|COMPLETED|Overall Study||384
542252|NCT00769314|1324483|P1|COMPLETED|Overall Study||361
542253|NCT00769314|1324482|P2|STARTED|Overall Study|The number of participants started is defined as those that were randomized and received treatment.|397
542254|NCT00769314|1324483|P1|STARTED|Overall Study|The number of participants started is defined as those that were randomized and received treatment.|378
542255|NCT00769184|1324509|P2|NOT COMPLETED|No Treatment (6 Weeks)||1
542256|NCT00769184|1324510|P1|NOT COMPLETED|No Treatment (6 Weeks)||1
542257|NCT00769184|1324509|P2|COMPLETED|No Treatment (6 Weeks)||6
542258|NCT00769184|1324510|P1|COMPLETED|No Treatment (6 Weeks)||5
542259|NCT00769184|1324509|P2|STARTED|No Treatment (6 Weeks)||7
542260|NCT00769184|1324510|P1|STARTED|No Treatment (6 Weeks)||6
542261|NCT00769184|1324509|P2|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0
542262|NCT00769184|1324510|P1|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0
542263|NCT00769184|1324509|P2|COMPLETED|+LCD / +Placebo Only (4 Weeks)||7
542264|NCT00769184|1324510|P1|COMPLETED|+LCD / +Placebo Only (4 Weeks)||6
542265|NCT00769184|1324509|P2|STARTED|+LCD / +Placebo Only (4 Weeks)||7
542266|NCT00769184|1324510|P1|STARTED|+LCD / +Placebo Only (4 Weeks)||6
542267|NCT00769184|1324509|P2|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1
542268|NCT00769184|1324510|P1|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1
542269|NCT00769184|1324509|P2|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7
542270|NCT00769184|1324510|P1|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||6
542271|NCT00769184|1324509|P2|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||8
542272|NCT00769184|1324510|P1|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7
542273|NCT00769132|1324518|P4|NOT COMPLETED|Period 4||0
542274|NCT00769132|1324519|P3|NOT COMPLETED|Period 4||0
542275|NCT00769132|1324520|P2|NOT COMPLETED|Period 4||1
542276|NCT00769132|1324521|P1|NOT COMPLETED|Period 4||0
542277|NCT00769132|1324518|P4|COMPLETED|Period 4||5
542278|NCT00769132|1324519|P3|COMPLETED|Period 4||6
542279|NCT00769132|1324520|P2|COMPLETED|Period 4||5
542280|NCT00769132|1324521|P1|COMPLETED|Period 4||5
542281|NCT00769132|1324518|P4|STARTED|Period 4||5
542282|NCT00769132|1324519|P3|STARTED|Period 4||6
542283|NCT00769132|1324520|P2|STARTED|Period 4||6
542284|NCT00769132|1324521|P1|STARTED|Period 4||5
542285|NCT00769132|1324518|P4|NOT COMPLETED|Period 3||0
542286|NCT00769132|1324519|P3|NOT COMPLETED|Period 3||0
542287|NCT00769132|1324520|P2|NOT COMPLETED|Period 3||0
542288|NCT00769132|1324521|P1|NOT COMPLETED|Period 3||1
542289|NCT00769132|1324518|P4|COMPLETED|Period 3||5
542290|NCT00769132|1324519|P3|COMPLETED|Period 3||6
542291|NCT00769132|1324520|P2|COMPLETED|Period 3||6
542292|NCT00769132|1324521|P1|COMPLETED|Period 3||5
542293|NCT00769132|1324518|P4|STARTED|Period 3||5
542294|NCT00769132|1324519|P3|STARTED|Period 3||6
542295|NCT00769132|1324520|P2|STARTED|Period 3||6
542296|NCT00769132|1324521|P1|STARTED|Period 3||6
542297|NCT00769132|1324518|P4|NOT COMPLETED|Period 2||1
542298|NCT00769132|1324519|P3|NOT COMPLETED|Period 2||0
542299|NCT00769132|1324520|P2|NOT COMPLETED|Period 2||0
542300|NCT00769132|1324521|P1|NOT COMPLETED|Period 2||0
542301|NCT00769132|1324518|P4|COMPLETED|Period 2||5
542302|NCT00769132|1324519|P3|COMPLETED|Period 2||6
542303|NCT00769132|1324520|P2|COMPLETED|Period 2||6
542304|NCT00769132|1324521|P1|COMPLETED|Period 2||6
542305|NCT00769132|1324518|P4|STARTED|Period 2||6
542306|NCT00769132|1324519|P3|STARTED|Period 2||6
542307|NCT00769132|1324520|P2|STARTED|Period 2||6
542308|NCT00769132|1324521|P1|STARTED|Period 2||6
542309|NCT00769132|1324518|P4|NOT COMPLETED|Period 1||1
542310|NCT00769132|1324519|P3|NOT COMPLETED|Period 1||0
542311|NCT00769132|1324520|P2|NOT COMPLETED|Period 1||0
542312|NCT00769132|1324521|P1|NOT COMPLETED|Period 1||1
542313|NCT00769132|1324518|P4|COMPLETED|Period 1||6
542314|NCT00769132|1324519|P3|COMPLETED|Period 1||6
542315|NCT00769132|1324520|P2|COMPLETED|Period 1||6
542316|NCT00769132|1324521|P1|COMPLETED|Period 1||6
542317|NCT00769132|1324518|P4|STARTED|Period 1||7
542318|NCT00769132|1324519|P3|STARTED|Period 1||6
542319|NCT00769132|1324520|P2|STARTED|Period 1||6
542320|NCT00769132|1324521|P1|STARTED|Period 1||7
542321|NCT00769119|1324537|P2|NOT COMPLETED|Overall Study||3
542322|NCT00769119|1324538|P1|NOT COMPLETED|Overall Study||2
542323|NCT00769119|1324537|P2|COMPLETED|Overall Study||13
542324|NCT00769119|1324538|P1|COMPLETED|Overall Study||20
542325|NCT00769119|1324537|P2|STARTED|Overall Study||16
542326|NCT00769119|1324538|P1|STARTED|Overall Study||22
542327|NCT00769067|1324584|P2|NOT COMPLETED|Overall Study||94
542328|NCT00769067|1324585|P1|NOT COMPLETED|Overall Study||94
542329|NCT00769067|1324584|P2|COMPLETED|Overall Study||0
542330|NCT00769067|1324585|P1|COMPLETED|Overall Study||0
542331|NCT00769067|1324584|P2|Treated|Overall Study|One participant was not treated: refused treatment for reason other than an adverse event (AE).|93
542332|NCT00769067|1324585|P1|Treated|Overall Study||94
542333|NCT00769067|1324584|P2|STARTED|Overall Study||94
542334|NCT00769067|1324585|P1|STARTED|Overall Study||94
542335|NCT00769015|1324612|P2|NOT COMPLETED|Overall Study||16
542336|NCT00769015|1324613|P1|NOT COMPLETED|Overall Study||9
542337|NCT00769015|1324612|P2|COMPLETED|Overall Study||76
542338|NCT00769015|1324613|P1|COMPLETED|Overall Study||87
542339|NCT00769015|1324612|P2|STARTED|Overall Study||92
542340|NCT00769015|1324613|P1|STARTED|Overall Study||96
542341|NCT00768989|1324633|P2|NOT COMPLETED|On or After Week 36||27
542342|NCT00768989|1324634|P1|NOT COMPLETED|On or After Week 36||51
542343|NCT00768989|1324633|P2|COMPLETED|On or After Week 36||0
542344|NCT00768989|1324634|P1|COMPLETED|On or After Week 36||0
542345|NCT00768989|1324633|P2|STARTED|On or After Week 36||27
542346|NCT00768989|1324634|P1|STARTED|On or After Week 36||51
542347|NCT00768989|1324633|P2|NOT COMPLETED|Week 24 to Prior to Week 36||0
542348|NCT00768989|1324634|P1|NOT COMPLETED|Week 24 to Prior to Week 36||8
542349|NCT00768989|1324633|P2|COMPLETED|Week 24 to Prior to Week 36||27
542350|NCT00768989|1324634|P1|COMPLETED|Week 24 to Prior to Week 36||51
542351|NCT00768989|1324633|P2|STARTED|Week 24 to Prior to Week 36||27
542352|NCT00768989|1324634|P1|STARTED|Week 24 to Prior to Week 36||59
542353|NCT00768989|1324633|P2|NOT COMPLETED|Prior to Week 24||3
542354|NCT00768989|1324634|P1|NOT COMPLETED|Prior to Week 24||4
542355|NCT00768989|1324633|P2|COMPLETED|Prior to Week 24||27
542356|NCT00768989|1324634|P1|COMPLETED|Prior to Week 24||59
542357|NCT00768989|1324633|P2|STARTED|Prior to Week 24||30
542358|NCT00768989|1324634|P1|STARTED|Prior to Week 24||63
542359|NCT00768898|1324682|P1|NOT COMPLETED|Overall Study||2
542360|NCT00768898|1324682|P1|COMPLETED|Overall Study||28
542361|NCT00768898|1324682|P1|STARTED|Overall Study||30
542362|NCT00768755|1324706|P4|NOT COMPLETED|Phase 2||57
542363|NCT00768755|1324707|P3|NOT COMPLETED|Phase 2||58
542364|NCT00768755|1324708|P2|NOT COMPLETED|Phase 2||55
542365|NCT00768755|1324709|P1|NOT COMPLETED|Phase 2||0
542366|NCT00768755|1324706|P4|COMPLETED|Phase 2||0
542367|NCT00768755|1324707|P3|COMPLETED|Phase 2||0
542368|NCT00768755|1324708|P2|COMPLETED|Phase 2||0
542369|NCT00768755|1324709|P1|COMPLETED|Phase 2||0
542370|NCT00768755|1324706|P4|Treated|Phase 2||55
542371|NCT00768755|1324707|P3|Treated|Phase 2||58
542372|NCT00768755|1324708|P2|Treated|Phase 2||55
542373|NCT00768755|1324709|P1|Treated|Phase 2||0
542374|NCT00768755|1324706|P4|STARTED|Phase 2||57
542375|NCT00768755|1324707|P3|STARTED|Phase 2||58
542376|NCT00768755|1324708|P2|STARTED|Phase 2||55
542377|NCT00768755|1324709|P1|STARTED|Phase 2||0
542378|NCT00768755|1324706|P4|NOT COMPLETED|Phase 1||0
542379|NCT00768755|1324707|P3|NOT COMPLETED|Phase 1||0
542380|NCT00768755|1324708|P2|NOT COMPLETED|Phase 1||0
542381|NCT00768755|1324709|P1|NOT COMPLETED|Phase 1||10
542382|NCT00768755|1324706|P4|COMPLETED|Phase 1||0
542383|NCT00768755|1324707|P3|COMPLETED|Phase 1||0
542384|NCT00768755|1324708|P2|COMPLETED|Phase 1||0
542385|NCT00768755|1324709|P1|COMPLETED|Phase 1||0
542386|NCT00768755|1324706|P4|STARTED|Phase 1||0
542387|NCT00768755|1324707|P3|STARTED|Phase 1||0
542388|NCT00768755|1324708|P2|STARTED|Phase 1||0
542389|NCT00768755|1324709|P1|STARTED|Phase 1||10
542390|NCT00768651|1324733|P1|NOT COMPLETED|Overall Study||1
542391|NCT00768651|1324733|P1|COMPLETED|Overall Study||7
542392|NCT00768651|1324733|P1|STARTED|Overall Study||8
542393|NCT00768599|1324741|P3|NOT COMPLETED|Overall Study||12
542394|NCT00768599|1324742|P2|NOT COMPLETED|Overall Study||16
542395|NCT00768599|1324743|P1|NOT COMPLETED|Overall Study||11
542396|NCT00768599|1324741|P3|COMPLETED|Overall Study||35
542397|NCT00768599|1324742|P2|COMPLETED|Overall Study||27
542398|NCT00768599|1324743|P1|COMPLETED|Overall Study||34
542399|NCT00768599|1324741|P3|STARTED|Overall Study||47
542400|NCT00768599|1324742|P2|STARTED|Overall Study||43
542401|NCT00768599|1324743|P1|STARTED|Overall Study||45
542402|NCT00768560|1324772|P6|NOT COMPLETED|Intervention Set 3||0
542403|NCT00768560|1324773|P5|NOT COMPLETED|Intervention Set 3||0
542404|NCT00768560|1324774|P4|NOT COMPLETED|Intervention Set 3||0
542405|NCT00768560|1324775|P3|NOT COMPLETED|Intervention Set 3||0
542406|NCT00768560|1324776|P2|NOT COMPLETED|Intervention Set 3||0
542407|NCT00768560|1324777|P1|NOT COMPLETED|Intervention Set 3||0
542408|NCT00768560|1324772|P6|COMPLETED|Intervention Set 3||6
542409|NCT00768560|1324773|P5|COMPLETED|Intervention Set 3||6
542410|NCT00768560|1324774|P4|COMPLETED|Intervention Set 3||6
542411|NCT00768560|1324775|P3|COMPLETED|Intervention Set 3||6
542412|NCT00768560|1324776|P2|COMPLETED|Intervention Set 3||5
542413|NCT00768560|1324777|P1|COMPLETED|Intervention Set 3||5
542414|NCT00768560|1324772|P6|STARTED|Intervention Set 3|40 mg OD for 2 weeks|6
542415|NCT00768560|1324773|P5|STARTED|Intervention Set 3|40 mg BID for 2 weeks|6
542416|NCT00768560|1324774|P4|STARTED|Intervention Set 3|80 mg OD for 2 weeks|6
542417|NCT00768560|1324775|P3|STARTED|Intervention Set 3|40 mg OD for 2 weeks|6
542418|NCT00768560|1324776|P2|STARTED|Intervention Set 3|40 mg BID for 2 weeks|5
542419|NCT00768560|1324777|P1|STARTED|Intervention Set 3|80 mg OD for 2 weeks|5
542420|NCT00768560|1324772|P6|NOT COMPLETED|Intervention Set 2||0
542421|NCT00768560|1324773|P5|NOT COMPLETED|Intervention Set 2||0
542422|NCT00768560|1324774|P4|NOT COMPLETED|Intervention Set 2||0
542423|NCT00768560|1324775|P3|NOT COMPLETED|Intervention Set 2||0
542424|NCT00768560|1324776|P2|NOT COMPLETED|Intervention Set 2||0
542425|NCT00768560|1324777|P1|NOT COMPLETED|Intervention Set 2||0
542426|NCT00768560|1324772|P6|COMPLETED|Intervention Set 2||6
542427|NCT00768560|1324773|P5|COMPLETED|Intervention Set 2||6
542428|NCT00768560|1324774|P4|COMPLETED|Intervention Set 2||6
542429|NCT00768560|1324775|P3|COMPLETED|Intervention Set 2||6
542430|NCT00768560|1324776|P2|COMPLETED|Intervention Set 2||5
542431|NCT00768560|1324777|P1|COMPLETED|Intervention Set 2||5
542432|NCT00768560|1324772|P6|STARTED|Intervention Set 2|40 mg BID for 2 weeks|6
542433|NCT00768560|1324773|P5|STARTED|Intervention Set 2|40 mg OD for 2 weeks|6
542434|NCT00768560|1324774|P4|STARTED|Intervention Set 2|40 mg OD for 2 weeks|6
542435|NCT00768560|1324775|P3|STARTED|Intervention Set 2|80 mg OD for 2 weeks|6
542436|NCT00768560|1324776|P2|STARTED|Intervention Set 2|80 mg OD for 2 weeks|5
542437|NCT00768560|1324777|P1|STARTED|Intervention Set 2|40 mg BID for 2 weeks|5
542438|NCT00768560|1324772|P6|NOT COMPLETED|Intervention Set 1||0
542439|NCT00768560|1324773|P5|NOT COMPLETED|Intervention Set 1||0
542440|NCT00768560|1324774|P4|NOT COMPLETED|Intervention Set 1||0
542441|NCT00768560|1324775|P3|NOT COMPLETED|Intervention Set 1||0
542442|NCT00768560|1324776|P2|NOT COMPLETED|Intervention Set 1||1
542443|NCT00768560|1324777|P1|NOT COMPLETED|Intervention Set 1||0
542444|NCT00768560|1324772|P6|COMPLETED|Intervention Set 1||6
542445|NCT00768560|1324773|P5|COMPLETED|Intervention Set 1||6
542446|NCT00768560|1324774|P4|COMPLETED|Intervention Set 1||6
542447|NCT00768560|1324775|P3|COMPLETED|Intervention Set 1||6
542448|NCT00768560|1324776|P2|COMPLETED|Intervention Set 1||5
542449|NCT00768560|1324777|P1|COMPLETED|Intervention Set 1||5
542450|NCT00768560|1324772|P6|Subjects Received Treatment|Intervention Set 1|80 mg OD for 2 weeks|6
542451|NCT00768560|1324773|P5|Subjects Received Treatment|Intervention Set 1|80 mg OD for 2 weeks|6
542452|NCT00768560|1324774|P4|Subjects Received Treatment|Intervention Set 1|40 mg BID for 2 weeks|6
542453|NCT00768560|1324775|P3|Subjects Received Treatment|Intervention Set 1|40 mg twice daily (BID) for 2 weeks|6
542454|NCT00768560|1324776|P2|Subjects Received Treatment|Intervention Set 1|40 mg OD for 2 weeks|6
542455|NCT00768560|1324777|P1|Subjects Received Treatment|Intervention Set 1|40 mg OD for 2 weeks|5
542456|NCT00768560|1324772|P6|STARTED|Intervention Set 1|3-period/treatment crossover|6
542457|NCT00768560|1324773|P5|STARTED|Intervention Set 1|3-period/treatment crossover|6
542458|NCT00768560|1324774|P4|STARTED|Intervention Set 1|3-period/treatment crossover|6
542459|NCT00768560|1324775|P3|STARTED|Intervention Set 1|3-period/treatment crossover|6
542460|NCT00768560|1324776|P2|STARTED|Intervention Set 1|3-period/treatment crossover|6
542461|NCT00768560|1324777|P1|STARTED|Intervention Set 1|3-period/treatment crossover|5
542462|NCT00768521|1324803|P2|NOT COMPLETED|Period 2||0
542463|NCT00768521|1324804|P1|NOT COMPLETED|Period 2||0
542464|NCT00768521|1324803|P2|COMPLETED|Period 2||11
542465|NCT00768521|1324804|P1|COMPLETED|Period 2||9
542466|NCT00768521|1324803|P2|STARTED|Period 2||11
542467|NCT00768521|1324804|P1|STARTED|Period 2||9
542468|NCT00768521|1324803|P2|NOT COMPLETED|Period 1||0
542469|NCT00768521|1324804|P1|NOT COMPLETED|Period 1||0
542470|NCT00768521|1324803|P2|COMPLETED|Period 1||11
542471|NCT00768521|1324804|P1|COMPLETED|Period 1||9
542472|NCT00768521|1324803|P2|STARTED|Period 1||11
542473|NCT00768521|1324804|P1|STARTED|Period 1||9
542474|NCT00768430|1324814|P2|NOT COMPLETED|7 Day Endpoint||3
542475|NCT00768430|1324815|P1|NOT COMPLETED|7 Day Endpoint||2
542476|NCT00768430|1324814|P2|COMPLETED|7 Day Endpoint||22
542477|NCT00768430|1324815|P1|COMPLETED|7 Day Endpoint||45
542478|NCT00768430|1324814|P2|STARTED|7 Day Endpoint||25
542479|NCT00768430|1324815|P1|STARTED|7 Day Endpoint||47
542480|NCT00768430|1324814|P2|NOT COMPLETED|24 Hour Endpoint||0
542481|NCT00768430|1324815|P1|NOT COMPLETED|24 Hour Endpoint||1
542482|NCT00768430|1324814|P2|COMPLETED|24 Hour Endpoint||25
542483|NCT00768430|1324815|P1|COMPLETED|24 Hour Endpoint||47
542484|NCT00768430|1324814|P2|STARTED|24 Hour Endpoint||25
542485|NCT00768430|1324815|P1|STARTED|24 Hour Endpoint||48
542486|NCT00768300|1324823|P2|NOT COMPLETED|Overall Study||163
542487|NCT00768300|1324824|P1|NOT COMPLETED|Overall Study||329
542488|NCT00768300|1324823|P2|COMPLETED|Overall Study||1
542489|NCT00768300|1324824|P1|COMPLETED|Overall Study||1
542490|NCT00768300|1324823|P2|Randomized and Treated|Overall Study||163
542491|NCT00768300|1324824|P1|Randomized and Treated|Overall Study||329
542492|NCT00768300|1324823|P2|STARTED|Overall Study||164
542493|NCT00768300|1324824|P1|STARTED|Overall Study||330
542494|NCT00768222|1324848|P2|NOT COMPLETED|Overall Study||4
542495|NCT00768222|1324849|P1|NOT COMPLETED|Overall Study||4
542496|NCT00768222|1324848|P2|COMPLETED|Overall Study||47
542497|NCT00768222|1324849|P1|COMPLETED|Overall Study||46
542498|NCT00768222|1324848|P2|STARTED|Overall Study||51
542499|NCT00768222|1324849|P1|STARTED|Overall Study||50
542500|NCT00768144|1324871|P1|NOT COMPLETED|Overall Study||36
542501|NCT00768144|1324871|P1|COMPLETED|Overall Study||0
542502|NCT00768144|1324871|P1|STARTED|Overall Study||36
542503|NCT00768118|1324877|P1|NOT COMPLETED|Overall Study||0
542504|NCT00768118|1324877|P1|COMPLETED|Overall Study||11
542505|NCT00768118|1324877|P1|STARTED|Overall Study||11
542506|NCT00768066|1324884|P3|NOT COMPLETED|Overall Study||0
542507|NCT00768066|1324885|P2|NOT COMPLETED|Overall Study||3
542508|NCT00768066|1324886|P1|NOT COMPLETED|Overall Study||3
542509|NCT00768066|1324884|P3|COMPLETED|Overall Study||21
542510|NCT00768066|1324885|P2|COMPLETED|Overall Study||19
542511|NCT00768066|1324886|P1|COMPLETED|Overall Study||19
542512|NCT00768066|1324884|P3|STARTED|Overall Study||21
542513|NCT00768066|1324885|P2|STARTED|Overall Study||22
542514|NCT00768066|1324886|P1|STARTED|Overall Study||22
542515|NCT00768053|1324918|P1|NOT COMPLETED|Overall Study||11
542516|NCT00768053|1324918|P1|COMPLETED|Overall Study||97
542517|NCT00768053|1324918|P1|STARTED|Overall Study||108
542518|NCT00768040|1324949|P2|NOT COMPLETED|Overall Study||3
542519|NCT00768040|1324950|P1|NOT COMPLETED|Overall Study||4
542520|NCT00768040|1324949|P2|COMPLETED|Overall Study||16
542521|NCT00768040|1324950|P1|COMPLETED|Overall Study||16
542522|NCT00768040|1324949|P2|STARTED|Overall Study||19
542523|NCT00768040|1324950|P1|STARTED|Overall Study|"Started indicates randomized, safety and full analysis set."|20
542524|NCT00767806|1324958|P2|NOT COMPLETED|Overall Study||47
542525|NCT00767806|1324959|P1|NOT COMPLETED|Overall Study||51
542526|NCT00767806|1324958|P2|COMPLETED|Overall Study||156
542527|NCT00767806|1324959|P1|COMPLETED|Overall Study||147
542528|NCT00767806|1324958|P2|STARTED|Overall Study||203
542529|NCT00767806|1324959|P1|STARTED|Overall Study||198
542530|NCT00767767|1325020|P5|NOT COMPLETED|Overall Study||0
542531|NCT00767767|1325021|P4|NOT COMPLETED|Overall Study||0
542532|NCT00767767|1325022|P3|NOT COMPLETED|Overall Study||0
542533|NCT00767767|1325023|P2|NOT COMPLETED|Overall Study||0
542534|NCT00767767|1325024|P1|NOT COMPLETED|Overall Study||0
542535|NCT00767767|1325020|P5|COMPLETED|Overall Study||3
542536|NCT00767767|1325021|P4|COMPLETED|Overall Study||3
542537|NCT00767767|1325022|P3|COMPLETED|Overall Study||20
542538|NCT00767767|1325023|P2|COMPLETED|Overall Study||20
542539|NCT00767767|1325024|P1|COMPLETED|Overall Study||21
542540|NCT00767767|1325020|P5|STARTED|Overall Study||3
542541|NCT00767767|1325021|P4|STARTED|Overall Study||3
542542|NCT00767767|1325022|P3|STARTED|Overall Study||20
542543|NCT00767767|1325023|P2|STARTED|Overall Study||20
542544|NCT00767767|1325024|P1|STARTED|Overall Study||21
542545|NCT00767676|1325036|P1|NOT COMPLETED|Overall Study||54
542546|NCT00767676|1325036|P1|COMPLETED|Overall Study||205
542547|NCT00767676|1325036|P1|STARTED|Overall Study||259
542548|NCT00767624|1325042|P2|NOT COMPLETED|Overall Study||17
542549|NCT00767624|1325043|P1|NOT COMPLETED|Overall Study||24
542550|NCT00767624|1325042|P2|COMPLETED|Overall Study||58
542551|NCT00767624|1325043|P1|COMPLETED|Overall Study||51
542552|NCT00767624|1325042|P2|STARTED|Overall Study||75
542553|NCT00767624|1325043|P1|STARTED|Overall Study||75
542554|NCT00767572|1325051|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
542555|NCT00767572|1325051|P1|COMPLETED|Second Intervention (12 Weeks)||12
542556|NCT00767572|1325051|P1|STARTED|Second Intervention (12 Weeks)||12
542557|NCT00767572|1325051|P1|NOT COMPLETED|Washout (4 Weeks)||0
542558|NCT00767572|1325051|P1|COMPLETED|Washout (4 Weeks)||12
542559|NCT00767572|1325051|P1|STARTED|Washout (4 Weeks)||12
542560|NCT00767572|1325051|P1|NOT COMPLETED|First Intervention (12 Weeks)||0
542561|NCT00767572|1325051|P1|COMPLETED|First Intervention (12 Weeks)||12
542562|NCT00767572|1325051|P1|STARTED|First Intervention (12 Weeks)||12
542563|NCT00767520|1325059|P2|NOT COMPLETED|Overall Study||17
542564|NCT00767520|1325060|P1|NOT COMPLETED|Overall Study||11
542565|NCT00767520|1325059|P2|COMPLETED|Overall Study|Completed=Off-treatment; Major reasons: disease progression-56, study drug toxicity-2,AE-1,Death-1|61
542566|NCT00767520|1325060|P1|COMPLETED|Overall Study|Completed=Off-treatment; Major reasons: disease progression-50, study drug toxicity-10,AE-3,Death-2|68
542567|NCT00767520|1325059|P2|STARTED|Overall Study||78
542568|NCT00767520|1325060|P1|STARTED|Overall Study||79
542569|NCT00767507|1325086|P4|NOT COMPLETED|Overall Study||3
542570|NCT00767507|1325087|P3|NOT COMPLETED|Overall Study||0
542571|NCT00767507|1325088|P2|NOT COMPLETED|Overall Study||0
542572|NCT00767507|1325089|P1|NOT COMPLETED|Overall Study||0
542573|NCT00767507|1325086|P4|COMPLETED|Overall Study||101
542574|NCT00767507|1325087|P3|COMPLETED|Overall Study||106
542575|NCT00767507|1325088|P2|COMPLETED|Overall Study||6
542576|NCT00767507|1325089|P1|COMPLETED|Overall Study||5
542577|NCT00767507|1325086|P4|STARTED|Overall Study||104
542578|NCT00767507|1325087|P3|STARTED|Overall Study||106
542579|NCT00767507|1325088|P2|STARTED|Overall Study||6
542580|NCT00767507|1325089|P1|STARTED|Overall Study||5
542581|NCT00767455|1325113|P1|NOT COMPLETED|Overall Study||19
542582|NCT00767455|1325113|P1|COMPLETED|Overall Study||40
542583|NCT00767455|1325113|P1|STARTED|Overall Study||59
542584|NCT00767364|1325121|P2|NOT COMPLETED|Overall Study||0
542585|NCT00767364|1325122|P1|NOT COMPLETED|Overall Study||0
542586|NCT00767364|1325121|P2|COMPLETED|Overall Study||3
542587|NCT00767364|1325122|P1|COMPLETED|Overall Study||5
542588|NCT00767364|1325121|P2|STARTED|Overall Study||3
542589|NCT00767364|1325122|P1|STARTED|Overall Study||5
542590|NCT00767338|1325134|P4|NOT COMPLETED|Overall Study||0
542591|NCT00767338|1325135|P3|NOT COMPLETED|Overall Study||0
542592|NCT00767338|1325136|P2|NOT COMPLETED|Overall Study||2
542593|NCT00767338|1325137|P1|NOT COMPLETED|Overall Study||1
542594|NCT00767338|1325134|P4|COMPLETED|Overall Study||0
542595|NCT00767338|1325135|P3|COMPLETED|Overall Study||0
542596|NCT00767338|1325136|P2|COMPLETED|Overall Study||0
542597|NCT00767338|1325137|P1|COMPLETED|Overall Study||0
542598|NCT00767338|1325134|P4|STARTED|Overall Study||0
542599|NCT00767338|1325135|P3|STARTED|Overall Study||0
542600|NCT00767338|1325136|P2|STARTED|Overall Study||2
542601|NCT00767338|1325137|P1|STARTED|Overall Study||1
542602|NCT00767325|1325147|P1|NOT COMPLETED|Overall Study||15
542603|NCT00767325|1325147|P1|COMPLETED|Overall Study||89
542604|NCT00767325|1325147|P1|STARTED|Overall Study||104
542605|NCT00767104|1325158|P2|NOT COMPLETED|Overall Study||2
542606|NCT00767104|1325159|P1|NOT COMPLETED|Overall Study||1
542607|NCT00767104|1325158|P2|COMPLETED|Overall Study||18
542608|NCT00767104|1325159|P1|COMPLETED|Overall Study||19
542609|NCT00767104|1325158|P2|STARTED|Overall Study||20
542610|NCT00767104|1325159|P1|STARTED|Overall Study||20
542611|NCT00767039|1325169|P2|NOT COMPLETED|Overall Study||2
542612|NCT00767039|1325170|P1|NOT COMPLETED|Overall Study||5
542613|NCT00767039|1325169|P2|COMPLETED|Overall Study||23
542614|NCT00767039|1325170|P1|COMPLETED|Overall Study||22
542615|NCT00767039|1325169|P2|STARTED|Overall Study||25
542616|NCT00767039|1325170|P1|STARTED|Overall Study|Two early deaths and 3 late deaths occurred in this group|27
542617|NCT00767000|1325201|P5|NOT COMPLETED|Optional 104-week Extension||4
542618|NCT00767000|1325202|P4|NOT COMPLETED|Optional 104-week Extension||2
542619|NCT00767000|1325203|P3|NOT COMPLETED|Optional 104-week Extension||7
542620|NCT00767000|1325204|P2|NOT COMPLETED|Optional 104-week Extension||3
542621|NCT00767000|1325205|P1|NOT COMPLETED|Optional 104-week Extension||7
542622|NCT00767000|1325201|P5|COMPLETED|Optional 104-week Extension||0
542623|NCT00767000|1325202|P4|COMPLETED|Optional 104-week Extension||0
542624|NCT00767000|1325203|P3|COMPLETED|Optional 104-week Extension||0
542625|NCT00767000|1325204|P2|COMPLETED|Optional 104-week Extension||0
542626|NCT00767000|1325205|P1|COMPLETED|Optional 104-week Extension||0
542627|NCT00767000|1325201|P5|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|4
542628|NCT00767000|1325202|P4|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|2
542629|NCT00767000|1325203|P3|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|7
542630|NCT00767000|1325204|P2|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|3
542631|NCT00767000|1325205|P1|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|7
542632|NCT00767000|1325201|P5|NOT COMPLETED|54-week Study||224
542633|NCT00767000|1325202|P4|NOT COMPLETED|54-week Study||225
542634|NCT00767000|1325203|P3|NOT COMPLETED|54-week Study||109
542635|NCT00767000|1325204|P2|NOT COMPLETED|54-week Study||113
542636|NCT00767000|1325205|P1|NOT COMPLETED|54-week Study||108
542637|NCT00767000|1325201|P5|COMPLETED|54-week Study||7
542638|NCT00767000|1325202|P4|COMPLETED|54-week Study||4
542639|NCT00767000|1325203|P3|COMPLETED|54-week Study||8
542640|NCT00767000|1325204|P2|COMPLETED|54-week Study||4
542641|NCT00767000|1325205|P1|COMPLETED|54-week Study||11
542642|NCT00767000|1325201|P5|STARTED|54-week Study|Includes additional participants enrolled to enhance evaluation of the safety profile of MK-0941|231
542643|NCT00767000|1325202|P4|STARTED|54-week Study|Includes additional participants enrolled to enhance evaluation of the safety profile of MK-0941|229
542644|NCT00767000|1325203|P3|STARTED|54-week Study||117
542645|NCT00767000|1325204|P2|STARTED|54-week Study||117
542646|NCT00767000|1325205|P1|STARTED|54-week Study||119
542647|NCT00766831|1325247|P1|NOT COMPLETED|Overall Study||115
542648|NCT00766831|1325247|P1|COMPLETED|Overall Study||75
542649|NCT00766831|1325247|P1|STARTED|Overall Study||190
542650|NCT00766753|1325265|P2|NOT COMPLETED|Overall Study||0
542651|NCT00766753|1325266|P1|NOT COMPLETED|Overall Study||0
542652|NCT00766753|1325265|P2|COMPLETED|Overall Study||11
542653|NCT00766753|1325266|P1|COMPLETED|Overall Study||11
542654|NCT00766753|1325265|P2|Completed at Least Four Vaccines|Overall Study||9
542655|NCT00766753|1325266|P1|Completed at Least Four Vaccines|Overall Study||10
542656|NCT00766753|1325265|P2|Received at Least One Vaccine|Overall Study||11
542657|NCT00766753|1325266|P1|Received at Least One Vaccine|Overall Study||11
542658|NCT00766753|1325265|P2|STARTED|Overall Study||11
542659|NCT00766753|1325266|P1|STARTED|Overall Study||11
542660|NCT00766675|1325277|P1|NOT COMPLETED|Overall Study||40
542661|NCT00766675|1325277|P1|COMPLETED|Overall Study||40
542662|NCT00766675|1325277|P1|STARTED|Overall Study||80
542663|NCT00766649|1325290|P1|NOT COMPLETED|Overall Study||10
542664|NCT00766649|1325290|P1|COMPLETED|Overall Study||1
542665|NCT00766649|1325290|P1|STARTED|Overall Study||11
542666|NCT00766636|1325304|P2|NOT COMPLETED|Overall Study||2
542667|NCT00766636|1325305|P1|NOT COMPLETED|Overall Study||3
542668|NCT00766636|1325304|P2|COMPLETED|Overall Study||0
542669|NCT00766636|1325305|P1|COMPLETED|Overall Study|Number that completed pre- and post-operative therapy as well as surgery.|0
542670|NCT00766636|1325304|P2|STARTED|Overall Study||2
542671|NCT00766636|1325305|P1|STARTED|Overall Study||3
542672|NCT00766597|1325311|P1|NOT COMPLETED|Overall Study||9
542673|NCT00766597|1325311|P1|COMPLETED|Overall Study|Treatment duration is 48 weeks plus 5 years of follow-up|0
542674|NCT00766597|1325311|P1|Completed Week 48|Overall Study|Week 48 is the second primary time point of analysis|0
542675|NCT00766597|1325311|P1|Completed Week 24|Overall Study|Week 24 is the first primary time point of analysis|1
542676|NCT00766597|1325311|P1|Without CCR5-tropic Virus|Overall Study|Not evaluable participants, did not receive the study drug|5
542677|NCT00766597|1325311|P1|With CCR5-tropic Virus|Overall Study|Evaluable participants, received the study drug|4
542678|NCT00766597|1325311|P1|STARTED|Overall Study|Screened participants who were evaluated for co-receptor tropism|9
542679|NCT00766532|1325323|P1|NOT COMPLETED|Overall Study||2
542680|NCT00766532|1325323|P1|COMPLETED|Overall Study||10
542681|NCT00766532|1325323|P1|STARTED|Overall Study||12
542682|NCT00766506|1325329|P2|NOT COMPLETED|Overall Study||2
542683|NCT00766506|1325330|P1|NOT COMPLETED|Overall Study||5
542684|NCT00766506|1325329|P2|COMPLETED|Overall Study||48
542685|NCT00766506|1325330|P1|COMPLETED|Overall Study||53
542686|NCT00766506|1325329|P2|STARTED|Overall Study||50
542687|NCT00766506|1325330|P1|STARTED|Overall Study||58
542688|NCT00766493|1325354|P1|NOT COMPLETED|30 Days Post-Procedure||12
542689|NCT00766493|1325354|P1|COMPLETED|30 Days Post-Procedure||238
542690|NCT00766493|1325354|P1|STARTED|30 Days Post-Procedure||250
542691|NCT00766493|1325354|P1|NOT COMPLETED|Pre-Discharge||0
542692|NCT00766493|1325354|P1|COMPLETED|Pre-Discharge||250
542693|NCT00766493|1325354|P1|STARTED|Pre-Discharge||250
542694|NCT00766467|1325364|P2|NOT COMPLETED|Overall Study||8
542695|NCT00766467|1325365|P1|NOT COMPLETED|Overall Study||11
542696|NCT00766467|1325364|P2|COMPLETED|Overall Study||31
542697|NCT00766467|1325365|P1|COMPLETED|Overall Study||31
542698|NCT00766467|1325364|P2|Initiated Treatment|Overall Study||38
542699|NCT00766467|1325365|P1|Initiated Treatment|Overall Study||39
542700|NCT00766467|1325364|P2|STARTED|Overall Study||39
542701|NCT00766467|1325365|P1|STARTED|Overall Study||42
542702|NCT00766415|1325377|P2|NOT COMPLETED|Overall Study||1
542703|NCT00766415|1325378|P1|NOT COMPLETED|Overall Study||0
542704|NCT00766415|1325377|P2|COMPLETED|Overall Study||26
542705|NCT00766415|1325378|P1|COMPLETED|Overall Study||25
542706|NCT00766415|1325377|P2|STARTED|Overall Study||27
542707|NCT00766415|1325378|P1|STARTED|Overall Study||25
542708|NCT00766376|1325426|P1|NOT COMPLETED|Overall Study||27
542709|NCT00766376|1325426|P1|COMPLETED|Overall Study||124
542710|NCT00766376|1325426|P1|STARTED|Overall Study||151
542711|NCT00766363|1325435|P4|NOT COMPLETED|Overall Study||0
542712|NCT00766363|1325436|P3|NOT COMPLETED|Overall Study||0
542713|NCT00766363|1325437|P2|NOT COMPLETED|Overall Study||1
542714|NCT00766363|1325438|P1|NOT COMPLETED|Overall Study||1
542715|NCT00766363|1325435|P4|COMPLETED|Overall Study||12
542716|NCT00766363|1325436|P3|COMPLETED|Overall Study||12
542717|NCT00766363|1325437|P2|COMPLETED|Overall Study||12
542718|NCT00766363|1325438|P1|COMPLETED|Overall Study||11
542719|NCT00766363|1325435|P4|PK POPULATION|Overall Study||13
542720|NCT00766363|1325436|P3|PK POPULATION|Overall Study||10
542721|NCT00766363|1325437|P2|PK POPULATION|Overall Study||13
542722|NCT00766363|1325438|P1|PK POPULATION|Overall Study||12
542723|NCT00766363|1325435|P4|SAFETY POPULATION|Overall Study|Increased by one subject who took placebo due to treatment assignment error.|13
542724|NCT00766363|1325436|P3|SAFETY POPULATION|Overall Study|Decreased by one subject who took placebo instead due to treatment assignment error.|11
542725|NCT00766363|1325437|P2|SAFETY POPULATION|Overall Study||13
542726|NCT00766363|1325438|P1|SAFETY POPULATION|Overall Study||12
542727|NCT00766363|1325435|P4|STARTED|Overall Study|Number randomized.|12
542728|NCT00766363|1325436|P3|STARTED|Overall Study|Number randomized.|12
542729|NCT00766363|1325437|P2|STARTED|Overall Study||13
542730|NCT00766363|1325438|P1|STARTED|Overall Study||12
542731|NCT00766090|1325477|P12|NOT COMPLETED|Treatment Period 3 (28 Days)||1
542732|NCT00766090|1325478|P11|NOT COMPLETED|Treatment Period 3 (28 Days)||0
542733|NCT00766090|1325479|P10|NOT COMPLETED|Treatment Period 3 (28 Days)||0
542734|NCT00766090|1325480|P9|NOT COMPLETED|Treatment Period 3 (28 Days)||0
542735|NCT00766090|1325481|P8|NOT COMPLETED|Treatment Period 3 (28 Days)||0
542736|NCT00766090|1325482|P7|NOT COMPLETED|Treatment Period 3 (28 Days)||0
542737|NCT00766090|1325483|P6|NOT COMPLETED|Treatment Period 3 (28 Days)||1
542738|NCT00766090|1325484|P5|NOT COMPLETED|Treatment Period 3 (28 Days)||1
542739|NCT00766090|1325485|P4|NOT COMPLETED|Treatment Period 3 (28 Days)||1
542740|NCT00766090|1325486|P3|NOT COMPLETED|Treatment Period 3 (28 Days)||0
542741|NCT00766090|1325487|P2|NOT COMPLETED|Treatment Period 3 (28 Days)||1
542742|NCT00766090|1325488|P1|NOT COMPLETED|Treatment Period 3 (28 Days)||0
542743|NCT00766090|1325477|P12|COMPLETED|Treatment Period 3 (28 Days)||6
542744|NCT00766090|1325478|P11|COMPLETED|Treatment Period 3 (28 Days)||7
542745|NCT00766090|1325479|P10|COMPLETED|Treatment Period 3 (28 Days)||8
542746|NCT00766090|1325480|P9|COMPLETED|Treatment Period 3 (28 Days)||6
542747|NCT00766090|1325481|P8|COMPLETED|Treatment Period 3 (28 Days)||8
542748|NCT00766090|1325482|P7|COMPLETED|Treatment Period 3 (28 Days)||6
542749|NCT00766090|1325483|P6|COMPLETED|Treatment Period 3 (28 Days)||22
542750|NCT00766090|1325484|P5|COMPLETED|Treatment Period 3 (28 Days)||20
542751|NCT00766090|1325485|P4|COMPLETED|Treatment Period 3 (28 Days)||24
542752|NCT00766090|1325486|P3|COMPLETED|Treatment Period 3 (28 Days)||20
542753|NCT00766090|1325487|P2|COMPLETED|Treatment Period 3 (28 Days)||26
542754|NCT00766090|1325488|P1|COMPLETED|Treatment Period 3 (28 Days)||22
542755|NCT00766090|1325477|P12|STARTED|Treatment Period 3 (28 Days)||7
542756|NCT00766090|1325478|P11|STARTED|Treatment Period 3 (28 Days)||7
542757|NCT00766090|1325479|P10|STARTED|Treatment Period 3 (28 Days)||8
542758|NCT00766090|1325480|P9|STARTED|Treatment Period 3 (28 Days)||6
542759|NCT00766090|1325481|P8|STARTED|Treatment Period 3 (28 Days)||8
542760|NCT00766090|1325482|P7|STARTED|Treatment Period 3 (28 Days)||6
542761|NCT00766090|1325483|P6|STARTED|Treatment Period 3 (28 Days)||23
542762|NCT00766090|1325484|P5|STARTED|Treatment Period 3 (28 Days)||21
542763|NCT00766090|1325485|P4|STARTED|Treatment Period 3 (28 Days)||25
542764|NCT00766090|1325486|P3|STARTED|Treatment Period 3 (28 Days)||20
542765|NCT00766090|1325487|P2|STARTED|Treatment Period 3 (28 Days)||27
542766|NCT00766090|1325488|P1|STARTED|Treatment Period 3 (28 Days)||22
542767|NCT00766090|1325477|P12|NOT COMPLETED|Washout Period 2 (14 Days)||0
542768|NCT00766090|1325478|P11|NOT COMPLETED|Washout Period 2 (14 Days)||0
542769|NCT00766090|1325479|P10|NOT COMPLETED|Washout Period 2 (14 Days)||0
542770|NCT00766090|1325480|P9|NOT COMPLETED|Washout Period 2 (14 Days)||0
542771|NCT00766090|1325481|P8|NOT COMPLETED|Washout Period 2 (14 Days)||0
542772|NCT00766090|1325482|P7|NOT COMPLETED|Washout Period 2 (14 Days)||0
542773|NCT00766090|1325483|P6|NOT COMPLETED|Washout Period 2 (14 Days)||0
542774|NCT00766090|1325484|P5|NOT COMPLETED|Washout Period 2 (14 Days)||0
542775|NCT00766090|1325485|P4|NOT COMPLETED|Washout Period 2 (14 Days)||0
542776|NCT00766090|1325486|P3|NOT COMPLETED|Washout Period 2 (14 Days)||1
542777|NCT00766090|1325487|P2|NOT COMPLETED|Washout Period 2 (14 Days)||0
542778|NCT00766090|1325488|P1|NOT COMPLETED|Washout Period 2 (14 Days)||0
542779|NCT00766090|1325477|P12|COMPLETED|Washout Period 2 (14 Days)||7
542780|NCT00766090|1325478|P11|COMPLETED|Washout Period 2 (14 Days)||7
542781|NCT00766090|1325479|P10|COMPLETED|Washout Period 2 (14 Days)||8
542782|NCT00766090|1325480|P9|COMPLETED|Washout Period 2 (14 Days)||6
542783|NCT00766090|1325481|P8|COMPLETED|Washout Period 2 (14 Days)||8
542784|NCT00766090|1325482|P7|COMPLETED|Washout Period 2 (14 Days)||6
542785|NCT00766090|1325483|P6|COMPLETED|Washout Period 2 (14 Days)||23
542786|NCT00766090|1325484|P5|COMPLETED|Washout Period 2 (14 Days)||21
542787|NCT00766090|1325485|P4|COMPLETED|Washout Period 2 (14 Days)||25
542788|NCT00766090|1325486|P3|COMPLETED|Washout Period 2 (14 Days)||20
542789|NCT00766090|1325487|P2|COMPLETED|Washout Period 2 (14 Days)||27
542790|NCT00766090|1325488|P1|COMPLETED|Washout Period 2 (14 Days)||22
542791|NCT00766090|1325477|P12|STARTED|Washout Period 2 (14 Days)||7
542792|NCT00766090|1325478|P11|STARTED|Washout Period 2 (14 Days)||7
542793|NCT00766090|1325479|P10|STARTED|Washout Period 2 (14 Days)||8
542794|NCT00766090|1325480|P9|STARTED|Washout Period 2 (14 Days)||6
542795|NCT00766090|1325481|P8|STARTED|Washout Period 2 (14 Days)||8
542796|NCT00766090|1325482|P7|STARTED|Washout Period 2 (14 Days)||6
542797|NCT00766090|1325483|P6|STARTED|Washout Period 2 (14 Days)||23
542798|NCT00766090|1325484|P5|STARTED|Washout Period 2 (14 Days)||21
542799|NCT00766090|1325485|P4|STARTED|Washout Period 2 (14 Days)||25
542800|NCT00766090|1325486|P3|STARTED|Washout Period 2 (14 Days)||21
542801|NCT00766090|1325487|P2|STARTED|Washout Period 2 (14 Days)||27
542802|NCT00766090|1325488|P1|STARTED|Washout Period 2 (14 Days)||22
542803|NCT00766090|1325477|P12|NOT COMPLETED|Treatment Period 2 (28 Days)||0
542804|NCT00766090|1325478|P11|NOT COMPLETED|Treatment Period 2 (28 Days)||0
542805|NCT00766090|1325479|P10|NOT COMPLETED|Treatment Period 2 (28 Days)||0
542806|NCT00766090|1325480|P9|NOT COMPLETED|Treatment Period 2 (28 Days)||0
542807|NCT00766090|1325481|P8|NOT COMPLETED|Treatment Period 2 (28 Days)||0
542808|NCT00766090|1325482|P7|NOT COMPLETED|Treatment Period 2 (28 Days)||0
542809|NCT00766090|1325483|P6|NOT COMPLETED|Treatment Period 2 (28 Days)||0
542810|NCT00766090|1325484|P5|NOT COMPLETED|Treatment Period 2 (28 Days)||2
542811|NCT00766090|1325485|P4|NOT COMPLETED|Treatment Period 2 (28 Days)||0
542812|NCT00766090|1325486|P3|NOT COMPLETED|Treatment Period 2 (28 Days)||1
542813|NCT00766090|1325487|P2|NOT COMPLETED|Treatment Period 2 (28 Days)||0
542814|NCT00766090|1325488|P1|NOT COMPLETED|Treatment Period 2 (28 Days)||0
542815|NCT00766090|1325477|P12|COMPLETED|Treatment Period 2 (28 Days)||7
542816|NCT00766090|1325478|P11|COMPLETED|Treatment Period 2 (28 Days)||7
542817|NCT00766090|1325479|P10|COMPLETED|Treatment Period 2 (28 Days)||8
542818|NCT00766090|1325480|P9|COMPLETED|Treatment Period 2 (28 Days)||6
542819|NCT00766090|1325481|P8|COMPLETED|Treatment Period 2 (28 Days)||8
542820|NCT00766090|1325482|P7|COMPLETED|Treatment Period 2 (28 Days)||6
542821|NCT00766090|1325483|P6|COMPLETED|Treatment Period 2 (28 Days)||23
542822|NCT00766090|1325484|P5|COMPLETED|Treatment Period 2 (28 Days)||21
542823|NCT00766090|1325485|P4|COMPLETED|Treatment Period 2 (28 Days)||25
542824|NCT00766090|1325486|P3|COMPLETED|Treatment Period 2 (28 Days)||21
542825|NCT00766090|1325487|P2|COMPLETED|Treatment Period 2 (28 Days)||27
542826|NCT00766090|1325488|P1|COMPLETED|Treatment Period 2 (28 Days)||22
542827|NCT00766090|1325477|P12|STARTED|Treatment Period 2 (28 Days)||7
542828|NCT00766090|1325478|P11|STARTED|Treatment Period 2 (28 Days)||7
542829|NCT00766090|1325479|P10|STARTED|Treatment Period 2 (28 Days)||8
542830|NCT00766090|1325480|P9|STARTED|Treatment Period 2 (28 Days)||6
542831|NCT00766090|1325481|P8|STARTED|Treatment Period 2 (28 Days)||8
542832|NCT00766090|1325482|P7|STARTED|Treatment Period 2 (28 Days)||6
542833|NCT00766090|1325483|P6|STARTED|Treatment Period 2 (28 Days)||23
542834|NCT00766090|1325484|P5|STARTED|Treatment Period 2 (28 Days)||23
542835|NCT00766090|1325485|P4|STARTED|Treatment Period 2 (28 Days)||25
542836|NCT00766090|1325486|P3|STARTED|Treatment Period 2 (28 Days)||22
542837|NCT00766090|1325487|P2|STARTED|Treatment Period 2 (28 Days)||27
542838|NCT00766090|1325488|P1|STARTED|Treatment Period 2 (28 Days)||22
542839|NCT00766090|1325477|P12|NOT COMPLETED|Washout Period 1 (14 Days)||0
542840|NCT00766090|1325478|P11|NOT COMPLETED|Washout Period 1 (14 Days)||0
542841|NCT00766090|1325479|P10|NOT COMPLETED|Washout Period 1 (14 Days)||0
542842|NCT00766090|1325480|P9|NOT COMPLETED|Washout Period 1 (14 Days)||0
542843|NCT00766090|1325481|P8|NOT COMPLETED|Washout Period 1 (14 Days)||0
542844|NCT00766090|1325482|P7|NOT COMPLETED|Washout Period 1 (14 Days)||0
542845|NCT00766090|1325483|P6|NOT COMPLETED|Washout Period 1 (14 Days)||0
542846|NCT00766090|1325484|P5|NOT COMPLETED|Washout Period 1 (14 Days)||0
542847|NCT00766090|1325485|P4|NOT COMPLETED|Washout Period 1 (14 Days)||0
542848|NCT00766090|1325486|P3|NOT COMPLETED|Washout Period 1 (14 Days)||1
542849|NCT00766090|1325487|P2|NOT COMPLETED|Washout Period 1 (14 Days)||0
542850|NCT00766090|1325488|P1|NOT COMPLETED|Washout Period 1 (14 Days)||0
542851|NCT00766090|1325477|P12|COMPLETED|Washout Period 1 (14 Days)||7
542852|NCT00766090|1325478|P11|COMPLETED|Washout Period 1 (14 Days)||7
542853|NCT00766090|1325479|P10|COMPLETED|Washout Period 1 (14 Days)||8
542854|NCT00766090|1325480|P9|COMPLETED|Washout Period 1 (14 Days)||6
542855|NCT00766090|1325481|P8|COMPLETED|Washout Period 1 (14 Days)||8
542856|NCT00766090|1325482|P7|COMPLETED|Washout Period 1 (14 Days)||6
542857|NCT00766090|1325483|P6|COMPLETED|Washout Period 1 (14 Days)||23
542858|NCT00766090|1325484|P5|COMPLETED|Washout Period 1 (14 Days)||23
542859|NCT00766090|1325485|P4|COMPLETED|Washout Period 1 (14 Days)||25
542860|NCT00766090|1325486|P3|COMPLETED|Washout Period 1 (14 Days)||22
542861|NCT00766090|1325487|P2|COMPLETED|Washout Period 1 (14 Days)||27
542862|NCT00766090|1325488|P1|COMPLETED|Washout Period 1 (14 Days)||22
542863|NCT00766090|1325477|P12|STARTED|Washout Period 1 (14 Days)||7
542864|NCT00766090|1325478|P11|STARTED|Washout Period 1 (14 Days)||7
542865|NCT00766090|1325479|P10|STARTED|Washout Period 1 (14 Days)||8
542866|NCT00766090|1325480|P9|STARTED|Washout Period 1 (14 Days)||6
542867|NCT00766090|1325481|P8|STARTED|Washout Period 1 (14 Days)||8
542868|NCT00766090|1325482|P7|STARTED|Washout Period 1 (14 Days)||6
542869|NCT00766090|1325483|P6|STARTED|Washout Period 1 (14 Days)||23
542870|NCT00766090|1325484|P5|STARTED|Washout Period 1 (14 Days)||23
542871|NCT00766090|1325485|P4|STARTED|Washout Period 1 (14 Days)||25
542872|NCT00766090|1325486|P3|STARTED|Washout Period 1 (14 Days)||23
542873|NCT00766090|1325487|P2|STARTED|Washout Period 1 (14 Days)||27
542874|NCT00766090|1325488|P1|STARTED|Washout Period 1 (14 Days)||22
542875|NCT00766090|1325477|P12|NOT COMPLETED|Treatment Period 1 (28 Days)||0
542876|NCT00766090|1325478|P11|NOT COMPLETED|Treatment Period 1 (28 Days)||0
542877|NCT00766090|1325479|P10|NOT COMPLETED|Treatment Period 1 (28 Days)||0
542878|NCT00766090|1325480|P9|NOT COMPLETED|Treatment Period 1 (28 Days)||1
542879|NCT00766090|1325481|P8|NOT COMPLETED|Treatment Period 1 (28 Days)||0
542880|NCT00766090|1325482|P7|NOT COMPLETED|Treatment Period 1 (28 Days)||0
542881|NCT00766090|1325483|P6|NOT COMPLETED|Treatment Period 1 (28 Days)||0
542882|NCT00766090|1325484|P5|NOT COMPLETED|Treatment Period 1 (28 Days)||0
542883|NCT00766090|1325485|P4|NOT COMPLETED|Treatment Period 1 (28 Days)||1
542884|NCT00766090|1325486|P3|NOT COMPLETED|Treatment Period 1 (28 Days)||0
542885|NCT00766090|1325487|P2|NOT COMPLETED|Treatment Period 1 (28 Days)||0
542886|NCT00766090|1325488|P1|NOT COMPLETED|Treatment Period 1 (28 Days)||3
542887|NCT00766090|1325477|P12|COMPLETED|Treatment Period 1 (28 Days)||7
542888|NCT00766090|1325478|P11|COMPLETED|Treatment Period 1 (28 Days)||7
542889|NCT00766090|1325479|P10|COMPLETED|Treatment Period 1 (28 Days)||8
542890|NCT00766090|1325480|P9|COMPLETED|Treatment Period 1 (28 Days)||6
542891|NCT00766090|1325481|P8|COMPLETED|Treatment Period 1 (28 Days)||8
542892|NCT00766090|1325482|P7|COMPLETED|Treatment Period 1 (28 Days)||6
542893|NCT00766090|1325483|P6|COMPLETED|Treatment Period 1 (28 Days)||23
542894|NCT00766090|1325484|P5|COMPLETED|Treatment Period 1 (28 Days)||23
542895|NCT00766090|1325485|P4|COMPLETED|Treatment Period 1 (28 Days)||25
542896|NCT00766090|1325486|P3|COMPLETED|Treatment Period 1 (28 Days)||23
542897|NCT00766090|1325487|P2|COMPLETED|Treatment Period 1 (28 Days)||27
542898|NCT00766090|1325488|P1|COMPLETED|Treatment Period 1 (28 Days)||22
542899|NCT00766090|1325477|P12|STARTED|Treatment Period 1 (28 Days)||7
542900|NCT00766090|1325478|P11|STARTED|Treatment Period 1 (28 Days)||7
542901|NCT00766090|1325479|P10|STARTED|Treatment Period 1 (28 Days)||8
542902|NCT00766090|1325480|P9|STARTED|Treatment Period 1 (28 Days)||7
542903|NCT00766090|1325481|P8|STARTED|Treatment Period 1 (28 Days)||8
542904|NCT00766090|1325482|P7|STARTED|Treatment Period 1 (28 Days)||6
542905|NCT00766090|1325483|P6|STARTED|Treatment Period 1 (28 Days)||23
542906|NCT00766090|1325484|P5|STARTED|Treatment Period 1 (28 Days)||23
542907|NCT00766090|1325485|P4|STARTED|Treatment Period 1 (28 Days)||26
542908|NCT00766090|1325486|P3|STARTED|Treatment Period 1 (28 Days)||23
542909|NCT00766090|1325487|P2|STARTED|Treatment Period 1 (28 Days)||27
542910|NCT00766090|1325488|P1|STARTED|Treatment Period 1 (28 Days)||25
542911|NCT00766051|1325529|P2|NOT COMPLETED|Overall Study||0
542912|NCT00766051|1325530|P1|NOT COMPLETED|Overall Study||2
542913|NCT00766051|1325529|P2|COMPLETED|Overall Study||10
542914|NCT00766051|1325530|P1|COMPLETED|Overall Study||10
542915|NCT00766051|1325529|P2|STARTED|Overall Study||10
542916|NCT00766051|1325530|P1|STARTED|Overall Study||12
542917|NCT00765947|1325540|P1|NOT COMPLETED|Overall Study||24
542918|NCT00765947|1325540|P1|COMPLETED|Overall Study||232
542919|NCT00765947|1325540|P1|STARTED|Overall Study||256
542920|NCT00765895|1325551|P2|NOT COMPLETED|Overall Study||0
542921|NCT00765895|1325552|P1|NOT COMPLETED|Overall Study||0
542922|NCT00765895|1325551|P2|COMPLETED|Overall Study||65
542923|NCT00765895|1325552|P1|COMPLETED|Overall Study||65
542924|NCT00765895|1325551|P2|STARTED|Overall Study||65
542925|NCT00765895|1325552|P1|STARTED|Overall Study||65
542926|NCT00765882|1325561|P3|NOT COMPLETED|Overall Study||36
542927|NCT00765882|1325562|P2|NOT COMPLETED|Overall Study||40
542928|NCT00765882|1325563|P1|NOT COMPLETED|Overall Study||24
542929|NCT00765882|1325561|P3|COMPLETED|Overall Study||169
542930|NCT00765882|1325562|P2|COMPLETED|Overall Study||173
542931|NCT00765882|1325563|P1|COMPLETED|Overall Study||191
542932|NCT00765882|1325561|P3|STARTED|Overall Study||205
542933|NCT00765882|1325562|P2|STARTED|Overall Study||213
542934|NCT00765882|1325563|P1|STARTED|Overall Study||215
542935|NCT00765843|1325595|P3|NOT COMPLETED|Overall Study||3
542936|NCT00765843|1325596|P2|NOT COMPLETED|Overall Study||4
542937|NCT00765843|1325597|P1|NOT COMPLETED|Overall Study||1
542938|NCT00765843|1325595|P3|COMPLETED|Overall Study||23
542939|NCT00765843|1325596|P2|COMPLETED|Overall Study||21
542940|NCT00765843|1325597|P1|COMPLETED|Overall Study||25
542941|NCT00765843|1325595|P3|STARTED|Overall Study||26
542942|NCT00765843|1325596|P2|STARTED|Overall Study||25
542943|NCT00765843|1325597|P1|STARTED|Overall Study||26
542944|NCT00765817|1325607|P2|NOT COMPLETED|Overall Study||22
542945|NCT00765817|1325608|P1|NOT COMPLETED|Overall Study||26
542946|NCT00765817|1325607|P2|COMPLETED|Overall Study||101
542947|NCT00765817|1325608|P1|COMPLETED|Overall Study||112
542948|NCT00765817|1325607|P2|STARTED|Overall Study|One subject withdrew prior to receiving study medication, not included in analysis set|123
542949|NCT00765817|1325608|P1|STARTED|Overall Study|One subject withdrew prior to receiving study medication, not included in analysis set|138
542950|NCT00765765|1325646|P1|NOT COMPLETED|Overall Study||0
542951|NCT00765765|1325646|P1|COMPLETED|Overall Study||6
542952|NCT00765765|1325646|P1|STARTED|Overall Study||6
542953|NCT00765726|1325656|P1|NOT COMPLETED|Overall Study||9
542954|NCT00765726|1325656|P1|COMPLETED|Overall Study||3
542955|NCT00765726|1325656|P1|STARTED|Overall Study||12
542956|NCT00765674|1325664|P4|NOT COMPLETED|Overall Study||25
542957|NCT00765674|1325665|P3|NOT COMPLETED|Overall Study||17
542958|NCT00765674|1325666|P2|NOT COMPLETED|Overall Study||22
542959|NCT00765674|1325667|P1|NOT COMPLETED|Overall Study||21
542960|NCT00765674|1325664|P4|COMPLETED|Overall Study||285
542961|NCT00765674|1325665|P3|COMPLETED|Overall Study||279
542962|NCT00765674|1325666|P2|COMPLETED|Overall Study||276
542963|NCT00765674|1325667|P1|COMPLETED|Overall Study||266
542964|NCT00765674|1325664|P4|STARTED|Overall Study|1 patient was randomized in error and discontinued without taking any double-blind study medication.|310
542965|NCT00765674|1325665|P3|STARTED|Overall Study||296
542966|NCT00765674|1325666|P2|STARTED|Overall Study|1 patient was randomized in error and discontinued without taking any double-blind study medication.|298
542967|NCT00765674|1325667|P1|STARTED|Overall Study||287
542968|NCT00765661|1325691|P2|NOT COMPLETED|Overall Study||0
542969|NCT00765661|1325692|P1|NOT COMPLETED|Overall Study||0
542970|NCT00765661|1325691|P2|COMPLETED|Overall Study||31
542971|NCT00765661|1325692|P1|COMPLETED|Overall Study||32
542972|NCT00765661|1325691|P2|STARTED|Overall Study||31
542973|NCT00765661|1325692|P1|STARTED|Overall Study||32
542974|NCT00765648|1325706|P2|NOT COMPLETED|Overall Study||2
542975|NCT00765648|1325707|P1|NOT COMPLETED|Overall Study||1
542976|NCT00765648|1325706|P2|COMPLETED|Overall Study||114
542977|NCT00765648|1325707|P1|COMPLETED|Overall Study||109
542978|NCT00765648|1325706|P2|STARTED|Overall Study||116
542979|NCT00765648|1325707|P1|STARTED|Overall Study||110
542980|NCT00765570|1325725|P2|NOT COMPLETED|Overall Study||0
542981|NCT00765570|1325726|P1|NOT COMPLETED|Overall Study||2
542982|NCT00765570|1325725|P2|COMPLETED|Overall Study||3
542983|NCT00765570|1325726|P1|COMPLETED|Overall Study||7
542984|NCT00765570|1325725|P2|STARTED|Overall Study||3
542985|NCT00765570|1325726|P1|STARTED|Overall Study||9
542986|NCT00765388|1325734|P2|NOT COMPLETED|Period 2||0
542987|NCT00765388|1325735|P1|NOT COMPLETED|Period 2||0
542988|NCT00765388|1325734|P2|COMPLETED|Period 2||6
542989|NCT00765388|1325735|P1|COMPLETED|Period 2||15
542990|NCT00765388|1325734|P2|STARTED|Period 2||6
542991|NCT00765388|1325735|P1|STARTED|Period 2||15
542992|NCT00765388|1325734|P2|NOT COMPLETED|Period 1||5
542993|NCT00765388|1325735|P1|NOT COMPLETED|Period 1||1
542994|NCT00765388|1325734|P2|COMPLETED|Period 1||6
542995|NCT00765388|1325735|P1|COMPLETED|Period 1||15
542996|NCT00765388|1325734|P2|STARTED|Period 1||11
542997|NCT00765388|1325735|P1|STARTED|Period 1|A cross-over study|16
543001|NCT00765362|1325769|P1|NOT COMPLETED|Overall Study||137
543002|NCT00765362|1325769|P1|COMPLETED|Overall Study||282
543003|NCT00765362|1325769|P1|STARTED|Overall Study||419
543004|NCT00765336|1325777|P2|NOT COMPLETED|Overall Study||16
543005|NCT00765336|1325778|P1|NOT COMPLETED|Overall Study||19
543006|NCT00765336|1325777|P2|COMPLETED|Overall Study||73
543007|NCT00765336|1325778|P1|COMPLETED|Overall Study||72
543008|NCT00765336|1325777|P2|STARTED|Overall Study||89
543009|NCT00765336|1325778|P1|STARTED|Overall Study||91
543010|NCT00765245|1325786|P2|NOT COMPLETED|Overall Study||2
543011|NCT00765245|1325787|P1|NOT COMPLETED|Overall Study||13
543012|NCT00765245|1325786|P2|COMPLETED|Overall Study||20
543013|NCT00765245|1325787|P1|COMPLETED|Overall Study||9
543014|NCT00765245|1325786|P2|STARTED|Overall Study||22
543015|NCT00765245|1325787|P1|STARTED|Overall Study||22
543016|NCT00765232|1325799|P2|NOT COMPLETED|Overall Study||0
543017|NCT00765232|1325800|P1|NOT COMPLETED|Overall Study||0
543018|NCT00765232|1325799|P2|COMPLETED|Overall Study||54
543019|NCT00765232|1325800|P1|COMPLETED|Overall Study||57
543020|NCT00765232|1325799|P2|STARTED|Overall Study||54
543021|NCT00765232|1325800|P1|STARTED|Overall Study||57
543022|NCT00765206|1325808|P4|NOT COMPLETED|Second Intervention||0
543023|NCT00765206|1325809|P3|NOT COMPLETED|Second Intervention||0
543024|NCT00765206|1325810|P2|NOT COMPLETED|Second Intervention||0
543025|NCT00765206|1325811|P1|NOT COMPLETED|Second Intervention||0
543026|NCT00765206|1325808|P4|COMPLETED|Second Intervention||15
543027|NCT00765206|1325809|P3|COMPLETED|Second Intervention||15
543028|NCT00765206|1325810|P2|COMPLETED|Second Intervention||15
543029|NCT00765206|1325811|P1|COMPLETED|Second Intervention||15
543030|NCT00765206|1325808|P4|STARTED|Second Intervention||15
543031|NCT00765206|1325809|P3|STARTED|Second Intervention||15
543032|NCT00765206|1325810|P2|STARTED|Second Intervention||15
543033|NCT00765206|1325811|P1|STARTED|Second Intervention||15
543034|NCT00765206|1325808|P4|NOT COMPLETED|Washout Period of 14 Days||0
543035|NCT00765206|1325809|P3|NOT COMPLETED|Washout Period of 14 Days||0
543036|NCT00765206|1325810|P2|NOT COMPLETED|Washout Period of 14 Days||0
543037|NCT00765206|1325811|P1|NOT COMPLETED|Washout Period of 14 Days||0
543038|NCT00765206|1325808|P4|COMPLETED|Washout Period of 14 Days||15
543039|NCT00765206|1325809|P3|COMPLETED|Washout Period of 14 Days||15
543040|NCT00765206|1325810|P2|COMPLETED|Washout Period of 14 Days||15
543041|NCT00765206|1325811|P1|COMPLETED|Washout Period of 14 Days||15
543042|NCT00765206|1325808|P4|STARTED|Washout Period of 14 Days||15
543043|NCT00765206|1325809|P3|STARTED|Washout Period of 14 Days||15
543044|NCT00765206|1325810|P2|STARTED|Washout Period of 14 Days||15
543045|NCT00765206|1325811|P1|STARTED|Washout Period of 14 Days||15
543046|NCT00765206|1325808|P4|NOT COMPLETED|First Intervention||0
543047|NCT00765206|1325809|P3|NOT COMPLETED|First Intervention||0
543048|NCT00765206|1325810|P2|NOT COMPLETED|First Intervention||0
543049|NCT00765206|1325811|P1|NOT COMPLETED|First Intervention||0
543050|NCT00765206|1325808|P4|COMPLETED|First Intervention||15
543051|NCT00765206|1325809|P3|COMPLETED|First Intervention||15
543052|NCT00765206|1325810|P2|COMPLETED|First Intervention||15
543053|NCT00765206|1325811|P1|COMPLETED|First Intervention||15
543054|NCT00765206|1325808|P4|STARTED|First Intervention||15
543055|NCT00765206|1325809|P3|STARTED|First Intervention||15
543056|NCT00765206|1325810|P2|STARTED|First Intervention||15
543057|NCT00765206|1325811|P1|STARTED|First Intervention||15
543058|NCT00765193|1325817|P1|NOT COMPLETED|Full Body Examination||0
543059|NCT00765193|1325817|P1|COMPLETED|Full Body Examination||14381
543060|NCT00765193|1325817|P1|STARTED|Full Body Examination||14381
543061|NCT00765193|1325817|P1|NOT COMPLETED|Problem Area Examination||0
543062|NCT00765193|1325817|P1|COMPLETED|Problem Area Examination||14381
543063|NCT00765193|1325817|P1|STARTED|Problem Area Examination||14381
543064|NCT00765128|1325824|P2|NOT COMPLETED|Overall Study||0
543065|NCT00765128|1325825|P1|NOT COMPLETED|Overall Study||0
543066|NCT00765128|1325824|P2|COMPLETED|Overall Study||9
543067|NCT00765128|1325825|P1|COMPLETED|Overall Study||8
543068|NCT00765128|1325824|P2|STARTED|Overall Study||9
543069|NCT00765128|1325825|P1|STARTED|Overall Study||8
543070|NCT00765102|1325833|P1|NOT COMPLETED|Overall Study||31
543071|NCT00765102|1325833|P1|COMPLETED|Overall Study|Completed 8 cycles of treatment|1
543072|NCT00765102|1325833|P1|STARTED|Overall Study||32
543073|NCT00765076|1325858|P3|NOT COMPLETED|Overall Study||1
543074|NCT00765076|1325859|P2|NOT COMPLETED|Overall Study||0
543075|NCT00765076|1325860|P1|NOT COMPLETED|Overall Study||1
543076|NCT00765076|1325858|P3|COMPLETED|Overall Study||49
543077|NCT00765076|1325859|P2|COMPLETED|Overall Study||73
543078|NCT00765076|1325860|P1|COMPLETED|Overall Study||68
543079|NCT00765076|1325858|P3|STARTED|Overall Study||50
543080|NCT00765076|1325859|P2|STARTED|Overall Study||73
543081|NCT00765076|1325860|P1|STARTED|Overall Study||69
543082|NCT00765063|1325913|P1|NOT COMPLETED|Overall Study||32
543083|NCT00765063|1325913|P1|COMPLETED|Overall Study||30
543084|NCT00765063|1325913|P1|STARTED|Overall Study||62
543085|NCT00765037|1325929|P1|NOT COMPLETED|Overall Study||6
543086|NCT00765037|1325929|P1|COMPLETED|Overall Study|Subjects who came in for 1 year visit.|13
543087|NCT00765037|1325929|P1|STARTED|Overall Study|Original number of eligible subjects who signed a consent form.|19
543088|NCT00764946|1325936|P3|NOT COMPLETED|Overall Study||4
543089|NCT00764946|1325937|P2|NOT COMPLETED|Overall Study||17
543090|NCT00764946|1325938|P1|NOT COMPLETED|Overall Study||13
543091|NCT00764946|1325936|P3|COMPLETED|Overall Study||18
543092|NCT00764946|1325937|P2|COMPLETED|Overall Study||72
543093|NCT00764946|1325938|P1|COMPLETED|Overall Study||85
543094|NCT00764946|1325936|P3|TREATED|Overall Study||21
543095|NCT00764946|1325937|P2|TREATED|Overall Study||88
543096|NCT00764946|1325938|P1|TREATED|Overall Study||97
543097|NCT00764946|1325936|P3|STARTED|Overall Study||22
543098|NCT00764946|1325937|P2|STARTED|Overall Study||89
543099|NCT00764946|1325938|P1|STARTED|Overall Study||98
543100|NCT00764881|1325966|P2|NOT COMPLETED|Overall Study||10
543101|NCT00764881|1325967|P1|NOT COMPLETED|Overall Study||16
543102|NCT00764881|1325966|P2|COMPLETED|Overall Study||99
543103|NCT00764881|1325967|P1|COMPLETED|Overall Study||92
543104|NCT00764881|1325966|P2|Subjects Received Treatment|Overall Study|Full Analysis Set (FAS)|107
543105|NCT00764881|1325967|P1|Subjects Received Treatment|Overall Study|Full Analysis Set (FAS)|106
543106|NCT00764881|1325966|P2|STARTED|Overall Study||109
543107|NCT00764881|1325967|P1|STARTED|Overall Study||108
543108|NCT00764868|1326191|P1|NOT COMPLETED|Overall Study||113
543109|NCT00764868|1326191|P1|COMPLETED|Overall Study||156
543110|NCT00764868|1326191|P1|STARTED|Overall Study||269
543111|NCT00764790|1326200|P3|NOT COMPLETED|Overall Study||30
543112|NCT00764790|1326201|P2|NOT COMPLETED|Overall Study||41
543113|NCT00764790|1326202|P1|NOT COMPLETED|Overall Study||38
543114|NCT00764790|1326200|P3|COMPLETED|Overall Study||1074
543115|NCT00764790|1326201|P2|COMPLETED|Overall Study||1065
543116|NCT00764790|1326202|P1|COMPLETED|Overall Study||1069
543117|NCT00764790|1326200|P3|STARTED|Overall Study||1104
543118|NCT00764790|1326201|P2|STARTED|Overall Study||1106
543119|NCT00764790|1326202|P1|STARTED|Overall Study||1107
543120|NCT00764699|1326234|P1|NOT COMPLETED|Overall Study||3
543121|NCT00764699|1326234|P1|COMPLETED|Overall Study||0
543122|NCT00764699|1326234|P1|STARTED|Overall Study||3
543123|NCT00764673|1326238|P1|NOT COMPLETED|Overall Study||12
543124|NCT00764673|1326238|P1|COMPLETED|Overall Study||59
543125|NCT00764673|1326238|P1|STARTED|Overall Study||71
543126|NCT00764660|1326248|P2|NOT COMPLETED|Overall Study||11
543127|NCT00764660|1326249|P1|NOT COMPLETED|Overall Study||22
543128|NCT00764660|1326248|P2|COMPLETED|Overall Study||55
543129|NCT00764660|1326249|P1|COMPLETED|Overall Study||53
543130|NCT00764660|1326248|P2|STARTED|Overall Study||66
543131|NCT00764660|1326249|P1|STARTED|Overall Study||75
543132|NCT00764517|1326283|P2|NOT COMPLETED|Overall Study||14
543133|NCT00764517|1326284|P1|NOT COMPLETED|Overall Study||15
543134|NCT00764517|1326283|P2|COMPLETED|Overall Study||4
543135|NCT00764517|1326284|P1|COMPLETED|Overall Study||24
543136|NCT00764517|1326283|P2|STARTED|Overall Study||18
543137|NCT00764517|1326284|P1|STARTED|Overall Study||39
543138|NCT00764504|1326305|P3|NOT COMPLETED|Overall Study||103
543139|NCT00764504|1326306|P2|NOT COMPLETED|Overall Study||70
543140|NCT00764504|1326307|P1|NOT COMPLETED|Overall Study||66
543141|NCT00764504|1326305|P3|COMPLETED|Overall Study||131
543142|NCT00764504|1326306|P2|COMPLETED|Overall Study||71
543143|NCT00764504|1326307|P1|COMPLETED|Overall Study||75
543144|NCT00764504|1326305|P3|STARTED|Overall Study||234
543145|NCT00764504|1326306|P2|STARTED|Overall Study||141
543146|NCT00764504|1326307|P1|STARTED|Overall Study||141
543147|NCT00764478|1326336|P3|NOT COMPLETED|Overall Study||8
543148|NCT00764478|1326337|P2|NOT COMPLETED|Overall Study||22
543149|NCT00764478|1326338|P1|NOT COMPLETED|Overall Study||15
543150|NCT00764478|1326336|P3|COMPLETED|Overall Study||118
543151|NCT00764478|1326337|P2|COMPLETED|Overall Study||97
543152|NCT00764478|1326338|P1|COMPLETED|Overall Study||107
543153|NCT00764478|1326336|P3|STARTED|Overall Study||126
543154|NCT00764478|1326337|P2|STARTED|Overall Study||119
543155|NCT00764478|1326338|P1|STARTED|Overall Study||122
543156|NCT00764465|1326418|P6|NOT COMPLETED|Overall Study||1
543157|NCT00764465|1326419|P5|NOT COMPLETED|Overall Study||1
543158|NCT00764465|1326420|P4|NOT COMPLETED|Overall Study||1
543159|NCT00764465|1326421|P3|NOT COMPLETED|Overall Study||1
543160|NCT00764465|1326422|P2|NOT COMPLETED|Overall Study||1
543161|NCT00764465|1326423|P1|NOT COMPLETED|Overall Study||2
543162|NCT00764465|1326418|P6|COMPLETED|Overall Study||7
543163|NCT00764465|1326419|P5|COMPLETED|Overall Study||6
543164|NCT00764465|1326420|P4|COMPLETED|Overall Study||6
543165|NCT00764465|1326421|P3|COMPLETED|Overall Study||6
543166|NCT00764465|1326422|P2|COMPLETED|Overall Study||6
543167|NCT00764465|1326423|P1|COMPLETED|Overall Study||7
543168|NCT00764465|1326418|P6|STARTED|Overall Study||8
543169|NCT00764465|1326419|P5|STARTED|Overall Study||7
543170|NCT00764465|1326420|P4|STARTED|Overall Study||7
543171|NCT00764465|1326421|P3|STARTED|Overall Study||7
543172|NCT00764465|1326422|P2|STARTED|Overall Study||7
543173|NCT00764465|1326423|P1|STARTED|Overall Study||9
543174|NCT00764361|1326451|P2|NOT COMPLETED|Overall Study||4
543175|NCT00764361|1326452|P1|NOT COMPLETED|Overall Study||2
543176|NCT00764361|1326451|P2|COMPLETED|Overall Study||3
543177|NCT00764361|1326452|P1|COMPLETED|Overall Study||6
543178|NCT00764361|1326451|P2|STARTED|Overall Study||7
543179|NCT00764361|1326452|P1|STARTED|Overall Study||8
543180|NCT00764322|1326460|P1|NOT COMPLETED|Overall Study||20
543181|NCT00764322|1326460|P1|COMPLETED|Overall Study||480
543182|NCT00764322|1326460|P1|STARTED|Overall Study||500
543183|NCT00764309|1326477|P1|NOT COMPLETED|Overall Study||0
543184|NCT00764309|1326477|P1|COMPLETED|Overall Study|Completed=off study. Major Reasons for off study: AE-13; withdrawn by sponsor-10; Lack of efficacy-3|31
543185|NCT00764309|1326477|P1|STARTED|Overall Study|Number of participants treated.|31
543186|NCT00763971|1326487|P3|NOT COMPLETED|Overall Study||69
543187|NCT00763971|1326488|P2|NOT COMPLETED|Overall Study||38
543188|NCT00763971|1326489|P1|NOT COMPLETED|Overall Study||33
543189|NCT00763971|1326487|P3|COMPLETED|Overall Study||42
543190|NCT00763971|1326488|P2|COMPLETED|Overall Study||74
543191|NCT00763971|1326489|P1|COMPLETED|Overall Study||80
543192|NCT00763971|1326487|P3|STARTED|Overall Study||111
543193|NCT00763971|1326488|P2|STARTED|Overall Study||112
543194|NCT00763971|1326489|P1|STARTED|Overall Study||113
543195|NCT00763958|1326520|P2|NOT COMPLETED|Overall Study||11
543196|NCT00763958|1326521|P1|NOT COMPLETED|Overall Study||14
543197|NCT00763958|1326520|P2|COMPLETED|Overall Study||5
543198|NCT00763958|1326521|P1|COMPLETED|Overall Study||14
543199|NCT00763958|1326520|P2|STARTED|Overall Study||16
543200|NCT00763958|1326521|P1|STARTED|Overall Study||28
543201|NCT00763919|1326531|P1|NOT COMPLETED|Overall Study||13
543202|NCT00763919|1326531|P1|COMPLETED|Overall Study||30
543203|NCT00763919|1326531|P1|STARTED|Overall Study||43
543204|NCT00763867|1326559|P2|NOT COMPLETED|Overall Study||12
543205|NCT00763867|1326560|P1|NOT COMPLETED|Overall Study||5
543206|NCT00763867|1326559|P2|COMPLETED|Overall Study||101
543207|NCT00763867|1326560|P1|COMPLETED|Overall Study||98
543208|NCT00763867|1326559|P2|STARTED|Overall Study||113
543209|NCT00763867|1326560|P1|STARTED|Overall Study||103
543210|NCT00763815|1326656|P2|NOT COMPLETED|Overall Study||84
543211|NCT00763815|1326657|P1|NOT COMPLETED|Overall Study||52
543212|NCT00763815|1326656|P2|COMPLETED|Overall Study||239
543213|NCT00763815|1326657|P1|COMPLETED|Overall Study||109
543214|NCT00763815|1326656|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||320
543215|NCT00763815|1326657|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|159
543216|NCT00763815|1326656|P2|Treated/Safety Population|Overall Study||323
543217|NCT00763815|1326657|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|161
543218|NCT00763815|1326656|P2|STARTED|Overall Study||323
543219|NCT00763815|1326657|P1|STARTED|Overall Study|Randomized.|161
543220|NCT00763750|1326681|P1|NOT COMPLETED|Overall Study||0
543221|NCT00763750|1326681|P1|COMPLETED|Overall Study||25
543222|NCT00763750|1326681|P1|STARTED|Overall Study||25
543223|NCT00763698|1326685|P1|NOT COMPLETED|Overall Study||10
543224|NCT00763698|1326685|P1|COMPLETED|Overall Study||76
543225|NCT00763698|1326685|P1|STARTED|Overall Study||86
543226|NCT00763490|1326691|P1|NOT COMPLETED|Overall Study||0
543227|NCT00763490|1326691|P1|COMPLETED|Overall Study||20
543228|NCT00763490|1326691|P1|STARTED|Overall Study||20
543229|NCT00763451|1326702|P4|NOT COMPLETED|Overall Study||30
543230|NCT00763451|1326703|P3|NOT COMPLETED|Overall Study||40
543231|NCT00763451|1326704|P2|NOT COMPLETED|Overall Study||22
543232|NCT00763451|1326705|P1|NOT COMPLETED|Overall Study||13
543233|NCT00763451|1326702|P4|COMPLETED|Overall Study||131
543234|NCT00763451|1326703|P3|COMPLETED|Overall Study||121
543235|NCT00763451|1326704|P2|COMPLETED|Overall Study||60
543236|NCT00763451|1326705|P1|COMPLETED|Overall Study||67
543237|NCT00763451|1326702|P4|Modified Intent-to-Treat(mITT)Population|Overall Study||160
543238|NCT00763451|1326703|P3|Modified Intent-to-Treat(mITT)Population|Overall Study||160
543239|NCT00763451|1326704|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||80
543240|NCT00763451|1326705|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|79
543241|NCT00763451|1326702|P4|Treated/Safety Population|Overall Study||161
543242|NCT00763451|1326703|P3|Treated/Safety Population|Overall Study||161
543243|NCT00763451|1326704|P2|Treated/Safety Population|Overall Study||81
543244|NCT00763451|1326705|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|79
543245|NCT00763451|1326702|P4|STARTED|Overall Study||161
543246|NCT00763451|1326703|P3|STARTED|Overall Study||161
543247|NCT00763451|1326704|P2|STARTED|Overall Study||82
543248|NCT00763451|1326705|P1|STARTED|Overall Study|Randomized.|80
543249|NCT00763412|1326739|P2|NOT COMPLETED|Overall Study||4
543250|NCT00763412|1326740|P1|NOT COMPLETED|Overall Study||4
543251|NCT00763412|1326739|P2|COMPLETED|Overall Study||4
543252|NCT00763412|1326740|P1|COMPLETED|Overall Study||4
543253|NCT00763412|1326739|P2|STARTED|Overall Study||8
543254|NCT00763412|1326740|P1|STARTED|Overall Study||8
543255|NCT00763386|1326764|P2|NOT COMPLETED|Overall Study||40
543256|NCT00763386|1326765|P1|NOT COMPLETED|Overall Study||48
543257|NCT00763386|1326764|P2|COMPLETED|Overall Study||127
543258|NCT00763386|1326765|P1|COMPLETED|Overall Study||116
543259|NCT00763386|1326764|P2|STARTED|Overall Study||167
543260|NCT00763386|1326765|P1|STARTED|Overall Study||164
543261|NCT00763360|1326776|P3|NOT COMPLETED|Overall Study||0
543262|NCT00763360|1326777|P2|NOT COMPLETED|Overall Study||2
543263|NCT00763360|1326778|P1|NOT COMPLETED|Overall Study||0
543264|NCT00763360|1326776|P3|COMPLETED|Overall Study||63
543265|NCT00763360|1326777|P2|COMPLETED|Overall Study||58
543266|NCT00763360|1326778|P1|COMPLETED|Overall Study||61
543267|NCT00763360|1326776|P3|STARTED|Overall Study||63
543268|NCT00763360|1326777|P2|STARTED|Overall Study||60
543269|NCT00763360|1326778|P1|STARTED|Overall Study||61
543270|NCT00763321|1326798|P3|NOT COMPLETED|Double-blind Period||29
543271|NCT00763321|1326799|P2|NOT COMPLETED|Double-blind Period||21
543272|NCT00763321|1326800|P1|NOT COMPLETED|Double-blind Period||0
543273|NCT00763321|1326798|P3|COMPLETED|Double-blind Period||84
543274|NCT00763321|1326799|P2|COMPLETED|Double-blind Period||88
543275|NCT00763321|1326800|P1|COMPLETED|Double-blind Period||0
543276|NCT00763321|1326798|P3|STARTED|Double-blind Period||113
543277|NCT00763321|1326799|P2|STARTED|Double-blind Period||109
543278|NCT00763321|1326800|P1|STARTED|Double-blind Period||0
543279|NCT00763321|1326798|P3|NOT COMPLETED|Open-label Period||0
543280|NCT00763321|1326799|P2|NOT COMPLETED|Open-label Period||0
543281|NCT00763321|1326800|P1|NOT COMPLETED|Open-label Period||63
543282|NCT00763321|1326798|P3|COMPLETED|Open-label Period||0
543283|NCT00763321|1326799|P2|COMPLETED|Open-label Period||0
543284|NCT00763321|1326800|P1|COMPLETED|Open-label Period||222
543285|NCT00763321|1326798|P3|STARTED|Open-label Period||0
543286|NCT00763321|1326799|P2|STARTED|Open-label Period||0
543287|NCT00763321|1326800|P1|STARTED|Open-label Period||285
543288|NCT00763282|1326811|P2|NOT COMPLETED|Overall Study||34
543289|NCT00763282|1326812|P1|NOT COMPLETED|Overall Study||32
543290|NCT00763282|1326811|P2|COMPLETED|Overall Study||38
543291|NCT00763282|1326812|P1|COMPLETED|Overall Study||40
543292|NCT00763282|1326811|P2|STARTED|Overall Study||72
543293|NCT00763282|1326812|P1|STARTED|Overall Study||72
543294|NCT00763269|1326828|P2|NOT COMPLETED|Overall Study||13
543295|NCT00763269|1326829|P1|NOT COMPLETED|Overall Study||12
543296|NCT00763269|1326828|P2|COMPLETED|Overall Study||299
543297|NCT00763269|1326829|P1|COMPLETED|Overall Study||302
543298|NCT00763269|1326828|P2|STARTED|Overall Study||312
543299|NCT00763269|1326829|P1|STARTED|Overall Study||314
543300|NCT00763256|1326843|P2|NOT COMPLETED|Overall Study||10
543301|NCT00763256|1326844|P1|NOT COMPLETED|Overall Study||7
543302|NCT00763256|1326843|P2|COMPLETED|Overall Study||8
543303|NCT00763256|1326844|P1|COMPLETED|Overall Study||8
543304|NCT00763256|1326843|P2|STARTED|Overall Study||18
543305|NCT00763256|1326844|P1|STARTED|Overall Study||15
543306|NCT00763243|1326858|P1|NOT COMPLETED|6-Month Follow-Up Period||0
543307|NCT00763243|1326858|P1|COMPLETED|6-Month Follow-Up Period||9
543308|NCT00763243|1326858|P1|STARTED|6-Month Follow-Up Period||9
543309|NCT00763243|1326858|P1|NOT COMPLETED|1-Month Follow-Up Period||0
543310|NCT00763243|1326858|P1|COMPLETED|1-Month Follow-Up Period||9
543311|NCT00763243|1326858|P1|STARTED|1-Month Follow-Up Period||9
543312|NCT00763243|1326858|P1|NOT COMPLETED|Training Period||0
543313|NCT00763243|1326858|P1|COMPLETED|Training Period||9
543314|NCT00763243|1326858|P1|STARTED|Training Period||9
543315|NCT00763243|1326858|P1|NOT COMPLETED|Waiting Period||0
543316|NCT00763243|1326858|P1|COMPLETED|Waiting Period||9
543317|NCT00763243|1326858|P1|STARTED|Waiting Period||9
543318|NCT00763139|1326880|P2|NOT COMPLETED|Overall Study||3
543319|NCT00763139|1326881|P1|NOT COMPLETED|Overall Study||5
543320|NCT00763139|1326880|P2|COMPLETED|Overall Study||14
543321|NCT00763139|1326881|P1|COMPLETED|Overall Study||12
543322|NCT00763139|1326880|P2|STARTED|Overall Study||17
543323|NCT00763139|1326881|P1|STARTED|Overall Study||17
543324|NCT00763061|1326903|P2|NOT COMPLETED|Overall Study||13
543325|NCT00763061|1326904|P1|NOT COMPLETED|Overall Study||5
543326|NCT00763061|1326903|P2|COMPLETED|Overall Study||44
543327|NCT00763061|1326904|P1|COMPLETED|Overall Study||49
543328|NCT00763061|1326903|P2|STARTED|Overall Study||57
543329|NCT00763061|1326904|P1|STARTED|Overall Study||54
543330|NCT00763048|1326918|P2|NOT COMPLETED|Overall Study||0
543331|NCT00763048|1326919|P1|NOT COMPLETED|Overall Study||0
543332|NCT00763048|1326918|P2|COMPLETED|Overall Study||18
543333|NCT00763048|1326919|P1|COMPLETED|Overall Study||21
543334|NCT00763048|1326918|P2|STARTED|Overall Study||18
543335|NCT00763048|1326919|P1|STARTED|Overall Study||21
543336|NCT00763009|1326943|P1|NOT COMPLETED|Overall Study||1
543337|NCT00763009|1326943|P1|COMPLETED|Overall Study||7
543338|NCT00763009|1326943|P1|STARTED|Overall Study||8
543339|NCT00762996|1326948|P4|NOT COMPLETED|Period Two||0
543340|NCT00762996|1326949|P3|NOT COMPLETED|Period Two||0
543341|NCT00762996|1326950|P2|NOT COMPLETED|Period Two||0
543342|NCT00762996|1326951|P1|NOT COMPLETED|Period Two||0
543343|NCT00762996|1326948|P4|COMPLETED|Period Two||16
543344|NCT00762996|1326949|P3|COMPLETED|Period Two||13
543345|NCT00762996|1326950|P2|COMPLETED|Period Two||16
543346|NCT00762996|1326951|P1|COMPLETED|Period Two||15
543347|NCT00762996|1326948|P4|STARTED|Period Two||16
543348|NCT00762996|1326949|P3|STARTED|Period Two||13
543349|NCT00762996|1326950|P2|STARTED|Period Two||16
543350|NCT00762996|1326951|P1|STARTED|Period Two||15
543351|NCT00762996|1326948|P4|NOT COMPLETED|Period One||1
543352|NCT00762996|1326949|P3|NOT COMPLETED|Period One||4
543353|NCT00762996|1326950|P2|NOT COMPLETED|Period One||0
543354|NCT00762996|1326951|P1|NOT COMPLETED|Period One||0
543355|NCT00762996|1326948|P4|COMPLETED|Period One||16
543356|NCT00762996|1326949|P3|COMPLETED|Period One||13
543357|NCT00762996|1326950|P2|COMPLETED|Period One||16
543358|NCT00762996|1326951|P1|COMPLETED|Period One||15
543359|NCT00762996|1326948|P4|STARTED|Period One||17
543360|NCT00762996|1326949|P3|STARTED|Period One||17
543361|NCT00762996|1326950|P2|STARTED|Period One||16
543362|NCT00762996|1326951|P1|STARTED|Period One||15
543363|NCT00762970|1326964|P3|NOT COMPLETED|Overall Study||1
543364|NCT00762970|1326965|P2|NOT COMPLETED|Overall Study||9
543365|NCT00762970|1326966|P1|NOT COMPLETED|Overall Study||12
543366|NCT00762970|1326964|P3|COMPLETED|Overall Study||46
543367|NCT00762970|1326965|P2|COMPLETED|Overall Study||35
543368|NCT00762970|1326966|P1|COMPLETED|Overall Study||34
543369|NCT00762970|1326964|P3|STARTED|Overall Study||47
543370|NCT00762970|1326965|P2|STARTED|Overall Study||44
543371|NCT00762970|1326966|P1|STARTED|Overall Study||46
543372|NCT00762931|1326977|P1|NOT COMPLETED|Overall Study||2
543373|NCT00762931|1326977|P1|COMPLETED|Overall Study||23
543374|NCT00762931|1326977|P1|STARTED|Overall Study||25
543375|NCT00762892|1326984|P2|NOT COMPLETED|Overall Study||6
543376|NCT00762892|1326985|P1|NOT COMPLETED|Overall Study||5
543377|NCT00762892|1326984|P2|COMPLETED|Overall Study||8
543378|NCT00762892|1326985|P1|COMPLETED|Overall Study||9
543379|NCT00762892|1326984|P2|STARTED|Overall Study||14
543380|NCT00762892|1326985|P1|STARTED|Overall Study||14
543381|NCT00762853|1327001|P2|NOT COMPLETED|Second Treatment Period||0
543382|NCT00762853|1327002|P1|NOT COMPLETED|Second Treatment Period||0
543383|NCT00762853|1327001|P2|COMPLETED|Second Treatment Period||10
543384|NCT00762853|1327002|P1|COMPLETED|Second Treatment Period||10
543385|NCT00762853|1327001|P2|STARTED|Second Treatment Period||10
543386|NCT00762853|1327002|P1|STARTED|Second Treatment Period||10
543387|NCT00762853|1327001|P2|NOT COMPLETED|1 Week Washout After Treatment 1||0
543388|NCT00762853|1327002|P1|NOT COMPLETED|1 Week Washout After Treatment 1||0
543389|NCT00762853|1327001|P2|COMPLETED|1 Week Washout After Treatment 1||10
543390|NCT00762853|1327002|P1|COMPLETED|1 Week Washout After Treatment 1||10
543391|NCT00762853|1327001|P2|STARTED|1 Week Washout After Treatment 1||10
543392|NCT00762853|1327002|P1|STARTED|1 Week Washout After Treatment 1||10
543393|NCT00762853|1327001|P2|NOT COMPLETED|First Treatment Period||0
543394|NCT00762853|1327002|P1|NOT COMPLETED|First Treatment Period||0
543395|NCT00762853|1327001|P2|COMPLETED|First Treatment Period||10
543396|NCT00762853|1327002|P1|COMPLETED|First Treatment Period||10
543397|NCT00762853|1327001|P2|STARTED|First Treatment Period||10
543398|NCT00762853|1327002|P1|STARTED|First Treatment Period||10
543399|NCT00762788|1327014|P6|NOT COMPLETED|Overall Study||21
543400|NCT00762788|1327015|P5|NOT COMPLETED|Overall Study||13
543401|NCT00762788|1327016|P4|NOT COMPLETED|Overall Study||26
543402|NCT00762788|1327017|P3|NOT COMPLETED|Overall Study||21
543403|NCT00762788|1327018|P2|NOT COMPLETED|Overall Study||37
543404|NCT00762788|1327019|P1|NOT COMPLETED|Overall Study||26
543405|NCT00762788|1327014|P6|COMPLETED|Overall Study||31
543406|NCT00762788|1327015|P5|COMPLETED|Overall Study||30
543407|NCT00762788|1327016|P4|COMPLETED|Overall Study||38
543408|NCT00762788|1327017|P3|COMPLETED|Overall Study||21
543409|NCT00762788|1327018|P2|COMPLETED|Overall Study||21
543410|NCT00762788|1327019|P1|COMPLETED|Overall Study||29
543411|NCT00762788|1327014|P6|STARTED|Overall Study||52
543412|NCT00762788|1327015|P5|STARTED|Overall Study||43
543413|NCT00762788|1327016|P4|STARTED|Overall Study||64
543414|NCT00762788|1327017|P3|STARTED|Overall Study||42
543415|NCT00762788|1327018|P2|STARTED|Overall Study||58
543416|NCT00762788|1327019|P1|STARTED|Overall Study||55
543417|NCT00762762|1327041|P2|NOT COMPLETED|Overall Study||10
543418|NCT00762762|1327042|P1|NOT COMPLETED|Overall Study||8
543419|NCT00762762|1327041|P2|COMPLETED|Overall Study||20
543420|NCT00762762|1327042|P1|COMPLETED|Overall Study||22
543421|NCT00762762|1327041|P2|STARTED|Overall Study||30
543422|NCT00762762|1327042|P1|STARTED|Overall Study||30
543423|NCT00762723|1327059|P3|NOT COMPLETED|Overall Study||3
543424|NCT00762723|1327060|P2|NOT COMPLETED|Overall Study||5
543425|NCT00762723|1327061|P1|NOT COMPLETED|Overall Study||5
543426|NCT00762723|1327059|P3|COMPLETED|Overall Study||0
543427|NCT00762723|1327060|P2|COMPLETED|Overall Study||6
543428|NCT00762723|1327061|P1|COMPLETED|Overall Study||0
543429|NCT00762723|1327059|P3|STARTED|Overall Study||3
543430|NCT00762723|1327060|P2|STARTED|Overall Study||11
543431|NCT00762723|1327061|P1|STARTED|Overall Study||5
543432|NCT00762645|1327071|P2|NOT COMPLETED|Overall Study||2
543433|NCT00762645|1327072|P1|NOT COMPLETED|Overall Study||4
543434|NCT00762645|1327071|P2|COMPLETED|Overall Study||12
543435|NCT00762645|1327072|P1|COMPLETED|Overall Study||12
543436|NCT00762645|1327071|P2|STARTED|Overall Study||14
543437|NCT00762645|1327072|P1|STARTED|Overall Study||16
543438|NCT00762619|1327082|P2|NOT COMPLETED|Overall Study||0
543439|NCT00762619|1327083|P1|NOT COMPLETED|Overall Study||0
543440|NCT00762619|1327082|P2|COMPLETED|Overall Study||50
543441|NCT00762619|1327083|P1|COMPLETED|Overall Study||55
543442|NCT00762619|1327082|P2|STARTED|Overall Study||50
543443|NCT00762619|1327083|P1|STARTED|Overall Study||55
543444|NCT00762606|1327225|P2|NOT COMPLETED|Overall Study||13
543445|NCT00762606|1327226|P1|NOT COMPLETED|Overall Study||18
543446|NCT00762606|1327225|P2|COMPLETED|Overall Study||38
543447|NCT00762606|1327226|P1|COMPLETED|Overall Study||37
543448|NCT00762606|1327225|P2|STARTED|Overall Study||51
543449|NCT00762606|1327226|P1|STARTED|Overall Study||55
543450|NCT00762528|1327236|P2|NOT COMPLETED|Overall Study||0
543451|NCT00762528|1327237|P1|NOT COMPLETED|Overall Study||0
543452|NCT00762528|1327236|P2|COMPLETED|Overall Study||25
543453|NCT00762528|1327237|P1|COMPLETED|Overall Study||24
543454|NCT00762528|1327236|P2|STARTED|Overall Study||25
543455|NCT00762528|1327237|P1|STARTED|Overall Study||24
543456|NCT00762515|1327259|P2|NOT COMPLETED|Overall Study||0
543457|NCT00762515|1327260|P1|NOT COMPLETED|Overall Study||0
543458|NCT00762515|1327259|P2|COMPLETED|Overall Study||22
543459|NCT00762515|1327260|P1|COMPLETED|Overall Study||22
543460|NCT00762515|1327259|P2|STARTED|Overall Study||22
543461|NCT00762515|1327260|P1|STARTED|Overall Study||22
543462|NCT00762502|1327271|P3|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0
543463|NCT00762502|1327272|P2|NOT COMPLETED|Month 3 to Month 6 (Period 2)||1
543464|NCT00762502|1327273|P1|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0
543465|NCT00762502|1327271|P3|COMPLETED|Month 3 to Month 6 (Period 2)||23
543466|NCT00762502|1327272|P2|COMPLETED|Month 3 to Month 6 (Period 2)||4
543467|NCT00762502|1327273|P1|COMPLETED|Month 3 to Month 6 (Period 2)||9
543468|NCT00762502|1327271|P3|STARTED|Month 3 to Month 6 (Period 2)||23
543469|NCT00762502|1327272|P2|STARTED|Month 3 to Month 6 (Period 2)||5
543470|NCT00762502|1327273|P1|STARTED|Month 3 to Month 6 (Period 2)||9
543471|NCT00762502|1327271|P3|NOT COMPLETED|Baseline to Month 3 (Period 1)||19
543472|NCT00762502|1327272|P2|NOT COMPLETED|Baseline to Month 3 (Period 1)||6
543473|NCT00762502|1327273|P1|NOT COMPLETED|Baseline to Month 3 (Period 1)||10
543474|NCT00762502|1327271|P3|COMPLETED|Baseline to Month 3 (Period 1)||32
543475|NCT00762502|1327272|P2|COMPLETED|Baseline to Month 3 (Period 1)||19
543476|NCT00762502|1327273|P1|COMPLETED|Baseline to Month 3 (Period 1)||26
543477|NCT00762502|1327271|P3|STARTED|Baseline to Month 3 (Period 1)||51
543478|NCT00762502|1327272|P2|STARTED|Baseline to Month 3 (Period 1)||25
543479|NCT00762502|1327273|P1|STARTED|Baseline to Month 3 (Period 1)||36
543480|NCT00762476|1327287|P2|NOT COMPLETED|Overall Study||36
543481|NCT00762476|1327288|P1|NOT COMPLETED|Overall Study||23
543482|NCT00762476|1327287|P2|COMPLETED|Overall Study||169
543483|NCT00762476|1327288|P1|COMPLETED|Overall Study||183
543484|NCT00762476|1327287|P2|STARTED|Overall Study||205
543485|NCT00762476|1327288|P1|STARTED|Overall Study||206
543486|NCT00762463|1327300|P4|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||2
543487|NCT00762463|1327301|P3|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||4
543488|NCT00762463|1327302|P2|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||1
543489|NCT00762463|1327303|P1|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||3
543490|NCT00762463|1327300|P4|COMPLETED|Extension Phase (Week 6 to Week 12)||52
543491|NCT00762463|1327301|P3|COMPLETED|Extension Phase (Week 6 to Week 12)||50
543492|NCT00762463|1327302|P2|COMPLETED|Extension Phase (Week 6 to Week 12)||54
543493|NCT00762463|1327303|P1|COMPLETED|Extension Phase (Week 6 to Week 12)||52
543494|NCT00762463|1327300|P4|STARTED|Extension Phase (Week 6 to Week 12)||54
543495|NCT00762463|1327301|P3|STARTED|Extension Phase (Week 6 to Week 12)||54
543496|NCT00762463|1327302|P2|STARTED|Extension Phase (Week 6 to Week 12)||55
543497|NCT00762463|1327303|P1|STARTED|Extension Phase (Week 6 to Week 12)||55
543498|NCT00762463|1327300|P4|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0
543499|NCT00762463|1327301|P3|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0
543500|NCT00762463|1327302|P2|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||1
543501|NCT00762463|1327303|P1|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||4
543502|NCT00762463|1327300|P4|COMPLETED|Enrollment in Extension Phase (Week 6)||0
543503|NCT00762463|1327301|P3|COMPLETED|Enrollment in Extension Phase (Week 6)||0
543504|NCT00762463|1327302|P2|COMPLETED|Enrollment in Extension Phase (Week 6)||109
543505|NCT00762463|1327303|P1|COMPLETED|Enrollment in Extension Phase (Week 6)||109
543506|NCT00762463|1327300|P4|STARTED|Enrollment in Extension Phase (Week 6)||0
543507|NCT00762463|1327301|P3|STARTED|Enrollment in Extension Phase (Week 6)||0
543508|NCT00762463|1327302|P2|STARTED|Enrollment in Extension Phase (Week 6)||110
543509|NCT00762463|1327303|P1|STARTED|Enrollment in Extension Phase (Week 6)||113
543510|NCT00762463|1327300|P4|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0
543511|NCT00762463|1327301|P3|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0
543512|NCT00762463|1327302|P2|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||10
543513|NCT00762463|1327303|P1|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||7
543514|NCT00762463|1327300|P4|COMPLETED|Double-blind Phase (Baseline to Week 6)||0
543515|NCT00762463|1327301|P3|COMPLETED|Double-blind Phase (Baseline to Week 6)||0
543516|NCT00762463|1327302|P2|COMPLETED|Double-blind Phase (Baseline to Week 6)||110
543517|NCT00762463|1327303|P1|COMPLETED|Double-blind Phase (Baseline to Week 6)||113
543518|NCT00762463|1327300|P4|STARTED|Double-blind Phase (Baseline to Week 6)||0
543519|NCT00762463|1327301|P3|STARTED|Double-blind Phase (Baseline to Week 6)||0
543520|NCT00762463|1327302|P2|STARTED|Double-blind Phase (Baseline to Week 6)||120
543521|NCT00762463|1327303|P1|STARTED|Double-blind Phase (Baseline to Week 6)||120
543522|NCT00762450|1327388|P3|NOT COMPLETED|3rd Treatment Period||0
543523|NCT00762450|1327389|P2|NOT COMPLETED|3rd Treatment Period||0
543524|NCT00762450|1327390|P1|NOT COMPLETED|3rd Treatment Period||0
543525|NCT00762450|1327388|P3|COMPLETED|3rd Treatment Period||2
543526|NCT00762450|1327389|P2|COMPLETED|3rd Treatment Period||2
543527|NCT00762450|1327390|P1|COMPLETED|3rd Treatment Period||2
543528|NCT00762450|1327388|P3|STARTED|3rd Treatment Period||2
543529|NCT00762450|1327389|P2|STARTED|3rd Treatment Period||2
543530|NCT00762450|1327390|P1|STARTED|3rd Treatment Period||2
543531|NCT00762450|1327388|P3|NOT COMPLETED|Washout After 2nd Treatment Period||0
543532|NCT00762450|1327389|P2|NOT COMPLETED|Washout After 2nd Treatment Period||0
543533|NCT00762450|1327390|P1|NOT COMPLETED|Washout After 2nd Treatment Period||0
543534|NCT00762450|1327388|P3|COMPLETED|Washout After 2nd Treatment Period||2
543535|NCT00762450|1327389|P2|COMPLETED|Washout After 2nd Treatment Period||2
543536|NCT00762450|1327390|P1|COMPLETED|Washout After 2nd Treatment Period||2
543537|NCT00762450|1327388|P3|STARTED|Washout After 2nd Treatment Period||2
543538|NCT00762450|1327389|P2|STARTED|Washout After 2nd Treatment Period||2
543539|NCT00762450|1327390|P1|STARTED|Washout After 2nd Treatment Period||2
543540|NCT00762450|1327388|P3|NOT COMPLETED|2nd Treatment Period||0
543541|NCT00762450|1327389|P2|NOT COMPLETED|2nd Treatment Period||0
543542|NCT00762450|1327390|P1|NOT COMPLETED|2nd Treatment Period||0
543543|NCT00762450|1327388|P3|COMPLETED|2nd Treatment Period||2
543544|NCT00762450|1327389|P2|COMPLETED|2nd Treatment Period||2
543545|NCT00762450|1327390|P1|COMPLETED|2nd Treatment Period||2
543546|NCT00762450|1327388|P3|STARTED|2nd Treatment Period||2
543547|NCT00762450|1327389|P2|STARTED|2nd Treatment Period||2
543548|NCT00762450|1327390|P1|STARTED|2nd Treatment Period||2
543549|NCT00762450|1327388|P3|NOT COMPLETED|Washout After 1st Treatment Period||0
543550|NCT00762450|1327389|P2|NOT COMPLETED|Washout After 1st Treatment Period||0
543551|NCT00762450|1327390|P1|NOT COMPLETED|Washout After 1st Treatment Period||0
543552|NCT00762450|1327388|P3|COMPLETED|Washout After 1st Treatment Period||2
543553|NCT00762450|1327389|P2|COMPLETED|Washout After 1st Treatment Period||2
543554|NCT00762450|1327390|P1|COMPLETED|Washout After 1st Treatment Period||2
543555|NCT00762450|1327388|P3|STARTED|Washout After 1st Treatment Period||2
543556|NCT00762450|1327389|P2|STARTED|Washout After 1st Treatment Period||2
543557|NCT00762450|1327390|P1|STARTED|Washout After 1st Treatment Period||2
543558|NCT00762450|1327388|P3|NOT COMPLETED|1st Treatment Period||0
543559|NCT00762450|1327389|P2|NOT COMPLETED|1st Treatment Period||0
543560|NCT00762450|1327390|P1|NOT COMPLETED|1st Treatment Period||0
543561|NCT00762450|1327388|P3|COMPLETED|1st Treatment Period||2
543562|NCT00762450|1327389|P2|COMPLETED|1st Treatment Period||2
543563|NCT00762450|1327390|P1|COMPLETED|1st Treatment Period||2
543564|NCT00762450|1327388|P3|STARTED|1st Treatment Period||2
543565|NCT00762450|1327389|P2|STARTED|1st Treatment Period||2
543566|NCT00762450|1327390|P1|STARTED|1st Treatment Period||2
543567|NCT00762424|1327400|P2|NOT COMPLETED|Overall Study||0
543568|NCT00762424|1327401|P1|NOT COMPLETED|Overall Study||0
543569|NCT00762424|1327400|P2|COMPLETED|Overall Study||25
543570|NCT00762424|1327401|P1|COMPLETED|Overall Study||28
543571|NCT00762424|1327400|P2|STARTED|Overall Study||25
543572|NCT00762424|1327401|P1|STARTED|Overall Study||28
543573|NCT00762411|1327409|P2|NOT COMPLETED|Safety Follow Up (SFU)-Optional||118
543574|NCT00762411|1327410|P1|NOT COMPLETED|Safety Follow Up (SFU)-Optional||84
543575|NCT00762411|1327409|P2|COMPLETED|Safety Follow Up (SFU)-Optional||312
543576|NCT00762411|1327410|P1|COMPLETED|Safety Follow Up (SFU)-Optional||228
543577|NCT00762411|1327409|P2|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|430
543578|NCT00762411|1327410|P1|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|312
543579|NCT00762411|1327409|P2|NOT COMPLETED|Delayed Start||26
543580|NCT00762411|1327410|P1|NOT COMPLETED|Delayed Start||17
543581|NCT00762411|1327409|P2|COMPLETED|Delayed Start||8
543582|NCT00762411|1327410|P1|COMPLETED|Delayed Start||5
543583|NCT00762411|1327409|P2|STARTED|Delayed Start||34
543584|NCT00762411|1327410|P1|STARTED|Delayed Start||22
543585|NCT00762411|1327409|P2|NOT COMPLETED|Initial Treatment||521
543586|NCT00762411|1327410|P1|NOT COMPLETED|Initial Treatment||534
543587|NCT00762411|1327409|P2|COMPLETED|Initial Treatment||34
543588|NCT00762411|1327410|P1|COMPLETED|Initial Treatment||22
543589|NCT00762411|1327409|P2|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who received at least 1 dose of study drug.|553
543590|NCT00762411|1327410|P1|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants(pts) who received at least 1 dose of study drug.|555
543591|NCT00762411|1327409|P2|STARTED|Initial Treatment||555
543592|NCT00762411|1327410|P1|STARTED|Initial Treatment||556
543593|NCT00762385|1327474|P2|NOT COMPLETED|Second Intervention||3
543594|NCT00762385|1327475|P1|NOT COMPLETED|Second Intervention||3
543595|NCT00762385|1327474|P2|COMPLETED|Second Intervention||39
543596|NCT00762385|1327475|P1|COMPLETED|Second Intervention||46
543597|NCT00762385|1327474|P2|STARTED|Second Intervention||42
543598|NCT00762385|1327475|P1|STARTED|Second Intervention||49
543599|NCT00762385|1327474|P2|NOT COMPLETED|First Intervention||4
543600|NCT00762385|1327475|P1|NOT COMPLETED|First Intervention||2
543601|NCT00762385|1327474|P2|COMPLETED|First Intervention||42
543602|NCT00762385|1327475|P1|COMPLETED|First Intervention||49
543603|NCT00762385|1327474|P2|STARTED|First Intervention||46
543604|NCT00762385|1327475|P1|STARTED|First Intervention||51
543605|NCT00762359|1327487|P2|NOT COMPLETED|Overall Study||57
543606|NCT00762359|1327488|P1|NOT COMPLETED|Overall Study||59
543607|NCT00762359|1327487|P2|COMPLETED|Overall Study||178
543608|NCT00762359|1327488|P1|COMPLETED|Overall Study||167
543609|NCT00762359|1327487|P2|STARTED|Overall Study||235
543610|NCT00762359|1327488|P1|STARTED|Overall Study||226
543611|NCT00762320|1327588|P1|NOT COMPLETED|Overall Study||0
543612|NCT00762320|1327588|P1|COMPLETED|Overall Study||8
543613|NCT00762320|1327588|P1|STARTED|Overall Study||8
543614|NCT00762268|1327605|P2|NOT COMPLETED|Overall Study||2
543615|NCT00762268|1327606|P1|NOT COMPLETED|Overall Study||1
543616|NCT00762268|1327605|P2|COMPLETED|Overall Study||8
543617|NCT00762268|1327606|P1|COMPLETED|Overall Study||9
543618|NCT00762268|1327605|P2|STARTED|Overall Study||10
543619|NCT00762268|1327606|P1|STARTED|Overall Study||10
543620|NCT00762229|1327614|P2|NOT COMPLETED|Overall Study||2
543621|NCT00762229|1327615|P1|NOT COMPLETED|Overall Study||1
543622|NCT00762229|1327614|P2|COMPLETED|Overall Study||22
543623|NCT00762229|1327615|P1|COMPLETED|Overall Study||14
543624|NCT00762229|1327614|P2|STARTED|Overall Study||24
543625|NCT00762229|1327615|P1|STARTED|Overall Study||15
543626|NCT00762216|1327623|P1|NOT COMPLETED|Overall Study||0
543627|NCT00762216|1327623|P1|COMPLETED|Overall Study||71
543628|NCT00762216|1327623|P1|STARTED|Overall Study||71
543629|NCT00762177|1327631|P3|NOT COMPLETED|3rd Treatment Period||0
543630|NCT00762177|1327632|P2|NOT COMPLETED|3rd Treatment Period||0
543631|NCT00762177|1327633|P1|NOT COMPLETED|3rd Treatment Period||0
543632|NCT00762177|1327631|P3|COMPLETED|3rd Treatment Period||8
543633|NCT00762177|1327632|P2|COMPLETED|3rd Treatment Period||8
543634|NCT00762177|1327633|P1|COMPLETED|3rd Treatment Period||8
543635|NCT00762177|1327631|P3|STARTED|3rd Treatment Period||8
543636|NCT00762177|1327632|P2|STARTED|3rd Treatment Period||8
543637|NCT00762177|1327633|P1|STARTED|3rd Treatment Period||8
543638|NCT00762177|1327631|P3|NOT COMPLETED|Washout After 2nd Treatment||0
543639|NCT00762177|1327632|P2|NOT COMPLETED|Washout After 2nd Treatment||0
543640|NCT00762177|1327633|P1|NOT COMPLETED|Washout After 2nd Treatment||0
543641|NCT00762177|1327631|P3|COMPLETED|Washout After 2nd Treatment||8
543642|NCT00762177|1327632|P2|COMPLETED|Washout After 2nd Treatment||8
543643|NCT00762177|1327633|P1|COMPLETED|Washout After 2nd Treatment||8
543644|NCT00762177|1327631|P3|STARTED|Washout After 2nd Treatment||8
543645|NCT00762177|1327632|P2|STARTED|Washout After 2nd Treatment||8
543646|NCT00762177|1327633|P1|STARTED|Washout After 2nd Treatment||8
543647|NCT00762177|1327631|P3|NOT COMPLETED|2nd Treatment Period||0
543648|NCT00762177|1327632|P2|NOT COMPLETED|2nd Treatment Period||0
543649|NCT00762177|1327633|P1|NOT COMPLETED|2nd Treatment Period||0
543650|NCT00762177|1327631|P3|COMPLETED|2nd Treatment Period||8
543651|NCT00762177|1327632|P2|COMPLETED|2nd Treatment Period||8
543652|NCT00762177|1327633|P1|COMPLETED|2nd Treatment Period||8
543653|NCT00762177|1327631|P3|STARTED|2nd Treatment Period||8
543654|NCT00762177|1327632|P2|STARTED|2nd Treatment Period||8
543655|NCT00762177|1327633|P1|STARTED|2nd Treatment Period||8
543656|NCT00762177|1327631|P3|NOT COMPLETED|Washout After 1st Treatment||0
543657|NCT00762177|1327632|P2|NOT COMPLETED|Washout After 1st Treatment||0
543658|NCT00762177|1327633|P1|NOT COMPLETED|Washout After 1st Treatment||0
543659|NCT00762177|1327631|P3|COMPLETED|Washout After 1st Treatment||8
543660|NCT00762177|1327632|P2|COMPLETED|Washout After 1st Treatment||8
543661|NCT00762177|1327633|P1|COMPLETED|Washout After 1st Treatment||8
543662|NCT00762177|1327631|P3|STARTED|Washout After 1st Treatment||8
543663|NCT00762177|1327632|P2|STARTED|Washout After 1st Treatment||8
543664|NCT00762177|1327633|P1|STARTED|Washout After 1st Treatment||8
543665|NCT00762177|1327631|P3|NOT COMPLETED|1st Treatment Period||0
543666|NCT00762177|1327632|P2|NOT COMPLETED|1st Treatment Period||0
543667|NCT00762177|1327633|P1|NOT COMPLETED|1st Treatment Period||0
543668|NCT00762177|1327631|P3|COMPLETED|1st Treatment Period||8
543669|NCT00762177|1327632|P2|COMPLETED|1st Treatment Period||8
543670|NCT00762177|1327633|P1|COMPLETED|1st Treatment Period||8
543671|NCT00762177|1327631|P3|STARTED|1st Treatment Period||8
543672|NCT00762177|1327632|P2|STARTED|1st Treatment Period||8
543673|NCT00762177|1327633|P1|STARTED|1st Treatment Period||8
543674|NCT00762164|1327712|P2|NOT COMPLETED|Overall Study||2
543675|NCT00762164|1327713|P1|NOT COMPLETED|Overall Study||3
543676|NCT00762164|1327712|P2|COMPLETED|Overall Study||15
543677|NCT00762164|1327713|P1|COMPLETED|Overall Study||14
543678|NCT00762164|1327712|P2|STARTED|Overall Study||17
543679|NCT00762164|1327713|P1|STARTED|Overall Study||17
543680|NCT00762086|1327723|P2|NOT COMPLETED|Overall Study||4
543681|NCT00762086|1327724|P1|NOT COMPLETED|Overall Study||6
543682|NCT00762086|1327723|P2|COMPLETED|Overall Study||24
543683|NCT00762086|1327724|P1|COMPLETED|Overall Study||33
543684|NCT00762086|1327723|P2|STARTED|Overall Study||28
543685|NCT00762086|1327724|P1|STARTED|Overall Study||39
543686|NCT00762073|1327734|P4|NOT COMPLETED|Overall Study||3
543687|NCT00762073|1327735|P3|NOT COMPLETED|Overall Study||2
543688|NCT00762073|1327736|P2|NOT COMPLETED|Overall Study||4
543689|NCT00762073|1327737|P1|NOT COMPLETED|Overall Study||4
543690|NCT00762073|1327734|P4|COMPLETED|Overall Study||17
543691|NCT00762073|1327735|P3|COMPLETED|Overall Study|One participant was enrolled and randomized then withdrew consent and did not receive study drug.|18
543692|NCT00762073|1327736|P2|COMPLETED|Overall Study||17
543693|NCT00762073|1327737|P1|COMPLETED|Overall Study||17
543694|NCT00762073|1327734|P4|STARTED|Overall Study||20
543695|NCT00762073|1327735|P3|STARTED|Overall Study||20
543696|NCT00762073|1327736|P2|STARTED|Overall Study||21
543697|NCT00762073|1327737|P1|STARTED|Overall Study||21
543698|NCT00762034|1327801|P2|NOT COMPLETED|Maintenance Period||298
543699|NCT00762034|1327802|P1|NOT COMPLETED|Maintenance Period||294
543700|NCT00762034|1327801|P2|COMPLETED|Maintenance Period||0
543701|NCT00762034|1327802|P1|COMPLETED|Maintenance Period||0
543702|NCT00762034|1327801|P2|Received at Least 1 Dose of Study Drug|Maintenance Period||298
543703|NCT00762034|1327802|P1|Received at Least 1 Dose of Study Drug|Maintenance Period||294
543704|NCT00762034|1327801|P2|STARTED|Maintenance Period||298
543705|NCT00762034|1327802|P1|STARTED|Maintenance Period||294
543706|NCT00762034|1327801|P2|NOT COMPLETED|Induction Period||169
543707|NCT00762034|1327802|P1|NOT COMPLETED|Induction Period||178
543708|NCT00762034|1327801|P2|COMPLETED|Induction Period||298
543709|NCT00762034|1327802|P1|COMPLETED|Induction Period||294
543710|NCT00762034|1327801|P2|Received at Least 1 Dose of Study Drug|Induction Period||443
543711|NCT00762034|1327802|P1|Received at Least 1 Dose of Study Drug|Induction Period||442
543712|NCT00762034|1327801|P2|STARTED|Induction Period||467
543713|NCT00762034|1327802|P1|STARTED|Induction Period||472
543714|NCT00762021|1327861|P2|NOT COMPLETED|Overall Study||8
543715|NCT00762021|1327862|P1|NOT COMPLETED|Overall Study||8
543716|NCT00762021|1327861|P2|COMPLETED|Overall Study||44
543717|NCT00762021|1327862|P1|COMPLETED|Overall Study||44
543718|NCT00762021|1327861|P2|STARTED|Overall Study||52
543719|NCT00762021|1327862|P1|STARTED|Overall Study||52
543720|NCT00761969|1327874|P2|NOT COMPLETED|Overall Study||140
543721|NCT00761969|1327875|P1|NOT COMPLETED|Overall Study||200
543722|NCT00761969|1327874|P2|COMPLETED|Overall Study||573
543723|NCT00761969|1327875|P1|COMPLETED|Overall Study||542
543724|NCT00761969|1327874|P2|STARTED|Overall Study||713
543725|NCT00761969|1327875|P1|STARTED|Overall Study||742
543726|NCT00761956|1327885|P2|NOT COMPLETED|Overall Study||54
543727|NCT00761956|1327886|P1|NOT COMPLETED|Overall Study||35
543728|NCT00761956|1327885|P2|COMPLETED|Overall Study||48
543729|NCT00761956|1327886|P1|COMPLETED|Overall Study||52
543730|NCT00761956|1327885|P2|STARTED|Overall Study||102
543731|NCT00761956|1327886|P1|STARTED|Overall Study||87
543732|NCT00761930|1327897|P3|NOT COMPLETED|Overall Study||0
543733|NCT00761930|1327898|P2|NOT COMPLETED|Overall Study||0
543734|NCT00761930|1327899|P1|NOT COMPLETED|Overall Study||0
543735|NCT00761930|1327897|P3|COMPLETED|Overall Study||35
543736|NCT00761930|1327898|P2|COMPLETED|Overall Study||34
543737|NCT00761930|1327899|P1|COMPLETED|Overall Study||34
543738|NCT00761930|1327897|P3|STARTED|Overall Study||35
543739|NCT00761930|1327898|P2|STARTED|Overall Study||34
543740|NCT00761930|1327899|P1|STARTED|Overall Study||34
543741|NCT00761865|1327915|P2|NOT COMPLETED|Overall Study||7
543742|NCT00761865|1327916|P1|NOT COMPLETED|Overall Study||8
543743|NCT00761865|1327915|P2|COMPLETED|Overall Study||11
543744|NCT00761865|1327916|P1|COMPLETED|Overall Study||8
543745|NCT00761865|1327915|P2|STARTED|Overall Study||18
543746|NCT00761865|1327916|P1|STARTED|Overall Study||16
543747|NCT00761813|1327926|P2|NOT COMPLETED|Overall Study||14
543748|NCT00761813|1327927|P1|NOT COMPLETED|Overall Study||15
543749|NCT00761813|1327926|P2|COMPLETED|Overall Study||537
543750|NCT00761813|1327927|P1|COMPLETED|Overall Study||542
543751|NCT00761813|1327926|P2|STARTED|Overall Study||551
543752|NCT00761813|1327927|P1|STARTED|Overall Study||557
543753|NCT00761774|1327937|P1|NOT COMPLETED|Overall Study||79
543754|NCT00761774|1327937|P1|COMPLETED|Overall Study||29
543755|NCT00761774|1327937|P1|STARTED|Overall Study||108
543756|NCT00761761|1327948|P2|NOT COMPLETED|Overall Study||1
543757|NCT00761761|1327949|P1|NOT COMPLETED|Overall Study||6
543758|NCT00761761|1327948|P2|COMPLETED|Overall Study||29
543759|NCT00761761|1327949|P1|COMPLETED|Overall Study||24
543760|NCT00761761|1327948|P2|STARTED|Overall Study||30
543761|NCT00761761|1327949|P1|STARTED|Overall Study||30
543762|NCT00761748|1327961|P2|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0
543763|NCT00761748|1327962|P1|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0
543764|NCT00761748|1327961|P2|COMPLETED|Second Intervention (21 +/- 3 Days)||7
543765|NCT00761748|1327962|P1|COMPLETED|Second Intervention (21 +/- 3 Days)||17
543766|NCT00761748|1327961|P2|STARTED|Second Intervention (21 +/- 3 Days)||7
543767|NCT00761748|1327962|P1|STARTED|Second Intervention (21 +/- 3 Days)||17
543768|NCT00761748|1327961|P2|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3
543769|NCT00761748|1327962|P1|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3
543770|NCT00761748|1327961|P2|COMPLETED|First Intervention (21 +/- 3 Days)||7
543771|NCT00761748|1327962|P1|COMPLETED|First Intervention (21 +/- 3 Days)||17
543772|NCT00761748|1327961|P2|STARTED|First Intervention (21 +/- 3 Days)||10
543773|NCT00761748|1327962|P1|STARTED|First Intervention (21 +/- 3 Days)||20
543774|NCT00761735|1327968|P1|NOT COMPLETED|Overall Study||14
543775|NCT00761735|1327968|P1|COMPLETED|Overall Study||80
543776|NCT00761735|1327968|P1|STARTED|Overall Study||94
543777|NCT00761631|1327984|P6|NOT COMPLETED|Overall Study||5
543778|NCT00761631|1327985|P5|NOT COMPLETED|Overall Study||22
543779|NCT00761631|1327986|P4|NOT COMPLETED|Overall Study||3
543780|NCT00761631|1327987|P3|NOT COMPLETED|Overall Study||16
543781|NCT00761631|1327988|P2|NOT COMPLETED|Overall Study||7
543782|NCT00761631|1327989|P1|NOT COMPLETED|Overall Study||15
543783|NCT00761631|1327984|P6|COMPLETED|Overall Study||294
543784|NCT00761631|1327985|P5|COMPLETED|Overall Study||277
543785|NCT00761631|1327986|P4|COMPLETED|Overall Study||116
543786|NCT00761631|1327987|P3|COMPLETED|Overall Study||160
543787|NCT00761631|1327988|P2|COMPLETED|Overall Study||174
543788|NCT00761631|1327989|P1|COMPLETED|Overall Study||111
543789|NCT00761631|1327984|P6|Vaccinated Dose 2|Overall Study||0
543790|NCT00761631|1327985|P5|Vaccinated Dose 2|Overall Study||0
543791|NCT00761631|1327986|P4|Vaccinated Dose 2|Overall Study||0
543792|NCT00761631|1327987|P3|Vaccinated Dose 2|Overall Study||165
543793|NCT00761631|1327988|P2|Vaccinated Dose 2|Overall Study||0
543794|NCT00761631|1327989|P1|Vaccinated Dose 2|Overall Study||112
543795|NCT00761631|1327984|P6|Vaccinated Dose 1|Overall Study||298
543796|NCT00761631|1327985|P5|Vaccinated Dose 1|Overall Study||294
543797|NCT00761631|1327986|P4|Vaccinated Dose 1|Overall Study||118
543798|NCT00761631|1327987|P3|Vaccinated Dose 1|Overall Study||175
543799|NCT00761631|1327988|P2|Vaccinated Dose 1|Overall Study||179
543800|NCT00761631|1327989|P1|Vaccinated Dose 1|Overall Study||124
543801|NCT00761631|1327984|P6|STARTED|Overall Study||299
543802|NCT00761631|1327985|P5|STARTED|Overall Study||299
543803|NCT00761631|1327986|P4|STARTED|Overall Study||119
543804|NCT00761631|1327987|P3|STARTED|Overall Study||176
543805|NCT00761631|1327988|P2|STARTED|Overall Study||181
543806|NCT00761631|1327989|P1|STARTED|Overall Study||126
543807|NCT00761605|1328024|P1|NOT COMPLETED|Overall Study||141
543808|NCT00761605|1328024|P1|COMPLETED|Overall Study||246
543809|NCT00761605|1328024|P1|STARTED|Overall Study||387
543810|NCT00761592|1328053|P2|NOT COMPLETED|Overall Study||1
543811|NCT00761592|1328054|P1|NOT COMPLETED|Overall Study||1
543812|NCT00761592|1328053|P2|COMPLETED|Overall Study||32
543813|NCT00761592|1328054|P1|COMPLETED|Overall Study||31
543814|NCT00761592|1328053|P2|STARTED|Overall Study||33
543815|NCT00761592|1328054|P1|STARTED|Overall Study||32
543816|NCT00761579|1328068|P1|NOT COMPLETED|Overall Study||92
543817|NCT00761579|1328068|P1|COMPLETED|Overall Study||98
543818|NCT00761579|1328068|P1|STARTED|Overall Study||190
543819|NCT00761527|1328101|P1|NOT COMPLETED|Overall Study||22
543820|NCT00761527|1328101|P1|COMPLETED|Overall Study||2958
543821|NCT00761527|1328101|P1|Received One Dose of Study Medication|Overall Study||2978
543822|NCT00761527|1328101|P1|STARTED|Overall Study||2980
543823|NCT00761514|1328108|P1|NOT COMPLETED|Overall Study||7
543824|NCT00761514|1328108|P1|COMPLETED|Overall Study||7
543825|NCT00761514|1328108|P1|STARTED|Overall Study||14
543826|NCT00761462|1328115|P2|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||51
543827|NCT00761462|1328116|P1|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||154
543828|NCT00761462|1328115|P2|COMPLETED|2 or 5 Years Long-term Safety Follow-up|Patients under safety evaluation at end of 2 year safety Follow-up.|456
543829|NCT00761462|1328116|P1|COMPLETED|2 or 5 Years Long-term Safety Follow-up|Patients under safety evaluation at end of 5 year safety Follow-up.|333
543830|NCT00761462|1328115|P2|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||507
543831|NCT00761462|1328116|P1|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||485
543832|NCT00761462|1328115|P2|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||507
543833|NCT00761462|1328116|P1|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||487
543834|NCT00761462|1328115|P2|STARTED|2 or 5 Years Long-term Safety Follow-up|Patients with confirmed intake of study drug entering long-term safety evaluation|507
543835|NCT00761462|1328116|P1|STARTED|2 or 5 Years Long-term Safety Follow-up|Patients with confirmed intake of study drug entering long-term safety evaluation|487
543836|NCT00761462|1328115|P2|NOT COMPLETED|Treatment||12
543837|NCT00761462|1328116|P1|NOT COMPLETED|Treatment||23
543838|NCT00761462|1328115|P2|COMPLETED|Treatment|Patients with confirmed intake of study drug|507
543839|NCT00761462|1328116|P1|COMPLETED|Treatment|Patients with confirmed intake of study drug|487
543840|NCT00761462|1328115|P2|STARTED|Treatment|Patients enrolled in study group|519
543841|NCT00761462|1328116|P1|STARTED|Treatment|Patients enrolled in study group|510
543842|NCT00761345|1328124|P1|NOT COMPLETED|Overall Study||3
543843|NCT00761345|1328124|P1|COMPLETED|Overall Study||24
543844|NCT00761345|1328124|P1|STARTED|Overall Study||27
543845|NCT00761319|1328130|P2|NOT COMPLETED|Overall Study||34
543846|NCT00761319|1328131|P1|NOT COMPLETED|Overall Study||48
543847|NCT00761319|1328130|P2|COMPLETED|Overall Study||318
543848|NCT00761319|1328131|P1|COMPLETED|Overall Study||305
543849|NCT00761319|1328130|P2|STARTED|Overall Study||352
543850|NCT00761319|1328131|P1|STARTED|Overall Study||353
543851|NCT00761306|1328139|P1|NOT COMPLETED|Overall Study||20
543852|NCT00761306|1328139|P1|COMPLETED|Overall Study||54
543853|NCT00761306|1328139|P1|STARTED|Overall Study||74
543854|NCT00761280|1328150|P2|NOT COMPLETED|First Dose to End of Study||11
543855|NCT00761280|1328151|P1|NOT COMPLETED|First Dose to End of Study||12
543856|NCT00761280|1328150|P2|COMPLETED|First Dose to End of Study|Study was discontinued early due to the inability to recruit a sufficient number of participants.|0
543857|NCT00761280|1328151|P1|COMPLETED|First Dose to End of Study|Study was discontinued early due to the inability to recruit a sufficient number of participants.|0
543858|NCT00761280|1328150|P2|STARTED|First Dose to End of Study||11
543859|NCT00761280|1328151|P1|STARTED|First Dose to End of Study||12
543860|NCT00761280|1328150|P2|NOT COMPLETED|Randomization to First Dose||2
543861|NCT00761280|1328151|P1|NOT COMPLETED|Randomization to First Dose||2
543862|NCT00761280|1328150|P2|COMPLETED|Randomization to First Dose||11
543863|NCT00761280|1328151|P1|COMPLETED|Randomization to First Dose||12
543864|NCT00761280|1328150|P2|First Dose of Study Drug / Chemotherapy|Randomization to First Dose|Safety population|11
543865|NCT00761280|1328151|P1|First Dose of Study Drug / Chemotherapy|Randomization to First Dose||12
543866|NCT00761280|1328150|P2|Catheter Surgery|Randomization to First Dose|Not applicable to control group|0
543867|NCT00761280|1328151|P1|Catheter Surgery|Randomization to First Dose|Safety population|13
543868|NCT00761280|1328150|P2|STARTED|Randomization to First Dose||13
543869|NCT00761280|1328151|P1|STARTED|Randomization to First Dose||14
543870|NCT00761215|1328182|P3|NOT COMPLETED|Overall Study||8
543871|NCT00761215|1328183|P2|NOT COMPLETED|Overall Study||4
543872|NCT00761215|1328184|P1|NOT COMPLETED|Overall Study||9
543873|NCT00761215|1328182|P3|COMPLETED|Overall Study||56
543874|NCT00761215|1328183|P2|COMPLETED|Overall Study||60
543875|NCT00761215|1328184|P1|COMPLETED|Overall Study||55
543876|NCT00761215|1328182|P3|STARTED|Overall Study||64
543877|NCT00761215|1328183|P2|STARTED|Overall Study||64
543878|NCT00761215|1328184|P1|STARTED|Overall Study||64
543879|NCT00761202|1328209|P2|NOT COMPLETED|Overall Study||2
543880|NCT00761202|1328210|P1|NOT COMPLETED|Overall Study||1
543881|NCT00761202|1328209|P2|COMPLETED|Overall Study||26
543882|NCT00761202|1328210|P1|COMPLETED|Overall Study||21
543883|NCT00761202|1328209|P2|STARTED|Overall Study||28
543884|NCT00761202|1328210|P1|STARTED|Overall Study||22
543885|NCT00761189|1328226|P1|NOT COMPLETED|Overall Study||185
543886|NCT00761189|1328226|P1|COMPLETED|Overall Study||306
543887|NCT00761189|1328226|P1|STARTED|Overall Study||491
543888|NCT00761176|1328243|P2|NOT COMPLETED|Overall Study||1
543889|NCT00761176|1328244|P1|NOT COMPLETED|Overall Study||2
543890|NCT00761176|1328243|P2|COMPLETED|Overall Study||3
543891|NCT00761176|1328244|P1|COMPLETED|Overall Study||2
543892|NCT00761176|1328243|P2|STARTED|Overall Study||4
543893|NCT00761176|1328244|P1|STARTED|Overall Study||4
543894|NCT00761150|1328253|P3|NOT COMPLETED|Double-blind Period||29
543895|NCT00761150|1328254|P2|NOT COMPLETED|Double-blind Period||14
543896|NCT00761150|1328255|P1|NOT COMPLETED|Double-blind Period||0
543897|NCT00761150|1328253|P3|COMPLETED|Double-blind Period||89
543898|NCT00761150|1328254|P2|COMPLETED|Double-blind Period||106
543899|NCT00761150|1328255|P1|COMPLETED|Double-blind Period||0
543900|NCT00761150|1328253|P3|STARTED|Double-blind Period||118
543901|NCT00761150|1328254|P2|STARTED|Double-blind Period||120
543902|NCT00761150|1328255|P1|STARTED|Double-blind Period||0
543903|NCT00761150|1328253|P3|NOT COMPLETED|Open-label Period||0
543904|NCT00761150|1328254|P2|NOT COMPLETED|Open-label Period||0
543905|NCT00761150|1328255|P1|NOT COMPLETED|Open-label Period||70
543906|NCT00761150|1328253|P3|COMPLETED|Open-label Period||0
543907|NCT00761150|1328254|P2|COMPLETED|Open-label Period||0
543908|NCT00761150|1328255|P1|COMPLETED|Open-label Period||238
543909|NCT00761150|1328253|P3|STARTED|Open-label Period||0
543910|NCT00761150|1328254|P2|STARTED|Open-label Period||0
543911|NCT00761150|1328255|P1|STARTED|Open-label Period||308
543912|NCT00761137|1328264|P1|NOT COMPLETED|Overall Study||0
543913|NCT00761137|1328264|P1|COMPLETED|Overall Study||19
543914|NCT00761137|1328264|P1|3 mg Tropicamide|Overall Study||19
543915|NCT00761137|1328264|P1|1 mg Tropicamide|Overall Study||19
543916|NCT00761137|1328264|P1|0.3 mg Tropicamide|Overall Study||19
543917|NCT00761137|1328264|P1|Placebo|Overall Study||19
543918|NCT00761137|1328264|P1|STARTED|Overall Study||19
543919|NCT00761007|1328279|P4|NOT COMPLETED|Overall Study||7
543920|NCT00761007|1328280|P3|NOT COMPLETED|Overall Study||18
543921|NCT00761007|1328281|P2|NOT COMPLETED|Overall Study||11
543922|NCT00761007|1328282|P1|NOT COMPLETED|Overall Study||13
543923|NCT00761007|1328279|P4|COMPLETED|Overall Study||131
543924|NCT00761007|1328280|P3|COMPLETED|Overall Study||121
543925|NCT00761007|1328281|P2|COMPLETED|Overall Study||124
543926|NCT00761007|1328282|P1|COMPLETED|Overall Study||129
543927|NCT00761007|1328279|P4|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||136
543928|NCT00761007|1328280|P3|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||135
543929|NCT00761007|1328281|P2|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||133
543930|NCT00761007|1328282|P1|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||140
543931|NCT00761007|1328279|P4|Safety (>=1 Dose of Study Medication)|Overall Study||137
543932|NCT00761007|1328280|P3|Safety (>=1 Dose of Study Medication)|Overall Study||139
543933|NCT00761007|1328281|P2|Safety (>=1 Dose of Study Medication)|Overall Study||135
543934|NCT00761007|1328282|P1|Safety (>=1 Dose of Study Medication)|Overall Study||140
543935|NCT00761007|1328279|P4|STARTED|Overall Study||138
543936|NCT00761007|1328280|P3|STARTED|Overall Study||139
543937|NCT00761007|1328281|P2|STARTED|Overall Study||135
543938|NCT00761007|1328282|P1|STARTED|Overall Study||142
543939|NCT00760877|1328306|P2|NOT COMPLETED|Overall Study||26
543940|NCT00760877|1328307|P1|NOT COMPLETED|Overall Study||45
543941|NCT00760877|1328306|P2|COMPLETED|Overall Study||77
543942|NCT00760877|1328307|P1|COMPLETED|Overall Study||59
543943|NCT00760877|1328306|P2|Safety Set|Overall Study||103
543944|NCT00760877|1328307|P1|Safety Set|Overall Study||101
543945|NCT00760877|1328306|P2|Cross-over to Nilotinib|Overall Study||46
543946|NCT00760877|1328307|P1|Cross-over to Nilotinib|Overall Study|Not applicable: cross-over occurred from imatinib to nilotinib only.|0
543947|NCT00760877|1328306|P2|STARTED|Overall Study||103
543948|NCT00760877|1328307|P1|STARTED|Overall Study||104
543949|NCT00760838|1328325|P2|NOT COMPLETED|Overall Study||2
543950|NCT00760838|1328326|P1|NOT COMPLETED|Overall Study||5
543951|NCT00760838|1328325|P2|COMPLETED|Overall Study||53
543952|NCT00760838|1328326|P1|COMPLETED|Overall Study||49
543953|NCT00760838|1328325|P2|STARTED|Overall Study||55
543954|NCT00760838|1328326|P1|STARTED|Overall Study||54
543955|NCT00760747|1328344|P2|NOT COMPLETED|Study Period III||3
543956|NCT00760747|1328345|P1|NOT COMPLETED|Study Period III||3
543957|NCT00760747|1328344|P2|COMPLETED|Study Period III||38
543958|NCT00760747|1328345|P1|COMPLETED|Study Period III||41
543959|NCT00760747|1328344|P2|STARTED|Study Period III||41
543960|NCT00760747|1328345|P1|STARTED|Study Period III||44
543961|NCT00760747|1328344|P2|NOT COMPLETED|Study Period II||14
543962|NCT00760747|1328345|P1|NOT COMPLETED|Study Period II||13
543963|NCT00760747|1328344|P2|COMPLETED|Study Period II||41
543964|NCT00760747|1328345|P1|COMPLETED|Study Period II||44
543965|NCT00760747|1328344|P2|Received at Least One Dose of Study Drug|Study Period II||54
543966|NCT00760747|1328345|P1|Received at Least One Dose of Study Drug|Study Period II||57
543967|NCT00760747|1328344|P2|STARTED|Study Period II||55
543968|NCT00760747|1328345|P1|STARTED|Study Period II||57
543969|NCT00760669|1328373|P1|NOT COMPLETED|Overall Study||30
543970|NCT00760669|1328373|P1|COMPLETED|Overall Study||1031
543971|NCT00760669|1328373|P1|STARTED|Overall Study||1061
543972|NCT00760617|1328390|P3|NOT COMPLETED|Overall Study||5
543973|NCT00760617|1328391|P2|NOT COMPLETED|Overall Study||2
543974|NCT00760617|1328392|P1|NOT COMPLETED|Overall Study||5
543975|NCT00760617|1328390|P3|COMPLETED|Overall Study||111
543976|NCT00760617|1328391|P2|COMPLETED|Overall Study||142
543977|NCT00760617|1328392|P1|COMPLETED|Overall Study||261
543978|NCT00760617|1328390|P3|STARTED|Overall Study||116
543979|NCT00760617|1328391|P2|STARTED|Overall Study||144
543980|NCT00760617|1328392|P1|STARTED|Overall Study||266
543981|NCT00760578|1328467|P4|NOT COMPLETED|Overall Study||4
543982|NCT00760578|1328468|P3|NOT COMPLETED|Overall Study||5
543983|NCT00760578|1328469|P2|NOT COMPLETED|Overall Study||2
543984|NCT00760578|1328470|P1|NOT COMPLETED|Overall Study||3
543985|NCT00760578|1328467|P4|COMPLETED|Overall Study||18
543986|NCT00760578|1328468|P3|COMPLETED|Overall Study||16
543987|NCT00760578|1328469|P2|COMPLETED|Overall Study||19
543988|NCT00760578|1328470|P1|COMPLETED|Overall Study||19
543989|NCT00760578|1328467|P4|Entered Drug Treatment Period|Overall Study||22
543990|NCT00760578|1328468|P3|Entered Drug Treatment Period|Overall Study||19
543991|NCT00760578|1328469|P2|Entered Drug Treatment Period|Overall Study||20
543992|NCT00760578|1328470|P1|Entered Drug Treatment Period|Overall Study||21
543993|NCT00760578|1328467|P4|STARTED|Overall Study||22
543994|NCT00760578|1328468|P3|STARTED|Overall Study||21
543995|NCT00760578|1328469|P2|STARTED|Overall Study||21
543996|NCT00760578|1328470|P1|STARTED|Overall Study||22
543997|NCT00760552|1328506|P2|NOT COMPLETED|Overall Study||10
543998|NCT00760552|1328507|P1|NOT COMPLETED|Overall Study||13
543999|NCT00760552|1328506|P2|COMPLETED|Overall Study||52
544000|NCT00760552|1328507|P1|COMPLETED|Overall Study||48
544001|NCT00760552|1328506|P2|STARTED|Overall Study||62
544002|NCT00760552|1328507|P1|STARTED|Overall Study||61
544003|NCT00760526|1328515|P2|NOT COMPLETED|Overall Study||4
544004|NCT00760526|1328516|P1|NOT COMPLETED|Overall Study||5
544005|NCT00760526|1328515|P2|COMPLETED|Overall Study||68
544006|NCT00760526|1328516|P1|COMPLETED|Overall Study||69
544007|NCT00760526|1328515|P2|STARTED|Overall Study||72
544008|NCT00760526|1328516|P1|STARTED|Overall Study||74
544009|NCT00760487|1328541|P1|NOT COMPLETED|Overall Study||3
544010|NCT00760487|1328541|P1|COMPLETED|Overall Study||117
544011|NCT00760487|1328541|P1|STARTED|Overall Study||120
544012|NCT00760474|1328547|P2|NOT COMPLETED|Period 2 (P2)||1
544013|NCT00760474|1328548|P1|NOT COMPLETED|Period 2 (P2)||1
544014|NCT00760474|1328547|P2|COMPLETED|Period 2 (P2)||11
544015|NCT00760474|1328548|P1|COMPLETED|Period 2 (P2)||11
544016|NCT00760474|1328547|P2|STARTED|Period 2 (P2)||12
544017|NCT00760474|1328548|P1|STARTED|Period 2 (P2)||12
544018|NCT00760474|1328547|P2|NOT COMPLETED|Placebo Washout Period||1
544019|NCT00760474|1328548|P1|NOT COMPLETED|Placebo Washout Period||0
544020|NCT00760474|1328547|P2|COMPLETED|Placebo Washout Period||12
544021|NCT00760474|1328548|P1|COMPLETED|Placebo Washout Period||12
544022|NCT00760474|1328547|P2|STARTED|Placebo Washout Period||13
544023|NCT00760474|1328548|P1|STARTED|Placebo Washout Period||12
544024|NCT00760474|1328547|P2|NOT COMPLETED|Period 1 (P1)||1
544025|NCT00760474|1328548|P1|NOT COMPLETED|Period 1 (P1)||1
544026|NCT00760474|1328547|P2|COMPLETED|Period 1 (P1)||13
544027|NCT00760474|1328548|P1|COMPLETED|Period 1 (P1)||12
544028|NCT00760474|1328547|P2|Overall Number of Unique Participants|Period 1 (P1)||13
544029|NCT00760474|1328548|P1|Overall Number of Unique Participants|Period 1 (P1)||12
544030|NCT00760474|1328547|P2|Treated|Period 1 (P1)|1 participant discontinued in P1; re-entered with new identification number and completed P1, P2.|14
544031|NCT00760474|1328548|P1|Treated|Period 1 (P1)|1 participant discontinued in P1; re-entered with new identification number and completed P1, P2.|13
544032|NCT00760474|1328547|P2|STARTED|Period 1 (P1)||14
544033|NCT00760474|1328548|P1|STARTED|Period 1 (P1)||13
544034|NCT00760461|1328584|P1|NOT COMPLETED|Overall Study||44
544035|NCT00760461|1328584|P1|COMPLETED|Overall Study||0
544036|NCT00760461|1328584|P1|STARTED|Overall Study||44
544037|NCT00760435|1328590|P2|NOT COMPLETED|Overall Study||5
544038|NCT00760435|1328591|P1|NOT COMPLETED|Overall Study||4
544039|NCT00760435|1328590|P2|COMPLETED|Overall Study||93
544040|NCT00760435|1328591|P1|COMPLETED|Overall Study||94
544041|NCT00760435|1328590|P2|STARTED|Overall Study||98
544042|NCT00760435|1328591|P1|STARTED|Overall Study||98
544043|NCT00760383|1328605|P2|NOT COMPLETED|Overall Study||7
544044|NCT00760383|1328606|P1|NOT COMPLETED|Overall Study||5
544045|NCT00760383|1328605|P2|COMPLETED|Overall Study||12
544046|NCT00760383|1328606|P1|COMPLETED|Overall Study||16
544047|NCT00760383|1328605|P2|STARTED|Overall Study||19
544048|NCT00760383|1328606|P1|STARTED|Overall Study||21
544049|NCT00760266|1328618|P2|NOT COMPLETED|Overall Study||18
544050|NCT00760266|1328619|P1|NOT COMPLETED|Overall Study||24
544051|NCT00760266|1328618|P2|COMPLETED|Overall Study||205
544052|NCT00760266|1328619|P1|COMPLETED|Overall Study||204
544053|NCT00760266|1328618|P2|STARTED|Overall Study||223
544054|NCT00760266|1328619|P1|STARTED|Overall Study||228
544055|NCT00760214|1328636|P3|NOT COMPLETED|Overall Study||41
544056|NCT00760214|1328637|P2|NOT COMPLETED|Overall Study||30
544057|NCT00760214|1328638|P1|NOT COMPLETED|Overall Study||30
544058|NCT00760214|1328636|P3|COMPLETED|Overall Study||255
544059|NCT00760214|1328637|P2|COMPLETED|Overall Study||264
544060|NCT00760214|1328638|P1|COMPLETED|Overall Study||265
544061|NCT00760214|1328636|P3|STARTED|Overall Study||296
544062|NCT00760214|1328637|P2|STARTED|Overall Study||294
544063|NCT00760214|1328638|P1|STARTED|Overall Study||295
544064|NCT00760084|1328679|P1|NOT COMPLETED|Overall Study||10
544065|NCT00760084|1328679|P1|COMPLETED|Overall Study||0
544066|NCT00760084|1328679|P1|STARTED|Overall Study||10
544067|NCT00760019|1328685|P4|NOT COMPLETED|Overall Study||0
544068|NCT00760019|1328686|P3|NOT COMPLETED|Overall Study||0
544069|NCT00760019|1328687|P2|NOT COMPLETED|Overall Study||0
544070|NCT00760019|1328688|P1|NOT COMPLETED|Overall Study||0
544071|NCT00760019|1328685|P4|COMPLETED|Overall Study||14
544072|NCT00760019|1328686|P3|COMPLETED|Overall Study||14
544073|NCT00760019|1328687|P2|COMPLETED|Overall Study||15
544074|NCT00760019|1328688|P1|COMPLETED|Overall Study||15
544075|NCT00760019|1328685|P4|STARTED|Overall Study||14
544076|NCT00760019|1328686|P3|STARTED|Overall Study||14
544077|NCT00760019|1328687|P2|STARTED|Overall Study||15
544078|NCT00760019|1328688|P1|STARTED|Overall Study||15
544079|NCT00760006|1328696|P2|NOT COMPLETED|Overall Study||0
544080|NCT00760006|1328697|P1|NOT COMPLETED|Overall Study||0
544081|NCT00760006|1328696|P2|COMPLETED|Overall Study||138
544082|NCT00760006|1328697|P1|COMPLETED|Overall Study||86
544083|NCT00760006|1328696|P2|STARTED|Overall Study||138
544084|NCT00760006|1328697|P1|STARTED|Overall Study||86
544085|NCT00759967|1328703|P2|NOT COMPLETED|Second Intervention||0
544086|NCT00759967|1328704|P1|NOT COMPLETED|Second Intervention||2
544087|NCT00759967|1328703|P2|COMPLETED|Second Intervention||9
544088|NCT00759967|1328704|P1|COMPLETED|Second Intervention||8
544089|NCT00759967|1328703|P2|STARTED|Second Intervention||9
544090|NCT00759967|1328704|P1|STARTED|Second Intervention||10
544091|NCT00759967|1328703|P2|NOT COMPLETED|First Intervention||0
544092|NCT00759967|1328704|P1|NOT COMPLETED|First Intervention||0
544093|NCT00759967|1328703|P2|COMPLETED|First Intervention||9
544094|NCT00759967|1328704|P1|COMPLETED|First Intervention||10
544095|NCT00759967|1328703|P2|STARTED|First Intervention||9
544096|NCT00759967|1328704|P1|STARTED|First Intervention||10
544097|NCT00759954|1328722|P2|NOT COMPLETED|Overall Study||2
544098|NCT00759954|1328723|P1|NOT COMPLETED|Overall Study||2
544099|NCT00759954|1328722|P2|COMPLETED|Overall Study|Two participants (#202 and #228) did not enter Period 2.|16
544100|NCT00759954|1328723|P1|COMPLETED|Overall Study|One participant(#225) did not enter Period 2 and one participant (#203)dropped out during Period 2|16
544101|NCT00759954|1328722|P2|STARTED|Overall Study|All assigned participants entered trial|18
544102|NCT00759954|1328723|P1|STARTED|Overall Study|All assigned participants entered trial|18
544103|NCT00759941|1328737|P2|NOT COMPLETED|Overall Study||1
544104|NCT00759941|1328738|P1|NOT COMPLETED|Overall Study||3
544105|NCT00759941|1328737|P2|COMPLETED|Overall Study||43
544106|NCT00759941|1328738|P1|COMPLETED|Overall Study||39
544107|NCT00759941|1328737|P2|STARTED|Overall Study||44
544108|NCT00759941|1328738|P1|STARTED|Overall Study||42
544109|NCT00759915|1328752|P2|NOT COMPLETED|Overall Study||1
544110|NCT00759915|1328753|P1|NOT COMPLETED|Overall Study||1
544111|NCT00759915|1328752|P2|COMPLETED|Overall Study||17
544112|NCT00759915|1328753|P1|COMPLETED|Overall Study||17
544113|NCT00759915|1328752|P2|STARTED|Overall Study||18
544114|NCT00759915|1328753|P1|STARTED|Overall Study||18
544115|NCT00759902|1328767|P2|NOT COMPLETED|Overall Study||1
544116|NCT00759902|1328768|P1|NOT COMPLETED|Overall Study||0
544117|NCT00759902|1328767|P2|COMPLETED|Overall Study||17
544118|NCT00759902|1328768|P1|COMPLETED|Overall Study||18
544119|NCT00759902|1328767|P2|STARTED|Overall Study||18
544120|NCT00759902|1328768|P1|STARTED|Overall Study||18
544121|NCT00759863|1328782|P2|NOT COMPLETED|Overall Study||18
544122|NCT00759863|1328783|P1|NOT COMPLETED|Overall Study||20
544123|NCT00759863|1328782|P2|COMPLETED|Overall Study||80
544124|NCT00759863|1328783|P1|COMPLETED|Overall Study||124
544125|NCT00759863|1328782|P2|STARTED|Overall Study||98
544126|NCT00759863|1328783|P1|STARTED|Overall Study||144
544127|NCT00759811|1328795|P2|NOT COMPLETED|Overall Study||1
544128|NCT00759811|1328796|P1|NOT COMPLETED|Overall Study||2
544129|NCT00759811|1328795|P2|COMPLETED|Overall Study||24
544130|NCT00759811|1328796|P1|COMPLETED|Overall Study||23
544131|NCT00759811|1328795|P2|STARTED|Overall Study||25
544132|NCT00759811|1328796|P1|STARTED|Overall Study||25
544133|NCT00759785|1328804|P2|NOT COMPLETED|Overall Study||5
544134|NCT00759785|1328805|P1|NOT COMPLETED|Overall Study||12
544135|NCT00759785|1328804|P2|COMPLETED|Overall Study||17
544136|NCT00759785|1328805|P1|COMPLETED|Overall Study||14
544137|NCT00759785|1328804|P2|Treated|Overall Study||20
544138|NCT00759785|1328805|P1|Treated|Overall Study||25
544139|NCT00759785|1328804|P2|STARTED|Overall Study||22
544140|NCT00759785|1328805|P1|STARTED|Overall Study||26
544141|NCT00759772|1328819|P2|NOT COMPLETED|Overall Study||0
544142|NCT00759772|1328820|P1|NOT COMPLETED|Overall Study||0
544143|NCT00759772|1328819|P2|COMPLETED|Overall Study||11
544144|NCT00759772|1328820|P1|COMPLETED|Overall Study||12
544145|NCT00759772|1328819|P2|STARTED|Overall Study||11
544146|NCT00759772|1328820|P1|STARTED|Overall Study||12
544147|NCT00759759|1328828|P2|NOT COMPLETED|Overall Study||1
544148|NCT00759759|1328829|P1|NOT COMPLETED|Overall Study||4
544149|NCT00759759|1328828|P2|COMPLETED|Overall Study||17
544150|NCT00759759|1328829|P1|COMPLETED|Overall Study||14
544151|NCT00759759|1328828|P2|STARTED|Overall Study||18
544152|NCT00759759|1328829|P1|STARTED|Overall Study||18
544153|NCT00759707|1328841|P1|NOT COMPLETED|Overall Study||0
544154|NCT00759707|1328841|P1|COMPLETED|Overall Study||19
544155|NCT00759707|1328841|P1|STARTED|Overall Study||19
544156|NCT00759681|1328847|P2|NOT COMPLETED|Overall Study||10
544157|NCT00759681|1328848|P1|NOT COMPLETED|Overall Study||10
544158|NCT00759681|1328847|P2|COMPLETED|Overall Study||100
544159|NCT00759681|1328848|P1|COMPLETED|Overall Study||97
544160|NCT00759681|1328847|P2|STARTED|Overall Study||110
544161|NCT00759681|1328848|P1|STARTED|Overall Study||107
544162|NCT00759668|1328858|P2|NOT COMPLETED|Overall Study||3
544163|NCT00759668|1328859|P1|NOT COMPLETED|Overall Study||1
544164|NCT00759668|1328858|P2|COMPLETED|Overall Study||15
544165|NCT00759668|1328859|P1|COMPLETED|Overall Study||16
544166|NCT00759668|1328858|P2|STARTED|Overall Study||18
544167|NCT00759668|1328859|P1|STARTED|Overall Study||17
544168|NCT00759655|1328875|P1|NOT COMPLETED|Overall Study||1
544169|NCT00759655|1328875|P1|COMPLETED|Overall Study||0
544170|NCT00759655|1328875|P1|STARTED|Overall Study||1
544171|NCT00759642|1328886|P1|NOT COMPLETED|Overall Study||0
544172|NCT00759642|1328886|P1|COMPLETED|Overall Study||33
544173|NCT00759642|1328886|P1|STARTED|Overall Study||33
544174|NCT00759603|1328890|P1|NOT COMPLETED|Overall Study||0
544175|NCT00759603|1328890|P1|COMPLETED|Overall Study||59
544176|NCT00759603|1328890|P1|STARTED|Overall Study||59
544177|NCT00759577|1328894|P1|NOT COMPLETED|Overall Study||0
544178|NCT00759577|1328894|P1|COMPLETED|Overall Study||36
544179|NCT00759577|1328894|P1|STARTED|Overall Study||36
544180|NCT00759564|1328903|P5|NOT COMPLETED|Second Intervention Period (4 Days)||0
544181|NCT00759564|1328904|P4|NOT COMPLETED|Second Intervention Period (4 Days)||0
544182|NCT00759564|1328905|P3|NOT COMPLETED|Second Intervention Period (4 Days)||0
544183|NCT00759564|1328906|P2|NOT COMPLETED|Second Intervention Period (4 Days)||0
544184|NCT00759564|1328907|P1|NOT COMPLETED|Second Intervention Period (4 Days)||0
544185|NCT00759564|1328903|P5|COMPLETED|Second Intervention Period (4 Days)||3
544186|NCT00759564|1328904|P4|COMPLETED|Second Intervention Period (4 Days)||1
544187|NCT00759564|1328905|P3|COMPLETED|Second Intervention Period (4 Days)||8
544188|NCT00759564|1328906|P2|COMPLETED|Second Intervention Period (4 Days)||8
544189|NCT00759564|1328907|P1|COMPLETED|Second Intervention Period (4 Days)||8
544190|NCT00759564|1328903|P5|STARTED|Second Intervention Period (4 Days)||3
544191|NCT00759564|1328904|P4|STARTED|Second Intervention Period (4 Days)||1
544192|NCT00759564|1328905|P3|STARTED|Second Intervention Period (4 Days)||8
544193|NCT00759564|1328906|P2|STARTED|Second Intervention Period (4 Days)||8
544194|NCT00759564|1328907|P1|STARTED|Second Intervention Period (4 Days)||8
544195|NCT00759564|1328903|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||1
544196|NCT00759564|1328904|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
544197|NCT00759564|1328905|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
544198|NCT00759564|1328906|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
544199|NCT00759564|1328907|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
544200|NCT00759564|1328903|P5|COMPLETED|Washout Period (at Least 14 Days)||3
544201|NCT00759564|1328904|P4|COMPLETED|Washout Period (at Least 14 Days)||1
544202|NCT00759564|1328905|P3|COMPLETED|Washout Period (at Least 14 Days)||8
544203|NCT00759564|1328906|P2|COMPLETED|Washout Period (at Least 14 Days)||8
544204|NCT00759564|1328907|P1|COMPLETED|Washout Period (at Least 14 Days)||8
544205|NCT00759564|1328903|P5|STARTED|Washout Period (at Least 14 Days)||4
544206|NCT00759564|1328904|P4|STARTED|Washout Period (at Least 14 Days)||1
544207|NCT00759564|1328905|P3|STARTED|Washout Period (at Least 14 Days)||8
544208|NCT00759564|1328906|P2|STARTED|Washout Period (at Least 14 Days)||8
544209|NCT00759564|1328907|P1|STARTED|Washout Period (at Least 14 Days)||8
544210|NCT00759564|1328903|P5|NOT COMPLETED|First Intervention Period (4 Days)||0
544211|NCT00759564|1328904|P4|NOT COMPLETED|First Intervention Period (4 Days)||0
544212|NCT00759564|1328905|P3|NOT COMPLETED|First Intervention Period (4 Days)||0
544213|NCT00759564|1328906|P2|NOT COMPLETED|First Intervention Period (4 Days)||0
544214|NCT00759564|1328907|P1|NOT COMPLETED|First Intervention Period (4 Days)||0
544215|NCT00759564|1328903|P5|COMPLETED|First Intervention Period (4 Days)||4
544216|NCT00759564|1328904|P4|COMPLETED|First Intervention Period (4 Days)||1
544217|NCT00759564|1328905|P3|COMPLETED|First Intervention Period (4 Days)||8
544218|NCT00759564|1328906|P2|COMPLETED|First Intervention Period (4 Days)||8
544219|NCT00759564|1328907|P1|COMPLETED|First Intervention Period (4 Days)||8
544220|NCT00759564|1328903|P5|STARTED|First Intervention Period (4 Days)||4
544221|NCT00759564|1328904|P4|STARTED|First Intervention Period (4 Days)||1
544222|NCT00759564|1328905|P3|STARTED|First Intervention Period (4 Days)||8
544223|NCT00759564|1328906|P2|STARTED|First Intervention Period (4 Days)||8
544224|NCT00759564|1328907|P1|STARTED|First Intervention Period (4 Days)||8
544225|NCT00759525|1329047|P2|NOT COMPLETED|Second Intervention (14 Days)||0
544226|NCT00759525|1329048|P1|NOT COMPLETED|Second Intervention (14 Days)||0
544227|NCT00759525|1329047|P2|COMPLETED|Second Intervention (14 Days)||8
544228|NCT00759525|1329048|P1|COMPLETED|Second Intervention (14 Days)||7
544229|NCT00759525|1329047|P2|STARTED|Second Intervention (14 Days)||8
544230|NCT00759525|1329048|P1|STARTED|Second Intervention (14 Days)||7
544231|NCT00759525|1329047|P2|NOT COMPLETED|Washout (14 Days)||0
544232|NCT00759525|1329048|P1|NOT COMPLETED|Washout (14 Days)||0
544233|NCT00759525|1329047|P2|COMPLETED|Washout (14 Days)||8
544234|NCT00759525|1329048|P1|COMPLETED|Washout (14 Days)||7
544235|NCT00759525|1329047|P2|STARTED|Washout (14 Days)||8
544236|NCT00759525|1329048|P1|STARTED|Washout (14 Days)||7
544237|NCT00759525|1329047|P2|NOT COMPLETED|First Intervention (14 Days)||0
544238|NCT00759525|1329048|P1|NOT COMPLETED|First Intervention (14 Days)||0
544239|NCT00759525|1329047|P2|COMPLETED|First Intervention (14 Days)||8
544240|NCT00759525|1329048|P1|COMPLETED|First Intervention (14 Days)||7
544241|NCT00759525|1329047|P2|STARTED|First Intervention (14 Days)||8
544242|NCT00759525|1329048|P1|STARTED|First Intervention (14 Days)||7
544243|NCT00759473|1329059|P5|NOT COMPLETED|Overall Study||0
544244|NCT00759473|1329060|P4|NOT COMPLETED|Overall Study||0
544245|NCT00759473|1329061|P3|NOT COMPLETED|Overall Study||0
544246|NCT00759473|1329062|P2|NOT COMPLETED|Overall Study||0
544247|NCT00759473|1329063|P1|NOT COMPLETED|Overall Study||0
544248|NCT00759473|1329059|P5|COMPLETED|Overall Study||24
544249|NCT00759473|1329060|P4|COMPLETED|Overall Study||23
544250|NCT00759473|1329061|P3|COMPLETED|Overall Study||12
544251|NCT00759473|1329062|P2|COMPLETED|Overall Study||10
544252|NCT00759473|1329063|P1|COMPLETED|Overall Study||10
544253|NCT00759473|1329059|P5|STARTED|Overall Study||24
544254|NCT00759473|1329060|P4|STARTED|Overall Study||23
544255|NCT00759473|1329061|P3|STARTED|Overall Study||12
544256|NCT00759473|1329062|P2|STARTED|Overall Study||10
544257|NCT00759473|1329063|P1|STARTED|Overall Study||10
544258|NCT00759395|1329077|P2|NOT COMPLETED|Overall Study||2
544259|NCT00759395|1329078|P1|NOT COMPLETED|Overall Study||2
544260|NCT00759395|1329077|P2|COMPLETED|Overall Study||7
544261|NCT00759395|1329078|P1|COMPLETED|Overall Study||11
544262|NCT00759395|1329077|P2|STARTED|Overall Study||9
544263|NCT00759395|1329078|P1|STARTED|Overall Study||13
544264|NCT00759356|1329094|P2|NOT COMPLETED|Overall Study||3
544265|NCT00759356|1329095|P1|NOT COMPLETED|Overall Study||1
544266|NCT00759356|1329094|P2|COMPLETED|Overall Study||15
544267|NCT00759356|1329095|P1|COMPLETED|Overall Study||17
544268|NCT00759356|1329094|P2|STARTED|Overall Study||18
544269|NCT00759356|1329095|P1|STARTED|Overall Study||18
544270|NCT00759330|1329111|P4|NOT COMPLETED|Overall Study||2
544271|NCT00759330|1329112|P3|NOT COMPLETED|Overall Study||0
544272|NCT00759330|1329113|P2|NOT COMPLETED|Overall Study||1
544273|NCT00759330|1329114|P1|NOT COMPLETED|Overall Study||1
544274|NCT00759330|1329111|P4|COMPLETED|Overall Study||41
544275|NCT00759330|1329112|P3|COMPLETED|Overall Study||22
544276|NCT00759330|1329113|P2|COMPLETED|Overall Study||41
544277|NCT00759330|1329114|P1|COMPLETED|Overall Study||19
544278|NCT00759330|1329111|P4|STARTED|Overall Study||43
544279|NCT00759330|1329112|P3|STARTED|Overall Study||22
544280|NCT00759330|1329113|P2|STARTED|Overall Study||42
544281|NCT00759330|1329114|P1|STARTED|Overall Study||20
544282|NCT00759187|1329163|P3|NOT COMPLETED|Overall Study||0
544283|NCT00759187|1329164|P2|NOT COMPLETED|Overall Study||0
544284|NCT00759187|1329165|P1|NOT COMPLETED|Overall Study||0
544285|NCT00759187|1329163|P3|COMPLETED|Overall Study||9
544286|NCT00759187|1329164|P2|COMPLETED|Overall Study||8
544287|NCT00759187|1329165|P1|COMPLETED|Overall Study||8
544288|NCT00759187|1329163|P3|STARTED|Overall Study||9
544289|NCT00759187|1329164|P2|STARTED|Overall Study||8
544290|NCT00759187|1329165|P1|STARTED|Overall Study||8
544291|NCT00759174|1329175|P2|NOT COMPLETED|Overall Study||2
544292|NCT00759174|1329176|P1|NOT COMPLETED|Overall Study||0
544293|NCT00759174|1329175|P2|COMPLETED|Overall Study||595
544294|NCT00759174|1329176|P1|COMPLETED|Overall Study||76
544295|NCT00759174|1329175|P2|STARTED|Overall Study||597
544296|NCT00759174|1329176|P1|STARTED|Overall Study||76
544297|NCT00759161|1329185|P1|NOT COMPLETED|Overall Study||0
544298|NCT00759161|1329185|P1|COMPLETED|Overall Study||35
544299|NCT00759161|1329185|P1|STARTED|Overall Study||35
544300|NCT00759148|1329200|P2|NOT COMPLETED|Overall Study||32
544301|NCT00759148|1329201|P1|NOT COMPLETED|Overall Study||14
544302|NCT00759148|1329200|P2|COMPLETED|Overall Study||554
544303|NCT00759148|1329201|P1|COMPLETED|Overall Study||579
544304|NCT00759148|1329200|P2|STARTED|Overall Study||586
544305|NCT00759148|1329201|P1|STARTED|Overall Study||593
544306|NCT00759109|1329211|P2|NOT COMPLETED|Overall Study||35
544307|NCT00759109|1329212|P1|NOT COMPLETED|Overall Study||39
544308|NCT00759109|1329211|P2|COMPLETED|Overall Study|From both arms combined, 7 discontinued due to death and there were 8 deaths during follow up.|41
544309|NCT00759109|1329212|P1|COMPLETED|Overall Study|From both arms combined, 7 discontinued due to death and there were 8 deaths during follow up.|35
544310|NCT00759109|1329211|P2|STARTED|Overall Study||76
544311|NCT00759109|1329212|P1|STARTED|Overall Study||74
544312|NCT00759096|1329228|P1|NOT COMPLETED|Overall Study||0
544313|NCT00759096|1329228|P1|COMPLETED|Overall Study||30
544314|NCT00759096|1329228|P1|STARTED|Overall Study||30
544315|NCT00759031|1329234|P2|NOT COMPLETED|Second Intervention (1 Day)||0
544316|NCT00759031|1329235|P1|NOT COMPLETED|Second Intervention (1 Day)||0
544317|NCT00759031|1329234|P2|COMPLETED|Second Intervention (1 Day)||8
544318|NCT00759031|1329235|P1|COMPLETED|Second Intervention (1 Day)||8
544319|NCT00759031|1329234|P2|STARTED|Second Intervention (1 Day)||8
544320|NCT00759031|1329235|P1|STARTED|Second Intervention (1 Day)||8
544321|NCT00759031|1329234|P2|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0
544322|NCT00759031|1329235|P1|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0
544323|NCT00759031|1329234|P2|COMPLETED|Washout After 1st Intervention (1 Week)||8
544324|NCT00759031|1329235|P1|COMPLETED|Washout After 1st Intervention (1 Week)||8
544325|NCT00759031|1329234|P2|STARTED|Washout After 1st Intervention (1 Week)||8
544326|NCT00759031|1329235|P1|STARTED|Washout After 1st Intervention (1 Week)||8
544327|NCT00759031|1329234|P2|NOT COMPLETED|First Intervention (1 Day)||1
544328|NCT00759031|1329235|P1|NOT COMPLETED|First Intervention (1 Day)||2
544329|NCT00759031|1329234|P2|COMPLETED|First Intervention (1 Day)||8
544330|NCT00759031|1329235|P1|COMPLETED|First Intervention (1 Day)||8
544331|NCT00759031|1329234|P2|STARTED|First Intervention (1 Day)||9
544332|NCT00759031|1329235|P1|STARTED|First Intervention (1 Day)||10
544333|NCT00758836|1329245|P4|NOT COMPLETED|Overall Study||32
544334|NCT00758836|1329246|P3|NOT COMPLETED|Overall Study||38
544335|NCT00758836|1329247|P2|NOT COMPLETED|Overall Study||26
544336|NCT00758836|1329248|P1|NOT COMPLETED|Overall Study||24
544337|NCT00758836|1329245|P4|COMPLETED|Overall Study||138
544338|NCT00758836|1329246|P3|COMPLETED|Overall Study||133
544339|NCT00758836|1329247|P2|COMPLETED|Overall Study||145
544340|NCT00758836|1329248|P1|COMPLETED|Overall Study||147
544341|NCT00758836|1329245|P4|Treated|Overall Study||138
544342|NCT00758836|1329246|P3|Treated|Overall Study||133
544343|NCT00758836|1329247|P2|Treated|Overall Study||145
544344|NCT00758836|1329248|P1|Treated|Overall Study||147
544345|NCT00758836|1329245|P4|STARTED|Overall Study||170
544346|NCT00758836|1329246|P3|STARTED|Overall Study||171
544347|NCT00758836|1329247|P2|STARTED|Overall Study||171
544348|NCT00758836|1329248|P1|STARTED|Overall Study||171
544349|NCT00758771|1329272|P2|NOT COMPLETED|Overall Study||5
544350|NCT00758771|1329273|P1|NOT COMPLETED|Overall Study||3
544351|NCT00758771|1329272|P2|COMPLETED|Overall Study||15
544352|NCT00758771|1329273|P1|COMPLETED|Overall Study||15
544353|NCT00758771|1329272|P2|STARTED|Overall Study||20
544354|NCT00758771|1329273|P1|STARTED|Overall Study||18
544355|NCT00758758|1329287|P8|NOT COMPLETED|Overall Study||0
544356|NCT00758758|1329288|P7|NOT COMPLETED|Overall Study||14
544357|NCT00758758|1329289|P6|NOT COMPLETED|Overall Study||14
544358|NCT00758758|1329290|P5|NOT COMPLETED|Overall Study||2
544359|NCT00758758|1329291|P4|NOT COMPLETED|Overall Study||2
544360|NCT00758758|1329292|P3|NOT COMPLETED|Overall Study||18
544361|NCT00758758|1329293|P2|NOT COMPLETED|Overall Study||25
544362|NCT00758758|1329294|P1|NOT COMPLETED|Overall Study||3
544363|NCT00758758|1329287|P8|COMPLETED|Overall Study||0
544364|NCT00758758|1329288|P7|COMPLETED|Overall Study||17
544365|NCT00758758|1329289|P6|COMPLETED|Overall Study||36
544366|NCT00758758|1329290|P5|COMPLETED|Overall Study||1
544367|NCT00758758|1329291|P4|COMPLETED|Overall Study||4
544368|NCT00758758|1329292|P3|COMPLETED|Overall Study||35
544369|NCT00758758|1329293|P2|COMPLETED|Overall Study||49
544370|NCT00758758|1329294|P1|COMPLETED|Overall Study||11
544371|NCT00758758|1329287|P8|STARTED|Overall Study||0
544372|NCT00758758|1329288|P7|STARTED|Overall Study||31
544373|NCT00758758|1329289|P6|STARTED|Overall Study||50
544374|NCT00758758|1329290|P5|STARTED|Overall Study||3
544375|NCT00758758|1329291|P4|STARTED|Overall Study||6
544376|NCT00758758|1329292|P3|STARTED|Overall Study||53
544377|NCT00758758|1329293|P2|STARTED|Overall Study||74
544378|NCT00758758|1329294|P1|STARTED|Overall Study||14
544379|NCT00758745|1329322|P2|NOT COMPLETED|Overall Study||21
544380|NCT00758745|1329323|P1|NOT COMPLETED|Overall Study||21
544381|NCT00758745|1329322|P2|COMPLETED|Overall Study||60
544382|NCT00758745|1329323|P1|COMPLETED|Overall Study||60
544383|NCT00758745|1329322|P2|STARTED|Overall Study||81
544384|NCT00758745|1329323|P1|STARTED|Overall Study||81
544385|NCT00758706|1329331|P2|NOT COMPLETED|Overall Study||4
544386|NCT00758706|1329332|P1|NOT COMPLETED|Overall Study||4
544387|NCT00758706|1329331|P2|COMPLETED|Overall Study||25
544388|NCT00758706|1329332|P1|COMPLETED|Overall Study||22
544389|NCT00758706|1329331|P2|STARTED|Overall Study||29
544390|NCT00758706|1329332|P1|STARTED|Overall Study||26
544391|NCT00758680|1329368|P10|NOT COMPLETED|Overall Study||1
544392|NCT00758680|1329369|P9|NOT COMPLETED|Overall Study||2
544393|NCT00758680|1329370|P8|NOT COMPLETED|Overall Study||1
544394|NCT00758680|1329371|P7|NOT COMPLETED|Overall Study||1
544395|NCT00758680|1329372|P6|NOT COMPLETED|Overall Study||0
544396|NCT00758680|1329373|P5|NOT COMPLETED|Overall Study||0
544397|NCT00758680|1329374|P4|NOT COMPLETED|Overall Study||0
544398|NCT00758680|1329375|P3|NOT COMPLETED|Overall Study||0
544399|NCT00758680|1329376|P2|NOT COMPLETED|Overall Study||0
544400|NCT00758680|1329377|P1|NOT COMPLETED|Overall Study||0
544401|NCT00758680|1329368|P10|COMPLETED|Overall Study||28
544402|NCT00758680|1329369|P9|COMPLETED|Overall Study||18
544403|NCT00758680|1329370|P8|COMPLETED|Overall Study||19
544404|NCT00758680|1329371|P7|COMPLETED|Overall Study||6
544405|NCT00758680|1329372|P6|COMPLETED|Overall Study||6
544406|NCT00758680|1329373|P5|COMPLETED|Overall Study||6
544407|NCT00758680|1329374|P4|COMPLETED|Overall Study||6
544408|NCT00758680|1329375|P3|COMPLETED|Overall Study||6
544409|NCT00758680|1329376|P2|COMPLETED|Overall Study||6
544410|NCT00758680|1329377|P1|COMPLETED|Overall Study||6
544411|NCT00758680|1329368|P10|STARTED|Overall Study||29
544412|NCT00758680|1329369|P9|STARTED|Overall Study||20
544413|NCT00758680|1329370|P8|STARTED|Overall Study||20
544414|NCT00758680|1329371|P7|STARTED|Overall Study||7
544415|NCT00758680|1329372|P6|STARTED|Overall Study||6
544416|NCT00758680|1329373|P5|STARTED|Overall Study||6
544417|NCT00758680|1329374|P4|STARTED|Overall Study||6
544418|NCT00758680|1329375|P3|STARTED|Overall Study||6
544419|NCT00758680|1329376|P2|STARTED|Overall Study||6
544420|NCT00758680|1329377|P1|STARTED|Overall Study||6
544421|NCT00758667|1329419|P2|NOT COMPLETED|Overall Study||0
544422|NCT00758667|1329420|P1|NOT COMPLETED|Overall Study||0
544423|NCT00758667|1329419|P2|COMPLETED|Overall Study||11
544424|NCT00758667|1329420|P1|COMPLETED|Overall Study||9
544425|NCT00758667|1329419|P2|STARTED|Overall Study||11
544426|NCT00758667|1329420|P1|STARTED|Overall Study||9
544427|NCT00758602|1329430|P2|NOT COMPLETED|Overall Study||22
544428|NCT00758602|1329431|P1|NOT COMPLETED|Overall Study||19
544429|NCT00758602|1329430|P2|COMPLETED|Overall Study||84
544430|NCT00758602|1329431|P1|COMPLETED|Overall Study||85
544431|NCT00758602|1329430|P2|STARTED|Overall Study||106
544432|NCT00758602|1329431|P1|STARTED|Overall Study||104
544433|NCT00758589|1329457|P4|NOT COMPLETED|Overall Study||6
544434|NCT00758589|1329458|P3|NOT COMPLETED|Overall Study||6
544435|NCT00758589|1329459|P2|NOT COMPLETED|Overall Study||3
544436|NCT00758589|1329460|P1|NOT COMPLETED|Overall Study||3
544437|NCT00758589|1329457|P4|COMPLETED|Overall Study||85
544438|NCT00758589|1329458|P3|COMPLETED|Overall Study||86
544439|NCT00758589|1329459|P2|COMPLETED|Overall Study||87
544440|NCT00758589|1329460|P1|COMPLETED|Overall Study||92
544441|NCT00758589|1329457|P4|STARTED|Overall Study||91
544442|NCT00758589|1329458|P3|STARTED|Overall Study||92
544443|NCT00758589|1329459|P2|STARTED|Overall Study||90
544444|NCT00758589|1329460|P1|STARTED|Overall Study||95
544445|NCT00758576|1329526|P1|NOT COMPLETED|Overall Study||1
544446|NCT00758576|1329526|P1|COMPLETED|Overall Study||63
544447|NCT00758576|1329526|P1|STARTED|Overall Study||64
544448|NCT00758563|1329534|P2|NOT COMPLETED|Overall Study||0
544449|NCT00758563|1329535|P1|NOT COMPLETED|Overall Study||0
544450|NCT00758563|1329534|P2|COMPLETED|Overall Study||8
544451|NCT00758563|1329535|P1|COMPLETED|Overall Study||7
544452|NCT00758563|1329534|P2|STARTED|Overall Study||8
544453|NCT00758563|1329535|P1|STARTED|Overall Study||7
544454|NCT00758550|1329541|P2|NOT COMPLETED|Overall Study||0
544455|NCT00758550|1329542|P1|NOT COMPLETED|Overall Study||0
544456|NCT00758550|1329541|P2|COMPLETED|Overall Study||30
544457|NCT00758550|1329542|P1|COMPLETED|Overall Study||30
544458|NCT00758550|1329541|P2|STARTED|Overall Study||30
544459|NCT00758550|1329542|P1|STARTED|Overall Study||30
544460|NCT00758498|1329553|P3|NOT COMPLETED|Overall Study||5
544461|NCT00758498|1329554|P2|NOT COMPLETED|Overall Study||2
544462|NCT00758498|1329555|P1|NOT COMPLETED|Overall Study||3
544463|NCT00758498|1329553|P3|COMPLETED|Overall Study||137
544464|NCT00758498|1329554|P2|COMPLETED|Overall Study||141
544465|NCT00758498|1329555|P1|COMPLETED|Overall Study||139
544466|NCT00758498|1329553|P3|STARTED|Overall Study||142
544467|NCT00758498|1329554|P2|STARTED|Overall Study||143
544468|NCT00758498|1329555|P1|STARTED|Overall Study||142
544469|NCT00758485|1329640|P2|NOT COMPLETED|Overall Study||3
544470|NCT00758485|1329641|P1|NOT COMPLETED|Overall Study||1
544471|NCT00758485|1329640|P2|COMPLETED|Overall Study||67
544472|NCT00758485|1329641|P1|COMPLETED|Overall Study||69
544473|NCT00758485|1329640|P2|TREATED|Overall Study||68
544474|NCT00758485|1329641|P1|TREATED|Overall Study||69
544475|NCT00758485|1329640|P2|STARTED|Overall Study||70
544476|NCT00758485|1329641|P1|STARTED|Overall Study||70
544477|NCT00758459|1329653|P2|NOT COMPLETED|Overall Study||4
544478|NCT00758459|1329654|P1|NOT COMPLETED|Overall Study||3
544479|NCT00758459|1329653|P2|COMPLETED|Overall Study||35
544480|NCT00758459|1329654|P1|COMPLETED|Overall Study||32
544481|NCT00758459|1329653|P2|STARTED|Overall Study||39
544482|NCT00758459|1329654|P1|STARTED|Overall Study||35
544483|NCT00758420|1329688|P2|NOT COMPLETED|Overall Study||0
544484|NCT00758420|1329689|P1|NOT COMPLETED|Overall Study||0
544485|NCT00758420|1329688|P2|COMPLETED|Overall Study||38
544486|NCT00758420|1329689|P1|COMPLETED|Overall Study||39
544487|NCT00758420|1329688|P2|STARTED|Overall Study||38
544488|NCT00758420|1329689|P1|STARTED|Overall Study||39
544489|NCT00758394|1329699|P4|NOT COMPLETED|4th Intervention||0
544490|NCT00758394|1329700|P3|NOT COMPLETED|4th Intervention||0
544491|NCT00758394|1329701|P2|NOT COMPLETED|4th Intervention||0
544492|NCT00758394|1329702|P1|NOT COMPLETED|4th Intervention||0
544493|NCT00758394|1329699|P4|COMPLETED|4th Intervention||7
544494|NCT00758394|1329700|P3|COMPLETED|4th Intervention||6
544495|NCT00758394|1329701|P2|COMPLETED|4th Intervention||6
544496|NCT00758394|1329702|P1|COMPLETED|4th Intervention||7
544497|NCT00758394|1329699|P4|STARTED|4th Intervention||7
544498|NCT00758394|1329700|P3|STARTED|4th Intervention||6
544499|NCT00758394|1329701|P2|STARTED|4th Intervention||6
544500|NCT00758394|1329702|P1|STARTED|4th Intervention||7
544501|NCT00758394|1329699|P4|NOT COMPLETED|Washout After 3rd Intervention||0
544502|NCT00758394|1329700|P3|NOT COMPLETED|Washout After 3rd Intervention||0
544503|NCT00758394|1329701|P2|NOT COMPLETED|Washout After 3rd Intervention||0
544504|NCT00758394|1329702|P1|NOT COMPLETED|Washout After 3rd Intervention||0
544505|NCT00758394|1329699|P4|COMPLETED|Washout After 3rd Intervention||7
544506|NCT00758394|1329700|P3|COMPLETED|Washout After 3rd Intervention||6
544507|NCT00758394|1329701|P2|COMPLETED|Washout After 3rd Intervention||6
544508|NCT00758394|1329702|P1|COMPLETED|Washout After 3rd Intervention||7
544509|NCT00758394|1329699|P4|STARTED|Washout After 3rd Intervention||7
544510|NCT00758394|1329700|P3|STARTED|Washout After 3rd Intervention||6
544511|NCT00758394|1329701|P2|STARTED|Washout After 3rd Intervention||6
544512|NCT00758394|1329702|P1|STARTED|Washout After 3rd Intervention||7
544513|NCT00758394|1329699|P4|NOT COMPLETED|3rd Intervention||1
544514|NCT00758394|1329700|P3|NOT COMPLETED|3rd Intervention||0
544515|NCT00758394|1329701|P2|NOT COMPLETED|3rd Intervention||0
544516|NCT00758394|1329702|P1|NOT COMPLETED|3rd Intervention||1
544517|NCT00758394|1329699|P4|COMPLETED|3rd Intervention||7
544518|NCT00758394|1329700|P3|COMPLETED|3rd Intervention||6
544519|NCT00758394|1329701|P2|COMPLETED|3rd Intervention||6
544520|NCT00758394|1329702|P1|COMPLETED|3rd Intervention||7
544521|NCT00758394|1329699|P4|STARTED|3rd Intervention||8
544522|NCT00758394|1329700|P3|STARTED|3rd Intervention||6
544523|NCT00758394|1329701|P2|STARTED|3rd Intervention||6
544524|NCT00758394|1329702|P1|STARTED|3rd Intervention||8
544525|NCT00758394|1329699|P4|NOT COMPLETED|Washout After 2nd Intervention||0
544526|NCT00758394|1329700|P3|NOT COMPLETED|Washout After 2nd Intervention||0
544527|NCT00758394|1329701|P2|NOT COMPLETED|Washout After 2nd Intervention||0
544528|NCT00758394|1329702|P1|NOT COMPLETED|Washout After 2nd Intervention||0
544529|NCT00758394|1329699|P4|COMPLETED|Washout After 2nd Intervention||8
544530|NCT00758394|1329700|P3|COMPLETED|Washout After 2nd Intervention||6
544531|NCT00758394|1329701|P2|COMPLETED|Washout After 2nd Intervention||6
544532|NCT00758394|1329702|P1|COMPLETED|Washout After 2nd Intervention||8
544533|NCT00758394|1329699|P4|STARTED|Washout After 2nd Intervention||8
544534|NCT00758394|1329700|P3|STARTED|Washout After 2nd Intervention||6
544535|NCT00758394|1329701|P2|STARTED|Washout After 2nd Intervention||6
544536|NCT00758394|1329702|P1|STARTED|Washout After 2nd Intervention||8
544537|NCT00758394|1329699|P4|NOT COMPLETED|2nd Intervention Order||0
544538|NCT00758394|1329700|P3|NOT COMPLETED|2nd Intervention Order||0
544539|NCT00758394|1329701|P2|NOT COMPLETED|2nd Intervention Order||1
544540|NCT00758394|1329702|P1|NOT COMPLETED|2nd Intervention Order||0
544541|NCT00758394|1329699|P4|COMPLETED|2nd Intervention Order||8
544542|NCT00758394|1329700|P3|COMPLETED|2nd Intervention Order||6
544543|NCT00758394|1329701|P2|COMPLETED|2nd Intervention Order||6
544544|NCT00758394|1329702|P1|COMPLETED|2nd Intervention Order||8
544545|NCT00758394|1329699|P4|STARTED|2nd Intervention Order||8
544546|NCT00758394|1329700|P3|STARTED|2nd Intervention Order||6
544547|NCT00758394|1329701|P2|STARTED|2nd Intervention Order||7
544548|NCT00758394|1329702|P1|STARTED|2nd Intervention Order||8
544549|NCT00758394|1329699|P4|NOT COMPLETED|Washout After 1st Intervention||0
544550|NCT00758394|1329700|P3|NOT COMPLETED|Washout After 1st Intervention||0
544551|NCT00758394|1329701|P2|NOT COMPLETED|Washout After 1st Intervention||0
544552|NCT00758394|1329702|P1|NOT COMPLETED|Washout After 1st Intervention||0
544553|NCT00758394|1329699|P4|COMPLETED|Washout After 1st Intervention||8
544554|NCT00758394|1329700|P3|COMPLETED|Washout After 1st Intervention||6
544555|NCT00758394|1329701|P2|COMPLETED|Washout After 1st Intervention||7
544556|NCT00758394|1329702|P1|COMPLETED|Washout After 1st Intervention||8
544557|NCT00758394|1329699|P4|STARTED|Washout After 1st Intervention||8
544558|NCT00758394|1329700|P3|STARTED|Washout After 1st Intervention||6
544559|NCT00758394|1329701|P2|STARTED|Washout After 1st Intervention||7
544560|NCT00758394|1329702|P1|STARTED|Washout After 1st Intervention||8
544561|NCT00758394|1329699|P4|NOT COMPLETED|1st Intervention||0
544562|NCT00758394|1329700|P3|NOT COMPLETED|1st Intervention||0
544563|NCT00758394|1329701|P2|NOT COMPLETED|1st Intervention||0
544564|NCT00758394|1329702|P1|NOT COMPLETED|1st Intervention||0
544565|NCT00758394|1329699|P4|COMPLETED|1st Intervention||8
544566|NCT00758394|1329700|P3|COMPLETED|1st Intervention||6
544567|NCT00758394|1329701|P2|COMPLETED|1st Intervention||7
544568|NCT00758394|1329702|P1|COMPLETED|1st Intervention||8
544569|NCT00758394|1329699|P4|STARTED|1st Intervention||8
544570|NCT00758394|1329700|P3|STARTED|1st Intervention||6
544571|NCT00758394|1329701|P2|STARTED|1st Intervention||7
544572|NCT00758394|1329702|P1|STARTED|1st Intervention||8
544573|NCT00758342|1329714|P2|NOT COMPLETED|Overall Study||1
544574|NCT00758342|1329715|P1|NOT COMPLETED|Overall Study||4
544575|NCT00758342|1329714|P2|COMPLETED|Overall Study||17
544576|NCT00758342|1329715|P1|COMPLETED|Overall Study||15
544577|NCT00758342|1329714|P2|STARTED|Overall Study||18
544578|NCT00758342|1329715|P1|STARTED|Overall Study||19
544579|NCT00758290|1329723|P2|NOT COMPLETED|Overall Study||0
544580|NCT00758290|1329724|P1|NOT COMPLETED|Overall Study||0
544581|NCT00758290|1329723|P2|COMPLETED|Overall Study||12
544582|NCT00758290|1329724|P1|COMPLETED|Overall Study||11
544583|NCT00758290|1329723|P2|STARTED|Overall Study||12
544584|NCT00758290|1329724|P1|STARTED|Overall Study||11
544585|NCT00758264|1329731|P3|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
544586|NCT00758264|1329732|P2|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
544587|NCT00758264|1329733|P1|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
544588|NCT00758264|1329731|P3|COMPLETED|Extended Safety Follow Up (ESFU) Phase||89
544589|NCT00758264|1329732|P2|COMPLETED|Extended Safety Follow Up (ESFU) Phase||90
544590|NCT00758264|1329733|P1|COMPLETED|Extended Safety Follow Up (ESFU) Phase||181
544591|NCT00758264|1329731|P3|STARTED|Extended Safety Follow Up (ESFU) Phase||89
544592|NCT00758264|1329732|P2|STARTED|Extended Safety Follow Up (ESFU) Phase||90
544593|NCT00758264|1329733|P1|STARTED|Extended Safety Follow Up (ESFU) Phase||181
544594|NCT00758264|1329731|P3|NOT COMPLETED|Active Phase||5
544595|NCT00758264|1329732|P2|NOT COMPLETED|Active Phase||0
544596|NCT00758264|1329733|P1|NOT COMPLETED|Active Phase||1
544597|NCT00758264|1329731|P3|COMPLETED|Active Phase||85
544598|NCT00758264|1329732|P2|COMPLETED|Active Phase||91
544599|NCT00758264|1329733|P1|COMPLETED|Active Phase||181
544600|NCT00758264|1329731|P3|STARTED|Active Phase||90
544601|NCT00758264|1329732|P2|STARTED|Active Phase||91
544602|NCT00758264|1329733|P1|STARTED|Active Phase||182
544603|NCT00758160|1329792|P1|NOT COMPLETED|Overall Study||66
544604|NCT00758160|1329792|P1|COMPLETED|Overall Study||230
544605|NCT00758160|1329792|P1|STARTED|Overall Study||296
544606|NCT00758069|1329813|P3|NOT COMPLETED|Overall Study||1
544607|NCT00758069|1329814|P2|NOT COMPLETED|Overall Study||0
544608|NCT00758069|1329815|P1|NOT COMPLETED|Overall Study||1
544609|NCT00758069|1329813|P3|COMPLETED|Overall Study||27
544610|NCT00758069|1329814|P2|COMPLETED|Overall Study||25
544611|NCT00758069|1329815|P1|COMPLETED|Overall Study||26
544612|NCT00758069|1329813|P3|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|28
544613|NCT00758069|1329814|P2|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|25
544614|NCT00758069|1329815|P1|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|27
544615|NCT00758043|1329830|P4|NOT COMPLETED|Overall Study||100
544616|NCT00758043|1329831|P3|NOT COMPLETED|Overall Study||39
544617|NCT00758043|1329832|P2|NOT COMPLETED|Overall Study||41
544618|NCT00758043|1329833|P1|NOT COMPLETED|Overall Study||1
544619|NCT00758043|1329830|P4|COMPLETED|Overall Study||0
544620|NCT00758043|1329831|P3|COMPLETED|Overall Study||79
544621|NCT00758043|1329832|P2|COMPLETED|Overall Study||119
544622|NCT00758043|1329833|P1|COMPLETED|Overall Study||161
544623|NCT00758043|1329830|P4|STARTED|Overall Study||100
544624|NCT00758043|1329831|P3|STARTED|Overall Study||118
544625|NCT00758043|1329832|P2|STARTED|Overall Study||160
544626|NCT00758043|1329833|P1|STARTED|Overall Study||162
544627|NCT00757848|1329861|P2|NOT COMPLETED|Overall Study||2
544628|NCT00757848|1329862|P1|NOT COMPLETED|Overall Study||3
544629|NCT00757848|1329861|P2|COMPLETED|Overall Study||27
544630|NCT00757848|1329862|P1|COMPLETED|Overall Study||24
544631|NCT00757848|1329861|P2|STARTED|Overall Study||29
544632|NCT00757848|1329862|P1|STARTED|Overall Study||27
544633|NCT00757822|1329908|P2|NOT COMPLETED|Overall Study||31
544634|NCT00757822|1329909|P1|NOT COMPLETED|Overall Study||28
544635|NCT00757822|1329908|P2|COMPLETED|Overall Study||57
544636|NCT00757822|1329909|P1|COMPLETED|Overall Study||64
544637|NCT00757822|1329908|P2|Data Lock, Unblinding Analysis|Overall Study||57
544638|NCT00757822|1329909|P1|Data Lock, Unblinding Analysis|Overall Study||64
544639|NCT00757822|1329908|P2|Withdrawn-protocol Deviation|Overall Study||8
544640|NCT00757822|1329909|P1|Withdrawn-protocol Deviation|Overall Study||9
544641|NCT00757822|1329908|P2|Withdrawn-low-risk for PONV|Overall Study|K score for PONV risk < 2|9
544642|NCT00757822|1329909|P1|Withdrawn-low-risk for PONV|Overall Study|K score for PONV risk<2|12
544643|NCT00757822|1329908|P2|Data Entry, QC Assessment|Overall Study||74
544644|NCT00757822|1329909|P1|Data Entry, QC Assessment|Overall Study||85
544645|NCT00757822|1329908|P2|2-6 wk Post-op Assessment|Overall Study||74
544646|NCT00757822|1329909|P1|2-6 wk Post-op Assessment|Overall Study||85
544647|NCT00757822|1329908|P2|24-48 hr Telephone Assessment|Overall Study||74
544648|NCT00757822|1329909|P1|24-48 hr Telephone Assessment|Overall Study||85
544649|NCT00757822|1329908|P2|DOS: Post-operative Assessments|Overall Study||74
544650|NCT00757822|1329909|P1|DOS: Post-operative Assessments|Overall Study||85
544651|NCT00757822|1329908|P2|Received Study Intervention|Overall Study||74
544652|NCT00757822|1329909|P1|Received Study Intervention|Overall Study||85
544653|NCT00757822|1329908|P2|DOS Withdrawn by Investigator|Overall Study|No longer met inclusion criteria or developed exclusion criteria on DOS|11
544654|NCT00757822|1329909|P1|DOS Withdrawn by Investigator|Overall Study|No longer met inclusion criteria or developed exclusion criteria on DOS|6
544655|NCT00757822|1329908|P2|Withdrawal by Subject-no Intervention|Overall Study||3
544656|NCT00757822|1329909|P1|Withdrawal by Subject-no Intervention|Overall Study||1
544657|NCT00757822|1329908|P2|Day of Surgery (DOS) Assessment|Overall Study||88
544658|NCT00757822|1329909|P1|Day of Surgery (DOS) Assessment|Overall Study||92
544659|NCT00757822|1329908|P2|STARTED|Overall Study||88
544660|NCT00757822|1329909|P1|STARTED|Overall Study||92
544661|NCT00757783|1329931|P2|NOT COMPLETED|Overall Study||6
544662|NCT00757783|1329932|P1|NOT COMPLETED|Overall Study||5
544663|NCT00757783|1329931|P2|COMPLETED|Overall Study||25
544664|NCT00757783|1329932|P1|COMPLETED|Overall Study||29
544665|NCT00757783|1329931|P2|STARTED|Overall Study||31
544666|NCT00757783|1329932|P1|STARTED|Overall Study||34
544667|NCT00757705|1329968|P1|NOT COMPLETED|Overall Study||121
544668|NCT00757705|1329968|P1|COMPLETED|Overall Study||178
544669|NCT00757705|1329968|P1|STARTED|Overall Study||299
544670|NCT00757666|1329982|P2|NOT COMPLETED|Overall Study||23
544671|NCT00757666|1329983|P1|NOT COMPLETED|Overall Study||22
544672|NCT00757666|1329982|P2|COMPLETED|Overall Study|Number of patients with complete CPX test results from 1 month and 2 month visits|11
544673|NCT00757666|1329983|P1|COMPLETED|Overall Study|Number of patients with complete CPX test results from 1 month and 2 month visits|12
544674|NCT00757666|1329982|P2|STARTED|Overall Study||34
544675|NCT00757666|1329983|P1|STARTED|Overall Study||34
544676|NCT00757627|1329997|P1|NOT COMPLETED|Overall Study||81
544677|NCT00757627|1329997|P1|COMPLETED|Overall Study||419
544678|NCT00757627|1329997|P1|STARTED|Overall Study||500
544679|NCT00757601|1330010|P12|NOT COMPLETED|Period 5||0
544680|NCT00757601|1330011|P11|NOT COMPLETED|Period 5||0
544681|NCT00757601|1330012|P10|NOT COMPLETED|Period 5||0
544682|NCT00757601|1330013|P9|NOT COMPLETED|Period 5||0
544683|NCT00757601|1330014|P8|NOT COMPLETED|Period 5||0
544684|NCT00757601|1330015|P7|NOT COMPLETED|Period 5||0
544685|NCT00757601|1330016|P6|NOT COMPLETED|Period 5||0
544686|NCT00757601|1330017|P5|NOT COMPLETED|Period 5||0
544687|NCT00757601|1330018|P4|NOT COMPLETED|Period 5||0
544688|NCT00757601|1330019|P3|NOT COMPLETED|Period 5||0
544689|NCT00757601|1330020|P2|NOT COMPLETED|Period 5||0
544690|NCT00757601|1330021|P1|NOT COMPLETED|Period 5||0
544691|NCT00757601|1330010|P12|COMPLETED|Period 5||1
544692|NCT00757601|1330011|P11|COMPLETED|Period 5||2
544693|NCT00757601|1330012|P10|COMPLETED|Period 5||1
544694|NCT00757601|1330013|P9|COMPLETED|Period 5||2
544695|NCT00757601|1330014|P8|COMPLETED|Period 5||2
544696|NCT00757601|1330015|P7|COMPLETED|Period 5||2
544697|NCT00757601|1330016|P6|COMPLETED|Period 5||2
544698|NCT00757601|1330017|P5|COMPLETED|Period 5||2
544699|NCT00757601|1330018|P4|COMPLETED|Period 5||2
544700|NCT00757601|1330019|P3|COMPLETED|Period 5||2
544701|NCT00757601|1330020|P2|COMPLETED|Period 5||2
544702|NCT00757601|1330021|P1|COMPLETED|Period 5||2
544703|NCT00757601|1330010|P12|STARTED|Period 5||1
544704|NCT00757601|1330011|P11|STARTED|Period 5||2
544705|NCT00757601|1330012|P10|STARTED|Period 5||1
544706|NCT00757601|1330013|P9|STARTED|Period 5||2
544707|NCT00757601|1330014|P8|STARTED|Period 5||2
544708|NCT00757601|1330015|P7|STARTED|Period 5||2
544709|NCT00757601|1330016|P6|STARTED|Period 5||2
544710|NCT00757601|1330017|P5|STARTED|Period 5||2
544711|NCT00757601|1330018|P4|STARTED|Period 5||2
544712|NCT00757601|1330019|P3|STARTED|Period 5||2
544713|NCT00757601|1330020|P2|STARTED|Period 5||2
544714|NCT00757601|1330021|P1|STARTED|Period 5||2
544715|NCT00757601|1330010|P12|NOT COMPLETED|Period 4||1
544716|NCT00757601|1330011|P11|NOT COMPLETED|Period 4||0
544717|NCT00757601|1330012|P10|NOT COMPLETED|Period 4||1
544718|NCT00757601|1330013|P9|NOT COMPLETED|Period 4||0
544719|NCT00757601|1330014|P8|NOT COMPLETED|Period 4||0
544720|NCT00757601|1330015|P7|NOT COMPLETED|Period 4||0
544721|NCT00757601|1330016|P6|NOT COMPLETED|Period 4||0
544722|NCT00757601|1330017|P5|NOT COMPLETED|Period 4||0
544723|NCT00757601|1330018|P4|NOT COMPLETED|Period 4||0
544724|NCT00757601|1330019|P3|NOT COMPLETED|Period 4||0
544725|NCT00757601|1330020|P2|NOT COMPLETED|Period 4||0
544726|NCT00757601|1330021|P1|NOT COMPLETED|Period 4||0
544727|NCT00757601|1330010|P12|COMPLETED|Period 4|Replacement participant discontinued after receiving placebo to 230mg MK1006 and was not replaced|1
544728|NCT00757601|1330011|P11|COMPLETED|Period 4||2
544729|NCT00757601|1330012|P10|COMPLETED|Period 4|One participant discontinued after receiving the 230 mg dose of MK1006 and was not replaced|1
544730|NCT00757601|1330013|P9|COMPLETED|Period 4||2
544731|NCT00757601|1330014|P8|COMPLETED|Period 4||2
544732|NCT00757601|1330015|P7|COMPLETED|Period 4||2
544733|NCT00757601|1330016|P6|COMPLETED|Period 4||2
544734|NCT00757601|1330017|P5|COMPLETED|Period 4||2
544735|NCT00757601|1330018|P4|COMPLETED|Period 4||2
544736|NCT00757601|1330019|P3|COMPLETED|Period 4||2
544737|NCT00757601|1330020|P2|COMPLETED|Period 4||2
544738|NCT00757601|1330021|P1|COMPLETED|Period 4||2
544739|NCT00757601|1330010|P12|STARTED|Period 4||2
544740|NCT00757601|1330011|P11|STARTED|Period 4||2
544741|NCT00757601|1330012|P10|STARTED|Period 4||2
544742|NCT00757601|1330013|P9|STARTED|Period 4||2
544743|NCT00757601|1330014|P8|STARTED|Period 4||2
544744|NCT00757601|1330015|P7|STARTED|Period 4||2
544745|NCT00757601|1330016|P6|STARTED|Period 4||2
544746|NCT00757601|1330017|P5|STARTED|Period 4||2
544747|NCT00757601|1330018|P4|STARTED|Period 4||2
544748|NCT00757601|1330019|P3|STARTED|Period 4||2
544749|NCT00757601|1330020|P2|STARTED|Period 4||2
544750|NCT00757601|1330021|P1|STARTED|Period 4||2
544751|NCT00757601|1330010|P12|NOT COMPLETED|Period 3||0
544752|NCT00757601|1330011|P11|NOT COMPLETED|Period 3||0
544753|NCT00757601|1330012|P10|NOT COMPLETED|Period 3||0
544754|NCT00757601|1330013|P9|NOT COMPLETED|Period 3||0
544755|NCT00757601|1330014|P8|NOT COMPLETED|Period 3||0
544756|NCT00757601|1330015|P7|NOT COMPLETED|Period 3||0
544757|NCT00757601|1330016|P6|NOT COMPLETED|Period 3||0
544758|NCT00757601|1330017|P5|NOT COMPLETED|Period 3||0
544759|NCT00757601|1330018|P4|NOT COMPLETED|Period 3||0
544760|NCT00757601|1330019|P3|NOT COMPLETED|Period 3||0
544761|NCT00757601|1330020|P2|NOT COMPLETED|Period 3||0
544762|NCT00757601|1330021|P1|NOT COMPLETED|Period 3||0
544763|NCT00757601|1330010|P12|COMPLETED|Period 3||2
544764|NCT00757601|1330011|P11|COMPLETED|Period 3||2
544765|NCT00757601|1330012|P10|COMPLETED|Period 3||2
544766|NCT00757601|1330013|P9|COMPLETED|Period 3||2
544767|NCT00757601|1330014|P8|COMPLETED|Period 3||2
544768|NCT00757601|1330015|P7|COMPLETED|Period 3||2
544769|NCT00757601|1330016|P6|COMPLETED|Period 3||2
544770|NCT00757601|1330017|P5|COMPLETED|Period 3||2
544771|NCT00757601|1330018|P4|COMPLETED|Period 3||2
544772|NCT00757601|1330019|P3|COMPLETED|Period 3||2
544773|NCT00757601|1330020|P2|COMPLETED|Period 3||2
544774|NCT00757601|1330021|P1|COMPLETED|Period 3||2
544775|NCT00757601|1330010|P12|STARTED|Period 3||2
544776|NCT00757601|1330011|P11|STARTED|Period 3||2
544777|NCT00757601|1330012|P10|STARTED|Period 3||2
544778|NCT00757601|1330013|P9|STARTED|Period 3||2
544779|NCT00757601|1330014|P8|STARTED|Period 3||2
544780|NCT00757601|1330015|P7|STARTED|Period 3||2
544781|NCT00757601|1330016|P6|STARTED|Period 3||2
544782|NCT00757601|1330017|P5|STARTED|Period 3||2
544783|NCT00757601|1330018|P4|STARTED|Period 3||2
544784|NCT00757601|1330019|P3|STARTED|Period 3||2
544785|NCT00757601|1330020|P2|STARTED|Period 3||2
544786|NCT00757601|1330021|P1|STARTED|Period 3||2
544787|NCT00757601|1330010|P12|NOT COMPLETED|Period 2||1
544788|NCT00757601|1330011|P11|NOT COMPLETED|Period 2||0
544789|NCT00757601|1330012|P10|NOT COMPLETED|Period 2||0
544790|NCT00757601|1330013|P9|NOT COMPLETED|Period 2||0
544791|NCT00757601|1330014|P8|NOT COMPLETED|Period 2||0
544792|NCT00757601|1330015|P7|NOT COMPLETED|Period 2||0
544793|NCT00757601|1330016|P6|NOT COMPLETED|Period 2||0
544794|NCT00757601|1330017|P5|NOT COMPLETED|Period 2||0
544795|NCT00757601|1330018|P4|NOT COMPLETED|Period 2||0
544796|NCT00757601|1330019|P3|NOT COMPLETED|Period 2||0
544797|NCT00757601|1330020|P2|NOT COMPLETED|Period 2||0
544798|NCT00757601|1330021|P1|NOT COMPLETED|Period 2||0
544799|NCT00757601|1330010|P12|COMPLETED|Period 2|One participant discontinued the study after Period 2 and was replaced by another participant.|2
544800|NCT00757601|1330011|P11|COMPLETED|Period 2||2
544801|NCT00757601|1330012|P10|COMPLETED|Period 2||2
544802|NCT00757601|1330013|P9|COMPLETED|Period 2||2
544803|NCT00757601|1330014|P8|COMPLETED|Period 2||2
544804|NCT00757601|1330015|P7|COMPLETED|Period 2||2
544805|NCT00757601|1330016|P6|COMPLETED|Period 2||2
544806|NCT00757601|1330017|P5|COMPLETED|Period 2||2
544807|NCT00757601|1330018|P4|COMPLETED|Period 2||2
544808|NCT00757601|1330019|P3|COMPLETED|Period 2||2
544809|NCT00757601|1330020|P2|COMPLETED|Period 2||2
544810|NCT00757601|1330021|P1|COMPLETED|Period 2||2
544811|NCT00757601|1330010|P12|STARTED|Period 2||3
544812|NCT00757601|1330011|P11|STARTED|Period 2||2
544813|NCT00757601|1330012|P10|STARTED|Period 2||2
544814|NCT00757601|1330013|P9|STARTED|Period 2||2
544815|NCT00757601|1330014|P8|STARTED|Period 2||2
544816|NCT00757601|1330015|P7|STARTED|Period 2||2
544817|NCT00757601|1330016|P6|STARTED|Period 2||2
544818|NCT00757601|1330017|P5|STARTED|Period 2||2
544819|NCT00757601|1330018|P4|STARTED|Period 2||2
544820|NCT00757601|1330019|P3|STARTED|Period 2||2
544821|NCT00757601|1330020|P2|STARTED|Period 2||2
544822|NCT00757601|1330021|P1|STARTED|Period 2||2
544823|NCT00757601|1330010|P12|NOT COMPLETED|Period 1||0
544824|NCT00757601|1330011|P11|NOT COMPLETED|Period 1||0
544825|NCT00757601|1330012|P10|NOT COMPLETED|Period 1||0
544826|NCT00757601|1330013|P9|NOT COMPLETED|Period 1||0
544827|NCT00757601|1330014|P8|NOT COMPLETED|Period 1||0
544828|NCT00757601|1330015|P7|NOT COMPLETED|Period 1||0
544829|NCT00757601|1330016|P6|NOT COMPLETED|Period 1||0
544830|NCT00757601|1330017|P5|NOT COMPLETED|Period 1||0
544831|NCT00757601|1330018|P4|NOT COMPLETED|Period 1||0
544832|NCT00757601|1330019|P3|NOT COMPLETED|Period 1||0
544833|NCT00757601|1330020|P2|NOT COMPLETED|Period 1||0
544834|NCT00757601|1330021|P1|NOT COMPLETED|Period 1||0
544835|NCT00757601|1330010|P12|COMPLETED|Period 1||3
544836|NCT00757601|1330011|P11|COMPLETED|Period 1||2
544837|NCT00757601|1330012|P10|COMPLETED|Period 1||2
544838|NCT00757601|1330013|P9|COMPLETED|Period 1||2
544839|NCT00757601|1330014|P8|COMPLETED|Period 1||2
544840|NCT00757601|1330015|P7|COMPLETED|Period 1||2
544841|NCT00757601|1330016|P6|COMPLETED|Period 1||2
544842|NCT00757601|1330017|P5|COMPLETED|Period 1||2
544843|NCT00757601|1330018|P4|COMPLETED|Period 1||2
544844|NCT00757601|1330019|P3|COMPLETED|Period 1||2
544845|NCT00757601|1330020|P2|COMPLETED|Period 1||2
544846|NCT00757601|1330021|P1|COMPLETED|Period 1||2
544847|NCT00757601|1330010|P12|STARTED|Period 1||3
544848|NCT00757601|1330011|P11|STARTED|Period 1||2
544849|NCT00757601|1330012|P10|STARTED|Period 1||2
544850|NCT00757601|1330013|P9|STARTED|Period 1||2
544851|NCT00757601|1330014|P8|STARTED|Period 1||2
544852|NCT00757601|1330015|P7|STARTED|Period 1||2
544853|NCT00757601|1330016|P6|STARTED|Period 1||2
544854|NCT00757601|1330017|P5|STARTED|Period 1||2
544855|NCT00757601|1330018|P4|STARTED|Period 1||2
544856|NCT00757601|1330019|P3|STARTED|Period 1||2
544857|NCT00757601|1330020|P2|STARTED|Period 1||2
544858|NCT00757601|1330021|P1|STARTED|Period 1||2
544859|NCT00757588|1330132|P2|NOT COMPLETED|Period 2: Long-term (52-week) Phase||9
544860|NCT00757588|1330133|P1|NOT COMPLETED|Period 2: Long-term (52-week) Phase||22
544861|NCT00757588|1330132|P2|COMPLETED|Period 2: Long-term (52-week) Phase||125
544862|NCT00757588|1330133|P1|COMPLETED|Period 2: Long-term (52-week) Phase||246
544863|NCT00757588|1330132|P2|STARTED|Period 2: Long-term (52-week) Phase||134
544864|NCT00757588|1330133|P1|STARTED|Period 2: Long-term (52-week) Phase|270 participants completed short-term phase; 2 of these did not enter long-term phase.|268
544865|NCT00757588|1330132|P2|NOT COMPLETED|Period 1: Short-term (24-week) Phase||17
544866|NCT00757588|1330133|P1|NOT COMPLETED|Period 1: Short-term (24-week) Phase||36
544867|NCT00757588|1330132|P2|COMPLETED|Period 1: Short-term (24-week) Phase||134
544868|NCT00757588|1330133|P1|COMPLETED|Period 1: Short-term (24-week) Phase|Does not include 2 who completed Period 1 but were erroneously reported in the CSR as noncompleters.|268
544869|NCT00757588|1330132|P2|STARTED|Period 1: Short-term (24-week) Phase||151
544870|NCT00757588|1330133|P1|STARTED|Period 1: Short-term (24-week) Phase||304
544871|NCT00757484|1330165|P1|NOT COMPLETED|Overall Study||0
544872|NCT00757484|1330165|P1|COMPLETED|Overall Study||491
544873|NCT00757484|1330165|P1|STARTED|Overall Study||491
544874|NCT00757237|1330174|P2|NOT COMPLETED|Overall Study||25
544875|NCT00757237|1330175|P1|NOT COMPLETED|Overall Study||13
544876|NCT00757237|1330174|P2|COMPLETED|Overall Study||111
544877|NCT00757237|1330175|P1|COMPLETED|Overall Study||124
544878|NCT00757237|1330174|P2|Treated|Overall Study||132
544879|NCT00757237|1330175|P1|Treated|Overall Study||136
544880|NCT00757237|1330174|P2|STARTED|Overall Study||136
544881|NCT00757237|1330175|P1|STARTED|Overall Study||137
544882|NCT00757172|1330203|P1|NOT COMPLETED|Overall Study||11
544883|NCT00757172|1330203|P1|COMPLETED|Overall Study|Participants underwent surgery.|54
544884|NCT00757172|1330203|P1|STARTED|Overall Study||65
544885|NCT00757003|1330211|P1|NOT COMPLETED|Overall Study||49
544886|NCT00757003|1330211|P1|COMPLETED|Overall Study||51
544887|NCT00757003|1330211|P1|STARTED|Overall Study||100
544888|NCT00756977|1330219|P2|NOT COMPLETED|Overall Study||11
544889|NCT00756977|1330220|P1|NOT COMPLETED|Overall Study||21
544890|NCT00756977|1330219|P2|COMPLETED|Overall Study||187
544891|NCT00756977|1330220|P1|COMPLETED|Overall Study||175
544892|NCT00756977|1330219|P2|STARTED|Overall Study||198
544893|NCT00756977|1330220|P1|STARTED|Overall Study||196
544894|NCT00756964|1330248|P2|NOT COMPLETED|Overall Study||0
544895|NCT00756964|1330249|P1|NOT COMPLETED|Overall Study||0
544896|NCT00756964|1330248|P2|COMPLETED|Overall Study||13
544897|NCT00756964|1330249|P1|COMPLETED|Overall Study||13
544898|NCT00756964|1330248|P2|STARTED|Overall Study||13
544899|NCT00756964|1330249|P1|STARTED|Overall Study||13
544900|NCT00756938|1330258|P4|NOT COMPLETED|Optional Extension||37
544901|NCT00756938|1330259|P3|NOT COMPLETED|Optional Extension||0
544902|NCT00756938|1330260|P2|NOT COMPLETED|Optional Extension||0
544903|NCT00756938|1330261|P1|NOT COMPLETED|Optional Extension||0
544904|NCT00756938|1330258|P4|COMPLETED|Optional Extension||53
544905|NCT00756938|1330259|P3|COMPLETED|Optional Extension||0
544906|NCT00756938|1330260|P2|COMPLETED|Optional Extension||0
544907|NCT00756938|1330261|P1|COMPLETED|Optional Extension||0
544908|NCT00756938|1330258|P4|STARTED|Optional Extension|7 participants who completed base study opted not to enter extension|90
544909|NCT00756938|1330259|P3|STARTED|Optional Extension||0
544910|NCT00756938|1330260|P2|STARTED|Optional Extension||0
544911|NCT00756938|1330261|P1|STARTED|Optional Extension||0
544912|NCT00756938|1330258|P4|NOT COMPLETED|12-week Base Study||0
544913|NCT00756938|1330259|P3|NOT COMPLETED|12-week Base Study||2
544914|NCT00756938|1330260|P2|NOT COMPLETED|12-week Base Study||0
544915|NCT00756938|1330261|P1|NOT COMPLETED|12-week Base Study||2
544916|NCT00756938|1330258|P4|COMPLETED|12-week Base Study||0
544917|NCT00756938|1330259|P3|COMPLETED|12-week Base Study||32
544918|NCT00756938|1330260|P2|COMPLETED|12-week Base Study||34
544919|NCT00756938|1330261|P1|COMPLETED|12-week Base Study||31
544920|NCT00756938|1330258|P4|STARTED|12-week Base Study||0
544921|NCT00756938|1330259|P3|STARTED|12-week Base Study||34
544922|NCT00756938|1330260|P2|STARTED|12-week Base Study||34
544923|NCT00756938|1330261|P1|STARTED|12-week Base Study||33
544924|NCT00756886|1330289|P2|NOT COMPLETED|Overall Study||7
544925|NCT00756886|1330290|P1|NOT COMPLETED|Overall Study||11
544926|NCT00756886|1330289|P2|COMPLETED|Overall Study||25
544927|NCT00756886|1330290|P1|COMPLETED|Overall Study||30
544928|NCT00756886|1330289|P2|STARTED|Overall Study||32
544929|NCT00756886|1330290|P1|STARTED|Overall Study||41
544930|NCT00756730|1330298|P2|NOT COMPLETED|Overall Study||2
544931|NCT00756730|1330299|P1|NOT COMPLETED|Overall Study||0
544932|NCT00756730|1330298|P2|COMPLETED|Overall Study||22
544933|NCT00756730|1330299|P1|COMPLETED|Overall Study||25
544934|NCT00756730|1330298|P2|STARTED|Overall Study||24
544935|NCT00756730|1330299|P1|STARTED|Overall Study||25
544936|NCT00756678|1330319|P1|NOT COMPLETED|Overall Study||1
544937|NCT00756678|1330319|P1|COMPLETED|Overall Study||50
544938|NCT00756678|1330319|P1|STARTED|Overall Study||51
544939|NCT00756574|1330332|P2|NOT COMPLETED|Overall Study||11
544940|NCT00756574|1330333|P1|NOT COMPLETED|Overall Study||13
544941|NCT00756574|1330332|P2|COMPLETED|Overall Study||210
544942|NCT00756574|1330333|P1|COMPLETED|Overall Study||212
544943|NCT00756574|1330332|P2|STARTED|Overall Study||221
544944|NCT00756574|1330333|P1|STARTED|Overall Study||225
544945|NCT00756561|1330343|P1|NOT COMPLETED|Overall Study||0
544946|NCT00756561|1330343|P1|COMPLETED|Overall Study||10
544947|NCT00756561|1330343|P1|STARTED|Overall Study||10
544948|NCT00756548|1330350|P2|NOT COMPLETED|Overall Study||0
544949|NCT00756548|1330351|P1|NOT COMPLETED|Overall Study||2
544950|NCT00756548|1330350|P2|COMPLETED|Overall Study||185
544951|NCT00756548|1330351|P1|COMPLETED|Overall Study||184
544952|NCT00756548|1330350|P2|STARTED|Overall Study||185
544953|NCT00756548|1330351|P1|STARTED|Overall Study||186
544954|NCT00756470|1330377|P1|NOT COMPLETED|Overall Study||5
544955|NCT00756470|1330377|P1|COMPLETED|Overall Study||10
544956|NCT00756470|1330377|P1|STARTED|Overall Study||15
544957|NCT00756457|1330384|P2|NOT COMPLETED|Overall Study||2
544958|NCT00756457|1330385|P1|NOT COMPLETED|Overall Study||1
544959|NCT00756457|1330384|P2|COMPLETED|Overall Study|One participant moved overseas; the other participant resumed cancer treatment|17
544960|NCT00756457|1330385|P1|COMPLETED|Overall Study|One participant in the Active treatment group decided to have surgery after the 2 week follow-up.|19
544961|NCT00756457|1330384|P2|STARTED|Overall Study||19
544962|NCT00756457|1330385|P1|STARTED|Overall Study||20
544963|NCT00756444|1330415|P2|NOT COMPLETED|Overall Study||21
544964|NCT00756444|1330416|P1|NOT COMPLETED|Overall Study||15
544965|NCT00756444|1330415|P2|COMPLETED|Overall Study||13
544966|NCT00756444|1330416|P1|COMPLETED|Overall Study||18
544967|NCT00756444|1330415|P2|STARTED|Overall Study||34
544968|NCT00756444|1330416|P1|STARTED|Overall Study||33
544969|NCT00756314|1330427|P2|NOT COMPLETED|Overall Study||59
544970|NCT00756314|1330428|P1|NOT COMPLETED|Overall Study||2
544971|NCT00756314|1330427|P2|COMPLETED|Overall Study|"4 participants did not do the follow up, 55 discontinued and were analyzed by intention to treat"|64
544972|NCT00756314|1330428|P1|COMPLETED|Overall Study|"2 participants discontinued the intervention and were analyzed by intention to treat analysis."|121
544973|NCT00756314|1330427|P2|STARTED|Overall Study||123
544974|NCT00756314|1330428|P1|STARTED|Overall Study||123
544975|NCT00756275|1330444|P2|NOT COMPLETED|Overall Study||28
544976|NCT00756275|1330445|P1|NOT COMPLETED|Overall Study||29
544977|NCT00756275|1330444|P2|COMPLETED|Overall Study||49
544978|NCT00756275|1330445|P1|COMPLETED|Overall Study||31
544979|NCT00756275|1330444|P2|STARTED|Overall Study||77
544980|NCT00756275|1330445|P1|STARTED|Overall Study||60
544981|NCT00756236|1330472|P3|NOT COMPLETED|Overall Study||0
544982|NCT00756236|1330473|P2|NOT COMPLETED|Overall Study||0
544983|NCT00756236|1330474|P1|NOT COMPLETED|Overall Study||0
544984|NCT00756236|1330472|P3|COMPLETED|Overall Study||20
544985|NCT00756236|1330473|P2|COMPLETED|Overall Study||20
544986|NCT00756236|1330474|P1|COMPLETED|Overall Study||20
544987|NCT00756236|1330472|P3|STARTED|Overall Study||20
544988|NCT00756236|1330473|P2|STARTED|Overall Study||20
544989|NCT00756236|1330474|P1|STARTED|Overall Study||20
544990|NCT00756093|1330482|P4|NOT COMPLETED|Fourth Intervention||0
544991|NCT00756093|1330483|P3|NOT COMPLETED|Fourth Intervention||0
544992|NCT00756093|1330484|P2|NOT COMPLETED|Fourth Intervention||0
544993|NCT00756093|1330485|P1|NOT COMPLETED|Fourth Intervention||0
544994|NCT00756093|1330482|P4|COMPLETED|Fourth Intervention||5
544995|NCT00756093|1330483|P3|COMPLETED|Fourth Intervention||5
544996|NCT00756093|1330484|P2|COMPLETED|Fourth Intervention||5
544997|NCT00756093|1330485|P1|COMPLETED|Fourth Intervention||5
544998|NCT00756093|1330482|P4|STARTED|Fourth Intervention||5
544999|NCT00756093|1330483|P3|STARTED|Fourth Intervention||5
545000|NCT00756093|1330484|P2|STARTED|Fourth Intervention||5
545001|NCT00756093|1330485|P1|STARTED|Fourth Intervention||5
545002|NCT00756093|1330482|P4|NOT COMPLETED|Third Intervention||0
545003|NCT00756093|1330483|P3|NOT COMPLETED|Third Intervention||0
545004|NCT00756093|1330484|P2|NOT COMPLETED|Third Intervention||0
545005|NCT00756093|1330485|P1|NOT COMPLETED|Third Intervention||0
545006|NCT00756093|1330482|P4|COMPLETED|Third Intervention||5
545007|NCT00756093|1330483|P3|COMPLETED|Third Intervention||5
545008|NCT00756093|1330484|P2|COMPLETED|Third Intervention||5
545009|NCT00756093|1330485|P1|COMPLETED|Third Intervention||5
545010|NCT00756093|1330482|P4|STARTED|Third Intervention||5
545011|NCT00756093|1330483|P3|STARTED|Third Intervention||5
545012|NCT00756093|1330484|P2|STARTED|Third Intervention||5
545013|NCT00756093|1330485|P1|STARTED|Third Intervention||5
545014|NCT00756093|1330482|P4|NOT COMPLETED|Second Intervention||0
545015|NCT00756093|1330483|P3|NOT COMPLETED|Second Intervention||0
545016|NCT00756093|1330484|P2|NOT COMPLETED|Second Intervention||0
545017|NCT00756093|1330485|P1|NOT COMPLETED|Second Intervention||0
545018|NCT00756093|1330482|P4|COMPLETED|Second Intervention||5
545019|NCT00756093|1330483|P3|COMPLETED|Second Intervention||5
545020|NCT00756093|1330484|P2|COMPLETED|Second Intervention||5
545021|NCT00756093|1330485|P1|COMPLETED|Second Intervention||5
545022|NCT00756093|1330482|P4|STARTED|Second Intervention||5
545023|NCT00756093|1330483|P3|STARTED|Second Intervention||5
545024|NCT00756093|1330484|P2|STARTED|Second Intervention||5
545025|NCT00756093|1330485|P1|STARTED|Second Intervention||5
545026|NCT00756093|1330482|P4|NOT COMPLETED|First Intervention||0
545027|NCT00756093|1330483|P3|NOT COMPLETED|First Intervention||0
545028|NCT00756093|1330484|P2|NOT COMPLETED|First Intervention||0
545029|NCT00756093|1330485|P1|NOT COMPLETED|First Intervention||0
545030|NCT00756093|1330482|P4|COMPLETED|First Intervention||5
545031|NCT00756093|1330483|P3|COMPLETED|First Intervention||5
545032|NCT00756093|1330484|P2|COMPLETED|First Intervention||5
545033|NCT00756093|1330485|P1|COMPLETED|First Intervention||5
545034|NCT00756093|1330482|P4|STARTED|First Intervention||5
545035|NCT00756093|1330483|P3|STARTED|First Intervention||5
545036|NCT00756093|1330484|P2|STARTED|First Intervention||5
545037|NCT00756093|1330485|P1|STARTED|First Intervention||5
545038|NCT00756002|1330497|P2|NOT COMPLETED|Placebo Run-out||0
545039|NCT00756002|1330498|P1|NOT COMPLETED|Placebo Run-out||0
545040|NCT00756002|1330497|P2|COMPLETED|Placebo Run-out||0
545041|NCT00756002|1330498|P1|COMPLETED|Placebo Run-out||114
545042|NCT00756002|1330497|P2|STARTED|Placebo Run-out||0
545043|NCT00756002|1330498|P1|STARTED|Placebo Run-out||114
545044|NCT00756002|1330497|P2|NOT COMPLETED|Double-Blind Treatment Period||15
545045|NCT00756002|1330498|P1|NOT COMPLETED|Double-Blind Treatment Period||15
545046|NCT00756002|1330497|P2|COMPLETED|Double-Blind Treatment Period||115
545047|NCT00756002|1330498|P1|COMPLETED|Double-Blind Treatment Period||114
545048|NCT00756002|1330497|P2|STARTED|Double-Blind Treatment Period||130
545049|NCT00756002|1330498|P1|STARTED|Double-Blind Treatment Period||129
545050|NCT00756002|1330497|P2|NOT COMPLETED|Placebo Run-in||0
545051|NCT00756002|1330498|P1|NOT COMPLETED|Placebo Run-in||229
545052|NCT00756002|1330497|P2|COMPLETED|Placebo Run-in||0
545053|NCT00756002|1330498|P1|COMPLETED|Placebo Run-in||259
545054|NCT00756002|1330497|P2|STARTED|Placebo Run-in||0
545055|NCT00756002|1330498|P1|STARTED|Placebo Run-in||488
545056|NCT00755937|1330592|P1|NOT COMPLETED|Observational Follow-up||148
545057|NCT00755937|1330592|P1|COMPLETED|Observational Follow-up|Subjects followed until end of study/subjects for whom end of participation data were collected|244
545058|NCT00755937|1330592|P1|STARTED|Observational Follow-up||392
545059|NCT00755937|1330592|P1|NOT COMPLETED|Recruitment||164
545060|NCT00755937|1330592|P1|COMPLETED|Recruitment|Subjects who had a baseline visit and at least 1 additional follow-up visit (analyzed population)|392
545061|NCT00755937|1330592|P1|STARTED|Recruitment|Subjects registered in the program|556
545062|NCT00755911|1330604|P2|NOT COMPLETED|Overall Study||0
545063|NCT00755911|1330605|P1|NOT COMPLETED|Overall Study||0
545064|NCT00755911|1330604|P2|COMPLETED|Overall Study||12
545065|NCT00755911|1330605|P1|COMPLETED|Overall Study||12
545066|NCT00755911|1330604|P2|STARTED|Overall Study||12
545067|NCT00755911|1330605|P1|STARTED|Overall Study||12
545068|NCT00755846|1330619|P6|NOT COMPLETED|Overall Study||14
545069|NCT00755846|1330620|P5|NOT COMPLETED|Overall Study||17
545070|NCT00755846|1330621|P4|NOT COMPLETED|Overall Study||13
545071|NCT00755846|1330622|P3|NOT COMPLETED|Overall Study||12
545072|NCT00755846|1330623|P2|NOT COMPLETED|Overall Study||17
545073|NCT00755846|1330624|P1|NOT COMPLETED|Overall Study||25
545074|NCT00755846|1330619|P6|COMPLETED|Overall Study||31
545075|NCT00755846|1330620|P5|COMPLETED|Overall Study||27
545076|NCT00755846|1330621|P4|COMPLETED|Overall Study||32
545077|NCT00755846|1330622|P3|COMPLETED|Overall Study||32
545078|NCT00755846|1330623|P2|COMPLETED|Overall Study||27
545079|NCT00755846|1330624|P1|COMPLETED|Overall Study||18
545080|NCT00755846|1330619|P6|STARTED|Overall Study||45
545081|NCT00755846|1330620|P5|STARTED|Overall Study||44
545082|NCT00755846|1330621|P4|STARTED|Overall Study||45
545083|NCT00755846|1330622|P3|STARTED|Overall Study||44
545084|NCT00755846|1330623|P2|STARTED|Overall Study||44
545085|NCT00755846|1330624|P1|STARTED|Overall Study||43
545086|NCT00755807|1330724|P2|NOT COMPLETED|Open-label Extension Phase||16
545087|NCT00755807|1330725|P1|NOT COMPLETED|Open-label Extension Phase||18
545088|NCT00755807|1330724|P2|COMPLETED|Open-label Extension Phase||93
545089|NCT00755807|1330725|P1|COMPLETED|Open-label Extension Phase||82
545090|NCT00755807|1330724|P2|STARTED|Open-label Extension Phase||109
545091|NCT00755807|1330725|P1|STARTED|Open-label Extension Phase||100
545092|NCT00755807|1330724|P2|NOT COMPLETED|Acute Phase||12
545093|NCT00755807|1330725|P1|NOT COMPLETED|Acute Phase||18
545094|NCT00755807|1330724|P2|COMPLETED|Acute Phase||109
545095|NCT00755807|1330725|P1|COMPLETED|Acute Phase||100
545096|NCT00755807|1330724|P2|STARTED|Acute Phase||121
545097|NCT00755807|1330725|P1|STARTED|Acute Phase||118
545098|NCT00755755|1330789|P3|NOT COMPLETED|Overall Study||3
545099|NCT00755755|1330790|P2|NOT COMPLETED|Overall Study||8
545100|NCT00755755|1330791|P1|NOT COMPLETED|Overall Study||6
545101|NCT00755755|1330789|P3|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|45
545102|NCT00755755|1330790|P2|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|90
545103|NCT00755755|1330791|P1|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|89
545104|NCT00755755|1330789|P3|STARTED|Overall Study|Safety population|48
545105|NCT00755755|1330790|P2|STARTED|Overall Study|Safety population|98
545106|NCT00755755|1330791|P1|STARTED|Overall Study|Safety population|95
545107|NCT00755716|1330805|P3|NOT COMPLETED|Overall Study||3
545108|NCT00755716|1330806|P2|NOT COMPLETED|Overall Study||8
545109|NCT00755716|1330807|P1|NOT COMPLETED|Overall Study||8
545110|NCT00755716|1330805|P3|COMPLETED|Overall Study||16
545111|NCT00755716|1330806|P2|COMPLETED|Overall Study||11
545112|NCT00755716|1330807|P1|COMPLETED|Overall Study||11
545113|NCT00755716|1330805|P3|STARTED|Overall Study||19
545114|NCT00755716|1330806|P2|STARTED|Overall Study||19
545115|NCT00755716|1330807|P1|STARTED|Overall Study||19
545116|NCT00755417|1330821|P3|NOT COMPLETED|Overall Study||42
545117|NCT00755417|1330822|P2|NOT COMPLETED|Overall Study||55
545118|NCT00755417|1330823|P1|NOT COMPLETED|Overall Study||62
545119|NCT00755417|1330821|P3|COMPLETED|Overall Study||135
545120|NCT00755417|1330822|P2|COMPLETED|Overall Study||126
545121|NCT00755417|1330823|P1|COMPLETED|Overall Study||112
545122|NCT00755417|1330821|P3|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|177
545123|NCT00755417|1330822|P2|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|181
545124|NCT00755417|1330823|P1|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|174
545125|NCT00755274|1330842|P2|NOT COMPLETED|Overall Study||0
545126|NCT00755274|1330843|P1|NOT COMPLETED|Overall Study||0
545127|NCT00755274|1330842|P2|COMPLETED|Overall Study||8
545128|NCT00755274|1330843|P1|COMPLETED|Overall Study||24
545129|NCT00755274|1330842|P2|STARTED|Overall Study||8
545130|NCT00755274|1330843|P1|STARTED|Overall Study||24
545131|NCT00755261|1330863|P1|NOT COMPLETED|Overall Study||2
545132|NCT00755261|1330863|P1|COMPLETED|Overall Study||4
545133|NCT00755261|1330863|P1|STARTED|Overall Study||6
545134|NCT00755235|1330869|P2|NOT COMPLETED|Overall Study||9
545135|NCT00755235|1330870|P1|NOT COMPLETED|Overall Study||2
545136|NCT00755235|1330869|P2|COMPLETED|Overall Study||93
545137|NCT00755235|1330870|P1|COMPLETED|Overall Study||104
545138|NCT00755235|1330869|P2|STARTED|Overall Study||102
545139|NCT00755235|1330870|P1|STARTED|Overall Study||106
545140|NCT00755222|1330880|P2|NOT COMPLETED|Overall Study||2
545141|NCT00755222|1330881|P1|NOT COMPLETED|Overall Study||8
545142|NCT00755222|1330880|P2|COMPLETED|Overall Study||34
545143|NCT00755222|1330881|P1|COMPLETED|Overall Study||103
545144|NCT00755222|1330880|P2|STARTED|Overall Study||36
545145|NCT00755222|1330881|P1|STARTED|Overall Study||111
545146|NCT00755196|1330895|P1|NOT COMPLETED|Overall Study||2
545147|NCT00755196|1330895|P1|COMPLETED|Overall Study||28
545148|NCT00755196|1330895|P1|STARTED|Overall Study||30
545149|NCT00755131|1330902|P2|NOT COMPLETED|Overall Study||0
545150|NCT00755131|1330903|P1|NOT COMPLETED|Overall Study||0
545151|NCT00755131|1330902|P2|COMPLETED|Overall Study||38
545152|NCT00755131|1330903|P1|COMPLETED|Overall Study||37
545153|NCT00755131|1330902|P2|STARTED|Overall Study||38
545154|NCT00755131|1330903|P1|STARTED|Overall Study||37
545155|NCT00755105|1330916|P3|NOT COMPLETED|Overall Study||4
545156|NCT00755105|1330917|P2|NOT COMPLETED|Overall Study||11
545157|NCT00755105|1330918|P1|NOT COMPLETED|Overall Study||9
545158|NCT00755105|1330916|P3|COMPLETED|Overall Study||5
545159|NCT00755105|1330917|P2|COMPLETED|Overall Study||19
545160|NCT00755105|1330918|P1|COMPLETED|Overall Study||29
545161|NCT00755105|1330916|P3|STARTED|Overall Study||9
545162|NCT00755105|1330917|P2|STARTED|Overall Study||30
545163|NCT00755105|1330918|P1|STARTED|Overall Study||38
545164|NCT00755079|1330928|P2|NOT COMPLETED|Overall Study||6
545165|NCT00755079|1330929|P1|NOT COMPLETED|Overall Study||1
545166|NCT00755079|1330928|P2|COMPLETED|Overall Study||16
545167|NCT00755079|1330929|P1|COMPLETED|Overall Study||17
545168|NCT00755079|1330928|P2|STARTED|Overall Study||22
545169|NCT00755079|1330929|P1|STARTED|Overall Study||18
545170|NCT00755040|1330939|P2|NOT COMPLETED|Overall Study||34
545171|NCT00755040|1330940|P1|NOT COMPLETED|Overall Study||43
545172|NCT00755040|1330939|P2|COMPLETED|Overall Study||47
545173|NCT00755040|1330940|P1|COMPLETED|Overall Study||40
545174|NCT00755040|1330939|P2|STARTED|Overall Study||81
545175|NCT00755040|1330940|P1|STARTED|Overall Study||83
545176|NCT00754923|1330948|P1|NOT COMPLETED|Overall Study||0
545177|NCT00754923|1330948|P1|COMPLETED|Overall Study||11
545178|NCT00754923|1330948|P1|STARTED|Overall Study||11
545179|NCT00754832|1330953|P2|NOT COMPLETED|Second 6 Weeks Intervention||2
545180|NCT00754832|1330954|P1|NOT COMPLETED|Second 6 Weeks Intervention||0
545181|NCT00754832|1330953|P2|COMPLETED|Second 6 Weeks Intervention||24
545182|NCT00754832|1330954|P1|COMPLETED|Second 6 Weeks Intervention||17
545183|NCT00754832|1330953|P2|STARTED|Second 6 Weeks Intervention||26
545184|NCT00754832|1330954|P1|STARTED|Second 6 Weeks Intervention||17
545185|NCT00754832|1330953|P2|NOT COMPLETED|2 Weeks Washout||2
545186|NCT00754832|1330954|P1|NOT COMPLETED|2 Weeks Washout||1
545187|NCT00754832|1330953|P2|COMPLETED|2 Weeks Washout||26
545188|NCT00754832|1330954|P1|COMPLETED|2 Weeks Washout||17
545189|NCT00754832|1330953|P2|STARTED|2 Weeks Washout||28
545190|NCT00754832|1330954|P1|STARTED|2 Weeks Washout||18
545191|NCT00754832|1330953|P2|NOT COMPLETED|First 6 Weeks Intervention||2
545192|NCT00754832|1330954|P1|NOT COMPLETED|First 6 Weeks Intervention||8
545193|NCT00754832|1330953|P2|COMPLETED|First 6 Weeks Intervention||28
545194|NCT00754832|1330954|P1|COMPLETED|First 6 Weeks Intervention||18
545195|NCT00754832|1330953|P2|STARTED|First 6 Weeks Intervention||30
545196|NCT00754832|1330954|P1|STARTED|First 6 Weeks Intervention||26
545197|NCT00754793|1330966|P2|NOT COMPLETED|Overall Study||1
545198|NCT00754793|1330967|P1|NOT COMPLETED|Overall Study||0
545199|NCT00754793|1330966|P2|COMPLETED|Overall Study||1
545200|NCT00754793|1330967|P1|COMPLETED|Overall Study||1
545201|NCT00754793|1330966|P2|STARTED|Overall Study||2
545202|NCT00754793|1330967|P1|STARTED|Overall Study||1
545203|NCT00754767|1330975|P2|NOT COMPLETED|Overall Study||0
545204|NCT00754767|1330976|P1|NOT COMPLETED|Overall Study||0
545205|NCT00754767|1330975|P2|COMPLETED|Overall Study||0
545206|NCT00754767|1330976|P1|COMPLETED|Overall Study||2
545207|NCT00754767|1330975|P2|STARTED|Overall Study||0
545208|NCT00754767|1330976|P1|STARTED|Overall Study||2
545209|NCT00754741|1330985|P3|NOT COMPLETED|Overall Study||54
545210|NCT00754741|1330986|P2|NOT COMPLETED|Overall Study||69
545211|NCT00754741|1330987|P1|NOT COMPLETED|Overall Study||57
545212|NCT00754741|1330985|P3|COMPLETED|Overall Study||502
545213|NCT00754741|1330986|P2|COMPLETED|Overall Study||500
545214|NCT00754741|1330987|P1|COMPLETED|Overall Study||510
545215|NCT00754741|1330985|P3|STARTED|Overall Study||556
545216|NCT00754741|1330986|P2|STARTED|Overall Study||569
545217|NCT00754741|1330987|P1|STARTED|Overall Study||567
545218|NCT00754650|1331034|P1|NOT COMPLETED|Overall Study||2
545219|NCT00754650|1331034|P1|COMPLETED|Overall Study||0
545220|NCT00754650|1331034|P1|STARTED|Overall Study||2
545221|NCT00754624|1331039|P1|NOT COMPLETED|Overall Study||69
545222|NCT00754624|1331039|P1|COMPLETED|Overall Study||160
545223|NCT00754624|1331039|P1|STARTED|Overall Study||229
545224|NCT00754572|1331049|P1|NOT COMPLETED|Overall Study||71
545225|NCT00754572|1331049|P1|COMPLETED|Overall Study||347
545226|NCT00754572|1331049|P1|STARTED|Overall Study||418
545227|NCT00754559|1331076|P1|NOT COMPLETED|Overall Study||47
545228|NCT00754559|1331076|P1|COMPLETED|Overall Study||239
545229|NCT00754559|1331076|P1|STARTED|Overall Study||286
545230|NCT00754546|1331100|P1|NOT COMPLETED|Overall Study||0
545231|NCT00754546|1331100|P1|COMPLETED|Overall Study||20
545232|NCT00754546|1331100|P1|STARTED|Overall Study||20
545233|NCT00754494|1331117|P3|NOT COMPLETED|Overall Study||1
545234|NCT00754494|1331118|P2|NOT COMPLETED|Overall Study||0
545235|NCT00754494|1331119|P1|NOT COMPLETED|Overall Study||2
545236|NCT00754494|1331117|P3|COMPLETED|Overall Study||14
545237|NCT00754494|1331118|P2|COMPLETED|Overall Study||15
545238|NCT00754494|1331119|P1|COMPLETED|Overall Study||13
545239|NCT00754494|1331117|P3|STARTED|Overall Study||15
545240|NCT00754494|1331118|P2|STARTED|Overall Study||15
545241|NCT00754494|1331119|P1|STARTED|Overall Study||15
545242|NCT00754468|1331165|P2|NOT COMPLETED|Overall Study||0
545243|NCT00754468|1331166|P1|NOT COMPLETED|Overall Study||0
545244|NCT00754468|1331165|P2|COMPLETED|Overall Study||3
545245|NCT00754468|1331166|P1|COMPLETED|Overall Study||4
545246|NCT00754468|1331165|P2|STARTED|Overall Study||3
545247|NCT00754468|1331166|P1|STARTED|Overall Study||4
545248|NCT00754442|1331176|P2|NOT COMPLETED|Overall Study||3
545249|NCT00754442|1331177|P1|NOT COMPLETED|Overall Study||5
545250|NCT00754442|1331176|P2|COMPLETED|Overall Study||6
545251|NCT00754442|1331177|P1|COMPLETED|Overall Study||6
545252|NCT00754442|1331176|P2|STARTED|Overall Study|patients 9|9
545253|NCT00754442|1331177|P1|STARTED|Overall Study|controls 11|11
545254|NCT00754390|1331184|P1|NOT COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||1
545255|NCT00754390|1331184|P1|COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||10
545256|NCT00754390|1331184|P1|STARTED|Ca/Phytate Test Meal 4 (Randomized)||11
545257|NCT00754390|1331184|P1|NOT COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||1
545258|NCT00754390|1331184|P1|COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||11
545259|NCT00754390|1331184|P1|STARTED|Ca/Phytate Test Meal 3 (Randomized)||12
545260|NCT00754390|1331184|P1|NOT COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||0
545261|NCT00754390|1331184|P1|COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||12
545262|NCT00754390|1331184|P1|STARTED|Ca/Phytate Test Meal 2 (Randomized)||12
545263|NCT00754390|1331184|P1|NOT COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||5
545264|NCT00754390|1331184|P1|COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||12
545265|NCT00754390|1331184|P1|STARTED|Ca/Phytate Test Meal 1 (Randomized)||17
545266|NCT00754377|1331193|P2|NOT COMPLETED|Overall Study||0
545267|NCT00754377|1331194|P1|NOT COMPLETED|Overall Study||0
545268|NCT00754377|1331193|P2|COMPLETED|Overall Study||42
545269|NCT00754377|1331194|P1|COMPLETED|Overall Study||50
545270|NCT00754377|1331193|P2|STARTED|Overall Study||42
545271|NCT00754377|1331194|P1|STARTED|Overall Study||50
545272|NCT00754338|1331206|P4|NOT COMPLETED|Second Intervention for Phase1&Phase2||1
545273|NCT00754338|1331207|P3|NOT COMPLETED|Second Intervention for Phase1&Phase2||0
545274|NCT00754338|1331208|P2|NOT COMPLETED|Second Intervention for Phase1&Phase2||1
545275|NCT00754338|1331209|P1|NOT COMPLETED|Second Intervention for Phase1&Phase2||0
545276|NCT00754338|1331206|P4|COMPLETED|Second Intervention for Phase1&Phase2||18
545277|NCT00754338|1331207|P3|COMPLETED|Second Intervention for Phase1&Phase2||16
545278|NCT00754338|1331208|P2|COMPLETED|Second Intervention for Phase1&Phase2||17
545279|NCT00754338|1331209|P1|COMPLETED|Second Intervention for Phase1&Phase2||17
545280|NCT00754338|1331206|P4|STARTED|Second Intervention for Phase1&Phase2||19
545281|NCT00754338|1331207|P3|STARTED|Second Intervention for Phase1&Phase2||16
545282|NCT00754338|1331208|P2|STARTED|Second Intervention for Phase1&Phase2||18
545283|NCT00754338|1331209|P1|STARTED|Second Intervention for Phase1&Phase2||17
545284|NCT00754338|1331206|P4|NOT COMPLETED|First Intervention for Phase1&Phase2||0
545285|NCT00754338|1331207|P3|NOT COMPLETED|First Intervention for Phase1&Phase2||3
545286|NCT00754338|1331208|P2|NOT COMPLETED|First Intervention for Phase1&Phase2||3
545287|NCT00754338|1331209|P1|NOT COMPLETED|First Intervention for Phase1&Phase2||0
545288|NCT00754338|1331206|P4|COMPLETED|First Intervention for Phase1&Phase2||19
545289|NCT00754338|1331207|P3|COMPLETED|First Intervention for Phase1&Phase2||16
545290|NCT00754338|1331208|P2|COMPLETED|First Intervention for Phase1&Phase2||18
545291|NCT00754338|1331209|P1|COMPLETED|First Intervention for Phase1&Phase2||17
545292|NCT00754338|1331206|P4|STARTED|First Intervention for Phase1&Phase2||19
545293|NCT00754338|1331207|P3|STARTED|First Intervention for Phase1&Phase2||19
545294|NCT00754338|1331208|P2|STARTED|First Intervention for Phase1&Phase2||21
545295|NCT00754338|1331209|P1|STARTED|First Intervention for Phase1&Phase2||17
545296|NCT00754325|1331241|P2|NOT COMPLETED|Progression and Cross-over||21
545297|NCT00754325|1331242|P1|NOT COMPLETED|Progression and Cross-over||0
545298|NCT00754325|1331241|P2|COMPLETED|Progression and Cross-over||0
545299|NCT00754325|1331242|P1|COMPLETED|Progression and Cross-over||0
545300|NCT00754325|1331241|P2|STARTED|Progression and Cross-over|Progressive disease participants in Arm 2 could add dasatinib (Arm 2b) at investigator discretion.|21
545301|NCT00754325|1331242|P1|STARTED|Progression and Cross-over|Arm 1 participants with dasatinib-related toxicity stop dasatinib, continue fulvestrant (Arm 1b).|0
545302|NCT00754325|1331241|P2|NOT COMPLETED|Initial Treatment||49
545303|NCT00754325|1331242|P1|NOT COMPLETED|Initial Treatment||50
545304|NCT00754325|1331241|P2|COMPLETED|Initial Treatment||0
545305|NCT00754325|1331242|P1|COMPLETED|Initial Treatment||0
545306|NCT00754325|1331241|P2|STARTED|Initial Treatment||49
545307|NCT00754325|1331242|P1|STARTED|Initial Treatment||50
545308|NCT00754234|1331261|P1|NOT COMPLETED|Overall Study||3
545309|NCT00754234|1331261|P1|COMPLETED|Overall Study|2 participants did not receive the Day 1,4,5,6 menu and 1 did not receive the Day 2 menu|13
545310|NCT00754234|1331261|P1|STARTED|Overall Study|7 Menus were consumed in randomized order|16
545311|NCT00754208|1331265|P1|NOT COMPLETED|Overall Study||0
545312|NCT00754208|1331265|P1|COMPLETED|Overall Study||7
545313|NCT00754208|1331265|P1|STARTED|Overall Study||7
545314|NCT00754156|1331274|P2|NOT COMPLETED|Overall Study||0
545315|NCT00754156|1331275|P1|NOT COMPLETED|Overall Study||0
545316|NCT00754156|1331274|P2|COMPLETED|Overall Study||6
545317|NCT00754156|1331275|P1|COMPLETED|Overall Study||8
545318|NCT00754156|1331274|P2|STARTED|Overall Study||6
545319|NCT00754156|1331275|P1|STARTED|Overall Study||8
545320|NCT00754130|1331299|P6|NOT COMPLETED|Period 2 (5 Days)||0
545321|NCT00754130|1331300|P5|NOT COMPLETED|Period 2 (5 Days)||0
545322|NCT00754130|1331301|P4|NOT COMPLETED|Period 2 (5 Days)||0
545323|NCT00754130|1331302|P3|NOT COMPLETED|Period 2 (5 Days)||0
545324|NCT00754130|1331303|P2|NOT COMPLETED|Period 2 (5 Days)||0
545325|NCT00754130|1331304|P1|NOT COMPLETED|Period 2 (5 Days)||0
545326|NCT00754130|1331299|P6|COMPLETED|Period 2 (5 Days)||4
545327|NCT00754130|1331300|P5|COMPLETED|Period 2 (5 Days)||2
545328|NCT00754130|1331301|P4|COMPLETED|Period 2 (5 Days)||2
545329|NCT00754130|1331302|P3|COMPLETED|Period 2 (5 Days)||4
545330|NCT00754130|1331303|P2|COMPLETED|Period 2 (5 Days)||2
545331|NCT00754130|1331304|P1|COMPLETED|Period 2 (5 Days)||2
545332|NCT00754130|1331299|P6|STARTED|Period 2 (5 Days)|One participant received MK-0941 35 mg starting with Dose 3 on Day 3.|4
545333|NCT00754130|1331300|P5|STARTED|Period 2 (5 Days)||2
545334|NCT00754130|1331301|P4|STARTED|Period 2 (5 Days)||2
545335|NCT00754130|1331302|P3|STARTED|Period 2 (5 Days)||4
545336|NCT00754130|1331303|P2|STARTED|Period 2 (5 Days)||2
545337|NCT00754130|1331304|P1|STARTED|Period 2 (5 Days)|One participant received MK-0941 15 mg starting with Dose 2 on Day 2.|2
545338|NCT00754130|1331299|P6|NOT COMPLETED|Washout Period (>=8 Days)||0
545339|NCT00754130|1331300|P5|NOT COMPLETED|Washout Period (>=8 Days)||0
545340|NCT00754130|1331301|P4|NOT COMPLETED|Washout Period (>=8 Days)||0
545341|NCT00754130|1331302|P3|NOT COMPLETED|Washout Period (>=8 Days)||0
545342|NCT00754130|1331303|P2|NOT COMPLETED|Washout Period (>=8 Days)||0
545343|NCT00754130|1331304|P1|NOT COMPLETED|Washout Period (>=8 Days)||0
545344|NCT00754130|1331299|P6|COMPLETED|Washout Period (>=8 Days)||4
545345|NCT00754130|1331300|P5|COMPLETED|Washout Period (>=8 Days)||2
545346|NCT00754130|1331301|P4|COMPLETED|Washout Period (>=8 Days)||2
545347|NCT00754130|1331302|P3|COMPLETED|Washout Period (>=8 Days)||4
545348|NCT00754130|1331303|P2|COMPLETED|Washout Period (>=8 Days)||2
545349|NCT00754130|1331304|P1|COMPLETED|Washout Period (>=8 Days)||2
545350|NCT00754130|1331299|P6|STARTED|Washout Period (>=8 Days)||4
545351|NCT00754130|1331300|P5|STARTED|Washout Period (>=8 Days)||2
545352|NCT00754130|1331301|P4|STARTED|Washout Period (>=8 Days)||2
545353|NCT00754130|1331302|P3|STARTED|Washout Period (>=8 Days)||4
545354|NCT00754130|1331303|P2|STARTED|Washout Period (>=8 Days)||2
545355|NCT00754130|1331304|P1|STARTED|Washout Period (>=8 Days)||2
545356|NCT00754130|1331299|P6|NOT COMPLETED|Period 1 (5 Days)||0
545357|NCT00754130|1331300|P5|NOT COMPLETED|Period 1 (5 Days)||0
545358|NCT00754130|1331301|P4|NOT COMPLETED|Period 1 (5 Days)||0
545359|NCT00754130|1331302|P3|NOT COMPLETED|Period 1 (5 Days)||0
545360|NCT00754130|1331303|P2|NOT COMPLETED|Period 1 (5 Days)||0
545361|NCT00754130|1331304|P1|NOT COMPLETED|Period 1 (5 Days)||0
545362|NCT00754130|1331299|P6|COMPLETED|Period 1 (5 Days)||4
545363|NCT00754130|1331300|P5|COMPLETED|Period 1 (5 Days)||2
545364|NCT00754130|1331301|P4|COMPLETED|Period 1 (5 Days)||2
545365|NCT00754130|1331302|P3|COMPLETED|Period 1 (5 Days)||4
545366|NCT00754130|1331303|P2|COMPLETED|Period 1 (5 Days)||2
545367|NCT00754130|1331304|P1|COMPLETED|Period 1 (5 Days)||2
545368|NCT00754130|1331299|P6|STARTED|Period 1 (5 Days)|One participant received MK-0941 10 mg in both Periods 1 and 2.|4
545369|NCT00754130|1331300|P5|STARTED|Period 1 (5 Days)||2
545370|NCT00754130|1331301|P4|STARTED|Period 1 (5 Days)||2
545371|NCT00754130|1331302|P3|STARTED|Period 1 (5 Days)||4
545372|NCT00754130|1331303|P2|STARTED|Period 1 (5 Days)||2
545373|NCT00754130|1331304|P1|STARTED|Period 1 (5 Days)||2
545374|NCT00754065|1331347|P2|NOT COMPLETED|Overall Study||80
545375|NCT00754065|1331348|P1|NOT COMPLETED|Overall Study||81
545376|NCT00754065|1331347|P2|COMPLETED|Overall Study||126
545377|NCT00754065|1331348|P1|COMPLETED|Overall Study||122
545378|NCT00754065|1331347|P2|Cycle 6|Overall Study||153
545379|NCT00754065|1331348|P1|Cycle 6|Overall Study||141
545380|NCT00754065|1331347|P2|Participants Received Treatment|Overall Study||204
545381|NCT00754065|1331348|P1|Participants Received Treatment|Overall Study||191
545382|NCT00754065|1331347|P2|STARTED|Overall Study||206
545383|NCT00754065|1331348|P1|STARTED|Overall Study||203
545384|NCT00754052|1331588|P2|NOT COMPLETED|Overall Study||3
545385|NCT00754052|1331589|P1|NOT COMPLETED|Overall Study||5
545386|NCT00754052|1331588|P2|COMPLETED|Overall Study||0
545387|NCT00754052|1331589|P1|COMPLETED|Overall Study||0
545388|NCT00754052|1331588|P2|STARTED|Overall Study||3
545389|NCT00754052|1331589|P1|STARTED|Overall Study||5
545390|NCT00754013|1331603|P2|NOT COMPLETED|Overall Study||5
545391|NCT00754013|1331604|P1|NOT COMPLETED|Overall Study||4
545392|NCT00754013|1331603|P2|COMPLETED|Overall Study||0
545393|NCT00754013|1331604|P1|COMPLETED|Overall Study||0
545394|NCT00754013|1331603|P2|STARTED|Overall Study||5
545395|NCT00754013|1331604|P1|STARTED|Overall Study||4
545396|NCT00753948|1331615|P3|NOT COMPLETED|Overall Study||0
545397|NCT00753948|1331616|P2|NOT COMPLETED|Overall Study||0
545398|NCT00753948|1331617|P1|NOT COMPLETED|Overall Study||0
545399|NCT00753948|1331615|P3|COMPLETED|Overall Study||7
545400|NCT00753948|1331616|P2|COMPLETED|Overall Study||7
545401|NCT00753948|1331617|P1|COMPLETED|Overall Study||9
545402|NCT00753948|1331615|P3|STARTED|Overall Study||7
545403|NCT00753948|1331616|P2|STARTED|Overall Study||7
545404|NCT00753948|1331617|P1|STARTED|Overall Study||9
545405|NCT00753935|1331627|P2|NOT COMPLETED|Overall Study||0
545406|NCT00753935|1331628|P1|NOT COMPLETED|Overall Study||0
545407|NCT00753935|1331627|P2|COMPLETED|Overall Study||47
545408|NCT00753935|1331628|P1|COMPLETED|Overall Study||45
545409|NCT00753935|1331627|P2|STARTED|Overall Study||47
545410|NCT00753935|1331628|P1|STARTED|Overall Study||45
545411|NCT00753922|1331638|P4|NOT COMPLETED|Overall Study||23
545412|NCT00753922|1331639|P3|NOT COMPLETED|Overall Study||63
545413|NCT00753922|1331640|P2|NOT COMPLETED|Overall Study||94
545414|NCT00753922|1331641|P1|NOT COMPLETED|Overall Study||246
545415|NCT00753922|1331638|P4|COMPLETED|Overall Study||37
545416|NCT00753922|1331639|P3|COMPLETED|Overall Study||82
545417|NCT00753922|1331640|P2|COMPLETED|Overall Study||157
545418|NCT00753922|1331641|P1|COMPLETED|Overall Study||306
545419|NCT00753922|1331638|P4|STARTED|Overall Study||60
545420|NCT00753922|1331639|P3|STARTED|Overall Study||145
545421|NCT00753922|1331640|P2|STARTED|Overall Study||251
545422|NCT00753922|1331641|P1|STARTED|Overall Study||552
545423|NCT00753896|1331671|P1|NOT COMPLETED|Overall Study||16
545424|NCT00753896|1331671|P1|COMPLETED|Overall Study||118
545425|NCT00753896|1331671|P1|STARTED|Overall Study||134
545426|NCT00753766|1331687|P2|NOT COMPLETED|Overall Study||0
545427|NCT00753766|1331688|P1|NOT COMPLETED|Overall Study||1
545428|NCT00753766|1331687|P2|COMPLETED|Overall Study||0
545429|NCT00753766|1331688|P1|COMPLETED|Overall Study||0
545430|NCT00753766|1331687|P2|STARTED|Overall Study||0
545431|NCT00753766|1331688|P1|STARTED|Overall Study||1
545432|NCT00753714|1331698|P2|NOT COMPLETED|Overall Study||62
545433|NCT00753714|1331699|P1|NOT COMPLETED|Overall Study||60
545434|NCT00753714|1331698|P2|COMPLETED|Overall Study||1
545435|NCT00753714|1331699|P1|COMPLETED|Overall Study||1
545436|NCT00753714|1331698|P2|STARTED|Overall Study||63
545437|NCT00753714|1331699|P1|STARTED|Overall Study||61
545438|NCT00753688|1331715|P2|NOT COMPLETED|Overall Study||246
545439|NCT00753688|1331716|P1|NOT COMPLETED|Overall Study||123
545440|NCT00753688|1331715|P2|COMPLETED|Overall Study||0
545441|NCT00753688|1331716|P1|COMPLETED|Overall Study||0
545442|NCT00753688|1331715|P2|Ongoing - in Follow-up|Overall Study||31
545443|NCT00753688|1331716|P1|Ongoing - in Follow-up|Overall Study||15
545444|NCT00753688|1331715|P2|STARTED|Overall Study||246
545445|NCT00753688|1331716|P1|STARTED|Overall Study||123
545446|NCT00753675|1331745|P3|NOT COMPLETED|Overall Study||56
545447|NCT00753675|1331746|P2|NOT COMPLETED|Overall Study||59
545448|NCT00753675|1331747|P1|NOT COMPLETED|Overall Study||59
545449|NCT00753675|1331745|P3|COMPLETED|Overall Study||0
545450|NCT00753675|1331746|P2|COMPLETED|Overall Study||0
545451|NCT00753675|1331747|P1|COMPLETED|Overall Study||0
545452|NCT00753675|1331745|P3|STARTED|Overall Study||56
545453|NCT00753675|1331746|P2|STARTED|Overall Study||59
545454|NCT00753675|1331747|P1|STARTED|Overall Study||59
545455|NCT00753649|1331769|P2|NOT COMPLETED|Overall Study||0
545456|NCT00753649|1331770|P1|NOT COMPLETED|Overall Study||7
545457|NCT00753649|1331769|P2|COMPLETED|Overall Study||112
545458|NCT00753649|1331770|P1|COMPLETED|Overall Study||105
545459|NCT00753649|1331769|P2|STARTED|Overall Study||112
545460|NCT00753649|1331770|P1|STARTED|Overall Study||112
545461|NCT00753636|1331790|P1|NOT COMPLETED|Overall Study||6
545462|NCT00753636|1331790|P1|COMPLETED|Overall Study||25
545463|NCT00753636|1331790|P1|STARTED|Overall Study||31
545464|NCT00753623|1331802|P2|NOT COMPLETED|Phase II (14 Days)||1
545465|NCT00753623|1331803|P1|NOT COMPLETED|Phase II (14 Days)||0
545466|NCT00753623|1331802|P2|COMPLETED|Phase II (14 Days)||7
545467|NCT00753623|1331803|P1|COMPLETED|Phase II (14 Days)||8
545468|NCT00753623|1331802|P2|STARTED|Phase II (14 Days)||8
545469|NCT00753623|1331803|P1|STARTED|Phase II (14 Days)||8
545470|NCT00753623|1331802|P2|NOT COMPLETED|Washout (7 Days)||0
545471|NCT00753623|1331803|P1|NOT COMPLETED|Washout (7 Days)||1
545472|NCT00753623|1331802|P2|COMPLETED|Washout (7 Days)||8
545473|NCT00753623|1331803|P1|COMPLETED|Washout (7 Days)||8
545474|NCT00753623|1331802|P2|STARTED|Washout (7 Days)||8
545475|NCT00753623|1331803|P1|STARTED|Washout (7 Days)||9
545476|NCT00753623|1331802|P2|NOT COMPLETED|Phase I (14 Days)||4
545477|NCT00753623|1331803|P1|NOT COMPLETED|Phase I (14 Days)||2
545478|NCT00753623|1331802|P2|COMPLETED|Phase I (14 Days)||8
545479|NCT00753623|1331803|P1|COMPLETED|Phase I (14 Days)||9
545480|NCT00753623|1331802|P2|STARTED|Phase I (14 Days)||12
545481|NCT00753623|1331803|P1|STARTED|Phase I (14 Days)||11
545482|NCT00753545|1331811|P2|NOT COMPLETED|Overall Study||118
545483|NCT00753545|1331812|P1|NOT COMPLETED|Overall Study||108
545484|NCT00753545|1331811|P2|COMPLETED|Overall Study|Patients completing the Study|11
545485|NCT00753545|1331812|P1|COMPLETED|Overall Study|Patients completing the Study|28
545486|NCT00753545|1331811|P2|STARTED|Overall Study|Patients randomized|129
545487|NCT00753545|1331812|P1|STARTED|Overall Study|Patients randomized|136
545488|NCT00753519|1331850|P2|NOT COMPLETED|Overall Study||2
545489|NCT00753519|1331851|P1|NOT COMPLETED|Overall Study||0
545490|NCT00753519|1331850|P2|COMPLETED|Overall Study||13
545491|NCT00753519|1331851|P1|COMPLETED|Overall Study||13
545492|NCT00753519|1331850|P2|STARTED|Overall Study||15
545493|NCT00753519|1331851|P1|STARTED|Overall Study||13
545494|NCT00753506|1331873|P2|NOT COMPLETED|Overall Study||2
545495|NCT00753506|1331874|P1|NOT COMPLETED|Overall Study||7
545496|NCT00753506|1331873|P2|COMPLETED|Overall Study||31
545497|NCT00753506|1331874|P1|COMPLETED|Overall Study||26
545498|NCT00753506|1331873|P2|STARTED|Overall Study||33
545499|NCT00753506|1331874|P1|STARTED|Overall Study||33
545500|NCT00753454|1331880|P1|NOT COMPLETED|Overall Study||14
545501|NCT00753454|1331880|P1|COMPLETED|Overall Study||154
545502|NCT00753454|1331880|P1|STARTED|Overall Study||168
545503|NCT00753415|1331914|P10|NOT COMPLETED|Part B||1
545504|NCT00753415|1331915|P9|NOT COMPLETED|Part B||3
545505|NCT00753415|1331916|P8|NOT COMPLETED|Part B||1
545506|NCT00753415|1331917|P7|NOT COMPLETED|Part B||0
545507|NCT00753415|1331918|P6|NOT COMPLETED|Part B||0
545508|NCT00753415|1331919|P5|NOT COMPLETED|Part B||0
545509|NCT00753415|1331920|P4|NOT COMPLETED|Part B||0
545510|NCT00753415|1331921|P3|NOT COMPLETED|Part B||0
545511|NCT00753415|1331922|P2|NOT COMPLETED|Part B||0
545512|NCT00753415|1331923|P1|NOT COMPLETED|Part B||0
545513|NCT00753415|1331914|P10|COMPLETED|Part B||8
545514|NCT00753415|1331915|P9|COMPLETED|Part B||6
545515|NCT00753415|1331916|P8|COMPLETED|Part B||6
545516|NCT00753415|1331917|P7|COMPLETED|Part B||2
545517|NCT00753415|1331918|P6|COMPLETED|Part B||1
545518|NCT00753415|1331919|P5|COMPLETED|Part B||0
545519|NCT00753415|1331920|P4|COMPLETED|Part B||0
545520|NCT00753415|1331921|P3|COMPLETED|Part B||0
545521|NCT00753415|1331922|P2|COMPLETED|Part B||0
545522|NCT00753415|1331923|P1|COMPLETED|Part B||0
545523|NCT00753415|1331914|P10|STARTED|Part B|Of 10 eligible participants who completed Part A, 9 chose to enter Part B|9
545524|NCT00753415|1331915|P9|STARTED|Part B|9 participants who completed Part A were eligible and enrolled in Part B|9
545525|NCT00753415|1331916|P8|STARTED|Part B|Of 8 eligible participants who completed Part A, 7 chose to enter Part B|7
545526|NCT00753415|1331917|P7|STARTED|Part B|Of 3 eligible participants who completed Part A, 2 chose to enter Part B|2
545527|NCT00753415|1331918|P6|STARTED|Part B|Of 2 eligible participants who completed Part A, 1 chose to enter Part B|1
545528|NCT00753415|1331919|P5|STARTED|Part B||0
545529|NCT00753415|1331920|P4|STARTED|Part B||0
545530|NCT00753415|1331921|P3|STARTED|Part B||0
545531|NCT00753415|1331922|P2|STARTED|Part B||0
545532|NCT00753415|1331923|P1|STARTED|Part B||0
545533|NCT00753415|1331914|P10|NOT COMPLETED|Part A||0
545534|NCT00753415|1331915|P9|NOT COMPLETED|Part A||0
545535|NCT00753415|1331916|P8|NOT COMPLETED|Part A||0
545536|NCT00753415|1331917|P7|NOT COMPLETED|Part A||0
545537|NCT00753415|1331918|P6|NOT COMPLETED|Part A||0
545538|NCT00753415|1331919|P5|NOT COMPLETED|Part A||0
545539|NCT00753415|1331920|P4|NOT COMPLETED|Part A||2
545540|NCT00753415|1331921|P3|NOT COMPLETED|Part A||2
545541|NCT00753415|1331922|P2|NOT COMPLETED|Part A||0
545542|NCT00753415|1331923|P1|NOT COMPLETED|Part A||1
545543|NCT00753415|1331914|P10|COMPLETED|Part A||0
545544|NCT00753415|1331915|P9|COMPLETED|Part A||0
545545|NCT00753415|1331916|P8|COMPLETED|Part A||0
545546|NCT00753415|1331917|P7|COMPLETED|Part A||0
545547|NCT00753415|1331918|P6|COMPLETED|Part A||0
545548|NCT00753415|1331919|P5|COMPLETED|Part A||10
545549|NCT00753415|1331920|P4|COMPLETED|Part A||9
545550|NCT00753415|1331921|P3|COMPLETED|Part A||8
545551|NCT00753415|1331922|P2|COMPLETED|Part A||3
545552|NCT00753415|1331923|P1|COMPLETED|Part A||2
545553|NCT00753415|1331914|P10|STARTED|Part A||0
545554|NCT00753415|1331915|P9|STARTED|Part A||0
545555|NCT00753415|1331916|P8|STARTED|Part A||0
545556|NCT00753415|1331917|P7|STARTED|Part A||0
545557|NCT00753415|1331918|P6|STARTED|Part A||0
545558|NCT00753415|1331919|P5|STARTED|Part A||10
545559|NCT00753415|1331920|P4|STARTED|Part A||11
545560|NCT00753415|1331921|P3|STARTED|Part A||10
545561|NCT00753415|1331922|P2|STARTED|Part A||3
545562|NCT00753415|1331923|P1|STARTED|Part A||3
545563|NCT00753363|1331967|P2|NOT COMPLETED|Overall Study||39
545564|NCT00753363|1331968|P1|NOT COMPLETED|Overall Study||40
545565|NCT00753363|1331967|P2|COMPLETED|Overall Study||21
545566|NCT00753363|1331968|P1|COMPLETED|Overall Study||19
545567|NCT00753363|1331967|P2|STARTED|Overall Study||60
545568|NCT00753363|1331968|P1|STARTED|Overall Study||59
545569|NCT00753337|1331978|P1|NOT COMPLETED|Overall Study||0
545570|NCT00753337|1331978|P1|COMPLETED|Overall Study||123
545571|NCT00753337|1331978|P1|STARTED|Overall Study||123
545572|NCT00753298|1331994|P2|NOT COMPLETED|Overall Study||4
545573|NCT00753298|1331995|P1|NOT COMPLETED|Overall Study||8
545574|NCT00753298|1331994|P2|COMPLETED|Overall Study||94
545575|NCT00753298|1331995|P1|COMPLETED|Overall Study||89
545576|NCT00753298|1331994|P2|STARTED|Overall Study||98
545577|NCT00753298|1331995|P1|STARTED|Overall Study||97
545578|NCT00753272|1332013|P2|NOT COMPLETED|Overall Study||4907
545579|NCT00753272|1332014|P1|NOT COMPLETED|Overall Study||4982
545580|NCT00753272|1332013|P2|COMPLETED|Overall Study||16895
545581|NCT00753272|1332014|P1|COMPLETED|Overall Study||16911
545582|NCT00753272|1332013|P2|STARTED|Overall Study||21802
545583|NCT00753272|1332014|P1|STARTED|Overall Study||21893
545584|NCT00753220|1332076|P1|NOT COMPLETED|Overall Study||5
545585|NCT00753220|1332076|P1|COMPLETED|Overall Study||2
545586|NCT00753220|1332076|P1|STARTED|Overall Study||7
545587|NCT00753142|1332083|P3|NOT COMPLETED|Overall Study||0
545588|NCT00753142|1332084|P2|NOT COMPLETED|Overall Study||0
545589|NCT00753142|1332085|P1|NOT COMPLETED|Overall Study||0
545590|NCT00753142|1332083|P3|COMPLETED|Overall Study||13
545591|NCT00753142|1332084|P2|COMPLETED|Overall Study||7
545592|NCT00753142|1332085|P1|COMPLETED|Overall Study||8
545593|NCT00753142|1332083|P3|STARTED|Overall Study||13
545594|NCT00753142|1332084|P2|STARTED|Overall Study||7
545595|NCT00753142|1332085|P1|STARTED|Overall Study||8
545596|NCT00753012|1332095|P2|NOT COMPLETED|Overall Study||1
545597|NCT00753012|1332096|P1|NOT COMPLETED|Overall Study||8
545598|NCT00753012|1332095|P2|COMPLETED|Overall Study||8
545599|NCT00753012|1332096|P1|COMPLETED|Overall Study||7
545600|NCT00753012|1332095|P2|STARTED|Overall Study||9
545601|NCT00753012|1332096|P1|STARTED|Overall Study||15
545602|NCT00752986|1332109|P3|NOT COMPLETED|Overall Study||2
545603|NCT00752986|1332110|P2|NOT COMPLETED|Overall Study||1
545604|NCT00752986|1332111|P1|NOT COMPLETED|Overall Study||5
545605|NCT00752986|1332109|P3|COMPLETED|Overall Study||9
545606|NCT00752986|1332110|P2|COMPLETED|Overall Study||11
545607|NCT00752986|1332111|P1|COMPLETED|Overall Study||11
545608|NCT00752986|1332109|P3|STARTED|Overall Study||11
545609|NCT00752986|1332110|P2|STARTED|Overall Study||12
545610|NCT00752986|1332111|P1|STARTED|Overall Study||16
545611|NCT00752973|1332128|P1|NOT COMPLETED|Overall Study||0
545612|NCT00752973|1332128|P1|COMPLETED|Overall Study||12
545613|NCT00752973|1332128|P1|STARTED|Overall Study||12
545614|NCT00752895|1332140|P2|NOT COMPLETED|Overall Study||3
545615|NCT00752895|1332141|P1|NOT COMPLETED|Overall Study||8
545616|NCT00752895|1332140|P2|COMPLETED|Overall Study||143
545617|NCT00752895|1332141|P1|COMPLETED|Overall Study||139
545618|NCT00752895|1332140|P2|STARTED|Overall Study||146
545619|NCT00752895|1332141|P1|STARTED|Overall Study||147
545620|NCT00752791|1332149|P1|NOT COMPLETED|Overall Study||16
545621|NCT00752791|1332149|P1|COMPLETED|Overall Study||43
545622|NCT00752791|1332149|P1|STARTED|Overall Study||59
545623|NCT00752726|1332161|P2|NOT COMPLETED|Overall Study||13
545624|NCT00752726|1332162|P1|NOT COMPLETED|Overall Study||11
545625|NCT00752726|1332161|P2|COMPLETED|Overall Study||53
545626|NCT00752726|1332162|P1|COMPLETED|Overall Study||54
545627|NCT00752726|1332161|P2|Intention to Treat (ITT) Population|Overall Study|ITT population had atleast 1 post treatment efficacy measurement.|61
545628|NCT00752726|1332162|P1|Intention to Treat (ITT) Population|Overall Study|ITT population had atleast 1 post treatment efficacy measurement.|62
545629|NCT00752726|1332161|P2|Safety Population|Overall Study|2 participants were never dosed with the study medication.|64
545630|NCT00752726|1332162|P1|Safety Population|Overall Study|2 participants were never dosed with the study medication.|63
545631|NCT00752726|1332161|P2|STARTED|Overall Study||66
545632|NCT00752726|1332162|P1|STARTED|Overall Study||65
545633|NCT00752622|1332187|P1|NOT COMPLETED|Interventional Phase||8
545634|NCT00752622|1332187|P1|COMPLETED|Interventional Phase|8 participants received at least 1 infusion of interventional treatment, but none completed trial|0
545635|NCT00752622|1332187|P1|STARTED|Interventional Phase|5 participants randomized into increased dose group and 3 randomized into shortened interval group|8
545636|NCT00752622|1332187|P1|NOT COMPLETED|Observational Phase||43
545637|NCT00752622|1332187|P1|COMPLETED|Observational Phase|14 completed without loss of response 8 had loss of response & randomized into interventional phase|22
545638|NCT00752622|1332187|P1|STARTED|Observational Phase||65
545639|NCT00752622|1332187|P1|NOT COMPLETED|Induction Phase||35
545640|NCT00752622|1332187|P1|COMPLETED|Induction Phase||65
545641|NCT00752622|1332187|P1|STARTED|Induction Phase|The ELIG population comprised of 98 participants|100
545642|NCT00752609|1332200|P2|NOT COMPLETED|Overall Study||2
545643|NCT00752609|1332201|P1|NOT COMPLETED|Overall Study||9
545644|NCT00752609|1332200|P2|COMPLETED|Overall Study||47
545645|NCT00752609|1332201|P1|COMPLETED|Overall Study||44
545646|NCT00752609|1332200|P2|Full Analysis Set|Overall Study||49
545647|NCT00752609|1332201|P1|Full Analysis Set|Overall Study|One patient withdrew consent before receiving any study medication.|52
545648|NCT00752609|1332200|P2|STARTED|Overall Study||49
545649|NCT00752609|1332201|P1|STARTED|Overall Study||53
545650|NCT00752232|1332227|P7|NOT COMPLETED|Overall Study||0
545651|NCT00752232|1332228|P6|NOT COMPLETED|Overall Study||1
545652|NCT00752232|1332229|P5|NOT COMPLETED|Overall Study||3
545653|NCT00752232|1332230|P4|NOT COMPLETED|Overall Study||1
545654|NCT00752232|1332231|P3|NOT COMPLETED|Overall Study||1
545655|NCT00752232|1332232|P2|NOT COMPLETED|Overall Study||0
545656|NCT00752232|1332233|P1|NOT COMPLETED|Overall Study||2
545657|NCT00752232|1332227|P7|COMPLETED|Overall Study||4
545658|NCT00752232|1332228|P6|COMPLETED|Overall Study||5
545659|NCT00752232|1332229|P5|COMPLETED|Overall Study||3
545660|NCT00752232|1332230|P4|COMPLETED|Overall Study||5
545661|NCT00752232|1332231|P3|COMPLETED|Overall Study||5
545662|NCT00752232|1332232|P2|COMPLETED|Overall Study||6
545663|NCT00752232|1332233|P1|COMPLETED|Overall Study||4
545664|NCT00752232|1332227|P7|STARTED|Overall Study||4
545665|NCT00752232|1332228|P6|STARTED|Overall Study||6
545666|NCT00752232|1332229|P5|STARTED|Overall Study||6
545667|NCT00752232|1332230|P4|STARTED|Overall Study||6
545668|NCT00752232|1332231|P3|STARTED|Overall Study||6
545669|NCT00752232|1332232|P2|STARTED|Overall Study||6
545670|NCT00752232|1332233|P1|STARTED|Overall Study||6
545671|NCT00752128|1332305|P1|NOT COMPLETED|Overall Study||4
545672|NCT00752128|1332305|P1|COMPLETED|Overall Study||2345
545673|NCT00752128|1332305|P1|STARTED|Overall Study||2349
545674|NCT00752102|1332312|P2|NOT COMPLETED|Overall Study||1
545675|NCT00752102|1332313|P1|NOT COMPLETED|Overall Study||3
545676|NCT00752102|1332312|P2|COMPLETED|Overall Study||21
545677|NCT00752102|1332313|P1|COMPLETED|Overall Study||19
545678|NCT00752102|1332312|P2|STARTED|Overall Study||22
545679|NCT00752102|1332313|P1|STARTED|Overall Study||22
545680|NCT00752089|1332319|P1|NOT COMPLETED|Overall Study||6
545681|NCT00752089|1332319|P1|COMPLETED|Overall Study||14
545682|NCT00752089|1332319|P1|Received Placebo|Overall Study||18
545683|NCT00752089|1332319|P1|Received NaF|Overall Study||18
545684|NCT00752089|1332319|P1|Received NaF/KNO3/ 0% Isopentane|Overall Study||17
545685|NCT00752089|1332319|P1|Received NaF/ KNO3/ 2% Isopentane|Overall Study||19
545686|NCT00752089|1332319|P1|STARTED|Overall Study||20
545687|NCT00751998|1332333|P1|NOT COMPLETED|Overall Study||20
545688|NCT00751998|1332333|P1|COMPLETED|Overall Study||277
545689|NCT00751998|1332333|P1|STARTED|Overall Study||297
545690|NCT00751972|1332339|P2|NOT COMPLETED|Overall Study||0
545691|NCT00751972|1332340|P1|NOT COMPLETED|Overall Study||0
545692|NCT00751972|1332339|P2|COMPLETED|Overall Study||499
545693|NCT00751972|1332340|P1|COMPLETED|Overall Study||140
545694|NCT00751972|1332339|P2|STARTED|Overall Study||499
545695|NCT00751972|1332340|P1|STARTED|Overall Study||140
545696|NCT00751933|1332352|P4|NOT COMPLETED|Overall Study||1
545697|NCT00751933|1332353|P3|NOT COMPLETED|Overall Study||1
545698|NCT00751933|1332354|P2|NOT COMPLETED|Overall Study||1
545699|NCT00751933|1332355|P1|NOT COMPLETED|Overall Study||0
545700|NCT00751933|1332352|P4|COMPLETED|Overall Study||0
545701|NCT00751933|1332353|P3|COMPLETED|Overall Study||0
545702|NCT00751933|1332354|P2|COMPLETED|Overall Study||0
545703|NCT00751933|1332355|P1|COMPLETED|Overall Study||0
545704|NCT00751933|1332352|P4|STARTED|Overall Study||1
545705|NCT00751933|1332353|P3|STARTED|Overall Study||1
545706|NCT00751933|1332354|P2|STARTED|Overall Study||1
545707|NCT00751933|1332355|P1|STARTED|Overall Study||0
545708|NCT00751881|1332363|P3|NOT COMPLETED|Extension Study Period||66
545709|NCT00751881|1332364|P2|NOT COMPLETED|Extension Study Period||71
545710|NCT00751881|1332365|P1|NOT COMPLETED|Extension Study Period||65
545711|NCT00751881|1332363|P3|COMPLETED|Extension Study Period||167
545712|NCT00751881|1332364|P2|COMPLETED|Extension Study Period||194
545713|NCT00751881|1332365|P1|COMPLETED|Extension Study Period||188
545795|NCT00750893|1332594|P1|STARTED|Overall Study||3111
545714|NCT00751881|1332363|P3|STARTED|Extension Study Period|11 participants completed core treatment period but did not enter in extension treatment period.|233
545715|NCT00751881|1332364|P2|STARTED|Extension Study Period|8 participants completed core treatment period but did not enter in extension treatment period.|265
545716|NCT00751881|1332365|P1|STARTED|Extension Study Period|10 participants completed core treatment period but did not enter in extension treatment period.|253
545717|NCT00751881|1332363|P3|NOT COMPLETED|Core Treatment Period||128
545718|NCT00751881|1332364|P2|NOT COMPLETED|Core Treatment Period||135
545719|NCT00751881|1332365|P1|NOT COMPLETED|Core Treatment Period||126
545720|NCT00751881|1332363|P3|COMPLETED|Core Treatment Period||244
545721|NCT00751881|1332364|P2|COMPLETED|Core Treatment Period||273
545722|NCT00751881|1332365|P1|COMPLETED|Core Treatment Period||263
545723|NCT00751881|1332363|P3|Treated|Core Treatment Period|1 participant received teriflunomide 7 mg and 1 participant placebo (at least 1 dose)|370
545724|NCT00751881|1332364|P2|Treated|Core Treatment Period|1 participant received placebo (at least 1 dose)|407
545725|NCT00751881|1332365|P1|Treated|Core Treatment Period|1 participant received teriflunomide 7 mg and 2 participants teriflunomide 14 mg (at least 1 dose)|388
545726|NCT00751881|1332363|P3|STARTED|Core Treatment Period|Randomized|372
545727|NCT00751881|1332364|P2|STARTED|Core Treatment Period|Randomized|408
545728|NCT00751881|1332365|P1|STARTED|Core Treatment Period|Randomized|389
545729|NCT00751790|1332412|P1|NOT COMPLETED|Overall Study||5
545730|NCT00751790|1332412|P1|COMPLETED|Overall Study||115
545731|NCT00751790|1332412|P1|STARTED|Overall Study||120
545732|NCT00751777|1332418|P2|NOT COMPLETED|Overall Study||3
545733|NCT00751777|1332419|P1|NOT COMPLETED|Overall Study||11
545734|NCT00751777|1332418|P2|COMPLETED|Overall Study|Day 194: study completion for placebo group|36
545735|NCT00751777|1332419|P1|COMPLETED|Overall Study|Day 380: study completion for LT group|70
545736|NCT00751777|1332418|P2|STARTED|Overall Study||39
545737|NCT00751777|1332419|P1|STARTED|Overall Study||81
545738|NCT00751634|1332429|P1|NOT COMPLETED|Overall Study||0
545739|NCT00751634|1332429|P1|COMPLETED|Overall Study||20
545740|NCT00751634|1332429|P1|STARTED|Overall Study||20
545741|NCT00751621|1332437|P1|NOT COMPLETED|Overall Study||4
545742|NCT00751621|1332437|P1|COMPLETED|Overall Study||36
545743|NCT00751621|1332437|P1|STARTED|Overall Study||40
545744|NCT00751530|1332456|P2|NOT COMPLETED|Overall Study||0
545745|NCT00751530|1332457|P1|NOT COMPLETED|Overall Study||0
545746|NCT00751530|1332456|P2|COMPLETED|Overall Study||110
545747|NCT00751530|1332457|P1|COMPLETED|Overall Study||332
545748|NCT00751530|1332456|P2|STARTED|Overall Study||110
545749|NCT00751530|1332457|P1|STARTED|Overall Study||332
545750|NCT00751400|1332471|P1|NOT COMPLETED|Overall Study||10
545751|NCT00751400|1332471|P1|COMPLETED|Overall Study||487
545752|NCT00751400|1332471|P1|Subjects Provided Detailed Use Data|Overall Study||467
545753|NCT00751400|1332471|P1|Subjects Consumed Drug|Overall Study||485
545754|NCT00751400|1332471|P1|Subjects Provided Drug|Overall Study||497
545755|NCT00751400|1332471|P1|STARTED|Overall Study||497
545756|NCT00751348|1332486|P2|NOT COMPLETED|Overall Study||2
545757|NCT00751348|1332487|P1|NOT COMPLETED|Overall Study||6
545758|NCT00751348|1332486|P2|COMPLETED|Overall Study||159
545759|NCT00751348|1332487|P1|COMPLETED|Overall Study||307
545760|NCT00751348|1332486|P2|STARTED|Overall Study||161
545761|NCT00751348|1332487|P1|STARTED|Overall Study||313
545762|NCT00751296|1332509|P1|NOT COMPLETED|Overall Study||2
545763|NCT00751296|1332509|P1|COMPLETED|Overall Study||25
545764|NCT00751296|1332509|P1|STARTED|Overall Study|The start date of the study was 25 August 2006.|27
545765|NCT00751179|1332516|P2|NOT COMPLETED|Overall Study||15
545766|NCT00751179|1332517|P1|NOT COMPLETED|Overall Study||14
545767|NCT00751179|1332516|P2|COMPLETED|Overall Study||70
545768|NCT00751179|1332517|P1|COMPLETED|Overall Study||62
545769|NCT00751179|1332516|P2|STARTED|Overall Study|5 of 85 randomized were not treated with succinylcholine|85
545770|NCT00751179|1332517|P1|STARTED|Overall Study|10 of 76 randomized were not treated with sugammadex; 4 of these 10 received rocuronium only|76
545771|NCT00751140|1332537|P1|NOT COMPLETED|Overall Study||1
545772|NCT00751140|1332537|P1|COMPLETED|Overall Study||19
545773|NCT00751140|1332537|P1|STARTED|Overall Study||20
545774|NCT00751114|1332547|P2|NOT COMPLETED|Overall Study||32
545775|NCT00751114|1332548|P1|NOT COMPLETED|Overall Study||38
545776|NCT00751114|1332547|P2|COMPLETED|Overall Study||233
545777|NCT00751114|1332548|P1|COMPLETED|Overall Study||212
545778|NCT00751114|1332547|P2|mITT Population|Overall Study||253
545779|NCT00751114|1332548|P1|mITT Population|Overall Study|modified Intent-To-Treat population: treated patients with at least 1 on-treatment efficacy measure|227
545780|NCT00751114|1332547|P2|TREATED = Safety Population|Overall Study||264
545781|NCT00751114|1332548|P1|TREATED = Safety Population|Overall Study|safety population: randomized patients who received at least one dose of investigational product|237
545782|NCT00751114|1332547|P2|STARTED|Overall Study||265
545783|NCT00751114|1332548|P1|STARTED|Overall Study|randomized|250
545784|NCT00751036|1332573|P2|NOT COMPLETED|Overall Study||46
545785|NCT00751036|1332574|P1|NOT COMPLETED|Overall Study||48
545786|NCT00751036|1332573|P2|COMPLETED|Overall Study|Reason Not Completed = Reason for End of Treatment|0
545787|NCT00751036|1332574|P1|COMPLETED|Overall Study|Reason Not Completed = Reason for End of Treatment|0
545788|NCT00751036|1332573|P2|STARTED|Overall Study|Started = Treated|46
545789|NCT00751036|1332574|P1|STARTED|Overall Study|Started = Treated|48
545790|NCT00750919|1332586|P1|NOT COMPLETED|Overall Study||58
545791|NCT00750919|1332586|P1|COMPLETED|Overall Study||126
545792|NCT00750919|1332586|P1|STARTED|Overall Study||184
545793|NCT00750893|1332594|P1|NOT COMPLETED|Overall Study||542
545794|NCT00750893|1332594|P1|COMPLETED|Overall Study||2569
545796|NCT00750880|1332609|P1|NOT COMPLETED|Overall Study||215
545797|NCT00750880|1332609|P1|COMPLETED|Overall Study||1466
545798|NCT00750880|1332609|P1|STARTED|Overall Study||1681
545799|NCT00750867|1332632|P1|NOT COMPLETED|Overall Study||2
545800|NCT00750867|1332632|P1|COMPLETED|Overall Study||7
545801|NCT00750867|1332632|P1|STARTED|Overall Study||9
545802|NCT00750815|1332639|P2|NOT COMPLETED|Overall Study||0
545803|NCT00750815|1332640|P1|NOT COMPLETED|Overall Study||0
545804|NCT00750815|1332639|P2|COMPLETED|Overall Study||46
545805|NCT00750815|1332640|P1|COMPLETED|Overall Study||12
545806|NCT00750815|1332639|P2|STARTED|Overall Study||46
545807|NCT00750815|1332640|P1|STARTED|Overall Study||12
545808|NCT00750737|1332653|P2|NOT COMPLETED|Overall Study||3
545809|NCT00750737|1332654|P1|NOT COMPLETED|Overall Study||3
545810|NCT00750737|1332653|P2|COMPLETED|Overall Study||19
545811|NCT00750737|1332654|P1|COMPLETED|Overall Study||21
545812|NCT00750737|1332653|P2|STARTED|Overall Study||22
545813|NCT00750737|1332654|P1|STARTED|Overall Study||24
545814|NCT00750373|1332664|P2|NOT COMPLETED|Overall Study||0
545815|NCT00750373|1332665|P1|NOT COMPLETED|Overall Study||0
545816|NCT00750373|1332664|P2|COMPLETED|Overall Study||37
545817|NCT00750373|1332665|P1|COMPLETED|Overall Study||39
545818|NCT00750373|1332664|P2|STARTED|Overall Study||37
545819|NCT00750373|1332665|P1|STARTED|Overall Study||39
545820|NCT00750360|1332677|P6|NOT COMPLETED|Overall Study||0
545821|NCT00750360|1332678|P5|NOT COMPLETED|Overall Study||0
545822|NCT00750360|1332679|P4|NOT COMPLETED|Overall Study||0
545823|NCT00750360|1332680|P3|NOT COMPLETED|Overall Study||0
545824|NCT00750360|1332681|P2|NOT COMPLETED|Overall Study||0
545825|NCT00750360|1332682|P1|NOT COMPLETED|Overall Study||0
545826|NCT00750360|1332677|P6|COMPLETED|Overall Study||71
545827|NCT00750360|1332678|P5|COMPLETED|Overall Study||46
545828|NCT00750360|1332679|P4|COMPLETED|Overall Study||79
545829|NCT00750360|1332680|P3|COMPLETED|Overall Study||384
545830|NCT00750360|1332681|P2|COMPLETED|Overall Study||1
545831|NCT00750360|1332682|P1|COMPLETED|Overall Study||294
545832|NCT00750360|1332677|P6|STARTED|Overall Study||71
545833|NCT00750360|1332678|P5|STARTED|Overall Study||46
545834|NCT00750360|1332679|P4|STARTED|Overall Study||79
545835|NCT00750360|1332680|P3|STARTED|Overall Study||384
545836|NCT00750360|1332681|P2|STARTED|Overall Study|"One subject enrolled in this group was not vaccinated and as such not included as STARTED."|1
545837|NCT00750360|1332682|P1|STARTED|Overall Study|"Seven subjects enrolled in this group were not vaccinated and as such not included as STARTED."|294
545838|NCT00750308|1332714|P12|NOT COMPLETED|Fourth Treatment||0
545839|NCT00750308|1332715|P11|NOT COMPLETED|Fourth Treatment||0
545840|NCT00750308|1332716|P10|NOT COMPLETED|Fourth Treatment||0
545841|NCT00750308|1332717|P9|NOT COMPLETED|Fourth Treatment||0
545842|NCT00750308|1332718|P8|NOT COMPLETED|Fourth Treatment||0
545843|NCT00750308|1332719|P7|NOT COMPLETED|Fourth Treatment||0
545844|NCT00750308|1332720|P6|NOT COMPLETED|Fourth Treatment||0
545845|NCT00750308|1332721|P5|NOT COMPLETED|Fourth Treatment||0
545846|NCT00750308|1332722|P4|NOT COMPLETED|Fourth Treatment||0
545847|NCT00750308|1332723|P3|NOT COMPLETED|Fourth Treatment||0
545848|NCT00750308|1332724|P2|NOT COMPLETED|Fourth Treatment||0
545849|NCT00750308|1332725|P1|NOT COMPLETED|Fourth Treatment||0
545850|NCT00750308|1332714|P12|COMPLETED|Fourth Treatment||1
545851|NCT00750308|1332715|P11|COMPLETED|Fourth Treatment||1
545852|NCT00750308|1332716|P10|COMPLETED|Fourth Treatment||2
545853|NCT00750308|1332717|P9|COMPLETED|Fourth Treatment||1
545854|NCT00750308|1332718|P8|COMPLETED|Fourth Treatment||2
545855|NCT00750308|1332719|P7|COMPLETED|Fourth Treatment||2
545856|NCT00750308|1332720|P6|COMPLETED|Fourth Treatment||2
545857|NCT00750308|1332721|P5|COMPLETED|Fourth Treatment||1
545858|NCT00750308|1332722|P4|COMPLETED|Fourth Treatment||1
545859|NCT00750308|1332723|P3|COMPLETED|Fourth Treatment||2
545860|NCT00750308|1332724|P2|COMPLETED|Fourth Treatment||1
545861|NCT00750308|1332725|P1|COMPLETED|Fourth Treatment||2
545862|NCT00750308|1332714|P12|STARTED|Fourth Treatment||1
545863|NCT00750308|1332715|P11|STARTED|Fourth Treatment||1
545864|NCT00750308|1332716|P10|STARTED|Fourth Treatment||2
545865|NCT00750308|1332717|P9|STARTED|Fourth Treatment||1
545866|NCT00750308|1332718|P8|STARTED|Fourth Treatment||2
545867|NCT00750308|1332719|P7|STARTED|Fourth Treatment||2
545868|NCT00750308|1332720|P6|STARTED|Fourth Treatment||2
545869|NCT00750308|1332721|P5|STARTED|Fourth Treatment||1
545870|NCT00750308|1332722|P4|STARTED|Fourth Treatment||1
545871|NCT00750308|1332723|P3|STARTED|Fourth Treatment||2
545872|NCT00750308|1332724|P2|STARTED|Fourth Treatment||1
545873|NCT00750308|1332725|P1|STARTED|Fourth Treatment||2
545874|NCT00750308|1332714|P12|NOT COMPLETED|Washout||0
545875|NCT00750308|1332715|P11|NOT COMPLETED|Washout||0
545876|NCT00750308|1332716|P10|NOT COMPLETED|Washout||0
545877|NCT00750308|1332717|P9|NOT COMPLETED|Washout||0
545878|NCT00750308|1332718|P8|NOT COMPLETED|Washout||0
545879|NCT00750308|1332719|P7|NOT COMPLETED|Washout||0
545880|NCT00750308|1332720|P6|NOT COMPLETED|Washout||0
545881|NCT00750308|1332721|P5|NOT COMPLETED|Washout||0
545882|NCT00750308|1332722|P4|NOT COMPLETED|Washout||0
545883|NCT00750308|1332723|P3|NOT COMPLETED|Washout||0
545884|NCT00750308|1332724|P2|NOT COMPLETED|Washout||0
545885|NCT00750308|1332725|P1|NOT COMPLETED|Washout||0
545886|NCT00750308|1332714|P12|COMPLETED|Washout||1
545887|NCT00750308|1332715|P11|COMPLETED|Washout||1
545888|NCT00750308|1332716|P10|COMPLETED|Washout||2
545889|NCT00750308|1332717|P9|COMPLETED|Washout||1
545890|NCT00750308|1332718|P8|COMPLETED|Washout||2
545891|NCT00750308|1332719|P7|COMPLETED|Washout||2
545892|NCT00750308|1332720|P6|COMPLETED|Washout||2
545893|NCT00750308|1332721|P5|COMPLETED|Washout||1
545894|NCT00750308|1332722|P4|COMPLETED|Washout||1
545895|NCT00750308|1332723|P3|COMPLETED|Washout||2
545896|NCT00750308|1332724|P2|COMPLETED|Washout||1
545897|NCT00750308|1332725|P1|COMPLETED|Washout||2
545898|NCT00750308|1332714|P12|STARTED|Washout||1
545899|NCT00750308|1332715|P11|STARTED|Washout||1
545900|NCT00750308|1332716|P10|STARTED|Washout||2
545901|NCT00750308|1332717|P9|STARTED|Washout||1
545902|NCT00750308|1332718|P8|STARTED|Washout||2
545903|NCT00750308|1332719|P7|STARTED|Washout||2
545904|NCT00750308|1332720|P6|STARTED|Washout||2
545905|NCT00750308|1332721|P5|STARTED|Washout||1
545906|NCT00750308|1332722|P4|STARTED|Washout||1
545907|NCT00750308|1332723|P3|STARTED|Washout||2
545908|NCT00750308|1332724|P2|STARTED|Washout||1
545909|NCT00750308|1332725|P1|STARTED|Washout||2
545910|NCT00750308|1332714|P12|NOT COMPLETED|Third Treatment||0
545911|NCT00750308|1332715|P11|NOT COMPLETED|Third Treatment||0
545912|NCT00750308|1332716|P10|NOT COMPLETED|Third Treatment||0
545913|NCT00750308|1332717|P9|NOT COMPLETED|Third Treatment||0
545914|NCT00750308|1332718|P8|NOT COMPLETED|Third Treatment||0
545915|NCT00750308|1332719|P7|NOT COMPLETED|Third Treatment||0
545916|NCT00750308|1332720|P6|NOT COMPLETED|Third Treatment||0
545917|NCT00750308|1332721|P5|NOT COMPLETED|Third Treatment||0
545918|NCT00750308|1332722|P4|NOT COMPLETED|Third Treatment||0
545919|NCT00750308|1332723|P3|NOT COMPLETED|Third Treatment||0
545920|NCT00750308|1332724|P2|NOT COMPLETED|Third Treatment||1
545921|NCT00750308|1332725|P1|NOT COMPLETED|Third Treatment||0
545922|NCT00750308|1332714|P12|COMPLETED|Third Treatment||1
545923|NCT00750308|1332715|P11|COMPLETED|Third Treatment||1
545924|NCT00750308|1332716|P10|COMPLETED|Third Treatment||2
545925|NCT00750308|1332717|P9|COMPLETED|Third Treatment||1
545926|NCT00750308|1332718|P8|COMPLETED|Third Treatment||2
545927|NCT00750308|1332719|P7|COMPLETED|Third Treatment||2
545928|NCT00750308|1332720|P6|COMPLETED|Third Treatment||2
545929|NCT00750308|1332721|P5|COMPLETED|Third Treatment||1
545930|NCT00750308|1332722|P4|COMPLETED|Third Treatment||1
545931|NCT00750308|1332723|P3|COMPLETED|Third Treatment||2
545932|NCT00750308|1332724|P2|COMPLETED|Third Treatment||1
545933|NCT00750308|1332725|P1|COMPLETED|Third Treatment||2
545934|NCT00750308|1332714|P12|STARTED|Third Treatment||1
545935|NCT00750308|1332715|P11|STARTED|Third Treatment||1
545936|NCT00750308|1332716|P10|STARTED|Third Treatment||2
545937|NCT00750308|1332717|P9|STARTED|Third Treatment||1
545938|NCT00750308|1332718|P8|STARTED|Third Treatment||2
545939|NCT00750308|1332719|P7|STARTED|Third Treatment||2
545940|NCT00750308|1332720|P6|STARTED|Third Treatment||2
545941|NCT00750308|1332721|P5|STARTED|Third Treatment||1
545942|NCT00750308|1332722|P4|STARTED|Third Treatment||1
545943|NCT00750308|1332723|P3|STARTED|Third Treatment||2
545944|NCT00750308|1332724|P2|STARTED|Third Treatment||2
545945|NCT00750308|1332725|P1|STARTED|Third Treatment||2
545946|NCT00750308|1332714|P12|NOT COMPLETED|Washout||0
545947|NCT00750308|1332715|P11|NOT COMPLETED|Washout||0
545948|NCT00750308|1332716|P10|NOT COMPLETED|Washout||0
545949|NCT00750308|1332717|P9|NOT COMPLETED|Washout||0
545950|NCT00750308|1332718|P8|NOT COMPLETED|Washout||0
545951|NCT00750308|1332719|P7|NOT COMPLETED|Washout||0
545952|NCT00750308|1332720|P6|NOT COMPLETED|Washout||0
545953|NCT00750308|1332721|P5|NOT COMPLETED|Washout||0
545954|NCT00750308|1332722|P4|NOT COMPLETED|Washout||0
545955|NCT00750308|1332723|P3|NOT COMPLETED|Washout||0
545956|NCT00750308|1332724|P2|NOT COMPLETED|Washout||0
545957|NCT00750308|1332725|P1|NOT COMPLETED|Washout||0
545958|NCT00750308|1332714|P12|COMPLETED|Washout||1
545959|NCT00750308|1332715|P11|COMPLETED|Washout||1
545960|NCT00750308|1332716|P10|COMPLETED|Washout||2
545961|NCT00750308|1332717|P9|COMPLETED|Washout||1
545962|NCT00750308|1332718|P8|COMPLETED|Washout||2
545963|NCT00750308|1332719|P7|COMPLETED|Washout||2
545964|NCT00750308|1332720|P6|COMPLETED|Washout||2
545965|NCT00750308|1332721|P5|COMPLETED|Washout||1
545966|NCT00750308|1332722|P4|COMPLETED|Washout||1
545967|NCT00750308|1332723|P3|COMPLETED|Washout||2
545968|NCT00750308|1332724|P2|COMPLETED|Washout||2
545969|NCT00750308|1332725|P1|COMPLETED|Washout||2
545970|NCT00750308|1332714|P12|STARTED|Washout||1
545971|NCT00750308|1332715|P11|STARTED|Washout||1
545972|NCT00750308|1332716|P10|STARTED|Washout||2
545973|NCT00750308|1332717|P9|STARTED|Washout||1
545974|NCT00750308|1332718|P8|STARTED|Washout||2
545975|NCT00750308|1332719|P7|STARTED|Washout||2
545976|NCT00750308|1332720|P6|STARTED|Washout||2
545977|NCT00750308|1332721|P5|STARTED|Washout||1
545978|NCT00750308|1332722|P4|STARTED|Washout||1
545979|NCT00750308|1332723|P3|STARTED|Washout||2
545980|NCT00750308|1332724|P2|STARTED|Washout||2
545981|NCT00750308|1332725|P1|STARTED|Washout||2
545982|NCT00750308|1332714|P12|NOT COMPLETED|Second Treatment||0
545983|NCT00750308|1332715|P11|NOT COMPLETED|Second Treatment||0
545984|NCT00750308|1332716|P10|NOT COMPLETED|Second Treatment||0
545985|NCT00750308|1332717|P9|NOT COMPLETED|Second Treatment||1
545986|NCT00750308|1332718|P8|NOT COMPLETED|Second Treatment||0
545987|NCT00750308|1332719|P7|NOT COMPLETED|Second Treatment||0
545988|NCT00750308|1332720|P6|NOT COMPLETED|Second Treatment||1
545989|NCT00750308|1332721|P5|NOT COMPLETED|Second Treatment||1
545990|NCT00750308|1332722|P4|NOT COMPLETED|Second Treatment||0
545991|NCT00750308|1332723|P3|NOT COMPLETED|Second Treatment||0
545992|NCT00750308|1332724|P2|NOT COMPLETED|Second Treatment||0
545993|NCT00750308|1332725|P1|NOT COMPLETED|Second Treatment||0
545994|NCT00750308|1332714|P12|COMPLETED|Second Treatment||1
545995|NCT00750308|1332715|P11|COMPLETED|Second Treatment||1
545996|NCT00750308|1332716|P10|COMPLETED|Second Treatment||2
545997|NCT00750308|1332717|P9|COMPLETED|Second Treatment||1
545998|NCT00750308|1332718|P8|COMPLETED|Second Treatment||2
545999|NCT00750308|1332719|P7|COMPLETED|Second Treatment||2
546000|NCT00750308|1332720|P6|COMPLETED|Second Treatment||2
546001|NCT00750308|1332721|P5|COMPLETED|Second Treatment||1
546002|NCT00750308|1332722|P4|COMPLETED|Second Treatment||1
546003|NCT00750308|1332723|P3|COMPLETED|Second Treatment||2
546004|NCT00750308|1332724|P2|COMPLETED|Second Treatment||2
546005|NCT00750308|1332725|P1|COMPLETED|Second Treatment||2
546006|NCT00750308|1332714|P12|STARTED|Second Treatment||1
546007|NCT00750308|1332715|P11|STARTED|Second Treatment||1
546008|NCT00750308|1332716|P10|STARTED|Second Treatment||2
546009|NCT00750308|1332717|P9|STARTED|Second Treatment||2
546010|NCT00750308|1332718|P8|STARTED|Second Treatment||2
546011|NCT00750308|1332719|P7|STARTED|Second Treatment||2
546012|NCT00750308|1332720|P6|STARTED|Second Treatment||3
546013|NCT00750308|1332721|P5|STARTED|Second Treatment||2
546014|NCT00750308|1332722|P4|STARTED|Second Treatment||1
546015|NCT00750308|1332723|P3|STARTED|Second Treatment||2
546016|NCT00750308|1332724|P2|STARTED|Second Treatment||2
546017|NCT00750308|1332725|P1|STARTED|Second Treatment||2
546018|NCT00750308|1332714|P12|NOT COMPLETED|Washout||0
546019|NCT00750308|1332715|P11|NOT COMPLETED|Washout||0
546020|NCT00750308|1332716|P10|NOT COMPLETED|Washout||0
546021|NCT00750308|1332717|P9|NOT COMPLETED|Washout||0
546022|NCT00750308|1332718|P8|NOT COMPLETED|Washout||0
546023|NCT00750308|1332719|P7|NOT COMPLETED|Washout||0
546024|NCT00750308|1332720|P6|NOT COMPLETED|Washout||0
546025|NCT00750308|1332721|P5|NOT COMPLETED|Washout||0
546026|NCT00750308|1332722|P4|NOT COMPLETED|Washout||0
546027|NCT00750308|1332723|P3|NOT COMPLETED|Washout||0
546028|NCT00750308|1332724|P2|NOT COMPLETED|Washout||0
546029|NCT00750308|1332725|P1|NOT COMPLETED|Washout||0
546030|NCT00750308|1332714|P12|COMPLETED|Washout||1
546031|NCT00750308|1332715|P11|COMPLETED|Washout||1
546032|NCT00750308|1332716|P10|COMPLETED|Washout||2
546033|NCT00750308|1332717|P9|COMPLETED|Washout||2
546034|NCT00750308|1332718|P8|COMPLETED|Washout||2
546035|NCT00750308|1332719|P7|COMPLETED|Washout||2
546036|NCT00750308|1332720|P6|COMPLETED|Washout||3
546037|NCT00750308|1332721|P5|COMPLETED|Washout||2
546038|NCT00750308|1332722|P4|COMPLETED|Washout||1
546039|NCT00750308|1332723|P3|COMPLETED|Washout||2
546040|NCT00750308|1332724|P2|COMPLETED|Washout||2
546041|NCT00750308|1332725|P1|COMPLETED|Washout||2
546042|NCT00750308|1332714|P12|STARTED|Washout||1
546043|NCT00750308|1332715|P11|STARTED|Washout||1
546044|NCT00750308|1332716|P10|STARTED|Washout||2
546045|NCT00750308|1332717|P9|STARTED|Washout||2
546046|NCT00750308|1332718|P8|STARTED|Washout||2
546047|NCT00750308|1332719|P7|STARTED|Washout||2
546048|NCT00750308|1332720|P6|STARTED|Washout||3
546049|NCT00750308|1332721|P5|STARTED|Washout||2
546050|NCT00750308|1332722|P4|STARTED|Washout||1
546051|NCT00750308|1332723|P3|STARTED|Washout||2
546052|NCT00750308|1332724|P2|STARTED|Washout||2
546053|NCT00750308|1332725|P1|STARTED|Washout||2
546054|NCT00750308|1332714|P12|NOT COMPLETED|First Treatment||1
546055|NCT00750308|1332715|P11|NOT COMPLETED|First Treatment||1
546056|NCT00750308|1332716|P10|NOT COMPLETED|First Treatment||0
546057|NCT00750308|1332717|P9|NOT COMPLETED|First Treatment||0
546058|NCT00750308|1332718|P8|NOT COMPLETED|First Treatment||1
546059|NCT00750308|1332719|P7|NOT COMPLETED|First Treatment||0
546060|NCT00750308|1332720|P6|NOT COMPLETED|First Treatment||0
546061|NCT00750308|1332721|P5|NOT COMPLETED|First Treatment||0
546062|NCT00750308|1332722|P4|NOT COMPLETED|First Treatment||1
546063|NCT00750308|1332723|P3|NOT COMPLETED|First Treatment||0
546064|NCT00750308|1332724|P2|NOT COMPLETED|First Treatment||1
546065|NCT00750308|1332725|P1|NOT COMPLETED|First Treatment||0
546066|NCT00750308|1332714|P12|COMPLETED|First Treatment||1
546067|NCT00750308|1332715|P11|COMPLETED|First Treatment||1
546068|NCT00750308|1332716|P10|COMPLETED|First Treatment||2
546069|NCT00750308|1332717|P9|COMPLETED|First Treatment||2
546070|NCT00750308|1332718|P8|COMPLETED|First Treatment||2
546071|NCT00750308|1332719|P7|COMPLETED|First Treatment||2
546072|NCT00750308|1332720|P6|COMPLETED|First Treatment||3
546073|NCT00750308|1332721|P5|COMPLETED|First Treatment||2
546074|NCT00750308|1332722|P4|COMPLETED|First Treatment||1
546075|NCT00750308|1332723|P3|COMPLETED|First Treatment||2
546076|NCT00750308|1332724|P2|COMPLETED|First Treatment||2
546077|NCT00750308|1332725|P1|COMPLETED|First Treatment||2
546078|NCT00750308|1332714|P12|STARTED|First Treatment||2
546079|NCT00750308|1332715|P11|STARTED|First Treatment||2
546080|NCT00750308|1332716|P10|STARTED|First Treatment||2
546081|NCT00750308|1332717|P9|STARTED|First Treatment||2
546082|NCT00750308|1332718|P8|STARTED|First Treatment||3
546083|NCT00750308|1332719|P7|STARTED|First Treatment||2
546084|NCT00750308|1332720|P6|STARTED|First Treatment||3
546085|NCT00750308|1332721|P5|STARTED|First Treatment||2
546086|NCT00750308|1332722|P4|STARTED|First Treatment||2
546087|NCT00750308|1332723|P3|STARTED|First Treatment||2
546088|NCT00750308|1332724|P2|STARTED|First Treatment||3
546089|NCT00750308|1332725|P1|STARTED|First Treatment|One female withdrew due to muscle pain|2
546090|NCT00750282|1332743|P4|NOT COMPLETED|Overall Study||1
546091|NCT00750282|1332744|P3|NOT COMPLETED|Overall Study||1
546092|NCT00750282|1332745|P2|NOT COMPLETED|Overall Study||1
546093|NCT00750282|1332746|P1|NOT COMPLETED|Overall Study||0
546094|NCT00750282|1332743|P4|COMPLETED|Overall Study||147
546095|NCT00750282|1332744|P3|COMPLETED|Overall Study||125
546096|NCT00750282|1332745|P2|COMPLETED|Overall Study||81
546097|NCT00750282|1332746|P1|COMPLETED|Overall Study||69
546098|NCT00750282|1332743|P4|STARTED|Overall Study||148
546099|NCT00750282|1332744|P3|STARTED|Overall Study||126
546100|NCT00750282|1332745|P2|STARTED|Overall Study||82
546101|NCT00750282|1332746|P1|STARTED|Overall Study||69
546102|NCT00750269|1332775|P5|NOT COMPLETED|Overall Study||10
546103|NCT00750269|1332776|P4|NOT COMPLETED|Overall Study||5
546104|NCT00750269|1332777|P3|NOT COMPLETED|Overall Study||4
546105|NCT00750269|1332778|P2|NOT COMPLETED|Overall Study||1
546106|NCT00750269|1332779|P1|NOT COMPLETED|Overall Study||0
546107|NCT00750269|1332775|P5|COMPLETED|Overall Study||33
546108|NCT00750269|1332776|P4|COMPLETED|Overall Study||38
546109|NCT00750269|1332777|P3|COMPLETED|Overall Study||14
546110|NCT00750269|1332778|P2|COMPLETED|Overall Study||7
546111|NCT00750269|1332779|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study|8
546112|NCT00750269|1332775|P5|STARTED|Overall Study||43
546113|NCT00750269|1332776|P4|STARTED|Overall Study||43
546114|NCT00750269|1332777|P3|STARTED|Overall Study||18
546115|NCT00750269|1332778|P2|STARTED|Overall Study||8
546116|NCT00750269|1332779|P1|STARTED|Overall Study||8
546117|NCT00750204|1332826|P2|NOT COMPLETED|Overall Study||1
546118|NCT00750204|1332827|P1|NOT COMPLETED|Overall Study||1
546119|NCT00750204|1332826|P2|COMPLETED|Overall Study||0
546120|NCT00750204|1332827|P1|COMPLETED|Overall Study||0
546121|NCT00750204|1332826|P2|STARTED|Overall Study||1
546122|NCT00750204|1332827|P1|STARTED|Overall Study||1
546123|NCT00750191|1332835|P2|NOT COMPLETED|Overall Study||10
546124|NCT00750191|1332836|P1|NOT COMPLETED|Overall Study||5
546125|NCT00750191|1332835|P2|COMPLETED|Overall Study||20
546126|NCT00750191|1332836|P1|COMPLETED|Overall Study||22
546127|NCT00750191|1332835|P2|STARTED|Overall Study||30
546128|NCT00750191|1332836|P1|STARTED|Overall Study||27
546129|NCT00750152|1332850|P2|NOT COMPLETED|Overall Study||27
546130|NCT00750152|1332851|P1|NOT COMPLETED|Overall Study||22
546131|NCT00750152|1332850|P2|COMPLETED|Overall Study||141
546132|NCT00750152|1332851|P1|COMPLETED|Overall Study||144
546133|NCT00750152|1332850|P2|STARTED|Overall Study||168
546134|NCT00750152|1332851|P1|STARTED|Overall Study||166
546135|NCT00750139|1332863|P4|NOT COMPLETED|Overall Study||46
546136|NCT00750139|1332864|P3|NOT COMPLETED|Overall Study||101
546137|NCT00750139|1332865|P2|NOT COMPLETED|Overall Study||59
546138|NCT00750139|1332866|P1|NOT COMPLETED|Overall Study||89
546139|NCT00750139|1332863|P4|COMPLETED|Overall Study||73
546140|NCT00750139|1332864|P3|COMPLETED|Overall Study||135
546141|NCT00750139|1332865|P2|COMPLETED|Overall Study||59
546142|NCT00750139|1332866|P1|COMPLETED|Overall Study||145
546143|NCT00750139|1332863|P4|STARTED|Overall Study||119
546144|NCT00750139|1332864|P3|STARTED|Overall Study||236
546145|NCT00750139|1332865|P2|STARTED|Overall Study||118
546146|NCT00750139|1332866|P1|STARTED|Overall Study||234
546147|NCT00750061|1332882|P2|NOT COMPLETED|Overall Study||2
546148|NCT00750061|1332883|P1|NOT COMPLETED|Overall Study||2
546149|NCT00750061|1332882|P2|COMPLETED|Overall Study||18
546150|NCT00750061|1332883|P1|COMPLETED|Overall Study||18
546151|NCT00750061|1332882|P2|STARTED|Overall Study||20
546152|NCT00750061|1332883|P1|STARTED|Overall Study||20
546153|NCT00749996|1332893|P2|NOT COMPLETED|Overall Study||13
546154|NCT00749996|1332894|P1|NOT COMPLETED|Overall Study||18
546155|NCT00749996|1332893|P2|COMPLETED|Overall Study||58
546156|NCT00749996|1332894|P1|COMPLETED|Overall Study||57
546157|NCT00749996|1332893|P2|24 Months Follow up|Overall Study|Withdrawn (n=3). Lost to follow-up (n=3)|58
546158|NCT00749996|1332894|P1|24 Months Follow up|Overall Study|Withdrawn (n=5) Accidental death (n=1) Lost to follow up (n=7)|57
546159|NCT00749996|1332893|P2|12 Months Follow-up|Overall Study|Withdrawn (n=1). Visit not done (n=4). Lost to follow-up (n=1)|60
546160|NCT00749996|1332894|P1|12 Months Follow-up|Overall Study|Withdrawn(n=4). Visit not done (n=2)|68
546161|NCT00749996|1332893|P2|6 Months Follow-up|Overall Study|Withdrawn (n=3). Visit not done (n=3)|63
546162|NCT00749996|1332894|P1|6 Months Follow-up|Overall Study|Visit not done (n=3)|71
546163|NCT00749996|1332893|P2|3 Months Follow-up|Overall Study|Visit not done (n=1)|68
546164|NCT00749996|1332894|P1|3 Months Follow-up|Overall Study|Visit not done (n=2)|72
546165|NCT00749996|1332893|P2|6 Weeks Follow-up|Overall Study|Withdrawn (n=2). Visit not done (n=2)|67
546166|NCT00749996|1332894|P1|6 Weeks Follow-up|Overall Study|Withdrawn (n=1). Visit not done (n=2)|72
546167|NCT00749996|1332893|P2|STARTED|Overall Study|5 pts were removed due to compliance issue. 1 pt was randomized but not treated (Non-eligible)|71
546168|NCT00749996|1332894|P1|STARTED|Overall Study|4 pts were removed due to compliance issue. 2 pts were randomized but not treated (non-eligible)|75
546169|NCT00749957|1332904|P2|NOT COMPLETED|Overall Study||0
546170|NCT00749957|1332905|P1|NOT COMPLETED|Overall Study||0
546171|NCT00749957|1332904|P2|COMPLETED|Overall Study||6
546172|NCT00749957|1332905|P1|COMPLETED|Overall Study||6
546173|NCT00749957|1332904|P2|STARTED|Overall Study||6
546174|NCT00749957|1332905|P1|STARTED|Overall Study||6
546175|NCT00749944|1332917|P2|NOT COMPLETED|Overall Study||1
546176|NCT00749944|1332918|P1|NOT COMPLETED|Overall Study||5
546177|NCT00749944|1332917|P2|COMPLETED|Overall Study||54
546178|NCT00749944|1332918|P1|COMPLETED|Overall Study||50
546179|NCT00749944|1332917|P2|STARTED|Overall Study||55
546180|NCT00749944|1332918|P1|STARTED|Overall Study||55
546181|NCT00749931|1332986|P3|NOT COMPLETED|Overall Study||0
546182|NCT00749931|1332987|P2|NOT COMPLETED|Overall Study||0
546183|NCT00749931|1332988|P1|NOT COMPLETED|Overall Study||0
546184|NCT00749931|1332986|P3|COMPLETED|Overall Study||68
546185|NCT00749931|1332987|P2|COMPLETED|Overall Study||298
546186|NCT00749931|1332988|P1|COMPLETED|Overall Study||298
546187|NCT00749931|1332986|P3|STARTED|Overall Study||68
546188|NCT00749931|1332987|P2|STARTED|Overall Study||298
546189|NCT00749931|1332988|P1|STARTED|Overall Study||298
546190|NCT00749775|1332997|P1|NOT COMPLETED|Overall Study||107
546191|NCT00749775|1332997|P1|COMPLETED|Overall Study||3210
546192|NCT00749775|1332997|P1|STARTED|Overall Study||3317
546193|NCT00749684|1333013|P1|NOT COMPLETED|Overall Study||82
546194|NCT00749684|1333013|P1|COMPLETED|Overall Study||56
546195|NCT00749684|1333013|P1|STARTED|Overall Study||138
546196|NCT00749671|1333020|P2|NOT COMPLETED|Overall Study||0
546197|NCT00749671|1333021|P1|NOT COMPLETED|Overall Study||0
546198|NCT00749671|1333020|P2|COMPLETED|Overall Study||9
546199|NCT00749671|1333021|P1|COMPLETED|Overall Study||11
546200|NCT00749671|1333020|P2|STARTED|Overall Study||9
546201|NCT00749671|1333021|P1|STARTED|Overall Study||11
546202|NCT00749606|1333031|P2|NOT COMPLETED|Year 3 (Observation)||3
546203|NCT00749606|1333032|P1|NOT COMPLETED|Year 3 (Observation)||0
546204|NCT00749606|1333031|P2|COMPLETED|Year 3 (Observation)||69
546205|NCT00749606|1333032|P1|COMPLETED|Year 3 (Observation)||63
546206|NCT00749606|1333031|P2|STARTED|Year 3 (Observation)||72
546207|NCT00749606|1333032|P1|STARTED|Year 3 (Observation)||63
546208|NCT00749606|1333031|P2|NOT COMPLETED|Year 2||8
546209|NCT00749606|1333032|P1|NOT COMPLETED|Year 2||11
546210|NCT00749606|1333031|P2|COMPLETED|Year 2||72
546211|NCT00749606|1333032|P1|COMPLETED|Year 2||63
546212|NCT00749606|1333031|P2|STARTED|Year 2||80
546213|NCT00749606|1333032|P1|STARTED|Year 2||74
546214|NCT00749606|1333031|P2|NOT COMPLETED|Year 1||48
546215|NCT00749606|1333032|P1|NOT COMPLETED|Year 1||55
546216|NCT00749606|1333031|P2|COMPLETED|Year 1||80
546217|NCT00749606|1333032|P1|COMPLETED|Year 1||74
546218|NCT00749606|1333031|P2|STARTED|Year 1||128
546219|NCT00749606|1333032|P1|STARTED|Year 1||129
546220|NCT00749580|1333052|P2|NOT COMPLETED|Overall Study||9
546221|NCT00749580|1333053|P1|NOT COMPLETED|Overall Study||4
546222|NCT00749580|1333052|P2|COMPLETED|Overall Study||16
546223|NCT00749580|1333053|P1|COMPLETED|Overall Study|December 2010|17
546224|NCT00749580|1333052|P2|STARTED|Overall Study||25
546225|NCT00749580|1333053|P1|STARTED|Overall Study|September 2008|21
546226|NCT00749476|1333061|P1|NOT COMPLETED|Overall Study||0
546227|NCT00749476|1333061|P1|COMPLETED|Overall Study||1
546228|NCT00749476|1333061|P1|STARTED|Overall Study||1
546229|NCT00749463|1333068|P3|NOT COMPLETED|Overall Study||1
546230|NCT00749463|1333069|P2|NOT COMPLETED|Overall Study||4
546231|NCT00749463|1333070|P1|NOT COMPLETED|Overall Study||1
546232|NCT00749463|1333068|P3|COMPLETED|Overall Study||149
546233|NCT00749463|1333069|P2|COMPLETED|Overall Study||60
546234|NCT00749463|1333070|P1|COMPLETED|Overall Study||85
546235|NCT00749463|1333068|P3|STARTED|Overall Study||150
546236|NCT00749463|1333069|P2|STARTED|Overall Study||64
546237|NCT00749463|1333070|P1|STARTED|Overall Study||86
546238|NCT00749398|1333096|P1|NOT COMPLETED|Overall Study||53
546239|NCT00749398|1333096|P1|COMPLETED|Overall Study||71
546240|NCT00749398|1333096|P1|STARTED|Overall Study|Nine participants were excluded because they did not fulfill the inclusion criteria.|124
546241|NCT00749268|1333114|P2|NOT COMPLETED|Overall Study||36
546242|NCT00749268|1333115|P1|NOT COMPLETED|Overall Study||34
546243|NCT00749268|1333114|P2|COMPLETED|Overall Study||74
546244|NCT00749268|1333115|P1|COMPLETED|Overall Study||72
546245|NCT00749268|1333114|P2|STARTED|Overall Study||110
546246|NCT00749268|1333115|P1|STARTED|Overall Study||106
546247|NCT00749203|1333139|P2|NOT COMPLETED|Second Infusion at 2 Weeks||2
546248|NCT00749203|1333140|P1|NOT COMPLETED|Second Infusion at 2 Weeks||0
546249|NCT00749203|1333139|P2|COMPLETED|Second Infusion at 2 Weeks||13
546250|NCT00749203|1333140|P1|COMPLETED|Second Infusion at 2 Weeks||16
546251|NCT00749203|1333139|P2|STARTED|Second Infusion at 2 Weeks||15
546252|NCT00749203|1333140|P1|STARTED|Second Infusion at 2 Weeks|N=6 completed the study at 2 wks due to CAPS scores < 50, precluding 2nd infusion.|16
546253|NCT00749203|1333139|P2|NOT COMPLETED|no Infusion at Week 1||4
546254|NCT00749203|1333140|P1|NOT COMPLETED|no Infusion at Week 1||0
546255|NCT00749203|1333139|P2|COMPLETED|no Infusion at Week 1||15
546256|NCT00749203|1333140|P1|COMPLETED|no Infusion at Week 1||22
546257|NCT00749203|1333139|P2|STARTED|no Infusion at Week 1||19
546258|NCT00749203|1333140|P1|STARTED|no Infusion at Week 1||22
546259|NCT00749203|1333139|P2|NOT COMPLETED|First Infusion Day 1||0
546260|NCT00749203|1333140|P1|NOT COMPLETED|First Infusion Day 1||0
546261|NCT00749203|1333139|P2|COMPLETED|First Infusion Day 1||19
546262|NCT00749203|1333140|P1|COMPLETED|First Infusion Day 1||22
546263|NCT00749203|1333139|P2|STARTED|First Infusion Day 1||19
546264|NCT00749203|1333140|P1|STARTED|First Infusion Day 1||22
546265|NCT00749190|1333161|P7|NOT COMPLETED|Overall Study||1
546266|NCT00749190|1333162|P6|NOT COMPLETED|Overall Study||5
546267|NCT00749190|1333163|P5|NOT COMPLETED|Overall Study||0
546268|NCT00749190|1333164|P4|NOT COMPLETED|Overall Study||5
546269|NCT00749190|1333165|P3|NOT COMPLETED|Overall Study||1
546270|NCT00749190|1333166|P2|NOT COMPLETED|Overall Study||5
546271|NCT00749190|1333167|P1|NOT COMPLETED|Overall Study||5
546272|NCT00749190|1333161|P7|COMPLETED|Overall Study||70
546273|NCT00749190|1333162|P6|COMPLETED|Overall Study||65
546274|NCT00749190|1333163|P5|COMPLETED|Overall Study||70
546275|NCT00749190|1333164|P4|COMPLETED|Overall Study||66
546276|NCT00749190|1333165|P3|COMPLETED|Overall Study||70
546277|NCT00749190|1333166|P2|COMPLETED|Overall Study||66
546278|NCT00749190|1333167|P1|COMPLETED|Overall Study||66
546279|NCT00749190|1333161|P7|STARTED|Overall Study||71
546280|NCT00749190|1333162|P6|STARTED|Overall Study||70
546281|NCT00749190|1333163|P5|STARTED|Overall Study||70
546282|NCT00749190|1333164|P4|STARTED|Overall Study||71
546283|NCT00749190|1333165|P3|STARTED|Overall Study||71
546284|NCT00749190|1333166|P2|STARTED|Overall Study||71
546285|NCT00749190|1333167|P1|STARTED|Overall Study||71
546286|NCT00749073|1333244|P1|NOT COMPLETED|Overall Study||0
546287|NCT00749073|1333244|P1|COMPLETED|Overall Study||10
546288|NCT00749073|1333244|P1|STARTED|Overall Study||10
546289|NCT00748982|1333252|P2|NOT COMPLETED|Overall Study||0
546290|NCT00748982|1333253|P1|NOT COMPLETED|Overall Study||0
546291|NCT00748982|1333252|P2|COMPLETED|Overall Study||4
546292|NCT00748982|1333253|P1|COMPLETED|Overall Study||12
546293|NCT00748982|1333252|P2|STARTED|Overall Study||4
546294|NCT00748982|1333253|P1|STARTED|Overall Study||12
546295|NCT00748969|1333267|P2|NOT COMPLETED|Overall Study||1
546296|NCT00748969|1333268|P1|NOT COMPLETED|Overall Study||1
546297|NCT00748969|1333267|P2|COMPLETED|Overall Study||0
546298|NCT00748969|1333268|P1|COMPLETED|Overall Study||0
546299|NCT00748969|1333267|P2|STARTED|Overall Study|Subject withdrew from study due to randomization to no treatment|1
546300|NCT00748969|1333268|P1|STARTED|Overall Study|Subject withdrew from study due to worsening sleep apnea|1
546301|NCT00748956|1333277|P3|NOT COMPLETED|Overall Study||0
546302|NCT00748956|1333278|P2|NOT COMPLETED|Overall Study||0
546303|NCT00748956|1333279|P1|NOT COMPLETED|Overall Study||0
546304|NCT00748956|1333277|P3|COMPLETED|Overall Study||5
546305|NCT00748956|1333278|P2|COMPLETED|Overall Study||5
546306|NCT00748956|1333279|P1|COMPLETED|Overall Study||0
546307|NCT00748956|1333277|P3|STARTED|Overall Study||5
546308|NCT00748956|1333278|P2|STARTED|Overall Study||5
546309|NCT00748956|1333279|P1|STARTED|Overall Study||0
546310|NCT00748865|1333302|P2|NOT COMPLETED|Overall Study||0
546311|NCT00748865|1333303|P1|NOT COMPLETED|Overall Study||0
546312|NCT00748865|1333302|P2|COMPLETED|Overall Study||10
546313|NCT00748865|1333303|P1|COMPLETED|Overall Study||10
546314|NCT00748865|1333302|P2|STARTED|Overall Study||10
546315|NCT00748865|1333303|P1|STARTED|Overall Study||10
546316|NCT00748826|1333309|P1|NOT COMPLETED|Overall Study||301
546317|NCT00748826|1333309|P1|COMPLETED|Overall Study||207
546318|NCT00748826|1333309|P1|STARTED|Overall Study|Of 576 total enrolled, 68 out of scope participants were not used for analyses|508
546319|NCT00748709|1333316|P1|NOT COMPLETED|Overall Study||20
546320|NCT00748709|1333316|P1|COMPLETED|Overall Study||0
546321|NCT00748709|1333316|P1|STARTED|Overall Study|Treated|20
546322|NCT00748657|1333328|P1|NOT COMPLETED|Overall Study||0
546323|NCT00748657|1333328|P1|COMPLETED|Overall Study||36
546324|NCT00748657|1333328|P1|STARTED|Overall Study||36
546325|NCT00748579|1333336|P2|NOT COMPLETED|Overall Study||0
546326|NCT00748579|1333337|P1|NOT COMPLETED|Overall Study||0
546327|NCT00748579|1333336|P2|COMPLETED|Overall Study||0
546328|NCT00748579|1333337|P1|COMPLETED|Overall Study||2
546329|NCT00748579|1333336|P2|STARTED|Overall Study||0
546330|NCT00748579|1333337|P1|STARTED|Overall Study||2
546331|NCT00748566|1333343|P1|NOT COMPLETED|Overall Study||112
546332|NCT00748566|1333343|P1|COMPLETED|Overall Study||60
546333|NCT00748566|1333343|P1|STARTED|Overall Study||172
546334|NCT00748553|1333373|P2|NOT COMPLETED|Overall Study||1
546335|NCT00748553|1333374|P1|NOT COMPLETED|Overall Study||3
546336|NCT00748553|1333373|P2|COMPLETED|Overall Study||13
546337|NCT00748553|1333374|P1|COMPLETED|Overall Study||13
546338|NCT00748553|1333373|P2|STARTED|Overall Study||14
546339|NCT00748553|1333374|P1|STARTED|Overall Study||16
546340|NCT00748410|1333383|P2|NOT COMPLETED|Overall Study||0
546341|NCT00748410|1333384|P1|NOT COMPLETED|Overall Study||0
546342|NCT00748410|1333383|P2|COMPLETED|Overall Study||2
546343|NCT00748410|1333384|P1|COMPLETED|Overall Study||1
546344|NCT00748410|1333383|P2|STARTED|Overall Study||2
546345|NCT00748410|1333384|P1|STARTED|Overall Study||1
546346|NCT00748241|1333400|P1|NOT COMPLETED|Overall Study||8
546347|NCT00748241|1333400|P1|COMPLETED|Overall Study||11
546348|NCT00748241|1333400|P1|STARTED|Overall Study||19
546349|NCT00748189|1333410|P2|NOT COMPLETED|Overall Study||221
546350|NCT00748189|1333411|P1|NOT COMPLETED|Overall Study||225
546351|NCT00748189|1333410|P2|COMPLETED|Overall Study||0
546352|NCT00748189|1333411|P1|COMPLETED|Overall Study|This participant was entered incorrectly by the site and has not completed the 5 year follow-up.|1
546353|NCT00748189|1333410|P2|Ongoing|Overall Study|One par. was incorrectly recorded as withdrawn due to “Study Terminated by Sponsor” and is ongoing.|162
546354|NCT00748189|1333411|P1|Ongoing|Overall Study||155
546355|NCT00748189|1333410|P2|STARTED|Overall Study||221
546356|NCT00748189|1333411|P1|STARTED|Overall Study||226
546357|NCT00748098|1333465|P2|NOT COMPLETED|Second Taper Period||0
546358|NCT00748098|1333466|P1|NOT COMPLETED|Second Taper Period||0
546359|NCT00748098|1333465|P2|COMPLETED|Second Taper Period||61
546360|NCT00748098|1333466|P1|COMPLETED|Second Taper Period||53
546361|NCT00748098|1333465|P2|STARTED|Second Taper Period||61
546362|NCT00748098|1333466|P1|STARTED|Second Taper Period||53
546363|NCT00748098|1333465|P2|NOT COMPLETED|Second Treatment Intervention Period||3
546364|NCT00748098|1333466|P1|NOT COMPLETED|Second Treatment Intervention Period||6
546365|NCT00748098|1333465|P2|COMPLETED|Second Treatment Intervention Period||61
546366|NCT00748098|1333466|P1|COMPLETED|Second Treatment Intervention Period||53
546367|NCT00748098|1333465|P2|STARTED|Second Treatment Intervention Period||64
546368|NCT00748098|1333466|P1|STARTED|Second Treatment Intervention Period||59
546369|NCT00748098|1333465|P2|NOT COMPLETED|1-Week Washout Period||1
546370|NCT00748098|1333466|P1|NOT COMPLETED|1-Week Washout Period||2
546371|NCT00748098|1333465|P2|COMPLETED|1-Week Washout Period||64
546372|NCT00748098|1333466|P1|COMPLETED|1-Week Washout Period||59
546373|NCT00748098|1333465|P2|STARTED|1-Week Washout Period||65
546374|NCT00748098|1333466|P1|STARTED|1-Week Washout Period||61
546375|NCT00748098|1333465|P2|NOT COMPLETED|First Taper Period||1
546376|NCT00748098|1333466|P1|NOT COMPLETED|First Taper Period||3
546377|NCT00748098|1333465|P2|COMPLETED|First Taper Period||65
546378|NCT00748098|1333466|P1|COMPLETED|First Taper Period||61
546379|NCT00748098|1333465|P2|STARTED|First Taper Period||66
546380|NCT00748098|1333466|P1|STARTED|First Taper Period||64
546381|NCT00748098|1333465|P2|NOT COMPLETED|First Treatment Intervention Period||1
546382|NCT00748098|1333466|P1|NOT COMPLETED|First Treatment Intervention Period||5
546383|NCT00748098|1333465|P2|COMPLETED|First Treatment Intervention Period||66
546384|NCT00748098|1333466|P1|COMPLETED|First Treatment Intervention Period||64
546385|NCT00748098|1333465|P2|STARTED|First Treatment Intervention Period||67
546386|NCT00748098|1333466|P1|STARTED|First Treatment Intervention Period||69
546387|NCT00748085|1333526|P1|NOT COMPLETED|Overall Study||0
546388|NCT00748085|1333526|P1|COMPLETED|Overall Study|No analysis -study terminated for business reasons.|5
546389|NCT00748085|1333526|P1|STARTED|Overall Study||5
546390|NCT00748072|1333533|P2|NOT COMPLETED|Overall Study||0
546391|NCT00748072|1333534|P1|NOT COMPLETED|Overall Study||0
546392|NCT00748072|1333533|P2|COMPLETED|Overall Study||80
546393|NCT00748072|1333534|P1|COMPLETED|Overall Study||82
546394|NCT00748072|1333533|P2|STARTED|Overall Study||80
546395|NCT00748072|1333534|P1|STARTED|Overall Study||82
546396|NCT00747916|1333540|P1|NOT COMPLETED|Overall Study||0
546397|NCT00747916|1333540|P1|COMPLETED|Overall Study||3
546398|NCT00747916|1333540|P1|STARTED|Overall Study||3
546399|NCT00747812|1333547|P2|NOT COMPLETED|Overall Study||3
546400|NCT00747812|1333548|P1|NOT COMPLETED|Overall Study||5
546401|NCT00747812|1333547|P2|COMPLETED|Overall Study||0
546402|NCT00747812|1333548|P1|COMPLETED|Overall Study||0
546403|NCT00747812|1333547|P2|STARTED|Overall Study|4 subjects were randomized to the Control Group; 1 was not implanted due to early enrollment closure|3
546404|NCT00747812|1333548|P1|STARTED|Overall Study||5
546405|NCT00747747|1333559|P3|NOT COMPLETED|Overall Study||0
546406|NCT00747747|1333560|P2|NOT COMPLETED|Overall Study||0
546407|NCT00747747|1333561|P1|NOT COMPLETED|Overall Study||0
546408|NCT00747747|1333559|P3|COMPLETED|Overall Study|17 with acute episode + 4 with recurrent episode|21
546409|NCT00747747|1333560|P2|COMPLETED|Overall Study|11 with acute episode + 3 with recurrent episode|14
546410|NCT00747747|1333561|P1|COMPLETED|Overall Study|13 with acute episode + 1 with recurrent episode|14
546411|NCT00747747|1333559|P3|STARTED|Overall Study||21
546412|NCT00747747|1333560|P2|STARTED|Overall Study||14
546413|NCT00747747|1333561|P1|STARTED|Overall Study||14
546414|NCT00747643|1333586|P2|NOT COMPLETED|Overall Study||27
546415|NCT00747643|1333587|P1|NOT COMPLETED|Overall Study||36
546416|NCT00747643|1333586|P2|COMPLETED|Overall Study||54
546417|NCT00747643|1333587|P1|COMPLETED|Overall Study||46
546418|NCT00747643|1333586|P2|STARTED|Overall Study||81
546419|NCT00747643|1333587|P1|STARTED|Overall Study||82
546420|NCT00747617|1333601|P2|NOT COMPLETED|Overall Study||1
546421|NCT00747617|1333602|P1|NOT COMPLETED|Overall Study||3
546422|NCT00747617|1333601|P2|COMPLETED|Overall Study||11
546423|NCT00747617|1333602|P1|COMPLETED|Overall Study||10
546424|NCT00747617|1333601|P2|STARTED|Overall Study||12
546425|NCT00747617|1333602|P1|STARTED|Overall Study||13
546426|NCT00747565|1333610|P2|NOT COMPLETED|Overall Study||7
546427|NCT00747565|1333611|P1|NOT COMPLETED|Overall Study||14
546428|NCT00747565|1333610|P2|COMPLETED|Overall Study||116
546429|NCT00747565|1333611|P1|COMPLETED|Overall Study|118 multifocal subjects in the original study plus 215 multifocal subejcts in the expansion study.|333
546430|NCT00747565|1333610|P2|STARTED|Overall Study||123
546431|NCT00747565|1333611|P1|STARTED|Overall Study|125 multifocal subjects in original study plus 222 multifocal subjects in the expansion study.|347
546432|NCT00747552|1333619|P1|NOT COMPLETED|Overall Study||0
546433|NCT00747552|1333619|P1|COMPLETED|Overall Study||30
546434|NCT00747552|1333619|P1|STARTED|Overall Study|This number does not include the 2 who were enrolled but had no data collected on them.|30
546435|NCT00747474|1333624|P12|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
546436|NCT00747474|1333625|P11|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
546437|NCT00747474|1333626|P10|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
546438|NCT00747474|1333627|P9|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
546439|NCT00747474|1333628|P8|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
546440|NCT00747474|1333629|P7|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
546441|NCT00747474|1333630|P6|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
546442|NCT00747474|1333631|P5|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
546443|NCT00747474|1333632|P4|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
546444|NCT00747474|1333633|P3|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
546445|NCT00747474|1333634|P2|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
546446|NCT00747474|1333635|P1|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
546447|NCT00747474|1333624|P12|COMPLETED|Cohort 12 (60 mg/m^2) Period||6
546448|NCT00747474|1333625|P11|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
546449|NCT00747474|1333626|P10|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
546450|NCT00747474|1333627|P9|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
546451|NCT00747474|1333628|P8|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
546452|NCT00747474|1333629|P7|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
546453|NCT00747474|1333630|P6|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
546454|NCT00747474|1333631|P5|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
546455|NCT00747474|1333632|P4|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
546456|NCT00747474|1333633|P3|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
546457|NCT00747474|1333634|P2|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
546458|NCT00747474|1333635|P1|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
546459|NCT00747474|1333624|P12|STARTED|Cohort 12 (60 mg/m^2) Period||6
546460|NCT00747474|1333625|P11|STARTED|Cohort 12 (60 mg/m^2) Period||0
546461|NCT00747474|1333626|P10|STARTED|Cohort 12 (60 mg/m^2) Period||0
546462|NCT00747474|1333627|P9|STARTED|Cohort 12 (60 mg/m^2) Period||0
546463|NCT00747474|1333628|P8|STARTED|Cohort 12 (60 mg/m^2) Period||0
546464|NCT00747474|1333629|P7|STARTED|Cohort 12 (60 mg/m^2) Period||0
546465|NCT00747474|1333630|P6|STARTED|Cohort 12 (60 mg/m^2) Period||0
546466|NCT00747474|1333631|P5|STARTED|Cohort 12 (60 mg/m^2) Period||0
546467|NCT00747474|1333632|P4|STARTED|Cohort 12 (60 mg/m^2) Period||0
546468|NCT00747474|1333633|P3|STARTED|Cohort 12 (60 mg/m^2) Period||0
546469|NCT00747474|1333634|P2|STARTED|Cohort 12 (60 mg/m^2) Period||0
546470|NCT00747474|1333635|P1|STARTED|Cohort 12 (60 mg/m^2) Period||0
546471|NCT00747474|1333624|P12|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
546472|NCT00747474|1333625|P11|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
546473|NCT00747474|1333626|P10|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
546474|NCT00747474|1333627|P9|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
546475|NCT00747474|1333628|P8|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
546476|NCT00747474|1333629|P7|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
546477|NCT00747474|1333630|P6|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
546478|NCT00747474|1333631|P5|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
546479|NCT00747474|1333632|P4|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
546480|NCT00747474|1333633|P3|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
546481|NCT00747474|1333634|P2|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
546482|NCT00747474|1333635|P1|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
546483|NCT00747474|1333624|P12|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
546484|NCT00747474|1333625|P11|COMPLETED|Cohort 11 (50 mg/m^2) Period||5
546485|NCT00747474|1333626|P10|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
546486|NCT00747474|1333627|P9|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
546487|NCT00747474|1333628|P8|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
546488|NCT00747474|1333629|P7|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
546489|NCT00747474|1333630|P6|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
546490|NCT00747474|1333631|P5|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
546491|NCT00747474|1333632|P4|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
546492|NCT00747474|1333633|P3|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
546493|NCT00747474|1333634|P2|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
546494|NCT00747474|1333635|P1|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
546495|NCT00747474|1333624|P12|STARTED|Cohort 11 (50 mg/m^2) Period||0
546496|NCT00747474|1333625|P11|STARTED|Cohort 11 (50 mg/m^2) Period||5
546497|NCT00747474|1333626|P10|STARTED|Cohort 11 (50 mg/m^2) Period||0
546498|NCT00747474|1333627|P9|STARTED|Cohort 11 (50 mg/m^2) Period||0
546499|NCT00747474|1333628|P8|STARTED|Cohort 11 (50 mg/m^2) Period||0
546500|NCT00747474|1333629|P7|STARTED|Cohort 11 (50 mg/m^2) Period||0
546501|NCT00747474|1333630|P6|STARTED|Cohort 11 (50 mg/m^2) Period||0
546502|NCT00747474|1333631|P5|STARTED|Cohort 11 (50 mg/m^2) Period||0
546503|NCT00747474|1333632|P4|STARTED|Cohort 11 (50 mg/m^2) Period||0
546504|NCT00747474|1333633|P3|STARTED|Cohort 11 (50 mg/m^2) Period||0
546505|NCT00747474|1333634|P2|STARTED|Cohort 11 (50 mg/m^2) Period||0
546506|NCT00747474|1333635|P1|STARTED|Cohort 11 (50 mg/m^2) Period||0
546507|NCT00747474|1333624|P12|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
546508|NCT00747474|1333625|P11|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
546509|NCT00747474|1333626|P10|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
546510|NCT00747474|1333627|P9|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
546511|NCT00747474|1333628|P8|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
546512|NCT00747474|1333629|P7|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
546513|NCT00747474|1333630|P6|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
546514|NCT00747474|1333631|P5|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
546515|NCT00747474|1333632|P4|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
546516|NCT00747474|1333633|P3|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
546517|NCT00747474|1333634|P2|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
546518|NCT00747474|1333635|P1|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
546519|NCT00747474|1333624|P12|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
546520|NCT00747474|1333625|P11|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
546521|NCT00747474|1333626|P10|COMPLETED|Cohort 10 (40 mg/m^2) Period||7
546522|NCT00747474|1333627|P9|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
546523|NCT00747474|1333628|P8|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
546524|NCT00747474|1333629|P7|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
546525|NCT00747474|1333630|P6|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
546526|NCT00747474|1333631|P5|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
546527|NCT00747474|1333632|P4|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
546528|NCT00747474|1333633|P3|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
546529|NCT00747474|1333634|P2|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
546530|NCT00747474|1333635|P1|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
546531|NCT00747474|1333624|P12|STARTED|Cohort 10 (40 mg/m^2) Period||0
546532|NCT00747474|1333625|P11|STARTED|Cohort 10 (40 mg/m^2) Period||0
546533|NCT00747474|1333626|P10|STARTED|Cohort 10 (40 mg/m^2) Period||7
546534|NCT00747474|1333627|P9|STARTED|Cohort 10 (40 mg/m^2) Period||0
546535|NCT00747474|1333628|P8|STARTED|Cohort 10 (40 mg/m^2) Period||0
546536|NCT00747474|1333629|P7|STARTED|Cohort 10 (40 mg/m^2) Period||0
546537|NCT00747474|1333630|P6|STARTED|Cohort 10 (40 mg/m^2) Period||0
546538|NCT00747474|1333631|P5|STARTED|Cohort 10 (40 mg/m^2) Period||0
546539|NCT00747474|1333632|P4|STARTED|Cohort 10 (40 mg/m^2) Period||0
546540|NCT00747474|1333633|P3|STARTED|Cohort 10 (40 mg/m^2) Period||0
546541|NCT00747474|1333634|P2|STARTED|Cohort 10 (40 mg/m^2) Period||0
546542|NCT00747474|1333635|P1|STARTED|Cohort 10 (40 mg/m^2) Period||0
546543|NCT00747474|1333624|P12|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
546544|NCT00747474|1333625|P11|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
546545|NCT00747474|1333626|P10|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
546546|NCT00747474|1333627|P9|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
546547|NCT00747474|1333628|P8|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
546548|NCT00747474|1333629|P7|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
546549|NCT00747474|1333630|P6|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
546550|NCT00747474|1333631|P5|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
546551|NCT00747474|1333632|P4|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
546552|NCT00747474|1333633|P3|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
546553|NCT00747474|1333634|P2|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
546554|NCT00747474|1333635|P1|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
546555|NCT00747474|1333624|P12|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
546556|NCT00747474|1333625|P11|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
546557|NCT00747474|1333626|P10|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
546558|NCT00747474|1333627|P9|COMPLETED|Cohort 9 (35 mg/m^2) Period||4
546559|NCT00747474|1333628|P8|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
546560|NCT00747474|1333629|P7|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
546561|NCT00747474|1333630|P6|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
546562|NCT00747474|1333631|P5|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
546563|NCT00747474|1333632|P4|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
546564|NCT00747474|1333633|P3|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
546565|NCT00747474|1333634|P2|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
546566|NCT00747474|1333635|P1|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
546567|NCT00747474|1333624|P12|STARTED|Cohort 9 (35 mg/m^2) Period||0
546568|NCT00747474|1333625|P11|STARTED|Cohort 9 (35 mg/m^2) Period||0
546569|NCT00747474|1333626|P10|STARTED|Cohort 9 (35 mg/m^2) Period||0
546570|NCT00747474|1333627|P9|STARTED|Cohort 9 (35 mg/m^2) Period||4
546571|NCT00747474|1333628|P8|STARTED|Cohort 9 (35 mg/m^2) Period||0
546572|NCT00747474|1333629|P7|STARTED|Cohort 9 (35 mg/m^2) Period||0
546573|NCT00747474|1333630|P6|STARTED|Cohort 9 (35 mg/m^2) Period||0
546574|NCT00747474|1333631|P5|STARTED|Cohort 9 (35 mg/m^2) Period||0
546575|NCT00747474|1333632|P4|STARTED|Cohort 9 (35 mg/m^2) Period||0
546576|NCT00747474|1333633|P3|STARTED|Cohort 9 (35 mg/m^2) Period||0
546577|NCT00747474|1333634|P2|STARTED|Cohort 9 (35 mg/m^2) Period||0
546578|NCT00747474|1333635|P1|STARTED|Cohort 9 (35 mg/m^2) Period||0
546579|NCT00747474|1333624|P12|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
546580|NCT00747474|1333625|P11|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
546581|NCT00747474|1333626|P10|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
546582|NCT00747474|1333627|P9|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
546583|NCT00747474|1333628|P8|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||1
546584|NCT00747474|1333629|P7|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
546585|NCT00747474|1333630|P6|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
546586|NCT00747474|1333631|P5|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
546587|NCT00747474|1333632|P4|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
546588|NCT00747474|1333633|P3|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
546589|NCT00747474|1333634|P2|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
546590|NCT00747474|1333635|P1|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
546591|NCT00747474|1333624|P12|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
546592|NCT00747474|1333625|P11|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
546593|NCT00747474|1333626|P10|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
546594|NCT00747474|1333627|P9|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
546595|NCT00747474|1333628|P8|COMPLETED|Cohort 8 (40 mg/m^2) Period||5
546596|NCT00747474|1333629|P7|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
546597|NCT00747474|1333630|P6|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
546598|NCT00747474|1333631|P5|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
546599|NCT00747474|1333632|P4|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
546600|NCT00747474|1333633|P3|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
546601|NCT00747474|1333634|P2|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
546602|NCT00747474|1333635|P1|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
546603|NCT00747474|1333624|P12|STARTED|Cohort 8 (40 mg/m^2) Period||0
546604|NCT00747474|1333625|P11|STARTED|Cohort 8 (40 mg/m^2) Period||0
546605|NCT00747474|1333626|P10|STARTED|Cohort 8 (40 mg/m^2) Period||0
546606|NCT00747474|1333627|P9|STARTED|Cohort 8 (40 mg/m^2) Period||0
546607|NCT00747474|1333628|P8|STARTED|Cohort 8 (40 mg/m^2) Period||6
546608|NCT00747474|1333629|P7|STARTED|Cohort 8 (40 mg/m^2) Period||0
546609|NCT00747474|1333630|P6|STARTED|Cohort 8 (40 mg/m^2) Period||0
546610|NCT00747474|1333631|P5|STARTED|Cohort 8 (40 mg/m^2) Period||0
546611|NCT00747474|1333632|P4|STARTED|Cohort 8 (40 mg/m^2) Period||0
546612|NCT00747474|1333633|P3|STARTED|Cohort 8 (40 mg/m^2) Period||0
546613|NCT00747474|1333634|P2|STARTED|Cohort 8 (40 mg/m^2) Period||0
546614|NCT00747474|1333635|P1|STARTED|Cohort 8 (40 mg/m^2) Period||0
546615|NCT00747474|1333624|P12|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
546616|NCT00747474|1333625|P11|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
546617|NCT00747474|1333626|P10|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
546618|NCT00747474|1333627|P9|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
546619|NCT00747474|1333628|P8|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
546620|NCT00747474|1333629|P7|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
546621|NCT00747474|1333630|P6|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
546622|NCT00747474|1333631|P5|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
546623|NCT00747474|1333632|P4|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
546624|NCT00747474|1333633|P3|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
546625|NCT00747474|1333634|P2|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
546626|NCT00747474|1333635|P1|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
546627|NCT00747474|1333624|P12|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
546628|NCT00747474|1333625|P11|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
546629|NCT00747474|1333626|P10|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
546630|NCT00747474|1333627|P9|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
546631|NCT00747474|1333628|P8|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
546632|NCT00747474|1333629|P7|COMPLETED|Cohort 7 (30 mg/m^2) Period||4
546633|NCT00747474|1333630|P6|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
546634|NCT00747474|1333631|P5|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
546635|NCT00747474|1333632|P4|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
546636|NCT00747474|1333633|P3|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
546637|NCT00747474|1333634|P2|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
546638|NCT00747474|1333635|P1|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
546639|NCT00747474|1333624|P12|STARTED|Cohort 7 (30 mg/m^2) Period||0
546640|NCT00747474|1333625|P11|STARTED|Cohort 7 (30 mg/m^2) Period||0
546641|NCT00747474|1333626|P10|STARTED|Cohort 7 (30 mg/m^2) Period||0
546642|NCT00747474|1333627|P9|STARTED|Cohort 7 (30 mg/m^2) Period||0
546643|NCT00747474|1333628|P8|STARTED|Cohort 7 (30 mg/m^2) Period||0
546644|NCT00747474|1333629|P7|STARTED|Cohort 7 (30 mg/m^2) Period||4
546645|NCT00747474|1333630|P6|STARTED|Cohort 7 (30 mg/m^2) Period||0
546646|NCT00747474|1333631|P5|STARTED|Cohort 7 (30 mg/m^2) Period||0
546647|NCT00747474|1333632|P4|STARTED|Cohort 7 (30 mg/m^2) Period||0
546648|NCT00747474|1333633|P3|STARTED|Cohort 7 (30 mg/m^2) Period||0
546649|NCT00747474|1333634|P2|STARTED|Cohort 7 (30 mg/m^2) Period||0
546650|NCT00747474|1333635|P1|STARTED|Cohort 7 (30 mg/m^2) Period||0
546651|NCT00747474|1333624|P12|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
546652|NCT00747474|1333625|P11|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
546653|NCT00747474|1333626|P10|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
546654|NCT00747474|1333627|P9|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
546655|NCT00747474|1333628|P8|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
546656|NCT00747474|1333629|P7|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
546657|NCT00747474|1333630|P6|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
546658|NCT00747474|1333631|P5|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
546659|NCT00747474|1333632|P4|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
546660|NCT00747474|1333633|P3|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
546661|NCT00747474|1333634|P2|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
546662|NCT00747474|1333635|P1|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
546663|NCT00747474|1333624|P12|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
546664|NCT00747474|1333625|P11|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
546665|NCT00747474|1333626|P10|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
546666|NCT00747474|1333627|P9|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
546667|NCT00747474|1333628|P8|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
546668|NCT00747474|1333629|P7|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
546669|NCT00747474|1333630|P6|COMPLETED|Cohort 6 (20 mg/m^2) Period||4
546670|NCT00747474|1333631|P5|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
546671|NCT00747474|1333632|P4|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
546672|NCT00747474|1333633|P3|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
546673|NCT00747474|1333634|P2|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
546674|NCT00747474|1333635|P1|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
546675|NCT00747474|1333624|P12|STARTED|Cohort 6 (20 mg/m^2) Period||0
546676|NCT00747474|1333625|P11|STARTED|Cohort 6 (20 mg/m^2) Period||0
546677|NCT00747474|1333626|P10|STARTED|Cohort 6 (20 mg/m^2) Period||0
546678|NCT00747474|1333627|P9|STARTED|Cohort 6 (20 mg/m^2) Period||0
546679|NCT00747474|1333628|P8|STARTED|Cohort 6 (20 mg/m^2) Period||0
546680|NCT00747474|1333629|P7|STARTED|Cohort 6 (20 mg/m^2) Period||0
546681|NCT00747474|1333630|P6|STARTED|Cohort 6 (20 mg/m^2) Period||4
546682|NCT00747474|1333631|P5|STARTED|Cohort 6 (20 mg/m^2) Period||0
546683|NCT00747474|1333632|P4|STARTED|Cohort 6 (20 mg/m^2) Period||0
546684|NCT00747474|1333633|P3|STARTED|Cohort 6 (20 mg/m^2) Period||0
546685|NCT00747474|1333634|P2|STARTED|Cohort 6 (20 mg/m^2) Period||0
546686|NCT00747474|1333635|P1|STARTED|Cohort 6 (20 mg/m^2) Period||0
546687|NCT00747474|1333624|P12|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
546688|NCT00747474|1333625|P11|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
546689|NCT00747474|1333626|P10|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
546690|NCT00747474|1333627|P9|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
546691|NCT00747474|1333628|P8|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
546692|NCT00747474|1333629|P7|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
546693|NCT00747474|1333630|P6|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
546694|NCT00747474|1333631|P5|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
546695|NCT00747474|1333632|P4|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
546696|NCT00747474|1333633|P3|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
546697|NCT00747474|1333634|P2|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
546698|NCT00747474|1333635|P1|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
546699|NCT00747474|1333624|P12|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
546700|NCT00747474|1333625|P11|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
546701|NCT00747474|1333626|P10|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
546702|NCT00747474|1333627|P9|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
546703|NCT00747474|1333628|P8|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
546704|NCT00747474|1333629|P7|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
546705|NCT00747474|1333630|P6|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
546706|NCT00747474|1333631|P5|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||4
546707|NCT00747474|1333632|P4|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
546708|NCT00747474|1333633|P3|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
546709|NCT00747474|1333634|P2|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
546710|NCT00747474|1333635|P1|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
546711|NCT00747474|1333624|P12|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
546712|NCT00747474|1333625|P11|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
546713|NCT00747474|1333626|P10|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
546714|NCT00747474|1333627|P9|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
546715|NCT00747474|1333628|P8|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
546716|NCT00747474|1333629|P7|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
546717|NCT00747474|1333630|P6|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
546718|NCT00747474|1333631|P5|STARTED|Cohort 5 (13.5 mg/m^2) Period||4
546719|NCT00747474|1333632|P4|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
546720|NCT00747474|1333633|P3|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
546721|NCT00747474|1333634|P2|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
546722|NCT00747474|1333635|P1|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
546723|NCT00747474|1333624|P12|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
546724|NCT00747474|1333625|P11|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
546725|NCT00747474|1333626|P10|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
546726|NCT00747474|1333627|P9|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
546727|NCT00747474|1333628|P8|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
546728|NCT00747474|1333629|P7|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
546729|NCT00747474|1333630|P6|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
546730|NCT00747474|1333631|P5|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
546731|NCT00747474|1333632|P4|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
546732|NCT00747474|1333633|P3|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
546733|NCT00747474|1333634|P2|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
546734|NCT00747474|1333635|P1|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
546735|NCT00747474|1333624|P12|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
546736|NCT00747474|1333625|P11|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
546737|NCT00747474|1333626|P10|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
546738|NCT00747474|1333627|P9|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
546739|NCT00747474|1333628|P8|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
546740|NCT00747474|1333629|P7|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
546741|NCT00747474|1333630|P6|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
546742|NCT00747474|1333631|P5|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
546743|NCT00747474|1333632|P4|COMPLETED|Cohort 4 (9 mg/m^2) Period||4
546744|NCT00747474|1333633|P3|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
546745|NCT00747474|1333634|P2|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
546746|NCT00747474|1333635|P1|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
546747|NCT00747474|1333624|P12|STARTED|Cohort 4 (9 mg/m^2) Period||0
546748|NCT00747474|1333625|P11|STARTED|Cohort 4 (9 mg/m^2) Period||0
546749|NCT00747474|1333626|P10|STARTED|Cohort 4 (9 mg/m^2) Period||0
546750|NCT00747474|1333627|P9|STARTED|Cohort 4 (9 mg/m^2) Period||0
546751|NCT00747474|1333628|P8|STARTED|Cohort 4 (9 mg/m^2) Period||0
546752|NCT00747474|1333629|P7|STARTED|Cohort 4 (9 mg/m^2) Period||0
546753|NCT00747474|1333630|P6|STARTED|Cohort 4 (9 mg/m^2) Period||0
546754|NCT00747474|1333631|P5|STARTED|Cohort 4 (9 mg/m^2) Period||0
546755|NCT00747474|1333632|P4|STARTED|Cohort 4 (9 mg/m^2) Period||4
546756|NCT00747474|1333633|P3|STARTED|Cohort 4 (9 mg/m^2) Period||0
546757|NCT00747474|1333634|P2|STARTED|Cohort 4 (9 mg/m^2) Period||0
546758|NCT00747474|1333635|P1|STARTED|Cohort 4 (9 mg/m^2) Period||0
546759|NCT00747474|1333624|P12|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
546760|NCT00747474|1333625|P11|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
546761|NCT00747474|1333626|P10|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
546762|NCT00747474|1333627|P9|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
546763|NCT00747474|1333628|P8|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
546764|NCT00747474|1333629|P7|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
546765|NCT00747474|1333630|P6|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
546766|NCT00747474|1333631|P5|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
546767|NCT00747474|1333632|P4|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
546768|NCT00747474|1333633|P3|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
546769|NCT00747474|1333634|P2|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
546770|NCT00747474|1333635|P1|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
546771|NCT00747474|1333624|P12|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
546772|NCT00747474|1333625|P11|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
546773|NCT00747474|1333626|P10|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
546774|NCT00747474|1333627|P9|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
546775|NCT00747474|1333628|P8|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
546776|NCT00747474|1333629|P7|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
546777|NCT00747474|1333630|P6|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
546778|NCT00747474|1333631|P5|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
546779|NCT00747474|1333632|P4|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
546780|NCT00747474|1333633|P3|COMPLETED|Cohort 3 (6 mg/m^2) Period||3
546781|NCT00747474|1333634|P2|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
546782|NCT00747474|1333635|P1|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
546783|NCT00747474|1333624|P12|STARTED|Cohort 3 (6 mg/m^2) Period||0
546784|NCT00747474|1333625|P11|STARTED|Cohort 3 (6 mg/m^2) Period||0
546785|NCT00747474|1333626|P10|STARTED|Cohort 3 (6 mg/m^2) Period||0
546786|NCT00747474|1333627|P9|STARTED|Cohort 3 (6 mg/m^2) Period||0
546787|NCT00747474|1333628|P8|STARTED|Cohort 3 (6 mg/m^2) Period||0
546788|NCT00747474|1333629|P7|STARTED|Cohort 3 (6 mg/m^2) Period||0
546789|NCT00747474|1333630|P6|STARTED|Cohort 3 (6 mg/m^2) Period||0
546790|NCT00747474|1333631|P5|STARTED|Cohort 3 (6 mg/m^2) Period||0
546791|NCT00747474|1333632|P4|STARTED|Cohort 3 (6 mg/m^2) Period||0
546792|NCT00747474|1333633|P3|STARTED|Cohort 3 (6 mg/m^2) Period||3
546793|NCT00747474|1333634|P2|STARTED|Cohort 3 (6 mg/m^2) Period||0
546794|NCT00747474|1333635|P1|STARTED|Cohort 3 (6 mg/m^2) Period||0
546795|NCT00747474|1333624|P12|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
546796|NCT00747474|1333625|P11|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
546797|NCT00747474|1333626|P10|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
546798|NCT00747474|1333627|P9|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
546799|NCT00747474|1333628|P8|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
546800|NCT00747474|1333629|P7|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
546801|NCT00747474|1333630|P6|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
546802|NCT00747474|1333631|P5|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
546803|NCT00747474|1333632|P4|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
546804|NCT00747474|1333633|P3|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
546805|NCT00747474|1333634|P2|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
546806|NCT00747474|1333635|P1|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
546807|NCT00747474|1333624|P12|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
546808|NCT00747474|1333625|P11|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
546809|NCT00747474|1333626|P10|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
546810|NCT00747474|1333627|P9|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
546811|NCT00747474|1333628|P8|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
546812|NCT00747474|1333629|P7|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
546813|NCT00747474|1333630|P6|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
546814|NCT00747474|1333631|P5|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
546815|NCT00747474|1333632|P4|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
546816|NCT00747474|1333633|P3|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
546817|NCT00747474|1333634|P2|COMPLETED|Cohort 2 (3 mg/m^2) Period||4
546818|NCT00747474|1333635|P1|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
546819|NCT00747474|1333624|P12|STARTED|Cohort 2 (3 mg/m^2) Period||0
546820|NCT00747474|1333625|P11|STARTED|Cohort 2 (3 mg/m^2) Period||0
546821|NCT00747474|1333626|P10|STARTED|Cohort 2 (3 mg/m^2) Period||0
546822|NCT00747474|1333627|P9|STARTED|Cohort 2 (3 mg/m^2) Period||0
546823|NCT00747474|1333628|P8|STARTED|Cohort 2 (3 mg/m^2) Period||0
546824|NCT00747474|1333629|P7|STARTED|Cohort 2 (3 mg/m^2) Period||0
546825|NCT00747474|1333630|P6|STARTED|Cohort 2 (3 mg/m^2) Period||0
546826|NCT00747474|1333631|P5|STARTED|Cohort 2 (3 mg/m^2) Period||0
546827|NCT00747474|1333632|P4|STARTED|Cohort 2 (3 mg/m^2) Period||0
546828|NCT00747474|1333633|P3|STARTED|Cohort 2 (3 mg/m^2) Period||0
546829|NCT00747474|1333634|P2|STARTED|Cohort 2 (3 mg/m^2) Period||4
546830|NCT00747474|1333635|P1|STARTED|Cohort 2 (3 mg/m^2) Period||0
546831|NCT00747474|1333624|P12|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
546832|NCT00747474|1333625|P11|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
546833|NCT00747474|1333626|P10|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
546834|NCT00747474|1333627|P9|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
546835|NCT00747474|1333628|P8|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
546836|NCT00747474|1333629|P7|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
546837|NCT00747474|1333630|P6|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
546838|NCT00747474|1333631|P5|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
546839|NCT00747474|1333632|P4|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
546840|NCT00747474|1333633|P3|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
546841|NCT00747474|1333634|P2|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
546842|NCT00747474|1333635|P1|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
546843|NCT00747474|1333624|P12|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
546844|NCT00747474|1333625|P11|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
546845|NCT00747474|1333626|P10|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
546846|NCT00747474|1333627|P9|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
546847|NCT00747474|1333628|P8|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
546848|NCT00747474|1333629|P7|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
546849|NCT00747474|1333630|P6|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
546850|NCT00747474|1333631|P5|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
546851|NCT00747474|1333632|P4|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
546852|NCT00747474|1333633|P3|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
546853|NCT00747474|1333634|P2|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
546854|NCT00747474|1333635|P1|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||3
546855|NCT00747474|1333624|P12|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
546856|NCT00747474|1333625|P11|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
546857|NCT00747474|1333626|P10|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
546858|NCT00747474|1333627|P9|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
546859|NCT00747474|1333628|P8|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
546860|NCT00747474|1333629|P7|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
546861|NCT00747474|1333630|P6|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
546862|NCT00747474|1333631|P5|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
546863|NCT00747474|1333632|P4|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
546864|NCT00747474|1333633|P3|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
546865|NCT00747474|1333634|P2|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
546866|NCT00747474|1333635|P1|STARTED|Cohort 1 (1.5 mg/m^2) Period||3
546867|NCT00747461|1333661|P1|NOT COMPLETED|Overall Study||5
546868|NCT00747461|1333661|P1|COMPLETED|Overall Study||0
546869|NCT00747461|1333661|P1|STARTED|Overall Study||5
546870|NCT00747435|1333666|P1|NOT COMPLETED|Overall Study||6
546871|NCT00747435|1333666|P1|COMPLETED|Overall Study||67
546872|NCT00747435|1333666|P1|STARTED|Overall Study||73
546873|NCT00747344|1333676|P4|NOT COMPLETED|After Controlled Period||1
546874|NCT00747344|1333677|P3|NOT COMPLETED|After Controlled Period||0
546875|NCT00747344|1333678|P2|NOT COMPLETED|After Controlled Period||0
546876|NCT00747344|1333679|P1|NOT COMPLETED|After Controlled Period||0
546877|NCT00747344|1333676|P4|COMPLETED|After Controlled Period||56
546878|NCT00747344|1333677|P3|COMPLETED|After Controlled Period||55
546879|NCT00747344|1333678|P2|COMPLETED|After Controlled Period||0
546880|NCT00747344|1333679|P1|COMPLETED|After Controlled Period||0
546881|NCT00747344|1333676|P4|STARTED|After Controlled Period|2 participants discontinued in CP, had follow-up, and are among frequent and serious adverse events.|57
546882|NCT00747344|1333677|P3|STARTED|After Controlled Period||55
546883|NCT00747344|1333678|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
546884|NCT00747344|1333679|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
546885|NCT00747344|1333676|P4|NOT COMPLETED|Controlled Period||0
546886|NCT00747344|1333677|P3|NOT COMPLETED|Controlled Period||0
546887|NCT00747344|1333678|P2|NOT COMPLETED|Controlled Period||4
546888|NCT00747344|1333679|P1|NOT COMPLETED|Controlled Period||5
546889|NCT00747344|1333676|P4|COMPLETED|Controlled Period||0
546890|NCT00747344|1333677|P3|COMPLETED|Controlled Period||0
546891|NCT00747344|1333678|P2|COMPLETED|Controlled Period||57
546892|NCT00747344|1333679|P1|COMPLETED|Controlled Period||55
546893|NCT00747344|1333676|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
546894|NCT00747344|1333677|P3|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
546895|NCT00747344|1333678|P2|STARTED|Controlled Period||61
546896|NCT00747344|1333679|P1|STARTED|Controlled Period||60
546897|NCT00747227|1333693|P2|NOT COMPLETED|Overall Study||4
546898|NCT00747227|1333694|P1|NOT COMPLETED|Overall Study||6
546899|NCT00747227|1333693|P2|COMPLETED|Overall Study||120
546900|NCT00747227|1333694|P1|COMPLETED|Overall Study||120
546901|NCT00747227|1333693|P2|STARTED|Overall Study||124
546902|NCT00747227|1333694|P1|STARTED|Overall Study||126
546903|NCT00747214|1333708|P2|NOT COMPLETED|Overall Study||3
546904|NCT00747214|1333709|P1|NOT COMPLETED|Overall Study||8
546905|NCT00747214|1333708|P2|COMPLETED|Overall Study||29
546906|NCT00747214|1333709|P1|COMPLETED|Overall Study||19
546907|NCT00747214|1333708|P2|STARTED|Overall Study||32
546908|NCT00747214|1333709|P1|STARTED|Overall Study||27
546909|NCT00747149|1333723|P2|NOT COMPLETED|Overall Study||43
546910|NCT00747149|1333724|P1|NOT COMPLETED|Overall Study||1
546911|NCT00747149|1333723|P2|COMPLETED|Overall Study||401
546912|NCT00747149|1333724|P1|COMPLETED|Overall Study||153
546913|NCT00747149|1333723|P2|STARTED|Overall Study||444
546914|NCT00747149|1333724|P1|STARTED|Overall Study||154
546915|NCT00747006|1333739|P3|NOT COMPLETED|Overall Study||1
546916|NCT00747006|1333740|P2|NOT COMPLETED|Overall Study||1
546917|NCT00747006|1333741|P1|NOT COMPLETED|Overall Study||3
546918|NCT00747006|1333739|P3|COMPLETED|Overall Study||2
546919|NCT00747006|1333740|P2|COMPLETED|Overall Study||7
546920|NCT00747006|1333741|P1|COMPLETED|Overall Study||4
546921|NCT00747006|1333739|P3|STARTED|Overall Study||3
546922|NCT00747006|1333740|P2|STARTED|Overall Study||8
546923|NCT00747006|1333741|P1|STARTED|Overall Study||7
546924|NCT00746954|1333807|P3|NOT COMPLETED|Overall Study||0
546925|NCT00746954|1333808|P2|NOT COMPLETED|Overall Study||0
546926|NCT00746954|1333809|P1|NOT COMPLETED|Overall Study||0
546927|NCT00746954|1333807|P3|COMPLETED|Overall Study||2
546928|NCT00746954|1333808|P2|COMPLETED|Overall Study||3
546929|NCT00746954|1333809|P1|COMPLETED|Overall Study||3
546930|NCT00746954|1333807|P3|STARTED|Overall Study||2
546931|NCT00746954|1333808|P2|STARTED|Overall Study||3
546932|NCT00746954|1333809|P1|STARTED|Overall Study||3
546933|NCT00746941|1333819|P4|NOT COMPLETED|Overall Study||13
546934|NCT00746941|1333820|P3|NOT COMPLETED|Overall Study||2
546935|NCT00746941|1333821|P2|NOT COMPLETED|Overall Study||4
546936|NCT00746941|1333822|P1|NOT COMPLETED|Overall Study||7
546937|NCT00746941|1333819|P4|COMPLETED|Overall Study||7
546938|NCT00746941|1333820|P3|COMPLETED|Overall Study||3
546939|NCT00746941|1333821|P2|COMPLETED|Overall Study||1
546940|NCT00746941|1333822|P1|COMPLETED|Overall Study||0
546941|NCT00746941|1333819|P4|STARTED|Overall Study||20
546942|NCT00746941|1333820|P3|STARTED|Overall Study||5
546943|NCT00746941|1333821|P2|STARTED|Overall Study||5
546944|NCT00746941|1333822|P1|STARTED|Overall Study||7
546945|NCT00746889|1333850|P2|NOT COMPLETED|Overall Study||4
546946|NCT00746889|1333851|P1|NOT COMPLETED|Overall Study||4
546947|NCT00746889|1333850|P2|COMPLETED|Overall Study||35
546948|NCT00746889|1333851|P1|COMPLETED|Overall Study||36
546949|NCT00746889|1333850|P2|STARTED|Overall Study||39
546950|NCT00746889|1333851|P1|STARTED|Overall Study||40
546951|NCT00746863|1333861|P2|NOT COMPLETED|Overall Study||0
546952|NCT00746863|1333862|P1|NOT COMPLETED|Overall Study||0
546953|NCT00746863|1333861|P2|COMPLETED|Overall Study||21
546954|NCT00746863|1333862|P1|COMPLETED|Overall Study||21
546955|NCT00746863|1333861|P2|STARTED|Overall Study||21
546956|NCT00746863|1333862|P1|STARTED|Overall Study||21
546957|NCT00746798|1333880|P4|NOT COMPLETED|Overall Study||0
546958|NCT00746798|1333881|P3|NOT COMPLETED|Overall Study||3
546959|NCT00746798|1333882|P2|NOT COMPLETED|Overall Study||2
546960|NCT00746798|1333883|P1|NOT COMPLETED|Overall Study||1
546961|NCT00746798|1333880|P4|COMPLETED|Overall Study||120
546962|NCT00746798|1333881|P3|COMPLETED|Overall Study||110
546963|NCT00746798|1333882|P2|COMPLETED|Overall Study||122
546964|NCT00746798|1333883|P1|COMPLETED|Overall Study||121
546965|NCT00746798|1333880|P4|STARTED|Overall Study||120
546966|NCT00746798|1333881|P3|STARTED|Overall Study||113
546967|NCT00746798|1333882|P2|STARTED|Overall Study||124
546968|NCT00746798|1333883|P1|STARTED|Overall Study||122
546969|NCT00746785|1333908|P3|NOT COMPLETED|Overall Study||27
546970|NCT00746785|1333909|P2|NOT COMPLETED|Overall Study||25
546971|NCT00746785|1333910|P1|NOT COMPLETED|Overall Study||29
546972|NCT00746785|1333908|P3|COMPLETED|Overall Study||13
546973|NCT00746785|1333909|P2|COMPLETED|Overall Study||21
546974|NCT00746785|1333910|P1|COMPLETED|Overall Study||14
546975|NCT00746785|1333908|P3|STARTED|Overall Study||40
546976|NCT00746785|1333909|P2|STARTED|Overall Study||46
546977|NCT00746785|1333910|P1|STARTED|Overall Study||43
546978|NCT00746733|1333918|P2|NOT COMPLETED|Fourth Intervention||0
546979|NCT00746733|1333919|P1|NOT COMPLETED|Fourth Intervention||0
546980|NCT00746733|1333918|P2|COMPLETED|Fourth Intervention||11
546981|NCT00746733|1333919|P1|COMPLETED|Fourth Intervention||10
546982|NCT00746733|1333918|P2|STARTED|Fourth Intervention||11
546983|NCT00746733|1333919|P1|STARTED|Fourth Intervention||10
546984|NCT00746733|1333918|P2|NOT COMPLETED|Third Intervention||1
546985|NCT00746733|1333919|P1|NOT COMPLETED|Third Intervention||1
546986|NCT00746733|1333918|P2|COMPLETED|Third Intervention||11
546987|NCT00746733|1333919|P1|COMPLETED|Third Intervention||10
546988|NCT00746733|1333918|P2|STARTED|Third Intervention||12
546989|NCT00746733|1333919|P1|STARTED|Third Intervention||11
546990|NCT00746733|1333918|P2|NOT COMPLETED|Second Intervention||0
546991|NCT00746733|1333919|P1|NOT COMPLETED|Second Intervention||1
546992|NCT00746733|1333918|P2|COMPLETED|Second Intervention||12
546993|NCT00746733|1333919|P1|COMPLETED|Second Intervention||11
546994|NCT00746733|1333918|P2|STARTED|Second Intervention||12
546995|NCT00746733|1333919|P1|STARTED|Second Intervention||12
546996|NCT00746733|1333918|P2|NOT COMPLETED|First Intervention||0
546997|NCT00746733|1333919|P1|NOT COMPLETED|First Intervention||0
546998|NCT00746733|1333918|P2|COMPLETED|First Intervention||12
546999|NCT00746733|1333919|P1|COMPLETED|First Intervention||12
547000|NCT00746733|1333918|P2|STARTED|First Intervention||12
547001|NCT00746733|1333919|P1|STARTED|First Intervention||12
547002|NCT00746694|1333979|P1|NOT COMPLETED|Overall Study||0
547003|NCT00746694|1333979|P1|COMPLETED|Overall Study||154
547004|NCT00746694|1333979|P1|STARTED|Overall Study||154
547005|NCT00746668|1333984|P7|NOT COMPLETED|Overall Study||0
547006|NCT00746668|1333985|P6|NOT COMPLETED|Overall Study||0
547007|NCT00746668|1333986|P5|NOT COMPLETED|Overall Study||0
547008|NCT00746668|1333987|P4|NOT COMPLETED|Overall Study||0
547009|NCT00746668|1333988|P3|NOT COMPLETED|Overall Study||0
547010|NCT00746668|1333989|P2|NOT COMPLETED|Overall Study||0
547011|NCT00746668|1333990|P1|NOT COMPLETED|Overall Study||0
547012|NCT00746668|1333984|P7|COMPLETED|Overall Study||5
547013|NCT00746668|1333985|P6|COMPLETED|Overall Study||5
547014|NCT00746668|1333986|P5|COMPLETED|Overall Study||5
547015|NCT00746668|1333987|P4|COMPLETED|Overall Study||5
547016|NCT00746668|1333988|P3|COMPLETED|Overall Study||5
547017|NCT00746668|1333989|P2|COMPLETED|Overall Study||5
547018|NCT00746668|1333990|P1|COMPLETED|Overall Study||6
547019|NCT00746668|1333984|P7|STARTED|Overall Study||5
547020|NCT00746668|1333985|P6|STARTED|Overall Study||5
547021|NCT00746668|1333986|P5|STARTED|Overall Study||5
547022|NCT00746668|1333987|P4|STARTED|Overall Study||5
547023|NCT00746668|1333988|P3|STARTED|Overall Study||5
547024|NCT00746668|1333989|P2|STARTED|Overall Study||5
547025|NCT00746668|1333990|P1|STARTED|Overall Study||6
547026|NCT00746590|1334003|P1|NOT COMPLETED|Overall Study||1
547027|NCT00746590|1334003|P1|COMPLETED|Overall Study||0
547028|NCT00746590|1334003|P1|STARTED|Overall Study||1
547029|NCT00746564|1334007|P1|NOT COMPLETED|Overall Study||2
547030|NCT00746564|1334007|P1|COMPLETED|Overall Study||73
547031|NCT00746564|1334007|P1|STARTED|Overall Study||75
547032|NCT00746551|1334022|P2|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15
547033|NCT00746551|1334023|P1|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15
547034|NCT00746551|1334022|P2|COMPLETED|At Delivery (GA of 39 Weeks)||25
547035|NCT00746551|1334023|P1|COMPLETED|At Delivery (GA of 39 Weeks)||25
547036|NCT00746551|1334022|P2|STARTED|At Delivery (GA of 39 Weeks)||40
547037|NCT00746551|1334023|P1|STARTED|At Delivery (GA of 39 Weeks)||40
547038|NCT00746551|1334022|P2|NOT COMPLETED|At Gestational Age of 36 Weeks||4
547039|NCT00746551|1334023|P1|NOT COMPLETED|At Gestational Age of 36 Weeks||2
547040|NCT00746551|1334022|P2|COMPLETED|At Gestational Age of 36 Weeks||36
547041|NCT00746551|1334023|P1|COMPLETED|At Gestational Age of 36 Weeks||38
547042|NCT00746551|1334022|P2|STARTED|At Gestational Age of 36 Weeks||40
547043|NCT00746551|1334023|P1|STARTED|At Gestational Age of 36 Weeks||40
547044|NCT00746512|1334035|P4|NOT COMPLETED|Overall Study||0
547045|NCT00746512|1334036|P3|NOT COMPLETED|Overall Study||0
547046|NCT00746512|1334037|P2|NOT COMPLETED|Overall Study||0
547047|NCT00746512|1334038|P1|NOT COMPLETED|Overall Study||0
547048|NCT00746512|1334035|P4|COMPLETED|Overall Study||9
547049|NCT00746512|1334036|P3|COMPLETED|Overall Study||18
547050|NCT00746512|1334037|P2|COMPLETED|Overall Study||10
547051|NCT00746512|1334038|P1|COMPLETED|Overall Study||8
547052|NCT00746512|1334035|P4|STARTED|Overall Study||9
547053|NCT00746512|1334036|P3|STARTED|Overall Study||18
547054|NCT00746512|1334037|P2|STARTED|Overall Study||10
547055|NCT00746512|1334038|P1|STARTED|Overall Study||8
547056|NCT00746421|1334054|P2|NOT COMPLETED|Overall Study||2
547057|NCT00746421|1334055|P1|NOT COMPLETED|Overall Study||7
547058|NCT00746421|1334054|P2|COMPLETED|Overall Study||9
547059|NCT00746421|1334055|P1|COMPLETED|Overall Study||5
547060|NCT00746421|1334054|P2|STARTED|Overall Study||11
547061|NCT00746421|1334055|P1|STARTED|Overall Study||12
547062|NCT00746395|1334065|P2|NOT COMPLETED|Overall Study||0
547063|NCT00746395|1334066|P1|NOT COMPLETED|Overall Study||0
547064|NCT00746395|1334065|P2|COMPLETED|Overall Study||20
547065|NCT00746395|1334066|P1|COMPLETED|Overall Study||20
547066|NCT00746395|1334065|P2|STARTED|Overall Study||20
547067|NCT00746395|1334066|P1|STARTED|Overall Study||20
547068|NCT00746356|1334074|P2|NOT COMPLETED|Overall Study||7
547069|NCT00746356|1334075|P1|NOT COMPLETED|Overall Study||11
547070|NCT00746356|1334074|P2|COMPLETED|Overall Study||40
547071|NCT00746356|1334075|P1|COMPLETED|Overall Study||70
547072|NCT00746356|1334074|P2|STARTED|Overall Study||47
547073|NCT00746356|1334075|P1|STARTED|Overall Study||81
547074|NCT00746330|1334087|P4|NOT COMPLETED|Period 4||0
547075|NCT00746330|1334088|P3|NOT COMPLETED|Period 4||0
547076|NCT00746330|1334089|P2|NOT COMPLETED|Period 4||0
547077|NCT00746330|1334090|P1|NOT COMPLETED|Period 4||0
547078|NCT00746330|1334087|P4|COMPLETED|Period 4||7
547079|NCT00746330|1334088|P3|COMPLETED|Period 4||8
547080|NCT00746330|1334089|P2|COMPLETED|Period 4||9
547081|NCT00746330|1334090|P1|COMPLETED|Period 4||7
547082|NCT00746330|1334087|P4|STARTED|Period 4||7
547083|NCT00746330|1334088|P3|STARTED|Period 4||8
547084|NCT00746330|1334089|P2|STARTED|Period 4||9
547085|NCT00746330|1334090|P1|STARTED|Period 4||7
547086|NCT00746330|1334087|P4|NOT COMPLETED|Period 3||0
547087|NCT00746330|1334088|P3|NOT COMPLETED|Period 3||0
547088|NCT00746330|1334089|P2|NOT COMPLETED|Period 3||0
547089|NCT00746330|1334090|P1|NOT COMPLETED|Period 3||0
547090|NCT00746330|1334087|P4|COMPLETED|Period 3||7
547091|NCT00746330|1334088|P3|COMPLETED|Period 3||8
547092|NCT00746330|1334089|P2|COMPLETED|Period 3||9
547093|NCT00746330|1334090|P1|COMPLETED|Period 3||7
547094|NCT00746330|1334087|P4|STARTED|Period 3||7
547095|NCT00746330|1334088|P3|STARTED|Period 3||8
547096|NCT00746330|1334089|P2|STARTED|Period 3||9
547097|NCT00746330|1334090|P1|STARTED|Period 3||7
547098|NCT00746330|1334087|P4|NOT COMPLETED|Period 2||0
547099|NCT00746330|1334088|P3|NOT COMPLETED|Period 2||0
547100|NCT00746330|1334089|P2|NOT COMPLETED|Period 2||0
547101|NCT00746330|1334090|P1|NOT COMPLETED|Period 2||0
547102|NCT00746330|1334087|P4|COMPLETED|Period 2||7
547103|NCT00746330|1334088|P3|COMPLETED|Period 2||8
547104|NCT00746330|1334089|P2|COMPLETED|Period 2||9
547105|NCT00746330|1334090|P1|COMPLETED|Period 2||7
547106|NCT00746330|1334087|P4|STARTED|Period 2||7
547107|NCT00746330|1334088|P3|STARTED|Period 2||8
547108|NCT00746330|1334089|P2|STARTED|Period 2||9
547109|NCT00746330|1334090|P1|STARTED|Period 2||7
547110|NCT00746330|1334087|P4|NOT COMPLETED|Period 1||0
547111|NCT00746330|1334088|P3|NOT COMPLETED|Period 1||1
547112|NCT00746330|1334089|P2|NOT COMPLETED|Period 1||0
547113|NCT00746330|1334090|P1|NOT COMPLETED|Period 1||0
547114|NCT00746330|1334087|P4|COMPLETED|Period 1||7
547115|NCT00746330|1334088|P3|COMPLETED|Period 1||8
547116|NCT00746330|1334089|P2|COMPLETED|Period 1||9
547117|NCT00746330|1334090|P1|COMPLETED|Period 1||7
547118|NCT00746330|1334087|P4|STARTED|Period 1||7
547119|NCT00746330|1334088|P3|STARTED|Period 1||9
547120|NCT00746330|1334089|P2|STARTED|Period 1||9
547121|NCT00746330|1334090|P1|STARTED|Period 1||7
547122|NCT00746252|1334120|P2|NOT COMPLETED|Overall Study||2
547123|NCT00746252|1334121|P1|NOT COMPLETED|Overall Study||1
547124|NCT00746252|1334120|P2|COMPLETED|Overall Study||0
547125|NCT00746252|1334121|P1|COMPLETED|Overall Study||0
547126|NCT00746252|1334120|P2|STARTED|Overall Study||2
547127|NCT00746252|1334121|P1|STARTED|Overall Study||1
547128|NCT00746239|1334127|P1|NOT COMPLETED|Overall Study||6
547129|NCT00746239|1334127|P1|COMPLETED|Overall Study|11 subjects total were enrolled - 6 withdrew from study and 5 competed|5
547130|NCT00746239|1334127|P1|STARTED|Overall Study||11
547131|NCT00746187|1334134|P2|NOT COMPLETED|Overall Study||2
547132|NCT00746187|1334135|P1|NOT COMPLETED|Overall Study||3
547133|NCT00746187|1334134|P2|COMPLETED|Overall Study||16
547134|NCT00746187|1334135|P1|COMPLETED|Overall Study||15
547135|NCT00746187|1334134|P2|STARTED|Overall Study||18
547136|NCT00746187|1334135|P1|STARTED|Overall Study||18
547137|NCT00746096|1334143|P2|NOT COMPLETED|Overall Study||3
547138|NCT00746096|1334144|P1|NOT COMPLETED|Overall Study||10
547139|NCT00746096|1334143|P2|COMPLETED|Overall Study||54
547140|NCT00746096|1334144|P1|COMPLETED|Overall Study||48
547141|NCT00746096|1334143|P2|STARTED|Overall Study||57
547142|NCT00746096|1334144|P1|STARTED|Overall Study||58
547143|NCT00746018|1334152|P1|NOT COMPLETED|Overall Study||0
547144|NCT00746018|1334152|P1|COMPLETED|Overall Study||39
547145|NCT00746018|1334152|P1|STARTED|Overall Study||39
547146|NCT00745940|1334158|P2|NOT COMPLETED|Overall Study||10
547147|NCT00745940|1334159|P1|NOT COMPLETED|Overall Study||19
547148|NCT00745940|1334158|P2|COMPLETED|Overall Study||38
547149|NCT00745940|1334159|P1|COMPLETED|Overall Study||38
547150|NCT00745940|1334158|P2|STARTED|Overall Study||48
547151|NCT00745940|1334159|P1|STARTED|Overall Study||57
547152|NCT00745901|1334175|P2|NOT COMPLETED|Overall Study||21
547153|NCT00745901|1334176|P1|NOT COMPLETED|Overall Study||24
547154|NCT00745901|1334175|P2|COMPLETED|Overall Study||156
547155|NCT00745901|1334176|P1|COMPLETED|Overall Study||154
547156|NCT00745901|1334175|P2|STARTED|Overall Study|Number of Patients Randomized|177
547157|NCT00745901|1334176|P1|STARTED|Overall Study|Number of Patients Randomized|178
547158|NCT00745875|1334222|P2|NOT COMPLETED|Overall Study||4
547159|NCT00745875|1334223|P1|NOT COMPLETED|Overall Study||4
547160|NCT00745875|1334222|P2|COMPLETED|Overall Study|Completed – Number of patients discontinued study treatment at data cut-off (17th January 2010)|26
547161|NCT00745875|1334223|P1|COMPLETED|Overall Study|Completed – Number of patients discontinued study treatment at data cut-off (17th January 2010)|32
547162|NCT00745875|1334222|P2|STARTED|Overall Study|Started – Number of patients randomised|30
547163|NCT00745875|1334223|P1|STARTED|Overall Study|Started – Number of patients randomised|36
547164|NCT00745823|1334233|P2|NOT COMPLETED|Overall Study||386
547165|NCT00745823|1334234|P1|NOT COMPLETED|Overall Study||385
547166|NCT00745823|1334233|P2|COMPLETED|Overall Study||3
547167|NCT00745823|1334234|P1|COMPLETED|Overall Study||1
547168|NCT00745823|1334233|P2|TREATED Week 0 - 96|Overall Study||388
547169|NCT00745823|1334234|P1|TREATED Week 0 - 96|Overall Study||382
547170|NCT00745823|1334233|P2|STARTED|Overall Study||389
547171|NCT00745823|1334234|P1|STARTED|Overall Study||386
547172|NCT00745498|1334261|P3|NOT COMPLETED|Overall Study||8
547173|NCT00745498|1334262|P2|NOT COMPLETED|Overall Study||6
547174|NCT00745498|1334263|P1|NOT COMPLETED|Overall Study||5
547175|NCT00745498|1334261|P3|COMPLETED|Overall Study||34
547176|NCT00745498|1334262|P2|COMPLETED|Overall Study||37
547177|NCT00745498|1334263|P1|COMPLETED|Overall Study||36
547178|NCT00745498|1334261|P3|STARTED|Overall Study||42
547179|NCT00745498|1334262|P2|STARTED|Overall Study||43
547180|NCT00745498|1334263|P1|STARTED|Overall Study||41
547181|NCT00745420|1334277|P1|NOT COMPLETED|Overall Study||1
547182|NCT00745420|1334277|P1|COMPLETED|Overall Study||29
547183|NCT00745420|1334277|P1|STARTED|Overall Study||30
547184|NCT00745368|1334294|P1|NOT COMPLETED|Overall Study||3
547185|NCT00745368|1334294|P1|COMPLETED|Overall Study|3 male subjects were unable to provide a sample and are not included in the results|16
547186|NCT00745368|1334294|P1|STARTED|Overall Study|Of the 28 subjects who enrolled, 19 participated in a study visit|19
547187|NCT00745290|1334307|P2|NOT COMPLETED|Overall Study||0
547188|NCT00745290|1334308|P1|NOT COMPLETED|Overall Study||0
547189|NCT00745290|1334307|P2|COMPLETED|Overall Study||122
547190|NCT00745290|1334308|P1|COMPLETED|Overall Study||123
547191|NCT00745290|1334307|P2|STARTED|Overall Study||122
547192|NCT00745290|1334308|P1|STARTED|Overall Study||123
547193|NCT00745251|1334316|P2|NOT COMPLETED|Overall Study||3
547194|NCT00745251|1334317|P1|NOT COMPLETED|Overall Study||2
547195|NCT00745251|1334316|P2|COMPLETED|Overall Study||19
547196|NCT00745251|1334317|P1|COMPLETED|Overall Study||21
547197|NCT00745251|1334316|P2|STARTED|Overall Study||22
547198|NCT00745251|1334317|P1|STARTED|Overall Study||23
547199|NCT00745095|1334331|P6|NOT COMPLETED|Overall Study||123
547200|NCT00745095|1334332|P5|NOT COMPLETED|Overall Study||122
547201|NCT00745095|1334333|P4|NOT COMPLETED|Overall Study||3
547202|NCT00745095|1334334|P3|NOT COMPLETED|Overall Study||3
547203|NCT00745095|1334335|P2|NOT COMPLETED|Overall Study||2
547204|NCT00745095|1334336|P1|NOT COMPLETED|Overall Study||1
547205|NCT00745095|1334331|P6|COMPLETED|Overall Study||27
547206|NCT00745095|1334332|P5|COMPLETED|Overall Study||28
547207|NCT00745095|1334333|P4|COMPLETED|Overall Study||12
547208|NCT00745095|1334334|P3|COMPLETED|Overall Study||12
547209|NCT00745095|1334335|P2|COMPLETED|Overall Study||13
547210|NCT00745095|1334336|P1|COMPLETED|Overall Study||14
547211|NCT00745095|1334331|P6|STARTED|Overall Study||150
547212|NCT00745095|1334332|P5|STARTED|Overall Study||150
547213|NCT00745095|1334333|P4|STARTED|Overall Study||15
547214|NCT00745095|1334334|P3|STARTED|Overall Study||15
547215|NCT00745095|1334335|P2|STARTED|Overall Study||15
547216|NCT00745095|1334336|P1|STARTED|Overall Study||15
547217|NCT00745030|1334358|P2|NOT COMPLETED|Overall Study||0
547218|NCT00745030|1334359|P1|NOT COMPLETED|Overall Study||0
547219|NCT00745030|1334358|P2|COMPLETED|Overall Study||2
547220|NCT00745030|1334359|P1|COMPLETED|Overall Study||1
547221|NCT00745030|1334358|P2|STARTED|Overall Study||2
547222|NCT00745030|1334359|P1|STARTED|Overall Study||1
547223|NCT00744978|1334367|P2|NOT COMPLETED|Period 2||1
547224|NCT00744978|1334368|P1|NOT COMPLETED|Period 2||0
547225|NCT00744978|1334367|P2|COMPLETED|Period 2||28
547226|NCT00744978|1334368|P1|COMPLETED|Period 2||26
547227|NCT00744978|1334367|P2|STARTED|Period 2||29
547228|NCT00744978|1334368|P1|STARTED|Period 2||26
547229|NCT00744978|1334367|P2|NOT COMPLETED|Placebo Washout||0
547230|NCT00744978|1334368|P1|NOT COMPLETED|Placebo Washout||0
547231|NCT00744978|1334367|P2|COMPLETED|Placebo Washout||29
547232|NCT00744978|1334368|P1|COMPLETED|Placebo Washout||26
547233|NCT00744978|1334367|P2|STARTED|Placebo Washout||29
547234|NCT00744978|1334368|P1|STARTED|Placebo Washout||26
547235|NCT00744978|1334367|P2|NOT COMPLETED|Period 1||5
547236|NCT00744978|1334368|P1|NOT COMPLETED|Period 1||6
547237|NCT00744978|1334367|P2|COMPLETED|Period 1||29
547238|NCT00744978|1334368|P1|COMPLETED|Period 1||26
547239|NCT00744978|1334367|P2|Treated|Period 1||33
547240|NCT00744978|1334368|P1|Treated|Period 1||31
547241|NCT00744978|1334367|P2|STARTED|Period 1||34
547242|NCT00744978|1334368|P1|STARTED|Period 1||32
547243|NCT00744939|1334420|P1|NOT COMPLETED|Overall Study||91
547244|NCT00744939|1334420|P1|COMPLETED|Overall Study||77
547245|NCT00744939|1334420|P1|Treatment Received|Overall Study||141
547246|NCT00744939|1334420|P1|STARTED|Overall Study||168
547247|NCT00744874|1334456|P1|NOT COMPLETED|Overall Study||4
547248|NCT00744874|1334456|P1|COMPLETED|Overall Study||51
547249|NCT00744874|1334456|P1|STARTED|Overall Study||55
547250|NCT00744848|1334474|P2|NOT COMPLETED|Overall Study||0
547251|NCT00744848|1334475|P1|NOT COMPLETED|Overall Study||0
547252|NCT00744848|1334474|P2|COMPLETED|Overall Study||101
547253|NCT00744848|1334475|P1|COMPLETED|Overall Study||103
547254|NCT00744848|1334474|P2|STARTED|Overall Study||101
547255|NCT00744848|1334475|P1|STARTED|Overall Study||103
547256|NCT00744757|1334481|P1|NOT COMPLETED|Overall Study||21
547257|NCT00744757|1334481|P1|COMPLETED|Overall Study||16
547258|NCT00744757|1334481|P1|STARTED|Overall Study||37
547259|NCT00744692|1334494|P1|NOT COMPLETED|Overall Study||0
547260|NCT00744692|1334494|P1|COMPLETED|Overall Study||22
547261|NCT00744692|1334494|P1|STARTED|Overall Study||22
547262|NCT00744653|1334506|P1|NOT COMPLETED|Overall Study||16
547263|NCT00744653|1334506|P1|COMPLETED|Overall Study||1
547264|NCT00744653|1334506|P1|STARTED|Overall Study||17
547265|NCT00744627|1334514|P2|NOT COMPLETED|Overall Study||22
547266|NCT00744627|1334515|P1|NOT COMPLETED|Overall Study||25
547267|NCT00744627|1334514|P2|COMPLETED|Overall Study||128
547268|NCT00744627|1334515|P1|COMPLETED|Overall Study||126
547269|NCT00744627|1334514|P2|Treated|Overall Study||150
547270|NCT00744627|1334515|P1|Treated|Overall Study||150
547271|NCT00744627|1334514|P2|STARTED|Overall Study||150
547272|NCT00744627|1334515|P1|STARTED|Overall Study||151
547273|NCT00744523|1334571|P2|NOT COMPLETED|30 Days After the Procedure||5
547274|NCT00744523|1334572|P1|NOT COMPLETED|30 Days After the Procedure||0
547275|NCT00744523|1334571|P2|COMPLETED|30 Days After the Procedure||220
547276|NCT00744523|1334572|P1|COMPLETED|30 Days After the Procedure||37
547277|NCT00744523|1334571|P2|STARTED|30 Days After the Procedure||225
547278|NCT00744523|1334572|P1|STARTED|30 Days After the Procedure||37
547279|NCT00744523|1334571|P2|NOT COMPLETED|Procedure||0
547280|NCT00744523|1334572|P1|NOT COMPLETED|Procedure||0
547281|NCT00744523|1334571|P2|COMPLETED|Procedure||225
547282|NCT00744523|1334572|P1|COMPLETED|Procedure||37
547283|NCT00744523|1334571|P2|STARTED|Procedure||225
547284|NCT00744523|1334572|P1|STARTED|Procedure||37
547285|NCT00744497|1334592|P2|NOT COMPLETED|Overall Study||762
547286|NCT00744497|1334593|P1|NOT COMPLETED|Overall Study||760
547287|NCT00744497|1334592|P2|COMPLETED|Overall Study||0
547288|NCT00744497|1334593|P1|COMPLETED|Overall Study||0
547289|NCT00744497|1334592|P2|Received Treatment|Overall Study||761
547290|NCT00744497|1334593|P1|Received Treatment|Overall Study||757
547291|NCT00744497|1334592|P2|STARTED|Overall Study|Randomized|762
547292|NCT00744497|1334593|P1|STARTED|Overall Study|Randomized|760
547293|NCT00744380|1334629|P2|NOT COMPLETED|Overall Study||0
547294|NCT00744380|1334630|P1|NOT COMPLETED|Overall Study||0
547295|NCT00744380|1334629|P2|COMPLETED|Overall Study||11
547296|NCT00744380|1334630|P1|COMPLETED|Overall Study||12
547297|NCT00744380|1334629|P2|STARTED|Overall Study||11
547298|NCT00744380|1334630|P1|STARTED|Overall Study||12
547299|NCT00744328|1334653|P3|NOT COMPLETED|Overall Study||8
547300|NCT00744328|1334654|P2|NOT COMPLETED|Overall Study||8
547301|NCT00744328|1334655|P1|NOT COMPLETED|Overall Study||7
547302|NCT00744328|1334653|P3|COMPLETED|Overall Study||21
547303|NCT00744328|1334654|P2|COMPLETED|Overall Study||22
547304|NCT00744328|1334655|P1|COMPLETED|Overall Study||19
547305|NCT00744328|1334653|P3|STARTED|Overall Study||29
547306|NCT00744328|1334654|P2|STARTED|Overall Study||30
547307|NCT00744328|1334655|P1|STARTED|Overall Study||26
547308|NCT00744263|1334665|P2|NOT COMPLETED|Overall Study||5320
547309|NCT00744263|1334666|P1|NOT COMPLETED|Overall Study||5236
547310|NCT00744263|1334665|P2|COMPLETED|Overall Study||36936
547311|NCT00744263|1334666|P1|COMPLETED|Overall Study||37004
547312|NCT00744263|1334665|P2|STARTED|Overall Study||42256
547313|NCT00744263|1334666|P1|STARTED|Overall Study||42240
547314|NCT00744237|1334689|P3|NOT COMPLETED|Overall Study||15
547315|NCT00744237|1334690|P2|NOT COMPLETED|Overall Study||27
547316|NCT00744237|1334691|P1|NOT COMPLETED|Overall Study||27
547317|NCT00744237|1334689|P3|COMPLETED|Overall Study||59
547318|NCT00744237|1334690|P2|COMPLETED|Overall Study||46
547319|NCT00744237|1334691|P1|COMPLETED|Overall Study||56
547320|NCT00744237|1334689|P3|STARTED|Overall Study||74
547321|NCT00744237|1334690|P2|STARTED|Overall Study||73
547322|NCT00744237|1334691|P1|STARTED|Overall Study||83
547323|NCT00744211|1334705|P3|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
547324|NCT00744211|1334706|P2|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
547325|NCT00744211|1334707|P1|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
547326|NCT00744211|1334705|P3|COMPLETED|24 Hours After Cardiopulmonary Bypass||10
547327|NCT00744211|1334706|P2|COMPLETED|24 Hours After Cardiopulmonary Bypass||9
547328|NCT00744211|1334707|P1|COMPLETED|24 Hours After Cardiopulmonary Bypass||10
547329|NCT00744211|1334705|P3|STARTED|24 Hours After Cardiopulmonary Bypass||10
547330|NCT00744211|1334706|P2|STARTED|24 Hours After Cardiopulmonary Bypass||9
547331|NCT00744211|1334707|P1|STARTED|24 Hours After Cardiopulmonary Bypass||10
547332|NCT00744211|1334705|P3|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
547333|NCT00744211|1334706|P2|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
547334|NCT00744211|1334707|P1|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
547335|NCT00744211|1334705|P3|COMPLETED|12 Hours After Cardiopulmonary Bypass||10
547336|NCT00744211|1334706|P2|COMPLETED|12 Hours After Cardiopulmonary Bypass||9
547337|NCT00744211|1334707|P1|COMPLETED|12 Hours After Cardiopulmonary Bypass||10
547338|NCT00744211|1334705|P3|STARTED|12 Hours After Cardiopulmonary Bypass||10
547339|NCT00744211|1334706|P2|STARTED|12 Hours After Cardiopulmonary Bypass||9
547340|NCT00744211|1334707|P1|STARTED|12 Hours After Cardiopulmonary Bypass||10
547341|NCT00744211|1334705|P3|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
547342|NCT00744211|1334706|P2|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
547343|NCT00744211|1334707|P1|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
547344|NCT00744211|1334705|P3|COMPLETED|6 Hours After Cardiopulmonary Bypass||10
547345|NCT00744211|1334706|P2|COMPLETED|6 Hours After Cardiopulmonary Bypass||9
547346|NCT00744211|1334707|P1|COMPLETED|6 Hours After Cardiopulmonary Bypass||10
547347|NCT00744211|1334705|P3|STARTED|6 Hours After Cardiopulmonary Bypass||10
547348|NCT00744211|1334706|P2|STARTED|6 Hours After Cardiopulmonary Bypass||9
547349|NCT00744211|1334707|P1|STARTED|6 Hours After Cardiopulmonary Bypass||10
547350|NCT00744211|1334705|P3|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
547351|NCT00744211|1334706|P2|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
547352|NCT00744211|1334707|P1|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
547353|NCT00744211|1334705|P3|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||10
547354|NCT00744211|1334706|P2|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||9
547355|NCT00744211|1334707|P1|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||10
547356|NCT00744211|1334705|P3|STARTED|0.5 Hours After Cardiopulmonary Bypass||10
547357|NCT00744211|1334706|P2|STARTED|0.5 Hours After Cardiopulmonary Bypass||9
547358|NCT00744211|1334707|P1|STARTED|0.5 Hours After Cardiopulmonary Bypass||10
547359|NCT00744211|1334705|P3|NOT COMPLETED|Baseline||0
547360|NCT00744211|1334706|P2|NOT COMPLETED|Baseline||0
547361|NCT00744211|1334707|P1|NOT COMPLETED|Baseline||0
547362|NCT00744211|1334705|P3|COMPLETED|Baseline||10
547363|NCT00744211|1334706|P2|COMPLETED|Baseline||9
547364|NCT00744211|1334707|P1|COMPLETED|Baseline||10
547365|NCT00744211|1334705|P3|STARTED|Baseline||10
547366|NCT00744211|1334706|P2|STARTED|Baseline||9
547367|NCT00744211|1334707|P1|STARTED|Baseline||10
547368|NCT00744055|1334725|P2|NOT COMPLETED|Overall Study||14
547369|NCT00744055|1334726|P1|NOT COMPLETED|Overall Study||7
547370|NCT00744055|1334725|P2|COMPLETED|Overall Study||32
547371|NCT00744055|1334726|P1|COMPLETED|Overall Study||43
547372|NCT00744055|1334725|P2|STARTED|Overall Study||46
547373|NCT00744055|1334726|P1|STARTED|Overall Study||50
547374|NCT00744042|1334734|P1|NOT COMPLETED|Overall Study||1
547375|NCT00744042|1334734|P1|COMPLETED|Overall Study||10
547376|NCT00744042|1334734|P1|STARTED|Overall Study||11
547386|NCT00743717|1334765|P2|NOT COMPLETED|Overall Study||0
547387|NCT00743717|1334766|P1|NOT COMPLETED|Overall Study||0
547388|NCT00743717|1334765|P2|COMPLETED|Overall Study||2
547389|NCT00743717|1334766|P1|COMPLETED|Overall Study||2
547390|NCT00743717|1334765|P2|STARTED|Overall Study||2
547391|NCT00743717|1334766|P1|STARTED|Overall Study||2
547392|NCT00743652|1334777|P5|NOT COMPLETED|Overall Study||0
547393|NCT00743652|1334778|P4|NOT COMPLETED|Overall Study||4
547394|NCT00743652|1334779|P3|NOT COMPLETED|Overall Study||2
547395|NCT00743652|1334780|P2|NOT COMPLETED|Overall Study||3
547396|NCT00743652|1334781|P1|NOT COMPLETED|Overall Study||10
547397|NCT00743652|1334777|P5|COMPLETED|Overall Study||79
547398|NCT00743652|1334778|P4|COMPLETED|Overall Study||63
547399|NCT00743652|1334779|P3|COMPLETED|Overall Study||23
547400|NCT00743652|1334780|P2|COMPLETED|Overall Study||48
547401|NCT00743652|1334781|P1|COMPLETED|Overall Study||141
547402|NCT00743652|1334777|P5|Toddler Dose|Overall Study||0
547403|NCT00743652|1334778|P4|Toddler Dose|Overall Study||0
547404|NCT00743652|1334779|P3|Toddler Dose|Overall Study||16
547405|NCT00743652|1334780|P2|Toddler Dose|Overall Study||23
547406|NCT00743652|1334781|P1|Toddler Dose|Overall Study||15
547407|NCT00743652|1334777|P5|Vaccinated Dose 3|Overall Study||0
547408|NCT00743652|1334778|P4|Vaccinated Dose 3|Overall Study||0
547409|NCT00743652|1334779|P3|Vaccinated Dose 3|Overall Study||0
547410|NCT00743652|1334780|P2|Vaccinated Dose 3|Overall Study||0
547411|NCT00743652|1334781|P1|Vaccinated Dose 3|Overall Study||74
547412|NCT00743652|1334777|P5|Vaccinated Dose 2|Overall Study||0
547413|NCT00743652|1334778|P4|Vaccinated Dose 2|Overall Study||49
547414|NCT00743652|1334779|P3|Vaccinated Dose 2|Overall Study||0
547415|NCT00743652|1334780|P2|Vaccinated Dose 2|Overall Study||41
547416|NCT00743652|1334781|P1|Vaccinated Dose 2|Overall Study||112
547417|NCT00743652|1334777|P5|Vaccinated Dose 1|Overall Study||79
547418|NCT00743652|1334778|P4|Vaccinated Dose 1|Overall Study||66
547419|NCT00743652|1334779|P3|Vaccinated Dose 1|Overall Study||25
547420|NCT00743652|1334780|P2|Vaccinated Dose 1|Overall Study||51
547421|NCT00743652|1334781|P1|Vaccinated Dose 1|Overall Study||151
547422|NCT00743652|1334777|P5|STARTED|Overall Study||79
547423|NCT00743652|1334778|P4|STARTED|Overall Study||67
547424|NCT00743652|1334779|P3|STARTED|Overall Study||25
547425|NCT00743652|1334780|P2|STARTED|Overall Study||51
547426|NCT00743652|1334781|P1|STARTED|Overall Study||151
547427|NCT00743574|1334856|P1|NOT COMPLETED|Overall Study||24
547428|NCT00743574|1334856|P1|COMPLETED|Overall Study||12
547429|NCT00743574|1334856|P1|Dropped Out After Initiating Trial|Overall Study||3
547430|NCT00743574|1334856|P1|Further Exclusions|Overall Study||8
547431|NCT00743574|1334856|P1|Dropped Out Before Eligibility Testing|Overall Study||13
547432|NCT00743574|1334856|P1|STARTED|Overall Study||36
547433|NCT00743509|1334865|P1|NOT COMPLETED|Overall Study||2
547434|NCT00743509|1334865|P1|COMPLETED|Overall Study||47
547435|NCT00743509|1334865|P1|STARTED|Overall Study||49
547436|NCT00743483|1334870|P1|NOT COMPLETED|Treatment Period||1
547437|NCT00743483|1334870|P1|COMPLETED|Treatment Period||13
547438|NCT00743483|1334870|P1|STARTED|Treatment Period||14
547439|NCT00743483|1334870|P1|NOT COMPLETED|Baseline Period||1
547440|NCT00743483|1334870|P1|COMPLETED|Baseline Period||14
547441|NCT00743483|1334870|P1|STARTED|Baseline Period||15
547442|NCT00743444|1334874|P2|NOT COMPLETED|Second Intervention||0
547443|NCT00743444|1334875|P1|NOT COMPLETED|Second Intervention||0
547444|NCT00743444|1334874|P2|COMPLETED|Second Intervention||11
547445|NCT00743444|1334875|P1|COMPLETED|Second Intervention||14
547446|NCT00743444|1334874|P2|STARTED|Second Intervention||11
547447|NCT00743444|1334875|P1|STARTED|Second Intervention||14
547448|NCT00743444|1334874|P2|NOT COMPLETED|Washout Period||1
547449|NCT00743444|1334875|P1|NOT COMPLETED|Washout Period||0
547450|NCT00743444|1334874|P2|COMPLETED|Washout Period||11
547451|NCT00743444|1334875|P1|COMPLETED|Washout Period||14
547452|NCT00743444|1334874|P2|STARTED|Washout Period||12
547453|NCT00743444|1334875|P1|STARTED|Washout Period||14
547454|NCT00743444|1334874|P2|NOT COMPLETED|First Intervention||1
547455|NCT00743444|1334875|P1|NOT COMPLETED|First Intervention||0
547456|NCT00743444|1334874|P2|COMPLETED|First Intervention||12
547457|NCT00743444|1334875|P1|COMPLETED|First Intervention||14
547458|NCT00743444|1334874|P2|STARTED|First Intervention||13
547459|NCT00743444|1334875|P1|STARTED|First Intervention||14
547460|NCT00743431|1334884|P1|NOT COMPLETED|Overall Study||126
547461|NCT00743431|1334884|P1|COMPLETED|Overall Study||98
547462|NCT00743431|1334884|P1|STARTED|Overall Study||224
547463|NCT00743366|1334888|P2|NOT COMPLETED|Intervention 2 (8 Days)||0
547464|NCT00743366|1334889|P1|NOT COMPLETED|Intervention 2 (8 Days)||0
547465|NCT00743366|1334888|P2|COMPLETED|Intervention 2 (8 Days)||7
547466|NCT00743366|1334889|P1|COMPLETED|Intervention 2 (8 Days)||7
547467|NCT00743366|1334888|P2|STARTED|Intervention 2 (8 Days)||7
547468|NCT00743366|1334889|P1|STARTED|Intervention 2 (8 Days)||7
547469|NCT00743366|1334888|P2|NOT COMPLETED|Intervention 1 (8 Days)||3
547470|NCT00743366|1334889|P1|NOT COMPLETED|Intervention 1 (8 Days)||3
547471|NCT00743366|1334888|P2|COMPLETED|Intervention 1 (8 Days)|A total of 6 participants withdrew before completion of the final inpatient phase|7
547472|NCT00743366|1334889|P1|COMPLETED|Intervention 1 (8 Days)|A total of 6 participants withdrew before completion of the final inpatient phase|7
547473|NCT00743366|1334888|P2|STARTED|Intervention 1 (8 Days)||10
547474|NCT00743366|1334889|P1|STARTED|Intervention 1 (8 Days)||10
547475|NCT00743340|1334895|P1|NOT COMPLETED|Overall Study||41
547476|NCT00743340|1334895|P1|COMPLETED|Overall Study||9
547477|NCT00743340|1334895|P1|STARTED|Overall Study||50
547478|NCT00743288|1334899|P7|NOT COMPLETED|Overall Study||9
547479|NCT00743288|1334900|P6|NOT COMPLETED|Overall Study||5
547480|NCT00743288|1334901|P5|NOT COMPLETED|Overall Study||6
547481|NCT00743288|1334902|P4|NOT COMPLETED|Overall Study||7
547482|NCT00743288|1334903|P3|NOT COMPLETED|Overall Study||5
547483|NCT00743288|1334904|P2|NOT COMPLETED|Overall Study||3
547484|NCT00743288|1334905|P1|NOT COMPLETED|Overall Study||3
547485|NCT00743288|1334899|P7|COMPLETED|Overall Study||0
547486|NCT00743288|1334900|P6|COMPLETED|Overall Study||1
547487|NCT00743288|1334901|P5|COMPLETED|Overall Study||0
547488|NCT00743288|1334902|P4|COMPLETED|Overall Study||0
547489|NCT00743288|1334903|P3|COMPLETED|Overall Study||1
547490|NCT00743288|1334904|P2|COMPLETED|Overall Study||0
547491|NCT00743288|1334905|P1|COMPLETED|Overall Study||0
547492|NCT00743288|1334899|P7|STARTED|Overall Study|6 subjects were enrolled in phase 1 and 3 subjects were enrolled as part of the phase 2 expansion.|9
547493|NCT00743288|1334900|P6|STARTED|Overall Study||6
547494|NCT00743288|1334901|P5|STARTED|Overall Study||6
547495|NCT00743288|1334902|P4|STARTED|Overall Study||7
547496|NCT00743288|1334903|P3|STARTED|Overall Study||6
547497|NCT00743288|1334904|P2|STARTED|Overall Study||3
547498|NCT00743288|1334905|P1|STARTED|Overall Study||3
547499|NCT00743275|1334919|P2|NOT COMPLETED|Overall Study||1
547500|NCT00743275|1334920|P1|NOT COMPLETED|Overall Study||0
547501|NCT00743275|1334919|P2|COMPLETED|Overall Study||60
547502|NCT00743275|1334920|P1|COMPLETED|Overall Study||59
547503|NCT00743275|1334919|P2|STARTED|Overall Study||61
547504|NCT00743275|1334920|P1|STARTED|Overall Study||59
547505|NCT00743262|1334932|P1|NOT COMPLETED|Overall Study||0
547506|NCT00743262|1334932|P1|COMPLETED|Overall Study||15
547507|NCT00743262|1334932|P1|STARTED|Overall Study||15
547508|NCT00743249|1334940|P2|NOT COMPLETED|Overall Study||6
547509|NCT00743249|1334941|P1|NOT COMPLETED|Overall Study||2
547510|NCT00743249|1334940|P2|COMPLETED|Overall Study||24
547511|NCT00743249|1334941|P1|COMPLETED|Overall Study||28
547512|NCT00743249|1334940|P2|STARTED|Overall Study||30
547513|NCT00743249|1334941|P1|STARTED|Overall Study||30
547514|NCT00743197|1334951|P2|NOT COMPLETED|Overall Study||2
547515|NCT00743197|1334952|P1|NOT COMPLETED|Overall Study||1
547516|NCT00743197|1334951|P2|COMPLETED|Overall Study||0
547517|NCT00743197|1334952|P1|COMPLETED|Overall Study||0
547518|NCT00743197|1334951|P2|STARTED|Overall Study||2
547519|NCT00743197|1334952|P1|STARTED|Overall Study||1
547520|NCT00743119|1334958|P1|NOT COMPLETED|Overall Study||4
547521|NCT00743119|1334958|P1|COMPLETED|Overall Study||30
547522|NCT00743119|1334958|P1|STARTED|Overall Study||34
547523|NCT00743106|1334972|P2|NOT COMPLETED|Overall Study||5
547524|NCT00743106|1334973|P1|NOT COMPLETED|Overall Study||8
547525|NCT00743106|1334972|P2|COMPLETED|Overall Study||43
547526|NCT00743106|1334973|P1|COMPLETED|Overall Study||34
547527|NCT00743106|1334972|P2|STARTED|Overall Study||48
547528|NCT00743106|1334973|P1|STARTED|Overall Study||42
547529|NCT00743093|1334983|P2|NOT COMPLETED|Extended Dosing Period||0
547530|NCT00743093|1334984|P1|NOT COMPLETED|Extended Dosing Period||3
547531|NCT00743093|1334983|P2|COMPLETED|Extended Dosing Period||1
547532|NCT00743093|1334984|P1|COMPLETED|Extended Dosing Period||48
547533|NCT00743093|1334983|P2|STARTED|Extended Dosing Period|Subjects not meeting stopping criteria after base continued into the extended dosing.|1
547534|NCT00743093|1334984|P1|STARTED|Extended Dosing Period|Subjects not meeting stopping criteria after base continued into the extended dosing.|51
547535|NCT00743093|1334983|P2|NOT COMPLETED|Base Study Period||5
547536|NCT00743093|1334984|P1|NOT COMPLETED|Base Study Period||19
547537|NCT00743093|1334983|P2|COMPLETED|Base Study Period||47
547538|NCT00743093|1334984|P1|COMPLETED|Base Study Period||205
547539|NCT00743093|1334983|P2|STARTED|Base Study Period||52
547540|NCT00743093|1334984|P1|STARTED|Base Study Period||224
547541|NCT00742963|1334992|P1|NOT COMPLETED|Overall Study||33
547542|NCT00742963|1334992|P1|COMPLETED|Overall Study||68
547543|NCT00742963|1334992|P1|Completed All Treatment Cycles|Overall Study||68
547544|NCT00742963|1334992|P1|STARTED|Overall Study||101
547545|NCT00742924|1335000|P4|NOT COMPLETED|Overall Study||6
547546|NCT00742924|1335001|P3|NOT COMPLETED|Overall Study||4
547547|NCT00742924|1335002|P2|NOT COMPLETED|Overall Study||2
547548|NCT00742924|1335003|P1|NOT COMPLETED|Overall Study||5
547549|NCT00742924|1335000|P4|COMPLETED|Overall Study||0
547550|NCT00742924|1335001|P3|COMPLETED|Overall Study||2
547551|NCT00742924|1335002|P2|COMPLETED|Overall Study||4
547552|NCT00742924|1335003|P1|COMPLETED|Overall Study||1
547553|NCT00742924|1335000|P4|STARTED|Overall Study||6
547554|NCT00742924|1335001|P3|STARTED|Overall Study||6
547555|NCT00742924|1335002|P2|STARTED|Overall Study||6
547556|NCT00742924|1335003|P1|STARTED|Overall Study||6
547557|NCT00742885|1335015|P2|NOT COMPLETED|Overall Study||0
547558|NCT00742885|1335016|P1|NOT COMPLETED|Overall Study||1
547559|NCT00742885|1335015|P2|COMPLETED|Overall Study|to Day 182|50
547560|NCT00742885|1335016|P1|COMPLETED|Overall Study|to Day 182|49
547561|NCT00742885|1335015|P2|STARTED|Overall Study||50
547562|NCT00742885|1335016|P1|STARTED|Overall Study||50
547563|NCT00742872|1335064|P2|NOT COMPLETED|Overall Study||8
547564|NCT00742872|1335065|P1|NOT COMPLETED|Overall Study||12
547565|NCT00742872|1335064|P2|COMPLETED|Overall Study||12
547566|NCT00742872|1335065|P1|COMPLETED|Overall Study||9
547567|NCT00742872|1335064|P2|STARTED|Overall Study||20
547568|NCT00742872|1335065|P1|STARTED|Overall Study||21
547569|NCT00742859|1335075|P4|NOT COMPLETED|Overall Study||8
547570|NCT00742859|1335076|P3|NOT COMPLETED|Overall Study||11
547571|NCT00742859|1335077|P2|NOT COMPLETED|Overall Study||12
547572|NCT00742859|1335078|P1|NOT COMPLETED|Overall Study||11
547573|NCT00742859|1335075|P4|COMPLETED|Overall Study||119
547574|NCT00742859|1335076|P3|COMPLETED|Overall Study||116
547575|NCT00742859|1335077|P2|COMPLETED|Overall Study||115
547576|NCT00742859|1335078|P1|COMPLETED|Overall Study||116
547577|NCT00742859|1335075|P4|STARTED|Overall Study||127
547578|NCT00742859|1335076|P3|STARTED|Overall Study||127
547579|NCT00742859|1335077|P2|STARTED|Overall Study||127
547580|NCT00742859|1335078|P1|STARTED|Overall Study||127
547581|NCT00742781|1335092|P1|NOT COMPLETED|Overall Study||3
547582|NCT00742781|1335092|P1|COMPLETED|Overall Study||18
547583|NCT00742781|1335092|P1|STARTED|Overall Study||21
547584|NCT00742625|1335101|P1|NOT COMPLETED|Consolidation||21
547585|NCT00742625|1335101|P1|COMPLETED|Consolidation||20
547586|NCT00742625|1335101|P1|STARTED|Consolidation||41
547587|NCT00742625|1335101|P1|NOT COMPLETED|Remission Induction||54
547588|NCT00742625|1335101|P1|COMPLETED|Remission Induction||41
547589|NCT00742625|1335101|P1|STARTED|Remission Induction||95
547590|NCT00742560|1335115|P5|NOT COMPLETED|Overall Study||37
547591|NCT00742560|1335116|P4|NOT COMPLETED|Overall Study||36
547592|NCT00742560|1335117|P3|NOT COMPLETED|Overall Study||22
547593|NCT00742560|1335118|P2|NOT COMPLETED|Overall Study||3
547594|NCT00742560|1335119|P1|NOT COMPLETED|Overall Study||3
547595|NCT00742560|1335115|P5|COMPLETED|Overall Study||0
547596|NCT00742560|1335116|P4|COMPLETED|Overall Study||0
547597|NCT00742560|1335117|P3|COMPLETED|Overall Study||0
547598|NCT00742560|1335118|P2|COMPLETED|Overall Study||0
547599|NCT00742560|1335119|P1|COMPLETED|Overall Study||0
547600|NCT00742560|1335115|P5|STARTED|Overall Study||37
547601|NCT00742560|1335116|P4|STARTED|Overall Study||36
547602|NCT00742560|1335117|P3|STARTED|Overall Study||22
547603|NCT00742560|1335118|P2|STARTED|Overall Study||3
547604|NCT00742560|1335119|P1|STARTED|Overall Study||3
547605|NCT00742508|1335193|P2|NOT COMPLETED|4-Week Exploratory Evaluation Period||1
547606|NCT00742508|1335194|P1|NOT COMPLETED|4-Week Exploratory Evaluation Period||0
547607|NCT00742508|1335193|P2|COMPLETED|4-Week Exploratory Evaluation Period||7
547608|NCT00742508|1335194|P1|COMPLETED|4-Week Exploratory Evaluation Period||0
547609|NCT00742508|1335193|P2|STARTED|4-Week Exploratory Evaluation Period||8
547610|NCT00742508|1335194|P1|STARTED|4-Week Exploratory Evaluation Period||0
547611|NCT00742508|1335193|P2|NOT COMPLETED|8-Week Primary Evaluation Period||11
547612|NCT00742508|1335194|P1|NOT COMPLETED|8-Week Primary Evaluation Period||11
547613|NCT00742508|1335193|P2|COMPLETED|8-Week Primary Evaluation Period||8
547614|NCT00742508|1335194|P1|COMPLETED|8-Week Primary Evaluation Period||11
547615|NCT00742508|1335193|P2|STARTED|8-Week Primary Evaluation Period||19
547616|NCT00742508|1335194|P1|STARTED|8-Week Primary Evaluation Period||22
547617|NCT00742417|1335258|P2|NOT COMPLETED|Maintenance II||0
547618|NCT00742417|1335259|P1|NOT COMPLETED|Maintenance II||0
547619|NCT00742417|1335258|P2|COMPLETED|Maintenance II||19
547620|NCT00742417|1335259|P1|COMPLETED|Maintenance II||16
547621|NCT00742417|1335258|P2|STARTED|Maintenance II||19
547622|NCT00742417|1335259|P1|STARTED|Maintenance II||16
547623|NCT00742417|1335258|P2|NOT COMPLETED|Maintenance I||0
547624|NCT00742417|1335259|P1|NOT COMPLETED|Maintenance I||0
547625|NCT00742417|1335258|P2|COMPLETED|Maintenance I||19
547626|NCT00742417|1335259|P1|COMPLETED|Maintenance I||16
547627|NCT00742417|1335258|P2|STARTED|Maintenance I||19
547628|NCT00742417|1335259|P1|STARTED|Maintenance I||16
547629|NCT00742417|1335258|P2|NOT COMPLETED|Intensive Period||1
547630|NCT00742417|1335259|P1|NOT COMPLETED|Intensive Period||3
547631|NCT00742417|1335258|P2|COMPLETED|Intensive Period|19 control patients completed all the 6 plasma exchange during the Intensive Period|19
547632|NCT00742417|1335259|P1|COMPLETED|Intensive Period|16 patients completed all the 6 plasma exchange with Albutein 5% during the Intensive Period|16
547633|NCT00742417|1335258|P2|STARTED|Intensive Period||20
547634|NCT00742417|1335259|P1|STARTED|Intensive Period||19
547635|NCT00742417|1335258|P2|NOT COMPLETED|Randomized||1
547636|NCT00742417|1335259|P1|NOT COMPLETED|Randomized||2
547637|NCT00742417|1335258|P2|COMPLETED|Randomized||20
547638|NCT00742417|1335259|P1|COMPLETED|Randomized||19
547639|NCT00742417|1335258|P2|STARTED|Randomized||21
547640|NCT00742417|1335259|P1|STARTED|Randomized||21
547641|NCT00742391|1335283|P2|NOT COMPLETED|Overall Study||1
547642|NCT00742391|1335284|P1|NOT COMPLETED|Overall Study||4
547643|NCT00742391|1335283|P2|COMPLETED|Overall Study||128
547644|NCT00742391|1335284|P1|COMPLETED|Overall Study||122
547645|NCT00742391|1335283|P2|STARTED|Overall Study||129
547646|NCT00742391|1335284|P1|STARTED|Overall Study||126
547647|NCT00742326|1335294|P2|NOT COMPLETED|Overall Study||1
547648|NCT00742326|1335295|P1|NOT COMPLETED|Overall Study||0
547649|NCT00742326|1335294|P2|COMPLETED|Overall Study||6
547650|NCT00742326|1335295|P1|COMPLETED|Overall Study||6
547651|NCT00742326|1335294|P2|STARTED|Overall Study||7
547652|NCT00742326|1335295|P1|STARTED|Overall Study||6
547653|NCT00742313|1335305|P2|NOT COMPLETED|Overall Study||0
547654|NCT00742313|1335306|P1|NOT COMPLETED|Overall Study||1
547655|NCT00742313|1335305|P2|COMPLETED|Overall Study||19
547656|NCT00742313|1335306|P1|COMPLETED|Overall Study||24
547657|NCT00742313|1335305|P2|STARTED|Overall Study||19
547658|NCT00742313|1335306|P1|STARTED|Overall Study||25
547659|NCT00742274|1335314|P2|NOT COMPLETED|Overall Study||3
547660|NCT00742274|1335315|P1|NOT COMPLETED|Overall Study||3
547661|NCT00742274|1335314|P2|COMPLETED|Overall Study||28
547662|NCT00742274|1335315|P1|COMPLETED|Overall Study||27
547663|NCT00742274|1335314|P2|STARTED|Overall Study||31
547664|NCT00742274|1335315|P1|STARTED|Overall Study||30
547665|NCT00742235|1335323|P2|NOT COMPLETED|Overall Study||31
547666|NCT00742235|1335324|P1|NOT COMPLETED|Overall Study||0
547667|NCT00742235|1335323|P2|COMPLETED|Overall Study||36
547668|NCT00742235|1335324|P1|COMPLETED|Overall Study||32
547669|NCT00742235|1335323|P2|STARTED|Overall Study||67
547670|NCT00742235|1335324|P1|STARTED|Overall Study||32
547671|NCT00742209|1335337|P5|NOT COMPLETED|Overall Study||25
547672|NCT00742209|1335338|P4|NOT COMPLETED|Overall Study||37
547673|NCT00742209|1335339|P3|NOT COMPLETED|Overall Study||46
547674|NCT00742209|1335340|P2|NOT COMPLETED|Overall Study||18
547675|NCT00742209|1335341|P1|NOT COMPLETED|Overall Study||34
547676|NCT00742209|1335337|P5|COMPLETED|Overall Study||37
547677|NCT00742209|1335338|P4|COMPLETED|Overall Study||97
547678|NCT00742209|1335339|P3|COMPLETED|Overall Study||88
547679|NCT00742209|1335340|P2|COMPLETED|Overall Study||49
547680|NCT00742209|1335341|P1|COMPLETED|Overall Study||95
547681|NCT00742209|1335337|P5|STARTED|Overall Study||62
547682|NCT00742209|1335338|P4|STARTED|Overall Study||134
547683|NCT00742209|1335339|P3|STARTED|Overall Study||134
547684|NCT00742209|1335340|P2|STARTED|Overall Study||67
547685|NCT00742209|1335341|P1|STARTED|Overall Study||129
547686|NCT00742183|1335444|P2|NOT COMPLETED|Overall Study||12
547687|NCT00742183|1335445|P1|NOT COMPLETED|Overall Study||9
547688|NCT00742183|1335444|P2|COMPLETED|Overall Study||39
547689|NCT00742183|1335445|P1|COMPLETED|Overall Study||40
547690|NCT00742183|1335444|P2|STARTED|Overall Study||51
547691|NCT00742183|1335445|P1|STARTED|Overall Study|50 subjects randomised, one of them did not receive any treatment.|49
547692|NCT00742170|1335453|P2|NOT COMPLETED|Overall Study||5
547693|NCT00742170|1335454|P1|NOT COMPLETED|Overall Study||2
547694|NCT00742170|1335453|P2|COMPLETED|Overall Study||24
547695|NCT00742170|1335454|P1|COMPLETED|Overall Study||24
547696|NCT00742170|1335453|P2|STARTED|Overall Study||29
547697|NCT00742170|1335454|P1|STARTED|Overall Study||26
547698|NCT00742079|1335464|P2|NOT COMPLETED|Overall Study||1
547699|NCT00742079|1335465|P1|NOT COMPLETED|Overall Study||0
547700|NCT00742079|1335464|P2|COMPLETED|Overall Study||9
547701|NCT00742079|1335465|P1|COMPLETED|Overall Study||11
547702|NCT00742079|1335464|P2|Week 2 (Received Dose 2)|Overall Study||9
547703|NCT00742079|1335465|P1|Week 2 (Received Dose 2)|Overall Study||11
547704|NCT00742079|1335464|P2|Baseline/Week 1 (Received Dose 1)|Overall Study||9
547705|NCT00742079|1335465|P1|Baseline/Week 1 (Received Dose 1)|Overall Study||11
547706|NCT00742079|1335464|P2|STARTED|Overall Study||10
547707|NCT00742079|1335465|P1|STARTED|Overall Study||11
547708|NCT00742053|1335479|P1|NOT COMPLETED|Overall Study||0
547709|NCT00742053|1335479|P1|COMPLETED|Overall Study||7
547710|NCT00742053|1335479|P1|STARTED|Overall Study||7
547711|NCT00741988|1335485|P2|NOT COMPLETED|Overall Study||4
547712|NCT00741988|1335486|P1|NOT COMPLETED|Overall Study||4
547713|NCT00741988|1335485|P2|COMPLETED|Overall Study||36
547714|NCT00741988|1335486|P1|COMPLETED|Overall Study||38
547715|NCT00741988|1335485|P2|STARTED|Overall Study||40
547716|NCT00741988|1335486|P1|STARTED|Overall Study||42
547717|NCT00741936|1335498|P2|NOT COMPLETED|Overall Study||8
547718|NCT00741936|1335499|P1|NOT COMPLETED|Overall Study||9
547719|NCT00741936|1335498|P2|COMPLETED|Overall Study||52
547720|NCT00741936|1335499|P1|COMPLETED|Overall Study||51
547721|NCT00741936|1335498|P2|STARTED|Overall Study||60
547722|NCT00741936|1335499|P1|STARTED|Overall Study||60
547723|NCT00741858|1335527|P2|NOT COMPLETED|Overall Study||0
547724|NCT00741858|1335528|P1|NOT COMPLETED|Overall Study||0
547725|NCT00741858|1335527|P2|COMPLETED|Overall Study||18
547726|NCT00741858|1335528|P1|COMPLETED|Overall Study||16
547727|NCT00741858|1335527|P2|STARTED|Overall Study||18
547728|NCT00741858|1335528|P1|STARTED|Overall Study||16
547729|NCT00741819|1335534|P1|NOT COMPLETED|Overall Study||8
547730|NCT00741819|1335534|P1|COMPLETED|Overall Study||65
547731|NCT00741819|1335534|P1|STARTED|Overall Study||73
547732|NCT00741611|1335548|P3|NOT COMPLETED|Overall Study||3
547733|NCT00741611|1335549|P2|NOT COMPLETED|Overall Study||2
547734|NCT00741611|1335550|P1|NOT COMPLETED|Overall Study||0
547735|NCT00741611|1335548|P3|COMPLETED|Overall Study||26
547736|NCT00741611|1335549|P2|COMPLETED|Overall Study||1
547737|NCT00741611|1335550|P1|COMPLETED|Overall Study||4
547738|NCT00741611|1335548|P3|STARTED|Overall Study||29
547739|NCT00741611|1335549|P2|STARTED|Overall Study||3
547740|NCT00741611|1335550|P1|STARTED|Overall Study||4
547741|NCT00741598|1335569|P2|NOT COMPLETED|Overall Study||9
547742|NCT00741598|1335570|P1|NOT COMPLETED|Overall Study||9
547743|NCT00741598|1335569|P2|COMPLETED|Overall Study||30
547744|NCT00741598|1335570|P1|COMPLETED|Overall Study||24
547745|NCT00741598|1335569|P2|STARTED|Overall Study||39
547746|NCT00741598|1335570|P1|STARTED|Overall Study||33
547747|NCT00741468|1335584|P1|NOT COMPLETED|Overall Study||0
547748|NCT00741468|1335584|P1|COMPLETED|Overall Study||18
547749|NCT00741468|1335584|P1|STARTED|Overall Study||18
547750|NCT00741390|1335592|P4|NOT COMPLETED|Visit 2||1
547751|NCT00741390|1335593|P3|NOT COMPLETED|Visit 2||1
547752|NCT00741390|1335594|P2|NOT COMPLETED|Visit 2||0
547753|NCT00741390|1335595|P1|NOT COMPLETED|Visit 2||0
547754|NCT00741390|1335592|P4|COMPLETED|Visit 2||60
547755|NCT00741390|1335593|P3|COMPLETED|Visit 2||54
547756|NCT00741390|1335594|P2|COMPLETED|Visit 2||61
547757|NCT00741390|1335595|P1|COMPLETED|Visit 2||59
547758|NCT00741390|1335592|P4|STARTED|Visit 2|1 subject lost to follow-up between Visit 1 and Visit 2.|61
547759|NCT00741390|1335593|P3|STARTED|Visit 2||55
547760|NCT00741390|1335594|P2|STARTED|Visit 2|2 subjects lost to follow-up between Visit 1 and Visit 2.|61
547761|NCT00741390|1335595|P1|STARTED|Visit 2|1 subject lost to follow-up between Visit 1 and Visit 2.|59
547762|NCT00741390|1335592|P4|NOT COMPLETED|Visit 1||1
547763|NCT00741390|1335593|P3|NOT COMPLETED|Visit 1||7
547764|NCT00741390|1335594|P2|NOT COMPLETED|Visit 1||0
547765|NCT00741390|1335595|P1|NOT COMPLETED|Visit 1||2
547766|NCT00741390|1335592|P4|COMPLETED|Visit 1||62
547767|NCT00741390|1335593|P3|COMPLETED|Visit 1||55
547768|NCT00741390|1335594|P2|COMPLETED|Visit 1||63
547769|NCT00741390|1335595|P1|COMPLETED|Visit 1||60
547770|NCT00741390|1335592|P4|STARTED|Visit 1||63
547771|NCT00741390|1335593|P3|STARTED|Visit 1||62
547772|NCT00741390|1335594|P2|STARTED|Visit 1||63
547773|NCT00741390|1335595|P1|STARTED|Visit 1||62
547774|NCT00741338|1335616|P2|NOT COMPLETED|Overall Study||1
547775|NCT00741338|1335617|P1|NOT COMPLETED|Overall Study||0
547776|NCT00741338|1335616|P2|COMPLETED|Overall Study||2
547777|NCT00741338|1335617|P1|COMPLETED|Overall Study||3
547778|NCT00741338|1335616|P2|STARTED|Overall Study||3
547779|NCT00741338|1335617|P1|STARTED|Overall Study||3
547780|NCT00741286|1335627|P2|NOT COMPLETED|Overall Study||19
547781|NCT00741286|1335628|P1|NOT COMPLETED|Overall Study||20
547782|NCT00741286|1335627|P2|COMPLETED|Overall Study||81
547783|NCT00741286|1335628|P1|COMPLETED|Overall Study||83
547784|NCT00741286|1335627|P2|STARTED|Overall Study||100
547785|NCT00741286|1335628|P1|STARTED|Overall Study||103
547786|NCT00741273|1335638|P2|NOT COMPLETED|Overall Study||0
547787|NCT00741273|1335639|P1|NOT COMPLETED|Overall Study||0
547788|NCT00741273|1335638|P2|COMPLETED|Overall Study||8
547789|NCT00741273|1335639|P1|COMPLETED|Overall Study||8
547790|NCT00741273|1335638|P2|STARTED|Overall Study||8
547791|NCT00741273|1335639|P1|STARTED|Overall Study||8
547792|NCT00741260|1335662|P7|NOT COMPLETED|Overall Study||7
547793|NCT00741260|1335663|P6|NOT COMPLETED|Overall Study||45
547794|NCT00741260|1335664|P5|NOT COMPLETED|Overall Study||9
547795|NCT00741260|1335665|P4|NOT COMPLETED|Overall Study||6
547796|NCT00741260|1335666|P3|NOT COMPLETED|Overall Study||4
547797|NCT00741260|1335667|P2|NOT COMPLETED|Overall Study||8
547798|NCT00741260|1335668|P1|NOT COMPLETED|Overall Study||6
547799|NCT00741260|1335662|P7|COMPLETED|Overall Study||0
547800|NCT00741260|1335663|P6|COMPLETED|Overall Study||20
547801|NCT00741260|1335664|P5|COMPLETED|Overall Study||0
547802|NCT00741260|1335665|P4|COMPLETED|Overall Study||0
547803|NCT00741260|1335666|P3|COMPLETED|Overall Study||0
547804|NCT00741260|1335667|P2|COMPLETED|Overall Study||0
547805|NCT00741260|1335668|P1|COMPLETED|Overall Study||0
547806|NCT00741260|1335662|P7|STARTED|Overall Study||7
547807|NCT00741260|1335663|P6|STARTED|Overall Study||65
547808|NCT00741260|1335664|P5|STARTED|Overall Study||9
547809|NCT00741260|1335665|P4|STARTED|Overall Study||6
547810|NCT00741260|1335666|P3|STARTED|Overall Study||4
547811|NCT00741260|1335667|P2|STARTED|Overall Study||8
547812|NCT00741260|1335668|P1|STARTED|Overall Study||6
547813|NCT00741156|1335693|P1|NOT COMPLETED|Overall Study||0
547814|NCT00741156|1335693|P1|COMPLETED|Overall Study||12
547815|NCT00741156|1335693|P1|STARTED|Overall Study||12
547816|NCT00741104|1335708|P1|NOT COMPLETED|Overall Study||0
547817|NCT00741104|1335708|P1|COMPLETED|Overall Study||363
547818|NCT00741104|1335708|P1|STARTED|Overall Study||363
547819|NCT00741091|1335715|P1|NOT COMPLETED|Overall Study||57
547820|NCT00741091|1335715|P1|COMPLETED|Overall Study||1040
547821|NCT00741091|1335715|P1|STARTED|Overall Study||1097
547822|NCT00741039|1335725|P2|NOT COMPLETED|Overall Study||0
547823|NCT00741039|1335726|P1|NOT COMPLETED|Overall Study||2
547824|NCT00741039|1335725|P2|COMPLETED|Overall Study||25
547825|NCT00741039|1335726|P1|COMPLETED|Overall Study||100
547826|NCT00741039|1335725|P2|STARTED|Overall Study||25
547827|NCT00741039|1335726|P1|STARTED|Overall Study||102
547828|NCT00741026|1335732|P1|NOT COMPLETED|Overall Study||0
547829|NCT00741026|1335732|P1|COMPLETED|Overall Study||15
547830|NCT00741026|1335732|P1|STARTED|Overall Study||15
547831|NCT00741013|1335763|P3|NOT COMPLETED|Overall Study||1
547832|NCT00741013|1335764|P2|NOT COMPLETED|Overall Study||2
547833|NCT00741013|1335765|P1|NOT COMPLETED|Overall Study||1
547834|NCT00741013|1335763|P3|COMPLETED|Overall Study||6
547835|NCT00741013|1335764|P2|COMPLETED|Overall Study||6
547836|NCT00741013|1335765|P1|COMPLETED|Overall Study||6
547837|NCT00741013|1335763|P3|STARTED|Overall Study||7
547838|NCT00741013|1335764|P2|STARTED|Overall Study||8
547839|NCT00741013|1335765|P1|STARTED|Overall Study||7
547840|NCT00740870|1335776|P1|NOT COMPLETED|Overall Study||21
547841|NCT00740870|1335776|P1|COMPLETED|Overall Study||150
547842|NCT00740870|1335776|P1|STARTED|Overall Study||171
547843|NCT00740857|1335791|P3|NOT COMPLETED|Overall Study||0
547844|NCT00740857|1335792|P2|NOT COMPLETED|Overall Study||0
547845|NCT00740857|1335793|P1|NOT COMPLETED|Overall Study||1
547846|NCT00740857|1335791|P3|COMPLETED|Overall Study||90
547847|NCT00740857|1335792|P2|COMPLETED|Overall Study||88
547848|NCT00740857|1335793|P1|COMPLETED|Overall Study||32
547849|NCT00740857|1335791|P3|STARTED|Overall Study||90
547850|NCT00740857|1335792|P2|STARTED|Overall Study||88
547851|NCT00740857|1335793|P1|STARTED|Overall Study||33
547852|NCT00740831|1335825|P3|NOT COMPLETED|Overall Study||6
547853|NCT00740831|1335826|P2|NOT COMPLETED|Overall Study||3
547854|NCT00740831|1335827|P1|NOT COMPLETED|Overall Study||4
547855|NCT00740831|1335825|P3|COMPLETED|Overall Study|Patients who completed part A (visit 6)|95
547856|NCT00740831|1335826|P2|COMPLETED|Overall Study|Patients who completed part A (visit 6)|100
547857|NCT00740831|1335827|P1|COMPLETED|Overall Study|Patients who completed part A (visit 6)|93
547858|NCT00740831|1335825|P3|STARTED|Overall Study|Safety population|101
547859|NCT00740831|1335826|P2|STARTED|Overall Study|Safety population|103
547860|NCT00740831|1335827|P1|STARTED|Overall Study|Safety population|97
547861|NCT00740792|1335848|P4|NOT COMPLETED|Overall Study||10
547862|NCT00740792|1335849|P3|NOT COMPLETED|Overall Study||9
547863|NCT00740792|1335850|P2|NOT COMPLETED|Overall Study||8
547864|NCT00740792|1335851|P1|NOT COMPLETED|Overall Study||10
547865|NCT00740792|1335848|P4|COMPLETED|Overall Study||190
547866|NCT00740792|1335849|P3|COMPLETED|Overall Study||180
547867|NCT00740792|1335850|P2|COMPLETED|Overall Study||186
547868|NCT00740792|1335851|P1|COMPLETED|Overall Study||183
547869|NCT00740792|1335848|P4|STARTED|Overall Study||200
547870|NCT00740792|1335849|P3|STARTED|Overall Study||189
547871|NCT00740792|1335850|P2|STARTED|Overall Study||194
547872|NCT00740792|1335851|P1|STARTED|Overall Study||193
547873|NCT00740779|1335872|P3|NOT COMPLETED|Overall Study||13
547874|NCT00740779|1335873|P2|NOT COMPLETED|Overall Study||14
547875|NCT00740779|1335874|P1|NOT COMPLETED|Overall Study||9
547876|NCT00740779|1335872|P3|COMPLETED|Overall Study||41
547877|NCT00740779|1335873|P2|COMPLETED|Overall Study||31
547878|NCT00740779|1335874|P1|COMPLETED|Overall Study||43
547879|NCT00740779|1335872|P3|STARTED|Overall Study||54
547880|NCT00740779|1335873|P2|STARTED|Overall Study||45
547881|NCT00740779|1335874|P1|STARTED|Overall Study||52
547882|NCT00740727|1335882|P1|NOT COMPLETED|Overall Study||0
547883|NCT00740727|1335882|P1|COMPLETED|Overall Study||18
547884|NCT00740727|1335882|P1|STARTED|Overall Study||18
547885|NCT00740714|1335891|P3|NOT COMPLETED|Overall Study||29
547886|NCT00740714|1335892|P2|NOT COMPLETED|Overall Study||19
547887|NCT00740714|1335893|P1|NOT COMPLETED|Overall Study||17
547888|NCT00740714|1335891|P3|COMPLETED|Overall Study||174
547889|NCT00740714|1335892|P2|COMPLETED|Overall Study||182
547890|NCT00740714|1335893|P1|COMPLETED|Overall Study||179
547891|NCT00740714|1335891|P3|Active Patients at Study Termination|Overall Study||33
547892|NCT00740714|1335892|P2|Active Patients at Study Termination|Overall Study||12
547893|NCT00740714|1335893|P1|Active Patients at Study Termination|Overall Study||24
547894|NCT00740714|1335891|P3|Reaching Endpoint Before May 6, 2011|Overall Study||94
547895|NCT00740714|1335892|P2|Reaching Endpoint Before May 6, 2011|Overall Study||87
547896|NCT00740714|1335893|P1|Reaching Endpoint Before May 6, 2011|Overall Study||86
547897|NCT00740714|1335891|P3|STARTED|Overall Study|Randomized throughout the recruitment period|203
547898|NCT00740714|1335892|P2|STARTED|Overall Study|Randomized throughout the recruitment period|201
547899|NCT00740714|1335893|P1|STARTED|Overall Study|Randomized throughout the recruitment period|196
547900|NCT00740636|1335969|P2|NOT COMPLETED|Overall Study||4
547901|NCT00740636|1335970|P1|NOT COMPLETED|Overall Study||2
547902|NCT00740636|1335969|P2|COMPLETED|Overall Study||63
547903|NCT00740636|1335970|P1|COMPLETED|Overall Study||23
547904|NCT00740636|1335969|P2|STARTED|Overall Study||67
547905|NCT00740636|1335970|P1|STARTED|Overall Study||25
547906|NCT00740597|1335976|P1|NOT COMPLETED|Overall Study||1
547907|NCT00740597|1335976|P1|COMPLETED|Overall Study||0
547908|NCT00740597|1335976|P1|STARTED|Overall Study||1
547909|NCT00740584|1335980|P1|NOT COMPLETED|Overall Study||1
547910|NCT00740584|1335980|P1|COMPLETED|Overall Study||11
547911|NCT00740584|1335980|P1|STARTED|Overall Study||12
547912|NCT00740480|1335984|P1|NOT COMPLETED|Overall Study||2
547913|NCT00740480|1335984|P1|COMPLETED|Overall Study||23
547914|NCT00740480|1335984|P1|STARTED|Overall Study||25
547915|NCT00740220|1335988|P1|NOT COMPLETED|Overall Study||9
547916|NCT00740220|1335988|P1|COMPLETED|Overall Study||88
547917|NCT00740220|1335988|P1|STARTED|Overall Study||97
547918|NCT00740207|1335994|P2|NOT COMPLETED|Overall Study||0
547919|NCT00740207|1335995|P1|NOT COMPLETED|Overall Study||0
547920|NCT00740207|1335994|P2|COMPLETED|Overall Study||16
547921|NCT00740207|1335995|P1|COMPLETED|Overall Study||17
547922|NCT00740207|1335994|P2|STARTED|Overall Study||16
547923|NCT00740207|1335995|P1|STARTED|Overall Study||17
547924|NCT00740181|1336007|P1|NOT COMPLETED|Overall Study||0
547925|NCT00740181|1336007|P1|COMPLETED|Overall Study||9
547926|NCT00740181|1336007|P1|STARTED|Overall Study||9
547927|NCT00740051|1336013|P2|NOT COMPLETED|Overall Study||32
547928|NCT00740051|1336014|P1|NOT COMPLETED|Overall Study||18
547929|NCT00740051|1336013|P2|COMPLETED|Overall Study||119
547930|NCT00740051|1336014|P1|COMPLETED|Overall Study||58
547931|NCT00740051|1336013|P2|STARTED|Overall Study||151
547932|NCT00740051|1336014|P1|STARTED|Overall Study||76
547933|NCT00739999|1336036|P2|NOT COMPLETED|Overall Study||0
547934|NCT00739999|1336037|P1|NOT COMPLETED|Overall Study||0
547935|NCT00739999|1336036|P2|COMPLETED|Overall Study||24
547936|NCT00739999|1336037|P1|COMPLETED|Overall Study||15
547937|NCT00739999|1336036|P2|STARTED|Overall Study||24
547938|NCT00739999|1336037|P1|STARTED|Overall Study||15
547939|NCT00739973|1336117|P9|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||14
547940|NCT00739973|1336118|P8|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||10
547941|NCT00739973|1336119|P7|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||13
547942|NCT00739973|1336120|P6|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12
547943|NCT00739973|1336121|P5|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19
547944|NCT00739973|1336122|P4|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12
547945|NCT00739973|1336123|P3|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19
547946|NCT00739973|1336124|P2|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||20
547947|NCT00739973|1336125|P1|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||30
547948|NCT00739973|1336117|P9|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170
547949|NCT00739973|1336118|P8|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168
547950|NCT00739973|1336119|P7|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170
547951|NCT00739973|1336120|P6|COMPLETED|Double-blind:Randomized Period (8 Weeks)||169
547952|NCT00739973|1336121|P5|COMPLETED|Double-blind:Randomized Period (8 Weeks)||162
547953|NCT00739973|1336122|P4|COMPLETED|Double-blind:Randomized Period (8 Weeks)||173
547954|NCT00739973|1336123|P3|COMPLETED|Double-blind:Randomized Period (8 Weeks)||184
547955|NCT00739973|1336124|P2|COMPLETED|Double-blind:Randomized Period (8 Weeks)||175
547956|NCT00739973|1336125|P1|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168
547957|NCT00739973|1336117|P9|STARTED|Double-blind:Randomized Period (8 Weeks)||184
547958|NCT00739973|1336118|P8|STARTED|Double-blind:Randomized Period (8 Weeks)||178
547959|NCT00739973|1336119|P7|STARTED|Double-blind:Randomized Period (8 Weeks)|2 pts. were mis-randomized, so discontinued from single-blind and were untreated in double-blind.|183
547960|NCT00739973|1336120|P6|STARTED|Double-blind:Randomized Period (8 Weeks)||181
547961|NCT00739973|1336121|P5|STARTED|Double-blind:Randomized Period (8 Weeks)||181
547962|NCT00739973|1336122|P4|STARTED|Double-blind:Randomized Period (8 Weeks)||185
547963|NCT00739973|1336123|P3|STARTED|Double-blind:Randomized Period (8 Weeks)||203
547964|NCT00739973|1336124|P2|STARTED|Double-blind:Randomized Period (8 Weeks)|One pt. was mis-randomized, so discontinued from single-blind and was untreated in the double-blind.|195
547965|NCT00739973|1336125|P1|STARTED|Double-blind:Randomized Period (8 Weeks)||198
547966|NCT00739973|1336117|P9|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
547967|NCT00739973|1336118|P8|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
547968|NCT00739973|1336119|P7|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
547969|NCT00739973|1336120|P6|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
547970|NCT00739973|1336121|P5|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
547971|NCT00739973|1336122|P4|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
547972|NCT00739973|1336123|P3|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
547973|NCT00739973|1336124|P2|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
547974|NCT00739973|1336125|P1|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||1009
547975|NCT00739973|1336117|P9|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
547976|NCT00739973|1336118|P8|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
547977|NCT00739973|1336119|P7|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
547978|NCT00739973|1336120|P6|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
547979|NCT00739973|1336121|P5|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
547980|NCT00739973|1336122|P4|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
547981|NCT00739973|1336123|P3|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
547982|NCT00739973|1336124|P2|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
547983|NCT00739973|1336125|P1|COMPLETED|Single-blind Period (2 to 4 Weeks)||1685
547984|NCT00739973|1336117|P9|STARTED|Single-blind Period (2 to 4 Weeks)||0
547985|NCT00739973|1336118|P8|STARTED|Single-blind Period (2 to 4 Weeks)||0
547986|NCT00739973|1336119|P7|STARTED|Single-blind Period (2 to 4 Weeks)||0
547987|NCT00739973|1336120|P6|STARTED|Single-blind Period (2 to 4 Weeks)||0
547988|NCT00739973|1336121|P5|STARTED|Single-blind Period (2 to 4 Weeks)||0
547989|NCT00739973|1336122|P4|STARTED|Single-blind Period (2 to 4 Weeks)||0
547990|NCT00739973|1336123|P3|STARTED|Single-blind Period (2 to 4 Weeks)||0
547991|NCT00739973|1336124|P2|STARTED|Single-blind Period (2 to 4 Weeks)||0
547992|NCT00739973|1336125|P1|STARTED|Single-blind Period (2 to 4 Weeks)|In this period, participants were enrolled to only Placebo arm.|2694
547993|NCT00739934|1336211|P1|NOT COMPLETED|Voriconazole Oral||3
547994|NCT00739934|1336211|P1|COMPLETED|Voriconazole Oral||31
547995|NCT00739934|1336211|P1|STARTED|Voriconazole Oral||34
547996|NCT00739934|1336211|P1|NOT COMPLETED|Voriconazole IV||6
547997|NCT00739934|1336211|P1|COMPLETED|Voriconazole IV||34
547998|NCT00739934|1336211|P1|STARTED|Voriconazole IV||40
547999|NCT00739908|1336233|P2|NOT COMPLETED|Overall Study||25
548000|NCT00739908|1336234|P1|NOT COMPLETED|Overall Study||25
548001|NCT00739908|1336233|P2|COMPLETED|Overall Study||118
548002|NCT00739908|1336234|P1|COMPLETED|Overall Study||117
548003|NCT00739908|1336233|P2|STARTED|Overall Study||143
548004|NCT00739908|1336234|P1|STARTED|Overall Study||142
548005|NCT00739882|1336254|P2|NOT COMPLETED|Open-label Period||5
548006|NCT00739882|1336255|P1|NOT COMPLETED|Open-label Period||10
548007|NCT00739882|1336254|P2|COMPLETED|Open-label Period||9
548008|NCT00739882|1336255|P1|COMPLETED|Open-label Period||7
548009|NCT00739882|1336254|P2|STARTED|Open-label Period||14
548010|NCT00739882|1336255|P1|STARTED|Open-label Period||17
548011|NCT00739882|1336254|P2|NOT COMPLETED|Double-blind Period||11
548012|NCT00739882|1336255|P1|NOT COMPLETED|Double-blind Period||19
548013|NCT00739882|1336254|P2|COMPLETED|Double-blind Period||14
548014|NCT00739882|1336255|P1|COMPLETED|Double-blind Period||32
548015|NCT00739882|1336254|P2|STARTED|Double-blind Period||25
548016|NCT00739882|1336255|P1|STARTED|Double-blind Period||51
548017|NCT00739765|1336276|P3|NOT COMPLETED|Overall Study||11
548018|NCT00739765|1336277|P2|NOT COMPLETED|Overall Study||11
548019|NCT00739765|1336278|P1|NOT COMPLETED|Overall Study||6
548020|NCT00739765|1336276|P3|COMPLETED|Overall Study||21
548021|NCT00739765|1336277|P2|COMPLETED|Overall Study||27
548022|NCT00739765|1336278|P1|COMPLETED|Overall Study||34
548023|NCT00739765|1336276|P3|STARTED|Overall Study||32
548024|NCT00739765|1336277|P2|STARTED|Overall Study||38
548025|NCT00739765|1336278|P1|STARTED|Overall Study||40
548026|NCT00739752|1336295|P6|NOT COMPLETED|Overall Study||0
548027|NCT00739752|1336296|P5|NOT COMPLETED|Overall Study||0
548028|NCT00739752|1336297|P4|NOT COMPLETED|Overall Study||0
548029|NCT00739752|1336298|P3|NOT COMPLETED|Overall Study||0
548030|NCT00739752|1336299|P2|NOT COMPLETED|Overall Study||0
548031|NCT00739752|1336300|P1|NOT COMPLETED|Overall Study||0
548032|NCT00739752|1336295|P6|COMPLETED|Overall Study||293
548033|NCT00739752|1336296|P5|COMPLETED|Overall Study||291
548034|NCT00739752|1336297|P4|COMPLETED|Overall Study||288
548035|NCT00739752|1336298|P3|COMPLETED|Overall Study||292
548036|NCT00739752|1336299|P2|COMPLETED|Overall Study||284
548037|NCT00739752|1336300|P1|COMPLETED|Overall Study||299
548038|NCT00739752|1336295|P6|STARTED|Overall Study||293
548039|NCT00739752|1336296|P5|STARTED|Overall Study||291
548040|NCT00739752|1336297|P4|STARTED|Overall Study||288
548041|NCT00739752|1336298|P3|STARTED|Overall Study||292
548042|NCT00739752|1336299|P2|STARTED|Overall Study||284
548043|NCT00739752|1336300|P1|STARTED|Overall Study||299
548044|NCT00739674|1336316|P2|NOT COMPLETED|Overall Study||122
548045|NCT00739674|1336317|P1|NOT COMPLETED|Overall Study||181
548046|NCT00739674|1336316|P2|COMPLETED|Overall Study||335
548047|NCT00739674|1336317|P1|COMPLETED|Overall Study||354
548048|NCT00739674|1336316|P2|Intent-to-treat (ITT) Population|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|400
548049|NCT00739674|1336317|P1|Intent-to-treat (ITT) Population|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|463
548050|NCT00739674|1336316|P2|Dietician Consultation >30 Days|Overall Study|Patients with dietician consultations >30 days after visit 1 were not included in the data analysis.|9
548051|NCT00739674|1336317|P1|Dietician Consultation >30 Days|Overall Study|Patients with dietician consultations >30 days after visit 1 were not included in the data analysis.|1
548052|NCT00739674|1336316|P2|No Follow-up Data|Overall Study||18
548053|NCT00739674|1336317|P1|No Follow-up Data|Overall Study||33
548054|NCT00739674|1336316|P2|Site 212 Removal|Overall Study|lack of source documentation & frequent discrepancies between source notes and case report entries.|13
548055|NCT00739674|1336317|P1|Site 212 Removal|Overall Study|lack of source documentation & frequent discrepancies between source notes and case report entries.|19
548056|NCT00739674|1336316|P2|Screening Failures|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|17
548057|NCT00739674|1336317|P1|Screening Failures|Overall Study||19
548058|NCT00739674|1336316|P2|STARTED|Overall Study||457
548059|NCT00739674|1336317|P1|STARTED|Overall Study||535
548060|NCT00739661|1336345|P2|NOT COMPLETED|Overall Study||42
548061|NCT00739661|1336346|P1|NOT COMPLETED|Overall Study||46
548062|NCT00739661|1336345|P2|COMPLETED|Overall Study||10
548063|NCT00739661|1336346|P1|COMPLETED|Overall Study||6
548064|NCT00739661|1336345|P2|STARTED|Overall Study||52
548065|NCT00739661|1336346|P1|STARTED|Overall Study||52
548066|NCT00739648|1336358|P2|NOT COMPLETED|Overall Study||53
548067|NCT00739648|1336359|P1|NOT COMPLETED|Overall Study||26
548068|NCT00739648|1336358|P2|COMPLETED|Overall Study||161
548069|NCT00739648|1336359|P1|COMPLETED|Overall Study||82
548070|NCT00739648|1336358|P2|STARTED|Overall Study||214
548071|NCT00739648|1336359|P1|STARTED|Overall Study||108
548072|NCT00739596|1336373|P2|NOT COMPLETED|Overall Study||17
548073|NCT00739596|1336374|P1|NOT COMPLETED|Overall Study||25
548074|NCT00739596|1336373|P2|COMPLETED|Overall Study||149
548075|NCT00739596|1336374|P1|COMPLETED|Overall Study||141
548076|NCT00739596|1336373|P2|STARTED|Overall Study||166
548077|NCT00739596|1336374|P1|STARTED|Overall Study||166
548078|NCT00739583|1336390|P2|NOT COMPLETED|Overall Study||0
548079|NCT00739583|1336391|P1|NOT COMPLETED|Overall Study||0
548080|NCT00739583|1336390|P2|COMPLETED|Overall Study||10
548081|NCT00739583|1336391|P1|COMPLETED|Overall Study||10
548082|NCT00739583|1336390|P2|STARTED|Overall Study||10
548083|NCT00739583|1336391|P1|STARTED|Overall Study||10
548084|NCT00739336|1336403|P2|NOT COMPLETED|Overall Study||0
548085|NCT00739336|1336404|P1|NOT COMPLETED|Overall Study||4
548086|NCT00739336|1336403|P2|COMPLETED|Overall Study||24
548087|NCT00739336|1336404|P1|COMPLETED|Overall Study||17
548088|NCT00739336|1336403|P2|STARTED|Overall Study||24
548089|NCT00739336|1336404|P1|STARTED|Overall Study||21
548090|NCT00739310|1336416|P1|NOT COMPLETED|Overall Study||7
548091|NCT00739310|1336416|P1|COMPLETED|Overall Study||22
548092|NCT00739310|1336416|P1|STARTED|Overall Study||29
548093|NCT00739297|1336421|P7|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1
548094|NCT00739297|1336422|P6|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1
548095|NCT00739297|1336423|P5|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
548096|NCT00739297|1336424|P4|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
548097|NCT00739297|1336425|P3|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
548098|NCT00739297|1336426|P2|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
548099|NCT00739297|1336427|P1|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
548100|NCT00739297|1336421|P7|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||65
548101|NCT00739297|1336422|P6|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8
548102|NCT00739297|1336423|P5|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||7
548103|NCT00739297|1336424|P4|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||15
548104|NCT00739297|1336425|P3|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8
548105|NCT00739297|1336426|P2|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||11
548106|NCT00739297|1336427|P1|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||16
548107|NCT00739297|1336421|P7|STARTED|Fourth Intervention(Visit 9 to Visit 10)||66
548108|NCT00739297|1336422|P6|STARTED|Fourth Intervention(Visit 9 to Visit 10)||9
548109|NCT00739297|1336423|P5|STARTED|Fourth Intervention(Visit 9 to Visit 10)||7
548110|NCT00739297|1336424|P4|STARTED|Fourth Intervention(Visit 9 to Visit 10)||15
548111|NCT00739297|1336425|P3|STARTED|Fourth Intervention(Visit 9 to Visit 10)||8
548112|NCT00739297|1336426|P2|STARTED|Fourth Intervention(Visit 9 to Visit 10)||11
548113|NCT00739297|1336427|P1|STARTED|Fourth Intervention(Visit 9 to Visit 10)||16
548114|NCT00739297|1336421|P7|NOT COMPLETED|Third Washout Period of 4-7 Days||0
548115|NCT00739297|1336422|P6|NOT COMPLETED|Third Washout Period of 4-7 Days||0
548116|NCT00739297|1336423|P5|NOT COMPLETED|Third Washout Period of 4-7 Days||0
548117|NCT00739297|1336424|P4|NOT COMPLETED|Third Washout Period of 4-7 Days||0
548118|NCT00739297|1336425|P3|NOT COMPLETED|Third Washout Period of 4-7 Days||0
548119|NCT00739297|1336426|P2|NOT COMPLETED|Third Washout Period of 4-7 Days||0
548120|NCT00739297|1336427|P1|NOT COMPLETED|Third Washout Period of 4-7 Days||0
548121|NCT00739297|1336421|P7|COMPLETED|Third Washout Period of 4-7 Days||66
548122|NCT00739297|1336422|P6|COMPLETED|Third Washout Period of 4-7 Days||8
548123|NCT00739297|1336423|P5|COMPLETED|Third Washout Period of 4-7 Days||6
548124|NCT00739297|1336424|P4|COMPLETED|Third Washout Period of 4-7 Days||18
548125|NCT00739297|1336425|P3|COMPLETED|Third Washout Period of 4-7 Days||6
548126|NCT00739297|1336426|P2|COMPLETED|Third Washout Period of 4-7 Days||12
548127|NCT00739297|1336427|P1|COMPLETED|Third Washout Period of 4-7 Days||16
548128|NCT00739297|1336421|P7|STARTED|Third Washout Period of 4-7 Days||66
548129|NCT00739297|1336422|P6|STARTED|Third Washout Period of 4-7 Days||8
548130|NCT00739297|1336423|P5|STARTED|Third Washout Period of 4-7 Days||6
548131|NCT00739297|1336424|P4|STARTED|Third Washout Period of 4-7 Days||18
548132|NCT00739297|1336425|P3|STARTED|Third Washout Period of 4-7 Days||6
548133|NCT00739297|1336426|P2|STARTED|Third Washout Period of 4-7 Days||12
548134|NCT00739297|1336427|P1|STARTED|Third Washout Period of 4-7 Days||16
548135|NCT00739297|1336421|P7|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
548136|NCT00739297|1336422|P6|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
548137|NCT00739297|1336423|P5|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
548138|NCT00739297|1336424|P4|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
548139|NCT00739297|1336425|P3|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
548140|NCT00739297|1336426|P2|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
548141|NCT00739297|1336427|P1|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
548142|NCT00739297|1336421|P7|COMPLETED|Third Intervention (Visit 7 to Visit 8)||66
548143|NCT00739297|1336422|P6|COMPLETED|Third Intervention (Visit 7 to Visit 8)||8
548144|NCT00739297|1336423|P5|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6
548145|NCT00739297|1336424|P4|COMPLETED|Third Intervention (Visit 7 to Visit 8)||18
548146|NCT00739297|1336425|P3|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6
548147|NCT00739297|1336426|P2|COMPLETED|Third Intervention (Visit 7 to Visit 8)||12
548148|NCT00739297|1336427|P1|COMPLETED|Third Intervention (Visit 7 to Visit 8)||16
548149|NCT00739297|1336421|P7|STARTED|Third Intervention (Visit 7 to Visit 8)||66
548150|NCT00739297|1336422|P6|STARTED|Third Intervention (Visit 7 to Visit 8)||8
548151|NCT00739297|1336423|P5|STARTED|Third Intervention (Visit 7 to Visit 8)||6
548152|NCT00739297|1336424|P4|STARTED|Third Intervention (Visit 7 to Visit 8)||18
548153|NCT00739297|1336425|P3|STARTED|Third Intervention (Visit 7 to Visit 8)||6
548154|NCT00739297|1336426|P2|STARTED|Third Intervention (Visit 7 to Visit 8)||12
548155|NCT00739297|1336427|P1|STARTED|Third Intervention (Visit 7 to Visit 8)||16
548156|NCT00739297|1336421|P7|NOT COMPLETED|Second Washout Period of 4-7 Days||0
548157|NCT00739297|1336422|P6|NOT COMPLETED|Second Washout Period of 4-7 Days||0
548158|NCT00739297|1336423|P5|NOT COMPLETED|Second Washout Period of 4-7 Days||0
548159|NCT00739297|1336424|P4|NOT COMPLETED|Second Washout Period of 4-7 Days||0
548160|NCT00739297|1336425|P3|NOT COMPLETED|Second Washout Period of 4-7 Days||0
548161|NCT00739297|1336426|P2|NOT COMPLETED|Second Washout Period of 4-7 Days||0
548162|NCT00739297|1336427|P1|NOT COMPLETED|Second Washout Period of 4-7 Days||0
548163|NCT00739297|1336421|P7|COMPLETED|Second Washout Period of 4-7 Days||66
548164|NCT00739297|1336422|P6|COMPLETED|Second Washout Period of 4-7 Days||10
548165|NCT00739297|1336423|P5|COMPLETED|Second Washout Period of 4-7 Days||6
548166|NCT00739297|1336424|P4|COMPLETED|Second Washout Period of 4-7 Days||14
548167|NCT00739297|1336425|P3|COMPLETED|Second Washout Period of 4-7 Days||10
548168|NCT00739297|1336426|P2|COMPLETED|Second Washout Period of 4-7 Days||8
548169|NCT00739297|1336427|P1|COMPLETED|Second Washout Period of 4-7 Days||18
548170|NCT00739297|1336421|P7|STARTED|Second Washout Period of 4-7 Days||66
548171|NCT00739297|1336422|P6|STARTED|Second Washout Period of 4-7 Days||10
548172|NCT00739297|1336423|P5|STARTED|Second Washout Period of 4-7 Days||6
548173|NCT00739297|1336424|P4|STARTED|Second Washout Period of 4-7 Days||14
548174|NCT00739297|1336425|P3|STARTED|Second Washout Period of 4-7 Days||10
548175|NCT00739297|1336426|P2|STARTED|Second Washout Period of 4-7 Days||8
548176|NCT00739297|1336427|P1|STARTED|Second Washout Period of 4-7 Days||18
548177|NCT00739297|1336421|P7|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
548178|NCT00739297|1336422|P6|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
548179|NCT00739297|1336423|P5|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
548180|NCT00739297|1336424|P4|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
548181|NCT00739297|1336425|P3|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
548182|NCT00739297|1336426|P2|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
548183|NCT00739297|1336427|P1|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
548184|NCT00739297|1336421|P7|COMPLETED|Second Intervention (Visit 5 to Visit 6)||66
548185|NCT00739297|1336422|P6|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10
548186|NCT00739297|1336423|P5|COMPLETED|Second Intervention (Visit 5 to Visit 6)||6
548187|NCT00739297|1336424|P4|COMPLETED|Second Intervention (Visit 5 to Visit 6)||14
548188|NCT00739297|1336425|P3|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10
548189|NCT00739297|1336426|P2|COMPLETED|Second Intervention (Visit 5 to Visit 6)||8
548190|NCT00739297|1336427|P1|COMPLETED|Second Intervention (Visit 5 to Visit 6)||18
548191|NCT00739297|1336421|P7|STARTED|Second Intervention (Visit 5 to Visit 6)||66
548192|NCT00739297|1336422|P6|STARTED|Second Intervention (Visit 5 to Visit 6)||10
548193|NCT00739297|1336423|P5|STARTED|Second Intervention (Visit 5 to Visit 6)||6
548194|NCT00739297|1336424|P4|STARTED|Second Intervention (Visit 5 to Visit 6)||14
548195|NCT00739297|1336425|P3|STARTED|Second Intervention (Visit 5 to Visit 6)||10
548196|NCT00739297|1336426|P2|STARTED|Second Intervention (Visit 5 to Visit 6)||8
548197|NCT00739297|1336427|P1|STARTED|Second Intervention (Visit 5 to Visit 6)||18
548198|NCT00739297|1336421|P7|NOT COMPLETED|First Washout Period of 4-7 Days||2
548199|NCT00739297|1336422|P6|NOT COMPLETED|First Washout Period of 4-7 Days||0
548200|NCT00739297|1336423|P5|NOT COMPLETED|First Washout Period of 4-7 Days||0
548201|NCT00739297|1336424|P4|NOT COMPLETED|First Washout Period of 4-7 Days||2
548202|NCT00739297|1336425|P3|NOT COMPLETED|First Washout Period of 4-7 Days||0
548203|NCT00739297|1336426|P2|NOT COMPLETED|First Washout Period of 4-7 Days||0
548204|NCT00739297|1336427|P1|NOT COMPLETED|First Washout Period of 4-7 Days||0
548205|NCT00739297|1336421|P7|COMPLETED|First Washout Period of 4-7 Days||66
548206|NCT00739297|1336422|P6|COMPLETED|First Washout Period of 4-7 Days||9
548207|NCT00739297|1336423|P5|COMPLETED|First Washout Period of 4-7 Days||6
548208|NCT00739297|1336424|P4|COMPLETED|First Washout Period of 4-7 Days||17
548209|NCT00739297|1336425|P3|COMPLETED|First Washout Period of 4-7 Days||6
548210|NCT00739297|1336426|P2|COMPLETED|First Washout Period of 4-7 Days||11
548211|NCT00739297|1336427|P1|COMPLETED|First Washout Period of 4-7 Days||17
548212|NCT00739297|1336421|P7|STARTED|First Washout Period of 4-7 Days||68
548213|NCT00739297|1336422|P6|STARTED|First Washout Period of 4-7 Days||9
548214|NCT00739297|1336423|P5|STARTED|First Washout Period of 4-7 Days||6
548215|NCT00739297|1336424|P4|STARTED|First Washout Period of 4-7 Days||19
548216|NCT00739297|1336425|P3|STARTED|First Washout Period of 4-7 Days||6
548217|NCT00739297|1336426|P2|STARTED|First Washout Period of 4-7 Days||11
548218|NCT00739297|1336427|P1|STARTED|First Washout Period of 4-7 Days||17
548219|NCT00739297|1336421|P7|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
548220|NCT00739297|1336422|P6|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
548221|NCT00739297|1336423|P5|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
548222|NCT00739297|1336424|P4|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
548223|NCT00739297|1336425|P3|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
548224|NCT00739297|1336426|P2|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
548225|NCT00739297|1336427|P1|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
548226|NCT00739297|1336421|P7|COMPLETED|First Intervention (Visit 3 to Visit 4)||68
548227|NCT00739297|1336422|P6|COMPLETED|First Intervention (Visit 3 to Visit 4)||9
548228|NCT00739297|1336423|P5|COMPLETED|First Intervention (Visit 3 to Visit 4)||6
548229|NCT00739297|1336424|P4|COMPLETED|First Intervention (Visit 3 to Visit 4)||19
548230|NCT00739297|1336425|P3|COMPLETED|First Intervention (Visit 3 to Visit 4)||6
548231|NCT00739297|1336426|P2|COMPLETED|First Intervention (Visit 3 to Visit 4)||11
548232|NCT00739297|1336427|P1|COMPLETED|First Intervention (Visit 3 to Visit 4)||17
548233|NCT00739297|1336421|P7|STARTED|First Intervention (Visit 3 to Visit 4)||68
548234|NCT00739297|1336422|P6|STARTED|First Intervention (Visit 3 to Visit 4)||9
548235|NCT00739297|1336423|P5|STARTED|First Intervention (Visit 3 to Visit 4)||6
548236|NCT00739297|1336424|P4|STARTED|First Intervention (Visit 3 to Visit 4)||19
548237|NCT00739297|1336425|P3|STARTED|First Intervention (Visit 3 to Visit 4)||6
548238|NCT00739297|1336426|P2|STARTED|First Intervention (Visit 3 to Visit 4)||11
548239|NCT00739297|1336427|P1|STARTED|First Intervention (Visit 3 to Visit 4)||17
548240|NCT00739102|1336455|P1|NOT COMPLETED|Overall Study||15
548241|NCT00739102|1336455|P1|COMPLETED|Overall Study|Completed 12-Month Follow-up|235
548242|NCT00739102|1336455|P1|STARTED|Overall Study||250
548243|NCT00739063|1336471|P1|NOT COMPLETED|Overall Study||8
548244|NCT00739063|1336471|P1|COMPLETED|Overall Study||3
548245|NCT00739063|1336471|P1|STARTED|Overall Study||11
548246|NCT00739050|1336475|P2|NOT COMPLETED|Overall Study||0
548247|NCT00739050|1336476|P1|NOT COMPLETED|Overall Study||1
548248|NCT00739050|1336475|P2|COMPLETED|Overall Study||0
548249|NCT00739050|1336476|P1|COMPLETED|Overall Study|These 3 patients completing treatment did not complete the required procedures during the trial.|3
548250|NCT00739050|1336475|P2|STARTED|Overall Study||0
548251|NCT00739050|1336476|P1|STARTED|Overall Study||4
548252|NCT00739024|1336490|P2|NOT COMPLETED|Overall Study||0
548253|NCT00739024|1336491|P1|NOT COMPLETED|Overall Study||0
548254|NCT00739024|1336490|P2|COMPLETED|Overall Study||6
548255|NCT00739024|1336491|P1|COMPLETED|Overall Study||7
548256|NCT00739024|1336490|P2|STARTED|Overall Study||6
548257|NCT00739024|1336491|P1|STARTED|Overall Study||7
548258|NCT00738972|1336501|P4|NOT COMPLETED|Overall Study||1
548259|NCT00738972|1336502|P3|NOT COMPLETED|Overall Study||0
548260|NCT00738972|1336503|P2|NOT COMPLETED|Overall Study||0
548261|NCT00738972|1336504|P1|NOT COMPLETED|Overall Study||0
548262|NCT00738972|1336501|P4|COMPLETED|Overall Study||2
548263|NCT00738972|1336502|P3|COMPLETED|Overall Study||3
548264|NCT00738972|1336503|P2|COMPLETED|Overall Study||3
548265|NCT00738972|1336504|P1|COMPLETED|Overall Study||3
548266|NCT00738972|1336501|P4|STARTED|Overall Study||3
548267|NCT00738972|1336502|P3|STARTED|Overall Study||3
548268|NCT00738972|1336503|P2|STARTED|Overall Study||3
548269|NCT00738972|1336504|P1|STARTED|Overall Study||3
548270|NCT00738881|1336516|P2|NOT COMPLETED|Overall Study||2
548271|NCT00738881|1336517|P1|NOT COMPLETED|Overall Study||0
548272|NCT00738881|1336516|P2|COMPLETED|Overall Study||10
548273|NCT00738881|1336517|P1|COMPLETED|Overall Study||11
548274|NCT00738881|1336516|P2|STARTED|Overall Study||12
548275|NCT00738881|1336517|P1|STARTED|Overall Study||11
548276|NCT00738699|1336531|P2|NOT COMPLETED|Overall Study||140
548277|NCT00738699|1336532|P1|NOT COMPLETED|Overall Study||275
548278|NCT00738699|1336531|P2|COMPLETED|Overall Study||0
548279|NCT00738699|1336532|P1|COMPLETED|Overall Study||0
548280|NCT00738699|1336531|P2|Participants Treated|Overall Study||139
548281|NCT00738699|1336532|P1|Participants Treated|Overall Study||273
548282|NCT00738699|1336531|P2|Participants Not Treated|Overall Study||1
548283|NCT00738699|1336532|P1|Participants Not Treated|Overall Study||2
548284|NCT00738699|1336531|P2|STARTED|Overall Study||140
548285|NCT00738699|1336532|P1|STARTED|Overall Study||275
548286|NCT00738673|1336550|P2|NOT COMPLETED|Overall Study||11
548287|NCT00738673|1336551|P1|NOT COMPLETED|Overall Study||24
548288|NCT00738673|1336550|P2|COMPLETED|Overall Study||1
548289|NCT00738673|1336551|P1|COMPLETED|Overall Study||1
548290|NCT00738673|1336550|P2|Intent to Treat Population|Overall Study||12
548291|NCT00738673|1336551|P1|Intent to Treat Population|Overall Study||24
548292|NCT00738673|1336550|P2|STARTED|Overall Study||12
548293|NCT00738673|1336551|P1|STARTED|Overall Study||25
548294|NCT00738543|1336579|P1|NOT COMPLETED|Control||0
548295|NCT00738543|1336579|P1|COMPLETED|Control||48
548296|NCT00738543|1336579|P1|STARTED|Control||48
548297|NCT00738543|1336579|P1|NOT COMPLETED|Sodium Hypochlorite||0
548298|NCT00738543|1336579|P1|COMPLETED|Sodium Hypochlorite||48
548299|NCT00738543|1336579|P1|STARTED|Sodium Hypochlorite||48
548300|NCT00738543|1336579|P1|NOT COMPLETED|Povidone Iodine||0
548301|NCT00738543|1336579|P1|COMPLETED|Povidone Iodine||48
548302|NCT00738543|1336579|P1|STARTED|Povidone Iodine||48
548303|NCT00738530|1336589|P2|NOT COMPLETED|Overall Study||238
548304|NCT00738530|1336590|P1|NOT COMPLETED|Overall Study||234
548305|NCT00738530|1336589|P2|COMPLETED|Overall Study||84
548306|NCT00738530|1336590|P1|COMPLETED|Overall Study||93
548307|NCT00738530|1336589|P2|Treated|Overall Study||316
548308|NCT00738530|1336590|P1|Treated|Overall Study||325
548309|NCT00738530|1336589|P2|STARTED|Overall Study||322
548310|NCT00738530|1336590|P1|STARTED|Overall Study||327
548311|NCT00738426|1336616|P2|NOT COMPLETED|Overall Study||3
548312|NCT00738426|1336617|P1|NOT COMPLETED|Overall Study||2
548313|NCT00738426|1336616|P2|COMPLETED|Overall Study||32
548314|NCT00738426|1336617|P1|COMPLETED|Overall Study||35
548315|NCT00738426|1336616|P2|STARTED|Overall Study||35
548316|NCT00738426|1336617|P1|STARTED|Overall Study||37
548317|NCT00738400|1336625|P2|NOT COMPLETED|Overall Study||7
548318|NCT00738400|1336626|P1|NOT COMPLETED|Overall Study||4
548319|NCT00738400|1336625|P2|COMPLETED|Overall Study||67
548320|NCT00738400|1336626|P1|COMPLETED|Overall Study||72
548321|NCT00738400|1336625|P2|ITT (Intent To Treatment) Population|Overall Study|No post-baseline efficacy measurement in 2 participants|70
548322|NCT00738400|1336626|P1|ITT (Intent To Treatment) Population|Overall Study||75
548323|NCT00738400|1336625|P2|Received Treatment, Safety Population|Overall Study|Two invalid participants (no evidence that these randomized participants took study medication).|72
548324|NCT00738400|1336626|P1|Received Treatment, Safety Population|Overall Study|One invalid participant (no evidence that this randomized participant took study medication).|75
548325|NCT00738400|1336625|P2|STARTED|Overall Study||74
548326|NCT00738400|1336626|P1|STARTED|Overall Study||76
548327|NCT00738374|1336647|P4|NOT COMPLETED|Maintenance Treatment/Observation Phase||12
548328|NCT00738374|1336648|P3|NOT COMPLETED|Maintenance Treatment/Observation Phase||7
548329|NCT00738374|1336649|P2|NOT COMPLETED|Maintenance Treatment/Observation Phase||7
548330|NCT00738374|1336650|P1|NOT COMPLETED|Maintenance Treatment/Observation Phase||0
548331|NCT00738374|1336647|P4|COMPLETED|Maintenance Treatment/Observation Phase||20
548332|NCT00738374|1336648|P3|COMPLETED|Maintenance Treatment/Observation Phase||27
548333|NCT00738374|1336649|P2|COMPLETED|Maintenance Treatment/Observation Phase||0
548334|NCT00738374|1336650|P1|COMPLETED|Maintenance Treatment/Observation Phase||0
548335|NCT00738374|1336647|P4|STARTED|Maintenance Treatment/Observation Phase||32
548336|NCT00738374|1336648|P3|STARTED|Maintenance Treatment/Observation Phase||34
548337|NCT00738374|1336649|P2|STARTED|Maintenance Treatment/Observation Phase||7
548338|NCT00738374|1336650|P1|STARTED|Maintenance Treatment/Observation Phase|Participants were randomized to either maintenance therapy or observation at the end of induction.|0
548339|NCT00738374|1336647|P4|NOT COMPLETED|Induction Treatment Phase||0
548340|NCT00738374|1336648|P3|NOT COMPLETED|Induction Treatment Phase||0
548341|NCT00738374|1336649|P2|NOT COMPLETED|Induction Treatment Phase||0
548342|NCT00738374|1336650|P1|NOT COMPLETED|Induction Treatment Phase||24
548343|NCT00738374|1336647|P4|COMPLETED|Induction Treatment Phase||0
548344|NCT00738374|1336648|P3|COMPLETED|Induction Treatment Phase||0
548345|NCT00738374|1336649|P2|COMPLETED|Induction Treatment Phase||0
548346|NCT00738374|1336650|P1|COMPLETED|Induction Treatment Phase||73
548347|NCT00738374|1336647|P4|STARTED|Induction Treatment Phase|Participants were randomized at the end of the Induction Treatment Phase.|0
548348|NCT00738374|1336648|P3|STARTED|Induction Treatment Phase|Participants were randomized at the end of the Induction Treatment Phase.|0
548349|NCT00738374|1336649|P2|STARTED|Induction Treatment Phase||0
548350|NCT00738374|1336650|P1|STARTED|Induction Treatment Phase||97
548351|NCT00738361|1336682|P1|NOT COMPLETED|Overall Study||0
548352|NCT00738361|1336682|P1|COMPLETED|Overall Study||4
548353|NCT00738361|1336682|P1|STARTED|Overall Study||4
548354|NCT00738283|1336688|P1|NOT COMPLETED|Overall Study||4
548355|NCT00738283|1336688|P1|COMPLETED|Overall Study||13
548356|NCT00738283|1336688|P1|STARTED|Overall Study||17
548357|NCT00738062|1336695|P3|NOT COMPLETED|Open-Label Extension||0
548358|NCT00738062|1336696|P2|NOT COMPLETED|Open-Label Extension||0
548359|NCT00738062|1336697|P1|NOT COMPLETED|Open-Label Extension||17
548360|NCT00738062|1336695|P3|COMPLETED|Open-Label Extension||0
548361|NCT00738062|1336696|P2|COMPLETED|Open-Label Extension||0
548362|NCT00738062|1336697|P1|COMPLETED|Open-Label Extension||57
548363|NCT00738062|1336695|P3|STARTED|Open-Label Extension||0
548364|NCT00738062|1336696|P2|STARTED|Open-Label Extension||0
548365|NCT00738062|1336697|P1|STARTED|Open-Label Extension|One patient completed double blind randomization but did not enter the open label extension|74
548366|NCT00738062|1336695|P3|NOT COMPLETED|2 Week Randomized Withdrawal||0
548367|NCT00738062|1336696|P2|NOT COMPLETED|2 Week Randomized Withdrawal||0
548368|NCT00738062|1336697|P1|NOT COMPLETED|2 Week Randomized Withdrawal||0
548369|NCT00738062|1336695|P3|COMPLETED|2 Week Randomized Withdrawal||37
548370|NCT00738062|1336696|P2|COMPLETED|2 Week Randomized Withdrawal||38
548371|NCT00738062|1336697|P1|COMPLETED|2 Week Randomized Withdrawal||0
548372|NCT00738062|1336695|P3|STARTED|2 Week Randomized Withdrawal||37
548373|NCT00738062|1336696|P2|STARTED|2 Week Randomized Withdrawal||38
548374|NCT00738062|1336697|P1|STARTED|2 Week Randomized Withdrawal|Patients completing the open label titration phase were randomized to either Droxidopa or Placebo|0
548375|NCT00738062|1336695|P3|NOT COMPLETED|Open Label Treatment||0
548376|NCT00738062|1336696|P2|NOT COMPLETED|Open Label Treatment||0
548377|NCT00738062|1336697|P1|NOT COMPLETED|Open Label Treatment||28
548378|NCT00738062|1336695|P3|COMPLETED|Open Label Treatment||0
548379|NCT00738062|1336696|P2|COMPLETED|Open Label Treatment||0
548380|NCT00738062|1336697|P1|COMPLETED|Open Label Treatment||75
548381|NCT00738062|1336695|P3|STARTED|Open Label Treatment||0
548382|NCT00738062|1336696|P2|STARTED|Open Label Treatment||0
548383|NCT00738062|1336697|P1|STARTED|Open Label Treatment||103
548384|NCT00738049|1336724|P2|NOT COMPLETED|Washout||0
548385|NCT00738049|1336725|P1|NOT COMPLETED|Washout||0
548386|NCT00738049|1336724|P2|COMPLETED|Washout||7
548387|NCT00738049|1336725|P1|COMPLETED|Washout||13
548388|NCT00738049|1336724|P2|STARTED|Washout||7
548389|NCT00738049|1336725|P1|STARTED|Washout||13
548390|NCT00738049|1336724|P2|NOT COMPLETED|2nd Intervention(14 Days)||0
548391|NCT00738049|1336725|P1|NOT COMPLETED|2nd Intervention(14 Days)||0
548392|NCT00738049|1336724|P2|COMPLETED|2nd Intervention(14 Days)||7
548393|NCT00738049|1336725|P1|COMPLETED|2nd Intervention(14 Days)||13
548394|NCT00738049|1336724|P2|STARTED|2nd Intervention(14 Days)||7
548395|NCT00738049|1336725|P1|STARTED|2nd Intervention(14 Days)||13
548396|NCT00738049|1336724|P2|NOT COMPLETED|1st Intervention(14 Days)||0
548397|NCT00738049|1336725|P1|NOT COMPLETED|1st Intervention(14 Days)||0
548398|NCT00738049|1336724|P2|COMPLETED|1st Intervention(14 Days)||7
548399|NCT00738049|1336725|P1|COMPLETED|1st Intervention(14 Days)||13
548400|NCT00738049|1336724|P2|STARTED|1st Intervention(14 Days)||7
548401|NCT00738049|1336725|P1|STARTED|1st Intervention(14 Days)||13
548402|NCT00738023|1336739|P2|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
548403|NCT00738023|1336740|P1|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
548404|NCT00738023|1336739|P2|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
548405|NCT00738023|1336740|P1|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||19
548406|NCT00738023|1336739|P2|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||0
548407|NCT00738023|1336740|P1|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||19
548408|NCT00738023|1336739|P2|NOT COMPLETED|Saline Infusion||0
548409|NCT00738023|1336740|P1|NOT COMPLETED|Saline Infusion||0
548410|NCT00738023|1336739|P2|COMPLETED|Saline Infusion||0
548411|NCT00738023|1336740|P1|COMPLETED|Saline Infusion||19
548412|NCT00738023|1336739|P2|STARTED|Saline Infusion||0
548413|NCT00738023|1336740|P1|STARTED|Saline Infusion||19
548414|NCT00738023|1336739|P2|NOT COMPLETED|Intralipid Infusion||0
548415|NCT00738023|1336740|P1|NOT COMPLETED|Intralipid Infusion||0
548416|NCT00738023|1336739|P2|COMPLETED|Intralipid Infusion||13
548417|NCT00738023|1336740|P1|COMPLETED|Intralipid Infusion||19
548418|NCT00738023|1336739|P2|STARTED|Intralipid Infusion||13
548419|NCT00738023|1336740|P1|STARTED|Intralipid Infusion||19
548420|NCT00737737|1336750|P2|NOT COMPLETED|Overall Study||0
548421|NCT00737737|1336751|P1|NOT COMPLETED|Overall Study||0
548422|NCT00737737|1336750|P2|COMPLETED|Overall Study||2
548423|NCT00737737|1336751|P1|COMPLETED|Overall Study||2
548424|NCT00737737|1336750|P2|STARTED|Overall Study||2
548425|NCT00737737|1336751|P1|STARTED|Overall Study||2
548426|NCT00737711|1336759|P1|NOT COMPLETED|Overall Study||31
548427|NCT00737711|1336759|P1|COMPLETED|Overall Study||158
548428|NCT00737711|1336759|P1|STARTED|Overall Study||189
548429|NCT00737672|1336792|P2|NOT COMPLETED|Overall Study||83
548430|NCT00737672|1336793|P1|NOT COMPLETED|Overall Study||80
548431|NCT00737672|1336792|P2|COMPLETED|Overall Study||65
548432|NCT00737672|1336793|P1|COMPLETED|Overall Study||65
548433|NCT00737672|1336792|P2|Per Protocol Population|Overall Study||138
548434|NCT00737672|1336793|P1|Per Protocol Population|Overall Study||131
548435|NCT00737672|1336792|P2|Exclusions Due to Protocol Deviations|Overall Study||10
548436|NCT00737672|1336793|P1|Exclusions Due to Protocol Deviations|Overall Study||14
548437|NCT00737672|1336792|P2|STARTED|Overall Study||148
548438|NCT00737672|1336793|P1|STARTED|Overall Study||145
548439|NCT00737633|1336831|P2|NOT COMPLETED|Overall Study||57
548440|NCT00737633|1336832|P1|NOT COMPLETED|Overall Study||44
548441|NCT00737633|1336831|P2|COMPLETED|Overall Study||0
548442|NCT00737633|1336832|P1|COMPLETED|Overall Study||0
548443|NCT00737633|1336831|P2|STARTED|Overall Study||57
548444|NCT00737633|1336832|P1|STARTED|Overall Study||44
548445|NCT00737594|1336843|P3|NOT COMPLETED|Overall Study||0
548446|NCT00737594|1336844|P2|NOT COMPLETED|Overall Study||0
548447|NCT00737594|1336845|P1|NOT COMPLETED|Overall Study||0
548448|NCT00737594|1336843|P3|COMPLETED|Overall Study||0
548449|NCT00737594|1336844|P2|COMPLETED|Overall Study||0
548450|NCT00737594|1336845|P1|COMPLETED|Overall Study||0
548451|NCT00737594|1336843|P3|STARTED|Overall Study||0
548452|NCT00737594|1336844|P2|STARTED|Overall Study||0
548453|NCT00737594|1336845|P1|STARTED|Overall Study||0
548454|NCT00737568|1336855|P2|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||18
548455|NCT00737568|1336856|P1|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||26
548456|NCT00737568|1336855|P2|COMPLETED|Treatment-Free Follow-up (TFFU) Period||19
548457|NCT00737568|1336856|P1|COMPLETED|Treatment-Free Follow-up (TFFU) Period||12
548458|NCT00737568|1336855|P2|STARTED|Treatment-Free Follow-up (TFFU) Period|4 participants not completing the 240 week treatment period enrolled in the TFFU period.|37
548459|NCT00737568|1336856|P1|STARTED|Treatment-Free Follow-up (TFFU) Period|1 participant not completing the 240 week treatment period enrolled in the TFFU period.|38
548460|NCT00737568|1336855|P2|NOT COMPLETED|Treatment Period Through Week 240||21
548461|NCT00737568|1336856|P1|NOT COMPLETED|Treatment Period Through Week 240||20
548462|NCT00737568|1336855|P2|COMPLETED|Treatment Period Through Week 240||118
548463|NCT00737568|1336856|P1|COMPLETED|Treatment Period Through Week 240||121
548464|NCT00737568|1336855|P2|STARTED|Treatment Period Through Week 240||139
548465|NCT00737568|1336856|P1|STARTED|Treatment Period Through Week 240||141
548466|NCT00737529|1336886|P1|NOT COMPLETED|Overall Study||112
548467|NCT00737529|1336886|P1|COMPLETED|Overall Study|Completed equals participants ongoing on treatment at the time of the data cut-off of 02 July 2012|22
548468|NCT00737529|1336886|P1|STARTED|Overall Study||134
548469|NCT00737477|1336900|P1|NOT COMPLETED|Overall Study||34
548470|NCT00737477|1336900|P1|COMPLETED|Overall Study||62
548471|NCT00737477|1336900|P1|STARTED|Overall Study||96
548472|NCT00737464|1336916|P1|NOT COMPLETED|Overall Study||18
548473|NCT00737464|1336916|P1|COMPLETED|Overall Study||114
548474|NCT00737464|1336916|P1|STARTED|Overall Study||132
548475|NCT00737438|1336937|P1|NOT COMPLETED|Overall Study||3
548476|NCT00737438|1336937|P1|COMPLETED|Overall Study||20
548477|NCT00737438|1336937|P1|STARTED|Overall Study||23
548478|NCT00737360|1336941|P1|NOT COMPLETED|Overall Study||0
548479|NCT00737360|1336941|P1|COMPLETED|Overall Study||27
548480|NCT00737360|1336941|P1|STARTED|Overall Study||27
548481|NCT00737282|1336950|P1|NOT COMPLETED|Overall Study||175
548482|NCT00737282|1336950|P1|COMPLETED|Overall Study||0
548483|NCT00737282|1336950|P1|STARTED|Overall Study||175
548484|NCT00737243|1336956|P1|NOT COMPLETED|Overall Study||95
548485|NCT00737243|1336956|P1|COMPLETED|Overall Study||194
548486|NCT00737243|1336956|P1|Empiric CUP Therapy|Overall Study||29
548487|NCT00737243|1336956|P1|Site Specific Therapy Less Responsive|Overall Study||79
548488|NCT00737243|1336956|P1|Site Specific Therapy More Responsive|Overall Study||115
548489|NCT00737243|1336956|P1|Not Treated|Overall Study|16 pts no longer met eligibility criteria; 13 came off study due to physician or pt preference.|29
548490|NCT00737243|1336956|P1|Treated|Overall Study||223
548491|NCT00737243|1336956|P1|Insufficient Tissue for Assay, Withdrawn|Overall Study||37
548492|NCT00737243|1336956|P1|Successful Assay Performed|Overall Study||252
548493|NCT00737243|1336956|P1|STARTED|Overall Study||289
548494|NCT00737204|1336964|P2|NOT COMPLETED|Overall Study||6
548495|NCT00737204|1336965|P1|NOT COMPLETED|Overall Study||0
548496|NCT00737204|1336964|P2|COMPLETED|Overall Study||28
548497|NCT00737204|1336965|P1|COMPLETED|Overall Study||36
548498|NCT00737204|1336964|P2|STARTED|Overall Study||34
548499|NCT00737204|1336965|P1|STARTED|Overall Study||36
548500|NCT00737178|1336979|P2|NOT COMPLETED|Overall Study||9
548501|NCT00737178|1336980|P1|NOT COMPLETED|Overall Study||5
548502|NCT00737178|1336979|P2|COMPLETED|Overall Study||76
548503|NCT00737178|1336980|P1|COMPLETED|Overall Study||66
548504|NCT00737178|1336979|P2|STARTED|Overall Study||85
548505|NCT00737178|1336980|P1|STARTED|Overall Study||71
548506|NCT00737100|1336993|P3|NOT COMPLETED|Overall Study||7
548507|NCT00737100|1336994|P2|NOT COMPLETED|Overall Study||7
548508|NCT00737100|1336995|P1|NOT COMPLETED|Overall Study||7
548509|NCT00737100|1336993|P3|COMPLETED|Overall Study||169
548510|NCT00737100|1336994|P2|COMPLETED|Overall Study||159
548511|NCT00737100|1336995|P1|COMPLETED|Overall Study||161
548512|NCT00737100|1336993|P3|STARTED|Overall Study||176
548513|NCT00737100|1336994|P2|STARTED|Overall Study||166
548514|NCT00737100|1336995|P1|STARTED|Overall Study||168
548515|NCT00737061|1337039|P1|NOT COMPLETED|1 Year Wearing Period||17
548516|NCT00737061|1337039|P1|COMPLETED|1 Year Wearing Period||553
548517|NCT00737061|1337039|P1|STARTED|1 Year Wearing Period||570
548518|NCT00737061|1337039|P1|NOT COMPLETED|Waiting Period||75
548519|NCT00737061|1337039|P1|COMPLETED|Waiting Period||570
548520|NCT00737061|1337039|P1|STARTED|Waiting Period||645
548521|NCT00737048|1337056|P3|NOT COMPLETED|Overall Study||4
548522|NCT00737048|1337057|P2|NOT COMPLETED|Overall Study||6
548523|NCT00737048|1337058|P1|NOT COMPLETED|Overall Study||3
548524|NCT00737048|1337056|P3|COMPLETED|Overall Study||126
548525|NCT00737048|1337057|P2|COMPLETED|Overall Study||60
548526|NCT00737048|1337058|P1|COMPLETED|Overall Study||129
548527|NCT00737048|1337056|P3|STARTED|Overall Study||130
548528|NCT00737048|1337057|P2|STARTED|Overall Study||66
548529|NCT00737048|1337058|P1|STARTED|Overall Study||132
548530|NCT00736996|1337102|P3|NOT COMPLETED|Overall Study||2
548531|NCT00736996|1337103|P2|NOT COMPLETED|Overall Study||9
548532|NCT00736996|1337104|P1|NOT COMPLETED|Overall Study||1
548533|NCT00736996|1337102|P3|COMPLETED|Overall Study||25
548534|NCT00736996|1337103|P2|COMPLETED|Overall Study||17
548535|NCT00736996|1337104|P1|COMPLETED|Overall Study||24
548536|NCT00736996|1337102|P3|STARTED|Overall Study||27
548537|NCT00736996|1337103|P2|STARTED|Overall Study||26
548538|NCT00736996|1337104|P1|STARTED|Overall Study||25
548539|NCT00736957|1337118|P1|NOT COMPLETED|Overall Study||122
548540|NCT00736957|1337118|P1|COMPLETED|Overall Study||97
548541|NCT00736957|1337118|P1|Treated|Overall Study||190
548542|NCT00736957|1337118|P1|STARTED|Overall Study||219
548543|NCT00736944|1337128|P1|NOT COMPLETED|Definitive Treatment||1
548544|NCT00736944|1337128|P1|COMPLETED|Definitive Treatment||28
548545|NCT00736944|1337128|P1|STARTED|Definitive Treatment||29
548546|NCT00736944|1337128|P1|NOT COMPLETED|Induction||1
548547|NCT00736944|1337128|P1|COMPLETED|Induction||29
548548|NCT00736944|1337128|P1|STARTED|Induction||30
548549|NCT00736879|1337159|P4|NOT COMPLETED|Follow up Period - No Drug Treatment||0
548550|NCT00736879|1337160|P3|NOT COMPLETED|Follow up Period - No Drug Treatment||0
548551|NCT00736879|1337161|P2|NOT COMPLETED|Follow up Period - No Drug Treatment||3
548552|NCT00736879|1337162|P1|NOT COMPLETED|Follow up Period - No Drug Treatment||1
548553|NCT00736879|1337159|P4|COMPLETED|Follow up Period - No Drug Treatment||62
548554|NCT00736879|1337160|P3|COMPLETED|Follow up Period - No Drug Treatment||66
548555|NCT00736879|1337161|P2|COMPLETED|Follow up Period - No Drug Treatment||67
548556|NCT00736879|1337162|P1|COMPLETED|Follow up Period - No Drug Treatment||65
548557|NCT00736879|1337159|P4|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|62
548558|NCT00736879|1337160|P3|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|66
548559|NCT00736879|1337161|P2|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|70
548560|NCT00736879|1337162|P1|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|66
548561|NCT00736879|1337159|P4|NOT COMPLETED|Double Blind Treatment Period||5
548562|NCT00736879|1337160|P3|NOT COMPLETED|Double Blind Treatment Period||7
548563|NCT00736879|1337161|P2|NOT COMPLETED|Double Blind Treatment Period||4
548564|NCT00736879|1337162|P1|NOT COMPLETED|Double Blind Treatment Period||3
548565|NCT00736879|1337159|P4|COMPLETED|Double Blind Treatment Period||63
548566|NCT00736879|1337160|P3|COMPLETED|Double Blind Treatment Period||67
548567|NCT00736879|1337161|P2|COMPLETED|Double Blind Treatment Period||68
548568|NCT00736879|1337162|P1|COMPLETED|Double Blind Treatment Period||65
548569|NCT00736879|1337159|P4|STARTED|Double Blind Treatment Period||68
548570|NCT00736879|1337160|P3|STARTED|Double Blind Treatment Period||74
548571|NCT00736879|1337161|P2|STARTED|Double Blind Treatment Period||72
548572|NCT00736879|1337162|P1|STARTED|Double Blind Treatment Period||68
548573|NCT00736853|1337216|P3|NOT COMPLETED|Double-Blind Period||48
548574|NCT00736853|1337217|P2|NOT COMPLETED|Double-Blind Period||24
548575|NCT00736853|1337218|P1|NOT COMPLETED|Double-Blind Period||0
548576|NCT00736853|1337216|P3|COMPLETED|Double-Blind Period||45
548577|NCT00736853|1337217|P2|COMPLETED|Double-Blind Period||70
548578|NCT00736853|1337218|P1|COMPLETED|Double-Blind Period||0
548579|NCT00736853|1337216|P3|STARTED|Double-Blind Period||93
548580|NCT00736853|1337217|P2|STARTED|Double-Blind Period||94
548581|NCT00736853|1337218|P1|STARTED|Double-Blind Period||0
548582|NCT00736853|1337216|P3|NOT COMPLETED|Open-Label Period||0
548583|NCT00736853|1337217|P2|NOT COMPLETED|Open-Label Period||0
548584|NCT00736853|1337218|P1|NOT COMPLETED|Open-Label Period||132
548585|NCT00736853|1337216|P3|COMPLETED|Open-Label Period||0
548586|NCT00736853|1337217|P2|COMPLETED|Open-Label Period||0
548587|NCT00736853|1337218|P1|COMPLETED|Open-Label Period||187
548588|NCT00736853|1337216|P3|Treated|Open-Label Period||0
548589|NCT00736853|1337217|P2|Treated|Open-Label Period||0
548590|NCT00736853|1337218|P1|Treated|Open-Label Period||277
548591|NCT00736853|1337216|P3|STARTED|Open-Label Period||0
548592|NCT00736853|1337217|P2|STARTED|Open-Label Period||0
548593|NCT00736853|1337218|P1|STARTED|Open-Label Period||319
548594|NCT00736840|1337258|P1|NOT COMPLETED|Overall Study||13
548595|NCT00736840|1337258|P1|COMPLETED|Overall Study|9 subjects-no biopsy results, 2-no breath test, 2 no biopsy results and no complete breath test|401
548596|NCT00736840|1337258|P1|STARTED|Overall Study||414
548597|NCT00736723|1337265|P2|NOT COMPLETED|Overall Study||3
548598|NCT00736723|1337266|P1|NOT COMPLETED|Overall Study||4
548599|NCT00736723|1337265|P2|COMPLETED|Overall Study||18
548600|NCT00736723|1337266|P1|COMPLETED|Overall Study||26
548601|NCT00736723|1337265|P2|STARTED|Overall Study||21
548602|NCT00736723|1337266|P1|STARTED|Overall Study||30
548603|NCT00736645|1337276|P4|NOT COMPLETED|Overall Study||0
548604|NCT00736645|1337277|P3|NOT COMPLETED|Overall Study||0
548605|NCT00736645|1337278|P2|NOT COMPLETED|Overall Study||2
548606|NCT00736645|1337279|P1|NOT COMPLETED|Overall Study||0
548607|NCT00736645|1337276|P4|COMPLETED|Overall Study||13
548608|NCT00736645|1337277|P3|COMPLETED|Overall Study||14
548609|NCT00736645|1337278|P2|COMPLETED|Overall Study||13
548610|NCT00736645|1337279|P1|COMPLETED|Overall Study||13
548611|NCT00736645|1337276|P4|STARTED|Overall Study||13
548612|NCT00736645|1337277|P3|STARTED|Overall Study||14
548613|NCT00736645|1337278|P2|STARTED|Overall Study||15
548614|NCT00736645|1337279|P1|STARTED|Overall Study||13
548615|NCT00736580|1337295|P2|NOT COMPLETED|Overall Study||0
548616|NCT00736580|1337296|P1|NOT COMPLETED|Overall Study||0
548617|NCT00736580|1337295|P2|COMPLETED|Overall Study||123
548618|NCT00736580|1337296|P1|COMPLETED|Overall Study||117
548619|NCT00736580|1337295|P2|STARTED|Overall Study||123
548620|NCT00736580|1337296|P1|STARTED|Overall Study||117
548621|NCT00736502|1337302|P1|NOT COMPLETED|Overall Study||65
548622|NCT00736502|1337302|P1|COMPLETED|Overall Study||213
548623|NCT00736502|1337302|P1|STARTED|Overall Study|Entered and treated.|278
548624|NCT00736489|1337308|P6|NOT COMPLETED|Period 6||0
548625|NCT00736489|1337309|P5|NOT COMPLETED|Period 6||0
548626|NCT00736489|1337310|P4|NOT COMPLETED|Period 6||0
548627|NCT00736489|1337311|P3|NOT COMPLETED|Period 6||0
548628|NCT00736489|1337312|P2|NOT COMPLETED|Period 6||0
548629|NCT00736489|1337313|P1|NOT COMPLETED|Period 6||0
548630|NCT00736489|1337308|P6|COMPLETED|Period 6||5
548631|NCT00736489|1337309|P5|COMPLETED|Period 6||7
548632|NCT00736489|1337310|P4|COMPLETED|Period 6||7
548633|NCT00736489|1337311|P3|COMPLETED|Period 6||6
548634|NCT00736489|1337312|P2|COMPLETED|Period 6||5
548635|NCT00736489|1337313|P1|COMPLETED|Period 6||5
548636|NCT00736489|1337308|P6|STARTED|Period 6||5
548637|NCT00736489|1337309|P5|STARTED|Period 6||7
548638|NCT00736489|1337310|P4|STARTED|Period 6||7
548639|NCT00736489|1337311|P3|STARTED|Period 6||6
548640|NCT00736489|1337312|P2|STARTED|Period 6||5
548641|NCT00736489|1337313|P1|STARTED|Period 6||5
548642|NCT00736489|1337308|P6|NOT COMPLETED|Period 5||0
548643|NCT00736489|1337309|P5|NOT COMPLETED|Period 5||0
548644|NCT00736489|1337310|P4|NOT COMPLETED|Period 5||0
548645|NCT00736489|1337311|P3|NOT COMPLETED|Period 5||0
548646|NCT00736489|1337312|P2|NOT COMPLETED|Period 5||0
548647|NCT00736489|1337313|P1|NOT COMPLETED|Period 5||0
548648|NCT00736489|1337308|P6|COMPLETED|Period 5||5
548649|NCT00736489|1337309|P5|COMPLETED|Period 5||7
548650|NCT00736489|1337310|P4|COMPLETED|Period 5||7
548651|NCT00736489|1337311|P3|COMPLETED|Period 5||6
548652|NCT00736489|1337312|P2|COMPLETED|Period 5||5
548653|NCT00736489|1337313|P1|COMPLETED|Period 5||5
548654|NCT00736489|1337308|P6|STARTED|Period 5||5
548655|NCT00736489|1337309|P5|STARTED|Period 5||7
548656|NCT00736489|1337310|P4|STARTED|Period 5||7
548657|NCT00736489|1337311|P3|STARTED|Period 5||6
548658|NCT00736489|1337312|P2|STARTED|Period 5||5
548659|NCT00736489|1337313|P1|STARTED|Period 5||5
548660|NCT00736489|1337308|P6|NOT COMPLETED|Period 4||0
548661|NCT00736489|1337309|P5|NOT COMPLETED|Period 4||0
548662|NCT00736489|1337310|P4|NOT COMPLETED|Period 4||0
548663|NCT00736489|1337311|P3|NOT COMPLETED|Period 4||0
548664|NCT00736489|1337312|P2|NOT COMPLETED|Period 4||0
548665|NCT00736489|1337313|P1|NOT COMPLETED|Period 4||0
548666|NCT00736489|1337308|P6|COMPLETED|Period 4||5
548667|NCT00736489|1337309|P5|COMPLETED|Period 4||7
548668|NCT00736489|1337310|P4|COMPLETED|Period 4||7
548669|NCT00736489|1337311|P3|COMPLETED|Period 4||6
548670|NCT00736489|1337312|P2|COMPLETED|Period 4||5
548671|NCT00736489|1337313|P1|COMPLETED|Period 4||5
548672|NCT00736489|1337308|P6|STARTED|Period 4||5
548673|NCT00736489|1337309|P5|STARTED|Period 4||7
548674|NCT00736489|1337310|P4|STARTED|Period 4||7
548675|NCT00736489|1337311|P3|STARTED|Period 4||6
548676|NCT00736489|1337312|P2|STARTED|Period 4||5
548677|NCT00736489|1337313|P1|STARTED|Period 4||5
548678|NCT00736489|1337308|P6|NOT COMPLETED|Period 3||0
548679|NCT00736489|1337309|P5|NOT COMPLETED|Period 3||0
548680|NCT00736489|1337310|P4|NOT COMPLETED|Period 3||0
548681|NCT00736489|1337311|P3|NOT COMPLETED|Period 3||0
548682|NCT00736489|1337312|P2|NOT COMPLETED|Period 3||0
548683|NCT00736489|1337313|P1|NOT COMPLETED|Period 3||0
548684|NCT00736489|1337308|P6|COMPLETED|Period 3||5
548685|NCT00736489|1337309|P5|COMPLETED|Period 3||7
548686|NCT00736489|1337310|P4|COMPLETED|Period 3||7
548687|NCT00736489|1337311|P3|COMPLETED|Period 3||6
548688|NCT00736489|1337312|P2|COMPLETED|Period 3||5
548689|NCT00736489|1337313|P1|COMPLETED|Period 3||5
548690|NCT00736489|1337308|P6|STARTED|Period 3||5
548691|NCT00736489|1337309|P5|STARTED|Period 3||7
548692|NCT00736489|1337310|P4|STARTED|Period 3||7
548693|NCT00736489|1337311|P3|STARTED|Period 3||6
548694|NCT00736489|1337312|P2|STARTED|Period 3||5
548695|NCT00736489|1337313|P1|STARTED|Period 3||5
548696|NCT00736489|1337308|P6|NOT COMPLETED|Period 2||0
548697|NCT00736489|1337309|P5|NOT COMPLETED|Period 2||0
548698|NCT00736489|1337310|P4|NOT COMPLETED|Period 2||0
548699|NCT00736489|1337311|P3|NOT COMPLETED|Period 2||0
548700|NCT00736489|1337312|P2|NOT COMPLETED|Period 2||0
548701|NCT00736489|1337313|P1|NOT COMPLETED|Period 2||0
548702|NCT00736489|1337308|P6|COMPLETED|Period 2||5
548703|NCT00736489|1337309|P5|COMPLETED|Period 2||7
548704|NCT00736489|1337310|P4|COMPLETED|Period 2||7
548705|NCT00736489|1337311|P3|COMPLETED|Period 2||6
548706|NCT00736489|1337312|P2|COMPLETED|Period 2||5
548707|NCT00736489|1337313|P1|COMPLETED|Period 2||5
548708|NCT00736489|1337308|P6|STARTED|Period 2||5
548709|NCT00736489|1337309|P5|STARTED|Period 2||7
548710|NCT00736489|1337310|P4|STARTED|Period 2||7
548711|NCT00736489|1337311|P3|STARTED|Period 2||6
548712|NCT00736489|1337312|P2|STARTED|Period 2||5
548713|NCT00736489|1337313|P1|STARTED|Period 2||5
548714|NCT00736489|1337308|P6|NOT COMPLETED|Period 1||1
548715|NCT00736489|1337309|P5|NOT COMPLETED|Period 1||0
548716|NCT00736489|1337310|P4|NOT COMPLETED|Period 1||0
548717|NCT00736489|1337311|P3|NOT COMPLETED|Period 1||0
548718|NCT00736489|1337312|P2|NOT COMPLETED|Period 1||0
548719|NCT00736489|1337313|P1|NOT COMPLETED|Period 1||1
548720|NCT00736489|1337308|P6|COMPLETED|Period 1||5
548721|NCT00736489|1337309|P5|COMPLETED|Period 1||7
548722|NCT00736489|1337310|P4|COMPLETED|Period 1||7
548723|NCT00736489|1337311|P3|COMPLETED|Period 1||6
548724|NCT00736489|1337312|P2|COMPLETED|Period 1||5
548725|NCT00736489|1337313|P1|COMPLETED|Period 1||5
548726|NCT00736489|1337308|P6|STARTED|Period 1||6
548727|NCT00736489|1337309|P5|STARTED|Period 1||7
548728|NCT00736489|1337310|P4|STARTED|Period 1||7
548729|NCT00736489|1337311|P3|STARTED|Period 1||6
548730|NCT00736489|1337312|P2|STARTED|Period 1||5
548731|NCT00736489|1337313|P1|STARTED|Period 1|Cross-over study|6
548732|NCT00736476|1337467|P2|NOT COMPLETED|Overall Study||0
548733|NCT00736476|1337468|P1|NOT COMPLETED|Overall Study||1
548734|NCT00736476|1337467|P2|COMPLETED|Overall Study||27
548735|NCT00736476|1337468|P1|COMPLETED|Overall Study||35
548736|NCT00736476|1337467|P2|STARTED|Overall Study||27
548737|NCT00736476|1337468|P1|STARTED|Overall Study||36
548738|NCT00736385|1337490|P2|NOT COMPLETED|Overall Study||3
548739|NCT00736385|1337491|P1|NOT COMPLETED|Overall Study||2
548740|NCT00736385|1337490|P2|COMPLETED|Overall Study||2
548741|NCT00736385|1337491|P1|COMPLETED|Overall Study||2
548742|NCT00736385|1337490|P2|STARTED|Overall Study||5
548743|NCT00736385|1337491|P1|STARTED|Overall Study||4
548744|NCT00736333|1337503|P1|NOT COMPLETED|Overall Study||111
548745|NCT00736333|1337503|P1|COMPLETED|Overall Study||56
548746|NCT00736333|1337503|P1|STARTED|Overall Study||167
548747|NCT00736255|1337514|P2|NOT COMPLETED|Overall Study||1
548748|NCT00736255|1337515|P1|NOT COMPLETED|Overall Study||3
548749|NCT00736255|1337514|P2|COMPLETED|Overall Study||14
548750|NCT00736255|1337515|P1|COMPLETED|Overall Study||14
548751|NCT00736255|1337514|P2|STARTED|Overall Study||15
548752|NCT00736255|1337515|P1|STARTED|Overall Study||17
548753|NCT00736242|1337525|P1|NOT COMPLETED|Overall Study||125
548754|NCT00736242|1337525|P1|COMPLETED|Overall Study||107
548755|NCT00736242|1337525|P1|Participants in Safety Analysis Set|Overall Study||229
548756|NCT00736242|1337525|P1|STARTED|Overall Study||232
548757|NCT00736229|1337539|P3|NOT COMPLETED|Overall Study||0
548758|NCT00736229|1337540|P2|NOT COMPLETED|Overall Study||0
548759|NCT00736229|1337541|P1|NOT COMPLETED|Overall Study||0
548760|NCT00736229|1337539|P3|COMPLETED|Overall Study||84
548761|NCT00736229|1337540|P2|COMPLETED|Overall Study||71
548762|NCT00736229|1337541|P1|COMPLETED|Overall Study|All patients received bolus and fixed infusion of study drug, thus completed the study|40
548763|NCT00736229|1337539|P3|STARTED|Overall Study|Historic Control|84
548764|NCT00736229|1337540|P2|STARTED|Overall Study|Historic control|71
548765|NCT00736229|1337541|P1|STARTED|Overall Study|Actively Enrolled|40
548766|NCT00736190|1337554|P1|NOT COMPLETED|Overall Study||3
548767|NCT00736190|1337554|P1|COMPLETED|Overall Study||87
548768|NCT00736190|1337554|P1|STARTED|Overall Study||90
548769|NCT00736125|1337569|P2|NOT COMPLETED|Overall Study||2
548770|NCT00736125|1337570|P1|NOT COMPLETED|Overall Study||1
548771|NCT00736125|1337569|P2|COMPLETED|Overall Study||8
548772|NCT00736125|1337570|P1|COMPLETED|Overall Study||9
548773|NCT00736125|1337569|P2|STARTED|Overall Study||10
548774|NCT00736125|1337570|P1|STARTED|Overall Study||10
548775|NCT00736099|1337580|P2|NOT COMPLETED|Overall Study||58
548776|NCT00736099|1337581|P1|NOT COMPLETED|Overall Study||183
548777|NCT00736099|1337580|P2|COMPLETED|Overall Study|Number who completed treatment.|531
548778|NCT00736099|1337581|P1|COMPLETED|Overall Study|Number who completed treatment.|1349
548779|NCT00736099|1337580|P2|STARTED|Overall Study|Number who started treatment.|589
548780|NCT00736099|1337581|P1|STARTED|Overall Study|Number who started treatment.|1532
548781|NCT00736073|1337679|P2|NOT COMPLETED|Overall Study||0
548782|NCT00736073|1337680|P1|NOT COMPLETED|Overall Study||0
548783|NCT00736073|1337679|P2|COMPLETED|Overall Study||39
548784|NCT00736073|1337680|P1|COMPLETED|Overall Study||34
548785|NCT00736073|1337679|P2|STARTED|Overall Study||39
548786|NCT00736073|1337680|P1|STARTED|Overall Study||34
548787|NCT00736034|1337690|P1|NOT COMPLETED|Overall Study||2
548788|NCT00736034|1337690|P1|COMPLETED|Overall Study||16
548789|NCT00736034|1337690|P1|STARTED|Overall Study||18
548790|NCT00735969|1337694|P1|NOT COMPLETED|Overall Study||0
548791|NCT00735969|1337694|P1|COMPLETED|Overall Study||21
548792|NCT00735969|1337694|P1|STARTED|Overall Study||21
548793|NCT00735943|1337698|P1|NOT COMPLETED|Overall Study||2
548794|NCT00735943|1337698|P1|COMPLETED|Overall Study||20
548795|NCT00735943|1337698|P1|STARTED|Overall Study||22
548796|NCT00735917|1337715|P1|NOT COMPLETED|Overall Study||0
548797|NCT00735917|1337715|P1|COMPLETED|Overall Study||19
548798|NCT00735917|1337715|P1|STARTED|Overall Study||19
548799|NCT00735904|1337723|P1|NOT COMPLETED|Overall Study||38
548800|NCT00735904|1337723|P1|COMPLETED|Overall Study||0
548801|NCT00735904|1337723|P1|STARTED|Overall Study||38
548802|NCT00735839|1337732|P2|NOT COMPLETED|Overall Study||0
548803|NCT00735839|1337733|P1|NOT COMPLETED|Overall Study||0
548804|NCT00735839|1337732|P2|COMPLETED|Overall Study||10
548805|NCT00735839|1337733|P1|COMPLETED|Overall Study||30
548806|NCT00735839|1337732|P2|STARTED|Overall Study||10
548807|NCT00735839|1337733|P1|STARTED|Overall Study||30
548808|NCT00735787|1337743|P2|NOT COMPLETED|Period 2||1
548809|NCT00735787|1337744|P1|NOT COMPLETED|Period 2||5
548810|NCT00735787|1337743|P2|COMPLETED|Period 2||40
548811|NCT00735787|1337744|P1|COMPLETED|Period 2||13
548812|NCT00735787|1337743|P2|STARTED|Period 2||41
548813|NCT00735787|1337744|P1|STARTED|Period 2||18
548814|NCT00735787|1337743|P2|NOT COMPLETED|Period 1||8
548815|NCT00735787|1337744|P1|NOT COMPLETED|Period 1||6
548816|NCT00735787|1337743|P2|COMPLETED|Period 1||41
548817|NCT00735787|1337744|P1|COMPLETED|Period 1|Per visit window, 18 completed; 17 completed per subject case report form.|17
548818|NCT00735787|1337743|P2|STARTED|Period 1||49
548819|NCT00735787|1337744|P1|STARTED|Period 1||23
548820|NCT00735709|1337792|P4|NOT COMPLETED|Overall Study||18
548821|NCT00735709|1337793|P3|NOT COMPLETED|Overall Study||11
548822|NCT00735709|1337794|P2|NOT COMPLETED|Overall Study||13
548823|NCT00735709|1337795|P1|NOT COMPLETED|Overall Study||13
548824|NCT00735709|1337792|P4|COMPLETED|Overall Study||122
548825|NCT00735709|1337793|P3|COMPLETED|Overall Study||129
548826|NCT00735709|1337794|P2|COMPLETED|Overall Study||127
548827|NCT00735709|1337795|P1|COMPLETED|Overall Study||127
548828|NCT00735709|1337792|P4|Treated|Overall Study||139
548829|NCT00735709|1337793|P3|Treated|Overall Study||140
548830|NCT00735709|1337794|P2|Treated|Overall Study||140
548831|NCT00735709|1337795|P1|Treated|Overall Study||140
548832|NCT00735709|1337792|P4|STARTED|Overall Study||140
548833|NCT00735709|1337793|P3|STARTED|Overall Study||140
548834|NCT00735709|1337794|P2|STARTED|Overall Study||140
548835|NCT00735709|1337795|P1|STARTED|Overall Study||140
548836|NCT00735696|1337905|P1|NOT COMPLETED|Overall Study||2
548837|NCT00735696|1337905|P1|COMPLETED|Overall Study||39
548838|NCT00735696|1337905|P1|Received Any Quantity of Study Drug|Overall Study||40
548839|NCT00735696|1337905|P1|STARTED|Overall Study||41
548840|NCT00735670|1337919|P2|NOT COMPLETED|Overall Study||5
548841|NCT00735670|1337920|P1|NOT COMPLETED|Overall Study||4
548842|NCT00735670|1337919|P2|COMPLETED|Overall Study||6
548843|NCT00735670|1337920|P1|COMPLETED|Overall Study||6
548844|NCT00735670|1337919|P2|STARTED|Overall Study||11
548845|NCT00735670|1337920|P1|STARTED|Overall Study||10
548846|NCT00735644|1337933|P5|NOT COMPLETED|Overall Study||0
548847|NCT00735644|1337934|P4|NOT COMPLETED|Overall Study||1
548848|NCT00735644|1337935|P3|NOT COMPLETED|Overall Study||1
548849|NCT00735644|1337936|P2|NOT COMPLETED|Overall Study||2
548850|NCT00735644|1337937|P1|NOT COMPLETED|Overall Study||0
548851|NCT00735644|1337933|P5|COMPLETED|Overall Study||102
548852|NCT00735644|1337934|P4|COMPLETED|Overall Study||198
548853|NCT00735644|1337935|P3|COMPLETED|Overall Study||295
548854|NCT00735644|1337936|P2|COMPLETED|Overall Study||298
548855|NCT00735644|1337937|P1|COMPLETED|Overall Study||303
548856|NCT00735644|1337933|P5|STARTED|Overall Study||102
548857|NCT00735644|1337934|P4|STARTED|Overall Study||199
548858|NCT00735644|1337935|P3|STARTED|Overall Study||296
548859|NCT00735644|1337936|P2|STARTED|Overall Study||300
548860|NCT00735644|1337937|P1|STARTED|Overall Study||303
548861|NCT00735618|1337974|P1|NOT COMPLETED|Overall Study||0
548862|NCT00735618|1337974|P1|COMPLETED|Overall Study||19
548863|NCT00735618|1337974|P1|STARTED|Overall Study||19
548864|NCT00735553|1337981|P1|NOT COMPLETED|Overall Study||77
548865|NCT00735553|1337981|P1|COMPLETED|Overall Study||0
548866|NCT00735553|1337981|P1|STARTED|Overall Study||77
548867|NCT00735475|1337991|P2|NOT COMPLETED|Overall Study||11
548868|NCT00735475|1337992|P1|NOT COMPLETED|Overall Study||8
548869|NCT00735475|1337991|P2|COMPLETED|Overall Study||626
548870|NCT00735475|1337992|P1|COMPLETED|Overall Study||623
548871|NCT00735475|1337991|P2|STARTED|Overall Study||637
548872|NCT00735475|1337992|P1|STARTED|Overall Study||631
548873|NCT00735462|1338013|P3|NOT COMPLETED|Overall Study||28
548874|NCT00735462|1338014|P2|NOT COMPLETED|Overall Study||55
548875|NCT00735462|1338015|P1|NOT COMPLETED|Overall Study||63
548876|NCT00735462|1338013|P3|COMPLETED|Overall Study||77
548877|NCT00735462|1338014|P2|COMPLETED|Overall Study||149
548878|NCT00735462|1338015|P1|COMPLETED|Overall Study||139
548879|NCT00735462|1338013|P3|STARTED|Overall Study||105
548880|NCT00735462|1338014|P2|STARTED|Overall Study||204
548881|NCT00735462|1338015|P1|STARTED|Overall Study||202
548882|NCT00735449|1338028|P2|NOT COMPLETED|Overall Study||6
548883|NCT00735449|1338029|P1|NOT COMPLETED|Overall Study||7
548884|NCT00735449|1338028|P2|COMPLETED|Overall Study||96
548885|NCT00735449|1338029|P1|COMPLETED|Overall Study||95
548886|NCT00735449|1338028|P2|STARTED|Overall Study||102
548887|NCT00735449|1338029|P1|STARTED|Overall Study||102
548888|NCT00735436|1338043|P1|NOT COMPLETED|Overall Study||0
548889|NCT00735436|1338043|P1|COMPLETED|Overall Study||18
548890|NCT00735436|1338043|P1|STARTED|Overall Study||18
548891|NCT00735397|1338052|P1|NOT COMPLETED|Overall Study||1183
548892|NCT00735397|1338052|P1|COMPLETED|Overall Study||35
548893|NCT00735397|1338052|P1|STARTED|Overall Study||1218
548894|NCT00735371|1338066|P4|NOT COMPLETED|Overall Study||10
548895|NCT00735371|1338067|P3|NOT COMPLETED|Overall Study||11
548896|NCT00735371|1338068|P2|NOT COMPLETED|Overall Study||13
548897|NCT00735371|1338069|P1|NOT COMPLETED|Overall Study||15
548898|NCT00735371|1338066|P4|COMPLETED|Overall Study||69
548899|NCT00735371|1338067|P3|COMPLETED|Overall Study||67
548900|NCT00735371|1338068|P2|COMPLETED|Overall Study||66
548901|NCT00735371|1338069|P1|COMPLETED|Overall Study||63
548902|NCT00735371|1338066|P4|STARTED|Overall Study||79
548903|NCT00735371|1338067|P3|STARTED|Overall Study||78
548904|NCT00735371|1338068|P2|STARTED|Overall Study||79
548905|NCT00735371|1338069|P1|STARTED|Overall Study||78
548906|NCT00735306|1338087|P1|NOT COMPLETED|Overall Study||0
548907|NCT00735306|1338087|P1|COMPLETED|Overall Study||12
548908|NCT00735306|1338087|P1|STARTED|Overall Study||12
548909|NCT00735254|1338097|P4|NOT COMPLETED|Overall Study||0
548910|NCT00735254|1338098|P3|NOT COMPLETED|Overall Study||1
548911|NCT00735254|1338099|P2|NOT COMPLETED|Overall Study||1
548912|NCT00735254|1338100|P1|NOT COMPLETED|Overall Study||1
548913|NCT00735254|1338097|P4|COMPLETED|Overall Study||0
548914|NCT00735254|1338098|P3|COMPLETED|Overall Study||0
548915|NCT00735254|1338099|P2|COMPLETED|Overall Study||0
548916|NCT00735254|1338100|P1|COMPLETED|Overall Study||0
548917|NCT00735254|1338097|P4|STARTED|Overall Study||0
548918|NCT00735254|1338098|P3|STARTED|Overall Study||1
548919|NCT00735254|1338099|P2|STARTED|Overall Study||1
548920|NCT00735254|1338100|P1|STARTED|Overall Study||1
548921|NCT00735072|1338112|P2|NOT COMPLETED|Overall Study||1
548922|NCT00735072|1338113|P1|NOT COMPLETED|Overall Study||1
548923|NCT00735072|1338112|P2|COMPLETED|Overall Study||21
548924|NCT00735072|1338113|P1|COMPLETED|Overall Study||22
548925|NCT00735072|1338112|P2|STARTED|Overall Study||22
548926|NCT00735072|1338113|P1|STARTED|Overall Study||23
548927|NCT00735007|1338119|P1|NOT COMPLETED|Overall Study||5
548928|NCT00735007|1338119|P1|COMPLETED|Overall Study||101
548929|NCT00735007|1338119|P1|STARTED|Overall Study||106
548930|NCT00734994|1338144|P1|NOT COMPLETED|Overall Study||1
548931|NCT00734994|1338144|P1|COMPLETED|Overall Study||14
548932|NCT00734994|1338144|P1|STARTED|Overall Study||15
548933|NCT00734968|1338151|P2|NOT COMPLETED|Overall Study||1
548934|NCT00734968|1338152|P1|NOT COMPLETED|Overall Study||1
548935|NCT00734968|1338151|P2|COMPLETED|Overall Study||75
548936|NCT00734968|1338152|P1|COMPLETED|Overall Study||76
548937|NCT00734968|1338151|P2|STARTED|Overall Study||76
548938|NCT00734968|1338152|P1|STARTED|Overall Study||77
548939|NCT00734929|1338164|P2|NOT COMPLETED|Overall Study||5
548940|NCT00734929|1338165|P1|NOT COMPLETED|Overall Study||6
548941|NCT00734929|1338164|P2|COMPLETED|Overall Study||53
548942|NCT00734929|1338165|P1|COMPLETED|Overall Study||51
548943|NCT00734929|1338164|P2|STARTED|Overall Study||58
548944|NCT00734929|1338165|P1|STARTED|Overall Study||57
548945|NCT00734851|1338193|P1|NOT COMPLETED|Overall Study||21
548946|NCT00734851|1338193|P1|COMPLETED|Overall Study||13
548947|NCT00734851|1338193|P1|STARTED|Overall Study||34
548948|NCT00734799|1338205|P2|NOT COMPLETED|Overall Study||4
548949|NCT00734799|1338206|P1|NOT COMPLETED|Overall Study||0
548950|NCT00734799|1338205|P2|COMPLETED|Overall Study||9
548951|NCT00734799|1338206|P1|COMPLETED|Overall Study||9
548952|NCT00734799|1338205|P2|STARTED|Overall Study||13
548953|NCT00734799|1338206|P1|STARTED|Overall Study||9
548954|NCT00734747|1338214|P1|NOT COMPLETED|6 Month Follow-up||3
548955|NCT00734747|1338214|P1|COMPLETED|6 Month Follow-up||66
548956|NCT00734747|1338214|P1|STARTED|6 Month Follow-up||69
548957|NCT00734747|1338214|P1|NOT COMPLETED|SRS Procedure||3
548958|NCT00734747|1338214|P1|COMPLETED|SRS Procedure||69
548959|NCT00734747|1338214|P1|STARTED|SRS Procedure||72
548960|NCT00734734|1338221|P1|NOT COMPLETED|Overall Study||0
548961|NCT00734734|1338221|P1|COMPLETED|Overall Study||64
548962|NCT00734734|1338221|P1|STARTED|Overall Study||64
548963|NCT00734656|1338228|P4|NOT COMPLETED|Lab Session 4||1
548964|NCT00734656|1338229|P3|NOT COMPLETED|Lab Session 4||0
548965|NCT00734656|1338230|P2|NOT COMPLETED|Lab Session 4||0
548966|NCT00734656|1338231|P1|NOT COMPLETED|Lab Session 4||0
548967|NCT00734656|1338228|P4|COMPLETED|Lab Session 4||19
548968|NCT00734656|1338229|P3|COMPLETED|Lab Session 4||16
548969|NCT00734656|1338230|P2|COMPLETED|Lab Session 4||18
548970|NCT00734656|1338231|P1|COMPLETED|Lab Session 4||20
548971|NCT00734656|1338228|P4|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|20
548972|NCT00734656|1338229|P3|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|16
548973|NCT00734656|1338230|P2|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|18
548974|NCT00734656|1338231|P1|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|20
548975|NCT00734656|1338228|P4|NOT COMPLETED|Washout 3||1
548976|NCT00734656|1338229|P3|NOT COMPLETED|Washout 3||0
548977|NCT00734656|1338230|P2|NOT COMPLETED|Washout 3||0
548978|NCT00734656|1338231|P1|NOT COMPLETED|Washout 3||1
548979|NCT00734656|1338228|P4|COMPLETED|Washout 3||18
548980|NCT00734656|1338229|P3|COMPLETED|Washout 3||20
548981|NCT00734656|1338230|P2|COMPLETED|Washout 3||19
548982|NCT00734656|1338231|P1|COMPLETED|Washout 3||17
548983|NCT00734656|1338228|P4|STARTED|Washout 3||19
548984|NCT00734656|1338229|P3|STARTED|Washout 3||20
548985|NCT00734656|1338230|P2|STARTED|Washout 3||19
548986|NCT00734656|1338231|P1|STARTED|Washout 3||18
548987|NCT00734656|1338228|P4|NOT COMPLETED|Lab Session 3||0
548988|NCT00734656|1338229|P3|NOT COMPLETED|Lab Session 3||0
548989|NCT00734656|1338230|P2|NOT COMPLETED|Lab Session 3||0
548990|NCT00734656|1338231|P1|NOT COMPLETED|Lab Session 3||0
548991|NCT00734656|1338228|P4|COMPLETED|Lab Session 3||19
548992|NCT00734656|1338229|P3|COMPLETED|Lab Session 3||20
548993|NCT00734656|1338230|P2|COMPLETED|Lab Session 3||19
548994|NCT00734656|1338231|P1|COMPLETED|Lab Session 3||18
548995|NCT00734656|1338228|P4|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|19
548996|NCT00734656|1338229|P3|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|20
548997|NCT00734656|1338230|P2|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|19
548998|NCT00734656|1338231|P1|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|18
548999|NCT00734656|1338228|P4|NOT COMPLETED|Washout 2||0
549000|NCT00734656|1338229|P3|NOT COMPLETED|Washout 2||1
549001|NCT00734656|1338230|P2|NOT COMPLETED|Washout 2||1
549002|NCT00734656|1338231|P1|NOT COMPLETED|Washout 2||1
549003|NCT00734656|1338228|P4|COMPLETED|Washout 2||19
549004|NCT00734656|1338229|P3|COMPLETED|Washout 2||20
549005|NCT00734656|1338230|P2|COMPLETED|Washout 2||20
549006|NCT00734656|1338231|P1|COMPLETED|Washout 2||17
549007|NCT00734656|1338228|P4|STARTED|Washout 2||19
549008|NCT00734656|1338229|P3|STARTED|Washout 2||21
549009|NCT00734656|1338230|P2|STARTED|Washout 2||21
549010|NCT00734656|1338231|P1|STARTED|Washout 2||18
549011|NCT00734656|1338228|P4|NOT COMPLETED|Lab Session 2||1
549012|NCT00734656|1338229|P3|NOT COMPLETED|Lab Session 2||0
549013|NCT00734656|1338230|P2|NOT COMPLETED|Lab Session 2||0
549014|NCT00734656|1338231|P1|NOT COMPLETED|Lab Session 2||1
549015|NCT00734656|1338228|P4|COMPLETED|Lab Session 2||19
549016|NCT00734656|1338229|P3|COMPLETED|Lab Session 2||21
549017|NCT00734656|1338230|P2|COMPLETED|Lab Session 2||21
549018|NCT00734656|1338231|P1|COMPLETED|Lab Session 2||18
549019|NCT00734656|1338228|P4|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|20
549020|NCT00734656|1338229|P3|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|21
549021|NCT00734656|1338230|P2|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|21
549022|NCT00734656|1338231|P1|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|19
549023|NCT00734656|1338228|P4|NOT COMPLETED|Washout 1||3
549024|NCT00734656|1338229|P3|NOT COMPLETED|Washout 1||2
549025|NCT00734656|1338230|P2|NOT COMPLETED|Washout 1||5
549026|NCT00734656|1338231|P1|NOT COMPLETED|Washout 1||1
549027|NCT00734656|1338228|P4|COMPLETED|Washout 1||18
549028|NCT00734656|1338229|P3|COMPLETED|Washout 1||24
549029|NCT00734656|1338230|P2|COMPLETED|Washout 1||18
549030|NCT00734656|1338231|P1|COMPLETED|Washout 1||21
549031|NCT00734656|1338228|P4|STARTED|Washout 1||21
549032|NCT00734656|1338229|P3|STARTED|Washout 1||26
549033|NCT00734656|1338230|P2|STARTED|Washout 1||23
549034|NCT00734656|1338231|P1|STARTED|Washout 1||22
549035|NCT00734656|1338228|P4|NOT COMPLETED|Lab Session 1||0
549036|NCT00734656|1338229|P3|NOT COMPLETED|Lab Session 1||0
549037|NCT00734656|1338230|P2|NOT COMPLETED|Lab Session 1||0
549038|NCT00734656|1338231|P1|NOT COMPLETED|Lab Session 1||2
549039|NCT00734656|1338228|P4|COMPLETED|Lab Session 1||21
549040|NCT00734656|1338229|P3|COMPLETED|Lab Session 1||26
549041|NCT00734656|1338230|P2|COMPLETED|Lab Session 1||23
549042|NCT00734656|1338231|P1|COMPLETED|Lab Session 1||22
549043|NCT00734656|1338228|P4|STARTED|Lab Session 1||21
549044|NCT00734656|1338229|P3|STARTED|Lab Session 1||26
549045|NCT00734656|1338230|P2|STARTED|Lab Session 1||23
549046|NCT00734656|1338231|P1|STARTED|Lab Session 1||24
549047|NCT00734630|1338255|P2|NOT COMPLETED|Overall Study||33
549048|NCT00734630|1338256|P1|NOT COMPLETED|Overall Study||29
549049|NCT00734630|1338255|P2|COMPLETED|Overall Study||200
549050|NCT00734630|1338256|P1|COMPLETED|Overall Study||229
549051|NCT00734630|1338255|P2|STARTED|Overall Study||233
549052|NCT00734630|1338256|P1|STARTED|Overall Study||258
549053|NCT00734617|1338266|P2|NOT COMPLETED|Overall Study||102
549054|NCT00734617|1338267|P1|NOT COMPLETED|Overall Study||107
549055|NCT00734617|1338266|P2|COMPLETED|Overall Study||128
549056|NCT00734617|1338267|P1|COMPLETED|Overall Study||142
549057|NCT00734617|1338266|P2|STARTED|Overall Study||230
549058|NCT00734617|1338267|P1|STARTED|Overall Study||249
549059|NCT00734604|1338279|P6|NOT COMPLETED|Overall Study||6
549060|NCT00734604|1338280|P5|NOT COMPLETED|Overall Study||8
549061|NCT00734604|1338281|P4|NOT COMPLETED|Overall Study||9
549062|NCT00734604|1338282|P3|NOT COMPLETED|Overall Study||6
549063|NCT00734604|1338283|P2|NOT COMPLETED|Overall Study||12
549064|NCT00734604|1338284|P1|NOT COMPLETED|Overall Study||3
549065|NCT00734604|1338279|P6|COMPLETED|Overall Study||58
549066|NCT00734604|1338280|P5|COMPLETED|Overall Study||55
549067|NCT00734604|1338281|P4|COMPLETED|Overall Study||54
549068|NCT00734604|1338282|P3|COMPLETED|Overall Study||57
549069|NCT00734604|1338283|P2|COMPLETED|Overall Study||51
549070|NCT00734604|1338284|P1|COMPLETED|Overall Study||59
549071|NCT00734604|1338279|P6|STARTED|Overall Study||64
549072|NCT00734604|1338280|P5|STARTED|Overall Study||63
549073|NCT00734604|1338281|P4|STARTED|Overall Study||63
549074|NCT00734604|1338282|P3|STARTED|Overall Study||63
549075|NCT00734604|1338283|P2|STARTED|Overall Study||63
549076|NCT00734604|1338284|P1|STARTED|Overall Study||62
549077|NCT00734591|1338334|P2|NOT COMPLETED|Prospective Period||44
549078|NCT00734591|1338335|P1|NOT COMPLETED|Prospective Period||51
549079|NCT00734591|1338334|P2|COMPLETED|Prospective Period||1229
549080|NCT00734591|1338335|P1|COMPLETED|Prospective Period||1307
549081|NCT00734591|1338334|P2|STARTED|Prospective Period||1273
549082|NCT00734591|1338335|P1|STARTED|Prospective Period||1358
549083|NCT00734591|1338334|P2|NOT COMPLETED|Screening for Prospective Period||2291
549084|NCT00734591|1338335|P1|NOT COMPLETED|Screening for Prospective Period||2517
549085|NCT00734591|1338334|P2|COMPLETED|Screening for Prospective Period||1273
549086|NCT00734591|1338335|P1|COMPLETED|Screening for Prospective Period||1358
549087|NCT00734591|1338334|P2|STARTED|Screening for Prospective Period||3564
549088|NCT00734591|1338335|P1|STARTED|Screening for Prospective Period||3875
549089|NCT00734591|1338334|P2|NOT COMPLETED|Retrospective Period||0
549090|NCT00734591|1338335|P1|NOT COMPLETED|Retrospective Period||0
549091|NCT00734591|1338334|P2|COMPLETED|Retrospective Period||3564
549092|NCT00734591|1338335|P1|COMPLETED|Retrospective Period||3875
549093|NCT00734591|1338334|P2|STARTED|Retrospective Period||3564
549094|NCT00734591|1338335|P1|STARTED|Retrospective Period||3875
549095|NCT00734578|1338350|P3|NOT COMPLETED|Overall Study||25
549096|NCT00734578|1338351|P2|NOT COMPLETED|Overall Study||25
549097|NCT00734578|1338352|P1|NOT COMPLETED|Overall Study||33
549098|NCT00734578|1338350|P3|COMPLETED|Overall Study||129
549099|NCT00734578|1338351|P2|COMPLETED|Overall Study||128
549100|NCT00734578|1338352|P1|COMPLETED|Overall Study||121
549101|NCT00734578|1338350|P3|STARTED|Overall Study||154
549102|NCT00734578|1338351|P2|STARTED|Overall Study||153
549103|NCT00734578|1338352|P1|STARTED|Overall Study||154
549104|NCT00734539|1338386|P2|NOT COMPLETED|Long Term Follow up||31
549105|NCT00734539|1338387|P1|NOT COMPLETED|Long Term Follow up||34
549106|NCT00734539|1338386|P2|COMPLETED|Long Term Follow up|Number of participants who completed the 18-22 months follow-up|107
549107|NCT00734539|1338387|P1|COMPLETED|Long Term Follow up|Number of participants who completed the 18-22 months follow-up|118
549108|NCT00734539|1338386|P2|STARTED|Long Term Follow up||138
549109|NCT00734539|1338387|P1|STARTED|Long Term Follow up||152
549110|NCT00734539|1338386|P2|NOT COMPLETED|Main Study||35
549111|NCT00734539|1338387|P1|NOT COMPLETED|Main Study||37
549112|NCT00734539|1338386|P2|COMPLETED|Main Study|Number of subjects who participated through hospital discharge or study end|138
549113|NCT00734539|1338387|P1|COMPLETED|Main Study|Number of subjects who participated through hospital discharge or study end|152
549114|NCT00734539|1338386|P2|STARTED|Main Study||173
549115|NCT00734539|1338387|P1|STARTED|Main Study||189
549116|NCT00734500|1338415|P1|NOT COMPLETED|Overall Study||1
549117|NCT00734500|1338415|P1|COMPLETED|Overall Study||14
549118|NCT00734500|1338415|P1|STARTED|Overall Study||15
549119|NCT00734474|1338429|P9|NOT COMPLETED|Overall Study||82
549120|NCT00734474|1338430|P8|NOT COMPLETED|Overall Study||129
549121|NCT00734474|1338431|P7|NOT COMPLETED|Overall Study||24
549122|NCT00734474|1338432|P6|NOT COMPLETED|Overall Study||25
549123|NCT00734474|1338433|P5|NOT COMPLETED|Overall Study||118
549124|NCT00734474|1338434|P4|NOT COMPLETED|Overall Study||10
549125|NCT00734474|1338435|P3|NOT COMPLETED|Overall Study||112
549126|NCT00734474|1338436|P2|NOT COMPLETED|Overall Study||30
549127|NCT00734474|1338437|P1|NOT COMPLETED|Overall Study||15
549128|NCT00734474|1338429|P9|COMPLETED|Overall Study||95
549129|NCT00734474|1338430|P8|COMPLETED|Overall Study||186
549130|NCT00734474|1338431|P7|COMPLETED|Overall Study||0
549131|NCT00734474|1338432|P6|COMPLETED|Overall Study||0
549132|NCT00734474|1338433|P5|COMPLETED|Overall Study||184
549133|NCT00734474|1338434|P4|COMPLETED|Overall Study||0
549134|NCT00734474|1338435|P3|COMPLETED|Overall Study||192
549135|NCT00734474|1338436|P2|COMPLETED|Overall Study||0
549136|NCT00734474|1338437|P1|COMPLETED|Overall Study||0
549137|NCT00734474|1338429|P9|Completed 52-Week Visit|Overall Study||112
549138|NCT00734474|1338430|P8|Completed 52-Week Visit|Overall Study||238
549139|NCT00734474|1338431|P7|Completed 52-Week Visit|Overall Study||0
549140|NCT00734474|1338432|P6|Completed 52-Week Visit|Overall Study||0
549141|NCT00734474|1338433|P5|Completed 52-Week Visit|Overall Study||243
549142|NCT00734474|1338434|P4|Completed 52-Week Visit|Overall Study||0
549143|NCT00734474|1338435|P3|Completed 52-Week Visit|Overall Study||238
549144|NCT00734474|1338436|P2|Completed 52-Week Visit|Overall Study||0
549145|NCT00734474|1338437|P1|Completed 52-Week Visit|Overall Study||0
549146|NCT00734474|1338429|P9|Completed 26-Week Visit|Overall Study||124
549147|NCT00734474|1338430|P8|Completed 26-Week Visit|Overall Study||270
549148|NCT00734474|1338431|P7|Completed 26-Week Visit|Overall Study||2
549149|NCT00734474|1338432|P6|Completed 26-Week Visit|Overall Study||2
549150|NCT00734474|1338433|P5|Completed 26-Week Visit|Overall Study||268
549151|NCT00734474|1338434|P4|Completed 26-Week Visit|Overall Study||2
549152|NCT00734474|1338435|P3|Completed 26-Week Visit|Overall Study||258
549153|NCT00734474|1338436|P2|Completed 26-Week Visit|Overall Study||0
549154|NCT00734474|1338437|P1|Completed 26-Week Visit|Overall Study||0
549155|NCT00734474|1338429|P9|Entered Study After Dose Decision Point|Overall Study||139
549156|NCT00734474|1338430|P8|Entered Study After Dose Decision Point|Overall Study||273
549157|NCT00734474|1338431|P7|Entered Study After Dose Decision Point|Overall Study||0
549158|NCT00734474|1338432|P6|Entered Study After Dose Decision Point|Overall Study||0
549159|NCT00734474|1338433|P5|Entered Study After Dose Decision Point|Overall Study||281
549160|NCT00734474|1338434|P4|Entered Study After Dose Decision Point|Overall Study||0
549161|NCT00734474|1338435|P3|Entered Study After Dose Decision Point|Overall Study||279
549162|NCT00734474|1338436|P2|Entered Study After Dose Decision Point|Overall Study||0
549163|NCT00734474|1338437|P1|Entered Study After Dose Decision Point|Overall Study||0
549164|NCT00734474|1338429|P9|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (comparator arm).|34
549165|NCT00734474|1338430|P8|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (comparator arm).|42
549166|NCT00734474|1338431|P7|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|23
549167|NCT00734474|1338432|P6|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|21
549168|NCT00734474|1338433|P5|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (selected arm).|21
549169|NCT00734474|1338434|P4|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|8
549170|NCT00734474|1338435|P3|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (selected arm).|24
549171|NCT00734474|1338436|P2|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|25
549172|NCT00734474|1338437|P1|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|8
549173|NCT00734474|1338429|P9|Entered Study Before Dose Decision Point|Overall Study||38
549174|NCT00734474|1338430|P8|Entered Study Before Dose Decision Point|Overall Study||42
549175|NCT00734474|1338431|P7|Entered Study Before Dose Decision Point|Overall Study||24
549176|NCT00734474|1338432|P6|Entered Study Before Dose Decision Point|Overall Study||25
549177|NCT00734474|1338433|P5|Entered Study Before Dose Decision Point|Overall Study||21
549178|NCT00734474|1338434|P4|Entered Study Before Dose Decision Point|Overall Study||10
549179|NCT00734474|1338435|P3|Entered Study Before Dose Decision Point|Overall Study||25
549180|NCT00734474|1338436|P2|Entered Study Before Dose Decision Point|Overall Study||30
549181|NCT00734474|1338437|P1|Entered Study Before Dose Decision Point|Overall Study||15
549182|NCT00734474|1338429|P9|Received at Least 1 Dose of Study Drug|Overall Study||177
549183|NCT00734474|1338430|P8|Received at Least 1 Dose of Study Drug|Overall Study||315
549184|NCT00734474|1338431|P7|Received at Least 1 Dose of Study Drug|Overall Study||24
549185|NCT00734474|1338432|P6|Received at Least 1 Dose of Study Drug|Overall Study||25
549186|NCT00734474|1338433|P5|Received at Least 1 Dose of Study Drug|Overall Study||302
549187|NCT00734474|1338434|P4|Received at Least 1 Dose of Study Drug|Overall Study||10
549188|NCT00734474|1338435|P3|Received at Least 1 Dose of Study Drug|Overall Study||304
549189|NCT00734474|1338436|P2|Received at Least 1 Dose of Study Drug|Overall Study||30
549190|NCT00734474|1338437|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
549191|NCT00734474|1338429|P9|STARTED|Overall Study||177
549192|NCT00734474|1338430|P8|STARTED|Overall Study||315
549193|NCT00734474|1338431|P7|STARTED|Overall Study||24
549194|NCT00734474|1338432|P6|STARTED|Overall Study||25
549195|NCT00734474|1338433|P5|STARTED|Overall Study||302
549196|NCT00734474|1338434|P4|STARTED|Overall Study||10
549197|NCT00734474|1338435|P3|STARTED|Overall Study||304
549198|NCT00734474|1338436|P2|STARTED|Overall Study||30
549199|NCT00734474|1338437|P1|STARTED|Overall Study||15
549200|NCT00734409|1338606|P2|NOT COMPLETED|Overall Study||0
549201|NCT00734409|1338607|P1|NOT COMPLETED|Overall Study||0
549202|NCT00734409|1338606|P2|COMPLETED|Overall Study||145
549203|NCT00734409|1338607|P1|COMPLETED|Overall Study||155
549204|NCT00734409|1338606|P2|STARTED|Overall Study||145
549205|NCT00734409|1338607|P1|STARTED|Overall Study||155
549206|NCT00734344|1338619|P2|NOT COMPLETED|Overall Study||0
549207|NCT00734344|1338620|P1|NOT COMPLETED|Overall Study||0
549208|NCT00734344|1338619|P2|COMPLETED|Overall Study||9
549209|NCT00734344|1338620|P1|COMPLETED|Overall Study||9
549210|NCT00734344|1338619|P2|STARTED|Overall Study||9
549211|NCT00734344|1338620|P1|STARTED|Overall Study||9
549212|NCT00734305|1338690|P7|NOT COMPLETED|Overall Study||0
549213|NCT00734305|1338691|P6|NOT COMPLETED|Overall Study||0
549214|NCT00734305|1338692|P5|NOT COMPLETED|Overall Study||0
549215|NCT00734305|1338693|P4|NOT COMPLETED|Overall Study||0
549216|NCT00734305|1338694|P3|NOT COMPLETED|Overall Study||0
549217|NCT00734305|1338695|P2|NOT COMPLETED|Overall Study||0
549218|NCT00734305|1338696|P1|NOT COMPLETED|Overall Study||1
549219|NCT00734305|1338690|P7|COMPLETED|Overall Study||18
549220|NCT00734305|1338691|P6|COMPLETED|Overall Study||4
549221|NCT00734305|1338692|P5|COMPLETED|Overall Study||5
549222|NCT00734305|1338693|P4|COMPLETED|Overall Study||3
549223|NCT00734305|1338694|P3|COMPLETED|Overall Study||4
549224|NCT00734305|1338695|P2|COMPLETED|Overall Study||3
549225|NCT00734305|1338696|P1|COMPLETED|Overall Study|1 patient was enrolled but did not meet eligibility criteria at C1W1, and thus was never dosed|6
549226|NCT00734305|1338690|P7|STARTED|Overall Study||18
549227|NCT00734305|1338691|P6|STARTED|Overall Study||4
549228|NCT00734305|1338692|P5|STARTED|Overall Study||5
549229|NCT00734305|1338693|P4|STARTED|Overall Study||3
549230|NCT00734305|1338694|P3|STARTED|Overall Study||4
549231|NCT00734305|1338695|P2|STARTED|Overall Study||3
549232|NCT00734305|1338696|P1|STARTED|Overall Study||7
549233|NCT00734214|1338727|P2|NOT COMPLETED|Overall Study||4
549234|NCT00734214|1338728|P1|NOT COMPLETED|Overall Study||4
549235|NCT00734214|1338727|P2|COMPLETED|Overall Study||126
549236|NCT00734214|1338728|P1|COMPLETED|Overall Study||124
549237|NCT00734214|1338727|P2|STARTED|Overall Study||130
549238|NCT00734214|1338728|P1|STARTED|Overall Study||128
549239|NCT00734162|1338738|P4|NOT COMPLETED|Open-Label Phase||3
549240|NCT00734162|1338739|P3|NOT COMPLETED|Open-Label Phase||1
549241|NCT00734162|1338740|P2|NOT COMPLETED|Open-Label Phase||2
549242|NCT00734162|1338741|P1|NOT COMPLETED|Open-Label Phase||3
549243|NCT00734162|1338738|P4|COMPLETED|Open-Label Phase||36
549244|NCT00734162|1338739|P3|COMPLETED|Open-Label Phase||12
549245|NCT00734162|1338740|P2|COMPLETED|Open-Label Phase||39
549246|NCT00734162|1338741|P1|COMPLETED|Open-Label Phase||7
549247|NCT00734162|1338738|P4|STARTED|Open-Label Phase|2 participants switched to open-label treatment before completing double-blind period (elevated ALT)|39
549248|NCT00734162|1338739|P3|STARTED|Open-Label Phase||13
549249|NCT00734162|1338740|P2|STARTED|Open-Label Phase||41
549250|NCT00734162|1338741|P1|STARTED|Open-Label Phase||10
549251|NCT00734162|1338738|P4|NOT COMPLETED|Randomized Phase (Through Week 72)||4
549252|NCT00734162|1338739|P3|NOT COMPLETED|Randomized Phase (Through Week 72)||0
549253|NCT00734162|1338740|P2|NOT COMPLETED|Randomized Phase (Through Week 72)||1
549254|NCT00734162|1338741|P1|NOT COMPLETED|Randomized Phase (Through Week 72)||0
549255|NCT00734162|1338738|P4|COMPLETED|Randomized Phase (Through Week 72)||37
549256|NCT00734162|1338739|P3|COMPLETED|Randomized Phase (Through Week 72)||13
549257|NCT00734162|1338740|P2|COMPLETED|Randomized Phase (Through Week 72)||41
549258|NCT00734162|1338741|P1|COMPLETED|Randomized Phase (Through Week 72)||10
549259|NCT00734162|1338738|P4|STARTED|Randomized Phase (Through Week 72)||41
549260|NCT00734162|1338739|P3|STARTED|Randomized Phase (Through Week 72)||13
549261|NCT00734162|1338740|P2|STARTED|Randomized Phase (Through Week 72)||42
549262|NCT00734162|1338741|P1|STARTED|Randomized Phase (Through Week 72)||10
549263|NCT00734149|1338965|P1|NOT COMPLETED|Overall Study||1
549264|NCT00734149|1338965|P1|COMPLETED|Overall Study||44
549265|NCT00734149|1338965|P1|STARTED|Overall Study||45
549266|NCT00734097|1338972|P1|NOT COMPLETED|Open Label||16
549267|NCT00734097|1338972|P1|COMPLETED|Open Label|16 patients discontinued after randomization|301
549268|NCT00734097|1338972|P1|Per Protocol|Open Label||301
549269|NCT00734097|1338972|P1|Full Analysis|Open Label||311
549270|NCT00734097|1338972|P1|Safety Analysis|Open Label||317
549271|NCT00734097|1338972|P1|STARTED|Open Label|Full analysis performed in 311|317
549272|NCT00734097|1338972|P1|NOT COMPLETED|Screening||20
549273|NCT00734097|1338972|P1|COMPLETED|Screening|20 participants were screening failure.|317
549274|NCT00734097|1338972|P1|STARTED|Screening||337
549275|NCT00734071|1338989|P2|NOT COMPLETED|Overall Study||27
549276|NCT00734071|1338990|P1|NOT COMPLETED|Overall Study||38
549277|NCT00734071|1338989|P2|COMPLETED|Overall Study||125
549278|NCT00734071|1338990|P1|COMPLETED|Overall Study||114
549279|NCT00734071|1338989|P2|Treated|Overall Study||148
549280|NCT00734071|1338990|P1|Treated|Overall Study||151
549281|NCT00734071|1338989|P2|STARTED|Overall Study||152
549282|NCT00734071|1338990|P1|STARTED|Overall Study||152
549283|NCT00734032|1339048|P4|NOT COMPLETED|Overall Study||0
549284|NCT00734032|1339049|P3|NOT COMPLETED|Overall Study||0
549285|NCT00734032|1339050|P2|NOT COMPLETED|Overall Study||1
549286|NCT00734032|1339051|P1|NOT COMPLETED|Overall Study||0
549287|NCT00734032|1339048|P4|COMPLETED|Overall Study||26
549288|NCT00734032|1339049|P3|COMPLETED|Overall Study||28
549289|NCT00734032|1339050|P2|COMPLETED|Overall Study||27
549290|NCT00734032|1339051|P1|COMPLETED|Overall Study||25
549291|NCT00734032|1339048|P4|STARTED|Overall Study||26
549292|NCT00734032|1339049|P3|STARTED|Overall Study||28
549293|NCT00734032|1339050|P2|STARTED|Overall Study||28
549294|NCT00734032|1339051|P1|STARTED|Overall Study||25
549295|NCT00733993|1339071|P2|NOT COMPLETED|Overall Study||0
549296|NCT00733993|1339072|P1|NOT COMPLETED|Overall Study||0
549297|NCT00733993|1339071|P2|COMPLETED|Overall Study||10
549298|NCT00733993|1339072|P1|COMPLETED|Overall Study||13
549299|NCT00733993|1339071|P2|STARTED|Overall Study||10
549300|NCT00733993|1339072|P1|STARTED|Overall Study||13
549301|NCT00733980|1339107|P2|NOT COMPLETED|Overall Study||21
549302|NCT00733980|1339108|P1|NOT COMPLETED|Overall Study||22
549303|NCT00733980|1339107|P2|COMPLETED|Overall Study||55
549304|NCT00733980|1339108|P1|COMPLETED|Overall Study||52
549305|NCT00733980|1339107|P2|STARTED|Overall Study||76
549306|NCT00733980|1339108|P1|STARTED|Overall Study||74
549307|NCT00733954|1339152|P2|NOT COMPLETED|Overall Study||2
549308|NCT00733954|1339153|P1|NOT COMPLETED|Overall Study||8
549309|NCT00733954|1339152|P2|COMPLETED|Overall Study||123
549310|NCT00733954|1339153|P1|COMPLETED|Overall Study||116
549311|NCT00733954|1339152|P2|STARTED|Overall Study||125
549312|NCT00733954|1339153|P1|STARTED|Overall Study||124
549313|NCT00733824|1339200|P5|NOT COMPLETED|Phase II||0
549314|NCT00733824|1339201|P4|NOT COMPLETED|Phase II||0
549315|NCT00733824|1339202|P3|NOT COMPLETED|Phase II||0
549316|NCT00733824|1339203|P2|NOT COMPLETED|Phase II||0
549317|NCT00733824|1339204|P1|NOT COMPLETED|Phase II||0
549318|NCT00733824|1339200|P5|COMPLETED|Phase II||36
549319|NCT00733824|1339201|P4|COMPLETED|Phase II||0
549320|NCT00733824|1339202|P3|COMPLETED|Phase II||0
549321|NCT00733824|1339203|P2|COMPLETED|Phase II||0
549322|NCT00733824|1339204|P1|COMPLETED|Phase II||0
549323|NCT00733824|1339200|P5|STARTED|Phase II||36
549324|NCT00733824|1339201|P4|STARTED|Phase II||0
549325|NCT00733824|1339202|P3|STARTED|Phase II||0
549326|NCT00733824|1339203|P2|STARTED|Phase II||0
549327|NCT00733824|1339204|P1|STARTED|Phase II||0
549328|NCT00733824|1339200|P5|NOT COMPLETED|Phase I||0
549329|NCT00733824|1339201|P4|NOT COMPLETED|Phase I||0
549330|NCT00733824|1339202|P3|NOT COMPLETED|Phase I||0
549331|NCT00733824|1339203|P2|NOT COMPLETED|Phase I||0
549332|NCT00733824|1339204|P1|NOT COMPLETED|Phase I||1
549333|NCT00733824|1339200|P5|COMPLETED|Phase I||0
549334|NCT00733824|1339201|P4|COMPLETED|Phase I||6
549335|NCT00733824|1339202|P3|COMPLETED|Phase I||6
549336|NCT00733824|1339203|P2|COMPLETED|Phase I||3
549337|NCT00733824|1339204|P1|COMPLETED|Phase I||9
549338|NCT00733824|1339200|P5|STARTED|Phase I||0
549339|NCT00733824|1339201|P4|STARTED|Phase I||6
549340|NCT00733824|1339202|P3|STARTED|Phase I||6
549341|NCT00733824|1339203|P2|STARTED|Phase I||3
549342|NCT00733824|1339204|P1|STARTED|Phase I||10
549343|NCT00733746|1339223|P1|NOT COMPLETED|Overall Study||5
549344|NCT00733746|1339223|P1|COMPLETED|Overall Study||114
549345|NCT00733746|1339223|P1|STARTED|Overall Study||119
549346|NCT00733512|1339231|P1|NOT COMPLETED|Overall Study||0
549347|NCT00733512|1339231|P1|COMPLETED|Overall Study||146
549348|NCT00733512|1339231|P1|STARTED|Overall Study||146
549349|NCT00733499|1339238|P2|NOT COMPLETED|24 Months Follow-up||1
549350|NCT00733499|1339239|P1|NOT COMPLETED|24 Months Follow-up||0
549351|NCT00733499|1339238|P2|COMPLETED|24 Months Follow-up||95
549352|NCT00733499|1339239|P1|COMPLETED|24 Months Follow-up||99
549353|NCT00733499|1339238|P2|STARTED|24 Months Follow-up||96
549354|NCT00733499|1339239|P1|STARTED|24 Months Follow-up||99
549355|NCT00733499|1339238|P2|NOT COMPLETED|12 Months Follow-up||1
549356|NCT00733499|1339239|P1|NOT COMPLETED|12 Months Follow-up||2
549357|NCT00733499|1339238|P2|COMPLETED|12 Months Follow-up||96
549358|NCT00733499|1339239|P1|COMPLETED|12 Months Follow-up||99
549359|NCT00733499|1339238|P2|STARTED|12 Months Follow-up||97
549360|NCT00733499|1339239|P1|STARTED|12 Months Follow-up||101
549361|NCT00733499|1339238|P2|NOT COMPLETED|6 Months Follow-up||3
549362|NCT00733499|1339239|P1|NOT COMPLETED|6 Months Follow-up||0
549363|NCT00733499|1339238|P2|COMPLETED|6 Months Follow-up||97
549364|NCT00733499|1339239|P1|COMPLETED|6 Months Follow-up||101
549365|NCT00733499|1339238|P2|STARTED|6 Months Follow-up||100
549366|NCT00733499|1339239|P1|STARTED|6 Months Follow-up||101
549367|NCT00733499|1339238|P2|NOT COMPLETED|3 Months Follow-up||2
549368|NCT00733499|1339239|P1|NOT COMPLETED|3 Months Follow-up||1
549369|NCT00733499|1339238|P2|COMPLETED|3 Months Follow-up||100
549370|NCT00733499|1339239|P1|COMPLETED|3 Months Follow-up||101
549371|NCT00733499|1339238|P2|STARTED|3 Months Follow-up||102
549372|NCT00733499|1339239|P1|STARTED|3 Months Follow-up||102
549373|NCT00733499|1339238|P2|NOT COMPLETED|Pre-operative||1
549374|NCT00733499|1339239|P1|NOT COMPLETED|Pre-operative||0
549375|NCT00733499|1339238|P2|COMPLETED|Pre-operative||102
549376|NCT00733499|1339239|P1|COMPLETED|Pre-operative||102
549377|NCT00733499|1339238|P2|STARTED|Pre-operative||103
549378|NCT00733499|1339239|P1|STARTED|Pre-operative||102
549379|NCT00733421|1339247|P2|NOT COMPLETED|Overall Study||1
549380|NCT00733421|1339248|P1|NOT COMPLETED|Overall Study||1
549381|NCT00733421|1339247|P2|COMPLETED|Overall Study|All but one randomised patient|49
549382|NCT00733421|1339248|P1|COMPLETED|Overall Study|All but one randomsied patient|49
549383|NCT00733421|1339247|P2|STARTED|Overall Study|November 2008|50
549384|NCT00733421|1339248|P1|STARTED|Overall Study|November 2008|50
549385|NCT00733369|1339272|P2|NOT COMPLETED|Overall Study||9
549386|NCT00733369|1339273|P1|NOT COMPLETED|Overall Study||10
549387|NCT00733369|1339272|P2|COMPLETED|Overall Study||47
549388|NCT00733369|1339273|P1|COMPLETED|Overall Study||40
549389|NCT00733369|1339272|P2|STARTED|Overall Study||56
549390|NCT00733369|1339273|P1|STARTED|Overall Study||50
549391|NCT00733356|1339389|P1|NOT COMPLETED|Modified Lab School, Reading Evaluation||0
549392|NCT00733356|1339389|P1|COMPLETED|Modified Lab School, Reading Evaluation||26
549393|NCT00733356|1339389|P1|STARTED|Modified Lab School, Reading Evaluation||26
549394|NCT00733356|1339389|P1|NOT COMPLETED|Vyvanse Dose Titration||2
549395|NCT00733356|1339389|P1|COMPLETED|Vyvanse Dose Titration||26
549396|NCT00733356|1339389|P1|STARTED|Vyvanse Dose Titration||28
549397|NCT00733330|1339395|P2|NOT COMPLETED|Overall Study||4
549398|NCT00733330|1339396|P1|NOT COMPLETED|Overall Study||2
549399|NCT00733330|1339395|P2|COMPLETED|Overall Study||48
549400|NCT00733330|1339396|P1|COMPLETED|Overall Study||30
549401|NCT00733330|1339395|P2|STARTED|Overall Study||52
549402|NCT00733330|1339396|P1|STARTED|Overall Study||32
549403|NCT00733304|1339481|P3|NOT COMPLETED|Overall Study||5
549404|NCT00733304|1339482|P2|NOT COMPLETED|Overall Study||3
549405|NCT00733304|1339483|P1|NOT COMPLETED|Overall Study||7
549406|NCT00733304|1339481|P3|COMPLETED|Overall Study||3
549407|NCT00733304|1339482|P2|COMPLETED|Overall Study||12
549408|NCT00733304|1339483|P1|COMPLETED|Overall Study||12
549409|NCT00733304|1339481|P3|STARTED|Overall Study||8
549410|NCT00733304|1339482|P2|STARTED|Overall Study||15
549411|NCT00733304|1339483|P1|STARTED|Overall Study||19
549412|NCT00733291|1339565|P4|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
549413|NCT00733291|1339566|P3|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
549414|NCT00733291|1339567|P2|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
549415|NCT00733291|1339568|P1|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
549416|NCT00733291|1339565|P4|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
549417|NCT00733291|1339566|P3|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
549418|NCT00733291|1339567|P2|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
549419|NCT00733291|1339568|P1|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||12
549420|NCT00733291|1339565|P4|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
549421|NCT00733291|1339566|P3|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
549422|NCT00733291|1339567|P2|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
549423|NCT00733291|1339568|P1|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||12
549424|NCT00733291|1339565|P4|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
549425|NCT00733291|1339566|P3|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
549426|NCT00733291|1339567|P2|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
549427|NCT00733291|1339568|P1|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||1
549428|NCT00733291|1339565|P4|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
549429|NCT00733291|1339566|P3|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
549430|NCT00733291|1339567|P2|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
549431|NCT00733291|1339568|P1|COMPLETED|Washout Period, 3 Days (+/-1 Day)||12
549432|NCT00733291|1339565|P4|STARTED|Washout Period, 3 Days (+/-1 Day)||17
549433|NCT00733291|1339566|P3|STARTED|Washout Period, 3 Days (+/-1 Day)||17
549434|NCT00733291|1339567|P2|STARTED|Washout Period, 3 Days (+/-1 Day)||17
549435|NCT00733291|1339568|P1|STARTED|Washout Period, 3 Days (+/-1 Day)||13
549436|NCT00733291|1339565|P4|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
549437|NCT00733291|1339566|P3|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
549438|NCT00733291|1339567|P2|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
549439|NCT00733291|1339568|P1|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
549440|NCT00733291|1339565|P4|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
549441|NCT00733291|1339566|P3|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
549442|NCT00733291|1339567|P2|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
549443|NCT00733291|1339568|P1|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||13
549444|NCT00733291|1339565|P4|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
549445|NCT00733291|1339566|P3|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
549446|NCT00733291|1339567|P2|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
549447|NCT00733291|1339568|P1|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||13
549448|NCT00733278|1339590|P1|NOT COMPLETED|Overall Study||0
549449|NCT00733278|1339590|P1|COMPLETED|Overall Study||7
549450|NCT00733278|1339590|P1|STARTED|Overall Study||7
549451|NCT00733226|1339597|P2|NOT COMPLETED|Overall Study||0
549452|NCT00733226|1339598|P1|NOT COMPLETED|Overall Study||5
549453|NCT00733226|1339597|P2|COMPLETED|Overall Study||40
549454|NCT00733226|1339598|P1|COMPLETED|Overall Study||35
549455|NCT00733226|1339597|P2|STARTED|Overall Study||40
549456|NCT00733226|1339598|P1|STARTED|Overall Study||40
549457|NCT00733135|1339614|P1|NOT COMPLETED|Overall Study||2
549458|NCT00733135|1339614|P1|COMPLETED|Overall Study||131
549459|NCT00733135|1339614|P1|STARTED|Overall Study||133
549460|NCT00733096|1339626|P3|NOT COMPLETED|Overall Study||0
549461|NCT00733096|1339627|P2|NOT COMPLETED|Overall Study||0
549462|NCT00733096|1339628|P1|NOT COMPLETED|Overall Study||0
549463|NCT00733096|1339626|P3|COMPLETED|Overall Study||30
549464|NCT00733096|1339627|P2|COMPLETED|Overall Study||26
549465|NCT00733096|1339628|P1|COMPLETED|Overall Study||28
549466|NCT00733096|1339626|P3|STARTED|Overall Study||30
549467|NCT00733096|1339627|P2|STARTED|Overall Study||26
549468|NCT00733096|1339628|P1|STARTED|Overall Study||28
549469|NCT00733005|1339647|P2|NOT COMPLETED|Overall Study||3
549470|NCT00733005|1339648|P1|NOT COMPLETED|Overall Study||2
549471|NCT00733005|1339647|P2|COMPLETED|Overall Study||159
549472|NCT00733005|1339648|P1|COMPLETED|Overall Study||160
549473|NCT00733005|1339647|P2|STARTED|Overall Study||162
549474|NCT00733005|1339648|P1|STARTED|Overall Study||162
549475|NCT00732992|1339658|P2|NOT COMPLETED|Overall Study||6
549476|NCT00732992|1339659|P1|NOT COMPLETED|Overall Study||6
549477|NCT00732992|1339658|P2|COMPLETED|Overall Study||0
549478|NCT00732992|1339659|P1|COMPLETED|Overall Study||0
549479|NCT00732992|1339658|P2|STARTED|Overall Study||6
549480|NCT00732992|1339659|P1|STARTED|Overall Study||6
549481|NCT00732940|1339678|P2|NOT COMPLETED|Overall Study||3
549482|NCT00732940|1339679|P1|NOT COMPLETED|Overall Study||2
549483|NCT00732940|1339678|P2|COMPLETED|Overall Study||25
549484|NCT00732940|1339679|P1|COMPLETED|Overall Study||26
549485|NCT00732940|1339678|P2|STARTED|Overall Study||28
549486|NCT00732940|1339679|P1|STARTED|Overall Study||28
549487|NCT00732901|1339749|P2|NOT COMPLETED|Overall Study||0
549488|NCT00732901|1339750|P1|NOT COMPLETED|Overall Study||0
549489|NCT00732901|1339749|P2|COMPLETED|Overall Study||12
549490|NCT00732901|1339750|P1|COMPLETED|Overall Study||11
549491|NCT00732901|1339749|P2|STARTED|Overall Study||12
549492|NCT00732901|1339750|P1|STARTED|Overall Study||11
549493|NCT00732875|1339760|P1|NOT COMPLETED|Overall Study||35
549494|NCT00732875|1339760|P1|COMPLETED|Overall Study|These participants continued treatment until trial was completed by Sponsor.|57
549495|NCT00732875|1339760|P1|STARTED|Overall Study||92
549496|NCT00732758|1339768|P2|NOT COMPLETED|Overall Study||16
549497|NCT00732758|1339769|P1|NOT COMPLETED|Overall Study||8
549498|NCT00732758|1339768|P2|COMPLETED|Overall Study||63
549499|NCT00732758|1339769|P1|COMPLETED|Overall Study||70
549500|NCT00732758|1339768|P2|STARTED|Overall Study||79
549501|NCT00732758|1339769|P1|STARTED|Overall Study||78
549502|NCT00732680|1339781|P1|NOT COMPLETED|Overall Study||0
549503|NCT00732680|1339781|P1|COMPLETED|Overall Study||9
549504|NCT00732680|1339781|P1|STARTED|Overall Study||9
549505|NCT00732654|1339788|P3|NOT COMPLETED|Overall Study||0
549506|NCT00732654|1339789|P2|NOT COMPLETED|Overall Study||1
549507|NCT00732654|1339790|P1|NOT COMPLETED|Overall Study||0
549508|NCT00732654|1339788|P3|COMPLETED|Overall Study||10
549509|NCT00732654|1339789|P2|COMPLETED|Overall Study||9
549510|NCT00732654|1339790|P1|COMPLETED|Overall Study||10
549511|NCT00732654|1339788|P3|STARTED|Overall Study||10
549512|NCT00732654|1339789|P2|STARTED|Overall Study||10
549513|NCT00732654|1339790|P1|STARTED|Overall Study||10
549514|NCT00732641|1339809|P2|NOT COMPLETED|Overall Study||112
549515|NCT00732641|1339810|P1|NOT COMPLETED|Overall Study||106
549516|NCT00732641|1339809|P2|COMPLETED|Overall Study||9
549517|NCT00732641|1339810|P1|COMPLETED|Overall Study||17
549518|NCT00732641|1339809|P2|STARTED|Overall Study||121
549519|NCT00732641|1339810|P1|STARTED|Overall Study||123
549520|NCT00732615|1339830|P2|NOT COMPLETED|Overall Study||5
549521|NCT00732615|1339831|P1|NOT COMPLETED|Overall Study||7
549522|NCT00732615|1339830|P2|COMPLETED|Overall Study||79
549523|NCT00732615|1339831|P1|COMPLETED|Overall Study||33
549524|NCT00732615|1339830|P2|STARTED|Overall Study||84
549525|NCT00732615|1339831|P1|STARTED|Overall Study||40
549526|NCT00732472|1339847|P4|NOT COMPLETED|Overall Study||3
549527|NCT00732472|1339848|P3|NOT COMPLETED|Overall Study||1
549528|NCT00732472|1339849|P2|NOT COMPLETED|Overall Study||3
549529|NCT00732472|1339850|P1|NOT COMPLETED|Overall Study||0
549530|NCT00732472|1339847|P4|COMPLETED|Overall Study||6
549531|NCT00732472|1339848|P3|COMPLETED|Overall Study||9
549532|NCT00732472|1339849|P2|COMPLETED|Overall Study||7
549533|NCT00732472|1339850|P1|COMPLETED|Overall Study||9
549534|NCT00732472|1339847|P4|STARTED|Overall Study||9
549535|NCT00732472|1339848|P3|STARTED|Overall Study||10
549536|NCT00732472|1339849|P2|STARTED|Overall Study|One par. (counted as 2 on outputs) was randomized/dosed with UMEC 250 µg on 2 separate occasions.|10
549537|NCT00732472|1339850|P1|STARTED|Overall Study||9
549538|NCT00732381|1339950|P2|NOT COMPLETED|Overall Study||1
549539|NCT00732381|1339951|P1|NOT COMPLETED|Overall Study||2
549540|NCT00732381|1339950|P2|COMPLETED|Overall Study||174
549541|NCT00732381|1339951|P1|COMPLETED|Overall Study||174
549542|NCT00732381|1339950|P2|STARTED|Overall Study||175
549543|NCT00732381|1339951|P1|STARTED|Overall Study||176
549544|NCT00732303|1339959|P1|NOT COMPLETED|Overall Study||2
549545|NCT00732303|1339959|P1|COMPLETED|Overall Study||6
549546|NCT00732303|1339959|P1|STARTED|Overall Study||8
549547|NCT00732251|1339965|P1|NOT COMPLETED|Overall Study||7
549548|NCT00732251|1339965|P1|COMPLETED|Overall Study||1
549549|NCT00732251|1339965|P1|STARTED|Overall Study||8
549550|NCT00732238|1339971|P2|NOT COMPLETED|Overall Study||1
549551|NCT00732238|1339972|P1|NOT COMPLETED|Overall Study||5
549552|NCT00732238|1339971|P2|COMPLETED|Overall Study||27
549553|NCT00732238|1339972|P1|COMPLETED|Overall Study||28
549554|NCT00732238|1339971|P2|STARTED|Overall Study||28
549555|NCT00732238|1339972|P1|STARTED|Overall Study||33
549556|NCT00732225|1339985|P5|NOT COMPLETED|Overall Study||6
549557|NCT00732225|1339986|P4|NOT COMPLETED|Overall Study||4
549558|NCT00732225|1339987|P3|NOT COMPLETED|Overall Study||3
549559|NCT00732225|1339988|P2|NOT COMPLETED|Overall Study||8
549560|NCT00732225|1339989|P1|NOT COMPLETED|Overall Study||11
549561|NCT00732225|1339985|P5|COMPLETED|Overall Study|48 eyes of 48 patients|48
549562|NCT00732225|1339986|P4|COMPLETED|Overall Study|29 eyes of 29 patients|29
549563|NCT00732225|1339987|P3|COMPLETED|Overall Study|23 eyes of 23 patients|23
549564|NCT00732225|1339988|P2|COMPLETED|Overall Study|33 eyes of 32 patients|32
549565|NCT00732225|1339989|P1|COMPLETED|Overall Study|64 eyes of 60 patients|60
549566|NCT00732225|1339985|P5|STARTED|Overall Study|55 eyes of 54 patients|54
549567|NCT00732225|1339986|P4|STARTED|Overall Study|33 eyes of 33 patients|33
549568|NCT00732225|1339987|P3|STARTED|Overall Study|26 eyes of 26 patients|26
549569|NCT00732225|1339988|P2|STARTED|Overall Study|41 eyes of 40 patients|40
549570|NCT00732225|1339989|P1|STARTED|Overall Study|76 eyes of 71 patients|71
549571|NCT00732212|1340040|P2|NOT COMPLETED|Overall Study||0
549572|NCT00732212|1340041|P1|NOT COMPLETED|Overall Study||0
549573|NCT00732212|1340040|P2|COMPLETED|Overall Study||123
549574|NCT00732212|1340041|P1|COMPLETED|Overall Study||112
549575|NCT00732212|1340040|P2|Temporarily Suspended|Overall Study||50
549576|NCT00732212|1340041|P1|Temporarily Suspended|Overall Study|Study was suspended for a 9 month period by the VA DMC because of slow enrollment, then restarted.|50
549577|NCT00732212|1340040|P2|STARTED|Overall Study||123
549578|NCT00732212|1340041|P1|STARTED|Overall Study||112
549579|NCT00732199|1340073|P2|NOT COMPLETED|Overall Study||26
549580|NCT00732199|1340074|P1|NOT COMPLETED|Overall Study||34
549581|NCT00732199|1340073|P2|COMPLETED|Overall Study||16
549582|NCT00732199|1340074|P1|COMPLETED|Overall Study||16
549583|NCT00732199|1340073|P2|STARTED|Overall Study||42
549584|NCT00732199|1340074|P1|STARTED|Overall Study||50
549585|NCT00732160|1340089|P4|NOT COMPLETED|Overall Study||2
549586|NCT00732160|1340090|P3|NOT COMPLETED|Overall Study||3
549587|NCT00732160|1340091|P2|NOT COMPLETED|Overall Study||4
549588|NCT00732160|1340092|P1|NOT COMPLETED|Overall Study||5
549589|NCT00732160|1340089|P4|COMPLETED|Overall Study||3
549590|NCT00732160|1340090|P3|COMPLETED|Overall Study||3
549591|NCT00732160|1340091|P2|COMPLETED|Overall Study||1
549592|NCT00732160|1340092|P1|COMPLETED|Overall Study||2
549593|NCT00732160|1340089|P4|LS Aldosterone|Overall Study||5
549594|NCT00732160|1340090|P3|LS Aldosterone|Overall Study||6
549595|NCT00732160|1340091|P2|LS Aldosterone|Overall Study||1
549596|NCT00732160|1340092|P1|LS Aldosterone|Overall Study||2
549597|NCT00732160|1340089|P4|LS Vehicle|Overall Study||5
549598|NCT00732160|1340090|P3|LS Vehicle|Overall Study||6
549599|NCT00732160|1340091|P2|LS Vehicle|Overall Study||1
549600|NCT00732160|1340092|P1|LS Vehicle|Overall Study||2
549601|NCT00732160|1340089|P4|HS Aldosterone|Overall Study||3
549602|NCT00732160|1340090|P3|HS Aldosterone|Overall Study||3
549603|NCT00732160|1340091|P2|HS Aldosterone|Overall Study||5
549604|NCT00732160|1340092|P1|HS Aldosterone|Overall Study||7
549605|NCT00732160|1340089|P4|HS Vehicle|Overall Study||3
549606|NCT00732160|1340090|P3|HS Vehicle|Overall Study||3
549607|NCT00732160|1340091|P2|HS Vehicle|Overall Study||5
549608|NCT00732160|1340092|P1|HS Vehicle|Overall Study||7
549609|NCT00732160|1340089|P4|STARTED|Overall Study||5
549610|NCT00732160|1340090|P3|STARTED|Overall Study||6
549611|NCT00732160|1340091|P2|STARTED|Overall Study||5
549612|NCT00732160|1340092|P1|STARTED|Overall Study||7
549613|NCT00732069|1340106|P6|NOT COMPLETED|Third Study Drug||0
549614|NCT00732069|1340107|P5|NOT COMPLETED|Third Study Drug||0
549615|NCT00732069|1340108|P4|NOT COMPLETED|Third Study Drug||0
549616|NCT00732069|1340109|P3|NOT COMPLETED|Third Study Drug||0
549617|NCT00732069|1340110|P2|NOT COMPLETED|Third Study Drug||0
549618|NCT00732069|1340111|P1|NOT COMPLETED|Third Study Drug||0
549619|NCT00732069|1340106|P6|COMPLETED|Third Study Drug||2
549620|NCT00732069|1340107|P5|COMPLETED|Third Study Drug||3
549621|NCT00732069|1340108|P4|COMPLETED|Third Study Drug||2
549622|NCT00732069|1340109|P3|COMPLETED|Third Study Drug||3
549623|NCT00732069|1340110|P2|COMPLETED|Third Study Drug||3
549624|NCT00732069|1340111|P1|COMPLETED|Third Study Drug||2
549625|NCT00732069|1340106|P6|STARTED|Third Study Drug||2
549626|NCT00732069|1340107|P5|STARTED|Third Study Drug||3
549627|NCT00732069|1340108|P4|STARTED|Third Study Drug||2
549628|NCT00732069|1340109|P3|STARTED|Third Study Drug||3
549629|NCT00732069|1340110|P2|STARTED|Third Study Drug||3
549630|NCT00732069|1340111|P1|STARTED|Third Study Drug||2
549631|NCT00732069|1340106|P6|NOT COMPLETED|Washout After Second Study Drug||0
549632|NCT00732069|1340107|P5|NOT COMPLETED|Washout After Second Study Drug||0
549633|NCT00732069|1340108|P4|NOT COMPLETED|Washout After Second Study Drug||0
549634|NCT00732069|1340109|P3|NOT COMPLETED|Washout After Second Study Drug||0
549635|NCT00732069|1340110|P2|NOT COMPLETED|Washout After Second Study Drug||0
549636|NCT00732069|1340111|P1|NOT COMPLETED|Washout After Second Study Drug||0
549637|NCT00732069|1340106|P6|COMPLETED|Washout After Second Study Drug||2
549638|NCT00732069|1340107|P5|COMPLETED|Washout After Second Study Drug||3
549639|NCT00732069|1340108|P4|COMPLETED|Washout After Second Study Drug||2
549640|NCT00732069|1340109|P3|COMPLETED|Washout After Second Study Drug||3
549641|NCT00732069|1340110|P2|COMPLETED|Washout After Second Study Drug||3
549642|NCT00732069|1340111|P1|COMPLETED|Washout After Second Study Drug||2
549643|NCT00732069|1340106|P6|STARTED|Washout After Second Study Drug||2
549644|NCT00732069|1340107|P5|STARTED|Washout After Second Study Drug||3
549645|NCT00732069|1340108|P4|STARTED|Washout After Second Study Drug||2
549646|NCT00732069|1340109|P3|STARTED|Washout After Second Study Drug||3
549647|NCT00732069|1340110|P2|STARTED|Washout After Second Study Drug||3
549648|NCT00732069|1340111|P1|STARTED|Washout After Second Study Drug||2
549649|NCT00732069|1340106|P6|NOT COMPLETED|Second Study Drug||0
549650|NCT00732069|1340107|P5|NOT COMPLETED|Second Study Drug||0
549651|NCT00732069|1340108|P4|NOT COMPLETED|Second Study Drug||0
549652|NCT00732069|1340109|P3|NOT COMPLETED|Second Study Drug||0
549653|NCT00732069|1340110|P2|NOT COMPLETED|Second Study Drug||0
549654|NCT00732069|1340111|P1|NOT COMPLETED|Second Study Drug||0
549655|NCT00732069|1340106|P6|COMPLETED|Second Study Drug||2
549656|NCT00732069|1340107|P5|COMPLETED|Second Study Drug||3
549657|NCT00732069|1340108|P4|COMPLETED|Second Study Drug||2
549658|NCT00732069|1340109|P3|COMPLETED|Second Study Drug||3
549659|NCT00732069|1340110|P2|COMPLETED|Second Study Drug||3
549660|NCT00732069|1340111|P1|COMPLETED|Second Study Drug||2
549661|NCT00732069|1340106|P6|STARTED|Second Study Drug||2
549662|NCT00732069|1340107|P5|STARTED|Second Study Drug||3
549663|NCT00732069|1340108|P4|STARTED|Second Study Drug||2
549664|NCT00732069|1340109|P3|STARTED|Second Study Drug||3
549665|NCT00732069|1340110|P2|STARTED|Second Study Drug||3
549666|NCT00732069|1340111|P1|STARTED|Second Study Drug||2
549667|NCT00732069|1340106|P6|NOT COMPLETED|Washout After First Study Drug||0
549668|NCT00732069|1340107|P5|NOT COMPLETED|Washout After First Study Drug||0
549669|NCT00732069|1340108|P4|NOT COMPLETED|Washout After First Study Drug||0
549670|NCT00732069|1340109|P3|NOT COMPLETED|Washout After First Study Drug||0
549671|NCT00732069|1340110|P2|NOT COMPLETED|Washout After First Study Drug||0
549672|NCT00732069|1340111|P1|NOT COMPLETED|Washout After First Study Drug||1
549673|NCT00732069|1340106|P6|COMPLETED|Washout After First Study Drug||2
549674|NCT00732069|1340107|P5|COMPLETED|Washout After First Study Drug||3
549675|NCT00732069|1340108|P4|COMPLETED|Washout After First Study Drug||2
549676|NCT00732069|1340109|P3|COMPLETED|Washout After First Study Drug||3
549677|NCT00732069|1340110|P2|COMPLETED|Washout After First Study Drug||3
549678|NCT00732069|1340111|P1|COMPLETED|Washout After First Study Drug||2
549679|NCT00732069|1340106|P6|STARTED|Washout After First Study Drug||2
549680|NCT00732069|1340107|P5|STARTED|Washout After First Study Drug||3
549681|NCT00732069|1340108|P4|STARTED|Washout After First Study Drug||2
549682|NCT00732069|1340109|P3|STARTED|Washout After First Study Drug||3
549683|NCT00732069|1340110|P2|STARTED|Washout After First Study Drug||3
549684|NCT00732069|1340111|P1|STARTED|Washout After First Study Drug||3
549685|NCT00732069|1340106|P6|NOT COMPLETED|First Study Drug||0
549686|NCT00732069|1340107|P5|NOT COMPLETED|First Study Drug||0
549687|NCT00732069|1340108|P4|NOT COMPLETED|First Study Drug||0
549688|NCT00732069|1340109|P3|NOT COMPLETED|First Study Drug||0
549689|NCT00732069|1340110|P2|NOT COMPLETED|First Study Drug||0
549690|NCT00732069|1340111|P1|NOT COMPLETED|First Study Drug||0
549691|NCT00732069|1340106|P6|COMPLETED|First Study Drug||2
549692|NCT00732069|1340107|P5|COMPLETED|First Study Drug||3
549693|NCT00732069|1340108|P4|COMPLETED|First Study Drug||2
549694|NCT00732069|1340109|P3|COMPLETED|First Study Drug||3
549695|NCT00732069|1340110|P2|COMPLETED|First Study Drug||3
549696|NCT00732069|1340111|P1|COMPLETED|First Study Drug||3
549697|NCT00732069|1340106|P6|STARTED|First Study Drug||2
549698|NCT00732069|1340107|P5|STARTED|First Study Drug||3
549699|NCT00732069|1340108|P4|STARTED|First Study Drug||2
549700|NCT00732069|1340109|P3|STARTED|First Study Drug||3
549701|NCT00732069|1340110|P2|STARTED|First Study Drug||3
549702|NCT00732069|1340111|P1|STARTED|First Study Drug||3
549703|NCT00732030|1340122|P1|NOT COMPLETED|Overall Study||2
549704|NCT00732030|1340122|P1|COMPLETED|Overall Study||24
549705|NCT00732030|1340122|P1|STARTED|Overall Study||26
549706|NCT00731939|1340129|P1|NOT COMPLETED|Overall Study||34
549707|NCT00731939|1340129|P1|COMPLETED|Overall Study||90
549708|NCT00731939|1340129|P1|STARTED|Overall Study||124
549709|NCT00731874|1340179|P2|NOT COMPLETED|Overall Study||0
549710|NCT00731874|1340180|P1|NOT COMPLETED|Overall Study||0
549711|NCT00731874|1340179|P2|COMPLETED|Overall Study||13
549712|NCT00731874|1340180|P1|COMPLETED|Overall Study||10
549713|NCT00731874|1340179|P2|STARTED|Overall Study||13
549714|NCT00731874|1340180|P1|STARTED|Overall Study||10
549715|NCT00731822|1340190|P2|NOT COMPLETED|Overall Study||1
549716|NCT00731822|1340191|P1|NOT COMPLETED|Overall Study||4
549717|NCT00731822|1340190|P2|COMPLETED|Overall Study||39
549718|NCT00731822|1340191|P1|COMPLETED|Overall Study||16
549719|NCT00731822|1340190|P2|STARTED|Overall Study||40
549720|NCT00731822|1340191|P1|STARTED|Overall Study||20
549721|NCT00731783|1340205|P2|NOT COMPLETED|12 Month Follow-Up Visit||7
549722|NCT00731783|1340206|P1|NOT COMPLETED|12 Month Follow-Up Visit||6
549723|NCT00731783|1340205|P2|COMPLETED|12 Month Follow-Up Visit||58
549724|NCT00731783|1340206|P1|COMPLETED|12 Month Follow-Up Visit||68
549725|NCT00731783|1340205|P2|STARTED|12 Month Follow-Up Visit||65
549726|NCT00731783|1340206|P1|STARTED|12 Month Follow-Up Visit||74
549727|NCT00731783|1340205|P2|NOT COMPLETED|Six Month Follow-Up Visit||3
549728|NCT00731783|1340206|P1|NOT COMPLETED|Six Month Follow-Up Visit||6
549729|NCT00731783|1340205|P2|COMPLETED|Six Month Follow-Up Visit||64
549730|NCT00731783|1340206|P1|COMPLETED|Six Month Follow-Up Visit||71
549731|NCT00731783|1340205|P2|STARTED|Six Month Follow-Up Visit||67
549732|NCT00731783|1340206|P1|STARTED|Six Month Follow-Up Visit||77
549733|NCT00731783|1340205|P2|NOT COMPLETED|Three Month Follow-Up Visit||16
549734|NCT00731783|1340206|P1|NOT COMPLETED|Three Month Follow-Up Visit||7
549735|NCT00731783|1340205|P2|COMPLETED|Three Month Follow-Up Visit||57
549736|NCT00731783|1340206|P1|COMPLETED|Three Month Follow-Up Visit||72
549737|NCT00731783|1340205|P2|STARTED|Three Month Follow-Up Visit||73
549738|NCT00731783|1340206|P1|STARTED|Three Month Follow-Up Visit||79
549739|NCT00731783|1340205|P2|NOT COMPLETED|One Month Follow-Up Visit||22
549740|NCT00731783|1340206|P1|NOT COMPLETED|One Month Follow-Up Visit||14
549741|NCT00731783|1340205|P2|COMPLETED|One Month Follow-Up Visit||69
549742|NCT00731783|1340206|P1|COMPLETED|One Month Follow-Up Visit||78
549743|NCT00731783|1340205|P2|STARTED|One Month Follow-Up Visit||91
549744|NCT00731783|1340206|P1|STARTED|One Month Follow-Up Visit||92
549745|NCT00731731|1340229|P3|NOT COMPLETED|Overall Study||3
549746|NCT00731731|1340230|P2|NOT COMPLETED|Overall Study||0
549747|NCT00731731|1340231|P1|NOT COMPLETED|Overall Study||0
549748|NCT00731731|1340229|P3|COMPLETED|Overall Study||107
549749|NCT00731731|1340230|P2|COMPLETED|Overall Study||3
549750|NCT00731731|1340231|P1|COMPLETED|Overall Study||12
549751|NCT00731731|1340229|P3|STARTED|Overall Study||110
549752|NCT00731731|1340230|P2|STARTED|Overall Study||3
549753|NCT00731731|1340231|P1|STARTED|Overall Study||12
549754|NCT00731692|1340249|P3|NOT COMPLETED|Extension Phase||301
549755|NCT00731692|1340250|P2|NOT COMPLETED|Extension Phase||196
549756|NCT00731692|1340251|P1|NOT COMPLETED|Extension Phase||74
549757|NCT00731692|1340249|P3|COMPLETED|Extension Phase||0
549758|NCT00731692|1340250|P2|COMPLETED|Extension Phase||0
549759|NCT00731692|1340251|P1|COMPLETED|Extension Phase||0
549760|NCT00731692|1340249|P3|STARTED|Extension Phase||301
549761|NCT00731692|1340250|P2|STARTED|Extension Phase||196
549762|NCT00731692|1340251|P1|STARTED|Extension Phase||74
549763|NCT00731692|1340249|P3|NOT COMPLETED|Core Study (36 Months)||170
549764|NCT00731692|1340250|P2|NOT COMPLETED|Core Study (36 Months)||116
549765|NCT00731692|1340251|P1|NOT COMPLETED|Core Study (36 Months)||68
549766|NCT00731692|1340249|P3|COMPLETED|Core Study (36 Months)||317
549767|NCT00731692|1340250|P2|COMPLETED|Core Study (36 Months)||220
549768|NCT00731692|1340251|P1|COMPLETED|Core Study (36 Months)||79
549769|NCT00731692|1340249|P3|Post Protocol Amendment 5 Switch|Core Study (36 Months)||0
549770|NCT00731692|1340250|P2|Post Protocol Amendment 5 Switch|Core Study (36 Months)|post protocol amendment 121 patients switch to 0.5 mg dose from 125mg dose|121
549771|NCT00731692|1340251|P1|Post Protocol Amendment 5 Switch|Core Study (36 Months)||0
549772|NCT00731692|1340249|P3|Pharmacokinetic Analysis Set|Core Study (36 Months)||0
549773|NCT00731692|1340250|P2|Pharmacokinetic Analysis Set|Core Study (36 Months)||249
549774|NCT00731692|1340251|P1|Pharmacokinetic Analysis Set|Core Study (36 Months)||102
549775|NCT00731692|1340249|P3|Full Analysis Set (FAS)|Core Study (36 Months)||487
549776|NCT00731692|1340250|P2|Full Analysis Set (FAS)|Core Study (36 Months)||336
549777|NCT00731692|1340251|P1|Full Analysis Set (FAS)|Core Study (36 Months)||0
549778|NCT00731692|1340249|P3|Safety Set (SAF)|Core Study (36 Months)||487
549779|NCT00731692|1340250|P2|Safety Set (SAF)|Core Study (36 Months)||336
549780|NCT00731692|1340251|P1|Safety Set (SAF)|Core Study (36 Months)||0
549781|NCT00731692|1340249|P3|STARTED|Core Study (36 Months)||487
549782|NCT00731692|1340250|P2|STARTED|Core Study (36 Months)||336
549783|NCT00731692|1340251|P1|STARTED|Core Study (36 Months)||147
549784|NCT00731679|1340297|P2|NOT COMPLETED|Overall Study||26
549785|NCT00731679|1340298|P1|NOT COMPLETED|Overall Study||22
549786|NCT00731679|1340297|P2|COMPLETED|Overall Study||283
549787|NCT00731679|1340298|P1|COMPLETED|Overall Study||292
549788|NCT00731679|1340297|P2|STARTED|Overall Study||309
549789|NCT00731679|1340298|P1|STARTED|Overall Study||314
549790|NCT00731666|1340306|P1|NOT COMPLETED|Overall Study||12
549791|NCT00731666|1340306|P1|COMPLETED|Overall Study||28
549792|NCT00731666|1340306|P1|STARTED|Overall Study||40
549793|NCT00731653|1340312|P1|NOT COMPLETED|Overall Study||9
549794|NCT00731653|1340312|P1|COMPLETED|Overall Study||72
549795|NCT00731653|1340312|P1|STARTED|Overall Study||81
549796|NCT00731640|1340318|P2|NOT COMPLETED|Overall Study||0
549797|NCT00731640|1340319|P1|NOT COMPLETED|Overall Study||0
549798|NCT00731640|1340318|P2|COMPLETED|Overall Study||32
549799|NCT00731640|1340319|P1|COMPLETED|Overall Study||20
549800|NCT00731640|1340318|P2|STARTED|Overall Study||32
549801|NCT00731640|1340319|P1|STARTED|Overall Study||20
549802|NCT00731614|1340333|P2|NOT COMPLETED|Overall Study||13
549803|NCT00731614|1340334|P1|NOT COMPLETED|Overall Study||7
549804|NCT00731614|1340333|P2|COMPLETED|Overall Study||18
549805|NCT00731614|1340334|P1|COMPLETED|Overall Study||16
549806|NCT00731614|1340333|P2|12 Weeks Posttreatment|Overall Study||23
549807|NCT00731614|1340334|P1|12 Weeks Posttreatment|Overall Study||18
549808|NCT00731614|1340333|P2|End of Treatment|Overall Study||24
549809|NCT00731614|1340334|P1|End of Treatment|Overall Study||16
549810|NCT00731614|1340333|P2|STARTED|Overall Study||31
549811|NCT00731614|1340334|P1|STARTED|Overall Study||23
549812|NCT00731549|1340340|P1|NOT COMPLETED|Overall Study||223
549813|NCT00731549|1340340|P1|COMPLETED|Overall Study||858
549814|NCT00731549|1340340|P1|STARTED|Overall Study||1081
549815|NCT00731484|1340353|P1|NOT COMPLETED|Overall Study||0
549816|NCT00731484|1340353|P1|COMPLETED|Overall Study||233
549817|NCT00731484|1340353|P1|STARTED|Overall Study||233
549818|NCT00731341|1340357|P1|NOT COMPLETED|Overall Study||0
549819|NCT00731341|1340357|P1|COMPLETED|Overall Study||3
549820|NCT00731341|1340357|P1|STARTED|Overall Study||3
549821|NCT00731211|1340366|P1|NOT COMPLETED|Overall Study||0
549822|NCT00731211|1340366|P1|COMPLETED|Overall Study||55
549823|NCT00731211|1340366|P1|STARTED|Overall Study|2 patients ineligible (papillary histologic type-1 pt. Previous treatment with everolimus alone-1 pt|55
549824|NCT00731198|1340373|P2|NOT COMPLETED|Overall Study||6
549825|NCT00731198|1340374|P1|NOT COMPLETED|Overall Study||6
549826|NCT00731198|1340373|P2|COMPLETED|Overall Study||319
549827|NCT00731198|1340374|P1|COMPLETED|Overall Study||319
549828|NCT00731198|1340373|P2|STARTED|Overall Study||325
549829|NCT00731198|1340374|P1|STARTED|Overall Study||325
549830|NCT00731133|1340380|P1|NOT COMPLETED|Overall Study||10
549831|NCT00731133|1340380|P1|COMPLETED|Overall Study||5
549832|NCT00731133|1340380|P1|STARTED|Overall Study||15
549833|NCT00731120|1340388|P3|NOT COMPLETED|Overall Study||36
549834|NCT00731120|1340389|P2|NOT COMPLETED|Overall Study||43
549835|NCT00731120|1340390|P1|NOT COMPLETED|Overall Study||42
549836|NCT00731120|1340388|P3|COMPLETED|Overall Study||116
549837|NCT00731120|1340389|P2|COMPLETED|Overall Study||109
549838|NCT00731120|1340390|P1|COMPLETED|Overall Study||111
549839|NCT00731120|1340388|P3|Treated|Overall Study||152
549840|NCT00731120|1340389|P2|Treated|Overall Study||151
549841|NCT00731120|1340390|P1|Treated|Overall Study||153
549842|NCT00731120|1340388|P3|STARTED|Overall Study||152
549843|NCT00731120|1340389|P2|STARTED|Overall Study||152
549844|NCT00731120|1340390|P1|STARTED|Overall Study||153
549845|NCT00731094|1340427|P2|NOT COMPLETED|Overall Study||11
549846|NCT00731094|1340428|P1|NOT COMPLETED|Overall Study||18
549847|NCT00731094|1340427|P2|COMPLETED|Overall Study||105
549848|NCT00731094|1340428|P1|COMPLETED|Overall Study||98
549849|NCT00731094|1340427|P2|Month 6|Overall Study||107
549850|NCT00731094|1340428|P1|Month 6|Overall Study||101
549851|NCT00731094|1340427|P2|STARTED|Overall Study||116
549852|NCT00731094|1340428|P1|STARTED|Overall Study||116
549853|NCT00731055|1340498|P1|NOT COMPLETED|Overall Study||0
549854|NCT00731055|1340498|P1|COMPLETED|Overall Study||16
549855|NCT00731055|1340498|P1|Received Varenicline 2.0 mg|Overall Study||16
549856|NCT00731055|1340498|P1|Received Varenicline 1.0 mg|Overall Study||16
549857|NCT00731055|1340498|P1|Received Varenicline 0.5 mg|Overall Study||16
549858|NCT00731055|1340498|P1|Received Placebo|Overall Study||16
549859|NCT00731055|1340498|P1|STARTED|Overall Study|This is a within-subjects study design.|16
549860|NCT00731042|1340507|P2|NOT COMPLETED|Second Intervention||2
549861|NCT00731042|1340508|P1|NOT COMPLETED|Second Intervention||0
549862|NCT00731042|1340507|P2|COMPLETED|Second Intervention|2 subjects did not met inclusion criteria for Period 2 Visual scoring skin condition|15
549863|NCT00731042|1340508|P1|COMPLETED|Second Intervention||16
549864|NCT00731042|1340507|P2|STARTED|Second Intervention||17
549865|NCT00731042|1340508|P1|STARTED|Second Intervention||16
549866|NCT00731042|1340507|P2|NOT COMPLETED|Wash-out||0
549867|NCT00731042|1340508|P1|NOT COMPLETED|Wash-out||0
549868|NCT00731042|1340507|P2|COMPLETED|Wash-out||17
549869|NCT00731042|1340508|P1|COMPLETED|Wash-out||16
549870|NCT00731042|1340507|P2|STARTED|Wash-out||17
549871|NCT00731042|1340508|P1|STARTED|Wash-out||16
549872|NCT00731042|1340507|P2|NOT COMPLETED|First Intervention||0
549873|NCT00731042|1340508|P1|NOT COMPLETED|First Intervention||0
549874|NCT00731042|1340507|P2|COMPLETED|First Intervention||17
549875|NCT00731042|1340508|P1|COMPLETED|First Intervention||16
549876|NCT00731042|1340507|P2|STARTED|First Intervention||17
549877|NCT00731042|1340508|P1|STARTED|First Intervention||16
549878|NCT00730964|1340514|P1|NOT COMPLETED|Overall Study||0
549879|NCT00730964|1340514|P1|COMPLETED|Overall Study||1039
549880|NCT00730964|1340514|P1|STARTED|Overall Study||1039
549881|NCT00730925|1340519|P1|NOT COMPLETED|Overall Study||41
549882|NCT00730925|1340519|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date|0
549883|NCT00730925|1340519|P1|STARTED|Overall Study||41
549884|NCT00730912|1340529|P3|NOT COMPLETED|Overall Study||1
549885|NCT00730912|1340530|P2|NOT COMPLETED|Overall Study||0
549886|NCT00730912|1340531|P1|NOT COMPLETED|Overall Study||0
549887|NCT00730912|1340529|P3|COMPLETED|Overall Study||103
549888|NCT00730912|1340530|P2|COMPLETED|Overall Study||104
549889|NCT00730912|1340531|P1|COMPLETED|Overall Study||53
549890|NCT00730912|1340529|P3|STARTED|Overall Study||104
549891|NCT00730912|1340530|P2|STARTED|Overall Study||104
549892|NCT00730912|1340531|P1|STARTED|Overall Study||53
549893|NCT00730847|1340542|P1|NOT COMPLETED|Overall Study||131
549894|NCT00730847|1340542|P1|COMPLETED|Overall Study||465
549895|NCT00730847|1340542|P1|STARTED|Overall Study||596
549896|NCT00730756|1340551|P2|NOT COMPLETED|Overall Study||5
549897|NCT00730756|1340552|P1|NOT COMPLETED|Overall Study||4
549898|NCT00730756|1340551|P2|COMPLETED|Overall Study||48
549899|NCT00730756|1340552|P1|COMPLETED|Overall Study||45
549900|NCT00730756|1340551|P2|STARTED|Overall Study||53
549901|NCT00730756|1340552|P1|STARTED|Overall Study||49
549902|NCT00730730|1340574|P1|NOT COMPLETED|Overall Study||0
549903|NCT00730730|1340574|P1|COMPLETED|Overall Study||50
549904|NCT00730730|1340574|P1|STARTED|Overall Study||50
549905|NCT00730691|1340586|P5|NOT COMPLETED|Overall Study||50
549906|NCT00730691|1340587|P4|NOT COMPLETED|Overall Study||45
549907|NCT00730691|1340588|P3|NOT COMPLETED|Overall Study||39
549908|NCT00730691|1340589|P2|NOT COMPLETED|Overall Study||36
549909|NCT00730691|1340590|P1|NOT COMPLETED|Overall Study||36
549910|NCT00730691|1340586|P5|COMPLETED|Overall Study||106
549911|NCT00730691|1340587|P4|COMPLETED|Overall Study||111
549912|NCT00730691|1340588|P3|COMPLETED|Overall Study||117
549913|NCT00730691|1340589|P2|COMPLETED|Overall Study||120
549914|NCT00730691|1340590|P1|COMPLETED|Overall Study||121
549915|NCT00730691|1340586|P5|STARTED|Overall Study||156
549916|NCT00730691|1340587|P4|STARTED|Overall Study||156
549917|NCT00730691|1340588|P3|STARTED|Overall Study|One participant was randomized by error. Reason not completed is reported as Other.|156
549918|NCT00730691|1340589|P2|STARTED|Overall Study||156
549919|NCT00730691|1340590|P1|STARTED|Overall Study||157
549920|NCT00730639|1340682|P5|NOT COMPLETED|Overall Study||131
549921|NCT00730639|1340683|P4|NOT COMPLETED|Overall Study||54
549922|NCT00730639|1340684|P3|NOT COMPLETED|Overall Study||86
549923|NCT00730639|1340685|P2|NOT COMPLETED|Overall Study||18
549924|NCT00730639|1340686|P1|NOT COMPLETED|Overall Study||17
549925|NCT00730639|1340682|P5|COMPLETED|Overall Study||0
549926|NCT00730639|1340683|P4|COMPLETED|Overall Study||0
549927|NCT00730639|1340684|P3|COMPLETED|Overall Study||0
549928|NCT00730639|1340685|P2|COMPLETED|Overall Study||0
549929|NCT00730639|1340686|P1|COMPLETED|Overall Study||0
549930|NCT00730639|1340682|P5|STARTED|Overall Study||131
549931|NCT00730639|1340683|P4|STARTED|Overall Study||54
549932|NCT00730639|1340684|P3|STARTED|Overall Study||86
549933|NCT00730639|1340685|P2|STARTED|Overall Study||18
549934|NCT00730639|1340686|P1|STARTED|Overall Study||17
549935|NCT00730483|1340750|P1|NOT COMPLETED|Overall Study||7
549936|NCT00730483|1340750|P1|COMPLETED|Overall Study||6
549937|NCT00730483|1340750|P1|6 Months After First DEB-TACE|Overall Study||10
549938|NCT00730483|1340750|P1|1 Month After First DEB-TACE|Overall Study||13
549939|NCT00730483|1340750|P1|STARTED|Overall Study||13
549940|NCT00730405|1340763|P5|NOT COMPLETED|Overall Study-follow-up Phase||22
549941|NCT00730405|1340764|P4|NOT COMPLETED|Overall Study-follow-up Phase||17
549942|NCT00730405|1340765|P3|NOT COMPLETED|Overall Study-follow-up Phase||23
549943|NCT00730405|1340766|P2|NOT COMPLETED|Overall Study-follow-up Phase||21
549944|NCT00730405|1340767|P1|NOT COMPLETED|Overall Study-follow-up Phase||21
549945|NCT00730405|1340763|P5|COMPLETED|Overall Study-follow-up Phase||93
549946|NCT00730405|1340764|P4|COMPLETED|Overall Study-follow-up Phase||100
549947|NCT00730405|1340765|P3|COMPLETED|Overall Study-follow-up Phase||94
549948|NCT00730405|1340766|P2|COMPLETED|Overall Study-follow-up Phase||96
549949|NCT00730405|1340767|P1|COMPLETED|Overall Study-follow-up Phase||95
549950|NCT00730405|1340763|P5|STARTED|Overall Study-follow-up Phase||115
549951|NCT00730405|1340764|P4|STARTED|Overall Study-follow-up Phase||117
549952|NCT00730405|1340765|P3|STARTED|Overall Study-follow-up Phase||117
549953|NCT00730405|1340766|P2|STARTED|Overall Study-follow-up Phase||117
549954|NCT00730405|1340767|P1|STARTED|Overall Study-follow-up Phase||116
549955|NCT00730405|1340763|P5|NOT COMPLETED|Overall Study-Treatment Phase||20
549956|NCT00730405|1340764|P4|NOT COMPLETED|Overall Study-Treatment Phase||19
549957|NCT00730405|1340765|P3|NOT COMPLETED|Overall Study-Treatment Phase||21
549958|NCT00730405|1340766|P2|NOT COMPLETED|Overall Study-Treatment Phase||21
549959|NCT00730405|1340767|P1|NOT COMPLETED|Overall Study-Treatment Phase||19
549960|NCT00730405|1340763|P5|COMPLETED|Overall Study-Treatment Phase||95
549961|NCT00730405|1340764|P4|COMPLETED|Overall Study-Treatment Phase||98
549962|NCT00730405|1340765|P3|COMPLETED|Overall Study-Treatment Phase||96
549963|NCT00730405|1340766|P2|COMPLETED|Overall Study-Treatment Phase||96
549964|NCT00730405|1340767|P1|COMPLETED|Overall Study-Treatment Phase||97
549965|NCT00730405|1340763|P5|STARTED|Overall Study-Treatment Phase||115
549966|NCT00730405|1340764|P4|STARTED|Overall Study-Treatment Phase||117
549967|NCT00730405|1340765|P3|STARTED|Overall Study-Treatment Phase||117
549968|NCT00730405|1340766|P2|STARTED|Overall Study-Treatment Phase||117
549969|NCT00730405|1340767|P1|STARTED|Overall Study-Treatment Phase||116
549970|NCT00730353|1340804|P1|NOT COMPLETED|Overall Study||0
549971|NCT00730353|1340804|P1|COMPLETED|Overall Study||28
549972|NCT00730353|1340804|P1|STARTED|Overall Study||28
549973|NCT00730327|1340814|P2|NOT COMPLETED|Overall Study||37
549974|NCT00730327|1340815|P1|NOT COMPLETED|Overall Study||27
549975|NCT00730327|1340814|P2|COMPLETED|Overall Study||93
550068|NCT00729846|1341278|P2|STARTED|Overall Study||11
549976|NCT00730327|1340815|P1|COMPLETED|Overall Study|Completed defined as subjects who completed the Week 52 follow-up visit.|98
549977|NCT00730327|1340814|P2|Completed Week 26|Overall Study||99
549978|NCT00730327|1340815|P1|Completed Week 26|Overall Study|Week 26 was halfway through the study, at which point the BIB group had their balloon removed.|125
549979|NCT00730327|1340814|P2|STARTED|Overall Study||130
549980|NCT00730327|1340815|P1|STARTED|Overall Study|Started is defined as subjects that began treatment.|125
549981|NCT00730275|1340840|P4|NOT COMPLETED|Overall Study||1
549982|NCT00730275|1340841|P3|NOT COMPLETED|Overall Study||0
549983|NCT00730275|1340842|P2|NOT COMPLETED|Overall Study||0
549984|NCT00730275|1340843|P1|NOT COMPLETED|Overall Study||0
549985|NCT00730275|1340840|P4|COMPLETED|Overall Study||8
549986|NCT00730275|1340841|P3|COMPLETED|Overall Study||8
549987|NCT00730275|1340842|P2|COMPLETED|Overall Study||9
549988|NCT00730275|1340843|P1|COMPLETED|Overall Study||9
549989|NCT00730275|1340840|P4|STARTED|Overall Study||9
549990|NCT00730275|1340841|P3|STARTED|Overall Study||8
549991|NCT00730275|1340842|P2|STARTED|Overall Study||9
549992|NCT00730275|1340843|P1|STARTED|Overall Study||9
549993|NCT00730236|1340869|P1|NOT COMPLETED|Overall Study||6
549994|NCT00730236|1340869|P1|COMPLETED|Overall Study||23
549995|NCT00730236|1340869|P1|STARTED|Overall Study||29
549996|NCT00730171|1340884|P1|NOT COMPLETED|Overall Study||771
549997|NCT00730171|1340884|P1|COMPLETED|Overall Study||954
549998|NCT00730171|1340884|P1|IBS-C Safety Population|Overall Study||1119
549999|NCT00730171|1340884|P1|CC Safety Population|Overall Study||607
550000|NCT00730171|1340884|P1|STARTED|Overall Study||1725
550001|NCT00730132|1340892|P1|NOT COMPLETED|Overall Study||155
550002|NCT00730132|1340892|P1|COMPLETED|Overall Study||557
550003|NCT00730132|1340892|P1|STARTED|Overall Study||712
550004|NCT00730041|1340910|P2|NOT COMPLETED|Overall Study||2
550005|NCT00730041|1340911|P1|NOT COMPLETED|Overall Study||0
550006|NCT00730041|1340910|P2|COMPLETED|Overall Study|One subject did not return for the final PSG or final visit, and one missed only the final visit.|23
550007|NCT00730041|1340911|P1|COMPLETED|Overall Study||26
550008|NCT00730041|1340910|P2|STARTED|Overall Study|4/25 (16.0%) female, 21/25 (84.0%) male|25
550009|NCT00730041|1340911|P1|STARTED|Overall Study|4/26 (15.4%) female, 22/26 (84.6%) male|26
550010|NCT00730028|1340934|P5|NOT COMPLETED|Overall Study||82
550011|NCT00730028|1340935|P4|NOT COMPLETED|Overall Study||56
550012|NCT00730028|1340936|P3|NOT COMPLETED|Overall Study||45
550013|NCT00730028|1340937|P2|NOT COMPLETED|Overall Study||66
550014|NCT00730028|1340938|P1|NOT COMPLETED|Overall Study||60
550015|NCT00730028|1340934|P5|COMPLETED|Overall Study||175
550016|NCT00730028|1340935|P4|COMPLETED|Overall Study||207
550017|NCT00730028|1340936|P3|COMPLETED|Overall Study||221
550018|NCT00730028|1340937|P2|COMPLETED|Overall Study||194
550019|NCT00730028|1340938|P1|COMPLETED|Overall Study||204
550020|NCT00730028|1340934|P5|STARTED|Overall Study||257
550021|NCT00730028|1340935|P4|STARTED|Overall Study||263
550022|NCT00730028|1340936|P3|STARTED|Overall Study||266
550023|NCT00730028|1340937|P2|STARTED|Overall Study||260
550024|NCT00730028|1340938|P1|STARTED|Overall Study||264
550025|NCT00730015|1340988|P3|NOT COMPLETED|Overall Study||32
550026|NCT00730015|1340989|P2|NOT COMPLETED|Overall Study||40
550027|NCT00730015|1340990|P1|NOT COMPLETED|Overall Study||31
550028|NCT00730015|1340988|P3|COMPLETED|Overall Study||177
550029|NCT00730015|1340989|P2|COMPLETED|Overall Study||177
550030|NCT00730015|1340990|P1|COMPLETED|Overall Study||186
550031|NCT00730015|1340988|P3|STARTED|Overall Study||209
550032|NCT00730015|1340989|P2|STARTED|Overall Study||217
550033|NCT00730015|1340990|P1|STARTED|Overall Study||217
550034|NCT00729937|1341030|P6|NOT COMPLETED|Overall Study||37
550035|NCT00729937|1341031|P5|NOT COMPLETED|Overall Study||28
550036|NCT00729937|1341032|P4|NOT COMPLETED|Overall Study||34
550037|NCT00729937|1341033|P3|NOT COMPLETED|Overall Study||29
550038|NCT00729937|1341034|P2|NOT COMPLETED|Overall Study||88
550039|NCT00729937|1341035|P1|NOT COMPLETED|Overall Study||74
550040|NCT00729937|1341030|P6|COMPLETED|Overall Study||214
550041|NCT00729937|1341031|P5|COMPLETED|Overall Study||221
550042|NCT00729937|1341032|P4|COMPLETED|Overall Study||215
550043|NCT00729937|1341033|P3|COMPLETED|Overall Study||222
550044|NCT00729937|1341034|P2|COMPLETED|Overall Study||548
550045|NCT00729937|1341035|P1|COMPLETED|Overall Study||555
550046|NCT00729937|1341030|P6|STARTED|Overall Study||251
550047|NCT00729937|1341031|P5|STARTED|Overall Study||249
550048|NCT00729937|1341032|P4|STARTED|Overall Study||249
550049|NCT00729937|1341033|P3|STARTED|Overall Study||251
550050|NCT00729937|1341034|P2|STARTED|Overall Study||636
550051|NCT00729937|1341035|P1|STARTED|Overall Study||629
550052|NCT00729924|1341229|P1|NOT COMPLETED|Overall Study||0
550053|NCT00729924|1341229|P1|COMPLETED|Overall Study||40
550054|NCT00729924|1341229|P1|STARTED|Overall Study||40
550055|NCT00729859|1341239|P3|NOT COMPLETED|Overall Study||0
550056|NCT00729859|1341240|P2|NOT COMPLETED|Overall Study||2
550057|NCT00729859|1341241|P1|NOT COMPLETED|Overall Study||0
550058|NCT00729859|1341239|P3|COMPLETED|Overall Study||8
550059|NCT00729859|1341240|P2|COMPLETED|Overall Study||6
550060|NCT00729859|1341241|P1|COMPLETED|Overall Study||8
550061|NCT00729859|1341239|P3|STARTED|Overall Study||8
550062|NCT00729859|1341240|P2|STARTED|Overall Study||8
550063|NCT00729859|1341241|P1|STARTED|Overall Study||8
550064|NCT00729846|1341278|P2|NOT COMPLETED|Overall Study||0
550065|NCT00729846|1341279|P1|NOT COMPLETED|Overall Study||0
550066|NCT00729846|1341278|P2|COMPLETED|Overall Study||11
550067|NCT00729846|1341279|P1|COMPLETED|Overall Study||11
550069|NCT00729846|1341279|P1|STARTED|Overall Study||11
550070|NCT00729833|1341285|P4|NOT COMPLETED|Overall Study||6
550071|NCT00729833|1341286|P3|NOT COMPLETED|Overall Study||12
550072|NCT00729833|1341287|P2|NOT COMPLETED|Overall Study||7
550073|NCT00729833|1341288|P1|NOT COMPLETED|Overall Study||20
550074|NCT00729833|1341285|P4|COMPLETED|Overall Study||0
550075|NCT00729833|1341286|P3|COMPLETED|Overall Study||0
550076|NCT00729833|1341287|P2|COMPLETED|Overall Study||0
550077|NCT00729833|1341288|P1|COMPLETED|Overall Study||0
550078|NCT00729833|1341285|P4|STARTED|Overall Study||6
550079|NCT00729833|1341286|P3|STARTED|Overall Study||12
550080|NCT00729833|1341287|P2|STARTED|Overall Study||7
550081|NCT00729833|1341288|P1|STARTED|Overall Study||20
550082|NCT00729807|1341327|P1|NOT COMPLETED|Overall Study||0
550083|NCT00729807|1341327|P1|COMPLETED|Overall Study||6
550084|NCT00729807|1341327|P1|STARTED|Overall Study||6
550085|NCT00729781|1341331|P1|NOT COMPLETED|Long-term Follow-up Study||0
550086|NCT00729781|1341331|P1|COMPLETED|Long-term Follow-up Study|All subjects completed the original study, but 3 did not consent to enroll in the follow-up study.|42
550087|NCT00729781|1341331|P1|STARTED|Long-term Follow-up Study|Enrollment in the long-term follow-up required contact and a new Informed Consent.|42
550088|NCT00729781|1341331|P1|NOT COMPLETED|Original Study||0
550089|NCT00729781|1341331|P1|COMPLETED|Original Study||45
550090|NCT00729781|1341331|P1|STARTED|Original Study||45
550091|NCT00729690|1341340|P3|NOT COMPLETED|Overall Study||2
550092|NCT00729690|1341341|P2|NOT COMPLETED|Overall Study||2
550093|NCT00729690|1341342|P1|NOT COMPLETED|Overall Study||0
550094|NCT00729690|1341340|P3|COMPLETED|Overall Study||14
550095|NCT00729690|1341341|P2|COMPLETED|Overall Study||14
550096|NCT00729690|1341342|P1|COMPLETED|Overall Study||16
550097|NCT00729690|1341340|P3|STARTED|Overall Study||16
550098|NCT00729690|1341341|P2|STARTED|Overall Study||16
550099|NCT00729690|1341342|P1|STARTED|Overall Study||16
550100|NCT00729677|1341359|P1|NOT COMPLETED|Overall Study||0
550101|NCT00729677|1341359|P1|COMPLETED|Overall Study||64
550102|NCT00729677|1341359|P1|STARTED|Overall Study||64
550103|NCT00729651|1341372|P2|NOT COMPLETED|Overall Study||18
550104|NCT00729651|1341373|P1|NOT COMPLETED|Overall Study||19
550105|NCT00729651|1341372|P2|COMPLETED|Overall Study||152
550106|NCT00729651|1341373|P1|COMPLETED|Overall Study||154
550107|NCT00729651|1341372|P2|STARTED|Overall Study||170
550108|NCT00729651|1341373|P1|STARTED|Overall Study||173
550109|NCT00729612|1341385|P1|NOT COMPLETED|Overall Study||10
550110|NCT00729612|1341385|P1|COMPLETED|Overall Study||53
550111|NCT00729612|1341385|P1|Died After Cycle 2 Before Response Eval|Overall Study||1
550112|NCT00729612|1341385|P1|Received Cycle 2|Overall Study||54
550113|NCT00729612|1341385|P1|Did Not Receive Cycle 2|Overall Study||7
550114|NCT00729612|1341385|P1|Received Cycle 1|Overall Study||62
550115|NCT00729612|1341385|P1|Died Before Cycle 1|Overall Study||1
550116|NCT00729612|1341385|P1|STARTED|Overall Study||63
550117|NCT00729560|1341392|P1|NOT COMPLETED|Overall Study||3
550118|NCT00729560|1341392|P1|COMPLETED|Overall Study||5
550119|NCT00729560|1341392|P1|STARTED|Overall Study|Arm assignment can not be determined as study was ended prior to unblinding and no key found.|8
550120|NCT00729521|1341399|P3|NOT COMPLETED|Overall Study||0
550121|NCT00729521|1341400|P2|NOT COMPLETED|Overall Study||0
550122|NCT00729521|1341401|P1|NOT COMPLETED|Overall Study||0
550123|NCT00729521|1341399|P3|COMPLETED|Overall Study|Average annual population over 65 years old.|7701
550124|NCT00729521|1341400|P2|COMPLETED|Overall Study|Average annual population over 65 years old.|14842
550125|NCT00729521|1341401|P1|COMPLETED|Overall Study|Average annual population over 65 years old.|12494
550126|NCT00729521|1341399|P3|STARTED|Overall Study|5 communities in Facilitative System with average annual pop. of 7,701 residents over 65 years.|7701
550127|NCT00729521|1341400|P2|STARTED|Overall Study|Five communities with average annual population of 14,842 residents over 65 years old.|14842
550128|NCT00729521|1341401|P1|STARTED|Overall Study|10 communities in Control with average annual population of 12,494 residents over 65 years old.|12494
550129|NCT00729482|1341409|P1|NOT COMPLETED|Overall Study||0
550130|NCT00729482|1341409|P1|COMPLETED|Overall Study||54
550131|NCT00729482|1341409|P1|STARTED|Overall Study||54
550132|NCT00729469|1341418|P2|NOT COMPLETED|Overall Study||47
550133|NCT00729469|1341419|P1|NOT COMPLETED|Overall Study||53
550134|NCT00729469|1341418|P2|COMPLETED|Overall Study||416
550135|NCT00729469|1341419|P1|COMPLETED|Overall Study||403
550136|NCT00729469|1341418|P2|STARTED|Overall Study||463
550137|NCT00729469|1341419|P1|STARTED|Overall Study||456
550138|NCT00729430|1341457|P2|NOT COMPLETED|Overall Study||50
550139|NCT00729430|1341458|P1|NOT COMPLETED|Overall Study||47
550140|NCT00729430|1341457|P2|COMPLETED|Overall Study||128
550141|NCT00729430|1341458|P1|COMPLETED|Overall Study||133
550142|NCT00729430|1341457|P2|STARTED|Overall Study||178
550143|NCT00729430|1341458|P1|STARTED|Overall Study||180
550144|NCT00729378|1341472|P2|NOT COMPLETED|36-months||6
550145|NCT00729378|1341473|P1|NOT COMPLETED|36-months||15
550146|NCT00729378|1341472|P2|COMPLETED|36-months||95
550147|NCT00729378|1341473|P1|COMPLETED|36-months||105
550148|NCT00729378|1341472|P2|STARTED|36-months||101
550149|NCT00729378|1341473|P1|STARTED|36-months||120
550150|NCT00729378|1341472|P2|NOT COMPLETED|24-months||51
550151|NCT00729378|1341473|P1|NOT COMPLETED|24-months||72
550152|NCT00729378|1341472|P2|COMPLETED|24-months||101
550153|NCT00729378|1341473|P1|COMPLETED|24-months||120
550154|NCT00729378|1341472|P2|STARTED|24-months||152
550155|NCT00729378|1341473|P1|STARTED|24-months||192
550156|NCT00729378|1341472|P2|NOT COMPLETED|12-months||65
550157|NCT00729378|1341473|P1|NOT COMPLETED|12-months||100
550158|NCT00729378|1341472|P2|COMPLETED|12-months||152
550159|NCT00729378|1341473|P1|COMPLETED|12-months||192
550160|NCT00729378|1341472|P2|STARTED|12-months||217
550161|NCT00729378|1341473|P1|STARTED|12-months||292
550162|NCT00729378|1341472|P2|NOT COMPLETED|Baseline||92
550163|NCT00729378|1341473|P1|NOT COMPLETED|Baseline||138
550164|NCT00729378|1341472|P2|COMPLETED|Baseline||217
550165|NCT00729378|1341473|P1|COMPLETED|Baseline||292
550166|NCT00729378|1341472|P2|STARTED|Baseline||309
550167|NCT00729378|1341473|P1|STARTED|Baseline||430
550168|NCT00729365|1341672|P3|NOT COMPLETED|Overall Study||7
550169|NCT00729365|1341673|P2|NOT COMPLETED|Overall Study||6
550170|NCT00729365|1341674|P1|NOT COMPLETED|Overall Study||33
550171|NCT00729365|1341672|P3|COMPLETED|Overall Study|Study terminated|0
550172|NCT00729365|1341673|P2|COMPLETED|Overall Study|Study Terminated|0
550173|NCT00729365|1341674|P1|COMPLETED|Overall Study|Study terminated|0
550174|NCT00729365|1341672|P3|STARTED|Overall Study||7
550175|NCT00729365|1341673|P2|STARTED|Overall Study||6
550176|NCT00729365|1341674|P1|STARTED|Overall Study||33
550177|NCT00729326|1341687|P2|NOT COMPLETED|Overall Study||9
550178|NCT00729326|1341688|P1|NOT COMPLETED|Overall Study||10
550179|NCT00729326|1341687|P2|COMPLETED|Overall Study||33
550180|NCT00729326|1341688|P1|COMPLETED|Overall Study||31
550181|NCT00729326|1341687|P2|STARTED|Overall Study||42
550182|NCT00729326|1341688|P1|STARTED|Overall Study||41
550183|NCT00729248|1341730|P1|NOT COMPLETED|Overall Study||2
550184|NCT00729248|1341730|P1|COMPLETED|Overall Study||10
550185|NCT00729248|1341730|P1|STARTED|Overall Study||12
550186|NCT00729183|1341737|P2|NOT COMPLETED|Overall Study||15
550187|NCT00729183|1341738|P1|NOT COMPLETED|Overall Study||25
550188|NCT00729183|1341737|P2|COMPLETED|Overall Study|Completed 24 month visit|90
550189|NCT00729183|1341738|P1|COMPLETED|Overall Study|Completed 24 month visit|84
550190|NCT00729183|1341737|P2|STARTED|Overall Study||105
550191|NCT00729183|1341738|P1|STARTED|Overall Study||109
550192|NCT00729157|1341770|P1|NOT COMPLETED|Overall Study||1
550193|NCT00729157|1341770|P1|COMPLETED|Overall Study||40
550194|NCT00729157|1341770|P1|STARTED|Overall Study||41
550195|NCT00729053|1341782|P4|NOT COMPLETED|Overall Study||0
550196|NCT00729053|1341783|P3|NOT COMPLETED|Overall Study||0
550197|NCT00729053|1341784|P2|NOT COMPLETED|Overall Study||0
550198|NCT00729053|1341785|P1|NOT COMPLETED|Overall Study||0
550199|NCT00729053|1341782|P4|COMPLETED|Overall Study||23
550200|NCT00729053|1341783|P3|COMPLETED|Overall Study||23
550201|NCT00729053|1341784|P2|COMPLETED|Overall Study||23
550202|NCT00729053|1341785|P1|COMPLETED|Overall Study||23
550203|NCT00729053|1341782|P4|STARTED|Overall Study||23
550204|NCT00729053|1341783|P3|STARTED|Overall Study||23
550205|NCT00729053|1341784|P2|STARTED|Overall Study||23
550206|NCT00729053|1341785|P1|STARTED|Overall Study||23
550207|NCT00728988|1341813|P2|NOT COMPLETED|Overall Study||88
550208|NCT00728988|1341814|P1|NOT COMPLETED|Overall Study||93
550209|NCT00728988|1341813|P2|COMPLETED|Overall Study||164
550210|NCT00728988|1341814|P1|COMPLETED|Overall Study||154
550211|NCT00728988|1341813|P2|Full Analysis Set|Overall Study||172
550212|NCT00728988|1341814|P1|Full Analysis Set|Overall Study||163
550213|NCT00728988|1341813|P2|Treated|Overall Study||250
550214|NCT00728988|1341814|P1|Treated|Overall Study||245
550215|NCT00728988|1341813|P2|STARTED|Overall Study||252
550216|NCT00728988|1341814|P1|STARTED|Overall Study||247
550217|NCT00728962|1341832|P1|NOT COMPLETED|Two Year Post Placement Follow-up||3
550218|NCT00728962|1341832|P1|COMPLETED|Two Year Post Placement Follow-up||59
550219|NCT00728962|1341832|P1|STARTED|Two Year Post Placement Follow-up||62
550220|NCT00728962|1341832|P1|NOT COMPLETED|One Year Post Placement Follow-up||0
550221|NCT00728962|1341832|P1|COMPLETED|One Year Post Placement Follow-up||62
550222|NCT00728962|1341832|P1|STARTED|One Year Post Placement Follow-up||62
550223|NCT00728962|1341832|P1|NOT COMPLETED|Permanent Prosthesis Placement||3
550224|NCT00728962|1341832|P1|COMPLETED|Permanent Prosthesis Placement||62
550225|NCT00728962|1341832|P1|STARTED|Permanent Prosthesis Placement||65
550226|NCT00728962|1341832|P1|NOT COMPLETED|Implant Placement Surgery||10
550227|NCT00728962|1341832|P1|COMPLETED|Implant Placement Surgery||65
550228|NCT00728962|1341832|P1|STARTED|Implant Placement Surgery||75
550229|NCT00728949|1341838|P2|NOT COMPLETED|Overall Study||4
550230|NCT00728949|1341839|P1|NOT COMPLETED|Overall Study||11
550231|NCT00728949|1341838|P2|COMPLETED|Overall Study||27
550232|NCT00728949|1341839|P1|COMPLETED|Overall Study||51
550233|NCT00728949|1341838|P2|STARTED|Overall Study||31
550234|NCT00728949|1341839|P1|STARTED|Overall Study||62
550235|NCT00728923|1341857|P1|NOT COMPLETED|Overall Study||0
550236|NCT00728923|1341857|P1|COMPLETED|Overall Study||9
550237|NCT00728923|1341857|P1|STARTED|Overall Study||9
550238|NCT00728910|1341862|P1|NOT COMPLETED|Atorvastatin+ABT335+ER Niacin||0
550239|NCT00728910|1341862|P1|COMPLETED|Atorvastatin+ABT335+ER Niacin||22
550240|NCT00728910|1341862|P1|STARTED|Atorvastatin+ABT335+ER Niacin||22
550241|NCT00728910|1341862|P1|NOT COMPLETED|Atorvastatin+ABT335||0
550242|NCT00728910|1341862|P1|COMPLETED|Atorvastatin+ABT335||22
550243|NCT00728910|1341862|P1|STARTED|Atorvastatin+ABT335||22
550244|NCT00728910|1341862|P1|NOT COMPLETED|Atorvastatin||3
550245|NCT00728910|1341862|P1|COMPLETED|Atorvastatin||22
550246|NCT00728910|1341862|P1|STARTED|Atorvastatin||25
550247|NCT00728884|1341874|P1|NOT COMPLETED|Two Year Post Placement Follow-up||0
550248|NCT00728884|1341874|P1|COMPLETED|Two Year Post Placement Follow-up||145
550249|NCT00728884|1341874|P1|STARTED|Two Year Post Placement Follow-up||145
550250|NCT00728884|1341874|P1|NOT COMPLETED|One Year Post Placement Follow-up||4
550251|NCT00728884|1341874|P1|COMPLETED|One Year Post Placement Follow-up||145
550252|NCT00728884|1341874|P1|STARTED|One Year Post Placement Follow-up||149
550253|NCT00728884|1341874|P1|NOT COMPLETED|Permanent Prosthesis Placement||13
550254|NCT00728884|1341874|P1|COMPLETED|Permanent Prosthesis Placement||149
550255|NCT00728884|1341874|P1|STARTED|Permanent Prosthesis Placement||162
550256|NCT00728884|1341874|P1|NOT COMPLETED|Implant Placement Surgery||0
550257|NCT00728884|1341874|P1|COMPLETED|Implant Placement Surgery||162
550258|NCT00728884|1341874|P1|STARTED|Implant Placement Surgery||162
550259|NCT00728845|1341880|P2|NOT COMPLETED|Overall Study||0
550260|NCT00728845|1341881|P1|NOT COMPLETED|Overall Study||0
550261|NCT00728845|1341880|P2|COMPLETED|Overall Study||0
550262|NCT00728845|1341881|P1|COMPLETED|Overall Study||8
550263|NCT00728845|1341880|P2|STARTED|Overall Study||0
550264|NCT00728845|1341881|P1|STARTED|Overall Study||8
550265|NCT00728819|1341897|P2|NOT COMPLETED|Overall Study||29
550266|NCT00728819|1341898|P1|NOT COMPLETED|Overall Study||36
550267|NCT00728819|1341897|P2|COMPLETED|Overall Study||139
550268|NCT00728819|1341898|P1|COMPLETED|Overall Study||135
550269|NCT00728819|1341897|P2|STARTED|Overall Study||168
550270|NCT00728819|1341898|P1|STARTED|Overall Study||171
550271|NCT00728754|1341910|P2|NOT COMPLETED|Two Year Post Placement Follow-up||0
550272|NCT00728754|1341911|P1|NOT COMPLETED|Two Year Post Placement Follow-up||0
550273|NCT00728754|1341910|P2|COMPLETED|Two Year Post Placement Follow-up|individual test implant units completed= 68|28
550274|NCT00728754|1341911|P1|COMPLETED|Two Year Post Placement Follow-up|individual test implant units completed= 65|24
550275|NCT00728754|1341910|P2|STARTED|Two Year Post Placement Follow-up|individual control implant units is 68|28
550276|NCT00728754|1341911|P1|STARTED|Two Year Post Placement Follow-up|individual test implant units is 65|24
550277|NCT00728754|1341910|P2|NOT COMPLETED|One Year Post Placement Follow-up||0
550278|NCT00728754|1341911|P1|NOT COMPLETED|One Year Post Placement Follow-up||1
550279|NCT00728754|1341910|P2|COMPLETED|One Year Post Placement Follow-up|individual control implant units completed= 68|28
550280|NCT00728754|1341911|P1|COMPLETED|One Year Post Placement Follow-up|individual test implant units completing is 65|24
550281|NCT00728754|1341910|P2|STARTED|One Year Post Placement Follow-up|individual control implant units is 68|28
550282|NCT00728754|1341911|P1|STARTED|One Year Post Placement Follow-up|individual test implant units is 66|25
550283|NCT00728754|1341910|P2|NOT COMPLETED|Permanent Prosthesis Placement||4
550284|NCT00728754|1341911|P1|NOT COMPLETED|Permanent Prosthesis Placement||4
550285|NCT00728754|1341910|P2|COMPLETED|Permanent Prosthesis Placement|Individual control implant units completed = 68|28
550286|NCT00728754|1341911|P1|COMPLETED|Permanent Prosthesis Placement|Individual test implant units completed = 66|25
550287|NCT00728754|1341910|P2|STARTED|Permanent Prosthesis Placement|Individual control implant units is 78|32
550288|NCT00728754|1341911|P1|STARTED|Permanent Prosthesis Placement|Individual test implant units is 75|29
550289|NCT00728754|1341910|P2|NOT COMPLETED|Implant Placement Surgery||0
550290|NCT00728754|1341911|P1|NOT COMPLETED|Implant Placement Surgery||0
550291|NCT00728754|1341910|P2|COMPLETED|Implant Placement Surgery|Individual control implant units completed = 78|32
550292|NCT00728754|1341911|P1|COMPLETED|Implant Placement Surgery|Individual test implant units completed = 75|29
550293|NCT00728754|1341910|P2|STARTED|Implant Placement Surgery|Individual control implant units is 78|32
550294|NCT00728754|1341911|P1|STARTED|Implant Placement Surgery|Individual test implant units is 75|29
550295|NCT00728728|1341919|P2|NOT COMPLETED|Overall Study||12
550296|NCT00728728|1341920|P1|NOT COMPLETED|Overall Study||4
550297|NCT00728728|1341919|P2|COMPLETED|Overall Study||34
550298|NCT00728728|1341920|P1|COMPLETED|Overall Study||38
550299|NCT00728728|1341919|P2|STARTED|Overall Study||46
550300|NCT00728728|1341920|P1|STARTED|Overall Study||42
550301|NCT00728689|1341940|P2|NOT COMPLETED|Second Intervention (Days 11 - 13)||0
550302|NCT00728689|1341941|P1|NOT COMPLETED|Second Intervention (Days 11 - 13)||0
550303|NCT00728689|1341940|P2|COMPLETED|Second Intervention (Days 11 - 13)||6
550304|NCT00728689|1341941|P1|COMPLETED|Second Intervention (Days 11 - 13)||5
550305|NCT00728689|1341940|P2|STARTED|Second Intervention (Days 11 - 13)||6
550306|NCT00728689|1341941|P1|STARTED|Second Intervention (Days 11 - 13)||5
550307|NCT00728689|1341940|P2|NOT COMPLETED|Washout Period (Days 4 - 10)||0
550308|NCT00728689|1341941|P1|NOT COMPLETED|Washout Period (Days 4 - 10)||1
550309|NCT00728689|1341940|P2|COMPLETED|Washout Period (Days 4 - 10)||6
550310|NCT00728689|1341941|P1|COMPLETED|Washout Period (Days 4 - 10)|Death in family during the Washout period. Completed First Intervention period with ST-246 Form I.|5
550311|NCT00728689|1341940|P2|STARTED|Washout Period (Days 4 - 10)||6
550312|NCT00728689|1341941|P1|STARTED|Washout Period (Days 4 - 10)||6
550313|NCT00728689|1341940|P2|NOT COMPLETED|First Intervention (Days 1 - 3)||0
550314|NCT00728689|1341941|P1|NOT COMPLETED|First Intervention (Days 1 - 3)||0
550315|NCT00728689|1341940|P2|COMPLETED|First Intervention (Days 1 - 3)||6
550316|NCT00728689|1341941|P1|COMPLETED|First Intervention (Days 1 - 3)||6
550317|NCT00728689|1341940|P2|STARTED|First Intervention (Days 1 - 3)||6
550318|NCT00728689|1341941|P1|STARTED|First Intervention (Days 1 - 3)||6
550319|NCT00728507|1341959|P2|NOT COMPLETED|Overall Study||8
550320|NCT00728507|1341960|P1|NOT COMPLETED|Overall Study||2
550321|NCT00728507|1341959|P2|COMPLETED|Overall Study||51
550322|NCT00728507|1341960|P1|COMPLETED|Overall Study||60
550323|NCT00728507|1341959|P2|STARTED|Overall Study||59
550324|NCT00728507|1341960|P1|STARTED|Overall Study||62
550325|NCT00728494|1341970|P2|NOT COMPLETED|Overall Study||7
550326|NCT00728494|1341971|P1|NOT COMPLETED|Overall Study||9
550327|NCT00728494|1341970|P2|COMPLETED|Overall Study||32
550328|NCT00728494|1341971|P1|COMPLETED|Overall Study||51
550329|NCT00728494|1341970|P2|STARTED|Overall Study||39
550330|NCT00728494|1341971|P1|STARTED|Overall Study||60
550331|NCT00728481|1341989|P2|NOT COMPLETED|Overall Study||4
550332|NCT00728481|1341990|P1|NOT COMPLETED|Overall Study||1
550333|NCT00728481|1341989|P2|COMPLETED|Overall Study||28
550334|NCT00728481|1341990|P1|COMPLETED|Overall Study||18
550335|NCT00728481|1341989|P2|STARTED|Overall Study||32
550336|NCT00728481|1341990|P1|STARTED|Overall Study||19
550337|NCT00728468|1342006|P1|NOT COMPLETED|Overall Study||16
550338|NCT00728468|1342006|P1|COMPLETED|Overall Study||0
550339|NCT00728468|1342006|P1|Treated|Overall Study||15
550340|NCT00728468|1342006|P1|STARTED|Overall Study||16
550341|NCT00728416|1342030|P2|NOT COMPLETED|Overall Study||2
550342|NCT00728416|1342031|P1|NOT COMPLETED|Overall Study||2
550343|NCT00728416|1342030|P2|COMPLETED|Overall Study||163
550344|NCT00728416|1342031|P1|COMPLETED|Overall Study||166
550345|NCT00728416|1342030|P2|STARTED|Overall Study||165
550346|NCT00728416|1342031|P1|STARTED|Overall Study||168
550347|NCT00728260|1342039|P1|NOT COMPLETED|Overall Study||0
550348|NCT00728260|1342039|P1|COMPLETED|Overall Study||1421
550349|NCT00728260|1342039|P1|STARTED|Overall Study||1421
550350|NCT00728182|1342047|P2|NOT COMPLETED|Overall Study||3
550351|NCT00728182|1342048|P1|NOT COMPLETED|Overall Study||3
550352|NCT00728182|1342047|P2|COMPLETED|Overall Study||90
550353|NCT00728182|1342048|P1|COMPLETED|Overall Study||89
550354|NCT00728182|1342047|P2|STARTED|Overall Study||93
550355|NCT00728182|1342048|P1|STARTED|Overall Study||92
550356|NCT00728130|1342076|P1|NOT COMPLETED|Overall Study||3
550357|NCT00728130|1342076|P1|COMPLETED|Overall Study||19
550358|NCT00728130|1342076|P1|STARTED|Overall Study||22
550359|NCT00727961|1342081|P1|NOT COMPLETED|Overall Study||37
550360|NCT00727961|1342081|P1|COMPLETED|Overall Study||21
550361|NCT00727961|1342081|P1|STARTED|Overall Study||58
550362|NCT00727909|1342091|P4|NOT COMPLETED|Overall Study||5
550363|NCT00727909|1342092|P3|NOT COMPLETED|Overall Study||9
550364|NCT00727909|1342093|P2|NOT COMPLETED|Overall Study||11
550365|NCT00727909|1342094|P1|NOT COMPLETED|Overall Study||5
550366|NCT00727909|1342091|P4|COMPLETED|Overall Study||70
550367|NCT00727909|1342092|P3|COMPLETED|Overall Study||58
550368|NCT00727909|1342093|P2|COMPLETED|Overall Study||61
550369|NCT00727909|1342094|P1|COMPLETED|Overall Study||60
550370|NCT00727909|1342091|P4|STARTED|Overall Study||75
550371|NCT00727909|1342092|P3|STARTED|Overall Study||67
550372|NCT00727909|1342093|P2|STARTED|Overall Study||72
550373|NCT00727909|1342094|P1|STARTED|Overall Study||65
550374|NCT00727857|1342101|P3|NOT COMPLETED|Overall Study||68
550375|NCT00727857|1342102|P2|NOT COMPLETED|Overall Study||64
550376|NCT00727857|1342103|P1|NOT COMPLETED|Overall Study||44
550377|NCT00727857|1342101|P3|COMPLETED|Overall Study||142
550378|NCT00727857|1342102|P2|COMPLETED|Overall Study||125
550379|NCT00727857|1342103|P1|COMPLETED|Overall Study||157
550380|NCT00727857|1342101|P3|STARTED|Overall Study||210
550381|NCT00727857|1342102|P2|STARTED|Overall Study||189
550382|NCT00727857|1342103|P1|STARTED|Overall Study||201
550383|NCT00727844|1342191|P4|NOT COMPLETED|Second Randomization||0
550384|NCT00727844|1342192|P3|NOT COMPLETED|Second Randomization||0
550385|NCT00727844|1342193|P2|NOT COMPLETED|Second Randomization||0
550386|NCT00727844|1342194|P1|NOT COMPLETED|Second Randomization||0
550387|NCT00727844|1342191|P4|COMPLETED|Second Randomization||16
550388|NCT00727844|1342192|P3|COMPLETED|Second Randomization||17
550389|NCT00727844|1342193|P2|COMPLETED|Second Randomization||0
550390|NCT00727844|1342194|P1|COMPLETED|Second Randomization||0
550391|NCT00727844|1342191|P4|STARTED|Second Randomization|6 patients excluded before 2nd randomization: 2 had withdrawn and 4 already dose reduced due to AE|16
550392|NCT00727844|1342192|P3|STARTED|Second Randomization|6 patients excluded before 2nd randomization: 2 had withdrawn and 4 already dose reduced due to AE|17
550393|NCT00727844|1342193|P2|STARTED|Second Randomization||0
550394|NCT00727844|1342194|P1|STARTED|Second Randomization||0
550395|NCT00727844|1342191|P4|NOT COMPLETED|Initial Randomization||0
550396|NCT00727844|1342192|P3|NOT COMPLETED|Initial Randomization||0
550397|NCT00727844|1342193|P2|NOT COMPLETED|Initial Randomization||0
550398|NCT00727844|1342194|P1|NOT COMPLETED|Initial Randomization||2
550399|NCT00727844|1342191|P4|COMPLETED|Initial Randomization||0
550400|NCT00727844|1342192|P3|COMPLETED|Initial Randomization||0
550401|NCT00727844|1342193|P2|COMPLETED|Initial Randomization||20
550402|NCT00727844|1342194|P1|COMPLETED|Initial Randomization||19
550403|NCT00727844|1342191|P4|Included in MITT Analysis|Initial Randomization||0
550404|NCT00727844|1342192|P3|Included in MITT Analysis|Initial Randomization||0
550405|NCT00727844|1342193|P2|Included in MITT Analysis|Initial Randomization||20
550406|NCT00727844|1342194|P1|Included in MITT Analysis|Initial Randomization||19
550407|NCT00727844|1342191|P4|STARTED|Initial Randomization||0
550408|NCT00727844|1342192|P3|STARTED|Initial Randomization||0
550409|NCT00727844|1342193|P2|STARTED|Initial Randomization||20
550410|NCT00727844|1342194|P1|STARTED|Initial Randomization|2 patients withdrawn before receiving any linezolid owing to baseline neuropathy|21
550411|NCT00727740|1342201|P2|NOT COMPLETED|Overall Study||0
550412|NCT00727740|1342202|P1|NOT COMPLETED|Overall Study||0
550413|NCT00727740|1342201|P2|COMPLETED|Overall Study||61
550414|NCT00727740|1342202|P1|COMPLETED|Overall Study||56
550415|NCT00727740|1342201|P2|STARTED|Overall Study||61
550416|NCT00727740|1342202|P1|STARTED|Overall Study||56
550417|NCT00727714|1342208|P1|NOT COMPLETED|Overall Study||2
550418|NCT00727714|1342208|P1|COMPLETED|Overall Study||93
550419|NCT00727714|1342208|P1|STARTED|Overall Study||95
550420|NCT00727649|1342218|P2|NOT COMPLETED|Second Intervention (4-weeks)||3
550421|NCT00727649|1342219|P1|NOT COMPLETED|Second Intervention (4-weeks)||1
550422|NCT00727649|1342218|P2|COMPLETED|Second Intervention (4-weeks)||34
550423|NCT00727649|1342219|P1|COMPLETED|Second Intervention (4-weeks)||29
550424|NCT00727649|1342218|P2|STARTED|Second Intervention (4-weeks)||37
550425|NCT00727649|1342219|P1|STARTED|Second Intervention (4-weeks)||30
550426|NCT00727649|1342218|P2|NOT COMPLETED|Wash-out (2-weeks)||3
550427|NCT00727649|1342219|P1|NOT COMPLETED|Wash-out (2-weeks)||4
550428|NCT00727649|1342218|P2|COMPLETED|Wash-out (2-weeks)||37
550429|NCT00727649|1342219|P1|COMPLETED|Wash-out (2-weeks)||30
550430|NCT00727649|1342218|P2|STARTED|Wash-out (2-weeks)||40
550431|NCT00727649|1342219|P1|STARTED|Wash-out (2-weeks)||34
550432|NCT00727649|1342218|P2|NOT COMPLETED|First Intervention (4-weeks)||3
550433|NCT00727649|1342219|P1|NOT COMPLETED|First Intervention (4-weeks)||3
550434|NCT00727649|1342218|P2|COMPLETED|First Intervention (4-weeks)||40
550435|NCT00727649|1342219|P1|COMPLETED|First Intervention (4-weeks)||34
550436|NCT00727649|1342218|P2|STARTED|First Intervention (4-weeks)||43
550437|NCT00727649|1342219|P1|STARTED|First Intervention (4-weeks)||37
550438|NCT00727636|1342233|P2|NOT COMPLETED|Overall Study||0
550439|NCT00727636|1342234|P1|NOT COMPLETED|Overall Study||4
550440|NCT00727636|1342233|P2|COMPLETED|Overall Study||15
550441|NCT00727636|1342234|P1|COMPLETED|Overall Study||33
550442|NCT00727636|1342233|P2|STARTED|Overall Study||15
550443|NCT00727636|1342234|P1|STARTED|Overall Study||37
550444|NCT00727597|1342248|P2|NOT COMPLETED|Overall Study||0
550445|NCT00727597|1342249|P1|NOT COMPLETED|Overall Study||0
550446|NCT00727597|1342248|P2|COMPLETED|Overall Study||50
550447|NCT00727597|1342249|P1|COMPLETED|Overall Study||51
550448|NCT00727597|1342248|P2|STARTED|Overall Study||50
550449|NCT00727597|1342249|P1|STARTED|Overall Study||51
550450|NCT00727571|1342261|P4|NOT COMPLETED|Overall Study||6
550451|NCT00727571|1342262|P3|NOT COMPLETED|Overall Study||30
550452|NCT00727571|1342263|P2|NOT COMPLETED|Overall Study||55
550453|NCT00727571|1342264|P1|NOT COMPLETED|Overall Study||1
550454|NCT00727571|1342261|P4|COMPLETED|Overall Study||163
550455|NCT00727571|1342262|P3|COMPLETED|Overall Study||135
550456|NCT00727571|1342263|P2|COMPLETED|Overall Study||173
550457|NCT00727571|1342264|P1|COMPLETED|Overall Study||231
550458|NCT00727571|1342261|P4|STARTED|Overall Study||169
550459|NCT00727571|1342262|P3|STARTED|Overall Study||165
550460|NCT00727571|1342263|P2|STARTED|Overall Study||228
550461|NCT00727571|1342264|P1|STARTED|Overall Study||232
550462|NCT00727558|1342291|P2|NOT COMPLETED|Overall Study||3
550463|NCT00727558|1342292|P1|NOT COMPLETED|Overall Study||2
550464|NCT00727558|1342291|P2|COMPLETED|Overall Study||118
550465|NCT00727558|1342292|P1|COMPLETED|Overall Study||125
550466|NCT00727558|1342291|P2|STARTED|Overall Study||121
550467|NCT00727558|1342292|P1|STARTED|Overall Study||127
550468|NCT00727506|1342316|P6|NOT COMPLETED|Overall Study||39
550469|NCT00727506|1342317|P5|NOT COMPLETED|Overall Study||41
550470|NCT00727506|1342318|P4|NOT COMPLETED|Overall Study||39
550471|NCT00727506|1342319|P3|NOT COMPLETED|Overall Study||18
550472|NCT00727506|1342320|P2|NOT COMPLETED|Overall Study||8
550473|NCT00727506|1342321|P1|NOT COMPLETED|Overall Study||6
550474|NCT00727506|1342316|P6|COMPLETED|Overall Study||0
550475|NCT00727506|1342317|P5|COMPLETED|Overall Study||0
550476|NCT00727506|1342318|P4|COMPLETED|Overall Study||0
550477|NCT00727506|1342319|P3|COMPLETED|Overall Study||0
550478|NCT00727506|1342320|P2|COMPLETED|Overall Study||0
550479|NCT00727506|1342321|P1|COMPLETED|Overall Study||0
550480|NCT00727506|1342316|P6|STARTED|Overall Study|Randomized|39
550481|NCT00727506|1342317|P5|STARTED|Overall Study|Randomized|41
550482|NCT00727506|1342318|P4|STARTED|Overall Study|Randomized|39
550483|NCT00727506|1342319|P3|STARTED|Overall Study|Entered|18
550484|NCT00727506|1342320|P2|STARTED|Overall Study|Entered|8
550485|NCT00727506|1342321|P1|STARTED|Overall Study|Entered|6
550486|NCT00727402|1342414|P1|NOT COMPLETED|Overall Study||116
550487|NCT00727402|1342414|P1|COMPLETED|Overall Study||89
550488|NCT00727402|1342414|P1|STARTED|Overall Study||205
550489|NCT00727337|1342422|P4|NOT COMPLETED|Overall Study||7
550490|NCT00727337|1342423|P3|NOT COMPLETED|Overall Study||9
550491|NCT00727337|1342424|P2|NOT COMPLETED|Overall Study||10
550492|NCT00727337|1342425|P1|NOT COMPLETED|Overall Study||10
550493|NCT00727337|1342422|P4|COMPLETED|Overall Study||61
550494|NCT00727337|1342423|P3|COMPLETED|Overall Study||64
550495|NCT00727337|1342424|P2|COMPLETED|Overall Study||63
550496|NCT00727337|1342425|P1|COMPLETED|Overall Study||55
550497|NCT00727337|1342422|P4|STARTED|Overall Study||68
550498|NCT00727337|1342423|P3|STARTED|Overall Study||73
550499|NCT00727337|1342424|P2|STARTED|Overall Study||73
550500|NCT00727337|1342425|P1|STARTED|Overall Study||65
550501|NCT00727311|1342435|P1|NOT COMPLETED|Overall Study||1107
550502|NCT00727311|1342435|P1|COMPLETED|Overall Study||1195
550503|NCT00727311|1342435|P1|STARTED|Overall Study||2302
550504|NCT00727298|1342442|P1|NOT COMPLETED|Overall Study||1257
550505|NCT00727298|1342442|P1|COMPLETED|Overall Study||3228
550506|NCT00727298|1342442|P1|STARTED|Overall Study||4485
550507|NCT00727272|1342448|P3|NOT COMPLETED|Period III||0
550508|NCT00727272|1342449|P2|NOT COMPLETED|Period III||0
550509|NCT00727272|1342450|P1|NOT COMPLETED|Period III||0
550510|NCT00727272|1342448|P3|COMPLETED|Period III||7
550511|NCT00727272|1342449|P2|COMPLETED|Period III||9
550512|NCT00727272|1342450|P1|COMPLETED|Period III||9
550513|NCT00727272|1342448|P3|STARTED|Period III||7
550514|NCT00727272|1342449|P2|STARTED|Period III||9
550515|NCT00727272|1342450|P1|STARTED|Period III||9
550516|NCT00727272|1342448|P3|NOT COMPLETED|Washout Period B||1
550517|NCT00727272|1342449|P2|NOT COMPLETED|Washout Period B||0
550518|NCT00727272|1342450|P1|NOT COMPLETED|Washout Period B||0
550519|NCT00727272|1342448|P3|COMPLETED|Washout Period B|personal reasons|7
550520|NCT00727272|1342449|P2|COMPLETED|Washout Period B||9
550521|NCT00727272|1342450|P1|COMPLETED|Washout Period B||9
550522|NCT00727272|1342448|P3|STARTED|Washout Period B||8
550523|NCT00727272|1342449|P2|STARTED|Washout Period B||9
550524|NCT00727272|1342450|P1|STARTED|Washout Period B||9
550525|NCT00727272|1342448|P3|NOT COMPLETED|Period II||0
550526|NCT00727272|1342449|P2|NOT COMPLETED|Period II||0
550527|NCT00727272|1342450|P1|NOT COMPLETED|Period II||0
550528|NCT00727272|1342448|P3|COMPLETED|Period II||8
550529|NCT00727272|1342449|P2|COMPLETED|Period II||9
550530|NCT00727272|1342450|P1|COMPLETED|Period II||9
550531|NCT00727272|1342448|P3|STARTED|Period II||8
550532|NCT00727272|1342449|P2|STARTED|Period II||9
550533|NCT00727272|1342450|P1|STARTED|Period II||9
550534|NCT00727272|1342448|P3|NOT COMPLETED|Washout Period A||1
550535|NCT00727272|1342449|P2|NOT COMPLETED|Washout Period A||0
550536|NCT00727272|1342450|P1|NOT COMPLETED|Washout Period A||0
550537|NCT00727272|1342448|P3|COMPLETED|Washout Period A|positive pregnancy test - recorded as an adverse event|8
550538|NCT00727272|1342449|P2|COMPLETED|Washout Period A||9
550539|NCT00727272|1342450|P1|COMPLETED|Washout Period A||9
550540|NCT00727272|1342448|P3|STARTED|Washout Period A||9
550541|NCT00727272|1342449|P2|STARTED|Washout Period A||9
550542|NCT00727272|1342450|P1|STARTED|Washout Period A||9
550543|NCT00727272|1342448|P3|NOT COMPLETED|Period I||0
550544|NCT00727272|1342449|P2|NOT COMPLETED|Period I||0
550545|NCT00727272|1342450|P1|NOT COMPLETED|Period I||0
550546|NCT00727272|1342448|P3|COMPLETED|Period I||9
550547|NCT00727272|1342449|P2|COMPLETED|Period I||9
550548|NCT00727272|1342450|P1|COMPLETED|Period I||9
550549|NCT00727272|1342448|P3|STARTED|Period I||9
550550|NCT00727272|1342449|P2|STARTED|Period I||9
550551|NCT00727272|1342450|P1|STARTED|Period I||9
550552|NCT00727259|1342467|P1|NOT COMPLETED|Overall Study||1055
550553|NCT00727259|1342467|P1|COMPLETED|Overall Study||940
550554|NCT00727259|1342467|P1|STARTED|Overall Study||1995
550555|NCT00727246|1342476|P4|NOT COMPLETED|Overall Study||2
550556|NCT00727246|1342477|P3|NOT COMPLETED|Overall Study||1
550557|NCT00727246|1342478|P2|NOT COMPLETED|Overall Study||1
550558|NCT00727246|1342479|P1|NOT COMPLETED|Overall Study||0
550559|NCT00727246|1342476|P4|COMPLETED|Overall Study||3
550560|NCT00727246|1342477|P3|COMPLETED|Overall Study||7
550561|NCT00727246|1342478|P2|COMPLETED|Overall Study||2
550562|NCT00727246|1342479|P1|COMPLETED|Overall Study||3
550563|NCT00727246|1342476|P4|STARTED|Overall Study||5
550564|NCT00727246|1342477|P3|STARTED|Overall Study||8
550565|NCT00727246|1342478|P2|STARTED|Overall Study||3
550566|NCT00727246|1342479|P1|STARTED|Overall Study||3
550567|NCT00727220|1342495|P2|NOT COMPLETED|Overall Study||4
550568|NCT00727220|1342496|P1|NOT COMPLETED|Overall Study||1
550569|NCT00727220|1342495|P2|COMPLETED|Overall Study||17
550570|NCT00727220|1342496|P1|COMPLETED|Overall Study||20
550571|NCT00727220|1342495|P2|STARTED|Overall Study||21
550572|NCT00727220|1342496|P1|STARTED|Overall Study||21
550573|NCT00727194|1342502|P3|NOT COMPLETED|Treatment Period 2||0
550574|NCT00727194|1342503|P2|NOT COMPLETED|Treatment Period 2||1
550575|NCT00727194|1342504|P1|NOT COMPLETED|Treatment Period 2||0
550576|NCT00727194|1342502|P3|COMPLETED|Treatment Period 2||0
550577|NCT00727194|1342503|P2|COMPLETED|Treatment Period 2||5
550578|NCT00727194|1342504|P1|COMPLETED|Treatment Period 2||6
550579|NCT00727194|1342502|P3|STARTED|Treatment Period 2||0
550580|NCT00727194|1342503|P2|STARTED|Treatment Period 2|Sponsor terminated study early; 2 patients (total) exited study without starting Treatment Period 2.|6
550581|NCT00727194|1342504|P1|STARTED|Treatment Period 2|Sponsor terminated study early; 2 patients (total) exited study without starting Treatment Period 2.|6
550582|NCT00727194|1342502|P3|NOT COMPLETED|Washout Period||0
550583|NCT00727194|1342503|P2|NOT COMPLETED|Washout Period||0
550584|NCT00727194|1342504|P1|NOT COMPLETED|Washout Period||0
550585|NCT00727194|1342502|P3|COMPLETED|Washout Period||0
550586|NCT00727194|1342503|P2|COMPLETED|Washout Period||7
550587|NCT00727194|1342504|P1|COMPLETED|Washout Period||7
550588|NCT00727194|1342502|P3|STARTED|Washout Period||0
550589|NCT00727194|1342503|P2|STARTED|Washout Period||7
550590|NCT00727194|1342504|P1|STARTED|Washout Period||7
550591|NCT00727194|1342502|P3|NOT COMPLETED|Treatment Period 1||0
550592|NCT00727194|1342503|P2|NOT COMPLETED|Treatment Period 1||0
550593|NCT00727194|1342504|P1|NOT COMPLETED|Treatment Period 1||0
550594|NCT00727194|1342502|P3|COMPLETED|Treatment Period 1||0
550595|NCT00727194|1342503|P2|COMPLETED|Treatment Period 1||7
550596|NCT00727194|1342504|P1|COMPLETED|Treatment Period 1||7
550597|NCT00727194|1342502|P3|STARTED|Treatment Period 1||0
550598|NCT00727194|1342503|P2|STARTED|Treatment Period 1||7
550599|NCT00727194|1342504|P1|STARTED|Treatment Period 1||7
550600|NCT00727194|1342502|P3|NOT COMPLETED|Screening Period||16
550601|NCT00727194|1342503|P2|NOT COMPLETED|Screening Period||0
550602|NCT00727194|1342504|P1|NOT COMPLETED|Screening Period||0
550603|NCT00727194|1342502|P3|COMPLETED|Screening Period||0
550604|NCT00727194|1342503|P2|COMPLETED|Screening Period||7
550605|NCT00727194|1342504|P1|COMPLETED|Screening Period||7
550606|NCT00727194|1342502|P3|STARTED|Screening Period||16
550607|NCT00727194|1342503|P2|STARTED|Screening Period||7
550608|NCT00727194|1342504|P1|STARTED|Screening Period||7
550609|NCT00727090|1342540|P2|NOT COMPLETED|Overall Study||0
550610|NCT00727090|1342541|P1|NOT COMPLETED|Overall Study||0
550611|NCT00727090|1342540|P2|COMPLETED|Overall Study||3
550612|NCT00727090|1342541|P1|COMPLETED|Overall Study||3
550613|NCT00727090|1342540|P2|STARTED|Overall Study||3
550614|NCT00727090|1342541|P1|STARTED|Overall Study||3
550615|NCT00727064|1342559|P2|NOT COMPLETED|Overall Study||0
550616|NCT00727064|1342560|P1|NOT COMPLETED|Overall Study||0
550617|NCT00727064|1342559|P2|COMPLETED|Overall Study||7
550618|NCT00727064|1342560|P1|COMPLETED|Overall Study||7
550619|NCT00727064|1342559|P2|STARTED|Overall Study||7
550620|NCT00727064|1342560|P1|STARTED|Overall Study||7
550621|NCT00727025|1342576|P1|NOT COMPLETED|Overall Study||23
550622|NCT00727025|1342576|P1|COMPLETED|Overall Study||51
550623|NCT00727025|1342576|P1|STARTED|Overall Study||74
550624|NCT00726999|1342588|P2|NOT COMPLETED|Overall Study||1
550625|NCT00726999|1342589|P1|NOT COMPLETED|Overall Study||3
550626|NCT00726999|1342588|P2|COMPLETED|Overall Study||30
550627|NCT00726999|1342589|P1|COMPLETED|Overall Study||29
550628|NCT00726999|1342588|P2|STARTED|Overall Study||31
550629|NCT00726999|1342589|P1|STARTED|Overall Study||32
550630|NCT00726986|1342599|P1|NOT COMPLETED|Maintenance Phase||3
550631|NCT00726986|1342599|P1|COMPLETED|Maintenance Phase||0
550632|NCT00726986|1342599|P1|STARTED|Maintenance Phase||3
550633|NCT00726986|1342599|P1|NOT COMPLETED|Induction Phase||15
550634|NCT00726986|1342599|P1|COMPLETED|Induction Phase||3
550635|NCT00726986|1342599|P1|Maintance|Induction Phase||3
550636|NCT00726986|1342599|P1|STARTED|Induction Phase||18
550637|NCT00726895|1342606|P2|NOT COMPLETED|Second Intervention||0
550638|NCT00726895|1342607|P1|NOT COMPLETED|Second Intervention||0
550639|NCT00726895|1342606|P2|COMPLETED|Second Intervention||11
550640|NCT00726895|1342607|P1|COMPLETED|Second Intervention||12
550641|NCT00726895|1342606|P2|STARTED|Second Intervention||11
550642|NCT00726895|1342607|P1|STARTED|Second Intervention||12
550643|NCT00726895|1342606|P2|NOT COMPLETED|Washout Period of 7 Days||1
550644|NCT00726895|1342607|P1|NOT COMPLETED|Washout Period of 7 Days||0
550645|NCT00726895|1342606|P2|COMPLETED|Washout Period of 7 Days||11
550646|NCT00726895|1342607|P1|COMPLETED|Washout Period of 7 Days||12
550647|NCT00726895|1342606|P2|STARTED|Washout Period of 7 Days||12
550648|NCT00726895|1342607|P1|STARTED|Washout Period of 7 Days||12
550649|NCT00726895|1342606|P2|NOT COMPLETED|First Intervention||0
550650|NCT00726895|1342607|P1|NOT COMPLETED|First Intervention||0
550651|NCT00726895|1342606|P2|COMPLETED|First Intervention||12
550652|NCT00726895|1342607|P1|COMPLETED|First Intervention||12
550653|NCT00726895|1342606|P2|STARTED|First Intervention||12
550654|NCT00726895|1342607|P1|STARTED|First Intervention||12
550655|NCT00726882|1342620|P1|NOT COMPLETED|Overall Study||22
550656|NCT00726882|1342620|P1|COMPLETED|Overall Study||13
550657|NCT00726882|1342620|P1|Received ABT-333 in Study M10-351|Overall Study|Participants who received ABT-333 (and not placebo) in previous study (NCT00696904/M10-351).|6
550658|NCT00726882|1342620|P1|Received ABT-333 in Study M10-380|Overall Study|Participants who received ABT-333 (and not placebo) in previous study (NCT00851890/M10-380).|22
550659|NCT00726882|1342620|P1|STARTED|Overall Study||35
550660|NCT00726830|1342628|P2|NOT COMPLETED|Overall Study||0
550661|NCT00726830|1342629|P1|NOT COMPLETED|Overall Study||0
550662|NCT00726830|1342628|P2|COMPLETED|Overall Study||0
550663|NCT00726830|1342629|P1|COMPLETED|Overall Study||1
550664|NCT00726830|1342628|P2|STARTED|Overall Study||0
550665|NCT00726830|1342629|P1|STARTED|Overall Study||1
550666|NCT00726752|1342635|P1|NOT COMPLETED|Overall Study||6
550667|NCT00726752|1342635|P1|COMPLETED|Overall Study||0
550668|NCT00726752|1342635|P1|STARTED|Overall Study||6
550669|NCT00726739|1342651|P2|NOT COMPLETED|Overall Study||0
550670|NCT00726739|1342652|P1|NOT COMPLETED|Overall Study||1
550671|NCT00726739|1342651|P2|COMPLETED|Overall Study||10
550672|NCT00726739|1342652|P1|COMPLETED|Overall Study|1 patient failed during screening due to brain metastasis.|10
550673|NCT00726739|1342651|P2|STARTED|Overall Study||10
550674|NCT00726739|1342652|P1|STARTED|Overall Study||11
550675|NCT00726713|1342668|P2|NOT COMPLETED|Overall Study||7
550676|NCT00726713|1342669|P1|NOT COMPLETED|Overall Study||7
550677|NCT00726713|1342668|P2|COMPLETED|Overall Study||101
550678|NCT00726713|1342669|P1|COMPLETED|Overall Study||99
550679|NCT00726713|1342668|P2|STARTED|Overall Study||108
550680|NCT00726713|1342669|P1|STARTED|Overall Study||106
550681|NCT00726661|1342697|P2|NOT COMPLETED|Overall Study||418
550682|NCT00726661|1342698|P1|NOT COMPLETED|Overall Study||814
550683|NCT00726661|1342697|P2|COMPLETED|Overall Study||17
550684|NCT00726661|1342698|P1|COMPLETED|Overall Study||18
550685|NCT00726661|1342697|P2|STARTED|Overall Study||435
550686|NCT00726661|1342698|P1|STARTED|Overall Study||832
550687|NCT00726622|1342715|P2|NOT COMPLETED|Overall Study||3
550688|NCT00726622|1342716|P1|NOT COMPLETED|Overall Study||18
550689|NCT00726622|1342715|P2|COMPLETED|Overall Study||240
550690|NCT00726622|1342716|P1|COMPLETED|Overall Study||225
550691|NCT00726622|1342715|P2|STARTED|Overall Study||243
550692|NCT00726622|1342716|P1|STARTED|Overall Study||243
550693|NCT00726609|1342734|P1|NOT COMPLETED|Overall Study||98
550864|NCT00725985|1342875|P12|STARTED|OLMP||0
550694|NCT00726609|1342734|P1|COMPLETED|Overall Study|For 26 participants in the Missing category, it is unknown if they completed the study.|116
550695|NCT00726609|1342734|P1|STARTED|Overall Study||214
550696|NCT00726557|1342738|P1|NOT COMPLETED|Overall Study||128
550697|NCT00726557|1342738|P1|COMPLETED|Overall Study|Completed is defined as those who finished the follow-up period.|118
550698|NCT00726557|1342738|P1|STARTED|Overall Study||246
550699|NCT00726453|1342745|P2|NOT COMPLETED|38 mm Length Group||3
550700|NCT00726453|1342746|P1|NOT COMPLETED|38 mm Length Group||0
550701|NCT00726453|1342745|P2|COMPLETED|38 mm Length Group|This sub-study completed the primary endpoint in March 2012 results not yet available.|111
550702|NCT00726453|1342746|P1|COMPLETED|38 mm Length Group||0
550703|NCT00726453|1342745|P2|STARTED|38 mm Length Group||114
550704|NCT00726453|1342746|P1|STARTED|38 mm Length Group||0
550705|NCT00726453|1342745|P2|NOT COMPLETED|Primary Enrollment Group||0
550706|NCT00726453|1342746|P1|NOT COMPLETED|Primary Enrollment Group||31
550707|NCT00726453|1342745|P2|COMPLETED|Primary Enrollment Group||0
550708|NCT00726453|1342746|P1|COMPLETED|Primary Enrollment Group||1371
550709|NCT00726453|1342745|P2|STARTED|Primary Enrollment Group||0
550710|NCT00726453|1342746|P1|STARTED|Primary Enrollment Group||1402
550711|NCT00726414|1342756|P2|NOT COMPLETED|Second Intervention||0
550712|NCT00726414|1342757|P1|NOT COMPLETED|Second Intervention||0
550713|NCT00726414|1342756|P2|COMPLETED|Second Intervention||11
550714|NCT00726414|1342757|P1|COMPLETED|Second Intervention||11
550715|NCT00726414|1342756|P2|STARTED|Second Intervention||11
550716|NCT00726414|1342757|P1|STARTED|Second Intervention||11
550717|NCT00726414|1342756|P2|NOT COMPLETED|Washout Period of 7 Days||0
550718|NCT00726414|1342757|P1|NOT COMPLETED|Washout Period of 7 Days||0
550719|NCT00726414|1342756|P2|COMPLETED|Washout Period of 7 Days||11
550720|NCT00726414|1342757|P1|COMPLETED|Washout Period of 7 Days||11
550721|NCT00726414|1342756|P2|STARTED|Washout Period of 7 Days||11
550722|NCT00726414|1342757|P1|STARTED|Washout Period of 7 Days||11
550723|NCT00726414|1342756|P2|NOT COMPLETED|First Intervention||0
550724|NCT00726414|1342757|P1|NOT COMPLETED|First Intervention||0
550725|NCT00726414|1342756|P2|COMPLETED|First Intervention||11
550726|NCT00726414|1342757|P1|COMPLETED|First Intervention||11
550727|NCT00726414|1342756|P2|STARTED|First Intervention||11
550728|NCT00726414|1342757|P1|STARTED|First Intervention||11
550729|NCT00726375|1342767|P1|NOT COMPLETED|Overall Study||0
550730|NCT00726375|1342767|P1|COMPLETED|Overall Study||34
550731|NCT00726375|1342767|P1|STARTED|Overall Study||34
550732|NCT00726323|1342774|P2|NOT COMPLETED|Overall Study||31
550733|NCT00726323|1342775|P1|NOT COMPLETED|Overall Study||37
550734|NCT00726323|1342774|P2|COMPLETED|Overall Study||6
550735|NCT00726323|1342775|P1|COMPLETED|Overall Study||0
550736|NCT00726323|1342774|P2|STARTED|Overall Study||37
550737|NCT00726323|1342775|P1|STARTED|Overall Study||37
550738|NCT00726232|1342805|P6|NOT COMPLETED|Overall Study||4
550739|NCT00726232|1342806|P5|NOT COMPLETED|Overall Study||5
550740|NCT00726232|1342807|P4|NOT COMPLETED|Overall Study||1
550741|NCT00726232|1342808|P3|NOT COMPLETED|Overall Study||0
550742|NCT00726232|1342809|P2|NOT COMPLETED|Overall Study||1
550743|NCT00726232|1342810|P1|NOT COMPLETED|Overall Study||5
550744|NCT00726232|1342805|P6|COMPLETED|Overall Study||5
550745|NCT00726232|1342806|P5|COMPLETED|Overall Study||17
550746|NCT00726232|1342807|P4|COMPLETED|Overall Study||7
550747|NCT00726232|1342808|P3|COMPLETED|Overall Study||7
550748|NCT00726232|1342809|P2|COMPLETED|Overall Study||7
550749|NCT00726232|1342810|P1|COMPLETED|Overall Study|Represents patients ongoing in the study as of the data cut-off date of 18 June 2010.|14
550750|NCT00726232|1342805|P6|STARTED|Overall Study||9
550751|NCT00726232|1342806|P5|STARTED|Overall Study|The starting dose selected for the ET expansion cohort was 25 mg bid hence the sample size is larger|22
550752|NCT00726232|1342807|P4|STARTED|Overall Study||8
550753|NCT00726232|1342808|P3|STARTED|Overall Study||7
550754|NCT00726232|1342809|P2|STARTED|Overall Study||8
550755|NCT00726232|1342810|P1|STARTED|Overall Study|The starting dose selected for the PV expansion cohort was 10 mg bid hence the sample size is larger|19
550756|NCT00726180|1342854|P1|NOT COMPLETED|Overall Study||0
550757|NCT00726180|1342854|P1|COMPLETED|Overall Study||1
550758|NCT00726180|1342854|P1|STARTED|Overall Study||1
550759|NCT00726063|1342860|P2|NOT COMPLETED|Overall Study||7
550760|NCT00726063|1342861|P1|NOT COMPLETED|Overall Study||9
550761|NCT00726063|1342860|P2|COMPLETED|Overall Study|Number of implants = 239|112
550762|NCT00726063|1342861|P1|COMPLETED|Overall Study|Number of implants =230|113
550763|NCT00726063|1342860|P2|STARTED|Overall Study|Number of implants= 246|119
550764|NCT00726063|1342861|P1|STARTED|Overall Study|Number of implants= 239|122
550765|NCT00726037|1342867|P1|NOT COMPLETED|Overall Study||0
550766|NCT00726037|1342867|P1|COMPLETED|Overall Study||7
550767|NCT00726037|1342867|P1|STARTED|Overall Study||7
550768|NCT00725985|1342875|P12|NOT COMPLETED|LTFU (No Cladribine Treatment)||14
550769|NCT00725985|1342876|P11|NOT COMPLETED|LTFU (No Cladribine Treatment)||36
550770|NCT00725985|1342877|P10|NOT COMPLETED|LTFU (No Cladribine Treatment)||34
550771|NCT00725985|1342878|P9|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
550772|NCT00725985|1342879|P8|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
550773|NCT00725985|1342880|P7|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
550774|NCT00725985|1342881|P6|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
550775|NCT00725985|1342882|P5|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
550776|NCT00725985|1342883|P4|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
550777|NCT00725985|1342884|P3|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
550778|NCT00725985|1342885|P2|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
550779|NCT00725985|1342886|P1|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
550780|NCT00725985|1342875|P12|COMPLETED|LTFU (No Cladribine Treatment)||0
550781|NCT00725985|1342876|P11|COMPLETED|LTFU (No Cladribine Treatment)||0
550782|NCT00725985|1342877|P10|COMPLETED|LTFU (No Cladribine Treatment)||0
550783|NCT00725985|1342878|P9|COMPLETED|LTFU (No Cladribine Treatment)||0
550784|NCT00725985|1342879|P8|COMPLETED|LTFU (No Cladribine Treatment)||0
550785|NCT00725985|1342880|P7|COMPLETED|LTFU (No Cladribine Treatment)||0
550786|NCT00725985|1342881|P6|COMPLETED|LTFU (No Cladribine Treatment)||0
550787|NCT00725985|1342882|P5|COMPLETED|LTFU (No Cladribine Treatment)||0
550788|NCT00725985|1342883|P4|COMPLETED|LTFU (No Cladribine Treatment)||0
550789|NCT00725985|1342884|P3|COMPLETED|LTFU (No Cladribine Treatment)||0
550790|NCT00725985|1342885|P2|COMPLETED|LTFU (No Cladribine Treatment)||0
550791|NCT00725985|1342886|P1|COMPLETED|LTFU (No Cladribine Treatment)||0
550792|NCT00725985|1342875|P12|STARTED|LTFU (No Cladribine Treatment)||14
550793|NCT00725985|1342876|P11|STARTED|LTFU (No Cladribine Treatment)||36
550794|NCT00725985|1342877|P10|STARTED|LTFU (No Cladribine Treatment)||34
550795|NCT00725985|1342878|P9|STARTED|LTFU (No Cladribine Treatment)||0
550796|NCT00725985|1342879|P8|STARTED|LTFU (No Cladribine Treatment)||0
550797|NCT00725985|1342880|P7|STARTED|LTFU (No Cladribine Treatment)||0
550798|NCT00725985|1342881|P6|STARTED|LTFU (No Cladribine Treatment)||0
550799|NCT00725985|1342882|P5|STARTED|LTFU (No Cladribine Treatment)||0
550800|NCT00725985|1342883|P4|STARTED|LTFU (No Cladribine Treatment)||0
550801|NCT00725985|1342884|P3|STARTED|LTFU (No Cladribine Treatment)||0
550802|NCT00725985|1342885|P2|STARTED|LTFU (No Cladribine Treatment)||0
550803|NCT00725985|1342886|P1|STARTED|LTFU (No Cladribine Treatment)||0
550804|NCT00725985|1342875|P12|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
550805|NCT00725985|1342876|P11|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
550806|NCT00725985|1342877|P10|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
550807|NCT00725985|1342878|P9|NOT COMPLETED|LTFU (With Cladribine Treatment)||17
550808|NCT00725985|1342879|P8|NOT COMPLETED|LTFU (With Cladribine Treatment)||9
550809|NCT00725985|1342880|P7|NOT COMPLETED|LTFU (With Cladribine Treatment)||9
550810|NCT00725985|1342881|P6|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
550811|NCT00725985|1342882|P5|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
550812|NCT00725985|1342883|P4|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
550813|NCT00725985|1342884|P3|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
550814|NCT00725985|1342885|P2|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
550815|NCT00725985|1342886|P1|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
550816|NCT00725985|1342875|P12|COMPLETED|LTFU (With Cladribine Treatment)||0
550817|NCT00725985|1342876|P11|COMPLETED|LTFU (With Cladribine Treatment)||0
550818|NCT00725985|1342877|P10|COMPLETED|LTFU (With Cladribine Treatment)||0
550819|NCT00725985|1342878|P9|COMPLETED|LTFU (With Cladribine Treatment)||0
550820|NCT00725985|1342879|P8|COMPLETED|LTFU (With Cladribine Treatment)||0
550821|NCT00725985|1342880|P7|COMPLETED|LTFU (With Cladribine Treatment)||0
550822|NCT00725985|1342881|P6|COMPLETED|LTFU (With Cladribine Treatment)||0
550823|NCT00725985|1342882|P5|COMPLETED|LTFU (With Cladribine Treatment)||0
550824|NCT00725985|1342883|P4|COMPLETED|LTFU (With Cladribine Treatment)||0
550825|NCT00725985|1342884|P3|COMPLETED|LTFU (With Cladribine Treatment)||0
550826|NCT00725985|1342885|P2|COMPLETED|LTFU (With Cladribine Treatment)||0
550827|NCT00725985|1342886|P1|COMPLETED|LTFU (With Cladribine Treatment)||0
550828|NCT00725985|1342875|P12|STARTED|LTFU (With Cladribine Treatment)||0
550829|NCT00725985|1342876|P11|STARTED|LTFU (With Cladribine Treatment)||0
550830|NCT00725985|1342877|P10|STARTED|LTFU (With Cladribine Treatment)||0
550831|NCT00725985|1342878|P9|STARTED|LTFU (With Cladribine Treatment)||17
550832|NCT00725985|1342879|P8|STARTED|LTFU (With Cladribine Treatment)||9
550833|NCT00725985|1342880|P7|STARTED|LTFU (With Cladribine Treatment)||9
550834|NCT00725985|1342881|P6|STARTED|LTFU (With Cladribine Treatment)||0
550835|NCT00725985|1342882|P5|STARTED|LTFU (With Cladribine Treatment)||0
550836|NCT00725985|1342883|P4|STARTED|LTFU (With Cladribine Treatment)||0
550837|NCT00725985|1342884|P3|STARTED|LTFU (With Cladribine Treatment)||0
550838|NCT00725985|1342885|P2|STARTED|LTFU (With Cladribine Treatment)||0
550839|NCT00725985|1342886|P1|STARTED|LTFU (With Cladribine Treatment)||0
550840|NCT00725985|1342875|P12|NOT COMPLETED|OLMP||0
550841|NCT00725985|1342876|P11|NOT COMPLETED|OLMP||0
550842|NCT00725985|1342877|P10|NOT COMPLETED|OLMP||0
550843|NCT00725985|1342878|P9|NOT COMPLETED|OLMP||0
550844|NCT00725985|1342879|P8|NOT COMPLETED|OLMP||0
550845|NCT00725985|1342880|P7|NOT COMPLETED|OLMP||0
550846|NCT00725985|1342881|P6|NOT COMPLETED|OLMP||53
550847|NCT00725985|1342882|P5|NOT COMPLETED|OLMP||23
550848|NCT00725985|1342883|P4|NOT COMPLETED|OLMP||18
550849|NCT00725985|1342884|P3|NOT COMPLETED|OLMP||0
550850|NCT00725985|1342885|P2|NOT COMPLETED|OLMP||0
550851|NCT00725985|1342886|P1|NOT COMPLETED|OLMP||0
550852|NCT00725985|1342875|P12|COMPLETED|OLMP||0
550853|NCT00725985|1342876|P11|COMPLETED|OLMP||0
550854|NCT00725985|1342877|P10|COMPLETED|OLMP||0
550855|NCT00725985|1342878|P9|COMPLETED|OLMP||0
550856|NCT00725985|1342879|P8|COMPLETED|OLMP||0
550857|NCT00725985|1342880|P7|COMPLETED|OLMP||0
550858|NCT00725985|1342881|P6|COMPLETED|OLMP||7
550859|NCT00725985|1342882|P5|COMPLETED|OLMP||2
550860|NCT00725985|1342883|P4|COMPLETED|OLMP||6
550861|NCT00725985|1342884|P3|COMPLETED|OLMP||0
550862|NCT00725985|1342885|P2|COMPLETED|OLMP||0
550863|NCT00725985|1342886|P1|COMPLETED|OLMP||0
550865|NCT00725985|1342876|P11|STARTED|OLMP||0
550866|NCT00725985|1342877|P10|STARTED|OLMP||0
550867|NCT00725985|1342878|P9|STARTED|OLMP||0
550868|NCT00725985|1342879|P8|STARTED|OLMP||0
550869|NCT00725985|1342880|P7|STARTED|OLMP||0
550870|NCT00725985|1342881|P6|STARTED|OLMP||60
550871|NCT00725985|1342882|P5|STARTED|OLMP||25
550872|NCT00725985|1342883|P4|STARTED|OLMP||24
550873|NCT00725985|1342884|P3|STARTED|OLMP||0
550874|NCT00725985|1342885|P2|STARTED|OLMP||0
550875|NCT00725985|1342886|P1|STARTED|OLMP||0
550876|NCT00725985|1342875|P12|NOT COMPLETED|ITP (Up to 96 Weeks)||0
550877|NCT00725985|1342876|P11|NOT COMPLETED|ITP (Up to 96 Weeks)||0
550878|NCT00725985|1342877|P10|NOT COMPLETED|ITP (Up to 96 Weeks)||0
550879|NCT00725985|1342878|P9|NOT COMPLETED|ITP (Up to 96 Weeks)||0
550880|NCT00725985|1342879|P8|NOT COMPLETED|ITP (Up to 96 Weeks)||0
550881|NCT00725985|1342880|P7|NOT COMPLETED|ITP (Up to 96 Weeks)||0
550882|NCT00725985|1342881|P6|NOT COMPLETED|ITP (Up to 96 Weeks)||0
550883|NCT00725985|1342882|P5|NOT COMPLETED|ITP (Up to 96 Weeks)||0
550884|NCT00725985|1342883|P4|NOT COMPLETED|ITP (Up to 96 Weeks)||0
550885|NCT00725985|1342884|P3|NOT COMPLETED|ITP (Up to 96 Weeks)||102
550886|NCT00725985|1342885|P2|NOT COMPLETED|ITP (Up to 96 Weeks)||75
550887|NCT00725985|1342886|P1|NOT COMPLETED|ITP (Up to 96 Weeks)||101
550888|NCT00725985|1342875|P12|COMPLETED|ITP (Up to 96 Weeks)||0
550889|NCT00725985|1342876|P11|COMPLETED|ITP (Up to 96 Weeks)||0
550890|NCT00725985|1342877|P10|COMPLETED|ITP (Up to 96 Weeks)||0
550891|NCT00725985|1342878|P9|COMPLETED|ITP (Up to 96 Weeks)||0
550892|NCT00725985|1342879|P8|COMPLETED|ITP (Up to 96 Weeks)||0
550893|NCT00725985|1342880|P7|COMPLETED|ITP (Up to 96 Weeks)||0
550894|NCT00725985|1342881|P6|COMPLETED|ITP (Up to 96 Weeks)||0
550895|NCT00725985|1342882|P5|COMPLETED|ITP (Up to 96 Weeks)||0
550896|NCT00725985|1342883|P4|COMPLETED|ITP (Up to 96 Weeks)||0
550897|NCT00725985|1342884|P3|COMPLETED|ITP (Up to 96 Weeks)||104
550898|NCT00725985|1342885|P2|COMPLETED|ITP (Up to 96 Weeks)||131
550899|NCT00725985|1342886|P1|COMPLETED|ITP (Up to 96 Weeks)||104
550900|NCT00725985|1342875|P12|Treated|ITP (Up to 96 Weeks)||0
550901|NCT00725985|1342876|P11|Treated|ITP (Up to 96 Weeks)||0
550902|NCT00725985|1342877|P10|Treated|ITP (Up to 96 Weeks)||0
550903|NCT00725985|1342878|P9|Treated|ITP (Up to 96 Weeks)||0
550904|NCT00725985|1342879|P8|Treated|ITP (Up to 96 Weeks)||0
550905|NCT00725985|1342880|P7|Treated|ITP (Up to 96 Weeks)||0
550906|NCT00725985|1342881|P6|Treated|ITP (Up to 96 Weeks)||0
550907|NCT00725985|1342882|P5|Treated|ITP (Up to 96 Weeks)||0
550908|NCT00725985|1342883|P4|Treated|ITP (Up to 96 Weeks)||0
550909|NCT00725985|1342884|P3|Treated|ITP (Up to 96 Weeks)||206
550910|NCT00725985|1342885|P2|Treated|ITP (Up to 96 Weeks)||206
550911|NCT00725985|1342886|P1|Treated|ITP (Up to 96 Weeks)||204
550912|NCT00725985|1342875|P12|STARTED|ITP (Up to 96 Weeks)||0
550913|NCT00725985|1342876|P11|STARTED|ITP (Up to 96 Weeks)||0
550914|NCT00725985|1342877|P10|STARTED|ITP (Up to 96 Weeks)||0
550915|NCT00725985|1342878|P9|STARTED|ITP (Up to 96 Weeks)||0
550916|NCT00725985|1342879|P8|STARTED|ITP (Up to 96 Weeks)||0
550917|NCT00725985|1342880|P7|STARTED|ITP (Up to 96 Weeks)||0
550918|NCT00725985|1342881|P6|STARTED|ITP (Up to 96 Weeks)||0
550919|NCT00725985|1342882|P5|STARTED|ITP (Up to 96 Weeks)||0
550920|NCT00725985|1342883|P4|STARTED|ITP (Up to 96 Weeks)||0
550921|NCT00725985|1342884|P3|STARTED|ITP (Up to 96 Weeks)||206
550922|NCT00725985|1342885|P2|STARTED|ITP (Up to 96 Weeks)||206
550923|NCT00725985|1342886|P1|STARTED|ITP (Up to 96 Weeks)||205
550924|NCT00725959|1342914|P2|NOT COMPLETED|Overall Study||197
550925|NCT00725959|1342915|P1|NOT COMPLETED|Overall Study||289
550926|NCT00725959|1342914|P2|COMPLETED|Overall Study||439
550927|NCT00725959|1342915|P1|COMPLETED|Overall Study||653
550928|NCT00725959|1342914|P2|STARTED|Overall Study||636
550929|NCT00725959|1342915|P1|STARTED|Overall Study||942
550930|NCT00725920|1342923|P2|NOT COMPLETED|Overall Study||6
550931|NCT00725920|1342924|P1|NOT COMPLETED|Overall Study||3
550932|NCT00725920|1342923|P2|COMPLETED|Overall Study||12
550933|NCT00725920|1342924|P1|COMPLETED|Overall Study||14
550934|NCT00725920|1342923|P2|STARTED|Overall Study||18
550935|NCT00725920|1342924|P1|STARTED|Overall Study||17
550936|NCT00725842|1342930|P1|NOT COMPLETED|Overall Study||40
550937|NCT00725842|1342930|P1|COMPLETED|Overall Study||57
550938|NCT00725842|1342930|P1|Participants Eligible for Analysis|Overall Study||90
550939|NCT00725842|1342930|P1|STARTED|Overall Study||97
550940|NCT00725764|1342937|P1|NOT COMPLETED|Overall Study||14
550941|NCT00725764|1342937|P1|COMPLETED|Overall Study||0
550942|NCT00725764|1342937|P1|STARTED|Overall Study||14
550943|NCT00725751|1342957|P2|NOT COMPLETED|Overall Study||108
550944|NCT00725751|1342958|P1|NOT COMPLETED|Overall Study||34
550945|NCT00725751|1342957|P2|COMPLETED|Overall Study||150
550946|NCT00725751|1342958|P1|COMPLETED|Overall Study||56
550947|NCT00725751|1342957|P2|STARTED|Overall Study||258
550948|NCT00725751|1342958|P1|STARTED|Overall Study||90
550949|NCT00725725|1342970|P3|NOT COMPLETED|Overall Study||5
550950|NCT00725725|1342971|P2|NOT COMPLETED|Overall Study||4
550951|NCT00725725|1342972|P1|NOT COMPLETED|Overall Study||4
550952|NCT00725725|1342970|P3|COMPLETED|Overall Study||12
550953|NCT00725725|1342971|P2|COMPLETED|Overall Study||11
550954|NCT00725725|1342972|P1|COMPLETED|Overall Study||10
550955|NCT00725725|1342970|P3|Treated|Overall Study||14
550956|NCT00725725|1342971|P2|Treated|Overall Study||15
550957|NCT00725725|1342972|P1|Treated|Overall Study||11
550958|NCT00725725|1342970|P3|STARTED|Overall Study||17
550959|NCT00725725|1342971|P2|STARTED|Overall Study||15
550960|NCT00725725|1342972|P1|STARTED|Overall Study||14
550961|NCT00725712|1343015|P2|NOT COMPLETED|Overall Study||26
550962|NCT00725712|1343016|P1|NOT COMPLETED|Overall Study||48
550963|NCT00725712|1343015|P2|COMPLETED|Overall Study||0
550964|NCT00725712|1343016|P1|COMPLETED|Overall Study||0
550965|NCT00725712|1343015|P2|STARTED|Overall Study||26
550966|NCT00725712|1343016|P1|STARTED|Overall Study||48
550967|NCT00725621|1343052|P1|NOT COMPLETED|Overall Study||271
550968|NCT00725621|1343052|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Remicade infusions.|245
550969|NCT00725621|1343052|P1|STARTED|Overall Study|Started was defined as the number of participants who received at least one infusion of Remicade.|516
550970|NCT00725608|1343075|P1|NOT COMPLETED|Overall Study||167
550971|NCT00725608|1343075|P1|COMPLETED|Overall Study|1 patient terminated treatment at day 368 and was counted as dropout|140
550972|NCT00725608|1343075|P1|STARTED|Overall Study|339 patients enrolled, 32 non-eligible datasets excluded from final general and safety analysis|307
550973|NCT00725543|1343081|P1|NOT COMPLETED|Overall Study||153
550974|NCT00725543|1343081|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Remicade infusions.|205
550975|NCT00725543|1343081|P1|STARTED|Overall Study||358
550976|NCT00725530|1343090|P2|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0
550977|NCT00725530|1343091|P1|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0
550978|NCT00725530|1343090|P2|COMPLETED|Second Intervention, 7 Days (+0/-1)||27
550979|NCT00725530|1343091|P1|COMPLETED|Second Intervention, 7 Days (+0/-1)||27
550980|NCT00725530|1343090|P2|STARTED|Second Intervention, 7 Days (+0/-1)||27
550981|NCT00725530|1343091|P1|STARTED|Second Intervention, 7 Days (+0/-1)||27
550982|NCT00725530|1343090|P2|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0
550983|NCT00725530|1343091|P1|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0
550984|NCT00725530|1343090|P2|COMPLETED|First Intervention, 7 Days (+0/-1)||27
550985|NCT00725530|1343091|P1|COMPLETED|First Intervention, 7 Days (+0/-1)||27
550986|NCT00725530|1343090|P2|STARTED|First Intervention, 7 Days (+0/-1)||27
550987|NCT00725530|1343091|P1|STARTED|First Intervention, 7 Days (+0/-1)||27
550988|NCT00725504|1343097|P1|NOT COMPLETED|Overall Study||0
550989|NCT00725504|1343097|P1|COMPLETED|Overall Study||71
550990|NCT00725504|1343097|P1|STARTED|Overall Study||71
550991|NCT00725491|1343106|P2|NOT COMPLETED|Overall Study||18
550992|NCT00725491|1343107|P1|NOT COMPLETED|Overall Study||9
550993|NCT00725491|1343106|P2|COMPLETED|Overall Study||102
550994|NCT00725491|1343107|P1|COMPLETED|Overall Study||104
550995|NCT00725491|1343106|P2|STARTED|Overall Study|Intent-to-Treat Group|120
550996|NCT00725491|1343107|P1|STARTED|Overall Study|Intent-to-Treat Group|113
550997|NCT00725452|1343113|P1|NOT COMPLETED|Overall Study||11
550998|NCT00725452|1343113|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Infliximab infusions.|15
550999|NCT00725452|1343113|P1|STARTED|Overall Study||26
551000|NCT00725361|1343122|P1|NOT COMPLETED|Overall Study||4
551001|NCT00725361|1343122|P1|COMPLETED|Overall Study||16
551002|NCT00725361|1343122|P1|STARTED|Overall Study||20
551003|NCT00725322|1343132|P2|NOT COMPLETED|Second Injection Visit||0
551004|NCT00725322|1343133|P1|NOT COMPLETED|Second Injection Visit||0
551005|NCT00725322|1343132|P2|COMPLETED|Second Injection Visit||14
551006|NCT00725322|1343133|P1|COMPLETED|Second Injection Visit||13
551007|NCT00725322|1343132|P2|STARTED|Second Injection Visit||14
551008|NCT00725322|1343133|P1|STARTED|Second Injection Visit||13
551009|NCT00725322|1343132|P2|NOT COMPLETED|Washout (28 Days)||1
551010|NCT00725322|1343133|P1|NOT COMPLETED|Washout (28 Days)||2
551011|NCT00725322|1343132|P2|COMPLETED|Washout (28 Days)||14
551012|NCT00725322|1343133|P1|COMPLETED|Washout (28 Days)||13
551013|NCT00725322|1343132|P2|STARTED|Washout (28 Days)||15
551014|NCT00725322|1343133|P1|STARTED|Washout (28 Days)||15
551015|NCT00725322|1343132|P2|NOT COMPLETED|First Injection Visit||0
551016|NCT00725322|1343133|P1|NOT COMPLETED|First Injection Visit||0
551017|NCT00725322|1343132|P2|COMPLETED|First Injection Visit||15
551018|NCT00725322|1343133|P1|COMPLETED|First Injection Visit||15
551019|NCT00725322|1343132|P2|STARTED|First Injection Visit||15
551020|NCT00725322|1343133|P1|STARTED|First Injection Visit||15
551021|NCT00725296|1343141|P1|NOT COMPLETED|Overall Study||62
551022|NCT00725296|1343141|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive infusions.|101
551023|NCT00725296|1343141|P1|STARTED|Overall Study|163 of the 178 enrolled participants received at least one dose of Infliximab.|163
551024|NCT00725270|1343152|P2|NOT COMPLETED|Overall Study||0
551025|NCT00725270|1343153|P1|NOT COMPLETED|Overall Study||0
551026|NCT00725270|1343152|P2|COMPLETED|Overall Study||7
551027|NCT00725270|1343153|P1|COMPLETED|Overall Study||5
551028|NCT00725270|1343152|P2|STARTED|Overall Study||7
551029|NCT00725270|1343153|P1|STARTED|Overall Study||5
551030|NCT00725205|1343161|P1|NOT COMPLETED|Overall Study||87
551031|NCT00725205|1343161|P1|COMPLETED|Overall Study||207
551032|NCT00725205|1343161|P1|STARTED|Overall Study||294
551033|NCT00725153|1343167|P2|NOT COMPLETED|Period Two, 10 Hours of Wear||0
551034|NCT00725153|1343168|P1|NOT COMPLETED|Period Two, 10 Hours of Wear||0
551035|NCT00725153|1343167|P2|COMPLETED|Period Two, 10 Hours of Wear||28
551036|NCT00725153|1343168|P1|COMPLETED|Period Two, 10 Hours of Wear||27
551037|NCT00725153|1343167|P2|STARTED|Period Two, 10 Hours of Wear||28
551038|NCT00725153|1343168|P1|STARTED|Period Two, 10 Hours of Wear||27
551039|NCT00725153|1343167|P2|NOT COMPLETED|Period One, 10 Hours of Wear||0
551040|NCT00725153|1343168|P1|NOT COMPLETED|Period One, 10 Hours of Wear||0
551041|NCT00725153|1343167|P2|COMPLETED|Period One, 10 Hours of Wear||28
551042|NCT00725153|1343168|P1|COMPLETED|Period One, 10 Hours of Wear||27
551043|NCT00725153|1343167|P2|STARTED|Period One, 10 Hours of Wear||28
551044|NCT00725153|1343168|P1|STARTED|Period One, 10 Hours of Wear||27
551045|NCT00725101|1343174|P1|NOT COMPLETED|Overall Study||495
551046|NCT00725101|1343174|P1|COMPLETED|Overall Study||1205
551047|NCT00725101|1343174|P1|STARTED|Overall Study||1700
551048|NCT00725075|1343197|P3|NOT COMPLETED|Overall Study||9
551049|NCT00725075|1343198|P2|NOT COMPLETED|Overall Study||8
551050|NCT00725075|1343199|P1|NOT COMPLETED|Overall Study||11
551051|NCT00725075|1343197|P3|COMPLETED|Overall Study||61
551052|NCT00725075|1343198|P2|COMPLETED|Overall Study||65
551053|NCT00725075|1343199|P1|COMPLETED|Overall Study||61
551054|NCT00725075|1343197|P3|Treated|Overall Study||70
551055|NCT00725075|1343198|P2|Treated|Overall Study||73
551056|NCT00725075|1343199|P1|Treated|Overall Study||71
551057|NCT00725075|1343197|P3|STARTED|Overall Study||70
551058|NCT00725075|1343198|P2|STARTED|Overall Study||73
551059|NCT00725075|1343199|P1|STARTED|Overall Study||72
551060|NCT00725049|1343245|P2|NOT COMPLETED|Overall Study||0
551061|NCT00725049|1343246|P1|NOT COMPLETED|Overall Study||0
551062|NCT00725049|1343245|P2|COMPLETED|Overall Study||20
551063|NCT00725049|1343246|P1|COMPLETED|Overall Study||17
551064|NCT00725049|1343245|P2|STARTED|Overall Study||20
551065|NCT00725049|1343246|P1|STARTED|Overall Study||17
551066|NCT00725010|1343252|P1|NOT COMPLETED|Overall Study||25
551067|NCT00725010|1343252|P1|COMPLETED|Overall Study||25
551068|NCT00725010|1343252|P1|STARTED|Overall Study|Only in 50 of 64 participants the documentation of therapy and follow-up was received and evaluated.|50
551069|NCT00724984|1343266|P6|NOT COMPLETED|Overall Study||5
551070|NCT00724984|1343267|P5|NOT COMPLETED|Overall Study||4
551071|NCT00724984|1343268|P4|NOT COMPLETED|Overall Study||2
551072|NCT00724984|1343269|P3|NOT COMPLETED|Overall Study||0
551073|NCT00724984|1343270|P2|NOT COMPLETED|Overall Study||1
551074|NCT00724984|1343271|P1|NOT COMPLETED|Overall Study||1
551075|NCT00724984|1343266|P6|COMPLETED|Overall Study||9
551076|NCT00724984|1343267|P5|COMPLETED|Overall Study||12
551077|NCT00724984|1343268|P4|COMPLETED|Overall Study||7
551078|NCT00724984|1343269|P3|COMPLETED|Overall Study||3
551079|NCT00724984|1343270|P2|COMPLETED|Overall Study||7
551080|NCT00724984|1343271|P1|COMPLETED|Overall Study||4
551081|NCT00724984|1343266|P6|STARTED|Overall Study||14
551082|NCT00724984|1343267|P5|STARTED|Overall Study||16
551083|NCT00724984|1343268|P4|STARTED|Overall Study||9
551084|NCT00724984|1343269|P3|STARTED|Overall Study||3
551085|NCT00724984|1343270|P2|STARTED|Overall Study||8
551086|NCT00724984|1343271|P1|STARTED|Overall Study||5
551087|NCT00724958|1343285|P1|NOT COMPLETED|Overall Study||182
551088|NCT00724958|1343285|P1|COMPLETED|Overall Study||166
551089|NCT00724958|1343285|P1|STARTED|Overall Study||348
551090|NCT00724945|1343294|P2|NOT COMPLETED|Period 2||0
551091|NCT00724945|1343295|P1|NOT COMPLETED|Period 2||4
551092|NCT00724945|1343294|P2|COMPLETED|Period 2||54
551093|NCT00724945|1343295|P1|COMPLETED|Period 2||51
551094|NCT00724945|1343294|P2|STARTED|Period 2||54
551095|NCT00724945|1343295|P1|STARTED|Period 2||55
551096|NCT00724945|1343294|P2|NOT COMPLETED|Period 1||1
551097|NCT00724945|1343295|P1|NOT COMPLETED|Period 1||3
551098|NCT00724945|1343294|P2|COMPLETED|Period 1||54
551099|NCT00724945|1343295|P1|COMPLETED|Period 1||55
551100|NCT00724945|1343294|P2|STARTED|Period 1||55
551101|NCT00724945|1343295|P1|STARTED|Period 1||58
551102|NCT00724932|1343307|P2|NOT COMPLETED|Overall Study||3
551103|NCT00724932|1343308|P1|NOT COMPLETED|Overall Study||5
551104|NCT00724932|1343307|P2|COMPLETED|Overall Study||67
551105|NCT00724932|1343308|P1|COMPLETED|Overall Study||65
551106|NCT00724932|1343307|P2|STARTED|Overall Study||70
551107|NCT00724932|1343308|P1|STARTED|Overall Study||70
551108|NCT00724893|1343379|P2|NOT COMPLETED|Overall Study||458
551109|NCT00724893|1343380|P1|NOT COMPLETED|Overall Study||364
551110|NCT00724893|1343379|P2|COMPLETED|Overall Study||670
551111|NCT00724893|1343380|P1|COMPLETED|Overall Study||938
551112|NCT00724893|1343379|P2|STARTED|Overall Study||1128
551113|NCT00724893|1343380|P1|STARTED|Overall Study||1302
551114|NCT00724867|1343448|P1|NOT COMPLETED|Overall Study||128
551115|NCT00724867|1343448|P1|COMPLETED|Overall Study||140
551116|NCT00724867|1343448|P1|STARTED|Overall Study||268
551117|NCT00724854|1343488|P2|NOT COMPLETED|Overall Study||31
551118|NCT00724854|1343489|P1|NOT COMPLETED|Overall Study||403
551119|NCT00724854|1343488|P2|COMPLETED|Overall Study||41
551120|NCT00724854|1343489|P1|COMPLETED|Overall Study||607
551121|NCT00724854|1343488|P2|STARTED|Overall Study|Number enrolled was 1146. 64 participants were screen failures.|72
551122|NCT00724854|1343489|P1|STARTED|Overall Study|Number enrolled was 1146. 64 participants were screen failures.|1010
551123|NCT00724815|1343506|P2|NOT COMPLETED|Overall Study||39
551124|NCT00724815|1343507|P1|NOT COMPLETED|Overall Study||43
551125|NCT00724815|1343506|P2|COMPLETED|Overall Study||226
551126|NCT00724815|1343507|P1|COMPLETED|Overall Study||222
551127|NCT00724815|1343506|P2|STARTED|Overall Study|subjects randomized|265
551128|NCT00724815|1343507|P1|STARTED|Overall Study|subjects randomized|265
551129|NCT00724750|1343521|P2|NOT COMPLETED|Overall Study||0
551130|NCT00724750|1343522|P1|NOT COMPLETED|Overall Study||0
551131|NCT00724750|1343521|P2|COMPLETED|Overall Study||42
551132|NCT00724750|1343522|P1|COMPLETED|Overall Study||45
551133|NCT00724750|1343521|P2|STARTED|Overall Study||42
551134|NCT00724750|1343522|P1|STARTED|Overall Study||45
551135|NCT00724711|1343540|P2|NOT COMPLETED|Overall Study||17
551136|NCT00724711|1343541|P1|NOT COMPLETED|Overall Study||17
551137|NCT00724711|1343540|P2|COMPLETED|Overall Study||139
551138|NCT00724711|1343541|P1|COMPLETED|Overall Study||138
551139|NCT00724711|1343540|P2|STARTED|Overall Study||156
551140|NCT00724711|1343541|P1|STARTED|Overall Study||155
551141|NCT00724698|1343573|P1|NOT COMPLETED|Overall Study||90
551142|NCT00724698|1343573|P1|COMPLETED|Overall Study||2921
551143|NCT00724698|1343573|P1|STARTED|Overall Study||3011
551144|NCT00724594|1343580|P4|NOT COMPLETED|Overall Study||1
551145|NCT00724594|1343581|P3|NOT COMPLETED|Overall Study||0
551146|NCT00724594|1343582|P2|NOT COMPLETED|Overall Study||0
551147|NCT00724594|1343583|P1|NOT COMPLETED|Overall Study||0
551148|NCT00724594|1343580|P4|COMPLETED|Overall Study||10
551149|NCT00724594|1343581|P3|COMPLETED|Overall Study||11
551150|NCT00724594|1343582|P2|COMPLETED|Overall Study||12
551151|NCT00724594|1343583|P1|COMPLETED|Overall Study||12
551152|NCT00724594|1343580|P4|STARTED|Overall Study||11
551153|NCT00724594|1343581|P3|STARTED|Overall Study||11
551154|NCT00724594|1343582|P2|STARTED|Overall Study||12
551155|NCT00724594|1343583|P1|STARTED|Overall Study||12
551156|NCT00724568|1343606|P2|NOT COMPLETED|Overall Study||0
551157|NCT00724568|1343607|P1|NOT COMPLETED|Overall Study||0
551158|NCT00724568|1343606|P2|COMPLETED|Overall Study||32
551159|NCT00724568|1343607|P1|COMPLETED|Overall Study||42
551160|NCT00724568|1343606|P2|STARTED|Overall Study||32
551161|NCT00724568|1343607|P1|STARTED|Overall Study||42
551162|NCT00724477|1343612|P1|NOT COMPLETED|Overall Study||0
551163|NCT00724477|1343612|P1|COMPLETED|Overall Study||1663
551164|NCT00724477|1343612|P1|STARTED|Overall Study|This safety population (SAF)analysed consisted of all patients who took at least one tablet of INEGY|1663
551165|NCT00724464|1343616|P1|NOT COMPLETED|Overall Study||23
551166|NCT00724464|1343616|P1|COMPLETED|Overall Study||309
551167|NCT00724464|1343616|P1|STARTED|Overall Study||332
551168|NCT00724451|1343628|P1|NOT COMPLETED|Overall Study||802
551169|NCT00724451|1343628|P1|COMPLETED|Overall Study|Completed defined as participants who completed anti-viral treatment.|326
551170|NCT00724451|1343628|P1|Received Antiviral Treatment|Overall Study||500
551171|NCT00724451|1343628|P1|STARTED|Overall Study||1128
551172|NCT00724373|1343634|P1|NOT COMPLETED|Overall Study||171
551173|NCT00724373|1343634|P1|COMPLETED|Overall Study||271
551174|NCT00724373|1343634|P1|STARTED|Overall Study||442
551175|NCT00724347|1343638|P1|NOT COMPLETED|Overall Study||2
551176|NCT00724347|1343638|P1|COMPLETED|Overall Study||16
551177|NCT00724347|1343638|P1|Baseline Testing|Overall Study||18
551178|NCT00724347|1343638|P1|STARTED|Overall Study|Training was the final step in the program, once the outcome tests had been developed.|18
551179|NCT00724308|1343644|P2|NOT COMPLETED|Overall Study||97
551180|NCT00724308|1343645|P1|NOT COMPLETED|Overall Study||80
551181|NCT00724308|1343644|P2|COMPLETED|Overall Study||210
551182|NCT00724308|1343645|P1|COMPLETED|Overall Study||190
551183|NCT00724308|1343644|P2|STARTED|Overall Study||307
551184|NCT00724308|1343645|P1|STARTED|Overall Study||270
551185|NCT00724282|1343651|P1|NOT COMPLETED|Overall Study||4
551186|NCT00724282|1343651|P1|COMPLETED|Overall Study||16
551187|NCT00724282|1343651|P1|STARTED|Overall Study||20
551188|NCT00724243|1343655|P1|NOT COMPLETED|Overall Study||15
551189|NCT00724243|1343655|P1|COMPLETED|Overall Study||18
551190|NCT00724243|1343655|P1|STARTED|Overall Study||33
551191|NCT00724152|1343665|P3|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1
551192|NCT00724152|1343666|P2|NOT COMPLETED|Three-arm Study Period (+Standard Care)||2
551193|NCT00724152|1343667|P1|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1
551194|NCT00724152|1343665|P3|COMPLETED|Three-arm Study Period (+Standard Care)||1
551195|NCT00724152|1343666|P2|COMPLETED|Three-arm Study Period (+Standard Care)||0
551196|NCT00724152|1343667|P1|COMPLETED|Three-arm Study Period (+Standard Care)||3
551197|NCT00724152|1343665|P3|STARTED|Three-arm Study Period (+Standard Care)|3-group randomization began|2
551198|NCT00724152|1343666|P2|STARTED|Three-arm Study Period (+Standard Care)||2
551199|NCT00724152|1343667|P1|STARTED|Three-arm Study Period (+Standard Care)||4
551200|NCT00724152|1343665|P3|NOT COMPLETED|Two-arm Study Period||0
551201|NCT00724152|1343666|P2|NOT COMPLETED|Two-arm Study Period||2
551202|NCT00724152|1343667|P1|NOT COMPLETED|Two-arm Study Period||3
551203|NCT00724152|1343665|P3|COMPLETED|Two-arm Study Period||0
551204|NCT00724152|1343666|P2|COMPLETED|Two-arm Study Period||9
551205|NCT00724152|1343667|P1|COMPLETED|Two-arm Study Period||11
551206|NCT00724152|1343665|P3|STARTED|Two-arm Study Period|Standard Care arm was added later (Period 2)|0
551207|NCT00724152|1343666|P2|STARTED|Two-arm Study Period||11
551208|NCT00724152|1343667|P1|STARTED|Two-arm Study Period||14
551209|NCT00724126|1343684|P2|NOT COMPLETED|Overall Study||15
551210|NCT00724126|1343685|P1|NOT COMPLETED|Overall Study||19
551211|NCT00724126|1343684|P2|COMPLETED|Overall Study||301
551212|NCT00724126|1343685|P1|COMPLETED|Overall Study||302
551213|NCT00724126|1343684|P2|STARTED|Overall Study||316
551214|NCT00724126|1343685|P1|STARTED|Overall Study||321
551215|NCT00724061|1343693|P1|NOT COMPLETED|Maintenance Therapy||0
551216|NCT00724061|1343693|P1|COMPLETED|Maintenance Therapy||2
551217|NCT00724061|1343693|P1|STARTED|Maintenance Therapy||2
551218|NCT00724061|1343693|P1|NOT COMPLETED|Dose Escalation Phase||5
551219|NCT00724061|1343693|P1|COMPLETED|Dose Escalation Phase||2
551220|NCT00724061|1343693|P1|STARTED|Dose Escalation Phase||7
551221|NCT00724009|1343697|P1|NOT COMPLETED|Overall Study||0
551222|NCT00724009|1343697|P1|COMPLETED|Overall Study|One patient underwent conditioning but died 1 day before stem cell infusion due to sepsis.|29
551223|NCT00724009|1343697|P1|STARTED|Overall Study||29
551224|NCT00723957|1343710|P2|NOT COMPLETED|Overall Study||53
551225|NCT00723957|1343711|P1|NOT COMPLETED|Overall Study||51
551226|NCT00723957|1343710|P2|COMPLETED|Overall Study|Completed 6 cycles of study drug (maximum per protocol)|46
551227|NCT00723957|1343711|P1|COMPLETED|Overall Study|Completed 6 cycles of study drug (maximum per protocol)|47
551228|NCT00723957|1343710|P2|STARTED|Overall Study|Randomized|99
551229|NCT00723957|1343711|P1|STARTED|Overall Study|Randomized|98
551230|NCT00723944|1343735|P2|NOT COMPLETED|Two Year Post Placement Follow-up||0
551231|NCT00723944|1343736|P1|NOT COMPLETED|Two Year Post Placement Follow-up||0
551232|NCT00723944|1343735|P2|COMPLETED|Two Year Post Placement Follow-up|number of individual implant units completing is 108|37
551233|NCT00723944|1343736|P1|COMPLETED|Two Year Post Placement Follow-up|number of individual implant units completing is 130|48
551234|NCT00723944|1343735|P2|STARTED|Two Year Post Placement Follow-up|number of individual implant units is 108|37
551235|NCT00723944|1343736|P1|STARTED|Two Year Post Placement Follow-up|number of individual implant units is 130|48
551236|NCT00723944|1343735|P2|NOT COMPLETED|One Year Post Placement Follow-up||4
551237|NCT00723944|1343736|P1|NOT COMPLETED|One Year Post Placement Follow-up||1
551238|NCT00723944|1343735|P2|COMPLETED|One Year Post Placement Follow-up|number of individual implant units completing is 108|37
551239|NCT00723944|1343736|P1|COMPLETED|One Year Post Placement Follow-up|number of individual implant units completing is 130|48
551240|NCT00723944|1343735|P2|STARTED|One Year Post Placement Follow-up|number of individual implant units is 112|41
551241|NCT00723944|1343736|P1|STARTED|One Year Post Placement Follow-up|number of individual implant units is 134|49
551242|NCT00723944|1343735|P2|NOT COMPLETED|Permanent Prosthesis Placement||9
551243|NCT00723944|1343736|P1|NOT COMPLETED|Permanent Prosthesis Placement||3
551244|NCT00723944|1343735|P2|COMPLETED|Permanent Prosthesis Placement|number of individual implant units completing is 112|41
551245|NCT00723944|1343736|P1|COMPLETED|Permanent Prosthesis Placement|number of individual implant units completing is 134|49
551246|NCT00723944|1343735|P2|STARTED|Permanent Prosthesis Placement|number of individual implant units is 138|50
551247|NCT00723944|1343736|P1|STARTED|Permanent Prosthesis Placement|number of individual implant units is 148|52
551248|NCT00723944|1343735|P2|NOT COMPLETED|Implant Placement Surgery||0
551249|NCT00723944|1343736|P1|NOT COMPLETED|Implant Placement Surgery||0
551250|NCT00723944|1343735|P2|COMPLETED|Implant Placement Surgery|number of individual implant units completing is 138|50
551251|NCT00723944|1343736|P1|COMPLETED|Implant Placement Surgery|number of individual implant units completing is 148|52
551252|NCT00723944|1343735|P2|STARTED|Implant Placement Surgery|number of individual implant units is 138|50
551253|NCT00723944|1343736|P1|STARTED|Implant Placement Surgery|number of individual implant units is 148|52
551254|NCT00723931|1343742|P1|NOT COMPLETED|Overall Study||0
551255|NCT00723931|1343742|P1|COMPLETED|Overall Study||1267
551256|NCT00723931|1343742|P1|STARTED|Overall Study||1267
551257|NCT00723892|1343749|P2|NOT COMPLETED|Overall Study||87
551258|NCT00723892|1343750|P1|NOT COMPLETED|Overall Study||107
551259|NCT00723892|1343749|P2|COMPLETED|Overall Study||168
551260|NCT00723892|1343750|P1|COMPLETED|Overall Study||206
551261|NCT00723892|1343749|P2|STARTED|Overall Study||255
551262|NCT00723892|1343750|P1|STARTED|Overall Study||313
551263|NCT00723840|1343757|P1|NOT COMPLETED|Overall Study||82
551264|NCT00723840|1343757|P1|COMPLETED|Overall Study||163
551265|NCT00723840|1343757|P1|STARTED|Overall Study||245
551266|NCT00723827|1343768|P1|NOT COMPLETED|Overall Study||0
551267|NCT00723827|1343768|P1|COMPLETED|Overall Study||682
551268|NCT00723827|1343768|P1|STARTED|Overall Study||682
551269|NCT00723801|1343778|P2|NOT COMPLETED|Overall Study||3
551270|NCT00723801|1343779|P1|NOT COMPLETED|Overall Study||3
551271|NCT00723801|1343778|P2|COMPLETED|Overall Study||17
551272|NCT00723801|1343779|P1|COMPLETED|Overall Study||17
551273|NCT00723801|1343778|P2|STARTED|Overall Study||20
551274|NCT00723801|1343779|P1|STARTED|Overall Study||20
551275|NCT00723788|1343787|P1|NOT COMPLETED|Overall Study||0
551276|NCT00723788|1343787|P1|COMPLETED|Overall Study||21
551277|NCT00723788|1343787|P1|STARTED|Overall Study||21
551278|NCT00723749|1343793|P1|NOT COMPLETED|Overall Study||163
551279|NCT00723749|1343793|P1|COMPLETED|Overall Study||182
551280|NCT00723749|1343793|P1|STARTED|Overall Study|384 patients were enrolled, 36 non-eligible datasets were excluded from analysis|345
551281|NCT00723736|1343800|P1|NOT COMPLETED|Overall Study||1
551282|NCT00723736|1343800|P1|COMPLETED|Overall Study|Subject's caregiver did not wish to continue, reasons unrelated.|99
551283|NCT00723736|1343800|P1|STARTED|Overall Study||100
551284|NCT00723710|1343804|P1|NOT COMPLETED|Overall Study||174
551285|NCT00723710|1343804|P1|COMPLETED|Overall Study||120
551286|NCT00723710|1343804|P1|STARTED|Overall Study||294
551287|NCT00723697|1343808|P1|NOT COMPLETED|Overall Study||18
551288|NCT00723697|1343808|P1|COMPLETED|Overall Study||1289
551289|NCT00723697|1343808|P1|STARTED|Overall Study||1307
551290|NCT00723645|1343816|P1|NOT COMPLETED|Visit 3 (Week 72 Post-treatment)||0
551291|NCT00723645|1343816|P1|COMPLETED|Visit 3 (Week 72 Post-treatment)||187
551292|NCT00723645|1343816|P1|STARTED|Visit 3 (Week 72 Post-treatment)|61 discontinued before V3; 26 lost to followup, 34 HCV RNA+ at Wk 24,1 death,1 HCV RNA not available|187
551293|NCT00723645|1343816|P1|NOT COMPLETED|Visit 2 (Week 24 Post-treatment)||0
551294|NCT00723645|1343816|P1|COMPLETED|Visit 2 (Week 24 Post-treatment)||248
551295|NCT00723645|1343816|P1|STARTED|Visit 2 (Week 24 Post-treatment)|10 discontinued before Visit 2; 7 lost to follow-up and 3 were HCV RNA+ before Wk 24|248
551296|NCT00723645|1343816|P1|NOT COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||0
551297|NCT00723645|1343816|P1|COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||258
551298|NCT00723645|1343816|P1|STARTED|Visit 1 (≤4 Weeks Post-treatment)||258
551299|NCT00723632|1343821|P1|NOT COMPLETED|Overall Study||203
551300|NCT00723632|1343821|P1|COMPLETED|Overall Study|Completed initial exam form and >= 1 follow up visit form; end of treatment and SVR status recorded|698
551301|NCT00723632|1343821|P1|STARTED|Overall Study||901
551302|NCT00723606|1343829|P2|NOT COMPLETED|Overall Study||7
551303|NCT00723606|1343830|P1|NOT COMPLETED|Overall Study||4
551304|NCT00723606|1343829|P2|COMPLETED|Overall Study||180
551305|NCT00723606|1343830|P1|COMPLETED|Overall Study||185
551306|NCT00723606|1343829|P2|STARTED|Overall Study||187
551307|NCT00723606|1343830|P1|STARTED|Overall Study||189
551308|NCT00723580|1343846|P1|NOT COMPLETED|Overall Study||0
551309|NCT00723580|1343846|P1|COMPLETED|Overall Study|Completion of repeated Measurements|1
551310|NCT00723580|1343846|P1|Baseline Measurements|Overall Study|Actigraphic, Psychometric and Observational Baseline Data Collected.|1
551311|NCT00723580|1343846|P1|STARTED|Overall Study|Study was extended with continued repeated measurements.|1
551312|NCT00723554|1343850|P1|NOT COMPLETED|Overall Study||29
551313|NCT00723554|1343850|P1|COMPLETED|Overall Study||34
551314|NCT00723554|1343850|P1|STARTED|Overall Study||63
551315|NCT00723528|1343900|P7|NOT COMPLETED|Period 2: After Controlled Period||4
551316|NCT00723528|1343901|P6|NOT COMPLETED|Period 2: After Controlled Period||6
551317|NCT00723528|1343902|P5|NOT COMPLETED|Period 2: After Controlled Period||2
551318|NCT00723528|1343903|P4|NOT COMPLETED|Period 2: After Controlled Period||1
551319|NCT00723528|1343904|P3|NOT COMPLETED|Period 2: After Controlled Period||0
551320|NCT00723528|1343905|P2|NOT COMPLETED|Period 2: After Controlled Period||0
551321|NCT00723528|1343906|P1|NOT COMPLETED|Period 2: After Controlled Period||0
551322|NCT00723528|1343900|P7|COMPLETED|Period 2: After Controlled Period||54
551323|NCT00723528|1343901|P6|COMPLETED|Period 2: After Controlled Period||58
551324|NCT00723528|1343902|P5|COMPLETED|Period 2: After Controlled Period||11
551325|NCT00723528|1343903|P4|COMPLETED|Period 2: After Controlled Period||14
551326|NCT00723528|1343904|P3|COMPLETED|Period 2: After Controlled Period||0
551327|NCT00723528|1343905|P2|COMPLETED|Period 2: After Controlled Period||0
551328|NCT00723528|1343906|P1|COMPLETED|Period 2: After Controlled Period||0
551329|NCT00723528|1343900|P7|STARTED|Period 2: After Controlled Period||58
551330|NCT00723528|1343901|P6|STARTED|Period 2: After Controlled Period||64
551331|NCT00723528|1343902|P5|STARTED|Period 2: After Controlled Period||13
551332|NCT00723528|1343903|P4|STARTED|Period 2: After Controlled Period||15
551333|NCT00723528|1343904|P3|STARTED|Period 2: After Controlled Period||0
551334|NCT00723528|1343905|P2|STARTED|Period 2: After Controlled Period||0
551335|NCT00723528|1343906|P1|STARTED|Period 2: After Controlled Period||0
551336|NCT00723528|1343900|P7|NOT COMPLETED|Period 1: Controlled Period (CP)||0
551337|NCT00723528|1343901|P6|NOT COMPLETED|Period 1: Controlled Period (CP)||0
551338|NCT00723528|1343902|P5|NOT COMPLETED|Period 1: Controlled Period (CP)||0
551339|NCT00723528|1343903|P4|NOT COMPLETED|Period 1: Controlled Period (CP)||0
551340|NCT00723528|1343904|P3|NOT COMPLETED|Period 1: Controlled Period (CP)||4
551341|NCT00723528|1343905|P2|NOT COMPLETED|Period 1: Controlled Period (CP)||0
551342|NCT00723528|1343906|P1|NOT COMPLETED|Period 1: Controlled Period (CP)||4
551343|NCT00723528|1343900|P7|COMPLETED|Period 1: Controlled Period (CP)||0
551344|NCT00723528|1343901|P6|COMPLETED|Period 1: Controlled Period (CP)||0
551345|NCT00723528|1343902|P5|COMPLETED|Period 1: Controlled Period (CP)||0
551346|NCT00723528|1343903|P4|COMPLETED|Period 1: Controlled Period (CP)||0
551347|NCT00723528|1343904|P3|COMPLETED|Period 1: Controlled Period (CP)||58
551348|NCT00723528|1343905|P2|COMPLETED|Period 1: Controlled Period (CP)||64
551349|NCT00723528|1343906|P1|COMPLETED|Period 1: Controlled Period (CP)||28
551350|NCT00723528|1343900|P7|STARTED|Period 1: Controlled Period (CP)||0
551351|NCT00723528|1343901|P6|STARTED|Period 1: Controlled Period (CP)||0
551352|NCT00723528|1343902|P5|STARTED|Period 1: Controlled Period (CP)||0
551353|NCT00723528|1343903|P4|STARTED|Period 1: Controlled Period (CP)||0
551354|NCT00723528|1343904|P3|STARTED|Period 1: Controlled Period (CP)||62
551355|NCT00723528|1343905|P2|STARTED|Period 1: Controlled Period (CP)||64
551356|NCT00723528|1343906|P1|STARTED|Period 1: Controlled Period (CP)||32
551357|NCT00723489|1343968|P4|NOT COMPLETED|Overall Study||3
551358|NCT00723489|1343969|P3|NOT COMPLETED|Overall Study||0
551359|NCT00723489|1343970|P2|NOT COMPLETED|Overall Study||4
551360|NCT00723489|1343971|P1|NOT COMPLETED|Overall Study||1
551361|NCT00723489|1343968|P4|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|20
551362|NCT00723489|1343969|P3|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|19
551363|NCT00723489|1343970|P2|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|15
551364|NCT00723489|1343971|P1|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|20
551365|NCT00723489|1343968|P4|STARTED|Overall Study||23
551366|NCT00723489|1343969|P3|STARTED|Overall Study||19
551367|NCT00723489|1343970|P2|STARTED|Overall Study||19
551368|NCT00723489|1343971|P1|STARTED|Overall Study||21
551369|NCT00723450|1343999|P3|NOT COMPLETED|Randomized Phase||67
551370|NCT00723450|1344000|P2|NOT COMPLETED|Randomized Phase||65
551371|NCT00723450|1344001|P1|NOT COMPLETED|Randomized Phase||0
551372|NCT00723450|1343999|P3|COMPLETED|Randomized Phase||20
551373|NCT00723450|1344000|P2|COMPLETED|Randomized Phase||21
551374|NCT00723450|1344001|P1|COMPLETED|Randomized Phase||0
551375|NCT00723450|1343999|P3|STARTED|Randomized Phase||87
551376|NCT00723450|1344000|P2|STARTED|Randomized Phase||86
551377|NCT00723450|1344001|P1|STARTED|Randomized Phase||0
551378|NCT00723450|1343999|P3|NOT COMPLETED|Open-Label Phase||0
551379|NCT00723450|1344000|P2|NOT COMPLETED|Open-Label Phase||0
551380|NCT00723450|1344001|P1|NOT COMPLETED|Open-Label Phase||125
551381|NCT00723450|1343999|P3|COMPLETED|Open-Label Phase||0
551382|NCT00723450|1344000|P2|COMPLETED|Open-Label Phase||0
551383|NCT00723450|1344001|P1|COMPLETED|Open-Label Phase||173
551384|NCT00723450|1343999|P3|STARTED|Open-Label Phase||0
551385|NCT00723450|1344000|P2|STARTED|Open-Label Phase||0
551386|NCT00723450|1344001|P1|STARTED|Open-Label Phase||298
551387|NCT00723294|1344042|P1|NOT COMPLETED|Overall Study||13
551388|NCT00723294|1344042|P1|COMPLETED|Overall Study||86
551389|NCT00723294|1344042|P1|STARTED|Overall Study||99
551390|NCT00723255|1344047|P1|NOT COMPLETED|Overall Study||4
551391|NCT00723255|1344047|P1|COMPLETED|Overall Study|Eligible and treated patients|49
551392|NCT00723255|1344047|P1|STARTED|Overall Study||53
551393|NCT00723229|1344074|P2|NOT COMPLETED|Second Intervention||0
551394|NCT00723229|1344075|P1|NOT COMPLETED|Second Intervention||0
551395|NCT00723229|1344074|P2|COMPLETED|Second Intervention||20
551396|NCT00723229|1344075|P1|COMPLETED|Second Intervention||18
551397|NCT00723229|1344074|P2|STARTED|Second Intervention||20
551398|NCT00723229|1344075|P1|STARTED|Second Intervention||18
551399|NCT00723229|1344074|P2|NOT COMPLETED|First Intervention||3
551400|NCT00723229|1344075|P1|NOT COMPLETED|First Intervention||7
551401|NCT00723229|1344074|P2|COMPLETED|First Intervention||20
551402|NCT00723229|1344075|P1|COMPLETED|First Intervention||18
551403|NCT00723229|1344074|P2|STARTED|First Intervention||23
551404|NCT00723229|1344075|P1|STARTED|First Intervention||25
551405|NCT00723203|1344087|P1|NOT COMPLETED|Overall Study||3
551406|NCT00723203|1344087|P1|COMPLETED|Overall Study||13
551407|NCT00723203|1344087|P1|STARTED|Overall Study||16
551408|NCT00723190|1344091|P1|NOT COMPLETED|Overall Study||142
551409|NCT00723190|1344091|P1|COMPLETED|Overall Study|53 participants completed 6-month protocol and 108 participants completed 12-month protocol|161
551410|NCT00723190|1344091|P1|SAFETY POPULATION|Overall Study||301
551411|NCT00723190|1344091|P1|STARTED|Overall Study|Study CLON-301 (168 participants) and Study CLON-302 (135 participants)|303
551412|NCT00723177|1344109|P3|NOT COMPLETED|Overall Study||5
551413|NCT00723177|1344110|P2|NOT COMPLETED|Overall Study||4
551414|NCT00723177|1344111|P1|NOT COMPLETED|Overall Study||5
551415|NCT00723177|1344109|P3|COMPLETED|Overall Study||10
551416|NCT00723177|1344110|P2|COMPLETED|Overall Study||10
551417|NCT00723177|1344111|P1|COMPLETED|Overall Study||10
551418|NCT00723177|1344109|P3|STARTED|Overall Study||15
551419|NCT00723177|1344110|P2|STARTED|Overall Study||14
551420|NCT00723177|1344111|P1|STARTED|Overall Study||15
551421|NCT00723125|1344124|P2|NOT COMPLETED|Overall Study||6
551422|NCT00723125|1344125|P1|NOT COMPLETED|Overall Study||18
551423|NCT00723125|1344124|P2|COMPLETED|Overall Study||21
551424|NCT00723125|1344125|P1|COMPLETED|Overall Study||15
551425|NCT00723125|1344124|P2|STARTED|Overall Study|27 evaluable Neo-adjuvant Of 27 patients neo-adjuvant, 24 DDAC Of 24 DDAC, 21 Avastin post-op|27
551426|NCT00723125|1344125|P1|STARTED|Overall Study|33 pts Neo-adjuvant, 28 evaluable,DDAC: Of 28 pts,27 treated DDAC Avastin:Of 27,15 Avastin post-op|33
551427|NCT00723073|1344137|P2|NOT COMPLETED|Overall Study||0
551428|NCT00723073|1344138|P1|NOT COMPLETED|Overall Study||0
551429|NCT00723073|1344137|P2|COMPLETED|Overall Study||174
551430|NCT00723073|1344138|P1|COMPLETED|Overall Study||149
551431|NCT00723073|1344137|P2|STARTED|Overall Study||174
551432|NCT00723073|1344138|P1|STARTED|Overall Study||149
551433|NCT00723021|1344162|P5|NOT COMPLETED|Intervention Period 5||0
551434|NCT00723021|1344163|P4|NOT COMPLETED|Intervention Period 5||0
551435|NCT00723021|1344164|P3|NOT COMPLETED|Intervention Period 5||0
551436|NCT00723021|1344165|P2|NOT COMPLETED|Intervention Period 5||0
551437|NCT00723021|1344166|P1|NOT COMPLETED|Intervention Period 5||0
551438|NCT00723021|1344162|P5|COMPLETED|Intervention Period 5||2
551439|NCT00723021|1344163|P4|COMPLETED|Intervention Period 5||3
551440|NCT00723021|1344164|P3|COMPLETED|Intervention Period 5||3
551441|NCT00723021|1344165|P2|COMPLETED|Intervention Period 5||3
551442|NCT00723021|1344166|P1|COMPLETED|Intervention Period 5||3
551443|NCT00723021|1344162|P5|STARTED|Intervention Period 5||2
551444|NCT00723021|1344163|P4|STARTED|Intervention Period 5||3
551445|NCT00723021|1344164|P3|STARTED|Intervention Period 5||3
551446|NCT00723021|1344165|P2|STARTED|Intervention Period 5||3
551447|NCT00723021|1344166|P1|STARTED|Intervention Period 5||3
551448|NCT00723021|1344162|P5|NOT COMPLETED|Intervention Period 4||1
551449|NCT00723021|1344163|P4|NOT COMPLETED|Intervention Period 4||0
551450|NCT00723021|1344164|P3|NOT COMPLETED|Intervention Period 4||0
551451|NCT00723021|1344165|P2|NOT COMPLETED|Intervention Period 4||0
551452|NCT00723021|1344166|P1|NOT COMPLETED|Intervention Period 4||0
551453|NCT00723021|1344162|P5|COMPLETED|Intervention Period 4||2
551454|NCT00723021|1344163|P4|COMPLETED|Intervention Period 4||3
551455|NCT00723021|1344164|P3|COMPLETED|Intervention Period 4||3
551456|NCT00723021|1344165|P2|COMPLETED|Intervention Period 4||3
551457|NCT00723021|1344166|P1|COMPLETED|Intervention Period 4||3
551458|NCT00723021|1344162|P5|STARTED|Intervention Period 4||3
551459|NCT00723021|1344163|P4|STARTED|Intervention Period 4||3
551460|NCT00723021|1344164|P3|STARTED|Intervention Period 4||3
551461|NCT00723021|1344165|P2|STARTED|Intervention Period 4||3
551462|NCT00723021|1344166|P1|STARTED|Intervention Period 4||3
551463|NCT00723021|1344162|P5|NOT COMPLETED|Intervention Period 3||0
551464|NCT00723021|1344163|P4|NOT COMPLETED|Intervention Period 3||0
551465|NCT00723021|1344164|P3|NOT COMPLETED|Intervention Period 3||0
551466|NCT00723021|1344165|P2|NOT COMPLETED|Intervention Period 3||0
551467|NCT00723021|1344166|P1|NOT COMPLETED|Intervention Period 3||0
551468|NCT00723021|1344162|P5|COMPLETED|Intervention Period 3||3
551469|NCT00723021|1344163|P4|COMPLETED|Intervention Period 3||3
551470|NCT00723021|1344164|P3|COMPLETED|Intervention Period 3||3
551471|NCT00723021|1344165|P2|COMPLETED|Intervention Period 3||3
551472|NCT00723021|1344166|P1|COMPLETED|Intervention Period 3||3
551473|NCT00723021|1344162|P5|STARTED|Intervention Period 3||3
551474|NCT00723021|1344163|P4|STARTED|Intervention Period 3||3
551475|NCT00723021|1344164|P3|STARTED|Intervention Period 3||3
551476|NCT00723021|1344165|P2|STARTED|Intervention Period 3||3
551477|NCT00723021|1344166|P1|STARTED|Intervention Period 3||3
551478|NCT00723021|1344162|P5|NOT COMPLETED|Intervention Period 2||0
551479|NCT00723021|1344163|P4|NOT COMPLETED|Intervention Period 2||0
551480|NCT00723021|1344164|P3|NOT COMPLETED|Intervention Period 2||0
551481|NCT00723021|1344165|P2|NOT COMPLETED|Intervention Period 2||0
551482|NCT00723021|1344166|P1|NOT COMPLETED|Intervention Period 2||0
551483|NCT00723021|1344162|P5|COMPLETED|Intervention Period 2||3
551484|NCT00723021|1344163|P4|COMPLETED|Intervention Period 2||3
551485|NCT00723021|1344164|P3|COMPLETED|Intervention Period 2||3
551486|NCT00723021|1344165|P2|COMPLETED|Intervention Period 2||3
551487|NCT00723021|1344166|P1|COMPLETED|Intervention Period 2||3
551488|NCT00723021|1344162|P5|STARTED|Intervention Period 2||3
551489|NCT00723021|1344163|P4|STARTED|Intervention Period 2||3
551490|NCT00723021|1344164|P3|STARTED|Intervention Period 2||3
551491|NCT00723021|1344165|P2|STARTED|Intervention Period 2||3
551492|NCT00723021|1344166|P1|STARTED|Intervention Period 2||3
551493|NCT00723021|1344162|P5|NOT COMPLETED|Intervention Period 1||0
551494|NCT00723021|1344163|P4|NOT COMPLETED|Intervention Period 1||0
551495|NCT00723021|1344164|P3|NOT COMPLETED|Intervention Period 1||0
551496|NCT00723021|1344165|P2|NOT COMPLETED|Intervention Period 1||0
551497|NCT00723021|1344166|P1|NOT COMPLETED|Intervention Period 1||0
551498|NCT00723021|1344162|P5|COMPLETED|Intervention Period 1||3
551499|NCT00723021|1344163|P4|COMPLETED|Intervention Period 1||3
551500|NCT00723021|1344164|P3|COMPLETED|Intervention Period 1||3
551501|NCT00723021|1344165|P2|COMPLETED|Intervention Period 1||3
551502|NCT00723021|1344166|P1|COMPLETED|Intervention Period 1||3
551503|NCT00723021|1344162|P5|STARTED|Intervention Period 1||3
551504|NCT00723021|1344163|P4|STARTED|Intervention Period 1||3
551505|NCT00723021|1344164|P3|STARTED|Intervention Period 1||3
551506|NCT00723021|1344165|P2|STARTED|Intervention Period 1||3
551507|NCT00723021|1344166|P1|STARTED|Intervention Period 1||3
551508|NCT00723008|1344220|P2|NOT COMPLETED|4-Week Unblinded Treatment||1
551509|NCT00723008|1344221|P1|NOT COMPLETED|4-Week Unblinded Treatment||1
551510|NCT00723008|1344220|P2|COMPLETED|4-Week Unblinded Treatment||3
551511|NCT00723008|1344221|P1|COMPLETED|4-Week Unblinded Treatment||4
551512|NCT00723008|1344220|P2|STARTED|4-Week Unblinded Treatment||4
551513|NCT00723008|1344221|P1|STARTED|4-Week Unblinded Treatment||5
551514|NCT00723008|1344220|P2|NOT COMPLETED|4-Week Double Blinded||5
551515|NCT00723008|1344221|P1|NOT COMPLETED|4-Week Double Blinded||5
551516|NCT00723008|1344220|P2|COMPLETED|4-Week Double Blinded||4
551517|NCT00723008|1344221|P1|COMPLETED|4-Week Double Blinded||5
551518|NCT00723008|1344220|P2|STARTED|4-Week Double Blinded||9
551519|NCT00723008|1344221|P1|STARTED|4-Week Double Blinded||10
551520|NCT00723008|1344220|P2|NOT COMPLETED|Enrollment||0
551521|NCT00723008|1344221|P1|NOT COMPLETED|Enrollment||1
551522|NCT00723008|1344220|P2|COMPLETED|Enrollment||9
551523|NCT00723008|1344221|P1|COMPLETED|Enrollment||10
551524|NCT00723008|1344220|P2|STARTED|Enrollment||9
551525|NCT00723008|1344221|P1|STARTED|Enrollment||11
551526|NCT00722865|1344243|P1|NOT COMPLETED|Overall Study||2
551527|NCT00722865|1344243|P1|COMPLETED|Overall Study||23
551528|NCT00722865|1344243|P1|STARTED|Overall Study||25
551529|NCT00722800|1344253|P2|NOT COMPLETED|Overall Study||0
551530|NCT00722800|1344254|P1|NOT COMPLETED|Overall Study||2
551531|NCT00722800|1344253|P2|COMPLETED|Overall Study||2
551532|NCT00722800|1344254|P1|COMPLETED|Overall Study||0
551533|NCT00722800|1344253|P2|STARTED|Overall Study||2
551534|NCT00722800|1344254|P1|STARTED|Overall Study||2
551535|NCT00722761|1344266|P2|NOT COMPLETED|Overall Study||6
551536|NCT00722761|1344267|P1|NOT COMPLETED|Overall Study||6
551537|NCT00722761|1344266|P2|COMPLETED|Overall Study||8
551538|NCT00722761|1344267|P1|COMPLETED|Overall Study||10
551539|NCT00722761|1344266|P2|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||10
551540|NCT00722761|1344267|P1|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||15
551541|NCT00722761|1344266|P2|STARTED|Overall Study||14
551542|NCT00722761|1344267|P1|STARTED|Overall Study||16
551543|NCT00722722|1344278|P3|NOT COMPLETED|Overall Study||0
551544|NCT00722722|1344279|P2|NOT COMPLETED|Overall Study||0
551545|NCT00722722|1344280|P1|NOT COMPLETED|Overall Study||0
551546|NCT00722722|1344278|P3|COMPLETED|Overall Study||10
551547|NCT00722722|1344279|P2|COMPLETED|Overall Study||5
551548|NCT00722722|1344280|P1|COMPLETED|Overall Study||3
551549|NCT00722722|1344278|P3|STARTED|Overall Study||10
551550|NCT00722722|1344279|P2|STARTED|Overall Study||5
551551|NCT00722722|1344280|P1|STARTED|Overall Study||3
551552|NCT00722566|1344290|P2|NOT COMPLETED|Overall Study||35
551553|NCT00722566|1344291|P1|NOT COMPLETED|Overall Study||67
551554|NCT00722566|1344290|P2|COMPLETED|Overall Study|Completed 8 cycles|39
551555|NCT00722566|1344291|P1|COMPLETED|Overall Study|Completed 8 cycles|81
551556|NCT00722566|1344290|P2|STARTED|Overall Study||74
551557|NCT00722566|1344291|P1|STARTED|Overall Study|One patient randomized and not dosed|148
551558|NCT00722553|1344299|P1|NOT COMPLETED|Overall Study||0
551559|NCT00722553|1344299|P1|COMPLETED|Overall Study||30
551560|NCT00722553|1344299|P1|STARTED|Overall Study||30
551561|NCT00722436|1344309|P2|NOT COMPLETED|Overall Study||0
551562|NCT00722436|1344310|P1|NOT COMPLETED|Overall Study||0
551563|NCT00722436|1344309|P2|COMPLETED|Overall Study||11
551564|NCT00722436|1344310|P1|COMPLETED|Overall Study||9
551565|NCT00722436|1344309|P2|STARTED|Overall Study||11
551566|NCT00722436|1344310|P1|STARTED|Overall Study||9
551567|NCT00722423|1344324|P2|NOT COMPLETED|Overall Study||1
551568|NCT00722423|1344325|P1|NOT COMPLETED|Overall Study||0
551569|NCT00722423|1344324|P2|COMPLETED|Overall Study||181
551570|NCT00722423|1344325|P1|COMPLETED|Overall Study||182
551571|NCT00722423|1344324|P2|STARTED|Overall Study||182
551572|NCT00722423|1344325|P1|STARTED|Overall Study||182
551573|NCT00722371|1344340|P7|NOT COMPLETED|Overall Study||51
551574|NCT00722371|1344341|P6|NOT COMPLETED|Overall Study||53
551575|NCT00722371|1344342|P5|NOT COMPLETED|Overall Study||48
551576|NCT00722371|1344343|P4|NOT COMPLETED|Overall Study||63
551577|NCT00722371|1344344|P3|NOT COMPLETED|Overall Study||65
551578|NCT00722371|1344345|P2|NOT COMPLETED|Overall Study||72
551579|NCT00722371|1344346|P1|NOT COMPLETED|Overall Study||56
551580|NCT00722371|1344340|P7|COMPLETED|Overall Study||179
551581|NCT00722371|1344341|P6|COMPLETED|Overall Study||178
551582|NCT00722371|1344342|P5|COMPLETED|Overall Study||182
551583|NCT00722371|1344343|P4|COMPLETED|Overall Study||167
551584|NCT00722371|1344344|P3|COMPLETED|Overall Study||168
551585|NCT00722371|1344345|P2|COMPLETED|Overall Study||158
551586|NCT00722371|1344346|P1|COMPLETED|Overall Study||175
551587|NCT00722371|1344340|P7|STARTED|Overall Study||230
551588|NCT00722371|1344341|P6|STARTED|Overall Study||231
551589|NCT00722371|1344342|P5|STARTED|Overall Study||230
551590|NCT00722371|1344343|P4|STARTED|Overall Study||230
551591|NCT00722371|1344344|P3|STARTED|Overall Study||233
551592|NCT00722371|1344345|P2|STARTED|Overall Study||230
551593|NCT00722371|1344346|P1|STARTED|Overall Study||231
551594|NCT00722137|1344399|P2|NOT COMPLETED|Overall Study||45
551595|NCT00722137|1344400|P1|NOT COMPLETED|Overall Study||48
551596|NCT00722137|1344399|P2|COMPLETED|Overall Study||199
551597|NCT00722137|1344400|P1|COMPLETED|Overall Study||195
551598|NCT00722137|1344399|P2|STARTED|Overall Study||244
551599|NCT00722137|1344400|P1|STARTED|Overall Study||243
551600|NCT00722124|1344427|P3|NOT COMPLETED|Overall Study||20
551601|NCT00722124|1344428|P2|NOT COMPLETED|Overall Study||14
551602|NCT00722124|1344429|P1|NOT COMPLETED|Overall Study||17
551603|NCT00722124|1344427|P3|COMPLETED|Overall Study||20
551604|NCT00722124|1344428|P2|COMPLETED|Overall Study||26
551605|NCT00722124|1344429|P1|COMPLETED|Overall Study||23
551606|NCT00722124|1344427|P3|STARTED|Overall Study||40
551607|NCT00722124|1344428|P2|STARTED|Overall Study||40
551608|NCT00722124|1344429|P1|STARTED|Overall Study||40
551609|NCT00722111|1344439|P2|NOT COMPLETED|Overall Study||0
551610|NCT00722111|1344440|P1|NOT COMPLETED|Overall Study||0
551611|NCT00722111|1344439|P2|COMPLETED|Overall Study||72
551612|NCT00722111|1344440|P1|COMPLETED|Overall Study||11
551613|NCT00722111|1344439|P2|STARTED|Overall Study||72
551614|NCT00722111|1344440|P1|STARTED|Overall Study||11
551615|NCT00722072|1344447|P1|NOT COMPLETED|Overall Study||3
551616|NCT00722072|1344447|P1|COMPLETED|Overall Study||9
551617|NCT00722072|1344447|P1|STARTED|Overall Study||12
551618|NCT00722020|1344457|P2|NOT COMPLETED|Overall Study||0
551619|NCT00722020|1344458|P1|NOT COMPLETED|Overall Study||0
551620|NCT00722020|1344457|P2|COMPLETED|Overall Study||24
551621|NCT00722020|1344458|P1|COMPLETED|Overall Study||19
551622|NCT00722020|1344457|P2|STARTED|Overall Study||24
551623|NCT00722020|1344458|P1|STARTED|Overall Study||19
551624|NCT00721968|1344468|P2|NOT COMPLETED|Overall Study||0
551625|NCT00721968|1344469|P1|NOT COMPLETED|Overall Study||2
551626|NCT00721968|1344468|P2|COMPLETED|Overall Study||17
551627|NCT00721968|1344469|P1|COMPLETED|Overall Study||25
551628|NCT00721968|1344468|P2|STARTED|Overall Study||17
551629|NCT00721968|1344469|P1|STARTED|Overall Study||27
551630|NCT00721955|1344480|P3|NOT COMPLETED|Overall Study||2
551631|NCT00721955|1344481|P2|NOT COMPLETED|Overall Study||0
551632|NCT00721955|1344482|P1|NOT COMPLETED|Overall Study||0
551633|NCT00721955|1344480|P3|COMPLETED|Overall Study||103
551634|NCT00721955|1344481|P2|COMPLETED|Overall Study||104
551635|NCT00721955|1344482|P1|COMPLETED|Overall Study||105
551636|NCT00721955|1344480|P3|STARTED|Overall Study||105
551637|NCT00721955|1344481|P2|STARTED|Overall Study||104
551638|NCT00721955|1344482|P1|STARTED|Overall Study||105
551639|NCT00721799|1344496|P1|NOT COMPLETED|Overall Study||8
551640|NCT00721799|1344496|P1|COMPLETED|Overall Study||25
551641|NCT00721799|1344496|P1|Received FLT PET Scan #2|Overall Study||25
551642|NCT00721799|1344496|P1|Recieved FLT PET Scan 1|Overall Study||26
551643|NCT00721799|1344496|P1|STARTED|Overall Study||33
551644|NCT00721734|1344536|P5|NOT COMPLETED|Overall Study||6
551645|NCT00721734|1344537|P4|NOT COMPLETED|Overall Study||6
551646|NCT00721734|1344538|P3|NOT COMPLETED|Overall Study||8
551647|NCT00721734|1344539|P2|NOT COMPLETED|Overall Study||12
551648|NCT00721734|1344540|P1|NOT COMPLETED|Overall Study||8
551649|NCT00721734|1344536|P5|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
551650|NCT00721734|1344537|P4|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
551651|NCT00721734|1344538|P3|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
551652|NCT00721734|1344539|P2|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|0
551653|NCT00721734|1344540|P1|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|4
551654|NCT00721734|1344536|P5|STARTED|Overall Study||8
551655|NCT00721734|1344537|P4|STARTED|Overall Study||8
551656|NCT00721734|1344538|P3|STARTED|Overall Study||10
551657|NCT00721734|1344539|P2|STARTED|Overall Study||12
551658|NCT00721734|1344540|P1|STARTED|Overall Study||12
551659|NCT00721630|1344652|P1|NOT COMPLETED|Overall Study||1
551660|NCT00721630|1344652|P1|COMPLETED|Overall Study||23
551661|NCT00721630|1344652|P1|STARTED|Overall Study||24
551662|NCT00721617|1344657|P1|NOT COMPLETED|8 Hours Into Intralipid/Dextrose||0
551663|NCT00721617|1344657|P1|COMPLETED|8 Hours Into Intralipid/Dextrose||12
551664|NCT00721617|1344657|P1|STARTED|8 Hours Into Intralipid/Dextrose||12
551665|NCT00721617|1344657|P1|NOT COMPLETED|4 Hours Into Intralipid/Dextrose||0
551666|NCT00721617|1344657|P1|COMPLETED|4 Hours Into Intralipid/Dextrose||12
551667|NCT00721617|1344657|P1|STARTED|4 Hours Into Intralipid/Dextrose||12
551668|NCT00721617|1344657|P1|NOT COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||0
551669|NCT00721617|1344657|P1|COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||12
551670|NCT00721617|1344657|P1|STARTED|0 Hour (Baseline) of Intralipid/Dextrose||12
551671|NCT00721617|1344657|P1|NOT COMPLETED|8 Hours Into Dextrose Infusion||0
551672|NCT00721617|1344657|P1|COMPLETED|8 Hours Into Dextrose Infusion||12
551673|NCT00721617|1344657|P1|STARTED|8 Hours Into Dextrose Infusion||12
551674|NCT00721617|1344657|P1|NOT COMPLETED|4 Hours Into Dextrose Infusion||0
551675|NCT00721617|1344657|P1|COMPLETED|4 Hours Into Dextrose Infusion||12
551676|NCT00721617|1344657|P1|STARTED|4 Hours Into Dextrose Infusion||12
551677|NCT00721617|1344657|P1|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0
551678|NCT00721617|1344657|P1|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12
551679|NCT00721617|1344657|P1|STARTED|0 Hour (Baseline) of Dextrose Infusion||12
551680|NCT00721617|1344657|P1|NOT COMPLETED|8 Hours Into Intralipid Infusion||0
551681|NCT00721617|1344657|P1|COMPLETED|8 Hours Into Intralipid Infusion||12
551682|NCT00721617|1344657|P1|STARTED|8 Hours Into Intralipid Infusion||12
551683|NCT00721617|1344657|P1|NOT COMPLETED|4 Hours Into Intralipid Infusion||0
551684|NCT00721617|1344657|P1|COMPLETED|4 Hours Into Intralipid Infusion||12
551685|NCT00721617|1344657|P1|STARTED|4 Hours Into Intralipid Infusion||12
551686|NCT00721617|1344657|P1|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0
551687|NCT00721617|1344657|P1|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12
551688|NCT00721617|1344657|P1|STARTED|0 Hour (Baseline) of Intralipid Infusion||12
551689|NCT00721617|1344657|P1|NOT COMPLETED|8 Hours Into Saline Infusion||0
551690|NCT00721617|1344657|P1|COMPLETED|8 Hours Into Saline Infusion||12
551691|NCT00721617|1344657|P1|STARTED|8 Hours Into Saline Infusion||12
551692|NCT00721617|1344657|P1|NOT COMPLETED|4 Hours Into Saline Infusion||0
551693|NCT00721617|1344657|P1|COMPLETED|4 Hours Into Saline Infusion||12
551694|NCT00721617|1344657|P1|STARTED|4 Hours Into Saline Infusion||12
551695|NCT00721617|1344657|P1|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0
551696|NCT00721617|1344657|P1|COMPLETED|0 Hour (Baseline) of Saline Infusion||12
551697|NCT00721617|1344657|P1|STARTED|0 Hour (Baseline) of Saline Infusion||12
551698|NCT00721578|1344681|P2|NOT COMPLETED|Overall Study||2
551699|NCT00721578|1344682|P1|NOT COMPLETED|Overall Study||2
551700|NCT00721578|1344681|P2|COMPLETED|Overall Study||9
551701|NCT00721578|1344682|P1|COMPLETED|Overall Study||10
551702|NCT00721578|1344681|P2|STARTED|Overall Study||11
551703|NCT00721578|1344682|P1|STARTED|Overall Study||12
551704|NCT00721539|1344694|P1|NOT COMPLETED|Overall Study||0
551705|NCT00721539|1344694|P1|COMPLETED|Overall Study||9
551706|NCT00721539|1344694|P1|STARTED|Overall Study||9
551707|NCT00721500|1344701|P4|NOT COMPLETED|Period Three||0
551708|NCT00721500|1344702|P3|NOT COMPLETED|Period Three||0
551709|NCT00721500|1344703|P2|NOT COMPLETED|Period Three||0
551710|NCT00721500|1344704|P1|NOT COMPLETED|Period Three||0
551711|NCT00721500|1344701|P4|COMPLETED|Period Three||6
551712|NCT00721500|1344702|P3|COMPLETED|Period Three||6
551713|NCT00721500|1344703|P2|COMPLETED|Period Three||7
551714|NCT00721500|1344704|P1|COMPLETED|Period Three||6
551715|NCT00721500|1344701|P4|STARTED|Period Three||6
551716|NCT00721500|1344702|P3|STARTED|Period Three||6
551717|NCT00721500|1344703|P2|STARTED|Period Three||7
551718|NCT00721500|1344704|P1|STARTED|Period Three||6
551719|NCT00721500|1344701|P4|NOT COMPLETED|Period Two||0
551720|NCT00721500|1344702|P3|NOT COMPLETED|Period Two||0
551721|NCT00721500|1344703|P2|NOT COMPLETED|Period Two||0
551722|NCT00721500|1344704|P1|NOT COMPLETED|Period Two||0
551723|NCT00721500|1344701|P4|COMPLETED|Period Two||6
551724|NCT00721500|1344702|P3|COMPLETED|Period Two||6
551725|NCT00721500|1344703|P2|COMPLETED|Period Two||7
551726|NCT00721500|1344704|P1|COMPLETED|Period Two||6
551727|NCT00721500|1344701|P4|STARTED|Period Two||6
551728|NCT00721500|1344702|P3|STARTED|Period Two||6
551729|NCT00721500|1344703|P2|STARTED|Period Two||7
551730|NCT00721500|1344704|P1|STARTED|Period Two||6
551731|NCT00721500|1344701|P4|NOT COMPLETED|Period One||0
551732|NCT00721500|1344702|P3|NOT COMPLETED|Period One||0
551733|NCT00721500|1344703|P2|NOT COMPLETED|Period One||0
551734|NCT00721500|1344704|P1|NOT COMPLETED|Period One||0
551735|NCT00721500|1344701|P4|COMPLETED|Period One||6
551736|NCT00721500|1344702|P3|COMPLETED|Period One||6
551737|NCT00721500|1344703|P2|COMPLETED|Period One||7
551738|NCT00721500|1344704|P1|COMPLETED|Period One||6
551739|NCT00721500|1344701|P4|STARTED|Period One||6
551740|NCT00721500|1344702|P3|STARTED|Period One||6
551741|NCT00721500|1344703|P2|STARTED|Period One||7
551742|NCT00721500|1344704|P1|STARTED|Period One||6
551743|NCT00721409|1344725|P3|NOT COMPLETED|Overall Study||81
551744|NCT00721409|1344726|P2|NOT COMPLETED|Overall Study||84
551745|NCT00721409|1344727|P1|NOT COMPLETED|Overall Study||12
551746|NCT00721409|1344725|P3|COMPLETED|Overall Study||0
551747|NCT00721409|1344726|P2|COMPLETED|Overall Study||0
551748|NCT00721409|1344727|P1|COMPLETED|Overall Study||0
551749|NCT00721409|1344725|P3|Treated|Overall Study||77
551750|NCT00721409|1344726|P2|Treated|Overall Study||83
551751|NCT00721409|1344727|P1|Treated|Overall Study||12
551752|NCT00721409|1344725|P3|STARTED|Overall Study||81
551753|NCT00721409|1344726|P2|STARTED|Overall Study||84
551754|NCT00721409|1344727|P1|STARTED|Overall Study||12
551755|NCT00721396|1344854|P4|NOT COMPLETED|Overall Study||10
551756|NCT00721396|1344855|P3|NOT COMPLETED|Overall Study||10
551757|NCT00721396|1344856|P2|NOT COMPLETED|Overall Study||36
551758|NCT00721396|1344857|P1|NOT COMPLETED|Overall Study||30
551759|NCT00721396|1344854|P4|COMPLETED|Overall Study||302
551760|NCT00721396|1344855|P3|COMPLETED|Overall Study||308
551761|NCT00721396|1344856|P2|COMPLETED|Overall Study||592
551762|NCT00721396|1344857|P1|COMPLETED|Overall Study||597
551763|NCT00721396|1344854|P4|STARTED|Overall Study||312
551764|NCT00721396|1344855|P3|STARTED|Overall Study||318
551765|NCT00721396|1344856|P2|STARTED|Overall Study||628
551766|NCT00721396|1344857|P1|STARTED|Overall Study||627
551767|NCT00721357|1344895|P2|NOT COMPLETED|Overall Study||0
551768|NCT00721357|1344896|P1|NOT COMPLETED|Overall Study||0
551769|NCT00721357|1344895|P2|COMPLETED|Overall Study||15
551770|NCT00721357|1344896|P1|COMPLETED|Overall Study||15
551771|NCT00721357|1344895|P2|STARTED|Overall Study||15
551772|NCT00721357|1344896|P1|STARTED|Overall Study||15
551773|NCT00721279|1344904|P2|NOT COMPLETED|Overall Study||24
551774|NCT00721279|1344905|P1|NOT COMPLETED|Overall Study||36
551775|NCT00721279|1344904|P2|COMPLETED|Overall Study||73
551776|NCT00721279|1344905|P1|COMPLETED|Overall Study||416
551777|NCT00721279|1344904|P2|STARTED|Overall Study||97
551778|NCT00721279|1344905|P1|STARTED|Overall Study||452
551779|NCT00721253|1344919|P3|NOT COMPLETED|Overall Study||0
551780|NCT00721253|1344920|P2|NOT COMPLETED|Overall Study||0
551781|NCT00721253|1344921|P1|NOT COMPLETED|Overall Study||0
551782|NCT00721253|1344919|P3|COMPLETED|Overall Study||0
551783|NCT00721253|1344920|P2|COMPLETED|Overall Study||22
551784|NCT00721253|1344921|P1|COMPLETED|Overall Study||20
551785|NCT00721253|1344919|P3|STARTED|Overall Study|There were no subjects that were implanted with the Tecnis lens.|0
551786|NCT00721253|1344920|P2|STARTED|Overall Study||22
551787|NCT00721253|1344921|P1|STARTED|Overall Study||20
551788|NCT00721227|1344933|P2|NOT COMPLETED|Overall Study||0
551789|NCT00721227|1344934|P1|NOT COMPLETED|Overall Study||4
551790|NCT00721227|1344933|P2|COMPLETED|Overall Study||6
551791|NCT00721227|1344934|P1|COMPLETED|Overall Study|3 subjects lost to follow up; 1 subject did not complete due to noncompliance of scheduled visits.|5
551792|NCT00721227|1344933|P2|STARTED|Overall Study||6
551793|NCT00721227|1344934|P1|STARTED|Overall Study||9
551794|NCT00721214|1344944|P1|NOT COMPLETED|Overall Study||4
551795|NCT00721214|1344944|P1|COMPLETED|Overall Study||12
551796|NCT00721214|1344944|P1|STARTED|Overall Study||16
551797|NCT00721188|1344955|P1|NOT COMPLETED|Overall Study||0
551798|NCT00721188|1344955|P1|COMPLETED|Overall Study||11
551799|NCT00721188|1344955|P1|STARTED|Overall Study||11
551800|NCT00721175|1344972|P2|NOT COMPLETED|Overall Study||0
551801|NCT00721175|1344973|P1|NOT COMPLETED|Overall Study||0
551802|NCT00721175|1344972|P2|COMPLETED|Overall Study||54
551803|NCT00721175|1344973|P1|COMPLETED|Overall Study||54
551804|NCT00721175|1344972|P2|STARTED|Overall Study||54
551805|NCT00721175|1344973|P1|STARTED|Overall Study||54
551806|NCT00721162|1344985|P1|NOT COMPLETED|Overall Study||0
551807|NCT00721162|1344985|P1|COMPLETED|Overall Study||60
551808|NCT00721162|1344985|P1|Received Any Amount of Study Drug|Overall Study||60
551809|NCT00721162|1344985|P1|STARTED|Overall Study||60
551810|NCT00721149|1344994|P1|NOT COMPLETED|Overall Study||1
551811|NCT00721149|1344994|P1|COMPLETED|Overall Study||9
551812|NCT00721149|1344994|P1|STARTED|Overall Study|Enrollment was stopped after 10 subjects entered the trial.|10
551813|NCT00721136|1345007|P4|NOT COMPLETED|Overall Study||0
551814|NCT00721136|1345008|P3|NOT COMPLETED|Overall Study||0
551815|NCT00721136|1345009|P2|NOT COMPLETED|Overall Study||0
551816|NCT00721136|1345010|P1|NOT COMPLETED|Overall Study||0
551817|NCT00721136|1345007|P4|COMPLETED|Overall Study||8
551818|NCT00721136|1345008|P3|COMPLETED|Overall Study||8
551819|NCT00721136|1345009|P2|COMPLETED|Overall Study||42
551820|NCT00721136|1345010|P1|COMPLETED|Overall Study||42
551821|NCT00721136|1345007|P4|STARTED|Overall Study||8
551822|NCT00721136|1345008|P3|STARTED|Overall Study||8
551823|NCT00721136|1345009|P2|STARTED|Overall Study||42
551824|NCT00721136|1345010|P1|STARTED|Overall Study||42
551825|NCT00721123|1345028|P1|NOT COMPLETED|Overall Study||183
551826|NCT00721123|1345028|P1|COMPLETED|Overall Study||355
551827|NCT00721123|1345028|P1|STARTED|Overall Study||538
551828|NCT00721110|1345106|P4|NOT COMPLETED|Overall Study||0
551829|NCT00721110|1345107|P3|NOT COMPLETED|Overall Study||1
551830|NCT00721110|1345108|P2|NOT COMPLETED|Overall Study||0
551831|NCT00721110|1345109|P1|NOT COMPLETED|Overall Study||1
551832|NCT00721110|1345106|P4|COMPLETED|Overall Study||16
551833|NCT00721110|1345107|P3|COMPLETED|Overall Study||15
551834|NCT00721110|1345108|P2|COMPLETED|Overall Study||16
551835|NCT00721110|1345109|P1|COMPLETED|Overall Study||15
551836|NCT00721110|1345106|P4|STARTED|Overall Study||16
551837|NCT00721110|1345107|P3|STARTED|Overall Study||16
551838|NCT00721110|1345108|P2|STARTED|Overall Study||16
551839|NCT00721110|1345109|P1|STARTED|Overall Study||16
551840|NCT00720941|1345137|P2|NOT COMPLETED|Overall Study||415
551841|NCT00720941|1345138|P1|NOT COMPLETED|Overall Study||413
551842|NCT00720941|1345137|P2|COMPLETED|Overall Study||138
551843|NCT00720941|1345138|P1|COMPLETED|Overall Study||144
551844|NCT00720941|1345137|P2|Ongoing|Overall Study||23
551845|NCT00720941|1345138|P1|Ongoing|Overall Study||34
551846|NCT00720941|1345137|P2|STARTED|Overall Study||553
551847|NCT00720941|1345138|P1|STARTED|Overall Study||557
551848|NCT00720798|1345178|P1|NOT COMPLETED|Overall Study||756
551849|NCT00720798|1345178|P1|COMPLETED|Overall Study||1311
551850|NCT00720798|1345178|P1|STARTED|Overall Study||2067
551851|NCT00720759|1345201|P4|NOT COMPLETED|Overall Study||0
551852|NCT00720759|1345202|P3|NOT COMPLETED|Overall Study||1
551853|NCT00720759|1345203|P2|NOT COMPLETED|Overall Study||1
551854|NCT00720759|1345204|P1|NOT COMPLETED|Overall Study||0
551855|NCT00720759|1345201|P4|COMPLETED|Overall Study||6
551856|NCT00720759|1345202|P3|COMPLETED|Overall Study||5
551857|NCT00720759|1345203|P2|COMPLETED|Overall Study||5
551858|NCT00720759|1345204|P1|COMPLETED|Overall Study||6
551859|NCT00720759|1345201|P4|STARTED|Overall Study||6
551860|NCT00720759|1345202|P3|STARTED|Overall Study||6
551861|NCT00720759|1345203|P2|STARTED|Overall Study||6
551862|NCT00720759|1345204|P1|STARTED|Overall Study||6
551863|NCT00720629|1345214|P1|NOT COMPLETED|Overall Study||0
551864|NCT00720629|1345214|P1|COMPLETED|Overall Study||8
551865|NCT00720629|1345214|P1|STARTED|Overall Study||8
551866|NCT00720499|1345224|P2|NOT COMPLETED|Treatment Period 2 (4 Weeks)||3
551867|NCT00720499|1345225|P1|NOT COMPLETED|Treatment Period 2 (4 Weeks)||2
551868|NCT00720499|1345224|P2|COMPLETED|Treatment Period 2 (4 Weeks)||67
551869|NCT00720499|1345225|P1|COMPLETED|Treatment Period 2 (4 Weeks)||64
551870|NCT00720499|1345224|P2|STARTED|Treatment Period 2 (4 Weeks)||70
551871|NCT00720499|1345225|P1|STARTED|Treatment Period 2 (4 Weeks)||66
551872|NCT00720499|1345224|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
551873|NCT00720499|1345225|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
551874|NCT00720499|1345224|P2|COMPLETED|Washout Period (2 Weeks)||70
551875|NCT00720499|1345225|P1|COMPLETED|Washout Period (2 Weeks)||66
551876|NCT00720499|1345224|P2|STARTED|Washout Period (2 Weeks)||70
551877|NCT00720499|1345225|P1|STARTED|Washout Period (2 Weeks)||66
551878|NCT00720499|1345224|P2|NOT COMPLETED|Treatment Period 1 (4 Weeks)||2
551879|NCT00720499|1345225|P1|NOT COMPLETED|Treatment Period 1 (4 Weeks)||3
551880|NCT00720499|1345224|P2|COMPLETED|Treatment Period 1 (4 Weeks)||70
551881|NCT00720499|1345225|P1|COMPLETED|Treatment Period 1 (4 Weeks)||66
551882|NCT00720499|1345224|P2|STARTED|Treatment Period 1 (4 Weeks)||72
551883|NCT00720499|1345225|P1|STARTED|Treatment Period 1 (4 Weeks)||69
551884|NCT00720473|1345289|P2|NOT COMPLETED|Overall Study||8
551885|NCT00720473|1345290|P1|NOT COMPLETED|Overall Study||30
551886|NCT00720473|1345289|P2|COMPLETED|Overall Study||16
551887|NCT00720473|1345290|P1|COMPLETED|Overall Study||15
551888|NCT00720473|1345289|P2|STARTED|Overall Study||24
551889|NCT00720473|1345290|P1|STARTED|Overall Study||45
551890|NCT00720434|1345318|P4|NOT COMPLETED|Open-Label Period (Week 5-72)||4
551891|NCT00720434|1345319|P3|NOT COMPLETED|Open-Label Period (Week 5-72)||4
551892|NCT00720434|1345320|P2|NOT COMPLETED|Open-Label Period (Week 5-72)||3
551893|NCT00720434|1345321|P1|NOT COMPLETED|Open-Label Period (Week 5-72)||6
551894|NCT00720434|1345318|P4|COMPLETED|Open-Label Period (Week 5-72)||4
551895|NCT00720434|1345319|P3|COMPLETED|Open-Label Period (Week 5-72)||4
551896|NCT00720434|1345320|P2|COMPLETED|Open-Label Period (Week 5-72)||5
551897|NCT00720434|1345321|P1|COMPLETED|Open-Label Period (Week 5-72)||4
551898|NCT00720434|1345318|P4|STARTED|Open-Label Period (Week 5-72)||8
551899|NCT00720434|1345319|P3|STARTED|Open-Label Period (Week 5-72)||8
551900|NCT00720434|1345320|P2|STARTED|Open-Label Period (Week 5-72)||8
551901|NCT00720434|1345321|P1|STARTED|Open-Label Period (Week 5-72)||10
551902|NCT00720434|1345318|P4|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
551903|NCT00720434|1345319|P3|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
551904|NCT00720434|1345320|P2|NOT COMPLETED|Double-Blind Period (Week 1-4)||1
551905|NCT00720434|1345321|P1|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
551906|NCT00720434|1345318|P4|COMPLETED|Double-Blind Period (Week 1-4)||8
551907|NCT00720434|1345319|P3|COMPLETED|Double-Blind Period (Week 1-4)||8
551908|NCT00720434|1345320|P2|COMPLETED|Double-Blind Period (Week 1-4)||8
551909|NCT00720434|1345321|P1|COMPLETED|Double-Blind Period (Week 1-4)||10
551910|NCT00720434|1345318|P4|STARTED|Double-Blind Period (Week 1-4)||8
551911|NCT00720434|1345319|P3|STARTED|Double-Blind Period (Week 1-4)||8
551912|NCT00720434|1345320|P2|STARTED|Double-Blind Period (Week 1-4)||9
551913|NCT00720434|1345321|P1|STARTED|Double-Blind Period (Week 1-4)||10
551914|NCT00720382|1345345|P2|NOT COMPLETED|Overall Study||59
551915|NCT00720382|1345346|P1|NOT COMPLETED|Overall Study||176
551916|NCT00720382|1345345|P2|COMPLETED|Overall Study||178
551917|NCT00720382|1345346|P1|COMPLETED|Overall Study||290
551918|NCT00720382|1345345|P2|STARTED|Overall Study||237
551919|NCT00720382|1345346|P1|STARTED|Overall Study||466
551920|NCT00720369|1345356|P2|NOT COMPLETED|Overall Study||0
551921|NCT00720369|1345357|P1|NOT COMPLETED|Overall Study||1
551922|NCT00720369|1345356|P2|COMPLETED|Overall Study||8
551923|NCT00720369|1345357|P1|COMPLETED|Overall Study|one subject discontinued due to an adverse event.|10
551924|NCT00720369|1345356|P2|STARTED|Overall Study||8
551925|NCT00720369|1345357|P1|STARTED|Overall Study||11
551926|NCT00720343|1345365|P1|NOT COMPLETED|Overall Study||6
551927|NCT00720343|1345365|P1|COMPLETED|Overall Study|3 removed by physician. 3 unable to be determined; Columbia will never have access to this data.|48
551928|NCT00720343|1345365|P1|STARTED|Overall Study||54
551929|NCT00720330|1345374|P3|NOT COMPLETED|Overall Study||0
551930|NCT00720330|1345375|P2|NOT COMPLETED|Overall Study||0
551931|NCT00720330|1345376|P1|NOT COMPLETED|Overall Study||0
551932|NCT00720330|1345374|P3|COMPLETED|Overall Study||3
551933|NCT00720330|1345375|P2|COMPLETED|Overall Study||4
551934|NCT00720330|1345376|P1|COMPLETED|Overall Study||5
551935|NCT00720330|1345374|P3|STARTED|Overall Study||3
551936|NCT00720330|1345375|P2|STARTED|Overall Study||4
551937|NCT00720330|1345376|P1|STARTED|Overall Study||5
551938|NCT00720278|1345399|P3|NOT COMPLETED|Overall Study||6
551939|NCT00720278|1345400|P2|NOT COMPLETED|Overall Study||4
551940|NCT00720278|1345401|P1|NOT COMPLETED|Overall Study||7
551941|NCT00720278|1345399|P3|COMPLETED|Overall Study||172
551942|NCT00720278|1345400|P2|COMPLETED|Overall Study||166
551943|NCT00720278|1345401|P1|COMPLETED|Overall Study||171
551944|NCT00720278|1345399|P3|STARTED|Overall Study|1 subject was randomized in error|178
551945|NCT00720278|1345400|P2|STARTED|Overall Study|1 subject was randomized in error|170
551946|NCT00720278|1345401|P1|STARTED|Overall Study|1 subject was randomized in error|178
551947|NCT00720226|1345423|P2|NOT COMPLETED|Overall Study||4
551948|NCT00720226|1345424|P1|NOT COMPLETED|Overall Study||7
551949|NCT00720226|1345423|P2|COMPLETED|Overall Study|Participants not completing did not have 12 month CT scan|48
551950|NCT00720226|1345424|P1|COMPLETED|Overall Study|Participants not completing did not have 12 month CT scan|47
551951|NCT00720226|1345423|P2|STARTED|Overall Study||52
551952|NCT00720226|1345424|P1|STARTED|Overall Study||54
551953|NCT00720122|1345432|P1|NOT COMPLETED|Overall Study||9
551954|NCT00720122|1345432|P1|COMPLETED|Overall Study||19
551955|NCT00720122|1345432|P1|STARTED|Overall Study||28
551956|NCT00720109|1345436|P3|NOT COMPLETED|Risk Stratification Period||8
551957|NCT00720109|1345437|P2|NOT COMPLETED|Risk Stratification Period||15
551958|NCT00720109|1345438|P1|NOT COMPLETED|Risk Stratification Period||0
551959|NCT00720109|1345436|P3|COMPLETED|Risk Stratification Period||1
551960|NCT00720109|1345437|P2|COMPLETED|Risk Stratification Period||33
551961|NCT00720109|1345438|P1|COMPLETED|Risk Stratification Period||0
551962|NCT00720109|1345436|P3|STARTED|Risk Stratification Period||9
551963|NCT00720109|1345437|P2|STARTED|Risk Stratification Period||48
551964|NCT00720109|1345438|P1|STARTED|Risk Stratification Period||0
551965|NCT00720109|1345436|P3|NOT COMPLETED|Induction Period||0
551966|NCT00720109|1345437|P2|NOT COMPLETED|Induction Period||0
551967|NCT00720109|1345438|P1|NOT COMPLETED|Induction Period||6
551968|NCT00720109|1345436|P3|COMPLETED|Induction Period||0
551969|NCT00720109|1345437|P2|COMPLETED|Induction Period||0
551970|NCT00720109|1345438|P1|COMPLETED|Induction Period||57
551971|NCT00720109|1345436|P3|STARTED|Induction Period||0
551972|NCT00720109|1345437|P2|STARTED|Induction Period||0
551973|NCT00720109|1345438|P1|STARTED|Induction Period||63
551974|NCT00720096|1345458|P2|NOT COMPLETED|Overall Study||2
551975|NCT00720096|1345459|P1|NOT COMPLETED|Overall Study||0
551976|NCT00720096|1345458|P2|COMPLETED|Overall Study||0
551977|NCT00720096|1345459|P1|COMPLETED|Overall Study||2
551978|NCT00720096|1345458|P2|STARTED|Overall Study||2
551979|NCT00720096|1345459|P1|STARTED|Overall Study||2
551980|NCT00720083|1345471|P2|NOT COMPLETED|Overall Study||2
551981|NCT00720083|1345472|P1|NOT COMPLETED|Overall Study||1
551982|NCT00720083|1345471|P2|COMPLETED|Overall Study||13
551983|NCT00720083|1345472|P1|COMPLETED|Overall Study|Subjects with data for the primary analysis are considered to have completed the study.|16
551984|NCT00720083|1345471|P2|STARTED|Overall Study||15
551985|NCT00720083|1345472|P1|STARTED|Overall Study||17
551986|NCT00720057|1345480|P2|NOT COMPLETED|Overall Study||3
551987|NCT00720057|1345481|P1|NOT COMPLETED|Overall Study||1
551988|NCT00720057|1345480|P2|COMPLETED|Overall Study||156
551989|NCT00720057|1345481|P1|COMPLETED|Overall Study||152
551990|NCT00720057|1345480|P2|STARTED|Overall Study||159
551991|NCT00720057|1345481|P1|STARTED|Overall Study||153
551992|NCT00719953|1345497|P1|NOT COMPLETED|Overall Study||4
551993|NCT00719953|1345497|P1|COMPLETED|Overall Study||26
551994|NCT00719953|1345497|P1|STARTED|Overall Study||30
551995|NCT00719914|1345503|P2|NOT COMPLETED|Overall Study||0
551996|NCT00719914|1345504|P1|NOT COMPLETED|Overall Study||0
551997|NCT00719914|1345503|P2|COMPLETED|Overall Study||7
551998|NCT00719914|1345504|P1|COMPLETED|Overall Study||10
551999|NCT00719914|1345503|P2|STARTED|Overall Study||7
552000|NCT00719914|1345504|P1|STARTED|Overall Study||10
552001|NCT00719901|1345510|P1|NOT COMPLETED|Overall Study||11
552002|NCT00719901|1345510|P1|COMPLETED|Overall Study||0
552003|NCT00719901|1345510|P1|STARTED|Overall Study||11
552004|NCT00719862|1345522|P2|NOT COMPLETED|Overall Study||6
552005|NCT00719862|1345523|P1|NOT COMPLETED|Overall Study||8
552006|NCT00719862|1345522|P2|COMPLETED|Overall Study||233
552007|NCT00719862|1345523|P1|COMPLETED|Overall Study||234
552008|NCT00719862|1345522|P2|STARTED|Overall Study|1 subject was randomized in error|239
552009|NCT00719862|1345523|P1|STARTED|Overall Study||242
552010|NCT00719849|1345541|P2|NOT COMPLETED|Overall Study||1
552011|NCT00719849|1345542|P1|NOT COMPLETED|Overall Study||0
552012|NCT00719849|1345541|P2|COMPLETED|Overall Study||8
552013|NCT00719849|1345542|P1|COMPLETED|Overall Study||4
552014|NCT00719849|1345541|P2|STARTED|Overall Study||9
552015|NCT00719849|1345542|P1|STARTED|Overall Study||4
552016|NCT00719810|1345581|P3|NOT COMPLETED|Overall Study||8
552017|NCT00719810|1345582|P2|NOT COMPLETED|Overall Study||4
552018|NCT00719810|1345583|P1|NOT COMPLETED|Overall Study||3
552019|NCT00719810|1345581|P3|COMPLETED|Overall Study||42
552020|NCT00719810|1345582|P2|COMPLETED|Overall Study||47
552021|NCT00719810|1345583|P1|COMPLETED|Overall Study||46
552022|NCT00719810|1345581|P3|STARTED|Overall Study||50
552023|NCT00719810|1345582|P2|STARTED|Overall Study||51
552024|NCT00719810|1345583|P1|STARTED|Overall Study||49
552025|NCT00719732|1345594|P1|NOT COMPLETED|Overall Study||22
552026|NCT00719732|1345594|P1|COMPLETED|Overall Study||196
552027|NCT00719732|1345594|P1|STARTED|Overall Study||218
552028|NCT00719706|1345600|P2|NOT COMPLETED|Overall Study||6
552029|NCT00719706|1345601|P1|NOT COMPLETED|Overall Study||9
552030|NCT00719706|1345600|P2|COMPLETED|Overall Study||14
552031|NCT00719706|1345601|P1|COMPLETED|Overall Study||11
552032|NCT00719706|1345600|P2|STARTED|Overall Study||20
552033|NCT00719706|1345601|P1|STARTED|Overall Study||20
552034|NCT00719680|1345615|P1|NOT COMPLETED|Overall Study||5
552035|NCT00719680|1345615|P1|COMPLETED|Overall Study||16
552036|NCT00719680|1345615|P1|STARTED|Overall Study||21
552037|NCT00719615|1345638|P3|NOT COMPLETED|Overall Study||0
552038|NCT00719615|1345639|P2|NOT COMPLETED|Overall Study||0
552039|NCT00719615|1345640|P1|NOT COMPLETED|Overall Study||0
552040|NCT00719615|1345638|P3|COMPLETED|Overall Study||24
552041|NCT00719615|1345639|P2|COMPLETED|Overall Study||45
552042|NCT00719615|1345640|P1|COMPLETED|Overall Study||42
552043|NCT00719615|1345638|P3|STARTED|Overall Study||24
552044|NCT00719615|1345639|P2|STARTED|Overall Study||45
552045|NCT00719615|1345640|P1|STARTED|Overall Study||42
552046|NCT00719576|1345650|P2|NOT COMPLETED|Overall Study||5
552047|NCT00719576|1345651|P1|NOT COMPLETED|Overall Study||2
552048|NCT00719576|1345650|P2|COMPLETED|Overall Study||67
552049|NCT00719576|1345651|P1|COMPLETED|Overall Study||70
552050|NCT00719576|1345650|P2|STARTED|Overall Study||72
552051|NCT00719576|1345651|P1|STARTED|Overall Study||72
552052|NCT00719563|1345671|P2|NOT COMPLETED|Overall Study||42
552053|NCT00719563|1345672|P1|NOT COMPLETED|Overall Study||38
552054|NCT00719563|1345671|P2|COMPLETED|Overall Study||128
552055|NCT00719563|1345672|P1|COMPLETED|Overall Study||133
552056|NCT00719563|1345671|P2|STARTED|Overall Study||170
552057|NCT00719563|1345672|P1|STARTED|Overall Study||171
552058|NCT00719537|1345704|P2|NOT COMPLETED|Overall Study||1
552059|NCT00719537|1345705|P1|NOT COMPLETED|Overall Study||1
552060|NCT00719537|1345704|P2|COMPLETED|Overall Study||0
552061|NCT00719537|1345705|P1|COMPLETED|Overall Study||1
552062|NCT00719537|1345704|P2|STARTED|Overall Study||1
552063|NCT00719537|1345705|P1|STARTED|Overall Study||2
552064|NCT00719472|1345711|P1|NOT COMPLETED|Received Cycle 2 Treatment||68
552065|NCT00719472|1345711|P1|COMPLETED|Received Cycle 2 Treatment||304
552066|NCT00719472|1345711|P1|STARTED|Received Cycle 2 Treatment||372
552067|NCT00719472|1345711|P1|NOT COMPLETED|Received Cycle 1 Treatment||53
552068|NCT00719472|1345711|P1|COMPLETED|Received Cycle 1 Treatment||372
552069|NCT00719472|1345711|P1|STARTED|Received Cycle 1 Treatment||425
552070|NCT00719472|1345711|P1|NOT COMPLETED|Enrolled in Study||26
552071|NCT00719472|1345711|P1|COMPLETED|Enrolled in Study||425
552072|NCT00719472|1345711|P1|STARTED|Enrolled in Study||451
552073|NCT00719355|1345722|P2|NOT COMPLETED|Overall Study||13
552074|NCT00719355|1345723|P1|NOT COMPLETED|Overall Study||18
552075|NCT00719355|1345722|P2|COMPLETED|Overall Study||39
552076|NCT00719355|1345723|P1|COMPLETED|Overall Study||33
552077|NCT00719355|1345722|P2|Completed 32 Weeks|Overall Study||39
552078|NCT00719355|1345723|P1|Completed 32 Weeks|Overall Study||33
552079|NCT00719355|1345722|P2|Completed 24 Weeks|Overall Study||43
552080|NCT00719355|1345723|P1|Completed 24 Weeks|Overall Study||34
552081|NCT00719355|1345722|P2|Completed 12 Weeks|Overall Study||46
552082|NCT00719355|1345723|P1|Completed 12 Weeks|Overall Study||43
552083|NCT00719355|1345722|P2|Completed 6 Weeks|Overall Study||48
552084|NCT00719355|1345723|P1|Completed 6 Weeks|Overall Study||49
552085|NCT00719355|1345722|P2|STARTED|Overall Study||52
552086|NCT00719355|1345723|P1|STARTED|Overall Study||51
552087|NCT00719329|1345734|P3|NOT COMPLETED|Overall Study||1
552088|NCT00719329|1345735|P2|NOT COMPLETED|Overall Study||2
552089|NCT00719329|1345736|P1|NOT COMPLETED|Overall Study||0
552090|NCT00719329|1345734|P3|COMPLETED|Overall Study||646
552091|NCT00719329|1345735|P2|COMPLETED|Overall Study||569
552092|NCT00719329|1345736|P1|COMPLETED|Overall Study||705
552093|NCT00719329|1345734|P3|Day 7 Swab|Overall Study||561
552094|NCT00719329|1345735|P2|Day 7 Swab|Overall Study||467
552095|NCT00719329|1345736|P1|Day 7 Swab|Overall Study||593
552096|NCT00719329|1345734|P3|Day 3 Swab|Overall Study||578
552097|NCT00719329|1345735|P2|Day 3 Swab|Overall Study||501
552098|NCT00719329|1345736|P1|Day 3 Swab|Overall Study||614
552099|NCT00719329|1345734|P3|Day 1 Swab|Overall Study||646
552100|NCT00719329|1345735|P2|Day 1 Swab|Overall Study||569
552101|NCT00719329|1345736|P1|Day 1 Swab|Overall Study||705
552102|NCT00719329|1345734|P3|STARTED|Overall Study||647
552103|NCT00719329|1345735|P2|STARTED|Overall Study||571
552104|NCT00719329|1345736|P1|STARTED|Overall Study||705
552105|NCT00719264|1345752|P2|NOT COMPLETED|Overall Study||183
552106|NCT00719264|1345753|P1|NOT COMPLETED|Overall Study||182
552107|NCT00719264|1345752|P2|COMPLETED|Overall Study||0
552108|NCT00719264|1345753|P1|COMPLETED|Overall Study||0
552109|NCT00719264|1345752|P2|Safety Set|Overall Study||181
552110|NCT00719264|1345753|P1|Safety Set|Overall Study||180
552111|NCT00719264|1345752|P2|Full Analysis Set|Overall Study||183
552112|NCT00719264|1345753|P1|Full Analysis Set|Overall Study||182
552113|NCT00719264|1345752|P2|STARTED|Overall Study||183
552114|NCT00719264|1345753|P1|STARTED|Overall Study||182
552115|NCT00719212|1345772|P1|NOT COMPLETED|Overall Study||44
552116|NCT00719212|1345772|P1|COMPLETED|Overall Study||17
552117|NCT00719212|1345772|P1|STARTED|Overall Study||61
552118|NCT00719186|1345784|P2|NOT COMPLETED|Overall Study||0
552119|NCT00719186|1345785|P1|NOT COMPLETED|Overall Study||0
552120|NCT00719186|1345784|P2|COMPLETED|Overall Study||374
552121|NCT00719186|1345785|P1|COMPLETED|Overall Study||376
552122|NCT00719186|1345784|P2|STARTED|Overall Study||374
552123|NCT00719186|1345785|P1|STARTED|Overall Study||376
552124|NCT00719160|1345799|P2|NOT COMPLETED|Overall Study||0
552125|NCT00719160|1345800|P1|NOT COMPLETED|Overall Study||0
552126|NCT00719160|1345799|P2|COMPLETED|Overall Study||6
552127|NCT00719160|1345800|P1|COMPLETED|Overall Study||6
552128|NCT00719160|1345799|P2|STARTED|Overall Study||6
552129|NCT00719160|1345800|P1|STARTED|Overall Study||6
552130|NCT00719134|1345807|P1|NOT COMPLETED|Overall Study||10
552131|NCT00719134|1345807|P1|COMPLETED|Overall Study||66
552132|NCT00719134|1345807|P1|STARTED|Overall Study||76
552133|NCT00719043|1345820|P7|NOT COMPLETED|Overall Study||28
552134|NCT00719043|1345821|P6|NOT COMPLETED|Overall Study||34
552135|NCT00719043|1345822|P5|NOT COMPLETED|Overall Study||27
552136|NCT00719043|1345823|P4|NOT COMPLETED|Overall Study||23
552137|NCT00719043|1345824|P3|NOT COMPLETED|Overall Study||20
552138|NCT00719043|1345825|P2|NOT COMPLETED|Overall Study||25
552139|NCT00719043|1345826|P1|NOT COMPLETED|Overall Study||32
552140|NCT00719043|1345820|P7|COMPLETED|Overall Study|Up to Day 909|92
552141|NCT00719043|1345821|P6|COMPLETED|Overall Study|Up to Day 909|86
552142|NCT00719043|1345822|P5|COMPLETED|Overall Study|Up to Day 909|95
552143|NCT00719043|1345823|P4|COMPLETED|Overall Study|Up to Day 909|96
552144|NCT00719043|1345824|P3|COMPLETED|Overall Study|Up to Day 909|99
552145|NCT00719043|1345825|P2|COMPLETED|Overall Study|Up to Day 909|96
552146|NCT00719043|1345826|P1|COMPLETED|Overall Study|Up to Day 909|88
552147|NCT00719043|1345820|P7|STARTED|Overall Study||120
552148|NCT00719043|1345821|P6|STARTED|Overall Study||120
552149|NCT00719043|1345822|P5|STARTED|Overall Study||122
552150|NCT00719043|1345823|P4|STARTED|Overall Study||119
552151|NCT00719043|1345824|P3|STARTED|Overall Study||119
552152|NCT00719043|1345825|P2|STARTED|Overall Study||121
552153|NCT00719043|1345826|P1|STARTED|Overall Study||120
552154|NCT00718887|1345950|P2|NOT COMPLETED|Overall Study||9
552155|NCT00718887|1345951|P1|NOT COMPLETED|Overall Study||5
552156|NCT00718887|1345950|P2|COMPLETED|Overall Study||68
552157|NCT00718887|1345951|P1|COMPLETED|Overall Study|Continued in study after 48 weeks|84
552158|NCT00718887|1345950|P2|STARTED|Overall Study|Participants who received treatment.|77
552159|NCT00718887|1345951|P1|STARTED|Overall Study|Participants who received treatment.|89
552160|NCT00718861|1345975|P2|NOT COMPLETED|Overall Study||18
552161|NCT00718861|1345976|P1|NOT COMPLETED|Overall Study||21
552162|NCT00718861|1345975|P2|COMPLETED|Overall Study||77
552163|NCT00718861|1345976|P1|COMPLETED|Overall Study||74
552164|NCT00718861|1345975|P2|Modified Intent to Treat|Overall Study|ITT patients with DXA total hip measure at extension 2 baseline and year 9|69
552165|NCT00718861|1345976|P1|Modified Intent to Treat|Overall Study|ITT patients with DXA total hip measure at extension 2 baseline and year 9|67
552166|NCT00718861|1345975|P2|Safety Set|Overall Study||95
552167|NCT00718861|1345976|P1|Safety Set|Overall Study|3 patients randomized but never received study drug|92
552168|NCT00718861|1345975|P2|STARTED|Overall Study||95
552169|NCT00718861|1345976|P1|STARTED|Overall Study|"Started indicates Randomized and Intent-to Treat (ITT) population"|95
552170|NCT00718809|1346004|P2|NOT COMPLETED|Overall Study||9
552171|NCT00718809|1346005|P1|NOT COMPLETED|Overall Study||12
552172|NCT00718809|1346004|P2|COMPLETED|Overall Study||0
552173|NCT00718809|1346005|P1|COMPLETED|Overall Study||0
552174|NCT00718809|1346004|P2|STARTED|Overall Study||9
552175|NCT00718809|1346005|P1|STARTED|Overall Study||12
552176|NCT00718770|1346019|P1|NOT COMPLETED|Overall Study||8
552177|NCT00718770|1346019|P1|COMPLETED|Overall Study||2
552178|NCT00718770|1346019|P1|STARTED|Overall Study||10
552179|NCT00718718|1346030|P10|NOT COMPLETED|Week 12 to End of Study||0
552180|NCT00718718|1346031|P9|NOT COMPLETED|Week 12 to End of Study||1
552181|NCT00718718|1346032|P8|NOT COMPLETED|Week 12 to End of Study||1
552182|NCT00718718|1346033|P7|NOT COMPLETED|Week 12 to End of Study||2
552183|NCT00718718|1346034|P6|NOT COMPLETED|Week 12 to End of Study||3
552184|NCT00718718|1346035|P5|NOT COMPLETED|Week 12 to End of Study||0
552185|NCT00718718|1346036|P4|NOT COMPLETED|Week 12 to End of Study||1
552186|NCT00718718|1346037|P3|NOT COMPLETED|Week 12 to End of Study||0
552187|NCT00718718|1346038|P2|NOT COMPLETED|Week 12 to End of Study||1
552188|NCT00718718|1346039|P1|NOT COMPLETED|Week 12 to End of Study||0
552189|NCT00718718|1346030|P10|COMPLETED|Week 12 to End of Study||31
552190|NCT00718718|1346031|P9|COMPLETED|Week 12 to End of Study||27
552191|NCT00718718|1346032|P8|COMPLETED|Week 12 to End of Study||27
552192|NCT00718718|1346033|P7|COMPLETED|Week 12 to End of Study||27
552193|NCT00718718|1346034|P6|COMPLETED|Week 12 to End of Study||24
552194|NCT00718718|1346035|P5|COMPLETED|Week 12 to End of Study||0
552195|NCT00718718|1346036|P4|COMPLETED|Week 12 to End of Study||15
552196|NCT00718718|1346037|P3|COMPLETED|Week 12 to End of Study||0
552197|NCT00718718|1346038|P2|COMPLETED|Week 12 to End of Study||17
552198|NCT00718718|1346039|P1|COMPLETED|Week 12 to End of Study||0
552199|NCT00718718|1346030|P10|Treated|Week 12 to End of Study||31
552200|NCT00718718|1346031|P9|Treated|Week 12 to End of Study||28
552201|NCT00718718|1346032|P8|Treated|Week 12 to End of Study||28
552202|NCT00718718|1346033|P7|Treated|Week 12 to End of Study||29
552203|NCT00718718|1346034|P6|Treated|Week 12 to End of Study||26
552204|NCT00718718|1346035|P5|Treated|Week 12 to End of Study||0
552205|NCT00718718|1346036|P4|Treated|Week 12 to End of Study||16
552206|NCT00718718|1346037|P3|Treated|Week 12 to End of Study||0
552207|NCT00718718|1346038|P2|Treated|Week 12 to End of Study||18
552208|NCT00718718|1346039|P1|Treated|Week 12 to End of Study||0
552209|NCT00718718|1346030|P10|STARTED|Week 12 to End of Study||31
552210|NCT00718718|1346031|P9|STARTED|Week 12 to End of Study||28
552211|NCT00718718|1346032|P8|STARTED|Week 12 to End of Study||28
552212|NCT00718718|1346033|P7|STARTED|Week 12 to End of Study||29
552213|NCT00718718|1346034|P6|STARTED|Week 12 to End of Study||27
552214|NCT00718718|1346035|P5|STARTED|Week 12 to End of Study||0
552215|NCT00718718|1346036|P4|STARTED|Week 12 to End of Study||16
552216|NCT00718718|1346037|P3|STARTED|Week 12 to End of Study||0
552217|NCT00718718|1346038|P2|STARTED|Week 12 to End of Study||18
552218|NCT00718718|1346039|P1|STARTED|Week 12 to End of Study||0
552219|NCT00718718|1346030|P10|NOT COMPLETED|Prior to Week 12||0
552220|NCT00718718|1346031|P9|NOT COMPLETED|Prior to Week 12||2
552221|NCT00718718|1346032|P8|NOT COMPLETED|Prior to Week 12||2
552222|NCT00718718|1346033|P7|NOT COMPLETED|Prior to Week 12||1
552223|NCT00718718|1346034|P6|NOT COMPLETED|Prior to Week 12||0
552224|NCT00718718|1346035|P5|NOT COMPLETED|Prior to Week 12||3
552225|NCT00718718|1346036|P4|NOT COMPLETED|Prior to Week 12||0
552226|NCT00718718|1346037|P3|NOT COMPLETED|Prior to Week 12||1
552227|NCT00718718|1346038|P2|NOT COMPLETED|Prior to Week 12||0
552228|NCT00718718|1346039|P1|NOT COMPLETED|Prior to Week 12||1
552229|NCT00718718|1346030|P10|COMPLETED|Prior to Week 12||31
552230|NCT00718718|1346031|P9|COMPLETED|Prior to Week 12||28
552231|NCT00718718|1346032|P8|COMPLETED|Prior to Week 12||28
552232|NCT00718718|1346033|P7|COMPLETED|Prior to Week 12||29
552233|NCT00718718|1346034|P6|COMPLETED|Prior to Week 12||0
552234|NCT00718718|1346035|P5|COMPLETED|Prior to Week 12||27
552235|NCT00718718|1346036|P4|COMPLETED|Prior to Week 12||0
552236|NCT00718718|1346037|P3|COMPLETED|Prior to Week 12||16
552237|NCT00718718|1346038|P2|COMPLETED|Prior to Week 12||0
552238|NCT00718718|1346039|P1|COMPLETED|Prior to Week 12||18
552239|NCT00718718|1346030|P10|STARTED|Prior to Week 12||31
552240|NCT00718718|1346031|P9|STARTED|Prior to Week 12||30
552241|NCT00718718|1346032|P8|STARTED|Prior to Week 12||30
552242|NCT00718718|1346033|P7|STARTED|Prior to Week 12||30
552243|NCT00718718|1346034|P6|STARTED|Prior to Week 12||0
552244|NCT00718718|1346035|P5|STARTED|Prior to Week 12||30
552245|NCT00718718|1346036|P4|STARTED|Prior to Week 12||0
552246|NCT00718718|1346037|P3|STARTED|Prior to Week 12||17
552247|NCT00718718|1346038|P2|STARTED|Prior to Week 12||0
552248|NCT00718718|1346039|P1|STARTED|Prior to Week 12||19
552249|NCT00718640|1346079|P1|NOT COMPLETED|Overall Study||7
552250|NCT00718640|1346079|P1|COMPLETED|Overall Study||3
552251|NCT00718640|1346079|P1|STARTED|Overall Study||10
552252|NCT00718523|1346093|P2|NOT COMPLETED|Overall Study||24
552253|NCT00718523|1346094|P1|NOT COMPLETED|Overall Study||18
552254|NCT00718523|1346093|P2|COMPLETED|Overall Study||62
552255|NCT00718523|1346094|P1|COMPLETED|Overall Study||66
552256|NCT00718523|1346093|P2|STARTED|Overall Study||86
552257|NCT00718523|1346094|P1|STARTED|Overall Study||84
552258|NCT00718510|1346106|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
552259|NCT00718510|1346107|P1|NOT COMPLETED|Second Intervention (3 Weeks)||1
552260|NCT00718510|1346106|P2|COMPLETED|Second Intervention (3 Weeks)||7
552261|NCT00718510|1346107|P1|COMPLETED|Second Intervention (3 Weeks)||6
552262|NCT00718510|1346106|P2|STARTED|Second Intervention (3 Weeks)||7
552263|NCT00718510|1346107|P1|STARTED|Second Intervention (3 Weeks)||7
552264|NCT00718510|1346106|P2|NOT COMPLETED|Washout (5 Days)||0
552265|NCT00718510|1346107|P1|NOT COMPLETED|Washout (5 Days)||0
552266|NCT00718510|1346106|P2|COMPLETED|Washout (5 Days)||7
552267|NCT00718510|1346107|P1|COMPLETED|Washout (5 Days)||7
552268|NCT00718510|1346106|P2|STARTED|Washout (5 Days)||7
552269|NCT00718510|1346107|P1|STARTED|Washout (5 Days)||7
552270|NCT00718510|1346106|P2|NOT COMPLETED|First Intervention (3 Weeks)||1
552271|NCT00718510|1346107|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
552272|NCT00718510|1346106|P2|COMPLETED|First Intervention (3 Weeks)||7
552273|NCT00718510|1346107|P1|COMPLETED|First Intervention (3 Weeks)||7
552274|NCT00718510|1346106|P2|Received Intervention|First Intervention (3 Weeks)||7
552275|NCT00718510|1346107|P1|Received Intervention|First Intervention (3 Weeks)||7
552276|NCT00718510|1346106|P2|STARTED|First Intervention (3 Weeks)||8
552277|NCT00718510|1346107|P1|STARTED|First Intervention (3 Weeks)||7
552278|NCT00718328|1346119|P2|NOT COMPLETED|Overall Study||0
552279|NCT00718328|1346120|P1|NOT COMPLETED|Overall Study||1
552280|NCT00718328|1346119|P2|COMPLETED|Overall Study|Terminated due to poor enrollment|0
552281|NCT00718328|1346120|P1|COMPLETED|Overall Study|Prematurely terminated due to poor enrollment|0
552282|NCT00718328|1346119|P2|STARTED|Overall Study||0
552283|NCT00718328|1346120|P1|STARTED|Overall Study||1
552284|NCT00718315|1346129|P3|NOT COMPLETED|Overall Study||21
552285|NCT00718315|1346130|P2|NOT COMPLETED|Overall Study||22
552286|NCT00718315|1346131|P1|NOT COMPLETED|Overall Study||19
552287|NCT00718315|1346129|P3|COMPLETED|Overall Study||46
552288|NCT00718315|1346130|P2|COMPLETED|Overall Study||45
552289|NCT00718315|1346131|P1|COMPLETED|Overall Study||48
552290|NCT00718315|1346129|P3|STARTED|Overall Study||67
552291|NCT00718315|1346130|P2|STARTED|Overall Study||67
552292|NCT00718315|1346131|P1|STARTED|Overall Study||67
552293|NCT00718302|1346165|P2|NOT COMPLETED|Overall Study||0
552294|NCT00718302|1346166|P1|NOT COMPLETED|Overall Study||0
552295|NCT00718302|1346165|P2|COMPLETED|Overall Study||114
552296|NCT00718302|1346166|P1|COMPLETED|Overall Study||119
552297|NCT00718302|1346165|P2|STARTED|Overall Study||114
552298|NCT00718302|1346166|P1|STARTED|Overall Study||119
552299|NCT00718237|1346182|P2|NOT COMPLETED|Overall Study||15
552300|NCT00718237|1346183|P1|NOT COMPLETED|Overall Study||13
552301|NCT00718237|1346182|P2|COMPLETED|Overall Study|Subjects who continued follow-up until the last visit, regardless of number of vaccinations received|366
552302|NCT00718237|1346183|P1|COMPLETED|Overall Study|Subjects who continued follow-up until the last visit, regardless of number of vaccinations received|368
552303|NCT00718237|1346182|P2|Vaccinated at Visit 3|Overall Study||369
552304|NCT00718237|1346183|P1|Vaccinated at Visit 3|Overall Study||371
552305|NCT00718237|1346182|P2|Vaccinated at Visit 2|Overall Study||374
552306|NCT00718237|1346183|P1|Vaccinated at Visit 2|Overall Study||373
552307|NCT00718237|1346182|P2|Vaccinated at Visit 1|Overall Study||381
552308|NCT00718237|1346183|P1|Vaccinated at Visit 1|Overall Study||380
552309|NCT00718237|1346182|P2|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized into the study|381
552310|NCT00718237|1346183|P1|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized into the study|381
552311|NCT00718120|1346195|P2|NOT COMPLETED|Overall Study||0
552312|NCT00718120|1346196|P1|NOT COMPLETED|Overall Study||0
552313|NCT00718120|1346195|P2|COMPLETED|Overall Study||55
552314|NCT00718120|1346196|P1|COMPLETED|Overall Study||55
552315|NCT00718120|1346195|P2|STARTED|Overall Study||55
552316|NCT00718120|1346196|P1|STARTED|Overall Study||55
552317|NCT00718094|1346216|P2|NOT COMPLETED|Overall Study||0
552318|NCT00718094|1346217|P1|NOT COMPLETED|Overall Study||0
552319|NCT00718094|1346216|P2|COMPLETED|Overall Study||5
552320|NCT00718094|1346217|P1|COMPLETED|Overall Study||15
552321|NCT00718094|1346216|P2|STARTED|Overall Study||5
552322|NCT00718094|1346217|P1|STARTED|Overall Study||15
552323|NCT00718081|1346226|P3|NOT COMPLETED|Overall Study||21
552324|NCT00718081|1346227|P2|NOT COMPLETED|Overall Study||4
552325|NCT00718081|1346228|P1|NOT COMPLETED|Overall Study||7
552326|NCT00718081|1346226|P3|COMPLETED|Overall Study||9
552327|NCT00718081|1346227|P2|COMPLETED|Overall Study||25
552328|NCT00718081|1346228|P1|COMPLETED|Overall Study||22
552329|NCT00718081|1346226|P3|STARTED|Overall Study||30
552330|NCT00718081|1346227|P2|STARTED|Overall Study||29
552331|NCT00718081|1346228|P1|STARTED|Overall Study||29
552332|NCT00718042|1346245|P6|NOT COMPLETED|Donor Follow-up||0
552333|NCT00718042|1346246|P5|NOT COMPLETED|Donor Follow-up||19
552334|NCT00718042|1346247|P4|NOT COMPLETED|Donor Follow-up||0
552335|NCT00718042|1346248|P3|NOT COMPLETED|Donor Follow-up||0
552336|NCT00718042|1346249|P2|NOT COMPLETED|Donor Follow-up||0
552337|NCT00718042|1346250|P1|NOT COMPLETED|Donor Follow-up||13
552338|NCT00718042|1346245|P6|COMPLETED|Donor Follow-up||0
552339|NCT00718042|1346246|P5|COMPLETED|Donor Follow-up||24
552340|NCT00718042|1346247|P4|COMPLETED|Donor Follow-up||0
552341|NCT00718042|1346248|P3|COMPLETED|Donor Follow-up||0
552342|NCT00718042|1346249|P2|COMPLETED|Donor Follow-up||0
552343|NCT00718042|1346250|P1|COMPLETED|Donor Follow-up||23
552344|NCT00718042|1346245|P6|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
552345|NCT00718042|1346246|P5|STARTED|Donor Follow-up||43
552346|NCT00718042|1346247|P4|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
552347|NCT00718042|1346248|P3|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
552348|NCT00718042|1346249|P2|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
552349|NCT00718042|1346250|P1|STARTED|Donor Follow-up||36
552350|NCT00718042|1346245|P6|NOT COMPLETED|ESA Chagas Testing||0
552351|NCT00718042|1346246|P5|NOT COMPLETED|ESA Chagas Testing||0
552352|NCT00718042|1346247|P4|NOT COMPLETED|ESA Chagas Testing||0
552353|NCT00718042|1346248|P3|NOT COMPLETED|ESA Chagas Testing||0
552354|NCT00718042|1346249|P2|NOT COMPLETED|ESA Chagas Testing||0
552355|NCT00718042|1346250|P1|NOT COMPLETED|ESA Chagas Testing||0
552356|NCT00718042|1346245|P6|COMPLETED|ESA Chagas Testing||330
552357|NCT00718042|1346246|P5|COMPLETED|ESA Chagas Testing||43
552358|NCT00718042|1346247|P4|COMPLETED|ESA Chagas Testing||110
552359|NCT00718042|1346248|P3|COMPLETED|ESA Chagas Testing||524
552360|NCT00718042|1346249|P2|COMPLETED|ESA Chagas Testing||287
552361|NCT00718042|1346250|P1|COMPLETED|ESA Chagas Testing||36
552362|NCT00718042|1346245|P6|STARTED|ESA Chagas Testing|Specimens only tested with ESA Chagas|330
552363|NCT00718042|1346246|P5|STARTED|ESA Chagas Testing|Only specimens repeatedly reactive by screening assay or PRISM grayzone tested with ESA Chagas|43
552364|NCT00718042|1346247|P4|STARTED|ESA Chagas Testing||110
552365|NCT00718042|1346248|P3|STARTED|ESA Chagas Testing||524
552366|NCT00718042|1346249|P2|STARTED|ESA Chagas Testing||287
552459|NCT00717405|1346362|P1|COMPLETED|Overall Study||52
552367|NCT00718042|1346250|P1|STARTED|ESA Chagas Testing|Only specimens repeatedly reactive by screening assay or PRISM grayzone tested with ESA Chagas|36
552368|NCT00718042|1346245|P6|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0
552369|NCT00718042|1346246|P5|NOT COMPLETED|ABBOTT PRISM Chagas Testing||38
552370|NCT00718042|1346247|P4|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0
552371|NCT00718042|1346248|P3|NOT COMPLETED|ABBOTT PRISM Chagas Testing||1
552372|NCT00718042|1346249|P2|NOT COMPLETED|ABBOTT PRISM Chagas Testing||2
552373|NCT00718042|1346250|P1|NOT COMPLETED|ABBOTT PRISM Chagas Testing||64
552374|NCT00718042|1346245|P6|COMPLETED|ABBOTT PRISM Chagas Testing||0
552375|NCT00718042|1346246|P5|COMPLETED|ABBOTT PRISM Chagas Testing||25511
552376|NCT00718042|1346247|P4|COMPLETED|ABBOTT PRISM Chagas Testing||110
552377|NCT00718042|1346248|P3|COMPLETED|ABBOTT PRISM Chagas Testing||524
552378|NCT00718042|1346249|P2|COMPLETED|ABBOTT PRISM Chagas Testing||287
552379|NCT00718042|1346250|P1|COMPLETED|ABBOTT PRISM Chagas Testing||16249
552380|NCT00718042|1346245|P6|STARTED|ABBOTT PRISM Chagas Testing|Specimens not screened with PRISM Chagas assay per protocol.|0
552381|NCT00718042|1346246|P5|STARTED|ABBOTT PRISM Chagas Testing||25549
552382|NCT00718042|1346247|P4|STARTED|ABBOTT PRISM Chagas Testing||110
552383|NCT00718042|1346248|P3|STARTED|ABBOTT PRISM Chagas Testing||525
552384|NCT00718042|1346249|P2|STARTED|ABBOTT PRISM Chagas Testing||289
552385|NCT00718042|1346250|P1|STARTED|ABBOTT PRISM Chagas Testing||16313
552386|NCT00717977|1346262|P1|NOT COMPLETED|Overall Study||0
552387|NCT00717977|1346262|P1|COMPLETED|Overall Study||74
552388|NCT00717977|1346262|P1|STARTED|Overall Study||74
552389|NCT00717912|1346290|P6|NOT COMPLETED|Overall Study||0
552390|NCT00717912|1346291|P5|NOT COMPLETED|Overall Study||0
552391|NCT00717912|1346292|P4|NOT COMPLETED|Overall Study||0
552392|NCT00717912|1346293|P3|NOT COMPLETED|Overall Study||0
552393|NCT00717912|1346294|P2|NOT COMPLETED|Overall Study||0
552394|NCT00717912|1346295|P1|NOT COMPLETED|Overall Study||0
552395|NCT00717912|1346290|P6|COMPLETED|Overall Study||1
552396|NCT00717912|1346291|P5|COMPLETED|Overall Study||1
552397|NCT00717912|1346292|P4|COMPLETED|Overall Study||1
552398|NCT00717912|1346293|P3|COMPLETED|Overall Study||1
552399|NCT00717912|1346294|P2|COMPLETED|Overall Study||1
552400|NCT00717912|1346295|P1|COMPLETED|Overall Study||1
552401|NCT00717912|1346290|P6|STARTED|Overall Study||1
552402|NCT00717912|1346291|P5|STARTED|Overall Study||1
552403|NCT00717912|1346292|P4|STARTED|Overall Study||1
552404|NCT00717912|1346293|P3|STARTED|Overall Study||1
552405|NCT00717912|1346294|P2|STARTED|Overall Study||1
552406|NCT00717912|1346295|P1|STARTED|Overall Study||1
552407|NCT00717886|1346306|P1|NOT COMPLETED|Overall Study||4
552408|NCT00717886|1346306|P1|COMPLETED|Overall Study||9
552409|NCT00717886|1346306|P1|STARTED|Overall Study||13
552410|NCT00717873|1346312|P2|NOT COMPLETED|Overall Study||0
552411|NCT00717873|1346313|P1|NOT COMPLETED|Overall Study||0
552412|NCT00717873|1346312|P2|COMPLETED|Overall Study||59
552413|NCT00717873|1346313|P1|COMPLETED|Overall Study||46
552414|NCT00717873|1346312|P2|STARTED|Overall Study||59
552415|NCT00717873|1346313|P1|STARTED|Overall Study||46
552416|NCT00717860|1346321|P2|NOT COMPLETED|Overall Study||28
552417|NCT00717860|1346322|P1|NOT COMPLETED|Overall Study||27
552418|NCT00717860|1346321|P2|COMPLETED|Overall Study||32
552419|NCT00717860|1346322|P1|COMPLETED|Overall Study||34
552420|NCT00717860|1346321|P2|STARTED|Overall Study||60
552421|NCT00717860|1346322|P1|STARTED|Overall Study||61
552422|NCT00717756|1346332|P1|NOT COMPLETED|Overall Study||1
552423|NCT00717756|1346332|P1|COMPLETED|Overall Study||40
552424|NCT00717756|1346332|P1|STARTED|Overall Study||41
552425|NCT00717574|1346338|P2|NOT COMPLETED|Overall Study||2
552426|NCT00717574|1346339|P1|NOT COMPLETED|Overall Study||2
552427|NCT00717574|1346338|P2|COMPLETED|Overall Study||14
552428|NCT00717574|1346339|P1|COMPLETED|Overall Study||14
552429|NCT00717574|1346338|P2|STARTED|Overall Study||16
552430|NCT00717574|1346339|P1|STARTED|Overall Study||16
552431|NCT00717522|1346345|P1|NOT COMPLETED|Overall Study||7
552432|NCT00717522|1346345|P1|COMPLETED|Overall Study||0
552433|NCT00717522|1346345|P1|STARTED|Overall Study||7
552434|NCT00717418|1346354|P4|NOT COMPLETED|1-Year Follow-Up||4
552435|NCT00717418|1346355|P3|NOT COMPLETED|1-Year Follow-Up||434
552436|NCT00717418|1346356|P2|NOT COMPLETED|1-Year Follow-Up||51
552437|NCT00717418|1346357|P1|NOT COMPLETED|1-Year Follow-Up||147
552438|NCT00717418|1346354|P4|COMPLETED|1-Year Follow-Up||0
552439|NCT00717418|1346355|P3|COMPLETED|1-Year Follow-Up||74
552440|NCT00717418|1346356|P2|COMPLETED|1-Year Follow-Up||23
552441|NCT00717418|1346357|P1|COMPLETED|1-Year Follow-Up||33
552442|NCT00717418|1346354|P4|STARTED|1-Year Follow-Up||4
552443|NCT00717418|1346355|P3|STARTED|1-Year Follow-Up||508
552444|NCT00717418|1346356|P2|STARTED|1-Year Follow-Up||74
552445|NCT00717418|1346357|P1|STARTED|1-Year Follow-Up||180
552446|NCT00717418|1346354|P4|NOT COMPLETED|Baseline||15
552447|NCT00717418|1346355|P3|NOT COMPLETED|Baseline||0
552448|NCT00717418|1346356|P2|NOT COMPLETED|Baseline||0
552449|NCT00717418|1346357|P1|NOT COMPLETED|Baseline||0
552450|NCT00717418|1346354|P4|COMPLETED|Baseline||4
552451|NCT00717418|1346355|P3|COMPLETED|Baseline||508
552452|NCT00717418|1346356|P2|COMPLETED|Baseline||74
552453|NCT00717418|1346357|P1|COMPLETED|Baseline||180
552454|NCT00717418|1346354|P4|STARTED|Baseline||19
552455|NCT00717418|1346355|P3|STARTED|Baseline||508
552456|NCT00717418|1346356|P2|STARTED|Baseline||74
552457|NCT00717418|1346357|P1|STARTED|Baseline||180
552458|NCT00717405|1346362|P1|NOT COMPLETED|Overall Study||0
552460|NCT00717405|1346362|P1|STARTED|Overall Study||52
552461|NCT00717366|1346381|P2|NOT COMPLETED|Extension Period (52 Weeks)||16
552462|NCT00717366|1346382|P1|NOT COMPLETED|Extension Period (52 Weeks)||4
552463|NCT00717366|1346381|P2|COMPLETED|Extension Period (52 Weeks)||12
552464|NCT00717366|1346382|P1|COMPLETED|Extension Period (52 Weeks)||5
552465|NCT00717366|1346381|P2|Received Visit/Week 21 Dose|Extension Period (52 Weeks)||28
552466|NCT00717366|1346382|P1|Received Visit/Week 21 Dose|Extension Period (52 Weeks)||8
552467|NCT00717366|1346381|P2|STARTED|Extension Period (52 Weeks)||28
552468|NCT00717366|1346382|P1|STARTED|Extension Period (52 Weeks)||9
552469|NCT00717366|1346381|P2|NOT COMPLETED|Core Study Period (20 Weeks)||13
552470|NCT00717366|1346382|P1|NOT COMPLETED|Core Study Period (20 Weeks)||4
552471|NCT00717366|1346381|P2|COMPLETED|Core Study Period (20 Weeks)||35
552472|NCT00717366|1346382|P1|COMPLETED|Core Study Period (20 Weeks)||12
552473|NCT00717366|1346381|P2|STARTED|Core Study Period (20 Weeks)||48
552474|NCT00717366|1346382|P1|STARTED|Core Study Period (20 Weeks)||16
552475|NCT00717314|1346406|P2|NOT COMPLETED|Overall Study||10
552476|NCT00717314|1346407|P1|NOT COMPLETED|Overall Study||6
552477|NCT00717314|1346406|P2|COMPLETED|Overall Study||34
552478|NCT00717314|1346407|P1|COMPLETED|Overall Study||37
552479|NCT00717314|1346406|P2|STARTED|Overall Study||44
552480|NCT00717314|1346407|P1|STARTED|Overall Study||43
552481|NCT00717288|1346428|P3|NOT COMPLETED|Overall Study||0
552482|NCT00717288|1346429|P2|NOT COMPLETED|Overall Study||0
552483|NCT00717288|1346430|P1|NOT COMPLETED|Overall Study||0
552484|NCT00717288|1346428|P3|COMPLETED|Overall Study||25
552485|NCT00717288|1346429|P2|COMPLETED|Overall Study||29
552486|NCT00717288|1346430|P1|COMPLETED|Overall Study||28
552487|NCT00717288|1346428|P3|STARTED|Overall Study||25
552488|NCT00717288|1346429|P2|STARTED|Overall Study||29
552489|NCT00717288|1346430|P1|STARTED|Overall Study||28
552490|NCT00717275|1346444|P1|NOT COMPLETED|Overall Study||3
552491|NCT00717275|1346444|P1|COMPLETED|Overall Study||0
552492|NCT00717275|1346444|P1|STARTED|Overall Study||3
552493|NCT00717249|1346450|P2|NOT COMPLETED|Overall Study||15
552494|NCT00717249|1346451|P1|NOT COMPLETED|Overall Study||22
552495|NCT00717249|1346450|P2|COMPLETED|Overall Study||150
552496|NCT00717249|1346451|P1|COMPLETED|Overall Study||304
552497|NCT00717249|1346450|P2|STARTED|Overall Study||165
552498|NCT00717249|1346451|P1|STARTED|Overall Study||326
552499|NCT00717236|1346465|P2|NOT COMPLETED|Open-Label Period||21
552500|NCT00717236|1346466|P1|NOT COMPLETED|Open-Label Period||125
552501|NCT00717236|1346465|P2|COMPLETED|Open-Label Period||163
552502|NCT00717236|1346466|P1|COMPLETED|Open-Label Period||646
552503|NCT00717236|1346465|P2|STARTED|Open-Label Period||184
552504|NCT00717236|1346466|P1|STARTED|Open-Label Period||771
552505|NCT00717236|1346465|P2|NOT COMPLETED|Double-Blind Period||28
552506|NCT00717236|1346466|P1|NOT COMPLETED|Double-Blind Period||80
552507|NCT00717236|1346465|P2|COMPLETED|Double-Blind Period||184
552508|NCT00717236|1346466|P1|COMPLETED|Double-Blind Period||771
552509|NCT00717236|1346465|P2|STARTED|Double-Blind Period||212
552510|NCT00717236|1346466|P1|STARTED|Double-Blind Period||851
552511|NCT00717197|1346535|P1|NOT COMPLETED|Overall Study||7
552512|NCT00717197|1346535|P1|COMPLETED|Overall Study||23
552513|NCT00717197|1346535|P1|STARTED|Overall Study||30
552514|NCT00717093|1346541|P2|NOT COMPLETED|Overall Study||48
552515|NCT00717093|1346542|P1|NOT COMPLETED|Overall Study||44
552516|NCT00717093|1346541|P2|COMPLETED|Overall Study||170
552517|NCT00717093|1346542|P1|COMPLETED|Overall Study||170
552518|NCT00717093|1346541|P2|Received Treatment|Overall Study||218
552519|NCT00717093|1346542|P1|Received Treatment|Overall Study||213
552520|NCT00717093|1346541|P2|STARTED|Overall Study||218
552521|NCT00717093|1346542|P1|STARTED|Overall Study||214
552522|NCT00717067|1346559|P5|NOT COMPLETED|Part 2: End Stage Renal Disease||0
552523|NCT00717067|1346560|P4|NOT COMPLETED|Part 2: End Stage Renal Disease||0
552524|NCT00717067|1346561|P3|NOT COMPLETED|Part 2: End Stage Renal Disease||0
552525|NCT00717067|1346562|P2|NOT COMPLETED|Part 2: End Stage Renal Disease||0
552526|NCT00717067|1346563|P1|NOT COMPLETED|Part 2: End Stage Renal Disease||0
552527|NCT00717067|1346559|P5|COMPLETED|Part 2: End Stage Renal Disease||6
552528|NCT00717067|1346560|P4|COMPLETED|Part 2: End Stage Renal Disease||0
552529|NCT00717067|1346561|P3|COMPLETED|Part 2: End Stage Renal Disease||0
552530|NCT00717067|1346562|P2|COMPLETED|Part 2: End Stage Renal Disease||0
552531|NCT00717067|1346563|P1|COMPLETED|Part 2: End Stage Renal Disease||0
552532|NCT00717067|1346559|P5|STARTED|Part 2: End Stage Renal Disease||6
552533|NCT00717067|1346560|P4|STARTED|Part 2: End Stage Renal Disease||0
552534|NCT00717067|1346561|P3|STARTED|Part 2: End Stage Renal Disease||0
552535|NCT00717067|1346562|P2|STARTED|Part 2: End Stage Renal Disease||0
552536|NCT00717067|1346563|P1|STARTED|Part 2: End Stage Renal Disease||0
552537|NCT00717067|1346559|P5|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
552538|NCT00717067|1346560|P4|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
552539|NCT00717067|1346561|P3|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
552540|NCT00717067|1346562|P2|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
552541|NCT00717067|1346563|P1|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
552542|NCT00717067|1346559|P5|COMPLETED|Part 1b: Severe Renal Impairment||0
552543|NCT00717067|1346560|P4|COMPLETED|Part 1b: Severe Renal Impairment||6
552544|NCT00717067|1346561|P3|COMPLETED|Part 1b: Severe Renal Impairment||0
552545|NCT00717067|1346562|P2|COMPLETED|Part 1b: Severe Renal Impairment||0
552546|NCT00717067|1346563|P1|COMPLETED|Part 1b: Severe Renal Impairment||0
552547|NCT00717067|1346559|P5|STARTED|Part 1b: Severe Renal Impairment||0
552548|NCT00717067|1346560|P4|STARTED|Part 1b: Severe Renal Impairment||6
552549|NCT00717067|1346561|P3|STARTED|Part 1b: Severe Renal Impairment||0
552550|NCT00717067|1346562|P2|STARTED|Part 1b: Severe Renal Impairment||0
552551|NCT00717067|1346563|P1|STARTED|Part 1b: Severe Renal Impairment||0
552552|NCT00717067|1346559|P5|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
552553|NCT00717067|1346560|P4|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
552554|NCT00717067|1346561|P3|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||1
552555|NCT00717067|1346562|P2|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
552556|NCT00717067|1346563|P1|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
552557|NCT00717067|1346559|P5|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
552558|NCT00717067|1346560|P4|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
552559|NCT00717067|1346561|P3|COMPLETED|Part 1a: Normal/Mild/Moderate Group||5
552560|NCT00717067|1346562|P2|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6
552561|NCT00717067|1346563|P1|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6
552562|NCT00717067|1346559|P5|STARTED|Part 1a: Normal/Mild/Moderate Group||0
552563|NCT00717067|1346560|P4|STARTED|Part 1a: Normal/Mild/Moderate Group||0
552564|NCT00717067|1346561|P3|STARTED|Part 1a: Normal/Mild/Moderate Group||6
552565|NCT00717067|1346562|P2|STARTED|Part 1a: Normal/Mild/Moderate Group||6
552566|NCT00717067|1346563|P1|STARTED|Part 1a: Normal/Mild/Moderate Group||6
552567|NCT00717054|1346647|P2|NOT COMPLETED|Overall Study||0
552568|NCT00717054|1346648|P1|NOT COMPLETED|Overall Study||0
552569|NCT00717054|1346647|P2|COMPLETED|Overall Study||57
552570|NCT00717054|1346648|P1|COMPLETED|Overall Study||58
552571|NCT00717054|1346647|P2|STARTED|Overall Study||57
552572|NCT00717054|1346648|P1|STARTED|Overall Study||58
552573|NCT00717041|1346660|P1|NOT COMPLETED|Overall Study||0
552574|NCT00717041|1346660|P1|COMPLETED|Overall Study||1206
552575|NCT00717041|1346660|P1|STARTED|Overall Study||1206
552576|NCT00716976|1346670|P2|NOT COMPLETED|Overall Study||9
552577|NCT00716976|1346671|P1|NOT COMPLETED|Overall Study||20
552578|NCT00716976|1346670|P2|COMPLETED|Overall Study||57
552579|NCT00716976|1346671|P1|COMPLETED|Overall Study||45
552580|NCT00716976|1346670|P2|STARTED|Overall Study||66
552581|NCT00716976|1346671|P1|STARTED|Overall Study||65
552582|NCT00716963|1346691|P6|NOT COMPLETED|Overall Study||0
552583|NCT00716963|1346692|P5|NOT COMPLETED|Overall Study||0
552584|NCT00716963|1346693|P4|NOT COMPLETED|Overall Study||0
552585|NCT00716963|1346694|P3|NOT COMPLETED|Overall Study||0
552586|NCT00716963|1346695|P2|NOT COMPLETED|Overall Study||0
552587|NCT00716963|1346696|P1|NOT COMPLETED|Overall Study||1
552588|NCT00716963|1346691|P6|COMPLETED|Overall Study||1
552589|NCT00716963|1346692|P5|COMPLETED|Overall Study||1
552590|NCT00716963|1346693|P4|COMPLETED|Overall Study||1
552591|NCT00716963|1346694|P3|COMPLETED|Overall Study||1
552592|NCT00716963|1346695|P2|COMPLETED|Overall Study||1
552593|NCT00716963|1346696|P1|COMPLETED|Overall Study||1
552594|NCT00716963|1346691|P6|STARTED|Overall Study||1
552595|NCT00716963|1346692|P5|STARTED|Overall Study||1
552596|NCT00716963|1346693|P4|STARTED|Overall Study||1
552597|NCT00716963|1346694|P3|STARTED|Overall Study||1
552598|NCT00716963|1346695|P2|STARTED|Overall Study||1
552599|NCT00716963|1346696|P1|STARTED|Overall Study||2
552600|NCT00716859|1346709|P2|NOT COMPLETED|Overall Study||5
552601|NCT00716859|1346710|P1|NOT COMPLETED|Overall Study||9
552602|NCT00716859|1346709|P2|COMPLETED|Overall Study||64
552603|NCT00716859|1346710|P1|COMPLETED|Overall Study||61
552604|NCT00716859|1346709|P2|Received Treatment|Overall Study||68
552605|NCT00716859|1346710|P1|Received Treatment|Overall Study||69
552606|NCT00716859|1346709|P2|STARTED|Overall Study||69
552607|NCT00716859|1346710|P1|STARTED|Overall Study||70
552608|NCT00716820|1346734|P1|NOT COMPLETED|Overall Study||0
552609|NCT00716820|1346734|P1|COMPLETED|Overall Study||472
552610|NCT00716820|1346734|P1|STARTED|Overall Study||472
552611|NCT00716807|1346769|P4|NOT COMPLETED|Overall Study||0
552612|NCT00716807|1346770|P3|NOT COMPLETED|Overall Study||0
552613|NCT00716807|1346771|P2|NOT COMPLETED|Overall Study||0
552614|NCT00716807|1346772|P1|NOT COMPLETED|Overall Study||0
552615|NCT00716807|1346769|P4|COMPLETED|Overall Study||15
552616|NCT00716807|1346770|P3|COMPLETED|Overall Study||18
552617|NCT00716807|1346771|P2|COMPLETED|Overall Study||5
552618|NCT00716807|1346772|P1|COMPLETED|Overall Study||8
552619|NCT00716807|1346769|P4|STARTED|Overall Study||15
552620|NCT00716807|1346770|P3|STARTED|Overall Study||18
552621|NCT00716807|1346771|P2|STARTED|Overall Study||5
552622|NCT00716807|1346772|P1|STARTED|Overall Study||8
552623|NCT00716742|1346785|P3|NOT COMPLETED|3 Year Follow-up||21
552624|NCT00716742|1346786|P2|NOT COMPLETED|3 Year Follow-up||32
552625|NCT00716742|1346787|P1|NOT COMPLETED|3 Year Follow-up||30
552626|NCT00716742|1346785|P3|COMPLETED|3 Year Follow-up||29
552627|NCT00716742|1346786|P2|COMPLETED|3 Year Follow-up||35
552628|NCT00716742|1346787|P1|COMPLETED|3 Year Follow-up||26
552629|NCT00716742|1346785|P3|STARTED|3 Year Follow-up||50
552630|NCT00716742|1346786|P2|STARTED|3 Year Follow-up||67
552631|NCT00716742|1346787|P1|STARTED|3 Year Follow-up||56
552632|NCT00716742|1346785|P3|NOT COMPLETED|2 Year Follow-up||102
552633|NCT00716742|1346786|P2|NOT COMPLETED|2 Year Follow-up||96
552634|NCT00716742|1346787|P1|NOT COMPLETED|2 Year Follow-up||104
552635|NCT00716742|1346785|P3|COMPLETED|2 Year Follow-up||50
552636|NCT00716742|1346786|P2|COMPLETED|2 Year Follow-up||67
552637|NCT00716742|1346787|P1|COMPLETED|2 Year Follow-up||56
552638|NCT00716742|1346785|P3|STARTED|2 Year Follow-up||152
552639|NCT00716742|1346786|P2|STARTED|2 Year Follow-up||163
552640|NCT00716742|1346787|P1|STARTED|2 Year Follow-up||160
552641|NCT00716742|1346785|P3|NOT COMPLETED|1 Year Follow-up||200
552642|NCT00716742|1346786|P2|NOT COMPLETED|1 Year Follow-up||193
552643|NCT00716742|1346787|P1|NOT COMPLETED|1 Year Follow-up||187
552644|NCT00716742|1346785|P3|COMPLETED|1 Year Follow-up||152
552645|NCT00716742|1346786|P2|COMPLETED|1 Year Follow-up||163
552646|NCT00716742|1346787|P1|COMPLETED|1 Year Follow-up||160
552647|NCT00716742|1346785|P3|STARTED|1 Year Follow-up||352
552648|NCT00716742|1346786|P2|STARTED|1 Year Follow-up||356
552649|NCT00716742|1346787|P1|STARTED|1 Year Follow-up||347
552650|NCT00716742|1346785|P3|NOT COMPLETED|Baseline||13
552651|NCT00716742|1346786|P2|NOT COMPLETED|Baseline||14
552652|NCT00716742|1346787|P1|NOT COMPLETED|Baseline||17
552653|NCT00716742|1346785|P3|COMPLETED|Baseline||352
552654|NCT00716742|1346786|P2|COMPLETED|Baseline||356
552655|NCT00716742|1346787|P1|COMPLETED|Baseline||347
552656|NCT00716742|1346785|P3|STARTED|Baseline||365
552657|NCT00716742|1346786|P2|STARTED|Baseline||370
552658|NCT00716742|1346787|P1|STARTED|Baseline||364
552659|NCT00716625|1346795|P1|NOT COMPLETED|Overall Study||1
552660|NCT00716625|1346795|P1|COMPLETED|Overall Study||1673
552661|NCT00716625|1346795|P1|STARTED|Overall Study||1674
552662|NCT00716482|1346820|P1|NOT COMPLETED|Overall Study||119
552663|NCT00716482|1346820|P1|COMPLETED|Overall Study||1562
552664|NCT00716482|1346820|P1|STARTED|Overall Study||1681
552665|NCT00716456|1346833|P3|NOT COMPLETED|Overall Study||0
552666|NCT00716456|1346834|P2|NOT COMPLETED|Overall Study||2
552667|NCT00716456|1346835|P1|NOT COMPLETED|Overall Study||0
552668|NCT00716456|1346833|P3|COMPLETED|Overall Study||13
552669|NCT00716456|1346834|P2|COMPLETED|Overall Study||3
552670|NCT00716456|1346835|P1|COMPLETED|Overall Study||3
552671|NCT00716456|1346833|P3|STARTED|Overall Study||13
552672|NCT00716456|1346834|P2|STARTED|Overall Study||5
552673|NCT00716456|1346835|P1|STARTED|Overall Study||3
552674|NCT00716443|1346843|P1|NOT COMPLETED|Overall Study||0
552675|NCT00716443|1346843|P1|COMPLETED|Overall Study||51
552676|NCT00716443|1346843|P1|STARTED|Overall Study||51
552677|NCT00716417|1346886|P10|NOT COMPLETED|Overall Study||3
552678|NCT00716417|1346887|P9|NOT COMPLETED|Overall Study||5
552679|NCT00716417|1346888|P8|NOT COMPLETED|Overall Study||3
552680|NCT00716417|1346889|P7|NOT COMPLETED|Overall Study||7
552681|NCT00716417|1346890|P6|NOT COMPLETED|Overall Study||3
552682|NCT00716417|1346891|P5|NOT COMPLETED|Overall Study||1
552683|NCT00716417|1346892|P4|NOT COMPLETED|Overall Study||11
552684|NCT00716417|1346893|P3|NOT COMPLETED|Overall Study||5
552685|NCT00716417|1346894|P2|NOT COMPLETED|Overall Study||6
552686|NCT00716417|1346895|P1|NOT COMPLETED|Overall Study||3
552687|NCT00716417|1346886|P10|COMPLETED|Overall Study||0
552688|NCT00716417|1346887|P9|COMPLETED|Overall Study||0
552689|NCT00716417|1346888|P8|COMPLETED|Overall Study||0
552690|NCT00716417|1346889|P7|COMPLETED|Overall Study||0
552691|NCT00716417|1346890|P6|COMPLETED|Overall Study||0
552692|NCT00716417|1346891|P5|COMPLETED|Overall Study||0
552693|NCT00716417|1346892|P4|COMPLETED|Overall Study||0
552694|NCT00716417|1346893|P3|COMPLETED|Overall Study||0
552695|NCT00716417|1346894|P2|COMPLETED|Overall Study||0
552696|NCT00716417|1346895|P1|COMPLETED|Overall Study||0
552697|NCT00716417|1346886|P10|STARTED|Overall Study||3
552698|NCT00716417|1346887|P9|STARTED|Overall Study||5
552699|NCT00716417|1346888|P8|STARTED|Overall Study||3
552700|NCT00716417|1346889|P7|STARTED|Overall Study||7
552701|NCT00716417|1346890|P6|STARTED|Overall Study||3
552702|NCT00716417|1346891|P5|STARTED|Overall Study||1
552703|NCT00716417|1346892|P4|STARTED|Overall Study||11
552704|NCT00716417|1346893|P3|STARTED|Overall Study||5
552705|NCT00716417|1346894|P2|STARTED|Overall Study||6
552706|NCT00716417|1346895|P1|STARTED|Overall Study||3
552707|NCT00716274|1346942|P6|NOT COMPLETED|Study Period III (16-Weeks)||0
552708|NCT00716274|1346943|P5|NOT COMPLETED|Study Period III (16-Weeks)||3
552709|NCT00716274|1346944|P4|NOT COMPLETED|Study Period III (16-Weeks)||1
552710|NCT00716274|1346945|P3|NOT COMPLETED|Study Period III (16-Weeks)||2
552711|NCT00716274|1346946|P2|NOT COMPLETED|Study Period III (16-Weeks)||0
552712|NCT00716274|1346947|P1|NOT COMPLETED|Study Period III (16-Weeks)||0
552713|NCT00716274|1346942|P6|COMPLETED|Study Period III (16-Weeks)||19
552714|NCT00716274|1346943|P5|COMPLETED|Study Period III (16-Weeks)||32
552715|NCT00716274|1346944|P4|COMPLETED|Study Period III (16-Weeks)||17
552716|NCT00716274|1346945|P3|COMPLETED|Study Period III (16-Weeks)||16
552717|NCT00716274|1346946|P2|COMPLETED|Study Period III (16-Weeks)||0
552718|NCT00716274|1346947|P1|COMPLETED|Study Period III (16-Weeks)||0
552719|NCT00716274|1346942|P6|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|19
552720|NCT00716274|1346943|P5|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|35
552721|NCT00716274|1346944|P4|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|18
552722|NCT00716274|1346945|P3|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|18
552723|NCT00716274|1346946|P2|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|0
552724|NCT00716274|1346947|P1|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|0
552725|NCT00716274|1346942|P6|NOT COMPLETED|Study Period II (16-Weeks)||2
552726|NCT00716274|1346943|P5|NOT COMPLETED|Study Period II (16-Weeks)||0
552727|NCT00716274|1346944|P4|NOT COMPLETED|Study Period II (16-Weeks)||0
552728|NCT00716274|1346945|P3|NOT COMPLETED|Study Period II (16-Weeks)||0
552729|NCT00716274|1346946|P2|NOT COMPLETED|Study Period II (16-Weeks)||9
552730|NCT00716274|1346947|P1|NOT COMPLETED|Study Period II (16-Weeks)||9
552731|NCT00716274|1346942|P6|COMPLETED|Study Period II (16-Weeks)||19
552732|NCT00716274|1346943|P5|COMPLETED|Study Period II (16-Weeks)||0
552733|NCT00716274|1346944|P4|COMPLETED|Study Period II (16-Weeks)||0
552734|NCT00716274|1346945|P3|COMPLETED|Study Period II (16-Weeks)||0
552735|NCT00716274|1346946|P2|COMPLETED|Study Period II (16-Weeks)||35
552736|NCT00716274|1346947|P1|COMPLETED|Study Period II (16-Weeks)||36
552737|NCT00716274|1346942|P6|STARTED|Study Period II (16-Weeks)||21
552738|NCT00716274|1346943|P5|STARTED|Study Period II (16-Weeks)||0
552739|NCT00716274|1346944|P4|STARTED|Study Period II (16-Weeks)||0
552740|NCT00716274|1346945|P3|STARTED|Study Period II (16-Weeks)||0
552741|NCT00716274|1346946|P2|STARTED|Study Period II (16-Weeks)||44
552742|NCT00716274|1346947|P1|STARTED|Study Period II (16-Weeks)||45
552743|NCT00716144|1347081|P4|NOT COMPLETED|Overall Study||12
552744|NCT00716144|1347082|P3|NOT COMPLETED|Overall Study||12
552745|NCT00716144|1347083|P2|NOT COMPLETED|Overall Study||7
552746|NCT00716144|1347084|P1|NOT COMPLETED|Overall Study||9
552747|NCT00716144|1347081|P4|COMPLETED|Overall Study||33
552748|NCT00716144|1347082|P3|COMPLETED|Overall Study||33
552749|NCT00716144|1347083|P2|COMPLETED|Overall Study||38
552750|NCT00716144|1347084|P1|COMPLETED|Overall Study||32
552751|NCT00716144|1347081|P4|STARTED|Overall Study||45
552752|NCT00716144|1347082|P3|STARTED|Overall Study||45
552753|NCT00716144|1347083|P2|STARTED|Overall Study||45
552754|NCT00716144|1347084|P1|STARTED|Overall Study||41
552755|NCT00716092|1347109|P3|NOT COMPLETED|Overall Study||0
552756|NCT00716092|1347110|P2|NOT COMPLETED|Overall Study||1
552757|NCT00716092|1347111|P1|NOT COMPLETED|Overall Study||2
552758|NCT00716092|1347109|P3|COMPLETED|Overall Study||41
552759|NCT00716092|1347110|P2|COMPLETED|Overall Study||39
552760|NCT00716092|1347111|P1|COMPLETED|Overall Study||38
552761|NCT00716092|1347109|P3|STARTED|Overall Study||41
552762|NCT00716092|1347110|P2|STARTED|Overall Study||40
552763|NCT00716092|1347111|P1|STARTED|Overall Study||40
552764|NCT00716079|1347142|P2|NOT COMPLETED|Overall Study||15
552765|NCT00716079|1347143|P1|NOT COMPLETED|Overall Study||9
552766|NCT00716079|1347142|P2|COMPLETED|Overall Study||1421
552767|NCT00716079|1347143|P1|COMPLETED|Overall Study||1394
552768|NCT00716079|1347142|P2|STARTED|Overall Study||1436
552769|NCT00716079|1347143|P1|STARTED|Overall Study||1403
552770|NCT00715962|1347153|P2|NOT COMPLETED|Overall Study||2
552771|NCT00715962|1347154|P1|NOT COMPLETED|Overall Study||6
552772|NCT00715962|1347153|P2|COMPLETED|Overall Study||48
552773|NCT00715962|1347154|P1|COMPLETED|Overall Study||44
552774|NCT00715962|1347153|P2|STARTED|Overall Study||50
552775|NCT00715962|1347154|P1|STARTED|Overall Study||50
552776|NCT00715949|1347164|P1|NOT COMPLETED|Overall Study||4
552777|NCT00715949|1347164|P1|COMPLETED|Overall Study|116 patients completed first test|116
552778|NCT00715949|1347164|P1|STARTED|Overall Study|4 dropped because could not finish first test|120
552779|NCT00715910|1347172|P6|NOT COMPLETED|Booster and ESFU Phase||13
552780|NCT00715910|1347173|P5|NOT COMPLETED|Booster and ESFU Phase||2
552781|NCT00715910|1347174|P4|NOT COMPLETED|Booster and ESFU Phase||11
552782|NCT00715910|1347175|P3|NOT COMPLETED|Booster and ESFU Phase||0
552783|NCT00715910|1347176|P2|NOT COMPLETED|Booster and ESFU Phase||0
552784|NCT00715910|1347177|P1|NOT COMPLETED|Booster and ESFU Phase||0
552785|NCT00715910|1347172|P6|COMPLETED|Booster and ESFU Phase||88
552786|NCT00715910|1347173|P5|COMPLETED|Booster and ESFU Phase||36
552787|NCT00715910|1347174|P4|COMPLETED|Booster and ESFU Phase||172
552788|NCT00715910|1347175|P3|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
552789|NCT00715910|1347176|P2|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
552790|NCT00715910|1347177|P1|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
552791|NCT00715910|1347172|P6|STARTED|Booster and ESFU Phase||101
552792|NCT00715910|1347173|P5|STARTED|Booster and ESFU Phase||38
552793|NCT00715910|1347174|P4|STARTED|Booster and ESFU Phase||183
552794|NCT00715910|1347175|P3|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
552795|NCT00715910|1347176|P2|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
552796|NCT00715910|1347177|P1|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
552797|NCT00715910|1347172|P6|NOT COMPLETED|Year 5||0
552798|NCT00715910|1347173|P5|NOT COMPLETED|Year 5||0
552799|NCT00715910|1347174|P4|NOT COMPLETED|Year 5||0
552800|NCT00715910|1347175|P3|NOT COMPLETED|Year 5||0
552801|NCT00715910|1347176|P2|NOT COMPLETED|Year 5||0
552802|NCT00715910|1347177|P1|NOT COMPLETED|Year 5||0
552803|NCT00715910|1347172|P6|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
552804|NCT00715910|1347173|P5|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
552805|NCT00715910|1347174|P4|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
552806|NCT00715910|1347175|P3|COMPLETED|Year 5||38
552807|NCT00715910|1347176|P2|COMPLETED|Year 5||56
552808|NCT00715910|1347177|P1|COMPLETED|Year 5||218
552809|NCT00715910|1347172|P6|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
552810|NCT00715910|1347173|P5|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
552811|NCT00715910|1347174|P4|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
552812|NCT00715910|1347175|P3|STARTED|Year 5||38
552813|NCT00715910|1347176|P2|STARTED|Year 5||56
552814|NCT00715910|1347177|P1|STARTED|Year 5||218
552815|NCT00715910|1347172|P6|NOT COMPLETED|Year 3||0
552816|NCT00715910|1347173|P5|NOT COMPLETED|Year 3||0
552817|NCT00715910|1347174|P4|NOT COMPLETED|Year 3||0
552818|NCT00715910|1347175|P3|NOT COMPLETED|Year 3||0
552819|NCT00715910|1347176|P2|NOT COMPLETED|Year 3||0
552820|NCT00715910|1347177|P1|NOT COMPLETED|Year 3||0
552821|NCT00715910|1347172|P6|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
552822|NCT00715910|1347173|P5|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
552823|NCT00715910|1347174|P4|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
552824|NCT00715910|1347175|P3|COMPLETED|Year 3||56
552825|NCT00715910|1347176|P2|COMPLETED|Year 3||86
552826|NCT00715910|1347177|P1|COMPLETED|Year 3||345
552827|NCT00715910|1347172|P6|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
552828|NCT00715910|1347173|P5|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
552829|NCT00715910|1347174|P4|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
552830|NCT00715910|1347175|P3|STARTED|Year 3||56
552831|NCT00715910|1347176|P2|STARTED|Year 3||86
552832|NCT00715910|1347177|P1|STARTED|Year 3||345
552833|NCT00715910|1347172|P6|NOT COMPLETED|Year 1||0
552834|NCT00715910|1347173|P5|NOT COMPLETED|Year 1||0
552835|NCT00715910|1347174|P4|NOT COMPLETED|Year 1||0
552836|NCT00715910|1347175|P3|NOT COMPLETED|Year 1||0
552837|NCT00715910|1347176|P2|NOT COMPLETED|Year 1||0
552838|NCT00715910|1347177|P1|NOT COMPLETED|Year 1||0
552839|NCT00715910|1347172|P6|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
552840|NCT00715910|1347173|P5|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
552841|NCT00715910|1347174|P4|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
552842|NCT00715910|1347175|P3|COMPLETED|Year 1||68
552843|NCT00715910|1347176|P2|COMPLETED|Year 1||147
552844|NCT00715910|1347177|P1|COMPLETED|Year 1||433
552845|NCT00715910|1347172|P6|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
552846|NCT00715910|1347173|P5|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
552847|NCT00715910|1347174|P4|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
552848|NCT00715910|1347175|P3|STARTED|Year 1||68
552849|NCT00715910|1347176|P2|STARTED|Year 1||147
552850|NCT00715910|1347177|P1|STARTED|Year 1||433
552851|NCT00715884|1347253|P2|NOT COMPLETED|Overall Study||1
552852|NCT00715884|1347254|P1|NOT COMPLETED|Overall Study||8
552853|NCT00715884|1347253|P2|COMPLETED|Overall Study||225
552854|NCT00715884|1347254|P1|COMPLETED|Overall Study||444
552855|NCT00715884|1347253|P2|STARTED|Overall Study||226
552856|NCT00715884|1347254|P1|STARTED|Overall Study||452
552857|NCT00715793|1347296|P2|NOT COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||2
552858|NCT00715793|1347297|P1|NOT COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
552859|NCT00715793|1347296|P2|COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||27
552860|NCT00715793|1347297|P1|COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
552861|NCT00715793|1347296|P2|STARTED|Phase 2 DAC (0.15 mg/kg) + TMZ||29
552862|NCT00715793|1347297|P1|STARTED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
552863|NCT00715793|1347296|P2|NOT COMPLETED|Phase 1 RP2D DAC + TMZ||0
552864|NCT00715793|1347297|P1|NOT COMPLETED|Phase 1 RP2D DAC + TMZ||1
552865|NCT00715793|1347296|P2|COMPLETED|Phase 1 RP2D DAC + TMZ||6
552866|NCT00715793|1347297|P1|COMPLETED|Phase 1 RP2D DAC + TMZ||3
552867|NCT00715793|1347296|P2|STARTED|Phase 1 RP2D DAC + TMZ||6
552868|NCT00715793|1347297|P1|STARTED|Phase 1 RP2D DAC + TMZ||4
552869|NCT00715754|1347309|P1|NOT COMPLETED|Overall Study||0
552870|NCT00715754|1347309|P1|COMPLETED|Overall Study||47
552871|NCT00715754|1347309|P1|STARTED|Overall Study||47
552872|NCT00715741|1347319|P4|NOT COMPLETED|Overall Study||0
552873|NCT00715741|1347320|P3|NOT COMPLETED|Overall Study||0
552874|NCT00715741|1347321|P2|NOT COMPLETED|Overall Study||0
552875|NCT00715741|1347322|P1|NOT COMPLETED|Overall Study||0
552876|NCT00715741|1347319|P4|COMPLETED|Overall Study||25
552877|NCT00715741|1347320|P3|COMPLETED|Overall Study||25
552878|NCT00715741|1347321|P2|COMPLETED|Overall Study||25
552879|NCT00715741|1347322|P1|COMPLETED|Overall Study||25
552880|NCT00715741|1347319|P4|STARTED|Overall Study||25
552881|NCT00715741|1347320|P3|STARTED|Overall Study||25
552882|NCT00715741|1347321|P2|STARTED|Overall Study||25
552883|NCT00715741|1347322|P1|STARTED|Overall Study||25
552884|NCT00715676|1347347|P3|NOT COMPLETED|Overall Study||32
552885|NCT00715676|1347348|P2|NOT COMPLETED|Overall Study||11
552886|NCT00715676|1347349|P1|NOT COMPLETED|Overall Study||6
552887|NCT00715676|1347347|P3|COMPLETED|Overall Study||21
552888|NCT00715676|1347348|P2|COMPLETED|Overall Study||43
552889|NCT00715676|1347349|P1|COMPLETED|Overall Study||43
552890|NCT00715676|1347347|P3|STARTED|Overall Study||53
552891|NCT00715676|1347348|P2|STARTED|Overall Study||54
552892|NCT00715676|1347349|P1|STARTED|Overall Study|1 additional subject was enrolled in the placebo group but discontinued before taking any study drug|49
552893|NCT00715650|1347377|P2|NOT COMPLETED|Follow-up||5
552894|NCT00715650|1347378|P1|NOT COMPLETED|Follow-up||13
552895|NCT00715650|1347377|P2|COMPLETED|Follow-up||37
552896|NCT00715650|1347378|P1|COMPLETED|Follow-up||29
552897|NCT00715650|1347377|P2|Completed Month 6 Follow-up|Follow-up||37
552898|NCT00715650|1347378|P1|Completed Month 6 Follow-up|Follow-up||29
552899|NCT00715650|1347377|P2|Completed Month 3 Follow-up|Follow-up||40
552900|NCT00715650|1347378|P1|Completed Month 3 Follow-up|Follow-up||35
552901|NCT00715650|1347377|P2|Completed Month 1 Follow-up|Follow-up||38
552902|NCT00715650|1347378|P1|Completed Month 1 Follow-up|Follow-up||40
552903|NCT00715650|1347377|P2|STARTED|Follow-up||42
552904|NCT00715650|1347378|P1|STARTED|Follow-up||42
552905|NCT00715650|1347377|P2|NOT COMPLETED|Intervention||3
552906|NCT00715650|1347378|P1|NOT COMPLETED|Intervention||5
552907|NCT00715650|1347377|P2|COMPLETED|Intervention||42
552908|NCT00715650|1347378|P1|COMPLETED|Intervention||42
552909|NCT00715650|1347377|P2|Attended ≥ 3 Sessions|Intervention||17
552910|NCT00715650|1347378|P1|Attended ≥ 3 Sessions|Intervention||23
552911|NCT00715650|1347377|P2|Attended ≥ 2 Sessions|Intervention||33
552912|NCT00715650|1347378|P1|Attended ≥ 2 Sessions|Intervention||36
552913|NCT00715650|1347377|P2|Received Any Session|Intervention||38
552914|NCT00715650|1347378|P1|Received Any Session|Intervention||39
552915|NCT00715650|1347377|P2|STARTED|Intervention||45
552916|NCT00715650|1347378|P1|STARTED|Intervention||47
552917|NCT00715624|1347392|P2|NOT COMPLETED|Overall Study||116
552918|NCT00715624|1347393|P1|NOT COMPLETED|Overall Study||52
552919|NCT00715624|1347392|P2|COMPLETED|Overall Study||213
552920|NCT00715624|1347393|P1|COMPLETED|Overall Study||115
552921|NCT00715624|1347392|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||327
552922|NCT00715624|1347393|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|166
552923|NCT00715624|1347392|P2|Treated/Safety Population|Overall Study||328
552924|NCT00715624|1347393|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|167
552925|NCT00715624|1347392|P2|STARTED|Overall Study||329
552926|NCT00715624|1347393|P1|STARTED|Overall Study|Randomized|167
552927|NCT00715559|1347421|P1|NOT COMPLETED|Overall Study||1
552928|NCT00715559|1347421|P1|COMPLETED|Overall Study||2
552929|NCT00715559|1347421|P1|STARTED|Overall Study||3
552930|NCT00715520|1347431|P3|NOT COMPLETED|Overall Study||2
552931|NCT00715520|1347432|P2|NOT COMPLETED|Overall Study||1
552932|NCT00715520|1347433|P1|NOT COMPLETED|Overall Study||10
552933|NCT00715520|1347431|P3|COMPLETED|Overall Study||1
552934|NCT00715520|1347432|P2|COMPLETED|Overall Study||9
552935|NCT00715520|1347433|P1|COMPLETED|Overall Study||10
552936|NCT00715520|1347431|P3|STARTED|Overall Study||3
552937|NCT00715520|1347432|P2|STARTED|Overall Study||10
552938|NCT00715520|1347433|P1|STARTED|Overall Study||20
552939|NCT00715403|1347453|P7|NOT COMPLETED|Overall Study||1
552940|NCT00715403|1347454|P6|NOT COMPLETED|Overall Study||19
552941|NCT00715403|1347455|P5|NOT COMPLETED|Overall Study||6
552942|NCT00715403|1347456|P4|NOT COMPLETED|Overall Study||9
552943|NCT00715403|1347457|P3|NOT COMPLETED|Overall Study||4
552944|NCT00715403|1347458|P2|NOT COMPLETED|Overall Study||1
552945|NCT00715403|1347459|P1|NOT COMPLETED|Overall Study||1
552946|NCT00715403|1347453|P7|COMPLETED|Overall Study||0
552947|NCT00715403|1347454|P6|COMPLETED|Overall Study||0
552948|NCT00715403|1347455|P5|COMPLETED|Overall Study||0
552949|NCT00715403|1347456|P4|COMPLETED|Overall Study||0
552950|NCT00715403|1347457|P3|COMPLETED|Overall Study||0
552951|NCT00715403|1347458|P2|COMPLETED|Overall Study||0
552952|NCT00715403|1347459|P1|COMPLETED|Overall Study||0
552953|NCT00715403|1347453|P7|STARTED|Overall Study||1
552954|NCT00715403|1347454|P6|STARTED|Overall Study||19
552955|NCT00715403|1347455|P5|STARTED|Overall Study||6
552956|NCT00715403|1347456|P4|STARTED|Overall Study||9
552957|NCT00715403|1347457|P3|STARTED|Overall Study||4
552958|NCT00715403|1347458|P2|STARTED|Overall Study||1
552959|NCT00715403|1347459|P1|STARTED|Overall Study||1
552960|NCT00715390|1347594|P1|NOT COMPLETED|Overall Study||0
552961|NCT00715390|1347594|P1|COMPLETED|Overall Study|These were broken down to different types of dysrhythymia.|234
552962|NCT00715390|1347594|P1|Eligible|Overall Study||234
552963|NCT00715390|1347594|P1|STARTED|Overall Study|114,209 Anesthetic records were screened to identify 234 records.|234
552964|NCT00715299|1347598|P1|NOT COMPLETED|Overall Study||6
552965|NCT00715299|1347598|P1|COMPLETED|Overall Study||30
552966|NCT00715299|1347598|P1|STARTED|Overall Study|A total of 38 participants were consented to the study, but only 36 made it to day one of testing.|36
552967|NCT00715208|1347604|P2|NOT COMPLETED|Overall Study||9
552968|NCT00715208|1347605|P1|NOT COMPLETED|Overall Study||1
552969|NCT00715208|1347604|P2|COMPLETED|Overall Study||39
552970|NCT00715208|1347605|P1|COMPLETED|Overall Study||6
552971|NCT00715208|1347604|P2|STARTED|Overall Study||48
552972|NCT00715208|1347605|P1|STARTED|Overall Study||7
552973|NCT00715117|1347621|P2|NOT COMPLETED|Overall Study||1
552974|NCT00715117|1347622|P1|NOT COMPLETED|Overall Study||0
552975|NCT00715117|1347621|P2|COMPLETED|Overall Study|One subject flared and was rescued with steroids|5
552976|NCT00715117|1347622|P1|COMPLETED|Overall Study||6
552977|NCT00715117|1347621|P2|Completion fo 8 Week Study|Overall Study||6
552978|NCT00715117|1347622|P1|Completion fo 8 Week Study|Overall Study||6
552979|NCT00715117|1347621|P2|STARTED|Overall Study||6
552980|NCT00715117|1347622|P1|STARTED|Overall Study||6
552981|NCT00715104|1347636|P3|NOT COMPLETED|Overall Study||0
552982|NCT00715104|1347637|P2|NOT COMPLETED|Overall Study||0
552983|NCT00715104|1347638|P1|NOT COMPLETED|Overall Study||0
552984|NCT00715104|1347636|P3|COMPLETED|Overall Study||8
552985|NCT00715104|1347637|P2|COMPLETED|Overall Study||16
552986|NCT00715104|1347638|P1|COMPLETED|Overall Study||18
552987|NCT00715104|1347636|P3|STARTED|Overall Study||8
552988|NCT00715104|1347637|P2|STARTED|Overall Study||16
552989|NCT00715104|1347638|P1|STARTED|Overall Study||18
552990|NCT00715078|1347690|P3|NOT COMPLETED|Overall Study||38
552991|NCT00715078|1347691|P2|NOT COMPLETED|Overall Study||36
552992|NCT00715078|1347692|P1|NOT COMPLETED|Overall Study||30
552993|NCT00715078|1347690|P3|COMPLETED|Overall Study||3
552994|NCT00715078|1347691|P2|COMPLETED|Overall Study||4
552995|NCT00715078|1347692|P1|COMPLETED|Overall Study||11
552996|NCT00715078|1347690|P3|Received ≥ 1 Leukapheresis|Overall Study||40
552997|NCT00715078|1347691|P2|Received ≥ 1 Leukapheresis|Overall Study||40
552998|NCT00715078|1347692|P1|Received ≥ 1 Leukapheresis|Overall Study||40
552999|NCT00715078|1347690|P3|Received ≥ 1 Study Infusion|Overall Study||39
553000|NCT00715078|1347691|P2|Received ≥ 1 Study Infusion|Overall Study||40
553001|NCT00715078|1347692|P1|Received ≥ 1 Study Infusion|Overall Study||40
553002|NCT00715078|1347690|P3|STARTED|Overall Study||41
553003|NCT00715078|1347691|P2|STARTED|Overall Study||40
553004|NCT00715078|1347692|P1|STARTED|Overall Study||41
553005|NCT00715026|1347700|P1|NOT COMPLETED|Overall Study||10
553006|NCT00715026|1347700|P1|COMPLETED|Overall Study|20 unilateral subjects and 1 bilateral|21
553007|NCT00715026|1347700|P1|Subjects That Received Surgery|Overall Study|24 unilateral subjects and 1 bilateral|25
553008|NCT00715026|1347700|P1|STARTED|Overall Study|30 unilateral subjects and 1 bilateral|31
553009|NCT00714948|1347705|P1|NOT COMPLETED|Overall Study||2
553010|NCT00714948|1347705|P1|COMPLETED|Overall Study||0
553011|NCT00714948|1347705|P1|STARTED|Overall Study||2
553012|NCT00714870|1347711|P2|NOT COMPLETED|Overall Study||5
553013|NCT00714870|1347712|P1|NOT COMPLETED|Overall Study||27
553014|NCT00714870|1347711|P2|COMPLETED|Overall Study||22
553015|NCT00714870|1347712|P1|COMPLETED|Overall Study||22
553016|NCT00714870|1347711|P2|STARTED|Overall Study||27
553017|NCT00714870|1347712|P1|STARTED|Overall Study||49
553018|NCT00714792|1347720|P2|NOT COMPLETED|Overall Study||0
553019|NCT00714792|1347721|P1|NOT COMPLETED|Overall Study||0
553020|NCT00714792|1347720|P2|COMPLETED|Overall Study||8
553021|NCT00714792|1347721|P1|COMPLETED|Overall Study||10
553022|NCT00714792|1347720|P2|STARTED|Overall Study||8
553023|NCT00714792|1347721|P1|STARTED|Overall Study||10
553024|NCT00714714|1347727|P1|NOT COMPLETED|Overall Study||1
553025|NCT00714714|1347727|P1|COMPLETED|Overall Study||24
553026|NCT00714714|1347727|P1|STARTED|Overall Study||25
553027|NCT00714688|1347736|P3|NOT COMPLETED|Overall Study||37
553028|NCT00714688|1347737|P2|NOT COMPLETED|Overall Study||35
553029|NCT00714688|1347738|P1|NOT COMPLETED|Overall Study||29
553030|NCT00714688|1347736|P3|COMPLETED|Overall Study||55
553031|NCT00714688|1347737|P2|COMPLETED|Overall Study||55
553032|NCT00714688|1347738|P1|COMPLETED|Overall Study||68
553033|NCT00714688|1347736|P3|STARTED|Overall Study||92
553034|NCT00714688|1347737|P2|STARTED|Overall Study||90
553035|NCT00714688|1347738|P1|STARTED|Overall Study||97
553036|NCT00714571|1347761|P6|NOT COMPLETED|Stage 2||0
553037|NCT00714571|1347762|P5|NOT COMPLETED|Stage 2||0
553038|NCT00714571|1347763|P4|NOT COMPLETED|Stage 2||0
553039|NCT00714571|1347764|P3|NOT COMPLETED|Stage 2||0
553040|NCT00714571|1347765|P2|NOT COMPLETED|Stage 2||0
553041|NCT00714571|1347766|P1|NOT COMPLETED|Stage 2||0
553042|NCT00714571|1347761|P6|COMPLETED|Stage 2||15
553043|NCT00714571|1347762|P5|COMPLETED|Stage 2||15
553044|NCT00714571|1347763|P4|COMPLETED|Stage 2||0
553045|NCT00714571|1347764|P3|COMPLETED|Stage 2||0
553046|NCT00714571|1347765|P2|COMPLETED|Stage 2||0
553047|NCT00714571|1347766|P1|COMPLETED|Stage 2||0
553048|NCT00714571|1347761|P6|STARTED|Stage 2||15
553049|NCT00714571|1347762|P5|STARTED|Stage 2||15
553050|NCT00714571|1347763|P4|STARTED|Stage 2||0
553051|NCT00714571|1347764|P3|STARTED|Stage 2||0
553052|NCT00714571|1347765|P2|STARTED|Stage 2||0
553053|NCT00714571|1347766|P1|STARTED|Stage 2||0
553054|NCT00714571|1347761|P6|NOT COMPLETED|Stage 1||0
553055|NCT00714571|1347762|P5|NOT COMPLETED|Stage 1||0
553056|NCT00714571|1347763|P4|NOT COMPLETED|Stage 1||0
553057|NCT00714571|1347764|P3|NOT COMPLETED|Stage 1||1
553058|NCT00714571|1347765|P2|NOT COMPLETED|Stage 1||0
553059|NCT00714571|1347766|P1|NOT COMPLETED|Stage 1||0
553060|NCT00714571|1347761|P6|COMPLETED|Stage 1||0
553061|NCT00714571|1347762|P5|COMPLETED|Stage 1||0
553062|NCT00714571|1347763|P4|COMPLETED|Stage 1||14
553063|NCT00714571|1347764|P3|COMPLETED|Stage 1||10
553064|NCT00714571|1347765|P2|COMPLETED|Stage 1||15
553065|NCT00714571|1347766|P1|COMPLETED|Stage 1|1 patient excluded who completed training but did not disclose ongoing chemotherapy for cancer|12
553066|NCT00714571|1347761|P6|STARTED|Stage 1||0
553067|NCT00714571|1347762|P5|STARTED|Stage 1||0
553068|NCT00714571|1347763|P4|STARTED|Stage 1||14
553069|NCT00714571|1347764|P3|STARTED|Stage 1||11
553070|NCT00714571|1347765|P2|STARTED|Stage 1|11 allocated to intervention, but 1 withdrew before the first intervention session|15
553071|NCT00714571|1347766|P1|STARTED|Stage 1||12
553072|NCT00714493|1347780|P1|NOT COMPLETED|Overall Study||49
553073|NCT00714493|1347780|P1|COMPLETED|Overall Study||154
553074|NCT00714493|1347780|P1|STARTED|Overall Study||203
553075|NCT00714389|1347790|P1|NOT COMPLETED|Overall Study||0
553076|NCT00714389|1347790|P1|COMPLETED|Overall Study||12
553077|NCT00714389|1347790|P1|STARTED|Overall Study||12
553078|NCT00714311|1347797|P2|NOT COMPLETED|Overall Study||22
553079|NCT00714311|1347798|P1|NOT COMPLETED|Overall Study||13
553080|NCT00714311|1347797|P2|COMPLETED|Overall Study||30
553081|NCT00714311|1347798|P1|COMPLETED|Overall Study||39
553082|NCT00714311|1347797|P2|STARTED|Overall Study||52
553083|NCT00714311|1347798|P1|STARTED|Overall Study||52
553084|NCT00714285|1347808|P4|NOT COMPLETED|Overall Study||1
553085|NCT00714285|1347809|P3|NOT COMPLETED|Overall Study||0
553086|NCT00714285|1347810|P2|NOT COMPLETED|Overall Study||3
553087|NCT00714285|1347811|P1|NOT COMPLETED|Overall Study||0
553088|NCT00714285|1347808|P4|COMPLETED|Overall Study|Completed upto Day 180|104
553089|NCT00714285|1347809|P3|COMPLETED|Overall Study|Completed upto Day 180|105
553090|NCT00714285|1347810|P2|COMPLETED|Overall Study|Completed upto Day 180|102
553091|NCT00714285|1347811|P1|COMPLETED|Overall Study|Completed upto Day 180|105
553092|NCT00714285|1347808|P4|STARTED|Overall Study||105
553093|NCT00714285|1347809|P3|STARTED|Overall Study||105
553094|NCT00714285|1347810|P2|STARTED|Overall Study||105
553095|NCT00714285|1347811|P1|STARTED|Overall Study||105
553096|NCT00714259|1347861|P1|NOT COMPLETED|Overall Study||2
553097|NCT00714259|1347861|P1|COMPLETED|Overall Study||3
553098|NCT00714259|1347861|P1|STARTED|Overall Study||5
553099|NCT00714233|1347875|P4|NOT COMPLETED|Overall Study||4
553100|NCT00714233|1347876|P3|NOT COMPLETED|Overall Study||1
553101|NCT00714233|1347877|P2|NOT COMPLETED|Overall Study||1
553102|NCT00714233|1347878|P1|NOT COMPLETED|Overall Study||4
553103|NCT00714233|1347875|P4|COMPLETED|Overall Study||6
553104|NCT00714233|1347876|P3|COMPLETED|Overall Study||10
553105|NCT00714233|1347877|P2|COMPLETED|Overall Study||10
553106|NCT00714233|1347878|P1|COMPLETED|Overall Study||6
553107|NCT00714233|1347875|P4|STARTED|Overall Study||10
553108|NCT00714233|1347876|P3|STARTED|Overall Study||11
553109|NCT00714233|1347877|P2|STARTED|Overall Study||11
553110|NCT00714233|1347878|P1|STARTED|Overall Study||10
553111|NCT00714168|1347907|P2|NOT COMPLETED|Overall Study||59
553112|NCT00714168|1347908|P1|NOT COMPLETED|Overall Study||44
553113|NCT00714168|1347907|P2|COMPLETED|Overall Study||139
553114|NCT00714168|1347908|P1|COMPLETED|Overall Study||121
553115|NCT00714168|1347907|P2|STARTED|Overall Study||198
553116|NCT00714168|1347908|P1|STARTED|Overall Study||165
553117|NCT00714051|1347924|P2|NOT COMPLETED|Overall Study||1
553118|NCT00714051|1347925|P1|NOT COMPLETED|Overall Study||1
553119|NCT00714051|1347924|P2|COMPLETED|Overall Study||27
553120|NCT00714051|1347925|P1|COMPLETED|Overall Study||26
553121|NCT00714051|1347924|P2|STARTED|Overall Study||28
553122|NCT00714051|1347925|P1|STARTED|Overall Study||27
553123|NCT00713830|1347933|P2|NOT COMPLETED|Overall Study||177
553124|NCT00713830|1347934|P1|NOT COMPLETED|Overall Study||82
553125|NCT00713830|1347933|P2|COMPLETED|Overall Study||396
553126|NCT00713830|1347934|P1|COMPLETED|Overall Study||204
553127|NCT00713830|1347933|P2|Subgroup for Standardized Meal Test|Overall Study||313
553128|NCT00713830|1347934|P1|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal challenge test was performed.|155
553129|NCT00713830|1347933|P2|Safety Population|Overall Study|1 patient randomized to placebo received Lixisenatide (at least one dose)|574
553130|NCT00713830|1347934|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|285
553131|NCT00713830|1347933|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||570
553132|NCT00713830|1347934|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|286
553133|NCT00713830|1347933|P2|STARTED|Overall Study||573
553134|NCT00713830|1347934|P1|STARTED|Overall Study|Randomized.|286
553135|NCT00713817|1347972|P2|NOT COMPLETED|Overall Study||0
553136|NCT00713817|1347973|P1|NOT COMPLETED|Overall Study||0
553137|NCT00713817|1347972|P2|COMPLETED|Overall Study||9
553138|NCT00713817|1347973|P1|COMPLETED|Overall Study||10
553139|NCT00713817|1347972|P2|STARTED|Overall Study||9
553140|NCT00713817|1347973|P1|STARTED|Overall Study||10
553141|NCT00713700|1347991|P1|NOT COMPLETED|Overall Study||4
553142|NCT00713700|1347991|P1|COMPLETED|Overall Study||188
553143|NCT00713700|1347991|P1|STARTED|Overall Study||192
553144|NCT00713661|1348000|P4|NOT COMPLETED|Overall Study||0
553145|NCT00713661|1348001|P3|NOT COMPLETED|Overall Study||0
553146|NCT00713661|1348002|P2|NOT COMPLETED|Overall Study||0
553147|NCT00713661|1348003|P1|NOT COMPLETED|Overall Study||0
553148|NCT00713661|1348000|P4|COMPLETED|Overall Study||5
553149|NCT00713661|1348001|P3|COMPLETED|Overall Study||4
553150|NCT00713661|1348002|P2|COMPLETED|Overall Study||9
553151|NCT00713661|1348003|P1|COMPLETED|Overall Study||7
553152|NCT00713661|1348000|P4|STARTED|Overall Study||5
553153|NCT00713661|1348001|P3|STARTED|Overall Study||4
553154|NCT00713661|1348002|P2|STARTED|Overall Study||9
553155|NCT00713661|1348003|P1|STARTED|Overall Study||7
553156|NCT00713648|1348017|P1|NOT COMPLETED|Overall Study||8
553157|NCT00713648|1348017|P1|COMPLETED|Overall Study||33
553158|NCT00713648|1348017|P1|STARTED|Overall Study||41
553159|NCT00713609|1348030|P6|NOT COMPLETED|Overall Study||8
553160|NCT00713609|1348031|P5|NOT COMPLETED|Overall Study||19
553161|NCT00713609|1348032|P4|NOT COMPLETED|Overall Study||9
553162|NCT00713609|1348033|P3|NOT COMPLETED|Overall Study||15
553163|NCT00713609|1348034|P2|NOT COMPLETED|Overall Study||15
553164|NCT00713609|1348035|P1|NOT COMPLETED|Overall Study||21
553165|NCT00713609|1348030|P6|COMPLETED|Overall Study||47
553166|NCT00713609|1348031|P5|COMPLETED|Overall Study||87
553167|NCT00713609|1348032|P4|COMPLETED|Overall Study||99
553168|NCT00713609|1348033|P3|COMPLETED|Overall Study||92
553169|NCT00713609|1348034|P2|COMPLETED|Overall Study||90
553170|NCT00713609|1348035|P1|COMPLETED|Overall Study||85
553171|NCT00713609|1348030|P6|STARTED|Overall Study||55
553172|NCT00713609|1348031|P5|STARTED|Overall Study||106
553173|NCT00713609|1348032|P4|STARTED|Overall Study||108
553174|NCT00713609|1348033|P3|STARTED|Overall Study||107
553175|NCT00713609|1348034|P2|STARTED|Overall Study||105
553176|NCT00713609|1348035|P1|STARTED|Overall Study||106
553177|NCT00713596|1348070|P3|NOT COMPLETED|Overall Study||2
553178|NCT00713596|1348071|P2|NOT COMPLETED|Overall Study||3
553179|NCT00713596|1348072|P1|NOT COMPLETED|Overall Study||2
553180|NCT00713596|1348070|P3|COMPLETED|Overall Study||6
553181|NCT00713596|1348071|P2|COMPLETED|Overall Study||5
553182|NCT00713596|1348072|P1|COMPLETED|Overall Study||7
553183|NCT00713596|1348070|P3|STARTED|Overall Study||8
553184|NCT00713596|1348071|P2|STARTED|Overall Study||8
553185|NCT00713596|1348072|P1|STARTED|Overall Study||9
553186|NCT00713583|1348085|P2|NOT COMPLETED|Overall Study||0
553187|NCT00713583|1348086|P1|NOT COMPLETED|Overall Study||0
553188|NCT00713583|1348085|P2|COMPLETED|Overall Study||40
553189|NCT00713583|1348086|P1|COMPLETED|Overall Study||45
553190|NCT00713583|1348085|P2|STARTED|Overall Study||40
553191|NCT00713583|1348086|P1|STARTED|Overall Study||45
553192|NCT00713544|1348098|P6|NOT COMPLETED|Overall Study||9
553193|NCT00713544|1348099|P5|NOT COMPLETED|Overall Study||8
553194|NCT00713544|1348100|P4|NOT COMPLETED|Overall Study||10
553195|NCT00713544|1348101|P3|NOT COMPLETED|Overall Study||11
553196|NCT00713544|1348102|P2|NOT COMPLETED|Overall Study||6
553197|NCT00713544|1348103|P1|NOT COMPLETED|Overall Study||7
553198|NCT00713544|1348098|P6|COMPLETED|Overall Study||67
553199|NCT00713544|1348099|P5|COMPLETED|Overall Study||57
553200|NCT00713544|1348100|P4|COMPLETED|Overall Study||66
553201|NCT00713544|1348101|P3|COMPLETED|Overall Study||41
553202|NCT00713544|1348102|P2|COMPLETED|Overall Study||46
553203|NCT00713544|1348103|P1|COMPLETED|Overall Study||45
553204|NCT00713544|1348098|P6|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|76
553205|NCT00713544|1348099|P5|STARTED|Overall Study||65
553206|NCT00713544|1348100|P4|STARTED|Overall Study||76
553207|NCT00713544|1348101|P3|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|52
553208|NCT00713544|1348102|P2|STARTED|Overall Study||52
553209|NCT00713544|1348103|P1|STARTED|Overall Study||52
553210|NCT00713479|1348141|P2|NOT COMPLETED|Next Medication Condition||0
553211|NCT00713479|1348142|P1|NOT COMPLETED|Next Medication Condition||0
553212|NCT00713479|1348141|P2|COMPLETED|Next Medication Condition||6
553213|NCT00713479|1348142|P1|COMPLETED|Next Medication Condition||2
553214|NCT00713479|1348141|P2|STARTED|Next Medication Condition||6
553215|NCT00713479|1348142|P1|STARTED|Next Medication Condition||2
553216|NCT00713479|1348141|P2|NOT COMPLETED|Washout||0
553217|NCT00713479|1348142|P1|NOT COMPLETED|Washout||0
553218|NCT00713479|1348141|P2|COMPLETED|Washout||6
553219|NCT00713479|1348142|P1|COMPLETED|Washout||2
553220|NCT00713479|1348141|P2|STARTED|Washout||6
553221|NCT00713479|1348142|P1|STARTED|Washout||2
553222|NCT00713479|1348141|P2|NOT COMPLETED|First Medication Condition||0
553223|NCT00713479|1348142|P1|NOT COMPLETED|First Medication Condition||4
553224|NCT00713479|1348141|P2|COMPLETED|First Medication Condition||6
553225|NCT00713479|1348142|P1|COMPLETED|First Medication Condition||2
553226|NCT00713479|1348141|P2|STARTED|First Medication Condition||6
553227|NCT00713479|1348142|P1|STARTED|First Medication Condition||6
553228|NCT00713349|1348154|P1|NOT COMPLETED|Overall Study||1
553229|NCT00713349|1348154|P1|COMPLETED|Overall Study||24
553230|NCT00713349|1348154|P1|STARTED|Overall Study||25
553231|NCT00713323|1348160|P1|NOT COMPLETED|Overall Study||146
553232|NCT00713323|1348160|P1|COMPLETED|Overall Study||234
553233|NCT00713323|1348160|P1|STARTED|Overall Study||380
553234|NCT00713310|1348173|P2|NOT COMPLETED|Overall Study||6
553235|NCT00713310|1348174|P1|NOT COMPLETED|Overall Study||5
553236|NCT00713310|1348173|P2|COMPLETED|Overall Study||36
553237|NCT00713310|1348174|P1|COMPLETED|Overall Study||36
553238|NCT00713310|1348173|P2|mITT Population|Overall Study|1 subject randomized to high dose not dosed so not included in the mITT population.|41
553239|NCT00713310|1348174|P1|mITT Population|Overall Study||41
553240|NCT00713310|1348173|P2|STARTED|Overall Study||42
553241|NCT00713310|1348174|P1|STARTED|Overall Study||41
553242|NCT00713258|1348184|P2|NOT COMPLETED|Overall Study||6
553243|NCT00713258|1348185|P1|NOT COMPLETED|Overall Study||5
553244|NCT00713258|1348184|P2|COMPLETED|Overall Study||28
553245|NCT00713258|1348185|P1|COMPLETED|Overall Study||36
553246|NCT00713258|1348184|P2|STARTED|Overall Study||34
553247|NCT00713258|1348185|P1|STARTED|Overall Study||41
553248|NCT00713219|1348193|P1|NOT COMPLETED|Overall Study||2
553249|NCT00713219|1348193|P1|COMPLETED|Overall Study||12
553250|NCT00713219|1348193|P1|STARTED|Overall Study||14
553251|NCT00713206|1348199|P2|NOT COMPLETED|Overall Study||3
553252|NCT00713206|1348200|P1|NOT COMPLETED|Overall Study||7
553253|NCT00713206|1348199|P2|COMPLETED|Overall Study||27
553254|NCT00713206|1348200|P1|COMPLETED|Overall Study||55
553255|NCT00713206|1348199|P2|STARTED|Overall Study||30
553256|NCT00713206|1348200|P1|STARTED|Overall Study||62
553257|NCT00712985|1348206|P1|NOT COMPLETED|Overall Study||5
553258|NCT00712985|1348206|P1|COMPLETED|Overall Study||13
553259|NCT00712985|1348206|P1|STARTED|Overall Study||18
553260|NCT00712959|1348212|P2|NOT COMPLETED|Overall Study||3
553261|NCT00712959|1348213|P1|NOT COMPLETED|Overall Study||19
553262|NCT00712959|1348212|P2|COMPLETED|Overall Study||404
553263|NCT00712959|1348213|P1|COMPLETED|Overall Study||342
553264|NCT00712959|1348212|P2|STARTED|Overall Study||407
553265|NCT00712959|1348213|P1|STARTED|Overall Study||361
553266|NCT00712933|1348231|P1|NOT COMPLETED|Overall Study||367
553267|NCT00712933|1348231|P1|COMPLETED|Overall Study||368
553268|NCT00712933|1348231|P1|STARTED|Overall Study||735
553269|NCT00712920|1348261|P3|NOT COMPLETED|Overall Study||12
553270|NCT00712920|1348262|P2|NOT COMPLETED|Overall Study||17
553271|NCT00712920|1348263|P1|NOT COMPLETED|Overall Study||17
553272|NCT00712920|1348261|P3|COMPLETED|Overall Study||180
553273|NCT00712920|1348262|P2|COMPLETED|Overall Study||180
553274|NCT00712920|1348263|P1|COMPLETED|Overall Study||175
553275|NCT00712920|1348261|P3|STARTED|Overall Study||192
553276|NCT00712920|1348262|P2|STARTED|Overall Study|3 subjects were randomized in error|197
553277|NCT00712920|1348263|P1|STARTED|Overall Study||192
553278|NCT00712725|1348291|P8|NOT COMPLETED|Overall Study||11
553279|NCT00712725|1348292|P7|NOT COMPLETED|Overall Study||22
553280|NCT00712725|1348293|P6|NOT COMPLETED|Overall Study||16
553281|NCT00712725|1348294|P5|NOT COMPLETED|Overall Study||19
553282|NCT00712725|1348295|P4|NOT COMPLETED|Overall Study||17
553283|NCT00712725|1348296|P3|NOT COMPLETED|Overall Study||10
553284|NCT00712725|1348297|P2|NOT COMPLETED|Overall Study||6
553285|NCT00712725|1348298|P1|NOT COMPLETED|Overall Study||29
553286|NCT00712725|1348291|P8|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|63
553287|NCT00712725|1348292|P7|COMPLETED|Overall Study|One patient received study drug. The remaining patients discontinued prior to receiving study drug.|61
553288|NCT00712725|1348293|P6|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|68
553289|NCT00712725|1348294|P5|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|67
553290|NCT00712725|1348295|P4|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|67
553291|NCT00712725|1348296|P3|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|47
553292|NCT00712725|1348297|P2|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|33
553293|NCT00712725|1348298|P1|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|140
553294|NCT00712725|1348291|P8|STARTED|Overall Study||74
553295|NCT00712725|1348292|P7|STARTED|Overall Study||83
553296|NCT00712725|1348293|P6|STARTED|Overall Study||84
553297|NCT00712725|1348294|P5|STARTED|Overall Study||86
553298|NCT00712725|1348295|P4|STARTED|Overall Study||84
553299|NCT00712725|1348296|P3|STARTED|Overall Study||57
553300|NCT00712725|1348297|P2|STARTED|Overall Study||39
553301|NCT00712725|1348298|P1|STARTED|Overall Study||169
553302|NCT00712673|1348359|P4|NOT COMPLETED|Overall Study||70
553303|NCT00712673|1348360|P3|NOT COMPLETED|Overall Study||57
553304|NCT00712673|1348361|P2|NOT COMPLETED|Overall Study||21
553305|NCT00712673|1348362|P1|NOT COMPLETED|Overall Study||21
553306|NCT00712673|1348359|P4|COMPLETED|Overall Study||185
553307|NCT00712673|1348360|P3|COMPLETED|Overall Study||198
553308|NCT00712673|1348361|P2|COMPLETED|Overall Study||64
553309|NCT00712673|1348362|P1|COMPLETED|Overall Study||64
553310|NCT00712673|1348359|P4|Subgroup for Standardized Meal Test|Overall Study||0
553311|NCT00712673|1348360|P3|Subgroup for Standardized Meal Test|Overall Study||255
553312|NCT00712673|1348361|P2|Subgroup for Standardized Meal Test|Overall Study||0
553313|NCT00712673|1348362|P1|Subgroup for Standardized Meal Test|Overall Study|Patients from morning injection arms where standardized meal test was performed.|85
553314|NCT00712673|1348359|P4|Modified Intent-to-Treat(mITT)Population|Overall Study||255
553315|NCT00712673|1348360|P3|Modified Intent-to-Treat(mITT)Population|Overall Study||255
553316|NCT00712673|1348361|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||85
553317|NCT00712673|1348362|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|85
553318|NCT00712673|1348359|P4|Safety Population|Overall Study||255
553319|NCT00712673|1348360|P3|Safety Population|Overall Study||255
553320|NCT00712673|1348361|P2|Safety Population|Overall Study||85
553321|NCT00712673|1348362|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|85
553322|NCT00712673|1348359|P4|STARTED|Overall Study||255
553323|NCT00712673|1348360|P3|STARTED|Overall Study||255
553324|NCT00712673|1348361|P2|STARTED|Overall Study||85
553325|NCT00712673|1348362|P1|STARTED|Overall Study|Randomized.|85
553326|NCT00712543|1348426|P2|NOT COMPLETED|Day 8-14||2
553327|NCT00712543|1348427|P1|NOT COMPLETED|Day 8-14||0
553328|NCT00712543|1348426|P2|COMPLETED|Day 8-14||25
553329|NCT00712543|1348427|P1|COMPLETED|Day 8-14||23
553330|NCT00712543|1348426|P2|STARTED|Day 8-14||27
553331|NCT00712543|1348427|P1|STARTED|Day 8-14||23
553332|NCT00712543|1348426|P2|NOT COMPLETED|Day 1-7||0
553333|NCT00712543|1348427|P1|NOT COMPLETED|Day 1-7||0
553334|NCT00712543|1348426|P2|COMPLETED|Day 1-7||27
553335|NCT00712543|1348427|P1|COMPLETED|Day 1-7||23
553336|NCT00712543|1348426|P2|STARTED|Day 1-7||27
553337|NCT00712543|1348427|P1|STARTED|Day 1-7||23
553338|NCT00712530|1348436|P3|NOT COMPLETED|Overall Study||0
553339|NCT00712530|1348437|P2|NOT COMPLETED|Overall Study||0
553340|NCT00712530|1348438|P1|NOT COMPLETED|Overall Study||0
553341|NCT00712530|1348436|P3|COMPLETED|Overall Study||3
553342|NCT00712530|1348437|P2|COMPLETED|Overall Study||3
553343|NCT00712530|1348438|P1|COMPLETED|Overall Study||3
553344|NCT00712530|1348436|P3|STARTED|Overall Study|Screened 4 patients, but one failed to meet entry criteria due to a history of bleeding and diabetes|3
553345|NCT00712530|1348437|P2|STARTED|Overall Study||3
553346|NCT00712530|1348438|P1|STARTED|Overall Study||3
553347|NCT00712348|1348461|P1|NOT COMPLETED|Overall Study||1
553348|NCT00712348|1348461|P1|COMPLETED|Overall Study||30
553349|NCT00712348|1348461|P1|STARTED|Overall Study||31
553350|NCT00712335|1348473|P5|NOT COMPLETED|Overall Study||0
553351|NCT00712335|1348474|P4|NOT COMPLETED|Overall Study||5
553352|NCT00712335|1348475|P3|NOT COMPLETED|Overall Study||5
553353|NCT00712335|1348476|P2|NOT COMPLETED|Overall Study||17
553354|NCT00712335|1348477|P1|NOT COMPLETED|Overall Study||3
553355|NCT00712335|1348473|P5|COMPLETED|Overall Study||30
553356|NCT00712335|1348474|P4|COMPLETED|Overall Study||19
553357|NCT00712335|1348475|P3|COMPLETED|Overall Study||6
553358|NCT00712335|1348476|P2|COMPLETED|Overall Study||15
553359|NCT00712335|1348477|P1|COMPLETED|Overall Study||5
553360|NCT00712335|1348473|P5|STARTED|Overall Study||30
553361|NCT00712335|1348474|P4|STARTED|Overall Study||24
553362|NCT00712335|1348475|P3|STARTED|Overall Study||11
553363|NCT00712335|1348476|P2|STARTED|Overall Study||32
553364|NCT00712335|1348477|P1|STARTED|Overall Study||8
553365|NCT00712244|1348523|P4|NOT COMPLETED|Overall Study||1
553366|NCT00712244|1348524|P3|NOT COMPLETED|Overall Study||2
553367|NCT00712244|1348525|P2|NOT COMPLETED|Overall Study||1
553368|NCT00712244|1348526|P1|NOT COMPLETED|Overall Study||4
553369|NCT00712244|1348523|P4|COMPLETED|Overall Study||26
553370|NCT00712244|1348524|P3|COMPLETED|Overall Study||25
553371|NCT00712244|1348525|P2|COMPLETED|Overall Study||28
553372|NCT00712244|1348526|P1|COMPLETED|Overall Study||25
553373|NCT00712244|1348523|P4|STARTED|Overall Study||27
553374|NCT00712244|1348524|P3|STARTED|Overall Study||27
553375|NCT00712244|1348525|P2|STARTED|Overall Study||29
553376|NCT00712244|1348526|P1|STARTED|Overall Study||29
553377|NCT00712179|1348568|P1|NOT COMPLETED|Overall Study||12
553378|NCT00712179|1348568|P1|COMPLETED|Overall Study|Data from 4 subjects was excluded due to noise in recorded EMG signal, so 33 subjects were analysed.|37
553379|NCT00712179|1348568|P1|STARTED|Overall Study||49
553380|NCT00712166|1348574|P2|NOT COMPLETED|Overall Study||1
553381|NCT00712166|1348575|P1|NOT COMPLETED|Overall Study||0
553382|NCT00712166|1348574|P2|COMPLETED|Overall Study||75
553383|NCT00712166|1348575|P1|COMPLETED|Overall Study||81
553384|NCT00712166|1348574|P2|STARTED|Overall Study||76
553385|NCT00712166|1348575|P1|STARTED|Overall Study||81
553386|NCT00712075|1348602|P3|NOT COMPLETED|Overall Study||11
553387|NCT00712075|1348603|P2|NOT COMPLETED|Overall Study||4
553388|NCT00712075|1348604|P1|NOT COMPLETED|Overall Study||5
553389|NCT00712075|1348602|P3|COMPLETED|Overall Study||14
553390|NCT00712075|1348603|P2|COMPLETED|Overall Study||26
553391|NCT00712075|1348604|P1|COMPLETED|Overall Study||17
553392|NCT00712075|1348602|P3|STARTED|Overall Study||25
553393|NCT00712075|1348603|P2|STARTED|Overall Study||30
553394|NCT00712075|1348604|P1|STARTED|Overall Study||22
553395|NCT00712010|1348618|P1|NOT COMPLETED|7th and Last Protein Testing (1 Day)||0
553396|NCT00712010|1348618|P1|COMPLETED|7th and Last Protein Testing (1 Day)||23
553397|NCT00712010|1348618|P1|STARTED|7th and Last Protein Testing (1 Day)||23
553398|NCT00712010|1348618|P1|NOT COMPLETED|Washout (7 Days)||0
553399|NCT00712010|1348618|P1|COMPLETED|Washout (7 Days)||23
553400|NCT00712010|1348618|P1|STARTED|Washout (7 Days)||23
553401|NCT00712010|1348618|P1|NOT COMPLETED|6th Protein Testing (1 Day)||0
553402|NCT00712010|1348618|P1|COMPLETED|6th Protein Testing (1 Day)||23
553403|NCT00712010|1348618|P1|STARTED|6th Protein Testing (1 Day)||23
553404|NCT00712010|1348618|P1|NOT COMPLETED|Washout (7 Days)||0
553405|NCT00712010|1348618|P1|COMPLETED|Washout (7 Days)||23
553406|NCT00712010|1348618|P1|STARTED|Washout (7 Days)||23
553407|NCT00712010|1348618|P1|NOT COMPLETED|5th Protein Testing (1 Day)||0
553408|NCT00712010|1348618|P1|COMPLETED|5th Protein Testing (1 Day)||23
553409|NCT00712010|1348618|P1|STARTED|5th Protein Testing (1 Day)||23
553410|NCT00712010|1348618|P1|NOT COMPLETED|Washout (7 Days)||1
553411|NCT00712010|1348618|P1|COMPLETED|Washout (7 Days)||23
553412|NCT00712010|1348618|P1|STARTED|Washout (7 Days)||24
553413|NCT00712010|1348618|P1|NOT COMPLETED|4th Protein Testing (1 Day)||0
553414|NCT00712010|1348618|P1|COMPLETED|4th Protein Testing (1 Day)||24
553415|NCT00712010|1348618|P1|STARTED|4th Protein Testing (1 Day)||24
553416|NCT00712010|1348618|P1|NOT COMPLETED|Washout (7 Days)||0
553417|NCT00712010|1348618|P1|COMPLETED|Washout (7 Days)||24
553418|NCT00712010|1348618|P1|STARTED|Washout (7 Days)||24
553419|NCT00712010|1348618|P1|NOT COMPLETED|3rd Protein Testing (1 Day)||0
553420|NCT00712010|1348618|P1|COMPLETED|3rd Protein Testing (1 Day)||24
553421|NCT00712010|1348618|P1|STARTED|3rd Protein Testing (1 Day)||24
553422|NCT00712010|1348618|P1|NOT COMPLETED|Washout (7 Days)||0
553423|NCT00712010|1348618|P1|COMPLETED|Washout (7 Days)||24
553424|NCT00712010|1348618|P1|STARTED|Washout (7 Days)||24
553425|NCT00712010|1348618|P1|NOT COMPLETED|2nd Protein Testing (1 Day)||0
553426|NCT00712010|1348618|P1|COMPLETED|2nd Protein Testing (1 Day)||24
553427|NCT00712010|1348618|P1|STARTED|2nd Protein Testing (1 Day)||24
553428|NCT00712010|1348618|P1|NOT COMPLETED|Washout (7 Days)||0
553429|NCT00712010|1348618|P1|COMPLETED|Washout (7 Days)||24
553430|NCT00712010|1348618|P1|STARTED|Washout (7 Days)||24
553431|NCT00712010|1348618|P1|NOT COMPLETED|1st Protein Testing (1 Day)||0
553432|NCT00712010|1348618|P1|COMPLETED|1st Protein Testing (1 Day)||24
553433|NCT00712010|1348618|P1|STARTED|1st Protein Testing (1 Day)|1 subject withdrew his consent form before to starting the 1st intervention|24
553434|NCT00711997|1348643|P2|NOT COMPLETED|Overall Study||0
553435|NCT00711997|1348644|P1|NOT COMPLETED|Overall Study||0
553436|NCT00711997|1348643|P2|COMPLETED|Overall Study||6
553437|NCT00711997|1348644|P1|COMPLETED|Overall Study||3
553438|NCT00711997|1348643|P2|STARTED|Overall Study||6
553439|NCT00711997|1348644|P1|STARTED|Overall Study||3
553440|NCT00711971|1348657|P3|NOT COMPLETED|Overall Study||1
553441|NCT00711971|1348658|P2|NOT COMPLETED|Overall Study||4
553442|NCT00711971|1348659|P1|NOT COMPLETED|Overall Study||3
553443|NCT00711971|1348657|P3|COMPLETED|Overall Study||41
553444|NCT00711971|1348658|P2|COMPLETED|Overall Study||38
553445|NCT00711971|1348659|P1|COMPLETED|Overall Study||39
553446|NCT00711971|1348657|P3|STARTED|Overall Study||42
553447|NCT00711971|1348658|P2|STARTED|Overall Study||42
553448|NCT00711971|1348659|P1|STARTED|Overall Study||42
553449|NCT00711958|1348693|P2|NOT COMPLETED|Overall Study||23
553450|NCT00711958|1348694|P1|NOT COMPLETED|Overall Study||33
553451|NCT00711958|1348693|P2|COMPLETED|Overall Study||17
553452|NCT00711958|1348694|P1|COMPLETED|Overall Study||41
553453|NCT00711958|1348693|P2|STARTED|Overall Study||40
553454|NCT00711958|1348694|P1|STARTED|Overall Study||74
553455|NCT00711880|1348702|P2|NOT COMPLETED|Overall Study||7
553456|NCT00711880|1348703|P1|NOT COMPLETED|Overall Study||13
553457|NCT00711880|1348702|P2|COMPLETED|Overall Study||55
553458|NCT00711880|1348703|P1|COMPLETED|Overall Study||50
553459|NCT00711880|1348702|P2|STARTED|Overall Study||62
553460|NCT00711880|1348703|P1|STARTED|Overall Study||63
553461|NCT00711867|1348741|P2|NOT COMPLETED|Overall Study||4
553462|NCT00711867|1348742|P1|NOT COMPLETED|Overall Study||5
553463|NCT00711867|1348741|P2|COMPLETED|Overall Study|3 received additional warming. 1 missing primary measure.|21
553464|NCT00711867|1348742|P1|COMPLETED|Overall Study|2 received additional warming. 3 missing primary measure.|25
553465|NCT00711867|1348741|P2|STARTED|Overall Study||25
553466|NCT00711867|1348742|P1|STARTED|Overall Study||30
553467|NCT00711828|1348748|P1|NOT COMPLETED|Overall Study||0
553468|NCT00711828|1348748|P1|COMPLETED|Overall Study||21
553469|NCT00711828|1348748|P1|STARTED|Overall Study||21
553470|NCT00711802|1348765|P8|NOT COMPLETED|Overall Study||2
553471|NCT00711802|1348766|P7|NOT COMPLETED|Overall Study||5
553472|NCT00711802|1348767|P6|NOT COMPLETED|Overall Study||8
553473|NCT00711802|1348768|P5|NOT COMPLETED|Overall Study||14
553474|NCT00711802|1348769|P4|NOT COMPLETED|Overall Study||3
553475|NCT00711802|1348770|P3|NOT COMPLETED|Overall Study||6
553476|NCT00711802|1348771|P2|NOT COMPLETED|Overall Study||6
553477|NCT00711802|1348772|P1|NOT COMPLETED|Overall Study||2
553478|NCT00711802|1348765|P8|COMPLETED|Overall Study||13
553479|NCT00711802|1348766|P7|COMPLETED|Overall Study||25
553480|NCT00711802|1348767|P6|COMPLETED|Overall Study||34
553481|NCT00711802|1348768|P5|COMPLETED|Overall Study||69
553482|NCT00711802|1348769|P4|COMPLETED|Overall Study||35
553483|NCT00711802|1348770|P3|COMPLETED|Overall Study||69
553484|NCT00711802|1348771|P2|COMPLETED|Overall Study||32
553485|NCT00711802|1348772|P1|COMPLETED|Overall Study||73
553486|NCT00711802|1348765|P8|Received at Least 1 Dose of Study Drug|Overall Study||15
553487|NCT00711802|1348766|P7|Received at Least 1 Dose of Study Drug|Overall Study||30
553488|NCT00711802|1348767|P6|Received at Least 1 Dose of Study Drug|Overall Study||42
553489|NCT00711802|1348768|P5|Received at Least 1 Dose of Study Drug|Overall Study||81
553490|NCT00711802|1348769|P4|Received at Least 1 Dose of Study Drug|Overall Study||38
553491|NCT00711802|1348770|P3|Received at Least 1 Dose of Study Drug|Overall Study||73
553492|NCT00711802|1348771|P2|Received at Least 1 Dose of Study Drug|Overall Study||37
553493|NCT00711802|1348772|P1|Received at Least 1 Dose of Study Drug|Overall Study||73
553494|NCT00711802|1348765|P8|STARTED|Overall Study||15
553495|NCT00711802|1348766|P7|STARTED|Overall Study||30
553496|NCT00711802|1348767|P6|STARTED|Overall Study||42
553497|NCT00711802|1348768|P5|STARTED|Overall Study||83
553498|NCT00711802|1348769|P4|STARTED|Overall Study||38
553499|NCT00711802|1348770|P3|STARTED|Overall Study||75
553500|NCT00711802|1348771|P2|STARTED|Overall Study||38
553501|NCT00711802|1348772|P1|STARTED|Overall Study||75
553502|NCT00711646|1348804|P2|NOT COMPLETED|Overall Study||3
553503|NCT00711646|1348805|P1|NOT COMPLETED|Overall Study||12
553504|NCT00711646|1348804|P2|COMPLETED|Overall Study||62
553505|NCT00711646|1348805|P1|COMPLETED|Overall Study||112
553506|NCT00711646|1348804|P2|STARTED|Overall Study||65
553507|NCT00711646|1348805|P1|STARTED|Overall Study||124
553508|NCT00711594|1348827|P4|NOT COMPLETED|Overall Study||62
553509|NCT00711594|1348828|P3|NOT COMPLETED|Overall Study||6
553510|NCT00711594|1348829|P2|NOT COMPLETED|Overall Study||3
553511|NCT00711594|1348830|P1|NOT COMPLETED|Overall Study||3
553512|NCT00711594|1348827|P4|COMPLETED|Overall Study||0
553513|NCT00711594|1348828|P3|COMPLETED|Overall Study||0
553514|NCT00711594|1348829|P2|COMPLETED|Overall Study||0
553515|NCT00711594|1348830|P1|COMPLETED|Overall Study||0
553516|NCT00711594|1348827|P4|STARTED|Overall Study||62
553517|NCT00711594|1348828|P3|STARTED|Overall Study||6
553518|NCT00711594|1348829|P2|STARTED|Overall Study||3
553519|NCT00711594|1348830|P1|STARTED|Overall Study||3
553520|NCT00711555|1348867|P1|NOT COMPLETED|Overall Study||3
553521|NCT00711555|1348867|P1|COMPLETED|Overall Study||19
553522|NCT00711555|1348867|P1|STARTED|Overall Study||22
553523|NCT00711529|1348876|P2|NOT COMPLETED|Overall Study||6
553524|NCT00711529|1348877|P1|NOT COMPLETED|Overall Study||4
553525|NCT00711529|1348876|P2|COMPLETED|Overall Study||8
553621|NCT00710866|1349382|P2|COMPLETED|Overall Study||128
553526|NCT00711529|1348877|P1|COMPLETED|Overall Study|2 women lost their hot flash diary, so only 7 patients were evaluable for primary endpoint.|9
553527|NCT00711529|1348876|P2|STARTED|Overall Study||14
553528|NCT00711529|1348877|P1|STARTED|Overall Study||13
553529|NCT00711516|1348901|P2|NOT COMPLETED|Overall Study||3
553530|NCT00711516|1348902|P1|NOT COMPLETED|Overall Study||1
553531|NCT00711516|1348901|P2|COMPLETED|Overall Study||16
553532|NCT00711516|1348902|P1|COMPLETED|Overall Study||20
553533|NCT00711516|1348901|P2|STARTED|Overall Study||19
553534|NCT00711516|1348902|P1|STARTED|Overall Study||21
553535|NCT00711490|1348996|P1|NOT COMPLETED|Overall Study||0
553536|NCT00711490|1348996|P1|COMPLETED|Overall Study||5
553537|NCT00711490|1348996|P1|STARTED|Overall Study||5
553538|NCT00711477|1349009|P2|NOT COMPLETED|Overall Study||3
553539|NCT00711477|1349010|P1|NOT COMPLETED|Overall Study||3
553540|NCT00711477|1349009|P2|COMPLETED|Overall Study||20
553541|NCT00711477|1349010|P1|COMPLETED|Overall Study||20
553542|NCT00711477|1349009|P2|STARTED|Overall Study||23
553543|NCT00711477|1349010|P1|STARTED|Overall Study||23
553544|NCT00711464|1349038|P1|NOT COMPLETED|Overall Study||0
553545|NCT00711464|1349038|P1|COMPLETED|Overall Study||29
553546|NCT00711464|1349038|P1|STARTED|Overall Study||29
553547|NCT00711425|1349056|P1|NOT COMPLETED|Overall Study||4
553548|NCT00711425|1349056|P1|COMPLETED|Overall Study||41
553549|NCT00711425|1349056|P1|STARTED|Overall Study|Implant placement in 45 patients. Implant loading (baseline) in 44 patients.|45
553550|NCT00711347|1349064|P2|NOT COMPLETED|Overall Study||0
553551|NCT00711347|1349065|P1|NOT COMPLETED|Overall Study||0
553552|NCT00711347|1349064|P2|COMPLETED|Overall Study||14
553553|NCT00711347|1349065|P1|COMPLETED|Overall Study||14
553554|NCT00711347|1349064|P2|STARTED|Overall Study||14
553555|NCT00711347|1349065|P1|STARTED|Overall Study||14
553556|NCT00711191|1349084|P3|NOT COMPLETED|Overall Study||12
553557|NCT00711191|1349085|P2|NOT COMPLETED|Overall Study||5
553558|NCT00711191|1349086|P1|NOT COMPLETED|Overall Study||3
553559|NCT00711191|1349084|P3|COMPLETED|Overall Study||1
553560|NCT00711191|1349085|P2|COMPLETED|Overall Study||1
553561|NCT00711191|1349086|P1|COMPLETED|Overall Study||0
553562|NCT00711191|1349084|P3|STARTED|Overall Study||13
553563|NCT00711191|1349085|P2|STARTED|Overall Study||6
553564|NCT00711191|1349086|P1|STARTED|Overall Study||3
553565|NCT00711113|1349123|P1|NOT COMPLETED|Overall Study||11
553566|NCT00711113|1349123|P1|COMPLETED|Overall Study||36
553567|NCT00711113|1349123|P1|STARTED|Overall Study||47
553568|NCT00711100|1349129|P1|NOT COMPLETED|Overall Study||13
553569|NCT00711100|1349129|P1|COMPLETED|Overall Study||91
553570|NCT00711100|1349129|P1|STARTED|Overall Study||104
553571|NCT00711087|1349147|P2|NOT COMPLETED|Overall Study||0
553572|NCT00711087|1349148|P1|NOT COMPLETED|Overall Study||1
553573|NCT00711087|1349147|P2|COMPLETED|Overall Study||0
553574|NCT00711087|1349148|P1|COMPLETED|Overall Study||0
553575|NCT00711087|1349147|P2|STARTED|Overall Study||0
553576|NCT00711087|1349148|P1|STARTED|Overall Study||1
553577|NCT00711022|1349154|P1|NOT COMPLETED|Overall Study||11
553578|NCT00711022|1349154|P1|COMPLETED|Overall Study||40
553579|NCT00711022|1349154|P1|STARTED|Overall Study||51
553580|NCT00711009|1349160|P2|NOT COMPLETED|Overall Study||19
553581|NCT00711009|1349161|P1|NOT COMPLETED|Overall Study||15
553582|NCT00711009|1349160|P2|COMPLETED|Overall Study||82
553583|NCT00711009|1349161|P1|COMPLETED|Overall Study||90
553584|NCT00711009|1349160|P2|STARTED|Overall Study||101
553585|NCT00711009|1349161|P1|STARTED|Overall Study||105
553586|NCT00710996|1349332|P3|NOT COMPLETED|Overall Study||0
553587|NCT00710996|1349333|P2|NOT COMPLETED|Overall Study||4
553588|NCT00710996|1349334|P1|NOT COMPLETED|Overall Study||1
553589|NCT00710996|1349332|P3|COMPLETED|Overall Study||21
553590|NCT00710996|1349333|P2|COMPLETED|Overall Study||16
553591|NCT00710996|1349334|P1|COMPLETED|Overall Study||16
553592|NCT00710996|1349332|P3|STARTED|Overall Study||21
553593|NCT00710996|1349333|P2|STARTED|Overall Study||20
553594|NCT00710996|1349334|P1|STARTED|Overall Study||17
553595|NCT00710970|1349342|P1|NOT COMPLETED|Overall Study||10
553596|NCT00710970|1349342|P1|COMPLETED|Overall Study||18
553597|NCT00710970|1349342|P1|STARTED|Overall Study||28
553598|NCT00710944|1349349|P3|NOT COMPLETED|Overall Study||2
553599|NCT00710944|1349350|P2|NOT COMPLETED|Overall Study||9
553600|NCT00710944|1349351|P1|NOT COMPLETED|Overall Study||10
553601|NCT00710944|1349349|P3|COMPLETED|Overall Study||17
553602|NCT00710944|1349350|P2|COMPLETED|Overall Study||49
553603|NCT00710944|1349351|P1|COMPLETED|Overall Study||45
553604|NCT00710944|1349349|P3|STARTED|Overall Study||19
553605|NCT00710944|1349350|P2|STARTED|Overall Study||58
553606|NCT00710944|1349351|P1|STARTED|Overall Study||55
553607|NCT00710931|1349359|P1|NOT COMPLETED|Overall Study||5
553608|NCT00710931|1349359|P1|COMPLETED|Overall Study||29
553609|NCT00710931|1349359|P1|STARTED|Overall Study||34
553610|NCT00710905|1349363|P1|NOT COMPLETED|Overall Study||16
553611|NCT00710905|1349363|P1|COMPLETED|Overall Study||34
553612|NCT00710905|1349363|P1|STARTED|Overall Study||50
553613|NCT00710879|1349369|P2|NOT COMPLETED|Overall Study||4
553614|NCT00710879|1349370|P1|NOT COMPLETED|Overall Study||2
553615|NCT00710879|1349369|P2|COMPLETED|Overall Study||113
553616|NCT00710879|1349370|P1|COMPLETED|Overall Study||58
553617|NCT00710879|1349369|P2|STARTED|Overall Study||117
553618|NCT00710879|1349370|P1|STARTED|Overall Study||60
553619|NCT00710866|1349382|P2|NOT COMPLETED|Overall Study||6
553620|NCT00710866|1349383|P1|NOT COMPLETED|Overall Study||9
553622|NCT00710866|1349383|P1|COMPLETED|Overall Study||124
553623|NCT00710866|1349382|P2|STARTED|Overall Study||134
553624|NCT00710866|1349383|P1|STARTED|Overall Study||133
553625|NCT00710840|1349405|P2|NOT COMPLETED|Overall Study||3
553626|NCT00710840|1349406|P1|NOT COMPLETED|Overall Study||0
553627|NCT00710840|1349405|P2|COMPLETED|Overall Study||19
553628|NCT00710840|1349406|P1|COMPLETED|Overall Study||22
553629|NCT00710840|1349405|P2|STARTED|Overall Study||22
553630|NCT00710840|1349406|P1|STARTED|Overall Study||22
553631|NCT00710814|1349420|P2|NOT COMPLETED|Overall Study||3
553632|NCT00710814|1349421|P1|NOT COMPLETED|Overall Study||1
553633|NCT00710814|1349420|P2|COMPLETED|Overall Study||13
553634|NCT00710814|1349421|P1|COMPLETED|Overall Study||14
553635|NCT00710814|1349420|P2|STARTED|Overall Study||16
553636|NCT00710814|1349421|P1|STARTED|Overall Study||15
553637|NCT00710762|1349429|P2|NOT COMPLETED|Overall Study||40
553638|NCT00710762|1349430|P1|NOT COMPLETED|Overall Study||39
553639|NCT00710762|1349429|P2|COMPLETED|Overall Study||0
553640|NCT00710762|1349430|P1|COMPLETED|Overall Study||5
553641|NCT00710762|1349429|P2|STARTED|Overall Study||40
553642|NCT00710762|1349430|P1|STARTED|Overall Study||44
553643|NCT00710749|1349446|P2|NOT COMPLETED|Second Intervention||0
553644|NCT00710749|1349447|P1|NOT COMPLETED|Second Intervention||0
553645|NCT00710749|1349446|P2|COMPLETED|Second Intervention||30
553646|NCT00710749|1349447|P1|COMPLETED|Second Intervention||29
553647|NCT00710749|1349446|P2|STARTED|Second Intervention||30
553648|NCT00710749|1349447|P1|STARTED|Second Intervention||29
553649|NCT00710749|1349446|P2|NOT COMPLETED|First Intervention||0
553650|NCT00710749|1349447|P1|NOT COMPLETED|First Intervention||1
553651|NCT00710749|1349446|P2|COMPLETED|First Intervention||30
553652|NCT00710749|1349447|P1|COMPLETED|First Intervention||29
553653|NCT00710749|1349446|P2|STARTED|First Intervention||30
553654|NCT00710749|1349447|P1|STARTED|First Intervention||30
553655|NCT00710749|1349446|P2|NOT COMPLETED|Clinic Baseline Recording||0
553656|NCT00710749|1349447|P1|NOT COMPLETED|Clinic Baseline Recording||0
553657|NCT00710749|1349446|P2|COMPLETED|Clinic Baseline Recording||30
553658|NCT00710749|1349447|P1|COMPLETED|Clinic Baseline Recording||30
553659|NCT00710749|1349446|P2|STARTED|Clinic Baseline Recording||30
553660|NCT00710749|1349447|P1|STARTED|Clinic Baseline Recording||30
553661|NCT00710684|1349458|P3|NOT COMPLETED|Overall Study||64
553662|NCT00710684|1349459|P2|NOT COMPLETED|Overall Study||74
553663|NCT00710684|1349460|P1|NOT COMPLETED|Overall Study||74
553664|NCT00710684|1349458|P3|COMPLETED|Overall Study||172
553665|NCT00710684|1349459|P2|COMPLETED|Overall Study||147
553666|NCT00710684|1349460|P1|COMPLETED|Overall Study||151
553667|NCT00710684|1349458|P3|STARTED|Overall Study||236
553668|NCT00710684|1349459|P2|STARTED|Overall Study||221
553669|NCT00710684|1349460|P1|STARTED|Overall Study||225
553670|NCT00710606|1349517|P2|NOT COMPLETED|Overall Study||2
553671|NCT00710606|1349518|P1|NOT COMPLETED|Overall Study||0
553672|NCT00710606|1349517|P2|COMPLETED|Overall Study||18
553673|NCT00710606|1349518|P1|COMPLETED|Overall Study||20
553674|NCT00710606|1349517|P2|STARTED|Overall Study||20
553675|NCT00710606|1349518|P1|STARTED|Overall Study||20
553676|NCT00710593|1349530|P2|NOT COMPLETED|Overall Study||5
553677|NCT00710593|1349531|P1|NOT COMPLETED|Overall Study||15
553678|NCT00710593|1349530|P2|COMPLETED|Overall Study|25 completed study and vaccine. 2 did not receive all vaccine, but completed all study visits.|25
553679|NCT00710593|1349531|P1|COMPLETED|Overall Study|54 completed study and vaccine. 6 did not receive all vaccine, but completed all study visits.|54
553680|NCT00710593|1349530|P2|STARTED|Overall Study||30
553681|NCT00710593|1349531|P1|STARTED|Overall Study||69
553682|NCT00710554|1349574|P2|NOT COMPLETED|Overall Study||24
553683|NCT00710554|1349575|P1|NOT COMPLETED|Overall Study||49
553684|NCT00710554|1349574|P2|COMPLETED|Overall Study||94
553685|NCT00710554|1349575|P1|COMPLETED|Overall Study||79
553686|NCT00710554|1349574|P2|STARTED|Overall Study||118
553687|NCT00710554|1349575|P1|STARTED|Overall Study||128
553688|NCT00710424|1349603|P2|NOT COMPLETED|Overall Study||23
553689|NCT00710424|1349604|P1|NOT COMPLETED|Overall Study||44
553690|NCT00710424|1349603|P2|COMPLETED|Overall Study||125
553691|NCT00710424|1349604|P1|COMPLETED|Overall Study||105
553692|NCT00710424|1349603|P2|STARTED|Overall Study||148
553693|NCT00710424|1349604|P1|STARTED|Overall Study||149
553694|NCT00710385|1349628|P1|NOT COMPLETED|Overall Study||5
553695|NCT00710385|1349628|P1|COMPLETED|Overall Study||12
553696|NCT00710385|1349628|P1|STARTED|Overall Study|19 participants signed consent for the study 2 withdrew before any study procedures were initiated.|17
553697|NCT00710203|1349645|P1|NOT COMPLETED|Overall Study||0
553698|NCT00710203|1349645|P1|COMPLETED|Overall Study||10
553699|NCT00710203|1349645|P1|STARTED|Overall Study||10
553700|NCT00710034|1349673|P2|NOT COMPLETED|Completed 12 Weeks of Treatment||11
553701|NCT00710034|1349674|P1|NOT COMPLETED|Completed 12 Weeks of Treatment||13
553702|NCT00710034|1349673|P2|COMPLETED|Completed 12 Weeks of Treatment||138
553703|NCT00710034|1349674|P1|COMPLETED|Completed 12 Weeks of Treatment||141
553704|NCT00710034|1349673|P2|STARTED|Completed 12 Weeks of Treatment||149
553705|NCT00710034|1349674|P1|STARTED|Completed 12 Weeks of Treatment||154
553706|NCT00710034|1349673|P2|NOT COMPLETED|Completed 6 Weeks of Treatment||47
553707|NCT00710034|1349674|P1|NOT COMPLETED|Completed 6 Weeks of Treatment||41
553708|NCT00710034|1349673|P2|COMPLETED|Completed 6 Weeks of Treatment|Completed 6 weeks of treatment for primary outcome assessment: N=149|149
553709|NCT00710034|1349674|P1|COMPLETED|Completed 6 Weeks of Treatment|Completed 6 weeks of treatment for primary outcome assessment: N=154|154
553710|NCT00710034|1349673|P2|STARTED|Completed 6 Weeks of Treatment||196
553711|NCT00710034|1349674|P1|STARTED|Completed 6 Weeks of Treatment||195
553712|NCT00710021|1349691|P3|NOT COMPLETED|Overall Study||1
553713|NCT00710021|1349692|P2|NOT COMPLETED|Overall Study||3
553714|NCT00710021|1349693|P1|NOT COMPLETED|Overall Study||1
553715|NCT00710021|1349691|P3|COMPLETED|Overall Study||18
553716|NCT00710021|1349692|P2|COMPLETED|Overall Study||16
553717|NCT00710021|1349693|P1|COMPLETED|Overall Study||18
553718|NCT00710021|1349691|P3|Modified Intent-to-Treat (mITT)|Overall Study|1 subject who did not take study drug was excluded from mITT|18
553719|NCT00710021|1349692|P2|Modified Intent-to-Treat (mITT)|Overall Study|2 subjects who did not take study drug were excluded from mITT|17
553720|NCT00710021|1349693|P1|Modified Intent-to-Treat (mITT)|Overall Study||19
553721|NCT00710021|1349691|P3|STARTED|Overall Study||19
553722|NCT00710021|1349692|P2|STARTED|Overall Study||19
553723|NCT00710021|1349693|P1|STARTED|Overall Study||19
553724|NCT00709956|1349808|P2|NOT COMPLETED|Overall Study||4
553725|NCT00709956|1349809|P1|NOT COMPLETED|Overall Study||3
553726|NCT00709956|1349808|P2|COMPLETED|Overall Study||33
553727|NCT00709956|1349809|P1|COMPLETED|Overall Study||30
553728|NCT00709956|1349808|P2|Double-blind Crossover-period|Overall Study|Days 2 and 3|33
553729|NCT00709956|1349809|P1|Double-blind Crossover-period|Overall Study|Days 2 and 3|31
553730|NCT00709956|1349808|P2|STARTED|Overall Study|Day 1 Single-blind placebo run-in|37
553731|NCT00709956|1349809|P1|STARTED|Overall Study|Day 1 Single-blind placebo run-in|33
553732|NCT00709891|1349817|P1|NOT COMPLETED|Longitudinal Follow-up Phase||4982
553733|NCT00709891|1349817|P1|COMPLETED|Longitudinal Follow-up Phase||5020
553734|NCT00709891|1349817|P1|STARTED|Longitudinal Follow-up Phase|Only participants who met study criteria in the Baseline phase started the Follow-up phase.|10002
553735|NCT00709891|1349817|P1|NOT COMPLETED|Baseline, Cross-sectional Phase||1450
553736|NCT00709891|1349817|P1|COMPLETED|Baseline, Cross-sectional Phase||45758
553737|NCT00709891|1349817|P1|STARTED|Baseline, Cross-sectional Phase||47208
553738|NCT00709878|1349826|P4|NOT COMPLETED|Overall Study||0
553739|NCT00709878|1349827|P3|NOT COMPLETED|Overall Study||0
553740|NCT00709878|1349828|P2|NOT COMPLETED|Overall Study||0
553741|NCT00709878|1349829|P1|NOT COMPLETED|Overall Study||0
553742|NCT00709878|1349826|P4|COMPLETED|Overall Study||8
553743|NCT00709878|1349827|P3|COMPLETED|Overall Study||8
553744|NCT00709878|1349828|P2|COMPLETED|Overall Study||8
553745|NCT00709878|1349829|P1|COMPLETED|Overall Study||8
553746|NCT00709878|1349826|P4|STARTED|Overall Study||8
553747|NCT00709878|1349827|P3|STARTED|Overall Study||8
553748|NCT00709878|1349828|P2|STARTED|Overall Study||8
553749|NCT00709878|1349829|P1|STARTED|Overall Study||8
553750|NCT00709852|1349839|P2|NOT COMPLETED|Period 2||2
553751|NCT00709852|1349840|P1|NOT COMPLETED|Period 2||9
553752|NCT00709852|1349839|P2|COMPLETED|Period 2||169
553753|NCT00709852|1349840|P1|COMPLETED|Period 2||211
553754|NCT00709852|1349839|P2|STARTED|Period 2||171
553755|NCT00709852|1349840|P1|STARTED|Period 2||220
553756|NCT00709852|1349839|P2|NOT COMPLETED|Period 1||3
553757|NCT00709852|1349840|P1|NOT COMPLETED|Period 1||8
553758|NCT00709852|1349839|P2|COMPLETED|Period 1||171
553759|NCT00709852|1349840|P1|COMPLETED|Period 1||220
553760|NCT00709852|1349839|P2|STARTED|Period 1||174
553761|NCT00709852|1349840|P1|STARTED|Period 1||228
553762|NCT00709826|1349995|P2|NOT COMPLETED|Overall Study||1
553763|NCT00709826|1349996|P1|NOT COMPLETED|Overall Study||2
553764|NCT00709826|1349995|P2|COMPLETED|Overall Study||38
553765|NCT00709826|1349996|P1|COMPLETED|Overall Study||68
553766|NCT00709826|1349995|P2|STARTED|Overall Study||39
553767|NCT00709826|1349996|P1|STARTED|Overall Study||70
553768|NCT00709761|1350004|P1|NOT COMPLETED|Overall Study||47
553769|NCT00709761|1350004|P1|COMPLETED|Overall Study||13
553770|NCT00709761|1350004|P1|Ongoing|Overall Study|At time of clinical data cut off, 11 participants were on study treatment; 29 were in follow up.|40
553771|NCT00709761|1350004|P1|STARTED|Overall Study||60
553772|NCT00709735|1350015|P2|NOT COMPLETED|Overall Study||2
553773|NCT00709735|1350016|P1|NOT COMPLETED|Overall Study||3
553774|NCT00709735|1350015|P2|COMPLETED|Overall Study||10
553775|NCT00709735|1350016|P1|COMPLETED|Overall Study||8
553776|NCT00709735|1350015|P2|STARTED|Overall Study||12
553777|NCT00709735|1350016|P1|STARTED|Overall Study||11
553778|NCT00709722|1350024|P1|NOT COMPLETED|Overall Study||1
553779|NCT00709722|1350024|P1|COMPLETED|Overall Study||20
553780|NCT00709722|1350024|P1|STARTED|Overall Study||21
553781|NCT00709696|1350032|P2|NOT COMPLETED|Overall Study||0
553782|NCT00709696|1350033|P1|NOT COMPLETED|Overall Study||0
553783|NCT00709696|1350032|P2|COMPLETED|Overall Study||3
553784|NCT00709696|1350033|P1|COMPLETED|Overall Study||4
553785|NCT00709696|1350032|P2|STARTED|Overall Study||3
553786|NCT00709696|1350033|P1|STARTED|Overall Study||4
553787|NCT00709618|1350039|P1|NOT COMPLETED|Overall Study||30
553788|NCT00709618|1350039|P1|COMPLETED|Overall Study||14
553789|NCT00709618|1350039|P1|STARTED|Overall Study||44
553790|NCT00709592|1350051|P2|NOT COMPLETED|Overall Study||1
553791|NCT00709592|1350052|P1|NOT COMPLETED|Overall Study||0
553792|NCT00709592|1350051|P2|COMPLETED|Overall Study||22
553793|NCT00709592|1350052|P1|COMPLETED|Overall Study||19
553794|NCT00709592|1350051|P2|STARTED|Overall Study||23
553795|NCT00709592|1350052|P1|STARTED|Overall Study||19
553796|NCT00709319|1350072|P1|NOT COMPLETED|Overall Study||6
553797|NCT00709319|1350072|P1|COMPLETED|Overall Study||81
553798|NCT00709319|1350072|P1|STARTED|Overall Study||87
553799|NCT00709306|1350084|P4|NOT COMPLETED|Overall Study||10
553800|NCT00709306|1350085|P3|NOT COMPLETED|Overall Study||10
553801|NCT00709306|1350086|P2|NOT COMPLETED|Overall Study||14
553802|NCT00709306|1350087|P1|NOT COMPLETED|Overall Study||9
553803|NCT00709306|1350084|P4|COMPLETED|Overall Study||37
553804|NCT00709306|1350085|P3|COMPLETED|Overall Study||48
553805|NCT00709306|1350086|P2|COMPLETED|Overall Study||30
553806|NCT00709306|1350087|P1|COMPLETED|Overall Study||39
553807|NCT00709306|1350084|P4|STARTED|Overall Study||47
553808|NCT00709306|1350085|P3|STARTED|Overall Study||58
553809|NCT00709306|1350086|P2|STARTED|Overall Study||44
553810|NCT00709306|1350087|P1|STARTED|Overall Study||48
553811|NCT00709228|1350101|P1|NOT COMPLETED|Overall Study||332
553812|NCT00709228|1350101|P1|COMPLETED|Overall Study|Number completed is defined as participants who completed the follow-up period.|164
553813|NCT00709228|1350101|P1|STARTED|Overall Study||496
553814|NCT00709124|1350107|P2|NOT COMPLETED|Overall Study||1
553815|NCT00709124|1350108|P1|NOT COMPLETED|Overall Study||4
553816|NCT00709124|1350107|P2|COMPLETED|Overall Study||17
553817|NCT00709124|1350108|P1|COMPLETED|Overall Study||12
553818|NCT00709124|1350107|P2|STARTED|Overall Study||18
553819|NCT00709124|1350108|P1|STARTED|Overall Study||16
553820|NCT00709111|1350142|P1|NOT COMPLETED|Overall Study||2
553821|NCT00709111|1350142|P1|COMPLETED|Overall Study||32
553822|NCT00709111|1350142|P1|Week 22/24|Overall Study||33
553823|NCT00709111|1350142|P1|STARTED|Overall Study||34
553824|NCT00709098|1350183|P3|NOT COMPLETED|Open-label Period||14
553825|NCT00709098|1350184|P2|NOT COMPLETED|Open-label Period||0
553826|NCT00709098|1350185|P1|NOT COMPLETED|Open-label Period||0
553827|NCT00709098|1350183|P3|COMPLETED|Open-label Period||18
553828|NCT00709098|1350184|P2|COMPLETED|Open-label Period||0
553829|NCT00709098|1350185|P1|COMPLETED|Open-label Period||0
553830|NCT00709098|1350183|P3|STARTED|Open-label Period|The open-label period was only made available to patients in US centers|32
553831|NCT00709098|1350184|P2|STARTED|Open-label Period||0
553832|NCT00709098|1350185|P1|STARTED|Open-label Period||0
553833|NCT00709098|1350183|P3|NOT COMPLETED|Double-blind Period||0
553834|NCT00709098|1350184|P2|NOT COMPLETED|Double-blind Period||8
553835|NCT00709098|1350185|P1|NOT COMPLETED|Double-blind Period||6
553836|NCT00709098|1350183|P3|COMPLETED|Double-blind Period||0
553837|NCT00709098|1350184|P2|COMPLETED|Double-blind Period||16
553838|NCT00709098|1350185|P1|COMPLETED|Double-blind Period||19
553839|NCT00709098|1350183|P3|STARTED|Double-blind Period||0
553840|NCT00709098|1350184|P2|STARTED|Double-blind Period||24
553841|NCT00709098|1350185|P1|STARTED|Double-blind Period||25
553842|NCT00709059|1350204|P1|NOT COMPLETED|Overall Study||94
553843|NCT00709059|1350204|P1|COMPLETED|Overall Study||444
553844|NCT00709059|1350204|P1|STARTED|Overall Study||538
553845|NCT00708942|1350213|P5|NOT COMPLETED|Overall Study||1
553846|NCT00708942|1350214|P4|NOT COMPLETED|Overall Study||0
553847|NCT00708942|1350215|P3|NOT COMPLETED|Overall Study||2
553848|NCT00708942|1350216|P2|NOT COMPLETED|Overall Study||1
553849|NCT00708942|1350217|P1|NOT COMPLETED|Overall Study||7
553850|NCT00708942|1350213|P5|COMPLETED|Overall Study||2
553851|NCT00708942|1350214|P4|COMPLETED|Overall Study||10
553852|NCT00708942|1350215|P3|COMPLETED|Overall Study||9
553853|NCT00708942|1350216|P2|COMPLETED|Overall Study||11
553854|NCT00708942|1350217|P1|COMPLETED|Overall Study||40
553855|NCT00708942|1350213|P5|STARTED|Overall Study||3
553856|NCT00708942|1350214|P4|STARTED|Overall Study||10
553857|NCT00708942|1350215|P3|STARTED|Overall Study||11
553858|NCT00708942|1350216|P2|STARTED|Overall Study||12
553859|NCT00708942|1350217|P1|STARTED|Overall Study||47
553860|NCT00708877|1350239|P1|NOT COMPLETED|Overall Study||0
553861|NCT00708877|1350239|P1|COMPLETED|Overall Study||5
553862|NCT00708877|1350239|P1|STARTED|Overall Study||5
553863|NCT00708851|1350243|P1|NOT COMPLETED|Overall Study||0
553864|NCT00708851|1350243|P1|COMPLETED|Overall Study||12
553865|NCT00708851|1350243|P1|STARTED|Overall Study||12
553866|NCT00708734|1350251|P1|NOT COMPLETED|Overall Study||7
553867|NCT00708734|1350251|P1|COMPLETED|Overall Study|Ten subjects enrolled, three completed the intervention and all follow up sessions.|3
553868|NCT00708734|1350251|P1|STARTED|Overall Study|94 subjects were screened, 45 did not meet criteria, and 39 declined participation after screening.|10
553869|NCT00708721|1350255|P4|NOT COMPLETED|Overall Study||0
553870|NCT00708721|1350256|P3|NOT COMPLETED|Overall Study||0
553871|NCT00708721|1350257|P2|NOT COMPLETED|Overall Study||0
553872|NCT00708721|1350258|P1|NOT COMPLETED|Overall Study||0
553873|NCT00708721|1350255|P4|COMPLETED|Overall Study||2
553874|NCT00708721|1350256|P3|COMPLETED|Overall Study||3
553875|NCT00708721|1350257|P2|COMPLETED|Overall Study||4
553876|NCT00708721|1350258|P1|COMPLETED|Overall Study||2
553877|NCT00708721|1350255|P4|STARTED|Overall Study||2
553878|NCT00708721|1350256|P3|STARTED|Overall Study||3
553879|NCT00708721|1350257|P2|STARTED|Overall Study||4
553880|NCT00708721|1350258|P1|STARTED|Overall Study||2
553881|NCT00708708|1350271|P1|NOT COMPLETED|Overall Study||742
553882|NCT00708708|1350271|P1|COMPLETED|Overall Study|Included participants completed total observation period and participants with planned study end.|213
553883|NCT00708708|1350271|P1|STARTED|Overall Study||955
553884|NCT00708682|1350319|P1|NOT COMPLETED|Toddler Dose||8
553885|NCT00708682|1350319|P1|COMPLETED|Toddler Dose||183
553886|NCT00708682|1350319|P1|STARTED|Toddler Dose||191
553887|NCT00708682|1350319|P1|NOT COMPLETED|After Infant Series||1
553888|NCT00708682|1350319|P1|COMPLETED|After Infant Series||191
553889|NCT00708682|1350319|P1|STARTED|After Infant Series||192
553890|NCT00708682|1350319|P1|NOT COMPLETED|Infant Series||33
553891|NCT00708682|1350319|P1|COMPLETED|Infant Series||192
553892|NCT00708682|1350319|P1|Vaccinated Dose 3|Infant Series||194
553893|NCT00708682|1350319|P1|Vaccinated Dose 2|Infant Series||214
553894|NCT00708682|1350319|P1|Vaccinated Dose 1|Infant Series||223
553895|NCT00708682|1350319|P1|STARTED|Infant Series||225
553896|NCT00708643|1350340|P2|NOT COMPLETED|Overall Study||1
553897|NCT00708643|1350341|P1|NOT COMPLETED|Overall Study||0
553898|NCT00708643|1350340|P2|COMPLETED|Overall Study||39
553899|NCT00708643|1350341|P1|COMPLETED|Overall Study||40
553900|NCT00708643|1350340|P2|STARTED|Overall Study||40
553901|NCT00708643|1350341|P1|STARTED|Overall Study||40
553902|NCT00708552|1350361|P4|NOT COMPLETED|Overall Study||21
553903|NCT00708552|1350362|P3|NOT COMPLETED|Overall Study||15
553904|NCT00708552|1350363|P2|NOT COMPLETED|Overall Study||18
553905|NCT00708552|1350364|P1|NOT COMPLETED|Overall Study||27
553906|NCT00708552|1350361|P4|COMPLETED|Overall Study||130
553907|NCT00708552|1350362|P3|COMPLETED|Overall Study||118
553908|NCT00708552|1350363|P2|COMPLETED|Overall Study||127
553909|NCT00708552|1350364|P1|COMPLETED|Overall Study||118
553910|NCT00708552|1350361|P4|STARTED|Overall Study||151
553911|NCT00708552|1350362|P3|STARTED|Overall Study||133
553912|NCT00708552|1350363|P2|STARTED|Overall Study||145
553913|NCT00708552|1350364|P1|STARTED|Overall Study||145
553914|NCT00708526|1350514|P2|NOT COMPLETED|Return of Cognitive Function||0
553915|NCT00708526|1350515|P1|NOT COMPLETED|Return of Cognitive Function||0
553916|NCT00708526|1350514|P2|COMPLETED|Return of Cognitive Function||11
553917|NCT00708526|1350515|P1|COMPLETED|Return of Cognitive Function||11
553918|NCT00708526|1350514|P2|STARTED|Return of Cognitive Function||11
553919|NCT00708526|1350515|P1|STARTED|Return of Cognitive Function||11
553920|NCT00708526|1350514|P2|NOT COMPLETED|Wake up After Anesthesia||0
553921|NCT00708526|1350515|P1|NOT COMPLETED|Wake up After Anesthesia||0
553922|NCT00708526|1350514|P2|COMPLETED|Wake up After Anesthesia||11
553923|NCT00708526|1350515|P1|COMPLETED|Wake up After Anesthesia||11
553924|NCT00708526|1350514|P2|STARTED|Wake up After Anesthesia||11
553925|NCT00708526|1350515|P1|STARTED|Wake up After Anesthesia||11
553926|NCT00708500|1350526|P3|NOT COMPLETED|FOLLOWUP||15
553927|NCT00708500|1350527|P2|NOT COMPLETED|FOLLOWUP||15
553928|NCT00708500|1350528|P1|NOT COMPLETED|FOLLOWUP||40
553929|NCT00708500|1350526|P3|COMPLETED|FOLLOWUP||143
553930|NCT00708500|1350527|P2|COMPLETED|FOLLOWUP||136
553931|NCT00708500|1350528|P1|COMPLETED|FOLLOWUP||37
553932|NCT00708500|1350526|P3|STARTED|FOLLOWUP||158
553933|NCT00708500|1350527|P2|STARTED|FOLLOWUP||151
553934|NCT00708500|1350528|P1|STARTED|FOLLOWUP||77
553935|NCT00708500|1350526|P3|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55
553936|NCT00708500|1350527|P2|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||52
553937|NCT00708500|1350528|P1|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55
553938|NCT00708500|1350526|P3|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||105
553939|NCT00708500|1350527|P2|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||104
553940|NCT00708500|1350528|P1|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||23
553941|NCT00708500|1350526|P3|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||160
553942|NCT00708500|1350527|P2|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||156
553943|NCT00708500|1350528|P1|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||78
553944|NCT00708500|1350526|P3|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2
553945|NCT00708500|1350527|P2|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||6
553946|NCT00708500|1350528|P1|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2
553947|NCT00708500|1350526|P3|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||160
553948|NCT00708500|1350527|P2|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||156
553949|NCT00708500|1350528|P1|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||78
553950|NCT00708500|1350526|P3|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||161
553951|NCT00708500|1350527|P2|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
553952|NCT00708500|1350528|P1|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80
553953|NCT00708500|1350526|P3|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
553954|NCT00708500|1350527|P2|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
553955|NCT00708500|1350528|P1|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80
553956|NCT00708461|1350547|P2|NOT COMPLETED|Overall Study||200
553957|NCT00708461|1350548|P1|NOT COMPLETED|Overall Study||141
553958|NCT00708461|1350547|P2|COMPLETED|Overall Study||795
553959|NCT00708461|1350548|P1|COMPLETED|Overall Study||611
553960|NCT00708461|1350547|P2|STARTED|Overall Study||995
553961|NCT00708461|1350548|P1|STARTED|Overall Study||752
553962|NCT00708435|1350556|P2|NOT COMPLETED|Overall Study||17
553963|NCT00708435|1350557|P1|NOT COMPLETED|Overall Study||25
553964|NCT00708435|1350556|P2|COMPLETED|Overall Study|These data are 'on-study' results collected up to the subject's Day 45 visit.|92
553965|NCT00708435|1350557|P1|COMPLETED|Overall Study|These data are 'on-study' results collected up to the subject's Day 45 visit.|82
553966|NCT00708435|1350556|P2|STARTED|Overall Study||109
553967|NCT00708435|1350557|P1|STARTED|Overall Study||107
553968|NCT00708422|1350584|P2|NOT COMPLETED|Overall Study||1
553969|NCT00708422|1350585|P1|NOT COMPLETED|Overall Study||4
553970|NCT00708422|1350584|P2|COMPLETED|Overall Study||114
553971|NCT00708422|1350585|P1|COMPLETED|Overall Study||112
553972|NCT00708422|1350584|P2|STARTED|Overall Study||115
553973|NCT00708422|1350585|P1|STARTED|Overall Study||116
553974|NCT00708305|1350593|P4|NOT COMPLETED|Period 4||0
553975|NCT00708305|1350594|P3|NOT COMPLETED|Period 4||0
553976|NCT00708305|1350595|P2|NOT COMPLETED|Period 4||0
553977|NCT00708305|1350596|P1|NOT COMPLETED|Period 4||0
553978|NCT00708305|1350593|P4|COMPLETED|Period 4||14
553979|NCT00708305|1350594|P3|COMPLETED|Period 4||14
553980|NCT00708305|1350595|P2|COMPLETED|Period 4||14
553981|NCT00708305|1350596|P1|COMPLETED|Period 4||12
553982|NCT00708305|1350593|P4|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
553983|NCT00708305|1350594|P3|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
553984|NCT00708305|1350595|P2|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
553985|NCT00708305|1350596|P1|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|12
553986|NCT00708305|1350593|P4|NOT COMPLETED|Period 3||0
553987|NCT00708305|1350594|P3|NOT COMPLETED|Period 3||0
553988|NCT00708305|1350595|P2|NOT COMPLETED|Period 3||2
553989|NCT00708305|1350596|P1|NOT COMPLETED|Period 3||1
553990|NCT00708305|1350593|P4|COMPLETED|Period 3||14
553991|NCT00708305|1350594|P3|COMPLETED|Period 3||14
553992|NCT00708305|1350595|P2|COMPLETED|Period 3||12
553993|NCT00708305|1350596|P1|COMPLETED|Period 3||14
553994|NCT00708305|1350593|P4|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
553995|NCT00708305|1350594|P3|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
553996|NCT00708305|1350595|P2|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
553997|NCT00708305|1350596|P1|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|15
553998|NCT00708305|1350593|P4|NOT COMPLETED|Period 2||1
553999|NCT00708305|1350594|P3|NOT COMPLETED|Period 2||0
554000|NCT00708305|1350595|P2|NOT COMPLETED|Period 2||2
554001|NCT00708305|1350596|P1|NOT COMPLETED|Period 2||1
554002|NCT00708305|1350593|P4|COMPLETED|Period 2||14
554003|NCT00708305|1350594|P3|COMPLETED|Period 2||16
554004|NCT00708305|1350595|P2|COMPLETED|Period 2||13
554005|NCT00708305|1350596|P1|COMPLETED|Period 2||14
554006|NCT00708305|1350593|P4|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
554007|NCT00708305|1350594|P3|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|16
554008|NCT00708305|1350595|P2|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
554009|NCT00708305|1350596|P1|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
554010|NCT00708305|1350593|P4|NOT COMPLETED|Period 1||2
554011|NCT00708305|1350594|P3|NOT COMPLETED|Period 1||1
554012|NCT00708305|1350595|P2|NOT COMPLETED|Period 1||0
554013|NCT00708305|1350596|P1|NOT COMPLETED|Period 1||1
554014|NCT00708305|1350593|P4|COMPLETED|Period 1||14
554015|NCT00708305|1350594|P3|COMPLETED|Period 1||16
554016|NCT00708305|1350595|P2|COMPLETED|Period 1||16
554017|NCT00708305|1350596|P1|COMPLETED|Period 1||15
554018|NCT00708305|1350593|P4|STARTED|Period 1||16
554019|NCT00708305|1350594|P3|STARTED|Period 1||17
554020|NCT00708305|1350595|P2|STARTED|Period 1||16
554021|NCT00708305|1350596|P1|STARTED|Period 1||16
554022|NCT00708227|1350632|P4|NOT COMPLETED|Overall Study||3
554023|NCT00708227|1350633|P3|NOT COMPLETED|Overall Study||1
554024|NCT00708227|1350634|P2|NOT COMPLETED|Overall Study||5
554025|NCT00708227|1350635|P1|NOT COMPLETED|Overall Study||1
554026|NCT00708227|1350632|P4|COMPLETED|Overall Study||22
554027|NCT00708227|1350633|P3|COMPLETED|Overall Study||17
554028|NCT00708227|1350634|P2|COMPLETED|Overall Study||21
554029|NCT00708227|1350635|P1|COMPLETED|Overall Study||18
554030|NCT00708227|1350632|P4|STARTED|Overall Study||25
554031|NCT00708227|1350633|P3|STARTED|Overall Study||18
554032|NCT00708227|1350634|P2|STARTED|Overall Study||26
554033|NCT00708227|1350635|P1|STARTED|Overall Study||19
554034|NCT00708214|1350668|P3|NOT COMPLETED|Overall Study||8
554035|NCT00708214|1350669|P2|NOT COMPLETED|Overall Study||13
554036|NCT00708214|1350670|P1|NOT COMPLETED|Overall Study||7
554037|NCT00708214|1350668|P3|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
554038|NCT00708214|1350669|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
554039|NCT00708214|1350670|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
554040|NCT00708214|1350668|P3|STARTED|Overall Study||8
554041|NCT00708214|1350669|P2|STARTED|Overall Study||13
554042|NCT00708214|1350670|P1|STARTED|Overall Study||7
554043|NCT00708201|1350713|P2|NOT COMPLETED|Overall Study||6
554044|NCT00708201|1350714|P1|NOT COMPLETED|Overall Study||7
554045|NCT00708201|1350713|P2|COMPLETED|Overall Study||137
554046|NCT00708201|1350714|P1|COMPLETED|Overall Study||130
554047|NCT00708201|1350713|P2|Received at Least 1 Dose of Study Drug|Overall Study||137
554048|NCT00708201|1350714|P1|Received at Least 1 Dose of Study Drug|Overall Study||130
554049|NCT00708201|1350713|P2|STARTED|Overall Study||143
554050|NCT00708201|1350714|P1|STARTED|Overall Study||137
554051|NCT00708175|1350738|P2|NOT COMPLETED|Overall Study||21
554052|NCT00708175|1350739|P1|NOT COMPLETED|Overall Study||18
554053|NCT00708175|1350738|P2|COMPLETED|Overall Study||57
554054|NCT00708175|1350739|P1|COMPLETED|Overall Study||60
554055|NCT00708175|1350738|P2|STARTED|Overall Study||78
554056|NCT00708175|1350739|P1|STARTED|Overall Study||78
554057|NCT00708162|1350755|P2|NOT COMPLETED|Open-Label Phase||30
554058|NCT00708162|1350756|P1|NOT COMPLETED|Open-Label Phase||44
554059|NCT00708162|1350755|P2|COMPLETED|Open-Label Phase||121
554060|NCT00708162|1350756|P1|COMPLETED|Open-Label Phase||152
554061|NCT00708162|1350755|P2|STARTED|Open-Label Phase|58 participants completing the Randomized Phase did not continue to the Open-Label Phase.|151
554062|NCT00708162|1350756|P1|STARTED|Open-Label Phase|9 participants completing the Randomized Phase did not continue to the Open-Label Phase.|196
554063|NCT00708162|1350755|P2|NOT COMPLETED|Randomized Phase||154
554064|NCT00708162|1350756|P1|NOT COMPLETED|Randomized Phase||156
554065|NCT00708162|1350755|P2|COMPLETED|Randomized Phase||209
554066|NCT00708162|1350756|P1|COMPLETED|Randomized Phase||205
554067|NCT00708162|1350755|P2|Randomized and Treated|Randomized Phase||358
554068|NCT00708162|1350756|P1|Randomized and Treated|Randomized Phase||354
554069|NCT00708162|1350755|P2|STARTED|Randomized Phase||363
554070|NCT00708162|1350756|P1|STARTED|Randomized Phase||361
554071|NCT00708123|1350797|P5|NOT COMPLETED|Period 5||0
554072|NCT00708123|1350798|P4|NOT COMPLETED|Period 5||0
554073|NCT00708123|1350799|P3|NOT COMPLETED|Period 5||0
554074|NCT00708123|1350800|P2|NOT COMPLETED|Period 5||0
554075|NCT00708123|1350801|P1|NOT COMPLETED|Period 5||0
554076|NCT00708123|1350797|P5|COMPLETED|Period 5||10
554077|NCT00708123|1350798|P4|COMPLETED|Period 5||11
554078|NCT00708123|1350799|P3|COMPLETED|Period 5||11
554079|NCT00708123|1350800|P2|COMPLETED|Period 5||10
554080|NCT00708123|1350801|P1|COMPLETED|Period 5||10
554081|NCT00708123|1350797|P5|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
554082|NCT00708123|1350798|P4|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|11
554083|NCT00708123|1350799|P3|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|11
554084|NCT00708123|1350800|P2|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
554085|NCT00708123|1350801|P1|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
554086|NCT00708123|1350797|P5|NOT COMPLETED|Period 4||0
554087|NCT00708123|1350798|P4|NOT COMPLETED|Period 4||0
554088|NCT00708123|1350799|P3|NOT COMPLETED|Period 4||0
554089|NCT00708123|1350800|P2|NOT COMPLETED|Period 4||1
554090|NCT00708123|1350801|P1|NOT COMPLETED|Period 4||0
554091|NCT00708123|1350797|P5|COMPLETED|Period 4||11
554092|NCT00708123|1350798|P4|COMPLETED|Period 4||10
554093|NCT00708123|1350799|P3|COMPLETED|Period 4||10
554094|NCT00708123|1350800|P2|COMPLETED|Period 4||11
554095|NCT00708123|1350801|P1|COMPLETED|Period 4||10
554096|NCT00708123|1350797|P5|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|11
554097|NCT00708123|1350798|P4|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
554098|NCT00708123|1350799|P3|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
554099|NCT00708123|1350800|P2|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|12
554100|NCT00708123|1350801|P1|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
554101|NCT00708123|1350797|P5|NOT COMPLETED|Period 3||0
554102|NCT00708123|1350798|P4|NOT COMPLETED|Period 3||1
554103|NCT00708123|1350799|P3|NOT COMPLETED|Period 3||1
554104|NCT00708123|1350800|P2|NOT COMPLETED|Period 3||0
554105|NCT00708123|1350801|P1|NOT COMPLETED|Period 3||0
554106|NCT00708123|1350797|P5|COMPLETED|Period 3||10
554107|NCT00708123|1350798|P4|COMPLETED|Period 3||11
554108|NCT00708123|1350799|P3|COMPLETED|Period 3||10
554109|NCT00708123|1350800|P2|COMPLETED|Period 3||10
554110|NCT00708123|1350801|P1|COMPLETED|Period 3||12
554111|NCT00708123|1350797|P5|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|10
554112|NCT00708123|1350798|P4|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|12
554113|NCT00708123|1350799|P3|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|11
554114|NCT00708123|1350800|P2|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|10
554115|NCT00708123|1350801|P1|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|12
554116|NCT00708123|1350797|P5|NOT COMPLETED|Period 2||0
554117|NCT00708123|1350798|P4|NOT COMPLETED|Period 2||1
554118|NCT00708123|1350799|P3|NOT COMPLETED|Period 2||0
554119|NCT00708123|1350800|P2|NOT COMPLETED|Period 2||0
554120|NCT00708123|1350801|P1|NOT COMPLETED|Period 2||1
554121|NCT00708123|1350797|P5|COMPLETED|Period 2||11
554122|NCT00708123|1350798|P4|COMPLETED|Period 2||10
554123|NCT00708123|1350799|P3|COMPLETED|Period 2||12
554124|NCT00708123|1350800|P2|COMPLETED|Period 2||12
554125|NCT00708123|1350801|P1|COMPLETED|Period 2||10
554126|NCT00708123|1350797|P5|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
554127|NCT00708123|1350798|P4|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
554128|NCT00708123|1350799|P3|STARTED|Period 2|Due to crossover design,different set of participants received this treatment compared to Period 1|12
554129|NCT00708123|1350800|P2|STARTED|Period 2|Due to crossover design,different set of participants received this treatment compared to Period 1|12
554130|NCT00708123|1350801|P1|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
554131|NCT00708123|1350797|P5|NOT COMPLETED|Period 1||0
554132|NCT00708123|1350798|P4|NOT COMPLETED|Period 1||1
554133|NCT00708123|1350799|P3|NOT COMPLETED|Period 1||1
554134|NCT00708123|1350800|P2|NOT COMPLETED|Period 1||1
554135|NCT00708123|1350801|P1|NOT COMPLETED|Period 1||0
554136|NCT00708123|1350797|P5|COMPLETED|Period 1||12
554137|NCT00708123|1350798|P4|COMPLETED|Period 1||11
554138|NCT00708123|1350799|P3|COMPLETED|Period 1||11
554139|NCT00708123|1350800|P2|COMPLETED|Period 1||11
554140|NCT00708123|1350801|P1|COMPLETED|Period 1||12
554141|NCT00708123|1350797|P5|STARTED|Period 1||12
554142|NCT00708123|1350798|P4|STARTED|Period 1||12
554143|NCT00708123|1350799|P3|STARTED|Period 1||12
554144|NCT00708123|1350800|P2|STARTED|Period 1||12
554145|NCT00708123|1350801|P1|STARTED|Period 1||12
554146|NCT00708110|1350825|P4|NOT COMPLETED|Overall Study||0
554147|NCT00708110|1350826|P3|NOT COMPLETED|Overall Study||0
554148|NCT00708110|1350827|P2|NOT COMPLETED|Overall Study||0
554149|NCT00708110|1350828|P1|NOT COMPLETED|Overall Study||0
554150|NCT00708110|1350825|P4|COMPLETED|Overall Study||10
554151|NCT00708110|1350826|P3|COMPLETED|Overall Study||9
554152|NCT00708110|1350827|P2|COMPLETED|Overall Study||9
554153|NCT00708110|1350828|P1|COMPLETED|Overall Study||7
554154|NCT00708110|1350825|P4|STARTED|Overall Study||10
554155|NCT00708110|1350826|P3|STARTED|Overall Study||9
554156|NCT00708110|1350827|P2|STARTED|Overall Study||9
554157|NCT00708110|1350828|P1|STARTED|Overall Study||7
554158|NCT00708097|1350934|P5|NOT COMPLETED|Period 5||0
554159|NCT00708097|1350935|P4|NOT COMPLETED|Period 5||0
554160|NCT00708097|1350936|P3|NOT COMPLETED|Period 5||0
554161|NCT00708097|1350937|P2|NOT COMPLETED|Period 5||0
554162|NCT00708097|1350938|P1|NOT COMPLETED|Period 5||0
554163|NCT00708097|1350934|P5|COMPLETED|Period 5||12
554164|NCT00708097|1350935|P4|COMPLETED|Period 5||10
554165|NCT00708097|1350936|P3|COMPLETED|Period 5||11
554166|NCT00708097|1350937|P2|COMPLETED|Period 5||9
554167|NCT00708097|1350938|P1|COMPLETED|Period 5||8
554168|NCT00708097|1350934|P5|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|12
554169|NCT00708097|1350935|P4|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|10
554170|NCT00708097|1350936|P3|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|11
554171|NCT00708097|1350937|P2|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|9
554172|NCT00708097|1350938|P1|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|8
554173|NCT00708097|1350934|P5|NOT COMPLETED|Period 4||0
554174|NCT00708097|1350935|P4|NOT COMPLETED|Period 4||0
554175|NCT00708097|1350936|P3|NOT COMPLETED|Period 4||0
554176|NCT00708097|1350937|P2|NOT COMPLETED|Period 4||0
554177|NCT00708097|1350938|P1|NOT COMPLETED|Period 4||0
554178|NCT00708097|1350934|P5|COMPLETED|Period 4||8
554179|NCT00708097|1350935|P4|COMPLETED|Period 4||11
554180|NCT00708097|1350936|P3|COMPLETED|Period 4||10
554181|NCT00708097|1350937|P2|COMPLETED|Period 4||9
554182|NCT00708097|1350938|P1|COMPLETED|Period 4||12
554183|NCT00708097|1350934|P5|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|8
554184|NCT00708097|1350935|P4|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|11
554185|NCT00708097|1350936|P3|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|10
554186|NCT00708097|1350937|P2|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|9
554187|NCT00708097|1350938|P1|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|12
554188|NCT00708097|1350934|P5|NOT COMPLETED|Period 3||0
554189|NCT00708097|1350935|P4|NOT COMPLETED|Period 3||0
554190|NCT00708097|1350936|P3|NOT COMPLETED|Period 3||0
554191|NCT00708097|1350937|P2|NOT COMPLETED|Period 3||0
554192|NCT00708097|1350938|P1|NOT COMPLETED|Period 3||0
554193|NCT00708097|1350934|P5|COMPLETED|Period 3||10
554194|NCT00708097|1350935|P4|COMPLETED|Period 3||10
554195|NCT00708097|1350936|P3|COMPLETED|Period 3||10
554196|NCT00708097|1350937|P2|COMPLETED|Period 3||11
554197|NCT00708097|1350938|P1|COMPLETED|Period 3||9
554198|NCT00708097|1350934|P5|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
554199|NCT00708097|1350935|P4|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
554200|NCT00708097|1350936|P3|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
554201|NCT00708097|1350937|P2|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|11
554202|NCT00708097|1350938|P1|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|9
554203|NCT00708097|1350934|P5|NOT COMPLETED|Period 2||0
554204|NCT00708097|1350935|P4|NOT COMPLETED|Period 2||1
554205|NCT00708097|1350936|P3|NOT COMPLETED|Period 2||1
554206|NCT00708097|1350937|P2|NOT COMPLETED|Period 2||1
554207|NCT00708097|1350938|P1|NOT COMPLETED|Period 2||0
554208|NCT00708097|1350934|P5|COMPLETED|Period 2||10
554209|NCT00708097|1350935|P4|COMPLETED|Period 2||10
554210|NCT00708097|1350936|P3|COMPLETED|Period 2||9
554211|NCT00708097|1350937|P2|COMPLETED|Period 2||11
554212|NCT00708097|1350938|P1|COMPLETED|Period 2||10
554213|NCT00708097|1350934|P5|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
554214|NCT00708097|1350935|P4|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|11
554215|NCT00708097|1350936|P3|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
554400|NCT00706966|1351526|P1|NOT COMPLETED|Overall Study||1
554216|NCT00708097|1350937|P2|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|12
554217|NCT00708097|1350938|P1|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
554218|NCT00708097|1350934|P5|NOT COMPLETED|Period 1||1
554219|NCT00708097|1350935|P4|NOT COMPLETED|Period 1||2
554220|NCT00708097|1350936|P3|NOT COMPLETED|Period 1||0
554221|NCT00708097|1350937|P2|NOT COMPLETED|Period 1||1
554222|NCT00708097|1350938|P1|NOT COMPLETED|Period 1||0
554223|NCT00708097|1350934|P5|COMPLETED|Period 1||10
554224|NCT00708097|1350935|P4|COMPLETED|Period 1||9
554225|NCT00708097|1350936|P3|COMPLETED|Period 1||12
554226|NCT00708097|1350937|P2|COMPLETED|Period 1||11
554227|NCT00708097|1350938|P1|COMPLETED|Period 1||11
554228|NCT00708097|1350934|P5|STARTED|Period 1||11
554229|NCT00708097|1350935|P4|STARTED|Period 1||11
554230|NCT00708097|1350936|P3|STARTED|Period 1||12
554231|NCT00708097|1350937|P2|STARTED|Period 1||12
554232|NCT00708097|1350938|P1|STARTED|Period 1||11
554233|NCT00708071|1350968|P1|NOT COMPLETED|Overall Study||0
554234|NCT00708071|1350968|P1|COMPLETED|Overall Study||45
554235|NCT00708071|1350968|P1|STARTED|Overall Study|Randomized and treated|45
554236|NCT00708032|1351048|P2|NOT COMPLETED|Overall Study||16
554237|NCT00708032|1351049|P1|NOT COMPLETED|Overall Study||10
554238|NCT00708032|1351048|P2|COMPLETED|Overall Study||22
554239|NCT00708032|1351049|P1|COMPLETED|Overall Study||26
554240|NCT00708032|1351048|P2|STARTED|Overall Study||38
554241|NCT00708032|1351049|P1|STARTED|Overall Study||36
554242|NCT00708019|1351065|P2|NOT COMPLETED|Overall Study||15
554243|NCT00708019|1351066|P1|NOT COMPLETED|Overall Study||15
554244|NCT00708019|1351065|P2|COMPLETED|Overall Study||78
554245|NCT00708019|1351066|P1|COMPLETED|Overall Study||77
554246|NCT00708019|1351065|P2|STARTED|Overall Study||93
554247|NCT00708019|1351066|P1|STARTED|Overall Study||92
554248|NCT00707993|1351076|P2|NOT COMPLETED|Overall Study||94
554249|NCT00707993|1351077|P1|NOT COMPLETED|Overall Study||89
554250|NCT00707993|1351076|P2|COMPLETED|Overall Study||125
554251|NCT00707993|1351077|P1|COMPLETED|Overall Study||133
554252|NCT00707993|1351076|P2|STARTED|Overall Study||219
554253|NCT00707993|1351077|P1|STARTED|Overall Study||222
554254|NCT00707980|1351119|P1|NOT COMPLETED|Overall Study||310
554255|NCT00707980|1351119|P1|COMPLETED|Overall Study||526
554256|NCT00707980|1351119|P1|Received Treatment|Overall Study||834
554257|NCT00707980|1351119|P1|STARTED|Overall Study||836
554258|NCT00707967|1351137|P3|NOT COMPLETED|Overall Study||0
554259|NCT00707967|1351138|P2|NOT COMPLETED|Overall Study||0
554260|NCT00707967|1351139|P1|NOT COMPLETED|Overall Study||0
554261|NCT00707967|1351137|P3|COMPLETED|Overall Study||7
554262|NCT00707967|1351138|P2|COMPLETED|Overall Study||8
554263|NCT00707967|1351139|P1|COMPLETED|Overall Study||22
554264|NCT00707967|1351137|P3|STARTED|Overall Study||7
554265|NCT00707967|1351138|P2|STARTED|Overall Study||8
554266|NCT00707967|1351139|P1|STARTED|Overall Study||22
554267|NCT00707954|1351203|P5|NOT COMPLETED|Overall Study||1
554268|NCT00707954|1351204|P4|NOT COMPLETED|Overall Study||0
554269|NCT00707954|1351205|P3|NOT COMPLETED|Overall Study||0
554270|NCT00707954|1351206|P2|NOT COMPLETED|Overall Study||0
554271|NCT00707954|1351207|P1|NOT COMPLETED|Overall Study||0
554272|NCT00707954|1351203|P5|COMPLETED|Overall Study||9
554273|NCT00707954|1351204|P4|COMPLETED|Overall Study||13
554274|NCT00707954|1351205|P3|COMPLETED|Overall Study||14
554275|NCT00707954|1351206|P2|COMPLETED|Overall Study||12
554276|NCT00707954|1351207|P1|COMPLETED|Overall Study||12
554277|NCT00707954|1351203|P5|STARTED|Overall Study||10
554278|NCT00707954|1351204|P4|STARTED|Overall Study||13
554279|NCT00707954|1351205|P3|STARTED|Overall Study||14
554280|NCT00707954|1351206|P2|STARTED|Overall Study||12
554281|NCT00707954|1351207|P1|STARTED|Overall Study||12
554282|NCT00707915|1351219|P1|NOT COMPLETED|Overall Study||0
554283|NCT00707915|1351219|P1|COMPLETED|Overall Study||30
554284|NCT00707915|1351219|P1|Effects of Discontinuing Benzodiazepine|Overall Study||30
554285|NCT00707915|1351219|P1|STARTED|Overall Study||30
554286|NCT00707863|1351230|P2|NOT COMPLETED|Overall Study||3
554287|NCT00707863|1351231|P1|NOT COMPLETED|Overall Study||0
554288|NCT00707863|1351230|P2|COMPLETED|Overall Study||8
554289|NCT00707863|1351231|P1|COMPLETED|Overall Study||6
554290|NCT00707863|1351230|P2|STARTED|Overall Study||11
554291|NCT00707863|1351231|P1|STARTED|Overall Study||6
554292|NCT00707759|1351239|P2|NOT COMPLETED|Overall Study||2
554293|NCT00707759|1351240|P1|NOT COMPLETED|Overall Study||2
554294|NCT00707759|1351239|P2|COMPLETED|Overall Study||12
554295|NCT00707759|1351240|P1|COMPLETED|Overall Study||12
554296|NCT00707759|1351239|P2|STARTED|Overall Study||14
554297|NCT00707759|1351240|P1|STARTED|Overall Study||14
554298|NCT00707746|1351248|P2|NOT COMPLETED|Follow-up Period||0
554299|NCT00707746|1351249|P1|NOT COMPLETED|Follow-up Period||0
554300|NCT00707746|1351248|P2|COMPLETED|Follow-up Period||21
554301|NCT00707746|1351249|P1|COMPLETED|Follow-up Period||12
554302|NCT00707746|1351248|P2|STARTED|Follow-up Period||21
554303|NCT00707746|1351249|P1|STARTED|Follow-up Period||12
554304|NCT00707746|1351248|P2|NOT COMPLETED|Treatment Period||5
554305|NCT00707746|1351249|P1|NOT COMPLETED|Treatment Period||2
554306|NCT00707746|1351248|P2|COMPLETED|Treatment Period||17
554307|NCT00707746|1351249|P1|COMPLETED|Treatment Period||10
554308|NCT00707746|1351248|P2|Full Analysis Set (FAS) and Safety Set|Treatment Period|FAS: Treated patients with a valid baseline & post-baseline LDL-C measurement|21
554309|NCT00707746|1351249|P1|Full Analysis Set (FAS) and Safety Set|Treatment Period|FAS: Treated patients with a valid baseline & post-baseline LDL-C measurement|12
554310|NCT00707746|1351248|P2|STARTED|Treatment Period||22
554311|NCT00707746|1351249|P1|STARTED|Treatment Period||12
554312|NCT00707655|1351297|P2|NOT COMPLETED|Overall Study||2
554313|NCT00707655|1351298|P1|NOT COMPLETED|Overall Study||0
554314|NCT00707655|1351297|P2|COMPLETED|Overall Study||3
554315|NCT00707655|1351298|P1|COMPLETED|Overall Study||3
554316|NCT00707655|1351297|P2|STARTED|Overall Study||5
554317|NCT00707655|1351298|P1|STARTED|Overall Study||3
554318|NCT00707577|1351310|P2|NOT COMPLETED|Overall Study||38
554319|NCT00707577|1351311|P1|NOT COMPLETED|Overall Study||54
554320|NCT00707577|1351310|P2|COMPLETED|Overall Study||118
554321|NCT00707577|1351311|P1|COMPLETED|Overall Study||120
554322|NCT00707577|1351310|P2|STARTED|Overall Study||156
554323|NCT00707577|1351311|P1|STARTED|Overall Study||174
554324|NCT00707486|1351317|P1|NOT COMPLETED|Overall Study||1
554325|NCT00707486|1351317|P1|COMPLETED|Overall Study||71
554326|NCT00707486|1351317|P1|STARTED|Overall Study||72
554327|NCT00707447|1351328|P2|NOT COMPLETED|Overall Study||8
554328|NCT00707447|1351329|P1|NOT COMPLETED|Overall Study||8
554329|NCT00707447|1351328|P2|COMPLETED|Overall Study||85
554330|NCT00707447|1351329|P1|COMPLETED|Overall Study||81
554331|NCT00707447|1351328|P2|STARTED|Overall Study||93
554332|NCT00707447|1351329|P1|STARTED|Overall Study||89
554333|NCT00707343|1351353|P1|NOT COMPLETED|Overall Study||0
554334|NCT00707343|1351353|P1|COMPLETED|Overall Study||15
554335|NCT00707343|1351353|P1|STARTED|Overall Study||15
554336|NCT00707239|1351360|P3|NOT COMPLETED|Overall Study||14
554337|NCT00707239|1351361|P2|NOT COMPLETED|Overall Study||11
554338|NCT00707239|1351362|P1|NOT COMPLETED|Overall Study||19
554339|NCT00707239|1351360|P3|COMPLETED|Overall Study||21
554340|NCT00707239|1351361|P2|COMPLETED|Overall Study||25
554341|NCT00707239|1351362|P1|COMPLETED|Overall Study||18
554342|NCT00707239|1351360|P3|Treated|Overall Study||34
554343|NCT00707239|1351361|P2|Treated|Overall Study||35
554344|NCT00707239|1351362|P1|Treated|Overall Study||36
554345|NCT00707239|1351360|P3|STARTED|Overall Study||35
554346|NCT00707239|1351361|P2|STARTED|Overall Study||36
554347|NCT00707239|1351362|P1|STARTED|Overall Study||37
554348|NCT00707174|1351410|P2|NOT COMPLETED|Overall Study||7
554349|NCT00707174|1351411|P1|NOT COMPLETED|Overall Study||5
554350|NCT00707174|1351410|P2|COMPLETED|Overall Study||37
554351|NCT00707174|1351411|P1|COMPLETED|Overall Study||41
554352|NCT00707174|1351410|P2|STARTED|Overall Study||44
554353|NCT00707174|1351411|P1|STARTED|Overall Study||46
554354|NCT00707161|1351417|P1|NOT COMPLETED|Overall Study||6
554355|NCT00707161|1351417|P1|COMPLETED|Overall Study||0
554356|NCT00707161|1351417|P1|STARTED|Overall Study|3 deceased (1-Huntsman Cancer Institute, 2- LDS Hospital).|6
554357|NCT00707057|1351423|P2|NOT COMPLETED|Overall Study||4
554358|NCT00707057|1351424|P1|NOT COMPLETED|Overall Study||8
554359|NCT00707057|1351423|P2|COMPLETED|Overall Study||83
554360|NCT00707057|1351424|P1|COMPLETED|Overall Study||161
554361|NCT00707057|1351423|P2|STARTED|Overall Study||87
554362|NCT00707057|1351424|P1|STARTED|Overall Study||169
554363|NCT00707031|1351458|P2|NOT COMPLETED|Overall Study||99
554364|NCT00707031|1351459|P1|NOT COMPLETED|Overall Study||104
554365|NCT00707031|1351458|P2|COMPLETED|Overall Study||220
554366|NCT00707031|1351459|P1|COMPLETED|Overall Study||216
554367|NCT00707031|1351458|P2|Modified Intent-to-Treat Population|Overall Study||315
554368|NCT00707031|1351459|P1|Modified Intent-to-Treat Population|Overall Study|All patients who received at least 1 dose;had baseline;at least 1 post-baseline efficacy assessment.|315
554369|NCT00707031|1351458|P2|Treated/Safety Population|Overall Study||316
554370|NCT00707031|1351459|P1|Treated/Safety Population|Overall Study|All patients who received at least 1 dose, regardless of amount of treatment administered.|318
554371|NCT00707031|1351458|P2|STARTED|Overall Study||319
554372|NCT00707031|1351459|P1|STARTED|Overall Study|Randomized|320
554373|NCT00706992|1351488|P7|NOT COMPLETED|Overall Study||3
554374|NCT00706992|1351489|P6|NOT COMPLETED|Overall Study||2
554375|NCT00706992|1351490|P5|NOT COMPLETED|Overall Study||4
554376|NCT00706992|1351491|P4|NOT COMPLETED|Overall Study||2
554377|NCT00706992|1351492|P3|NOT COMPLETED|Overall Study||6
554378|NCT00706992|1351493|P2|NOT COMPLETED|Overall Study||5
554379|NCT00706992|1351494|P1|NOT COMPLETED|Overall Study||5
554380|NCT00706992|1351488|P7|COMPLETED|Overall Study||3
554381|NCT00706992|1351489|P6|COMPLETED|Overall Study||3
554382|NCT00706992|1351490|P5|COMPLETED|Overall Study||2
554383|NCT00706992|1351491|P4|COMPLETED|Overall Study||6
554384|NCT00706992|1351492|P3|COMPLETED|Overall Study||3
554385|NCT00706992|1351493|P2|COMPLETED|Overall Study||3
554386|NCT00706992|1351494|P1|COMPLETED|Overall Study||3
554387|NCT00706992|1351488|P7|STARTED|Overall Study||6
554388|NCT00706992|1351489|P6|STARTED|Overall Study||5
554389|NCT00706992|1351490|P5|STARTED|Overall Study||6
554390|NCT00706992|1351491|P4|STARTED|Overall Study||8
554391|NCT00706992|1351492|P3|STARTED|Overall Study||9
554392|NCT00706992|1351493|P2|STARTED|Overall Study||8
554393|NCT00706992|1351494|P1|STARTED|Overall Study||8
554394|NCT00706979|1351513|P2|NOT COMPLETED|Overall Study||0
554395|NCT00706979|1351514|P1|NOT COMPLETED|Overall Study||0
554396|NCT00706979|1351513|P2|COMPLETED|Overall Study||423
554397|NCT00706979|1351514|P1|COMPLETED|Overall Study||426
554398|NCT00706979|1351513|P2|STARTED|Overall Study||423
554399|NCT00706979|1351514|P1|STARTED|Overall Study||426
554401|NCT00706966|1351526|P1|COMPLETED|Overall Study||9
554402|NCT00706966|1351526|P1|STARTED|Overall Study||10
554403|NCT00706914|1351562|P3|NOT COMPLETED|Overall Study||1
554404|NCT00706914|1351563|P2|NOT COMPLETED|Overall Study||4
554405|NCT00706914|1351564|P1|NOT COMPLETED|Overall Study||6
554406|NCT00706914|1351562|P3|COMPLETED|Overall Study||30
554407|NCT00706914|1351563|P2|COMPLETED|Overall Study||58
554408|NCT00706914|1351564|P1|COMPLETED|Overall Study||57
554409|NCT00706914|1351562|P3|STARTED|Overall Study||31
554410|NCT00706914|1351563|P2|STARTED|Overall Study||62
554411|NCT00706914|1351564|P1|STARTED|Overall Study||63
554412|NCT00706901|1351587|P3|NOT COMPLETED|Overall Study||8
554413|NCT00706901|1351588|P2|NOT COMPLETED|Overall Study||5
554414|NCT00706901|1351589|P1|NOT COMPLETED|Overall Study||8
554415|NCT00706901|1351587|P3|COMPLETED|Overall Study||51
554416|NCT00706901|1351588|P2|COMPLETED|Overall Study||57
554417|NCT00706901|1351589|P1|COMPLETED|Overall Study||51
554418|NCT00706901|1351587|P3|STARTED|Overall Study||59
554419|NCT00706901|1351588|P2|STARTED|Overall Study||62
554420|NCT00706901|1351589|P1|STARTED|Overall Study||59
554421|NCT00706849|1351614|P2|NOT COMPLETED|Follow-up Period||3
554422|NCT00706849|1351615|P1|NOT COMPLETED|Follow-up Period||0
554423|NCT00706849|1351614|P2|COMPLETED|Follow-up Period||25
554424|NCT00706849|1351615|P1|COMPLETED|Follow-up Period||3
554425|NCT00706849|1351614|P2|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|28
554426|NCT00706849|1351615|P1|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|3
554427|NCT00706849|1351614|P2|NOT COMPLETED|Treatment Period||10
554428|NCT00706849|1351615|P1|NOT COMPLETED|Treatment Period||0
554429|NCT00706849|1351614|P2|COMPLETED|Treatment Period|55 patients entered the open-label extension study (301012-CS6; NCT00694109).|73
554430|NCT00706849|1351615|P1|COMPLETED|Treatment Period|38 patients entered the open-label extension study (301012-CS6; NCT00694109).|41
554431|NCT00706849|1351614|P2|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement.|82
554432|NCT00706849|1351615|P1|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|41
554433|NCT00706849|1351614|P2|STARTED|Treatment Period||83
554434|NCT00706849|1351615|P1|STARTED|Treatment Period||41
554435|NCT00706836|1351659|P1|NOT COMPLETED|Overall Study||0
554436|NCT00706836|1351659|P1|COMPLETED|Overall Study||16
554437|NCT00706836|1351659|P1|STARTED|Overall Study||16
554438|NCT00706823|1351669|P2|NOT COMPLETED|Overall Study||0
554439|NCT00706823|1351670|P1|NOT COMPLETED|Overall Study||0
554440|NCT00706823|1351669|P2|COMPLETED|Overall Study||25
554441|NCT00706823|1351670|P1|COMPLETED|Overall Study||25
554442|NCT00706823|1351669|P2|STARTED|Overall Study||25
554443|NCT00706823|1351670|P1|STARTED|Overall Study||25
554444|NCT00706810|1351686|P1|NOT COMPLETED|Overall Study||1
554445|NCT00706810|1351686|P1|COMPLETED|Overall Study||7
554446|NCT00706810|1351686|P1|STARTED|Overall Study||8
554447|NCT00706797|1351693|P2|NOT COMPLETED|Overall Study||71
554448|NCT00706797|1351694|P1|NOT COMPLETED|Overall Study||69
554449|NCT00706797|1351693|P2|COMPLETED|Overall Study||0
554450|NCT00706797|1351694|P1|COMPLETED|Overall Study||1
554451|NCT00706797|1351693|P2|Safety Population|Overall Study||71
554452|NCT00706797|1351694|P1|Safety Population|Overall Study|Safety population=all randomly assigned subjects who had at least 1 dose of study treatment.|63
554453|NCT00706797|1351693|P2|STARTED|Overall Study||71
554454|NCT00706797|1351694|P1|STARTED|Overall Study||70
554455|NCT00706784|1351736|P2|NOT COMPLETED|Overall Study||0
554456|NCT00706784|1351737|P1|NOT COMPLETED|Overall Study||0
554457|NCT00706784|1351736|P2|COMPLETED|Overall Study||3
554458|NCT00706784|1351737|P1|COMPLETED|Overall Study||3
554459|NCT00706784|1351736|P2|STARTED|Overall Study||3
554460|NCT00706784|1351737|P1|STARTED|Overall Study||3
554461|NCT00706719|1351746|P3|NOT COMPLETED|Overall Study||4
554462|NCT00706719|1351747|P2|NOT COMPLETED|Overall Study||1
554463|NCT00706719|1351748|P1|NOT COMPLETED|Overall Study||0
554464|NCT00706719|1351746|P3|COMPLETED|Overall Study||1
554465|NCT00706719|1351747|P2|COMPLETED|Overall Study||6
554466|NCT00706719|1351748|P1|COMPLETED|Overall Study||5
554467|NCT00706719|1351746|P3|STARTED|Overall Study||5
554468|NCT00706719|1351747|P2|STARTED|Overall Study||7
554469|NCT00706719|1351748|P1|STARTED|Overall Study||5
554470|NCT00706706|1351763|P1|NOT COMPLETED|Overall Study||105
554471|NCT00706706|1351763|P1|COMPLETED|Overall Study||0
554472|NCT00706706|1351763|P1|STARTED|Overall Study||105
554473|NCT00706654|1351773|P4|NOT COMPLETED|Depot Maintenance Phase||70
554474|NCT00706654|1351774|P3|NOT COMPLETED|Depot Maintenance Phase||88
554475|NCT00706654|1351775|P2|NOT COMPLETED|Depot Maintenance Phase||69
554476|NCT00706654|1351776|P1|NOT COMPLETED|Depot Maintenance Phase||0
554477|NCT00706654|1351773|P4|COMPLETED|Depot Maintenance Phase||61
554478|NCT00706654|1351774|P3|COMPLETED|Depot Maintenance Phase||178
554479|NCT00706654|1351775|P2|COMPLETED|Depot Maintenance Phase||196
554480|NCT00706654|1351776|P1|COMPLETED|Depot Maintenance Phase||0
554481|NCT00706654|1351773|P4|STARTED|Depot Maintenance Phase||131
554482|NCT00706654|1351774|P3|STARTED|Depot Maintenance Phase||266
554483|NCT00706654|1351775|P2|STARTED|Depot Maintenance Phase||265
554484|NCT00706654|1351776|P1|STARTED|Depot Maintenance Phase|Patients were randomized into the 3 aripiprazole treatment groups in this phase of the study.|0
554485|NCT00706654|1351773|P4|NOT COMPLETED|Oral Stabilization Phase||0
554486|NCT00706654|1351774|P3|NOT COMPLETED|Oral Stabilization Phase||0
554487|NCT00706654|1351775|P2|NOT COMPLETED|Oral Stabilization Phase||0
554488|NCT00706654|1351776|P1|NOT COMPLETED|Oral Stabilization Phase||180
554489|NCT00706654|1351773|P4|COMPLETED|Oral Stabilization Phase||0
554490|NCT00706654|1351774|P3|COMPLETED|Oral Stabilization Phase||0
554491|NCT00706654|1351775|P2|COMPLETED|Oral Stabilization Phase||0
554492|NCT00706654|1351776|P1|COMPLETED|Oral Stabilization Phase||662
554493|NCT00706654|1351773|P4|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
554494|NCT00706654|1351774|P3|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
554495|NCT00706654|1351775|P2|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
554496|NCT00706654|1351776|P1|STARTED|Oral Stabilization Phase|228 of the 842 patients who started this phase enrolled directly into this phase of the study.|842
554497|NCT00706654|1351773|P4|NOT COMPLETED|Conversion Phase||0
554498|NCT00706654|1351774|P3|NOT COMPLETED|Conversion Phase||0
554499|NCT00706654|1351775|P2|NOT COMPLETED|Conversion Phase||0
554500|NCT00706654|1351776|P1|NOT COMPLETED|Conversion Phase||95
554501|NCT00706654|1351773|P4|COMPLETED|Conversion Phase||0
554502|NCT00706654|1351774|P3|COMPLETED|Conversion Phase||0
554503|NCT00706654|1351775|P2|COMPLETED|Conversion Phase||0
554504|NCT00706654|1351776|P1|COMPLETED|Conversion Phase||614
554505|NCT00706654|1351773|P4|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
554506|NCT00706654|1351774|P3|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
554507|NCT00706654|1351775|P2|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
554508|NCT00706654|1351776|P1|STARTED|Conversion Phase||709
554509|NCT00706641|1351795|P1|NOT COMPLETED|Radical Cystectomy||1
554510|NCT00706641|1351795|P1|COMPLETED|Radical Cystectomy||22
554511|NCT00706641|1351795|P1|STARTED|Radical Cystectomy||23
554512|NCT00706641|1351795|P1|NOT COMPLETED|Dasatinib Administration||2
554513|NCT00706641|1351795|P1|COMPLETED|Dasatinib Administration||23
554514|NCT00706641|1351795|P1|Toxicity Evaluation|Dasatinib Administration||24
554515|NCT00706641|1351795|P1|STARTED|Dasatinib Administration||25
554516|NCT00706628|1351809|P4|NOT COMPLETED|Overall Study||3
554517|NCT00706628|1351810|P3|NOT COMPLETED|Overall Study||16
554518|NCT00706628|1351811|P2|NOT COMPLETED|Overall Study||21
554519|NCT00706628|1351812|P1|NOT COMPLETED|Overall Study||47
554520|NCT00706628|1351809|P4|COMPLETED|Overall Study||0
554521|NCT00706628|1351810|P3|COMPLETED|Overall Study||0
554522|NCT00706628|1351811|P2|COMPLETED|Overall Study||0
554523|NCT00706628|1351812|P1|COMPLETED|Overall Study||0
554524|NCT00706628|1351809|P4|STARTED|Overall Study||3
554525|NCT00706628|1351810|P3|STARTED|Overall Study||16
554526|NCT00706628|1351811|P2|STARTED|Overall Study||21
554527|NCT00706628|1351812|P1|STARTED|Overall Study||47
554528|NCT00706589|1351862|P2|NOT COMPLETED|Overall Study||4
554529|NCT00706589|1351863|P1|NOT COMPLETED|Overall Study||3
554530|NCT00706589|1351862|P2|COMPLETED|Overall Study||25
554531|NCT00706589|1351863|P1|COMPLETED|Overall Study||29
554532|NCT00706589|1351862|P2|STARTED|Overall Study||29
554533|NCT00706589|1351863|P1|STARTED|Overall Study||32
554534|NCT00706563|1351871|P2|NOT COMPLETED|Overall Study||0
554535|NCT00706563|1351872|P1|NOT COMPLETED|Overall Study||0
554536|NCT00706563|1351871|P2|COMPLETED|Overall Study||59
554537|NCT00706563|1351872|P1|COMPLETED|Overall Study||61
554538|NCT00706563|1351871|P2|STARTED|Overall Study||59
554539|NCT00706563|1351872|P1|STARTED|Overall Study||61
554540|NCT00706550|1351896|P2|NOT COMPLETED|Overall Study||28
554541|NCT00706550|1351897|P1|NOT COMPLETED|Overall Study||7
554542|NCT00706550|1351896|P2|COMPLETED|Overall Study||36
554543|NCT00706550|1351897|P1|COMPLETED|Overall Study||36
554544|NCT00706550|1351896|P2|STARTED|Overall Study||64
554545|NCT00706550|1351897|P1|STARTED|Overall Study||43
554546|NCT00706485|1351913|P1|NOT COMPLETED|Overall Study||0
554547|NCT00706485|1351913|P1|COMPLETED|Overall Study||5
554548|NCT00706485|1351913|P1|STARTED|Overall Study||5
554549|NCT00706446|1351925|P6|NOT COMPLETED|Overall Study||38
554550|NCT00706446|1351926|P5|NOT COMPLETED|Overall Study||44
554551|NCT00706446|1351927|P4|NOT COMPLETED|Overall Study||22
554552|NCT00706446|1351928|P3|NOT COMPLETED|Overall Study||37
554553|NCT00706446|1351929|P2|NOT COMPLETED|Overall Study||49
554554|NCT00706446|1351930|P1|NOT COMPLETED|Overall Study||26
554555|NCT00706446|1351925|P6|COMPLETED|Overall Study||7
554556|NCT00706446|1351926|P5|COMPLETED|Overall Study||10
554557|NCT00706446|1351927|P4|COMPLETED|Overall Study||4
554558|NCT00706446|1351928|P3|COMPLETED|Overall Study||7
554559|NCT00706446|1351929|P2|COMPLETED|Overall Study||8
554560|NCT00706446|1351930|P1|COMPLETED|Overall Study||3
554561|NCT00706446|1351925|P6|STARTED|Overall Study||45
554562|NCT00706446|1351926|P5|STARTED|Overall Study||54
554563|NCT00706446|1351927|P4|STARTED|Overall Study||26
554564|NCT00706446|1351928|P3|STARTED|Overall Study||44
554565|NCT00706446|1351929|P2|STARTED|Overall Study||57
554566|NCT00706446|1351930|P1|STARTED|Overall Study||29
554567|NCT00706433|1351972|P4|NOT COMPLETED|Overall Study||2
554568|NCT00706433|1351973|P3|NOT COMPLETED|Overall Study||10
554569|NCT00706433|1351974|P2|NOT COMPLETED|Overall Study||3
554570|NCT00706433|1351975|P1|NOT COMPLETED|Overall Study||5
554571|NCT00706433|1351972|P4|COMPLETED|Overall Study||64
554572|NCT00706433|1351973|P3|COMPLETED|Overall Study||57
554573|NCT00706433|1351974|P2|COMPLETED|Overall Study||62
554574|NCT00706433|1351975|P1|COMPLETED|Overall Study||63
554575|NCT00706433|1351972|P4|STARTED|Overall Study||66
554576|NCT00706433|1351973|P3|STARTED|Overall Study||67
554577|NCT00706433|1351974|P2|STARTED|Overall Study||65
554578|NCT00706433|1351975|P1|STARTED|Overall Study||68
554579|NCT00706407|1352291|P1|NOT COMPLETED|Overall Study||9
554580|NCT00706407|1352291|P1|COMPLETED|Overall Study||33
554581|NCT00706407|1352291|P1|STARTED|Overall Study||42
554582|NCT00706355|1352302|P4|NOT COMPLETED|Period 4: PF-04217903 150 mg||4
554583|NCT00706355|1352303|P3|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
554584|NCT00706355|1352304|P2|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
554585|NCT00706355|1352305|P1|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
554586|NCT00706355|1352302|P4|COMPLETED|Period 4: PF-04217903 150 mg||0
554587|NCT00706355|1352303|P3|COMPLETED|Period 4: PF-04217903 150 mg||0
554588|NCT00706355|1352304|P2|COMPLETED|Period 4: PF-04217903 150 mg||0
554589|NCT00706355|1352305|P1|COMPLETED|Period 4: PF-04217903 150 mg||0
554590|NCT00706355|1352302|P4|STARTED|Period 4: PF-04217903 150 mg||4
554591|NCT00706355|1352303|P3|STARTED|Period 4: PF-04217903 150 mg||0
554592|NCT00706355|1352304|P2|STARTED|Period 4: PF-04217903 150 mg||0
554593|NCT00706355|1352305|P1|STARTED|Period 4: PF-04217903 150 mg||0
554594|NCT00706355|1352302|P4|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
554595|NCT00706355|1352303|P3|NOT COMPLETED|Period 3: PF-04217903 200 mg||2
554596|NCT00706355|1352304|P2|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
554597|NCT00706355|1352305|P1|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
554598|NCT00706355|1352302|P4|COMPLETED|Period 3: PF-04217903 200 mg||0
554599|NCT00706355|1352303|P3|COMPLETED|Period 3: PF-04217903 200 mg||0
554600|NCT00706355|1352304|P2|COMPLETED|Period 3: PF-04217903 200 mg||0
554601|NCT00706355|1352305|P1|COMPLETED|Period 3: PF-04217903 200 mg||0
554602|NCT00706355|1352302|P4|STARTED|Period 3: PF-04217903 200 mg||0
554603|NCT00706355|1352303|P3|STARTED|Period 3: PF-04217903 200 mg||2
554604|NCT00706355|1352304|P2|STARTED|Period 3: PF-04217903 200 mg||0
554605|NCT00706355|1352305|P1|STARTED|Period 3: PF-04217903 200 mg||0
554606|NCT00706355|1352302|P4|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
554607|NCT00706355|1352303|P3|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
554608|NCT00706355|1352304|P2|NOT COMPLETED|Period 2: PF-04217903 100 mg||7
554609|NCT00706355|1352305|P1|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
554610|NCT00706355|1352302|P4|COMPLETED|Period 2: PF-04217903 100 mg||0
554611|NCT00706355|1352303|P3|COMPLETED|Period 2: PF-04217903 100 mg||0
554612|NCT00706355|1352304|P2|COMPLETED|Period 2: PF-04217903 100 mg||0
554613|NCT00706355|1352305|P1|COMPLETED|Period 2: PF-04217903 100 mg||0
554614|NCT00706355|1352302|P4|STARTED|Period 2: PF-04217903 100 mg||0
554615|NCT00706355|1352303|P3|STARTED|Period 2: PF-04217903 100 mg||0
554616|NCT00706355|1352304|P2|STARTED|Period 2: PF-04217903 100 mg||7
554617|NCT00706355|1352305|P1|STARTED|Period 2: PF-04217903 100 mg||0
554618|NCT00706355|1352302|P4|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
554619|NCT00706355|1352303|P3|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
554620|NCT00706355|1352304|P2|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
554621|NCT00706355|1352305|P1|NOT COMPLETED|Period 1: PF-04217903 50 mg||3
554622|NCT00706355|1352302|P4|COMPLETED|Period 1: PF-04217903 50 mg||0
554623|NCT00706355|1352303|P3|COMPLETED|Period 1: PF-04217903 50 mg||0
554624|NCT00706355|1352304|P2|COMPLETED|Period 1: PF-04217903 50 mg||0
554625|NCT00706355|1352305|P1|COMPLETED|Period 1: PF-04217903 50 mg||0
554626|NCT00706355|1352302|P4|STARTED|Period 1: PF-04217903 50 mg||0
554627|NCT00706355|1352303|P3|STARTED|Period 1: PF-04217903 50 mg||0
554628|NCT00706355|1352304|P2|STARTED|Period 1: PF-04217903 50 mg||0
554629|NCT00706355|1352305|P1|STARTED|Period 1: PF-04217903 50 mg||3
554630|NCT00706342|1352357|P1|NOT COMPLETED|Overall Study||18
554631|NCT00706342|1352357|P1|COMPLETED|Overall Study||0
554632|NCT00706342|1352357|P1|STARTED|Overall Study||18
554633|NCT00706329|1352366|P1|NOT COMPLETED|Overall Study||0
554634|NCT00706329|1352366|P1|COMPLETED|Overall Study||25
554635|NCT00706329|1352366|P1|STARTED|Overall Study||25
554636|NCT00706134|1352374|P4|NOT COMPLETED|Overall Study||11
554637|NCT00706134|1352375|P3|NOT COMPLETED|Overall Study||6
554638|NCT00706134|1352376|P2|NOT COMPLETED|Overall Study||19
554639|NCT00706134|1352377|P1|NOT COMPLETED|Overall Study||20
554640|NCT00706134|1352374|P4|COMPLETED|Overall Study||175
554641|NCT00706134|1352375|P3|COMPLETED|Overall Study||183
554642|NCT00706134|1352376|P2|COMPLETED|Overall Study||173
554643|NCT00706134|1352377|P1|COMPLETED|Overall Study||169
554644|NCT00706134|1352374|P4|Entered Double-blind Period|Overall Study||186
554645|NCT00706134|1352375|P3|Entered Double-blind Period|Overall Study||189
554646|NCT00706134|1352376|P2|Entered Double-blind Period|Overall Study||192
554647|NCT00706134|1352377|P1|Entered Double-blind Period|Overall Study||187
554648|NCT00706134|1352374|P4|STARTED|Overall Study||186
554649|NCT00706134|1352375|P3|STARTED|Overall Study||189
554650|NCT00706134|1352376|P2|STARTED|Overall Study||192
554651|NCT00706134|1352377|P1|STARTED|Overall Study||189
554652|NCT00706121|1352411|P4|NOT COMPLETED|Overall Study||352
554653|NCT00706121|1352412|P3|NOT COMPLETED|Overall Study||404
554654|NCT00706121|1352413|P2|NOT COMPLETED|Overall Study||396
554655|NCT00706121|1352414|P1|NOT COMPLETED|Overall Study||396
554656|NCT00706121|1352411|P4|COMPLETED|Overall Study||1577
554657|NCT00706121|1352412|P3|COMPLETED|Overall Study||1626
554658|NCT00706121|1352413|P2|COMPLETED|Overall Study||1700
554659|NCT00706121|1352414|P1|COMPLETED|Overall Study||1643
554660|NCT00706121|1352411|P4|STARTED|Overall Study||1929
554661|NCT00706121|1352412|P3|STARTED|Overall Study||2030
554662|NCT00706121|1352413|P2|STARTED|Overall Study||2096
554663|NCT00706121|1352414|P1|STARTED|Overall Study||2039
554664|NCT00706095|1352443|P3|NOT COMPLETED|Overall Study||5
554665|NCT00706095|1352444|P2|NOT COMPLETED|Overall Study||7
554666|NCT00706095|1352445|P1|NOT COMPLETED|Overall Study||6
554667|NCT00706095|1352443|P3|COMPLETED|Overall Study||0
554668|NCT00706095|1352444|P2|COMPLETED|Overall Study||0
554669|NCT00706095|1352445|P1|COMPLETED|Overall Study||0
554670|NCT00706095|1352443|P3|STARTED|Overall Study||5
554671|NCT00706095|1352444|P2|STARTED|Overall Study||7
554672|NCT00706095|1352445|P1|STARTED|Overall Study||6
554673|NCT00706030|1352463|P4|NOT COMPLETED|Overall Study||16
554674|NCT00706030|1352464|P3|NOT COMPLETED|Overall Study||60
554675|NCT00706030|1352465|P2|NOT COMPLETED|Overall Study||6
554676|NCT00706030|1352466|P1|NOT COMPLETED|Overall Study||6
554677|NCT00706030|1352463|P4|COMPLETED|Overall Study||0
554678|NCT00706030|1352464|P3|COMPLETED|Overall Study||4
554679|NCT00706030|1352465|P2|COMPLETED|Overall Study||0
554680|NCT00706030|1352466|P1|COMPLETED|Overall Study||0
554681|NCT00706030|1352463|P4|Treated|Overall Study||15
554682|NCT00706030|1352464|P3|Treated|Overall Study||64
554683|NCT00706030|1352465|P2|Treated|Overall Study||6
554684|NCT00706030|1352466|P1|Treated|Overall Study||6
554685|NCT00706030|1352463|P4|STARTED|Overall Study||16
554686|NCT00706030|1352464|P3|STARTED|Overall Study||64
554687|NCT00706030|1352465|P2|STARTED|Overall Study||6
554688|NCT00706030|1352466|P1|STARTED|Overall Study||6
554689|NCT00706004|1352481|P1|NOT COMPLETED|Overall Study||2
554690|NCT00706004|1352481|P1|COMPLETED|Overall Study||7
554691|NCT00706004|1352481|P1|STARTED|Overall Study||9
554692|NCT00705939|1352509|P3|NOT COMPLETED|Overall Study||4
554693|NCT00705939|1352510|P2|NOT COMPLETED|Overall Study||2
554694|NCT00705939|1352511|P1|NOT COMPLETED|Overall Study||0
554695|NCT00705939|1352509|P3|COMPLETED|Overall Study||14
554696|NCT00705939|1352510|P2|COMPLETED|Overall Study||12
554697|NCT00705939|1352511|P1|COMPLETED|Overall Study||12
554698|NCT00705939|1352509|P3|STARTED|Overall Study|1 subject enrolled but not treated in this protocol.|18
554699|NCT00705939|1352510|P2|STARTED|Overall Study||14
554700|NCT00705939|1352511|P1|STARTED|Overall Study||12
554701|NCT00705874|1352541|P7|NOT COMPLETED|Overall Study||0
554702|NCT00705874|1352542|P6|NOT COMPLETED|Overall Study||4
554703|NCT00705874|1352543|P5|NOT COMPLETED|Overall Study||12
554704|NCT00705874|1352544|P4|NOT COMPLETED|Overall Study||1
554705|NCT00705874|1352545|P3|NOT COMPLETED|Overall Study||2
554706|NCT00705874|1352546|P2|NOT COMPLETED|Overall Study||1
554707|NCT00705874|1352547|P1|NOT COMPLETED|Overall Study||2
554708|NCT00705874|1352541|P7|COMPLETED|Overall Study||3
554709|NCT00705874|1352542|P6|COMPLETED|Overall Study||28
554710|NCT00705874|1352543|P5|COMPLETED|Overall Study||36
554711|NCT00705874|1352544|P4|COMPLETED|Overall Study||33
554712|NCT00705874|1352545|P3|COMPLETED|Overall Study||32
554713|NCT00705874|1352546|P2|COMPLETED|Overall Study||8
554714|NCT00705874|1352547|P1|COMPLETED|Overall Study||10
554715|NCT00705874|1352541|P7|STARTED|Overall Study||3
554716|NCT00705874|1352542|P6|STARTED|Overall Study||32
554717|NCT00705874|1352543|P5|STARTED|Overall Study||48
554718|NCT00705874|1352544|P4|STARTED|Overall Study||34
554719|NCT00705874|1352545|P3|STARTED|Overall Study||34
554720|NCT00705874|1352546|P2|STARTED|Overall Study||9
554721|NCT00705874|1352547|P1|STARTED|Overall Study||12
554722|NCT00705783|1352565|P3|NOT COMPLETED|Depot Maintenance Phase||131
554723|NCT00705783|1352566|P2|NOT COMPLETED|Depot Maintenance Phase||246
554724|NCT00705783|1352567|P1|NOT COMPLETED|Depot Maintenance Phase||0
554725|NCT00705783|1352565|P3|COMPLETED|Depot Maintenance Phase||3
554726|NCT00705783|1352566|P2|COMPLETED|Depot Maintenance Phase||23
554727|NCT00705783|1352567|P1|COMPLETED|Depot Maintenance Phase||0
554728|NCT00705783|1352565|P3|STARTED|Depot Maintenance Phase||134
554729|NCT00705783|1352566|P2|STARTED|Depot Maintenance Phase||269
554730|NCT00705783|1352567|P1|STARTED|Depot Maintenance Phase|Patients were randomized into the aripiprazole and placebo depot groups in this phase of the study.|0
554731|NCT00705783|1352565|P3|NOT COMPLETED|Depot Stabilization Phase||0
554732|NCT00705783|1352566|P2|NOT COMPLETED|Depot Stabilization Phase||0
554733|NCT00705783|1352567|P1|NOT COMPLETED|Depot Stabilization Phase||173
554734|NCT00705783|1352565|P3|COMPLETED|Depot Stabilization Phase||0
554735|NCT00705783|1352566|P2|COMPLETED|Depot Stabilization Phase||0
554736|NCT00705783|1352567|P1|COMPLETED|Depot Stabilization Phase||403
554737|NCT00705783|1352565|P3|STARTED|Depot Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
554738|NCT00705783|1352566|P2|STARTED|Depot Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
554739|NCT00705783|1352567|P1|STARTED|Depot Stabilization Phase||576
554740|NCT00705783|1352565|P3|NOT COMPLETED|Oral Stabilization Phase||0
554741|NCT00705783|1352566|P2|NOT COMPLETED|Oral Stabilization Phase||0
554742|NCT00705783|1352567|P1|NOT COMPLETED|Oral Stabilization Phase||134
554743|NCT00705783|1352565|P3|COMPLETED|Oral Stabilization Phase||0
554744|NCT00705783|1352566|P2|COMPLETED|Oral Stabilization Phase||0
554745|NCT00705783|1352567|P1|COMPLETED|Oral Stabilization Phase||576
554746|NCT00705783|1352565|P3|Received Study Medication|Oral Stabilization Phase||0
554747|NCT00705783|1352566|P2|Received Study Medication|Oral Stabilization Phase||0
554748|NCT00705783|1352567|P1|Received Study Medication|Oral Stabilization Phase||709
554749|NCT00705783|1352565|P3|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
554750|NCT00705783|1352566|P2|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
554751|NCT00705783|1352567|P1|STARTED|Oral Stabilization Phase|210 of the 710 patients who started this phase enrolled in this study directly into this phase.|710
554752|NCT00705783|1352565|P3|NOT COMPLETED|Conversion Phase||0
554753|NCT00705783|1352566|P2|NOT COMPLETED|Conversion Phase||0
554754|NCT00705783|1352567|P1|NOT COMPLETED|Conversion Phase||133
554755|NCT00705783|1352565|P3|COMPLETED|Conversion Phase||0
554756|NCT00705783|1352566|P2|COMPLETED|Conversion Phase||0
554757|NCT00705783|1352567|P1|COMPLETED|Conversion Phase||500
554758|NCT00705783|1352565|P3|Received Study Medication|Conversion Phase||0
554759|NCT00705783|1352566|P2|Received Study Medication|Conversion Phase||0
554760|NCT00705783|1352567|P1|Received Study Medication|Conversion Phase||632
554761|NCT00705783|1352565|P3|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
554762|NCT00705783|1352566|P2|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
554763|NCT00705783|1352567|P1|STARTED|Conversion Phase||633
554764|NCT00705757|1352597|P3|NOT COMPLETED|Overall Study||11
554765|NCT00705757|1352598|P2|NOT COMPLETED|Overall Study||8
554766|NCT00705757|1352599|P1|NOT COMPLETED|Overall Study||13
554767|NCT00705757|1352597|P3|COMPLETED|Overall Study||17
554768|NCT00705757|1352598|P2|COMPLETED|Overall Study||21
554769|NCT00705757|1352599|P1|COMPLETED|Overall Study||19
554770|NCT00705757|1352597|P3|STARTED|Overall Study||28
554771|NCT00705757|1352598|P2|STARTED|Overall Study||29
554772|NCT00705757|1352599|P1|STARTED|Overall Study||32
554773|NCT00705718|1352609|P2|NOT COMPLETED|Overall Study||22
554774|NCT00705718|1352610|P1|NOT COMPLETED|Overall Study||7
554775|NCT00705718|1352609|P2|COMPLETED|Overall Study||128
554776|NCT00705718|1352610|P1|COMPLETED|Overall Study||37
554777|NCT00705718|1352609|P2|12 Month Follow up|Overall Study|4 Deaths, 12 Subjects Not due for next visit, 4 Subjects Missed Visit|128
554778|NCT00705718|1352610|P1|12 Month Follow up|Overall Study|2 Deaths|37
554779|NCT00705718|1352609|P2|6 Month Follow up|Overall Study|2 Deaths, 5 Subjects Missed Visit|143
554780|NCT00705718|1352610|P1|6 Month Follow up|Overall Study|3 Deaths|40
554781|NCT00705718|1352609|P2|1 Month Follow up|Overall Study|1 Subject Missed Visit|149
554782|NCT00705718|1352610|P1|1 Month Follow up|Overall Study|1 Death|43
554783|NCT00705718|1352609|P2|STARTED|Overall Study||150
554784|NCT00705718|1352610|P1|STARTED|Overall Study||44
554785|NCT00705679|1352631|P5|NOT COMPLETED|Overall Study||69
554786|NCT00705679|1352632|P4|NOT COMPLETED|Overall Study||80
554787|NCT00705679|1352633|P3|NOT COMPLETED|Overall Study||115
554788|NCT00705679|1352634|P2|NOT COMPLETED|Overall Study||139
554789|NCT00705679|1352635|P1|NOT COMPLETED|Overall Study||65
554790|NCT00705679|1352631|P5|COMPLETED|Overall Study||934
554791|NCT00705679|1352632|P4|COMPLETED|Overall Study||927
554792|NCT00705679|1352633|P3|COMPLETED|Overall Study||894
554793|NCT00705679|1352634|P2|COMPLETED|Overall Study||864
554794|NCT00705679|1352635|P1|COMPLETED|Overall Study||942
554795|NCT00705679|1352631|P5|STARTED|Overall Study||1003
554796|NCT00705679|1352632|P4|STARTED|Overall Study||1007
554797|NCT00705679|1352633|P3|STARTED|Overall Study||1009
554798|NCT00705679|1352634|P2|STARTED|Overall Study||1003
554799|NCT00705679|1352635|P1|STARTED|Overall Study||1007
554800|NCT00705666|1352670|P1|NOT COMPLETED|Overall Study||339
554801|NCT00705666|1352670|P1|COMPLETED|Overall Study||450
554802|NCT00705666|1352670|P1|STARTED|Overall Study||789
554803|NCT00705653|1352674|P1|NOT COMPLETED|Overall Study||0
554804|NCT00705653|1352674|P1|COMPLETED|Overall Study||46
554805|NCT00705653|1352674|P1|STARTED|Overall Study||46
554806|NCT00705614|1352681|P2|NOT COMPLETED|Switch to Remicade||49
554807|NCT00705614|1352682|P1|NOT COMPLETED|Switch to Remicade||0
554808|NCT00705614|1352681|P2|COMPLETED|Switch to Remicade||249
554809|NCT00705614|1352682|P1|COMPLETED|Switch to Remicade||0
554810|NCT00705614|1352681|P2|STARTED|Switch to Remicade||298
554811|NCT00705614|1352682|P1|STARTED|Switch to Remicade||0
554812|NCT00705614|1352681|P2|NOT COMPLETED|Initial Intervention||321
554813|NCT00705614|1352682|P1|NOT COMPLETED|Initial Intervention||518
554814|NCT00705614|1352681|P2|COMPLETED|Initial Intervention||800
554815|NCT00705614|1352682|P1|COMPLETED|Initial Intervention||1023
554816|NCT00705614|1352681|P2|STARTED|Initial Intervention||1121
554817|NCT00705614|1352682|P1|STARTED|Initial Intervention||1541
554818|NCT00705575|1352731|P2|NOT COMPLETED|Overall Study||46
554819|NCT00705575|1352732|P1|NOT COMPLETED|Overall Study||23
554820|NCT00705575|1352731|P2|COMPLETED|Overall Study||293
554821|NCT00705575|1352732|P1|COMPLETED|Overall Study||326
554822|NCT00705575|1352731|P2|STARTED|Overall Study||339
554823|NCT00705575|1352732|P1|STARTED|Overall Study||349
554824|NCT00705536|1352746|P4|NOT COMPLETED|Completed Study||0
554825|NCT00705536|1352747|P3|NOT COMPLETED|Completed Study||0
554826|NCT00705536|1352748|P2|NOT COMPLETED|Completed Study||0
554827|NCT00705536|1352749|P1|NOT COMPLETED|Completed Study||0
554828|NCT00705536|1352746|P4|COMPLETED|Completed Study||6
554829|NCT00705536|1352747|P3|COMPLETED|Completed Study||7
554830|NCT00705536|1352748|P2|COMPLETED|Completed Study||6
554831|NCT00705536|1352749|P1|COMPLETED|Completed Study||6
554832|NCT00705536|1352746|P4|STARTED|Completed Study||6
554833|NCT00705536|1352747|P3|STARTED|Completed Study||7
554834|NCT00705536|1352748|P2|STARTED|Completed Study||6
554835|NCT00705536|1352749|P1|STARTED|Completed Study||6
554836|NCT00705536|1352746|P4|NOT COMPLETED|Start Period 2||0
554837|NCT00705536|1352747|P3|NOT COMPLETED|Start Period 2||0
554838|NCT00705536|1352748|P2|NOT COMPLETED|Start Period 2||0
554839|NCT00705536|1352749|P1|NOT COMPLETED|Start Period 2||0
554840|NCT00705536|1352746|P4|COMPLETED|Start Period 2||6
554841|NCT00705536|1352747|P3|COMPLETED|Start Period 2||7
554842|NCT00705536|1352748|P2|COMPLETED|Start Period 2||6
554843|NCT00705536|1352749|P1|COMPLETED|Start Period 2||6
554844|NCT00705536|1352746|P4|STARTED|Start Period 2||6
554845|NCT00705536|1352747|P3|STARTED|Start Period 2||7
554846|NCT00705536|1352748|P2|STARTED|Start Period 2||6
554847|NCT00705536|1352749|P1|STARTED|Start Period 2||6
554848|NCT00705536|1352746|P4|NOT COMPLETED|Washout Period of at Least 6 Days||0
554849|NCT00705536|1352747|P3|NOT COMPLETED|Washout Period of at Least 6 Days||0
554850|NCT00705536|1352748|P2|NOT COMPLETED|Washout Period of at Least 6 Days||0
554851|NCT00705536|1352749|P1|NOT COMPLETED|Washout Period of at Least 6 Days||0
554852|NCT00705536|1352746|P4|COMPLETED|Washout Period of at Least 6 Days||6
554853|NCT00705536|1352747|P3|COMPLETED|Washout Period of at Least 6 Days||7
554854|NCT00705536|1352748|P2|COMPLETED|Washout Period of at Least 6 Days||6
554855|NCT00705536|1352749|P1|COMPLETED|Washout Period of at Least 6 Days||6
554856|NCT00705536|1352746|P4|STARTED|Washout Period of at Least 6 Days||6
554857|NCT00705536|1352747|P3|STARTED|Washout Period of at Least 6 Days||7
554858|NCT00705536|1352748|P2|STARTED|Washout Period of at Least 6 Days||6
554859|NCT00705536|1352749|P1|STARTED|Washout Period of at Least 6 Days||6
554860|NCT00705536|1352746|P4|NOT COMPLETED|Start Period 1||1
554861|NCT00705536|1352747|P3|NOT COMPLETED|Start Period 1||0
554862|NCT00705536|1352748|P2|NOT COMPLETED|Start Period 1||0
554863|NCT00705536|1352749|P1|NOT COMPLETED|Start Period 1||0
554864|NCT00705536|1352746|P4|COMPLETED|Start Period 1||6
554865|NCT00705536|1352747|P3|COMPLETED|Start Period 1||7
554866|NCT00705536|1352748|P2|COMPLETED|Start Period 1||6
554867|NCT00705536|1352749|P1|COMPLETED|Start Period 1||6
554868|NCT00705536|1352746|P4|Received at Least 1 Dose of Study Drug|Start Period 1||7
554869|NCT00705536|1352747|P3|Received at Least 1 Dose of Study Drug|Start Period 1||7
554870|NCT00705536|1352748|P2|Received at Least 1 Dose of Study Drug|Start Period 1||6
554871|NCT00705536|1352749|P1|Received at Least 1 Dose of Study Drug|Start Period 1||6
554872|NCT00705536|1352746|P4|STARTED|Start Period 1||7
554873|NCT00705536|1352747|P3|STARTED|Start Period 1||7
554874|NCT00705536|1352748|P2|STARTED|Start Period 1||6
554875|NCT00705536|1352749|P1|STARTED|Start Period 1||6
554876|NCT00705523|1352810|P2|NOT COMPLETED|Overall Study||3
554877|NCT00705523|1352811|P1|NOT COMPLETED|Overall Study||2
554878|NCT00705523|1352810|P2|COMPLETED|Overall Study||18
554879|NCT00705523|1352811|P1|COMPLETED|Overall Study||17
554880|NCT00705523|1352810|P2|STARTED|Overall Study||21
554881|NCT00705523|1352811|P1|STARTED|Overall Study||19
554882|NCT00705432|1352825|P6|NOT COMPLETED|Follow-up Period (Upto Week 72)||7
554883|NCT00705432|1352826|P5|NOT COMPLETED|Follow-up Period (Upto Week 72)||6
554884|NCT00705432|1352827|P4|NOT COMPLETED|Follow-up Period (Upto Week 72)||14
554885|NCT00705432|1352828|P3|NOT COMPLETED|Follow-up Period (Upto Week 72)||25
554886|NCT00705432|1352829|P2|NOT COMPLETED|Follow-up Period (Upto Week 72)||43
554887|NCT00705432|1352830|P1|NOT COMPLETED|Follow-up Period (Upto Week 72)||71
554888|NCT00705432|1352825|P6|COMPLETED|Follow-up Period (Upto Week 72)||46
554889|NCT00705432|1352826|P5|COMPLETED|Follow-up Period (Upto Week 72)||38
554890|NCT00705432|1352827|P4|COMPLETED|Follow-up Period (Upto Week 72)||28
554891|NCT00705432|1352828|P3|COMPLETED|Follow-up Period (Upto Week 72)||266
554892|NCT00705432|1352829|P2|COMPLETED|Follow-up Period (Upto Week 72)||252
554893|NCT00705432|1352830|P1|COMPLETED|Follow-up Period (Upto Week 72)||207
554894|NCT00705432|1352825|P6|STARTED|Follow-up Period (Upto Week 72)||53
554895|NCT00705432|1352826|P5|STARTED|Follow-up Period (Upto Week 72)||44
554896|NCT00705432|1352827|P4|STARTED|Follow-up Period (Upto Week 72)||42
554897|NCT00705432|1352828|P3|STARTED|Follow-up Period (Upto Week 72)||291
554898|NCT00705432|1352829|P2|STARTED|Follow-up Period (Upto Week 72)||295
554899|NCT00705432|1352830|P1|STARTED|Follow-up Period (Upto Week 72)||278
554900|NCT00705432|1352825|P6|NOT COMPLETED|Treatment Period||30
554901|NCT00705432|1352826|P5|NOT COMPLETED|Treatment Period||28
554902|NCT00705432|1352827|P4|NOT COMPLETED|Treatment Period||41
554903|NCT00705432|1352828|P3|NOT COMPLETED|Treatment Period||121
554904|NCT00705432|1352829|P2|NOT COMPLETED|Treatment Period||111
554905|NCT00705432|1352830|P1|NOT COMPLETED|Treatment Period||163
554906|NCT00705432|1352825|P6|COMPLETED|Treatment Period||25
554907|NCT00705432|1352826|P5|COMPLETED|Treatment Period||24
554908|NCT00705432|1352827|P4|COMPLETED|Treatment Period||11
554909|NCT00705432|1352828|P3|COMPLETED|Treatment Period||190
554910|NCT00705432|1352829|P2|COMPLETED|Treatment Period||205
554911|NCT00705432|1352830|P1|COMPLETED|Treatment Period||148
554912|NCT00705432|1352825|P6|STARTED BOCEPREVIR/PLACEBO|Treatment Period||55
554913|NCT00705432|1352826|P5|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47
554914|NCT00705432|1352827|P4|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47
554915|NCT00705432|1352828|P3|STARTED BOCEPREVIR/PLACEBO|Treatment Period||299
554916|NCT00705432|1352829|P2|STARTED BOCEPREVIR/PLACEBO|Treatment Period||303
554917|NCT00705432|1352830|P1|STARTED BOCEPREVIR/PLACEBO|Treatment Period||297
554918|NCT00705432|1352825|P6|STARTED|Treatment Period||55
554919|NCT00705432|1352826|P5|STARTED|Treatment Period||52
554920|NCT00705432|1352827|P4|STARTED|Treatment Period||52
554921|NCT00705432|1352828|P3|STARTED|Treatment Period||311
554922|NCT00705432|1352829|P2|STARTED|Treatment Period||316
554923|NCT00705432|1352830|P1|STARTED|Treatment Period||311
554924|NCT00705406|1352867|P2|NOT COMPLETED|Overall Study||5
554925|NCT00705406|1352868|P1|NOT COMPLETED|Overall Study||4
554926|NCT00705406|1352867|P2|COMPLETED|Overall Study||197
554927|NCT00705406|1352868|P1|COMPLETED|Overall Study||199
554928|NCT00705406|1352867|P2|STARTED|Overall Study||202
554929|NCT00705406|1352868|P1|STARTED|Overall Study||203
554930|NCT00705367|1352892|P2|NOT COMPLETED|Long-term Extension Period||0
554931|NCT00705367|1352893|P1|NOT COMPLETED|Long-term Extension Period||9
554932|NCT00705367|1352892|P2|COMPLETED|Long-term Extension Period||0
554933|NCT00705367|1352893|P1|COMPLETED|Long-term Extension Period||0
554934|NCT00705367|1352892|P2|STARTED|Long-term Extension Period||0
554935|NCT00705367|1352893|P1|STARTED|Long-term Extension Period||9
554936|NCT00705367|1352892|P2|NOT COMPLETED|Short-term Period||0
554937|NCT00705367|1352893|P1|NOT COMPLETED|Short-term Period||0
554938|NCT00705367|1352892|P2|COMPLETED|Short-term Period||3
554939|NCT00705367|1352893|P1|COMPLETED|Short-term Period||6
554940|NCT00705367|1352892|P2|STARTED|Short-term Period||3
554941|NCT00705367|1352893|P1|STARTED|Short-term Period||6
554942|NCT00705341|1352920|P4|NOT COMPLETED|Phase 2: Trial||4
554943|NCT00705341|1352921|P3|NOT COMPLETED|Phase 2: Trial||7
554944|NCT00705341|1352922|P2|NOT COMPLETED|Phase 2: Trial||0
554945|NCT00705341|1352923|P1|NOT COMPLETED|Phase 2: Trial||0
554946|NCT00705341|1352920|P4|COMPLETED|Phase 2: Trial||28
554947|NCT00705341|1352921|P3|COMPLETED|Phase 2: Trial||23
554948|NCT00705341|1352922|P2|COMPLETED|Phase 2: Trial||0
554949|NCT00705341|1352923|P1|COMPLETED|Phase 2: Trial||0
554950|NCT00705341|1352920|P4|STARTED|Phase 2: Trial|This group was randomized from asthmatic controls in phase 1 if they met criteria to be in phase 2|32
554951|NCT00705341|1352921|P3|STARTED|Phase 2: Trial|This group was randomized from asthmatic controls in phase 1 if they met criteria to be in phase 2|30
554952|NCT00705341|1352922|P2|STARTED|Phase 2: Trial||0
554953|NCT00705341|1352923|P1|STARTED|Phase 2: Trial||0
554954|NCT00705341|1352920|P4|NOT COMPLETED|Phase 1:Control Challenge||0
554955|NCT00705341|1352921|P3|NOT COMPLETED|Phase 1:Control Challenge||0
554956|NCT00705341|1352922|P2|NOT COMPLETED|Phase 1:Control Challenge||0
554957|NCT00705341|1352923|P1|NOT COMPLETED|Phase 1:Control Challenge||0
554958|NCT00705341|1352920|P4|COMPLETED|Phase 1:Control Challenge||0
554959|NCT00705341|1352921|P3|COMPLETED|Phase 1:Control Challenge||0
554960|NCT00705341|1352922|P2|COMPLETED|Phase 1:Control Challenge|Nonasthmatic controls did not advance to phase 2 due to design of study|93
554961|NCT00705341|1352923|P1|COMPLETED|Phase 1:Control Challenge|If participants in this group met criteria, they were randomized into phase 2|126
554962|NCT00705341|1352920|P4|STARTED|Phase 1:Control Challenge||0
554963|NCT00705341|1352921|P3|STARTED|Phase 1:Control Challenge||0
554964|NCT00705341|1352922|P2|STARTED|Phase 1:Control Challenge||93
554965|NCT00705341|1352923|P1|STARTED|Phase 1:Control Challenge||126
554966|NCT00705289|1352931|P1|NOT COMPLETED|Overall Study||131
554967|NCT00705289|1352931|P1|COMPLETED|Overall Study||597
554968|NCT00705289|1352931|P1|STARTED|Overall Study||728
554969|NCT00705263|1352955|P1|NOT COMPLETED|Overall Study||2
554970|NCT00705263|1352955|P1|COMPLETED|Overall Study||108
554971|NCT00705263|1352955|P1|STARTED|Overall Study|113 patients started the treatment; however, data were available for only 110 patients.|110
554972|NCT00705250|1352959|P1|NOT COMPLETED|Overall Study||2
554973|NCT00705250|1352959|P1|COMPLETED|Overall Study||34
554974|NCT00705250|1352959|P1|STARTED|Overall Study||36
554975|NCT00705224|1352963|P1|NOT COMPLETED|Overall Study||11
554976|NCT00705224|1352963|P1|COMPLETED|Overall Study||239
554977|NCT00705224|1352963|P1|STARTED|Overall Study||250
554978|NCT00705159|1352979|P4|NOT COMPLETED|Overall Study||4
554979|NCT00705159|1352980|P3|NOT COMPLETED|Overall Study||5
554980|NCT00705159|1352981|P2|NOT COMPLETED|Overall Study||2
554981|NCT00705159|1352982|P1|NOT COMPLETED|Overall Study||0
554982|NCT00705159|1352979|P4|COMPLETED|Overall Study||30
554983|NCT00705159|1352980|P3|COMPLETED|Overall Study||29
554984|NCT00705159|1352981|P2|COMPLETED|Overall Study||33
554985|NCT00705159|1352982|P1|COMPLETED|Overall Study||34
554986|NCT00705159|1352979|P4|STARTED|Overall Study||34
554987|NCT00705159|1352980|P3|STARTED|Overall Study||34
554988|NCT00705159|1352981|P2|STARTED|Overall Study||35
554989|NCT00705159|1352982|P1|STARTED|Overall Study||34
554990|NCT00705146|1353002|P2|NOT COMPLETED|Overall Study||1
554991|NCT00705146|1353003|P1|NOT COMPLETED|Overall Study||1
554992|NCT00705146|1353002|P2|COMPLETED|Overall Study||23
554993|NCT00705146|1353003|P1|COMPLETED|Overall Study||31
554994|NCT00705146|1353002|P2|STARTED|Overall Study||24
554995|NCT00705146|1353003|P1|STARTED|Overall Study||32
554996|NCT00705107|1353011|P1|NOT COMPLETED|Overall Study||49
554997|NCT00705107|1353011|P1|COMPLETED|Overall Study||218
554998|NCT00705107|1353011|P1|STARTED|Overall Study||267
554999|NCT00705081|1353018|P2|NOT COMPLETED|Overall Study||0
555000|NCT00705081|1353019|P1|NOT COMPLETED|Overall Study||0
555001|NCT00705081|1353018|P2|COMPLETED|Overall Study||198
555002|NCT00705081|1353019|P1|COMPLETED|Overall Study||255
555003|NCT00705081|1353018|P2|STARTED|Overall Study||198
555004|NCT00705081|1353019|P1|STARTED|Overall Study||255
555005|NCT00705016|1353032|P3|NOT COMPLETED|Overall Study||58
555006|NCT00705016|1353033|P2|NOT COMPLETED|Overall Study||58
555007|NCT00705016|1353034|P1|NOT COMPLETED|Overall Study||60
555008|NCT00705016|1353032|P3|COMPLETED|Overall Study||4
555009|NCT00705016|1353033|P2|COMPLETED|Overall Study||2
555010|NCT00705016|1353034|P1|COMPLETED|Overall Study||2
555011|NCT00705016|1353032|P3|STARTED|Overall Study||62
555012|NCT00705016|1353033|P2|STARTED|Overall Study||60
555013|NCT00705016|1353034|P1|STARTED|Overall Study||62
555014|NCT00705003|1353063|P3|NOT COMPLETED|Treated||3
555015|NCT00705003|1353064|P2|NOT COMPLETED|Treated||6
555016|NCT00705003|1353065|P1|NOT COMPLETED|Treated||13
555017|NCT00705003|1353063|P3|COMPLETED|Treated||30
555018|NCT00705003|1353064|P2|COMPLETED|Treated||28
555019|NCT00705003|1353065|P1|COMPLETED|Treated||54
555020|NCT00705003|1353063|P3|STARTED|Treated||33
555021|NCT00705003|1353064|P2|STARTED|Treated||34
555022|NCT00705003|1353065|P1|STARTED|Treated||67
555023|NCT00705003|1353063|P3|NOT COMPLETED|Enrolled||1
555024|NCT00705003|1353064|P2|NOT COMPLETED|Enrolled||3
555025|NCT00705003|1353065|P1|NOT COMPLETED|Enrolled||4
555026|NCT00705003|1353063|P3|COMPLETED|Enrolled||33
555027|NCT00705003|1353064|P2|COMPLETED|Enrolled||34
555028|NCT00705003|1353065|P1|COMPLETED|Enrolled||67
555029|NCT00705003|1353063|P3|STARTED|Enrolled||34
555030|NCT00705003|1353064|P2|STARTED|Enrolled||37
555031|NCT00705003|1353065|P1|STARTED|Enrolled||71
555032|NCT00704964|1353085|P1|NOT COMPLETED|Overall Study||328
555033|NCT00704964|1353085|P1|COMPLETED|Overall Study|Number of participants who completed therapy as scheduled.|418
555034|NCT00704964|1353085|P1|STARTED|Overall Study|Number of participants who took at least one dose of study medication.|746
555035|NCT00704938|1353092|P2|NOT COMPLETED|Overall Study||0
555036|NCT00704938|1353093|P1|NOT COMPLETED|Overall Study||0
555037|NCT00704938|1353092|P2|COMPLETED|Overall Study||1
555038|NCT00704938|1353093|P1|COMPLETED|Overall Study||2
555039|NCT00704938|1353092|P2|STARTED|Overall Study||1
555040|NCT00704938|1353093|P1|STARTED|Overall Study||2
555041|NCT00704912|1353104|P3|NOT COMPLETED|Overall Study||7
555042|NCT00704912|1353105|P2|NOT COMPLETED|Overall Study||4
555043|NCT00704912|1353106|P1|NOT COMPLETED|Overall Study||6
555044|NCT00704912|1353104|P3|COMPLETED|Overall Study||43
555045|NCT00704912|1353105|P2|COMPLETED|Overall Study||45
555046|NCT00704912|1353106|P1|COMPLETED|Overall Study||44
555047|NCT00704912|1353104|P3|STARTED|Overall Study||50
555048|NCT00704912|1353105|P2|STARTED|Overall Study||49
555049|NCT00704912|1353106|P1|STARTED|Overall Study||50
555050|NCT00704847|1353125|P2|NOT COMPLETED|Overall Study||170
555051|NCT00704847|1353126|P1|NOT COMPLETED|Overall Study||221
555052|NCT00704847|1353125|P2|COMPLETED|Overall Study||339
555053|NCT00704847|1353126|P1|COMPLETED|Overall Study||300
555054|NCT00704847|1353125|P2|STARTED|Overall Study||509
555055|NCT00704847|1353126|P1|STARTED|Overall Study||521
555056|NCT00704808|1353134|P1|NOT COMPLETED|Overall Study||131
555057|NCT00704808|1353134|P1|COMPLETED|Overall Study||49
555058|NCT00704808|1353134|P1|STARTED|Overall Study||180
555059|NCT00704769|1353138|P1|NOT COMPLETED|Overall Study||0
555060|NCT00704769|1353138|P1|COMPLETED|Overall Study||591
555061|NCT00704769|1353138|P1|STARTED|Overall Study||591
555062|NCT00704730|1353145|P2|NOT COMPLETED|Overall Study||96
555063|NCT00704730|1353146|P1|NOT COMPLETED|Overall Study||121
555064|NCT00704730|1353145|P2|COMPLETED|Overall Study|Continuing study treatment at the time of data cut-off.|15
555065|NCT00704730|1353146|P1|COMPLETED|Overall Study|Continuing study treatment at the time of data cut-off.|98
555066|NCT00704730|1353145|P2|STARTED|Overall Study|Randomized|111
555067|NCT00704730|1353146|P1|STARTED|Overall Study|Randomized|219
555068|NCT00704717|1353162|P1|NOT COMPLETED|Overall Study||0
555069|NCT00704717|1353162|P1|COMPLETED|Overall Study||185
555070|NCT00704717|1353162|P1|STARTED|Overall Study||185
555071|NCT00704535|1353166|P1|NOT COMPLETED|Overall Study||146
555072|NCT00704535|1353166|P1|COMPLETED|Overall Study||3959
555073|NCT00704535|1353166|P1|STARTED|Overall Study||4105
555074|NCT00704522|1353179|P2|NOT COMPLETED|Overall Study||45
555075|NCT00704522|1353180|P1|NOT COMPLETED|Overall Study||183
555076|NCT00704522|1353179|P2|COMPLETED|Overall Study||75
555077|NCT00704522|1353180|P1|COMPLETED|Overall Study||298
555078|NCT00704522|1353179|P2|STARTED|Overall Study||120
555079|NCT00704522|1353180|P1|STARTED|Overall Study||481
555080|NCT00704496|1353189|P2|NOT COMPLETED|Overall Study||0
555081|NCT00704496|1353190|P1|NOT COMPLETED|Overall Study||0
555082|NCT00704496|1353189|P2|COMPLETED|Overall Study||0
555083|NCT00704496|1353190|P1|COMPLETED|Overall Study||0
555084|NCT00704496|1353189|P2|STARTED|Overall Study||0
555085|NCT00704496|1353190|P1|STARTED|Overall Study||0
555086|NCT00704418|1353200|P2|NOT COMPLETED|Overall Study||6
555087|NCT00704418|1353201|P1|NOT COMPLETED|Overall Study||5
555088|NCT00704418|1353200|P2|COMPLETED|Overall Study||72
555089|NCT00704418|1353201|P1|COMPLETED|Overall Study||73
555090|NCT00704418|1353200|P2|STARTED|Overall Study||78
555091|NCT00704418|1353201|P1|STARTED|Overall Study||78
555092|NCT00704405|1353214|P5|NOT COMPLETED|Overall Study (C Population)||0
555093|NCT00704405|1353215|P4|NOT COMPLETED|Overall Study (C Population)||1
555094|NCT00704405|1353216|P3|NOT COMPLETED|Overall Study (C Population)||1
555095|NCT00704405|1353217|P2|NOT COMPLETED|Overall Study (C Population)||3
555096|NCT00704405|1353218|P1|NOT COMPLETED|Overall Study (C Population)||1
555097|NCT00704405|1353214|P5|COMPLETED|Overall Study (C Population)||14
555098|NCT00704405|1353215|P4|COMPLETED|Overall Study (C Population)||14
555099|NCT00704405|1353216|P3|COMPLETED|Overall Study (C Population)||14
555100|NCT00704405|1353217|P2|COMPLETED|Overall Study (C Population)||11
555101|NCT00704405|1353218|P1|COMPLETED|Overall Study (C Population)||15
555102|NCT00704405|1353214|P5|STARTED|Overall Study (C Population)||14
555103|NCT00704405|1353215|P4|STARTED|Overall Study (C Population)||15
555104|NCT00704405|1353216|P3|STARTED|Overall Study (C Population)||15
555105|NCT00704405|1353217|P2|STARTED|Overall Study (C Population)||14
555106|NCT00704405|1353218|P1|STARTED|Overall Study (C Population)||16
555107|NCT00704405|1353214|P5|NOT COMPLETED|Overall Study (NC Population)||5
555108|NCT00704405|1353215|P4|NOT COMPLETED|Overall Study (NC Population)||4
555109|NCT00704405|1353216|P3|NOT COMPLETED|Overall Study (NC Population)||3
555110|NCT00704405|1353217|P2|NOT COMPLETED|Overall Study (NC Population)||4
555111|NCT00704405|1353218|P1|NOT COMPLETED|Overall Study (NC Population)||5
555112|NCT00704405|1353214|P5|COMPLETED|Overall Study (NC Population)||37
555113|NCT00704405|1353215|P4|COMPLETED|Overall Study (NC Population)||38
555114|NCT00704405|1353216|P3|COMPLETED|Overall Study (NC Population)||38
555115|NCT00704405|1353217|P2|COMPLETED|Overall Study (NC Population)||40
555116|NCT00704405|1353218|P1|COMPLETED|Overall Study (NC Population)||37
555117|NCT00704405|1353214|P5|STARTED|Overall Study (NC Population)||42
555118|NCT00704405|1353215|P4|STARTED|Overall Study (NC Population)||42
555119|NCT00704405|1353216|P3|STARTED|Overall Study (NC Population)||41
555120|NCT00704405|1353217|P2|STARTED|Overall Study (NC Population)||44
555121|NCT00704405|1353218|P1|STARTED|Overall Study (NC Population)||42
555122|NCT00704379|1353248|P2|NOT COMPLETED|Overall Study||7
555123|NCT00704379|1353249|P1|NOT COMPLETED|Overall Study||7
555124|NCT00704379|1353248|P2|COMPLETED|Overall Study||41
555125|NCT00704379|1353249|P1|COMPLETED|Overall Study||39
555126|NCT00704379|1353248|P2|STARTED|Overall Study||48
555127|NCT00704379|1353249|P1|STARTED|Overall Study||46
555128|NCT00704353|1353267|P2|NOT COMPLETED|Overall Study||114
555129|NCT00704353|1353268|P1|NOT COMPLETED|Overall Study||98
555130|NCT00704353|1353267|P2|COMPLETED|Overall Study||255
555131|NCT00704353|1353268|P1|COMPLETED|Overall Study||268
555132|NCT00704353|1353267|P2|STARTED|Overall Study||369
555133|NCT00704353|1353268|P1|STARTED|Overall Study||366
555134|NCT00704340|1353276|P2|NOT COMPLETED|Overall Study||2
555135|NCT00704340|1353277|P1|NOT COMPLETED|Overall Study||2
555136|NCT00704340|1353276|P2|COMPLETED|Overall Study||115
555137|NCT00704340|1353277|P1|COMPLETED|Overall Study||118
555138|NCT00704340|1353276|P2|STARTED|Overall Study||117
555139|NCT00704340|1353277|P1|STARTED|Overall Study||120
555140|NCT00704184|1353292|P5|NOT COMPLETED|Open-Label Treatment||3
555141|NCT00704184|1353293|P4|NOT COMPLETED|Open-Label Treatment||5
555142|NCT00704184|1353294|P3|NOT COMPLETED|Open-Label Treatment||4
555143|NCT00704184|1353295|P2|NOT COMPLETED|Open-Label Treatment||2
555144|NCT00704184|1353296|P1|NOT COMPLETED|Open-Label Treatment||1
555145|NCT00704184|1353292|P5|COMPLETED|Open-Label Treatment||16
555146|NCT00704184|1353293|P4|COMPLETED|Open-Label Treatment||13
555147|NCT00704184|1353294|P3|COMPLETED|Open-Label Treatment||16
555148|NCT00704184|1353295|P2|COMPLETED|Open-Label Treatment||16
555149|NCT00704184|1353296|P1|COMPLETED|Open-Label Treatment||18
555150|NCT00704184|1353292|P5|STARTED|Open-Label Treatment||19
555151|NCT00704184|1353293|P4|STARTED|Open-Label Treatment||18
555152|NCT00704184|1353294|P3|STARTED|Open-Label Treatment||20
555153|NCT00704184|1353295|P2|STARTED|Open-Label Treatment||18
555154|NCT00704184|1353296|P1|STARTED|Open-Label Treatment||19
555155|NCT00704184|1353292|P5|NOT COMPLETED|Double-Blind Treatment||0
555156|NCT00704184|1353293|P4|NOT COMPLETED|Double-Blind Treatment||0
555157|NCT00704184|1353294|P3|NOT COMPLETED|Double-Blind Treatment||0
555158|NCT00704184|1353295|P2|NOT COMPLETED|Double-Blind Treatment||0
555159|NCT00704184|1353296|P1|NOT COMPLETED|Double-Blind Treatment||1
555160|NCT00704184|1353292|P5|COMPLETED|Double-Blind Treatment||19
555161|NCT00704184|1353293|P4|COMPLETED|Double-Blind Treatment||18
555162|NCT00704184|1353294|P3|COMPLETED|Double-Blind Treatment||20
555163|NCT00704184|1353295|P2|COMPLETED|Double-Blind Treatment||18
555164|NCT00704184|1353296|P1|COMPLETED|Double-Blind Treatment||19
555165|NCT00704184|1353292|P5|Treated|Double-Blind Treatment||19
555166|NCT00704184|1353293|P4|Treated|Double-Blind Treatment||18
555167|NCT00704184|1353294|P3|Treated|Double-Blind Treatment||20
555168|NCT00704184|1353295|P2|Treated|Double-Blind Treatment||18
555169|NCT00704184|1353296|P1|Treated|Double-Blind Treatment|One participant was randomized to placebo but withdrew prior to receiving study medication.|19
555170|NCT00704184|1353292|P5|STARTED|Double-Blind Treatment||19
555171|NCT00704184|1353293|P4|STARTED|Double-Blind Treatment||18
555172|NCT00704184|1353294|P3|STARTED|Double-Blind Treatment||20
555173|NCT00704184|1353295|P2|STARTED|Double-Blind Treatment||18
555174|NCT00704184|1353296|P1|STARTED|Double-Blind Treatment||20
555175|NCT00704171|1353335|P2|NOT COMPLETED|Overall Study||0
555176|NCT00704171|1353336|P1|NOT COMPLETED|Overall Study||1
555177|NCT00704171|1353335|P2|COMPLETED|Overall Study|All control subjects completed the study.|59
555178|NCT00704171|1353336|P1|COMPLETED|Overall Study|One subject withdrew consent prior to study completion. No reason given.|61
555179|NCT00704171|1353335|P2|STARTED|Overall Study||59
555180|NCT00704171|1353336|P1|STARTED|Overall Study||62
555181|NCT00704132|1353354|P2|NOT COMPLETED|Overall Study||2
555182|NCT00704132|1353355|P1|NOT COMPLETED|Overall Study||1
555183|NCT00704132|1353354|P2|COMPLETED|Overall Study||22
555184|NCT00704132|1353355|P1|COMPLETED|Overall Study||25
555185|NCT00704132|1353354|P2|STARTED|Overall Study||24
555186|NCT00704132|1353355|P1|STARTED|Overall Study||26
555187|NCT00704028|1353363|P2|NOT COMPLETED|Overall Study||21
555188|NCT00704028|1353364|P1|NOT COMPLETED|Overall Study||12
555189|NCT00704028|1353363|P2|COMPLETED|Overall Study||57
555190|NCT00704028|1353364|P1|COMPLETED|Overall Study||70
555286|NCT00703157|1353649|P1|6 Months FU|Overall Study||25
555191|NCT00704028|1353363|P2|STARTED|Overall Study|A subject randomized to iron dextran never received study drug and was d/c due to subject request.|78
555192|NCT00704028|1353364|P1|STARTED|Overall Study||82
555193|NCT00703976|1353372|P2|NOT COMPLETED|Overall Study||0
555194|NCT00703976|1353373|P1|NOT COMPLETED|Overall Study||0
555195|NCT00703976|1353372|P2|COMPLETED|Overall Study||41
555196|NCT00703976|1353373|P1|COMPLETED|Overall Study||37
555197|NCT00703976|1353372|P2|STARTED|Overall Study||41
555198|NCT00703976|1353373|P1|STARTED|Overall Study||37
555199|NCT00703963|1353383|P2|NOT COMPLETED|Overall Study||14
555200|NCT00703963|1353384|P1|NOT COMPLETED|Overall Study||7
555201|NCT00703963|1353383|P2|COMPLETED|Overall Study||86
555202|NCT00703963|1353384|P1|COMPLETED|Overall Study||93
555203|NCT00703963|1353383|P2|STARTED|Overall Study||100
555204|NCT00703963|1353384|P1|STARTED|Overall Study||100
555205|NCT00703937|1353396|P2|NOT COMPLETED|Overall Study||93
555206|NCT00703937|1353397|P1|NOT COMPLETED|Overall Study||65
555207|NCT00703937|1353396|P2|COMPLETED|Overall Study||267
555208|NCT00703937|1353397|P1|COMPLETED|Overall Study||278
555209|NCT00703937|1353396|P2|STARTED|Overall Study||360
555210|NCT00703937|1353397|P1|STARTED|Overall Study||343
555211|NCT00703924|1353405|P2|NOT COMPLETED|Overall Study||1
555212|NCT00703924|1353406|P1|NOT COMPLETED|Overall Study||1
555213|NCT00703924|1353405|P2|COMPLETED|Overall Study||41
555214|NCT00703924|1353406|P1|COMPLETED|Overall Study||49
555215|NCT00703924|1353405|P2|STARTED|Overall Study||42
555216|NCT00703924|1353406|P1|STARTED|Overall Study||50
555217|NCT00703911|1353422|P1|NOT COMPLETED|Overall Study||10
555218|NCT00703911|1353422|P1|COMPLETED|Overall Study||92
555219|NCT00703911|1353422|P1|STARTED|Overall Study||102
555220|NCT00703885|1353450|P1|NOT COMPLETED|Overall Study||0
555221|NCT00703885|1353450|P1|COMPLETED|Overall Study||16
555222|NCT00703885|1353450|P1|STARTED|Overall Study||16
555223|NCT00703846|1353455|P1|NOT COMPLETED|Overall Study||137
555224|NCT00703846|1353455|P1|COMPLETED|Overall Study||363
555225|NCT00703846|1353455|P1|STARTED|Overall Study||500
555226|NCT00703820|1353471|P2|NOT COMPLETED|Overall Study||34
555227|NCT00703820|1353472|P1|NOT COMPLETED|Overall Study||35
555228|NCT00703820|1353471|P2|COMPLETED|Overall Study||95
555229|NCT00703820|1353472|P1|COMPLETED|Overall Study||98
555230|NCT00703820|1353471|P2|STARTED|Overall Study||129
555231|NCT00703820|1353472|P1|STARTED|Overall Study||133
555232|NCT00703781|1353481|P2|NOT COMPLETED|Overall Study||2
555233|NCT00703781|1353482|P1|NOT COMPLETED|Overall Study||2
555234|NCT00703781|1353481|P2|COMPLETED|Overall Study||61
555235|NCT00703781|1353482|P1|COMPLETED|Overall Study||61
555236|NCT00703781|1353481|P2|STARTED|Overall Study||63
555237|NCT00703781|1353482|P1|STARTED|Overall Study||63
555238|NCT00703729|1353492|P2|NOT COMPLETED|Overall Study||3
555239|NCT00703729|1353493|P1|NOT COMPLETED|Overall Study||0
555240|NCT00703729|1353492|P2|COMPLETED|Overall Study||21
555241|NCT00703729|1353493|P1|COMPLETED|Overall Study||25
555242|NCT00703729|1353492|P2|STARTED|Overall Study||24
555243|NCT00703729|1353493|P1|STARTED|Overall Study||25
555244|NCT00703677|1353527|P1|NOT COMPLETED|Overall Study||3
555245|NCT00703677|1353527|P1|COMPLETED|Overall Study||14
555246|NCT00703677|1353527|P1|STARTED|Overall Study||17
555247|NCT00703534|1353542|P2|NOT COMPLETED|Overall Study||25
555248|NCT00703534|1353543|P1|NOT COMPLETED|Overall Study||30
555249|NCT00703534|1353542|P2|COMPLETED|Overall Study||218
555250|NCT00703534|1353543|P1|COMPLETED|Overall Study||205
555251|NCT00703534|1353542|P2|STARTED|Overall Study||243
555252|NCT00703534|1353543|P1|STARTED|Overall Study||235
555253|NCT00703508|1353549|P1|NOT COMPLETED|Overall Study||0
555254|NCT00703508|1353549|P1|COMPLETED|Overall Study||26
555255|NCT00703508|1353549|P1|STARTED|Overall Study||26
555256|NCT00703391|1353563|P2|NOT COMPLETED|Overall Study||0
555257|NCT00703391|1353564|P1|NOT COMPLETED|Overall Study||0
555258|NCT00703391|1353563|P2|COMPLETED|Overall Study||6
555259|NCT00703391|1353564|P1|COMPLETED|Overall Study||12
555260|NCT00703391|1353563|P2|STARTED|Overall Study||6
555261|NCT00703391|1353564|P1|STARTED|Overall Study||12
555262|NCT00703339|1353608|P1|NOT COMPLETED|Overall Study||0
555263|NCT00703339|1353608|P1|COMPLETED|Overall Study||1
555264|NCT00703339|1353608|P1|STARTED|Overall Study||1
555265|NCT00703326|1353615|P2|NOT COMPLETED|Overall Study||225
555266|NCT00703326|1353616|P1|NOT COMPLETED|Overall Study||447
555267|NCT00703326|1353615|P2|COMPLETED|Overall Study||160
555268|NCT00703326|1353616|P1|COMPLETED|Overall Study||312
555269|NCT00703326|1353615|P2|Received at Least 1 Dose of Study Drug|Overall Study||382
555270|NCT00703326|1353616|P1|Received at Least 1 Dose of Study Drug|Overall Study||752
555271|NCT00703326|1353615|P2|STARTED|Overall Study||385
555272|NCT00703326|1353616|P1|STARTED|Overall Study||759
555273|NCT00703261|1353638|P2|NOT COMPLETED|Overall Study||6
555274|NCT00703261|1353639|P1|NOT COMPLETED|Overall Study||6
555275|NCT00703261|1353638|P2|COMPLETED|Overall Study||35
555276|NCT00703261|1353639|P1|COMPLETED|Overall Study||36
555277|NCT00703261|1353638|P2|STARTED|Overall Study||41
555278|NCT00703261|1353639|P1|STARTED|Overall Study||42
555279|NCT00703157|1353648|P2|NOT COMPLETED|Overall Study||2
555280|NCT00703157|1353649|P1|NOT COMPLETED|Overall Study||4
555281|NCT00703157|1353648|P2|COMPLETED|Overall Study||24
555282|NCT00703157|1353649|P1|COMPLETED|Overall Study||22
555283|NCT00703157|1353648|P2|24 Months FU|Overall Study||24
555284|NCT00703157|1353649|P1|24 Months FU|Overall Study||22
555285|NCT00703157|1353648|P2|6 Months FU|Overall Study||25
555287|NCT00703157|1353648|P2|STARTED|Overall Study||26
555288|NCT00703157|1353649|P1|STARTED|Overall Study||26
555289|NCT00703118|1353683|P3|NOT COMPLETED|Overall Study||22
555290|NCT00703118|1353684|P2|NOT COMPLETED|Overall Study||16
555291|NCT00703118|1353685|P1|NOT COMPLETED|Overall Study||21
555292|NCT00703118|1353683|P3|COMPLETED|Overall Study||110
555293|NCT00703118|1353684|P2|COMPLETED|Overall Study||248
555294|NCT00703118|1353685|P1|COMPLETED|Overall Study||245
555295|NCT00703118|1353683|P3|STARTED|Overall Study||132
555296|NCT00703118|1353684|P2|STARTED|Overall Study||264
555297|NCT00703118|1353685|P1|STARTED|Overall Study||266
555298|NCT00703092|1353716|P1|NOT COMPLETED|Overall Study||2
555299|NCT00703092|1353716|P1|COMPLETED|Overall Study||0
555300|NCT00703092|1353716|P1|STARTED|Overall Study||2
555301|NCT00703053|1353730|P9|NOT COMPLETED|Overall Study||1
555302|NCT00703053|1353731|P8|NOT COMPLETED|Overall Study||6
555303|NCT00703053|1353732|P7|NOT COMPLETED|Overall Study||7
555304|NCT00703053|1353733|P6|NOT COMPLETED|Overall Study||6
555305|NCT00703053|1353734|P5|NOT COMPLETED|Overall Study||1
555306|NCT00703053|1353735|P4|NOT COMPLETED|Overall Study||3
555307|NCT00703053|1353736|P3|NOT COMPLETED|Overall Study||3
555308|NCT00703053|1353737|P2|NOT COMPLETED|Overall Study||2
555309|NCT00703053|1353738|P1|NOT COMPLETED|Overall Study||1
555310|NCT00703053|1353730|P9|COMPLETED|Overall Study||102
555311|NCT00703053|1353731|P8|COMPLETED|Overall Study||91
555312|NCT00703053|1353732|P7|COMPLETED|Overall Study||45
555313|NCT00703053|1353733|P6|COMPLETED|Overall Study||43
555314|NCT00703053|1353734|P5|COMPLETED|Overall Study||50
555315|NCT00703053|1353735|P4|COMPLETED|Overall Study||46
555316|NCT00703053|1353736|P3|COMPLETED|Overall Study||48
555317|NCT00703053|1353737|P2|COMPLETED|Overall Study||24
555318|NCT00703053|1353738|P1|COMPLETED|Overall Study||26
555319|NCT00703053|1353730|P9|STARTED|Overall Study||103
555320|NCT00703053|1353731|P8|STARTED|Overall Study||97
555321|NCT00703053|1353732|P7|STARTED|Overall Study||52
555322|NCT00703053|1353733|P6|STARTED|Overall Study||49
555323|NCT00703053|1353734|P5|STARTED|Overall Study||51
555324|NCT00703053|1353735|P4|STARTED|Overall Study||49
555325|NCT00703053|1353736|P3|STARTED|Overall Study||51
555326|NCT00703053|1353737|P2|STARTED|Overall Study||26
555327|NCT00703053|1353738|P1|STARTED|Overall Study||27
555328|NCT00703014|1353924|P4|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||42
555329|NCT00703014|1353925|P3|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||47
555330|NCT00703014|1353926|P2|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
555331|NCT00703014|1353927|P1|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
555332|NCT00703014|1353924|P4|COMPLETED|Fetuses/Infants Follow Up Trial P05712|Infants in P05712 with Follow Up Completed|284
555333|NCT00703014|1353925|P3|COMPLETED|Fetuses/Infants Follow Up Trial P05712|Infants in P05712 with Follow Up Completed|305
555334|NCT00703014|1353926|P2|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
555335|NCT00703014|1353927|P1|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
555336|NCT00703014|1353924|P4|Live Born Infants|Fetuses/Infants Follow Up Trial P05712|Live born infants in Follow Up Trail P05712|315
555337|NCT00703014|1353925|P3|Live Born Infants|Fetuses/Infants Follow Up Trial P05712|Live born infants in Follow Up Trail P05712|344
555338|NCT00703014|1353926|P2|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0
555339|NCT00703014|1353927|P1|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0
555340|NCT00703014|1353924|P4|STARTED|Fetuses/Infants Follow Up Trial P05712|Fetuses in Follow Up Trial P05712|326
555341|NCT00703014|1353925|P3|STARTED|Fetuses/Infants Follow Up Trial P05712|Fetuses in Follow Up Trial P05712|352
555342|NCT00703014|1353926|P2|STARTED|Fetuses/Infants Follow Up Trial P05712||0
555343|NCT00703014|1353927|P1|STARTED|Fetuses/Infants Follow Up Trial P05712||0
555344|NCT00703014|1353924|P4|NOT COMPLETED|Mothers Follow Up Trial P05712||0
555345|NCT00703014|1353925|P3|NOT COMPLETED|Mothers Follow Up Trial P05712||0
555346|NCT00703014|1353926|P2|NOT COMPLETED|Mothers Follow Up Trial P05712||32
555347|NCT00703014|1353927|P1|NOT COMPLETED|Mothers Follow Up Trial P05712||33
555348|NCT00703014|1353924|P4|COMPLETED|Mothers Follow Up Trial P05712||0
555349|NCT00703014|1353925|P3|COMPLETED|Mothers Follow Up Trial P05712||0
555350|NCT00703014|1353926|P2|COMPLETED|Mothers Follow Up Trial P05712|Completed Follow Up in Trial P05712|235
555351|NCT00703014|1353927|P1|COMPLETED|Mothers Follow Up Trial P05712|Completed Follow Up in Trial P05712|241
555352|NCT00703014|1353924|P4|STARTED|Mothers Follow Up Trial P05712||0
555353|NCT00703014|1353925|P3|STARTED|Mothers Follow Up Trial P05712||0
555354|NCT00703014|1353926|P2|STARTED|Mothers Follow Up Trial P05712|Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712|267
555355|NCT00703014|1353927|P1|STARTED|Mothers Follow Up Trial P05712|Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712|274
555356|NCT00703014|1353924|P4|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
555357|NCT00703014|1353925|P3|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
555358|NCT00703014|1353926|P2|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||466
555359|NCT00703014|1353927|P1|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||462
555360|NCT00703014|1353924|P4|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
555361|NCT00703014|1353925|P3|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
555362|NCT00703014|1353926|P2|COMPLETED|Mothers Base Trial P05787 (NCT00696800)|ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)|286
555363|NCT00703014|1353927|P1|COMPLETED|Mothers Base Trial P05787 (NCT00696800)|ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)|295
555364|NCT00703014|1353924|P4|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0
555365|NCT00703014|1353925|P3|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0
555366|NCT00703014|1353926|P2|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)|Embryo transfer (ET) in Base Trial P05787 (NCT006968000)|704
555367|NCT00703014|1353927|P1|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)|Embryo transfer (ET) in Base Trial P05787 (NCT006968000)|672
555368|NCT00703014|1353924|P4|Treated|Mothers Base Trial P05787 (NCT00696800)||0
555369|NCT00703014|1353925|P3|Treated|Mothers Base Trial P05787 (NCT00696800)||0
555370|NCT00703014|1353926|P2|Treated|Mothers Base Trial P05787 (NCT00696800)|ITT group in Base Trial P05787 (NCT006968000)|750
555371|NCT00703014|1353927|P1|Treated|Mothers Base Trial P05787 (NCT00696800)|Intent-To-Treat (ITT) group in Base Trial P05787 (NCT00696800)|756
555372|NCT00703014|1353924|P4|STARTED|Mothers Base Trial P05787 (NCT00696800)||0
555373|NCT00703014|1353925|P3|STARTED|Mothers Base Trial P05787 (NCT00696800)||0
555374|NCT00703014|1353926|P2|STARTED|Mothers Base Trial P05787 (NCT00696800)|Randomized in Base Trial P05787 (NCT00696800)|752
555375|NCT00703014|1353927|P1|STARTED|Mothers Base Trial P05787 (NCT00696800)|Randomized in Base Trial P05787 (NCT00696800)|757
555376|NCT00702949|1353948|P3|NOT COMPLETED|Overall Study||8
555377|NCT00702949|1353949|P2|NOT COMPLETED|Overall Study||9
555378|NCT00702949|1353950|P1|NOT COMPLETED|Overall Study||5
555379|NCT00702949|1353948|P3|COMPLETED|Overall Study||54
555380|NCT00702949|1353949|P2|COMPLETED|Overall Study||57
555381|NCT00702949|1353950|P1|COMPLETED|Overall Study||58
555382|NCT00702949|1353948|P3|Evaluable for Primary Endpoint|Overall Study||51
555383|NCT00702949|1353949|P2|Evaluable for Primary Endpoint|Overall Study||56
555384|NCT00702949|1353950|P1|Evaluable for Primary Endpoint|Overall Study||56
555385|NCT00702949|1353948|P3|STARTED|Overall Study||62
555386|NCT00702949|1353949|P2|STARTED|Overall Study||66
555387|NCT00702949|1353950|P1|STARTED|Overall Study||63
555388|NCT00702923|1353975|P1|NOT COMPLETED|Overall Study||1
555389|NCT00702923|1353975|P1|COMPLETED|Overall Study||11
555390|NCT00702923|1353975|P1|STARTED|Overall Study||12
555391|NCT00702884|1353984|P1|NOT COMPLETED|Overall Study||0
555392|NCT00702884|1353984|P1|COMPLETED|Overall Study||25
555393|NCT00702884|1353984|P1|STARTED|Overall Study||25
555394|NCT00702845|1353998|P2|NOT COMPLETED|Overall Study||8
555395|NCT00702845|1353999|P1|NOT COMPLETED|Overall Study||22
555396|NCT00702845|1353998|P2|COMPLETED|Overall Study||121
555397|NCT00702845|1353999|P1|COMPLETED|Overall Study||246
555398|NCT00702845|1353998|P2|Randomized|Overall Study||128
555399|NCT00702845|1353999|P1|Randomized|Overall Study||268
555400|NCT00702845|1353998|P2|STARTED|Overall Study|Includes one treated participant who was not randomized|129
555401|NCT00702845|1353999|P1|STARTED|Overall Study||268
555402|NCT00702780|1354039|P2|NOT COMPLETED|Overall Study||8
555403|NCT00702780|1354040|P1|NOT COMPLETED|Overall Study||9
555404|NCT00702780|1354039|P2|COMPLETED|Overall Study||29
555405|NCT00702780|1354040|P1|COMPLETED|Overall Study||28
555406|NCT00702780|1354039|P2|STARTED|Overall Study||37
555407|NCT00702780|1354040|P1|STARTED|Overall Study||37
555408|NCT00702754|1354048|P1|NOT COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||24
555409|NCT00702754|1354048|P1|COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||329
555410|NCT00702754|1354048|P1|STARTED|MYOBLOC Treatment Session 8 (App 84 Wks)||353
555411|NCT00702754|1354048|P1|NOT COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||24
555412|NCT00702754|1354048|P1|COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||353
555413|NCT00702754|1354048|P1|STARTED|MYOBLOC Treatment Session 7 (App 72 Wks)||377
555414|NCT00702754|1354048|P1|NOT COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||19
555415|NCT00702754|1354048|P1|COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||377
555416|NCT00702754|1354048|P1|STARTED|MYOBLOC Treatment Session 6 (App 60 Wks)||396
555417|NCT00702754|1354048|P1|NOT COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||32
555418|NCT00702754|1354048|P1|COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||396
555419|NCT00702754|1354048|P1|STARTED|MYOBLOC Treatment Session 5 (App 48 Wks)||428
555420|NCT00702754|1354048|P1|NOT COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||22
555421|NCT00702754|1354048|P1|COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||428
555422|NCT00702754|1354048|P1|STARTED|MYOBLOC Treatment Session 4 (App 36 Wks)||450
555423|NCT00702754|1354048|P1|NOT COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||25
555424|NCT00702754|1354048|P1|COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||450
555425|NCT00702754|1354048|P1|STARTED|MYOBLOC Treatment Session 3 (App 24 Wks)||475
555426|NCT00702754|1354048|P1|NOT COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||20
555427|NCT00702754|1354048|P1|COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||475
555428|NCT00702754|1354048|P1|STARTED|MYOBLOC Treatment Session 2 (App 12 Wks)||495
555429|NCT00702754|1354048|P1|NOT COMPLETED|MYOBLOC Treatment Session 1 (Time 0)||7
555430|NCT00702754|1354048|P1|COMPLETED|MYOBLOC Treatment Session 1 (Time 0)|Approximately 70% of subjects completed at least 2 years of treatment.|495
555431|NCT00702754|1354048|P1|STARTED|MYOBLOC Treatment Session 1 (Time 0)||502
555432|NCT00702715|1354061|P2|NOT COMPLETED|Overall Study||0
555433|NCT00702715|1354062|P1|NOT COMPLETED|Overall Study||1
555434|NCT00702715|1354061|P2|COMPLETED|Overall Study||33
555435|NCT00702715|1354062|P1|COMPLETED|Overall Study||34
555436|NCT00702715|1354061|P2|STARTED|Overall Study|One subject was enrolled but did not start study|33
555437|NCT00702715|1354062|P1|STARTED|Overall Study||35
555438|NCT00702702|1354075|P1|NOT COMPLETED|Overall Study||56
555439|NCT00702702|1354075|P1|COMPLETED|Overall Study||0
555440|NCT00702702|1354075|P1|STARTED|Overall Study||56
555441|NCT00702689|1354083|P1|NOT COMPLETED|Overall Study||6
555442|NCT00702689|1354083|P1|COMPLETED|Overall Study||14
555443|NCT00702689|1354083|P1|STARTED|Overall Study||20
555444|NCT00702650|1354094|P1|NOT COMPLETED|Overall Study||20
555445|NCT00702650|1354094|P1|COMPLETED|Overall Study||135
555446|NCT00702650|1354094|P1|STARTED|Overall Study||155
555447|NCT00702624|1354114|P4|NOT COMPLETED|Fetuses/Infant Follow-up||0
555448|NCT00702624|1354115|P3|NOT COMPLETED|Fetuses/Infant Follow-up||10
555449|NCT00702624|1354116|P2|NOT COMPLETED|Fetuses/Infant Follow-up||0
555450|NCT00702624|1354117|P1|NOT COMPLETED|Fetuses/Infant Follow-up||0
555451|NCT00702624|1354114|P4|COMPLETED|Fetuses/Infant Follow-up|To complete the study, infants must have completed a follow-up visit at 4-12 weeks postpartum.|55
555452|NCT00702624|1354115|P3|COMPLETED|Fetuses/Infant Follow-up|To complete the study, infants must have completed a follow-up visit at 4-12 weeks postpartum.|78
555453|NCT00702624|1354116|P2|COMPLETED|Fetuses/Infant Follow-up||0
555454|NCT00702624|1354117|P1|COMPLETED|Fetuses/Infant Follow-up||0
555455|NCT00702624|1354114|P4|Live Born Infants|Fetuses/Infant Follow-up|Infants born to eligible mothers were followed for safety and efficacy.|55
555456|NCT00702624|1354115|P3|Live Born Infants|Fetuses/Infant Follow-up|Infants born to eligible mothers were followed for safety and efficacy|80
555457|NCT00702624|1354116|P2|Live Born Infants|Fetuses/Infant Follow-up||0
555458|NCT00702624|1354117|P1|Live Born Infants|Fetuses/Infant Follow-up||0
555459|NCT00702624|1354114|P4|STARTED|Fetuses/Infant Follow-up||55
555460|NCT00702624|1354115|P3|STARTED|Fetuses/Infant Follow-up||88
555461|NCT00702624|1354116|P2|STARTED|Fetuses/Infant Follow-up||0
555462|NCT00702624|1354117|P1|STARTED|Fetuses/Infant Follow-up||0
555463|NCT00702624|1354114|P4|NOT COMPLETED|Expectant Mother Follow-up||0
555464|NCT00702624|1354115|P3|NOT COMPLETED|Expectant Mother Follow-up||0
555465|NCT00702624|1354116|P2|NOT COMPLETED|Expectant Mother Follow-up||0
555466|NCT00702624|1354117|P1|NOT COMPLETED|Expectant Mother Follow-up||7
555467|NCT00702624|1354114|P4|COMPLETED|Expectant Mother Follow-up||0
555468|NCT00702624|1354115|P3|COMPLETED|Expectant Mother Follow-up||0
555469|NCT00702624|1354116|P2|COMPLETED|Expectant Mother Follow-up|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|45
555470|NCT00702624|1354117|P1|COMPLETED|Expectant Mother Follow-up|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|61
555471|NCT00702624|1354114|P4|STARTED|Expectant Mother Follow-up||0
555472|NCT00702624|1354115|P3|STARTED|Expectant Mother Follow-up||0
555473|NCT00702624|1354116|P2|STARTED|Expectant Mother Follow-up||45
555474|NCT00702624|1354117|P1|STARTED|Expectant Mother Follow-up||68
555475|NCT00702624|1354114|P4|NOT COMPLETED|Base Study P05690 (NCT00702845)||0
555476|NCT00702624|1354115|P3|NOT COMPLETED|Base Study P05690 (NCT00702845)||0
555477|NCT00702624|1354116|P2|NOT COMPLETED|Base Study P05690 (NCT00702845)||7
555478|NCT00702624|1354117|P1|NOT COMPLETED|Base Study P05690 (NCT00702845)||22
555479|NCT00702624|1354114|P4|COMPLETED|Base Study P05690 (NCT00702845)||0
555480|NCT00702624|1354115|P3|COMPLETED|Base Study P05690 (NCT00702845)||0
555481|NCT00702624|1354116|P2|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|121
555482|NCT00702624|1354117|P1|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|246
555483|NCT00702624|1354114|P4|STARTED|Base Study P05690 (NCT00702845)||0
555484|NCT00702624|1354115|P3|STARTED|Base Study P05690 (NCT00702845)||0
555485|NCT00702624|1354116|P2|STARTED|Base Study P05690 (NCT00702845)||128
555486|NCT00702624|1354117|P1|STARTED|Base Study P05690 (NCT00702845)||268
555487|NCT00702546|1354135|P2|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||1
555488|NCT00702546|1354136|P1|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||5
555489|NCT00702546|1354135|P2|COMPLETED|Follow Up Study P05711 (NCT00702546)|Participants with embryo transfer in any FTET cycle|24
555490|NCT00702546|1354136|P1|COMPLETED|Follow Up Study P05711 (NCT00702546)|Participants with embryo transfer in any FTET cycle|72
555491|NCT00702546|1354135|P2|STARTED|Follow Up Study P05711 (NCT00702546)|Participants from base study P05690 with at least one embryo thawed for use in FTET cycle.|25
555492|NCT00702546|1354136|P1|STARTED|Follow Up Study P05711 (NCT00702546)|Participants from base study P05690 with at least one embryo thawed for use in FTET cycle.|77
555493|NCT00702546|1354135|P2|NOT COMPLETED|Base Study P05690 (NCT00702845)||7
555494|NCT00702546|1354136|P1|NOT COMPLETED|Base Study P05690 (NCT00702845)||22
555495|NCT00702546|1354135|P2|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|121
555496|NCT00702546|1354136|P1|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|246
555497|NCT00702546|1354135|P2|STARTED|Base Study P05690 (NCT00702845)||128
555498|NCT00702546|1354136|P1|STARTED|Base Study P05690 (NCT00702845)||268
555499|NCT00702520|1354156|P4|NOT COMPLETED|Follow-up Study P05783||0
555500|NCT00702520|1354157|P3|NOT COMPLETED|Follow-up Study P05783||0
555501|NCT00702520|1354158|P2|NOT COMPLETED|Follow-up Study P05783||0
555502|NCT00702520|1354159|P1|NOT COMPLETED|Follow-up Study P05783||0
555503|NCT00702520|1354156|P4|COMPLETED|Follow-up Study P05783||11
555504|NCT00702520|1354157|P3|COMPLETED|Follow-up Study P05783||8
555505|NCT00702520|1354158|P2|COMPLETED|Follow-up Study P05783||8
555506|NCT00702520|1354159|P1|COMPLETED|Follow-up Study P05783||7
555507|NCT00702520|1354156|P4|STARTED|Follow-up Study P05783|This is the number of infants born from mothers administered Corifollitropin alpha 150 ug.|11
555508|NCT00702520|1354157|P3|STARTED|Follow-up Study P05783|This is the number of infants born from mothers administered Corifollitropin alpha 100 ug.|8
555509|NCT00702520|1354158|P2|STARTED|Follow-up Study P05783||8
555510|NCT00702520|1354159|P1|STARTED|Follow-up Study P05783||7
555511|NCT00702520|1354156|P4|NOT COMPLETED|Base Study P05788 - Follow-Up||0
555512|NCT00702520|1354157|P3|NOT COMPLETED|Base Study P05788 - Follow-Up||0
555513|NCT00702520|1354158|P2|NOT COMPLETED|Base Study P05788 - Follow-Up||10
555514|NCT00702520|1354159|P1|NOT COMPLETED|Base Study P05788 - Follow-Up||15
555515|NCT00702520|1354156|P4|COMPLETED|Base Study P05788 - Follow-Up||0
555516|NCT00702520|1354157|P3|COMPLETED|Base Study P05788 - Follow-Up||0
555517|NCT00702520|1354158|P2|COMPLETED|Base Study P05788 - Follow-Up||8
555518|NCT00702520|1354159|P1|COMPLETED|Base Study P05788 - Follow-Up||7
555519|NCT00702520|1354156|P4|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0
555520|NCT00702520|1354157|P3|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0
555521|NCT00702520|1354158|P2|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||8
555522|NCT00702520|1354159|P1|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||7
555523|NCT00702520|1354156|P4|STARTED|Base Study P05788 - Follow-Up||0
555524|NCT00702520|1354157|P3|STARTED|Base Study P05788 - Follow-Up||0
555525|NCT00702520|1354158|P2|STARTED|Base Study P05788 - Follow-Up||18
555526|NCT00702520|1354159|P1|STARTED|Base Study P05788 - Follow-Up||22
555527|NCT00702520|1354156|P4|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0
555528|NCT00702520|1354157|P3|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0
555529|NCT00702520|1354158|P2|NOT COMPLETED|Base Study P05788 - Embryo Transfer||6
555530|NCT00702520|1354159|P1|NOT COMPLETED|Base Study P05788 - Embryo Transfer||3
555531|NCT00702520|1354156|P4|COMPLETED|Base Study P05788 - Embryo Transfer||0
555532|NCT00702520|1354157|P3|COMPLETED|Base Study P05788 - Embryo Transfer||0
555533|NCT00702520|1354158|P2|COMPLETED|Base Study P05788 - Embryo Transfer||18
555534|NCT00702520|1354159|P1|COMPLETED|Base Study P05788 - Embryo Transfer||22
555535|NCT00702520|1354156|P4|Embryo Transfer|Base Study P05788 - Embryo Transfer||0
555536|NCT00702520|1354157|P3|Embryo Transfer|Base Study P05788 - Embryo Transfer||0
555537|NCT00702520|1354158|P2|Embryo Transfer|Base Study P05788 - Embryo Transfer||18
555538|NCT00702520|1354159|P1|Embryo Transfer|Base Study P05788 - Embryo Transfer||22
555539|NCT00702520|1354156|P4|STARTED|Base Study P05788 - Embryo Transfer||0
555540|NCT00702520|1354157|P3|STARTED|Base Study P05788 - Embryo Transfer||0
555541|NCT00702520|1354158|P2|STARTED|Base Study P05788 - Embryo Transfer||24
555542|NCT00702520|1354159|P1|STARTED|Base Study P05788 - Embryo Transfer||25
555543|NCT00702520|1354156|P4|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
555544|NCT00702520|1354157|P3|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
555545|NCT00702520|1354158|P2|NOT COMPLETED|Base Study P05788 - Assigned Treatment||1
555546|NCT00702520|1354159|P1|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
555547|NCT00702520|1354156|P4|COMPLETED|Base Study P05788 - Assigned Treatment||0
555548|NCT00702520|1354157|P3|COMPLETED|Base Study P05788 - Assigned Treatment||0
555549|NCT00702520|1354158|P2|COMPLETED|Base Study P05788 - Assigned Treatment||24
555550|NCT00702520|1354159|P1|COMPLETED|Base Study P05788 - Assigned Treatment||25
555551|NCT00702520|1354156|P4|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0
555552|NCT00702520|1354157|P3|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0
555553|NCT00702520|1354158|P2|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||24
555554|NCT00702520|1354159|P1|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||25
555555|NCT00702520|1354156|P4|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0
555556|NCT00702520|1354157|P3|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0
555557|NCT00702520|1354158|P2|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||24
555558|NCT00702520|1354159|P1|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||25
555559|NCT00702520|1354156|P4|STARTED|Base Study P05788 - Assigned Treatment||0
555560|NCT00702520|1354157|P3|STARTED|Base Study P05788 - Assigned Treatment||0
555561|NCT00702520|1354158|P2|STARTED|Base Study P05788 - Assigned Treatment||25
555562|NCT00702520|1354159|P1|STARTED|Base Study P05788 - Assigned Treatment||25
555563|NCT00702507|1354175|P1|NOT COMPLETED|Follow-up Phase||27
555564|NCT00702507|1354175|P1|COMPLETED|Follow-up Phase||132
555565|NCT00702507|1354175|P1|STARTED|Follow-up Phase||159
555566|NCT00702507|1354175|P1|NOT COMPLETED|Initial Treatment Phase||41
555567|NCT00702507|1354175|P1|COMPLETED|Initial Treatment Phase||159
555568|NCT00702507|1354175|P1|STARTED|Initial Treatment Phase||200
555569|NCT00702468|1354189|P2|NOT COMPLETED|Overall Study||16
555570|NCT00702468|1354190|P1|NOT COMPLETED|Overall Study||3
555571|NCT00702468|1354189|P2|COMPLETED|Overall Study||2
555572|NCT00702468|1354190|P1|COMPLETED|Overall Study||15
555573|NCT00702468|1354189|P2|STARTED|Overall Study||18
555574|NCT00702468|1354190|P1|STARTED|Overall Study||18
555575|NCT00702403|1354212|P1|NOT COMPLETED|From Engraftment to Study Completion||27
555576|NCT00702403|1354212|P1|COMPLETED|From Engraftment to Study Completion||13
555577|NCT00702403|1354212|P1|Patient Drop-outs|From Engraftment to Study Completion||27
555578|NCT00702403|1354212|P1|STARTED|From Engraftment to Study Completion||40
555579|NCT00702403|1354212|P1|NOT COMPLETED|From Consent to Engraftment||17
555580|NCT00702403|1354212|P1|COMPLETED|From Consent to Engraftment|40 of 57 originally consented subjects remained eligible at engraftment (= the 2nd ITT population)|40
555581|NCT00702403|1354212|P1|Ineligible for Study Drug|From Consent to Engraftment||17
555582|NCT00702403|1354212|P1|STARTED|From Consent to Engraftment|"57 agreed to participate and completed informed consent (= the 1st intention to treat population)"|57
555583|NCT00702377|1354222|P2|NOT COMPLETED|Overall Study||3
555584|NCT00702377|1354223|P1|NOT COMPLETED|Overall Study||1
555585|NCT00702377|1354222|P2|COMPLETED|Overall Study||53
555586|NCT00702377|1354223|P1|COMPLETED|Overall Study||52
555587|NCT00702377|1354222|P2|STARTED|Overall Study||56
555588|NCT00702377|1354223|P1|STARTED|Overall Study||53
555589|NCT00702364|1354235|P2|NOT COMPLETED|Overall Study||4
555590|NCT00702364|1354236|P1|NOT COMPLETED|Overall Study||2
555591|NCT00702364|1354235|P2|COMPLETED|Overall Study||25
555592|NCT00702364|1354236|P1|COMPLETED|Overall Study||24
555593|NCT00702364|1354235|P2|STARTED|Overall Study||29
555594|NCT00702364|1354236|P1|STARTED|Overall Study||26
555595|NCT00702338|1354248|P3|NOT COMPLETED|Follow-up Study: Infant FU||2
555596|NCT00702338|1354249|P2|NOT COMPLETED|Follow-up Study: Infant FU||0
555597|NCT00702338|1354250|P1|NOT COMPLETED|Follow-up Study: Infant FU||0
555598|NCT00702338|1354248|P3|COMPLETED|Follow-up Study: Infant FU||0
555599|NCT00702338|1354249|P2|COMPLETED|Follow-up Study: Infant FU||0
555600|NCT00702338|1354250|P1|COMPLETED|Follow-up Study: Infant FU||0
555601|NCT00702338|1354248|P3|STARTED|Follow-up Study: Infant FU|Participants died on day of delivery, did not complete follow-up visit at 4-12 weeks postpartum.|2
555602|NCT00702338|1354249|P2|STARTED|Follow-up Study: Infant FU||0
555603|NCT00702338|1354250|P1|STARTED|Follow-up Study: Infant FU||0
555604|NCT00702338|1354248|P3|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0
555605|NCT00702338|1354249|P2|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||1
555606|NCT00702338|1354250|P1|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0
555607|NCT00702338|1354248|P3|COMPLETED|Follow-up Study: Expectant Mothers FU||0
555608|NCT00702338|1354249|P2|COMPLETED|Follow-up Study: Expectant Mothers FU|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|0
555609|NCT00702338|1354250|P1|COMPLETED|Follow-up Study: Expectant Mothers FU||0
555610|NCT00702338|1354248|P3|STARTED|Follow-up Study: Expectant Mothers FU||0
555611|NCT00702338|1354249|P2|STARTED|Follow-up Study: Expectant Mothers FU|To enroll in follow-up study, confirmed pregnancy at ≥10 wks after hCG bolus injection was required|1
555612|NCT00702338|1354250|P1|STARTED|Follow-up Study: Expectant Mothers FU|To enroll in follow-up study, confirmed pregnancy at ≥10 wks after hCG bolus injection was required|0
555613|NCT00702338|1354248|P3|NOT COMPLETED|Base Study (NCT00697255)||0
555614|NCT00702338|1354249|P2|NOT COMPLETED|Base Study (NCT00697255)||2
555615|NCT00702338|1354250|P1|NOT COMPLETED|Base Study (NCT00697255)||3
555616|NCT00702338|1354248|P3|COMPLETED|Base Study (NCT00697255)||0
555617|NCT00702338|1354249|P2|COMPLETED|Base Study (NCT00697255)|To complete the study, participants must have received hCG bolus injection.|1
555618|NCT00702338|1354250|P1|COMPLETED|Base Study (NCT00697255)|To complete the study, participants must have received hCG bolus injection.|2
555619|NCT00702338|1354248|P3|STARTED|Base Study (NCT00697255)||0
555620|NCT00702338|1354249|P2|STARTED|Base Study (NCT00697255)||3
555621|NCT00702338|1354250|P1|STARTED|Base Study (NCT00697255)||5
555622|NCT00702325|1354266|P2|NOT COMPLETED|Overall Study||53
555623|NCT00702325|1354267|P1|NOT COMPLETED|Overall Study||38
555624|NCT00702325|1354266|P2|COMPLETED|Overall Study|Completed participants based on randomized population (155) minus discontinued participants (53).|102
555625|NCT00702325|1354267|P1|COMPLETED|Overall Study|Completed participants based on randomized population (156) minus discontinued participants (38).|118
555626|NCT00702325|1354266|P2|STARTED|Overall Study|Randomized|155
555627|NCT00702325|1354267|P1|STARTED|Overall Study|Randomized|156
555628|NCT00702299|1354319|P1|NOT COMPLETED|Overall Study||0
555629|NCT00702299|1354319|P1|COMPLETED|Overall Study||15
555630|NCT00702299|1354319|P1|STARTED|Overall Study||15
555631|NCT00702273|1354332|P2|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||29
555632|NCT00702273|1354333|P1|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||20
555633|NCT00702273|1354332|P2|COMPLETED|Follow Up Study P05716 (NCT00702273)|Participants with embryo transfer in any FTET cycle|147
555634|NCT00702273|1354333|P1|COMPLETED|Follow Up Study P05716 (NCT00702273)|Participants with embryo transfer in any FTET cycle|148
555635|NCT00702273|1354332|P2|STARTED|Follow Up Study P05716 (NCT00702273)|Participants from base study, who had at least one embryo thawed for a FTET cycle|176
555636|NCT00702273|1354333|P1|STARTED|Follow Up Study P05716 (NCT00702273)|Participants from base study,who had at least one embryo thawed for a FTET cycle.|168
555637|NCT00702273|1354332|P2|NOT COMPLETED|Base Study P05787 (NCT00696800)||48
555638|NCT00702273|1354333|P1|NOT COMPLETED|Base Study P05787 (NCT00696800)||85
555639|NCT00702273|1354332|P2|COMPLETED|Base Study P05787 (NCT00696800)|To complete study, participants from the base study P05787 (NCT00696800) had embryos transferred|704
555640|NCT00702273|1354333|P1|COMPLETED|Base Study P05787 (NCT00696800)|To complete study, participants from the base study P05787 (NCT00696800) had embryos transferred|672
555641|NCT00702273|1354332|P2|Treated|Base Study P05787 (NCT00696800)|Participants from the Intent to Treat group (ITT) from the base study P05787 (NCT00696800)|750
555642|NCT00702273|1354333|P1|Treated|Base Study P05787 (NCT00696800)|Participants from the Intent to Treat group (ITT) from the base study P05787 (NCT00696800)|756
555643|NCT00702273|1354332|P2|STARTED|Base Study P05787 (NCT00696800)|Participants randomized to the base study P05787 (NCT00696800)|752
555644|NCT00702273|1354333|P1|STARTED|Base Study P05787 (NCT00696800)|Participants randomized to the base study P05787 (NCT00696800)|757
555645|NCT00702234|1354351|P2|NOT COMPLETED|Follow-up Study: Fetuses/Infants||27
555646|NCT00702234|1354352|P1|NOT COMPLETED|Follow-up Study: Fetuses/Infants||0
555647|NCT00702234|1354351|P2|COMPLETED|Follow-up Study: Fetuses/Infants|All 288 who completed were live born infants|288
555648|NCT00702234|1354352|P1|COMPLETED|Follow-up Study: Fetuses/Infants||0
555649|NCT00702234|1354351|P2|Live Born Infants|Follow-up Study: Fetuses/Infants|Of the 11 that were not live born infants, outcome is known for 8 (fetus was lost) and unknown for 3|304
555650|NCT00702234|1354352|P1|Live Born Infants|Follow-up Study: Fetuses/Infants||0
555651|NCT00702234|1354351|P2|STARTED|Follow-up Study: Fetuses/Infants|Fetuses present 10 weeks after fresh ET and/or at enrollment of expectant mother in follow-up study|315
555652|NCT00702234|1354352|P1|STARTED|Follow-up Study: Fetuses/Infants||0
555653|NCT00702234|1354351|P2|NOT COMPLETED|Follow-up Study: Expectant Mothers||0
555654|NCT00702234|1354352|P1|NOT COMPLETED|Follow-up Study: Expectant Mothers||22
555655|NCT00702234|1354351|P2|COMPLETED|Follow-up Study: Expectant Mothers||0
555656|NCT00702234|1354352|P1|COMPLETED|Follow-up Study: Expectant Mothers||246
555657|NCT00702234|1354351|P2|STARTED|Follow-up Study: Expectant Mothers||0
555658|NCT00702234|1354352|P1|STARTED|Follow-up Study: Expectant Mothers|"A participant could enter follow-up study without meeting definition for Completion of base study"|268
555659|NCT00702234|1354351|P2|NOT COMPLETED|Base Study (NCT00696878)||0
555660|NCT00702234|1354352|P1|NOT COMPLETED|Base Study (NCT00696878)||504
555661|NCT00702234|1354351|P2|COMPLETED|Base Study (NCT00696878)||0
555662|NCT00702234|1354352|P1|COMPLETED|Base Study (NCT00696878)||178
555663|NCT00702234|1354351|P2|STARTED|Base Study (NCT00696878)||0
555664|NCT00702234|1354352|P1|STARTED|Base Study (NCT00696878)||682
555665|NCT00702221|1354363|P2|NOT COMPLETED|Overall Study||3
555666|NCT00702221|1354364|P1|NOT COMPLETED|Overall Study||4
555667|NCT00702221|1354363|P2|COMPLETED|Overall Study||7
555668|NCT00702221|1354364|P1|COMPLETED|Overall Study||6
555669|NCT00702221|1354363|P2|STARTED|Overall Study||10
555670|NCT00702221|1354364|P1|STARTED|Overall Study||10
555671|NCT00702208|1354370|P1|NOT COMPLETED|Overall Study||31
555672|NCT00702208|1354370|P1|COMPLETED|Overall Study||167
555673|NCT00702208|1354370|P1|STARTED|Overall Study||198
555674|NCT00702143|1354379|P3|NOT COMPLETED|Overall Study||1
555675|NCT00702143|1354380|P2|NOT COMPLETED|Overall Study||0
555676|NCT00702143|1354381|P1|NOT COMPLETED|Overall Study||0
555677|NCT00702143|1354379|P3|COMPLETED|Overall Study||78
555678|NCT00702143|1354380|P2|COMPLETED|Overall Study||60
555679|NCT00702143|1354381|P1|COMPLETED|Overall Study||45
555680|NCT00702143|1354379|P3|STARTED|Overall Study||79
555681|NCT00702143|1354380|P2|STARTED|Overall Study||60
555682|NCT00702143|1354381|P1|STARTED|Overall Study||45
555683|NCT00701935|1354395|P2|NOT COMPLETED|Overall Study||11
555684|NCT00701935|1354396|P1|NOT COMPLETED|Overall Study||16
555685|NCT00701935|1354395|P2|COMPLETED|Overall Study||26
555686|NCT00701935|1354396|P1|COMPLETED|Overall Study||27
555687|NCT00701935|1354395|P2|STARTED|Overall Study||37
555688|NCT00701935|1354396|P1|STARTED|Overall Study||43
555689|NCT00701805|1354430|P4|NOT COMPLETED|Overall Study||4
555690|NCT00701805|1354431|P3|NOT COMPLETED|Overall Study||7
555691|NCT00701805|1354432|P2|NOT COMPLETED|Overall Study||4
555692|NCT00701805|1354433|P1|NOT COMPLETED|Overall Study||3
555693|NCT00701805|1354430|P4|COMPLETED|Overall Study||22
555694|NCT00701805|1354431|P3|COMPLETED|Overall Study||16
555695|NCT00701805|1354432|P2|COMPLETED|Overall Study||25
555696|NCT00701805|1354433|P1|COMPLETED|Overall Study||23
555697|NCT00701805|1354430|P4|STARTED|Overall Study||26
555698|NCT00701805|1354431|P3|STARTED|Overall Study||23
555699|NCT00701805|1354432|P2|STARTED|Overall Study||29
555700|NCT00701805|1354433|P1|STARTED|Overall Study||26
555701|NCT00701779|1354483|P1|NOT COMPLETED|Overall Study||9
555702|NCT00701779|1354483|P1|COMPLETED|Overall Study||54
555703|NCT00701779|1354483|P1|12 Month|Overall Study||54
555704|NCT00701779|1354483|P1|9 Month|Overall Study||56
555705|NCT00701779|1354483|P1|6 Month|Overall Study||58
555706|NCT00701779|1354483|P1|3 Month|Overall Study||60
555707|NCT00701779|1354483|P1|STARTED|Overall Study||63
555708|NCT00701727|1354492|P2|NOT COMPLETED|Second Treatment Period||0
555709|NCT00701727|1354493|P1|NOT COMPLETED|Second Treatment Period||2
555710|NCT00701727|1354492|P2|COMPLETED|Second Treatment Period||13
555711|NCT00701727|1354493|P1|COMPLETED|Second Treatment Period||13
555712|NCT00701727|1354492|P2|STARTED|Second Treatment Period||13
555713|NCT00701727|1354493|P1|STARTED|Second Treatment Period||15
555714|NCT00701727|1354492|P2|NOT COMPLETED|First Treatment Period||2
555715|NCT00701727|1354493|P1|NOT COMPLETED|First Treatment Period||1
555716|NCT00701727|1354492|P2|COMPLETED|First Treatment Period||13
555717|NCT00701727|1354493|P1|COMPLETED|First Treatment Period||15
555718|NCT00701727|1354492|P2|STARTED|First Treatment Period||15
555719|NCT00701727|1354493|P1|STARTED|First Treatment Period||16
555720|NCT00701714|1354513|P2|NOT COMPLETED|Safety Follow-up Period (6 Months)||7
555721|NCT00701714|1354514|P1|NOT COMPLETED|Safety Follow-up Period (6 Months)||7
555722|NCT00701714|1354513|P2|COMPLETED|Safety Follow-up Period (6 Months)||112
555723|NCT00701714|1354514|P1|COMPLETED|Safety Follow-up Period (6 Months)||144
555724|NCT00701714|1354513|P2|STARTED|Safety Follow-up Period (6 Months)|Study terminated prematurely, all available randomized patients followed-up 6 months for safety|119
555725|NCT00701714|1354514|P1|STARTED|Safety Follow-up Period (6 Months)|Study terminated prematurely, all available randomized patients followed-up 6 months for safety|151
555726|NCT00701714|1354513|P2|NOT COMPLETED|Treatment Period (up to 1 Year)||134
555727|NCT00701714|1354514|P1|NOT COMPLETED|Treatment Period (up to 1 Year)||137
555728|NCT00701714|1354513|P2|COMPLETED|Treatment Period (up to 1 Year)||29
555729|NCT00701714|1354514|P1|COMPLETED|Treatment Period (up to 1 Year)||37
555730|NCT00701714|1354513|P2|STARTED|Treatment Period (up to 1 Year)||163
555731|NCT00701714|1354514|P1|STARTED|Treatment Period (up to 1 Year)||174
555732|NCT00701675|1354529|P3|NOT COMPLETED|Overall Study||7
555733|NCT00701675|1354530|P2|NOT COMPLETED|Overall Study||8
555734|NCT00701675|1354531|P1|NOT COMPLETED|Overall Study||4
555735|NCT00701675|1354529|P3|COMPLETED|Overall Study||7
555736|NCT00701675|1354530|P2|COMPLETED|Overall Study||6
555737|NCT00701675|1354531|P1|COMPLETED|Overall Study||10
555738|NCT00701675|1354529|P3|STARTED|Overall Study||14
555739|NCT00701675|1354530|P2|STARTED|Overall Study||14
555740|NCT00701675|1354531|P1|STARTED|Overall Study||14
555741|NCT00701662|1354539|P1|NOT COMPLETED|Overall Study||1
555742|NCT00701662|1354539|P1|COMPLETED|Overall Study||7
555743|NCT00701662|1354539|P1|STARTED|Overall Study||8
555744|NCT00701636|1354558|P2|NOT COMPLETED|Overall Study||0
555745|NCT00701636|1354559|P1|NOT COMPLETED|Overall Study||0
555746|NCT00701636|1354558|P2|COMPLETED|Overall Study||15
555747|NCT00701636|1354559|P1|COMPLETED|Overall Study||15
555748|NCT00701636|1354558|P2|STARTED|Overall Study||15
555749|NCT00701636|1354559|P1|STARTED|Overall Study||15
555750|NCT00701558|1354564|P1|NOT COMPLETED|Overall Study||15
555751|NCT00701558|1354564|P1|COMPLETED|Overall Study||4
555752|NCT00701558|1354564|P1|STARTED|Overall Study||19
555753|NCT00701441|1354572|P2|NOT COMPLETED|Overall Study||4
555754|NCT00701441|1354573|P1|NOT COMPLETED|Overall Study||0
555755|NCT00701441|1354572|P2|COMPLETED|Overall Study||12
555756|NCT00701441|1354573|P1|COMPLETED|Overall Study||9
555757|NCT00701441|1354572|P2|STARTED|Overall Study||16
555758|NCT00701441|1354573|P1|STARTED|Overall Study||9
555759|NCT00701415|1354585|P2|NOT COMPLETED|Overall Study||1
555760|NCT00701415|1354586|P1|NOT COMPLETED|Overall Study||1
555761|NCT00701415|1354585|P2|COMPLETED|Overall Study||14
555762|NCT00701415|1354586|P1|COMPLETED|Overall Study||15
555763|NCT00701415|1354585|P2|STARTED|Overall Study||15
555764|NCT00701415|1354586|P1|STARTED|Overall Study||16
555765|NCT00701389|1354596|P4|NOT COMPLETED|Period 4||0
555766|NCT00701389|1354597|P3|NOT COMPLETED|Period 4||0
555767|NCT00701389|1354598|P2|NOT COMPLETED|Period 4||0
555768|NCT00701389|1354599|P1|NOT COMPLETED|Period 4||0
555769|NCT00701389|1354596|P4|COMPLETED|Period 4||6
555770|NCT00701389|1354597|P3|COMPLETED|Period 4||6
555771|NCT00701389|1354598|P2|COMPLETED|Period 4||6
555772|NCT00701389|1354599|P1|COMPLETED|Period 4||6
555773|NCT00701389|1354596|P4|STARTED|Period 4||6
555774|NCT00701389|1354597|P3|STARTED|Period 4||6
555775|NCT00701389|1354598|P2|STARTED|Period 4||6
555776|NCT00701389|1354599|P1|STARTED|Period 4||6
555777|NCT00701389|1354596|P4|NOT COMPLETED|Period 3||0
555778|NCT00701389|1354597|P3|NOT COMPLETED|Period 3||0
555779|NCT00701389|1354598|P2|NOT COMPLETED|Period 3||0
555780|NCT00701389|1354599|P1|NOT COMPLETED|Period 3||0
555781|NCT00701389|1354596|P4|COMPLETED|Period 3||6
555782|NCT00701389|1354597|P3|COMPLETED|Period 3||6
555783|NCT00701389|1354598|P2|COMPLETED|Period 3||6
555784|NCT00701389|1354599|P1|COMPLETED|Period 3||6
555785|NCT00701389|1354596|P4|STARTED|Period 3||6
555786|NCT00701389|1354597|P3|STARTED|Period 3||6
555787|NCT00701389|1354598|P2|STARTED|Period 3||6
555788|NCT00701389|1354599|P1|STARTED|Period 3||6
555789|NCT00701389|1354596|P4|NOT COMPLETED|Period 2||0
555790|NCT00701389|1354597|P3|NOT COMPLETED|Period 2||0
555791|NCT00701389|1354598|P2|NOT COMPLETED|Period 2||0
555792|NCT00701389|1354599|P1|NOT COMPLETED|Period 2||0
555793|NCT00701389|1354596|P4|COMPLETED|Period 2||6
555794|NCT00701389|1354597|P3|COMPLETED|Period 2||6
555795|NCT00701389|1354598|P2|COMPLETED|Period 2||6
555796|NCT00701389|1354599|P1|COMPLETED|Period 2||6
555797|NCT00701389|1354596|P4|STARTED|Period 2||6
555798|NCT00701389|1354597|P3|STARTED|Period 2||6
555799|NCT00701389|1354598|P2|STARTED|Period 2||6
555800|NCT00701389|1354599|P1|STARTED|Period 2||6
555801|NCT00701389|1354596|P4|NOT COMPLETED|Period 1||0
555802|NCT00701389|1354597|P3|NOT COMPLETED|Period 1||0
555803|NCT00701389|1354598|P2|NOT COMPLETED|Period 1||0
555804|NCT00701389|1354599|P1|NOT COMPLETED|Period 1||0
555805|NCT00701389|1354596|P4|COMPLETED|Period 1||6
555806|NCT00701389|1354597|P3|COMPLETED|Period 1||6
555807|NCT00701389|1354598|P2|COMPLETED|Period 1||6
555808|NCT00701389|1354599|P1|COMPLETED|Period 1||6
555809|NCT00701389|1354596|P4|STARTED|Period 1||6
555810|NCT00701389|1354597|P3|STARTED|Period 1||6
555811|NCT00701389|1354598|P2|STARTED|Period 1||6
555812|NCT00701389|1354599|P1|STARTED|Period 1||6
555813|NCT00701363|1354621|P4|NOT COMPLETED|Treatment Phase 2||0
555814|NCT00701363|1354622|P3|NOT COMPLETED|Treatment Phase 2||2
555815|NCT00701363|1354623|P2|NOT COMPLETED|Treatment Phase 2||0
555816|NCT00701363|1354624|P1|NOT COMPLETED|Treatment Phase 2||0
555817|NCT00701363|1354621|P4|COMPLETED|Treatment Phase 2||26
555818|NCT00701363|1354622|P3|COMPLETED|Treatment Phase 2||68
555819|NCT00701363|1354623|P2|COMPLETED|Treatment Phase 2||13
555820|NCT00701363|1354624|P1|COMPLETED|Treatment Phase 2||0
555821|NCT00701363|1354621|P4|STARTED|Treatment Phase 2||26
555822|NCT00701363|1354622|P3|STARTED|Treatment Phase 2||70
555823|NCT00701363|1354623|P2|STARTED|Treatment Phase 2||13
555824|NCT00701363|1354624|P1|STARTED|Treatment Phase 2||0
555825|NCT00701363|1354621|P4|NOT COMPLETED|Treatment Phase 1||0
555826|NCT00701363|1354622|P3|NOT COMPLETED|Treatment Phase 1||0
555827|NCT00701363|1354623|P2|NOT COMPLETED|Treatment Phase 1||0
555828|NCT00701363|1354624|P1|NOT COMPLETED|Treatment Phase 1||15
555829|NCT00701363|1354621|P4|COMPLETED|Treatment Phase 1||0
555830|NCT00701363|1354622|P3|COMPLETED|Treatment Phase 1||0
555831|NCT00701363|1354623|P2|COMPLETED|Treatment Phase 1||0
555832|NCT00701363|1354624|P1|COMPLETED|Treatment Phase 1||109
555833|NCT00701363|1354621|P4|STARTED|Treatment Phase 1||0
555834|NCT00701363|1354622|P3|STARTED|Treatment Phase 1||0
555835|NCT00701363|1354623|P2|STARTED|Treatment Phase 1||0
555836|NCT00701363|1354624|P1|STARTED|Treatment Phase 1||124
555837|NCT00701363|1354621|P4|NOT COMPLETED|Screening (Pre-assignment) Phase||0
555923|NCT00701051|1354835|P2|COMPLETED|Screening||0
555838|NCT00701363|1354622|P3|NOT COMPLETED|Screening (Pre-assignment) Phase||0
555839|NCT00701363|1354623|P2|NOT COMPLETED|Screening (Pre-assignment) Phase||0
555840|NCT00701363|1354624|P1|NOT COMPLETED|Screening (Pre-assignment) Phase||4
555841|NCT00701363|1354621|P4|COMPLETED|Screening (Pre-assignment) Phase||0
555842|NCT00701363|1354622|P3|COMPLETED|Screening (Pre-assignment) Phase||0
555843|NCT00701363|1354623|P2|COMPLETED|Screening (Pre-assignment) Phase||0
555844|NCT00701363|1354624|P1|COMPLETED|Screening (Pre-assignment) Phase||124
555845|NCT00701363|1354621|P4|STARTED|Screening (Pre-assignment) Phase||0
555846|NCT00701363|1354622|P3|STARTED|Screening (Pre-assignment) Phase||0
555847|NCT00701363|1354623|P2|STARTED|Screening (Pre-assignment) Phase||0
555848|NCT00701363|1354624|P1|STARTED|Screening (Pre-assignment) Phase||128
555849|NCT00701311|1354664|P1|NOT COMPLETED|Overall Study||8
555850|NCT00701311|1354664|P1|COMPLETED|Overall Study|Eight subjects did not complete full period of treatment but their data was included in analysis.|9
555851|NCT00701311|1354664|P1|STARTED|Overall Study||17
555852|NCT00701129|1354668|P1|NOT COMPLETED|Overall Study||2
555853|NCT00701129|1354668|P1|COMPLETED|Overall Study||2
555854|NCT00701129|1354668|P1|Full Analysis Set (FAS)|Overall Study|All enrolled patients who signed informed consent, received at least 1 dose of alglucosidase alfa.|4
555855|NCT00701129|1354668|P1|STARTED|Overall Study||4
555856|NCT00701103|1354690|P11|NOT COMPLETED|Overall Study||11
555857|NCT00701103|1354691|P10|NOT COMPLETED|Overall Study||11
555858|NCT00701103|1354692|P9|NOT COMPLETED|Overall Study||9
555859|NCT00701103|1354693|P8|NOT COMPLETED|Overall Study||7
555860|NCT00701103|1354694|P7|NOT COMPLETED|Overall Study||8
555861|NCT00701103|1354695|P6|NOT COMPLETED|Overall Study||6
555862|NCT00701103|1354696|P5|NOT COMPLETED|Overall Study||6
555863|NCT00701103|1354697|P4|NOT COMPLETED|Overall Study||6
555864|NCT00701103|1354698|P3|NOT COMPLETED|Overall Study||8
555865|NCT00701103|1354699|P2|NOT COMPLETED|Overall Study||3
555866|NCT00701103|1354700|P1|NOT COMPLETED|Overall Study||5
555867|NCT00701103|1354690|P11|COMPLETED|Overall Study||0
555868|NCT00701103|1354691|P10|COMPLETED|Overall Study||0
555869|NCT00701103|1354692|P9|COMPLETED|Overall Study||0
555870|NCT00701103|1354693|P8|COMPLETED|Overall Study||0
555871|NCT00701103|1354694|P7|COMPLETED|Overall Study||0
555872|NCT00701103|1354695|P6|COMPLETED|Overall Study||0
555873|NCT00701103|1354696|P5|COMPLETED|Overall Study||0
555874|NCT00701103|1354697|P4|COMPLETED|Overall Study||0
555875|NCT00701103|1354698|P3|COMPLETED|Overall Study||0
555876|NCT00701103|1354699|P2|COMPLETED|Overall Study||0
555877|NCT00701103|1354700|P1|COMPLETED|Overall Study||0
555878|NCT00701103|1354690|P11|STARTED|Overall Study||11
555879|NCT00701103|1354691|P10|STARTED|Overall Study||11
555880|NCT00701103|1354692|P9|STARTED|Overall Study||9
555881|NCT00701103|1354693|P8|STARTED|Overall Study||7
555882|NCT00701103|1354694|P7|STARTED|Overall Study||8
555883|NCT00701103|1354695|P6|STARTED|Overall Study||6
555884|NCT00701103|1354696|P5|STARTED|Overall Study||6
555885|NCT00701103|1354697|P4|STARTED|Overall Study||6
555886|NCT00701103|1354698|P3|STARTED|Overall Study||8
555887|NCT00701103|1354699|P2|STARTED|Overall Study||3
555888|NCT00701103|1354700|P1|STARTED|Overall Study||5
555889|NCT00701090|1354806|P2|NOT COMPLETED|Overall Study||51
555890|NCT00701090|1354807|P1|NOT COMPLETED|Overall Study||48
555891|NCT00701090|1354806|P2|COMPLETED|Overall Study||468
555892|NCT00701090|1354807|P1|COMPLETED|Overall Study||468
555893|NCT00701090|1354806|P2|STARTED|Overall Study||519
555894|NCT00701090|1354807|P1|STARTED|Overall Study||516
555895|NCT00701064|1354825|P2|NOT COMPLETED|Overall Study||4
555896|NCT00701064|1354826|P1|NOT COMPLETED|Overall Study||4
555897|NCT00701064|1354825|P2|COMPLETED|Overall Study||32
555898|NCT00701064|1354826|P1|COMPLETED|Overall Study||31
555899|NCT00701064|1354825|P2|STARTED|Overall Study||36
555900|NCT00701064|1354826|P1|STARTED|Overall Study||35
555901|NCT00701051|1354834|P3|NOT COMPLETED|Detraining Intervention (Optional)||0
555902|NCT00701051|1354835|P2|NOT COMPLETED|Detraining Intervention (Optional)||0
555903|NCT00701051|1354836|P1|NOT COMPLETED|Detraining Intervention (Optional)||0
555904|NCT00701051|1354834|P3|COMPLETED|Detraining Intervention (Optional)||6
555905|NCT00701051|1354835|P2|COMPLETED|Detraining Intervention (Optional)||6
555906|NCT00701051|1354836|P1|COMPLETED|Detraining Intervention (Optional)||0
555907|NCT00701051|1354834|P3|STARTED|Detraining Intervention (Optional)|Participation in this period was optional.|6
555908|NCT00701051|1354835|P2|STARTED|Detraining Intervention (Optional)|Participation in this period was optional.|6
555909|NCT00701051|1354836|P1|STARTED|Detraining Intervention (Optional)||0
555910|NCT00701051|1354834|P3|NOT COMPLETED|Exercise Intervention||3
555911|NCT00701051|1354835|P2|NOT COMPLETED|Exercise Intervention||5
555912|NCT00701051|1354836|P1|NOT COMPLETED|Exercise Intervention||0
555913|NCT00701051|1354834|P3|COMPLETED|Exercise Intervention||9
555914|NCT00701051|1354835|P2|COMPLETED|Exercise Intervention||14
555915|NCT00701051|1354836|P1|COMPLETED|Exercise Intervention||0
555916|NCT00701051|1354834|P3|STARTED|Exercise Intervention|Participants assigned to group after Period 1: Screening|12
555917|NCT00701051|1354835|P2|STARTED|Exercise Intervention|Participants assigned to group after Period 1: Screening|19
555918|NCT00701051|1354836|P1|STARTED|Exercise Intervention|Participants assigned to Normal or Impaired glucose tolerance arm after screening.|0
555919|NCT00701051|1354834|P3|NOT COMPLETED|Screening||0
555920|NCT00701051|1354835|P2|NOT COMPLETED|Screening||0
555921|NCT00701051|1354836|P1|NOT COMPLETED|Screening||59
555922|NCT00701051|1354834|P3|COMPLETED|Screening||0
555924|NCT00701051|1354836|P1|COMPLETED|Screening|Arm assignment not known until baseline testing; both arms included in this number|31
555925|NCT00701051|1354834|P3|STARTED|Screening||0
555926|NCT00701051|1354835|P2|STARTED|Screening||0
555927|NCT00701051|1354836|P1|STARTED|Screening|Arm assignment not known until baseline testing; both arms included in this number|90
555928|NCT00701038|1354854|P2|NOT COMPLETED|Overall Study||4
555929|NCT00701038|1354855|P1|NOT COMPLETED|Overall Study||4
555930|NCT00701038|1354854|P2|COMPLETED|Overall Study||23
555931|NCT00701038|1354855|P1|COMPLETED|Overall Study||23
555932|NCT00701038|1354854|P2|STARTED|Overall Study||27
555933|NCT00701038|1354855|P1|STARTED|Overall Study||27
555934|NCT00700999|1354863|P2|NOT COMPLETED|Overall Study||9
555935|NCT00700999|1354864|P1|NOT COMPLETED|Overall Study||15
555936|NCT00700999|1354863|P2|COMPLETED|Overall Study||20
555937|NCT00700999|1354864|P1|COMPLETED|Overall Study||21
555938|NCT00700999|1354863|P2|Second MRI Scan|Overall Study||18
555939|NCT00700999|1354864|P1|Second MRI Scan|Overall Study||19
555940|NCT00700999|1354863|P2|First MRI Scan|Overall Study||22
555941|NCT00700999|1354864|P1|First MRI Scan|Overall Study||29
555942|NCT00700999|1354863|P2|STARTED|Overall Study||29
555943|NCT00700999|1354864|P1|STARTED|Overall Study||36
555944|NCT00700973|1354872|P2|NOT COMPLETED|Overall Study||7
555945|NCT00700973|1354873|P1|NOT COMPLETED|Overall Study||8
555946|NCT00700973|1354872|P2|COMPLETED|Overall Study||63
555947|NCT00700973|1354873|P1|COMPLETED|Overall Study||63
555948|NCT00700973|1354872|P2|STARTED|Overall Study||70
555949|NCT00700973|1354873|P1|STARTED|Overall Study||71
555950|NCT00700817|1354884|P5|NOT COMPLETED|Week 52-78 (Extension Period 2)||5
555951|NCT00700817|1354885|P4|NOT COMPLETED|Week 52-78 (Extension Period 2)||8
555952|NCT00700817|1354886|P3|NOT COMPLETED|Week 52-78 (Extension Period 2)||0
555953|NCT00700817|1354887|P2|NOT COMPLETED|Week 52-78 (Extension Period 2)||15
555954|NCT00700817|1354888|P1|NOT COMPLETED|Week 52-78 (Extension Period 2)||10
555955|NCT00700817|1354884|P5|COMPLETED|Week 52-78 (Extension Period 2)||63
555956|NCT00700817|1354885|P4|COMPLETED|Week 52-78 (Extension Period 2)||59
555957|NCT00700817|1354886|P3|COMPLETED|Week 52-78 (Extension Period 2)||0
555958|NCT00700817|1354887|P2|COMPLETED|Week 52-78 (Extension Period 2)||135
555959|NCT00700817|1354888|P1|COMPLETED|Week 52-78 (Extension Period 2)||124
555960|NCT00700817|1354884|P5|STARTED|Week 52-78 (Extension Period 2)|Re-randomised from sita treatment group. Some subjects withdrew before entry to extension period 2.|68
555961|NCT00700817|1354885|P4|STARTED|Week 52-78 (Extension Period 2)|Re-randomised from sita treatment group. Some subjects withdrew before entry to extension period 2.|67
555962|NCT00700817|1354886|P3|STARTED|Week 52-78 (Extension Period 2)|Re-randomised to lira 1.2 or 1.8 mg|0
555963|NCT00700817|1354887|P2|STARTED|Week 52-78 (Extension Period 2)||150
555964|NCT00700817|1354888|P1|STARTED|Week 52-78 (Extension Period 2)|Subject withdrew before entry to extension period 2|134
555965|NCT00700817|1354884|P5|NOT COMPLETED|Week 26-52 (Extension Period 1)||0
555966|NCT00700817|1354885|P4|NOT COMPLETED|Week 26-52 (Extension Period 1)||0
555967|NCT00700817|1354886|P3|NOT COMPLETED|Week 26-52 (Extension Period 1)||15
555968|NCT00700817|1354887|P2|NOT COMPLETED|Week 26-52 (Extension Period 1)||26
555969|NCT00700817|1354888|P1|NOT COMPLETED|Week 26-52 (Extension Period 1)||20
555970|NCT00700817|1354884|P5|COMPLETED|Week 26-52 (Extension Period 1)||0
555971|NCT00700817|1354885|P4|COMPLETED|Week 26-52 (Extension Period 1)||0
555972|NCT00700817|1354886|P3|COMPLETED|Week 26-52 (Extension Period 1)||151
555973|NCT00700817|1354887|P2|COMPLETED|Week 26-52 (Extension Period 1)||150
555974|NCT00700817|1354888|P1|COMPLETED|Week 26-52 (Extension Period 1)||135
555975|NCT00700817|1354884|P5|STARTED|Week 26-52 (Extension Period 1)||0
555976|NCT00700817|1354885|P4|STARTED|Week 26-52 (Extension Period 1)||0
555977|NCT00700817|1354886|P3|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|166
555978|NCT00700817|1354887|P2|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|176
555979|NCT00700817|1354888|P1|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|155
555980|NCT00700817|1354884|P5|NOT COMPLETED|Week 0-26 (Main Period)||0
555981|NCT00700817|1354885|P4|NOT COMPLETED|Week 0-26 (Main Period)||0
555982|NCT00700817|1354886|P3|NOT COMPLETED|Week 0-26 (Main Period)||25
555983|NCT00700817|1354887|P2|NOT COMPLETED|Week 0-26 (Main Period)||30
555984|NCT00700817|1354888|P1|NOT COMPLETED|Week 0-26 (Main Period)||56
555985|NCT00700817|1354884|P5|COMPLETED|Week 0-26 (Main Period)||0
555986|NCT00700817|1354885|P4|COMPLETED|Week 0-26 (Main Period)||0
555987|NCT00700817|1354886|P3|COMPLETED|Week 0-26 (Main Period)||194
555988|NCT00700817|1354887|P2|COMPLETED|Week 0-26 (Main Period)||191
555989|NCT00700817|1354888|P1|COMPLETED|Week 0-26 (Main Period)||169
555990|NCT00700817|1354884|P5|Exposed|Week 0-26 (Main Period)||0
555991|NCT00700817|1354885|P4|Exposed|Week 0-26 (Main Period)||0
555992|NCT00700817|1354886|P3|Exposed|Week 0-26 (Main Period)||219
555993|NCT00700817|1354887|P2|Exposed|Week 0-26 (Main Period)|3 subjects withdrew before exposure to trial drug and were not included in Full Analysis Set (FAS)|218
555994|NCT00700817|1354888|P1|Exposed|Week 0-26 (Main Period)|4 subjects withdrew before exposure to trial drug and were not included in Full Analysis Set (FAS)|221
555995|NCT00700817|1354884|P5|STARTED|Week 0-26 (Main Period)||0
555996|NCT00700817|1354885|P4|STARTED|Week 0-26 (Main Period)||0
555997|NCT00700817|1354886|P3|STARTED|Week 0-26 (Main Period)|Randomised|219
555998|NCT00700817|1354887|P2|STARTED|Week 0-26 (Main Period)|Randomised|221
555999|NCT00700817|1354888|P1|STARTED|Week 0-26 (Main Period)|Randomised|225
556000|NCT00700804|1355270|P2|NOT COMPLETED|Overall Study||4
556001|NCT00700804|1355271|P1|NOT COMPLETED|Overall Study||3
556002|NCT00700804|1355270|P2|COMPLETED|Overall Study||13
556003|NCT00700804|1355271|P1|COMPLETED|Overall Study||14
556004|NCT00700804|1355270|P2|STARTED|Overall Study||17
556005|NCT00700804|1355271|P1|STARTED|Overall Study||17
556006|NCT00700752|1355279|P2|NOT COMPLETED|Second Intervention||0
556007|NCT00700752|1355280|P1|NOT COMPLETED|Second Intervention||0
556008|NCT00700752|1355279|P2|COMPLETED|Second Intervention||18
556009|NCT00700752|1355280|P1|COMPLETED|Second Intervention||20
556010|NCT00700752|1355279|P2|STARTED|Second Intervention||18
556011|NCT00700752|1355280|P1|STARTED|Second Intervention||20
556012|NCT00700752|1355279|P2|NOT COMPLETED|First Intervention||2
556013|NCT00700752|1355280|P1|NOT COMPLETED|First Intervention||0
556014|NCT00700752|1355279|P2|COMPLETED|First Intervention||18
556015|NCT00700752|1355280|P1|COMPLETED|First Intervention||20
556016|NCT00700752|1355279|P2|STARTED|First Intervention||20
556017|NCT00700752|1355280|P1|STARTED|First Intervention||20
556018|NCT00700739|1355288|P2|NOT COMPLETED|Overall Study||4
556019|NCT00700739|1355289|P1|NOT COMPLETED|Overall Study||4
556020|NCT00700739|1355288|P2|COMPLETED|Overall Study||12
556021|NCT00700739|1355289|P1|COMPLETED|Overall Study||18
556022|NCT00700739|1355288|P2|STARTED|Overall Study||16
556023|NCT00700739|1355289|P1|STARTED|Overall Study||22
556024|NCT00700713|1355328|P3|NOT COMPLETED|Overall Study||2
556025|NCT00700713|1355329|P2|NOT COMPLETED|Overall Study||0
556026|NCT00700713|1355330|P1|NOT COMPLETED|Overall Study||1
556027|NCT00700713|1355328|P3|COMPLETED|Overall Study||65
556028|NCT00700713|1355329|P2|COMPLETED|Overall Study||66
556029|NCT00700713|1355330|P1|COMPLETED|Overall Study||47
556030|NCT00700713|1355328|P3|STARTED|Overall Study||67
556031|NCT00700713|1355329|P2|STARTED|Overall Study||66
556032|NCT00700713|1355330|P1|STARTED|Overall Study||48
556033|NCT00700635|1355347|P3|NOT COMPLETED|Overall Study||1
556034|NCT00700635|1355348|P2|NOT COMPLETED|Overall Study||8
556035|NCT00700635|1355349|P1|NOT COMPLETED|Overall Study||11
556036|NCT00700635|1355347|P3|COMPLETED|Overall Study||110
556037|NCT00700635|1355348|P2|COMPLETED|Overall Study||103
556038|NCT00700635|1355349|P1|COMPLETED|Overall Study||100
556039|NCT00700635|1355347|P3|STARTED|Overall Study||111
556040|NCT00700635|1355348|P2|STARTED|Overall Study||111
556041|NCT00700635|1355349|P1|STARTED|Overall Study||111
556042|NCT00700622|1355371|P2|NOT COMPLETED|Overall Study||5
556043|NCT00700622|1355372|P1|NOT COMPLETED|Overall Study||13
556044|NCT00700622|1355371|P2|COMPLETED|Overall Study||60
556045|NCT00700622|1355372|P1|COMPLETED|Overall Study||52
556046|NCT00700622|1355371|P2|STARTED|Overall Study||65
556047|NCT00700622|1355372|P1|STARTED|Overall Study||65
556048|NCT00700570|1355380|P2|NOT COMPLETED|Overall Study||26
556049|NCT00700570|1355381|P1|NOT COMPLETED|Overall Study||11
556050|NCT00700570|1355380|P2|COMPLETED|Overall Study||0
556051|NCT00700570|1355381|P1|COMPLETED|Overall Study||8
556052|NCT00700570|1355380|P2|STARTED|Overall Study||26
556053|NCT00700570|1355381|P1|STARTED|Overall Study||19
556054|NCT00700440|1355393|P1|NOT COMPLETED|Overall Study||0
556055|NCT00700440|1355393|P1|COMPLETED|Overall Study||100
556056|NCT00700440|1355393|P1|STARTED|Overall Study||100
556057|NCT00700427|1355397|P5|NOT COMPLETED|Study Period 4 (Open-Label Extension)||84
556058|NCT00700427|1355398|P4|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
556059|NCT00700427|1355399|P3|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
556060|NCT00700427|1355400|P2|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
556061|NCT00700427|1355401|P1|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
556062|NCT00700427|1355397|P5|COMPLETED|Study Period 4 (Open-Label Extension)||96
556063|NCT00700427|1355398|P4|COMPLETED|Study Period 4 (Open-Label Extension)||0
556064|NCT00700427|1355399|P3|COMPLETED|Study Period 4 (Open-Label Extension)||0
556065|NCT00700427|1355400|P2|COMPLETED|Study Period 4 (Open-Label Extension)||0
556066|NCT00700427|1355401|P1|COMPLETED|Study Period 4 (Open-Label Extension)||0
556067|NCT00700427|1355397|P5|STARTED|Study Period 4 (Open-Label Extension)||180
556068|NCT00700427|1355398|P4|STARTED|Study Period 4 (Open-Label Extension)||0
556069|NCT00700427|1355399|P3|STARTED|Study Period 4 (Open-Label Extension)||0
556070|NCT00700427|1355400|P2|STARTED|Study Period 4 (Open-Label Extension)||0
556071|NCT00700427|1355401|P1|STARTED|Study Period 4 (Open-Label Extension)||0
556072|NCT00700427|1355397|P5|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
556073|NCT00700427|1355398|P4|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||93
556074|NCT00700427|1355399|P3|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||82
556075|NCT00700427|1355400|P2|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
556076|NCT00700427|1355401|P1|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
556077|NCT00700427|1355397|P5|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
556078|NCT00700427|1355398|P4|COMPLETED|Study Period 3B (Randomized Withdrawal)||165
556079|NCT00700427|1355399|P3|COMPLETED|Study Period 3B (Randomized Withdrawal)||184
556080|NCT00700427|1355400|P2|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
556081|NCT00700427|1355401|P1|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
556082|NCT00700427|1355397|P5|STARTED|Study Period 3B (Randomized Withdrawal)||0
556083|NCT00700427|1355398|P4|STARTED|Study Period 3B (Randomized Withdrawal)||258
556084|NCT00700427|1355399|P3|STARTED|Study Period 3B (Randomized Withdrawal)||266
556085|NCT00700427|1355400|P2|STARTED|Study Period 3B (Randomized Withdrawal)||0
556086|NCT00700427|1355401|P1|STARTED|Study Period 3B (Randomized Withdrawal)||0
556087|NCT00700427|1355397|P5|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
556088|NCT00700427|1355398|P4|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
556089|NCT00700427|1355399|P3|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
556090|NCT00700427|1355400|P2|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||481
556091|NCT00700427|1355401|P1|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
556092|NCT00700427|1355397|P5|COMPLETED|Study Period 3A (Blinded Maintenance)||0
556093|NCT00700427|1355398|P4|COMPLETED|Study Period 3A (Blinded Maintenance)||0
556094|NCT00700427|1355399|P3|COMPLETED|Study Period 3A (Blinded Maintenance)||0
556095|NCT00700427|1355400|P2|COMPLETED|Study Period 3A (Blinded Maintenance)||524
556096|NCT00700427|1355401|P1|COMPLETED|Study Period 3A (Blinded Maintenance)||0
556097|NCT00700427|1355397|P5|STARTED|Study Period 3A (Blinded Maintenance)||0
556098|NCT00700427|1355398|P4|STARTED|Study Period 3A (Blinded Maintenance)||0
556099|NCT00700427|1355399|P3|STARTED|Study Period 3A (Blinded Maintenance)||0
556100|NCT00700427|1355400|P2|STARTED|Study Period 3A (Blinded Maintenance)||1005
556101|NCT00700427|1355401|P1|STARTED|Study Period 3A (Blinded Maintenance)||0
556102|NCT00700427|1355397|P5|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
556103|NCT00700427|1355398|P4|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
556104|NCT00700427|1355399|P3|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
556105|NCT00700427|1355400|P2|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
556106|NCT00700427|1355401|P1|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||1011
556107|NCT00700427|1355397|P5|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
556108|NCT00700427|1355398|P4|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
556109|NCT00700427|1355399|P3|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
556110|NCT00700427|1355400|P2|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
556111|NCT00700427|1355401|P1|COMPLETED|Study Period 2 (Open-Label Acute Trx)|One participant was mistakenly recorded as completed. The reason for discontinuation is unknown.|1006
556112|NCT00700427|1355397|P5|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
556113|NCT00700427|1355398|P4|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
556114|NCT00700427|1355399|P3|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
556115|NCT00700427|1355400|P2|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
556116|NCT00700427|1355401|P1|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||2011
556117|NCT00700427|1355397|P5|STARTED|Study Period 2 (Open-Label Acute Trx)||0
556118|NCT00700427|1355398|P4|STARTED|Study Period 2 (Open-Label Acute Trx)||0
556119|NCT00700427|1355399|P3|STARTED|Study Period 2 (Open-Label Acute Trx)||0
556120|NCT00700427|1355400|P2|STARTED|Study Period 2 (Open-Label Acute Trx)||0
556121|NCT00700427|1355401|P1|STARTED|Study Period 2 (Open-Label Acute Trx)||2017
556122|NCT00700401|1355423|P1|NOT COMPLETED|Overall Study||94
556123|NCT00700401|1355423|P1|COMPLETED|Overall Study||168
556124|NCT00700401|1355423|P1|STARTED|Overall Study||262
556125|NCT00700375|1355436|P2|NOT COMPLETED|Overall Study||0
556126|NCT00700375|1355437|P1|NOT COMPLETED|Overall Study||0
556127|NCT00700375|1355436|P2|COMPLETED|Overall Study||29
556128|NCT00700375|1355437|P1|COMPLETED|Overall Study||30
556129|NCT00700375|1355436|P2|2 Days After Creatinine Mesurement|Overall Study||29
556130|NCT00700375|1355437|P1|2 Days After Creatinine Mesurement|Overall Study||30
556131|NCT00700375|1355436|P2|STARTED|Overall Study||29
556132|NCT00700375|1355437|P1|STARTED|Overall Study||30
556133|NCT00700310|1355447|P4|NOT COMPLETED|Overall Study||26
556134|NCT00700310|1355448|P3|NOT COMPLETED|Overall Study||16
556135|NCT00700310|1355449|P2|NOT COMPLETED|Overall Study||26
556136|NCT00700310|1355450|P1|NOT COMPLETED|Overall Study||21
556137|NCT00700310|1355447|P4|COMPLETED|Overall Study||145
556138|NCT00700310|1355448|P3|COMPLETED|Overall Study||158
556139|NCT00700310|1355449|P2|COMPLETED|Overall Study||154
556140|NCT00700310|1355450|P1|COMPLETED|Overall Study||166
556141|NCT00700310|1355447|P4|STARTED|Overall Study||171
556142|NCT00700310|1355448|P3|STARTED|Overall Study||174
556143|NCT00700310|1355449|P2|STARTED|Overall Study||180
556144|NCT00700310|1355450|P1|STARTED|Overall Study||187
556145|NCT00700271|1355470|P2|NOT COMPLETED|Overall Study||12
556146|NCT00700271|1355471|P1|NOT COMPLETED|Overall Study||14
556147|NCT00700271|1355470|P2|COMPLETED|Overall Study||256
556148|NCT00700271|1355471|P1|COMPLETED|Overall Study||264
556149|NCT00700271|1355470|P2|STARTED|Overall Study||268
556150|NCT00700271|1355471|P1|STARTED|Overall Study||278
556151|NCT00700180|1355499|P2|NOT COMPLETED|Overall Study||149
556152|NCT00700180|1355500|P1|NOT COMPLETED|Overall Study||154
556153|NCT00700180|1355499|P2|COMPLETED|Overall Study|Clinical cutoff date: July 11, 2011|0
556154|NCT00700180|1355500|P1|COMPLETED|Overall Study|Clinical cutoff date: July 11, 2011|0
556155|NCT00700180|1355499|P2|STARTED|Overall Study||149
556156|NCT00700180|1355500|P1|STARTED|Overall Study||154
556157|NCT00700141|1355522|P1|NOT COMPLETED|Overall Study||0
556158|NCT00700141|1355522|P1|COMPLETED|Overall Study||482
556159|NCT00700141|1355522|P1|STARTED|Overall Study||482
556160|NCT00700115|1355529|P2|NOT COMPLETED|Overall Study||1
556161|NCT00700115|1355530|P1|NOT COMPLETED|Overall Study||1
556162|NCT00700115|1355529|P2|COMPLETED|Overall Study||19
556163|NCT00700115|1355530|P1|COMPLETED|Overall Study||39
556164|NCT00700115|1355529|P2|STARTED|Overall Study||20
556165|NCT00700115|1355530|P1|STARTED|Overall Study||40
556166|NCT00700102|1355540|P2|NOT COMPLETED|Overall Study||395
556167|NCT00700102|1355541|P1|NOT COMPLETED|Overall Study||402
556168|NCT00700102|1355540|P2|COMPLETED|Overall Study||14
556169|NCT00700102|1355541|P1|COMPLETED|Overall Study||9
556170|NCT00700102|1355540|P2|Received at Least One Dose|Overall Study||403
556171|NCT00700102|1355541|P1|Received at Least One Dose|Overall Study||407
556172|NCT00700102|1355540|P2|Intention to Treat|Overall Study||409
556173|NCT00700102|1355541|P1|Intention to Treat|Overall Study||410
556174|NCT00700102|1355540|P2|STARTED|Overall Study||409
556175|NCT00700102|1355541|P1|STARTED|Overall Study||411
556176|NCT00700063|1355565|P8|NOT COMPLETED|Overall Study||0
556177|NCT00700063|1355566|P7|NOT COMPLETED|Overall Study||0
556178|NCT00700063|1355567|P6|NOT COMPLETED|Overall Study||0
556179|NCT00700063|1355568|P5|NOT COMPLETED|Overall Study||2
556180|NCT00700063|1355569|P4|NOT COMPLETED|Overall Study||2
556181|NCT00700063|1355570|P3|NOT COMPLETED|Overall Study||0
556182|NCT00700063|1355571|P2|NOT COMPLETED|Overall Study||0
556183|NCT00700063|1355572|P1|NOT COMPLETED|Overall Study||1
556184|NCT00700063|1355565|P8|COMPLETED|Overall Study||33
556185|NCT00700063|1355566|P7|COMPLETED|Overall Study||32
556186|NCT00700063|1355567|P6|COMPLETED|Overall Study||34
556187|NCT00700063|1355568|P5|COMPLETED|Overall Study||31
556188|NCT00700063|1355569|P4|COMPLETED|Overall Study||31
556189|NCT00700063|1355570|P3|COMPLETED|Overall Study||33
556190|NCT00700063|1355571|P2|COMPLETED|Overall Study||34
556191|NCT00700063|1355572|P1|COMPLETED|Overall Study||32
556192|NCT00700063|1355565|P8|STARTED|Overall Study||33
556193|NCT00700063|1355566|P7|STARTED|Overall Study||32
556194|NCT00700063|1355567|P6|STARTED|Overall Study||34
556195|NCT00700063|1355568|P5|STARTED|Overall Study||33
556196|NCT00700063|1355569|P4|STARTED|Overall Study||33
556197|NCT00700063|1355570|P3|STARTED|Overall Study||33
556198|NCT00700063|1355571|P2|STARTED|Overall Study||34
556199|NCT00700063|1355572|P1|STARTED|Overall Study||33
556200|NCT00700011|1355680|P2|NOT COMPLETED|Overall Study||1
556201|NCT00700011|1355681|P1|NOT COMPLETED|Overall Study||0
556202|NCT00700011|1355680|P2|COMPLETED|Overall Study||1
556203|NCT00700011|1355681|P1|COMPLETED|Overall Study||8
556204|NCT00700011|1355680|P2|STARTED|Overall Study||2
556205|NCT00700011|1355681|P1|STARTED|Overall Study||8
556206|NCT00699998|1355697|P4|NOT COMPLETED|Overall Study||82
556207|NCT00699998|1355698|P3|NOT COMPLETED|Overall Study||206
556208|NCT00699998|1355699|P2|NOT COMPLETED|Overall Study||86
556209|NCT00699998|1355700|P1|NOT COMPLETED|Overall Study||199
556210|NCT00699998|1355697|P4|COMPLETED|Overall Study||958
556211|NCT00699998|1355698|P3|COMPLETED|Overall Study||3417
556212|NCT00699998|1355699|P2|COMPLETED|Overall Study||957
556213|NCT00699998|1355700|P1|COMPLETED|Overall Study||3421
556214|NCT00699998|1355697|P4|Received at Least 1 Dose of Study Drug|Overall Study||1027
556215|NCT00699998|1355698|P3|Received at Least 1 Dose of Study Drug|Overall Study||3590
556216|NCT00699998|1355699|P2|Received at Least 1 Dose of Study Drug|Overall Study||1033
556217|NCT00699998|1355700|P1|Received at Least 1 Dose of Study Drug|Overall Study||3590
556218|NCT00699998|1355697|P4|STARTED|Overall Study||1040
556219|NCT00699998|1355698|P3|STARTED|Overall Study||3623
556220|NCT00699998|1355699|P2|STARTED|Overall Study||1043
556221|NCT00699998|1355700|P1|STARTED|Overall Study||3620
556222|NCT00699972|1355745|P3|NOT COMPLETED|Overall Study||35
556223|NCT00699972|1355746|P2|NOT COMPLETED|Overall Study||19
556224|NCT00699972|1355747|P1|NOT COMPLETED|Overall Study||16
556225|NCT00699972|1355745|P3|COMPLETED|Overall Study||100
556226|NCT00699972|1355746|P2|COMPLETED|Overall Study||114
556227|NCT00699972|1355747|P1|COMPLETED|Overall Study||106
556228|NCT00699972|1355745|P3|STARTED|Overall Study||135
556229|NCT00699972|1355746|P2|STARTED|Overall Study||133
556230|NCT00699972|1355747|P1|STARTED|Overall Study||122
556231|NCT00699907|1355764|P3|NOT COMPLETED|Overall Study||8
556232|NCT00699907|1355765|P2|NOT COMPLETED|Overall Study||10
556233|NCT00699907|1355766|P1|NOT COMPLETED|Overall Study||2
556234|NCT00699907|1355764|P3|COMPLETED|Overall Study||48
556235|NCT00699907|1355765|P2|COMPLETED|Overall Study||47
556236|NCT00699907|1355766|P1|COMPLETED|Overall Study||12
556237|NCT00699907|1355764|P3|STARTED|Overall Study||56
556238|NCT00699907|1355765|P2|STARTED|Overall Study||57
556239|NCT00699907|1355766|P1|STARTED|Overall Study||14
556240|NCT00699842|1355801|P3|NOT COMPLETED|Overall Study||0
556241|NCT00699842|1355802|P2|NOT COMPLETED|Overall Study||1
556242|NCT00699842|1355803|P1|NOT COMPLETED|Overall Study||0
556243|NCT00699842|1355801|P3|COMPLETED|Overall Study||0
556244|NCT00699842|1355802|P2|COMPLETED|Overall Study||4
556245|NCT00699842|1355803|P1|COMPLETED|Overall Study||3
556246|NCT00699842|1355801|P3|STARTED|Overall Study||0
556247|NCT00699842|1355802|P2|STARTED|Overall Study||5
556248|NCT00699842|1355803|P1|STARTED|Overall Study||3
556249|NCT00699816|1355816|P2|NOT COMPLETED|Overall Study||3
556250|NCT00699816|1355817|P1|NOT COMPLETED|Overall Study||1
556251|NCT00699816|1355816|P2|COMPLETED|Overall Study||112
556252|NCT00699816|1355817|P1|COMPLETED|Overall Study||114
556253|NCT00699816|1355816|P2|STARTED|Overall Study||115
556254|NCT00699816|1355817|P1|STARTED|Overall Study||115
556255|NCT00699751|1355835|P2|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||9
556256|NCT00699751|1355836|P1|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||0
556257|NCT00699751|1355835|P2|COMPLETED|Period 2:Switched From Placebo to Xofigo|Completed all 6 injections|17
556258|NCT00699751|1355836|P1|COMPLETED|Period 2:Switched From Placebo to Xofigo||0
556259|NCT00699751|1355835|P2|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
556260|NCT00699751|1355836|P1|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
556340|NCT00699608|1355947|P2|STARTED|Second Intervention||15
556261|NCT00699751|1355835|P2|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||15
556262|NCT00699751|1355836|P1|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
556263|NCT00699751|1355835|P2|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||24
556264|NCT00699751|1355836|P1|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||0
556265|NCT00699751|1355835|P2|STARTED|Period 2:Switched From Placebo to Xofigo|Participants in the placebo group switched to Xofigo treatment|26
556266|NCT00699751|1355836|P1|STARTED|Period 2:Switched From Placebo to Xofigo||0
556267|NCT00699751|1355835|P2|NOT COMPLETED|Period 1: Without/Before Drug Switch||162
556268|NCT00699751|1355836|P1|NOT COMPLETED|Period 1: Without/Before Drug Switch||225
556269|NCT00699751|1355835|P2|COMPLETED|Period 1: Without/Before Drug Switch|Completed all 6 injections|145
556270|NCT00699751|1355836|P1|COMPLETED|Period 1: Without/Before Drug Switch|Completed all 6 injections|389
556271|NCT00699751|1355835|P2|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||12
556272|NCT00699751|1355836|P1|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||49
556273|NCT00699751|1355835|P2|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch|Participants were not required to complete all 6 injections to enter to 3-year follow-up period.|168
556274|NCT00699751|1355836|P1|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch|Participants were not required to complete all 6 injections to enter to 3-year follow-up period.|407
556275|NCT00699751|1355835|P2|Participants Received Treatment|Period 1: Without/Before Drug Switch||301
556276|NCT00699751|1355836|P1|Participants Received Treatment|Period 1: Without/Before Drug Switch||600
556277|NCT00699751|1355835|P2|STARTED|Period 1: Without/Before Drug Switch||307
556278|NCT00699751|1355836|P1|STARTED|Period 1: Without/Before Drug Switch||614
556279|NCT00699699|1355921|P1|NOT COMPLETED|Overall Study||57
556280|NCT00699699|1355921|P1|COMPLETED|Overall Study||1223
556281|NCT00699699|1355921|P1|STARTED|Overall Study||1280
556282|NCT00699660|1355930|P2|NOT COMPLETED|Overall Study||8
556283|NCT00699660|1355931|P1|NOT COMPLETED|Overall Study||14
556284|NCT00699660|1355930|P2|COMPLETED|Overall Study||208
556285|NCT00699660|1355931|P1|COMPLETED|Overall Study||176
556286|NCT00699660|1355930|P2|STARTED|Overall Study||216
556287|NCT00699660|1355931|P1|STARTED|Overall Study||190
556288|NCT00699608|1355943|P6|NOT COMPLETED|Third Intervention||0
556289|NCT00699608|1355944|P5|NOT COMPLETED|Third Intervention||0
556290|NCT00699608|1355945|P4|NOT COMPLETED|Third Intervention||0
556291|NCT00699608|1355946|P3|NOT COMPLETED|Third Intervention||0
556292|NCT00699608|1355947|P2|NOT COMPLETED|Third Intervention||0
556293|NCT00699608|1355948|P1|NOT COMPLETED|Third Intervention||0
556294|NCT00699608|1355943|P6|COMPLETED|Third Intervention||15
556295|NCT00699608|1355944|P5|COMPLETED|Third Intervention||14
556296|NCT00699608|1355945|P4|COMPLETED|Third Intervention||14
556297|NCT00699608|1355946|P3|COMPLETED|Third Intervention||13
556298|NCT00699608|1355947|P2|COMPLETED|Third Intervention||15
556299|NCT00699608|1355948|P1|COMPLETED|Third Intervention||16
556300|NCT00699608|1355943|P6|STARTED|Third Intervention||15
556301|NCT00699608|1355944|P5|STARTED|Third Intervention||14
556302|NCT00699608|1355945|P4|STARTED|Third Intervention||14
556303|NCT00699608|1355946|P3|STARTED|Third Intervention||13
556304|NCT00699608|1355947|P2|STARTED|Third Intervention||15
556305|NCT00699608|1355948|P1|STARTED|Third Intervention||16
556306|NCT00699608|1355943|P6|NOT COMPLETED|Second 4-14 Day Washout Period||0
556307|NCT00699608|1355944|P5|NOT COMPLETED|Second 4-14 Day Washout Period||0
556308|NCT00699608|1355945|P4|NOT COMPLETED|Second 4-14 Day Washout Period||0
556309|NCT00699608|1355946|P3|NOT COMPLETED|Second 4-14 Day Washout Period||0
556310|NCT00699608|1355947|P2|NOT COMPLETED|Second 4-14 Day Washout Period||0
556311|NCT00699608|1355948|P1|NOT COMPLETED|Second 4-14 Day Washout Period||0
556312|NCT00699608|1355943|P6|COMPLETED|Second 4-14 Day Washout Period||15
556313|NCT00699608|1355944|P5|COMPLETED|Second 4-14 Day Washout Period||14
556314|NCT00699608|1355945|P4|COMPLETED|Second 4-14 Day Washout Period||14
556315|NCT00699608|1355946|P3|COMPLETED|Second 4-14 Day Washout Period||13
556316|NCT00699608|1355947|P2|COMPLETED|Second 4-14 Day Washout Period||15
556317|NCT00699608|1355948|P1|COMPLETED|Second 4-14 Day Washout Period||16
556318|NCT00699608|1355943|P6|STARTED|Second 4-14 Day Washout Period||15
556319|NCT00699608|1355944|P5|STARTED|Second 4-14 Day Washout Period||14
556320|NCT00699608|1355945|P4|STARTED|Second 4-14 Day Washout Period||14
556321|NCT00699608|1355946|P3|STARTED|Second 4-14 Day Washout Period||13
556322|NCT00699608|1355947|P2|STARTED|Second 4-14 Day Washout Period||15
556323|NCT00699608|1355948|P1|STARTED|Second 4-14 Day Washout Period||16
556324|NCT00699608|1355943|P6|NOT COMPLETED|Second Intervention||0
556325|NCT00699608|1355944|P5|NOT COMPLETED|Second Intervention||0
556326|NCT00699608|1355945|P4|NOT COMPLETED|Second Intervention||1
556327|NCT00699608|1355946|P3|NOT COMPLETED|Second Intervention||1
556328|NCT00699608|1355947|P2|NOT COMPLETED|Second Intervention||0
556329|NCT00699608|1355948|P1|NOT COMPLETED|Second Intervention||0
556330|NCT00699608|1355943|P6|COMPLETED|Second Intervention||15
556331|NCT00699608|1355944|P5|COMPLETED|Second Intervention||14
556332|NCT00699608|1355945|P4|COMPLETED|Second Intervention||14
556333|NCT00699608|1355946|P3|COMPLETED|Second Intervention||13
556334|NCT00699608|1355947|P2|COMPLETED|Second Intervention||15
556335|NCT00699608|1355948|P1|COMPLETED|Second Intervention||16
556336|NCT00699608|1355943|P6|STARTED|Second Intervention||15
556337|NCT00699608|1355944|P5|STARTED|Second Intervention||14
556338|NCT00699608|1355945|P4|STARTED|Second Intervention||15
556339|NCT00699608|1355946|P3|STARTED|Second Intervention||14
556341|NCT00699608|1355948|P1|STARTED|Second Intervention||16
556342|NCT00699608|1355943|P6|NOT COMPLETED|First 4-14 Day Washout Period||0
556343|NCT00699608|1355944|P5|NOT COMPLETED|First 4-14 Day Washout Period||0
556344|NCT00699608|1355945|P4|NOT COMPLETED|First 4-14 Day Washout Period||0
556345|NCT00699608|1355946|P3|NOT COMPLETED|First 4-14 Day Washout Period||0
556346|NCT00699608|1355947|P2|NOT COMPLETED|First 4-14 Day Washout Period||0
556347|NCT00699608|1355948|P1|NOT COMPLETED|First 4-14 Day Washout Period||0
556348|NCT00699608|1355943|P6|COMPLETED|First 4-14 Day Washout Period||15
556349|NCT00699608|1355944|P5|COMPLETED|First 4-14 Day Washout Period||14
556350|NCT00699608|1355945|P4|COMPLETED|First 4-14 Day Washout Period||15
556351|NCT00699608|1355946|P3|COMPLETED|First 4-14 Day Washout Period||14
556352|NCT00699608|1355947|P2|COMPLETED|First 4-14 Day Washout Period||15
556353|NCT00699608|1355948|P1|COMPLETED|First 4-14 Day Washout Period||16
556354|NCT00699608|1355943|P6|STARTED|First 4-14 Day Washout Period||15
556355|NCT00699608|1355944|P5|STARTED|First 4-14 Day Washout Period||14
556356|NCT00699608|1355945|P4|STARTED|First 4-14 Day Washout Period||15
556357|NCT00699608|1355946|P3|STARTED|First 4-14 Day Washout Period||14
556358|NCT00699608|1355947|P2|STARTED|First 4-14 Day Washout Period||15
556359|NCT00699608|1355948|P1|STARTED|First 4-14 Day Washout Period||16
556360|NCT00699608|1355943|P6|NOT COMPLETED|First Intervention||0
556361|NCT00699608|1355944|P5|NOT COMPLETED|First Intervention||1
556362|NCT00699608|1355945|P4|NOT COMPLETED|First Intervention||0
556363|NCT00699608|1355946|P3|NOT COMPLETED|First Intervention||1
556364|NCT00699608|1355947|P2|NOT COMPLETED|First Intervention||0
556365|NCT00699608|1355948|P1|NOT COMPLETED|First Intervention||0
556366|NCT00699608|1355943|P6|COMPLETED|First Intervention||15
556367|NCT00699608|1355944|P5|COMPLETED|First Intervention||14
556368|NCT00699608|1355945|P4|COMPLETED|First Intervention||15
556369|NCT00699608|1355946|P3|COMPLETED|First Intervention||14
556370|NCT00699608|1355947|P2|COMPLETED|First Intervention||15
556371|NCT00699608|1355948|P1|COMPLETED|First Intervention||16
556372|NCT00699608|1355943|P6|STARTED|First Intervention||15
556373|NCT00699608|1355944|P5|STARTED|First Intervention||15
556374|NCT00699608|1355945|P4|STARTED|First Intervention||15
556375|NCT00699608|1355946|P3|STARTED|First Intervention||15
556376|NCT00699608|1355947|P2|STARTED|First Intervention||15
556377|NCT00699608|1355948|P1|STARTED|First Intervention||16
556378|NCT00699582|1356001|P3|NOT COMPLETED|Overall Study||28
556379|NCT00699582|1356002|P2|NOT COMPLETED|Overall Study||22
556380|NCT00699582|1356003|P1|NOT COMPLETED|Overall Study||18
556381|NCT00699582|1356001|P3|COMPLETED|Overall Study||93
556382|NCT00699582|1356002|P2|COMPLETED|Overall Study||108
556383|NCT00699582|1356003|P1|COMPLETED|Overall Study||120
556384|NCT00699582|1356001|P3|STARTED|Overall Study||121
556385|NCT00699582|1356002|P2|STARTED|Overall Study||130
556386|NCT00699582|1356003|P1|STARTED|Overall Study||138
556387|NCT00699556|1356017|P2|NOT COMPLETED|Second Intervention (1 Day)||0
556388|NCT00699556|1356018|P1|NOT COMPLETED|Second Intervention (1 Day)||0
556389|NCT00699556|1356017|P2|COMPLETED|Second Intervention (1 Day)||11
556390|NCT00699556|1356018|P1|COMPLETED|Second Intervention (1 Day)||11
556391|NCT00699556|1356017|P2|STARTED|Second Intervention (1 Day)||11
556392|NCT00699556|1356018|P1|STARTED|Second Intervention (1 Day)||11
556393|NCT00699556|1356017|P2|NOT COMPLETED|First Intervention (1 Day)||0
556394|NCT00699556|1356018|P1|NOT COMPLETED|First Intervention (1 Day)||0
556395|NCT00699556|1356017|P2|COMPLETED|First Intervention (1 Day)||11
556396|NCT00699556|1356018|P1|COMPLETED|First Intervention (1 Day)||11
556397|NCT00699556|1356017|P2|STARTED|First Intervention (1 Day)||11
556398|NCT00699556|1356018|P1|STARTED|First Intervention (1 Day)||11
556399|NCT00699491|1356032|P6|NOT COMPLETED|Overall Study||0
556400|NCT00699491|1356033|P5|NOT COMPLETED|Overall Study||0
556401|NCT00699491|1356034|P4|NOT COMPLETED|Overall Study||0
556402|NCT00699491|1356035|P3|NOT COMPLETED|Overall Study||0
556403|NCT00699491|1356036|P2|NOT COMPLETED|Overall Study||0
556404|NCT00699491|1356037|P1|NOT COMPLETED|Overall Study||0
556405|NCT00699491|1356032|P6|COMPLETED|Overall Study||22
556406|NCT00699491|1356033|P5|COMPLETED|Overall Study||8
556407|NCT00699491|1356034|P4|COMPLETED|Overall Study||6
556408|NCT00699491|1356035|P3|COMPLETED|Overall Study||7
556409|NCT00699491|1356036|P2|COMPLETED|Overall Study||2
556410|NCT00699491|1356037|P1|COMPLETED|Overall Study||3
556411|NCT00699491|1356032|P6|STARTED|Overall Study||22
556412|NCT00699491|1356033|P5|STARTED|Overall Study||8
556413|NCT00699491|1356034|P4|STARTED|Overall Study||6
556414|NCT00699491|1356035|P3|STARTED|Overall Study||7
556415|NCT00699491|1356036|P2|STARTED|Overall Study||2
556416|NCT00699491|1356037|P1|STARTED|Overall Study||3
556417|NCT00699413|1356058|P2|NOT COMPLETED|Overall Study||2
556418|NCT00699413|1356059|P1|NOT COMPLETED|Overall Study||0
556419|NCT00699413|1356058|P2|COMPLETED|Overall Study||2
556420|NCT00699413|1356059|P1|COMPLETED|Overall Study||4
556421|NCT00699413|1356058|P2|STARTED|Overall Study||4
556422|NCT00699413|1356059|P1|STARTED|Overall Study||4
556423|NCT00699400|1356068|P6|NOT COMPLETED|Overall Study||11
556424|NCT00699400|1356069|P5|NOT COMPLETED|Overall Study||0
556425|NCT00699400|1356070|P4|NOT COMPLETED|Overall Study||0
556426|NCT00699400|1356071|P3|NOT COMPLETED|Overall Study||0
556427|NCT00699400|1356072|P2|NOT COMPLETED|Overall Study||0
556428|NCT00699400|1356073|P1|NOT COMPLETED|Overall Study||0
556429|NCT00699400|1356068|P6|COMPLETED|Overall Study||0
556430|NCT00699400|1356069|P5|COMPLETED|Overall Study||4
556431|NCT00699400|1356070|P4|COMPLETED|Overall Study||6
556432|NCT00699400|1356071|P3|COMPLETED|Overall Study||138
556433|NCT00699400|1356072|P2|COMPLETED|Overall Study||3
556434|NCT00699400|1356073|P1|COMPLETED|Overall Study||42
556435|NCT00699400|1356068|P6|STARTED|Overall Study||11
556436|NCT00699400|1356069|P5|STARTED|Overall Study||4
556437|NCT00699400|1356070|P4|STARTED|Overall Study||6
556438|NCT00699400|1356071|P3|STARTED|Overall Study||138
556439|NCT00699400|1356072|P2|STARTED|Overall Study||3
556440|NCT00699400|1356073|P1|STARTED|Overall Study||42
556441|NCT00699374|1356107|P2|NOT COMPLETED|Overall Study||544
556442|NCT00699374|1356108|P1|NOT COMPLETED|Overall Study||530
556443|NCT00699374|1356107|P2|COMPLETED|Overall Study||0
556444|NCT00699374|1356108|P1|COMPLETED|Overall Study||0
556445|NCT00699374|1356107|P2|Treated|Overall Study||542
556446|NCT00699374|1356108|P1|Treated|Overall Study||526
556447|NCT00699374|1356107|P2|STARTED|Overall Study||544
556448|NCT00699374|1356108|P1|STARTED|Overall Study||530
556449|NCT00699348|1356120|P1|NOT COMPLETED|Overall Study||90
556450|NCT00699348|1356120|P1|COMPLETED|Overall Study||261
556451|NCT00699348|1356120|P1|STARTED|Overall Study||351
556452|NCT00699335|1356129|P1|NOT COMPLETED|Overall Study||228
556453|NCT00699335|1356129|P1|COMPLETED|Overall Study||5080
556454|NCT00699335|1356129|P1|STARTED|Overall Study||5308
556455|NCT00699283|1356162|P2|NOT COMPLETED|Overall Study||8
556456|NCT00699283|1356163|P1|NOT COMPLETED|Overall Study||33
556457|NCT00699283|1356162|P2|COMPLETED|Overall Study||7
556458|NCT00699283|1356163|P1|COMPLETED|Overall Study||14
556459|NCT00699283|1356162|P2|STARTED|Overall Study||15
556460|NCT00699283|1356163|P1|STARTED|Overall Study||47
556461|NCT00699192|1356171|P3|NOT COMPLETED|Overall Study||11
556462|NCT00699192|1356172|P2|NOT COMPLETED|Overall Study||12
556463|NCT00699192|1356173|P1|NOT COMPLETED|Overall Study||16
556464|NCT00699192|1356171|P3|COMPLETED|Overall Study||261
556465|NCT00699192|1356172|P2|COMPLETED|Overall Study||260
556466|NCT00699192|1356173|P1|COMPLETED|Overall Study||259
556467|NCT00699192|1356171|P3|STARTED|Overall Study||272
556468|NCT00699192|1356172|P2|STARTED|Overall Study||272
556469|NCT00699192|1356173|P1|STARTED|Overall Study||275
556470|NCT00699153|1356195|P2|NOT COMPLETED|Overall Study||2
556471|NCT00699153|1356196|P1|NOT COMPLETED|Overall Study||3
556472|NCT00699153|1356195|P2|COMPLETED|Overall Study||200
556473|NCT00699153|1356196|P1|COMPLETED|Overall Study||200
556474|NCT00699153|1356195|P2|STARTED|Overall Study|Intent to treat population|202
556475|NCT00699153|1356196|P1|STARTED|Overall Study|Intent to treat population|203
556476|NCT00699140|1356208|P1|NOT COMPLETED|Overall Study||0
556477|NCT00699140|1356208|P1|COMPLETED|Overall Study||18
556478|NCT00699140|1356208|P1|STARTED|Overall Study||18
556479|NCT00698932|1356222|P2|NOT COMPLETED|Overall Study||36
556480|NCT00698932|1356223|P1|NOT COMPLETED|Overall Study||22
556481|NCT00698932|1356222|P2|COMPLETED|Overall Study|Completed 24 Weeks of treatment|248
556482|NCT00698932|1356223|P1|COMPLETED|Overall Study|Completed 24 Weeks of treatment|262
556483|NCT00698932|1356222|P2|STARTED|Overall Study|Randomized and treated|284
556484|NCT00698932|1356223|P1|STARTED|Overall Study|Randomized and treated|284
556485|NCT00698867|1356239|P1|NOT COMPLETED|Overall Study||91
556486|NCT00698867|1356239|P1|COMPLETED|Overall Study||27
556487|NCT00698867|1356239|P1|Subjects With 4 Year Data|Overall Study||34
556488|NCT00698867|1356239|P1|Subjects With 3 Year Data|Overall Study||35
556489|NCT00698867|1356239|P1|Subjects With 2 Year Data|Overall Study||55
556490|NCT00698867|1356239|P1|Subjects With 1 Year Data|Overall Study||68
556491|NCT00698867|1356239|P1|STARTED|Overall Study||118
556492|NCT00698841|1356249|P1|NOT COMPLETED|Overall Study||18
556493|NCT00698841|1356249|P1|COMPLETED|Overall Study||33
556494|NCT00698841|1356249|P1|STARTED|Overall Study||51
556495|NCT00698815|1356263|P3|NOT COMPLETED|Overall Study||10
556496|NCT00698815|1356264|P2|NOT COMPLETED|Overall Study||14
556497|NCT00698815|1356265|P1|NOT COMPLETED|Overall Study||10
556498|NCT00698815|1356263|P3|COMPLETED|Overall Study||31
556499|NCT00698815|1356264|P2|COMPLETED|Overall Study||33
556500|NCT00698815|1356265|P1|COMPLETED|Overall Study||32
556501|NCT00698815|1356263|P3|STARTED|Overall Study||41
556502|NCT00698815|1356264|P2|STARTED|Overall Study||47
556503|NCT00698815|1356265|P1|STARTED|Overall Study||42
556504|NCT00698685|1356282|P1|NOT COMPLETED|Overall Study||2
556505|NCT00698685|1356282|P1|COMPLETED|Overall Study||12
556506|NCT00698685|1356282|P1|STARTED|Overall Study||14
556507|NCT00698646|1356290|P3|NOT COMPLETED|Overall Study||29
556508|NCT00698646|1356291|P2|NOT COMPLETED|Overall Study||31
556509|NCT00698646|1356292|P1|NOT COMPLETED|Overall Study||36
556510|NCT00698646|1356290|P3|COMPLETED|Overall Study||99
556511|NCT00698646|1356291|P2|COMPLETED|Overall Study||97
556512|NCT00698646|1356292|P1|COMPLETED|Overall Study||92
556513|NCT00698646|1356290|P3|STARTED|Overall Study||128
556514|NCT00698646|1356291|P2|STARTED|Overall Study||128
556515|NCT00698646|1356292|P1|STARTED|Overall Study||128
556516|NCT00698581|1356317|P2|NOT COMPLETED|Overall Study||12
556517|NCT00698581|1356318|P1|NOT COMPLETED|Overall Study||45
556518|NCT00698581|1356317|P2|COMPLETED|Overall Study||8
556519|NCT00698581|1356318|P1|COMPLETED|Overall Study||23
556520|NCT00698581|1356317|P2|STARTED|Overall Study||20
556521|NCT00698581|1356318|P1|STARTED|Overall Study||68
556522|NCT00698516|1356329|P1|NOT COMPLETED|Overall Study||5
556523|NCT00698516|1356329|P1|COMPLETED|Overall Study||45
556524|NCT00698516|1356329|P1|STARTED|Overall Study||50
556525|NCT00698451|1356347|P1|NOT COMPLETED|Overall Study||39
556526|NCT00698451|1356347|P1|COMPLETED|Overall Study||15
556527|NCT00698451|1356347|P1|STARTED|Overall Study||54
556528|NCT00698204|1356354|P2|NOT COMPLETED|Overall Study||0
556529|NCT00698204|1356355|P1|NOT COMPLETED|Overall Study||1
556530|NCT00698204|1356354|P2|COMPLETED|Overall Study||20
556531|NCT00698204|1356355|P1|COMPLETED|Overall Study||19
556532|NCT00698204|1356354|P2|STARTED|Overall Study||20
556533|NCT00698204|1356355|P1|STARTED|Overall Study||20
556534|NCT00698139|1356366|P3|NOT COMPLETED|Overall Study||0
556535|NCT00698139|1356367|P2|NOT COMPLETED|Overall Study||0
556536|NCT00698139|1356368|P1|NOT COMPLETED|Overall Study||0
556537|NCT00698139|1356366|P3|COMPLETED|Overall Study||1
556538|NCT00698139|1356367|P2|COMPLETED|Overall Study||1
556539|NCT00698139|1356368|P1|COMPLETED|Overall Study||1
556540|NCT00698139|1356366|P3|2nd Visit|Overall Study|1 subject in the Intervention Group did not have a 2nd visit (per design).|0
556541|NCT00698139|1356367|P2|2nd Visit|Overall Study||1
556542|NCT00698139|1356368|P1|2nd Visit|Overall Study||1
556543|NCT00698139|1356366|P3|STARTED|Overall Study||1
556544|NCT00698139|1356367|P2|STARTED|Overall Study||1
556545|NCT00698139|1356368|P1|STARTED|Overall Study||1
556546|NCT00698035|1356384|P2|NOT COMPLETED|Overall Study||2
556547|NCT00698035|1356385|P1|NOT COMPLETED|Overall Study||4
556548|NCT00698035|1356384|P2|COMPLETED|Overall Study||34
556549|NCT00698035|1356385|P1|COMPLETED|Overall Study||35
556550|NCT00698035|1356384|P2|STARTED|Overall Study||36
556551|NCT00698035|1356385|P1|STARTED|Overall Study||39
556552|NCT00698022|1356405|P3|NOT COMPLETED|Overall Study||2
556553|NCT00698022|1356406|P2|NOT COMPLETED|Overall Study||10
556554|NCT00698022|1356407|P1|NOT COMPLETED|Overall Study||16
556555|NCT00698022|1356405|P3|COMPLETED|Overall Study||14
556556|NCT00698022|1356406|P2|COMPLETED|Overall Study||20
556557|NCT00698022|1356407|P1|COMPLETED|Overall Study||14
556558|NCT00698022|1356405|P3|STARTED|Overall Study||16
556559|NCT00698022|1356406|P2|STARTED|Overall Study||30
556560|NCT00698022|1356407|P1|STARTED|Overall Study||30
556561|NCT00698009|1356415|P1|NOT COMPLETED|Overall Study||1
556562|NCT00698009|1356415|P1|COMPLETED|Overall Study||0
556563|NCT00698009|1356415|P1|STARTED|Overall Study||1
556564|NCT00697827|1356421|P2|NOT COMPLETED|Overall Study||1
556565|NCT00697827|1356422|P1|NOT COMPLETED|Overall Study||2
556566|NCT00697827|1356421|P2|COMPLETED|Overall Study||15
556567|NCT00697827|1356422|P1|COMPLETED|Overall Study||26
556568|NCT00697827|1356421|P2|STARTED|Overall Study||16
556569|NCT00697827|1356422|P1|STARTED|Overall Study||28
556570|NCT00697801|1356433|P3|NOT COMPLETED|Overall Study||24
556571|NCT00697801|1356434|P2|NOT COMPLETED|Overall Study||12
556572|NCT00697801|1356435|P1|NOT COMPLETED|Overall Study||12
556573|NCT00697801|1356433|P3|COMPLETED|Overall Study||45
556574|NCT00697801|1356434|P2|COMPLETED|Overall Study||58
556575|NCT00697801|1356435|P1|COMPLETED|Overall Study||57
556576|NCT00697801|1356433|P3|STARTED|Overall Study||69
556577|NCT00697801|1356434|P2|STARTED|Overall Study||70
556578|NCT00697801|1356435|P1|STARTED|Overall Study||69
556579|NCT00697788|1356449|P8|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
556580|NCT00697788|1356450|P7|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
556581|NCT00697788|1356451|P6|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
556582|NCT00697788|1356452|P5|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
556583|NCT00697788|1356453|P4|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
556584|NCT00697788|1356454|P3|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
556585|NCT00697788|1356455|P2|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
556586|NCT00697788|1356456|P1|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
556587|NCT00697788|1356449|P8|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||2
556588|NCT00697788|1356450|P7|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
556589|NCT00697788|1356451|P6|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
556590|NCT00697788|1356452|P5|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
556591|NCT00697788|1356453|P4|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
556592|NCT00697788|1356454|P3|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
556593|NCT00697788|1356455|P2|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
556594|NCT00697788|1356456|P1|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
556595|NCT00697788|1356449|P8|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||2
556596|NCT00697788|1356450|P7|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
556597|NCT00697788|1356451|P6|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
556598|NCT00697788|1356452|P5|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
556599|NCT00697788|1356453|P4|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
556600|NCT00697788|1356454|P3|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
556601|NCT00697788|1356455|P2|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
556602|NCT00697788|1356456|P1|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
556603|NCT00697788|1356449|P8|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
556604|NCT00697788|1356450|P7|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
556605|NCT00697788|1356451|P6|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
556606|NCT00697788|1356452|P5|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
556607|NCT00697788|1356453|P4|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
556608|NCT00697788|1356454|P3|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
556609|NCT00697788|1356455|P2|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
556610|NCT00697788|1356456|P1|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
556611|NCT00697788|1356449|P8|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
556612|NCT00697788|1356450|P7|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||2
556613|NCT00697788|1356451|P6|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
556614|NCT00697788|1356452|P5|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
556615|NCT00697788|1356453|P4|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
556616|NCT00697788|1356454|P3|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
556617|NCT00697788|1356455|P2|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
556618|NCT00697788|1356456|P1|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
556619|NCT00697788|1356449|P8|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
556620|NCT00697788|1356450|P7|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||2
556621|NCT00697788|1356451|P6|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
556622|NCT00697788|1356452|P5|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
556623|NCT00697788|1356453|P4|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
556624|NCT00697788|1356454|P3|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
556625|NCT00697788|1356455|P2|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
556626|NCT00697788|1356456|P1|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
556627|NCT00697788|1356449|P8|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
556628|NCT00697788|1356450|P7|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
556629|NCT00697788|1356451|P6|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
556630|NCT00697788|1356452|P5|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
556631|NCT00697788|1356453|P4|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
556632|NCT00697788|1356454|P3|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
556633|NCT00697788|1356455|P2|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
556634|NCT00697788|1356456|P1|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
556635|NCT00697788|1356449|P8|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
556636|NCT00697788|1356450|P7|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
556637|NCT00697788|1356451|P6|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||2
556638|NCT00697788|1356452|P5|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
556639|NCT00697788|1356453|P4|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
556640|NCT00697788|1356454|P3|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
556641|NCT00697788|1356455|P2|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
556642|NCT00697788|1356456|P1|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
556643|NCT00697788|1356449|P8|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
556644|NCT00697788|1356450|P7|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
556645|NCT00697788|1356451|P6|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||2
556646|NCT00697788|1356452|P5|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
556647|NCT00697788|1356453|P4|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
556648|NCT00697788|1356454|P3|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
556649|NCT00697788|1356455|P2|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
556650|NCT00697788|1356456|P1|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
556651|NCT00697788|1356449|P8|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
556652|NCT00697788|1356450|P7|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
556653|NCT00697788|1356451|P6|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
556654|NCT00697788|1356452|P5|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||1
556655|NCT00697788|1356453|P4|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
556656|NCT00697788|1356454|P3|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
556657|NCT00697788|1356455|P2|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
556658|NCT00697788|1356456|P1|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
556659|NCT00697788|1356449|P8|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
556660|NCT00697788|1356450|P7|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
556661|NCT00697788|1356451|P6|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
556662|NCT00697788|1356452|P5|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||2
556663|NCT00697788|1356453|P4|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
556664|NCT00697788|1356454|P3|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
556665|NCT00697788|1356455|P2|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
556666|NCT00697788|1356456|P1|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
556667|NCT00697788|1356449|P8|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
556668|NCT00697788|1356450|P7|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
556669|NCT00697788|1356451|P6|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
556670|NCT00697788|1356452|P5|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||3
556671|NCT00697788|1356453|P4|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
556672|NCT00697788|1356454|P3|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
556673|NCT00697788|1356455|P2|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
556674|NCT00697788|1356456|P1|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
556675|NCT00697788|1356449|P8|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
556676|NCT00697788|1356450|P7|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
556677|NCT00697788|1356451|P6|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
556678|NCT00697788|1356452|P5|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
556679|NCT00697788|1356453|P4|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
556680|NCT00697788|1356454|P3|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
556681|NCT00697788|1356455|P2|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
556682|NCT00697788|1356456|P1|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
556683|NCT00697788|1356449|P8|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
556684|NCT00697788|1356450|P7|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
556685|NCT00697788|1356451|P6|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
556686|NCT00697788|1356452|P5|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
556687|NCT00697788|1356453|P4|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||3
556688|NCT00697788|1356454|P3|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
556689|NCT00697788|1356455|P2|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
556690|NCT00697788|1356456|P1|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
556691|NCT00697788|1356449|P8|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
556692|NCT00697788|1356450|P7|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
556693|NCT00697788|1356451|P6|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
556694|NCT00697788|1356452|P5|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
556695|NCT00697788|1356453|P4|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||3
556696|NCT00697788|1356454|P3|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
556697|NCT00697788|1356455|P2|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
556698|NCT00697788|1356456|P1|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
556699|NCT00697788|1356449|P8|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
556700|NCT00697788|1356450|P7|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
556701|NCT00697788|1356451|P6|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
556702|NCT00697788|1356452|P5|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
556703|NCT00697788|1356453|P4|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
556704|NCT00697788|1356454|P3|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
556705|NCT00697788|1356455|P2|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
556706|NCT00697788|1356456|P1|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
556707|NCT00697788|1356449|P8|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
556708|NCT00697788|1356450|P7|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
556709|NCT00697788|1356451|P6|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
556710|NCT00697788|1356452|P5|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
556711|NCT00697788|1356453|P4|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
556712|NCT00697788|1356454|P3|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||3
556713|NCT00697788|1356455|P2|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
556714|NCT00697788|1356456|P1|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
556715|NCT00697788|1356449|P8|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
556716|NCT00697788|1356450|P7|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
556717|NCT00697788|1356451|P6|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
556718|NCT00697788|1356452|P5|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
556719|NCT00697788|1356453|P4|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
556720|NCT00697788|1356454|P3|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion|2 participants did not begin this infusion due to hypotension (MAP<50)|3
556721|NCT00697788|1356455|P2|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
556722|NCT00697788|1356456|P1|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
556723|NCT00697788|1356449|P8|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
556724|NCT00697788|1356450|P7|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
556725|NCT00697788|1356451|P6|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
556726|NCT00697788|1356452|P5|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
556727|NCT00697788|1356453|P4|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
556728|NCT00697788|1356454|P3|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
556729|NCT00697788|1356455|P2|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||2
556730|NCT00697788|1356456|P1|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
556731|NCT00697788|1356449|P8|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
556732|NCT00697788|1356450|P7|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
556733|NCT00697788|1356451|P6|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
556734|NCT00697788|1356452|P5|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
556735|NCT00697788|1356453|P4|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
556736|NCT00697788|1356454|P3|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
556737|NCT00697788|1356455|P2|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||5
556738|NCT00697788|1356456|P1|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
556739|NCT00697788|1356449|P8|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
556740|NCT00697788|1356450|P7|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
556741|NCT00697788|1356451|P6|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
556742|NCT00697788|1356452|P5|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
556743|NCT00697788|1356453|P4|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
556744|NCT00697788|1356454|P3|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
556745|NCT00697788|1356455|P2|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion|1 participant did not begin infusion due to hypotension (MAP<50)|7
556746|NCT00697788|1356456|P1|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
556747|NCT00697788|1356449|P8|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
556748|NCT00697788|1356450|P7|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
556749|NCT00697788|1356451|P6|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
556750|NCT00697788|1356452|P5|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
556751|NCT00697788|1356453|P4|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
556752|NCT00697788|1356454|P3|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
556753|NCT00697788|1356455|P2|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
556754|NCT00697788|1356456|P1|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
556755|NCT00697788|1356449|P8|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
556756|NCT00697788|1356450|P7|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
556757|NCT00697788|1356451|P6|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
556758|NCT00697788|1356452|P5|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
556759|NCT00697788|1356453|P4|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
556760|NCT00697788|1356454|P3|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
556761|NCT00697788|1356455|P2|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
556762|NCT00697788|1356456|P1|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||8
556763|NCT00697788|1356449|P8|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
556764|NCT00697788|1356450|P7|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
556765|NCT00697788|1356451|P6|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
556766|NCT00697788|1356452|P5|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
556767|NCT00697788|1356453|P4|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
556768|NCT00697788|1356454|P3|STARTED|Dexmedetomidine Bolus 1 mcg/kg|2 participants did not begin the ascending (1.0 mcg/kg/hr) due to MAP<50|0
556769|NCT00697788|1356455|P2|STARTED|Dexmedetomidine Bolus 1 mcg/kg|One participant did not begin infusion due to hypotension (mean pressure <50)|0
556770|NCT00697788|1356456|P1|STARTED|Dexmedetomidine Bolus 1 mcg/kg||8
556771|NCT00697697|1356500|P2|NOT COMPLETED|Overall Study||54
556772|NCT00697697|1356501|P1|NOT COMPLETED|Overall Study||49
556773|NCT00697697|1356500|P2|COMPLETED|Overall Study||44
556774|NCT00697697|1356501|P1|COMPLETED|Overall Study||45
556775|NCT00697697|1356500|P2|STARTED|Overall Study||98
556776|NCT00697697|1356501|P1|STARTED|Overall Study||94
556777|NCT00697619|1356511|P2|NOT COMPLETED|Overall Study||8
556778|NCT00697619|1356512|P1|NOT COMPLETED|Overall Study||6
556779|NCT00697619|1356511|P2|COMPLETED|Overall Study||22
556780|NCT00697619|1356512|P1|COMPLETED|Overall Study||24
556781|NCT00697619|1356511|P2|STARTED|Overall Study||30
556782|NCT00697619|1356512|P1|STARTED|Overall Study||30
556783|NCT00697593|1356518|P1|NOT COMPLETED|Overall Study||19
556784|NCT00697593|1356518|P1|COMPLETED|Overall Study||51
556785|NCT00697593|1356518|P1|STARTED|Overall Study||70
556786|NCT00697541|1356551|P2|NOT COMPLETED|Overall Study||1
556787|NCT00697541|1356552|P1|NOT COMPLETED|Overall Study||2
556788|NCT00697541|1356551|P2|COMPLETED|Overall Study||9
556789|NCT00697541|1356552|P1|COMPLETED|Overall Study||8
556790|NCT00697541|1356551|P2|STARTED|Overall Study||10
556791|NCT00697541|1356552|P1|STARTED|Overall Study||10
556792|NCT00697515|1356562|P2|NOT COMPLETED|Second Intervention (Crossover Period)||1
556793|NCT00697515|1356563|P1|NOT COMPLETED|Second Intervention (Crossover Period)||1
556794|NCT00697515|1356562|P2|COMPLETED|Second Intervention (Crossover Period)||51
556795|NCT00697515|1356563|P1|COMPLETED|Second Intervention (Crossover Period)||52
556796|NCT00697515|1356562|P2|STARTED|Second Intervention (Crossover Period)||52
556797|NCT00697515|1356563|P1|STARTED|Second Intervention (Crossover Period)||53
556798|NCT00697515|1356562|P2|NOT COMPLETED|First Intervention (Crossover Period)||12
556799|NCT00697515|1356563|P1|NOT COMPLETED|First Intervention (Crossover Period)||10
556800|NCT00697515|1356562|P2|COMPLETED|First Intervention (Crossover Period)||52
556801|NCT00697515|1356563|P1|COMPLETED|First Intervention (Crossover Period)||53
556802|NCT00697515|1356562|P2|STARTED|First Intervention (Crossover Period)||64
556803|NCT00697515|1356563|P1|STARTED|First Intervention (Crossover Period)||63
556804|NCT00697515|1356562|P2|NOT COMPLETED|Dose Optimization Period||0
556805|NCT00697515|1356563|P1|NOT COMPLETED|Dose Optimization Period||15
556806|NCT00697515|1356562|P2|COMPLETED|Dose Optimization Period||0
556807|NCT00697515|1356563|P1|COMPLETED|Dose Optimization Period||127
556808|NCT00697515|1356562|P2|STARTED|Dose Optimization Period||0
556809|NCT00697515|1356563|P1|STARTED|Dose Optimization Period||142
556810|NCT00697255|1356593|P2|NOT COMPLETED|Stage 1b||2
556811|NCT00697255|1356594|P1|NOT COMPLETED|Stage 1b||0
556812|NCT00697255|1356593|P2|COMPLETED|Stage 1b|Participants who completed 1b received hCG bolus injection and did not proceed further in the trial|1
556813|NCT00697255|1356594|P1|COMPLETED|Stage 1b||0
556814|NCT00697255|1356593|P2|STARTED|Stage 1b|After enrollment in Stage 1a completed, a new cohort of participants enrolled in Stage 1b.|3
556815|NCT00697255|1356594|P1|STARTED|Stage 1b||0
556816|NCT00697255|1356593|P2|NOT COMPLETED|Stage 1a||0
556817|NCT00697255|1356594|P1|NOT COMPLETED|Stage 1a||3
556818|NCT00697255|1356593|P2|COMPLETED|Stage 1a||0
556819|NCT00697255|1356594|P1|COMPLETED|Stage 1a|Participants who completed 1a received hCG bolus injection and did not proceed further in the trial|2
556820|NCT00697255|1356593|P2|STARTED|Stage 1a||0
556821|NCT00697255|1356594|P1|STARTED|Stage 1a||5
556822|NCT00697190|1356610|P2|NOT COMPLETED|Second Intervention||0
556823|NCT00697190|1356611|P1|NOT COMPLETED|Second Intervention||0
556824|NCT00697190|1356610|P2|COMPLETED|Second Intervention||20
556825|NCT00697190|1356611|P1|COMPLETED|Second Intervention||18
556826|NCT00697190|1356610|P2|STARTED|Second Intervention||20
556827|NCT00697190|1356611|P1|STARTED|Second Intervention|one subject moved away between the first period and second period.|18
556828|NCT00697190|1356610|P2|NOT COMPLETED|First Intervention||0
556829|NCT00697190|1356611|P1|NOT COMPLETED|First Intervention||0
556830|NCT00697190|1356610|P2|COMPLETED|First Intervention||20
556831|NCT00697190|1356611|P1|COMPLETED|First Intervention||19
556832|NCT00697190|1356610|P2|STARTED|First Intervention||20
556833|NCT00697190|1356611|P1|STARTED|First Intervention||19
556834|NCT00697112|1356645|P1|NOT COMPLETED|Overall Study||10
556835|NCT00697112|1356645|P1|COMPLETED|Overall Study||43
556836|NCT00697112|1356645|P1|Met the Inclusion Criteria|Overall Study||52
556837|NCT00697112|1356645|P1|STARTED|Overall Study||53
556838|NCT00697073|1356669|P1|NOT COMPLETED|Overall Study||9
556839|NCT00697073|1356669|P1|COMPLETED|Overall Study||59
556840|NCT00697073|1356669|P1|STARTED|Overall Study||68
556841|NCT00696878|1356673|P1|NOT COMPLETED|Overall Study||504
556842|NCT00696878|1356673|P1|COMPLETED|Overall Study||178
556843|NCT00696878|1356673|P1|STARTED|Overall Study||682
556844|NCT00696800|1356747|P2|NOT COMPLETED|Overall Study||48
556845|NCT00696800|1356748|P1|NOT COMPLETED|Overall Study||85
556846|NCT00696800|1356747|P2|COMPLETED|Overall Study|Participants who had embryos transferred|704
556847|NCT00696800|1356748|P1|COMPLETED|Overall Study|Participants who had embryos transferred|672
556848|NCT00696800|1356747|P2|Treated (ITT)|Overall Study|The ITT group|750
556849|NCT00696800|1356748|P1|Treated (ITT)|Overall Study|The ITT group|756
556850|NCT00696800|1356747|P2|STARTED|Overall Study||752
556851|NCT00696800|1356748|P1|STARTED|Overall Study||757
556852|NCT00696787|1356801|P3|NOT COMPLETED|Overall Study||26
556853|NCT00696787|1356802|P2|NOT COMPLETED|Overall Study||20
556854|NCT00696787|1356803|P1|NOT COMPLETED|Overall Study||15
556855|NCT00696787|1356801|P3|COMPLETED|Overall Study||17
556856|NCT00696787|1356802|P2|COMPLETED|Overall Study||22
556857|NCT00696787|1356803|P1|COMPLETED|Overall Study||25
556858|NCT00696787|1356801|P3|STARTED|Overall Study||43
556859|NCT00696787|1356802|P2|STARTED|Overall Study||42
556860|NCT00696787|1356803|P1|STARTED|Overall Study||40
556861|NCT00696774|1356817|P3|NOT COMPLETED|Period III||0
556862|NCT00696774|1356818|P2|NOT COMPLETED|Period III||7
556863|NCT00696774|1356819|P1|NOT COMPLETED|Period III||7
556864|NCT00696774|1356817|P3|COMPLETED|Period III||0
556865|NCT00696774|1356818|P2|COMPLETED|Period III|82 participants were reported at Week 8; 81 completed Week 8 as 1 participant decided to withdraw.|81
556866|NCT00696774|1356819|P1|COMPLETED|Period III||106
556867|NCT00696774|1356817|P3|STARTED|Period III||0
556868|NCT00696774|1356818|P2|STARTED|Period III|91 reported at Week 4; 88 start Period 3 (1 adverse event, 1 protocol violation, 1 lack of efficacy)|88
556869|NCT00696774|1356819|P1|STARTED|Period III|115 reported at Week 4; 113 started Period 3 (1 lost to follow-up and 1 protocol violation).|113
556870|NCT00696774|1356817|P3|NOT COMPLETED|Period II||36
556871|NCT00696774|1356818|P2|NOT COMPLETED|Period II||0
556872|NCT00696774|1356819|P1|NOT COMPLETED|Period II||0
556873|NCT00696774|1356817|P3|COMPLETED|Period II||0
556874|NCT00696774|1356818|P2|COMPLETED|Period II||91
556875|NCT00696774|1356819|P1|COMPLETED|Period II||115
556876|NCT00696774|1356817|P3|STARTED|Period II|1 participant did not receive study drug and was not included in the safety analyses.|36
556877|NCT00696774|1356818|P2|STARTED|Period II||91
556878|NCT00696774|1356819|P1|STARTED|Period II||115
556879|NCT00696761|1356857|P4|NOT COMPLETED|Overall Study||10
556880|NCT00696761|1356858|P3|NOT COMPLETED|Overall Study||11
556881|NCT00696761|1356859|P2|NOT COMPLETED|Overall Study||26
556882|NCT00696761|1356860|P1|NOT COMPLETED|Overall Study||20
556883|NCT00696761|1356857|P4|COMPLETED|Overall Study||44
556884|NCT00696761|1356858|P3|COMPLETED|Overall Study||30
556885|NCT00696761|1356859|P2|COMPLETED|Overall Study||50
556886|NCT00696761|1356860|P1|COMPLETED|Overall Study||41
556887|NCT00696761|1356857|P4|STARTED|Overall Study||54
556888|NCT00696761|1356858|P3|STARTED|Overall Study||41
556889|NCT00696761|1356859|P2|STARTED|Overall Study||76
556890|NCT00696761|1356860|P1|STARTED|Overall Study||61
556891|NCT00696696|1356874|P1|NOT COMPLETED|Overall Study||18
556892|NCT00696696|1356874|P1|COMPLETED|Overall Study|number of patients off treatment due to progression of disease only|26
556893|NCT00696696|1356874|P1|STARTED|Overall Study||44
556894|NCT00696618|1356883|P3|NOT COMPLETED|Overall Study||0
556895|NCT00696618|1356884|P2|NOT COMPLETED|Overall Study||0
556896|NCT00696618|1356885|P1|NOT COMPLETED|Overall Study||0
556897|NCT00696618|1356883|P3|COMPLETED|Overall Study||3
556898|NCT00696618|1356884|P2|COMPLETED|Overall Study||3
556899|NCT00696618|1356885|P1|COMPLETED|Overall Study||3
556900|NCT00696618|1356883|P3|STARTED|Overall Study||3
556901|NCT00696618|1356884|P2|STARTED|Overall Study||3
556902|NCT00696618|1356885|P1|STARTED|Overall Study||3
556903|NCT00696488|1356899|P1|NOT COMPLETED|Overall Study||0
556904|NCT00696488|1356899|P1|COMPLETED|Overall Study||20
556905|NCT00696488|1356899|P1|STARTED|Overall Study||20
556906|NCT00696449|1356907|P4|NOT COMPLETED|Overall Study||3
556907|NCT00696449|1356908|P3|NOT COMPLETED|Overall Study||1
556908|NCT00696449|1356909|P2|NOT COMPLETED|Overall Study||6
556909|NCT00696449|1356910|P1|NOT COMPLETED|Overall Study||3
556910|NCT00696449|1356907|P4|COMPLETED|Overall Study||13
556911|NCT00696449|1356908|P3|COMPLETED|Overall Study||14
556912|NCT00696449|1356909|P2|COMPLETED|Overall Study||9
556913|NCT00696449|1356910|P1|COMPLETED|Overall Study||12
556914|NCT00696449|1356907|P4|STARTED|Overall Study||16
556915|NCT00696449|1356908|P3|STARTED|Overall Study||15
556916|NCT00696449|1356909|P2|STARTED|Overall Study||15
556917|NCT00696449|1356910|P1|STARTED|Overall Study||15
556918|NCT00696436|1356925|P5|NOT COMPLETED|Overall Study||13
556919|NCT00696436|1356926|P4|NOT COMPLETED|Overall Study||22
556920|NCT00696436|1356927|P3|NOT COMPLETED|Overall Study||28
556921|NCT00696436|1356928|P2|NOT COMPLETED|Overall Study||30
556922|NCT00696436|1356929|P1|NOT COMPLETED|Overall Study||23
556923|NCT00696436|1356925|P5|COMPLETED|Overall Study||141
556924|NCT00696436|1356926|P4|COMPLETED|Overall Study||268
556925|NCT00696436|1356927|P3|COMPLETED|Overall Study||254
556926|NCT00696436|1356928|P2|COMPLETED|Overall Study||255
556927|NCT00696436|1356929|P1|COMPLETED|Overall Study||257
556928|NCT00696436|1356925|P5|STARTED|Overall Study|Randomized participants only.|154
556929|NCT00696436|1356926|P4|STARTED|Overall Study|Randomized participants only.|290
556930|NCT00696436|1356927|P3|STARTED|Overall Study|Randomized participants only.|282
556931|NCT00696436|1356928|P2|STARTED|Overall Study|Randomized participants only. One participant treated but not randomized and is not included.|285
556932|NCT00696436|1356929|P1|STARTED|Overall Study|Randomized participants only.|280
556933|NCT00696423|1357013|P2|NOT COMPLETED|Overall Study||5
556934|NCT00696423|1357014|P1|NOT COMPLETED|Overall Study||0
556935|NCT00696423|1357013|P2|COMPLETED|Overall Study||218
556936|NCT00696423|1357014|P1|COMPLETED|Overall Study||244
556937|NCT00696423|1357013|P2|STARTED|Overall Study||223
556938|NCT00696423|1357014|P1|STARTED|Overall Study||244
556939|NCT00696410|1357046|P2|NOT COMPLETED|Overall Study||0
556940|NCT00696410|1357047|P1|NOT COMPLETED|Overall Study||13
556941|NCT00696410|1357046|P2|COMPLETED|Overall Study||10
556942|NCT00696410|1357047|P1|COMPLETED|Overall Study||25
556943|NCT00696410|1357046|P2|STARTED|Overall Study||10
556944|NCT00696410|1357047|P1|STARTED|Overall Study||38
556945|NCT00696384|1357061|P3|NOT COMPLETED|Double Blind Phase||6
556946|NCT00696384|1357062|P2|NOT COMPLETED|Double Blind Phase||11
556947|NCT00696384|1357063|P1|NOT COMPLETED|Double Blind Phase||0
556948|NCT00696384|1357061|P3|COMPLETED|Double Blind Phase||145
556949|NCT00696384|1357062|P2|COMPLETED|Double Blind Phase||137
556950|NCT00696384|1357063|P1|COMPLETED|Double Blind Phase||0
556951|NCT00696384|1357061|P3|STARTED|Double Blind Phase||151
556952|NCT00696384|1357062|P2|STARTED|Double Blind Phase||148
556953|NCT00696384|1357063|P1|STARTED|Double Blind Phase||0
556954|NCT00696384|1357061|P3|NOT COMPLETED|Open Label Phase||0
556955|NCT00696384|1357062|P2|NOT COMPLETED|Open Label Phase||0
556956|NCT00696384|1357063|P1|NOT COMPLETED|Open Label Phase||119
556957|NCT00696384|1357061|P3|COMPLETED|Open Label Phase||0
556958|NCT00696384|1357062|P2|COMPLETED|Open Label Phase||0
556959|NCT00696384|1357063|P1|COMPLETED|Open Label Phase||299
556960|NCT00696384|1357061|P3|STARTED|Open Label Phase||0
556961|NCT00696384|1357062|P2|STARTED|Open Label Phase||0
556962|NCT00696384|1357063|P1|STARTED|Open Label Phase||418
556963|NCT00696293|1357077|P1|NOT COMPLETED|Overall Study||2
556964|NCT00696293|1357077|P1|COMPLETED|Overall Study||28
556965|NCT00696293|1357077|P1|STARTED|Overall Study||30
556966|NCT00696241|1357087|P5|NOT COMPLETED|Overall Study||12
556967|NCT00696241|1357088|P4|NOT COMPLETED|Overall Study||14
556968|NCT00696241|1357089|P3|NOT COMPLETED|Overall Study||24
556969|NCT00696241|1357090|P2|NOT COMPLETED|Overall Study||22
556970|NCT00696241|1357091|P1|NOT COMPLETED|Overall Study||24
556971|NCT00696241|1357087|P5|COMPLETED|Overall Study||130
556972|NCT00696241|1357088|P4|COMPLETED|Overall Study||268
556973|NCT00696241|1357089|P3|COMPLETED|Overall Study||261
556974|NCT00696241|1357090|P2|COMPLETED|Overall Study||261
556975|NCT00696241|1357091|P1|COMPLETED|Overall Study||259
556976|NCT00696241|1357087|P5|STARTED|Overall Study||142
556977|NCT00696241|1357088|P4|STARTED|Overall Study||282
556978|NCT00696241|1357089|P3|STARTED|Overall Study||285
556979|NCT00696241|1357090|P2|STARTED|Overall Study||283
556980|NCT00696241|1357091|P1|STARTED|Overall Study||283
556981|NCT00696072|1357175|P2|NOT COMPLETED|Overall Study||63
556982|NCT00696072|1357176|P1|NOT COMPLETED|Overall Study||57
556983|NCT00696072|1357175|P2|COMPLETED|Overall Study||0
556984|NCT00696072|1357176|P1|COMPLETED|Overall Study||0
556985|NCT00696072|1357175|P2|STARTED|Overall Study||63
556986|NCT00696072|1357176|P1|STARTED|Overall Study||57
556987|NCT00696020|1357197|P4|NOT COMPLETED|Overall Study||4
556988|NCT00696020|1357198|P3|NOT COMPLETED|Overall Study||3
556989|NCT00696020|1357199|P2|NOT COMPLETED|Overall Study||2
556990|NCT00696020|1357200|P1|NOT COMPLETED|Overall Study||4
556991|NCT00696020|1357197|P4|COMPLETED|Overall Study||84
556992|NCT00696020|1357198|P3|COMPLETED|Overall Study||90
556993|NCT00696020|1357199|P2|COMPLETED|Overall Study||87
556994|NCT00696020|1357200|P1|COMPLETED|Overall Study||86
556995|NCT00696020|1357197|P4|STARTED|Overall Study||88
556996|NCT00696020|1357198|P3|STARTED|Overall Study||93
556997|NCT00696020|1357199|P2|STARTED|Overall Study||89
556998|NCT00696020|1357200|P1|STARTED|Overall Study||90
556999|NCT00695955|1357308|P1|NOT COMPLETED|Cohort 2||104
557000|NCT00695955|1357308|P1|COMPLETED|Cohort 2||203
557001|NCT00695955|1357308|P1|STARTED|Cohort 2||307
557002|NCT00695955|1357308|P1|NOT COMPLETED|Cohort 1||102
557003|NCT00695955|1357308|P1|COMPLETED|Cohort 1||260
557004|NCT00695955|1357308|P1|STARTED|Cohort 1||362
557005|NCT00695903|1357320|P2|NOT COMPLETED|Had Test of Cure (TOC) Assessment||1
557006|NCT00695903|1357321|P1|NOT COMPLETED|Had Test of Cure (TOC) Assessment||2
557007|NCT00695903|1357320|P2|COMPLETED|Had Test of Cure (TOC) Assessment||3
557008|NCT00695903|1357321|P1|COMPLETED|Had Test of Cure (TOC) Assessment||5
557009|NCT00695903|1357320|P2|STARTED|Had Test of Cure (TOC) Assessment||4
557010|NCT00695903|1357321|P1|STARTED|Had Test of Cure (TOC) Assessment||7
557011|NCT00695903|1357320|P2|NOT COMPLETED|Had End of Therapy (EOT) Assessment||15
557012|NCT00695903|1357321|P1|NOT COMPLETED|Had End of Therapy (EOT) Assessment||12
557013|NCT00695903|1357320|P2|COMPLETED|Had End of Therapy (EOT) Assessment||4
557014|NCT00695903|1357321|P1|COMPLETED|Had End of Therapy (EOT) Assessment||7
557015|NCT00695903|1357320|P2|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||6
557016|NCT00695903|1357321|P1|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||9
557017|NCT00695903|1357320|P2|STARTED|Had End of Therapy (EOT) Assessment||19
557018|NCT00695903|1357321|P1|STARTED|Had End of Therapy (EOT) Assessment||19
557019|NCT00695864|1357333|P1|NOT COMPLETED|Ondansetron||5
557020|NCT00695864|1357333|P1|COMPLETED|Ondansetron||9
557021|NCT00695864|1357333|P1|STARTED|Ondansetron||14
557022|NCT00695864|1357333|P1|NOT COMPLETED|Placebo||5
557023|NCT00695864|1357333|P1|COMPLETED|Placebo||9
557024|NCT00695864|1357333|P1|STARTED|Placebo||14
557025|NCT00695669|1357343|P4|NOT COMPLETED|Overall Study||4
557026|NCT00695669|1357344|P3|NOT COMPLETED|Overall Study||3
557027|NCT00695669|1357345|P2|NOT COMPLETED|Overall Study||4
557028|NCT00695669|1357346|P1|NOT COMPLETED|Overall Study||4
557029|NCT00695669|1357343|P4|COMPLETED|Overall Study||74
557030|NCT00695669|1357344|P3|COMPLETED|Overall Study||75
557031|NCT00695669|1357345|P2|COMPLETED|Overall Study||74
557032|NCT00695669|1357346|P1|COMPLETED|Overall Study||74
557033|NCT00695669|1357343|P4|STARTED|Overall Study||78
557034|NCT00695669|1357344|P3|STARTED|Overall Study||78
557035|NCT00695669|1357345|P2|STARTED|Overall Study||78
557036|NCT00695669|1357346|P1|STARTED|Overall Study||78
557037|NCT00695565|1357422|P2|NOT COMPLETED|Overall Study||9
557038|NCT00695565|1357423|P1|NOT COMPLETED|Overall Study||13
557039|NCT00695565|1357422|P2|COMPLETED|Overall Study||81
557040|NCT00695565|1357423|P1|COMPLETED|Overall Study||77
557041|NCT00695565|1357422|P2|STARTED|Overall Study||90
557042|NCT00695565|1357423|P1|STARTED|Overall Study||90
557043|NCT00695500|1357457|P2|NOT COMPLETED|Overall Study||5
557044|NCT00695500|1357458|P1|NOT COMPLETED|Overall Study||3
557045|NCT00695500|1357457|P2|COMPLETED|Overall Study||17
557046|NCT00695500|1357458|P1|COMPLETED|Overall Study||21
557047|NCT00695500|1357457|P2|STARTED|Overall Study||22
557048|NCT00695500|1357458|P1|STARTED|Overall Study||24
557049|NCT00695435|1357468|P3|NOT COMPLETED|Overall Study||0
557050|NCT00695435|1357469|P2|NOT COMPLETED|Overall Study||0
557051|NCT00695435|1357470|P1|NOT COMPLETED|Overall Study||0
557052|NCT00695435|1357468|P3|COMPLETED|Overall Study||7
557053|NCT00695435|1357469|P2|COMPLETED|Overall Study||7
557054|NCT00695435|1357470|P1|COMPLETED|Overall Study||7
557055|NCT00695435|1357468|P3|STARTED|Overall Study||7
557056|NCT00695435|1357469|P2|STARTED|Overall Study||7
557057|NCT00695435|1357470|P1|STARTED|Overall Study||7
557058|NCT00695396|1357484|P3|NOT COMPLETED|Overall Study||8
557059|NCT00695396|1357485|P2|NOT COMPLETED|Overall Study||8
557060|NCT00695396|1357486|P1|NOT COMPLETED|Overall Study||7
557061|NCT00695396|1357484|P3|COMPLETED|Overall Study||1
557062|NCT00695396|1357485|P2|COMPLETED|Overall Study||0
557063|NCT00695396|1357486|P1|COMPLETED|Overall Study||1
557064|NCT00695396|1357484|P3|STARTED|Overall Study||9
557065|NCT00695396|1357485|P2|STARTED|Overall Study||8
557066|NCT00695396|1357486|P1|STARTED|Overall Study||8
557067|NCT00695318|1357502|P2|NOT COMPLETED|Overall Study||1
557068|NCT00695318|1357503|P1|NOT COMPLETED|Overall Study||5
557069|NCT00695318|1357502|P2|COMPLETED|Overall Study||6
557070|NCT00695318|1357503|P1|COMPLETED|Overall Study||5
557071|NCT00695318|1357502|P2|STARTED|Overall Study||7
557072|NCT00695318|1357503|P1|STARTED|Overall Study||10
557073|NCT00695292|1357514|P1|NOT COMPLETED|Overall Study||0
557074|NCT00695292|1357514|P1|COMPLETED|Overall Study||37
557075|NCT00695292|1357514|P1|STARTED|Overall Study||37
557076|NCT00695188|1357521|P2|NOT COMPLETED|Overall Study||0
557077|NCT00695188|1357522|P1|NOT COMPLETED|Overall Study||0
557078|NCT00695188|1357521|P2|COMPLETED|Overall Study||9
557079|NCT00695188|1357522|P1|COMPLETED|Overall Study||10
557080|NCT00695188|1357521|P2|STARTED|Overall Study||9
557081|NCT00695188|1357522|P1|STARTED|Overall Study||10
557082|NCT00695136|1357528|P1|NOT COMPLETED|Overall Study||2
557083|NCT00695136|1357528|P1|COMPLETED|Overall Study||5
557084|NCT00695136|1357528|P1|STARTED|Overall Study|7|7
557085|NCT00695097|1357534|P2|NOT COMPLETED|Overall Study||0
557086|NCT00695097|1357535|P1|NOT COMPLETED|Overall Study||1
557087|NCT00695097|1357534|P2|COMPLETED|Overall Study||5
557088|NCT00695097|1357535|P1|COMPLETED|Overall Study||9
557089|NCT00695097|1357534|P2|STARTED|Overall Study||5
557090|NCT00695097|1357535|P1|STARTED|Overall Study||10
557091|NCT00695019|1357544|P3|NOT COMPLETED|Overall Study||10
557092|NCT00695019|1357545|P2|NOT COMPLETED|Overall Study||14
557093|NCT00695019|1357546|P1|NOT COMPLETED|Overall Study||13
557094|NCT00695019|1357544|P3|COMPLETED|Overall Study||47
557095|NCT00695019|1357545|P2|COMPLETED|Overall Study||39
557096|NCT00695019|1357546|P1|COMPLETED|Overall Study||46
557097|NCT00695019|1357544|P3|STARTED|Overall Study||57
557098|NCT00695019|1357545|P2|STARTED|Overall Study||53
557099|NCT00695019|1357546|P1|STARTED|Overall Study||59
557100|NCT00694603|1357575|P1|NOT COMPLETED|Overall Study||0
557101|NCT00694603|1357575|P1|COMPLETED|Overall Study||18
557102|NCT00694603|1357575|P1|STARTED|Overall Study||18
557103|NCT00694564|1357580|P1|NOT COMPLETED|Overall Study||2
557104|NCT00694564|1357580|P1|COMPLETED|Overall Study||6
557105|NCT00694564|1357580|P1|STARTED|Overall Study||8
557106|NCT00694551|1357587|P3|NOT COMPLETED|Overall Study||1
557107|NCT00694551|1357588|P2|NOT COMPLETED|Overall Study||0
557108|NCT00694551|1357589|P1|NOT COMPLETED|Overall Study||1
557109|NCT00694551|1357587|P3|COMPLETED|Overall Study||8
557110|NCT00694551|1357588|P2|COMPLETED|Overall Study||10
557111|NCT00694551|1357589|P1|COMPLETED|Overall Study||9
557112|NCT00694551|1357587|P3|STARTED|Overall Study||9
557113|NCT00694551|1357588|P2|STARTED|Overall Study||10
557114|NCT00694551|1357589|P1|STARTED|Overall Study||10
557115|NCT00694473|1357603|P1|NOT COMPLETED|Overall Study||7
557116|NCT00694473|1357603|P1|COMPLETED|Overall Study|Dec 2010|69
557117|NCT00694473|1357603|P1|STARTED|Overall Study|Aug 2008|76
557118|NCT00694369|1357618|P5|NOT COMPLETED|Overall Study||6
557119|NCT00694369|1357619|P4|NOT COMPLETED|Overall Study||3
557120|NCT00694369|1357620|P3|NOT COMPLETED|Overall Study||2
557121|NCT00694369|1357621|P2|NOT COMPLETED|Overall Study||3
557122|NCT00694369|1357622|P1|NOT COMPLETED|Overall Study||1
557123|NCT00694369|1357618|P5|COMPLETED|Overall Study||56
557124|NCT00694369|1357619|P4|COMPLETED|Overall Study||189
557125|NCT00694369|1357620|P3|COMPLETED|Overall Study||95
557126|NCT00694369|1357621|P2|COMPLETED|Overall Study||188
557127|NCT00694369|1357622|P1|COMPLETED|Overall Study||45
557128|NCT00694369|1357618|P5|STARTED|Overall Study||62
557129|NCT00694369|1357619|P4|STARTED|Overall Study||192
557130|NCT00694369|1357620|P3|STARTED|Overall Study||97
557131|NCT00694369|1357621|P2|STARTED|Overall Study||191
557132|NCT00694369|1357622|P1|STARTED|Overall Study||46
557133|NCT00694356|1357642|P3|NOT COMPLETED|Overall Study||6
557134|NCT00694356|1357643|P2|NOT COMPLETED|Overall Study||6
557135|NCT00694356|1357644|P1|NOT COMPLETED|Overall Study||3
557136|NCT00694356|1357642|P3|COMPLETED|Overall Study||0
557137|NCT00694356|1357643|P2|COMPLETED|Overall Study||0
557138|NCT00694356|1357644|P1|COMPLETED|Overall Study||0
557139|NCT00694356|1357642|P3|STARTED|Overall Study||6
557140|NCT00694356|1357643|P2|STARTED|Overall Study||6
557141|NCT00694356|1357644|P1|STARTED|Overall Study||3
557142|NCT00694304|1357679|P1|NOT COMPLETED|Overall Study||207
557143|NCT00694304|1357679|P1|COMPLETED|Overall Study||328
557144|NCT00694304|1357679|P1|STARTED|Overall Study||535
557145|NCT00694161|1357692|P1|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||3
557146|NCT00694161|1357692|P1|COMPLETED|Part 2 (After Week 6 up to Month 12)||32
557147|NCT00694161|1357692|P1|STARTED|Part 2 (After Week 6 up to Month 12)||35
557148|NCT00694161|1357692|P1|NOT COMPLETED|Part 1 (up to Week 6)||0
557149|NCT00694161|1357692|P1|COMPLETED|Part 1 (up to Week 6)||35
557150|NCT00694161|1357692|P1|STARTED|Part 1 (up to Week 6)||35
557151|NCT00694122|1357731|P2|NOT COMPLETED|Second Intervention (3-4 Weeks)||0
557152|NCT00694122|1357732|P1|NOT COMPLETED|Second Intervention (3-4 Weeks)||0
557153|NCT00694122|1357731|P2|COMPLETED|Second Intervention (3-4 Weeks)||5
557154|NCT00694122|1357732|P1|COMPLETED|Second Intervention (3-4 Weeks)||10
557155|NCT00694122|1357731|P2|STARTED|Second Intervention (3-4 Weeks)||5
557156|NCT00694122|1357732|P1|STARTED|Second Intervention (3-4 Weeks)||10
557157|NCT00694122|1357731|P2|NOT COMPLETED|Washout (1 Day)||0
557158|NCT00694122|1357732|P1|NOT COMPLETED|Washout (1 Day)||0
557159|NCT00694122|1357731|P2|COMPLETED|Washout (1 Day)||5
557160|NCT00694122|1357732|P1|COMPLETED|Washout (1 Day)||10
557161|NCT00694122|1357731|P2|STARTED|Washout (1 Day)||5
557162|NCT00694122|1357732|P1|STARTED|Washout (1 Day)||10
557163|NCT00694122|1357731|P2|NOT COMPLETED|First Intervention (3-4 Weeks)||2
557164|NCT00694122|1357732|P1|NOT COMPLETED|First Intervention (3-4 Weeks)||10
557165|NCT00694122|1357731|P2|COMPLETED|First Intervention (3-4 Weeks)||5
557166|NCT00694122|1357732|P1|COMPLETED|First Intervention (3-4 Weeks)||10
557167|NCT00694122|1357731|P2|STARTED|First Intervention (3-4 Weeks)|Started on NPH then on Lantus.|7
557168|NCT00694122|1357732|P1|STARTED|First Intervention (3-4 Weeks)|Started Lantus then on NPH.|20
557169|NCT00694109|1357748|P1|NOT COMPLETED|Overall Study||117
557170|NCT00694109|1357748|P1|COMPLETED|Overall Study||25
557171|NCT00694109|1357748|P1|Completed Consented Length of Treatment|Overall Study||60
557172|NCT00694109|1357748|P1|Consented 2 Years Additional Treatment|Overall Study||42
557173|NCT00694109|1357748|P1|Treated|Overall Study||141
557174|NCT00694109|1357748|P1|STARTED|Overall Study|This does not include 2 patients from phase 2 trial with very different treatment experience.|142
557175|NCT00694096|1357772|P1|NOT COMPLETED|Overall Study||5
557176|NCT00694096|1357772|P1|COMPLETED|Overall Study||20
557177|NCT00694096|1357772|P1|STARTED|Overall Study||25
557178|NCT00694070|1357778|P1|NOT COMPLETED|Overall Study||0
557179|NCT00694070|1357778|P1|COMPLETED|Overall Study||51
557180|NCT00694070|1357778|P1|STARTED|Overall Study||51
557181|NCT00694018|1357786|P2|NOT COMPLETED|Overall Study||9
557182|NCT00694018|1357787|P1|NOT COMPLETED|Overall Study||13
557183|NCT00694018|1357786|P2|COMPLETED|Overall Study||102
557184|NCT00694018|1357787|P1|COMPLETED|Overall Study||105
557185|NCT00694018|1357786|P2|6 Months|Overall Study||101
557186|NCT00694018|1357787|P1|6 Months|Overall Study||106
557187|NCT00694018|1357786|P2|STARTED|Overall Study||111
557188|NCT00694018|1357787|P1|STARTED|Overall Study||118
557189|NCT00693992|1357795|P2|NOT COMPLETED|Overall Study||0
557190|NCT00693992|1357796|P1|NOT COMPLETED|Overall Study||0
557191|NCT00693992|1357795|P2|COMPLETED|Overall Study||104
557192|NCT00693992|1357796|P1|COMPLETED|Overall Study||106
557193|NCT00693992|1357795|P2|STARTED|Overall Study||104
557194|NCT00693992|1357796|P1|STARTED|Overall Study||106
557195|NCT00693784|1357812|P1|NOT COMPLETED|Overall Study||4
557196|NCT00693784|1357812|P1|COMPLETED|Overall Study||11
557197|NCT00693784|1357812|P1|104-week Extended Follow-up|Overall Study||11
557198|NCT00693784|1357812|P1|52-week Extended Follow-up|Overall Study||13
557199|NCT00693784|1357812|P1|26-Week Primary Endpoint|Overall Study||15
557200|NCT00693784|1357812|P1|STARTED|Overall Study||15
557201|NCT00693719|1357818|P1|NOT COMPLETED|Overall Study||0
557202|NCT00693719|1357818|P1|COMPLETED|Overall Study||31
557203|NCT00693719|1357818|P1|STARTED|Overall Study||31
557204|NCT00693706|1357825|P2|NOT COMPLETED|Overall Study||1
557205|NCT00693706|1357826|P1|NOT COMPLETED|Overall Study||0
557206|NCT00693706|1357825|P2|COMPLETED|Overall Study||98
557207|NCT00693706|1357826|P1|COMPLETED|Overall Study||101
557208|NCT00693706|1357825|P2|STARTED|Overall Study||99
557209|NCT00693706|1357826|P1|STARTED|Overall Study||101
557210|NCT00693693|1357853|P3|NOT COMPLETED|Overall Study||2
557211|NCT00693693|1357854|P2|NOT COMPLETED|Overall Study||1
557212|NCT00693693|1357855|P1|NOT COMPLETED|Overall Study||1
557213|NCT00693693|1357853|P3|COMPLETED|Overall Study||7
557214|NCT00693693|1357854|P2|COMPLETED|Overall Study||8
557215|NCT00693693|1357855|P1|COMPLETED|Overall Study||6
557216|NCT00693693|1357853|P3|STARTED|Overall Study||9
557217|NCT00693693|1357854|P2|STARTED|Overall Study||9
557218|NCT00693693|1357855|P1|STARTED|Overall Study||7
557219|NCT00693654|1357865|P2|NOT COMPLETED|Overall Study||0
557220|NCT00693654|1357866|P1|NOT COMPLETED|Overall Study||0
557221|NCT00693654|1357865|P2|COMPLETED|Overall Study||14
557222|NCT00693654|1357866|P1|COMPLETED|Overall Study||14
557223|NCT00693654|1357865|P2|STARTED|Overall Study||14
557224|NCT00693654|1357866|P1|STARTED|Overall Study||14
557225|NCT00693628|1357876|P2|NOT COMPLETED|Overall Study||0
557226|NCT00693628|1357877|P1|NOT COMPLETED|Overall Study||0
557227|NCT00693628|1357876|P2|COMPLETED|Overall Study|Only 4 patients enrolled in study. No data indicating their group assignment.|0
557228|NCT00693628|1357877|P1|COMPLETED|Overall Study|Only 4 patients enrolled in study. No data indicating their group assignment|0
557229|NCT00693628|1357876|P2|STARTED|Overall Study|No data is available indicating to which group patients were assigned .|0
557230|NCT00693628|1357877|P1|STARTED|Overall Study|No data is available indicating to which group patients were assigned.|0
557231|NCT00693498|1357885|P2|NOT COMPLETED|Overall Study||0
557232|NCT00693498|1357886|P1|NOT COMPLETED|Overall Study||0
557233|NCT00693498|1357885|P2|COMPLETED|Overall Study||81
557234|NCT00693498|1357886|P1|COMPLETED|Overall Study||81
557235|NCT00693498|1357885|P2|STARTED|Overall Study||81
557236|NCT00693498|1357886|P1|STARTED|Overall Study||81
557237|NCT00693485|1357897|P3|NOT COMPLETED|Overall Study||0
557238|NCT00693485|1357898|P2|NOT COMPLETED|Overall Study||2
557239|NCT00693485|1357899|P1|NOT COMPLETED|Overall Study||0
557240|NCT00693485|1357897|P3|COMPLETED|Overall Study||24
557241|NCT00693485|1357898|P2|COMPLETED|Overall Study||19
557242|NCT00693485|1357899|P1|COMPLETED|Overall Study||25
557243|NCT00693485|1357897|P3|STARTED|Overall Study||24
557244|NCT00693485|1357898|P2|STARTED|Overall Study||21
557245|NCT00693485|1357899|P1|STARTED|Overall Study||25
557246|NCT00693472|1357914|P4|NOT COMPLETED|Part 2||2
557247|NCT00693472|1357915|P3|NOT COMPLETED|Part 2||2
557248|NCT00693472|1357916|P2|NOT COMPLETED|Part 2||0
557249|NCT00693472|1357917|P1|NOT COMPLETED|Part 2||0
557250|NCT00693472|1357914|P4|COMPLETED|Part 2||4
557251|NCT00693472|1357915|P3|COMPLETED|Part 2||6
557252|NCT00693472|1357916|P2|COMPLETED|Part 2||0
557253|NCT00693472|1357917|P1|COMPLETED|Part 2||0
557254|NCT00693472|1357914|P4|STARTED|Part 2||6
557255|NCT00693472|1357915|P3|STARTED|Part 2||8
557256|NCT00693472|1357916|P2|STARTED|Part 2||0
557257|NCT00693472|1357917|P1|STARTED|Part 2||0
557258|NCT00693472|1357914|P4|NOT COMPLETED|Part 1||0
557259|NCT00693472|1357915|P3|NOT COMPLETED|Part 1||0
557260|NCT00693472|1357916|P2|NOT COMPLETED|Part 1||4
557261|NCT00693472|1357917|P1|NOT COMPLETED|Part 1||6
557262|NCT00693472|1357914|P4|COMPLETED|Part 1||0
557263|NCT00693472|1357915|P3|COMPLETED|Part 1||0
557264|NCT00693472|1357916|P2|COMPLETED|Part 1||9
557265|NCT00693472|1357917|P1|COMPLETED|Part 1||13
557266|NCT00693472|1357914|P4|STARTED|Part 1||0
557267|NCT00693472|1357915|P3|STARTED|Part 1||0
557268|NCT00693472|1357916|P2|STARTED|Part 1||13
557269|NCT00693472|1357917|P1|STARTED|Part 1||19
557270|NCT00693420|1357937|P2|NOT COMPLETED|Overall Study||15
557271|NCT00693420|1357938|P1|NOT COMPLETED|Overall Study||6
557272|NCT00693420|1357937|P2|COMPLETED|Overall Study||126
557273|NCT00693420|1357938|P1|COMPLETED|Overall Study||131
557274|NCT00693420|1357937|P2|STARTED|Overall Study||141
557275|NCT00693420|1357938|P1|STARTED|Overall Study||137
557276|NCT00693303|1357962|P1|NOT COMPLETED|Overall Study||0
557277|NCT00693303|1357962|P1|COMPLETED|Overall Study||21
557278|NCT00693303|1357962|P1|STARTED|Overall Study||21
557279|NCT00693238|1357968|P2|NOT COMPLETED|Overall Study||0
557280|NCT00693238|1357969|P1|NOT COMPLETED|Overall Study||0
557281|NCT00693238|1357968|P2|COMPLETED|Overall Study||106
557282|NCT00693238|1357969|P1|COMPLETED|Overall Study||122
557283|NCT00693238|1357968|P2|STARTED|Overall Study||106
557284|NCT00693238|1357969|P1|STARTED|Overall Study||122
557285|NCT00693225|1357977|P2|NOT COMPLETED|Overall Study||5
557286|NCT00693225|1357978|P1|NOT COMPLETED|Overall Study||2
557287|NCT00693225|1357977|P2|COMPLETED|Overall Study||43
557288|NCT00693225|1357978|P1|COMPLETED|Overall Study||41
557289|NCT00693225|1357977|P2|STARTED|Overall Study||48
557290|NCT00693225|1357978|P1|STARTED|Overall Study||43
557291|NCT00693160|1357990|P2|NOT COMPLETED|Overall Study||0
557292|NCT00693160|1357991|P1|NOT COMPLETED|Overall Study||0
557293|NCT00693160|1357990|P2|COMPLETED|Overall Study||16
557294|NCT00693160|1357991|P1|COMPLETED|Overall Study||14
557295|NCT00693160|1357990|P2|STARTED|Overall Study||16
557296|NCT00693160|1357991|P1|STARTED|Overall Study||14
557297|NCT00693017|1358001|P2|NOT COMPLETED|Overall Study||2
557298|NCT00693017|1358002|P1|NOT COMPLETED|Overall Study||2
557299|NCT00693017|1358001|P2|COMPLETED|Overall Study||0
557300|NCT00693017|1358002|P1|COMPLETED|Overall Study||0
557301|NCT00693017|1358001|P2|STARTED|Overall Study||2
557302|NCT00693017|1358002|P1|STARTED|Overall Study||2
557303|NCT00692913|1358012|P2|NOT COMPLETED|Overall Study||30
557304|NCT00692913|1358013|P1|NOT COMPLETED|Overall Study||29
557305|NCT00692913|1358012|P2|COMPLETED|Overall Study||228
557306|NCT00692913|1358013|P1|COMPLETED|Overall Study||228
557307|NCT00692913|1358012|P2|STARTED|Overall Study||258
557308|NCT00692913|1358013|P1|STARTED|Overall Study||257
557309|NCT00692770|1358035|P2|NOT COMPLETED|Overall Study||558
557310|NCT00692770|1358036|P1|NOT COMPLETED|Overall Study||556
557311|NCT00692770|1358035|P2|COMPLETED|Overall Study||0
557312|NCT00692770|1358036|P1|COMPLETED|Overall Study||0
557313|NCT00692770|1358035|P2|Participants Received Treatment|Overall Study||554
557314|NCT00692770|1358036|P1|Participants Received Treatment|Overall Study||553
557315|NCT00692770|1358035|P2|STARTED|Overall Study||558
557316|NCT00692770|1358036|P1|STARTED|Overall Study||556
557317|NCT00692692|1358060|P2|NOT COMPLETED|Overall Study||0
557318|NCT00692692|1358061|P1|NOT COMPLETED|Overall Study||0
557319|NCT00692692|1358060|P2|COMPLETED|Overall Study||16
557320|NCT00692692|1358061|P1|COMPLETED|Overall Study||20
557321|NCT00692692|1358060|P2|STARTED|Overall Study||16
557322|NCT00692692|1358061|P1|STARTED|Overall Study||20
557323|NCT00692419|1358071|P2|NOT COMPLETED|Overall Study||18
557324|NCT00692419|1358072|P1|NOT COMPLETED|Overall Study||16
557325|NCT00692419|1358071|P2|COMPLETED|Overall Study||102
557326|NCT00692419|1358072|P1|COMPLETED|Overall Study||84
557327|NCT00692419|1358071|P2|STARTED|Overall Study||120
557328|NCT00692419|1358072|P1|STARTED|Overall Study||100
557329|NCT00692406|1358082|P1|NOT COMPLETED|Overall Study||57
557330|NCT00692406|1358082|P1|COMPLETED|Overall Study|This group quit smoking before their second scan.|23
557331|NCT00692406|1358082|P1|STARTED|Overall Study|Initially this group was assigned to quit smoking before the second scan.|80
557332|NCT00692341|1358096|P3|NOT COMPLETED|Overall Study||0
557333|NCT00692341|1358097|P2|NOT COMPLETED|Overall Study||0
557334|NCT00692341|1358098|P1|NOT COMPLETED|Overall Study||0
557335|NCT00692341|1358096|P3|COMPLETED|Overall Study||8
557336|NCT00692341|1358097|P2|COMPLETED|Overall Study||8
557337|NCT00692341|1358098|P1|COMPLETED|Overall Study||8
557338|NCT00692341|1358096|P3|STARTED|Overall Study||8
557339|NCT00692341|1358097|P2|STARTED|Overall Study||8
557340|NCT00692341|1358098|P1|STARTED|Overall Study||8
557341|NCT00692237|1358144|P2|NOT COMPLETED|Overall Study||4
557342|NCT00692237|1358145|P1|NOT COMPLETED|Overall Study||1
557343|NCT00692237|1358144|P2|COMPLETED|Overall Study||25
557344|NCT00692237|1358145|P1|COMPLETED|Overall Study||29
557345|NCT00692237|1358144|P2|STARTED|Overall Study||29
557346|NCT00692237|1358145|P1|STARTED|Overall Study||30
557347|NCT00692211|1358155|P2|NOT COMPLETED|Overall Study||0
557348|NCT00692211|1358156|P1|NOT COMPLETED|Overall Study||0
557349|NCT00692211|1358155|P2|COMPLETED|Overall Study||202
557350|NCT00692211|1358156|P1|COMPLETED|Overall Study||202
557351|NCT00692211|1358155|P2|STARTED|Overall Study||202
557352|NCT00692211|1358156|P1|STARTED|Overall Study||202
557353|NCT00692198|1358164|P2|NOT COMPLETED|Overall Study||0
557354|NCT00692198|1358165|P1|NOT COMPLETED|Overall Study||0
557355|NCT00692198|1358164|P2|COMPLETED|Overall Study||370
557356|NCT00692198|1358165|P1|COMPLETED|Overall Study||368
557357|NCT00692198|1358164|P2|STARTED|Overall Study||370
557358|NCT00692198|1358165|P1|STARTED|Overall Study||368
557359|NCT00692185|1358200|P2|NOT COMPLETED|Overall Study||3
557360|NCT00692185|1358201|P1|NOT COMPLETED|Overall Study||3
557361|NCT00692185|1358200|P2|COMPLETED|Overall Study||9
557362|NCT00692185|1358201|P1|COMPLETED|Overall Study||8
557363|NCT00692185|1358200|P2|STARTED|Overall Study||12
557364|NCT00692185|1358201|P1|STARTED|Overall Study||11
557365|NCT00692003|1358209|P2|NOT COMPLETED|Overall Study||1
557366|NCT00692003|1358210|P1|NOT COMPLETED|Overall Study||5
557367|NCT00692003|1358209|P2|COMPLETED|Overall Study||0
557368|NCT00692003|1358210|P1|COMPLETED|Overall Study||0
557369|NCT00692003|1358209|P2|STARTED|Overall Study||1
557370|NCT00692003|1358210|P1|STARTED|Overall Study||5
557371|NCT00691938|1358225|P7|NOT COMPLETED|Overall Study||0
557372|NCT00691938|1358226|P6|NOT COMPLETED|Overall Study||0
557373|NCT00691938|1358227|P5|NOT COMPLETED|Overall Study||0
557374|NCT00691938|1358228|P4|NOT COMPLETED|Overall Study||0
557375|NCT00691938|1358229|P3|NOT COMPLETED|Overall Study||0
557376|NCT00691938|1358230|P2|NOT COMPLETED|Overall Study||0
557377|NCT00691938|1358231|P1|NOT COMPLETED|Overall Study||1
557378|NCT00691938|1358225|P7|COMPLETED|Overall Study||14
557379|NCT00691938|1358226|P6|COMPLETED|Overall Study||6
557380|NCT00691938|1358227|P5|COMPLETED|Overall Study||10
557381|NCT00691938|1358228|P4|COMPLETED|Overall Study||8
557382|NCT00691938|1358229|P3|COMPLETED|Overall Study||6
557383|NCT00691938|1358230|P2|COMPLETED|Overall Study||3
557384|NCT00691938|1358231|P1|COMPLETED|Overall Study||4
557385|NCT00691938|1358225|P7|STARTED|Overall Study||14
557386|NCT00691938|1358226|P6|STARTED|Overall Study||6
557387|NCT00691938|1358227|P5|STARTED|Overall Study||10
557388|NCT00691938|1358228|P4|STARTED|Overall Study||8
557389|NCT00691938|1358229|P3|STARTED|Overall Study||6
557390|NCT00691938|1358230|P2|STARTED|Overall Study||3
557391|NCT00691938|1358231|P1|STARTED|Overall Study||5
557392|NCT00691808|1358255|P3|NOT COMPLETED|Overall Study||0
557393|NCT00691808|1358256|P2|NOT COMPLETED|Overall Study||1
557394|NCT00691808|1358257|P1|NOT COMPLETED|Overall Study||0
557395|NCT00691808|1358255|P3|COMPLETED|Overall Study||32
557396|NCT00691808|1358256|P2|COMPLETED|Overall Study||35
557397|NCT00691808|1358257|P1|COMPLETED|Overall Study||35
557398|NCT00691808|1358255|P3|STARTED|Overall Study||32
557399|NCT00691808|1358256|P2|STARTED|Overall Study||36
557400|NCT00691808|1358257|P1|STARTED|Overall Study||35
557401|NCT00691704|1358298|P1|NOT COMPLETED|Two Years of Maintenance Therapy||13
557402|NCT00691704|1358298|P1|COMPLETED|Two Years of Maintenance Therapy||3
557403|NCT00691704|1358298|P1|STARTED|Two Years of Maintenance Therapy||16
557404|NCT00691704|1358298|P1|NOT COMPLETED|Induction Therapy||2
557405|NCT00691704|1358298|P1|COMPLETED|Induction Therapy||16
557406|NCT00691704|1358298|P1|STARTED|Induction Therapy||18
557407|NCT00691665|1358308|P2|NOT COMPLETED|Overall Study||0
557408|NCT00691665|1358309|P1|NOT COMPLETED|Overall Study||0
557409|NCT00691665|1358308|P2|COMPLETED|Overall Study||65
557410|NCT00691665|1358309|P1|COMPLETED|Overall Study||65
557411|NCT00691665|1358308|P2|STARTED|Overall Study||65
557412|NCT00691665|1358309|P1|STARTED|Overall Study||65
557413|NCT00691652|1358321|P1|NOT COMPLETED|Overall Study||1
557414|NCT00691652|1358321|P1|COMPLETED|Overall Study||1
557415|NCT00691652|1358321|P1|STARTED|Overall Study||2
557416|NCT00691483|1358327|P2|NOT COMPLETED|Overall Study||25
557417|NCT00691483|1358328|P1|NOT COMPLETED|Overall Study||68
557418|NCT00691483|1358327|P2|COMPLETED|Overall Study||141
557419|NCT00691483|1358328|P1|COMPLETED|Overall Study|Completed refers to completion of the study.|425
557420|NCT00691483|1358327|P2|Received Treatment|Overall Study||165
557421|NCT00691483|1358328|P1|Received Treatment|Overall Study||486
557422|NCT00691483|1358327|P2|STARTED|Overall Study||166
557423|NCT00691483|1358328|P1|STARTED|Overall Study||493
557424|NCT00691327|1358346|P2|NOT COMPLETED|Overall Study||2508
557425|NCT00691327|1358347|P1|NOT COMPLETED|Overall Study||2841
557426|NCT00691327|1358346|P2|COMPLETED|Overall Study||36766
557427|NCT00691327|1358347|P1|COMPLETED|Overall Study||42214
557428|NCT00691327|1358346|P2|STARTED|Overall Study||39274
557429|NCT00691327|1358347|P1|STARTED|Overall Study||45055
557430|NCT00691301|1358355|P1|NOT COMPLETED|Overall Study||54
557431|NCT00691301|1358355|P1|COMPLETED|Overall Study||1
557432|NCT00691301|1358355|P1|STARTED|Overall Study||55
557433|NCT00691210|1358375|P8|NOT COMPLETED|Overall Study||0
557434|NCT00691210|1358376|P7|NOT COMPLETED|Overall Study||0
557435|NCT00691210|1358377|P6|NOT COMPLETED|Overall Study||1
557436|NCT00691210|1358378|P5|NOT COMPLETED|Overall Study||0
557437|NCT00691210|1358379|P4|NOT COMPLETED|Overall Study||3
557438|NCT00691210|1358380|P3|NOT COMPLETED|Overall Study||0
557439|NCT00691210|1358381|P2|NOT COMPLETED|Overall Study||0
557440|NCT00691210|1358382|P1|NOT COMPLETED|Overall Study||0
557441|NCT00691210|1358375|P8|COMPLETED|Overall Study||0
557442|NCT00691210|1358376|P7|COMPLETED|Overall Study||6
557443|NCT00691210|1358377|P6|COMPLETED|Overall Study||6
557444|NCT00691210|1358378|P5|COMPLETED|Overall Study||5
557445|NCT00691210|1358379|P4|COMPLETED|Overall Study||6
557446|NCT00691210|1358380|P3|COMPLETED|Overall Study||3
557447|NCT00691210|1358381|P2|COMPLETED|Overall Study||5
557448|NCT00691210|1358382|P1|COMPLETED|Overall Study||3
557449|NCT00691210|1358375|P8|STARTED|Overall Study||0
557450|NCT00691210|1358376|P7|STARTED|Overall Study||6
557451|NCT00691210|1358377|P6|STARTED|Overall Study||7
557452|NCT00691210|1358378|P5|STARTED|Overall Study||5
557453|NCT00691210|1358379|P4|STARTED|Overall Study||9
557454|NCT00691210|1358380|P3|STARTED|Overall Study||3
557455|NCT00691210|1358381|P2|STARTED|Overall Study||5
557456|NCT00691210|1358382|P1|STARTED|Overall Study||3
557457|NCT00691197|1358402|P2|NOT COMPLETED|Overall Study||5
557458|NCT00691197|1358403|P1|NOT COMPLETED|Overall Study||11
557459|NCT00691197|1358402|P2|COMPLETED|Overall Study||75
557460|NCT00691197|1358403|P1|COMPLETED|Overall Study||155
557461|NCT00691197|1358402|P2|STARTED|Overall Study||80
557462|NCT00691197|1358403|P1|STARTED|Overall Study||166
557463|NCT00691132|1358417|P2|NOT COMPLETED|Overall Study||13
557464|NCT00691132|1358418|P1|NOT COMPLETED|Overall Study||12
557465|NCT00691132|1358417|P2|COMPLETED|Overall Study|45 completed, but 4 excluded b/c urinary measures indicated they did not smoke study cigarettes.|41
557466|NCT00691132|1358418|P1|COMPLETED|Overall Study||41
557467|NCT00691132|1358417|P2|STARTED|Overall Study|107 total randomized. Approximately 1/2 per arm.|54
557468|NCT00691132|1358418|P1|STARTED|Overall Study||53
557469|NCT00691093|1358437|P1|NOT COMPLETED|Overall Study||7
557470|NCT00691093|1358437|P1|COMPLETED|Overall Study||816
557471|NCT00691093|1358437|P1|STARTED|Overall Study||823
557472|NCT00691054|1358471|P1|NOT COMPLETED|Overall Study||1
557473|NCT00691054|1358471|P1|COMPLETED|Overall Study||19
557474|NCT00691054|1358471|P1|STARTED|Overall Study||20
557475|NCT00691028|1358483|P4|NOT COMPLETED|Double-blind Period||0
557476|NCT00691028|1358484|P3|NOT COMPLETED|Double-blind Period||9
557477|NCT00691028|1358485|P2|NOT COMPLETED|Double-blind Period||13
557478|NCT00691028|1358486|P1|NOT COMPLETED|Double-blind Period||13
557479|NCT00691028|1358483|P4|COMPLETED|Double-blind Period||0
557480|NCT00691028|1358484|P3|COMPLETED|Double-blind Period||95
557481|NCT00691028|1358485|P2|COMPLETED|Double-blind Period||91
557482|NCT00691028|1358486|P1|COMPLETED|Double-blind Period||86
557483|NCT00691028|1358483|P4|STARTED|Double-blind Period||0
557484|NCT00691028|1358484|P3|STARTED|Double-blind Period||104
557485|NCT00691028|1358485|P2|STARTED|Double-blind Period||104
557486|NCT00691028|1358486|P1|STARTED|Double-blind Period||99
557487|NCT00691028|1358483|P4|NOT COMPLETED|Open-label Period||20
557488|NCT00691028|1358484|P3|NOT COMPLETED|Open-label Period||0
557489|NCT00691028|1358485|P2|NOT COMPLETED|Open-label Period||0
557490|NCT00691028|1358486|P1|NOT COMPLETED|Open-label Period||0
557491|NCT00691028|1358483|P4|COMPLETED|Open-label Period||307
557492|NCT00691028|1358484|P3|COMPLETED|Open-label Period||0
557493|NCT00691028|1358485|P2|COMPLETED|Open-label Period||0
557494|NCT00691028|1358486|P1|COMPLETED|Open-label Period||0
557495|NCT00691028|1358483|P4|STARTED|Open-label Period||327
557496|NCT00691028|1358484|P3|STARTED|Open-label Period||0
557497|NCT00691028|1358485|P2|STARTED|Open-label Period||0
557498|NCT00691028|1358486|P1|STARTED|Open-label Period||0
557499|NCT00691015|1358519|P1|NOT COMPLETED|Overall Study||1
557500|NCT00691015|1358519|P1|COMPLETED|Overall Study||47
557501|NCT00691015|1358519|P1|STARTED|Overall Study||48
557502|NCT00690924|1358530|P1|NOT COMPLETED|Overall Study||0
557503|NCT00690924|1358530|P1|COMPLETED|Overall Study||16
557504|NCT00690924|1358530|P1|STARTED|Overall Study||16
557505|NCT00690898|1358534|P1|NOT COMPLETED|TREATMENT||26
557506|NCT00690898|1358534|P1|COMPLETED|TREATMENT||64
557507|NCT00690898|1358534|P1|STARTED|TREATMENT|Total number of patients treated.|90
557508|NCT00690898|1358534|P1|NOT COMPLETED|SCREENING||18
557509|NCT00690898|1358534|P1|COMPLETED|SCREENING|Number of patients included in the study.|90
557510|NCT00690898|1358534|P1|STARTED|SCREENING|Total of patients screened for the study.|108
557511|NCT00690833|1358548|P1|NOT COMPLETED|Overall Study||2
557512|NCT00690833|1358548|P1|COMPLETED|Overall Study||39
557513|NCT00690833|1358548|P1|STARTED|Overall Study||41
557514|NCT00690820|1358554|P2|NOT COMPLETED|Period 2||0
557515|NCT00690820|1358555|P1|NOT COMPLETED|Period 2||0
557516|NCT00690820|1358554|P2|COMPLETED|Period 2||8
557517|NCT00690820|1358555|P1|COMPLETED|Period 2||8
557518|NCT00690820|1358554|P2|STARTED|Period 2||8
557519|NCT00690820|1358555|P1|STARTED|Period 2||8
557520|NCT00690820|1358554|P2|NOT COMPLETED|Period 1||1
557521|NCT00690820|1358555|P1|NOT COMPLETED|Period 1||0
557522|NCT00690820|1358554|P2|COMPLETED|Period 1||8
557523|NCT00690820|1358555|P1|COMPLETED|Period 1||8
557524|NCT00690820|1358554|P2|STARTED|Period 1||9
557525|NCT00690820|1358555|P1|STARTED|Period 1||8
557526|NCT00690794|1358577|P2|NOT COMPLETED|Overall Study||35
557527|NCT00690794|1358578|P1|NOT COMPLETED|Overall Study||21
557528|NCT00690794|1358577|P2|COMPLETED|Overall Study||328
557529|NCT00690794|1358578|P1|COMPLETED|Overall Study||342
557530|NCT00690794|1358577|P2|STARTED|Overall Study||363
557531|NCT00690794|1358578|P1|STARTED|Overall Study||363
557532|NCT00690755|1358593|P7|NOT COMPLETED|Overall Study||0
557533|NCT00690755|1358594|P6|NOT COMPLETED|Overall Study||4
557534|NCT00690755|1358595|P5|NOT COMPLETED|Overall Study||0
557535|NCT00690755|1358596|P4|NOT COMPLETED|Overall Study||5
557536|NCT00690755|1358597|P3|NOT COMPLETED|Overall Study||46
557537|NCT00690755|1358598|P2|NOT COMPLETED|Overall Study||0
557538|NCT00690755|1358599|P1|NOT COMPLETED|Overall Study||2
557539|NCT00690755|1358593|P7|COMPLETED|Overall Study||0
557540|NCT00690755|1358594|P6|COMPLETED|Overall Study||6
557541|NCT00690755|1358595|P5|COMPLETED|Overall Study||0
557542|NCT00690755|1358596|P4|COMPLETED|Overall Study||15
557543|NCT00690755|1358597|P3|COMPLETED|Overall Study||51
557544|NCT00690755|1358598|P2|COMPLETED|Overall Study||0
557545|NCT00690755|1358599|P1|COMPLETED|Overall Study|Patient recruitment ended on 12/31/2010|28
557546|NCT00690755|1358593|P7|STARTED|Overall Study||0
557547|NCT00690755|1358594|P6|STARTED|Overall Study||10
557548|NCT00690755|1358595|P5|STARTED|Overall Study||0
557549|NCT00690755|1358596|P4|STARTED|Overall Study||20
557550|NCT00690755|1358597|P3|STARTED|Overall Study||97
557551|NCT00690755|1358598|P2|STARTED|Overall Study||0
557552|NCT00690755|1358599|P1|STARTED|Overall Study||30
557553|NCT00690612|1358615|P1|NOT COMPLETED|Overall Study||3
557554|NCT00690612|1358615|P1|COMPLETED|Overall Study||32
557555|NCT00690612|1358615|P1|STARTED|Overall Study||35
557556|NCT00690573|1358620|P1|NOT COMPLETED|Overall Study||9
557557|NCT00690573|1358620|P1|COMPLETED|Overall Study||16
557558|NCT00690573|1358620|P1|STARTED|Overall Study||25
557559|NCT00690495|1358630|P2|NOT COMPLETED|Overall Study||0
557560|NCT00690495|1358631|P1|NOT COMPLETED|Overall Study||0
557561|NCT00690495|1358630|P2|COMPLETED|Overall Study||50
557562|NCT00690495|1358631|P1|COMPLETED|Overall Study||50
557563|NCT00690495|1358630|P2|Primary Endpoint|Overall Study||50
557564|NCT00690495|1358631|P1|Primary Endpoint|Overall Study||50
557565|NCT00690495|1358630|P2|STARTED|Overall Study||50
557566|NCT00690495|1358631|P1|STARTED|Overall Study||50
557567|NCT00690482|1358639|P2|NOT COMPLETED|Overall Study||3
557568|NCT00690482|1358640|P1|NOT COMPLETED|Overall Study||4
557569|NCT00690482|1358639|P2|COMPLETED|Overall Study||54
557570|NCT00690482|1358640|P1|COMPLETED|Overall Study||57
557571|NCT00690482|1358639|P2|STARTED|Overall Study||57
557572|NCT00690482|1358640|P1|STARTED|Overall Study||61
557573|NCT00690443|1358674|P2|NOT COMPLETED|Overall Study||2
557574|NCT00690443|1358675|P1|NOT COMPLETED|Overall Study||1
557575|NCT00690443|1358674|P2|COMPLETED|Overall Study||19
557576|NCT00690443|1358675|P1|COMPLETED|Overall Study||22
557577|NCT00690443|1358674|P2|STARTED|Overall Study||21
557578|NCT00690443|1358675|P1|STARTED|Overall Study||23
557579|NCT00690430|1358685|P3|NOT COMPLETED|Extension Phase||13
557580|NCT00690430|1358686|P2|NOT COMPLETED|Extension Phase||5
557581|NCT00690430|1358687|P1|NOT COMPLETED|Extension Phase||18
557582|NCT00690430|1358685|P3|COMPLETED|Extension Phase||2
557583|NCT00690430|1358686|P2|COMPLETED|Extension Phase||1
557584|NCT00690430|1358687|P1|COMPLETED|Extension Phase||2
557585|NCT00690430|1358685|P3|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|15
557586|NCT00690430|1358686|P2|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|6
557587|NCT00690430|1358687|P1|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|20
557588|NCT00690430|1358685|P3|NOT COMPLETED|Core Phase||0
557589|NCT00690430|1358686|P2|NOT COMPLETED|Core Phase||23
557590|NCT00690430|1358687|P1|NOT COMPLETED|Core Phase||18
557591|NCT00690430|1358685|P3|COMPLETED|Core Phase||0
557592|NCT00690430|1358686|P2|COMPLETED|Core Phase||34
557593|NCT00690430|1358687|P1|COMPLETED|Core Phase||35
557594|NCT00690430|1358685|P3|STARTED|Core Phase|This arm belongs to Extension Phase.|0
557595|NCT00690430|1358686|P2|STARTED|Core Phase||57
557596|NCT00690430|1358687|P1|STARTED|Core Phase|"Started indicates Full Analysis Set (FAS) and Safety Set."|53
557597|NCT00690378|1358716|P2|NOT COMPLETED|Overall Study||14
557598|NCT00690378|1358717|P1|NOT COMPLETED|Overall Study||20
557599|NCT00690378|1358716|P2|COMPLETED|Overall Study|Up to LFU visit|54
557600|NCT00690378|1358717|P1|COMPLETED|Overall Study|Up to Late follow up (LFU) visit|49
557601|NCT00690378|1358716|P2|Treated|Overall Study||67
557602|NCT00690378|1358717|P1|Treated|Overall Study||68
557603|NCT00690378|1358716|P2|STARTED|Overall Study|Randomized|68
557604|NCT00690378|1358717|P1|STARTED|Overall Study|Randomized|69
557605|NCT00690339|1358765|P4|NOT COMPLETED|Overall Study||25
557606|NCT00690339|1358766|P3|NOT COMPLETED|Overall Study||57
557607|NCT00690339|1358767|P2|NOT COMPLETED|Overall Study||81
557608|NCT00690339|1358768|P1|NOT COMPLETED|Overall Study||117
557609|NCT00690339|1358765|P4|COMPLETED|Overall Study||43
557610|NCT00690339|1358766|P3|COMPLETED|Overall Study||99
557611|NCT00690339|1358767|P2|COMPLETED|Overall Study||144
557612|NCT00690339|1358768|P1|COMPLETED|Overall Study||375
557613|NCT00690339|1358765|P4|STARTED|Overall Study||68
557614|NCT00690339|1358766|P3|STARTED|Overall Study||156
557615|NCT00690339|1358767|P2|STARTED|Overall Study||225
557616|NCT00690339|1358768|P1|STARTED|Overall Study||492
557617|NCT00690040|1358784|P2|NOT COMPLETED|Overall Study||0
557618|NCT00690040|1358785|P1|NOT COMPLETED|Overall Study||0
557619|NCT00690040|1358784|P2|COMPLETED|Overall Study||148
557620|NCT00690040|1358785|P1|COMPLETED|Overall Study||145
557621|NCT00690040|1358784|P2|STARTED|Overall Study||148
557622|NCT00690040|1358785|P1|STARTED|Overall Study||145
557623|NCT00689936|1358794|P3|NOT COMPLETED|Long-Term Follow Up Phase||144
557624|NCT00689936|1358795|P2|NOT COMPLETED|Long-Term Follow Up Phase||188
557625|NCT00689936|1358796|P1|NOT COMPLETED|Long-Term Follow Up Phase||127
557626|NCT00689936|1358794|P3|COMPLETED|Long-Term Follow Up Phase||315
557627|NCT00689936|1358795|P2|COMPLETED|Long-Term Follow Up Phase||275
557628|NCT00689936|1358796|P1|COMPLETED|Long-Term Follow Up Phase||255
557629|NCT00689936|1358794|P3|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|459
557630|NCT00689936|1358795|P2|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|463
557631|NCT00689936|1358796|P1|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|382
557632|NCT00689936|1358794|P3|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
557633|NCT00689936|1358795|P2|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
557634|NCT00689936|1358796|P1|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
557635|NCT00689936|1358794|P3|COMPLETED|Progression Free Survival-PFS-Follow-Up||273
557636|NCT00689936|1358795|P2|COMPLETED|Progression Free Survival-PFS-Follow-Up||300
557637|NCT00689936|1358796|P1|COMPLETED|Progression Free Survival-PFS-Follow-Up||87
557638|NCT00689936|1358794|P3|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who completed 12 cycles MPT and did not experience progressive disease.|273
557639|NCT00689936|1358795|P2|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who completed 18 cycles (Rd18) and did not experience progressive disease.|300
557640|NCT00689936|1358796|P1|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who discontinued treatment for reasons other than progressive disease.|87
557641|NCT00689936|1358794|P3|NOT COMPLETED|Active Treatment Phase||547
557642|NCT00689936|1358795|P2|NOT COMPLETED|Active Treatment Phase||541
557643|NCT00689936|1358796|P1|NOT COMPLETED|Active Treatment Phase||535
557644|NCT00689936|1358794|P3|COMPLETED|Active Treatment Phase||0
557645|NCT00689936|1358795|P2|COMPLETED|Active Treatment Phase||0
557646|NCT00689936|1358796|P1|COMPLETED|Active Treatment Phase||0
557647|NCT00689936|1358794|P3|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|6
557648|NCT00689936|1358795|P2|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|1
557649|NCT00689936|1358796|P1|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|3
557650|NCT00689936|1358794|P3|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|541
557651|NCT00689936|1358795|P2|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|540
557652|NCT00689936|1358796|P1|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|532
557653|NCT00689936|1358794|P3|STARTED|Active Treatment Phase||547
557654|NCT00689936|1358795|P2|STARTED|Active Treatment Phase||541
557655|NCT00689936|1358796|P1|STARTED|Active Treatment Phase||535
557656|NCT00689884|1358936|P1|NOT COMPLETED|Overall Study||0
557657|NCT00689884|1358936|P1|COMPLETED|Overall Study||7
557658|NCT00689884|1358936|P1|STARTED|Overall Study||7
557659|NCT00689871|1358945|P4|NOT COMPLETED|Overall Study||7
557660|NCT00689871|1358946|P3|NOT COMPLETED|Overall Study||73
557661|NCT00689871|1358947|P2|NOT COMPLETED|Overall Study||52
557662|NCT00689871|1358948|P1|NOT COMPLETED|Overall Study||175
557663|NCT00689871|1358945|P4|COMPLETED|Overall Study|4 Patients discontinued|8
557664|NCT00689871|1358946|P3|COMPLETED|Overall Study|28 Patients discontinued|74
557665|NCT00689871|1358947|P2|COMPLETED|Overall Study|35 Patients discontinued|46
557666|NCT00689871|1358948|P1|COMPLETED|Overall Study|35 Patients discontinued|280
557667|NCT00689871|1358945|P4|STARTED|Overall Study|25 Implants|15
557668|NCT00689871|1358946|P3|STARTED|Overall Study|288 Implants|147
557669|NCT00689871|1358947|P2|STARTED|Overall Study|127 Implants|98
557670|NCT00689871|1358948|P1|STARTED|Overall Study|908 Implants|455
557671|NCT00689819|1358964|P2|NOT COMPLETED|Overall Study||15
557672|NCT00689819|1358965|P1|NOT COMPLETED|Overall Study||20
557673|NCT00689819|1358964|P2|COMPLETED|Overall Study||43
557674|NCT00689819|1358965|P1|COMPLETED|Overall Study||45
557675|NCT00689819|1358964|P2|STARTED|Overall Study||58
557676|NCT00689819|1358965|P1|STARTED|Overall Study||65
557677|NCT00689793|1358975|P2|NOT COMPLETED|Overall Study||5
557678|NCT00689793|1358976|P1|NOT COMPLETED|Overall Study||4
557679|NCT00689793|1358975|P2|COMPLETED|Overall Study||71
557680|NCT00689793|1358976|P1|COMPLETED|Overall Study||74
557681|NCT00689793|1358975|P2|STARTED|Overall Study||76
557682|NCT00689793|1358976|P1|STARTED|Overall Study||78
557683|NCT00689611|1358994|P2|NOT COMPLETED|Overall Study||46
557684|NCT00689611|1358995|P1|NOT COMPLETED|Overall Study||41
557685|NCT00689611|1358994|P2|COMPLETED|Overall Study||146
557686|NCT00689611|1358995|P1|COMPLETED|Overall Study||159
557687|NCT00689611|1358994|P2|STARTED|Overall Study||192
557688|NCT00689611|1358995|P1|STARTED|Overall Study||200
557689|NCT00689481|1359005|P2|NOT COMPLETED|Overall Study||14
557690|NCT00689481|1359006|P1|NOT COMPLETED|Overall Study||24
557691|NCT00689481|1359005|P2|COMPLETED|Overall Study||95
557692|NCT00689481|1359006|P1|COMPLETED|Overall Study||190
557693|NCT00689481|1359005|P2|STARTED|Overall Study||109
557694|NCT00689481|1359006|P1|STARTED|Overall Study||214
557695|NCT00689390|1359024|P2|NOT COMPLETED|Overall Study||10
557696|NCT00689390|1359025|P1|NOT COMPLETED|Overall Study||426
557697|NCT00689390|1359024|P2|COMPLETED|Overall Study||37
557698|NCT00689390|1359025|P1|COMPLETED|Overall Study||1481
557699|NCT00689390|1359024|P2|STARTED|Overall Study||47
557700|NCT00689390|1359025|P1|STARTED|Overall Study||1907
557701|NCT00689351|1359043|P2|NOT COMPLETED|Toddler Dose||0
557702|NCT00689351|1359044|P1|NOT COMPLETED|Toddler Dose||0
557703|NCT00689351|1359043|P2|COMPLETED|Toddler Dose||88
557704|NCT00689351|1359044|P1|COMPLETED|Toddler Dose||84
557705|NCT00689351|1359043|P2|STARTED|Toddler Dose||88
557706|NCT00689351|1359044|P1|STARTED|Toddler Dose||84
557707|NCT00689351|1359043|P2|NOT COMPLETED|After Infant Series||0
557708|NCT00689351|1359044|P1|NOT COMPLETED|After Infant Series||1
557709|NCT00689351|1359043|P2|COMPLETED|After Infant Series||88
557710|NCT00689351|1359044|P1|COMPLETED|After Infant Series||84
557711|NCT00689351|1359043|P2|STARTED|After Infant Series||88
557712|NCT00689351|1359044|P1|STARTED|After Infant Series||85
557713|NCT00689351|1359043|P2|NOT COMPLETED|Infant Series of Dosing||1
557714|NCT00689351|1359044|P1|NOT COMPLETED|Infant Series of Dosing||6
557715|NCT00689351|1359043|P2|COMPLETED|Infant Series of Dosing||88
557716|NCT00689351|1359044|P1|COMPLETED|Infant Series of Dosing||85
557717|NCT00689351|1359043|P2|Vaccinated Dose 3|Infant Series of Dosing||88
557718|NCT00689351|1359044|P1|Vaccinated Dose 3|Infant Series of Dosing||85
557719|NCT00689351|1359043|P2|Vaccinated Dose 2|Infant Series of Dosing||88
557720|NCT00689351|1359044|P1|Vaccinated Dose 2|Infant Series of Dosing||86
557721|NCT00689351|1359043|P2|Vaccinated Dose 1|Infant Series of Dosing||89
557722|NCT00689351|1359044|P1|Vaccinated Dose 1|Infant Series of Dosing||88
557723|NCT00689351|1359043|P2|STARTED|Infant Series of Dosing||89
557724|NCT00689351|1359044|P1|STARTED|Infant Series of Dosing||91
557725|NCT00689338|1359076|P1|NOT COMPLETED|Overall Study||143
557726|NCT00689338|1359076|P1|COMPLETED|Overall Study||73
557727|NCT00689338|1359076|P1|STARTED|Overall Study||216
557728|NCT00689299|1359089|P3|NOT COMPLETED|Overall Study||5
557729|NCT00689299|1359090|P2|NOT COMPLETED|Overall Study||3
557730|NCT00689299|1359091|P1|NOT COMPLETED|Overall Study||7
557731|NCT00689299|1359089|P3|COMPLETED|Overall Study||49
557732|NCT00689299|1359090|P2|COMPLETED|Overall Study||54
557733|NCT00689299|1359091|P1|COMPLETED|Overall Study||51
557734|NCT00689299|1359089|P3|STARTED|Overall Study||54
557735|NCT00689299|1359090|P2|STARTED|Overall Study||57
557736|NCT00689299|1359091|P1|STARTED|Overall Study||58
557737|NCT00689260|1359101|P2|NOT COMPLETED|Overall Study||0
557738|NCT00689260|1359102|P1|NOT COMPLETED|Overall Study||2
557739|NCT00689260|1359101|P2|COMPLETED|Overall Study||21
557740|NCT00689260|1359102|P1|COMPLETED|Overall Study||19
557741|NCT00689260|1359101|P2|STARTED|Overall Study||21
557742|NCT00689260|1359102|P1|STARTED|Overall Study||21
557743|NCT00689221|1359120|P2|NOT COMPLETED|Overall Study||36
557744|NCT00689221|1359121|P1|NOT COMPLETED|Overall Study||39
557745|NCT00689221|1359120|P2|COMPLETED|Overall Study||237
557746|NCT00689221|1359121|P1|COMPLETED|Overall Study||233
557747|NCT00689221|1359120|P2|STARTED|Overall Study||273
557748|NCT00689221|1359121|P1|STARTED|Overall Study||272
557749|NCT00689117|1359150|P4|NOT COMPLETED|Overall Study||31
557750|NCT00689117|1359151|P3|NOT COMPLETED|Overall Study||59
557751|NCT00689117|1359152|P2|NOT COMPLETED|Overall Study||51
557752|NCT00689117|1359153|P1|NOT COMPLETED|Overall Study||62
557753|NCT00689117|1359150|P4|COMPLETED|Overall Study||211
557754|NCT00689117|1359151|P3|COMPLETED|Overall Study||405
557755|NCT00689117|1359152|P2|COMPLETED|Overall Study||416
557756|NCT00689117|1359153|P1|COMPLETED|Overall Study||414
557757|NCT00689117|1359150|P4|STARTED|Overall Study||242
557758|NCT00689117|1359151|P3|STARTED|Overall Study||464
557759|NCT00689117|1359152|P2|STARTED|Overall Study||467
557760|NCT00689117|1359153|P1|STARTED|Overall Study||476
557761|NCT00689104|1359183|P4|NOT COMPLETED|Overall Study||50
557762|NCT00689104|1359184|P3|NOT COMPLETED|Overall Study||45
557763|NCT00689104|1359185|P2|NOT COMPLETED|Overall Study||57
557764|NCT00689104|1359186|P1|NOT COMPLETED|Overall Study||44
557765|NCT00689104|1359183|P4|COMPLETED|Overall Study||445
557766|NCT00689104|1359184|P3|COMPLETED|Overall Study||453
557767|NCT00689104|1359185|P2|COMPLETED|Overall Study||440
557768|NCT00689104|1359186|P1|COMPLETED|Overall Study||453
557769|NCT00689104|1359183|P4|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|300
557770|NCT00689104|1359184|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|281
557771|NCT00689104|1359185|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|293
557772|NCT00689104|1359186|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|291
557773|NCT00689104|1359183|P4|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|475
557774|NCT00689104|1359184|P3|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|478
557775|NCT00689104|1359185|P2|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|473
557776|NCT00689104|1359186|P1|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|480
557777|NCT00689104|1359183|P4|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|495
557778|NCT00689104|1359184|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|496
557779|NCT00689104|1359185|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|493
557780|NCT00689104|1359186|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|494
557781|NCT00689104|1359183|P4|STARTED|Overall Study||495
557782|NCT00689104|1359184|P3|STARTED|Overall Study||498
557783|NCT00689104|1359185|P2|STARTED|Overall Study||497
557784|NCT00689104|1359186|P1|STARTED|Overall Study||497
557785|NCT00689091|1359318|P2|NOT COMPLETED|Overall Study||1394
557786|NCT00689091|1359319|P1|NOT COMPLETED|Overall Study||1371
557787|NCT00689091|1359318|P2|COMPLETED|Overall Study||9376
557788|NCT00689091|1359319|P1|COMPLETED|Overall Study||9460
557789|NCT00689091|1359318|P2|STARTED|Overall Study||10770
557790|NCT00689091|1359319|P1|STARTED|Overall Study||10831
557791|NCT00689052|1359339|P2|NOT COMPLETED|Overall Study||30
557792|NCT00689052|1359340|P1|NOT COMPLETED|Overall Study||31
557793|NCT00689052|1359339|P2|COMPLETED|Overall Study||0
557794|NCT00689052|1359340|P1|COMPLETED|Overall Study||0
557795|NCT00689052|1359339|P2|STARTED|Overall Study||30
557796|NCT00689052|1359340|P1|STARTED|Overall Study||31
557797|NCT00689026|1359372|P2|NOT COMPLETED|Overall Study||6
557798|NCT00689026|1359373|P1|NOT COMPLETED|Overall Study||13
557799|NCT00689026|1359372|P2|COMPLETED|Overall Study||24
557800|NCT00689026|1359373|P1|COMPLETED|Overall Study||17
557801|NCT00689026|1359372|P2|STARTED|Overall Study||30
557802|NCT00689026|1359373|P1|STARTED|Overall Study||30
557803|NCT00688870|1359381|P2|NOT COMPLETED|Toddler Dose||0
557804|NCT00688870|1359382|P1|NOT COMPLETED|Toddler Dose||0
557805|NCT00688870|1359381|P2|COMPLETED|Toddler Dose||84
557806|NCT00688870|1359382|P1|COMPLETED|Toddler Dose||80
557807|NCT00688870|1359381|P2|STARTED|Toddler Dose||84
557808|NCT00688870|1359382|P1|STARTED|Toddler Dose||80
557809|NCT00688870|1359381|P2|NOT COMPLETED|After Infant Series||0
557810|NCT00688870|1359382|P1|NOT COMPLETED|After Infant Series||0
557811|NCT00688870|1359381|P2|COMPLETED|After Infant Series||84
557812|NCT00688870|1359382|P1|COMPLETED|After Infant Series||80
557813|NCT00688870|1359381|P2|STARTED|After Infant Series||84
557814|NCT00688870|1359382|P1|STARTED|After Infant Series||80
557815|NCT00688870|1359381|P2|NOT COMPLETED|Infant Series||0
557816|NCT00688870|1359382|P1|NOT COMPLETED|Infant Series||4
557817|NCT00688870|1359381|P2|COMPLETED|Infant Series||84
557818|NCT00688870|1359382|P1|COMPLETED|Infant Series||80
557819|NCT00688870|1359381|P2|Vaccinated Dose 3|Infant Series||84
557820|NCT00688870|1359382|P1|Vaccinated Dose 3|Infant Series||80
557821|NCT00688870|1359381|P2|Vaccinated Dose 2|Infant Series||84
557822|NCT00688870|1359382|P1|Vaccinated Dose 2|Infant Series||80
557823|NCT00688870|1359381|P2|Vaccinated Dose 1|Infant Series||84
557824|NCT00688870|1359382|P1|Vaccinated Dose 1|Infant Series||83
557825|NCT00688870|1359381|P2|STARTED|Infant Series||84
557826|NCT00688870|1359382|P1|STARTED|Infant Series||84
557827|NCT00688844|1359414|P1|NOT COMPLETED|Overall Study||10
557828|NCT00688844|1359414|P1|COMPLETED|Overall Study||48
557829|NCT00688844|1359414|P1|STARTED|Overall Study||58
557830|NCT00688753|1359424|P1|NOT COMPLETED|Overall Study||92
557831|NCT00688753|1359424|P1|COMPLETED|Overall Study||0
557832|NCT00688753|1359424|P1|STARTED|Overall Study||92
557833|NCT00688740|1359435|P2|NOT COMPLETED|Overall Study||35
557834|NCT00688740|1359436|P1|NOT COMPLETED|Overall Study||66
557835|NCT00688740|1359435|P2|COMPLETED|Overall Study||711
557836|NCT00688740|1359436|P1|COMPLETED|Overall Study||679
557837|NCT00688740|1359435|P2|STARTED|Overall Study||746
557838|NCT00688740|1359436|P1|STARTED|Overall Study||745
557839|NCT00688701|1359449|P4|NOT COMPLETED|Overall Study||11
557840|NCT00688701|1359450|P3|NOT COMPLETED|Overall Study||10
557841|NCT00688701|1359451|P2|NOT COMPLETED|Overall Study||5
557842|NCT00688701|1359452|P1|NOT COMPLETED|Overall Study||4
557843|NCT00688701|1359449|P4|COMPLETED|Overall Study||108
557844|NCT00688701|1359450|P3|COMPLETED|Overall Study||110
557845|NCT00688701|1359451|P2|COMPLETED|Overall Study||56
557846|NCT00688701|1359452|P1|COMPLETED|Overall Study||57
557847|NCT00688701|1359449|P4|Subgroup for Standardized Meal Test|Overall Study||65
557848|NCT00688701|1359450|P3|Subgroup for Standardized Meal Test|Overall Study||60
557849|NCT00688701|1359451|P2|Subgroup for Standardized Meal Test|Overall Study||35
557850|NCT00688701|1359452|P1|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal test was performed.|27
557851|NCT00688701|1359449|P4|Modified Intent-to-Treat(mITT)Population|Overall Study||118
557852|NCT00688701|1359450|P3|Modified Intent-to-Treat(mITT)Population|Overall Study||120
557853|NCT00688701|1359451|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||60
557854|NCT00688701|1359452|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|61
557855|NCT00688701|1359449|P4|Treated/Safety Population|Overall Study||119
557856|NCT00688701|1359450|P3|Treated/Safety Population|Overall Study||120
557857|NCT00688701|1359451|P2|Treated/Safety Population|Overall Study||61
557858|NCT00688701|1359452|P1|Treated/Safety Population|Overall Study|All patients who received at least 1 dose, regardless of amount of treatment administered.|61
557859|NCT00688701|1359449|P4|STARTED|Overall Study||119
557860|NCT00688701|1359450|P3|STARTED|Overall Study||120
557861|NCT00688701|1359451|P2|STARTED|Overall Study||61
557862|NCT00688701|1359452|P1|STARTED|Overall Study|Randomized|61
557863|NCT00688688|1359493|P3|NOT COMPLETED|Overall Study||192
557864|NCT00688688|1359494|P2|NOT COMPLETED|Overall Study||179
557865|NCT00688688|1359495|P1|NOT COMPLETED|Overall Study||186
557866|NCT00688688|1359493|P3|COMPLETED|Overall Study||621
557867|NCT00688688|1359494|P2|COMPLETED|Overall Study||645
557868|NCT00688688|1359495|P1|COMPLETED|Overall Study||629
557869|NCT00688688|1359493|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|488
557870|NCT00688688|1359494|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|483
557871|NCT00688688|1359495|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|479
557872|NCT00688688|1359493|P3|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|791
557873|NCT00688688|1359494|P2|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|802
557874|NCT00688688|1359495|P1|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|789
557875|NCT00688688|1359493|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|812
557876|NCT00688688|1359494|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|820
557877|NCT00688688|1359495|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|812
557878|NCT00688688|1359493|P3|STARTED|Overall Study||813
557879|NCT00688688|1359494|P2|STARTED|Overall Study||824
557880|NCT00688688|1359495|P1|STARTED|Overall Study||815
557881|NCT00688662|1359586|P2|NOT COMPLETED|Overall Study||18
557882|NCT00688662|1359587|P1|NOT COMPLETED|Overall Study||23
557883|NCT00688662|1359586|P2|COMPLETED|Overall Study||55
557884|NCT00688662|1359587|P1|COMPLETED|Overall Study||118
557885|NCT00688662|1359586|P2|STARTED|Overall Study||73
557886|NCT00688662|1359587|P1|STARTED|Overall Study||141
557887|NCT00688636|1359597|P2|NOT COMPLETED|Overall Study||1
557888|NCT00688636|1359598|P1|NOT COMPLETED|Overall Study||2
557889|NCT00688636|1359597|P2|COMPLETED|Overall Study||12
557890|NCT00688636|1359598|P1|COMPLETED|Overall Study||9
557891|NCT00688636|1359597|P2|STARTED|Overall Study||13
557892|NCT00688636|1359598|P1|STARTED|Overall Study||11
557893|NCT00688545|1359614|P2|NOT COMPLETED|Overall Study||15
557894|NCT00688545|1359615|P1|NOT COMPLETED|Overall Study||5
557895|NCT00688545|1359614|P2|COMPLETED|Overall Study||204
557896|NCT00688545|1359615|P1|COMPLETED|Overall Study||50
557897|NCT00688545|1359614|P2|Switched Treatment at Least Once|Overall Study||13
557898|NCT00688545|1359615|P1|Switched Treatment at Least Once|Overall Study||6
557899|NCT00688545|1359614|P2|STARTED|Overall Study||219
557900|NCT00688545|1359615|P1|STARTED|Overall Study||55
557901|NCT00688519|1359625|P2|NOT COMPLETED|Overall Study||15
557902|NCT00688519|1359626|P1|NOT COMPLETED|Overall Study||19
557903|NCT00688519|1359625|P2|COMPLETED|Overall Study||98
557904|NCT00688519|1359626|P1|COMPLETED|Overall Study||204
557905|NCT00688519|1359625|P2|STARTED|Overall Study||113
557906|NCT00688519|1359626|P1|STARTED|Overall Study||223
557907|NCT00688467|1359644|P2|NOT COMPLETED|Treatment Period 2||2
557908|NCT00688467|1359645|P1|NOT COMPLETED|Treatment Period 2||0
557909|NCT00688467|1359644|P2|COMPLETED|Treatment Period 2||6
557910|NCT00688467|1359645|P1|COMPLETED|Treatment Period 2||7
557911|NCT00688467|1359644|P2|STARTED|Treatment Period 2||8
557912|NCT00688467|1359645|P1|STARTED|Treatment Period 2||7
557913|NCT00688467|1359644|P2|NOT COMPLETED|Treatment Period 1||2
557914|NCT00688467|1359645|P1|NOT COMPLETED|Treatment Period 1||2
557915|NCT00688467|1359644|P2|COMPLETED|Treatment Period 1||8
557916|NCT00688467|1359645|P1|COMPLETED|Treatment Period 1||7
557917|NCT00688467|1359644|P2|STARTED|Treatment Period 1||10
557918|NCT00688467|1359645|P1|STARTED|Treatment Period 1||9
557919|NCT00688324|1359675|P1|NOT COMPLETED|Overall Study||8
557920|NCT00688324|1359675|P1|COMPLETED|Overall Study||28
557921|NCT00688324|1359675|P1|STARTED|Overall Study||36
557922|NCT00688259|1359720|P2|NOT COMPLETED|Overall Study||8
557923|NCT00688259|1359721|P1|NOT COMPLETED|Overall Study||7
557924|NCT00688259|1359720|P2|COMPLETED|Overall Study||36
557925|NCT00688259|1359721|P1|COMPLETED|Overall Study||37
557926|NCT00688259|1359720|P2|End to Active Treatment,|Overall Study||37
557927|NCT00688259|1359721|P1|End to Active Treatment,|Overall Study||37
557928|NCT00688259|1359720|P2|STARTED|Overall Study||44
557929|NCT00688259|1359721|P1|STARTED|Overall Study||44
557930|NCT00688155|1359741|P4|NOT COMPLETED|Overall Study||1
557931|NCT00688155|1359742|P3|NOT COMPLETED|Overall Study||1
557932|NCT00688155|1359743|P2|NOT COMPLETED|Overall Study||2
557933|NCT00688155|1359744|P1|NOT COMPLETED|Overall Study||2
557934|NCT00688155|1359741|P4|COMPLETED|Overall Study||17
557935|NCT00688155|1359742|P3|COMPLETED|Overall Study||18
557936|NCT00688155|1359743|P2|COMPLETED|Overall Study||16
557937|NCT00688155|1359744|P1|COMPLETED|Overall Study||16
557938|NCT00688155|1359741|P4|STARTED|Overall Study||18
557939|NCT00688155|1359742|P3|STARTED|Overall Study||19
557940|NCT00688155|1359743|P2|STARTED|Overall Study||18
557941|NCT00688155|1359744|P1|STARTED|Overall Study||18
557942|NCT00688103|1359764|P2|NOT COMPLETED|Overall Study||13
557943|NCT00688103|1359765|P1|NOT COMPLETED|Overall Study||30
557944|NCT00688103|1359764|P2|COMPLETED|Overall Study||64
557945|NCT00688103|1359765|P1|COMPLETED|Overall Study||44
557946|NCT00688103|1359764|P2|Actually Treated|Overall Study||76
557947|NCT00688103|1359765|P1|Actually Treated|Overall Study||71
557948|NCT00688103|1359764|P2|STARTED|Overall Study||77
557949|NCT00688103|1359765|P1|STARTED|Overall Study||74
557950|NCT00688064|1359777|P2|NOT COMPLETED|Overall Study||26
557951|NCT00688064|1359778|P1|NOT COMPLETED|Overall Study||21
557952|NCT00688064|1359777|P2|COMPLETED|Overall Study||201
557953|NCT00688064|1359778|P1|COMPLETED|Overall Study||211
557954|NCT00688064|1359777|P2|STARTED|Overall Study||227
557955|NCT00688064|1359778|P1|STARTED|Overall Study||232
557956|NCT00687973|1359794|P2|NOT COMPLETED|Overall Study||38
557957|NCT00687973|1359795|P1|NOT COMPLETED|Overall Study||24
557958|NCT00687973|1359794|P2|COMPLETED|Overall Study||162
557959|NCT00687973|1359795|P1|COMPLETED|Overall Study||169
557960|NCT00687973|1359794|P2|STARTED|Overall Study||200
557961|NCT00687973|1359795|P1|STARTED|Overall Study||193
557962|NCT00687908|1359824|P2|NOT COMPLETED|Overall Study||42
557963|NCT00687908|1359825|P1|NOT COMPLETED|Overall Study||18
557964|NCT00687908|1359824|P2|COMPLETED|Overall Study||78
557965|NCT00687908|1359825|P1|COMPLETED|Overall Study||105
557966|NCT00687908|1359824|P2|STARTED|Overall Study||120
557967|NCT00687908|1359825|P1|STARTED|Overall Study||123
557968|NCT00687856|1359839|P1|NOT COMPLETED|Overall Study||0
557969|NCT00687856|1359839|P1|COMPLETED|Overall Study||211
557970|NCT00687856|1359839|P1|STARTED|Overall Study||211
557971|NCT00687830|1359845|P2|NOT COMPLETED|Overall Study||0
557972|NCT00687830|1359846|P1|NOT COMPLETED|Overall Study||0
557973|NCT00687830|1359845|P2|COMPLETED|Overall Study||68
557974|NCT00687830|1359846|P1|COMPLETED|Overall Study||68
557975|NCT00687830|1359845|P2|STARTED|Overall Study||68
557976|NCT00687830|1359846|P1|STARTED|Overall Study||68
557977|NCT00687804|1359857|P3|NOT COMPLETED|Open-Label Extension Study||11
557978|NCT00687804|1359858|P2|NOT COMPLETED|Open-Label Extension Study||11
557979|NCT00687804|1359859|P1|NOT COMPLETED|Open-Label Extension Study||10
557980|NCT00687804|1359857|P3|COMPLETED|Open-Label Extension Study||63
557981|NCT00687804|1359858|P2|COMPLETED|Open-Label Extension Study||72
557982|NCT00687804|1359859|P1|COMPLETED|Open-Label Extension Study||73
557983|NCT00687804|1359857|P3|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||15
557984|NCT00687804|1359858|P2|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||21
557985|NCT00687804|1359859|P1|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||16
557986|NCT00687804|1359857|P3|STARTED|Open-Label Extension Study||74
557987|NCT00687804|1359858|P2|STARTED|Open-Label Extension Study||83
557988|NCT00687804|1359859|P1|STARTED|Open-Label Extension Study||83
557989|NCT00687804|1359857|P3|NOT COMPLETED|Core Study||13
557990|NCT00687804|1359858|P2|NOT COMPLETED|Core Study||15
557991|NCT00687804|1359859|P1|NOT COMPLETED|Core Study||14
557992|NCT00687804|1359857|P3|COMPLETED|Core Study||98
557993|NCT00687804|1359858|P2|COMPLETED|Core Study||103
557994|NCT00687804|1359859|P1|COMPLETED|Core Study||102
557995|NCT00687804|1359857|P3|STARTED|Core Study||111
557996|NCT00687804|1359858|P2|STARTED|Core Study||118
557997|NCT00687804|1359859|P1|STARTED|Core Study||116
557998|NCT00687713|1359904|P2|NOT COMPLETED|Overall Study||40
557999|NCT00687713|1359905|P1|NOT COMPLETED|Overall Study||32
558000|NCT00687713|1359904|P2|COMPLETED|Overall Study||64
558001|NCT00687713|1359905|P1|COMPLETED|Overall Study||68
558002|NCT00687713|1359904|P2|STARTED|Overall Study||104
558003|NCT00687713|1359905|P1|STARTED|Overall Study||100
558004|NCT00687674|1359913|P1|NOT COMPLETED|Overall Study||2
558005|NCT00687674|1359913|P1|COMPLETED|Overall Study||11
558006|NCT00687674|1359913|P1|STARTED|Overall Study||13
558007|NCT00687609|1359920|P1|NOT COMPLETED|Overall Study||3
558008|NCT00687609|1359920|P1|COMPLETED|Overall Study||4
558009|NCT00687609|1359920|P1|STARTED|Overall Study||7
558010|NCT00687544|1359934|P1|NOT COMPLETED|Overall Study||11
558011|NCT00687544|1359934|P1|COMPLETED|Overall Study||0
558012|NCT00687544|1359934|P1|STARTED|Overall Study||11
558013|NCT00687531|1359943|P1|NOT COMPLETED|Overall Study||135
558014|NCT00687531|1359943|P1|COMPLETED|Overall Study||250
558015|NCT00687531|1359943|P1|RECEIVED TREATMENT|Overall Study||281
558016|NCT00687531|1359943|P1|STARTED|Overall Study|Completed screening procedures|385
558017|NCT00687453|1359959|P2|NOT COMPLETED|Overall Study||6
558018|NCT00687453|1359960|P1|NOT COMPLETED|Overall Study||3
558019|NCT00687453|1359959|P2|COMPLETED|Overall Study||7
558020|NCT00687453|1359960|P1|COMPLETED|Overall Study||8
558021|NCT00687453|1359959|P2|STARTED|Overall Study||13
558022|NCT00687453|1359960|P1|STARTED|Overall Study||11
558023|NCT00687440|1359966|P1|NOT COMPLETED|Overall Study||12
558024|NCT00687440|1359966|P1|COMPLETED|Overall Study||15
558025|NCT00687440|1359966|P1|STARTED|Overall Study|Number of screened participants|27
558026|NCT00687401|1359970|P1|NOT COMPLETED|Overall Study||30
558027|NCT00687401|1359970|P1|COMPLETED|Overall Study||129
558028|NCT00687401|1359970|P1|STARTED|Overall Study|215 participants enrolled in the study, of which 56 failed screening and did not receive study drug.|159
558029|NCT00687362|1359975|P1|NOT COMPLETED|Overall Study||3
558030|NCT00687362|1359975|P1|COMPLETED|Overall Study|Completed protocol at Week 24|19
558031|NCT00687362|1359975|P1|STARTED|Overall Study||22
558032|NCT00687323|1359979|P1|NOT COMPLETED|Overall Study||180
558033|NCT00687323|1359979|P1|COMPLETED|Overall Study|Number of participants alive at one year|15
558034|NCT00687323|1359979|P1|Received Treatment|Overall Study||47
558035|NCT00687323|1359979|P1|STARTED|Overall Study|Number of screened participants|195
558036|NCT00687297|1359995|P2|NOT COMPLETED|Maintenance||1
558037|NCT00687297|1359996|P1|NOT COMPLETED|Maintenance||3
558038|NCT00687297|1359995|P2|COMPLETED|Maintenance||25
558039|NCT00687297|1359996|P1|COMPLETED|Maintenance||29
558040|NCT00687297|1359995|P2|STARTED|Maintenance||26
558041|NCT00687297|1359996|P1|STARTED|Maintenance||32
558042|NCT00687297|1359995|P2|NOT COMPLETED|Induction||55
558043|NCT00687297|1359996|P1|NOT COMPLETED|Induction||45
558044|NCT00687297|1359995|P2|COMPLETED|Induction||26
558045|NCT00687297|1359996|P1|COMPLETED|Induction||32
558046|NCT00687297|1359995|P2|STARTED|Induction||81
558047|NCT00687297|1359996|P1|STARTED|Induction||77
558048|NCT00687297|1359995|P2|NOT COMPLETED|Randomization||1
558049|NCT00687297|1359996|P1|NOT COMPLETED|Randomization||3
558050|NCT00687297|1359995|P2|COMPLETED|Randomization||81
558051|NCT00687297|1359996|P1|COMPLETED|Randomization||77
558052|NCT00687297|1359995|P2|STARTED|Randomization||82
558053|NCT00687297|1359996|P1|STARTED|Randomization||80
558054|NCT00687219|1360006|P1|NOT COMPLETED|Overall Study||51
558055|NCT00687219|1360006|P1|COMPLETED|Overall Study||51
558056|NCT00687219|1360006|P1|STARTED|Overall Study||102
558057|NCT00687193|1360018|P6|NOT COMPLETED|Overall Study||4
558058|NCT00687193|1360019|P5|NOT COMPLETED|Overall Study||2
558059|NCT00687193|1360020|P4|NOT COMPLETED|Overall Study||4
558060|NCT00687193|1360021|P3|NOT COMPLETED|Overall Study||2
558061|NCT00687193|1360022|P2|NOT COMPLETED|Overall Study||4
558062|NCT00687193|1360023|P1|NOT COMPLETED|Overall Study||2
558063|NCT00687193|1360018|P6|COMPLETED|Overall Study||48
558064|NCT00687193|1360019|P5|COMPLETED|Overall Study||52
558065|NCT00687193|1360020|P4|COMPLETED|Overall Study||49
558066|NCT00687193|1360021|P3|COMPLETED|Overall Study||50
558067|NCT00687193|1360022|P2|COMPLETED|Overall Study||49
558068|NCT00687193|1360023|P1|COMPLETED|Overall Study||51
558069|NCT00687193|1360018|P6|STARTED|Overall Study|One participant withdrew after randomization but prior to treatment.|52
558070|NCT00687193|1360019|P5|STARTED|Overall Study||54
558071|NCT00687193|1360020|P4|STARTED|Overall Study||53
558072|NCT00687193|1360021|P3|STARTED|Overall Study||52
558073|NCT00687193|1360022|P2|STARTED|Overall Study||53
558074|NCT00687193|1360023|P1|STARTED|Overall Study||53
558075|NCT00687167|1360187|P2|NOT COMPLETED|Second Intervention||0
558076|NCT00687167|1360188|P1|NOT COMPLETED|Second Intervention||0
558077|NCT00687167|1360187|P2|COMPLETED|Second Intervention||17
558078|NCT00687167|1360188|P1|COMPLETED|Second Intervention||17
558079|NCT00687167|1360187|P2|STARTED|Second Intervention||17
558080|NCT00687167|1360188|P1|STARTED|Second Intervention||17
558081|NCT00687167|1360187|P2|NOT COMPLETED|Washout Period of 28 Days||0
558082|NCT00687167|1360188|P1|NOT COMPLETED|Washout Period of 28 Days||0
558083|NCT00687167|1360187|P2|COMPLETED|Washout Period of 28 Days||17
558084|NCT00687167|1360188|P1|COMPLETED|Washout Period of 28 Days||17
558085|NCT00687167|1360187|P2|STARTED|Washout Period of 28 Days||17
558086|NCT00687167|1360188|P1|STARTED|Washout Period of 28 Days||17
558087|NCT00687167|1360187|P2|NOT COMPLETED|First Intervention||0
558088|NCT00687167|1360188|P1|NOT COMPLETED|First Intervention||0
558089|NCT00687167|1360187|P2|COMPLETED|First Intervention||17
558090|NCT00687167|1360188|P1|COMPLETED|First Intervention||17
558091|NCT00687167|1360187|P2|STARTED|First Intervention||17
558092|NCT00687167|1360188|P1|STARTED|First Intervention||17
558093|NCT00687102|1360198|P2|NOT COMPLETED|Overall Study||0
558094|NCT00687102|1360199|P1|NOT COMPLETED|Overall Study||0
558095|NCT00687102|1360198|P2|COMPLETED|Overall Study||765
558096|NCT00687102|1360199|P1|COMPLETED|Overall Study||733
558097|NCT00687102|1360198|P2|STARTED|Overall Study||765
558098|NCT00687102|1360199|P1|STARTED|Overall Study||733
558099|NCT00687076|1360221|P2|NOT COMPLETED|Overall Study||30
558100|NCT00687076|1360222|P1|NOT COMPLETED|Overall Study||32
558101|NCT00687076|1360221|P2|COMPLETED|Overall Study||21
558102|NCT00687076|1360222|P1|COMPLETED|Overall Study||19
558103|NCT00687076|1360221|P2|STARTED|Overall Study||51
558104|NCT00687076|1360222|P1|STARTED|Overall Study||51
558105|NCT00686998|1360233|P3|NOT COMPLETED|Overall Study||4
558106|NCT00686998|1360234|P2|NOT COMPLETED|Overall Study||8
558107|NCT00686998|1360235|P1|NOT COMPLETED|Overall Study||13
558108|NCT00686998|1360233|P3|COMPLETED|Overall Study||18
558109|NCT00686998|1360234|P2|COMPLETED|Overall Study||33
558110|NCT00686998|1360235|P1|COMPLETED|Overall Study||30
558111|NCT00686998|1360233|P3|Completed Scheduled Treatment|Overall Study||18
558112|NCT00686998|1360234|P2|Completed Scheduled Treatment|Overall Study||33
558113|NCT00686998|1360235|P1|Completed Scheduled Treatment|Overall Study||30
558114|NCT00686998|1360233|P3|Eligible for Efficacy Analysis|Overall Study||21
558115|NCT00686998|1360234|P2|Eligible for Efficacy Analysis|Overall Study||39
558116|NCT00686998|1360235|P1|Eligible for Efficacy Analysis|Overall Study||42
558117|NCT00686998|1360233|P3|Received Treatment|Overall Study||22
558118|NCT00686998|1360234|P2|Received Treatment|Overall Study||41
558119|NCT00686998|1360235|P1|Received Treatment|Overall Study||43
558120|NCT00686998|1360233|P3|Randomized|Overall Study||22
558121|NCT00686998|1360234|P2|Randomized|Overall Study||41
558122|NCT00686998|1360235|P1|Randomized|Overall Study||43
558123|NCT00686998|1360233|P3|STARTED|Overall Study|Randomized & received study medication|22
558124|NCT00686998|1360234|P2|STARTED|Overall Study|Randomized & received study medication|41
558125|NCT00686998|1360235|P1|STARTED|Overall Study|Randomized & received study medication|43
558126|NCT00686972|1360243|P1|NOT COMPLETED|Overall Study||51
558127|NCT00686972|1360243|P1|COMPLETED|Overall Study||0
558128|NCT00686972|1360243|P1|STARTED|Overall Study||51
558129|NCT00686959|1360249|P2|NOT COMPLETED|Overall Study||117
558130|NCT00686959|1360250|P1|NOT COMPLETED|Overall Study||124
558131|NCT00686959|1360249|P2|COMPLETED|Overall Study|Study completion includes death due to any cause.|180
558132|NCT00686959|1360250|P1|COMPLETED|Overall Study|Study completion includes death due to any cause|177
558133|NCT00686959|1360249|P2|Entered Consolidation Phase|Overall Study||202
558134|NCT00686959|1360250|P1|Entered Consolidation Phase|Overall Study||229
558135|NCT00686959|1360249|P2|Received at Least One Dose of Study Drug|Overall Study||272
558136|NCT00686959|1360250|P1|Received at Least One Dose of Study Drug|Overall Study||283
558137|NCT00686959|1360249|P2|STARTED|Overall Study||297
558138|NCT00686959|1360250|P1|STARTED|Overall Study||301
558139|NCT00686894|1360268|P1|NOT COMPLETED|Overall Study||6
558140|NCT00686894|1360268|P1|COMPLETED|Overall Study||1
558141|NCT00686894|1360268|P1|STARTED|Overall Study||7
558142|NCT00686881|1360274|P2|NOT COMPLETED|Overall Study||81
558143|NCT00686881|1360275|P1|NOT COMPLETED|Overall Study||82
558144|NCT00686881|1360274|P2|COMPLETED|Overall Study||53
558145|NCT00686881|1360275|P1|COMPLETED|Overall Study||45
558146|NCT00686881|1360274|P2|STARTED|Overall Study|After randomization, 6 participants withdrew consent and did not receive study drug.|134
558147|NCT00686881|1360275|P1|STARTED|Overall Study|After randomization, 2 participants withdrew consent and did not receive study drug.|127
558148|NCT00686855|1360287|P2|NOT COMPLETED|Overall Study||1
558149|NCT00686855|1360288|P1|NOT COMPLETED|Overall Study||1
558150|NCT00686855|1360287|P2|COMPLETED|Overall Study||17
558151|NCT00686855|1360288|P1|COMPLETED|Overall Study||27
558152|NCT00686855|1360287|P2|STARTED|Overall Study||18
558153|NCT00686855|1360288|P1|STARTED|Overall Study||28
558154|NCT00686842|1360294|P1|NOT COMPLETED|Overall Study||0
558155|NCT00686842|1360294|P1|COMPLETED|Overall Study||17
558156|NCT00686842|1360294|P1|STARTED|Overall Study||17
558157|NCT00686803|1360301|P3|NOT COMPLETED|Overall Study||0
558158|NCT00686803|1360302|P2|NOT COMPLETED|Overall Study||0
558159|NCT00686803|1360303|P1|NOT COMPLETED|Overall Study||0
558160|NCT00686803|1360301|P3|COMPLETED|Overall Study||3
558161|NCT00686803|1360302|P2|COMPLETED|Overall Study||12
558162|NCT00686803|1360303|P1|COMPLETED|Overall Study||6
558163|NCT00686803|1360301|P3|STARTED|Overall Study||3
558164|NCT00686803|1360302|P2|STARTED|Overall Study||12
558165|NCT00686803|1360303|P1|STARTED|Overall Study||6
558166|NCT00686790|1360314|P1|NOT COMPLETED|Overall Study||16
558167|NCT00686790|1360314|P1|COMPLETED|Overall Study||32
558168|NCT00686790|1360314|P1|STARTED|Overall Study||48
558169|NCT00686777|1360322|P1|NOT COMPLETED|Overall Study||10
558170|NCT00686777|1360322|P1|COMPLETED|Overall Study|Of 10 noncompleters, 6 had AEs including 4 meeting protocol prespecified AE discontinuance criteria.|65
558171|NCT00686777|1360322|P1|Completed 24 Weeks of Follow-up|Overall Study||70
558172|NCT00686777|1360322|P1|Included in Follow-up (All Treated)|Overall Study||75
558173|NCT00686777|1360322|P1|Completed 48 Weeks of Treatment|Overall Study||65
558174|NCT00686777|1360322|P1|Completed 24 Weeks of Treatment|Overall Study||69
558175|NCT00686777|1360322|P1|STARTED|Overall Study||75
558176|NCT00686725|1360330|P2|NOT COMPLETED|Overall Study||42
558177|NCT00686725|1360331|P1|NOT COMPLETED|Overall Study||46
558178|NCT00686725|1360330|P2|COMPLETED|Overall Study|Completers were defined as those who completed the established treatment.|10
558179|NCT00686725|1360331|P1|COMPLETED|Overall Study|Completers were defined as those who completed the established treatment.|1
558180|NCT00686725|1360330|P2|STARTED|Overall Study||52
558181|NCT00686725|1360331|P1|STARTED|Overall Study||47
558182|NCT00686712|1360356|P3|NOT COMPLETED|Overall Study||13
558183|NCT00686712|1360357|P2|NOT COMPLETED|Overall Study||11
558184|NCT00686712|1360358|P1|NOT COMPLETED|Overall Study||10
558185|NCT00686712|1360356|P3|COMPLETED|Overall Study||17
558186|NCT00686712|1360357|P2|COMPLETED|Overall Study||14
558187|NCT00686712|1360358|P1|COMPLETED|Overall Study||20
558188|NCT00686712|1360356|P3|STARTED|Overall Study||30
558189|NCT00686712|1360357|P2|STARTED|Overall Study||25
558190|NCT00686712|1360358|P1|STARTED|Overall Study||30
558191|NCT00686699|1360386|P2|NOT COMPLETED|Treatment Period 2||0
558192|NCT00686699|1360387|P1|NOT COMPLETED|Treatment Period 2||0
558193|NCT00686699|1360386|P2|COMPLETED|Treatment Period 2||5
558194|NCT00686699|1360387|P1|COMPLETED|Treatment Period 2||4
558195|NCT00686699|1360386|P2|STARTED|Treatment Period 2||5
558196|NCT00686699|1360387|P1|STARTED|Treatment Period 2||4
558197|NCT00686699|1360386|P2|NOT COMPLETED|Treatment Period 1||2
558198|NCT00686699|1360387|P1|NOT COMPLETED|Treatment Period 1||0
558199|NCT00686699|1360386|P2|COMPLETED|Treatment Period 1||5
558200|NCT00686699|1360387|P1|COMPLETED|Treatment Period 1||4
558201|NCT00686699|1360386|P2|STARTED|Treatment Period 1||7
558202|NCT00686699|1360387|P1|STARTED|Treatment Period 1||4
558203|NCT00686686|1360411|P1|NOT COMPLETED|Overall Study||6
558204|NCT00686686|1360411|P1|COMPLETED|Overall Study||17
558205|NCT00686686|1360411|P1|STARTED|Overall Study||23
558206|NCT00686647|1360419|P1|NOT COMPLETED|Overall Study||2
558207|NCT00686647|1360419|P1|COMPLETED|Overall Study||91
558208|NCT00686647|1360419|P1|STARTED|Overall Study||93
558209|NCT00686634|1360425|P1|NOT COMPLETED|Overall Study||6
558210|NCT00686634|1360425|P1|COMPLETED|Overall Study||102
558211|NCT00686634|1360425|P1|STARTED|Overall Study||108
558212|NCT00686595|1360432|P1|NOT COMPLETED|Overall Study||7
558213|NCT00686595|1360432|P1|COMPLETED|Overall Study||31
558214|NCT00686595|1360432|P1|STARTED|Overall Study||38
558215|NCT00686543|1360461|P4|NOT COMPLETED|Overall Study||3
558216|NCT00686543|1360462|P3|NOT COMPLETED|Overall Study||5
558217|NCT00686543|1360463|P2|NOT COMPLETED|Overall Study||1
558218|NCT00686543|1360464|P1|NOT COMPLETED|Overall Study||14
558219|NCT00686543|1360461|P4|COMPLETED|Overall Study||17
558220|NCT00686543|1360462|P3|COMPLETED|Overall Study||15
558221|NCT00686543|1360463|P2|COMPLETED|Overall Study||20
558222|NCT00686543|1360464|P1|COMPLETED|Overall Study||0
558223|NCT00686543|1360461|P4|STARTED|Overall Study||20
558224|NCT00686543|1360462|P3|STARTED|Overall Study||20
558225|NCT00686543|1360463|P2|STARTED|Overall Study||21
558226|NCT00686543|1360464|P1|STARTED|Overall Study||14
558227|NCT00686517|1360485|P3|NOT COMPLETED|Follow-up||10
558228|NCT00686517|1360486|P2|NOT COMPLETED|Follow-up||10
558229|NCT00686517|1360487|P1|NOT COMPLETED|Follow-up||8
558230|NCT00686517|1360485|P3|COMPLETED|Follow-up||29
558231|NCT00686517|1360486|P2|COMPLETED|Follow-up||28
558232|NCT00686517|1360487|P1|COMPLETED|Follow-up||29
558233|NCT00686517|1360485|P3|STARTED|Follow-up||39
558234|NCT00686517|1360486|P2|STARTED|Follow-up||38
558235|NCT00686517|1360487|P1|STARTED|Follow-up||37
558236|NCT00686517|1360485|P3|NOT COMPLETED|Treatment||1
558237|NCT00686517|1360486|P2|NOT COMPLETED|Treatment||3
558238|NCT00686517|1360487|P1|NOT COMPLETED|Treatment||6
558239|NCT00686517|1360485|P3|COMPLETED|Treatment||42
558240|NCT00686517|1360486|P2|COMPLETED|Treatment||40
558241|NCT00686517|1360487|P1|COMPLETED|Treatment||38
558242|NCT00686517|1360485|P3|Completed Final Treatment Visit|Treatment|Included 1 that discontinued the treatment before completion,but performed the Final Treatment Visit|43
558243|NCT00686517|1360486|P2|Completed Final Treatment Visit|Treatment|Included 3 that discontinued the treatment before completion,but performed the Final Treatment Visit|43
558244|NCT00686517|1360487|P1|Completed Final Treatment Visit|Treatment|Included 6 that discontinued the treatment before completion,but performed the Final Treatment Visit|44
558245|NCT00686517|1360485|P3|STARTED|Treatment||43
558246|NCT00686517|1360486|P2|STARTED|Treatment||43
558247|NCT00686517|1360487|P1|STARTED|Treatment||44
558248|NCT00686374|1360510|P1|NOT COMPLETED|Overall Study||61
558249|NCT00686374|1360510|P1|COMPLETED|Overall Study||39
558250|NCT00686374|1360510|P1|STARTED|Overall Study||100
558251|NCT00686335|1360521|P1|NOT COMPLETED|Treatment Period||0
558252|NCT00686335|1360521|P1|COMPLETED|Treatment Period||7
558253|NCT00686335|1360521|P1|STARTED|Treatment Period||7
558254|NCT00686335|1360521|P1|NOT COMPLETED|Run-in Period||5
558255|NCT00686335|1360521|P1|COMPLETED|Run-in Period||7
558256|NCT00686335|1360521|P1|STARTED|Run-in Period||12
558257|NCT00686257|1360529|P2|NOT COMPLETED|Overall Study||0
558258|NCT00686257|1360530|P1|NOT COMPLETED|Overall Study||0
558259|NCT00686257|1360529|P2|COMPLETED|Overall Study||31
558260|NCT00686257|1360530|P1|COMPLETED|Overall Study||29
558261|NCT00686257|1360529|P2|STARTED|Overall Study||31
558262|NCT00686257|1360530|P1|STARTED|Overall Study||29
558263|NCT00686231|1360553|P3|NOT COMPLETED|Overall Study||0
558264|NCT00686231|1360554|P2|NOT COMPLETED|Overall Study||0
558265|NCT00686231|1360555|P1|NOT COMPLETED|Overall Study||0
558266|NCT00686231|1360553|P3|COMPLETED|Overall Study||20
558267|NCT00686231|1360554|P2|COMPLETED|Overall Study||20
558268|NCT00686231|1360555|P1|COMPLETED|Overall Study||20
558269|NCT00686231|1360553|P3|STARTED|Overall Study||20
558270|NCT00686231|1360554|P2|STARTED|Overall Study||20
558271|NCT00686231|1360555|P1|STARTED|Overall Study||20
558272|NCT00686205|1360565|P2|NOT COMPLETED|Overall Study||981
558273|NCT00686205|1360566|P1|NOT COMPLETED|Overall Study||6007
558274|NCT00686205|1360565|P2|COMPLETED|Overall Study||1524
558275|NCT00686205|1360566|P1|COMPLETED|Overall Study||15599
558276|NCT00686205|1360565|P2|STARTED|Overall Study||2505
558277|NCT00686205|1360566|P1|STARTED|Overall Study||21606
558278|NCT00686166|1360572|P1|NOT COMPLETED|Overall Study||20
558279|NCT00686166|1360572|P1|COMPLETED|Overall Study||63
558280|NCT00686166|1360572|P1|Eligible and Began Protocol Therapy|Overall Study||74
558281|NCT00686166|1360572|P1|Eligible|Overall Study||78
558282|NCT00686166|1360572|P1|STARTED|Overall Study||83
558283|NCT00686127|1360584|P2|NOT COMPLETED|Overall Study||6
558284|NCT00686127|1360585|P1|NOT COMPLETED|Overall Study||14
558285|NCT00686127|1360584|P2|COMPLETED|Overall Study||1
558286|NCT00686127|1360585|P1|COMPLETED|Overall Study|Patients withdrew from the study because they did not like wearing the patch.|0
558287|NCT00686127|1360584|P2|STARTED|Overall Study||7
558288|NCT00686127|1360585|P1|STARTED|Overall Study||14
558289|NCT00686075|1360601|P10|NOT COMPLETED|Overall Study||10
558290|NCT00686075|1360602|P9|NOT COMPLETED|Overall Study||6
558291|NCT00686075|1360603|P8|NOT COMPLETED|Overall Study||2
558292|NCT00686075|1360604|P7|NOT COMPLETED|Overall Study||0
558293|NCT00686075|1360605|P6|NOT COMPLETED|Overall Study||3
558294|NCT00686075|1360606|P5|NOT COMPLETED|Overall Study||4
558295|NCT00686075|1360607|P4|NOT COMPLETED|Overall Study||9
558296|NCT00686075|1360608|P3|NOT COMPLETED|Overall Study||6
558297|NCT00686075|1360609|P2|NOT COMPLETED|Overall Study||10
558298|NCT00686075|1360610|P1|NOT COMPLETED|Overall Study||8
558299|NCT00686075|1360601|P10|COMPLETED|Overall Study||69
558300|NCT00686075|1360602|P9|COMPLETED|Overall Study||75
558301|NCT00686075|1360603|P8|COMPLETED|Overall Study||76
558302|NCT00686075|1360604|P7|COMPLETED|Overall Study||82
558303|NCT00686075|1360605|P6|COMPLETED|Overall Study||37
558304|NCT00686075|1360606|P5|COMPLETED|Overall Study||36
558305|NCT00686075|1360607|P4|COMPLETED|Overall Study||71
558306|NCT00686075|1360608|P3|COMPLETED|Overall Study||74
558307|NCT00686075|1360609|P2|COMPLETED|Overall Study||71
558308|NCT00686075|1360610|P1|COMPLETED|Overall Study||71
558309|NCT00686075|1360601|P10|Treated|Overall Study||78
558310|NCT00686075|1360602|P9|Treated|Overall Study||80
558311|NCT00686075|1360603|P8|Treated|Overall Study||77
558312|NCT00686075|1360604|P7|Treated|Overall Study||82
558313|NCT00686075|1360605|P6|Treated|Overall Study||40
558314|NCT00686075|1360606|P5|Treated|Overall Study||40
558315|NCT00686075|1360607|P4|Treated|Overall Study||80
558316|NCT00686075|1360608|P3|Treated|Overall Study||80
558317|NCT00686075|1360609|P2|Treated|Overall Study||79
558318|NCT00686075|1360610|P1|Treated|Overall Study||78
558319|NCT00686075|1360601|P10|STARTED|Overall Study||79
558320|NCT00686075|1360602|P9|STARTED|Overall Study||81
558321|NCT00686075|1360603|P8|STARTED|Overall Study||78
558322|NCT00686075|1360604|P7|STARTED|Overall Study||82
558323|NCT00686075|1360605|P6|STARTED|Overall Study||40
558324|NCT00686075|1360606|P5|STARTED|Overall Study||40
558325|NCT00686075|1360607|P4|STARTED|Overall Study||80
558326|NCT00686075|1360608|P3|STARTED|Overall Study||80
558327|NCT00686075|1360609|P2|STARTED|Overall Study||81
558328|NCT00686075|1360610|P1|STARTED|Overall Study||79
558329|NCT00686036|1360804|P2|NOT COMPLETED|Overall Study||6
558330|NCT00686036|1360805|P1|NOT COMPLETED|Overall Study||9
558331|NCT00686036|1360804|P2|COMPLETED|Overall Study||2
558332|NCT00686036|1360805|P1|COMPLETED|Overall Study||0
558333|NCT00686036|1360804|P2|STARTED|Overall Study||8
558334|NCT00686036|1360805|P1|STARTED|Overall Study||9
558335|NCT00685945|1360817|P1|NOT COMPLETED|Sildenafil + L-NMMA + Bradykinin||0
558336|NCT00685945|1360817|P1|COMPLETED|Sildenafil + L-NMMA + Bradykinin||12
558337|NCT00685945|1360817|P1|STARTED|Sildenafil + L-NMMA + Bradykinin||12
558338|NCT00685945|1360817|P1|NOT COMPLETED|Isosorbide + L-NMMA + Bradykinin||0
558339|NCT00685945|1360817|P1|COMPLETED|Isosorbide + L-NMMA + Bradykinin||11
558340|NCT00685945|1360817|P1|STARTED|Isosorbide + L-NMMA + Bradykinin||11
558341|NCT00685945|1360817|P1|NOT COMPLETED|L-NMMA + Bradykinin||1
558342|NCT00685945|1360817|P1|COMPLETED|L-NMMA + Bradykinin||23
558343|NCT00685945|1360817|P1|STARTED|L-NMMA + Bradykinin||24
558344|NCT00685945|1360817|P1|NOT COMPLETED|Control (Bradykinin Infusion)||0
558345|NCT00685945|1360817|P1|COMPLETED|Control (Bradykinin Infusion)||24
558346|NCT00685945|1360817|P1|STARTED|Control (Bradykinin Infusion)|A total of 24 subjects received an infusion of bradykinin|24
558347|NCT00685932|1360834|P2|NOT COMPLETED|Overall Study||20
558348|NCT00685932|1360835|P1|NOT COMPLETED|Overall Study||21
558349|NCT00685932|1360834|P2|COMPLETED|Overall Study||58
558350|NCT00685932|1360835|P1|COMPLETED|Overall Study||55
558351|NCT00685932|1360834|P2|STARTED|Overall Study||78
558352|NCT00685932|1360835|P1|STARTED|Overall Study||76
558353|NCT00685880|1360845|P2|NOT COMPLETED|Overall Study||0
558354|NCT00685880|1360846|P1|NOT COMPLETED|Overall Study||0
558355|NCT00685880|1360845|P2|COMPLETED|Overall Study||2
558356|NCT00685880|1360846|P1|COMPLETED|Overall Study||0
558357|NCT00685880|1360845|P2|STARTED|Overall Study||2
558358|NCT00685880|1360846|P1|STARTED|Overall Study||0
558359|NCT00685802|1360852|P2|NOT COMPLETED|Second Intervention||0
558360|NCT00685802|1360853|P1|NOT COMPLETED|Second Intervention||0
558361|NCT00685802|1360852|P2|COMPLETED|Second Intervention||15
558362|NCT00685802|1360853|P1|COMPLETED|Second Intervention||14
558363|NCT00685802|1360852|P2|STARTED|Second Intervention||15
558364|NCT00685802|1360853|P1|STARTED|Second Intervention||14
558365|NCT00685802|1360852|P2|NOT COMPLETED|Washout Period of 7 Days||1
558366|NCT00685802|1360853|P1|NOT COMPLETED|Washout Period of 7 Days||2
558367|NCT00685802|1360852|P2|COMPLETED|Washout Period of 7 Days||15
558368|NCT00685802|1360853|P1|COMPLETED|Washout Period of 7 Days||14
558369|NCT00685802|1360852|P2|STARTED|Washout Period of 7 Days||16
558370|NCT00685802|1360853|P1|STARTED|Washout Period of 7 Days||16
558371|NCT00685802|1360852|P2|NOT COMPLETED|First Intervention||0
558372|NCT00685802|1360853|P1|NOT COMPLETED|First Intervention||0
558373|NCT00685802|1360852|P2|COMPLETED|First Intervention||16
558374|NCT00685802|1360853|P1|COMPLETED|First Intervention||16
558375|NCT00685802|1360852|P2|STARTED|First Intervention||16
558376|NCT00685802|1360853|P1|STARTED|First Intervention||16
558377|NCT00685763|1360863|P1|NOT COMPLETED|Overall Study||2
558378|NCT00685763|1360863|P1|COMPLETED|Overall Study||11
558379|NCT00685763|1360863|P1|STARTED|Overall Study||13
558380|NCT00685698|1360867|P1|NOT COMPLETED|Overall Study||13
558381|NCT00685698|1360867|P1|COMPLETED|Overall Study||25
558382|NCT00685698|1360867|P1|STARTED|Overall Study||38
558383|NCT00685685|1360902|P2|NOT COMPLETED|Second Intervention||0
558384|NCT00685685|1360903|P1|NOT COMPLETED|Second Intervention||0
558385|NCT00685685|1360902|P2|COMPLETED|Second Intervention||26
558386|NCT00685685|1360903|P1|COMPLETED|Second Intervention||25
558387|NCT00685685|1360902|P2|STARTED|Second Intervention||26
558388|NCT00685685|1360903|P1|STARTED|Second Intervention||25
558389|NCT00685685|1360902|P2|NOT COMPLETED|Washout Period of 7 Days||1
558390|NCT00685685|1360903|P1|NOT COMPLETED|Washout Period of 7 Days||2
558391|NCT00685685|1360902|P2|COMPLETED|Washout Period of 7 Days||26
558392|NCT00685685|1360903|P1|COMPLETED|Washout Period of 7 Days||25
558393|NCT00685685|1360902|P2|STARTED|Washout Period of 7 Days||27
558394|NCT00685685|1360903|P1|STARTED|Washout Period of 7 Days||27
558395|NCT00685685|1360902|P2|NOT COMPLETED|First Intervention||0
558396|NCT00685685|1360903|P1|NOT COMPLETED|First Intervention||0
558397|NCT00685685|1360902|P2|COMPLETED|First Intervention||27
558398|NCT00685685|1360903|P1|COMPLETED|First Intervention||27
558399|NCT00685685|1360902|P2|STARTED|First Intervention||27
558400|NCT00685685|1360903|P1|STARTED|First Intervention||27
558401|NCT00685659|1360916|P3|NOT COMPLETED|Overall Study||15
558402|NCT00685659|1360917|P2|NOT COMPLETED|Overall Study||25
558403|NCT00685659|1360918|P1|NOT COMPLETED|Overall Study||31
558404|NCT00685659|1360916|P3|COMPLETED|Overall Study||92
558405|NCT00685659|1360917|P2|COMPLETED|Overall Study||81
558406|NCT00685659|1360918|P1|COMPLETED|Overall Study||77
558407|NCT00685659|1360916|P3|STARTED|Overall Study||107
558408|NCT00685659|1360917|P2|STARTED|Overall Study||106
558409|NCT00685659|1360918|P1|STARTED|Overall Study||108
558410|NCT00685516|1361016|P3|NOT COMPLETED|Overall Study||7
558411|NCT00685516|1361017|P2|NOT COMPLETED|Overall Study||5
558412|NCT00685516|1361018|P1|NOT COMPLETED|Overall Study||8
558413|NCT00685516|1361016|P3|COMPLETED|Overall Study||26
558414|NCT00685516|1361017|P2|COMPLETED|Overall Study||33
558415|NCT00685516|1361018|P1|COMPLETED|Overall Study||34
558416|NCT00685516|1361016|P3|STARTED|Overall Study||33
558417|NCT00685516|1361017|P2|STARTED|Overall Study||38
558418|NCT00685516|1361018|P1|STARTED|Overall Study||42
558419|NCT00685477|1361035|P6|NOT COMPLETED|Overall Study||0
558420|NCT00685477|1361036|P5|NOT COMPLETED|Overall Study||0
558421|NCT00685477|1361037|P4|NOT COMPLETED|Overall Study||0
558422|NCT00685477|1361038|P3|NOT COMPLETED|Overall Study||0
558423|NCT00685477|1361039|P2|NOT COMPLETED|Overall Study||0
558424|NCT00685477|1361040|P1|NOT COMPLETED|Overall Study||0
558425|NCT00685477|1361035|P6|COMPLETED|Overall Study||10
558426|NCT00685477|1361036|P5|COMPLETED|Overall Study||10
558427|NCT00685477|1361037|P4|COMPLETED|Overall Study||10
558428|NCT00685477|1361038|P3|COMPLETED|Overall Study||10
558429|NCT00685477|1361039|P2|COMPLETED|Overall Study||10
558430|NCT00685477|1361040|P1|COMPLETED|Overall Study||10
558431|NCT00685477|1361035|P6|STARTED|Overall Study||10
558432|NCT00685477|1361036|P5|STARTED|Overall Study||10
558433|NCT00685477|1361037|P4|STARTED|Overall Study||10
558434|NCT00685477|1361038|P3|STARTED|Overall Study||10
558435|NCT00685477|1361039|P2|STARTED|Overall Study||10
558436|NCT00685477|1361040|P1|STARTED|Overall Study||10
558437|NCT00685399|1361056|P8|NOT COMPLETED|Extension||0
558438|NCT00685399|1361057|P7|NOT COMPLETED|Extension||0
558439|NCT00685399|1361058|P6|NOT COMPLETED|Extension||0
558440|NCT00685399|1361059|P5|NOT COMPLETED|Extension||0
558441|NCT00685399|1361060|P4|NOT COMPLETED|Extension||7
558442|NCT00685399|1361061|P3|NOT COMPLETED|Extension||0
558443|NCT00685399|1361062|P2|NOT COMPLETED|Extension||0
558444|NCT00685399|1361063|P1|NOT COMPLETED|Extension||0
558445|NCT00685399|1361056|P8|COMPLETED|Extension||0
558446|NCT00685399|1361057|P7|COMPLETED|Extension||0
558447|NCT00685399|1361058|P6|COMPLETED|Extension||0
558448|NCT00685399|1361059|P5|COMPLETED|Extension||0
558449|NCT00685399|1361060|P4|COMPLETED|Extension||21
558450|NCT00685399|1361061|P3|COMPLETED|Extension||0
558451|NCT00685399|1361062|P2|COMPLETED|Extension||0
558452|NCT00685399|1361063|P1|COMPLETED|Extension||0
558453|NCT00685399|1361056|P8|STARTED|Extension||0
558454|NCT00685399|1361057|P7|STARTED|Extension||0
558455|NCT00685399|1361058|P6|STARTED|Extension||0
558456|NCT00685399|1361059|P5|STARTED|Extension||0
558457|NCT00685399|1361060|P4|STARTED|Extension||28
558458|NCT00685399|1361061|P3|STARTED|Extension||0
558459|NCT00685399|1361062|P2|STARTED|Extension||0
558460|NCT00685399|1361063|P1|STARTED|Extension||0
558461|NCT00685399|1361056|P8|NOT COMPLETED|Treatment Period 2||2
558462|NCT00685399|1361057|P7|NOT COMPLETED|Treatment Period 2||0
558463|NCT00685399|1361058|P6|NOT COMPLETED|Treatment Period 2||2
558464|NCT00685399|1361059|P5|NOT COMPLETED|Treatment Period 2||0
558465|NCT00685399|1361060|P4|NOT COMPLETED|Treatment Period 2||0
558466|NCT00685399|1361061|P3|NOT COMPLETED|Treatment Period 2||3
558467|NCT00685399|1361062|P2|NOT COMPLETED|Treatment Period 2||12
558468|NCT00685399|1361063|P1|NOT COMPLETED|Treatment Period 2||0
558469|NCT00685399|1361056|P8|COMPLETED|Treatment Period 2||10
558470|NCT00685399|1361057|P7|COMPLETED|Treatment Period 2||13
558471|NCT00685399|1361058|P6|COMPLETED|Treatment Period 2||10
558472|NCT00685399|1361059|P5|COMPLETED|Treatment Period 2||4
558473|NCT00685399|1361060|P4|COMPLETED|Treatment Period 2|in extension period only|0
558474|NCT00685399|1361061|P3|COMPLETED|Treatment Period 2||2
558475|NCT00685399|1361062|P2|COMPLETED|Treatment Period 2||2
558476|NCT00685399|1361063|P1|COMPLETED|Treatment Period 2||0
558477|NCT00685399|1361056|P8|STARTED|Treatment Period 2||12
558478|NCT00685399|1361057|P7|STARTED|Treatment Period 2||13
558479|NCT00685399|1361058|P6|STARTED|Treatment Period 2||12
558480|NCT00685399|1361059|P5|STARTED|Treatment Period 2||4
558481|NCT00685399|1361060|P4|STARTED|Treatment Period 2|in extension period only|0
558482|NCT00685399|1361061|P3|STARTED|Treatment Period 2||5
558483|NCT00685399|1361062|P2|STARTED|Treatment Period 2||14
558484|NCT00685399|1361063|P1|STARTED|Treatment Period 2||0
558485|NCT00685399|1361056|P8|NOT COMPLETED|Treatment Period 1||0
558486|NCT00685399|1361057|P7|NOT COMPLETED|Treatment Period 1||0
558487|NCT00685399|1361058|P6|NOT COMPLETED|Treatment Period 1||0
558488|NCT00685399|1361059|P5|NOT COMPLETED|Treatment Period 1||0
558489|NCT00685399|1361060|P4|NOT COMPLETED|Treatment Period 1||0
558490|NCT00685399|1361061|P3|NOT COMPLETED|Treatment Period 1||0
558491|NCT00685399|1361062|P2|NOT COMPLETED|Treatment Period 1||0
558492|NCT00685399|1361063|P1|NOT COMPLETED|Treatment Period 1||6
558493|NCT00685399|1361056|P8|COMPLETED|Treatment Period 1||0
558494|NCT00685399|1361057|P7|COMPLETED|Treatment Period 1||0
558495|NCT00685399|1361058|P6|COMPLETED|Treatment Period 1||0
558496|NCT00685399|1361059|P5|COMPLETED|Treatment Period 1||0
558497|NCT00685399|1361060|P4|COMPLETED|Treatment Period 1||0
558498|NCT00685399|1361061|P3|COMPLETED|Treatment Period 1||0
558499|NCT00685399|1361062|P2|COMPLETED|Treatment Period 1||0
558500|NCT00685399|1361063|P1|COMPLETED|Treatment Period 1||10
558501|NCT00685399|1361056|P8|STARTED|Treatment Period 1||0
558502|NCT00685399|1361057|P7|STARTED|Treatment Period 1||0
558503|NCT00685399|1361058|P6|STARTED|Treatment Period 1||0
558504|NCT00685399|1361059|P5|STARTED|Treatment Period 1||0
558505|NCT00685399|1361060|P4|STARTED|Treatment Period 1||0
558506|NCT00685399|1361061|P3|STARTED|Treatment Period 1||0
558507|NCT00685399|1361062|P2|STARTED|Treatment Period 1||0
558508|NCT00685399|1361063|P1|STARTED|Treatment Period 1||16
558509|NCT00685373|1361096|P1|NOT COMPLETED|Overall Study||15
558510|NCT00685373|1361096|P1|COMPLETED|Overall Study||151
558511|NCT00685373|1361096|P1|STARTED|Overall Study||166
558512|NCT00685334|1361105|P2|NOT COMPLETED|Overall Study||7
558513|NCT00685334|1361106|P1|NOT COMPLETED|Overall Study||10
558514|NCT00685334|1361105|P2|COMPLETED|Overall Study||3
558515|NCT00685334|1361106|P1|COMPLETED|Overall Study||2
558516|NCT00685334|1361105|P2|STARTED|Overall Study||10
558517|NCT00685334|1361106|P1|STARTED|Overall Study||12
558518|NCT00685295|1361116|P2|NOT COMPLETED|Overall Study||0
558519|NCT00685295|1361117|P1|NOT COMPLETED|Overall Study||0
558520|NCT00685295|1361116|P2|COMPLETED|Overall Study||30
558521|NCT00685295|1361117|P1|COMPLETED|Overall Study||30
558522|NCT00685295|1361116|P2|STARTED|Overall Study||30
558523|NCT00685295|1361117|P1|STARTED|Overall Study||30
558524|NCT00685178|1361131|P4|NOT COMPLETED|Overall Study||14
558525|NCT00685178|1361132|P3|NOT COMPLETED|Overall Study||12
558526|NCT00685178|1361133|P2|NOT COMPLETED|Overall Study||19
558527|NCT00685178|1361134|P1|NOT COMPLETED|Overall Study||13
558528|NCT00685178|1361131|P4|COMPLETED|Overall Study||33
558529|NCT00685178|1361132|P3|COMPLETED|Overall Study||27
558530|NCT00685178|1361133|P2|COMPLETED|Overall Study||26
558531|NCT00685178|1361134|P1|COMPLETED|Overall Study||27
558532|NCT00685178|1361131|P4|STARTED|Overall Study||47
558533|NCT00685178|1361132|P3|STARTED|Overall Study||39
558534|NCT00685178|1361133|P2|STARTED|Overall Study||45
558535|NCT00685178|1361134|P1|STARTED|Overall Study||40
558536|NCT00685165|1361148|P2|NOT COMPLETED|Second Intervention||0
558537|NCT00685165|1361149|P1|NOT COMPLETED|Second Intervention||0
558538|NCT00685165|1361148|P2|COMPLETED|Second Intervention||11
558539|NCT00685165|1361149|P1|COMPLETED|Second Intervention||10
558540|NCT00685165|1361148|P2|STARTED|Second Intervention||11
558541|NCT00685165|1361149|P1|STARTED|Second Intervention||10
558542|NCT00685165|1361148|P2|NOT COMPLETED|Washout Period of 14 Days||0
558543|NCT00685165|1361149|P1|NOT COMPLETED|Washout Period of 14 Days||1
558544|NCT00685165|1361148|P2|COMPLETED|Washout Period of 14 Days||11
558545|NCT00685165|1361149|P1|COMPLETED|Washout Period of 14 Days|adverse event- possible upper respiratory infection|10
558546|NCT00685165|1361148|P2|STARTED|Washout Period of 14 Days||11
558547|NCT00685165|1361149|P1|STARTED|Washout Period of 14 Days||11
558548|NCT00685165|1361148|P2|NOT COMPLETED|First Intervention||0
558549|NCT00685165|1361149|P1|NOT COMPLETED|First Intervention||0
558550|NCT00685165|1361148|P2|COMPLETED|First Intervention||11
558551|NCT00685165|1361149|P1|COMPLETED|First Intervention||11
558552|NCT00685165|1361148|P2|STARTED|First Intervention||11
558553|NCT00685165|1361149|P1|STARTED|First Intervention||11
558554|NCT00685139|1361159|P2|NOT COMPLETED|Second Intervention||0
558555|NCT00685139|1361160|P1|NOT COMPLETED|Second Intervention||0
558556|NCT00685139|1361159|P2|COMPLETED|Second Intervention||17
558557|NCT00685139|1361160|P1|COMPLETED|Second Intervention||17
558558|NCT00685139|1361159|P2|STARTED|Second Intervention||17
558559|NCT00685139|1361160|P1|STARTED|Second Intervention||17
558560|NCT00685139|1361159|P2|NOT COMPLETED|Washout Period of 28 Days||0
558561|NCT00685139|1361160|P1|NOT COMPLETED|Washout Period of 28 Days||0
558562|NCT00685139|1361159|P2|COMPLETED|Washout Period of 28 Days||17
558563|NCT00685139|1361160|P1|COMPLETED|Washout Period of 28 Days||17
558564|NCT00685139|1361159|P2|STARTED|Washout Period of 28 Days||17
558565|NCT00685139|1361160|P1|STARTED|Washout Period of 28 Days||17
558566|NCT00685139|1361159|P2|NOT COMPLETED|First Intervention||0
558567|NCT00685139|1361160|P1|NOT COMPLETED|First Intervention||0
558568|NCT00685139|1361159|P2|COMPLETED|First Intervention||17
558569|NCT00685139|1361160|P1|COMPLETED|First Intervention||17
558570|NCT00685139|1361159|P2|STARTED|First Intervention||17
558571|NCT00685139|1361160|P1|STARTED|First Intervention||17
558572|NCT00685035|1361168|P2|NOT COMPLETED|Period 3: 2nd Intervention||0
558573|NCT00685035|1361169|P1|NOT COMPLETED|Period 3: 2nd Intervention||0
558574|NCT00685035|1361168|P2|COMPLETED|Period 3: 2nd Intervention||8
558575|NCT00685035|1361169|P1|COMPLETED|Period 3: 2nd Intervention||8
558576|NCT00685035|1361168|P2|STARTED|Period 3: 2nd Intervention||8
558577|NCT00685035|1361169|P1|STARTED|Period 3: 2nd Intervention||8
558578|NCT00685035|1361168|P2|NOT COMPLETED|Period 2: 2-day Washout||0
558579|NCT00685035|1361169|P1|NOT COMPLETED|Period 2: 2-day Washout||0
558580|NCT00685035|1361168|P2|COMPLETED|Period 2: 2-day Washout||8
558581|NCT00685035|1361169|P1|COMPLETED|Period 2: 2-day Washout||8
558582|NCT00685035|1361168|P2|STARTED|Period 2: 2-day Washout||8
558583|NCT00685035|1361169|P1|STARTED|Period 2: 2-day Washout||8
558584|NCT00685035|1361168|P2|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||0
558585|NCT00685035|1361169|P1|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||1
558586|NCT00685035|1361168|P2|COMPLETED|Period 1: First Intervention: 30 Minutes||8
558587|NCT00685035|1361169|P1|COMPLETED|Period 1: First Intervention: 30 Minutes||8
558588|NCT00685035|1361168|P2|STARTED|Period 1: First Intervention: 30 Minutes||8
558589|NCT00685035|1361169|P1|STARTED|Period 1: First Intervention: 30 Minutes||9
558590|NCT00684996|1361193|P1|NOT COMPLETED|Overall Study||5
558591|NCT00684996|1361193|P1|COMPLETED|Overall Study||0
558592|NCT00684996|1361193|P1|Eligible|Overall Study||5
558593|NCT00684996|1361193|P1|STARTED|Overall Study||5
558594|NCT00684983|1361208|P2|NOT COMPLETED|Overall Study||0
558595|NCT00684983|1361209|P1|NOT COMPLETED|Overall Study||0
558596|NCT00684983|1361208|P2|COMPLETED|Overall Study|One major violation patient in Arm B is included in the primary analysis per protocol.|45
558597|NCT00684983|1361209|P1|COMPLETED|Overall Study||19
558598|NCT00684983|1361208|P2|STARTED|Overall Study||45
558599|NCT00684983|1361209|P1|STARTED|Overall Study||19
558600|NCT00684814|1361225|P2|NOT COMPLETED|Second Intervention||0
558601|NCT00684814|1361226|P1|NOT COMPLETED|Second Intervention||1
558602|NCT00684814|1361225|P2|COMPLETED|Second Intervention||15
558603|NCT00684814|1361226|P1|COMPLETED|Second Intervention||16
558604|NCT00684814|1361225|P2|STARTED|Second Intervention||15
558605|NCT00684814|1361226|P1|STARTED|Second Intervention||17
558606|NCT00684814|1361225|P2|NOT COMPLETED|Washout Period of 7 Days||4
558607|NCT00684814|1361226|P1|NOT COMPLETED|Washout Period of 7 Days||2
558608|NCT00684814|1361225|P2|COMPLETED|Washout Period of 7 Days||15
558609|NCT00684814|1361226|P1|COMPLETED|Washout Period of 7 Days||17
558610|NCT00684814|1361225|P2|STARTED|Washout Period of 7 Days||19
558611|NCT00684814|1361226|P1|STARTED|Washout Period of 7 Days||19
558612|NCT00684814|1361225|P2|NOT COMPLETED|First Intervention||0
558613|NCT00684814|1361226|P1|NOT COMPLETED|First Intervention||0
558614|NCT00684814|1361225|P2|COMPLETED|First Intervention||19
558615|NCT00684814|1361226|P1|COMPLETED|First Intervention||19
558616|NCT00684814|1361225|P2|STARTED|First Intervention||19
558617|NCT00684814|1361226|P1|STARTED|First Intervention||19
558618|NCT00684788|1361238|P2|NOT COMPLETED|Overall Study||0
558619|NCT00684788|1361239|P1|NOT COMPLETED|Overall Study||0
558620|NCT00684788|1361238|P2|COMPLETED|Overall Study||18
558621|NCT00684788|1361239|P1|COMPLETED|Overall Study||17
558622|NCT00684788|1361238|P2|STARTED|Overall Study||18
558623|NCT00684788|1361239|P1|STARTED|Overall Study||17
558624|NCT00684775|1361259|P2|NOT COMPLETED|Overall Study||0
558625|NCT00684775|1361260|P1|NOT COMPLETED|Overall Study||0
558626|NCT00684775|1361259|P2|COMPLETED|Overall Study||19
558627|NCT00684775|1361260|P1|COMPLETED|Overall Study||19
558628|NCT00684775|1361259|P2|STARTED|Overall Study||19
558629|NCT00684775|1361260|P1|STARTED|Overall Study||19
558630|NCT00684762|1361278|P2|NOT COMPLETED|Second Intervention||0
558631|NCT00684762|1361279|P1|NOT COMPLETED|Second Intervention||0
558632|NCT00684762|1361278|P2|COMPLETED|Second Intervention||14
558633|NCT00684762|1361279|P1|COMPLETED|Second Intervention||14
558634|NCT00684762|1361278|P2|STARTED|Second Intervention||14
558635|NCT00684762|1361279|P1|STARTED|Second Intervention||14
558636|NCT00684762|1361278|P2|NOT COMPLETED|Washout Period of 7 Days||2
558637|NCT00684762|1361279|P1|NOT COMPLETED|Washout Period of 7 Days||2
558638|NCT00684762|1361278|P2|COMPLETED|Washout Period of 7 Days||14
558639|NCT00684762|1361279|P1|COMPLETED|Washout Period of 7 Days||14
558640|NCT00684762|1361278|P2|STARTED|Washout Period of 7 Days||16
558641|NCT00684762|1361279|P1|STARTED|Washout Period of 7 Days||16
558642|NCT00684762|1361278|P2|NOT COMPLETED|First Intervention||0
558643|NCT00684762|1361279|P1|NOT COMPLETED|First Intervention||0
558644|NCT00684762|1361278|P2|COMPLETED|First Intervention||16
558645|NCT00684762|1361279|P1|COMPLETED|First Intervention||16
558646|NCT00684762|1361278|P2|STARTED|First Intervention||16
558647|NCT00684762|1361279|P1|STARTED|First Intervention||16
558648|NCT00684749|1361289|P1|NOT COMPLETED|Overall Study||0
558649|NCT00684749|1361289|P1|COMPLETED|Overall Study||142
558650|NCT00684749|1361289|P1|STARTED|Overall Study||142
558651|NCT00684723|1361293|P2|NOT COMPLETED|Second Intervention||0
558652|NCT00684723|1361294|P1|NOT COMPLETED|Second Intervention||0
558653|NCT00684723|1361293|P2|COMPLETED|Second Intervention||27
558654|NCT00684723|1361294|P1|COMPLETED|Second Intervention||27
558655|NCT00684723|1361293|P2|STARTED|Second Intervention||27
558656|NCT00684723|1361294|P1|STARTED|Second Intervention||27
558657|NCT00684723|1361293|P2|NOT COMPLETED|Washout Period of 7 Days||0
558658|NCT00684723|1361294|P1|NOT COMPLETED|Washout Period of 7 Days||0
558659|NCT00684723|1361293|P2|COMPLETED|Washout Period of 7 Days||27
558660|NCT00684723|1361294|P1|COMPLETED|Washout Period of 7 Days||27
558661|NCT00684723|1361293|P2|STARTED|Washout Period of 7 Days||27
558662|NCT00684723|1361294|P1|STARTED|Washout Period of 7 Days||27
558663|NCT00684723|1361293|P2|NOT COMPLETED|First Intervention||0
558664|NCT00684723|1361294|P1|NOT COMPLETED|First Intervention||0
558665|NCT00684723|1361293|P2|COMPLETED|First Intervention||27
558666|NCT00684723|1361294|P1|COMPLETED|First Intervention||27
558667|NCT00684723|1361293|P2|STARTED|First Intervention||27
558668|NCT00684723|1361294|P1|STARTED|First Intervention||27
558669|NCT00684671|1361307|P3|NOT COMPLETED|Overall Study||0
558670|NCT00684671|1361308|P2|NOT COMPLETED|Overall Study||0
558671|NCT00684671|1361309|P1|NOT COMPLETED|Overall Study||3
558672|NCT00684671|1361307|P3|COMPLETED|Overall Study||164
558673|NCT00684671|1361308|P2|COMPLETED|Overall Study||170
558674|NCT00684671|1361309|P1|COMPLETED|Overall Study||169
558675|NCT00684671|1361307|P3|STARTED|Overall Study||164
558676|NCT00684671|1361308|P2|STARTED|Overall Study||170
558677|NCT00684671|1361309|P1|STARTED|Overall Study||172
558678|NCT00684645|1361338|P1|NOT COMPLETED|Overall Study||114
558679|NCT00684645|1361338|P1|COMPLETED|Overall Study||72
558680|NCT00684645|1361338|P1|STARTED|Overall Study||186
558681|NCT00684593|1361358|P2|NOT COMPLETED|Overall Study||2
558682|NCT00684593|1361359|P1|NOT COMPLETED|Overall Study||0
558683|NCT00684593|1361358|P2|COMPLETED|Overall Study||8
558684|NCT00684593|1361359|P1|COMPLETED|Overall Study||21
558685|NCT00684593|1361358|P2|STARTED|Overall Study||10
558686|NCT00684593|1361359|P1|STARTED|Overall Study||21
558687|NCT00684567|1361371|P1|NOT COMPLETED|Monotherapy Period||14
558688|NCT00684567|1361371|P1|COMPLETED|Monotherapy Period||9
558689|NCT00684567|1361371|P1|STARTED|Monotherapy Period|5 subjects completed radiotherapy combined therapy phase but did not proceed to monotherapy phase.|23
558690|NCT00684567|1361371|P1|NOT COMPLETED|Concomitant Radiotherapy Period||2
558691|NCT00684567|1361371|P1|COMPLETED|Concomitant Radiotherapy Period||28
558692|NCT00684567|1361371|P1|STARTED|Concomitant Radiotherapy Period||30
558693|NCT00684554|1361381|P2|NOT COMPLETED|Overall Study||0
558694|NCT00684554|1361382|P1|NOT COMPLETED|Overall Study||0
558695|NCT00684554|1361381|P2|COMPLETED|Overall Study||10
558696|NCT00684554|1361382|P1|COMPLETED|Overall Study||10
558697|NCT00684554|1361381|P2|STARTED|Overall Study||10
558698|NCT00684554|1361382|P1|STARTED|Overall Study||10
558699|NCT00684541|1361392|P2|NOT COMPLETED|Overall Study||3
558700|NCT00684541|1361393|P1|NOT COMPLETED|Overall Study||3
558701|NCT00684541|1361392|P2|COMPLETED|Overall Study||23
558702|NCT00684541|1361393|P1|COMPLETED|Overall Study||20
558703|NCT00684541|1361392|P2|STARTED|Overall Study||26
558704|NCT00684541|1361393|P1|STARTED|Overall Study||23
558705|NCT00684515|1361404|P3|NOT COMPLETED|Overall Study||1
558706|NCT00684515|1361405|P2|NOT COMPLETED|Overall Study||3
558707|NCT00684515|1361406|P1|NOT COMPLETED|Overall Study||4
558708|NCT00684515|1361404|P3|COMPLETED|Overall Study||27
558709|NCT00684515|1361405|P2|COMPLETED|Overall Study||26
558710|NCT00684515|1361406|P1|COMPLETED|Overall Study||29
558711|NCT00684515|1361404|P3|STARTED|Overall Study||28
558712|NCT00684515|1361405|P2|STARTED|Overall Study||29
558713|NCT00684515|1361406|P1|STARTED|Overall Study||33
558714|NCT00684424|1361429|P1|NOT COMPLETED|Overall Study||5
558715|NCT00684424|1361429|P1|COMPLETED|Overall Study||194
558716|NCT00684424|1361429|P1|STARTED|Overall Study||199
558717|NCT00684411|1361444|P1|NOT COMPLETED|Overall Study||12
558718|NCT00684411|1361444|P1|COMPLETED|Overall Study||0
558719|NCT00684411|1361444|P1|Disease Evaluable|Overall Study||11
558720|NCT00684411|1361444|P1|STARTED|Overall Study||12
558721|NCT00684320|1361452|P2|NOT COMPLETED|Overall Study||0
558722|NCT00684320|1361453|P1|NOT COMPLETED|Overall Study||4
558723|NCT00684320|1361452|P2|COMPLETED|Overall Study||22
558724|NCT00684320|1361453|P1|COMPLETED|Overall Study||22
558725|NCT00684320|1361452|P2|STARTED|Overall Study||22
558726|NCT00684320|1361453|P1|STARTED|Overall Study||26
558727|NCT00684307|1361466|P5|NOT COMPLETED|Overall Study||25
558728|NCT00684307|1361467|P4|NOT COMPLETED|Overall Study||32
558729|NCT00684307|1361468|P3|NOT COMPLETED|Overall Study||28
558730|NCT00684307|1361469|P2|NOT COMPLETED|Overall Study||22
558731|NCT00684307|1361470|P1|NOT COMPLETED|Overall Study||24
558732|NCT00684307|1361466|P5|COMPLETED|Overall Study||293
558733|NCT00684307|1361467|P4|COMPLETED|Overall Study||128
558734|NCT00684307|1361468|P3|COMPLETED|Overall Study||128
558735|NCT00684307|1361469|P2|COMPLETED|Overall Study||129
558736|NCT00684307|1361470|P1|COMPLETED|Overall Study||140
558737|NCT00684307|1361466|P5|On Treatment Period Completed|Overall Study||293
558738|NCT00684307|1361467|P4|On Treatment Period Completed|Overall Study||128
558739|NCT00684307|1361468|P3|On Treatment Period Completed|Overall Study||128
558740|NCT00684307|1361469|P2|On Treatment Period Completed|Overall Study||129
558741|NCT00684307|1361470|P1|On Treatment Period Completed|Overall Study|Patients who completed treatment|140
558742|NCT00684307|1361466|P5|On Treatment Period Started|Overall Study||318
558743|NCT00684307|1361467|P4|On Treatment Period Started|Overall Study||160
558744|NCT00684307|1361468|P3|On Treatment Period Started|Overall Study||156
558745|NCT00684307|1361469|P2|On Treatment Period Started|Overall Study||151
558746|NCT00684307|1361470|P1|On Treatment Period Started|Overall Study||164
558747|NCT00684307|1361466|P5|STARTED|Overall Study||318
558748|NCT00684307|1361467|P4|STARTED|Overall Study||160
558749|NCT00684307|1361468|P3|STARTED|Overall Study||156
558750|NCT00684307|1361469|P2|STARTED|Overall Study||151
558751|NCT00684307|1361470|P1|STARTED|Overall Study|Patients who received treatment|164
558752|NCT00684255|1361537|P1|NOT COMPLETED|Overall Study||0
558753|NCT00684255|1361537|P1|COMPLETED|Overall Study||1
558754|NCT00684255|1361537|P1|STARTED|Overall Study||1
558755|NCT00684242|1361542|P1|NOT COMPLETED|Overall Study||0
558756|NCT00684242|1361542|P1|COMPLETED|Overall Study||3
558757|NCT00684242|1361542|P1|STARTED|Overall Study||3
558758|NCT00684203|1361552|P6|NOT COMPLETED|Overall Study||0
558759|NCT00684203|1361553|P5|NOT COMPLETED|Overall Study||0
558760|NCT00684203|1361554|P4|NOT COMPLETED|Overall Study||0
558761|NCT00684203|1361555|P3|NOT COMPLETED|Overall Study||9
558762|NCT00684203|1361556|P2|NOT COMPLETED|Overall Study||8
558763|NCT00684203|1361557|P1|NOT COMPLETED|Overall Study||9
558764|NCT00684203|1361552|P6|COMPLETED|Overall Study||2
558765|NCT00684203|1361553|P5|COMPLETED|Overall Study||17
558766|NCT00684203|1361554|P4|COMPLETED|Overall Study||6
558767|NCT00684203|1361555|P3|COMPLETED|Overall Study||12
558768|NCT00684203|1361556|P2|COMPLETED|Overall Study||23
558769|NCT00684203|1361557|P1|COMPLETED|Overall Study||31
558770|NCT00684203|1361552|P6|STARTED|Overall Study||2
558771|NCT00684203|1361553|P5|STARTED|Overall Study||17
558772|NCT00684203|1361554|P4|STARTED|Overall Study||6
558773|NCT00684203|1361555|P3|STARTED|Overall Study||21
558774|NCT00684203|1361556|P2|STARTED|Overall Study||31
558775|NCT00684203|1361557|P1|STARTED|Overall Study||40
558776|NCT00684177|1361618|P2|NOT COMPLETED|Overall Study||23
558777|NCT00684177|1361619|P1|NOT COMPLETED|Overall Study||21
558778|NCT00684177|1361618|P2|COMPLETED|Overall Study||141
558779|NCT00684177|1361619|P1|COMPLETED|Overall Study||322
558780|NCT00684177|1361618|P2|STARTED|Overall Study||164
558781|NCT00684177|1361619|P1|STARTED|Overall Study||343
558782|NCT00684138|1361637|P2|NOT COMPLETED|Overall Study||8
558783|NCT00684138|1361638|P1|NOT COMPLETED|Overall Study||3
558784|NCT00684138|1361637|P2|COMPLETED|Overall Study||131
558785|NCT00684138|1361638|P1|COMPLETED|Overall Study||138
558786|NCT00684138|1361637|P2|STARTED|Overall Study||139
558787|NCT00684138|1361638|P1|STARTED|Overall Study||141
558788|NCT00684073|1361654|P1|NOT COMPLETED|Treatment (Days 1 Through 5)||1
558789|NCT00684073|1361654|P1|COMPLETED|Treatment (Days 1 Through 5)|number of subjects who had a Day 5 visit (and therefore completed study)|52
558790|NCT00684073|1361654|P1|STARTED|Treatment (Days 1 Through 5)|number of subjects who had a Day 1 visit|53
558791|NCT00684073|1361654|P1|NOT COMPLETED|Selection||7
558792|NCT00684073|1361654|P1|COMPLETED|Selection|number of subjects who had a Day 1 visit|53
558793|NCT00684073|1361654|P1|STARTED|Selection||60
558794|NCT00684060|1361664|P2|NOT COMPLETED|Overall Study||3
558795|NCT00684060|1361665|P1|NOT COMPLETED|Overall Study||3
558796|NCT00684060|1361664|P2|COMPLETED|Overall Study||26
558797|NCT00684060|1361665|P1|COMPLETED|Overall Study||55
558798|NCT00684060|1361664|P2|STARTED|Overall Study||29
558799|NCT00684060|1361665|P1|STARTED|Overall Study||58
558800|NCT00684047|1361688|P3|NOT COMPLETED|Overall Study||5
558801|NCT00684047|1361689|P2|NOT COMPLETED|Overall Study||16
558802|NCT00684047|1361690|P1|NOT COMPLETED|Overall Study||13
558803|NCT00684047|1361688|P3|COMPLETED|Overall Study||52
558804|NCT00684047|1361689|P2|COMPLETED|Overall Study||94
558805|NCT00684047|1361690|P1|COMPLETED|Overall Study||59
558806|NCT00684047|1361688|P3|STARTED|Overall Study||57
558807|NCT00684047|1361689|P2|STARTED|Overall Study||110
558808|NCT00684047|1361690|P1|STARTED|Overall Study||72
558809|NCT00684021|1361704|P4|NOT COMPLETED|Overall Study||2
558810|NCT00684021|1361705|P3|NOT COMPLETED|Overall Study||2
558811|NCT00684021|1361706|P2|NOT COMPLETED|Overall Study||2
558812|NCT00684021|1361707|P1|NOT COMPLETED|Overall Study||2
558813|NCT00684021|1361704|P4|COMPLETED|Overall Study||15
558814|NCT00684021|1361705|P3|COMPLETED|Overall Study||34
558815|NCT00684021|1361706|P2|COMPLETED|Overall Study||22
558816|NCT00684021|1361707|P1|COMPLETED|Overall Study||41
558817|NCT00684021|1361704|P4|STARTED|Overall Study||17
558818|NCT00684021|1361705|P3|STARTED|Overall Study||36
558819|NCT00684021|1361706|P2|STARTED|Overall Study||24
558820|NCT00684021|1361707|P1|STARTED|Overall Study||43
558821|NCT00683930|1361748|P3|NOT COMPLETED|Overall Study||9
558822|NCT00683930|1361749|P2|NOT COMPLETED|Overall Study||3
558823|NCT00683930|1361750|P1|NOT COMPLETED|Overall Study||7
558824|NCT00683930|1361748|P3|COMPLETED|Overall Study||28
558825|NCT00683930|1361749|P2|COMPLETED|Overall Study||18
558826|NCT00683930|1361750|P1|COMPLETED|Overall Study||29
558827|NCT00683930|1361748|P3|STARTED|Overall Study||37
558828|NCT00683930|1361749|P2|STARTED|Overall Study|One subject not included: no study drug dispensed.|21
558829|NCT00683930|1361750|P1|STARTED|Overall Study|One subject not included: no study drug dispensed.|36
558830|NCT00683917|1361768|P1|NOT COMPLETED|Overall Study||10
558831|NCT00683917|1361768|P1|COMPLETED|Overall Study||0
558832|NCT00683917|1361768|P1|STARTED|Overall Study||10
558833|NCT00683904|1361778|P2|NOT COMPLETED|Dose Level 2||2
558834|NCT00683904|1361779|P1|NOT COMPLETED|Dose Level 2||0
558835|NCT00683904|1361778|P2|COMPLETED|Dose Level 2||4
558836|NCT00683904|1361779|P1|COMPLETED|Dose Level 2||0
558837|NCT00683904|1361778|P2|STARTED|Dose Level 2||6
558838|NCT00683904|1361779|P1|STARTED|Dose Level 2||0
558839|NCT00683904|1361778|P2|NOT COMPLETED|Dose Level 1||0
558840|NCT00683904|1361779|P1|NOT COMPLETED|Dose Level 1||3
558841|NCT00683904|1361778|P2|COMPLETED|Dose Level 1||0
558842|NCT00683904|1361779|P1|COMPLETED|Dose Level 1||3
558843|NCT00683904|1361778|P2|STARTED|Dose Level 1||0
558844|NCT00683904|1361779|P1|STARTED|Dose Level 1||6
558845|NCT00683878|1361815|P3|NOT COMPLETED|Overall Study||14
558846|NCT00683878|1361816|P2|NOT COMPLETED|Overall Study||16
558847|NCT00683878|1361817|P1|NOT COMPLETED|Overall Study||23
558848|NCT00683878|1361815|P3|COMPLETED|Overall Study||126
558849|NCT00683878|1361816|P2|COMPLETED|Overall Study||125
558850|NCT00683878|1361817|P1|COMPLETED|Overall Study||116
558851|NCT00683878|1361815|P3|STARTED|Overall Study||140
558852|NCT00683878|1361816|P2|STARTED|Overall Study||141
558853|NCT00683878|1361817|P1|STARTED|Overall Study||139
558854|NCT00683852|1361845|P3|NOT COMPLETED|30-Day Phase 2 Period||9
558855|NCT00683852|1361846|P2|NOT COMPLETED|30-Day Phase 2 Period||5
558856|NCT00683852|1361847|P1|NOT COMPLETED|30-Day Phase 2 Period||6
558857|NCT00683852|1361845|P3|COMPLETED|30-Day Phase 2 Period||75
558858|NCT00683852|1361846|P2|COMPLETED|30-Day Phase 2 Period||78
558859|NCT00683852|1361847|P1|COMPLETED|30-Day Phase 2 Period||48
558860|NCT00683852|1361845|P3|STARTED|30-Day Phase 2 Period||84
558861|NCT00683852|1361846|P2|STARTED|30-Day Phase 2 Period||83
558862|NCT00683852|1361847|P1|STARTED|30-Day Phase 2 Period||54
558863|NCT00683852|1361845|P3|NOT COMPLETED|30-Day Phase 1 Period||1
558864|NCT00683852|1361846|P2|NOT COMPLETED|30-Day Phase 1 Period||1
558865|NCT00683852|1361847|P1|NOT COMPLETED|30-Day Phase 1 Period||2
558866|NCT00683852|1361845|P3|COMPLETED|30-Day Phase 1 Period||84
558867|NCT00683852|1361846|P2|COMPLETED|30-Day Phase 1 Period||83
558868|NCT00683852|1361847|P1|COMPLETED|30-Day Phase 1 Period||54
558869|NCT00683852|1361845|P3|STARTED|30-Day Phase 1 Period||85
558870|NCT00683852|1361846|P2|STARTED|30-Day Phase 1 Period||84
558871|NCT00683852|1361847|P1|STARTED|30-Day Phase 1 Period||56
558872|NCT00683826|1361881|P1|NOT COMPLETED|Overall Study||1
558873|NCT00683826|1361881|P1|COMPLETED|Overall Study||7
558874|NCT00683826|1361881|P1|4g Leucine|Overall Study||7
558875|NCT00683826|1361881|P1|8g Leucine|Overall Study||8
558876|NCT00683826|1361881|P1|0g Leucine|Overall Study||8
558877|NCT00683826|1361881|P1|STARTED|Overall Study||8
558878|NCT00683800|1361891|P2|NOT COMPLETED|Overall Study||366
558879|NCT00683800|1361892|P1|NOT COMPLETED|Overall Study||432
558880|NCT00683800|1361891|P2|COMPLETED|Overall Study||719
558881|NCT00683800|1361892|P1|COMPLETED|Overall Study||669
558882|NCT00683800|1361891|P2|Treated|Overall Study||1052
558883|NCT00683800|1361892|P1|Treated|Overall Study||1066
558884|NCT00683800|1361891|P2|STARTED|Overall Study||1085
558885|NCT00683800|1361892|P1|STARTED|Overall Study||1101
558886|NCT00683787|1361959|P3|NOT COMPLETED|Overall Study||2
558887|NCT00683787|1361960|P2|NOT COMPLETED|Overall Study||3
558888|NCT00683787|1361961|P1|NOT COMPLETED|Overall Study||3
558889|NCT00683787|1361959|P3|COMPLETED|Overall Study||0
558890|NCT00683787|1361960|P2|COMPLETED|Overall Study||0
558891|NCT00683787|1361961|P1|COMPLETED|Overall Study||0
558892|NCT00683787|1361959|P3|STARTED|Overall Study||2
558893|NCT00683787|1361960|P2|STARTED|Overall Study||3
558894|NCT00683787|1361961|P1|STARTED|Overall Study||3
558895|NCT00683774|1361980|P2|NOT COMPLETED|Overall Study||1
558896|NCT00683774|1361981|P1|NOT COMPLETED|Overall Study||3
558897|NCT00683774|1361980|P2|COMPLETED|Overall Study||9
558898|NCT00683774|1361981|P1|COMPLETED|Overall Study||8
558899|NCT00683774|1361980|P2|STARTED|Overall Study||10
558900|NCT00683774|1361981|P1|STARTED|Overall Study||11
558901|NCT00683696|1361991|P2|NOT COMPLETED|Overall Study||405
558902|NCT00683696|1361992|P1|NOT COMPLETED|Overall Study||404
558903|NCT00683696|1361991|P2|COMPLETED|Overall Study||0
558904|NCT00683696|1361992|P1|COMPLETED|Overall Study||0
558905|NCT00683696|1361991|P2|STARTED|Overall Study||405
558906|NCT00683696|1361992|P1|STARTED|Overall Study||404
558907|NCT00683657|1362011|P2|NOT COMPLETED|Overall Study||1
558908|NCT00683657|1362012|P1|NOT COMPLETED|Overall Study||1
558909|NCT00683657|1362011|P2|COMPLETED|Overall Study||46
558910|NCT00683657|1362012|P1|COMPLETED|Overall Study||45
558911|NCT00683657|1362011|P2|Randomized Subjects Data Set|Overall Study|Randomized subjects who took at least 1 dose of double-blind study medication.|47
558912|NCT00683657|1362012|P1|Randomized Subjects Data Set|Overall Study|Randomized subjects who took at least 1 dose of double-blind study medication.|46
558913|NCT00683657|1362011|P2|STARTED|Overall Study||47
558914|NCT00683657|1362012|P1|STARTED|Overall Study||46
558915|NCT00683644|1362028|P2|NOT COMPLETED|Overall Study||14
558916|NCT00683644|1362029|P1|NOT COMPLETED|Overall Study||13
558917|NCT00683644|1362028|P2|COMPLETED|Overall Study||44
558918|NCT00683644|1362029|P1|COMPLETED|Overall Study||45
558919|NCT00683644|1362028|P2|STARTED|Overall Study||58
558920|NCT00683644|1362029|P1|STARTED|Overall Study||58
558921|NCT00683618|1362042|P3|NOT COMPLETED|Extension Treatment Period||0
558922|NCT00683618|1362043|P2|NOT COMPLETED|Extension Treatment Period||0
558923|NCT00683618|1362044|P1|NOT COMPLETED|Extension Treatment Period||3
558924|NCT00683618|1362042|P3|COMPLETED|Extension Treatment Period||0
558925|NCT00683618|1362043|P2|COMPLETED|Extension Treatment Period||23
558926|NCT00683618|1362044|P1|COMPLETED|Extension Treatment Period||33
558927|NCT00683618|1362042|P3|STARTED|Extension Treatment Period||0
558928|NCT00683618|1362043|P2|STARTED|Extension Treatment Period||23
558929|NCT00683618|1362044|P1|STARTED|Extension Treatment Period||36
558930|NCT00683618|1362042|P3|NOT COMPLETED|Randomised Treatment Period||6
558931|NCT00683618|1362043|P2|NOT COMPLETED|Randomised Treatment Period||2
558932|NCT00683618|1362044|P1|NOT COMPLETED|Randomised Treatment Period||6
558933|NCT00683618|1362042|P3|COMPLETED|Randomised Treatment Period||140
558934|NCT00683618|1362043|P2|COMPLETED|Randomised Treatment Period||143
558935|NCT00683618|1362044|P1|COMPLETED|Randomised Treatment Period||139
558936|NCT00683618|1362042|P3|STARTED|Randomised Treatment Period||146
558937|NCT00683618|1362043|P2|STARTED|Randomised Treatment Period||145
558938|NCT00683618|1362044|P1|STARTED|Randomised Treatment Period||145
558939|NCT00683592|1362094|P2|NOT COMPLETED|Overall Study||46
558940|NCT00683592|1362095|P1|NOT COMPLETED|Overall Study||47
558941|NCT00683592|1362094|P2|COMPLETED|Overall Study||195
558942|NCT00683592|1362095|P1|COMPLETED|Overall Study||193
558943|NCT00683592|1362094|P2|Safety Population|Overall Study||233
558944|NCT00683592|1362095|P1|Safety Population|Overall Study||235
558945|NCT00683592|1362094|P2|Intent to Treat Population|Overall Study||232
558946|NCT00683592|1362095|P1|Intent to Treat Population|Overall Study||231
558947|NCT00683592|1362094|P2|STARTED|Overall Study||241
558948|NCT00683592|1362095|P1|STARTED|Overall Study||240
558949|NCT00683475|1362113|P2|NOT COMPLETED|Overall Study||3
558950|NCT00683475|1362114|P1|NOT COMPLETED|Overall Study||4
558951|NCT00683475|1362113|P2|COMPLETED|Overall Study||66
558952|NCT00683475|1362114|P1|COMPLETED|Overall Study||65
558953|NCT00683475|1362113|P2|Received Any Quantity of Study Drug|Overall Study||66
558954|NCT00683475|1362114|P1|Received Any Quantity of Study Drug|Overall Study||66
558955|NCT00683475|1362113|P2|STARTED|Overall Study||69
558956|NCT00683475|1362114|P1|STARTED|Overall Study||69
558957|NCT00683449|1362149|P5|NOT COMPLETED|Overall Study||0
558958|NCT00683449|1362150|P4|NOT COMPLETED|Overall Study||0
558959|NCT00683449|1362151|P3|NOT COMPLETED|Overall Study||0
558960|NCT00683449|1362152|P2|NOT COMPLETED|Overall Study||1
558961|NCT00683449|1362153|P1|NOT COMPLETED|Overall Study||0
558962|NCT00683449|1362149|P5|COMPLETED|Overall Study||2
558963|NCT00683449|1362150|P4|COMPLETED|Overall Study||6
558964|NCT00683449|1362151|P3|COMPLETED|Overall Study||3
558965|NCT00683449|1362152|P2|COMPLETED|Overall Study||12
558966|NCT00683449|1362153|P1|COMPLETED|Overall Study||5
558967|NCT00683449|1362149|P5|STARTED|Overall Study||2
558968|NCT00683449|1362150|P4|STARTED|Overall Study||6
558969|NCT00683449|1362151|P3|STARTED|Overall Study||3
558970|NCT00683449|1362152|P2|STARTED|Overall Study||13
558971|NCT00683449|1362153|P1|STARTED|Overall Study||5
558972|NCT00683410|1362175|P1|NOT COMPLETED|Overall Study||0
558973|NCT00683410|1362175|P1|COMPLETED|Overall Study||3366
558974|NCT00683410|1362175|P1|Vaccinated Dose 4|Overall Study||175
558975|NCT00683410|1362175|P1|Vaccinated Dose 3|Overall Study||817
558976|NCT00683410|1362175|P1|Vaccinated Dose 2|Overall Study||1623
558977|NCT00683410|1362175|P1|Vaccinated Dose 1|Overall Study||3240
558978|NCT00683410|1362175|P1|STARTED|Overall Study||3366
558979|NCT00683384|1362179|P1|NOT COMPLETED|Overall Study||2
558980|NCT00683384|1362179|P1|COMPLETED|Overall Study||91
558981|NCT00683384|1362179|P1|STARTED|Overall Study||93
558982|NCT00683332|1362183|P1|NOT COMPLETED|Overall Study||0
558983|NCT00683332|1362183|P1|COMPLETED|Overall Study||621
558984|NCT00683332|1362183|P1|STARTED|Overall Study||621
558985|NCT00683293|1362189|P2|NOT COMPLETED|Overall Study||3
558986|NCT00683293|1362190|P1|NOT COMPLETED|Overall Study||2
558987|NCT00683293|1362189|P2|COMPLETED|Overall Study||47
558988|NCT00683293|1362190|P1|COMPLETED|Overall Study||48
558989|NCT00683293|1362189|P2|STARTED|Overall Study||50
558990|NCT00683293|1362190|P1|STARTED|Overall Study||50
558991|NCT00683163|1362200|P2|NOT COMPLETED|Overall Study||0
558992|NCT00683163|1362201|P1|NOT COMPLETED|Overall Study||0
558993|NCT00683163|1362200|P2|COMPLETED|Overall Study||22
558994|NCT00683163|1362201|P1|COMPLETED|Overall Study||22
558995|NCT00683163|1362200|P2|STARTED|Overall Study||22
558996|NCT00683163|1362201|P1|STARTED|Overall Study||22
558997|NCT00683085|1362209|P1|NOT COMPLETED|Overall Study||0
558998|NCT00683085|1362209|P1|COMPLETED|Overall Study||2
558999|NCT00683085|1362209|P1|STARTED|Overall Study||2
559000|NCT00683046|1362214|P1|NOT COMPLETED|Overall Study||0
559001|NCT00683046|1362214|P1|COMPLETED|Overall Study||204
559002|NCT00683046|1362214|P1|STARTED|Overall Study||204
559003|NCT00683020|1362221|P2|NOT COMPLETED|Overall Study||55
559004|NCT00683020|1362222|P1|NOT COMPLETED|Overall Study||55
559005|NCT00683020|1362221|P2|COMPLETED|Overall Study||125
559006|NCT00683020|1362222|P1|COMPLETED|Overall Study||127
559007|NCT00683020|1362221|P2|STARTED|Overall Study||180
559008|NCT00683020|1362222|P1|STARTED|Overall Study||182
559009|NCT00682929|1362253|P3|NOT COMPLETED|Overall Study||2
559010|NCT00682929|1362254|P2|NOT COMPLETED|Overall Study||5
559011|NCT00682929|1362255|P1|NOT COMPLETED|Overall Study||6
559012|NCT00682929|1362253|P3|COMPLETED|Overall Study||12
559013|NCT00682929|1362254|P2|COMPLETED|Overall Study||9
559014|NCT00682929|1362255|P1|COMPLETED|Overall Study||7
559015|NCT00682929|1362253|P3|STARTED|Overall Study||14
559016|NCT00682929|1362254|P2|STARTED|Overall Study||14
559017|NCT00682929|1362255|P1|STARTED|Overall Study||13
559018|NCT00682890|1362424|P2|NOT COMPLETED|Overall Study||2
559019|NCT00682890|1362425|P1|NOT COMPLETED|Overall Study||2
559020|NCT00682890|1362424|P2|COMPLETED|Overall Study||9
559021|NCT00682890|1362425|P1|COMPLETED|Overall Study||10
559022|NCT00682890|1362424|P2|STARTED|Overall Study||11
559023|NCT00682890|1362425|P1|STARTED|Overall Study||12
559024|NCT00682851|1362435|P2|NOT COMPLETED|Overall Study||0
559025|NCT00682851|1362436|P1|NOT COMPLETED|Overall Study||0
559026|NCT00682851|1362435|P2|COMPLETED|Overall Study||268
559027|NCT00682851|1362436|P1|COMPLETED|Overall Study||251
559028|NCT00682851|1362435|P2|STARTED|Overall Study||268
559029|NCT00682851|1362436|P1|STARTED|Overall Study||251
559030|NCT00682838|1362452|P4|NOT COMPLETED|Overall Study||0
559031|NCT00682838|1362453|P3|NOT COMPLETED|Overall Study||0
559032|NCT00682838|1362454|P2|NOT COMPLETED|Overall Study||0
559033|NCT00682838|1362455|P1|NOT COMPLETED|Overall Study||0
559034|NCT00682838|1362452|P4|COMPLETED|Overall Study||73
559035|NCT00682838|1362453|P3|COMPLETED|Overall Study||75
559036|NCT00682838|1362454|P2|COMPLETED|Overall Study||67
559037|NCT00682838|1362455|P1|COMPLETED|Overall Study||65
559038|NCT00682838|1362452|P4|STARTED|Overall Study||73
559039|NCT00682838|1362453|P3|STARTED|Overall Study||75
559040|NCT00682838|1362454|P2|STARTED|Overall Study||67
559041|NCT00682838|1362455|P1|STARTED|Overall Study||65
559042|NCT00682786|1362467|P2|NOT COMPLETED|Overall Study||3
559043|NCT00682786|1362468|P1|NOT COMPLETED|Overall Study||2
559044|NCT00682786|1362467|P2|COMPLETED|Overall Study||34
559045|NCT00682786|1362468|P1|COMPLETED|Overall Study||96
559046|NCT00682786|1362467|P2|STARTED|Overall Study||37
559047|NCT00682786|1362468|P1|STARTED|Overall Study||98
559048|NCT00682734|1362505|P3|NOT COMPLETED|48 Hour Follow-up||11
559049|NCT00682734|1362506|P2|NOT COMPLETED|48 Hour Follow-up||6
559050|NCT00682734|1362507|P1|NOT COMPLETED|48 Hour Follow-up||6
559051|NCT00682734|1362505|P3|COMPLETED|48 Hour Follow-up||106
559052|NCT00682734|1362506|P2|COMPLETED|48 Hour Follow-up||111
559053|NCT00682734|1362507|P1|COMPLETED|48 Hour Follow-up||107
559054|NCT00682734|1362505|P3|STARTED|48 Hour Follow-up||117
559055|NCT00682734|1362506|P2|STARTED|48 Hour Follow-up||117
559056|NCT00682734|1362507|P1|STARTED|48 Hour Follow-up||113
559057|NCT00682734|1362505|P3|NOT COMPLETED|Emergency Department Portion||1
559058|NCT00682734|1362506|P2|NOT COMPLETED|Emergency Department Portion||1
559059|NCT00682734|1362507|P1|NOT COMPLETED|Emergency Department Portion||0
559060|NCT00682734|1362505|P3|COMPLETED|Emergency Department Portion||117
559061|NCT00682734|1362506|P2|COMPLETED|Emergency Department Portion||117
559062|NCT00682734|1362507|P1|COMPLETED|Emergency Department Portion||113
559063|NCT00682734|1362505|P3|STARTED|Emergency Department Portion||118
559064|NCT00682734|1362506|P2|STARTED|Emergency Department Portion||118
559065|NCT00682734|1362507|P1|STARTED|Emergency Department Portion||113
559066|NCT00682643|1362517|P2|NOT COMPLETED|Overall Study||169
559067|NCT00682643|1362518|P1|NOT COMPLETED|Overall Study||78
559068|NCT00682643|1362517|P2|COMPLETED|Overall Study||199
559069|NCT00682643|1362518|P1|COMPLETED|Overall Study||104
559070|NCT00682643|1362517|P2|STARTED|Overall Study||368
559071|NCT00682643|1362518|P1|STARTED|Overall Study||182
559072|NCT00682565|1362553|P3|NOT COMPLETED|Overall Study||0
559073|NCT00682565|1362554|P2|NOT COMPLETED|Overall Study||2
559074|NCT00682565|1362555|P1|NOT COMPLETED|Overall Study||1
559075|NCT00682565|1362553|P3|COMPLETED|Overall Study||29
559076|NCT00682565|1362554|P2|COMPLETED|Overall Study||32
559077|NCT00682565|1362555|P1|COMPLETED|Overall Study||30
559078|NCT00682565|1362553|P3|STARTED|Overall Study||29
559079|NCT00682565|1362554|P2|STARTED|Overall Study||34
559080|NCT00682565|1362555|P1|STARTED|Overall Study||31
559081|NCT00682539|1362579|P3|NOT COMPLETED|Ranibizumab vs Triamcinolone||8
559082|NCT00682539|1362580|P2|NOT COMPLETED|Ranibizumab vs Triamcinolone||3
559083|NCT00682539|1362581|P1|NOT COMPLETED|Ranibizumab vs Triamcinolone||0
559084|NCT00682539|1362579|P3|COMPLETED|Ranibizumab vs Triamcinolone||10
559085|NCT00682539|1362580|P2|COMPLETED|Ranibizumab vs Triamcinolone||15
559086|NCT00682539|1362581|P1|COMPLETED|Ranibizumab vs Triamcinolone||0
559087|NCT00682539|1362579|P3|STARTED|Ranibizumab vs Triamcinolone|Both periods recruited independently following the same criteria.|18
559088|NCT00682539|1362580|P2|STARTED|Ranibizumab vs Triamcinolone|None of the patients of the 1st period was included in the second period.|18
559089|NCT00682539|1362581|P1|STARTED|Ranibizumab vs Triamcinolone|Two independent periods.|0
559090|NCT00682539|1362579|P3|NOT COMPLETED|Bevacizumab vs Triamcinolone||0
559091|NCT00682539|1362580|P2|NOT COMPLETED|Bevacizumab vs Triamcinolone||1
559092|NCT00682539|1362581|P1|NOT COMPLETED|Bevacizumab vs Triamcinolone||3
559093|NCT00682539|1362579|P3|COMPLETED|Bevacizumab vs Triamcinolone||0
559094|NCT00682539|1362580|P2|COMPLETED|Bevacizumab vs Triamcinolone||15
559095|NCT00682539|1362581|P1|COMPLETED|Bevacizumab vs Triamcinolone||15
559096|NCT00682539|1362579|P3|STARTED|Bevacizumab vs Triamcinolone||0
559097|NCT00682539|1362580|P2|STARTED|Bevacizumab vs Triamcinolone||16
559098|NCT00682539|1362581|P1|STARTED|Bevacizumab vs Triamcinolone||18
559099|NCT00682461|1362594|P2|NOT COMPLETED|Overall Study||31
559100|NCT00682461|1362595|P1|NOT COMPLETED|Overall Study||25
559101|NCT00682461|1362594|P2|COMPLETED|Overall Study||69
559102|NCT00682461|1362595|P1|COMPLETED|Overall Study||75
559103|NCT00682461|1362594|P2|STARTED|Overall Study||100
559104|NCT00682461|1362595|P1|STARTED|Overall Study||100
559105|NCT00682357|1362612|P3|NOT COMPLETED|Overall Study||0
559106|NCT00682357|1362613|P2|NOT COMPLETED|Overall Study||0
559107|NCT00682357|1362614|P1|NOT COMPLETED|Overall Study||0
559108|NCT00682357|1362612|P3|COMPLETED|Overall Study||5
559109|NCT00682357|1362613|P2|COMPLETED|Overall Study||10
559110|NCT00682357|1362614|P1|COMPLETED|Overall Study||10
559111|NCT00682357|1362612|P3|STARTED|Overall Study||5
559112|NCT00682357|1362613|P2|STARTED|Overall Study||10
559113|NCT00682357|1362614|P1|STARTED|Overall Study||10
559114|NCT00681889|1362631|P1|NOT COMPLETED|Overall Study||0
559115|NCT00681889|1362631|P1|COMPLETED|Overall Study||9
559116|NCT00681889|1362631|P1|STARTED|Overall Study||9
559117|NCT00681863|1362635|P1|NOT COMPLETED|Overall Study||23
559118|NCT00681863|1362635|P1|COMPLETED|Overall Study||22
559119|NCT00681863|1362635|P1|STARTED|Overall Study||45
559120|NCT00681824|1362683|P3|NOT COMPLETED|Overall Study||1
559121|NCT00681824|1362684|P2|NOT COMPLETED|Overall Study||1
559122|NCT00681824|1362685|P1|NOT COMPLETED|Overall Study||1
559123|NCT00681824|1362683|P3|COMPLETED|Overall Study||33
559124|NCT00681824|1362684|P2|COMPLETED|Overall Study||12
559125|NCT00681824|1362685|P1|COMPLETED|Overall Study||27
559126|NCT00681824|1362683|P3|STARTED|Overall Study||34
559127|NCT00681824|1362684|P2|STARTED|Overall Study||13
559128|NCT00681824|1362685|P1|STARTED|Overall Study||28
559129|NCT00681811|1362703|P2|NOT COMPLETED|Overall Study||4
559130|NCT00681811|1362704|P1|NOT COMPLETED|Overall Study||3
559131|NCT00681811|1362703|P2|COMPLETED|Overall Study||1
559132|NCT00681811|1362704|P1|COMPLETED|Overall Study||3
559133|NCT00681811|1362703|P2|STARTED|Overall Study||5
559134|NCT00681811|1362704|P1|STARTED|Overall Study||6
559135|NCT00681668|1362732|P1|NOT COMPLETED|Overall Study||2
559136|NCT00681668|1362732|P1|COMPLETED|Overall Study||3
559137|NCT00681668|1362732|P1|STARTED|Overall Study||5
559138|NCT00681629|1362741|P2|NOT COMPLETED|Overall Study||2
559139|NCT00681629|1362742|P1|NOT COMPLETED|Overall Study||5
559140|NCT00681629|1362741|P2|COMPLETED|Overall Study||0
559141|NCT00681629|1362742|P1|COMPLETED|Overall Study||0
559142|NCT00681629|1362741|P2|STARTED|Overall Study|It was planned to recruit 100 patient|2
559143|NCT00681629|1362742|P1|STARTED|Overall Study|It was planned to recruit 100 patient|5
559144|NCT00681590|1362788|P2|NOT COMPLETED|Overall Study||12
559145|NCT00681590|1362789|P1|NOT COMPLETED|Overall Study||2
559146|NCT00681590|1362788|P2|COMPLETED|Overall Study||59
559147|NCT00681590|1362789|P1|COMPLETED|Overall Study||32
559148|NCT00681590|1362788|P2|STARTED|Overall Study||71
559149|NCT00681590|1362789|P1|STARTED|Overall Study||34
559150|NCT00681564|1362799|P2|NOT COMPLETED|Overall Study||8
559151|NCT00681564|1362800|P1|NOT COMPLETED|Overall Study||6
559152|NCT00681564|1362799|P2|COMPLETED|Overall Study||47
559153|NCT00681564|1362800|P1|COMPLETED|Overall Study||41
559154|NCT00681564|1362799|P2|STARTED|Overall Study||55
559155|NCT00681564|1362800|P1|STARTED|Overall Study||47
559156|NCT00681538|1362830|P2|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||2
559157|NCT00681538|1362831|P1|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||15
559158|NCT00681538|1362830|P2|COMPLETED|Phase B- Responders;12 Week Double-blind||115
559159|NCT00681538|1362831|P1|COMPLETED|Phase B- Responders;12 Week Double-blind||109
559160|NCT00681538|1362830|P2|STARTED|Phase B- Responders;12 Week Double-blind||117
559161|NCT00681538|1362831|P1|STARTED|Phase B- Responders;12 Week Double-blind||124
559162|NCT00681538|1362830|P2|NOT COMPLETED|Phase A- 4 Weeks Single Blind||0
559163|NCT00681538|1362831|P1|NOT COMPLETED|Phase A- 4 Weeks Single Blind||34
559164|NCT00681538|1362830|P2|COMPLETED|Phase A- 4 Weeks Single Blind||0
559165|NCT00681538|1362831|P1|COMPLETED|Phase A- 4 Weeks Single Blind||538
559166|NCT00681538|1362830|P2|STARTED|Phase A- 4 Weeks Single Blind||0
559167|NCT00681538|1362831|P1|STARTED|Phase A- 4 Weeks Single Blind||572
559168|NCT00681473|1362861|P1|NOT COMPLETED|Overall Study||0
559169|NCT00681473|1362861|P1|COMPLETED|Overall Study|All 20 patients completed RT and tolerated treatment well.|20
559170|NCT00681473|1362861|P1|STARTED|Overall Study|20 patients with WHO Grade 2 Glioma were enrolled.|20
559171|NCT00681291|1362869|P2|NOT COMPLETED|Overall Study||27
559172|NCT00681291|1362870|P1|NOT COMPLETED|Overall Study||13
559173|NCT00681291|1362869|P2|COMPLETED|Overall Study||57
559174|NCT00681291|1362870|P1|COMPLETED|Overall Study||75
559175|NCT00681291|1362869|P2|STARTED|Overall Study||84
559176|NCT00681291|1362870|P1|STARTED|Overall Study||88
559177|NCT00681265|1362882|P1|NOT COMPLETED|Overall Study||0
559178|NCT00681265|1362882|P1|COMPLETED|Overall Study||16
559179|NCT00681265|1362882|P1|STARTED|Overall Study||16
559180|NCT00681187|1362892|P2|NOT COMPLETED|Overall Study||2
559181|NCT00681187|1362893|P1|NOT COMPLETED|Overall Study||1
559182|NCT00681187|1362892|P2|COMPLETED|Overall Study||13
559183|NCT00681187|1362893|P1|COMPLETED|Overall Study||10
559184|NCT00681187|1362892|P2|STARTED|Overall Study||15
559185|NCT00681187|1362893|P1|STARTED|Overall Study||11
559186|NCT00681109|1362928|P3|NOT COMPLETED|Overall Study||0
559187|NCT00681109|1362929|P2|NOT COMPLETED|Overall Study||6
559188|NCT00681109|1362930|P1|NOT COMPLETED|Overall Study||2
559189|NCT00681109|1362928|P3|COMPLETED|Overall Study||15
559190|NCT00681109|1362929|P2|COMPLETED|Overall Study||24
559191|NCT00681109|1362930|P1|COMPLETED|Overall Study||28
559192|NCT00681109|1362928|P3|STARTED|Overall Study||15
559193|NCT00681109|1362929|P2|STARTED|Overall Study||30
559194|NCT00681109|1362930|P1|STARTED|Overall Study||30
559195|NCT00681044|1362947|P1|NOT COMPLETED|Overall Study||0
559196|NCT00681044|1362947|P1|COMPLETED|Overall Study||4
559197|NCT00681044|1362947|P1|STARTED|Overall Study||4
559198|NCT00681031|1362955|P1|NOT COMPLETED|Overall Study||0
559199|NCT00681031|1362955|P1|COMPLETED|Overall Study||96
559200|NCT00681031|1362955|P1|STARTED|Overall Study||96
559201|NCT00680953|1362962|P3|NOT COMPLETED|Overall Study||47
559202|NCT00680953|1362963|P2|NOT COMPLETED|Overall Study||95
559203|NCT00680953|1362964|P1|NOT COMPLETED|Overall Study||86
559204|NCT00680953|1362962|P3|COMPLETED|Overall Study||204
559205|NCT00680953|1362963|P2|COMPLETED|Overall Study||416
559206|NCT00680953|1362964|P1|COMPLETED|Overall Study||414
559207|NCT00680953|1362962|P3|STARTED|Overall Study||251
559208|NCT00680953|1362963|P2|STARTED|Overall Study||511
559209|NCT00680953|1362964|P1|STARTED|Overall Study||500
559210|NCT00680914|1362980|P2|NOT COMPLETED|Overall Study||4
559211|NCT00680914|1362981|P1|NOT COMPLETED|Overall Study||10
559212|NCT00680914|1362980|P2|COMPLETED|Overall Study||125
559213|NCT00680914|1362981|P1|COMPLETED|Overall Study||364
559214|NCT00680914|1362980|P2|STARTED|Overall Study||129
559215|NCT00680914|1362981|P1|STARTED|Overall Study||374
559216|NCT00680901|1363015|P2|NOT COMPLETED|Overall Study||76
559217|NCT00680901|1363016|P1|NOT COMPLETED|Overall Study||73
559218|NCT00680901|1363015|P2|COMPLETED|Overall Study||197
559219|NCT00680901|1363016|P1|COMPLETED|Overall Study||199
559220|NCT00680901|1363015|P2|Ongoing: In Follow Up|Overall Study||41
559221|NCT00680901|1363016|P1|Ongoing: In Follow Up|Overall Study||45
559222|NCT00680901|1363015|P2|Ongoing: On Study Treatment|Overall Study||13
559223|NCT00680901|1363016|P1|Ongoing: On Study Treatment|Overall Study||16
559224|NCT00680901|1363015|P2|STARTED|Overall Study||273
559225|NCT00680901|1363016|P1|STARTED|Overall Study||272
559226|NCT00680862|1363048|P1|NOT COMPLETED|Overall Study||0
559227|NCT00680862|1363048|P1|COMPLETED|Overall Study||25
559228|NCT00680862|1363048|P1|STARTED|Overall Study||25
559229|NCT00680836|1363054|P2|NOT COMPLETED|Overall Study||2
559230|NCT00680836|1363055|P1|NOT COMPLETED|Overall Study||8
559231|NCT00680836|1363054|P2|COMPLETED|Overall Study||25
559232|NCT00680836|1363055|P1|COMPLETED|Overall Study||19
559233|NCT00680836|1363054|P2|STARTED|Overall Study||27
559234|NCT00680836|1363055|P1|STARTED|Overall Study||27
559235|NCT00680823|1363074|P3|NOT COMPLETED|Overall Study||0
559236|NCT00680823|1363075|P2|NOT COMPLETED|Overall Study||0
559237|NCT00680823|1363076|P1|NOT COMPLETED|Overall Study||0
559238|NCT00680823|1363074|P3|COMPLETED|Overall Study||50
559239|NCT00680823|1363075|P2|COMPLETED|Overall Study||50
559240|NCT00680823|1363076|P1|COMPLETED|Overall Study||50
559241|NCT00680823|1363074|P3|STARTED|Overall Study||50
559242|NCT00680823|1363075|P2|STARTED|Overall Study||50
559243|NCT00680823|1363076|P1|STARTED|Overall Study||50
559244|NCT00680797|1363094|P4|NOT COMPLETED|Overall Study||0
559245|NCT00680797|1363095|P3|NOT COMPLETED|Overall Study||0
559246|NCT00680797|1363096|P2|NOT COMPLETED|Overall Study||0
559247|NCT00680797|1363097|P1|NOT COMPLETED|Overall Study||0
559248|NCT00680797|1363094|P4|COMPLETED|Overall Study||8
559249|NCT00680797|1363095|P3|COMPLETED|Overall Study||8
559250|NCT00680797|1363096|P2|COMPLETED|Overall Study||8
559251|NCT00680797|1363097|P1|COMPLETED|Overall Study||9
559252|NCT00680797|1363094|P4|STARTED|Overall Study||8
559253|NCT00680797|1363095|P3|STARTED|Overall Study||8
559254|NCT00680797|1363096|P2|STARTED|Overall Study||8
559255|NCT00680797|1363097|P1|STARTED|Overall Study||9
559256|NCT00680771|1363109|P2|NOT COMPLETED|Overall Study||2
559257|NCT00680771|1363110|P1|NOT COMPLETED|Overall Study||6
559258|NCT00680771|1363109|P2|COMPLETED|Overall Study||11
559259|NCT00680771|1363110|P1|COMPLETED|Overall Study||9
559260|NCT00680771|1363109|P2|STARTED|Overall Study||13
559261|NCT00680771|1363110|P1|STARTED|Overall Study||15
559262|NCT00680745|1363120|P4|NOT COMPLETED|Overall Study||13
559263|NCT00680745|1363121|P3|NOT COMPLETED|Overall Study||10
559264|NCT00680745|1363122|P2|NOT COMPLETED|Overall Study||13
559265|NCT00680745|1363123|P1|NOT COMPLETED|Overall Study||14
559266|NCT00680745|1363120|P4|COMPLETED|Overall Study||133
559267|NCT00680745|1363121|P3|COMPLETED|Overall Study||141
559268|NCT00680745|1363122|P2|COMPLETED|Overall Study||132
559269|NCT00680745|1363123|P1|COMPLETED|Overall Study||140
559270|NCT00680745|1363120|P4|STARTED|Overall Study|Safety Analysis Set|146
559271|NCT00680745|1363121|P3|STARTED|Overall Study|Safety Analysis Set|151
559272|NCT00680745|1363122|P2|STARTED|Overall Study|Safety Analysis Set|145
559273|NCT00680745|1363123|P1|STARTED|Overall Study|Safety Analysis Set|154
559274|NCT00680706|1363155|P2|NOT COMPLETED|Overall Study||5
559275|NCT00680706|1363156|P1|NOT COMPLETED|Overall Study||7
559276|NCT00680706|1363155|P2|COMPLETED|Overall Study||55
559277|NCT00680706|1363156|P1|COMPLETED|Overall Study||63
559278|NCT00680706|1363155|P2|STARTED|Overall Study||60
559279|NCT00680706|1363156|P1|STARTED|Overall Study||70
559280|NCT00680628|1363166|P2|NOT COMPLETED|Overall Study||0
559281|NCT00680628|1363167|P1|NOT COMPLETED|Overall Study||0
559282|NCT00680628|1363166|P2|COMPLETED|Overall Study||40
559283|NCT00680628|1363167|P1|COMPLETED|Overall Study||43
559284|NCT00680628|1363166|P2|STARTED|Overall Study||40
559285|NCT00680628|1363167|P1|STARTED|Overall Study||43
559286|NCT00680524|1363177|P1|NOT COMPLETED|Overall Study||3
559287|NCT00680524|1363177|P1|COMPLETED|Overall Study||17
559288|NCT00680524|1363177|P1|STARTED|Overall Study||20
559289|NCT00680459|1363183|P2|NOT COMPLETED|Overall Study||0
559290|NCT00680459|1363184|P1|NOT COMPLETED|Overall Study||0
559291|NCT00680459|1363183|P2|COMPLETED|Overall Study||6
559292|NCT00680459|1363184|P1|COMPLETED|Overall Study||7
559293|NCT00680459|1363183|P2|STARTED|Overall Study||6
559294|NCT00680459|1363184|P1|STARTED|Overall Study||7
559295|NCT00680407|1363197|P3|NOT COMPLETED|Overall Study||3
559296|NCT00680407|1363198|P2|NOT COMPLETED|Overall Study||5
559297|NCT00680407|1363199|P1|NOT COMPLETED|Overall Study||8
559298|NCT00680407|1363197|P3|COMPLETED|Overall Study||22
559299|NCT00680407|1363198|P2|COMPLETED|Overall Study||22
559300|NCT00680407|1363199|P1|COMPLETED|Overall Study||18
559301|NCT00680407|1363197|P3|STARTED|Overall Study||25
559302|NCT00680407|1363198|P2|STARTED|Overall Study||27
559303|NCT00680407|1363199|P1|STARTED|Overall Study||26
559304|NCT00680368|1363213|P1|NOT COMPLETED|Overall Study||15
559305|NCT00680368|1363213|P1|COMPLETED|Overall Study|15 residents excluded because their attending physician was not participating in the study|97
559306|NCT00680368|1363213|P1|STARTED|Overall Study||112
559307|NCT00680316|1363221|P2|NOT COMPLETED|Overall Study||0
559308|NCT00680316|1363222|P1|NOT COMPLETED|Overall Study||0
559309|NCT00680316|1363221|P2|COMPLETED|Overall Study||2
559310|NCT00680316|1363222|P1|COMPLETED|Overall Study||1
559311|NCT00680316|1363221|P2|STARTED|Overall Study||2
559312|NCT00680316|1363222|P1|STARTED|Overall Study||1
559313|NCT00680225|1363234|P1|NOT COMPLETED|Overall Study||2
559314|NCT00680225|1363234|P1|COMPLETED|Overall Study||8
559315|NCT00680225|1363234|P1|STARTED|Overall Study||10
559316|NCT00680186|1363241|P2|NOT COMPLETED|Overall Study||116
559317|NCT00680186|1363242|P1|NOT COMPLETED|Overall Study||125
559318|NCT00680186|1363241|P2|COMPLETED|Overall Study|Completed planned observation time.|1172
559319|NCT00680186|1363242|P1|COMPLETED|Overall Study|Completed planned observation time.|1155
559320|NCT00680186|1363241|P2|STARTED|Overall Study|Started treatment.|1288
559321|NCT00680186|1363242|P1|STARTED|Overall Study|Started treatment.|1280
559322|NCT00680121|1363268|P2|NOT COMPLETED|Overall Study||23
559323|NCT00680121|1363269|P1|NOT COMPLETED|Overall Study||27
559324|NCT00680121|1363268|P2|COMPLETED|Overall Study||37
559325|NCT00680121|1363269|P1|COMPLETED|Overall Study||33
559326|NCT00680121|1363268|P2|STARTED|Overall Study||60
559327|NCT00680121|1363269|P1|STARTED|Overall Study||60
559328|NCT00680056|1363283|P2|NOT COMPLETED|Second Intervention||1
559329|NCT00680056|1363284|P1|NOT COMPLETED|Second Intervention||3
559330|NCT00680056|1363283|P2|COMPLETED|Second Intervention||14
559331|NCT00680056|1363284|P1|COMPLETED|Second Intervention||12
559332|NCT00680056|1363283|P2|STARTED|Second Intervention||15
559333|NCT00680056|1363284|P1|STARTED|Second Intervention||15
559334|NCT00680056|1363283|P2|NOT COMPLETED|Washout Period of One Week||0
559335|NCT00680056|1363284|P1|NOT COMPLETED|Washout Period of One Week||0
559336|NCT00680056|1363283|P2|COMPLETED|Washout Period of One Week||15
559337|NCT00680056|1363284|P1|COMPLETED|Washout Period of One Week||15
559338|NCT00680056|1363283|P2|STARTED|Washout Period of One Week||15
559339|NCT00680056|1363284|P1|STARTED|Washout Period of One Week||15
559340|NCT00680056|1363283|P2|NOT COMPLETED|First Intervention||2
559341|NCT00680056|1363284|P1|NOT COMPLETED|First Intervention||1
559342|NCT00680056|1363283|P2|COMPLETED|First Intervention||15
559343|NCT00680056|1363284|P1|COMPLETED|First Intervention||15
559344|NCT00680056|1363283|P2|STARTED|First Intervention||17
559345|NCT00680056|1363284|P1|STARTED|First Intervention||16
559346|NCT00680043|1363295|P3|NOT COMPLETED|Overall Study||4
559347|NCT00680043|1363296|P2|NOT COMPLETED|Overall Study||1
559348|NCT00680043|1363297|P1|NOT COMPLETED|Overall Study||2
559349|NCT00680043|1363295|P3|COMPLETED|Overall Study||34
559350|NCT00680043|1363296|P2|COMPLETED|Overall Study||36
559351|NCT00680043|1363297|P1|COMPLETED|Overall Study||37
559352|NCT00680043|1363295|P3|STARTED|Overall Study||38
559353|NCT00680043|1363296|P2|STARTED|Overall Study||37
559354|NCT00680043|1363297|P1|STARTED|Overall Study||39
559355|NCT00680017|1363313|P2|NOT COMPLETED|Overall Study||12
559356|NCT00680017|1363314|P1|NOT COMPLETED|Overall Study||17
559357|NCT00680017|1363313|P2|COMPLETED|Overall Study||128
559358|NCT00680017|1363314|P1|COMPLETED|Overall Study||123
559359|NCT00680017|1363313|P2|STARTED|Overall Study||140
559360|NCT00680017|1363314|P1|STARTED|Overall Study||140
559361|NCT00679952|1363324|P2|NOT COMPLETED|Overall Study||0
559362|NCT00679952|1363325|P1|NOT COMPLETED|Overall Study||0
559363|NCT00679952|1363324|P2|COMPLETED|Overall Study||82
559364|NCT00679952|1363325|P1|COMPLETED|Overall Study||86
559365|NCT00679952|1363324|P2|STARTED|Overall Study||82
559366|NCT00679952|1363325|P1|STARTED|Overall Study||86
559367|NCT00679939|1363333|P2|NOT COMPLETED|24-Week Open-Label (OL) Period||4
559368|NCT00679939|1363334|P1|NOT COMPLETED|24-Week Open-Label (OL) Period||7
559369|NCT00679939|1363333|P2|COMPLETED|24-Week Open-Label (OL) Period||80
559370|NCT00679939|1363334|P1|COMPLETED|24-Week Open-Label (OL) Period||69
559371|NCT00679939|1363333|P2|STARTED|24-Week Open-Label (OL) Period|One participant who completed the DB Period did not receive the OL dose of MET.|84
559372|NCT00679939|1363334|P1|STARTED|24-Week Open-Label (OL) Period|One participant who completed the DB Period did not receive the OL dose of MET.|76
559373|NCT00679939|1363333|P2|NOT COMPLETED|52-Week Double-Blind (DB) Period||27
559374|NCT00679939|1363334|P1|NOT COMPLETED|52-Week Double-Blind (DB) Period||37
559375|NCT00679939|1363333|P2|COMPLETED|52-Week Double-Blind (DB) Period||85
559376|NCT00679939|1363334|P1|COMPLETED|52-Week Double-Blind (DB) Period||77
559377|NCT00679939|1363333|P2|STARTED|52-Week Double-Blind (DB) Period||112
559378|NCT00679939|1363334|P1|STARTED|52-Week Double-Blind (DB) Period||114
559379|NCT00679913|1363485|P2|NOT COMPLETED|Overall Study||13
559380|NCT00679913|1363486|P1|NOT COMPLETED|Overall Study||18
559381|NCT00679913|1363485|P2|COMPLETED|Overall Study||86
559382|NCT00679913|1363486|P1|COMPLETED|Overall Study||83
559383|NCT00679913|1363485|P2|STARTED|Overall Study||99
559384|NCT00679913|1363486|P1|STARTED|Overall Study||101
559385|NCT00679783|1363501|P7|NOT COMPLETED|Overall Study||1
559386|NCT00679783|1363502|P6|NOT COMPLETED|Overall Study||0
559387|NCT00679783|1363503|P5|NOT COMPLETED|Overall Study||1
559388|NCT00679783|1363504|P4|NOT COMPLETED|Overall Study||20
559389|NCT00679783|1363505|P3|NOT COMPLETED|Overall Study||1
559390|NCT00679783|1363506|P2|NOT COMPLETED|Overall Study||3
559391|NCT00679783|1363507|P1|NOT COMPLETED|Overall Study||2
559392|NCT00679783|1363501|P7|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|15
559393|NCT00679783|1363502|P6|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|5
559394|NCT00679783|1363503|P5|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|4
559395|NCT00679783|1363504|P4|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|25
559396|NCT00679783|1363505|P3|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|2
559397|NCT00679783|1363506|P2|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|10
559398|NCT00679783|1363507|P1|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|2
559399|NCT00679783|1363501|P7|STARTED|Overall Study|Gave Informed consent and passed screening|16
559400|NCT00679783|1363502|P6|STARTED|Overall Study|Gave Informed consent and passed screening|5
559401|NCT00679783|1363503|P5|STARTED|Overall Study|Gave Informed consent and passed screening|5
559402|NCT00679783|1363504|P4|STARTED|Overall Study|Gave Informed consent and passed screening|45
559403|NCT00679783|1363505|P3|STARTED|Overall Study|Gave Informed consent and passed screening|3
559404|NCT00679783|1363506|P2|STARTED|Overall Study|Gave Informed consent and passed screening|13
559405|NCT00679783|1363507|P1|STARTED|Overall Study|Gave Informed consent and passed screening|4
559406|NCT00679627|1363560|P2|NOT COMPLETED|Overall Study||685
559407|NCT00679627|1363561|P1|NOT COMPLETED|Overall Study||699
559408|NCT00679627|1363560|P2|COMPLETED|Overall Study||339
559409|NCT00679627|1363561|P1|COMPLETED|Overall Study||322
559410|NCT00679627|1363560|P2|STARTED|Overall Study||1024
559411|NCT00679627|1363561|P1|STARTED|Overall Study||1021
559412|NCT00679432|1363587|P4|NOT COMPLETED|Overall Study||32
559413|NCT00679432|1363588|P3|NOT COMPLETED|Overall Study||53
559414|NCT00679432|1363589|P2|NOT COMPLETED|Overall Study||38
559415|NCT00679432|1363590|P1|NOT COMPLETED|Overall Study||37
559416|NCT00679432|1363587|P4|COMPLETED|Overall Study||95
559417|NCT00679432|1363588|P3|COMPLETED|Overall Study||76
559418|NCT00679432|1363589|P2|COMPLETED|Overall Study||89
559419|NCT00679432|1363590|P1|COMPLETED|Overall Study||89
559420|NCT00679432|1363587|P4|STARTED|Overall Study||127
559421|NCT00679432|1363588|P3|STARTED|Overall Study||129
559422|NCT00679432|1363589|P2|STARTED|Overall Study||127
559423|NCT00679432|1363590|P1|STARTED|Overall Study||126
559424|NCT00679380|1363612|P4|NOT COMPLETED|Overall Study||28
559425|NCT00679380|1363613|P3|NOT COMPLETED|Overall Study||35
559426|NCT00679380|1363614|P2|NOT COMPLETED|Overall Study||33
559427|NCT00679380|1363615|P1|NOT COMPLETED|Overall Study||42
559428|NCT00679380|1363612|P4|COMPLETED|Overall Study||61
559429|NCT00679380|1363613|P3|COMPLETED|Overall Study||68
559430|NCT00679380|1363614|P2|COMPLETED|Overall Study||76
559431|NCT00679380|1363615|P1|COMPLETED|Overall Study||67
559432|NCT00679380|1363612|P4|STARTED|Overall Study||89
559433|NCT00679380|1363613|P3|STARTED|Overall Study||103
559434|NCT00679380|1363614|P2|STARTED|Overall Study||109
559435|NCT00679380|1363615|P1|STARTED|Overall Study||109
559436|NCT00679367|1363633|P1|NOT COMPLETED|Overall Study||12
559437|NCT00679367|1363633|P1|COMPLETED|Overall Study||4
559438|NCT00679367|1363633|P1|STARTED|Overall Study||16
559439|NCT00679354|1363639|P1|NOT COMPLETED|Overall Study||30
559440|NCT00679354|1363639|P1|COMPLETED|Overall Study||0
559441|NCT00679354|1363639|P1|STARTED|Overall Study||30
559442|NCT00679341|1363645|P2|NOT COMPLETED|Overall Study||51
559443|NCT00679341|1363646|P1|NOT COMPLETED|Overall Study||53
559444|NCT00679341|1363645|P2|COMPLETED|Overall Study||19
559445|NCT00679341|1363646|P1|COMPLETED|Overall Study||14
559446|NCT00679341|1363645|P2|STARTED|Overall Study||70
559447|NCT00679341|1363646|P1|STARTED|Overall Study||67
559448|NCT00679302|1363666|P2|NOT COMPLETED|Overall Study||4
559449|NCT00679302|1363667|P1|NOT COMPLETED|Overall Study||8
559450|NCT00679302|1363666|P2|COMPLETED|Overall Study||73
559451|NCT00679302|1363667|P1|COMPLETED|Overall Study||76
559452|NCT00679302|1363666|P2|STARTED|Overall Study||77
559453|NCT00679302|1363667|P1|STARTED|Overall Study||84
559454|NCT00679289|1363678|P3|NOT COMPLETED|Overall Study||23
559455|NCT00679289|1363679|P2|NOT COMPLETED|Overall Study||6
559456|NCT00679289|1363680|P1|NOT COMPLETED|Overall Study||5
559457|NCT00679289|1363678|P3|COMPLETED|Overall Study||1
559458|NCT00679289|1363679|P2|COMPLETED|Overall Study||0
559459|NCT00679289|1363680|P1|COMPLETED|Overall Study||1
559460|NCT00679289|1363678|P3|STARTED|Overall Study||24
559461|NCT00679289|1363679|P2|STARTED|Overall Study||6
559462|NCT00679289|1363680|P1|STARTED|Overall Study||6
559463|NCT00679263|1363702|P3|NOT COMPLETED|Visit 2/Dose 1||0
559464|NCT00679263|1363703|P2|NOT COMPLETED|Visit 2/Dose 1||1
559465|NCT00679263|1363704|P1|NOT COMPLETED|Visit 2/Dose 1||2
559466|NCT00679263|1363702|P3|COMPLETED|Visit 2/Dose 1||11
559467|NCT00679263|1363703|P2|COMPLETED|Visit 2/Dose 1||5
559468|NCT00679263|1363704|P1|COMPLETED|Visit 2/Dose 1||9
559469|NCT00679263|1363702|P3|STARTED|Visit 2/Dose 1||11
559470|NCT00679263|1363703|P2|STARTED|Visit 2/Dose 1||6
559471|NCT00679263|1363704|P1|STARTED|Visit 2/Dose 1||11
559472|NCT00679263|1363702|P3|NOT COMPLETED|Visit 3/Dose 2||0
559473|NCT00679263|1363703|P2|NOT COMPLETED|Visit 3/Dose 2||5
559474|NCT00679263|1363704|P1|NOT COMPLETED|Visit 3/Dose 2||1
559475|NCT00679263|1363702|P3|COMPLETED|Visit 3/Dose 2||11
559476|NCT00679263|1363703|P2|COMPLETED|Visit 3/Dose 2||6
559477|NCT00679263|1363704|P1|COMPLETED|Visit 3/Dose 2||9
559478|NCT00679263|1363702|P3|STARTED|Visit 3/Dose 2||11
559479|NCT00679263|1363703|P2|STARTED|Visit 3/Dose 2||11
559480|NCT00679263|1363704|P1|STARTED|Visit 3/Dose 2||10
559481|NCT00679211|1363715|P1|NOT COMPLETED|Overall Study||110
559482|NCT00679211|1363715|P1|COMPLETED|Overall Study||0
559483|NCT00679211|1363715|P1|STARTED|Overall Study||110
559484|NCT00679172|1363732|P5|NOT COMPLETED|Overall Study||0
559485|NCT00679172|1363733|P4|NOT COMPLETED|Overall Study||1
559486|NCT00679172|1363734|P3|NOT COMPLETED|Overall Study||1
559487|NCT00679172|1363735|P2|NOT COMPLETED|Overall Study||1
559488|NCT00679172|1363736|P1|NOT COMPLETED|Overall Study||1
559489|NCT00679172|1363732|P5|COMPLETED|Overall Study||37
559490|NCT00679172|1363733|P4|COMPLETED|Overall Study||38
559491|NCT00679172|1363734|P3|COMPLETED|Overall Study||35
559492|NCT00679172|1363735|P2|COMPLETED|Overall Study||37
559493|NCT00679172|1363736|P1|COMPLETED|Overall Study||36
559494|NCT00679172|1363732|P5|STARTED|Overall Study||37
559495|NCT00679172|1363733|P4|STARTED|Overall Study||39
559496|NCT00679172|1363734|P3|STARTED|Overall Study||36
559497|NCT00679172|1363735|P2|STARTED|Overall Study||38
559498|NCT00679172|1363736|P1|STARTED|Overall Study||37
559499|NCT00679081|1363799|P1|NOT COMPLETED|Overall Study||1
559500|NCT00679081|1363799|P1|COMPLETED|Overall Study||14
559501|NCT00679081|1363799|P1|STARTED|Overall Study|Study design was within-subject control.|15
559502|NCT00679055|1363809|P2|NOT COMPLETED|Overall Study||5
559503|NCT00679055|1363810|P1|NOT COMPLETED|Overall Study||2
559504|NCT00679055|1363809|P2|COMPLETED|Overall Study||1
559505|NCT00679055|1363810|P1|COMPLETED|Overall Study||6
559506|NCT00679055|1363809|P2|STARTED|Overall Study||6
559507|NCT00679055|1363810|P1|STARTED|Overall Study||8
559508|NCT00678899|1363820|P1|NOT COMPLETED|Overall Study||1
559509|NCT00678899|1363820|P1|COMPLETED|Overall Study||49
559510|NCT00678899|1363820|P1|STARTED|Overall Study||50
559511|NCT00678886|1363829|P4|NOT COMPLETED|Overall Study||9
559512|NCT00678886|1363830|P3|NOT COMPLETED|Overall Study||9
559513|NCT00678886|1363831|P2|NOT COMPLETED|Overall Study||0
559514|NCT00678886|1363832|P1|NOT COMPLETED|Overall Study||0
559515|NCT00678886|1363829|P4|COMPLETED|Overall Study||153
559516|NCT00678886|1363830|P3|COMPLETED|Overall Study||72
559517|NCT00678886|1363831|P2|COMPLETED|Overall Study||19
559518|NCT00678886|1363832|P1|COMPLETED|Overall Study||10
559519|NCT00678886|1363829|P4|STARTED|Overall Study||162
559520|NCT00678886|1363830|P3|STARTED|Overall Study||81
559521|NCT00678886|1363831|P2|STARTED|Overall Study||19
559522|NCT00678886|1363832|P1|STARTED|Overall Study||10
559523|NCT00678834|1363879|P3|NOT COMPLETED|Overall Study||9
559524|NCT00678834|1363880|P2|NOT COMPLETED|Overall Study||0
559525|NCT00678834|1363881|P1|NOT COMPLETED|Overall Study||16
559526|NCT00678834|1363879|P3|COMPLETED|Overall Study||16
559527|NCT00678834|1363880|P2|COMPLETED|Overall Study||15
559528|NCT00678834|1363881|P1|COMPLETED|Overall Study||24
559529|NCT00678834|1363879|P3|STARTED|Overall Study||25
559530|NCT00678834|1363880|P2|STARTED|Overall Study||15
559531|NCT00678834|1363881|P1|STARTED|Overall Study||40
559532|NCT00678795|1363901|P2|NOT COMPLETED|Overall Study||6
559533|NCT00678795|1363902|P1|NOT COMPLETED|Overall Study||11
559534|NCT00678795|1363901|P2|COMPLETED|Overall Study||62
559535|NCT00678795|1363902|P1|COMPLETED|Overall Study||56
559536|NCT00678795|1363901|P2|STARTED|Overall Study||68
559537|NCT00678795|1363902|P1|STARTED|Overall Study||67
559538|NCT00678691|1363924|P2|NOT COMPLETED|Overall Study||4
559539|NCT00678691|1363925|P1|NOT COMPLETED|Overall Study||6
559540|NCT00678691|1363924|P2|COMPLETED|Overall Study||24
559541|NCT00678691|1363925|P1|COMPLETED|Overall Study||21
559542|NCT00678691|1363924|P2|STARTED|Overall Study||28
559543|NCT00678691|1363925|P1|STARTED|Overall Study||27
559544|NCT00678652|1363935|P4|NOT COMPLETED|Overall Study||0
559545|NCT00678652|1363936|P3|NOT COMPLETED|Overall Study||1
559546|NCT00678652|1363937|P2|NOT COMPLETED|Overall Study||0
559547|NCT00678652|1363938|P1|NOT COMPLETED|Overall Study||3
559548|NCT00678652|1363935|P4|COMPLETED|Overall Study||9
559549|NCT00678652|1363936|P3|COMPLETED|Overall Study||8
559550|NCT00678652|1363937|P2|COMPLETED|Overall Study||9
559551|NCT00678652|1363938|P1|COMPLETED|Overall Study||6
559552|NCT00678652|1363935|P4|STARTED|Overall Study||9
559553|NCT00678652|1363936|P3|STARTED|Overall Study||9
559554|NCT00678652|1363937|P2|STARTED|Overall Study||9
559555|NCT00678652|1363938|P1|STARTED|Overall Study||9
559556|NCT00678639|1363962|P2|NOT COMPLETED|Overall Study||0
559557|NCT00678639|1363963|P1|NOT COMPLETED|Overall Study||2
559558|NCT00678639|1363962|P2|COMPLETED|Overall Study||57
559559|NCT00678639|1363963|P1|COMPLETED|Overall Study||51
559560|NCT00678639|1363962|P2|Hospital Discharge|Overall Study||57
559561|NCT00678639|1363963|P1|Hospital Discharge|Overall Study||53
559562|NCT00678639|1363962|P2|STARTED|Overall Study||57
559563|NCT00678639|1363963|P1|STARTED|Overall Study||53
559564|NCT00678587|1363978|P2|NOT COMPLETED|Overall Study||18
559565|NCT00678587|1363979|P1|NOT COMPLETED|Overall Study||20
559566|NCT00678587|1363978|P2|COMPLETED|Overall Study||127
559567|NCT00678587|1363979|P1|COMPLETED|Overall Study||127
559568|NCT00678587|1363978|P2|STARTED|Overall Study||145
559569|NCT00678587|1363979|P1|STARTED|Overall Study||147
559570|NCT00678574|1364013|P2|NOT COMPLETED|Overall Study||0
559571|NCT00678574|1364014|P1|NOT COMPLETED|Overall Study||0
559572|NCT00678574|1364013|P2|COMPLETED|Overall Study||27
559573|NCT00678574|1364014|P1|COMPLETED|Overall Study||18
559574|NCT00678574|1364013|P2|STARTED|Overall Study||27
559575|NCT00678574|1364014|P1|STARTED|Overall Study||18
559576|NCT00678535|1364022|P2|NOT COMPLETED|Overall Study||98
559577|NCT00678535|1364023|P1|NOT COMPLETED|Overall Study||93
559578|NCT00678535|1364022|P2|COMPLETED|Overall Study|subjects who died before or at 31 March 2012|351
559579|NCT00678535|1364023|P1|COMPLETED|Overall Study|subjects who died before or at 31 March 2012|362
559580|NCT00678535|1364022|P2|STARTED|Overall Study|ITT population|449
559581|NCT00678535|1364023|P1|STARTED|Overall Study|ITT population|455
559582|NCT00678470|1364039|P1|NOT COMPLETED|Overall Study||3
559583|NCT00678470|1364039|P1|COMPLETED|Overall Study||15
559584|NCT00678470|1364039|P1|STARTED|Overall Study||18
559585|NCT00678418|1364045|P2|NOT COMPLETED|Part B (Open Label)||0
559586|NCT00678418|1364046|P1|NOT COMPLETED|Part B (Open Label)||43
559587|NCT00678418|1364045|P2|COMPLETED|Part B (Open Label)||0
559588|NCT00678418|1364046|P1|COMPLETED|Part B (Open Label)||71
559589|NCT00678418|1364045|P2|STARTED|Part B (Open Label)||0
559590|NCT00678418|1364046|P1|STARTED|Part B (Open Label)|All participants who received placebo in Part A were switched to open-label VIVITROL in Part B.|114
559591|NCT00678418|1364045|P2|NOT COMPLETED|Part A (Double Blind)||77
559592|NCT00678418|1364046|P1|NOT COMPLETED|Part A (Double Blind)||59
559593|NCT00678418|1364045|P2|COMPLETED|Part A (Double Blind)||47
559594|NCT00678418|1364046|P1|COMPLETED|Part A (Double Blind)||67
559595|NCT00678418|1364045|P2|STARTED|Part A (Double Blind)||124
559596|NCT00678418|1364046|P1|STARTED|Part A (Double Blind)||126
559597|NCT00678392|1364062|P2|NOT COMPLETED|Overall Study||362
559598|NCT00678392|1364063|P1|NOT COMPLETED|Overall Study||361
559599|NCT00678392|1364062|P2|COMPLETED|Overall Study||0
559600|NCT00678392|1364063|P1|COMPLETED|Overall Study||0
559601|NCT00678392|1364062|P2|Treated|Overall Study||355
559602|NCT00678392|1364063|P1|Treated|Overall Study||359
559603|NCT00678392|1364062|P2|STARTED|Overall Study||362
559604|NCT00678392|1364063|P1|STARTED|Overall Study||361
559605|NCT00678379|1364098|P3|NOT COMPLETED|Overall Study||4
559606|NCT00678379|1364099|P2|NOT COMPLETED|Overall Study||3
559607|NCT00678379|1364100|P1|NOT COMPLETED|Overall Study||6
559608|NCT00678379|1364098|P3|COMPLETED|Overall Study||36
559609|NCT00678379|1364099|P2|COMPLETED|Overall Study||37
559610|NCT00678379|1364100|P1|COMPLETED|Overall Study||34
559611|NCT00678379|1364098|P3|STARTED|Overall Study||40
559612|NCT00678379|1364099|P2|STARTED|Overall Study||40
559613|NCT00678379|1364100|P1|STARTED|Overall Study||40
559614|NCT00678301|1364128|P2|NOT COMPLETED|Overall Study||2
559615|NCT00678301|1364129|P1|NOT COMPLETED|Overall Study||8
559616|NCT00678301|1364128|P2|COMPLETED|Overall Study||116
559617|NCT00678301|1364129|P1|COMPLETED|Overall Study||231
559618|NCT00678301|1364128|P2|STARTED|Overall Study||118
559619|NCT00678301|1364129|P1|STARTED|Overall Study||239
559620|NCT00678288|1364187|P2|NOT COMPLETED|Overall Study||6
559621|NCT00678288|1364188|P1|NOT COMPLETED|Overall Study||10
559622|NCT00678288|1364187|P2|COMPLETED|Overall Study||0
559623|NCT00678288|1364188|P1|COMPLETED|Overall Study||0
559624|NCT00678288|1364187|P2|STARTED|Overall Study||6
559625|NCT00678288|1364188|P1|STARTED|Overall Study||10
559626|NCT00678249|1364205|P3|NOT COMPLETED|Overall Study||0
559627|NCT00678249|1364206|P2|NOT COMPLETED|Overall Study||0
559628|NCT00678249|1364207|P1|NOT COMPLETED|Overall Study||0
559629|NCT00678249|1364205|P3|COMPLETED|Overall Study||37
559630|NCT00678249|1364206|P2|COMPLETED|Overall Study||93
559631|NCT00678249|1364207|P1|COMPLETED|Overall Study||97
559632|NCT00678249|1364205|P3|STARTED|Overall Study||37
559633|NCT00678249|1364206|P2|STARTED|Overall Study||93
559634|NCT00678249|1364207|P1|STARTED|Overall Study||97
559635|NCT00678210|1364243|P4|NOT COMPLETED|Overall Study||20
559636|NCT00678210|1364244|P3|NOT COMPLETED|Overall Study||6
559637|NCT00678210|1364245|P2|NOT COMPLETED|Overall Study||11
559638|NCT00678210|1364246|P1|NOT COMPLETED|Overall Study||11
559639|NCT00678210|1364243|P4|COMPLETED|Overall Study||30
559640|NCT00678210|1364244|P3|COMPLETED|Overall Study||43
559641|NCT00678210|1364245|P2|COMPLETED|Overall Study||38
559642|NCT00678210|1364246|P1|COMPLETED|Overall Study||38
559643|NCT00678210|1364243|P4|STARTED|Overall Study||50
559644|NCT00678210|1364244|P3|STARTED|Overall Study||49
559645|NCT00678210|1364245|P2|STARTED|Overall Study||49
559646|NCT00678210|1364246|P1|STARTED|Overall Study||49
559647|NCT00678041|1364282|P2|NOT COMPLETED|Overall Study||5
559648|NCT00678041|1364283|P1|NOT COMPLETED|Overall Study||5
559649|NCT00678041|1364282|P2|COMPLETED|Overall Study||0
559650|NCT00678041|1364283|P1|COMPLETED|Overall Study||0
559651|NCT00678041|1364282|P2|STARTED|Overall Study||5
559652|NCT00678041|1364283|P1|STARTED|Overall Study||5
559653|NCT00678015|1364295|P1|NOT COMPLETED|Overall Study||0
559654|NCT00678015|1364295|P1|COMPLETED|Overall Study||12
559655|NCT00678015|1364295|P1|STARTED|Overall Study||12
559656|NCT00677924|1364304|P2|NOT COMPLETED|Overall Study||0
559657|NCT00677924|1364305|P1|NOT COMPLETED|Overall Study||0
559658|NCT00677924|1364304|P2|COMPLETED|Overall Study||6
559659|NCT00677924|1364305|P1|COMPLETED|Overall Study||3
559660|NCT00677924|1364304|P2|STARTED|Overall Study||6
559661|NCT00677924|1364305|P1|STARTED|Overall Study||3
559662|NCT00677898|1364315|P2|NOT COMPLETED|Overall Study||18
559663|NCT00677898|1364316|P1|NOT COMPLETED|Overall Study||20
559664|NCT00677898|1364315|P2|COMPLETED|Overall Study||102
559665|NCT00677898|1364316|P1|COMPLETED|Overall Study||99
559666|NCT00677898|1364315|P2|STARTED|Overall Study||120
559667|NCT00677898|1364316|P1|STARTED|Overall Study||119
559668|NCT00677833|1364336|P4|NOT COMPLETED|Overall Study||3
559669|NCT00677833|1364337|P3|NOT COMPLETED|Overall Study||2
559670|NCT00677833|1364338|P2|NOT COMPLETED|Overall Study||0
559671|NCT00677833|1364339|P1|NOT COMPLETED|Overall Study||4
559672|NCT00677833|1364336|P4|COMPLETED|Overall Study||128
559673|NCT00677833|1364337|P3|COMPLETED|Overall Study||122
559674|NCT00677833|1364338|P2|COMPLETED|Overall Study||51
559675|NCT00677833|1364339|P1|COMPLETED|Overall Study||51
559676|NCT00677833|1364336|P4|STARTED|Overall Study||131
559677|NCT00677833|1364337|P3|STARTED|Overall Study||124
559678|NCT00677833|1364338|P2|STARTED|Overall Study||51
559679|NCT00677833|1364339|P1|STARTED|Overall Study||55
559680|NCT00677820|1364389|P2|NOT COMPLETED|Overall Study||0
559681|NCT00677820|1364390|P1|NOT COMPLETED|Overall Study||1
559682|NCT00677820|1364389|P2|COMPLETED|Overall Study||60
559683|NCT00677820|1364390|P1|COMPLETED|Overall Study||239
559684|NCT00677820|1364389|P2|STARTED|Overall Study||60
559685|NCT00677820|1364390|P1|STARTED|Overall Study||240
559686|NCT00677807|1364411|P3|NOT COMPLETED|Overall Study||20
559687|NCT00677807|1364412|P2|NOT COMPLETED|Overall Study||11
559688|NCT00677807|1364413|P1|NOT COMPLETED|Overall Study||18
559689|NCT00677807|1364411|P3|COMPLETED|Overall Study||105
559690|NCT00677807|1364412|P2|COMPLETED|Overall Study||135
559691|NCT00677807|1364413|P1|COMPLETED|Overall Study||126
559692|NCT00677807|1364411|P3|Safety/ITT: Received Study Drug|Overall Study|One patient did not take study medication.|124
559693|NCT00677807|1364412|P2|Safety/ITT: Received Study Drug|Overall Study||146
559694|NCT00677807|1364413|P1|Safety/ITT: Received Study Drug|Overall Study||144
559695|NCT00677807|1364411|P3|STARTED|Overall Study||125
559696|NCT00677807|1364412|P2|STARTED|Overall Study||146
559697|NCT00677807|1364413|P1|STARTED|Overall Study||144
559698|NCT00677690|1364444|P2|NOT COMPLETED|Overall Study||0
559699|NCT00677690|1364445|P1|NOT COMPLETED|Overall Study||0
559700|NCT00677690|1364444|P2|COMPLETED|Overall Study||41
559701|NCT00677690|1364445|P1|COMPLETED|Overall Study||42
559702|NCT00677690|1364444|P2|STARTED|Overall Study||41
559703|NCT00677690|1364445|P1|STARTED|Overall Study||42
559704|NCT00677534|1364459|P1|NOT COMPLETED|After Paricalcitol Restart (Weeks 13-14)||0
559705|NCT00677534|1364459|P1|COMPLETED|After Paricalcitol Restart (Weeks 13-14)||7
559706|NCT00677534|1364459|P1|STARTED|After Paricalcitol Restart (Weeks 13-14)||7
559707|NCT00677534|1364459|P1|NOT COMPLETED|Cholecalciferol (Weeks 5-12)||0
559708|NCT00677534|1364459|P1|COMPLETED|Cholecalciferol (Weeks 5-12)||7
559709|NCT00677534|1364459|P1|STARTED|Cholecalciferol (Weeks 5-12)||7
559710|NCT00677534|1364459|P1|NOT COMPLETED|Washout (Weeks 1-4)||3
559711|NCT00677534|1364459|P1|COMPLETED|Washout (Weeks 1-4)||7
559712|NCT00677534|1364459|P1|STARTED|Washout (Weeks 1-4)||10
559713|NCT00677365|1364467|P4|NOT COMPLETED|Overall Study||3
559714|NCT00677365|1364468|P3|NOT COMPLETED|Overall Study||2
559715|NCT00677365|1364469|P2|NOT COMPLETED|Overall Study||1
559716|NCT00677365|1364470|P1|NOT COMPLETED|Overall Study||2
559717|NCT00677365|1364467|P4|COMPLETED|Overall Study||36
559718|NCT00677365|1364468|P3|COMPLETED|Overall Study||35
559719|NCT00677365|1364469|P2|COMPLETED|Overall Study||37
559720|NCT00677365|1364470|P1|COMPLETED|Overall Study||35
559721|NCT00677365|1364467|P4|STARTED|Overall Study||39
559722|NCT00677365|1364468|P3|STARTED|Overall Study||37
559723|NCT00677365|1364469|P2|STARTED|Overall Study||38
559724|NCT00677365|1364470|P1|STARTED|Overall Study||37
559725|NCT00677352|1364502|P2|NOT COMPLETED|Tapering Phase||10
559726|NCT00677352|1364503|P1|NOT COMPLETED|Tapering Phase||6
559727|NCT00677352|1364502|P2|COMPLETED|Tapering Phase||112
559728|NCT00677352|1364503|P1|COMPLETED|Tapering Phase||126
559729|NCT00677352|1364502|P2|STARTED|Tapering Phase||122
559730|NCT00677352|1364503|P1|STARTED|Tapering Phase||132
559731|NCT00677352|1364502|P2|NOT COMPLETED|Treatment Phase||42
559732|NCT00677352|1364503|P1|NOT COMPLETED|Treatment Phase||25
559733|NCT00677352|1364502|P2|COMPLETED|Treatment Phase||122
559734|NCT00677352|1364503|P1|COMPLETED|Treatment Phase||132
559735|NCT00677352|1364502|P2|STARTED|Treatment Phase|2 subjects were not teated, therefore 162 subjects were treated with paroxetine.|164
559736|NCT00677352|1364503|P1|STARTED|Treatment Phase|All 157 subjects were treated with Sertraline.|157
559737|NCT00677235|1364523|P2|NOT COMPLETED|Overall Study||38
559738|NCT00677235|1364524|P1|NOT COMPLETED|Overall Study||41
559739|NCT00677235|1364523|P2|COMPLETED|Overall Study||94
559740|NCT00677235|1364524|P1|COMPLETED|Overall Study||97
559741|NCT00677235|1364523|P2|STARTED|Overall Study||132
559742|NCT00677235|1364524|P1|STARTED|Overall Study||138
559743|NCT00677092|1364564|P1|NOT COMPLETED|Overall Study||6
559744|NCT00677092|1364564|P1|COMPLETED|Overall Study||6
559745|NCT00677092|1364564|P1|Received Study Treatment|Overall Study||11
559746|NCT00677092|1364564|P1|STARTED|Overall Study||12
559747|NCT00677040|1364573|P1|NOT COMPLETED|Overall Study||0
559748|NCT00677040|1364573|P1|COMPLETED|Overall Study||20
559749|NCT00677040|1364573|P1|STARTED|Overall Study||20
559750|NCT00677014|1364581|P3|NOT COMPLETED|Overall Study||49
559751|NCT00677014|1364582|P2|NOT COMPLETED|Overall Study||41
559752|NCT00677014|1364583|P1|NOT COMPLETED|Overall Study||44
559753|NCT00677014|1364581|P3|COMPLETED|Overall Study||283
559754|NCT00677014|1364582|P2|COMPLETED|Overall Study||282
559755|NCT00677014|1364583|P1|COMPLETED|Overall Study||281
559756|NCT00677014|1364581|P3|STARTED|Overall Study||332
559757|NCT00677014|1364582|P2|STARTED|Overall Study||323
559758|NCT00677014|1364583|P1|STARTED|Overall Study||325
559759|NCT00676897|1364593|P2|NOT COMPLETED|Overall Study||0
559760|NCT00676897|1364594|P1|NOT COMPLETED|Overall Study||0
559761|NCT00676897|1364593|P2|COMPLETED|Overall Study||10
559762|NCT00676897|1364594|P1|COMPLETED|Overall Study||8
559763|NCT00676897|1364593|P2|STARTED|Overall Study||10
559764|NCT00676897|1364594|P1|STARTED|Overall Study||8
559765|NCT00676806|1364604|P2|NOT COMPLETED|Overall Study||0
559766|NCT00676806|1364605|P1|NOT COMPLETED|Overall Study||0
559767|NCT00676806|1364604|P2|COMPLETED|Overall Study||3
559768|NCT00676806|1364605|P1|COMPLETED|Overall Study||3
559769|NCT00676806|1364604|P2|STARTED|Overall Study||3
559770|NCT00676806|1364605|P1|STARTED|Overall Study||3
559771|NCT00676793|1364621|P1|NOT COMPLETED|Overall Study||13
559772|NCT00676793|1364621|P1|COMPLETED|Overall Study||19
559773|NCT00676793|1364621|P1|STARTED|Overall Study||32
559774|NCT00676780|1364626|P1|NOT COMPLETED|Overall Study||7
559775|NCT00676780|1364626|P1|COMPLETED|Overall Study||26
559776|NCT00676780|1364626|P1|STARTED|Overall Study||33
559777|NCT00676715|1364636|P4|NOT COMPLETED|Overall Study||40
559778|NCT00676715|1364637|P3|NOT COMPLETED|Overall Study||41
559779|NCT00676715|1364638|P2|NOT COMPLETED|Overall Study||47
559780|NCT00676715|1364639|P1|NOT COMPLETED|Overall Study||40
559781|NCT00676715|1364636|P4|COMPLETED|Overall Study||14
559782|NCT00676715|1364637|P3|COMPLETED|Overall Study||14
559783|NCT00676715|1364638|P2|COMPLETED|Overall Study||8
559784|NCT00676715|1364639|P1|COMPLETED|Overall Study||14
559785|NCT00676715|1364636|P4|STARTED|Overall Study||54
559786|NCT00676715|1364637|P3|STARTED|Overall Study||55
559787|NCT00676715|1364638|P2|STARTED|Overall Study||55
559788|NCT00676715|1364639|P1|STARTED|Overall Study||54
559789|NCT00676689|1364669|P1|NOT COMPLETED|Overall Study||61
559790|NCT00676689|1364669|P1|COMPLETED|Overall Study||20
559791|NCT00676689|1364669|P1|1 Year Follow-up|Overall Study||64
559792|NCT00676689|1364669|P1|30 Day Follow-up|Overall Study||78
559793|NCT00676689|1364669|P1|Procedure|Overall Study|Two enrolled patients did not meet eligibility criteria and did not undergo the study procedure.|79
559794|NCT00676689|1364669|P1|STARTED|Overall Study||81
559795|NCT00676676|1364675|P1|NOT COMPLETED|Overall Study||0
559796|NCT00676676|1364675|P1|COMPLETED|Overall Study||9
559797|NCT00676676|1364675|P1|STARTED|Overall Study||9
559798|NCT00676650|1364681|P2|NOT COMPLETED|Overall Study||289
559799|NCT00676650|1364682|P1|NOT COMPLETED|Overall Study||584
559800|NCT00676650|1364681|P2|COMPLETED|Overall Study||0
559801|NCT00676650|1364682|P1|COMPLETED|Overall Study||0
559802|NCT00676650|1364681|P2|Treated|Overall Study||285
559803|NCT00676650|1364682|P1|Treated|Overall Study||581
559804|NCT00676650|1364681|P2|STARTED|Overall Study||289
559805|NCT00676650|1364682|P1|STARTED|Overall Study||584
559806|NCT00676585|1364702|P2|NOT COMPLETED|Overall Study||0
559807|NCT00676585|1364703|P1|NOT COMPLETED|Overall Study||0
559808|NCT00676585|1364702|P2|COMPLETED|Overall Study||25
559809|NCT00676585|1364703|P1|COMPLETED|Overall Study||25
559810|NCT00676585|1364702|P2|STARTED|Overall Study||25
559811|NCT00676585|1364703|P1|STARTED|Overall Study||25
559812|NCT00676520|1364713|P1|NOT COMPLETED|Overall Study||731
559813|NCT00676520|1364713|P1|COMPLETED|Overall Study||7309
559814|NCT00676520|1364713|P1|STARTED|Overall Study||8040
559815|NCT00676494|1364770|P1|NOT COMPLETED|Overall Study||14
559816|NCT00676494|1364770|P1|COMPLETED|Overall Study||158
559817|NCT00676494|1364770|P1|STARTED|Overall Study||172
559818|NCT00676455|1364776|P1|NOT COMPLETED|Overall Study||0
559819|NCT00676455|1364776|P1|COMPLETED|Overall Study||14
559820|NCT00676455|1364776|P1|STARTED|Overall Study||14
559821|NCT00676403|1364787|P6|NOT COMPLETED|Overall Study||5
559822|NCT00676403|1364788|P5|NOT COMPLETED|Overall Study||1
559823|NCT00676403|1364789|P4|NOT COMPLETED|Overall Study||5
559824|NCT00676403|1364790|P3|NOT COMPLETED|Overall Study||1
559825|NCT00676403|1364791|P2|NOT COMPLETED|Overall Study||2
559826|NCT00676403|1364792|P1|NOT COMPLETED|Overall Study||2
559827|NCT00676403|1364787|P6|COMPLETED|Overall Study||18
559828|NCT00676403|1364788|P5|COMPLETED|Overall Study||23
559829|NCT00676403|1364789|P4|COMPLETED|Overall Study||17
559830|NCT00676403|1364790|P3|COMPLETED|Overall Study||22
559831|NCT00676403|1364791|P2|COMPLETED|Overall Study||20
559832|NCT00676403|1364792|P1|COMPLETED|Overall Study||21
559833|NCT00676403|1364787|P6|STARTED|Overall Study||23
559834|NCT00676403|1364788|P5|STARTED|Overall Study||24
559835|NCT00676403|1364789|P4|STARTED|Overall Study||22
559836|NCT00676403|1364790|P3|STARTED|Overall Study||23
559837|NCT00676403|1364791|P2|STARTED|Overall Study||22
559838|NCT00676403|1364792|P1|STARTED|Overall Study||23
559839|NCT00676364|1364922|P2|NOT COMPLETED|Overall Study||0
559840|NCT00676364|1364923|P1|NOT COMPLETED|Overall Study||0
559841|NCT00676364|1364922|P2|COMPLETED|Overall Study||57
559842|NCT00676364|1364923|P1|COMPLETED|Overall Study||57
559843|NCT00676364|1364922|P2|STARTED|Overall Study||57
559844|NCT00676364|1364923|P1|STARTED|Overall Study||57
559845|NCT00676338|1364935|P4|NOT COMPLETED|Overall Study||23
559846|NCT00676338|1364936|P3|NOT COMPLETED|Overall Study||30
559847|NCT00676338|1364937|P2|NOT COMPLETED|Overall Study||33
559848|NCT00676338|1364938|P1|NOT COMPLETED|Overall Study||38
559849|NCT00676338|1364935|P4|COMPLETED|Overall Study||140
559850|NCT00676338|1364936|P3|COMPLETED|Overall Study||133
559851|NCT00676338|1364937|P2|COMPLETED|Overall Study||213
559852|NCT00676338|1364938|P1|COMPLETED|Overall Study||210
559853|NCT00676338|1364935|P4|STARTED|Overall Study||163
559854|NCT00676338|1364936|P3|STARTED|Overall Study||163
559855|NCT00676338|1364937|P2|STARTED|Overall Study||246
559856|NCT00676338|1364938|P1|STARTED|Overall Study||248
559857|NCT00676208|1364990|P2|NOT COMPLETED|Overall Study||6
559858|NCT00676208|1364991|P1|NOT COMPLETED|Overall Study||2
559859|NCT00676208|1364990|P2|COMPLETED|Overall Study||13
559860|NCT00676208|1364991|P1|COMPLETED|Overall Study||12
559861|NCT00676208|1364990|P2|STARTED|Overall Study||19
559862|NCT00676208|1364991|P1|STARTED|Overall Study||14
559863|NCT00676195|1364999|P1|NOT COMPLETED|Overall Study||3
559864|NCT00676195|1364999|P1|COMPLETED|Overall Study||21
559865|NCT00676195|1364999|P1|STARTED|Overall Study||24
559866|NCT00676182|1365009|P1|NOT COMPLETED|Overall Study||0
559867|NCT00676182|1365009|P1|COMPLETED|Overall Study||75
559868|NCT00676182|1365009|P1|STARTED|Overall Study||75
559869|NCT00676143|1365024|P2|NOT COMPLETED|Overall Study||260
559870|NCT00676143|1365025|P1|NOT COMPLETED|Overall Study||156
559871|NCT00676143|1365024|P2|COMPLETED|Overall Study||398
559872|NCT00676143|1365025|P1|COMPLETED|Overall Study||285
559873|NCT00676143|1365024|P2|Treated|Overall Study||654
559874|NCT00676143|1365025|P1|Treated|Overall Study||439
559875|NCT00676143|1365024|P2|STARTED|Overall Study||658
559876|NCT00676143|1365025|P1|STARTED|Overall Study||441
559877|NCT00676130|1365065|P2|NOT COMPLETED|Overall Study||4
559878|NCT00676130|1365066|P1|NOT COMPLETED|Overall Study||3
559879|NCT00676130|1365065|P2|COMPLETED|Overall Study||73
559880|NCT00676130|1365066|P1|COMPLETED|Overall Study||73
559881|NCT00676130|1365065|P2|STARTED|Overall Study||77
559882|NCT00676130|1365066|P1|STARTED|Overall Study||76
559883|NCT00676091|1365076|P2|NOT COMPLETED|Toddler Dose||0
559884|NCT00676091|1365077|P1|NOT COMPLETED|Toddler Dose||3
559885|NCT00676091|1365076|P2|COMPLETED|Toddler Dose||156
559886|NCT00676091|1365077|P1|COMPLETED|Toddler Dose||153
559887|NCT00676091|1365076|P2|STARTED|Toddler Dose||156
559888|NCT00676091|1365077|P1|STARTED|Toddler Dose||156
559889|NCT00676091|1365076|P2|NOT COMPLETED|After Infant Series||3
559890|NCT00676091|1365077|P1|NOT COMPLETED|After Infant Series||1
559891|NCT00676091|1365076|P2|COMPLETED|After Infant Series||156
559892|NCT00676091|1365077|P1|COMPLETED|After Infant Series||156
559893|NCT00676091|1365076|P2|STARTED|After Infant Series||159
559894|NCT00676091|1365077|P1|STARTED|After Infant Series||157
559895|NCT00676091|1365076|P2|NOT COMPLETED|Infant Series||18
559896|NCT00676091|1365077|P1|NOT COMPLETED|Infant Series||20
559897|NCT00676091|1365076|P2|COMPLETED|Infant Series||159
559898|NCT00676091|1365077|P1|COMPLETED|Infant Series||157
559899|NCT00676091|1365076|P2|Vaccinated Dose 3|Infant Series||161
559900|NCT00676091|1365077|P1|Vaccinated Dose 3|Infant Series||158
559901|NCT00676091|1365076|P2|Vaccinated Dose 2|Infant Series||162
559902|NCT00676091|1365077|P1|Vaccinated Dose 2|Infant Series||159
559903|NCT00676091|1365076|P2|Vaccinated Dose 1|Infant Series||162
559904|NCT00676091|1365077|P1|Vaccinated Dose 1|Infant Series||163
559905|NCT00676091|1365076|P2|STARTED|Infant Series||177
559906|NCT00676091|1365077|P1|STARTED|Infant Series||177
559907|NCT00676065|1365112|P3|NOT COMPLETED|Overall Study||0
559908|NCT00676065|1365113|P2|NOT COMPLETED|Overall Study||0
559909|NCT00676065|1365114|P1|NOT COMPLETED|Overall Study||0
559910|NCT00676065|1365112|P3|COMPLETED|Overall Study||26341
559911|NCT00676065|1365113|P2|COMPLETED|Overall Study||15428
559912|NCT00676065|1365114|P1|COMPLETED|Overall Study||16534
559913|NCT00676065|1365112|P3|STARTED|Overall Study||26341
559914|NCT00676065|1365113|P2|STARTED|Overall Study||15428
559915|NCT00676065|1365114|P1|STARTED|Overall Study||16534
559916|NCT00676052|1365134|P6|NOT COMPLETED|Overall Study||6
559917|NCT00676052|1365135|P5|NOT COMPLETED|Overall Study||6
559918|NCT00676052|1365136|P4|NOT COMPLETED|Overall Study||5
559919|NCT00676052|1365137|P3|NOT COMPLETED|Overall Study||6
559920|NCT00676052|1365138|P2|NOT COMPLETED|Overall Study||7
559921|NCT00676052|1365139|P1|NOT COMPLETED|Overall Study||9
559922|NCT00676052|1365134|P6|COMPLETED|Overall Study||91
559923|NCT00676052|1365135|P5|COMPLETED|Overall Study||89
559924|NCT00676052|1365136|P4|COMPLETED|Overall Study||92
559925|NCT00676052|1365137|P3|COMPLETED|Overall Study||90
559926|NCT00676052|1365138|P2|COMPLETED|Overall Study||88
559927|NCT00676052|1365139|P1|COMPLETED|Overall Study||87
559928|NCT00676052|1365134|P6|STARTED|Overall Study||97
559929|NCT00676052|1365135|P5|STARTED|Overall Study||95
559930|NCT00676052|1365136|P4|STARTED|Overall Study||97
559931|NCT00676052|1365137|P3|STARTED|Overall Study||96
559932|NCT00676052|1365138|P2|STARTED|Overall Study||95
559933|NCT00676052|1365139|P1|STARTED|Overall Study||96
559934|NCT00676026|1365171|P1|NOT COMPLETED|Overall Study||0
559935|NCT00676026|1365171|P1|COMPLETED|Overall Study||8
559936|NCT00676026|1365171|P1|STARTED|Overall Study||8
559937|NCT00675987|1365177|P2|NOT COMPLETED|Overall Study||0
559938|NCT00675987|1365178|P1|NOT COMPLETED|Overall Study||0
559939|NCT00675987|1365177|P2|COMPLETED|Overall Study||27
559940|NCT00675987|1365178|P1|COMPLETED|Overall Study||26
559941|NCT00675987|1365177|P2|STARTED|Overall Study||27
559942|NCT00675987|1365178|P1|STARTED|Overall Study||26
559943|NCT00675948|1365188|P2|NOT COMPLETED|Overall Study||3
559944|NCT00675948|1365189|P1|NOT COMPLETED|Overall Study||39
559945|NCT00675948|1365188|P2|COMPLETED|Overall Study||1
559946|NCT00675948|1365189|P1|COMPLETED|Overall Study||0
559947|NCT00675948|1365188|P2|STARTED|Overall Study||4
559948|NCT00675948|1365189|P1|STARTED|Overall Study||39
559949|NCT00675922|1365199|P1|NOT COMPLETED|Overall Study||0
559950|NCT00675922|1365199|P1|COMPLETED|Overall Study||98
559951|NCT00675922|1365199|P1|STARTED|Overall Study||98
559952|NCT00675909|1365207|P3|NOT COMPLETED|Overall Study||0
559953|NCT00675909|1365208|P2|NOT COMPLETED|Overall Study||0
559954|NCT00675909|1365209|P1|NOT COMPLETED|Overall Study||0
559955|NCT00675909|1365207|P3|COMPLETED|Overall Study||60
559956|NCT00675909|1365208|P2|COMPLETED|Overall Study||60
559957|NCT00675909|1365209|P1|COMPLETED|Overall Study||60
559958|NCT00675909|1365207|P3|STARTED|Overall Study||60
559959|NCT00675909|1365208|P2|STARTED|Overall Study||60
559960|NCT00675909|1365209|P1|STARTED|Overall Study||60
559961|NCT00675792|1365219|P2|NOT COMPLETED|Overall Study||0
559962|NCT00675792|1365220|P1|NOT COMPLETED|Overall Study||0
559963|NCT00675792|1365219|P2|COMPLETED|Overall Study||49
559964|NCT00675792|1365220|P1|COMPLETED|Overall Study||51
559965|NCT00675792|1365219|P2|STARTED|Overall Study||49
559966|NCT00675792|1365220|P1|STARTED|Overall Study||51
559967|NCT00675766|1365240|P4|NOT COMPLETED|Overall Study||26
559968|NCT00675766|1365241|P3|NOT COMPLETED|Overall Study||21
559969|NCT00675766|1365242|P2|NOT COMPLETED|Overall Study||5
559970|NCT00675766|1365243|P1|NOT COMPLETED|Overall Study||6
559971|NCT00675766|1365240|P4|COMPLETED|Overall Study||11
559972|NCT00675766|1365241|P3|COMPLETED|Overall Study||29
559973|NCT00675766|1365242|P2|COMPLETED|Overall Study||25
559974|NCT00675766|1365243|P1|COMPLETED|Overall Study||100
559975|NCT00675766|1365240|P4|Year 3|Overall Study||11
559976|NCT00675766|1365241|P3|Year 3|Overall Study||29
559977|NCT00675766|1365242|P2|Year 3|Overall Study||25
559978|NCT00675766|1365243|P1|Year 3|Overall Study||100
559979|NCT00675766|1365240|P4|Year 2|Overall Study||20
559980|NCT00675766|1365241|P3|Year 2|Overall Study||34
559981|NCT00675766|1365242|P2|Year 2|Overall Study||28
559982|NCT00675766|1365243|P1|Year 2|Overall Study||105
559983|NCT00675766|1365240|P4|STARTED|Overall Study||37
559984|NCT00675766|1365241|P3|STARTED|Overall Study||50
559985|NCT00675766|1365242|P2|STARTED|Overall Study||30
559986|NCT00675766|1365243|P1|STARTED|Overall Study||106
559987|NCT00675597|1365253|P1|NOT COMPLETED|Overall Study||3
559988|NCT00675597|1365253|P1|COMPLETED|Overall Study||23
559989|NCT00675597|1365253|P1|STARTED|Overall Study||26
559990|NCT00675584|1365259|P2|NOT COMPLETED|Overall Study||26
559991|NCT00675584|1365260|P1|NOT COMPLETED|Overall Study||39
559992|NCT00675584|1365259|P2|COMPLETED|Overall Study||113
559993|NCT00675584|1365260|P1|COMPLETED|Overall Study||100
559994|NCT00675584|1365259|P2|STARTED|Overall Study||139
559995|NCT00675584|1365260|P1|STARTED|Overall Study||139
559996|NCT00675558|1365289|P3|NOT COMPLETED|Second Operation||0
559997|NCT00675558|1365290|P2|NOT COMPLETED|Second Operation||0
559998|NCT00675558|1365291|P1|NOT COMPLETED|Second Operation||0
559999|NCT00675558|1365289|P3|COMPLETED|Second Operation||10
560000|NCT00675558|1365290|P2|COMPLETED|Second Operation||0
560001|NCT00675558|1365291|P1|COMPLETED|Second Operation||0
560002|NCT00675558|1365289|P3|STARTED|Second Operation|As predicted, only 10 SMO patients medically required a second operation, and thus met study goals.|10
560003|NCT00675558|1365290|P2|STARTED|Second Operation|No medical reason, and none for the goals of the study, for MO pts to have a second procedure .|0
560004|NCT00675558|1365291|P1|STARTED|Second Operation|No medical reason, and no study-related reason for non-obese pts to have a second procedure.|0
560005|NCT00675558|1365289|P3|NOT COMPLETED|Surgery||0
560006|NCT00675558|1365290|P2|NOT COMPLETED|Surgery||0
560007|NCT00675558|1365291|P1|NOT COMPLETED|Surgery||0
560008|NCT00675558|1365289|P3|COMPLETED|Surgery||30
560009|NCT00675558|1365290|P2|COMPLETED|Surgery||10
560010|NCT00675558|1365291|P1|COMPLETED|Surgery||10
560011|NCT00675558|1365289|P3|STARTED|Surgery||30
560012|NCT00675558|1365290|P2|STARTED|Surgery||10
560013|NCT00675558|1365291|P1|STARTED|Surgery||10
560014|NCT00675506|1365307|P2|NOT COMPLETED|Overall Study||12
560015|NCT00675506|1365308|P1|NOT COMPLETED|Overall Study||12
560016|NCT00675506|1365307|P2|COMPLETED|Overall Study||17
560017|NCT00675506|1365308|P1|COMPLETED|Overall Study||19
560018|NCT00675506|1365307|P2|Received Intervention|Overall Study||29
560019|NCT00675506|1365308|P1|Received Intervention|Overall Study|Two subjects did not start treatment: 1) disclosed cancer history, 2) declined participation.|29
560020|NCT00675506|1365307|P2|STARTED|Overall Study||29
560021|NCT00675506|1365308|P1|STARTED|Overall Study||31
560022|NCT00675441|1365324|P1|NOT COMPLETED|Overall Study||3
560023|NCT00675441|1365324|P1|COMPLETED|Overall Study||2
560024|NCT00675441|1365324|P1|STARTED|Overall Study||5
560025|NCT00675428|1365330|P2|NOT COMPLETED|Overall Study||3
560026|NCT00675428|1365331|P1|NOT COMPLETED|Overall Study||3
560027|NCT00675428|1365330|P2|COMPLETED|Overall Study||0
560028|NCT00675428|1365331|P1|COMPLETED|Overall Study||0
560029|NCT00675428|1365330|P2|STARTED|Overall Study||3
560030|NCT00675428|1365331|P1|STARTED|Overall Study||3
560031|NCT00675415|1365351|P2|NOT COMPLETED|Overall Study||8
560032|NCT00675415|1365352|P1|NOT COMPLETED|Overall Study||8
560033|NCT00675415|1365351|P2|COMPLETED|Overall Study||123
560034|NCT00675415|1365352|P1|COMPLETED|Overall Study||124
560035|NCT00675415|1365351|P2|STARTED|Overall Study||131
560036|NCT00675415|1365352|P1|STARTED|Overall Study||132
560037|NCT00675259|1365364|P1|NOT COMPLETED|Overall Study||14
560038|NCT00675259|1365364|P1|COMPLETED|Overall Study||19
560039|NCT00675259|1365364|P1|STARTED|Overall Study||33
560040|NCT00675103|1365373|P1|NOT COMPLETED|Overall Study||3
560041|NCT00675103|1365373|P1|COMPLETED|Overall Study||4
560042|NCT00675103|1365373|P1|STARTED|Overall Study||7
560043|NCT00674986|1365380|P2|NOT COMPLETED|Overall Study||81
560044|NCT00674986|1365381|P1|NOT COMPLETED|Overall Study||43
560045|NCT00674986|1365380|P2|COMPLETED|Overall Study||188
560046|NCT00674986|1365381|P1|COMPLETED|Overall Study||187
560047|NCT00674986|1365380|P2|Intent to Treat Population|Overall Study||256
560048|NCT00674986|1365381|P1|Intent to Treat Population|Overall Study||227
560049|NCT00674986|1365380|P2|STARTED|Overall Study||269
560050|NCT00674986|1365381|P1|STARTED|Overall Study||230
560051|NCT00674973|1365402|P2|NOT COMPLETED|Overall Study||102
560052|NCT00674973|1365403|P1|NOT COMPLETED|Overall Study||100
560053|NCT00674973|1365402|P2|COMPLETED|Overall Study|Completed double-blind treatment.|2
560054|NCT00674973|1365403|P1|COMPLETED|Overall Study|Completed double-blind treatment.|3
560055|NCT00674973|1365402|P2|Switch to Open-Label Erlotinib|Overall Study||0
560056|NCT00674973|1365403|P1|Switch to Open-Label Erlotinib|Overall Study|Participants with PD were given opportunity to switch.|57
560057|NCT00674973|1365402|P2|STARTED|Overall Study||104
560058|NCT00674973|1365403|P1|STARTED|Overall Study||103
560059|NCT00674817|1365417|P1|NOT COMPLETED|Period 6||0
560060|NCT00674817|1365417|P1|COMPLETED|Period 6||38
560061|NCT00674817|1365417|P1|STARTED|Period 6||38
560062|NCT00674817|1365417|P1|NOT COMPLETED|Period 5||0
560063|NCT00674817|1365417|P1|COMPLETED|Period 5||38
560064|NCT00674817|1365417|P1|STARTED|Period 5||38
560065|NCT00674817|1365417|P1|NOT COMPLETED|Period 4||1
560066|NCT00674817|1365417|P1|COMPLETED|Period 4||38
560067|NCT00674817|1365417|P1|STARTED|Period 4||39
560068|NCT00674817|1365417|P1|NOT COMPLETED|Period 3||2
560069|NCT00674817|1365417|P1|COMPLETED|Period 3||39
560070|NCT00674817|1365417|P1|STARTED|Period 3||41
560071|NCT00674817|1365417|P1|NOT COMPLETED|Period 2||0
560072|NCT00674817|1365417|P1|COMPLETED|Period 2||41
560073|NCT00674817|1365417|P1|STARTED|Period 2||41
560074|NCT00674817|1365417|P1|NOT COMPLETED|Period 1||3
560075|NCT00674817|1365417|P1|COMPLETED|Period 1||41
560076|NCT00674817|1365417|P1|STARTED|Period 1||44
560077|NCT00674765|1365565|P2|NOT COMPLETED|Overall Study||29
560078|NCT00674765|1365566|P1|NOT COMPLETED|Overall Study||36
560079|NCT00674765|1365565|P2|COMPLETED|Overall Study||46
560080|NCT00674765|1365566|P1|COMPLETED|Overall Study||45
560081|NCT00674765|1365565|P2|STARTED|Overall Study||75
560082|NCT00674765|1365566|P1|STARTED|Overall Study||81
560083|NCT00674739|1365575|P3|NOT COMPLETED|Overall Study||32
560084|NCT00674739|1365576|P2|NOT COMPLETED|Overall Study||59
560085|NCT00674739|1365577|P1|NOT COMPLETED|Overall Study||57
560086|NCT00674739|1365575|P3|COMPLETED|Overall Study||65
560087|NCT00674739|1365576|P2|COMPLETED|Overall Study||136
560088|NCT00674739|1365577|P1|COMPLETED|Overall Study||121
560089|NCT00674739|1365575|P3|STARTED|Overall Study||97
560090|NCT00674739|1365576|P2|STARTED|Overall Study||195
560091|NCT00674739|1365577|P1|STARTED|Overall Study||178
560092|NCT00674700|1365594|P3|NOT COMPLETED|Year 2 Follow-up Without Treatment||12
560093|NCT00674700|1365595|P2|NOT COMPLETED|Year 2 Follow-up Without Treatment||12
560094|NCT00674700|1365596|P1|NOT COMPLETED|Year 2 Follow-up Without Treatment||6
560095|NCT00674700|1365594|P3|COMPLETED|Year 2 Follow-up Without Treatment||141
560096|NCT00674700|1365595|P2|COMPLETED|Year 2 Follow-up Without Treatment||123
560097|NCT00674700|1365596|P1|COMPLETED|Year 2 Follow-up Without Treatment||133
560098|NCT00674700|1365594|P3|STARTED|Year 2 Follow-up Without Treatment||153
560099|NCT00674700|1365595|P2|STARTED|Year 2 Follow-up Without Treatment||135
560100|NCT00674700|1365596|P1|STARTED|Year 2 Follow-up Without Treatment||139
560101|NCT00674700|1365594|P3|NOT COMPLETED|Year 1||17
560102|NCT00674700|1365595|P2|NOT COMPLETED|Year 1||34
560103|NCT00674700|1365596|P1|NOT COMPLETED|Year 1||31
560104|NCT00674700|1365594|P3|COMPLETED|Year 1||153
560105|NCT00674700|1365595|P2|COMPLETED|Year 1||135
560106|NCT00674700|1365596|P1|COMPLETED|Year 1||139
560107|NCT00674700|1365594|P3|STARTED|Year 1||170
560108|NCT00674700|1365595|P2|STARTED|Year 1||169
560109|NCT00674700|1365596|P1|STARTED|Year 1||170
560110|NCT00674661|1365609|P2|NOT COMPLETED|Overall Study||15
560111|NCT00674661|1365610|P1|NOT COMPLETED|Overall Study||11
560112|NCT00674661|1365609|P2|COMPLETED|Overall Study||48
560113|NCT00674661|1365610|P1|COMPLETED|Overall Study||56
560114|NCT00674661|1365609|P2|STARTED|Overall Study||63
560115|NCT00674661|1365610|P1|STARTED|Overall Study||67
560116|NCT00674622|1365619|P3|NOT COMPLETED|Overall Study||0
560117|NCT00674622|1365620|P2|NOT COMPLETED|Overall Study||4
560118|NCT00674622|1365621|P1|NOT COMPLETED|Overall Study||1
560119|NCT00674622|1365619|P3|COMPLETED|Overall Study||22
560120|NCT00674622|1365620|P2|COMPLETED|Overall Study||18
560121|NCT00674622|1365621|P1|COMPLETED|Overall Study||21
560122|NCT00674622|1365619|P3|STARTED|Overall Study||22
560123|NCT00674622|1365620|P2|STARTED|Overall Study||22
560124|NCT00674622|1365621|P1|STARTED|Overall Study||22
560125|NCT00674609|1365644|P3|NOT COMPLETED|Overall Study||8
560126|NCT00674609|1365645|P2|NOT COMPLETED|Overall Study||13
560127|NCT00674609|1365646|P1|NOT COMPLETED|Overall Study||12
560128|NCT00674609|1365644|P3|COMPLETED|Overall Study||51
560129|NCT00674609|1365645|P2|COMPLETED|Overall Study||45
560130|NCT00674609|1365646|P1|COMPLETED|Overall Study||48
560131|NCT00674609|1365644|P3|STARTED|Overall Study||59
560132|NCT00674609|1365645|P2|STARTED|Overall Study||58
560133|NCT00674609|1365646|P1|STARTED|Overall Study||60
560134|NCT00674583|1365680|P2|NOT COMPLETED|Overall Study||0
560135|NCT00674583|1365681|P1|NOT COMPLETED|Overall Study||0
560136|NCT00674583|1365680|P2|COMPLETED|Overall Study||103
560137|NCT00674583|1365681|P1|COMPLETED|Overall Study||311
560138|NCT00674583|1365680|P2|STARTED|Overall Study||103
560139|NCT00674583|1365681|P1|STARTED|Overall Study||311
560140|NCT00674492|1365705|P1|NOT COMPLETED|Overall Study||0
560141|NCT00674492|1365705|P1|COMPLETED|Overall Study||21
560142|NCT00674492|1365705|P1|STARTED|Overall Study||21
560143|NCT00674466|1365712|P3|NOT COMPLETED|Overall Study||9
560144|NCT00674466|1365713|P2|NOT COMPLETED|Overall Study||8
560145|NCT00674466|1365714|P1|NOT COMPLETED|Overall Study||7
560146|NCT00674466|1365712|P3|COMPLETED|Overall Study||21
560147|NCT00674466|1365713|P2|COMPLETED|Overall Study||22
560148|NCT00674466|1365714|P1|COMPLETED|Overall Study||23
560149|NCT00674466|1365712|P3|STARTED|Overall Study||30
560150|NCT00674466|1365713|P2|STARTED|Overall Study||30
560151|NCT00674466|1365714|P1|STARTED|Overall Study||30
560152|NCT00674362|1365730|P2|NOT COMPLETED|Open Label||0
560153|NCT00674362|1365731|P1|NOT COMPLETED|Open Label||2
560154|NCT00674362|1365730|P2|COMPLETED|Open Label||7
560155|NCT00674362|1365731|P1|COMPLETED|Open Label||18
560156|NCT00674362|1365730|P2|STARTED|Open Label||7
560157|NCT00674362|1365731|P1|STARTED|Open Label||20
560158|NCT00674362|1365730|P2|NOT COMPLETED|Double Blind||18
560159|NCT00674362|1365731|P1|NOT COMPLETED|Double Blind||12
560160|NCT00674362|1365730|P2|COMPLETED|Double Blind||80
560161|NCT00674362|1365731|P1|COMPLETED|Double Blind||84
560162|NCT00674362|1365730|P2|STARTED|Double Blind||98
560163|NCT00674362|1365731|P1|STARTED|Double Blind||96
560164|NCT00674323|1365799|P3|NOT COMPLETED|Overall Study||0
560165|NCT00674323|1365800|P2|NOT COMPLETED|Overall Study||1
560166|NCT00674323|1365801|P1|NOT COMPLETED|Overall Study||1
560167|NCT00674323|1365799|P3|COMPLETED|Overall Study||21
560168|NCT00674323|1365800|P2|COMPLETED|Overall Study||20
560169|NCT00674323|1365801|P1|COMPLETED|Overall Study||18
560170|NCT00674323|1365799|P3|STARTED|Overall Study||21
560171|NCT00674323|1365800|P2|STARTED|Overall Study||21
560172|NCT00674323|1365801|P1|STARTED|Overall Study||19
560173|NCT00674297|1365818|P4|NOT COMPLETED|Overall Study||3
560174|NCT00674297|1365819|P3|NOT COMPLETED|Overall Study||4
560175|NCT00674297|1365820|P2|NOT COMPLETED|Overall Study||0
560176|NCT00674297|1365821|P1|NOT COMPLETED|Overall Study||10
560177|NCT00674297|1365818|P4|COMPLETED|Overall Study||4
560178|NCT00674297|1365819|P3|COMPLETED|Overall Study||5
560179|NCT00674297|1365820|P2|COMPLETED|Overall Study||7
560180|NCT00674297|1365821|P1|COMPLETED|Overall Study||8
560181|NCT00674297|1365818|P4|STARTED|Overall Study||7
560182|NCT00674297|1365819|P3|STARTED|Overall Study||9
560183|NCT00674297|1365820|P2|STARTED|Overall Study||7
560184|NCT00674297|1365821|P1|STARTED|Overall Study||18
560185|NCT00674206|1365836|P1|NOT COMPLETED|Overall Study||0
560186|NCT00674206|1365836|P1|COMPLETED|Overall Study||6
560187|NCT00674206|1365836|P1|STARTED|Overall Study||6
560188|NCT00674154|1365843|P2|NOT COMPLETED|Overall Study||3
560189|NCT00674154|1365844|P1|NOT COMPLETED|Overall Study||3
560190|NCT00674154|1365843|P2|COMPLETED|Overall Study||20
560191|NCT00674154|1365844|P1|COMPLETED|Overall Study||20
560192|NCT00674154|1365843|P2|STARTED|Overall Study||23
560193|NCT00674154|1365844|P1|STARTED|Overall Study||23
560194|NCT00674128|1365852|P2|NOT COMPLETED|Overall Study||23
560195|NCT00674128|1365853|P1|NOT COMPLETED|Overall Study||25
560196|NCT00674128|1365852|P2|COMPLETED|Overall Study||21
560197|NCT00674128|1365853|P1|COMPLETED|Overall Study||25
560198|NCT00674128|1365852|P2|STARTED|Overall Study||44
560199|NCT00674128|1365853|P1|STARTED|Overall Study||50
560200|NCT00674115|1365859|P4|NOT COMPLETED|Third Intervention||0
560201|NCT00674115|1365860|P3|NOT COMPLETED|Third Intervention||0
560202|NCT00674115|1365861|P2|NOT COMPLETED|Third Intervention||0
560203|NCT00674115|1365862|P1|NOT COMPLETED|Third Intervention||0
560204|NCT00674115|1365859|P4|COMPLETED|Third Intervention||0
560205|NCT00674115|1365860|P3|COMPLETED|Third Intervention||0
560206|NCT00674115|1365861|P2|COMPLETED|Third Intervention||16
560207|NCT00674115|1365862|P1|COMPLETED|Third Intervention||14
560208|NCT00674115|1365859|P4|STARTED|Third Intervention||0
560209|NCT00674115|1365860|P3|STARTED|Third Intervention||0
560210|NCT00674115|1365861|P2|STARTED|Third Intervention||16
560211|NCT00674115|1365862|P1|STARTED|Third Intervention||14
560212|NCT00674115|1365859|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
560213|NCT00674115|1365860|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
560214|NCT00674115|1365861|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
560215|NCT00674115|1365862|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
560216|NCT00674115|1365859|P4|COMPLETED|Washout Period of 2 Weeks||0
560217|NCT00674115|1365860|P3|COMPLETED|Washout Period of 2 Weeks||0
560218|NCT00674115|1365861|P2|COMPLETED|Washout Period of 2 Weeks||16
560219|NCT00674115|1365862|P1|COMPLETED|Washout Period of 2 Weeks||14
560220|NCT00674115|1365859|P4|STARTED|Washout Period of 2 Weeks||0
560221|NCT00674115|1365860|P3|STARTED|Washout Period of 2 Weeks||0
560222|NCT00674115|1365861|P2|STARTED|Washout Period of 2 Weeks||16
560223|NCT00674115|1365862|P1|STARTED|Washout Period of 2 Weeks||14
560224|NCT00674115|1365859|P4|NOT COMPLETED|Second Intervention||0
560225|NCT00674115|1365860|P3|NOT COMPLETED|Second Intervention||0
560226|NCT00674115|1365861|P2|NOT COMPLETED|Second Intervention||0
560227|NCT00674115|1365862|P1|NOT COMPLETED|Second Intervention||0
560228|NCT00674115|1365859|P4|COMPLETED|Second Intervention||16
560229|NCT00674115|1365860|P3|COMPLETED|Second Intervention||14
560230|NCT00674115|1365861|P2|COMPLETED|Second Intervention||16
560231|NCT00674115|1365862|P1|COMPLETED|Second Intervention||14
560232|NCT00674115|1365859|P4|STARTED|Second Intervention||16
560233|NCT00674115|1365860|P3|STARTED|Second Intervention||14
560234|NCT00674115|1365861|P2|STARTED|Second Intervention||16
560235|NCT00674115|1365862|P1|STARTED|Second Intervention||14
560236|NCT00674115|1365859|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
560237|NCT00674115|1365860|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
560238|NCT00674115|1365861|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
560239|NCT00674115|1365862|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
560240|NCT00674115|1365859|P4|COMPLETED|Washout Period of 2 Weeks||16
560241|NCT00674115|1365860|P3|COMPLETED|Washout Period of 2 Weeks||14
560242|NCT00674115|1365861|P2|COMPLETED|Washout Period of 2 Weeks||16
560243|NCT00674115|1365862|P1|COMPLETED|Washout Period of 2 Weeks||14
560244|NCT00674115|1365859|P4|STARTED|Washout Period of 2 Weeks||16
560245|NCT00674115|1365860|P3|STARTED|Washout Period of 2 Weeks||14
560246|NCT00674115|1365861|P2|STARTED|Washout Period of 2 Weeks||16
560247|NCT00674115|1365862|P1|STARTED|Washout Period of 2 Weeks||14
560248|NCT00674115|1365859|P4|NOT COMPLETED|First Intervention||0
560249|NCT00674115|1365860|P3|NOT COMPLETED|First Intervention||0
560250|NCT00674115|1365861|P2|NOT COMPLETED|First Intervention||0
560251|NCT00674115|1365862|P1|NOT COMPLETED|First Intervention||0
560252|NCT00674115|1365859|P4|COMPLETED|First Intervention||16
560253|NCT00674115|1365860|P3|COMPLETED|First Intervention||14
560254|NCT00674115|1365861|P2|COMPLETED|First Intervention||16
560255|NCT00674115|1365862|P1|COMPLETED|First Intervention||14
560256|NCT00674115|1365859|P4|STARTED|First Intervention||16
560257|NCT00674115|1365860|P3|STARTED|First Intervention||14
560258|NCT00674115|1365861|P2|STARTED|First Intervention||16
560259|NCT00674115|1365862|P1|STARTED|First Intervention||14
560260|NCT00673959|1365871|P2|NOT COMPLETED|Overall Study||0
560261|NCT00673959|1365872|P1|NOT COMPLETED|Overall Study||0
560262|NCT00673959|1365871|P2|COMPLETED|Overall Study||10
560263|NCT00673959|1365872|P1|COMPLETED|Overall Study||10
560264|NCT00673959|1365871|P2|STARTED|Overall Study||10
560265|NCT00673959|1365872|P1|STARTED|Overall Study||10
560266|NCT00673933|1365878|P1|NOT COMPLETED|Overall Study||3
560267|NCT00673933|1365878|P1|COMPLETED|Overall Study||17
560268|NCT00673933|1365878|P1|STARTED|Overall Study||20
560269|NCT00673881|1365894|P1|NOT COMPLETED|Overall Study||1
560270|NCT00673881|1365894|P1|COMPLETED|Overall Study||24
560271|NCT00673881|1365894|P1|STARTED|Overall Study||25
560272|NCT00673855|1365901|P2|NOT COMPLETED|Second Intervention||0
560273|NCT00673855|1365902|P1|NOT COMPLETED|Second Intervention||0
560274|NCT00673855|1365901|P2|COMPLETED|Second Intervention||10
560275|NCT00673855|1365902|P1|COMPLETED|Second Intervention||10
560276|NCT00673855|1365901|P2|STARTED|Second Intervention||10
560277|NCT00673855|1365902|P1|STARTED|Second Intervention||10
560278|NCT00673855|1365901|P2|NOT COMPLETED|First Intervention||0
560279|NCT00673855|1365902|P1|NOT COMPLETED|First Intervention||0
560280|NCT00673855|1365901|P2|COMPLETED|First Intervention||10
560281|NCT00673855|1365902|P1|COMPLETED|First Intervention||10
560282|NCT00673855|1365901|P2|STARTED|First Intervention||10
560283|NCT00673855|1365902|P1|STARTED|First Intervention||10
560284|NCT00673816|1365908|P1|NOT COMPLETED|Overall Study||2
560285|NCT00673816|1365908|P1|COMPLETED|Overall Study||0
560286|NCT00673816|1365908|P1|STARTED|Overall Study||2
560287|NCT00673764|1365915|P2|NOT COMPLETED|Overall Study||0
560288|NCT00673764|1365916|P1|NOT COMPLETED|Overall Study||0
560289|NCT00673764|1365915|P2|COMPLETED|Overall Study||24
560290|NCT00673764|1365916|P1|COMPLETED|Overall Study||24
560291|NCT00673764|1365915|P2|STARTED|Overall Study||24
560292|NCT00673764|1365916|P1|STARTED|Overall Study||24
560293|NCT00673738|1365924|P1|NOT COMPLETED|Overall Study||0
560294|NCT00673738|1365924|P1|COMPLETED|Overall Study||27
560295|NCT00673738|1365924|P1|STARTED|Overall Study||27
560296|NCT00673712|1365932|P2|NOT COMPLETED|Overall Study||0
560297|NCT00673712|1365933|P1|NOT COMPLETED|Overall Study||0
560298|NCT00673712|1365932|P2|COMPLETED|Overall Study||326
560299|NCT00673712|1365933|P1|COMPLETED|Overall Study||321
560300|NCT00673712|1365932|P2|STARTED|Overall Study||326
560301|NCT00673712|1365933|P1|STARTED|Overall Study||321
560302|NCT00673673|1365943|P1|NOT COMPLETED|Overall Study||36
560303|NCT00673673|1365943|P1|COMPLETED|Overall Study||3
560304|NCT00673673|1365943|P1|STARTED|Overall Study||39
560305|NCT00673660|1365949|P1|NOT COMPLETED|Overall Study||107
560306|NCT00673660|1365949|P1|COMPLETED|Overall Study||268
560307|NCT00673660|1365949|P1|STARTED|Overall Study||375
560308|NCT00673595|1365962|P2|NOT COMPLETED|Overall Study||0
560309|NCT00673595|1365963|P1|NOT COMPLETED|Overall Study||0
560310|NCT00673595|1365962|P2|COMPLETED|Overall Study||11
560311|NCT00673595|1365963|P1|COMPLETED|Overall Study||8
560312|NCT00673595|1365962|P2|STARTED|Overall Study||11
560313|NCT00673595|1365963|P1|STARTED|Overall Study||8
560314|NCT00673465|1365971|P12|NOT COMPLETED|Part 2 (India)||0
560315|NCT00673465|1365972|P11|NOT COMPLETED|Part 2 (India)||0
560316|NCT00673465|1365973|P10|NOT COMPLETED|Part 2 (India)||0
560317|NCT00673465|1365974|P9|NOT COMPLETED|Part 2 (India)||0
560318|NCT00673465|1365975|P8|NOT COMPLETED|Part 2 (India)||0
560319|NCT00673465|1365976|P7|NOT COMPLETED|Part 2 (India)||0
560320|NCT00673465|1365977|P6|NOT COMPLETED|Part 2 (India)||0
560321|NCT00673465|1365978|P5|NOT COMPLETED|Part 2 (India)||0
560322|NCT00673465|1365979|P4|NOT COMPLETED|Part 2 (India)||0
560323|NCT00673465|1365980|P3|NOT COMPLETED|Part 2 (India)||0
560324|NCT00673465|1365981|P2|NOT COMPLETED|Part 2 (India)||0
560325|NCT00673465|1365982|P1|NOT COMPLETED|Part 2 (India)||0
560326|NCT00673465|1365971|P12|COMPLETED|Part 2 (India)||0
560327|NCT00673465|1365972|P11|COMPLETED|Part 2 (India)||0
560328|NCT00673465|1365973|P10|COMPLETED|Part 2 (India)||0
560329|NCT00673465|1365974|P9|COMPLETED|Part 2 (India)||0
560330|NCT00673465|1365975|P8|COMPLETED|Part 2 (India)||0
560331|NCT00673465|1365976|P7|COMPLETED|Part 2 (India)||0
560332|NCT00673465|1365977|P6|COMPLETED|Part 2 (India)||0
560333|NCT00673465|1365978|P5|COMPLETED|Part 2 (India)||0
560334|NCT00673465|1365979|P4|COMPLETED|Part 2 (India)||0
560335|NCT00673465|1365980|P3|COMPLETED|Part 2 (India)||0
560336|NCT00673465|1365981|P2|COMPLETED|Part 2 (India)||0
560337|NCT00673465|1365982|P1|COMPLETED|Part 2 (India)||0
560338|NCT00673465|1365971|P12|STARTED|Part 2 (India)||0
560339|NCT00673465|1365972|P11|STARTED|Part 2 (India)||0
560340|NCT00673465|1365973|P10|STARTED|Part 2 (India)||0
560341|NCT00673465|1365974|P9|STARTED|Part 2 (India)||0
560342|NCT00673465|1365975|P8|STARTED|Part 2 (India)||0
560343|NCT00673465|1365976|P7|STARTED|Part 2 (India)||0
560344|NCT00673465|1365977|P6|STARTED|Part 2 (India)||0
560345|NCT00673465|1365978|P5|STARTED|Part 2 (India)||0
560346|NCT00673465|1365979|P4|STARTED|Part 2 (India)||0
560347|NCT00673465|1365980|P3|STARTED|Part 2 (India)||0
560348|NCT00673465|1365981|P2|STARTED|Part 2 (India)||0
560349|NCT00673465|1365982|P1|STARTED|Part 2 (India)||0
560350|NCT00673465|1365971|P12|NOT COMPLETED|Part 1/Period 3 (United States)||0
560351|NCT00673465|1365972|P11|NOT COMPLETED|Part 1/Period 3 (United States)||0
560352|NCT00673465|1365973|P10|NOT COMPLETED|Part 1/Period 3 (United States)||0
560353|NCT00673465|1365974|P9|NOT COMPLETED|Part 1/Period 3 (United States)||0
560354|NCT00673465|1365975|P8|NOT COMPLETED|Part 1/Period 3 (United States)||0
560355|NCT00673465|1365976|P7|NOT COMPLETED|Part 1/Period 3 (United States)||0
560356|NCT00673465|1365977|P6|NOT COMPLETED|Part 1/Period 3 (United States)||0
560357|NCT00673465|1365978|P5|NOT COMPLETED|Part 1/Period 3 (United States)||0
560358|NCT00673465|1365979|P4|NOT COMPLETED|Part 1/Period 3 (United States)||0
560359|NCT00673465|1365980|P3|NOT COMPLETED|Part 1/Period 3 (United States)||0
560360|NCT00673465|1365981|P2|NOT COMPLETED|Part 1/Period 3 (United States)||0
560361|NCT00673465|1365982|P1|NOT COMPLETED|Part 1/Period 3 (United States)||0
560362|NCT00673465|1365971|P12|COMPLETED|Part 1/Period 3 (United States)||0
560363|NCT00673465|1365972|P11|COMPLETED|Part 1/Period 3 (United States)||0
560364|NCT00673465|1365973|P10|COMPLETED|Part 1/Period 3 (United States)||0
560365|NCT00673465|1365974|P9|COMPLETED|Part 1/Period 3 (United States)||0
560366|NCT00673465|1365975|P8|COMPLETED|Part 1/Period 3 (United States)||0
560367|NCT00673465|1365976|P7|COMPLETED|Part 1/Period 3 (United States)||0
560368|NCT00673465|1365977|P6|COMPLETED|Part 1/Period 3 (United States)||1
560369|NCT00673465|1365978|P5|COMPLETED|Part 1/Period 3 (United States)||1
560370|NCT00673465|1365979|P4|COMPLETED|Part 1/Period 3 (United States)||3
560371|NCT00673465|1365980|P3|COMPLETED|Part 1/Period 3 (United States)||3
560372|NCT00673465|1365981|P2|COMPLETED|Part 1/Period 3 (United States)||3
560373|NCT00673465|1365982|P1|COMPLETED|Part 1/Period 3 (United States)||3
560374|NCT00673465|1365971|P12|STARTED|Part 1/Period 3 (United States)||0
560375|NCT00673465|1365972|P11|STARTED|Part 1/Period 3 (United States)||0
560376|NCT00673465|1365973|P10|STARTED|Part 1/Period 3 (United States)||0
560377|NCT00673465|1365974|P9|STARTED|Part 1/Period 3 (United States)||0
560378|NCT00673465|1365975|P8|STARTED|Part 1/Period 3 (United States)||0
560379|NCT00673465|1365976|P7|STARTED|Part 1/Period 3 (United States)||0
560380|NCT00673465|1365977|P6|STARTED|Part 1/Period 3 (United States)||1
560381|NCT00673465|1365978|P5|STARTED|Part 1/Period 3 (United States)||1
560382|NCT00673465|1365979|P4|STARTED|Part 1/Period 3 (United States)||3
560383|NCT00673465|1365980|P3|STARTED|Part 1/Period 3 (United States)||3
560384|NCT00673465|1365981|P2|STARTED|Part 1/Period 3 (United States)||3
560385|NCT00673465|1365982|P1|STARTED|Part 1/Period 3 (United States)||3
560386|NCT00673465|1365971|P12|NOT COMPLETED|Part 1/Period 2 (United States)||0
560387|NCT00673465|1365972|P11|NOT COMPLETED|Part 1/Period 2 (United States)||0
560388|NCT00673465|1365973|P10|NOT COMPLETED|Part 1/Period 2 (United States)||0
560389|NCT00673465|1365974|P9|NOT COMPLETED|Part 1/Period 2 (United States)||0
560390|NCT00673465|1365975|P8|NOT COMPLETED|Part 1/Period 2 (United States)||0
560391|NCT00673465|1365976|P7|NOT COMPLETED|Part 1/Period 2 (United States)||0
560392|NCT00673465|1365977|P6|NOT COMPLETED|Part 1/Period 2 (United States)||0
560393|NCT00673465|1365978|P5|NOT COMPLETED|Part 1/Period 2 (United States)||1
560394|NCT00673465|1365979|P4|NOT COMPLETED|Part 1/Period 2 (United States)||0
560395|NCT00673465|1365980|P3|NOT COMPLETED|Part 1/Period 2 (United States)||0
560396|NCT00673465|1365981|P2|NOT COMPLETED|Part 1/Period 2 (United States)||0
560397|NCT00673465|1365982|P1|NOT COMPLETED|Part 1/Period 2 (United States)||0
560398|NCT00673465|1365971|P12|COMPLETED|Part 1/Period 2 (United States)||0
560399|NCT00673465|1365972|P11|COMPLETED|Part 1/Period 2 (United States)||0
560400|NCT00673465|1365973|P10|COMPLETED|Part 1/Period 2 (United States)||0
560401|NCT00673465|1365974|P9|COMPLETED|Part 1/Period 2 (United States)||0
560402|NCT00673465|1365975|P8|COMPLETED|Part 1/Period 2 (United States)||0
560403|NCT00673465|1365976|P7|COMPLETED|Part 1/Period 2 (United States)||0
560404|NCT00673465|1365977|P6|COMPLETED|Part 1/Period 2 (United States)||1
560405|NCT00673465|1365978|P5|COMPLETED|Part 1/Period 2 (United States)||1
560406|NCT00673465|1365979|P4|COMPLETED|Part 1/Period 2 (United States)||3
560407|NCT00673465|1365980|P3|COMPLETED|Part 1/Period 2 (United States)||3
560408|NCT00673465|1365981|P2|COMPLETED|Part 1/Period 2 (United States)||3
560409|NCT00673465|1365982|P1|COMPLETED|Part 1/Period 2 (United States)||3
560410|NCT00673465|1365971|P12|STARTED|Part 1/Period 2 (United States)||0
560411|NCT00673465|1365972|P11|STARTED|Part 1/Period 2 (United States)||0
560412|NCT00673465|1365973|P10|STARTED|Part 1/Period 2 (United States)||0
560413|NCT00673465|1365974|P9|STARTED|Part 1/Period 2 (United States)||0
560414|NCT00673465|1365975|P8|STARTED|Part 1/Period 2 (United States)||0
560415|NCT00673465|1365976|P7|STARTED|Part 1/Period 2 (United States)||0
560416|NCT00673465|1365977|P6|STARTED|Part 1/Period 2 (United States)||1
560417|NCT00673465|1365978|P5|STARTED|Part 1/Period 2 (United States)||2
560418|NCT00673465|1365979|P4|STARTED|Part 1/Period 2 (United States)||3
560419|NCT00673465|1365980|P3|STARTED|Part 1/Period 2 (United States)||3
560420|NCT00673465|1365981|P2|STARTED|Part 1/Period 2 (United States)||3
560421|NCT00673465|1365982|P1|STARTED|Part 1/Period 2 (United States)||3
560422|NCT00673465|1365971|P12|NOT COMPLETED|Part 1/Period 1 (United States)||0
560423|NCT00673465|1365972|P11|NOT COMPLETED|Part 1/Period 1 (United States)||0
560424|NCT00673465|1365973|P10|NOT COMPLETED|Part 1/Period 1 (United States)||0
560425|NCT00673465|1365974|P9|NOT COMPLETED|Part 1/Period 1 (United States)||0
560426|NCT00673465|1365975|P8|NOT COMPLETED|Part 1/Period 1 (United States)||0
560427|NCT00673465|1365976|P7|NOT COMPLETED|Part 1/Period 1 (United States)||0
560428|NCT00673465|1365977|P6|NOT COMPLETED|Part 1/Period 1 (United States)||1
560429|NCT00673465|1365978|P5|NOT COMPLETED|Part 1/Period 1 (United States)||1
560430|NCT00673465|1365979|P4|NOT COMPLETED|Part 1/Period 1 (United States)||0
560431|NCT00673465|1365980|P3|NOT COMPLETED|Part 1/Period 1 (United States)||0
560432|NCT00673465|1365981|P2|NOT COMPLETED|Part 1/Period 1 (United States)||0
560433|NCT00673465|1365982|P1|NOT COMPLETED|Part 1/Period 1 (United States)||0
560434|NCT00673465|1365971|P12|COMPLETED|Part 1/Period 1 (United States)||0
560435|NCT00673465|1365972|P11|COMPLETED|Part 1/Period 1 (United States)||0
560436|NCT00673465|1365973|P10|COMPLETED|Part 1/Period 1 (United States)||0
560437|NCT00673465|1365974|P9|COMPLETED|Part 1/Period 1 (United States)||0
560438|NCT00673465|1365975|P8|COMPLETED|Part 1/Period 1 (United States)||0
560439|NCT00673465|1365976|P7|COMPLETED|Part 1/Period 1 (United States)||0
560440|NCT00673465|1365977|P6|COMPLETED|Part 1/Period 1 (United States)||1
560441|NCT00673465|1365978|P5|COMPLETED|Part 1/Period 1 (United States)||2
560442|NCT00673465|1365979|P4|COMPLETED|Part 1/Period 1 (United States)||3
560443|NCT00673465|1365980|P3|COMPLETED|Part 1/Period 1 (United States)||3
560444|NCT00673465|1365981|P2|COMPLETED|Part 1/Period 1 (United States)||3
560445|NCT00673465|1365982|P1|COMPLETED|Part 1/Period 1 (United States)||3
560446|NCT00673465|1365971|P12|STARTED|Part 1/Period 1 (United States)||0
560447|NCT00673465|1365972|P11|STARTED|Part 1/Period 1 (United States)||0
560448|NCT00673465|1365973|P10|STARTED|Part 1/Period 1 (United States)||0
560449|NCT00673465|1365974|P9|STARTED|Part 1/Period 1 (United States)||0
560450|NCT00673465|1365975|P8|STARTED|Part 1/Period 1 (United States)||0
560451|NCT00673465|1365976|P7|STARTED|Part 1/Period 1 (United States)||0
560452|NCT00673465|1365977|P6|STARTED|Part 1/Period 1 (United States)||2
560453|NCT00673465|1365978|P5|STARTED|Part 1/Period 1 (United States)||3
560454|NCT00673465|1365979|P4|STARTED|Part 1/Period 1 (United States)||3
560455|NCT00673465|1365980|P3|STARTED|Part 1/Period 1 (United States)||3
560456|NCT00673465|1365981|P2|STARTED|Part 1/Period 1 (United States)||3
560457|NCT00673465|1365982|P1|STARTED|Part 1/Period 1 (United States)||3
560458|NCT00673452|1366031|P2|NOT COMPLETED|Continuation Double-Blind Phase||34
560459|NCT00673452|1366032|P1|NOT COMPLETED|Continuation Double-Blind Phase||25
560460|NCT00673452|1366031|P2|COMPLETED|Continuation Double-Blind Phase||153
560461|NCT00673452|1366032|P1|COMPLETED|Continuation Double-Blind Phase||151
560462|NCT00673452|1366031|P2|STARTED|Continuation Double-Blind Phase|Patients on placebo in acute phase received 60 mg duloxetine during the continuation phase.|187
560463|NCT00673452|1366032|P1|STARTED|Continuation Double-Blind Phase||176
560464|NCT00673452|1366031|P2|NOT COMPLETED|Acute Double-Blind Phase||80
560465|NCT00673452|1366032|P1|NOT COMPLETED|Acute Double-Blind Phase||87
560466|NCT00673452|1366031|P2|COMPLETED|Acute Double-Blind Phase||187
560467|NCT00673452|1366032|P1|COMPLETED|Acute Double-Blind Phase||176
560468|NCT00673452|1366031|P2|STARTED|Acute Double-Blind Phase||267
560469|NCT00673452|1366032|P1|STARTED|Acute Double-Blind Phase||263
560470|NCT00673439|1366066|P1|NOT COMPLETED|Overall Study||0
560471|NCT00673439|1366066|P1|COMPLETED|Overall Study||3
560472|NCT00673439|1366066|P1|STARTED|Overall Study||3
560473|NCT00673400|1366070|P1|NOT COMPLETED|Overall Study||0
560474|NCT00673400|1366070|P1|COMPLETED|Overall Study||52
560475|NCT00673400|1366070|P1|STARTED|Overall Study||52
560476|NCT00673387|1366095|P8|NOT COMPLETED|Overall Study||35
560477|NCT00673387|1366096|P7|NOT COMPLETED|Overall Study||30
560478|NCT00673387|1366097|P6|NOT COMPLETED|Overall Study||34
560479|NCT00673387|1366098|P5|NOT COMPLETED|Overall Study||30
560480|NCT00673387|1366099|P4|NOT COMPLETED|Overall Study||26
560481|NCT00673387|1366100|P3|NOT COMPLETED|Overall Study||31
560482|NCT00673387|1366101|P2|NOT COMPLETED|Overall Study||23
560483|NCT00673387|1366102|P1|NOT COMPLETED|Overall Study||29
560484|NCT00673387|1366095|P8|COMPLETED|Overall Study||40
560485|NCT00673387|1366096|P7|COMPLETED|Overall Study||48
560486|NCT00673387|1366097|P6|COMPLETED|Overall Study||44
560487|NCT00673387|1366098|P5|COMPLETED|Overall Study||48
560488|NCT00673387|1366099|P4|COMPLETED|Overall Study||49
560489|NCT00673387|1366100|P3|COMPLETED|Overall Study||41
560490|NCT00673387|1366101|P2|COMPLETED|Overall Study||54
560491|NCT00673387|1366102|P1|COMPLETED|Overall Study||46
560492|NCT00673387|1366095|P8|STARTED|Overall Study||75
560493|NCT00673387|1366096|P7|STARTED|Overall Study||78
560494|NCT00673387|1366097|P6|STARTED|Overall Study||78
560495|NCT00673387|1366098|P5|STARTED|Overall Study||78
560496|NCT00673387|1366099|P4|STARTED|Overall Study||75
560497|NCT00673387|1366100|P3|STARTED|Overall Study||72
560498|NCT00673387|1366101|P2|STARTED|Overall Study||77
560499|NCT00673387|1366102|P1|STARTED|Overall Study||75
560500|NCT00673361|1366318|P1|NOT COMPLETED|Overall Study||2
560501|NCT00673361|1366318|P1|COMPLETED|Overall Study||7
560502|NCT00673361|1366318|P1|STARTED|Overall Study||9
560503|NCT00673257|1366322|P1|NOT COMPLETED|Overall Study||5
560504|NCT00673257|1366322|P1|COMPLETED|Overall Study||102
560505|NCT00673257|1366322|P1|STARTED|Overall Study||107
560506|NCT00673231|1366331|P4|NOT COMPLETED|Overall Study||18
560507|NCT00673231|1366332|P3|NOT COMPLETED|Overall Study||26
560508|NCT00673231|1366333|P2|NOT COMPLETED|Overall Study||22
560509|NCT00673231|1366334|P1|NOT COMPLETED|Overall Study||29
560510|NCT00673231|1366331|P4|COMPLETED|Overall Study||178
560511|NCT00673231|1366332|P3|COMPLETED|Overall Study||186
560512|NCT00673231|1366333|P2|COMPLETED|Overall Study||180
560513|NCT00673231|1366334|P1|COMPLETED|Overall Study||168
560514|NCT00673231|1366331|P4|STARTED|Overall Study|Of the 196 randomized participants only 194 were included in the full analysis set|196
560515|NCT00673231|1366332|P3|STARTED|Overall Study|Of the 212 randomized participants only 211 were included in the full analysis set|212
560516|NCT00673231|1366333|P2|STARTED|Overall Study|All 202 were included in the full analysis set|202
560517|NCT00673231|1366334|P1|STARTED|Overall Study|Of the 197 randomized participants only 193 were included in the full analysis set|197
560518|NCT00673179|1366366|P2|NOT COMPLETED|Overall Study||0
560519|NCT00673179|1366367|P1|NOT COMPLETED|Overall Study||3
560520|NCT00673179|1366366|P2|COMPLETED|Overall Study||0
560521|NCT00673179|1366367|P1|COMPLETED|Overall Study||4
560522|NCT00673179|1366366|P2|STARTED|Overall Study||0
560523|NCT00673179|1366367|P1|STARTED|Overall Study||7
560524|NCT00673153|1366373|P1|NOT COMPLETED|Overall Study||1
560525|NCT00673153|1366373|P1|COMPLETED|Overall Study||30
560526|NCT00673153|1366373|P1|STARTED|Overall Study||31
560527|NCT00673127|1366381|P1|NOT COMPLETED|Overall Study||0
560528|NCT00673127|1366381|P1|COMPLETED|Overall Study||57
560529|NCT00673127|1366381|P1|STARTED|Overall Study||57
560530|NCT00673114|1366386|P1|NOT COMPLETED|Overall Study||0
560531|NCT00673114|1366386|P1|COMPLETED|Overall Study||3
560532|NCT00673114|1366386|P1|STARTED|Overall Study||3
560533|NCT00673075|1366399|P2|NOT COMPLETED|Overall Study||7
560534|NCT00673075|1366400|P1|NOT COMPLETED|Overall Study||9
560535|NCT00673075|1366399|P2|COMPLETED|Overall Study||11
560536|NCT00673075|1366400|P1|COMPLETED|Overall Study||12
560537|NCT00673075|1366399|P2|STARTED|Overall Study||18
560538|NCT00673075|1366400|P1|STARTED|Overall Study||21
560539|NCT00673049|1366416|P4|NOT COMPLETED|After Progression on Erlotinib||83
560540|NCT00673049|1366417|P3|NOT COMPLETED|After Progression on Erlotinib||0
560541|NCT00673049|1366418|P2|NOT COMPLETED|After Progression on Erlotinib||0
560542|NCT00673049|1366419|P1|NOT COMPLETED|After Progression on Erlotinib||0
560543|NCT00673049|1366416|P4|COMPLETED|After Progression on Erlotinib||0
560544|NCT00673049|1366417|P3|COMPLETED|After Progression on Erlotinib||0
560545|NCT00673049|1366418|P2|COMPLETED|After Progression on Erlotinib||0
560546|NCT00673049|1366419|P1|COMPLETED|After Progression on Erlotinib||0
560547|NCT00673049|1366416|P4|STARTED|After Progression on Erlotinib||83
560548|NCT00673049|1366417|P3|STARTED|After Progression on Erlotinib||0
560549|NCT00673049|1366418|P2|STARTED|After Progression on Erlotinib||0
560550|NCT00673049|1366419|P1|STARTED|After Progression on Erlotinib||0
560551|NCT00673049|1366416|P4|NOT COMPLETED|Before Progression on Erlotinib||0
560552|NCT00673049|1366417|P3|NOT COMPLETED|Before Progression on Erlotinib||1
560553|NCT00673049|1366418|P2|NOT COMPLETED|Before Progression on Erlotinib||290
560554|NCT00673049|1366419|P1|NOT COMPLETED|Before Progression on Erlotinib||292
560555|NCT00673049|1366416|P4|COMPLETED|Before Progression on Erlotinib||0
560556|NCT00673049|1366417|P3|COMPLETED|Before Progression on Erlotinib||0
560557|NCT00673049|1366418|P2|COMPLETED|Before Progression on Erlotinib||0
560558|NCT00673049|1366419|P1|COMPLETED|Before Progression on Erlotinib||0
560559|NCT00673049|1366416|P4|Treated|Before Progression on Erlotinib||0
560560|NCT00673049|1366417|P3|Treated|Before Progression on Erlotinib||1
560561|NCT00673049|1366418|P2|Treated|Before Progression on Erlotinib||289
560562|NCT00673049|1366419|P1|Treated|Before Progression on Erlotinib||289
560563|NCT00673049|1366416|P4|STARTED|Before Progression on Erlotinib|Participants treated with erlo alone who subsequently received figi upon disease progression.|0
560564|NCT00673049|1366417|P3|STARTED|Before Progression on Erlotinib||1
560565|NCT00673049|1366418|P2|STARTED|Before Progression on Erlotinib||290
560566|NCT00673049|1366419|P1|STARTED|Before Progression on Erlotinib||292
560567|NCT00672984|1366443|P3|NOT COMPLETED|Third Intervention||1
560568|NCT00672984|1366444|P2|NOT COMPLETED|Third Intervention||0
560569|NCT00672984|1366445|P1|NOT COMPLETED|Third Intervention||1
560570|NCT00672984|1366443|P3|COMPLETED|Third Intervention||23
560571|NCT00672984|1366444|P2|COMPLETED|Third Intervention||17
560572|NCT00672984|1366445|P1|COMPLETED|Third Intervention||21
560573|NCT00672984|1366443|P3|STARTED|Third Intervention||24
560574|NCT00672984|1366444|P2|STARTED|Third Intervention||17
560575|NCT00672984|1366445|P1|STARTED|Third Intervention||22
560576|NCT00672984|1366443|P3|NOT COMPLETED|Second Intervention||1
560577|NCT00672984|1366444|P2|NOT COMPLETED|Second Intervention||6
560578|NCT00672984|1366445|P1|NOT COMPLETED|Second Intervention||0
560579|NCT00672984|1366443|P3|COMPLETED|Second Intervention||24
560580|NCT00672984|1366444|P2|COMPLETED|Second Intervention||17
560581|NCT00672984|1366445|P1|COMPLETED|Second Intervention||22
560582|NCT00672984|1366443|P3|STARTED|Second Intervention||25
560583|NCT00672984|1366444|P2|STARTED|Second Intervention||23
560584|NCT00672984|1366445|P1|STARTED|Second Intervention||22
560585|NCT00672984|1366443|P3|NOT COMPLETED|First Intervention||2
560586|NCT00672984|1366444|P2|NOT COMPLETED|First Intervention||2
560587|NCT00672984|1366445|P1|NOT COMPLETED|First Intervention||9
560588|NCT00672984|1366443|P3|COMPLETED|First Intervention||25
560589|NCT00672984|1366444|P2|COMPLETED|First Intervention||23
560590|NCT00672984|1366445|P1|COMPLETED|First Intervention||22
560591|NCT00672984|1366443|P3|STARTED|First Intervention||27
560592|NCT00672984|1366444|P2|STARTED|First Intervention||25
560593|NCT00672984|1366445|P1|STARTED|First Intervention||31
560594|NCT00672958|1366496|P2|NOT COMPLETED|Overall Study||56
560595|NCT00672958|1366497|P1|NOT COMPLETED|Overall Study||64
560596|NCT00672958|1366496|P2|COMPLETED|Overall Study||244
560597|NCT00672958|1366497|P1|COMPLETED|Overall Study||236
560598|NCT00672958|1366496|P2|Full Analysis Set|Overall Study|All safety set patients who had at least 1 valid postbaseline primary efficacy assessment.|292
560599|NCT00672958|1366497|P1|Full Analysis Set|Overall Study|All safety set patients who had at least 1 valid postbaseline primary efficacy assessment.|286
560600|NCT00672958|1366496|P2|Safety Set|Overall Study|All randomized patients who received at least 1 dose of double-blind study drug.|299
560601|NCT00672958|1366497|P1|Safety Set|Overall Study|All randomized patients who received at least 1 dose of double-blind study drug.|298
560602|NCT00672958|1366496|P2|STARTED|Overall Study||300
560603|NCT00672958|1366497|P1|STARTED|Overall Study||300
560604|NCT00672932|1366529|P2|NOT COMPLETED|Overall Study||0
560605|NCT00672932|1366530|P1|NOT COMPLETED|Overall Study||0
560606|NCT00672932|1366529|P2|COMPLETED|Overall Study||9
560607|NCT00672932|1366530|P1|COMPLETED|Overall Study||9
560608|NCT00672932|1366529|P2|Rolled Over to Raltegravir|Overall Study|6 subjects randomized to no drug later rolled over to receive raltegravir|6
560609|NCT00672932|1366530|P1|Rolled Over to Raltegravir|Overall Study||0
560610|NCT00672932|1366529|P2|Provided Analyzable Blood and CSF Sample|Overall Study||9
560611|NCT00672932|1366530|P1|Provided Analyzable Blood and CSF Sample|Overall Study|one subject was censored when pharmacological study showed no drug in plasma or CSF|8
560612|NCT00672932|1366529|P2|Completed Initial 12-week Assignment|Overall Study||9
560613|NCT00672932|1366530|P1|Completed Initial 12-week Assignment|Overall Study||9
560614|NCT00672932|1366529|P2|STARTED|Overall Study||9
560615|NCT00672932|1366530|P1|STARTED|Overall Study||9
560616|NCT00672854|1366540|P2|NOT COMPLETED|Overall Study||0
560617|NCT00672854|1366541|P1|NOT COMPLETED|Overall Study||0
560618|NCT00672854|1366540|P2|COMPLETED|Overall Study||51
560619|NCT00672854|1366541|P1|COMPLETED|Overall Study||49
560620|NCT00672854|1366540|P2|STARTED|Overall Study||51
560621|NCT00672854|1366541|P1|STARTED|Overall Study||49
560622|NCT00672841|1366549|P2|NOT COMPLETED|Overall Study||15
560623|NCT00672841|1366550|P1|NOT COMPLETED|Overall Study||1
560624|NCT00672841|1366549|P2|COMPLETED|Overall Study||32
560625|NCT00672841|1366550|P1|COMPLETED|Overall Study||16
560626|NCT00672841|1366549|P2|STARTED|Overall Study||47
560627|NCT00672841|1366550|P1|STARTED|Overall Study||17
560628|NCT00672737|1366562|P1|NOT COMPLETED|Overall Study||8
560629|NCT00672737|1366562|P1|COMPLETED|Overall Study||48
560630|NCT00672737|1366562|P1|STARTED|Overall Study||56
560631|NCT00672646|1366572|P3|NOT COMPLETED|Overall Study||3
560632|NCT00672646|1366573|P2|NOT COMPLETED|Overall Study||1
560633|NCT00672646|1366574|P1|NOT COMPLETED|Overall Study||0
560634|NCT00672646|1366572|P3|COMPLETED|Overall Study||37
560635|NCT00672646|1366573|P2|COMPLETED|Overall Study||22
560636|NCT00672646|1366574|P1|COMPLETED|Overall Study||40
560637|NCT00672646|1366572|P3|STARTED|Overall Study||40
560638|NCT00672646|1366573|P2|STARTED|Overall Study||23
560639|NCT00672646|1366574|P1|STARTED|Overall Study||40
560640|NCT00672633|1366599|P2|NOT COMPLETED|Overall Study||1
560641|NCT00672633|1366600|P1|NOT COMPLETED|Overall Study||0
560642|NCT00672633|1366599|P2|COMPLETED|Overall Study||12
560643|NCT00672633|1366600|P1|COMPLETED|Overall Study||12
560644|NCT00672633|1366599|P2|STARTED|Overall Study||13
560645|NCT00672633|1366600|P1|STARTED|Overall Study||12
560646|NCT00672620|1366614|P4|NOT COMPLETED|Overall Study||42
560647|NCT00672620|1366615|P3|NOT COMPLETED|Overall Study||31
560648|NCT00672620|1366616|P2|NOT COMPLETED|Overall Study||54
560649|NCT00672620|1366617|P1|NOT COMPLETED|Overall Study||33
560650|NCT00672620|1366614|P4|COMPLETED|Overall Study||110
560651|NCT00672620|1366615|P3|COMPLETED|Overall Study||122
560652|NCT00672620|1366616|P2|COMPLETED|Overall Study||99
560653|NCT00672620|1366617|P1|COMPLETED|Overall Study||120
560654|NCT00672620|1366614|P4|Treated|Overall Study||150
560655|NCT00672620|1366615|P3|Treated|Overall Study||153
560656|NCT00672620|1366616|P2|Treated|Overall Study||149
560657|NCT00672620|1366617|P1|Treated|Overall Study||151
560658|NCT00672620|1366614|P4|STARTED|Overall Study||152
560659|NCT00672620|1366615|P3|STARTED|Overall Study||153
560660|NCT00672620|1366616|P2|STARTED|Overall Study||153
560661|NCT00672620|1366617|P1|STARTED|Overall Study||153
560662|NCT00672594|1366671|P1|NOT COMPLETED|Overall Study||3
560663|NCT00672594|1366671|P1|COMPLETED|Overall Study||27
560664|NCT00672594|1366671|P1|STARTED|Overall Study||30
560665|NCT00672555|1366682|P1|NOT COMPLETED|Overall Study||6
560666|NCT00672555|1366682|P1|COMPLETED|Overall Study|All patients were seen at 3 weeks in the outpatient clinic.|64
560667|NCT00672555|1366682|P1|STARTED|Overall Study||70
560668|NCT00672490|1366693|P2|NOT COMPLETED|Overall Study||32
560669|NCT00672490|1366694|P1|NOT COMPLETED|Overall Study||24
560670|NCT00672490|1366693|P2|COMPLETED|Overall Study||157
560671|NCT00672490|1366694|P1|COMPLETED|Overall Study||163
560672|NCT00672490|1366693|P2|STARTED|Overall Study||189
560673|NCT00672490|1366694|P1|STARTED|Overall Study||187
560674|NCT00672477|1366718|P2|NOT COMPLETED|Overall Study||26
560675|NCT00672477|1366719|P1|NOT COMPLETED|Overall Study||27
560676|NCT00672477|1366718|P2|COMPLETED|Overall Study||88
560677|NCT00672477|1366719|P1|COMPLETED|Overall Study|One subject had missing data as reason for study termination - not counted as early termination.|89
560678|NCT00672477|1366718|P2|STARTED|Overall Study|117 subjects were randomized to this group, but only 114 subjects received study drug.|114
560679|NCT00672477|1366719|P1|STARTED|Overall Study|120 subjects were randomized to this group, but only 116 subjects received study drug.|116
560680|NCT00672438|1366729|P2|NOT COMPLETED|Infusion 2||0
560681|NCT00672438|1366730|P1|NOT COMPLETED|Infusion 2||0
560682|NCT00672438|1366729|P2|COMPLETED|Infusion 2||118
560683|NCT00672438|1366730|P1|COMPLETED|Infusion 2||119
560684|NCT00672438|1366729|P2|STARTED|Infusion 2||118
560685|NCT00672438|1366730|P1|STARTED|Infusion 2||119
560686|NCT00672438|1366729|P2|NOT COMPLETED|Washout||0
560687|NCT00672438|1366730|P1|NOT COMPLETED|Washout||0
560688|NCT00672438|1366729|P2|COMPLETED|Washout||118
560689|NCT00672438|1366730|P1|COMPLETED|Washout||119
560690|NCT00672438|1366729|P2|STARTED|Washout||118
560691|NCT00672438|1366730|P1|STARTED|Washout||119
560692|NCT00672438|1366729|P2|NOT COMPLETED|Infusion 1||0
560693|NCT00672438|1366730|P1|NOT COMPLETED|Infusion 1||0
560694|NCT00672438|1366729|P2|COMPLETED|Infusion 1||118
560695|NCT00672438|1366730|P1|COMPLETED|Infusion 1||119
560696|NCT00672438|1366729|P2|STARTED|Infusion 1||118
560697|NCT00672438|1366730|P1|STARTED|Infusion 1||119
560698|NCT00672256|1366761|P1|NOT COMPLETED|Overall Study||44
560699|NCT00672256|1366761|P1|COMPLETED|Overall Study||18
560700|NCT00672256|1366761|P1|STARTED|Overall Study|January 2007|62
560701|NCT00672243|1366768|P1|NOT COMPLETED|Overall Study||0
560702|NCT00672243|1366768|P1|COMPLETED|Overall Study||32
560703|NCT00672243|1366768|P1|STARTED|Overall Study||32
560704|NCT00672204|1366776|P1|NOT COMPLETED|Overall Study||20
560705|NCT00672204|1366776|P1|COMPLETED|Overall Study||3
560706|NCT00672204|1366776|P1|STARTED|Overall Study||23
560707|NCT00672178|1366780|P1|NOT COMPLETED|Overall Study||0
560708|NCT00672178|1366780|P1|COMPLETED|Overall Study||1
560709|NCT00672178|1366780|P1|STARTED|Overall Study||1
560710|NCT00672139|1366786|P2|NOT COMPLETED|Overall Study||45
560711|NCT00672139|1366787|P1|NOT COMPLETED|Overall Study||30
560712|NCT00672139|1366786|P2|COMPLETED|Overall Study||47
560713|NCT00672139|1366787|P1|COMPLETED|Overall Study||27
560714|NCT00672139|1366786|P2|STARTED|Overall Study|Four of 96 enrolled subjects did not receive study drug.|92
560715|NCT00672139|1366787|P1|STARTED|Overall Study|Three of 60 enrolled subjects did not receive study drug.|57
560716|NCT00672100|1366796|P3|NOT COMPLETED|Overall Study||0
560717|NCT00672100|1366797|P2|NOT COMPLETED|Overall Study||0
560718|NCT00672100|1366798|P1|NOT COMPLETED|Overall Study||0
560719|NCT00672100|1366796|P3|COMPLETED|Overall Study||12
560720|NCT00672100|1366797|P2|COMPLETED|Overall Study||12
560721|NCT00672100|1366798|P1|COMPLETED|Overall Study||12
560722|NCT00672100|1366796|P3|PACU (Within 8 Hours)|Overall Study||12
560723|NCT00672100|1366797|P2|PACU (Within 8 Hours)|Overall Study||12
560724|NCT00672100|1366798|P1|PACU (Within 8 Hours)|Overall Study||12
560725|NCT00672100|1366796|P3|STARTED|Overall Study||12
560726|NCT00672100|1366797|P2|STARTED|Overall Study||12
560727|NCT00672100|1366798|P1|STARTED|Overall Study||12
560728|NCT00671970|1366815|P2|NOT COMPLETED|Overall Study||0
560729|NCT00671970|1366816|P1|NOT COMPLETED|Overall Study||0
560730|NCT00671970|1366815|P2|COMPLETED|Overall Study||25
560731|NCT00671970|1366816|P1|COMPLETED|Overall Study||32
560732|NCT00671970|1366815|P2|STARTED|Overall Study||25
560733|NCT00671970|1366816|P1|STARTED|Overall Study||32
560734|NCT00671931|1366844|P5|NOT COMPLETED|Overall Study||1
560735|NCT00671931|1366845|P4|NOT COMPLETED|Overall Study||2
560736|NCT00671931|1366846|P3|NOT COMPLETED|Overall Study||0
560737|NCT00671931|1366847|P2|NOT COMPLETED|Overall Study||0
560738|NCT00671931|1366848|P1|NOT COMPLETED|Overall Study||1
560739|NCT00671931|1366844|P5|COMPLETED|Overall Study|Low heart rate requiring treatment|7
560740|NCT00671931|1366845|P4|COMPLETED|Overall Study|Prepositioning - Neuromonitoring required|8
560741|NCT00671931|1366846|P3|COMPLETED|Overall Study|all completed|9
560742|NCT00671931|1366847|P2|COMPLETED|Overall Study|All completed|8
560743|NCT00671931|1366848|P1|COMPLETED|Overall Study|Nueromonitoring equipment falure|8
560744|NCT00671931|1366844|P5|STARTED|Overall Study||8
560745|NCT00671931|1366845|P4|STARTED|Overall Study||10
560746|NCT00671931|1366846|P3|STARTED|Overall Study||9
560747|NCT00671931|1366847|P2|STARTED|Overall Study||8
560748|NCT00671931|1366848|P1|STARTED|Overall Study||9
560749|NCT00671918|1366860|P1|NOT COMPLETED|Overall Study||17
560750|NCT00671918|1366860|P1|COMPLETED|Overall Study||169
560751|NCT00671918|1366860|P1|STARTED|Overall Study||186
560752|NCT00671879|1366868|P3|NOT COMPLETED|Overall Study||6
560753|NCT00671879|1366869|P2|NOT COMPLETED|Overall Study||4
560754|NCT00671879|1366870|P1|NOT COMPLETED|Overall Study||0
560755|NCT00671879|1366868|P3|COMPLETED|Overall Study||274
560756|NCT00671879|1366869|P2|COMPLETED|Overall Study||275
560757|NCT00671879|1366870|P1|COMPLETED|Overall Study||281
560758|NCT00671879|1366868|P3|STARTED|Overall Study||280
560759|NCT00671879|1366869|P2|STARTED|Overall Study||279
560760|NCT00671879|1366870|P1|STARTED|Overall Study||281
560761|NCT00671853|1366883|P2|NOT COMPLETED|Overall Study||27
560762|NCT00671853|1366884|P1|NOT COMPLETED|Overall Study||20
560763|NCT00671853|1366883|P2|COMPLETED|Overall Study||18
560764|NCT00671853|1366884|P1|COMPLETED|Overall Study||26
560765|NCT00671853|1366883|P2|STARTED|Overall Study||45
560766|NCT00671853|1366884|P1|STARTED|Overall Study||46
560767|NCT00671788|1366900|P1|NOT COMPLETED|Overall Study||14
560768|NCT00671788|1366900|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|21
560769|NCT00671788|1366900|P1|STARTED|Overall Study||35
560770|NCT00671749|1366907|P1|NOT COMPLETED|Overall Study||8
560771|NCT00671749|1366907|P1|COMPLETED|Overall Study||92
560772|NCT00671749|1366907|P1|STARTED|Overall Study||100
560773|NCT00671723|1366920|P3|NOT COMPLETED|Overall Study||0
560774|NCT00671723|1366921|P2|NOT COMPLETED|Overall Study||0
560775|NCT00671723|1366922|P1|NOT COMPLETED|Overall Study||0
560776|NCT00671723|1366920|P3|COMPLETED|Overall Study||11
560777|NCT00671723|1366921|P2|COMPLETED|Overall Study||11
560778|NCT00671723|1366922|P1|COMPLETED|Overall Study||11
560779|NCT00671723|1366920|P3|STARTED|Overall Study||11
560780|NCT00671723|1366921|P2|STARTED|Overall Study||11
560781|NCT00671723|1366922|P1|STARTED|Overall Study||11
560782|NCT00671671|1366935|P2|NOT COMPLETED|Overall Study||0
560783|NCT00671671|1366936|P1|NOT COMPLETED|Overall Study||0
560784|NCT00671671|1366935|P2|COMPLETED|Overall Study||10
560785|NCT00671671|1366936|P1|COMPLETED|Overall Study||10
560786|NCT00671671|1366935|P2|STARTED|Overall Study||10
560787|NCT00671671|1366936|P1|STARTED|Overall Study||10
560788|NCT00671606|1366962|P1|NOT COMPLETED|Overall Study||0
560789|NCT00671606|1366962|P1|COMPLETED|Overall Study||5
560790|NCT00671606|1366962|P1|STARTED|Overall Study||5
560791|NCT00671554|1366966|P1|NOT COMPLETED|Overall Study||3
560792|NCT00671554|1366966|P1|COMPLETED|Overall Study||0
560793|NCT00671554|1366966|P1|STARTED|Overall Study||3
560794|NCT00671528|1366974|P3|NOT COMPLETED|Overall Study||0
560795|NCT00671528|1366975|P2|NOT COMPLETED|Overall Study||0
560796|NCT00671528|1366976|P1|NOT COMPLETED|Overall Study||0
560797|NCT00671528|1366974|P3|COMPLETED|Overall Study||1
560798|NCT00671528|1366975|P2|COMPLETED|Overall Study||1
560799|NCT00671528|1366976|P1|COMPLETED|Overall Study||1
560800|NCT00671528|1366974|P3|STARTED|Overall Study||1
560801|NCT00671528|1366975|P2|STARTED|Overall Study||1
560802|NCT00671528|1366976|P1|STARTED|Overall Study||1
560803|NCT00671515|1366987|P1|NOT COMPLETED|Phase 2||4
560804|NCT00671515|1366987|P1|COMPLETED|Phase 2||9
560805|NCT00671515|1366987|P1|STARTED|Phase 2||13
560806|NCT00671515|1366987|P1|NOT COMPLETED|Phase 1||3
560807|NCT00671515|1366987|P1|COMPLETED|Phase 1||20
560808|NCT00671515|1366987|P1|STARTED|Phase 1||23
560809|NCT00671502|1366995|P3|NOT COMPLETED|Overall Study||27
560810|NCT00671502|1366996|P2|NOT COMPLETED|Overall Study||39
560811|NCT00671502|1366997|P1|NOT COMPLETED|Overall Study||39
560812|NCT00671502|1366995|P3|COMPLETED|Overall Study||252
560813|NCT00671502|1366996|P2|COMPLETED|Overall Study||241
560814|NCT00671502|1366997|P1|COMPLETED|Overall Study||242
560815|NCT00671502|1366995|P3|STARTED|Overall Study||279
560816|NCT00671502|1366996|P2|STARTED|Overall Study||280
560817|NCT00671502|1366997|P1|STARTED|Overall Study||281
560818|NCT00671437|1367005|P1|NOT COMPLETED|Overall Study||15
560819|NCT00671437|1367005|P1|COMPLETED|Overall Study||27
560820|NCT00671437|1367005|P1|STARTED|Overall Study||42
560821|NCT00671177|1367026|P2|NOT COMPLETED|Overall Study||1
560822|NCT00671177|1367027|P1|NOT COMPLETED|Overall Study||2
560823|NCT00671177|1367026|P2|COMPLETED|Overall Study||114
560824|NCT00671177|1367027|P1|COMPLETED|Overall Study||112
560825|NCT00671177|1367026|P2|STARTED|Overall Study||115
560826|NCT00671177|1367027|P1|STARTED|Overall Study||114
560827|NCT00671060|1367039|P2|NOT COMPLETED|Overall Study||1
560828|NCT00671060|1367040|P1|NOT COMPLETED|Overall Study||1
560829|NCT00671060|1367039|P2|COMPLETED|Overall Study|1 woman was withdrawn from the study due to preeclampsia.|75
560830|NCT00671060|1367040|P1|COMPLETED|Overall Study|1 woman completed study but was excluded from analysis because gestational age <14 weeks.|76
560831|NCT00671060|1367039|P2|STARTED|Overall Study||76
560832|NCT00671060|1367040|P1|STARTED|Overall Study||77
560833|NCT00670982|1367048|P2|NOT COMPLETED|Overall Study||0
560834|NCT00670982|1367049|P1|NOT COMPLETED|Overall Study||0
560835|NCT00670982|1367048|P2|COMPLETED|Overall Study||7
560836|NCT00670982|1367049|P1|COMPLETED|Overall Study||22
560837|NCT00670982|1367048|P2|STARTED|Overall Study||7
560838|NCT00670982|1367049|P1|STARTED|Overall Study||22
560839|NCT00670956|1367058|P1|NOT COMPLETED|Overall Study||0
560840|NCT00670956|1367058|P1|COMPLETED|Overall Study||1
560841|NCT00670956|1367058|P1|STARTED|Overall Study||1
560842|NCT00670930|1367066|P2|NOT COMPLETED|Overall Study||1
560843|NCT00670930|1367067|P1|NOT COMPLETED|Overall Study||1
560844|NCT00670930|1367066|P2|COMPLETED|Overall Study||12
560845|NCT00670930|1367067|P1|COMPLETED|Overall Study||22
560846|NCT00670930|1367066|P2|Intent to Treat (ITT) Population|Overall Study||12
560847|NCT00670930|1367067|P1|Intent to Treat (ITT) Population|Overall Study||23
560848|NCT00670930|1367066|P2|STARTED|Overall Study||13
560849|NCT00670930|1367067|P1|STARTED|Overall Study|"Started indicates Randomized and Safety populaiton"|23
560850|NCT00670800|1367083|P2|NOT COMPLETED|Overall Study||2
560851|NCT00670800|1367084|P1|NOT COMPLETED|Overall Study||0
560852|NCT00670800|1367083|P2|COMPLETED|Overall Study|Two controls were found to have insulin resistance and were excluded from analysis.|5
560853|NCT00670800|1367084|P1|COMPLETED|Overall Study||7
560854|NCT00670800|1367083|P2|STARTED|Overall Study||7
560855|NCT00670800|1367084|P1|STARTED|Overall Study||7
560856|NCT00670774|1367100|P1|NOT COMPLETED|Overall Study||0
560857|NCT00670774|1367100|P1|COMPLETED|Overall Study||26
560858|NCT00670774|1367100|P1|STARTED|Overall Study||26
560859|NCT00670748|1367115|P4|NOT COMPLETED|Overall Study||1
560860|NCT00670748|1367116|P3|NOT COMPLETED|Overall Study||2
560861|NCT00670748|1367117|P2|NOT COMPLETED|Overall Study||2
560862|NCT00670748|1367118|P1|NOT COMPLETED|Overall Study||3
560863|NCT00670748|1367115|P4|COMPLETED|Overall Study||4
560864|NCT00670748|1367116|P3|COMPLETED|Overall Study||5
560865|NCT00670748|1367117|P2|COMPLETED|Overall Study||14
560866|NCT00670748|1367118|P1|COMPLETED|Overall Study||14
560867|NCT00670748|1367115|P4|STARTED|Overall Study||5
560868|NCT00670748|1367116|P3|STARTED|Overall Study||7
560869|NCT00670748|1367117|P2|STARTED|Overall Study||16
560870|NCT00670748|1367118|P1|STARTED|Overall Study||17
560871|NCT00670709|1367138|P2|NOT COMPLETED|Overall Study||0
560872|NCT00670709|1367139|P1|NOT COMPLETED|Overall Study||0
560873|NCT00670709|1367138|P2|COMPLETED|Overall Study||15
560874|NCT00670709|1367139|P1|COMPLETED|Overall Study||27
560875|NCT00670709|1367138|P2|STARTED|Overall Study||15
560876|NCT00670709|1367139|P1|STARTED|Overall Study||27
560877|NCT00670631|1367147|P1|NOT COMPLETED|Overall Study||0
560878|NCT00670631|1367147|P1|COMPLETED|Overall Study||0
560879|NCT00670631|1367147|P1|STARTED|Overall Study||0
560880|NCT00670540|1367153|P1|NOT COMPLETED|Overall Study||3325
560881|NCT00670540|1367153|P1|COMPLETED|Overall Study|total recruited for the follow up|4931
560882|NCT00670540|1367153|P1|STARTED|Overall Study||8256
560883|NCT00670462|1367165|P2|NOT COMPLETED|Overall Study||31
560884|NCT00670462|1367166|P1|NOT COMPLETED|Overall Study||30
560885|NCT00670462|1367165|P2|COMPLETED|Overall Study||76
560886|NCT00670462|1367166|P1|COMPLETED|Overall Study||76
560887|NCT00670462|1367165|P2|STARTED|Overall Study||107
560888|NCT00670462|1367166|P1|STARTED|Overall Study||106
560889|NCT00670449|1367198|P4|NOT COMPLETED|Overall Study||8
560890|NCT00670449|1367199|P3|NOT COMPLETED|Overall Study||9
560891|NCT00670449|1367200|P2|NOT COMPLETED|Overall Study||10
560892|NCT00670449|1367201|P1|NOT COMPLETED|Overall Study||9
560893|NCT00670449|1367198|P4|COMPLETED|Overall Study||15
560894|NCT00670449|1367199|P3|COMPLETED|Overall Study||18
560895|NCT00670449|1367200|P2|COMPLETED|Overall Study||36
560896|NCT00670449|1367201|P1|COMPLETED|Overall Study||38
560897|NCT00670449|1367198|P4|Switched to 0.5mg (Open Label)|Overall Study|Following protocol amendment, study became open-label with all patients receiving FTY720 0.5 mg/day|17
560898|NCT00670449|1367199|P3|Switched to 0.5mg (Open Label)|Overall Study||23
560899|NCT00670449|1367200|P2|Switched to 0.5mg (Open Label)|Overall Study|Following protocol amendment, study became open-label with all patients receiving FTY720 0.5 mg/day|41
560900|NCT00670449|1367201|P1|Switched to 0.5mg (Open Label)|Overall Study||45
560901|NCT00670449|1367198|P4|STARTED|Overall Study||23
560902|NCT00670449|1367199|P3|STARTED|Overall Study||27
560903|NCT00670449|1367200|P2|STARTED|Overall Study||46
560904|NCT00670449|1367201|P1|STARTED|Overall Study||47
560905|NCT00670306|1367225|P1|NOT COMPLETED|Overall Study||55
560906|NCT00670306|1367225|P1|COMPLETED|Overall Study||473
560907|NCT00670306|1367225|P1|STARTED|Overall Study||528
560908|NCT00670267|1367229|P1|NOT COMPLETED|Overall Study||1
560909|NCT00670267|1367229|P1|COMPLETED|Overall Study||9
560910|NCT00670267|1367229|P1|STARTED|Overall Study||10
560911|NCT00670241|1367240|P3|NOT COMPLETED|Overall Study||27
560912|NCT00670241|1367241|P2|NOT COMPLETED|Overall Study||21
560913|NCT00670241|1367242|P1|NOT COMPLETED|Overall Study||12
560914|NCT00670241|1367240|P3|COMPLETED|Overall Study||64
560915|NCT00670241|1367241|P2|COMPLETED|Overall Study||163
560916|NCT00670241|1367242|P1|COMPLETED|Overall Study||171
560917|NCT00670241|1367240|P3|STARTED|Overall Study||91
560918|NCT00670241|1367241|P2|STARTED|Overall Study||184
560919|NCT00670241|1367242|P1|STARTED|Overall Study||183
560920|NCT00670228|1367264|P2|NOT COMPLETED|Overall Study||3
560921|NCT00670228|1367265|P1|NOT COMPLETED|Overall Study||5
560922|NCT00670228|1367264|P2|COMPLETED|Overall Study||12
560923|NCT00670228|1367265|P1|COMPLETED|Overall Study||13
560924|NCT00670228|1367264|P2|STARTED|Overall Study||15
560925|NCT00670228|1367265|P1|STARTED|Overall Study||18
560926|NCT00670202|1367279|P2|NOT COMPLETED|Overall Study||0
560927|NCT00670202|1367280|P1|NOT COMPLETED|Overall Study||0
560928|NCT00670202|1367279|P2|COMPLETED|Overall Study||0
560929|NCT00670202|1367280|P1|COMPLETED|Overall Study|Investigators blinded to study drug assignment due to early termination of study|2
560930|NCT00670202|1367279|P2|STARTED|Overall Study||0
560931|NCT00670202|1367280|P1|STARTED|Overall Study|Investigators blinded to study drug assignment due to early termination of study|2
560932|NCT00670111|1367289|P3|NOT COMPLETED|Six Months to Twelve Months||0
560933|NCT00670111|1367290|P2|NOT COMPLETED|Six Months to Twelve Months||0
560934|NCT00670111|1367291|P1|NOT COMPLETED|Six Months to Twelve Months||0
560935|NCT00670111|1367289|P3|COMPLETED|Six Months to Twelve Months||0
560936|NCT00670111|1367290|P2|COMPLETED|Six Months to Twelve Months||8
560937|NCT00670111|1367291|P1|COMPLETED|Six Months to Twelve Months||4
560938|NCT00670111|1367289|P3|STARTED|Six Months to Twelve Months||0
560939|NCT00670111|1367290|P2|STARTED|Six Months to Twelve Months||8
560940|NCT00670111|1367291|P1|STARTED|Six Months to Twelve Months||4
560941|NCT00670111|1367289|P3|NOT COMPLETED|One Month to Six Months||0
560942|NCT00670111|1367290|P2|NOT COMPLETED|One Month to Six Months||0
560943|NCT00670111|1367291|P1|NOT COMPLETED|One Month to Six Months||0
560944|NCT00670111|1367289|P3|COMPLETED|One Month to Six Months||0
560945|NCT00670111|1367290|P2|COMPLETED|One Month to Six Months|8 patients in this group completed the 1 month visit; 4 had data eligible for endpoint analysis.|8
560946|NCT00670111|1367291|P1|COMPLETED|One Month to Six Months|4 patients in this group completed the 1 month visit; 0 had data eligible for endpoint analysis.|4
560947|NCT00670111|1367289|P3|STARTED|One Month to Six Months||0
560948|NCT00670111|1367290|P2|STARTED|One Month to Six Months||8
560949|NCT00670111|1367291|P1|STARTED|One Month to Six Months||4
560950|NCT00670111|1367289|P3|NOT COMPLETED|One Month Period B||0
560951|NCT00670111|1367290|P2|NOT COMPLETED|One Month Period B||0
560952|NCT00670111|1367291|P1|NOT COMPLETED|One Month Period B||0
560953|NCT00670111|1367289|P3|COMPLETED|One Month Period B||0
560954|NCT00670111|1367290|P2|COMPLETED|One Month Period B|8 patients in this group completed the 1 month visit; 6 had data eligible for endpoint analysis.|8
560955|NCT00670111|1367291|P1|COMPLETED|One Month Period B|4 patients in this group completed the 1 month visit; 0 had data eligible for endpoint analysis.|4
560956|NCT00670111|1367289|P3|STARTED|One Month Period B||0
560957|NCT00670111|1367290|P2|STARTED|One Month Period B||8
560958|NCT00670111|1367291|P1|STARTED|One Month Period B||4
560959|NCT00670111|1367289|P3|NOT COMPLETED|One Month Period A||0
560960|NCT00670111|1367290|P2|NOT COMPLETED|One Month Period A||0
560961|NCT00670111|1367291|P1|NOT COMPLETED|One Month Period A||0
560962|NCT00670111|1367289|P3|COMPLETED|One Month Period A||0
560963|NCT00670111|1367290|P2|COMPLETED|One Month Period A||8
560964|NCT00670111|1367291|P1|COMPLETED|One Month Period A||4
560965|NCT00670111|1367289|P3|STARTED|One Month Period A||0
560966|NCT00670111|1367290|P2|STARTED|One Month Period A||8
560967|NCT00670111|1367291|P1|STARTED|One Month Period A||4
560968|NCT00670111|1367289|P3|NOT COMPLETED|Enrollment to One Month||19
560969|NCT00670111|1367290|P2|NOT COMPLETED|Enrollment to One Month||0
560970|NCT00670111|1367291|P1|NOT COMPLETED|Enrollment to One Month||1
560971|NCT00670111|1367289|P3|COMPLETED|Enrollment to One Month||0
560972|NCT00670111|1367290|P2|COMPLETED|Enrollment to One Month||8
560973|NCT00670111|1367291|P1|COMPLETED|Enrollment to One Month||4
560974|NCT00670111|1367289|P3|STARTED|Enrollment to One Month||19
560975|NCT00670111|1367290|P2|STARTED|Enrollment to One Month||8
560976|NCT00670111|1367291|P1|STARTED|Enrollment to One Month||5
560977|NCT00670007|1367299|P1|NOT COMPLETED|Overall Study||9
560978|NCT00670007|1367299|P1|COMPLETED|Overall Study||131
560979|NCT00670007|1367299|P1|STARTED|Overall Study||140
560980|NCT00669955|1367326|P2|NOT COMPLETED|Overall Study||27
560981|NCT00669955|1367327|P1|NOT COMPLETED|Overall Study||14
560982|NCT00669955|1367326|P2|COMPLETED|Overall Study||195
560983|NCT00669955|1367327|P1|COMPLETED|Overall Study||204
560984|NCT00669955|1367326|P2|STARTED|Overall Study||222
560985|NCT00669955|1367327|P1|STARTED|Overall Study|216 patients received study drug. 2 patients were dispensed study drug but did not take it|218
560986|NCT00669942|1367357|P12|NOT COMPLETED|Healthy Volunteers||0
560987|NCT00669942|1367358|P11|NOT COMPLETED|Healthy Volunteers||1
560988|NCT00669942|1367359|P10|NOT COMPLETED|Healthy Volunteers||0
560989|NCT00669942|1367360|P9|NOT COMPLETED|Healthy Volunteers||0
560990|NCT00669942|1367361|P8|NOT COMPLETED|Healthy Volunteers||0
560991|NCT00669942|1367362|P7|NOT COMPLETED|Healthy Volunteers||0
560992|NCT00669942|1367363|P6|NOT COMPLETED|Healthy Volunteers||0
560993|NCT00669942|1367364|P5|NOT COMPLETED|Healthy Volunteers||0
560994|NCT00669942|1367365|P4|NOT COMPLETED|Healthy Volunteers||0
560995|NCT00669942|1367366|P3|NOT COMPLETED|Healthy Volunteers||0
560996|NCT00669942|1367367|P2|NOT COMPLETED|Healthy Volunteers||0
560997|NCT00669942|1367368|P1|NOT COMPLETED|Healthy Volunteers||0
560998|NCT00669942|1367357|P12|COMPLETED|Healthy Volunteers||2
560999|NCT00669942|1367358|P11|COMPLETED|Healthy Volunteers||2
561000|NCT00669942|1367359|P10|COMPLETED|Healthy Volunteers||3
561001|NCT00669942|1367360|P9|COMPLETED|Healthy Volunteers||0
561002|NCT00669942|1367361|P8|COMPLETED|Healthy Volunteers||0
561003|NCT00669942|1367362|P7|COMPLETED|Healthy Volunteers||0
561004|NCT00669942|1367363|P6|COMPLETED|Healthy Volunteers||0
561005|NCT00669942|1367364|P5|COMPLETED|Healthy Volunteers||0
561006|NCT00669942|1367365|P4|COMPLETED|Healthy Volunteers||0
561007|NCT00669942|1367366|P3|COMPLETED|Healthy Volunteers||0
561008|NCT00669942|1367367|P2|COMPLETED|Healthy Volunteers||0
561009|NCT00669942|1367368|P1|COMPLETED|Healthy Volunteers||0
561010|NCT00669942|1367357|P12|STARTED|Healthy Volunteers||2
561011|NCT00669942|1367358|P11|STARTED|Healthy Volunteers||3
561012|NCT00669942|1367359|P10|STARTED|Healthy Volunteers||3
561013|NCT00669942|1367360|P9|STARTED|Healthy Volunteers||0
561014|NCT00669942|1367361|P8|STARTED|Healthy Volunteers||0
561015|NCT00669942|1367362|P7|STARTED|Healthy Volunteers||0
561016|NCT00669942|1367363|P6|STARTED|Healthy Volunteers||0
561017|NCT00669942|1367364|P5|STARTED|Healthy Volunteers||0
561018|NCT00669942|1367365|P4|STARTED|Healthy Volunteers||0
561019|NCT00669942|1367366|P3|STARTED|Healthy Volunteers||0
561020|NCT00669942|1367367|P2|STARTED|Healthy Volunteers||0
561021|NCT00669942|1367368|P1|STARTED|Healthy Volunteers||0
561022|NCT00669942|1367357|P12|NOT COMPLETED|Parts 2 and 3||0
561023|NCT00669942|1367358|P11|NOT COMPLETED|Parts 2 and 3||0
561024|NCT00669942|1367359|P10|NOT COMPLETED|Parts 2 and 3||0
561025|NCT00669942|1367360|P9|NOT COMPLETED|Parts 2 and 3||3
561026|NCT00669942|1367361|P8|NOT COMPLETED|Parts 2 and 3||2
561027|NCT00669942|1367362|P7|NOT COMPLETED|Parts 2 and 3||0
561028|NCT00669942|1367363|P6|NOT COMPLETED|Parts 2 and 3||2
561029|NCT00669942|1367364|P5|NOT COMPLETED|Parts 2 and 3||0
561030|NCT00669942|1367365|P4|NOT COMPLETED|Parts 2 and 3||0
561031|NCT00669942|1367366|P3|NOT COMPLETED|Parts 2 and 3||0
561032|NCT00669942|1367367|P2|NOT COMPLETED|Parts 2 and 3||0
561033|NCT00669942|1367368|P1|NOT COMPLETED|Parts 2 and 3||0
561034|NCT00669942|1367357|P12|COMPLETED|Parts 2 and 3||0
561035|NCT00669942|1367358|P11|COMPLETED|Parts 2 and 3||0
561036|NCT00669942|1367359|P10|COMPLETED|Parts 2 and 3||0
561037|NCT00669942|1367360|P9|COMPLETED|Parts 2 and 3||23
561038|NCT00669942|1367361|P8|COMPLETED|Parts 2 and 3||24
561039|NCT00669942|1367362|P7|COMPLETED|Parts 2 and 3||6
561040|NCT00669942|1367363|P6|COMPLETED|Parts 2 and 3||4
561041|NCT00669942|1367364|P5|COMPLETED|Parts 2 and 3||0
561042|NCT00669942|1367365|P4|COMPLETED|Parts 2 and 3||0
561043|NCT00669942|1367366|P3|COMPLETED|Parts 2 and 3||0
561044|NCT00669942|1367367|P2|COMPLETED|Parts 2 and 3||0
561045|NCT00669942|1367368|P1|COMPLETED|Parts 2 and 3||0
561046|NCT00669942|1367357|P12|STARTED|Parts 2 and 3||0
561047|NCT00669942|1367358|P11|STARTED|Parts 2 and 3||0
561048|NCT00669942|1367359|P10|STARTED|Parts 2 and 3||0
561049|NCT00669942|1367360|P9|STARTED|Parts 2 and 3||26
561050|NCT00669942|1367361|P8|STARTED|Parts 2 and 3||26
561051|NCT00669942|1367362|P7|STARTED|Parts 2 and 3||6
561052|NCT00669942|1367363|P6|STARTED|Parts 2 and 3||6
561053|NCT00669942|1367364|P5|STARTED|Parts 2 and 3||0
561054|NCT00669942|1367365|P4|STARTED|Parts 2 and 3||0
561055|NCT00669942|1367366|P3|STARTED|Parts 2 and 3||0
561056|NCT00669942|1367367|P2|STARTED|Parts 2 and 3||0
561057|NCT00669942|1367368|P1|STARTED|Parts 2 and 3||0
561058|NCT00669942|1367357|P12|NOT COMPLETED|Part 1||0
561059|NCT00669942|1367358|P11|NOT COMPLETED|Part 1||0
561060|NCT00669942|1367359|P10|NOT COMPLETED|Part 1||0
561061|NCT00669942|1367360|P9|NOT COMPLETED|Part 1||0
561062|NCT00669942|1367361|P8|NOT COMPLETED|Part 1||0
561063|NCT00669942|1367362|P7|NOT COMPLETED|Part 1||0
561064|NCT00669942|1367363|P6|NOT COMPLETED|Part 1||0
561065|NCT00669942|1367364|P5|NOT COMPLETED|Part 1||0
561066|NCT00669942|1367365|P4|NOT COMPLETED|Part 1||0
561067|NCT00669942|1367366|P3|NOT COMPLETED|Part 1||0
561068|NCT00669942|1367367|P2|NOT COMPLETED|Part 1||0
561069|NCT00669942|1367368|P1|NOT COMPLETED|Part 1||0
561070|NCT00669942|1367357|P12|COMPLETED|Part 1||0
561071|NCT00669942|1367358|P11|COMPLETED|Part 1||0
561072|NCT00669942|1367359|P10|COMPLETED|Part 1||0
561073|NCT00669942|1367360|P9|COMPLETED|Part 1||0
561074|NCT00669942|1367361|P8|COMPLETED|Part 1||0
561075|NCT00669942|1367362|P7|COMPLETED|Part 1||0
561076|NCT00669942|1367363|P6|COMPLETED|Part 1||0
561077|NCT00669942|1367364|P5|COMPLETED|Part 1||8
561078|NCT00669942|1367365|P4|COMPLETED|Part 1||6
561079|NCT00669942|1367366|P3|COMPLETED|Part 1||6
561080|NCT00669942|1367367|P2|COMPLETED|Part 1||6
561081|NCT00669942|1367368|P1|COMPLETED|Part 1||6
561082|NCT00669942|1367357|P12|STARTED|Part 1||0
561083|NCT00669942|1367358|P11|STARTED|Part 1||0
561084|NCT00669942|1367359|P10|STARTED|Part 1||0
561085|NCT00669942|1367360|P9|STARTED|Part 1||0
561086|NCT00669942|1367361|P8|STARTED|Part 1||0
561087|NCT00669942|1367362|P7|STARTED|Part 1||0
561088|NCT00669942|1367363|P6|STARTED|Part 1||0
561089|NCT00669942|1367364|P5|STARTED|Part 1||8
561090|NCT00669942|1367365|P4|STARTED|Part 1||6
561091|NCT00669942|1367366|P3|STARTED|Part 1||6
561092|NCT00669942|1367367|P2|STARTED|Part 1||6
561093|NCT00669942|1367368|P1|STARTED|Part 1||6
561094|NCT00669916|1367432|P2|NOT COMPLETED|Overall Study||0
561095|NCT00669916|1367433|P1|NOT COMPLETED|Overall Study||0
561096|NCT00669916|1367432|P2|COMPLETED|Overall Study||18
561097|NCT00669916|1367433|P1|COMPLETED|Overall Study||18
561098|NCT00669916|1367432|P2|STARTED|Overall Study||18
561099|NCT00669916|1367433|P1|STARTED|Overall Study||18
561100|NCT00669903|1367451|P4|NOT COMPLETED|Overall Study||4
561101|NCT00669903|1367452|P3|NOT COMPLETED|Overall Study||5
561102|NCT00669903|1367453|P2|NOT COMPLETED|Overall Study||5
561103|NCT00669903|1367454|P1|NOT COMPLETED|Overall Study||1
561104|NCT00669903|1367451|P4|COMPLETED|Overall Study||18
561105|NCT00669903|1367452|P3|COMPLETED|Overall Study||13
561106|NCT00669903|1367453|P2|COMPLETED|Overall Study||32
561107|NCT00669903|1367454|P1|COMPLETED|Overall Study||22
561108|NCT00669903|1367451|P4|Completed Treatment Period|Overall Study||19
561109|NCT00669903|1367452|P3|Completed Treatment Period|Overall Study||13
561110|NCT00669903|1367453|P2|Completed Treatment Period|Overall Study||33
561111|NCT00669903|1367454|P1|Completed Treatment Period|Overall Study||23
561112|NCT00669903|1367451|P4|STARTED|Overall Study||22
561113|NCT00669903|1367452|P3|STARTED|Overall Study||18
561114|NCT00669903|1367453|P2|STARTED|Overall Study||37
561115|NCT00669903|1367454|P1|STARTED|Overall Study||23
561116|NCT00669877|1367484|P1|NOT COMPLETED|Overall Study||4
561117|NCT00669877|1367484|P1|COMPLETED|Overall Study||52
561118|NCT00669877|1367484|P1|STARTED|Overall Study||56
561119|NCT00669864|1367489|P1|NOT COMPLETED|Overall Study||9
561120|NCT00669864|1367489|P1|COMPLETED|Overall Study||284
561121|NCT00669864|1367489|P1|STARTED|Overall Study||293
561122|NCT00669682|1367498|P1|NOT COMPLETED|Overall Study||0
561123|NCT00669682|1367498|P1|COMPLETED|Overall Study||9
561124|NCT00669682|1367498|P1|STARTED|Overall Study||9
561125|NCT00669617|1367503|P5|NOT COMPLETED|Period 5||0
561126|NCT00669617|1367504|P4|NOT COMPLETED|Period 5||0
561127|NCT00669617|1367505|P3|NOT COMPLETED|Period 5||0
561128|NCT00669617|1367506|P2|NOT COMPLETED|Period 5||0
561129|NCT00669617|1367507|P1|NOT COMPLETED|Period 5||0
561130|NCT00669617|1367503|P5|COMPLETED|Period 5||17
561131|NCT00669617|1367504|P4|COMPLETED|Period 5||18
561132|NCT00669617|1367505|P3|COMPLETED|Period 5||17
561133|NCT00669617|1367506|P2|COMPLETED|Period 5||17
561134|NCT00669617|1367507|P1|COMPLETED|Period 5||17
561135|NCT00669617|1367503|P5|STARTED|Period 5||17
561136|NCT00669617|1367504|P4|STARTED|Period 5||18
561137|NCT00669617|1367505|P3|STARTED|Period 5||17
561138|NCT00669617|1367506|P2|STARTED|Period 5||17
561139|NCT00669617|1367507|P1|STARTED|Period 5||17
561140|NCT00669617|1367503|P5|NOT COMPLETED|Period 4||0
561141|NCT00669617|1367504|P4|NOT COMPLETED|Period 4||0
561142|NCT00669617|1367505|P3|NOT COMPLETED|Period 4||0
561143|NCT00669617|1367506|P2|NOT COMPLETED|Period 4||0
561144|NCT00669617|1367507|P1|NOT COMPLETED|Period 4||0
561145|NCT00669617|1367503|P5|COMPLETED|Period 4||17
561146|NCT00669617|1367504|P4|COMPLETED|Period 4||18
561147|NCT00669617|1367505|P3|COMPLETED|Period 4||17
561148|NCT00669617|1367506|P2|COMPLETED|Period 4||17
561149|NCT00669617|1367507|P1|COMPLETED|Period 4||17
561150|NCT00669617|1367503|P5|STARTED|Period 4||17
561151|NCT00669617|1367504|P4|STARTED|Period 4||18
561152|NCT00669617|1367505|P3|STARTED|Period 4||17
561153|NCT00669617|1367506|P2|STARTED|Period 4||17
561154|NCT00669617|1367507|P1|STARTED|Period 4||17
561155|NCT00669617|1367503|P5|NOT COMPLETED|Period 3||0
561156|NCT00669617|1367504|P4|NOT COMPLETED|Period 3||0
561157|NCT00669617|1367505|P3|NOT COMPLETED|Period 3||0
561158|NCT00669617|1367506|P2|NOT COMPLETED|Period 3||0
561159|NCT00669617|1367507|P1|NOT COMPLETED|Period 3||1
561160|NCT00669617|1367503|P5|COMPLETED|Period 3||17
561161|NCT00669617|1367504|P4|COMPLETED|Period 3||18
561162|NCT00669617|1367505|P3|COMPLETED|Period 3||17
561163|NCT00669617|1367506|P2|COMPLETED|Period 3||17
561164|NCT00669617|1367507|P1|COMPLETED|Period 3||17
561165|NCT00669617|1367503|P5|STARTED|Period 3||17
561166|NCT00669617|1367504|P4|STARTED|Period 3||18
561167|NCT00669617|1367505|P3|STARTED|Period 3||17
561168|NCT00669617|1367506|P2|STARTED|Period 3||17
561169|NCT00669617|1367507|P1|STARTED|Period 3||18
561170|NCT00669617|1367503|P5|NOT COMPLETED|Period 2||0
561171|NCT00669617|1367504|P4|NOT COMPLETED|Period 2||0
561172|NCT00669617|1367505|P3|NOT COMPLETED|Period 2||0
561173|NCT00669617|1367506|P2|NOT COMPLETED|Period 2||0
561174|NCT00669617|1367507|P1|NOT COMPLETED|Period 2||0
561175|NCT00669617|1367503|P5|COMPLETED|Period 2||17
561176|NCT00669617|1367504|P4|COMPLETED|Period 2||18
561177|NCT00669617|1367505|P3|COMPLETED|Period 2||17
561178|NCT00669617|1367506|P2|COMPLETED|Period 2||17
561179|NCT00669617|1367507|P1|COMPLETED|Period 2||18
561180|NCT00669617|1367503|P5|STARTED|Period 2||17
561181|NCT00669617|1367504|P4|STARTED|Period 2||18
561182|NCT00669617|1367505|P3|STARTED|Period 2||17
561183|NCT00669617|1367506|P2|STARTED|Period 2||17
561184|NCT00669617|1367507|P1|STARTED|Period 2||18
561185|NCT00669617|1367503|P5|NOT COMPLETED|Period 1||1
561186|NCT00669617|1367504|P4|NOT COMPLETED|Period 1||0
561187|NCT00669617|1367505|P3|NOT COMPLETED|Period 1||1
561188|NCT00669617|1367506|P2|NOT COMPLETED|Period 1||0
561189|NCT00669617|1367507|P1|NOT COMPLETED|Period 1||0
561190|NCT00669617|1367503|P5|COMPLETED|Period 1||17
561191|NCT00669617|1367504|P4|COMPLETED|Period 1||18
561192|NCT00669617|1367505|P3|COMPLETED|Period 1||17
561193|NCT00669617|1367506|P2|COMPLETED|Period 1||17
561194|NCT00669617|1367507|P1|COMPLETED|Period 1||18
561195|NCT00669617|1367503|P5|STARTED|Period 1||18
561196|NCT00669617|1367504|P4|STARTED|Period 1||18
561197|NCT00669617|1367505|P3|STARTED|Period 1||18
561198|NCT00669617|1367506|P2|STARTED|Period 1||17
561199|NCT00669617|1367507|P1|STARTED|Period 1||18
561200|NCT00669578|1367521|P2|NOT COMPLETED|Overall Study||0
561201|NCT00669578|1367522|P1|NOT COMPLETED|Overall Study||0
561202|NCT00669578|1367521|P2|COMPLETED|Overall Study||65
561203|NCT00669578|1367522|P1|COMPLETED|Overall Study||12
561204|NCT00669578|1367521|P2|STARTED|Overall Study||65
561205|NCT00669578|1367522|P1|STARTED|Overall Study||12
561206|NCT00669552|1367535|P1|NOT COMPLETED|Overall Study||0
561207|NCT00669552|1367535|P1|COMPLETED|Overall Study||11
561208|NCT00669552|1367535|P1|STARTED|Overall Study||11
561209|NCT00669539|1367541|P2|NOT COMPLETED|Overall Study||9
561210|NCT00669539|1367542|P1|NOT COMPLETED|Overall Study||8
561211|NCT00669539|1367541|P2|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|43
561212|NCT00669539|1367542|P1|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|86
561213|NCT00669539|1367541|P2|STARTED|Overall Study||52
561214|NCT00669539|1367542|P1|STARTED|Overall Study||94
561215|NCT00669461|1367548|P1|NOT COMPLETED|Overall Study||0
561216|NCT00669461|1367548|P1|COMPLETED|Overall Study||1
561217|NCT00669461|1367548|P1|STARTED|Overall Study||1
561218|NCT00669396|1367555|P2|NOT COMPLETED|Overall Study||12
561219|NCT00669396|1367556|P1|NOT COMPLETED|Overall Study||10
561220|NCT00669396|1367555|P2|COMPLETED|Overall Study||22
561221|NCT00669396|1367556|P1|COMPLETED|Overall Study||13
561222|NCT00669396|1367555|P2|STARTED|Overall Study||34
561223|NCT00669396|1367556|P1|STARTED|Overall Study||23
561224|NCT00669331|1367570|P2|NOT COMPLETED|Blinded Treatment Period||39
561225|NCT00669331|1367571|P1|NOT COMPLETED|Blinded Treatment Period||42
561226|NCT00669331|1367570|P2|COMPLETED|Blinded Treatment Period||189
561227|NCT00669331|1367571|P1|COMPLETED|Blinded Treatment Period||191
561228|NCT00669331|1367570|P2|STARTED|Blinded Treatment Period||228
561229|NCT00669331|1367571|P1|STARTED|Blinded Treatment Period||233
561230|NCT00669331|1367570|P2|NOT COMPLETED|Randomisation to First Dose||13
561231|NCT00669331|1367571|P1|NOT COMPLETED|Randomisation to First Dose||11
561232|NCT00669331|1367570|P2|COMPLETED|Randomisation to First Dose||228
561233|NCT00669331|1367571|P1|COMPLETED|Randomisation to First Dose||233
561234|NCT00669331|1367570|P2|STARTED|Randomisation to First Dose||241
561235|NCT00669331|1367571|P1|STARTED|Randomisation to First Dose||244
561236|NCT00669318|1367613|P1|NOT COMPLETED|Overall Study||2
561237|NCT00669318|1367613|P1|COMPLETED|Overall Study||39
561238|NCT00669318|1367613|P1|STARTED|Overall Study||41
561239|NCT00669279|1367623|P2|NOT COMPLETED|Overall Study||0
561240|NCT00669279|1367624|P1|NOT COMPLETED|Overall Study||0
561241|NCT00669279|1367623|P2|COMPLETED|Overall Study||19
561242|NCT00669279|1367624|P1|COMPLETED|Overall Study||22
561243|NCT00669279|1367623|P2|STARTED|Overall Study||19
561244|NCT00669279|1367624|P1|STARTED|Overall Study||22
561245|NCT00669240|1367630|P1|NOT COMPLETED|Overall Study||165
561246|NCT00669240|1367630|P1|COMPLETED|Overall Study||402
561247|NCT00669240|1367630|P1|Received Treatment|Overall Study||551
561248|NCT00669240|1367630|P1|Assigned to Treatment|Overall Study||566
561249|NCT00669240|1367630|P1|STARTED|Overall Study||567
561250|NCT00669214|1367646|P2|NOT COMPLETED|Open-Label Treatment Period (Week 24)||9
561251|NCT00669214|1367647|P1|NOT COMPLETED|Open-Label Treatment Period (Week 24)||4
561252|NCT00669214|1367646|P2|COMPLETED|Open-Label Treatment Period (Week 24)||46
561253|NCT00669214|1367647|P1|COMPLETED|Open-Label Treatment Period (Week 24)||18
561254|NCT00669214|1367646|P2|STARTED|Open-Label Treatment Period (Week 24)||55
561255|NCT00669214|1367647|P1|STARTED|Open-Label Treatment Period (Week 24)||22
561256|NCT00669214|1367646|P2|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||7
561257|NCT00669214|1367647|P1|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||5
561258|NCT00669214|1367646|P2|COMPLETED|Double-Blind Treatment Period (Week 12)||55
561259|NCT00669214|1367647|P1|COMPLETED|Double-Blind Treatment Period (Week 12)||22
561260|NCT00669214|1367646|P2|STARTED|Double-Blind Treatment Period (Week 12)||62
561261|NCT00669214|1367647|P1|STARTED|Double-Blind Treatment Period (Week 12)||27
561262|NCT00669110|1367681|P2|NOT COMPLETED|Overall Study||13
561263|NCT00669110|1367682|P1|NOT COMPLETED|Overall Study||8
561264|NCT00669110|1367681|P2|COMPLETED|Overall Study||7
561265|NCT00669110|1367682|P1|COMPLETED|Overall Study||12
561266|NCT00669110|1367681|P2|STARTED|Overall Study||20
561267|NCT00669110|1367682|P1|STARTED|Overall Study||20
561268|NCT00669071|1367718|P1|NOT COMPLETED|Overall Study||4
561269|NCT00669071|1367718|P1|COMPLETED|Overall Study||52
561270|NCT00669071|1367718|P1|STARTED|Overall Study||56
561271|NCT00669032|1367739|P2|NOT COMPLETED|Overall Study||59
561272|NCT00669032|1367740|P1|NOT COMPLETED|Overall Study||44
561273|NCT00669032|1367739|P2|COMPLETED|Overall Study||94
561274|NCT00669032|1367740|P1|COMPLETED|Overall Study||109
561275|NCT00669032|1367739|P2|STARTED|Overall Study||153
561276|NCT00669032|1367740|P1|STARTED|Overall Study||153
561277|NCT00669019|1367768|P1|NOT COMPLETED|Overall Study||0
561278|NCT00669019|1367768|P1|COMPLETED|Overall Study||23
561279|NCT00669019|1367768|P1|STARTED|Overall Study||23
561280|NCT00668902|1367776|P3|NOT COMPLETED|Overall Study||0
561281|NCT00668902|1367777|P2|NOT COMPLETED|Overall Study||0
561282|NCT00668902|1367778|P1|NOT COMPLETED|Overall Study||0
561283|NCT00668902|1367776|P3|COMPLETED|Overall Study||5
561284|NCT00668902|1367777|P2|COMPLETED|Overall Study||10
561285|NCT00668902|1367778|P1|COMPLETED|Overall Study||10
561286|NCT00668902|1367776|P3|STARTED|Overall Study||5
561287|NCT00668902|1367777|P2|STARTED|Overall Study||10
561288|NCT00668902|1367778|P1|STARTED|Overall Study||10
561289|NCT00668863|1367786|P1|NOT COMPLETED|Overall Study||71
561290|NCT00668863|1367786|P1|COMPLETED|Overall Study||0
561291|NCT00668863|1367786|P1|STARTED|Overall Study||71
561292|NCT00668811|1367805|P1|NOT COMPLETED|Overall Study||0
561293|NCT00668811|1367805|P1|COMPLETED|Overall Study||23
561294|NCT00668811|1367805|P1|STARTED|Overall Study||23
561295|NCT00668785|1367810|P1|NOT COMPLETED|Overall Study||0
561296|NCT00668785|1367810|P1|COMPLETED|Overall Study||6
561297|NCT00668785|1367810|P1|STARTED|Overall Study||6
561298|NCT00668746|1367816|P2|NOT COMPLETED|Overall Study||1
561299|NCT00668746|1367817|P1|NOT COMPLETED|Overall Study||2
561300|NCT00668746|1367816|P2|COMPLETED|Overall Study||11
561301|NCT00668746|1367817|P1|COMPLETED|Overall Study||21
561302|NCT00668746|1367816|P2|STARTED|Overall Study||12
561303|NCT00668746|1367817|P1|STARTED|Overall Study||23
561304|NCT00668733|1367837|P2|NOT COMPLETED|Overall Study||7
561305|NCT00668733|1367838|P1|NOT COMPLETED|Overall Study||2
561306|NCT00668733|1367837|P2|COMPLETED|Overall Study||83
561307|NCT00668733|1367838|P1|COMPLETED|Overall Study||87
561308|NCT00668733|1367837|P2|STARTED|Overall Study||90
561309|NCT00668733|1367838|P1|STARTED|Overall Study||89
561310|NCT00668564|1367844|P1|NOT COMPLETED|Overall Study||0
561311|NCT00668564|1367844|P1|COMPLETED|Overall Study||18
561312|NCT00668564|1367844|P1|STARTED|Overall Study||18
561313|NCT00668525|1367852|P3|NOT COMPLETED|Overall Study||53
561314|NCT00668525|1367853|P2|NOT COMPLETED|Overall Study||93
561315|NCT00668525|1367854|P1|NOT COMPLETED|Overall Study||77
561316|NCT00668525|1367852|P3|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|167
561317|NCT00668525|1367853|P2|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|239
561318|NCT00668525|1367854|P1|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|248
561319|NCT00668525|1367852|P3|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|220
561320|NCT00668525|1367853|P2|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|332
561321|NCT00668525|1367854|P1|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|325
561322|NCT00668434|1367867|P2|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||11
561323|NCT00668434|1367868|P1|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||22
561324|NCT00668434|1367867|P2|COMPLETED|Secondary Outcome Time Point (52 Weeks)||77
561325|NCT00668434|1367868|P1|COMPLETED|Secondary Outcome Time Point (52 Weeks)||157
561326|NCT00668434|1367867|P2|STARTED|Secondary Outcome Time Point (52 Weeks)|Baseline|88
561327|NCT00668434|1367868|P1|STARTED|Secondary Outcome Time Point (52 Weeks)|Baseline|179
561328|NCT00668434|1367867|P2|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||0
561329|NCT00668434|1367868|P1|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||2
561330|NCT00668434|1367867|P2|COMPLETED|Primary Outcome Time Point (3 Weeks)||88
561331|NCT00668434|1367868|P1|COMPLETED|Primary Outcome Time Point (3 Weeks)||179
561332|NCT00668434|1367867|P2|STARTED|Primary Outcome Time Point (3 Weeks)|Baseline|88
561333|NCT00668434|1367868|P1|STARTED|Primary Outcome Time Point (3 Weeks)|Baseline|181
561334|NCT00668395|1367883|P3|NOT COMPLETED|Overall Study||1
561335|NCT00668395|1367884|P2|NOT COMPLETED|Overall Study||6
561336|NCT00668395|1367885|P1|NOT COMPLETED|Overall Study||6
561337|NCT00668395|1367883|P3|COMPLETED|Overall Study||5
561338|NCT00668395|1367884|P2|COMPLETED|Overall Study||16
561339|NCT00668395|1367885|P1|COMPLETED|Overall Study||39
561340|NCT00668395|1367883|P3|STARTED|Overall Study||6
561341|NCT00668395|1367884|P2|STARTED|Overall Study||22
561342|NCT00668395|1367885|P1|STARTED|Overall Study||45
561343|NCT00668382|1367893|P1|NOT COMPLETED|Overall Study||0
561344|NCT00668382|1367893|P1|COMPLETED|Overall Study||11
561345|NCT00668382|1367893|P1|STARTED|Overall Study|beginning of trial|11
561346|NCT00668317|1367897|P1|NOT COMPLETED|Overall Study||2
561347|NCT00668317|1367897|P1|COMPLETED|Overall Study||3
561348|NCT00668317|1367897|P1|STARTED|Overall Study||5
561349|NCT00668265|1367903|P2|NOT COMPLETED|Overall Study||5
561350|NCT00668265|1367904|P1|NOT COMPLETED|Overall Study||9
561351|NCT00668265|1367903|P2|COMPLETED|Overall Study|The PI left, no records avaialable; the number of subjects who completed the study is not known|0
561352|NCT00668265|1367904|P1|COMPLETED|Overall Study|The PI left, no records avaialable; the number of subjects who completed the study is not known|0
561353|NCT00668265|1367903|P2|STARTED|Overall Study||5
561354|NCT00668265|1367904|P1|STARTED|Overall Study||9
561355|NCT00668200|1367912|P1|NOT COMPLETED|Overall Study||3
561356|NCT00668200|1367912|P1|COMPLETED|Overall Study||77
561357|NCT00668200|1367912|P1|Intent to Treat (ITT)|Overall Study||80
561358|NCT00668200|1367912|P1|Safety Population|Overall Study|1 patient was not included in the ITT patient was enrolled in error|81
561359|NCT00668200|1367912|P1|STARTED|Overall Study||80
561360|NCT00667992|1367920|P2|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0
561361|NCT00667992|1367921|P1|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0
561362|NCT00667992|1367920|P2|COMPLETED|Forth Intervention 400 Mcg Twice Daily||35
561363|NCT00667992|1367921|P1|COMPLETED|Forth Intervention 400 Mcg Twice Daily||33
561364|NCT00667992|1367920|P2|STARTED|Forth Intervention 400 Mcg Twice Daily||35
561365|NCT00667992|1367921|P1|STARTED|Forth Intervention 400 Mcg Twice Daily||33
561366|NCT00667992|1367920|P2|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1
561367|NCT00667992|1367921|P1|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1
561368|NCT00667992|1367920|P2|COMPLETED|Third Intervention 100 Mcg Twice Daily||35
561369|NCT00667992|1367921|P1|COMPLETED|Third Intervention 100 Mcg Twice Daily||33
561370|NCT00667992|1367920|P2|STARTED|Third Intervention 100 Mcg Twice Daily||36
561371|NCT00667992|1367921|P1|STARTED|Third Intervention 100 Mcg Twice Daily||34
561372|NCT00667992|1367920|P2|NOT COMPLETED|Wash-out||5
561373|NCT00667992|1367921|P1|NOT COMPLETED|Wash-out||7
561374|NCT00667992|1367920|P2|COMPLETED|Wash-out||36
561375|NCT00667992|1367921|P1|COMPLETED|Wash-out||34
561376|NCT00667992|1367920|P2|STARTED|Wash-out||41
561377|NCT00667992|1367921|P1|STARTED|Wash-out||41
561378|NCT00667992|1367920|P2|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||4
561379|NCT00667992|1367921|P1|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||3
561380|NCT00667992|1367920|P2|COMPLETED|Second Intervention 400 Mcg Twice Daily||41
561381|NCT00667992|1367921|P1|COMPLETED|Second Intervention 400 Mcg Twice Daily||41
561382|NCT00667992|1367920|P2|STARTED|Second Intervention 400 Mcg Twice Daily||45
561383|NCT00667992|1367921|P1|STARTED|Second Intervention 400 Mcg Twice Daily||44
561384|NCT00667992|1367920|P2|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5
561385|NCT00667992|1367921|P1|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5
561386|NCT00667992|1367920|P2|COMPLETED|First Intervention 100 Mcg Twice Daily||45
561387|NCT00667992|1367921|P1|COMPLETED|First Intervention 100 Mcg Twice Daily||44
561388|NCT00667992|1367920|P2|STARTED|First Intervention 100 Mcg Twice Daily||50
561389|NCT00667992|1367921|P1|STARTED|First Intervention 100 Mcg Twice Daily||49
561390|NCT00667875|1367978|P3|NOT COMPLETED|Overall Study||13
561391|NCT00667875|1367979|P2|NOT COMPLETED|Overall Study||11
561392|NCT00667875|1367980|P1|NOT COMPLETED|Overall Study||10
561393|NCT00667875|1367978|P3|COMPLETED|Overall Study||8
561394|NCT00667875|1367979|P2|COMPLETED|Overall Study||10
561395|NCT00667875|1367980|P1|COMPLETED|Overall Study|Subjects who dropped out during treatment are considered completed if they provide end of study data|13
561396|NCT00667875|1367978|P3|Subjects Included in Analysisd|Overall Study||19
561397|NCT00667875|1367979|P2|Subjects Included in Analysisd|Overall Study||21
561398|NCT00667875|1367980|P1|Subjects Included in Analysisd|Overall Study||20
561399|NCT00667875|1367978|P3|STARTED|Overall Study|2 subjects had no data following randomization and were excluded from the analysis.|21
561400|NCT00667875|1367979|P2|STARTED|Overall Study||21
561401|NCT00667875|1367980|P1|STARTED|Overall Study|3 subjects had no data after randomization and were excluded from analysis|23
561402|NCT00667849|1367999|P2|NOT COMPLETED|Overall Study||121
561403|NCT00667849|1368000|P1|NOT COMPLETED|Overall Study||108
561404|NCT00667849|1367999|P2|COMPLETED|Overall Study||130
561405|NCT00667849|1368000|P1|COMPLETED|Overall Study||142
561406|NCT00667849|1367999|P2|STARTED|Overall Study||251
561407|NCT00667849|1368000|P1|STARTED|Overall Study||250
561408|NCT00667810|1368014|P4|NOT COMPLETED|Overall Study||2
561409|NCT00667810|1368015|P3|NOT COMPLETED|Overall Study||222
561410|NCT00667810|1368016|P2|NOT COMPLETED|Overall Study||170
561411|NCT00667810|1368017|P1|NOT COMPLETED|Overall Study||167
561412|NCT00667810|1368014|P4|COMPLETED|Overall Study||9
561413|NCT00667810|1368015|P3|COMPLETED|Overall Study||124
561414|NCT00667810|1368016|P2|COMPLETED|Overall Study||94
561415|NCT00667810|1368017|P1|COMPLETED|Overall Study||102
561416|NCT00667810|1368014|P4|Treated|Overall Study||11
561417|NCT00667810|1368015|P3|Treated|Overall Study||344
561418|NCT00667810|1368016|P2|Treated|Overall Study||263
561419|NCT00667810|1368017|P1|Treated|Overall Study||267
561420|NCT00667810|1368014|P4|STARTED|Overall Study||11
561421|NCT00667810|1368015|P3|STARTED|Overall Study||346
561422|NCT00667810|1368016|P2|STARTED|Overall Study||264
561423|NCT00667810|1368017|P1|STARTED|Overall Study||269
561424|NCT00667745|1368076|P2|NOT COMPLETED|Overall Study||21
561425|NCT00667745|1368077|P1|NOT COMPLETED|Overall Study||25
561426|NCT00667745|1368076|P2|COMPLETED|Overall Study||121
561427|NCT00667745|1368077|P1|COMPLETED|Overall Study||116
561428|NCT00667745|1368076|P2|STARTED|Overall Study||142
561429|NCT00667745|1368077|P1|STARTED|Overall Study||141
561430|NCT00667732|1368093|P3|NOT COMPLETED|Extension (26 Weeks)||0
561431|NCT00667732|1368094|P2|NOT COMPLETED|Extension (26 Weeks)||0
561432|NCT00667732|1368095|P1|NOT COMPLETED|Extension (26 Weeks)||0
561433|NCT00667732|1368093|P3|COMPLETED|Extension (26 Weeks)||17
561434|NCT00667732|1368094|P2|COMPLETED|Extension (26 Weeks)||14
561435|NCT00667732|1368095|P1|COMPLETED|Extension (26 Weeks)||0
561436|NCT00667732|1368093|P3|STARTED|Extension (26 Weeks)||17
561437|NCT00667732|1368094|P2|STARTED|Extension (26 Weeks)||14
561438|NCT00667732|1368095|P1|STARTED|Extension (26 Weeks)||0
561439|NCT00667732|1368093|P3|NOT COMPLETED|Randomization (24 Weeks)||0
561440|NCT00667732|1368094|P2|NOT COMPLETED|Randomization (24 Weeks)||1
561441|NCT00667732|1368095|P1|NOT COMPLETED|Randomization (24 Weeks)||0
561442|NCT00667732|1368093|P3|COMPLETED|Randomization (24 Weeks)||17
561443|NCT00667732|1368094|P2|COMPLETED|Randomization (24 Weeks)||16
561444|NCT00667732|1368095|P1|COMPLETED|Randomization (24 Weeks)||0
561445|NCT00667732|1368093|P3|Participants Enrolled in Substudy|Randomization (24 Weeks)||9
561446|NCT00667732|1368094|P2|Participants Enrolled in Substudy|Randomization (24 Weeks)||11
561447|NCT00667732|1368095|P1|Participants Enrolled in Substudy|Randomization (24 Weeks)||0
561448|NCT00667732|1368093|P3|STARTED|Randomization (24 Weeks)||17
561449|NCT00667732|1368094|P2|STARTED|Randomization (24 Weeks)||17
561450|NCT00667732|1368095|P1|STARTED|Randomization (24 Weeks)||0
561451|NCT00667732|1368093|P3|NOT COMPLETED|Run -In (8 Weeks)||0
561452|NCT00667732|1368094|P2|NOT COMPLETED|Run -In (8 Weeks)||0
561453|NCT00667732|1368095|P1|NOT COMPLETED|Run -In (8 Weeks)||7
561454|NCT00667732|1368093|P3|COMPLETED|Run -In (8 Weeks)||0
561455|NCT00667732|1368094|P2|COMPLETED|Run -In (8 Weeks)||0
561456|NCT00667732|1368095|P1|COMPLETED|Run -In (8 Weeks)||34
561457|NCT00667732|1368093|P3|Participants Enrolled in Substudy|Run -In (8 Weeks)||0
561458|NCT00667732|1368094|P2|Participants Enrolled in Substudy|Run -In (8 Weeks)||0
561459|NCT00667732|1368095|P1|Participants Enrolled in Substudy|Run -In (8 Weeks)||20
561460|NCT00667732|1368093|P3|STARTED|Run -In (8 Weeks)||0
561461|NCT00667732|1368094|P2|STARTED|Run -In (8 Weeks)||0
561462|NCT00667732|1368095|P1|STARTED|Run -In (8 Weeks)||41
561463|NCT00667693|1368108|P2|NOT COMPLETED|Overall Study||2
561464|NCT00667693|1368109|P1|NOT COMPLETED|Overall Study||0
561465|NCT00667693|1368108|P2|COMPLETED|Overall Study||50
561466|NCT00667693|1368109|P1|COMPLETED|Overall Study||49
561467|NCT00667693|1368108|P2|STARTED|Overall Study||52
561468|NCT00667693|1368109|P1|STARTED|Overall Study||49
561469|NCT00667615|1368115|P1|NOT COMPLETED|Overall Study||0
561470|NCT00667615|1368115|P1|COMPLETED|Overall Study||30
561471|NCT00667615|1368115|P1|STARTED|Overall Study||30
561472|NCT00667602|1368123|P3|NOT COMPLETED|Overall Study||18
561473|NCT00667602|1368124|P2|NOT COMPLETED|Overall Study||15
561474|NCT00667602|1368125|P1|NOT COMPLETED|Overall Study||8
561475|NCT00667602|1368123|P3|COMPLETED|Overall Study||197
561476|NCT00667602|1368124|P2|COMPLETED|Overall Study||213
561477|NCT00667602|1368125|P1|COMPLETED|Overall Study||211
561478|NCT00667602|1368123|P3|STARTED|Overall Study||215
561479|NCT00667602|1368124|P2|STARTED|Overall Study||228
561480|NCT00667602|1368125|P1|STARTED|Overall Study||219
561481|NCT00667589|1368175|P4|NOT COMPLETED|Overall Study||1
561482|NCT00667589|1368176|P3|NOT COMPLETED|Overall Study||3
561483|NCT00667589|1368177|P2|NOT COMPLETED|Overall Study||0
561484|NCT00667589|1368178|P1|NOT COMPLETED|Overall Study||1
561485|NCT00667589|1368175|P4|COMPLETED|Overall Study||1
561486|NCT00667589|1368176|P3|COMPLETED|Overall Study||0
561487|NCT00667589|1368177|P2|COMPLETED|Overall Study||0
561488|NCT00667589|1368178|P1|COMPLETED|Overall Study||0
561489|NCT00667589|1368175|P4|STARTED|Overall Study||2
561490|NCT00667589|1368176|P3|STARTED|Overall Study||3
561491|NCT00667589|1368177|P2|STARTED|Overall Study||0
561492|NCT00667589|1368178|P1|STARTED|Overall Study||1
561493|NCT00667576|1368193|P5|NOT COMPLETED|Overall Study||1
561494|NCT00667576|1368194|P4|NOT COMPLETED|Overall Study||4
561495|NCT00667576|1368195|P3|NOT COMPLETED|Overall Study||2
561496|NCT00667576|1368196|P2|NOT COMPLETED|Overall Study||1
561497|NCT00667576|1368197|P1|NOT COMPLETED|Overall Study||2
561498|NCT00667576|1368193|P5|COMPLETED|Overall Study||29
561499|NCT00667576|1368194|P4|COMPLETED|Overall Study||27
561500|NCT00667576|1368195|P3|COMPLETED|Overall Study||29
561501|NCT00667576|1368196|P2|COMPLETED|Overall Study||30
561502|NCT00667576|1368197|P1|COMPLETED|Overall Study||28
561503|NCT00667576|1368193|P5|STARTED|Overall Study||30
561504|NCT00667576|1368194|P4|STARTED|Overall Study||31
561505|NCT00667576|1368195|P3|STARTED|Overall Study||31
561506|NCT00667576|1368196|P2|STARTED|Overall Study||31
561507|NCT00667576|1368197|P1|STARTED|Overall Study||30
561508|NCT00667563|1368244|P1|NOT COMPLETED|Overall Study||24
561509|NCT00667563|1368244|P1|COMPLETED|Overall Study||126
561510|NCT00667563|1368244|P1|STARTED|Overall Study||150
561511|NCT00667511|1368254|P1|NOT COMPLETED|Intervention 2: Home NHD||4
561512|NCT00667511|1368254|P1|COMPLETED|Intervention 2: Home NHD||39
561513|NCT00667511|1368254|P1|STARTED|Intervention 2: Home NHD||43
561514|NCT00667511|1368254|P1|NOT COMPLETED|Training/Transition Period||8
561515|NCT00667511|1368254|P1|COMPLETED|Training/Transition Period||43
561516|NCT00667511|1368254|P1|STARTED|Training/Transition Period||51
561517|NCT00667511|1368254|P1|NOT COMPLETED|Intervention 1: Home DHD||7
561518|NCT00667511|1368254|P1|COMPLETED|Intervention 1: Home DHD||51
561519|NCT00667511|1368254|P1|STARTED|Intervention 1: Home DHD||58
561520|NCT00667459|1368264|P2|NOT COMPLETED|Overall Study||45
561521|NCT00667459|1368265|P1|NOT COMPLETED|Overall Study||8
561522|NCT00667459|1368264|P2|COMPLETED|Overall Study||220
561523|NCT00667459|1368265|P1|COMPLETED|Overall Study||272
561524|NCT00667459|1368264|P2|STARTED|Overall Study||265
561525|NCT00667459|1368265|P1|STARTED|Overall Study||280
561526|NCT00667446|1368307|P2|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||1
561527|NCT00667446|1368308|P1|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||0
561528|NCT00667446|1368307|P2|COMPLETED|Safety Follow-up Period (12 Weeks)||25
561529|NCT00667446|1368308|P1|COMPLETED|Safety Follow-up Period (12 Weeks)||28
561530|NCT00667446|1368307|P2|STARTED|Safety Follow-up Period (12 Weeks)||26
561531|NCT00667446|1368308|P1|STARTED|Safety Follow-up Period (12 Weeks)||28
561532|NCT00667446|1368307|P2|NOT COMPLETED|Treatment Period (36 Months)||25
561533|NCT00667446|1368308|P1|NOT COMPLETED|Treatment Period (36 Months)||23
561534|NCT00667446|1368307|P2|COMPLETED|Treatment Period (36 Months)||13
561535|NCT00667446|1368308|P1|COMPLETED|Treatment Period (36 Months)||11
561536|NCT00667446|1368307|P2|STARTED|Treatment Period (36 Months)||38
561537|NCT00667446|1368308|P1|STARTED|Treatment Period (36 Months)||34
561538|NCT00667420|1368330|P1|NOT COMPLETED|Overall Study||10
561539|NCT00667420|1368330|P1|COMPLETED|Overall Study||7
561540|NCT00667420|1368330|P1|Completion of Surgery/Re-staging|Overall Study||11
561541|NCT00667420|1368330|P1|Completion of Pre-operative EOX-P|Overall Study||15
561542|NCT00667420|1368330|P1|STARTED|Overall Study||17
561543|NCT00667394|1368340|P2|NOT COMPLETED|Overall Study||0
561544|NCT00667394|1368341|P1|NOT COMPLETED|Overall Study||4
561545|NCT00667394|1368340|P2|COMPLETED|Overall Study||1
561546|NCT00667394|1368341|P1|COMPLETED|Overall Study||37
561547|NCT00667394|1368340|P2|STARTED|Overall Study||1
561548|NCT00667394|1368341|P1|STARTED|Overall Study||41
561549|NCT00667381|1368351|P2|NOT COMPLETED|Overall Study||0
561550|NCT00667381|1368352|P1|NOT COMPLETED|Overall Study||0
561551|NCT00667381|1368351|P2|COMPLETED|Overall Study||503
561552|NCT00667381|1368352|P1|COMPLETED|Overall Study||501
561553|NCT00667381|1368351|P2|STARTED|Overall Study||503
561554|NCT00667381|1368352|P1|STARTED|Overall Study||501
561555|NCT00667368|1368368|P2|NOT COMPLETED|Overall Study||172
561556|NCT00667368|1368369|P1|NOT COMPLETED|Overall Study||200
561557|NCT00667368|1368368|P2|COMPLETED|Overall Study||511
561558|NCT00667368|1368369|P1|COMPLETED|Overall Study||482
561559|NCT00667368|1368368|P2|STARTED|Overall Study||683
561560|NCT00667368|1368369|P1|STARTED|Overall Study||682
561561|NCT00667355|1368377|P1|NOT COMPLETED|Overall Study||11
561562|NCT00667355|1368377|P1|COMPLETED|Overall Study||30
561563|NCT00667355|1368377|P1|STARTED|Overall Study||41
561564|NCT00667342|1368402|P3|NOT COMPLETED|Overall Study||9
561565|NCT00667342|1368403|P2|NOT COMPLETED|Overall Study||0
561566|NCT00667342|1368404|P1|NOT COMPLETED|Overall Study||14
561567|NCT00667342|1368402|P3|COMPLETED|Overall Study||3
561568|NCT00667342|1368403|P2|COMPLETED|Overall Study||0
561569|NCT00667342|1368404|P1|COMPLETED|Overall Study||17
561570|NCT00667342|1368402|P3|STARTED|Overall Study||12
561571|NCT00667342|1368403|P2|STARTED|Overall Study||0
561572|NCT00667342|1368404|P1|STARTED|Overall Study||31
561573|NCT00667277|1368442|P1|NOT COMPLETED|Overall Study||2
561574|NCT00667277|1368442|P1|COMPLETED|Overall Study||11
561575|NCT00667277|1368442|P1|STARTED|Overall Study||13
561576|NCT00667251|1368449|P2|NOT COMPLETED|Overall Study||95
561577|NCT00667251|1368450|P1|NOT COMPLETED|Overall Study||70
561578|NCT00667251|1368449|P2|COMPLETED|Overall Study||231
561579|NCT00667251|1368450|P1|COMPLETED|Overall Study||256
561580|NCT00667251|1368449|P2|Not Started|Overall Study||1
561581|NCT00667251|1368450|P1|Not Started|Overall Study||4
561582|NCT00667251|1368449|P2|Monotherapy|Overall Study||232
561583|NCT00667251|1368450|P1|Monotherapy|Overall Study||225
561584|NCT00667251|1368449|P2|Combination Rx|Overall Study||325
561585|NCT00667251|1368450|P1|Combination Rx|Overall Study||322
561586|NCT00667251|1368449|P2|STARTED|Overall Study||326
561587|NCT00667251|1368450|P1|STARTED|Overall Study||326
561588|NCT00667225|1368476|P2|NOT COMPLETED|Overall Study||1
561589|NCT00667225|1368477|P1|NOT COMPLETED|Overall Study||1
561590|NCT00667225|1368476|P2|COMPLETED|Overall Study||12
561591|NCT00667225|1368477|P1|COMPLETED|Overall Study||15
561592|NCT00667225|1368476|P2|STARTED|Overall Study||13
561593|NCT00667225|1368477|P1|STARTED|Overall Study||16
561594|NCT00667186|1368487|P2|NOT COMPLETED|Overall Study||0
561595|NCT00667186|1368488|P1|NOT COMPLETED|Overall Study||0
561596|NCT00667186|1368487|P2|COMPLETED|Overall Study||4880
561597|NCT00667186|1368488|P1|COMPLETED|Overall Study||4692
561598|NCT00667186|1368487|P2|STARTED|Overall Study||4880
561599|NCT00667186|1368488|P1|STARTED|Overall Study||4692
561600|NCT00667095|1368498|P2|NOT COMPLETED|Overall Study||1
561601|NCT00667095|1368499|P1|NOT COMPLETED|Overall Study||0
561602|NCT00667095|1368498|P2|COMPLETED|Overall Study||9
561603|NCT00667095|1368499|P1|COMPLETED|Overall Study||11
561604|NCT00667095|1368498|P2|STARTED|Overall Study||10
561605|NCT00667095|1368499|P1|STARTED|Overall Study||11
561606|NCT00666978|1368517|P2|NOT COMPLETED|Overall Study||83
561607|NCT00666978|1368518|P1|NOT COMPLETED|Overall Study||78
561608|NCT00666978|1368517|P2|COMPLETED|Overall Study||187
561609|NCT00666978|1368518|P1|COMPLETED|Overall Study||192
561610|NCT00666978|1368517|P2|STARTED|Overall Study||270
561611|NCT00666978|1368518|P1|STARTED|Overall Study||270
561612|NCT00666965|1368531|P4|NOT COMPLETED|Overall Study||15
561613|NCT00666965|1368532|P3|NOT COMPLETED|Overall Study||2
561614|NCT00666965|1368533|P2|NOT COMPLETED|Overall Study||4
561615|NCT00666965|1368534|P1|NOT COMPLETED|Overall Study||3
561616|NCT00666965|1368531|P4|COMPLETED|Overall Study||42
561617|NCT00666965|1368532|P3|COMPLETED|Overall Study||56
561618|NCT00666965|1368533|P2|COMPLETED|Overall Study||53
561619|NCT00666965|1368534|P1|COMPLETED|Overall Study||55
561620|NCT00666965|1368531|P4|STARTED|Overall Study||57
561621|NCT00666965|1368532|P3|STARTED|Overall Study||58
561622|NCT00666965|1368533|P2|STARTED|Overall Study||57
561623|NCT00666965|1368534|P1|STARTED|Overall Study||58
561624|NCT00666926|1368564|P16|NOT COMPLETED|Overall Study||8
561625|NCT00666926|1368565|P15|NOT COMPLETED|Overall Study||7
561626|NCT00666926|1368566|P14|NOT COMPLETED|Overall Study||4
561627|NCT00666926|1368567|P13|NOT COMPLETED|Overall Study||3
561628|NCT00666926|1368568|P12|NOT COMPLETED|Overall Study||33
561629|NCT00666926|1368569|P11|NOT COMPLETED|Overall Study||6
561630|NCT00666926|1368570|P10|NOT COMPLETED|Overall Study||10
561631|NCT00666926|1368571|P9|NOT COMPLETED|Overall Study||3
561632|NCT00666926|1368572|P8|NOT COMPLETED|Overall Study||1
561633|NCT00666926|1368573|P7|NOT COMPLETED|Overall Study||4
561634|NCT00666926|1368574|P6|NOT COMPLETED|Overall Study||4
561635|NCT00666926|1368575|P5|NOT COMPLETED|Overall Study||3
561636|NCT00666926|1368576|P4|NOT COMPLETED|Overall Study||4
561637|NCT00666926|1368577|P3|NOT COMPLETED|Overall Study||3
561638|NCT00666926|1368578|P2|NOT COMPLETED|Overall Study||4
561639|NCT00666926|1368579|P1|NOT COMPLETED|Overall Study||2
561640|NCT00666926|1368564|P16|COMPLETED|Overall Study||0
561641|NCT00666926|1368565|P15|COMPLETED|Overall Study||0
561642|NCT00666926|1368566|P14|COMPLETED|Overall Study||0
561643|NCT00666926|1368567|P13|COMPLETED|Overall Study||0
561644|NCT00666926|1368568|P12|COMPLETED|Overall Study||0
561645|NCT00666926|1368569|P11|COMPLETED|Overall Study||0
561646|NCT00666926|1368570|P10|COMPLETED|Overall Study||0
561647|NCT00666926|1368571|P9|COMPLETED|Overall Study||0
561648|NCT00666926|1368572|P8|COMPLETED|Overall Study||0
561649|NCT00666926|1368573|P7|COMPLETED|Overall Study||0
561650|NCT00666926|1368574|P6|COMPLETED|Overall Study||0
561651|NCT00666926|1368575|P5|COMPLETED|Overall Study||0
561652|NCT00666926|1368576|P4|COMPLETED|Overall Study||0
561653|NCT00666926|1368577|P3|COMPLETED|Overall Study||0
561654|NCT00666926|1368578|P2|COMPLETED|Overall Study||0
561655|NCT00666926|1368579|P1|COMPLETED|Overall Study||0
561656|NCT00666926|1368564|P16|STARTED|Overall Study||8
561657|NCT00666926|1368565|P15|STARTED|Overall Study||7
561658|NCT00666926|1368566|P14|STARTED|Overall Study||4
561659|NCT00666926|1368567|P13|STARTED|Overall Study||3
561660|NCT00666926|1368568|P12|STARTED|Overall Study||33
561661|NCT00666926|1368569|P11|STARTED|Overall Study||6
561662|NCT00666926|1368570|P10|STARTED|Overall Study||10
561663|NCT00666926|1368571|P9|STARTED|Overall Study||3
561664|NCT00666926|1368572|P8|STARTED|Overall Study||1
561665|NCT00666926|1368573|P7|STARTED|Overall Study||4
561666|NCT00666926|1368574|P6|STARTED|Overall Study||4
561667|NCT00666926|1368575|P5|STARTED|Overall Study||3
561668|NCT00666926|1368576|P4|STARTED|Overall Study||4
561669|NCT00666926|1368577|P3|STARTED|Overall Study||3
561670|NCT00666926|1368578|P2|STARTED|Overall Study||4
561671|NCT00666926|1368579|P1|STARTED|Overall Study||2
561672|NCT00666848|1368873|P3|NOT COMPLETED|Overall Study||0
561673|NCT00666848|1368874|P2|NOT COMPLETED|Overall Study||0
561674|NCT00666848|1368875|P1|NOT COMPLETED|Overall Study||0
561675|NCT00666848|1368873|P3|COMPLETED|Overall Study|finished Aim 3|7
561676|NCT00666848|1368874|P2|COMPLETED|Overall Study|finished Aim 1|9
561677|NCT00666848|1368875|P1|COMPLETED|Overall Study|finished Aim 2|8
561678|NCT00666848|1368873|P3|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|7
561679|NCT00666848|1368874|P2|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|9
561680|NCT00666848|1368875|P1|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|8
561681|NCT00666835|1368888|P2|NOT COMPLETED|Overall Study||22
561682|NCT00666835|1368889|P1|NOT COMPLETED|Overall Study||53
561683|NCT00666835|1368888|P2|COMPLETED|Overall Study||142
561684|NCT00666835|1368889|P1|COMPLETED|Overall Study||261
561685|NCT00666835|1368888|P2|STARTED|Overall Study||164
561686|NCT00666835|1368889|P1|STARTED|Overall Study||314
561687|NCT00666757|1368899|P2|NOT COMPLETED|Overall Study||97
561688|NCT00666757|1368900|P1|NOT COMPLETED|Overall Study||100
561689|NCT00666757|1368899|P2|COMPLETED|Overall Study||281
561690|NCT00666757|1368900|P1|COMPLETED|Overall Study||272
561691|NCT00666757|1368899|P2|STARTED|Overall Study||378
561692|NCT00666757|1368900|P1|STARTED|Overall Study||372
561693|NCT00666718|1368959|P2|NOT COMPLETED|Overall Study||18
561694|NCT00666718|1368960|P1|NOT COMPLETED|Overall Study||12
561695|NCT00666718|1368959|P2|COMPLETED|Overall Study||169
561696|NCT00666718|1368960|P1|COMPLETED|Overall Study||175
561697|NCT00666718|1368959|P2|STARTED|Overall Study||187
561698|NCT00666718|1368960|P1|STARTED|Overall Study||187
561699|NCT00666705|1368986|P1|NOT COMPLETED|Overall Study||1
561700|NCT00666705|1368986|P1|COMPLETED|Overall Study||17
561701|NCT00666705|1368986|P1|Raltegravir + Maraviroc (Days 12 - 14)|Overall Study|400 mg Raltegravir every 12 hours plus 300 mg Maraviroc every 12 hours (AM doses only on Day 14)|17
561702|NCT00666705|1368986|P1|Maraviroc Alone (Days 6 - 11)|Overall Study|300 mg Maraviroc every 12 hours|18
561703|NCT00666705|1368986|P1|Washout (Days 4 - 5)|Overall Study||18
561704|NCT00666705|1368986|P1|Raltegravir Alone (Days 1 - 3)|Overall Study|400 mg Raltegravir every 12 hours (AM dose on Day 3)|18
561705|NCT00666705|1368986|P1|STARTED|Overall Study||18
561706|NCT00666679|1369005|P2|NOT COMPLETED|Second Intervention||1
561707|NCT00666679|1369006|P1|NOT COMPLETED|Second Intervention||1
561708|NCT00666679|1369005|P2|COMPLETED|Second Intervention||64
561709|NCT00666679|1369006|P1|COMPLETED|Second Intervention||61
561710|NCT00666679|1369005|P2|STARTED|Second Intervention||65
561711|NCT00666679|1369006|P1|STARTED|Second Intervention||62
561712|NCT00666679|1369005|P2|NOT COMPLETED|Washout Period of 1 Week||2
561713|NCT00666679|1369006|P1|NOT COMPLETED|Washout Period of 1 Week||0
561714|NCT00666679|1369005|P2|COMPLETED|Washout Period of 1 Week||65
561715|NCT00666679|1369006|P1|COMPLETED|Washout Period of 1 Week||62
561716|NCT00666679|1369005|P2|STARTED|Washout Period of 1 Week||67
561717|NCT00666679|1369006|P1|STARTED|Washout Period of 1 Week||62
561718|NCT00666679|1369005|P2|NOT COMPLETED|First Intervention||1
561719|NCT00666679|1369006|P1|NOT COMPLETED|First Intervention||4
561720|NCT00666679|1369005|P2|COMPLETED|First Intervention||67
561721|NCT00666679|1369006|P1|COMPLETED|First Intervention||62
561722|NCT00666679|1369005|P2|STARTED|First Intervention||68
561723|NCT00666679|1369006|P1|STARTED|First Intervention||66
561724|NCT00666666|1369026|P1|NOT COMPLETED|Overall Study||0
561725|NCT00666666|1369026|P1|COMPLETED|Overall Study||55
561726|NCT00666666|1369026|P1|STARTED|Overall Study||55
561727|NCT00666588|1369036|P4|NOT COMPLETED|Overall Study||2
561728|NCT00666588|1369037|P3|NOT COMPLETED|Overall Study||0
561729|NCT00666588|1369038|P2|NOT COMPLETED|Overall Study||0
561730|NCT00666588|1369039|P1|NOT COMPLETED|Overall Study||4
561731|NCT00666588|1369036|P4|COMPLETED|Overall Study||20
561732|NCT00666588|1369037|P3|COMPLETED|Overall Study||6
561733|NCT00666588|1369038|P2|COMPLETED|Overall Study||6
561734|NCT00666588|1369039|P1|COMPLETED|Overall Study||14
561735|NCT00666588|1369036|P4|STARTED|Overall Study||22
561736|NCT00666588|1369037|P3|STARTED|Overall Study||6
561737|NCT00666588|1369038|P2|STARTED|Overall Study||6
561738|NCT00666588|1369039|P1|STARTED|Overall Study||18
561739|NCT00666562|1369072|P3|NOT COMPLETED|Overall Study||0
561740|NCT00666562|1369073|P2|NOT COMPLETED|Overall Study||2
561741|NCT00666562|1369074|P1|NOT COMPLETED|Overall Study||0
561742|NCT00666562|1369072|P3|COMPLETED|Overall Study||10
561743|NCT00666562|1369073|P2|COMPLETED|Overall Study||8
561744|NCT00666562|1369074|P1|COMPLETED|Overall Study||11
561745|NCT00666562|1369072|P3|STARTED|Overall Study||10
561746|NCT00666562|1369073|P2|STARTED|Overall Study||10
561747|NCT00666562|1369074|P1|STARTED|Overall Study||11
561748|NCT00666536|1369121|P2|NOT COMPLETED|Overall Study||37
561749|NCT00666536|1369122|P1|NOT COMPLETED|Overall Study||33
561750|NCT00666536|1369121|P2|COMPLETED|Overall Study||322
561751|NCT00666536|1369122|P1|COMPLETED|Overall Study||336
561752|NCT00666536|1369121|P2|STARTED|Overall Study||359
561753|NCT00666536|1369122|P1|STARTED|Overall Study||369
561754|NCT00666458|1369140|P2|NOT COMPLETED|Overall Study||24
561755|NCT00666458|1369141|P1|NOT COMPLETED|Overall Study||38
561756|NCT00666458|1369140|P2|COMPLETED|Overall Study|Completed 18 weeks of treatment|374
561757|NCT00666458|1369141|P1|COMPLETED|Overall Study|Completed 18 weeks of treatment|365
561758|NCT00666458|1369140|P2|STARTED|Overall Study|Randomized and treated|398
561759|NCT00666458|1369141|P1|STARTED|Overall Study|Randomized and treated|403
561760|NCT00666406|1369153|P2|NOT COMPLETED|Second PK Infusion||0
561761|NCT00666406|1369154|P1|NOT COMPLETED|Second PK Infusion||0
561762|NCT00666406|1369153|P2|COMPLETED|Second PK Infusion||3
561763|NCT00666406|1369154|P1|COMPLETED|Second PK Infusion||6
561764|NCT00666406|1369153|P2|STARTED|Second PK Infusion||3
561765|NCT00666406|1369154|P1|STARTED|Second PK Infusion||6
561766|NCT00666406|1369153|P2|NOT COMPLETED|First PK Infusion||0
561767|NCT00666406|1369154|P1|NOT COMPLETED|First PK Infusion||0
561768|NCT00666406|1369153|P2|COMPLETED|First PK Infusion||3
561769|NCT00666406|1369154|P1|COMPLETED|First PK Infusion||6
561770|NCT00666406|1369153|P2|STARTED|First PK Infusion||3
561771|NCT00666406|1369154|P1|STARTED|First PK Infusion||6
561772|NCT00666328|1369229|P1|NOT COMPLETED|Overall Study||5
561773|NCT00666328|1369229|P1|COMPLETED|Overall Study|30/35 completed the study within the Safety population; 28/33 completed within the mITT population.|30
561774|NCT00666328|1369229|P1|Modified Intent To Treat (mITT)|Overall Study|mITT population: participants dosed and in whom all inclusion and no exclusion criteria were met|33
561775|NCT00666328|1369229|P1|STARTED|Overall Study|Safety population: participants dosed with study drug (primary population for Safety analyses)|35
561776|NCT00666276|1369242|P1|NOT COMPLETED|Overall Study||34
561777|NCT00666276|1369242|P1|COMPLETED|Overall Study||970
561778|NCT00666276|1369242|P1|STARTED|Overall Study||1004
561779|NCT00666263|1369266|P2|NOT COMPLETED|End of Study Visit||0
561780|NCT00666263|1369267|P1|NOT COMPLETED|End of Study Visit||0
561781|NCT00666263|1369266|P2|COMPLETED|End of Study Visit||22
561782|NCT00666263|1369267|P1|COMPLETED|End of Study Visit||22
561783|NCT00666263|1369266|P2|STARTED|End of Study Visit|End of Study Visit done on all 22 randomized regardless of participation in Study Parts|22
561784|NCT00666263|1369267|P1|STARTED|End of Study Visit|End of Study Visit done on all 22 randomized regardless of participation in Study Parts|22
561785|NCT00666263|1369266|P2|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||1
561786|NCT00666263|1369267|P1|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||0
561787|NCT00666263|1369266|P2|COMPLETED|Study Part 5 (Stabilization Phase 3)||20
561788|NCT00666263|1369267|P1|COMPLETED|Study Part 5 (Stabilization Phase 3)||21
561789|NCT00666263|1369266|P2|STARTED|Study Part 5 (Stabilization Phase 3)||21
561790|NCT00666263|1369267|P1|STARTED|Study Part 5 (Stabilization Phase 3)||21
561791|NCT00666263|1369266|P2|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||0
561792|NCT00666263|1369267|P1|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||1
561793|NCT00666263|1369266|P2|COMPLETED|Study Part 4 (Cross-over Period 2)||21
561794|NCT00666263|1369267|P1|COMPLETED|Study Part 4 (Cross-over Period 2)||21
561795|NCT00666263|1369266|P2|STARTED|Study Part 4 (Cross-over Period 2)||21
561796|NCT00666263|1369267|P1|STARTED|Study Part 4 (Cross-over Period 2)||22
561797|NCT00666263|1369266|P2|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0
561798|NCT00666263|1369267|P1|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0
561799|NCT00666263|1369266|P2|COMPLETED|Study Part 3 (Stabilization Phase 2)||21
561800|NCT00666263|1369267|P1|COMPLETED|Study Part 3 (Stabilization Phase 2)||22
561801|NCT00666263|1369266|P2|STARTED|Study Part 3 (Stabilization Phase 2)||21
561802|NCT00666263|1369267|P1|STARTED|Study Part 3 (Stabilization Phase 2)||22
561803|NCT00666263|1369266|P2|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0
561804|NCT00666263|1369267|P1|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0
561805|NCT00666263|1369266|P2|COMPLETED|Study Part 2 (Cross-over Period 1)||21
561806|NCT00666263|1369267|P1|COMPLETED|Study Part 2 (Cross-over Period 1)||22
561807|NCT00666263|1369266|P2|STARTED|Study Part 2 (Cross-over Period 1)||21
561808|NCT00666263|1369267|P1|STARTED|Study Part 2 (Cross-over Period 1)||22
561809|NCT00666263|1369266|P2|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||1
561810|NCT00666263|1369267|P1|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||0
561811|NCT00666263|1369266|P2|COMPLETED|Study Part 1 (Stabilization Phase 1)||21
561812|NCT00666263|1369267|P1|COMPLETED|Study Part 1 (Stabilization Phase 1)||22
561813|NCT00666263|1369266|P2|STARTED|Study Part 1 (Stabilization Phase 1)||22
561814|NCT00666263|1369267|P1|STARTED|Study Part 1 (Stabilization Phase 1)||22
561815|NCT00666224|1369411|P2|NOT COMPLETED|Open-Label||85
561816|NCT00666224|1369412|P1|NOT COMPLETED|Open-Label||35
561817|NCT00666224|1369411|P2|COMPLETED|Open-Label||126
561818|NCT00666224|1369412|P1|COMPLETED|Open-Label||163
561819|NCT00666224|1369411|P2|STARTED|Open-Label||211
561820|NCT00666224|1369412|P1|STARTED|Open-Label|454 participants took at least one dose of GA including 45 who didn't continue into the OL.|198
561821|NCT00666224|1369411|P2|NOT COMPLETED|Double-Blind||27
561822|NCT00666224|1369412|P1|NOT COMPLETED|Double-Blind||45
561823|NCT00666224|1369411|P2|COMPLETED|Double-Blind|55 completed 3 years treatment, 109 converted to CDMS, 47 switched to OL as per DMC|211
561824|NCT00666224|1369412|P1|COMPLETED|Double-Blind|78 completed 3 years treatment, 66 converted to CDMS, 54 switched to OL as per DMC|198
561825|NCT00666224|1369411|P2|STARTED|Double-Blind||238
561826|NCT00666224|1369412|P1|STARTED|Double-Blind||243
561827|NCT00666211|1369431|P2|NOT COMPLETED|Overall Study||38
561828|NCT00666211|1369432|P1|NOT COMPLETED|Overall Study||20
561829|NCT00666211|1369431|P2|COMPLETED|Overall Study||18
561830|NCT00666211|1369432|P1|COMPLETED|Overall Study||22
561831|NCT00666211|1369431|P2|STARTED|Overall Study||56
561832|NCT00666211|1369432|P1|STARTED|Overall Study||42
561833|NCT00666198|1369450|P1|NOT COMPLETED|Overall Study||33
561834|NCT00666198|1369450|P1|COMPLETED|Overall Study||3304
561835|NCT00666198|1369450|P1|STARTED|Overall Study||3337
561836|NCT00666029|1369465|P2|NOT COMPLETED|Overall Study||0
561837|NCT00666029|1369466|P1|NOT COMPLETED|Overall Study||1
561838|NCT00666029|1369465|P2|COMPLETED|Overall Study||20
561839|NCT00666029|1369466|P1|COMPLETED|Overall Study||19
561840|NCT00666029|1369465|P2|STARTED|Overall Study||20
561841|NCT00666029|1369466|P1|STARTED|Overall Study||20
561842|NCT00665925|1369478|P4|NOT COMPLETED|Overall Study||21
561843|NCT00665925|1369479|P3|NOT COMPLETED|Overall Study||26
561844|NCT00665925|1369480|P2|NOT COMPLETED|Overall Study||17
561845|NCT00665925|1369481|P1|NOT COMPLETED|Overall Study||15
561846|NCT00665925|1369478|P4|COMPLETED|Overall Study|Participants completed the study|131
561847|NCT00665925|1369479|P3|COMPLETED|Overall Study|Participants completed the study|126
561848|NCT00665925|1369480|P2|COMPLETED|Overall Study|Participants completed the study|59
561849|NCT00665925|1369481|P1|COMPLETED|Overall Study|Participants completed the study|62
561850|NCT00665925|1369478|P4|STARTED|Overall Study|Participants randomized|152
561851|NCT00665925|1369479|P3|STARTED|Overall Study|Participants randomized|152
561852|NCT00665925|1369480|P2|STARTED|Overall Study|Participants randomized|76
561853|NCT00665925|1369481|P1|STARTED|Overall Study|Participants randomized|77
561854|NCT00665847|1369892|P1|NOT COMPLETED|Overall Study||25
561855|NCT00665847|1369892|P1|COMPLETED|Overall Study||76
561856|NCT00665847|1369892|P1|STARTED|Overall Study||101
561857|NCT00665704|1369904|P1|NOT COMPLETED|Overall Study||0
561858|NCT00665704|1369904|P1|COMPLETED|Overall Study||9
561859|NCT00665704|1369904|P1|STARTED|Overall Study||9
561860|NCT00665626|1369911|P2|NOT COMPLETED|Overall Study||22
561861|NCT00665626|1369912|P1|NOT COMPLETED|Overall Study||10
561862|NCT00665626|1369911|P2|COMPLETED|Overall Study|Participants completed the study|124
561863|NCT00665626|1369912|P1|COMPLETED|Overall Study|Participants completed the study|63
561864|NCT00665626|1369911|P2|STARTED|Overall Study|Participants randomized|146
561865|NCT00665626|1369912|P1|STARTED|Overall Study|Participants randomized|73
561866|NCT00665470|1369980|P2|NOT COMPLETED|Overall Study||0
561867|NCT00665470|1369981|P1|NOT COMPLETED|Overall Study||0
561868|NCT00665470|1369980|P2|COMPLETED|Overall Study||0
561869|NCT00665470|1369981|P1|COMPLETED|Overall Study||10
561870|NCT00665470|1369980|P2|STARTED|Overall Study||0
561871|NCT00665470|1369981|P1|STARTED|Overall Study||10
561872|NCT00665444|1369989|P1|NOT COMPLETED|Overall Study||2
561873|NCT00665444|1369989|P1|COMPLETED|Overall Study||1
561874|NCT00665444|1369989|P1|STARTED|Overall Study||3
561875|NCT00665431|1370001|P3|NOT COMPLETED|Overall Study||24
561876|NCT00665431|1370002|P2|NOT COMPLETED|Overall Study||57
561877|NCT00665431|1370003|P1|NOT COMPLETED|Overall Study||40
561878|NCT00665431|1370001|P3|COMPLETED|Overall Study||98
561879|NCT00665431|1370002|P2|COMPLETED|Overall Study||188
561880|NCT00665431|1370003|P1|COMPLETED|Overall Study||203
561881|NCT00665431|1370001|P3|STARTED|Overall Study|Safety population|122
561882|NCT00665431|1370002|P2|STARTED|Overall Study|Safety population|245
561883|NCT00665431|1370003|P1|STARTED|Overall Study|Safety population|243
561884|NCT00665366|1370046|P2|NOT COMPLETED|Overall Study||59
561885|NCT00665366|1370047|P1|NOT COMPLETED|Overall Study||58
561886|NCT00665366|1370046|P2|COMPLETED|Overall Study||122
561887|NCT00665366|1370047|P1|COMPLETED|Overall Study||131
561888|NCT00665366|1370046|P2|STARTED|Overall Study|Participants randomized|181
561889|NCT00665366|1370047|P1|STARTED|Overall Study|Participants randomized|189
561890|NCT00665353|1370075|P1|NOT COMPLETED|Study Step 2||14
561891|NCT00665353|1370075|P1|COMPLETED|Study Step 2||2
561892|NCT00665353|1370075|P1|STARTED|Study Step 2||16
561893|NCT00665353|1370075|P1|NOT COMPLETED|Study Step 1||3
561894|NCT00665353|1370075|P1|COMPLETED|Study Step 1||16
561895|NCT00665353|1370075|P1|STARTED|Study Step 1||19
561896|NCT00665132|1370085|P1|NOT COMPLETED|Overall Study||0
561897|NCT00665132|1370085|P1|COMPLETED|Overall Study||10
561898|NCT00665132|1370085|P1|STARTED|Overall Study||10
561899|NCT00665002|1370092|P1|NOT COMPLETED|Overall Study||12
561900|NCT00665002|1370092|P1|COMPLETED|Overall Study||4
561901|NCT00665002|1370092|P1|STARTED|Overall Study||16
561902|NCT00664755|1370099|P2|NOT COMPLETED|Overall Study||0
561903|NCT00664755|1370100|P1|NOT COMPLETED|Overall Study||0
561904|NCT00664755|1370099|P2|COMPLETED|Overall Study||73
561905|NCT00664755|1370100|P1|COMPLETED|Overall Study||67
561906|NCT00664755|1370099|P2|STARTED|Overall Study||73
561907|NCT00664755|1370100|P1|STARTED|Overall Study||67
561908|NCT00664742|1370106|P1|NOT COMPLETED|Overall Study||126
561909|NCT00664742|1370106|P1|COMPLETED|Overall Study||481
561910|NCT00664742|1370106|P1|STARTED|Overall Study||607
561911|NCT00664560|1370114|P3|NOT COMPLETED|Overall Study||19
561912|NCT00664560|1370115|P2|NOT COMPLETED|Overall Study||35
561913|NCT00664560|1370116|P1|NOT COMPLETED|Overall Study||39
561914|NCT00664560|1370114|P3|COMPLETED|Overall Study||105
561915|NCT00664560|1370115|P2|COMPLETED|Overall Study||208
561916|NCT00664560|1370116|P1|COMPLETED|Overall Study||208
561917|NCT00664560|1370114|P3|STARTED|Overall Study|Safety Population|124
561918|NCT00664560|1370115|P2|STARTED|Overall Study|Safety Population|243
561919|NCT00664560|1370116|P1|STARTED|Overall Study|Safety Population|247
561920|NCT00664534|1370159|P2|NOT COMPLETED|Overall Study||33
561921|NCT00664534|1370160|P1|NOT COMPLETED|Overall Study||41
561922|NCT00664534|1370159|P2|COMPLETED|Overall Study||138
561923|NCT00664534|1370160|P1|COMPLETED|Overall Study||132
561924|NCT00664534|1370159|P2|STARTED|Overall Study||171
561925|NCT00664534|1370160|P1|STARTED|Overall Study||173
561926|NCT00664521|1370188|P2|NOT COMPLETED|Overall Study||1
561927|NCT00664521|1370189|P1|NOT COMPLETED|Overall Study||6
561928|NCT00664521|1370188|P2|COMPLETED|Overall Study||8
561929|NCT00664521|1370189|P1|COMPLETED|Overall Study||12
561930|NCT00664521|1370188|P2|STARTED|Overall Study||9
561931|NCT00664521|1370189|P1|STARTED|Overall Study||18
561932|NCT00664430|1370209|P1|NOT COMPLETED|Overall Study||13
561933|NCT00664430|1370209|P1|COMPLETED|Overall Study|Study terminated early due to low enrollment rate.|0
561934|NCT00664430|1370209|P1|STARTED|Overall Study||13
561935|NCT00664326|1370215|P1|NOT COMPLETED|Overall Study||24
561936|NCT00664326|1370215|P1|COMPLETED|Overall Study||25
561937|NCT00664326|1370215|P1|STARTED|Overall Study||49
561938|NCT00664209|1370234|P1|NOT COMPLETED|Study Treatment Period||6
561939|NCT00664209|1370234|P1|COMPLETED|Study Treatment Period||0
561940|NCT00664209|1370234|P1|STARTED|Study Treatment Period||6
561941|NCT00664209|1370234|P1|NOT COMPLETED|Motor Fluctuations Screen||7
561942|NCT00664209|1370234|P1|COMPLETED|Motor Fluctuations Screen||6
561943|NCT00664209|1370234|P1|STARTED|Motor Fluctuations Screen||13
561944|NCT00664105|1370242|P1|NOT COMPLETED|Overall Study||24
561945|NCT00664105|1370242|P1|COMPLETED|Overall Study||39
561946|NCT00664105|1370242|P1|STARTED|Overall Study||63
561947|NCT00664066|1370249|P1|NOT COMPLETED|Overall Study||3
561948|NCT00664066|1370249|P1|COMPLETED|Overall Study||0
561949|NCT00664066|1370249|P1|STARTED|Overall Study||3
561950|NCT00663962|1370255|P2|NOT COMPLETED|Overall Study||0
561951|NCT00663962|1370256|P1|NOT COMPLETED|Overall Study||1
561952|NCT00663962|1370255|P2|COMPLETED|Overall Study||8
561953|NCT00663962|1370256|P1|COMPLETED|Overall Study|1 patient excluded for somnolence and unblinded--in 300mg group|6
561954|NCT00663962|1370255|P2|STARTED|Overall Study||8
561955|NCT00663962|1370256|P1|STARTED|Overall Study||7
561956|NCT00663923|1370262|P1|NOT COMPLETED|Overall Study||2
561957|NCT00663923|1370262|P1|COMPLETED|Overall Study||48
561958|NCT00663923|1370262|P1|STARTED|Overall Study||50
561959|NCT00663858|1370279|P3|NOT COMPLETED|Overall Study||20
561960|NCT00663858|1370280|P2|NOT COMPLETED|Overall Study||10
561961|NCT00663858|1370281|P1|NOT COMPLETED|Overall Study||34
561962|NCT00663858|1370279|P3|COMPLETED|Overall Study||82
561963|NCT00663858|1370280|P2|COMPLETED|Overall Study||96
561964|NCT00663858|1370281|P1|COMPLETED|Overall Study||178
561965|NCT00663858|1370279|P3|STARTED|Overall Study||102
561966|NCT00663858|1370280|P2|STARTED|Overall Study||106
561967|NCT00663858|1370281|P1|STARTED|Overall Study||212
561968|NCT00663819|1370291|P2|NOT COMPLETED|Overall Study||0
561969|NCT00663819|1370292|P1|NOT COMPLETED|Overall Study||0
561970|NCT00663819|1370291|P2|COMPLETED|Overall Study||135
561971|NCT00663819|1370292|P1|COMPLETED|Overall Study||123
561972|NCT00663819|1370291|P2|STARTED|Overall Study||135
561973|NCT00663819|1370292|P1|STARTED|Overall Study||123
561974|NCT00663793|1370306|P2|NOT COMPLETED|Overall Study||0
561975|NCT00663793|1370307|P1|NOT COMPLETED|Overall Study||0
561976|NCT00663793|1370306|P2|COMPLETED|Overall Study||8
561977|NCT00663793|1370307|P1|COMPLETED|Overall Study||8
561978|NCT00663793|1370306|P2|STARTED|Overall Study||8
561979|NCT00663793|1370307|P1|STARTED|Overall Study||8
561980|NCT00663702|1370319|P2|NOT COMPLETED|Overall Study||10
561981|NCT00663702|1370320|P1|NOT COMPLETED|Overall Study||18
561982|NCT00663702|1370319|P2|COMPLETED|Overall Study||61
561983|NCT00663702|1370320|P1|COMPLETED|Overall Study||34
561984|NCT00663702|1370319|P2|STARTED|Overall Study||71
561985|NCT00663702|1370320|P1|STARTED|Overall Study||52
561986|NCT00663403|1370343|P1|NOT COMPLETED|Overall Study||0
561987|NCT00663403|1370343|P1|COMPLETED|Overall Study||8
561988|NCT00663403|1370343|P1|STARTED|Overall Study||8
561989|NCT00663260|1370356|P3|NOT COMPLETED|Overall Study||16
561990|NCT00663260|1370357|P2|NOT COMPLETED|Overall Study||11
561991|NCT00663260|1370358|P1|NOT COMPLETED|Overall Study||21
561992|NCT00663260|1370356|P3|COMPLETED|Overall Study||69
561993|NCT00663260|1370357|P2|COMPLETED|Overall Study||72
561994|NCT00663260|1370358|P1|COMPLETED|Overall Study||63
561995|NCT00663260|1370356|P3|STARTED|Overall Study||85
561996|NCT00663260|1370357|P2|STARTED|Overall Study||83
561997|NCT00663260|1370358|P1|STARTED|Overall Study||84
561998|NCT00663234|1370372|P1|NOT COMPLETED|Overall Study||1
561999|NCT00663234|1370372|P1|COMPLETED|Overall Study||27
562000|NCT00663234|1370372|P1|Dose Increased to 20 mg at Week 8|Overall Study||10
562001|NCT00663234|1370372|P1|STARTED|Overall Study||28
562002|NCT00663208|1370405|P7|NOT COMPLETED|Follow-up Period||1
562003|NCT00663208|1370406|P6|NOT COMPLETED|Follow-up Period||0
562004|NCT00663208|1370407|P5|NOT COMPLETED|Follow-up Period||0
562005|NCT00663208|1370408|P4|NOT COMPLETED|Follow-up Period||2
562006|NCT00663208|1370409|P3|NOT COMPLETED|Follow-up Period||3
562007|NCT00663208|1370410|P2|NOT COMPLETED|Follow-up Period||0
562008|NCT00663208|1370411|P1|NOT COMPLETED|Follow-up Period||3
562009|NCT00663208|1370405|P7|COMPLETED|Follow-up Period||5
562010|NCT00663208|1370406|P6|COMPLETED|Follow-up Period||4
562011|NCT00663208|1370407|P5|COMPLETED|Follow-up Period||4
562012|NCT00663208|1370408|P4|COMPLETED|Follow-up Period||2
562013|NCT00663208|1370409|P3|COMPLETED|Follow-up Period||1
562014|NCT00663208|1370410|P2|COMPLETED|Follow-up Period||3
562015|NCT00663208|1370411|P1|COMPLETED|Follow-up Period||1
562016|NCT00663208|1370405|P7|STARTED|Follow-up Period||6
562017|NCT00663208|1370406|P6|STARTED|Follow-up Period||4
562018|NCT00663208|1370407|P5|STARTED|Follow-up Period||4
562019|NCT00663208|1370408|P4|STARTED|Follow-up Period||4
562020|NCT00663208|1370409|P3|STARTED|Follow-up Period||4
562021|NCT00663208|1370410|P2|STARTED|Follow-up Period||3
562022|NCT00663208|1370411|P1|STARTED|Follow-up Period||4
562023|NCT00663208|1370405|P7|NOT COMPLETED|Treatment Period||0
562024|NCT00663208|1370406|P6|NOT COMPLETED|Treatment Period||0
562025|NCT00663208|1370407|P5|NOT COMPLETED|Treatment Period||0
562026|NCT00663208|1370408|P4|NOT COMPLETED|Treatment Period||0
562027|NCT00663208|1370409|P3|NOT COMPLETED|Treatment Period||0
562028|NCT00663208|1370410|P2|NOT COMPLETED|Treatment Period||1
562029|NCT00663208|1370411|P1|NOT COMPLETED|Treatment Period||0
562030|NCT00663208|1370405|P7|COMPLETED|Treatment Period||6
562031|NCT00663208|1370406|P6|COMPLETED|Treatment Period||4
562032|NCT00663208|1370407|P5|COMPLETED|Treatment Period||4
562033|NCT00663208|1370408|P4|COMPLETED|Treatment Period||4
562034|NCT00663208|1370409|P3|COMPLETED|Treatment Period||4
562035|NCT00663208|1370410|P2|COMPLETED|Treatment Period||3
562036|NCT00663208|1370411|P1|COMPLETED|Treatment Period||4
562037|NCT00663208|1370405|P7|STARTED|Treatment Period||6
562038|NCT00663208|1370406|P6|STARTED|Treatment Period||4
562039|NCT00663208|1370407|P5|STARTED|Treatment Period||4
562040|NCT00663208|1370408|P4|STARTED|Treatment Period||4
562041|NCT00663208|1370409|P3|STARTED|Treatment Period||4
562042|NCT00663208|1370410|P2|STARTED|Treatment Period||4
562043|NCT00663208|1370411|P1|STARTED|Treatment Period||4
562044|NCT00663169|1370563|P2|NOT COMPLETED|Overall Study||0
562045|NCT00663169|1370564|P1|NOT COMPLETED|Overall Study||0
562046|NCT00663169|1370563|P2|COMPLETED|Overall Study||3
562047|NCT00663169|1370564|P1|COMPLETED|Overall Study||3
562048|NCT00663169|1370563|P2|STARTED|Overall Study||3
562049|NCT00663169|1370564|P1|STARTED|Overall Study||3
562050|NCT00663117|1370589|P2|NOT COMPLETED|Overall Study||0
562051|NCT00663117|1370590|P1|NOT COMPLETED|Overall Study||1
562052|NCT00663117|1370589|P2|COMPLETED|Overall Study||20
562053|NCT00663117|1370590|P1|COMPLETED|Overall Study|One patient in placebo flared and was unblinded and crossed over to active drug|19
562054|NCT00663117|1370589|P2|STARTED|Overall Study||20
562055|NCT00663117|1370590|P1|STARTED|Overall Study||20
562056|NCT00663052|1370604|P2|NOT COMPLETED|Overall Study||10
562057|NCT00663052|1370605|P1|NOT COMPLETED|Overall Study||12
562058|NCT00663052|1370604|P2|COMPLETED|Overall Study||127
562059|NCT00663052|1370605|P1|COMPLETED|Overall Study||124
562060|NCT00663052|1370604|P2|STARTED|Overall Study||137
562061|NCT00663052|1370605|P1|STARTED|Overall Study||136
562062|NCT00663026|1370688|P3|NOT COMPLETED|Overall Study||4
562063|NCT00663026|1370689|P2|NOT COMPLETED|Overall Study||6
562064|NCT00663026|1370690|P1|NOT COMPLETED|Overall Study||2
562065|NCT00663026|1370688|P3|COMPLETED|Overall Study||27
562066|NCT00663026|1370689|P2|COMPLETED|Overall Study||23
562067|NCT00663026|1370690|P1|COMPLETED|Overall Study||17
562068|NCT00663026|1370688|P3|STARTED|Overall Study||31
562069|NCT00663026|1370689|P2|STARTED|Overall Study||29
562070|NCT00663026|1370690|P1|STARTED|Overall Study||19
562071|NCT00662909|1370713|P3|NOT COMPLETED|Overall Study||53
562072|NCT00662909|1370714|P2|NOT COMPLETED|Overall Study||59
562073|NCT00662909|1370715|P1|NOT COMPLETED|Overall Study||69
562074|NCT00662909|1370713|P3|COMPLETED|Overall Study||380
562075|NCT00662909|1370714|P2|COMPLETED|Overall Study||383
562076|NCT00662909|1370715|P1|COMPLETED|Overall Study||385
562077|NCT00662909|1370713|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|296
562078|NCT00662909|1370714|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|312
562079|NCT00662909|1370715|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|325
562080|NCT00662909|1370713|P3|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|412
562081|NCT00662909|1370714|P2|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|425
562082|NCT00662909|1370715|P1|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|433
562083|NCT00662909|1370713|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|433
562084|NCT00662909|1370714|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|442
562168|NCT00662649|1370912|P3|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||0
562085|NCT00662909|1370715|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|453
562086|NCT00662909|1370713|P3|STARTED|Overall Study||433
562087|NCT00662909|1370714|P2|STARTED|Overall Study||442
562088|NCT00662909|1370715|P1|STARTED|Overall Study||454
562089|NCT00662857|1370813|P2|NOT COMPLETED|Lispro Dosing Period (1 Day)||0
562090|NCT00662857|1370814|P1|NOT COMPLETED|Lispro Dosing Period (1 Day)||0
562091|NCT00662857|1370813|P2|COMPLETED|Lispro Dosing Period (1 Day)||14
562092|NCT00662857|1370814|P1|COMPLETED|Lispro Dosing Period (1 Day)||12
562093|NCT00662857|1370813|P2|STARTED|Lispro Dosing Period (1 Day)||14
562094|NCT00662857|1370814|P1|STARTED|Lispro Dosing Period (1 Day)||12
562095|NCT00662857|1370813|P2|NOT COMPLETED|Washout 2 (3 - 14 Days)||0
562096|NCT00662857|1370814|P1|NOT COMPLETED|Washout 2 (3 - 14 Days)||1
562097|NCT00662857|1370813|P2|COMPLETED|Washout 2 (3 - 14 Days)||14
562098|NCT00662857|1370814|P1|COMPLETED|Washout 2 (3 - 14 Days)||12
562099|NCT00662857|1370813|P2|STARTED|Washout 2 (3 - 14 Days)||14
562100|NCT00662857|1370814|P1|STARTED|Washout 2 (3 - 14 Days)||13
562101|NCT00662857|1370813|P2|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0
562102|NCT00662857|1370814|P1|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0
562103|NCT00662857|1370813|P2|COMPLETED|TI Dosing Period 2 (1 Day)||14
562104|NCT00662857|1370814|P1|COMPLETED|TI Dosing Period 2 (1 Day)||13
562105|NCT00662857|1370813|P2|STARTED|TI Dosing Period 2 (1 Day)||14
562106|NCT00662857|1370814|P1|STARTED|TI Dosing Period 2 (1 Day)||13
562107|NCT00662857|1370813|P2|NOT COMPLETED|Washout 1 (3 - 14 Days)||2
562108|NCT00662857|1370814|P1|NOT COMPLETED|Washout 1 (3 - 14 Days)||0
562109|NCT00662857|1370813|P2|COMPLETED|Washout 1 (3 - 14 Days)||14
562110|NCT00662857|1370814|P1|COMPLETED|Washout 1 (3 - 14 Days)||13
562111|NCT00662857|1370813|P2|STARTED|Washout 1 (3 - 14 Days)||16
562112|NCT00662857|1370814|P1|STARTED|Washout 1 (3 - 14 Days)||13
562113|NCT00662857|1370813|P2|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0
562114|NCT00662857|1370814|P1|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0
562115|NCT00662857|1370813|P2|COMPLETED|TI Dosing Period 1 (1 Day)||16
562116|NCT00662857|1370814|P1|COMPLETED|TI Dosing Period 1 (1 Day)||13
562117|NCT00662857|1370813|P2|STARTED|TI Dosing Period 1 (1 Day)||16
562118|NCT00662857|1370814|P1|STARTED|TI Dosing Period 1 (1 Day)||13
562119|NCT00662831|1370829|P2|NOT COMPLETED|Overall Study||59
562120|NCT00662831|1370830|P1|NOT COMPLETED|Overall Study||106
562121|NCT00662831|1370829|P2|COMPLETED|Overall Study||33
562122|NCT00662831|1370830|P1|COMPLETED|Overall Study||78
562123|NCT00662831|1370829|P2|STARTED|Overall Study||92
562124|NCT00662831|1370830|P1|STARTED|Overall Study||184
562125|NCT00662818|1370870|P2|NOT COMPLETED|Period 2 (6 Weeks)||12
562126|NCT00662818|1370871|P1|NOT COMPLETED|Period 2 (6 Weeks)||13
562127|NCT00662818|1370870|P2|COMPLETED|Period 2 (6 Weeks)||41
562128|NCT00662818|1370871|P1|COMPLETED|Period 2 (6 Weeks)||38
562129|NCT00662818|1370870|P2|STARTED|Period 2 (6 Weeks)||53
562130|NCT00662818|1370871|P1|STARTED|Period 2 (6 Weeks)||51
562131|NCT00662818|1370870|P2|NOT COMPLETED|Wash-Out (14 Days)||5
562132|NCT00662818|1370871|P1|NOT COMPLETED|Wash-Out (14 Days)||5
562133|NCT00662818|1370870|P2|COMPLETED|Wash-Out (14 Days)||53
562134|NCT00662818|1370871|P1|COMPLETED|Wash-Out (14 Days)||51
562135|NCT00662818|1370870|P2|STARTED|Wash-Out (14 Days)||58
562136|NCT00662818|1370871|P1|STARTED|Wash-Out (14 Days)||56
562137|NCT00662818|1370870|P2|NOT COMPLETED|Period 1 (6 Weeks)||23
562138|NCT00662818|1370871|P1|NOT COMPLETED|Period 1 (6 Weeks)||28
562139|NCT00662818|1370870|P2|COMPLETED|Period 1 (6 Weeks)||58
562140|NCT00662818|1370871|P1|COMPLETED|Period 1 (6 Weeks)||56
562141|NCT00662818|1370870|P2|Treated|Period 1 (6 Weeks)||58
562142|NCT00662818|1370871|P1|Treated|Period 1 (6 Weeks)||56
562143|NCT00662818|1370870|P2|STARTED|Period 1 (6 Weeks)||81
562144|NCT00662818|1370871|P1|STARTED|Period 1 (6 Weeks)||84
562145|NCT00662675|1370895|P2|NOT COMPLETED|Overall Study||0
562146|NCT00662675|1370896|P1|NOT COMPLETED|Overall Study||0
562147|NCT00662675|1370895|P2|COMPLETED|Overall Study||20
562148|NCT00662675|1370896|P1|COMPLETED|Overall Study||20
562149|NCT00662675|1370895|P2|STARTED|Overall Study||20
562150|NCT00662675|1370896|P1|STARTED|Overall Study||20
562151|NCT00662649|1370910|P5|NOT COMPLETED|Extension Study (Month 24 to 60)||29
562152|NCT00662649|1370911|P4|NOT COMPLETED|Extension Study (Month 24 to 60)||33
562153|NCT00662649|1370912|P3|NOT COMPLETED|Extension Study (Month 24 to 60)||0
562154|NCT00662649|1370913|P2|NOT COMPLETED|Extension Study (Month 24 to 60)||41
562155|NCT00662649|1370914|P1|NOT COMPLETED|Extension Study (Month 24 to 60)||44
562156|NCT00662649|1370910|P5|COMPLETED|Extension Study (Month 24 to 60)||126
562157|NCT00662649|1370911|P4|COMPLETED|Extension Study (Month 24 to 60)||112
562158|NCT00662649|1370912|P3|COMPLETED|Extension Study (Month 24 to 60)||0
562159|NCT00662649|1370913|P2|COMPLETED|Extension Study (Month 24 to 60)||290
562160|NCT00662649|1370914|P1|COMPLETED|Extension Study (Month 24 to 60)|"completed refers to patients that completed extension study in different time points."|245
562161|NCT00662649|1370910|P5|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||13
562162|NCT00662649|1370911|P4|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||11
562163|NCT00662649|1370912|P3|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||0
562164|NCT00662649|1370913|P2|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||32
562165|NCT00662649|1370914|P1|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||31
562166|NCT00662649|1370910|P5|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||67
562167|NCT00662649|1370911|P4|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||58
562169|NCT00662649|1370913|P2|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||152
562170|NCT00662649|1370914|P1|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||125
562171|NCT00662649|1370910|P5|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||136
562172|NCT00662649|1370911|P4|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||120
562173|NCT00662649|1370912|P3|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||0
562174|NCT00662649|1370913|P2|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||301
562175|NCT00662649|1370914|P1|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||254
562176|NCT00662649|1370910|P5|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||145
562177|NCT00662649|1370911|P4|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||130
562178|NCT00662649|1370912|P3|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||0
562179|NCT00662649|1370913|P2|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||311
562180|NCT00662649|1370914|P1|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||270
562181|NCT00662649|1370910|P5|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||152
562182|NCT00662649|1370911|P4|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||136
562183|NCT00662649|1370912|P3|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||0
562184|NCT00662649|1370913|P2|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||324
562185|NCT00662649|1370914|P1|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||276
562186|NCT00662649|1370910|P5|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||155
562187|NCT00662649|1370911|P4|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||145
562188|NCT00662649|1370912|P3|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||0
562189|NCT00662649|1370913|P2|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||331
562190|NCT00662649|1370914|P1|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||289
562191|NCT00662649|1370910|P5|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||154
562192|NCT00662649|1370911|P4|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||145
562193|NCT00662649|1370912|P3|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||0
562194|NCT00662649|1370913|P2|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||330
562195|NCT00662649|1370914|P1|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||287
562196|NCT00662649|1370910|P5|STARTED|Extension Study (Month 24 to 60)||155
562197|NCT00662649|1370911|P4|STARTED|Extension Study (Month 24 to 60)||145
562198|NCT00662649|1370912|P3|STARTED|Extension Study (Month 24 to 60)|This reporting group is used only for core study|0
562199|NCT00662649|1370913|P2|STARTED|Extension Study (Month 24 to 60)||331
562200|NCT00662649|1370914|P1|STARTED|Extension Study (Month 24 to 60)||289
562201|NCT00662649|1370910|P5|NOT COMPLETED|Core Study (24 Months)||0
562202|NCT00662649|1370911|P4|NOT COMPLETED|Core Study (24 Months)||0
562203|NCT00662649|1370912|P3|NOT COMPLETED|Core Study (24 Months)||86
562204|NCT00662649|1370913|P2|NOT COMPLETED|Core Study (24 Months)||56
562205|NCT00662649|1370914|P1|NOT COMPLETED|Core Study (24 Months)||97
562206|NCT00662649|1370910|P5|COMPLETED|Core Study (24 Months)||0
562207|NCT00662649|1370911|P4|COMPLETED|Core Study (24 Months)||0
562208|NCT00662649|1370912|P3|COMPLETED|Core Study (24 Months)||332
562209|NCT00662649|1370913|P2|COMPLETED|Core Study (24 Months)||369
562210|NCT00662649|1370914|P1|COMPLETED|Core Study (24 Months)||332
562211|NCT00662649|1370910|P5|Intent to Treat (ITT)|Core Study (24 Months)||0
562212|NCT00662649|1370911|P4|Intent to Treat (ITT)|Core Study (24 Months)||0
562213|NCT00662649|1370912|P3|Intent to Treat (ITT)|Core Study (24 Months)||418
562214|NCT00662649|1370913|P2|Intent to Treat (ITT)|Core Study (24 Months)||425
562215|NCT00662649|1370914|P1|Intent to Treat (ITT)|Core Study (24 Months)||429
562216|NCT00662649|1370910|P5|STARTED|Core Study (24 Months)|This reporting group is used only in extension study.|0
562217|NCT00662649|1370911|P4|STARTED|Core Study (24 Months)|This reporting group is used only in extension study.|0
562218|NCT00662649|1370912|P3|STARTED|Core Study (24 Months)||418
562219|NCT00662649|1370913|P2|STARTED|Core Study (24 Months)||425
562220|NCT00662649|1370914|P1|STARTED|Core Study (24 Months)||429
562221|NCT00662558|1370954|P2|NOT COMPLETED|Overall Study||110
562222|NCT00662558|1370955|P1|NOT COMPLETED|Overall Study||56
562223|NCT00662558|1370954|P2|COMPLETED|Overall Study||294
562224|NCT00662558|1370955|P1|COMPLETED|Overall Study||342
562225|NCT00662558|1370954|P2|Received Treatment|Overall Study||396
562226|NCT00662558|1370955|P1|Received Treatment|Overall Study||396
562227|NCT00662558|1370954|P2|STARTED|Overall Study||404
562228|NCT00662558|1370955|P1|STARTED|Overall Study||398
562229|NCT00662545|1370989|P2|NOT COMPLETED|Overall Study||0
562230|NCT00662545|1370990|P1|NOT COMPLETED|Overall Study||0
562231|NCT00662545|1370989|P2|COMPLETED|Overall Study||5
562232|NCT00662545|1370990|P1|COMPLETED|Overall Study||5
562233|NCT00662545|1370989|P2|STARTED|Overall Study||5
562234|NCT00662545|1370990|P1|STARTED|Overall Study||5
562235|NCT00662532|1371006|P2|NOT COMPLETED|Overall Study||2
562236|NCT00662532|1371007|P1|NOT COMPLETED|Overall Study||0
562237|NCT00662532|1371006|P2|COMPLETED|Overall Study||20
562238|NCT00662532|1371007|P1|COMPLETED|Overall Study||22
562239|NCT00662532|1371006|P2|STARTED|Overall Study||22
562240|NCT00662532|1371007|P1|STARTED|Overall Study||22
562241|NCT00662389|1371017|P1|NOT COMPLETED|Overall Study||0
562242|NCT00662389|1371017|P1|COMPLETED|Overall Study||4
562243|NCT00662389|1371017|P1|STARTED|Overall Study||4
562244|NCT00662363|1371022|P2|NOT COMPLETED|Overall Study||10
562245|NCT00662363|1371023|P1|NOT COMPLETED|Overall Study||11
562246|NCT00662363|1371022|P2|COMPLETED|Overall Study|one subject died before receiving any study med 2 subjects withdrew before taking any study med|22
562247|NCT00662363|1371023|P1|COMPLETED|Overall Study|1 subject withdrew before taking any study medication|21
562248|NCT00662363|1371022|P2|STARTED|Overall Study||32
562249|NCT00662363|1371023|P1|STARTED|Overall Study||32
562250|NCT00662311|1371034|P3|NOT COMPLETED|Overall Study||0
562251|NCT00662311|1371035|P2|NOT COMPLETED|Overall Study||0
562252|NCT00662311|1371036|P1|NOT COMPLETED|Overall Study||1
562253|NCT00662311|1371034|P3|COMPLETED|Overall Study||0
562254|NCT00662311|1371035|P2|COMPLETED|Overall Study||0
562255|NCT00662311|1371036|P1|COMPLETED|Overall Study||4
562256|NCT00662311|1371034|P3|STARTED|Overall Study||0
562257|NCT00662311|1371035|P2|STARTED|Overall Study||0
562258|NCT00662311|1371036|P1|STARTED|Overall Study||5
562259|NCT00662207|1371059|P1|NOT COMPLETED|Overall Study||0
562260|NCT00662207|1371059|P1|COMPLETED|Overall Study||3
562261|NCT00662207|1371059|P1|STARTED|Overall Study||3
562262|NCT00662155|1371070|P4|NOT COMPLETED|Overall Study||4
562263|NCT00662155|1371071|P3|NOT COMPLETED|Overall Study||7
562264|NCT00662155|1371072|P2|NOT COMPLETED|Overall Study||5
562265|NCT00662155|1371073|P1|NOT COMPLETED|Overall Study||3
562266|NCT00662155|1371070|P4|COMPLETED|Overall Study||14
562267|NCT00662155|1371071|P3|COMPLETED|Overall Study||13
562268|NCT00662155|1371072|P2|COMPLETED|Overall Study||15
562269|NCT00662155|1371073|P1|COMPLETED|Overall Study||13
562270|NCT00662155|1371070|P4|STARTED|Overall Study||18
562271|NCT00662155|1371071|P3|STARTED|Overall Study||20
562272|NCT00662155|1371072|P2|STARTED|Overall Study||20
562273|NCT00662155|1371073|P1|STARTED|Overall Study||16
562274|NCT00662129|1371087|P1|NOT COMPLETED|Overall Study||3
562275|NCT00662129|1371087|P1|COMPLETED|Overall Study||47
562276|NCT00662129|1371087|P1|STARTED|Overall Study||50
562277|NCT00662038|1371097|P1|NOT COMPLETED|Overall Study||631
562278|NCT00662038|1371097|P1|COMPLETED|Overall Study||427
562279|NCT00662038|1371097|P1|STARTED|Overall Study||1058
562280|NCT00662025|1371101|P1|NOT COMPLETED|Overall Study||63
562281|NCT00662025|1371101|P1|COMPLETED|Overall Study||0
562282|NCT00662025|1371101|P1|STARTED|Overall Study|All 63 participants were included in Full Analysis Set population.|63
562283|NCT00662012|1371121|P1|NOT COMPLETED|Overall Study||87
562284|NCT00662012|1371121|P1|COMPLETED|Overall Study||327
562285|NCT00662012|1371121|P1|STARTED|Overall Study||414
562286|NCT00661999|1371129|P3|NOT COMPLETED|Overall Study||57
562287|NCT00661999|1371130|P2|NOT COMPLETED|Overall Study||50
562288|NCT00661999|1371131|P1|NOT COMPLETED|Overall Study||59
562289|NCT00661999|1371129|P3|COMPLETED|Overall Study||106
562290|NCT00661999|1371130|P2|COMPLETED|Overall Study||113
562291|NCT00661999|1371131|P1|COMPLETED|Overall Study||105
562292|NCT00661999|1371129|P3|STARTED|Overall Study||163
562293|NCT00661999|1371130|P2|STARTED|Overall Study||163
562294|NCT00661999|1371131|P1|STARTED|Overall Study||164
562295|NCT00661960|1371187|P3|NOT COMPLETED|Overall Study||1
562296|NCT00661960|1371188|P2|NOT COMPLETED|Overall Study||3
562297|NCT00661960|1371189|P1|NOT COMPLETED|Overall Study||0
562298|NCT00661960|1371187|P3|COMPLETED|Overall Study||9
562299|NCT00661960|1371188|P2|COMPLETED|Overall Study||7
562300|NCT00661960|1371189|P1|COMPLETED|Overall Study||5
562301|NCT00661960|1371187|P3|STARTED|Overall Study||10
562302|NCT00661960|1371188|P2|STARTED|Overall Study||10
562303|NCT00661960|1371189|P1|STARTED|Overall Study||5
562304|NCT00661895|1371199|P2|NOT COMPLETED|Overall Study||0
562305|NCT00661895|1371200|P1|NOT COMPLETED|Overall Study||0
562306|NCT00661895|1371199|P2|COMPLETED|Overall Study||50
562307|NCT00661895|1371200|P1|COMPLETED|Overall Study||49
562308|NCT00661895|1371199|P2|STARTED|Overall Study||50
562309|NCT00661895|1371200|P1|STARTED|Overall Study||49
562310|NCT00661830|1371208|P2|NOT COMPLETED|Overall Study||42
562311|NCT00661830|1371209|P1|NOT COMPLETED|Overall Study||40
562312|NCT00661830|1371208|P2|COMPLETED|Overall Study||6
562313|NCT00661830|1371209|P1|COMPLETED|Overall Study||9
562314|NCT00661830|1371208|P2|STARTED|Overall Study||48
562315|NCT00661830|1371209|P1|STARTED|Overall Study||49
562316|NCT00661778|1371221|P1|NOT COMPLETED|Overall Study||50
562317|NCT00661778|1371221|P1|COMPLETED|Overall Study||0
562318|NCT00661778|1371221|P1|STARTED|Overall Study||50
562319|NCT00661726|1371228|P1|NOT COMPLETED|Overall Study||1
562320|NCT00661726|1371228|P1|COMPLETED|Overall Study||5
562321|NCT00661726|1371228|P1|STARTED|Overall Study||6
562322|NCT00661713|1371251|P8|NOT COMPLETED|Overall Study||11
562323|NCT00661713|1371252|P7|NOT COMPLETED|Overall Study||64
562324|NCT00661713|1371253|P6|NOT COMPLETED|Overall Study||37
562325|NCT00661713|1371254|P5|NOT COMPLETED|Overall Study||20
562326|NCT00661713|1371255|P4|NOT COMPLETED|Overall Study||28
562327|NCT00661713|1371256|P3|NOT COMPLETED|Overall Study||17
562328|NCT00661713|1371257|P2|NOT COMPLETED|Overall Study||39
562329|NCT00661713|1371258|P1|NOT COMPLETED|Overall Study||16
562330|NCT00661713|1371251|P8|COMPLETED|Overall Study||117
562331|NCT00661713|1371252|P7|COMPLETED|Overall Study||309
562332|NCT00661713|1371253|P6|COMPLETED|Overall Study||216
562333|NCT00661713|1371254|P5|COMPLETED|Overall Study||107
562334|NCT00661713|1371255|P4|COMPLETED|Overall Study||219
562335|NCT00661713|1371256|P3|COMPLETED|Overall Study||111
562336|NCT00661713|1371257|P2|COMPLETED|Overall Study||208
562337|NCT00661713|1371258|P1|COMPLETED|Overall Study||112
562338|NCT00661713|1371251|P8|STARTED|Overall Study||128
562339|NCT00661713|1371252|P7|STARTED|Overall Study||373
562340|NCT00661713|1371253|P6|STARTED|Overall Study||253
562341|NCT00661713|1371254|P5|STARTED|Overall Study||127
562342|NCT00661713|1371255|P4|STARTED|Overall Study||247
562343|NCT00661713|1371256|P3|STARTED|Overall Study||128
562344|NCT00661713|1371257|P2|STARTED|Overall Study||247
562345|NCT00661713|1371258|P1|STARTED|Overall Study||128
562346|NCT00661687|1371348|P1|NOT COMPLETED|Overall Study||15
562347|NCT00661687|1371348|P1|COMPLETED|Overall Study|Number indicates number of subjects successfully completing study.|189
562348|NCT00661687|1371348|P1|STARTED|Overall Study|Contralateral study design, numbers indicate number of subjects.|204
562349|NCT00661674|1371358|P6|NOT COMPLETED|Overall Study||0
562350|NCT00661674|1371359|P5|NOT COMPLETED|Overall Study||0
562351|NCT00661674|1371360|P4|NOT COMPLETED|Overall Study||0
562352|NCT00661674|1371361|P3|NOT COMPLETED|Overall Study||0
562353|NCT00661674|1371362|P2|NOT COMPLETED|Overall Study||0
562354|NCT00661674|1371363|P1|NOT COMPLETED|Overall Study||0
562355|NCT00661674|1371358|P6|COMPLETED|Overall Study|Participant 9 completed sequence 6|1
562356|NCT00661674|1371359|P5|COMPLETED|Overall Study|Participants 6 & 8 completed sequence 5|2
562357|NCT00661674|1371360|P4|COMPLETED|Overall Study|Participant 5 completed sequence 4|1
562358|NCT00661674|1371361|P3|COMPLETED|Overall Study|Participants 4 & 7 completed sequence 3|2
562359|NCT00661674|1371362|P2|COMPLETED|Overall Study|Participants 2 & 3 completed sequence 2|2
562360|NCT00661674|1371363|P1|COMPLETED|Overall Study|Participants 1 & 10 completed sequence 1|2
562361|NCT00661674|1371358|P6|STARTED|Overall Study|Participant 9 was assigned to sequence 6|1
562362|NCT00661674|1371359|P5|STARTED|Overall Study|Participants 6 & 8 were assigned to sequence 5|2
562363|NCT00661674|1371360|P4|STARTED|Overall Study|Participant 5 was assigned to sequence 4|1
562364|NCT00661674|1371361|P3|STARTED|Overall Study|Participants 4 & 7 were assigned to sequence 3|2
562365|NCT00661674|1371362|P2|STARTED|Overall Study|Participants 2 & 3 were assigned to sequence 2|2
562366|NCT00661674|1371363|P1|STARTED|Overall Study|Participants 1 & 10 were assigned to sequence 1|2
562367|NCT00661661|1371376|P2|NOT COMPLETED|Overall Study||39
562368|NCT00661661|1371377|P1|NOT COMPLETED|Overall Study||140
562369|NCT00661661|1371376|P2|COMPLETED|Overall Study||66
562370|NCT00661661|1371377|P1|COMPLETED|Overall Study||242
562371|NCT00661661|1371376|P2|STARTED|Overall Study||105
562372|NCT00661661|1371377|P1|STARTED|Overall Study||382
562373|NCT00661622|1371453|P2|NOT COMPLETED|Overall Study||0
562374|NCT00661622|1371454|P1|NOT COMPLETED|Overall Study||1
562375|NCT00661622|1371453|P2|COMPLETED|Overall Study||27
562376|NCT00661622|1371454|P1|COMPLETED|Overall Study||25
562377|NCT00661622|1371453|P2|STARTED|Overall Study||27
562378|NCT00661622|1371454|P1|STARTED|Overall Study||26
562379|NCT00661609|1371468|P1|NOT COMPLETED|Overall Study||41
562380|NCT00661609|1371468|P1|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
562381|NCT00661609|1371468|P1|STARTED|Overall Study|All dosed patients|41
562382|NCT00661583|1371478|P3|NOT COMPLETED|Overall Study||0
562383|NCT00661583|1371479|P2|NOT COMPLETED|Overall Study||0
562384|NCT00661583|1371480|P1|NOT COMPLETED|Overall Study||0
562385|NCT00661583|1371478|P3|COMPLETED|Overall Study||10
562386|NCT00661583|1371479|P2|COMPLETED|Overall Study||10
562387|NCT00661583|1371480|P1|COMPLETED|Overall Study||10
562388|NCT00661583|1371478|P3|STARTED|Overall Study||10
562389|NCT00661583|1371479|P2|STARTED|Overall Study||10
562390|NCT00661583|1371480|P1|STARTED|Overall Study||10
562391|NCT00661570|1371497|P1|NOT COMPLETED|Overall Study||0
562392|NCT00661570|1371497|P1|COMPLETED|Overall Study||26
562393|NCT00661570|1371497|P1|STARTED|Overall Study||26
562394|NCT00661544|1371504|P1|NOT COMPLETED|Overall Study||0
562395|NCT00661544|1371504|P1|COMPLETED|Overall Study||48
562396|NCT00661544|1371504|P1|STARTED|Overall Study||48
562397|NCT00661531|1371508|P1|NOT COMPLETED|Overall Study||3
562398|NCT00661531|1371508|P1|COMPLETED|Overall Study||8
562399|NCT00661531|1371508|P1|STARTED|Overall Study||11
562400|NCT00661505|1371513|P1|NOT COMPLETED|Overall Study||30
562401|NCT00661505|1371513|P1|COMPLETED|Overall Study||102
562402|NCT00661505|1371513|P1|STARTED|Overall Study||132
562403|NCT00661492|1371541|P2|NOT COMPLETED|Overall Study||29
562404|NCT00661492|1371542|P1|NOT COMPLETED|Overall Study||68
562405|NCT00661492|1371541|P2|COMPLETED|Overall Study||11
562406|NCT00661492|1371542|P1|COMPLETED|Overall Study||7
562407|NCT00661492|1371541|P2|STARTED|Overall Study||40
562408|NCT00661492|1371542|P1|STARTED|Overall Study||75
562409|NCT00661479|1371566|P4|NOT COMPLETED|Overall Study||0
562410|NCT00661479|1371567|P3|NOT COMPLETED|Overall Study||0
562411|NCT00661479|1371568|P2|NOT COMPLETED|Overall Study||0
562412|NCT00661479|1371569|P1|NOT COMPLETED|Overall Study||0
562413|NCT00661479|1371566|P4|COMPLETED|Overall Study||3
562414|NCT00661479|1371567|P3|COMPLETED|Overall Study||3
562415|NCT00661479|1371568|P2|COMPLETED|Overall Study||3
562416|NCT00661479|1371569|P1|COMPLETED|Overall Study||12
562417|NCT00661479|1371566|P4|STARTED|Overall Study||3
562418|NCT00661479|1371567|P3|STARTED|Overall Study||3
562419|NCT00661479|1371568|P2|STARTED|Overall Study||3
562420|NCT00661479|1371569|P1|STARTED|Overall Study||12
562421|NCT00661453|1371582|P1|NOT COMPLETED|Overall Study||13
562422|NCT00661453|1371582|P1|COMPLETED|Overall Study||25
562423|NCT00661453|1371582|P1|STARTED|Overall Study||38
562424|NCT00661427|1371588|P2|NOT COMPLETED|Overall Study||7
562425|NCT00661427|1371589|P1|NOT COMPLETED|Overall Study||5
562426|NCT00661427|1371588|P2|COMPLETED|Overall Study||19
562427|NCT00661427|1371589|P1|COMPLETED|Overall Study||30
562428|NCT00661427|1371588|P2|STARTED|Overall Study||26
562429|NCT00661427|1371589|P1|STARTED|Overall Study||35
562430|NCT00661388|1371597|P1|NOT COMPLETED|Overall Study||24
562431|NCT00661388|1371597|P1|COMPLETED|Overall Study||51
562432|NCT00661388|1371597|P1|STARTED|Overall Study||75
562433|NCT00661362|1371620|P2|NOT COMPLETED|Overall Study||40
562434|NCT00661362|1371621|P1|NOT COMPLETED|Overall Study||29
562435|NCT00661362|1371620|P2|COMPLETED|Overall Study|Completed 24 Weeks of treatment|247
562436|NCT00661362|1371621|P1|COMPLETED|Overall Study|Completed 24 Weeks of treatment|254
562437|NCT00661362|1371620|P2|STARTED|Overall Study|Randomized and treated|287
562438|NCT00661362|1371621|P1|STARTED|Overall Study|Randomized and treated|283
562439|NCT00661271|1371639|P2|NOT COMPLETED|Overall Study||25
562440|NCT00661271|1371640|P1|NOT COMPLETED|Overall Study||28
562441|NCT00661271|1371639|P2|COMPLETED|Overall Study||20
562442|NCT00661271|1371640|P1|COMPLETED|Overall Study||20
562443|NCT00661271|1371639|P2|STARTED|Overall Study||45
562444|NCT00661271|1371640|P1|STARTED|Overall Study||48
562445|NCT00661258|1371650|P2|NOT COMPLETED|Overall Study||1
562446|NCT00661258|1371651|P1|NOT COMPLETED|Overall Study||3
562447|NCT00661258|1371650|P2|COMPLETED|Overall Study||33
562448|NCT00661258|1371651|P1|COMPLETED|Overall Study||31
562449|NCT00661258|1371650|P2|STARTED|Overall Study||34
562450|NCT00661258|1371651|P1|STARTED|Overall Study||34
562451|NCT00661193|1371661|P2|NOT COMPLETED|Overall Study||26
562452|NCT00661193|1371662|P1|NOT COMPLETED|Overall Study||33
562453|NCT00661193|1371661|P2|COMPLETED|Overall Study||0
562454|NCT00661193|1371662|P1|COMPLETED|Overall Study||0
562455|NCT00661193|1371661|P2|STARTED|Overall Study||26
562456|NCT00661193|1371662|P1|STARTED|Overall Study||33
562457|NCT00661141|1371673|P6|NOT COMPLETED|Overall Study||0
562458|NCT00661141|1371674|P5|NOT COMPLETED|Overall Study||0
562459|NCT00661141|1371675|P4|NOT COMPLETED|Overall Study||0
562460|NCT00661141|1371676|P3|NOT COMPLETED|Overall Study||0
562461|NCT00661141|1371677|P2|NOT COMPLETED|Overall Study||0
562462|NCT00661141|1371678|P1|NOT COMPLETED|Overall Study||0
562463|NCT00661141|1371673|P6|COMPLETED|Overall Study||4
562464|NCT00661141|1371674|P5|COMPLETED|Overall Study||4
562465|NCT00661141|1371675|P4|COMPLETED|Overall Study||4
562466|NCT00661141|1371676|P3|COMPLETED|Overall Study||4
562467|NCT00661141|1371677|P2|COMPLETED|Overall Study||8
562468|NCT00661141|1371678|P1|COMPLETED|Overall Study||8
562469|NCT00661141|1371673|P6|Administered 30 Minutes After Ethanol|Overall Study||0
562470|NCT00661141|1371674|P5|Administered 30 Minutes After Ethanol|Overall Study||0
562471|NCT00661141|1371675|P4|Administered 30 Minutes After Ethanol|Overall Study||2
562472|NCT00661141|1371676|P3|Administered 30 Minutes After Ethanol|Overall Study||2
562473|NCT00661141|1371677|P2|Administered 30 Minutes After Ethanol|Overall Study||2
562474|NCT00661141|1371678|P1|Administered 30 Minutes After Ethanol|Overall Study||2
562475|NCT00661141|1371673|P6|Administered 30 Minutes Prior to Ethanol|Overall Study||4
562476|NCT00661141|1371674|P5|Administered 30 Minutes Prior to Ethanol|Overall Study||4
562477|NCT00661141|1371675|P4|Administered 30 Minutes Prior to Ethanol|Overall Study||2
562478|NCT00661141|1371676|P3|Administered 30 Minutes Prior to Ethanol|Overall Study||2
562479|NCT00661141|1371677|P2|Administered 30 Minutes Prior to Ethanol|Overall Study||6
562480|NCT00661141|1371678|P1|Administered 30 Minutes Prior to Ethanol|Overall Study||6
562481|NCT00661141|1371673|P6|STARTED|Overall Study||4
562482|NCT00661141|1371674|P5|STARTED|Overall Study||4
562483|NCT00661141|1371675|P4|STARTED|Overall Study||4
562484|NCT00661141|1371676|P3|STARTED|Overall Study||4
562485|NCT00661141|1371677|P2|STARTED|Overall Study||8
562486|NCT00661141|1371678|P1|STARTED|Overall Study||8
562487|NCT00661089|1371887|P2|NOT COMPLETED|Overall Study||2
562488|NCT00661089|1371888|P1|NOT COMPLETED|Overall Study||0
562489|NCT00661089|1371887|P2|COMPLETED|Overall Study||9
562490|NCT00661089|1371888|P1|COMPLETED|Overall Study||10
562491|NCT00661089|1371887|P2|STARTED|Overall Study||11
562492|NCT00661089|1371888|P1|STARTED|Overall Study||10
562493|NCT00661037|1371898|P2|NOT COMPLETED|Overall Study||257
562494|NCT00661037|1371899|P1|NOT COMPLETED|Overall Study||154
562495|NCT00661037|1371898|P2|COMPLETED|Overall Study||1027
562496|NCT00661037|1371899|P1|COMPLETED|Overall Study||682
562497|NCT00661037|1371898|P2|Deaths|Overall Study||188
562498|NCT00661037|1371899|P1|Deaths|Overall Study||108
562499|NCT00661037|1371898|P2|Witdrawn|Overall Study||68
562500|NCT00661037|1371899|P1|Witdrawn|Overall Study||47
562501|NCT00661037|1371898|P2|STARTED|Overall Study||1284
562502|NCT00661037|1371899|P1|STARTED|Overall Study||836
562503|NCT00660985|1371911|P2|NOT COMPLETED|Overall Study||0
562504|NCT00660985|1371912|P1|NOT COMPLETED|Overall Study||1
562505|NCT00660985|1371911|P2|COMPLETED|Overall Study||25
562506|NCT00660985|1371912|P1|COMPLETED|Overall Study||25
562507|NCT00660985|1371911|P2|STARTED|Overall Study||25
562508|NCT00660985|1371912|P1|STARTED|Overall Study||26
562509|NCT00660907|1371936|P2|NOT COMPLETED|Overall Study||94
562510|NCT00660907|1371937|P1|NOT COMPLETED|Overall Study||84
562511|NCT00660907|1371936|P2|COMPLETED|Overall Study||314
562512|NCT00660907|1371937|P1|COMPLETED|Overall Study||322
562513|NCT00660907|1371936|P2|STARTED|Overall Study|Of the 408 randomized participants only 401 were included in the full analysis set.|408
562514|NCT00660907|1371937|P1|STARTED|Overall Study|Of the 406 randomized participants only 400 were included in the full analysis set.|406
562515|NCT00660829|1371951|P2|NOT COMPLETED|Overall Study||19
562516|NCT00660829|1371952|P1|NOT COMPLETED|Overall Study||18
562517|NCT00660829|1371951|P2|COMPLETED|Overall Study||249
562518|NCT00660829|1371952|P1|COMPLETED|Overall Study||250
562519|NCT00660829|1371951|P2|STARTED|Overall Study|2 subjects were randomized in error|268
562520|NCT00660829|1371952|P1|STARTED|Overall Study|2 subjects were randomized in error|268
562521|NCT00660816|1371970|P2|NOT COMPLETED|Overall Study||19
562522|NCT00660816|1371971|P1|NOT COMPLETED|Overall Study||20
562523|NCT00660816|1371970|P2|COMPLETED|Overall Study||3
562524|NCT00660816|1371971|P1|COMPLETED|Overall Study||4
562525|NCT00660816|1371970|P2|STARTED|Overall Study||22
562526|NCT00660816|1371971|P1|STARTED|Overall Study||24
562527|NCT00660699|1371983|P1|NOT COMPLETED|Overall Study||2
562528|NCT00660699|1371983|P1|COMPLETED|Overall Study||48
562529|NCT00660699|1371983|P1|STARTED|Overall Study||50
562530|NCT00660660|1371999|P2|NOT COMPLETED|Overall Study||9
562531|NCT00660660|1372000|P1|NOT COMPLETED|Overall Study||5
562532|NCT00660660|1371999|P2|COMPLETED|Overall Study|Number of completed patients is based on randomized population (133) minus withdrawals (9).|124
562533|NCT00660660|1372000|P1|COMPLETED|Overall Study|Number of completed patients is based on randomized population (143) minus withdrawals (5).|138
562534|NCT00660660|1371999|P2|Met Criteria for MITT Population|Overall Study||125
562535|NCT00660660|1372000|P1|Met Criteria for MITT Population|Overall Study||137
562536|NCT00660660|1371999|P2|STARTED|Overall Study|Randomized|133
562537|NCT00660660|1372000|P1|STARTED|Overall Study|Randomized|143
562538|NCT00660595|1372100|P2|NOT COMPLETED|Overall Study||9
562539|NCT00660595|1372101|P1|NOT COMPLETED|Overall Study||18
562540|NCT00660595|1372100|P2|COMPLETED|Overall Study|One of the two was lost to follow-up|1
562541|NCT00660595|1372101|P1|COMPLETED|Overall Study||1
562542|NCT00660595|1372100|P2|STARTED|Overall Study||10
562543|NCT00660595|1372101|P1|STARTED|Overall Study||19
562544|NCT00660543|1372113|P1|NOT COMPLETED|Overall Study||0
562545|NCT00660543|1372113|P1|COMPLETED|Overall Study||14
562546|NCT00660543|1372113|P1|STARTED|Overall Study||14
562547|NCT00660517|1372126|P4|NOT COMPLETED|Overall Study||7
562548|NCT00660517|1372127|P3|NOT COMPLETED|Overall Study||7
562549|NCT00660517|1372128|P2|NOT COMPLETED|Overall Study||8
562550|NCT00660517|1372129|P1|NOT COMPLETED|Overall Study||8
562551|NCT00660517|1372126|P4|COMPLETED|Overall Study||144
562552|NCT00660517|1372127|P3|COMPLETED|Overall Study||144
562553|NCT00660517|1372128|P2|COMPLETED|Overall Study||144
562554|NCT00660517|1372129|P1|COMPLETED|Overall Study||145
562555|NCT00660517|1372126|P4|STARTED|Overall Study||151
562556|NCT00660517|1372127|P3|STARTED|Overall Study||151
562557|NCT00660517|1372128|P2|STARTED|Overall Study||152
562558|NCT00660517|1372129|P1|STARTED|Overall Study||153
562559|NCT00660504|1372149|P2|NOT COMPLETED|Overall Study||1
562560|NCT00660504|1372150|P1|NOT COMPLETED|Overall Study||0
562561|NCT00660504|1372149|P2|COMPLETED|Overall Study||150
562562|NCT00660504|1372150|P1|COMPLETED|Overall Study||149
562563|NCT00660504|1372149|P2|STARTED|Overall Study||151
562564|NCT00660504|1372150|P1|STARTED|Overall Study||149
562565|NCT00660400|1372162|P1|NOT COMPLETED|Overall Study||4
562566|NCT00660400|1372162|P1|COMPLETED|Overall Study||21
562567|NCT00660400|1372162|P1|STARTED|Overall Study||25
562568|NCT00660387|1372171|P2|NOT COMPLETED|Overall Study||3
562569|NCT00660387|1372172|P1|NOT COMPLETED|Overall Study||2
562570|NCT00660387|1372171|P2|COMPLETED|Overall Study||31
562571|NCT00660387|1372172|P1|COMPLETED|Overall Study||35
562572|NCT00660387|1372171|P2|STARTED|Overall Study||34
562573|NCT00660387|1372172|P1|STARTED|Overall Study||37
562574|NCT00660348|1372226|P2|NOT COMPLETED|Overall Study||0
562575|NCT00660348|1372227|P1|NOT COMPLETED|Overall Study||1
562576|NCT00660348|1372226|P2|COMPLETED|Overall Study||0
562577|NCT00660348|1372227|P1|COMPLETED|Overall Study||0
562578|NCT00660348|1372226|P2|STARTED|Overall Study||0
562579|NCT00660348|1372227|P1|STARTED|Overall Study||1
562580|NCT00660309|1372235|P2|NOT COMPLETED|Overall Study||3
562581|NCT00660309|1372236|P1|NOT COMPLETED|Overall Study||2
562582|NCT00660309|1372235|P2|COMPLETED|Overall Study||19
562583|NCT00660309|1372236|P1|COMPLETED|Overall Study||21
562584|NCT00660309|1372235|P2|Pharmacodynamic Analysis Set|Overall Study||20
562585|NCT00660309|1372236|P1|Pharmacodynamic Analysis Set|Overall Study||22
562586|NCT00660309|1372235|P2|Treated With Aliskiren or Irbesartan|Overall Study||21
562587|NCT00660309|1372236|P1|Treated With Aliskiren or Irbesartan|Overall Study||22
562588|NCT00660309|1372235|P2|STARTED|Overall Study|Represents participants who received one dose of Captopril.|22
562589|NCT00660309|1372236|P1|STARTED|Overall Study|Represents participants who received one dose of Captopril.|23
562590|NCT00660192|1372277|P2|NOT COMPLETED|Overall Study||3
562591|NCT00660192|1372278|P1|NOT COMPLETED|Overall Study||2
562592|NCT00660192|1372277|P2|COMPLETED|Overall Study||10
562593|NCT00660192|1372278|P1|COMPLETED|Overall Study||10
562594|NCT00660192|1372277|P2|STARTED|Overall Study||13
562595|NCT00660192|1372278|P1|STARTED|Overall Study||12
562596|NCT00660179|1372289|P3|NOT COMPLETED|Overall Study||41
562597|NCT00660179|1372290|P2|NOT COMPLETED|Overall Study||58
562598|NCT00660179|1372291|P1|NOT COMPLETED|Overall Study||56
562599|NCT00660179|1372289|P3|COMPLETED|Overall Study||201
562600|NCT00660179|1372290|P2|COMPLETED|Overall Study||192
562601|NCT00660179|1372291|P1|COMPLETED|Overall Study||194
562602|NCT00660179|1372289|P3|STARTED|Overall Study||242
562603|NCT00660179|1372290|P2|STARTED|Overall Study||250
562604|NCT00660179|1372291|P1|STARTED|Overall Study||250
562605|NCT00660075|1372325|P2|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0
562606|NCT00660075|1372326|P1|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0
562695|NCT00659438|1372561|P2|NOT COMPLETED|Overall Study||8
562607|NCT00660075|1372325|P2|COMPLETED|Second Intervention (Week 11 to Week 16||18
562608|NCT00660075|1372326|P1|COMPLETED|Second Intervention (Week 11 to Week 16||18
562609|NCT00660075|1372325|P2|STARTED|Second Intervention (Week 11 to Week 16||18
562610|NCT00660075|1372326|P1|STARTED|Second Intervention (Week 11 to Week 16||18
562611|NCT00660075|1372325|P2|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0
562612|NCT00660075|1372326|P1|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0
562613|NCT00660075|1372325|P2|COMPLETED|Washout Period (Week 7 to Week 10)||18
562614|NCT00660075|1372326|P1|COMPLETED|Washout Period (Week 7 to Week 10)||18
562615|NCT00660075|1372325|P2|STARTED|Washout Period (Week 7 to Week 10)||18
562616|NCT00660075|1372326|P1|STARTED|Washout Period (Week 7 to Week 10)||18
562617|NCT00660075|1372325|P2|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0
562618|NCT00660075|1372326|P1|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0
562619|NCT00660075|1372325|P2|COMPLETED|First Intervention (Week 1 to Week 6)||18
562620|NCT00660075|1372326|P1|COMPLETED|First Intervention (Week 1 to Week 6)||18
562621|NCT00660075|1372325|P2|STARTED|First Intervention (Week 1 to Week 6)||18
562622|NCT00660075|1372326|P1|STARTED|First Intervention (Week 1 to Week 6)||18
562623|NCT00660049|1372332|P1|NOT COMPLETED|Overall Study||6
562624|NCT00660049|1372332|P1|COMPLETED|Overall Study||6
562625|NCT00660049|1372332|P1|STARTED|Overall Study||12
562626|NCT00660023|1372336|P1|NOT COMPLETED|Overall Study||29
562627|NCT00660023|1372336|P1|COMPLETED|Overall Study||95
562628|NCT00660023|1372336|P1|Treated|Overall Study||114
562629|NCT00660023|1372336|P1|STARTED|Overall Study||124
562630|NCT00660010|1372347|P1|NOT COMPLETED|Overall Study||9
562631|NCT00660010|1372347|P1|COMPLETED|Overall Study||46
562632|NCT00660010|1372347|P1|STARTED|Overall Study||55
562633|NCT00659984|1372361|P1|NOT COMPLETED|Overall Study||1
562634|NCT00659984|1372361|P1|COMPLETED|Overall Study||14
562635|NCT00659984|1372361|P1|STARTED|Overall Study||15
562636|NCT00659945|1372374|P2|NOT COMPLETED|Overall Study||0
562637|NCT00659945|1372375|P1|NOT COMPLETED|Overall Study||0
562638|NCT00659945|1372374|P2|COMPLETED|Overall Study||75
562639|NCT00659945|1372375|P1|COMPLETED|Overall Study||75
562640|NCT00659945|1372374|P2|STARTED|Overall Study||75
562641|NCT00659945|1372375|P1|STARTED|Overall Study||75
562642|NCT00659880|1372381|P1|NOT COMPLETED|Overall Study||5
562643|NCT00659880|1372381|P1|COMPLETED|Overall Study|60 months|4
562644|NCT00659880|1372381|P1|24 Months|Overall Study||6
562645|NCT00659880|1372381|P1|12 Months|Overall Study||7
562646|NCT00659880|1372381|P1|6 Months|Overall Study||9
562647|NCT00659880|1372381|P1|6 Weeks|Overall Study||9
562648|NCT00659880|1372381|P1|STARTED|Overall Study||9
562649|NCT00659815|1372388|P2|NOT COMPLETED|Overall Study||4
562650|NCT00659815|1372389|P1|NOT COMPLETED|Overall Study||4
562651|NCT00659815|1372388|P2|COMPLETED|Overall Study||147
562652|NCT00659815|1372389|P1|COMPLETED|Overall Study||153
562653|NCT00659815|1372388|P2|STARTED|Overall Study||151
562654|NCT00659815|1372389|P1|STARTED|Overall Study||157
562655|NCT00659789|1372401|P2|NOT COMPLETED|Overall Study||7
562656|NCT00659789|1372402|P1|NOT COMPLETED|Overall Study||7
562657|NCT00659789|1372401|P2|COMPLETED|Overall Study||36
562658|NCT00659789|1372402|P1|COMPLETED|Overall Study||86
562659|NCT00659789|1372401|P2|STARTED|Overall Study||43
562660|NCT00659789|1372402|P1|STARTED|Overall Study||93
562661|NCT00659737|1372420|P2|NOT COMPLETED|Overall Study||0
562662|NCT00659737|1372421|P1|NOT COMPLETED|Overall Study||0
562663|NCT00659737|1372420|P2|COMPLETED|Overall Study||58
562664|NCT00659737|1372421|P1|COMPLETED|Overall Study||57
562665|NCT00659737|1372420|P2|STARTED|Overall Study||58
562666|NCT00659737|1372421|P1|STARTED|Overall Study||57
562667|NCT00659724|1372427|P1|NOT COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||0
562668|NCT00659724|1372427|P1|COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||33
562669|NCT00659724|1372427|P1|STARTED|Weeks 3-4: Assessment of HD-C4 Big||33
562670|NCT00659724|1372427|P1|NOT COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||0
562671|NCT00659724|1372427|P1|COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||33
562672|NCT00659724|1372427|P1|STARTED|Weeks 1-2: Assessment of 180NR or 200NR||33
562673|NCT00659633|1372445|P1|NOT COMPLETED|Overall Study||0
562674|NCT00659633|1372445|P1|COMPLETED|Overall Study||10
562675|NCT00659633|1372445|P1|STARTED|Overall Study||10
562676|NCT00659607|1372449|P1|NOT COMPLETED|Overall Study||316
562677|NCT00659607|1372449|P1|COMPLETED|Overall Study||3616
562678|NCT00659607|1372449|P1|STARTED|Overall Study||3932
562679|NCT00659581|1372467|P1|NOT COMPLETED|Overall Study||8582
562680|NCT00659581|1372467|P1|COMPLETED|Overall Study||12412
562681|NCT00659581|1372467|P1|STARTED|Overall Study||20994
562682|NCT00659529|1372479|P1|NOT COMPLETED|Overall Study||16
562683|NCT00659529|1372479|P1|COMPLETED|Overall Study|4 patients withdrew as a result of side effects. 3 subjects were withdrawn by the investigator.|20
562684|NCT00659529|1372479|P1|Received at Least One Dose of Study Drug|Overall Study|Received at least one dose of study drug|27
562685|NCT00659529|1372479|P1|STARTED|Overall Study|There were 9 screen failures (subjects who did not meet inclusion/exclusion criteria)|36
562686|NCT00659490|1372486|P3|NOT COMPLETED|Overall Study||1
562687|NCT00659490|1372487|P2|NOT COMPLETED|Overall Study||0
562688|NCT00659490|1372488|P1|NOT COMPLETED|Overall Study||2
562689|NCT00659490|1372486|P3|COMPLETED|Overall Study||30
562690|NCT00659490|1372487|P2|COMPLETED|Overall Study||59
562691|NCT00659490|1372488|P1|COMPLETED|Overall Study||59
562692|NCT00659490|1372486|P3|STARTED|Overall Study||31
562693|NCT00659490|1372487|P2|STARTED|Overall Study||59
562694|NCT00659490|1372488|P1|STARTED|Overall Study||61
562696|NCT00659438|1372562|P1|NOT COMPLETED|Overall Study||14
562697|NCT00659438|1372561|P2|COMPLETED|Overall Study||40
562698|NCT00659438|1372562|P1|COMPLETED|Overall Study||33
562699|NCT00659438|1372561|P2|Safety Analysis Set|Overall Study||47
562700|NCT00659438|1372562|P1|Safety Analysis Set|Overall Study|One patient randomized to placebo was accounted in vandetanib group as he mistakenly received drug|48
562701|NCT00659438|1372561|P2|Secondary Analysis Set|Overall Study||48
562702|NCT00659438|1372562|P1|Secondary Analysis Set|Overall Study||47
562703|NCT00659438|1372561|P2|Assessable Set : Primary Analysis|Overall Study||45
562704|NCT00659438|1372562|P1|Assessable Set : Primary Analysis|Overall Study||44
562705|NCT00659438|1372561|P2|STARTED|Overall Study||48
562706|NCT00659438|1372562|P1|STARTED|Overall Study||47
562707|NCT00659425|1372594|P10|NOT COMPLETED|Overall Study||13
562708|NCT00659425|1372595|P9|NOT COMPLETED|Overall Study||6
562709|NCT00659425|1372596|P8|NOT COMPLETED|Overall Study||11
562710|NCT00659425|1372597|P7|NOT COMPLETED|Overall Study||8
562711|NCT00659425|1372598|P6|NOT COMPLETED|Overall Study||4
562712|NCT00659425|1372599|P5|NOT COMPLETED|Overall Study||4
562713|NCT00659425|1372600|P4|NOT COMPLETED|Overall Study||4
562714|NCT00659425|1372601|P3|NOT COMPLETED|Overall Study||1
562715|NCT00659425|1372602|P2|NOT COMPLETED|Overall Study||1
562716|NCT00659425|1372603|P1|NOT COMPLETED|Overall Study||1
562717|NCT00659425|1372594|P10|COMPLETED|Overall Study||1
562718|NCT00659425|1372595|P9|COMPLETED|Overall Study||0
562719|NCT00659425|1372596|P8|COMPLETED|Overall Study||0
562720|NCT00659425|1372597|P7|COMPLETED|Overall Study||0
562721|NCT00659425|1372598|P6|COMPLETED|Overall Study||1
562722|NCT00659425|1372599|P5|COMPLETED|Overall Study||0
562723|NCT00659425|1372600|P4|COMPLETED|Overall Study||0
562724|NCT00659425|1372601|P3|COMPLETED|Overall Study||0
562725|NCT00659425|1372602|P2|COMPLETED|Overall Study||0
562726|NCT00659425|1372603|P1|COMPLETED|Overall Study||0
562727|NCT00659425|1372594|P10|STARTED|Overall Study||14
562728|NCT00659425|1372595|P9|STARTED|Overall Study||6
562729|NCT00659425|1372596|P8|STARTED|Overall Study||11
562730|NCT00659425|1372597|P7|STARTED|Overall Study||8
562731|NCT00659425|1372598|P6|STARTED|Overall Study||5
562732|NCT00659425|1372599|P5|STARTED|Overall Study||4
562733|NCT00659425|1372600|P4|STARTED|Overall Study||4
562734|NCT00659425|1372601|P3|STARTED|Overall Study||1
562735|NCT00659425|1372602|P2|STARTED|Overall Study||1
562736|NCT00659425|1372603|P1|STARTED|Overall Study||1
562737|NCT00659373|1372834|P2|NOT COMPLETED|Overall Study||7
562738|NCT00659373|1372835|P1|NOT COMPLETED|Overall Study||5
562739|NCT00659373|1372834|P2|COMPLETED|Overall Study||54
562740|NCT00659373|1372835|P1|COMPLETED|Overall Study||20
562741|NCT00659373|1372834|P2|STARTED|Overall Study||61
562742|NCT00659373|1372835|P1|STARTED|Overall Study||25
562746|NCT00659334|1372857|P7|NOT COMPLETED|Overall Study||1
562747|NCT00659334|1372858|P6|NOT COMPLETED|Overall Study||0
562748|NCT00659334|1372859|P5|NOT COMPLETED|Overall Study||0
562749|NCT00659334|1372860|P4|NOT COMPLETED|Overall Study||0
562750|NCT00659334|1372861|P3|NOT COMPLETED|Overall Study||0
562751|NCT00659334|1372862|P2|NOT COMPLETED|Overall Study||5
562752|NCT00659334|1372863|P1|NOT COMPLETED|Overall Study||8
562753|NCT00659334|1372857|P7|COMPLETED|Overall Study|1 screen failure|20
562754|NCT00659334|1372858|P6|COMPLETED|Overall Study||0
562755|NCT00659334|1372859|P5|COMPLETED|Overall Study||1
562756|NCT00659334|1372860|P4|COMPLETED|Overall Study||2
562757|NCT00659334|1372861|P3|COMPLETED|Overall Study||5
562758|NCT00659334|1372862|P2|COMPLETED|Overall Study|5 Screen failures|36
562759|NCT00659334|1372863|P1|COMPLETED|Overall Study|8 Screen failures|38
562760|NCT00659334|1372857|P7|STARTED|Overall Study||21
562761|NCT00659334|1372858|P6|STARTED|Overall Study||0
562762|NCT00659334|1372859|P5|STARTED|Overall Study||1
562763|NCT00659334|1372860|P4|STARTED|Overall Study||2
562764|NCT00659334|1372861|P3|STARTED|Overall Study||5
562765|NCT00659334|1372862|P2|STARTED|Overall Study||41
562766|NCT00659334|1372863|P1|STARTED|Overall Study||46
562767|NCT00659295|1372881|P2|NOT COMPLETED|Overall Study||5603
562768|NCT00659295|1372882|P1|NOT COMPLETED|Overall Study||2708
562769|NCT00659295|1372881|P2|COMPLETED|Overall Study||32038
562770|NCT00659295|1372882|P1|COMPLETED|Overall Study||10821
562771|NCT00659295|1372881|P2|STARTED|Overall Study||37641
562772|NCT00659295|1372882|P1|STARTED|Overall Study||13529
562773|NCT00659269|1372890|P2|NOT COMPLETED|Overall Study||1
562774|NCT00659269|1372891|P1|NOT COMPLETED|Overall Study||1
562775|NCT00659269|1372890|P2|COMPLETED|Overall Study||161
562776|NCT00659269|1372891|P1|COMPLETED|Overall Study||156
562777|NCT00659269|1372890|P2|Group 3 (Taxanes)|Overall Study||97
562778|NCT00659269|1372891|P1|Group 3 (Taxanes)|Overall Study||92
562779|NCT00659269|1372890|P2|Group 2 (Vinca Alkaloids)|Overall Study||12
562780|NCT00659269|1372891|P1|Group 2 (Vinca Alkaloids)|Overall Study||12
562781|NCT00659269|1372890|P2|Group 1 (Heavy Metals)|Overall Study||52
562782|NCT00659269|1372891|P1|Group 1 (Heavy Metals)|Overall Study||52
562783|NCT00659269|1372890|P2|STARTED|Overall Study||162
562784|NCT00659269|1372891|P1|STARTED|Overall Study||157
562785|NCT00659230|1372921|P2|NOT COMPLETED|Overall Study||12
562786|NCT00659230|1372922|P1|NOT COMPLETED|Overall Study||9
562787|NCT00659230|1372921|P2|COMPLETED|Overall Study||37
562788|NCT00659230|1372922|P1|COMPLETED|Overall Study||42
562789|NCT00659230|1372921|P2|STARTED|Overall Study|3 did not return post-randomization, 4 lost source documents, thus 7 excluded from results analysis|49
562790|NCT00659230|1372922|P1|STARTED|Overall Study|2 did not return post-randomization, 5 lost source documents, thus 7 excluded from results analysis|51
562791|NCT00659165|1372936|P2|NOT COMPLETED|Overall Study||0
562792|NCT00659165|1372937|P1|NOT COMPLETED|Overall Study||0
562793|NCT00659165|1372936|P2|COMPLETED|Overall Study||5
562794|NCT00659165|1372937|P1|COMPLETED|Overall Study||5
562795|NCT00659165|1372936|P2|STARTED|Overall Study||5
562796|NCT00659165|1372937|P1|STARTED|Overall Study||5
562797|NCT00659061|1372945|P2|NOT COMPLETED|Overall Study||15
562798|NCT00659061|1372946|P1|NOT COMPLETED|Overall Study||21
562799|NCT00659061|1372945|P2|COMPLETED|Overall Study|Those with either complete or partial biochemical and anthropometric data|287
562800|NCT00659061|1372946|P1|COMPLETED|Overall Study|Those with either complete or partial biochemical and anthropometric data|287
562801|NCT00659061|1372945|P2|STARTED|Overall Study||302
562802|NCT00659061|1372946|P1|STARTED|Overall Study||308
562803|NCT00658996|1372964|P2|NOT COMPLETED|Second Intervention||1
562804|NCT00658996|1372965|P1|NOT COMPLETED|Second Intervention||1
562805|NCT00658996|1372964|P2|COMPLETED|Second Intervention||104
562806|NCT00658996|1372965|P1|COMPLETED|Second Intervention||105
562807|NCT00658996|1372964|P2|STARTED|Second Intervention||105
562808|NCT00658996|1372965|P1|STARTED|Second Intervention||106
562809|NCT00658996|1372964|P2|NOT COMPLETED|Crossover Period||1
562810|NCT00658996|1372965|P1|NOT COMPLETED|Crossover Period||2
562811|NCT00658996|1372964|P2|COMPLETED|Crossover Period||105
562812|NCT00658996|1372965|P1|COMPLETED|Crossover Period||106
562813|NCT00658996|1372964|P2|STARTED|Crossover Period||106
562814|NCT00658996|1372965|P1|STARTED|Crossover Period||108
562815|NCT00658996|1372964|P2|NOT COMPLETED|First Intervention||1
562816|NCT00658996|1372965|P1|NOT COMPLETED|First Intervention||1
562817|NCT00658996|1372964|P2|COMPLETED|First Intervention||106
562818|NCT00658996|1372965|P1|COMPLETED|First Intervention||108
562819|NCT00658996|1372964|P2|STARTED|First Intervention||107
562820|NCT00658996|1372965|P1|STARTED|First Intervention||109
562821|NCT00658814|1372977|P2|NOT COMPLETED|Maintenance Therapy||1
562822|NCT00658814|1372978|P1|NOT COMPLETED|Maintenance Therapy||3
562823|NCT00658814|1372977|P2|COMPLETED|Maintenance Therapy||7
562824|NCT00658814|1372978|P1|COMPLETED|Maintenance Therapy||17
562825|NCT00658814|1372977|P2|Eligible|Maintenance Therapy||8
562826|NCT00658814|1372978|P1|Eligible|Maintenance Therapy||19
562827|NCT00658814|1372977|P2|STARTED|Maintenance Therapy||8
562828|NCT00658814|1372978|P1|STARTED|Maintenance Therapy||20
562829|NCT00658814|1372977|P2|NOT COMPLETED|Consolidation Therapy||3
562830|NCT00658814|1372978|P1|NOT COMPLETED|Consolidation Therapy||2
562831|NCT00658814|1372977|P2|COMPLETED|Consolidation Therapy||10
562832|NCT00658814|1372978|P1|COMPLETED|Consolidation Therapy||22
562833|NCT00658814|1372977|P2|Eligible|Consolidation Therapy||11
562834|NCT00658814|1372978|P1|Eligible|Consolidation Therapy||22
562835|NCT00658814|1372977|P2|STARTED|Consolidation Therapy||13
562836|NCT00658814|1372978|P1|STARTED|Consolidation Therapy||24
562837|NCT00658814|1372977|P2|NOT COMPLETED|Remission Induction Chemotherapy||18
562838|NCT00658814|1372978|P1|NOT COMPLETED|Remission Induction Chemotherapy||8
562839|NCT00658814|1372977|P2|COMPLETED|Remission Induction Chemotherapy||41
562840|NCT00658814|1372978|P1|COMPLETED|Remission Induction Chemotherapy||75
562841|NCT00658814|1372977|P2|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||54
562842|NCT00658814|1372978|P1|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||79
562843|NCT00658814|1372977|P2|Eligible|Remission Induction Chemotherapy||57
562844|NCT00658814|1372978|P1|Eligible|Remission Induction Chemotherapy||82
562845|NCT00658814|1372977|P2|STARTED|Remission Induction Chemotherapy||59
562846|NCT00658814|1372978|P1|STARTED|Remission Induction Chemotherapy||83
562847|NCT00658788|1372992|P1|NOT COMPLETED|Overall Study||74
562848|NCT00658788|1372992|P1|COMPLETED|Overall Study||231
562849|NCT00658788|1372992|P1|STARTED|Overall Study||305
562850|NCT00658775|1373047|P2|NOT COMPLETED|Overall Study||43
562851|NCT00658775|1373048|P1|NOT COMPLETED|Overall Study||42
562852|NCT00658775|1373047|P2|COMPLETED|Overall Study||485
562853|NCT00658775|1373048|P1|COMPLETED|Overall Study||495
562854|NCT00658775|1373047|P2|STARTED|Overall Study|Treated|528
562855|NCT00658775|1373048|P1|STARTED|Overall Study|Treated|537
562856|NCT00658736|1373060|P2|NOT COMPLETED|Overall Study||2
562857|NCT00658736|1373061|P1|NOT COMPLETED|Overall Study||6
562858|NCT00658736|1373060|P2|COMPLETED|Overall Study||19
562859|NCT00658736|1373061|P1|COMPLETED|Overall Study||13
562860|NCT00658736|1373060|P2|STARTED|Overall Study||21
562861|NCT00658736|1373061|P1|STARTED|Overall Study||19
562862|NCT00658723|1373071|P3|NOT COMPLETED|Overall Study||7
562863|NCT00658723|1373072|P2|NOT COMPLETED|Overall Study||4
562864|NCT00658723|1373073|P1|NOT COMPLETED|Overall Study||4
562865|NCT00658723|1373071|P3|COMPLETED|Overall Study||44
562866|NCT00658723|1373072|P2|COMPLETED|Overall Study||26
562867|NCT00658723|1373073|P1|COMPLETED|Overall Study||56
562868|NCT00658723|1373071|P3|STARTED|Overall Study||51
562869|NCT00658723|1373072|P2|STARTED|Overall Study||30
562870|NCT00658723|1373073|P1|STARTED|Overall Study||60
562871|NCT00658697|1373100|P1|NOT COMPLETED|Overall Study||0
562872|NCT00658697|1373100|P1|COMPLETED|Overall Study||41
562873|NCT00658697|1373100|P1|STARTED|Overall Study||41
562874|NCT00658684|1373111|P4|NOT COMPLETED|Overall Study||1
562875|NCT00658684|1373112|P3|NOT COMPLETED|Overall Study||3
562876|NCT00658684|1373113|P2|NOT COMPLETED|Overall Study||15
562877|NCT00658684|1373114|P1|NOT COMPLETED|Overall Study||19
562878|NCT00658684|1373111|P4|COMPLETED|Overall Study||27
562879|NCT00658684|1373112|P3|COMPLETED|Overall Study||22
562880|NCT00658684|1373113|P2|COMPLETED|Overall Study||84
562881|NCT00658684|1373114|P1|COMPLETED|Overall Study||133
562882|NCT00658684|1373111|P4|STARTED|Overall Study||28
562883|NCT00658684|1373112|P3|STARTED|Overall Study||25
562884|NCT00658684|1373113|P2|STARTED|Overall Study||99
562885|NCT00658684|1373114|P1|STARTED|Overall Study||152
562886|NCT00658658|1373169|P5|NOT COMPLETED|Overall Study||5
562887|NCT00658658|1373170|P4|NOT COMPLETED|Overall Study||2
562888|NCT00658658|1373171|P3|NOT COMPLETED|Overall Study||0
562889|NCT00658658|1373172|P2|NOT COMPLETED|Overall Study||2
562890|NCT00658658|1373173|P1|NOT COMPLETED|Overall Study||5
562891|NCT00658658|1373169|P5|COMPLETED|Overall Study||3
562892|NCT00658658|1373170|P4|COMPLETED|Overall Study||4
562893|NCT00658658|1373171|P3|COMPLETED|Overall Study||4
562894|NCT00658658|1373172|P2|COMPLETED|Overall Study||5
562895|NCT00658658|1373173|P1|COMPLETED|Overall Study||1
562896|NCT00658658|1373169|P5|STARTED|Overall Study||8
562897|NCT00658658|1373170|P4|STARTED|Overall Study||6
562898|NCT00658658|1373171|P3|STARTED|Overall Study||4
562899|NCT00658658|1373172|P2|STARTED|Overall Study||7
562900|NCT00658658|1373173|P1|STARTED|Overall Study||6
562901|NCT00658632|1373232|P2|NOT COMPLETED|Overall Study||65
562902|NCT00658632|1373233|P1|NOT COMPLETED|Overall Study||64
562903|NCT00658632|1373232|P2|COMPLETED|Overall Study||633
562904|NCT00658632|1373233|P1|COMPLETED|Overall Study||618
562905|NCT00658632|1373232|P2|STARTED|Overall Study|Treated|698
562906|NCT00658632|1373233|P1|STARTED|Overall Study|Treated|682
562907|NCT00658619|1373248|P5|NOT COMPLETED|Overall Study||2
562908|NCT00658619|1373249|P4|NOT COMPLETED|Overall Study||12
562909|NCT00658619|1373250|P3|NOT COMPLETED|Overall Study||10
562910|NCT00658619|1373251|P2|NOT COMPLETED|Overall Study||1
562911|NCT00658619|1373252|P1|NOT COMPLETED|Overall Study||0
562912|NCT00658619|1373248|P5|COMPLETED|Overall Study||21
562913|NCT00658619|1373249|P4|COMPLETED|Overall Study||37
562914|NCT00658619|1373250|P3|COMPLETED|Overall Study||31
562915|NCT00658619|1373251|P2|COMPLETED|Overall Study||2
562916|NCT00658619|1373252|P1|COMPLETED|Overall Study||3
562917|NCT00658619|1373248|P5|STARTED|Overall Study||23
562918|NCT00658619|1373249|P4|STARTED|Overall Study||49
562919|NCT00658619|1373250|P3|STARTED|Overall Study||41
562920|NCT00658619|1373251|P2|STARTED|Overall Study||3
562921|NCT00658619|1373252|P1|STARTED|Overall Study||3
562922|NCT00658606|1373274|P2|NOT COMPLETED|Overall Study||23
562923|NCT00658606|1373275|P1|NOT COMPLETED|Overall Study||16
562924|NCT00658606|1373274|P2|COMPLETED|Overall Study|Represents patients who completed follow-up|26
562925|NCT00658606|1373275|P1|COMPLETED|Overall Study|Represents patients who completed follow-up|33
562926|NCT00658606|1373274|P2|Completed Treatment|Overall Study||44
562927|NCT00658606|1373275|P1|Completed Treatment|Overall Study||42
562928|NCT00658606|1373274|P2|STARTED|Overall Study||49
562929|NCT00658606|1373275|P1|STARTED|Overall Study||49
562930|NCT00658567|1373304|P3|NOT COMPLETED|Overall Study||6
562931|NCT00658567|1373305|P2|NOT COMPLETED|Overall Study||4
562932|NCT00658567|1373306|P1|NOT COMPLETED|Overall Study||8
562933|NCT00658567|1373304|P3|COMPLETED|Overall Study||35
562934|NCT00658567|1373305|P2|COMPLETED|Overall Study||38
562935|NCT00658567|1373306|P1|COMPLETED|Overall Study||32
562936|NCT00658567|1373304|P3|STARTED|Overall Study||41
562937|NCT00658567|1373305|P2|STARTED|Overall Study||42
562938|NCT00658567|1373306|P1|STARTED|Overall Study||40
562939|NCT00658541|1373317|P2|NOT COMPLETED|Second Intervention||0
562940|NCT00658541|1373318|P1|NOT COMPLETED|Second Intervention||0
562941|NCT00658541|1373317|P2|COMPLETED|Second Intervention||17
562942|NCT00658541|1373318|P1|COMPLETED|Second Intervention||18
562943|NCT00658541|1373317|P2|STARTED|Second Intervention||17
562944|NCT00658541|1373318|P1|STARTED|Second Intervention||18
562945|NCT00658541|1373317|P2|NOT COMPLETED|Washout Period of 7 Days||2
562946|NCT00658541|1373318|P1|NOT COMPLETED|Washout Period of 7 Days||1
562947|NCT00658541|1373317|P2|COMPLETED|Washout Period of 7 Days||17
562948|NCT00658541|1373318|P1|COMPLETED|Washout Period of 7 Days||18
562949|NCT00658541|1373317|P2|STARTED|Washout Period of 7 Days||19
562950|NCT00658541|1373318|P1|STARTED|Washout Period of 7 Days||19
562951|NCT00658541|1373317|P2|NOT COMPLETED|First Intervention||0
562952|NCT00658541|1373318|P1|NOT COMPLETED|First Intervention||0
562953|NCT00658541|1373317|P2|COMPLETED|First Intervention||19
562954|NCT00658541|1373318|P1|COMPLETED|First Intervention||19
562955|NCT00658541|1373317|P2|STARTED|First Intervention||19
562956|NCT00658541|1373318|P1|STARTED|First Intervention||19
562957|NCT00658528|1373330|P2|NOT COMPLETED|Overall Study||45
562958|NCT00658528|1373331|P1|NOT COMPLETED|Overall Study||40
562959|NCT00658528|1373330|P2|COMPLETED|Overall Study||479
562960|NCT00658528|1373331|P1|COMPLETED|Overall Study||491
562961|NCT00658528|1373330|P2|STARTED|Overall Study|Treated|524
562962|NCT00658528|1373331|P1|STARTED|Overall Study|Treated|531
562963|NCT00658411|1373341|P1|NOT COMPLETED|Overall Study||0
562964|NCT00658411|1373341|P1|COMPLETED|Overall Study||5
562965|NCT00658411|1373341|P1|STARTED|Overall Study||5
562966|NCT00658385|1373349|P1|NOT COMPLETED|Overall Study||0
562967|NCT00658385|1373349|P1|COMPLETED|Overall Study||5
562968|NCT00658385|1373349|P1|STARTED|Overall Study||5
562969|NCT00658359|1373356|P3|NOT COMPLETED|Overall Study||46
562970|NCT00658359|1373357|P2|NOT COMPLETED|Overall Study||45
562971|NCT00658359|1373358|P1|NOT COMPLETED|Overall Study||28
562972|NCT00658359|1373356|P3|COMPLETED|Overall Study||8
562973|NCT00658359|1373357|P2|COMPLETED|Overall Study||15
562974|NCT00658359|1373358|P1|COMPLETED|Overall Study||36
562975|NCT00658359|1373356|P3|STARTED|Overall Study||54
562976|NCT00658359|1373357|P2|STARTED|Overall Study||60
562977|NCT00658359|1373358|P1|STARTED|Overall Study||64
562978|NCT00658333|1373446|P2|NOT COMPLETED|Overall Study||1
562979|NCT00658333|1373447|P1|NOT COMPLETED|Overall Study||2
562980|NCT00658333|1373446|P2|COMPLETED|Overall Study||14
562981|NCT00658333|1373447|P1|COMPLETED|Overall Study||13
562982|NCT00658333|1373446|P2|STARTED|Overall Study||15
562983|NCT00658333|1373447|P1|STARTED|Overall Study||15
562984|NCT00658320|1373457|P2|NOT COMPLETED|Extension Study: After Month 24||0
562985|NCT00658320|1373458|P1|NOT COMPLETED|Extension Study: After Month 24||2
562986|NCT00658320|1373457|P2|COMPLETED|Extension Study: After Month 24||0
562987|NCT00658320|1373458|P1|COMPLETED|Extension Study: After Month 24||42
562988|NCT00658320|1373457|P2|STARTED|Extension Study: After Month 24||0
562989|NCT00658320|1373458|P1|STARTED|Extension Study: After Month 24||44
562990|NCT00658320|1373457|P2|NOT COMPLETED|Extension Study: Month 12 to Month 24||7
562991|NCT00658320|1373458|P1|NOT COMPLETED|Extension Study: Month 12 to Month 24||6
562992|NCT00658320|1373457|P2|COMPLETED|Extension Study: Month 12 to Month 24||50
562993|NCT00658320|1373458|P1|COMPLETED|Extension Study: Month 12 to Month 24||47
562994|NCT00658320|1373457|P2|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50
562995|NCT00658320|1373458|P1|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50
562996|NCT00658320|1373457|P2|STARTED|Extension Study: Month 12 to Month 24||57
562997|NCT00658320|1373458|P1|STARTED|Extension Study: Month 12 to Month 24||53
562998|NCT00658320|1373457|P2|NOT COMPLETED|Core Study: 12 Months||3
562999|NCT00658320|1373458|P1|NOT COMPLETED|Core Study: 12 Months||5
563000|NCT00658320|1373457|P2|COMPLETED|Core Study: 12 Months||58
563001|NCT00658320|1373458|P1|COMPLETED|Core Study: 12 Months||56
563002|NCT00658320|1373457|P2|STARTED|Core Study: 12 Months||61
563003|NCT00658320|1373458|P1|STARTED|Core Study: 12 Months||61
563004|NCT00658138|1373481|P1|NOT COMPLETED|Overall Study||21
563005|NCT00658138|1373481|P1|COMPLETED|Overall Study||40
563006|NCT00658138|1373481|P1|STARTED|Overall Study||61
563007|NCT00658112|1373486|P1|NOT COMPLETED|Overall Study||9
563008|NCT00658112|1373486|P1|COMPLETED|Overall Study||11
563009|NCT00658112|1373486|P1|STARTED|Overall Study||20
563010|NCT00657709|1373495|P5|NOT COMPLETED|Overall Study||33
563011|NCT00657709|1373496|P4|NOT COMPLETED|Overall Study||14
563012|NCT00657709|1373497|P3|NOT COMPLETED|Overall Study||28
563013|NCT00657709|1373498|P2|NOT COMPLETED|Overall Study||33
563014|NCT00657709|1373499|P1|NOT COMPLETED|Overall Study||23
563015|NCT00657709|1373495|P5|COMPLETED|Overall Study||457
563016|NCT00657709|1373496|P4|COMPLETED|Overall Study||645
563017|NCT00657709|1373497|P3|COMPLETED|Overall Study||792
563018|NCT00657709|1373498|P2|COMPLETED|Overall Study||795
563019|NCT00657709|1373499|P1|COMPLETED|Overall Study||810
563020|NCT00657709|1373495|P5|STARTED|Overall Study||490
563021|NCT00657709|1373496|P4|STARTED|Overall Study||659
563022|NCT00657709|1373497|P3|STARTED|Overall Study||820
563023|NCT00657709|1373498|P2|STARTED|Overall Study||828
563024|NCT00657709|1373499|P1|STARTED|Overall Study||833
563025|NCT00657657|1373540|P1|NOT COMPLETED|Overall Study||0
563026|NCT00657657|1373540|P1|COMPLETED|Overall Study||29
563027|NCT00657657|1373540|P1|STARTED|Overall Study||29
563028|NCT00657618|1373548|P1|NOT COMPLETED|Overall Study||43
563029|NCT00657618|1373548|P1|COMPLETED|Overall Study||34
563030|NCT00657618|1373548|P1|STARTED|Overall Study||77
563031|NCT00657553|1373555|P2|NOT COMPLETED|Overall Study||5
563032|NCT00657553|1373556|P1|NOT COMPLETED|Overall Study||5
563033|NCT00657553|1373555|P2|COMPLETED|Overall Study||0
563034|NCT00657553|1373556|P1|COMPLETED|Overall Study||0
563035|NCT00657553|1373555|P2|STARTED|Overall Study||5
563036|NCT00657553|1373556|P1|STARTED|Overall Study||5
563037|NCT00657540|1373564|P2|NOT COMPLETED|Overall Study||4
563038|NCT00657540|1373565|P1|NOT COMPLETED|Overall Study||1
563039|NCT00657540|1373564|P2|COMPLETED|Overall Study|All subjects had a known treatment failure disposition at time of loss to follow-up.|27
563040|NCT00657540|1373565|P1|COMPLETED|Overall Study|All subjects had a known treatment failure disposition at time of loss to follow-up.|28
563041|NCT00657540|1373564|P2|STARTED|Overall Study||31
563042|NCT00657540|1373565|P1|STARTED|Overall Study||29
563043|NCT00657371|1373579|P1|NOT COMPLETED|Overall Study||39
563044|NCT00657371|1373579|P1|COMPLETED|Overall Study||249
563045|NCT00657371|1373579|P1|STARTED|Overall Study||288
563046|NCT00657358|1373584|P1|NOT COMPLETED|Overall Study||6
563047|NCT00657358|1373584|P1|COMPLETED|Overall Study||16
563048|NCT00657358|1373584|P1|STARTED|Overall Study||22
563049|NCT00657280|1373592|P1|NOT COMPLETED|Overall Study||0
563050|NCT00657280|1373592|P1|COMPLETED|Overall Study||16
563051|NCT00657280|1373592|P1|STARTED|Overall Study||16
563052|NCT00657267|1373596|P1|NOT COMPLETED|Overall Study||54
563053|NCT00657267|1373596|P1|COMPLETED|Overall Study||4
563054|NCT00657267|1373596|P1|STARTED|Overall Study||58
563055|NCT00657150|1373606|P2|NOT COMPLETED|Treatment||97
563056|NCT00657150|1373607|P1|NOT COMPLETED|Treatment||107
563057|NCT00657150|1373606|P2|COMPLETED|Treatment||906
563058|NCT00657150|1373607|P1|COMPLETED|Treatment||903
563059|NCT00657150|1373606|P2|STARTED|Treatment||1003
563060|NCT00657150|1373607|P1|STARTED|Treatment||1010
563061|NCT00657150|1373606|P2|NOT COMPLETED|Overall Study||93
563062|NCT00657150|1373607|P1|NOT COMPLETED|Overall Study||115
563063|NCT00657150|1373606|P2|COMPLETED|Overall Study||910
563064|NCT00657150|1373607|P1|COMPLETED|Overall Study||895
563065|NCT00657150|1373606|P2|STARTED|Overall Study||1003
563066|NCT00657150|1373607|P1|STARTED|Overall Study||1010
563067|NCT00657046|1373638|P3|NOT COMPLETED|Overall Study||2
563068|NCT00657046|1373639|P2|NOT COMPLETED|Overall Study||3
563069|NCT00657046|1373640|P1|NOT COMPLETED|Overall Study||4
563070|NCT00657046|1373638|P3|COMPLETED|Overall Study||21
563071|NCT00657046|1373639|P2|COMPLETED|Overall Study||29
563072|NCT00657046|1373640|P1|COMPLETED|Overall Study||26
563073|NCT00657046|1373638|P3|Had Visits up to Visit 18|Overall Study||23
563074|NCT00657046|1373639|P2|Had Visits up to Visit 18|Overall Study||30
563075|NCT00657046|1373640|P1|Had Visits up to Visit 18|Overall Study||28
563076|NCT00657046|1373638|P3|Had at Least 1 Post Baseline Visit|Overall Study||23
563077|NCT00657046|1373639|P2|Had at Least 1 Post Baseline Visit|Overall Study||31
563078|NCT00657046|1373640|P1|Had at Least 1 Post Baseline Visit|Overall Study||30
563079|NCT00657046|1373638|P3|STARTED|Overall Study||23
563080|NCT00657046|1373639|P2|STARTED|Overall Study||32
563081|NCT00657046|1373640|P1|STARTED|Overall Study||30
563082|NCT00657020|1373672|P2|NOT COMPLETED|PERIOD 2||0
563083|NCT00657020|1373673|P1|NOT COMPLETED|PERIOD 2||0
563084|NCT00657020|1373672|P2|COMPLETED|PERIOD 2||11
563085|NCT00657020|1373673|P1|COMPLETED|PERIOD 2||11
563086|NCT00657020|1373672|P2|STARTED|PERIOD 2||11
563087|NCT00657020|1373673|P1|STARTED|PERIOD 2||11
563088|NCT00657020|1373672|P2|NOT COMPLETED|PERIOD 1||1
563089|NCT00657020|1373673|P1|NOT COMPLETED|PERIOD 1||0
563090|NCT00657020|1373672|P2|COMPLETED|PERIOD 1||11
563091|NCT00657020|1373673|P1|COMPLETED|PERIOD 1||11
563092|NCT00657020|1373672|P2|STARTED|PERIOD 1||12
563093|NCT00657020|1373673|P1|STARTED|PERIOD 1||11
563094|NCT00656968|1373703|P2|NOT COMPLETED|Overall Study||0
563095|NCT00656968|1373704|P1|NOT COMPLETED|Overall Study||0
563096|NCT00656968|1373703|P2|COMPLETED|Overall Study||117
563097|NCT00656968|1373704|P1|COMPLETED|Overall Study||115
563098|NCT00656968|1373703|P2|STARTED|Overall Study||117
563099|NCT00656968|1373704|P1|STARTED|Overall Study||115
563100|NCT00656916|1373714|P2|NOT COMPLETED|Overall Study||0
563101|NCT00656916|1373715|P1|NOT COMPLETED|Overall Study||0
563102|NCT00656916|1373714|P2|COMPLETED|Overall Study||0
563103|NCT00656916|1373715|P1|COMPLETED|Overall Study||1
563104|NCT00656916|1373714|P2|STARTED|Overall Study||0
563105|NCT00656916|1373715|P1|STARTED|Overall Study||1
563106|NCT00656851|1373723|P2|NOT COMPLETED|Overall Study||4
563107|NCT00656851|1373724|P1|NOT COMPLETED|Overall Study||0
563108|NCT00656851|1373723|P2|COMPLETED|Overall Study||8
563109|NCT00656851|1373724|P1|COMPLETED|Overall Study||12
563110|NCT00656851|1373723|P2|STARTED|Overall Study||12
563111|NCT00656851|1373724|P1|STARTED|Overall Study||12
563112|NCT00656799|1373746|P1|NOT COMPLETED|Overall Study||2
563113|NCT00656799|1373746|P1|COMPLETED|Overall Study||4
563114|NCT00656799|1373746|P1|STARTED|Overall Study||6
563115|NCT00656669|1373768|P1|NOT COMPLETED|AC (Cycles 6-9)||2
563116|NCT00656669|1373768|P1|COMPLETED|AC (Cycles 6-9)||15
563117|NCT00656669|1373768|P1|STARTED|AC (Cycles 6-9)||17
563118|NCT00656669|1373768|P1|NOT COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||6
563119|NCT00656669|1373768|P1|COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||17
563120|NCT00656669|1373768|P1|STARTED|Paclitaxel/Sunitinib (Cycles 2-5)||23
563121|NCT00656669|1373768|P1|NOT COMPLETED|Single Agent Sunitinib (Cycle 1)||0
563122|NCT00656669|1373768|P1|COMPLETED|Single Agent Sunitinib (Cycle 1)||23
563123|NCT00656669|1373768|P1|STARTED|Single Agent Sunitinib (Cycle 1)||23
563124|NCT00656656|1373777|P1|NOT COMPLETED|Overall Study||0
563125|NCT00656656|1373777|P1|COMPLETED|Overall Study||23
563126|NCT00656656|1373777|P1|STARTED|Overall Study||23
563127|NCT00656630|1373785|P3|NOT COMPLETED|Overall Study||2
563128|NCT00656630|1373786|P2|NOT COMPLETED|Overall Study||2
563129|NCT00656630|1373787|P1|NOT COMPLETED|Overall Study||2
563130|NCT00656630|1373785|P3|COMPLETED|Overall Study||17
563131|NCT00656630|1373786|P2|COMPLETED|Overall Study||25
563132|NCT00656630|1373787|P1|COMPLETED|Overall Study||20
563133|NCT00656630|1373785|P3|STARTED|Overall Study||19
563134|NCT00656630|1373786|P2|STARTED|Overall Study||27
563135|NCT00656630|1373787|P1|STARTED|Overall Study||22
563136|NCT00656617|1373807|P1|NOT COMPLETED|Overall Study||7
563137|NCT00656617|1373807|P1|COMPLETED|Overall Study||99
563138|NCT00656617|1373807|P1|Induction Phase|Overall Study|Induction phase following determination of safe combination Vorinostat with Idarubicin.|103
563139|NCT00656617|1373807|P1|Run-in Induction Phase|Overall Study|Initial run-in: Vorinostat induction dose 500 mg orally three times daily for 3 days.|3
563140|NCT00656617|1373807|P1|STARTED|Overall Study||106
563141|NCT00656513|1373816|P3|NOT COMPLETED|Overall Study||22
563142|NCT00656513|1373817|P2|NOT COMPLETED|Overall Study||30
563143|NCT00656513|1373818|P1|NOT COMPLETED|Overall Study||4
563144|NCT00656513|1373816|P3|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|53
563145|NCT00656513|1373817|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|43
563146|NCT00656513|1373818|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|44
563147|NCT00656513|1373816|P3|STARTED|Overall Study||75
563148|NCT00656513|1373817|P2|STARTED|Overall Study||73
563149|NCT00656513|1373818|P1|STARTED|Overall Study||48
563150|NCT00656487|1373840|P3|NOT COMPLETED|Overall Study||0
563151|NCT00656487|1373841|P2|NOT COMPLETED|Overall Study||4
563152|NCT00656487|1373842|P1|NOT COMPLETED|Overall Study||2
563153|NCT00656487|1373840|P3|COMPLETED|Overall Study||20
563154|NCT00656487|1373841|P2|COMPLETED|Overall Study||19
563155|NCT00656487|1373842|P1|COMPLETED|Overall Study||21
563156|NCT00656487|1373840|P3|STARTED|Overall Study||20
563157|NCT00656487|1373841|P2|STARTED|Overall Study||23
563158|NCT00656487|1373842|P1|STARTED|Overall Study||23
563159|NCT00656474|1373865|P1|NOT COMPLETED|Overall Study||1
563160|NCT00656474|1373865|P1|COMPLETED|Overall Study||11
563161|NCT00656474|1373865|P1|STARTED|Overall Study||12
563162|NCT00656448|1373874|P2|NOT COMPLETED|Overall Study||0
563163|NCT00656448|1373875|P1|NOT COMPLETED|Overall Study||0
563164|NCT00656448|1373874|P2|COMPLETED|Overall Study||25
563165|NCT00656448|1373875|P1|COMPLETED|Overall Study||25
563166|NCT00656448|1373874|P2|STARTED|Overall Study||25
563167|NCT00656448|1373875|P1|STARTED|Overall Study||25
563168|NCT00656370|1373883|P1|NOT COMPLETED|Overall Study||10
563169|NCT00656370|1373883|P1|COMPLETED|Overall Study|15 subjects were randomized and completed stage 1.|15
563170|NCT00656370|1373883|P1|STARTED|Overall Study|25 subjects were assessed for eligibility and signed an Informed Consent Form.|25
563171|NCT00656292|1373891|P2|NOT COMPLETED|Overall Study||5
563172|NCT00656292|1373892|P1|NOT COMPLETED|Overall Study||3
563173|NCT00656292|1373891|P2|COMPLETED|Overall Study||24
563174|NCT00656292|1373892|P1|COMPLETED|Overall Study||29
563175|NCT00656292|1373891|P2|STARTED|Overall Study||29
563176|NCT00656292|1373892|P1|STARTED|Overall Study||32
563177|NCT00656201|1373910|P2|NOT COMPLETED|Overall Study||32
563178|NCT00656201|1373911|P1|NOT COMPLETED|Overall Study||29
563179|NCT00656201|1373910|P2|COMPLETED|Overall Study||201
563180|NCT00656201|1373911|P1|COMPLETED|Overall Study||206
563181|NCT00656201|1373910|P2|STARTED|Overall Study||233
563182|NCT00656201|1373911|P1|STARTED|Overall Study||235
563183|NCT00656175|1373919|P2|NOT COMPLETED|Overall Study||1
563184|NCT00656175|1373920|P1|NOT COMPLETED|Overall Study||1
563185|NCT00656175|1373919|P2|COMPLETED|Overall Study||20
563186|NCT00656175|1373920|P1|COMPLETED|Overall Study||17
563187|NCT00656175|1373919|P2|STARTED|Overall Study||21
563188|NCT00656175|1373920|P1|STARTED|Overall Study||18
563189|NCT00656136|1373928|P2|NOT COMPLETED|Overall Study||390
563190|NCT00656136|1373929|P1|NOT COMPLETED|Overall Study||195
563191|NCT00656136|1373928|P2|COMPLETED|Overall Study||0
563192|NCT00656136|1373929|P1|COMPLETED|Overall Study||0
563193|NCT00656136|1373928|P2|STARTED|Overall Study|Randomised patients.|390
563194|NCT00656136|1373929|P1|STARTED|Overall Study|Randomised patients.|195
563195|NCT00656084|1373939|P1|NOT COMPLETED|Overall Study||7
563196|NCT00656084|1373939|P1|COMPLETED|Overall Study||9
563197|NCT00656084|1373939|P1|STARTED|Overall Study||16
563198|NCT00656058|1373946|P1|NOT COMPLETED|Overall Study||6
563199|NCT00656058|1373946|P1|COMPLETED|Overall Study||19
563200|NCT00656058|1373946|P1|STARTED|Overall Study||25
563201|NCT00656019|1373959|P4|NOT COMPLETED|Overall Study||0
563202|NCT00656019|1373960|P3|NOT COMPLETED|Overall Study||0
563203|NCT00656019|1373961|P2|NOT COMPLETED|Overall Study||1
563204|NCT00656019|1373962|P1|NOT COMPLETED|Overall Study||14
563205|NCT00656019|1373959|P4|COMPLETED|Overall Study||4
563206|NCT00656019|1373960|P3|COMPLETED|Overall Study||11
563207|NCT00656019|1373961|P2|COMPLETED|Overall Study||18
563208|NCT00656019|1373962|P1|COMPLETED|Overall Study||15
563209|NCT00656019|1373959|P4|STARTED|Overall Study||4
563210|NCT00656019|1373960|P3|STARTED|Overall Study||11
563211|NCT00656019|1373961|P2|STARTED|Overall Study||19
563212|NCT00656019|1373962|P1|STARTED|Overall Study||29
563213|NCT00655889|1373972|P1|NOT COMPLETED|Overall Study||2
563214|NCT00655889|1373972|P1|COMPLETED|Overall Study||11
563215|NCT00655889|1373972|P1|STARTED|Overall Study||13
563216|NCT00655876|1373979|P2|NOT COMPLETED|Overall Study||7
563217|NCT00655876|1373980|P1|NOT COMPLETED|Overall Study||9
563218|NCT00655876|1373979|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|169
563219|NCT00655876|1373980|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|159
563220|NCT00655876|1373979|P2|STARTED|Overall Study||176
563221|NCT00655876|1373980|P1|STARTED|Overall Study||168
563222|NCT00655863|1373999|P3|NOT COMPLETED|Overall Study||1
563223|NCT00655863|1374000|P2|NOT COMPLETED|Overall Study||0
563224|NCT00655863|1374001|P1|NOT COMPLETED|Overall Study||0
563225|NCT00655863|1373999|P3|COMPLETED|Overall Study||21
563226|NCT00655863|1374000|P2|COMPLETED|Overall Study||25
563227|NCT00655863|1374001|P1|COMPLETED|Overall Study||24
563228|NCT00655863|1373999|P3|STARTED|Overall Study||22
563229|NCT00655863|1374000|P2|STARTED|Overall Study||25
563230|NCT00655863|1374001|P1|STARTED|Overall Study||24
563231|NCT00655850|1374060|P1|NOT COMPLETED|Overall Study||3
563232|NCT00655850|1374060|P1|COMPLETED|Overall Study||36
563233|NCT00655850|1374060|P1|STARTED|Overall Study||39
563234|NCT00655824|1374067|P1|NOT COMPLETED|Overall Study||84
563235|NCT00655824|1374067|P1|COMPLETED|Overall Study||8
563236|NCT00655824|1374067|P1|STARTED|Overall Study||92
563237|NCT00655811|1374101|P1|NOT COMPLETED|Overall Study||0
563238|NCT00655811|1374101|P1|COMPLETED|Overall Study||40
563239|NCT00655811|1374101|P1|STARTED|Overall Study||40
563240|NCT00655746|1374115|P1|NOT COMPLETED|Overall Study||1
563241|NCT00655746|1374115|P1|COMPLETED|Overall Study||13
563242|NCT00655746|1374115|P1|STARTED|Overall Study||14
563243|NCT00655733|1374134|P2|NOT COMPLETED|Overall Study||8
563244|NCT00655733|1374135|P1|NOT COMPLETED|Overall Study||7
563245|NCT00655733|1374134|P2|COMPLETED|Overall Study||42
563246|NCT00655733|1374135|P1|COMPLETED|Overall Study||44
563247|NCT00655733|1374134|P2|STARTED|Overall Study||50
563248|NCT00655733|1374135|P1|STARTED|Overall Study||51
563249|NCT00655668|1374141|P1|NOT COMPLETED|Overall Study||54
563250|NCT00655668|1374141|P1|COMPLETED|Overall Study|Participants dosed up to 24 months, disease progression or unacceptable adverse events developed.|0
563251|NCT00655668|1374141|P1|STARTED|Overall Study|Planned enrollment: 80 participants|54
563252|NCT00655642|1374153|P4|NOT COMPLETED|Overall Study||2
563253|NCT00655642|1374154|P3|NOT COMPLETED|Overall Study||2
563254|NCT00655642|1374155|P2|NOT COMPLETED|Overall Study||3
563255|NCT00655642|1374156|P1|NOT COMPLETED|Overall Study||1
563256|NCT00655642|1374153|P4|COMPLETED|Overall Study|1 patient's initial Visual analog scale (VAS)<40; 1 patient was withdrawn by treating physician|39
563257|NCT00655642|1374154|P3|COMPLETED|Overall Study|1 patient left the ED prior to receiving drug; 1 patient's nausea resolved prior to receiving drug|43
563258|NCT00655642|1374155|P2|COMPLETED|Overall Study|1 patient given drug orally rather than intravenous(iv);1 patient refused iv; 1 pt lost to follow-up|40
563259|NCT00655642|1374156|P1|COMPLETED|Overall Study|1 patient withdrawn by treating physician after consent|41
563260|NCT00655642|1374153|P4|STARTED|Overall Study||41
563261|NCT00655642|1374154|P3|STARTED|Overall Study||45
563262|NCT00655642|1374155|P2|STARTED|Overall Study||43
563263|NCT00655642|1374156|P1|STARTED|Overall Study||42
563264|NCT00655629|1374168|P2|NOT COMPLETED|Overall Study||23
563265|NCT00655629|1374169|P1|NOT COMPLETED|Overall Study||21
563266|NCT00655629|1374168|P2|COMPLETED|Overall Study||144
563267|NCT00655629|1374169|P1|COMPLETED|Overall Study||151
563268|NCT00655629|1374168|P2|Participants Received Treatment|Overall Study|1 patient could not verify drug ingestion.(safety population)|166
563269|NCT00655629|1374169|P1|Participants Received Treatment|Overall Study|1 patient could not verify drug ingestion. (safety population)|171
563270|NCT00655629|1374168|P2|STARTED|Overall Study||167
563271|NCT00655629|1374169|P1|STARTED|Overall Study||172
563272|NCT00655564|1374205|P1|NOT COMPLETED|Overall Study||3
563273|NCT00655564|1374205|P1|COMPLETED|Overall Study||12
563274|NCT00655564|1374205|P1|STARTED|Overall Study||15
563275|NCT00655551|1374213|P3|NOT COMPLETED|Period 4 (up to 7 Days)||0
563276|NCT00655551|1374214|P2|NOT COMPLETED|Period 4 (up to 7 Days)||2
563277|NCT00655551|1374215|P1|NOT COMPLETED|Period 4 (up to 7 Days)||0
563278|NCT00655551|1374213|P3|COMPLETED|Period 4 (up to 7 Days)||0
563279|NCT00655551|1374214|P2|COMPLETED|Period 4 (up to 7 Days)||23
563280|NCT00655551|1374215|P1|COMPLETED|Period 4 (up to 7 Days)||0
563281|NCT00655551|1374213|P3|STARTED|Period 4 (up to 7 Days)||0
563282|NCT00655551|1374214|P2|STARTED|Period 4 (up to 7 Days)||25
563283|NCT00655551|1374215|P1|STARTED|Period 4 (up to 7 Days)||0
563284|NCT00655551|1374213|P3|NOT COMPLETED|Period 3 (up to 7 Days)||4
563285|NCT00655551|1374214|P2|NOT COMPLETED|Period 3 (up to 7 Days)||0
563286|NCT00655551|1374215|P1|NOT COMPLETED|Period 3 (up to 7 Days)||0
563287|NCT00655551|1374213|P3|COMPLETED|Period 3 (up to 7 Days)||21
563288|NCT00655551|1374214|P2|COMPLETED|Period 3 (up to 7 Days)||0
563289|NCT00655551|1374215|P1|COMPLETED|Period 3 (up to 7 Days)||0
563290|NCT00655551|1374213|P3|STARTED|Period 3 (up to 7 Days)||25
563291|NCT00655551|1374214|P2|STARTED|Period 3 (up to 7 Days)||0
563292|NCT00655551|1374215|P1|STARTED|Period 3 (up to 7 Days)||0
563293|NCT00655551|1374213|P3|NOT COMPLETED|Period 2 (up to 7 Days)||0
563294|NCT00655551|1374214|P2|NOT COMPLETED|Period 2 (up to 7 Days)||1
563295|NCT00655551|1374215|P1|NOT COMPLETED|Period 2 (up to 7 Days)||0
563296|NCT00655551|1374213|P3|COMPLETED|Period 2 (up to 7 Days)||0
563297|NCT00655551|1374214|P2|COMPLETED|Period 2 (up to 7 Days)||24
563298|NCT00655551|1374215|P1|COMPLETED|Period 2 (up to 7 Days)||0
563299|NCT00655551|1374213|P3|STARTED|Period 2 (up to 7 Days)||0
563300|NCT00655551|1374214|P2|STARTED|Period 2 (up to 7 Days)||25
563301|NCT00655551|1374215|P1|STARTED|Period 2 (up to 7 Days)||0
563302|NCT00655551|1374213|P3|NOT COMPLETED|Period 1 (up to 7 Days)||0
563303|NCT00655551|1374214|P2|NOT COMPLETED|Period 1 (up to 7 Days)||0
563304|NCT00655551|1374215|P1|NOT COMPLETED|Period 1 (up to 7 Days)||0
563305|NCT00655551|1374213|P3|COMPLETED|Period 1 (up to 7 Days)||0
563306|NCT00655551|1374214|P2|COMPLETED|Period 1 (up to 7 Days)||0
563307|NCT00655551|1374215|P1|COMPLETED|Period 1 (up to 7 Days)||25
563308|NCT00655551|1374213|P3|STARTED|Period 1 (up to 7 Days)||0
563309|NCT00655551|1374214|P2|STARTED|Period 1 (up to 7 Days)||0
563310|NCT00655551|1374215|P1|STARTED|Period 1 (up to 7 Days)||25
563311|NCT00655551|1374213|P3|NOT COMPLETED|All Periods Combined||4
563312|NCT00655551|1374214|P2|NOT COMPLETED|All Periods Combined||3
563313|NCT00655551|1374215|P1|NOT COMPLETED|All Periods Combined||0
563314|NCT00655551|1374213|P3|COMPLETED|All Periods Combined||21
563315|NCT00655551|1374214|P2|COMPLETED|All Periods Combined||47
563316|NCT00655551|1374215|P1|COMPLETED|All Periods Combined||25
563317|NCT00655551|1374213|P3|STARTED|All Periods Combined||25
563318|NCT00655551|1374214|P2|STARTED|All Periods Combined||50
563319|NCT00655551|1374215|P1|STARTED|All Periods Combined||25
563320|NCT00655486|1374229|P1|NOT COMPLETED|Overall Study||28
563321|NCT00655486|1374229|P1|COMPLETED|Overall Study||69
563322|NCT00655486|1374229|P1|STARTED|Overall Study||97
563323|NCT00655356|1374236|P2|NOT COMPLETED|Overall Study||10
563324|NCT00655356|1374237|P1|NOT COMPLETED|Overall Study||17
563325|NCT00655356|1374236|P2|COMPLETED|Overall Study||98
563326|NCT00655356|1374237|P1|COMPLETED|Overall Study||93
563327|NCT00655356|1374236|P2|STARTED|Overall Study||108
563328|NCT00655356|1374237|P1|STARTED|Overall Study||110
563329|NCT00655083|1374251|P2|NOT COMPLETED|Overall Study||0
563330|NCT00655083|1374252|P1|NOT COMPLETED|Overall Study||0
563331|NCT00655083|1374251|P2|COMPLETED|Overall Study||8
563332|NCT00655083|1374252|P1|COMPLETED|Overall Study||12
563333|NCT00655083|1374251|P2|STARTED|Overall Study||8
563334|NCT00655083|1374252|P1|STARTED|Overall Study||12
563335|NCT00654992|1374266|P2|NOT COMPLETED|Overall Study||0
563336|NCT00654992|1374267|P1|NOT COMPLETED|Overall Study||0
563337|NCT00654992|1374266|P2|COMPLETED|Overall Study||35
563338|NCT00654992|1374267|P1|COMPLETED|Overall Study||36
563339|NCT00654992|1374266|P2|STARTED|Overall Study||35
563340|NCT00654992|1374267|P1|STARTED|Overall Study||36
563341|NCT00654953|1374276|P3|NOT COMPLETED|Overall Study||22
563342|NCT00654953|1374277|P2|NOT COMPLETED|Overall Study||28
563343|NCT00654953|1374278|P1|NOT COMPLETED|Overall Study||30
563344|NCT00654953|1374276|P3|COMPLETED|Overall Study||8
563345|NCT00654953|1374277|P2|COMPLETED|Overall Study||8
563346|NCT00654953|1374278|P1|COMPLETED|Overall Study||6
563347|NCT00654953|1374276|P3|STARTED|Overall Study||30
563348|NCT00654953|1374277|P2|STARTED|Overall Study||36
563349|NCT00654953|1374278|P1|STARTED|Overall Study||36
563350|NCT00654940|1374288|P2|NOT COMPLETED|Period 2||0
563351|NCT00654940|1374289|P1|NOT COMPLETED|Period 2||0
563352|NCT00654940|1374288|P2|COMPLETED|Period 2||11
563353|NCT00654940|1374289|P1|COMPLETED|Period 2||12
563354|NCT00654940|1374288|P2|STARTED|Period 2||11
563355|NCT00654940|1374289|P1|STARTED|Period 2||12
563356|NCT00654940|1374288|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
563357|NCT00654940|1374289|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
563358|NCT00654940|1374288|P2|COMPLETED|Washout Period of 2 Weeks||11
563359|NCT00654940|1374289|P1|COMPLETED|Washout Period of 2 Weeks||12
563360|NCT00654940|1374288|P2|STARTED|Washout Period of 2 Weeks||11
563361|NCT00654940|1374289|P1|STARTED|Washout Period of 2 Weeks||12
563362|NCT00654940|1374288|P2|NOT COMPLETED|Period 1||1
563363|NCT00654940|1374289|P1|NOT COMPLETED|Period 1||1
563364|NCT00654940|1374288|P2|COMPLETED|Period 1||11
563365|NCT00654940|1374289|P1|COMPLETED|Period 1||12
563366|NCT00654940|1374288|P2|Received Study Treatment|Period 1||12
563367|NCT00654940|1374289|P1|Received Study Treatment|Period 1||12
563368|NCT00654940|1374288|P2|STARTED|Period 1|Assigned to study treatment.|12
563369|NCT00654940|1374289|P1|STARTED|Period 1|Assigned to study treatment.|13
563370|NCT00654927|1374301|P1|NOT COMPLETED|Overall Study||107
563371|NCT00654927|1374301|P1|COMPLETED|Overall Study||70
563372|NCT00654927|1374301|P1|STARTED|Overall Study||177
563373|NCT00654901|1374313|P4|NOT COMPLETED|Overall Study||0
563374|NCT00654901|1374314|P3|NOT COMPLETED|Overall Study||2
563375|NCT00654901|1374315|P2|NOT COMPLETED|Overall Study||0
563376|NCT00654901|1374316|P1|NOT COMPLETED|Overall Study||4
563377|NCT00654901|1374313|P4|COMPLETED|Overall Study||113
563378|NCT00654901|1374314|P3|COMPLETED|Overall Study||250
563379|NCT00654901|1374315|P2|COMPLETED|Overall Study||262
563380|NCT00654901|1374316|P1|COMPLETED|Overall Study||250
563381|NCT00654901|1374313|P4|STARTED|Overall Study||113
563382|NCT00654901|1374314|P3|STARTED|Overall Study||252
563383|NCT00654901|1374315|P2|STARTED|Overall Study||262
563384|NCT00654901|1374316|P1|STARTED|Overall Study||254
563385|NCT00654875|1374336|P2|NOT COMPLETED|Overall Study||17
563386|NCT00654875|1374337|P1|NOT COMPLETED|Overall Study||17
563387|NCT00654875|1374336|P2|COMPLETED|Overall Study||147
563388|NCT00654875|1374337|P1|COMPLETED|Overall Study||147
563389|NCT00654875|1374336|P2|STARTED|Overall Study||164
563390|NCT00654875|1374337|P1|STARTED|Overall Study||164
563391|NCT00654836|1374355|P1|NOT COMPLETED|Overall Study||0
563392|NCT00654836|1374355|P1|COMPLETED|Overall Study||32
563393|NCT00654836|1374355|P1|STARTED|Overall Study||32
563394|NCT00654784|1374363|P2|NOT COMPLETED|Overall Study||0
563395|NCT00654784|1374364|P1|NOT COMPLETED|Overall Study||0
563396|NCT00654784|1374363|P2|COMPLETED|Overall Study||8
563397|NCT00654784|1374364|P1|COMPLETED|Overall Study||13
563398|NCT00654784|1374363|P2|STARTED|Overall Study||8
563399|NCT00654784|1374364|P1|STARTED|Overall Study||13
563400|NCT00654745|1374370|P1|NOT COMPLETED|Overall Study||43
563401|NCT00654745|1374370|P1|COMPLETED|Overall Study||164
563402|NCT00654745|1374370|P1|STARTED|Overall Study|This is single group study in which subjects were titrated to the next of 7 arms if BP goal not met.|207
563403|NCT00654654|1374408|P1|NOT COMPLETED|Overall Study||7
563404|NCT00654654|1374408|P1|COMPLETED|Overall Study||43
563405|NCT00654654|1374408|P1|STARTED|Overall Study||50
563406|NCT00654641|1374415|P2|NOT COMPLETED|Overall Study||3
563407|NCT00654641|1374416|P1|NOT COMPLETED|Overall Study||2
563408|NCT00654641|1374415|P2|COMPLETED|Overall Study||23
563409|NCT00654641|1374416|P1|COMPLETED|Overall Study||26
563410|NCT00654641|1374415|P2|STARTED|Overall Study||26
563411|NCT00654641|1374416|P1|STARTED|Overall Study||28
563412|NCT00654628|1374422|P1|NOT COMPLETED|6 –Week Extension Period (Single Site)||5
563413|NCT00654628|1374422|P1|COMPLETED|6 –Week Extension Period (Single Site)||55
563414|NCT00654628|1374422|P1|STARTED|6 –Week Extension Period (Single Site)|Subjects who completed the first 6-week period and participated in the second 6-week study period.|60
563415|NCT00654628|1374422|P1|NOT COMPLETED|6-week Active Treatment Period||21
563416|NCT00654628|1374422|P1|COMPLETED|6-week Active Treatment Period||152
563417|NCT00654628|1374422|P1|STARTED|6-week Active Treatment Period||173
563418|NCT00654615|1374439|P2|NOT COMPLETED|Overall Study||7
563419|NCT00654615|1374440|P1|NOT COMPLETED|Overall Study||8
563420|NCT00654615|1374439|P2|COMPLETED|Overall Study||23
563421|NCT00654615|1374440|P1|COMPLETED|Overall Study||22
563422|NCT00654615|1374439|P2|STARTED|Overall Study||30
563423|NCT00654615|1374440|P1|STARTED|Overall Study||30
563424|NCT00654511|1374452|P4|NOT COMPLETED|Overall Study||0
563425|NCT00654511|1374453|P3|NOT COMPLETED|Overall Study||0
563426|NCT00654511|1374454|P2|NOT COMPLETED|Overall Study||0
563427|NCT00654511|1374455|P1|NOT COMPLETED|Overall Study||0
563428|NCT00654511|1374452|P4|COMPLETED|Overall Study||25
563429|NCT00654511|1374453|P3|COMPLETED|Overall Study||25
563430|NCT00654511|1374454|P2|COMPLETED|Overall Study||25
563431|NCT00654511|1374455|P1|COMPLETED|Overall Study||26
563432|NCT00654511|1374452|P4|STARTED|Overall Study||25
563433|NCT00654511|1374453|P3|STARTED|Overall Study||25
563434|NCT00654511|1374454|P2|STARTED|Overall Study||25
563435|NCT00654511|1374455|P1|STARTED|Overall Study||26
563436|NCT00654498|1374471|P2|NOT COMPLETED|Overall Study||12
563437|NCT00654498|1374472|P1|NOT COMPLETED|Overall Study||14
563438|NCT00654498|1374471|P2|COMPLETED|Overall Study||91
563439|NCT00654498|1374472|P1|COMPLETED|Overall Study||189
563440|NCT00654498|1374471|P2|STARTED|Overall Study||103
563441|NCT00654498|1374472|P1|STARTED|Overall Study||203
563442|NCT00654420|1374504|P4|NOT COMPLETED|Phase II||38
563443|NCT00654420|1374505|P3|NOT COMPLETED|Phase II||37
563444|NCT00654420|1374506|P2|NOT COMPLETED|Phase II||0
563445|NCT00654420|1374507|P1|NOT COMPLETED|Phase II||0
563446|NCT00654420|1374504|P4|COMPLETED|Phase II||0
563447|NCT00654420|1374505|P3|COMPLETED|Phase II||0
563448|NCT00654420|1374506|P2|COMPLETED|Phase II||0
563449|NCT00654420|1374507|P1|COMPLETED|Phase II||0
563450|NCT00654420|1374504|P4|STARTED|Phase II|New participants were enrolled in the Phase II part of the study that did not participate in Phase 1|38
563451|NCT00654420|1374505|P3|STARTED|Phase II|New participants were enrolled in the Phase II part of the study that did not participate in Phase 1|37
563452|NCT00654420|1374506|P2|STARTED|Phase II||0
563453|NCT00654420|1374507|P1|STARTED|Phase II||0
563454|NCT00654420|1374504|P4|NOT COMPLETED|Phase I (Dose Escalation)||0
563455|NCT00654420|1374505|P3|NOT COMPLETED|Phase I (Dose Escalation)||0
563456|NCT00654420|1374506|P2|NOT COMPLETED|Phase I (Dose Escalation)||16
563457|NCT00654420|1374507|P1|NOT COMPLETED|Phase I (Dose Escalation)||4
563458|NCT00654420|1374504|P4|COMPLETED|Phase I (Dose Escalation)||0
563459|NCT00654420|1374505|P3|COMPLETED|Phase I (Dose Escalation)||0
563460|NCT00654420|1374506|P2|COMPLETED|Phase I (Dose Escalation)||0
563461|NCT00654420|1374507|P1|COMPLETED|Phase I (Dose Escalation)||0
563462|NCT00654420|1374504|P4|STARTED|Phase I (Dose Escalation)||0
563463|NCT00654420|1374505|P3|STARTED|Phase I (Dose Escalation)||0
563464|NCT00654420|1374506|P2|STARTED|Phase I (Dose Escalation)||16
563465|NCT00654420|1374507|P1|STARTED|Phase I (Dose Escalation)||4
563466|NCT00654381|1374533|P6|NOT COMPLETED|Extension Stage||3
563467|NCT00654381|1374534|P5|NOT COMPLETED|Extension Stage||3
563468|NCT00654381|1374535|P4|NOT COMPLETED|Extension Stage||9
563469|NCT00654381|1374536|P3|NOT COMPLETED|Extension Stage||11
563470|NCT00654381|1374537|P2|NOT COMPLETED|Extension Stage||2
563471|NCT00654381|1374538|P1|NOT COMPLETED|Extension Stage||1
563472|NCT00654381|1374533|P6|COMPLETED|Extension Stage||73
563473|NCT00654381|1374534|P5|COMPLETED|Extension Stage||68
563474|NCT00654381|1374535|P4|COMPLETED|Extension Stage||142
563475|NCT00654381|1374536|P3|COMPLETED|Extension Stage||142
563476|NCT00654381|1374537|P2|COMPLETED|Extension Stage||36
563477|NCT00654381|1374538|P1|COMPLETED|Extension Stage||33
563478|NCT00654381|1374533|P6|STARTED|Extension Stage||76
563479|NCT00654381|1374534|P5|STARTED|Extension Stage||71
563480|NCT00654381|1374535|P4|STARTED|Extension Stage||151
563481|NCT00654381|1374536|P3|STARTED|Extension Stage||153
563482|NCT00654381|1374537|P2|STARTED|Extension Stage||38
563483|NCT00654381|1374538|P1|STARTED|Extension Stage||34
563484|NCT00654381|1374533|P6|NOT COMPLETED|2nd Stage||3
563485|NCT00654381|1374534|P5|NOT COMPLETED|2nd Stage||8
563486|NCT00654381|1374535|P4|NOT COMPLETED|2nd Stage||4
563487|NCT00654381|1374536|P3|NOT COMPLETED|2nd Stage||3
563488|NCT00654381|1374537|P2|NOT COMPLETED|2nd Stage||0
563489|NCT00654381|1374538|P1|NOT COMPLETED|2nd Stage||2
563490|NCT00654381|1374533|P6|COMPLETED|2nd Stage||76
563491|NCT00654381|1374534|P5|COMPLETED|2nd Stage||71
563492|NCT00654381|1374535|P4|COMPLETED|2nd Stage||151
563493|NCT00654381|1374536|P3|COMPLETED|2nd Stage||153
563494|NCT00654381|1374537|P2|COMPLETED|2nd Stage||38
563495|NCT00654381|1374538|P1|COMPLETED|2nd Stage||34
563496|NCT00654381|1374533|P6|STARTED|2nd Stage||79
563497|NCT00654381|1374534|P5|STARTED|2nd Stage||79
563498|NCT00654381|1374535|P4|STARTED|2nd Stage||155
563499|NCT00654381|1374536|P3|STARTED|2nd Stage||156
563500|NCT00654381|1374537|P2|STARTED|2nd Stage||38
563501|NCT00654381|1374538|P1|STARTED|2nd Stage||36
563502|NCT00654381|1374533|P6|NOT COMPLETED|1st Stage||2
563503|NCT00654381|1374534|P5|NOT COMPLETED|1st Stage||2
563504|NCT00654381|1374535|P4|NOT COMPLETED|1st Stage||5
563505|NCT00654381|1374536|P3|NOT COMPLETED|1st Stage||3
563506|NCT00654381|1374537|P2|NOT COMPLETED|1st Stage||3
563507|NCT00654381|1374538|P1|NOT COMPLETED|1st Stage||3
563508|NCT00654381|1374533|P6|COMPLETED|1st Stage||79
563509|NCT00654381|1374534|P5|COMPLETED|1st Stage||79
563510|NCT00654381|1374535|P4|COMPLETED|1st Stage||155
563511|NCT00654381|1374536|P3|COMPLETED|1st Stage||156
563512|NCT00654381|1374537|P2|COMPLETED|1st Stage||38
563513|NCT00654381|1374538|P1|COMPLETED|1st Stage||36
563514|NCT00654381|1374533|P6|STARTED|1st Stage||81
563515|NCT00654381|1374534|P5|STARTED|1st Stage||81
563516|NCT00654381|1374535|P4|STARTED|1st Stage||160
563517|NCT00654381|1374536|P3|STARTED|1st Stage||159
563518|NCT00654381|1374537|P2|STARTED|1st Stage||41
563519|NCT00654381|1374538|P1|STARTED|1st Stage||39
563520|NCT00654368|1374575|P3|NOT COMPLETED|Overall Study||32
563521|NCT00654368|1374576|P2|NOT COMPLETED|Overall Study||48
563522|NCT00654368|1374577|P1|NOT COMPLETED|Overall Study||53
563523|NCT00654368|1374575|P3|COMPLETED|Overall Study||75
563524|NCT00654368|1374576|P2|COMPLETED|Overall Study||50
563525|NCT00654368|1374577|P1|COMPLETED|Overall Study||0
563526|NCT00654368|1374575|P3|STARTED|Overall Study||107
563527|NCT00654368|1374576|P2|STARTED|Overall Study||98
563528|NCT00654368|1374577|P1|STARTED|Overall Study||53
563529|NCT00654355|1374610|P2|NOT COMPLETED|Overall Study||2
563530|NCT00654355|1374611|P1|NOT COMPLETED|Overall Study||2
563531|NCT00654355|1374610|P2|COMPLETED|Overall Study||13
563532|NCT00654355|1374611|P1|COMPLETED|Overall Study||13
563533|NCT00654355|1374610|P2|STARTED|Overall Study||15
563534|NCT00654355|1374611|P1|STARTED|Overall Study||15
563535|NCT00654329|1374625|P4|NOT COMPLETED|Overall Study||0
563536|NCT00654329|1374626|P3|NOT COMPLETED|Overall Study||0
563537|NCT00654329|1374627|P2|NOT COMPLETED|Overall Study||0
563538|NCT00654329|1374628|P1|NOT COMPLETED|Overall Study||0
563539|NCT00654329|1374625|P4|COMPLETED|Overall Study||27
563540|NCT00654329|1374626|P3|COMPLETED|Overall Study||23
563541|NCT00654329|1374627|P2|COMPLETED|Overall Study||28
563542|NCT00654329|1374628|P1|COMPLETED|Overall Study||23
563543|NCT00654329|1374625|P4|STARTED|Overall Study||27
563544|NCT00654329|1374626|P3|STARTED|Overall Study||23
563545|NCT00654329|1374627|P2|STARTED|Overall Study||28
563546|NCT00654329|1374628|P1|STARTED|Overall Study||23
563547|NCT00654186|1374642|P1|NOT COMPLETED|Overall Study||5
563548|NCT00654186|1374642|P1|COMPLETED|Overall Study||27
563549|NCT00654186|1374642|P1|STARTED|Overall Study||32
563550|NCT00654147|1374650|P2|NOT COMPLETED|Overall Study||4
563551|NCT00654147|1374651|P1|NOT COMPLETED|Overall Study||2
563552|NCT00654147|1374650|P2|COMPLETED|Overall Study||19
563553|NCT00654147|1374651|P1|COMPLETED|Overall Study||19
563554|NCT00654147|1374650|P2|STARTED|Overall Study||23
563555|NCT00654147|1374651|P1|STARTED|Overall Study||21
563556|NCT00654095|1374667|P1|NOT COMPLETED|Overall Study||32
563557|NCT00654095|1374667|P1|COMPLETED|Overall Study||114
563558|NCT00654095|1374667|P1|STARTED|Overall Study||146
563559|NCT00654030|1374671|P1|NOT COMPLETED|Overall Study||1
563560|NCT00654030|1374671|P1|COMPLETED|Overall Study||11
563561|NCT00654030|1374671|P1|STARTED|Overall Study||12
563562|NCT00654004|1374677|P2|NOT COMPLETED|Overall Study||0
563563|NCT00654004|1374678|P1|NOT COMPLETED|Overall Study||1
563564|NCT00654004|1374677|P2|COMPLETED|Overall Study||12
563565|NCT00654004|1374678|P1|COMPLETED|Overall Study||13
563566|NCT00654004|1374677|P2|STARTED|Overall Study||12
563567|NCT00654004|1374678|P1|STARTED|Overall Study||14
563568|NCT00653939|1374694|P2|NOT COMPLETED|Overall Study||15
563569|NCT00653939|1374695|P1|NOT COMPLETED|Overall Study||12
563570|NCT00653939|1374694|P2|COMPLETED|Overall Study||17
563571|NCT00653939|1374695|P1|COMPLETED|Overall Study||19
563572|NCT00653939|1374694|P2|STARTED|Overall Study|1 patient randomized did not receive treatment due to acute renal failure.|32
563573|NCT00653939|1374695|P1|STARTED|Overall Study|2 patients randomized did not receive treatment due to brain metastasis or consent withdrawal.|31
563574|NCT00653861|1374711|P1|NOT COMPLETED|Overall Study||0
563575|NCT00653861|1374711|P1|COMPLETED|Overall Study||72
563576|NCT00653861|1374711|P1|STARTED|Overall Study||72
563577|NCT00653523|1374720|P1|NOT COMPLETED|Overall Study||19
563578|NCT00653523|1374720|P1|COMPLETED|Overall Study||132
563579|NCT00653523|1374720|P1|STARTED|Overall Study||151
563580|NCT00653328|1374724|P1|NOT COMPLETED|Overall Study||15
563581|NCT00653328|1374724|P1|COMPLETED|Overall Study||0
563582|NCT00653328|1374724|P1|STARTED|Overall Study||15
563583|NCT00653263|1374731|P1|NOT COMPLETED|Overall Study||2
563584|NCT00653263|1374731|P1|COMPLETED|Overall Study||6
563585|NCT00653263|1374731|P1|STARTED|Overall Study|1 dropped out of treatment and the other had untreated hypertension|8
563586|NCT00653224|1374739|P2|NOT COMPLETED|Overall Study||7
563587|NCT00653224|1374740|P1|NOT COMPLETED|Overall Study||7
563588|NCT00653224|1374739|P2|COMPLETED|Overall Study||280
563589|NCT00653224|1374740|P1|COMPLETED|Overall Study||286
563590|NCT00653224|1374739|P2|STARTED|Overall Study||287
563591|NCT00653224|1374740|P1|STARTED|Overall Study||293
563592|NCT00653159|1374926|P2|NOT COMPLETED|Overall Study||3
563593|NCT00653159|1374927|P1|NOT COMPLETED|Overall Study||5
563594|NCT00653159|1374926|P2|COMPLETED|Overall Study||9
563595|NCT00653159|1374927|P1|COMPLETED|Overall Study||6
563596|NCT00653159|1374926|P2|STARTED|Overall Study||12
563597|NCT00653159|1374927|P1|STARTED|Overall Study||11
563598|NCT00653133|1374943|P2|NOT COMPLETED|Overall Study||0
563599|NCT00653133|1374944|P1|NOT COMPLETED|Overall Study||0
563600|NCT00653133|1374943|P2|COMPLETED|Overall Study||497
563601|NCT00653133|1374944|P1|COMPLETED|Overall Study||1324
563602|NCT00653133|1374943|P2|STARTED|Overall Study||497
563603|NCT00653133|1374944|P1|STARTED|Overall Study||1324
563604|NCT00653068|1374954|P1|NOT COMPLETED|Overall Study||50
563605|NCT00653068|1374954|P1|COMPLETED|Overall Study||20
563606|NCT00653068|1374954|P1|STARTED|Overall Study||70
563607|NCT00652938|1374968|P3|NOT COMPLETED|Overall Study||5
563608|NCT00652938|1374969|P2|NOT COMPLETED|Overall Study||7
563609|NCT00652938|1374970|P1|NOT COMPLETED|Overall Study||1
563610|NCT00652938|1374968|P3|COMPLETED|Overall Study||242
563611|NCT00652938|1374969|P2|COMPLETED|Overall Study||240
563612|NCT00652938|1374970|P1|COMPLETED|Overall Study||246
563613|NCT00652938|1374968|P3|STARTED|Overall Study||247
563614|NCT00652938|1374969|P2|STARTED|Overall Study||247
563615|NCT00652938|1374970|P1|STARTED|Overall Study||247
563616|NCT00652899|1375035|P1|NOT COMPLETED|Overall Study||2
563617|NCT00652899|1375035|P1|COMPLETED|Overall Study||12
563618|NCT00652899|1375035|P1|STARTED|Overall Study||14
563619|NCT00652834|1375045|P1|NOT COMPLETED|Overall Study||5
563620|NCT00652834|1375045|P1|COMPLETED|Overall Study|3 subjects withdrew after completing baseline questionnaire. 2 did not complete 30-day visit.|18
563621|NCT00652834|1375045|P1|STARTED|Overall Study||23
563622|NCT00652626|1375056|P7|NOT COMPLETED|Extension Phase||3
563623|NCT00652626|1375057|P6|NOT COMPLETED|Extension Phase||12
563624|NCT00652626|1375058|P5|NOT COMPLETED|Extension Phase||0
563625|NCT00652626|1375059|P4|NOT COMPLETED|Extension Phase||0
563626|NCT00652626|1375060|P3|NOT COMPLETED|Extension Phase||0
563627|NCT00652626|1375061|P2|NOT COMPLETED|Extension Phase||0
563628|NCT00652626|1375062|P1|NOT COMPLETED|Extension Phase||0
563629|NCT00652626|1375056|P7|COMPLETED|Extension Phase|A participant was considered completed if they had completed 6 cycles of therapy.|1
563630|NCT00652626|1375057|P6|COMPLETED|Extension Phase|A participant was considered completed if they had completed 6 cycles of therapy.|2
563631|NCT00652626|1375058|P5|COMPLETED|Extension Phase||0
563632|NCT00652626|1375059|P4|COMPLETED|Extension Phase||0
563633|NCT00652626|1375060|P3|COMPLETED|Extension Phase||0
563634|NCT00652626|1375061|P2|COMPLETED|Extension Phase||0
563635|NCT00652626|1375062|P1|COMPLETED|Extension Phase||0
563636|NCT00652626|1375056|P7|STARTED|Extension Phase||4
563637|NCT00652626|1375057|P6|STARTED|Extension Phase||14
563638|NCT00652626|1375058|P5|STARTED|Extension Phase||0
563639|NCT00652626|1375059|P4|STARTED|Extension Phase||0
563640|NCT00652626|1375060|P3|STARTED|Extension Phase||0
563641|NCT00652626|1375061|P2|STARTED|Extension Phase||0
563642|NCT00652626|1375062|P1|STARTED|Extension Phase||0
563643|NCT00652626|1375056|P7|NOT COMPLETED|Initial Treatment Phase||0
563644|NCT00652626|1375057|P6|NOT COMPLETED|Initial Treatment Phase||0
563645|NCT00652626|1375058|P5|NOT COMPLETED|Initial Treatment Phase||3
563646|NCT00652626|1375059|P4|NOT COMPLETED|Initial Treatment Phase||1
563647|NCT00652626|1375060|P3|NOT COMPLETED|Initial Treatment Phase||1
563648|NCT00652626|1375061|P2|NOT COMPLETED|Initial Treatment Phase||0
563649|NCT00652626|1375062|P1|NOT COMPLETED|Initial Treatment Phase||0
563650|NCT00652626|1375056|P7|COMPLETED|Initial Treatment Phase||0
563651|NCT00652626|1375057|P6|COMPLETED|Initial Treatment Phase||0
563652|NCT00652626|1375058|P5|COMPLETED|Initial Treatment Phase||5
563653|NCT00652626|1375059|P4|COMPLETED|Initial Treatment Phase||5
563654|NCT00652626|1375060|P3|COMPLETED|Initial Treatment Phase||6
563655|NCT00652626|1375061|P2|COMPLETED|Initial Treatment Phase||5
563656|NCT00652626|1375062|P1|COMPLETED|Initial Treatment Phase||5
563657|NCT00652626|1375056|P7|Received Study Drug|Initial Treatment Phase||0
563658|NCT00652626|1375057|P6|Received Study Drug|Initial Treatment Phase||0
563659|NCT00652626|1375058|P5|Received Study Drug|Initial Treatment Phase||6
563660|NCT00652626|1375059|P4|Received Study Drug|Initial Treatment Phase||5
563661|NCT00652626|1375060|P3|Received Study Drug|Initial Treatment Phase||6
563662|NCT00652626|1375061|P2|Received Study Drug|Initial Treatment Phase||5
563663|NCT00652626|1375062|P1|Received Study Drug|Initial Treatment Phase||5
563664|NCT00652626|1375056|P7|STARTED|Initial Treatment Phase||0
563665|NCT00652626|1375057|P6|STARTED|Initial Treatment Phase||0
563666|NCT00652626|1375058|P5|STARTED|Initial Treatment Phase||8
563667|NCT00652626|1375059|P4|STARTED|Initial Treatment Phase||6
563668|NCT00652626|1375060|P3|STARTED|Initial Treatment Phase||7
563669|NCT00652626|1375061|P2|STARTED|Initial Treatment Phase||5
563670|NCT00652626|1375062|P1|STARTED|Initial Treatment Phase||5
563671|NCT00652366|1375131|P5|NOT COMPLETED|Overall Study||36
563672|NCT00652366|1375132|P4|NOT COMPLETED|Overall Study||179
563673|NCT00652366|1375133|P3|NOT COMPLETED|Overall Study||71
563674|NCT00652366|1375134|P2|NOT COMPLETED|Overall Study||75
563675|NCT00652366|1375135|P1|NOT COMPLETED|Overall Study||106
563676|NCT00652366|1375131|P5|COMPLETED|Overall Study||0
563677|NCT00652366|1375132|P4|COMPLETED|Overall Study||0
563678|NCT00652366|1375133|P3|COMPLETED|Overall Study||0
563679|NCT00652366|1375134|P2|COMPLETED|Overall Study||0
563680|NCT00652366|1375135|P1|COMPLETED|Overall Study||0
563681|NCT00652366|1375131|P5|STARTED|Overall Study||36
563682|NCT00652366|1375132|P4|STARTED|Overall Study||179
563683|NCT00652366|1375133|P3|STARTED|Overall Study||71
563684|NCT00652366|1375134|P2|STARTED|Overall Study||75
563685|NCT00652366|1375135|P1|STARTED|Overall Study||106
563686|NCT00652340|1375170|P2|NOT COMPLETED|Overall Study||3
563687|NCT00652340|1375171|P1|NOT COMPLETED|Overall Study||4
563688|NCT00652340|1375170|P2|COMPLETED|Overall Study|3 patients remained on study at database lock.|39
563689|NCT00652340|1375171|P1|COMPLETED|Overall Study|4 patients remained on study at database lock.|74
563690|NCT00652340|1375170|P2|STARTED|Overall Study||42
563691|NCT00652340|1375171|P1|STARTED|Overall Study||78
563692|NCT00652327|1375181|P2|NOT COMPLETED|Overall Study||5
563693|NCT00652327|1375182|P1|NOT COMPLETED|Overall Study||0
563694|NCT00652327|1375181|P2|COMPLETED|Overall Study||36
563695|NCT00652327|1375182|P1|COMPLETED|Overall Study||42
563696|NCT00652327|1375181|P2|STARTED|Overall Study|Participants who recieved randomized treatment assignment to double the dose of ongoing statin|41
563697|NCT00652327|1375182|P1|STARTED|Overall Study|Participants who recieved randomized treatment assignment to ezetimibe and ongoing statin|42
563698|NCT00652314|1375190|P2|NOT COMPLETED|Overall Study||9
563699|NCT00652314|1375191|P1|NOT COMPLETED|Overall Study||9
563700|NCT00652314|1375190|P2|COMPLETED|Overall Study||26
563701|NCT00652314|1375191|P1|COMPLETED|Overall Study||53
563702|NCT00652314|1375190|P2|STARTED|Overall Study||35
563703|NCT00652314|1375191|P1|STARTED|Overall Study||62
563704|NCT00652145|1375207|P2|NOT COMPLETED|Overall Study||0
563705|NCT00652145|1375208|P1|NOT COMPLETED|Overall Study||0
563706|NCT00652145|1375207|P2|COMPLETED|Overall Study||26
563707|NCT00652145|1375208|P1|COMPLETED|Overall Study||26
563708|NCT00652145|1375207|P2|STARTED|Overall Study||26
563709|NCT00652145|1375208|P1|STARTED|Overall Study||26
563710|NCT00652093|1375224|P6|NOT COMPLETED|Overall Study||0
563711|NCT00652093|1375225|P5|NOT COMPLETED|Overall Study||2
563712|NCT00652093|1375226|P4|NOT COMPLETED|Overall Study||0
563713|NCT00652093|1375227|P3|NOT COMPLETED|Overall Study||1
563714|NCT00652093|1375228|P2|NOT COMPLETED|Overall Study||0
563715|NCT00652093|1375229|P1|NOT COMPLETED|Overall Study||0
563716|NCT00652093|1375224|P6|COMPLETED|Overall Study||4
563717|NCT00652093|1375225|P5|COMPLETED|Overall Study||2
563718|NCT00652093|1375226|P4|COMPLETED|Overall Study||4
563719|NCT00652093|1375227|P3|COMPLETED|Overall Study||3
563720|NCT00652093|1375228|P2|COMPLETED|Overall Study||4
563721|NCT00652093|1375229|P1|COMPLETED|Overall Study||4
563722|NCT00652093|1375224|P6|STARTED|Overall Study||4
563723|NCT00652093|1375225|P5|STARTED|Overall Study||4
563724|NCT00652093|1375226|P4|STARTED|Overall Study||4
563725|NCT00652093|1375227|P3|STARTED|Overall Study||4
563726|NCT00652093|1375228|P2|STARTED|Overall Study||4
563727|NCT00652093|1375229|P1|STARTED|Overall Study||4
563728|NCT00652028|1375313|P4|NOT COMPLETED|Overall Study||0
563729|NCT00652028|1375314|P3|NOT COMPLETED|Overall Study||1
563730|NCT00652028|1375315|P2|NOT COMPLETED|Overall Study||1
563731|NCT00652028|1375316|P1|NOT COMPLETED|Overall Study||1
563732|NCT00652028|1375313|P4|COMPLETED|Overall Study||14
563733|NCT00652028|1375314|P3|COMPLETED|Overall Study||14
563734|NCT00652028|1375315|P2|COMPLETED|Overall Study||13
563735|NCT00652028|1375316|P1|COMPLETED|Overall Study||15
563736|NCT00652028|1375313|P4|STARTED|Overall Study||14
563737|NCT00652028|1375314|P3|STARTED|Overall Study||15
563738|NCT00652028|1375315|P2|STARTED|Overall Study||14
563739|NCT00652028|1375316|P1|STARTED|Overall Study||16
563740|NCT00651924|1375360|P2|NOT COMPLETED|Overall Study||7
563741|NCT00651924|1375361|P1|NOT COMPLETED|Overall Study||0
563742|NCT00651924|1375360|P2|COMPLETED|Overall Study||2
563743|NCT00651924|1375361|P1|COMPLETED|Overall Study||18
563744|NCT00651924|1375360|P2|STARTED|Overall Study||9
563745|NCT00651924|1375361|P1|STARTED|Overall Study||18
563746|NCT00651820|1375367|P1|NOT COMPLETED|Overall Study||2
563747|NCT00651820|1375367|P1|COMPLETED|Overall Study||26
563748|NCT00651820|1375367|P1|STARTED|Overall Study||28
563749|NCT00651794|1375377|P3|NOT COMPLETED|Overall Study||21
563750|NCT00651794|1375378|P2|NOT COMPLETED|Overall Study||22
563751|NCT00651794|1375379|P1|NOT COMPLETED|Overall Study||21
563752|NCT00651794|1375377|P3|COMPLETED|Overall Study||10
563753|NCT00651794|1375378|P2|COMPLETED|Overall Study||9
563754|NCT00651794|1375379|P1|COMPLETED|Overall Study||15
563755|NCT00651794|1375377|P3|STARTED|Overall Study||31
563756|NCT00651794|1375378|P2|STARTED|Overall Study||31
563757|NCT00651794|1375379|P1|STARTED|Overall Study||36
563758|NCT00651755|1375399|P2|NOT COMPLETED|Cycle 2 (Second 21 Days)||1
563759|NCT00651755|1375400|P1|NOT COMPLETED|Cycle 2 (Second 21 Days)||0
563760|NCT00651755|1375399|P2|COMPLETED|Cycle 2 (Second 21 Days)||8
563761|NCT00651755|1375400|P1|COMPLETED|Cycle 2 (Second 21 Days)||10
563762|NCT00651755|1375399|P2|STARTED|Cycle 2 (Second 21 Days)||9
563763|NCT00651755|1375400|P1|STARTED|Cycle 2 (Second 21 Days)||10
563764|NCT00651755|1375399|P2|NOT COMPLETED|Cycle 1 (First 21 Days)||0
563765|NCT00651755|1375400|P1|NOT COMPLETED|Cycle 1 (First 21 Days)||1
563766|NCT00651755|1375399|P2|COMPLETED|Cycle 1 (First 21 Days)||9
563767|NCT00651755|1375400|P1|COMPLETED|Cycle 1 (First 21 Days)||10
563768|NCT00651755|1375399|P2|STARTED|Cycle 1 (First 21 Days)||9
563769|NCT00651755|1375400|P1|STARTED|Cycle 1 (First 21 Days)||11
563770|NCT00651625|1375418|P2|NOT COMPLETED|Overall Study||0
563771|NCT00651625|1375419|P1|NOT COMPLETED|Overall Study||0
563772|NCT00651625|1375418|P2|COMPLETED|Overall Study||218
563773|NCT00651625|1375419|P1|COMPLETED|Overall Study||219
563774|NCT00651625|1375418|P2|STARTED|Overall Study||218
563775|NCT00651625|1375419|P1|STARTED|Overall Study||219
563776|NCT00651482|1375431|P1|NOT COMPLETED|Overall Study||0
563777|NCT00651482|1375431|P1|COMPLETED|Overall Study||10
563778|NCT00651482|1375431|P1|STARTED|Overall Study||10
563779|NCT00651313|1375445|P2|NOT COMPLETED|Overall Study||6
563780|NCT00651313|1375446|P1|NOT COMPLETED|Overall Study||6
563781|NCT00651313|1375445|P2|COMPLETED|Overall Study||37
563782|NCT00651313|1375446|P1|COMPLETED|Overall Study||35
563783|NCT00651313|1375445|P2|STARTED|Overall Study||43
563784|NCT00651313|1375446|P1|STARTED|Overall Study||41
563785|NCT00651261|1375454|P2|NOT COMPLETED|Overall Study||306
563786|NCT00651261|1375455|P1|NOT COMPLETED|Overall Study||291
563787|NCT00651261|1375454|P2|COMPLETED|Overall Study||51
563788|NCT00651261|1375455|P1|COMPLETED|Overall Study||69
563789|NCT00651261|1375454|P2|STARTED|Overall Study||357
563790|NCT00651261|1375455|P1|STARTED|Overall Study||360
563791|NCT00651183|1375471|P2|NOT COMPLETED|Overall Study||10
563792|NCT00651183|1375472|P1|NOT COMPLETED|Overall Study||20
563793|NCT00651183|1375471|P2|COMPLETED|Overall Study|"other reasons. No explanation was required to be given by the physicians"|87
563794|NCT00651183|1375472|P1|COMPLETED|Overall Study|Case Report Form (CRF) listed reasons for early termination, of which one was|169
563795|NCT00651183|1375471|P2|STARTED|Overall Study||97
563796|NCT00651183|1375472|P1|STARTED|Overall Study|"For one patient the information was not given, therefore, the patient was listed missing"|189
563797|NCT00651157|1375484|P1|NOT COMPLETED|Overall Study||2
563798|NCT00651157|1375484|P1|COMPLETED|Overall Study||21
563799|NCT00651157|1375484|P1|STARTED|Overall Study||23
563800|NCT00651118|1375494|P4|NOT COMPLETED|Overall Study||7
563801|NCT00651118|1375495|P3|NOT COMPLETED|Overall Study||11
563802|NCT00651118|1375496|P2|NOT COMPLETED|Overall Study||7
563803|NCT00651118|1375497|P1|NOT COMPLETED|Overall Study||9
563804|NCT00651118|1375494|P4|COMPLETED|Overall Study||203
563805|NCT00651118|1375495|P3|COMPLETED|Overall Study||197
563806|NCT00651118|1375496|P2|COMPLETED|Overall Study||200
563807|NCT00651118|1375497|P1|COMPLETED|Overall Study||198
563808|NCT00651118|1375494|P4|STARTED|Overall Study||210
563809|NCT00651118|1375495|P3|STARTED|Overall Study||208
563810|NCT00651118|1375496|P2|STARTED|Overall Study||207
563811|NCT00651118|1375497|P1|STARTED|Overall Study||207
563812|NCT00651040|1375517|P2|NOT COMPLETED|Overall Study||1
563813|NCT00651040|1375518|P1|NOT COMPLETED|Overall Study||3
563814|NCT00651040|1375517|P2|COMPLETED|Overall Study||14
563815|NCT00651040|1375518|P1|COMPLETED|Overall Study||13
563816|NCT00651040|1375517|P2|STARTED|Overall Study||15
563817|NCT00651040|1375518|P1|STARTED|Overall Study||16
563818|NCT00650858|1375527|P3|NOT COMPLETED|Overall Study||0
563819|NCT00650858|1375528|P2|NOT COMPLETED|Overall Study||0
563820|NCT00650858|1375529|P1|NOT COMPLETED|Overall Study||0
563821|NCT00650858|1375527|P3|COMPLETED|Overall Study||36
563822|NCT00650858|1375528|P2|COMPLETED|Overall Study||8
563823|NCT00650858|1375529|P1|COMPLETED|Overall Study||8
563824|NCT00650858|1375527|P3|STARTED|Overall Study||36
563825|NCT00650858|1375528|P2|STARTED|Overall Study||8
563826|NCT00650858|1375529|P1|STARTED|Overall Study||8
563827|NCT00650845|1375560|P2|NOT COMPLETED|Overall Study||13
563828|NCT00650845|1375561|P1|NOT COMPLETED|Overall Study||5
563829|NCT00650845|1375560|P2|COMPLETED|Overall Study||44
563830|NCT00650845|1375561|P1|COMPLETED|Overall Study||70
563831|NCT00650845|1375560|P2|STARTED|Overall Study||57
563832|NCT00650845|1375561|P1|STARTED|Overall Study||75
563833|NCT00650806|1375581|P4|NOT COMPLETED|Overall Study||26
563834|NCT00650806|1375582|P3|NOT COMPLETED|Overall Study||29
563835|NCT00650806|1375583|P2|NOT COMPLETED|Overall Study||21
563836|NCT00650806|1375584|P1|NOT COMPLETED|Overall Study||18
563837|NCT00650806|1375581|P4|COMPLETED|Overall Study||70
563838|NCT00650806|1375582|P3|COMPLETED|Overall Study||64
563839|NCT00650806|1375583|P2|COMPLETED|Overall Study||77
563840|NCT00650806|1375584|P1|COMPLETED|Overall Study||71
563841|NCT00650806|1375581|P4|STARTED|Overall Study||96
563842|NCT00650806|1375582|P3|STARTED|Overall Study||93
563843|NCT00650806|1375583|P2|STARTED|Overall Study||98
563844|NCT00650806|1375584|P1|STARTED|Overall Study||89
563845|NCT00650767|1375626|P4|NOT COMPLETED|Overall Study||11
563846|NCT00650767|1375627|P3|NOT COMPLETED|Overall Study||14
563847|NCT00650767|1375628|P2|NOT COMPLETED|Overall Study||9
563848|NCT00650767|1375629|P1|NOT COMPLETED|Overall Study||5
563849|NCT00650767|1375626|P4|COMPLETED|Overall Study||39
563850|NCT00650767|1375627|P3|COMPLETED|Overall Study||36
563851|NCT00650767|1375628|P2|COMPLETED|Overall Study||41
563852|NCT00650767|1375629|P1|COMPLETED|Overall Study||46
563853|NCT00650767|1375626|P4|STARTED|Overall Study||50
563854|NCT00650767|1375627|P3|STARTED|Overall Study||50
563855|NCT00650767|1375628|P2|STARTED|Overall Study||50
563856|NCT00650767|1375629|P1|STARTED|Overall Study||51
563857|NCT00650585|1376133|P2|NOT COMPLETED|Overall Study||1477
563858|NCT00650585|1376134|P1|NOT COMPLETED|Overall Study||1797
563859|NCT00650585|1376133|P2|COMPLETED|Overall Study|Completed posttest--a self-report survey administered 30 approximately 30 days after treatment|2513
563860|NCT00650585|1376134|P1|COMPLETED|Overall Study|Completed posttest--a self-report survey administered 30 approximately 30 days after treatment|2551
563861|NCT00650585|1376133|P2|STARTED|Overall Study||3990
563862|NCT00650585|1376134|P1|STARTED|Overall Study||4348
563863|NCT00650546|1376154|P1|NOT COMPLETED|Overall Study||0
563864|NCT00650546|1376154|P1|COMPLETED|Overall Study||8
563865|NCT00650546|1376154|P1|STARTED|Overall Study||8
563866|NCT00650260|1376161|P2|NOT COMPLETED|Overall Study||0
563867|NCT00650260|1376162|P1|NOT COMPLETED|Overall Study||0
563868|NCT00650260|1376161|P2|COMPLETED|Overall Study||21
563869|NCT00650260|1376162|P1|COMPLETED|Overall Study||21
563870|NCT00650260|1376161|P2|STARTED|Overall Study||21
563871|NCT00650260|1376162|P1|STARTED|Overall Study||21
563872|NCT00650104|1376178|P1|NOT COMPLETED|Overall Study||41
563873|NCT00650104|1376178|P1|COMPLETED|Overall Study||42
563874|NCT00650104|1376178|P1|STARTED|Overall Study||83
563875|NCT00650091|1376193|P3|NOT COMPLETED|Amended Study Design||0
563876|NCT00650091|1376194|P2|NOT COMPLETED|Amended Study Design||20
563877|NCT00650091|1376195|P1|NOT COMPLETED|Amended Study Design||23
563878|NCT00650091|1376193|P3|COMPLETED|Amended Study Design||0
563879|NCT00650091|1376194|P2|COMPLETED|Amended Study Design||111
563880|NCT00650091|1376195|P1|COMPLETED|Amended Study Design||110
563881|NCT00650091|1376193|P3|STARTED|Amended Study Design|Study Drug was discontinued for all subjects due to safety concerns.|0
563882|NCT00650091|1376194|P2|STARTED|Amended Study Design||131
563883|NCT00650091|1376195|P1|STARTED|Amended Study Design||133
563884|NCT00650091|1376193|P3|NOT COMPLETED|Initial Study Design - Interim Analysis||0
563885|NCT00650091|1376194|P2|NOT COMPLETED|Initial Study Design - Interim Analysis||0
563886|NCT00650091|1376195|P1|NOT COMPLETED|Initial Study Design - Interim Analysis||0
563887|NCT00650091|1376193|P3|COMPLETED|Initial Study Design - Interim Analysis||77
563888|NCT00650091|1376194|P2|COMPLETED|Initial Study Design - Interim Analysis||78
563889|NCT00650091|1376195|P1|COMPLETED|Initial Study Design - Interim Analysis||81
563890|NCT00650091|1376193|P3|STARTED|Initial Study Design - Interim Analysis||77
563891|NCT00650091|1376194|P2|STARTED|Initial Study Design - Interim Analysis||78
563892|NCT00650091|1376195|P1|STARTED|Initial Study Design - Interim Analysis||81
563893|NCT00650078|1376215|P2|NOT COMPLETED|Overall Study||13
563894|NCT00650078|1376216|P1|NOT COMPLETED|Overall Study||14
563895|NCT00650078|1376215|P2|COMPLETED|Overall Study||106
563896|NCT00650078|1376216|P1|COMPLETED|Overall Study||217
563897|NCT00650078|1376215|P2|STARTED|Overall Study||119
563898|NCT00650078|1376216|P1|STARTED|Overall Study||231
563899|NCT00649961|1376224|P1|NOT COMPLETED|Overall Study||0
563900|NCT00649961|1376224|P1|COMPLETED|Overall Study||18
563901|NCT00649961|1376224|P1|STARTED|Overall Study||18
563902|NCT00649792|1376228|P1|NOT COMPLETED|Overall Study||68
563903|NCT00649792|1376228|P1|COMPLETED|Overall Study||146
563904|NCT00649792|1376228|P1|STARTED|Overall Study||214
563905|NCT00649428|1376238|P2|NOT COMPLETED|Overall Study||15
563906|NCT00649428|1376239|P1|NOT COMPLETED|Overall Study||20
563907|NCT00649428|1376238|P2|COMPLETED|Overall Study||88
563908|NCT00649428|1376239|P1|COMPLETED|Overall Study||80
563909|NCT00649428|1376238|P2|STARTED|Overall Study||103
563910|NCT00649428|1376239|P1|STARTED|Overall Study||100
563911|NCT00649389|1376255|P4|NOT COMPLETED|Overall Study||111
563912|NCT00649389|1376256|P3|NOT COMPLETED|Overall Study||88
563913|NCT00649389|1376257|P2|NOT COMPLETED|Overall Study||106
563914|NCT00649389|1376258|P1|NOT COMPLETED|Overall Study||71
563915|NCT00649389|1376255|P4|COMPLETED|Overall Study||516
563916|NCT00649389|1376256|P3|COMPLETED|Overall Study||512
563917|NCT00649389|1376257|P2|COMPLETED|Overall Study||531
563918|NCT00649389|1376258|P1|COMPLETED|Overall Study||557
563919|NCT00649389|1376255|P4|STARTED|Overall Study||627
563920|NCT00649389|1376256|P3|STARTED|Overall Study||600
563921|NCT00649389|1376257|P2|STARTED|Overall Study||637
563922|NCT00649389|1376258|P1|STARTED|Overall Study||628
563923|NCT00649220|1376280|P1|NOT COMPLETED|Overall Study||3
563924|NCT00649220|1376280|P1|COMPLETED|Overall Study||16
563925|NCT00649220|1376280|P1|STARTED|Overall Study||19
563926|NCT00648908|1376291|P1|NOT COMPLETED|Overall Study||115
563927|NCT00648908|1376291|P1|COMPLETED|Overall Study||154
563928|NCT00648908|1376291|P1|STARTED|Overall Study||269
563929|NCT00648895|1376301|P2|NOT COMPLETED|Overall Study||1
563930|NCT00648895|1376302|P1|NOT COMPLETED|Overall Study||0
563931|NCT00648895|1376301|P2|COMPLETED|Overall Study||5
563932|NCT00648895|1376302|P1|COMPLETED|Overall Study||6
563933|NCT00648895|1376301|P2|STARTED|Overall Study||6
563934|NCT00648895|1376302|P1|STARTED|Overall Study||6
563935|NCT00648167|1376308|P1|NOT COMPLETED|Overall Study||7
563936|NCT00648167|1376308|P1|COMPLETED|Overall Study||48
563937|NCT00648167|1376308|P1|Start Dose 6 g/Day|Overall Study||21
563938|NCT00648167|1376308|P1|Start Dose 4.5 g/Day|Overall Study||34
563939|NCT00648167|1376308|P1|STARTED|Overall Study||55
563940|NCT00648115|1376315|P3|NOT COMPLETED|Overall Study||0
563941|NCT00648115|1376316|P2|NOT COMPLETED|Overall Study||0
563942|NCT00648115|1376317|P1|NOT COMPLETED|Overall Study||0
563943|NCT00648115|1376315|P3|COMPLETED|Overall Study||27
563944|NCT00648115|1376316|P2|COMPLETED|Overall Study||42
563945|NCT00648115|1376317|P1|COMPLETED|Overall Study||42
563946|NCT00648115|1376315|P3|STARTED|Overall Study||27
563947|NCT00648115|1376316|P2|STARTED|Overall Study||42
563948|NCT00648115|1376317|P1|STARTED|Overall Study||42
563949|NCT00648037|1376328|P1|NOT COMPLETED|Overall Study||16
563950|NCT00648037|1376328|P1|COMPLETED|Overall Study||10
563951|NCT00648037|1376328|P1|STARTED|Overall Study||26
563952|NCT00647998|1376334|P2|NOT COMPLETED|Overall Study||0
563953|NCT00647998|1376335|P1|NOT COMPLETED|Overall Study||0
563954|NCT00647998|1376334|P2|COMPLETED|Overall Study||9
563955|NCT00647998|1376335|P1|COMPLETED|Overall Study||9
563956|NCT00647998|1376334|P2|STARTED|Overall Study||9
563957|NCT00647998|1376335|P1|STARTED|Overall Study||9
563958|NCT00647699|1376347|P2|NOT COMPLETED|Overall Study||12
563959|NCT00647699|1376348|P1|NOT COMPLETED|Overall Study||8
563960|NCT00647699|1376347|P2|COMPLETED|Overall Study||62
563961|NCT00647699|1376348|P1|COMPLETED|Overall Study||65
563962|NCT00647699|1376347|P2|STARTED|Overall Study||74
563963|NCT00647699|1376348|P1|STARTED|Overall Study||73
563964|NCT00647556|1376356|P2|NOT COMPLETED|Overall Study||2
563965|NCT00647556|1376357|P1|NOT COMPLETED|Overall Study||3
563966|NCT00647556|1376356|P2|COMPLETED|Overall Study||13
563967|NCT00647556|1376357|P1|COMPLETED|Overall Study||12
563968|NCT00647556|1376356|P2|STARTED|Overall Study||15
563969|NCT00647556|1376357|P1|STARTED|Overall Study||15
563970|NCT00647400|1376373|P2|NOT COMPLETED|Overall Study||13
563971|NCT00647400|1376374|P1|NOT COMPLETED|Overall Study||22
563972|NCT00647400|1376373|P2|COMPLETED|Overall Study||45
563973|NCT00647400|1376374|P1|COMPLETED|Overall Study||67
563974|NCT00647400|1376373|P2|STARTED|Overall Study||58
563975|NCT00647400|1376374|P1|STARTED|Overall Study||89
563976|NCT00647270|1376387|P3|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||7
563977|NCT00647270|1376388|P2|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||9
563978|NCT00647270|1376389|P1|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||3
563979|NCT00647270|1376387|P3|COMPLETED|Period 2, Placebo Switched to Adalimumab||175
563980|NCT00647270|1376388|P2|COMPLETED|Period 2, Placebo Switched to Adalimumab||137
563981|NCT00647270|1376389|P1|COMPLETED|Period 2, Placebo Switched to Adalimumab||45
563982|NCT00647270|1376387|P3|STARTED|Period 2, Placebo Switched to Adalimumab||182
563983|NCT00647270|1376388|P2|STARTED|Period 2, Placebo Switched to Adalimumab||146
563984|NCT00647270|1376389|P1|STARTED|Period 2, Placebo Switched to Adalimumab|Placebo subjects in Period 1 received adalimumab 40 mg eow in Period 2|48
563985|NCT00647270|1376387|P3|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||23
563986|NCT00647270|1376388|P2|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||13
563987|NCT00647270|1376389|P1|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||8
563988|NCT00647270|1376387|P3|COMPLETED|Period 1, Placebo-control (12 Weeks)||182
563989|NCT00647270|1376388|P2|COMPLETED|Period 1, Placebo-control (12 Weeks)||146
563990|NCT00647270|1376389|P1|COMPLETED|Period 1, Placebo-control (12 Weeks)||48
563991|NCT00647270|1376387|P3|STARTED|Period 1, Placebo-control (12 Weeks)||205
563992|NCT00647270|1376388|P2|STARTED|Period 1, Placebo-control (12 Weeks)||159
563993|NCT00647270|1376389|P1|STARTED|Period 1, Placebo-control (12 Weeks)|Placebo subjects in Period 1 received adalimumab 40 mg every other week in Period 2.|56
563994|NCT00646958|1376415|P3|NOT COMPLETED|Overall Study||9
563995|NCT00646958|1376416|P2|NOT COMPLETED|Overall Study||9
563996|NCT00646958|1376417|P1|NOT COMPLETED|Overall Study||11
563997|NCT00646958|1376415|P3|COMPLETED|Overall Study||40
563998|NCT00646958|1376416|P2|COMPLETED|Overall Study||41
563999|NCT00646958|1376417|P1|COMPLETED|Overall Study||40
564000|NCT00646958|1376415|P3|STARTED|Overall Study|No. Participants Randomized|49
564001|NCT00646958|1376416|P2|STARTED|Overall Study|No. Participants Randomized|50
564002|NCT00646958|1376417|P1|STARTED|Overall Study|Number (No.) Participants Randomized|51
564003|NCT00646776|1376430|P2|NOT COMPLETED|Overall Study||13
564004|NCT00646776|1376431|P1|NOT COMPLETED|Overall Study||1
564005|NCT00646776|1376430|P2|COMPLETED|Overall Study||5
564006|NCT00646776|1376431|P1|COMPLETED|Overall Study||14
564007|NCT00646776|1376430|P2|STARTED|Overall Study|Treated on Day 1|18
564008|NCT00646776|1376431|P1|STARTED|Overall Study|Treated on Day 1|15
564009|NCT00646763|1376480|P2|NOT COMPLETED|Overall Study||0
564010|NCT00646763|1376481|P1|NOT COMPLETED|Overall Study||0
564011|NCT00646763|1376480|P2|COMPLETED|Overall Study||17
564012|NCT00646763|1376481|P1|COMPLETED|Overall Study||18
564013|NCT00646763|1376480|P2|STARTED|Overall Study||17
564014|NCT00646763|1376481|P1|STARTED|Overall Study||18
564015|NCT00646646|1376495|P4|NOT COMPLETED|Overall Study||0
564016|NCT00646646|1376496|P3|NOT COMPLETED|Overall Study||0
564017|NCT00646646|1376497|P2|NOT COMPLETED|Overall Study||0
564018|NCT00646646|1376498|P1|NOT COMPLETED|Overall Study||0
564019|NCT00646646|1376495|P4|COMPLETED|Overall Study||20
564020|NCT00646646|1376496|P3|COMPLETED|Overall Study||15
564021|NCT00646646|1376497|P2|COMPLETED|Overall Study||15
564022|NCT00646646|1376498|P1|COMPLETED|Overall Study||15
564023|NCT00646646|1376495|P4|STARTED|Overall Study||20
564024|NCT00646646|1376496|P3|STARTED|Overall Study||15
564025|NCT00646646|1376497|P2|STARTED|Overall Study||15
564026|NCT00646646|1376498|P1|STARTED|Overall Study||15
564027|NCT00646581|1376510|P2|NOT COMPLETED|Overall Study||0
564028|NCT00646581|1376511|P1|NOT COMPLETED|Overall Study||0
564029|NCT00646581|1376510|P2|COMPLETED|Overall Study||15
564030|NCT00646581|1376511|P1|COMPLETED|Overall Study||15
564031|NCT00646581|1376510|P2|STARTED|Overall Study||15
564032|NCT00646581|1376511|P1|STARTED|Overall Study||15
564033|NCT00646399|1376529|P2|NOT COMPLETED|Overall Study||74
564034|NCT00646399|1376530|P1|NOT COMPLETED|Overall Study||83
564035|NCT00646399|1376529|P2|COMPLETED|Overall Study||713
564036|NCT00646399|1376530|P1|COMPLETED|Overall Study||709
564037|NCT00646399|1376529|P2|STARTED|Overall Study||787
564038|NCT00646399|1376530|P1|STARTED|Overall Study||792
564039|NCT00646282|1376538|P2|NOT COMPLETED|Overall Study||4
564040|NCT00646282|1376539|P1|NOT COMPLETED|Overall Study||4
564041|NCT00646282|1376538|P2|COMPLETED|Overall Study||0
564042|NCT00646282|1376539|P1|COMPLETED|Overall Study||0
564043|NCT00646282|1376538|P2|STARTED|Overall Study||4
564044|NCT00646282|1376539|P1|STARTED|Overall Study||4
564045|NCT00646048|1376545|P1|NOT COMPLETED|Overall Study||16
564046|NCT00646048|1376545|P1|COMPLETED|Overall Study||27
564047|NCT00646048|1376545|P1|STARTED|Overall Study||43
564048|NCT00645970|1376553|P2|NOT COMPLETED|Overall Study||186
564049|NCT00645970|1376554|P1|NOT COMPLETED|Overall Study||109
564050|NCT00645970|1376553|P2|COMPLETED|Overall Study||32
564051|NCT00645970|1376554|P1|COMPLETED|Overall Study||32
564052|NCT00645970|1376553|P2|1 Year|Overall Study||42
564053|NCT00645970|1376554|P1|1 Year|Overall Study||37
564054|NCT00645970|1376553|P2|6 Months|Overall Study||97
564055|NCT00645970|1376554|P1|6 Months|Overall Study||58
564056|NCT00645970|1376553|P2|STARTED|Overall Study||218
564057|NCT00645970|1376554|P1|STARTED|Overall Study||141
564058|NCT00645944|1376562|P2|NOT COMPLETED|Received Medication||3
564059|NCT00645944|1376563|P1|NOT COMPLETED|Received Medication||6
564060|NCT00645944|1376562|P2|COMPLETED|Received Medication||14
564061|NCT00645944|1376563|P1|COMPLETED|Received Medication||13
564062|NCT00645944|1376562|P2|STARTED|Received Medication||17
564063|NCT00645944|1376563|P1|STARTED|Received Medication||19
564064|NCT00645944|1376562|P2|NOT COMPLETED|Randomized||2
564065|NCT00645944|1376563|P1|NOT COMPLETED|Randomized||1
564066|NCT00645944|1376562|P2|COMPLETED|Randomized||17
564067|NCT00645944|1376563|P1|COMPLETED|Randomized||19
564068|NCT00645944|1376562|P2|STARTED|Randomized||19
564069|NCT00645944|1376563|P1|STARTED|Randomized||20
564070|NCT00645853|1376571|P2|NOT COMPLETED|Overall Study||57
564071|NCT00645853|1376572|P1|NOT COMPLETED|Overall Study||92
564072|NCT00645853|1376571|P2|COMPLETED|Overall Study||178
564073|NCT00645853|1376572|P1|COMPLETED|Overall Study||196
564074|NCT00645853|1376571|P2|AZ Study Closure in Hungary|Overall Study||40
564075|NCT00645853|1376572|P1|AZ Study Closure in Hungary|Overall Study||60
564076|NCT00645853|1376571|P2|Discontinued Patient No Due to Closure|Overall Study|No of patients discontinued due the study termination caused tablet formulation stability problems|178
564077|NCT00645853|1376572|P1|Discontinued Patient No Due to Closure|Overall Study|No of patients discontinued due the study termination caused tablet formulation stability problems|196
564078|NCT00645853|1376571|P2|No of Patients After Dose Switch|Overall Study|No changes for VKA patients|188
564079|NCT00645853|1376572|P1|No of Patients After Dose Switch|Overall Study|All patients in the AZD0837 arm switched from their initial doses, to a general dose of 300 mg od|209
564080|NCT00645853|1376571|P2|STARTED|Overall Study||235
564081|NCT00645853|1376572|P1|STARTED|Overall Study||288
564082|NCT00645827|1376592|P2|NOT COMPLETED|Overall Study||0
564083|NCT00645827|1376593|P1|NOT COMPLETED|Overall Study||0
564084|NCT00645827|1376592|P2|COMPLETED|Overall Study||17
564085|NCT00645827|1376593|P1|COMPLETED|Overall Study||14
564086|NCT00645827|1376592|P2|STARTED|Overall Study||17
564087|NCT00645827|1376593|P1|STARTED|Overall Study||14
564088|NCT00645788|1376603|P4|NOT COMPLETED|Overall Study||14
564089|NCT00645788|1376604|P3|NOT COMPLETED|Overall Study||18
564090|NCT00645788|1376605|P2|NOT COMPLETED|Overall Study||27
564091|NCT00645788|1376606|P1|NOT COMPLETED|Overall Study||20
564092|NCT00645788|1376603|P4|COMPLETED|Overall Study||21
564093|NCT00645788|1376604|P3|COMPLETED|Overall Study||47
564094|NCT00645788|1376605|P2|COMPLETED|Overall Study||67
564095|NCT00645788|1376606|P1|COMPLETED|Overall Study||74
564096|NCT00645788|1376603|P4|Participants Receive Treatment|Overall Study||35
564097|NCT00645788|1376604|P3|Participants Receive Treatment|Overall Study||65
564098|NCT00645788|1376605|P2|Participants Receive Treatment|Overall Study||93
564099|NCT00645788|1376606|P1|Participants Receive Treatment|Overall Study||93
564100|NCT00645788|1376603|P4|STARTED|Overall Study||35
564101|NCT00645788|1376604|P3|STARTED|Overall Study||65
564102|NCT00645788|1376605|P2|STARTED|Overall Study||94
564103|NCT00645788|1376606|P1|STARTED|Overall Study||94
564104|NCT00645762|1376656|P1|NOT COMPLETED|Overall Study||4
564105|NCT00645762|1376656|P1|COMPLETED|Overall Study||67
564106|NCT00645762|1376656|P1|STARTED|Overall Study||71
564107|NCT00645671|1376664|P2|NOT COMPLETED|Overall Study||6
564108|NCT00645671|1376665|P1|NOT COMPLETED|Overall Study||1
564109|NCT00645671|1376664|P2|COMPLETED|Overall Study||193
564110|NCT00645671|1376665|P1|COMPLETED|Overall Study||200
564111|NCT00645671|1376664|P2|STARTED|Overall Study||199
564112|NCT00645671|1376665|P1|STARTED|Overall Study||201
564113|NCT00645593|1376679|P2|NOT COMPLETED|Overall Study||0
564114|NCT00645593|1376680|P1|NOT COMPLETED|Overall Study||1
564115|NCT00645593|1376679|P2|COMPLETED|Overall Study||60
564116|NCT00645593|1376680|P1|COMPLETED|Overall Study||28
564117|NCT00645593|1376679|P2|STARTED|Overall Study||60
564118|NCT00645593|1376680|P1|STARTED|Overall Study||29
564119|NCT00645567|1376692|P1|NOT COMPLETED|Overall Study||1
564120|NCT00645567|1376692|P1|COMPLETED|Overall Study|One individual provided consent & was dropped due to an unrelated injury to his hand at his home.|4
564121|NCT00645567|1376692|P1|STARTED|Overall Study||5
564122|NCT00645528|1376700|P1|NOT COMPLETED|Overall Study||7
564123|NCT00645528|1376700|P1|COMPLETED|Overall Study||32
564124|NCT00645528|1376700|P1|STARTED|Overall Study||39
564125|NCT00645411|1376713|P4|NOT COMPLETED|Overall Study||103
564126|NCT00645411|1376714|P3|NOT COMPLETED|Overall Study||151
564127|NCT00645411|1376715|P2|NOT COMPLETED|Overall Study||6
564128|NCT00645411|1376716|P1|NOT COMPLETED|Overall Study||13
564129|NCT00645411|1376713|P4|COMPLETED|Overall Study||919
564130|NCT00645411|1376714|P3|COMPLETED|Overall Study||1457
564131|NCT00645411|1376715|P2|COMPLETED|Overall Study||312
564132|NCT00645411|1376716|P1|COMPLETED|Overall Study||643
564133|NCT00645411|1376713|P4|STARTED|Overall Study||1022
564134|NCT00645411|1376714|P3|STARTED|Overall Study||1608
564135|NCT00645411|1376715|P2|STARTED|Overall Study||318
564136|NCT00645411|1376716|P1|STARTED|Overall Study||656
564137|NCT00645359|1376748|P1|NOT COMPLETED|Overall Study||0
564138|NCT00645359|1376748|P1|COMPLETED|Overall Study||9
564139|NCT00645359|1376748|P1|STARTED|Overall Study||9
564140|NCT00645333|1376753|P1|NOT COMPLETED|Overall Study||0
564141|NCT00645333|1376753|P1|COMPLETED|Overall Study||30
564142|NCT00645333|1376753|P1|STARTED|Overall Study||30
564143|NCT00645164|1376758|P1|NOT COMPLETED|Overall Study||7
564144|NCT00645164|1376758|P1|COMPLETED|Overall Study||52
564145|NCT00645164|1376758|P1|STARTED|Overall Study||59
564146|NCT00645099|1376764|P2|NOT COMPLETED|Overall Study||42
564147|NCT00645099|1376765|P1|NOT COMPLETED|Overall Study||71
564148|NCT00645099|1376764|P2|COMPLETED|Overall Study||178
564149|NCT00645099|1376765|P1|COMPLETED|Overall Study||168
564150|NCT00645099|1376764|P2|STARTED|Overall Study||220
564151|NCT00645099|1376765|P1|STARTED|Overall Study||239
564152|NCT00645047|1376809|P2|NOT COMPLETED|Overall Study||39
564153|NCT00645047|1376810|P1|NOT COMPLETED|Overall Study||43
564154|NCT00645047|1376809|P2|COMPLETED|Overall Study||65
564155|NCT00645047|1376810|P1|COMPLETED|Overall Study|6 month follow up|60
564156|NCT00645047|1376809|P2|Post|Overall Study||80
564157|NCT00645047|1376810|P1|Post|Overall Study||74
564158|NCT00645047|1376809|P2|STARTED|Overall Study||104
564159|NCT00645047|1376810|P1|STARTED|Overall Study||103
564160|NCT00644995|1376834|P2|NOT COMPLETED|Overall Study||4
564161|NCT00644995|1376835|P1|NOT COMPLETED|Overall Study||2
564162|NCT00644995|1376834|P2|COMPLETED|Overall Study||23
564163|NCT00644995|1376835|P1|COMPLETED|Overall Study|Completed 6 month assessment|23
564164|NCT00644995|1376834|P2|Completed 4 Month Assessment|Overall Study||24
564165|NCT00644995|1376835|P1|Completed 4 Month Assessment|Overall Study||23
564166|NCT00644995|1376834|P2|STARTED|Overall Study||27
564167|NCT00644995|1376835|P1|STARTED|Overall Study||25
564168|NCT00644969|1376855|P2|NOT COMPLETED|Post Treatment Phase||3
564169|NCT00644969|1376856|P1|NOT COMPLETED|Post Treatment Phase||10
564170|NCT00644969|1376855|P2|COMPLETED|Post Treatment Phase||37
564171|NCT00644969|1376856|P1|COMPLETED|Post Treatment Phase||61
564172|NCT00644969|1376855|P2|STARTED|Post Treatment Phase||40
564173|NCT00644969|1376856|P1|STARTED|Post Treatment Phase||71
564174|NCT00644969|1376855|P2|NOT COMPLETED|Treatment Phase||3
564175|NCT00644969|1376856|P1|NOT COMPLETED|Treatment Phase||14
564176|NCT00644969|1376855|P2|COMPLETED|Treatment Phase||40
564177|NCT00644969|1376856|P1|COMPLETED|Treatment Phase||71
564178|NCT00644969|1376855|P2|STARTED|Treatment Phase||43
564179|NCT00644969|1376856|P1|STARTED|Treatment Phase||85
564180|NCT00644917|1376902|P1|NOT COMPLETED|Overall Study||2
564181|NCT00644917|1376902|P1|COMPLETED|Overall Study||36
564182|NCT00644917|1376902|P1|STARTED|Overall Study||38
564183|NCT00644787|1376910|P3|NOT COMPLETED|Period 2: Double Blind Phase||7
564184|NCT00644787|1376911|P2|NOT COMPLETED|Period 2: Double Blind Phase||9
564185|NCT00644787|1376912|P1|NOT COMPLETED|Period 2: Double Blind Phase||0
564186|NCT00644787|1376910|P3|COMPLETED|Period 2: Double Blind Phase||55
564187|NCT00644787|1376911|P2|COMPLETED|Period 2: Double Blind Phase||49
564188|NCT00644787|1376912|P1|COMPLETED|Period 2: Double Blind Phase||0
564189|NCT00644787|1376910|P3|STARTED|Period 2: Double Blind Phase||62
564190|NCT00644787|1376911|P2|STARTED|Period 2: Double Blind Phase||58
564191|NCT00644787|1376912|P1|STARTED|Period 2: Double Blind Phase||0
564192|NCT00644787|1376910|P3|NOT COMPLETED|Period 1: Titration Phase||0
564193|NCT00644787|1376911|P2|NOT COMPLETED|Period 1: Titration Phase||0
564194|NCT00644787|1376912|P1|NOT COMPLETED|Period 1: Titration Phase||27
564195|NCT00644787|1376910|P3|COMPLETED|Period 1: Titration Phase||0
564196|NCT00644787|1376911|P2|COMPLETED|Period 1: Titration Phase||0
564197|NCT00644787|1376912|P1|COMPLETED|Period 1: Titration Phase||129
564198|NCT00644787|1376910|P3|STARTED|Period 1: Titration Phase||0
564199|NCT00644787|1376911|P2|STARTED|Period 1: Titration Phase||0
564200|NCT00644787|1376912|P1|STARTED|Period 1: Titration Phase||156
564201|NCT00644657|1376940|P1|NOT COMPLETED|Overall Study||0
564202|NCT00644657|1376940|P1|COMPLETED|Overall Study||27
564203|NCT00644657|1376940|P1|STARTED|Overall Study||27
564204|NCT00644592|1376947|P2|NOT COMPLETED|Overall Study||0
564205|NCT00644592|1376948|P1|NOT COMPLETED|Overall Study||0
564206|NCT00644592|1376947|P2|COMPLETED|Overall Study||6
564207|NCT00644592|1376948|P1|COMPLETED|Overall Study||5
564208|NCT00644592|1376947|P2|STARTED|Overall Study||6
564209|NCT00644592|1376948|P1|STARTED|Overall Study||5
564210|NCT00644358|1376954|P1|NOT COMPLETED|Overall Study||362
564211|NCT00644358|1376954|P1|COMPLETED|Overall Study||254
564212|NCT00644358|1376954|P1|STARTED|Overall Study||616
564213|NCT00644332|1376961|P1|NOT COMPLETED|Overall Study||21
564214|NCT00644332|1376961|P1|COMPLETED|Overall Study||150
564215|NCT00644332|1376961|P1|STARTED|Overall Study|172 patients were enrolled; one withdrew consent prior to starting treatment|171
564216|NCT00644280|1376976|P2|NOT COMPLETED|Overall Study||0
564217|NCT00644280|1376977|P1|NOT COMPLETED|Overall Study||0
564218|NCT00644280|1376976|P2|COMPLETED|Overall Study||5
564219|NCT00644280|1376977|P1|COMPLETED|Overall Study||6
564220|NCT00644280|1376976|P2|STARTED|Overall Study||5
564221|NCT00644280|1376977|P1|STARTED|Overall Study||6
564222|NCT00644228|1376987|P2|NOT COMPLETED|Maintenance||135
564223|NCT00644228|1376988|P1|NOT COMPLETED|Maintenance||143
564224|NCT00644228|1376987|P2|COMPLETED|Maintenance||0
564225|NCT00644228|1376988|P1|COMPLETED|Maintenance||0
564226|NCT00644228|1376987|P2|STARTED|Maintenance|2 patients who completed induction did not continue on to maintenance due to other (2).|135
564227|NCT00644228|1376988|P1|STARTED|Maintenance|3 patients who completed induction did not continue on to maintenance due to refusal (1), other (2).|143
564228|NCT00644228|1376987|P2|NOT COMPLETED|Induction Therapy||105
564229|NCT00644228|1376988|P1|NOT COMPLETED|Induction Therapy||83
564230|NCT00644228|1376987|P2|COMPLETED|Induction Therapy||137
564231|NCT00644228|1376988|P1|COMPLETED|Induction Therapy||146
564232|NCT00644228|1376987|P2|STARTED|Induction Therapy||242
564233|NCT00644228|1376988|P1|STARTED|Induction Therapy||229
564234|NCT00644228|1376987|P2|NOT COMPLETED|Randomization & Eligibility||22
564235|NCT00644228|1376988|P1|NOT COMPLETED|Randomization & Eligibility||32
564236|NCT00644228|1376987|P2|COMPLETED|Randomization & Eligibility||242
564237|NCT00644228|1376988|P1|COMPLETED|Randomization & Eligibility||229
564238|NCT00644228|1376987|P2|Eligible and Analyzable|Randomization & Eligibility||242
564239|NCT00644228|1376988|P1|Eligible and Analyzable|Randomization & Eligibility||229
564240|NCT00644228|1376987|P2|STARTED|Randomization & Eligibility||264
564241|NCT00644228|1376988|P1|STARTED|Randomization & Eligibility||261
564242|NCT00644189|1376998|P4|NOT COMPLETED|Phase II||0
564243|NCT00644189|1376999|P3|NOT COMPLETED|Phase II||0
564244|NCT00644189|1377000|P2|NOT COMPLETED|Phase II||0
564245|NCT00644189|1377001|P1|NOT COMPLETED|Phase II||0
564246|NCT00644189|1376998|P4|COMPLETED|Phase II||50
564247|NCT00644189|1376999|P3|COMPLETED|Phase II||0
564248|NCT00644189|1377000|P2|COMPLETED|Phase II||0
564249|NCT00644189|1377001|P1|COMPLETED|Phase II||0
564250|NCT00644189|1376998|P4|Completed All 6 Cycles of Treatment|Phase II||19
564251|NCT00644189|1376999|P3|Completed All 6 Cycles of Treatment|Phase II||0
564252|NCT00644189|1377000|P2|Completed All 6 Cycles of Treatment|Phase II||0
564253|NCT00644189|1377001|P1|Completed All 6 Cycles of Treatment|Phase II||0
564254|NCT00644189|1376998|P4|STARTED|Phase II|Additional participants were added to the phase I sample at the phase II 3mg dose level|50
564255|NCT00644189|1376999|P3|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
564256|NCT00644189|1377000|P2|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
564257|NCT00644189|1377001|P1|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
564258|NCT00644189|1376998|P4|NOT COMPLETED|Phase I||0
564259|NCT00644189|1376999|P3|NOT COMPLETED|Phase I||0
564260|NCT00644189|1377000|P2|NOT COMPLETED|Phase I||0
564261|NCT00644189|1377001|P1|NOT COMPLETED|Phase I||0
564262|NCT00644189|1376998|P4|COMPLETED|Phase I||18
564263|NCT00644189|1376999|P3|COMPLETED|Phase I||6
564264|NCT00644189|1377000|P2|COMPLETED|Phase I||3
564265|NCT00644189|1377001|P1|COMPLETED|Phase I||3
564266|NCT00644189|1376998|P4|STARTED|Phase I||18
564267|NCT00644189|1376999|P3|STARTED|Phase I||6
564268|NCT00644189|1377000|P2|STARTED|Phase I||3
564269|NCT00644189|1377001|P1|STARTED|Phase I||3
564270|NCT00644059|1377017|P3|NOT COMPLETED|Overall Study||65
564271|NCT00644059|1377018|P2|NOT COMPLETED|Overall Study||123
564272|NCT00644059|1377019|P1|NOT COMPLETED|Overall Study||124
564273|NCT00644059|1377017|P3|COMPLETED|Overall Study||969
564274|NCT00644059|1377018|P2|COMPLETED|Overall Study||1726
564275|NCT00644059|1377019|P1|COMPLETED|Overall Study||1895
564276|NCT00644059|1377017|P3|STARTED|Overall Study||1034
564277|NCT00644059|1377018|P2|STARTED|Overall Study||1849
564278|NCT00644059|1377019|P1|STARTED|Overall Study||2019
564279|NCT00643916|1377109|P6|NOT COMPLETED|Overall Study||1
564280|NCT00643916|1377110|P5|NOT COMPLETED|Overall Study||2
564281|NCT00643916|1377111|P4|NOT COMPLETED|Overall Study||2
564282|NCT00643916|1377112|P3|NOT COMPLETED|Overall Study||6
564283|NCT00643916|1377113|P2|NOT COMPLETED|Overall Study||6
564284|NCT00643916|1377114|P1|NOT COMPLETED|Overall Study||4
564285|NCT00643916|1377109|P6|COMPLETED|Overall Study||66
564286|NCT00643916|1377110|P5|COMPLETED|Overall Study||57
564287|NCT00643916|1377111|P4|COMPLETED|Overall Study||60
564288|NCT00643916|1377112|P3|COMPLETED|Overall Study||62
564289|NCT00643916|1377113|P2|COMPLETED|Overall Study||61
564290|NCT00643916|1377114|P1|COMPLETED|Overall Study||51
564291|NCT00643916|1377109|P6|STARTED|Overall Study||67
564292|NCT00643916|1377110|P5|STARTED|Overall Study||59
564293|NCT00643916|1377111|P4|STARTED|Overall Study||62
564294|NCT00643916|1377112|P3|STARTED|Overall Study||68
564295|NCT00643916|1377113|P2|STARTED|Overall Study||67
564296|NCT00643916|1377114|P1|STARTED|Overall Study||55
564297|NCT00643851|1377137|P3|NOT COMPLETED|Overall Study||30
564298|NCT00643851|1377138|P2|NOT COMPLETED|Overall Study||33
564299|NCT00643851|1377139|P1|NOT COMPLETED|Overall Study||17
564300|NCT00643851|1377137|P3|COMPLETED|Overall Study||171
564301|NCT00643851|1377138|P2|COMPLETED|Overall Study||170
564302|NCT00643851|1377139|P1|COMPLETED|Overall Study||177
564303|NCT00643851|1377137|P3|STARTED|Overall Study||201
564304|NCT00643851|1377138|P2|STARTED|Overall Study||203
564305|NCT00643851|1377139|P1|STARTED|Overall Study||194
564306|NCT00643760|1377167|P5|NOT COMPLETED|Overall Study||19
564307|NCT00643760|1377168|P4|NOT COMPLETED|Overall Study||38
564308|NCT00643760|1377169|P3|NOT COMPLETED|Overall Study||19
564309|NCT00643760|1377170|P2|NOT COMPLETED|Overall Study||15
564310|NCT00643760|1377171|P1|NOT COMPLETED|Overall Study||30
564311|NCT00643760|1377167|P5|COMPLETED|Overall Study||47
564312|NCT00643760|1377168|P4|COMPLETED|Overall Study||79
564313|NCT00643760|1377169|P3|COMPLETED|Overall Study||37
564314|NCT00643760|1377170|P2|COMPLETED|Overall Study||47
564315|NCT00643760|1377171|P1|COMPLETED|Overall Study||90
564316|NCT00643760|1377167|P5|ITT Population|Overall Study||66
564317|NCT00643760|1377168|P4|ITT Population|Overall Study||116
564318|NCT00643760|1377169|P3|ITT Population|Overall Study||56
564319|NCT00643760|1377170|P2|ITT Population|Overall Study||62
564320|NCT00643760|1377171|P1|ITT Population|Overall Study||120
564321|NCT00643760|1377167|P5|Safety Population/Treated With Drug|Overall Study||66
564322|NCT00643760|1377168|P4|Safety Population/Treated With Drug|Overall Study||116
564323|NCT00643760|1377169|P3|Safety Population/Treated With Drug|Overall Study||56
564324|NCT00643760|1377170|P2|Safety Population/Treated With Drug|Overall Study||62
564325|NCT00643760|1377171|P1|Safety Population/Treated With Drug|Overall Study||120
564326|NCT00643760|1377167|P5|STARTED|Overall Study||66
564327|NCT00643760|1377168|P4|STARTED|Overall Study||117
564328|NCT00643760|1377169|P3|STARTED|Overall Study||56
564329|NCT00643760|1377170|P2|STARTED|Overall Study||62
564330|NCT00643760|1377171|P1|STARTED|Overall Study||120
564331|NCT00643682|1377275|P2|NOT COMPLETED|Overall Study||509
564332|NCT00643682|1377276|P1|NOT COMPLETED|Overall Study||522
564333|NCT00643682|1377275|P2|COMPLETED|Overall Study||492
564334|NCT00643682|1377276|P1|COMPLETED|Overall Study||477
564335|NCT00643682|1377275|P2|STARTED|Overall Study||1001
564336|NCT00643682|1377276|P1|STARTED|Overall Study||999
564337|NCT00643604|1377288|P1|NOT COMPLETED|Overall Study||1
564338|NCT00643604|1377288|P1|COMPLETED|Overall Study||6
564339|NCT00643604|1377288|P1|STARTED|Overall Study||7
564340|NCT00643578|1377305|P2|NOT COMPLETED|Overall Study||0
564341|NCT00643578|1377306|P1|NOT COMPLETED|Overall Study||2
564342|NCT00643578|1377305|P2|COMPLETED|Overall Study||6
564343|NCT00643578|1377306|P1|COMPLETED|Overall Study||4
564344|NCT00643578|1377305|P2|STARTED|Overall Study||6
564345|NCT00643578|1377306|P1|STARTED|Overall Study||6
564346|NCT00643565|1377316|P2|NOT COMPLETED|Overall Study||74
564347|NCT00643565|1377317|P1|NOT COMPLETED|Overall Study||80
564348|NCT00643565|1377316|P2|COMPLETED|Overall Study||0
564349|NCT00643565|1377317|P1|COMPLETED|Overall Study||0
564350|NCT00643565|1377316|P2|STARTED|Overall Study||74
564351|NCT00643565|1377317|P1|STARTED|Overall Study||80
564352|NCT00643487|1377339|P1|NOT COMPLETED|Overall Study||3
564353|NCT00643487|1377339|P1|COMPLETED|Overall Study||5
564354|NCT00643487|1377339|P1|STARTED|Overall Study||8
564355|NCT00643448|1377346|P3|NOT COMPLETED|Overall Study||6
564356|NCT00643448|1377347|P2|NOT COMPLETED|Overall Study||5
564357|NCT00643448|1377348|P1|NOT COMPLETED|Overall Study||4
564358|NCT00643448|1377346|P3|COMPLETED|Overall Study||16
564359|NCT00643448|1377347|P2|COMPLETED|Overall Study||17
564360|NCT00643448|1377348|P1|COMPLETED|Overall Study||17
564361|NCT00643448|1377346|P3|STARTED|Overall Study||22
564362|NCT00643448|1377347|P2|STARTED|Overall Study||22
564363|NCT00643448|1377348|P1|STARTED|Overall Study||21
564364|NCT00643201|1377365|P2|NOT COMPLETED|Completed Study Follow Up||79
564365|NCT00643201|1377366|P1|NOT COMPLETED|Completed Study Follow Up||70
564366|NCT00643201|1377365|P2|COMPLETED|Completed Study Follow Up|Of 79 who did not complete follow up: 3 completed treatment, 76 discontinued treatment|2560
564367|NCT00643201|1377366|P1|COMPLETED|Completed Study Follow Up|Of 70 who did not complete follow up: 7 completed treatment; 63 discontinued treatment|2547
564368|NCT00643201|1377365|P2|STARTED|Completed Study Follow Up||2639
564369|NCT00643201|1377366|P1|STARTED|Completed Study Follow Up||2617
564370|NCT00643201|1377365|P2|NOT COMPLETED|Randomized, Completed 6 Months of Study||413
564371|NCT00643201|1377366|P1|NOT COMPLETED|Randomized, Completed 6 Months of Study||377
564372|NCT00643201|1377365|P2|COMPLETED|Randomized, Completed 6 Months of Study||2291
564373|NCT00643201|1377366|P1|COMPLETED|Randomized, Completed 6 Months of Study||2314
564374|NCT00643201|1377365|P2|STARTED|Randomized, Completed 6 Months of Study|15 participants were randomized to treatment but not treated.|2704
564375|NCT00643201|1377366|P1|STARTED|Randomized, Completed 6 Months of Study|15 participants were randomized to treatment but not treated.|2691
564376|NCT00643123|1377414|P2|NOT COMPLETED|Overall Study||1
564377|NCT00643123|1377415|P1|NOT COMPLETED|Overall Study||5
564378|NCT00643123|1377414|P2|COMPLETED|Overall Study||11
564379|NCT00643123|1377415|P1|COMPLETED|Overall Study||10
564380|NCT00643123|1377414|P2|STARTED|Overall Study||12
564381|NCT00643123|1377415|P1|STARTED|Overall Study||15
564382|NCT00643097|1377424|P3|NOT COMPLETED|Overall Study||0
564383|NCT00643097|1377425|P2|NOT COMPLETED|Overall Study||0
564384|NCT00643097|1377426|P1|NOT COMPLETED|Overall Study||0
564385|NCT00643097|1377424|P3|COMPLETED|Overall Study||10
564386|NCT00643097|1377425|P2|COMPLETED|Overall Study||12
564387|NCT00643097|1377426|P1|COMPLETED|Overall Study||18
564388|NCT00643097|1377424|P3|STARTED|Overall Study||10
564389|NCT00643097|1377425|P2|STARTED|Overall Study||12
564390|NCT00643097|1377426|P1|STARTED|Overall Study||18
564391|NCT00643006|1377445|P2|NOT COMPLETED|Overall Study||4
564392|NCT00643006|1377446|P1|NOT COMPLETED|Overall Study||5
564393|NCT00643006|1377445|P2|COMPLETED|Overall Study||29
564394|NCT00643006|1377446|P1|COMPLETED|Overall Study||29
564395|NCT00643006|1377445|P2|STARTED|Overall Study||33
564396|NCT00643006|1377446|P1|STARTED|Overall Study||34
564397|NCT00642993|1377456|P2|NOT COMPLETED|Overall Study||16
564398|NCT00642993|1377457|P1|NOT COMPLETED|Overall Study||106
564399|NCT00642993|1377456|P2|COMPLETED|Overall Study||118
564400|NCT00642993|1377457|P1|COMPLETED|Overall Study||161
564401|NCT00642993|1377456|P2|STARTED|Overall Study||134
564402|NCT00642993|1377457|P1|STARTED|Overall Study||267
564403|NCT00642902|1377475|P4|NOT COMPLETED|Overall Study||40
564404|NCT00642902|1377476|P3|NOT COMPLETED|Overall Study||43
564405|NCT00642902|1377477|P2|NOT COMPLETED|Overall Study||42
564406|NCT00642902|1377478|P1|NOT COMPLETED|Overall Study||40
564407|NCT00642902|1377475|P4|COMPLETED|Overall Study||25
564408|NCT00642902|1377476|P3|COMPLETED|Overall Study||21
564409|NCT00642902|1377477|P2|COMPLETED|Overall Study||21
564410|NCT00642902|1377478|P1|COMPLETED|Overall Study||23
564411|NCT00642902|1377475|P4|Treated|Overall Study||65
564412|NCT00642902|1377476|P3|Treated|Overall Study||63
564413|NCT00642902|1377477|P2|Treated|Overall Study||63
564414|NCT00642902|1377478|P1|Treated|Overall Study||63
564415|NCT00642902|1377475|P4|STARTED|Overall Study||65
564416|NCT00642902|1377476|P3|STARTED|Overall Study||64
564417|NCT00642902|1377477|P2|STARTED|Overall Study||63
564418|NCT00642902|1377478|P1|STARTED|Overall Study||63
564419|NCT00642850|1377500|P1|NOT COMPLETED|Overall Study||33
564420|NCT00642850|1377500|P1|COMPLETED|Overall Study||155
564421|NCT00642850|1377500|P1|STARTED|Overall Study||188
564422|NCT00642811|1377516|P6|NOT COMPLETED|Overall Study||1
564423|NCT00642811|1377517|P5|NOT COMPLETED|Overall Study||1
564424|NCT00642811|1377518|P4|NOT COMPLETED|Overall Study||1
564425|NCT00642811|1377519|P3|NOT COMPLETED|Overall Study||0
564426|NCT00642811|1377520|P2|NOT COMPLETED|Overall Study||4
564427|NCT00642811|1377521|P1|NOT COMPLETED|Overall Study||3
564428|NCT00642811|1377516|P6|COMPLETED|Overall Study||13
564429|NCT00642811|1377517|P5|COMPLETED|Overall Study||13
564430|NCT00642811|1377518|P4|COMPLETED|Overall Study||15
564431|NCT00642811|1377519|P3|COMPLETED|Overall Study||13
564432|NCT00642811|1377520|P2|COMPLETED|Overall Study||17
564433|NCT00642811|1377521|P1|COMPLETED|Overall Study||17
564434|NCT00642811|1377516|P6|STARTED|Overall Study||14
564435|NCT00642811|1377517|P5|STARTED|Overall Study||14
564436|NCT00642811|1377518|P4|STARTED|Overall Study||16
564437|NCT00642811|1377519|P3|STARTED|Overall Study||13
564438|NCT00642811|1377520|P2|STARTED|Overall Study||21
564439|NCT00642811|1377521|P1|STARTED|Overall Study||20
564440|NCT00642772|1377543|P1|NOT COMPLETED|Overall Study||10
564441|NCT00642772|1377543|P1|COMPLETED|Overall Study||14
564442|NCT00642772|1377543|P1|STARTED|Overall Study||24
564443|NCT00642759|1377547|P1|NOT COMPLETED|Overall Study||1
564444|NCT00642759|1377547|P1|COMPLETED|Overall Study||35
564445|NCT00642759|1377547|P1|STARTED|Overall Study||36
564446|NCT00642746|1377556|P2|NOT COMPLETED|Overall Study||0
564447|NCT00642746|1377557|P1|NOT COMPLETED|Overall Study||1
564448|NCT00642746|1377556|P2|COMPLETED|Overall Study||1
564449|NCT00642746|1377557|P1|COMPLETED|Overall Study||9
564450|NCT00642746|1377556|P2|STARTED|Overall Study||1
564451|NCT00642746|1377557|P1|STARTED|Overall Study||10
564452|NCT00642707|1377571|P4|NOT COMPLETED|Overall Study||2
564453|NCT00642707|1377572|P3|NOT COMPLETED|Overall Study||0
564454|NCT00642707|1377573|P2|NOT COMPLETED|Overall Study||0
564455|NCT00642707|1377574|P1|NOT COMPLETED|Overall Study||1
564456|NCT00642707|1377571|P4|COMPLETED|Overall Study||8
564457|NCT00642707|1377572|P3|COMPLETED|Overall Study||12
564458|NCT00642707|1377573|P2|COMPLETED|Overall Study||11
564459|NCT00642707|1377574|P1|COMPLETED|Overall Study||10
564460|NCT00642707|1377571|P4|STARTED|Overall Study||10
564461|NCT00642707|1377572|P3|STARTED|Overall Study||12
564462|NCT00642707|1377573|P2|STARTED|Overall Study||11
564463|NCT00642707|1377574|P1|STARTED|Overall Study||11
564464|NCT00642694|1377586|P2|NOT COMPLETED|Overall Study||4
564465|NCT00642694|1377587|P1|NOT COMPLETED|Overall Study||6
564466|NCT00642694|1377586|P2|COMPLETED|Overall Study||11
564467|NCT00642694|1377587|P1|COMPLETED|Overall Study||8
564468|NCT00642694|1377586|P2|STARTED|Overall Study||15
564469|NCT00642694|1377587|P1|STARTED|Overall Study||14
564470|NCT00642668|1377595|P1|NOT COMPLETED|Overall Study||14
564471|NCT00642668|1377595|P1|COMPLETED|Overall Study||21
564472|NCT00642668|1377595|P1|STARTED|Overall Study||35
564473|NCT00642642|1377603|P1|NOT COMPLETED|Treatment & Follow Up||17
564474|NCT00642642|1377603|P1|COMPLETED|Treatment & Follow Up||92
564475|NCT00642642|1377603|P1|STARTED|Treatment & Follow Up||109
564476|NCT00642642|1377603|P1|NOT COMPLETED|Biopsy & Product Manufacture||13
564477|NCT00642642|1377603|P1|COMPLETED|Biopsy & Product Manufacture|Patients biopsied and for whom study product could be produced are considered completed|109
564478|NCT00642642|1377603|P1|STARTED|Biopsy & Product Manufacture||122
564479|NCT00642616|1377620|P4|NOT COMPLETED|Overall Study||7
564480|NCT00642616|1377621|P3|NOT COMPLETED|Overall Study||9
564481|NCT00642616|1377622|P2|NOT COMPLETED|Overall Study||7
564482|NCT00642616|1377623|P1|NOT COMPLETED|Overall Study||9
564483|NCT00642616|1377620|P4|COMPLETED|Overall Study||1
564484|NCT00642616|1377621|P3|COMPLETED|Overall Study||0
564485|NCT00642616|1377622|P2|COMPLETED|Overall Study||1
564486|NCT00642616|1377623|P1|COMPLETED|Overall Study||0
564487|NCT00642616|1377620|P4|STARTED|Overall Study||8
564488|NCT00642616|1377621|P3|STARTED|Overall Study||9
564489|NCT00642616|1377622|P2|STARTED|Overall Study||8
564490|NCT00642616|1377623|P1|STARTED|Overall Study||9
564491|NCT00642603|1377647|P2|NOT COMPLETED|Overall Study||18
564492|NCT00642603|1377648|P1|NOT COMPLETED|Overall Study||21
564493|NCT00642603|1377647|P2|COMPLETED|Overall Study||2
564494|NCT00642603|1377648|P1|COMPLETED|Overall Study||0
564495|NCT00642603|1377647|P2|Safety Population|Overall Study||20
564496|NCT00642603|1377648|P1|Safety Population|Overall Study||19
564497|NCT00642603|1377647|P2|STARTED|Overall Study||20
564498|NCT00642603|1377648|P1|STARTED|Overall Study||21
564499|NCT00642473|1377656|P2|NOT COMPLETED|Overall Study||11
564500|NCT00642473|1377657|P1|NOT COMPLETED|Overall Study||4
564501|NCT00642473|1377656|P2|COMPLETED|Overall Study||5
564502|NCT00642473|1377657|P1|COMPLETED|Overall Study||14
564503|NCT00642473|1377656|P2|STARTED|Overall Study||16
564504|NCT00642473|1377657|P1|STARTED|Overall Study||18
564505|NCT00642460|1377671|P6|NOT COMPLETED|Part III: Open-Label Up to Week 260||21
564506|NCT00642460|1377672|P5|NOT COMPLETED|Part III: Open-Label Up to Week 260||25
564507|NCT00642460|1377673|P4|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
564508|NCT00642460|1377674|P3|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
564509|NCT00642460|1377675|P2|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
564510|NCT00642460|1377676|P1|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
564511|NCT00642460|1377671|P6|COMPLETED|Part III: Open-Label Up to Week 260||38
564512|NCT00642460|1377672|P5|COMPLETED|Part III: Open-Label Up to Week 260||28
564513|NCT00642460|1377673|P4|COMPLETED|Part III: Open-Label Up to Week 260||0
564514|NCT00642460|1377674|P3|COMPLETED|Part III: Open-Label Up to Week 260||0
564515|NCT00642460|1377675|P2|COMPLETED|Part III: Open-Label Up to Week 260||0
564516|NCT00642460|1377676|P1|COMPLETED|Part III: Open-Label Up to Week 260||0
564517|NCT00642460|1377671|P6|STARTED|Part III: Open-Label Up to Week 260||59
564518|NCT00642460|1377672|P5|STARTED|Part III: Open-Label Up to Week 260||53
564519|NCT00642460|1377673|P4|STARTED|Part III: Open-Label Up to Week 260||0
564520|NCT00642460|1377674|P3|STARTED|Part III: Open-Label Up to Week 260||0
564521|NCT00642460|1377675|P2|STARTED|Part III: Open-Label Up to Week 260||0
564522|NCT00642460|1377676|P1|STARTED|Part III: Open-Label Up to Week 260||0
564523|NCT00642460|1377671|P6|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
564524|NCT00642460|1377672|P5|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
564525|NCT00642460|1377673|P4|NOT COMPLETED|Part II: Open-Label Up to Week 92||3
564526|NCT00642460|1377674|P3|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
564527|NCT00642460|1377675|P2|NOT COMPLETED|Part II: Open-Label Up to Week 92||8
564528|NCT00642460|1377676|P1|NOT COMPLETED|Part II: Open-Label Up to Week 92||9
564529|NCT00642460|1377671|P6|COMPLETED|Part II: Open-Label Up to Week 92||0
564530|NCT00642460|1377672|P5|COMPLETED|Part II: Open-Label Up to Week 92||0
564531|NCT00642460|1377673|P4|COMPLETED|Part II: Open-Label Up to Week 92||17
564532|NCT00642460|1377674|P3|COMPLETED|Part II: Open-Label Up to Week 92||0
564533|NCT00642460|1377675|P2|COMPLETED|Part II: Open-Label Up to Week 92||32
564534|NCT00642460|1377676|P1|COMPLETED|Part II: Open-Label Up to Week 92||43
564535|NCT00642460|1377671|P6|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
564536|NCT00642460|1377672|P5|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
564537|NCT00642460|1377673|P4|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||20
564538|NCT00642460|1377674|P3|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
564539|NCT00642460|1377675|P2|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||40
564540|NCT00642460|1377676|P1|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||52
564541|NCT00642460|1377671|P6|STARTED|Part II: Open-Label Up to Week 92||0
564542|NCT00642460|1377672|P5|STARTED|Part II: Open-Label Up to Week 92||0
564543|NCT00642460|1377673|P4|STARTED|Part II: Open-Label Up to Week 92|19 Participants switched from 12 mg/kg to 8 mg/kg and 1 Participant switched from 8mg/kg to 12 mg/kg|20
564544|NCT00642460|1377674|P3|STARTED|Part II: Open-Label Up to Week 92|Placebo group received open-label Tocilizumab 8 mg/kg or 12 mg/kg based on body weight in Part II.|0
564545|NCT00642460|1377675|P2|STARTED|Part II: Open-Label Up to Week 92||40
564546|NCT00642460|1377676|P1|STARTED|Part II: Open-Label Up to Week 92|Includes Participants who received Open-Label in Part II or Open-Label escape therapy in Part I.|52
564547|NCT00642460|1377671|P6|NOT COMPLETED|Part I: 12 Week Double-Blind||0
564548|NCT00642460|1377672|P5|NOT COMPLETED|Part I: 12 Week Double-Blind||0
564549|NCT00642460|1377673|P4|NOT COMPLETED|Part I: 12 Week Double-Blind||0
564550|NCT00642460|1377674|P3|NOT COMPLETED|Part I: 12 Week Double-Blind||1
564551|NCT00642460|1377675|P2|NOT COMPLETED|Part I: 12 Week Double-Blind||1
564552|NCT00642460|1377676|P1|NOT COMPLETED|Part I: 12 Week Double-Blind||1
564553|NCT00642460|1377671|P6|COMPLETED|Part I: 12 Week Double-Blind||0
564554|NCT00642460|1377672|P5|COMPLETED|Part I: 12 Week Double-Blind||0
564555|NCT00642460|1377673|P4|COMPLETED|Part I: 12 Week Double-Blind||0
564556|NCT00642460|1377674|P3|COMPLETED|Part I: 12 Week Double-Blind||36
564557|NCT00642460|1377675|P2|COMPLETED|Part I: 12 Week Double-Blind||37
564558|NCT00642460|1377676|P1|COMPLETED|Part I: 12 Week Double-Blind||36
564559|NCT00642460|1377671|P6|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
564560|NCT00642460|1377672|P5|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
564561|NCT00642460|1377673|P4|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
564562|NCT00642460|1377674|P3|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37
564563|NCT00642460|1377675|P2|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||38
564564|NCT00642460|1377676|P1|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37
564565|NCT00642460|1377671|P6|STARTED|Part I: 12 Week Double-Blind||0
564566|NCT00642460|1377672|P5|STARTED|Part I: 12 Week Double-Blind||0
564567|NCT00642460|1377673|P4|STARTED|Part I: 12 Week Double-Blind||0
564568|NCT00642460|1377674|P3|STARTED|Part I: 12 Week Double-Blind||37
564569|NCT00642460|1377675|P2|STARTED|Part I: 12 Week Double-Blind||38
564570|NCT00642460|1377676|P1|STARTED|Part I: 12 Week Double-Blind||37
564571|NCT00642382|1377742|P2|NOT COMPLETED|Overall Study||0
564572|NCT00642382|1377743|P1|NOT COMPLETED|Overall Study||0
564573|NCT00642382|1377742|P2|COMPLETED|Overall Study||0
564574|NCT00642382|1377743|P1|COMPLETED|Overall Study||0
564575|NCT00642382|1377742|P2|STARTED|Overall Study||0
564576|NCT00642382|1377743|P1|STARTED|Overall Study||0
564577|NCT00642369|1377751|P2|NOT COMPLETED|Overall Study||6
564578|NCT00642369|1377752|P1|NOT COMPLETED|Overall Study||5
564579|NCT00642369|1377751|P2|COMPLETED|Overall Study||24
564580|NCT00642369|1377752|P1|COMPLETED|Overall Study||25
564581|NCT00642369|1377751|P2|STARTED|Overall Study||30
564582|NCT00642369|1377752|P1|STARTED|Overall Study||30
564583|NCT00642356|1377762|P2|NOT COMPLETED|Overall Study||3
564584|NCT00642356|1377763|P1|NOT COMPLETED|Overall Study||2
564585|NCT00642356|1377762|P2|COMPLETED|Overall Study||4
564586|NCT00642356|1377763|P1|COMPLETED|Overall Study||5
564587|NCT00642356|1377762|P2|STARTED|Overall Study||7
564588|NCT00642356|1377763|P1|STARTED|Overall Study||7
564589|NCT00642304|1377771|P1|NOT COMPLETED|Overall Study||6
564590|NCT00642304|1377771|P1|COMPLETED|Overall Study||14
564591|NCT00642304|1377771|P1|STARTED|Overall Study||20
564592|NCT00642278|1377787|P7|NOT COMPLETED|Overall Study||5
564593|NCT00642278|1377788|P6|NOT COMPLETED|Overall Study||7
564594|NCT00642278|1377789|P5|NOT COMPLETED|Overall Study||8
564595|NCT00642278|1377790|P4|NOT COMPLETED|Overall Study||9
564596|NCT00642278|1377791|P3|NOT COMPLETED|Overall Study||5
564597|NCT00642278|1377792|P2|NOT COMPLETED|Overall Study||5
564598|NCT00642278|1377793|P1|NOT COMPLETED|Overall Study||10
564599|NCT00642278|1377787|P7|COMPLETED|Overall Study||60
564600|NCT00642278|1377788|P6|COMPLETED|Overall Study||57
564601|NCT00642278|1377789|P5|COMPLETED|Overall Study||56
564602|NCT00642278|1377790|P4|COMPLETED|Overall Study||56
564603|NCT00642278|1377791|P3|COMPLETED|Overall Study||59
564604|NCT00642278|1377792|P2|COMPLETED|Overall Study||59
564605|NCT00642278|1377793|P1|COMPLETED|Overall Study||55
564606|NCT00642278|1377787|P7|STARTED|Overall Study||65
564607|NCT00642278|1377788|P6|STARTED|Overall Study||64
564608|NCT00642278|1377789|P5|STARTED|Overall Study||64
564609|NCT00642278|1377790|P4|STARTED|Overall Study||65
564610|NCT00642278|1377791|P3|STARTED|Overall Study||64
564611|NCT00642278|1377792|P2|STARTED|Overall Study||64
564612|NCT00642278|1377793|P1|STARTED|Overall Study||65
564613|NCT00642174|1377846|P2|NOT COMPLETED|Period 2 - Crossover Drug||0
564614|NCT00642174|1377847|P1|NOT COMPLETED|Period 2 - Crossover Drug||0
564615|NCT00642174|1377846|P2|COMPLETED|Period 2 - Crossover Drug||16
564616|NCT00642174|1377847|P1|COMPLETED|Period 2 - Crossover Drug||18
564617|NCT00642174|1377846|P2|STARTED|Period 2 - Crossover Drug||16
564618|NCT00642174|1377847|P1|STARTED|Period 2 - Crossover Drug||18
564619|NCT00642174|1377846|P2|NOT COMPLETED|Period 1 - Initial Drug||1
564620|NCT00642174|1377847|P1|NOT COMPLETED|Period 1 - Initial Drug||0
564621|NCT00642174|1377846|P2|COMPLETED|Period 1 - Initial Drug||16
564622|NCT00642174|1377847|P1|COMPLETED|Period 1 - Initial Drug||18
564623|NCT00642174|1377846|P2|STARTED|Period 1 - Initial Drug||17
564624|NCT00642174|1377847|P1|STARTED|Period 1 - Initial Drug||18
564625|NCT00641862|1377863|P2|NOT COMPLETED|Overall Study||38
564626|NCT00641862|1377864|P1|NOT COMPLETED|Overall Study||44
564627|NCT00641862|1377863|P2|COMPLETED|Overall Study||145
564628|NCT00641862|1377864|P1|COMPLETED|Overall Study||139
564629|NCT00641862|1377863|P2|STARTED|Overall Study||183
564630|NCT00641862|1377864|P1|STARTED|Overall Study||183
564631|NCT00641797|1377872|P2|NOT COMPLETED|Overall Study||0
564632|NCT00641797|1377873|P1|NOT COMPLETED|Overall Study||0
564633|NCT00641797|1377872|P2|COMPLETED|Overall Study||15
564634|NCT00641797|1377873|P1|COMPLETED|Overall Study||11
564635|NCT00641797|1377872|P2|STARTED|Overall Study||15
564636|NCT00641797|1377873|P1|STARTED|Overall Study||11
564637|NCT00641745|1377881|P2|NOT COMPLETED|Overall Study||113
564638|NCT00641745|1377882|P1|NOT COMPLETED|Overall Study||280
564639|NCT00641745|1377881|P2|COMPLETED|Overall Study||89
564640|NCT00641745|1377882|P1|COMPLETED|Overall Study||147
564641|NCT00641745|1377881|P2|STARTED|Overall Study||202
564642|NCT00641745|1377882|P1|STARTED|Overall Study||427
564643|NCT00641719|1377890|P2|NOT COMPLETED|Overall Study||37
564644|NCT00641719|1377891|P1|NOT COMPLETED|Overall Study||30
564645|NCT00641719|1377890|P2|COMPLETED|Overall Study|1 participant discontinued during taper phase, not during treatment phase.|92
564646|NCT00641719|1377891|P1|COMPLETED|Overall Study||99
564647|NCT00641719|1377890|P2|STARTED|Overall Study||129
564648|NCT00641719|1377891|P1|STARTED|Overall Study||129
564649|NCT00641706|1377915|P2|NOT COMPLETED|Overall Study||3
564650|NCT00641706|1377916|P1|NOT COMPLETED|Overall Study||9
564651|NCT00641706|1377915|P2|COMPLETED|Overall Study||4
564652|NCT00641706|1377916|P1|COMPLETED|Overall Study||28
564653|NCT00641706|1377915|P2|STARTED|Overall Study||7
564654|NCT00641706|1377916|P1|STARTED|Overall Study||37
564655|NCT00641667|1377928|P1|NOT COMPLETED|Overall Study||6
564656|NCT00641667|1377928|P1|COMPLETED|Overall Study||60
564657|NCT00641667|1377928|P1|STARTED|Overall Study||66
564658|NCT00641641|1377938|P1|NOT COMPLETED|Overall Study||0
564659|NCT00641641|1377938|P1|COMPLETED|Overall Study||16
564660|NCT00641641|1377938|P1|STARTED|Overall Study||16
564661|NCT00641563|1377942|P2|NOT COMPLETED|Infusion 2||0
564662|NCT00641563|1377943|P1|NOT COMPLETED|Infusion 2||0
564663|NCT00641563|1377942|P2|COMPLETED|Infusion 2||5
564664|NCT00641563|1377943|P1|COMPLETED|Infusion 2||5
564665|NCT00641563|1377942|P2|STARTED|Infusion 2||5
564666|NCT00641563|1377943|P1|STARTED|Infusion 2||5
564667|NCT00641563|1377942|P2|NOT COMPLETED|Infusion 1||0
564668|NCT00641563|1377943|P1|NOT COMPLETED|Infusion 1||0
564669|NCT00641563|1377942|P2|COMPLETED|Infusion 1||5
564670|NCT00641563|1377943|P1|COMPLETED|Infusion 1||5
564671|NCT00641563|1377942|P2|STARTED|Infusion 1||5
564672|NCT00641563|1377943|P1|STARTED|Infusion 1||5
564673|NCT00641537|1377956|P8|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
564674|NCT00641537|1377957|P7|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
564675|NCT00641537|1377958|P6|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
564676|NCT00641537|1377959|P5|NOT COMPLETED|24-Week Supplemental Follow-up Period||5
564677|NCT00641537|1377960|P4|NOT COMPLETED|24-Week Supplemental Follow-up Period||4
564678|NCT00641537|1377961|P3|NOT COMPLETED|24-Week Supplemental Follow-up Period||3
564679|NCT00641537|1377962|P2|NOT COMPLETED|24-Week Supplemental Follow-up Period||3
564680|NCT00641537|1377963|P1|NOT COMPLETED|24-Week Supplemental Follow-up Period||0
564681|NCT00641537|1377956|P8|COMPLETED|24-Week Supplemental Follow-up Period||10
564682|NCT00641537|1377957|P7|COMPLETED|24-Week Supplemental Follow-up Period||8
564683|NCT00641537|1377958|P6|COMPLETED|24-Week Supplemental Follow-up Period||14
564684|NCT00641537|1377959|P5|COMPLETED|24-Week Supplemental Follow-up Period||193
564685|NCT00641537|1377960|P4|COMPLETED|24-Week Supplemental Follow-up Period||147
564686|NCT00641537|1377961|P3|COMPLETED|24-Week Supplemental Follow-up Period||140
564687|NCT00641537|1377962|P2|COMPLETED|24-Week Supplemental Follow-up Period||66
564688|NCT00641537|1377963|P1|COMPLETED|24-Week Supplemental Follow-up Period||75
564689|NCT00641537|1377956|P8|STARTED|24-Week Supplemental Follow-up Period||11
564690|NCT00641537|1377957|P7|STARTED|24-Week Supplemental Follow-up Period||9
564691|NCT00641537|1377958|P6|STARTED|24-Week Supplemental Follow-up Period||15
564692|NCT00641537|1377959|P5|STARTED|24-Week Supplemental Follow-up Period||198
564693|NCT00641537|1377960|P4|STARTED|24-Week Supplemental Follow-up Period||151
564694|NCT00641537|1377961|P3|STARTED|24-Week Supplemental Follow-up Period||143
564695|NCT00641537|1377962|P2|STARTED|24-Week Supplemental Follow-up Period||69
564696|NCT00641537|1377963|P1|STARTED|24-Week Supplemental Follow-up Period||75
564697|NCT00641537|1377956|P8|NOT COMPLETED|96-week Period||6
564698|NCT00641537|1377957|P7|NOT COMPLETED|96-week Period||5
564699|NCT00641537|1377958|P6|NOT COMPLETED|96-week Period||7
564700|NCT00641537|1377959|P5|NOT COMPLETED|96-week Period||18
564701|NCT00641537|1377960|P4|NOT COMPLETED|96-week Period||12
564702|NCT00641537|1377961|P3|NOT COMPLETED|96-week Period||20
564703|NCT00641537|1377962|P2|NOT COMPLETED|96-week Period||10
564704|NCT00641537|1377963|P1|NOT COMPLETED|96-week Period||9
564705|NCT00641537|1377956|P8|COMPLETED|96-week Period||16
564706|NCT00641537|1377957|P7|COMPLETED|96-week Period||12
564707|NCT00641537|1377958|P6|COMPLETED|96-week Period||15
564708|NCT00641537|1377959|P5|COMPLETED|96-week Period||226
564709|NCT00641537|1377960|P4|COMPLETED|96-week Period||174
564710|NCT00641537|1377961|P3|COMPLETED|96-week Period||166
564711|NCT00641537|1377962|P2|COMPLETED|96-week Period||82
564712|NCT00641537|1377963|P1|COMPLETED|96-week Period||89
564713|NCT00641537|1377956|P8|STARTED|96-week Period||22
564714|NCT00641537|1377957|P7|STARTED|96-week Period||17
564715|NCT00641537|1377958|P6|STARTED|96-week Period||22
564716|NCT00641537|1377959|P5|STARTED|96-week Period||244
564717|NCT00641537|1377960|P4|STARTED|96-week Period||186
564718|NCT00641537|1377961|P3|STARTED|96-week Period||186
564719|NCT00641537|1377962|P2|STARTED|96-week Period||92
564720|NCT00641537|1377963|P1|STARTED|96-week Period||98
564721|NCT00641147|1378018|P2|NOT COMPLETED|Completed 16 Months.||0
564722|NCT00641147|1378019|P1|NOT COMPLETED|Completed 16 Months.||2
564723|NCT00641147|1378018|P2|COMPLETED|Completed 16 Months.||19
564724|NCT00641147|1378019|P1|COMPLETED|Completed 16 Months.||13
564725|NCT00641147|1378018|P2|STARTED|Completed 16 Months.||19
564726|NCT00641147|1378019|P1|STARTED|Completed 16 Months.||15
564727|NCT00641147|1378018|P2|NOT COMPLETED|Completed 12 Months.||2
564728|NCT00641147|1378019|P1|NOT COMPLETED|Completed 12 Months.||1
564729|NCT00641147|1378018|P2|COMPLETED|Completed 12 Months.||19
564730|NCT00641147|1378019|P1|COMPLETED|Completed 12 Months.||15
564731|NCT00641147|1378018|P2|STARTED|Completed 12 Months.||21
564732|NCT00641147|1378019|P1|STARTED|Completed 12 Months.||16
564733|NCT00641147|1378018|P2|NOT COMPLETED|Completed 8 Months.||2
564734|NCT00641147|1378019|P1|NOT COMPLETED|Completed 8 Months.||3
564735|NCT00641147|1378018|P2|COMPLETED|Completed 8 Months.||21
564736|NCT00641147|1378019|P1|COMPLETED|Completed 8 Months.||16
564737|NCT00641147|1378018|P2|STARTED|Completed 8 Months.||23
564738|NCT00641147|1378019|P1|STARTED|Completed 8 Months.||19
564739|NCT00641147|1378018|P2|NOT COMPLETED|Completed 4 Months.||0
564740|NCT00641147|1378019|P1|NOT COMPLETED|Completed 4 Months.||2
564741|NCT00641147|1378018|P2|COMPLETED|Completed 4 Months.||23
564742|NCT00641147|1378019|P1|COMPLETED|Completed 4 Months.||19
564743|NCT00641147|1378018|P2|STARTED|Completed 4 Months.||23
564744|NCT00641147|1378019|P1|STARTED|Completed 4 Months.||21
564745|NCT00641056|1378063|P2|NOT COMPLETED|Overall Study||25
564746|NCT00641056|1378064|P1|NOT COMPLETED|Overall Study||29
564747|NCT00641056|1378063|P2|COMPLETED|Overall Study||209
564748|NCT00641056|1378064|P1|COMPLETED|Overall Study||204
564749|NCT00641056|1378063|P2|Intent to Treat (ITT)|Overall Study||223
564750|NCT00641056|1378064|P1|Intent to Treat (ITT)|Overall Study||233
564751|NCT00641056|1378063|P2|STARTED|Overall Study||234
564752|NCT00641056|1378064|P1|STARTED|Overall Study||233
564753|NCT00641043|1378092|P2|NOT COMPLETED|Overall Study||15
564754|NCT00641043|1378093|P1|NOT COMPLETED|Overall Study||19
564755|NCT00641043|1378092|P2|COMPLETED|Overall Study|number who completed treatment|244
564756|NCT00641043|1378093|P1|COMPLETED|Overall Study|number who completed treatment|111
564757|NCT00641043|1378092|P2|STARTED|Overall Study|number who started treatment|259
564758|NCT00641043|1378093|P1|STARTED|Overall Study|number who started treatment|130
564759|NCT00640978|1378123|P1|NOT COMPLETED|Overall Study||0
564760|NCT00640978|1378123|P1|COMPLETED|Overall Study||15
564761|NCT00640978|1378123|P1|STARTED|Overall Study||15
564762|NCT00640926|1378130|P3|NOT COMPLETED|Overall Study||8
564763|NCT00640926|1378131|P2|NOT COMPLETED|Overall Study||6
564764|NCT00640926|1378132|P1|NOT COMPLETED|Overall Study||8
564765|NCT00640926|1378130|P3|COMPLETED|Overall Study||45
564766|NCT00640926|1378131|P2|COMPLETED|Overall Study||46
564767|NCT00640926|1378132|P1|COMPLETED|Overall Study||45
564768|NCT00640926|1378130|P3|STARTED|Overall Study||53
564769|NCT00640926|1378131|P2|STARTED|Overall Study||52
564770|NCT00640926|1378132|P1|STARTED|Overall Study||53
564771|NCT00640835|1378145|P2|NOT COMPLETED|Overall Study||57
564772|NCT00640835|1378146|P1|NOT COMPLETED|Overall Study||76
564773|NCT00640835|1378145|P2|COMPLETED|Overall Study||131
564774|NCT00640835|1378146|P1|COMPLETED|Overall Study||118
564775|NCT00640835|1378145|P2|STARTED|Overall Study||188
564776|NCT00640835|1378146|P1|STARTED|Overall Study||194
564777|NCT00640822|1378157|P3|NOT COMPLETED|Overall Study||25
564778|NCT00640822|1378158|P2|NOT COMPLETED|Overall Study||59
564779|NCT00640822|1378159|P1|NOT COMPLETED|Overall Study||43
564780|NCT00640822|1378157|P3|COMPLETED|Overall Study||77
564781|NCT00640822|1378158|P2|COMPLETED|Overall Study||258
564782|NCT00640822|1378159|P1|COMPLETED|Overall Study||279
564783|NCT00640822|1378157|P3|STARTED|Overall Study||102
564784|NCT00640822|1378158|P2|STARTED|Overall Study||317
564785|NCT00640822|1378159|P1|STARTED|Overall Study||322
564786|NCT00640653|1378172|P5|NOT COMPLETED|Overall Study||5
564787|NCT00640653|1378173|P4|NOT COMPLETED|Overall Study||2
564788|NCT00640653|1378174|P3|NOT COMPLETED|Overall Study||0
564789|NCT00640653|1378175|P2|NOT COMPLETED|Overall Study||3
564790|NCT00640653|1378176|P1|NOT COMPLETED|Overall Study||3
564791|NCT00640653|1378172|P5|COMPLETED|Overall Study||129
564792|NCT00640653|1378173|P4|COMPLETED|Overall Study||132
564793|NCT00640653|1378174|P3|COMPLETED|Overall Study||129
564794|NCT00640653|1378175|P2|COMPLETED|Overall Study||131
564795|NCT00640653|1378176|P1|COMPLETED|Overall Study||128
564796|NCT00640653|1378172|P5|Followed-up at 24 mo|Overall Study||112
564797|NCT00640653|1378173|P4|Followed-up at 24 mo|Overall Study||112
564798|NCT00640653|1378174|P3|Followed-up at 24 mo|Overall Study||105
564799|NCT00640653|1378175|P2|Followed-up at 24 mo|Overall Study||116
564800|NCT00640653|1378176|P1|Followed-up at 24 mo|Overall Study||114
564801|NCT00640653|1378172|P5|Followed-up at 18 mo|Overall Study||117
564802|NCT00640653|1378173|P4|Followed-up at 18 mo|Overall Study||117
564803|NCT00640653|1378174|P3|Followed-up at 18 mo|Overall Study||113
564804|NCT00640653|1378175|P2|Followed-up at 18 mo|Overall Study||112
564805|NCT00640653|1378176|P1|Followed-up at 18 mo|Overall Study||118
564806|NCT00640653|1378172|P5|Followed-up at 12 mo|Overall Study||116
564807|NCT00640653|1378173|P4|Followed-up at 12 mo|Overall Study||122
564808|NCT00640653|1378174|P3|Followed-up at 12 mo|Overall Study||115
564809|NCT00640653|1378175|P2|Followed-up at 12 mo|Overall Study||121
564810|NCT00640653|1378176|P1|Followed-up at 12 mo|Overall Study||124
564811|NCT00640653|1378172|P5|Followed-up at 6 mo|Overall Study||125
564812|NCT00640653|1378173|P4|Followed-up at 6 mo|Overall Study||130
564813|NCT00640653|1378174|P3|Followed-up at 6 mo|Overall Study||124
564814|NCT00640653|1378175|P2|Followed-up at 6 mo|Overall Study||130
564815|NCT00640653|1378176|P1|Followed-up at 6 mo|Overall Study||127
564816|NCT00640653|1378172|P5|Followed-up at 3 mo|Overall Study||126
564817|NCT00640653|1378173|P4|Followed-up at 3 mo|Overall Study||129
564818|NCT00640653|1378174|P3|Followed-up at 3 mo|Overall Study||125
564819|NCT00640653|1378175|P2|Followed-up at 3 mo|Overall Study||127
564820|NCT00640653|1378176|P1|Followed-up at 3 mo|Overall Study||126
564821|NCT00640653|1378172|P5|STARTED|Overall Study||134
564822|NCT00640653|1378173|P4|STARTED|Overall Study||134
564823|NCT00640653|1378174|P3|STARTED|Overall Study||129
564824|NCT00640653|1378175|P2|STARTED|Overall Study||134
564825|NCT00640653|1378176|P1|STARTED|Overall Study||131
564826|NCT00640614|1378210|P2|NOT COMPLETED|Overall Study||0
564827|NCT00640614|1378211|P1|NOT COMPLETED|Overall Study||1
564828|NCT00640614|1378210|P2|COMPLETED|Overall Study||110
564829|NCT00640614|1378211|P1|COMPLETED|Overall Study||124
564830|NCT00640614|1378210|P2|STARTED|Overall Study||110
564831|NCT00640614|1378211|P1|STARTED|Overall Study||125
564832|NCT00640601|1378253|P1|NOT COMPLETED|Overall Study||112
564833|NCT00640601|1378253|P1|COMPLETED|Overall Study||183
564834|NCT00640601|1378253|P1|STARTED|Overall Study|331 patients enrolled and 295 patients started investigational product (IP)|295
564835|NCT00640562|1378269|P2|NOT COMPLETED|Overall Study||26
564836|NCT00640562|1378270|P1|NOT COMPLETED|Overall Study||18
564837|NCT00640562|1378269|P2|COMPLETED|Overall Study||81
564838|NCT00640562|1378270|P1|COMPLETED|Overall Study||91
564839|NCT00640562|1378269|P2|STARTED|Overall Study||107
564840|NCT00640562|1378270|P1|STARTED|Overall Study||109
564841|NCT00640510|1378298|P2|NOT COMPLETED|Overall Study||2
564842|NCT00640510|1378299|P1|NOT COMPLETED|Overall Study||1
564843|NCT00640510|1378298|P2|COMPLETED|Overall Study||15
564844|NCT00640510|1378299|P1|COMPLETED|Overall Study||16
564845|NCT00640510|1378298|P2|STARTED|Overall Study|One patient randomized to placebo discontinued prior to receiving study drug.|17
564846|NCT00640510|1378299|P1|STARTED|Overall Study||17
564847|NCT00640393|1378311|P3|NOT COMPLETED|Part 2||3
564848|NCT00640393|1378312|P2|NOT COMPLETED|Part 2||10
564849|NCT00640393|1378313|P1|NOT COMPLETED|Part 2||0
564850|NCT00640393|1378311|P3|COMPLETED|Part 2|Per protocol analysis of 27 to 29 participants that were compliant depending on evaluation or visit|35
564851|NCT00640393|1378312|P2|COMPLETED|Part 2|Per Protocol analysis is of 7 participants that were compliant to protocol|27
564852|NCT00640393|1378313|P1|COMPLETED|Part 2||0
564853|NCT00640393|1378311|P3|STARTED|Part 2||38
564854|NCT00640393|1378312|P2|STARTED|Part 2||37
564855|NCT00640393|1378313|P1|STARTED|Part 2||0
564856|NCT00640393|1378311|P3|NOT COMPLETED|Randomization||0
564857|NCT00640393|1378312|P2|NOT COMPLETED|Randomization||0
564858|NCT00640393|1378313|P1|NOT COMPLETED|Randomization||19
564859|NCT00640393|1378311|P3|COMPLETED|Randomization||0
564860|NCT00640393|1378312|P2|COMPLETED|Randomization||0
564861|NCT00640393|1378313|P1|COMPLETED|Randomization||75
564862|NCT00640393|1378311|P3|STARTED|Randomization||0
564863|NCT00640393|1378312|P2|STARTED|Randomization||0
564864|NCT00640393|1378313|P1|STARTED|Randomization||94
564865|NCT00640393|1378311|P3|NOT COMPLETED|Part 1||0
564866|NCT00640393|1378312|P2|NOT COMPLETED|Part 1||0
564867|NCT00640393|1378313|P1|NOT COMPLETED|Part 1||5
564868|NCT00640393|1378311|P3|COMPLETED|Part 1||0
564869|NCT00640393|1378312|P2|COMPLETED|Part 1||0
564870|NCT00640393|1378313|P1|COMPLETED|Part 1||94
564871|NCT00640393|1378311|P3|STARTED|Part 1||0
564872|NCT00640393|1378312|P2|STARTED|Part 1||0
564873|NCT00640393|1378313|P1|STARTED|Part 1||99
564874|NCT00640341|1378378|P3|NOT COMPLETED|Overall Study||7
564875|NCT00640341|1378379|P2|NOT COMPLETED|Overall Study||5
564876|NCT00640341|1378380|P1|NOT COMPLETED|Overall Study||21
564877|NCT00640341|1378378|P3|COMPLETED|Overall Study||163
564878|NCT00640341|1378379|P2|COMPLETED|Overall Study||165
564879|NCT00640341|1378380|P1|COMPLETED|Overall Study||149
564880|NCT00640341|1378378|P3|Eligible Participants at Baseline|Overall Study||168
564881|NCT00640341|1378379|P2|Eligible Participants at Baseline|Overall Study||167
564882|NCT00640341|1378380|P1|Eligible Participants at Baseline|Overall Study||165
564883|NCT00640341|1378378|P3|STARTED|Overall Study||170
564884|NCT00640341|1378379|P2|STARTED|Overall Study||170
564885|NCT00640341|1378380|P1|STARTED|Overall Study|All Starting participants were dispensed lenses|170
564886|NCT00640328|1378400|P6|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
564887|NCT00640328|1378401|P5|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
564888|NCT00640328|1378402|P4|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
564889|NCT00640328|1378403|P3|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
564890|NCT00640328|1378404|P2|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
564891|NCT00640328|1378405|P1|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
564892|NCT00640328|1378400|P6|COMPLETED|IFUP (Week 48 to Individual Termination)||4
564893|NCT00640328|1378401|P5|COMPLETED|IFUP (Week 48 to Individual Termination)||4
564894|NCT00640328|1378402|P4|COMPLETED|IFUP (Week 48 to Individual Termination)||3
564895|NCT00640328|1378403|P3|COMPLETED|IFUP (Week 48 to Individual Termination)||6
564896|NCT00640328|1378404|P2|COMPLETED|IFUP (Week 48 to Individual Termination)||10
564897|NCT00640328|1378405|P1|COMPLETED|IFUP (Week 48 to Individual Termination)||8
564898|NCT00640328|1378400|P6|STARTED|IFUP (Week 48 to Individual Termination)||4
564899|NCT00640328|1378401|P5|STARTED|IFUP (Week 48 to Individual Termination)||4
564900|NCT00640328|1378402|P4|STARTED|IFUP (Week 48 to Individual Termination)||4
564901|NCT00640328|1378403|P3|STARTED|IFUP (Week 48 to Individual Termination)||7
564902|NCT00640328|1378404|P2|STARTED|IFUP (Week 48 to Individual Termination)||11
564903|NCT00640328|1378405|P1|STARTED|IFUP (Week 48 to Individual Termination)||8
564904|NCT00640328|1378400|P6|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
564905|NCT00640328|1378401|P5|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||1
564906|NCT00640328|1378402|P4|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
564907|NCT00640328|1378403|P3|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
564908|NCT00640328|1378404|P2|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
564909|NCT00640328|1378405|P1|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
564910|NCT00640328|1378400|P6|COMPLETED|Second Treatment Period (Weeks 24-48)||4
564911|NCT00640328|1378401|P5|COMPLETED|Second Treatment Period (Weeks 24-48)||3
564912|NCT00640328|1378402|P4|COMPLETED|Second Treatment Period (Weeks 24-48)||4
564913|NCT00640328|1378403|P3|COMPLETED|Second Treatment Period (Weeks 24-48)||7
564914|NCT00640328|1378404|P2|COMPLETED|Second Treatment Period (Weeks 24-48)||10
564915|NCT00640328|1378405|P1|COMPLETED|Second Treatment Period (Weeks 24-48)||8
564916|NCT00640328|1378400|P6|STARTED|Second Treatment Period (Weeks 24-48)||4
564917|NCT00640328|1378401|P5|STARTED|Second Treatment Period (Weeks 24-48)||4
564918|NCT00640328|1378402|P4|STARTED|Second Treatment Period (Weeks 24-48)||4
564919|NCT00640328|1378403|P3|STARTED|Second Treatment Period (Weeks 24-48)||7
564920|NCT00640328|1378404|P2|STARTED|Second Treatment Period (Weeks 24-48)||10
564921|NCT00640328|1378405|P1|STARTED|Second Treatment Period (Weeks 24-48)||8
564922|NCT00640328|1378400|P6|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
564923|NCT00640328|1378401|P5|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
564924|NCT00640328|1378402|P4|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
564925|NCT00640328|1378403|P3|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
564926|NCT00640328|1378404|P2|NOT COMPLETED|First Treatment Period (Weeks 0-24)||1
564927|NCT00640328|1378405|P1|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
564928|NCT00640328|1378400|P6|COMPLETED|First Treatment Period (Weeks 0-24)||4
564929|NCT00640328|1378401|P5|COMPLETED|First Treatment Period (Weeks 0-24)||4
564930|NCT00640328|1378402|P4|COMPLETED|First Treatment Period (Weeks 0-24)||4
564931|NCT00640328|1378403|P3|COMPLETED|First Treatment Period (Weeks 0-24)||7
564932|NCT00640328|1378404|P2|COMPLETED|First Treatment Period (Weeks 0-24)||10
564933|NCT00640328|1378405|P1|COMPLETED|First Treatment Period (Weeks 0-24)||8
564934|NCT00640328|1378400|P6|STARTED|First Treatment Period (Weeks 0-24)||4
564935|NCT00640328|1378401|P5|STARTED|First Treatment Period (Weeks 0-24)||4
564936|NCT00640328|1378402|P4|STARTED|First Treatment Period (Weeks 0-24)||4
564937|NCT00640328|1378403|P3|STARTED|First Treatment Period (Weeks 0-24)||7
564938|NCT00640328|1378404|P2|STARTED|First Treatment Period (Weeks 0-24)||11
564939|NCT00640328|1378405|P1|STARTED|First Treatment Period (Weeks 0-24)||8
564940|NCT00640315|1378571|P2|NOT COMPLETED|Overall Study||1
564941|NCT00640315|1378572|P1|NOT COMPLETED|Overall Study||0
564942|NCT00640315|1378571|P2|COMPLETED|Overall Study||12
564943|NCT00640315|1378572|P1|COMPLETED|Overall Study||10
564944|NCT00640315|1378571|P2|Participants Received Treatment|Overall Study||13
564945|NCT00640315|1378572|P1|Participants Received Treatment|Overall Study||10
564946|NCT00640315|1378571|P2|STARTED|Overall Study||13
564947|NCT00640315|1378572|P1|STARTED|Overall Study||10
564948|NCT00640250|1378698|P1|NOT COMPLETED|Overall Study||0
564949|NCT00640250|1378698|P1|COMPLETED|Overall Study||48
564950|NCT00640250|1378698|P1|STARTED|Overall Study||48
564951|NCT00640224|1378805|P4|NOT COMPLETED|Overall Study||0
564952|NCT00640224|1378806|P3|NOT COMPLETED|Overall Study||0
564953|NCT00640224|1378807|P2|NOT COMPLETED|Overall Study||3
564954|NCT00640224|1378808|P1|NOT COMPLETED|Overall Study||6
564955|NCT00640224|1378805|P4|COMPLETED|Overall Study||0
564956|NCT00640224|1378806|P3|COMPLETED|Overall Study||0
564957|NCT00640224|1378807|P2|COMPLETED|Overall Study||20
564958|NCT00640224|1378808|P1|COMPLETED|Overall Study||17
564959|NCT00640224|1378805|P4|STARTED|Overall Study||0
564960|NCT00640224|1378806|P3|STARTED|Overall Study||0
564961|NCT00640224|1378807|P2|STARTED|Overall Study||23
564962|NCT00640224|1378808|P1|STARTED|Overall Study||23
564963|NCT00640042|1378906|P1|NOT COMPLETED|Treatment||926
564964|NCT00640042|1378906|P1|COMPLETED|Treatment||561
564965|NCT00640042|1378906|P1|STARTED|Treatment||1487
564966|NCT00640042|1378906|P1|NOT COMPLETED|Enrollment||83
564967|NCT00640042|1378906|P1|COMPLETED|Enrollment|Number of patients with evidence of study drug receipt|1487
564968|NCT00640042|1378906|P1|STARTED|Enrollment|Number of patients with evidence of prescription card receipt|1570
564969|NCT00640016|1378922|P4|NOT COMPLETED|Overall Study||3
564970|NCT00640016|1378923|P3|NOT COMPLETED|Overall Study||3
564971|NCT00640016|1378924|P2|NOT COMPLETED|Overall Study||2
564972|NCT00640016|1378925|P1|NOT COMPLETED|Overall Study||2
564973|NCT00640016|1378922|P4|COMPLETED|Overall Study||1
564974|NCT00640016|1378923|P3|COMPLETED|Overall Study||1
564975|NCT00640016|1378924|P2|COMPLETED|Overall Study||1
564976|NCT00640016|1378925|P1|COMPLETED|Overall Study||1
564977|NCT00640016|1378922|P4|Treated|Overall Study||4
564978|NCT00640016|1378923|P3|Treated|Overall Study||4
564979|NCT00640016|1378924|P2|Treated|Overall Study||2
564980|NCT00640016|1378925|P1|Treated|Overall Study||3
564981|NCT00640016|1378922|P4|STARTED|Overall Study||4
564982|NCT00640016|1378923|P3|STARTED|Overall Study||4
564983|NCT00640016|1378924|P2|STARTED|Overall Study||3
564984|NCT00640016|1378925|P1|STARTED|Overall Study||3
564985|NCT00639860|1378969|P1|NOT COMPLETED|Overall Study||0
564986|NCT00639860|1378969|P1|COMPLETED|Overall Study||10
564987|NCT00639860|1378969|P1|STARTED|Overall Study||10
564988|NCT00639769|1378977|P1|NOT COMPLETED|Overall Study||40
564989|NCT00639769|1378977|P1|COMPLETED|Overall Study||0
564990|NCT00639769|1378977|P1|STARTED|Overall Study||40
564991|NCT00639717|1378982|P1|NOT COMPLETED|Overall Study||0
564992|NCT00639717|1378982|P1|COMPLETED|Overall Study||48
564993|NCT00639717|1378982|P1|STARTED|Overall Study||48
564994|NCT00639678|1378994|P4|NOT COMPLETED|Overall Study||0
564995|NCT00639678|1378995|P3|NOT COMPLETED|Overall Study||11
564996|NCT00639678|1378996|P2|NOT COMPLETED|Overall Study||1
564997|NCT00639678|1378997|P1|NOT COMPLETED|Overall Study||4
564998|NCT00639678|1378994|P4|COMPLETED|Overall Study||23
564999|NCT00639678|1378995|P3|COMPLETED|Overall Study||206
565000|NCT00639678|1378996|P2|COMPLETED|Overall Study||5
565001|NCT00639678|1378997|P1|COMPLETED|Overall Study||70
565002|NCT00639678|1378994|P4|STARTED|Overall Study||23
565003|NCT00639678|1378995|P3|STARTED|Overall Study||217
565004|NCT00639678|1378996|P2|STARTED|Overall Study||6
565005|NCT00639678|1378997|P1|STARTED|Overall Study||74
565006|NCT00639626|1379057|P1|NOT COMPLETED|Overall Study||0
565007|NCT00639626|1379057|P1|COMPLETED|Overall Study||0
565008|NCT00639626|1379057|P1|STARTED|Overall Study||0
565009|NCT00639509|1379062|P1|NOT COMPLETED|Overall Study||1
565010|NCT00639509|1379062|P1|COMPLETED|Overall Study||23
565011|NCT00639509|1379062|P1|STARTED|Overall Study||24
565012|NCT00639457|1379070|P2|NOT COMPLETED|Overall Study||3
565013|NCT00639457|1379071|P1|NOT COMPLETED|Overall Study||2
565014|NCT00639457|1379070|P2|COMPLETED|Overall Study||19
565015|NCT00639457|1379071|P1|COMPLETED|Overall Study||20
565016|NCT00639457|1379070|P2|STARTED|Overall Study||22
565017|NCT00639457|1379071|P1|STARTED|Overall Study||22
565018|NCT00639418|1379109|P4|NOT COMPLETED|Overall Study||0
565019|NCT00639418|1379110|P3|NOT COMPLETED|Overall Study||0
565020|NCT00639418|1379111|P2|NOT COMPLETED|Overall Study||0
565021|NCT00639418|1379112|P1|NOT COMPLETED|Overall Study||0
565022|NCT00639418|1379109|P4|COMPLETED|Overall Study||46930
565023|NCT00639418|1379110|P3|COMPLETED|Overall Study||36496
565024|NCT00639418|1379111|P2|COMPLETED|Overall Study||35967
565025|NCT00639418|1379112|P1|COMPLETED|Overall Study||28101
565026|NCT00639418|1379109|P4|STARTED|Overall Study||46930
565027|NCT00639418|1379110|P3|STARTED|Overall Study||36496
565028|NCT00639418|1379111|P2|STARTED|Overall Study||35967
565029|NCT00639418|1379112|P1|STARTED|Overall Study||28101
565030|NCT00639379|1379130|P2|NOT COMPLETED|Period 2 - 2 Weeks||0
565031|NCT00639379|1379131|P1|NOT COMPLETED|Period 2 - 2 Weeks||0
565032|NCT00639379|1379130|P2|COMPLETED|Period 2 - 2 Weeks||45
565033|NCT00639379|1379131|P1|COMPLETED|Period 2 - 2 Weeks||39
565034|NCT00639379|1379130|P2|STARTED|Period 2 - 2 Weeks||45
565035|NCT00639379|1379131|P1|STARTED|Period 2 - 2 Weeks||39
565036|NCT00639379|1379130|P2|NOT COMPLETED|Period 1 - 2 Weeks||0
565037|NCT00639379|1379131|P1|NOT COMPLETED|Period 1 - 2 Weeks||5
565038|NCT00639379|1379130|P2|COMPLETED|Period 1 - 2 Weeks||45
565039|NCT00639379|1379131|P1|COMPLETED|Period 1 - 2 Weeks||39
565040|NCT00639379|1379130|P2|STARTED|Period 1 - 2 Weeks||45
565041|NCT00639379|1379131|P1|STARTED|Period 1 - 2 Weeks||44
565042|NCT00639223|1379147|P2|NOT COMPLETED|Overall Study||2
565043|NCT00639223|1379148|P1|NOT COMPLETED|Overall Study||0
565044|NCT00639223|1379147|P2|COMPLETED|Overall Study||19
565045|NCT00639223|1379148|P1|COMPLETED|Overall Study||22
565046|NCT00639223|1379147|P2|STARTED|Overall Study||21
565047|NCT00639223|1379148|P1|STARTED|Overall Study||22
565048|NCT00639158|1379158|P2|NOT COMPLETED|Overall Study||30
565049|NCT00639158|1379159|P1|NOT COMPLETED|Overall Study||26
565050|NCT00639158|1379158|P2|COMPLETED|Overall Study|30 subjects prematurely discontinued treatment|240
565051|NCT00639158|1379159|P1|COMPLETED|Overall Study|26 subjects prematurely discontinued treatment.|246
565052|NCT00639158|1379158|P2|STARTED|Overall Study|1 subject was randomized but not treated because of an abnormal ECG that precluded treatment.|270
565053|NCT00639158|1379159|P1|STARTED|Overall Study|All randomized subjects were treated.|272
565054|NCT00639093|1379181|P2|NOT COMPLETED|Overall Study||0
565055|NCT00639093|1379182|P1|NOT COMPLETED|Overall Study||0
565056|NCT00639093|1379181|P2|COMPLETED|Overall Study|46|46
565057|NCT00639093|1379182|P1|COMPLETED|Overall Study|45|45
565058|NCT00639093|1379181|P2|STARTED|Overall Study|46|46
565059|NCT00639093|1379182|P1|STARTED|Overall Study|45|45
565060|NCT00639002|1379188|P1|NOT COMPLETED|Overall Study||13
565061|NCT00639002|1379188|P1|COMPLETED|Overall Study||0
565062|NCT00639002|1379188|P1|Received Ruxolitinib + Dexamethasone|Overall Study||7
565063|NCT00639002|1379188|P1|Received Ruxolitinib|Overall Study||13
565064|NCT00639002|1379188|P1|STARTED|Overall Study||13
565065|NCT00638989|1379197|P3|NOT COMPLETED|Overall Study||1
565066|NCT00638989|1379198|P2|NOT COMPLETED|Overall Study||0
565067|NCT00638989|1379199|P1|NOT COMPLETED|Overall Study||0
565068|NCT00638989|1379197|P3|COMPLETED|Overall Study||9
565069|NCT00638989|1379198|P2|COMPLETED|Overall Study||10
565070|NCT00638989|1379199|P1|COMPLETED|Overall Study||10
565071|NCT00638989|1379197|P3|STARTED|Overall Study||10
565072|NCT00638989|1379198|P2|STARTED|Overall Study||10
565073|NCT00638989|1379199|P1|STARTED|Overall Study||10
565074|NCT00638963|1379239|P2|NOT COMPLETED|Overall Study||0
565075|NCT00638963|1379240|P1|NOT COMPLETED|Overall Study||1
565076|NCT00638963|1379239|P2|COMPLETED|Overall Study|including follow-up at Week 38 & Week 52|3
565077|NCT00638963|1379240|P1|COMPLETED|Overall Study|including follow-up at Week 38 & Week 52|2
565078|NCT00638963|1379239|P2|STARTED|Overall Study|Received randomized treatment assignment|3
565079|NCT00638963|1379240|P1|STARTED|Overall Study|Received randomized treatment assignment|3
565080|NCT00638937|1379259|P1|NOT COMPLETED|Overall Study||0
565081|NCT00638937|1379259|P1|COMPLETED|Overall Study||37
565082|NCT00638937|1379259|P1|STARTED|Overall Study||37
565083|NCT00638924|1379270|P1|NOT COMPLETED|Overall Study||0
565084|NCT00638924|1379270|P1|COMPLETED|Overall Study||40
565085|NCT00638924|1379270|P1|2 Months|Overall Study||40
565086|NCT00638924|1379270|P1|STARTED|Overall Study||40
565087|NCT00638885|1379275|P1|NOT COMPLETED|Overall Study||0
565088|NCT00638885|1379275|P1|COMPLETED|Overall Study||142
565089|NCT00638885|1379275|P1|STARTED|Overall Study||142
565090|NCT00638846|1379281|P2|NOT COMPLETED|Overall Study||6
565091|NCT00638846|1379282|P1|NOT COMPLETED|Overall Study||4
565092|NCT00638846|1379281|P2|COMPLETED|Overall Study||133
565093|NCT00638846|1379282|P1|COMPLETED|Overall Study||133
565094|NCT00638846|1379281|P2|STARTED|Overall Study||139
565095|NCT00638846|1379282|P1|STARTED|Overall Study||137
565096|NCT00638820|1379298|P1|NOT COMPLETED|Overall Study||0
565097|NCT00638820|1379298|P1|COMPLETED|Overall Study||3
565098|NCT00638820|1379298|P1|STARTED|Overall Study||3
565099|NCT00638716|1379308|P3|NOT COMPLETED|Overall Study||12
565100|NCT00638716|1379309|P2|NOT COMPLETED|Overall Study||15
565101|NCT00638716|1379310|P1|NOT COMPLETED|Overall Study||7
565102|NCT00638716|1379308|P3|COMPLETED|Overall Study||46
565103|NCT00638716|1379309|P2|COMPLETED|Overall Study||37
565104|NCT00638716|1379310|P1|COMPLETED|Overall Study||43
565105|NCT00638716|1379308|P3|STARTED|Overall Study||58
565106|NCT00638716|1379309|P2|STARTED|Overall Study||52
565107|NCT00638716|1379310|P1|STARTED|Overall Study||50
565108|NCT00638690|1379326|P2|NOT COMPLETED|Overall Study||342
565109|NCT00638690|1379327|P1|NOT COMPLETED|Overall Study||681
565110|NCT00638690|1379326|P2|COMPLETED|Overall Study||56
565111|NCT00638690|1379327|P1|COMPLETED|Overall Study||116
565112|NCT00638690|1379326|P2|STARTED|Overall Study||398
565113|NCT00638690|1379327|P1|STARTED|Overall Study||797
565114|NCT00638651|1379340|P1|NOT COMPLETED|Overall Study||0
565115|NCT00638651|1379340|P1|COMPLETED|Overall Study||3
565116|NCT00638651|1379340|P1|STARTED|Overall Study||3
565117|NCT00638443|1379345|P2|NOT COMPLETED|Second Intervention||0
565118|NCT00638443|1379346|P1|NOT COMPLETED|Second Intervention||0
565119|NCT00638443|1379345|P2|COMPLETED|Second Intervention||14
565120|NCT00638443|1379346|P1|COMPLETED|Second Intervention||12
565121|NCT00638443|1379345|P2|STARTED|Second Intervention||14
565122|NCT00638443|1379346|P1|STARTED|Second Intervention||12
565123|NCT00638443|1379345|P2|NOT COMPLETED|Washout||0
565124|NCT00638443|1379346|P1|NOT COMPLETED|Washout||0
565125|NCT00638443|1379345|P2|COMPLETED|Washout||14
565126|NCT00638443|1379346|P1|COMPLETED|Washout||12
565127|NCT00638443|1379345|P2|STARTED|Washout||14
565128|NCT00638443|1379346|P1|STARTED|Washout||12
565129|NCT00638443|1379345|P2|NOT COMPLETED|First Intervention||1
565130|NCT00638443|1379346|P1|NOT COMPLETED|First Intervention||2
565131|NCT00638443|1379345|P2|COMPLETED|First Intervention||14
565132|NCT00638443|1379346|P1|COMPLETED|First Intervention||12
565133|NCT00638443|1379345|P2|STARTED|First Intervention||15
565134|NCT00638443|1379346|P1|STARTED|First Intervention||14
565135|NCT00638378|1379374|P1|NOT COMPLETED|Overall Study||22
565136|NCT00638378|1379374|P1|COMPLETED|Overall Study||0
565137|NCT00638378|1379374|P1|STARTED|Overall Study||22
565138|NCT00638365|1379384|P3|NOT COMPLETED|Overall Study||0
565139|NCT00638365|1379385|P2|NOT COMPLETED|Overall Study||0
565140|NCT00638365|1379386|P1|NOT COMPLETED|Overall Study||0
565141|NCT00638365|1379384|P3|COMPLETED|Overall Study||8
565142|NCT00638365|1379385|P2|COMPLETED|Overall Study||10
565143|NCT00638365|1379386|P1|COMPLETED|Overall Study||9
565144|NCT00638365|1379384|P3|STARTED|Overall Study||8
565145|NCT00638365|1379385|P2|STARTED|Overall Study||10
565146|NCT00638365|1379386|P1|STARTED|Overall Study||9
565147|NCT00638235|1379403|P9|NOT COMPLETED|Overall Study||18
565148|NCT00638235|1379404|P8|NOT COMPLETED|Overall Study||1
565149|NCT00638235|1379405|P7|NOT COMPLETED|Overall Study||0
565150|NCT00638235|1379406|P6|NOT COMPLETED|Overall Study||26
565151|NCT00638235|1379407|P5|NOT COMPLETED|Overall Study||13
565152|NCT00638235|1379408|P4|NOT COMPLETED|Overall Study||10
565153|NCT00638235|1379409|P3|NOT COMPLETED|Overall Study||18
565154|NCT00638235|1379410|P2|NOT COMPLETED|Overall Study||3
565155|NCT00638235|1379411|P1|NOT COMPLETED|Overall Study||31
565156|NCT00638235|1379403|P9|COMPLETED|Overall Study||124
565157|NCT00638235|1379404|P8|COMPLETED|Overall Study|Ph-VI ended after 12M b/c next generation of Elevate Anterior was already under trial in Phase VII|34
565158|NCT00638235|1379405|P7|COMPLETED|Overall Study||23
565159|NCT00638235|1379406|P6|COMPLETED|Overall Study||113
565160|NCT00638235|1379407|P5|COMPLETED|Overall Study||42
565161|NCT00638235|1379408|P4|COMPLETED|Overall Study||46
565162|NCT00638235|1379409|P3|COMPLETED|Overall Study|Ph-II ended before all subjects had 24M b/c Perigee next generation was already under trial P-III/IV|63
565163|NCT00638235|1379410|P2|COMPLETED|Overall Study||23
565164|NCT00638235|1379411|P1|COMPLETED|Overall Study||110
565165|NCT00638235|1379403|P9|STARTED|Overall Study||142
565166|NCT00638235|1379404|P8|STARTED|Overall Study||35
565167|NCT00638235|1379405|P7|STARTED|Overall Study||23
565168|NCT00638235|1379406|P6|STARTED|Overall Study||139
565169|NCT00638235|1379407|P5|STARTED|Overall Study||55
565170|NCT00638235|1379408|P4|STARTED|Overall Study||56
565171|NCT00638235|1379409|P3|STARTED|Overall Study||81
565172|NCT00638235|1379410|P2|STARTED|Overall Study||26
565173|NCT00638235|1379411|P1|STARTED|Overall Study||141
565174|NCT00638222|1379812|P3|NOT COMPLETED|Overall Study||0
565175|NCT00638222|1379813|P2|NOT COMPLETED|Overall Study||0
565176|NCT00638222|1379814|P1|NOT COMPLETED|Overall Study||0
565177|NCT00638222|1379812|P3|COMPLETED|Overall Study||6
565178|NCT00638222|1379813|P2|COMPLETED|Overall Study||0
565179|NCT00638222|1379814|P1|COMPLETED|Overall Study||0
565180|NCT00638222|1379812|P3|STARTED|Overall Study||6
565181|NCT00638222|1379813|P2|STARTED|Overall Study||0
565182|NCT00638222|1379814|P1|STARTED|Overall Study||0
565183|NCT00638183|1379821|P1|NOT COMPLETED|Overall Study||119
565184|NCT00638183|1379821|P1|COMPLETED|Overall Study||266
565185|NCT00638183|1379821|P1|STARTED|Overall Study||385
565186|NCT00638157|1379830|P2|NOT COMPLETED|Overall Study||4
565187|NCT00638157|1379831|P1|NOT COMPLETED|Overall Study||7
565188|NCT00638157|1379830|P2|COMPLETED|Overall Study|4 subjects completed study drug in this arm|8
565189|NCT00638157|1379831|P1|COMPLETED|Overall Study|4 subjects completed study drug in this arm|5
565190|NCT00638157|1379830|P2|Treated|Overall Study||12
565191|NCT00638157|1379831|P1|Treated|Overall Study||10
565192|NCT00638157|1379830|P2|STARTED|Overall Study||12
565193|NCT00638157|1379831|P1|STARTED|Overall Study||12
565194|NCT00638027|1379841|P2|NOT COMPLETED|Overall Study||2
565195|NCT00638027|1379842|P1|NOT COMPLETED|Overall Study||0
565196|NCT00638027|1379841|P2|COMPLETED|Overall Study|all 10 included in analyses|8
565197|NCT00638027|1379842|P1|COMPLETED|Overall Study||11
565198|NCT00638027|1379841|P2|STARTED|Overall Study||10
565199|NCT00638027|1379842|P1|STARTED|Overall Study||11
565200|NCT00638014|1379854|P2|NOT COMPLETED|Overall Study||0
565201|NCT00638014|1379855|P1|NOT COMPLETED|Overall Study||0
565202|NCT00638014|1379854|P2|COMPLETED|Overall Study||28
565203|NCT00638014|1379855|P1|COMPLETED|Overall Study||23
565204|NCT00638014|1379854|P2|STARTED|Overall Study||28
565205|NCT00638014|1379855|P1|STARTED|Overall Study||23
565206|NCT00637923|1379865|P2|NOT COMPLETED|Overall Study||19
565207|NCT00637923|1379866|P1|NOT COMPLETED|Overall Study||30
565208|NCT00637923|1379865|P2|COMPLETED|Overall Study||18
565209|NCT00637923|1379866|P1|COMPLETED|Overall Study||45
565210|NCT00637923|1379865|P2|STARTED|Overall Study||37
565211|NCT00637923|1379866|P1|STARTED|Overall Study||75
565212|NCT00637806|1379889|P4|NOT COMPLETED|Extension Phase||1
565213|NCT00637806|1379890|P3|NOT COMPLETED|Extension Phase||0
565214|NCT00637806|1379891|P2|NOT COMPLETED|Extension Phase||0
565215|NCT00637806|1379892|P1|NOT COMPLETED|Extension Phase||0
565216|NCT00637806|1379889|P4|COMPLETED|Extension Phase||0
565217|NCT00637806|1379890|P3|COMPLETED|Extension Phase||0
565218|NCT00637806|1379891|P2|COMPLETED|Extension Phase||0
565219|NCT00637806|1379892|P1|COMPLETED|Extension Phase||0
565220|NCT00637806|1379889|P4|STARTED|Extension Phase||1
565221|NCT00637806|1379890|P3|STARTED|Extension Phase||0
565222|NCT00637806|1379891|P2|STARTED|Extension Phase||0
565223|NCT00637806|1379892|P1|STARTED|Extension Phase||0
565224|NCT00637806|1379889|P4|NOT COMPLETED|Double-blind Phase||0
565225|NCT00637806|1379890|P3|NOT COMPLETED|Double-blind Phase||1
565226|NCT00637806|1379891|P2|NOT COMPLETED|Double-blind Phase||0
565227|NCT00637806|1379892|P1|NOT COMPLETED|Double-blind Phase||2
565228|NCT00637806|1379889|P4|COMPLETED|Double-blind Phase||0
565229|NCT00637806|1379890|P3|COMPLETED|Double-blind Phase||1
565230|NCT00637806|1379891|P2|COMPLETED|Double-blind Phase||0
565231|NCT00637806|1379892|P1|COMPLETED|Double-blind Phase||0
565232|NCT00637806|1379889|P4|STARTED|Double-blind Phase||0
565233|NCT00637806|1379890|P3|STARTED|Double-blind Phase||2
565234|NCT00637806|1379891|P2|STARTED|Double-blind Phase||0
565235|NCT00637806|1379892|P1|STARTED|Double-blind Phase||2
565236|NCT00637780|1379910|P1|NOT COMPLETED|Overall Study||0
565237|NCT00637780|1379910|P1|COMPLETED|Overall Study||2
565238|NCT00637780|1379910|P1|STARTED|Overall Study||2
565239|NCT00637728|1379927|P3|NOT COMPLETED|Extension Phase||0
565240|NCT00637728|1379928|P2|NOT COMPLETED|Extension Phase||0
565241|NCT00637728|1379929|P1|NOT COMPLETED|Extension Phase||0
565242|NCT00637728|1379927|P3|COMPLETED|Extension Phase||0
565243|NCT00637728|1379928|P2|COMPLETED|Extension Phase||0
565244|NCT00637728|1379929|P1|COMPLETED|Extension Phase||0
565245|NCT00637728|1379927|P3|STARTED|Extension Phase||0
565246|NCT00637728|1379928|P2|STARTED|Extension Phase||0
565247|NCT00637728|1379929|P1|STARTED|Extension Phase||0
565248|NCT00637728|1379927|P3|NOT COMPLETED|Double-blind Phase||0
565249|NCT00637728|1379928|P2|NOT COMPLETED|Double-blind Phase||1
565250|NCT00637728|1379929|P1|NOT COMPLETED|Double-blind Phase||4
565251|NCT00637728|1379927|P3|COMPLETED|Double-blind Phase||0
565252|NCT00637728|1379928|P2|COMPLETED|Double-blind Phase||0
565253|NCT00637728|1379929|P1|COMPLETED|Double-blind Phase||0
565254|NCT00637728|1379927|P3|STARTED|Double-blind Phase||0
565255|NCT00637728|1379928|P2|STARTED|Double-blind Phase||1
565256|NCT00637728|1379929|P1|STARTED|Double-blind Phase||4
565257|NCT00637572|1379944|P2|NOT COMPLETED|Overall Study||7
565258|NCT00637572|1379945|P1|NOT COMPLETED|Overall Study||3
565259|NCT00637572|1379944|P2|COMPLETED|Overall Study||24
565260|NCT00637572|1379945|P1|COMPLETED|Overall Study||29
565261|NCT00637572|1379944|P2|STARTED|Overall Study||31
565262|NCT00637572|1379945|P1|STARTED|Overall Study||32
565263|NCT00637494|1379973|P2|NOT COMPLETED|Overall Study||43
565264|NCT00637494|1379974|P1|NOT COMPLETED|Overall Study||32
565265|NCT00637494|1379973|P2|COMPLETED|Overall Study||108
565266|NCT00637494|1379974|P1|COMPLETED|Overall Study||109
565267|NCT00637494|1379973|P2|STARTED|Overall Study||151
565268|NCT00637494|1379974|P1|STARTED|Overall Study||141
565269|NCT00637416|1379984|P2|NOT COMPLETED|Overall Study||2
565270|NCT00637416|1379985|P1|NOT COMPLETED|Overall Study||1
565271|NCT00637416|1379984|P2|COMPLETED|Overall Study||3
565272|NCT00637416|1379985|P1|COMPLETED|Overall Study||3
565273|NCT00637416|1379984|P2|STARTED|Overall Study||5
565274|NCT00637416|1379985|P1|STARTED|Overall Study||4
565275|NCT00637377|1379995|P4|NOT COMPLETED|Overall Study||29
565276|NCT00637377|1379996|P3|NOT COMPLETED|Overall Study||37
565277|NCT00637377|1379997|P2|NOT COMPLETED|Overall Study||32
565278|NCT00637377|1379998|P1|NOT COMPLETED|Overall Study||27
565279|NCT00637377|1379995|P4|COMPLETED|Overall Study||284
565280|NCT00637377|1379996|P3|COMPLETED|Overall Study||274
565281|NCT00637377|1379997|P2|COMPLETED|Overall Study||281
565282|NCT00637377|1379998|P1|COMPLETED|Overall Study||276
565283|NCT00637377|1379995|P4|Participants Treated (FAS)|Overall Study||306
565284|NCT00637377|1379996|P3|Participants Treated (FAS)|Overall Study||296
565285|NCT00637377|1379997|P2|Participants Treated (FAS)|Overall Study||309
565286|NCT00637377|1379998|P1|Participants Treated (FAS)|Overall Study||291
565287|NCT00637377|1379995|P4|Participants Received Treatment|Overall Study|safety population|307
565288|NCT00637377|1379996|P3|Participants Received Treatment|Overall Study|safety population|297
565289|NCT00637377|1379997|P2|Participants Received Treatment|Overall Study|safety population|309
565290|NCT00637377|1379998|P1|Participants Received Treatment|Overall Study|safety population|291
565291|NCT00637377|1379995|P4|STARTED|Overall Study||313
565292|NCT00637377|1379996|P3|STARTED|Overall Study||311
565293|NCT00637377|1379997|P2|STARTED|Overall Study||313
565294|NCT00637377|1379998|P1|STARTED|Overall Study||303
565295|NCT00637312|1380026|P2|NOT COMPLETED|Overall Study||17
565296|NCT00637312|1380027|P1|NOT COMPLETED|Overall Study||42
565297|NCT00637312|1380026|P2|COMPLETED|Overall Study||19
565298|NCT00637312|1380027|P1|COMPLETED|Overall Study||30
565299|NCT00637312|1380026|P2|STARTED|Overall Study||36
565300|NCT00637312|1380027|P1|STARTED|Overall Study||72
565301|NCT00637299|1380035|P2|NOT COMPLETED|Overall Study||0
565302|NCT00637299|1380036|P1|NOT COMPLETED|Overall Study||0
565303|NCT00637299|1380035|P2|COMPLETED|Overall Study||10
565304|NCT00637299|1380036|P1|COMPLETED|Overall Study||10
565305|NCT00637299|1380035|P2|STARTED|Overall Study||10
565306|NCT00637299|1380036|P1|STARTED|Overall Study||10
565307|NCT00637273|1380047|P3|NOT COMPLETED|Overall Study||41
565308|NCT00637273|1380048|P2|NOT COMPLETED|Overall Study||28
565309|NCT00637273|1380049|P1|NOT COMPLETED|Overall Study||43
565310|NCT00637273|1380047|P3|COMPLETED|Overall Study||131
565311|NCT00637273|1380048|P2|COMPLETED|Overall Study||144
565312|NCT00637273|1380049|P1|COMPLETED|Overall Study||127
565313|NCT00637273|1380047|P3|Intent to Treat (ITT)|Overall Study||165
565314|NCT00637273|1380048|P2|Intent to Treat (ITT)|Overall Study||166
565315|NCT00637273|1380049|P1|Intent to Treat (ITT)|Overall Study||160
565316|NCT00637273|1380047|P3|STARTED|Overall Study||172
565317|NCT00637273|1380048|P2|STARTED|Overall Study||172
565318|NCT00637273|1380049|P1|STARTED|Overall Study||170
565319|NCT00637247|1380092|P2|NOT COMPLETED|Overall Study||0
565320|NCT00637247|1380093|P1|NOT COMPLETED|Overall Study||0
565321|NCT00637247|1380092|P2|COMPLETED|Overall Study||70
565322|NCT00637247|1380093|P1|COMPLETED|Overall Study||72
565323|NCT00637247|1380092|P2|STARTED|Overall Study||70
565324|NCT00637247|1380093|P1|STARTED|Overall Study||72
565325|NCT00637195|1380105|P2|NOT COMPLETED|Overall Study||1
565326|NCT00637195|1380106|P1|NOT COMPLETED|Overall Study||3
565327|NCT00637195|1380105|P2|COMPLETED|Overall Study||75
565328|NCT00637195|1380106|P1|COMPLETED|Overall Study||73
565329|NCT00637195|1380105|P2|STARTED|Overall Study||76
565330|NCT00637195|1380106|P1|STARTED|Overall Study||76
565331|NCT00637156|1380142|P2|NOT COMPLETED|Overall Study||24
565332|NCT00637156|1380143|P1|NOT COMPLETED|Overall Study||10
565333|NCT00637156|1380142|P2|COMPLETED|Overall Study||164
565334|NCT00637156|1380143|P1|COMPLETED|Overall Study||199
565335|NCT00637156|1380142|P2|STARTED|Overall Study||188
565336|NCT00637156|1380143|P1|STARTED|Overall Study||209
565337|NCT00637000|1380185|P2|NOT COMPLETED|Overall Study||3
565338|NCT00637000|1380186|P1|NOT COMPLETED|Overall Study||4
565339|NCT00637000|1380185|P2|COMPLETED|Overall Study||15
565340|NCT00637000|1380186|P1|COMPLETED|Overall Study||16
565341|NCT00637000|1380185|P2|Evaluable|Overall Study||16
565342|NCT00637000|1380186|P1|Evaluable|Overall Study||18
565343|NCT00637000|1380185|P2|STARTED|Overall Study|Randomized and treated|18
565344|NCT00637000|1380186|P1|STARTED|Overall Study|Randomized and treated|20
565345|NCT00636987|1380226|P1|NOT COMPLETED|Overall Study||189
565346|NCT00636987|1380226|P1|COMPLETED|Overall Study||108
565347|NCT00636987|1380226|P1|STARTED|Overall Study||297
565348|NCT00636961|1380236|P2|NOT COMPLETED|Period 2||0
565349|NCT00636961|1380237|P1|NOT COMPLETED|Period 2||1
565350|NCT00636961|1380236|P2|COMPLETED|Period 2||12
565351|NCT00636961|1380237|P1|COMPLETED|Period 2||12
565352|NCT00636961|1380236|P2|STARTED|Period 2||12
565353|NCT00636961|1380237|P1|STARTED|Period 2||13
565354|NCT00636961|1380236|P2|NOT COMPLETED|Period 1||1
565355|NCT00636961|1380237|P1|NOT COMPLETED|Period 1||1
565356|NCT00636961|1380236|P2|COMPLETED|Period 1||12
565357|NCT00636961|1380237|P1|COMPLETED|Period 1||13
565358|NCT00636961|1380236|P2|STARTED|Period 1||13
565359|NCT00636961|1380237|P1|STARTED|Period 1||14
565360|NCT00636818|1380251|P1|NOT COMPLETED|Overall Study||11
565361|NCT00636818|1380251|P1|COMPLETED|Overall Study||34
565362|NCT00636818|1380251|P1|Received at Least One Dose of Study Drug|Overall Study|One patient was lost to follow up and did not receive any study drug.|44
565363|NCT00636818|1380251|P1|STARTED|Overall Study||45
565364|NCT00636805|1380266|P1|NOT COMPLETED|Overall Study||0
565365|NCT00636805|1380266|P1|COMPLETED|Overall Study||63
565366|NCT00636805|1380266|P1|STARTED|Overall Study||63
565367|NCT00636792|1380276|P1|NOT COMPLETED|Overall Study||33
565368|NCT00636792|1380276|P1|COMPLETED|Overall Study||40
565369|NCT00636792|1380276|P1|STARTED|Overall Study||73
565370|NCT00636701|1380283|P2|NOT COMPLETED|Overall Study||0
565371|NCT00636701|1380284|P1|NOT COMPLETED|Overall Study||0
565372|NCT00636701|1380283|P2|COMPLETED|Overall Study||2
565373|NCT00636701|1380284|P1|COMPLETED|Overall Study||2
565374|NCT00636701|1380283|P2|STARTED|Overall Study||2
565375|NCT00636701|1380284|P1|STARTED|Overall Study||2
565376|NCT00636649|1380292|P2|NOT COMPLETED|Overall Study||0
565377|NCT00636649|1380293|P1|NOT COMPLETED|Overall Study||0
565378|NCT00636649|1380292|P2|COMPLETED|Overall Study||20
565379|NCT00636649|1380293|P1|COMPLETED|Overall Study||20
565380|NCT00636649|1380292|P2|STARTED|Overall Study||20
565381|NCT00636649|1380293|P1|STARTED|Overall Study||20
565382|NCT00636636|1380323|P2|NOT COMPLETED|Overall Study||39
565383|NCT00636636|1380324|P1|NOT COMPLETED|Overall Study||36
565384|NCT00636636|1380323|P2|COMPLETED|Overall Study||192
565385|NCT00636636|1380324|P1|COMPLETED|Overall Study||185
565386|NCT00636636|1380323|P2|379|Overall Study|1 patient randomized twice, not included in ITT, but completed medication and counted as completer|194
565387|NCT00636636|1380324|P1|379|Overall Study||186
565388|NCT00636636|1380323|P2|Safety & Efficacy of Gabapentin ER|Overall Study|1 patient randomized twice, not included in ITT, but completed medication and counted as completer|194
565389|NCT00636636|1380324|P1|Safety & Efficacy of Gabapentin ER|Overall Study||186
565390|NCT00636636|1380323|P2|STARTED|Overall Study||231
565391|NCT00636636|1380324|P1|STARTED|Overall Study||221
565392|NCT00636610|1380340|P2|NOT COMPLETED|Overall Study||83
565393|NCT00636610|1380341|P1|NOT COMPLETED|Overall Study||92
565394|NCT00636610|1380340|P2|COMPLETED|Overall Study||18
565395|NCT00636610|1380341|P1|COMPLETED|Overall Study||6
565396|NCT00636610|1380340|P2|STARTED|Overall Study||101
565397|NCT00636610|1380341|P1|STARTED|Overall Study||98
565398|NCT00636441|1380358|P7|NOT COMPLETED|Overall Study||18
565399|NCT00636441|1380359|P6|NOT COMPLETED|Overall Study||1
565400|NCT00636441|1380360|P5|NOT COMPLETED|Overall Study||0
565401|NCT00636441|1380361|P4|NOT COMPLETED|Overall Study||0
565402|NCT00636441|1380362|P3|NOT COMPLETED|Overall Study||1
565403|NCT00636441|1380363|P2|NOT COMPLETED|Overall Study||1
565404|NCT00636441|1380364|P1|NOT COMPLETED|Overall Study||0
565405|NCT00636441|1380358|P7|COMPLETED|Overall Study||0
565406|NCT00636441|1380359|P6|COMPLETED|Overall Study||6
565407|NCT00636441|1380360|P5|COMPLETED|Overall Study||6
565408|NCT00636441|1380361|P4|COMPLETED|Overall Study||6
565409|NCT00636441|1380362|P3|COMPLETED|Overall Study||5
565410|NCT00636441|1380363|P2|COMPLETED|Overall Study||6
565411|NCT00636441|1380364|P1|COMPLETED|Overall Study||6
565412|NCT00636441|1380358|P7|Assigned Treatment|Overall Study|This is a late determined ineligibility.|1
565413|NCT00636441|1380359|P6|Assigned Treatment|Overall Study||7
565414|NCT00636441|1380360|P5|Assigned Treatment|Overall Study||6
565415|NCT00636441|1380361|P4|Assigned Treatment|Overall Study||6
565416|NCT00636441|1380362|P3|Assigned Treatment|Overall Study||6
565417|NCT00636441|1380363|P2|Assigned Treatment|Overall Study||7
565418|NCT00636441|1380364|P1|Assigned Treatment|Overall Study||6
565419|NCT00636441|1380358|P7|STARTED|Overall Study||18
565420|NCT00636441|1380359|P6|STARTED|Overall Study||7
565421|NCT00636441|1380360|P5|STARTED|Overall Study||6
565422|NCT00636441|1380361|P4|STARTED|Overall Study||6
565423|NCT00636441|1380362|P3|STARTED|Overall Study||6
565424|NCT00636441|1380363|P2|STARTED|Overall Study||7
565425|NCT00636441|1380364|P1|STARTED|Overall Study||6
565426|NCT00636389|1380393|P2|NOT COMPLETED|Period 2 - 1 Week||0
565427|NCT00636389|1380394|P1|NOT COMPLETED|Period 2 - 1 Week||0
565428|NCT00636389|1380393|P2|COMPLETED|Period 2 - 1 Week||5
565429|NCT00636389|1380394|P1|COMPLETED|Period 2 - 1 Week||7
565430|NCT00636389|1380393|P2|STARTED|Period 2 - 1 Week||5
565431|NCT00636389|1380394|P1|STARTED|Period 2 - 1 Week||7
565432|NCT00636389|1380393|P2|NOT COMPLETED|Period 1 - 1 Week||0
565433|NCT00636389|1380394|P1|NOT COMPLETED|Period 1 - 1 Week||0
565434|NCT00636389|1380393|P2|COMPLETED|Period 1 - 1 Week||5
565435|NCT00636389|1380394|P1|COMPLETED|Period 1 - 1 Week||7
565436|NCT00636389|1380393|P2|STARTED|Period 1 - 1 Week||5
565437|NCT00636389|1380394|P1|STARTED|Period 1 - 1 Week||7
565438|NCT00636363|1380407|P3|NOT COMPLETED|Overall Study||18
565439|NCT00636363|1380408|P2|NOT COMPLETED|Overall Study||20
565440|NCT00636363|1380409|P1|NOT COMPLETED|Overall Study||13
565441|NCT00636363|1380407|P3|COMPLETED|Overall Study||163
565442|NCT00636363|1380408|P2|COMPLETED|Overall Study||156
565443|NCT00636363|1380409|P1|COMPLETED|Overall Study||165
565444|NCT00636363|1380407|P3|STARTED|Overall Study||181
565445|NCT00636363|1380408|P2|STARTED|Overall Study||176
565446|NCT00636363|1380409|P1|STARTED|Overall Study||178
565447|NCT00636220|1380423|P1|NOT COMPLETED|Overall Study||0
565448|NCT00636220|1380423|P1|COMPLETED|Overall Study||101
565449|NCT00636220|1380423|P1|STARTED|Overall Study||101
565450|NCT00636207|1380430|P7|NOT COMPLETED|Overall Study||0
565451|NCT00636207|1380431|P6|NOT COMPLETED|Overall Study||0
565452|NCT00636207|1380432|P5|NOT COMPLETED|Overall Study||1
565453|NCT00636207|1380433|P4|NOT COMPLETED|Overall Study||0
565454|NCT00636207|1380434|P3|NOT COMPLETED|Overall Study||0
565455|NCT00636207|1380435|P2|NOT COMPLETED|Overall Study||1
565456|NCT00636207|1380436|P1|NOT COMPLETED|Overall Study||1
565457|NCT00636207|1380430|P7|COMPLETED|Overall Study||3
565458|NCT00636207|1380431|P6|COMPLETED|Overall Study||1
565459|NCT00636207|1380432|P5|COMPLETED|Overall Study||8
565460|NCT00636207|1380433|P4|COMPLETED|Overall Study||6
565461|NCT00636207|1380434|P3|COMPLETED|Overall Study||18
565462|NCT00636207|1380435|P2|COMPLETED|Overall Study||7
565463|NCT00636207|1380436|P1|COMPLETED|Overall Study||0
565464|NCT00636207|1380430|P7|STARTED|Overall Study||3
565465|NCT00636207|1380431|P6|STARTED|Overall Study||1
565466|NCT00636207|1380432|P5|STARTED|Overall Study|One participant withdrew consent after completing all study doses.|9
565467|NCT00636207|1380433|P4|STARTED|Overall Study||6
565468|NCT00636207|1380434|P3|STARTED|Overall Study||18
565469|NCT00636207|1380435|P2|STARTED|Overall Study|One participant withdrew consent after completing all study doses.|8
565470|NCT00636207|1380436|P1|STARTED|Overall Study|One participant discontinued after completing Period 2. Doses in Periods 1 and 2 were Montelukast.|1
565471|NCT00636194|1380500|P2|NOT COMPLETED|Overall Study||0
565472|NCT00636194|1380501|P1|NOT COMPLETED|Overall Study||3
565473|NCT00636194|1380500|P2|COMPLETED|Overall Study||175
565474|NCT00636194|1380501|P1|COMPLETED|Overall Study||172
565475|NCT00636194|1380500|P2|STARTED|Overall Study||175
565476|NCT00636194|1380501|P1|STARTED|Overall Study||175
565477|NCT00636168|1380513|P2|NOT COMPLETED|Treated With Study Drug||411
565478|NCT00636168|1380514|P1|NOT COMPLETED|Treated With Study Drug||447
565479|NCT00636168|1380513|P2|COMPLETED|Treated With Study Drug||63
565480|NCT00636168|1380514|P1|COMPLETED|Treated With Study Drug||24
565481|NCT00636168|1380513|P2|STARTED|Treated With Study Drug||474
565482|NCT00636168|1380514|P1|STARTED|Treated With Study Drug||471
565483|NCT00636168|1380513|P2|NOT COMPLETED|Randomized to Study Drug||2
565484|NCT00636168|1380514|P1|NOT COMPLETED|Randomized to Study Drug||4
565485|NCT00636168|1380513|P2|COMPLETED|Randomized to Study Drug||474
565486|NCT00636168|1380514|P1|COMPLETED|Randomized to Study Drug||471
565487|NCT00636168|1380513|P2|STARTED|Randomized to Study Drug||476
565488|NCT00636168|1380514|P1|STARTED|Randomized to Study Drug||475
565489|NCT00636155|1380534|P1|NOT COMPLETED|Overall Study||18
565490|NCT00636155|1380534|P1|COMPLETED|Overall Study|Completed maximum 6 cycles of treatment|2
565491|NCT00636155|1380534|P1|STARTED|Overall Study||20
565492|NCT00636077|1380540|P4|NOT COMPLETED|Week 4||0
565493|NCT00636077|1380541|P3|NOT COMPLETED|Week 4||0
565494|NCT00636077|1380542|P2|NOT COMPLETED|Week 4||0
565495|NCT00636077|1380543|P1|NOT COMPLETED|Week 4||0
565496|NCT00636077|1380540|P4|COMPLETED|Week 4||3
565497|NCT00636077|1380541|P3|COMPLETED|Week 4||3
565498|NCT00636077|1380542|P2|COMPLETED|Week 4||3
565499|NCT00636077|1380543|P1|COMPLETED|Week 4||3
565500|NCT00636077|1380540|P4|STARTED|Week 4||3
565501|NCT00636077|1380541|P3|STARTED|Week 4||3
565502|NCT00636077|1380542|P2|STARTED|Week 4||3
565503|NCT00636077|1380543|P1|STARTED|Week 4||3
565504|NCT00636077|1380540|P4|NOT COMPLETED|Week 3||0
565505|NCT00636077|1380541|P3|NOT COMPLETED|Week 3||0
565506|NCT00636077|1380542|P2|NOT COMPLETED|Week 3||0
565507|NCT00636077|1380543|P1|NOT COMPLETED|Week 3||0
565508|NCT00636077|1380540|P4|COMPLETED|Week 3||3
565509|NCT00636077|1380541|P3|COMPLETED|Week 3||3
565510|NCT00636077|1380542|P2|COMPLETED|Week 3||3
565511|NCT00636077|1380543|P1|COMPLETED|Week 3||3
565512|NCT00636077|1380540|P4|STARTED|Week 3||3
565513|NCT00636077|1380541|P3|STARTED|Week 3||3
565514|NCT00636077|1380542|P2|STARTED|Week 3||3
565515|NCT00636077|1380543|P1|STARTED|Week 3||3
565516|NCT00636077|1380540|P4|NOT COMPLETED|Week 2||0
565517|NCT00636077|1380541|P3|NOT COMPLETED|Week 2||0
565518|NCT00636077|1380542|P2|NOT COMPLETED|Week 2||0
565519|NCT00636077|1380543|P1|NOT COMPLETED|Week 2||0
565520|NCT00636077|1380540|P4|COMPLETED|Week 2||3
565521|NCT00636077|1380541|P3|COMPLETED|Week 2||3
565522|NCT00636077|1380542|P2|COMPLETED|Week 2||3
565523|NCT00636077|1380543|P1|COMPLETED|Week 2||3
565524|NCT00636077|1380540|P4|STARTED|Week 2||3
565525|NCT00636077|1380541|P3|STARTED|Week 2||3
565526|NCT00636077|1380542|P2|STARTED|Week 2||3
565527|NCT00636077|1380543|P1|STARTED|Week 2||3
565528|NCT00636077|1380540|P4|NOT COMPLETED|Week 1||0
565529|NCT00636077|1380541|P3|NOT COMPLETED|Week 1||0
565530|NCT00636077|1380542|P2|NOT COMPLETED|Week 1||0
565531|NCT00636077|1380543|P1|NOT COMPLETED|Week 1||0
565532|NCT00636077|1380540|P4|COMPLETED|Week 1||3
565533|NCT00636077|1380541|P3|COMPLETED|Week 1||3
565534|NCT00636077|1380542|P2|COMPLETED|Week 1||3
565535|NCT00636077|1380543|P1|COMPLETED|Week 1||3
565536|NCT00636077|1380540|P4|STARTED|Week 1||3
565537|NCT00636077|1380541|P3|STARTED|Week 1||3
565538|NCT00636077|1380542|P2|STARTED|Week 1||3
565539|NCT00636077|1380543|P1|STARTED|Week 1||3
565540|NCT00635999|1380576|P3|NOT COMPLETED|Overall Study||1
565541|NCT00635999|1380577|P2|NOT COMPLETED|Overall Study||2
565542|NCT00635999|1380578|P1|NOT COMPLETED|Overall Study||4
565543|NCT00635999|1380576|P3|COMPLETED|Overall Study||23
565544|NCT00635999|1380577|P2|COMPLETED|Overall Study||23
565545|NCT00635999|1380578|P1|COMPLETED|Overall Study||23
565546|NCT00635999|1380576|P3|STARTED|Overall Study||24
565547|NCT00635999|1380577|P2|STARTED|Overall Study||25
565548|NCT00635999|1380578|P1|STARTED|Overall Study||27
565549|NCT00635882|1380595|P6|NOT COMPLETED|Overall Study||0
565550|NCT00635882|1380596|P5|NOT COMPLETED|Overall Study||0
565551|NCT00635882|1380597|P4|NOT COMPLETED|Overall Study||0
565552|NCT00635882|1380598|P3|NOT COMPLETED|Overall Study||0
565553|NCT00635882|1380599|P2|NOT COMPLETED|Overall Study||0
565554|NCT00635882|1380600|P1|NOT COMPLETED|Overall Study||1
565555|NCT00635882|1380595|P6|COMPLETED|Overall Study||13
565556|NCT00635882|1380596|P5|COMPLETED|Overall Study||16
565557|NCT00635882|1380597|P4|COMPLETED|Overall Study||15
565558|NCT00635882|1380598|P3|COMPLETED|Overall Study||12
565559|NCT00635882|1380599|P2|COMPLETED|Overall Study||17
565560|NCT00635882|1380600|P1|COMPLETED|Overall Study||19
565561|NCT00635882|1380595|P6|STARTED|Overall Study||13
565562|NCT00635882|1380596|P5|STARTED|Overall Study||16
565563|NCT00635882|1380597|P4|STARTED|Overall Study||15
565564|NCT00635882|1380598|P3|STARTED|Overall Study||12
565565|NCT00635882|1380599|P2|STARTED|Overall Study||17
565566|NCT00635882|1380600|P1|STARTED|Overall Study||20
565567|NCT00635830|1380664|P2|NOT COMPLETED|Overall Study||0
565568|NCT00635830|1380665|P1|NOT COMPLETED|Overall Study||0
565569|NCT00635830|1380664|P2|COMPLETED|Overall Study||20
565570|NCT00635830|1380665|P1|COMPLETED|Overall Study||20
565571|NCT00635830|1380664|P2|STARTED|Overall Study||20
565572|NCT00635830|1380665|P1|STARTED|Overall Study||20
565573|NCT00635817|1380675|P4|NOT COMPLETED|Overall Study||0
565574|NCT00635817|1380676|P3|NOT COMPLETED|Overall Study||2
565575|NCT00635817|1380677|P2|NOT COMPLETED|Overall Study||2
565576|NCT00635817|1380678|P1|NOT COMPLETED|Overall Study||6
565577|NCT00635817|1380675|P4|COMPLETED|Overall Study||21
565578|NCT00635817|1380676|P3|COMPLETED|Overall Study||19
565579|NCT00635817|1380677|P2|COMPLETED|Overall Study||19
565580|NCT00635817|1380678|P1|COMPLETED|Overall Study||15
565581|NCT00635817|1380675|P4|STARTED|Overall Study||21
565582|NCT00635817|1380676|P3|STARTED|Overall Study||21
565583|NCT00635817|1380677|P2|STARTED|Overall Study||21
565584|NCT00635817|1380678|P1|STARTED|Overall Study||21
565585|NCT00635804|1380730|P8|NOT COMPLETED|Overall Study||0
565586|NCT00635804|1380731|P7|NOT COMPLETED|Overall Study||0
565587|NCT00635804|1380732|P6|NOT COMPLETED|Overall Study||1
565588|NCT00635804|1380733|P5|NOT COMPLETED|Overall Study||0
565589|NCT00635804|1380734|P4|NOT COMPLETED|Overall Study||0
565590|NCT00635804|1380735|P3|NOT COMPLETED|Overall Study||0
565591|NCT00635804|1380736|P2|NOT COMPLETED|Overall Study||0
565592|NCT00635804|1380737|P1|NOT COMPLETED|Overall Study||1
565593|NCT00635804|1380730|P8|COMPLETED|Overall Study||14
565594|NCT00635804|1380731|P7|COMPLETED|Overall Study||3
565595|NCT00635804|1380732|P6|COMPLETED|Overall Study||11
565596|NCT00635804|1380733|P5|COMPLETED|Overall Study||6
565597|NCT00635804|1380734|P4|COMPLETED|Overall Study||6
565598|NCT00635804|1380735|P3|COMPLETED|Overall Study||6
565599|NCT00635804|1380736|P2|COMPLETED|Overall Study||6
565600|NCT00635804|1380737|P1|COMPLETED|Overall Study||6
565601|NCT00635804|1380730|P8|STARTED|Overall Study||14
565602|NCT00635804|1380731|P7|STARTED|Overall Study||3
565603|NCT00635804|1380732|P6|STARTED|Overall Study||12
565604|NCT00635804|1380733|P5|STARTED|Overall Study||6
565605|NCT00635804|1380734|P4|STARTED|Overall Study||6
565606|NCT00635804|1380735|P3|STARTED|Overall Study||6
565607|NCT00635804|1380736|P2|STARTED|Overall Study||6
565608|NCT00635804|1380737|P1|STARTED|Overall Study||7
565609|NCT00635700|1380836|P2|NOT COMPLETED|Overall Study||14
565610|NCT00635700|1380837|P1|NOT COMPLETED|Overall Study||15
565611|NCT00635700|1380836|P2|COMPLETED|Overall Study||13
565612|NCT00635700|1380837|P1|COMPLETED|Overall Study||9
565613|NCT00635700|1380836|P2|STARTED|Overall Study||27
565614|NCT00635700|1380837|P1|STARTED|Overall Study||24
565615|NCT00635661|1380843|P1|NOT COMPLETED|Overall Study||4
565616|NCT00635661|1380843|P1|COMPLETED|Overall Study||30
565617|NCT00635661|1380843|P1|STARTED|Overall Study||34
565618|NCT00635648|1380847|P1|NOT COMPLETED|Overall Study||37
565619|NCT00635648|1380847|P1|COMPLETED|Overall Study||26
565620|NCT00635648|1380847|P1|STARTED|Overall Study||63
565621|NCT00635609|1380856|P2|NOT COMPLETED|Overall Study||3
565622|NCT00635609|1380857|P1|NOT COMPLETED|Overall Study||7
565623|NCT00635609|1380856|P2|COMPLETED|Overall Study||42
565624|NCT00635609|1380857|P1|COMPLETED|Overall Study||41
565625|NCT00635609|1380856|P2|STARTED|Overall Study||45
565626|NCT00635609|1380857|P1|STARTED|Overall Study||48
565627|NCT00635570|1380869|P2|NOT COMPLETED|Overall Study||11
565628|NCT00635570|1380870|P1|NOT COMPLETED|Overall Study||15
565629|NCT00635570|1380869|P2|COMPLETED|Overall Study||126
565630|NCT00635570|1380870|P1|COMPLETED|Overall Study||121
565631|NCT00635570|1380869|P2|STARTED|Overall Study||137
565632|NCT00635570|1380870|P1|STARTED|Overall Study||136
565633|NCT00635492|1380884|P2|NOT COMPLETED|Overall Study||282
565634|NCT00635492|1380885|P1|NOT COMPLETED|Overall Study||279
565635|NCT00635492|1380884|P2|COMPLETED|Overall Study|This population consists of patients that completed the 24 month study.|992
565636|NCT00635492|1380885|P1|COMPLETED|Overall Study|This population consists of patients that completed the 24 month study.|835
565637|NCT00635492|1380884|P2|STARTED|Overall Study|This population consists of the analysis population.|1274
565638|NCT00635492|1380885|P1|STARTED|Overall Study|This population consists of the analysis population.|1114
565639|NCT00635479|1380931|P2|NOT COMPLETED|Overall Study||18
565640|NCT00635479|1380932|P1|NOT COMPLETED|Overall Study||6
565641|NCT00635479|1380931|P2|COMPLETED|Overall Study||42
565642|NCT00635479|1380932|P1|COMPLETED|Overall Study||49
565643|NCT00635479|1380931|P2|STARTED|Overall Study||60
565644|NCT00635479|1380932|P1|STARTED|Overall Study||55
565645|NCT00635427|1380943|P5|NOT COMPLETED|Overall Study||8
565646|NCT00635427|1380944|P4|NOT COMPLETED|Overall Study||9
565647|NCT00635427|1380945|P3|NOT COMPLETED|Overall Study||11
565648|NCT00635427|1380946|P2|NOT COMPLETED|Overall Study||6
565649|NCT00635427|1380947|P1|NOT COMPLETED|Overall Study||12
565650|NCT00635427|1380943|P5|COMPLETED|Overall Study||30
565651|NCT00635427|1380944|P4|COMPLETED|Overall Study||7
565652|NCT00635427|1380945|P3|COMPLETED|Overall Study||5
565653|NCT00635427|1380946|P2|COMPLETED|Overall Study||6
565654|NCT00635427|1380947|P1|COMPLETED|Overall Study||1
565655|NCT00635427|1380943|P5|STARTED|Overall Study||38
565656|NCT00635427|1380944|P4|STARTED|Overall Study||16
565657|NCT00635427|1380945|P3|STARTED|Overall Study||16
565658|NCT00635427|1380946|P2|STARTED|Overall Study|11 participants were considered ITT population as 1 participant did not have type 1 Gaucher disease|12
565659|NCT00635427|1380947|P1|STARTED|Overall Study|12 participants were considered ITT population as 1 participant did not have type 1 Gaucher disease|13
565660|NCT00635362|1380969|P2|NOT COMPLETED|Overall Study||8
565661|NCT00635362|1380970|P1|NOT COMPLETED|Overall Study||13
565662|NCT00635362|1380969|P2|COMPLETED|Overall Study||12
565663|NCT00635362|1380970|P1|COMPLETED|Overall Study||9
565664|NCT00635362|1380969|P2|STARTED|Overall Study||20
565665|NCT00635362|1380970|P1|STARTED|Overall Study||22
565666|NCT00635349|1380986|P2|NOT COMPLETED|Overall Study||48
565667|NCT00635349|1380987|P1|NOT COMPLETED|Overall Study||44
565668|NCT00635349|1380986|P2|COMPLETED|Overall Study||19
565669|NCT00635349|1380987|P1|COMPLETED|Overall Study||29
565670|NCT00635349|1380986|P2|STARTED|Overall Study||67
565671|NCT00635349|1380987|P1|STARTED|Overall Study||73
565672|NCT00635232|1381010|P5|NOT COMPLETED|Overall Study||8
565673|NCT00635232|1381011|P4|NOT COMPLETED|Overall Study||10
565674|NCT00635232|1381012|P3|NOT COMPLETED|Overall Study||3
565675|NCT00635232|1381013|P2|NOT COMPLETED|Overall Study||20
565676|NCT00635232|1381014|P1|NOT COMPLETED|Overall Study||14
565677|NCT00635232|1381010|P5|COMPLETED|Overall Study||20
565678|NCT00635232|1381011|P4|COMPLETED|Overall Study||48
565679|NCT00635232|1381012|P3|COMPLETED|Overall Study||55
565680|NCT00635232|1381013|P2|COMPLETED|Overall Study||39
565681|NCT00635232|1381014|P1|COMPLETED|Overall Study||44
565682|NCT00635232|1381010|P5|STARTED|Overall Study||28
565683|NCT00635232|1381011|P4|STARTED|Overall Study||58
565684|NCT00635232|1381012|P3|STARTED|Overall Study||58
565685|NCT00635232|1381013|P2|STARTED|Overall Study||59
565686|NCT00635232|1381014|P1|STARTED|Overall Study||58
565687|NCT00635219|1381041|P5|NOT COMPLETED|Overall Study||42
565688|NCT00635219|1381042|P4|NOT COMPLETED|Overall Study||34
565689|NCT00635219|1381043|P3|NOT COMPLETED|Overall Study||35
565690|NCT00635219|1381044|P2|NOT COMPLETED|Overall Study||25
565691|NCT00635219|1381045|P1|NOT COMPLETED|Overall Study||25
565692|NCT00635219|1381041|P5|COMPLETED|Overall Study||113
565693|NCT00635219|1381042|P4|COMPLETED|Overall Study||117
565694|NCT00635219|1381043|P3|COMPLETED|Overall Study||122
565695|NCT00635219|1381044|P2|COMPLETED|Overall Study||130
565696|NCT00635219|1381045|P1|COMPLETED|Overall Study||123
565697|NCT00635219|1381041|P5|STARTED|Overall Study||155
565698|NCT00635219|1381042|P4|STARTED|Overall Study||151
565699|NCT00635219|1381043|P3|STARTED|Overall Study||157
565700|NCT00635219|1381044|P2|STARTED|Overall Study||155
565701|NCT00635219|1381045|P1|STARTED|Overall Study||148
565702|NCT00635154|1381102|P1|NOT COMPLETED|Overall Study||33
565703|NCT00635154|1381102|P1|COMPLETED|Overall Study||21
565704|NCT00635154|1381102|P1|STARTED|Overall Study||54
565705|NCT00635128|1381114|P2|NOT COMPLETED|Overall Study||0
565706|NCT00635128|1381115|P1|NOT COMPLETED|Overall Study||0
565707|NCT00635128|1381114|P2|COMPLETED|Overall Study||64
565708|NCT00635128|1381115|P1|COMPLETED|Overall Study||351
565709|NCT00635128|1381114|P2|STARTED|Overall Study||64
565710|NCT00635128|1381115|P1|STARTED|Overall Study||351
565711|NCT00635102|1381145|P2|NOT COMPLETED|Overall Study||8
565712|NCT00635102|1381146|P1|NOT COMPLETED|Overall Study||7
565713|NCT00635102|1381145|P2|COMPLETED|Overall Study||22
565714|NCT00635102|1381146|P1|COMPLETED|Overall Study||20
565715|NCT00635102|1381145|P2|STARTED|Overall Study||30
565716|NCT00635102|1381146|P1|STARTED|Overall Study||27
565717|NCT00635089|1381240|P1|NOT COMPLETED|Overall Study||78
565718|NCT00635089|1381240|P1|COMPLETED|Overall Study|Participants who had not withdrawn at the time of study termination.|112
565719|NCT00635089|1381240|P1|Completed >/= 16 Weeks of Study|Overall Study||181
565720|NCT00635089|1381240|P1|STARTED|Overall Study||190
565721|NCT00635050|1381267|P1|NOT COMPLETED|Overall Study||1
565722|NCT00635050|1381267|P1|COMPLETED|Overall Study|Followup through 10 years planned.|31
565723|NCT00635050|1381267|P1|STARTED|Overall Study|No patient received regimen B due to grade 3 toxicity in the third patient treated on regimen A.|32
565724|NCT00635024|1381274|P1|NOT COMPLETED|Overall Study||1
565725|NCT00635024|1381274|P1|COMPLETED|Overall Study||0
565726|NCT00635024|1381274|P1|STARTED|Overall Study||1
565727|NCT00634933|1381285|P5|NOT COMPLETED|Part B: Week 24 to Week 52||10
565728|NCT00634933|1381286|P4|NOT COMPLETED|Part B: Week 24 to Week 52||6
565729|NCT00634933|1381287|P3|NOT COMPLETED|Part B: Week 24 to Week 52||22
565730|NCT00634933|1381288|P2|NOT COMPLETED|Part B: Week 24 to Week 52||14
565731|NCT00634933|1381289|P1|NOT COMPLETED|Part B: Week 24 to Week 52||0
565732|NCT00634933|1381285|P5|COMPLETED|Part B: Week 24 to Week 52||22
565733|NCT00634933|1381286|P4|COMPLETED|Part B: Week 24 to Week 52||25
565734|NCT00634933|1381287|P3|COMPLETED|Part B: Week 24 to Week 52||33
565735|NCT00634933|1381288|P2|COMPLETED|Part B: Week 24 to Week 52||42
565736|NCT00634933|1381289|P1|COMPLETED|Part B: Week 24 to Week 52||0
565737|NCT00634933|1381285|P5|STARTED|Part B: Week 24 to Week 52||32
565738|NCT00634933|1381286|P4|STARTED|Part B: Week 24 to Week 52||31
565739|NCT00634933|1381287|P3|STARTED|Part B: Week 24 to Week 52||55
565740|NCT00634933|1381288|P2|STARTED|Part B: Week 24 to Week 52||56
565741|NCT00634933|1381289|P1|STARTED|Part B: Week 24 to Week 52||0
565742|NCT00634933|1381285|P5|NOT COMPLETED|Between Part A and Part B||0
565743|NCT00634933|1381286|P4|NOT COMPLETED|Between Part A and Part B||0
565744|NCT00634933|1381287|P3|NOT COMPLETED|Between Part A and Part B||0
565745|NCT00634933|1381288|P2|NOT COMPLETED|Between Part A and Part B||1
565746|NCT00634933|1381289|P1|NOT COMPLETED|Between Part A and Part B||0
565747|NCT00634933|1381285|P5|COMPLETED|Between Part A and Part B||32
565748|NCT00634933|1381286|P4|COMPLETED|Between Part A and Part B||31
565749|NCT00634933|1381287|P3|COMPLETED|Between Part A and Part B||55
565750|NCT00634933|1381288|P2|COMPLETED|Between Part A and Part B||56
565751|NCT00634933|1381289|P1|COMPLETED|Between Part A and Part B||0
565752|NCT00634933|1381285|P5|STARTED|Between Part A and Part B||32
565753|NCT00634933|1381286|P4|STARTED|Between Part A and Part B||31
565754|NCT00634933|1381287|P3|STARTED|Between Part A and Part B||55
565755|NCT00634933|1381288|P2|STARTED|Between Part A and Part B||57
565756|NCT00634933|1381289|P1|STARTED|Between Part A and Part B||0
565757|NCT00634933|1381285|P5|NOT COMPLETED|Part A: Baseline to Week 24||0
565758|NCT00634933|1381286|P4|NOT COMPLETED|Part A: Baseline to Week 24||0
565759|NCT00634933|1381287|P3|NOT COMPLETED|Part A: Baseline to Week 24||18
565760|NCT00634933|1381288|P2|NOT COMPLETED|Part A: Baseline to Week 24||18
565761|NCT00634933|1381289|P1|NOT COMPLETED|Part A: Baseline to Week 24||11
565762|NCT00634933|1381285|P5|COMPLETED|Part A: Baseline to Week 24||0
565763|NCT00634933|1381286|P4|COMPLETED|Part A: Baseline to Week 24||0
565764|NCT00634933|1381287|P3|COMPLETED|Part A: Baseline to Week 24||55
565765|NCT00634933|1381288|P2|COMPLETED|Part A: Baseline to Week 24||57
565766|NCT00634933|1381289|P1|COMPLETED|Part A: Baseline to Week 24||63
565767|NCT00634933|1381285|P5|STARTED|Part A: Baseline to Week 24||0
565768|NCT00634933|1381286|P4|STARTED|Part A: Baseline to Week 24||0
565769|NCT00634933|1381287|P3|STARTED|Part A: Baseline to Week 24||73
565770|NCT00634933|1381288|P2|STARTED|Part A: Baseline to Week 24||75
565771|NCT00634933|1381289|P1|STARTED|Part A: Baseline to Week 24||74
565772|NCT00634920|1381358|P3|NOT COMPLETED|Period 2 - Post-Randomization||0
565773|NCT00634920|1381359|P2|NOT COMPLETED|Period 2 - Post-Randomization||32
565774|NCT00634920|1381360|P1|NOT COMPLETED|Period 2 - Post-Randomization||61
565775|NCT00634920|1381358|P3|COMPLETED|Period 2 - Post-Randomization||0
565776|NCT00634920|1381359|P2|COMPLETED|Period 2 - Post-Randomization||68
565777|NCT00634920|1381360|P1|COMPLETED|Period 2 - Post-Randomization||43
565778|NCT00634920|1381358|P3|Full Analysis Set (FAS)|Period 2 - Post-Randomization||0
565779|NCT00634920|1381359|P2|Full Analysis Set (FAS)|Period 2 - Post-Randomization||90
565780|NCT00634920|1381360|P1|Full Analysis Set (FAS)|Period 2 - Post-Randomization||92
565781|NCT00634920|1381358|P3|STARTED|Period 2 - Post-Randomization|This group included patients who had renal TX but did not qualify for randomization at Visit 2.|0
565782|NCT00634920|1381359|P2|STARTED|Period 2 - Post-Randomization||100
565783|NCT00634920|1381360|P1|STARTED|Period 2 - Post-Randomization|2 patients randomized in this group did not receive at least one dose of study drug.|104
565784|NCT00634920|1381358|P3|NOT COMPLETED|Period 1 - Pre-Randomization||137
565785|NCT00634920|1381359|P2|NOT COMPLETED|Period 1 - Pre-Randomization||0
565786|NCT00634920|1381360|P1|NOT COMPLETED|Period 1 - Pre-Randomization||0
565787|NCT00634920|1381358|P3|COMPLETED|Period 1 - Pre-Randomization|Total number of patients who became randomized|204
565788|NCT00634920|1381359|P2|COMPLETED|Period 1 - Pre-Randomization||0
565789|NCT00634920|1381360|P1|COMPLETED|Period 1 - Pre-Randomization||0
565790|NCT00634920|1381358|P3|STARTED|Period 1 - Pre-Randomization|Total number of Enrolled patients|341
565791|NCT00634920|1381359|P2|STARTED|Period 1 - Pre-Randomization||0
565792|NCT00634920|1381360|P1|STARTED|Period 1 - Pre-Randomization||0
565793|NCT00634907|1381404|P2|NOT COMPLETED|Overall Study||17
565794|NCT00634907|1381405|P1|NOT COMPLETED|Overall Study||17
565795|NCT00634907|1381404|P2|COMPLETED|Overall Study||115
565796|NCT00634907|1381405|P1|COMPLETED|Overall Study||114
565797|NCT00634907|1381404|P2|STARTED|Overall Study||132
565798|NCT00634907|1381405|P1|STARTED|Overall Study||131
565799|NCT00634842|1381429|P2|NOT COMPLETED|Overall Study||18
565800|NCT00634842|1381430|P1|NOT COMPLETED|Overall Study||15
565801|NCT00634842|1381429|P2|COMPLETED|Overall Study||104
565802|NCT00634842|1381430|P1|COMPLETED|Overall Study||107
565803|NCT00634842|1381429|P2|STARTED|Overall Study||122
565804|NCT00634842|1381430|P1|STARTED|Overall Study||122
565805|NCT00634751|1381446|P4|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||1
565806|NCT00634751|1381447|P3|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||1
565807|NCT00634751|1381448|P2|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||0
565808|NCT00634751|1381449|P1|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||0
565809|NCT00634751|1381446|P4|COMPLETED|Pancreatic and Bilial Tract Cancer||7
565810|NCT00634751|1381447|P3|COMPLETED|Pancreatic and Bilial Tract Cancer||23
565811|NCT00634751|1381448|P2|COMPLETED|Pancreatic and Bilial Tract Cancer||0
565812|NCT00634751|1381449|P1|COMPLETED|Pancreatic and Bilial Tract Cancer||0
565813|NCT00634751|1381446|P4|STARTED|Pancreatic and Bilial Tract Cancer||8
565814|NCT00634751|1381447|P3|STARTED|Pancreatic and Bilial Tract Cancer||24
565815|NCT00634751|1381448|P2|STARTED|Pancreatic and Bilial Tract Cancer||0
565816|NCT00634751|1381449|P1|STARTED|Pancreatic and Bilial Tract Cancer||0
565817|NCT00634751|1381446|P4|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
565818|NCT00634751|1381447|P3|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
565819|NCT00634751|1381448|P2|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||1
565820|NCT00634751|1381449|P1|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
565821|NCT00634751|1381446|P4|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
565822|NCT00634751|1381447|P3|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
565823|NCT00634751|1381448|P2|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||6
565824|NCT00634751|1381449|P1|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
565825|NCT00634751|1381446|P4|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
565826|NCT00634751|1381447|P3|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
565827|NCT00634751|1381448|P2|STARTED|Phase I: 400mg Sorafenib BID+2DOC||7
565828|NCT00634751|1381449|P1|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
565829|NCT00634751|1381446|P4|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
565830|NCT00634751|1381447|P3|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
565831|NCT00634751|1381448|P2|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
565832|NCT00634751|1381449|P1|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||1
565833|NCT00634751|1381446|P4|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
565834|NCT00634751|1381447|P3|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
565835|NCT00634751|1381448|P2|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
565836|NCT00634751|1381449|P1|COMPLETED|Phase I: 200mg Sorafenib+2DOC||8
565837|NCT00634751|1381446|P4|STARTED|Phase I: 200mg Sorafenib+2DOC||0
565838|NCT00634751|1381447|P3|STARTED|Phase I: 200mg Sorafenib+2DOC||0
565839|NCT00634751|1381448|P2|STARTED|Phase I: 200mg Sorafenib+2DOC||0
565840|NCT00634751|1381449|P1|STARTED|Phase I: 200mg Sorafenib+2DOC||9
565841|NCT00634647|1381467|P1|NOT COMPLETED|Overall Study||9
565842|NCT00634647|1381467|P1|COMPLETED|Overall Study||15
565843|NCT00634647|1381467|P1|STARTED|Overall Study||24
565844|NCT00634621|1381472|P1|NOT COMPLETED|Overall Study||0
565845|NCT00634621|1381472|P1|COMPLETED|Overall Study||283
565846|NCT00634621|1381472|P1|STARTED|Overall Study||283
565847|NCT00634582|1381480|P1|NOT COMPLETED|Overall Study||0
565848|NCT00634582|1381480|P1|COMPLETED|Overall Study||2
565849|NCT00634582|1381480|P1|STARTED|Overall Study||2
565850|NCT00634569|1381486|P2|NOT COMPLETED|Overall Study||5
565851|NCT00634569|1381487|P1|NOT COMPLETED|Overall Study||0
565852|NCT00634569|1381486|P2|COMPLETED|Overall Study||5
565853|NCT00634569|1381487|P1|COMPLETED|Overall Study||14
565854|NCT00634569|1381486|P2|STARTED|Overall Study||10
565855|NCT00634569|1381487|P1|STARTED|Overall Study||14
565856|NCT00634543|1381501|P2|NOT COMPLETED|Overall Study||21
565857|NCT00634543|1381502|P1|NOT COMPLETED|Overall Study||19
565858|NCT00634543|1381501|P2|COMPLETED|Overall Study||63
565859|NCT00634543|1381502|P1|COMPLETED|Overall Study||59
565860|NCT00634543|1381501|P2|Treated|Overall Study||80
565861|NCT00634543|1381502|P1|Treated|Overall Study||76
565862|NCT00634543|1381501|P2|STARTED|Overall Study||84
565863|NCT00634543|1381502|P1|STARTED|Overall Study||78
565864|NCT00634504|1381520|P2|NOT COMPLETED|Overall Study||0
565865|NCT00634504|1381521|P1|NOT COMPLETED|Overall Study||1
565866|NCT00634504|1381520|P2|COMPLETED|Overall Study||9
565867|NCT00634504|1381521|P1|COMPLETED|Overall Study||10
565868|NCT00634504|1381520|P2|STARTED|Overall Study||9
565869|NCT00634504|1381521|P1|STARTED|Overall Study||11
565870|NCT00634322|1381530|P3|NOT COMPLETED|Overall Study||0
565871|NCT00634322|1381531|P2|NOT COMPLETED|Overall Study||0
565872|NCT00634322|1381532|P1|NOT COMPLETED|Overall Study||0
565873|NCT00634322|1381530|P3|COMPLETED|Overall Study||5
565874|NCT00634322|1381531|P2|COMPLETED|Overall Study||1
565875|NCT00634322|1381532|P1|COMPLETED|Overall Study||1
565876|NCT00634322|1381530|P3|STARTED|Overall Study||5
565877|NCT00634322|1381531|P2|STARTED|Overall Study||1
565878|NCT00634322|1381532|P1|STARTED|Overall Study||1
565879|NCT00634270|1381542|P2|NOT COMPLETED|Overall Study||1
565880|NCT00634270|1381543|P1|NOT COMPLETED|Overall Study||3
565881|NCT00634270|1381542|P2|COMPLETED|Overall Study||12
565882|NCT00634270|1381543|P1|COMPLETED|Overall Study||46
565883|NCT00634270|1381542|P2|STARTED|Overall Study||13
565884|NCT00634270|1381543|P1|STARTED|Overall Study|February 12, 2008|49
565885|NCT00634244|1381572|P3|NOT COMPLETED|Overall Study||0
565886|NCT00634244|1381573|P2|NOT COMPLETED|Overall Study||13
565887|NCT00634244|1381574|P1|NOT COMPLETED|Overall Study||1
565888|NCT00634244|1381572|P3|COMPLETED|Overall Study||20
565889|NCT00634244|1381573|P2|COMPLETED|Overall Study||24
565890|NCT00634244|1381574|P1|COMPLETED|Overall Study||34
565891|NCT00634244|1381572|P3|Eligible and Treated|Overall Study||20
565892|NCT00634244|1381573|P2|Eligible and Treated|Overall Study||36
565893|NCT00634244|1381574|P1|Eligible and Treated|Overall Study||35
565894|NCT00634244|1381572|P3|STARTED|Overall Study||20
565895|NCT00634244|1381573|P2|STARTED|Overall Study||37
565896|NCT00634244|1381574|P1|STARTED|Overall Study||35
565897|NCT00634179|1381585|P1|NOT COMPLETED|Phase II: Maintenance||1
565898|NCT00634179|1381585|P1|COMPLETED|Phase II: Maintenance||29
565899|NCT00634179|1381585|P1|STARTED|Phase II: Maintenance||30
565900|NCT00634179|1381585|P1|NOT COMPLETED|Phase I: Induction||0
565901|NCT00634179|1381585|P1|COMPLETED|Phase I: Induction||19
565902|NCT00634179|1381585|P1|STARTED|Phase I: Induction||19
565903|NCT00634166|1381594|P2|NOT COMPLETED|Overall Study||60
565904|NCT00634166|1381595|P1|NOT COMPLETED|Overall Study||60
565905|NCT00634166|1381594|P2|COMPLETED|Overall Study||78
565906|NCT00634166|1381595|P1|COMPLETED|Overall Study||22
565907|NCT00634166|1381594|P2|STARTED|Overall Study||138
565908|NCT00634166|1381595|P1|STARTED|Overall Study||82
565909|NCT00634114|1381604|P3|NOT COMPLETED|Overall Study||39
565910|NCT00634114|1381605|P2|NOT COMPLETED|Overall Study||35
565911|NCT00634114|1381606|P1|NOT COMPLETED|Overall Study||28
565912|NCT00634114|1381604|P3|COMPLETED|Overall Study|Completed|148
565913|NCT00634114|1381605|P2|COMPLETED|Overall Study|Completed|154
565914|NCT00634114|1381606|P1|COMPLETED|Overall Study|Completed|160
565915|NCT00634114|1381604|P3|STARTED|Overall Study|Randomised|187
565916|NCT00634114|1381605|P2|STARTED|Overall Study|Randomised|189
565917|NCT00634114|1381606|P1|STARTED|Overall Study|Randomised|188
565918|NCT00634088|1381624|P4|NOT COMPLETED|Time Period 4: Triplet Combination||0
565919|NCT00634088|1381625|P3|NOT COMPLETED|Time Period 4: Triplet Combination||0
565920|NCT00634088|1381626|P2|NOT COMPLETED|Time Period 4: Triplet Combination||0
565921|NCT00634088|1381627|P1|NOT COMPLETED|Time Period 4: Triplet Combination||0
565922|NCT00634088|1381624|P4|COMPLETED|Time Period 4: Triplet Combination||0
565923|NCT00634088|1381625|P3|COMPLETED|Time Period 4: Triplet Combination||0
565924|NCT00634088|1381626|P2|COMPLETED|Time Period 4: Triplet Combination||0
565925|NCT00634088|1381627|P1|COMPLETED|Time Period 4: Triplet Combination||0
565926|NCT00634088|1381624|P4|STARTED|Time Period 4: Triplet Combination||0
565927|NCT00634088|1381625|P3|STARTED|Time Period 4: Triplet Combination||0
565928|NCT00634088|1381626|P2|STARTED|Time Period 4: Triplet Combination||0
565929|NCT00634088|1381627|P1|STARTED|Time Period 4: Triplet Combination||0
565930|NCT00634088|1381624|P4|NOT COMPLETED|Time Period 3: Dose Level 3||0
565931|NCT00634088|1381625|P3|NOT COMPLETED|Time Period 3: Dose Level 3||1
565932|NCT00634088|1381626|P2|NOT COMPLETED|Time Period 3: Dose Level 3||0
565933|NCT00634088|1381627|P1|NOT COMPLETED|Time Period 3: Dose Level 3||0
565934|NCT00634088|1381624|P4|COMPLETED|Time Period 3: Dose Level 3||0
565935|NCT00634088|1381625|P3|COMPLETED|Time Period 3: Dose Level 3||0
565936|NCT00634088|1381626|P2|COMPLETED|Time Period 3: Dose Level 3||0
565937|NCT00634088|1381627|P1|COMPLETED|Time Period 3: Dose Level 3||0
565938|NCT00634088|1381624|P4|STARTED|Time Period 3: Dose Level 3||0
565939|NCT00634088|1381625|P3|STARTED|Time Period 3: Dose Level 3||1
565940|NCT00634088|1381626|P2|STARTED|Time Period 3: Dose Level 3||0
565941|NCT00634088|1381627|P1|STARTED|Time Period 3: Dose Level 3||0
565942|NCT00634088|1381624|P4|NOT COMPLETED|Time Period 2: Dose Level 2||0
565943|NCT00634088|1381625|P3|NOT COMPLETED|Time Period 2: Dose Level 2||0
565944|NCT00634088|1381626|P2|NOT COMPLETED|Time Period 2: Dose Level 2||3
565945|NCT00634088|1381627|P1|NOT COMPLETED|Time Period 2: Dose Level 2||0
565946|NCT00634088|1381624|P4|COMPLETED|Time Period 2: Dose Level 2||0
565947|NCT00634088|1381625|P3|COMPLETED|Time Period 2: Dose Level 2||0
565948|NCT00634088|1381626|P2|COMPLETED|Time Period 2: Dose Level 2||0
565949|NCT00634088|1381627|P1|COMPLETED|Time Period 2: Dose Level 2||0
565950|NCT00634088|1381624|P4|STARTED|Time Period 2: Dose Level 2||0
565951|NCT00634088|1381625|P3|STARTED|Time Period 2: Dose Level 2||0
565952|NCT00634088|1381626|P2|STARTED|Time Period 2: Dose Level 2||3
565953|NCT00634088|1381627|P1|STARTED|Time Period 2: Dose Level 2||0
565954|NCT00634088|1381624|P4|NOT COMPLETED|Time Period 1: Dose Level 1||0
565955|NCT00634088|1381625|P3|NOT COMPLETED|Time Period 1: Dose Level 1||0
565956|NCT00634088|1381626|P2|NOT COMPLETED|Time Period 1: Dose Level 1||0
565957|NCT00634088|1381627|P1|NOT COMPLETED|Time Period 1: Dose Level 1||6
565958|NCT00634088|1381624|P4|COMPLETED|Time Period 1: Dose Level 1||0
565959|NCT00634088|1381625|P3|COMPLETED|Time Period 1: Dose Level 1||0
565960|NCT00634088|1381626|P2|COMPLETED|Time Period 1: Dose Level 1||0
565961|NCT00634088|1381627|P1|COMPLETED|Time Period 1: Dose Level 1||0
565962|NCT00634088|1381624|P4|STARTED|Time Period 1: Dose Level 1||0
565963|NCT00634088|1381625|P3|STARTED|Time Period 1: Dose Level 1||0
565964|NCT00634088|1381626|P2|STARTED|Time Period 1: Dose Level 1||0
565965|NCT00634088|1381627|P1|STARTED|Time Period 1: Dose Level 1||6
565966|NCT00634049|1381678|P1|NOT COMPLETED|Overall Study||3
565967|NCT00634049|1381678|P1|COMPLETED|Overall Study||146
565968|NCT00634049|1381678|P1|STARTED|Overall Study||149
565969|NCT00634036|1381757|P2|NOT COMPLETED|Overall Study||2
565970|NCT00634036|1381758|P1|NOT COMPLETED|Overall Study||2
565971|NCT00634036|1381757|P2|COMPLETED|Overall Study||9
565972|NCT00634036|1381758|P1|COMPLETED|Overall Study||10
565973|NCT00634036|1381757|P2|STARTED|Overall Study||11
565974|NCT00634036|1381758|P1|STARTED|Overall Study||12
565975|NCT00634010|1381772|P2|NOT COMPLETED|Overall Study||14
565976|NCT00634010|1381773|P1|NOT COMPLETED|Overall Study||10
565977|NCT00634010|1381772|P2|COMPLETED|Overall Study||4
565978|NCT00634010|1381773|P1|COMPLETED|Overall Study||8
565979|NCT00634010|1381772|P2|STARTED|Overall Study||18
565980|NCT00634010|1381773|P1|STARTED|Overall Study||18
565981|NCT00633984|1381781|P2|NOT COMPLETED|Overall Study||13
565982|NCT00633984|1381782|P1|NOT COMPLETED|Overall Study||9
565983|NCT00633984|1381781|P2|COMPLETED|Overall Study||69
565984|NCT00633984|1381782|P1|COMPLETED|Overall Study||78
565985|NCT00633984|1381781|P2|STARTED|Overall Study||82
565986|NCT00633984|1381782|P1|STARTED|Overall Study||87
565987|NCT00633932|1381793|P3|NOT COMPLETED|Overall Study||11
565988|NCT00633932|1381794|P2|NOT COMPLETED|Overall Study||14
565989|NCT00633932|1381795|P1|NOT COMPLETED|Overall Study||12
565990|NCT00633932|1381793|P3|COMPLETED|Overall Study||180
565991|NCT00633932|1381794|P2|COMPLETED|Overall Study||176
565992|NCT00633932|1381795|P1|COMPLETED|Overall Study||179
565993|NCT00633932|1381793|P3|STARTED|Overall Study|Randomised|191
565994|NCT00633932|1381794|P2|STARTED|Overall Study|Randomised|190
565995|NCT00633932|1381795|P1|STARTED|Overall Study|Randomised|191
565996|NCT00633919|1381808|P2|NOT COMPLETED|Overall Study||22
565997|NCT00633919|1381809|P1|NOT COMPLETED|Overall Study||27
565998|NCT00633919|1381808|P2|COMPLETED|Overall Study||39
565999|NCT00633919|1381809|P1|COMPLETED|Overall Study||36
566000|NCT00633919|1381808|P2|STARTED|Overall Study||61
566001|NCT00633919|1381809|P1|STARTED|Overall Study||63
566002|NCT00633893|1381826|P3|NOT COMPLETED|Overall Study||188
566003|NCT00633893|1381827|P2|NOT COMPLETED|Overall Study||129
566004|NCT00633893|1381828|P1|NOT COMPLETED|Overall Study||114
566005|NCT00633893|1381826|P3|COMPLETED|Overall Study||641
566006|NCT00633893|1381827|P2|COMPLETED|Overall Study||684
566007|NCT00633893|1381828|P1|COMPLETED|Overall Study||726
566008|NCT00633893|1381826|P3|STARTED|Overall Study|3 participants were randomized to placebo but not treated.|829
566009|NCT00633893|1381827|P2|STARTED|Overall Study|2 participants were randomized to 5 mg study drug but not treated.|813
566010|NCT00633893|1381828|P1|STARTED|Overall Study||840
566011|NCT00633880|1381902|P3|NOT COMPLETED|Randomized Double Blind||0
566012|NCT00633880|1381903|P2|NOT COMPLETED|Randomized Double Blind||0
566013|NCT00633880|1381904|P1|NOT COMPLETED|Randomized Double Blind||0
566014|NCT00633880|1381902|P3|COMPLETED|Randomized Double Blind||51
566015|NCT00633880|1381903|P2|COMPLETED|Randomized Double Blind||50
566016|NCT00633880|1381904|P1|COMPLETED|Randomized Double Blind||0
566017|NCT00633880|1381902|P3|STARTED|Randomized Double Blind||51
566018|NCT00633880|1381903|P2|STARTED|Randomized Double Blind||50
566019|NCT00633880|1381904|P1|STARTED|Randomized Double Blind||0
566020|NCT00633880|1381902|P3|NOT COMPLETED|Open Label Titration||0
566021|NCT00633880|1381903|P2|NOT COMPLETED|Open Label Titration||0
566022|NCT00633880|1381904|P1|NOT COMPLETED|Open Label Titration||80
566023|NCT00633880|1381902|P3|COMPLETED|Open Label Titration||0
566024|NCT00633880|1381903|P2|COMPLETED|Open Label Titration||0
566025|NCT00633880|1381904|P1|COMPLETED|Open Label Titration||101
566026|NCT00633880|1381902|P3|STARTED|Open Label Titration||0
566027|NCT00633880|1381903|P2|STARTED|Open Label Titration||0
566028|NCT00633880|1381904|P1|STARTED|Open Label Titration||181
566029|NCT00633867|1381933|P2|NOT COMPLETED|Overall Study||0
566030|NCT00633867|1381934|P1|NOT COMPLETED|Overall Study||0
566031|NCT00633867|1381933|P2|COMPLETED|Overall Study||60
566032|NCT00633867|1381934|P1|COMPLETED|Overall Study||60
566033|NCT00633867|1381933|P2|STARTED|Overall Study||60
566034|NCT00633867|1381934|P1|STARTED|Overall Study||60
566035|NCT00633750|1381940|P1|NOT COMPLETED|Overall Study||5
566036|NCT00633750|1381940|P1|COMPLETED|Overall Study||42
566037|NCT00633750|1381940|P1|STARTED|Overall Study||47
566038|NCT00633594|1381949|P3|NOT COMPLETED|Overall Study||10
566039|NCT00633594|1381950|P2|NOT COMPLETED|Overall Study||5
566040|NCT00633594|1381951|P1|NOT COMPLETED|Overall Study||0
566041|NCT00633594|1381949|P3|COMPLETED|Overall Study||16
566042|NCT00633594|1381950|P2|COMPLETED|Overall Study||3
566043|NCT00633594|1381951|P1|COMPLETED|Overall Study||5
566044|NCT00633594|1381949|P3|STARTED|Overall Study||26
566045|NCT00633594|1381950|P2|STARTED|Overall Study||8
566046|NCT00633594|1381951|P1|STARTED|Overall Study||5
566047|NCT00633477|1381980|P2|NOT COMPLETED|Overall Study||0
566048|NCT00633477|1381981|P1|NOT COMPLETED|Overall Study||2
566049|NCT00633477|1381980|P2|COMPLETED|Overall Study|Include all subjects who could be evaluated for 28-d survival.|11
566050|NCT00633477|1381981|P1|COMPLETED|Overall Study|Include all subjects who could be evaluated for 28-d survival.|5
566051|NCT00633477|1381980|P2|Completed Study Through Day 28|Overall Study||8
566052|NCT00633477|1381981|P1|Completed Study Through Day 28|Overall Study||4
566053|NCT00633477|1381980|P2|Prematurely Discontinued Study Drug|Overall Study||0
566054|NCT00633477|1381981|P1|Prematurely Discontinued Study Drug|Overall Study||1
566055|NCT00633477|1381980|P2|Randomized But Not Treated|Overall Study||0
566056|NCT00633477|1381981|P1|Randomized But Not Treated|Overall Study||1
566057|NCT00633477|1381980|P2|STARTED|Overall Study||11
566058|NCT00633477|1381981|P1|STARTED|Overall Study|Seven subjects were randomized, however, one was not treated.|7
566059|NCT00633464|1381997|P2|NOT COMPLETED|Overall Study||2
566060|NCT00633464|1381998|P1|NOT COMPLETED|Overall Study||0
566061|NCT00633464|1381997|P2|COMPLETED|Overall Study|Completed=Offstudy;major reasons:Disease progression-25,study drug toxicity-4,subject request-3|37
566062|NCT00633464|1381998|P1|COMPLETED|Overall Study|Completed=Offstudy;major reasons:Disease progression-27,study drug toxicity-7,max clinical benefit-3|40
566063|NCT00633464|1381997|P2|Treated|Overall Study||37
566064|NCT00633464|1381998|P1|Treated|Overall Study||40
566065|NCT00633464|1381997|P2|STARTED|Overall Study||39
566066|NCT00633464|1381998|P1|STARTED|Overall Study||40
566067|NCT00633399|1382020|P2|NOT COMPLETED|Overall Study||15
566068|NCT00633399|1382021|P1|NOT COMPLETED|Overall Study||22
566069|NCT00633399|1382020|P2|COMPLETED|Overall Study||53
566070|NCT00633399|1382021|P1|COMPLETED|Overall Study||49
566071|NCT00633399|1382020|P2|STARTED|Overall Study||68
566072|NCT00633399|1382021|P1|STARTED|Overall Study||71
566073|NCT00633360|1382033|P2|NOT COMPLETED|Overall Study||3
566074|NCT00633360|1382034|P1|NOT COMPLETED|Overall Study||4
566075|NCT00633360|1382033|P2|COMPLETED|Overall Study||13
566076|NCT00633360|1382034|P1|COMPLETED|Overall Study||12
566077|NCT00633360|1382033|P2|STARTED|Overall Study||16
566078|NCT00633360|1382034|P1|STARTED|Overall Study||16
566079|NCT00633256|1382044|P2|NOT COMPLETED|Overall Study||3
566080|NCT00633256|1382045|P1|NOT COMPLETED|Overall Study||4
566081|NCT00633256|1382044|P2|COMPLETED|Overall Study||10
566082|NCT00633256|1382045|P1|COMPLETED|Overall Study||8
566083|NCT00633256|1382044|P2|STARTED|Overall Study||13
566084|NCT00633256|1382045|P1|STARTED|Overall Study||12
566085|NCT00633243|1382057|P2|NOT COMPLETED|Overall Study||7
566086|NCT00633243|1382058|P1|NOT COMPLETED|Overall Study||1
566087|NCT00633243|1382057|P2|COMPLETED|Overall Study||2
566088|NCT00633243|1382058|P1|COMPLETED|Overall Study||11
566089|NCT00633243|1382057|P2|STARTED|Overall Study||9
566090|NCT00633243|1382058|P1|STARTED|Overall Study||12
566091|NCT00633217|1382066|P2|NOT COMPLETED|Overall Study||23
566092|NCT00633217|1382067|P1|NOT COMPLETED|Overall Study||15
566093|NCT00633217|1382066|P2|COMPLETED|Overall Study||103
566094|NCT00633217|1382067|P1|COMPLETED|Overall Study||106
566095|NCT00633217|1382066|P2|STARTED|Overall Study||126
566096|NCT00633217|1382067|P1|STARTED|Overall Study||121
566097|NCT00633152|1382079|P2|NOT COMPLETED|Overall Study||6
566098|NCT00633152|1382080|P1|NOT COMPLETED|Overall Study||14
566099|NCT00633152|1382079|P2|COMPLETED|Overall Study||41
566100|NCT00633152|1382080|P1|COMPLETED|Overall Study||89
566101|NCT00633152|1382079|P2|Clinically Evaluable Population|Overall Study||39
566102|NCT00633152|1382080|P1|Clinically Evaluable Population|Overall Study||86
566103|NCT00633152|1382079|P2|MITT and Safety Population|Overall Study||45
566104|NCT00633152|1382080|P1|MITT and Safety Population|Overall Study||98
566105|NCT00633152|1382079|P2|STARTED|Overall Study||47
566106|NCT00633152|1382080|P1|STARTED|Overall Study||103
566107|NCT00633139|1382091|P3|NOT COMPLETED|Overall Study||1
566108|NCT00633139|1382092|P2|NOT COMPLETED|Overall Study||1
566109|NCT00633139|1382093|P1|NOT COMPLETED|Overall Study||0
566110|NCT00633139|1382091|P3|COMPLETED|Overall Study||3
566111|NCT00633139|1382092|P2|COMPLETED|Overall Study||4
566112|NCT00633139|1382093|P1|COMPLETED|Overall Study||4
566113|NCT00633139|1382091|P3|STARTED|Overall Study||4
566114|NCT00633139|1382092|P2|STARTED|Overall Study||5
566115|NCT00633139|1382093|P1|STARTED|Overall Study||4
566116|NCT00633126|1382107|P1|NOT COMPLETED|Overall Study||1
566117|NCT00633126|1382107|P1|COMPLETED|Overall Study||8
566118|NCT00633126|1382107|P1|STARTED|Overall Study||9
566119|NCT00633087|1382112|P1|NOT COMPLETED|Overall Study||0
566120|NCT00633087|1382112|P1|COMPLETED|Overall Study||12
566121|NCT00633087|1382112|P1|STARTED|Overall Study||12
566122|NCT00633074|1382121|P2|NOT COMPLETED|Overall Study||0
566123|NCT00633074|1382122|P1|NOT COMPLETED|Overall Study||1
566124|NCT00633074|1382121|P2|COMPLETED|Overall Study||360
566125|NCT00633074|1382122|P1|COMPLETED|Overall Study||359
566126|NCT00633074|1382121|P2|STARTED|Overall Study||360
566127|NCT00633074|1382122|P1|STARTED|Overall Study||360
566128|NCT00633009|1382153|P3|NOT COMPLETED|Overall Study||1
566129|NCT00633009|1382154|P2|NOT COMPLETED|Overall Study||4
566130|NCT00633009|1382155|P1|NOT COMPLETED|Overall Study||4
566131|NCT00633009|1382153|P3|COMPLETED|Overall Study||10
566132|NCT00633009|1382154|P2|COMPLETED|Overall Study||23
566133|NCT00633009|1382155|P1|COMPLETED|Overall Study||8
566134|NCT00633009|1382153|P3|STARTED|Overall Study||11
566135|NCT00633009|1382154|P2|STARTED|Overall Study||27
566136|NCT00633009|1382155|P1|STARTED|Overall Study||12
566137|NCT00632970|1382168|P2|NOT COMPLETED|Overall Study||0
566138|NCT00632970|1382169|P1|NOT COMPLETED|Overall Study||0
566139|NCT00632970|1382168|P2|COMPLETED|Overall Study||3
566140|NCT00632970|1382169|P1|COMPLETED|Overall Study||3
566141|NCT00632970|1382168|P2|STARTED|Overall Study||3
566142|NCT00632970|1382169|P1|STARTED|Overall Study||3
566143|NCT00632931|1382175|P3|NOT COMPLETED|Part 2||24
566144|NCT00632931|1382176|P2|NOT COMPLETED|Part 2||0
566145|NCT00632931|1382177|P1|NOT COMPLETED|Part 2||0
566146|NCT00632931|1382175|P3|COMPLETED|Part 2||0
566147|NCT00632931|1382176|P2|COMPLETED|Part 2||0
566148|NCT00632931|1382177|P1|COMPLETED|Part 2||0
566149|NCT00632931|1382175|P3|STARTED|Part 2||24
566150|NCT00632931|1382176|P2|STARTED|Part 2||0
566151|NCT00632931|1382177|P1|STARTED|Part 2||0
566152|NCT00632931|1382175|P3|NOT COMPLETED|Post-Part 1 Washout||0
566153|NCT00632931|1382176|P2|NOT COMPLETED|Post-Part 1 Washout||0
566154|NCT00632931|1382177|P1|NOT COMPLETED|Post-Part 1 Washout||0
566155|NCT00632931|1382175|P3|COMPLETED|Post-Part 1 Washout||0
566156|NCT00632931|1382176|P2|COMPLETED|Post-Part 1 Washout||12
566157|NCT00632931|1382177|P1|COMPLETED|Post-Part 1 Washout||12
566158|NCT00632931|1382175|P3|STARTED|Post-Part 1 Washout||0
566159|NCT00632931|1382176|P2|STARTED|Post-Part 1 Washout||12
566160|NCT00632931|1382177|P1|STARTED|Post-Part 1 Washout|1 patient who did not complete Period 1 was subsequently enrolled into Post Part 1|12
566161|NCT00632931|1382175|P3|NOT COMPLETED|Part 1, Period 2||0
566162|NCT00632931|1382176|P2|NOT COMPLETED|Part 1, Period 2||0
566163|NCT00632931|1382177|P1|NOT COMPLETED|Part 1, Period 2||0
566164|NCT00632931|1382175|P3|COMPLETED|Part 1, Period 2||0
566165|NCT00632931|1382176|P2|COMPLETED|Part 1, Period 2||12
566166|NCT00632931|1382177|P1|COMPLETED|Part 1, Period 2||11
566167|NCT00632931|1382175|P3|STARTED|Part 1, Period 2||0
566168|NCT00632931|1382176|P2|STARTED|Part 1, Period 2||12
566169|NCT00632931|1382177|P1|STARTED|Part 1, Period 2||11
566170|NCT00632931|1382175|P3|NOT COMPLETED|Part 1, Washout||0
566171|NCT00632931|1382176|P2|NOT COMPLETED|Part 1, Washout||0
566172|NCT00632931|1382177|P1|NOT COMPLETED|Part 1, Washout||0
566173|NCT00632931|1382175|P3|COMPLETED|Part 1, Washout||0
566174|NCT00632931|1382176|P2|COMPLETED|Part 1, Washout||12
566175|NCT00632931|1382177|P1|COMPLETED|Part 1, Washout||11
566176|NCT00632931|1382175|P3|STARTED|Part 1, Washout||0
566177|NCT00632931|1382176|P2|STARTED|Part 1, Washout||12
566178|NCT00632931|1382177|P1|STARTED|Part 1, Washout||11
566179|NCT00632931|1382175|P3|NOT COMPLETED|Part 1, Period 1||0
566180|NCT00632931|1382176|P2|NOT COMPLETED|Part 1, Period 1||0
566181|NCT00632931|1382177|P1|NOT COMPLETED|Part 1, Period 1||2
566182|NCT00632931|1382175|P3|COMPLETED|Part 1, Period 1||0
566183|NCT00632931|1382176|P2|COMPLETED|Part 1, Period 1||12
566184|NCT00632931|1382177|P1|COMPLETED|Part 1, Period 1||11
566185|NCT00632931|1382175|P3|STARTED|Part 1, Period 1||0
566186|NCT00632931|1382176|P2|STARTED|Part 1, Period 1||12
566187|NCT00632931|1382177|P1|STARTED|Part 1, Period 1||13
566188|NCT00632814|1382199|P3|NOT COMPLETED|Overall Study||0
566189|NCT00632814|1382200|P2|NOT COMPLETED|Overall Study||0
566190|NCT00632814|1382201|P1|NOT COMPLETED|Overall Study||0
566191|NCT00632814|1382199|P3|COMPLETED|Overall Study||8
566192|NCT00632814|1382200|P2|COMPLETED|Overall Study||13
566193|NCT00632814|1382201|P1|COMPLETED|Overall Study||11
566194|NCT00632814|1382199|P3|STARTED|Overall Study||8
566195|NCT00632814|1382200|P2|STARTED|Overall Study||13
566196|NCT00632814|1382201|P1|STARTED|Overall Study||11
566197|NCT00632749|1382247|P14|NOT COMPLETED|Overall Study||6
566198|NCT00632749|1382248|P13|NOT COMPLETED|Overall Study||3
566199|NCT00632749|1382249|P12|NOT COMPLETED|Overall Study||4
566200|NCT00632749|1382250|P11|NOT COMPLETED|Overall Study||7
566201|NCT00632749|1382251|P10|NOT COMPLETED|Overall Study||3
566202|NCT00632749|1382252|P9|NOT COMPLETED|Overall Study||5
566203|NCT00632749|1382253|P8|NOT COMPLETED|Overall Study||4
566204|NCT00632749|1382254|P7|NOT COMPLETED|Overall Study||5
566205|NCT00632749|1382255|P6|NOT COMPLETED|Overall Study||8
566206|NCT00632749|1382256|P5|NOT COMPLETED|Overall Study||7
566207|NCT00632749|1382257|P4|NOT COMPLETED|Overall Study||4
566208|NCT00632749|1382258|P3|NOT COMPLETED|Overall Study||3
566209|NCT00632749|1382259|P2|NOT COMPLETED|Overall Study||5
566210|NCT00632749|1382260|P1|NOT COMPLETED|Overall Study||4
566211|NCT00632749|1382247|P14|COMPLETED|Overall Study||0
566212|NCT00632749|1382248|P13|COMPLETED|Overall Study||0
566213|NCT00632749|1382249|P12|COMPLETED|Overall Study||0
566214|NCT00632749|1382250|P11|COMPLETED|Overall Study||0
566215|NCT00632749|1382251|P10|COMPLETED|Overall Study||0
566216|NCT00632749|1382252|P9|COMPLETED|Overall Study||0
566217|NCT00632749|1382253|P8|COMPLETED|Overall Study||0
566218|NCT00632749|1382254|P7|COMPLETED|Overall Study||0
566219|NCT00632749|1382255|P6|COMPLETED|Overall Study||0
566220|NCT00632749|1382256|P5|COMPLETED|Overall Study||0
566221|NCT00632749|1382257|P4|COMPLETED|Overall Study||0
566222|NCT00632749|1382258|P3|COMPLETED|Overall Study||0
566223|NCT00632749|1382259|P2|COMPLETED|Overall Study||0
566224|NCT00632749|1382260|P1|COMPLETED|Overall Study||0
566225|NCT00632749|1382247|P14|Not Treated|Overall Study||0
566226|NCT00632749|1382248|P13|Not Treated|Overall Study||0
566227|NCT00632749|1382249|P12|Not Treated|Overall Study||0
566228|NCT00632749|1382250|P11|Not Treated|Overall Study||0
566229|NCT00632749|1382251|P10|Not Treated|Overall Study||0
566230|NCT00632749|1382252|P9|Not Treated|Overall Study||0
566231|NCT00632749|1382253|P8|Not Treated|Overall Study||0
566232|NCT00632749|1382254|P7|Not Treated|Overall Study||1
566233|NCT00632749|1382255|P6|Not Treated|Overall Study||1
566234|NCT00632749|1382256|P5|Not Treated|Overall Study||0
566235|NCT00632749|1382257|P4|Not Treated|Overall Study||0
566236|NCT00632749|1382258|P3|Not Treated|Overall Study||0
566237|NCT00632749|1382259|P2|Not Treated|Overall Study||2
566238|NCT00632749|1382260|P1|Not Treated|Overall Study||0
566239|NCT00632749|1382247|P14|Treated|Overall Study||6
566240|NCT00632749|1382248|P13|Treated|Overall Study||3
566241|NCT00632749|1382249|P12|Treated|Overall Study||4
566242|NCT00632749|1382250|P11|Treated|Overall Study||7
566243|NCT00632749|1382251|P10|Treated|Overall Study||3
566244|NCT00632749|1382252|P9|Treated|Overall Study||5
566245|NCT00632749|1382253|P8|Treated|Overall Study||4
566246|NCT00632749|1382254|P7|Treated|Overall Study||4
566247|NCT00632749|1382255|P6|Treated|Overall Study||7
566248|NCT00632749|1382256|P5|Treated|Overall Study||7
566249|NCT00632749|1382257|P4|Treated|Overall Study||4
566250|NCT00632749|1382258|P3|Treated|Overall Study||3
566251|NCT00632749|1382259|P2|Treated|Overall Study||3
566252|NCT00632749|1382260|P1|Treated|Overall Study||4
566253|NCT00632749|1382247|P14|STARTED|Overall Study||6
566254|NCT00632749|1382248|P13|STARTED|Overall Study||3
566255|NCT00632749|1382249|P12|STARTED|Overall Study||4
566256|NCT00632749|1382250|P11|STARTED|Overall Study||7
566257|NCT00632749|1382251|P10|STARTED|Overall Study||3
566258|NCT00632749|1382252|P9|STARTED|Overall Study||5
566259|NCT00632749|1382253|P8|STARTED|Overall Study||4
566260|NCT00632749|1382254|P7|STARTED|Overall Study||5
566261|NCT00632749|1382255|P6|STARTED|Overall Study||8
566262|NCT00632749|1382256|P5|STARTED|Overall Study||7
566263|NCT00632749|1382257|P4|STARTED|Overall Study||4
566264|NCT00632749|1382258|P3|STARTED|Overall Study||3
566265|NCT00632749|1382259|P2|STARTED|Overall Study||5
566266|NCT00632749|1382260|P1|STARTED|Overall Study||4
566267|NCT00632736|1382554|P1|NOT COMPLETED|Overall Study||268
566268|NCT00632736|1382554|P1|COMPLETED|Overall Study||151
566269|NCT00632736|1382554|P1|STARTED|Overall Study||419
566270|NCT00632632|1382561|P2|NOT COMPLETED|Overall Study||3
566271|NCT00632632|1382562|P1|NOT COMPLETED|Overall Study||0
566272|NCT00632632|1382561|P2|COMPLETED|Overall Study||9
566273|NCT00632632|1382562|P1|COMPLETED|Overall Study||13
566274|NCT00632632|1382561|P2|STARTED|Overall Study||12
566275|NCT00632632|1382562|P1|STARTED|Overall Study||13
566276|NCT00632619|1382574|P2|NOT COMPLETED|Overall Study||4
566277|NCT00632619|1382575|P1|NOT COMPLETED|Overall Study||8
566278|NCT00632619|1382574|P2|COMPLETED|Overall Study|"st cohort completed follow up by 5/24/10~nd cohort completed follow up 7/18/11"|31
566279|NCT00632619|1382575|P1|COMPLETED|Overall Study|"st cohort completed follow up by 5/24/10~nd cohort completed follow up 7/18/11"|25
566280|NCT00632619|1382574|P2|STARTED|Overall Study|first cohort started 9/11/09 second cohort started 12/7/11|35
566281|NCT00632619|1382575|P1|STARTED|Overall Study|first cohort started 9/11/09 second cohort started 12/7/11|33
566282|NCT00632541|1382589|P1|NOT COMPLETED|Overall Study||7
566283|NCT00632541|1382589|P1|COMPLETED|Overall Study||11
566284|NCT00632541|1382589|P1|STARTED|Overall Study|18 subjects were accrued to the study|18
566285|NCT00632502|1382598|P2|NOT COMPLETED|Overall Study||1
566286|NCT00632502|1382599|P1|NOT COMPLETED|Overall Study||3
566287|NCT00632502|1382598|P2|COMPLETED|Overall Study||11
566288|NCT00632502|1382599|P1|COMPLETED|Overall Study||22
566289|NCT00632502|1382598|P2|Completed Treatment|Overall Study||9
566290|NCT00632502|1382599|P1|Completed Treatment|Overall Study||19
566291|NCT00632502|1382598|P2|Treated|Overall Study||12
566292|NCT00632502|1382599|P1|Treated|Overall Study||22
566293|NCT00632502|1382598|P2|STARTED|Overall Study||12
566294|NCT00632502|1382599|P1|STARTED|Overall Study||25
566295|NCT00632489|1382627|P3|NOT COMPLETED|Overall Study||0
566296|NCT00632489|1382628|P2|NOT COMPLETED|Overall Study||5
566297|NCT00632489|1382629|P1|NOT COMPLETED|Overall Study||15
566298|NCT00632489|1382627|P3|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
566299|NCT00632489|1382628|P2|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
566300|NCT00632489|1382629|P1|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
566301|NCT00632489|1382627|P3|STARTED|Overall Study||0
566302|NCT00632489|1382628|P2|STARTED|Overall Study||5
566303|NCT00632489|1382629|P1|STARTED|Overall Study||15
566304|NCT00632463|1382643|P3|NOT COMPLETED|Overall Study||0
566305|NCT00632463|1382644|P2|NOT COMPLETED|Overall Study||1
566306|NCT00632463|1382645|P1|NOT COMPLETED|Overall Study||0
566307|NCT00632463|1382643|P3|COMPLETED|Overall Study||7
566308|NCT00632463|1382644|P2|COMPLETED|Overall Study||6
566309|NCT00632463|1382645|P1|COMPLETED|Overall Study||7
566310|NCT00632463|1382643|P3|STARTED|Overall Study||7
566311|NCT00632463|1382644|P2|STARTED|Overall Study||7
566312|NCT00632463|1382645|P1|STARTED|Overall Study||7
566313|NCT00632424|1382662|P1|NOT COMPLETED|Overall Study||18
566314|NCT00632424|1382662|P1|COMPLETED|Overall Study||0
566315|NCT00632424|1382662|P1|STARTED|Overall Study||18
566316|NCT00632411|1382686|P2|NOT COMPLETED|Overall Study||176
566317|NCT00632411|1382687|P1|NOT COMPLETED|Overall Study||160
566318|NCT00632411|1382686|P2|COMPLETED|Overall Study||473
566319|NCT00632411|1382687|P1|COMPLETED|Overall Study||489
566320|NCT00632411|1382686|P2|STARTED|Overall Study||649
566321|NCT00632411|1382687|P1|STARTED|Overall Study||649
566322|NCT00632281|1382693|P1|NOT COMPLETED|Overall Study||0
566323|NCT00632281|1382693|P1|COMPLETED|Overall Study||38
566324|NCT00632281|1382693|P1|STARTED|Overall Study||38
566325|NCT00632229|1382700|P2|NOT COMPLETED|Overall Study||6
566326|NCT00632229|1382701|P1|NOT COMPLETED|Overall Study||6
566327|NCT00632229|1382700|P2|COMPLETED|Overall Study||11
566328|NCT00632229|1382701|P1|COMPLETED|Overall Study||11
566329|NCT00632229|1382700|P2|STARTED|Overall Study||17
566330|NCT00632229|1382701|P1|STARTED|Overall Study||17
566331|NCT00632203|1382711|P2|NOT COMPLETED|Overall Study||0
566332|NCT00632203|1382712|P1|NOT COMPLETED|Overall Study||1
566333|NCT00632203|1382711|P2|COMPLETED|Overall Study||27
566334|NCT00632203|1382712|P1|COMPLETED|Overall Study||25
566335|NCT00632203|1382711|P2|STARTED|Overall Study||27
566336|NCT00632203|1382712|P1|STARTED|Overall Study||26
566337|NCT00632125|1382730|P1|NOT COMPLETED|Overall Study||302
566338|NCT00632125|1382730|P1|COMPLETED|Overall Study||1393
566339|NCT00632125|1382730|P1|STARTED|Overall Study|1,698 patients were enrolled but 3 patients did not receive any study medication.|1695
566340|NCT00632099|1382736|P2|NOT COMPLETED|Overall Study||3
566341|NCT00632099|1382737|P1|NOT COMPLETED|Overall Study||3
566342|NCT00632099|1382736|P2|COMPLETED|Overall Study||8
566343|NCT00632099|1382737|P1|COMPLETED|Overall Study||7
566344|NCT00632099|1382736|P2|STARTED|Overall Study||11
566345|NCT00632099|1382737|P1|STARTED|Overall Study||10
566346|NCT00632021|1382745|P2|NOT COMPLETED|Overall Study||7
566347|NCT00632021|1382746|P1|NOT COMPLETED|Overall Study||4
566348|NCT00632021|1382745|P2|COMPLETED|Overall Study||423
566349|NCT00632021|1382746|P1|COMPLETED|Overall Study||428
566350|NCT00632021|1382745|P2|STARTED|Overall Study||430
566351|NCT00632021|1382746|P1|STARTED|Overall Study||432
566352|NCT00631969|1382756|P2|NOT COMPLETED|Overall Study||21
566353|NCT00631969|1382757|P1|NOT COMPLETED|Overall Study||15
566354|NCT00631969|1382756|P2|COMPLETED|Overall Study||155
566355|NCT00631969|1382757|P1|COMPLETED|Overall Study||171
566356|NCT00631969|1382756|P2|Received Treatment|Overall Study|safety population|174
566357|NCT00631969|1382757|P1|Received Treatment|Overall Study|safety population|184
566358|NCT00631969|1382756|P2|STARTED|Overall Study||176
566359|NCT00631969|1382757|P1|STARTED|Overall Study||186
566360|NCT00631917|1382803|P2|NOT COMPLETED|Overall Study||108
566361|NCT00631917|1382804|P1|NOT COMPLETED|Overall Study||88
566362|NCT00631917|1382803|P2|COMPLETED|Overall Study||291
566363|NCT00631917|1382804|P1|COMPLETED|Overall Study||287
566364|NCT00631917|1382803|P2|STARTED|Overall Study||399
566365|NCT00631917|1382804|P1|STARTED|Overall Study||375
566366|NCT00631748|1382820|P2|NOT COMPLETED|Overall Study||22
566367|NCT00631748|1382821|P1|NOT COMPLETED|Overall Study||18
566368|NCT00631748|1382820|P2|COMPLETED|Overall Study|9 participants completed the double-blind portion of the study; 5 participants completed follow-up.|9
566369|NCT00631748|1382821|P1|COMPLETED|Overall Study|11 participants completed the double-blind portion of the study; 8 participants completed follow-up.|11
566370|NCT00631748|1382820|P2|STARTED|Overall Study||31
566371|NCT00631748|1382821|P1|STARTED|Overall Study||29
566372|NCT00631696|1382831|P2|NOT COMPLETED|Overall Study||40
566373|NCT00631696|1382832|P1|NOT COMPLETED|Overall Study||37
566374|NCT00631696|1382831|P2|COMPLETED|Overall Study|Completed study at time of database release 18Oct2011.|70
566375|NCT00631696|1382832|P1|COMPLETED|Overall Study|Completed study at time of database release 18Oct2011.|75
566376|NCT00631696|1382831|P2|Ongoing at Database Release 18Oct2011|Overall Study||0
566377|NCT00631696|1382832|P1|Ongoing at Database Release 18Oct2011|Overall Study|Completed Tx at time of database release 18Oct2011; included in all analyses.|2
566378|NCT00631696|1382831|P2|Received Study Treatment (Tx)|Overall Study||109
566379|NCT00631696|1382832|P1|Received Study Treatment (Tx)|Overall Study||111
566380|NCT00631696|1382831|P2|STARTED|Overall Study||110
566381|NCT00631696|1382832|P1|STARTED|Overall Study||112
566382|NCT00631670|1382858|P2|NOT COMPLETED|Overall Study||0
566383|NCT00631670|1382859|P1|NOT COMPLETED|Overall Study||0
566384|NCT00631670|1382858|P2|COMPLETED|Overall Study||0
566385|NCT00631670|1382859|P1|COMPLETED|Overall Study||21
566386|NCT00631670|1382858|P2|STARTED|Overall Study||0
566387|NCT00631670|1382859|P1|STARTED|Overall Study||21
566388|NCT00631657|1382875|P3|NOT COMPLETED|7-Day Discontinuation Period||1
566389|NCT00631657|1382876|P2|NOT COMPLETED|7-Day Discontinuation Period||1
566390|NCT00631657|1382877|P1|NOT COMPLETED|7-Day Discontinuation Period||2
566391|NCT00631657|1382875|P3|COMPLETED|7-Day Discontinuation Period||65
566392|NCT00631657|1382876|P2|COMPLETED|7-Day Discontinuation Period||136
566393|NCT00631657|1382877|P1|COMPLETED|7-Day Discontinuation Period||65
566394|NCT00631657|1382875|P3|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|65
566395|NCT00631657|1382876|P2|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|136
566396|NCT00631657|1382877|P1|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|66
566397|NCT00631657|1382875|P3|STARTED|7-Day Discontinuation Period||66
566398|NCT00631657|1382876|P2|STARTED|7-Day Discontinuation Period||137
566399|NCT00631657|1382877|P1|STARTED|7-Day Discontinuation Period|One participant was radomized in the Discont. Period, without completing the Treatment Period.|67
566400|NCT00631657|1382875|P3|NOT COMPLETED|6-Month Treatment Period||50
566401|NCT00631657|1382876|P2|NOT COMPLETED|6-Month Treatment Period||0
566402|NCT00631657|1382877|P1|NOT COMPLETED|6-Month Treatment Period||141
566403|NCT00631657|1382875|P3|COMPLETED|6-Month Treatment Period||66
566404|NCT00631657|1382876|P2|COMPLETED|6-Month Treatment Period||0
566405|NCT00631657|1382877|P1|COMPLETED|6-Month Treatment Period||203
566406|NCT00631657|1382875|P3|Treated|6-Month Treatment Period|One randomized participant was not treated during the 6-month Treatment Period.|115
566407|NCT00631657|1382876|P2|Treated|6-Month Treatment Period||0
566408|NCT00631657|1382877|P1|Treated|6-Month Treatment Period|Two randomized participants were not treated during the 6-month Treatment Period.|342
566409|NCT00631657|1382875|P3|STARTED|6-Month Treatment Period||116
566410|NCT00631657|1382876|P2|STARTED|6-Month Treatment Period||0
566411|NCT00631657|1382877|P1|STARTED|6-Month Treatment Period||344
566412|NCT00631540|1382904|P1|NOT COMPLETED|Overall Study||14
566413|NCT00631540|1382904|P1|COMPLETED|Overall Study||86
566414|NCT00631540|1382904|P1|STARTED|Overall Study||100
566415|NCT00631488|1382916|P3|NOT COMPLETED|Overall Study||2
566416|NCT00631488|1382917|P2|NOT COMPLETED|Overall Study||2
566417|NCT00631488|1382918|P1|NOT COMPLETED|Overall Study||4
566418|NCT00631488|1382916|P3|COMPLETED|Overall Study||47
566419|NCT00631488|1382917|P2|COMPLETED|Overall Study||47
566420|NCT00631488|1382918|P1|COMPLETED|Overall Study||44
566421|NCT00631488|1382916|P3|Completed Post-Treatment Period|Overall Study||47
566422|NCT00631488|1382917|P2|Completed Post-Treatment Period|Overall Study||47
566423|NCT00631488|1382918|P1|Completed Post-Treatment Period|Overall Study||44
566424|NCT00631488|1382916|P3|STARTED|Overall Study||49
566425|NCT00631488|1382917|P2|STARTED|Overall Study||49
566426|NCT00631488|1382918|P1|STARTED|Overall Study||48
566427|NCT00631475|1382938|P1|NOT COMPLETED|Overall Study||45
566428|NCT00631475|1382938|P1|COMPLETED|Overall Study||83
566429|NCT00631475|1382938|P1|STARTED|Overall Study||128
566430|NCT00631449|1382948|P2|NOT COMPLETED|Overall Study||0
566431|NCT00631449|1382949|P1|NOT COMPLETED|Overall Study||0
566432|NCT00631449|1382948|P2|COMPLETED|Overall Study||15
566433|NCT00631449|1382949|P1|COMPLETED|Overall Study||15
566434|NCT00631449|1382948|P2|STARTED|Overall Study||15
566435|NCT00631449|1382949|P1|STARTED|Overall Study||15
566436|NCT00631410|1382957|P2|NOT COMPLETED|Overall Study||6
566437|NCT00631410|1382958|P1|NOT COMPLETED|Overall Study||6
566438|NCT00631410|1382957|P2|COMPLETED|Overall Study||0
566439|NCT00631410|1382958|P1|COMPLETED|Overall Study||0
566440|NCT00631410|1382957|P2|STARTED|Overall Study||6
566441|NCT00631410|1382958|P1|STARTED|Overall Study||6
566442|NCT00631371|1382977|P2|NOT COMPLETED|Overall Study||391
566443|NCT00631371|1382978|P1|NOT COMPLETED|Overall Study||400
566444|NCT00631371|1382977|P2|COMPLETED|Overall Study||0
566445|NCT00631371|1382978|P1|COMPLETED|Overall Study||0
566446|NCT00631371|1382977|P2|Treated|Overall Study||391
566447|NCT00631371|1382978|P1|Treated|Overall Study||393
566448|NCT00631371|1382977|P2|STARTED|Overall Study||391
566449|NCT00631371|1382978|P1|STARTED|Overall Study||400
566450|NCT00631358|1382992|P2|NOT COMPLETED|Overall Study||2
566451|NCT00631358|1382993|P1|NOT COMPLETED|Overall Study||6
566452|NCT00631358|1382992|P2|COMPLETED|Overall Study||45
566453|NCT00631358|1382993|P1|COMPLETED|Overall Study||44
566454|NCT00631358|1382992|P2|STARTED|Overall Study||47
566455|NCT00631358|1382993|P1|STARTED|Overall Study||50
566456|NCT00631189|1383011|P4|NOT COMPLETED|Treatment Phase||7
566457|NCT00631189|1383012|P3|NOT COMPLETED|Treatment Phase||11
566458|NCT00631189|1383013|P2|NOT COMPLETED|Treatment Phase||7
566459|NCT00631189|1383014|P1|NOT COMPLETED|Treatment Phase||0
566460|NCT00631189|1383011|P4|COMPLETED|Treatment Phase||103
566461|NCT00631189|1383012|P3|COMPLETED|Treatment Phase||92
566462|NCT00631189|1383013|P2|COMPLETED|Treatment Phase||97
566463|NCT00631189|1383014|P1|COMPLETED|Treatment Phase||0
566464|NCT00631189|1383011|P4|STARTED|Treatment Phase||110
566465|NCT00631189|1383012|P3|STARTED|Treatment Phase||103
566466|NCT00631189|1383013|P2|STARTED|Treatment Phase||104
566467|NCT00631189|1383014|P1|STARTED|Treatment Phase||0
566468|NCT00631189|1383011|P4|NOT COMPLETED|Initial Phase||0
566469|NCT00631189|1383012|P3|NOT COMPLETED|Initial Phase||0
566470|NCT00631189|1383013|P2|NOT COMPLETED|Initial Phase||0
566471|NCT00631189|1383014|P1|NOT COMPLETED|Initial Phase||351
566472|NCT00631189|1383011|P4|COMPLETED|Initial Phase||0
566473|NCT00631189|1383012|P3|COMPLETED|Initial Phase||0
566474|NCT00631189|1383013|P2|COMPLETED|Initial Phase||0
566475|NCT00631189|1383014|P1|COMPLETED|Initial Phase||317
566476|NCT00631189|1383011|P4|STARTED|Initial Phase||0
566477|NCT00631189|1383012|P3|STARTED|Initial Phase||0
566478|NCT00631189|1383013|P2|STARTED|Initial Phase||0
566479|NCT00631189|1383014|P1|STARTED|Initial Phase||668
566480|NCT00631020|1383056|P1|NOT COMPLETED|Overall Study||8
566481|NCT00631020|1383056|P1|COMPLETED|Overall Study||26
566482|NCT00631020|1383056|P1|STARTED|Overall Study||34
566483|NCT00631007|1383071|P6|NOT COMPLETED|Overall Study||15
566484|NCT00631007|1383072|P5|NOT COMPLETED|Overall Study||12
566485|NCT00631007|1383073|P4|NOT COMPLETED|Overall Study||9
566486|NCT00631007|1383074|P3|NOT COMPLETED|Overall Study||10
566487|NCT00631007|1383075|P2|NOT COMPLETED|Overall Study||11
566488|NCT00631007|1383076|P1|NOT COMPLETED|Overall Study||11
566489|NCT00631007|1383071|P6|COMPLETED|Overall Study||46
566490|NCT00631007|1383072|P5|COMPLETED|Overall Study||48
566491|NCT00631007|1383073|P4|COMPLETED|Overall Study||53
566492|NCT00631007|1383074|P3|COMPLETED|Overall Study||53
566493|NCT00631007|1383075|P2|COMPLETED|Overall Study||50
566494|NCT00631007|1383076|P1|COMPLETED|Overall Study||49
566495|NCT00631007|1383071|P6|STARTED|Overall Study||61
566496|NCT00631007|1383072|P5|STARTED|Overall Study||60
566497|NCT00631007|1383073|P4|STARTED|Overall Study||62
566498|NCT00631007|1383074|P3|STARTED|Overall Study||63
566499|NCT00631007|1383075|P2|STARTED|Overall Study||61
566500|NCT00631007|1383076|P1|STARTED|Overall Study||60
566501|NCT00630994|1383096|P1|NOT COMPLETED|Overall Study||4
566502|NCT00630994|1383096|P1|COMPLETED|Overall Study||0
566503|NCT00630994|1383096|P1|STARTED|Overall Study||4
566504|NCT00630955|1383107|P3|NOT COMPLETED|Overall Study||12
566505|NCT00630955|1383108|P2|NOT COMPLETED|Overall Study||6
566506|NCT00630955|1383109|P1|NOT COMPLETED|Overall Study||3
566507|NCT00630955|1383107|P3|COMPLETED|Overall Study||28
566508|NCT00630955|1383108|P2|COMPLETED|Overall Study||31
566509|NCT00630955|1383109|P1|COMPLETED|Overall Study||31
566510|NCT00630955|1383107|P3|STARTED|Overall Study||40
566511|NCT00630955|1383108|P2|STARTED|Overall Study||37
566512|NCT00630955|1383109|P1|STARTED|Overall Study||34
566513|NCT00630916|1383126|P1|NOT COMPLETED|Overall Study||210
566514|NCT00630916|1383126|P1|COMPLETED|Overall Study|The number of patients that were active (i.e. not drop out) at the end of the study.|546
566515|NCT00630916|1383126|P1|Study Cohort|Overall Study|Enrolled but did not receive device via physician decision, protocol violation, or lack of efficacy.|699
566516|NCT00630916|1383126|P1|STARTED|Overall Study|Total patients enrolled (i.e. consented) to participate in the study.|756
566517|NCT00630877|1383136|P3|NOT COMPLETED|Overall Study||10
566518|NCT00630877|1383137|P2|NOT COMPLETED|Overall Study||15
566519|NCT00630877|1383138|P1|NOT COMPLETED|Overall Study||19
566520|NCT00630877|1383136|P3|COMPLETED|Overall Study||80
566521|NCT00630877|1383137|P2|COMPLETED|Overall Study||75
566522|NCT00630877|1383138|P1|COMPLETED|Overall Study||72
566523|NCT00630877|1383136|P3|STARTED|Overall Study||90
566524|NCT00630877|1383137|P2|STARTED|Overall Study||90
566525|NCT00630877|1383138|P1|STARTED|Overall Study|For all arms, started means treated.|91
566526|NCT00630864|1383156|P1|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||2
566527|NCT00630864|1383156|P1|COMPLETED|Part 2 (After Week 6 up to Month 12)||18
566528|NCT00630864|1383156|P1|STARTED|Part 2 (After Week 6 up to Month 12)||20
566529|NCT00630864|1383156|P1|NOT COMPLETED|Part 1 (up to Week 6)||1
566530|NCT00630864|1383156|P1|COMPLETED|Part 1 (up to Week 6)||20
566531|NCT00630864|1383156|P1|STARTED|Part 1 (up to Week 6)||21
566532|NCT00630838|1383195|P2|NOT COMPLETED|Overall Study||2
566533|NCT00630838|1383196|P1|NOT COMPLETED|Overall Study||0
566534|NCT00630838|1383195|P2|COMPLETED|Overall Study||28
566535|NCT00630838|1383196|P1|COMPLETED|Overall Study||32
566536|NCT00630838|1383195|P2|STARTED|Overall Study||30
566537|NCT00630838|1383196|P1|STARTED|Overall Study||32
566538|NCT00630825|1383208|P4|NOT COMPLETED|Overall Study||6
566539|NCT00630825|1383209|P3|NOT COMPLETED|Overall Study||8
566540|NCT00630825|1383210|P2|NOT COMPLETED|Overall Study||7
566541|NCT00630825|1383211|P1|NOT COMPLETED|Overall Study||9
566542|NCT00630825|1383208|P4|COMPLETED|Overall Study||60
566543|NCT00630825|1383209|P3|COMPLETED|Overall Study||58
566544|NCT00630825|1383210|P2|COMPLETED|Overall Study||58
566545|NCT00630825|1383211|P1|COMPLETED|Overall Study||56
566546|NCT00630825|1383208|P4|Received at Least One Dose of Study Drug|Overall Study||66
566547|NCT00630825|1383209|P3|Received at Least One Dose of Study Drug|Overall Study||66
566548|NCT00630825|1383210|P2|Received at Least One Dose of Study Drug|Overall Study||65
566549|NCT00630825|1383211|P1|Received at Least One Dose of Study Drug|Overall Study||65
566550|NCT00630825|1383208|P4|STARTED|Overall Study||66
566551|NCT00630825|1383209|P3|STARTED|Overall Study||66
566552|NCT00630825|1383210|P2|STARTED|Overall Study||65
566553|NCT00630825|1383211|P1|STARTED|Overall Study||65
566554|NCT00630786|1383283|P3|NOT COMPLETED|Overall Study||2
566555|NCT00630786|1383284|P2|NOT COMPLETED|Overall Study||2
566556|NCT00630786|1383285|P1|NOT COMPLETED|Overall Study||1
566557|NCT00630786|1383283|P3|COMPLETED|Overall Study|Completed study defined as participant death|7
566558|NCT00630786|1383284|P2|COMPLETED|Overall Study|Completed study defined as participant death|23
566559|NCT00630786|1383285|P1|COMPLETED|Overall Study|Completed study defined as participant death|18
566560|NCT00630786|1383283|P3|Received Study Medication|Overall Study||8
566561|NCT00630786|1383284|P2|Received Study Medication|Overall Study||25
566562|NCT00630786|1383285|P1|Received Study Medication|Overall Study||19
566563|NCT00630786|1383283|P3|STARTED|Overall Study|All patients were enrolled in Part 2.|9
566564|NCT00630786|1383284|P2|STARTED|Overall Study|Includes 3 patients enrolled in Part 1 and 22 patients enrolled in Part 2.|25
566565|NCT00630786|1383285|P1|STARTED|Overall Study|Includes 2 patients enrolled in Part 1 and 17 patients enrolled in Part 2.|19
566566|NCT00630747|1383304|P1|NOT COMPLETED|Overall Study||9
566567|NCT00630747|1383304|P1|COMPLETED|Overall Study||85
566568|NCT00630747|1383304|P1|Participants Treated in Phase I of Study|Overall Study||94
566569|NCT00630747|1383304|P1|STARTED|Overall Study||94
566570|NCT00630734|1383316|P3|NOT COMPLETED|Overall Study||1
566571|NCT00630734|1383317|P2|NOT COMPLETED|Overall Study||1
566572|NCT00630734|1383318|P1|NOT COMPLETED|Overall Study||2
566573|NCT00630734|1383316|P3|COMPLETED|Overall Study||7
566574|NCT00630734|1383317|P2|COMPLETED|Overall Study||12
566575|NCT00630734|1383318|P1|COMPLETED|Overall Study||9
566576|NCT00630734|1383316|P3|STARTED|Overall Study||8
566577|NCT00630734|1383317|P2|STARTED|Overall Study||13
566578|NCT00630734|1383318|P1|STARTED|Overall Study||11
566579|NCT00630539|1383357|P4|NOT COMPLETED|Overall Study||3
566580|NCT00630539|1383358|P3|NOT COMPLETED|Overall Study||1
566581|NCT00630539|1383359|P2|NOT COMPLETED|Overall Study||4
566582|NCT00630539|1383360|P1|NOT COMPLETED|Overall Study||1
566583|NCT00630539|1383357|P4|COMPLETED|Overall Study||27
566584|NCT00630539|1383358|P3|COMPLETED|Overall Study||28
566585|NCT00630539|1383359|P2|COMPLETED|Overall Study||29
566586|NCT00630539|1383360|P1|COMPLETED|Overall Study||33
566587|NCT00630539|1383357|P4|STARTED|Overall Study||30
566588|NCT00630539|1383358|P3|STARTED|Overall Study||29
566589|NCT00630539|1383359|P2|STARTED|Overall Study||33
566590|NCT00630539|1383360|P1|STARTED|Overall Study||34
566591|NCT00630487|1383416|P2|NOT COMPLETED|Overall Study||0
566592|NCT00630487|1383417|P1|NOT COMPLETED|Overall Study||0
566593|NCT00630487|1383416|P2|COMPLETED|Overall Study||0
566594|NCT00630487|1383417|P1|COMPLETED|Overall Study||0
566595|NCT00630487|1383416|P2|STARTED|Overall Study||0
566596|NCT00630487|1383417|P1|STARTED|Overall Study||0
566597|NCT00630409|1383451|P1|NOT COMPLETED|Overall Study||1
566598|NCT00630409|1383451|P1|COMPLETED|Overall Study||4
566599|NCT00630409|1383451|P1|STARTED|Overall Study||5
566600|NCT00630396|1383456|P1|NOT COMPLETED|Overall Study||7
566601|NCT00630396|1383456|P1|COMPLETED|Overall Study||53
566602|NCT00630396|1383456|P1|STARTED|Overall Study||60
566603|NCT00630344|1383462|P1|NOT COMPLETED|Overall Study||36
566604|NCT00630344|1383462|P1|COMPLETED|Overall Study||0
566605|NCT00630344|1383462|P1|STARTED|Overall Study||36
566606|NCT00630331|1383474|P3|NOT COMPLETED|Overall Study||188
566607|NCT00630331|1383475|P2|NOT COMPLETED|Overall Study||166
566608|NCT00630331|1383476|P1|NOT COMPLETED|Overall Study||206
566609|NCT00630331|1383474|P3|COMPLETED|Overall Study||3712
566610|NCT00630331|1383475|P2|COMPLETED|Overall Study||3510
566611|NCT00630331|1383476|P1|COMPLETED|Overall Study||3622
566612|NCT00630331|1383474|P3|STARTED|Overall Study||3900
566613|NCT00630331|1383475|P2|STARTED|Overall Study||3676
566614|NCT00630331|1383476|P1|STARTED|Overall Study||3828
566615|NCT00630305|1383517|P1|NOT COMPLETED|Overall Study||2
566616|NCT00630305|1383517|P1|COMPLETED|Overall Study||35
566617|NCT00630305|1383517|P1|STARTED|Overall Study||37
566618|NCT00630292|1383539|P1|NOT COMPLETED|Overall Study||1
566619|NCT00630292|1383539|P1|COMPLETED|Overall Study||5
566620|NCT00630292|1383539|P1|STARTED|Overall Study||6
566621|NCT00630058|1383545|P2|NOT COMPLETED|Overall Study||4
566622|NCT00630058|1383546|P1|NOT COMPLETED|Overall Study||4
566623|NCT00630058|1383545|P2|COMPLETED|Overall Study||6
566624|NCT00630058|1383546|P1|COMPLETED|Overall Study||6
566625|NCT00630058|1383545|P2|STARTED|Overall Study||10
566626|NCT00630058|1383546|P1|STARTED|Overall Study||10
566627|NCT00629850|1383564|P2|NOT COMPLETED|Overall Study||0
566628|NCT00629850|1383565|P1|NOT COMPLETED|Overall Study||0
566629|NCT00629850|1383564|P2|COMPLETED|Overall Study||0
566630|NCT00629850|1383565|P1|COMPLETED|Overall Study||1
566631|NCT00629850|1383564|P2|STARTED|Overall Study||0
566632|NCT00629850|1383565|P1|STARTED|Overall Study||1
566633|NCT00629772|1383577|P2|NOT COMPLETED|Second Intervention Week 14 - Week 26||2
566634|NCT00629772|1383578|P1|NOT COMPLETED|Second Intervention Week 14 - Week 26||1
566635|NCT00629772|1383577|P2|COMPLETED|Second Intervention Week 14 - Week 26||10
566636|NCT00629772|1383578|P1|COMPLETED|Second Intervention Week 14 - Week 26||11
566637|NCT00629772|1383577|P2|STARTED|Second Intervention Week 14 - Week 26||12
566638|NCT00629772|1383578|P1|STARTED|Second Intervention Week 14 - Week 26|Patient withdrew at Week 14 and therefore never received infliximab.|12
566639|NCT00629772|1383577|P2|NOT COMPLETED|First Intervention - Day 0 - Week 14||0
566640|NCT00629772|1383578|P1|NOT COMPLETED|First Intervention - Day 0 - Week 14||0
566641|NCT00629772|1383577|P2|COMPLETED|First Intervention - Day 0 - Week 14||12
566642|NCT00629772|1383578|P1|COMPLETED|First Intervention - Day 0 - Week 14||12
566643|NCT00629772|1383577|P2|STARTED|First Intervention - Day 0 - Week 14||12
566644|NCT00629772|1383578|P1|STARTED|First Intervention - Day 0 - Week 14||12
566645|NCT00629707|1383598|P2|NOT COMPLETED|Overall Study||2
566646|NCT00629707|1383599|P1|NOT COMPLETED|Overall Study||0
566647|NCT00629707|1383598|P2|COMPLETED|Overall Study||8
566648|NCT00629707|1383599|P1|COMPLETED|Overall Study||10
566649|NCT00629707|1383598|P2|STARTED|Overall Study||10
566650|NCT00629707|1383599|P1|STARTED|Overall Study||10
566651|NCT00629525|1383605|P1|NOT COMPLETED|Overall Study||3
566652|NCT00629525|1383605|P1|COMPLETED|Overall Study||32
566653|NCT00629525|1383605|P1|STARTED|Overall Study||35
566654|NCT00629499|1383613|P1|NOT COMPLETED|Overall Study||0
566655|NCT00629499|1383613|P1|COMPLETED|Overall Study||63
566656|NCT00629499|1383613|P1|STARTED|Overall Study||63
566657|NCT00629265|1383619|P2|NOT COMPLETED|Overall Study||20
566658|NCT00629265|1383620|P1|NOT COMPLETED|Overall Study||32
566659|NCT00629265|1383619|P2|COMPLETED|Overall Study||34
566660|NCT00629265|1383620|P1|COMPLETED|Overall Study||84
566661|NCT00629265|1383619|P2|STARTED|Overall Study||54
566662|NCT00629265|1383620|P1|STARTED|Overall Study||116
566663|NCT00629239|1383630|P2|NOT COMPLETED|Overall Study||4
566664|NCT00629239|1383631|P1|NOT COMPLETED|Overall Study||8
566665|NCT00629239|1383630|P2|COMPLETED|Overall Study||28
566666|NCT00629239|1383631|P1|COMPLETED|Overall Study||26
566667|NCT00629239|1383630|P2|STARTED|Overall Study||32
566668|NCT00629239|1383631|P1|STARTED|Overall Study||34
566669|NCT00629122|1383665|P2|NOT COMPLETED|Third Period: Day 6-8 (Oral)||0
566670|NCT00629122|1383666|P1|NOT COMPLETED|Third Period: Day 6-8 (Oral)||0
566671|NCT00629122|1383665|P2|COMPLETED|Third Period: Day 6-8 (Oral)||3
566672|NCT00629122|1383666|P1|COMPLETED|Third Period: Day 6-8 (Oral)||2
566673|NCT00629122|1383665|P2|STARTED|Third Period: Day 6-8 (Oral)||3
566674|NCT00629122|1383666|P1|STARTED|Third Period: Day 6-8 (Oral)||2
566675|NCT00629122|1383665|P2|NOT COMPLETED|Second Period: Day 3-5 (Washout)||0
566676|NCT00629122|1383666|P1|NOT COMPLETED|Second Period: Day 3-5 (Washout)||0
566677|NCT00629122|1383665|P2|COMPLETED|Second Period: Day 3-5 (Washout)||3
566678|NCT00629122|1383666|P1|COMPLETED|Second Period: Day 3-5 (Washout)||2
566679|NCT00629122|1383665|P2|STARTED|Second Period: Day 3-5 (Washout)||3
566680|NCT00629122|1383666|P1|STARTED|Second Period: Day 3-5 (Washout)||2
566681|NCT00629122|1383665|P2|NOT COMPLETED|First Period: Day 1- 3 (Sublingual)||0
566682|NCT00629122|1383666|P1|NOT COMPLETED|First Period: Day 1- 3 (Sublingual)||0
566683|NCT00629122|1383665|P2|COMPLETED|First Period: Day 1- 3 (Sublingual)||3
566684|NCT00629122|1383666|P1|COMPLETED|First Period: Day 1- 3 (Sublingual)||2
566685|NCT00629122|1383665|P2|STARTED|First Period: Day 1- 3 (Sublingual)||3
566686|NCT00629122|1383666|P1|STARTED|First Period: Day 1- 3 (Sublingual)||2
566687|NCT00629018|1383684|P2|NOT COMPLETED|Overall Study||0
566688|NCT00629018|1383685|P1|NOT COMPLETED|Overall Study||0
566689|NCT00629018|1383684|P2|COMPLETED|Overall Study||55
566690|NCT00629018|1383685|P1|COMPLETED|Overall Study||55
566691|NCT00629018|1383684|P2|STARTED|Overall Study||55
566692|NCT00629018|1383685|P1|STARTED|Overall Study||55
566693|NCT00628927|1383695|P2|NOT COMPLETED|Overall Study||0
566694|NCT00628927|1383696|P1|NOT COMPLETED|Overall Study||8
566695|NCT00628927|1383695|P2|COMPLETED|Overall Study||30
566696|NCT00628927|1383696|P1|COMPLETED|Overall Study||175
566697|NCT00628927|1383695|P2|STARTED|Overall Study||30
566698|NCT00628927|1383696|P1|STARTED|Overall Study||183
566699|NCT00628901|1383709|P2|NOT COMPLETED|Overall Study||1
566700|NCT00628901|1383710|P1|NOT COMPLETED|Overall Study||3
566701|NCT00628901|1383709|P2|COMPLETED|Overall Study||29
566702|NCT00628901|1383710|P1|COMPLETED|Overall Study||27
566703|NCT00628901|1383709|P2|STARTED|Overall Study||30
566704|NCT00628901|1383710|P1|STARTED|Overall Study||30
566705|NCT00628862|1383741|P3|NOT COMPLETED|Overall Study||22
566706|NCT00628862|1383742|P2|NOT COMPLETED|Overall Study||17
566707|NCT00628862|1383743|P1|NOT COMPLETED|Overall Study||11
566708|NCT00628862|1383741|P3|COMPLETED|Overall Study|randomised patients|186
566709|NCT00628862|1383742|P2|COMPLETED|Overall Study|randomised patients|182
566710|NCT00628862|1383743|P1|COMPLETED|Overall Study|randomised patients|195
566711|NCT00628862|1383741|P3|STARTED|Overall Study|randomised patients|208
566712|NCT00628862|1383742|P2|STARTED|Overall Study|randomised patients|199
566713|NCT00628862|1383743|P1|STARTED|Overall Study|randomised patients|206
566714|NCT00628758|1383789|P2|NOT COMPLETED|Overall Study||42
566715|NCT00628758|1383790|P1|NOT COMPLETED|Overall Study||44
566716|NCT00628758|1383789|P2|COMPLETED|Overall Study||179
566717|NCT00628758|1383790|P1|COMPLETED|Overall Study||165
566718|NCT00628758|1383789|P2|STARTED|Overall Study||221
566719|NCT00628758|1383790|P1|STARTED|Overall Study||209
566720|NCT00628628|1383804|P2|NOT COMPLETED|Overall Study||0
566721|NCT00628628|1383805|P1|NOT COMPLETED|Overall Study||0
566722|NCT00628628|1383804|P2|COMPLETED|Overall Study||40
566723|NCT00628628|1383805|P1|COMPLETED|Overall Study||40
566724|NCT00628628|1383804|P2|STARTED|Overall Study||40
566725|NCT00628628|1383805|P1|STARTED|Overall Study||40
566726|NCT00628589|1383814|P3|NOT COMPLETED|Overall Study||3
566727|NCT00628589|1383815|P2|NOT COMPLETED|Overall Study||2
566728|NCT00628589|1383816|P1|NOT COMPLETED|Overall Study||1
566729|NCT00628589|1383814|P3|COMPLETED|Overall Study||110
566730|NCT00628589|1383815|P2|COMPLETED|Overall Study||114
566731|NCT00628589|1383816|P1|COMPLETED|Overall Study||114
566732|NCT00628589|1383814|P3|STARTED|Overall Study||113
566733|NCT00628589|1383815|P2|STARTED|Overall Study||116
566734|NCT00628589|1383816|P1|STARTED|Overall Study||115
566735|NCT00628498|1383830|P1|NOT COMPLETED|Overall Study||52
566736|NCT00628498|1383830|P1|COMPLETED|Overall Study||1154
566737|NCT00628498|1383830|P1|STARTED|Overall Study||1206
566738|NCT00628446|1383834|P1|NOT COMPLETED|Overall Study||7
566739|NCT00628446|1383834|P1|COMPLETED|Overall Study||38
566740|NCT00628446|1383834|P1|STARTED|Overall Study||45
566741|NCT00628407|1383839|P1|NOT COMPLETED|Overall Study||0
566742|NCT00628407|1383839|P1|COMPLETED|Overall Study||13
566743|NCT00628407|1383839|P1|STARTED|Overall Study||13
566744|NCT00628355|1383845|P2|NOT COMPLETED|Overall Study||1
566745|NCT00628355|1383846|P1|NOT COMPLETED|Overall Study||1
566746|NCT00628355|1383845|P2|COMPLETED|Overall Study||14
566747|NCT00628355|1383846|P1|COMPLETED|Overall Study||14
566748|NCT00628355|1383845|P2|STARTED|Overall Study||15
566749|NCT00628355|1383846|P1|STARTED|Overall Study||15
566750|NCT00628251|1383857|P3|NOT COMPLETED|Cross-over/ Continuation of Olaparib||17
566751|NCT00628251|1383858|P2|NOT COMPLETED|Cross-over/ Continuation of Olaparib||26
566752|NCT00628251|1383859|P1|NOT COMPLETED|Cross-over/ Continuation of Olaparib||27
566753|NCT00628251|1383857|P3|COMPLETED|Cross-over/ Continuation of Olaparib|Patients ongoing crossover treatment|8
566754|NCT00628251|1383858|P2|COMPLETED|Cross-over/ Continuation of Olaparib|Ongoing initial study treatment at primary data cut-off|6
566755|NCT00628251|1383859|P1|COMPLETED|Cross-over/ Continuation of Olaparib|Ongoing initial study treatment at primary data cut-off|5
566756|NCT00628251|1383857|P3|STARTED|Cross-over/ Continuation of Olaparib|Patients who crossed over from Liposomal doxorubicin to Olaparib 400 mg bd|25
566757|NCT00628251|1383858|P2|STARTED|Cross-over/ Continuation of Olaparib|Patients who received treatment|32
566758|NCT00628251|1383859|P1|STARTED|Cross-over/ Continuation of Olaparib|Patients who received treatment|32
566759|NCT00628251|1383857|P3|NOT COMPLETED|Randomised Part||8
566760|NCT00628251|1383858|P2|NOT COMPLETED|Randomised Part||0
566761|NCT00628251|1383859|P1|NOT COMPLETED|Randomised Part||0
566762|NCT00628251|1383857|P3|COMPLETED|Randomised Part|Patients who received olaparib (crossed over). 1 of 33 did not receive Liposomal Doxorubicin.|25
566763|NCT00628251|1383858|P2|COMPLETED|Randomised Part|Patients who received olaparib treatment|32
566764|NCT00628251|1383859|P1|COMPLETED|Randomised Part|Patients who received olaparib treatment|32
566765|NCT00628251|1383857|P3|STARTED|Randomised Part|Patients randomised|33
566766|NCT00628251|1383858|P2|STARTED|Randomised Part|Patients randomised|32
566767|NCT00628251|1383859|P1|STARTED|Randomised Part|Patients randomised|32
566768|NCT00628212|1383902|P4|NOT COMPLETED|Overall Study||5
566769|NCT00628212|1383903|P3|NOT COMPLETED|Overall Study||3
566770|NCT00628212|1383904|P2|NOT COMPLETED|Overall Study||1
566771|NCT00628212|1383905|P1|NOT COMPLETED|Overall Study||3
566772|NCT00628212|1383902|P4|COMPLETED|Overall Study||76
566773|NCT00628212|1383903|P3|COMPLETED|Overall Study||76
566774|NCT00628212|1383904|P2|COMPLETED|Overall Study||83
566775|NCT00628212|1383905|P1|COMPLETED|Overall Study||77
566776|NCT00628212|1383902|P4|STARTED|Overall Study||81
566777|NCT00628212|1383903|P3|STARTED|Overall Study||79
566778|NCT00628212|1383904|P2|STARTED|Overall Study||84
566779|NCT00628212|1383905|P1|STARTED|Overall Study||80
566780|NCT00628147|1383929|P2|NOT COMPLETED|Overall Study||1
566781|NCT00628147|1383930|P1|NOT COMPLETED|Overall Study||7
566782|NCT00628147|1383929|P2|COMPLETED|Overall Study||141
566783|NCT00628147|1383930|P1|COMPLETED|Overall Study||135
566784|NCT00628147|1383929|P2|STARTED|Overall Study||142
566785|NCT00628147|1383930|P1|STARTED|Overall Study||142
566786|NCT00628134|1383942|P2|NOT COMPLETED|Overall Study||0
566787|NCT00628134|1383943|P1|NOT COMPLETED|Overall Study||0
566788|NCT00628134|1383942|P2|COMPLETED|Overall Study||4
566789|NCT00628134|1383943|P1|COMPLETED|Overall Study||4
566790|NCT00628134|1383942|P2|STARTED|Overall Study||4
566791|NCT00628134|1383943|P1|STARTED|Overall Study||4
566792|NCT00628108|1383953|P2|NOT COMPLETED|Overall Study||3
566793|NCT00628108|1383954|P1|NOT COMPLETED|Overall Study||1
566794|NCT00628108|1383953|P2|COMPLETED|Overall Study||43
566795|NCT00628108|1383954|P1|COMPLETED|Overall Study||22
566796|NCT00628108|1383953|P2|Safety Population|Overall Study|Subjects in the Safety Population were analyzed as treated.|45
566797|NCT00628108|1383954|P1|Safety Population|Overall Study||24
566798|NCT00628108|1383953|P2|STARTED|Overall Study|One subject was randomized to levocetirizine but received placebo.|46
566799|NCT00628108|1383954|P1|STARTED|Overall Study||23
566800|NCT00628030|1383986|P2|NOT COMPLETED|Post to 6 Month Follow-up||30
566801|NCT00628030|1383987|P1|NOT COMPLETED|Post to 6 Month Follow-up||32
566802|NCT00628030|1383986|P2|COMPLETED|Post to 6 Month Follow-up||33
566803|NCT00628030|1383987|P1|COMPLETED|Post to 6 Month Follow-up||27
566804|NCT00628030|1383986|P2|STARTED|Post to 6 Month Follow-up||63
566805|NCT00628030|1383987|P1|STARTED|Post to 6 Month Follow-up||59
566806|NCT00628030|1383986|P2|NOT COMPLETED|Baseline to Post-Assessment||29
566807|NCT00628030|1383987|P1|NOT COMPLETED|Baseline to Post-Assessment||33
566808|NCT00628030|1383986|P2|COMPLETED|Baseline to Post-Assessment||63
566809|NCT00628030|1383987|P1|COMPLETED|Baseline to Post-Assessment||59
566810|NCT00628030|1383986|P2|STARTED|Baseline to Post-Assessment||92
566811|NCT00628030|1383987|P1|STARTED|Baseline to Post-Assessment||92
566812|NCT00627978|1384003|P2|NOT COMPLETED|Overall Study||0
566813|NCT00627978|1384004|P1|NOT COMPLETED|Overall Study||0
566814|NCT00627978|1384003|P2|COMPLETED|Overall Study||5
566815|NCT00627978|1384004|P1|COMPLETED|Overall Study||10
566816|NCT00627978|1384003|P2|STARTED|Overall Study||5
566817|NCT00627978|1384004|P1|STARTED|Overall Study||10
566818|NCT00627926|1384013|P3|NOT COMPLETED|Overall Study||95
566819|NCT00627926|1384014|P2|NOT COMPLETED|Overall Study||104
566820|NCT00627926|1384015|P1|NOT COMPLETED|Overall Study||159
566821|NCT00627926|1384013|P3|COMPLETED|Overall Study||268
566822|NCT00627926|1384014|P2|COMPLETED|Overall Study||260
566823|NCT00627926|1384015|P1|COMPLETED|Overall Study||202
566824|NCT00627926|1384013|P3|STARTED|Overall Study||363
566825|NCT00627926|1384014|P2|STARTED|Overall Study||364
566826|NCT00627926|1384015|P1|STARTED|Overall Study||361
566827|NCT00627861|1384059|P1|NOT COMPLETED|Overall Study||0
566828|NCT00627861|1384059|P1|COMPLETED|Overall Study||1
566829|NCT00627861|1384059|P1|STARTED|Overall Study||1
566830|NCT00627705|1384067|P2|NOT COMPLETED|Overall Study||6
566831|NCT00627705|1384068|P1|NOT COMPLETED|Overall Study||2
566832|NCT00627705|1384067|P2|COMPLETED|Overall Study||12
566833|NCT00627705|1384068|P1|COMPLETED|Overall Study||13
566834|NCT00627705|1384067|P2|STARTED|Overall Study||18
566835|NCT00627705|1384068|P1|STARTED|Overall Study||15
566836|NCT00627679|1384088|P4|NOT COMPLETED|Overall Study||0
566837|NCT00627679|1384089|P3|NOT COMPLETED|Overall Study||0
566838|NCT00627679|1384090|P2|NOT COMPLETED|Overall Study||0
566839|NCT00627679|1384091|P1|NOT COMPLETED|Overall Study||0
566840|NCT00627679|1384088|P4|COMPLETED|Overall Study||4
566841|NCT00627679|1384089|P3|COMPLETED|Overall Study||4
566842|NCT00627679|1384090|P2|COMPLETED|Overall Study||4
566843|NCT00627679|1384091|P1|COMPLETED|Overall Study||4
566844|NCT00627679|1384088|P4|STARTED|Overall Study||4
566845|NCT00627679|1384089|P3|STARTED|Overall Study||4
566846|NCT00627679|1384090|P2|STARTED|Overall Study||4
566847|NCT00627679|1384091|P1|STARTED|Overall Study||4
566848|NCT00627523|1384119|P2|NOT COMPLETED|Overall Study||2
566849|NCT00627523|1384120|P1|NOT COMPLETED|Overall Study||2
566850|NCT00627523|1384119|P2|COMPLETED|Overall Study||20
566851|NCT00627523|1384120|P1|COMPLETED|Overall Study||19
566852|NCT00627523|1384119|P2|STARTED|Overall Study||22
566853|NCT00627523|1384120|P1|STARTED|Overall Study|22 assigned to Genotropin and 21 in Control; 1 did not take Genotropin, so considered as Control.|21
566854|NCT00627497|1384148|P4|NOT COMPLETED|Overall Study||0
566855|NCT00627497|1384149|P3|NOT COMPLETED|Overall Study||0
566856|NCT00627497|1384150|P2|NOT COMPLETED|Overall Study||1
566857|NCT00627497|1384151|P1|NOT COMPLETED|Overall Study||1
566858|NCT00627497|1384148|P4|COMPLETED|Overall Study||2
566859|NCT00627497|1384149|P3|COMPLETED|Overall Study||4
566860|NCT00627497|1384150|P2|COMPLETED|Overall Study||11
566861|NCT00627497|1384151|P1|COMPLETED|Overall Study||13
566862|NCT00627497|1384148|P4|STARTED|Overall Study||2
566863|NCT00627497|1384149|P3|STARTED|Overall Study||4
566864|NCT00627497|1384150|P2|STARTED|Overall Study||12
566865|NCT00627497|1384151|P1|STARTED|Overall Study||14
566866|NCT00627458|1384212|P3|NOT COMPLETED|Overall Study||6
566867|NCT00627458|1384213|P2|NOT COMPLETED|Overall Study||7
566868|NCT00627458|1384214|P1|NOT COMPLETED|Overall Study||4
566869|NCT00627458|1384212|P3|COMPLETED|Overall Study||133
566870|NCT00627458|1384213|P2|COMPLETED|Overall Study||130
566871|NCT00627458|1384214|P1|COMPLETED|Overall Study||123
566872|NCT00627458|1384212|P3|STARTED|Overall Study||139
566873|NCT00627458|1384213|P2|STARTED|Overall Study||137
566874|NCT00627458|1384214|P1|STARTED|Overall Study||127
566875|NCT00627445|1384289|P2|NOT COMPLETED|Overall Study||12
566876|NCT00627445|1384290|P1|NOT COMPLETED|Overall Study||9
566877|NCT00627445|1384289|P2|COMPLETED|Overall Study||210
566878|NCT00627445|1384290|P1|COMPLETED|Overall Study||210
566879|NCT00627445|1384289|P2|Exposed to Study Drug|Overall Study||222
566880|NCT00627445|1384290|P1|Exposed to Study Drug|Overall Study||219
566881|NCT00627445|1384289|P2|STARTED|Overall Study||222
566882|NCT00627445|1384290|P1|STARTED|Overall Study||219
566883|NCT00627406|1384314|P4|NOT COMPLETED|Overall Study||0
566884|NCT00627406|1384315|P3|NOT COMPLETED|Overall Study||0
566885|NCT00627406|1384316|P2|NOT COMPLETED|Overall Study||0
566886|NCT00627406|1384317|P1|NOT COMPLETED|Overall Study||0
566887|NCT00627406|1384314|P4|COMPLETED|Overall Study||141
566888|NCT00627406|1384315|P3|COMPLETED|Overall Study||125
566889|NCT00627406|1384316|P2|COMPLETED|Overall Study||58
566890|NCT00627406|1384317|P1|COMPLETED|Overall Study||60
566891|NCT00627406|1384314|P4|STARTED|Overall Study||141
566892|NCT00627406|1384315|P3|STARTED|Overall Study||125
566893|NCT00627406|1384316|P2|STARTED|Overall Study||58
566894|NCT00627406|1384317|P1|STARTED|Overall Study||60
566895|NCT00627393|1384333|P2|NOT COMPLETED|Per-Protocol Analysis||13
566896|NCT00627393|1384334|P1|NOT COMPLETED|Per-Protocol Analysis||10
566897|NCT00627393|1384333|P2|COMPLETED|Per-Protocol Analysis||35
566898|NCT00627393|1384334|P1|COMPLETED|Per-Protocol Analysis||39
566899|NCT00627393|1384333|P2|STARTED|Per-Protocol Analysis||48
566900|NCT00627393|1384334|P1|STARTED|Per-Protocol Analysis||49
566901|NCT00627393|1384333|P2|NOT COMPLETED|Intention-To-Treat Analysis||8
566902|NCT00627393|1384334|P1|NOT COMPLETED|Intention-To-Treat Analysis||9
566903|NCT00627393|1384333|P2|COMPLETED|Intention-To-Treat Analysis||48
566904|NCT00627393|1384334|P1|COMPLETED|Intention-To-Treat Analysis||49
566905|NCT00627393|1384333|P2|STARTED|Intention-To-Treat Analysis||56
566906|NCT00627393|1384334|P1|STARTED|Intention-To-Treat Analysis||58
566907|NCT00627367|1384355|P2|NOT COMPLETED|Overall Study||0
566908|NCT00627367|1384356|P1|NOT COMPLETED|Overall Study||0
566909|NCT00627367|1384355|P2|COMPLETED|Overall Study||112
566910|NCT00627367|1384356|P1|COMPLETED|Overall Study||112
566911|NCT00627367|1384355|P2|STARTED|Overall Study||112
566912|NCT00627367|1384356|P1|STARTED|Overall Study||112
566913|NCT00627094|1384370|P2|NOT COMPLETED|Overall Study||15
566914|NCT00627094|1384371|P1|NOT COMPLETED|Overall Study||12
566915|NCT00627094|1384370|P2|COMPLETED|Overall Study||45
566916|NCT00627094|1384371|P1|COMPLETED|Overall Study||48
566917|NCT00627094|1384370|P2|STARTED|Overall Study||60
566918|NCT00627094|1384371|P1|STARTED|Overall Study||60
566919|NCT00627042|1384383|P1|NOT COMPLETED|Overall Study||2
566920|NCT00627042|1384383|P1|COMPLETED|Overall Study||40
566921|NCT00627042|1384383|P1|Received at Least 1 Dose of Study Drug|Overall Study||42
566922|NCT00627042|1384383|P1|STARTED|Overall Study||42
566923|NCT00627016|1384395|P2|NOT COMPLETED|Overall Study||6
566924|NCT00627016|1384396|P1|NOT COMPLETED|Overall Study||6
566925|NCT00627016|1384395|P2|COMPLETED|Overall Study||146
566926|NCT00627016|1384396|P1|COMPLETED|Overall Study||147
566927|NCT00627016|1384395|P2|STARTED|Overall Study||152
566928|NCT00627016|1384396|P1|STARTED|Overall Study||153
566929|NCT00626925|1384408|P2|NOT COMPLETED|Overall Study||9
566930|NCT00626925|1384409|P1|NOT COMPLETED|Overall Study||12
566931|NCT00626925|1384408|P2|COMPLETED|Overall Study||62
566932|NCT00626925|1384409|P1|COMPLETED|Overall Study||55
566933|NCT00626925|1384408|P2|STARTED|Overall Study||71
566934|NCT00626925|1384409|P1|STARTED|Overall Study||67
566935|NCT00626821|1384441|P1|NOT COMPLETED|Overall Study||221
566936|NCT00626821|1384441|P1|COMPLETED|Overall Study||2796
566937|NCT00626821|1384441|P1|Quality of Life|Overall Study|Attended both visit 1 and visit 2|2672
566938|NCT00626821|1384441|P1|STARTED|Overall Study||3017
566939|NCT00626808|1384449|P4|NOT COMPLETED|Overall Study||0
566940|NCT00626808|1384450|P3|NOT COMPLETED|Overall Study||0
566941|NCT00626808|1384451|P2|NOT COMPLETED|Overall Study||0
566942|NCT00626808|1384452|P1|NOT COMPLETED|Overall Study||0
566943|NCT00626808|1384449|P4|COMPLETED|Overall Study||2906
566944|NCT00626808|1384450|P3|COMPLETED|Overall Study||30011
566945|NCT00626808|1384451|P2|COMPLETED|Overall Study||34316
566946|NCT00626808|1384452|P1|COMPLETED|Overall Study||254464
566947|NCT00626808|1384449|P4|STARTED|Overall Study||2906
566948|NCT00626808|1384450|P3|STARTED|Overall Study||30011
566949|NCT00626808|1384451|P2|STARTED|Overall Study||34316
566950|NCT00626808|1384452|P1|STARTED|Overall Study||254464
566951|NCT00626782|1384520|P2|NOT COMPLETED|Overall Study||0
566952|NCT00626782|1384521|P1|NOT COMPLETED|Overall Study||0
566953|NCT00626782|1384520|P2|COMPLETED|Overall Study||12
566954|NCT00626782|1384521|P1|COMPLETED|Overall Study||12
566955|NCT00626782|1384520|P2|STARTED|Overall Study||12
566956|NCT00626782|1384521|P1|STARTED|Overall Study||12
566957|NCT00626743|1384531|P2|NOT COMPLETED|Treatment Period 2||0
566958|NCT00626743|1384532|P1|NOT COMPLETED|Treatment Period 2||0
566959|NCT00626743|1384531|P2|COMPLETED|Treatment Period 2||6
566960|NCT00626743|1384532|P1|COMPLETED|Treatment Period 2||6
566961|NCT00626743|1384531|P2|STARTED|Treatment Period 2||6
566962|NCT00626743|1384532|P1|STARTED|Treatment Period 2||6
566963|NCT00626743|1384531|P2|NOT COMPLETED|Wash-out Period of 6 Days||0
566964|NCT00626743|1384532|P1|NOT COMPLETED|Wash-out Period of 6 Days||0
566965|NCT00626743|1384531|P2|COMPLETED|Wash-out Period of 6 Days||6
566966|NCT00626743|1384532|P1|COMPLETED|Wash-out Period of 6 Days||6
566967|NCT00626743|1384531|P2|STARTED|Wash-out Period of 6 Days||6
566968|NCT00626743|1384532|P1|STARTED|Wash-out Period of 6 Days||6
566969|NCT00626743|1384531|P2|NOT COMPLETED|Treatment Period 1||1
566970|NCT00626743|1384532|P1|NOT COMPLETED|Treatment Period 1||0
566971|NCT00626743|1384531|P2|COMPLETED|Treatment Period 1||6
566972|NCT00626743|1384532|P1|COMPLETED|Treatment Period 1||6
566973|NCT00626743|1384531|P2|STARTED|Treatment Period 1||7
566974|NCT00626743|1384532|P1|STARTED|Treatment Period 1||6
566975|NCT00626639|1384542|P2|NOT COMPLETED|Overall Study||2
566976|NCT00626639|1384543|P1|NOT COMPLETED|Overall Study||2
566977|NCT00626639|1384542|P2|COMPLETED|Overall Study|Participants who received all 8 doses of investigational product.|1
566978|NCT00626639|1384543|P1|COMPLETED|Overall Study|Participants who received all 8 doses of investigational product.|0
566979|NCT00626639|1384542|P2|STARTED|Overall Study||3
566980|NCT00626639|1384543|P1|STARTED|Overall Study||2
566981|NCT00626626|1384563|P2|NOT COMPLETED|Overall Study||0
566982|NCT00626626|1384564|P1|NOT COMPLETED|Overall Study||0
566983|NCT00626626|1384563|P2|COMPLETED|Overall Study||3
566984|NCT00626626|1384564|P1|COMPLETED|Overall Study||5
566985|NCT00626626|1384563|P2|STARTED|Overall Study||3
566986|NCT00626626|1384564|P1|STARTED|Overall Study||5
566987|NCT00626574|1384576|P2|NOT COMPLETED|Overall Study||0
566988|NCT00626574|1384577|P1|NOT COMPLETED|Overall Study||0
566989|NCT00626574|1384576|P2|COMPLETED|Overall Study||1
566990|NCT00626574|1384577|P1|COMPLETED|Overall Study||2
566991|NCT00626574|1384576|P2|STARTED|Overall Study||1
566992|NCT00626574|1384577|P1|STARTED|Overall Study||2
566993|NCT00626561|1384583|P1|NOT COMPLETED|Overall Study||4
566994|NCT00626561|1384583|P1|COMPLETED|Overall Study||0
566995|NCT00626561|1384583|P1|STARTED|Overall Study||4
566996|NCT00626548|1384589|P2|NOT COMPLETED|Overall Study||716
566997|NCT00626548|1384590|P1|NOT COMPLETED|Overall Study||705
566998|NCT00626548|1384589|P2|COMPLETED|Overall Study||0
566999|NCT00626548|1384590|P1|COMPLETED|Overall Study||0
567000|NCT00626548|1384589|P2|Patients Received Treatment|Overall Study||712
567001|NCT00626548|1384590|P1|Patients Received Treatment|Overall Study||703
567002|NCT00626548|1384589|P2|STARTED|Overall Study||716
567003|NCT00626548|1384590|P1|STARTED|Overall Study||705
567004|NCT00626522|1384604|P6|NOT COMPLETED|Overall Study||2
567005|NCT00626522|1384605|P5|NOT COMPLETED|Overall Study||7
567006|NCT00626522|1384606|P4|NOT COMPLETED|Overall Study||2
567007|NCT00626522|1384607|P3|NOT COMPLETED|Overall Study||8
567008|NCT00626522|1384608|P2|NOT COMPLETED|Overall Study||7
567009|NCT00626522|1384609|P1|NOT COMPLETED|Overall Study||6
567010|NCT00626522|1384604|P6|COMPLETED|Overall Study||57
567011|NCT00626522|1384605|P5|COMPLETED|Overall Study||58
567012|NCT00626522|1384606|P4|COMPLETED|Overall Study||74
567013|NCT00626522|1384607|P3|COMPLETED|Overall Study||117
567014|NCT00626522|1384608|P2|COMPLETED|Overall Study||113
567015|NCT00626522|1384609|P1|COMPLETED|Overall Study||115
567016|NCT00626522|1384604|P6|STARTED|Overall Study||59
567017|NCT00626522|1384605|P5|STARTED|Overall Study||65
567018|NCT00626522|1384606|P4|STARTED|Overall Study||76
567019|NCT00626522|1384607|P3|STARTED|Overall Study||125
567020|NCT00626522|1384608|P2|STARTED|Overall Study||120
567021|NCT00626522|1384609|P1|STARTED|Overall Study||121
567022|NCT00626444|1384647|P1|NOT COMPLETED|Overall Study||0
567023|NCT00626444|1384647|P1|COMPLETED|Overall Study||2
567024|NCT00626444|1384647|P1|STARTED|Overall Study||2
567025|NCT00626431|1384654|P2|NOT COMPLETED|Overall Study||45
567026|NCT00626431|1384655|P1|NOT COMPLETED|Overall Study||17
567027|NCT00626431|1384654|P2|COMPLETED|Overall Study||114
567028|NCT00626431|1384655|P1|COMPLETED|Overall Study||134
567201|NCT00626275|1384745|P4|COMPLETED|Part A - Treatment Period 2||8
567029|NCT00626431|1384654|P2|STARTED|Overall Study|Separate groups of subjects received Formulation A and B and data were not compared between groups.|159
567030|NCT00626431|1384655|P1|STARTED|Overall Study|Separate groups of subjects received Formulation A and B and data were not compared between groups.|151
567031|NCT00626405|1384672|P2|NOT COMPLETED|Overall Study||1
567032|NCT00626405|1384673|P1|NOT COMPLETED|Overall Study||1
567033|NCT00626405|1384672|P2|COMPLETED|Overall Study||51
567034|NCT00626405|1384673|P1|COMPLETED|Overall Study||42
567035|NCT00626405|1384672|P2|STARTED|Overall Study||52
567036|NCT00626405|1384673|P1|STARTED|Overall Study||43
567037|NCT00626392|1384689|P6|NOT COMPLETED|Coadministration Period||6
567038|NCT00626392|1384690|P5|NOT COMPLETED|Coadministration Period||5
567039|NCT00626392|1384691|P4|NOT COMPLETED|Coadministration Period||7
567040|NCT00626392|1384692|P3|NOT COMPLETED|Coadministration Period||10
567041|NCT00626392|1384693|P2|NOT COMPLETED|Coadministration Period||5
567042|NCT00626392|1384694|P1|NOT COMPLETED|Coadministration Period||4
567043|NCT00626392|1384689|P6|COMPLETED|Coadministration Period||38
567044|NCT00626392|1384690|P5|COMPLETED|Coadministration Period||36
567045|NCT00626392|1384691|P4|COMPLETED|Coadministration Period||36
567046|NCT00626392|1384692|P3|COMPLETED|Coadministration Period||31
567047|NCT00626392|1384693|P2|COMPLETED|Coadministration Period||38
567048|NCT00626392|1384694|P1|COMPLETED|Coadministration Period||40
567049|NCT00626392|1384689|P6|STARTED|Coadministration Period||44
567050|NCT00626392|1384690|P5|STARTED|Coadministration Period||41
567051|NCT00626392|1384691|P4|STARTED|Coadministration Period||43
567052|NCT00626392|1384692|P3|STARTED|Coadministration Period||41
567053|NCT00626392|1384693|P2|STARTED|Coadministration Period||43
567054|NCT00626392|1384694|P1|STARTED|Coadministration Period||44
567055|NCT00626392|1384689|P6|NOT COMPLETED|Run-in Period||1
567056|NCT00626392|1384690|P5|NOT COMPLETED|Run-in Period||4
567057|NCT00626392|1384691|P4|NOT COMPLETED|Run-in Period||1
567058|NCT00626392|1384692|P3|NOT COMPLETED|Run-in Period||3
567059|NCT00626392|1384693|P2|NOT COMPLETED|Run-in Period||1
567060|NCT00626392|1384694|P1|NOT COMPLETED|Run-in Period||1
567061|NCT00626392|1384689|P6|COMPLETED|Run-in Period||44
567062|NCT00626392|1384690|P5|COMPLETED|Run-in Period||41
567063|NCT00626392|1384691|P4|COMPLETED|Run-in Period||43
567064|NCT00626392|1384692|P3|COMPLETED|Run-in Period||41
567065|NCT00626392|1384693|P2|COMPLETED|Run-in Period||43
567066|NCT00626392|1384694|P1|COMPLETED|Run-in Period||44
567067|NCT00626392|1384689|P6|STARTED|Run-in Period||45
567068|NCT00626392|1384690|P5|STARTED|Run-in Period||45
567069|NCT00626392|1384691|P4|STARTED|Run-in Period||44
567070|NCT00626392|1384692|P3|STARTED|Run-in Period||44
567071|NCT00626392|1384693|P2|STARTED|Run-in Period||44
567072|NCT00626392|1384694|P1|STARTED|Run-in Period||45
567073|NCT00626340|1384706|P1|NOT COMPLETED|Overall Study||0
567074|NCT00626340|1384706|P1|COMPLETED|Overall Study||18
567075|NCT00626340|1384706|P1|STARTED|Overall Study||18
567076|NCT00626327|1384713|P3|NOT COMPLETED|Overall Study||88
567077|NCT00626327|1384714|P2|NOT COMPLETED|Overall Study||59
567078|NCT00626327|1384715|P1|NOT COMPLETED|Overall Study||78
567079|NCT00626327|1384713|P3|COMPLETED|Overall Study||422
567080|NCT00626327|1384714|P2|COMPLETED|Overall Study||557
567081|NCT00626327|1384715|P1|COMPLETED|Overall Study||426
567082|NCT00626327|1384713|P3|STARTED|Overall Study||510
567083|NCT00626327|1384714|P2|STARTED|Overall Study||616
567084|NCT00626327|1384715|P1|STARTED|Overall Study||504
567085|NCT00626275|1384741|P8|NOT COMPLETED|Part B||1
567086|NCT00626275|1384742|P7|NOT COMPLETED|Part B||1
567087|NCT00626275|1384743|P6|NOT COMPLETED|Part B||0
567088|NCT00626275|1384744|P5|NOT COMPLETED|Part B||0
567089|NCT00626275|1384745|P4|NOT COMPLETED|Part B||0
567090|NCT00626275|1384746|P3|NOT COMPLETED|Part B||0
567091|NCT00626275|1384747|P2|NOT COMPLETED|Part B||0
567092|NCT00626275|1384748|P1|NOT COMPLETED|Part B||0
567093|NCT00626275|1384741|P8|COMPLETED|Part B||23
567094|NCT00626275|1384742|P7|COMPLETED|Part B||19
567095|NCT00626275|1384743|P6|COMPLETED|Part B||0
567096|NCT00626275|1384744|P5|COMPLETED|Part B||0
567097|NCT00626275|1384745|P4|COMPLETED|Part B||0
567098|NCT00626275|1384746|P3|COMPLETED|Part B||0
567099|NCT00626275|1384747|P2|COMPLETED|Part B||0
567100|NCT00626275|1384748|P1|COMPLETED|Part B||0
567101|NCT00626275|1384741|P8|STARTED|Part B||24
567102|NCT00626275|1384742|P7|STARTED|Part B||20
567103|NCT00626275|1384743|P6|STARTED|Part B||0
567104|NCT00626275|1384744|P5|STARTED|Part B||0
567105|NCT00626275|1384745|P4|STARTED|Part B||0
567106|NCT00626275|1384746|P3|STARTED|Part B||0
567107|NCT00626275|1384747|P2|STARTED|Part B||0
567108|NCT00626275|1384748|P1|STARTED|Part B||0
567109|NCT00626275|1384741|P8|NOT COMPLETED|Re-randomization Period for Part B||0
567110|NCT00626275|1384742|P7|NOT COMPLETED|Re-randomization Period for Part B||0
567111|NCT00626275|1384743|P6|NOT COMPLETED|Re-randomization Period for Part B||0
567112|NCT00626275|1384744|P5|NOT COMPLETED|Re-randomization Period for Part B||0
567113|NCT00626275|1384745|P4|NOT COMPLETED|Re-randomization Period for Part B||0
567114|NCT00626275|1384746|P3|NOT COMPLETED|Re-randomization Period for Part B||0
567115|NCT00626275|1384747|P2|NOT COMPLETED|Re-randomization Period for Part B||0
567116|NCT00626275|1384748|P1|NOT COMPLETED|Re-randomization Period for Part B||0
567117|NCT00626275|1384741|P8|COMPLETED|Re-randomization Period for Part B||24
567118|NCT00626275|1384742|P7|COMPLETED|Re-randomization Period for Part B||20
567119|NCT00626275|1384743|P6|COMPLETED|Re-randomization Period for Part B||0
567120|NCT00626275|1384744|P5|COMPLETED|Re-randomization Period for Part B||0
567121|NCT00626275|1384745|P4|COMPLETED|Re-randomization Period for Part B||0
567122|NCT00626275|1384746|P3|COMPLETED|Re-randomization Period for Part B||0
567123|NCT00626275|1384747|P2|COMPLETED|Re-randomization Period for Part B||0
567124|NCT00626275|1384748|P1|COMPLETED|Re-randomization Period for Part B||0
567125|NCT00626275|1384741|P8|STARTED|Re-randomization Period for Part B||24
567126|NCT00626275|1384742|P7|STARTED|Re-randomization Period for Part B||20
567127|NCT00626275|1384743|P6|STARTED|Re-randomization Period for Part B||0
567128|NCT00626275|1384744|P5|STARTED|Re-randomization Period for Part B||0
567129|NCT00626275|1384745|P4|STARTED|Re-randomization Period for Part B||0
567130|NCT00626275|1384746|P3|STARTED|Re-randomization Period for Part B||0
567131|NCT00626275|1384747|P2|STARTED|Re-randomization Period for Part B||0
567132|NCT00626275|1384748|P1|STARTED|Re-randomization Period for Part B||0
567133|NCT00626275|1384741|P8|NOT COMPLETED|Part A - Treatment Period 3||0
567134|NCT00626275|1384742|P7|NOT COMPLETED|Part A - Treatment Period 3||0
567135|NCT00626275|1384743|P6|NOT COMPLETED|Part A - Treatment Period 3||0
567136|NCT00626275|1384744|P5|NOT COMPLETED|Part A - Treatment Period 3||0
567137|NCT00626275|1384745|P4|NOT COMPLETED|Part A - Treatment Period 3||0
567138|NCT00626275|1384746|P3|NOT COMPLETED|Part A - Treatment Period 3||0
567139|NCT00626275|1384747|P2|NOT COMPLETED|Part A - Treatment Period 3||0
567140|NCT00626275|1384748|P1|NOT COMPLETED|Part A - Treatment Period 3||0
567141|NCT00626275|1384741|P8|COMPLETED|Part A - Treatment Period 3||0
567142|NCT00626275|1384742|P7|COMPLETED|Part A - Treatment Period 3||0
567143|NCT00626275|1384743|P6|COMPLETED|Part A - Treatment Period 3||8
567144|NCT00626275|1384744|P5|COMPLETED|Part A - Treatment Period 3||9
567145|NCT00626275|1384745|P4|COMPLETED|Part A - Treatment Period 3||8
567146|NCT00626275|1384746|P3|COMPLETED|Part A - Treatment Period 3||6
567147|NCT00626275|1384747|P2|COMPLETED|Part A - Treatment Period 3||7
567148|NCT00626275|1384748|P1|COMPLETED|Part A - Treatment Period 3||6
567149|NCT00626275|1384741|P8|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0
567150|NCT00626275|1384742|P7|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0
567151|NCT00626275|1384743|P6|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8
567152|NCT00626275|1384744|P5|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||9
567153|NCT00626275|1384745|P4|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8
567154|NCT00626275|1384746|P3|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6
567155|NCT00626275|1384747|P2|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||7
567156|NCT00626275|1384748|P1|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6
567157|NCT00626275|1384741|P8|STARTED|Part A - Treatment Period 3||0
567158|NCT00626275|1384742|P7|STARTED|Part A - Treatment Period 3||0
567159|NCT00626275|1384743|P6|STARTED|Part A - Treatment Period 3||8
567160|NCT00626275|1384744|P5|STARTED|Part A - Treatment Period 3||9
567161|NCT00626275|1384745|P4|STARTED|Part A - Treatment Period 3||8
567162|NCT00626275|1384746|P3|STARTED|Part A - Treatment Period 3||6
567163|NCT00626275|1384747|P2|STARTED|Part A - Treatment Period 3||7
567164|NCT00626275|1384748|P1|STARTED|Part A - Treatment Period 3||6
567165|NCT00626275|1384741|P8|NOT COMPLETED|Part A - Washout Period 2||0
567166|NCT00626275|1384742|P7|NOT COMPLETED|Part A - Washout Period 2||0
567167|NCT00626275|1384743|P6|NOT COMPLETED|Part A - Washout Period 2||0
567168|NCT00626275|1384744|P5|NOT COMPLETED|Part A - Washout Period 2||0
567169|NCT00626275|1384745|P4|NOT COMPLETED|Part A - Washout Period 2||0
567170|NCT00626275|1384746|P3|NOT COMPLETED|Part A - Washout Period 2||0
567171|NCT00626275|1384747|P2|NOT COMPLETED|Part A - Washout Period 2||0
567172|NCT00626275|1384748|P1|NOT COMPLETED|Part A - Washout Period 2||0
567173|NCT00626275|1384741|P8|COMPLETED|Part A - Washout Period 2||0
567174|NCT00626275|1384742|P7|COMPLETED|Part A - Washout Period 2||0
567175|NCT00626275|1384743|P6|COMPLETED|Part A - Washout Period 2||8
567176|NCT00626275|1384744|P5|COMPLETED|Part A - Washout Period 2||9
567177|NCT00626275|1384745|P4|COMPLETED|Part A - Washout Period 2||8
567178|NCT00626275|1384746|P3|COMPLETED|Part A - Washout Period 2||6
567179|NCT00626275|1384747|P2|COMPLETED|Part A - Washout Period 2||7
567180|NCT00626275|1384748|P1|COMPLETED|Part A - Washout Period 2||6
567181|NCT00626275|1384741|P8|STARTED|Part A - Washout Period 2||0
567182|NCT00626275|1384742|P7|STARTED|Part A - Washout Period 2||0
567183|NCT00626275|1384743|P6|STARTED|Part A - Washout Period 2||8
567184|NCT00626275|1384744|P5|STARTED|Part A - Washout Period 2||9
567185|NCT00626275|1384745|P4|STARTED|Part A - Washout Period 2||8
567186|NCT00626275|1384746|P3|STARTED|Part A - Washout Period 2||6
567187|NCT00626275|1384747|P2|STARTED|Part A - Washout Period 2||7
567188|NCT00626275|1384748|P1|STARTED|Part A - Washout Period 2||6
567189|NCT00626275|1384741|P8|NOT COMPLETED|Part A - Treatment Period 2||0
567190|NCT00626275|1384742|P7|NOT COMPLETED|Part A - Treatment Period 2||0
567191|NCT00626275|1384743|P6|NOT COMPLETED|Part A - Treatment Period 2||0
567192|NCT00626275|1384744|P5|NOT COMPLETED|Part A - Treatment Period 2||0
567193|NCT00626275|1384745|P4|NOT COMPLETED|Part A - Treatment Period 2||0
567194|NCT00626275|1384746|P3|NOT COMPLETED|Part A - Treatment Period 2||0
567195|NCT00626275|1384747|P2|NOT COMPLETED|Part A - Treatment Period 2||0
567196|NCT00626275|1384748|P1|NOT COMPLETED|Part A - Treatment Period 2||0
567197|NCT00626275|1384741|P8|COMPLETED|Part A - Treatment Period 2||0
567198|NCT00626275|1384742|P7|COMPLETED|Part A - Treatment Period 2||0
567199|NCT00626275|1384743|P6|COMPLETED|Part A - Treatment Period 2||8
567200|NCT00626275|1384744|P5|COMPLETED|Part A - Treatment Period 2||9
567202|NCT00626275|1384746|P3|COMPLETED|Part A - Treatment Period 2||6
567203|NCT00626275|1384747|P2|COMPLETED|Part A - Treatment Period 2||7
567204|NCT00626275|1384748|P1|COMPLETED|Part A - Treatment Period 2||6
567205|NCT00626275|1384741|P8|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0
567206|NCT00626275|1384742|P7|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0
567207|NCT00626275|1384743|P6|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8
567208|NCT00626275|1384744|P5|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||9
567209|NCT00626275|1384745|P4|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8
567210|NCT00626275|1384746|P3|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6
567211|NCT00626275|1384747|P2|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||7
567212|NCT00626275|1384748|P1|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6
567213|NCT00626275|1384741|P8|STARTED|Part A - Treatment Period 2||0
567214|NCT00626275|1384742|P7|STARTED|Part A - Treatment Period 2||0
567215|NCT00626275|1384743|P6|STARTED|Part A - Treatment Period 2||8
567216|NCT00626275|1384744|P5|STARTED|Part A - Treatment Period 2||9
567217|NCT00626275|1384745|P4|STARTED|Part A - Treatment Period 2||8
567218|NCT00626275|1384746|P3|STARTED|Part A - Treatment Period 2||6
567219|NCT00626275|1384747|P2|STARTED|Part A - Treatment Period 2||7
567220|NCT00626275|1384748|P1|STARTED|Part A - Treatment Period 2||6
567221|NCT00626275|1384741|P8|NOT COMPLETED|Part A - Washout Period 1||0
567222|NCT00626275|1384742|P7|NOT COMPLETED|Part A - Washout Period 1||0
567223|NCT00626275|1384743|P6|NOT COMPLETED|Part A - Washout Period 1||0
567224|NCT00626275|1384744|P5|NOT COMPLETED|Part A - Washout Period 1||0
567225|NCT00626275|1384745|P4|NOT COMPLETED|Part A - Washout Period 1||0
567226|NCT00626275|1384746|P3|NOT COMPLETED|Part A - Washout Period 1||0
567227|NCT00626275|1384747|P2|NOT COMPLETED|Part A - Washout Period 1||0
567228|NCT00626275|1384748|P1|NOT COMPLETED|Part A - Washout Period 1||0
567229|NCT00626275|1384741|P8|COMPLETED|Part A - Washout Period 1||0
567230|NCT00626275|1384742|P7|COMPLETED|Part A - Washout Period 1||0
567231|NCT00626275|1384743|P6|COMPLETED|Part A - Washout Period 1||8
567232|NCT00626275|1384744|P5|COMPLETED|Part A - Washout Period 1||9
567233|NCT00626275|1384745|P4|COMPLETED|Part A - Washout Period 1||8
567234|NCT00626275|1384746|P3|COMPLETED|Part A - Washout Period 1||6
567235|NCT00626275|1384747|P2|COMPLETED|Part A - Washout Period 1||7
567236|NCT00626275|1384748|P1|COMPLETED|Part A - Washout Period 1||6
567237|NCT00626275|1384741|P8|STARTED|Part A - Washout Period 1||0
567238|NCT00626275|1384742|P7|STARTED|Part A - Washout Period 1||0
567239|NCT00626275|1384743|P6|STARTED|Part A - Washout Period 1||8
567240|NCT00626275|1384744|P5|STARTED|Part A - Washout Period 1||9
567241|NCT00626275|1384745|P4|STARTED|Part A - Washout Period 1||8
567242|NCT00626275|1384746|P3|STARTED|Part A - Washout Period 1||6
567243|NCT00626275|1384747|P2|STARTED|Part A - Washout Period 1||7
567244|NCT00626275|1384748|P1|STARTED|Part A - Washout Period 1||6
567245|NCT00626275|1384741|P8|NOT COMPLETED|Part A - Treatment Period 1||0
567246|NCT00626275|1384742|P7|NOT COMPLETED|Part A - Treatment Period 1||0
567247|NCT00626275|1384743|P6|NOT COMPLETED|Part A - Treatment Period 1||0
567248|NCT00626275|1384744|P5|NOT COMPLETED|Part A - Treatment Period 1||0
567249|NCT00626275|1384745|P4|NOT COMPLETED|Part A - Treatment Period 1||0
567250|NCT00626275|1384746|P3|NOT COMPLETED|Part A - Treatment Period 1||1
567251|NCT00626275|1384747|P2|NOT COMPLETED|Part A - Treatment Period 1||0
567252|NCT00626275|1384748|P1|NOT COMPLETED|Part A - Treatment Period 1||1
567253|NCT00626275|1384741|P8|COMPLETED|Part A - Treatment Period 1||0
567254|NCT00626275|1384742|P7|COMPLETED|Part A - Treatment Period 1||0
567255|NCT00626275|1384743|P6|COMPLETED|Part A - Treatment Period 1||8
567256|NCT00626275|1384744|P5|COMPLETED|Part A - Treatment Period 1||9
567257|NCT00626275|1384745|P4|COMPLETED|Part A - Treatment Period 1||8
567258|NCT00626275|1384746|P3|COMPLETED|Part A - Treatment Period 1||6
567259|NCT00626275|1384747|P2|COMPLETED|Part A - Treatment Period 1||7
567260|NCT00626275|1384748|P1|COMPLETED|Part A - Treatment Period 1||6
567261|NCT00626275|1384741|P8|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0
567262|NCT00626275|1384742|P7|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0
567263|NCT00626275|1384743|P6|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8
567264|NCT00626275|1384744|P5|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||9
567265|NCT00626275|1384745|P4|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8
567266|NCT00626275|1384746|P3|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
567267|NCT00626275|1384747|P2|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
567268|NCT00626275|1384748|P1|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
567269|NCT00626275|1384741|P8|STARTED|Part A - Treatment Period 1||0
567270|NCT00626275|1384742|P7|STARTED|Part A - Treatment Period 1||0
567271|NCT00626275|1384743|P6|STARTED|Part A - Treatment Period 1||8
567272|NCT00626275|1384744|P5|STARTED|Part A - Treatment Period 1||9
567273|NCT00626275|1384745|P4|STARTED|Part A - Treatment Period 1||8
567274|NCT00626275|1384746|P3|STARTED|Part A - Treatment Period 1||7
567275|NCT00626275|1384747|P2|STARTED|Part A - Treatment Period 1||7
567276|NCT00626275|1384748|P1|STARTED|Part A - Treatment Period 1||7
567277|NCT00626210|1384788|P1|NOT COMPLETED|Overall Study||0
567278|NCT00626210|1384788|P1|COMPLETED|Overall Study||2
567279|NCT00626210|1384788|P1|STARTED|Overall Study||2
567280|NCT00626093|1384792|P1|NOT COMPLETED|Overall Study||23
567281|NCT00626093|1384792|P1|COMPLETED|Overall Study||54
567282|NCT00626093|1384792|P1|STARTED|Overall Study||77
567283|NCT00626028|1384799|P2|NOT COMPLETED|Treatment 3 10 Minute Dose NO or O2||0
567284|NCT00626028|1384800|P1|NOT COMPLETED|Treatment 3 10 Minute Dose NO or O2||0
567285|NCT00626028|1384799|P2|COMPLETED|Treatment 3 10 Minute Dose NO or O2||59
567286|NCT00626028|1384800|P1|COMPLETED|Treatment 3 10 Minute Dose NO or O2||62
567287|NCT00626028|1384799|P2|STARTED|Treatment 3 10 Minute Dose NO or O2||59
567288|NCT00626028|1384800|P1|STARTED|Treatment 3 10 Minute Dose NO or O2||62
567289|NCT00626028|1384799|P2|NOT COMPLETED|Washout Period of 10 Minutes||0
567290|NCT00626028|1384800|P1|NOT COMPLETED|Washout Period of 10 Minutes||0
567291|NCT00626028|1384799|P2|COMPLETED|Washout Period of 10 Minutes||59
567292|NCT00626028|1384800|P1|COMPLETED|Washout Period of 10 Minutes||62
567293|NCT00626028|1384799|P2|STARTED|Washout Period of 10 Minutes||59
567294|NCT00626028|1384800|P1|STARTED|Washout Period of 10 Minutes||62
567295|NCT00626028|1384799|P2|NOT COMPLETED|Treatment 2 10 Minute Dose NO Plus O2||0
567296|NCT00626028|1384800|P1|NOT COMPLETED|Treatment 2 10 Minute Dose NO Plus O2||0
567297|NCT00626028|1384799|P2|COMPLETED|Treatment 2 10 Minute Dose NO Plus O2||59
567298|NCT00626028|1384800|P1|COMPLETED|Treatment 2 10 Minute Dose NO Plus O2||62
567299|NCT00626028|1384799|P2|STARTED|Treatment 2 10 Minute Dose NO Plus O2||59
567300|NCT00626028|1384800|P1|STARTED|Treatment 2 10 Minute Dose NO Plus O2||62
567301|NCT00626028|1384799|P2|NOT COMPLETED|Treatment 1 NO First, O2 Last||9
567302|NCT00626028|1384800|P1|NOT COMPLETED|Treatment 1 NO First, O2 Last||6
567303|NCT00626028|1384799|P2|COMPLETED|Treatment 1 NO First, O2 Last||59
567304|NCT00626028|1384800|P1|COMPLETED|Treatment 1 NO First, O2 Last||62
567305|NCT00626028|1384799|P2|STARTED|Treatment 1 NO First, O2 Last||68
567306|NCT00626028|1384800|P1|STARTED|Treatment 1 NO First, O2 Last||68
567307|NCT00625989|1384810|P2|NOT COMPLETED|Overall Study||0
567308|NCT00625989|1384811|P1|NOT COMPLETED|Overall Study||0
567309|NCT00625989|1384810|P2|COMPLETED|Overall Study||6
567310|NCT00625989|1384811|P1|COMPLETED|Overall Study||6
567311|NCT00625989|1384810|P2|STARTED|Overall Study||6
567312|NCT00625989|1384811|P1|STARTED|Overall Study||6
567313|NCT00625872|1384820|P2|NOT COMPLETED|Overall Study||6
567314|NCT00625872|1384821|P1|NOT COMPLETED|Overall Study||4
567315|NCT00625872|1384820|P2|COMPLETED|Overall Study||5
567316|NCT00625872|1384821|P1|COMPLETED|Overall Study||8
567317|NCT00625872|1384820|P2|Treated|Overall Study||10
567318|NCT00625872|1384821|P1|Treated|Overall Study||12
567319|NCT00625872|1384820|P2|STARTED|Overall Study||11
567320|NCT00625872|1384821|P1|STARTED|Overall Study||12
567321|NCT00625820|1384931|P1|NOT COMPLETED|Overall Study||1
567322|NCT00625820|1384931|P1|COMPLETED|Overall Study||16
567323|NCT00625820|1384931|P1|STARTED|Overall Study||17
567324|NCT00625742|1384937|P1|NOT COMPLETED|Overall Study||12
567325|NCT00625742|1384937|P1|COMPLETED|Overall Study||3
567326|NCT00625742|1384937|P1|STARTED|Overall Study||15
567327|NCT00625729|1384942|P1|NOT COMPLETED|Overall Study||0
567328|NCT00625729|1384942|P1|COMPLETED|Overall Study||6
567329|NCT00625729|1384942|P1|STARTED|Overall Study||6
567330|NCT00625586|1384951|P1|NOT COMPLETED|Overall Study||1
567331|NCT00625586|1384951|P1|COMPLETED|Overall Study||1
567332|NCT00625586|1384951|P1|STARTED|Overall Study||2
567333|NCT00625443|1384964|P3|NOT COMPLETED|Overall Study||5
567334|NCT00625443|1384965|P2|NOT COMPLETED|Overall Study||11
567335|NCT00625443|1384966|P1|NOT COMPLETED|Overall Study||2
567336|NCT00625443|1384964|P3|COMPLETED|Overall Study||10
567337|NCT00625443|1384965|P2|COMPLETED|Overall Study||15
567338|NCT00625443|1384966|P1|COMPLETED|Overall Study||10
567339|NCT00625443|1384964|P3|STARTED|Overall Study||15
567340|NCT00625443|1384965|P2|STARTED|Overall Study||26
567341|NCT00625443|1384966|P1|STARTED|Overall Study||12
567342|NCT00625404|1384996|P2|NOT COMPLETED|Overall Study||173
567343|NCT00625404|1384997|P1|NOT COMPLETED|Overall Study||207
567344|NCT00625404|1384996|P2|COMPLETED|Overall Study||885
567345|NCT00625404|1384997|P1|COMPLETED|Overall Study||855
567346|NCT00625404|1384996|P2|STARTED|Overall Study||1058
567347|NCT00625404|1384997|P1|STARTED|Overall Study||1062
567348|NCT00625391|1385029|P4|NOT COMPLETED|Overall Study||1
567349|NCT00625391|1385030|P3|NOT COMPLETED|Overall Study||5
567350|NCT00625391|1385031|P2|NOT COMPLETED|Overall Study||8
567351|NCT00625391|1385032|P1|NOT COMPLETED|Overall Study||7
567352|NCT00625391|1385029|P4|COMPLETED|Overall Study||37
567353|NCT00625391|1385030|P3|COMPLETED|Overall Study||37
567354|NCT00625391|1385031|P2|COMPLETED|Overall Study||39
567355|NCT00625391|1385032|P1|COMPLETED|Overall Study||37
567356|NCT00625391|1385029|P4|STARTED|Overall Study||38
567357|NCT00625391|1385030|P3|STARTED|Overall Study||42
567358|NCT00625391|1385031|P2|STARTED|Overall Study||47
567359|NCT00625391|1385032|P1|STARTED|Overall Study||44
567360|NCT00625365|1385046|P1|NOT COMPLETED|Overall Study||7
567361|NCT00625365|1385046|P1|COMPLETED|Overall Study|Participants who were analyzed for safety|1053
567362|NCT00625365|1385046|P1|STARTED|Overall Study||1060
567363|NCT00625183|1385052|P1|NOT COMPLETED|Overall Study||1
567364|NCT00625183|1385052|P1|COMPLETED|Overall Study||4
567365|NCT00625183|1385052|P1|STARTED|Overall Study||5
567366|NCT00625131|1385063|P3|NOT COMPLETED|Overall Study||5
567367|NCT00625131|1385064|P2|NOT COMPLETED|Overall Study||2
567368|NCT00625131|1385065|P1|NOT COMPLETED|Overall Study||4
567369|NCT00625131|1385063|P3|COMPLETED|Overall Study||0
567370|NCT00625131|1385064|P2|COMPLETED|Overall Study||42
567371|NCT00625131|1385065|P1|COMPLETED|Overall Study||34
567372|NCT00625131|1385063|P3|STARTED|Overall Study|These participants were not included in any analyses.|5
567373|NCT00625131|1385064|P2|STARTED|Overall Study||44
567374|NCT00625131|1385065|P1|STARTED|Overall Study||38
567375|NCT00624923|1385077|P2|NOT COMPLETED|Overall Study||23
567376|NCT00624923|1385078|P1|NOT COMPLETED|Overall Study||38
567377|NCT00624923|1385077|P2|COMPLETED|Overall Study||101
567378|NCT00624923|1385078|P1|COMPLETED|Overall Study||89
567379|NCT00624923|1385077|P2|STARTED|Overall Study||124
567380|NCT00624923|1385078|P1|STARTED|Overall Study||127
567381|NCT00624832|1385088|P4|NOT COMPLETED|Overall Study||1
567382|NCT00624832|1385089|P3|NOT COMPLETED|Overall Study||0
567383|NCT00624832|1385090|P2|NOT COMPLETED|Overall Study||1
567384|NCT00624832|1385091|P1|NOT COMPLETED|Overall Study||2
567385|NCT00624832|1385088|P4|COMPLETED|Overall Study||15
567386|NCT00624832|1385089|P3|COMPLETED|Overall Study||10
567387|NCT00624832|1385090|P2|COMPLETED|Overall Study||15
567388|NCT00624832|1385091|P1|COMPLETED|Overall Study||16
567389|NCT00624832|1385088|P4|STARTED|Overall Study||16
567390|NCT00624832|1385089|P3|STARTED|Overall Study||10
567391|NCT00624832|1385090|P2|STARTED|Overall Study||16
567392|NCT00624832|1385091|P1|STARTED|Overall Study||18
567393|NCT00624806|1385105|P2|NOT COMPLETED|Overall Study||0
567394|NCT00624806|1385106|P1|NOT COMPLETED|Overall Study||0
567395|NCT00624806|1385105|P2|COMPLETED|Overall Study||8
567396|NCT00624806|1385106|P1|COMPLETED|Overall Study||10
567397|NCT00624806|1385105|P2|STARTED|Overall Study||8
567398|NCT00624806|1385106|P1|STARTED|Overall Study||10
567399|NCT00624780|1385122|P6|NOT COMPLETED|Follow-up (Week 26)||0
567400|NCT00624780|1385123|P5|NOT COMPLETED|Follow-up (Week 26)||2
567401|NCT00624780|1385124|P4|NOT COMPLETED|Follow-up (Week 26)||0
567402|NCT00624780|1385125|P3|NOT COMPLETED|Follow-up (Week 26)||2
567403|NCT00624780|1385126|P2|NOT COMPLETED|Follow-up (Week 26)||1
567404|NCT00624780|1385127|P1|NOT COMPLETED|Follow-up (Week 26)||2
567405|NCT00624780|1385122|P6|COMPLETED|Follow-up (Week 26)||29
567406|NCT00624780|1385123|P5|COMPLETED|Follow-up (Week 26)||93
567407|NCT00624780|1385124|P4|COMPLETED|Follow-up (Week 26)||26
567408|NCT00624780|1385125|P3|COMPLETED|Follow-up (Week 26)||89
567409|NCT00624780|1385126|P2|COMPLETED|Follow-up (Week 26)||27
567410|NCT00624780|1385127|P1|COMPLETED|Follow-up (Week 26)||102
567411|NCT00624780|1385122|P6|STARTED|Follow-up (Week 26)||29
567412|NCT00624780|1385123|P5|STARTED|Follow-up (Week 26)||95
567413|NCT00624780|1385124|P4|STARTED|Follow-up (Week 26)||26
567414|NCT00624780|1385125|P3|STARTED|Follow-up (Week 26)||91
567415|NCT00624780|1385126|P2|STARTED|Follow-up (Week 26)||28
567416|NCT00624780|1385127|P1|STARTED|Follow-up (Week 26)||104
567417|NCT00624780|1385122|P6|NOT COMPLETED|Treatment Discontinuation (Week 25)||1
567418|NCT00624780|1385123|P5|NOT COMPLETED|Treatment Discontinuation (Week 25)||0
567419|NCT00624780|1385124|P4|NOT COMPLETED|Treatment Discontinuation (Week 25)||1
567420|NCT00624780|1385125|P3|NOT COMPLETED|Treatment Discontinuation (Week 25)||3
567421|NCT00624780|1385126|P2|NOT COMPLETED|Treatment Discontinuation (Week 25)||0
567422|NCT00624780|1385127|P1|NOT COMPLETED|Treatment Discontinuation (Week 25)||2
567423|NCT00624780|1385122|P6|COMPLETED|Treatment Discontinuation (Week 25)||29
567424|NCT00624780|1385123|P5|COMPLETED|Treatment Discontinuation (Week 25)||95
567425|NCT00624780|1385124|P4|COMPLETED|Treatment Discontinuation (Week 25)||26
567426|NCT00624780|1385125|P3|COMPLETED|Treatment Discontinuation (Week 25)||91
567427|NCT00624780|1385126|P2|COMPLETED|Treatment Discontinuation (Week 25)||28
567428|NCT00624780|1385127|P1|COMPLETED|Treatment Discontinuation (Week 25)||104
567429|NCT00624780|1385122|P6|STARTED|Treatment Discontinuation (Week 25)||30
567430|NCT00624780|1385123|P5|STARTED|Treatment Discontinuation (Week 25)||95
567431|NCT00624780|1385124|P4|STARTED|Treatment Discontinuation (Week 25)||27
567432|NCT00624780|1385125|P3|STARTED|Treatment Discontinuation (Week 25)||94
567433|NCT00624780|1385126|P2|STARTED|Treatment Discontinuation (Week 25)||28
567434|NCT00624780|1385127|P1|STARTED|Treatment Discontinuation (Week 25)||106
567435|NCT00624780|1385122|P6|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||9
567436|NCT00624780|1385123|P5|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||19
567437|NCT00624780|1385124|P4|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11
567438|NCT00624780|1385125|P3|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||18
567439|NCT00624780|1385126|P2|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11
567440|NCT00624780|1385127|P1|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||15
567441|NCT00624780|1385122|P6|COMPLETED|Fixed Dosing (Week 13 to Week 24)||30
567442|NCT00624780|1385123|P5|COMPLETED|Fixed Dosing (Week 13 to Week 24)||95
567443|NCT00624780|1385124|P4|COMPLETED|Fixed Dosing (Week 13 to Week 24)||27
567444|NCT00624780|1385125|P3|COMPLETED|Fixed Dosing (Week 13 to Week 24)||94
567445|NCT00624780|1385126|P2|COMPLETED|Fixed Dosing (Week 13 to Week 24)||28
567446|NCT00624780|1385127|P1|COMPLETED|Fixed Dosing (Week 13 to Week 24)||106
567447|NCT00624780|1385122|P6|STARTED|Fixed Dosing (Week 13 to Week 24)||39
567448|NCT00624780|1385123|P5|STARTED|Fixed Dosing (Week 13 to Week 24)||114
567449|NCT00624780|1385124|P4|STARTED|Fixed Dosing (Week 13 to Week 24)||38
567450|NCT00624780|1385125|P3|STARTED|Fixed Dosing (Week 13 to Week 24)||112
567451|NCT00624780|1385126|P2|STARTED|Fixed Dosing (Week 13 to Week 24)||39
567452|NCT00624780|1385127|P1|STARTED|Fixed Dosing (Week 13 to Week 24)||121
567453|NCT00624780|1385122|P6|NOT COMPLETED|Treatment Optimization (Up to Week 12)||11
567454|NCT00624780|1385123|P5|NOT COMPLETED|Treatment Optimization (Up to Week 12)||39
567455|NCT00624780|1385124|P4|NOT COMPLETED|Treatment Optimization (Up to Week 12)||14
567456|NCT00624780|1385125|P3|NOT COMPLETED|Treatment Optimization (Up to Week 12)||42
567457|NCT00624780|1385126|P2|NOT COMPLETED|Treatment Optimization (Up to Week 12)||13
567458|NCT00624780|1385127|P1|NOT COMPLETED|Treatment Optimization (Up to Week 12)||33
567459|NCT00624780|1385122|P6|COMPLETED|Treatment Optimization (Up to Week 12)||39
567460|NCT00624780|1385123|P5|COMPLETED|Treatment Optimization (Up to Week 12)||114
567461|NCT00624780|1385124|P4|COMPLETED|Treatment Optimization (Up to Week 12)||38
567462|NCT00624780|1385125|P3|COMPLETED|Treatment Optimization (Up to Week 12)||112
567463|NCT00624780|1385126|P2|COMPLETED|Treatment Optimization (Up to Week 12)||39
567464|NCT00624780|1385127|P1|COMPLETED|Treatment Optimization (Up to Week 12)||121
567465|NCT00624780|1385122|P6|STARTED|Treatment Optimization (Up to Week 12)||50
567466|NCT00624780|1385123|P5|STARTED|Treatment Optimization (Up to Week 12)||153
567467|NCT00624780|1385124|P4|STARTED|Treatment Optimization (Up to Week 12)||52
567468|NCT00624780|1385125|P3|STARTED|Treatment Optimization (Up to Week 12)||154
567469|NCT00624780|1385126|P2|STARTED|Treatment Optimization (Up to Week 12)||52
567470|NCT00624780|1385127|P1|STARTED|Treatment Optimization (Up to Week 12)||154
567471|NCT00624585|1385309|P1|NOT COMPLETED|Overall Study||12
567472|NCT00624585|1385309|P1|COMPLETED|Overall Study||6
567473|NCT00624585|1385309|P1|STARTED|Overall Study||18
567474|NCT00624559|1385320|P4|NOT COMPLETED|Overall Study||0
567475|NCT00624559|1385321|P3|NOT COMPLETED|Overall Study||0
567476|NCT00624559|1385322|P2|NOT COMPLETED|Overall Study||0
567477|NCT00624559|1385323|P1|NOT COMPLETED|Overall Study||0
567478|NCT00624559|1385320|P4|COMPLETED|Overall Study||3
567479|NCT00624559|1385321|P3|COMPLETED|Overall Study||3
567480|NCT00624559|1385322|P2|COMPLETED|Overall Study||3
567481|NCT00624559|1385323|P1|COMPLETED|Overall Study||3
567482|NCT00624559|1385320|P4|STARTED|Overall Study|Placebo 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day|3
567483|NCT00624559|1385321|P3|STARTED|Overall Study|Placebo 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day|3
567484|NCT00624559|1385322|P2|STARTED|Overall Study|Celebrex 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day|3
567485|NCT00624559|1385323|P1|STARTED|Overall Study|Celebrex 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day|3
567486|NCT00624520|1385339|P2|NOT COMPLETED|Overall Study||8
567487|NCT00624520|1385340|P1|NOT COMPLETED|Overall Study||12
567488|NCT00624520|1385339|P2|COMPLETED|Overall Study||39
567489|NCT00624520|1385340|P1|COMPLETED|Overall Study||44
567490|NCT00624520|1385339|P2|STARTED|Overall Study||47
567491|NCT00624520|1385340|P1|STARTED|Overall Study||56
567492|NCT00624468|1385367|P4|NOT COMPLETED|Safety Follow-up (SFU) Period||3
567493|NCT00624468|1385368|P3|NOT COMPLETED|Safety Follow-up (SFU) Period||2
567494|NCT00624468|1385369|P2|NOT COMPLETED|Safety Follow-up (SFU) Period||0
567495|NCT00624468|1385370|P1|NOT COMPLETED|Safety Follow-up (SFU) Period||0
567496|NCT00624468|1385367|P4|COMPLETED|Safety Follow-up (SFU) Period||11
567497|NCT00624468|1385368|P3|COMPLETED|Safety Follow-up (SFU) Period||11
567498|NCT00624468|1385369|P2|COMPLETED|Safety Follow-up (SFU) Period||0
567499|NCT00624468|1385370|P1|COMPLETED|Safety Follow-up (SFU) Period||0
567500|NCT00624468|1385367|P4|STARTED|Safety Follow-up (SFU) Period||14
567501|NCT00624468|1385368|P3|STARTED|Safety Follow-up (SFU) Period||13
567502|NCT00624468|1385369|P2|STARTED|Safety Follow-up (SFU) Period||0
567503|NCT00624468|1385370|P1|STARTED|Safety Follow-up (SFU) Period||0
567504|NCT00624468|1385367|P4|NOT COMPLETED|Double-blind Period||0
567505|NCT00624468|1385368|P3|NOT COMPLETED|Double-blind Period||0
567506|NCT00624468|1385369|P2|NOT COMPLETED|Double-blind Period||13
567507|NCT00624468|1385370|P1|NOT COMPLETED|Double-blind Period||14
567508|NCT00624468|1385367|P4|COMPLETED|Double-blind Period||0
567509|NCT00624468|1385368|P3|COMPLETED|Double-blind Period||0
567510|NCT00624468|1385369|P2|COMPLETED|Double-blind Period||4
567511|NCT00624468|1385370|P1|COMPLETED|Double-blind Period||3
567512|NCT00624468|1385367|P4|STARTED|Double-blind Period||0
567513|NCT00624468|1385368|P3|STARTED|Double-blind Period||0
567514|NCT00624468|1385369|P2|STARTED|Double-blind Period||17
567515|NCT00624468|1385370|P1|STARTED|Double-blind Period||17
567516|NCT00624442|1385401|P5|NOT COMPLETED|Overall Study||2
567517|NCT00624442|1385402|P4|NOT COMPLETED|Overall Study||0
567518|NCT00624442|1385403|P3|NOT COMPLETED|Overall Study||2
567519|NCT00624442|1385404|P2|NOT COMPLETED|Overall Study||1
567520|NCT00624442|1385405|P1|NOT COMPLETED|Overall Study||0
567521|NCT00624442|1385401|P5|COMPLETED|Overall Study|Two patients discontinued after meeting termination criteria during dosing.|8
567522|NCT00624442|1385402|P4|COMPLETED|Overall Study||8
567523|NCT00624442|1385403|P3|COMPLETED|Overall Study|Two patients discontinued after meeting termination criteria during dosing.|8
567524|NCT00624442|1385404|P2|COMPLETED|Overall Study|One patient was discontinued after inadvertant overdose.|8
567525|NCT00624442|1385405|P1|COMPLETED|Overall Study||8
567526|NCT00624442|1385401|P5|STARTED|Overall Study||10
567527|NCT00624442|1385402|P4|STARTED|Overall Study||8
567528|NCT00624442|1385403|P3|STARTED|Overall Study||10
567529|NCT00624442|1385404|P2|STARTED|Overall Study||9
567530|NCT00624442|1385405|P1|STARTED|Overall Study||8
567531|NCT00624416|1385431|P1|NOT COMPLETED|Overall Study||0
567532|NCT00624416|1385431|P1|COMPLETED|Overall Study||10
567533|NCT00624416|1385431|P1|STARTED|Overall Study||10
567534|NCT00624377|1385437|P1|NOT COMPLETED|Overall Study||644
567535|NCT00624377|1385437|P1|COMPLETED|Overall Study||1387
567536|NCT00624377|1385437|P1|STARTED|Overall Study||2031
567537|NCT00624338|1385451|P3|NOT COMPLETED|Overall Study||46
567538|NCT00624338|1385452|P2|NOT COMPLETED|Overall Study||83
567539|NCT00624338|1385453|P1|NOT COMPLETED|Overall Study||47
567540|NCT00624338|1385451|P3|COMPLETED|Overall Study||111
567541|NCT00624338|1385452|P2|COMPLETED|Overall Study||62
567542|NCT00624338|1385453|P1|COMPLETED|Overall Study||112
567543|NCT00624338|1385451|P3|Treated|Overall Study||154
567544|NCT00624338|1385452|P2|Treated|Overall Study||144
567545|NCT00624338|1385453|P1|Treated|Overall Study||157
567546|NCT00624338|1385451|P3|STARTED|Overall Study||157
567547|NCT00624338|1385452|P2|STARTED|Overall Study||145
567548|NCT00624338|1385453|P1|STARTED|Overall Study||159
567549|NCT00624286|1385475|P2|NOT COMPLETED|Overall Study||27
567550|NCT00624286|1385476|P1|NOT COMPLETED|Overall Study||25
567551|NCT00624286|1385475|P2|COMPLETED|Overall Study||178
567552|NCT00624286|1385476|P1|COMPLETED|Overall Study||186
567553|NCT00624286|1385475|P2|STARTED|Overall Study||205
567554|NCT00624286|1385476|P1|STARTED|Overall Study||211
567555|NCT00624234|1385490|P6|NOT COMPLETED|Overall Study||0
567556|NCT00624234|1385491|P5|NOT COMPLETED|Overall Study||0
567557|NCT00624234|1385492|P4|NOT COMPLETED|Overall Study||0
567558|NCT00624234|1385493|P3|NOT COMPLETED|Overall Study||0
567559|NCT00624234|1385494|P2|NOT COMPLETED|Overall Study||0
567560|NCT00624234|1385495|P1|NOT COMPLETED|Overall Study||0
567561|NCT00624234|1385490|P6|COMPLETED|Overall Study||14
567562|NCT00624234|1385491|P5|COMPLETED|Overall Study||18
567563|NCT00624234|1385492|P4|COMPLETED|Overall Study||14
567564|NCT00624234|1385493|P3|COMPLETED|Overall Study||26
567565|NCT00624234|1385494|P2|COMPLETED|Overall Study||9
567566|NCT00624234|1385495|P1|COMPLETED|Overall Study||8
567567|NCT00624234|1385490|P6|STARTED|Overall Study||14
567568|NCT00624234|1385491|P5|STARTED|Overall Study||18
567569|NCT00624234|1385492|P4|STARTED|Overall Study||14
567570|NCT00624234|1385493|P3|STARTED|Overall Study||26
567571|NCT00624234|1385494|P2|STARTED|Overall Study||9
567572|NCT00624234|1385495|P1|STARTED|Overall Study||8
567573|NCT00624221|1385511|P2|NOT COMPLETED|Overall Study||0
567574|NCT00624221|1385512|P1|NOT COMPLETED|Overall Study||0
567575|NCT00624221|1385511|P2|COMPLETED|Overall Study||20
567576|NCT00624221|1385512|P1|COMPLETED|Overall Study||20
567577|NCT00624221|1385511|P2|STARTED|Overall Study||20
567578|NCT00624221|1385512|P1|STARTED|Overall Study||20
567579|NCT00624195|1385520|P2|NOT COMPLETED|Overall Study||7
567580|NCT00624195|1385521|P1|NOT COMPLETED|Overall Study||3
567581|NCT00624195|1385520|P2|COMPLETED|Overall Study||23
567582|NCT00624195|1385521|P1|COMPLETED|Overall Study||26
567583|NCT00624195|1385520|P2|STARTED|Overall Study||30
567584|NCT00624195|1385521|P1|STARTED|Overall Study||29
567585|NCT00624065|1385529|P2|NOT COMPLETED|Overall Study||24
567586|NCT00624065|1385530|P1|NOT COMPLETED|Overall Study||19
567587|NCT00624065|1385529|P2|COMPLETED|Overall Study||192
567588|NCT00624065|1385530|P1|COMPLETED|Overall Study||197
567589|NCT00624065|1385529|P2|STARTED|Overall Study||216
567590|NCT00624065|1385530|P1|STARTED|Overall Study||216
567591|NCT00624052|1385542|P4|NOT COMPLETED|Overall Study||4
567592|NCT00624052|1385543|P3|NOT COMPLETED|Overall Study||3
567593|NCT00624052|1385544|P2|NOT COMPLETED|Overall Study||14
567594|NCT00624052|1385545|P1|NOT COMPLETED|Overall Study||15
567595|NCT00624052|1385542|P4|COMPLETED|Overall Study||88
567596|NCT00624052|1385543|P3|COMPLETED|Overall Study||88
567597|NCT00624052|1385544|P2|COMPLETED|Overall Study||422
567598|NCT00624052|1385545|P1|COMPLETED|Overall Study||204
567599|NCT00624052|1385542|P4|STARTED|Overall Study||92
567600|NCT00624052|1385543|P3|STARTED|Overall Study||91
567601|NCT00624052|1385544|P2|STARTED|Overall Study||436
567602|NCT00624052|1385545|P1|STARTED|Overall Study||219
567603|NCT00624013|1385596|P2|NOT COMPLETED|Overall Study||6
567604|NCT00624013|1385597|P1|NOT COMPLETED|Overall Study||8
567605|NCT00624013|1385596|P2|COMPLETED|Overall Study||39
567606|NCT00624013|1385597|P1|COMPLETED|Overall Study||36
567607|NCT00624013|1385596|P2|STARTED|Overall Study||45
567608|NCT00624013|1385597|P1|STARTED|Overall Study||44
567609|NCT00623974|1385609|P4|NOT COMPLETED|Overall Study||0
567610|NCT00623974|1385610|P3|NOT COMPLETED|Overall Study||0
567611|NCT00623974|1385611|P2|NOT COMPLETED|Overall Study||0
567612|NCT00623974|1385612|P1|NOT COMPLETED|Overall Study||0
567613|NCT00623974|1385609|P4|COMPLETED|Overall Study||0
567614|NCT00623974|1385610|P3|COMPLETED|Overall Study||0
567615|NCT00623974|1385611|P2|COMPLETED|Overall Study||0
567616|NCT00623974|1385612|P1|COMPLETED|Overall Study||0
567617|NCT00623974|1385609|P4|STARTED|Overall Study||0
567618|NCT00623974|1385610|P3|STARTED|Overall Study||0
567619|NCT00623974|1385611|P2|STARTED|Overall Study||0
567620|NCT00623974|1385612|P1|STARTED|Overall Study||0
567621|NCT00623935|1385622|P1|NOT COMPLETED|Overall Study||2
567622|NCT00623935|1385622|P1|COMPLETED|Overall Study||54
567623|NCT00623935|1385622|P1|STARTED|Overall Study||56
567624|NCT00623831|1385629|P2|NOT COMPLETED|Overall Study||1
567625|NCT00623831|1385630|P1|NOT COMPLETED|Overall Study||1
567626|NCT00623831|1385629|P2|COMPLETED|Overall Study||3
567627|NCT00623831|1385630|P1|COMPLETED|Overall Study||12
567628|NCT00623831|1385629|P2|STARTED|Overall Study||4
567629|NCT00623831|1385630|P1|STARTED|Overall Study||13
567630|NCT00623805|1385642|P2|NOT COMPLETED|Overall Study||22
567631|NCT00623805|1385643|P1|NOT COMPLETED|Overall Study||20
567632|NCT00623805|1385642|P2|COMPLETED|Overall Study||39
567633|NCT00623805|1385643|P1|COMPLETED|Overall Study||42
567634|NCT00623805|1385642|P2|STARTED|Overall Study||61
567635|NCT00623805|1385643|P1|STARTED|Overall Study||62
567636|NCT00623779|1385660|P3|NOT COMPLETED|Overall Study||1
567637|NCT00623779|1385661|P2|NOT COMPLETED|Overall Study||3
567638|NCT00623779|1385662|P1|NOT COMPLETED|Overall Study||3
567639|NCT00623779|1385660|P3|COMPLETED|Overall Study||44
567640|NCT00623779|1385661|P2|COMPLETED|Overall Study||39
567641|NCT00623779|1385662|P1|COMPLETED|Overall Study||38
567642|NCT00623779|1385660|P3|STARTED|Overall Study||45
567643|NCT00623779|1385661|P2|STARTED|Overall Study||42
567644|NCT00623779|1385662|P1|STARTED|Overall Study||41
567645|NCT00623766|1385711|P2|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||2
567646|NCT00623766|1385712|P1|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||10
567647|NCT00623766|1385711|P2|COMPLETED|Maintenance Phase (Week 24 to Year 2)||0
567648|NCT00623766|1385712|P1|COMPLETED|Maintenance Phase (Week 24 to Year 2)|Inadvertently not noted as discontinued (disease progression); data collection error at site closure|1
567649|NCT00623766|1385711|P2|STARTED|Maintenance Phase (Week 24 to Year 2)||2
567650|NCT00623766|1385712|P1|STARTED|Maintenance Phase (Week 24 to Year 2)||11
567651|NCT00623766|1385711|P2|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||16
567652|NCT00623766|1385712|P1|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||36
567653|NCT00623766|1385711|P2|COMPLETED|Induction Phase (Day 1 to Week 24)|3 patients completed Induction but did not enter Maintenance; they were only followed up with scans.|5
567654|NCT00623766|1385712|P1|COMPLETED|Induction Phase (Day 1 to Week 24)|4 patients completed Induction but did not enter Maintenance; they were only followed up with scans.|15
567655|NCT00623766|1385711|P2|STARTED|Induction Phase (Day 1 to Week 24)|Participants who received treatment|21
567656|NCT00623766|1385712|P1|STARTED|Induction Phase (Day 1 to Week 24)|Participants who received treatment|51
567657|NCT00623727|1385736|P2|NOT COMPLETED|Open Label Extension Period||0
567658|NCT00623727|1385737|P1|NOT COMPLETED|Open Label Extension Period||0
567659|NCT00623727|1385736|P2|COMPLETED|Open Label Extension Period||0
567660|NCT00623727|1385737|P1|COMPLETED|Open Label Extension Period||20
567661|NCT00623727|1385736|P2|STARTED|Open Label Extension Period||0
567662|NCT00623727|1385737|P1|STARTED|Open Label Extension Period|10 participants of each group entered open-label extension period after completion of DB study|20
567663|NCT00623727|1385736|P2|NOT COMPLETED|Open Label Follow-up||8
567664|NCT00623727|1385737|P1|NOT COMPLETED|Open Label Follow-up||0
567665|NCT00623727|1385736|P2|COMPLETED|Open Label Follow-up||18
567666|NCT00623727|1385737|P1|COMPLETED|Open Label Follow-up||0
567667|NCT00623727|1385736|P2|STARTED|Open Label Follow-up|13 Participants from each group after DB period terminated entered open label follow up.|26
567668|NCT00623727|1385737|P1|STARTED|Open Label Follow-up||0
567669|NCT00623727|1385736|P2|NOT COMPLETED|Double Blind (DB)||32
567670|NCT00623727|1385737|P1|NOT COMPLETED|Double Blind (DB)||36
567671|NCT00623727|1385736|P2|COMPLETED|Double Blind (DB)||41
567672|NCT00623727|1385737|P1|COMPLETED|Double Blind (DB)||34
567673|NCT00623727|1385736|P2|Participants Received Treatment|Double Blind (DB)||72
567674|NCT00623727|1385737|P1|Participants Received Treatment|Double Blind (DB)||67
567675|NCT00623727|1385736|P2|STARTED|Double Blind (DB)|only 72 participants are applicable for baseline characteristic evaluation|73
567676|NCT00623727|1385737|P1|STARTED|Double Blind (DB)|only 67 participants are applicable for baseline characteristic evaluation|70
567677|NCT00623714|1385757|P2|NOT COMPLETED|Period 2||0
567678|NCT00623714|1385758|P1|NOT COMPLETED|Period 2||0
567679|NCT00623714|1385757|P2|COMPLETED|Period 2||7
567680|NCT00623714|1385758|P1|COMPLETED|Period 2||6
567681|NCT00623714|1385757|P2|STARTED|Period 2||7
567682|NCT00623714|1385758|P1|STARTED|Period 2||6
567683|NCT00623714|1385757|P2|NOT COMPLETED|Period 1||0
567684|NCT00623714|1385758|P1|NOT COMPLETED|Period 1||0
567685|NCT00623714|1385757|P2|COMPLETED|Period 1||7
567686|NCT00623714|1385758|P1|COMPLETED|Period 1||6
567687|NCT00623714|1385757|P2|STARTED|Period 1||7
567688|NCT00623714|1385758|P1|STARTED|Period 1||6
567689|NCT00623636|1385768|P2|NOT COMPLETED|Open Label||412
567690|NCT00623636|1385769|P1|NOT COMPLETED|Open Label||0
567691|NCT00623636|1385768|P2|COMPLETED|Open Label||263
567692|NCT00623636|1385769|P1|COMPLETED|Open Label||0
567693|NCT00623636|1385768|P2|STARTED|Open Label|Includes eligible Placebo and MAP0004 patients from the double-blind period.|675
567694|NCT00623636|1385769|P1|STARTED|Open Label|Eligible double-blind placebo patients received MAP0004 in the open-label period.|0
567695|NCT00623636|1385768|P2|NOT COMPLETED|Double Blind||28
567696|NCT00623636|1385769|P1|NOT COMPLETED|Double Blind||33
567697|NCT00623636|1385768|P2|COMPLETED|Double Blind||422
567698|NCT00623636|1385769|P1|COMPLETED|Double Blind||419
567699|NCT00623636|1385768|P2|STARTED|Double Blind||450
567700|NCT00623636|1385769|P1|STARTED|Double Blind||452
567701|NCT00623597|1385792|P2|NOT COMPLETED|Overall Study||0
567702|NCT00623597|1385793|P1|NOT COMPLETED|Overall Study||1
567703|NCT00623597|1385792|P2|COMPLETED|Overall Study||13
567704|NCT00623597|1385793|P1|COMPLETED|Overall Study||4
567705|NCT00623597|1385792|P2|STARTED|Overall Study||13
567706|NCT00623597|1385793|P1|STARTED|Overall Study||5
567707|NCT00623545|1385856|P1|NOT COMPLETED|Overall Study||10
567708|NCT00623545|1385856|P1|COMPLETED|Overall Study||18
567709|NCT00623545|1385856|P1|STARTED|Overall Study||28
567710|NCT00623506|1385863|P2|NOT COMPLETED|Overall Study||4
567711|NCT00623506|1385864|P1|NOT COMPLETED|Overall Study||4
567712|NCT00623506|1385863|P2|COMPLETED|Overall Study||11
567713|NCT00623506|1385864|P1|COMPLETED|Overall Study||11
567714|NCT00623506|1385863|P2|Week 4|Overall Study||11
567715|NCT00623506|1385864|P1|Week 4|Overall Study||11
567716|NCT00623506|1385863|P2|STARTED|Overall Study||15
567717|NCT00623506|1385864|P1|STARTED|Overall Study||15
567718|NCT00623480|1385876|P2|NOT COMPLETED|Overall Study||7
567719|NCT00623480|1385877|P1|NOT COMPLETED|Overall Study||7
567720|NCT00623480|1385876|P2|COMPLETED|Overall Study||35
567721|NCT00623480|1385877|P1|COMPLETED|Overall Study||35
567722|NCT00623480|1385876|P2|STARTED|Overall Study||42
567723|NCT00623480|1385877|P1|STARTED|Overall Study||42
567724|NCT00623467|1385889|P1|NOT COMPLETED|Overall Study||7
567725|NCT00623467|1385889|P1|COMPLETED|Overall Study||336
567726|NCT00623467|1385889|P1|STARTED|Overall Study||343
567727|NCT00623441|1385953|P1|NOT COMPLETED|Overall Study||0
567728|NCT00623441|1385953|P1|COMPLETED|Overall Study|12 months follow-up compliance was 94.2%|8314
567729|NCT00623441|1385953|P1|STARTED|Overall Study||8314
567730|NCT00623428|1385959|P2|NOT COMPLETED|Follow-up Period||15
567731|NCT00623428|1385960|P1|NOT COMPLETED|Follow-up Period||29
567732|NCT00623428|1385959|P2|COMPLETED|Follow-up Period|Patients who had an HCV RNA sample at 24 weeks of follow-up|78
567733|NCT00623428|1385960|P1|COMPLETED|Follow-up Period|Patients who had an HCV RNA sample at 48 weeks of follow-up|66
567734|NCT00623428|1385959|P2|STARTED|Follow-up Period||93
567735|NCT00623428|1385960|P1|STARTED|Follow-up Period||95
567736|NCT00623428|1385959|P2|NOT COMPLETED|Treatment Period||27
567737|NCT00623428|1385960|P1|NOT COMPLETED|Treatment Period||0
567738|NCT00623428|1385959|P2|COMPLETED|Treatment Period|Patients who completed 48 weeks of treatment|66
567739|NCT00623428|1385960|P1|COMPLETED|Treatment Period|Patients who completed 24 weeks of treatment|95
567740|NCT00623428|1385959|P2|STARTED|Treatment Period||93
567741|NCT00623428|1385960|P1|STARTED|Treatment Period||95
567742|NCT00623233|1385978|P1|NOT COMPLETED|Overall Study||24
567743|NCT00623233|1385978|P1|COMPLETED|Overall Study|Included those who discontinued due to PD or death and those who achieved complete response (CR).|28
567744|NCT00623233|1385978|P1|STARTED|Overall Study||52
567745|NCT00623194|1385985|P1|NOT COMPLETED|Overall Study||5
567746|NCT00623194|1385985|P1|COMPLETED|Overall Study||141
567747|NCT00623194|1385985|P1|STARTED|Overall Study||146
567748|NCT00623181|1386007|P2|NOT COMPLETED|Overall Study||0
567749|NCT00623181|1386008|P1|NOT COMPLETED|Overall Study||0
567750|NCT00623181|1386007|P2|COMPLETED|Overall Study||54
567751|NCT00623181|1386008|P1|COMPLETED|Overall Study||56
567752|NCT00623181|1386007|P2|STARTED|Overall Study||54
567753|NCT00623181|1386008|P1|STARTED|Overall Study||56
567754|NCT00623103|1386022|P2|NOT COMPLETED|Overall Study||113
567755|NCT00623103|1386023|P1|NOT COMPLETED|Overall Study||111
567756|NCT00623103|1386022|P2|COMPLETED|Overall Study||175
567757|NCT00623103|1386023|P1|COMPLETED|Overall Study||184
567758|NCT00623103|1386022|P2|Safety Set: Received Study Drug|Overall Study||288
567759|NCT00623103|1386023|P1|Safety Set: Received Study Drug|Overall Study|One randomized participant did not receive study drug and was not included in the Safety set.|294
567760|NCT00623103|1386022|P2|STARTED|Overall Study||288
567761|NCT00623103|1386023|P1|STARTED|Overall Study||295
567762|NCT00623012|1386043|P1|NOT COMPLETED|Overall Study||0
567763|NCT00623012|1386043|P1|COMPLETED|Overall Study||2
567764|NCT00623012|1386043|P1|STARTED|Overall Study||2
567765|NCT00622908|1386051|P2|NOT COMPLETED|Overall Study||10
567766|NCT00622908|1386052|P1|NOT COMPLETED|Overall Study||3
567767|NCT00622908|1386051|P2|COMPLETED|Overall Study||122
567768|NCT00622908|1386052|P1|COMPLETED|Overall Study||134
567769|NCT00622908|1386051|P2|STARTED|Overall Study|Intent to treat population|132
567770|NCT00622908|1386052|P1|STARTED|Overall Study|Intent to treat population|137
567771|NCT00622895|1386064|P1|NOT COMPLETED|Overall Study||0
567772|NCT00622895|1386064|P1|COMPLETED|Overall Study||3
567773|NCT00622895|1386064|P1|STARTED|Overall Study||3
567774|NCT00622869|1386082|P3|NOT COMPLETED|Overall Study||39
567775|NCT00622869|1386083|P2|NOT COMPLETED|Overall Study||57
567776|NCT00622869|1386084|P1|NOT COMPLETED|Overall Study||43
567777|NCT00622869|1386082|P3|COMPLETED|Overall Study||204
567778|NCT00622869|1386083|P2|COMPLETED|Overall Study||174
567779|NCT00622869|1386084|P1|COMPLETED|Overall Study||202
567780|NCT00622869|1386082|P3|STARTED|Overall Study||243
567781|NCT00622869|1386083|P2|STARTED|Overall Study||231
567782|NCT00622869|1386084|P1|STARTED|Overall Study||245
567783|NCT00622739|1386103|P2|NOT COMPLETED|Overall Study||6
567784|NCT00622739|1386104|P1|NOT COMPLETED|Overall Study||2
567785|NCT00622739|1386103|P2|COMPLETED|Overall Study||9
567786|NCT00622739|1386104|P1|COMPLETED|Overall Study||11
567787|NCT00622739|1386103|P2|STARTED|Overall Study||15
567788|NCT00622739|1386104|P1|STARTED|Overall Study||13
567789|NCT00622726|1386112|P2|NOT COMPLETED|August, 2010 to April, 2013||5
567790|NCT00622726|1386113|P1|NOT COMPLETED|August, 2010 to April, 2013||1
567791|NCT00622726|1386112|P2|COMPLETED|August, 2010 to April, 2013||68
567792|NCT00622726|1386113|P1|COMPLETED|August, 2010 to April, 2013||69
567793|NCT00622726|1386112|P2|STARTED|August, 2010 to April, 2013||73
567794|NCT00622726|1386113|P1|STARTED|August, 2010 to April, 2013||70
567795|NCT00622726|1386112|P2|NOT COMPLETED|March, 2008 to August, 2010||2
567796|NCT00622726|1386113|P1|NOT COMPLETED|March, 2008 to August, 2010||5
567797|NCT00622726|1386112|P2|COMPLETED|March, 2008 to August, 2010|All infants were extremely immature with multiple neonatal intensive care unit complications.|73
567798|NCT00622726|1386113|P1|COMPLETED|March, 2008 to August, 2010|All infants were extremely immature with multiple neonatal intensive care unit complications.|70
567799|NCT00622726|1386112|P2|STARTED|March, 2008 to August, 2010||75
567800|NCT00622726|1386113|P1|STARTED|March, 2008 to August, 2010||75
567801|NCT00622713|1386123|P1|NOT COMPLETED|Overall Study||59
567802|NCT00622713|1386123|P1|COMPLETED|Overall Study||169
567803|NCT00622713|1386123|P1|Intent to Treat (ITT) Population|Overall Study||218
567804|NCT00622713|1386123|P1|Exposed to Study Drug|Overall Study||226
567805|NCT00622713|1386123|P1|STARTED|Overall Study||228
567806|NCT00622700|1386134|P7|NOT COMPLETED|Extension Treatment Period||30
567807|NCT00622700|1386135|P6|NOT COMPLETED|Extension Treatment Period||17
567808|NCT00622700|1386136|P5|NOT COMPLETED|Extension Treatment Period||39
567809|NCT00622700|1386137|P4|NOT COMPLETED|Extension Treatment Period||21
567810|NCT00622700|1386138|P3|NOT COMPLETED|Extension Treatment Period||0
567811|NCT00622700|1386139|P2|NOT COMPLETED|Extension Treatment Period||0
567812|NCT00622700|1386140|P1|NOT COMPLETED|Extension Treatment Period||0
567813|NCT00622700|1386134|P7|COMPLETED|Extension Treatment Period||120
567814|NCT00622700|1386135|P6|COMPLETED|Extension Treatment Period||50
567815|NCT00622700|1386136|P5|COMPLETED|Extension Treatment Period||103
567816|NCT00622700|1386137|P4|COMPLETED|Extension Treatment Period||43
567817|NCT00622700|1386138|P3|COMPLETED|Extension Treatment Period||0
567818|NCT00622700|1386139|P2|COMPLETED|Extension Treatment Period||0
567819|NCT00622700|1386140|P1|COMPLETED|Extension Treatment Period||0
567820|NCT00622700|1386134|P7|STARTED|Extension Treatment Period|13 participants completed core treatment period but did not enter in extension treatment period.|150
567821|NCT00622700|1386135|P6|STARTED|Extension Treatment Period|10 participants completed core treatment period but did not enter in extension treatment period.|67
567822|NCT00622700|1386136|P5|STARTED|Extension Treatment Period|8 participants completed core treatment period but did not enter in extension treatment period.|142
567823|NCT00622700|1386137|P4|STARTED|Extension Treatment Period|10 participants completed core treatment period but did not enter in extension treatment period.|64
567824|NCT00622700|1386138|P3|STARTED|Extension Treatment Period||0
567825|NCT00622700|1386139|P2|STARTED|Extension Treatment Period||0
567826|NCT00622700|1386140|P1|STARTED|Extension Treatment Period|Participants were re-randomized in a 1:1 ratio to either teriflunomide 7 mg or 14 mg treatment arm.|0
567827|NCT00622700|1386134|P7|NOT COMPLETED|Core Treatment Period||0
567828|NCT00622700|1386135|P6|NOT COMPLETED|Core Treatment Period||0
567829|NCT00622700|1386136|P5|NOT COMPLETED|Core Treatment Period||0
567830|NCT00622700|1386137|P4|NOT COMPLETED|Core Treatment Period||0
567831|NCT00622700|1386138|P3|NOT COMPLETED|Core Treatment Period||53
567832|NCT00622700|1386139|P2|NOT COMPLETED|Core Treatment Period||55
567833|NCT00622700|1386140|P1|NOT COMPLETED|Core Treatment Period||56
567834|NCT00622700|1386134|P7|COMPLETED|Core Treatment Period||0
567835|NCT00622700|1386135|P6|COMPLETED|Core Treatment Period||0
567836|NCT00622700|1386136|P5|COMPLETED|Core Treatment Period||0
567837|NCT00622700|1386137|P4|COMPLETED|Core Treatment Period||0
567838|NCT00622700|1386138|P3|COMPLETED|Core Treatment Period||163
567839|NCT00622700|1386139|P2|COMPLETED|Core Treatment Period||150
567840|NCT00622700|1386140|P1|COMPLETED|Core Treatment Period||141
567841|NCT00622700|1386134|P7|Treated|Core Treatment Period||0
567842|NCT00622700|1386135|P6|Treated|Core Treatment Period||0
567843|NCT00622700|1386136|P5|Treated|Core Treatment Period||0
567844|NCT00622700|1386137|P4|Treated|Core Treatment Period||0
567845|NCT00622700|1386138|P3|Treated|Core Treatment Period||214
567846|NCT00622700|1386139|P2|Treated|Core Treatment Period||203
567847|NCT00622700|1386140|P1|Treated|Core Treatment Period||197
567848|NCT00622700|1386134|P7|STARTED|Core Treatment Period||0
567849|NCT00622700|1386135|P6|STARTED|Core Treatment Period||0
567850|NCT00622700|1386136|P5|STARTED|Core Treatment Period||0
567851|NCT00622700|1386137|P4|STARTED|Core Treatment Period||0
567852|NCT00622700|1386138|P3|STARTED|Core Treatment Period||216
567853|NCT00622700|1386139|P2|STARTED|Core Treatment Period||205
567854|NCT00622700|1386140|P1|STARTED|Core Treatment Period||197
567855|NCT00622635|1386199|P6|NOT COMPLETED|Treatment Period 3||0
567856|NCT00622635|1386200|P5|NOT COMPLETED|Treatment Period 3||0
567857|NCT00622635|1386201|P4|NOT COMPLETED|Treatment Period 3||3
567858|NCT00622635|1386202|P3|NOT COMPLETED|Treatment Period 3||0
567859|NCT00622635|1386203|P2|NOT COMPLETED|Treatment Period 3||0
567860|NCT00622635|1386204|P1|NOT COMPLETED|Treatment Period 3||0
567861|NCT00622635|1386199|P6|COMPLETED|Treatment Period 3||10
567862|NCT00622635|1386200|P5|COMPLETED|Treatment Period 3||9
567863|NCT00622635|1386201|P4|COMPLETED|Treatment Period 3||10
567864|NCT00622635|1386202|P3|COMPLETED|Treatment Period 3||10
567865|NCT00622635|1386203|P2|COMPLETED|Treatment Period 3||10
567866|NCT00622635|1386204|P1|COMPLETED|Treatment Period 3||12
567867|NCT00622635|1386199|P6|STARTED|Treatment Period 3||10
567868|NCT00622635|1386200|P5|STARTED|Treatment Period 3||9
567869|NCT00622635|1386201|P4|STARTED|Treatment Period 3||13
567870|NCT00622635|1386202|P3|STARTED|Treatment Period 3||10
567871|NCT00622635|1386203|P2|STARTED|Treatment Period 3||10
567872|NCT00622635|1386204|P1|STARTED|Treatment Period 3||12
567873|NCT00622635|1386199|P6|NOT COMPLETED|Treatment Period 2||0
567874|NCT00622635|1386200|P5|NOT COMPLETED|Treatment Period 2||0
567875|NCT00622635|1386201|P4|NOT COMPLETED|Treatment Period 2||0
567876|NCT00622635|1386202|P3|NOT COMPLETED|Treatment Period 2||0
567877|NCT00622635|1386203|P2|NOT COMPLETED|Treatment Period 2||0
567878|NCT00622635|1386204|P1|NOT COMPLETED|Treatment Period 2||1
567879|NCT00622635|1386199|P6|COMPLETED|Treatment Period 2||10
567880|NCT00622635|1386200|P5|COMPLETED|Treatment Period 2||9
567881|NCT00622635|1386201|P4|COMPLETED|Treatment Period 2||13
567882|NCT00622635|1386202|P3|COMPLETED|Treatment Period 2||10
567883|NCT00622635|1386203|P2|COMPLETED|Treatment Period 2||10
567884|NCT00622635|1386204|P1|COMPLETED|Treatment Period 2||12
567885|NCT00622635|1386199|P6|STARTED|Treatment Period 2||10
567886|NCT00622635|1386200|P5|STARTED|Treatment Period 2||9
567887|NCT00622635|1386201|P4|STARTED|Treatment Period 2||13
567888|NCT00622635|1386202|P3|STARTED|Treatment Period 2||10
567889|NCT00622635|1386203|P2|STARTED|Treatment Period 2||10
567890|NCT00622635|1386204|P1|STARTED|Treatment Period 2||13
567891|NCT00622635|1386199|P6|NOT COMPLETED|Treatment Period 1||0
567892|NCT00622635|1386200|P5|NOT COMPLETED|Treatment Period 1||1
567893|NCT00622635|1386201|P4|NOT COMPLETED|Treatment Period 1||0
567894|NCT00622635|1386202|P3|NOT COMPLETED|Treatment Period 1||1
567895|NCT00622635|1386203|P2|NOT COMPLETED|Treatment Period 1||1
567896|NCT00622635|1386204|P1|NOT COMPLETED|Treatment Period 1||0
567897|NCT00622635|1386199|P6|COMPLETED|Treatment Period 1||10
567898|NCT00622635|1386200|P5|COMPLETED|Treatment Period 1||9
567899|NCT00622635|1386201|P4|COMPLETED|Treatment Period 1||13
567900|NCT00622635|1386202|P3|COMPLETED|Treatment Period 1||10
567901|NCT00622635|1386203|P2|COMPLETED|Treatment Period 1||10
567902|NCT00622635|1386204|P1|COMPLETED|Treatment Period 1||13
567903|NCT00622635|1386199|P6|STARTED|Treatment Period 1||10
567904|NCT00622635|1386200|P5|STARTED|Treatment Period 1||10
567905|NCT00622635|1386201|P4|STARTED|Treatment Period 1||13
567906|NCT00622635|1386202|P3|STARTED|Treatment Period 1||11
567907|NCT00622635|1386203|P2|STARTED|Treatment Period 1||11
567908|NCT00622635|1386204|P1|STARTED|Treatment Period 1||13
567909|NCT00622518|1386271|P2|NOT COMPLETED|Overall Study||0
567910|NCT00622518|1386272|P1|NOT COMPLETED|Overall Study||0
567911|NCT00622518|1386271|P2|COMPLETED|Overall Study||60
567912|NCT00622518|1386272|P1|COMPLETED|Overall Study||59
567913|NCT00622518|1386271|P2|STARTED|Overall Study||60
567914|NCT00622518|1386272|P1|STARTED|Overall Study||59
567915|NCT00622440|1386282|P2|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||1
567916|NCT00622440|1386283|P1|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||0
567917|NCT00622440|1386282|P2|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||27
567918|NCT00622440|1386283|P1|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||28
567919|NCT00622440|1386282|P2|STARTED|Week 60 (Post-treatment Follow-up Visit)||28
567920|NCT00622440|1386283|P1|STARTED|Week 60 (Post-treatment Follow-up Visit)||28
567921|NCT00622440|1386282|P2|NOT COMPLETED|Week 12 - Week 48 (Treatment)||6
567922|NCT00622440|1386283|P1|NOT COMPLETED|Week 12 - Week 48 (Treatment)||3
567923|NCT00622440|1386282|P2|COMPLETED|Week 12 - Week 48 (Treatment)||28
567924|NCT00622440|1386283|P1|COMPLETED|Week 12 - Week 48 (Treatment)||28
567925|NCT00622440|1386282|P2|STARTED|Week 12 - Week 48 (Treatment)||34
567926|NCT00622440|1386283|P1|STARTED|Week 12 - Week 48 (Treatment)||31
567927|NCT00622440|1386282|P2|NOT COMPLETED|Baseline - Week 12 (Treatment)||1
567928|NCT00622440|1386283|P1|NOT COMPLETED|Baseline - Week 12 (Treatment)||4
567929|NCT00622440|1386282|P2|COMPLETED|Baseline - Week 12 (Treatment)||34
567930|NCT00622440|1386283|P1|COMPLETED|Baseline - Week 12 (Treatment)||31
567931|NCT00622440|1386282|P2|STARTED|Baseline - Week 12 (Treatment)||35
567932|NCT00622440|1386283|P1|STARTED|Baseline - Week 12 (Treatment)||35
567933|NCT00622427|1386297|P2|NOT COMPLETED|Overall Study||0
567934|NCT00622427|1386298|P1|NOT COMPLETED|Overall Study||0
567935|NCT00622427|1386297|P2|COMPLETED|Overall Study|each subject received 2 weeks of placebo, then 2 weeks of Ramelteon after a two week wash out period|16
567936|NCT00622427|1386298|P1|COMPLETED|Overall Study|each subject received 2 weeks of Ramelteon, then 2 weeks of placebo after a two week wash out period|16
567937|NCT00622427|1386297|P2|STARTED|Overall Study||16
567938|NCT00622427|1386298|P1|STARTED|Overall Study||16
567939|NCT00622401|1386309|P3|NOT COMPLETED|Overall Study||0
567940|NCT00622401|1386310|P2|NOT COMPLETED|Overall Study||2
567941|NCT00622401|1386311|P1|NOT COMPLETED|Overall Study||3
567942|NCT00622401|1386309|P3|COMPLETED|Overall Study||0
567943|NCT00622401|1386310|P2|COMPLETED|Overall Study||0
567944|NCT00622401|1386311|P1|COMPLETED|Overall Study||3
567945|NCT00622401|1386309|P3|STARTED|Overall Study|Never Opened|0
567946|NCT00622401|1386310|P2|STARTED|Overall Study||2
567947|NCT00622401|1386311|P1|STARTED|Overall Study||6
567948|NCT00622388|1386318|P1|NOT COMPLETED|Overall Study||72
567949|NCT00622388|1386318|P1|COMPLETED|Overall Study||9
567950|NCT00622388|1386318|P1|STARTED|Overall Study||81
567951|NCT00622336|1386336|P1|NOT COMPLETED|Extension Phase||21
567952|NCT00622336|1386336|P1|COMPLETED|Extension Phase||0
567953|NCT00622336|1386336|P1|STARTED|Extension Phase||21
567954|NCT00622336|1386336|P1|NOT COMPLETED|Treatment Phase||309
567955|NCT00622336|1386336|P1|COMPLETED|Treatment Phase|Completed = those who completed the treatment phase and were ongoing in the extension study|21
567956|NCT00622336|1386336|P1|Safety Population|Treatment Phase||330
567957|NCT00622336|1386336|P1|STARTED|Treatment Phase||330
567958|NCT00622284|1386347|P2|NOT COMPLETED|Overall Study||171
567959|NCT00622284|1386348|P1|NOT COMPLETED|Overall Study||189
567960|NCT00622284|1386347|P2|COMPLETED|Overall Study|Number who completed treatment.|604
567961|NCT00622284|1386348|P1|COMPLETED|Overall Study|Number who completed treatment.|587
567962|NCT00622284|1386347|P2|STARTED|Overall Study|Number who started treatment.|775
567963|NCT00622284|1386348|P1|STARTED|Overall Study|Number who started treatment. One patient in the Linagliptin group was randomized but not treated.|776
567964|NCT00622167|1386410|P1|NOT COMPLETED|Overall Study||20
567965|NCT00622167|1386410|P1|COMPLETED|Overall Study||4
567966|NCT00622167|1386410|P1|STARTED|Overall Study||24
567967|NCT00621985|1386414|P1|NOT COMPLETED|Dexamethasone Admission||1
567968|NCT00621985|1386414|P1|COMPLETED|Dexamethasone Admission||4
567969|NCT00621985|1386414|P1|STARTED|Dexamethasone Admission||5
567970|NCT00621985|1386414|P1|NOT COMPLETED|Hydrocortisone Admission||0
567971|NCT00621985|1386414|P1|COMPLETED|Hydrocortisone Admission||5
567972|NCT00621985|1386414|P1|STARTED|Hydrocortisone Admission||5
567973|NCT00621959|1386422|P2|NOT COMPLETED|Overall Study||9
567974|NCT00621959|1386423|P1|NOT COMPLETED|Overall Study||7
567975|NCT00621959|1386422|P2|COMPLETED|Overall Study||292
567976|NCT00621959|1386423|P1|COMPLETED|Overall Study||288
567977|NCT00621959|1386422|P2|STARTED|Overall Study||301
567978|NCT00621959|1386423|P1|STARTED|Overall Study|In all 791 subjects have been screened and 596 have been randomized|295
567979|NCT00621946|1386433|P2|NOT COMPLETED|Overall Study||1
567980|NCT00621946|1386434|P1|NOT COMPLETED|Overall Study||0
567981|NCT00621946|1386433|P2|COMPLETED|Overall Study||12
567982|NCT00621946|1386434|P1|COMPLETED|Overall Study||13
567983|NCT00621946|1386433|P2|STARTED|Overall Study||13
567984|NCT00621946|1386434|P1|STARTED|Overall Study||13
567985|NCT00621933|1386450|P1|NOT COMPLETED|Overall Study||0
567986|NCT00621933|1386450|P1|COMPLETED|Overall Study||399
567987|NCT00621933|1386450|P1|STARTED|Overall Study||399
567988|NCT00621855|1386462|P5|NOT COMPLETED|Overall Study||55
567989|NCT00621855|1386463|P4|NOT COMPLETED|Overall Study||67
567990|NCT00621855|1386464|P3|NOT COMPLETED|Overall Study||81
567991|NCT00621855|1386465|P2|NOT COMPLETED|Overall Study||61
567992|NCT00621855|1386466|P1|NOT COMPLETED|Overall Study||76
567993|NCT00621855|1386462|P5|COMPLETED|Overall Study|Completed means completed treatment|318
567994|NCT00621855|1386463|P4|COMPLETED|Overall Study|Completed means completed treatment|284
567995|NCT00621855|1386464|P3|COMPLETED|Overall Study|Completed means completed treatment|330
567996|NCT00621855|1386465|P2|COMPLETED|Overall Study|Completed means completed treatment|310
567997|NCT00621855|1386466|P1|COMPLETED|Overall Study|Completed means completed treatment|296
567998|NCT00621855|1386462|P5|STARTED|Overall Study|Started means randomised to treatment|373
567999|NCT00621855|1386463|P4|STARTED|Overall Study|Started means randomised to treatment|351
568000|NCT00621855|1386464|P3|STARTED|Overall Study|Started means randomised to treatment|411
568001|NCT00621855|1386465|P2|STARTED|Overall Study|Started means randomised to treatment|371
568002|NCT00621855|1386466|P1|STARTED|Overall Study|Started means randomised to treatment|372
568003|NCT00621842|1386508|P1|NOT COMPLETED|Overall Study||19
568004|NCT00621842|1386508|P1|COMPLETED|Overall Study||38
568005|NCT00621842|1386508|P1|STARTED|Overall Study||57
568006|NCT00621777|1386525|P2|NOT COMPLETED|Randomized Phase||19
568007|NCT00621777|1386526|P1|NOT COMPLETED|Randomized Phase||7
568008|NCT00621777|1386525|P2|COMPLETED|Randomized Phase||28
568009|NCT00621777|1386526|P1|COMPLETED|Randomized Phase||33
568010|NCT00621777|1386525|P2|STARTED|Randomized Phase||47
568011|NCT00621777|1386526|P1|STARTED|Randomized Phase|87 open phase participants were continuously abstinent for at least 14 days and were randomized|40
568012|NCT00621777|1386525|P2|NOT COMPLETED|Open Phase||0
568013|NCT00621777|1386526|P1|NOT COMPLETED|Open Phase||116
568014|NCT00621777|1386525|P2|COMPLETED|Open Phase||0
568015|NCT00621777|1386526|P1|COMPLETED|Open Phase||87
568016|NCT00621777|1386525|P2|STARTED|Open Phase|During this open label phase, all study participants received varenicline|0
568017|NCT00621777|1386526|P1|STARTED|Open Phase||203
568018|NCT00621764|1386541|P4|NOT COMPLETED|Overall Study||1
568019|NCT00621764|1386542|P3|NOT COMPLETED|Overall Study||0
568020|NCT00621764|1386543|P2|NOT COMPLETED|Overall Study||0
568021|NCT00621764|1386544|P1|NOT COMPLETED|Overall Study||0
568022|NCT00621764|1386541|P4|COMPLETED|Overall Study||98
568023|NCT00621764|1386542|P3|COMPLETED|Overall Study||101
568024|NCT00621764|1386543|P2|COMPLETED|Overall Study||50
568025|NCT00621764|1386544|P1|COMPLETED|Overall Study||50
568026|NCT00621764|1386541|P4|STARTED|Overall Study||99
568027|NCT00621764|1386542|P3|STARTED|Overall Study||101
568028|NCT00621764|1386543|P2|STARTED|Overall Study||50
568029|NCT00621764|1386544|P1|STARTED|Overall Study||50
568030|NCT00621686|1386576|P2|NOT COMPLETED|Overall Study||0
568031|NCT00621686|1386577|P1|NOT COMPLETED|Overall Study||0
568032|NCT00621686|1386576|P2|COMPLETED|Overall Study||35
568033|NCT00621686|1386577|P1|COMPLETED|Overall Study||19
568034|NCT00621686|1386576|P2|STARTED|Overall Study||35
568035|NCT00621686|1386577|P1|STARTED|Overall Study||19
568036|NCT00621621|1386590|P2|NOT COMPLETED|Overall Study||0
568037|NCT00621621|1386591|P1|NOT COMPLETED|Overall Study||30
568038|NCT00621621|1386590|P2|COMPLETED|Overall Study||705
568039|NCT00621621|1386591|P1|COMPLETED|Overall Study|Treated with the experimental catheter|75
568040|NCT00621621|1386590|P2|STARTED|Overall Study||705
568041|NCT00621621|1386591|P1|STARTED|Overall Study|Date of Post- Approval Study protocol approval|105
568042|NCT00621582|1386599|P1|NOT COMPLETED|Overall Study||106
568043|NCT00621582|1386599|P1|COMPLETED|Overall Study||4812
568044|NCT00621582|1386599|P1|STARTED|Overall Study||4918
568045|NCT00621543|1386606|P1|NOT COMPLETED|Overall Study||23
568046|NCT00621543|1386606|P1|COMPLETED|Overall Study||97
568047|NCT00621543|1386606|P1|STARTED|Overall Study||120
568048|NCT00621530|1386613|P2|NOT COMPLETED|Overall Study||3
568049|NCT00621530|1386614|P1|NOT COMPLETED|Overall Study||2
568050|NCT00621530|1386613|P2|COMPLETED|Overall Study||29
568051|NCT00621530|1386614|P1|COMPLETED|Overall Study||28
568052|NCT00621530|1386613|P2|STARTED|Overall Study||32
568053|NCT00621530|1386614|P1|STARTED|Overall Study||30
568054|NCT00621517|1386630|P2|NOT COMPLETED|Overall Study||7
568055|NCT00621517|1386631|P1|NOT COMPLETED|Overall Study||7
568056|NCT00621517|1386630|P2|COMPLETED|Overall Study||24
568057|NCT00621517|1386631|P1|COMPLETED|Overall Study||22
568058|NCT00621517|1386630|P2|STARTED|Overall Study||31
568059|NCT00621517|1386631|P1|STARTED|Overall Study||29
568060|NCT00621504|1386639|P2|NOT COMPLETED|Overall Study||25
568061|NCT00621504|1386640|P1|NOT COMPLETED|Overall Study||26
568062|NCT00621504|1386639|P2|COMPLETED|Overall Study||282
568063|NCT00621504|1386640|P1|COMPLETED|Overall Study||273
568064|NCT00621504|1386639|P2|STARTED|Overall Study||307
568065|NCT00621504|1386640|P1|STARTED|Overall Study||299
568066|NCT00621348|1386649|P3|NOT COMPLETED|Overall Study||0
568067|NCT00621348|1386650|P2|NOT COMPLETED|Overall Study||0
568068|NCT00621348|1386651|P1|NOT COMPLETED|Overall Study||0
568069|NCT00621348|1386649|P3|COMPLETED|Overall Study||56
568070|NCT00621348|1386650|P2|COMPLETED|Overall Study||53
568071|NCT00621348|1386651|P1|COMPLETED|Overall Study||58
568072|NCT00621348|1386649|P3|STARTED|Overall Study||56
568073|NCT00621348|1386650|P2|STARTED|Overall Study||53
568074|NCT00621348|1386651|P1|STARTED|Overall Study||58
568075|NCT00621322|1386674|P6|NOT COMPLETED|Overall Study||4
568076|NCT00621322|1386675|P5|NOT COMPLETED|Overall Study||1
568077|NCT00621322|1386676|P4|NOT COMPLETED|Overall Study||3
568078|NCT00621322|1386677|P3|NOT COMPLETED|Overall Study||2
568079|NCT00621322|1386678|P2|NOT COMPLETED|Overall Study||0
568080|NCT00621322|1386679|P1|NOT COMPLETED|Overall Study||1
568081|NCT00621322|1386674|P6|COMPLETED|Overall Study||36
568082|NCT00621322|1386675|P5|COMPLETED|Overall Study||39
568083|NCT00621322|1386676|P4|COMPLETED|Overall Study||37
568084|NCT00621322|1386677|P3|COMPLETED|Overall Study||38
568085|NCT00621322|1386678|P2|COMPLETED|Overall Study||10
568086|NCT00621322|1386679|P1|COMPLETED|Overall Study||9
568087|NCT00621322|1386674|P6|STARTED|Overall Study||40
568088|NCT00621322|1386675|P5|STARTED|Overall Study||40
568089|NCT00621322|1386676|P4|STARTED|Overall Study||40
568090|NCT00621322|1386677|P3|STARTED|Overall Study||40
568091|NCT00621322|1386678|P2|STARTED|Overall Study||10
568092|NCT00621322|1386679|P1|STARTED|Overall Study||10
568093|NCT00621296|1386759|P1|NOT COMPLETED|Overall Study||14
568094|NCT00621296|1386759|P1|COMPLETED|Overall Study||1
568095|NCT00621296|1386759|P1|STARTED|Overall Study||15
568096|NCT00621257|1386768|P5|NOT COMPLETED|Overall Study||9
568097|NCT00621257|1386769|P4|NOT COMPLETED|Overall Study||6
568098|NCT00621257|1386770|P3|NOT COMPLETED|Overall Study||3
568099|NCT00621257|1386771|P2|NOT COMPLETED|Overall Study||3
568100|NCT00621257|1386772|P1|NOT COMPLETED|Overall Study||4
568101|NCT00621257|1386768|P5|COMPLETED|Overall Study||22
568102|NCT00621257|1386769|P4|COMPLETED|Overall Study||26
568103|NCT00621257|1386770|P3|COMPLETED|Overall Study||20
568104|NCT00621257|1386771|P2|COMPLETED|Overall Study||21
568105|NCT00621257|1386772|P1|COMPLETED|Overall Study||20
568106|NCT00621257|1386768|P5|STARTED|Overall Study||31
568107|NCT00621257|1386769|P4|STARTED|Overall Study||32
568108|NCT00621257|1386770|P3|STARTED|Overall Study||23
568109|NCT00621257|1386771|P2|STARTED|Overall Study||24
568110|NCT00621257|1386772|P1|STARTED|Overall Study||24
568111|NCT00621244|1386788|P4|NOT COMPLETED|Overall Study||23
568112|NCT00621244|1386789|P3|NOT COMPLETED|Overall Study||33
568113|NCT00621244|1386790|P2|NOT COMPLETED|Overall Study||34
568114|NCT00621244|1386791|P1|NOT COMPLETED|Overall Study||86
568115|NCT00621244|1386788|P4|COMPLETED|Overall Study||0
568116|NCT00621244|1386789|P3|COMPLETED|Overall Study||0
568117|NCT00621244|1386790|P2|COMPLETED|Overall Study||0
568118|NCT00621244|1386791|P1|COMPLETED|Overall Study||0
568119|NCT00621244|1386788|P4|STARTED|Overall Study||23
568120|NCT00621244|1386789|P3|STARTED|Overall Study||33
568121|NCT00621244|1386790|P2|STARTED|Overall Study||34
568122|NCT00621244|1386791|P1|STARTED|Overall Study||86
568123|NCT00621192|1386895|P4|NOT COMPLETED|Overall Study||3
568124|NCT00621192|1386896|P3|NOT COMPLETED|Overall Study||5
568125|NCT00621192|1386897|P2|NOT COMPLETED|Overall Study||9
568126|NCT00621192|1386898|P1|NOT COMPLETED|Overall Study||4
568127|NCT00621192|1386895|P4|COMPLETED|Overall Study||24
568128|NCT00621192|1386896|P3|COMPLETED|Overall Study||26
568129|NCT00621192|1386897|P2|COMPLETED|Overall Study||94
568130|NCT00621192|1386898|P1|COMPLETED|Overall Study||35
568131|NCT00621192|1386895|P4|Efficacy Population|Overall Study||27
568132|NCT00621192|1386896|P3|Efficacy Population|Overall Study||28
568133|NCT00621192|1386897|P2|Efficacy Population|Overall Study||101
568134|NCT00621192|1386898|P1|Efficacy Population|Overall Study||39
568135|NCT00621192|1386895|P4|Safety Population|Overall Study||27
568136|NCT00621192|1386896|P3|Safety Population|Overall Study||31
568137|NCT00621192|1386897|P2|Safety Population|Overall Study||103
568138|NCT00621192|1386898|P1|Safety Population|Overall Study||39
568139|NCT00621192|1386895|P4|STARTED|Overall Study||27
568140|NCT00621192|1386896|P3|STARTED|Overall Study||31
568141|NCT00621192|1386897|P2|STARTED|Overall Study||103
568142|NCT00621192|1386898|P1|STARTED|Overall Study||39
568143|NCT00621153|1386922|P2|NOT COMPLETED|Overall Study||15
568144|NCT00621153|1386923|P1|NOT COMPLETED|Overall Study||20
568145|NCT00621153|1386922|P2|COMPLETED|Overall Study|completed|101
568146|NCT00621153|1386923|P1|COMPLETED|Overall Study|completed|97
568147|NCT00621153|1386922|P2|Discontinued|Overall Study||15
568148|NCT00621153|1386923|P1|Discontinued|Overall Study||20
568149|NCT00621153|1386922|P2|STARTED|Overall Study|randomised|116
568150|NCT00621153|1386923|P1|STARTED|Overall Study|randomised|117
568151|NCT00621140|1386931|P2|NOT COMPLETED|Overall Study||18
568152|NCT00621140|1386932|P1|NOT COMPLETED|Overall Study||15
568153|NCT00621140|1386931|P2|COMPLETED|Overall Study|number who completed treatment|318
568154|NCT00621140|1386932|P1|COMPLETED|Overall Study|number who completed treatment|152
568155|NCT00621140|1386931|P2|STARTED|Overall Study|number who started treatment|336
568156|NCT00621140|1386932|P1|STARTED|Overall Study|number who started treatment|167
568157|NCT00621049|1386966|P2|NOT COMPLETED|Maintenance Treatment||0
568158|NCT00621049|1386967|P1|NOT COMPLETED|Maintenance Treatment||15
568159|NCT00621049|1386966|P2|COMPLETED|Maintenance Treatment||0
568160|NCT00621049|1386967|P1|COMPLETED|Maintenance Treatment||34
568161|NCT00621049|1386966|P2|STARTED|Maintenance Treatment|Per protocol, only the Docetaxel/Carboplatin/Bevacizumab/Erlotinib arm enters maintenance therapy|0
568162|NCT00621049|1386967|P1|STARTED|Maintenance Treatment|3 patients came off study between the end of adjuvant therapy and the start of maintenance|49
568163|NCT00621049|1386966|P2|NOT COMPLETED|Adjuvant Treatment||10
568164|NCT00621049|1386967|P1|NOT COMPLETED|Adjuvant Treatment||3
568165|NCT00621049|1386966|P2|COMPLETED|Adjuvant Treatment||47
568166|NCT00621049|1386967|P1|COMPLETED|Adjuvant Treatment||52
568167|NCT00621049|1386966|P2|STARTED|Adjuvant Treatment||57
568168|NCT00621049|1386967|P1|STARTED|Adjuvant Treatment||55
568169|NCT00621023|1386979|P1|NOT COMPLETED|Overall Study||6
568170|NCT00621023|1386979|P1|COMPLETED|Overall Study|Completed is defined as 5 years of follow up.|0
568171|NCT00621023|1386979|P1|STARTED|Overall Study||6
568172|NCT00620945|1386985|P1|NOT COMPLETED|Overall Study||0
568173|NCT00620945|1386985|P1|COMPLETED|Overall Study||87
568174|NCT00620945|1386985|P1|STARTED|Overall Study|Total number in the study|87
568175|NCT00620854|1386996|P6|NOT COMPLETED|Period 3||0
568176|NCT00620854|1386997|P5|NOT COMPLETED|Period 3||0
568177|NCT00620854|1386998|P4|NOT COMPLETED|Period 3||0
568178|NCT00620854|1386999|P3|NOT COMPLETED|Period 3||0
568179|NCT00620854|1387000|P2|NOT COMPLETED|Period 3||0
568180|NCT00620854|1387001|P1|NOT COMPLETED|Period 3||0
568181|NCT00620854|1386996|P6|COMPLETED|Period 3||4
568182|NCT00620854|1386997|P5|COMPLETED|Period 3||4
568183|NCT00620854|1386998|P4|COMPLETED|Period 3||3
568184|NCT00620854|1386999|P3|COMPLETED|Period 3||3
568185|NCT00620854|1387000|P2|COMPLETED|Period 3||4
568186|NCT00620854|1387001|P1|COMPLETED|Period 3||4
568187|NCT00620854|1386996|P6|STARTED|Period 3||4
568188|NCT00620854|1386997|P5|STARTED|Period 3||4
568189|NCT00620854|1386998|P4|STARTED|Period 3||3
568190|NCT00620854|1386999|P3|STARTED|Period 3||3
568191|NCT00620854|1387000|P2|STARTED|Period 3||4
568192|NCT00620854|1387001|P1|STARTED|Period 3||4
568193|NCT00620854|1386996|P6|NOT COMPLETED|Washout 2||0
568194|NCT00620854|1386997|P5|NOT COMPLETED|Washout 2||0
568195|NCT00620854|1386998|P4|NOT COMPLETED|Washout 2||0
568196|NCT00620854|1386999|P3|NOT COMPLETED|Washout 2||0
568197|NCT00620854|1387000|P2|NOT COMPLETED|Washout 2||0
568198|NCT00620854|1387001|P1|NOT COMPLETED|Washout 2||0
568199|NCT00620854|1386996|P6|COMPLETED|Washout 2||4
568200|NCT00620854|1386997|P5|COMPLETED|Washout 2||4
568201|NCT00620854|1386998|P4|COMPLETED|Washout 2||3
568202|NCT00620854|1386999|P3|COMPLETED|Washout 2||3
568203|NCT00620854|1387000|P2|COMPLETED|Washout 2||4
568204|NCT00620854|1387001|P1|COMPLETED|Washout 2||4
568205|NCT00620854|1386996|P6|STARTED|Washout 2||4
568206|NCT00620854|1386997|P5|STARTED|Washout 2||4
568207|NCT00620854|1386998|P4|STARTED|Washout 2||3
568208|NCT00620854|1386999|P3|STARTED|Washout 2||3
568209|NCT00620854|1387000|P2|STARTED|Washout 2||4
568210|NCT00620854|1387001|P1|STARTED|Washout 2||4
568211|NCT00620854|1386996|P6|NOT COMPLETED|Period 2||0
568212|NCT00620854|1386997|P5|NOT COMPLETED|Period 2||0
568213|NCT00620854|1386998|P4|NOT COMPLETED|Period 2||0
568214|NCT00620854|1386999|P3|NOT COMPLETED|Period 2||0
568215|NCT00620854|1387000|P2|NOT COMPLETED|Period 2||0
568216|NCT00620854|1387001|P1|NOT COMPLETED|Period 2||0
568217|NCT00620854|1386996|P6|COMPLETED|Period 2||4
568218|NCT00620854|1386997|P5|COMPLETED|Period 2||4
568219|NCT00620854|1386998|P4|COMPLETED|Period 2||3
568220|NCT00620854|1386999|P3|COMPLETED|Period 2||3
568221|NCT00620854|1387000|P2|COMPLETED|Period 2||4
568222|NCT00620854|1387001|P1|COMPLETED|Period 2||4
568223|NCT00620854|1386996|P6|STARTED|Period 2||4
568224|NCT00620854|1386997|P5|STARTED|Period 2||4
568225|NCT00620854|1386998|P4|STARTED|Period 2||3
568226|NCT00620854|1386999|P3|STARTED|Period 2||3
568227|NCT00620854|1387000|P2|STARTED|Period 2||4
568228|NCT00620854|1387001|P1|STARTED|Period 2||4
568229|NCT00620854|1386996|P6|NOT COMPLETED|Washout 1||0
568230|NCT00620854|1386997|P5|NOT COMPLETED|Washout 1||0
568231|NCT00620854|1386998|P4|NOT COMPLETED|Washout 1||1
568232|NCT00620854|1386999|P3|NOT COMPLETED|Washout 1||1
568233|NCT00620854|1387000|P2|NOT COMPLETED|Washout 1||0
568234|NCT00620854|1387001|P1|NOT COMPLETED|Washout 1||0
568235|NCT00620854|1386996|P6|COMPLETED|Washout 1||4
568236|NCT00620854|1386997|P5|COMPLETED|Washout 1||4
568237|NCT00620854|1386998|P4|COMPLETED|Washout 1||3
568238|NCT00620854|1386999|P3|COMPLETED|Washout 1||3
568239|NCT00620854|1387000|P2|COMPLETED|Washout 1||4
568240|NCT00620854|1387001|P1|COMPLETED|Washout 1||4
568241|NCT00620854|1386996|P6|STARTED|Washout 1||4
568242|NCT00620854|1386997|P5|STARTED|Washout 1||4
568243|NCT00620854|1386998|P4|STARTED|Washout 1||4
568244|NCT00620854|1386999|P3|STARTED|Washout 1||4
568245|NCT00620854|1387000|P2|STARTED|Washout 1||4
568246|NCT00620854|1387001|P1|STARTED|Washout 1||4
568247|NCT00620854|1386996|P6|NOT COMPLETED|Period 1||0
568248|NCT00620854|1386997|P5|NOT COMPLETED|Period 1||0
568249|NCT00620854|1386998|P4|NOT COMPLETED|Period 1||0
568250|NCT00620854|1386999|P3|NOT COMPLETED|Period 1||0
568251|NCT00620854|1387000|P2|NOT COMPLETED|Period 1||0
568252|NCT00620854|1387001|P1|NOT COMPLETED|Period 1||0
568253|NCT00620854|1386996|P6|COMPLETED|Period 1||4
568254|NCT00620854|1386997|P5|COMPLETED|Period 1||4
568255|NCT00620854|1386998|P4|COMPLETED|Period 1||4
568256|NCT00620854|1386999|P3|COMPLETED|Period 1||4
568257|NCT00620854|1387000|P2|COMPLETED|Period 1||4
568258|NCT00620854|1387001|P1|COMPLETED|Period 1||4
568259|NCT00620854|1386996|P6|STARTED|Period 1||4
568260|NCT00620854|1386997|P5|STARTED|Period 1||4
568261|NCT00620854|1386998|P4|STARTED|Period 1||4
568262|NCT00620854|1386999|P3|STARTED|Period 1||4
568263|NCT00620854|1387000|P2|STARTED|Period 1||4
568264|NCT00620854|1387001|P1|STARTED|Period 1||4
568265|NCT00620828|1387014|P2|NOT COMPLETED|Overall Study||0
568266|NCT00620828|1387015|P1|NOT COMPLETED|Overall Study||0
568267|NCT00620828|1387014|P2|COMPLETED|Overall Study||35
568268|NCT00620828|1387015|P1|COMPLETED|Overall Study||32
568269|NCT00620828|1387014|P2|Number of Subjects Enrolled = 67|Overall Study||35
568270|NCT00620828|1387015|P1|Number of Subjects Enrolled = 67|Overall Study||32
568271|NCT00620828|1387014|P2|STARTED|Overall Study||35
568272|NCT00620828|1387015|P1|STARTED|Overall Study||32
568273|NCT00620815|1387032|P3|NOT COMPLETED|Overall Study||7
568274|NCT00620815|1387033|P2|NOT COMPLETED|Overall Study||11
568275|NCT00620815|1387034|P1|NOT COMPLETED|Overall Study||4
568276|NCT00620815|1387032|P3|COMPLETED|Overall Study||192
568277|NCT00620815|1387033|P2|COMPLETED|Overall Study||192
568278|NCT00620815|1387034|P1|COMPLETED|Overall Study||195
568279|NCT00620815|1387032|P3|STARTED|Overall Study||199
568280|NCT00620815|1387033|P2|STARTED|Overall Study||203
568281|NCT00620815|1387034|P1|STARTED|Overall Study||199
568282|NCT00620776|1387074|P2|NOT COMPLETED|Overall Study||16
568283|NCT00620776|1387075|P1|NOT COMPLETED|Overall Study||12
568284|NCT00620776|1387074|P2|COMPLETED|Overall Study|24 out of 35 attended the week 24 (last) assessment.|24
568285|NCT00620776|1387075|P1|COMPLETED|Overall Study|17 out of 26 attended the week 24 (last) assessment.|17
568286|NCT00620776|1387074|P2|Received at Least One Session/Dose|Overall Study|35 out of 40 that consented to receive medication alone received at least one dose of medication.|35
568287|NCT00620776|1387075|P1|Received at Least One Session/Dose|Overall Study|26 out of 29 that consented to the combined treatment option received at least one session of CBT.|26
568288|NCT00620776|1387074|P2|STARTED|Overall Study|All 40 patients that were randomly assigned to not be offered CBT consented to this option.|40
568289|NCT00620776|1387075|P1|STARTED|Overall Study|29 patients (of the 77 that were randomly assigned to add on CBT) consented to this option.|29
568290|NCT00620763|1387103|P2|NOT COMPLETED|Period: Second Intervention||0
568291|NCT00620763|1387104|P1|NOT COMPLETED|Period: Second Intervention||1
568292|NCT00620763|1387103|P2|COMPLETED|Period: Second Intervention||7
568293|NCT00620763|1387104|P1|COMPLETED|Period: Second Intervention||9
568294|NCT00620763|1387103|P2|STARTED|Period: Second Intervention||7
568295|NCT00620763|1387104|P1|STARTED|Period: Second Intervention||10
568296|NCT00620763|1387103|P2|NOT COMPLETED|Period: Washout Period of 1 Week||0
568297|NCT00620763|1387104|P1|NOT COMPLETED|Period: Washout Period of 1 Week||0
568298|NCT00620763|1387103|P2|COMPLETED|Period: Washout Period of 1 Week||7
568299|NCT00620763|1387104|P1|COMPLETED|Period: Washout Period of 1 Week||10
568300|NCT00620763|1387103|P2|STARTED|Period: Washout Period of 1 Week||7
568301|NCT00620763|1387104|P1|STARTED|Period: Washout Period of 1 Week||10
568302|NCT00620763|1387103|P2|NOT COMPLETED|Period: First Intervention||5
568303|NCT00620763|1387104|P1|NOT COMPLETED|Period: First Intervention||0
568304|NCT00620763|1387103|P2|COMPLETED|Period: First Intervention||7
568305|NCT00620763|1387104|P1|COMPLETED|Period: First Intervention||10
568306|NCT00620763|1387103|P2|STARTED|Period: First Intervention||12
568307|NCT00620763|1387104|P1|STARTED|Period: First Intervention||10
568308|NCT00620750|1387110|P1|NOT COMPLETED|Overall Study||25
568309|NCT00620750|1387110|P1|COMPLETED|Overall Study||40
568310|NCT00620750|1387110|P1|STARTED|Overall Study||65
568311|NCT00620711|1387114|P1|NOT COMPLETED|Overall Study||0
568312|NCT00620711|1387114|P1|COMPLETED|Overall Study||4
568313|NCT00620711|1387114|P1|STARTED|Overall Study||4
568314|NCT00620698|1387119|P1|NOT COMPLETED|Overall Study||29
568315|NCT00620698|1387119|P1|COMPLETED|Overall Study||60
568316|NCT00620698|1387119|P1|STARTED|Overall Study||89
568317|NCT00620659|1387125|P6|NOT COMPLETED|Treatment Period 3||0
568318|NCT00620659|1387126|P5|NOT COMPLETED|Treatment Period 3||0
568319|NCT00620659|1387127|P4|NOT COMPLETED|Treatment Period 3||1
568320|NCT00620659|1387128|P3|NOT COMPLETED|Treatment Period 3||0
568321|NCT00620659|1387129|P2|NOT COMPLETED|Treatment Period 3||2
568322|NCT00620659|1387130|P1|NOT COMPLETED|Treatment Period 3||0
568323|NCT00620659|1387125|P6|COMPLETED|Treatment Period 3||20
568324|NCT00620659|1387126|P5|COMPLETED|Treatment Period 3||15
568325|NCT00620659|1387127|P4|COMPLETED|Treatment Period 3||17
568326|NCT00620659|1387128|P3|COMPLETED|Treatment Period 3||19
568327|NCT00620659|1387129|P2|COMPLETED|Treatment Period 3||16
568328|NCT00620659|1387130|P1|COMPLETED|Treatment Period 3||16
568329|NCT00620659|1387125|P6|STARTED|Treatment Period 3||20
568330|NCT00620659|1387126|P5|STARTED|Treatment Period 3||15
568331|NCT00620659|1387127|P4|STARTED|Treatment Period 3||18
568332|NCT00620659|1387128|P3|STARTED|Treatment Period 3||19
568333|NCT00620659|1387129|P2|STARTED|Treatment Period 3||18
568334|NCT00620659|1387130|P1|STARTED|Treatment Period 3||16
568335|NCT00620659|1387125|P6|NOT COMPLETED|Placebo Washout Period 2||0
568336|NCT00620659|1387126|P5|NOT COMPLETED|Placebo Washout Period 2||0
568337|NCT00620659|1387127|P4|NOT COMPLETED|Placebo Washout Period 2||0
568338|NCT00620659|1387128|P3|NOT COMPLETED|Placebo Washout Period 2||0
568339|NCT00620659|1387129|P2|NOT COMPLETED|Placebo Washout Period 2||0
568340|NCT00620659|1387130|P1|NOT COMPLETED|Placebo Washout Period 2||2
568341|NCT00620659|1387125|P6|COMPLETED|Placebo Washout Period 2||20
568342|NCT00620659|1387126|P5|COMPLETED|Placebo Washout Period 2||15
568343|NCT00620659|1387127|P4|COMPLETED|Placebo Washout Period 2||18
568344|NCT00620659|1387128|P3|COMPLETED|Placebo Washout Period 2||19
568345|NCT00620659|1387129|P2|COMPLETED|Placebo Washout Period 2||18
568346|NCT00620659|1387130|P1|COMPLETED|Placebo Washout Period 2||16
568347|NCT00620659|1387125|P6|STARTED|Placebo Washout Period 2||20
568348|NCT00620659|1387126|P5|STARTED|Placebo Washout Period 2||15
568349|NCT00620659|1387127|P4|STARTED|Placebo Washout Period 2||18
568350|NCT00620659|1387128|P3|STARTED|Placebo Washout Period 2||19
568351|NCT00620659|1387129|P2|STARTED|Placebo Washout Period 2||18
568352|NCT00620659|1387130|P1|STARTED|Placebo Washout Period 2||18
568353|NCT00620659|1387125|P6|NOT COMPLETED|Treatment Period 2||0
568354|NCT00620659|1387126|P5|NOT COMPLETED|Treatment Period 2||5
568355|NCT00620659|1387127|P4|NOT COMPLETED|Treatment Period 2||0
568356|NCT00620659|1387128|P3|NOT COMPLETED|Treatment Period 2||1
568357|NCT00620659|1387129|P2|NOT COMPLETED|Treatment Period 2||3
568358|NCT00620659|1387130|P1|NOT COMPLETED|Treatment Period 2||0
568359|NCT00620659|1387125|P6|COMPLETED|Treatment Period 2||20
568360|NCT00620659|1387126|P5|COMPLETED|Treatment Period 2||15
568361|NCT00620659|1387127|P4|COMPLETED|Treatment Period 2||18
568362|NCT00620659|1387128|P3|COMPLETED|Treatment Period 2||19
568363|NCT00620659|1387129|P2|COMPLETED|Treatment Period 2||18
568364|NCT00620659|1387130|P1|COMPLETED|Treatment Period 2||18
568365|NCT00620659|1387125|P6|STARTED|Treatment Period 2||20
568366|NCT00620659|1387126|P5|STARTED|Treatment Period 2||20
568367|NCT00620659|1387127|P4|STARTED|Treatment Period 2||18
568368|NCT00620659|1387128|P3|STARTED|Treatment Period 2||20
568369|NCT00620659|1387129|P2|STARTED|Treatment Period 2||21
568370|NCT00620659|1387130|P1|STARTED|Treatment Period 2||18
568371|NCT00620659|1387125|P6|NOT COMPLETED|Placebo Washout Period 1||0
568372|NCT00620659|1387126|P5|NOT COMPLETED|Placebo Washout Period 1||0
568373|NCT00620659|1387127|P4|NOT COMPLETED|Placebo Washout Period 1||1
568374|NCT00620659|1387128|P3|NOT COMPLETED|Placebo Washout Period 1||0
568375|NCT00620659|1387129|P2|NOT COMPLETED|Placebo Washout Period 1||0
568376|NCT00620659|1387130|P1|NOT COMPLETED|Placebo Washout Period 1||0
568377|NCT00620659|1387125|P6|COMPLETED|Placebo Washout Period 1||20
568378|NCT00620659|1387126|P5|COMPLETED|Placebo Washout Period 1||20
568379|NCT00620659|1387127|P4|COMPLETED|Placebo Washout Period 1||18
568380|NCT00620659|1387128|P3|COMPLETED|Placebo Washout Period 1||20
568381|NCT00620659|1387129|P2|COMPLETED|Placebo Washout Period 1||21
568382|NCT00620659|1387130|P1|COMPLETED|Placebo Washout Period 1||18
568383|NCT00620659|1387125|P6|STARTED|Placebo Washout Period 1||20
568384|NCT00620659|1387126|P5|STARTED|Placebo Washout Period 1||20
568385|NCT00620659|1387127|P4|STARTED|Placebo Washout Period 1||19
568386|NCT00620659|1387128|P3|STARTED|Placebo Washout Period 1||20
568387|NCT00620659|1387129|P2|STARTED|Placebo Washout Period 1||21
568388|NCT00620659|1387130|P1|STARTED|Placebo Washout Period 1||18
568389|NCT00620659|1387125|P6|NOT COMPLETED|Treatment Period 1||0
568390|NCT00620659|1387126|P5|NOT COMPLETED|Treatment Period 1||1
568391|NCT00620659|1387127|P4|NOT COMPLETED|Treatment Period 1||3
568392|NCT00620659|1387128|P3|NOT COMPLETED|Treatment Period 1||1
568393|NCT00620659|1387129|P2|NOT COMPLETED|Treatment Period 1||0
568394|NCT00620659|1387130|P1|NOT COMPLETED|Treatment Period 1||3
568395|NCT00620659|1387125|P6|COMPLETED|Treatment Period 1||20
568396|NCT00620659|1387126|P5|COMPLETED|Treatment Period 1||20
568397|NCT00620659|1387127|P4|COMPLETED|Treatment Period 1|1 patient discontinued from MK0249, but continued in following periods, & completed the study|18
568398|NCT00620659|1387128|P3|COMPLETED|Treatment Period 1||20
568399|NCT00620659|1387129|P2|COMPLETED|Treatment Period 1||21
568400|NCT00620659|1387130|P1|COMPLETED|Treatment Period 1||18
568401|NCT00620659|1387125|P6|STARTED|Treatment Period 1||20
568402|NCT00620659|1387126|P5|STARTED|Treatment Period 1||21
568403|NCT00620659|1387127|P4|STARTED|Treatment Period 1||21
568404|NCT00620659|1387128|P3|STARTED|Treatment Period 1||21
568405|NCT00620659|1387129|P2|STARTED|Treatment Period 1||21
568406|NCT00620659|1387130|P1|STARTED|Treatment Period 1||21
568407|NCT00620555|1387148|P1|NOT COMPLETED|Overall Study||21
568408|NCT00620555|1387148|P1|COMPLETED|Overall Study||44
568409|NCT00620555|1387148|P1|STARTED|Overall Study||65
568410|NCT00620542|1387157|P4|NOT COMPLETED|Part B (2 Year Core Study)||144
568411|NCT00620542|1387158|P3|NOT COMPLETED|Part B (2 Year Core Study)||148
568412|NCT00620542|1387159|P2|NOT COMPLETED|Part B (2 Year Core Study)||0
568413|NCT00620542|1387160|P1|NOT COMPLETED|Part B (2 Year Core Study)||0
568414|NCT00620542|1387157|P4|COMPLETED|Part B (2 Year Core Study)||547
568415|NCT00620542|1387158|P3|COMPLETED|Part B (2 Year Core Study)||546
568416|NCT00620542|1387159|P2|COMPLETED|Part B (2 Year Core Study)||0
568417|NCT00620542|1387160|P1|COMPLETED|Part B (2 Year Core Study)||0
568418|NCT00620542|1387157|P4|Intent-to-treat Population|Part B (2 Year Core Study)|Patients who received treatment and had a baseline and end of study (Week 104) IVUS|519
568419|NCT00620542|1387158|P3|Intent-to-treat Population|Part B (2 Year Core Study)|Patients who received treatment and had a baseline and end of study (Week 104) IVUS|520
568420|NCT00620542|1387159|P2|Intent-to-treat Population|Part B (2 Year Core Study)||0
568421|NCT00620542|1387160|P1|Intent-to-treat Population|Part B (2 Year Core Study)||0
568422|NCT00620542|1387157|P4|Received Treatment|Part B (2 Year Core Study)||689
568423|NCT00620542|1387158|P3|Received Treatment|Part B (2 Year Core Study)||691
568424|NCT00620542|1387159|P2|Received Treatment|Part B (2 Year Core Study)||0
568425|NCT00620542|1387160|P1|Received Treatment|Part B (2 Year Core Study)||0
568426|NCT00620542|1387157|P4|STARTED|Part B (2 Year Core Study)|Of 691 patients randomized, N=689 received treatment.|691
568427|NCT00620542|1387158|P3|STARTED|Part B (2 Year Core Study)|Of 694 patients randomized, N=691 received treatment.|694
568428|NCT00620542|1387159|P2|STARTED|Part B (2 Year Core Study)||0
568429|NCT00620542|1387160|P1|STARTED|Part B (2 Year Core Study)||0
568430|NCT00620542|1387157|P4|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0
568431|NCT00620542|1387158|P3|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0
568432|NCT00620542|1387159|P2|NOT COMPLETED|Part A (Run-in - 2 Weeks)||476
568433|NCT00620542|1387160|P1|NOT COMPLETED|Part A (Run-in - 2 Weeks)||472
568434|NCT00620542|1387157|P4|COMPLETED|Part A (Run-in - 2 Weeks)||0
568435|NCT00620542|1387158|P3|COMPLETED|Part A (Run-in - 2 Weeks)||0
568436|NCT00620542|1387159|P2|COMPLETED|Part A (Run-in - 2 Weeks)||690
568437|NCT00620542|1387160|P1|COMPLETED|Part A (Run-in - 2 Weeks)||695
568438|NCT00620542|1387157|P4|Received Treatment|Part A (Run-in - 2 Weeks)||0
568439|NCT00620542|1387158|P3|Received Treatment|Part A (Run-in - 2 Weeks)||0
568440|NCT00620542|1387159|P2|Received Treatment|Part A (Run-in - 2 Weeks)||795
568441|NCT00620542|1387160|P1|Received Treatment|Part A (Run-in - 2 Weeks)||783
568442|NCT00620542|1387157|P4|STARTED|Part A (Run-in - 2 Weeks)||0
568443|NCT00620542|1387158|P3|STARTED|Part A (Run-in - 2 Weeks)||0
568444|NCT00620542|1387159|P2|STARTED|Part A (Run-in - 2 Weeks)|Of 1166 randomized, N=795 received treatment.|1166
568445|NCT00620542|1387160|P1|STARTED|Part A (Run-in - 2 Weeks)|Of 1167 randomized, N=783 received treatment.|1167
568446|NCT00620464|1387200|P2|NOT COMPLETED|Overall Study||24
568447|NCT00620464|1387201|P1|NOT COMPLETED|Overall Study||20
568448|NCT00620464|1387200|P2|COMPLETED|Overall Study||32
568449|NCT00620464|1387201|P1|COMPLETED|Overall Study||32
568450|NCT00620464|1387200|P2|STARTED|Overall Study||56
568451|NCT00620464|1387201|P1|STARTED|Overall Study||52
568452|NCT00620425|1387209|P1|NOT COMPLETED|Overall Study||0
568453|NCT00620425|1387209|P1|COMPLETED|Overall Study||18
568454|NCT00620425|1387209|P1|STARTED|Overall Study||18
568455|NCT00620373|1387220|P1|NOT COMPLETED|Overall Study||33
568456|NCT00620373|1387220|P1|COMPLETED|Overall Study||936
568457|NCT00620373|1387220|P1|STARTED|Overall Study||969
568458|NCT00620282|1387239|P3|NOT COMPLETED|Overall Study||1
568459|NCT00620282|1387240|P2|NOT COMPLETED|Overall Study||2
568460|NCT00620282|1387241|P1|NOT COMPLETED|Overall Study||0
568461|NCT00620282|1387239|P3|COMPLETED|Overall Study||16
568462|NCT00620282|1387240|P2|COMPLETED|Overall Study||14
568463|NCT00620282|1387241|P1|COMPLETED|Overall Study||16
568464|NCT00620282|1387239|P3|STARTED|Overall Study||17
568465|NCT00620282|1387240|P2|STARTED|Overall Study||16
568466|NCT00620282|1387241|P1|STARTED|Overall Study||16
568467|NCT00620126|1387290|P2|NOT COMPLETED|Overall Study||5
568468|NCT00620126|1387291|P1|NOT COMPLETED|Overall Study||11
568469|NCT00620126|1387290|P2|COMPLETED|Overall Study||17
568470|NCT00620126|1387291|P1|COMPLETED|Overall Study||14
568471|NCT00620126|1387290|P2|STARTED|Overall Study||22
568472|NCT00620126|1387291|P1|STARTED|Overall Study||25
568473|NCT00620113|1387305|P4|NOT COMPLETED|Overall Study||10
568474|NCT00620113|1387306|P3|NOT COMPLETED|Overall Study||5
568475|NCT00620113|1387307|P2|NOT COMPLETED|Overall Study||7
568476|NCT00620113|1387308|P1|NOT COMPLETED|Overall Study||13
568477|NCT00620113|1387305|P4|COMPLETED|Overall Study||59
568478|NCT00620113|1387306|P3|COMPLETED|Overall Study|Includes 1 participant who also received 50 mg dose by accident during study.|66
568479|NCT00620113|1387307|P2|COMPLETED|Overall Study||67
568480|NCT00620113|1387308|P1|COMPLETED|Overall Study||60
568481|NCT00620113|1387305|P4|Efficacy/Safety Population|Overall Study||69
568482|NCT00620113|1387306|P3|Efficacy/Safety Population|Overall Study||70
568483|NCT00620113|1387307|P2|Efficacy/Safety Population|Overall Study||74
568484|NCT00620113|1387308|P1|Efficacy/Safety Population|Overall Study||73
568485|NCT00620113|1387305|P4|STARTED|Overall Study||69
568486|NCT00620113|1387306|P3|STARTED|Overall Study|Includes 1 participant who also received 50 mg dose by accident during study.|71
568487|NCT00620113|1387307|P2|STARTED|Overall Study||74
568488|NCT00620113|1387308|P1|STARTED|Overall Study||73
568489|NCT00620074|1387358|P1|NOT COMPLETED|Overall Study||1
568490|NCT00620074|1387358|P1|COMPLETED|Overall Study||5
568491|NCT00620074|1387358|P1|STARTED|Overall Study||6
568492|NCT00620035|1387366|P1|NOT COMPLETED|Overall Study||145
568493|NCT00620035|1387366|P1|COMPLETED|Overall Study||156
568494|NCT00620035|1387366|P1|STARTED|Overall Study||301
568495|NCT00620022|1387376|P2|NOT COMPLETED|Treatment Period 2||2
568496|NCT00620022|1387377|P1|NOT COMPLETED|Treatment Period 2||2
568497|NCT00620022|1387376|P2|COMPLETED|Treatment Period 2||35
568498|NCT00620022|1387377|P1|COMPLETED|Treatment Period 2||39
568499|NCT00620022|1387376|P2|STARTED|Treatment Period 2||37
568500|NCT00620022|1387377|P1|STARTED|Treatment Period 2||41
568501|NCT00620022|1387376|P2|NOT COMPLETED|Treatment Period 1||6
568502|NCT00620022|1387377|P1|NOT COMPLETED|Treatment Period 1||5
568503|NCT00620022|1387376|P2|COMPLETED|Treatment Period 1||37
568504|NCT00620022|1387377|P1|COMPLETED|Treatment Period 1||41
568505|NCT00620022|1387376|P2|STARTED|Treatment Period 1|Of 44 randomized patients, 1 patient discontinued before receiving any study treatment.|43
568506|NCT00620022|1387377|P1|STARTED|Treatment Period 1||46
568507|NCT00619983|1387389|P4|NOT COMPLETED|Gabapentin Alone||0
568508|NCT00619983|1387390|P3|NOT COMPLETED|Gabapentin Alone||0
568509|NCT00619983|1387391|P2|NOT COMPLETED|Gabapentin Alone||0
568510|NCT00619983|1387392|P1|NOT COMPLETED|Gabapentin Alone||0
568511|NCT00619983|1387389|P4|COMPLETED|Gabapentin Alone||3
568512|NCT00619983|1387390|P3|COMPLETED|Gabapentin Alone||4
568513|NCT00619983|1387391|P2|COMPLETED|Gabapentin Alone||4
568514|NCT00619983|1387392|P1|COMPLETED|Gabapentin Alone||3
568515|NCT00619983|1387389|P4|STARTED|Gabapentin Alone||3
568516|NCT00619983|1387390|P3|STARTED|Gabapentin Alone||4
568517|NCT00619983|1387391|P2|STARTED|Gabapentin Alone||4
568518|NCT00619983|1387392|P1|STARTED|Gabapentin Alone||3
568519|NCT00619983|1387389|P4|NOT COMPLETED|Test Drug Plus Gabapentin||0
568520|NCT00619983|1387390|P3|NOT COMPLETED|Test Drug Plus Gabapentin||0
568521|NCT00619983|1387391|P2|NOT COMPLETED|Test Drug Plus Gabapentin||0
568522|NCT00619983|1387392|P1|NOT COMPLETED|Test Drug Plus Gabapentin||0
568523|NCT00619983|1387389|P4|COMPLETED|Test Drug Plus Gabapentin||3
568524|NCT00619983|1387390|P3|COMPLETED|Test Drug Plus Gabapentin||4
568525|NCT00619983|1387391|P2|COMPLETED|Test Drug Plus Gabapentin||4
568526|NCT00619983|1387392|P1|COMPLETED|Test Drug Plus Gabapentin||3
568527|NCT00619983|1387389|P4|STARTED|Test Drug Plus Gabapentin||3
568528|NCT00619983|1387390|P3|STARTED|Test Drug Plus Gabapentin||4
568529|NCT00619983|1387391|P2|STARTED|Test Drug Plus Gabapentin||4
568530|NCT00619983|1387392|P1|STARTED|Test Drug Plus Gabapentin||3
568531|NCT00619983|1387389|P4|NOT COMPLETED|Test Drug Alone||3
568532|NCT00619983|1387390|P3|NOT COMPLETED|Test Drug Alone||2
568533|NCT00619983|1387391|P2|NOT COMPLETED|Test Drug Alone||1
568534|NCT00619983|1387392|P1|NOT COMPLETED|Test Drug Alone||2
568535|NCT00619983|1387389|P4|COMPLETED|Test Drug Alone||3
568536|NCT00619983|1387390|P3|COMPLETED|Test Drug Alone||4
568537|NCT00619983|1387391|P2|COMPLETED|Test Drug Alone||4
568538|NCT00619983|1387392|P1|COMPLETED|Test Drug Alone||3
568539|NCT00619983|1387389|P4|STARTED|Test Drug Alone||6
568540|NCT00619983|1387390|P3|STARTED|Test Drug Alone||6
568541|NCT00619983|1387391|P2|STARTED|Test Drug Alone||5
568542|NCT00619983|1387392|P1|STARTED|Test Drug Alone||5
568543|NCT00619970|1387405|P3|NOT COMPLETED|Overall Study||2
568544|NCT00619970|1387406|P2|NOT COMPLETED|Overall Study||3
568545|NCT00619970|1387407|P1|NOT COMPLETED|Overall Study||0
568546|NCT00619970|1387405|P3|COMPLETED|Overall Study||24
568547|NCT00619970|1387406|P2|COMPLETED|Overall Study||46
568548|NCT00619970|1387407|P1|COMPLETED|Overall Study||40
568549|NCT00619970|1387405|P3|STARTED|Overall Study||26
568550|NCT00619970|1387406|P2|STARTED|Overall Study||49
568551|NCT00619970|1387407|P1|STARTED|Overall Study||40
568552|NCT00619957|1387419|P2|NOT COMPLETED|Month 48 Open-Label||17
568553|NCT00619957|1387420|P1|NOT COMPLETED|Month 48 Open-Label||12
568554|NCT00619957|1387419|P2|COMPLETED|Month 48 Open-Label||134
568555|NCT00619957|1387420|P1|COMPLETED|Month 48 Open-Label||55
568556|NCT00619957|1387419|P2|STARTED|Month 48 Open-Label||151
568557|NCT00619957|1387420|P1|STARTED|Month 48 Open-Label||67
568558|NCT00619957|1387419|P2|NOT COMPLETED|Month 24 Double-Blind||17
568559|NCT00619957|1387420|P1|NOT COMPLETED|Month 24 Double-Blind||18
568560|NCT00619957|1387419|P2|COMPLETED|Month 24 Double-Blind||175
568561|NCT00619957|1387420|P1|COMPLETED|Month 24 Double-Blind||75
568562|NCT00619957|1387419|P2|Intent to Treat (ITT Population)|Month 24 Double-Blind|One subject did not take any study medication.|191
568563|NCT00619957|1387420|P1|Intent to Treat (ITT Population)|Month 24 Double-Blind||93
568564|NCT00619957|1387419|P2|STARTED|Month 24 Double-Blind||192
568565|NCT00619957|1387420|P1|STARTED|Month 24 Double-Blind||93
568566|NCT00619918|1387502|P2|NOT COMPLETED|Overall Study||22
568567|NCT00619918|1387503|P1|NOT COMPLETED|Overall Study||20
568568|NCT00619918|1387502|P2|COMPLETED|Overall Study||195
568569|NCT00619918|1387503|P1|COMPLETED|Overall Study||210
568570|NCT00619918|1387502|P2|STARTED|Overall Study||217
568571|NCT00619918|1387503|P1|STARTED|Overall Study||230
568572|NCT00619892|1387513|P2|NOT COMPLETED|Overall Study||2
568573|NCT00619892|1387514|P1|NOT COMPLETED|Overall Study||3
568574|NCT00619892|1387513|P2|COMPLETED|Overall Study||11
568575|NCT00619892|1387514|P1|COMPLETED|Overall Study||10
568576|NCT00619892|1387513|P2|STARTED|Overall Study||13
568577|NCT00619892|1387514|P1|STARTED|Overall Study||13
568578|NCT00619827|1387524|P2|NOT COMPLETED|Overall Study||4
568579|NCT00619827|1387525|P1|NOT COMPLETED|Overall Study||3
568580|NCT00619827|1387524|P2|COMPLETED|Overall Study||40
568581|NCT00619827|1387525|P1|COMPLETED|Overall Study||42
568582|NCT00619827|1387524|P2|STARTED|Overall Study||44
568583|NCT00619827|1387525|P1|STARTED|Overall Study||45
568584|NCT00619801|1387533|P2|NOT COMPLETED|Overall Study||3
568585|NCT00619801|1387534|P1|NOT COMPLETED|Overall Study||1
568586|NCT00619801|1387533|P2|COMPLETED|Overall Study||111
568587|NCT00619801|1387534|P1|COMPLETED|Overall Study||58
568588|NCT00619801|1387533|P2|Safety Population|Overall Study||114
568589|NCT00619801|1387534|P1|Safety Population|Overall Study||59
568590|NCT00619801|1387533|P2|STARTED|Overall Study||114
568591|NCT00619801|1387534|P1|STARTED|Overall Study||59
568592|NCT00619762|1387564|P1|NOT COMPLETED|Overall Study||3
568593|NCT00619762|1387564|P1|COMPLETED|Overall Study|(25 breasts) last patient visit 11/09/2009|14
568594|NCT00619762|1387564|P1|STARTED|Overall Study|(29 breasts) First patient implanted 10/23/2007|17
568595|NCT00619723|1387571|P2|NOT COMPLETED|Overall Study||6
568596|NCT00619723|1387572|P1|NOT COMPLETED|Overall Study||2
568597|NCT00619723|1387571|P2|COMPLETED|Overall Study||61
568598|NCT00619723|1387572|P1|COMPLETED|Overall Study||61
568599|NCT00619723|1387571|P2|STARTED|Overall Study||67
568600|NCT00619723|1387572|P1|STARTED|Overall Study||63
568601|NCT00619684|1387582|P1|NOT COMPLETED|Overall Study||0
568602|NCT00619684|1387582|P1|COMPLETED|Overall Study||18
568603|NCT00619684|1387582|P1|STARTED|Overall Study||18
568604|NCT00619645|1387591|P1|NOT COMPLETED|Overall Study||1
568605|NCT00619645|1387591|P1|COMPLETED|Overall Study||7
568606|NCT00619645|1387591|P1|STARTED|Overall Study||8
568607|NCT00619619|1387605|P8|NOT COMPLETED|Overall Study||3
568608|NCT00619619|1387606|P7|NOT COMPLETED|Overall Study||1
568609|NCT00619619|1387607|P6|NOT COMPLETED|Overall Study||0
568610|NCT00619619|1387608|P5|NOT COMPLETED|Overall Study||2
568611|NCT00619619|1387609|P4|NOT COMPLETED|Overall Study||1
568612|NCT00619619|1387610|P3|NOT COMPLETED|Overall Study||1
568613|NCT00619619|1387611|P2|NOT COMPLETED|Overall Study||0
568614|NCT00619619|1387612|P1|NOT COMPLETED|Overall Study||0
568615|NCT00619619|1387605|P8|COMPLETED|Overall Study||5
568616|NCT00619619|1387606|P7|COMPLETED|Overall Study||7
568617|NCT00619619|1387607|P6|COMPLETED|Overall Study||7
568618|NCT00619619|1387608|P5|COMPLETED|Overall Study||5
568619|NCT00619619|1387609|P4|COMPLETED|Overall Study||6
568620|NCT00619619|1387610|P3|COMPLETED|Overall Study||8
568621|NCT00619619|1387611|P2|COMPLETED|Overall Study||7
568622|NCT00619619|1387612|P1|COMPLETED|Overall Study|Completed=conclusion of Test Article (treatment) phase for all treatment groups in 3151A6-2000.|6
568623|NCT00619619|1387605|P8|Entered the Extension Study|Overall Study||7
568624|NCT00619619|1387606|P7|Entered the Extension Study|Overall Study||6
568625|NCT00619619|1387607|P6|Entered the Extension Study|Overall Study||6
568626|NCT00619619|1387608|P5|Entered the Extension Study|Overall Study||7
568627|NCT00619619|1387609|P4|Entered the Extension Study|Overall Study||3
568628|NCT00619619|1387610|P3|Entered the Extension Study|Overall Study||8
568629|NCT00619619|1387611|P2|Entered the Extension Study|Overall Study||5
568630|NCT00619619|1387612|P1|Entered the Extension Study|Overall Study|Extension study: 3151A6-2001 (NCT00669110)|6
568631|NCT00619619|1387605|P8|STARTED|Overall Study||8
568632|NCT00619619|1387606|P7|STARTED|Overall Study||8
568633|NCT00619619|1387607|P6|STARTED|Overall Study||7
568634|NCT00619619|1387608|P5|STARTED|Overall Study||7
568635|NCT00619619|1387609|P4|STARTED|Overall Study||7
568636|NCT00619619|1387610|P3|STARTED|Overall Study||9
568637|NCT00619619|1387611|P2|STARTED|Overall Study||7
568638|NCT00619619|1387612|P1|STARTED|Overall Study||6
568639|NCT00619502|1387699|P2|NOT COMPLETED|Overall Study||10
568640|NCT00619502|1387700|P1|NOT COMPLETED|Overall Study||8
568641|NCT00619502|1387699|P2|COMPLETED|Overall Study||114
568642|NCT00619502|1387700|P1|COMPLETED|Overall Study||122
568643|NCT00619502|1387699|P2|STARTED|Overall Study||124
568644|NCT00619502|1387700|P1|STARTED|Overall Study||130
568645|NCT00619489|1387712|P2|NOT COMPLETED|Overall Study||34
568646|NCT00619489|1387713|P1|NOT COMPLETED|Overall Study||23
568647|NCT00619489|1387712|P2|COMPLETED|Overall Study||1
568648|NCT00619489|1387713|P1|COMPLETED|Overall Study||14
568649|NCT00619489|1387712|P2|STARTED|Overall Study||35
568650|NCT00619489|1387713|P1|STARTED|Overall Study||37
568651|NCT00619476|1387735|P4|NOT COMPLETED|Overall Study||34
568652|NCT00619476|1387736|P3|NOT COMPLETED|Overall Study||24
568653|NCT00619476|1387737|P2|NOT COMPLETED|Overall Study||22
568654|NCT00619476|1387738|P1|NOT COMPLETED|Overall Study||31
568655|NCT00619476|1387735|P4|COMPLETED|Overall Study||56
568656|NCT00619476|1387736|P3|COMPLETED|Overall Study||60
568657|NCT00619476|1387737|P2|COMPLETED|Overall Study||85
568658|NCT00619476|1387738|P1|COMPLETED|Overall Study||64
568659|NCT00619476|1387735|P4|Safety Population|Overall Study||87
568660|NCT00619476|1387736|P3|Safety Population|Overall Study||82
568661|NCT00619476|1387737|P2|Safety Population|Overall Study||107
568662|NCT00619476|1387738|P1|Safety Population|Overall Study||95
568663|NCT00619476|1387735|P4|Intent-to-Treat Population|Overall Study||87
568664|NCT00619476|1387736|P3|Intent-to-Treat Population|Overall Study||82
568665|NCT00619476|1387737|P2|Intent-to-Treat Population|Overall Study||107
568666|NCT00619476|1387738|P1|Intent-to-Treat Population|Overall Study||95
568667|NCT00619476|1387735|P4|STARTED|Overall Study||90
568668|NCT00619476|1387736|P3|STARTED|Overall Study||84
568669|NCT00619476|1387737|P2|STARTED|Overall Study||107
568670|NCT00619476|1387738|P1|STARTED|Overall Study||95
568671|NCT00619385|1387823|P3|NOT COMPLETED|Overall Study||4
568672|NCT00619385|1387824|P2|NOT COMPLETED|Overall Study||2
568673|NCT00619385|1387825|P1|NOT COMPLETED|Overall Study||1
568674|NCT00619385|1387823|P3|COMPLETED|Overall Study||6
568675|NCT00619385|1387824|P2|COMPLETED|Overall Study||6
568676|NCT00619385|1387825|P1|COMPLETED|Overall Study||6
568677|NCT00619385|1387823|P3|STARTED|Overall Study||10
568678|NCT00619385|1387824|P2|STARTED|Overall Study||8
568679|NCT00619385|1387825|P1|STARTED|Overall Study||7
568680|NCT00619359|1387840|P2|NOT COMPLETED|Overall Study||81
568681|NCT00619359|1387841|P1|NOT COMPLETED|Overall Study||67
568682|NCT00619359|1387840|P2|COMPLETED|Overall Study||1094
568683|NCT00619359|1387841|P1|COMPLETED|Overall Study||1080
568684|NCT00619359|1387840|P2|STARTED|Overall Study||1175
568685|NCT00619359|1387841|P1|STARTED|Overall Study||1147
568686|NCT00619307|1387853|P2|NOT COMPLETED|Overall Study||4
568687|NCT00619307|1387854|P1|NOT COMPLETED|Overall Study||4
568688|NCT00619307|1387853|P2|COMPLETED|Overall Study||53
568689|NCT00619307|1387854|P1|COMPLETED|Overall Study||56
568690|NCT00619307|1387853|P2|STARTED|Overall Study||57
568691|NCT00619307|1387854|P1|STARTED|Overall Study||60
568692|NCT00619255|1387870|P2|NOT COMPLETED|Overall Study||0
568693|NCT00619255|1387871|P1|NOT COMPLETED|Overall Study||2
568694|NCT00619255|1387870|P2|COMPLETED|Overall Study||61
568695|NCT00619255|1387871|P1|COMPLETED|Overall Study||57
568696|NCT00619255|1387870|P2|STARTED|Overall Study||61
568697|NCT00619255|1387871|P1|STARTED|Overall Study||59
568698|NCT00619242|1387885|P1|NOT COMPLETED|Overall Study||0
568699|NCT00619242|1387885|P1|COMPLETED|Overall Study||3
568700|NCT00619242|1387885|P1|STARTED|Overall Study||3
568701|NCT00619229|1387891|P2|NOT COMPLETED|Overall Study||2
568702|NCT00619229|1387892|P1|NOT COMPLETED|Overall Study||4
568703|NCT00619229|1387891|P2|COMPLETED|Overall Study||16
568704|NCT00619229|1387892|P1|COMPLETED|Overall Study||14
568705|NCT00619229|1387891|P2|Full Analysis Set (FAS)|Overall Study||17
568706|NCT00619229|1387892|P1|Full Analysis Set (FAS)|Overall Study||16
568707|NCT00619229|1387891|P2|STARTED|Overall Study||18
568708|NCT00619229|1387892|P1|STARTED|Overall Study||18
568709|NCT00619190|1387920|P2|NOT COMPLETED|Overall Study||0
568710|NCT00619190|1387921|P1|NOT COMPLETED|Overall Study||1
568711|NCT00619190|1387920|P2|COMPLETED|Overall Study||9
568712|NCT00619190|1387921|P1|COMPLETED|Overall Study||20
568713|NCT00619190|1387920|P2|STARTED|Overall Study||9
568714|NCT00619190|1387921|P1|STARTED|Overall Study||21
568715|NCT00619177|1387931|P1|NOT COMPLETED|Overall Study||508
568716|NCT00619177|1387931|P1|COMPLETED|Overall Study|"Due to some missing termination information, the number of completed may be larger than 3061."|3061
568717|NCT00619177|1387931|P1|STARTED|Overall Study|treated set = 3569 (treated with Movalis)|3569
568718|NCT00619151|1387941|P2|NOT COMPLETED|Overall Study||0
568719|NCT00619151|1387942|P1|NOT COMPLETED|Overall Study||1
568720|NCT00619151|1387941|P2|COMPLETED|Overall Study||0
568721|NCT00619151|1387942|P1|COMPLETED|Overall Study||1
568722|NCT00619151|1387941|P2|STARTED|Overall Study||0
568723|NCT00619151|1387942|P1|STARTED|Overall Study||2
568724|NCT00619112|1387952|P2|NOT COMPLETED|Overall Study||2
568725|NCT00619112|1387953|P1|NOT COMPLETED|Overall Study||1
568726|NCT00619112|1387952|P2|COMPLETED|Overall Study|Data from patients who didn't complete study was still included in the final analysis.|18
568727|NCT00619112|1387953|P1|COMPLETED|Overall Study|Data from patient who didn't complete study was still included in the final analysis.|39
568728|NCT00619112|1387952|P2|STARTED|Overall Study||20
568729|NCT00619112|1387953|P1|STARTED|Overall Study||40
568730|NCT00619099|1387974|P2|NOT COMPLETED|Overall Study||19
568731|NCT00619099|1387975|P1|NOT COMPLETED|Overall Study||33
568732|NCT00619099|1387974|P2|COMPLETED|Overall Study||4
568733|NCT00619099|1387975|P1|COMPLETED|Overall Study||11
568734|NCT00619099|1387974|P2|Received at Least 2 Cycles of Treatment|Overall Study|Subjects included in the Modified Intent to Treat Population|22
568735|NCT00619099|1387975|P1|Received at Least 2 Cycles of Treatment|Overall Study|Subjects included in the Modified Intent to Treat Population|43
568736|NCT00619099|1387974|P2|STARTED|Overall Study|All randomized subjects|23
568737|NCT00619099|1387975|P1|STARTED|Overall Study|All randomized subjects|44
568738|NCT00619073|1387981|P2|NOT COMPLETED|Second Intervention - 60 Days||0
568739|NCT00619073|1387982|P1|NOT COMPLETED|Second Intervention - 60 Days||0
568740|NCT00619073|1387981|P2|COMPLETED|Second Intervention - 60 Days||8
568741|NCT00619073|1387982|P1|COMPLETED|Second Intervention - 60 Days||8
568742|NCT00619073|1387981|P2|STARTED|Second Intervention - 60 Days||8
568743|NCT00619073|1387982|P1|STARTED|Second Intervention - 60 Days||8
568744|NCT00619073|1387981|P2|NOT COMPLETED|Washout Period (30 Days)||0
568745|NCT00619073|1387982|P1|NOT COMPLETED|Washout Period (30 Days)||0
568746|NCT00619073|1387981|P2|COMPLETED|Washout Period (30 Days)||8
568747|NCT00619073|1387982|P1|COMPLETED|Washout Period (30 Days)||8
568748|NCT00619073|1387981|P2|STARTED|Washout Period (30 Days)||8
568749|NCT00619073|1387982|P1|STARTED|Washout Period (30 Days)||8
568750|NCT00619073|1387981|P2|NOT COMPLETED|First Intervention - 60 Days||0
568751|NCT00619073|1387982|P1|NOT COMPLETED|First Intervention - 60 Days||0
568752|NCT00619073|1387981|P2|COMPLETED|First Intervention - 60 Days||8
568753|NCT00619073|1387982|P1|COMPLETED|First Intervention - 60 Days||8
568754|NCT00619073|1387981|P2|STARTED|First Intervention - 60 Days||8
568755|NCT00619073|1387982|P1|STARTED|First Intervention - 60 Days||8
568756|NCT00619060|1387988|P2|NOT COMPLETED|Overall Study||0
568757|NCT00619060|1387989|P1|NOT COMPLETED|Overall Study||0
568758|NCT00619060|1387988|P2|COMPLETED|Overall Study||12
568759|NCT00619060|1387989|P1|COMPLETED|Overall Study||10
568760|NCT00619060|1387988|P2|STARTED|Overall Study||12
568761|NCT00619060|1387989|P1|STARTED|Overall Study||10
568762|NCT00618995|1387997|P4|NOT COMPLETED|Period 4||0
568763|NCT00618995|1387998|P3|NOT COMPLETED|Period 4||0
568764|NCT00618995|1387999|P2|NOT COMPLETED|Period 4||0
568765|NCT00618995|1388000|P1|NOT COMPLETED|Period 4||1
568766|NCT00618995|1387997|P4|COMPLETED|Period 4||6
568767|NCT00618995|1387998|P3|COMPLETED|Period 4||4
568768|NCT00618995|1387999|P2|COMPLETED|Period 4||6
568769|NCT00618995|1388000|P1|COMPLETED|Period 4||5
568770|NCT00618995|1387997|P4|STARTED|Period 4||6
568771|NCT00618995|1387998|P3|STARTED|Period 4||4
568772|NCT00618995|1387999|P2|STARTED|Period 4||6
568773|NCT00618995|1388000|P1|STARTED|Period 4||6
568774|NCT00618995|1387997|P4|NOT COMPLETED|Period 3||0
568775|NCT00618995|1387998|P3|NOT COMPLETED|Period 3||0
568776|NCT00618995|1387999|P2|NOT COMPLETED|Period 3||0
568777|NCT00618995|1388000|P1|NOT COMPLETED|Period 3||0
568778|NCT00618995|1387997|P4|COMPLETED|Period 3||6
568779|NCT00618995|1387998|P3|COMPLETED|Period 3||4
568780|NCT00618995|1387999|P2|COMPLETED|Period 3||6
568781|NCT00618995|1388000|P1|COMPLETED|Period 3||6
568782|NCT00618995|1387997|P4|STARTED|Period 3||6
568783|NCT00618995|1387998|P3|STARTED|Period 3||4
568784|NCT00618995|1387999|P2|STARTED|Period 3||6
568785|NCT00618995|1388000|P1|STARTED|Period 3||6
568786|NCT00618995|1387997|P4|NOT COMPLETED|Period 2||0
568787|NCT00618995|1387998|P3|NOT COMPLETED|Period 2||1
568788|NCT00618995|1387999|P2|NOT COMPLETED|Period 2||0
568789|NCT00618995|1388000|P1|NOT COMPLETED|Period 2||0
568790|NCT00618995|1387997|P4|COMPLETED|Period 2||6
568791|NCT00618995|1387998|P3|COMPLETED|Period 2||4
568792|NCT00618995|1387999|P2|COMPLETED|Period 2||6
568793|NCT00618995|1388000|P1|COMPLETED|Period 2||6
568794|NCT00618995|1387997|P4|STARTED|Period 2||6
568795|NCT00618995|1387998|P3|STARTED|Period 2||5
568796|NCT00618995|1387999|P2|STARTED|Period 2||6
568797|NCT00618995|1388000|P1|STARTED|Period 2||6
568798|NCT00618995|1387997|P4|NOT COMPLETED|Period 1||0
568799|NCT00618995|1387998|P3|NOT COMPLETED|Period 1||2
568800|NCT00618995|1387999|P2|NOT COMPLETED|Period 1||1
568801|NCT00618995|1388000|P1|NOT COMPLETED|Period 1||0
568802|NCT00618995|1387997|P4|COMPLETED|Period 1||6
568803|NCT00618995|1387998|P3|COMPLETED|Period 1||5
568804|NCT00618995|1387999|P2|COMPLETED|Period 1||6
568805|NCT00618995|1388000|P1|COMPLETED|Period 1||6
568806|NCT00618995|1387997|P4|STARTED|Period 1||6
568807|NCT00618995|1387998|P3|STARTED|Period 1||7
568808|NCT00618995|1387999|P2|STARTED|Period 1||7
568809|NCT00618995|1388000|P1|STARTED|Period 1||6
568810|NCT00618982|1388014|P1|NOT COMPLETED|Overall Study||50
568811|NCT00618982|1388014|P1|COMPLETED|Overall Study||33
568812|NCT00618982|1388014|P1|STARTED|Overall Study||83
568813|NCT00618956|1388037|P2|NOT COMPLETED|Overall Study||50
568814|NCT00618956|1388038|P1|NOT COMPLETED|Overall Study||25
568815|NCT00618956|1388037|P2|COMPLETED|Overall Study||160
568816|NCT00618956|1388038|P1|COMPLETED|Overall Study||86
568817|NCT00618956|1388037|P2|STARTED|Overall Study||210
568818|NCT00618956|1388038|P1|STARTED|Overall Study||111
568819|NCT00618839|1388054|P1|NOT COMPLETED|Overall Study||0
568820|NCT00618839|1388054|P1|COMPLETED|Overall Study||15
568821|NCT00618839|1388054|P1|STARTED|Overall Study||15
568822|NCT00618826|1388063|P1|NOT COMPLETED|Overall Study||1
568823|NCT00618826|1388063|P1|COMPLETED|Overall Study||13
568824|NCT00618826|1388063|P1|STARTED|Overall Study||14
568825|NCT00618813|1388068|P1|NOT COMPLETED|Overall Study||4
568826|NCT00618813|1388068|P1|COMPLETED|Overall Study||31
568827|NCT00618813|1388068|P1|Completed Week 29 to Week 37 Therapy|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|33
568828|NCT00618813|1388068|P1|Completed Week 23 to Week 28 Therapy|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|34
568829|NCT00618813|1388068|P1|Completed Week 13 to Week 22 Treatment|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|34
568830|NCT00618813|1388068|P1|Completed Enrollment - Week 12 Treatment|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|35
568831|NCT00618813|1388068|P1|STARTED|Overall Study||35
568832|NCT00618787|1388078|P2|NOT COMPLETED|Overall Study||2
568833|NCT00618787|1388079|P1|NOT COMPLETED|Overall Study||3
568834|NCT00618787|1388078|P2|COMPLETED|Overall Study||21
568835|NCT00618787|1388079|P1|COMPLETED|Overall Study||19
568836|NCT00618787|1388078|P2|STARTED|Overall Study||23
568837|NCT00618787|1388079|P1|STARTED|Overall Study||22
568838|NCT00618774|1388087|P2|NOT COMPLETED|Overall Study||3
568839|NCT00618774|1388088|P1|NOT COMPLETED|Overall Study||6
568840|NCT00618774|1388087|P2|COMPLETED|Overall Study||45
568841|NCT00618774|1388088|P1|COMPLETED|Overall Study||205
568842|NCT00618774|1388087|P2|STARTED|Overall Study||48
568843|NCT00618774|1388088|P1|STARTED|Overall Study||211
568844|NCT00618748|1388121|P3|NOT COMPLETED|Overall Study||14
568845|NCT00618748|1388122|P2|NOT COMPLETED|Overall Study||5
568846|NCT00618748|1388123|P1|NOT COMPLETED|Overall Study||11
568847|NCT00618748|1388121|P3|COMPLETED|Overall Study||6
568848|NCT00618748|1388122|P2|COMPLETED|Overall Study||20
568849|NCT00618748|1388123|P1|COMPLETED|Overall Study||45
568850|NCT00618748|1388121|P3|STARTED|Overall Study||20
568851|NCT00618748|1388122|P2|STARTED|Overall Study||25
568852|NCT00618748|1388123|P1|STARTED|Overall Study||56
568853|NCT00618722|1388168|P4|NOT COMPLETED|Overall Study||4
568854|NCT00618722|1388169|P3|NOT COMPLETED|Overall Study||3
568855|NCT00618722|1388170|P2|NOT COMPLETED|Overall Study||2
568856|NCT00618722|1388171|P1|NOT COMPLETED|Overall Study||3
568857|NCT00618722|1388168|P4|COMPLETED|Overall Study||18
568858|NCT00618722|1388169|P3|COMPLETED|Overall Study||19
568859|NCT00618722|1388170|P2|COMPLETED|Overall Study||18
568860|NCT00618722|1388171|P1|COMPLETED|Overall Study||18
568861|NCT00618722|1388168|P4|Received Treatment|Overall Study||22
568862|NCT00618722|1388169|P3|Received Treatment|Overall Study||22
568863|NCT00618722|1388170|P2|Received Treatment|Overall Study||20
568864|NCT00618722|1388171|P1|Received Treatment|Overall Study||20
568865|NCT00618722|1388168|P4|STARTED|Overall Study||22
568866|NCT00618722|1388169|P3|STARTED|Overall Study||22
568867|NCT00618722|1388170|P2|STARTED|Overall Study||20
568868|NCT00618722|1388171|P1|STARTED|Overall Study||21
568869|NCT00618618|1388209|P4|NOT COMPLETED|Overall Study||1
568870|NCT00618618|1388210|P3|NOT COMPLETED|Overall Study||3
568871|NCT00618618|1388211|P2|NOT COMPLETED|Overall Study||3
568872|NCT00618618|1388212|P1|NOT COMPLETED|Overall Study||4
568873|NCT00618618|1388209|P4|COMPLETED|Overall Study||13
568874|NCT00618618|1388210|P3|COMPLETED|Overall Study||18
568875|NCT00618618|1388211|P2|COMPLETED|Overall Study||11
568876|NCT00618618|1388212|P1|COMPLETED|Overall Study||20
568877|NCT00618618|1388209|P4|Received Treatment|Overall Study||14
568878|NCT00618618|1388210|P3|Received Treatment|Overall Study||20
568879|NCT00618618|1388211|P2|Received Treatment|Overall Study||13
568880|NCT00618618|1388212|P1|Received Treatment|Overall Study||24
568881|NCT00618618|1388209|P4|STARTED|Overall Study||14
568882|NCT00618618|1388210|P3|STARTED|Overall Study||21
568883|NCT00618618|1388211|P2|STARTED|Overall Study||14
568884|NCT00618618|1388212|P1|STARTED|Overall Study||24
568885|NCT00618540|1388258|P1|NOT COMPLETED|Overall Study||0
568886|NCT00618540|1388258|P1|COMPLETED|Overall Study||1
568887|NCT00618540|1388258|P1|STARTED|Overall Study||1
568888|NCT00618514|1388271|P3|NOT COMPLETED|Overall Study||4
568889|NCT00618514|1388272|P2|NOT COMPLETED|Overall Study||12
568890|NCT00618514|1388273|P1|NOT COMPLETED|Overall Study||11
568891|NCT00618514|1388271|P3|COMPLETED|Overall Study||12
568892|NCT00618514|1388272|P2|COMPLETED|Overall Study||26
568893|NCT00618514|1388273|P1|COMPLETED|Overall Study||25
568894|NCT00618514|1388271|P3|STARTED|Overall Study||16
568895|NCT00618514|1388272|P2|STARTED|Overall Study||38
568896|NCT00618514|1388273|P1|STARTED|Overall Study||36
568897|NCT00618449|1388293|P2|NOT COMPLETED|Overall Study||110
568898|NCT00618449|1388294|P1|NOT COMPLETED|Overall Study||98
568899|NCT00618449|1388293|P2|COMPLETED|Overall Study||558
568900|NCT00618449|1388294|P1|COMPLETED|Overall Study||581
568901|NCT00618449|1388293|P2|1-year, Post-treatment|Overall Study||558
568902|NCT00618449|1388294|P1|1-year, Post-treatment|Overall Study||581
568903|NCT00618449|1388293|P2|1-month, Post-treatment|Overall Study||656
568904|NCT00618449|1388294|P1|1-month, Post-treatment|Overall Study||666
568905|NCT00618449|1388293|P2|STARTED|Overall Study||668
568906|NCT00618449|1388294|P1|STARTED|Overall Study||679
568907|NCT00618436|1388302|P2|NOT COMPLETED|Overall Study||0
568908|NCT00618436|1388303|P1|NOT COMPLETED|Overall Study||0
568909|NCT00618436|1388302|P2|COMPLETED|Overall Study||18
568910|NCT00618436|1388303|P1|COMPLETED|Overall Study||34
568911|NCT00618436|1388302|P2|STARTED|Overall Study||18
568912|NCT00618436|1388303|P1|STARTED|Overall Study||34
568913|NCT00618410|1388313|P2|NOT COMPLETED|Second Intervention||0
568914|NCT00618410|1388314|P1|NOT COMPLETED|Second Intervention||0
568915|NCT00618410|1388313|P2|COMPLETED|Second Intervention||5
568916|NCT00618410|1388314|P1|COMPLETED|Second Intervention||7
568917|NCT00618410|1388313|P2|STARTED|Second Intervention||5
568918|NCT00618410|1388314|P1|STARTED|Second Intervention||7
568919|NCT00618410|1388313|P2|NOT COMPLETED|Washout Period (2 Weeks)||1
568920|NCT00618410|1388314|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
568921|NCT00618410|1388313|P2|COMPLETED|Washout Period (2 Weeks)||5
568922|NCT00618410|1388314|P1|COMPLETED|Washout Period (2 Weeks)||7
568923|NCT00618410|1388313|P2|STARTED|Washout Period (2 Weeks)||6
568924|NCT00618410|1388314|P1|STARTED|Washout Period (2 Weeks)||7
568925|NCT00618410|1388313|P2|NOT COMPLETED|First Intervention||0
568926|NCT00618410|1388314|P1|NOT COMPLETED|First Intervention||0
568927|NCT00618410|1388313|P2|COMPLETED|First Intervention||6
568928|NCT00618410|1388314|P1|COMPLETED|First Intervention||7
568929|NCT00618410|1388313|P2|STARTED|First Intervention||6
568930|NCT00618410|1388314|P1|STARTED|First Intervention||7
568931|NCT00618371|1388330|P1|NOT COMPLETED|Overall Study||2
568932|NCT00618371|1388330|P1|COMPLETED|Overall Study||10
568933|NCT00618371|1388330|P1|STARTED|Overall Study||12
568934|NCT00618332|1388337|P2|NOT COMPLETED|Overall Study||0
568935|NCT00618332|1388338|P1|NOT COMPLETED|Overall Study||0
568936|NCT00618332|1388337|P2|COMPLETED|Overall Study||20
568937|NCT00618332|1388338|P1|COMPLETED|Overall Study||20
568938|NCT00618332|1388337|P2|STARTED|Overall Study||20
568939|NCT00618332|1388338|P1|STARTED|Overall Study||20
568940|NCT00618072|1388363|P3|NOT COMPLETED|Overall Study||4
568941|NCT00618072|1388364|P2|NOT COMPLETED|Overall Study||1
568942|NCT00618072|1388365|P1|NOT COMPLETED|Overall Study||2
568943|NCT00618072|1388363|P3|COMPLETED|Overall Study||11
568944|NCT00618072|1388364|P2|COMPLETED|Overall Study||14
568945|NCT00618072|1388365|P1|COMPLETED|Overall Study||14
568946|NCT00618072|1388363|P3|STARTED|Overall Study||15
568947|NCT00618072|1388364|P2|STARTED|Overall Study||15
568948|NCT00618072|1388365|P1|STARTED|Overall Study||16
568949|NCT00617981|1388399|P2|NOT COMPLETED|Overall Study||102
568950|NCT00617981|1388400|P1|NOT COMPLETED|Overall Study||110
568951|NCT00617981|1388399|P2|COMPLETED|Overall Study||245
568952|NCT00617981|1388400|P1|COMPLETED|Overall Study||244
568953|NCT00617981|1388399|P2|STARTED|Overall Study||347
568954|NCT00617981|1388400|P1|STARTED|Overall Study||354
568955|NCT00617942|1388408|P2|NOT COMPLETED|Overall Study||4
568956|NCT00617942|1388409|P1|NOT COMPLETED|Overall Study||8
568957|NCT00617942|1388408|P2|COMPLETED|Overall Study||19
568958|NCT00617942|1388409|P1|COMPLETED|Overall Study||29
568959|NCT00617942|1388408|P2|STARTED|Overall Study||23
568960|NCT00617942|1388409|P1|STARTED|Overall Study||37
568961|NCT00617929|1388421|P1|NOT COMPLETED|Overall Study||1
568962|NCT00617929|1388421|P1|COMPLETED|Overall Study||11
568963|NCT00617929|1388421|P1|STARTED|Overall Study||12
568964|NCT00617903|1388433|P2|NOT COMPLETED|Overall Study||7
568965|NCT00617903|1388434|P1|NOT COMPLETED|Overall Study||3
568966|NCT00617903|1388433|P2|COMPLETED|Overall Study||35
568967|NCT00617903|1388434|P1|COMPLETED|Overall Study||38
568968|NCT00617903|1388433|P2|STARTED|Overall Study||42
568969|NCT00617903|1388434|P1|STARTED|Overall Study||41
568970|NCT00617890|1388480|P4|NOT COMPLETED|Overall Study||115
568971|NCT00617890|1388481|P3|NOT COMPLETED|Overall Study||35
568972|NCT00617890|1388482|P2|NOT COMPLETED|Overall Study||28
568973|NCT00617890|1388483|P1|NOT COMPLETED|Overall Study||31
568974|NCT00617890|1388480|P4|COMPLETED|Overall Study||1
568975|NCT00617890|1388481|P3|COMPLETED|Overall Study||0
568976|NCT00617890|1388482|P2|COMPLETED|Overall Study||5
568977|NCT00617890|1388483|P1|COMPLETED|Overall Study||4
568978|NCT00617890|1388480|P4|Received Treatment|Overall Study||115
568979|NCT00617890|1388481|P3|Received Treatment|Overall Study||34
568980|NCT00617890|1388482|P2|Received Treatment|Overall Study||33
568981|NCT00617890|1388483|P1|Received Treatment|Overall Study||34
568982|NCT00617890|1388480|P4|STARTED|Overall Study||116
568983|NCT00617890|1388481|P3|STARTED|Overall Study||35
568984|NCT00617890|1388482|P2|STARTED|Overall Study||33
568985|NCT00617890|1388483|P1|STARTED|Overall Study||35
568986|NCT00617851|1388519|P4|NOT COMPLETED|Overall Study||25
568987|NCT00617851|1388520|P3|NOT COMPLETED|Overall Study||45
568988|NCT00617851|1388521|P2|NOT COMPLETED|Overall Study||40
568989|NCT00617851|1388522|P1|NOT COMPLETED|Overall Study||47
568990|NCT00617851|1388519|P4|COMPLETED|Overall Study||192
568991|NCT00617851|1388520|P3|COMPLETED|Overall Study||384
568992|NCT00617851|1388521|P2|COMPLETED|Overall Study||391
568993|NCT00617851|1388522|P1|COMPLETED|Overall Study||383
568994|NCT00617851|1388519|P4|STARTED|Overall Study||217
568995|NCT00617851|1388520|P3|STARTED|Overall Study||429
568996|NCT00617851|1388521|P2|STARTED|Overall Study||431
568997|NCT00617851|1388522|P1|STARTED|Overall Study||430
568998|NCT00617773|1388560|P1|NOT COMPLETED|Overall Study||24
568999|NCT00617773|1388560|P1|COMPLETED|Overall Study|Patients COMPLETED were evaluated as having no disease progression at the end of cycle 3.|7
569000|NCT00617773|1388560|P1|STARTED|Overall Study||31
569001|NCT00617734|1388577|P2|NOT COMPLETED|Overall Study||6
569002|NCT00617734|1388578|P1|NOT COMPLETED|Overall Study||8
569003|NCT00617734|1388577|P2|COMPLETED|Overall Study||42
569004|NCT00617734|1388578|P1|COMPLETED|Overall Study||41
569005|NCT00617734|1388577|P2|Received at Least 1 Dose of Study Drug|Overall Study||44
569006|NCT00617734|1388578|P1|Received at Least 1 Dose of Study Drug|Overall Study||47
569007|NCT00617734|1388577|P2|STARTED|Overall Study||48
569008|NCT00617734|1388578|P1|STARTED|Overall Study||49
569009|NCT00617708|1388599|P3|NOT COMPLETED|Overall Study||64
569010|NCT00617708|1388600|P2|NOT COMPLETED|Overall Study||60
569011|NCT00617708|1388601|P1|NOT COMPLETED|Overall Study||10
569012|NCT00617708|1388599|P3|COMPLETED|Overall Study||0
569013|NCT00617708|1388600|P2|COMPLETED|Overall Study||0
569014|NCT00617708|1388601|P1|COMPLETED|Overall Study||0
569015|NCT00617708|1388599|P3|Eligible and Began Protocol Therapy|Overall Study||59
569016|NCT00617708|1388600|P2|Eligible and Began Protocol Therapy|Overall Study||57
569017|NCT00617708|1388601|P1|Eligible and Began Protocol Therapy|Overall Study||9
569018|NCT00617708|1388599|P3|STARTED|Overall Study||64
569019|NCT00617708|1388600|P2|STARTED|Overall Study||60
569020|NCT00617708|1388601|P1|STARTED|Overall Study||10
569021|NCT00617669|1388618|P2|NOT COMPLETED|Overall Study||451
569022|NCT00617669|1388619|P1|NOT COMPLETED|Overall Study||430
569023|NCT00617669|1388618|P2|COMPLETED|Overall Study|Patients receiving placebo at data cut-off|77
569024|NCT00617669|1388619|P1|COMPLETED|Overall Study|Patients receiving ZD4054 10 mg at data cut-off|94
569025|NCT00617669|1388618|P2|Patients Who Received IP|Overall Study||525
569026|NCT00617669|1388619|P1|Patients Who Received IP|Overall Study||522
569027|NCT00617669|1388618|P2|STARTED|Overall Study||528
569028|NCT00617669|1388619|P1|STARTED|Overall Study||524
569029|NCT00617604|1388641|P2|NOT COMPLETED|Overall Study||20
569030|NCT00617604|1388642|P1|NOT COMPLETED|Overall Study||18
569031|NCT00617604|1388641|P2|COMPLETED|Overall Study|Completed Month 6 assessment|88
569032|NCT00617604|1388642|P1|COMPLETED|Overall Study|Completed Month 6 assessment|92
569033|NCT00617604|1388641|P2|Completed 12 Weeks of Treatment|Overall Study||83
569034|NCT00617604|1388642|P1|Completed 12 Weeks of Treatment|Overall Study||89
569035|NCT00617604|1388641|P2|Received Treatment|Overall Study||105
569036|NCT00617604|1388642|P1|Received Treatment|Overall Study||107
569037|NCT00617604|1388641|P2|STARTED|Overall Study||108
569038|NCT00617604|1388642|P1|STARTED|Overall Study||110
569039|NCT00617591|1388686|P1|NOT COMPLETED|Overall Study||10
569040|NCT00617591|1388686|P1|COMPLETED|Overall Study||47
569041|NCT00617591|1388686|P1|STARTED|Overall Study||57
569042|NCT00617539|1388694|P1|NOT COMPLETED|Overall Study||0
569043|NCT00617539|1388694|P1|COMPLETED|Overall Study||30
569044|NCT00617539|1388694|P1|STARTED|Overall Study||30
569045|NCT00617461|1388702|P2|NOT COMPLETED|6-Day Down-Titration Period||2
569046|NCT00617461|1388703|P1|NOT COMPLETED|6-Day Down-Titration Period||2
569047|NCT00617461|1388702|P2|COMPLETED|6-Day Down-Titration Period||35
569048|NCT00617461|1388703|P1|COMPLETED|6-Day Down-Titration Period||39
569049|NCT00617461|1388702|P2|STARTED|6-Day Down-Titration Period||37
569050|NCT00617461|1388703|P1|STARTED|6-Day Down-Titration Period||41
569051|NCT00617461|1388702|P2|NOT COMPLETED|Second Treatment Intervention Period||4
569052|NCT00617461|1388703|P1|NOT COMPLETED|Second Treatment Intervention Period||0
569053|NCT00617461|1388702|P2|COMPLETED|Second Treatment Intervention Period||37
569054|NCT00617461|1388703|P1|COMPLETED|Second Treatment Intervention Period||41
569055|NCT00617461|1388702|P2|STARTED|Second Treatment Intervention Period||41
569056|NCT00617461|1388703|P1|STARTED|Second Treatment Intervention Period||41
569057|NCT00617461|1388702|P2|NOT COMPLETED|4-Day Crossover Period||0
569058|NCT00617461|1388703|P1|NOT COMPLETED|4-Day Crossover Period||1
569059|NCT00617461|1388702|P2|COMPLETED|4-Day Crossover Period||40
569060|NCT00617461|1388703|P1|COMPLETED|4-Day Crossover Period||41
569061|NCT00617461|1388702|P2|STARTED|4-Day Crossover Period|One 3600:1200 participant skipped the Crossover period, going directly to second Treatment Period.|40
569062|NCT00617461|1388703|P1|STARTED|4-Day Crossover Period||42
569063|NCT00617461|1388702|P2|NOT COMPLETED|First Treatment Intervention Period||3
569064|NCT00617461|1388703|P1|NOT COMPLETED|First Treatment Intervention Period||10
569065|NCT00617461|1388702|P2|COMPLETED|First Treatment Intervention Period||41
569066|NCT00617461|1388703|P1|COMPLETED|First Treatment Intervention Period||42
569067|NCT00617461|1388702|P2|STARTED|First Treatment Intervention Period||44
569068|NCT00617461|1388703|P1|STARTED|First Treatment Intervention Period|2 par. (1 withdrawal due to inv. discretion, 1 withdrawal by subject) did not take study drug.|52
569069|NCT00617409|1388759|P3|NOT COMPLETED|Overall Study||27
569070|NCT00617409|1388760|P2|NOT COMPLETED|Overall Study||18
569071|NCT00617409|1388761|P1|NOT COMPLETED|Overall Study||16
569072|NCT00617409|1388759|P3|COMPLETED|Overall Study||4
569073|NCT00617409|1388760|P2|COMPLETED|Overall Study||2
569074|NCT00617409|1388761|P1|COMPLETED|Overall Study||2
569075|NCT00617409|1388759|P3|STARTED|Overall Study||31
569076|NCT00617409|1388760|P2|STARTED|Overall Study||20
569077|NCT00617409|1388761|P1|STARTED|Overall Study||18
569078|NCT00617396|1388772|P1|NOT COMPLETED|Overall Study||0
569079|NCT00617396|1388772|P1|COMPLETED|Overall Study||25
569080|NCT00617396|1388772|P1|STARTED|Overall Study||25
569081|NCT00617357|1388776|P1|NOT COMPLETED|Overall Study||16
569082|NCT00617357|1388776|P1|COMPLETED|Overall Study|67 subjects completed study; 7 completed early, 60 completed 24 month visit|67
569083|NCT00617357|1388776|P1|STARTED|Overall Study|83 subjects enrolled, 80 subjects received Strattice reinforcement of hernia repair|83
569084|NCT00617305|1388789|P3|NOT COMPLETED|Overall Study||1
569085|NCT00617305|1388790|P2|NOT COMPLETED|Overall Study||0
569086|NCT00617305|1388791|P1|NOT COMPLETED|Overall Study||8
569087|NCT00617305|1388789|P3|COMPLETED|Overall Study||0
569088|NCT00617305|1388790|P2|COMPLETED|Overall Study||4
569089|NCT00617305|1388791|P1|COMPLETED|Overall Study||25
569090|NCT00617305|1388789|P3|Completed 24-week Primary Analysis|Overall Study||0
569091|NCT00617305|1388790|P2|Completed 24-week Primary Analysis|Overall Study||4
569092|NCT00617305|1388791|P1|Completed 24-week Primary Analysis|Overall Study||31
569093|NCT00617305|1388789|P3|STARTED|Overall Study||1
569094|NCT00617305|1388790|P2|STARTED|Overall Study||4
569095|NCT00617305|1388791|P1|STARTED|Overall Study||33
569096|NCT00617279|1388847|P2|NOT COMPLETED|Overall Study||17
569097|NCT00617279|1388848|P1|NOT COMPLETED|Overall Study||14
569098|NCT00617279|1388847|P2|COMPLETED|Overall Study||0
569099|NCT00617279|1388848|P1|COMPLETED|Overall Study||0
569100|NCT00617279|1388847|P2|STARTED|Overall Study||17
569101|NCT00617279|1388848|P1|STARTED|Overall Study||14
569102|NCT00617240|1388904|P2|NOT COMPLETED|Overall Study||0
569103|NCT00617240|1388905|P1|NOT COMPLETED|Overall Study||1
569104|NCT00617240|1388904|P2|COMPLETED|Overall Study||4
569105|NCT00617240|1388905|P1|COMPLETED|Overall Study||4
569106|NCT00617240|1388904|P2|STARTED|Overall Study||4
569107|NCT00617240|1388905|P1|STARTED|Overall Study||5
569108|NCT00617201|1388925|P2|NOT COMPLETED|Overall Study||13
569109|NCT00617201|1388926|P1|NOT COMPLETED|Overall Study||9
569110|NCT00617201|1388925|P2|COMPLETED|Overall Study||12
569111|NCT00617201|1388926|P1|COMPLETED|Overall Study||16
569112|NCT00617201|1388925|P2|STARTED|Overall Study||25
569113|NCT00617201|1388926|P1|STARTED|Overall Study||25
569114|NCT00617188|1388934|P1|NOT COMPLETED|Overall Study||0
569115|NCT00617188|1388934|P1|COMPLETED|Overall Study||26
569116|NCT00617188|1388934|P1|STARTED|Overall Study||26
569117|NCT00617175|1388945|P2|NOT COMPLETED|Overall Study||0
569118|NCT00617175|1388946|P1|NOT COMPLETED|Overall Study||0
569119|NCT00617175|1388945|P2|COMPLETED|Overall Study||948
569120|NCT00617175|1388946|P1|COMPLETED|Overall Study||954
569121|NCT00617175|1388945|P2|STARTED|Overall Study||948
569122|NCT00617175|1388946|P1|STARTED|Overall Study||954
569123|NCT00617123|1388954|P2|NOT COMPLETED|Study Treatment Period||16
569124|NCT00617123|1388955|P1|NOT COMPLETED|Study Treatment Period||17
569125|NCT00617123|1388954|P2|COMPLETED|Study Treatment Period||79
569126|NCT00617123|1388955|P1|COMPLETED|Study Treatment Period||81
569127|NCT00617123|1388954|P2|Treated|Study Treatment Period||95
569128|NCT00617123|1388955|P1|Treated|Study Treatment Period|1 participant was not treated|97
569129|NCT00617123|1388954|P2|STARTED|Study Treatment Period||95
569130|NCT00617123|1388955|P1|STARTED|Study Treatment Period||98
569131|NCT00617123|1388954|P2|NOT COMPLETED|Referral Screening Period||26
569132|NCT00617123|1388955|P1|NOT COMPLETED|Referral Screening Period||39
569133|NCT00617123|1388954|P2|COMPLETED|Referral Screening Period||95
569134|NCT00617123|1388955|P1|COMPLETED|Referral Screening Period||98
569135|NCT00617123|1388954|P2|STARTED|Referral Screening Period||121
569136|NCT00617123|1388955|P1|STARTED|Referral Screening Period||137
569137|NCT00617097|1388971|P2|NOT COMPLETED|Overall Study||0
569138|NCT00617097|1388972|P1|NOT COMPLETED|Overall Study||0
569139|NCT00617097|1388971|P2|COMPLETED|Overall Study||25
569140|NCT00617097|1388972|P1|COMPLETED|Overall Study||25
569141|NCT00617097|1388971|P2|STARTED|Overall Study||25
569142|NCT00617097|1388972|P1|STARTED|Overall Study||25
569143|NCT00617084|1388986|P2|NOT COMPLETED|Overall Study||26
569144|NCT00617084|1388987|P1|NOT COMPLETED|Overall Study||21
569145|NCT00617084|1388986|P2|COMPLETED|Overall Study||1126
569146|NCT00617084|1388987|P1|COMPLETED|Overall Study||1119
569147|NCT00617084|1388986|P2|STARTED|Overall Study||1152
569148|NCT00617084|1388987|P1|STARTED|Overall Study||1140
569149|NCT00617058|1388998|P3|NOT COMPLETED|Overall Study||0
569150|NCT00617058|1388999|P2|NOT COMPLETED|Overall Study||0
569151|NCT00617058|1389000|P1|NOT COMPLETED|Overall Study||0
569152|NCT00617058|1388998|P3|COMPLETED|Overall Study||0
569153|NCT00617058|1388999|P2|COMPLETED|Overall Study||0
569154|NCT00617058|1389000|P1|COMPLETED|Overall Study||1
569155|NCT00617058|1388998|P3|STARTED|Overall Study||0
569156|NCT00617058|1388999|P2|STARTED|Overall Study||0
569157|NCT00617058|1389000|P1|STARTED|Overall Study||1
569158|NCT00616967|1389040|P3|NOT COMPLETED|Overall Study||1
569159|NCT00616967|1389041|P2|NOT COMPLETED|Overall Study||0
569160|NCT00616967|1389042|P1|NOT COMPLETED|Overall Study||0
569161|NCT00616967|1389040|P3|COMPLETED|Overall Study||30
569162|NCT00616967|1389041|P2|COMPLETED|Overall Study||31
569163|NCT00616967|1389042|P1|COMPLETED|Overall Study||6
569164|NCT00616967|1389040|P3|STARTED|Overall Study||31
569165|NCT00616967|1389041|P2|STARTED|Overall Study||31
569166|NCT00616967|1389042|P1|STARTED|Overall Study||6
569167|NCT00616928|1389055|P4|NOT COMPLETED|Overall Study||7
569168|NCT00616928|1389056|P3|NOT COMPLETED|Overall Study||17
569169|NCT00616928|1389057|P2|NOT COMPLETED|Overall Study||18
569170|NCT00616928|1389058|P1|NOT COMPLETED|Overall Study||62
569171|NCT00616928|1389055|P4|COMPLETED|Overall Study||364
569172|NCT00616928|1389056|P3|COMPLETED|Overall Study||1101
569173|NCT00616928|1389057|P2|COMPLETED|Overall Study||750
569174|NCT00616928|1389058|P1|COMPLETED|Overall Study||2242
569175|NCT00616928|1389055|P4|STARTED|Overall Study||371
569176|NCT00616928|1389056|P3|STARTED|Overall Study||1118
569177|NCT00616928|1389057|P2|STARTED|Overall Study||768
569178|NCT00616928|1389058|P1|STARTED|Overall Study||2304
569179|NCT00616902|1389122|P2|NOT COMPLETED|Overall Study||6
569180|NCT00616902|1389123|P1|NOT COMPLETED|Overall Study||6
569181|NCT00616902|1389122|P2|COMPLETED|Overall Study||0
569182|NCT00616902|1389123|P1|COMPLETED|Overall Study||0
569183|NCT00616902|1389122|P2|STARTED|Overall Study||6
569184|NCT00616902|1389123|P1|STARTED|Overall Study||6
569185|NCT00616772|1389149|P2|NOT COMPLETED|Overall Study||102
569186|NCT00616772|1389150|P1|NOT COMPLETED|Overall Study||115
569187|NCT00616772|1389149|P2|COMPLETED|Overall Study||240
569188|NCT00616772|1389150|P1|COMPLETED|Overall Study||225
569189|NCT00616772|1389149|P2|Treated|Overall Study||339
569190|NCT00616772|1389150|P1|Treated|Overall Study||337
569191|NCT00616772|1389149|P2|STARTED|Overall Study||342
569192|NCT00616772|1389150|P1|STARTED|Overall Study||340
569193|NCT00616759|1389166|P2|NOT COMPLETED|Overall Study||2
569194|NCT00616759|1389167|P1|NOT COMPLETED|Overall Study||3
569195|NCT00616759|1389166|P2|COMPLETED|Overall Study||8
569196|NCT00616759|1389167|P1|COMPLETED|Overall Study||7
569197|NCT00616759|1389166|P2|STARTED|Overall Study||10
569198|NCT00616759|1389167|P1|STARTED|Overall Study||10
569199|NCT00616655|1389176|P3|NOT COMPLETED|Overall Study||48
569200|NCT00616655|1389177|P2|NOT COMPLETED|Overall Study||41
569201|NCT00616655|1389178|P1|NOT COMPLETED|Overall Study||35
569202|NCT00616655|1389176|P3|COMPLETED|Overall Study||103
569203|NCT00616655|1389177|P2|COMPLETED|Overall Study||112
569204|NCT00616655|1389178|P1|COMPLETED|Overall Study||117
569205|NCT00616655|1389176|P3|STARTED|Overall Study||151
569206|NCT00616655|1389177|P2|STARTED|Overall Study||153
569207|NCT00616655|1389178|P1|STARTED|Overall Study||152
569208|NCT00616642|1389218|P2|NOT COMPLETED|Overall Study||1
569209|NCT00616642|1389219|P1|NOT COMPLETED|Overall Study||0
569210|NCT00616642|1389218|P2|COMPLETED|Overall Study||0
569211|NCT00616642|1389219|P1|COMPLETED|Overall Study||0
569212|NCT00616642|1389218|P2|STARTED|Overall Study||1
569213|NCT00616642|1389219|P1|STARTED|Overall Study||0
569214|NCT00616629|1389230|P5|NOT COMPLETED|Overall Study||0
569215|NCT00616629|1389231|P4|NOT COMPLETED|Overall Study||0
569216|NCT00616629|1389232|P3|NOT COMPLETED|Overall Study||1
569217|NCT00616629|1389233|P2|NOT COMPLETED|Overall Study||2
569218|NCT00616629|1389234|P1|NOT COMPLETED|Overall Study||2
569219|NCT00616629|1389230|P5|COMPLETED|Overall Study||12
569220|NCT00616629|1389231|P4|COMPLETED|Overall Study||2
569221|NCT00616629|1389232|P3|COMPLETED|Overall Study||13
569222|NCT00616629|1389233|P2|COMPLETED|Overall Study||12
569223|NCT00616629|1389234|P1|COMPLETED|Overall Study||11
569224|NCT00616629|1389230|P5|STARTED|Overall Study||12
569225|NCT00616629|1389231|P4|STARTED|Overall Study||2
569226|NCT00616629|1389232|P3|STARTED|Overall Study|One patient never received study drug|14
569227|NCT00616629|1389233|P2|STARTED|Overall Study|Two patients never received study drug|14
569228|NCT00616629|1389234|P1|STARTED|Overall Study|Two patients never received study drug|13
569229|NCT00616603|1389279|P3|NOT COMPLETED|Overall Study||2
569230|NCT00616603|1389280|P2|NOT COMPLETED|Overall Study||0
569231|NCT00616603|1389281|P1|NOT COMPLETED|Overall Study||2
569232|NCT00616603|1389279|P3|COMPLETED|Overall Study||13
569233|NCT00616603|1389280|P2|COMPLETED|Overall Study||14
569234|NCT00616603|1389281|P1|COMPLETED|Overall Study||12
569235|NCT00616603|1389279|P3|STARTED|Overall Study||15
569236|NCT00616603|1389280|P2|STARTED|Overall Study||14
569237|NCT00616603|1389281|P1|STARTED|Overall Study||14
569238|NCT00616577|1389292|P3|NOT COMPLETED|Overall Study||0
569239|NCT00616577|1389293|P2|NOT COMPLETED|Overall Study||0
569240|NCT00616577|1389294|P1|NOT COMPLETED|Overall Study||0
569241|NCT00616577|1389292|P3|COMPLETED|Overall Study||7
569242|NCT00616577|1389293|P2|COMPLETED|Overall Study||9
569243|NCT00616577|1389294|P1|COMPLETED|Overall Study||6
569244|NCT00616577|1389292|P3|STARTED|Overall Study||7
569245|NCT00616577|1389293|P2|STARTED|Overall Study||9
569246|NCT00616577|1389294|P1|STARTED|Overall Study||6
569247|NCT00616434|1389304|P2|NOT COMPLETED|Overall Study||8
569248|NCT00616434|1389305|P1|NOT COMPLETED|Overall Study||6
569249|NCT00616434|1389304|P2|COMPLETED|Overall Study||53
569250|NCT00616434|1389305|P1|COMPLETED|Overall Study||56
569251|NCT00616434|1389304|P2|STARTED|Overall Study||61
569252|NCT00616434|1389305|P1|STARTED|Overall Study||62
569253|NCT00616421|1389318|P3|NOT COMPLETED|Overall Study||41
569254|NCT00616421|1389319|P2|NOT COMPLETED|Overall Study||38
569255|NCT00616421|1389320|P1|NOT COMPLETED|Overall Study||26
569256|NCT00616421|1389318|P3|COMPLETED|Overall Study||1229
569257|NCT00616421|1389319|P2|COMPLETED|Overall Study||1240
569258|NCT00616421|1389320|P1|COMPLETED|Overall Study||333
569259|NCT00616421|1389318|P3|STARTED|Overall Study||1270
569260|NCT00616421|1389319|P2|STARTED|Overall Study||1278
569261|NCT00616421|1389320|P1|STARTED|Overall Study||359
569262|NCT00616343|1389357|P1|NOT COMPLETED|Overall Study||0
569263|NCT00616343|1389357|P1|COMPLETED|Overall Study||9
569264|NCT00616343|1389357|P1|STARTED|Overall Study||9
569265|NCT00616239|1389361|P1|NOT COMPLETED|Overall Study||2
569266|NCT00616239|1389361|P1|COMPLETED|Overall Study||18
569267|NCT00616239|1389361|P1|STARTED|Overall Study||20
569268|NCT00616200|1389365|P1|NOT COMPLETED|Four Week Very Low Carbohydrate Diet||3
569269|NCT00616200|1389365|P1|COMPLETED|Four Week Very Low Carbohydrate Diet||13
569270|NCT00616200|1389365|P1|STARTED|Four Week Very Low Carbohydrate Diet||16
569271|NCT00616200|1389365|P1|NOT COMPLETED|Two Week Standard Diet||1
569272|NCT00616200|1389365|P1|COMPLETED|Two Week Standard Diet||16
569273|NCT00616200|1389365|P1|STARTED|Two Week Standard Diet||17
569274|NCT00616122|1389371|P1|NOT COMPLETED|Overall Study||7
569275|NCT00616122|1389371|P1|COMPLETED|Overall Study||25
569276|NCT00616122|1389371|P1|STARTED|Overall Study||32
569277|NCT00616109|1389378|P1|NOT COMPLETED|Overall Study||0
569278|NCT00616109|1389378|P1|COMPLETED|Overall Study||16
569279|NCT00616109|1389378|P1|STARTED|Overall Study||16
569280|NCT00616018|1389385|P1|NOT COMPLETED|Overall Study||3
569281|NCT00616018|1389385|P1|COMPLETED|Overall Study||24
569282|NCT00616018|1389385|P1|STARTED|Overall Study||27
569283|NCT00615992|1389390|P1|NOT COMPLETED|Overall Study||67
569284|NCT00615992|1389390|P1|COMPLETED|Overall Study||687
569285|NCT00615992|1389390|P1|STARTED|Overall Study||754
569286|NCT00615927|1389401|P2|NOT COMPLETED|Overall Study||0
569287|NCT00615927|1389402|P1|NOT COMPLETED|Overall Study||0
569288|NCT00615927|1389401|P2|COMPLETED|Overall Study||32
569289|NCT00615927|1389402|P1|COMPLETED|Overall Study||32
569290|NCT00615927|1389401|P2|STARTED|Overall Study||32
569291|NCT00615927|1389402|P1|STARTED|Overall Study||32
569292|NCT00615914|1389416|P1|NOT COMPLETED|Overall Study||637
569293|NCT00615914|1389416|P1|COMPLETED|Overall Study||1008
569294|NCT00615914|1389416|P1|STARTED|Overall Study|The number of patients enrolled|1645
569295|NCT00615901|1389423|P1|NOT COMPLETED|Overall Study||9
569296|NCT00615901|1389423|P1|COMPLETED|Overall Study||29
569297|NCT00615901|1389423|P1|STARTED|Overall Study||38
569298|NCT00615836|1389431|P5|NOT COMPLETED|Extension Study (FE992026 CS31)||0
569299|NCT00615836|1389432|P4|NOT COMPLETED|Extension Study (FE992026 CS31)||84
569300|NCT00615836|1389433|P3|NOT COMPLETED|Extension Study (FE992026 CS31)||73
569301|NCT00615836|1389434|P2|NOT COMPLETED|Extension Study (FE992026 CS31)||86
569302|NCT00615836|1389435|P1|NOT COMPLETED|Extension Study (FE992026 CS31)||141
569303|NCT00615836|1389431|P5|COMPLETED|Extension Study (FE992026 CS31)||0
569304|NCT00615836|1389432|P4|COMPLETED|Extension Study (FE992026 CS31)||53
569305|NCT00615836|1389433|P3|COMPLETED|Extension Study (FE992026 CS31)||59
569306|NCT00615836|1389434|P2|COMPLETED|Extension Study (FE992026 CS31)||58
569307|NCT00615836|1389435|P1|COMPLETED|Extension Study (FE992026 CS31)||0
569308|NCT00615836|1389431|P5|STARTED|Extension Study (FE992026 CS31)||0
569309|NCT00615836|1389432|P4|STARTED|Extension Study (FE992026 CS31)||137
569310|NCT00615836|1389433|P3|STARTED|Extension Study (FE992026 CS31)||132
569311|NCT00615836|1389434|P2|STARTED|Extension Study (FE992026 CS31)||144
569312|NCT00615836|1389435|P1|STARTED|Extension Study (FE992026 CS31)||141
569313|NCT00615836|1389431|P5|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||15
569314|NCT00615836|1389432|P4|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||25
569315|NCT00615836|1389433|P3|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||20
569316|NCT00615836|1389434|P2|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||10
569317|NCT00615836|1389435|P1|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||19
569318|NCT00615836|1389431|P5|COMPLETED|Part I of Core Study (FE992026 CS29)||145
569319|NCT00615836|1389432|P4|COMPLETED|Part I of Core Study (FE992026 CS29)||135
569320|NCT00615836|1389433|P3|COMPLETED|Part I of Core Study (FE992026 CS29)||138
569321|NCT00615836|1389434|P2|COMPLETED|Part I of Core Study (FE992026 CS29)||148
569322|NCT00615836|1389435|P1|COMPLETED|Part I of Core Study (FE992026 CS29)||144
569323|NCT00615836|1389431|P5|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|156
569324|NCT00615836|1389432|P4|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|146
569325|NCT00615836|1389433|P3|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|148
569326|NCT00615836|1389434|P2|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|152
569327|NCT00615836|1389435|P1|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|155
569328|NCT00615836|1389431|P5|STARTED|Part I of Core Study (FE992026 CS29)||160
569329|NCT00615836|1389432|P4|STARTED|Part I of Core Study (FE992026 CS29)||160
569330|NCT00615836|1389433|P3|STARTED|Part I of Core Study (FE992026 CS29)||158
569331|NCT00615836|1389434|P2|STARTED|Part I of Core Study (FE992026 CS29)||158
569332|NCT00615836|1389435|P1|STARTED|Part I of Core Study (FE992026 CS29)||163
569333|NCT00615719|1389495|P1|NOT COMPLETED|Overall Study||5
569334|NCT00615719|1389495|P1|COMPLETED|Overall Study||30
569335|NCT00615719|1389495|P1|STARTED|Overall Study||35
569336|NCT00615589|1389499|P1|NOT COMPLETED|Overall Study||0
569337|NCT00615589|1389499|P1|COMPLETED|Overall Study||22
569338|NCT00615589|1389499|P1|STARTED|Overall Study||22
569339|NCT00615550|1389509|P2|NOT COMPLETED|Overall Study||1
569340|NCT00615550|1389510|P1|NOT COMPLETED|Overall Study||6
569341|NCT00615550|1389509|P2|COMPLETED|Overall Study||235
569342|NCT00615550|1389510|P1|COMPLETED|Overall Study||223
569343|NCT00615550|1389509|P2|STARTED|Overall Study||236
569344|NCT00615550|1389510|P1|STARTED|Overall Study||229
569345|NCT00615472|1389526|P2|NOT COMPLETED|Overall Study||0
569346|NCT00615472|1389527|P1|NOT COMPLETED|Overall Study||0
569347|NCT00615472|1389526|P2|COMPLETED|Overall Study||28
569348|NCT00615472|1389527|P1|COMPLETED|Overall Study||30
569349|NCT00615472|1389526|P2|STARTED|Overall Study||28
569350|NCT00615472|1389527|P1|STARTED|Overall Study||30
569351|NCT00615459|1389533|P4|NOT COMPLETED|Period III||0
569352|NCT00615459|1389534|P3|NOT COMPLETED|Period III||1
569353|NCT00615459|1389535|P2|NOT COMPLETED|Period III||3
569354|NCT00615459|1389536|P1|NOT COMPLETED|Period III||0
569355|NCT00615459|1389533|P4|COMPLETED|Period III||41
569356|NCT00615459|1389534|P3|COMPLETED|Period III||39
569357|NCT00615459|1389535|P2|COMPLETED|Period III||37
569358|NCT00615459|1389536|P1|COMPLETED|Period III||36
569359|NCT00615459|1389533|P4|STARTED|Period III||41
569360|NCT00615459|1389534|P3|STARTED|Period III||40
569361|NCT00615459|1389535|P2|STARTED|Period III||40
569362|NCT00615459|1389536|P1|STARTED|Period III||36
569363|NCT00615459|1389533|P4|NOT COMPLETED|Period II||1
569364|NCT00615459|1389534|P3|NOT COMPLETED|Period II||0
569365|NCT00615459|1389535|P2|NOT COMPLETED|Period II||0
569366|NCT00615459|1389536|P1|NOT COMPLETED|Period II||1
569367|NCT00615459|1389533|P4|COMPLETED|Period II||41
569368|NCT00615459|1389534|P3|COMPLETED|Period II||40
569369|NCT00615459|1389535|P2|COMPLETED|Period II||40
569370|NCT00615459|1389536|P1|COMPLETED|Period II||36
569371|NCT00615459|1389533|P4|STARTED|Period II||42
569372|NCT00615459|1389534|P3|STARTED|Period II||40
569373|NCT00615459|1389535|P2|STARTED|Period II||40
569374|NCT00615459|1389536|P1|STARTED|Period II||37
569375|NCT00615459|1389533|P4|NOT COMPLETED|Period I||1
569376|NCT00615459|1389534|P3|NOT COMPLETED|Period I||2
569377|NCT00615459|1389535|P2|NOT COMPLETED|Period I||1
569378|NCT00615459|1389536|P1|NOT COMPLETED|Period I||4
569379|NCT00615459|1389533|P4|COMPLETED|Period I||42
569380|NCT00615459|1389534|P3|COMPLETED|Period I||40
569381|NCT00615459|1389535|P2|COMPLETED|Period I||40
569382|NCT00615459|1389536|P1|COMPLETED|Period I||37
569383|NCT00615459|1389533|P4|STARTED|Period I||43
569384|NCT00615459|1389534|P3|STARTED|Period I|1 randomized patient of this sequence was never exposed to drug. Hence, dropped out before Period I.|42
569385|NCT00615459|1389535|P2|STARTED|Period I|1 randomized patient of this sequence was never exposed to drug. Hence, dropped out before Period I.|41
569386|NCT00615459|1389536|P1|STARTED|Period I||41
569387|NCT00615433|1389554|P4|NOT COMPLETED|Overall Study||45
569388|NCT00615433|1389555|P3|NOT COMPLETED|Overall Study||39
569389|NCT00615433|1389556|P2|NOT COMPLETED|Overall Study||53
569390|NCT00615433|1389557|P1|NOT COMPLETED|Overall Study||43
569391|NCT00615433|1389554|P4|COMPLETED|Overall Study||71
569392|NCT00615433|1389555|P3|COMPLETED|Overall Study||84
569393|NCT00615433|1389556|P2|COMPLETED|Overall Study||66
569394|NCT00615433|1389557|P1|COMPLETED|Overall Study||77
569395|NCT00615433|1389554|P4|STARTED|Overall Study||116
569396|NCT00615433|1389555|P3|STARTED|Overall Study||123
569397|NCT00615433|1389556|P2|STARTED|Overall Study||119
569398|NCT00615433|1389557|P1|STARTED|Overall Study||120
569399|NCT00615290|1389571|P1|NOT COMPLETED|Overall Study||8
569400|NCT00615290|1389571|P1|COMPLETED|Overall Study||34
569401|NCT00615290|1389571|P1|STARTED|Overall Study||42
569402|NCT00615264|1389585|P2|NOT COMPLETED|Overall Study||52
569403|NCT00615264|1389586|P1|NOT COMPLETED|Overall Study||50
569404|NCT00615264|1389585|P2|COMPLETED|Overall Study||180
569405|NCT00615264|1389586|P1|COMPLETED|Overall Study||175
569406|NCT00615264|1389585|P2|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||213
569407|NCT00615264|1389586|P1|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||209
569408|NCT00615264|1389585|P2|Received at Least One Dose (ITT)|Overall Study||231
569409|NCT00615264|1389586|P1|Received at Least One Dose (ITT)|Overall Study||225
569410|NCT00615264|1389585|P2|STARTED|Overall Study||232
569411|NCT00615264|1389586|P1|STARTED|Overall Study||225
569412|NCT00615199|1389598|P4|NOT COMPLETED|Overall Study||2
569413|NCT00615199|1389599|P3|NOT COMPLETED|Overall Study||1
569414|NCT00615199|1389600|P2|NOT COMPLETED|Overall Study||2
569415|NCT00615199|1389601|P1|NOT COMPLETED|Overall Study||8
569416|NCT00615199|1389598|P4|COMPLETED|Overall Study||33
569417|NCT00615199|1389599|P3|COMPLETED|Overall Study||33
569418|NCT00615199|1389600|P2|COMPLETED|Overall Study||34
569419|NCT00615199|1389601|P1|COMPLETED|Overall Study||26
569420|NCT00615199|1389598|P4|STARTED|Overall Study||35
569421|NCT00615199|1389599|P3|STARTED|Overall Study||34
569422|NCT00615199|1389600|P2|STARTED|Overall Study||36
569423|NCT00615199|1389601|P1|STARTED|Overall Study||34
569424|NCT00615108|1389635|P1|NOT COMPLETED|Overall Study||507
569425|NCT00615108|1389635|P1|COMPLETED|Overall Study||2641
569426|NCT00615108|1389635|P1|STARTED|Overall Study||3148
569427|NCT00615069|1389650|P1|NOT COMPLETED|Overall Study||16
569428|NCT00615069|1389650|P1|COMPLETED|Overall Study||19
569429|NCT00615069|1389650|P1|STARTED|Overall Study||35
569430|NCT00615056|1389659|P4|NOT COMPLETED|Overall Study||35
569431|NCT00615056|1389660|P3|NOT COMPLETED|Overall Study||36
569432|NCT00615056|1389661|P2|NOT COMPLETED|Overall Study||51
569433|NCT00615056|1389662|P1|NOT COMPLETED|Overall Study||49
569434|NCT00615056|1389659|P4|COMPLETED|Overall Study||0
569435|NCT00615056|1389660|P3|COMPLETED|Overall Study||0
569436|NCT00615056|1389661|P2|COMPLETED|Overall Study||0
569437|NCT00615056|1389662|P1|COMPLETED|Overall Study||0
569438|NCT00615056|1389659|P4|Treated|Overall Study||35
569439|NCT00615056|1389660|P3|Treated|Overall Study||36
569440|NCT00615056|1389661|P2|Treated|Overall Study||51
569441|NCT00615056|1389662|P1|Treated|Overall Study||46
569442|NCT00615056|1389659|P4|STARTED|Overall Study||35
569443|NCT00615056|1389660|P3|STARTED|Overall Study||36
569444|NCT00615056|1389661|P2|STARTED|Overall Study||51
569445|NCT00615056|1389662|P1|STARTED|Overall Study||49
569446|NCT00615030|1389692|P12|NOT COMPLETED|Period III||0
569447|NCT00615030|1389693|P11|NOT COMPLETED|Period III||0
569448|NCT00615030|1389694|P10|NOT COMPLETED|Period III||0
569449|NCT00615030|1389695|P9|NOT COMPLETED|Period III||0
569450|NCT00615030|1389696|P8|NOT COMPLETED|Period III||0
569451|NCT00615030|1389697|P7|NOT COMPLETED|Period III||0
569452|NCT00615030|1389698|P6|NOT COMPLETED|Period III||0
569453|NCT00615030|1389699|P5|NOT COMPLETED|Period III||0
569454|NCT00615030|1389700|P4|NOT COMPLETED|Period III||1
569455|NCT00615030|1389701|P3|NOT COMPLETED|Period III||0
569456|NCT00615030|1389702|P2|NOT COMPLETED|Period III||0
569457|NCT00615030|1389703|P1|NOT COMPLETED|Period III||1
569458|NCT00615030|1389692|P12|COMPLETED|Period III||6
569459|NCT00615030|1389693|P11|COMPLETED|Period III||7
569460|NCT00615030|1389694|P10|COMPLETED|Period III||8
569461|NCT00615030|1389695|P9|COMPLETED|Period III||7
569462|NCT00615030|1389696|P8|COMPLETED|Period III||7
569463|NCT00615030|1389697|P7|COMPLETED|Period III||6
569464|NCT00615030|1389698|P6|COMPLETED|Period III||5
569465|NCT00615030|1389699|P5|COMPLETED|Period III||8
569466|NCT00615030|1389700|P4|COMPLETED|Period III||6
569467|NCT00615030|1389701|P3|COMPLETED|Period III||8
569468|NCT00615030|1389702|P2|COMPLETED|Period III||8
569469|NCT00615030|1389703|P1|COMPLETED|Period III||7
569470|NCT00615030|1389692|P12|STARTED|Period III||6
569471|NCT00615030|1389693|P11|STARTED|Period III||7
569472|NCT00615030|1389694|P10|STARTED|Period III||8
569473|NCT00615030|1389695|P9|STARTED|Period III||7
569474|NCT00615030|1389696|P8|STARTED|Period III||7
569475|NCT00615030|1389697|P7|STARTED|Period III||6
569476|NCT00615030|1389698|P6|STARTED|Period III||5
569477|NCT00615030|1389699|P5|STARTED|Period III||8
569478|NCT00615030|1389700|P4|STARTED|Period III||7
569479|NCT00615030|1389701|P3|STARTED|Period III||8
569480|NCT00615030|1389702|P2|STARTED|Period III||8
569481|NCT00615030|1389703|P1|STARTED|Period III||8
569482|NCT00615030|1389692|P12|NOT COMPLETED|Period II||0
569483|NCT00615030|1389693|P11|NOT COMPLETED|Period II||0
569484|NCT00615030|1389694|P10|NOT COMPLETED|Period II||0
569485|NCT00615030|1389695|P9|NOT COMPLETED|Period II||1
569486|NCT00615030|1389696|P8|NOT COMPLETED|Period II||0
569487|NCT00615030|1389697|P7|NOT COMPLETED|Period II||1
569488|NCT00615030|1389698|P6|NOT COMPLETED|Period II||0
569489|NCT00615030|1389699|P5|NOT COMPLETED|Period II||0
569490|NCT00615030|1389700|P4|NOT COMPLETED|Period II||1
569491|NCT00615030|1389701|P3|NOT COMPLETED|Period II||1
569492|NCT00615030|1389702|P2|NOT COMPLETED|Period II||0
569493|NCT00615030|1389703|P1|NOT COMPLETED|Period II||0
569494|NCT00615030|1389692|P12|COMPLETED|Period II||6
569495|NCT00615030|1389693|P11|COMPLETED|Period II||7
569496|NCT00615030|1389694|P10|COMPLETED|Period II||8
569497|NCT00615030|1389695|P9|COMPLETED|Period II||7
569498|NCT00615030|1389696|P8|COMPLETED|Period II||7
569499|NCT00615030|1389697|P7|COMPLETED|Period II||6
569500|NCT00615030|1389698|P6|COMPLETED|Period II||5
569501|NCT00615030|1389699|P5|COMPLETED|Period II||8
569502|NCT00615030|1389700|P4|COMPLETED|Period II||7
569503|NCT00615030|1389701|P3|COMPLETED|Period II||8
569504|NCT00615030|1389702|P2|COMPLETED|Period II||8
569505|NCT00615030|1389703|P1|COMPLETED|Period II||8
569506|NCT00615030|1389692|P12|STARTED|Period II||6
569507|NCT00615030|1389693|P11|STARTED|Period II||7
569508|NCT00615030|1389694|P10|STARTED|Period II||8
569509|NCT00615030|1389695|P9|STARTED|Period II||8
569510|NCT00615030|1389696|P8|STARTED|Period II||7
569511|NCT00615030|1389697|P7|STARTED|Period II||7
569512|NCT00615030|1389698|P6|STARTED|Period II||5
569513|NCT00615030|1389699|P5|STARTED|Period II||8
569514|NCT00615030|1389700|P4|STARTED|Period II||8
569515|NCT00615030|1389701|P3|STARTED|Period II||9
569516|NCT00615030|1389702|P2|STARTED|Period II||8
569517|NCT00615030|1389703|P1|STARTED|Period II||8
569518|NCT00615030|1389692|P12|NOT COMPLETED|Period I||1
569519|NCT00615030|1389693|P11|NOT COMPLETED|Period I||1
569520|NCT00615030|1389694|P10|NOT COMPLETED|Period I||0
569521|NCT00615030|1389695|P9|NOT COMPLETED|Period I||1
569522|NCT00615030|1389696|P8|NOT COMPLETED|Period I||0
569523|NCT00615030|1389697|P7|NOT COMPLETED|Period I||0
569524|NCT00615030|1389698|P6|NOT COMPLETED|Period I||1
569525|NCT00615030|1389699|P5|NOT COMPLETED|Period I||1
569526|NCT00615030|1389700|P4|NOT COMPLETED|Period I||0
569527|NCT00615030|1389701|P3|NOT COMPLETED|Period I||0
569528|NCT00615030|1389702|P2|NOT COMPLETED|Period I||0
569529|NCT00615030|1389703|P1|NOT COMPLETED|Period I||1
569530|NCT00615030|1389692|P12|COMPLETED|Period I||6
569531|NCT00615030|1389693|P11|COMPLETED|Period I||7
569532|NCT00615030|1389694|P10|COMPLETED|Period I||8
569533|NCT00615030|1389695|P9|COMPLETED|Period I||8
569534|NCT00615030|1389696|P8|COMPLETED|Period I||7
569535|NCT00615030|1389697|P7|COMPLETED|Period I||7
569536|NCT00615030|1389698|P6|COMPLETED|Period I||5
569537|NCT00615030|1389699|P5|COMPLETED|Period I||8
569538|NCT00615030|1389700|P4|COMPLETED|Period I||8
569539|NCT00615030|1389701|P3|COMPLETED|Period I||9
569540|NCT00615030|1389702|P2|COMPLETED|Period I||8
569541|NCT00615030|1389703|P1|COMPLETED|Period I||8
569542|NCT00615030|1389692|P12|STARTED|Period I||7
569543|NCT00615030|1389693|P11|STARTED|Period I||8
569544|NCT00615030|1389694|P10|STARTED|Period I||8
569545|NCT00615030|1389695|P9|STARTED|Period I||9
569546|NCT00615030|1389696|P8|STARTED|Period I||7
569547|NCT00615030|1389697|P7|STARTED|Period I||7
569548|NCT00615030|1389698|P6|STARTED|Period I|1 randomized patient in this sequence dropped out before exposure to study drug in Period I.|6
569549|NCT00615030|1389699|P5|STARTED|Period I||9
569550|NCT00615030|1389700|P4|STARTED|Period I||8
569551|NCT00615030|1389701|P3|STARTED|Period I||9
569552|NCT00615030|1389702|P2|STARTED|Period I||8
569553|NCT00615030|1389703|P1|STARTED|Period I||9
569554|NCT00615017|1389723|P6|NOT COMPLETED|Overall Study||3
569555|NCT00615017|1389724|P5|NOT COMPLETED|Overall Study||1
569556|NCT00615017|1389725|P4|NOT COMPLETED|Overall Study||1
569557|NCT00615017|1389726|P3|NOT COMPLETED|Overall Study||5
569558|NCT00615017|1389727|P2|NOT COMPLETED|Overall Study||1
569559|NCT00615017|1389728|P1|NOT COMPLETED|Overall Study||0
569560|NCT00615017|1389723|P6|COMPLETED|Overall Study|Patient completed the study drug|20
569561|NCT00615017|1389724|P5|COMPLETED|Overall Study|Patient completed the study drug|7
569562|NCT00615017|1389725|P4|COMPLETED|Overall Study|Patient completed the study drug|9
569563|NCT00615017|1389726|P3|COMPLETED|Overall Study|Patient completed the study drug|7
569564|NCT00615017|1389727|P2|COMPLETED|Overall Study|Patient completed the study drug|8
569565|NCT00615017|1389728|P1|COMPLETED|Overall Study|Patient completed the study drug|8
569566|NCT00615017|1389723|P6|STARTED|Overall Study|Patients received treatment|23
569567|NCT00615017|1389724|P5|STARTED|Overall Study|Patients received treatment|8
569568|NCT00615017|1389725|P4|STARTED|Overall Study|Patients received treatment|10
569569|NCT00615017|1389726|P3|STARTED|Overall Study|Patients received treatment|12
569570|NCT00615017|1389727|P2|STARTED|Overall Study|Patients received treatment|9
569571|NCT00615017|1389728|P1|STARTED|Overall Study|Patients received treatment|8
569572|NCT00614991|1389886|P6|NOT COMPLETED|Overall Study||0
569573|NCT00614991|1389887|P5|NOT COMPLETED|Overall Study||1
569574|NCT00614991|1389888|P4|NOT COMPLETED|Overall Study||0
569575|NCT00614991|1389889|P3|NOT COMPLETED|Overall Study||0
569576|NCT00614991|1389890|P2|NOT COMPLETED|Overall Study||3
569577|NCT00614991|1389891|P1|NOT COMPLETED|Overall Study||3
569578|NCT00614991|1389886|P6|COMPLETED|Overall Study||6
569579|NCT00614991|1389887|P5|COMPLETED|Overall Study||6
569580|NCT00614991|1389888|P4|COMPLETED|Overall Study||7
569581|NCT00614991|1389889|P3|COMPLETED|Overall Study||7
569582|NCT00614991|1389890|P2|COMPLETED|Overall Study||6
569583|NCT00614991|1389891|P1|COMPLETED|Overall Study||5
569584|NCT00614991|1389886|P6|STARTED|Overall Study||6
569585|NCT00614991|1389887|P5|STARTED|Overall Study||7
569586|NCT00614991|1389888|P4|STARTED|Overall Study||7
569587|NCT00614991|1389889|P3|STARTED|Overall Study||7
569588|NCT00614991|1389890|P2|STARTED|Overall Study||9
569589|NCT00614991|1389891|P1|STARTED|Overall Study||8
569590|NCT00614939|1389925|P2|NOT COMPLETED|Overall Study||43
569591|NCT00614939|1389926|P1|NOT COMPLETED|Overall Study||35
569592|NCT00614939|1389925|P2|COMPLETED|Overall Study|Completed 52 weeks of treatment|42
569593|NCT00614939|1389926|P1|COMPLETED|Overall Study|Completed 52 weeks of treatment|50
569594|NCT00614939|1389925|P2|STARTED|Overall Study|Randomized and treated|85
569595|NCT00614939|1389926|P1|STARTED|Overall Study|Randomized and treated|85
569596|NCT00614926|1389960|P2|NOT COMPLETED|Overall Study||0
569597|NCT00614926|1389961|P1|NOT COMPLETED|Overall Study||4
569598|NCT00614926|1389960|P2|COMPLETED|Overall Study||7
569599|NCT00614926|1389961|P1|COMPLETED|Overall Study||21
569600|NCT00614926|1389960|P2|STARTED|Overall Study||7
569601|NCT00614926|1389961|P1|STARTED|Overall Study||25
569602|NCT00614913|1389969|P1|NOT COMPLETED|Overall Study||0
569603|NCT00614913|1389969|P1|COMPLETED|Overall Study||76
569604|NCT00614913|1389969|P1|STARTED|Overall Study||76
569605|NCT00614874|1389974|P1|NOT COMPLETED|Overall Study||2
569606|NCT00614874|1389974|P1|COMPLETED|Overall Study||14
569607|NCT00614874|1389974|P1|STARTED|Overall Study||16
569608|NCT00614744|1389983|P2|NOT COMPLETED|Overall Study||6
569609|NCT00614744|1389984|P1|NOT COMPLETED|Overall Study||5
569610|NCT00614744|1389983|P2|COMPLETED|Overall Study||79
569611|NCT00614744|1389984|P1|COMPLETED|Overall Study||78
569612|NCT00614744|1389983|P2|STARTED|Overall Study||85
569613|NCT00614744|1389984|P1|STARTED|Overall Study||83
569614|NCT00614614|1390010|P5|NOT COMPLETED|Booster Vaccination Phase||13
569615|NCT00614614|1390011|P4|NOT COMPLETED|Booster Vaccination Phase||19
569616|NCT00614614|1390012|P3|NOT COMPLETED|Booster Vaccination Phase||27
569617|NCT00614614|1390013|P2|NOT COMPLETED|Booster Vaccination Phase||6
569618|NCT00614614|1390014|P1|NOT COMPLETED|Booster Vaccination Phase||0
569619|NCT00614614|1390010|P5|COMPLETED|Booster Vaccination Phase||396
569620|NCT00614614|1390011|P4|COMPLETED|Booster Vaccination Phase||210
569621|NCT00614614|1390012|P3|COMPLETED|Booster Vaccination Phase||405
569622|NCT00614614|1390013|P2|COMPLETED|Booster Vaccination Phase||227
569623|NCT00614614|1390014|P1|COMPLETED|Booster Vaccination Phase|Menhibrix 1 Group was re-randomized to Nimenrix 1,Menhibrix 2 and Nimenrix 2 Groups in booster phase|0
569624|NCT00614614|1390010|P5|STARTED|Booster Vaccination Phase||409
569625|NCT00614614|1390011|P4|STARTED|Booster Vaccination Phase||229
569626|NCT00614614|1390012|P3|STARTED|Booster Vaccination Phase||432
569627|NCT00614614|1390013|P2|STARTED|Booster Vaccination Phase||233
569628|NCT00614614|1390014|P1|STARTED|Booster Vaccination Phase|Menhibrix 1 Group was re-randomized to Nimenrix 1,Menhibrix 2 and Nimenrix 2 Groups in booster phase|0
569629|NCT00614614|1390010|P5|NOT COMPLETED|Primary Vaccination Phase||0
569630|NCT00614614|1390011|P4|NOT COMPLETED|Primary Vaccination Phase||0
569631|NCT00614614|1390012|P3|NOT COMPLETED|Primary Vaccination Phase||0
569632|NCT00614614|1390013|P2|NOT COMPLETED|Primary Vaccination Phase||17
569633|NCT00614614|1390014|P1|NOT COMPLETED|Primary Vaccination Phase||90
569634|NCT00614614|1390010|P5|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
569635|NCT00614614|1390011|P4|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
569636|NCT00614614|1390012|P3|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
569637|NCT00614614|1390013|P2|COMPLETED|Primary Vaccination Phase||265
569638|NCT00614614|1390014|P1|COMPLETED|Primary Vaccination Phase||1182
569639|NCT00614614|1390010|P5|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
569640|NCT00614614|1390011|P4|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
569641|NCT00614614|1390012|P3|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
569642|NCT00614614|1390013|P2|STARTED|Primary Vaccination Phase||282
569643|NCT00614614|1390014|P1|STARTED|Primary Vaccination Phase||1272
569644|NCT00614575|1390137|P1|NOT COMPLETED|Overall Study||228
569645|NCT00614575|1390137|P1|COMPLETED|Overall Study||861
569646|NCT00614575|1390137|P1|STARTED|Overall Study|The number of patients enrolled.|1089
569647|NCT00614523|1390148|P2|NOT COMPLETED|Overall Study||131
569648|NCT00614523|1390149|P1|NOT COMPLETED|Overall Study||63
569649|NCT00614523|1390148|P2|COMPLETED|Overall Study||36
569650|NCT00614523|1390149|P1|COMPLETED|Overall Study||20
569651|NCT00614523|1390148|P2|STARTED|Overall Study||167
569652|NCT00614523|1390149|P1|STARTED|Overall Study||83
569653|NCT00614484|1390173|P1|NOT COMPLETED|Overall Study||0
569654|NCT00614484|1390173|P1|COMPLETED|Overall Study||28
569655|NCT00614484|1390173|P1|STARTED|Overall Study||28
569656|NCT00614458|1390178|P1|NOT COMPLETED|Overall Study||0
569657|NCT00614458|1390178|P1|COMPLETED|Overall Study||6
569658|NCT00614458|1390178|P1|STARTED|Overall Study||6
569659|NCT00614445|1390184|P2|NOT COMPLETED|Overall Study||49
569660|NCT00614445|1390185|P1|NOT COMPLETED|Overall Study||28
569661|NCT00614445|1390184|P2|COMPLETED|Overall Study||91
569662|NCT00614445|1390185|P1|COMPLETED|Overall Study||112
569663|NCT00614445|1390184|P2|STARTED|Overall Study||140
569664|NCT00614445|1390185|P1|STARTED|Overall Study||140
569665|NCT00614406|1390193|P2|NOT COMPLETED|Overall Study||0
569666|NCT00614406|1390194|P1|NOT COMPLETED|Overall Study||0
569667|NCT00614406|1390193|P2|COMPLETED|Overall Study||4
569668|NCT00614406|1390194|P1|COMPLETED|Overall Study||7
569669|NCT00614406|1390193|P2|STARTED|Overall Study||4
569670|NCT00614406|1390194|P1|STARTED|Overall Study||7
569671|NCT00614393|1390205|P5|NOT COMPLETED|Overall Study||180
569672|NCT00614393|1390206|P4|NOT COMPLETED|Overall Study||180
569673|NCT00614393|1390207|P3|NOT COMPLETED|Overall Study||10
569674|NCT00614393|1390208|P2|NOT COMPLETED|Overall Study||8
569675|NCT00614393|1390209|P1|NOT COMPLETED|Overall Study||180
569676|NCT00614393|1390205|P5|COMPLETED|Overall Study||0
569677|NCT00614393|1390206|P4|COMPLETED|Overall Study||0
569678|NCT00614393|1390207|P3|COMPLETED|Overall Study||0
569679|NCT00614393|1390208|P2|COMPLETED|Overall Study||0
569680|NCT00614393|1390209|P1|COMPLETED|Overall Study||0
569681|NCT00614393|1390205|P5|Treated|Overall Study||178
569682|NCT00614393|1390206|P4|Treated|Overall Study||180
569683|NCT00614393|1390207|P3|Treated|Overall Study||10
569684|NCT00614393|1390208|P2|Treated|Overall Study||8
569685|NCT00614393|1390209|P1|Treated|Overall Study||180
569686|NCT00614393|1390205|P5|STARTED|Overall Study||180
569687|NCT00614393|1390206|P4|STARTED|Overall Study||180
569688|NCT00614393|1390207|P3|STARTED|Overall Study||10
569689|NCT00614393|1390208|P2|STARTED|Overall Study||8
569690|NCT00614393|1390209|P1|STARTED|Overall Study||180
569691|NCT00614380|1390255|P4|NOT COMPLETED|Overall Study||2
569692|NCT00614380|1390256|P3|NOT COMPLETED|Overall Study||1
569693|NCT00614380|1390257|P2|NOT COMPLETED|Overall Study||8
569694|NCT00614380|1390258|P1|NOT COMPLETED|Overall Study||35
569695|NCT00614380|1390255|P4|COMPLETED|Overall Study||179
569696|NCT00614380|1390256|P3|COMPLETED|Overall Study||24
569697|NCT00614380|1390257|P2|COMPLETED|Overall Study||198
569698|NCT00614380|1390258|P1|COMPLETED|Overall Study||529
569699|NCT00614380|1390255|P4|STARTED|Overall Study||181
569700|NCT00614380|1390256|P3|STARTED|Overall Study||25
569701|NCT00614380|1390257|P2|STARTED|Overall Study||206
569702|NCT00614380|1390258|P1|STARTED|Overall Study||564
569703|NCT00614315|1390307|P1|NOT COMPLETED|Overall Study||0
569704|NCT00614315|1390307|P1|COMPLETED|Overall Study||30
569705|NCT00614315|1390307|P1|STARTED|Overall Study||30
569706|NCT00614198|1390314|P2|NOT COMPLETED|Stage 2||12
569707|NCT00614198|1390315|P1|NOT COMPLETED|Stage 2||8
569708|NCT00614198|1390314|P2|COMPLETED|Stage 2||17
569709|NCT00614198|1390315|P1|COMPLETED|Stage 2||18
569710|NCT00614198|1390314|P2|STARTED|Stage 2|Reallocated to gluten- and casein-free dietary intervention|29
569711|NCT00614198|1390315|P1|STARTED|Stage 2||26
569712|NCT00614198|1390314|P2|NOT COMPLETED|Stage 1||5
569713|NCT00614198|1390315|P1|NOT COMPLETED|Stage 1||12
569714|NCT00614198|1390314|P2|COMPLETED|Stage 1||29
569715|NCT00614198|1390315|P1|COMPLETED|Stage 1||26
569716|NCT00614198|1390314|P2|STARTED|Stage 1||34
569717|NCT00614198|1390315|P1|STARTED|Stage 1||38
569718|NCT00614120|1390325|P4|NOT COMPLETED|Overall Study||16
569719|NCT00614120|1390326|P3|NOT COMPLETED|Overall Study||59
569720|NCT00614120|1390327|P2|NOT COMPLETED|Overall Study||46
569721|NCT00614120|1390328|P1|NOT COMPLETED|Overall Study||29
569722|NCT00614120|1390325|P4|COMPLETED|Overall Study||215
569723|NCT00614120|1390326|P3|COMPLETED|Overall Study||175
569724|NCT00614120|1390327|P2|COMPLETED|Overall Study||187
569725|NCT00614120|1390328|P1|COMPLETED|Overall Study||202
569726|NCT00614120|1390325|P4|Exposed to Study Drug|Overall Study||231
569727|NCT00614120|1390326|P3|Exposed to Study Drug|Overall Study|Subject withdrew before exposure to study products, and thus not included in full analysis set.|233
569728|NCT00614120|1390327|P2|Exposed to Study Drug|Overall Study||233
569729|NCT00614120|1390328|P1|Exposed to Study Drug|Overall Study||231
569730|NCT00614120|1390325|P4|STARTED|Overall Study|Randomised|231
569731|NCT00614120|1390326|P3|STARTED|Overall Study|Randomised|234
569732|NCT00614120|1390327|P2|STARTED|Overall Study|Randomised|233
569733|NCT00614120|1390328|P1|STARTED|Overall Study|Randomised|231
569734|NCT00614055|1390369|P3|NOT COMPLETED|Overall Study||5
569735|NCT00614055|1390370|P2|NOT COMPLETED|Overall Study||6
569736|NCT00614055|1390371|P1|NOT COMPLETED|Overall Study||4
569737|NCT00614055|1390369|P3|COMPLETED|Overall Study||55
569738|NCT00614055|1390370|P2|COMPLETED|Overall Study||53
569739|NCT00614055|1390371|P1|COMPLETED|Overall Study||55
569740|NCT00614055|1390369|P3|Exposed|Overall Study||60
569741|NCT00614055|1390370|P2|Exposed|Overall Study||59
569742|NCT00614055|1390371|P1|Exposed|Overall Study||59
569743|NCT00614055|1390369|P3|STARTED|Overall Study||60
569744|NCT00614055|1390370|P2|STARTED|Overall Study||59
569745|NCT00614055|1390371|P1|STARTED|Overall Study||59
569746|NCT00613951|1390418|P3|NOT COMPLETED|Overall Study||5
569747|NCT00613951|1390419|P2|NOT COMPLETED|Overall Study||5
569748|NCT00613951|1390420|P1|NOT COMPLETED|Overall Study||7
569749|NCT00613951|1390418|P3|COMPLETED|Overall Study||57
569750|NCT00613951|1390419|P2|COMPLETED|Overall Study||54
569751|NCT00613951|1390420|P1|COMPLETED|Overall Study||54
569752|NCT00613951|1390418|P3|Exposed|Overall Study||62
569753|NCT00613951|1390419|P2|Exposed|Overall Study||59
569754|NCT00613951|1390420|P1|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|60
569755|NCT00613951|1390418|P3|STARTED|Overall Study||62
569756|NCT00613951|1390419|P2|STARTED|Overall Study||59
569757|NCT00613951|1390420|P1|STARTED|Overall Study||61
569758|NCT00613938|1390465|P4|NOT COMPLETED|Overall Study||26
569759|NCT00613938|1390466|P3|NOT COMPLETED|Overall Study||23
569760|NCT00613938|1390467|P2|NOT COMPLETED|Overall Study||28
569761|NCT00613938|1390468|P1|NOT COMPLETED|Overall Study||20
569762|NCT00613938|1390465|P4|COMPLETED|Overall Study||253
569763|NCT00613938|1390466|P3|COMPLETED|Overall Study||255
569764|NCT00613938|1390467|P2|COMPLETED|Overall Study||247
569765|NCT00613938|1390468|P1|COMPLETED|Overall Study||49
569766|NCT00613938|1390465|P4|STARTED|Overall Study|one patient did not have a valid baseline score therefore excluded from above|279
569767|NCT00613938|1390466|P3|STARTED|Overall Study||278
569768|NCT00613938|1390467|P2|STARTED|Overall Study||275
569769|NCT00613938|1390468|P1|STARTED|Overall Study||69
569770|NCT00613925|1390500|P2|NOT COMPLETED|Overall Study||1
569771|NCT00613925|1390501|P1|NOT COMPLETED|Overall Study||0
569772|NCT00613925|1390500|P2|COMPLETED|Overall Study||32
569773|NCT00613925|1390501|P1|COMPLETED|Overall Study||37
569774|NCT00613925|1390500|P2|STARTED|Overall Study||33
569775|NCT00613925|1390501|P1|STARTED|Overall Study||37
569776|NCT00613821|1390511|P2|NOT COMPLETED|Overall Study||1
569777|NCT00613821|1390512|P1|NOT COMPLETED|Overall Study||2
569778|NCT00613821|1390511|P2|COMPLETED|Overall Study||39
569779|NCT00613821|1390512|P1|COMPLETED|Overall Study||38
569780|NCT00613821|1390511|P2|STARTED|Overall Study||40
569781|NCT00613821|1390512|P1|STARTED|Overall Study||40
569782|NCT00613730|1390518|P1|NOT COMPLETED|Overall Study||3
569783|NCT00613730|1390518|P1|COMPLETED|Overall Study||0
569784|NCT00613730|1390518|P1|STARTED|Overall Study||3
569785|NCT00613626|1390527|P3|NOT COMPLETED|Overall Study||0
569786|NCT00613626|1390528|P2|NOT COMPLETED|Overall Study||1
569787|NCT00613626|1390529|P1|NOT COMPLETED|Overall Study||0
569788|NCT00613626|1390527|P3|COMPLETED|Overall Study||7
569789|NCT00613626|1390528|P2|COMPLETED|Overall Study||33
569790|NCT00613626|1390529|P1|COMPLETED|Overall Study||33
569791|NCT00613626|1390527|P3|1st Dose ZD6474|Overall Study||7
569792|NCT00613626|1390528|P2|1st Dose ZD6474|Overall Study||34
569793|NCT00613626|1390529|P1|1st Dose ZD6474|Overall Study||33
569794|NCT00613626|1390527|P3|STARTED|Overall Study|These participants provided the toxicity data to determine if ZD6474+Etopiside+Cisplatin was safe.|7
569795|NCT00613626|1390528|P2|STARTED|Overall Study||34
569796|NCT00613626|1390529|P1|STARTED|Overall Study||33
569797|NCT00613574|1390545|P1|NOT COMPLETED|Overall Study||6
569798|NCT00613574|1390545|P1|COMPLETED|Overall Study||401
569799|NCT00613574|1390545|P1|STARTED|Overall Study||407
569800|NCT00613509|1390557|P2|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0
569801|NCT00613509|1390558|P1|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0
569802|NCT00613509|1390557|P2|COMPLETED|Cycle 2 (Group 2 = Crossover)||4
569803|NCT00613509|1390558|P1|COMPLETED|Cycle 2 (Group 2 = Crossover)||11
569804|NCT00613509|1390557|P2|STARTED|Cycle 2 (Group 2 = Crossover)||4
569805|NCT00613509|1390558|P1|STARTED|Cycle 2 (Group 2 = Crossover)||11
569806|NCT00613509|1390557|P2|NOT COMPLETED|Cycle 1||8
569807|NCT00613509|1390558|P1|NOT COMPLETED|Cycle 1||5
569808|NCT00613509|1390557|P2|COMPLETED|Cycle 1|Completion of Cycle 1. 12 participants were deemed evaluable|4
569809|NCT00613509|1390558|P1|COMPLETED|Cycle 1|Completion of Cycle 1. 9 participants were deemed evaluable|6
569810|NCT00613509|1390557|P2|STARTED|Cycle 1||12
569811|NCT00613509|1390558|P1|STARTED|Cycle 1||11
569812|NCT00613405|1390582|P2|NOT COMPLETED|Overall Study||0
569813|NCT00613405|1390583|P1|NOT COMPLETED|Overall Study||0
569814|NCT00613405|1390582|P2|COMPLETED|Overall Study||42
569815|NCT00613405|1390583|P1|COMPLETED|Overall Study||45
569816|NCT00613405|1390582|P2|STARTED|Overall Study||42
569817|NCT00613405|1390583|P1|STARTED|Overall Study||45
569818|NCT00613379|1390592|P3|NOT COMPLETED|Overall Study||0
569819|NCT00613379|1390593|P2|NOT COMPLETED|Overall Study||0
569820|NCT00613379|1390594|P1|NOT COMPLETED|Overall Study||0
569821|NCT00613379|1390592|P3|COMPLETED|Overall Study||11
569822|NCT00613379|1390593|P2|COMPLETED|Overall Study||10
569823|NCT00613379|1390594|P1|COMPLETED|Overall Study||10
569824|NCT00613379|1390592|P3|STARTED|Overall Study||11
569825|NCT00613379|1390593|P2|STARTED|Overall Study||10
569826|NCT00613379|1390594|P1|STARTED|Overall Study||10
569827|NCT00613366|1390604|P2|NOT COMPLETED|Overall Study||2
569828|NCT00613366|1390605|P1|NOT COMPLETED|Overall Study||3
569829|NCT00613366|1390604|P2|COMPLETED|Overall Study||18
569830|NCT00613366|1390605|P1|COMPLETED|Overall Study||17
569831|NCT00613366|1390604|P2|STARTED|Overall Study||20
569832|NCT00613366|1390605|P1|STARTED|Overall Study||20
569833|NCT00613327|1390613|P1|NOT COMPLETED|Overall Study||101
569834|NCT00613327|1390613|P1|COMPLETED|Overall Study||244
569835|NCT00613327|1390613|P1|STARTED|Overall Study||345
569836|NCT00613314|1390632|P1|NOT COMPLETED|Overall Study||155
569837|NCT00613314|1390632|P1|COMPLETED|Overall Study||15113
569838|NCT00613314|1390632|P1|STARTED|Overall Study||15268
569839|NCT00613301|1390640|P1|NOT COMPLETED|Overall Study||228
569840|NCT00613301|1390640|P1|COMPLETED|Overall Study||188
569841|NCT00613301|1390640|P1|STARTED|Overall Study||416
569842|NCT00613106|1390649|P2|NOT COMPLETED|Overall Study||9
569843|NCT00613106|1390650|P1|NOT COMPLETED|Overall Study||20
569844|NCT00613106|1390649|P2|COMPLETED|Overall Study||38
569845|NCT00613106|1390650|P1|COMPLETED|Overall Study||112
569846|NCT00613106|1390649|P2|STARTED|Overall Study||47
569847|NCT00613106|1390650|P1|STARTED|Overall Study||132
569848|NCT00613080|1390656|P1|NOT COMPLETED|Overall Study||11
569849|NCT00613080|1390656|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|68
569850|NCT00613080|1390656|P1|STARTED|Overall Study||79
569851|NCT00613028|1390662|P2|NOT COMPLETED|Overall Study||1
569852|NCT00613028|1390663|P1|NOT COMPLETED|Overall Study||0
569853|NCT00613028|1390662|P2|COMPLETED|Overall Study||12
569854|NCT00613028|1390663|P1|COMPLETED|Overall Study||10
569855|NCT00613028|1390662|P2|STARTED|Overall Study||13
569856|NCT00613028|1390663|P1|STARTED|Overall Study||10
569857|NCT00613015|1390683|P6|NOT COMPLETED|Overall Study||3
569858|NCT00613015|1390684|P5|NOT COMPLETED|Overall Study||2
569859|NCT00613015|1390685|P4|NOT COMPLETED|Overall Study||3
569860|NCT00613015|1390686|P3|NOT COMPLETED|Overall Study||3
569861|NCT00613015|1390687|P2|NOT COMPLETED|Overall Study||1
569862|NCT00613015|1390688|P1|NOT COMPLETED|Overall Study||0
569863|NCT00613015|1390683|P6|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|16
569864|NCT00613015|1390684|P5|COMPLETED|Overall Study|Two participants did not complete one-week follow-up visit.|13
569865|NCT00613015|1390685|P4|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|21
569866|NCT00613015|1390686|P3|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|23
569867|NCT00613015|1390687|P2|COMPLETED|Overall Study|One participant did not complete the one-week follow-up visit.|11
569868|NCT00613015|1390688|P1|COMPLETED|Overall Study||13
569869|NCT00613015|1390683|P6|STARTED|Overall Study||19
569870|NCT00613015|1390684|P5|STARTED|Overall Study||15
569871|NCT00613015|1390685|P4|STARTED|Overall Study||24
569872|NCT00613015|1390686|P3|STARTED|Overall Study||26
569873|NCT00613015|1390687|P2|STARTED|Overall Study||12
569874|NCT00613015|1390688|P1|STARTED|Overall Study||13
569875|NCT00612924|1390710|P2|NOT COMPLETED|Overall Study||9
569876|NCT00612924|1390711|P1|NOT COMPLETED|Overall Study||7
569877|NCT00612924|1390710|P2|COMPLETED|Overall Study||85
569878|NCT00612924|1390711|P1|COMPLETED|Overall Study||94
569879|NCT00612924|1390710|P2|STARTED|Overall Study||94
569880|NCT00612924|1390711|P1|STARTED|Overall Study||101
569881|NCT00612807|1390724|P2|NOT COMPLETED|Overall Study||0
569882|NCT00612807|1390725|P1|NOT COMPLETED|Overall Study||2
569883|NCT00612807|1390724|P2|COMPLETED|Overall Study||28
569884|NCT00612807|1390725|P1|COMPLETED|Overall Study||12
569885|NCT00612807|1390724|P2|STARTED|Overall Study||28
569886|NCT00612807|1390725|P1|STARTED|Overall Study||14
569887|NCT00612768|1390733|P1|NOT COMPLETED|Overall Study||0
569888|NCT00612768|1390733|P1|COMPLETED|Overall Study||50
569889|NCT00612768|1390733|P1|STARTED|Overall Study||50
569890|NCT00612690|1390760|P2|NOT COMPLETED|Overall Study||118
569891|NCT00612690|1390761|P1|NOT COMPLETED|Overall Study||115
569892|NCT00612690|1390760|P2|COMPLETED|Overall Study||89
569893|NCT00612690|1390761|P1|COMPLETED|Overall Study||160
569894|NCT00612690|1390760|P2|STARTED|Overall Study||207
569895|NCT00612690|1390761|P1|STARTED|Overall Study||275
569896|NCT00612677|1390769|P1|NOT COMPLETED|Overall Study||1
569897|NCT00612677|1390769|P1|COMPLETED|Overall Study||0
569898|NCT00612677|1390769|P1|STARTED|Overall Study||1
569899|NCT00612573|1390779|P4|NOT COMPLETED|Overall Study||13
569900|NCT00612573|1390780|P3|NOT COMPLETED|Overall Study||9
569901|NCT00612573|1390781|P2|NOT COMPLETED|Overall Study||14
569902|NCT00612573|1390782|P1|NOT COMPLETED|Overall Study||12
569903|NCT00612573|1390779|P4|COMPLETED|Overall Study||54
569904|NCT00612573|1390780|P3|COMPLETED|Overall Study||52
569905|NCT00612573|1390781|P2|COMPLETED|Overall Study||51
569906|NCT00612573|1390782|P1|COMPLETED|Overall Study||52
569907|NCT00612573|1390779|P4|STARTED|Overall Study||67
569908|NCT00612573|1390780|P3|STARTED|Overall Study||61
569909|NCT00612573|1390781|P2|STARTED|Overall Study||65
569910|NCT00612573|1390782|P1|STARTED|Overall Study||64
569911|NCT00612560|1390808|P4|NOT COMPLETED|Overall Study||0
569912|NCT00612560|1390809|P3|NOT COMPLETED|Overall Study||0
569913|NCT00612560|1390810|P2|NOT COMPLETED|Overall Study||0
569914|NCT00612560|1390811|P1|NOT COMPLETED|Overall Study||0
569915|NCT00612560|1390808|P4|COMPLETED|Overall Study||6
569916|NCT00612560|1390809|P3|COMPLETED|Overall Study||8
569917|NCT00612560|1390810|P2|COMPLETED|Overall Study||7
569918|NCT00612560|1390811|P1|COMPLETED|Overall Study||7
569919|NCT00612560|1390808|P4|STARTED|Overall Study||6
569920|NCT00612560|1390809|P3|STARTED|Overall Study||8
569921|NCT00612560|1390810|P2|STARTED|Overall Study||7
569922|NCT00612560|1390811|P1|STARTED|Overall Study||7
569923|NCT00612534|1390837|P4|NOT COMPLETED|Overall Study||17
569924|NCT00612534|1390838|P3|NOT COMPLETED|Overall Study||7
569925|NCT00612534|1390839|P2|NOT COMPLETED|Overall Study||17
569926|NCT00612534|1390840|P1|NOT COMPLETED|Overall Study||13
569927|NCT00612534|1390837|P4|COMPLETED|Overall Study||7
569928|NCT00612534|1390838|P3|COMPLETED|Overall Study||13
569929|NCT00612534|1390839|P2|COMPLETED|Overall Study||9
569930|NCT00612534|1390840|P1|COMPLETED|Overall Study||11
569931|NCT00612534|1390837|P4|STARTED|Overall Study||24
569932|NCT00612534|1390838|P3|STARTED|Overall Study||20
569933|NCT00612534|1390839|P2|STARTED|Overall Study||26
569934|NCT00612534|1390840|P1|STARTED|Overall Study||24
569935|NCT00612508|1390852|P2|NOT COMPLETED|Overall Study||4
569936|NCT00612508|1390853|P1|NOT COMPLETED|Overall Study||3
569937|NCT00612508|1390852|P2|COMPLETED|Overall Study|6 nuvaring users returned for the 84 day biopsy|3
569938|NCT00612508|1390853|P1|COMPLETED|Overall Study|5 desogen users returned for the 84 day biopsy|4
569939|NCT00612508|1390852|P2|STARTED|Overall Study||7
569940|NCT00612508|1390853|P1|STARTED|Overall Study||7
569941|NCT00612456|1390864|P3|NOT COMPLETED|Overall Study||0
569942|NCT00612456|1390865|P2|NOT COMPLETED|Overall Study||2
569943|NCT00612456|1390866|P1|NOT COMPLETED|Overall Study||2
569944|NCT00612456|1390864|P3|COMPLETED|Overall Study||16
569945|NCT00612456|1390865|P2|COMPLETED|Overall Study||25
569946|NCT00612456|1390866|P1|COMPLETED|Overall Study||25
569947|NCT00612456|1390864|P3|STARTED|Overall Study||16
569948|NCT00612456|1390865|P2|STARTED|Overall Study||27
569949|NCT00612456|1390866|P1|STARTED|Overall Study||27
569950|NCT00612430|1390912|P2|NOT COMPLETED|Overall Study||0
569951|NCT00612430|1390913|P1|NOT COMPLETED|Overall Study||0
569952|NCT00612430|1390912|P2|COMPLETED|Overall Study||27
569953|NCT00612430|1390913|P1|COMPLETED|Overall Study||32
569954|NCT00612430|1390912|P2|STARTED|Overall Study||27
569955|NCT00612430|1390913|P1|STARTED|Overall Study||32
569956|NCT00612352|1390929|P2|NOT COMPLETED|Overall Study||6
569957|NCT00612352|1390930|P1|NOT COMPLETED|Overall Study||9
569958|NCT00612352|1390929|P2|COMPLETED|Overall Study||109
569959|NCT00612352|1390930|P1|COMPLETED|Overall Study||56
569960|NCT00612352|1390929|P2|Placebo|Overall Study||4
569961|NCT00612352|1390930|P1|Placebo|Overall Study||4
569962|NCT00612352|1390929|P2|40%mg|Overall Study||0
569963|NCT00612352|1390930|P1|40%mg|Overall Study||1
569964|NCT00612352|1390929|P2|100%mg|Overall Study||1
569965|NCT00612352|1390930|P1|100%mg|Overall Study||2
569966|NCT00612352|1390929|P2|Placebo & 100%mg|Overall Study||0
569967|NCT00612352|1390930|P1|Placebo & 100%mg|Overall Study||1
569968|NCT00612352|1390929|P2|40%mg & 100%mg|Overall Study||1
569969|NCT00612352|1390930|P1|40%mg & 100%mg|Overall Study||1
569970|NCT00612352|1390929|P2|STARTED|Overall Study||115
569971|NCT00612352|1390930|P1|STARTED|Overall Study||65
569972|NCT00612339|1391044|P1|NOT COMPLETED|Overall Study||0
569973|NCT00612339|1391044|P1|COMPLETED|Overall Study||41
569974|NCT00612339|1391044|P1|STARTED|Overall Study||41
569975|NCT00612313|1391050|P2|NOT COMPLETED|Overall Study||13
569976|NCT00612313|1391051|P1|NOT COMPLETED|Overall Study||17
569977|NCT00612313|1391050|P2|COMPLETED|Overall Study||62
569978|NCT00612313|1391051|P1|COMPLETED|Overall Study||52
569979|NCT00612313|1391050|P2|STARTED|Overall Study||75
569980|NCT00612313|1391051|P1|STARTED|Overall Study||69
569981|NCT00612222|1391067|P1|NOT COMPLETED|Overall Study||0
569982|NCT00612222|1391067|P1|COMPLETED|Overall Study||4
569983|NCT00612222|1391067|P1|STARTED|Overall Study||4
569984|NCT00612105|1391075|P2|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||0
569985|NCT00612105|1391076|P1|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||1
569986|NCT00612105|1391075|P2|COMPLETED|Period Title 3: 3-Week Taper Phase||58
569987|NCT00612105|1391076|P1|COMPLETED|Period Title 3: 3-Week Taper Phase||85
569988|NCT00612105|1391075|P2|STARTED|Period Title 3: 3-Week Taper Phase|Includes participants who discontinued during the titration phase and entered taper phase.|58
569989|NCT00612105|1391076|P1|STARTED|Period Title 3: 3-Week Taper Phase|Includes participants who discontinued during the titration phase and entered taper phase.|86
569990|NCT00612105|1391075|P2|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||2
569991|NCT00612105|1391076|P1|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||11
569992|NCT00612105|1391075|P2|COMPLETED|Period Title 2: 4-Week Maintenance Phase||55
569993|NCT00612105|1391076|P1|COMPLETED|Period Title 2: 4-Week Maintenance Phase||78
569994|NCT00612105|1391075|P2|STARTED|Period Title 2: 4-Week Maintenance Phase||57
569995|NCT00612105|1391076|P1|STARTED|Period Title 2: 4-Week Maintenance Phase||89
569996|NCT00612105|1391075|P2|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||5
569997|NCT00612105|1391076|P1|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||36
569998|NCT00612105|1391075|P2|COMPLETED|Period Title 1: 6-Week Titration Phase||57
569999|NCT00612105|1391076|P1|COMPLETED|Period Title 1: 6-Week Titration Phase||89
570000|NCT00612105|1391075|P2|STARTED|Period Title 1: 6-Week Titration Phase||62
570001|NCT00612105|1391076|P1|STARTED|Period Title 1: 6-Week Titration Phase||125
570002|NCT00612066|1391126|P1|NOT COMPLETED|Overall Study||1
570003|NCT00612066|1391126|P1|COMPLETED|Overall Study||1
570004|NCT00612066|1391126|P1|STARTED|Overall Study||2
570005|NCT00612040|1391133|P3|NOT COMPLETED|Overall Study||7
570006|NCT00612040|1391134|P2|NOT COMPLETED|Overall Study||7
570007|NCT00612040|1391135|P1|NOT COMPLETED|Overall Study||5
570008|NCT00612040|1391133|P3|COMPLETED|Overall Study||52
570009|NCT00612040|1391134|P2|COMPLETED|Overall Study||52
570010|NCT00612040|1391135|P1|COMPLETED|Overall Study||55
570011|NCT00612040|1391133|P3|Exposed|Overall Study||59
570012|NCT00612040|1391134|P2|Exposed|Overall Study||59
570013|NCT00612040|1391135|P1|Exposed|Overall Study||60
570014|NCT00612040|1391133|P3|STARTED|Overall Study||59
570015|NCT00612040|1391134|P2|STARTED|Overall Study||59
570016|NCT00612040|1391135|P1|STARTED|Overall Study||60
570017|NCT00611897|1391179|P2|NOT COMPLETED|Day 2: Crossover Treatment||0
570018|NCT00611897|1391180|P1|NOT COMPLETED|Day 2: Crossover Treatment||0
570019|NCT00611897|1391179|P2|COMPLETED|Day 2: Crossover Treatment||8
570020|NCT00611897|1391180|P1|COMPLETED|Day 2: Crossover Treatment||8
570021|NCT00611897|1391179|P2|STARTED|Day 2: Crossover Treatment||8
570022|NCT00611897|1391180|P1|STARTED|Day 2: Crossover Treatment||8
570023|NCT00611897|1391179|P2|NOT COMPLETED|Day 1: Initial Treatment||0
570024|NCT00611897|1391180|P1|NOT COMPLETED|Day 1: Initial Treatment||0
570025|NCT00611897|1391179|P2|COMPLETED|Day 1: Initial Treatment||8
570026|NCT00611897|1391180|P1|COMPLETED|Day 1: Initial Treatment||8
570027|NCT00611897|1391179|P2|STARTED|Day 1: Initial Treatment||8
570028|NCT00611897|1391180|P1|STARTED|Day 1: Initial Treatment||8
570029|NCT00611884|1391208|P4|NOT COMPLETED|Overall Study||6
570030|NCT00611884|1391209|P3|NOT COMPLETED|Overall Study||4
570031|NCT00611884|1391210|P2|NOT COMPLETED|Overall Study||9
570032|NCT00611884|1391211|P1|NOT COMPLETED|Overall Study||9
570033|NCT00611884|1391208|P4|COMPLETED|Overall Study||56
570034|NCT00611884|1391209|P3|COMPLETED|Overall Study||58
570035|NCT00611884|1391210|P2|COMPLETED|Overall Study||51
570036|NCT00611884|1391211|P1|COMPLETED|Overall Study||52
570037|NCT00611884|1391208|P4|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|61
570038|NCT00611884|1391209|P3|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|61
570039|NCT00611884|1391210|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|59
570040|NCT00611884|1391211|P1|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug|58
570041|NCT00611884|1391208|P4|STARTED|Overall Study||62
570042|NCT00611884|1391209|P3|STARTED|Overall Study||62
570043|NCT00611884|1391210|P2|STARTED|Overall Study||60
570044|NCT00611884|1391211|P1|STARTED|Overall Study||61
570045|NCT00611806|1391267|P2|NOT COMPLETED|Overall Study||3
570046|NCT00611806|1391268|P1|NOT COMPLETED|Overall Study||16
570047|NCT00611806|1391267|P2|COMPLETED|Overall Study||43
570048|NCT00611806|1391268|P1|COMPLETED|Overall Study||78
570049|NCT00611806|1391267|P2|STARTED|Overall Study||46
570050|NCT00611806|1391268|P1|STARTED|Overall Study||94
570051|NCT00611767|1391282|P2|NOT COMPLETED|Overall Study||2
570052|NCT00611767|1391283|P1|NOT COMPLETED|Overall Study||9
570053|NCT00611767|1391282|P2|COMPLETED|Overall Study||22
570054|NCT00611767|1391283|P1|COMPLETED|Overall Study||40
570055|NCT00611767|1391282|P2|Placebo Test Day|Overall Study||1
570056|NCT00611767|1391283|P1|Placebo Test Day|Overall Study||6
570057|NCT00611767|1391282|P2|Thiopental Test Day|Overall Study||1
570058|NCT00611767|1391283|P1|Thiopental Test Day|Overall Study||3
570059|NCT00611767|1391282|P2|STARTED|Overall Study||24
570060|NCT00611767|1391283|P1|STARTED|Overall Study||49
570061|NCT00611715|1391445|P2|NOT COMPLETED|Overall Study||6
570062|NCT00611715|1391446|P1|NOT COMPLETED|Overall Study||41
570063|NCT00611715|1391445|P2|COMPLETED|Overall Study||0
570064|NCT00611715|1391446|P1|COMPLETED|Overall Study|"2 pts in Arm 1 remain on-tx. They are not accounted for in off-tx reasonor completed data fields"|1
570065|NCT00611715|1391445|P2|STARTED|Overall Study||6
570066|NCT00611715|1391446|P1|STARTED|Overall Study||42
570067|NCT00611624|1391458|P1|NOT COMPLETED|Overall Study||0
570068|NCT00611624|1391458|P1|COMPLETED|Overall Study||28
570069|NCT00611624|1391458|P1|STARTED|Overall Study||28
570070|NCT00611559|1391466|P3|NOT COMPLETED|Overall Study||1
570071|NCT00611559|1391467|P2|NOT COMPLETED|Overall Study||1
570072|NCT00611559|1391468|P1|NOT COMPLETED|Overall Study||1
570073|NCT00611559|1391466|P3|COMPLETED|Overall Study||56
570074|NCT00611559|1391467|P2|COMPLETED|Overall Study||114
570075|NCT00611559|1391468|P1|COMPLETED|Overall Study||110
570076|NCT00611559|1391466|P3|STARTED|Overall Study||57
570077|NCT00611559|1391467|P2|STARTED|Overall Study||115
570078|NCT00611559|1391468|P1|STARTED|Overall Study||111
570079|NCT00611533|1391527|P2|NOT COMPLETED|Second Intervention (6 Weeks)||2
570080|NCT00611533|1391528|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
570081|NCT00611533|1391527|P2|COMPLETED|Second Intervention (6 Weeks)||4
570082|NCT00611533|1391528|P1|COMPLETED|Second Intervention (6 Weeks)||8
570083|NCT00611533|1391527|P2|STARTED|Second Intervention (6 Weeks)||6
570084|NCT00611533|1391528|P1|STARTED|Second Intervention (6 Weeks)||8
570085|NCT00611533|1391527|P2|NOT COMPLETED|First Intervention (6 Weeks)||2
570086|NCT00611533|1391528|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
570087|NCT00611533|1391527|P2|COMPLETED|First Intervention (6 Weeks)||6
570088|NCT00611533|1391528|P1|COMPLETED|First Intervention (6 Weeks)||8
570089|NCT00611533|1391527|P2|STARTED|First Intervention (6 Weeks)||8
570090|NCT00611533|1391528|P1|STARTED|First Intervention (6 Weeks)||8
570091|NCT00611468|1391547|P4|NOT COMPLETED|Overall Study||0
570092|NCT00611468|1391548|P3|NOT COMPLETED|Overall Study||0
570093|NCT00611468|1391549|P2|NOT COMPLETED|Overall Study||1
570094|NCT00611468|1391550|P1|NOT COMPLETED|Overall Study||0
570095|NCT00611468|1391547|P4|COMPLETED|Overall Study||13
570096|NCT00611468|1391548|P3|COMPLETED|Overall Study||6
570097|NCT00611468|1391549|P2|COMPLETED|Overall Study|One subject did not complete Cycle 1 of treatment and was replaced.|6
570098|NCT00611468|1391550|P1|COMPLETED|Overall Study||3
570099|NCT00611468|1391547|P4|STARTED|Overall Study||13
570100|NCT00611468|1391548|P3|STARTED|Overall Study||6
570101|NCT00611468|1391549|P2|STARTED|Overall Study||7
570102|NCT00611468|1391550|P1|STARTED|Overall Study||3
570103|NCT00611455|1391562|P3|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||211
570104|NCT00611455|1391563|P2|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
570105|NCT00611455|1391564|P1|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
570106|NCT00611455|1391562|P3|COMPLETED|Follow-up Period (Approximately 2 Years)||49
570107|NCT00611455|1391563|P2|COMPLETED|Follow-up Period (Approximately 2 Years)||0
570108|NCT00611455|1391564|P1|COMPLETED|Follow-up Period (Approximately 2 Years)||0
570109|NCT00611455|1391562|P3|STARTED|Follow-up Period (Approximately 2 Years)|These participants received at least one infusion of placebo or ofatumumab.|260
570110|NCT00611455|1391563|P2|STARTED|Follow-up Period (Approximately 2 Years)||0
570111|NCT00611455|1391564|P1|STARTED|Follow-up Period (Approximately 2 Years)||0
570112|NCT00611455|1391562|P3|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
570113|NCT00611455|1391563|P2|NOT COMPLETED|OL Treatment Period (120 Weeks)||179
570114|NCT00611455|1391564|P1|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
570115|NCT00611455|1391562|P3|COMPLETED|OL Treatment Period (120 Weeks)||0
570116|NCT00611455|1391563|P2|COMPLETED|OL Treatment Period (120 Weeks)||52
570117|NCT00611455|1391564|P1|COMPLETED|OL Treatment Period (120 Weeks)||0
570118|NCT00611455|1391562|P3|STARTED|OL Treatment Period (120 Weeks)||0
570119|NCT00611455|1391563|P2|STARTED|OL Treatment Period (120 Weeks)|118 participants received OFA during the DB Period; 113 received placebo during the DB Period.|231
570120|NCT00611455|1391564|P1|STARTED|OL Treatment Period (120 Weeks)||0
570121|NCT00611455|1391562|P3|NOT COMPLETED|DB Treatment Period (24 Weeks)||0
570122|NCT00611455|1391563|P2|NOT COMPLETED|DB Treatment Period (24 Weeks)||14
570123|NCT00611455|1391564|P1|NOT COMPLETED|DB Treatment Period (24 Weeks)||13
570124|NCT00611455|1391562|P3|COMPLETED|DB Treatment Period (24 Weeks)||0
570125|NCT00611455|1391563|P2|COMPLETED|DB Treatment Period (24 Weeks)||117
570126|NCT00611455|1391564|P1|COMPLETED|DB Treatment Period (24 Weeks)||121
570127|NCT00611455|1391562|P3|STARTED|DB Treatment Period (24 Weeks)||0
570128|NCT00611455|1391563|P2|STARTED|DB Treatment Period (24 Weeks)||131
570129|NCT00611455|1391564|P1|STARTED|DB Treatment Period (24 Weeks)||134
570130|NCT00611442|1391692|P2|NOT COMPLETED|Overall Study||2
570131|NCT00611442|1391693|P1|NOT COMPLETED|Overall Study||1
570132|NCT00611442|1391692|P2|COMPLETED|Overall Study||94
570133|NCT00611442|1391693|P1|COMPLETED|Overall Study||94
570134|NCT00611442|1391692|P2|STARTED|Overall Study||96
570135|NCT00611442|1391693|P1|STARTED|Overall Study||95
570136|NCT00611403|1391707|P2|NOT COMPLETED|Post Treatment Extension Phase||1
570137|NCT00611403|1391708|P1|NOT COMPLETED|Post Treatment Extension Phase||4
570138|NCT00611403|1391707|P2|COMPLETED|Post Treatment Extension Phase||24
570139|NCT00611403|1391708|P1|COMPLETED|Post Treatment Extension Phase||22
570140|NCT00611403|1391707|P2|STARTED|Post Treatment Extension Phase|25 of 69 pts who received ENDURA® in the Treatment Phase entered the Post Treatment Extension Phase|25
570141|NCT00611403|1391708|P1|STARTED|Post Treatment Extension Phase|26 of 68 pts who received RESTASIS® in the Treatment Phase entered the Post Treatment Ext. Phase|26
570142|NCT00611403|1391707|P2|NOT COMPLETED|Treatment Phase||11
570143|NCT00611403|1391708|P1|NOT COMPLETED|Treatment Phase||6
570144|NCT00611403|1391707|P2|COMPLETED|Treatment Phase||58
570145|NCT00611403|1391708|P1|COMPLETED|Treatment Phase||62
570146|NCT00611403|1391707|P2|STARTED|Treatment Phase||69
570147|NCT00611403|1391708|P1|STARTED|Treatment Phase||68
570148|NCT00611351|1391718|P1|NOT COMPLETED|Overall Study||2
570149|NCT00611351|1391718|P1|COMPLETED|Overall Study||3
570150|NCT00611351|1391718|P1|STARTED|Overall Study||5
570151|NCT00611325|1391727|P2|NOT COMPLETED|Overall Study||0
570152|NCT00611325|1391728|P1|NOT COMPLETED|Overall Study||0
570153|NCT00611325|1391727|P2|COMPLETED|Overall Study||28
570154|NCT00611325|1391728|P1|COMPLETED|Overall Study||28
570155|NCT00611325|1391727|P2|STARTED|Overall Study||28
570156|NCT00611325|1391728|P1|STARTED|Overall Study||28
570157|NCT00611247|1391744|P2|NOT COMPLETED|Overall Study||21
570158|NCT00611247|1391745|P1|NOT COMPLETED|Overall Study||2
570159|NCT00611247|1391744|P2|COMPLETED|Overall Study||10
570160|NCT00611247|1391745|P1|COMPLETED|Overall Study||3
570161|NCT00611247|1391744|P2|STARTED|Overall Study||31
570162|NCT00611247|1391745|P1|STARTED|Overall Study||5
570163|NCT00611130|1391757|P2|NOT COMPLETED|Overall Study||47
570164|NCT00611130|1391758|P1|NOT COMPLETED|Overall Study||49
570165|NCT00611130|1391757|P2|COMPLETED|Overall Study||47
570166|NCT00611130|1391758|P1|COMPLETED|Overall Study||43
570167|NCT00611130|1391757|P2|Completed 12 Week Treatment Phase|Overall Study||64
570168|NCT00611130|1391758|P1|Completed 12 Week Treatment Phase|Overall Study||61
570169|NCT00611130|1391757|P2|STARTED|Overall Study||94
570170|NCT00611130|1391758|P1|STARTED|Overall Study||92
570171|NCT00611026|1391768|P3|NOT COMPLETED|Double-blind Treatment Period||98
570172|NCT00611026|1391769|P2|NOT COMPLETED|Double-blind Treatment Period||88
570173|NCT00611026|1391770|P1|NOT COMPLETED|Double-blind Treatment Period||47
570174|NCT00611026|1391768|P3|COMPLETED|Double-blind Treatment Period||862
570175|NCT00611026|1391769|P2|COMPLETED|Double-blind Treatment Period||885
570176|NCT00611026|1391770|P1|COMPLETED|Double-blind Treatment Period||431
570177|NCT00611026|1391768|P3|STARTED|Double-blind Treatment Period||960
570178|NCT00611026|1391769|P2|STARTED|Double-blind Treatment Period||973
570179|NCT00611026|1391770|P1|STARTED|Double-blind Treatment Period||478
570180|NCT00611026|1391768|P3|NOT COMPLETED|Randomized to Double-blind Treatment||3
570181|NCT00611026|1391769|P2|NOT COMPLETED|Randomized to Double-blind Treatment||1
570182|NCT00611026|1391770|P1|NOT COMPLETED|Randomized to Double-blind Treatment||2
570183|NCT00611026|1391768|P3|COMPLETED|Randomized to Double-blind Treatment||960
570184|NCT00611026|1391769|P2|COMPLETED|Randomized to Double-blind Treatment||973
570185|NCT00611026|1391770|P1|COMPLETED|Randomized to Double-blind Treatment||478
570186|NCT00611026|1391768|P3|STARTED|Randomized to Double-blind Treatment||963
570187|NCT00611026|1391769|P2|STARTED|Randomized to Double-blind Treatment||974
570188|NCT00611026|1391770|P1|STARTED|Randomized to Double-blind Treatment||480
570189|NCT00610987|1391836|P2|NOT COMPLETED|Overall Study||0
570190|NCT00610987|1391837|P1|NOT COMPLETED|Overall Study||0
570191|NCT00610987|1391836|P2|COMPLETED|Overall Study||71
570192|NCT00610987|1391837|P1|COMPLETED|Overall Study||75
570193|NCT00610987|1391836|P2|STARTED|Overall Study||71
570194|NCT00610987|1391837|P1|STARTED|Overall Study||75
570195|NCT00610883|1391843|P1|NOT COMPLETED|Overall Study||0
570196|NCT00610883|1391843|P1|COMPLETED|Overall Study||17
570197|NCT00610883|1391843|P1|STARTED|Overall Study||17
570198|NCT00610857|1391847|P1|NOT COMPLETED|Overall Study||2
570199|NCT00610857|1391847|P1|COMPLETED|Overall Study||35
570200|NCT00610857|1391847|P1|STARTED|Overall Study||37
570201|NCT00610740|1391854|P1|NOT COMPLETED|Overall Study||0
570202|NCT00610740|1391854|P1|COMPLETED|Overall Study||18
570203|NCT00610740|1391854|P1|STARTED|Overall Study||18
570204|NCT00610714|1391862|P2|NOT COMPLETED|Overall Study||24
570205|NCT00610714|1391863|P1|NOT COMPLETED|Overall Study||26
570206|NCT00610714|1391862|P2|COMPLETED|Overall Study||82
570207|NCT00610714|1391863|P1|COMPLETED|Overall Study||79
570208|NCT00610714|1391862|P2|STARTED|Overall Study||106
570209|NCT00610714|1391863|P1|STARTED|Overall Study||105
570210|NCT00610701|1391875|P2|NOT COMPLETED|Overall Study||11
570211|NCT00610701|1391876|P1|NOT COMPLETED|Overall Study||10
570212|NCT00610701|1391875|P2|COMPLETED|Overall Study||9
570213|NCT00610701|1391876|P1|COMPLETED|Overall Study||5
570214|NCT00610701|1391875|P2|STARTED|Overall Study||20
570215|NCT00610701|1391876|P1|STARTED|Overall Study||15
570216|NCT00610688|1391885|P3|NOT COMPLETED|Overall Study||8
570217|NCT00610688|1391886|P2|NOT COMPLETED|Overall Study||13
570218|NCT00610688|1391887|P1|NOT COMPLETED|Overall Study||9
570219|NCT00610688|1391885|P3|COMPLETED|Overall Study||55
570220|NCT00610688|1391886|P2|COMPLETED|Overall Study||52
570221|NCT00610688|1391887|P1|COMPLETED|Overall Study||55
570222|NCT00610688|1391885|P3|STARTED|Overall Study||63
570223|NCT00610688|1391886|P2|STARTED|Overall Study||65
570224|NCT00610688|1391887|P1|STARTED|Overall Study||64
570225|NCT00610675|1391901|P1|NOT COMPLETED|Overall Study||220
570226|NCT00610675|1391901|P1|COMPLETED|Overall Study||126
570227|NCT00610675|1391901|P1|Treated|Overall Study||342
570228|NCT00610675|1391901|P1|STARTED|Overall Study||346
570229|NCT00610649|1391923|P11|NOT COMPLETED|Overall Study||1
570230|NCT00610649|1391924|P10|NOT COMPLETED|Overall Study||1
570231|NCT00610649|1391925|P9|NOT COMPLETED|Overall Study||0
570232|NCT00610649|1391926|P8|NOT COMPLETED|Overall Study||0
570233|NCT00610649|1391927|P7|NOT COMPLETED|Overall Study||0
570234|NCT00610649|1391928|P6|NOT COMPLETED|Overall Study||0
570235|NCT00610649|1391929|P5|NOT COMPLETED|Overall Study||0
570236|NCT00610649|1391930|P4|NOT COMPLETED|Overall Study||0
570237|NCT00610649|1391931|P3|NOT COMPLETED|Overall Study||0
570238|NCT00610649|1391932|P2|NOT COMPLETED|Overall Study||1
570239|NCT00610649|1391933|P1|NOT COMPLETED|Overall Study||1
570240|NCT00610649|1391923|P11|COMPLETED|Overall Study||9
570241|NCT00610649|1391924|P10|COMPLETED|Overall Study||9
570242|NCT00610649|1391925|P9|COMPLETED|Overall Study||10
570243|NCT00610649|1391926|P8|COMPLETED|Overall Study||2
570244|NCT00610649|1391927|P7|COMPLETED|Overall Study||4
570245|NCT00610649|1391928|P6|COMPLETED|Overall Study||2
570246|NCT00610649|1391929|P5|COMPLETED|Overall Study||4
570247|NCT00610649|1391930|P4|COMPLETED|Overall Study||2
570248|NCT00610649|1391931|P3|COMPLETED|Overall Study||4
570249|NCT00610649|1391932|P2|COMPLETED|Overall Study||1
570250|NCT00610649|1391933|P1|COMPLETED|Overall Study||3
570251|NCT00610649|1391923|P11|STARTED|Overall Study||10
570252|NCT00610649|1391924|P10|STARTED|Overall Study||10
570253|NCT00610649|1391925|P9|STARTED|Overall Study||10
570254|NCT00610649|1391926|P8|STARTED|Overall Study||2
570255|NCT00610649|1391927|P7|STARTED|Overall Study||4
570256|NCT00610649|1391928|P6|STARTED|Overall Study||2
570257|NCT00610649|1391929|P5|STARTED|Overall Study||4
570258|NCT00610649|1391930|P4|STARTED|Overall Study||2
570259|NCT00610649|1391931|P3|STARTED|Overall Study||4
570260|NCT00610649|1391932|P2|STARTED|Overall Study||2
570261|NCT00610649|1391933|P1|STARTED|Overall Study||4
570262|NCT00610532|1391987|P1|NOT COMPLETED|Intravenous Phenytoin Plus Probenecid||0
570263|NCT00610532|1391987|P1|COMPLETED|Intravenous Phenytoin Plus Probenecid||7
570264|NCT00610532|1391987|P1|STARTED|Intravenous Phenytoin Plus Probenecid|one participant dropped out between periods|7
570265|NCT00610532|1391987|P1|NOT COMPLETED|Intravenous Phenytoin Alone||0
570266|NCT00610532|1391987|P1|COMPLETED|Intravenous Phenytoin Alone||8
570267|NCT00610532|1391987|P1|STARTED|Intravenous Phenytoin Alone||8
570268|NCT00610441|1391997|P4|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2
570269|NCT00610441|1391998|P3|NOT COMPLETED|Treatment Period 2 - 3 Weeks||0
570270|NCT00610441|1391999|P2|NOT COMPLETED|Treatment Period 2 - 3 Weeks||1
570271|NCT00610441|1392000|P1|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2
570272|NCT00610441|1391997|P4|COMPLETED|Treatment Period 2 - 3 Weeks||14
570273|NCT00610441|1391998|P3|COMPLETED|Treatment Period 2 - 3 Weeks||9
570274|NCT00610441|1391999|P2|COMPLETED|Treatment Period 2 - 3 Weeks||12
570275|NCT00610441|1392000|P1|COMPLETED|Treatment Period 2 - 3 Weeks||10
570276|NCT00610441|1391997|P4|STARTED|Treatment Period 2 - 3 Weeks||16
570277|NCT00610441|1391998|P3|STARTED|Treatment Period 2 - 3 Weeks||9
570278|NCT00610441|1391999|P2|STARTED|Treatment Period 2 - 3 Weeks||13
570279|NCT00610441|1392000|P1|STARTED|Treatment Period 2 - 3 Weeks||12
570280|NCT00610441|1391997|P4|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0
570281|NCT00610441|1391998|P3|NOT COMPLETED|Placebo Washout Period - 2 Weeks||2
570282|NCT00610441|1391999|P2|NOT COMPLETED|Placebo Washout Period - 2 Weeks||1
570283|NCT00610441|1392000|P1|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0
570284|NCT00610441|1391997|P4|COMPLETED|Placebo Washout Period - 2 Weeks||16
570285|NCT00610441|1391998|P3|COMPLETED|Placebo Washout Period - 2 Weeks||9
570286|NCT00610441|1391999|P2|COMPLETED|Placebo Washout Period - 2 Weeks||13
570287|NCT00610441|1392000|P1|COMPLETED|Placebo Washout Period - 2 Weeks||12
570288|NCT00610441|1391997|P4|STARTED|Placebo Washout Period - 2 Weeks||16
570289|NCT00610441|1391998|P3|STARTED|Placebo Washout Period - 2 Weeks||11
570290|NCT00610441|1391999|P2|STARTED|Placebo Washout Period - 2 Weeks||14
570291|NCT00610441|1392000|P1|STARTED|Placebo Washout Period - 2 Weeks||12
570292|NCT00610441|1391997|P4|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2
570293|NCT00610441|1391998|P3|NOT COMPLETED|Treatment Period 1 - 3 Weeks||7
570294|NCT00610441|1391999|P2|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2
570295|NCT00610441|1392000|P1|NOT COMPLETED|Treatment Period 1 - 3 Weeks||3
570296|NCT00610441|1391997|P4|COMPLETED|Treatment Period 1 - 3 Weeks||16
570297|NCT00610441|1391998|P3|COMPLETED|Treatment Period 1 - 3 Weeks||11
570298|NCT00610441|1391999|P2|COMPLETED|Treatment Period 1 - 3 Weeks||14
570299|NCT00610441|1392000|P1|COMPLETED|Treatment Period 1 - 3 Weeks||12
570300|NCT00610441|1391997|P4|STARTED|Treatment Period 1 - 3 Weeks||18
570301|NCT00610441|1391998|P3|STARTED|Treatment Period 1 - 3 Weeks||18
570302|NCT00610441|1391999|P2|STARTED|Treatment Period 1 - 3 Weeks||16
570303|NCT00610441|1392000|P1|STARTED|Treatment Period 1 - 3 Weeks||15
570304|NCT00610428|1392094|P3|NOT COMPLETED|Overall Study||2
570305|NCT00610428|1392095|P2|NOT COMPLETED|Overall Study||1
570306|NCT00610428|1392096|P1|NOT COMPLETED|Overall Study||0
570307|NCT00610428|1392094|P3|COMPLETED|Overall Study||25
570308|NCT00610428|1392095|P2|COMPLETED|Overall Study||23
570309|NCT00610428|1392096|P1|COMPLETED|Overall Study||24
570310|NCT00610428|1392094|P3|STARTED|Overall Study||27
570311|NCT00610428|1392095|P2|STARTED|Overall Study||24
570312|NCT00610428|1392096|P1|STARTED|Overall Study||24
570313|NCT00610363|1392109|P2|NOT COMPLETED|Overall Study||3
570314|NCT00610363|1392110|P1|NOT COMPLETED|Overall Study||11
570315|NCT00610363|1392109|P2|COMPLETED|Overall Study||38
570316|NCT00610363|1392110|P1|COMPLETED|Overall Study||31
570317|NCT00610363|1392109|P2|STARTED|Overall Study||41
570318|NCT00610363|1392110|P1|STARTED|Overall Study||42
570319|NCT00610311|1392128|P1|NOT COMPLETED|Overall Study||0
570320|NCT00610311|1392128|P1|COMPLETED|Overall Study||3
570321|NCT00610311|1392128|P1|STARTED|Overall Study||3
570322|NCT00610207|1392135|P1|NOT COMPLETED|Overall Study||3
570323|NCT00610207|1392135|P1|COMPLETED|Overall Study||18
570324|NCT00610207|1392135|P1|STARTED|Overall Study||21
570325|NCT00610168|1392142|P2|NOT COMPLETED|Overall Study||0
570326|NCT00610168|1392143|P1|NOT COMPLETED|Overall Study||2
570327|NCT00610168|1392142|P2|COMPLETED|Overall Study||7
570328|NCT00610168|1392143|P1|COMPLETED|Overall Study||73
570329|NCT00610168|1392142|P2|STARTED|Overall Study||7
570330|NCT00610168|1392143|P1|STARTED|Overall Study||75
570331|NCT00610155|1392162|P6|NOT COMPLETED|Period 3||0
570332|NCT00610155|1392163|P5|NOT COMPLETED|Period 3||0
570333|NCT00610155|1392164|P4|NOT COMPLETED|Period 3||0
570334|NCT00610155|1392165|P3|NOT COMPLETED|Period 3||0
570335|NCT00610155|1392166|P2|NOT COMPLETED|Period 3||0
570336|NCT00610155|1392167|P1|NOT COMPLETED|Period 3||1
570337|NCT00610155|1392162|P6|COMPLETED|Period 3||1
570338|NCT00610155|1392163|P5|COMPLETED|Period 3||3
570339|NCT00610155|1392164|P4|COMPLETED|Period 3||3
570340|NCT00610155|1392165|P3|COMPLETED|Period 3||3
570341|NCT00610155|1392166|P2|COMPLETED|Period 3||3
570342|NCT00610155|1392167|P1|COMPLETED|Period 3||3
570343|NCT00610155|1392162|P6|STARTED|Period 3||1
570344|NCT00610155|1392163|P5|STARTED|Period 3||3
570345|NCT00610155|1392164|P4|STARTED|Period 3||3
570346|NCT00610155|1392165|P3|STARTED|Period 3||3
570347|NCT00610155|1392166|P2|STARTED|Period 3||3
570348|NCT00610155|1392167|P1|STARTED|Period 3||4
570349|NCT00610155|1392162|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
570350|NCT00610155|1392163|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
570351|NCT00610155|1392164|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
570352|NCT00610155|1392165|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
570353|NCT00610155|1392166|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
570354|NCT00610155|1392167|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
570355|NCT00610155|1392162|P6|COMPLETED|Washout Period 2 (7 Days)||1
570356|NCT00610155|1392163|P5|COMPLETED|Washout Period 2 (7 Days)||3
570357|NCT00610155|1392164|P4|COMPLETED|Washout Period 2 (7 Days)||3
570358|NCT00610155|1392165|P3|COMPLETED|Washout Period 2 (7 Days)||3
570359|NCT00610155|1392166|P2|COMPLETED|Washout Period 2 (7 Days)||3
570360|NCT00610155|1392167|P1|COMPLETED|Washout Period 2 (7 Days)||4
570361|NCT00610155|1392162|P6|STARTED|Washout Period 2 (7 Days)||1
570362|NCT00610155|1392163|P5|STARTED|Washout Period 2 (7 Days)||3
570363|NCT00610155|1392164|P4|STARTED|Washout Period 2 (7 Days)||3
570364|NCT00610155|1392165|P3|STARTED|Washout Period 2 (7 Days)||3
570365|NCT00610155|1392166|P2|STARTED|Washout Period 2 (7 Days)||3
570366|NCT00610155|1392167|P1|STARTED|Washout Period 2 (7 Days)||4
570367|NCT00610155|1392162|P6|NOT COMPLETED|Period 2||0
570368|NCT00610155|1392163|P5|NOT COMPLETED|Period 2||0
570369|NCT00610155|1392164|P4|NOT COMPLETED|Period 2||0
570370|NCT00610155|1392165|P3|NOT COMPLETED|Period 2||0
570371|NCT00610155|1392166|P2|NOT COMPLETED|Period 2||0
570372|NCT00610155|1392167|P1|NOT COMPLETED|Period 2||0
570373|NCT00610155|1392162|P6|COMPLETED|Period 2||1
570374|NCT00610155|1392163|P5|COMPLETED|Period 2||3
570375|NCT00610155|1392164|P4|COMPLETED|Period 2||3
570376|NCT00610155|1392165|P3|COMPLETED|Period 2||3
570377|NCT00610155|1392166|P2|COMPLETED|Period 2||3
570378|NCT00610155|1392167|P1|COMPLETED|Period 2||4
570379|NCT00610155|1392162|P6|STARTED|Period 2||1
570380|NCT00610155|1392163|P5|STARTED|Period 2||3
570381|NCT00610155|1392164|P4|STARTED|Period 2||3
570382|NCT00610155|1392165|P3|STARTED|Period 2||3
570383|NCT00610155|1392166|P2|STARTED|Period 2||3
570384|NCT00610155|1392167|P1|STARTED|Period 2||4
570385|NCT00610155|1392162|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
570386|NCT00610155|1392163|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
570387|NCT00610155|1392164|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
570388|NCT00610155|1392165|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
570389|NCT00610155|1392166|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
570390|NCT00610155|1392167|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
570391|NCT00610155|1392162|P6|COMPLETED|Washout Period 1 (7 Days)||1
570392|NCT00610155|1392163|P5|COMPLETED|Washout Period 1 (7 Days)||3
570393|NCT00610155|1392164|P4|COMPLETED|Washout Period 1 (7 Days)||3
570394|NCT00610155|1392165|P3|COMPLETED|Washout Period 1 (7 Days)||3
570395|NCT00610155|1392166|P2|COMPLETED|Washout Period 1 (7 Days)||3
570396|NCT00610155|1392167|P1|COMPLETED|Washout Period 1 (7 Days)||4
570397|NCT00610155|1392162|P6|STARTED|Washout Period 1 (7 Days)||1
570398|NCT00610155|1392163|P5|STARTED|Washout Period 1 (7 Days)||3
570399|NCT00610155|1392164|P4|STARTED|Washout Period 1 (7 Days)||3
570400|NCT00610155|1392165|P3|STARTED|Washout Period 1 (7 Days)||3
570401|NCT00610155|1392166|P2|STARTED|Washout Period 1 (7 Days)||3
570402|NCT00610155|1392167|P1|STARTED|Washout Period 1 (7 Days)||4
570403|NCT00610155|1392162|P6|NOT COMPLETED|Period 1||0
570404|NCT00610155|1392163|P5|NOT COMPLETED|Period 1||0
570405|NCT00610155|1392164|P4|NOT COMPLETED|Period 1||0
570406|NCT00610155|1392165|P3|NOT COMPLETED|Period 1||1
570407|NCT00610155|1392166|P2|NOT COMPLETED|Period 1||0
570408|NCT00610155|1392167|P1|NOT COMPLETED|Period 1||0
570409|NCT00610155|1392162|P6|COMPLETED|Period 1||1
570410|NCT00610155|1392163|P5|COMPLETED|Period 1||3
570411|NCT00610155|1392164|P4|COMPLETED|Period 1||3
570412|NCT00610155|1392165|P3|COMPLETED|Period 1||3
570413|NCT00610155|1392166|P2|COMPLETED|Period 1||3
570414|NCT00610155|1392167|P1|COMPLETED|Period 1||4
570415|NCT00610155|1392162|P6|STARTED|Period 1||1
570416|NCT00610155|1392163|P5|STARTED|Period 1||3
570417|NCT00610155|1392164|P4|STARTED|Period 1||3
570418|NCT00610155|1392165|P3|STARTED|Period 1||4
570419|NCT00610155|1392166|P2|STARTED|Period 1||3
570420|NCT00610155|1392167|P1|STARTED|Period 1||4
570421|NCT00610129|1392214|P1|NOT COMPLETED|Overall Study||3
570422|NCT00610129|1392214|P1|COMPLETED|Overall Study||25
570423|NCT00610129|1392214|P1|STARTED|Overall Study||28
570424|NCT00609986|1392220|P2|NOT COMPLETED|Overall Study||3
570425|NCT00609986|1392221|P1|NOT COMPLETED|Overall Study||8
570426|NCT00609986|1392220|P2|COMPLETED|Overall Study||49
570427|NCT00609986|1392221|P1|COMPLETED|Overall Study||44
570428|NCT00609986|1392220|P2|Received Transplant|Overall Study||49
570429|NCT00609986|1392221|P1|Received Transplant|Overall Study||44
570430|NCT00609986|1392220|P2|STARTED|Overall Study||52
570431|NCT00609986|1392221|P1|STARTED|Overall Study||52
570432|NCT00609973|1392235|P2|NOT COMPLETED|Overall Study||6
570433|NCT00609973|1392236|P1|NOT COMPLETED|Overall Study||8
570434|NCT00609973|1392235|P2|COMPLETED|Overall Study||10
570435|NCT00609973|1392236|P1|COMPLETED|Overall Study||9
570436|NCT00609973|1392235|P2|STARTED|Overall Study||16
570437|NCT00609973|1392236|P1|STARTED|Overall Study||17
570438|NCT00609947|1392244|P1|NOT COMPLETED|Overall Study||1
570439|NCT00609947|1392244|P1|COMPLETED|Overall Study|One death due to automobile accident.|240
570440|NCT00609947|1392244|P1|STARTED|Overall Study||241
570441|NCT00609869|1392249|P1|NOT COMPLETED|Overall Study||11
570442|NCT00609869|1392249|P1|COMPLETED|Overall Study||18
570443|NCT00609869|1392249|P1|STARTED|Overall Study||29
570444|NCT00609804|1392257|P2|NOT COMPLETED|Overall Study||28
570445|NCT00609804|1392258|P1|NOT COMPLETED|Overall Study||25
570446|NCT00609804|1392257|P2|COMPLETED|Overall Study|Pts remained on study until required to end treatment due to progression/toxicity/MD decision/etc|0
570447|NCT00609804|1392258|P1|COMPLETED|Overall Study|Pts remained on study until required to end treatment due to progression/toxicity/MD decision/etc|0
570448|NCT00609804|1392257|P2|STARTED|Overall Study||28
570449|NCT00609804|1392258|P1|STARTED|Overall Study||25
570450|NCT00609765|1392268|P1|NOT COMPLETED|Overall Study||1
570451|NCT00609765|1392268|P1|COMPLETED|Overall Study||0
570452|NCT00609765|1392268|P1|STARTED|Overall Study||1
570453|NCT00609739|1392273|P1|NOT COMPLETED|Overall Study||0
570454|NCT00609739|1392273|P1|COMPLETED|Overall Study||1
570455|NCT00609739|1392273|P1|STARTED|Overall Study||1
570456|NCT00609674|1392282|P2|NOT COMPLETED|Overall Study||7
570457|NCT00609674|1392283|P1|NOT COMPLETED|Overall Study||7
570458|NCT00609674|1392282|P2|COMPLETED|Overall Study||153
570459|NCT00609674|1392283|P1|COMPLETED|Overall Study||148
570460|NCT00609674|1392282|P2|STARTED|Overall Study||160
570461|NCT00609674|1392283|P1|STARTED|Overall Study||155
570462|NCT00609622|1392319|P2|NOT COMPLETED|Overall Study||95
570463|NCT00609622|1392320|P1|NOT COMPLETED|Overall Study||96
570464|NCT00609622|1392319|P2|COMPLETED|Overall Study||0
570465|NCT00609622|1392320|P1|COMPLETED|Overall Study||0
570466|NCT00609622|1392319|P2|STARTED|Overall Study||95
570467|NCT00609622|1392320|P1|STARTED|Overall Study||96
570468|NCT00609609|1392342|P2|NOT COMPLETED|Overall Study||2
570469|NCT00609609|1392343|P1|NOT COMPLETED|Overall Study||6
570470|NCT00609609|1392342|P2|COMPLETED|Overall Study||49
570471|NCT00609609|1392343|P1|COMPLETED|Overall Study||24
570472|NCT00609609|1392342|P2|STARTED|Overall Study||51
570473|NCT00609609|1392343|P1|STARTED|Overall Study||30
570474|NCT00609518|1392355|P2|NOT COMPLETED|Overall Study||40
570475|NCT00609518|1392356|P1|NOT COMPLETED|Overall Study||43
570476|NCT00609518|1392355|P2|COMPLETED|Overall Study||17
570477|NCT00609518|1392356|P1|COMPLETED|Overall Study||11
570478|NCT00609518|1392355|P2|Completed 6 Treatment Cycles|Overall Study||22
570479|NCT00609518|1392356|P1|Completed 6 Treatment Cycles|Overall Study||19
570480|NCT00609518|1392355|P2|STARTED|Overall Study||57
570481|NCT00609518|1392356|P1|STARTED|Overall Study||54
570482|NCT00609492|1392371|P3|NOT COMPLETED|Overall Study||7
570483|NCT00609492|1392372|P2|NOT COMPLETED|Overall Study||3
570484|NCT00609492|1392373|P1|NOT COMPLETED|Overall Study||1
570485|NCT00609492|1392371|P3|COMPLETED|Overall Study||122
570486|NCT00609492|1392372|P2|COMPLETED|Overall Study||69
570487|NCT00609492|1392373|P1|COMPLETED|Overall Study||43
570488|NCT00609492|1392371|P3|STARTED|Overall Study||129
570489|NCT00609492|1392372|P2|STARTED|Overall Study||72
570490|NCT00609492|1392373|P1|STARTED|Overall Study||44
570491|NCT00609466|1392458|P3|NOT COMPLETED|Overall Study||4
570492|NCT00609466|1392459|P2|NOT COMPLETED|Overall Study||6
570493|NCT00609466|1392460|P1|NOT COMPLETED|Overall Study||2
570494|NCT00609466|1392458|P3|COMPLETED|Overall Study||95
570495|NCT00609466|1392459|P2|COMPLETED|Overall Study||90
570496|NCT00609466|1392460|P1|COMPLETED|Overall Study||94
570497|NCT00609466|1392458|P3|STARTED|Overall Study||99
570498|NCT00609466|1392459|P2|STARTED|Overall Study||96
570499|NCT00609466|1392460|P1|STARTED|Overall Study||96
570500|NCT00609362|1392488|P2|NOT COMPLETED|Overall Study||1
570501|NCT00609362|1392489|P1|NOT COMPLETED|Overall Study||3
570502|NCT00609362|1392488|P2|COMPLETED|Overall Study||27
570503|NCT00609362|1392489|P1|COMPLETED|Overall Study||26
570504|NCT00609362|1392488|P2|STARTED|Overall Study||28
570505|NCT00609362|1392489|P1|STARTED|Overall Study||29
570506|NCT00609336|1392499|P1|NOT COMPLETED|Overall Study||13
570507|NCT00609336|1392499|P1|COMPLETED|Overall Study||22
570508|NCT00609336|1392499|P1|Surgery|Overall Study||22
570509|NCT00609336|1392499|P1|STARTED|Overall Study||35
570510|NCT00609245|1392511|P1|NOT COMPLETED|Overall Study||1
570511|NCT00609245|1392511|P1|COMPLETED|Overall Study||12
570512|NCT00609245|1392511|P1|STARTED|Overall Study||13
570513|NCT00609167|1392519|P2|NOT COMPLETED|Overall Study||7
570514|NCT00609167|1392520|P1|NOT COMPLETED|Overall Study||8
570515|NCT00609167|1392519|P2|COMPLETED|Overall Study||23
570516|NCT00609167|1392520|P1|COMPLETED|Overall Study||25
570517|NCT00609167|1392519|P2|STARTED|Overall Study||30
570518|NCT00609167|1392520|P1|STARTED|Overall Study||33
570519|NCT00608985|1392546|P4|NOT COMPLETED|Overall Study||9
570520|NCT00608985|1392547|P3|NOT COMPLETED|Overall Study||6
570521|NCT00608985|1392548|P2|NOT COMPLETED|Overall Study||13
570522|NCT00608985|1392549|P1|NOT COMPLETED|Overall Study||16
570523|NCT00608985|1392546|P4|COMPLETED|Overall Study|Completed follow-up|159
570524|NCT00608985|1392547|P3|COMPLETED|Overall Study|Completed follow-up|170
570525|NCT00608985|1392548|P2|COMPLETED|Overall Study|Completed follow-up|173
570526|NCT00608985|1392549|P1|COMPLETED|Overall Study|Completed follow-up|161
570527|NCT00608985|1392546|P4|Completed Double-blind Treatment|Overall Study||161
570528|NCT00608985|1392547|P3|Completed Double-blind Treatment|Overall Study||171
570529|NCT00608985|1392548|P2|Completed Double-blind Treatment|Overall Study||174
570530|NCT00608985|1392549|P1|Completed Double-blind Treatment|Overall Study||163
570531|NCT00608985|1392546|P4|STARTED|Overall Study|Randomized and started double-blind treatment|168
570532|NCT00608985|1392547|P3|STARTED|Overall Study|Randomized and started double-blind treatment|176
570533|NCT00608985|1392548|P2|STARTED|Overall Study|Randomized and started double-blind treatment|186
570534|NCT00608985|1392549|P1|STARTED|Overall Study|Randomized and started double-blind treatment|177
570535|NCT00608959|1392581|P1|NOT COMPLETED|Part 2||0
570536|NCT00608959|1392581|P1|COMPLETED|Part 2||25
570537|NCT00608959|1392581|P1|STARTED|Part 2|20 Part 1 subjects also participated in Part 2.Five more subjects were enrolled for a total of 25.|25
570538|NCT00608959|1392581|P1|NOT COMPLETED|Part 1||1
570539|NCT00608959|1392581|P1|COMPLETED|Part 1||24
570540|NCT00608959|1392581|P1|STARTED|Part 1|25 subjects each participated in Parts 1 and 2 .A total of 20 subjects participated in both parts.|25
570541|NCT00608907|1392594|P3|NOT COMPLETED|Overall Study||1
570542|NCT00608907|1392595|P2|NOT COMPLETED|Overall Study||0
570543|NCT00608907|1392596|P1|NOT COMPLETED|Overall Study||12
570544|NCT00608907|1392594|P3|COMPLETED|Overall Study||17
570545|NCT00608907|1392595|P2|COMPLETED|Overall Study||13
570546|NCT00608907|1392596|P1|COMPLETED|Overall Study||18
570547|NCT00608907|1392594|P3|STARTED|Overall Study||18
570548|NCT00608907|1392595|P2|STARTED|Overall Study||13
570549|NCT00608907|1392596|P1|STARTED|Overall Study||30
570550|NCT00608881|1392606|P2|NOT COMPLETED|Overall Study||66
570551|NCT00608881|1392607|P1|NOT COMPLETED|Overall Study||79
570552|NCT00608881|1392606|P2|COMPLETED|Overall Study||240
570553|NCT00608881|1392607|P1|COMPLETED|Overall Study||224
570554|NCT00608881|1392606|P2|STARTED|Overall Study||306
570555|NCT00608881|1392607|P1|STARTED|Overall Study||303
570556|NCT00608868|1392641|P1|NOT COMPLETED|Overall Study||15
570557|NCT00608868|1392641|P1|COMPLETED|Overall Study||141
570558|NCT00608868|1392641|P1|Per Protocol (PP) Population|Overall Study||121
570559|NCT00608868|1392641|P1|Intention to Treat (ITT) Population|Overall Study|8 patients who had no target lesion and 8 who had no tumor assessment after baseline were excluded|138
570560|NCT00608868|1392641|P1|Treatment Completed|Overall Study||141
570561|NCT00608868|1392641|P1|Safety Population|Overall Study|2 patients who received no study treatment were excluded|154
570562|NCT00608868|1392641|P1|Enrolled|Overall Study||156
570563|NCT00608868|1392641|P1|STARTED|Overall Study||156
570564|NCT00608842|1392652|P4|NOT COMPLETED|Overall Study||1
570565|NCT00608842|1392653|P3|NOT COMPLETED|Overall Study||2
570566|NCT00608842|1392654|P2|NOT COMPLETED|Overall Study||1
570567|NCT00608842|1392655|P1|NOT COMPLETED|Overall Study||1
570568|NCT00608842|1392652|P4|COMPLETED|Overall Study||16
570569|NCT00608842|1392653|P3|COMPLETED|Overall Study||13
570570|NCT00608842|1392654|P2|COMPLETED|Overall Study||14
570571|NCT00608842|1392655|P1|COMPLETED|Overall Study||14
570572|NCT00608842|1392652|P4|STARTED|Overall Study||17
570573|NCT00608842|1392653|P3|STARTED|Overall Study||15
570574|NCT00608842|1392654|P2|STARTED|Overall Study||15
570575|NCT00608842|1392655|P1|STARTED|Overall Study||15
570576|NCT00608829|1392689|P1|NOT COMPLETED|Overall Study||15
570577|NCT00608829|1392689|P1|COMPLETED|Overall Study||8
570578|NCT00608829|1392689|P1|STARTED|Overall Study||23
570579|NCT00608777|1392693|P1|NOT COMPLETED|Overall Study||0
570580|NCT00608777|1392693|P1|COMPLETED|Overall Study||6
570581|NCT00608777|1392693|P1|STARTED|Overall Study||6
570582|NCT00608634|1392700|P3|NOT COMPLETED|Overall Study||1
570583|NCT00608634|1392701|P2|NOT COMPLETED|Overall Study||1
570584|NCT00608634|1392702|P1|NOT COMPLETED|Overall Study||2
570585|NCT00608634|1392700|P3|COMPLETED|Overall Study||27
570586|NCT00608634|1392701|P2|COMPLETED|Overall Study||26
570587|NCT00608634|1392702|P1|COMPLETED|Overall Study||26
570588|NCT00608634|1392700|P3|STARTED|Overall Study||28
570589|NCT00608634|1392701|P2|STARTED|Overall Study||27
570590|NCT00608634|1392702|P1|STARTED|Overall Study||28
570591|NCT00608582|1392715|P2|NOT COMPLETED|Overall Study||4
570592|NCT00608582|1392716|P1|NOT COMPLETED|Overall Study||4
570593|NCT00608582|1392715|P2|COMPLETED|Overall Study||7
570594|NCT00608582|1392716|P1|COMPLETED|Overall Study||10
570595|NCT00608582|1392715|P2|STARTED|Overall Study||11
570596|NCT00608582|1392716|P1|STARTED|Overall Study||14
570597|NCT00608569|1392726|P2|NOT COMPLETED|Overall Study||9
570598|NCT00608569|1392727|P1|NOT COMPLETED|Overall Study||10
570599|NCT00608569|1392726|P2|COMPLETED|Overall Study||119
570600|NCT00608569|1392727|P1|COMPLETED|Overall Study||119
570601|NCT00608569|1392726|P2|STARTED|Overall Study||128
570602|NCT00608569|1392727|P1|STARTED|Overall Study||129
570603|NCT00608543|1392747|P1|NOT COMPLETED|Overall Study||4
570604|NCT00608543|1392747|P1|COMPLETED|Overall Study||13
570605|NCT00608543|1392747|P1|STARTED|Overall Study||17
570606|NCT00608530|1392760|P4|NOT COMPLETED|Study 2 Nurse-delivered Treatments||7
570607|NCT00608530|1392761|P3|NOT COMPLETED|Study 2 Nurse-delivered Treatments||12
570608|NCT00608530|1392762|P2|NOT COMPLETED|Study 2 Nurse-delivered Treatments||0
570609|NCT00608530|1392763|P1|NOT COMPLETED|Study 2 Nurse-delivered Treatments||0
570610|NCT00608530|1392760|P4|COMPLETED|Study 2 Nurse-delivered Treatments||27
570611|NCT00608530|1392761|P3|COMPLETED|Study 2 Nurse-delivered Treatments||21
570612|NCT00608530|1392762|P2|COMPLETED|Study 2 Nurse-delivered Treatments||0
570613|NCT00608530|1392763|P1|COMPLETED|Study 2 Nurse-delivered Treatments||0
570614|NCT00608530|1392760|P4|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||31
570615|NCT00608530|1392761|P3|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||30
570616|NCT00608530|1392762|P2|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||0
570617|NCT00608530|1392763|P1|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||0
570618|NCT00608530|1392760|P4|STARTED|Study 2 Nurse-delivered Treatments||34
570619|NCT00608530|1392761|P3|STARTED|Study 2 Nurse-delivered Treatments||33
570620|NCT00608530|1392762|P2|STARTED|Study 2 Nurse-delivered Treatments||0
570621|NCT00608530|1392763|P1|STARTED|Study 2 Nurse-delivered Treatments||0
570622|NCT00608530|1392760|P4|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||0
570623|NCT00608530|1392761|P3|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||0
570624|NCT00608530|1392762|P2|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||5
570625|NCT00608530|1392763|P1|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||11
570626|NCT00608530|1392760|P4|COMPLETED|Study 1 Psychologist-delivered Treatment||0
570627|NCT00608530|1392761|P3|COMPLETED|Study 1 Psychologist-delivered Treatment||0
570628|NCT00608530|1392762|P2|COMPLETED|Study 1 Psychologist-delivered Treatment||28
570629|NCT00608530|1392763|P1|COMPLETED|Study 1 Psychologist-delivered Treatment||22
570630|NCT00608530|1392760|P4|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||0
570631|NCT00608530|1392761|P3|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||0
570632|NCT00608530|1392762|P2|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||31
570633|NCT00608530|1392763|P1|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||28
570634|NCT00608530|1392760|P4|STARTED|Study 1 Psychologist-delivered Treatment||0
570635|NCT00608530|1392761|P3|STARTED|Study 1 Psychologist-delivered Treatment||0
570636|NCT00608530|1392762|P2|STARTED|Study 1 Psychologist-delivered Treatment|Randomized|33
570637|NCT00608530|1392763|P1|STARTED|Study 1 Psychologist-delivered Treatment|Randomized|33
570638|NCT00608517|1392784|P3|NOT COMPLETED|Overall Study||0
570639|NCT00608517|1392785|P2|NOT COMPLETED|Overall Study||0
570640|NCT00608517|1392786|P1|NOT COMPLETED|Overall Study||1
570641|NCT00608517|1392784|P3|COMPLETED|Overall Study||1
570642|NCT00608517|1392785|P2|COMPLETED|Overall Study||3
570643|NCT00608517|1392786|P1|COMPLETED|Overall Study||1
570644|NCT00608517|1392784|P3|STARTED|Overall Study||1
570645|NCT00608517|1392785|P2|STARTED|Overall Study||3
570646|NCT00608517|1392786|P1|STARTED|Overall Study||2
570647|NCT00608491|1392814|P2|NOT COMPLETED|Overall Study||22
570648|NCT00608491|1392815|P1|NOT COMPLETED|Overall Study||21
570649|NCT00608491|1392814|P2|COMPLETED|Overall Study||72
570650|NCT00608491|1392815|P1|COMPLETED|Overall Study||73
570651|NCT00608491|1392814|P2|STARTED|Overall Study||94
570652|NCT00608491|1392815|P1|STARTED|Overall Study||94
570653|NCT00608465|1392959|P1|NOT COMPLETED|Overall Study||0
570654|NCT00608465|1392959|P1|COMPLETED|Overall Study||4
570655|NCT00608465|1392959|P1|STARTED|Overall Study||4
570656|NCT00608426|1392966|P2|NOT COMPLETED|Overall Study||905
570657|NCT00608426|1392967|P1|NOT COMPLETED|Overall Study||836
570658|NCT00608426|1392966|P2|COMPLETED|Overall Study|This is total # of completed surveys. Not completed primary outcome.|1614
570659|NCT00608426|1392967|P1|COMPLETED|Overall Study|This is total # of completed surveys. Not completed primary outcome.|1768
570660|NCT00608426|1392966|P2|STARTED|Overall Study||2519
570661|NCT00608426|1392967|P1|STARTED|Overall Study||2604
570662|NCT00608322|1392979|P2|NOT COMPLETED|Overall Study||1
570663|NCT00608322|1392980|P1|NOT COMPLETED|Overall Study||2
570664|NCT00608322|1392979|P2|COMPLETED|Overall Study||22
570665|NCT00608322|1392980|P1|COMPLETED|Overall Study||24
570666|NCT00608322|1392979|P2|STARTED|Overall Study||23
570667|NCT00608322|1392980|P1|STARTED|Overall Study||26
570668|NCT00608244|1392986|P1|NOT COMPLETED|Overall Study||2
570669|NCT00608244|1392986|P1|COMPLETED|Overall Study||57
570670|NCT00608244|1392986|P1|STARTED|Overall Study||59
570671|NCT00608205|1392997|P2|NOT COMPLETED|Overall Study||3
570672|NCT00608205|1392998|P1|NOT COMPLETED|Overall Study||3
570673|NCT00608205|1392997|P2|COMPLETED|Overall Study||31
570674|NCT00608205|1392998|P1|COMPLETED|Overall Study||32
570675|NCT00608205|1392997|P2|STARTED|Overall Study||34
570676|NCT00608205|1392998|P1|STARTED|Overall Study||35
570677|NCT00608140|1393088|P2|NOT COMPLETED|Overall Study||1
570678|NCT00608140|1393089|P1|NOT COMPLETED|Overall Study||1
570679|NCT00608140|1393088|P2|COMPLETED|Overall Study|Study ended early due to low enrollment|0
570680|NCT00608140|1393089|P1|COMPLETED|Overall Study|Study ended early due to low enrollment|0
570681|NCT00608140|1393088|P2|STARTED|Overall Study||1
570682|NCT00608140|1393089|P1|STARTED|Overall Study||1
570683|NCT00608023|1393115|P3|NOT COMPLETED|Overall Study||14
570684|NCT00608023|1393116|P2|NOT COMPLETED|Overall Study||22
570685|NCT00608023|1393117|P1|NOT COMPLETED|Overall Study||12
570686|NCT00608023|1393115|P3|COMPLETED|Overall Study||72
570687|NCT00608023|1393116|P2|COMPLETED|Overall Study||63
570688|NCT00608023|1393117|P1|COMPLETED|Overall Study||80
570689|NCT00608023|1393115|P3|STARTED|Overall Study||86
570690|NCT00608023|1393116|P2|STARTED|Overall Study||85
570691|NCT00608023|1393117|P1|STARTED|Overall Study||92
570692|NCT00607997|1393141|P4|NOT COMPLETED|Overall Study||16
570693|NCT00607997|1393142|P3|NOT COMPLETED|Overall Study||24
570694|NCT00607997|1393143|P2|NOT COMPLETED|Overall Study||27
570695|NCT00607997|1393144|P1|NOT COMPLETED|Overall Study||27
570696|NCT00607997|1393141|P4|COMPLETED|Overall Study||4
570697|NCT00607997|1393142|P3|COMPLETED|Overall Study||5
570698|NCT00607997|1393143|P2|COMPLETED|Overall Study||8
570699|NCT00607997|1393144|P1|COMPLETED|Overall Study||2
570700|NCT00607997|1393141|P4|STARTED|Overall Study||20
570701|NCT00607997|1393142|P3|STARTED|Overall Study||29
570702|NCT00607997|1393143|P2|STARTED|Overall Study||35
570703|NCT00607997|1393144|P1|STARTED|Overall Study||29
570704|NCT00607919|1393202|P2|NOT COMPLETED|Open-Label Phase||12
570705|NCT00607919|1393203|P1|NOT COMPLETED|Open-Label Phase||10
570706|NCT00607919|1393202|P2|COMPLETED|Open-Label Phase||59
570707|NCT00607919|1393203|P1|COMPLETED|Open-Label Phase||74
570708|NCT00607919|1393202|P2|STARTED|Open-Label Phase||71
570709|NCT00607919|1393203|P1|STARTED|Open-Label Phase||84
570710|NCT00607919|1393202|P2|NOT COMPLETED|Acute Phase||16
570711|NCT00607919|1393203|P1|NOT COMPLETED|Acute Phase||34
570712|NCT00607919|1393202|P2|COMPLETED|Acute Phase|2 participants completed acute phase but did not continue into open-label.|73
570713|NCT00607919|1393203|P1|COMPLETED|Acute Phase|2 participants completed acute phase but did not continue into open-label.|86
570714|NCT00607919|1393202|P2|STARTED|Acute Phase||89
570715|NCT00607919|1393203|P1|STARTED|Acute Phase||120
570716|NCT00607893|1393261|P2|NOT COMPLETED|Overall Study||4
570717|NCT00607893|1393262|P1|NOT COMPLETED|Overall Study||6
570718|NCT00607893|1393261|P2|COMPLETED|Overall Study||72
570719|NCT00607893|1393262|P1|COMPLETED|Overall Study||71
570720|NCT00607893|1393261|P2|Completed 12 Week Visit|Overall Study|12 Week Visit only offered to participants on actual CPAP Treatment|29
570721|NCT00607893|1393262|P1|Completed 12 Week Visit|Overall Study|12 Week Visit only offered to participants on actual CPAP Treatment|0
570722|NCT00607893|1393261|P2|Completed 8 Week Visit|Overall Study||72
570723|NCT00607893|1393262|P1|Completed 8 Week Visit|Overall Study||71
570724|NCT00607893|1393261|P2|Completed Baseline Visit|Overall Study||75
570725|NCT00607893|1393262|P1|Completed Baseline Visit|Overall Study||74
570726|NCT00607893|1393261|P2|STARTED|Overall Study||76
570727|NCT00607893|1393262|P1|STARTED|Overall Study||77
570728|NCT00607880|1393290|P2|NOT COMPLETED|Overall Study||0
570729|NCT00607880|1393291|P1|NOT COMPLETED|Overall Study||1
570730|NCT00607880|1393290|P2|COMPLETED|Overall Study||50
570731|NCT00607880|1393291|P1|COMPLETED|Overall Study||49
570732|NCT00607880|1393290|P2|STARTED|Overall Study||50
570733|NCT00607880|1393291|P1|STARTED|Overall Study||50
570734|NCT00607867|1393305|P2|NOT COMPLETED|Overall Study||0
570735|NCT00607867|1393306|P1|NOT COMPLETED|Overall Study||0
570736|NCT00607867|1393305|P2|COMPLETED|Overall Study||7
570737|NCT00607867|1393306|P1|COMPLETED|Overall Study||7
570738|NCT00607867|1393305|P2|STARTED|Overall Study||7
570739|NCT00607867|1393306|P1|STARTED|Overall Study||7
570740|NCT00607815|1393324|P2|NOT COMPLETED|Overall Study||11
570741|NCT00607815|1393325|P1|NOT COMPLETED|Overall Study||23
570742|NCT00607815|1393324|P2|COMPLETED|Overall Study||25
570743|NCT00607815|1393325|P1|COMPLETED|Overall Study||20
570744|NCT00607815|1393324|P2|STARTED|Overall Study||36
570745|NCT00607815|1393325|P1|STARTED|Overall Study||43
570746|NCT00607789|1393341|P2|NOT COMPLETED|Overall Study||6
570747|NCT00607789|1393342|P1|NOT COMPLETED|Overall Study||7
570748|NCT00607789|1393341|P2|COMPLETED|Overall Study||14
570749|NCT00607789|1393342|P1|COMPLETED|Overall Study||13
570750|NCT00607789|1393341|P2|STARTED|Overall Study||20
570751|NCT00607789|1393342|P1|STARTED|Overall Study|20 participants were randomized in each group|20
570752|NCT00607724|1393357|P7|NOT COMPLETED|Stage 2: Expanded Cohort||11
570753|NCT00607724|1393358|P6|NOT COMPLETED|Stage 2: Expanded Cohort||12
570754|NCT00607724|1393359|P5|NOT COMPLETED|Stage 2: Expanded Cohort||9
570755|NCT00607724|1393360|P4|NOT COMPLETED|Stage 2: Expanded Cohort||5
570756|NCT00607724|1393361|P3|NOT COMPLETED|Stage 2: Expanded Cohort||0
570757|NCT00607724|1393362|P2|NOT COMPLETED|Stage 2: Expanded Cohort||0
570758|NCT00607724|1393363|P1|NOT COMPLETED|Stage 2: Expanded Cohort||0
570759|NCT00607724|1393357|P7|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered ‘completers’.|5
570760|NCT00607724|1393358|P6|COMPLETED|Stage 2: Expanded Cohort||0
570941|NCT00606892|1393810|P2|STARTED|Second Intervention||4
570761|NCT00607724|1393359|P5|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered ‘completers’.|5
570762|NCT00607724|1393360|P4|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered ‘completers’.|1
570763|NCT00607724|1393361|P3|COMPLETED|Stage 2: Expanded Cohort||0
570764|NCT00607724|1393362|P2|COMPLETED|Stage 2: Expanded Cohort||0
570765|NCT00607724|1393363|P1|COMPLETED|Stage 2: Expanded Cohort||0
570766|NCT00607724|1393357|P7|STARTED|Stage 2: Expanded Cohort||16
570767|NCT00607724|1393358|P6|STARTED|Stage 2: Expanded Cohort||12
570768|NCT00607724|1393359|P5|STARTED|Stage 2: Expanded Cohort||14
570769|NCT00607724|1393360|P4|STARTED|Stage 2: Expanded Cohort||6
570770|NCT00607724|1393361|P3|STARTED|Stage 2: Expanded Cohort||0
570771|NCT00607724|1393362|P2|STARTED|Stage 2: Expanded Cohort||0
570772|NCT00607724|1393363|P1|STARTED|Stage 2: Expanded Cohort||0
570773|NCT00607724|1393357|P7|NOT COMPLETED|Stage 1: Dose Escalation||0
570774|NCT00607724|1393358|P6|NOT COMPLETED|Stage 1: Dose Escalation||0
570775|NCT00607724|1393359|P5|NOT COMPLETED|Stage 1: Dose Escalation||0
570776|NCT00607724|1393360|P4|NOT COMPLETED|Stage 1: Dose Escalation||0
570777|NCT00607724|1393361|P3|NOT COMPLETED|Stage 1: Dose Escalation||4
570778|NCT00607724|1393362|P2|NOT COMPLETED|Stage 1: Dose Escalation||8
570779|NCT00607724|1393363|P1|NOT COMPLETED|Stage 1: Dose Escalation||7
570780|NCT00607724|1393357|P7|COMPLETED|Stage 1: Dose Escalation||0
570781|NCT00607724|1393358|P6|COMPLETED|Stage 1: Dose Escalation||0
570782|NCT00607724|1393359|P5|COMPLETED|Stage 1: Dose Escalation||0
570783|NCT00607724|1393360|P4|COMPLETED|Stage 1: Dose Escalation||0
570784|NCT00607724|1393361|P3|COMPLETED|Stage 1: Dose Escalation||0
570785|NCT00607724|1393362|P2|COMPLETED|Stage 1: Dose Escalation|Participants still on treatment at time of study closure were considered ‘completers’.|1
570786|NCT00607724|1393363|P1|COMPLETED|Stage 1: Dose Escalation||0
570787|NCT00607724|1393357|P7|STARTED|Stage 1: Dose Escalation||0
570788|NCT00607724|1393358|P6|STARTED|Stage 1: Dose Escalation||0
570789|NCT00607724|1393359|P5|STARTED|Stage 1: Dose Escalation||0
570790|NCT00607724|1393360|P4|STARTED|Stage 1: Dose Escalation||0
570791|NCT00607724|1393361|P3|STARTED|Stage 1: Dose Escalation||4
570792|NCT00607724|1393362|P2|STARTED|Stage 1: Dose Escalation||9
570793|NCT00607724|1393363|P1|STARTED|Stage 1: Dose Escalation||7
570794|NCT00607672|1393442|P3|NOT COMPLETED|Overall Study||5
570795|NCT00607672|1393443|P2|NOT COMPLETED|Overall Study||3
570796|NCT00607672|1393444|P1|NOT COMPLETED|Overall Study||4
570797|NCT00607672|1393442|P3|COMPLETED|Overall Study||22
570798|NCT00607672|1393443|P2|COMPLETED|Overall Study||24
570799|NCT00607672|1393444|P1|COMPLETED|Overall Study||28
570800|NCT00607672|1393442|P3|STARTED|Overall Study||27
570801|NCT00607672|1393443|P2|STARTED|Overall Study||27
570802|NCT00607672|1393444|P1|STARTED|Overall Study||32
570803|NCT00607620|1393490|P2|NOT COMPLETED|Overall Study||0
570804|NCT00607620|1393491|P1|NOT COMPLETED|Overall Study||0
570805|NCT00607620|1393490|P2|COMPLETED|Overall Study||469
570806|NCT00607620|1393491|P1|COMPLETED|Overall Study||409
570807|NCT00607620|1393490|P2|STARTED|Overall Study||469
570808|NCT00607620|1393491|P1|STARTED|Overall Study||409
570809|NCT00607594|1393505|P1|NOT COMPLETED|Overall Study||0
570810|NCT00607594|1393505|P1|COMPLETED|Overall Study||21
570811|NCT00607594|1393505|P1|STARTED|Overall Study||21
570812|NCT00607477|1393514|P2|NOT COMPLETED|Overall Study||0
570813|NCT00607477|1393515|P1|NOT COMPLETED|Overall Study||0
570814|NCT00607477|1393514|P2|COMPLETED|Overall Study||2
570815|NCT00607477|1393515|P1|COMPLETED|Overall Study||0
570816|NCT00607477|1393514|P2|STARTED|Overall Study||2
570817|NCT00607477|1393515|P1|STARTED|Overall Study||0
570818|NCT00607386|1393521|P1|NOT COMPLETED|Overall Study||1
570819|NCT00607386|1393521|P1|COMPLETED|Overall Study||27
570820|NCT00607386|1393521|P1|STARTED|Overall Study||28
570821|NCT00607373|1393536|P2|NOT COMPLETED|Follow-up Period||5
570822|NCT00607373|1393537|P1|NOT COMPLETED|Follow-up Period||1
570823|NCT00607373|1393536|P2|COMPLETED|Follow-up Period||6
570824|NCT00607373|1393537|P1|COMPLETED|Follow-up Period||0
570825|NCT00607373|1393536|P2|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|11
570826|NCT00607373|1393537|P1|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|1
570827|NCT00607373|1393536|P2|NOT COMPLETED|Treatment Period||6
570828|NCT00607373|1393537|P1|NOT COMPLETED|Treatment Period||0
570829|NCT00607373|1393536|P2|COMPLETED|Treatment Period|23 enrolled in open-label extension study NCT00694109|28
570830|NCT00607373|1393537|P1|COMPLETED|Treatment Period|16 enrolled in open-label extension study NCT00694109|17
570831|NCT00607373|1393536|P2|STARTED|Treatment Period||34
570832|NCT00607373|1393537|P1|STARTED|Treatment Period||17
570833|NCT00607321|1393581|P1|NOT COMPLETED|Overall Study||0
570834|NCT00607321|1393581|P1|COMPLETED|Overall Study||60
570835|NCT00607321|1393581|P1|STARTED|Overall Study||60
570836|NCT00607269|1393591|P2|NOT COMPLETED|Overall Study||0
570837|NCT00607269|1393592|P1|NOT COMPLETED|Overall Study||0
570838|NCT00607269|1393591|P2|COMPLETED|Overall Study||64
570839|NCT00607269|1393592|P1|COMPLETED|Overall Study||67
570840|NCT00607269|1393591|P2|STARTED|Overall Study||64
570841|NCT00607269|1393592|P1|STARTED|Overall Study||67
570842|NCT00607243|1393606|P2|NOT COMPLETED|Telephone Safety Assessment Period||2
570843|NCT00607243|1393607|P1|NOT COMPLETED|Telephone Safety Assessment Period||5
570844|NCT00607243|1393606|P2|COMPLETED|Telephone Safety Assessment Period|40 Available for 3 months 39 Available for 6 months|39
570845|NCT00607243|1393607|P1|COMPLETED|Telephone Safety Assessment Period|80 Available for 3 months 77 Available for 6 months|77
570846|NCT00607243|1393606|P2|STARTED|Telephone Safety Assessment Period||41
570847|NCT00607243|1393607|P1|STARTED|Telephone Safety Assessment Period||82
570848|NCT00607243|1393606|P2|NOT COMPLETED|Initial Post-vaccination Period||0
570849|NCT00607243|1393607|P1|NOT COMPLETED|Initial Post-vaccination Period||0
570850|NCT00607243|1393606|P2|COMPLETED|Initial Post-vaccination Period||41
570851|NCT00607243|1393607|P1|COMPLETED|Initial Post-vaccination Period||82
570852|NCT00607243|1393606|P2|STARTED|Initial Post-vaccination Period||41
570853|NCT00607243|1393607|P1|STARTED|Initial Post-vaccination Period||82
570854|NCT00607126|1393615|P2|NOT COMPLETED|Overall Study||0
570855|NCT00607126|1393616|P1|NOT COMPLETED|Overall Study||0
570856|NCT00607126|1393615|P2|COMPLETED|Overall Study||19
570857|NCT00607126|1393616|P1|COMPLETED|Overall Study||17
570858|NCT00607126|1393615|P2|STARTED|Overall Study||19
570859|NCT00607126|1393616|P1|STARTED|Overall Study||17
570860|NCT00607113|1393630|P2|NOT COMPLETED|Overall Study||0
570861|NCT00607113|1393631|P1|NOT COMPLETED|Overall Study||0
570862|NCT00607113|1393630|P2|COMPLETED|Overall Study||20
570863|NCT00607113|1393631|P1|COMPLETED|Overall Study||19
570864|NCT00607113|1393630|P2|STARTED|Overall Study||20
570865|NCT00607113|1393631|P1|STARTED|Overall Study||19
570866|NCT00607087|1393639|P3|NOT COMPLETED|Period 3||0
570867|NCT00607087|1393640|P2|NOT COMPLETED|Period 3||2
570868|NCT00607087|1393641|P1|NOT COMPLETED|Period 3||2
570869|NCT00607087|1393639|P3|COMPLETED|Period 3||84
570870|NCT00607087|1393640|P2|COMPLETED|Period 3||84
570871|NCT00607087|1393641|P1|COMPLETED|Period 3||84
570872|NCT00607087|1393639|P3|STARTED|Period 3||84
570873|NCT00607087|1393640|P2|STARTED|Period 3||86
570874|NCT00607087|1393641|P1|STARTED|Period 3||86
570875|NCT00607087|1393639|P3|NOT COMPLETED|Period 2||5
570876|NCT00607087|1393640|P2|NOT COMPLETED|Period 2||3
570877|NCT00607087|1393641|P1|NOT COMPLETED|Period 2||1
570878|NCT00607087|1393639|P3|COMPLETED|Period 2||84
570879|NCT00607087|1393640|P2|COMPLETED|Period 2||86
570880|NCT00607087|1393641|P1|COMPLETED|Period 2||86
570881|NCT00607087|1393639|P3|STARTED|Period 2||89
570882|NCT00607087|1393640|P2|STARTED|Period 2||89
570883|NCT00607087|1393641|P1|STARTED|Period 2||87
570884|NCT00607087|1393639|P3|NOT COMPLETED|Period 1||5
570885|NCT00607087|1393640|P2|NOT COMPLETED|Period 1||6
570886|NCT00607087|1393641|P1|NOT COMPLETED|Period 1||12
570887|NCT00607087|1393639|P3|COMPLETED|Period 1||89
570888|NCT00607087|1393640|P2|COMPLETED|Period 1||89
570889|NCT00607087|1393641|P1|COMPLETED|Period 1||87
570890|NCT00607087|1393639|P3|STARTED|Period 1||94
570891|NCT00607087|1393640|P2|STARTED|Period 1||95
570892|NCT00607087|1393641|P1|STARTED|Period 1||99
570893|NCT00607087|1393639|P3|NOT COMPLETED|Overall Study||10
570894|NCT00607087|1393640|P2|NOT COMPLETED|Overall Study||11
570895|NCT00607087|1393641|P1|NOT COMPLETED|Overall Study||15
570896|NCT00607087|1393639|P3|COMPLETED|Overall Study||84
570897|NCT00607087|1393640|P2|COMPLETED|Overall Study||84
570898|NCT00607087|1393641|P1|COMPLETED|Overall Study||84
570899|NCT00607087|1393639|P3|STARTED|Overall Study||94
570900|NCT00607087|1393640|P2|STARTED|Overall Study||95
570901|NCT00607087|1393641|P1|STARTED|Overall Study||99
570902|NCT00607048|1393699|P6|NOT COMPLETED|Overall Study||5
570903|NCT00607048|1393700|P5|NOT COMPLETED|Overall Study||6
570904|NCT00607048|1393701|P4|NOT COMPLETED|Overall Study||3
570905|NCT00607048|1393702|P3|NOT COMPLETED|Overall Study||4
570906|NCT00607048|1393703|P2|NOT COMPLETED|Overall Study||4
570907|NCT00607048|1393704|P1|NOT COMPLETED|Overall Study||3
570908|NCT00607048|1393699|P6|COMPLETED|Overall Study||2
570909|NCT00607048|1393700|P5|COMPLETED|Overall Study||0
570910|NCT00607048|1393701|P4|COMPLETED|Overall Study||0
570911|NCT00607048|1393702|P3|COMPLETED|Overall Study||3
570912|NCT00607048|1393703|P2|COMPLETED|Overall Study||2
570913|NCT00607048|1393704|P1|COMPLETED|Overall Study||0
570914|NCT00607048|1393699|P6|STARTED|Overall Study||7
570915|NCT00607048|1393700|P5|STARTED|Overall Study||6
570916|NCT00607048|1393701|P4|STARTED|Overall Study||3
570917|NCT00607048|1393702|P3|STARTED|Overall Study||7
570918|NCT00607048|1393703|P2|STARTED|Overall Study||6
570919|NCT00607048|1393704|P1|STARTED|Overall Study||3
570920|NCT00606944|1393788|P2|NOT COMPLETED|Overall Study||0
570921|NCT00606944|1393789|P1|NOT COMPLETED|Overall Study||0
570922|NCT00606944|1393788|P2|COMPLETED|Overall Study||100
570923|NCT00606944|1393789|P1|COMPLETED|Overall Study||98
570924|NCT00606944|1393788|P2|STARTED|Overall Study||100
570925|NCT00606944|1393789|P1|STARTED|Overall Study||98
570926|NCT00606931|1393795|P1|NOT COMPLETED|Overall Study||3
570927|NCT00606931|1393795|P1|COMPLETED|Overall Study||19
570928|NCT00606931|1393795|P1|STARTED|Overall Study||22
570929|NCT00606905|1393803|P2|NOT COMPLETED|Overall Study||15
570930|NCT00606905|1393804|P1|NOT COMPLETED|Overall Study||15
570931|NCT00606905|1393803|P2|COMPLETED|Overall Study||24
570932|NCT00606905|1393804|P1|COMPLETED|Overall Study||23
570933|NCT00606905|1393803|P2|Pregnancy|Overall Study||33
570934|NCT00606905|1393804|P1|Pregnancy|Overall Study||29
570935|NCT00606905|1393803|P2|STARTED|Overall Study||39
570936|NCT00606905|1393804|P1|STARTED|Overall Study||38
570937|NCT00606892|1393810|P2|NOT COMPLETED|Second Intervention||0
570938|NCT00606892|1393811|P1|NOT COMPLETED|Second Intervention||0
570939|NCT00606892|1393810|P2|COMPLETED|Second Intervention||4
570940|NCT00606892|1393811|P1|COMPLETED|Second Intervention||8
570942|NCT00606892|1393811|P1|STARTED|Second Intervention||8
570943|NCT00606892|1393810|P2|NOT COMPLETED|Washout Period||0
570944|NCT00606892|1393811|P1|NOT COMPLETED|Washout Period||0
570945|NCT00606892|1393810|P2|COMPLETED|Washout Period||4
570946|NCT00606892|1393811|P1|COMPLETED|Washout Period||8
570947|NCT00606892|1393810|P2|STARTED|Washout Period||4
570948|NCT00606892|1393811|P1|STARTED|Washout Period||8
570949|NCT00606892|1393810|P2|NOT COMPLETED|First Intervention||4
570950|NCT00606892|1393811|P1|NOT COMPLETED|First Intervention||1
570951|NCT00606892|1393810|P2|COMPLETED|First Intervention||4
570952|NCT00606892|1393811|P1|COMPLETED|First Intervention||8
570953|NCT00606892|1393810|P2|STARTED|First Intervention||8
570954|NCT00606892|1393811|P1|STARTED|First Intervention||9
570955|NCT00606892|1393810|P2|NOT COMPLETED|Adaptation||0
570956|NCT00606892|1393811|P1|NOT COMPLETED|Adaptation||0
570957|NCT00606892|1393810|P2|COMPLETED|Adaptation||8
570958|NCT00606892|1393811|P1|COMPLETED|Adaptation||9
570959|NCT00606892|1393810|P2|STARTED|Adaptation||8
570960|NCT00606892|1393811|P1|STARTED|Adaptation||9
570961|NCT00606801|1393845|P2|NOT COMPLETED|Intervention||3
570962|NCT00606801|1393846|P1|NOT COMPLETED|Intervention||3
570963|NCT00606801|1393845|P2|COMPLETED|Intervention||14
570964|NCT00606801|1393846|P1|COMPLETED|Intervention||14
570965|NCT00606801|1393845|P2|STARTED|Intervention||17
570966|NCT00606801|1393846|P1|STARTED|Intervention||17
570967|NCT00606801|1393845|P2|NOT COMPLETED|Adaptation||0
570968|NCT00606801|1393846|P1|NOT COMPLETED|Adaptation||0
570969|NCT00606801|1393845|P2|COMPLETED|Adaptation||17
570970|NCT00606801|1393846|P1|COMPLETED|Adaptation||17
570971|NCT00606801|1393845|P2|STARTED|Adaptation||17
570972|NCT00606801|1393846|P1|STARTED|Adaptation||17
570973|NCT00606684|1393874|P7|NOT COMPLETED|Double-Blind Treatment Period||8
570974|NCT00606684|1393875|P6|NOT COMPLETED|Double-Blind Treatment Period||9
570975|NCT00606684|1393876|P5|NOT COMPLETED|Double-Blind Treatment Period||9
570976|NCT00606684|1393877|P4|NOT COMPLETED|Double-Blind Treatment Period||10
570977|NCT00606684|1393878|P3|NOT COMPLETED|Double-Blind Treatment Period||11
570978|NCT00606684|1393879|P2|NOT COMPLETED|Double-Blind Treatment Period||16
570979|NCT00606684|1393880|P1|NOT COMPLETED|Double-Blind Treatment Period||0
570980|NCT00606684|1393874|P7|COMPLETED|Double-Blind Treatment Period||91
570981|NCT00606684|1393875|P6|COMPLETED|Double-Blind Treatment Period||92
570982|NCT00606684|1393876|P5|COMPLETED|Double-Blind Treatment Period||92
570983|NCT00606684|1393877|P4|COMPLETED|Double-Blind Treatment Period||91
570984|NCT00606684|1393878|P3|COMPLETED|Double-Blind Treatment Period||88
570985|NCT00606684|1393879|P2|COMPLETED|Double-Blind Treatment Period||85
570986|NCT00606684|1393880|P1|COMPLETED|Double-Blind Treatment Period||0
570987|NCT00606684|1393874|P7|STARTED|Double-Blind Treatment Period||99
570988|NCT00606684|1393875|P6|STARTED|Double-Blind Treatment Period||101
570989|NCT00606684|1393876|P5|STARTED|Double-Blind Treatment Period||101
570990|NCT00606684|1393877|P4|STARTED|Double-Blind Treatment Period||101
570991|NCT00606684|1393878|P3|STARTED|Double-Blind Treatment Period||99
570992|NCT00606684|1393879|P2|STARTED|Double-Blind Treatment Period||101
570993|NCT00606684|1393880|P1|STARTED|Double-Blind Treatment Period||0
570994|NCT00606684|1393874|P7|NOT COMPLETED|2-week Single-Blind Run-in Period||0
570995|NCT00606684|1393875|P6|NOT COMPLETED|2-week Single-Blind Run-in Period||0
570996|NCT00606684|1393876|P5|NOT COMPLETED|2-week Single-Blind Run-in Period||0
570997|NCT00606684|1393877|P4|NOT COMPLETED|2-week Single-Blind Run-in Period||0
570998|NCT00606684|1393878|P3|NOT COMPLETED|2-week Single-Blind Run-in Period||0
570999|NCT00606684|1393879|P2|NOT COMPLETED|2-week Single-Blind Run-in Period||0
571000|NCT00606684|1393880|P1|NOT COMPLETED|2-week Single-Blind Run-in Period||246
571001|NCT00606684|1393874|P7|COMPLETED|2-week Single-Blind Run-in Period||0
571002|NCT00606684|1393875|P6|COMPLETED|2-week Single-Blind Run-in Period||0
571003|NCT00606684|1393876|P5|COMPLETED|2-week Single-Blind Run-in Period||0
571004|NCT00606684|1393877|P4|COMPLETED|2-week Single-Blind Run-in Period||0
571005|NCT00606684|1393878|P3|COMPLETED|2-week Single-Blind Run-in Period||0
571006|NCT00606684|1393879|P2|COMPLETED|2-week Single-Blind Run-in Period||0
571007|NCT00606684|1393880|P1|COMPLETED|2-week Single-Blind Run-in Period||605
571008|NCT00606684|1393874|P7|STARTED|2-week Single-Blind Run-in Period||0
571009|NCT00606684|1393875|P6|STARTED|2-week Single-Blind Run-in Period||0
571010|NCT00606684|1393876|P5|STARTED|2-week Single-Blind Run-in Period||0
571011|NCT00606684|1393877|P4|STARTED|2-week Single-Blind Run-in Period||0
571012|NCT00606684|1393878|P3|STARTED|2-week Single-Blind Run-in Period||0
571013|NCT00606684|1393879|P2|STARTED|2-week Single-Blind Run-in Period||0
571014|NCT00606684|1393880|P1|STARTED|2-week Single-Blind Run-in Period||851
571015|NCT00606632|1393912|P1|NOT COMPLETED|Overall Study||22
571016|NCT00606632|1393912|P1|COMPLETED|Overall Study||204
571017|NCT00606632|1393912|P1|STARTED|Overall Study||226
571018|NCT00606593|1393919|P10|NOT COMPLETED|Overall Study||0
571019|NCT00606593|1393920|P9|NOT COMPLETED|Overall Study||1
571020|NCT00606593|1393921|P8|NOT COMPLETED|Overall Study||2
571021|NCT00606593|1393922|P7|NOT COMPLETED|Overall Study||1
571022|NCT00606593|1393923|P6|NOT COMPLETED|Overall Study||0
571023|NCT00606593|1393924|P5|NOT COMPLETED|Overall Study||1
571024|NCT00606593|1393925|P4|NOT COMPLETED|Overall Study||1
571025|NCT00606593|1393926|P3|NOT COMPLETED|Overall Study||2
571026|NCT00606593|1393927|P2|NOT COMPLETED|Overall Study||0
571027|NCT00606593|1393928|P1|NOT COMPLETED|Overall Study||1
571028|NCT00606593|1393919|P10|COMPLETED|Overall Study||11
571029|NCT00606593|1393920|P9|COMPLETED|Overall Study||11
571030|NCT00606593|1393921|P8|COMPLETED|Overall Study||9
571031|NCT00606593|1393922|P7|COMPLETED|Overall Study||10
571032|NCT00606593|1393923|P6|COMPLETED|Overall Study||11
571033|NCT00606593|1393924|P5|COMPLETED|Overall Study||11
571034|NCT00606593|1393925|P4|COMPLETED|Overall Study||10
571035|NCT00606593|1393926|P3|COMPLETED|Overall Study||9
571036|NCT00606593|1393927|P2|COMPLETED|Overall Study||11
571037|NCT00606593|1393928|P1|COMPLETED|Overall Study||10
571038|NCT00606593|1393919|P10|5th Double-blind Treatment|Overall Study||11
571039|NCT00606593|1393920|P9|5th Double-blind Treatment|Overall Study||11
571040|NCT00606593|1393921|P8|5th Double-blind Treatment|Overall Study||9
571041|NCT00606593|1393922|P7|5th Double-blind Treatment|Overall Study||10
571042|NCT00606593|1393923|P6|5th Double-blind Treatment|Overall Study||11
571043|NCT00606593|1393924|P5|5th Double-blind Treatment|Overall Study||11
571044|NCT00606593|1393925|P4|5th Double-blind Treatment|Overall Study||10
571045|NCT00606593|1393926|P3|5th Double-blind Treatment|Overall Study||9
571046|NCT00606593|1393927|P2|5th Double-blind Treatment|Overall Study||11
571047|NCT00606593|1393928|P1|5th Double-blind Treatment|Overall Study||10
571048|NCT00606593|1393919|P10|4th Double-blind Treatment|Overall Study||11
571049|NCT00606593|1393920|P9|4th Double-blind Treatment|Overall Study||11
571050|NCT00606593|1393921|P8|4th Double-blind Treatment|Overall Study||9
571051|NCT00606593|1393922|P7|4th Double-blind Treatment|Overall Study||10
571052|NCT00606593|1393923|P6|4th Double-blind Treatment|Overall Study||11
571053|NCT00606593|1393924|P5|4th Double-blind Treatment|Overall Study||11
571054|NCT00606593|1393925|P4|4th Double-blind Treatment|Overall Study||10
571055|NCT00606593|1393926|P3|4th Double-blind Treatment|Overall Study||10
571056|NCT00606593|1393927|P2|4th Double-blind Treatment|Overall Study||11
571057|NCT00606593|1393928|P1|4th Double-blind Treatment|Overall Study||10
571058|NCT00606593|1393919|P10|3rd Double-blind Treatment|Overall Study||11
571059|NCT00606593|1393920|P9|3rd Double-blind Treatment|Overall Study||12
571060|NCT00606593|1393921|P8|3rd Double-blind Treatment|Overall Study||9
571061|NCT00606593|1393922|P7|3rd Double-blind Treatment|Overall Study||10
571062|NCT00606593|1393923|P6|3rd Double-blind Treatment|Overall Study||11
571063|NCT00606593|1393924|P5|3rd Double-blind Treatment|Overall Study||11
571064|NCT00606593|1393925|P4|3rd Double-blind Treatment|Overall Study||10
571065|NCT00606593|1393926|P3|3rd Double-blind Treatment|Overall Study||10
571066|NCT00606593|1393927|P2|3rd Double-blind Treatment|Overall Study||11
571067|NCT00606593|1393928|P1|3rd Double-blind Treatment|Overall Study||11
571068|NCT00606593|1393919|P10|2nd Double-blind Treatment|Overall Study||11
571069|NCT00606593|1393920|P9|2nd Double-blind Treatment|Overall Study||12
571070|NCT00606593|1393921|P8|2nd Double-blind Treatment|Overall Study||9
571071|NCT00606593|1393922|P7|2nd Double-blind Treatment|Overall Study||10
571072|NCT00606593|1393923|P6|2nd Double-blind Treatment|Overall Study||11
571073|NCT00606593|1393924|P5|2nd Double-blind Treatment|Overall Study||12
571074|NCT00606593|1393925|P4|2nd Double-blind Treatment|Overall Study||10
571075|NCT00606593|1393926|P3|2nd Double-blind Treatment|Overall Study||11
571076|NCT00606593|1393927|P2|2nd Double-blind Treatment|Overall Study||11
571077|NCT00606593|1393928|P1|2nd Double-blind Treatment|Overall Study||11
571078|NCT00606593|1393919|P10|1st Double-blind Treatment|Overall Study||11
571079|NCT00606593|1393920|P9|1st Double-blind Treatment|Overall Study||12
571080|NCT00606593|1393921|P8|1st Double-blind Treatment|Overall Study||11
571081|NCT00606593|1393922|P7|1st Double-blind Treatment|Overall Study||11
571082|NCT00606593|1393923|P6|1st Double-blind Treatment|Overall Study||11
571083|NCT00606593|1393924|P5|1st Double-blind Treatment|Overall Study||12
571084|NCT00606593|1393925|P4|1st Double-blind Treatment|Overall Study||11
571085|NCT00606593|1393926|P3|1st Double-blind Treatment|Overall Study||11
571086|NCT00606593|1393927|P2|1st Double-blind Treatment|Overall Study||11
571087|NCT00606593|1393928|P1|1st Double-blind Treatment|Overall Study||11
571088|NCT00606593|1393919|P10|STARTED|Overall Study|Randomized participants|11
571089|NCT00606593|1393920|P9|STARTED|Overall Study|Randomized participants|12
571090|NCT00606593|1393921|P8|STARTED|Overall Study|Randomized participants. One participant actually received the treatment sequence 200/P/100/ 50/25|11
571091|NCT00606593|1393922|P7|STARTED|Overall Study|Randomized participants|11
571092|NCT00606593|1393923|P6|STARTED|Overall Study|Randomized participants|11
571093|NCT00606593|1393924|P5|STARTED|Overall Study|Randomized participants|12
571094|NCT00606593|1393925|P4|STARTED|Overall Study|Randomized participants|11
571095|NCT00606593|1393926|P3|STARTED|Overall Study|Randomized participants|11
571096|NCT00606593|1393927|P2|STARTED|Overall Study|Randomized participants|11
571097|NCT00606593|1393928|P1|STARTED|Overall Study|Randomized participants|11
571098|NCT00606580|1393949|P3|NOT COMPLETED|Overall Study||22
571099|NCT00606580|1393950|P2|NOT COMPLETED|Overall Study||3
571100|NCT00606580|1393951|P1|NOT COMPLETED|Overall Study||2
571101|NCT00606580|1393949|P3|COMPLETED|Overall Study||103
571102|NCT00606580|1393950|P2|COMPLETED|Overall Study||122
571103|NCT00606580|1393951|P1|COMPLETED|Overall Study||123
571104|NCT00606580|1393949|P3|STARTED|Overall Study||125
571105|NCT00606580|1393950|P2|STARTED|Overall Study||125
571106|NCT00606580|1393951|P1|STARTED|Overall Study||125
571107|NCT00606554|1393994|P2|NOT COMPLETED|Overall Study||0
571108|NCT00606554|1393995|P1|NOT COMPLETED|Overall Study||0
571109|NCT00606554|1393994|P2|COMPLETED|Overall Study||18
571110|NCT00606554|1393995|P1|COMPLETED|Overall Study||15
571111|NCT00606554|1393994|P2|STARTED|Overall Study||18
571112|NCT00606554|1393995|P1|STARTED|Overall Study||15
571113|NCT00606502|1394017|P2|NOT COMPLETED|Treatment||3
571114|NCT00606502|1394018|P1|NOT COMPLETED|Treatment||0
571115|NCT00606502|1394017|P2|COMPLETED|Treatment||98
571116|NCT00606502|1394018|P1|COMPLETED|Treatment||97
571117|NCT00606502|1394017|P2|STARTED|Treatment||101
571118|NCT00606502|1394018|P1|STARTED|Treatment||97
571119|NCT00606502|1394017|P2|NOT COMPLETED|Randomization||0
571120|NCT00606502|1394018|P1|NOT COMPLETED|Randomization||3
571121|NCT00606502|1394017|P2|COMPLETED|Randomization||101
571122|NCT00606502|1394018|P1|COMPLETED|Randomization||97
571123|NCT00606502|1394017|P2|STARTED|Randomization||101
571124|NCT00606502|1394018|P1|STARTED|Randomization||100
571125|NCT00606489|1394032|P2|NOT COMPLETED|Overall Study||0
571126|NCT00606489|1394033|P1|NOT COMPLETED|Overall Study||0
571127|NCT00606489|1394032|P2|COMPLETED|Overall Study||40
571128|NCT00606489|1394033|P1|COMPLETED|Overall Study||21
571129|NCT00606489|1394032|P2|STARTED|Overall Study||40
571130|NCT00606489|1394033|P1|STARTED|Overall Study||21
571131|NCT00606320|1394039|P1|NOT COMPLETED|Overall Study||37
571132|NCT00606320|1394039|P1|COMPLETED|Overall Study||22
571133|NCT00606320|1394039|P1|STARTED|Overall Study||59
571134|NCT00606281|1394046|P2|NOT COMPLETED|Overall Study||66
571135|NCT00606281|1394047|P1|NOT COMPLETED|Overall Study||56
571136|NCT00606281|1394046|P2|COMPLETED|Overall Study||64
571137|NCT00606281|1394047|P1|COMPLETED|Overall Study||72
571138|NCT00606281|1394046|P2|STARTED|Overall Study||130
571139|NCT00606281|1394047|P1|STARTED|Overall Study||128
571140|NCT00606229|1394055|P1|NOT COMPLETED|Overall Study||22
571141|NCT00606229|1394055|P1|COMPLETED|Overall Study||19
571142|NCT00606229|1394055|P1|STARTED|Overall Study||41
571143|NCT00606177|1394062|P2|NOT COMPLETED|Overall Study||25
571144|NCT00606177|1394063|P1|NOT COMPLETED|Overall Study||27
571145|NCT00606177|1394062|P2|COMPLETED|Overall Study||19
571146|NCT00606177|1394063|P1|COMPLETED|Overall Study||28
571147|NCT00606177|1394062|P2|STARTED|Overall Study||44
571148|NCT00606177|1394063|P1|STARTED|Overall Study||55
571149|NCT00606138|1394073|P2|NOT COMPLETED|Overall Study||0
571150|NCT00606138|1394074|P1|NOT COMPLETED|Overall Study||0
571151|NCT00606138|1394073|P2|COMPLETED|Overall Study||2
571152|NCT00606138|1394074|P1|COMPLETED|Overall Study||6
571153|NCT00606138|1394073|P2|STARTED|Overall Study||2
571154|NCT00606138|1394074|P1|STARTED|Overall Study||6
571155|NCT00606086|1394090|P2|NOT COMPLETED|Overall Study||15
571156|NCT00606086|1394091|P1|NOT COMPLETED|Overall Study||12
571157|NCT00606086|1394090|P2|COMPLETED|Overall Study||53
571158|NCT00606086|1394091|P1|COMPLETED|Overall Study||60
571159|NCT00606086|1394090|P2|STARTED|Overall Study||68
571160|NCT00606086|1394091|P1|STARTED|Overall Study||72
571161|NCT00606034|1394097|P1|NOT COMPLETED|Overall Study||1
571162|NCT00606034|1394097|P1|COMPLETED|Overall Study||20
571163|NCT00606034|1394097|P1|STARTED|Overall Study||21
571164|NCT00606021|1394105|P3|NOT COMPLETED|Maintenance Phase||17
571165|NCT00606021|1394106|P2|NOT COMPLETED|Maintenance Phase||23
571166|NCT00606021|1394107|P1|NOT COMPLETED|Maintenance Phase||0
571167|NCT00606021|1394105|P3|COMPLETED|Maintenance Phase||10
571168|NCT00606021|1394106|P2|COMPLETED|Maintenance Phase||5
571169|NCT00606021|1394107|P1|COMPLETED|Maintenance Phase||0
571170|NCT00606021|1394105|P3|STARTED|Maintenance Phase||27
571171|NCT00606021|1394106|P2|STARTED|Maintenance Phase||28
571172|NCT00606021|1394107|P1|STARTED|Maintenance Phase||0
571173|NCT00606021|1394105|P3|NOT COMPLETED|Induction Phase||0
571174|NCT00606021|1394106|P2|NOT COMPLETED|Induction Phase||0
571175|NCT00606021|1394107|P1|NOT COMPLETED|Induction Phase||87
571176|NCT00606021|1394105|P3|COMPLETED|Induction Phase||0
571177|NCT00606021|1394106|P2|COMPLETED|Induction Phase||0
571178|NCT00606021|1394107|P1|COMPLETED|Induction Phase||19
571179|NCT00606021|1394105|P3|STARTED|Induction Phase||0
571180|NCT00606021|1394106|P2|STARTED|Induction Phase||0
571181|NCT00606021|1394107|P1|STARTED|Induction Phase||106
571182|NCT00606008|1394125|P1|NOT COMPLETED|Overall Study||5
571183|NCT00606008|1394125|P1|COMPLETED|Overall Study||25
571184|NCT00606008|1394125|P1|STARTED|Overall Study||30
571185|NCT00605917|1394139|P1|NOT COMPLETED|Overall Study||79
571186|NCT00605917|1394139|P1|COMPLETED|Overall Study||908
571187|NCT00605917|1394139|P1|STARTED|Overall Study||987
571188|NCT00605904|1394180|P2|NOT COMPLETED|Infusion Sessions||3
571189|NCT00605904|1394181|P1|NOT COMPLETED|Infusion Sessions||1
571190|NCT00605904|1394180|P2|COMPLETED|Infusion Sessions|Subjects who completed all three types of infusion (given in a different order for each subject)|13
571191|NCT00605904|1394181|P1|COMPLETED|Infusion Sessions|Subjects who completed all three types of infusion (given in a different order for each subject)|12
571192|NCT00605904|1394180|P2|Yohimbine Infusion|Infusion Sessions|Milestones (infusions) were not received in the same order for each subjects so are not consecutive.|15
571193|NCT00605904|1394181|P1|Yohimbine Infusion|Infusion Sessions||12
571194|NCT00605904|1394180|P2|mCPP Infusion|Infusion Sessions||13
571195|NCT00605904|1394181|P1|mCPP Infusion|Infusion Sessions||12
571196|NCT00605904|1394180|P2|Saline Infusion|Infusion Sessions||14
571197|NCT00605904|1394181|P1|Saline Infusion|Infusion Sessions||13
571198|NCT00605904|1394180|P2|STARTED|Infusion Sessions||16
571199|NCT00605904|1394181|P1|STARTED|Infusion Sessions||13
571200|NCT00605904|1394180|P2|NOT COMPLETED|Baseline Data Collection and Dosing||5
571201|NCT00605904|1394181|P1|NOT COMPLETED|Baseline Data Collection and Dosing||0
571202|NCT00605904|1394180|P2|COMPLETED|Baseline Data Collection and Dosing||16
571203|NCT00605904|1394181|P1|COMPLETED|Baseline Data Collection and Dosing||13
571296|NCT00605306|1394516|P1|COMPLETED|Overall Study||14
571204|NCT00605904|1394180|P2|STARTED|Baseline Data Collection and Dosing|While 37 subjects were enrolled in the protocol, only 34 were randomized to a study arm|21
571205|NCT00605904|1394181|P1|STARTED|Baseline Data Collection and Dosing|While 37 subjects were enrolled in the protocol, only 34 were randomized to a study arm|13
571206|NCT00605865|1394191|P1|NOT COMPLETED|Overall Study||115
571207|NCT00605865|1394191|P1|COMPLETED|Overall Study||2157
571208|NCT00605865|1394191|P1|STARTED|Overall Study||2272
571209|NCT00605839|1394233|P3|NOT COMPLETED|Overall Study||0
571210|NCT00605839|1394234|P2|NOT COMPLETED|Overall Study||0
571211|NCT00605839|1394235|P1|NOT COMPLETED|Overall Study||1
571212|NCT00605839|1394233|P3|COMPLETED|Overall Study||28
571213|NCT00605839|1394234|P2|COMPLETED|Overall Study||37
571214|NCT00605839|1394235|P1|COMPLETED|Overall Study|One patient would not keep to the text messaging constraints and had to be removed.|39
571215|NCT00605839|1394233|P3|STARTED|Overall Study||28
571216|NCT00605839|1394234|P2|STARTED|Overall Study||37
571217|NCT00605839|1394235|P1|STARTED|Overall Study||40
571218|NCT00605813|1394243|P1|NOT COMPLETED|Overall Study||25
571219|NCT00605813|1394243|P1|COMPLETED|Overall Study||517
571220|NCT00605813|1394243|P1|STARTED|Overall Study||542
571221|NCT00605722|1394256|P1|NOT COMPLETED|Overall Study||51
571222|NCT00605722|1394256|P1|COMPLETED|Overall Study|Completed=Completed Treatment.|0
571223|NCT00605722|1394256|P1|STARTED|Overall Study||51
571224|NCT00605696|1394268|P2|NOT COMPLETED|Overall Study||0
571225|NCT00605696|1394269|P1|NOT COMPLETED|Overall Study||0
571226|NCT00605696|1394268|P2|COMPLETED|Overall Study||11
571227|NCT00605696|1394269|P1|COMPLETED|Overall Study||7
571228|NCT00605696|1394268|P2|STARTED|Overall Study||11
571229|NCT00605696|1394269|P1|STARTED|Overall Study||7
571230|NCT00605657|1394277|P1|NOT COMPLETED|Overall Study||2
571231|NCT00605657|1394277|P1|COMPLETED|Overall Study||3
571232|NCT00605657|1394277|P1|STARTED|Overall Study||5
571233|NCT00605540|1394282|P1|NOT COMPLETED|Overall Study||38
571234|NCT00605540|1394282|P1|COMPLETED|Overall Study||95
571235|NCT00605540|1394282|P1|STARTED|Overall Study||133
571236|NCT00605475|1394300|P10|NOT COMPLETED|Overall Study||2
571237|NCT00605475|1394301|P9|NOT COMPLETED|Overall Study||2
571238|NCT00605475|1394302|P8|NOT COMPLETED|Overall Study||0
571239|NCT00605475|1394303|P7|NOT COMPLETED|Overall Study||1
571240|NCT00605475|1394304|P6|NOT COMPLETED|Overall Study||2
571241|NCT00605475|1394305|P5|NOT COMPLETED|Overall Study||1
571242|NCT00605475|1394306|P4|NOT COMPLETED|Overall Study||0
571243|NCT00605475|1394307|P3|NOT COMPLETED|Overall Study||0
571244|NCT00605475|1394308|P2|NOT COMPLETED|Overall Study||0
571245|NCT00605475|1394309|P1|NOT COMPLETED|Overall Study||0
571246|NCT00605475|1394300|P10|COMPLETED|Overall Study||8
571247|NCT00605475|1394301|P9|COMPLETED|Overall Study||18
571248|NCT00605475|1394302|P8|COMPLETED|Overall Study||24
571249|NCT00605475|1394303|P7|COMPLETED|Overall Study||22
571250|NCT00605475|1394304|P6|COMPLETED|Overall Study||22
571251|NCT00605475|1394305|P5|COMPLETED|Overall Study||24
571252|NCT00605475|1394306|P4|COMPLETED|Overall Study||45
571253|NCT00605475|1394307|P3|COMPLETED|Overall Study||45
571254|NCT00605475|1394308|P2|COMPLETED|Overall Study||5
571255|NCT00605475|1394309|P1|COMPLETED|Overall Study||10
571256|NCT00605475|1394300|P10|STARTED|Overall Study||10
571257|NCT00605475|1394301|P9|STARTED|Overall Study||20
571258|NCT00605475|1394302|P8|STARTED|Overall Study||24
571259|NCT00605475|1394303|P7|STARTED|Overall Study||23
571260|NCT00605475|1394304|P6|STARTED|Overall Study||24
571261|NCT00605475|1394305|P5|STARTED|Overall Study||25
571262|NCT00605475|1394306|P4|STARTED|Overall Study||45
571263|NCT00605475|1394307|P3|STARTED|Overall Study||45
571264|NCT00605475|1394308|P2|STARTED|Overall Study||5
571265|NCT00605475|1394309|P1|STARTED|Overall Study||10
571266|NCT00605423|1394433|P2|NOT COMPLETED|Overall Study||0
571267|NCT00605423|1394434|P1|NOT COMPLETED|Overall Study||0
571268|NCT00605423|1394433|P2|COMPLETED|Overall Study||2
571269|NCT00605423|1394434|P1|COMPLETED|Overall Study||4
571270|NCT00605423|1394433|P2|STARTED|Overall Study||2
571271|NCT00605423|1394434|P1|STARTED|Overall Study||4
571272|NCT00605384|1394446|P2|NOT COMPLETED|Overall Study||1
571273|NCT00605384|1394447|P1|NOT COMPLETED|Overall Study||1
571274|NCT00605384|1394446|P2|COMPLETED|Overall Study|study terminated early|0
571275|NCT00605384|1394447|P1|COMPLETED|Overall Study|study terminated early|0
571276|NCT00605384|1394446|P2|STARTED|Overall Study||1
571277|NCT00605384|1394447|P1|STARTED|Overall Study||1
571278|NCT00605358|1394477|P2|NOT COMPLETED|Overall Study||0
571279|NCT00605358|1394478|P1|NOT COMPLETED|Overall Study||0
571280|NCT00605358|1394477|P2|COMPLETED|Overall Study||80
571281|NCT00605358|1394478|P1|COMPLETED|Overall Study||81
571282|NCT00605358|1394477|P2|STARTED|Overall Study||80
571283|NCT00605358|1394478|P1|STARTED|Overall Study||81
571284|NCT00605345|1394486|P2|NOT COMPLETED|Overall Study||3
571285|NCT00605345|1394487|P1|NOT COMPLETED|Overall Study||1
571286|NCT00605345|1394486|P2|COMPLETED|Overall Study||22
571287|NCT00605345|1394487|P1|COMPLETED|Overall Study||45
571288|NCT00605345|1394486|P2|STARTED|Overall Study||25
571289|NCT00605345|1394487|P1|STARTED|Overall Study||46
571290|NCT00605319|1394503|P1|NOT COMPLETED|Overall Study||6
571291|NCT00605319|1394503|P1|COMPLETED|Overall Study||11
571292|NCT00605319|1394503|P1|STARTED|Overall Study||17
571293|NCT00605306|1394515|P2|NOT COMPLETED|Overall Study||1
571294|NCT00605306|1394516|P1|NOT COMPLETED|Overall Study||0
571295|NCT00605306|1394515|P2|COMPLETED|Overall Study||13
571297|NCT00605306|1394515|P2|STARTED|Overall Study||14
571298|NCT00605306|1394516|P1|STARTED|Overall Study||14
571299|NCT00605293|1394530|P2|NOT COMPLETED|Overall Study||5
571300|NCT00605293|1394531|P1|NOT COMPLETED|Overall Study||17
571301|NCT00605293|1394530|P2|COMPLETED|Overall Study||31
571302|NCT00605293|1394531|P1|COMPLETED|Overall Study||48
571303|NCT00605293|1394530|P2|STARTED|Overall Study||36
571304|NCT00605293|1394531|P1|STARTED|Overall Study||65
571305|NCT00605280|1394551|P4|NOT COMPLETED|Year 3 Extension||9
571306|NCT00605280|1394552|P3|NOT COMPLETED|Year 3 Extension||0
571307|NCT00605280|1394553|P2|NOT COMPLETED|Year 3 Extension||0
571308|NCT00605280|1394554|P1|NOT COMPLETED|Year 3 Extension||8
571309|NCT00605280|1394551|P4|COMPLETED|Year 3 Extension||45
571310|NCT00605280|1394552|P3|COMPLETED|Year 3 Extension||0
571311|NCT00605280|1394553|P2|COMPLETED|Year 3 Extension||0
571312|NCT00605280|1394554|P1|COMPLETED|Year 3 Extension||38
571313|NCT00605280|1394551|P4|Received 0.3 mg Treatment|Year 3 Extension||54
571314|NCT00605280|1394552|P3|Received 0.3 mg Treatment|Year 3 Extension||0
571315|NCT00605280|1394553|P2|Received 0.3 mg Treatment|Year 3 Extension||0
571316|NCT00605280|1394554|P1|Received 0.3 mg Treatment|Year 3 Extension||46
571317|NCT00605280|1394551|P4|STARTED|Year 3 Extension||54
571318|NCT00605280|1394552|P3|STARTED|Year 3 Extension||0
571319|NCT00605280|1394553|P2|STARTED|Year 3 Extension||0
571320|NCT00605280|1394554|P1|STARTED|Year 3 Extension||46
571321|NCT00605280|1394551|P4|NOT COMPLETED|Year 2||22
571322|NCT00605280|1394552|P3|NOT COMPLETED|Year 2||6
571323|NCT00605280|1394553|P2|NOT COMPLETED|Year 2||6
571324|NCT00605280|1394554|P1|NOT COMPLETED|Year 2||24
571325|NCT00605280|1394551|P4|COMPLETED|Year 2||102
571326|NCT00605280|1394552|P3|COMPLETED|Year 2||0
571327|NCT00605280|1394553|P2|COMPLETED|Year 2||5
571328|NCT00605280|1394554|P1|COMPLETED|Year 2||102
571329|NCT00605280|1394551|P4|Received 0.3 mg Treatment|Year 2||0
571330|NCT00605280|1394552|P3|Received 0.3 mg Treatment|Year 2||2
571331|NCT00605280|1394553|P2|Received 0.3 mg Treatment|Year 2||3
571332|NCT00605280|1394554|P1|Received 0.3 mg Treatment|Year 2||126
571333|NCT00605280|1394551|P4|STARTED|Year 2||124
571334|NCT00605280|1394552|P3|STARTED|Year 2||6
571335|NCT00605280|1394553|P2|STARTED|Year 2||11
571336|NCT00605280|1394554|P1|STARTED|Year 2||126
571337|NCT00605280|1394551|P4|NOT COMPLETED|Year 1||19
571338|NCT00605280|1394552|P3|NOT COMPLETED|Year 1||1
571339|NCT00605280|1394553|P2|NOT COMPLETED|Year 1||11
571340|NCT00605280|1394554|P1|NOT COMPLETED|Year 1||19
571341|NCT00605280|1394551|P4|COMPLETED|Year 1||124
571342|NCT00605280|1394552|P3|COMPLETED|Year 1||6
571343|NCT00605280|1394553|P2|COMPLETED|Year 1||11
571344|NCT00605280|1394554|P1|COMPLETED|Year 1||126
571345|NCT00605280|1394551|P4|Received 0.3 mg Treatment|Year 1||0
571346|NCT00605280|1394552|P3|Received 0.3 mg Treatment|Year 1||3
571347|NCT00605280|1394553|P2|Received 0.3 mg Treatment|Year 1||13
571348|NCT00605280|1394554|P1|Received 0.3 mg Treatment|Year 1||144
571349|NCT00605280|1394551|P4|STARTED|Year 1||143
571350|NCT00605280|1394552|P3|STARTED|Year 1||7
571351|NCT00605280|1394553|P2|STARTED|Year 1||22
571352|NCT00605280|1394554|P1|STARTED|Year 1||145
571353|NCT00605267|1394588|P2|NOT COMPLETED|Overall Study||9
571354|NCT00605267|1394589|P1|NOT COMPLETED|Overall Study||3
571355|NCT00605267|1394588|P2|COMPLETED|Overall Study|Breast surgery performed|90
571356|NCT00605267|1394589|P1|COMPLETED|Overall Study|Breast surgery performed|95
571357|NCT00605267|1394588|P2|STARTED|Overall Study||99
571358|NCT00605267|1394589|P1|STARTED|Overall Study||98
571359|NCT00605202|1394627|P2|NOT COMPLETED|Second Intervention||0
571360|NCT00605202|1394628|P1|NOT COMPLETED|Second Intervention||0
571361|NCT00605202|1394627|P2|COMPLETED|Second Intervention||5
571362|NCT00605202|1394628|P1|COMPLETED|Second Intervention||5
571363|NCT00605202|1394627|P2|STARTED|Second Intervention||5
571364|NCT00605202|1394628|P1|STARTED|Second Intervention||5
571365|NCT00605202|1394627|P2|NOT COMPLETED|Washout Period of 3 Weeks||0
571366|NCT00605202|1394628|P1|NOT COMPLETED|Washout Period of 3 Weeks||0
571367|NCT00605202|1394627|P2|COMPLETED|Washout Period of 3 Weeks||5
571368|NCT00605202|1394628|P1|COMPLETED|Washout Period of 3 Weeks||5
571369|NCT00605202|1394627|P2|STARTED|Washout Period of 3 Weeks||5
571370|NCT00605202|1394628|P1|STARTED|Washout Period of 3 Weeks||5
571371|NCT00605202|1394627|P2|NOT COMPLETED|First Intervention||0
571372|NCT00605202|1394628|P1|NOT COMPLETED|First Intervention||0
571373|NCT00605202|1394627|P2|COMPLETED|First Intervention||5
571374|NCT00605202|1394628|P1|COMPLETED|First Intervention||5
571375|NCT00605202|1394627|P2|STARTED|First Intervention||5
571376|NCT00605202|1394628|P1|STARTED|First Intervention||5
571377|NCT00605176|1394637|P3|NOT COMPLETED|Overall Study||9
571378|NCT00605176|1394638|P2|NOT COMPLETED|Overall Study||6
571379|NCT00605176|1394639|P1|NOT COMPLETED|Overall Study||11
571380|NCT00605176|1394637|P3|COMPLETED|Overall Study||150
571381|NCT00605176|1394638|P2|COMPLETED|Overall Study||154
571382|NCT00605176|1394639|P1|COMPLETED|Overall Study||149
571383|NCT00605176|1394637|P3|STARTED|Overall Study||159
571384|NCT00605176|1394638|P2|STARTED|Overall Study||160
571385|NCT00605176|1394639|P1|STARTED|Overall Study||160
571386|NCT00605150|1394656|P1|NOT COMPLETED|Overall Study||1
571387|NCT00605150|1394656|P1|COMPLETED|Overall Study||10
571388|NCT00605150|1394656|P1|STARTED|Overall Study|11 started|11
571389|NCT00605085|1394662|P2|NOT COMPLETED|Overall Study||25
571390|NCT00605085|1394663|P1|NOT COMPLETED|Overall Study||50
571391|NCT00605085|1394662|P2|COMPLETED|Overall Study||638
571392|NCT00605085|1394663|P1|COMPLETED|Overall Study||1962
571393|NCT00605085|1394662|P2|STARTED|Overall Study||663
571394|NCT00605085|1394663|P1|STARTED|Overall Study||2012
571395|NCT00605072|1394672|P3|NOT COMPLETED|Overall Study||4
571396|NCT00605072|1394673|P2|NOT COMPLETED|Overall Study||11
571397|NCT00605072|1394674|P1|NOT COMPLETED|Overall Study||7
571398|NCT00605072|1394672|P3|COMPLETED|Overall Study||11
571399|NCT00605072|1394673|P2|COMPLETED|Overall Study||9
571400|NCT00605072|1394674|P1|COMPLETED|Overall Study||11
571401|NCT00605072|1394672|P3|STARTED|Overall Study||15
571402|NCT00605072|1394673|P2|STARTED|Overall Study||20
571403|NCT00605072|1394674|P1|STARTED|Overall Study||18
571404|NCT00605033|1394696|P2|NOT COMPLETED|Overall Study||8
571405|NCT00605033|1394697|P1|NOT COMPLETED|Overall Study||7
571406|NCT00605033|1394696|P2|COMPLETED|Overall Study||90
571407|NCT00605033|1394697|P1|COMPLETED|Overall Study||136
571408|NCT00605033|1394696|P2|STARTED|Overall Study|One participant was randomized but withdrew before taking any study medication (treated n=97).|98
571409|NCT00605033|1394697|P1|STARTED|Overall Study||143
571410|NCT00604968|1394703|P1|NOT COMPLETED|Overall Study||0
571411|NCT00604968|1394703|P1|COMPLETED|Overall Study|Due to the nature of study, all subjects receiving drug were considered to have completed.|25
571412|NCT00604968|1394703|P1|STARTED|Overall Study||25
571413|NCT00604825|1394720|P4|NOT COMPLETED|Overall Study||11
571414|NCT00604825|1394721|P3|NOT COMPLETED|Overall Study||16
571415|NCT00604825|1394722|P2|NOT COMPLETED|Overall Study||15
571416|NCT00604825|1394723|P1|NOT COMPLETED|Overall Study||9
571417|NCT00604825|1394720|P4|COMPLETED|Overall Study||79
571418|NCT00604825|1394721|P3|COMPLETED|Overall Study||73
571419|NCT00604825|1394722|P2|COMPLETED|Overall Study||72
571420|NCT00604825|1394723|P1|COMPLETED|Overall Study||81
571421|NCT00604825|1394720|P4|STARTED|Overall Study||90
571422|NCT00604825|1394721|P3|STARTED|Overall Study||89
571423|NCT00604825|1394722|P2|STARTED|Overall Study||87
571424|NCT00604825|1394723|P1|STARTED|Overall Study||90
571425|NCT00604812|1394924|P6|NOT COMPLETED|Overall Study||0
571426|NCT00604812|1394925|P5|NOT COMPLETED|Overall Study||0
571427|NCT00604812|1394926|P4|NOT COMPLETED|Overall Study||0
571428|NCT00604812|1394927|P3|NOT COMPLETED|Overall Study||0
571429|NCT00604812|1394928|P2|NOT COMPLETED|Overall Study||0
571430|NCT00604812|1394929|P1|NOT COMPLETED|Overall Study||0
571431|NCT00604812|1394924|P6|COMPLETED|Overall Study||1
571432|NCT00604812|1394925|P5|COMPLETED|Overall Study||5
571433|NCT00604812|1394926|P4|COMPLETED|Overall Study||3
571434|NCT00604812|1394927|P3|COMPLETED|Overall Study||10
571435|NCT00604812|1394928|P2|COMPLETED|Overall Study||3
571436|NCT00604812|1394929|P1|COMPLETED|Overall Study||9
571437|NCT00604812|1394924|P6|STARTED|Overall Study||1
571438|NCT00604812|1394925|P5|STARTED|Overall Study||5
571439|NCT00604812|1394926|P4|STARTED|Overall Study||3
571440|NCT00604812|1394927|P3|STARTED|Overall Study||10
571441|NCT00604812|1394928|P2|STARTED|Overall Study||3
571442|NCT00604812|1394929|P1|STARTED|Overall Study||9
571443|NCT00604786|1394951|P2|NOT COMPLETED|Overall Study||0
571444|NCT00604786|1394952|P1|NOT COMPLETED|Overall Study||2
571445|NCT00604786|1394951|P2|COMPLETED|Overall Study||4
571446|NCT00604786|1394952|P1|COMPLETED|Overall Study||12
571447|NCT00604786|1394951|P2|STARTED|Overall Study||4
571448|NCT00604786|1394952|P1|STARTED|Overall Study||14
571449|NCT00604721|1394958|P1|NOT COMPLETED|Overall Study||2
571450|NCT00604721|1394958|P1|COMPLETED|Overall Study|2 patients failed to complete a full cycle of therapy.|17
571451|NCT00604721|1394958|P1|STARTED|Overall Study||19
571452|NCT00604708|1394966|P2|NOT COMPLETED|Overall Study||40
571453|NCT00604708|1394967|P1|NOT COMPLETED|Overall Study||31
571454|NCT00604708|1394966|P2|COMPLETED|Overall Study||397
571455|NCT00604708|1394967|P1|COMPLETED|Overall Study||399
571456|NCT00604708|1394966|P2|STARTED|Overall Study||437
571457|NCT00604708|1394967|P1|STARTED|Overall Study||430
571458|NCT00604695|1394977|P2|NOT COMPLETED|Overall Study||4
571459|NCT00604695|1394978|P1|NOT COMPLETED|Overall Study||0
571460|NCT00604695|1394977|P2|COMPLETED|Overall Study||16
571461|NCT00604695|1394978|P1|COMPLETED|Overall Study||20
571462|NCT00604695|1394977|P2|STARTED|Overall Study||20
571463|NCT00604695|1394978|P1|STARTED|Overall Study||20
571464|NCT00604669|1395000|P1|NOT COMPLETED|Overall Study||7
571465|NCT00604669|1395000|P1|COMPLETED|Overall Study||163
571466|NCT00604669|1395000|P1|STARTED|Overall Study||170
571467|NCT00604565|1395006|P2|NOT COMPLETED|Overall Study||3
571468|NCT00604565|1395007|P1|NOT COMPLETED|Overall Study||0
571469|NCT00604565|1395006|P2|COMPLETED|Overall Study||4
571470|NCT00604565|1395007|P1|COMPLETED|Overall Study||4
571471|NCT00604565|1395006|P2|STARTED|Overall Study||7
571472|NCT00604565|1395007|P1|STARTED|Overall Study||4
571473|NCT00604552|1395017|P2|NOT COMPLETED|Overall Study||0
571474|NCT00604552|1395018|P1|NOT COMPLETED|Overall Study||0
571475|NCT00604552|1395017|P2|COMPLETED|Overall Study||160
571476|NCT00604552|1395018|P1|COMPLETED|Overall Study||189
571477|NCT00604552|1395017|P2|STARTED|Overall Study||160
571478|NCT00604552|1395018|P1|STARTED|Overall Study||189
571479|NCT00604500|1395026|P1|NOT COMPLETED|Overall Study||11
571480|NCT00604500|1395026|P1|COMPLETED|Overall Study|There were 233 participants who took at least 90% of the labeled actuations (Completer Population).|261
571481|NCT00604500|1395026|P1|STARTED|Overall Study||272
571482|NCT00604461|1395033|P1|NOT COMPLETED|Overall Study||1
571572|NCT00603902|1395236|P3|STARTED|Overall Study||1603
571483|NCT00604461|1395033|P1|COMPLETED|Overall Study|Death within 30 days of treatment occurred in 1 patient.|12
571484|NCT00604461|1395033|P1|STARTED|Overall Study||13
571485|NCT00604383|1395040|P2|NOT COMPLETED|Overall Study||84
571486|NCT00604383|1395041|P1|NOT COMPLETED|Overall Study||87
571487|NCT00604383|1395040|P2|COMPLETED|Overall Study||256
571488|NCT00604383|1395041|P1|COMPLETED|Overall Study||258
571489|NCT00604383|1395040|P2|Received Extended Treatment|Overall Study||141
571490|NCT00604383|1395041|P1|Received Extended Treatment|Overall Study||136
571491|NCT00604383|1395040|P2|Received at Least 1 Dose of Study Drug|Overall Study||340
571492|NCT00604383|1395041|P1|Received at Least 1 Dose of Study Drug|Overall Study||345
571493|NCT00604383|1395040|P2|STARTED|Overall Study||340
571494|NCT00604383|1395041|P1|STARTED|Overall Study||345
571495|NCT00604279|1395057|P2|NOT COMPLETED|Overall Study||38
571496|NCT00604279|1395058|P1|NOT COMPLETED|Overall Study||64
571497|NCT00604279|1395057|P2|COMPLETED|Overall Study||185
571498|NCT00604279|1395058|P1|COMPLETED|Overall Study||165
571499|NCT00604279|1395057|P2|STARTED|Overall Study||223
571500|NCT00604279|1395058|P1|STARTED|Overall Study||229
571501|NCT00604214|1395074|P2|NOT COMPLETED|Day 91 to Day 180||32
571502|NCT00604214|1395075|P1|NOT COMPLETED|Day 91 to Day 180||26
571503|NCT00604214|1395074|P2|COMPLETED|Day 91 to Day 180||521
571504|NCT00604214|1395075|P1|COMPLETED|Day 91 to Day 180||529
571505|NCT00604214|1395074|P2|STARTED|Day 91 to Day 180||553
571506|NCT00604214|1395075|P1|STARTED|Day 91 to Day 180||555
571507|NCT00604214|1395074|P2|NOT COMPLETED|Day 29 to Day 90||79
571508|NCT00604214|1395075|P1|NOT COMPLETED|Day 29 to Day 90||68
571509|NCT00604214|1395074|P2|COMPLETED|Day 29 to Day 90||553
571510|NCT00604214|1395075|P1|COMPLETED|Day 29 to Day 90||555
571511|NCT00604214|1395074|P2|STARTED|Day 29 to Day 90||632
571512|NCT00604214|1395075|P1|STARTED|Day 29 to Day 90||623
571513|NCT00604214|1395074|P2|NOT COMPLETED|Baseline to Day 28||213
571514|NCT00604214|1395075|P1|NOT COMPLETED|Baseline to Day 28||228
571515|NCT00604214|1395074|P2|COMPLETED|Baseline to Day 28||632
571516|NCT00604214|1395075|P1|COMPLETED|Baseline to Day 28||623
571517|NCT00604214|1395074|P2|Received Study Drug|Baseline to Day 28||833
571518|NCT00604214|1395075|P1|Received Study Drug|Baseline to Day 28||833
571519|NCT00604214|1395074|P2|STARTED|Baseline to Day 28||845
571520|NCT00604214|1395075|P1|STARTED|Baseline to Day 28||851
571521|NCT00604188|1395107|P2|NOT COMPLETED|Overall Study||25
571522|NCT00604188|1395108|P1|NOT COMPLETED|Overall Study||27
571523|NCT00604188|1395107|P2|COMPLETED|Overall Study||70
571524|NCT00604188|1395108|P1|COMPLETED|Overall Study||66
571525|NCT00604188|1395107|P2|STARTED|Overall Study|The ITT population for Subutex-to-Suboxone Induction is 94 participants|95
571526|NCT00604188|1395108|P1|STARTED|Overall Study||93
571527|NCT00604175|1395131|P3|NOT COMPLETED|Week 29 Through Week 72||4
571528|NCT00604175|1395132|P2|NOT COMPLETED|Week 29 Through Week 72||7
571529|NCT00604175|1395133|P1|NOT COMPLETED|Week 29 Through Week 72||12
571530|NCT00604175|1395131|P3|COMPLETED|Week 29 Through Week 72||89
571531|NCT00604175|1395132|P2|COMPLETED|Week 29 Through Week 72||85
571532|NCT00604175|1395133|P1|COMPLETED|Week 29 Through Week 72||108
571533|NCT00604175|1395131|P3|STARTED|Week 29 Through Week 72||93
571534|NCT00604175|1395132|P2|STARTED|Week 29 Through Week 72||92
571535|NCT00604175|1395133|P1|STARTED|Week 29 Through Week 72||120
571536|NCT00604175|1395131|P3|NOT COMPLETED|Entry Through Week 28||1
571537|NCT00604175|1395132|P2|NOT COMPLETED|Entry Through Week 28||3
571538|NCT00604175|1395133|P1|NOT COMPLETED|Entry Through Week 28||10
571539|NCT00604175|1395131|P3|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|93
571540|NCT00604175|1395132|P2|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|92
571541|NCT00604175|1395133|P1|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|120
571542|NCT00604175|1395131|P3|STARTED|Entry Through Week 28||94
571543|NCT00604175|1395132|P2|STARTED|Entry Through Week 28||95
571544|NCT00604175|1395133|P1|STARTED|Entry Through Week 28||130
571545|NCT00604162|1395186|P1|NOT COMPLETED|Overall Study||4
571546|NCT00604162|1395186|P1|COMPLETED|Overall Study||328
571547|NCT00604162|1395186|P1|STARTED|Overall Study||332
571548|NCT00604045|1395199|P2|NOT COMPLETED|Overall Study||1
571549|NCT00604045|1395200|P1|NOT COMPLETED|Overall Study||1
571550|NCT00604045|1395199|P2|COMPLETED|Overall Study||9
571551|NCT00604045|1395200|P1|COMPLETED|Overall Study||14
571552|NCT00604045|1395199|P2|STARTED|Overall Study||10
571553|NCT00604045|1395200|P1|STARTED|Overall Study||15
571554|NCT00604019|1395208|P2|NOT COMPLETED|Overall Study||0
571555|NCT00604019|1395209|P1|NOT COMPLETED|Overall Study||0
571556|NCT00604019|1395208|P2|COMPLETED|Overall Study||118
571557|NCT00604019|1395209|P1|COMPLETED|Overall Study||134
571558|NCT00604019|1395208|P2|STARTED|Overall Study||118
571559|NCT00604019|1395209|P1|STARTED|Overall Study||134
571560|NCT00603993|1395215|P1|NOT COMPLETED|Overall Study||20
571561|NCT00603993|1395215|P1|COMPLETED|Overall Study||68
571562|NCT00603993|1395215|P1|STARTED|Overall Study||88
571563|NCT00603915|1395228|P1|NOT COMPLETED|Overall Study||1
571564|NCT00603915|1395228|P1|COMPLETED|Overall Study||19
571565|NCT00603915|1395228|P1|STARTED|Overall Study||20
571566|NCT00603902|1395236|P3|NOT COMPLETED|Overall Study||769
571567|NCT00603902|1395237|P2|NOT COMPLETED|Overall Study||686
571568|NCT00603902|1395238|P1|NOT COMPLETED|Overall Study||329
571569|NCT00603902|1395236|P3|COMPLETED|Overall Study||834
571570|NCT00603902|1395237|P2|COMPLETED|Overall Study||917
571571|NCT00603902|1395238|P1|COMPLETED|Overall Study||473
571573|NCT00603902|1395237|P2|STARTED|Overall Study||1603
571574|NCT00603902|1395238|P1|STARTED|Overall Study||802
571575|NCT00603889|1395249|P1|NOT COMPLETED|Overall Study||0
571576|NCT00603889|1395249|P1|COMPLETED|Overall Study||12
571577|NCT00603889|1395249|P1|STARTED|Overall Study||12
571578|NCT00603837|1395258|P2|NOT COMPLETED|Overall Study||0
571579|NCT00603837|1395259|P1|NOT COMPLETED|Overall Study||3
571580|NCT00603837|1395258|P2|COMPLETED|Overall Study||19
571581|NCT00603837|1395259|P1|COMPLETED|Overall Study||17
571582|NCT00603837|1395258|P2|STARTED|Overall Study||19
571583|NCT00603837|1395259|P1|STARTED|Overall Study||20
571584|NCT00603798|1395268|P3|NOT COMPLETED|Overall Study||10
571585|NCT00603798|1395269|P2|NOT COMPLETED|Overall Study||7
571586|NCT00603798|1395270|P1|NOT COMPLETED|Overall Study||10
571587|NCT00603798|1395268|P3|COMPLETED|Overall Study||154
571588|NCT00603798|1395269|P2|COMPLETED|Overall Study||157
571589|NCT00603798|1395270|P1|COMPLETED|Overall Study||152
571590|NCT00603798|1395268|P3|STARTED|Overall Study||164
571591|NCT00603798|1395269|P2|STARTED|Overall Study||164
571592|NCT00603798|1395270|P1|STARTED|Overall Study||162
571593|NCT00603746|1395293|P6|NOT COMPLETED|Overall Study||13
571594|NCT00603746|1395294|P5|NOT COMPLETED|Overall Study||17
571595|NCT00603746|1395295|P4|NOT COMPLETED|Overall Study||13
571596|NCT00603746|1395296|P3|NOT COMPLETED|Overall Study||8
571597|NCT00603746|1395297|P2|NOT COMPLETED|Overall Study||18
571598|NCT00603746|1395298|P1|NOT COMPLETED|Overall Study||38
571599|NCT00603746|1395293|P6|COMPLETED|Overall Study||97
571600|NCT00603746|1395294|P5|COMPLETED|Overall Study||85
571601|NCT00603746|1395295|P4|COMPLETED|Overall Study||94
571602|NCT00603746|1395296|P3|COMPLETED|Overall Study||93
571603|NCT00603746|1395297|P2|COMPLETED|Overall Study||81
571604|NCT00603746|1395298|P1|COMPLETED|Overall Study||65
571605|NCT00603746|1395293|P6|STARTED|Overall Study||110
571606|NCT00603746|1395294|P5|STARTED|Overall Study||102
571607|NCT00603746|1395295|P4|STARTED|Overall Study||107
571608|NCT00603746|1395296|P3|STARTED|Overall Study||101
571609|NCT00603746|1395297|P2|STARTED|Overall Study||99
571610|NCT00603746|1395298|P1|STARTED|Overall Study||103
571611|NCT00603733|1395446|P2|NOT COMPLETED|Maintenance Phase ITT||16
571612|NCT00603733|1395447|P1|NOT COMPLETED|Maintenance Phase ITT||10
571613|NCT00603733|1395446|P2|COMPLETED|Maintenance Phase ITT||66
571614|NCT00603733|1395447|P1|COMPLETED|Maintenance Phase ITT||61
571615|NCT00603733|1395446|P2|STARTED|Maintenance Phase ITT||82
571616|NCT00603733|1395447|P1|STARTED|Maintenance Phase ITT|Note:82 subjects randomized at Active phase & 71 at Run-In phase progressed to the maintenance phase|71
571617|NCT00603733|1395446|P2|NOT COMPLETED|Run-In Phase - 4 Weeks||13
571618|NCT00603733|1395447|P1|NOT COMPLETED|Run-In Phase - 4 Weeks||14
571619|NCT00603733|1395446|P2|COMPLETED|Run-In Phase - 4 Weeks||36
571620|NCT00603733|1395447|P1|COMPLETED|Run-In Phase - 4 Weeks||35
571621|NCT00603733|1395446|P2|STARTED|Run-In Phase - 4 Weeks||49
571622|NCT00603733|1395447|P1|STARTED|Run-In Phase - 4 Weeks|Note: Of the 98 subjects randomized at Run-In, 71 progressed into the maintenance phase.|49
571623|NCT00603733|1395446|P2|NOT COMPLETED|Active Phase ITT||17
571624|NCT00603733|1395447|P1|NOT COMPLETED|Active Phase ITT||11
571625|NCT00603733|1395446|P2|COMPLETED|Active Phase ITT||78
571626|NCT00603733|1395447|P1|COMPLETED|Active Phase ITT||84
571627|NCT00603733|1395446|P2|STARTED|Active Phase ITT||95
571628|NCT00603733|1395447|P1|STARTED|Active Phase ITT|Note: a total of 190 new participants were enrolled and randomized in the Active Phase|95
571629|NCT00603642|1395459|P2|NOT COMPLETED|Overall Study||0
571630|NCT00603642|1395460|P1|NOT COMPLETED|Overall Study||0
571631|NCT00603642|1395459|P2|COMPLETED|Overall Study||22
571632|NCT00603642|1395460|P1|COMPLETED|Overall Study||12
571633|NCT00603642|1395459|P2|STARTED|Overall Study||22
571634|NCT00603642|1395460|P1|STARTED|Overall Study||12
571635|NCT00603590|1395476|P2|NOT COMPLETED|Overall Study||51
571636|NCT00603590|1395477|P1|NOT COMPLETED|Overall Study||76
571637|NCT00603590|1395476|P2|COMPLETED|Overall Study||183
571638|NCT00603590|1395477|P1|COMPLETED|Overall Study||165
571639|NCT00603590|1395476|P2|Eight Months|Overall Study||194
571640|NCT00603590|1395477|P1|Eight Months|Overall Study||178
571641|NCT00603590|1395476|P2|Four Months|Overall Study||200
571642|NCT00603590|1395477|P1|Four Months|Overall Study||187
571643|NCT00603590|1395476|P2|One Month|Overall Study||212
571644|NCT00603590|1395477|P1|One Month|Overall Study||204
571645|NCT00603590|1395476|P2|STARTED|Overall Study||234
571646|NCT00603590|1395477|P1|STARTED|Overall Study||241
571647|NCT00603564|1395489|P2|NOT COMPLETED|Overall Study||0
571648|NCT00603564|1395490|P1|NOT COMPLETED|Overall Study||0
571649|NCT00603564|1395489|P2|COMPLETED|Overall Study|February 2008|27
571650|NCT00603564|1395490|P1|COMPLETED|Overall Study|February 2008|20
571651|NCT00603564|1395489|P2|STARTED|Overall Study|January 2006|27
571652|NCT00603564|1395490|P1|STARTED|Overall Study|January 2006|20
571653|NCT00603538|1395501|P3|NOT COMPLETED|Overall Study||2
571654|NCT00603538|1395502|P2|NOT COMPLETED|Overall Study||4
571655|NCT00603538|1395503|P1|NOT COMPLETED|Overall Study||3
571656|NCT00603538|1395501|P3|COMPLETED|Overall Study||4
571657|NCT00603538|1395502|P2|COMPLETED|Overall Study||3
571658|NCT00603538|1395503|P1|COMPLETED|Overall Study||3
571659|NCT00603538|1395501|P3|STARTED|Overall Study||6
571660|NCT00603538|1395502|P2|STARTED|Overall Study|Including one participant who discontinued from the study prior to CP-751,871 administration.|7
571661|NCT00603538|1395503|P1|STARTED|Overall Study||6
571662|NCT00603525|1395543|P3|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||111
571663|NCT00603525|1395544|P2|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
571664|NCT00603525|1395545|P1|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
571665|NCT00603525|1395543|P3|COMPLETED|Follow-up Period (Approximately 2 Years)||13
571666|NCT00603525|1395544|P2|COMPLETED|Follow-up Period (Approximately 2 Years)||0
571667|NCT00603525|1395545|P1|COMPLETED|Follow-up Period (Approximately 2 Years)||0
571668|NCT00603525|1395543|P3|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)|As par. were not on active drug during the Follow-up Period, withdrawal reasons were not collected.|111
571669|NCT00603525|1395544|P2|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0
571670|NCT00603525|1395545|P1|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0
571671|NCT00603525|1395543|P3|STARTED|Follow-up Period (Approximately 2 Years)|124 participants (par) completing/withdrawing from the DB or OL Periods attended >=1 follow-up visit|124
571672|NCT00603525|1395544|P2|STARTED|Follow-up Period (Approximately 2 Years)||0
571673|NCT00603525|1395545|P1|STARTED|Follow-up Period (Approximately 2 Years)||0
571674|NCT00603525|1395543|P3|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
571675|NCT00603525|1395544|P2|NOT COMPLETED|OL Treatment Period (120 Weeks)||112
571676|NCT00603525|1395545|P1|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
571677|NCT00603525|1395543|P3|COMPLETED|OL Treatment Period (120 Weeks)||0
571678|NCT00603525|1395544|P2|COMPLETED|OL Treatment Period (120 Weeks)||13
571679|NCT00603525|1395545|P1|COMPLETED|OL Treatment Period (120 Weeks)||0
571680|NCT00603525|1395543|P3|STARTED|OL Treatment Period (120 Weeks)||0
571681|NCT00603525|1395544|P2|STARTED|OL Treatment Period (120 Weeks)|61 participants received OFA during the DB Period; 64 received placebo during the DB Period.|125
571682|NCT00603525|1395545|P1|STARTED|OL Treatment Period (120 Weeks)||0
571683|NCT00603525|1395543|P3|NOT COMPLETED|DB Treatment Period (24 Weeks)||0
571684|NCT00603525|1395544|P2|NOT COMPLETED|DB Treatment Period (24 Weeks)||22
571685|NCT00603525|1395545|P1|NOT COMPLETED|DB Treatment Period (24 Weeks)||17
571686|NCT00603525|1395543|P3|COMPLETED|DB Treatment Period (24 Weeks)||0
571687|NCT00603525|1395544|P2|COMPLETED|DB Treatment Period (24 Weeks)||63
571688|NCT00603525|1395545|P1|COMPLETED|DB Treatment Period (24 Weeks)||67
571689|NCT00603525|1395543|P3|STARTED|DB Treatment Period (24 Weeks)||0
571690|NCT00603525|1395544|P2|STARTED|DB Treatment Period (24 Weeks)||85
571691|NCT00603525|1395545|P1|STARTED|DB Treatment Period (24 Weeks)||84
571692|NCT00603512|1395677|P5|NOT COMPLETED|Overall Study||5
571693|NCT00603512|1395678|P4|NOT COMPLETED|Overall Study||7
571694|NCT00603512|1395679|P3|NOT COMPLETED|Overall Study||5
571695|NCT00603512|1395680|P2|NOT COMPLETED|Overall Study||5
571696|NCT00603512|1395681|P1|NOT COMPLETED|Overall Study||2
571697|NCT00603512|1395677|P5|COMPLETED|Overall Study||23
571698|NCT00603512|1395678|P4|COMPLETED|Overall Study||21
571699|NCT00603512|1395679|P3|COMPLETED|Overall Study||23
571700|NCT00603512|1395680|P2|COMPLETED|Overall Study||23
571701|NCT00603512|1395681|P1|COMPLETED|Overall Study||26
571702|NCT00603512|1395677|P5|Treated|Overall Study||28
571703|NCT00603512|1395678|P4|Treated|Overall Study||26
571704|NCT00603512|1395679|P3|Treated|Overall Study||27
571705|NCT00603512|1395680|P2|Treated|Overall Study||27
571706|NCT00603512|1395681|P1|Treated|Overall Study||28
571707|NCT00603512|1395677|P5|STARTED|Overall Study||28
571708|NCT00603512|1395678|P4|STARTED|Overall Study||28
571709|NCT00603512|1395679|P3|STARTED|Overall Study||28
571710|NCT00603512|1395680|P2|STARTED|Overall Study||28
571711|NCT00603512|1395681|P1|STARTED|Overall Study||28
571712|NCT00603473|1395823|P1|NOT COMPLETED|Overall Study||9
571713|NCT00603473|1395823|P1|COMPLETED|Overall Study||80
571714|NCT00603473|1395823|P1|STARTED|Overall Study||89
571715|NCT00603447|1395836|P7|NOT COMPLETED|Overall Study||24
571716|NCT00603447|1395837|P6|NOT COMPLETED|Overall Study||2
571717|NCT00603447|1395838|P5|NOT COMPLETED|Overall Study||5
571718|NCT00603447|1395839|P4|NOT COMPLETED|Overall Study||2
571719|NCT00603447|1395840|P3|NOT COMPLETED|Overall Study||2
571720|NCT00603447|1395841|P2|NOT COMPLETED|Overall Study||3
571721|NCT00603447|1395842|P1|NOT COMPLETED|Overall Study||0
571722|NCT00603447|1395836|P7|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|20
571723|NCT00603447|1395837|P6|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
571724|NCT00603447|1395838|P5|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|1
571725|NCT00603447|1395839|P4|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|4
571726|NCT00603447|1395840|P3|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
571727|NCT00603447|1395841|P2|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|3
571728|NCT00603447|1395842|P1|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
571729|NCT00603447|1395836|P7|STARTED|Overall Study||44
571730|NCT00603447|1395837|P6|STARTED|Overall Study||8
571731|NCT00603447|1395838|P5|STARTED|Overall Study||6
571732|NCT00603447|1395839|P4|STARTED|Overall Study||6
571733|NCT00603447|1395840|P3|STARTED|Overall Study||8
571734|NCT00603447|1395841|P2|STARTED|Overall Study||6
571735|NCT00603447|1395842|P1|STARTED|Overall Study||6
571736|NCT00603408|1395864|P1|NOT COMPLETED|Overall Study||0
571737|NCT00603408|1395864|P1|COMPLETED|Overall Study||5
571738|NCT00603408|1395864|P1|STARTED|Overall Study||5
571739|NCT00603382|1395881|P6|NOT COMPLETED|Overall Study||18
571740|NCT00603382|1395882|P5|NOT COMPLETED|Overall Study||9
571741|NCT00603382|1395883|P4|NOT COMPLETED|Overall Study||12
571742|NCT00603382|1395884|P3|NOT COMPLETED|Overall Study||9
571743|NCT00603382|1395885|P2|NOT COMPLETED|Overall Study||14
571744|NCT00603382|1395886|P1|NOT COMPLETED|Overall Study||18
571745|NCT00603382|1395881|P6|COMPLETED|Overall Study||84
571746|NCT00603382|1395882|P5|COMPLETED|Overall Study||86
571747|NCT00603382|1395883|P4|COMPLETED|Overall Study||98
571748|NCT00603382|1395884|P3|COMPLETED|Overall Study||91
571749|NCT00603382|1395885|P2|COMPLETED|Overall Study||83
571750|NCT00603382|1395886|P1|COMPLETED|Overall Study||76
571751|NCT00603382|1395881|P6|STARTED|Overall Study||102
571752|NCT00603382|1395882|P5|STARTED|Overall Study||95
571753|NCT00603382|1395883|P4|STARTED|Overall Study||110
571754|NCT00603382|1395884|P3|STARTED|Overall Study||100
571755|NCT00603382|1395885|P2|STARTED|Overall Study||97
571756|NCT00603382|1395886|P1|STARTED|Overall Study||94
571757|NCT00603304|1396034|P2|NOT COMPLETED|Overall Study||31
571758|NCT00603304|1396035|P1|NOT COMPLETED|Overall Study||32
571759|NCT00603304|1396034|P2|COMPLETED|Overall Study||155
571760|NCT00603304|1396035|P1|COMPLETED|Overall Study||151
571761|NCT00603304|1396034|P2|STARTED|Overall Study||186
571762|NCT00603304|1396035|P1|STARTED|Overall Study||183
571763|NCT00603291|1396072|P3|NOT COMPLETED|Overall Study||96
571764|NCT00603291|1396073|P2|NOT COMPLETED|Overall Study||87
571765|NCT00603291|1396074|P1|NOT COMPLETED|Overall Study||20
571766|NCT00603291|1396072|P3|COMPLETED|Overall Study||157
571767|NCT00603291|1396073|P2|COMPLETED|Overall Study||169
571768|NCT00603291|1396074|P1|COMPLETED|Overall Study||75
571769|NCT00603291|1396072|P3|STARTED|Overall Study||253
571770|NCT00603291|1396073|P2|STARTED|Overall Study||256
571771|NCT00603291|1396074|P1|STARTED|Overall Study||95
571772|NCT00603278|1396091|P6|NOT COMPLETED|Overall Study||19
571773|NCT00603278|1396092|P5|NOT COMPLETED|Overall Study||13
571774|NCT00603278|1396093|P4|NOT COMPLETED|Overall Study||11
571775|NCT00603278|1396094|P3|NOT COMPLETED|Overall Study||14
571776|NCT00603278|1396095|P2|NOT COMPLETED|Overall Study||17
571777|NCT00603278|1396096|P1|NOT COMPLETED|Overall Study||41
571778|NCT00603278|1396091|P6|COMPLETED|Overall Study||81
571779|NCT00603278|1396092|P5|COMPLETED|Overall Study||86
571780|NCT00603278|1396093|P4|COMPLETED|Overall Study||92
571781|NCT00603278|1396094|P3|COMPLETED|Overall Study||87
571782|NCT00603278|1396095|P2|COMPLETED|Overall Study||88
571783|NCT00603278|1396096|P1|COMPLETED|Overall Study||66
571784|NCT00603278|1396091|P6|STARTED|Overall Study||100
571785|NCT00603278|1396092|P5|STARTED|Overall Study||99
571786|NCT00603278|1396093|P4|STARTED|Overall Study||103
571787|NCT00603278|1396094|P3|STARTED|Overall Study||101
571788|NCT00603278|1396095|P2|STARTED|Overall Study||105
571789|NCT00603278|1396096|P1|STARTED|Overall Study||107
571790|NCT00603265|1396245|P3|NOT COMPLETED|Overall Study||5
571791|NCT00603265|1396246|P2|NOT COMPLETED|Overall Study||16
571792|NCT00603265|1396247|P1|NOT COMPLETED|Overall Study||7
571793|NCT00603265|1396245|P3|COMPLETED|Overall Study||67
571794|NCT00603265|1396246|P2|COMPLETED|Overall Study||62
571795|NCT00603265|1396247|P1|COMPLETED|Overall Study||69
571796|NCT00603265|1396245|P3|Received at Least 1 Dose of Study Drug|Overall Study||72
571797|NCT00603265|1396246|P2|Received at Least 1 Dose of Study Drug|Overall Study||78
571798|NCT00603265|1396247|P1|Received at Least 1 Dose of Study Drug|Overall Study||75
571799|NCT00603265|1396245|P3|STARTED|Overall Study||72
571800|NCT00603265|1396246|P2|STARTED|Overall Study||78
571801|NCT00603265|1396247|P1|STARTED|Overall Study|1 participant was randomized in error and did not receive study medication|76
571802|NCT00603239|1396275|P2|NOT COMPLETED|Overall Study||4
571803|NCT00603239|1396276|P1|NOT COMPLETED|Overall Study||15
571804|NCT00603239|1396275|P2|COMPLETED|Overall Study||50
571805|NCT00603239|1396276|P1|COMPLETED|Overall Study||96
571806|NCT00603239|1396275|P2|STARTED|Overall Study||54
571807|NCT00603239|1396276|P1|STARTED|Overall Study||111
571808|NCT00603187|1396302|P1|NOT COMPLETED|Overall Study||0
571809|NCT00603187|1396302|P1|COMPLETED|Overall Study||4
571810|NCT00603187|1396302|P1|STARTED|Overall Study||4
571811|NCT00603044|1396310|P2|NOT COMPLETED|Overall Study||0
571812|NCT00603044|1396311|P1|NOT COMPLETED|Overall Study||0
571813|NCT00603044|1396310|P2|COMPLETED|Overall Study||13
571814|NCT00603044|1396311|P1|COMPLETED|Overall Study||11
571815|NCT00603044|1396310|P2|STARTED|Overall Study||13
571816|NCT00603044|1396311|P1|STARTED|Overall Study||11
571817|NCT00603018|1396327|P1|NOT COMPLETED|Overall Study||0
571818|NCT00603018|1396327|P1|COMPLETED|Overall Study||23
571819|NCT00603018|1396327|P1|STARTED|Overall Study||23
571820|NCT00602979|1396337|P5|NOT COMPLETED|Overall Study||3
571821|NCT00602979|1396338|P4|NOT COMPLETED|Overall Study||3
571822|NCT00602979|1396339|P3|NOT COMPLETED|Overall Study||3
571823|NCT00602979|1396340|P2|NOT COMPLETED|Overall Study||3
571824|NCT00602979|1396341|P1|NOT COMPLETED|Overall Study||3
571825|NCT00602979|1396337|P5|COMPLETED|Overall Study||45
571826|NCT00602979|1396338|P4|COMPLETED|Overall Study||45
571827|NCT00602979|1396339|P3|COMPLETED|Overall Study||45
571828|NCT00602979|1396340|P2|COMPLETED|Overall Study||45
571829|NCT00602979|1396341|P1|COMPLETED|Overall Study||45
571830|NCT00602979|1396337|P5|STARTED|Overall Study||48
571831|NCT00602979|1396338|P4|STARTED|Overall Study||48
571832|NCT00602979|1396339|P3|STARTED|Overall Study||48
571833|NCT00602979|1396340|P2|STARTED|Overall Study||48
571834|NCT00602979|1396341|P1|STARTED|Overall Study||48
571835|NCT00602953|1396358|P5|NOT COMPLETED|Overall Study||0
571836|NCT00602953|1396359|P4|NOT COMPLETED|Overall Study||0
571837|NCT00602953|1396360|P3|NOT COMPLETED|Overall Study||0
571838|NCT00602953|1396361|P2|NOT COMPLETED|Overall Study||0
571839|NCT00602953|1396362|P1|NOT COMPLETED|Overall Study||0
571840|NCT00602953|1396358|P5|COMPLETED|Overall Study||0
571841|NCT00602953|1396359|P4|COMPLETED|Overall Study||13
571842|NCT00602953|1396360|P3|COMPLETED|Overall Study||47
571843|NCT00602953|1396361|P2|COMPLETED|Overall Study||26
571844|NCT00602953|1396362|P1|COMPLETED|Overall Study||15
571845|NCT00602953|1396358|P5|STARTED|Overall Study||0
571846|NCT00602953|1396359|P4|STARTED|Overall Study||13
571847|NCT00602953|1396360|P3|STARTED|Overall Study||47
571848|NCT00602953|1396361|P2|STARTED|Overall Study||26
571849|NCT00602953|1396362|P1|STARTED|Overall Study||15
571850|NCT00602927|1396391|P2|NOT COMPLETED|Period 3: 13 Days||3
571851|NCT00602927|1396392|P1|NOT COMPLETED|Period 3: 13 Days||2
571852|NCT00602927|1396391|P2|COMPLETED|Period 3: 13 Days||9
571853|NCT00602927|1396392|P1|COMPLETED|Period 3: 13 Days||13
571854|NCT00602927|1396391|P2|STARTED|Period 3: 13 Days||12
571855|NCT00602927|1396392|P1|STARTED|Period 3: 13 Days||15
571856|NCT00602927|1396391|P2|NOT COMPLETED|Period 2: 14 Days||2
571857|NCT00602927|1396392|P1|NOT COMPLETED|Period 2: 14 Days||0
571858|NCT00602927|1396391|P2|COMPLETED|Period 2: 14 Days||12
571859|NCT00602927|1396392|P1|COMPLETED|Period 2: 14 Days||15
571860|NCT00602927|1396391|P2|STARTED|Period 2: 14 Days||14
571861|NCT00602927|1396392|P1|STARTED|Period 2: 14 Days||15
571862|NCT00602927|1396391|P2|NOT COMPLETED|Period 1: 13 Days||5
571863|NCT00602927|1396392|P1|NOT COMPLETED|Period 1: 13 Days||4
571864|NCT00602927|1396391|P2|COMPLETED|Period 1: 13 Days||14
571865|NCT00602927|1396392|P1|COMPLETED|Period 1: 13 Days||15
571866|NCT00602927|1396391|P2|STARTED|Period 1: 13 Days||19
571867|NCT00602927|1396392|P1|STARTED|Period 1: 13 Days||19
571868|NCT00602836|1396400|P1|NOT COMPLETED|Overall Study||5
571869|NCT00602836|1396400|P1|COMPLETED|Overall Study||39
571870|NCT00602836|1396400|P1|STARTED|Overall Study||44
571871|NCT00602797|1396404|P1|NOT COMPLETED|Overall Study||1
571872|NCT00602797|1396404|P1|COMPLETED|Overall Study||19
571873|NCT00602797|1396404|P1|STARTED|Overall Study||20
571874|NCT00602771|1396412|P2|NOT COMPLETED|Overall Study||0
571875|NCT00602771|1396413|P1|NOT COMPLETED|Overall Study||1
571876|NCT00602771|1396412|P2|COMPLETED|Overall Study||21
571877|NCT00602771|1396413|P1|COMPLETED|Overall Study||62
571878|NCT00602771|1396412|P2|STARTED|Overall Study||21
571879|NCT00602771|1396413|P1|STARTED|Overall Study||63
571880|NCT00602641|1396421|P2|NOT COMPLETED|Overall Study||152
571881|NCT00602641|1396422|P1|NOT COMPLETED|Overall Study||154
571882|NCT00602641|1396421|P2|COMPLETED|Overall Study|Treatment continued until progression of disease, unacceptable toxicity or patient withdrawal.|0
571883|NCT00602641|1396422|P1|COMPLETED|Overall Study|Treatment continued until progression of disease, unacceptable toxicity or patient withdrawal.|0
571884|NCT00602641|1396421|P2|Started Protocol Therapy|Overall Study||150
571885|NCT00602641|1396422|P1|Started Protocol Therapy|Overall Study||148
571886|NCT00602641|1396421|P2|STARTED|Overall Study||152
571887|NCT00602641|1396422|P1|STARTED|Overall Study||154
571888|NCT00602537|1396436|P2|NOT COMPLETED|Follow Up Study Comparison||3
571889|NCT00602537|1396437|P1|NOT COMPLETED|Follow Up Study Comparison||11
571890|NCT00602537|1396436|P2|COMPLETED|Follow Up Study Comparison||14
571891|NCT00602537|1396437|P1|COMPLETED|Follow Up Study Comparison||31
571892|NCT00602537|1396436|P2|STARTED|Follow Up Study Comparison||17
571893|NCT00602537|1396437|P1|STARTED|Follow Up Study Comparison||42
571894|NCT00602537|1396436|P2|NOT COMPLETED|12 Week Double Blind Comparison||47
571895|NCT00602537|1396437|P1|NOT COMPLETED|12 Week Double Blind Comparison||23
571896|NCT00602537|1396436|P2|COMPLETED|12 Week Double Blind Comparison||17
571897|NCT00602537|1396437|P1|COMPLETED|12 Week Double Blind Comparison||42
571898|NCT00602537|1396436|P2|Responded|12 Week Double Blind Comparison||22
571899|NCT00602537|1396437|P1|Responded|12 Week Double Blind Comparison||44
571900|NCT00602537|1396436|P2|STARTED|12 Week Double Blind Comparison||64
571901|NCT00602537|1396437|P1|STARTED|12 Week Double Blind Comparison||65
571902|NCT00602472|1396447|P2|NOT COMPLETED|Overall Study||58
571903|NCT00602472|1396448|P1|NOT COMPLETED|Overall Study||21
571904|NCT00602472|1396447|P2|COMPLETED|Overall Study|number who completed treatment|734
571905|NCT00602472|1396448|P1|COMPLETED|Overall Study|number who completed treatment|242
571906|NCT00602472|1396447|P2|STARTED|Overall Study|3 randomised patients never took medication.|792
571907|NCT00602472|1396448|P1|STARTED|Overall Study|3 randomised patients never took medication.|263
571908|NCT00602459|1396482|P4|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
571909|NCT00602459|1396483|P3|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
571910|NCT00602459|1396484|P2|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
571911|NCT00602459|1396485|P1|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
571912|NCT00602459|1396482|P4|COMPLETED|Re-assignment After Del(11q22.3) Testing||31
571913|NCT00602459|1396483|P3|COMPLETED|Re-assignment After Del(11q22.3) Testing||137
571914|NCT00602459|1396484|P2|COMPLETED|Re-assignment After Del(11q22.3) Testing||109
571915|NCT00602459|1396485|P1|COMPLETED|Re-assignment After Del(11q22.3) Testing||123
571916|NCT00602459|1396482|P4|STARTED|Re-assignment After Del(11q22.3) Testing||31
571917|NCT00602459|1396483|P3|STARTED|Re-assignment After Del(11q22.3) Testing||137
571918|NCT00602459|1396484|P2|STARTED|Re-assignment After Del(11q22.3) Testing||109
571919|NCT00602459|1396485|P1|STARTED|Re-assignment After Del(11q22.3) Testing||123
571920|NCT00602459|1396482|P4|NOT COMPLETED|Initial Registration/Randomization||0
571921|NCT00602459|1396483|P3|NOT COMPLETED|Initial Registration/Randomization||3
571922|NCT00602459|1396484|P2|NOT COMPLETED|Initial Registration/Randomization||10
571923|NCT00602459|1396485|P1|NOT COMPLETED|Initial Registration/Randomization||5
571924|NCT00602459|1396482|P4|COMPLETED|Initial Registration/Randomization||0
571925|NCT00602459|1396483|P3|COMPLETED|Initial Registration/Randomization||137
571926|NCT00602459|1396484|P2|COMPLETED|Initial Registration/Randomization||130
571927|NCT00602459|1396485|P1|COMPLETED|Initial Registration/Randomization||133
571928|NCT00602459|1396482|P4|STARTED|Initial Registration/Randomization||0
571929|NCT00602459|1396483|P3|STARTED|Initial Registration/Randomization||140
571930|NCT00602459|1396484|P2|STARTED|Initial Registration/Randomization||140
571931|NCT00602459|1396485|P1|STARTED|Initial Registration/Randomization||138
571932|NCT00602446|1396501|P1|NOT COMPLETED|Overall Study||0
571933|NCT00602446|1396501|P1|COMPLETED|Overall Study||3
571934|NCT00602446|1396501|P1|STARTED|Overall Study||3
571935|NCT00602420|1396508|P2|NOT COMPLETED|Overall Study||24
571936|NCT00602420|1396509|P1|NOT COMPLETED|Overall Study||25
571937|NCT00602420|1396508|P2|COMPLETED|Overall Study||229
571938|NCT00602420|1396509|P1|COMPLETED|Overall Study||232
571939|NCT00602420|1396508|P2|STARTED|Overall Study||253
571940|NCT00602420|1396509|P1|STARTED|Overall Study||257
571941|NCT00602355|1396518|P3|NOT COMPLETED|Overall Study||10
571942|NCT00602355|1396519|P2|NOT COMPLETED|Overall Study||18
571943|NCT00602355|1396520|P1|NOT COMPLETED|Overall Study||9
571944|NCT00602355|1396518|P3|COMPLETED|Overall Study||43
571945|NCT00602355|1396519|P2|COMPLETED|Overall Study||38
571946|NCT00602355|1396520|P1|COMPLETED|Overall Study||44
571947|NCT00602355|1396518|P3|STARTED|Overall Study||53
571948|NCT00602355|1396519|P2|STARTED|Overall Study||56
571949|NCT00602355|1396520|P1|STARTED|Overall Study||53
571950|NCT00602290|1396543|P3|NOT COMPLETED|Overall Study||1
571951|NCT00602290|1396544|P2|NOT COMPLETED|Overall Study||2
571952|NCT00602290|1396545|P1|NOT COMPLETED|Overall Study||2
571953|NCT00602290|1396543|P3|COMPLETED|Overall Study||46
571954|NCT00602290|1396544|P2|COMPLETED|Overall Study||46
571955|NCT00602290|1396545|P1|COMPLETED|Overall Study||46
571956|NCT00602290|1396543|P3|STARTED|Overall Study||47
571957|NCT00602290|1396544|P2|STARTED|Overall Study||48
571958|NCT00602290|1396545|P1|STARTED|Overall Study||48
571959|NCT00602225|1396556|P1|NOT COMPLETED|Overall Study||0
571960|NCT00602225|1396556|P1|COMPLETED|Overall Study||50
571961|NCT00602225|1396556|P1|STARTED|Overall Study||50
571962|NCT00602043|1396569|P1|NOT COMPLETED|Overall Study||5
571963|NCT00602043|1396569|P1|COMPLETED|Overall Study||15
571964|NCT00602043|1396569|P1|STARTED|Overall Study||20
571965|NCT00601965|1396583|P4|NOT COMPLETED|Overall Study||1
571966|NCT00601965|1396584|P3|NOT COMPLETED|Overall Study||0
571967|NCT00601965|1396585|P2|NOT COMPLETED|Overall Study||2
571968|NCT00601965|1396586|P1|NOT COMPLETED|Overall Study||0
571969|NCT00601965|1396583|P4|COMPLETED|Overall Study||17
571970|NCT00601965|1396584|P3|COMPLETED|Overall Study||19
571971|NCT00601965|1396585|P2|COMPLETED|Overall Study||16
571972|NCT00601965|1396586|P1|COMPLETED|Overall Study||18
571973|NCT00601965|1396583|P4|STARTED|Overall Study||18
571974|NCT00601965|1396584|P3|STARTED|Overall Study||19
571975|NCT00601965|1396585|P2|STARTED|Overall Study||18
571976|NCT00601965|1396586|P1|STARTED|Overall Study||18
571977|NCT00601952|1396602|P2|NOT COMPLETED|Overall Study||0
571978|NCT00601952|1396603|P1|NOT COMPLETED|Overall Study||2
571979|NCT00601952|1396602|P2|COMPLETED|Overall Study||17
571980|NCT00601952|1396603|P1|COMPLETED|Overall Study||12
571981|NCT00601952|1396602|P2|STARTED|Overall Study||17
571982|NCT00601952|1396603|P1|STARTED|Overall Study||14
571983|NCT00601926|1396609|P1|NOT COMPLETED|Overall Study||0
571984|NCT00601926|1396609|P1|COMPLETED|Overall Study||5
571985|NCT00601926|1396609|P1|STARTED|Overall Study||5
571986|NCT00601900|1396617|P2|NOT COMPLETED|Overall Study||3
571987|NCT00601900|1396618|P1|NOT COMPLETED|Overall Study||0
571988|NCT00601900|1396617|P2|COMPLETED|Overall Study||196
571989|NCT00601900|1396618|P1|COMPLETED|Overall Study||195
571990|NCT00601900|1396617|P2|STARTED|Overall Study||199
571991|NCT00601900|1396618|P1|STARTED|Overall Study||195
571992|NCT00601835|1396634|P2|NOT COMPLETED|Overall Study||14
571993|NCT00601835|1396635|P1|NOT COMPLETED|Overall Study||60
571994|NCT00601835|1396634|P2|COMPLETED|Overall Study||686
571995|NCT00601835|1396635|P1|COMPLETED|Overall Study||2890
571996|NCT00601835|1396634|P2|STARTED|Overall Study||700
571997|NCT00601835|1396635|P1|STARTED|Overall Study||2950
571998|NCT00601796|1396645|P1|NOT COMPLETED|Overall Study||0
571999|NCT00601796|1396645|P1|COMPLETED|Overall Study||24
572000|NCT00601796|1396645|P1|STARTED|Overall Study||24
572001|NCT00601731|1396664|P4|NOT COMPLETED|Overall Study||1
572002|NCT00601731|1396665|P3|NOT COMPLETED|Overall Study||15
572003|NCT00601731|1396666|P2|NOT COMPLETED|Overall Study||0
572004|NCT00601731|1396667|P1|NOT COMPLETED|Overall Study||23
572005|NCT00601731|1396664|P4|COMPLETED|Overall Study||29
572006|NCT00601731|1396665|P3|COMPLETED|Overall Study||151
572007|NCT00601731|1396666|P2|COMPLETED|Overall Study||43
572008|NCT00601731|1396667|P1|COMPLETED|Overall Study||120
572009|NCT00601731|1396664|P4|STARTED|Overall Study||30
572010|NCT00601731|1396665|P3|STARTED|Overall Study||166
572011|NCT00601731|1396666|P2|STARTED|Overall Study||43
572012|NCT00601731|1396667|P1|STARTED|Overall Study||143
572013|NCT00601718|1396717|P1|NOT COMPLETED|Overall Study||0
572014|NCT00601718|1396717|P1|COMPLETED|Overall Study||29
572015|NCT00601718|1396717|P1|STARTED|Overall Study||29
572016|NCT00601640|1396727|P3|NOT COMPLETED|Overall Study||10
572017|NCT00601640|1396728|P2|NOT COMPLETED|Overall Study||5
572018|NCT00601640|1396729|P1|NOT COMPLETED|Overall Study||5
572019|NCT00601640|1396727|P3|COMPLETED|Overall Study||42
572020|NCT00601640|1396728|P2|COMPLETED|Overall Study||47
572021|NCT00601640|1396729|P1|COMPLETED|Overall Study||47
572022|NCT00601640|1396727|P3|STARTED|Overall Study||52
572023|NCT00601640|1396728|P2|STARTED|Overall Study||52
572024|NCT00601640|1396729|P1|STARTED|Overall Study||52
572025|NCT00601627|1396743|P1|NOT COMPLETED|Overall Study||0
572026|NCT00601627|1396743|P1|COMPLETED|Overall Study||51
572027|NCT00601627|1396743|P1|STARTED|Overall Study||51
572028|NCT00601523|1396754|P2|NOT COMPLETED|Overall Study||26
572029|NCT00601523|1396755|P1|NOT COMPLETED|Overall Study||77
572030|NCT00601523|1396754|P2|COMPLETED|Overall Study||117
572031|NCT00601523|1396755|P1|COMPLETED|Overall Study||291
572032|NCT00601523|1396754|P2|STARTED|Overall Study||143
572033|NCT00601523|1396755|P1|STARTED|Overall Study||368
572034|NCT00601458|1396790|P3|NOT COMPLETED|Overall Study||2
572035|NCT00601458|1396791|P2|NOT COMPLETED|Overall Study||5
572036|NCT00601458|1396792|P1|NOT COMPLETED|Overall Study||4
572037|NCT00601458|1396790|P3|COMPLETED|Overall Study||28
572038|NCT00601458|1396791|P2|COMPLETED|Overall Study||29
572039|NCT00601458|1396792|P1|COMPLETED|Overall Study||32
572040|NCT00601458|1396790|P3|STARTED|Overall Study||30
572041|NCT00601458|1396791|P2|STARTED|Overall Study||34
572042|NCT00601458|1396792|P1|STARTED|Overall Study||36
572043|NCT00601419|1396803|P1|NOT COMPLETED|Overall Study||4
572044|NCT00601419|1396803|P1|COMPLETED|Overall Study||226
572045|NCT00601419|1396803|P1|STARTED|Overall Study||230
572046|NCT00601367|1396827|P1|NOT COMPLETED|Overall Study||187
572047|NCT00601367|1396827|P1|COMPLETED|Overall Study||293
572048|NCT00601367|1396827|P1|STARTED|Overall Study||480
572049|NCT00601354|1396833|P2|NOT COMPLETED|Overall Study||5
572050|NCT00601354|1396834|P1|NOT COMPLETED|Overall Study||4
572051|NCT00601354|1396833|P2|COMPLETED|Overall Study||4
572052|NCT00601354|1396834|P1|COMPLETED|Overall Study||4
572053|NCT00601354|1396833|P2|STARTED|Overall Study||9
572054|NCT00601354|1396834|P1|STARTED|Overall Study||8
572055|NCT00601250|1396846|P2|NOT COMPLETED|Overall Study||39
572056|NCT00601250|1396847|P1|NOT COMPLETED|Overall Study||14
572057|NCT00601250|1396846|P2|COMPLETED|Overall Study|number who completed treatment|484
572058|NCT00601250|1396847|P1|COMPLETED|Overall Study|number who completed treatment|163
572059|NCT00601250|1396846|P2|STARTED|Overall Study|number who started treatment. One additional patient was randomised but not treated.|523
572060|NCT00601250|1396847|P1|STARTED|Overall Study|number who started treatment|177
572061|NCT00601172|1396883|P2|NOT COMPLETED|Overall Study||127
572062|NCT00601172|1396884|P1|NOT COMPLETED|Overall Study||141
572063|NCT00601172|1396883|P2|COMPLETED|Overall Study||228
572064|NCT00601172|1396884|P1|COMPLETED|Overall Study||214
572065|NCT00601172|1396883|P2|STARTED|Overall Study||355
572066|NCT00601172|1396884|P1|STARTED|Overall Study||355
572067|NCT00601146|1396933|P1|NOT COMPLETED|Overall Study||161
572068|NCT00601146|1396933|P1|COMPLETED|Overall Study||39
572069|NCT00601146|1396933|P1|STARTED|Overall Study||200
572070|NCT00601107|1396941|P4|NOT COMPLETED|Overall Study||12
572071|NCT00601107|1396942|P3|NOT COMPLETED|Overall Study||12
572072|NCT00601107|1396943|P2|NOT COMPLETED|Overall Study||9
572073|NCT00601107|1396944|P1|NOT COMPLETED|Overall Study||13
572074|NCT00601107|1396941|P4|COMPLETED|Overall Study||13
572075|NCT00601107|1396942|P3|COMPLETED|Overall Study||16
572076|NCT00601107|1396943|P2|COMPLETED|Overall Study||22
572077|NCT00601107|1396944|P1|COMPLETED|Overall Study||14
572078|NCT00601107|1396941|P4|Treated|Overall Study||25
572079|NCT00601107|1396942|P3|Treated|Overall Study||28
572080|NCT00601107|1396943|P2|Treated|Overall Study||31
572081|NCT00601107|1396944|P1|Treated|Overall Study||27
572082|NCT00601107|1396941|P4|STARTED|Overall Study||25
572083|NCT00601107|1396942|P3|STARTED|Overall Study||28
572084|NCT00601107|1396943|P2|STARTED|Overall Study||31
572085|NCT00601107|1396944|P1|STARTED|Overall Study|Randomized.|27
572086|NCT00600938|1396964|P4|NOT COMPLETED|Extension Study||1
572087|NCT00600938|1396965|P3|NOT COMPLETED|Extension Study||9
572088|NCT00600938|1396966|P2|NOT COMPLETED|Extension Study||5
572089|NCT00600938|1396967|P1|NOT COMPLETED|Extension Study||9
572090|NCT00600938|1396964|P4|COMPLETED|Extension Study||0
572091|NCT00600938|1396965|P3|COMPLETED|Extension Study||33
572092|NCT00600938|1396966|P2|COMPLETED|Extension Study||24
572093|NCT00600938|1396967|P1|COMPLETED|Extension Study||65
572094|NCT00600938|1396964|P4|Extension Safety Set|Extension Study||1
572095|NCT00600938|1396965|P3|Extension Safety Set|Extension Study||42
572096|NCT00600938|1396966|P2|Extension Safety Set|Extension Study||29
572097|NCT00600938|1396967|P1|Extension Safety Set|Extension Study|1 patient did not receive drug in the ext. phase but received drug in the core phase|73
572098|NCT00600938|1396964|P4|STARTED|Extension Study|Of the 82 patients who completed the ICL core, 74 continued on the ICL ext. phase; 1 went to ICL-DFO|1
572099|NCT00600938|1396965|P3|STARTED|Extension Study|Of the 78 patients who completed the DFO core, 29 went on DFO ext. phase; 42 went to the DFO-ICL|42
572100|NCT00600938|1396966|P2|STARTED|Extension Study|Of the 78 patients who completed the DFO core, 29 went on DFO ext. phase; 42 went to the DFO-ICL|29
572101|NCT00600938|1396967|P1|STARTED|Extension Study|Of the 82 patients who completed the ICL core, 74 continued on the ICL ext. phase; 1 went to ICL-DFO|74
572102|NCT00600938|1396964|P4|NOT COMPLETED|Core Study||0
572103|NCT00600938|1396965|P3|NOT COMPLETED|Core Study||0
572104|NCT00600938|1396966|P2|NOT COMPLETED|Core Study||21
572105|NCT00600938|1396967|P1|NOT COMPLETED|Core Study||16
572106|NCT00600938|1396964|P4|COMPLETED|Core Study||0
572107|NCT00600938|1396965|P3|COMPLETED|Core Study||0
572108|NCT00600938|1396966|P2|COMPLETED|Core Study||78
572109|NCT00600938|1396967|P1|COMPLETED|Core Study||82
572110|NCT00600938|1396964|P4|Per Protocol Set (PPS)|Core Study||0
572111|NCT00600938|1396965|P3|Per Protocol Set (PPS)|Core Study||0
572112|NCT00600938|1396966|P2|Per Protocol Set (PPS)|Core Study||81
572113|NCT00600938|1396967|P1|Per Protocol Set (PPS)|Core Study||91
572114|NCT00600938|1396964|P4|Core Safety Set|Core Study||0
572115|NCT00600938|1396965|P3|Core Safety Set|Core Study||0
572116|NCT00600938|1396966|P2|Core Safety Set|Core Study||91
572117|NCT00600938|1396967|P1|Core Safety Set|Core Study||96
572118|NCT00600938|1396964|P4|STARTED|Core Study||0
572119|NCT00600938|1396965|P3|STARTED|Core Study||0
572120|NCT00600938|1396966|P2|STARTED|Core Study||99
572121|NCT00600938|1396967|P1|STARTED|Core Study||98
572122|NCT00600886|1397031|P2|NOT COMPLETED|Extension - After Crossover (CAS)||13
572123|NCT00600886|1397032|P1|NOT COMPLETED|Extension - After Crossover (CAS)||62
572124|NCT00600886|1397031|P2|COMPLETED|Extension - After Crossover (CAS)|Completed the study|25
572125|NCT00600886|1397032|P1|COMPLETED|Extension - After Crossover (CAS)|Completed after month 26: transferred to a roll-over protocol or commercial supply of Pas.LAR|19
572126|NCT00600886|1397031|P2|Discontinued After M26|Extension - After Crossover (CAS)|Per protocol, Pts who received Octreotide LAR in Ext. phase were not followed in study after M26|0
572127|NCT00600886|1397032|P1|Discontinued After M26|Extension - After Crossover (CAS)||31
572128|NCT00600886|1397031|P2|Discontinued Between M12 and M26|Extension - After Crossover (CAS)||13
572129|NCT00600886|1397032|P1|Discontinued Between M12 and M26|Extension - After Crossover (CAS)||31
572130|NCT00600886|1397031|P2|Completed After Month 26|Extension - After Crossover (CAS)|Per protocol, pts who received Octreotide LAR in ext. phase were not followed in study after M26|0
572131|NCT00600886|1397032|P1|Completed After Month 26|Extension - After Crossover (CAS)|Completed = Pts who transferred to a roll-over protocol or commercial supply of Pasireotide LAR|19
572132|NCT00600886|1397031|P2|Completed Study at Month 26|Extension - After Crossover (CAS)|Per protocol, Pts who received Octreotide LAR in Ext. phase were not followed in study after M26|25
572133|NCT00600886|1397032|P1|Completed Study at Month 26|Extension - After Crossover (CAS)|Pas. LAR pts in Ext. were not considered completers at M26 as treatment could continue after M26.|0
572134|NCT00600886|1397031|P2|STARTED|Extension - After Crossover (CAS)|Started = anyone who entered the extension and crossed over to Octreotide LAR|38
572135|NCT00600886|1397032|P1|STARTED|Extension - After Crossover (CAS)|Started = anyone who entered the extension and crossed over to Pasireotide LAR|81
572136|NCT00600886|1397031|P2|NOT COMPLETED|Extension - Same Treatment (FAS)||11
572137|NCT00600886|1397032|P1|NOT COMPLETED|Extension - Same Treatment (FAS)||46
572138|NCT00600886|1397031|P2|COMPLETED|Extension - Same Treatment (FAS)|Completed = completed the study|35
572139|NCT00600886|1397032|P1|COMPLETED|Extension - Same Treatment (FAS)|Completed= completed after M26, switched to commercial pasireotide LAR or entered roll-over protocol|28
572140|NCT00600886|1397031|P2|Discontinued Between M12 and M26|Extension - Same Treatment (FAS)||10
572141|NCT00600886|1397032|P1|Discontinued Between M12 and M26|Extension - Same Treatment (FAS)||23
572142|NCT00600886|1397031|P2|Discontinued After Month 26|Extension - Same Treatment (FAS)|Received treatment and discontinued after M26: Recorded as protocol deviation|1
572143|NCT00600886|1397032|P1|Discontinued After Month 26|Extension - Same Treatment (FAS)||23
572144|NCT00600886|1397031|P2|Completed Study After Month 26|Extension - Same Treatment (FAS)|Received treatment and completed after M26: Recorded as protocol deviation|4
572145|NCT00600886|1397032|P1|Completed Study After Month 26|Extension - Same Treatment (FAS)|Completed = Pts who transferred to a roll-over protocol or commercial supply of Pasireotide LAR|28
572146|NCT00600886|1397031|P2|Completed Study at Month 26|Extension - Same Treatment (FAS)|Per protocol, pts who received Octreotide LAR in ext. phase were not followed in the study after M26|31
572147|NCT00600886|1397032|P1|Completed Study at Month 26|Extension - Same Treatment (FAS)|Pas. LAR pts in Ext. were not considered completers at M26 as treatment could continue after M26.|0
572148|NCT00600886|1397031|P2|STARTED|Extension - Same Treatment (FAS)|Started = anyone who entered the extension and continued the same treatment of Octreotide LAR|46
572149|NCT00600886|1397032|P1|STARTED|Extension - Same Treatment (FAS)|Started = anyone who entered the extension and continued the same treatment of Pasireotide LAR|74
572150|NCT00600886|1397031|P2|NOT COMPLETED|Core Phase - Full Analysis Set (FAS)||26
572151|NCT00600886|1397032|P1|NOT COMPLETED|Core Phase - Full Analysis Set (FAS)||35
572152|NCT00600886|1397031|P2|COMPLETED|Core Phase - Full Analysis Set (FAS)|Completed = anyone who did not discontinue prior to month 12.|156
572153|NCT00600886|1397032|P1|COMPLETED|Core Phase - Full Analysis Set (FAS)|Completed = anyone who did not discontinue prior to month 12.|141
572154|NCT00600886|1397031|P2|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set (FAS)||46
572155|NCT00600886|1397032|P1|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set (FAS)||74
572156|NCT00600886|1397031|P2|Entered Extension, Crossed Over|Core Phase - Full Analysis Set (FAS)||81
572157|NCT00600886|1397032|P1|Entered Extension, Crossed Over|Core Phase - Full Analysis Set (FAS)||38
572158|NCT00600886|1397031|P2|Did Not Enter Extension|Core Phase - Full Analysis Set (FAS)||29
572159|NCT00600886|1397032|P1|Did Not Enter Extension|Core Phase - Full Analysis Set (FAS)||29
572160|NCT00600886|1397031|P2|STARTED|Core Phase - Full Analysis Set (FAS)||182
572161|NCT00600886|1397032|P1|STARTED|Core Phase - Full Analysis Set (FAS)||176
572162|NCT00600821|1397096|P2|NOT COMPLETED|Overall Study||60
572163|NCT00600821|1397097|P1|NOT COMPLETED|Overall Study||58
572164|NCT00600821|1397096|P2|COMPLETED|Overall Study||0
572165|NCT00600821|1397097|P1|COMPLETED|Overall Study||0
572166|NCT00600821|1397096|P2|Treated|Overall Study||59
572167|NCT00600821|1397097|P1|Treated|Overall Study||58
572168|NCT00600821|1397096|P2|STARTED|Overall Study||60
572169|NCT00600821|1397097|P1|STARTED|Overall Study||58
572170|NCT00600756|1397125|P2|NOT COMPLETED|Overall Study Analysis After 12 Months||176
572171|NCT00600756|1397126|P1|NOT COMPLETED|Overall Study Analysis After 12 Months||183
572172|NCT00600756|1397125|P2|COMPLETED|Overall Study Analysis After 12 Months|Completed study to Visit 7 (includes premature withdrawals with final visit in the Visit 7 window)|227
572173|NCT00600756|1397126|P1|COMPLETED|Overall Study Analysis After 12 Months|Completed study to Visit 7 (includes premature withdrawals with final visit in the Visit 7 window)|212
572174|NCT00600756|1397125|P2|ITT Analysis|Overall Study Analysis After 12 Months||392
572175|NCT00600756|1397126|P1|ITT Analysis|Overall Study Analysis After 12 Months||379
572176|NCT00600756|1397125|P2|Safety Analysis|Overall Study Analysis After 12 Months||402
572177|NCT00600756|1397126|P1|Safety Analysis|Overall Study Analysis After 12 Months||391
572178|NCT00600756|1397125|P2|Randomized Analysis|Overall Study Analysis After 12 Months||403
572179|NCT00600756|1397126|P1|Randomized Analysis|Overall Study Analysis After 12 Months||395
572180|NCT00600756|1397125|P2|STARTED|Overall Study Analysis After 12 Months||403
572181|NCT00600756|1397126|P1|STARTED|Overall Study Analysis After 12 Months||395
572182|NCT00600756|1397125|P2|NOT COMPLETED|Analysis After 6 Months||120
572183|NCT00600756|1397126|P1|NOT COMPLETED|Analysis After 6 Months||131
572184|NCT00600756|1397125|P2|COMPLETED|Analysis After 6 Months|Completers are all patients who completed the study up to Visit 5 (including premature withdraw)|283
572185|NCT00600756|1397126|P1|COMPLETED|Analysis After 6 Months|Completers are all patients who completed the study up to Visit 5 (including premature withdraw)|264
572186|NCT00600756|1397125|P2|STARTED|Analysis After 6 Months||403
572187|NCT00600756|1397126|P1|STARTED|Analysis After 6 Months||395
572188|NCT00600743|1397196|P4|NOT COMPLETED|Overall Study||0
572189|NCT00600743|1397197|P3|NOT COMPLETED|Overall Study||0
572190|NCT00600743|1397198|P2|NOT COMPLETED|Overall Study||0
572191|NCT00600743|1397199|P1|NOT COMPLETED|Overall Study||0
572192|NCT00600743|1397196|P4|COMPLETED|Overall Study||7
572193|NCT00600743|1397197|P3|COMPLETED|Overall Study||8
572194|NCT00600743|1397198|P2|COMPLETED|Overall Study||4
572195|NCT00600743|1397199|P1|COMPLETED|Overall Study||4
572196|NCT00600743|1397196|P4|STARTED|Overall Study||7
572197|NCT00600743|1397197|P3|STARTED|Overall Study||8
572198|NCT00600743|1397198|P2|STARTED|Overall Study||4
572199|NCT00600743|1397199|P1|STARTED|Overall Study||4
572200|NCT00600704|1397228|P2|NOT COMPLETED|Overall Study||0
572201|NCT00600704|1397229|P1|NOT COMPLETED|Overall Study||0
572202|NCT00600704|1397228|P2|COMPLETED|Overall Study||92
572203|NCT00600704|1397229|P1|COMPLETED|Overall Study||100
572204|NCT00600704|1397228|P2|STARTED|Overall Study||92
572205|NCT00600704|1397229|P1|STARTED|Overall Study||100
572206|NCT00600613|1397235|P1|NOT COMPLETED|Overall Study||1
572207|NCT00600613|1397235|P1|COMPLETED|Overall Study||5
572208|NCT00600613|1397235|P1|STARTED|Overall Study||6
572209|NCT00600353|1397241|P2|NOT COMPLETED|Overall Study||1
572210|NCT00600353|1397242|P1|NOT COMPLETED|Overall Study||1
572211|NCT00600353|1397241|P2|COMPLETED|Overall Study||9
572212|NCT00600353|1397242|P1|COMPLETED|Overall Study||9
572213|NCT00600353|1397241|P2|STARTED|Overall Study||10
572214|NCT00600353|1397242|P1|STARTED|Overall Study||10
572215|NCT00600171|1397260|P6|NOT COMPLETED|Overall Study||5
572216|NCT00600171|1397261|P5|NOT COMPLETED|Overall Study||8
572217|NCT00600171|1397262|P4|NOT COMPLETED|Overall Study||12
572218|NCT00600171|1397263|P3|NOT COMPLETED|Overall Study||10
572219|NCT00600171|1397264|P2|NOT COMPLETED|Overall Study||17
572220|NCT00600171|1397265|P1|NOT COMPLETED|Overall Study||16
572221|NCT00600171|1397260|P6|COMPLETED|Overall Study||97
572222|NCT00600171|1397261|P5|COMPLETED|Overall Study||93
572223|NCT00600171|1397262|P4|COMPLETED|Overall Study||88
572224|NCT00600171|1397263|P3|COMPLETED|Overall Study||91
572225|NCT00600171|1397264|P2|COMPLETED|Overall Study||84
572226|NCT00600171|1397265|P1|COMPLETED|Overall Study||86
572227|NCT00600171|1397260|P6|STARTED|Overall Study||102
572228|NCT00600171|1397261|P5|STARTED|Overall Study||101
572229|NCT00600171|1397262|P4|STARTED|Overall Study||100
572230|NCT00600171|1397263|P3|STARTED|Overall Study||101
572231|NCT00600171|1397264|P2|STARTED|Overall Study||101
572232|NCT00600171|1397265|P1|STARTED|Overall Study||102
572233|NCT00600119|1397339|P6|NOT COMPLETED|Follow-up Period||1
572234|NCT00600119|1397340|P5|NOT COMPLETED|Follow-up Period||0
572235|NCT00600119|1397341|P4|NOT COMPLETED|Follow-up Period||0
572236|NCT00600119|1397342|P3|NOT COMPLETED|Follow-up Period||0
572237|NCT00600119|1397343|P2|NOT COMPLETED|Follow-up Period||0
572238|NCT00600119|1397344|P1|NOT COMPLETED|Follow-up Period||1
572239|NCT00600119|1397339|P6|COMPLETED|Follow-up Period||20
572240|NCT00600119|1397340|P5|COMPLETED|Follow-up Period||31
572241|NCT00600119|1397341|P4|COMPLETED|Follow-up Period||28
572242|NCT00600119|1397342|P3|COMPLETED|Follow-up Period||27
572243|NCT00600119|1397343|P2|COMPLETED|Follow-up Period||28
572244|NCT00600119|1397344|P1|COMPLETED|Follow-up Period||26
572245|NCT00600119|1397339|P6|STARTED|Follow-up Period||21
572246|NCT00600119|1397340|P5|STARTED|Follow-up Period||31
572247|NCT00600119|1397341|P4|STARTED|Follow-up Period||28
572248|NCT00600119|1397342|P3|STARTED|Follow-up Period||27
572249|NCT00600119|1397343|P2|STARTED|Follow-up Period||28
572250|NCT00600119|1397344|P1|STARTED|Follow-up Period||27
572251|NCT00600119|1397339|P6|NOT COMPLETED|Double-blind Treatment Period||14
572252|NCT00600119|1397340|P5|NOT COMPLETED|Double-blind Treatment Period||6
572253|NCT00600119|1397341|P4|NOT COMPLETED|Double-blind Treatment Period||2
572254|NCT00600119|1397342|P3|NOT COMPLETED|Double-blind Treatment Period||0
572255|NCT00600119|1397343|P2|NOT COMPLETED|Double-blind Treatment Period||5
572256|NCT00600119|1397344|P1|NOT COMPLETED|Double-blind Treatment Period||5
572257|NCT00600119|1397339|P6|COMPLETED|Double-blind Treatment Period||21
572258|NCT00600119|1397340|P5|COMPLETED|Double-blind Treatment Period||31
572259|NCT00600119|1397341|P4|COMPLETED|Double-blind Treatment Period||28
572260|NCT00600119|1397342|P3|COMPLETED|Double-blind Treatment Period||27
572261|NCT00600119|1397343|P2|COMPLETED|Double-blind Treatment Period||28
572262|NCT00600119|1397344|P1|COMPLETED|Double-blind Treatment Period||27
572263|NCT00600119|1397339|P6|STARTED|Double-blind Treatment Period||35
572264|NCT00600119|1397340|P5|STARTED|Double-blind Treatment Period||37
572265|NCT00600119|1397341|P4|STARTED|Double-blind Treatment Period||30
572266|NCT00600119|1397342|P3|STARTED|Double-blind Treatment Period||27
572267|NCT00600119|1397343|P2|STARTED|Double-blind Treatment Period||33
572268|NCT00600119|1397344|P1|STARTED|Double-blind Treatment Period||32
572269|NCT00600119|1397339|P6|NOT COMPLETED|Single-blind Placebo run-in Period||2
572270|NCT00600119|1397340|P5|NOT COMPLETED|Single-blind Placebo run-in Period||2
572271|NCT00600119|1397341|P4|NOT COMPLETED|Single-blind Placebo run-in Period||1
572272|NCT00600119|1397342|P3|NOT COMPLETED|Single-blind Placebo run-in Period||2
572273|NCT00600119|1397343|P2|NOT COMPLETED|Single-blind Placebo run-in Period||2
572274|NCT00600119|1397344|P1|NOT COMPLETED|Single-blind Placebo run-in Period||4
572275|NCT00600119|1397339|P6|COMPLETED|Single-blind Placebo run-in Period||35
572276|NCT00600119|1397340|P5|COMPLETED|Single-blind Placebo run-in Period||37
572277|NCT00600119|1397341|P4|COMPLETED|Single-blind Placebo run-in Period||30
572278|NCT00600119|1397342|P3|COMPLETED|Single-blind Placebo run-in Period||27
572279|NCT00600119|1397343|P2|COMPLETED|Single-blind Placebo run-in Period||33
572280|NCT00600119|1397344|P1|COMPLETED|Single-blind Placebo run-in Period||32
572281|NCT00600119|1397339|P6|STARTED|Single-blind Placebo run-in Period||37
572282|NCT00600119|1397340|P5|STARTED|Single-blind Placebo run-in Period||39
572283|NCT00600119|1397341|P4|STARTED|Single-blind Placebo run-in Period||31
572284|NCT00600119|1397342|P3|STARTED|Single-blind Placebo run-in Period||29
572285|NCT00600119|1397343|P2|STARTED|Single-blind Placebo run-in Period||35
572286|NCT00600119|1397344|P1|STARTED|Single-blind Placebo run-in Period||36
572287|NCT00600106|1397378|P2|NOT COMPLETED|Overall Study||1
572288|NCT00600106|1397379|P1|NOT COMPLETED|Overall Study||1
572289|NCT00600106|1397378|P2|COMPLETED|Overall Study||18
572290|NCT00600106|1397379|P1|COMPLETED|Overall Study||17
572291|NCT00600106|1397378|P2|STARTED|Overall Study||19
572292|NCT00600106|1397379|P1|STARTED|Overall Study||18
572293|NCT00600080|1397411|P2|NOT COMPLETED|Period 2: One-week to Two-weeks||0
572294|NCT00600080|1397412|P1|NOT COMPLETED|Period 2: One-week to Two-weeks||0
572295|NCT00600080|1397411|P2|COMPLETED|Period 2: One-week to Two-weeks||32
572296|NCT00600080|1397412|P1|COMPLETED|Period 2: One-week to Two-weeks||28
572297|NCT00600080|1397411|P2|STARTED|Period 2: One-week to Two-weeks|This is a crossover study, arms are switched at period change.|32
572298|NCT00600080|1397412|P1|STARTED|Period 2: One-week to Two-weeks|This is a crossover study, arms are switched at period change.|28
572299|NCT00600080|1397411|P2|NOT COMPLETED|Period 1: Baseline to One-week||0
572300|NCT00600080|1397412|P1|NOT COMPLETED|Period 1: Baseline to One-week||0
572301|NCT00600080|1397411|P2|COMPLETED|Period 1: Baseline to One-week||32
572302|NCT00600080|1397412|P1|COMPLETED|Period 1: Baseline to One-week||28
572303|NCT00600080|1397411|P2|STARTED|Period 1: Baseline to One-week||32
572304|NCT00600080|1397412|P1|STARTED|Period 1: Baseline to One-week||28
572305|NCT00600067|1397426|P2|NOT COMPLETED|Overall Study||7
572306|NCT00600067|1397427|P1|NOT COMPLETED|Overall Study||3
572307|NCT00600067|1397426|P2|COMPLETED|Overall Study||68
572308|NCT00600067|1397427|P1|COMPLETED|Overall Study||52
572309|NCT00600067|1397426|P2|STARTED|Overall Study||75
572310|NCT00600067|1397427|P1|STARTED|Overall Study||55
572311|NCT00600028|1397437|P2|NOT COMPLETED|Second Intervention (12 Weeks)||2
572312|NCT00600028|1397438|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
572313|NCT00600028|1397437|P2|COMPLETED|Second Intervention (12 Weeks)||8
572314|NCT00600028|1397438|P1|COMPLETED|Second Intervention (12 Weeks)||12
572315|NCT00600028|1397437|P2|STARTED|Second Intervention (12 Weeks)|Number of participants starting the second intervention (after a 2-week washout)|10
572316|NCT00600028|1397438|P1|STARTED|Second Intervention (12 Weeks)|Number of participants starting the second intervention (after a 2-week washout)|12
572317|NCT00600028|1397437|P2|NOT COMPLETED|First Intervention (12 Weeks)||1
572318|NCT00600028|1397438|P1|NOT COMPLETED|First Intervention (12 Weeks)||1
572319|NCT00600028|1397437|P2|COMPLETED|First Intervention (12 Weeks)||10
572320|NCT00600028|1397438|P1|COMPLETED|First Intervention (12 Weeks)||12
572321|NCT00600028|1397437|P2|STARTED|First Intervention (12 Weeks)|Number of participants starting the first intervention (prior to washout)|11
572322|NCT00600028|1397438|P1|STARTED|First Intervention (12 Weeks)|Number of participants starting the first intervention (prior to washout)|13
572323|NCT00600015|1397452|P2|NOT COMPLETED|Overall Study||35
572324|NCT00600015|1397453|P1|NOT COMPLETED|Overall Study||60
572325|NCT00600015|1397452|P2|COMPLETED|Overall Study|Completed >=2 cycles|20
572326|NCT00600015|1397453|P1|COMPLETED|Overall Study|Completed >=2 cycles|51
572327|NCT00600015|1397452|P2|STARTED|Overall Study||55
572328|NCT00600015|1397453|P1|STARTED|Overall Study||111
572329|NCT00599924|1397468|P7|NOT COMPLETED|Overall Study||5
572330|NCT00599924|1397469|P6|NOT COMPLETED|Overall Study||4
572331|NCT00599924|1397470|P5|NOT COMPLETED|Overall Study||6
572332|NCT00599924|1397471|P4|NOT COMPLETED|Overall Study||8
572333|NCT00599924|1397472|P3|NOT COMPLETED|Overall Study||2
572334|NCT00599924|1397473|P2|NOT COMPLETED|Overall Study||5
572335|NCT00599924|1397474|P1|NOT COMPLETED|Overall Study||3
572336|NCT00599924|1397468|P7|COMPLETED|Overall Study||3
572337|NCT00599924|1397469|P6|COMPLETED|Overall Study||2
572338|NCT00599924|1397470|P5|COMPLETED|Overall Study||3
572339|NCT00599924|1397471|P4|COMPLETED|Overall Study||4
572340|NCT00599924|1397472|P3|COMPLETED|Overall Study||3
572341|NCT00599924|1397473|P2|COMPLETED|Overall Study||4
572342|NCT00599924|1397474|P1|COMPLETED|Overall Study||1
572343|NCT00599924|1397468|P7|STARTED|Overall Study||8
572344|NCT00599924|1397469|P6|STARTED|Overall Study||6
572345|NCT00599924|1397470|P5|STARTED|Overall Study||9
572346|NCT00599924|1397471|P4|STARTED|Overall Study||12
572347|NCT00599924|1397472|P3|STARTED|Overall Study||5
572348|NCT00599924|1397473|P2|STARTED|Overall Study||9
572349|NCT00599924|1397474|P1|STARTED|Overall Study||4
572350|NCT00599872|1397561|P2|NOT COMPLETED|Overall Study||33
572351|NCT00599872|1397562|P1|NOT COMPLETED|Overall Study||49
572352|NCT00599872|1397561|P2|COMPLETED|Overall Study||181
572353|NCT00599872|1397562|P1|COMPLETED|Overall Study||167
572354|NCT00599872|1397561|P2|STARTED|Overall Study||214
572355|NCT00599872|1397562|P1|STARTED|Overall Study||216
572356|NCT00599755|1397578|P1|NOT COMPLETED|Overall Study||19
572357|NCT00599755|1397578|P1|COMPLETED|Overall Study||49
572358|NCT00599755|1397578|P1|STARTED|Overall Study||68
572359|NCT00599521|1397589|P2|NOT COMPLETED|Overall Study||69
572360|NCT00599521|1397590|P1|NOT COMPLETED|Overall Study||60
572361|NCT00599521|1397589|P2|COMPLETED|Overall Study||462
572362|NCT00599521|1397590|P1|COMPLETED|Overall Study||475
572363|NCT00599521|1397589|P2|STARTED|Overall Study||531
572364|NCT00599521|1397590|P1|STARTED|Overall Study||535
572365|NCT00599339|1397604|P1|NOT COMPLETED|Overall Study||664
572366|NCT00599339|1397604|P1|COMPLETED|Overall Study||1531
572367|NCT00599339|1397604|P1|Safety Set|Overall Study||2179
572368|NCT00599339|1397604|P1|STARTED|Overall Study||2195
572369|NCT00599326|1397706|P1|NOT COMPLETED|Overall Study||2
572370|NCT00599326|1397706|P1|COMPLETED|Overall Study||8
572371|NCT00599326|1397706|P1|STARTED|Overall Study||10
572372|NCT00599313|1397711|P1|NOT COMPLETED|Overall Study||36
572373|NCT00599313|1397711|P1|COMPLETED|Overall Study||0
572374|NCT00599313|1397711|P1|STARTED|Overall Study||36
572375|NCT00599248|1397722|P4|NOT COMPLETED|Overall Study||0
572376|NCT00599248|1397723|P3|NOT COMPLETED|Overall Study||0
572377|NCT00599248|1397724|P2|NOT COMPLETED|Overall Study||0
572378|NCT00599248|1397725|P1|NOT COMPLETED|Overall Study||0
572379|NCT00599248|1397722|P4|COMPLETED|Overall Study||3
572380|NCT00599248|1397723|P3|COMPLETED|Overall Study||3
572381|NCT00599248|1397724|P2|COMPLETED|Overall Study||3
572382|NCT00599248|1397725|P1|COMPLETED|Overall Study||3
572383|NCT00599248|1397722|P4|STARTED|Overall Study||3
572384|NCT00599248|1397723|P3|STARTED|Overall Study||3
572385|NCT00599248|1397724|P2|STARTED|Overall Study||3
572386|NCT00599248|1397725|P1|STARTED|Overall Study||3
572387|NCT00599196|1397753|P1|NOT COMPLETED|Overall Study||381
572388|NCT00599196|1397753|P1|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
572389|NCT00599196|1397753|P1|STARTED|Overall Study||381
572390|NCT00599131|1397759|P1|NOT COMPLETED|Overall Study||0
572391|NCT00599131|1397759|P1|COMPLETED|Overall Study||4
572392|NCT00599131|1397759|P1|STARTED|Overall Study||4
572393|NCT00599053|1397769|P2|NOT COMPLETED|Overall Study||0
572394|NCT00599053|1397770|P1|NOT COMPLETED|Overall Study||0
572395|NCT00599053|1397769|P2|COMPLETED|Overall Study||2
572396|NCT00599053|1397770|P1|COMPLETED|Overall Study||5
572397|NCT00599053|1397769|P2|STARTED|Overall Study||2
572398|NCT00599053|1397770|P1|STARTED|Overall Study||5
572399|NCT00599027|1397784|P2|NOT COMPLETED|Overall Study||3
572400|NCT00599027|1397785|P1|NOT COMPLETED|Overall Study||1
572401|NCT00599027|1397784|P2|COMPLETED|Overall Study||22
572402|NCT00599027|1397785|P1|COMPLETED|Overall Study||25
572403|NCT00599027|1397784|P2|STARTED|Overall Study||25
572404|NCT00599027|1397785|P1|STARTED|Overall Study||26
572405|NCT00599014|1397791|P1|NOT COMPLETED|Overall Study||0
572406|NCT00599014|1397791|P1|COMPLETED|Overall Study||335
572407|NCT00599014|1397791|P1|STARTED|Overall Study||335
572408|NCT00598871|1397798|P2|NOT COMPLETED|Overall Study||1
572409|NCT00598871|1397799|P1|NOT COMPLETED|Overall Study||0
572410|NCT00598871|1397798|P2|COMPLETED|Overall Study||8
572411|NCT00598871|1397799|P1|COMPLETED|Overall Study||3
572412|NCT00598871|1397798|P2|STARTED|Overall Study||9
572413|NCT00598871|1397799|P1|STARTED|Overall Study||3
572414|NCT00598832|1397809|P2|NOT COMPLETED|Overall Study||82
572415|NCT00598832|1397810|P1|NOT COMPLETED|Overall Study||62
572416|NCT00598832|1397809|P2|COMPLETED|Overall Study||460
572417|NCT00598832|1397810|P1|COMPLETED|Overall Study||471
572418|NCT00598832|1397809|P2|STARTED|Overall Study||542
572419|NCT00598832|1397810|P1|STARTED|Overall Study||533
572420|NCT00598819|1397824|P1|NOT COMPLETED|Overall Study||0
572421|NCT00598819|1397824|P1|COMPLETED|Overall Study||14
572422|NCT00598819|1397824|P1|STARTED|Overall Study||14
572423|NCT00598806|1397834|P2|NOT COMPLETED|Overall Study||64
572424|NCT00598806|1397835|P1|NOT COMPLETED|Overall Study||73
572425|NCT00598806|1397834|P2|COMPLETED|Overall Study||346
572426|NCT00598806|1397835|P1|COMPLETED|Overall Study||329
572427|NCT00598806|1397834|P2|STARTED|Overall Study||410
572428|NCT00598806|1397835|P1|STARTED|Overall Study||402
572429|NCT00598702|1397863|P8|NOT COMPLETED|Overall Study||0
572430|NCT00598702|1397864|P7|NOT COMPLETED|Overall Study||1
572431|NCT00598702|1397865|P6|NOT COMPLETED|Overall Study||12
572432|NCT00598702|1397866|P5|NOT COMPLETED|Overall Study||3
572433|NCT00598702|1397867|P4|NOT COMPLETED|Overall Study||8
572434|NCT00598702|1397868|P3|NOT COMPLETED|Overall Study||2
572435|NCT00598702|1397869|P2|NOT COMPLETED|Overall Study||2
572436|NCT00598702|1397870|P1|NOT COMPLETED|Overall Study||0
572437|NCT00598702|1397863|P8|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|4
572438|NCT00598702|1397864|P7|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|0
572439|NCT00598702|1397865|P6|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|30
572440|NCT00598702|1397866|P5|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|6
572441|NCT00598702|1397867|P4|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|25
572442|NCT00598702|1397868|P3|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|5
572443|NCT00598702|1397869|P2|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|1
572444|NCT00598702|1397870|P1|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|1
572445|NCT00598702|1397863|P8|STARTED|Overall Study||4
572446|NCT00598702|1397864|P7|STARTED|Overall Study||1
572447|NCT00598702|1397865|P6|STARTED|Overall Study||42
572448|NCT00598702|1397866|P5|STARTED|Overall Study||9
572449|NCT00598702|1397867|P4|STARTED|Overall Study||33
572450|NCT00598702|1397868|P3|STARTED|Overall Study||7
572451|NCT00598702|1397869|P2|STARTED|Overall Study||3
572452|NCT00598702|1397870|P1|STARTED|Overall Study||1
572453|NCT00598689|1397914|P2|NOT COMPLETED|Overall Study||0
572454|NCT00598689|1397915|P1|NOT COMPLETED|Overall Study||0
572455|NCT00598689|1397914|P2|COMPLETED|Overall Study||40
572456|NCT00598689|1397915|P1|COMPLETED|Overall Study||40
572457|NCT00598689|1397914|P2|STARTED|Overall Study||40
572458|NCT00598689|1397915|P1|STARTED|Overall Study||40
572459|NCT00598650|1397925|P1|NOT COMPLETED|Overall Study||27
572460|NCT00598650|1397925|P1|COMPLETED|Overall Study|5 subjects withdrew for multiple reasons|81
572461|NCT00598650|1397925|P1|STARTED|Overall Study||108
572462|NCT00598585|1397934|P2|NOT COMPLETED|Overall Study||0
572463|NCT00598585|1397935|P1|NOT COMPLETED|Overall Study||1
572464|NCT00598585|1397934|P2|COMPLETED|Overall Study||6
572465|NCT00598585|1397935|P1|COMPLETED|Overall Study||5
572466|NCT00598585|1397934|P2|STARTED|Overall Study||6
572467|NCT00598585|1397935|P1|STARTED|Overall Study||6
572468|NCT00598559|1397944|P3|NOT COMPLETED|Overall Study||3
572469|NCT00598559|1397945|P2|NOT COMPLETED|Overall Study||28
572470|NCT00598559|1397946|P1|NOT COMPLETED|Overall Study||27
572471|NCT00598559|1397944|P3|COMPLETED|Overall Study|Subjects completed 5 days of treatment|27
572472|NCT00598559|1397945|P2|COMPLETED|Overall Study|Subjects completed 5 days of treatment|63
572473|NCT00598559|1397946|P1|COMPLETED|Overall Study|Subjects completed 5 days of treatment|65
572474|NCT00598559|1397944|P3|STARTED|Overall Study||30
572475|NCT00598559|1397945|P2|STARTED|Overall Study||91
572476|NCT00598559|1397946|P1|STARTED|Overall Study||92
572477|NCT00598507|1397963|P1|NOT COMPLETED|Overall Study||0
572478|NCT00598507|1397963|P1|COMPLETED|Overall Study||35
572479|NCT00598507|1397963|P1|STARTED|Overall Study||35
572480|NCT00598442|1397973|P3|NOT COMPLETED|Overall Study||24
572481|NCT00598442|1397974|P2|NOT COMPLETED|Overall Study||39
572482|NCT00598442|1397975|P1|NOT COMPLETED|Overall Study||43
572483|NCT00598442|1397973|P3|COMPLETED|Overall Study||139
572484|NCT00598442|1397974|P2|COMPLETED|Overall Study||124
572485|NCT00598442|1397975|P1|COMPLETED|Overall Study||124
572486|NCT00598442|1397973|P3|STARTED|Overall Study||163
572487|NCT00598442|1397974|P2|STARTED|Overall Study||163
572488|NCT00598442|1397975|P1|STARTED|Overall Study||167
572489|NCT00598273|1397992|P3|NOT COMPLETED|Overall Study||39
572490|NCT00598273|1397993|P2|NOT COMPLETED|Overall Study||38
572491|NCT00598273|1397994|P1|NOT COMPLETED|Overall Study||41
572492|NCT00598273|1397992|P3|COMPLETED|Overall Study||125
572493|NCT00598273|1397993|P2|COMPLETED|Overall Study||127
572494|NCT00598273|1397994|P1|COMPLETED|Overall Study||120
572495|NCT00598273|1397992|P3|STARTED|Overall Study||164
572496|NCT00598273|1397993|P2|STARTED|Overall Study||165
572497|NCT00598273|1397994|P1|STARTED|Overall Study||161
572498|NCT00598078|1398008|P2|NOT COMPLETED|Period 3 (Day 3)||0
572499|NCT00598078|1398009|P1|NOT COMPLETED|Period 3 (Day 3)||0
572500|NCT00598078|1398008|P2|COMPLETED|Period 3 (Day 3)||10
572501|NCT00598078|1398009|P1|COMPLETED|Period 3 (Day 3)||9
572502|NCT00598078|1398008|P2|STARTED|Period 3 (Day 3)||10
572503|NCT00598078|1398009|P1|STARTED|Period 3 (Day 3)||9
572504|NCT00598078|1398008|P2|NOT COMPLETED|Period 2 (Day 2)||0
572505|NCT00598078|1398009|P1|NOT COMPLETED|Period 2 (Day 2)||1
572506|NCT00598078|1398008|P2|COMPLETED|Period 2 (Day 2)||10
572507|NCT00598078|1398009|P1|COMPLETED|Period 2 (Day 2)||9
572508|NCT00598078|1398008|P2|STARTED|Period 2 (Day 2)||10
572509|NCT00598078|1398009|P1|STARTED|Period 2 (Day 2)||10
572510|NCT00598078|1398008|P2|NOT COMPLETED|Period 1 (Day 1)||0
572511|NCT00598078|1398009|P1|NOT COMPLETED|Period 1 (Day 1)||0
572512|NCT00598078|1398008|P2|COMPLETED|Period 1 (Day 1)||10
572513|NCT00598078|1398009|P1|COMPLETED|Period 1 (Day 1)||10
572514|NCT00598078|1398008|P2|STARTED|Period 1 (Day 1)||10
572515|NCT00598078|1398009|P1|STARTED|Period 1 (Day 1)||10
572516|NCT00597909|1398020|P3|NOT COMPLETED|Overall Study||0
572517|NCT00597909|1398021|P2|NOT COMPLETED|Overall Study||0
572518|NCT00597909|1398022|P1|NOT COMPLETED|Overall Study||0
572519|NCT00597909|1398020|P3|COMPLETED|Overall Study||0
572520|NCT00597909|1398021|P2|COMPLETED|Overall Study||0
572521|NCT00597909|1398022|P1|COMPLETED|Overall Study||0
572522|NCT00597909|1398020|P3|STARTED|Overall Study||0
572523|NCT00597909|1398021|P2|STARTED|Overall Study||0
572524|NCT00597909|1398022|P1|STARTED|Overall Study||0
572525|NCT00597896|1398032|P2|NOT COMPLETED|Overall Study||2
572526|NCT00597896|1398033|P1|NOT COMPLETED|Overall Study||3
572527|NCT00597896|1398032|P2|COMPLETED|Overall Study||24
572528|NCT00597896|1398033|P1|COMPLETED|Overall Study||21
572529|NCT00597896|1398032|P2|STARTED|Overall Study||26
572530|NCT00597896|1398033|P1|STARTED|Overall Study||24
572531|NCT00597766|1398062|P3|NOT COMPLETED|Follow-up 3, Week 12||0
572532|NCT00597766|1398063|P2|NOT COMPLETED|Follow-up 3, Week 12||0
572533|NCT00597766|1398064|P1|NOT COMPLETED|Follow-up 3, Week 12||0
572534|NCT00597766|1398062|P3|COMPLETED|Follow-up 3, Week 12||9
572535|NCT00597766|1398063|P2|COMPLETED|Follow-up 3, Week 12||9
572536|NCT00597766|1398064|P1|COMPLETED|Follow-up 3, Week 12||8
572537|NCT00597766|1398062|P3|STARTED|Follow-up 3, Week 12||9
572538|NCT00597766|1398063|P2|STARTED|Follow-up 3, Week 12||9
572539|NCT00597766|1398064|P1|STARTED|Follow-up 3, Week 12||8
572540|NCT00597766|1398062|P3|NOT COMPLETED|Follow-up 2, Week 8||1
572541|NCT00597766|1398063|P2|NOT COMPLETED|Follow-up 2, Week 8||0
572542|NCT00597766|1398064|P1|NOT COMPLETED|Follow-up 2, Week 8||0
572543|NCT00597766|1398062|P3|COMPLETED|Follow-up 2, Week 8||9
572544|NCT00597766|1398063|P2|COMPLETED|Follow-up 2, Week 8||9
572545|NCT00597766|1398064|P1|COMPLETED|Follow-up 2, Week 8||8
572546|NCT00597766|1398062|P3|STARTED|Follow-up 2, Week 8||10
572547|NCT00597766|1398063|P2|STARTED|Follow-up 2, Week 8||9
572548|NCT00597766|1398064|P1|STARTED|Follow-up 2, Week 8||8
572549|NCT00597766|1398062|P3|NOT COMPLETED|Follow-up 1, Week 4||0
572550|NCT00597766|1398063|P2|NOT COMPLETED|Follow-up 1, Week 4||0
572551|NCT00597766|1398064|P1|NOT COMPLETED|Follow-up 1, Week 4||1
572552|NCT00597766|1398062|P3|COMPLETED|Follow-up 1, Week 4||10
572553|NCT00597766|1398063|P2|COMPLETED|Follow-up 1, Week 4||9
572554|NCT00597766|1398064|P1|COMPLETED|Follow-up 1, Week 4||8
572555|NCT00597766|1398062|P3|STARTED|Follow-up 1, Week 4||10
572556|NCT00597766|1398063|P2|STARTED|Follow-up 1, Week 4||9
572557|NCT00597766|1398064|P1|STARTED|Follow-up 1, Week 4||9
572558|NCT00597766|1398062|P3|NOT COMPLETED|Enrolled||0
572559|NCT00597766|1398063|P2|NOT COMPLETED|Enrolled||0
572560|NCT00597766|1398064|P1|NOT COMPLETED|Enrolled||0
572561|NCT00597766|1398062|P3|COMPLETED|Enrolled||10
572562|NCT00597766|1398063|P2|COMPLETED|Enrolled||9
572563|NCT00597766|1398064|P1|COMPLETED|Enrolled||9
572564|NCT00597766|1398062|P3|STARTED|Enrolled||10
572565|NCT00597766|1398063|P2|STARTED|Enrolled||9
572566|NCT00597766|1398064|P1|STARTED|Enrolled||9
572567|NCT00597753|1398083|P2|NOT COMPLETED|Overall Study||69
572568|NCT00597753|1398084|P1|NOT COMPLETED|Overall Study||166
572569|NCT00597753|1398083|P2|COMPLETED|Overall Study||202
572570|NCT00597753|1398084|P1|COMPLETED|Overall Study||366
572571|NCT00597753|1398083|P2|STARTED|Overall Study||271
572572|NCT00597753|1398084|P1|STARTED|Overall Study|Randomization was 2:1 peginesatide to epoetin alfa|532
572573|NCT00597727|1398098|P5|NOT COMPLETED|Open-label Extended Maintenance Phase||2
572574|NCT00597727|1398099|P4|NOT COMPLETED|Open-label Extended Maintenance Phase||3
572575|NCT00597727|1398100|P3|NOT COMPLETED|Open-label Extended Maintenance Phase||6
572576|NCT00597727|1398101|P2|NOT COMPLETED|Open-label Extended Maintenance Phase||0
572577|NCT00597727|1398102|P1|NOT COMPLETED|Open-label Extended Maintenance Phase||0
572578|NCT00597727|1398098|P5|COMPLETED|Open-label Extended Maintenance Phase||1
572579|NCT00597727|1398099|P4|COMPLETED|Open-label Extended Maintenance Phase||14
572580|NCT00597727|1398100|P3|COMPLETED|Open-label Extended Maintenance Phase||23
572581|NCT00597727|1398101|P2|COMPLETED|Open-label Extended Maintenance Phase||0
572582|NCT00597727|1398102|P1|COMPLETED|Open-label Extended Maintenance Phase||0
572583|NCT00597727|1398098|P5|STARTED|Open-label Extended Maintenance Phase||3
572584|NCT00597727|1398099|P4|STARTED|Open-label Extended Maintenance Phase||17
572585|NCT00597727|1398100|P3|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding.|29
572586|NCT00597727|1398101|P2|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding|0
572587|NCT00597727|1398102|P1|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding|0
572588|NCT00597727|1398098|P5|NOT COMPLETED|12 Month Blinded Phase||1
572589|NCT00597727|1398099|P4|NOT COMPLETED|12 Month Blinded Phase||10
572590|NCT00597727|1398100|P3|NOT COMPLETED|12 Month Blinded Phase||0
572591|NCT00597727|1398101|P2|NOT COMPLETED|12 Month Blinded Phase||0
572592|NCT00597727|1398102|P1|NOT COMPLETED|12 Month Blinded Phase||0
572593|NCT00597727|1398098|P5|COMPLETED|12 Month Blinded Phase||3
572594|NCT00597727|1398099|P4|COMPLETED|12 Month Blinded Phase||17
572595|NCT00597727|1398100|P3|COMPLETED|12 Month Blinded Phase||0
572596|NCT00597727|1398101|P2|COMPLETED|12 Month Blinded Phase||15
572597|NCT00597727|1398102|P1|COMPLETED|12 Month Blinded Phase||14
572598|NCT00597727|1398098|P5|STARTED|12 Month Blinded Phase||4
572599|NCT00597727|1398099|P4|STARTED|12 Month Blinded Phase||27
572600|NCT00597727|1398100|P3|STARTED|12 Month Blinded Phase||0
572601|NCT00597727|1398101|P2|STARTED|12 Month Blinded Phase||15
572602|NCT00597727|1398102|P1|STARTED|12 Month Blinded Phase||14
572603|NCT00597714|1398118|P3|NOT COMPLETED|Overall Study||10
572604|NCT00597714|1398119|P2|NOT COMPLETED|Overall Study||46
572605|NCT00597714|1398120|P1|NOT COMPLETED|Overall Study||56
572606|NCT00597714|1398118|P3|COMPLETED|Overall Study||84
572607|NCT00597714|1398119|P2|COMPLETED|Overall Study||11
572608|NCT00597714|1398120|P1|COMPLETED|Overall Study||24
572609|NCT00597714|1398118|P3|STARTED|Overall Study||94
572610|NCT00597714|1398119|P2|STARTED|Overall Study||57
572611|NCT00597714|1398120|P1|STARTED|Overall Study||80
572612|NCT00597701|1398132|P2|NOT COMPLETED|Overall Study||8
572613|NCT00597701|1398133|P1|NOT COMPLETED|Overall Study||7
572614|NCT00597701|1398132|P2|COMPLETED|Overall Study||13
572615|NCT00597701|1398133|P1|COMPLETED|Overall Study||18
572616|NCT00597701|1398132|P2|STARTED|Overall Study||21
572617|NCT00597701|1398133|P1|STARTED|Overall Study||25
572618|NCT00597675|1398141|P2|NOT COMPLETED|Open Label Phase||0
572619|NCT00597675|1398142|P1|NOT COMPLETED|Open Label Phase||0
572620|NCT00597675|1398141|P2|COMPLETED|Open Label Phase||5
572621|NCT00597675|1398142|P1|COMPLETED|Open Label Phase||2
572622|NCT00597675|1398141|P2|STARTED|Open Label Phase||5
572623|NCT00597675|1398142|P1|STARTED|Open Label Phase|Patients previously on placebo were crossed over onto open label peanut OIT|2
572624|NCT00597675|1398141|P2|NOT COMPLETED|Blinded Phase||1
572625|NCT00597675|1398142|P1|NOT COMPLETED|Blinded Phase||2
572626|NCT00597675|1398141|P2|COMPLETED|Blinded Phase||5
572627|NCT00597675|1398142|P1|COMPLETED|Blinded Phase||2
572628|NCT00597675|1398141|P2|STARTED|Blinded Phase||6
572629|NCT00597675|1398142|P1|STARTED|Blinded Phase||4
572630|NCT00597584|1398155|P2|NOT COMPLETED|Overall Study||63
572631|NCT00597584|1398156|P1|NOT COMPLETED|Overall Study||128
572632|NCT00597584|1398155|P2|COMPLETED|Overall Study||211
572633|NCT00597584|1398156|P1|COMPLETED|Overall Study||421
572634|NCT00597584|1398155|P2|STARTED|Overall Study||274
572635|NCT00597584|1398156|P1|STARTED|Overall Study|Randomization was 2:1 peginesatide to epoetin|549
572636|NCT00597558|1398166|P1|NOT COMPLETED|Overall Study||4
572637|NCT00597558|1398166|P1|COMPLETED|Overall Study||9
572638|NCT00597558|1398166|P1|STARTED|Overall Study||13
572639|NCT00597545|1398174|P2|NOT COMPLETED|Overall Study||0
572640|NCT00597545|1398175|P1|NOT COMPLETED|Overall Study||0
572641|NCT00597545|1398174|P2|COMPLETED|Overall Study||6
572642|NCT00597545|1398175|P1|COMPLETED|Overall Study||4
572643|NCT00597545|1398174|P2|STARTED|Overall Study||6
572644|NCT00597545|1398175|P1|STARTED|Overall Study||4
572645|NCT00597519|1398181|P1|NOT COMPLETED|Overall Study||1
572646|NCT00597519|1398181|P1|COMPLETED|Overall Study||27
572647|NCT00597519|1398181|P1|STARTED|Overall Study||28
572648|NCT00597506|1398185|P1|NOT COMPLETED|Overall Study||1
572649|NCT00597506|1398185|P1|COMPLETED|Overall Study||49
572650|NCT00597506|1398185|P1|STARTED|Overall Study||50
572651|NCT00597493|1398190|P1|NOT COMPLETED|Overall Study||0
572652|NCT00597493|1398190|P1|COMPLETED|Overall Study||32
572653|NCT00597493|1398190|P1|STARTED|Overall Study||32
572654|NCT00597428|1398209|P2|NOT COMPLETED|Overall Study||71
572655|NCT00597428|1398210|P1|NOT COMPLETED|Overall Study||61
572656|NCT00597428|1398209|P2|COMPLETED|Overall Study||152
572657|NCT00597428|1398210|P1|COMPLETED|Overall Study||153
572658|NCT00597428|1398209|P2|STARTED|Overall Study||223
572659|NCT00597428|1398210|P1|STARTED|Overall Study||214
572660|NCT00597402|1398226|P1|NOT COMPLETED|Overall Study||0
572661|NCT00597402|1398226|P1|COMPLETED|Overall Study||125
572662|NCT00597402|1398226|P1|STARTED|Overall Study||125
572663|NCT00597376|1398235|P2|NOT COMPLETED|Overall Study||4
572664|NCT00597376|1398236|P1|NOT COMPLETED|Overall Study||8
572665|NCT00597376|1398235|P2|COMPLETED|Overall Study|All participants started (53) were included in primary analyses.|49
572666|NCT00597376|1398236|P1|COMPLETED|Overall Study|All participants started (51) were included in primary analyses.|43
572667|NCT00597376|1398235|P2|STARTED|Overall Study||53
572668|NCT00597376|1398236|P1|STARTED|Overall Study||51
572669|NCT00597272|1398253|P7|NOT COMPLETED|Overall Study||0
572670|NCT00597272|1398254|P6|NOT COMPLETED|Overall Study||0
572671|NCT00597272|1398255|P5|NOT COMPLETED|Overall Study||0
572672|NCT00597272|1398256|P4|NOT COMPLETED|Overall Study||0
572673|NCT00597272|1398257|P3|NOT COMPLETED|Overall Study||0
572674|NCT00597272|1398258|P2|NOT COMPLETED|Overall Study||0
572675|NCT00597272|1398259|P1|NOT COMPLETED|Overall Study||0
572676|NCT00597272|1398253|P7|COMPLETED|Overall Study||10
572677|NCT00597272|1398254|P6|COMPLETED|Overall Study||10
572678|NCT00597272|1398255|P5|COMPLETED|Overall Study||1
572679|NCT00597272|1398256|P4|COMPLETED|Overall Study||1
572680|NCT00597272|1398257|P3|COMPLETED|Overall Study||10
572681|NCT00597272|1398258|P2|COMPLETED|Overall Study||1
572682|NCT00597272|1398259|P1|COMPLETED|Overall Study||1
572683|NCT00597272|1398253|P7|STARTED|Overall Study||10
572684|NCT00597272|1398254|P6|STARTED|Overall Study||10
572685|NCT00597272|1398255|P5|STARTED|Overall Study||1
572686|NCT00597272|1398256|P4|STARTED|Overall Study||1
572687|NCT00597272|1398257|P3|STARTED|Overall Study||10
572688|NCT00597272|1398258|P2|STARTED|Overall Study||1
572689|NCT00597272|1398259|P1|STARTED|Overall Study||1
572690|NCT00597207|1398277|P2|NOT COMPLETED|Overall Study||7
572691|NCT00597207|1398278|P1|NOT COMPLETED|Overall Study||5
572692|NCT00597207|1398277|P2|COMPLETED|Overall Study||2125
572693|NCT00597207|1398278|P1|COMPLETED|Overall Study||2094
572694|NCT00597207|1398277|P2|STARTED|Overall Study||2132
572695|NCT00597207|1398278|P1|STARTED|Overall Study||2099
572696|NCT00597116|1398286|P2|NOT COMPLETED|Overall Study||11
572697|NCT00597116|1398287|P1|NOT COMPLETED|Overall Study||14
572698|NCT00597116|1398286|P2|COMPLETED|Overall Study|Randomised patients ongoing study treatment at data cut-off|0
572699|NCT00597116|1398287|P1|COMPLETED|Overall Study|Randomised patients ongoing study treatment at data cut-off|0
572700|NCT00597116|1398286|P2|STARTED|Overall Study||11
572701|NCT00597116|1398287|P1|STARTED|Overall Study||14
572702|NCT00597038|1398301|P2|NOT COMPLETED|Overall Study||4
572703|NCT00597038|1398302|P1|NOT COMPLETED|Overall Study||2
572704|NCT00597038|1398301|P2|COMPLETED|Overall Study|Two patients withdrew, one did not complete due to progressive disease, one patient died.|30
572705|NCT00597038|1398302|P1|COMPLETED|Overall Study|One did not complete due to PI decision, one did not complete due to progressive disease.|14
572706|NCT00597038|1398301|P2|STARTED|Overall Study||34
572707|NCT00597038|1398302|P1|STARTED|Overall Study||16
572708|NCT00597012|1398313|P2|NOT COMPLETED|Overall Study||8
572709|NCT00597012|1398314|P1|NOT COMPLETED|Overall Study||13
572710|NCT00597012|1398313|P2|COMPLETED|Overall Study||169
572711|NCT00597012|1398314|P1|COMPLETED|Overall Study||161
572712|NCT00597012|1398313|P2|STARTED|Overall Study||177
572713|NCT00597012|1398314|P1|STARTED|Overall Study||174
572714|NCT00596960|1398326|P2|NOT COMPLETED|Overall Study||9
572715|NCT00596960|1398327|P1|NOT COMPLETED|Overall Study||11
572716|NCT00596960|1398326|P2|COMPLETED|Overall Study||60
572717|NCT00596960|1398327|P1|COMPLETED|Overall Study||59
572718|NCT00596960|1398326|P2|STARTED|Overall Study|One subject did not have any alcohol use data and thus was excluded from the statistical analysis|69
572719|NCT00596960|1398327|P1|STARTED|Overall Study||70
572720|NCT00596947|1398339|P2|NOT COMPLETED|Overall Study||3
572721|NCT00596947|1398340|P1|NOT COMPLETED|Overall Study||6
572722|NCT00596947|1398339|P2|COMPLETED|Overall Study||6
572723|NCT00596947|1398340|P1|COMPLETED|Overall Study||3
572724|NCT00596947|1398339|P2|STARTED|Overall Study||9
572725|NCT00596947|1398340|P1|STARTED|Overall Study||9
572726|NCT00596934|1398380|P1|NOT COMPLETED|Overall Study||2
572727|NCT00596934|1398380|P1|COMPLETED|Overall Study||7
572728|NCT00596934|1398380|P1|STARTED|Overall Study||9
572729|NCT00596830|1398393|P2|NOT COMPLETED|Overall Study||339
572730|NCT00596830|1398394|P1|NOT COMPLETED|Overall Study||342
572731|NCT00596830|1398393|P2|COMPLETED|Overall Study||0
572732|NCT00596830|1398394|P1|COMPLETED|Overall Study||0
572733|NCT00596830|1398393|P2|Treated|Overall Study||332
572734|NCT00596830|1398394|P1|Treated|Overall Study|1 participant in this group only received chemo and did not complete due to death.|339
572735|NCT00596830|1398393|P2|STARTED|Overall Study||339
572736|NCT00596830|1398394|P1|STARTED|Overall Study|1 participant in this group only received paclitaxel and carboplatin (chemo).|342
572737|NCT00596817|1398420|P2|NOT COMPLETED|Double-blind Period||79
572738|NCT00596817|1398421|P1|NOT COMPLETED|Double-blind Period||88
572739|NCT00596817|1398420|P2|COMPLETED|Double-blind Period||125
572740|NCT00596817|1398421|P1|COMPLETED|Double-blind Period||104
572741|NCT00596817|1398420|P2|STARTED|Double-blind Period|206 patients were randomised. 2 did not receive study medication. 204 is FAS.|204
572742|NCT00596817|1398421|P1|STARTED|Double-blind Period|194 patients were randomised. 2 did not receive study medication. 192 is full-analysis set (FAS).|192
572743|NCT00596817|1398420|P2|NOT COMPLETED|Open-label Period to Double-blind Period||92
572744|NCT00596817|1398421|P1|NOT COMPLETED|Open-label Period to Double-blind Period||0
572745|NCT00596817|1398420|P2|COMPLETED|Open-label Period to Double-blind Period||400
572746|NCT00596817|1398421|P1|COMPLETED|Open-label Period to Double-blind Period||0
572747|NCT00596817|1398420|P2|STARTED|Open-label Period to Double-blind Period||492
572748|NCT00596817|1398421|P1|STARTED|Open-label Period to Double-blind Period||0
572749|NCT00596817|1398420|P2|NOT COMPLETED|Open-label Period||147
572750|NCT00596817|1398421|P1|NOT COMPLETED|Open-label Period||0
572751|NCT00596817|1398420|P2|COMPLETED|Open-label Period||492
572752|NCT00596817|1398421|P1|COMPLETED|Open-label Period||0
572753|NCT00596817|1398420|P2|STARTED|Open-label Period||639
572754|NCT00596817|1398421|P1|STARTED|Open-label Period||0
572755|NCT00596752|1398446|P2|NOT COMPLETED|Overall Study||143
572756|NCT00596752|1398447|P1|NOT COMPLETED|Overall Study||126
572757|NCT00596752|1398446|P2|COMPLETED|Overall Study||282
572758|NCT00596752|1398447|P1|COMPLETED|Overall Study||289
572759|NCT00596752|1398446|P2|Randomized and Treated|Overall Study||424
572760|NCT00596752|1398447|P1|Randomized and Treated|Overall Study||415
572761|NCT00596752|1398446|P2|STARTED|Overall Study||425
572762|NCT00596752|1398447|P1|STARTED|Overall Study||415
572763|NCT00596687|1398477|P2|NOT COMPLETED|Overall Study||9
572764|NCT00596687|1398478|P1|NOT COMPLETED|Overall Study||14
572765|NCT00596687|1398477|P2|COMPLETED|Overall Study||107
572766|NCT00596687|1398478|P1|COMPLETED|Overall Study||104
572767|NCT00596687|1398477|P2|STARTED|Overall Study||116
572768|NCT00596687|1398478|P1|STARTED|Overall Study||118
572769|NCT00596635|1398489|P3|NOT COMPLETED|Overall Study||8
572770|NCT00596635|1398490|P2|NOT COMPLETED|Overall Study||13
572771|NCT00596635|1398491|P1|NOT COMPLETED|Overall Study||7
572772|NCT00596635|1398489|P3|COMPLETED|Overall Study||11
572773|NCT00596635|1398490|P2|COMPLETED|Overall Study||7
572774|NCT00596635|1398491|P1|COMPLETED|Overall Study||10
572775|NCT00596635|1398489|P3|STARTED|Overall Study||19
572776|NCT00596635|1398490|P2|STARTED|Overall Study||20
572777|NCT00596635|1398491|P1|STARTED|Overall Study||17
572778|NCT00596622|1398508|P1|NOT COMPLETED|Overall Study||13
572779|NCT00596622|1398508|P1|COMPLETED|Overall Study||33
572780|NCT00596622|1398508|P1|STARTED|Overall Study||46
572781|NCT00596466|1398517|P1|NOT COMPLETED|Overall Study||17
572782|NCT00596466|1398517|P1|COMPLETED|Overall Study||58
572783|NCT00596466|1398517|P1|Enrolled, Treated|Overall Study||73
572784|NCT00596466|1398517|P1|STARTED|Overall Study||75
572785|NCT00596453|1398525|P2|NOT COMPLETED|Overall Study||3
572786|NCT00596453|1398526|P1|NOT COMPLETED|Overall Study||1
572787|NCT00596453|1398525|P2|COMPLETED|Overall Study||12
572788|NCT00596453|1398526|P1|COMPLETED|Overall Study||12
572789|NCT00596453|1398525|P2|STARTED|Overall Study||15
572790|NCT00596453|1398526|P1|STARTED|Overall Study||13
572791|NCT00596440|1398534|P2|NOT COMPLETED|Overall Study||80
572792|NCT00596440|1398535|P1|NOT COMPLETED|Overall Study||65
572793|NCT00596440|1398534|P2|COMPLETED|Overall Study||41
572794|NCT00596440|1398535|P1|COMPLETED|Overall Study||48
572795|NCT00596440|1398534|P2|Showed to First Treatment Session|Overall Study||52
572796|NCT00596440|1398535|P1|Showed to First Treatment Session|Overall Study||61
572797|NCT00596440|1398534|P2|Showed to Eligibility Visit|Overall Study||72
572798|NCT00596440|1398535|P1|Showed to Eligibility Visit|Overall Study||85
572799|NCT00596440|1398534|P2|STARTED|Overall Study||121
572800|NCT00596440|1398535|P1|STARTED|Overall Study||113
572801|NCT00596427|1398547|P2|NOT COMPLETED|Overall Study||2
572802|NCT00596427|1398548|P1|NOT COMPLETED|Overall Study||4
572803|NCT00596427|1398547|P2|COMPLETED|Overall Study||28
572804|NCT00596427|1398548|P1|COMPLETED|Overall Study||26
572805|NCT00596427|1398547|P2|STARTED|Overall Study||30
572806|NCT00596427|1398548|P1|STARTED|Overall Study||30
572807|NCT00596362|1398576|P1|NOT COMPLETED|Overall Study||1
572808|NCT00596362|1398576|P1|COMPLETED|Overall Study||0
572809|NCT00596362|1398576|P1|STARTED|Overall Study||1
572810|NCT00596271|1398583|P3|NOT COMPLETED|Overall Study||1
572811|NCT00596271|1398584|P2|NOT COMPLETED|Overall Study||6
572812|NCT00596271|1398585|P1|NOT COMPLETED|Overall Study||5
572813|NCT00596271|1398583|P3|COMPLETED|Overall Study||61
572814|NCT00596271|1398584|P2|COMPLETED|Overall Study||59
572815|NCT00596271|1398585|P1|COMPLETED|Overall Study||60
572816|NCT00596271|1398583|P3|STARTED|Overall Study||62
572817|NCT00596271|1398584|P2|STARTED|Overall Study||65
572818|NCT00596271|1398585|P1|STARTED|Overall Study||65
572819|NCT00596167|1398594|P1|NOT COMPLETED|Overall Study||0
572820|NCT00596167|1398594|P1|COMPLETED|Overall Study||6
572821|NCT00596167|1398594|P1|STARTED|Overall Study|All recruited subjects completed the study.|6
572822|NCT00596102|1398601|P3|NOT COMPLETED|Up to Month 60||637
572823|NCT00596102|1398602|P2|NOT COMPLETED|Up to Month 60||338
572824|NCT00596102|1398603|P1|NOT COMPLETED|Up to Month 60||2181
572825|NCT00596102|1398601|P3|COMPLETED|Up to Month 60||0
572826|NCT00596102|1398602|P2|COMPLETED|Up to Month 60||0
572827|NCT00596102|1398603|P1|COMPLETED|Up to Month 60|"long-term safety follow-up beyond Month 6 for a sub-set of subjects in IC51 group only"|102
572828|NCT00596102|1398601|P3|STARTED|Up to Month 60||637
572829|NCT00596102|1398602|P2|STARTED|Up to Month 60||338
572830|NCT00596102|1398603|P1|STARTED|Up to Month 60||2283
572831|NCT00596102|1398601|P3|NOT COMPLETED|Up to Month 6||0
572832|NCT00596102|1398602|P2|NOT COMPLETED|Up to Month 6||0
572833|NCT00596102|1398603|P1|NOT COMPLETED|Up to Month 6||0
572834|NCT00596102|1398601|P3|COMPLETED|Up to Month 6||637
572835|NCT00596102|1398602|P2|COMPLETED|Up to Month 6||338
572836|NCT00596102|1398603|P1|COMPLETED|Up to Month 6||2283
572837|NCT00596102|1398601|P3|STARTED|Up to Month 6||637
572838|NCT00596102|1398602|P2|STARTED|Up to Month 6||338
572839|NCT00596102|1398603|P1|STARTED|Up to Month 6||2283
572846|NCT00595959|1398629|P1|NOT COMPLETED|Overall Study||2
572847|NCT00595959|1398629|P1|COMPLETED|Overall Study||63
572848|NCT00595959|1398629|P1|STARTED|Overall Study||65
572849|NCT00595946|1398646|P2|NOT COMPLETED|Overall Study||69
572850|NCT00595946|1398647|P1|NOT COMPLETED|Overall Study||64
572851|NCT00595946|1398646|P2|COMPLETED|Overall Study||152
572852|NCT00595946|1398647|P1|COMPLETED|Overall Study||154
572853|NCT00595946|1398646|P2|STARTED|Overall Study||221
572854|NCT00595946|1398647|P1|STARTED|Overall Study||218
572855|NCT00595920|1398663|P1|NOT COMPLETED|Overall Study||116
572856|NCT00595920|1398663|P1|COMPLETED|Overall Study||0
572857|NCT00595920|1398663|P1|Patients Dosed|Overall Study|116 patients enrolled; however, only 38 received at least 1 dose.|38
572858|NCT00595920|1398663|P1|STARTED|Overall Study||116
572859|NCT00595881|1398667|P1|NOT COMPLETED|Overall Study||0
572860|NCT00595881|1398667|P1|COMPLETED|Overall Study||420
572861|NCT00595881|1398667|P1|STARTED|Overall Study||420
572862|NCT00595868|1398674|P2|NOT COMPLETED|Overall Study||50
572863|NCT00595868|1398675|P1|NOT COMPLETED|Overall Study||45
572864|NCT00595868|1398674|P2|COMPLETED|Overall Study||61
572865|NCT00595868|1398675|P1|COMPLETED|Overall Study||62
572866|NCT00595868|1398674|P2|STARTED|Overall Study||111
572867|NCT00595868|1398675|P1|STARTED|Overall Study||107
572868|NCT00595790|1398686|P3|NOT COMPLETED|Overall Study||3
572869|NCT00595790|1398687|P2|NOT COMPLETED|Overall Study||1
572870|NCT00595790|1398688|P1|NOT COMPLETED|Overall Study||2
572871|NCT00595790|1398686|P3|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|122
572872|NCT00595790|1398687|P2|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|123
572873|NCT00595790|1398688|P1|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|123
572874|NCT00595790|1398686|P3|STARTED|Overall Study|125 subjects randomized to this group, 124 subjects received 1x6 mcg.(Safety Population: N=124)|125
572875|NCT00595790|1398687|P2|STARTED|Overall Study|124 subjects randomized to this group, 125 subjects received 1x12 mcg.(Safety Population: N=125)|124
572876|NCT00595790|1398688|P1|STARTED|Overall Study||125
572877|NCT00595764|1398698|P2|NOT COMPLETED|Overall Study||43
572878|NCT00595764|1398699|P1|NOT COMPLETED|Overall Study||39
572879|NCT00595764|1398698|P2|COMPLETED|Overall Study||27
572880|NCT00595764|1398699|P1|COMPLETED|Overall Study||32
572881|NCT00595764|1398698|P2|STARTED|Overall Study||70
572882|NCT00595764|1398699|P1|STARTED|Overall Study||71
572883|NCT00595582|1398713|P1|NOT COMPLETED|Overall Study||10
572884|NCT00595582|1398713|P1|COMPLETED|Overall Study||0
572885|NCT00595582|1398713|P1|STARTED|Overall Study||10
572886|NCT00595556|1398719|P2|NOT COMPLETED|Overall Study||1
572887|NCT00595556|1398720|P1|NOT COMPLETED|Overall Study||3
572888|NCT00595556|1398719|P2|COMPLETED|Overall Study||19
572889|NCT00595556|1398720|P1|COMPLETED|Overall Study||17
572890|NCT00595556|1398719|P2|STARTED|Overall Study||20
572891|NCT00595556|1398720|P1|STARTED|Overall Study||20
572892|NCT00595530|1398734|P1|NOT COMPLETED|Overall Study||0
572893|NCT00595530|1398734|P1|COMPLETED|Overall Study||3
572894|NCT00595530|1398734|P1|STARTED|Overall Study||3
572895|NCT00595517|1398738|P1|NOT COMPLETED|Overall Study||19
572896|NCT00595517|1398738|P1|COMPLETED|Overall Study||111
572897|NCT00595517|1398738|P1|STARTED|Overall Study||130
572898|NCT00595504|1398747|P2|NOT COMPLETED|Overall Study||3
572899|NCT00595504|1398748|P1|NOT COMPLETED|Overall Study||2
572900|NCT00595504|1398747|P2|COMPLETED|Overall Study||6
572901|NCT00595504|1398748|P1|COMPLETED|Overall Study||14
572902|NCT00595504|1398747|P2|STARTED|Overall Study||9
572903|NCT00595504|1398748|P1|STARTED|Overall Study||16
572904|NCT00595478|1398760|P2|NOT COMPLETED|36-week Follow-up Period||8
572905|NCT00595478|1398761|P1|NOT COMPLETED|36-week Follow-up Period||9
572906|NCT00595478|1398760|P2|COMPLETED|36-week Follow-up Period||30
572907|NCT00595478|1398761|P1|COMPLETED|36-week Follow-up Period||28
572908|NCT00595478|1398760|P2|STARTED|36-week Follow-up Period||38
572909|NCT00595478|1398761|P1|STARTED|36-week Follow-up Period||37
572910|NCT00595478|1398760|P2|NOT COMPLETED|Treatment||0
572911|NCT00595478|1398761|P1|NOT COMPLETED|Treatment||0
572912|NCT00595478|1398760|P2|COMPLETED|Treatment||38
572913|NCT00595478|1398761|P1|COMPLETED|Treatment||37
572914|NCT00595478|1398760|P2|STARTED|Treatment||38
572915|NCT00595478|1398761|P1|STARTED|Treatment||37
572916|NCT00595465|1398772|P3|NOT COMPLETED|Overall Study||7
572917|NCT00595465|1398773|P2|NOT COMPLETED|Overall Study||4
572918|NCT00595465|1398774|P1|NOT COMPLETED|Overall Study||6
572919|NCT00595465|1398772|P3|COMPLETED|Overall Study||121
572920|NCT00595465|1398773|P2|COMPLETED|Overall Study||125
572921|NCT00595465|1398774|P1|COMPLETED|Overall Study||124
572922|NCT00595465|1398772|P3|STARTED|Overall Study||128
572923|NCT00595465|1398773|P2|STARTED|Overall Study||129
572924|NCT00595465|1398774|P1|STARTED|Overall Study||130
572925|NCT00595413|1398786|P4|NOT COMPLETED|Overall Study||4
572926|NCT00595413|1398787|P3|NOT COMPLETED|Overall Study||8
572927|NCT00595413|1398788|P2|NOT COMPLETED|Overall Study||5
572928|NCT00595413|1398789|P1|NOT COMPLETED|Overall Study||7
572929|NCT00595413|1398786|P4|COMPLETED|Overall Study||75
572930|NCT00595413|1398787|P3|COMPLETED|Overall Study||70
572931|NCT00595413|1398788|P2|COMPLETED|Overall Study||73
572932|NCT00595413|1398789|P1|COMPLETED|Overall Study||69
572933|NCT00595413|1398786|P4|STARTED|Overall Study||79
572934|NCT00595413|1398787|P3|STARTED|Overall Study||78
572935|NCT00595413|1398788|P2|STARTED|Overall Study||78
572936|NCT00595413|1398789|P1|STARTED|Overall Study||76
572937|NCT00595361|1398817|P2|NOT COMPLETED|Overall Study||0
572938|NCT00595361|1398818|P1|NOT COMPLETED|Overall Study||0
572939|NCT00595361|1398817|P2|COMPLETED|Overall Study||18
572940|NCT00595361|1398818|P1|COMPLETED|Overall Study||12
572941|NCT00595361|1398817|P2|STARTED|Overall Study||18
572942|NCT00595361|1398818|P1|STARTED|Overall Study||12
572943|NCT00595335|1398830|P2|NOT COMPLETED|Six Months to Twelve Months||1
572944|NCT00595335|1398831|P1|NOT COMPLETED|Six Months to Twelve Months||1
572945|NCT00595335|1398830|P2|COMPLETED|Six Months to Twelve Months||9
572946|NCT00595335|1398831|P1|COMPLETED|Six Months to Twelve Months||10
572947|NCT00595335|1398830|P2|STARTED|Six Months to Twelve Months||10
572948|NCT00595335|1398831|P1|STARTED|Six Months to Twelve Months||11
572949|NCT00595335|1398830|P2|NOT COMPLETED|Baseline to Six Months||2
572950|NCT00595335|1398831|P1|NOT COMPLETED|Baseline to Six Months||2
572951|NCT00595335|1398830|P2|COMPLETED|Baseline to Six Months||10
572952|NCT00595335|1398831|P1|COMPLETED|Baseline to Six Months||11
572953|NCT00595335|1398830|P2|STARTED|Baseline to Six Months||12
572954|NCT00595335|1398831|P1|STARTED|Baseline to Six Months||13
572955|NCT00595309|1398851|P1|NOT COMPLETED|Overall Study||4
572956|NCT00595309|1398851|P1|COMPLETED|Overall Study||194
572957|NCT00595309|1398851|P1|STARTED|Overall Study||198
572958|NCT00595270|1398858|P3|NOT COMPLETED|Overall Study||8
572959|NCT00595270|1398859|P2|NOT COMPLETED|Overall Study||10
572960|NCT00595270|1398860|P1|NOT COMPLETED|Overall Study||6
572961|NCT00595270|1398858|P3|COMPLETED|Overall Study||108
572962|NCT00595270|1398859|P2|COMPLETED|Overall Study||107
572963|NCT00595270|1398860|P1|COMPLETED|Overall Study||110
572964|NCT00595270|1398858|P3|STARTED|Overall Study||116
572965|NCT00595270|1398859|P2|STARTED|Overall Study||117
572966|NCT00595270|1398860|P1|STARTED|Overall Study||116
572967|NCT00595153|1398871|P3|NOT COMPLETED|Overall Study||25
572968|NCT00595153|1398872|P2|NOT COMPLETED|Overall Study||16
572969|NCT00595153|1398873|P1|NOT COMPLETED|Overall Study||4
572970|NCT00595153|1398871|P3|COMPLETED|Overall Study||36
572971|NCT00595153|1398872|P2|COMPLETED|Overall Study||26
572972|NCT00595153|1398873|P1|COMPLETED|Overall Study||20
572973|NCT00595153|1398871|P3|STARTED|Overall Study||61
572974|NCT00595153|1398872|P2|STARTED|Overall Study||42
572975|NCT00595153|1398873|P1|STARTED|Overall Study||24
572976|NCT00595127|1398881|P1|NOT COMPLETED|Overall Study||10
572977|NCT00595127|1398881|P1|COMPLETED|Overall Study||11
572978|NCT00595127|1398881|P1|STARTED|Overall Study||21
572979|NCT00595114|1398887|P2|NOT COMPLETED|Overall Study||0
572980|NCT00595114|1398888|P1|NOT COMPLETED|Overall Study||0
572981|NCT00595114|1398887|P2|COMPLETED|Overall Study||19
572982|NCT00595114|1398888|P1|COMPLETED|Overall Study||24
572983|NCT00595114|1398887|P2|STARTED|Overall Study||19
572984|NCT00595114|1398888|P1|STARTED|Overall Study||24
572985|NCT00595088|1398894|P1|NOT COMPLETED|Overall Study||40
572986|NCT00595088|1398894|P1|COMPLETED|Overall Study|5 patients ongoing, 7 completed the study (week 46)and 35 withdrew prematurely|7
572987|NCT00595088|1398894|P1|STARTED|Overall Study||47
572988|NCT00595075|1398903|P2|NOT COMPLETED|Overall Study||0
572989|NCT00595075|1398904|P1|NOT COMPLETED|Overall Study||1
572990|NCT00595075|1398903|P2|COMPLETED|Overall Study||5
572991|NCT00595075|1398904|P1|COMPLETED|Overall Study||5
572992|NCT00595075|1398903|P2|STARTED|Overall Study||5
572993|NCT00595075|1398904|P1|STARTED|Overall Study||6
572994|NCT00594958|1398925|P3|NOT COMPLETED|Overall Study||10
572995|NCT00594958|1398926|P2|NOT COMPLETED|Overall Study||3
572996|NCT00594958|1398927|P1|NOT COMPLETED|Overall Study||14
572997|NCT00594958|1398925|P3|COMPLETED|Overall Study||202
572998|NCT00594958|1398926|P2|COMPLETED|Overall Study||210
572999|NCT00594958|1398927|P1|COMPLETED|Overall Study||200
573000|NCT00594958|1398925|P3|Randomized and at Least 1 Vaccination|Overall Study||211
573001|NCT00594958|1398926|P2|Randomized and at Least 1 Vaccination|Overall Study||213
573002|NCT00594958|1398927|P1|Randomized and at Least 1 Vaccination|Overall Study||212
573003|NCT00594958|1398925|P3|STARTED|Overall Study||212
573004|NCT00594958|1398926|P2|STARTED|Overall Study||213
573005|NCT00594958|1398927|P1|STARTED|Overall Study||214
573006|NCT00594945|1398938|P3|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
573007|NCT00594945|1398939|P2|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
573008|NCT00594945|1398940|P1|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
573009|NCT00594945|1398938|P3|COMPLETED|Cohort 2 / Treatment Period 2||2
573010|NCT00594945|1398939|P2|COMPLETED|Cohort 2 / Treatment Period 2||3
573011|NCT00594945|1398940|P1|COMPLETED|Cohort 2 / Treatment Period 2||0
573012|NCT00594945|1398938|P3|STARTED|Cohort 2 / Treatment Period 2||2
573013|NCT00594945|1398939|P2|STARTED|Cohort 2 / Treatment Period 2||3
573014|NCT00594945|1398940|P1|STARTED|Cohort 2 / Treatment Period 2||0
573015|NCT00594945|1398938|P3|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
573016|NCT00594945|1398939|P2|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
573017|NCT00594945|1398940|P1|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
573018|NCT00594945|1398938|P3|COMPLETED|Cohort 1 / Treatment Period 1||2
573019|NCT00594945|1398939|P2|COMPLETED|Cohort 1 / Treatment Period 1||0
573020|NCT00594945|1398940|P1|COMPLETED|Cohort 1 / Treatment Period 1||4
573021|NCT00594945|1398938|P3|STARTED|Cohort 1 / Treatment Period 1||2
573022|NCT00594945|1398939|P2|STARTED|Cohort 1 / Treatment Period 1||0
573023|NCT00594945|1398940|P1|STARTED|Cohort 1 / Treatment Period 1||4
573024|NCT00594906|1398948|P2|NOT COMPLETED|Overall Study||2
573025|NCT00594906|1398949|P1|NOT COMPLETED|Overall Study||1
573026|NCT00594906|1398948|P2|COMPLETED|Overall Study||1
573027|NCT00594906|1398949|P1|COMPLETED|Overall Study||6
573028|NCT00594906|1398948|P2|STARTED|Overall Study||3
573029|NCT00594906|1398949|P1|STARTED|Overall Study||7
573030|NCT00594880|1398957|P2|NOT COMPLETED|Overall Study||1
573031|NCT00594880|1398958|P1|NOT COMPLETED|Overall Study||2
573032|NCT00594880|1398957|P2|COMPLETED|Overall Study||10
573033|NCT00594880|1398958|P1|COMPLETED|Overall Study||10
573034|NCT00594880|1398957|P2|STARTED|Overall Study||11
573035|NCT00594880|1398958|P1|STARTED|Overall Study||12
573036|NCT00594854|1398970|P2|NOT COMPLETED|Overall Study||10
573037|NCT00594854|1398971|P1|NOT COMPLETED|Overall Study||7
573038|NCT00594854|1398970|P2|COMPLETED|Overall Study|POZEN reached an agreement with the FDA to terminate the study due to low and inadequate enrollment.|1
573039|NCT00594854|1398971|P1|COMPLETED|Overall Study|POZEN reached an agreement with the FDA to terminate the study due to low and inadequate enrollment.|2
573040|NCT00594854|1398970|P2|STARTED|Overall Study||11
573041|NCT00594854|1398971|P1|STARTED|Overall Study||9
573042|NCT00594815|1398981|P1|NOT COMPLETED|Overall Study||9
573043|NCT00594815|1398981|P1|COMPLETED|Overall Study||43
573044|NCT00594815|1398981|P1|STARTED|Overall Study||52
573045|NCT00594685|1398986|P1|NOT COMPLETED|Overall Study||0
573046|NCT00594685|1398986|P1|COMPLETED|Overall Study||10
573047|NCT00594685|1398986|P1|STARTED|Overall Study||10
573048|NCT00594659|1399006|P3|NOT COMPLETED|Overall Study||7
573049|NCT00594659|1399007|P2|NOT COMPLETED|Overall Study||9
573050|NCT00594659|1399008|P1|NOT COMPLETED|Overall Study||13
573051|NCT00594659|1399006|P3|COMPLETED|Overall Study||9
573052|NCT00594659|1399007|P2|COMPLETED|Overall Study||21
573053|NCT00594659|1399008|P1|COMPLETED|Overall Study||16
573054|NCT00594659|1399006|P3|STARTED|Overall Study||16
573055|NCT00594659|1399007|P2|STARTED|Overall Study||30
573056|NCT00594659|1399008|P1|STARTED|Overall Study||29
573057|NCT00594646|1399019|P1|NOT COMPLETED|Overall Study||16
573058|NCT00594646|1399019|P1|COMPLETED|Overall Study||84
573059|NCT00594646|1399019|P1|STARTED|Overall Study||100
573060|NCT00594568|1399027|P3|NOT COMPLETED|Safety Follow Up (SFU)-Optional||42
573061|NCT00594568|1399028|P2|NOT COMPLETED|Safety Follow Up (SFU)-Optional||55
573062|NCT00594568|1399029|P1|NOT COMPLETED|Safety Follow Up (SFU)-Optional||61
573063|NCT00594568|1399027|P3|COMPLETED|Safety Follow Up (SFU)-Optional||172
573064|NCT00594568|1399028|P2|COMPLETED|Safety Follow Up (SFU)-Optional||168
573065|NCT00594568|1399029|P1|COMPLETED|Safety Follow Up (SFU)-Optional||229
573066|NCT00594568|1399027|P3|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional, pts entered from initial treatment and delayed start or did not enter SFU.|214
573067|NCT00594568|1399028|P2|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|223
573068|NCT00594568|1399029|P1|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|290
573069|NCT00594568|1399027|P3|NOT COMPLETED|Delayed Start||66
573070|NCT00594568|1399028|P2|NOT COMPLETED|Delayed Start||77
573071|NCT00594568|1399029|P1|NOT COMPLETED|Delayed Start||98
573072|NCT00594568|1399027|P3|COMPLETED|Delayed Start||55
573073|NCT00594568|1399028|P2|COMPLETED|Delayed Start||76
573074|NCT00594568|1399029|P1|COMPLETED|Delayed Start||91
573075|NCT00594568|1399027|P3|STARTED|Delayed Start||121
573076|NCT00594568|1399028|P2|STARTED|Delayed Start||153
573077|NCT00594568|1399029|P1|STARTED|Delayed Start||189
573078|NCT00594568|1399027|P3|NOT COMPLETED|Initial Treatment||408
573079|NCT00594568|1399028|P2|NOT COMPLETED|Initial Treatment||354
573080|NCT00594568|1399029|P1|NOT COMPLETED|Initial Treatment||312
573081|NCT00594568|1399027|P3|COMPLETED|Initial Treatment||121
573082|NCT00594568|1399028|P2|COMPLETED|Initial Treatment||153
573083|NCT00594568|1399029|P1|COMPLETED|Initial Treatment||189
573084|NCT00594568|1399027|P3|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who had at least 1 dose of study drug.|527
573085|NCT00594568|1399028|P2|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who had at least 1 dose of study drug.|506
573086|NCT00594568|1399029|P1|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants (pts) who had at least 1 dose of study drug.|501
573087|NCT00594568|1399027|P3|STARTED|Initial Treatment||529
573088|NCT00594568|1399028|P2|STARTED|Initial Treatment||507
573089|NCT00594568|1399029|P1|STARTED|Initial Treatment||501
573090|NCT00594516|1399117|P3|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||8
573091|NCT00594516|1399118|P2|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||7
573092|NCT00594516|1399119|P1|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||0
573093|NCT00594516|1399117|P3|COMPLETED|DB: Tapentadol IR to ER & ER to IR||35
573094|NCT00594516|1399118|P2|COMPLETED|DB: Tapentadol IR to ER & ER to IR||37
573095|NCT00594516|1399119|P1|COMPLETED|DB: Tapentadol IR to ER & ER to IR||0
573096|NCT00594516|1399117|P3|STARTED|DB: Tapentadol IR to ER & ER to IR||43
573097|NCT00594516|1399118|P2|STARTED|DB: Tapentadol IR to ER & ER to IR||44
573098|NCT00594516|1399119|P1|STARTED|DB: Tapentadol IR to ER & ER to IR||0
573099|NCT00594516|1399117|P3|NOT COMPLETED|Open Label (OL): Tapentadol IR||0
573100|NCT00594516|1399118|P2|NOT COMPLETED|Open Label (OL): Tapentadol IR||0
573101|NCT00594516|1399119|P1|NOT COMPLETED|Open Label (OL): Tapentadol IR||29
573102|NCT00594516|1399117|P3|COMPLETED|Open Label (OL): Tapentadol IR||0
573103|NCT00594516|1399118|P2|COMPLETED|Open Label (OL): Tapentadol IR||0
573104|NCT00594516|1399119|P1|COMPLETED|Open Label (OL): Tapentadol IR||87
573105|NCT00594516|1399117|P3|STARTED|Open Label (OL): Tapentadol IR||0
573106|NCT00594516|1399118|P2|STARTED|Open Label (OL): Tapentadol IR||0
573107|NCT00594516|1399119|P1|STARTED|Open Label (OL): Tapentadol IR|one patient was enrolled but lost to follow up at the start of open label therefore was not included|116
573108|NCT00594464|1399127|P1|NOT COMPLETED|Overall Study||3
573109|NCT00594464|1399127|P1|COMPLETED|Overall Study||11
573110|NCT00594464|1399127|P1|STARTED|Overall Study||14
573111|NCT00594425|1399142|P3|NOT COMPLETED|Overall Study||10
573112|NCT00594425|1399143|P2|NOT COMPLETED|Overall Study||14
573113|NCT00594425|1399144|P1|NOT COMPLETED|Overall Study||7
573114|NCT00594425|1399142|P3|COMPLETED|Overall Study||42
573115|NCT00594425|1399143|P2|COMPLETED|Overall Study||34
573116|NCT00594425|1399144|P1|COMPLETED|Overall Study||43
573117|NCT00594425|1399142|P3|STARTED|Overall Study||52
573118|NCT00594425|1399143|P2|STARTED|Overall Study||48
573119|NCT00594425|1399144|P1|STARTED|Overall Study||50
573120|NCT00594399|1399256|P3|NOT COMPLETED|Rerandomization Arm 1 Only||0
573121|NCT00594399|1399257|P2|NOT COMPLETED|Rerandomization Arm 1 Only||4
573122|NCT00594399|1399258|P1|NOT COMPLETED|Rerandomization Arm 1 Only||2
573123|NCT00594399|1399256|P3|COMPLETED|Rerandomization Arm 1 Only||82
573124|NCT00594399|1399257|P2|COMPLETED|Rerandomization Arm 1 Only||114
573125|NCT00594399|1399258|P1|COMPLETED|Rerandomization Arm 1 Only||79
573126|NCT00594399|1399256|P3|Rerandomization|Rerandomization Arm 1 Only||82
573127|NCT00594399|1399257|P2|Rerandomization|Rerandomization Arm 1 Only||114
573128|NCT00594399|1399258|P1|Rerandomization|Rerandomization Arm 1 Only|Rerandomized to continue to receive telephone calls every 2 weeks or at a reduced dose of 1/ month|81
573129|NCT00594399|1399256|P3|STARTED|Rerandomization Arm 1 Only|This sample reflects newly randomized study Arm|82
573130|NCT00594399|1399257|P2|STARTED|Rerandomization Arm 1 Only||118
573131|NCT00594399|1399258|P1|STARTED|Rerandomization Arm 1 Only|Total sample in Arm 1 was rerandomized and allocated to remain in Arm 1 or assigned to Arm 3|81
573132|NCT00594399|1399256|P3|NOT COMPLETED|Initial 3 Month Counseling||0
573133|NCT00594399|1399257|P2|NOT COMPLETED|Initial 3 Month Counseling||4
573134|NCT00594399|1399258|P1|NOT COMPLETED|Initial 3 Month Counseling||17
573135|NCT00594399|1399256|P3|COMPLETED|Initial 3 Month Counseling||0
573136|NCT00594399|1399257|P2|COMPLETED|Initial 3 Month Counseling||118
573137|NCT00594399|1399258|P1|COMPLETED|Initial 3 Month Counseling||163
573138|NCT00594399|1399256|P3|STARTED|Initial 3 Month Counseling||0
573139|NCT00594399|1399257|P2|STARTED|Initial 3 Month Counseling||122
573140|NCT00594399|1399258|P1|STARTED|Initial 3 Month Counseling||180
573141|NCT00594386|1399280|P1|NOT COMPLETED|Overall Study||258
573142|NCT00594386|1399280|P1|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
573143|NCT00594386|1399280|P1|STARTED|Overall Study||258
573144|NCT00594308|1399286|P1|NOT COMPLETED|Overall Study||0
573145|NCT00594308|1399286|P1|COMPLETED|Overall Study||10
573146|NCT00594308|1399286|P1|STARTED|Overall Study||10
573147|NCT00594256|1399294|P1|NOT COMPLETED|Overall Study||0
573148|NCT00594256|1399294|P1|COMPLETED|Overall Study||8
573149|NCT00594256|1399294|P1|STARTED|Overall Study||8
573150|NCT00594230|1399304|P2|NOT COMPLETED|Overall Study||9
573151|NCT00594230|1399305|P1|NOT COMPLETED|Overall Study||15
573152|NCT00594230|1399304|P2|COMPLETED|Overall Study||1
573153|NCT00594230|1399305|P1|COMPLETED|Overall Study||1
573154|NCT00594230|1399304|P2|STARTED|Overall Study||10
573155|NCT00594230|1399305|P1|STARTED|Overall Study||16
573156|NCT00594204|1399313|P2|NOT COMPLETED|Overall Study||45
573157|NCT00594204|1399314|P1|NOT COMPLETED|Overall Study||58
573158|NCT00594204|1399313|P2|COMPLETED|Overall Study||154
573159|NCT00594204|1399314|P1|COMPLETED|Overall Study||336
573160|NCT00594204|1399313|P2|Received Treatment|Overall Study||198
573161|NCT00594204|1399314|P1|Received Treatment|Overall Study||390
573162|NCT00594204|1399313|P2|STARTED|Overall Study||199
573163|NCT00594204|1399314|P1|STARTED|Overall Study||394
573164|NCT00594178|1399324|P1|NOT COMPLETED|Overall Study||5
573165|NCT00594178|1399324|P1|COMPLETED|Overall Study||12
573166|NCT00594178|1399324|P1|STARTED|Overall Study||17
573167|NCT00594165|1399329|P1|NOT COMPLETED|Overall Study||217
573168|NCT00594165|1399329|P1|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
573169|NCT00594165|1399329|P1|STARTED|Overall Study||217
573170|NCT00594100|1399335|P1|NOT COMPLETED|Follow-up Through 30 Days Post Procedure||12
573171|NCT00594100|1399335|P1|COMPLETED|Follow-up Through 30 Days Post Procedure||224
573172|NCT00594100|1399335|P1|STARTED|Follow-up Through 30 Days Post Procedure||236
573173|NCT00594100|1399335|P1|NOT COMPLETED|Procedure||9
573174|NCT00594100|1399335|P1|COMPLETED|Procedure||236
573175|NCT00594100|1399335|P1|STARTED|Procedure||245
573176|NCT00594061|1399344|P1|NOT COMPLETED|Overall Study||0
573177|NCT00594061|1399344|P1|COMPLETED|Overall Study||9
573178|NCT00594061|1399344|P1|STARTED|Overall Study||9
573179|NCT00594035|1399351|P2|NOT COMPLETED|Overall Study||3
573180|NCT00594035|1399352|P1|NOT COMPLETED|Overall Study||2
573181|NCT00594035|1399351|P2|COMPLETED|Overall Study|53 control group subjects were evaluable at the 90-day visit|53
573182|NCT00594035|1399352|P1|COMPLETED|Overall Study|100 Spinal Sealant subjects were evaluable at the 90-day visit|100
573183|NCT00594035|1399351|P2|STARTED|Overall Study|56 subjects were randomized to the control group (standard of care)|56
573184|NCT00594035|1399352|P1|STARTED|Overall Study|102 subjects were randomized to Spinal Sealant|102
573185|NCT00594022|1399360|P2|NOT COMPLETED|Overall Study||0
573186|NCT00594022|1399361|P1|NOT COMPLETED|Overall Study||0
573187|NCT00594022|1399360|P2|COMPLETED|Overall Study||173
573188|NCT00594022|1399361|P1|COMPLETED|Overall Study||176
573189|NCT00594022|1399360|P2|STARTED|Overall Study||173
573190|NCT00594022|1399361|P1|STARTED|Overall Study||176
573191|NCT00593957|1399378|P3|NOT COMPLETED|Overall Study||2
573192|NCT00593957|1399379|P2|NOT COMPLETED|Overall Study||1
573193|NCT00593957|1399380|P1|NOT COMPLETED|Overall Study||0
573194|NCT00593957|1399378|P3|COMPLETED|Overall Study||10
573195|NCT00593957|1399379|P2|COMPLETED|Overall Study||12
573196|NCT00593957|1399380|P1|COMPLETED|Overall Study||13
573197|NCT00593957|1399378|P3|STARTED|Overall Study||12
573198|NCT00593957|1399379|P2|STARTED|Overall Study||13
573199|NCT00593957|1399380|P1|STARTED|Overall Study||13
573200|NCT00593918|1399404|P2|NOT COMPLETED|Overall Study||24
573201|NCT00593918|1399405|P1|NOT COMPLETED|Overall Study||5
573202|NCT00593918|1399404|P2|COMPLETED|Overall Study|Some children did not come in for the blood draw at visit 2|50
573203|NCT00593918|1399405|P1|COMPLETED|Overall Study|Some children did not come in for the blood draw at visit 2|12
573204|NCT00593918|1399404|P2|STARTED|Overall Study|Number of children with Toll-like Receptor 4 (TLR4) -2026/AG and AA genotypes|74
573205|NCT00593918|1399405|P1|STARTED|Overall Study|Number of children with Toll-like Receptor 4 (TLR4) -2026/GG Genotype|17
573206|NCT00593866|1399413|P1|NOT COMPLETED|Overall Study||0
573207|NCT00593866|1399413|P1|COMPLETED|Overall Study||50
573208|NCT00593866|1399413|P1|STARTED|Overall Study||50
573209|NCT00593840|1399418|P1|NOT COMPLETED|Overall Study||1
573210|NCT00593840|1399418|P1|COMPLETED|Overall Study||72
573211|NCT00593840|1399418|P1|STARTED|Overall Study||73
573212|NCT00593827|1399430|P2|NOT COMPLETED|Overall Study||2
573213|NCT00593827|1399431|P1|NOT COMPLETED|Overall Study||0
573214|NCT00593827|1399430|P2|COMPLETED|Overall Study|Completed=off-study (Major reasons: AEs=30; disease progression=55; not treated=2).|89
573215|NCT00593827|1399431|P1|COMPLETED|Overall Study|Completed=off-study (Major reasons: Adverse events (AE)=15; disease progression=76; not treated=3).|85
573216|NCT00593827|1399430|P2|Evaluable Population|Overall Study|Treated participants with CR, PR, SD, PD, or NE response. Refer outcome measure 3 and 4 for details.|89
573217|NCT00593827|1399431|P1|Evaluable Population|Overall Study|Treated participants with CR, PR, SD, PD, or NE response. Refer outcome measure 3 and 4 for details.|79
573218|NCT00593827|1399430|P2|Safety Population|Overall Study|Participants (eligible and ineligible) who received at least 1 dose of study drug.|89
573219|NCT00593827|1399431|P1|Safety Population|Overall Study|Participants (eligible and ineligible) who received at least 1 dose of study drug.|82
573220|NCT00593827|1399430|P2|STARTED|Overall Study|ITT Population: Participants who were randomized (eligible and ineligible).|91
573221|NCT00593827|1399431|P1|STARTED|Overall Study|Intent-to-Treat (ITT) Population: Participants who were randomized (eligible and ineligible).|85
573222|NCT00593814|1399455|P2|NOT COMPLETED|Overall Study||0
573223|NCT00593814|1399456|P1|NOT COMPLETED|Overall Study||24
573224|NCT00593814|1399455|P2|COMPLETED|Overall Study||120
573225|NCT00593814|1399456|P1|COMPLETED|Overall Study||115
573226|NCT00593814|1399455|P2|STARTED|Overall Study||120
573227|NCT00593814|1399456|P1|STARTED|Overall Study||139
573228|NCT00593736|1399468|P4|NOT COMPLETED|Treatment Period and Placebo Run-out||4
573229|NCT00593736|1399469|P3|NOT COMPLETED|Treatment Period and Placebo Run-out||5
573230|NCT00593736|1399470|P2|NOT COMPLETED|Treatment Period and Placebo Run-out||2
573231|NCT00593736|1399471|P1|NOT COMPLETED|Treatment Period and Placebo Run-out||3
573232|NCT00593736|1399468|P4|COMPLETED|Treatment Period and Placebo Run-out||28
573233|NCT00593736|1399469|P3|COMPLETED|Treatment Period and Placebo Run-out||30
573234|NCT00593736|1399470|P2|COMPLETED|Treatment Period and Placebo Run-out||31
573235|NCT00593736|1399471|P1|COMPLETED|Treatment Period and Placebo Run-out||29
573236|NCT00593736|1399468|P4|STARTED|Treatment Period and Placebo Run-out||32
573237|NCT00593736|1399469|P3|STARTED|Treatment Period and Placebo Run-out||35
573238|NCT00593736|1399470|P2|STARTED|Treatment Period and Placebo Run-out||33
573239|NCT00593736|1399471|P1|STARTED|Treatment Period and Placebo Run-out||32
573240|NCT00593736|1399468|P4|NOT COMPLETED|Screening Period and Placebo Run-in||417
573241|NCT00593736|1399469|P3|NOT COMPLETED|Screening Period and Placebo Run-in||0
573242|NCT00593736|1399470|P2|NOT COMPLETED|Screening Period and Placebo Run-in||0
573243|NCT00593736|1399471|P1|NOT COMPLETED|Screening Period and Placebo Run-in||0
573244|NCT00593736|1399468|P4|COMPLETED|Screening Period and Placebo Run-in||132
573245|NCT00593736|1399469|P3|COMPLETED|Screening Period and Placebo Run-in||0
573246|NCT00593736|1399470|P2|COMPLETED|Screening Period and Placebo Run-in||0
573247|NCT00593736|1399471|P1|COMPLETED|Screening Period and Placebo Run-in||0
573248|NCT00593736|1399468|P4|STARTED|Screening Period and Placebo Run-in||549
573249|NCT00593736|1399469|P3|STARTED|Screening Period and Placebo Run-in||0
573250|NCT00593736|1399470|P2|STARTED|Screening Period and Placebo Run-in||0
573251|NCT00593736|1399471|P1|STARTED|Screening Period and Placebo Run-in||0
573252|NCT00593684|1399719|P2|NOT COMPLETED|Overall Study||1
573253|NCT00593684|1399720|P1|NOT COMPLETED|Overall Study||2
573254|NCT00593684|1399719|P2|COMPLETED|Overall Study||24
573255|NCT00593684|1399720|P1|COMPLETED|Overall Study||23
573256|NCT00593684|1399719|P2|STARTED|Overall Study||25
573257|NCT00593684|1399720|P1|STARTED|Overall Study||25
573258|NCT00593645|1399732|P1|NOT COMPLETED|Overall Study||0
573259|NCT00593645|1399732|P1|COMPLETED|Overall Study||7
573260|NCT00593645|1399732|P1|STARTED|Overall Study||7
573261|NCT00593606|1399746|P1|NOT COMPLETED|Overall Study||27
573262|NCT00593606|1399746|P1|COMPLETED|Overall Study||97
573263|NCT00593606|1399746|P1|Treatment Period Completed|Overall Study||99
573264|NCT00593606|1399746|P1|Full Analysis Set|Overall Study||114
573265|NCT00593606|1399746|P1|Start of Treatment - Safety Set|Overall Study||116
573266|NCT00593606|1399746|P1|STARTED|Overall Study||124
573267|NCT00593554|1399844|P2|NOT COMPLETED|Overall Study||5
573268|NCT00593554|1399845|P1|NOT COMPLETED|Overall Study||3
573269|NCT00593554|1399844|P2|COMPLETED|Overall Study||0
573270|NCT00593554|1399845|P1|COMPLETED|Overall Study||0
573271|NCT00593554|1399844|P2|STARTED|Overall Study||5
573272|NCT00593554|1399845|P1|STARTED|Overall Study||3
573273|NCT00593450|1399867|P4|NOT COMPLETED|Overall Study||29
573274|NCT00593450|1399868|P3|NOT COMPLETED|Overall Study||13
573275|NCT00593450|1399869|P2|NOT COMPLETED|Overall Study||21
573276|NCT00593450|1399870|P1|NOT COMPLETED|Overall Study||17
573277|NCT00593450|1399867|P4|COMPLETED|Overall Study||271
573278|NCT00593450|1399868|P3|COMPLETED|Overall Study||285
573279|NCT00593450|1399869|P2|COMPLETED|Overall Study||265
573280|NCT00593450|1399870|P1|COMPLETED|Overall Study||284
573281|NCT00593450|1399867|P4|STARTED|Overall Study||300
573282|NCT00593450|1399868|P3|STARTED|Overall Study||298
573283|NCT00593450|1399869|P2|STARTED|Overall Study||286
573284|NCT00593450|1399870|P1|STARTED|Overall Study||301
573285|NCT00593385|1399940|P1|NOT COMPLETED|Overall Study||40
573286|NCT00593385|1399940|P1|COMPLETED|Overall Study|125 of 165 enrolled patients completed the study.|125
573287|NCT00593385|1399940|P1|Intention to Treat (ITT) Population|Overall Study|Excludes 13 subjects who did not meet inclusion/exclusion criteria.|152
573288|NCT00593385|1399940|P1|STARTED|Overall Study||165
573289|NCT00593372|1399977|P2|NOT COMPLETED|Overall Study||0
573290|NCT00593372|1399978|P1|NOT COMPLETED|Overall Study||0
573291|NCT00593372|1399977|P2|COMPLETED|Overall Study|Three evaluated and completed protocol.|3
573292|NCT00593372|1399978|P1|COMPLETED|Overall Study|Eight completed behavioral treatment.|8
573293|NCT00593372|1399977|P2|STARTED|Overall Study|Three evaluated but only maintained medical treatment.|3
573294|NCT00593372|1399978|P1|STARTED|Overall Study|Eight enrolled in behavioral treatment.|8
573295|NCT00593346|1399984|P1|NOT COMPLETED|Overall Study||0
573296|NCT00593346|1399984|P1|COMPLETED|Overall Study||151
573297|NCT00593346|1399984|P1|STARTED|Overall Study||151
573298|NCT00593333|1400001|P2|NOT COMPLETED|Overall Study||11
573299|NCT00593333|1400002|P1|NOT COMPLETED|Overall Study||10
573300|NCT00593333|1400001|P2|COMPLETED|Overall Study||45
573301|NCT00593333|1400002|P1|COMPLETED|Overall Study||44
573302|NCT00593333|1400001|P2|STARTED|Overall Study||56
573303|NCT00593333|1400002|P1|STARTED|Overall Study||54
573304|NCT00593320|1400010|P2|NOT COMPLETED|Overall Study||0
573305|NCT00593320|1400011|P1|NOT COMPLETED|Overall Study||0
573306|NCT00593320|1400010|P2|COMPLETED|Overall Study||1
573307|NCT00593320|1400011|P1|COMPLETED|Overall Study||1
573308|NCT00593320|1400010|P2|STARTED|Overall Study||1
573309|NCT00593320|1400011|P1|STARTED|Overall Study||1
573310|NCT00593112|1400025|P2|NOT COMPLETED|Overall Study||0
573311|NCT00593112|1400026|P1|NOT COMPLETED|Overall Study||10
573312|NCT00593112|1400025|P2|COMPLETED|Overall Study||12
573313|NCT00593112|1400026|P1|COMPLETED|Overall Study||17
573314|NCT00593112|1400025|P2|STARTED|Overall Study||12
573315|NCT00593112|1400026|P1|STARTED|Overall Study||27
573316|NCT00592943|1400038|P2|NOT COMPLETED|Overall Study||0
573317|NCT00592943|1400039|P1|NOT COMPLETED|Overall Study||0
573318|NCT00592943|1400038|P2|COMPLETED|Overall Study||6
573319|NCT00592943|1400039|P1|COMPLETED|Overall Study||6
573320|NCT00592943|1400038|P2|STARTED|Overall Study||6
573321|NCT00592943|1400039|P1|STARTED|Overall Study||6
573322|NCT00592904|1400053|P4|NOT COMPLETED|Overall Study||11
573323|NCT00592904|1400054|P3|NOT COMPLETED|Overall Study||17
573324|NCT00592904|1400055|P2|NOT COMPLETED|Overall Study||55
573325|NCT00592904|1400056|P1|NOT COMPLETED|Overall Study||25
573326|NCT00592904|1400053|P4|COMPLETED|Overall Study||19
573327|NCT00592904|1400054|P3|COMPLETED|Overall Study||10
573328|NCT00592904|1400055|P2|COMPLETED|Overall Study||93
573329|NCT00592904|1400056|P1|COMPLETED|Overall Study||32
573330|NCT00592904|1400053|P4|STARTED|Overall Study||30
573331|NCT00592904|1400054|P3|STARTED|Overall Study||27
573332|NCT00592904|1400055|P2|STARTED|Overall Study||148
573333|NCT00592904|1400056|P1|STARTED|Overall Study||57
573334|NCT00592852|1400082|P1|NOT COMPLETED|Overall Study||6
573335|NCT00592852|1400082|P1|COMPLETED|Overall Study||7
573336|NCT00592852|1400082|P1|STARTED|Overall Study||13
573337|NCT00592839|1400090|P3|NOT COMPLETED|Overall Study||6
573338|NCT00592839|1400091|P2|NOT COMPLETED|Overall Study||4
573339|NCT00592839|1400092|P1|NOT COMPLETED|Overall Study||2
573340|NCT00592839|1400090|P3|COMPLETED|Overall Study||46
573341|NCT00592839|1400091|P2|COMPLETED|Overall Study||48
573342|NCT00592839|1400092|P1|COMPLETED|Overall Study||51
573343|NCT00592839|1400090|P3|STARTED|Overall Study||52
573344|NCT00592839|1400091|P2|STARTED|Overall Study||52
573345|NCT00592839|1400092|P1|STARTED|Overall Study||53
573346|NCT00592774|1400120|P5|NOT COMPLETED|Overall Study||14
573347|NCT00592774|1400121|P4|NOT COMPLETED|Overall Study||14
573348|NCT00592774|1400122|P3|NOT COMPLETED|Overall Study||4
573349|NCT00592774|1400123|P2|NOT COMPLETED|Overall Study||32
573350|NCT00592774|1400124|P1|NOT COMPLETED|Overall Study||11
573351|NCT00592774|1400120|P5|COMPLETED|Overall Study||9
573352|NCT00592774|1400121|P4|COMPLETED|Overall Study||8
573353|NCT00592774|1400122|P3|COMPLETED|Overall Study||18
573354|NCT00592774|1400123|P2|COMPLETED|Overall Study||21
573355|NCT00592774|1400124|P1|COMPLETED|Overall Study||15
573356|NCT00592774|1400120|P5|STARTED|Overall Study||23
573357|NCT00592774|1400121|P4|STARTED|Overall Study||22
573358|NCT00592774|1400122|P3|STARTED|Overall Study||22
573359|NCT00592774|1400123|P2|STARTED|Overall Study||53
573360|NCT00592774|1400124|P1|STARTED|Overall Study||26
573361|NCT00592761|1400181|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
573362|NCT00592761|1400182|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
573363|NCT00592761|1400181|P2|COMPLETED|Second Intervention (2 Weeks)||9
573364|NCT00592761|1400182|P1|COMPLETED|Second Intervention (2 Weeks)||9
573365|NCT00592761|1400181|P2|STARTED|Second Intervention (2 Weeks)||9
573366|NCT00592761|1400182|P1|STARTED|Second Intervention (2 Weeks)||9
573367|NCT00592761|1400181|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
573368|NCT00592761|1400182|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
573369|NCT00592761|1400181|P2|COMPLETED|First Intervention (2 Weeks)||9
573370|NCT00592761|1400182|P1|COMPLETED|First Intervention (2 Weeks)||9
573371|NCT00592761|1400181|P2|STARTED|First Intervention (2 Weeks)||9
573372|NCT00592761|1400182|P1|STARTED|First Intervention (2 Weeks)||9
573373|NCT00592683|1400196|P2|NOT COMPLETED|Overall Study||4
573374|NCT00592683|1400197|P1|NOT COMPLETED|Overall Study||4
573375|NCT00592683|1400196|P2|COMPLETED|Overall Study||6
573376|NCT00592683|1400197|P1|COMPLETED|Overall Study||6
573377|NCT00592683|1400196|P2|STARTED|Overall Study||10
573378|NCT00592683|1400197|P1|STARTED|Overall Study||10
573379|NCT00592631|1400207|P2|NOT COMPLETED|Overall Study||2
573380|NCT00592631|1400208|P1|NOT COMPLETED|Overall Study||0
573381|NCT00592631|1400207|P2|COMPLETED|Overall Study||9
573382|NCT00592631|1400208|P1|COMPLETED|Overall Study||16
573383|NCT00592631|1400207|P2|STARTED|Overall Study||11
573384|NCT00592631|1400208|P1|STARTED|Overall Study||16
573385|NCT00592488|1400216|P2|NOT COMPLETED|Overall Study||0
573386|NCT00592488|1400217|P1|NOT COMPLETED|Overall Study||0
573387|NCT00592488|1400216|P2|COMPLETED|Overall Study||7
573388|NCT00592488|1400217|P1|COMPLETED|Overall Study||6
573389|NCT00592488|1400216|P2|STARTED|Overall Study||7
573390|NCT00592488|1400217|P1|STARTED|Overall Study||6
573391|NCT00592475|1400230|P3|NOT COMPLETED|Overall Study||0
573392|NCT00592475|1400231|P2|NOT COMPLETED|Overall Study||0
573393|NCT00592475|1400232|P1|NOT COMPLETED|Overall Study||0
573394|NCT00592475|1400230|P3|COMPLETED|Overall Study||5
573395|NCT00592475|1400231|P2|COMPLETED|Overall Study||9
573396|NCT00592475|1400232|P1|COMPLETED|Overall Study||6
573397|NCT00592475|1400230|P3|STARTED|Overall Study||5
573398|NCT00592475|1400231|P2|STARTED|Overall Study||9
573399|NCT00592475|1400232|P1|STARTED|Overall Study||6
573400|NCT00592384|1400257|P2|NOT COMPLETED|Overall Study||6
573401|NCT00592384|1400258|P1|NOT COMPLETED|Overall Study||5
573402|NCT00592384|1400257|P2|COMPLETED|Overall Study||63
573403|NCT00592384|1400258|P1|COMPLETED|Overall Study||59
573404|NCT00592384|1400257|P2|STARTED|Overall Study||69
573405|NCT00592384|1400258|P1|STARTED|Overall Study||64
573406|NCT00592358|1400266|P1|NOT COMPLETED|Overall Study||6
573407|NCT00592358|1400266|P1|COMPLETED|Overall Study||11
573408|NCT00592358|1400266|P1|STARTED|Overall Study||17
573409|NCT00592319|1400273|P2|NOT COMPLETED|Overall Study||3
573410|NCT00592319|1400274|P1|NOT COMPLETED|Overall Study||0
573411|NCT00592319|1400273|P2|COMPLETED|Overall Study||5
573412|NCT00592319|1400274|P1|COMPLETED|Overall Study||2
573413|NCT00592319|1400273|P2|STARTED|Overall Study||8
573414|NCT00592319|1400274|P1|STARTED|Overall Study||2
573415|NCT00592176|1400282|P1|NOT COMPLETED|Overall Study||0
573416|NCT00592176|1400282|P1|COMPLETED|Overall Study||5
573417|NCT00592176|1400282|P1|STARTED|Overall Study||5
573418|NCT00592124|1400293|P6|NOT COMPLETED|Overall Study||3
573419|NCT00592124|1400294|P5|NOT COMPLETED|Overall Study||3
573420|NCT00592124|1400295|P4|NOT COMPLETED|Overall Study||3
573421|NCT00592124|1400296|P3|NOT COMPLETED|Overall Study||6
573422|NCT00592124|1400297|P2|NOT COMPLETED|Overall Study||5
573423|NCT00592124|1400298|P1|NOT COMPLETED|Overall Study||4
573424|NCT00592124|1400293|P6|COMPLETED|Overall Study||24
573425|NCT00592124|1400294|P5|COMPLETED|Overall Study||24
573426|NCT00592124|1400295|P4|COMPLETED|Overall Study||24
573427|NCT00592124|1400296|P3|COMPLETED|Overall Study||24
573428|NCT00592124|1400297|P2|COMPLETED|Overall Study||24
573429|NCT00592124|1400298|P1|COMPLETED|Overall Study||24
573430|NCT00592124|1400293|P6|STARTED|Overall Study||27
573431|NCT00592124|1400294|P5|STARTED|Overall Study||27
573432|NCT00592124|1400295|P4|STARTED|Overall Study||27
573433|NCT00592124|1400296|P3|STARTED|Overall Study||30
573434|NCT00592124|1400297|P2|STARTED|Overall Study||29
573435|NCT00592124|1400298|P1|STARTED|Overall Study||28
573436|NCT00592072|1400349|P2|NOT COMPLETED|Second Sequence||0
573437|NCT00592072|1400350|P1|NOT COMPLETED|Second Sequence||0
573438|NCT00592072|1400349|P2|COMPLETED|Second Sequence||5
573439|NCT00592072|1400350|P1|COMPLETED|Second Sequence||5
573440|NCT00592072|1400349|P2|STARTED|Second Sequence||5
573441|NCT00592072|1400350|P1|STARTED|Second Sequence||5
573442|NCT00592072|1400349|P2|NOT COMPLETED|Wash Out Period||1
573443|NCT00592072|1400350|P1|NOT COMPLETED|Wash Out Period||1
573444|NCT00592072|1400349|P2|COMPLETED|Wash Out Period||5
573445|NCT00592072|1400350|P1|COMPLETED|Wash Out Period||5
573446|NCT00592072|1400349|P2|STARTED|Wash Out Period||6
573447|NCT00592072|1400350|P1|STARTED|Wash Out Period||6
573448|NCT00592072|1400349|P2|NOT COMPLETED|First Sequence||0
573449|NCT00592072|1400350|P1|NOT COMPLETED|First Sequence||0
573450|NCT00592072|1400349|P2|COMPLETED|First Sequence||6
573451|NCT00592072|1400350|P1|COMPLETED|First Sequence||6
573452|NCT00592072|1400349|P2|STARTED|First Sequence||6
573453|NCT00592072|1400350|P1|STARTED|First Sequence||6
573454|NCT00592007|1400372|P1|NOT COMPLETED|Overall Study||2
573455|NCT00592007|1400372|P1|COMPLETED|Overall Study||5
573456|NCT00592007|1400372|P1|STARTED|Overall Study||7
573457|NCT00591942|1400377|P2|NOT COMPLETED|Overall Study||0
573458|NCT00591942|1400378|P1|NOT COMPLETED|Overall Study||0
573459|NCT00591942|1400377|P2|COMPLETED|Overall Study||36
573460|NCT00591942|1400378|P1|COMPLETED|Overall Study||36
573461|NCT00591942|1400377|P2|STARTED|Overall Study||36
573462|NCT00591942|1400378|P1|STARTED|Overall Study||36
573463|NCT00591864|1400384|P1|NOT COMPLETED|Overall Study||5
573464|NCT00591864|1400384|P1|COMPLETED|Overall Study||84
573465|NCT00591864|1400384|P1|STARTED|Overall Study||89
573466|NCT00591851|1400390|P1|NOT COMPLETED|Overall Study||6
573467|NCT00591851|1400390|P1|COMPLETED|Overall Study||64
573468|NCT00591851|1400390|P1|STARTED|Overall Study||70
573469|NCT00591825|1400398|P4|NOT COMPLETED|Overall Study||0
573470|NCT00591825|1400399|P3|NOT COMPLETED|Overall Study||0
573471|NCT00591825|1400400|P2|NOT COMPLETED|Overall Study||0
573472|NCT00591825|1400401|P1|NOT COMPLETED|Overall Study||0
573473|NCT00591825|1400398|P4|COMPLETED|Overall Study||14
573474|NCT00591825|1400399|P3|COMPLETED|Overall Study||13
573475|NCT00591825|1400400|P2|COMPLETED|Overall Study||13
573476|NCT00591825|1400401|P1|COMPLETED|Overall Study||14
573477|NCT00591825|1400398|P4|STARTED|Overall Study||14
573478|NCT00591825|1400399|P3|STARTED|Overall Study||13
573479|NCT00591825|1400400|P2|STARTED|Overall Study||13
573480|NCT00591825|1400401|P1|STARTED|Overall Study||14
573481|NCT00591773|1400430|P3|NOT COMPLETED|Overall Study||16
573482|NCT00591773|1400431|P2|NOT COMPLETED|Overall Study||24
573483|NCT00591773|1400432|P1|NOT COMPLETED|Overall Study||16
573484|NCT00591773|1400430|P3|COMPLETED|Overall Study||168
573485|NCT00591773|1400431|P2|COMPLETED|Overall Study||158
573486|NCT00591773|1400432|P1|COMPLETED|Overall Study||169
573487|NCT00591773|1400430|P3|STARTED|Overall Study||184
573488|NCT00591773|1400431|P2|STARTED|Overall Study||182
573489|NCT00591773|1400432|P1|STARTED|Overall Study||185
573490|NCT00591760|1400484|P2|NOT COMPLETED|Overall Study||0
573491|NCT00591760|1400485|P1|NOT COMPLETED|Overall Study||0
573492|NCT00591760|1400484|P2|COMPLETED|Overall Study||28
573493|NCT00591760|1400485|P1|COMPLETED|Overall Study||28
573494|NCT00591760|1400484|P2|STARTED|Overall Study||28
573495|NCT00591760|1400485|P1|STARTED|Overall Study||28
573496|NCT00591734|1400491|P1|NOT COMPLETED|Overall Study||53
573497|NCT00591734|1400491|P1|COMPLETED|Overall Study||4
573498|NCT00591734|1400491|P1|STARTED|Overall Study||57
573499|NCT00591721|1400497|P2|NOT COMPLETED|Overall Study||22
573500|NCT00591721|1400498|P1|NOT COMPLETED|Overall Study||21
573501|NCT00591721|1400497|P2|COMPLETED|Overall Study||70
573502|NCT00591721|1400498|P1|COMPLETED|Overall Study||68
573503|NCT00591721|1400497|P2|STARTED|Overall Study||92
573504|NCT00591721|1400498|P1|STARTED|Overall Study||89
573505|NCT00591591|1400506|P2|NOT COMPLETED|Overall Study||39
573506|NCT00591591|1400507|P1|NOT COMPLETED|Overall Study||11
573507|NCT00591591|1400506|P2|COMPLETED|Overall Study||94
573508|NCT00591591|1400507|P1|COMPLETED|Overall Study||165
573509|NCT00591591|1400506|P2|STARTED|Overall Study||133
573510|NCT00591591|1400507|P1|STARTED|Overall Study||176
573511|NCT00591578|1400524|P3|NOT COMPLETED|Open-Label Extension Phase||0
573512|NCT00591578|1400525|P2|NOT COMPLETED|Open-Label Extension Phase||10
573513|NCT00591578|1400526|P1|NOT COMPLETED|Open-Label Extension Phase||6
573514|NCT00591578|1400524|P3|COMPLETED|Open-Label Extension Phase||0
573515|NCT00591578|1400525|P2|COMPLETED|Open-Label Extension Phase||105
573516|NCT00591578|1400526|P1|COMPLETED|Open-Label Extension Phase||49
573517|NCT00591578|1400524|P3|STARTED|Open-Label Extension Phase||0
573518|NCT00591578|1400525|P2|STARTED|Open-Label Extension Phase||115
573519|NCT00591578|1400526|P1|STARTED|Open-Label Extension Phase||55
573520|NCT00591578|1400524|P3|NOT COMPLETED|Double-Blind Treatment Phase||84
573521|NCT00591578|1400525|P2|NOT COMPLETED|Double-Blind Treatment Phase||80
573522|NCT00591578|1400526|P1|NOT COMPLETED|Double-Blind Treatment Phase||78
573523|NCT00591578|1400524|P3|COMPLETED|Double-Blind Treatment Phase||244
573524|NCT00591578|1400525|P2|COMPLETED|Double-Blind Treatment Phase||249
573525|NCT00591578|1400526|P1|COMPLETED|Double-Blind Treatment Phase||249
573526|NCT00591578|1400524|P3|STARTED|Double-Blind Treatment Phase|Two participants randomized but not treated.|328
573527|NCT00591578|1400525|P2|STARTED|Double-Blind Treatment Phase||329
573528|NCT00591578|1400526|P1|STARTED|Double-Blind Treatment Phase||327
573529|NCT00591565|1400577|P1|NOT COMPLETED|Overall Study||5
573530|NCT00591565|1400577|P1|COMPLETED|Overall Study||8
573531|NCT00591565|1400577|P1|STARTED|Overall Study||13
573532|NCT00591370|1400581|P1|NOT COMPLETED|Overall Study||2
573533|NCT00591370|1400581|P1|COMPLETED|Overall Study||49
573534|NCT00591370|1400581|P1|STARTED|Overall Study||51
573535|NCT00591344|1400589|P2|NOT COMPLETED|Overall Study||8
573536|NCT00591344|1400590|P1|NOT COMPLETED|Overall Study||5
573537|NCT00591344|1400589|P2|COMPLETED|Overall Study|Number of subjects who completed the final 24 month test|18
573538|NCT00591344|1400590|P1|COMPLETED|Overall Study|Number of subjects who completed the final 24 month test|20
573539|NCT00591344|1400589|P2|Completed the 6 Month Test|Overall Study|Number of subjects who completed the 6 month test|24
573540|NCT00591344|1400590|P1|Completed the 6 Month Test|Overall Study|Number of subjects who completed the 6 month test|24
573541|NCT00591344|1400589|P2|STARTED|Overall Study|26 randomized, 2 withdrew before the 6 month test and were replaced, 24 completed 6 month test|26
573542|NCT00591344|1400590|P1|STARTED|Overall Study|25 randomized, 1 withdrew before the 6 month test and was replaced; 24 completed the 6 month test|25
573543|NCT00591305|1400602|P2|NOT COMPLETED|Overall Study||0
573544|NCT00591305|1400603|P1|NOT COMPLETED|Overall Study||0
573545|NCT00591305|1400602|P2|COMPLETED|Overall Study||0
573546|NCT00591305|1400603|P1|COMPLETED|Overall Study||1
573547|NCT00591305|1400602|P2|1st Follow-up in 2 Wks After Surgery|Overall Study||0
573548|NCT00591305|1400603|P1|1st Follow-up in 2 Wks After Surgery|Overall Study||1
573549|NCT00591305|1400602|P2|STARTED|Overall Study||0
573550|NCT00591305|1400603|P1|STARTED|Overall Study||1
573551|NCT00591266|1400616|P3|NOT COMPLETED|Overall Study||14
573552|NCT00591266|1400617|P2|NOT COMPLETED|Overall Study||11
573553|NCT00591266|1400618|P1|NOT COMPLETED|Overall Study||9
573554|NCT00591266|1400616|P3|COMPLETED|Overall Study||175
573555|NCT00591266|1400617|P2|COMPLETED|Overall Study||177
573556|NCT00591266|1400618|P1|COMPLETED|Overall Study||180
573557|NCT00591266|1400616|P3|STARTED|Overall Study|Randomized only|189
573558|NCT00591266|1400617|P2|STARTED|Overall Study|Randomized only|188
573559|NCT00591266|1400618|P1|STARTED|Overall Study|Randomized only|189
573560|NCT00591253|1400671|P3|NOT COMPLETED|Overall Study||15
573561|NCT00591253|1400672|P2|NOT COMPLETED|Overall Study||21
573562|NCT00591253|1400673|P1|NOT COMPLETED|Overall Study||14
573563|NCT00591253|1400671|P3|COMPLETED|Overall Study||123
573564|NCT00591253|1400672|P2|COMPLETED|Overall Study||116
573565|NCT00591253|1400673|P1|COMPLETED|Overall Study||126
573566|NCT00591253|1400671|P3|STARTED|Overall Study|Randomized or Treated|138
573567|NCT00591253|1400672|P2|STARTED|Overall Study|Randomized or Treated|137
573568|NCT00591253|1400673|P1|STARTED|Overall Study|Randomized or Treated|140
573569|NCT00591240|1400725|P2|NOT COMPLETED|Overall Study||0
573570|NCT00591240|1400726|P1|NOT COMPLETED|Overall Study||0
573571|NCT00591240|1400725|P2|COMPLETED|Overall Study||222
573572|NCT00591240|1400726|P1|COMPLETED|Overall Study||116
573573|NCT00591240|1400725|P2|STARTED|Overall Study||222
573574|NCT00591240|1400726|P1|STARTED|Overall Study||116
573575|NCT00591227|1400734|P2|NOT COMPLETED|Overall Study||0
573576|NCT00591227|1400735|P1|NOT COMPLETED|Overall Study||0
573577|NCT00591227|1400734|P2|COMPLETED|Overall Study||87
573578|NCT00591227|1400735|P1|COMPLETED|Overall Study||89
573579|NCT00591227|1400734|P2|STARTED|Overall Study||87
573580|NCT00591227|1400735|P1|STARTED|Overall Study||89
573581|NCT00591214|1400741|P1|NOT COMPLETED|Overall Study||8
573582|NCT00591214|1400741|P1|COMPLETED|Overall Study||2
573583|NCT00591214|1400741|P1|STARTED|Overall Study||10
573584|NCT00591149|1400750|P1|NOT COMPLETED|Overall Study||5
573585|NCT00591149|1400750|P1|COMPLETED|Overall Study||11
573586|NCT00591149|1400750|P1|STARTED|Overall Study||16
573587|NCT00591019|1400754|P2|NOT COMPLETED|Intevention 2 (14 Days)||0
573588|NCT00591019|1400755|P1|NOT COMPLETED|Intevention 2 (14 Days)||0
573589|NCT00591019|1400754|P2|COMPLETED|Intevention 2 (14 Days)||3
573590|NCT00591019|1400755|P1|COMPLETED|Intevention 2 (14 Days)||2
573591|NCT00591019|1400754|P2|STARTED|Intevention 2 (14 Days)||3
573592|NCT00591019|1400755|P1|STARTED|Intevention 2 (14 Days)||2
573593|NCT00591019|1400754|P2|NOT COMPLETED|Intervention 1 (14 Days)||0
573594|NCT00591019|1400755|P1|NOT COMPLETED|Intervention 1 (14 Days)||0
573595|NCT00591019|1400754|P2|COMPLETED|Intervention 1 (14 Days)||3
573596|NCT00591019|1400755|P1|COMPLETED|Intervention 1 (14 Days)||2
573597|NCT00591019|1400754|P2|STARTED|Intervention 1 (14 Days)|One subject dropped out after baseline|3
573598|NCT00591019|1400755|P1|STARTED|Intervention 1 (14 Days)|One subject dropped out after baseline|2
573599|NCT00591019|1400754|P2|NOT COMPLETED|Baseline (1 Day)||0
573600|NCT00591019|1400755|P1|NOT COMPLETED|Baseline (1 Day)||0
573601|NCT00591019|1400754|P2|COMPLETED|Baseline (1 Day)||4
573602|NCT00591019|1400755|P1|COMPLETED|Baseline (1 Day)||3
573603|NCT00591019|1400754|P2|STARTED|Baseline (1 Day)||4
573604|NCT00591019|1400755|P1|STARTED|Baseline (1 Day)||3
573605|NCT00591006|1400766|P24|NOT COMPLETED|Overall Study||1
573606|NCT00591006|1400767|P23|NOT COMPLETED|Overall Study||1
573607|NCT00591006|1400768|P22|NOT COMPLETED|Overall Study||0
573608|NCT00591006|1400769|P21|NOT COMPLETED|Overall Study||0
573609|NCT00591006|1400770|P20|NOT COMPLETED|Overall Study||0
573610|NCT00591006|1400771|P19|NOT COMPLETED|Overall Study||0
573611|NCT00591006|1400772|P18|NOT COMPLETED|Overall Study||0
573612|NCT00591006|1400773|P17|NOT COMPLETED|Overall Study||0
573613|NCT00591006|1400774|P16|NOT COMPLETED|Overall Study||1
573614|NCT00591006|1400775|P15|NOT COMPLETED|Overall Study||0
573615|NCT00591006|1400776|P14|NOT COMPLETED|Overall Study||0
573616|NCT00591006|1400777|P13|NOT COMPLETED|Overall Study||0
573617|NCT00591006|1400778|P12|NOT COMPLETED|Overall Study||0
573618|NCT00591006|1400779|P11|NOT COMPLETED|Overall Study||0
573619|NCT00591006|1400780|P10|NOT COMPLETED|Overall Study||0
573620|NCT00591006|1400781|P9|NOT COMPLETED|Overall Study||0
573621|NCT00591006|1400782|P8|NOT COMPLETED|Overall Study||0
573622|NCT00591006|1400783|P7|NOT COMPLETED|Overall Study||0
573623|NCT00591006|1400784|P6|NOT COMPLETED|Overall Study||0
573624|NCT00591006|1400785|P5|NOT COMPLETED|Overall Study||0
573625|NCT00591006|1400786|P4|NOT COMPLETED|Overall Study||0
573626|NCT00591006|1400787|P3|NOT COMPLETED|Overall Study||0
573627|NCT00591006|1400788|P2|NOT COMPLETED|Overall Study||0
573628|NCT00591006|1400789|P1|NOT COMPLETED|Overall Study||0
573629|NCT00591006|1400766|P24|COMPLETED|Overall Study||0
573630|NCT00591006|1400767|P23|COMPLETED|Overall Study||0
573631|NCT00591006|1400768|P22|COMPLETED|Overall Study||1
573632|NCT00591006|1400769|P21|COMPLETED|Overall Study||0
573633|NCT00591006|1400770|P20|COMPLETED|Overall Study||1
573634|NCT00591006|1400771|P19|COMPLETED|Overall Study||0
573635|NCT00591006|1400772|P18|COMPLETED|Overall Study||1
573636|NCT00591006|1400773|P17|COMPLETED|Overall Study||0
573637|NCT00591006|1400774|P16|COMPLETED|Overall Study||0
573638|NCT00591006|1400775|P15|COMPLETED|Overall Study||0
573639|NCT00591006|1400776|P14|COMPLETED|Overall Study||2
573640|NCT00591006|1400777|P13|COMPLETED|Overall Study||1
573641|NCT00591006|1400778|P12|COMPLETED|Overall Study||1
573642|NCT00591006|1400779|P11|COMPLETED|Overall Study||0
573643|NCT00591006|1400780|P10|COMPLETED|Overall Study||1
573644|NCT00591006|1400781|P9|COMPLETED|Overall Study||1
573645|NCT00591006|1400782|P8|COMPLETED|Overall Study||0
573646|NCT00591006|1400783|P7|COMPLETED|Overall Study||1
573647|NCT00591006|1400784|P6|COMPLETED|Overall Study||0
573648|NCT00591006|1400785|P5|COMPLETED|Overall Study||1
573649|NCT00591006|1400786|P4|COMPLETED|Overall Study||1
573650|NCT00591006|1400787|P3|COMPLETED|Overall Study||1
573651|NCT00591006|1400788|P2|COMPLETED|Overall Study||0
573652|NCT00591006|1400789|P1|COMPLETED|Overall Study||1
573653|NCT00591006|1400766|P24|Treatment #4|Overall Study||0
573654|NCT00591006|1400767|P23|Treatment #4|Overall Study||0
573655|NCT00591006|1400768|P22|Treatment #4|Overall Study||1
573656|NCT00591006|1400769|P21|Treatment #4|Overall Study||0
573657|NCT00591006|1400770|P20|Treatment #4|Overall Study||1
573658|NCT00591006|1400771|P19|Treatment #4|Overall Study||0
573659|NCT00591006|1400772|P18|Treatment #4|Overall Study||1
573660|NCT00591006|1400773|P17|Treatment #4|Overall Study||0
573661|NCT00591006|1400774|P16|Treatment #4|Overall Study||0
573662|NCT00591006|1400775|P15|Treatment #4|Overall Study||0
573663|NCT00591006|1400776|P14|Treatment #4|Overall Study||2
573664|NCT00591006|1400777|P13|Treatment #4|Overall Study||1
573665|NCT00591006|1400778|P12|Treatment #4|Overall Study||1
573666|NCT00591006|1400779|P11|Treatment #4|Overall Study||0
573667|NCT00591006|1400780|P10|Treatment #4|Overall Study||1
573668|NCT00591006|1400781|P9|Treatment #4|Overall Study||1
573669|NCT00591006|1400782|P8|Treatment #4|Overall Study||0
573670|NCT00591006|1400783|P7|Treatment #4|Overall Study||1
573671|NCT00591006|1400784|P6|Treatment #4|Overall Study||0
573672|NCT00591006|1400785|P5|Treatment #4|Overall Study||1
573673|NCT00591006|1400786|P4|Treatment #4|Overall Study||1
573674|NCT00591006|1400787|P3|Treatment #4|Overall Study||1
573675|NCT00591006|1400788|P2|Treatment #4|Overall Study||0
573676|NCT00591006|1400789|P1|Treatment #4|Overall Study||1
573677|NCT00591006|1400766|P24|Treatment #3|Overall Study||1
573678|NCT00591006|1400767|P23|Treatment #3|Overall Study||1
573679|NCT00591006|1400768|P22|Treatment #3|Overall Study||1
573680|NCT00591006|1400769|P21|Treatment #3|Overall Study||0
573681|NCT00591006|1400770|P20|Treatment #3|Overall Study||1
573682|NCT00591006|1400771|P19|Treatment #3|Overall Study||0
573683|NCT00591006|1400772|P18|Treatment #3|Overall Study||1
573684|NCT00591006|1400773|P17|Treatment #3|Overall Study||0
573685|NCT00591006|1400774|P16|Treatment #3|Overall Study||0
573686|NCT00591006|1400775|P15|Treatment #3|Overall Study||0
573687|NCT00591006|1400776|P14|Treatment #3|Overall Study||2
573688|NCT00591006|1400777|P13|Treatment #3|Overall Study||1
573689|NCT00591006|1400778|P12|Treatment #3|Overall Study||1
573690|NCT00591006|1400779|P11|Treatment #3|Overall Study||0
573691|NCT00591006|1400780|P10|Treatment #3|Overall Study||1
573692|NCT00591006|1400781|P9|Treatment #3|Overall Study||1
573693|NCT00591006|1400782|P8|Treatment #3|Overall Study||0
573694|NCT00591006|1400783|P7|Treatment #3|Overall Study||1
573695|NCT00591006|1400784|P6|Treatment #3|Overall Study||0
573696|NCT00591006|1400785|P5|Treatment #3|Overall Study||1
573697|NCT00591006|1400786|P4|Treatment #3|Overall Study||1
573698|NCT00591006|1400787|P3|Treatment #3|Overall Study||1
573699|NCT00591006|1400788|P2|Treatment #3|Overall Study||0
573700|NCT00591006|1400789|P1|Treatment #3|Overall Study||1
573701|NCT00591006|1400766|P24|Treatment #2|Overall Study||1
573702|NCT00591006|1400767|P23|Treatment #2|Overall Study||1
573703|NCT00591006|1400768|P22|Treatment #2|Overall Study||1
573704|NCT00591006|1400769|P21|Treatment #2|Overall Study||0
573705|NCT00591006|1400770|P20|Treatment #2|Overall Study||1
573706|NCT00591006|1400771|P19|Treatment #2|Overall Study||0
573707|NCT00591006|1400772|P18|Treatment #2|Overall Study||1
573708|NCT00591006|1400773|P17|Treatment #2|Overall Study||0
573709|NCT00591006|1400774|P16|Treatment #2|Overall Study||0
573710|NCT00591006|1400775|P15|Treatment #2|Overall Study||0
573711|NCT00591006|1400776|P14|Treatment #2|Overall Study||2
573712|NCT00591006|1400777|P13|Treatment #2|Overall Study||1
573713|NCT00591006|1400778|P12|Treatment #2|Overall Study||1
573714|NCT00591006|1400779|P11|Treatment #2|Overall Study||0
573715|NCT00591006|1400780|P10|Treatment #2|Overall Study||1
573716|NCT00591006|1400781|P9|Treatment #2|Overall Study||1
573717|NCT00591006|1400782|P8|Treatment #2|Overall Study||0
573718|NCT00591006|1400783|P7|Treatment #2|Overall Study||1
573719|NCT00591006|1400784|P6|Treatment #2|Overall Study||0
573720|NCT00591006|1400785|P5|Treatment #2|Overall Study||1
573721|NCT00591006|1400786|P4|Treatment #2|Overall Study||1
573722|NCT00591006|1400787|P3|Treatment #2|Overall Study||1
573723|NCT00591006|1400788|P2|Treatment #2|Overall Study||0
573724|NCT00591006|1400789|P1|Treatment #2|Overall Study||1
573725|NCT00591006|1400766|P24|STARTED|Overall Study||1
573726|NCT00591006|1400767|P23|STARTED|Overall Study||1
573727|NCT00591006|1400768|P22|STARTED|Overall Study||1
573728|NCT00591006|1400769|P21|STARTED|Overall Study||0
573729|NCT00591006|1400770|P20|STARTED|Overall Study||1
573730|NCT00591006|1400771|P19|STARTED|Overall Study||0
573731|NCT00591006|1400772|P18|STARTED|Overall Study||1
573732|NCT00591006|1400773|P17|STARTED|Overall Study||0
573733|NCT00591006|1400774|P16|STARTED|Overall Study||1
573734|NCT00591006|1400775|P15|STARTED|Overall Study||0
573735|NCT00591006|1400776|P14|STARTED|Overall Study||2
573736|NCT00591006|1400777|P13|STARTED|Overall Study||1
573737|NCT00591006|1400778|P12|STARTED|Overall Study||1
573738|NCT00591006|1400779|P11|STARTED|Overall Study||0
573739|NCT00591006|1400780|P10|STARTED|Overall Study||1
573740|NCT00591006|1400781|P9|STARTED|Overall Study||1
573741|NCT00591006|1400782|P8|STARTED|Overall Study||0
573742|NCT00591006|1400783|P7|STARTED|Overall Study||1
573743|NCT00591006|1400784|P6|STARTED|Overall Study||0
573744|NCT00591006|1400785|P5|STARTED|Overall Study||1
573745|NCT00591006|1400786|P4|STARTED|Overall Study||1
573746|NCT00591006|1400787|P3|STARTED|Overall Study||1
573747|NCT00591006|1400788|P2|STARTED|Overall Study||0
573748|NCT00591006|1400789|P1|STARTED|Overall Study||1
573749|NCT00590980|1400807|P1|NOT COMPLETED|Overall Study||10
573750|NCT00590980|1400807|P1|COMPLETED|Overall Study||72
573751|NCT00590980|1400807|P1|STARTED|Overall Study||82
573752|NCT00590967|1400813|P2|NOT COMPLETED|Overall Study||5
573753|NCT00590967|1400814|P1|NOT COMPLETED|Overall Study||3
573754|NCT00590967|1400813|P2|COMPLETED|Overall Study||20
573755|NCT00590967|1400814|P1|COMPLETED|Overall Study||41
573756|NCT00590967|1400813|P2|STARTED|Overall Study||25
573757|NCT00590967|1400814|P1|STARTED|Overall Study||44
573758|NCT00590902|1400826|P1|NOT COMPLETED|Overall Study||1
573759|NCT00590902|1400826|P1|COMPLETED|Overall Study||80
573760|NCT00590902|1400826|P1|STARTED|Overall Study||81
573761|NCT00590889|1400832|P2|NOT COMPLETED|Overall Study||299
573762|NCT00590889|1400833|P1|NOT COMPLETED|Overall Study||286
573763|NCT00590889|1400832|P2|COMPLETED|Overall Study||104
573764|NCT00590889|1400833|P1|COMPLETED|Overall Study||118
573765|NCT00590889|1400832|P2|STARTED|Overall Study||403
573766|NCT00590889|1400833|P1|STARTED|Overall Study||404
573767|NCT00590863|1400842|P3|NOT COMPLETED|Overall Study||78
573768|NCT00590863|1400843|P2|NOT COMPLETED|Overall Study||82
573769|NCT00590863|1400844|P1|NOT COMPLETED|Overall Study||84
573770|NCT00590863|1400842|P3|COMPLETED|Overall Study||146
573771|NCT00590863|1400843|P2|COMPLETED|Overall Study||138
573772|NCT00590863|1400844|P1|COMPLETED|Overall Study||137
573773|NCT00590863|1400842|P3|STARTED|Overall Study||224
573774|NCT00590863|1400843|P2|STARTED|Overall Study||220
573775|NCT00590863|1400844|P1|STARTED|Overall Study||221
573776|NCT00590772|1400855|P1|NOT COMPLETED|Overall Study||0
573777|NCT00590772|1400855|P1|COMPLETED|Overall Study||31
573778|NCT00590772|1400855|P1|STARTED|Overall Study||31
573779|NCT00590759|1400861|P1|NOT COMPLETED|Overall Study||80
573780|NCT00590759|1400861|P1|COMPLETED|Overall Study||70
573781|NCT00590759|1400861|P1|STARTED|Overall Study||150
573782|NCT00590720|1400868|P2|NOT COMPLETED|Overall Study||1
573783|NCT00590720|1400869|P1|NOT COMPLETED|Overall Study||1
573784|NCT00590720|1400868|P2|COMPLETED|Overall Study||6
573785|NCT00590720|1400869|P1|COMPLETED|Overall Study||3
573786|NCT00590720|1400868|P2|STARTED|Overall Study||7
573787|NCT00590720|1400869|P1|STARTED|Overall Study||4
573788|NCT00590707|1400913|P2|NOT COMPLETED|Overall Study||0
573789|NCT00590707|1400914|P1|NOT COMPLETED|Overall Study||0
573790|NCT00590707|1400913|P2|COMPLETED|Overall Study||100
573791|NCT00590707|1400914|P1|COMPLETED|Overall Study||100
573792|NCT00590707|1400913|P2|STARTED|Overall Study||100
573793|NCT00590707|1400914|P1|STARTED|Overall Study||100
573794|NCT00590590|1400931|P3|NOT COMPLETED|Overall Study||6
573795|NCT00590590|1400932|P2|NOT COMPLETED|Overall Study||6
573796|NCT00590590|1400933|P1|NOT COMPLETED|Overall Study||7
573797|NCT00590590|1400931|P3|COMPLETED|Overall Study||21
573798|NCT00590590|1400932|P2|COMPLETED|Overall Study||33
573799|NCT00590590|1400933|P1|COMPLETED|Overall Study||32
573800|NCT00590590|1400931|P3|STARTED|Overall Study||27
573801|NCT00590590|1400932|P2|STARTED|Overall Study||39
573802|NCT00590590|1400933|P1|STARTED|Overall Study||39
573803|NCT00590577|1400960|P4|NOT COMPLETED|Overall Study||93
573804|NCT00590577|1400961|P3|NOT COMPLETED|Overall Study||73
573805|NCT00590577|1400962|P2|NOT COMPLETED|Overall Study||76
573806|NCT00590577|1400963|P1|NOT COMPLETED|Overall Study||77
573807|NCT00590577|1400960|P4|COMPLETED|Overall Study||71
573808|NCT00590577|1400961|P3|COMPLETED|Overall Study||90
573809|NCT00590577|1400962|P2|COMPLETED|Overall Study||89
573810|NCT00590577|1400963|P1|COMPLETED|Overall Study||83
573811|NCT00590577|1400960|P4|STARTED|Overall Study||164
573812|NCT00590577|1400961|P3|STARTED|Overall Study||163
573813|NCT00590577|1400962|P2|STARTED|Overall Study||165
573814|NCT00590577|1400963|P1|STARTED|Overall Study||160
573815|NCT00590564|1400981|P1|NOT COMPLETED|Overall Study||18
573816|NCT00590564|1400981|P1|COMPLETED|Overall Study||24
573817|NCT00590564|1400981|P1|STARTED|Overall Study||42
573818|NCT00590538|1400985|P1|NOT COMPLETED|Overall Study||2
573819|NCT00590538|1400985|P1|COMPLETED|Overall Study||7
573820|NCT00590538|1400985|P1|STARTED|Overall Study|STUDY NOT UNBLINDED AT TIME OF TERMINATION; THEREFORE NUMBER ASSIGNED TO EACH GROUP IS NOT KNOWN.|9
573821|NCT00590460|1400993|P1|NOT COMPLETED|Overall Study||0
573822|NCT00590460|1400993|P1|COMPLETED|Overall Study||5
573823|NCT00590460|1400993|P1|STARTED|Overall Study||5
573824|NCT00590369|1401008|P2|NOT COMPLETED|Overall Study||0
573825|NCT00590369|1401009|P1|NOT COMPLETED|Overall Study||0
573826|NCT00590369|1401008|P2|COMPLETED|Overall Study||5
573827|NCT00590369|1401009|P1|COMPLETED|Overall Study|Study stopped early due to difficulty recruiting subjects|6
573828|NCT00590369|1401008|P2|STARTED|Overall Study||5
573829|NCT00590369|1401009|P1|STARTED|Overall Study||6
573830|NCT00590317|1401027|P2|NOT COMPLETED|Overall Study||5
573831|NCT00590317|1401028|P1|NOT COMPLETED|Overall Study||1
573832|NCT00590317|1401027|P2|COMPLETED|Overall Study||27
573833|NCT00590317|1401028|P1|COMPLETED|Overall Study||31
573834|NCT00590317|1401027|P2|STARTED|Overall Study||32
573835|NCT00590317|1401028|P1|STARTED|Overall Study||32
573836|NCT00590226|1401040|P2|NOT COMPLETED|Overall Study||0
573837|NCT00590226|1401041|P1|NOT COMPLETED|Overall Study||0
573838|NCT00590226|1401040|P2|COMPLETED|Overall Study||63
573839|NCT00590226|1401041|P1|COMPLETED|Overall Study||67
573840|NCT00590226|1401040|P2|STARTED|Overall Study||63
573841|NCT00590226|1401041|P1|STARTED|Overall Study||67
573842|NCT00590161|1401051|P2|NOT COMPLETED|Overall Study||3
573843|NCT00590161|1401052|P1|NOT COMPLETED|Overall Study||3
573844|NCT00590161|1401051|P2|COMPLETED|Overall Study||26
573845|NCT00590161|1401052|P1|COMPLETED|Overall Study||23
573846|NCT00590161|1401051|P2|STARTED|Overall Study||29
573847|NCT00590161|1401052|P1|STARTED|Overall Study||26
573848|NCT00590135|1401058|P1|NOT COMPLETED|Overall Study||59
573849|NCT00590135|1401058|P1|COMPLETED|Overall Study||0
573850|NCT00590135|1401058|P1|STARTED|Overall Study||59
573851|NCT00590044|1401068|P2|NOT COMPLETED|Overall Study||2
573852|NCT00590044|1401069|P1|NOT COMPLETED|Overall Study||4
573853|NCT00590044|1401068|P2|COMPLETED|Overall Study||34
573854|NCT00590044|1401069|P1|COMPLETED|Overall Study||34
573855|NCT00590044|1401068|P2|STARTED|Overall Study||36
573856|NCT00590044|1401069|P1|STARTED|Overall Study||38
573857|NCT00590031|1401075|P1|NOT COMPLETED|Overall Study||6
573858|NCT00590031|1401075|P1|COMPLETED|Overall Study||55
573859|NCT00590031|1401075|P1|STARTED|Overall Study||61
573860|NCT00590018|1401082|P2|NOT COMPLETED|Overall Study||0
573861|NCT00590018|1401083|P1|NOT COMPLETED|Overall Study||0
573862|NCT00590018|1401082|P2|COMPLETED|Overall Study||9
573863|NCT00590018|1401083|P1|COMPLETED|Overall Study||9
573864|NCT00590018|1401082|P2|STARTED|Overall Study||9
573865|NCT00590018|1401083|P1|STARTED|Overall Study||9
573866|NCT00590005|1401091|P2|NOT COMPLETED|Overall Study||0
573867|NCT00590005|1401092|P1|NOT COMPLETED|Overall Study||0
573868|NCT00590005|1401091|P2|COMPLETED|Overall Study||119
573869|NCT00590005|1401092|P1|COMPLETED|Overall Study||106
573870|NCT00590005|1401091|P2|STARTED|Overall Study||119
573871|NCT00590005|1401092|P1|STARTED|Overall Study||106
573872|NCT00589979|1401102|P3|NOT COMPLETED|Double-Blind Treatment Period 3||1
573873|NCT00589979|1401103|P2|NOT COMPLETED|Double-Blind Treatment Period 3||1
573874|NCT00589979|1401104|P1|NOT COMPLETED|Double-Blind Treatment Period 3||0
573875|NCT00589979|1401102|P3|COMPLETED|Double-Blind Treatment Period 3||38
573876|NCT00589979|1401103|P2|COMPLETED|Double-Blind Treatment Period 3||46
573877|NCT00589979|1401104|P1|COMPLETED|Double-Blind Treatment Period 3||0
573878|NCT00589979|1401102|P3|STARTED|Double-Blind Treatment Period 3|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|39
573879|NCT00589979|1401103|P2|STARTED|Double-Blind Treatment Period 3|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|47
573880|NCT00589979|1401104|P1|STARTED|Double-Blind Treatment Period 3||0
573881|NCT00589979|1401102|P3|NOT COMPLETED|Double-Blind Treatment Period 2||2
573882|NCT00589979|1401103|P2|NOT COMPLETED|Double-Blind Treatment Period 2||1
573883|NCT00589979|1401104|P1|NOT COMPLETED|Double-Blind Treatment Period 2||0
573884|NCT00589979|1401102|P3|COMPLETED|Double-Blind Treatment Period 2||39
573885|NCT00589979|1401103|P2|COMPLETED|Double-Blind Treatment Period 2||47
573886|NCT00589979|1401104|P1|COMPLETED|Double-Blind Treatment Period 2||0
573887|NCT00589979|1401102|P3|STARTED|Double-Blind Treatment Period 2|N=20 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|41
573888|NCT00589979|1401103|P2|STARTED|Double-Blind Treatment Period 2|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|48
573889|NCT00589979|1401104|P1|STARTED|Double-Blind Treatment Period 2||0
573890|NCT00589979|1401102|P3|NOT COMPLETED|Double-Blind Treatment Period 1||2
573891|NCT00589979|1401103|P2|NOT COMPLETED|Double-Blind Treatment Period 1||2
573892|NCT00589979|1401104|P1|NOT COMPLETED|Double-Blind Treatment Period 1||0
573893|NCT00589979|1401102|P3|COMPLETED|Double-Blind Treatment Period 1||41
573894|NCT00589979|1401103|P2|COMPLETED|Double-Blind Treatment Period 1||48
573895|NCT00589979|1401104|P1|COMPLETED|Double-Blind Treatment Period 1||0
573896|NCT00589979|1401102|P3|STARTED|Double-Blind Treatment Period 1|N=21 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|43
573897|NCT00589979|1401103|P2|STARTED|Double-Blind Treatment Period 1|N=21 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|50
573898|NCT00589979|1401104|P1|STARTED|Double-Blind Treatment Period 1|Participants completing the Run-in Period were then randomized to two different treatment sequences.|0
573899|NCT00589979|1401102|P3|NOT COMPLETED|Run-In Period||0
573900|NCT00589979|1401103|P2|NOT COMPLETED|Run-In Period||0
573901|NCT00589979|1401104|P1|NOT COMPLETED|Run-In Period||76
573902|NCT00589979|1401102|P3|COMPLETED|Run-In Period||0
573903|NCT00589979|1401103|P2|COMPLETED|Run-In Period||0
573904|NCT00589979|1401104|P1|COMPLETED|Run-In Period||93
573905|NCT00589979|1401102|P3|STARTED|Run-In Period||0
573906|NCT00589979|1401103|P2|STARTED|Run-In Period||0
573907|NCT00589979|1401104|P1|STARTED|Run-In Period||169
573908|NCT00589914|1401143|P2|NOT COMPLETED|Overall Study||137
573909|NCT00589914|1401144|P1|NOT COMPLETED|Overall Study||150
573910|NCT00589914|1401143|P2|COMPLETED|Overall Study||471
573911|NCT00589914|1401144|P1|COMPLETED|Overall Study||456
573912|NCT00589914|1401143|P2|STARTED|Overall Study||608
573913|NCT00589914|1401144|P1|STARTED|Overall Study||606
573914|NCT00589888|1401154|P5|NOT COMPLETED|64-gram Oral Fat Load||0
573915|NCT00589888|1401155|P4|NOT COMPLETED|64-gram Oral Fat Load||0
573916|NCT00589888|1401156|P3|NOT COMPLETED|64-gram Oral Fat Load||0
573917|NCT00589888|1401157|P2|NOT COMPLETED|64-gram Oral Fat Load||0
573918|NCT00589888|1401158|P1|NOT COMPLETED|64-gram Oral Fat Load||0
573919|NCT00589888|1401154|P5|COMPLETED|64-gram Oral Fat Load||13
573920|NCT00589888|1401155|P4|COMPLETED|64-gram Oral Fat Load||0
573921|NCT00589888|1401156|P3|COMPLETED|64-gram Oral Fat Load||0
573922|NCT00589888|1401157|P2|COMPLETED|64-gram Oral Fat Load||0
573923|NCT00589888|1401158|P1|COMPLETED|64-gram Oral Fat Load||0
573924|NCT00589888|1401154|P5|STARTED|64-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|13
573925|NCT00589888|1401155|P4|STARTED|64-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|0
573926|NCT00589888|1401156|P3|STARTED|64-gram Oral Fat Load||0
573927|NCT00589888|1401157|P2|STARTED|64-gram Oral Fat Load||0
573928|NCT00589888|1401158|P1|STARTED|64-gram Oral Fat Load||0
573929|NCT00589888|1401154|P5|NOT COMPLETED|32-gram Oral Fat Load||0
573930|NCT00589888|1401155|P4|NOT COMPLETED|32-gram Oral Fat Load||0
573931|NCT00589888|1401156|P3|NOT COMPLETED|32-gram Oral Fat Load||0
573932|NCT00589888|1401157|P2|NOT COMPLETED|32-gram Oral Fat Load||0
573933|NCT00589888|1401158|P1|NOT COMPLETED|32-gram Oral Fat Load||0
573934|NCT00589888|1401154|P5|COMPLETED|32-gram Oral Fat Load||0
573935|NCT00589888|1401155|P4|COMPLETED|32-gram Oral Fat Load||13
573936|NCT00589888|1401156|P3|COMPLETED|32-gram Oral Fat Load||0
573937|NCT00589888|1401157|P2|COMPLETED|32-gram Oral Fat Load||0
573938|NCT00589888|1401158|P1|COMPLETED|32-gram Oral Fat Load||0
573939|NCT00589888|1401154|P5|STARTED|32-gram Oral Fat Load||0
573940|NCT00589888|1401155|P4|STARTED|32-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|13
573941|NCT00589888|1401156|P3|STARTED|32-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|0
573942|NCT00589888|1401157|P2|STARTED|32-gram Oral Fat Load||0
573943|NCT00589888|1401158|P1|STARTED|32-gram Oral Fat Load||0
573944|NCT00589888|1401154|P5|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
573945|NCT00589888|1401155|P4|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
573946|NCT00589888|1401156|P3|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
573947|NCT00589888|1401157|P2|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
573948|NCT00589888|1401158|P1|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
573949|NCT00589888|1401154|P5|COMPLETED|Intralipid 20% @ 40cc/Hour||0
573950|NCT00589888|1401155|P4|COMPLETED|Intralipid 20% @ 40cc/Hour||0
573951|NCT00589888|1401156|P3|COMPLETED|Intralipid 20% @ 40cc/Hour||13
573952|NCT00589888|1401157|P2|COMPLETED|Intralipid 20% @ 40cc/Hour||0
573953|NCT00589888|1401158|P1|COMPLETED|Intralipid 20% @ 40cc/Hour||0
573954|NCT00589888|1401154|P5|STARTED|Intralipid 20% @ 40cc/Hour||0
573955|NCT00589888|1401155|P4|STARTED|Intralipid 20% @ 40cc/Hour||0
573956|NCT00589888|1401156|P3|STARTED|Intralipid 20% @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|13
573957|NCT00589888|1401157|P2|STARTED|Intralipid 20% @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|0
573958|NCT00589888|1401158|P1|STARTED|Intralipid 20% @ 40cc/Hour||0
573959|NCT00589888|1401154|P5|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
573960|NCT00589888|1401155|P4|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
573961|NCT00589888|1401156|P3|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
573962|NCT00589888|1401157|P2|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
573963|NCT00589888|1401158|P1|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
573964|NCT00589888|1401154|P5|COMPLETED|Intralipid 20% @ 20cc/hr||0
573965|NCT00589888|1401155|P4|COMPLETED|Intralipid 20% @ 20cc/hr||0
573966|NCT00589888|1401156|P3|COMPLETED|Intralipid 20% @ 20cc/hr||0
573967|NCT00589888|1401157|P2|COMPLETED|Intralipid 20% @ 20cc/hr||13
573968|NCT00589888|1401158|P1|COMPLETED|Intralipid 20% @ 20cc/hr||0
573969|NCT00589888|1401154|P5|STARTED|Intralipid 20% @ 20cc/hr||0
573970|NCT00589888|1401155|P4|STARTED|Intralipid 20% @ 20cc/hr||0
573971|NCT00589888|1401156|P3|STARTED|Intralipid 20% @ 20cc/hr||0
573972|NCT00589888|1401157|P2|STARTED|Intralipid 20% @ 20cc/hr||13
573973|NCT00589888|1401158|P1|STARTED|Intralipid 20% @ 20cc/hr|the same 13 patients did each of the 5 arms at 5 different visits|0
573974|NCT00589888|1401154|P5|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
573975|NCT00589888|1401155|P4|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
573976|NCT00589888|1401156|P3|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
573977|NCT00589888|1401157|P2|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
573978|NCT00589888|1401158|P1|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
573979|NCT00589888|1401154|P5|COMPLETED|Normal Saline @ 40cc/Hour||0
573980|NCT00589888|1401155|P4|COMPLETED|Normal Saline @ 40cc/Hour||0
573981|NCT00589888|1401156|P3|COMPLETED|Normal Saline @ 40cc/Hour||0
573982|NCT00589888|1401157|P2|COMPLETED|Normal Saline @ 40cc/Hour||0
573983|NCT00589888|1401158|P1|COMPLETED|Normal Saline @ 40cc/Hour||13
573984|NCT00589888|1401154|P5|STARTED|Normal Saline @ 40cc/Hour||0
573985|NCT00589888|1401155|P4|STARTED|Normal Saline @ 40cc/Hour||0
573986|NCT00589888|1401156|P3|STARTED|Normal Saline @ 40cc/Hour||0
573987|NCT00589888|1401157|P2|STARTED|Normal Saline @ 40cc/Hour||0
573988|NCT00589888|1401158|P1|STARTED|Normal Saline @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|13
573989|NCT00589849|1401170|P1|NOT COMPLETED|Overall Study||0
573990|NCT00589849|1401170|P1|COMPLETED|Overall Study||32
573991|NCT00589849|1401170|P1|STARTED|Overall Study||32
573992|NCT00589836|1401174|P1|NOT COMPLETED|Overall Study||0
573993|NCT00589836|1401174|P1|COMPLETED|Overall Study||20
573994|NCT00589836|1401174|P1|STARTED|Overall Study||20
573995|NCT00589784|1401180|P2|NOT COMPLETED|Overall Study||10
573996|NCT00589784|1401181|P1|NOT COMPLETED|Overall Study||1
573997|NCT00589784|1401180|P2|COMPLETED|Overall Study||4
573998|NCT00589784|1401181|P1|COMPLETED|Overall Study||35
573999|NCT00589784|1401180|P2|STARTED|Overall Study||14
574000|NCT00589784|1401181|P1|STARTED|Overall Study||36
574001|NCT00589693|1401188|P2|NOT COMPLETED|Overall Study||29
574002|NCT00589693|1401189|P1|NOT COMPLETED|Overall Study||44
574003|NCT00589693|1401188|P2|COMPLETED|Overall Study||83
574004|NCT00589693|1401189|P1|COMPLETED|Overall Study||71
574005|NCT00589693|1401188|P2|STARTED|Overall Study||112
574006|NCT00589693|1401189|P1|STARTED|Overall Study||115
574007|NCT00589667|1401203|P1|NOT COMPLETED|Overall Study||3
574008|NCT00589667|1401203|P1|COMPLETED|Overall Study||23
574009|NCT00589667|1401203|P1|STARTED|Overall Study||26
574010|NCT00589628|1401210|P2|NOT COMPLETED|Overall Study||1
574011|NCT00589628|1401211|P1|NOT COMPLETED|Overall Study||0
574012|NCT00589628|1401210|P2|COMPLETED|Overall Study||5
574013|NCT00589628|1401211|P1|COMPLETED|Overall Study||7
574014|NCT00589628|1401210|P2|STARTED|Overall Study||6
574015|NCT00589628|1401211|P1|STARTED|Overall Study||7
574016|NCT00589602|1401217|P1|NOT COMPLETED|Overall Study||1
574017|NCT00589602|1401217|P1|COMPLETED|Overall Study||12
574018|NCT00589602|1401217|P1|STARTED|Overall Study||13
574019|NCT00589563|1401225|P1|NOT COMPLETED|Overall Study||0
574020|NCT00589563|1401225|P1|COMPLETED|Overall Study||32
574021|NCT00589563|1401225|P1|STARTED|Overall Study||32
574022|NCT00589550|1401242|P1|NOT COMPLETED|Overall Study||1
574023|NCT00589550|1401242|P1|COMPLETED|Overall Study||0
574024|NCT00589550|1401242|P1|Withdrew From Study|Overall Study||1
574025|NCT00589550|1401242|P1|STARTED|Overall Study||1
574026|NCT00589472|1401252|P1|NOT COMPLETED|Overall Study||1
574027|NCT00589472|1401252|P1|COMPLETED|Overall Study||18
574028|NCT00589472|1401252|P1|STARTED|Overall Study||19
574029|NCT00589303|1401264|P2|NOT COMPLETED|Overall Study||1
574030|NCT00589303|1401265|P1|NOT COMPLETED|Overall Study||2
574031|NCT00589303|1401264|P2|COMPLETED|Overall Study||12
574032|NCT00589303|1401265|P1|COMPLETED|Overall Study||12
574033|NCT00589303|1401264|P2|STARTED|Overall Study||13
574034|NCT00589303|1401265|P1|STARTED|Overall Study||14
574035|NCT00589290|1401271|P1|NOT COMPLETED|Overall Study||1
574036|NCT00589290|1401271|P1|COMPLETED|Overall Study||40
574037|NCT00589290|1401271|P1|STARTED|Overall Study||41
574038|NCT00589277|1401281|P2|NOT COMPLETED|Overall Study||286
574039|NCT00589277|1401282|P1|NOT COMPLETED|Overall Study||460
574040|NCT00589277|1401281|P2|COMPLETED|Overall Study||524
574041|NCT00589277|1401282|P1|COMPLETED|Overall Study||762
574042|NCT00589277|1401281|P2|Completed 3 Month Follow Up|Overall Study||524
574043|NCT00589277|1401282|P1|Completed 3 Month Follow Up|Overall Study||762
574044|NCT00589277|1401281|P2|Completed 2 Week Follow Up|Overall Study||424
574045|NCT00589277|1401282|P1|Completed 2 Week Follow Up|Overall Study||603
574046|NCT00589277|1401281|P2|STARTED|Overall Study||810
574047|NCT00589277|1401282|P1|STARTED|Overall Study||1222
574048|NCT00589121|1401294|P2|NOT COMPLETED|Overall Study||7
574049|NCT00589121|1401295|P1|NOT COMPLETED|Overall Study||2
574050|NCT00589121|1401294|P2|COMPLETED|Overall Study|Subjects with data available for the analysis are considered to have completed the study.|79
574051|NCT00589121|1401295|P1|COMPLETED|Overall Study|Subjects with data available for the analysis are considered to have completed the study.|10
574052|NCT00589121|1401294|P2|STARTED|Overall Study||86
574053|NCT00589121|1401295|P1|STARTED|Overall Study||12
574054|NCT00589108|1401315|P3|NOT COMPLETED|Overall Study||5
574055|NCT00589108|1401316|P2|NOT COMPLETED|Overall Study||4
574056|NCT00589108|1401317|P1|NOT COMPLETED|Overall Study||4
574057|NCT00589108|1401315|P3|COMPLETED|Overall Study||75
574058|NCT00589108|1401316|P2|COMPLETED|Overall Study||76
574059|NCT00589108|1401317|P1|COMPLETED|Overall Study||76
574060|NCT00589108|1401315|P3|STARTED|Overall Study||80
574061|NCT00589108|1401316|P2|STARTED|Overall Study||80
574062|NCT00589108|1401317|P1|STARTED|Overall Study||80
574063|NCT00588965|1401337|P1|NOT COMPLETED|Overall Study||0
574064|NCT00588965|1401337|P1|COMPLETED|Overall Study||35
574065|NCT00588965|1401337|P1|STARTED|Overall Study||35
574066|NCT00588952|1401347|P2|NOT COMPLETED|Overall Study||7
574067|NCT00588952|1401348|P1|NOT COMPLETED|Overall Study||3
574068|NCT00588952|1401347|P2|COMPLETED|Overall Study||63
574069|NCT00588952|1401348|P1|COMPLETED|Overall Study||26
574070|NCT00588952|1401347|P2|STARTED|Overall Study||70
574071|NCT00588952|1401348|P1|STARTED|Overall Study||29
574072|NCT00588900|1401368|P1|NOT COMPLETED|Overall Study||0
574073|NCT00588900|1401368|P1|COMPLETED|Overall Study||5
574074|NCT00588900|1401368|P1|STARTED|Overall Study||5
574075|NCT00588861|1401376|P2|NOT COMPLETED|10 Years||114
574076|NCT00588861|1401377|P1|NOT COMPLETED|10 Years||107
574077|NCT00588861|1401376|P2|COMPLETED|10 Years||0
574078|NCT00588861|1401377|P1|COMPLETED|10 Years||0
574079|NCT00588861|1401376|P2|STARTED|10 Years|114 cases were due at 10 Years, however no patients returned for follow-up.|114
574080|NCT00588861|1401377|P1|STARTED|10 Years|107 cases were due at 10 Years, however no patients returned for follow-up.|107
574081|NCT00588861|1401376|P2|NOT COMPLETED|8 Years||114
574082|NCT00588861|1401377|P1|NOT COMPLETED|8 Years||105
574083|NCT00588861|1401376|P2|COMPLETED|8 Years||0
574084|NCT00588861|1401377|P1|COMPLETED|8 Years||2
574085|NCT00588861|1401376|P2|STARTED|8 Years|114 cases were due at 8 Years, however no patients returned for follow-up.|114
574086|NCT00588861|1401377|P1|STARTED|8 Years|107 cases were due at 8 Years, however only 2 returned for follow-up.|107
574087|NCT00588861|1401376|P2|NOT COMPLETED|6 Years||109
574088|NCT00588861|1401377|P1|NOT COMPLETED|6 Years||104
574089|NCT00588861|1401376|P2|COMPLETED|6 Years||5
574090|NCT00588861|1401377|P1|COMPLETED|6 Years||3
574091|NCT00588861|1401376|P2|STARTED|6 Years|114 cases were due at 6 Years, however only 5 returned for follow-up.|114
574092|NCT00588861|1401377|P1|STARTED|6 Years|107 cases were due at 6 Years, however only 3 returned for follow-up.|107
574093|NCT00588861|1401376|P2|NOT COMPLETED|4 Years||103
574094|NCT00588861|1401377|P1|NOT COMPLETED|4 Years||91
574095|NCT00588861|1401376|P2|COMPLETED|4 Years||11
574096|NCT00588861|1401377|P1|COMPLETED|4 Years||16
574097|NCT00588861|1401376|P2|STARTED|4 Years|114 cases were due at 4 Years, however only 11 returned for follow-up.|114
574098|NCT00588861|1401377|P1|STARTED|4 Years|107 cases were due at 4 Years, however only 16 returned for follow-up.|107
574099|NCT00588861|1401376|P2|NOT COMPLETED|2 Years||87
574100|NCT00588861|1401377|P1|NOT COMPLETED|2 Years||92
574101|NCT00588861|1401376|P2|COMPLETED|2 Years||27
574102|NCT00588861|1401377|P1|COMPLETED|2 Years||15
574103|NCT00588861|1401376|P2|STARTED|2 Years|114 cases were due at 2 Years, however only 27 returned for follow-up.|114
574104|NCT00588861|1401377|P1|STARTED|2 Years|107 cases were due at 2 Years, however only 15 returned for follow-up.|107
574105|NCT00588861|1401376|P2|NOT COMPLETED|1 Year||82
574106|NCT00588861|1401377|P1|NOT COMPLETED|1 Year||89
574107|NCT00588861|1401376|P2|COMPLETED|1 Year||32
574108|NCT00588861|1401377|P1|COMPLETED|1 Year||18
574109|NCT00588861|1401376|P2|STARTED|1 Year|114 cases were due at 1 Year, however only 32 returned for follow-up.|114
574110|NCT00588861|1401377|P1|STARTED|1 Year|107 cases were due at 1 Year, however only 18 returned for follow-up.|107
574111|NCT00588861|1401376|P2|NOT COMPLETED|6 Months||73
574112|NCT00588861|1401377|P1|NOT COMPLETED|6 Months||98
574113|NCT00588861|1401376|P2|COMPLETED|6 Months||41
574114|NCT00588861|1401377|P1|COMPLETED|6 Months||9
574115|NCT00588861|1401376|P2|STARTED|6 Months|114 cases were due at 6 Months, however only 41 returned for follow-up.|114
574116|NCT00588861|1401377|P1|STARTED|6 Months|107 cases were due at 6 Months, however only 9 returned for follow-up.|107
574117|NCT00588861|1401376|P2|NOT COMPLETED|Pre-Operative||86
574118|NCT00588861|1401377|P1|NOT COMPLETED|Pre-Operative||95
574119|NCT00588861|1401376|P2|COMPLETED|Pre-Operative||114
574120|NCT00588861|1401377|P1|COMPLETED|Pre-Operative||107
574121|NCT00588861|1401376|P2|STARTED|Pre-Operative|200 patients were enrolled, however only 114 contributed preop data.|200
574122|NCT00588861|1401377|P1|STARTED|Pre-Operative|202 Patients were enrolled, however only 107 contributed preop data.|202
574123|NCT00588848|1401387|P2|NOT COMPLETED|Overall Study||0
574124|NCT00588848|1401388|P1|NOT COMPLETED|Overall Study||0
574125|NCT00588848|1401387|P2|COMPLETED|Overall Study||8
574126|NCT00588848|1401388|P1|COMPLETED|Overall Study||3
574127|NCT00588848|1401387|P2|STARTED|Overall Study||8
574128|NCT00588848|1401388|P1|STARTED|Overall Study||3
574129|NCT00588822|1401398|P1|NOT COMPLETED|Overall Study||8
574130|NCT00588822|1401398|P1|COMPLETED|Overall Study||13
574131|NCT00588822|1401398|P1|STARTED|Overall Study||21
574132|NCT00588809|1401407|P1|NOT COMPLETED|Overall Study||0
574133|NCT00588809|1401407|P1|COMPLETED|Overall Study||47
574134|NCT00588809|1401407|P1|STARTED|Overall Study||47
574135|NCT00588731|1401418|P2|NOT COMPLETED|Overall Study||2
574136|NCT00588731|1401419|P1|NOT COMPLETED|Overall Study||3
574137|NCT00588731|1401418|P2|COMPLETED|Overall Study||18
574138|NCT00588731|1401419|P1|COMPLETED|Overall Study||18
574139|NCT00588731|1401418|P2|STARTED|Overall Study||20
574140|NCT00588731|1401419|P1|STARTED|Overall Study||21
574141|NCT00588692|1401429|P2|NOT COMPLETED|Overall Study||3
574142|NCT00588692|1401430|P1|NOT COMPLETED|Overall Study||7
574143|NCT00588692|1401429|P2|COMPLETED|Overall Study||27
574144|NCT00588692|1401430|P1|COMPLETED|Overall Study||23
574145|NCT00588692|1401429|P2|STARTED|Overall Study||30
574146|NCT00588692|1401430|P1|STARTED|Overall Study||30
574147|NCT00588666|1401466|P1|NOT COMPLETED|Overall Study||4
574148|NCT00588666|1401466|P1|COMPLETED|Overall Study||47
574149|NCT00588666|1401466|P1|STARTED|Overall Study||51
574150|NCT00588640|1401471|P1|NOT COMPLETED|Overall Study||2
574151|NCT00588640|1401471|P1|COMPLETED|Overall Study||8
574152|NCT00588640|1401471|P1|STARTED|Overall Study||10
574153|NCT00588536|1401475|P1|NOT COMPLETED|Overall Study||0
574154|NCT00588536|1401475|P1|COMPLETED|Overall Study||5
574155|NCT00588536|1401475|P1|STARTED|Overall Study||5
574156|NCT00588471|1401481|P2|NOT COMPLETED|Overall Study||0
574157|NCT00588471|1401482|P1|NOT COMPLETED|Overall Study||0
574158|NCT00588471|1401481|P2|COMPLETED|Overall Study||29
574159|NCT00588471|1401482|P1|COMPLETED|Overall Study||28
574160|NCT00588471|1401481|P2|STARTED|Overall Study||29
574161|NCT00588471|1401482|P1|STARTED|Overall Study||28
574162|NCT00588445|1401490|P1|NOT COMPLETED|Overall Study||15
574163|NCT00588445|1401490|P1|COMPLETED|Overall Study||50
574164|NCT00588445|1401490|P1|STARTED|Overall Study||65
574165|NCT00588406|1401498|P2|NOT COMPLETED|Overall Study||0
574166|NCT00588406|1401499|P1|NOT COMPLETED|Overall Study||0
574167|NCT00588406|1401498|P2|COMPLETED|Overall Study||49
574168|NCT00588406|1401499|P1|COMPLETED|Overall Study||46
574169|NCT00588406|1401498|P2|STARTED|Overall Study||49
574170|NCT00588406|1401499|P1|STARTED|Overall Study||46
574171|NCT00588380|1401507|P1|NOT COMPLETED|Overall Study||0
574172|NCT00588380|1401507|P1|COMPLETED|Overall Study||88
574173|NCT00588380|1401507|P1|STARTED|Overall Study||88
574174|NCT00588354|1401514|P2|NOT COMPLETED|Baseline to 4 Weeks||1
574175|NCT00588354|1401515|P1|NOT COMPLETED|Baseline to 4 Weeks||0
574176|NCT00588354|1401514|P2|COMPLETED|Baseline to 4 Weeks||14
574177|NCT00588354|1401515|P1|COMPLETED|Baseline to 4 Weeks||9
574178|NCT00588354|1401514|P2|STARTED|Baseline to 4 Weeks||15
574179|NCT00588354|1401515|P1|STARTED|Baseline to 4 Weeks||9
574180|NCT00588354|1401514|P2|NOT COMPLETED|Baseline to 2 Weeks||0
574181|NCT00588354|1401515|P1|NOT COMPLETED|Baseline to 2 Weeks||2
574182|NCT00588354|1401514|P2|COMPLETED|Baseline to 2 Weeks||15
574183|NCT00588354|1401515|P1|COMPLETED|Baseline to 2 Weeks||9
574184|NCT00588354|1401514|P2|STARTED|Baseline to 2 Weeks||15
574185|NCT00588354|1401515|P1|STARTED|Baseline to 2 Weeks||11
574186|NCT00588341|1401535|P1|NOT COMPLETED|Overall Study||5
574187|NCT00588341|1401535|P1|COMPLETED|Overall Study||19
574188|NCT00588341|1401535|P1|STARTED|Overall Study||24
574189|NCT00588237|1401539|P1|NOT COMPLETED|Overall Study||4
574190|NCT00588237|1401539|P1|COMPLETED|Overall Study||38
574191|NCT00588237|1401539|P1|STARTED|Overall Study||42
574192|NCT00588159|1401545|P2|NOT COMPLETED|Overall Study||11
574193|NCT00588159|1401546|P1|NOT COMPLETED|Overall Study||15
574194|NCT00588159|1401545|P2|COMPLETED|Overall Study||63
574195|NCT00588159|1401546|P1|COMPLETED|Overall Study||57
574196|NCT00588159|1401545|P2|STARTED|Overall Study||74
574197|NCT00588159|1401546|P1|STARTED|Overall Study||72
574198|NCT00588146|1401562|P2|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0
574199|NCT00588146|1401563|P1|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0
574200|NCT00588146|1401562|P2|COMPLETED|Second Intervention (6 Months to 1 Year)||2
574201|NCT00588146|1401563|P1|COMPLETED|Second Intervention (6 Months to 1 Year)||1
574202|NCT00588146|1401562|P2|STARTED|Second Intervention (6 Months to 1 Year)||2
574203|NCT00588146|1401563|P1|STARTED|Second Intervention (6 Months to 1 Year)||1
574204|NCT00588146|1401562|P2|NOT COMPLETED|First Intervention (Baseline to 6 mo)||3
574205|NCT00588146|1401563|P1|NOT COMPLETED|First Intervention (Baseline to 6 mo)||4
574206|NCT00588146|1401562|P2|COMPLETED|First Intervention (Baseline to 6 mo)||2
574207|NCT00588146|1401563|P1|COMPLETED|First Intervention (Baseline to 6 mo)||1
574208|NCT00588146|1401562|P2|STARTED|First Intervention (Baseline to 6 mo)||5
574209|NCT00588146|1401563|P1|STARTED|First Intervention (Baseline to 6 mo)||5
574210|NCT00588094|1401569|P1|NOT COMPLETED|Overall Study||5
574211|NCT00588094|1401569|P1|COMPLETED|Overall Study||15
574212|NCT00588094|1401569|P1|STARTED|Overall Study||20
574213|NCT00587990|1401576|P3|NOT COMPLETED|Overall Study||0
574214|NCT00587990|1401577|P2|NOT COMPLETED|Overall Study||0
574215|NCT00587990|1401578|P1|NOT COMPLETED|Overall Study||0
574216|NCT00587990|1401576|P3|COMPLETED|Overall Study||3
574217|NCT00587990|1401577|P2|COMPLETED|Overall Study||4
574218|NCT00587990|1401578|P1|COMPLETED|Overall Study||2
574219|NCT00587990|1401576|P3|STARTED|Overall Study||3
574220|NCT00587990|1401577|P2|STARTED|Overall Study||4
574221|NCT00587990|1401578|P1|STARTED|Overall Study||2
574222|NCT00587964|1401592|P1|NOT COMPLETED|Overall Study||12
574223|NCT00587964|1401592|P1|COMPLETED|Overall Study||39
574224|NCT00587964|1401592|P1|STARTED|Overall Study||51
574225|NCT00587860|1401598|P2|NOT COMPLETED|Overall Study||5
574226|NCT00587860|1401599|P1|NOT COMPLETED|Overall Study||5
574227|NCT00587860|1401598|P2|COMPLETED|Overall Study||30
574228|NCT00587860|1401599|P1|COMPLETED|Overall Study||30
574229|NCT00587860|1401598|P2|STARTED|Overall Study||35
574230|NCT00587860|1401599|P1|STARTED|Overall Study||35
574231|NCT00587847|1401619|P1|NOT COMPLETED|Overall Study||7
574232|NCT00587847|1401619|P1|COMPLETED|Overall Study||5
574233|NCT00587847|1401619|P1|STARTED|Overall Study||12
574234|NCT00587834|1401624|P1|NOT COMPLETED|Overall Study||0
574235|NCT00587834|1401624|P1|COMPLETED|Overall Study||96
574236|NCT00587834|1401624|P1|STARTED|Overall Study||96
574237|NCT00587795|1401642|P2|NOT COMPLETED|Overall Study||0
574238|NCT00587795|1401643|P1|NOT COMPLETED|Overall Study||1
574239|NCT00587795|1401642|P2|COMPLETED|Overall Study||0
574240|NCT00587795|1401643|P1|COMPLETED|Overall Study||0
574241|NCT00587795|1401642|P2|STARTED|Overall Study||0
574242|NCT00587795|1401643|P1|STARTED|Overall Study||1
574243|NCT00587769|1401649|P1|NOT COMPLETED|Overall Study||0
574244|NCT00587769|1401649|P1|COMPLETED|Overall Study||38
574245|NCT00587769|1401649|P1|STARTED|Overall Study||38
574246|NCT00587678|1401657|P3|NOT COMPLETED|Overall Study||8
574247|NCT00587678|1401658|P2|NOT COMPLETED|Overall Study||4
574248|NCT00587678|1401659|P1|NOT COMPLETED|Overall Study||6
574249|NCT00587678|1401657|P3|COMPLETED|Overall Study||33
574250|NCT00587678|1401658|P2|COMPLETED|Overall Study||18
574251|NCT00587678|1401659|P1|COMPLETED|Overall Study||16
574252|NCT00587678|1401657|P3|STARTED|Overall Study||41
574253|NCT00587678|1401658|P2|STARTED|Overall Study||22
574254|NCT00587678|1401659|P1|STARTED|Overall Study||22
574255|NCT00587639|1401697|P1|NOT COMPLETED|Overall Study||1
574256|NCT00587639|1401697|P1|COMPLETED|Overall Study||7
574257|NCT00587639|1401697|P1|STARTED|Overall Study||8
574258|NCT00587587|1401704|P2|NOT COMPLETED|Overall Study||1
574259|NCT00587587|1401705|P1|NOT COMPLETED|Overall Study||6
574260|NCT00587587|1401704|P2|COMPLETED|Overall Study||12
574261|NCT00587587|1401705|P1|COMPLETED|Overall Study||11
574262|NCT00587587|1401704|P2|STARTED|Overall Study||13
574263|NCT00587587|1401705|P1|STARTED|Overall Study||17
574264|NCT00587483|1401728|P3|NOT COMPLETED|Overall Study||0
574265|NCT00587483|1401729|P2|NOT COMPLETED|Overall Study||0
574266|NCT00587483|1401730|P1|NOT COMPLETED|Overall Study||0
574267|NCT00587483|1401728|P3|COMPLETED|Overall Study||112
574268|NCT00587483|1401729|P2|COMPLETED|Overall Study||115
574269|NCT00587483|1401730|P1|COMPLETED|Overall Study||115
574270|NCT00587483|1401728|P3|STARTED|Overall Study||112
574271|NCT00587483|1401729|P2|STARTED|Overall Study||115
574272|NCT00587483|1401730|P1|STARTED|Overall Study||115
574273|NCT00587457|1401759|P3|NOT COMPLETED|Overall Study||5
574274|NCT00587457|1401760|P2|NOT COMPLETED|Overall Study||3
574275|NCT00587457|1401761|P1|NOT COMPLETED|Overall Study||3
574276|NCT00587457|1401759|P3|COMPLETED|Overall Study||0
574277|NCT00587457|1401760|P2|COMPLETED|Overall Study||0
574278|NCT00587457|1401761|P1|COMPLETED|Overall Study||0
574279|NCT00587457|1401759|P3|STARTED|Overall Study||5
574280|NCT00587457|1401760|P2|STARTED|Overall Study||3
574281|NCT00587457|1401761|P1|STARTED|Overall Study||3
574282|NCT00587431|1401798|P2|NOT COMPLETED|Overall Study||1
574283|NCT00587431|1401799|P1|NOT COMPLETED|Overall Study||1
574284|NCT00587431|1401798|P2|COMPLETED|Overall Study||38
574285|NCT00587431|1401799|P1|COMPLETED|Overall Study||62
574286|NCT00587431|1401798|P2|STARTED|Overall Study||39
574287|NCT00587431|1401799|P1|STARTED|Overall Study||63
574288|NCT00587288|1401810|P2|NOT COMPLETED|Overall Study||9
574289|NCT00587288|1401811|P1|NOT COMPLETED|Overall Study||3
574290|NCT00587288|1401810|P2|COMPLETED|Overall Study||44
574291|NCT00587288|1401811|P1|COMPLETED|Overall Study||50
574292|NCT00587288|1401810|P2|STARTED|Overall Study||53
574293|NCT00587288|1401811|P1|STARTED|Overall Study||53
574294|NCT00587223|1401829|P1|NOT COMPLETED|Overall Study||1
574295|NCT00587223|1401829|P1|COMPLETED|Overall Study|Subject withdrawn from study at Day 7.|0
574296|NCT00587223|1401829|P1|STARTED|Overall Study|Study design was within-subject control. Only 1 subject was enrolled in the study.|1
574297|NCT00587171|1401846|P2|NOT COMPLETED|Overall Study||1
574298|NCT00587171|1401847|P1|NOT COMPLETED|Overall Study||1
574299|NCT00587171|1401846|P2|COMPLETED|Overall Study||9
574300|NCT00587171|1401847|P1|COMPLETED|Overall Study||8
574301|NCT00587171|1401846|P2|STARTED|Overall Study||10
574302|NCT00587171|1401847|P1|STARTED|Overall Study||9
574303|NCT00587158|1401877|P2|NOT COMPLETED|Overall Study||8
574304|NCT00587158|1401878|P1|NOT COMPLETED|Overall Study||5
574305|NCT00587158|1401877|P2|COMPLETED|Overall Study||43
574306|NCT00587158|1401878|P1|COMPLETED|Overall Study||44
574307|NCT00587158|1401877|P2|Continued in Study|Overall Study||46
574308|NCT00587158|1401878|P1|Continued in Study|Overall Study||45
574309|NCT00587158|1401877|P2|STARTED|Overall Study||51
574310|NCT00587158|1401878|P1|STARTED|Overall Study||49
574311|NCT00587132|1401912|P4|NOT COMPLETED|Overall Study||0
574312|NCT00587132|1401913|P3|NOT COMPLETED|Overall Study||0
574313|NCT00587132|1401914|P2|NOT COMPLETED|Overall Study||0
574314|NCT00587132|1401915|P1|NOT COMPLETED|Overall Study||0
574315|NCT00587132|1401912|P4|COMPLETED|Overall Study||0
574316|NCT00587132|1401913|P3|COMPLETED|Overall Study||0
574317|NCT00587132|1401914|P2|COMPLETED|Overall Study||0
574318|NCT00587132|1401915|P1|COMPLETED|Overall Study||4
574319|NCT00587132|1401912|P4|STARTED|Overall Study||0
574320|NCT00587132|1401913|P3|STARTED|Overall Study||0
574321|NCT00587132|1401914|P2|STARTED|Overall Study||0
574322|NCT00587132|1401915|P1|STARTED|Overall Study||4
574323|NCT00587067|1401925|P1|NOT COMPLETED|Overall Study||0
574324|NCT00587067|1401925|P1|COMPLETED|Overall Study||34
574325|NCT00587067|1401925|P1|STARTED|Overall Study||34
574326|NCT00587054|1401931|P1|NOT COMPLETED|Overall Study||9
574327|NCT00587054|1401931|P1|COMPLETED|Overall Study||120
574328|NCT00587054|1401931|P1|STARTED|Overall Study||129
574329|NCT00587041|1401938|P3|NOT COMPLETED|Overall Study||0
574330|NCT00587041|1401939|P2|NOT COMPLETED|Overall Study||0
574331|NCT00587041|1401940|P1|NOT COMPLETED|Overall Study||0
574332|NCT00587041|1401938|P3|COMPLETED|Overall Study||14
574333|NCT00587041|1401939|P2|COMPLETED|Overall Study||14
574334|NCT00587041|1401940|P1|COMPLETED|Overall Study||12
574335|NCT00587041|1401938|P3|STARTED|Overall Study||14
574336|NCT00587041|1401939|P2|STARTED|Overall Study||14
574337|NCT00587041|1401940|P1|STARTED|Overall Study||12
574338|NCT00586898|1401951|P1|NOT COMPLETED|Overall Study||7
574339|NCT00586898|1401951|P1|COMPLETED|Overall Study||29
574340|NCT00586898|1401951|P1|STARTED|Overall Study||36
574341|NCT00586846|1401955|P1|NOT COMPLETED|Overall Study||6
574342|NCT00586846|1401955|P1|COMPLETED|Overall Study||34
574343|NCT00586846|1401955|P1|STARTED|Overall Study||40
574344|NCT00586820|1401961|P2|NOT COMPLETED|Overall Study||0
574345|NCT00586820|1401962|P1|NOT COMPLETED|Overall Study||1
574346|NCT00586820|1401961|P2|COMPLETED|Overall Study||11
574347|NCT00586820|1401962|P1|COMPLETED|Overall Study||11
574348|NCT00586820|1401961|P2|STARTED|Overall Study||11
574349|NCT00586820|1401962|P1|STARTED|Overall Study||12
574350|NCT00586729|1401972|P2|NOT COMPLETED|Overall Study||1
574351|NCT00586729|1401973|P1|NOT COMPLETED|Overall Study||3
574352|NCT00586729|1401972|P2|COMPLETED|Overall Study||8
574353|NCT00586729|1401973|P1|COMPLETED|Overall Study||11
574354|NCT00586729|1401972|P2|STARTED|Overall Study||9
574355|NCT00586729|1401973|P1|STARTED|Overall Study||14
574356|NCT00586716|1401985|P2|NOT COMPLETED|Overall Study||0
574357|NCT00586716|1401986|P1|NOT COMPLETED|Overall Study||0
574358|NCT00586716|1401985|P2|COMPLETED|Overall Study||8
574359|NCT00586716|1401986|P1|COMPLETED|Overall Study||14
574360|NCT00586716|1401985|P2|STARTED|Overall Study||8
574361|NCT00586716|1401986|P1|STARTED|Overall Study||14
574362|NCT00586703|1401993|P1|NOT COMPLETED|Overall Study||12
574363|NCT00586703|1401993|P1|COMPLETED|Overall Study||4
574364|NCT00586703|1401993|P1|STARTED|Overall Study||16
574365|NCT00586690|1402000|P2|NOT COMPLETED|Overall Study||0
574366|NCT00586690|1402001|P1|NOT COMPLETED|Overall Study||16
574367|NCT00586690|1402000|P2|COMPLETED|Overall Study||22
574368|NCT00586690|1402001|P1|COMPLETED|Overall Study||5
574369|NCT00586690|1402000|P2|STARTED|Overall Study||22
574370|NCT00586690|1402001|P1|STARTED|Overall Study|Four consented subjects were screen failures.|21
574371|NCT00586664|1402011|P3|NOT COMPLETED|Overall Study||1
574372|NCT00586664|1402012|P2|NOT COMPLETED|Overall Study||7
574373|NCT00586664|1402013|P1|NOT COMPLETED|Overall Study||5
574374|NCT00586664|1402011|P3|COMPLETED|Overall Study||43
574375|NCT00586664|1402012|P2|COMPLETED|Overall Study||36
574376|NCT00586664|1402013|P1|COMPLETED|Overall Study||38
574377|NCT00586664|1402011|P3|STARTED|Overall Study||44
574378|NCT00586664|1402012|P2|STARTED|Overall Study||43
574379|NCT00586664|1402013|P1|STARTED|Overall Study||43
574380|NCT00586625|1402059|P2|NOT COMPLETED|Overall Study||17
574381|NCT00586625|1402060|P1|NOT COMPLETED|Overall Study||43
574382|NCT00586625|1402059|P2|COMPLETED|Overall Study||269
574383|NCT00586625|1402060|P1|COMPLETED|Overall Study||532
574384|NCT00586625|1402059|P2|STARTED|Overall Study||286
574385|NCT00586625|1402060|P1|STARTED|Overall Study||575
574386|NCT00586612|1402068|P2|NOT COMPLETED|Booster Phase||1
574387|NCT00586612|1402069|P1|NOT COMPLETED|Booster Phase||3
574388|NCT00586612|1402068|P2|COMPLETED|Booster Phase||143
574389|NCT00586612|1402069|P1|COMPLETED|Booster Phase||151
574390|NCT00586612|1402068|P2|STARTED|Booster Phase||144
574391|NCT00586612|1402069|P1|STARTED|Booster Phase||154
574392|NCT00586612|1402068|P2|NOT COMPLETED|Primary Phase||3
574393|NCT00586612|1402069|P1|NOT COMPLETED|Primary Phase||1
574394|NCT00586612|1402068|P2|COMPLETED|Primary Phase||147
574395|NCT00586612|1402069|P1|COMPLETED|Primary Phase||162
574396|NCT00586612|1402068|P2|STARTED|Primary Phase||150
574397|NCT00586612|1402069|P1|STARTED|Primary Phase||163
574398|NCT00586573|1402135|P1|NOT COMPLETED|Overall Study||6
574399|NCT00586573|1402135|P1|COMPLETED|Overall Study||28
574400|NCT00586573|1402135|P1|STARTED|Overall Study||34
574401|NCT00586521|1402139|P1|NOT COMPLETED|Prophylactic Treatment (Months 8-13)||0
574402|NCT00586521|1402139|P1|COMPLETED|Prophylactic Treatment (Months 8-13)||19
574403|NCT00586521|1402139|P1|STARTED|Prophylactic Treatment (Months 8-13)||19
574404|NCT00586521|1402139|P1|NOT COMPLETED|On Demand Treatment (Months 1-6)||1
574405|NCT00586521|1402139|P1|COMPLETED|On Demand Treatment (Months 1-6)||19
574406|NCT00586521|1402139|P1|STARTED|On Demand Treatment (Months 1-6)||20
574407|NCT00586495|1402146|P1|NOT COMPLETED|Follow-up||92
574408|NCT00586495|1402146|P1|COMPLETED|Follow-up||0
574409|NCT00586495|1402146|P1|STARTED|Follow-up||92
574410|NCT00586495|1402146|P1|NOT COMPLETED|Treatment Period||95
574411|NCT00586495|1402146|P1|COMPLETED|Treatment Period||0
574412|NCT00586495|1402146|P1|STARTED|Treatment Period||95
574413|NCT00586482|1402158|P2|NOT COMPLETED|Overall Study||0
574414|NCT00586482|1402159|P1|NOT COMPLETED|Overall Study||0
574415|NCT00586482|1402158|P2|COMPLETED|Overall Study||24
574416|NCT00586482|1402159|P1|COMPLETED|Overall Study||22
574417|NCT00586482|1402158|P2|STARTED|Overall Study||24
574418|NCT00586482|1402159|P1|STARTED|Overall Study||22
574419|NCT00586469|1402175|P2|NOT COMPLETED|Overall Study||1
574420|NCT00586469|1402176|P1|NOT COMPLETED|Overall Study||0
574421|NCT00586469|1402175|P2|COMPLETED|Overall Study||499
574422|NCT00586469|1402176|P1|COMPLETED|Overall Study||500
574423|NCT00586469|1402175|P2|STARTED|Overall Study||500
574424|NCT00586469|1402176|P1|STARTED|Overall Study||500
574425|NCT00586339|1402203|P3|NOT COMPLETED|Overall Study||6
574426|NCT00586339|1402204|P2|NOT COMPLETED|Overall Study||7
574427|NCT00586339|1402205|P1|NOT COMPLETED|Overall Study||7
574428|NCT00586339|1402203|P3|COMPLETED|Overall Study||24
574429|NCT00586339|1402204|P2|COMPLETED|Overall Study||52
574430|NCT00586339|1402205|P1|COMPLETED|Overall Study||54
574431|NCT00586339|1402203|P3|STARTED|Overall Study||30
574432|NCT00586339|1402204|P2|STARTED|Overall Study||59
574433|NCT00586339|1402205|P1|STARTED|Overall Study||61
574434|NCT00586326|1402303|P1|NOT COMPLETED|Treated Through 5-yr Follow Up-Treated||26
574435|NCT00586326|1402303|P1|COMPLETED|Treated Through 5-yr Follow Up-Treated||74
574436|NCT00586326|1402303|P1|STARTED|Treated Through 5-yr Follow Up-Treated||100
574437|NCT00586326|1402303|P1|NOT COMPLETED|Device Placed toTreatment-ITT||18
574438|NCT00586326|1402303|P1|COMPLETED|Device Placed toTreatment-ITT||100
574439|NCT00586326|1402303|P1|STARTED|Device Placed toTreatment-ITT||118
574440|NCT00586326|1402303|P1|NOT COMPLETED|Enrollment to Device Placement-Enrolled||15
574441|NCT00586326|1402303|P1|COMPLETED|Enrollment to Device Placement-Enrolled||118
574442|NCT00586326|1402303|P1|STARTED|Enrollment to Device Placement-Enrolled||133
574443|NCT00586313|1402314|P1|NOT COMPLETED|Overall Study||2
574444|NCT00586313|1402314|P1|COMPLETED|Overall Study||19
574445|NCT00586313|1402314|P1|STARTED|Overall Study||21
574446|NCT00586261|1402321|P2|NOT COMPLETED|Overall Study||0
574447|NCT00586261|1402322|P1|NOT COMPLETED|Overall Study||0
574448|NCT00586261|1402321|P2|COMPLETED|Overall Study||19
574449|NCT00586261|1402322|P1|COMPLETED|Overall Study||17
574450|NCT00586261|1402321|P2|STARTED|Overall Study||19
574451|NCT00586261|1402322|P1|STARTED|Overall Study||17
574452|NCT00586196|1402330|P2|NOT COMPLETED|Overall Study||0
574453|NCT00586196|1402331|P1|NOT COMPLETED|Overall Study||0
574454|NCT00586196|1402330|P2|COMPLETED|Overall Study||9
574455|NCT00586196|1402331|P1|COMPLETED|Overall Study||7
574456|NCT00586196|1402330|P2|STARTED|Overall Study||9
574457|NCT00586196|1402331|P1|STARTED|Overall Study||7
574458|NCT00586170|1402341|P2|NOT COMPLETED|Overall Study||0
574459|NCT00586170|1402342|P1|NOT COMPLETED|Overall Study||0
574460|NCT00586170|1402341|P2|COMPLETED|Overall Study||3
574461|NCT00586170|1402342|P1|COMPLETED|Overall Study||5
574462|NCT00586170|1402341|P2|STARTED|Overall Study|Initially enrollment was listed as 9. 1 placebo patient withdrew prior to surgery, so enrollment=8.|3
574463|NCT00586170|1402342|P1|STARTED|Overall Study||5
574464|NCT00586157|1402350|P2|NOT COMPLETED|Second Intervention||1
574465|NCT00586157|1402351|P1|NOT COMPLETED|Second Intervention||2
574466|NCT00586157|1402350|P2|COMPLETED|Second Intervention||14
574467|NCT00586157|1402351|P1|COMPLETED|Second Intervention||12
574468|NCT00586157|1402350|P2|STARTED|Second Intervention||15
574469|NCT00586157|1402351|P1|STARTED|Second Intervention||14
574470|NCT00586157|1402350|P2|NOT COMPLETED|First Intervention||0
574471|NCT00586157|1402351|P1|NOT COMPLETED|First Intervention||1
574472|NCT00586157|1402350|P2|COMPLETED|First Intervention||15
574473|NCT00586157|1402351|P1|COMPLETED|First Intervention||14
574474|NCT00586157|1402350|P2|STARTED|First Intervention||15
574475|NCT00586157|1402351|P1|STARTED|First Intervention||15
574476|NCT00586105|1402361|P1|NOT COMPLETED|Overall Study||39
574477|NCT00586105|1402361|P1|COMPLETED|Overall Study||0
574478|NCT00586105|1402361|P1|STARTED|Overall Study||39
574479|NCT00586066|1402376|P2|NOT COMPLETED|Overall Study||10
574480|NCT00586066|1402377|P1|NOT COMPLETED|Overall Study||18
574481|NCT00586066|1402376|P2|COMPLETED|Overall Study||14
574482|NCT00586066|1402377|P1|COMPLETED|Overall Study||30
574483|NCT00586066|1402376|P2|STARTED|Overall Study||24
574484|NCT00586066|1402377|P1|STARTED|Overall Study||48
574485|NCT00585975|1402389|P2|NOT COMPLETED|Overall Study||13
574486|NCT00585975|1402390|P1|NOT COMPLETED|Overall Study||15
574487|NCT00585975|1402389|P2|COMPLETED|Overall Study||278
574488|NCT00585975|1402390|P1|COMPLETED|Overall Study||262
574489|NCT00585975|1402389|P2|STARTED|Overall Study||291
574490|NCT00585975|1402390|P1|STARTED|Overall Study||277
574491|NCT00585923|1402400|P2|NOT COMPLETED|Overall Study||33
574492|NCT00585923|1402401|P1|NOT COMPLETED|Overall Study||31
574493|NCT00585923|1402400|P2|COMPLETED|Overall Study||26
574494|NCT00585923|1402401|P1|COMPLETED|Overall Study||25
574495|NCT00585923|1402400|P2|STARTED|Overall Study||59
574496|NCT00585923|1402401|P1|STARTED|Overall Study||56
574497|NCT00585910|1402415|P1|NOT COMPLETED|ATMX + Osmotic-Release Methylphenidate||9
574498|NCT00585910|1402415|P1|COMPLETED|ATMX + Osmotic-Release Methylphenidate||41
574499|NCT00585910|1402415|P1|STARTED|ATMX + Osmotic-Release Methylphenidate|Number of participants to add OROS MPH to their ATMX regimen|50
574500|NCT00585910|1402415|P1|NOT COMPLETED|Atomoxetine (ATMX) Alone||17
574501|NCT00585910|1402415|P1|COMPLETED|Atomoxetine (ATMX) Alone|Number of subjects who completed Phase I. 15 completed only Phase I. 40 proceeded onto Phase II.|55
574502|NCT00585910|1402415|P1|STARTED|Atomoxetine (ATMX) Alone|This is the number of subjects who were exposed to ATMX in Phase I of the study.|72
574503|NCT00585715|1402423|P2|NOT COMPLETED|Overall Study||0
574504|NCT00585715|1402424|P1|NOT COMPLETED|Overall Study||3
574505|NCT00585715|1402423|P2|COMPLETED|Overall Study||11
574506|NCT00585715|1402424|P1|COMPLETED|Overall Study||8
574507|NCT00585715|1402423|P2|STARTED|Overall Study||11
574508|NCT00585715|1402424|P1|STARTED|Overall Study||11
574509|NCT00585689|1402432|P1|NOT COMPLETED|Overall Study||7
574510|NCT00585689|1402432|P1|COMPLETED|Overall Study||22
574511|NCT00585689|1402432|P1|STARTED|Overall Study||29
574512|NCT00585650|1402438|P2|NOT COMPLETED|Overall Study||0
574513|NCT00585650|1402439|P1|NOT COMPLETED|Overall Study||0
574514|NCT00585650|1402438|P2|COMPLETED|Overall Study||12
574515|NCT00585650|1402439|P1|COMPLETED|Overall Study||8
574516|NCT00585650|1402438|P2|STARTED|Overall Study||12
574517|NCT00585650|1402439|P1|STARTED|Overall Study||8
574518|NCT00585637|1402449|P4|NOT COMPLETED|6-month Time Point||6
574519|NCT00585637|1402450|P3|NOT COMPLETED|6-month Time Point||11
574520|NCT00585637|1402451|P2|NOT COMPLETED|6-month Time Point||13
574521|NCT00585637|1402452|P1|NOT COMPLETED|6-month Time Point||6
574522|NCT00585637|1402449|P4|COMPLETED|6-month Time Point||77
574523|NCT00585637|1402450|P3|COMPLETED|6-month Time Point||72
574524|NCT00585637|1402451|P2|COMPLETED|6-month Time Point||68
574525|NCT00585637|1402452|P1|COMPLETED|6-month Time Point||75
574526|NCT00585637|1402449|P4|STARTED|6-month Time Point||83
574527|NCT00585637|1402450|P3|STARTED|6-month Time Point||83
574528|NCT00585637|1402451|P2|STARTED|6-month Time Point||81
574529|NCT00585637|1402452|P1|STARTED|6-month Time Point||81
574530|NCT00585637|1402449|P4|NOT COMPLETED|3-month Time Point||5
574531|NCT00585637|1402450|P3|NOT COMPLETED|3-month Time Point||7
574532|NCT00585637|1402451|P2|NOT COMPLETED|3-month Time Point||14
574533|NCT00585637|1402452|P1|NOT COMPLETED|3-month Time Point||10
574534|NCT00585637|1402449|P4|COMPLETED|3-month Time Point||78
574535|NCT00585637|1402450|P3|COMPLETED|3-month Time Point||76
574536|NCT00585637|1402451|P2|COMPLETED|3-month Time Point||67
574537|NCT00585637|1402452|P1|COMPLETED|3-month Time Point||71
574538|NCT00585637|1402449|P4|STARTED|3-month Time Point||83
574539|NCT00585637|1402450|P3|STARTED|3-month Time Point||83
574540|NCT00585637|1402451|P2|STARTED|3-month Time Point||81
574541|NCT00585637|1402452|P1|STARTED|3-month Time Point||81
574542|NCT00585637|1402449|P4|NOT COMPLETED|Baseline||0
574543|NCT00585637|1402450|P3|NOT COMPLETED|Baseline||0
574544|NCT00585637|1402451|P2|NOT COMPLETED|Baseline||0
574545|NCT00585637|1402452|P1|NOT COMPLETED|Baseline||0
574546|NCT00585637|1402449|P4|COMPLETED|Baseline||83
574547|NCT00585637|1402450|P3|COMPLETED|Baseline||83
574548|NCT00585637|1402451|P2|COMPLETED|Baseline||81
574549|NCT00585637|1402452|P1|COMPLETED|Baseline||81
574550|NCT00585637|1402449|P4|STARTED|Baseline||83
574551|NCT00585637|1402450|P3|STARTED|Baseline||83
574552|NCT00585637|1402451|P2|STARTED|Baseline||81
574553|NCT00585637|1402452|P1|STARTED|Baseline||81
574554|NCT00585585|1402478|P1|NOT COMPLETED|Overall Study||1
574555|NCT00585585|1402478|P1|COMPLETED|Overall Study||0
574556|NCT00585585|1402478|P1|Patients Receiving Drug|Overall Study||1
574557|NCT00585585|1402478|P1|STARTED|Overall Study||1
574558|NCT00585546|1402482|P1|NOT COMPLETED|Clenbuterol Treatment - up to 12 Months||4
574559|NCT00585546|1402482|P1|COMPLETED|Clenbuterol Treatment - up to 12 Months||9
574560|NCT00585546|1402482|P1|STARTED|Clenbuterol Treatment - up to 12 Months||13
574561|NCT00585546|1402482|P1|NOT COMPLETED|LVAD Implantation Required for 4 Months||5
574562|NCT00585546|1402482|P1|COMPLETED|LVAD Implantation Required for 4 Months||13
574563|NCT00585546|1402482|P1|STARTED|LVAD Implantation Required for 4 Months||18
574564|NCT00585533|1402496|P1|NOT COMPLETED|Overall Study||9
574565|NCT00585533|1402496|P1|COMPLETED|Overall Study||31
574566|NCT00585533|1402496|P1|STARTED|Overall Study||40
574567|NCT00585494|1402501|P1|NOT COMPLETED|Overall Study||56
574568|NCT00585494|1402501|P1|COMPLETED|Overall Study||244
574569|NCT00585494|1402501|P1|STARTED|Overall Study||300
574570|NCT00585468|1402505|P2|NOT COMPLETED|Second Intervention||0
574571|NCT00585468|1402506|P1|NOT COMPLETED|Second Intervention||0
574572|NCT00585468|1402505|P2|COMPLETED|Second Intervention||10
574573|NCT00585468|1402506|P1|COMPLETED|Second Intervention||9
574574|NCT00585468|1402505|P2|STARTED|Second Intervention||10
574575|NCT00585468|1402506|P1|STARTED|Second Intervention||9
574576|NCT00585468|1402505|P2|NOT COMPLETED|First Intervention||1
574577|NCT00585468|1402506|P1|NOT COMPLETED|First Intervention||1
574578|NCT00585468|1402505|P2|COMPLETED|First Intervention||10
574579|NCT00585468|1402506|P1|COMPLETED|First Intervention||9
574580|NCT00585468|1402505|P2|STARTED|First Intervention||11
574581|NCT00585468|1402506|P1|STARTED|First Intervention||10
574582|NCT00585377|1402526|P1|NOT COMPLETED|Overall Study||0
574583|NCT00585377|1402526|P1|COMPLETED|Overall Study||50
574584|NCT00585377|1402526|P1|STARTED|Overall Study||50
574585|NCT00585351|1402538|P8|NOT COMPLETED|Enrollment Period (Intervention)||1
574586|NCT00585351|1402539|P7|NOT COMPLETED|Enrollment Period (Intervention)||2
574587|NCT00585351|1402540|P6|NOT COMPLETED|Enrollment Period (Intervention)||2
574588|NCT00585351|1402541|P5|NOT COMPLETED|Enrollment Period (Intervention)||2
574589|NCT00585351|1402542|P4|NOT COMPLETED|Enrollment Period (Intervention)||0
574590|NCT00585351|1402543|P3|NOT COMPLETED|Enrollment Period (Intervention)||0
574591|NCT00585351|1402544|P2|NOT COMPLETED|Enrollment Period (Intervention)||0
574592|NCT00585351|1402545|P1|NOT COMPLETED|Enrollment Period (Intervention)||0
574593|NCT00585351|1402538|P8|COMPLETED|Enrollment Period (Intervention)||2
574594|NCT00585351|1402539|P7|COMPLETED|Enrollment Period (Intervention)||5
574595|NCT00585351|1402540|P6|COMPLETED|Enrollment Period (Intervention)||5
574596|NCT00585351|1402541|P5|COMPLETED|Enrollment Period (Intervention)||3
574597|NCT00585351|1402542|P4|COMPLETED|Enrollment Period (Intervention)||15
574598|NCT00585351|1402543|P3|COMPLETED|Enrollment Period (Intervention)||15
574599|NCT00585351|1402544|P2|COMPLETED|Enrollment Period (Intervention)||0
574600|NCT00585351|1402545|P1|COMPLETED|Enrollment Period (Intervention)||0
574601|NCT00585351|1402538|P8|STARTED|Enrollment Period (Intervention)||3
574602|NCT00585351|1402539|P7|STARTED|Enrollment Period (Intervention)||7
574603|NCT00585351|1402540|P6|STARTED|Enrollment Period (Intervention)||7
574604|NCT00585351|1402541|P5|STARTED|Enrollment Period (Intervention)||5
574605|NCT00585351|1402542|P4|STARTED|Enrollment Period (Intervention)||15
574606|NCT00585351|1402543|P3|STARTED|Enrollment Period (Intervention)||15
574607|NCT00585351|1402544|P2|STARTED|Enrollment Period (Intervention)|"Please refer to additional columns for subjects in No Advanced Notification group for this period."|0
574608|NCT00585351|1402545|P1|STARTED|Enrollment Period (Intervention)|"Please refer to additional columns for subjects in Advanced Notification group for this period."|0
574609|NCT00585351|1402538|P8|NOT COMPLETED|Notification Period (Informed Consent)||0
574610|NCT00585351|1402539|P7|NOT COMPLETED|Notification Period (Informed Consent)||0
574611|NCT00585351|1402540|P6|NOT COMPLETED|Notification Period (Informed Consent)||0
574612|NCT00585351|1402541|P5|NOT COMPLETED|Notification Period (Informed Consent)||0
574613|NCT00585351|1402542|P4|NOT COMPLETED|Notification Period (Informed Consent)||0
574614|NCT00585351|1402543|P3|NOT COMPLETED|Notification Period (Informed Consent)||0
574615|NCT00585351|1402544|P2|NOT COMPLETED|Notification Period (Informed Consent)||25
574616|NCT00585351|1402545|P1|NOT COMPLETED|Notification Period (Informed Consent)||23
574617|NCT00585351|1402538|P8|COMPLETED|Notification Period (Informed Consent)||0
574618|NCT00585351|1402539|P7|COMPLETED|Notification Period (Informed Consent)||0
574619|NCT00585351|1402540|P6|COMPLETED|Notification Period (Informed Consent)||0
574620|NCT00585351|1402541|P5|COMPLETED|Notification Period (Informed Consent)||0
574621|NCT00585351|1402542|P4|COMPLETED|Notification Period (Informed Consent)||0
574622|NCT00585351|1402543|P3|COMPLETED|Notification Period (Informed Consent)||0
574623|NCT00585351|1402544|P2|COMPLETED|Notification Period (Informed Consent)||25
574624|NCT00585351|1402545|P1|COMPLETED|Notification Period (Informed Consent)||27
574625|NCT00585351|1402538|P8|STARTED|Notification Period (Informed Consent)||0
574626|NCT00585351|1402539|P7|STARTED|Notification Period (Informed Consent)||0
574627|NCT00585351|1402540|P6|STARTED|Notification Period (Informed Consent)||0
574628|NCT00585351|1402541|P5|STARTED|Notification Period (Informed Consent)||0
574629|NCT00585351|1402542|P4|STARTED|Notification Period (Informed Consent)||0
574630|NCT00585351|1402543|P3|STARTED|Notification Period (Informed Consent)||0
574631|NCT00585351|1402544|P2|STARTED|Notification Period (Informed Consent)||50
574632|NCT00585351|1402545|P1|STARTED|Notification Period (Informed Consent)||50
574633|NCT00585325|1402561|P2|NOT COMPLETED|Overall Study||1
574634|NCT00585325|1402562|P1|NOT COMPLETED|Overall Study||1
574635|NCT00585325|1402561|P2|COMPLETED|Overall Study||12
574636|NCT00585325|1402562|P1|COMPLETED|Overall Study||9
574637|NCT00585325|1402561|P2|STARTED|Overall Study||13
574638|NCT00585325|1402562|P1|STARTED|Overall Study||10
574639|NCT00585312|1402570|P2|NOT COMPLETED|Overall Study||44
574640|NCT00585312|1402571|P1|NOT COMPLETED|Overall Study||51
574641|NCT00585312|1402570|P2|COMPLETED|Overall Study||7
574642|NCT00585312|1402571|P1|COMPLETED|Overall Study||4
574643|NCT00585312|1402570|P2|Treated|Overall Study||48
574644|NCT00585312|1402571|P1|Treated|Overall Study||53
574645|NCT00585312|1402570|P2|STARTED|Overall Study|STARTED=Randomized|51
574646|NCT00585312|1402571|P1|STARTED|Overall Study|STARTED=Randomized|55
574647|NCT00585286|1402583|P1|NOT COMPLETED|Overall Study||1
574648|NCT00585286|1402583|P1|COMPLETED|Overall Study||14
574649|NCT00585286|1402583|P1|STARTED|Overall Study||15
574650|NCT00585247|1402592|P2|NOT COMPLETED|Overall Study||0
574651|NCT00585247|1402593|P1|NOT COMPLETED|Overall Study||0
574652|NCT00585247|1402592|P2|COMPLETED|Overall Study||13
574653|NCT00585247|1402593|P1|COMPLETED|Overall Study||14
574654|NCT00585247|1402592|P2|STARTED|Overall Study||13
574655|NCT00585247|1402593|P1|STARTED|Overall Study||14
574656|NCT00585221|1402599|P1|NOT COMPLETED|Overall Study||8
574657|NCT00585221|1402599|P1|COMPLETED|Overall Study||0
574658|NCT00585221|1402599|P1|STARTED|Overall Study||8
574659|NCT00585182|1402604|P1|NOT COMPLETED|Overall Study||0
574660|NCT00585182|1402604|P1|COMPLETED|Overall Study||28
574661|NCT00585182|1402604|P1|STARTED|Overall Study||28
574662|NCT00585169|1402609|P1|NOT COMPLETED|Overall Study||1
574663|NCT00585169|1402609|P1|COMPLETED|Overall Study||28
574664|NCT00585169|1402609|P1|STARTED|Overall Study||29
574665|NCT00585104|1402615|P1|NOT COMPLETED|Overall Study||4
574666|NCT00585104|1402615|P1|COMPLETED|Overall Study||6
574667|NCT00585104|1402615|P1|STARTED|Overall Study||10
574668|NCT00585078|1402619|P1|NOT COMPLETED|Overall Study||40
574669|NCT00585078|1402619|P1|COMPLETED|Overall Study||0
574670|NCT00585078|1402619|P1|Response Evaluable|Overall Study||24
574671|NCT00585078|1402619|P1|Toxicity Evaluable|Overall Study||36
574672|NCT00585078|1402619|P1|Treated|Overall Study||37
574673|NCT00585078|1402619|P1|STARTED|Overall Study||40
574674|NCT00585052|1402626|P1|NOT COMPLETED|Overall Study||1
574675|NCT00585052|1402626|P1|COMPLETED|Overall Study||10
574676|NCT00585052|1402626|P1|STARTED|Overall Study||11
574677|NCT00585039|1402633|P2|NOT COMPLETED|Overall Study||0
574678|NCT00585039|1402634|P1|NOT COMPLETED|Overall Study||2
574679|NCT00585039|1402633|P2|COMPLETED|Overall Study||44
574680|NCT00585039|1402634|P1|COMPLETED|Overall Study||55
574681|NCT00585039|1402633|P2|STARTED|Overall Study||44
574682|NCT00585039|1402634|P1|STARTED|Overall Study||57
574683|NCT00585013|1402644|P2|NOT COMPLETED|Overall Study||0
574684|NCT00585013|1402645|P1|NOT COMPLETED|Overall Study||0
574685|NCT00585013|1402644|P2|COMPLETED|Overall Study||8
574686|NCT00585013|1402645|P1|COMPLETED|Overall Study||8
574687|NCT00585013|1402644|P2|STARTED|Overall Study||8
574688|NCT00585013|1402645|P1|STARTED|Overall Study||8
574689|NCT00584987|1402663|P4|NOT COMPLETED|Overall Study||1
574690|NCT00584987|1402664|P3|NOT COMPLETED|Overall Study||1
574691|NCT00584987|1402665|P2|NOT COMPLETED|Overall Study||1
574692|NCT00584987|1402666|P1|NOT COMPLETED|Overall Study||1
574693|NCT00584987|1402663|P4|COMPLETED|Overall Study||15
574694|NCT00584987|1402664|P3|COMPLETED|Overall Study||16
574695|NCT00584987|1402665|P2|COMPLETED|Overall Study||15
574696|NCT00584987|1402666|P1|COMPLETED|Overall Study||14
574697|NCT00584987|1402663|P4|STARTED|Overall Study||16
574698|NCT00584987|1402664|P3|STARTED|Overall Study||17
574699|NCT00584987|1402665|P2|STARTED|Overall Study||16
574700|NCT00584987|1402666|P1|STARTED|Overall Study||15
574701|NCT00584948|1402698|P2|NOT COMPLETED|Overall Study||11
574702|NCT00584948|1402699|P1|NOT COMPLETED|Overall Study||13
574703|NCT00584948|1402698|P2|COMPLETED|Overall Study||36
574704|NCT00584948|1402699|P1|COMPLETED|Overall Study||34
574705|NCT00584948|1402698|P2|STARTED|Overall Study||47
574706|NCT00584948|1402699|P1|STARTED|Overall Study||47
574707|NCT00584935|1402707|P1|NOT COMPLETED|Overall Study||0
574708|NCT00584935|1402707|P1|COMPLETED|Overall Study||3
574709|NCT00584935|1402707|P1|STARTED|Overall Study||3
574710|NCT00584909|1402714|P1|NOT COMPLETED|Overall Study||4
574711|NCT00584909|1402714|P1|COMPLETED|Overall Study||9
574712|NCT00584909|1402714|P1|STARTED|Overall Study||13
574713|NCT00584857|1402719|P1|NOT COMPLETED|Overall Study||0
574714|NCT00584857|1402719|P1|COMPLETED|Overall Study||30
574715|NCT00584857|1402719|P1|STARTED|Overall Study||30
574716|NCT00584844|1402724|P1|NOT COMPLETED|Overall Study||79
574717|NCT00584844|1402724|P1|COMPLETED|Overall Study||405
574718|NCT00584844|1402724|P1|STARTED|Overall Study||484
574719|NCT00584831|1402734|P19|NOT COMPLETED|Intervention 4||0
574720|NCT00584831|1402735|P18|NOT COMPLETED|Intervention 4||0
574721|NCT00584831|1402736|P17|NOT COMPLETED|Intervention 4||0
574722|NCT00584831|1402737|P16|NOT COMPLETED|Intervention 4||0
574723|NCT00584831|1402738|P15|NOT COMPLETED|Intervention 4||0
574724|NCT00584831|1402739|P14|NOT COMPLETED|Intervention 4||0
574725|NCT00584831|1402740|P13|NOT COMPLETED|Intervention 4||0
574726|NCT00584831|1402741|P12|NOT COMPLETED|Intervention 4||0
574727|NCT00584831|1402742|P11|NOT COMPLETED|Intervention 4||0
574728|NCT00584831|1402743|P10|NOT COMPLETED|Intervention 4||0
574729|NCT00584831|1402744|P9|NOT COMPLETED|Intervention 4||0
574730|NCT00584831|1402745|P8|NOT COMPLETED|Intervention 4||0
574731|NCT00584831|1402746|P7|NOT COMPLETED|Intervention 4||0
574732|NCT00584831|1402747|P6|NOT COMPLETED|Intervention 4||0
574733|NCT00584831|1402748|P5|NOT COMPLETED|Intervention 4||0
574734|NCT00584831|1402749|P4|NOT COMPLETED|Intervention 4||0
574735|NCT00584831|1402750|P3|NOT COMPLETED|Intervention 4||0
574736|NCT00584831|1402751|P2|NOT COMPLETED|Intervention 4||0
574737|NCT00584831|1402752|P1|NOT COMPLETED|Intervention 4||0
574738|NCT00584831|1402734|P19|COMPLETED|Intervention 4||1
574739|NCT00584831|1402735|P18|COMPLETED|Intervention 4||1
574740|NCT00584831|1402736|P17|COMPLETED|Intervention 4||4
574741|NCT00584831|1402737|P16|COMPLETED|Intervention 4||1
574742|NCT00584831|1402738|P15|COMPLETED|Intervention 4||2
574743|NCT00584831|1402739|P14|COMPLETED|Intervention 4||1
574744|NCT00584831|1402740|P13|COMPLETED|Intervention 4||2
574745|NCT00584831|1402741|P12|COMPLETED|Intervention 4||1
574746|NCT00584831|1402742|P11|COMPLETED|Intervention 4||2
574747|NCT00584831|1402743|P10|COMPLETED|Intervention 4||2
574748|NCT00584831|1402744|P9|COMPLETED|Intervention 4||3
574749|NCT00584831|1402745|P8|COMPLETED|Intervention 4||2
574750|NCT00584831|1402746|P7|COMPLETED|Intervention 4||6
574751|NCT00584831|1402747|P6|COMPLETED|Intervention 4||1
574752|NCT00584831|1402748|P5|COMPLETED|Intervention 4||2
574753|NCT00584831|1402749|P4|COMPLETED|Intervention 4||1
574754|NCT00584831|1402750|P3|COMPLETED|Intervention 4||2
574755|NCT00584831|1402751|P2|COMPLETED|Intervention 4||3
574756|NCT00584831|1402752|P1|COMPLETED|Intervention 4||1
574757|NCT00584831|1402734|P19|STARTED|Intervention 4||1
574758|NCT00584831|1402735|P18|STARTED|Intervention 4||1
574759|NCT00584831|1402736|P17|STARTED|Intervention 4||4
574760|NCT00584831|1402737|P16|STARTED|Intervention 4||1
574761|NCT00584831|1402738|P15|STARTED|Intervention 4||2
574762|NCT00584831|1402739|P14|STARTED|Intervention 4||1
574763|NCT00584831|1402740|P13|STARTED|Intervention 4||2
574764|NCT00584831|1402741|P12|STARTED|Intervention 4||1
574765|NCT00584831|1402742|P11|STARTED|Intervention 4||2
574766|NCT00584831|1402743|P10|STARTED|Intervention 4||2
574767|NCT00584831|1402744|P9|STARTED|Intervention 4||3
574768|NCT00584831|1402745|P8|STARTED|Intervention 4||2
574769|NCT00584831|1402746|P7|STARTED|Intervention 4||6
574770|NCT00584831|1402747|P6|STARTED|Intervention 4||1
574771|NCT00584831|1402748|P5|STARTED|Intervention 4||2
574772|NCT00584831|1402749|P4|STARTED|Intervention 4||1
574773|NCT00584831|1402750|P3|STARTED|Intervention 4||2
574774|NCT00584831|1402751|P2|STARTED|Intervention 4||3
574775|NCT00584831|1402752|P1|STARTED|Intervention 4||1
574776|NCT00584831|1402734|P19|NOT COMPLETED|Intervention 3||0
574777|NCT00584831|1402735|P18|NOT COMPLETED|Intervention 3||0
574778|NCT00584831|1402736|P17|NOT COMPLETED|Intervention 3||0
574779|NCT00584831|1402737|P16|NOT COMPLETED|Intervention 3||0
574780|NCT00584831|1402738|P15|NOT COMPLETED|Intervention 3||0
574781|NCT00584831|1402739|P14|NOT COMPLETED|Intervention 3||0
574782|NCT00584831|1402740|P13|NOT COMPLETED|Intervention 3||0
574783|NCT00584831|1402741|P12|NOT COMPLETED|Intervention 3||0
574784|NCT00584831|1402742|P11|NOT COMPLETED|Intervention 3||0
574785|NCT00584831|1402743|P10|NOT COMPLETED|Intervention 3||0
574786|NCT00584831|1402744|P9|NOT COMPLETED|Intervention 3||0
574787|NCT00584831|1402745|P8|NOT COMPLETED|Intervention 3||0
574788|NCT00584831|1402746|P7|NOT COMPLETED|Intervention 3||0
574789|NCT00584831|1402747|P6|NOT COMPLETED|Intervention 3||0
574790|NCT00584831|1402748|P5|NOT COMPLETED|Intervention 3||0
574791|NCT00584831|1402749|P4|NOT COMPLETED|Intervention 3||0
574792|NCT00584831|1402750|P3|NOT COMPLETED|Intervention 3||0
574793|NCT00584831|1402751|P2|NOT COMPLETED|Intervention 3||0
574794|NCT00584831|1402752|P1|NOT COMPLETED|Intervention 3||0
574795|NCT00584831|1402734|P19|COMPLETED|Intervention 3||1
574796|NCT00584831|1402735|P18|COMPLETED|Intervention 3||1
574797|NCT00584831|1402736|P17|COMPLETED|Intervention 3||4
574798|NCT00584831|1402737|P16|COMPLETED|Intervention 3||1
574799|NCT00584831|1402738|P15|COMPLETED|Intervention 3||3
574800|NCT00584831|1402739|P14|COMPLETED|Intervention 3||1
574801|NCT00584831|1402740|P13|COMPLETED|Intervention 3||2
574802|NCT00584831|1402741|P12|COMPLETED|Intervention 3||1
574803|NCT00584831|1402742|P11|COMPLETED|Intervention 3||2
574804|NCT00584831|1402743|P10|COMPLETED|Intervention 3||2
574805|NCT00584831|1402744|P9|COMPLETED|Intervention 3||4
574806|NCT00584831|1402745|P8|COMPLETED|Intervention 3||2
574807|NCT00584831|1402746|P7|COMPLETED|Intervention 3||6
574808|NCT00584831|1402747|P6|COMPLETED|Intervention 3||1
574809|NCT00584831|1402748|P5|COMPLETED|Intervention 3||2
574810|NCT00584831|1402749|P4|COMPLETED|Intervention 3||1
574811|NCT00584831|1402750|P3|COMPLETED|Intervention 3||2
574812|NCT00584831|1402751|P2|COMPLETED|Intervention 3||3
574813|NCT00584831|1402752|P1|COMPLETED|Intervention 3||1
574814|NCT00584831|1402734|P19|STARTED|Intervention 3||1
574815|NCT00584831|1402735|P18|STARTED|Intervention 3||1
574816|NCT00584831|1402736|P17|STARTED|Intervention 3||4
574817|NCT00584831|1402737|P16|STARTED|Intervention 3||1
574818|NCT00584831|1402738|P15|STARTED|Intervention 3||3
574819|NCT00584831|1402739|P14|STARTED|Intervention 3||1
574820|NCT00584831|1402740|P13|STARTED|Intervention 3||2
574821|NCT00584831|1402741|P12|STARTED|Intervention 3||1
574822|NCT00584831|1402742|P11|STARTED|Intervention 3||2
574823|NCT00584831|1402743|P10|STARTED|Intervention 3||2
574824|NCT00584831|1402744|P9|STARTED|Intervention 3||4
574825|NCT00584831|1402745|P8|STARTED|Intervention 3||2
574826|NCT00584831|1402746|P7|STARTED|Intervention 3||6
574827|NCT00584831|1402747|P6|STARTED|Intervention 3||1
574828|NCT00584831|1402748|P5|STARTED|Intervention 3||2
574829|NCT00584831|1402749|P4|STARTED|Intervention 3||1
574830|NCT00584831|1402750|P3|STARTED|Intervention 3||2
574831|NCT00584831|1402751|P2|STARTED|Intervention 3||3
574832|NCT00584831|1402752|P1|STARTED|Intervention 3||1
574833|NCT00584831|1402734|P19|NOT COMPLETED|Intervention 2||0
574834|NCT00584831|1402735|P18|NOT COMPLETED|Intervention 2||0
574835|NCT00584831|1402736|P17|NOT COMPLETED|Intervention 2||0
574836|NCT00584831|1402737|P16|NOT COMPLETED|Intervention 2||0
574837|NCT00584831|1402738|P15|NOT COMPLETED|Intervention 2||0
574838|NCT00584831|1402739|P14|NOT COMPLETED|Intervention 2||0
574839|NCT00584831|1402740|P13|NOT COMPLETED|Intervention 2||0
574840|NCT00584831|1402741|P12|NOT COMPLETED|Intervention 2||0
574841|NCT00584831|1402742|P11|NOT COMPLETED|Intervention 2||0
574842|NCT00584831|1402743|P10|NOT COMPLETED|Intervention 2||0
574843|NCT00584831|1402744|P9|NOT COMPLETED|Intervention 2||0
574844|NCT00584831|1402745|P8|NOT COMPLETED|Intervention 2||0
574845|NCT00584831|1402746|P7|NOT COMPLETED|Intervention 2||0
574846|NCT00584831|1402747|P6|NOT COMPLETED|Intervention 2||0
574847|NCT00584831|1402748|P5|NOT COMPLETED|Intervention 2||0
574848|NCT00584831|1402749|P4|NOT COMPLETED|Intervention 2||0
574849|NCT00584831|1402750|P3|NOT COMPLETED|Intervention 2||0
574850|NCT00584831|1402751|P2|NOT COMPLETED|Intervention 2||0
574851|NCT00584831|1402752|P1|NOT COMPLETED|Intervention 2||0
574852|NCT00584831|1402734|P19|COMPLETED|Intervention 2||1
574853|NCT00584831|1402735|P18|COMPLETED|Intervention 2||1
574854|NCT00584831|1402736|P17|COMPLETED|Intervention 2||4
574855|NCT00584831|1402737|P16|COMPLETED|Intervention 2||1
574856|NCT00584831|1402738|P15|COMPLETED|Intervention 2||3
574857|NCT00584831|1402739|P14|COMPLETED|Intervention 2||1
574858|NCT00584831|1402740|P13|COMPLETED|Intervention 2||2
574859|NCT00584831|1402741|P12|COMPLETED|Intervention 2||1
574860|NCT00584831|1402742|P11|COMPLETED|Intervention 2||2
574861|NCT00584831|1402743|P10|COMPLETED|Intervention 2||2
574862|NCT00584831|1402744|P9|COMPLETED|Intervention 2||4
574863|NCT00584831|1402745|P8|COMPLETED|Intervention 2||2
574864|NCT00584831|1402746|P7|COMPLETED|Intervention 2||6
574865|NCT00584831|1402747|P6|COMPLETED|Intervention 2||1
574866|NCT00584831|1402748|P5|COMPLETED|Intervention 2||2
574867|NCT00584831|1402749|P4|COMPLETED|Intervention 2||1
574868|NCT00584831|1402750|P3|COMPLETED|Intervention 2||2
574869|NCT00584831|1402751|P2|COMPLETED|Intervention 2||3
574870|NCT00584831|1402752|P1|COMPLETED|Intervention 2||1
574871|NCT00584831|1402734|P19|STARTED|Intervention 2||1
574872|NCT00584831|1402735|P18|STARTED|Intervention 2||1
574873|NCT00584831|1402736|P17|STARTED|Intervention 2||4
574874|NCT00584831|1402737|P16|STARTED|Intervention 2||1
574875|NCT00584831|1402738|P15|STARTED|Intervention 2||3
574876|NCT00584831|1402739|P14|STARTED|Intervention 2||1
574877|NCT00584831|1402740|P13|STARTED|Intervention 2||2
574878|NCT00584831|1402741|P12|STARTED|Intervention 2||1
574879|NCT00584831|1402742|P11|STARTED|Intervention 2||2
574880|NCT00584831|1402743|P10|STARTED|Intervention 2||2
574881|NCT00584831|1402744|P9|STARTED|Intervention 2||4
574882|NCT00584831|1402745|P8|STARTED|Intervention 2||2
574883|NCT00584831|1402746|P7|STARTED|Intervention 2||6
574884|NCT00584831|1402747|P6|STARTED|Intervention 2||1
574885|NCT00584831|1402748|P5|STARTED|Intervention 2||2
574886|NCT00584831|1402749|P4|STARTED|Intervention 2||1
574887|NCT00584831|1402750|P3|STARTED|Intervention 2||2
574888|NCT00584831|1402751|P2|STARTED|Intervention 2||3
574889|NCT00584831|1402752|P1|STARTED|Intervention 2||1
574890|NCT00584831|1402734|P19|NOT COMPLETED|Intervention 1||0
574891|NCT00584831|1402735|P18|NOT COMPLETED|Intervention 1||0
574892|NCT00584831|1402736|P17|NOT COMPLETED|Intervention 1||0
574893|NCT00584831|1402737|P16|NOT COMPLETED|Intervention 1||0
574894|NCT00584831|1402738|P15|NOT COMPLETED|Intervention 1||0
574895|NCT00584831|1402739|P14|NOT COMPLETED|Intervention 1||0
574896|NCT00584831|1402740|P13|NOT COMPLETED|Intervention 1||0
574897|NCT00584831|1402741|P12|NOT COMPLETED|Intervention 1||0
574898|NCT00584831|1402742|P11|NOT COMPLETED|Intervention 1||0
574899|NCT00584831|1402743|P10|NOT COMPLETED|Intervention 1||0
574900|NCT00584831|1402744|P9|NOT COMPLETED|Intervention 1||0
574901|NCT00584831|1402745|P8|NOT COMPLETED|Intervention 1||0
574902|NCT00584831|1402746|P7|NOT COMPLETED|Intervention 1||0
574903|NCT00584831|1402747|P6|NOT COMPLETED|Intervention 1||0
574904|NCT00584831|1402748|P5|NOT COMPLETED|Intervention 1||0
574905|NCT00584831|1402749|P4|NOT COMPLETED|Intervention 1||0
574906|NCT00584831|1402750|P3|NOT COMPLETED|Intervention 1||0
574907|NCT00584831|1402751|P2|NOT COMPLETED|Intervention 1||0
574908|NCT00584831|1402752|P1|NOT COMPLETED|Intervention 1||0
574909|NCT00584831|1402734|P19|COMPLETED|Intervention 1||1
574910|NCT00584831|1402735|P18|COMPLETED|Intervention 1||1
574911|NCT00584831|1402736|P17|COMPLETED|Intervention 1||4
574912|NCT00584831|1402737|P16|COMPLETED|Intervention 1||1
574913|NCT00584831|1402738|P15|COMPLETED|Intervention 1||3
574914|NCT00584831|1402739|P14|COMPLETED|Intervention 1||1
574915|NCT00584831|1402740|P13|COMPLETED|Intervention 1||2
574916|NCT00584831|1402741|P12|COMPLETED|Intervention 1||1
574917|NCT00584831|1402742|P11|COMPLETED|Intervention 1||2
574918|NCT00584831|1402743|P10|COMPLETED|Intervention 1||2
574919|NCT00584831|1402744|P9|COMPLETED|Intervention 1||4
574920|NCT00584831|1402745|P8|COMPLETED|Intervention 1||2
574921|NCT00584831|1402746|P7|COMPLETED|Intervention 1||6
574922|NCT00584831|1402747|P6|COMPLETED|Intervention 1||1
574923|NCT00584831|1402748|P5|COMPLETED|Intervention 1||2
574924|NCT00584831|1402749|P4|COMPLETED|Intervention 1||1
574925|NCT00584831|1402750|P3|COMPLETED|Intervention 1||2
574926|NCT00584831|1402751|P2|COMPLETED|Intervention 1||3
574927|NCT00584831|1402752|P1|COMPLETED|Intervention 1||1
574928|NCT00584831|1402734|P19|STARTED|Intervention 1||1
574929|NCT00584831|1402735|P18|STARTED|Intervention 1||1
574930|NCT00584831|1402736|P17|STARTED|Intervention 1||4
574931|NCT00584831|1402737|P16|STARTED|Intervention 1||1
574932|NCT00584831|1402738|P15|STARTED|Intervention 1||3
574933|NCT00584831|1402739|P14|STARTED|Intervention 1||1
574934|NCT00584831|1402740|P13|STARTED|Intervention 1||2
574935|NCT00584831|1402741|P12|STARTED|Intervention 1||1
574936|NCT00584831|1402742|P11|STARTED|Intervention 1||2
574937|NCT00584831|1402743|P10|STARTED|Intervention 1||2
574938|NCT00584831|1402744|P9|STARTED|Intervention 1||4
574939|NCT00584831|1402745|P8|STARTED|Intervention 1||2
574940|NCT00584831|1402746|P7|STARTED|Intervention 1||6
574941|NCT00584831|1402747|P6|STARTED|Intervention 1||1
574942|NCT00584831|1402748|P5|STARTED|Intervention 1||2
574943|NCT00584831|1402749|P4|STARTED|Intervention 1||1
574944|NCT00584831|1402750|P3|STARTED|Intervention 1||2
574945|NCT00584831|1402751|P2|STARTED|Intervention 1||3
574946|NCT00584831|1402752|P1|STARTED|Intervention 1||1
574947|NCT00584740|1402776|P2|NOT COMPLETED|Overall Study||6
574948|NCT00584740|1402777|P1|NOT COMPLETED|Overall Study||12
574949|NCT00584740|1402776|P2|COMPLETED|Overall Study||14
574950|NCT00584740|1402777|P1|COMPLETED|Overall Study||27
574951|NCT00584740|1402776|P2|STARTED|Overall Study||20
574952|NCT00584740|1402777|P1|STARTED|Overall Study||39
574953|NCT00584727|1402795|P6|NOT COMPLETED|Third Intervention||2
574954|NCT00584727|1402796|P5|NOT COMPLETED|Third Intervention||4
574955|NCT00584727|1402797|P4|NOT COMPLETED|Third Intervention||0
574956|NCT00584727|1402798|P3|NOT COMPLETED|Third Intervention||1
574957|NCT00584727|1402799|P2|NOT COMPLETED|Third Intervention||0
574958|NCT00584727|1402800|P1|NOT COMPLETED|Third Intervention||0
574959|NCT00584727|1402795|P6|COMPLETED|Third Intervention||14
574960|NCT00584727|1402796|P5|COMPLETED|Third Intervention||12
574961|NCT00584727|1402797|P4|COMPLETED|Third Intervention||14
574962|NCT00584727|1402798|P3|COMPLETED|Third Intervention||14
574963|NCT00584727|1402799|P2|COMPLETED|Third Intervention||17
574964|NCT00584727|1402800|P1|COMPLETED|Third Intervention||17
574965|NCT00584727|1402795|P6|STARTED|Third Intervention||16
574966|NCT00584727|1402796|P5|STARTED|Third Intervention||16
574967|NCT00584727|1402797|P4|STARTED|Third Intervention||14
574968|NCT00584727|1402798|P3|STARTED|Third Intervention||15
574969|NCT00584727|1402799|P2|STARTED|Third Intervention||17
574970|NCT00584727|1402800|P1|STARTED|Third Intervention||17
574971|NCT00584727|1402795|P6|NOT COMPLETED|Second Intervention||0
574972|NCT00584727|1402796|P5|NOT COMPLETED|Second Intervention||0
574973|NCT00584727|1402797|P4|NOT COMPLETED|Second Intervention||0
574974|NCT00584727|1402798|P3|NOT COMPLETED|Second Intervention||0
574975|NCT00584727|1402799|P2|NOT COMPLETED|Second Intervention||0
574976|NCT00584727|1402800|P1|NOT COMPLETED|Second Intervention||0
574977|NCT00584727|1402795|P6|COMPLETED|Second Intervention||16
574978|NCT00584727|1402796|P5|COMPLETED|Second Intervention||16
574979|NCT00584727|1402797|P4|COMPLETED|Second Intervention||14
574980|NCT00584727|1402798|P3|COMPLETED|Second Intervention||15
574981|NCT00584727|1402799|P2|COMPLETED|Second Intervention||17
574982|NCT00584727|1402800|P1|COMPLETED|Second Intervention||17
574983|NCT00584727|1402795|P6|STARTED|Second Intervention||16
574984|NCT00584727|1402796|P5|STARTED|Second Intervention||16
574985|NCT00584727|1402797|P4|STARTED|Second Intervention||14
574986|NCT00584727|1402798|P3|STARTED|Second Intervention||15
574987|NCT00584727|1402799|P2|STARTED|Second Intervention||17
574988|NCT00584727|1402800|P1|STARTED|Second Intervention||17
574989|NCT00584727|1402795|P6|NOT COMPLETED|First Intervention||0
574990|NCT00584727|1402796|P5|NOT COMPLETED|First Intervention||0
574991|NCT00584727|1402797|P4|NOT COMPLETED|First Intervention||0
574992|NCT00584727|1402798|P3|NOT COMPLETED|First Intervention||1
574993|NCT00584727|1402799|P2|NOT COMPLETED|First Intervention||0
574994|NCT00584727|1402800|P1|NOT COMPLETED|First Intervention||0
574995|NCT00584727|1402795|P6|COMPLETED|First Intervention||16
574996|NCT00584727|1402796|P5|COMPLETED|First Intervention||16
574997|NCT00584727|1402797|P4|COMPLETED|First Intervention||14
574998|NCT00584727|1402798|P3|COMPLETED|First Intervention||15
574999|NCT00584727|1402799|P2|COMPLETED|First Intervention||17
575000|NCT00584727|1402800|P1|COMPLETED|First Intervention||17
575001|NCT00584727|1402795|P6|STARTED|First Intervention||16
575002|NCT00584727|1402796|P5|STARTED|First Intervention||16
575003|NCT00584727|1402797|P4|STARTED|First Intervention||14
575004|NCT00584727|1402798|P3|STARTED|First Intervention||16
575005|NCT00584727|1402799|P2|STARTED|First Intervention||17
575006|NCT00584727|1402800|P1|STARTED|First Intervention||17
575007|NCT00584701|1402824|P1|NOT COMPLETED|Follow-up||12
575008|NCT00584701|1402824|P1|COMPLETED|Follow-up||34
575009|NCT00584701|1402824|P1|STARTED|Follow-up||46
575010|NCT00584701|1402824|P1|NOT COMPLETED|Active Risperidone||3
575011|NCT00584701|1402824|P1|COMPLETED|Active Risperidone||46
575012|NCT00584701|1402824|P1|STARTED|Active Risperidone||49
575013|NCT00584558|1402829|P1|NOT COMPLETED|Overall Study||0
575014|NCT00584558|1402829|P1|COMPLETED|Overall Study||2420
575015|NCT00584558|1402829|P1|STARTED|Overall Study||2420
575016|NCT00584480|1402834|P1|NOT COMPLETED|Second 8 Weeks (40 Treatments)||0
575017|NCT00584480|1402834|P1|COMPLETED|Second 8 Weeks (40 Treatments)||10
575018|NCT00584480|1402834|P1|STARTED|Second 8 Weeks (40 Treatments)||10
575019|NCT00584480|1402834|P1|NOT COMPLETED|4-Week Break From Treatment||0
575020|NCT00584480|1402834|P1|COMPLETED|4-Week Break From Treatment||10
575021|NCT00584480|1402834|P1|STARTED|4-Week Break From Treatment||10
575022|NCT00584480|1402834|P1|NOT COMPLETED|First 8 Weeks (40 Treatments)||0
575023|NCT00584480|1402834|P1|COMPLETED|First 8 Weeks (40 Treatments)||10
575024|NCT00584480|1402834|P1|STARTED|First 8 Weeks (40 Treatments)||10
575025|NCT00584454|1402838|P1|NOT COMPLETED|Overall Study||4
575026|NCT00584454|1402838|P1|COMPLETED|Overall Study||6
575027|NCT00584454|1402838|P1|STARTED|Overall Study||10
575028|NCT00584415|1402842|P1|NOT COMPLETED|Overall Study||7
575029|NCT00584415|1402842|P1|COMPLETED|Overall Study||112
575030|NCT00584415|1402842|P1|STARTED|Overall Study|A total of 119 enrolled and 112 underwent the ablation procedure;|119
575031|NCT00584402|1402847|P1|NOT COMPLETED|Overall Study||0
575032|NCT00584402|1402847|P1|COMPLETED|Overall Study||8
575033|NCT00584402|1402847|P1|STARTED|Overall Study||8
575034|NCT00584220|1402852|P2|NOT COMPLETED|Second Period||0
575035|NCT00584220|1402853|P1|NOT COMPLETED|Second Period||0
575036|NCT00584220|1402852|P2|COMPLETED|Second Period||39
575037|NCT00584220|1402853|P1|COMPLETED|Second Period||48
575038|NCT00584220|1402852|P2|STARTED|Second Period||39
575039|NCT00584220|1402853|P1|STARTED|Second Period||48
575040|NCT00584220|1402852|P2|NOT COMPLETED|First Period||0
575041|NCT00584220|1402853|P1|NOT COMPLETED|First Period||0
575042|NCT00584220|1402852|P2|COMPLETED|First Period||39
575043|NCT00584220|1402853|P1|COMPLETED|First Period||48
575044|NCT00584220|1402852|P2|STARTED|First Period||39
575045|NCT00584220|1402853|P1|STARTED|First Period||48
575046|NCT00584194|1402861|P1|NOT COMPLETED|Overall Study||135
575047|NCT00584194|1402861|P1|COMPLETED|Overall Study||143
575048|NCT00584194|1402861|P1|STARTED|Overall Study||278
575049|NCT00584077|1402869|P1|NOT COMPLETED|Overall Study||0
575050|NCT00584077|1402869|P1|COMPLETED|Overall Study||15
575051|NCT00584077|1402869|P1|STARTED|Overall Study||15
575052|NCT00583947|1402875|P2|NOT COMPLETED|Open Label Period||0
575053|NCT00583947|1402876|P1|NOT COMPLETED|Open Label Period||0
575054|NCT00583947|1402875|P2|COMPLETED|Open Label Period||24
575055|NCT00583947|1402876|P1|COMPLETED|Open Label Period||22
575056|NCT00583947|1402875|P2|STARTED|Open Label Period|3 subjects were dosed with arformoterol 7.5 microgram in error|24
575057|NCT00583947|1402876|P1|STARTED|Open Label Period|3 subjects were dosed with arformoterol 7.5 microgram in error|22
575058|NCT00583947|1402875|P2|NOT COMPLETED|Washout||0
575059|NCT00583947|1402876|P1|NOT COMPLETED|Washout||0
575060|NCT00583947|1402875|P2|COMPLETED|Washout||24
575061|NCT00583947|1402876|P1|COMPLETED|Washout||22
575062|NCT00583947|1402875|P2|STARTED|Washout||24
575063|NCT00583947|1402876|P1|STARTED|Washout||22
575064|NCT00583947|1402875|P2|NOT COMPLETED|Cross-over Period||2
575065|NCT00583947|1402876|P1|NOT COMPLETED|Cross-over Period||5
575066|NCT00583947|1402875|P2|COMPLETED|Cross-over Period||24
575067|NCT00583947|1402876|P1|COMPLETED|Cross-over Period||22
575068|NCT00583947|1402875|P2|STARTED|Cross-over Period|Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years|26
575069|NCT00583947|1402876|P1|STARTED|Cross-over Period|Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years|27
575070|NCT00583908|1402926|P12|NOT COMPLETED|Period 4 - Fourth Intervention||0
575071|NCT00583908|1402927|P11|NOT COMPLETED|Period 4 - Fourth Intervention||0
575072|NCT00583908|1402928|P10|NOT COMPLETED|Period 4 - Fourth Intervention||0
575073|NCT00583908|1402929|P9|NOT COMPLETED|Period 4 - Fourth Intervention||0
575074|NCT00583908|1402930|P8|NOT COMPLETED|Period 4 - Fourth Intervention||0
575075|NCT00583908|1402931|P7|NOT COMPLETED|Period 4 - Fourth Intervention||0
575076|NCT00583908|1402932|P6|NOT COMPLETED|Period 4 - Fourth Intervention||0
575077|NCT00583908|1402933|P5|NOT COMPLETED|Period 4 - Fourth Intervention||0
575078|NCT00583908|1402934|P4|NOT COMPLETED|Period 4 - Fourth Intervention||0
575079|NCT00583908|1402935|P3|NOT COMPLETED|Period 4 - Fourth Intervention||0
575080|NCT00583908|1402936|P2|NOT COMPLETED|Period 4 - Fourth Intervention||0
575081|NCT00583908|1402937|P1|NOT COMPLETED|Period 4 - Fourth Intervention||0
575082|NCT00583908|1402926|P12|COMPLETED|Period 4 - Fourth Intervention||1
575083|NCT00583908|1402927|P11|COMPLETED|Period 4 - Fourth Intervention||1
575084|NCT00583908|1402928|P10|COMPLETED|Period 4 - Fourth Intervention||1
575085|NCT00583908|1402929|P9|COMPLETED|Period 4 - Fourth Intervention||1
575086|NCT00583908|1402930|P8|COMPLETED|Period 4 - Fourth Intervention||1
575087|NCT00583908|1402931|P7|COMPLETED|Period 4 - Fourth Intervention||1
575088|NCT00583908|1402932|P6|COMPLETED|Period 4 - Fourth Intervention||1
575089|NCT00583908|1402933|P5|COMPLETED|Period 4 - Fourth Intervention||2
575090|NCT00583908|1402934|P4|COMPLETED|Period 4 - Fourth Intervention||1
575091|NCT00583908|1402935|P3|COMPLETED|Period 4 - Fourth Intervention||1
575092|NCT00583908|1402936|P2|COMPLETED|Period 4 - Fourth Intervention||2
575093|NCT00583908|1402937|P1|COMPLETED|Period 4 - Fourth Intervention||1
575094|NCT00583908|1402926|P12|STARTED|Period 4 - Fourth Intervention||1
575095|NCT00583908|1402927|P11|STARTED|Period 4 - Fourth Intervention||1
575096|NCT00583908|1402928|P10|STARTED|Period 4 - Fourth Intervention||1
575097|NCT00583908|1402929|P9|STARTED|Period 4 - Fourth Intervention||1
575098|NCT00583908|1402930|P8|STARTED|Period 4 - Fourth Intervention||1
575099|NCT00583908|1402931|P7|STARTED|Period 4 - Fourth Intervention||1
575100|NCT00583908|1402932|P6|STARTED|Period 4 - Fourth Intervention||1
575101|NCT00583908|1402933|P5|STARTED|Period 4 - Fourth Intervention||2
575102|NCT00583908|1402934|P4|STARTED|Period 4 - Fourth Intervention||1
575103|NCT00583908|1402935|P3|STARTED|Period 4 - Fourth Intervention||1
575104|NCT00583908|1402936|P2|STARTED|Period 4 - Fourth Intervention||2
575105|NCT00583908|1402937|P1|STARTED|Period 4 - Fourth Intervention||1
575106|NCT00583908|1402926|P12|NOT COMPLETED|Period 3 - Third Intervention||0
575107|NCT00583908|1402927|P11|NOT COMPLETED|Period 3 - Third Intervention||0
575108|NCT00583908|1402928|P10|NOT COMPLETED|Period 3 - Third Intervention||0
575109|NCT00583908|1402929|P9|NOT COMPLETED|Period 3 - Third Intervention||0
575110|NCT00583908|1402930|P8|NOT COMPLETED|Period 3 - Third Intervention||0
575111|NCT00583908|1402931|P7|NOT COMPLETED|Period 3 - Third Intervention||0
575112|NCT00583908|1402932|P6|NOT COMPLETED|Period 3 - Third Intervention||0
575113|NCT00583908|1402933|P5|NOT COMPLETED|Period 3 - Third Intervention||0
575114|NCT00583908|1402934|P4|NOT COMPLETED|Period 3 - Third Intervention||0
575115|NCT00583908|1402935|P3|NOT COMPLETED|Period 3 - Third Intervention||0
575116|NCT00583908|1402936|P2|NOT COMPLETED|Period 3 - Third Intervention||0
575117|NCT00583908|1402937|P1|NOT COMPLETED|Period 3 - Third Intervention||0
575118|NCT00583908|1402926|P12|COMPLETED|Period 3 - Third Intervention||1
575119|NCT00583908|1402927|P11|COMPLETED|Period 3 - Third Intervention||1
575120|NCT00583908|1402928|P10|COMPLETED|Period 3 - Third Intervention||1
575121|NCT00583908|1402929|P9|COMPLETED|Period 3 - Third Intervention||1
575122|NCT00583908|1402930|P8|COMPLETED|Period 3 - Third Intervention||1
575123|NCT00583908|1402931|P7|COMPLETED|Period 3 - Third Intervention||1
575124|NCT00583908|1402932|P6|COMPLETED|Period 3 - Third Intervention||1
575125|NCT00583908|1402933|P5|COMPLETED|Period 3 - Third Intervention||2
575126|NCT00583908|1402934|P4|COMPLETED|Period 3 - Third Intervention||1
575127|NCT00583908|1402935|P3|COMPLETED|Period 3 - Third Intervention||1
575128|NCT00583908|1402936|P2|COMPLETED|Period 3 - Third Intervention||2
575129|NCT00583908|1402937|P1|COMPLETED|Period 3 - Third Intervention||1
575130|NCT00583908|1402926|P12|STARTED|Period 3 - Third Intervention||1
575131|NCT00583908|1402927|P11|STARTED|Period 3 - Third Intervention||1
575132|NCT00583908|1402928|P10|STARTED|Period 3 - Third Intervention||1
575133|NCT00583908|1402929|P9|STARTED|Period 3 - Third Intervention||1
575134|NCT00583908|1402930|P8|STARTED|Period 3 - Third Intervention||1
575135|NCT00583908|1402931|P7|STARTED|Period 3 - Third Intervention||1
575136|NCT00583908|1402932|P6|STARTED|Period 3 - Third Intervention||1
575137|NCT00583908|1402933|P5|STARTED|Period 3 - Third Intervention||2
575138|NCT00583908|1402934|P4|STARTED|Period 3 - Third Intervention||1
575139|NCT00583908|1402935|P3|STARTED|Period 3 - Third Intervention||1
575140|NCT00583908|1402936|P2|STARTED|Period 3 - Third Intervention||2
575141|NCT00583908|1402937|P1|STARTED|Period 3 - Third Intervention||1
575142|NCT00583908|1402926|P12|NOT COMPLETED|Period 2 - Second Intervention||0
575143|NCT00583908|1402927|P11|NOT COMPLETED|Period 2 - Second Intervention||0
575144|NCT00583908|1402928|P10|NOT COMPLETED|Period 2 - Second Intervention||0
575145|NCT00583908|1402929|P9|NOT COMPLETED|Period 2 - Second Intervention||0
575146|NCT00583908|1402930|P8|NOT COMPLETED|Period 2 - Second Intervention||0
575147|NCT00583908|1402931|P7|NOT COMPLETED|Period 2 - Second Intervention||0
575148|NCT00583908|1402932|P6|NOT COMPLETED|Period 2 - Second Intervention||0
575149|NCT00583908|1402933|P5|NOT COMPLETED|Period 2 - Second Intervention||0
575150|NCT00583908|1402934|P4|NOT COMPLETED|Period 2 - Second Intervention||0
575151|NCT00583908|1402935|P3|NOT COMPLETED|Period 2 - Second Intervention||0
575152|NCT00583908|1402936|P2|NOT COMPLETED|Period 2 - Second Intervention||0
575153|NCT00583908|1402937|P1|NOT COMPLETED|Period 2 - Second Intervention||0
575154|NCT00583908|1402926|P12|COMPLETED|Period 2 - Second Intervention||1
575155|NCT00583908|1402927|P11|COMPLETED|Period 2 - Second Intervention||1
575156|NCT00583908|1402928|P10|COMPLETED|Period 2 - Second Intervention||1
575157|NCT00583908|1402929|P9|COMPLETED|Period 2 - Second Intervention||1
575158|NCT00583908|1402930|P8|COMPLETED|Period 2 - Second Intervention||1
575159|NCT00583908|1402931|P7|COMPLETED|Period 2 - Second Intervention||1
575160|NCT00583908|1402932|P6|COMPLETED|Period 2 - Second Intervention||1
575161|NCT00583908|1402933|P5|COMPLETED|Period 2 - Second Intervention||2
575162|NCT00583908|1402934|P4|COMPLETED|Period 2 - Second Intervention||1
575163|NCT00583908|1402935|P3|COMPLETED|Period 2 - Second Intervention||1
575164|NCT00583908|1402936|P2|COMPLETED|Period 2 - Second Intervention||2
575165|NCT00583908|1402937|P1|COMPLETED|Period 2 - Second Intervention||1
575166|NCT00583908|1402926|P12|STARTED|Period 2 - Second Intervention||1
575167|NCT00583908|1402927|P11|STARTED|Period 2 - Second Intervention||1
575168|NCT00583908|1402928|P10|STARTED|Period 2 - Second Intervention||1
575169|NCT00583908|1402929|P9|STARTED|Period 2 - Second Intervention||1
575170|NCT00583908|1402930|P8|STARTED|Period 2 - Second Intervention||1
575171|NCT00583908|1402931|P7|STARTED|Period 2 - Second Intervention||1
575172|NCT00583908|1402932|P6|STARTED|Period 2 - Second Intervention||1
575173|NCT00583908|1402933|P5|STARTED|Period 2 - Second Intervention||2
575174|NCT00583908|1402934|P4|STARTED|Period 2 - Second Intervention||1
575175|NCT00583908|1402935|P3|STARTED|Period 2 - Second Intervention||1
575176|NCT00583908|1402936|P2|STARTED|Period 2 - Second Intervention||2
575177|NCT00583908|1402937|P1|STARTED|Period 2 - Second Intervention||1
575178|NCT00583908|1402926|P12|NOT COMPLETED|Period 1 - First Intervention||0
575179|NCT00583908|1402927|P11|NOT COMPLETED|Period 1 - First Intervention||0
575180|NCT00583908|1402928|P10|NOT COMPLETED|Period 1 - First Intervention||0
575181|NCT00583908|1402929|P9|NOT COMPLETED|Period 1 - First Intervention||0
575182|NCT00583908|1402930|P8|NOT COMPLETED|Period 1 - First Intervention||0
575183|NCT00583908|1402931|P7|NOT COMPLETED|Period 1 - First Intervention||0
575184|NCT00583908|1402932|P6|NOT COMPLETED|Period 1 - First Intervention||0
575185|NCT00583908|1402933|P5|NOT COMPLETED|Period 1 - First Intervention||0
575186|NCT00583908|1402934|P4|NOT COMPLETED|Period 1 - First Intervention||0
575187|NCT00583908|1402935|P3|NOT COMPLETED|Period 1 - First Intervention||0
575188|NCT00583908|1402936|P2|NOT COMPLETED|Period 1 - First Intervention||0
575189|NCT00583908|1402937|P1|NOT COMPLETED|Period 1 - First Intervention||0
575190|NCT00583908|1402926|P12|COMPLETED|Period 1 - First Intervention||1
575191|NCT00583908|1402927|P11|COMPLETED|Period 1 - First Intervention||1
575192|NCT00583908|1402928|P10|COMPLETED|Period 1 - First Intervention||1
575193|NCT00583908|1402929|P9|COMPLETED|Period 1 - First Intervention||1
575194|NCT00583908|1402930|P8|COMPLETED|Period 1 - First Intervention||1
575195|NCT00583908|1402931|P7|COMPLETED|Period 1 - First Intervention||1
575196|NCT00583908|1402932|P6|COMPLETED|Period 1 - First Intervention||1
575197|NCT00583908|1402933|P5|COMPLETED|Period 1 - First Intervention||2
575198|NCT00583908|1402934|P4|COMPLETED|Period 1 - First Intervention||1
575199|NCT00583908|1402935|P3|COMPLETED|Period 1 - First Intervention||1
575200|NCT00583908|1402936|P2|COMPLETED|Period 1 - First Intervention||2
575201|NCT00583908|1402937|P1|COMPLETED|Period 1 - First Intervention||1
575202|NCT00583908|1402926|P12|STARTED|Period 1 - First Intervention||1
575203|NCT00583908|1402927|P11|STARTED|Period 1 - First Intervention||1
575204|NCT00583908|1402928|P10|STARTED|Period 1 - First Intervention||1
575205|NCT00583908|1402929|P9|STARTED|Period 1 - First Intervention||1
575206|NCT00583908|1402930|P8|STARTED|Period 1 - First Intervention||1
575207|NCT00583908|1402931|P7|STARTED|Period 1 - First Intervention||1
575208|NCT00583908|1402932|P6|STARTED|Period 1 - First Intervention||1
575209|NCT00583908|1402933|P5|STARTED|Period 1 - First Intervention||2
575210|NCT00583908|1402934|P4|STARTED|Period 1 - First Intervention||1
575211|NCT00583908|1402935|P3|STARTED|Period 1 - First Intervention||1
575212|NCT00583908|1402936|P2|STARTED|Period 1 - First Intervention||2
575213|NCT00583908|1402937|P1|STARTED|Period 1 - First Intervention||1
575214|NCT00583804|1402991|P1|NOT COMPLETED|Overall Study||0
575215|NCT00583804|1402991|P1|COMPLETED|Overall Study|Subjects were considered enrolled when they underwent implantation of the device. All completed.|10
575216|NCT00583804|1402991|P1|STARTED|Overall Study||10
575217|NCT00583713|1403000|P3|NOT COMPLETED|Overall Study||0
575218|NCT00583713|1403001|P2|NOT COMPLETED|Overall Study||0
575219|NCT00583713|1403002|P1|NOT COMPLETED|Overall Study||0
575220|NCT00583713|1403000|P3|COMPLETED|Overall Study||6
575221|NCT00583713|1403001|P2|COMPLETED|Overall Study||6
575222|NCT00583713|1403002|P1|COMPLETED|Overall Study||6
575223|NCT00583713|1403000|P3|STARTED|Overall Study||6
575224|NCT00583713|1403001|P2|STARTED|Overall Study||6
575225|NCT00583713|1403002|P1|STARTED|Overall Study||6
575226|NCT00583700|1403027|P2|NOT COMPLETED|Overall Study||4
575227|NCT00583700|1403028|P1|NOT COMPLETED|Overall Study||3
575228|NCT00583700|1403027|P2|COMPLETED|Overall Study||23
575229|NCT00583700|1403028|P1|COMPLETED|Overall Study||24
575230|NCT00583700|1403027|P2|STARTED|Overall Study||27
575231|NCT00583700|1403028|P1|STARTED|Overall Study||27
575232|NCT00583661|1403036|P1|NOT COMPLETED|Overall Study||0
575233|NCT00583661|1403036|P1|COMPLETED|Overall Study||48
575234|NCT00583661|1403036|P1|STARTED|Overall Study||48
575235|NCT00583622|1403043|P1|NOT COMPLETED|Overall Study||0
575236|NCT00583622|1403043|P1|COMPLETED|Overall Study||12
575237|NCT00583622|1403043|P1|STARTED|Overall Study||12
575238|NCT00583596|1403048|P1|NOT COMPLETED|Overall Study||284
575239|NCT00583596|1403048|P1|COMPLETED|Overall Study||152
575240|NCT00583596|1403048|P1|STARTED|Overall Study|Subjects in Phase 2 clinical trial who received the AMPLATZER Duct Occluder.|436
575241|NCT00583557|1403053|P1|NOT COMPLETED|Overall Study||70
575242|NCT00583557|1403053|P1|COMPLETED|Overall Study|Completer defined as subjects whose reason for discontinuation was sponsor discontinuation of study|85
575243|NCT00583557|1403053|P1|Received at Least 1 Dose Belimumab|Overall Study||153
575244|NCT00583557|1403053|P1|STARTED|Overall Study||155
575245|NCT00583492|1403059|P2|NOT COMPLETED|Overall Study||0
575246|NCT00583492|1403060|P1|NOT COMPLETED|Overall Study||0
575247|NCT00583492|1403059|P2|COMPLETED|Overall Study||23
575248|NCT00583492|1403060|P1|COMPLETED|Overall Study||21
575249|NCT00583492|1403059|P2|STARTED|Overall Study||23
575250|NCT00583492|1403060|P1|STARTED|Overall Study||21
575251|NCT00583466|1403076|P1|NOT COMPLETED|Overall Study||0
575252|NCT00583466|1403076|P1|COMPLETED|Overall Study||18
575253|NCT00583466|1403076|P1|STARTED|Overall Study||18
575254|NCT00583453|1403084|P2|NOT COMPLETED|Overall Study||2
575255|NCT00583453|1403085|P1|NOT COMPLETED|Overall Study||0
575256|NCT00583453|1403084|P2|COMPLETED|Overall Study||6
575257|NCT00583453|1403085|P1|COMPLETED|Overall Study||9
575258|NCT00583453|1403084|P2|STARTED|Overall Study||8
575259|NCT00583453|1403085|P1|STARTED|Overall Study||9
575260|NCT00583375|1403101|P2|NOT COMPLETED|Overall Study||0
575261|NCT00583375|1403102|P1|NOT COMPLETED|Overall Study||0
575262|NCT00583375|1403101|P2|COMPLETED|Overall Study||272
575263|NCT00583375|1403102|P1|COMPLETED|Overall Study||142
575264|NCT00583375|1403101|P2|STARTED|Overall Study||272
575265|NCT00583375|1403102|P1|STARTED|Overall Study||142
575266|NCT00583362|1403118|P1|NOT COMPLETED|Overall Study||202
575267|NCT00583362|1403118|P1|COMPLETED|Overall Study||96
575268|NCT00583362|1403118|P1|STARTED|Overall Study||298
575269|NCT00583219|1403142|P1|NOT COMPLETED|Phase 2||1
575270|NCT00583219|1403142|P1|COMPLETED|Phase 2||21
575271|NCT00583219|1403142|P1|STARTED|Phase 2|6 subjects from P1 continued in P2; plus 16 new subjects. All subjects in P2 got 300 units Botox.|22
575272|NCT00583219|1403142|P1|NOT COMPLETED|Phase 1||0
575273|NCT00583219|1403142|P1|COMPLETED|Phase 1||9
575274|NCT00583219|1403142|P1|STARTED|Phase 1|First 3 subjects in Phase 1 received 200 units Botox. The remaining subjects got 300 units Botox.|9
575275|NCT00583115|1403159|P1|NOT COMPLETED|Overall Study||1
575276|NCT00583115|1403159|P1|COMPLETED|Overall Study||0
575277|NCT00583115|1403159|P1|STARTED|Overall Study||1
575278|NCT00583102|1403164|P1|NOT COMPLETED|Overall Study||3
575279|NCT00583102|1403164|P1|COMPLETED|Overall Study||20
575280|NCT00583102|1403164|P1|STARTED|Overall Study||23
575281|NCT00582972|1403168|P1|NOT COMPLETED|Overall Study||2
575282|NCT00582972|1403168|P1|COMPLETED|Overall Study||21
575283|NCT00582972|1403168|P1|STARTED|Overall Study||23
575284|NCT00582946|1403173|P1|NOT COMPLETED|Overall Study||0
575285|NCT00582946|1403173|P1|COMPLETED|Overall Study||16
575286|NCT00582946|1403173|P1|STARTED|Overall Study||16
575287|NCT00582933|1403177|P1|NOT COMPLETED|Overall Study||3
575288|NCT00582933|1403177|P1|COMPLETED|Overall Study||92
575289|NCT00582933|1403177|P1|STARTED|Overall Study||95
575290|NCT00582907|1403181|P4|NOT COMPLETED|4th Course||0
575291|NCT00582907|1403182|P3|NOT COMPLETED|4th Course||0
575292|NCT00582907|1403183|P2|NOT COMPLETED|4th Course||0
575293|NCT00582907|1403184|P1|NOT COMPLETED|4th Course||0
575294|NCT00582907|1403181|P4|COMPLETED|4th Course||3
575295|NCT00582907|1403182|P3|COMPLETED|4th Course||3
575296|NCT00582907|1403183|P2|COMPLETED|4th Course||3
575297|NCT00582907|1403184|P1|COMPLETED|4th Course||2
575298|NCT00582907|1403181|P4|STARTED|4th Course||3
575299|NCT00582907|1403182|P3|STARTED|4th Course||3
575300|NCT00582907|1403183|P2|STARTED|4th Course||3
575301|NCT00582907|1403184|P1|STARTED|4th Course||2
575302|NCT00582907|1403181|P4|NOT COMPLETED|3rd Course||0
575303|NCT00582907|1403182|P3|NOT COMPLETED|3rd Course||0
575304|NCT00582907|1403183|P2|NOT COMPLETED|3rd Course||0
575305|NCT00582907|1403184|P1|NOT COMPLETED|3rd Course||0
575306|NCT00582907|1403181|P4|COMPLETED|3rd Course||3
575307|NCT00582907|1403182|P3|COMPLETED|3rd Course||3
575308|NCT00582907|1403183|P2|COMPLETED|3rd Course||3
575309|NCT00582907|1403184|P1|COMPLETED|3rd Course||2
575310|NCT00582907|1403181|P4|STARTED|3rd Course||3
575311|NCT00582907|1403182|P3|STARTED|3rd Course||3
575312|NCT00582907|1403183|P2|STARTED|3rd Course||3
575313|NCT00582907|1403184|P1|STARTED|3rd Course||2
575314|NCT00582907|1403181|P4|NOT COMPLETED|2nd Course||0
575315|NCT00582907|1403182|P3|NOT COMPLETED|2nd Course||0
575316|NCT00582907|1403183|P2|NOT COMPLETED|2nd Course||0
575317|NCT00582907|1403184|P1|NOT COMPLETED|2nd Course||1
575318|NCT00582907|1403181|P4|COMPLETED|2nd Course||3
575319|NCT00582907|1403182|P3|COMPLETED|2nd Course||3
575320|NCT00582907|1403183|P2|COMPLETED|2nd Course||3
575321|NCT00582907|1403184|P1|COMPLETED|2nd Course||2
575322|NCT00582907|1403181|P4|STARTED|2nd Course||3
575323|NCT00582907|1403182|P3|STARTED|2nd Course||3
575324|NCT00582907|1403183|P2|STARTED|2nd Course||3
575325|NCT00582907|1403184|P1|STARTED|2nd Course||3
575326|NCT00582907|1403181|P4|NOT COMPLETED|1st Course||1
575327|NCT00582907|1403182|P3|NOT COMPLETED|1st Course||0
575328|NCT00582907|1403183|P2|NOT COMPLETED|1st Course||0
575329|NCT00582907|1403184|P1|NOT COMPLETED|1st Course||1
575330|NCT00582907|1403181|P4|COMPLETED|1st Course|Patient lost to follow-up towards end of 1st course|3
575331|NCT00582907|1403182|P3|COMPLETED|1st Course||3
575332|NCT00582907|1403183|P2|COMPLETED|1st Course||3
575333|NCT00582907|1403184|P1|COMPLETED|1st Course|1 left after 1st course (transportation issues)|3
575334|NCT00582907|1403181|P4|STARTED|1st Course||4
575335|NCT00582907|1403182|P3|STARTED|1st Course||3
575336|NCT00582907|1403183|P2|STARTED|1st Course||3
575337|NCT00582907|1403184|P1|STARTED|1st Course||4
575338|NCT00582894|1403216|P1|NOT COMPLETED|Overall Study||0
575339|NCT00582894|1403216|P1|COMPLETED|Overall Study||17
575340|NCT00582894|1403216|P1|Day 100 Post Transplant|Overall Study||17
575341|NCT00582894|1403216|P1|STARTED|Overall Study||17
575342|NCT00582816|1403223|P1|NOT COMPLETED|Overall Study||3
575343|NCT00582816|1403223|P1|COMPLETED|Overall Study|"Completed here means patients stably engrafted with donor cells."|6
575344|NCT00582816|1403223|P1|STARTED|Overall Study||9
575345|NCT00582790|1403233|P1|NOT COMPLETED|Overall Study||1
575346|NCT00582790|1403233|P1|COMPLETED|Overall Study||11
575347|NCT00582790|1403233|P1|STARTED|Overall Study|only 11 of the 12 patients received study treatment.|12
575348|NCT00582738|1403242|P2|NOT COMPLETED|Overall Study||18
575349|NCT00582738|1403243|P1|NOT COMPLETED|Overall Study||9
575350|NCT00582738|1403242|P2|COMPLETED|Overall Study||4
575351|NCT00582738|1403243|P1|COMPLETED|Overall Study||12
575352|NCT00582738|1403242|P2|STARTED|Overall Study||22
575353|NCT00582738|1403243|P1|STARTED|Overall Study||21
575354|NCT00582712|1403267|P1|NOT COMPLETED|Overall Study||4
575355|NCT00582712|1403267|P1|COMPLETED|Overall Study||1
575356|NCT00582712|1403267|P1|STARTED|Overall Study||5
575357|NCT00582660|1403273|P2|NOT COMPLETED|Overall Study||0
575358|NCT00582660|1403274|P1|NOT COMPLETED|Overall Study||0
575359|NCT00582660|1403273|P2|COMPLETED|Overall Study||20
575360|NCT00582660|1403274|P1|COMPLETED|Overall Study||20
575361|NCT00582660|1403273|P2|STARTED|Overall Study||20
575362|NCT00582660|1403274|P1|STARTED|Overall Study||20
575363|NCT00582608|1403282|P1|NOT COMPLETED|Overall Study||12
575364|NCT00582608|1403282|P1|COMPLETED|Overall Study||0
575365|NCT00582608|1403282|P1|STARTED|Overall Study||12
575366|NCT00582556|1403289|P3|NOT COMPLETED|Overall Study||2
575367|NCT00582556|1403290|P2|NOT COMPLETED|Overall Study||1
575368|NCT00582556|1403291|P1|NOT COMPLETED|Overall Study||0
575369|NCT00582556|1403289|P3|COMPLETED|Overall Study||12
575370|NCT00582556|1403290|P2|COMPLETED|Overall Study||14
575371|NCT00582556|1403291|P1|COMPLETED|Overall Study||14
575372|NCT00582556|1403289|P3|STARTED|Overall Study||14
575373|NCT00582556|1403290|P2|STARTED|Overall Study||15
575374|NCT00582556|1403291|P1|STARTED|Overall Study||14
575375|NCT00582517|1403310|P2|NOT COMPLETED|Overall Study||0
575376|NCT00582517|1403311|P1|NOT COMPLETED|Overall Study||0
575377|NCT00582517|1403310|P2|COMPLETED|Overall Study||55
575378|NCT00582517|1403311|P1|COMPLETED|Overall Study||45
575379|NCT00582517|1403310|P2|STARTED|Overall Study||55
575380|NCT00582517|1403311|P1|STARTED|Overall Study||45
575381|NCT00582491|1403319|P2|NOT COMPLETED|Overall Study||0
575382|NCT00582491|1403320|P1|NOT COMPLETED|Overall Study||1
575383|NCT00582491|1403319|P2|COMPLETED|Overall Study||10
575384|NCT00582491|1403320|P1|COMPLETED|Overall Study||10
575385|NCT00582491|1403319|P2|STARTED|Overall Study||10
575386|NCT00582491|1403320|P1|STARTED|Overall Study||11
575387|NCT00582426|1403344|P2|NOT COMPLETED|Overall Study||13
575388|NCT00582426|1403345|P1|NOT COMPLETED|Overall Study||20
575389|NCT00582426|1403344|P2|COMPLETED|Overall Study||58
575390|NCT00582426|1403345|P1|COMPLETED|Overall Study||48
575391|NCT00582426|1403344|P2|STARTED|Overall Study||71
575392|NCT00582426|1403345|P1|STARTED|Overall Study|"Patient in both arms belongs to started indicates safety and intent to treat (ITT) populations."|68
575393|NCT00582400|1403371|P1|NOT COMPLETED|Overall Study||3
575394|NCT00582400|1403371|P1|COMPLETED|Overall Study||6
575395|NCT00582400|1403371|P1|STARTED|Overall Study||9
575396|NCT00582361|1403380|P2|NOT COMPLETED|Overall Study||0
575397|NCT00582361|1403381|P1|NOT COMPLETED|Overall Study||0
575398|NCT00582361|1403380|P2|COMPLETED|Overall Study||38
575399|NCT00582361|1403381|P1|COMPLETED|Overall Study||25
575400|NCT00582361|1403380|P2|STARTED|Overall Study||38
575401|NCT00582361|1403381|P1|STARTED|Overall Study||25
575402|NCT00582309|1403392|P3|NOT COMPLETED|Overall Study||2
575403|NCT00582309|1403393|P2|NOT COMPLETED|Overall Study||0
575404|NCT00582309|1403394|P1|NOT COMPLETED|Overall Study||0
575405|NCT00582309|1403392|P3|COMPLETED|Overall Study|2 did not have enough data collected to be used|44
575406|NCT00582309|1403393|P2|COMPLETED|Overall Study||49
575407|NCT00582309|1403394|P1|COMPLETED|Overall Study||56
575408|NCT00582309|1403392|P3|STARTED|Overall Study||46
575409|NCT00582309|1403393|P2|STARTED|Overall Study||49
575410|NCT00582309|1403394|P1|STARTED|Overall Study||56
575411|NCT00582205|1403402|P1|NOT COMPLETED|Overall Study||10
575412|NCT00582205|1403402|P1|COMPLETED|Overall Study||11
575413|NCT00582205|1403402|P1|STARTED|Overall Study||21
575414|NCT00582114|1403409|P2|NOT COMPLETED|Overall Study||54
575415|NCT00582114|1403410|P1|NOT COMPLETED|Overall Study||42
575416|NCT00582114|1403409|P2|COMPLETED|Overall Study||46
575417|NCT00582114|1403410|P1|COMPLETED|Overall Study||58
575418|NCT00582114|1403409|P2|STARTED|Overall Study||100
575419|NCT00582114|1403410|P1|STARTED|Overall Study||100
575420|NCT00582075|1403418|P1|NOT COMPLETED|Overall Study||0
575421|NCT00582075|1403418|P1|COMPLETED|Overall Study||25
575422|NCT00582075|1403418|P1|STARTED|Overall Study||25
575423|NCT00582036|1403425|P2|NOT COMPLETED|Overall Study||1
575424|NCT00582036|1403426|P1|NOT COMPLETED|Overall Study||0
575425|NCT00582036|1403425|P2|COMPLETED|Overall Study|One patient withdrew consent|5
575426|NCT00582036|1403426|P1|COMPLETED|Overall Study||5
575427|NCT00582036|1403425|P2|STARTED|Overall Study||6
575428|NCT00582036|1403426|P1|STARTED|Overall Study||5
575429|NCT00582010|1403434|P2|NOT COMPLETED|Overall Study||1
575430|NCT00582010|1403435|P1|NOT COMPLETED|Overall Study||0
575431|NCT00582010|1403434|P2|COMPLETED|Overall Study||39
575432|NCT00582010|1403435|P1|COMPLETED|Overall Study||40
575433|NCT00582010|1403434|P2|STARTED|Overall Study||40
575434|NCT00582010|1403435|P1|STARTED|Overall Study||40
575435|NCT00581971|1403457|P1|NOT COMPLETED|Overall Study||0
575436|NCT00581971|1403457|P1|COMPLETED|Overall Study||30
575437|NCT00581971|1403457|P1|STARTED|Overall Study||30
575438|NCT00581945|1403464|P2|NOT COMPLETED|Overall Study||10
575439|NCT00581945|1403465|P1|NOT COMPLETED|Overall Study||9
575440|NCT00581945|1403464|P2|COMPLETED|Overall Study||63
575441|NCT00581945|1403465|P1|COMPLETED|Overall Study||65
575442|NCT00581945|1403464|P2|STARTED|Overall Study||73
575443|NCT00581945|1403465|P1|STARTED|Overall Study||74
575444|NCT00581919|1403481|P1|NOT COMPLETED|Overall Study||24
575445|NCT00581919|1403481|P1|COMPLETED|Overall Study||8
575446|NCT00581919|1403481|P1|STARTED|Overall Study||32
575447|NCT00581867|1403487|P2|NOT COMPLETED|Second Intervention||0
575448|NCT00581867|1403488|P1|NOT COMPLETED|Second Intervention||0
575449|NCT00581867|1403487|P2|COMPLETED|Second Intervention||14
575450|NCT00581867|1403488|P1|COMPLETED|Second Intervention||15
575451|NCT00581867|1403487|P2|STARTED|Second Intervention|1 individual completed period 1 (Intranasal Insulin) but did not complete period 2 (Placebo).|14
575452|NCT00581867|1403488|P1|STARTED|Second Intervention|n=1 completed period 1 (placebo) but not period 2 (insulin). This individuals died between periods.|15
575453|NCT00581867|1403487|P2|NOT COMPLETED|First Intervention||0
575454|NCT00581867|1403488|P1|NOT COMPLETED|First Intervention||0
575455|NCT00581867|1403487|P2|COMPLETED|First Intervention||15
575456|NCT00581867|1403488|P1|COMPLETED|First Intervention||16
575457|NCT00581867|1403487|P2|STARTED|First Intervention||15
575458|NCT00581867|1403488|P1|STARTED|First Intervention||16
575459|NCT00581854|1403496|P1|NOT COMPLETED|Overall Study||0
575460|NCT00581854|1403496|P1|COMPLETED|Overall Study||22
575461|NCT00581854|1403496|P1|STARTED|Overall Study||22
575462|NCT00581828|1403500|P1|NOT COMPLETED|Overall Study||1
575463|NCT00581828|1403500|P1|COMPLETED|Overall Study||18
575464|NCT00581828|1403500|P1|STARTED|Overall Study||19
575465|NCT00581776|1403504|P1|NOT COMPLETED|Overall Study||3
575466|NCT00581776|1403504|P1|COMPLETED|Overall Study|3 subjects did not complete the planned induction chemotherapy.|27
575467|NCT00581776|1403504|P1|STARTED|Overall Study||30
575468|NCT00581581|1403513|P2|NOT COMPLETED|Overall Study||0
575469|NCT00581581|1403514|P1|NOT COMPLETED|Overall Study||0
575470|NCT00581581|1403513|P2|COMPLETED|Overall Study||30
575471|NCT00581581|1403514|P1|COMPLETED|Overall Study||32
575472|NCT00581581|1403513|P2|STARTED|Overall Study||30
575473|NCT00581581|1403514|P1|STARTED|Overall Study||32
575474|NCT00581555|1403522|P2|NOT COMPLETED|Overall Study||20
575475|NCT00581555|1403523|P1|NOT COMPLETED|Overall Study||43
575476|NCT00581555|1403522|P2|COMPLETED|Overall Study||38
575477|NCT00581555|1403523|P1|COMPLETED|Overall Study||19
575478|NCT00581555|1403522|P2|STARTED|Overall Study||58
575479|NCT00581555|1403523|P1|STARTED|Overall Study||62
575480|NCT00581542|1403547|P2|NOT COMPLETED|Overall Study||23
575481|NCT00581542|1403548|P1|NOT COMPLETED|Overall Study||11
575482|NCT00581542|1403547|P2|COMPLETED|Overall Study||39
575483|NCT00581542|1403548|P1|COMPLETED|Overall Study||51
575484|NCT00581542|1403547|P2|STARTED|Overall Study||62
575485|NCT00581542|1403548|P1|STARTED|Overall Study||62
575486|NCT00581529|1403556|P1|NOT COMPLETED|Overall Study||0
575487|NCT00581529|1403556|P1|COMPLETED|Overall Study||34
575488|NCT00581529|1403556|P1|STARTED|Overall Study||34
575489|NCT00581399|1403565|P2|NOT COMPLETED|Overall Study||0
575490|NCT00581399|1403566|P1|NOT COMPLETED|Overall Study||0
575491|NCT00581399|1403565|P2|COMPLETED|Overall Study||48
575492|NCT00581399|1403566|P1|COMPLETED|Overall Study||46
575493|NCT00581399|1403565|P2|STARTED|Overall Study||48
575494|NCT00581399|1403566|P1|STARTED|Overall Study||46
575495|NCT00581386|1403577|P3|NOT COMPLETED|Overall Study||0
575496|NCT00581386|1403578|P2|NOT COMPLETED|Overall Study||0
575497|NCT00581386|1403579|P1|NOT COMPLETED|Overall Study||0
575498|NCT00581386|1403577|P3|COMPLETED|Overall Study|04/15/2009|72
575499|NCT00581386|1403578|P2|COMPLETED|Overall Study|04/15/2009|73
575500|NCT00581386|1403579|P1|COMPLETED|Overall Study|04/15/2009|73
575501|NCT00581386|1403577|P3|STARTED|Overall Study|05/30/2007|72
575502|NCT00581386|1403578|P2|STARTED|Overall Study|05/30/2007|73
575503|NCT00581386|1403579|P1|STARTED|Overall Study|05/30/2007|73
575504|NCT00581360|1403602|P1|NOT COMPLETED|Overall Study||1
575505|NCT00581360|1403602|P1|COMPLETED|Overall Study||9
575506|NCT00581360|1403602|P1|STARTED|Overall Study||10
575507|NCT00581347|1403612|P2|NOT COMPLETED|Overall Study||0
575508|NCT00581347|1403613|P1|NOT COMPLETED|Overall Study||0
575509|NCT00581347|1403612|P2|COMPLETED|Overall Study||3707
575510|NCT00581347|1403613|P1|COMPLETED|Overall Study||3839
575511|NCT00581347|1403612|P2|STARTED|Overall Study||3707
575512|NCT00581347|1403613|P1|STARTED|Overall Study||3839
575513|NCT00581308|1403621|P1|NOT COMPLETED|60 Months||3
575514|NCT00581308|1403621|P1|COMPLETED|60 Months||158
575515|NCT00581308|1403621|P1|STARTED|60 Months||161
575516|NCT00581308|1403621|P1|NOT COMPLETED|48 Months||9
575517|NCT00581308|1403621|P1|COMPLETED|48 Months||161
575518|NCT00581308|1403621|P1|STARTED|48 Months||170
575519|NCT00581308|1403621|P1|NOT COMPLETED|36 Months||6
575520|NCT00581308|1403621|P1|COMPLETED|36 Months||170
575521|NCT00581308|1403621|P1|STARTED|36 Months||176
575522|NCT00581308|1403621|P1|NOT COMPLETED|24 Months||6
575523|NCT00581308|1403621|P1|COMPLETED|24 Months||176
575524|NCT00581308|1403621|P1|STARTED|24 Months||182
575525|NCT00581308|1403621|P1|NOT COMPLETED|Month 12||20
575526|NCT00581308|1403621|P1|COMPLETED|Month 12||182
575527|NCT00581308|1403621|P1|STARTED|Month 12||202
575528|NCT00581308|1403621|P1|NOT COMPLETED|Month 6||3
575529|NCT00581308|1403621|P1|COMPLETED|Month 6||202
575530|NCT00581308|1403621|P1|STARTED|Month 6||205
575531|NCT00581308|1403621|P1|NOT COMPLETED|Month 1||8
575532|NCT00581308|1403621|P1|COMPLETED|Month 1||205
575533|NCT00581308|1403621|P1|STARTED|Month 1||213
575534|NCT00581308|1403621|P1|NOT COMPLETED|Pre Discharge||2
575535|NCT00581308|1403621|P1|COMPLETED|Pre Discharge||213
575536|NCT00581308|1403621|P1|STARTED|Pre Discharge||215
575537|NCT00581256|1403630|P2|NOT COMPLETED|Overall Study||0
575538|NCT00581256|1403631|P1|NOT COMPLETED|Overall Study||0
575539|NCT00581256|1403630|P2|COMPLETED|Overall Study||26
575540|NCT00581256|1403631|P1|COMPLETED|Overall Study||28
575541|NCT00581256|1403630|P2|STARTED|Overall Study||26
575542|NCT00581256|1403631|P1|STARTED|Overall Study||28
575543|NCT00581230|1403643|P1|NOT COMPLETED|Overall Study||0
575544|NCT00581230|1403643|P1|COMPLETED|Overall Study||51
575545|NCT00581230|1403643|P1|Laryngoscopy With RAMP|Overall Study||51
575546|NCT00581230|1403643|P1|Laryngoscopy Without RAMP|Overall Study||51
575547|NCT00581230|1403643|P1|STARTED|Overall Study||51
575548|NCT00581113|1403652|P2|NOT COMPLETED|Overall Study||1
575549|NCT00581113|1403653|P1|NOT COMPLETED|Overall Study||0
575550|NCT00581113|1403652|P2|COMPLETED|Overall Study||3
575551|NCT00581113|1403653|P1|COMPLETED|Overall Study||4
575552|NCT00581113|1403652|P2|STARTED|Overall Study||4
575553|NCT00581113|1403653|P1|STARTED|Overall Study||4
575554|NCT00581100|1403663|P2|NOT COMPLETED|Overall Study||5
575555|NCT00581100|1403664|P1|NOT COMPLETED|Overall Study||7
575556|NCT00581100|1403663|P2|COMPLETED|Overall Study||29
575557|NCT00581100|1403664|P1|COMPLETED|Overall Study||31
575558|NCT00581100|1403663|P2|Modified Intent-To-Treat Population|Overall Study|At least one dose of study medication, and had baseline and post-baseline data.|33
575559|NCT00581100|1403664|P1|Modified Intent-To-Treat Population|Overall Study|At least one dose of study medication, and had baseline and post-baseline data.|36
575560|NCT00581100|1403663|P2|STARTED|Overall Study||34
575561|NCT00581100|1403664|P1|STARTED|Overall Study||38
575562|NCT00581061|1403700|P1|NOT COMPLETED|Overall Study||0
575563|NCT00581061|1403700|P1|COMPLETED|Overall Study||13
575564|NCT00581061|1403700|P1|STARTED|Overall Study||13
575565|NCT00581048|1403706|P1|NOT COMPLETED|Overall Study||0
575566|NCT00581048|1403706|P1|COMPLETED|Overall Study||33
575567|NCT00581048|1403706|P1|STARTED|Overall Study||33
575568|NCT00580983|1403717|P1|NOT COMPLETED|Overall Study||7
575569|NCT00580983|1403717|P1|COMPLETED|Overall Study||73
575570|NCT00580983|1403717|P1|STARTED|Overall Study||80
575571|NCT00580970|1403724|P1|NOT COMPLETED|Treatment (Lovastatin)||19
575572|NCT00580970|1403724|P1|COMPLETED|Treatment (Lovastatin)||53
575573|NCT00580970|1403724|P1|6 Months of Treatment|Treatment (Lovastatin)|Subjects evaluable for analysis|53
575574|NCT00580970|1403724|P1|STARTED|Treatment (Lovastatin)||72
575575|NCT00580970|1403724|P1|NOT COMPLETED|Pre-treatment||1
575576|NCT00580970|1403724|P1|COMPLETED|Pre-treatment||72
575577|NCT00580970|1403724|P1|STARTED|Pre-treatment||73
575578|NCT00580957|1403730|P2|NOT COMPLETED|Overall Study||7
575579|NCT00580957|1403731|P1|NOT COMPLETED|Overall Study||7
575580|NCT00580957|1403730|P2|COMPLETED|Overall Study||21
575581|NCT00580957|1403731|P1|COMPLETED|Overall Study||21
575582|NCT00580957|1403730|P2|STARTED|Overall Study||28
575583|NCT00580957|1403731|P1|STARTED|Overall Study||28
575584|NCT00580866|1403739|P2|NOT COMPLETED|Overall Study||2
575585|NCT00580866|1403740|P1|NOT COMPLETED|Overall Study||2
575586|NCT00580866|1403739|P2|COMPLETED|Overall Study||5
575587|NCT00580866|1403740|P1|COMPLETED|Overall Study||8
575588|NCT00580866|1403739|P2|STARTED|Overall Study||7
575589|NCT00580866|1403740|P1|STARTED|Overall Study||10
575590|NCT00580853|1403751|P3|NOT COMPLETED|Overall Study||0
575591|NCT00580853|1403752|P2|NOT COMPLETED|Overall Study||0
575592|NCT00580853|1403753|P1|NOT COMPLETED|Overall Study||0
575593|NCT00580853|1403751|P3|COMPLETED|Overall Study||21
575594|NCT00580853|1403752|P2|COMPLETED|Overall Study||21
575595|NCT00580853|1403753|P1|COMPLETED|Overall Study||20
575596|NCT00580853|1403751|P3|STARTED|Overall Study||21
575597|NCT00580853|1403752|P2|STARTED|Overall Study||21
575598|NCT00580853|1403753|P1|STARTED|Overall Study||20
575599|NCT00580840|1403764|P4|NOT COMPLETED|Double-Blind||15
575600|NCT00580840|1403765|P3|NOT COMPLETED|Double-Blind||9
575601|NCT00580840|1403766|P2|NOT COMPLETED|Double-Blind||7
575602|NCT00580840|1403767|P1|NOT COMPLETED|Double-Blind||0
575603|NCT00580840|1403764|P4|COMPLETED|Double-Blind||54
575604|NCT00580840|1403765|P3|COMPLETED|Double-Blind||61
575605|NCT00580840|1403766|P2|COMPLETED|Double-Blind||63
575606|NCT00580840|1403767|P1|COMPLETED|Double-Blind||0
575607|NCT00580840|1403764|P4|STARTED|Double-Blind||69
575608|NCT00580840|1403765|P3|STARTED|Double-Blind||70
575609|NCT00580840|1403766|P2|STARTED|Double-Blind||70
575610|NCT00580840|1403767|P1|STARTED|Double-Blind||0
575611|NCT00580840|1403764|P4|NOT COMPLETED|Run-in||0
575612|NCT00580840|1403765|P3|NOT COMPLETED|Run-in||0
575613|NCT00580840|1403766|P2|NOT COMPLETED|Run-in||0
575614|NCT00580840|1403767|P1|NOT COMPLETED|Run-in||124
575615|NCT00580840|1403764|P4|COMPLETED|Run-in||0
575616|NCT00580840|1403765|P3|COMPLETED|Run-in||0
575617|NCT00580840|1403766|P2|COMPLETED|Run-in||0
575618|NCT00580840|1403767|P1|COMPLETED|Run-in|Of the 209 randomized participants, 208 are in the Full Analysis Set (FAS).|209
575619|NCT00580840|1403764|P4|STARTED|Run-in||0
575620|NCT00580840|1403765|P3|STARTED|Run-in||0
575621|NCT00580840|1403766|P2|STARTED|Run-in||0
575622|NCT00580840|1403767|P1|STARTED|Run-in|620 subjects were screened for the study with 333 being enrolled.|333
575623|NCT00580801|1403875|P3|NOT COMPLETED|Overall Study||3
575624|NCT00580801|1403876|P2|NOT COMPLETED|Overall Study||1
575625|NCT00580801|1403877|P1|NOT COMPLETED|Overall Study||6
575626|NCT00580801|1403875|P3|COMPLETED|Overall Study||5
575627|NCT00580801|1403876|P2|COMPLETED|Overall Study||7
575628|NCT00580801|1403877|P1|COMPLETED|Overall Study||2
575629|NCT00580801|1403875|P3|STARTED|Overall Study||8
575630|NCT00580801|1403876|P2|STARTED|Overall Study||8
575631|NCT00580801|1403877|P1|STARTED|Overall Study||8
575632|NCT00580788|1403916|P4|NOT COMPLETED|Overall Study||1
575633|NCT00580788|1403917|P3|NOT COMPLETED|Overall Study||0
575634|NCT00580788|1403918|P2|NOT COMPLETED|Overall Study||0
575635|NCT00580788|1403919|P1|NOT COMPLETED|Overall Study||0
575636|NCT00580788|1403916|P4|COMPLETED|Overall Study|One subject was stopped early for hypertension. One subject completed but was not analyzed.|1
575637|NCT00580788|1403917|P3|COMPLETED|Overall Study||3
575638|NCT00580788|1403918|P2|COMPLETED|Overall Study||6
575639|NCT00580788|1403919|P1|COMPLETED|Overall Study||3
575640|NCT00580788|1403916|P4|STARTED|Overall Study||2
575641|NCT00580788|1403917|P3|STARTED|Overall Study||3
575642|NCT00580788|1403918|P2|STARTED|Overall Study||6
575643|NCT00580788|1403919|P1|STARTED|Overall Study||3
575644|NCT00580723|1403977|P1|NOT COMPLETED|Overall Study||8
575645|NCT00580723|1403977|P1|COMPLETED|Overall Study||16
575646|NCT00580723|1403977|P1|STARTED|Overall Study||24
575647|NCT00580671|1403986|P3|NOT COMPLETED|Overall Study||17
575648|NCT00580671|1403987|P2|NOT COMPLETED|Overall Study||16
575649|NCT00580671|1403988|P1|NOT COMPLETED|Overall Study||16
575650|NCT00580671|1403986|P3|COMPLETED|Overall Study||34
575651|NCT00580671|1403987|P2|COMPLETED|Overall Study||35
575652|NCT00580671|1403988|P1|COMPLETED|Overall Study||35
575653|NCT00580671|1403986|P3|STARTED|Overall Study||51
575654|NCT00580671|1403987|P2|STARTED|Overall Study||51
575655|NCT00580671|1403988|P1|STARTED|Overall Study||51
575656|NCT00580645|1404005|P3|NOT COMPLETED|Overall Study||0
575657|NCT00580645|1404006|P2|NOT COMPLETED|Overall Study||0
575658|NCT00580645|1404007|P1|NOT COMPLETED|Overall Study||0
575659|NCT00580645|1404005|P3|COMPLETED|Overall Study||20
575660|NCT00580645|1404006|P2|COMPLETED|Overall Study||20
575661|NCT00580645|1404007|P1|COMPLETED|Overall Study||20
575662|NCT00580645|1404005|P3|STARTED|Overall Study||20
575663|NCT00580645|1404006|P2|STARTED|Overall Study||20
575664|NCT00580645|1404007|P1|STARTED|Overall Study||20
575665|NCT00580606|1404020|P2|NOT COMPLETED|Open Label (OL)||12
575666|NCT00580606|1404021|P1|NOT COMPLETED|Open Label (OL)||9
575667|NCT00580606|1404020|P2|COMPLETED|Open Label (OL)|Completed dosing & final Wk 164 desensitization OFC & Wk 172 tolerance OFC (if passed Wk 164 OFC).|5
575668|NCT00580606|1404021|P1|COMPLETED|Open Label (OL)|Completed dosing & final Wk 164 desensitization OFC & Wk 172 tolerance OFC (if passed Wk 164 OFC).|9
575669|NCT00580606|1404020|P2|Had Week 172 Oral Food Challenge|Open Label (OL)||2
575670|NCT00580606|1404021|P1|Had Week 172 Oral Food Challenge|Open Label (OL)||2
575671|NCT00580606|1404020|P2|Had Week 164 Oral Food Challenge|Open Label (OL)||5
575672|NCT00580606|1404021|P1|Had Week 164 Oral Food Challenge|Open Label (OL)||9
575673|NCT00580606|1404020|P2|Had Week 116 Oral Food Challenge|Open Label (OL)||6
575674|NCT00580606|1404021|P1|Had Week 116 Oral Food Challenge|Open Label (OL)||13
575675|NCT00580606|1404020|P2|Had Week 68 Oral Food Challenge|Open Label (OL)||12
575676|NCT00580606|1404021|P1|Had Week 68 Oral Food Challenge|Open Label (OL)||15
575677|NCT00580606|1404020|P2|Had Week 44 Oral Food Challenge|Open Label (OL)|After 44 weeks of OL high dose SLIT; 1 additional participant declined Week 44 OFC in OL period.|12
575678|NCT00580606|1404021|P1|Had Week 44 Oral Food Challenge|Open Label (OL)|The Week 44 OFC for Low Dose Peanut SLIT was done at the end of the DB Period, not the OL period.|0
575679|NCT00580606|1404020|P2|STARTED|Open Label (OL)|1 participant discontinued dosing before OL period; 2 passed Week 44 OFC & ineligible to crossover.|17
575680|NCT00580606|1404021|P1|STARTED|Open Label (OL)|2 participants discontinued dosing before Open Label (OL) period.|18
575681|NCT00580606|1404020|P2|NOT COMPLETED|Double Blind (DB)||0
575682|NCT00580606|1404021|P1|NOT COMPLETED|Double Blind (DB)||0
575683|NCT00580606|1404020|P2|COMPLETED|Double Blind (DB)|Completed: Participants who were assessed for the primary outcome measure.|20
575684|NCT00580606|1404021|P1|COMPLETED|Double Blind (DB)|Completed: Participants who were assessed for the primary outcome measure.|20
575685|NCT00580606|1404020|P2|Had Week 44 Oral Food Challenge|Double Blind (DB)||19
575686|NCT00580606|1404021|P1|Had Week 44 Oral Food Challenge|Double Blind (DB)||18
575687|NCT00580606|1404020|P2|STARTED|Double Blind (DB)||20
575688|NCT00580606|1404021|P1|STARTED|Double Blind (DB)||20
575689|NCT00580502|1404039|P1|NOT COMPLETED|Overall Study||0
575690|NCT00580502|1404039|P1|COMPLETED|Overall Study||50
575691|NCT00580502|1404039|P1|STARTED|Overall Study||50
575692|NCT00580398|1404048|P2|NOT COMPLETED|Overall Study||0
575693|NCT00580398|1404049|P1|NOT COMPLETED|Overall Study||0
575694|NCT00580398|1404048|P2|COMPLETED|Overall Study||32
575695|NCT00580398|1404049|P1|COMPLETED|Overall Study||17
575696|NCT00580398|1404048|P2|STARTED|Overall Study||32
575697|NCT00580398|1404049|P1|STARTED|Overall Study||17
575698|NCT00580372|1404057|P1|NOT COMPLETED|Overall Study||0
575699|NCT00580372|1404057|P1|COMPLETED|Overall Study||231
575700|NCT00580372|1404057|P1|STARTED|Overall Study||231
575701|NCT00580333|1404061|P1|NOT COMPLETED|Overall Study||0
575702|NCT00580333|1404061|P1|COMPLETED|Overall Study||51
575703|NCT00580333|1404061|P1|STARTED|Overall Study||51
575704|NCT00580294|1404068|P1|NOT COMPLETED|Overall Study||0
575705|NCT00580294|1404068|P1|COMPLETED|Overall Study||12
575706|NCT00580294|1404068|P1|STARTED|Overall Study||12
575707|NCT00580229|1404072|P1|NOT COMPLETED|Overall Study||0
575708|NCT00580229|1404072|P1|COMPLETED|Overall Study||50
575709|NCT00580229|1404072|P1|STARTED|Overall Study||50
575710|NCT00580151|1404078|P2|NOT COMPLETED|Overall Study||0
575711|NCT00580151|1404079|P1|NOT COMPLETED|Overall Study||0
575712|NCT00580151|1404078|P2|COMPLETED|Overall Study||0
575713|NCT00580151|1404079|P1|COMPLETED|Overall Study||9
575714|NCT00580151|1404078|P2|STARTED|Overall Study||0
575715|NCT00580151|1404079|P1|STARTED|Overall Study||9
575716|NCT00580138|1404087|P1|NOT COMPLETED|Overall Study||0
575717|NCT00580138|1404087|P1|COMPLETED|Overall Study||30
575718|NCT00580138|1404087|P1|STARTED|Overall Study||30
575719|NCT00580073|1404091|P1|NOT COMPLETED|Overall Study||0
575720|NCT00580073|1404091|P1|COMPLETED|Overall Study||6
575721|NCT00580073|1404091|P1|STARTED|Overall Study||6
575722|NCT00580047|1404100|P3|NOT COMPLETED|Overall Study||2
575723|NCT00580047|1404101|P2|NOT COMPLETED|Overall Study||2
575724|NCT00580047|1404102|P1|NOT COMPLETED|Overall Study||3
575725|NCT00580047|1404100|P3|COMPLETED|Overall Study||10
575726|NCT00580047|1404101|P2|COMPLETED|Overall Study||21
575727|NCT00580047|1404102|P1|COMPLETED|Overall Study||21
575728|NCT00580047|1404100|P3|STARTED|Overall Study||12
575729|NCT00580047|1404101|P2|STARTED|Overall Study||23
575730|NCT00580047|1404102|P1|STARTED|Overall Study||24
575731|NCT00580034|1404113|P2|NOT COMPLETED|Overall Study||0
575732|NCT00580034|1404114|P1|NOT COMPLETED|Overall Study||10
575733|NCT00580034|1404113|P2|COMPLETED|Overall Study||88
575734|NCT00580034|1404114|P1|COMPLETED|Overall Study||78
575735|NCT00580034|1404113|P2|STARTED|Overall Study||88
575736|NCT00580034|1404114|P1|STARTED|Overall Study||88
575737|NCT00579982|1404120|P1|NOT COMPLETED|Overall Study||8
575738|NCT00579982|1404120|P1|COMPLETED|Overall Study||89
575739|NCT00579982|1404120|P1|STARTED|Overall Study||97
575740|NCT00579826|1404141|P2|NOT COMPLETED|Overall Study||3
575741|NCT00579826|1404142|P1|NOT COMPLETED|Overall Study||5
575742|NCT00579826|1404141|P2|COMPLETED|Overall Study|Optional open label letrozole months 6-12; followed by RPFNA,|23
575743|NCT00579826|1404142|P1|COMPLETED|Overall Study|Optional open label letrozole months 6-12; followed by RPFNA,|24
575744|NCT00579826|1404141|P2|6 Months|Overall Study|RPFNA for assessment for primary endpoint.|25
575745|NCT00579826|1404142|P1|6 Months|Overall Study|RPFNA for assessment for primary endpoint.|28
575746|NCT00579826|1404141|P2|STARTED|Overall Study||26
575747|NCT00579826|1404142|P1|STARTED|Overall Study||29
575748|NCT00579813|1404154|P2|NOT COMPLETED|Overall Study||0
575749|NCT00579813|1404155|P1|NOT COMPLETED|Overall Study||0
575750|NCT00579813|1404154|P2|COMPLETED|Overall Study||10
575751|NCT00579813|1404155|P1|COMPLETED|Overall Study||60
575752|NCT00579813|1404154|P2|STARTED|Overall Study||10
575753|NCT00579813|1404155|P1|STARTED|Overall Study||60
575754|NCT00579670|1404176|P5|NOT COMPLETED|Overall Study||0
575755|NCT00579670|1404177|P4|NOT COMPLETED|Overall Study||22
575756|NCT00579670|1404178|P3|NOT COMPLETED|Overall Study||4
575757|NCT00579670|1404179|P2|NOT COMPLETED|Overall Study||1
575758|NCT00579670|1404180|P1|NOT COMPLETED|Overall Study||2
575759|NCT00579670|1404176|P5|COMPLETED|Overall Study||5
575760|NCT00579670|1404177|P4|COMPLETED|Overall Study||263
575761|NCT00579670|1404178|P3|COMPLETED|Overall Study||84
575762|NCT00579670|1404179|P2|COMPLETED|Overall Study||56
575763|NCT00579670|1404180|P1|COMPLETED|Overall Study||13
575764|NCT00579670|1404176|P5|Population: Within SmPC (Completed)|Overall Study||0
575765|NCT00579670|1404177|P4|Population: Within SmPC (Completed)|Overall Study|DC: AE N=2; Lack of efficacy N=5; LTFU N=3; Other unspecified N=2|147
575766|NCT00579670|1404178|P3|Population: Within SmPC (Completed)|Overall Study|DC: AE N=1; Lack of efficacy N=1; Other unspecified N=1; Withdrawal by subject N=1|79
575767|NCT00579670|1404179|P2|Population: Within SmPC (Completed)|Overall Study|DC: Lost to follow-up (LTFU) N=1|55
575768|NCT00579670|1404180|P1|Population: Within SmPC (Completed)|Overall Study|Not Completed (DC): Subject died N=1; Adverse Event (AE) N=1|13
575769|NCT00579670|1404176|P5|Population: Within SmPC (Started)|Overall Study|"Ziprasidone Unknown reporting group is not applicable to the Within SmPC population"|0
575770|NCT00579670|1404177|P4|Population: Within SmPC (Started)|Overall Study||159
575771|NCT00579670|1404178|P3|Population: Within SmPC (Started)|Overall Study||83
575772|NCT00579670|1404179|P2|Population: Within SmPC (Started)|Overall Study||56
575773|NCT00579670|1404180|P1|Population: Within SmPC (Started)|Overall Study|"Within summary of product characteristics (SmPC): FAS subjects who received all doses Within SmPC"|15
575774|NCT00579670|1404176|P5|STARTED|Overall Study||5
575775|NCT00579670|1404177|P4|STARTED|Overall Study||285
575776|NCT00579670|1404178|P3|STARTED|Overall Study||88
575777|NCT00579670|1404179|P2|STARTED|Overall Study||57
575778|NCT00579670|1404180|P1|STARTED|Overall Study|Full Analysis Set (FAS): at least 1 dose study medication and at least 1 efficacy measurement|15
575779|NCT00579501|1404392|P1|NOT COMPLETED|Overall Study||29
575780|NCT00579501|1404392|P1|COMPLETED|Overall Study||0
575781|NCT00579501|1404392|P1|STARTED|Overall Study||29
575782|NCT00579436|1404399|P2|NOT COMPLETED|Overall Study||0
575783|NCT00579436|1404400|P1|NOT COMPLETED|Overall Study||0
575784|NCT00579436|1404399|P2|COMPLETED|Overall Study||14
575785|NCT00579436|1404400|P1|COMPLETED|Overall Study||19
575786|NCT00579436|1404399|P2|STARTED|Overall Study||14
575787|NCT00579436|1404400|P1|STARTED|Overall Study||19
575788|NCT00579345|1404420|P8|NOT COMPLETED|Overall Study||2
575789|NCT00579345|1404421|P7|NOT COMPLETED|Overall Study||0
575790|NCT00579345|1404422|P6|NOT COMPLETED|Overall Study||0
575791|NCT00579345|1404423|P5|NOT COMPLETED|Overall Study||0
575792|NCT00579345|1404424|P4|NOT COMPLETED|Overall Study||1
575793|NCT00579345|1404425|P3|NOT COMPLETED|Overall Study||2
575794|NCT00579345|1404426|P2|NOT COMPLETED|Overall Study||1
575795|NCT00579345|1404427|P1|NOT COMPLETED|Overall Study||5
575796|NCT00579345|1404420|P8|COMPLETED|Overall Study||42
575797|NCT00579345|1404421|P7|COMPLETED|Overall Study||57
575798|NCT00579345|1404422|P6|COMPLETED|Overall Study||78
575799|NCT00579345|1404423|P5|COMPLETED|Overall Study||90
575800|NCT00579345|1404424|P4|COMPLETED|Overall Study||143
575801|NCT00579345|1404425|P3|COMPLETED|Overall Study||389
575802|NCT00579345|1404426|P2|COMPLETED|Overall Study||168
575803|NCT00579345|1404427|P1|COMPLETED|Overall Study||544
575804|NCT00579345|1404420|P8|STARTED|Overall Study||44
575805|NCT00579345|1404421|P7|STARTED|Overall Study||57
575806|NCT00579345|1404422|P6|STARTED|Overall Study||78
575807|NCT00579345|1404423|P5|STARTED|Overall Study||90
575808|NCT00579345|1404424|P4|STARTED|Overall Study||144
575809|NCT00579345|1404425|P3|STARTED|Overall Study||391
575810|NCT00579345|1404426|P2|STARTED|Overall Study||169
575811|NCT00579345|1404427|P1|STARTED|Overall Study||549
575812|NCT00579254|1404459|P1|NOT COMPLETED|Overall Study||112
575813|NCT00579254|1404459|P1|COMPLETED|Overall Study||0
575814|NCT00579254|1404459|P1|STARTED|Overall Study||112
575815|NCT00579137|1404463|P1|NOT COMPLETED|Overall Study||0
575816|NCT00579137|1404463|P1|COMPLETED|Overall Study||3
575817|NCT00579137|1404463|P1|STARTED|Overall Study||3
575818|NCT00579111|1404472|P2|NOT COMPLETED|Overall Study||1
575819|NCT00579111|1404473|P1|NOT COMPLETED|Overall Study||2
575820|NCT00579111|1404472|P2|COMPLETED|Overall Study||0
575821|NCT00579111|1404473|P1|COMPLETED|Overall Study||1
575822|NCT00579111|1404472|P2|STARTED|Overall Study||1
575823|NCT00579111|1404473|P1|STARTED|Overall Study||3
575824|NCT00579098|1404483|P2|NOT COMPLETED|Overall Study||8
575825|NCT00579098|1404484|P1|NOT COMPLETED|Overall Study||9
575826|NCT00579098|1404483|P2|COMPLETED|Overall Study||55
575827|NCT00579098|1404484|P1|COMPLETED|Overall Study||53
575828|NCT00579098|1404483|P2|STARTED|Overall Study||63
575829|NCT00579098|1404484|P1|STARTED|Overall Study||62
575830|NCT00579059|1404500|P2|NOT COMPLETED|Overall Study||10
575831|NCT00579059|1404501|P1|NOT COMPLETED|Overall Study||21
575832|NCT00579059|1404500|P2|COMPLETED|Overall Study|No Patients completed through 5 years due to study closure at 1-year of follow-up.|0
575833|NCT00579059|1404501|P1|COMPLETED|Overall Study|No Patients completed through 5 years due to study closure at 1-year of follow-up.|0
575834|NCT00579059|1404500|P2|5 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
575835|NCT00579059|1404501|P1|5 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
575836|NCT00579059|1404500|P2|3 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
575837|NCT00579059|1404501|P1|3 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
575838|NCT00579059|1404500|P2|1 Year|Overall Study|7 patients didn't return for follow-up.|3
575839|NCT00579059|1404501|P1|1 Year|Overall Study|13 patients didn't return for follow-up.|8
575840|NCT00579059|1404500|P2|6 Months|Overall Study|6 patients didn't return for follow-up.|4
575841|NCT00579059|1404501|P1|6 Months|Overall Study|10 Patients didn't return for follow-up.|11
575842|NCT00579059|1404500|P2|Immediate Post-Op|Overall Study|1 Patient didn't return for follow-up.|9
575843|NCT00579059|1404501|P1|Immediate Post-Op|Overall Study|1 Patient didn't return for follow-up.|20
575844|NCT00579059|1404500|P2|STARTED|Overall Study|Enrollment was incomplete due to study cancellation.|10
575845|NCT00579059|1404501|P1|STARTED|Overall Study|Enrollment was incomplete due to study cancellation.|21
575846|NCT00578968|1404512|P3|NOT COMPLETED|Intervention||0
575847|NCT00578968|1404513|P2|NOT COMPLETED|Intervention||0
575848|NCT00578968|1404514|P1|NOT COMPLETED|Intervention||0
575849|NCT00578968|1404512|P3|COMPLETED|Intervention||0
575850|NCT00578968|1404513|P2|COMPLETED|Intervention||12
575851|NCT00578968|1404514|P1|COMPLETED|Intervention||12
575852|NCT00578968|1404512|P3|STARTED|Intervention||0
575853|NCT00578968|1404513|P2|STARTED|Intervention||12
575854|NCT00578968|1404514|P1|STARTED|Intervention||12
575855|NCT00578968|1404512|P3|NOT COMPLETED|Baseline (Prior to Intervention)||0
575856|NCT00578968|1404513|P2|NOT COMPLETED|Baseline (Prior to Intervention)||0
575857|NCT00578968|1404514|P1|NOT COMPLETED|Baseline (Prior to Intervention)||0
575858|NCT00578968|1404512|P3|COMPLETED|Baseline (Prior to Intervention)||12
575859|NCT00578968|1404513|P2|COMPLETED|Baseline (Prior to Intervention)||12
575860|NCT00578968|1404514|P1|COMPLETED|Baseline (Prior to Intervention)||12
575861|NCT00578968|1404512|P3|STARTED|Baseline (Prior to Intervention)||12
575862|NCT00578968|1404513|P2|STARTED|Baseline (Prior to Intervention)||12
575863|NCT00578968|1404514|P1|STARTED|Baseline (Prior to Intervention)||12
575864|NCT00578942|1404575|P1|NOT COMPLETED|Overall Study||1
575865|NCT00578942|1404575|P1|COMPLETED|Overall Study||47
575866|NCT00578942|1404575|P1|STARTED|Overall Study||48
575867|NCT00578929|1404585|P4|NOT COMPLETED|Randomized Period||14
575868|NCT00578929|1404586|P3|NOT COMPLETED|Randomized Period||8
575869|NCT00578929|1404587|P2|NOT COMPLETED|Randomized Period||14
575870|NCT00578929|1404588|P1|NOT COMPLETED|Randomized Period||17
575871|NCT00578929|1404585|P4|COMPLETED|Randomized Period||283
575872|NCT00578929|1404586|P3|COMPLETED|Randomized Period||288
575873|NCT00578929|1404587|P2|COMPLETED|Randomized Period||283
575874|NCT00578929|1404588|P1|COMPLETED|Randomized Period||281
575875|NCT00578929|1404585|P4|STARTED|Randomized Period||297
575876|NCT00578929|1404586|P3|STARTED|Randomized Period||296
575877|NCT00578929|1404587|P2|STARTED|Randomized Period||297
575878|NCT00578929|1404588|P1|STARTED|Randomized Period||298
575879|NCT00578929|1404585|P4|NOT COMPLETED|Vehicle Run-In Period||0
575880|NCT00578929|1404586|P3|NOT COMPLETED|Vehicle Run-In Period||0
575881|NCT00578929|1404587|P2|NOT COMPLETED|Vehicle Run-In Period||0
575882|NCT00578929|1404588|P1|NOT COMPLETED|Vehicle Run-In Period||0
575883|NCT00578929|1404585|P4|COMPLETED|Vehicle Run-In Period||0
575884|NCT00578929|1404586|P3|COMPLETED|Vehicle Run-In Period||0
575885|NCT00578929|1404587|P2|COMPLETED|Vehicle Run-In Period||2388
575886|NCT00578929|1404588|P1|COMPLETED|Vehicle Run-In Period||0
575887|NCT00578929|1404585|P4|STARTED|Vehicle Run-In Period||0
575888|NCT00578929|1404586|P3|STARTED|Vehicle Run-In Period||0
575889|NCT00578929|1404587|P2|STARTED|Vehicle Run-In Period||2388
575890|NCT00578929|1404588|P1|STARTED|Vehicle Run-In Period||0
575891|NCT00578903|1404603|P1|NOT COMPLETED|Overall Study||0
575892|NCT00578903|1404603|P1|COMPLETED|Overall Study||22
575893|NCT00578903|1404603|P1|STARTED|Overall Study||22
575894|NCT00578877|1404614|P2|NOT COMPLETED|Overall Study||128
575895|NCT00578877|1404615|P1|NOT COMPLETED|Overall Study||81
575896|NCT00578877|1404614|P2|COMPLETED|Overall Study||172
575897|NCT00578877|1404615|P1|COMPLETED|Overall Study||69
575898|NCT00578877|1404614|P2|STARTED|Overall Study||300
575899|NCT00578877|1404615|P1|STARTED|Overall Study||150
575900|NCT00578864|1404623|P2|NOT COMPLETED|Overall Study||0
575901|NCT00578864|1404624|P1|NOT COMPLETED|Overall Study||1
575902|NCT00578864|1404623|P2|COMPLETED|Overall Study||6
575903|NCT00578864|1404624|P1|COMPLETED|Overall Study|died of complications of surgery after 2 cycles|6
575904|NCT00578864|1404623|P2|STARTED|Overall Study||6
575905|NCT00578864|1404624|P1|STARTED|Overall Study||7
575906|NCT00578812|1404640|P2|NOT COMPLETED|Overall Study||7
575907|NCT00578812|1404641|P1|NOT COMPLETED|Overall Study||6
575908|NCT00578812|1404640|P2|COMPLETED|Overall Study||185
575909|NCT00578812|1404641|P1|COMPLETED|Overall Study|Modified Intent-to-Treat (treated patients; analyzed as randomized).|218
575910|NCT00578812|1404640|P2|STARTED|Overall Study||192
575911|NCT00578812|1404641|P1|STARTED|Overall Study|Does not include investigational training patients (78 STARTED, 76 COMPLETED, 2 Not Treated).|224
575912|NCT00578786|1404680|P3|NOT COMPLETED|Overall Study||30
575913|NCT00578786|1404681|P2|NOT COMPLETED|Overall Study||66
575914|NCT00578786|1404682|P1|NOT COMPLETED|Overall Study||39
575915|NCT00578786|1404680|P3|COMPLETED|Overall Study||67
575916|NCT00578786|1404681|P2|COMPLETED|Overall Study||124
575917|NCT00578786|1404682|P1|COMPLETED|Overall Study||57
575918|NCT00578786|1404680|P3|STARTED|Overall Study||97
575919|NCT00578786|1404681|P2|STARTED|Overall Study||190
575920|NCT00578786|1404682|P1|STARTED|Overall Study||96
575921|NCT00578734|1404763|P2|NOT COMPLETED|Overall Study||0
575922|NCT00578734|1404764|P1|NOT COMPLETED|Overall Study||0
575923|NCT00578734|1404763|P2|COMPLETED|Overall Study||81
575924|NCT00578734|1404764|P1|COMPLETED|Overall Study||84
575925|NCT00578734|1404763|P2|STARTED|Overall Study||81
575926|NCT00578734|1404764|P1|STARTED|Overall Study||84
575927|NCT00578617|1404774|P2|NOT COMPLETED|Overall Study||0
575928|NCT00578617|1404775|P1|NOT COMPLETED|Overall Study||0
575929|NCT00578617|1404774|P2|COMPLETED|Overall Study||29
575930|NCT00578617|1404775|P1|COMPLETED|Overall Study||31
575931|NCT00578617|1404774|P2|STARTED|Overall Study||29
575932|NCT00578617|1404775|P1|STARTED|Overall Study||31
575933|NCT00578565|1404781|P1|NOT COMPLETED|Overall Study||3
575934|NCT00578565|1404781|P1|COMPLETED|Overall Study||7
575935|NCT00578565|1404781|P1|STARTED|Overall Study||10
575936|NCT00578552|1404793|P3|NOT COMPLETED|Overall Study||15
575937|NCT00578552|1404794|P2|NOT COMPLETED|Overall Study||14
575938|NCT00578552|1404795|P1|NOT COMPLETED|Overall Study||15
575939|NCT00578552|1404793|P3|COMPLETED|Overall Study||11
575940|NCT00578552|1404794|P2|COMPLETED|Overall Study||13
575941|NCT00578552|1404795|P1|COMPLETED|Overall Study||12
575942|NCT00578552|1404793|P3|STARTED|Overall Study||26
575943|NCT00578552|1404794|P2|STARTED|Overall Study||27
575944|NCT00578552|1404795|P1|STARTED|Overall Study||27
575945|NCT00578539|1404803|P1|NOT COMPLETED|Overall Study||0
575946|NCT00578539|1404803|P1|COMPLETED|Overall Study||24
575947|NCT00578539|1404803|P1|STARTED|Overall Study||24
575948|NCT00578461|1404807|P1|NOT COMPLETED|Overall Study||0
575949|NCT00578461|1404807|P1|COMPLETED|Overall Study||26
575950|NCT00578461|1404807|P1|STARTED|Overall Study||26
575951|NCT00578448|1404811|P1|NOT COMPLETED|1 Year Long Term Extension (LTE)||1
575952|NCT00578448|1404811|P1|COMPLETED|1 Year Long Term Extension (LTE)||8
575953|NCT00578448|1404811|P1|STARTED|1 Year Long Term Extension (LTE)||9
575954|NCT00578448|1404811|P1|NOT COMPLETED|Day 1 up to 3 Years of Planned Study||3
575955|NCT00578448|1404811|P1|COMPLETED|Day 1 up to 3 Years of Planned Study||9
575956|NCT00578448|1404811|P1|STARTED|Day 1 up to 3 Years of Planned Study||12
575957|NCT00578383|1404829|P4|NOT COMPLETED|Overall Study||6
575958|NCT00578383|1404830|P3|NOT COMPLETED|Overall Study||6
575959|NCT00578383|1404831|P2|NOT COMPLETED|Overall Study||16
575960|NCT00578383|1404832|P1|NOT COMPLETED|Overall Study||16
575961|NCT00578383|1404829|P4|COMPLETED|Overall Study||9
575962|NCT00578383|1404830|P3|COMPLETED|Overall Study||13
575963|NCT00578383|1404831|P2|COMPLETED|Overall Study||20
575964|NCT00578383|1404832|P1|COMPLETED|Overall Study||21
575965|NCT00578383|1404829|P4|STARTED|Overall Study||15
575966|NCT00578383|1404830|P3|STARTED|Overall Study||19
575967|NCT00578383|1404831|P2|STARTED|Overall Study||36
575968|NCT00578383|1404832|P1|STARTED|Overall Study||37
575969|NCT00578331|1404864|P2|NOT COMPLETED|Overall Study||125
575970|NCT00578331|1404865|P1|NOT COMPLETED|Overall Study||116
575971|NCT00578331|1404864|P2|COMPLETED|Overall Study||320
575972|NCT00578331|1404865|P1|COMPLETED|Overall Study||329
575973|NCT00578331|1404864|P2|STARTED|Overall Study||445
575974|NCT00578331|1404865|P1|STARTED|Overall Study||445
575975|NCT00578318|1404875|P2|NOT COMPLETED|Overall Study||0
575976|NCT00578318|1404876|P1|NOT COMPLETED|Overall Study||3
575977|NCT00578318|1404875|P2|COMPLETED|Overall Study||8
575978|NCT00578318|1404876|P1|COMPLETED|Overall Study||5
575979|NCT00578318|1404875|P2|STARTED|Overall Study||8
575980|NCT00578318|1404876|P1|STARTED|Overall Study||8
575981|NCT00578305|1404885|P3|NOT COMPLETED|Safety Follow-up Phase||46
575982|NCT00578305|1404886|P2|NOT COMPLETED|Safety Follow-up Phase||45
575983|NCT00578305|1404887|P1|NOT COMPLETED|Safety Follow-up Phase||46
575984|NCT00578305|1404885|P3|COMPLETED|Safety Follow-up Phase||8
575985|NCT00578305|1404886|P2|COMPLETED|Safety Follow-up Phase||9
575986|NCT00578305|1404887|P1|COMPLETED|Safety Follow-up Phase||11
575987|NCT00578305|1404885|P3|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|54
575988|NCT00578305|1404886|P2|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|54
575989|NCT00578305|1404887|P1|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|57
575990|NCT00578305|1404885|P3|NOT COMPLETED|Extension Phase||3
575991|NCT00578305|1404886|P2|NOT COMPLETED|Extension Phase||1
575992|NCT00578305|1404887|P1|NOT COMPLETED|Extension Phase||4
575993|NCT00578305|1404885|P3|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|40
575994|NCT00578305|1404886|P2|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|49
575995|NCT00578305|1404887|P1|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|49
575996|NCT00578305|1404885|P3|STARTED|Extension Phase||43
575997|NCT00578305|1404886|P2|STARTED|Extension Phase||50
575998|NCT00578305|1404887|P1|STARTED|Extension Phase||53
575999|NCT00578305|1404885|P3|NOT COMPLETED|Double-blind Treatment Phase||14
576000|NCT00578305|1404886|P2|NOT COMPLETED|Double-blind Treatment Phase||4
576001|NCT00578305|1404887|P1|NOT COMPLETED|Double-blind Treatment Phase||3
576002|NCT00578305|1404885|P3|COMPLETED|Double-blind Treatment Phase||49
576003|NCT00578305|1404886|P2|COMPLETED|Double-blind Treatment Phase||56
576004|NCT00578305|1404887|P1|COMPLETED|Double-blind Treatment Phase||59
576005|NCT00578305|1404885|P3|Treated|Double-blind Treatment Phase||63
576006|NCT00578305|1404886|P2|Treated|Double-blind Treatment Phase||60
576007|NCT00578305|1404887|P1|Treated|Double-blind Treatment Phase||62
576008|NCT00578305|1404885|P3|STARTED|Double-blind Treatment Phase||63
576009|NCT00578305|1404886|P2|STARTED|Double-blind Treatment Phase||60
576010|NCT00578305|1404887|P1|STARTED|Double-blind Treatment Phase||62
576011|NCT00578279|1404948|P2|NOT COMPLETED|Overall Study||0
576012|NCT00578279|1404949|P1|NOT COMPLETED|Overall Study||0
576013|NCT00578279|1404948|P2|COMPLETED|Overall Study||10
576014|NCT00578279|1404949|P1|COMPLETED|Overall Study||10
576015|NCT00578279|1404948|P2|STARTED|Overall Study||10
576016|NCT00578279|1404949|P1|STARTED|Overall Study||10
576017|NCT00578227|1404958|P3|NOT COMPLETED|Overall Study||4
576018|NCT00578227|1404959|P2|NOT COMPLETED|Overall Study||2
576019|NCT00578227|1404960|P1|NOT COMPLETED|Overall Study||5
576020|NCT00578227|1404958|P3|COMPLETED|Overall Study||267
576021|NCT00578227|1404959|P2|COMPLETED|Overall Study||268
576022|NCT00578227|1404960|P1|COMPLETED|Overall Study||267
576023|NCT00578227|1404958|P3|STARTED|Overall Study||271
576024|NCT00578227|1404959|P2|STARTED|Overall Study||270
576025|NCT00578227|1404960|P1|STARTED|Overall Study||272
576026|NCT00578214|1405033|P3|NOT COMPLETED|Overall Study||0
576027|NCT00578214|1405034|P2|NOT COMPLETED|Overall Study||0
576028|NCT00578214|1405035|P1|NOT COMPLETED|Overall Study||0
576029|NCT00578214|1405033|P3|COMPLETED|Overall Study||31
576030|NCT00578214|1405034|P2|COMPLETED|Overall Study||22
576031|NCT00578214|1405035|P1|COMPLETED|Overall Study||22
576032|NCT00578214|1405033|P3|STARTED|Overall Study||31
576033|NCT00578214|1405034|P2|STARTED|Overall Study||22
576034|NCT00578214|1405035|P1|STARTED|Overall Study||22
576035|NCT00578175|1405085|P3|NOT COMPLETED|Overall Study||24
576036|NCT00578175|1405086|P2|NOT COMPLETED|Overall Study||43
576037|NCT00578175|1405087|P1|NOT COMPLETED|Overall Study||70
576038|NCT00578175|1405085|P3|COMPLETED|Overall Study||365
576039|NCT00578175|1405086|P2|COMPLETED|Overall Study||646
576040|NCT00578175|1405087|P1|COMPLETED|Overall Study||635
576041|NCT00578175|1405085|P3|STARTED|Overall Study||389
576042|NCT00578175|1405086|P2|STARTED|Overall Study||689
576043|NCT00578175|1405087|P1|STARTED|Overall Study||705
576044|NCT00578136|1405166|P2|NOT COMPLETED|Overall Study||1
576045|NCT00578136|1405167|P1|NOT COMPLETED|Overall Study||1
576046|NCT00578136|1405166|P2|COMPLETED|Overall Study||26
576047|NCT00578136|1405167|P1|COMPLETED|Overall Study||26
576048|NCT00578136|1405166|P2|STARTED|Overall Study||27
576049|NCT00578136|1405167|P1|STARTED|Overall Study||27
576050|NCT00578071|1405175|P1|NOT COMPLETED|Overall Study||0
576051|NCT00578071|1405175|P1|COMPLETED|Overall Study||29
576052|NCT00578071|1405175|P1|STARTED|Overall Study||29
576053|NCT00577889|1405185|P3|NOT COMPLETED|Overall Study||0
576054|NCT00577889|1405186|P2|NOT COMPLETED|Overall Study||0
576055|NCT00577889|1405187|P1|NOT COMPLETED|Overall Study||1
576056|NCT00577889|1405185|P3|COMPLETED|Overall Study||6
576057|NCT00577889|1405186|P2|COMPLETED|Overall Study||6
576058|NCT00577889|1405187|P1|COMPLETED|Overall Study||8
576059|NCT00577889|1405185|P3|STARTED|Overall Study||6
576060|NCT00577889|1405186|P2|STARTED|Overall Study||6
576061|NCT00577889|1405187|P1|STARTED|Overall Study||9
576062|NCT00577863|1405206|P2|NOT COMPLETED|Overall Study||14
576063|NCT00577863|1405207|P1|NOT COMPLETED|Overall Study||10
576064|NCT00577863|1405206|P2|COMPLETED|Overall Study||94
576065|NCT00577863|1405207|P1|COMPLETED|Overall Study||82
576066|NCT00577863|1405206|P2|Received at Least One Injection|Overall Study||107
576067|NCT00577863|1405207|P1|Received at Least One Injection|Overall Study||92
576068|NCT00577863|1405206|P2|STARTED|Overall Study||108
576069|NCT00577863|1405207|P1|STARTED|Overall Study||92
576070|NCT00577824|1405249|P3|NOT COMPLETED|Overall Study||2
576071|NCT00577824|1405250|P2|NOT COMPLETED|Overall Study||20
576072|NCT00577824|1405251|P1|NOT COMPLETED|Overall Study||7
576073|NCT00577824|1405249|P3|COMPLETED|Overall Study||34
576074|NCT00577824|1405250|P2|COMPLETED|Overall Study||53
576075|NCT00577824|1405251|P1|COMPLETED|Overall Study||65
576076|NCT00577824|1405249|P3|Full Analysis Set|Overall Study||35
576077|NCT00577824|1405250|P2|Full Analysis Set|Overall Study||72
576078|NCT00577824|1405251|P1|Full Analysis Set|Overall Study|Full Analysis Set=subject received at least one dose of study medication (active or placebo)|72
576079|NCT00577824|1405249|P3|STARTED|Overall Study||36
576080|NCT00577824|1405250|P2|STARTED|Overall Study||73
576081|NCT00577824|1405251|P1|STARTED|Overall Study|Started=Randomized|72
576082|NCT00577772|1405309|P2|NOT COMPLETED|Overall Study||1
576083|NCT00577772|1405310|P1|NOT COMPLETED|Overall Study||0
576084|NCT00577772|1405309|P2|COMPLETED|Overall Study||6
576085|NCT00577772|1405310|P1|COMPLETED|Overall Study||10
576086|NCT00577772|1405309|P2|STARTED|Overall Study||7
576087|NCT00577772|1405310|P1|STARTED|Overall Study||10
576088|NCT00577720|1405320|P4|NOT COMPLETED|Overall Study||7
576089|NCT00577720|1405321|P3|NOT COMPLETED|Overall Study||1
576090|NCT00577720|1405322|P2|NOT COMPLETED|Overall Study||1
576091|NCT00577720|1405323|P1|NOT COMPLETED|Overall Study||4
576092|NCT00577720|1405320|P4|COMPLETED|Overall Study||65
576093|NCT00577720|1405321|P3|COMPLETED|Overall Study||35
576094|NCT00577720|1405322|P2|COMPLETED|Overall Study||35
576095|NCT00577720|1405323|P1|COMPLETED|Overall Study||33
576096|NCT00577720|1405320|P4|ITT (Intent to Treat) Population|Overall Study||65
576097|NCT00577720|1405321|P3|ITT (Intent to Treat) Population|Overall Study||35
576098|NCT00577720|1405322|P2|ITT (Intent to Treat) Population|Overall Study||35
576099|NCT00577720|1405323|P1|ITT (Intent to Treat) Population|Overall Study||34
576100|NCT00577720|1405320|P4|STARTED|Overall Study||72
576101|NCT00577720|1405321|P3|STARTED|Overall Study||36
576102|NCT00577720|1405322|P2|STARTED|Overall Study||36
576103|NCT00577720|1405323|P1|STARTED|Overall Study||37
576104|NCT00577707|1405341|P1|NOT COMPLETED|Overall Study||3
576105|NCT00577707|1405341|P1|COMPLETED|Overall Study||6
576106|NCT00577707|1405341|P1|STARTED|Overall Study||9
576107|NCT00577655|1405349|P2|NOT COMPLETED|Overall Study||4
576108|NCT00577655|1405350|P1|NOT COMPLETED|Overall Study||1
576109|NCT00577655|1405349|P2|COMPLETED|Overall Study||47
576110|NCT00577655|1405350|P1|COMPLETED|Overall Study||51
576111|NCT00577655|1405349|P2|STARTED|Overall Study|This number represents the number of participants randomized.|51
576112|NCT00577655|1405350|P1|STARTED|Overall Study|This number represents the number of participants randomized.|52
576113|NCT00577642|1405388|P1|NOT COMPLETED|Overall Study||1
576114|NCT00577642|1405388|P1|COMPLETED|Overall Study||28
576115|NCT00577642|1405388|P1|STARTED|Overall Study||29
576116|NCT00577629|1405392|P1|NOT COMPLETED|Long Term Follow-Up||25
576117|NCT00577629|1405392|P1|COMPLETED|Long Term Follow-Up||13
576118|NCT00577629|1405392|P1|STARTED|Long Term Follow-Up||38
576119|NCT00577629|1405392|P1|NOT COMPLETED|Treatment Period||1
576120|NCT00577629|1405392|P1|COMPLETED|Treatment Period||38
576121|NCT00577629|1405392|P1|STARTED|Treatment Period||39
576122|NCT00577512|1405400|P1|NOT COMPLETED|Overall Study||4
576123|NCT00577512|1405400|P1|COMPLETED|Overall Study||0
576124|NCT00577512|1405400|P1|STARTED|Overall Study||4
576125|NCT00577473|1405406|P2|NOT COMPLETED|Overall Study||24
576126|NCT00577473|1405407|P1|NOT COMPLETED|Overall Study||21
576127|NCT00577473|1405406|P2|COMPLETED|Overall Study||123
576128|NCT00577473|1405407|P1|COMPLETED|Overall Study||133
576129|NCT00577473|1405406|P2|ITT Population|Overall Study||136
576130|NCT00577473|1405407|P1|ITT Population|Overall Study||150
576131|NCT00577473|1405406|P2|STARTED|Overall Study||147
576132|NCT00577473|1405407|P1|STARTED|Overall Study||154
576133|NCT00577460|1405438|P3|NOT COMPLETED|Overall Study||27
576134|NCT00577460|1405439|P2|NOT COMPLETED|Overall Study||19
576135|NCT00577460|1405440|P1|NOT COMPLETED|Overall Study||16
576136|NCT00577460|1405438|P3|COMPLETED|Overall Study||112
576137|NCT00577460|1405439|P2|COMPLETED|Overall Study||104
576138|NCT00577460|1405440|P1|COMPLETED|Overall Study||113
576139|NCT00577460|1405438|P3|STARTED|Overall Study||139
576140|NCT00577460|1405439|P2|STARTED|Overall Study||123
576141|NCT00577460|1405440|P1|STARTED|Overall Study||129
576142|NCT00577408|1405549|P2|NOT COMPLETED|Overall Study||23
576143|NCT00577408|1405550|P1|NOT COMPLETED|Overall Study||12
576144|NCT00577408|1405549|P2|COMPLETED|Overall Study||9
576145|NCT00577408|1405550|P1|COMPLETED|Overall Study||16
576146|NCT00577408|1405549|P2|STARTED|Overall Study||32
576147|NCT00577408|1405550|P1|STARTED|Overall Study||28
576148|NCT00577395|1405558|P2|NOT COMPLETED|Overall Study||6
576149|NCT00577395|1405559|P1|NOT COMPLETED|Overall Study||7
576150|NCT00577395|1405558|P2|COMPLETED|Overall Study|The study was terminated early by the Sponsor for lack of enrollment|0
576151|NCT00577395|1405559|P1|COMPLETED|Overall Study|The study was terminated early by the Sponsor for lack of enrollment|0
576152|NCT00577395|1405558|P2|STARTED|Overall Study|67 were planned for Treatment 1, but due to enrollment difficulties this was not met.|6
576153|NCT00577395|1405559|P1|STARTED|Overall Study|67 planned for Treatment 2, but due to enrollment difficulties this was not met.|7
576154|NCT00577382|1405569|P2|NOT COMPLETED|Overall Study||31
576155|NCT00577382|1405570|P1|NOT COMPLETED|Overall Study||21
576156|NCT00577382|1405569|P2|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
576157|NCT00577382|1405570|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
576158|NCT00577382|1405569|P2|STARTED|Overall Study||31
576159|NCT00577382|1405570|P1|STARTED|Overall Study||21
576160|NCT00577356|1405582|P1|NOT COMPLETED|Overall Study||0
576161|NCT00577356|1405582|P1|COMPLETED|Overall Study||6
576162|NCT00577356|1405582|P1|STARTED|Overall Study||6
576163|NCT00577135|1405590|P4|NOT COMPLETED|Overall Study||0
576164|NCT00577135|1405591|P3|NOT COMPLETED|Overall Study||0
576165|NCT00577135|1405592|P2|NOT COMPLETED|Overall Study||0
576166|NCT00577135|1405593|P1|NOT COMPLETED|Overall Study||0
576167|NCT00577135|1405590|P4|COMPLETED|Overall Study||75
576168|NCT00577135|1405591|P3|COMPLETED|Overall Study||77
576169|NCT00577135|1405592|P2|COMPLETED|Overall Study||82
576170|NCT00577135|1405593|P1|COMPLETED|Overall Study||74
576171|NCT00577135|1405590|P4|STARTED|Overall Study||75
576172|NCT00577135|1405591|P3|STARTED|Overall Study||77
576173|NCT00577135|1405592|P2|STARTED|Overall Study||82
576174|NCT00577135|1405593|P1|STARTED|Overall Study||74
576175|NCT00577122|1405713|P2|NOT COMPLETED|Overall Study||16
576176|NCT00577122|1405714|P1|NOT COMPLETED|Overall Study||14
576177|NCT00577122|1405713|P2|COMPLETED|Overall Study||0
576178|NCT00577122|1405714|P1|COMPLETED|Overall Study||0
576179|NCT00577122|1405713|P2|STARTED|Overall Study||16
576180|NCT00577122|1405714|P1|STARTED|Overall Study||14
576181|NCT00577096|1405728|P2|NOT COMPLETED|Long Term Participation||0
576182|NCT00577096|1405729|P1|NOT COMPLETED|Long Term Participation||0
576183|NCT00577096|1405728|P2|COMPLETED|Long Term Participation|Sub-set of patients (n=69) who completed short term (n=120) continued in long term participation.|35
576184|NCT00577096|1405729|P1|COMPLETED|Long Term Participation||34
576185|NCT00577096|1405728|P2|STARTED|Long Term Participation|Only 35 patients who met long-term eligibility (response to EPO) were enrolled.|35
576186|NCT00577096|1405729|P1|STARTED|Long Term Participation|Only the first 34 patients who met long-term eligibility (response to EPO) were enrolled.|34
576187|NCT00577096|1405728|P2|NOT COMPLETED|Short Term Participation||8
576188|NCT00577096|1405729|P1|NOT COMPLETED|Short Term Participation||7
576189|NCT00577096|1405728|P2|COMPLETED|Short Term Participation||58
576190|NCT00577096|1405729|P1|COMPLETED|Short Term Participation||62
576191|NCT00577096|1405728|P2|STARTED|Short Term Participation||66
576192|NCT00577096|1405729|P1|STARTED|Short Term Participation||69
576193|NCT00577083|1405755|P2|NOT COMPLETED|Second Intervention (14days)||0
576194|NCT00577083|1405756|P1|NOT COMPLETED|Second Intervention (14days)||0
576195|NCT00577083|1405755|P2|COMPLETED|Second Intervention (14days)||52
576196|NCT00577083|1405756|P1|COMPLETED|Second Intervention (14days)||48
576197|NCT00577083|1405755|P2|STARTED|Second Intervention (14days)||52
576198|NCT00577083|1405756|P1|STARTED|Second Intervention (14days)||48
576199|NCT00577083|1405755|P2|NOT COMPLETED|Washout (14 Days)||0
576200|NCT00577083|1405756|P1|NOT COMPLETED|Washout (14 Days)||0
576201|NCT00577083|1405755|P2|COMPLETED|Washout (14 Days)||52
576202|NCT00577083|1405756|P1|COMPLETED|Washout (14 Days)||48
576203|NCT00577083|1405755|P2|STARTED|Washout (14 Days)||52
576204|NCT00577083|1405756|P1|STARTED|Washout (14 Days)||48
576205|NCT00577083|1405755|P2|NOT COMPLETED|First Intervention (14 Days)||0
576206|NCT00577083|1405756|P1|NOT COMPLETED|First Intervention (14 Days)||0
576207|NCT00577083|1405755|P2|COMPLETED|First Intervention (14 Days)||52
576208|NCT00577083|1405756|P1|COMPLETED|First Intervention (14 Days)||48
576209|NCT00577083|1405755|P2|STARTED|First Intervention (14 Days)||52
576210|NCT00577083|1405756|P1|STARTED|First Intervention (14 Days)||48
576211|NCT00577031|1405762|P1|NOT COMPLETED|Overall Study||205
576212|NCT00577031|1405762|P1|COMPLETED|Overall Study||0
576213|NCT00577031|1405762|P1|STARTED|Overall Study||205
576214|NCT00577005|1405783|P2|NOT COMPLETED|Overall Study||3
576215|NCT00577005|1405784|P1|NOT COMPLETED|Overall Study||5
576216|NCT00577005|1405783|P2|COMPLETED|Overall Study||9
576217|NCT00577005|1405784|P1|COMPLETED|Overall Study||11
576218|NCT00577005|1405783|P2|STARTED|Overall Study||12
576219|NCT00577005|1405784|P1|STARTED|Overall Study||16
576220|NCT00576927|1405798|P1|NOT COMPLETED|Randomization 1:1 Placebo or Active Drug||0
576221|NCT00576927|1405798|P1|COMPLETED|Randomization 1:1 Placebo or Active Drug||22
576222|NCT00576927|1405798|P1|STARTED|Randomization 1:1 Placebo or Active Drug||22
576223|NCT00576927|1405798|P1|NOT COMPLETED|Sleep Hygiene With Study Drug||0
576224|NCT00576927|1405798|P1|COMPLETED|Sleep Hygiene With Study Drug||22
576225|NCT00576927|1405798|P1|STARTED|Sleep Hygiene With Study Drug||22
576226|NCT00576927|1405798|P1|NOT COMPLETED|Sleep Hygiene With the Placebo||1
576227|NCT00576927|1405798|P1|COMPLETED|Sleep Hygiene With the Placebo||22
576228|NCT00576927|1405798|P1|STARTED|Sleep Hygiene With the Placebo||23
576229|NCT00576927|1405798|P1|NOT COMPLETED|Sleep Hygiene Behavioral Intervention||7
576230|NCT00576927|1405798|P1|COMPLETED|Sleep Hygiene Behavioral Intervention||23
576231|NCT00576927|1405798|P1|STARTED|Sleep Hygiene Behavioral Intervention||30
576232|NCT00576927|1405798|P1|NOT COMPLETED|Baseline||13
576233|NCT00576927|1405798|P1|COMPLETED|Baseline||30
576234|NCT00576927|1405798|P1|STARTED|Baseline||43
576235|NCT00576927|1405798|P1|NOT COMPLETED|Clinical Assessment||36
576236|NCT00576927|1405798|P1|COMPLETED|Clinical Assessment||43
576237|NCT00576927|1405798|P1|STARTED|Clinical Assessment||79
576238|NCT00576901|1405810|P1|NOT COMPLETED|Overall Study||3
576239|NCT00576901|1405810|P1|COMPLETED|Overall Study||20
576240|NCT00576901|1405810|P1|STARTED|Overall Study||23
576241|NCT00576823|1405821|P3|NOT COMPLETED|40-week Safety Extension Phase||0
576242|NCT00576823|1405822|P2|NOT COMPLETED|40-week Safety Extension Phase||0
576243|NCT00576823|1405823|P1|NOT COMPLETED|40-week Safety Extension Phase||1
576244|NCT00576823|1405821|P3|COMPLETED|40-week Safety Extension Phase||6
576245|NCT00576823|1405822|P2|COMPLETED|40-week Safety Extension Phase||6
576246|NCT00576823|1405823|P1|COMPLETED|40-week Safety Extension Phase||10
576247|NCT00576823|1405821|P3|STARTED|40-week Safety Extension Phase|One patient refused to continue in the extension phase.|6
576248|NCT00576823|1405822|P2|STARTED|40-week Safety Extension Phase||6
576249|NCT00576823|1405823|P1|STARTED|40-week Safety Extension Phase||11
576250|NCT00576823|1405821|P3|NOT COMPLETED|12-week Efficacy Phase||0
576251|NCT00576823|1405822|P2|NOT COMPLETED|12-week Efficacy Phase||0
576252|NCT00576823|1405823|P1|NOT COMPLETED|12-week Efficacy Phase||1
576253|NCT00576823|1405821|P3|COMPLETED|12-week Efficacy Phase||7
576254|NCT00576823|1405822|P2|COMPLETED|12-week Efficacy Phase||6
576255|NCT00576823|1405823|P1|COMPLETED|12-week Efficacy Phase||11
576256|NCT00576823|1405821|P3|STARTED|12-week Efficacy Phase||7
576257|NCT00576823|1405822|P2|STARTED|12-week Efficacy Phase||6
576258|NCT00576823|1405823|P1|STARTED|12-week Efficacy Phase||12
576259|NCT00576758|1405839|P2|NOT COMPLETED|Follow-up Period||17
576260|NCT00576758|1405840|P1|NOT COMPLETED|Follow-up Period||27
576261|NCT00576758|1405839|P2|COMPLETED|Follow-up Period||34
576262|NCT00576758|1405840|P1|COMPLETED|Follow-up Period||28
576263|NCT00576758|1405839|P2|STARTED|Follow-up Period|Includes 21 pts who entered follow-up after induction and didn't enter the extended treatment phase.|51
576264|NCT00576758|1405840|P1|STARTED|Follow-up Period|Includes 23 pts who entered follow-up after induction and didn't enter the extended treatment phase.|55
576265|NCT00576758|1405839|P2|NOT COMPLETED|Extension Treatment Period||43
576266|NCT00576758|1405840|P1|NOT COMPLETED|Extension Treatment Period||42
576267|NCT00576758|1405839|P2|COMPLETED|Extension Treatment Period||30
576268|NCT00576758|1405840|P1|COMPLETED|Extension Treatment Period|+ 2 patients (pts) who withdrew prior to receiving study drug.|30
576269|NCT00576758|1405839|P2|STARTED|Extension Treatment Period|8 patients did not enter extended treatment phase/follow-up phase + 2 patients entered follow-up.|73
576270|NCT00576758|1405840|P1|STARTED|Extension Treatment Period|6 patients did not enter extended treatment phase/follow-up + 1 patient entered follow-up.|72
576271|NCT00576758|1405839|P2|NOT COMPLETED|Induction Treatment Period||5
576272|NCT00576758|1405840|P1|NOT COMPLETED|Induction Treatment Period||8
576273|NCT00576758|1405839|P2|COMPLETED|Induction Treatment Period||83
576274|NCT00576758|1405840|P1|COMPLETED|Induction Treatment Period||79
576275|NCT00576758|1405839|P2|Received Treatment|Induction Treatment Period||87
576276|NCT00576758|1405840|P1|Received Treatment|Induction Treatment Period||86
576277|NCT00576758|1405839|P2|STARTED|Induction Treatment Period||88
576278|NCT00576758|1405840|P1|STARTED|Induction Treatment Period||87
576279|NCT00576732|1405886|P6|NOT COMPLETED|OPEN LABEL||8
576280|NCT00576732|1405887|P5|NOT COMPLETED|OPEN LABEL||4
576281|NCT00576732|1405888|P4|NOT COMPLETED|OPEN LABEL||11
576282|NCT00576732|1405889|P3|NOT COMPLETED|OPEN LABEL||0
576283|NCT00576732|1405890|P2|NOT COMPLETED|OPEN LABEL||0
576284|NCT00576732|1405891|P1|NOT COMPLETED|OPEN LABEL||0
576285|NCT00576732|1405886|P6|COMPLETED|OPEN LABEL||17
576286|NCT00576732|1405887|P5|COMPLETED|OPEN LABEL||20
576287|NCT00576732|1405888|P4|COMPLETED|OPEN LABEL||19
576288|NCT00576732|1405889|P3|COMPLETED|OPEN LABEL||0
576289|NCT00576732|1405890|P2|COMPLETED|OPEN LABEL||0
576290|NCT00576732|1405891|P1|COMPLETED|OPEN LABEL||0
576291|NCT00576732|1405886|P6|STARTED|OPEN LABEL|All 25 double-blind RIS high dose completers and 0 RIS high dose non-completers entered open-label.|25
576292|NCT00576732|1405887|P5|STARTED|OPEN LABEL|24 of 25 double-blind RIS low dose completers and 0 RIS low dose non-completers entered open-label.|24
576293|NCT00576732|1405888|P4|STARTED|OPEN LABEL|26 of 27 double-blind placebo completers and 4 of 8 placebo non-completers entered open-label.|30
576294|NCT00576732|1405889|P3|STARTED|OPEN LABEL||0
576295|NCT00576732|1405890|P2|STARTED|OPEN LABEL||0
576296|NCT00576732|1405891|P1|STARTED|OPEN LABEL||0
576297|NCT00576732|1405886|P6|NOT COMPLETED|DOUBLE BLIND||0
576298|NCT00576732|1405887|P5|NOT COMPLETED|DOUBLE BLIND||0
576299|NCT00576732|1405888|P4|NOT COMPLETED|DOUBLE BLIND||0
576300|NCT00576732|1405889|P3|NOT COMPLETED|DOUBLE BLIND||6
576301|NCT00576732|1405890|P2|NOT COMPLETED|DOUBLE BLIND||5
576302|NCT00576732|1405891|P1|NOT COMPLETED|DOUBLE BLIND||8
576303|NCT00576732|1405886|P6|COMPLETED|DOUBLE BLIND||0
576304|NCT00576732|1405887|P5|COMPLETED|DOUBLE BLIND||0
576305|NCT00576732|1405888|P4|COMPLETED|DOUBLE BLIND||0
576306|NCT00576732|1405889|P3|COMPLETED|DOUBLE BLIND||25
576307|NCT00576732|1405890|P2|COMPLETED|DOUBLE BLIND||25
576308|NCT00576732|1405891|P1|COMPLETED|DOUBLE BLIND||27
576309|NCT00576732|1405886|P6|STARTED|DOUBLE BLIND||0
576310|NCT00576732|1405887|P5|STARTED|DOUBLE BLIND||0
576311|NCT00576732|1405888|P4|STARTED|DOUBLE BLIND||0
576312|NCT00576732|1405889|P3|STARTED|DOUBLE BLIND||31
576313|NCT00576732|1405890|P2|STARTED|DOUBLE BLIND||30
576314|NCT00576732|1405891|P1|STARTED|DOUBLE BLIND||35
576315|NCT00576693|1405923|P2|NOT COMPLETED|Overall Study||24
576316|NCT00576693|1405924|P1|NOT COMPLETED|Overall Study||10
576317|NCT00576693|1405923|P2|COMPLETED|Overall Study||203
576318|NCT00576693|1405924|P1|COMPLETED|Overall Study||214
576319|NCT00576693|1405923|P2|STARTED|Overall Study||227
576320|NCT00576693|1405924|P1|STARTED|Overall Study||224
576321|NCT00576628|1405930|P1|NOT COMPLETED|Overall Study||43
576322|NCT00576628|1405930|P1|COMPLETED|Overall Study||82
576323|NCT00576628|1405930|P1|STARTED|Overall Study||125
576324|NCT00576576|1405950|P1|NOT COMPLETED|Overall Study||7
576325|NCT00576576|1405950|P1|COMPLETED|Overall Study||20
576326|NCT00576576|1405950|P1|STARTED|Overall Study||27
576327|NCT00576524|1405958|P2|NOT COMPLETED|Overall Study||0
576328|NCT00576524|1405959|P1|NOT COMPLETED|Overall Study||0
576329|NCT00576524|1405958|P2|COMPLETED|Overall Study||0
576330|NCT00576524|1405959|P1|COMPLETED|Overall Study||2
576331|NCT00576524|1405958|P2|STARTED|Overall Study||0
576332|NCT00576524|1405959|P1|STARTED|Overall Study||2
576333|NCT00576472|1405984|P15|NOT COMPLETED|MPH Home Maintenance Phase||23
576334|NCT00576472|1405985|P14|NOT COMPLETED|MPH Home Maintenance Phase||27
576335|NCT00576472|1405986|P13|NOT COMPLETED|MPH Home Maintenance Phase||0
576336|NCT00576472|1405987|P12|NOT COMPLETED|MPH Home Maintenance Phase||0
576337|NCT00576472|1405988|P11|NOT COMPLETED|MPH Home Maintenance Phase||0
576338|NCT00576472|1405989|P10|NOT COMPLETED|MPH Home Maintenance Phase||0
576339|NCT00576472|1405990|P9|NOT COMPLETED|MPH Home Maintenance Phase||0
576340|NCT00576472|1405991|P8|NOT COMPLETED|MPH Home Maintenance Phase||0
576341|NCT00576472|1405992|P7|NOT COMPLETED|MPH Home Maintenance Phase||0
576342|NCT00576472|1405993|P6|NOT COMPLETED|MPH Home Maintenance Phase||0
576343|NCT00576472|1405994|P5|NOT COMPLETED|MPH Home Maintenance Phase||0
576344|NCT00576472|1405995|P4|NOT COMPLETED|MPH Home Maintenance Phase||0
576345|NCT00576472|1405996|P3|NOT COMPLETED|MPH Home Maintenance Phase||0
576346|NCT00576472|1405997|P2|NOT COMPLETED|MPH Home Maintenance Phase||0
576347|NCT00576472|1405998|P1|NOT COMPLETED|MPH Home Maintenance Phase||0
576348|NCT00576472|1405984|P15|COMPLETED|MPH Home Maintenance Phase||68
576349|NCT00576472|1405985|P14|COMPLETED|MPH Home Maintenance Phase||0
576350|NCT00576472|1405986|P13|COMPLETED|MPH Home Maintenance Phase||0
576351|NCT00576472|1405987|P12|COMPLETED|MPH Home Maintenance Phase||0
576352|NCT00576472|1405988|P11|COMPLETED|MPH Home Maintenance Phase||0
576353|NCT00576472|1405989|P10|COMPLETED|MPH Home Maintenance Phase||0
576354|NCT00576472|1405990|P9|COMPLETED|MPH Home Maintenance Phase||0
576355|NCT00576472|1405991|P8|COMPLETED|MPH Home Maintenance Phase||0
576356|NCT00576472|1405992|P7|COMPLETED|MPH Home Maintenance Phase||0
576357|NCT00576472|1405993|P6|COMPLETED|MPH Home Maintenance Phase||0
576358|NCT00576472|1405994|P5|COMPLETED|MPH Home Maintenance Phase||0
576359|NCT00576472|1405995|P4|COMPLETED|MPH Home Maintenance Phase||0
576360|NCT00576472|1405996|P3|COMPLETED|MPH Home Maintenance Phase||0
576361|NCT00576472|1405997|P2|COMPLETED|MPH Home Maintenance Phase||0
576362|NCT00576472|1405998|P1|COMPLETED|MPH Home Maintenance Phase||0
576363|NCT00576472|1405984|P15|STARTED|MPH Home Maintenance Phase||91
576364|NCT00576472|1405985|P14|STARTED|MPH Home Maintenance Phase||27
576365|NCT00576472|1405986|P13|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
576366|NCT00576472|1405987|P12|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
576367|NCT00576472|1405988|P11|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
576368|NCT00576472|1405989|P10|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
576369|NCT00576472|1405990|P9|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
576370|NCT00576472|1405991|P8|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
576371|NCT00576472|1405992|P7|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
576372|NCT00576472|1405993|P6|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
576373|NCT00576472|1405994|P5|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
576374|NCT00576472|1405995|P4|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
576375|NCT00576472|1405996|P3|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
576376|NCT00576472|1405997|P2|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
576377|NCT00576472|1405998|P1|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
576378|NCT00576472|1405984|P15|NOT COMPLETED|MPH Cross Over Phase||0
576379|NCT00576472|1405985|P14|NOT COMPLETED|MPH Cross Over Phase||0
576380|NCT00576472|1405986|P13|NOT COMPLETED|MPH Cross Over Phase||0
576381|NCT00576472|1405987|P12|NOT COMPLETED|MPH Cross Over Phase||1
576382|NCT00576472|1405988|P11|NOT COMPLETED|MPH Cross Over Phase||1
576383|NCT00576472|1405989|P10|NOT COMPLETED|MPH Cross Over Phase||0
576384|NCT00576472|1405990|P9|NOT COMPLETED|MPH Cross Over Phase||2
576385|NCT00576472|1405991|P8|NOT COMPLETED|MPH Cross Over Phase||0
576386|NCT00576472|1405992|P7|NOT COMPLETED|MPH Cross Over Phase||12
576387|NCT00576472|1405993|P6|NOT COMPLETED|MPH Cross Over Phase||0
576388|NCT00576472|1405994|P5|NOT COMPLETED|MPH Cross Over Phase||0
576389|NCT00576472|1405995|P4|NOT COMPLETED|MPH Cross Over Phase||0
576390|NCT00576472|1405996|P3|NOT COMPLETED|MPH Cross Over Phase||0
576391|NCT00576472|1405997|P2|NOT COMPLETED|MPH Cross Over Phase||0
576392|NCT00576472|1405998|P1|NOT COMPLETED|MPH Cross Over Phase||0
576393|NCT00576472|1405984|P15|COMPLETED|MPH Cross Over Phase||0
576394|NCT00576472|1405985|P14|COMPLETED|MPH Cross Over Phase||0
576395|NCT00576472|1405986|P13|COMPLETED|MPH Cross Over Phase||21
576396|NCT00576472|1405987|P12|COMPLETED|MPH Cross Over Phase||17
576397|NCT00576472|1405988|P11|COMPLETED|MPH Cross Over Phase||22
576398|NCT00576472|1405989|P10|COMPLETED|MPH Cross Over Phase||22
576399|NCT00576472|1405990|P9|COMPLETED|MPH Cross Over Phase||16
576400|NCT00576472|1405991|P8|COMPLETED|MPH Cross Over Phase||20
576401|NCT00576472|1405992|P7|COMPLETED|MPH Cross Over Phase||0
576402|NCT00576472|1405993|P6|COMPLETED|MPH Cross Over Phase||0
576403|NCT00576472|1405994|P5|COMPLETED|MPH Cross Over Phase||0
576404|NCT00576472|1405995|P4|COMPLETED|MPH Cross Over Phase||0
576405|NCT00576472|1405996|P3|COMPLETED|MPH Cross Over Phase||0
576406|NCT00576472|1405997|P2|COMPLETED|MPH Cross Over Phase||0
576407|NCT00576472|1405998|P1|COMPLETED|MPH Cross Over Phase||0
576408|NCT00576472|1405984|P15|STARTED|MPH Cross Over Phase||0
576409|NCT00576472|1405985|P14|STARTED|MPH Cross Over Phase||0
576410|NCT00576472|1405986|P13|STARTED|MPH Cross Over Phase||21
576411|NCT00576472|1405987|P12|STARTED|MPH Cross Over Phase||18
576412|NCT00576472|1405988|P11|STARTED|MPH Cross Over Phase||23
576413|NCT00576472|1405989|P10|STARTED|MPH Cross Over Phase||22
576414|NCT00576472|1405990|P9|STARTED|MPH Cross Over Phase||18
576415|NCT00576472|1405991|P8|STARTED|MPH Cross Over Phase||20
576416|NCT00576472|1405992|P7|STARTED|MPH Cross Over Phase||12
576417|NCT00576472|1405993|P6|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
576418|NCT00576472|1405994|P5|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
576419|NCT00576472|1405995|P4|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
576420|NCT00576472|1405996|P3|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
576421|NCT00576472|1405997|P2|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
576422|NCT00576472|1405998|P1|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
576423|NCT00576472|1405984|P15|NOT COMPLETED|MPH In-Lab Phase||0
576424|NCT00576472|1405985|P14|NOT COMPLETED|MPH In-Lab Phase||0
576425|NCT00576472|1405986|P13|NOT COMPLETED|MPH In-Lab Phase||0
576426|NCT00576472|1405987|P12|NOT COMPLETED|MPH In-Lab Phase||0
576427|NCT00576472|1405988|P11|NOT COMPLETED|MPH In-Lab Phase||0
576428|NCT00576472|1405989|P10|NOT COMPLETED|MPH In-Lab Phase||0
576429|NCT00576472|1405990|P9|NOT COMPLETED|MPH In-Lab Phase||0
576430|NCT00576472|1405991|P8|NOT COMPLETED|MPH In-Lab Phase||0
576431|NCT00576472|1405992|P7|NOT COMPLETED|MPH In-Lab Phase||0
576432|NCT00576472|1405993|P6|NOT COMPLETED|MPH In-Lab Phase||0
576433|NCT00576472|1405994|P5|NOT COMPLETED|MPH In-Lab Phase||0
576434|NCT00576472|1405995|P4|NOT COMPLETED|MPH In-Lab Phase||335
576435|NCT00576472|1405996|P3|NOT COMPLETED|MPH In-Lab Phase||0
576436|NCT00576472|1405997|P2|NOT COMPLETED|MPH In-Lab Phase||0
576437|NCT00576472|1405998|P1|NOT COMPLETED|MPH In-Lab Phase||0
576438|NCT00576472|1405984|P15|COMPLETED|MPH In-Lab Phase||0
576439|NCT00576472|1405985|P14|COMPLETED|MPH In-Lab Phase||0
576440|NCT00576472|1405986|P13|COMPLETED|MPH In-Lab Phase||0
576441|NCT00576472|1405987|P12|COMPLETED|MPH In-Lab Phase||0
576442|NCT00576472|1405988|P11|COMPLETED|MPH In-Lab Phase||0
576443|NCT00576472|1405989|P10|COMPLETED|MPH In-Lab Phase||0
576444|NCT00576472|1405990|P9|COMPLETED|MPH In-Lab Phase||0
576445|NCT00576472|1405991|P8|COMPLETED|MPH In-Lab Phase||0
576446|NCT00576472|1405992|P7|COMPLETED|MPH In-Lab Phase||0
576447|NCT00576472|1405993|P6|COMPLETED|MPH In-Lab Phase||67
576448|NCT00576472|1405994|P5|COMPLETED|MPH In-Lab Phase||67
576449|NCT00576472|1405995|P4|COMPLETED|MPH In-Lab Phase||0
576450|NCT00576472|1405996|P3|COMPLETED|MPH In-Lab Phase||0
576451|NCT00576472|1405997|P2|COMPLETED|MPH In-Lab Phase||0
576452|NCT00576472|1405998|P1|COMPLETED|MPH In-Lab Phase||0
576453|NCT00576472|1405984|P15|STARTED|MPH In-Lab Phase||0
576454|NCT00576472|1405985|P14|STARTED|MPH In-Lab Phase||0
576455|NCT00576472|1405986|P13|STARTED|MPH In-Lab Phase||0
576456|NCT00576472|1405987|P12|STARTED|MPH In-Lab Phase||0
576457|NCT00576472|1405988|P11|STARTED|MPH In-Lab Phase||0
576458|NCT00576472|1405989|P10|STARTED|MPH In-Lab Phase||0
576459|NCT00576472|1405990|P9|STARTED|MPH In-Lab Phase||0
576460|NCT00576472|1405991|P8|STARTED|MPH In-Lab Phase||0
576461|NCT00576472|1405992|P7|STARTED|MPH In-Lab Phase||0
576462|NCT00576472|1405993|P6|STARTED|MPH In-Lab Phase||67
576463|NCT00576472|1405994|P5|STARTED|MPH In-Lab Phase||67
576464|NCT00576472|1405995|P4|STARTED|MPH In-Lab Phase||335
576465|NCT00576472|1405996|P3|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
576466|NCT00576472|1405997|P2|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
576467|NCT00576472|1405998|P1|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
576468|NCT00576472|1405984|P15|NOT COMPLETED|Initial Screening||0
576469|NCT00576472|1405985|P14|NOT COMPLETED|Initial Screening||0
576470|NCT00576472|1405986|P13|NOT COMPLETED|Initial Screening||0
576471|NCT00576472|1405987|P12|NOT COMPLETED|Initial Screening||0
576472|NCT00576472|1405988|P11|NOT COMPLETED|Initial Screening||0
576473|NCT00576472|1405989|P10|NOT COMPLETED|Initial Screening||0
576474|NCT00576472|1405990|P9|NOT COMPLETED|Initial Screening||0
576475|NCT00576472|1405991|P8|NOT COMPLETED|Initial Screening||0
576476|NCT00576472|1405992|P7|NOT COMPLETED|Initial Screening||0
576477|NCT00576472|1405993|P6|NOT COMPLETED|Initial Screening||0
576478|NCT00576472|1405994|P5|NOT COMPLETED|Initial Screening||0
576479|NCT00576472|1405995|P4|NOT COMPLETED|Initial Screening||0
576480|NCT00576472|1405996|P3|NOT COMPLETED|Initial Screening||0
576481|NCT00576472|1405997|P2|NOT COMPLETED|Initial Screening||0
576482|NCT00576472|1405998|P1|NOT COMPLETED|Initial Screening||0
576483|NCT00576472|1405984|P15|COMPLETED|Initial Screening||0
576484|NCT00576472|1405985|P14|COMPLETED|Initial Screening||0
576485|NCT00576472|1405986|P13|COMPLETED|Initial Screening||0
576486|NCT00576472|1405987|P12|COMPLETED|Initial Screening||0
576487|NCT00576472|1405988|P11|COMPLETED|Initial Screening||0
576488|NCT00576472|1405989|P10|COMPLETED|Initial Screening||0
576489|NCT00576472|1405990|P9|COMPLETED|Initial Screening||0
576490|NCT00576472|1405991|P8|COMPLETED|Initial Screening||0
576491|NCT00576472|1405992|P7|COMPLETED|Initial Screening||0
576492|NCT00576472|1405993|P6|COMPLETED|Initial Screening||0
576493|NCT00576472|1405994|P5|COMPLETED|Initial Screening||0
576494|NCT00576472|1405995|P4|COMPLETED|Initial Screening||0
576495|NCT00576472|1405996|P3|COMPLETED|Initial Screening||199
576496|NCT00576472|1405997|P2|COMPLETED|Initial Screening||40
576497|NCT00576472|1405998|P1|COMPLETED|Initial Screening||230
576498|NCT00576472|1405984|P15|STARTED|Initial Screening||0
576499|NCT00576472|1405985|P14|STARTED|Initial Screening||0
576500|NCT00576472|1405986|P13|STARTED|Initial Screening||0
576501|NCT00576472|1405987|P12|STARTED|Initial Screening||0
576502|NCT00576472|1405988|P11|STARTED|Initial Screening||0
576503|NCT00576472|1405989|P10|STARTED|Initial Screening||0
576504|NCT00576472|1405990|P9|STARTED|Initial Screening||0
576505|NCT00576472|1405991|P8|STARTED|Initial Screening||0
576506|NCT00576472|1405992|P7|STARTED|Initial Screening||0
576507|NCT00576472|1405993|P6|STARTED|Initial Screening||0
576508|NCT00576472|1405994|P5|STARTED|Initial Screening||0
576509|NCT00576472|1405995|P4|STARTED|Initial Screening||0
576510|NCT00576472|1405996|P3|STARTED|Initial Screening||199
576511|NCT00576472|1405997|P2|STARTED|Initial Screening||40
576512|NCT00576472|1405998|P1|STARTED|Initial Screening||230
576513|NCT00576420|1406091|P3|NOT COMPLETED|Overall Study||1
576514|NCT00576420|1406092|P2|NOT COMPLETED|Overall Study||0
576515|NCT00576420|1406093|P1|NOT COMPLETED|Overall Study||0
576516|NCT00576420|1406091|P3|COMPLETED|Overall Study||22
576517|NCT00576420|1406092|P2|COMPLETED|Overall Study||24
576518|NCT00576420|1406093|P1|COMPLETED|Overall Study||26
576519|NCT00576420|1406091|P3|STARTED|Overall Study||23
576520|NCT00576420|1406092|P2|STARTED|Overall Study||24
576521|NCT00576420|1406093|P1|STARTED|Overall Study||26
576522|NCT00576381|1406258|P1|NOT COMPLETED|Overall Study||7
576523|NCT00576381|1406258|P1|COMPLETED|Overall Study||23
576524|NCT00576381|1406258|P1|STARTED|Overall Study||30
576525|NCT00576316|1406262|P1|NOT COMPLETED|Overall Study||20
576526|NCT00576316|1406262|P1|COMPLETED|Overall Study|Number of patients who completed study|181
576527|NCT00576316|1406262|P1|STARTED|Overall Study|Number of patients recruited|201
576528|NCT00576303|1406267|P1|NOT COMPLETED|Long Term Safety Period||16
576529|NCT00576303|1406267|P1|COMPLETED|Long Term Safety Period||162
576530|NCT00576303|1406267|P1|STARTED|Long Term Safety Period||178
576531|NCT00576303|1406267|P1|NOT COMPLETED|Efficacy Evaluation Period||5
576532|NCT00576303|1406267|P1|COMPLETED|Efficacy Evaluation Period||178
576533|NCT00576303|1406267|P1|STARTED|Efficacy Evaluation Period||183
576534|NCT00576303|1406267|P1|NOT COMPLETED|Dose Titration Period||17
576535|NCT00576303|1406267|P1|COMPLETED|Dose Titration Period||183
576536|NCT00576303|1406267|P1|STARTED|Dose Titration Period||200
576537|NCT00576251|1406278|P2|NOT COMPLETED|Overall Study||1
576538|NCT00576251|1406279|P1|NOT COMPLETED|Overall Study||1
576539|NCT00576251|1406278|P2|COMPLETED|Overall Study||111
576540|NCT00576251|1406279|P1|COMPLETED|Overall Study||108
576541|NCT00576251|1406278|P2|STARTED|Overall Study||112
576542|NCT00576251|1406279|P1|STARTED|Overall Study||109
576543|NCT00576199|1406285|P1|NOT COMPLETED|Overall Study||30
576544|NCT00576199|1406285|P1|COMPLETED|Overall Study||0
576545|NCT00576199|1406285|P1|STARTED|Overall Study||30
576546|NCT00576147|1406294|P1|NOT COMPLETED|Overall Study||0
576547|NCT00576147|1406294|P1|COMPLETED|Overall Study||431
576548|NCT00576147|1406294|P1|STARTED|Overall Study||431
576549|NCT00576056|1406298|P1|NOT COMPLETED|Overall Study||14
576550|NCT00576056|1406298|P1|COMPLETED|Overall Study||5
576551|NCT00576056|1406298|P1|STARTED|Overall Study||19
576552|NCT00575965|1406303|P1|NOT COMPLETED|Overall Study||0
576553|NCT00575965|1406303|P1|COMPLETED|Overall Study||18
576554|NCT00575965|1406303|P1|STARTED|Overall Study||18
576555|NCT00575887|1406308|P1|NOT COMPLETED|Overall Study||0
576556|NCT00575887|1406308|P1|COMPLETED|Overall Study||25
576557|NCT00575887|1406308|P1|STARTED|Overall Study||25
576558|NCT00575666|1406314|P2|NOT COMPLETED|Overall Study||3
576559|NCT00575666|1406315|P1|NOT COMPLETED|Overall Study||4
576560|NCT00575666|1406314|P2|COMPLETED|Overall Study||21
576561|NCT00575666|1406315|P1|COMPLETED|Overall Study||17
576562|NCT00575666|1406314|P2|STARTED|Overall Study||24
576563|NCT00575666|1406315|P1|STARTED|Overall Study||21
576564|NCT00575588|1406355|P2|NOT COMPLETED|Overall Study||283
576565|NCT00575588|1406356|P1|NOT COMPLETED|Overall Study||263
576566|NCT00575588|1406355|P2|COMPLETED|Overall Study|Completed 104 weeks of treatment|147
576567|NCT00575588|1406356|P1|COMPLETED|Overall Study|Completed 104 weeks of treatment|165
576568|NCT00575588|1406355|P2|STARTED|Overall Study|Randomized and treated|430
576569|NCT00575588|1406356|P1|STARTED|Overall Study|Randomized and treated|428
576570|NCT00575510|1406379|P3|NOT COMPLETED|Overall Study||17
576571|NCT00575510|1406380|P2|NOT COMPLETED|Overall Study||13
576572|NCT00575510|1406381|P1|NOT COMPLETED|Overall Study||12
576573|NCT00575510|1406379|P3|COMPLETED|Overall Study||96
576574|NCT00575510|1406380|P2|COMPLETED|Overall Study||101
576575|NCT00575510|1406381|P1|COMPLETED|Overall Study||102
576576|NCT00575510|1406379|P3|STARTED|Overall Study||113
576577|NCT00575510|1406380|P2|STARTED|Overall Study||114
576578|NCT00575510|1406381|P1|STARTED|Overall Study||114
576579|NCT00575380|1406394|P2|NOT COMPLETED|Overall Study||3
576580|NCT00575380|1406395|P1|NOT COMPLETED|Overall Study||1
576581|NCT00575380|1406394|P2|COMPLETED|Overall Study||55
576582|NCT00575380|1406395|P1|COMPLETED|Overall Study||57
576583|NCT00575380|1406394|P2|STARTED|Overall Study||58
576584|NCT00575380|1406395|P1|STARTED|Overall Study||58
576585|NCT00575367|1406405|P2|NOT COMPLETED|Overall Study||0
576586|NCT00575367|1406406|P1|NOT COMPLETED|Overall Study||0
576587|NCT00575367|1406405|P2|COMPLETED|Overall Study||18
576588|NCT00575367|1406406|P1|COMPLETED|Overall Study||19
576589|NCT00575367|1406405|P2|STARTED|Overall Study||18
576590|NCT00575367|1406406|P1|STARTED|Overall Study||19
576591|NCT00575185|1406414|P2|NOT COMPLETED|Overall Study||0
576592|NCT00575185|1406415|P1|NOT COMPLETED|Overall Study||0
576593|NCT00575185|1406414|P2|COMPLETED|Overall Study||11
576594|NCT00575185|1406415|P1|COMPLETED|Overall Study||12
576595|NCT00575185|1406414|P2|STARTED|Overall Study||11
576596|NCT00575185|1406415|P1|STARTED|Overall Study||12
576597|NCT00575159|1406423|P1|NOT COMPLETED|Overall Study||0
576598|NCT00575159|1406423|P1|COMPLETED|Overall Study||10
576599|NCT00575159|1406423|P1|STARTED|Overall Study||10
576600|NCT00575146|1406531|P1|NOT COMPLETED|Overall Study||3
576601|NCT00575146|1406531|P1|COMPLETED|Overall Study||17
576602|NCT00575146|1406531|P1|STARTED|Overall Study||20
576603|NCT00575094|1406537|P1|NOT COMPLETED|Overall Study||3
576604|NCT00575094|1406537|P1|COMPLETED|Overall Study||6
576605|NCT00575094|1406537|P1|STARTED|Overall Study||9
576606|NCT00575042|1406541|P1|NOT COMPLETED|Overall Study||3
576607|NCT00575042|1406541|P1|COMPLETED|Overall Study|2 with side effects and 1 lost to follow-up|17
576608|NCT00575042|1406541|P1|STARTED|Overall Study||20
576609|NCT00575029|1406546|P1|NOT COMPLETED|Overall Study||0
576610|NCT00575029|1406546|P1|COMPLETED|Overall Study||7
576611|NCT00575029|1406546|P1|STARTED|Overall Study||7
576612|NCT00575016|1406555|P4|NOT COMPLETED|Treatment Cycle 2||0
576613|NCT00575016|1406556|P3|NOT COMPLETED|Treatment Cycle 2||0
576614|NCT00575016|1406557|P2|NOT COMPLETED|Treatment Cycle 2||0
576615|NCT00575016|1406558|P1|NOT COMPLETED|Treatment Cycle 2||1
576616|NCT00575016|1406555|P4|COMPLETED|Treatment Cycle 2||0
576617|NCT00575016|1406556|P3|COMPLETED|Treatment Cycle 2||0
576618|NCT00575016|1406557|P2|COMPLETED|Treatment Cycle 2||0
576619|NCT00575016|1406558|P1|COMPLETED|Treatment Cycle 2||30
576620|NCT00575016|1406555|P4|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
576621|NCT00575016|1406556|P3|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
576622|NCT00575016|1406557|P2|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
576623|NCT00575016|1406558|P1|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|31
576624|NCT00575016|1406555|P4|NOT COMPLETED|Treatment Cycle 1||5
576625|NCT00575016|1406556|P3|NOT COMPLETED|Treatment Cycle 1||4
576626|NCT00575016|1406557|P2|NOT COMPLETED|Treatment Cycle 1||5
576627|NCT00575016|1406558|P1|NOT COMPLETED|Treatment Cycle 1||9
576628|NCT00575016|1406555|P4|COMPLETED|Treatment Cycle 1|9 pts from Placebo group entered Cycle 2|12
576629|NCT00575016|1406556|P3|COMPLETED|Treatment Cycle 1|8 pts from 50U group entered Cycle 2|15
576630|NCT00575016|1406557|P2|COMPLETED|Treatment Cycle 1|11 pts from 100U group entered Cycle 2|16
576631|NCT00575016|1406558|P1|COMPLETED|Treatment Cycle 1|3 pts from 200U group entered Cycle 2|8
576632|NCT00575016|1406555|P4|STARTED|Treatment Cycle 1|1 pt randomized to Placebo never received treatment|17
576633|NCT00575016|1406556|P3|STARTED|Treatment Cycle 1||19
576634|NCT00575016|1406557|P2|STARTED|Treatment Cycle 1||21
576635|NCT00575016|1406558|P1|STARTED|Treatment Cycle 1||17
576636|NCT00574990|1406579|P3|NOT COMPLETED|Overall Study||0
576637|NCT00574990|1406580|P2|NOT COMPLETED|Overall Study||0
576638|NCT00574990|1406581|P1|NOT COMPLETED|Overall Study||0
576639|NCT00574990|1406579|P3|COMPLETED|Overall Study||8
576640|NCT00574990|1406580|P2|COMPLETED|Overall Study||19
576641|NCT00574990|1406581|P1|COMPLETED|Overall Study||12
576642|NCT00574990|1406579|P3|STARTED|Overall Study||8
576643|NCT00574990|1406580|P2|STARTED|Overall Study||19
576644|NCT00574990|1406581|P1|STARTED|Overall Study||12
576645|NCT00574951|1406592|P1|NOT COMPLETED|Overall Study||1
576646|NCT00574951|1406592|P1|COMPLETED|Overall Study||22
576647|NCT00574951|1406592|P1|STARTED|Overall Study||23
576648|NCT00574912|1406600|P1|NOT COMPLETED|Overall Study||8
576649|NCT00574912|1406600|P1|COMPLETED|Overall Study||12
576650|NCT00574912|1406600|P1|Completed 2.0|Overall Study||12
576651|NCT00574912|1406600|P1|Completed 1.5|Overall Study||12
576652|NCT00574912|1406600|P1|Completed 1.0|Overall Study||12
576653|NCT00574912|1406600|P1|Completed 0.5|Overall Study||12
576654|NCT00574912|1406600|P1|Completed Placebo|Overall Study|12 original participants started the trial.|12
576655|NCT00574912|1406600|P1|STARTED|Overall Study||20
576656|NCT00574873|1406614|P2|NOT COMPLETED|Overall Study||251
576657|NCT00574873|1406615|P1|NOT COMPLETED|Overall Study||238
576658|NCT00574873|1406614|P2|COMPLETED|Overall Study||1
576659|NCT00574873|1406615|P1|COMPLETED|Overall Study||12
576660|NCT00574873|1406614|P2|Treated|Overall Study||251
576661|NCT00574873|1406615|P1|Treated|Overall Study||248
576662|NCT00574873|1406614|P2|STARTED|Overall Study||252
576663|NCT00574873|1406615|P1|STARTED|Overall Study||250
576664|NCT00574847|1406633|P2|NOT COMPLETED|Overall Study||7
576665|NCT00574847|1406634|P1|NOT COMPLETED|Overall Study||8
576666|NCT00574847|1406633|P2|COMPLETED|Overall Study||56
576667|NCT00574847|1406634|P1|COMPLETED|Overall Study||56
576668|NCT00574847|1406633|P2|STARTED|Overall Study||63
576669|NCT00574847|1406634|P1|STARTED|Overall Study||64
576670|NCT00574834|1406669|P3|NOT COMPLETED|Overall Study||0
576671|NCT00574834|1406670|P2|NOT COMPLETED|Overall Study||0
576672|NCT00574834|1406671|P1|NOT COMPLETED|Overall Study||0
576673|NCT00574834|1406669|P3|COMPLETED|Overall Study||4
576674|NCT00574834|1406670|P2|COMPLETED|Overall Study||4
576675|NCT00574834|1406671|P1|COMPLETED|Overall Study||9
576676|NCT00574834|1406669|P3|STARTED|Overall Study||4
576677|NCT00574834|1406670|P2|STARTED|Overall Study||4
576678|NCT00574834|1406671|P1|STARTED|Overall Study||9
576679|NCT00574795|1406679|P1|NOT COMPLETED|Toddler Dose||1
576680|NCT00574795|1406679|P1|COMPLETED|Toddler Dose||184
576681|NCT00574795|1406679|P1|STARTED|Toddler Dose||185
576682|NCT00574795|1406679|P1|NOT COMPLETED|After Infant Series||3
576683|NCT00574795|1406679|P1|COMPLETED|After Infant Series||185
576684|NCT00574795|1406679|P1|STARTED|After Infant Series||188
576685|NCT00574795|1406679|P1|NOT COMPLETED|Infant Series||5
576686|NCT00574795|1406679|P1|COMPLETED|Infant Series||188
576687|NCT00574795|1406679|P1|Vaccinated Dose 3|Infant Series||190
576688|NCT00574795|1406679|P1|Vaccinated Dose 2|Infant Series||190
576689|NCT00574795|1406679|P1|Vaccinated Dose 1|Infant Series||193
576690|NCT00574795|1406679|P1|STARTED|Infant Series||193
576691|NCT00574704|1406700|P4|NOT COMPLETED|Overall Study||0
576692|NCT00574704|1406701|P3|NOT COMPLETED|Overall Study||1
576693|NCT00574704|1406702|P2|NOT COMPLETED|Overall Study||0
576694|NCT00574704|1406703|P1|NOT COMPLETED|Overall Study||0
576695|NCT00574704|1406700|P4|COMPLETED|Overall Study||10
576696|NCT00574704|1406701|P3|COMPLETED|Overall Study||9
576697|NCT00574704|1406702|P2|COMPLETED|Overall Study||10
576698|NCT00574704|1406703|P1|COMPLETED|Overall Study||10
576699|NCT00574704|1406700|P4|STARTED|Overall Study||10
576700|NCT00574704|1406701|P3|STARTED|Overall Study||10
576701|NCT00574704|1406702|P2|STARTED|Overall Study||10
576702|NCT00574704|1406703|P1|STARTED|Overall Study||10
576703|NCT00574548|1406715|P2|NOT COMPLETED|Overall Study||16
576704|NCT00574548|1406716|P1|NOT COMPLETED|Overall Study||61
576705|NCT00574548|1406715|P2|COMPLETED|Overall Study||222
576706|NCT00574548|1406716|P1|COMPLETED|Overall Study||421
576707|NCT00574548|1406715|P2|Completed Vax 2 (6 Month Contact)|Overall Study||222
576708|NCT00574548|1406716|P1|Completed Vax 2 (6 Month Contact)|Overall Study||421
576709|NCT00574548|1406715|P2|Received Vax 2|Overall Study||223
576710|NCT00574548|1406716|P1|Received Vax 2|Overall Study||427
576711|NCT00574548|1406715|P2|Withdrawn Before Vax 2|Overall Study||11
576712|NCT00574548|1406716|P1|Withdrawn Before Vax 2|Overall Study||41
576713|NCT00574548|1406715|P2|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||3
576714|NCT00574548|1406716|P1|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||7
576715|NCT00574548|1406715|P2|Completed Vax 1 (6 Month Contact)|Overall Study||234
576716|NCT00574548|1406716|P1|Completed Vax 1 (6 Month Contact)|Overall Study||468
576717|NCT00574548|1406715|P2|Received Vaccination 1 (Vax 1)|Overall Study||237
576718|NCT00574548|1406716|P1|Received Vaccination 1 (Vax 1)|Overall Study||478
576719|NCT00574548|1406715|P2|STARTED|Overall Study||238
576720|NCT00574548|1406716|P1|STARTED|Overall Study||482
576721|NCT00574405|1406762|P2|NOT COMPLETED|Overall Study||2
576722|NCT00574405|1406763|P1|NOT COMPLETED|Overall Study||3
576723|NCT00574405|1406762|P2|COMPLETED|Overall Study||10
576724|NCT00574405|1406763|P1|COMPLETED|Overall Study||9
576725|NCT00574405|1406762|P2|STARTED|Overall Study||12
576726|NCT00574405|1406763|P1|STARTED|Overall Study||12
576727|NCT00574340|1406769|P2|NOT COMPLETED|Study 2 (2 Days)||0
576728|NCT00574340|1406770|P1|NOT COMPLETED|Study 2 (2 Days)||0
576729|NCT00574340|1406769|P2|COMPLETED|Study 2 (2 Days)||6
576730|NCT00574340|1406770|P1|COMPLETED|Study 2 (2 Days)||6
576731|NCT00574340|1406769|P2|STARTED|Study 2 (2 Days)||6
576732|NCT00574340|1406770|P1|STARTED|Study 2 (2 Days)||6
576733|NCT00574340|1406769|P2|NOT COMPLETED|Study 1 (2 Days)||0
576734|NCT00574340|1406770|P1|NOT COMPLETED|Study 1 (2 Days)||0
576735|NCT00574340|1406769|P2|COMPLETED|Study 1 (2 Days)||10
576736|NCT00574340|1406770|P1|COMPLETED|Study 1 (2 Days)||10
576737|NCT00574340|1406769|P2|STARTED|Study 1 (2 Days)||10
576738|NCT00574340|1406770|P1|STARTED|Study 1 (2 Days)||10
576739|NCT00574288|1406783|P7|NOT COMPLETED|Overall Study||28
576740|NCT00574288|1406784|P6|NOT COMPLETED|Overall Study||26
576741|NCT00574288|1406785|P5|NOT COMPLETED|Overall Study||2
576742|NCT00574288|1406786|P4|NOT COMPLETED|Overall Study||2
576743|NCT00574288|1406787|P3|NOT COMPLETED|Overall Study||3
576744|NCT00574288|1406788|P2|NOT COMPLETED|Overall Study||3
576745|NCT00574288|1406789|P1|NOT COMPLETED|Overall Study||20
576746|NCT00574288|1406783|P7|COMPLETED|Overall Study||14
576747|NCT00574288|1406784|P6|COMPLETED|Overall Study||4
576748|NCT00574288|1406785|P5|COMPLETED|Overall Study||1
576749|NCT00574288|1406786|P4|COMPLETED|Overall Study||1
576750|NCT00574288|1406787|P3|COMPLETED|Overall Study||0
576751|NCT00574288|1406788|P2|COMPLETED|Overall Study||0
576752|NCT00574288|1406789|P1|COMPLETED|Overall Study||0
576753|NCT00574288|1406783|P7|STARTED|Overall Study||42
576754|NCT00574288|1406784|P6|STARTED|Overall Study||30
576755|NCT00574288|1406785|P5|STARTED|Overall Study||3
576756|NCT00574288|1406786|P4|STARTED|Overall Study||3
576757|NCT00574288|1406787|P3|STARTED|Overall Study||3
576758|NCT00574288|1406788|P2|STARTED|Overall Study||3
576759|NCT00574288|1406789|P1|STARTED|Overall Study||20
576760|NCT00574275|1406827|P2|NOT COMPLETED|Overall Study||271
576761|NCT00574275|1406828|P1|NOT COMPLETED|Overall Study||275
576762|NCT00574275|1406827|P2|COMPLETED|Overall Study|All participants stopped when they met treatment discontinuation criteria or by DMC recommendation|0
576763|NCT00574275|1406828|P1|COMPLETED|Overall Study|All participants stopped when they met treatment discontinuation criteria or by DMC recommendation|0
576764|NCT00574275|1406827|P2|SAFETY POPULATION|Overall Study|Includes 2 participants from the Placebo and Gemcitabine arm who received 1 dose of Aflibercept|270
576765|NCT00574275|1406828|P1|SAFETY POPULATION|Overall Study|Excludes 2 participants who received 1 dose of Aflibercept|271
576766|NCT00574275|1406827|P2|TREATED|Overall Study||268
576767|NCT00574275|1406828|P1|TREATED|Overall Study||273
576768|NCT00574275|1406827|P2|STARTED|Overall Study||271
576769|NCT00574275|1406828|P1|STARTED|Overall Study||275
576770|NCT00574249|1406846|P2|NOT COMPLETED|Overall Study||28
576771|NCT00574249|1406847|P1|NOT COMPLETED|Overall Study||26
576772|NCT00574249|1406846|P2|COMPLETED|Overall Study||338
576773|NCT00574249|1406847|P1|COMPLETED|Overall Study||338
576774|NCT00574249|1406846|P2|STARTED|Overall Study||366
576775|NCT00574249|1406847|P1|STARTED|Overall Study||364
576776|NCT00574236|1406887|P1|NOT COMPLETED|Overall Study||0
576777|NCT00574236|1406887|P1|COMPLETED|Overall Study||4
576778|NCT00574236|1406887|P1|STARTED|Overall Study||4
576779|NCT00574171|1406892|P1|NOT COMPLETED|Overall Study||0
576780|NCT00574171|1406892|P1|COMPLETED|Overall Study||29
576781|NCT00574171|1406892|P1|STARTED|Overall Study||29
576782|NCT00574145|1406898|P2|NOT COMPLETED|Overall Study||1
576783|NCT00574145|1406899|P1|NOT COMPLETED|Overall Study||2
576784|NCT00574145|1406898|P2|COMPLETED|Overall Study||21
576785|NCT00574145|1406899|P1|COMPLETED|Overall Study||20
576786|NCT00574145|1406898|P2|STARTED|Overall Study||22
576787|NCT00574145|1406899|P1|STARTED|Overall Study||22
576788|NCT00574080|1406911|P2|NOT COMPLETED|Overall Study||10
576789|NCT00574080|1406912|P1|NOT COMPLETED|Overall Study||10
576790|NCT00574080|1406911|P2|COMPLETED|Overall Study||0
576791|NCT00574080|1406912|P1|COMPLETED|Overall Study||0
576792|NCT00574080|1406911|P2|STARTED|Overall Study||10
576793|NCT00574080|1406912|P1|STARTED|Overall Study||10
576794|NCT00574067|1406922|P4|NOT COMPLETED|Overall Study||0
576795|NCT00574067|1406923|P3|NOT COMPLETED|Overall Study||0
576796|NCT00574067|1406924|P2|NOT COMPLETED|Overall Study||1
576797|NCT00574067|1406925|P1|NOT COMPLETED|Overall Study||1
576798|NCT00574067|1406922|P4|COMPLETED|Overall Study||53
576799|NCT00574067|1406923|P3|COMPLETED|Overall Study||54
576800|NCT00574067|1406924|P2|COMPLETED|Overall Study||52
576801|NCT00574067|1406925|P1|COMPLETED|Overall Study||52
576802|NCT00574067|1406922|P4|STARTED|Overall Study||53
576803|NCT00574067|1406923|P3|STARTED|Overall Study||54
576804|NCT00574067|1406924|P2|STARTED|Overall Study||53
576805|NCT00574067|1406925|P1|STARTED|Overall Study||53
576806|NCT00573937|1406961|P2|NOT COMPLETED|Overall Study||1
576807|NCT00573937|1406962|P1|NOT COMPLETED|Overall Study||0
576808|NCT00573937|1406961|P2|COMPLETED|Overall Study||0
576809|NCT00573937|1406962|P1|COMPLETED|Overall Study||0
576810|NCT00573937|1406961|P2|STARTED|Overall Study||1
576811|NCT00573937|1406962|P1|STARTED|Overall Study||0
576812|NCT00573872|1406970|P1|NOT COMPLETED|Overall Study||11
576813|NCT00573872|1406970|P1|COMPLETED|Overall Study|# of patients that completed treatment|32
576814|NCT00573872|1406970|P1|STARTED|Overall Study|# of patients that signed consent|43
576815|NCT00573859|1406976|P1|NOT COMPLETED|Smoking Versus Abstinence||12
576816|NCT00573859|1406976|P1|COMPLETED|Smoking Versus Abstinence||15
576817|NCT00573859|1406976|P1|STARTED|Smoking Versus Abstinence||27
576818|NCT00573859|1406976|P1|NOT COMPLETED|Medication Versus Placebo||12
576819|NCT00573859|1406976|P1|COMPLETED|Medication Versus Placebo||15
576820|NCT00573859|1406976|P1|STARTED|Medication Versus Placebo||27
576821|NCT00573833|1406982|P1|NOT COMPLETED|Overall Study||2
576822|NCT00573833|1406982|P1|COMPLETED|Overall Study||21
576823|NCT00573833|1406982|P1|STARTED|Overall Study||23
576824|NCT00573794|1406989|P1|NOT COMPLETED|Overall Study||330
576825|NCT00573794|1406989|P1|COMPLETED|Overall Study||255
576826|NCT00573794|1406989|P1|STARTED|Overall Study||585
576827|NCT00573768|1407020|P3|NOT COMPLETED|Overall Study||4
576828|NCT00573768|1407021|P2|NOT COMPLETED|Overall Study||2
576829|NCT00573768|1407022|P1|NOT COMPLETED|Overall Study||2
576830|NCT00573768|1407020|P3|COMPLETED|Overall Study||87
576831|NCT00573768|1407021|P2|COMPLETED|Overall Study||89
576832|NCT00573768|1407022|P1|COMPLETED|Overall Study||87
576833|NCT00573768|1407020|P3|STARTED|Overall Study||91
576834|NCT00573768|1407021|P2|STARTED|Overall Study||91
576835|NCT00573768|1407022|P1|STARTED|Overall Study||89
576836|NCT00573755|1407032|P2|NOT COMPLETED|Overall Study||0
576837|NCT00573755|1407033|P1|NOT COMPLETED|Overall Study||1
576838|NCT00573755|1407032|P2|COMPLETED|Overall Study||2
576839|NCT00573755|1407033|P1|COMPLETED|Overall Study||1
576840|NCT00573755|1407032|P2|STARTED|Overall Study||2
576841|NCT00573755|1407033|P1|STARTED|Overall Study||2
576842|NCT00573534|1407049|P1|NOT COMPLETED|Overall Study||3
576843|NCT00573534|1407049|P1|COMPLETED|Overall Study||5
576844|NCT00573534|1407049|P1|STARTED|Overall Study||8
576845|NCT00573508|1407056|P2|NOT COMPLETED|Overall Study||41
576846|NCT00573508|1407057|P1|NOT COMPLETED|Overall Study||64
576847|NCT00573508|1407056|P2|COMPLETED|Overall Study||345
576848|NCT00573508|1407057|P1|COMPLETED|Overall Study||318
576849|NCT00573508|1407056|P2|Full Analysis Set (FAS)|Overall Study|Patients who took >= 1 dose of double-blind study drug, had a baseline OAB-q & >= 1 subsequent visit|377
576850|NCT00573508|1407057|P1|Full Analysis Set (FAS)|Overall Study|Patients who took >= 1 dose of double-blind study drug, had a baseline OAB-q & >= 1 subsequent visit|374
576851|NCT00573508|1407056|P2|STARTED|Overall Study||386
576852|NCT00573508|1407057|P1|STARTED|Overall Study||382
576853|NCT00573469|1407090|P3|NOT COMPLETED|Overall Study||4
576854|NCT00573469|1407091|P2|NOT COMPLETED|Overall Study||4
576855|NCT00573469|1407092|P1|NOT COMPLETED|Overall Study||6
576856|NCT00573469|1407090|P3|COMPLETED|Overall Study||22
576857|NCT00573469|1407091|P2|COMPLETED|Overall Study||21
576858|NCT00573469|1407092|P1|COMPLETED|Overall Study||20
576859|NCT00573469|1407090|P3|STARTED|Overall Study||26
576860|NCT00573469|1407091|P2|STARTED|Overall Study||25
576861|NCT00573469|1407092|P1|STARTED|Overall Study||26
576862|NCT00573443|1407115|P3|NOT COMPLETED|Open-Label Extension Phase||0
576863|NCT00573443|1407116|P2|NOT COMPLETED|Open-Label Extension Phase||0
576864|NCT00573443|1407117|P1|NOT COMPLETED|Open-Label Extension Phase||18
576865|NCT00573443|1407115|P3|COMPLETED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
576866|NCT00573443|1407116|P2|COMPLETED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
576867|NCT00573443|1407117|P1|COMPLETED|Open-Label Extension Phase||235
576868|NCT00573443|1407115|P3|Subjects With PBA Secondary to MS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
576869|NCT00573443|1407116|P2|Subjects With PBA Secondary to MS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
576870|NCT00573443|1407117|P1|Subjects With PBA Secondary to MS|Open-Label Extension Phase||107
576871|NCT00573443|1407115|P3|Subjects With PBA Secondary to ALS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
576872|NCT00573443|1407116|P2|Subjects With PBA Secondary to ALS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
576873|NCT00573443|1407117|P1|Subjects With PBA Secondary to ALS|Open-Label Extension Phase||146
576874|NCT00573443|1407115|P3|STARTED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
576875|NCT00573443|1407116|P2|STARTED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
576876|NCT00573443|1407117|P1|STARTED|Open-Label Extension Phase|Subjects who completed any of the arms in the DB phase had the option to enroll in this OLE phase|253
576877|NCT00573443|1407115|P3|NOT COMPLETED|Double-Blind Phase||15
576878|NCT00573443|1407116|P2|NOT COMPLETED|Double-Blind Phase||19
576879|NCT00573443|1407117|P1|NOT COMPLETED|Double-Blind Phase||9
576880|NCT00573443|1407115|P3|COMPLETED|Double-Blind Phase||94
576881|NCT00573443|1407116|P2|COMPLETED|Double-Blind Phase||88
576882|NCT00573443|1407117|P1|COMPLETED|Double-Blind Phase||101
576883|NCT00573443|1407115|P3|Subjects With PBA Secondary to MS|Double-Blind Phase||45
576884|NCT00573443|1407116|P2|Subjects With PBA Secondary to MS|Double-Blind Phase||39
576885|NCT00573443|1407117|P1|Subjects With PBA Secondary to MS|Double-Blind Phase||45
576886|NCT00573443|1407115|P3|Subjects With PBA Secondary to ALS|Double-Blind Phase||64
576887|NCT00573443|1407116|P2|Subjects With PBA Secondary to ALS|Double-Blind Phase||68
576888|NCT00573443|1407117|P1|Subjects With PBA Secondary to ALS|Double-Blind Phase||65
576889|NCT00573443|1407115|P3|STARTED|Double-Blind Phase||109
576890|NCT00573443|1407116|P2|STARTED|Double-Blind Phase||107
576891|NCT00573443|1407117|P1|STARTED|Double-Blind Phase||110
576892|NCT00573430|1407147|P3|NOT COMPLETED|Overall Study||10
576893|NCT00573430|1407148|P2|NOT COMPLETED|Overall Study||5
576894|NCT00573430|1407149|P1|NOT COMPLETED|Overall Study||1
576895|NCT00573430|1407147|P3|COMPLETED|Overall Study||33
576896|NCT00573430|1407148|P2|COMPLETED|Overall Study||40
576897|NCT00573430|1407149|P1|COMPLETED|Overall Study||39
576898|NCT00573430|1407147|P3|STARTED|Overall Study|randomized|43
576899|NCT00573430|1407148|P2|STARTED|Overall Study|randomized|45
576900|NCT00573430|1407149|P1|STARTED|Overall Study|randomized|40
576901|NCT00573391|1407171|P2|NOT COMPLETED|Overall Study||2
576902|NCT00573391|1407172|P1|NOT COMPLETED|Overall Study||3
576903|NCT00573391|1407171|P2|COMPLETED|Overall Study||0
576904|NCT00573391|1407172|P1|COMPLETED|Overall Study||0
576905|NCT00573391|1407171|P2|STARTED|Overall Study||2
576906|NCT00573391|1407172|P1|STARTED|Overall Study||3
576907|NCT00573313|1407182|P4|NOT COMPLETED|Overall Study||0
576908|NCT00573313|1407183|P3|NOT COMPLETED|Overall Study||6
576909|NCT00573313|1407184|P2|NOT COMPLETED|Overall Study||0
576910|NCT00573313|1407185|P1|NOT COMPLETED|Overall Study||5
576911|NCT00573313|1407182|P4|COMPLETED|Overall Study||26
576912|NCT00573313|1407183|P3|COMPLETED|Overall Study||13
576913|NCT00573313|1407184|P2|COMPLETED|Overall Study||28
576914|NCT00573313|1407185|P1|COMPLETED|Overall Study||13
576915|NCT00573313|1407182|P4|STARTED|Overall Study||26
576916|NCT00573313|1407183|P3|STARTED|Overall Study|Nineteen recruited to start.|19
576917|NCT00573313|1407184|P2|STARTED|Overall Study||28
576918|NCT00573313|1407185|P1|STARTED|Overall Study|Eighteen participants recruited to start.|18
576919|NCT00573287|1407195|P2|NOT COMPLETED|Overall Study||3
576920|NCT00573287|1407196|P1|NOT COMPLETED|Overall Study||4
576921|NCT00573287|1407195|P2|COMPLETED|Overall Study||4
576922|NCT00573287|1407196|P1|COMPLETED|Overall Study||3
576923|NCT00573287|1407195|P2|STARTED|Overall Study||7
576924|NCT00573287|1407196|P1|STARTED|Overall Study||7
576925|NCT00573261|1407204|P2|NOT COMPLETED|Overall Study||5
576926|NCT00573261|1407205|P1|NOT COMPLETED|Overall Study||6
576927|NCT00573261|1407204|P2|COMPLETED|Overall Study||15
576928|NCT00573261|1407205|P1|COMPLETED|Overall Study||14
576929|NCT00573261|1407204|P2|STARTED|Overall Study||20
576930|NCT00573261|1407205|P1|STARTED|Overall Study||20
576931|NCT00573248|1407233|P2|NOT COMPLETED|Overall Study||11
576932|NCT00573248|1407234|P1|NOT COMPLETED|Overall Study||15
576933|NCT00573248|1407233|P2|COMPLETED|Overall Study||27
576934|NCT00573248|1407234|P1|COMPLETED|Overall Study||25
576935|NCT00573248|1407233|P2|Nicotine Patches and Placebo Patches|Overall Study||27
576936|NCT00573248|1407234|P1|Nicotine Patches and Placebo Patches|Overall Study||25
576937|NCT00573248|1407233|P2|STARTED|Overall Study||38
576938|NCT00573248|1407234|P1|STARTED|Overall Study||40
576939|NCT00573183|1407248|P2|NOT COMPLETED|Overall Study||63
576940|NCT00573183|1407249|P1|NOT COMPLETED|Overall Study||72
576941|NCT00573183|1407248|P2|COMPLETED|Overall Study||174
576942|NCT00573183|1407249|P1|COMPLETED|Overall Study||162
576943|NCT00573183|1407248|P2|STARTED|Overall Study||237
576944|NCT00573183|1407249|P1|STARTED|Overall Study||234
576945|NCT00573170|1407257|P6|NOT COMPLETED|Third Treatment Period||2
576946|NCT00573170|1407258|P5|NOT COMPLETED|Third Treatment Period||0
576947|NCT00573170|1407259|P4|NOT COMPLETED|Third Treatment Period||0
576948|NCT00573170|1407260|P3|NOT COMPLETED|Third Treatment Period||0
576949|NCT00573170|1407261|P2|NOT COMPLETED|Third Treatment Period||0
576950|NCT00573170|1407262|P1|NOT COMPLETED|Third Treatment Period||1
576951|NCT00573170|1407257|P6|COMPLETED|Third Treatment Period||51
576952|NCT00573170|1407258|P5|COMPLETED|Third Treatment Period||51
576953|NCT00573170|1407259|P4|COMPLETED|Third Treatment Period||56
576954|NCT00573170|1407260|P3|COMPLETED|Third Treatment Period||55
576955|NCT00573170|1407261|P2|COMPLETED|Third Treatment Period||54
576956|NCT00573170|1407262|P1|COMPLETED|Third Treatment Period||50
576957|NCT00573170|1407257|P6|STARTED|Third Treatment Period||53
576958|NCT00573170|1407258|P5|STARTED|Third Treatment Period||51
576959|NCT00573170|1407259|P4|STARTED|Third Treatment Period||56
576960|NCT00573170|1407260|P3|STARTED|Third Treatment Period||55
576961|NCT00573170|1407261|P2|STARTED|Third Treatment Period||54
576962|NCT00573170|1407262|P1|STARTED|Third Treatment Period||51
576963|NCT00573170|1407257|P6|NOT COMPLETED|Second Washout Period||2
576964|NCT00573170|1407258|P5|NOT COMPLETED|Second Washout Period||8
576965|NCT00573170|1407259|P4|NOT COMPLETED|Second Washout Period||5
576966|NCT00573170|1407260|P3|NOT COMPLETED|Second Washout Period||4
576967|NCT00573170|1407261|P2|NOT COMPLETED|Second Washout Period||4
576968|NCT00573170|1407262|P1|NOT COMPLETED|Second Washout Period||5
576969|NCT00573170|1407257|P6|COMPLETED|Second Washout Period||53
576970|NCT00573170|1407258|P5|COMPLETED|Second Washout Period||51
576971|NCT00573170|1407259|P4|COMPLETED|Second Washout Period||56
576972|NCT00573170|1407260|P3|COMPLETED|Second Washout Period||55
576973|NCT00573170|1407261|P2|COMPLETED|Second Washout Period||54
576974|NCT00573170|1407262|P1|COMPLETED|Second Washout Period||51
576975|NCT00573170|1407257|P6|STARTED|Second Washout Period||55
576976|NCT00573170|1407258|P5|STARTED|Second Washout Period||59
576977|NCT00573170|1407259|P4|STARTED|Second Washout Period||61
576978|NCT00573170|1407260|P3|STARTED|Second Washout Period||59
576979|NCT00573170|1407261|P2|STARTED|Second Washout Period||58
576980|NCT00573170|1407262|P1|STARTED|Second Washout Period||56
576981|NCT00573170|1407257|P6|NOT COMPLETED|Second Treatment Period||0
576982|NCT00573170|1407258|P5|NOT COMPLETED|Second Treatment Period||0
576983|NCT00573170|1407259|P4|NOT COMPLETED|Second Treatment Period||0
576984|NCT00573170|1407260|P3|NOT COMPLETED|Second Treatment Period||0
576985|NCT00573170|1407261|P2|NOT COMPLETED|Second Treatment Period||0
576986|NCT00573170|1407262|P1|NOT COMPLETED|Second Treatment Period||0
576987|NCT00573170|1407257|P6|COMPLETED|Second Treatment Period||55
576988|NCT00573170|1407258|P5|COMPLETED|Second Treatment Period||59
576989|NCT00573170|1407259|P4|COMPLETED|Second Treatment Period||61
576990|NCT00573170|1407260|P3|COMPLETED|Second Treatment Period||59
576991|NCT00573170|1407261|P2|COMPLETED|Second Treatment Period||58
576992|NCT00573170|1407262|P1|COMPLETED|Second Treatment Period||56
576993|NCT00573170|1407257|P6|STARTED|Second Treatment Period||55
576994|NCT00573170|1407258|P5|STARTED|Second Treatment Period||59
576995|NCT00573170|1407259|P4|STARTED|Second Treatment Period||61
576996|NCT00573170|1407260|P3|STARTED|Second Treatment Period||59
576997|NCT00573170|1407261|P2|STARTED|Second Treatment Period||58
576998|NCT00573170|1407262|P1|STARTED|Second Treatment Period||56
576999|NCT00573170|1407257|P6|NOT COMPLETED|First Washout Period||7
577000|NCT00573170|1407258|P5|NOT COMPLETED|First Washout Period||3
577001|NCT00573170|1407259|P4|NOT COMPLETED|First Washout Period||5
577002|NCT00573170|1407260|P3|NOT COMPLETED|First Washout Period||1
577003|NCT00573170|1407261|P2|NOT COMPLETED|First Washout Period||2
577004|NCT00573170|1407262|P1|NOT COMPLETED|First Washout Period||8
577005|NCT00573170|1407257|P6|COMPLETED|First Washout Period||55
577006|NCT00573170|1407258|P5|COMPLETED|First Washout Period|Source data list 4 noncompleters; per number starting next period, there were only 3 noncompleters.|59
577007|NCT00573170|1407259|P4|COMPLETED|First Washout Period||61
577008|NCT00573170|1407260|P3|COMPLETED|First Washout Period||59
577009|NCT00573170|1407261|P2|COMPLETED|First Washout Period||58
577010|NCT00573170|1407262|P1|COMPLETED|First Washout Period||56
577011|NCT00573170|1407257|P6|STARTED|First Washout Period||62
577012|NCT00573170|1407258|P5|STARTED|First Washout Period||62
577013|NCT00573170|1407259|P4|STARTED|First Washout Period||66
577014|NCT00573170|1407260|P3|STARTED|First Washout Period||60
577015|NCT00573170|1407261|P2|STARTED|First Washout Period||60
577016|NCT00573170|1407262|P1|STARTED|First Washout Period||64
577017|NCT00573170|1407257|P6|NOT COMPLETED|First Treatment Period||0
577018|NCT00573170|1407258|P5|NOT COMPLETED|First Treatment Period||1
577019|NCT00573170|1407259|P4|NOT COMPLETED|First Treatment Period||0
577020|NCT00573170|1407260|P3|NOT COMPLETED|First Treatment Period||0
577021|NCT00573170|1407261|P2|NOT COMPLETED|First Treatment Period||0
577022|NCT00573170|1407262|P1|NOT COMPLETED|First Treatment Period||0
577023|NCT00573170|1407257|P6|COMPLETED|First Treatment Period||62
577024|NCT00573170|1407258|P5|COMPLETED|First Treatment Period||62
577025|NCT00573170|1407259|P4|COMPLETED|First Treatment Period||66
577026|NCT00573170|1407260|P3|COMPLETED|First Treatment Period||60
577027|NCT00573170|1407261|P2|COMPLETED|First Treatment Period||60
577028|NCT00573170|1407262|P1|COMPLETED|First Treatment Period||64
577029|NCT00573170|1407257|P6|STARTED|First Treatment Period||62
577030|NCT00573170|1407258|P5|STARTED|First Treatment Period||63
577031|NCT00573170|1407259|P4|STARTED|First Treatment Period||66
577032|NCT00573170|1407260|P3|STARTED|First Treatment Period||60
577033|NCT00573170|1407261|P2|STARTED|First Treatment Period||60
577034|NCT00573170|1407262|P1|STARTED|First Treatment Period||64
577035|NCT00573157|1407338|P2|NOT COMPLETED|Overall Study||2
577036|NCT00573157|1407339|P1|NOT COMPLETED|Overall Study||4
577037|NCT00573157|1407338|P2|COMPLETED|Overall Study||0
577038|NCT00573157|1407339|P1|COMPLETED|Overall Study||0
577039|NCT00573157|1407338|P2|STARTED|Overall Study||2
577040|NCT00573157|1407339|P1|STARTED|Overall Study||4
577041|NCT00573144|1407351|P2|NOT COMPLETED|Overall Study||3
577042|NCT00573144|1407352|P1|NOT COMPLETED|Overall Study||2
577043|NCT00573144|1407351|P2|COMPLETED|Overall Study||25
577044|NCT00573144|1407352|P1|COMPLETED|Overall Study||28
577045|NCT00573144|1407351|P2|STARTED|Overall Study||28
577046|NCT00573144|1407352|P1|STARTED|Overall Study||30
577047|NCT00573131|1407364|P2|NOT COMPLETED|Overall Study||8
577048|NCT00573131|1407365|P1|NOT COMPLETED|Overall Study||10
577049|NCT00573131|1407364|P2|COMPLETED|Overall Study||57
577050|NCT00573131|1407365|P1|COMPLETED|Overall Study||62
577051|NCT00573131|1407364|P2|STARTED|Overall Study||65
577052|NCT00573131|1407365|P1|STARTED|Overall Study||72
577053|NCT00573066|1407371|P1|NOT COMPLETED|Overall Study||20
577054|NCT00573066|1407371|P1|COMPLETED|Overall Study||36
577055|NCT00573066|1407371|P1|STARTED|Overall Study||56
577056|NCT00572936|1407375|P6|NOT COMPLETED|Third Intervention||0
577057|NCT00572936|1407376|P5|NOT COMPLETED|Third Intervention||0
577058|NCT00572936|1407377|P4|NOT COMPLETED|Third Intervention||0
577059|NCT00572936|1407378|P3|NOT COMPLETED|Third Intervention||0
577060|NCT00572936|1407379|P2|NOT COMPLETED|Third Intervention||0
577061|NCT00572936|1407380|P1|NOT COMPLETED|Third Intervention||0
577062|NCT00572936|1407375|P6|COMPLETED|Third Intervention||5
577063|NCT00572936|1407376|P5|COMPLETED|Third Intervention||3
577064|NCT00572936|1407377|P4|COMPLETED|Third Intervention||5
577065|NCT00572936|1407378|P3|COMPLETED|Third Intervention||4
577066|NCT00572936|1407379|P2|COMPLETED|Third Intervention||3
577067|NCT00572936|1407380|P1|COMPLETED|Third Intervention||4
577068|NCT00572936|1407375|P6|STARTED|Third Intervention||5
577069|NCT00572936|1407376|P5|STARTED|Third Intervention|1 participant dropped out between second intervention and third intervention due to increased IOP|3
577070|NCT00572936|1407377|P4|STARTED|Third Intervention||5
577071|NCT00572936|1407378|P3|STARTED|Third Intervention||4
577072|NCT00572936|1407379|P2|STARTED|Third Intervention||3
577073|NCT00572936|1407380|P1|STARTED|Third Intervention||4
577074|NCT00572936|1407375|P6|NOT COMPLETED|Second Intervention||0
577075|NCT00572936|1407376|P5|NOT COMPLETED|Second Intervention||0
577076|NCT00572936|1407377|P4|NOT COMPLETED|Second Intervention||0
577077|NCT00572936|1407378|P3|NOT COMPLETED|Second Intervention||0
577078|NCT00572936|1407379|P2|NOT COMPLETED|Second Intervention||0
577079|NCT00572936|1407380|P1|NOT COMPLETED|Second Intervention||0
577080|NCT00572936|1407375|P6|COMPLETED|Second Intervention||5
577081|NCT00572936|1407376|P5|COMPLETED|Second Intervention||4
577082|NCT00572936|1407377|P4|COMPLETED|Second Intervention||5
577083|NCT00572936|1407378|P3|COMPLETED|Second Intervention||4
577084|NCT00572936|1407379|P2|COMPLETED|Second Intervention||3
577085|NCT00572936|1407380|P1|COMPLETED|Second Intervention||4
577086|NCT00572936|1407375|P6|STARTED|Second Intervention||5
577087|NCT00572936|1407376|P5|STARTED|Second Intervention|1 participant dropped out between first intervention and second intervention due to increased IOP|4
577088|NCT00572936|1407377|P4|STARTED|Second Intervention||5
577089|NCT00572936|1407378|P3|STARTED|Second Intervention|1 participant dropped out between first intervention and second intervention due to increased IOP|4
577090|NCT00572936|1407379|P2|STARTED|Second Intervention|1 participant dropped out between the first and second intervention due to car accident|3
577091|NCT00572936|1407380|P1|STARTED|Second Intervention||4
577092|NCT00572936|1407375|P6|NOT COMPLETED|First Intervention||0
577093|NCT00572936|1407376|P5|NOT COMPLETED|First Intervention||0
577094|NCT00572936|1407377|P4|NOT COMPLETED|First Intervention||0
577095|NCT00572936|1407378|P3|NOT COMPLETED|First Intervention||0
577096|NCT00572936|1407379|P2|NOT COMPLETED|First Intervention||0
577097|NCT00572936|1407380|P1|NOT COMPLETED|First Intervention||0
577098|NCT00572936|1407375|P6|COMPLETED|First Intervention||5
577099|NCT00572936|1407376|P5|COMPLETED|First Intervention||5
577100|NCT00572936|1407377|P4|COMPLETED|First Intervention||5
577101|NCT00572936|1407378|P3|COMPLETED|First Intervention||5
577102|NCT00572936|1407379|P2|COMPLETED|First Intervention||4
577103|NCT00572936|1407380|P1|COMPLETED|First Intervention||4
577104|NCT00572936|1407375|P6|STARTED|First Intervention||5
577105|NCT00572936|1407376|P5|STARTED|First Intervention||5
577106|NCT00572936|1407377|P4|STARTED|First Intervention||5
577107|NCT00572936|1407378|P3|STARTED|First Intervention||5
577108|NCT00572936|1407379|P2|STARTED|First Intervention||4
577109|NCT00572936|1407380|P1|STARTED|First Intervention||4
577110|NCT00572910|1407415|P11|NOT COMPLETED|Overall Study||3
577111|NCT00572910|1407416|P10|NOT COMPLETED|Overall Study||6
577112|NCT00572910|1407417|P9|NOT COMPLETED|Overall Study||3
577113|NCT00572910|1407418|P8|NOT COMPLETED|Overall Study||4
577114|NCT00572910|1407419|P7|NOT COMPLETED|Overall Study||4
577115|NCT00572910|1407420|P6|NOT COMPLETED|Overall Study||3
577116|NCT00572910|1407421|P5|NOT COMPLETED|Overall Study||2
577117|NCT00572910|1407422|P4|NOT COMPLETED|Overall Study||4
577118|NCT00572910|1407423|P3|NOT COMPLETED|Overall Study||2
577119|NCT00572910|1407424|P2|NOT COMPLETED|Overall Study||3
577120|NCT00572910|1407425|P1|NOT COMPLETED|Overall Study||4
577121|NCT00572910|1407415|P11|COMPLETED|Overall Study||15
577122|NCT00572910|1407416|P10|COMPLETED|Overall Study||13
577123|NCT00572910|1407417|P9|COMPLETED|Overall Study||16
577124|NCT00572910|1407418|P8|COMPLETED|Overall Study||15
577125|NCT00572910|1407419|P7|COMPLETED|Overall Study||15
577126|NCT00572910|1407420|P6|COMPLETED|Overall Study||16
577127|NCT00572910|1407421|P5|COMPLETED|Overall Study||17
577128|NCT00572910|1407422|P4|COMPLETED|Overall Study||14
577129|NCT00572910|1407423|P3|COMPLETED|Overall Study||17
577130|NCT00572910|1407424|P2|COMPLETED|Overall Study||15
577131|NCT00572910|1407425|P1|COMPLETED|Overall Study||15
577132|NCT00572910|1407415|P11|STARTED|Overall Study||18
577133|NCT00572910|1407416|P10|STARTED|Overall Study||19
577134|NCT00572910|1407417|P9|STARTED|Overall Study||19
577135|NCT00572910|1407418|P8|STARTED|Overall Study||19
577136|NCT00572910|1407419|P7|STARTED|Overall Study||19
577137|NCT00572910|1407420|P6|STARTED|Overall Study||19
577138|NCT00572910|1407421|P5|STARTED|Overall Study||19
577139|NCT00572910|1407422|P4|STARTED|Overall Study||18
577140|NCT00572910|1407423|P3|STARTED|Overall Study||19
577141|NCT00572910|1407424|P2|STARTED|Overall Study||18
577142|NCT00572910|1407425|P1|STARTED|Overall Study||19
577143|NCT00572897|1407473|P2|NOT COMPLETED|Overall Study||0
577144|NCT00572897|1407474|P1|NOT COMPLETED|Overall Study||0
577145|NCT00572897|1407473|P2|COMPLETED|Overall Study||34
577146|NCT00572897|1407474|P1|COMPLETED|Overall Study||32
577147|NCT00572897|1407473|P2|STARTED|Overall Study||34
577148|NCT00572897|1407474|P1|STARTED|Overall Study||32
577149|NCT00572832|1407492|P2|NOT COMPLETED|Overall Study||12
577150|NCT00572832|1407493|P1|NOT COMPLETED|Overall Study||0
577151|NCT00572832|1407492|P2|COMPLETED|Overall Study||88
577152|NCT00572832|1407493|P1|COMPLETED|Overall Study||100
577153|NCT00572832|1407492|P2|STARTED|Overall Study||100
577154|NCT00572832|1407493|P1|STARTED|Overall Study||100
577155|NCT00572728|1407499|P1|NOT COMPLETED|Overall Study||39
577156|NCT00572728|1407499|P1|COMPLETED|Overall Study|51 patients eligible for primary objective analysis|51
577157|NCT00572728|1407499|P1|RCB Evaluation|Overall Study|Secondary: histopathology was available in 35 patients for RCB evaluation|35
577158|NCT00572728|1407499|P1|LN Evaluation After NAC|Overall Study|Secondary:38 patients were available for histopathological LN evaluation after NAC|38
577159|NCT00572728|1407499|P1|Completed FLT3 Scan|Overall Study|Secondary analysis milestone: 43 pts had FLT-3 performed.|43
577160|NCT00572728|1407499|P1|Pathology Complete|Overall Study||51
577161|NCT00572728|1407499|P1|Second Chemotherapy Initiated After FLT2|Overall Study||52
577162|NCT00572728|1407499|P1|Second Chemotherapy Initiated|Overall Study||59
577163|NCT00572728|1407499|P1|Completed FLT2 Scan|Overall Study||60
577164|NCT00572728|1407499|P1|First Therapy Initiated|Overall Study||65
577165|NCT00572728|1407499|P1|Completed FLT1 Scan|Overall Study||67
577166|NCT00572728|1407499|P1|On Study|Overall Study||71
577167|NCT00572728|1407499|P1|Did Not Withdraw|Overall Study||72
577168|NCT00572728|1407499|P1|Enrolled Under Amendment 5 or Later|Overall Study||82
577169|NCT00572728|1407499|P1|Eligible|Overall Study||87
577170|NCT00572728|1407499|P1|STARTED|Overall Study|Registered|90
577171|NCT00572624|1407513|P2|NOT COMPLETED|Overall Study||4
577172|NCT00572624|1407514|P1|NOT COMPLETED|Overall Study||17
577173|NCT00572624|1407513|P2|COMPLETED|Overall Study||10
577174|NCT00572624|1407514|P1|COMPLETED|Overall Study||20
577175|NCT00572624|1407513|P2|STARTED|Overall Study||14
577176|NCT00572624|1407514|P1|STARTED|Overall Study||37
577177|NCT00572572|1407542|P2|NOT COMPLETED|Overall Study||6
577178|NCT00572572|1407543|P1|NOT COMPLETED|Overall Study||3
577179|NCT00572572|1407542|P2|COMPLETED|Overall Study||28
577180|NCT00572572|1407543|P1|COMPLETED|Overall Study||32
577181|NCT00572572|1407542|P2|STARTED|Overall Study||34
577182|NCT00572572|1407543|P1|STARTED|Overall Study||35
577183|NCT00572533|1407561|P2|NOT COMPLETED|Overall Study||3
577184|NCT00572533|1407562|P1|NOT COMPLETED|Overall Study||7
577185|NCT00572533|1407561|P2|COMPLETED|Overall Study||28
577186|NCT00572533|1407562|P1|COMPLETED|Overall Study||24
577187|NCT00572533|1407561|P2|STARTED|Overall Study||31
577188|NCT00572533|1407562|P1|STARTED|Overall Study||31
577189|NCT00572468|1407584|P2|NOT COMPLETED|Overall Study||4
577190|NCT00572468|1407585|P1|NOT COMPLETED|Overall Study||2
577191|NCT00572468|1407584|P2|COMPLETED|Overall Study||16
577192|NCT00572468|1407585|P1|COMPLETED|Overall Study||20
577193|NCT00572468|1407584|P2|STARTED|Overall Study||20
577194|NCT00572468|1407585|P1|STARTED|Overall Study||22
577195|NCT00572260|1407593|P1|NOT COMPLETED|Overall Study||0
577196|NCT00572260|1407593|P1|COMPLETED|Overall Study||11
577197|NCT00572260|1407593|P1|STARTED|Overall Study||11
577198|NCT00572156|1407601|P4|NOT COMPLETED|Overall Study||25
577199|NCT00572156|1407602|P3|NOT COMPLETED|Overall Study||27
577200|NCT00572156|1407603|P2|NOT COMPLETED|Overall Study||26
577201|NCT00572156|1407604|P1|NOT COMPLETED|Overall Study||26
577202|NCT00572156|1407601|P4|COMPLETED|Overall Study||1
577203|NCT00572156|1407602|P3|COMPLETED|Overall Study||0
577204|NCT00572156|1407603|P2|COMPLETED|Overall Study||1
577205|NCT00572156|1407604|P1|COMPLETED|Overall Study||0
577206|NCT00572156|1407601|P4|STARTED|Overall Study||26
577207|NCT00572156|1407602|P3|STARTED|Overall Study||27
577208|NCT00572156|1407603|P2|STARTED|Overall Study||27
577209|NCT00572156|1407604|P1|STARTED|Overall Study||26
577210|NCT00572117|1407664|P2|NOT COMPLETED|Overall Study||2
577211|NCT00572117|1407665|P1|NOT COMPLETED|Overall Study||2
577212|NCT00572117|1407664|P2|COMPLETED|Overall Study||5
577213|NCT00572117|1407665|P1|COMPLETED|Overall Study||3
577214|NCT00572117|1407664|P2|STARTED|Overall Study||7
577215|NCT00572117|1407665|P1|STARTED|Overall Study||5
577216|NCT00572039|1407675|P2|NOT COMPLETED|Overall Study||10
577217|NCT00572039|1407676|P1|NOT COMPLETED|Overall Study||16
577218|NCT00572039|1407675|P2|COMPLETED|Overall Study||110
577219|NCT00572039|1407676|P1|COMPLETED|Overall Study||105
577220|NCT00572039|1407675|P2|STARTED|Overall Study||120
577221|NCT00572039|1407676|P1|STARTED|Overall Study||121
577222|NCT00571987|1407688|P1|NOT COMPLETED|Overall Study||7
577223|NCT00571987|1407688|P1|COMPLETED|Overall Study||100
577224|NCT00571987|1407688|P1|STARTED|Overall Study||107
577225|NCT00571974|1407695|P2|NOT COMPLETED|Phase II||4
577226|NCT00571974|1407696|P1|NOT COMPLETED|Phase II||0
577227|NCT00571974|1407695|P2|COMPLETED|Phase II||17
577228|NCT00571974|1407696|P1|COMPLETED|Phase II||0
577229|NCT00571974|1407695|P2|STARTED|Phase II|3 participants are from phase I|21
577230|NCT00571974|1407696|P1|STARTED|Phase II||0
577231|NCT00571974|1407695|P2|NOT COMPLETED|Phase I||0
577232|NCT00571974|1407696|P1|NOT COMPLETED|Phase I||0
577233|NCT00571974|1407695|P2|COMPLETED|Phase I||0
577234|NCT00571974|1407696|P1|COMPLETED|Phase I||9
577235|NCT00571974|1407695|P2|STARTED|Phase I||0
577236|NCT00571974|1407696|P1|STARTED|Phase I||9
577237|NCT00571961|1407702|P1|NOT COMPLETED|Overall Study||0
577238|NCT00571961|1407702|P1|COMPLETED|Overall Study||12
577239|NCT00571961|1407702|P1|STARTED|Overall Study||12
577240|NCT00571948|1407708|P2|NOT COMPLETED|Overall Study||14
577241|NCT00571948|1407709|P1|NOT COMPLETED|Overall Study||11
577242|NCT00571948|1407708|P2|COMPLETED|Overall Study|Excluded n = 3) Reasons: diet record < 75 % of days (n = 2); blood analysis failed (n= 1)|52
577243|NCT00571948|1407709|P1|COMPLETED|Overall Study|Excluded from analysis (n = 2) Reason: diet record for less than 75 % of days (n = 2)|55
577244|NCT00571948|1407708|P2|STARTED|Overall Study||66
577245|NCT00571948|1407709|P1|STARTED|Overall Study||66
577246|NCT00571922|1407717|P2|NOT COMPLETED|Overall Study||36
577247|NCT00571922|1407718|P1|NOT COMPLETED|Overall Study||36
577248|NCT00571922|1407717|P2|COMPLETED|Overall Study||0
577249|NCT00571922|1407718|P1|COMPLETED|Overall Study||0
577250|NCT00571922|1407717|P2|STARTED|Overall Study||36
577251|NCT00571922|1407718|P1|STARTED|Overall Study||36
577252|NCT00571701|1407728|P2|NOT COMPLETED|Second Intervention 12 Months||1
577253|NCT00571701|1407729|P1|NOT COMPLETED|Second Intervention 12 Months||3
577254|NCT00571701|1407728|P2|COMPLETED|Second Intervention 12 Months||20
577255|NCT00571701|1407729|P1|COMPLETED|Second Intervention 12 Months||13
577256|NCT00571701|1407728|P2|STARTED|Second Intervention 12 Months||21
577257|NCT00571701|1407729|P1|STARTED|Second Intervention 12 Months||16
577258|NCT00571701|1407728|P2|NOT COMPLETED|First Intervention 12 Months||1
577259|NCT00571701|1407729|P1|NOT COMPLETED|First Intervention 12 Months||3
577260|NCT00571701|1407728|P2|COMPLETED|First Intervention 12 Months||21
577261|NCT00571701|1407729|P1|COMPLETED|First Intervention 12 Months||16
577262|NCT00571701|1407728|P2|STARTED|First Intervention 12 Months||22
577263|NCT00571701|1407729|P1|STARTED|First Intervention 12 Months||19
577264|NCT00571688|1407755|P2|NOT COMPLETED|Overall Study||6
577265|NCT00571688|1407756|P1|NOT COMPLETED|Overall Study||5
577266|NCT00571688|1407755|P2|COMPLETED|Overall Study||19
577267|NCT00571688|1407756|P1|COMPLETED|Overall Study||20
577268|NCT00571688|1407755|P2|STARTED|Overall Study||25
577269|NCT00571688|1407756|P1|STARTED|Overall Study||25
577270|NCT00571662|1407762|P1|NOT COMPLETED|Overall Study||8
577271|NCT00571662|1407762|P1|COMPLETED|Overall Study||68
577272|NCT00571662|1407762|P1|STARTED|Overall Study||76
577273|NCT00571649|1407770|P2|NOT COMPLETED|Follow-up Period||528
577274|NCT00571649|1407771|P1|NOT COMPLETED|Follow-up Period||545
577275|NCT00571649|1407770|P2|COMPLETED|Follow-up Period|Began day after last dose study drug; ended on Day 90 (+/- 7 days) .|3107
577276|NCT00571649|1407771|P1|COMPLETED|Follow-up Period|Began day after last dose study drug; ended on Day 90 (+/- 7 days) .|3038
577277|NCT00571649|1407770|P2|STARTED|Follow-up Period|Participants were required to enter follow-up even if treatment period not completed.|3635
577278|NCT00571649|1407771|P1|STARTED|Follow-up Period|Participants were required to enter follow-up even if treatment period not completed.|3583
577279|NCT00571649|1407770|P2|NOT COMPLETED|Treatment Period||1004
577280|NCT00571649|1407771|P1|NOT COMPLETED|Treatment Period||1092
577281|NCT00571649|1407770|P2|COMPLETED|Treatment Period||3047
577282|NCT00571649|1407771|P1|COMPLETED|Treatment Period||2958
577283|NCT00571649|1407770|P2|Day 35|Treatment Period||3115
577284|NCT00571649|1407771|P1|Day 35|Treatment Period||3033
577285|NCT00571649|1407770|P2|Day 10|Treatment Period||3499
577286|NCT00571649|1407771|P1|Day 10|Treatment Period||3454
577287|NCT00571649|1407770|P2|Participants Received Treatment|Treatment Period||4001
577288|NCT00571649|1407771|P1|Participants Received Treatment|Treatment Period||3997
577289|NCT00571649|1407770|P2|STARTED|Treatment Period||4051
577290|NCT00571649|1407771|P1|STARTED|Treatment Period||4050
577291|NCT00571428|1407805|P2|NOT COMPLETED|Overall Study||0
577292|NCT00571428|1407806|P1|NOT COMPLETED|Overall Study||0
577293|NCT00571428|1407805|P2|COMPLETED|Overall Study||18
577294|NCT00571428|1407806|P1|COMPLETED|Overall Study||15
577295|NCT00571428|1407805|P2|STARTED|Overall Study||18
577296|NCT00571428|1407806|P1|STARTED|Overall Study||15
577297|NCT00571324|1407838|P2|NOT COMPLETED|Intervention 2 (7 Hours)||0
577298|NCT00571324|1407839|P1|NOT COMPLETED|Intervention 2 (7 Hours)||0
577299|NCT00571324|1407838|P2|COMPLETED|Intervention 2 (7 Hours)||4
577300|NCT00571324|1407839|P1|COMPLETED|Intervention 2 (7 Hours)||5
577301|NCT00571324|1407838|P2|STARTED|Intervention 2 (7 Hours)||4
577302|NCT00571324|1407839|P1|STARTED|Intervention 2 (7 Hours)||5
577303|NCT00571324|1407838|P2|NOT COMPLETED|Intervention 1 (7 Hours)||0
577304|NCT00571324|1407839|P1|NOT COMPLETED|Intervention 1 (7 Hours)||0
577305|NCT00571324|1407838|P2|COMPLETED|Intervention 1 (7 Hours)||4
577306|NCT00571324|1407839|P1|COMPLETED|Intervention 1 (7 Hours)||5
577307|NCT00571324|1407838|P2|STARTED|Intervention 1 (7 Hours)||4
577308|NCT00571324|1407839|P1|STARTED|Intervention 1 (7 Hours)||5
577309|NCT00571194|1407851|P1|NOT COMPLETED|Overall Study||0
577310|NCT00571194|1407851|P1|COMPLETED|Overall Study||7
577311|NCT00571194|1407851|P1|STARTED|Overall Study||7
577312|NCT00571103|1407855|P1|NOT COMPLETED|Overall Study||2
577313|NCT00571103|1407855|P1|COMPLETED|Overall Study|Of the 28 participants, 1 subject withdrew and 1 was lost to follow-up after their baseline visit.|26
577314|NCT00571103|1407855|P1|STARTED|Overall Study||28
577315|NCT00571064|1407860|P1|NOT COMPLETED|Overall Study||21
577316|NCT00571064|1407860|P1|COMPLETED|Overall Study||76
577317|NCT00571064|1407860|P1|STARTED|Overall Study||97
577318|NCT00571038|1407875|P2|NOT COMPLETED|Overall Study||14
577319|NCT00571038|1407876|P1|NOT COMPLETED|Overall Study||11
577320|NCT00571038|1407875|P2|COMPLETED|Overall Study|5 died 2 moved 3 asked to be withdrawn 4 unable to reach|171
577321|NCT00571038|1407876|P1|COMPLETED|Overall Study|"7 died 2 moved~1 asked to be withdrawn~1 unable to reach"|208
577322|NCT00571038|1407875|P2|18 Month Survey Only|Overall Study||163
577323|NCT00571038|1407876|P1|18 Month Survey Only|Overall Study||199
577324|NCT00571038|1407875|P2|6 Month Follow up|Overall Study||176
577325|NCT00571038|1407876|P1|6 Month Follow up|Overall Study||208
577326|NCT00571038|1407875|P2|STARTED|Overall Study||185
577327|NCT00571038|1407876|P1|STARTED|Overall Study||219
577328|NCT00570960|1407924|P2|NOT COMPLETED|Overall Study||0
577329|NCT00570960|1407925|P1|NOT COMPLETED|Overall Study||0
577330|NCT00570960|1407924|P2|COMPLETED|Overall Study||4
577331|NCT00570960|1407925|P1|COMPLETED|Overall Study||4
577332|NCT00570960|1407924|P2|STARTED|Overall Study||4
577333|NCT00570960|1407925|P1|STARTED|Overall Study||4
577334|NCT00570921|1407931|P1|NOT COMPLETED|Overall Study||2
577335|NCT00570921|1407931|P1|COMPLETED|Overall Study||31
577336|NCT00570921|1407931|P1|STARTED|Overall Study||33
577337|NCT00570908|1407937|P1|NOT COMPLETED|Overall Study||7
577338|NCT00570908|1407937|P1|COMPLETED|Overall Study|5 patients progressed during the study treatment|5
577339|NCT00570908|1407937|P1|STARTED|Overall Study||12
577340|NCT00570778|1407941|P4|NOT COMPLETED|Overall Study||4
577341|NCT00570778|1407942|P3|NOT COMPLETED|Overall Study||7
577342|NCT00570778|1407943|P2|NOT COMPLETED|Overall Study||4
577343|NCT00570778|1407944|P1|NOT COMPLETED|Overall Study||4
577344|NCT00570778|1407941|P4|COMPLETED|Overall Study||34
577345|NCT00570778|1407942|P3|COMPLETED|Overall Study||30
577346|NCT00570778|1407943|P2|COMPLETED|Overall Study||34
577347|NCT00570778|1407944|P1|COMPLETED|Overall Study||37
577348|NCT00570778|1407941|P4|Modified Intent-to-treat Population|Overall Study||37
577349|NCT00570778|1407942|P3|Modified Intent-to-treat Population|Overall Study||35
577350|NCT00570778|1407943|P2|Modified Intent-to-treat Population|Overall Study||37
577351|NCT00570778|1407944|P1|Modified Intent-to-treat Population|Overall Study||40
577352|NCT00570778|1407941|P4|Safety Population: Received Study Drug|Overall Study||38
577353|NCT00570778|1407942|P3|Safety Population: Received Study Drug|Overall Study||36
577354|NCT00570778|1407943|P2|Safety Population: Received Study Drug|Overall Study||38
577355|NCT00570778|1407944|P1|Safety Population: Received Study Drug|Overall Study|Safety Population included all participants who received at least 1 dose of any study drug.|41
577356|NCT00570778|1407941|P4|STARTED|Overall Study||38
577357|NCT00570778|1407942|P3|STARTED|Overall Study||37
577358|NCT00570778|1407943|P2|STARTED|Overall Study||38
577359|NCT00570778|1407944|P1|STARTED|Overall Study||41
577360|NCT00570765|1407965|P3|NOT COMPLETED|Overall Study||0
577361|NCT00570765|1407966|P2|NOT COMPLETED|Overall Study||7
577362|NCT00570765|1407967|P1|NOT COMPLETED|Overall Study||4
577363|NCT00570765|1407965|P3|COMPLETED|Overall Study||23
577364|NCT00570765|1407966|P2|COMPLETED|Overall Study||9
577365|NCT00570765|1407967|P1|COMPLETED|Overall Study||16
577366|NCT00570765|1407965|P3|STARTED|Overall Study||23
577367|NCT00570765|1407966|P2|STARTED|Overall Study||16
577368|NCT00570765|1407967|P1|STARTED|Overall Study||20
577369|NCT00570739|1407985|P4|NOT COMPLETED|Overall Study||12
577370|NCT00570739|1407986|P3|NOT COMPLETED|Overall Study||16
577371|NCT00570739|1407987|P2|NOT COMPLETED|Overall Study||21
577372|NCT00570739|1407988|P1|NOT COMPLETED|Overall Study||21
577373|NCT00570739|1407985|P4|COMPLETED|Overall Study||96
577374|NCT00570739|1407986|P3|COMPLETED|Overall Study||92
577375|NCT00570739|1407987|P2|COMPLETED|Overall Study||124
577376|NCT00570739|1407988|P1|COMPLETED|Overall Study||120
577377|NCT00570739|1407985|P4|STARTED|Overall Study||108
577378|NCT00570739|1407986|P3|STARTED|Overall Study||108
577379|NCT00570739|1407987|P2|STARTED|Overall Study||145
577380|NCT00570739|1407988|P1|STARTED|Overall Study||141
577381|NCT00570713|1408140|P2|NOT COMPLETED|Overall Study||77
577382|NCT00570713|1408141|P1|NOT COMPLETED|Overall Study||78
577383|NCT00570713|1408140|P2|COMPLETED|Overall Study||0
577384|NCT00570713|1408141|P1|COMPLETED|Overall Study||0
577385|NCT00570713|1408140|P2|STARTED|Overall Study||77
577386|NCT00570713|1408141|P1|STARTED|Overall Study||78
577387|NCT00570700|1408151|P1|NOT COMPLETED|Overall Study||11
577388|NCT00570700|1408151|P1|COMPLETED|Overall Study||27
577389|NCT00570700|1408151|P1|STARTED|Overall Study||38
577390|NCT00570687|1408159|P10|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
577391|NCT00570687|1408160|P9|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
577392|NCT00570687|1408161|P8|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
577393|NCT00570687|1408162|P7|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
577394|NCT00570687|1408163|P6|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
577395|NCT00570687|1408164|P5|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
577396|NCT00570687|1408165|P4|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
577397|NCT00570687|1408166|P3|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
577398|NCT00570687|1408167|P2|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
577399|NCT00570687|1408168|P1|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
577400|NCT00570687|1408159|P10|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
577401|NCT00570687|1408160|P9|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
577402|NCT00570687|1408161|P8|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
577403|NCT00570687|1408162|P7|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
577404|NCT00570687|1408163|P6|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
577405|NCT00570687|1408164|P5|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
577406|NCT00570687|1408165|P4|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4
577407|NCT00570687|1408166|P3|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2
577408|NCT00570687|1408167|P2|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2
577409|NCT00570687|1408168|P1|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4
577410|NCT00570687|1408159|P10|STARTED|Clamp 2 (1 Day) - Amendment 1||0
577411|NCT00570687|1408160|P9|STARTED|Clamp 2 (1 Day) - Amendment 1||0
577412|NCT00570687|1408161|P8|STARTED|Clamp 2 (1 Day) - Amendment 1||0
577413|NCT00570687|1408162|P7|STARTED|Clamp 2 (1 Day) - Amendment 1||0
577414|NCT00570687|1408163|P6|STARTED|Clamp 2 (1 Day) - Amendment 1||0
577415|NCT00570687|1408164|P5|STARTED|Clamp 2 (1 Day) - Amendment 1||0
577416|NCT00570687|1408165|P4|STARTED|Clamp 2 (1 Day) - Amendment 1||4
577417|NCT00570687|1408166|P3|STARTED|Clamp 2 (1 Day) - Amendment 1||2
577418|NCT00570687|1408167|P2|STARTED|Clamp 2 (1 Day) - Amendment 1||2
577419|NCT00570687|1408168|P1|STARTED|Clamp 2 (1 Day) - Amendment 1||4
577420|NCT00570687|1408159|P10|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
577421|NCT00570687|1408160|P9|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
577422|NCT00570687|1408161|P8|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
577423|NCT00570687|1408162|P7|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
577424|NCT00570687|1408163|P6|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
577425|NCT00570687|1408164|P5|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
577426|NCT00570687|1408165|P4|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
577427|NCT00570687|1408166|P3|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
577428|NCT00570687|1408167|P2|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
577429|NCT00570687|1408168|P1|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
577430|NCT00570687|1408159|P10|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
577431|NCT00570687|1408160|P9|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
577432|NCT00570687|1408161|P8|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
577433|NCT00570687|1408162|P7|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
577434|NCT00570687|1408163|P6|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
577435|NCT00570687|1408164|P5|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
577436|NCT00570687|1408165|P4|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4
577437|NCT00570687|1408166|P3|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2
577438|NCT00570687|1408167|P2|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2
577439|NCT00570687|1408168|P1|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4
577440|NCT00570687|1408159|P10|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
577441|NCT00570687|1408160|P9|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
577442|NCT00570687|1408161|P8|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
577443|NCT00570687|1408162|P7|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
577444|NCT00570687|1408163|P6|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
577445|NCT00570687|1408164|P5|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
577446|NCT00570687|1408165|P4|STARTED|Washout 3 (7-21 Days) - Amendment 1||4
577447|NCT00570687|1408166|P3|STARTED|Washout 3 (7-21 Days) - Amendment 1||2
577448|NCT00570687|1408167|P2|STARTED|Washout 3 (7-21 Days) - Amendment 1||2
577449|NCT00570687|1408168|P1|STARTED|Washout 3 (7-21 Days) - Amendment 1||4
577450|NCT00570687|1408159|P10|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
577451|NCT00570687|1408160|P9|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
577452|NCT00570687|1408161|P8|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
577453|NCT00570687|1408162|P7|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
577454|NCT00570687|1408163|P6|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
577455|NCT00570687|1408164|P5|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
577456|NCT00570687|1408165|P4|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
577457|NCT00570687|1408166|P3|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
577458|NCT00570687|1408167|P2|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
577459|NCT00570687|1408168|P1|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
577460|NCT00570687|1408159|P10|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
577461|NCT00570687|1408160|P9|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
577462|NCT00570687|1408161|P8|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
577463|NCT00570687|1408162|P7|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
577464|NCT00570687|1408163|P6|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
577465|NCT00570687|1408164|P5|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
577466|NCT00570687|1408165|P4|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4
577467|NCT00570687|1408166|P3|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2
577468|NCT00570687|1408167|P2|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2
577469|NCT00570687|1408168|P1|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4
577470|NCT00570687|1408159|P10|STARTED|Clamp 1 (1 Day) - Amendment 1||0
577471|NCT00570687|1408160|P9|STARTED|Clamp 1 (1 Day) - Amendment 1||0
577472|NCT00570687|1408161|P8|STARTED|Clamp 1 (1 Day) - Amendment 1||0
577473|NCT00570687|1408162|P7|STARTED|Clamp 1 (1 Day) - Amendment 1||0
577474|NCT00570687|1408163|P6|STARTED|Clamp 1 (1 Day) - Amendment 1||0
577475|NCT00570687|1408164|P5|STARTED|Clamp 1 (1 Day) - Amendment 1||0
577476|NCT00570687|1408165|P4|STARTED|Clamp 1 (1 Day) - Amendment 1||4
577477|NCT00570687|1408166|P3|STARTED|Clamp 1 (1 Day) - Amendment 1||2
577478|NCT00570687|1408167|P2|STARTED|Clamp 1 (1 Day) - Amendment 1||2
577479|NCT00570687|1408168|P1|STARTED|Clamp 1 (1 Day) - Amendment 1||4
577480|NCT00570687|1408159|P10|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
577481|NCT00570687|1408160|P9|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
577482|NCT00570687|1408161|P8|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
577483|NCT00570687|1408162|P7|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
577484|NCT00570687|1408163|P6|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
577485|NCT00570687|1408164|P5|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
577486|NCT00570687|1408165|P4|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
577487|NCT00570687|1408166|P3|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
577488|NCT00570687|1408167|P2|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
577489|NCT00570687|1408168|P1|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
577490|NCT00570687|1408159|P10|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
577491|NCT00570687|1408160|P9|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
577492|NCT00570687|1408161|P8|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
577493|NCT00570687|1408162|P7|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
577494|NCT00570687|1408163|P6|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
577495|NCT00570687|1408164|P5|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
577496|NCT00570687|1408165|P4|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4
577497|NCT00570687|1408166|P3|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2
577498|NCT00570687|1408167|P2|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2
577499|NCT00570687|1408168|P1|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4
577500|NCT00570687|1408159|P10|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
577501|NCT00570687|1408160|P9|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
577502|NCT00570687|1408161|P8|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
577503|NCT00570687|1408162|P7|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
577504|NCT00570687|1408163|P6|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
577505|NCT00570687|1408164|P5|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
577506|NCT00570687|1408165|P4|STARTED|Washout 2 (8 Weeks) - Amendment 1||4
577507|NCT00570687|1408166|P3|STARTED|Washout 2 (8 Weeks) - Amendment 1||2
577508|NCT00570687|1408167|P2|STARTED|Washout 2 (8 Weeks) - Amendment 1||2
577509|NCT00570687|1408168|P1|STARTED|Washout 2 (8 Weeks) - Amendment 1||4
577510|NCT00570687|1408159|P10|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
577511|NCT00570687|1408160|P9|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
577512|NCT00570687|1408161|P8|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
577513|NCT00570687|1408162|P7|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
577514|NCT00570687|1408163|P6|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
577515|NCT00570687|1408164|P5|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
577516|NCT00570687|1408165|P4|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
577517|NCT00570687|1408166|P3|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
577518|NCT00570687|1408167|P2|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
577519|NCT00570687|1408168|P1|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
577520|NCT00570687|1408159|P10|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
577521|NCT00570687|1408160|P9|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
577522|NCT00570687|1408161|P8|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
577523|NCT00570687|1408162|P7|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
577524|NCT00570687|1408163|P6|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
577525|NCT00570687|1408164|P5|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
577526|NCT00570687|1408165|P4|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4
577527|NCT00570687|1408166|P3|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2
577528|NCT00570687|1408167|P2|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2
577529|NCT00570687|1408168|P1|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4
577530|NCT00570687|1408159|P10|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
577531|NCT00570687|1408160|P9|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
577532|NCT00570687|1408161|P8|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
577533|NCT00570687|1408162|P7|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
577534|NCT00570687|1408163|P6|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
577535|NCT00570687|1408164|P5|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
577536|NCT00570687|1408165|P4|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4
577537|NCT00570687|1408166|P3|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2
577538|NCT00570687|1408167|P2|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2
577539|NCT00570687|1408168|P1|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4
577540|NCT00570687|1408159|P10|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
577541|NCT00570687|1408160|P9|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
577542|NCT00570687|1408161|P8|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
577543|NCT00570687|1408162|P7|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
577544|NCT00570687|1408163|P6|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
577545|NCT00570687|1408164|P5|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
577546|NCT00570687|1408165|P4|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
577547|NCT00570687|1408166|P3|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
577548|NCT00570687|1408167|P2|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
577549|NCT00570687|1408168|P1|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
577550|NCT00570687|1408159|P10|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
577551|NCT00570687|1408160|P9|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
577552|NCT00570687|1408161|P8|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
577553|NCT00570687|1408162|P7|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
577554|NCT00570687|1408163|P6|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
577555|NCT00570687|1408164|P5|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
577556|NCT00570687|1408165|P4|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4
577557|NCT00570687|1408166|P3|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2
577558|NCT00570687|1408167|P2|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2
577559|NCT00570687|1408168|P1|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4
577560|NCT00570687|1408159|P10|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
577561|NCT00570687|1408160|P9|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
577562|NCT00570687|1408161|P8|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
577563|NCT00570687|1408162|P7|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
577564|NCT00570687|1408163|P6|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
577565|NCT00570687|1408164|P5|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
577566|NCT00570687|1408165|P4|STARTED|Washout 1 (7-21 Days) - Amendment 1||4
577567|NCT00570687|1408166|P3|STARTED|Washout 1 (7-21 Days) - Amendment 1||2
577568|NCT00570687|1408167|P2|STARTED|Washout 1 (7-21 Days) - Amendment 1||2
577569|NCT00570687|1408168|P1|STARTED|Washout 1 (7-21 Days) - Amendment 1||4
577570|NCT00570687|1408159|P10|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
577571|NCT00570687|1408160|P9|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
577572|NCT00570687|1408161|P8|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
577573|NCT00570687|1408162|P7|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
577574|NCT00570687|1408163|P6|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
577575|NCT00570687|1408164|P5|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
577576|NCT00570687|1408165|P4|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
577577|NCT00570687|1408166|P3|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
577578|NCT00570687|1408167|P2|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
577579|NCT00570687|1408168|P1|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
577580|NCT00570687|1408159|P10|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
577581|NCT00570687|1408160|P9|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
577582|NCT00570687|1408161|P8|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
577583|NCT00570687|1408162|P7|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
577584|NCT00570687|1408163|P6|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
577585|NCT00570687|1408164|P5|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
577586|NCT00570687|1408165|P4|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4
577587|NCT00570687|1408166|P3|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2
577588|NCT00570687|1408167|P2|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2
577589|NCT00570687|1408168|P1|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4
577590|NCT00570687|1408159|P10|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
577591|NCT00570687|1408160|P9|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
577592|NCT00570687|1408161|P8|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
577593|NCT00570687|1408162|P7|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
577594|NCT00570687|1408163|P6|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
577595|NCT00570687|1408164|P5|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
577596|NCT00570687|1408165|P4|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4
577597|NCT00570687|1408166|P3|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2
577598|NCT00570687|1408167|P2|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2
577599|NCT00570687|1408168|P1|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4
577600|NCT00570687|1408159|P10|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
577601|NCT00570687|1408160|P9|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
577602|NCT00570687|1408161|P8|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
577603|NCT00570687|1408162|P7|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||1
577604|NCT00570687|1408163|P6|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
577605|NCT00570687|1408164|P5|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
577606|NCT00570687|1408165|P4|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
577607|NCT00570687|1408166|P3|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
577608|NCT00570687|1408167|P2|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
577609|NCT00570687|1408168|P1|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
577610|NCT00570687|1408159|P10|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
577611|NCT00570687|1408160|P9|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
577612|NCT00570687|1408161|P8|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
577613|NCT00570687|1408162|P7|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
577614|NCT00570687|1408163|P6|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
577615|NCT00570687|1408164|P5|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
577616|NCT00570687|1408165|P4|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
577617|NCT00570687|1408166|P3|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
577618|NCT00570687|1408167|P2|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
577619|NCT00570687|1408168|P1|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
577620|NCT00570687|1408159|P10|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
577621|NCT00570687|1408160|P9|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
577622|NCT00570687|1408161|P8|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
577623|NCT00570687|1408162|P7|STARTED|Washout 5 (7-21 Days) - Orig Protocol||1
577624|NCT00570687|1408163|P6|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
577625|NCT00570687|1408164|P5|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
577626|NCT00570687|1408165|P4|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
577627|NCT00570687|1408166|P3|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
577628|NCT00570687|1408167|P2|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
577629|NCT00570687|1408168|P1|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
577630|NCT00570687|1408159|P10|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
577631|NCT00570687|1408160|P9|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
577632|NCT00570687|1408161|P8|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
577633|NCT00570687|1408162|P7|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
577634|NCT00570687|1408163|P6|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
577635|NCT00570687|1408164|P5|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
577636|NCT00570687|1408165|P4|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
577637|NCT00570687|1408166|P3|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
577638|NCT00570687|1408167|P2|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
577639|NCT00570687|1408168|P1|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
577640|NCT00570687|1408159|P10|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
577641|NCT00570687|1408160|P9|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
577642|NCT00570687|1408161|P8|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
577643|NCT00570687|1408162|P7|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||1
577644|NCT00570687|1408163|P6|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
577645|NCT00570687|1408164|P5|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
577646|NCT00570687|1408165|P4|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
577647|NCT00570687|1408166|P3|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
577648|NCT00570687|1408167|P2|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
577649|NCT00570687|1408168|P1|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
577650|NCT00570687|1408159|P10|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
577651|NCT00570687|1408160|P9|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
577652|NCT00570687|1408161|P8|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
577653|NCT00570687|1408162|P7|STARTED|Clamp 2 (1 Day) - Orig Protocol||1
577654|NCT00570687|1408163|P6|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
577655|NCT00570687|1408164|P5|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
577656|NCT00570687|1408165|P4|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
577657|NCT00570687|1408166|P3|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
577658|NCT00570687|1408167|P2|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
577659|NCT00570687|1408168|P1|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
577660|NCT00570687|1408159|P10|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
577661|NCT00570687|1408160|P9|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1
577662|NCT00570687|1408161|P8|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
577663|NCT00570687|1408162|P7|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
577664|NCT00570687|1408163|P6|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
577665|NCT00570687|1408164|P5|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
577666|NCT00570687|1408165|P4|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
577667|NCT00570687|1408166|P3|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
577668|NCT00570687|1408167|P2|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
577669|NCT00570687|1408168|P1|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
577670|NCT00570687|1408159|P10|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
577671|NCT00570687|1408160|P9|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
577672|NCT00570687|1408161|P8|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
577673|NCT00570687|1408162|P7|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1
577674|NCT00570687|1408163|P6|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
577675|NCT00570687|1408164|P5|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
577676|NCT00570687|1408165|P4|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
577677|NCT00570687|1408166|P3|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
577678|NCT00570687|1408167|P2|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
577679|NCT00570687|1408168|P1|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
577680|NCT00570687|1408159|P10|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
577681|NCT00570687|1408160|P9|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1
577682|NCT00570687|1408161|P8|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
577683|NCT00570687|1408162|P7|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1
577684|NCT00570687|1408163|P6|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
577685|NCT00570687|1408164|P5|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
577686|NCT00570687|1408165|P4|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
577687|NCT00570687|1408166|P3|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
577688|NCT00570687|1408167|P2|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
577689|NCT00570687|1408168|P1|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
577690|NCT00570687|1408159|P10|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
577691|NCT00570687|1408160|P9|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
577692|NCT00570687|1408161|P8|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
577693|NCT00570687|1408162|P7|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
577694|NCT00570687|1408163|P6|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
577695|NCT00570687|1408164|P5|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
577696|NCT00570687|1408165|P4|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
577697|NCT00570687|1408166|P3|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
577698|NCT00570687|1408167|P2|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
577699|NCT00570687|1408168|P1|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
577700|NCT00570687|1408159|P10|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
577701|NCT00570687|1408160|P9|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1
577702|NCT00570687|1408161|P8|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
577703|NCT00570687|1408162|P7|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1
577704|NCT00570687|1408163|P6|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
577705|NCT00570687|1408164|P5|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
577706|NCT00570687|1408165|P4|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
577707|NCT00570687|1408166|P3|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
577708|NCT00570687|1408167|P2|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
577709|NCT00570687|1408168|P1|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
577710|NCT00570687|1408159|P10|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
577711|NCT00570687|1408160|P9|STARTED|Clamp 1 (1 Day) - Orig Protocol||1
577712|NCT00570687|1408161|P8|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
577713|NCT00570687|1408162|P7|STARTED|Clamp 1 (1 Day) - Orig Protocol||1
577714|NCT00570687|1408163|P6|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
577715|NCT00570687|1408164|P5|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
577716|NCT00570687|1408165|P4|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
577717|NCT00570687|1408166|P3|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
577718|NCT00570687|1408167|P2|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
577719|NCT00570687|1408168|P1|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
577720|NCT00570687|1408159|P10|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
577721|NCT00570687|1408160|P9|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2
577722|NCT00570687|1408161|P8|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
577723|NCT00570687|1408162|P7|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2
577724|NCT00570687|1408163|P6|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
577725|NCT00570687|1408164|P5|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
577726|NCT00570687|1408165|P4|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
577727|NCT00570687|1408166|P3|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
577728|NCT00570687|1408167|P2|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
577729|NCT00570687|1408168|P1|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
577730|NCT00570687|1408159|P10|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
577731|NCT00570687|1408160|P9|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1
577732|NCT00570687|1408161|P8|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
577733|NCT00570687|1408162|P7|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1
577734|NCT00570687|1408163|P6|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
577735|NCT00570687|1408164|P5|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
577736|NCT00570687|1408165|P4|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
577737|NCT00570687|1408166|P3|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
577738|NCT00570687|1408167|P2|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
577739|NCT00570687|1408168|P1|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
577740|NCT00570687|1408159|P10|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
577741|NCT00570687|1408160|P9|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
577742|NCT00570687|1408161|P8|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
577743|NCT00570687|1408162|P7|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
577744|NCT00570687|1408163|P6|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
577745|NCT00570687|1408164|P5|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
577746|NCT00570687|1408165|P4|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
577747|NCT00570687|1408166|P3|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
577748|NCT00570687|1408167|P2|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
577749|NCT00570687|1408168|P1|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
577750|NCT00570687|1408159|P10|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
577751|NCT00570687|1408160|P9|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
577752|NCT00570687|1408161|P8|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
577753|NCT00570687|1408162|P7|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
577754|NCT00570687|1408163|P6|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
577755|NCT00570687|1408164|P5|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
577756|NCT00570687|1408165|P4|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
577757|NCT00570687|1408166|P3|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
577758|NCT00570687|1408167|P2|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
577759|NCT00570687|1408168|P1|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
577760|NCT00570687|1408159|P10|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
577761|NCT00570687|1408160|P9|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
577762|NCT00570687|1408161|P8|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
577763|NCT00570687|1408162|P7|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
577764|NCT00570687|1408163|P6|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
577765|NCT00570687|1408164|P5|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
577766|NCT00570687|1408165|P4|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
577767|NCT00570687|1408166|P3|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
577768|NCT00570687|1408167|P2|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
577769|NCT00570687|1408168|P1|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
577770|NCT00570687|1408159|P10|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
577771|NCT00570687|1408160|P9|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
577772|NCT00570687|1408161|P8|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
577773|NCT00570687|1408162|P7|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
577774|NCT00570687|1408163|P6|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
577775|NCT00570687|1408164|P5|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
577776|NCT00570687|1408165|P4|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
577777|NCT00570687|1408166|P3|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
577778|NCT00570687|1408167|P2|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
577779|NCT00570687|1408168|P1|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
577780|NCT00570687|1408159|P10|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
577781|NCT00570687|1408160|P9|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
577782|NCT00570687|1408161|P8|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
577783|NCT00570687|1408162|P7|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
577784|NCT00570687|1408163|P6|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
577785|NCT00570687|1408164|P5|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
577786|NCT00570687|1408165|P4|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
577787|NCT00570687|1408166|P3|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
577788|NCT00570687|1408167|P2|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
577789|NCT00570687|1408168|P1|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
577790|NCT00570687|1408159|P10|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
577791|NCT00570687|1408160|P9|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
577792|NCT00570687|1408161|P8|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
577793|NCT00570687|1408162|P7|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
577794|NCT00570687|1408163|P6|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
577795|NCT00570687|1408164|P5|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
577796|NCT00570687|1408165|P4|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
577797|NCT00570687|1408166|P3|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
577798|NCT00570687|1408167|P2|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
577799|NCT00570687|1408168|P1|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
577800|NCT00570687|1408159|P10|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
577801|NCT00570687|1408160|P9|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
577802|NCT00570687|1408161|P8|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
577803|NCT00570687|1408162|P7|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
577804|NCT00570687|1408163|P6|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
577805|NCT00570687|1408164|P5|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
577806|NCT00570687|1408165|P4|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
577807|NCT00570687|1408166|P3|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
577808|NCT00570687|1408167|P2|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
577809|NCT00570687|1408168|P1|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
577810|NCT00570687|1408159|P10|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
577811|NCT00570687|1408160|P9|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
577812|NCT00570687|1408161|P8|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
577813|NCT00570687|1408162|P7|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
577814|NCT00570687|1408163|P6|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
577815|NCT00570687|1408164|P5|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
577816|NCT00570687|1408165|P4|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
577817|NCT00570687|1408166|P3|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
577818|NCT00570687|1408167|P2|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
577819|NCT00570687|1408168|P1|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
577820|NCT00570687|1408159|P10|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
577821|NCT00570687|1408160|P9|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
577822|NCT00570687|1408161|P8|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
577823|NCT00570687|1408162|P7|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
577824|NCT00570687|1408163|P6|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
577825|NCT00570687|1408164|P5|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
577826|NCT00570687|1408165|P4|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
577827|NCT00570687|1408166|P3|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
577828|NCT00570687|1408167|P2|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
577829|NCT00570687|1408168|P1|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
577830|NCT00570687|1408159|P10|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
577831|NCT00570687|1408160|P9|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
577832|NCT00570687|1408161|P8|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
577833|NCT00570687|1408162|P7|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
577834|NCT00570687|1408163|P6|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
577835|NCT00570687|1408164|P5|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
577836|NCT00570687|1408165|P4|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
577837|NCT00570687|1408166|P3|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
577838|NCT00570687|1408167|P2|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
577839|NCT00570687|1408168|P1|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
577840|NCT00570687|1408159|P10|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
577841|NCT00570687|1408160|P9|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
577842|NCT00570687|1408161|P8|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
577843|NCT00570687|1408162|P7|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
577844|NCT00570687|1408163|P6|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
577845|NCT00570687|1408164|P5|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
577846|NCT00570687|1408165|P4|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
577847|NCT00570687|1408166|P3|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
577848|NCT00570687|1408167|P2|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
577849|NCT00570687|1408168|P1|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
577850|NCT00570687|1408159|P10|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
577851|NCT00570687|1408160|P9|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
577852|NCT00570687|1408161|P8|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
577853|NCT00570687|1408162|P7|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
577854|NCT00570687|1408163|P6|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
577855|NCT00570687|1408164|P5|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
577856|NCT00570687|1408165|P4|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
577857|NCT00570687|1408166|P3|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
577858|NCT00570687|1408167|P2|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
577859|NCT00570687|1408168|P1|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
577860|NCT00570687|1408159|P10|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
577861|NCT00570687|1408160|P9|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
577862|NCT00570687|1408161|P8|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
577863|NCT00570687|1408162|P7|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
577864|NCT00570687|1408163|P6|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
577865|NCT00570687|1408164|P5|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
577866|NCT00570687|1408165|P4|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
577867|NCT00570687|1408166|P3|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
577868|NCT00570687|1408167|P2|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
577869|NCT00570687|1408168|P1|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
577870|NCT00570687|1408159|P10|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
577871|NCT00570687|1408160|P9|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
577872|NCT00570687|1408161|P8|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
577873|NCT00570687|1408162|P7|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
577874|NCT00570687|1408163|P6|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
577875|NCT00570687|1408164|P5|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
577876|NCT00570687|1408165|P4|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
577877|NCT00570687|1408166|P3|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
577878|NCT00570687|1408167|P2|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
577879|NCT00570687|1408168|P1|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
577880|NCT00570687|1408159|P10|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
577881|NCT00570687|1408160|P9|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
577882|NCT00570687|1408161|P8|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
577883|NCT00570687|1408162|P7|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
577884|NCT00570687|1408163|P6|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
577885|NCT00570687|1408164|P5|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
577886|NCT00570687|1408165|P4|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
577887|NCT00570687|1408166|P3|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
577888|NCT00570687|1408167|P2|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
577889|NCT00570687|1408168|P1|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
577890|NCT00570687|1408159|P10|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
577891|NCT00570687|1408160|P9|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
577892|NCT00570687|1408161|P8|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
577893|NCT00570687|1408162|P7|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
577894|NCT00570687|1408163|P6|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
577895|NCT00570687|1408164|P5|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
577896|NCT00570687|1408165|P4|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
577897|NCT00570687|1408166|P3|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
577898|NCT00570687|1408167|P2|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
577899|NCT00570687|1408168|P1|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
577900|NCT00570674|1408194|P7|NOT COMPLETED|Overall Study||0
577901|NCT00570674|1408195|P6|NOT COMPLETED|Overall Study||0
577902|NCT00570674|1408196|P5|NOT COMPLETED|Overall Study||0
577903|NCT00570674|1408197|P4|NOT COMPLETED|Overall Study||0
577904|NCT00570674|1408198|P3|NOT COMPLETED|Overall Study||1
577905|NCT00570674|1408199|P2|NOT COMPLETED|Overall Study||0
577906|NCT00570674|1408200|P1|NOT COMPLETED|Overall Study||0
577907|NCT00570674|1408194|P7|COMPLETED|Overall Study||0
577908|NCT00570674|1408195|P6|COMPLETED|Overall Study||10
577909|NCT00570674|1408196|P5|COMPLETED|Overall Study||3
577910|NCT00570674|1408197|P4|COMPLETED|Overall Study||3
577911|NCT00570674|1408198|P3|COMPLETED|Overall Study||3
577912|NCT00570674|1408199|P2|COMPLETED|Overall Study||3
577913|NCT00570674|1408200|P1|COMPLETED|Overall Study||6
577914|NCT00570674|1408194|P7|PEG Evaluable|Overall Study||0
577915|NCT00570674|1408195|P6|PEG Evaluable|Overall Study||10
577916|NCT00570674|1408196|P5|PEG Evaluable|Overall Study||2
577917|NCT00570674|1408197|P4|PEG Evaluable|Overall Study||3
577918|NCT00570674|1408198|P3|PEG Evaluable|Overall Study||3
577919|NCT00570674|1408199|P2|PEG Evaluable|Overall Study||3
577920|NCT00570674|1408200|P1|PEG Evaluable|Overall Study||6
577921|NCT00570674|1408194|P7|Treated|Overall Study||0
577922|NCT00570674|1408195|P6|Treated|Overall Study||10
577923|NCT00570674|1408196|P5|Treated|Overall Study||3
577924|NCT00570674|1408197|P4|Treated|Overall Study||3
577925|NCT00570674|1408198|P3|Treated|Overall Study||3
577926|NCT00570674|1408199|P2|Treated|Overall Study||3
577927|NCT00570674|1408200|P1|Treated|Overall Study||6
577928|NCT00570674|1408194|P7|STARTED|Overall Study|The study did not continue beyond phase I.|0
577929|NCT00570674|1408195|P6|STARTED|Overall Study||10
577930|NCT00570674|1408196|P5|STARTED|Overall Study||3
577931|NCT00570674|1408197|P4|STARTED|Overall Study||3
577932|NCT00570674|1408198|P3|STARTED|Overall Study||4
577933|NCT00570674|1408199|P2|STARTED|Overall Study||3
577934|NCT00570674|1408200|P1|STARTED|Overall Study||6
577935|NCT00570531|1408217|P1|NOT COMPLETED|Overall Study||0
577936|NCT00570531|1408217|P1|COMPLETED|Overall Study||6
577937|NCT00570531|1408217|P1|STARTED|Overall Study||6
577938|NCT00570505|1408223|P1|NOT COMPLETED|Overall Study||41
577939|NCT00570505|1408223|P1|COMPLETED|Overall Study|The number of subjects completing the 60-month study|108
577940|NCT00570505|1408223|P1|STARTED|Overall Study||149
577941|NCT00570492|1408236|P3|NOT COMPLETED|52-week Double-blind Treatment Period||51
577942|NCT00570492|1408237|P2|NOT COMPLETED|52-week Double-blind Treatment Period||50
577943|NCT00570492|1408238|P1|NOT COMPLETED|52-week Double-blind Treatment Period||0
577944|NCT00570492|1408236|P3|COMPLETED|52-week Double-blind Treatment Period||186
577945|NCT00570492|1408237|P2|COMPLETED|52-week Double-blind Treatment Period||187
577946|NCT00570492|1408238|P1|COMPLETED|52-week Double-blind Treatment Period||0
577947|NCT00570492|1408236|P3|STARTED|52-week Double-blind Treatment Period||237
577948|NCT00570492|1408237|P2|STARTED|52-week Double-blind Treatment Period||237
577949|NCT00570492|1408238|P1|STARTED|52-week Double-blind Treatment Period||0
577950|NCT00570492|1408236|P3|NOT COMPLETED|16-week Single-blind Baseline Period||0
577951|NCT00570492|1408237|P2|NOT COMPLETED|16-week Single-blind Baseline Period||0
577952|NCT00570492|1408238|P1|NOT COMPLETED|16-week Single-blind Baseline Period||436
577953|NCT00570492|1408236|P3|COMPLETED|16-week Single-blind Baseline Period||0
577954|NCT00570492|1408237|P2|COMPLETED|16-week Single-blind Baseline Period||0
577955|NCT00570492|1408238|P1|COMPLETED|16-week Single-blind Baseline Period||474
577956|NCT00570492|1408236|P3|STARTED|16-week Single-blind Baseline Period||0
577957|NCT00570492|1408237|P2|STARTED|16-week Single-blind Baseline Period||0
577958|NCT00570492|1408238|P1|STARTED|16-week Single-blind Baseline Period||910
577959|NCT00570401|1408276|P1|NOT COMPLETED|Overall Study||2
577960|NCT00570401|1408276|P1|COMPLETED|Overall Study||19
577961|NCT00570401|1408276|P1|STARTED|Overall Study||21
577962|NCT00570362|1408282|P2|NOT COMPLETED|Overall Study||0
577963|NCT00570362|1408283|P1|NOT COMPLETED|Overall Study||0
577964|NCT00570362|1408282|P2|COMPLETED|Overall Study||30
577965|NCT00570362|1408283|P1|COMPLETED|Overall Study||19
577966|NCT00570362|1408282|P2|STARTED|Overall Study||30
577967|NCT00570362|1408283|P1|STARTED|Overall Study||19
577968|NCT00570349|1408292|P3|NOT COMPLETED|Overall Study||0
577969|NCT00570349|1408293|P2|NOT COMPLETED|Overall Study||0
577970|NCT00570349|1408294|P1|NOT COMPLETED|Overall Study||0
577971|NCT00570349|1408292|P3|COMPLETED|Overall Study||6
577972|NCT00570349|1408293|P2|COMPLETED|Overall Study||6
577973|NCT00570349|1408294|P1|COMPLETED|Overall Study||6
577974|NCT00570349|1408292|P3|STARTED|Overall Study||6
577975|NCT00570349|1408293|P2|STARTED|Overall Study||6
577976|NCT00570349|1408294|P1|STARTED|Overall Study||6
577977|NCT00570310|1408310|P2|NOT COMPLETED|Overall Study||6
577978|NCT00570310|1408311|P1|NOT COMPLETED|Overall Study||2
577979|NCT00570310|1408310|P2|COMPLETED|Overall Study||45
577980|NCT00570310|1408311|P1|COMPLETED|Overall Study||51
577981|NCT00570310|1408310|P2|STARTED|Overall Study||51
577982|NCT00570310|1408311|P1|STARTED|Overall Study||53
577983|NCT00570232|1408319|P1|NOT COMPLETED|Overall Study||23
577984|NCT00570232|1408319|P1|COMPLETED|Overall Study||8
577985|NCT00570232|1408319|P1|STARTED|Overall Study||31
577986|NCT00570141|1408325|P1|NOT COMPLETED|Overall Study||3
577987|NCT00570141|1408325|P1|COMPLETED|Overall Study||10
577988|NCT00570141|1408325|P1|STARTED|Overall Study||13
577989|NCT00570089|1408330|P2|NOT COMPLETED|Perod 2||0
577990|NCT00570089|1408331|P1|NOT COMPLETED|Perod 2||0
577991|NCT00570089|1408330|P2|COMPLETED|Perod 2||10
577992|NCT00570089|1408331|P1|COMPLETED|Perod 2||10
577993|NCT00570089|1408330|P2|STARTED|Perod 2||10
577994|NCT00570089|1408331|P1|STARTED|Perod 2||10
577995|NCT00570089|1408330|P2|NOT COMPLETED|Period 1||0
577996|NCT00570089|1408331|P1|NOT COMPLETED|Period 1||0
577997|NCT00570089|1408330|P2|COMPLETED|Period 1||10
577998|NCT00570089|1408331|P1|COMPLETED|Period 1||10
577999|NCT00570089|1408330|P2|STARTED|Period 1||10
578000|NCT00570089|1408331|P1|STARTED|Period 1||10
578001|NCT00570063|1408341|P2|NOT COMPLETED|Overall Study||8
578002|NCT00570063|1408342|P1|NOT COMPLETED|Overall Study||15
578003|NCT00570063|1408341|P2|COMPLETED|Overall Study||3
578004|NCT00570063|1408342|P1|COMPLETED|Overall Study||9
578005|NCT00570063|1408341|P2|STARTED|Overall Study||11
578006|NCT00570063|1408342|P1|STARTED|Overall Study||24
578007|NCT00570037|1408408|P2|NOT COMPLETED|Overall Study||69
578008|NCT00570037|1408409|P1|NOT COMPLETED|Overall Study||44
578009|NCT00570037|1408408|P2|COMPLETED|Overall Study||237
578010|NCT00570037|1408409|P1|COMPLETED|Overall Study||194
578011|NCT00570037|1408408|P2|STARTED|Overall Study||306
578012|NCT00570037|1408409|P1|STARTED|Overall Study||238
578013|NCT00569946|1408419|P1|NOT COMPLETED|Overall Study||59
578014|NCT00569946|1408419|P1|COMPLETED|Overall Study||5
578015|NCT00569946|1408419|P1|STARTED|Overall Study||64
578016|NCT00569868|1408435|P1|NOT COMPLETED|Overall Study||0
578017|NCT00569868|1408435|P1|COMPLETED|Overall Study||11
578018|NCT00569868|1408435|P1|STARTED|Overall Study||11
578019|NCT00569855|1408439|P1|NOT COMPLETED|Overall Study||0
578020|NCT00569855|1408439|P1|COMPLETED|Overall Study|785 subjects treated with study drug|785
578021|NCT00569855|1408439|P1|STARTED|Overall Study|832 subjects enrolled; however, study records only available for analysis from 2004 =446 subjects|785
578022|NCT00569803|1408451|P8|NOT COMPLETED|Overall Study||1
578023|NCT00569803|1408452|P7|NOT COMPLETED|Overall Study||0
578024|NCT00569803|1408453|P6|NOT COMPLETED|Overall Study||0
578025|NCT00569803|1408454|P5|NOT COMPLETED|Overall Study||0
578026|NCT00569803|1408455|P4|NOT COMPLETED|Overall Study||1
578027|NCT00569803|1408456|P3|NOT COMPLETED|Overall Study||0
578028|NCT00569803|1408457|P2|NOT COMPLETED|Overall Study||0
578029|NCT00569803|1408458|P1|NOT COMPLETED|Overall Study||1
578030|NCT00569803|1408451|P8|COMPLETED|Overall Study||5
578031|NCT00569803|1408452|P7|COMPLETED|Overall Study||10
578032|NCT00569803|1408453|P6|COMPLETED|Overall Study||5
578033|NCT00569803|1408454|P5|COMPLETED|Overall Study||5
578034|NCT00569803|1408455|P4|COMPLETED|Overall Study||5
578035|NCT00569803|1408456|P3|COMPLETED|Overall Study||5
578036|NCT00569803|1408457|P2|COMPLETED|Overall Study||5
578037|NCT00569803|1408458|P1|COMPLETED|Overall Study||4
578038|NCT00569803|1408451|P8|STARTED|Overall Study||6
578039|NCT00569803|1408452|P7|STARTED|Overall Study||10
578040|NCT00569803|1408453|P6|STARTED|Overall Study||5
578041|NCT00569803|1408454|P5|STARTED|Overall Study||5
578042|NCT00569803|1408455|P4|STARTED|Overall Study||6
578043|NCT00569803|1408456|P3|STARTED|Overall Study||5
578044|NCT00569803|1408457|P2|STARTED|Overall Study||5
578045|NCT00569803|1408458|P1|STARTED|Overall Study||5
578046|NCT00569777|1408585|P2|NOT COMPLETED|Overall Study||3
578047|NCT00569777|1408586|P1|NOT COMPLETED|Overall Study||10
578048|NCT00569777|1408585|P2|COMPLETED|Overall Study||101
578049|NCT00569777|1408586|P1|COMPLETED|Overall Study||196
578050|NCT00569777|1408585|P2|STARTED|Overall Study||104
578051|NCT00569777|1408586|P1|STARTED|Overall Study||206
578052|NCT00569673|1408628|P1|NOT COMPLETED|Overall Study||0
578053|NCT00569673|1408628|P1|COMPLETED|Overall Study|Total number participants that are eligible and evaluable.|71
578054|NCT00569673|1408628|P1|STARTED|Overall Study|Total number participants enrolled on study|71
578055|NCT00569660|1408633|P1|NOT COMPLETED|Overall Study||0
578056|NCT00569660|1408633|P1|COMPLETED|Overall Study||34
578057|NCT00569660|1408633|P1|STARTED|Overall Study||34
578058|NCT00569582|1408637|P1|NOT COMPLETED|Overall Study||16
578059|NCT00569582|1408637|P1|COMPLETED|Overall Study||34
578060|NCT00569582|1408637|P1|STARTED|Overall Study||50
578061|NCT00569530|1408644|P2|NOT COMPLETED|Overall Study||0
578062|NCT00569530|1408645|P1|NOT COMPLETED|Overall Study||0
578063|NCT00569530|1408644|P2|COMPLETED|Overall Study||42
578064|NCT00569530|1408645|P1|COMPLETED|Overall Study||43
578065|NCT00569530|1408644|P2|STARTED|Overall Study||42
578066|NCT00569530|1408645|P1|STARTED|Overall Study||43
578067|NCT00569374|1408653|P1|NOT COMPLETED|Overall Study||4
578068|NCT00569374|1408653|P1|COMPLETED|Overall Study||4
578069|NCT00569374|1408653|P1|STARTED|Overall Study||8
578070|NCT00569309|1408663|P1|NOT COMPLETED|Overall Study||0
578071|NCT00569309|1408663|P1|COMPLETED|Overall Study||30
578072|NCT00569309|1408663|P1|STARTED|Overall Study||30
578073|NCT00569270|1408672|P2|NOT COMPLETED|Period: Second Intervention||0
578074|NCT00569270|1408673|P1|NOT COMPLETED|Period: Second Intervention||0
578075|NCT00569270|1408672|P2|COMPLETED|Period: Second Intervention||14
578076|NCT00569270|1408673|P1|COMPLETED|Period: Second Intervention||15
578077|NCT00569270|1408672|P2|29 Days|Period: Second Intervention||14
578078|NCT00569270|1408673|P1|29 Days|Period: Second Intervention||15
578079|NCT00569270|1408672|P2|STARTED|Period: Second Intervention||14
578080|NCT00569270|1408673|P1|STARTED|Period: Second Intervention||15
578081|NCT00569270|1408672|P2|NOT COMPLETED|Period: First Intervention||1
578082|NCT00569270|1408673|P1|NOT COMPLETED|Period: First Intervention||0
578083|NCT00569270|1408672|P2|COMPLETED|Period: First Intervention||14
578084|NCT00569270|1408673|P1|COMPLETED|Period: First Intervention||15
578085|NCT00569270|1408672|P2|STARTED|Period: First Intervention||15
578086|NCT00569270|1408673|P1|STARTED|Period: First Intervention|randomized cross over study|15
578087|NCT00569231|1408708|P1|NOT COMPLETED|Overall Study||7
578088|NCT00569231|1408708|P1|COMPLETED|Overall Study||11
578089|NCT00569231|1408708|P1|STARTED|Overall Study||18
578090|NCT00569192|1408718|P3|NOT COMPLETED|Overall Study||25
578091|NCT00569192|1408719|P2|NOT COMPLETED|Overall Study||20
578092|NCT00569192|1408720|P1|NOT COMPLETED|Overall Study||23
578093|NCT00569192|1408718|P3|COMPLETED|Overall Study||99
578094|NCT00569192|1408719|P2|COMPLETED|Overall Study||105
578095|NCT00569192|1408720|P1|COMPLETED|Overall Study||88
578096|NCT00569192|1408718|P3|STARTED|Overall Study||124
578097|NCT00569192|1408719|P2|STARTED|Overall Study||125
578098|NCT00569192|1408720|P1|STARTED|Overall Study||111
578099|NCT00569166|1408746|P3|NOT COMPLETED|Overall Study||4
578100|NCT00569166|1408747|P2|NOT COMPLETED|Overall Study||6
578101|NCT00569166|1408748|P1|NOT COMPLETED|Overall Study||9
578102|NCT00569166|1408746|P3|COMPLETED|Overall Study||27
578103|NCT00569166|1408747|P2|COMPLETED|Overall Study||25
578104|NCT00569166|1408748|P1|COMPLETED|Overall Study||21
578105|NCT00569166|1408746|P3|STARTED|Overall Study||31
578106|NCT00569166|1408747|P2|STARTED|Overall Study||31
578107|NCT00569166|1408748|P1|STARTED|Overall Study||30
578108|NCT00569127|1408782|P2|NOT COMPLETED|Overall Study||213
578109|NCT00569127|1408783|P1|NOT COMPLETED|Overall Study||214
578110|NCT00569127|1408782|P2|COMPLETED|Overall Study||0
578111|NCT00569127|1408783|P1|COMPLETED|Overall Study||0
578112|NCT00569127|1408782|P2|Eligible|Overall Study||202
578113|NCT00569127|1408783|P1|Eligible|Overall Study||200
578114|NCT00569127|1408782|P2|STARTED|Overall Study||213
578115|NCT00569127|1408783|P1|STARTED|Overall Study||214
578116|NCT00569010|1408803|P4|NOT COMPLETED|Overall Study||0
578117|NCT00569010|1408804|P3|NOT COMPLETED|Overall Study||0
578118|NCT00569010|1408805|P2|NOT COMPLETED|Overall Study||0
578119|NCT00569010|1408806|P1|NOT COMPLETED|Overall Study||0
578120|NCT00569010|1408803|P4|COMPLETED|Overall Study||11
578121|NCT00569010|1408804|P3|COMPLETED|Overall Study||11
578122|NCT00569010|1408805|P2|COMPLETED|Overall Study||6
578123|NCT00569010|1408806|P1|COMPLETED|Overall Study||6
578124|NCT00569010|1408803|P4|STARTED|Overall Study||11
578125|NCT00569010|1408804|P3|STARTED|Overall Study||11
578126|NCT00569010|1408805|P2|STARTED|Overall Study||6
578127|NCT00569010|1408806|P1|STARTED|Overall Study||6
578128|NCT00568958|1408818|P2|NOT COMPLETED|Follow-Up||4
578129|NCT00568958|1408819|P1|NOT COMPLETED|Follow-Up||8
578130|NCT00568958|1408818|P2|COMPLETED|Follow-Up||63
578131|NCT00568958|1408819|P1|COMPLETED|Follow-Up||53
578132|NCT00568958|1408818|P2|STARTED|Follow-Up||67
578133|NCT00568958|1408819|P1|STARTED|Follow-Up||61
578134|NCT00568958|1408818|P2|NOT COMPLETED|Allocation||3
578135|NCT00568958|1408819|P1|NOT COMPLETED|Allocation||9
578136|NCT00568958|1408818|P2|COMPLETED|Allocation||67
578137|NCT00568958|1408819|P1|COMPLETED|Allocation||61
578138|NCT00568958|1408818|P2|STARTED|Allocation||70
578139|NCT00568958|1408819|P1|STARTED|Allocation||70
578140|NCT00568854|1408839|P2|NOT COMPLETED|Overall Study||0
578141|NCT00568854|1408840|P1|NOT COMPLETED|Overall Study||0
578142|NCT00568854|1408839|P2|COMPLETED|Overall Study||4
578143|NCT00568854|1408840|P1|COMPLETED|Overall Study||6
578144|NCT00568854|1408839|P2|STARTED|Overall Study||4
578145|NCT00568854|1408840|P1|STARTED|Overall Study||6
578146|NCT00568776|1408852|P4|NOT COMPLETED|Overall Study||72
578147|NCT00568776|1408853|P3|NOT COMPLETED|Overall Study||74
578148|NCT00568776|1408854|P2|NOT COMPLETED|Overall Study||36
578149|NCT00568776|1408855|P1|NOT COMPLETED|Overall Study||30
578150|NCT00568776|1408852|P4|COMPLETED|Overall Study||19
578151|NCT00568776|1408853|P3|COMPLETED|Overall Study||15
578152|NCT00568776|1408854|P2|COMPLETED|Overall Study||52
578153|NCT00568776|1408855|P1|COMPLETED|Overall Study||53
578154|NCT00568776|1408852|P4|STARTED|Overall Study|42 patients withdrawn per interim safety review (sponsors decision); excluded in efficacy analysis.|91
578155|NCT00568776|1408853|P3|STARTED|Overall Study|41 patients withdrawn per interim safety review (sponsors decision); excluded in efficacy analysis.|89
578156|NCT00568776|1408854|P2|STARTED|Overall Study|One randomized patient withdrew consent and did not receive ELND005 250 mg BID|88
578157|NCT00568776|1408855|P1|STARTED|Overall Study|One randomized patient withdrew consent and did not receive placebo|83
578158|NCT00568685|1408892|P3|NOT COMPLETED|Overall Study||5
578159|NCT00568685|1408893|P2|NOT COMPLETED|Overall Study||5
578160|NCT00568685|1408894|P1|NOT COMPLETED|Overall Study||10
578161|NCT00568685|1408892|P3|COMPLETED|Overall Study||46
578162|NCT00568685|1408893|P2|COMPLETED|Overall Study||46
578163|NCT00568685|1408894|P1|COMPLETED|Overall Study||41
578164|NCT00568685|1408892|P3|STARTED|Overall Study||51
578165|NCT00568685|1408893|P2|STARTED|Overall Study||51
578166|NCT00568685|1408894|P1|STARTED|Overall Study||51
578167|NCT00568555|1408928|P2|NOT COMPLETED|Overall Study||1
578168|NCT00568555|1408929|P1|NOT COMPLETED|Overall Study||1
578169|NCT00568555|1408928|P2|COMPLETED|Overall Study||14
578170|NCT00568555|1408929|P1|COMPLETED|Overall Study||15
578171|NCT00568555|1408928|P2|STARTED|Overall Study||15
578172|NCT00568555|1408929|P1|STARTED|Overall Study||16
578173|NCT00568451|1408947|P4|NOT COMPLETED|Overall Study||7
578174|NCT00568451|1408948|P3|NOT COMPLETED|Overall Study||2
578175|NCT00568451|1408949|P2|NOT COMPLETED|Overall Study||0
578176|NCT00568451|1408950|P1|NOT COMPLETED|Overall Study||0
578177|NCT00568451|1408947|P4|COMPLETED|Overall Study||2
578178|NCT00568451|1408948|P3|COMPLETED|Overall Study||0
578179|NCT00568451|1408949|P2|COMPLETED|Overall Study||0
578180|NCT00568451|1408950|P1|COMPLETED|Overall Study||0
578181|NCT00568451|1408947|P4|STARTED|Overall Study||9
578182|NCT00568451|1408948|P3|STARTED|Overall Study||2
578183|NCT00568451|1408949|P2|STARTED|Overall Study||0
578184|NCT00568451|1408950|P1|STARTED|Overall Study||0
578185|NCT00568399|1408966|P1|NOT COMPLETED|Overall Study||15
578186|NCT00568399|1408966|P1|COMPLETED|Overall Study|Of 48 subject enrolled, 37 initiated sodium thiosulfate treatment. 22 completed the entire protocol|22
578187|NCT00568399|1408966|P1|STARTED|Overall Study||37
578188|NCT00568386|1408972|P2|NOT COMPLETED|Overall Study||0
578189|NCT00568386|1408973|P1|NOT COMPLETED|Overall Study||0
578190|NCT00568386|1408972|P2|COMPLETED|Overall Study||20
578191|NCT00568386|1408973|P1|COMPLETED|Overall Study||20
578192|NCT00568386|1408972|P2|STARTED|Overall Study||20
578193|NCT00568386|1408973|P1|STARTED|Overall Study||20
578194|NCT00568334|1408981|P2|NOT COMPLETED|Overall Study||1
578195|NCT00568334|1408982|P1|NOT COMPLETED|Overall Study||1
578196|NCT00568334|1408981|P2|COMPLETED|Overall Study||121
578197|NCT00568334|1408982|P1|COMPLETED|Overall Study||121
578198|NCT00568334|1408981|P2|STARTED|Overall Study||122
578199|NCT00568334|1408982|P1|STARTED|Overall Study||122
578200|NCT00568178|1409008|P6|NOT COMPLETED|Open Label Extension||80
578201|NCT00568178|1409009|P5|NOT COMPLETED|Open Label Extension||79
578202|NCT00568178|1409010|P4|NOT COMPLETED|Open Label Extension||0
578203|NCT00568178|1409011|P3|NOT COMPLETED|Open Label Extension||0
578204|NCT00568178|1409012|P2|NOT COMPLETED|Open Label Extension||0
578205|NCT00568178|1409013|P1|NOT COMPLETED|Open Label Extension||0
578206|NCT00568178|1409008|P6|COMPLETED|Open Label Extension||54
578207|NCT00568178|1409009|P5|COMPLETED|Open Label Extension||55
578208|NCT00568178|1409010|P4|COMPLETED|Open Label Extension||0
578209|NCT00568178|1409011|P3|COMPLETED|Open Label Extension||0
578210|NCT00568178|1409012|P2|COMPLETED|Open Label Extension||0
578211|NCT00568178|1409013|P1|COMPLETED|Open Label Extension||0
578212|NCT00568178|1409008|P6|STARTED|Open Label Extension||134
578213|NCT00568178|1409009|P5|STARTED|Open Label Extension||134
578214|NCT00568178|1409010|P4|STARTED|Open Label Extension||0
578215|NCT00568178|1409011|P3|STARTED|Open Label Extension||0
578216|NCT00568178|1409012|P2|STARTED|Open Label Extension||0
578217|NCT00568178|1409013|P1|STARTED|Open Label Extension||0
578218|NCT00568178|1409008|P6|NOT COMPLETED|Double Blind Base Study||0
578219|NCT00568178|1409009|P5|NOT COMPLETED|Double Blind Base Study||0
578220|NCT00568178|1409010|P4|NOT COMPLETED|Double Blind Base Study||5
578221|NCT00568178|1409011|P3|NOT COMPLETED|Double Blind Base Study||1
578222|NCT00568178|1409012|P2|NOT COMPLETED|Double Blind Base Study||6
578223|NCT00568178|1409013|P1|NOT COMPLETED|Double Blind Base Study||6
578224|NCT00568178|1409008|P6|COMPLETED|Double Blind Base Study||0
578225|NCT00568178|1409009|P5|COMPLETED|Double Blind Base Study||0
578226|NCT00568178|1409010|P4|COMPLETED|Double Blind Base Study||25
578227|NCT00568178|1409011|P3|COMPLETED|Double Blind Base Study||29
578228|NCT00568178|1409012|P2|COMPLETED|Double Blind Base Study||118
578229|NCT00568178|1409013|P1|COMPLETED|Double Blind Base Study||116
578230|NCT00568178|1409008|P6|STARTED|Double Blind Base Study||0
578231|NCT00568178|1409009|P5|STARTED|Double Blind Base Study||0
578232|NCT00568178|1409010|P4|STARTED|Double Blind Base Study||30
578233|NCT00568178|1409011|P3|STARTED|Double Blind Base Study||30
578234|NCT00568178|1409012|P2|STARTED|Double Blind Base Study||124
578235|NCT00568178|1409013|P1|STARTED|Double Blind Base Study||122
578236|NCT00568087|1409031|P2|NOT COMPLETED|Overall Study||7
578237|NCT00568087|1409032|P1|NOT COMPLETED|Overall Study||7
578238|NCT00568087|1409031|P2|COMPLETED|Overall Study||17
578239|NCT00568087|1409032|P1|COMPLETED|Overall Study||15
578240|NCT00568087|1409031|P2|Received Intervention|Overall Study||23
578241|NCT00568087|1409032|P1|Received Intervention|Overall Study||21
578242|NCT00568087|1409031|P2|STARTED|Overall Study||24
578243|NCT00568087|1409032|P1|STARTED|Overall Study||22
578244|NCT00568061|1409044|P2|NOT COMPLETED|Overall Study||2
578245|NCT00568061|1409045|P1|NOT COMPLETED|Overall Study||5
578246|NCT00568061|1409044|P2|COMPLETED|Overall Study||14
578247|NCT00568061|1409045|P1|COMPLETED|Overall Study||8
578248|NCT00568061|1409044|P2|STARTED|Overall Study||16
578249|NCT00568061|1409045|P1|STARTED|Overall Study||13
578250|NCT00568022|1409054|P3|NOT COMPLETED|Overall Study||0
578251|NCT00568022|1409055|P2|NOT COMPLETED|Overall Study||0
578252|NCT00568022|1409056|P1|NOT COMPLETED|Overall Study||0
578253|NCT00568022|1409054|P3|COMPLETED|Overall Study||3
578254|NCT00568022|1409055|P2|COMPLETED|Overall Study||3
578255|NCT00568022|1409056|P1|COMPLETED|Overall Study||3
578256|NCT00568022|1409054|P3|STARTED|Overall Study||3
578257|NCT00568022|1409055|P2|STARTED|Overall Study||3
578258|NCT00568022|1409056|P1|STARTED|Overall Study||3
578259|NCT00567996|1409089|P3|NOT COMPLETED|Overall Study||70
578260|NCT00567996|1409090|P2|NOT COMPLETED|Overall Study||50
578261|NCT00567996|1409091|P1|NOT COMPLETED|Overall Study||44
578262|NCT00567996|1409089|P3|COMPLETED|Overall Study||265
578263|NCT00567996|1409090|P2|COMPLETED|Overall Study||284
578264|NCT00567996|1409091|P1|COMPLETED|Overall Study||289
578265|NCT00567996|1409089|P3|Intent-to-treat: Received Study Drug|Overall Study||335
578266|NCT00567996|1409090|P2|Intent-to-treat: Received Study Drug|Overall Study||333
578267|NCT00567996|1409091|P1|Intent-to-treat: Received Study Drug|Overall Study||330
578268|NCT00567996|1409089|P3|STARTED|Overall Study||335
578269|NCT00567996|1409090|P2|STARTED|Overall Study||334
578270|NCT00567996|1409091|P1|STARTED|Overall Study|Randomized participants|333
578271|NCT00567892|1409107|P4|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||1
578272|NCT00567892|1409108|P3|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
578273|NCT00567892|1409109|P2|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
578274|NCT00567892|1409110|P1|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
578275|NCT00567892|1409107|P4|COMPLETED|Second Treatment (2 or 4 Weeks)||5
578276|NCT00567892|1409108|P3|COMPLETED|Second Treatment (2 or 4 Weeks)||9
578277|NCT00567892|1409109|P2|COMPLETED|Second Treatment (2 or 4 Weeks)||7
578278|NCT00567892|1409110|P1|COMPLETED|Second Treatment (2 or 4 Weeks)||7
578279|NCT00567892|1409107|P4|STARTED|Second Treatment (2 or 4 Weeks)||6
578280|NCT00567892|1409108|P3|STARTED|Second Treatment (2 or 4 Weeks)||9
578281|NCT00567892|1409109|P2|STARTED|Second Treatment (2 or 4 Weeks)||7
578282|NCT00567892|1409110|P1|STARTED|Second Treatment (2 or 4 Weeks)||7
578283|NCT00567892|1409107|P4|NOT COMPLETED|Washout (2 Weeks)||0
578284|NCT00567892|1409108|P3|NOT COMPLETED|Washout (2 Weeks)||0
578285|NCT00567892|1409109|P2|NOT COMPLETED|Washout (2 Weeks)||0
578286|NCT00567892|1409110|P1|NOT COMPLETED|Washout (2 Weeks)||0
578287|NCT00567892|1409107|P4|COMPLETED|Washout (2 Weeks)||6
578288|NCT00567892|1409108|P3|COMPLETED|Washout (2 Weeks)||9
578289|NCT00567892|1409109|P2|COMPLETED|Washout (2 Weeks)||7
578290|NCT00567892|1409110|P1|COMPLETED|Washout (2 Weeks)||7
578291|NCT00567892|1409107|P4|STARTED|Washout (2 Weeks)||6
578292|NCT00567892|1409108|P3|STARTED|Washout (2 Weeks)||9
578293|NCT00567892|1409109|P2|STARTED|Washout (2 Weeks)||7
578294|NCT00567892|1409110|P1|STARTED|Washout (2 Weeks)||7
578295|NCT00567892|1409107|P4|NOT COMPLETED|First Treatment (2 or 4 Weeks)||4
578296|NCT00567892|1409108|P3|NOT COMPLETED|First Treatment (2 or 4 Weeks)||1
578297|NCT00567892|1409109|P2|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0
578298|NCT00567892|1409110|P1|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0
578299|NCT00567892|1409107|P4|COMPLETED|First Treatment (2 or 4 Weeks)||6
578300|NCT00567892|1409108|P3|COMPLETED|First Treatment (2 or 4 Weeks)||9
578301|NCT00567892|1409109|P2|COMPLETED|First Treatment (2 or 4 Weeks)||7
578302|NCT00567892|1409110|P1|COMPLETED|First Treatment (2 or 4 Weeks)||7
578303|NCT00567892|1409107|P4|STARTED|First Treatment (2 or 4 Weeks)||10
578304|NCT00567892|1409108|P3|STARTED|First Treatment (2 or 4 Weeks)||10
578305|NCT00567892|1409109|P2|STARTED|First Treatment (2 or 4 Weeks)||7
578306|NCT00567892|1409110|P1|STARTED|First Treatment (2 or 4 Weeks)||7
578307|NCT00567879|1409128|P6|NOT COMPLETED|Overall Study||3
578308|NCT00567879|1409129|P5|NOT COMPLETED|Overall Study||12
578309|NCT00567879|1409130|P4|NOT COMPLETED|Overall Study||6
578310|NCT00567879|1409131|P3|NOT COMPLETED|Overall Study||21
578311|NCT00567879|1409132|P2|NOT COMPLETED|Overall Study||7
578312|NCT00567879|1409133|P1|NOT COMPLETED|Overall Study||7
578313|NCT00567879|1409128|P6|COMPLETED|Overall Study||0
578314|NCT00567879|1409129|P5|COMPLETED|Overall Study||0
578315|NCT00567879|1409130|P4|COMPLETED|Overall Study||0
578316|NCT00567879|1409131|P3|COMPLETED|Overall Study||0
578317|NCT00567879|1409132|P2|COMPLETED|Overall Study||0
578318|NCT00567879|1409133|P1|COMPLETED|Overall Study||0
578319|NCT00567879|1409128|P6|Maximum Tolerated Dose Determining Set|Overall Study||3
578320|NCT00567879|1409129|P5|Maximum Tolerated Dose Determining Set|Overall Study||12
578321|NCT00567879|1409130|P4|Maximum Tolerated Dose Determining Set|Overall Study||6
578322|NCT00567879|1409131|P3|Maximum Tolerated Dose Determining Set|Overall Study|6 participants belonged to the dose expansion group at 20mg/m2 i.v.|18
578323|NCT00567879|1409132|P2|Maximum Tolerated Dose Determining Set|Overall Study||7
578324|NCT00567879|1409133|P1|Maximum Tolerated Dose Determining Set|Overall Study||5
578325|NCT00567879|1409128|P6|STARTED|Overall Study||3
578326|NCT00567879|1409129|P5|STARTED|Overall Study||12
578327|NCT00567879|1409130|P4|STARTED|Overall Study||6
578328|NCT00567879|1409131|P3|STARTED|Overall Study|7 participants belonged to the dose expansion group at 20mg/m2 i.v.|21
578329|NCT00567879|1409132|P2|STARTED|Overall Study||7
578330|NCT00567879|1409133|P1|STARTED|Overall Study||7
578331|NCT00567840|1409159|P5|NOT COMPLETED|Overall Study||0
578332|NCT00567840|1409160|P4|NOT COMPLETED|Overall Study||1
578333|NCT00567840|1409161|P3|NOT COMPLETED|Overall Study||1
578334|NCT00567840|1409162|P2|NOT COMPLETED|Overall Study||0
578335|NCT00567840|1409163|P1|NOT COMPLETED|Overall Study||2
578336|NCT00567840|1409159|P5|COMPLETED|Overall Study||8
578337|NCT00567840|1409160|P4|COMPLETED|Overall Study||14
578338|NCT00567840|1409161|P3|COMPLETED|Overall Study||15
578339|NCT00567840|1409162|P2|COMPLETED|Overall Study||15
578340|NCT00567840|1409163|P1|COMPLETED|Overall Study||13
578341|NCT00567840|1409159|P5|STARTED|Overall Study||8
578342|NCT00567840|1409160|P4|STARTED|Overall Study||15
578343|NCT00567840|1409161|P3|STARTED|Overall Study||16
578344|NCT00567840|1409162|P2|STARTED|Overall Study||15
578345|NCT00567840|1409163|P1|STARTED|Overall Study||15
578346|NCT00567593|1409200|P1|NOT COMPLETED|Overall Study||2
578347|NCT00567593|1409200|P1|COMPLETED|Overall Study||10
578348|NCT00567593|1409200|P1|STARTED|Overall Study||12
578349|NCT00567567|1409207|P3|NOT COMPLETED|Overall Study||278
578350|NCT00567567|1409208|P2|NOT COMPLETED|Overall Study||134
578351|NCT00567567|1409209|P1|NOT COMPLETED|Overall Study||152
578352|NCT00567567|1409207|P3|COMPLETED|Overall Study||1
578353|NCT00567567|1409208|P2|COMPLETED|Overall Study||42
578354|NCT00567567|1409209|P1|COMPLETED|Overall Study||58
578355|NCT00567567|1409207|P3|STARTED|Overall Study||279
578356|NCT00567567|1409208|P2|STARTED|Overall Study||176
578357|NCT00567567|1409209|P1|STARTED|Overall Study||210
578358|NCT00567541|1409235|P2|NOT COMPLETED|Overall Study||1
578359|NCT00567541|1409236|P1|NOT COMPLETED|Overall Study||0
578360|NCT00567541|1409235|P2|COMPLETED|Overall Study||8
578361|NCT00567541|1409236|P1|COMPLETED|Overall Study||7
578362|NCT00567541|1409235|P2|STARTED|Overall Study||9
578363|NCT00567541|1409236|P1|STARTED|Overall Study||7
578364|NCT00567502|1409246|P4|NOT COMPLETED|Overall Study||87
578365|NCT00567502|1409247|P3|NOT COMPLETED|Overall Study||908
578366|NCT00567502|1409248|P2|NOT COMPLETED|Overall Study||33
578367|NCT00567502|1409249|P1|NOT COMPLETED|Overall Study||241
578368|NCT00567502|1409246|P4|COMPLETED|Overall Study||23
578369|NCT00567502|1409247|P3|COMPLETED|Overall Study||1758
578370|NCT00567502|1409248|P2|COMPLETED|Overall Study||108
578371|NCT00567502|1409249|P1|COMPLETED|Overall Study||563
578372|NCT00567502|1409246|P4|Initiated Treatment|Overall Study||38
578373|NCT00567502|1409247|P3|Initiated Treatment|Overall Study||2666
578374|NCT00567502|1409248|P2|Initiated Treatment|Overall Study||141
578375|NCT00567502|1409249|P1|Initiated Treatment|Overall Study||804
578376|NCT00567502|1409246|P4|STARTED|Overall Study||110
578377|NCT00567502|1409247|P3|STARTED|Overall Study||2666
578378|NCT00567502|1409248|P2|STARTED|Overall Study||141
578379|NCT00567502|1409249|P1|STARTED|Overall Study||804
578380|NCT00567476|1409286|P2|NOT COMPLETED|Overall Study||4
578381|NCT00567476|1409287|P1|NOT COMPLETED|Overall Study||8
578382|NCT00567476|1409286|P2|COMPLETED|Overall Study||34
578383|NCT00567476|1409287|P1|COMPLETED|Overall Study||70
578384|NCT00567476|1409286|P2|STARTED|Overall Study||38
578385|NCT00567476|1409287|P1|STARTED|Overall Study||78
578386|NCT00567320|1409313|P2|NOT COMPLETED|Overall Study||0
578387|NCT00567320|1409314|P1|NOT COMPLETED|Overall Study||0
578388|NCT00567320|1409313|P2|COMPLETED|Overall Study||18
578389|NCT00567320|1409314|P1|COMPLETED|Overall Study||13
578390|NCT00567320|1409313|P2|STARTED|Overall Study||18
578391|NCT00567320|1409314|P1|STARTED|Overall Study||13
578392|NCT00567307|1409322|P2|NOT COMPLETED|Overall Study||1
578393|NCT00567307|1409323|P1|NOT COMPLETED|Overall Study||12
578394|NCT00567307|1409322|P2|COMPLETED|Overall Study||104
578395|NCT00567307|1409323|P1|COMPLETED|Overall Study||99
578396|NCT00567307|1409322|P2|STARTED|Overall Study||105
578397|NCT00567307|1409323|P1|STARTED|Overall Study||111
578398|NCT00567268|1409329|P1|NOT COMPLETED|Overall Study||50
578399|NCT00567268|1409329|P1|COMPLETED|Overall Study||1144
578400|NCT00567268|1409329|P1|STARTED|Overall Study||1194
578401|NCT00567255|1409380|P2|NOT COMPLETED|Overall Study||228
578402|NCT00567255|1409381|P1|NOT COMPLETED|Overall Study||463
578403|NCT00567255|1409380|P2|COMPLETED|Overall Study||267
578404|NCT00567255|1409381|P1|COMPLETED|Overall Study||538
578405|NCT00567255|1409380|P2|STARTED|Overall Study||495
578406|NCT00567255|1409381|P1|STARTED|Overall Study||1001
578407|NCT00567242|1409427|P2|NOT COMPLETED|Overall Study||0
578408|NCT00567242|1409428|P1|NOT COMPLETED|Overall Study||0
578409|NCT00567242|1409427|P2|COMPLETED|Overall Study||7
578410|NCT00567242|1409428|P1|COMPLETED|Overall Study||7
578411|NCT00567242|1409427|P2|STARTED|Overall Study||7
578412|NCT00567242|1409428|P1|STARTED|Overall Study||7
578413|NCT00567229|1409438|P1|NOT COMPLETED|Overall Study||0
578414|NCT00567229|1409438|P1|COMPLETED|Overall Study||3
578415|NCT00567229|1409438|P1|STARTED|Overall Study||3
578416|NCT00567190|1409444|P2|NOT COMPLETED|Overall Study||264
578417|NCT00567190|1409445|P1|NOT COMPLETED|Overall Study||210
578418|NCT00567190|1409444|P2|COMPLETED|Overall Study|On 11 February 2014, 37 were alive and on study treatment; 105 were alive and in survival follow-up|142
578419|NCT00567190|1409445|P1|COMPLETED|Overall Study|On 11 February 2014, 67 were alive and on study treatment; 125 were alive and in survival follow-up|192
578420|NCT00567190|1409444|P2|STARTED|Overall Study|All randomized patients (Intent-to-Treat [ITT]) population|406
578421|NCT00567190|1409445|P1|STARTED|Overall Study|All randomized patients (Intent-to-Treat [ITT]) population|402
578422|NCT00567164|1409465|P3|NOT COMPLETED|Overall Study||72
578423|NCT00567164|1409466|P2|NOT COMPLETED|Overall Study||73
578424|NCT00567164|1409467|P1|NOT COMPLETED|Overall Study||546
578425|NCT00567164|1409465|P3|COMPLETED|Overall Study||160
578426|NCT00567164|1409466|P2|COMPLETED|Overall Study||161
578427|NCT00567164|1409467|P1|COMPLETED|Overall Study||875
578428|NCT00567164|1409465|P3|Subjects Received Treatment|Overall Study|Full Analysis Set|226
578429|NCT00567164|1409466|P2|Subjects Received Treatment|Overall Study|Full Analysis Set|232
578430|NCT00567164|1409467|P1|Subjects Received Treatment|Overall Study|Full Analysis Set|1406
578431|NCT00567164|1409465|P3|STARTED|Overall Study||232
578432|NCT00567164|1409466|P2|STARTED|Overall Study||234
578433|NCT00567164|1409467|P1|STARTED|Overall Study||1421
578434|NCT00567112|1409539|P3|NOT COMPLETED|Treatment Period 4 (3 Days)||0
578435|NCT00567112|1409540|P2|NOT COMPLETED|Treatment Period 4 (3 Days)||0
578436|NCT00567112|1409541|P1|NOT COMPLETED|Treatment Period 4 (3 Days)||0
578437|NCT00567112|1409539|P3|COMPLETED|Treatment Period 4 (3 Days)||3
578438|NCT00567112|1409540|P2|COMPLETED|Treatment Period 4 (3 Days)||7
578439|NCT00567112|1409541|P1|COMPLETED|Treatment Period 4 (3 Days)||4
578440|NCT00567112|1409539|P3|STARTED|Treatment Period 4 (3 Days)||3
578441|NCT00567112|1409540|P2|STARTED|Treatment Period 4 (3 Days)||7
578442|NCT00567112|1409541|P1|STARTED|Treatment Period 4 (3 Days)||4
578443|NCT00567112|1409539|P3|NOT COMPLETED|Washout Period 3 (3 Days)||0
578444|NCT00567112|1409540|P2|NOT COMPLETED|Washout Period 3 (3 Days)||0
578445|NCT00567112|1409541|P1|NOT COMPLETED|Washout Period 3 (3 Days)||3
578446|NCT00567112|1409539|P3|COMPLETED|Washout Period 3 (3 Days)||3
578447|NCT00567112|1409540|P2|COMPLETED|Washout Period 3 (3 Days)||7
578448|NCT00567112|1409541|P1|COMPLETED|Washout Period 3 (3 Days)||4
578449|NCT00567112|1409539|P3|STARTED|Washout Period 3 (3 Days)||3
578450|NCT00567112|1409540|P2|STARTED|Washout Period 3 (3 Days)||7
578451|NCT00567112|1409541|P1|STARTED|Washout Period 3 (3 Days)||7
578452|NCT00567112|1409539|P3|NOT COMPLETED|Treatment Period 3 (3 Days)||0
578453|NCT00567112|1409540|P2|NOT COMPLETED|Treatment Period 3 (3 Days)||0
578454|NCT00567112|1409541|P1|NOT COMPLETED|Treatment Period 3 (3 Days)||0
578455|NCT00567112|1409539|P3|COMPLETED|Treatment Period 3 (3 Days)||3
578456|NCT00567112|1409540|P2|COMPLETED|Treatment Period 3 (3 Days)||7
578457|NCT00567112|1409541|P1|COMPLETED|Treatment Period 3 (3 Days)||7
578458|NCT00567112|1409539|P3|STARTED|Treatment Period 3 (3 Days)||3
578459|NCT00567112|1409540|P2|STARTED|Treatment Period 3 (3 Days)||7
578460|NCT00567112|1409541|P1|STARTED|Treatment Period 3 (3 Days)||7
578461|NCT00567112|1409539|P3|NOT COMPLETED|Washout Period 2 (3 Days)||0
578462|NCT00567112|1409540|P2|NOT COMPLETED|Washout Period 2 (3 Days)||0
578463|NCT00567112|1409541|P1|NOT COMPLETED|Washout Period 2 (3 Days)||0
578464|NCT00567112|1409539|P3|COMPLETED|Washout Period 2 (3 Days)||3
578465|NCT00567112|1409540|P2|COMPLETED|Washout Period 2 (3 Days)||7
578466|NCT00567112|1409541|P1|COMPLETED|Washout Period 2 (3 Days)||7
578467|NCT00567112|1409539|P3|STARTED|Washout Period 2 (3 Days)||3
578468|NCT00567112|1409540|P2|STARTED|Washout Period 2 (3 Days)||7
578469|NCT00567112|1409541|P1|STARTED|Washout Period 2 (3 Days)||7
578470|NCT00567112|1409539|P3|NOT COMPLETED|Treatment Period 2 (3 Days)||0
578471|NCT00567112|1409540|P2|NOT COMPLETED|Treatment Period 2 (3 Days)||1
578472|NCT00567112|1409541|P1|NOT COMPLETED|Treatment Period 2 (3 Days)||0
578473|NCT00567112|1409539|P3|COMPLETED|Treatment Period 2 (3 Days)||3
578474|NCT00567112|1409540|P2|COMPLETED|Treatment Period 2 (3 Days)||7
578475|NCT00567112|1409541|P1|COMPLETED|Treatment Period 2 (3 Days)||7
578476|NCT00567112|1409539|P3|STARTED|Treatment Period 2 (3 Days)|3 new participants added to Treatment Group ABCD & received treatment sequence BCD for Periods 2-4|3
578477|NCT00567112|1409540|P2|STARTED|Treatment Period 2 (3 Days)||8
578478|NCT00567112|1409541|P1|STARTED|Treatment Period 2 (3 Days)||7
578479|NCT00567112|1409539|P3|NOT COMPLETED|Washout Period 1 (3 Days)||0
578480|NCT00567112|1409540|P2|NOT COMPLETED|Washout Period 1 (3 Days)||0
578481|NCT00567112|1409541|P1|NOT COMPLETED|Washout Period 1 (3 Days)||0
578482|NCT00567112|1409539|P3|COMPLETED|Washout Period 1 (3 Days)||0
578483|NCT00567112|1409540|P2|COMPLETED|Washout Period 1 (3 Days)||8
578484|NCT00567112|1409541|P1|COMPLETED|Washout Period 1 (3 Days)||7
578485|NCT00567112|1409539|P3|STARTED|Washout Period 1 (3 Days)||0
578486|NCT00567112|1409540|P2|STARTED|Washout Period 1 (3 Days)||8
578487|NCT00567112|1409541|P1|STARTED|Washout Period 1 (3 Days)||7
578488|NCT00567112|1409539|P3|NOT COMPLETED|Treatment Period 1 (3 Days)||0
578489|NCT00567112|1409540|P2|NOT COMPLETED|Treatment Period 1 (3 Days)||0
578490|NCT00567112|1409541|P1|NOT COMPLETED|Treatment Period 1 (3 Days)||0
578491|NCT00567112|1409539|P3|COMPLETED|Treatment Period 1 (3 Days)||0
578492|NCT00567112|1409540|P2|COMPLETED|Treatment Period 1 (3 Days)||8
578493|NCT00567112|1409541|P1|COMPLETED|Treatment Period 1 (3 Days)||7
578494|NCT00567112|1409539|P3|STARTED|Treatment Period 1 (3 Days)||0
578495|NCT00567112|1409540|P2|STARTED|Treatment Period 1 (3 Days)||8
578496|NCT00567112|1409541|P1|STARTED|Treatment Period 1 (3 Days)||7
578497|NCT00567008|1409565|P2|NOT COMPLETED|Overall Study||1
578498|NCT00567008|1409566|P1|NOT COMPLETED|Overall Study||1
578499|NCT00567008|1409565|P2|COMPLETED|Overall Study||18
578500|NCT00567008|1409566|P1|COMPLETED|Overall Study||17
578501|NCT00567008|1409565|P2|STARTED|Overall Study||19
578502|NCT00567008|1409566|P1|STARTED|Overall Study||18
578503|NCT00566995|1409572|P1|NOT COMPLETED|Overall Study||8
578504|NCT00566995|1409572|P1|COMPLETED|Overall Study||29
578505|NCT00566995|1409572|P1|STARTED|Overall Study||37
578506|NCT00566982|1409579|P2|NOT COMPLETED|Overall Study||69
578507|NCT00566982|1409580|P1|NOT COMPLETED|Overall Study||8
578508|NCT00566982|1409579|P2|COMPLETED|Overall Study||294
578509|NCT00566982|1409580|P1|COMPLETED|Overall Study||55
578510|NCT00566982|1409579|P2|STARTED|Overall Study||363
578511|NCT00566982|1409580|P1|STARTED|Overall Study||63
578512|NCT00566969|1409605|P3|NOT COMPLETED|Overall Study||12
578513|NCT00566969|1409606|P2|NOT COMPLETED|Overall Study||9
578514|NCT00566969|1409607|P1|NOT COMPLETED|Overall Study||15
578515|NCT00566969|1409605|P3|COMPLETED|Overall Study||23
578516|NCT00566969|1409606|P2|COMPLETED|Overall Study||28
578517|NCT00566969|1409607|P1|COMPLETED|Overall Study||19
578518|NCT00566969|1409605|P3|STARTED|Overall Study||35
578519|NCT00566969|1409606|P2|STARTED|Overall Study||37
578520|NCT00566969|1409607|P1|STARTED|Overall Study||34
578521|NCT00566943|1409617|P2|NOT COMPLETED|Overall Study||0
578522|NCT00566943|1409618|P1|NOT COMPLETED|Overall Study||0
578523|NCT00566943|1409617|P2|COMPLETED|Overall Study||49
578524|NCT00566943|1409618|P1|COMPLETED|Overall Study||52
578525|NCT00566943|1409617|P2|STARTED|Overall Study||49
578526|NCT00566943|1409618|P1|STARTED|Overall Study||52
578527|NCT00566930|1409633|P3|NOT COMPLETED|Overall Study||1
578528|NCT00566930|1409634|P2|NOT COMPLETED|Overall Study||4
578529|NCT00566930|1409635|P1|NOT COMPLETED|Overall Study||2
578530|NCT00566930|1409633|P3|COMPLETED|Overall Study||32
578531|NCT00566930|1409634|P2|COMPLETED|Overall Study||32
578532|NCT00566930|1409635|P1|COMPLETED|Overall Study||27
578533|NCT00566930|1409633|P3|STARTED|Overall Study||33
578534|NCT00566930|1409634|P2|STARTED|Overall Study||36
578535|NCT00566930|1409635|P1|STARTED|Overall Study||29
578536|NCT00566852|1409645|P2|NOT COMPLETED|Overall Study||198
578537|NCT00566852|1409646|P1|NOT COMPLETED|Overall Study||207
578538|NCT00566852|1409645|P2|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|78
578539|NCT00566852|1409646|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|71
578540|NCT00566852|1409645|P2|STARTED|Overall Study||276
578541|NCT00566852|1409646|P1|STARTED|Overall Study||278
578542|NCT00566735|1409664|P2|NOT COMPLETED|Overall Study||7
578543|NCT00566735|1409665|P1|NOT COMPLETED|Overall Study||2
578632|NCT00566254|1409841|P2|COMPLETED|Overall Study||93
578544|NCT00566735|1409664|P2|COMPLETED|Overall Study|7 participants withdrew before baselines. Therefore, 12 participants will be included in baselines.|12
578545|NCT00566735|1409665|P1|COMPLETED|Overall Study|2 participants withdrew before baselines. Therefore, 18 participants will be included in baselines.|18
578546|NCT00566735|1409664|P2|Withdrew Before Baseline Measures|Overall Study||7
578547|NCT00566735|1409665|P1|Withdrew Before Baseline Measures|Overall Study||2
578548|NCT00566735|1409664|P2|STARTED|Overall Study||19
578549|NCT00566735|1409665|P1|STARTED|Overall Study||20
578550|NCT00566722|1409678|P3|NOT COMPLETED|Overall Study||9
578551|NCT00566722|1409679|P2|NOT COMPLETED|Overall Study||5
578552|NCT00566722|1409680|P1|NOT COMPLETED|Overall Study||2
578553|NCT00566722|1409678|P3|COMPLETED|Overall Study||73
578554|NCT00566722|1409679|P2|COMPLETED|Overall Study||24
578555|NCT00566722|1409680|P1|COMPLETED|Overall Study||39
578556|NCT00566722|1409678|P3|STARTED|Overall Study||82
578557|NCT00566722|1409679|P2|STARTED|Overall Study||29
578558|NCT00566722|1409680|P1|STARTED|Overall Study||41
578559|NCT00566709|1409726|P2|NOT COMPLETED|Overall Study||0
578560|NCT00566709|1409727|P1|NOT COMPLETED|Overall Study||5
578561|NCT00566709|1409726|P2|COMPLETED|Overall Study||51
578562|NCT00566709|1409727|P1|COMPLETED|Overall Study||46
578563|NCT00566709|1409726|P2|STARTED|Overall Study||51
578564|NCT00566709|1409727|P1|STARTED|Overall Study||51
578565|NCT00566696|1409743|P1|NOT COMPLETED|Overall Study||42
578566|NCT00566696|1409743|P1|COMPLETED|Overall Study||31
578567|NCT00566696|1409743|P1|STARTED|Overall Study||73
578568|NCT00566631|1409751|P1|NOT COMPLETED|Part 2: Extension Phase||82
578569|NCT00566631|1409751|P1|COMPLETED|Part 2: Extension Phase||57
578570|NCT00566631|1409751|P1|STARTED|Part 2: Extension Phase||139
578571|NCT00566631|1409751|P1|NOT COMPLETED|Between Treatment and Extension Phase||95
578572|NCT00566631|1409751|P1|COMPLETED|Between Treatment and Extension Phase||139
578573|NCT00566631|1409751|P1|STARTED|Between Treatment and Extension Phase||234
578574|NCT00566631|1409751|P1|NOT COMPLETED|Part 1: Core Treatment Phase||60
578575|NCT00566631|1409751|P1|COMPLETED|Part 1: Core Treatment Phase||234
578576|NCT00566631|1409751|P1|STARTED|Part 1: Core Treatment Phase||294
578577|NCT00566579|1409768|P2|NOT COMPLETED|Overall Study||0
578578|NCT00566579|1409769|P1|NOT COMPLETED|Overall Study||0
578579|NCT00566579|1409768|P2|COMPLETED|Overall Study||31
578580|NCT00566579|1409769|P1|COMPLETED|Overall Study||29
578581|NCT00566579|1409768|P2|STARTED|Overall Study||31
578582|NCT00566579|1409769|P1|STARTED|Overall Study||29
578583|NCT00566527|1409778|P3|NOT COMPLETED|Overall Study||78
578584|NCT00566527|1409779|P2|NOT COMPLETED|Overall Study||66
578585|NCT00566527|1409780|P1|NOT COMPLETED|Overall Study||17
578586|NCT00566527|1409778|P3|COMPLETED|Overall Study||461
578587|NCT00566527|1409779|P2|COMPLETED|Overall Study||474
578588|NCT00566527|1409780|P1|COMPLETED|Overall Study||524
578589|NCT00566527|1409778|P3|Received ProQuad® Dose 2|Overall Study||462
578590|NCT00566527|1409779|P2|Received ProQuad® Dose 2|Overall Study||478
578591|NCT00566527|1409780|P1|Received ProQuad® Dose 2|Overall Study||525
578592|NCT00566527|1409778|P3|Received ProQuad® Dose 1|Overall Study||470
578593|NCT00566527|1409779|P2|Received ProQuad® Dose 1|Overall Study||484
578594|NCT00566527|1409780|P1|Received ProQuad® Dose 1|Overall Study||529
578595|NCT00566527|1409778|P3|STARTED|Overall Study|Number randomized.|539
578596|NCT00566527|1409779|P2|STARTED|Overall Study|Number randomized.|540
578597|NCT00566527|1409780|P1|STARTED|Overall Study|Number randomized.|541
578598|NCT00566501|1409821|P2|NOT COMPLETED|Overall Study||126
578599|NCT00566501|1409822|P1|NOT COMPLETED|Overall Study||156
578600|NCT00566501|1409821|P2|COMPLETED|Overall Study||210
578601|NCT00566501|1409822|P1|COMPLETED|Overall Study||423
578602|NCT00566501|1409821|P2|Not Determined|Overall Study||0
578603|NCT00566501|1409822|P1|Not Determined|Overall Study||1
578604|NCT00566501|1409821|P2|Other ( Not Specified)|Overall Study||21
578605|NCT00566501|1409822|P1|Other ( Not Specified)|Overall Study||24
578606|NCT00566501|1409821|P2|Medication Non-compliance|Overall Study||0
578607|NCT00566501|1409822|P1|Medication Non-compliance|Overall Study||5
578608|NCT00566501|1409821|P2|Protocol Violation|Overall Study||2
578609|NCT00566501|1409822|P1|Protocol Violation|Overall Study||2
578610|NCT00566501|1409821|P2|Request of Investigator or Sponsor|Overall Study||7
578611|NCT00566501|1409822|P1|Request of Investigator or Sponsor|Overall Study||6
578612|NCT00566501|1409821|P2|Withdraw of Consent by Subject|Overall Study||30
578613|NCT00566501|1409822|P1|Withdraw of Consent by Subject|Overall Study||33
578614|NCT00566501|1409821|P2|Lack of Efficacy|Overall Study||3
578615|NCT00566501|1409822|P1|Lack of Efficacy|Overall Study||8
578616|NCT00566501|1409821|P2|Adverse Event|Overall Study||59
578617|NCT00566501|1409822|P1|Adverse Event|Overall Study||68
578618|NCT00566501|1409821|P2|Discontinued|Overall Study||122
578619|NCT00566501|1409822|P1|Discontinued|Overall Study||146
578620|NCT00566501|1409821|P2|Safety Population|Overall Study||332
578621|NCT00566501|1409822|P1|Safety Population|Overall Study||570
578622|NCT00566501|1409821|P2|STARTED|Overall Study||336
578623|NCT00566501|1409822|P1|STARTED|Overall Study||579
578624|NCT00566462|1409830|P2|NOT COMPLETED|Overall Study||0
578625|NCT00566462|1409831|P1|NOT COMPLETED|Overall Study||0
578626|NCT00566462|1409830|P2|COMPLETED|Overall Study||0
578627|NCT00566462|1409831|P1|COMPLETED|Overall Study||1
578628|NCT00566462|1409830|P2|STARTED|Overall Study||0
578629|NCT00566462|1409831|P1|STARTED|Overall Study||1
578630|NCT00566254|1409841|P2|NOT COMPLETED|Overall Study||14
578631|NCT00566254|1409842|P1|NOT COMPLETED|Overall Study||10
578633|NCT00566254|1409842|P1|COMPLETED|Overall Study||90
578634|NCT00566254|1409841|P2|STARTED|Overall Study||107
578635|NCT00566254|1409842|P1|STARTED|Overall Study||100
578636|NCT00566150|1409856|P2|NOT COMPLETED|Overall Study||5
578637|NCT00566150|1409857|P1|NOT COMPLETED|Overall Study||9
578638|NCT00566150|1409856|P2|COMPLETED|Overall Study||11
578639|NCT00566150|1409857|P1|COMPLETED|Overall Study||10
578640|NCT00566150|1409856|P2|STARTED|Overall Study||16
578641|NCT00566150|1409857|P1|STARTED|Overall Study||19
578642|NCT00566111|1409871|P2|NOT COMPLETED|Overall Study||2
578643|NCT00566111|1409872|P1|NOT COMPLETED|Overall Study||0
578644|NCT00566111|1409871|P2|COMPLETED|Overall Study||1
578645|NCT00566111|1409872|P1|COMPLETED|Overall Study||2
578646|NCT00566111|1409871|P2|STARTED|Overall Study||3
578647|NCT00566111|1409872|P1|STARTED|Overall Study||2
578648|NCT00566020|1409886|P2|NOT COMPLETED|46-week Long-term Administration Phase||17
578649|NCT00566020|1409887|P1|NOT COMPLETED|46-week Long-term Administration Phase||0
578650|NCT00566020|1409886|P2|COMPLETED|46-week Long-term Administration Phase||68
578651|NCT00566020|1409887|P1|COMPLETED|46-week Long-term Administration Phase||0
578652|NCT00566020|1409886|P2|STARTED|46-week Long-term Administration Phase||85
578653|NCT00566020|1409887|P1|STARTED|46-week Long-term Administration Phase||0
578654|NCT00566020|1409886|P2|NOT COMPLETED|6-week Dosage Adjustment Phase||0
578655|NCT00566020|1409887|P1|NOT COMPLETED|6-week Dosage Adjustment Phase||7
578656|NCT00566020|1409886|P2|COMPLETED|6-week Dosage Adjustment Phase||0
578657|NCT00566020|1409887|P1|COMPLETED|6-week Dosage Adjustment Phase||85
578658|NCT00566020|1409886|P2|STARTED|6-week Dosage Adjustment Phase||0
578659|NCT00566020|1409887|P1|STARTED|6-week Dosage Adjustment Phase||92
578660|NCT00565812|1409915|P3|NOT COMPLETED|Overall Study||130
578661|NCT00565812|1409916|P2|NOT COMPLETED|Overall Study||135
578662|NCT00565812|1409917|P1|NOT COMPLETED|Overall Study||144
578663|NCT00565812|1409915|P3|COMPLETED|Overall Study||356
578664|NCT00565812|1409916|P2|COMPLETED|Overall Study||351
578665|NCT00565812|1409917|P1|COMPLETED|Overall Study||341
578666|NCT00565812|1409915|P3|STARTED|Overall Study||486
578667|NCT00565812|1409916|P2|STARTED|Overall Study||486
578668|NCT00565812|1409917|P1|STARTED|Overall Study||485
578669|NCT00565747|1410056|P2|NOT COMPLETED|Overall Study||73
578670|NCT00565747|1410057|P1|NOT COMPLETED|Overall Study||67
578671|NCT00565747|1410056|P2|COMPLETED|Overall Study|Completed with an embryo transfer|605
578672|NCT00565747|1410057|P1|COMPLETED|Overall Study|Completed with an embryo transfer|587
578673|NCT00565747|1410056|P2|STARTED|Overall Study||678
578674|NCT00565747|1410057|P1|STARTED|Overall Study||654
578675|NCT00565721|1410067|P1|NOT COMPLETED|Overall Study||17
578676|NCT00565721|1410067|P1|COMPLETED|Overall Study||16
578677|NCT00565721|1410067|P1|STARTED|Overall Study||33
578678|NCT00565643|1410088|P2|NOT COMPLETED|Overall Study||0
578679|NCT00565643|1410089|P1|NOT COMPLETED|Overall Study||0
578680|NCT00565643|1410088|P2|COMPLETED|Overall Study||373
578681|NCT00565643|1410089|P1|COMPLETED|Overall Study||380
578682|NCT00565643|1410088|P2|Primary Outcome (Subsequent Cesarean)|Overall Study||92
578683|NCT00565643|1410089|P1|Primary Outcome (Subsequent Cesarean)|Overall Study||80
578684|NCT00565643|1410088|P2|Safety Data|Overall Study||373
578685|NCT00565643|1410089|P1|Safety Data|Overall Study||380
578686|NCT00565643|1410088|P2|STARTED|Overall Study||373
578687|NCT00565643|1410089|P1|STARTED|Overall Study||380
578688|NCT00565617|1410107|P1|NOT COMPLETED|Overall Study||1
578689|NCT00565617|1410107|P1|COMPLETED|Overall Study||5
578690|NCT00565617|1410107|P1|STARTED|Overall Study||6
578691|NCT00565604|1410111|P1|NOT COMPLETED|Overall Study||4
578692|NCT00565604|1410111|P1|COMPLETED|Overall Study||39
578693|NCT00565604|1410111|P1|6 Month|Overall Study||39
578694|NCT00565604|1410111|P1|6 Week|Overall Study||39
578695|NCT00565604|1410111|P1|2 Week|Overall Study||41
578696|NCT00565604|1410111|P1|7 Day|Overall Study||41
578697|NCT00565604|1410111|P1|STARTED|Overall Study||43
578698|NCT00565461|1410122|P4|NOT COMPLETED|Overall Study||3
578699|NCT00565461|1410123|P3|NOT COMPLETED|Overall Study||1
578700|NCT00565461|1410124|P2|NOT COMPLETED|Overall Study||1
578701|NCT00565461|1410125|P1|NOT COMPLETED|Overall Study||0
578702|NCT00565461|1410122|P4|COMPLETED|Overall Study||37
578703|NCT00565461|1410123|P3|COMPLETED|Overall Study||39
578704|NCT00565461|1410124|P2|COMPLETED|Overall Study||39
578705|NCT00565461|1410125|P1|COMPLETED|Overall Study||40
578706|NCT00565461|1410122|P4|STARTED|Overall Study||40
578707|NCT00565461|1410123|P3|STARTED|Overall Study||40
578708|NCT00565461|1410124|P2|STARTED|Overall Study||40
578709|NCT00565461|1410125|P1|STARTED|Overall Study||40
578710|NCT00565448|1410139|P2|NOT COMPLETED|Overall Study||2
578711|NCT00565448|1410140|P1|NOT COMPLETED|Overall Study||3
578712|NCT00565448|1410139|P2|COMPLETED|Overall Study|Completed induction period as per protocol.|23
578713|NCT00565448|1410140|P1|COMPLETED|Overall Study|Completed induction period as per protocol.|47
578714|NCT00565448|1410139|P2|STARTED|Overall Study|ITT population: all randomized participants. All were treated.|25
578715|NCT00565448|1410140|P1|STARTED|Overall Study|Intent to treat (ITT) population: all randomized participants. All were treated.|50
578716|NCT00565409|1410151|P4|NOT COMPLETED|Period 2 Double-Blind||59
578717|NCT00565409|1410152|P3|NOT COMPLETED|Period 2 Double-Blind||27
578718|NCT00565409|1410153|P2|NOT COMPLETED|Period 2 Double-Blind||21
578719|NCT00565409|1410154|P1|NOT COMPLETED|Period 2 Double-Blind||0
578720|NCT00565409|1410151|P4|COMPLETED|Period 2 Double-Blind||141
578721|NCT00565409|1410152|P3|COMPLETED|Period 2 Double-Blind||175
578722|NCT00565409|1410153|P2|COMPLETED|Period 2 Double-Blind||181
578723|NCT00565409|1410154|P1|COMPLETED|Period 2 Double-Blind||0
578724|NCT00565409|1410151|P4|STARTED|Period 2 Double-Blind||200
578725|NCT00565409|1410152|P3|STARTED|Period 2 Double-Blind||202
578726|NCT00565409|1410153|P2|STARTED|Period 2 Double-Blind||202
578727|NCT00565409|1410154|P1|STARTED|Period 2 Double-Blind||0
578728|NCT00565409|1410151|P4|NOT COMPLETED|After Period 1, Prior to Period 2||0
578729|NCT00565409|1410152|P3|NOT COMPLETED|After Period 1, Prior to Period 2||0
578730|NCT00565409|1410153|P2|NOT COMPLETED|After Period 1, Prior to Period 2||0
578731|NCT00565409|1410154|P1|NOT COMPLETED|After Period 1, Prior to Period 2||152
578732|NCT00565409|1410151|P4|COMPLETED|After Period 1, Prior to Period 2||0
578733|NCT00565409|1410152|P3|COMPLETED|After Period 1, Prior to Period 2||0
578734|NCT00565409|1410153|P2|COMPLETED|After Period 1, Prior to Period 2||0
578735|NCT00565409|1410154|P1|COMPLETED|After Period 1, Prior to Period 2||604
578736|NCT00565409|1410151|P4|STARTED|After Period 1, Prior to Period 2||0
578737|NCT00565409|1410152|P3|STARTED|After Period 1, Prior to Period 2||0
578738|NCT00565409|1410153|P2|STARTED|After Period 1, Prior to Period 2||0
578739|NCT00565409|1410154|P1|STARTED|After Period 1, Prior to Period 2||756
578740|NCT00565409|1410151|P4|NOT COMPLETED|Period 1 Open Label||0
578741|NCT00565409|1410152|P3|NOT COMPLETED|Period 1 Open Label||0
578742|NCT00565409|1410153|P2|NOT COMPLETED|Period 1 Open Label||0
578743|NCT00565409|1410154|P1|NOT COMPLETED|Period 1 Open Label||78
578744|NCT00565409|1410151|P4|COMPLETED|Period 1 Open Label||0
578745|NCT00565409|1410152|P3|COMPLETED|Period 1 Open Label||0
578746|NCT00565409|1410153|P2|COMPLETED|Period 1 Open Label||0
578747|NCT00565409|1410154|P1|COMPLETED|Period 1 Open Label||756
578748|NCT00565409|1410151|P4|STARTED|Period 1 Open Label||0
578749|NCT00565409|1410152|P3|STARTED|Period 1 Open Label||0
578750|NCT00565409|1410153|P2|STARTED|Period 1 Open Label||0
578751|NCT00565409|1410154|P1|STARTED|Period 1 Open Label||834
578752|NCT00565370|1410256|P1|NOT COMPLETED|Overall Study||0
578753|NCT00565370|1410256|P1|COMPLETED|Overall Study||21
578754|NCT00565370|1410256|P1|STARTED|Overall Study||21
578755|NCT00565266|1410264|P1|NOT COMPLETED|Overall Study||36
578756|NCT00565266|1410264|P1|COMPLETED|Overall Study||174
578757|NCT00565266|1410264|P1|STARTED|Overall Study||210
578758|NCT00565136|1410290|P1|NOT COMPLETED|Overall Study||3
578759|NCT00565136|1410290|P1|COMPLETED|Overall Study||26
578760|NCT00565136|1410290|P1|STARTED|Overall Study||29
578761|NCT00565110|1410310|P2|NOT COMPLETED|Overall Study||131
578762|NCT00565110|1410311|P1|NOT COMPLETED|Overall Study||131
578763|NCT00565110|1410310|P2|COMPLETED|Overall Study||111
578764|NCT00565110|1410311|P1|COMPLETED|Overall Study||99
578765|NCT00565110|1410310|P2|12-Month|Overall Study||144
578766|NCT00565110|1410311|P1|12-Month|Overall Study||114
578767|NCT00565110|1410310|P2|STARTED|Overall Study||242
578768|NCT00565110|1410311|P1|STARTED|Overall Study||230
578769|NCT00565084|1410319|P3|NOT COMPLETED|Third Treatment Period||0
578770|NCT00565084|1410320|P2|NOT COMPLETED|Third Treatment Period||0
578771|NCT00565084|1410321|P1|NOT COMPLETED|Third Treatment Period||0
578772|NCT00565084|1410319|P3|COMPLETED|Third Treatment Period||11
578773|NCT00565084|1410320|P2|COMPLETED|Third Treatment Period||11
578774|NCT00565084|1410321|P1|COMPLETED|Third Treatment Period||11
578775|NCT00565084|1410319|P3|STARTED|Third Treatment Period||11
578776|NCT00565084|1410320|P2|STARTED|Third Treatment Period||11
578777|NCT00565084|1410321|P1|STARTED|Third Treatment Period||11
578778|NCT00565084|1410319|P3|NOT COMPLETED|Second Treatment Period||0
578779|NCT00565084|1410320|P2|NOT COMPLETED|Second Treatment Period||0
578780|NCT00565084|1410321|P1|NOT COMPLETED|Second Treatment Period||0
578781|NCT00565084|1410319|P3|COMPLETED|Second Treatment Period||11
578782|NCT00565084|1410320|P2|COMPLETED|Second Treatment Period||11
578783|NCT00565084|1410321|P1|COMPLETED|Second Treatment Period||11
578784|NCT00565084|1410319|P3|STARTED|Second Treatment Period||11
578785|NCT00565084|1410320|P2|STARTED|Second Treatment Period||11
578786|NCT00565084|1410321|P1|STARTED|Second Treatment Period||11
578787|NCT00565084|1410319|P3|NOT COMPLETED|First Treatment Period||0
578788|NCT00565084|1410320|P2|NOT COMPLETED|First Treatment Period||0
578789|NCT00565084|1410321|P1|NOT COMPLETED|First Treatment Period||0
578790|NCT00565084|1410319|P3|COMPLETED|First Treatment Period||11
578791|NCT00565084|1410320|P2|COMPLETED|First Treatment Period||11
578792|NCT00565084|1410321|P1|COMPLETED|First Treatment Period||11
578793|NCT00565084|1410319|P3|STARTED|First Treatment Period||11
578794|NCT00565084|1410320|P2|STARTED|First Treatment Period||11
578795|NCT00565084|1410321|P1|STARTED|First Treatment Period||11
578796|NCT00565058|1410331|P2|NOT COMPLETED|Overall Study||0
578797|NCT00565058|1410332|P1|NOT COMPLETED|Overall Study||1
578798|NCT00565058|1410331|P2|COMPLETED|Overall Study||15
578799|NCT00565058|1410332|P1|COMPLETED|Overall Study||9
578800|NCT00565058|1410331|P2|STARTED|Overall Study||15
578801|NCT00565058|1410332|P1|STARTED|Overall Study||10
578802|NCT00565045|1410342|P2|NOT COMPLETED|Overall Study||3
578803|NCT00565045|1410343|P1|NOT COMPLETED|Overall Study||1
578804|NCT00565045|1410342|P2|COMPLETED|Overall Study||8
578805|NCT00565045|1410343|P1|COMPLETED|Overall Study||9
578806|NCT00565045|1410342|P2|STARTED|Overall Study||11
578807|NCT00565045|1410343|P1|STARTED|Overall Study||10
578808|NCT00564954|1410359|P2|NOT COMPLETED|Period 2- 1 Week||0
578809|NCT00564954|1410360|P1|NOT COMPLETED|Period 2- 1 Week||0
578810|NCT00564954|1410359|P2|COMPLETED|Period 2- 1 Week||42
578811|NCT00564954|1410360|P1|COMPLETED|Period 2- 1 Week||44
578812|NCT00564954|1410359|P2|STARTED|Period 2- 1 Week||42
578813|NCT00564954|1410360|P1|STARTED|Period 2- 1 Week||44
578814|NCT00564954|1410359|P2|NOT COMPLETED|Period 1- 1 Week||0
578815|NCT00564954|1410360|P1|NOT COMPLETED|Period 1- 1 Week||0
578816|NCT00564954|1410359|P2|COMPLETED|Period 1- 1 Week||42
578817|NCT00564954|1410360|P1|COMPLETED|Period 1- 1 Week||44
578818|NCT00564954|1410359|P2|STARTED|Period 1- 1 Week||42
578819|NCT00564954|1410360|P1|STARTED|Period 1- 1 Week||44
578820|NCT00564902|1410379|P3|NOT COMPLETED|Overall Study||4
578821|NCT00564902|1410380|P2|NOT COMPLETED|Overall Study||4
578822|NCT00564902|1410381|P1|NOT COMPLETED|Overall Study||1
578823|NCT00564902|1410379|P3|COMPLETED|Overall Study||21
578824|NCT00564902|1410380|P2|COMPLETED|Overall Study||21
578825|NCT00564902|1410381|P1|COMPLETED|Overall Study||9
578826|NCT00564902|1410379|P3|12 Months|Overall Study||21
578827|NCT00564902|1410380|P2|12 Months|Overall Study||21
578828|NCT00564902|1410381|P1|12 Months|Overall Study||9
578829|NCT00564902|1410379|P3|8 Months|Overall Study||21
578830|NCT00564902|1410380|P2|8 Months|Overall Study||22
578831|NCT00564902|1410381|P1|8 Months|Overall Study||9
578832|NCT00564902|1410379|P3|4 Months|Overall Study||23
578833|NCT00564902|1410380|P2|4 Months|Overall Study||24
578834|NCT00564902|1410381|P1|4 Months|Overall Study||9
578835|NCT00564902|1410379|P3|STARTED|Overall Study||25
578836|NCT00564902|1410380|P2|STARTED|Overall Study||25
578837|NCT00564902|1410381|P1|STARTED|Overall Study||10
578838|NCT00564889|1410413|P1|NOT COMPLETED|Overall Study||29
578839|NCT00564889|1410413|P1|COMPLETED|Overall Study||6
578840|NCT00564889|1410413|P1|STARTED|Overall Study||35
578841|NCT00564876|1410421|P1|NOT COMPLETED|Overall Study||0
578842|NCT00564876|1410421|P1|COMPLETED|Overall Study||2
578843|NCT00564876|1410421|P1|STARTED|Overall Study||2
578844|NCT00564850|1410428|P1|NOT COMPLETED|Overall Study||2
578845|NCT00564850|1410428|P1|COMPLETED|Overall Study||35
578846|NCT00564850|1410428|P1|STARTED|Overall Study||37
578847|NCT00564733|1410446|P1|NOT COMPLETED|Overall Study||9
578848|NCT00564733|1410446|P1|COMPLETED|Overall Study||46
578849|NCT00564733|1410446|P1|STARTED|Overall Study||55
578850|NCT00564681|1410454|P4|NOT COMPLETED|Overall Study||2
578851|NCT00564681|1410455|P3|NOT COMPLETED|Overall Study||3
578852|NCT00564681|1410456|P2|NOT COMPLETED|Overall Study||3
578853|NCT00564681|1410457|P1|NOT COMPLETED|Overall Study||11
578854|NCT00564681|1410454|P4|COMPLETED|Overall Study||19
578855|NCT00564681|1410455|P3|COMPLETED|Overall Study||40
578856|NCT00564681|1410456|P2|COMPLETED|Overall Study||58
578857|NCT00564681|1410457|P1|COMPLETED|Overall Study||106
578858|NCT00564681|1410454|P4|STARTED|Overall Study||21
578859|NCT00564681|1410455|P3|STARTED|Overall Study||43
578860|NCT00564681|1410456|P2|STARTED|Overall Study||61
578861|NCT00564681|1410457|P1|STARTED|Overall Study||117
578862|NCT00564629|1410480|P2|NOT COMPLETED|Overall Study||9
578863|NCT00564629|1410481|P1|NOT COMPLETED|Overall Study||15
578864|NCT00564629|1410480|P2|COMPLETED|Overall Study||45
578865|NCT00564629|1410481|P1|COMPLETED|Overall Study||36
578866|NCT00564629|1410480|P2|STARTED|Overall Study||54
578867|NCT00564629|1410481|P1|STARTED|Overall Study||51
578868|NCT00564486|1410506|P4|NOT COMPLETED|Overall Study||7
578869|NCT00564486|1410507|P3|NOT COMPLETED|Overall Study||3
578870|NCT00564486|1410508|P2|NOT COMPLETED|Overall Study||1
578871|NCT00564486|1410509|P1|NOT COMPLETED|Overall Study||7
578872|NCT00564486|1410506|P4|COMPLETED|Overall Study||60
578873|NCT00564486|1410507|P3|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|39
578874|NCT00564486|1410508|P2|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|91
578875|NCT00564486|1410509|P1|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|36
578876|NCT00564486|1410506|P4|STARTED|Overall Study||67
578877|NCT00564486|1410507|P3|STARTED|Overall Study|One subject randomized to receive 1 g IVAPAP but was administered 650 mg IV in error|42
578878|NCT00564486|1410508|P2|STARTED|Overall Study|One subject was randomized to receive 1 g IVAPAP but was administered 650 mg IV in error|92
578879|NCT00564486|1410509|P1|STARTED|Overall Study||43
578880|NCT00564447|1410533|P8|NOT COMPLETED|Overall Study||0
578881|NCT00564447|1410534|P7|NOT COMPLETED|Overall Study||0
578882|NCT00564447|1410535|P6|NOT COMPLETED|Overall Study||0
578883|NCT00564447|1410536|P5|NOT COMPLETED|Overall Study||0
578884|NCT00564447|1410537|P4|NOT COMPLETED|Overall Study||0
578885|NCT00564447|1410538|P3|NOT COMPLETED|Overall Study||0
578886|NCT00564447|1410539|P2|NOT COMPLETED|Overall Study||0
578887|NCT00564447|1410540|P1|NOT COMPLETED|Overall Study||0
578888|NCT00564447|1410533|P8|COMPLETED|Overall Study||6
578889|NCT00564447|1410534|P7|COMPLETED|Overall Study||6
578890|NCT00564447|1410535|P6|COMPLETED|Overall Study||6
578891|NCT00564447|1410536|P5|COMPLETED|Overall Study||6
578892|NCT00564447|1410537|P4|COMPLETED|Overall Study||6
578893|NCT00564447|1410538|P3|COMPLETED|Overall Study||6
578894|NCT00564447|1410539|P2|COMPLETED|Overall Study||6
578895|NCT00564447|1410540|P1|COMPLETED|Overall Study||6
578896|NCT00564447|1410533|P8|STARTED|Overall Study||6
578897|NCT00564447|1410534|P7|STARTED|Overall Study||6
578898|NCT00564447|1410535|P6|STARTED|Overall Study||6
578899|NCT00564447|1410536|P5|STARTED|Overall Study||6
578900|NCT00564447|1410537|P4|STARTED|Overall Study||6
578901|NCT00564447|1410538|P3|STARTED|Overall Study||6
578902|NCT00564447|1410539|P2|STARTED|Overall Study||6
578903|NCT00564447|1410540|P1|STARTED|Overall Study||6
578904|NCT00564278|1410560|P2|NOT COMPLETED|Overall Study||42
578905|NCT00564278|1410561|P1|NOT COMPLETED|Overall Study||47
578906|NCT00564278|1410560|P2|COMPLETED|Overall Study||56
578907|NCT00564278|1410561|P1|COMPLETED|Overall Study||50
578908|NCT00564278|1410560|P2|STARTED|Overall Study||98
578909|NCT00564278|1410561|P1|STARTED|Overall Study||97
578910|NCT00564265|1410577|P1|NOT COMPLETED|Overall Study||0
578911|NCT00564265|1410577|P1|COMPLETED|Overall Study||24
578912|NCT00564265|1410577|P1|STARTED|Overall Study||24
578913|NCT00564070|1410583|P2|NOT COMPLETED|Overall Study||7
578914|NCT00564070|1410584|P1|NOT COMPLETED|Overall Study||12
578915|NCT00564070|1410583|P2|COMPLETED|Overall Study||38
578916|NCT00564070|1410584|P1|COMPLETED|Overall Study||30
578917|NCT00564070|1410583|P2|STARTED|Overall Study||45
578918|NCT00564070|1410584|P1|STARTED|Overall Study||42
578919|NCT00563797|1410610|P2|NOT COMPLETED|Overall Study||2
578920|NCT00563797|1410611|P1|NOT COMPLETED|Overall Study||7
578921|NCT00563797|1410610|P2|COMPLETED|Overall Study||8
578922|NCT00563797|1410611|P1|COMPLETED|Overall Study||4
578923|NCT00563797|1410610|P2|Follow-Up|Overall Study||10
578924|NCT00563797|1410611|P1|Follow-Up|Overall Study||11
578925|NCT00563797|1410610|P2|Received Allocated Intervention|Overall Study||10
578926|NCT00563797|1410611|P1|Received Allocated Intervention|Overall Study||11
578927|NCT00563797|1410610|P2|STARTED|Overall Study||10
578928|NCT00563797|1410611|P1|STARTED|Overall Study||11
578929|NCT00563706|1410632|P9|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
578930|NCT00563706|1410633|P8|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
578931|NCT00563706|1410634|P7|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
578932|NCT00563706|1410635|P6|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
578933|NCT00563706|1410636|P5|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
578934|NCT00563706|1410637|P4|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
578935|NCT00563706|1410638|P3|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
578936|NCT00563706|1410639|P2|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
578937|NCT00563706|1410640|P1|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
578938|NCT00563706|1410632|P9|COMPLETED|Taper Phase (Day 29 up to Day 35)||32
578939|NCT00563706|1410633|P8|COMPLETED|Taper Phase (Day 29 up to Day 35)||16
578940|NCT00563706|1410634|P7|COMPLETED|Taper Phase (Day 29 up to Day 35)||9
578941|NCT00563706|1410635|P6|COMPLETED|Taper Phase (Day 29 up to Day 35)||14
578942|NCT00563706|1410636|P5|COMPLETED|Taper Phase (Day 29 up to Day 35)||11
578943|NCT00563706|1410637|P4|COMPLETED|Taper Phase (Day 29 up to Day 35)||9
578944|NCT00563706|1410638|P3|COMPLETED|Taper Phase (Day 29 up to Day 35)||3
578945|NCT00563706|1410639|P2|COMPLETED|Taper Phase (Day 29 up to Day 35)||13
578946|NCT00563706|1410640|P1|COMPLETED|Taper Phase (Day 29 up to Day 35)||20
578947|NCT00563706|1410632|P9|STARTED|Taper Phase (Day 29 up to Day 35)||32
578948|NCT00563706|1410633|P8|STARTED|Taper Phase (Day 29 up to Day 35)||16
578949|NCT00563706|1410634|P7|STARTED|Taper Phase (Day 29 up to Day 35)||9
578950|NCT00563706|1410635|P6|STARTED|Taper Phase (Day 29 up to Day 35)||14
578951|NCT00563706|1410636|P5|STARTED|Taper Phase (Day 29 up to Day 35)||11
578952|NCT00563706|1410637|P4|STARTED|Taper Phase (Day 29 up to Day 35)||9
578953|NCT00563706|1410638|P3|STARTED|Taper Phase (Day 29 up to Day 35)||3
578954|NCT00563706|1410639|P2|STARTED|Taper Phase (Day 29 up to Day 35)||13
578955|NCT00563706|1410640|P1|STARTED|Taper Phase (Day 29 up to Day 35)||20
578956|NCT00563706|1410632|P9|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11
578957|NCT00563706|1410633|P8|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14
578958|NCT00563706|1410634|P7|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3
578959|NCT00563706|1410635|P6|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
578960|NCT00563706|1410636|P5|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
578961|NCT00563706|1410637|P4|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||10
578962|NCT00563706|1410638|P3|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
578963|NCT00563706|1410639|P2|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
578964|NCT00563706|1410640|P1|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||17
578965|NCT00563706|1410632|P9|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||32
578966|NCT00563706|1410633|P8|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||16
578967|NCT00563706|1410634|P7|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9
578968|NCT00563706|1410635|P6|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14
578969|NCT00563706|1410636|P5|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11
578970|NCT00563706|1410637|P4|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9
578971|NCT00563706|1410638|P3|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3
578972|NCT00563706|1410639|P2|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||13
578973|NCT00563706|1410640|P1|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||20
578974|NCT00563706|1410632|P9|STARTED|DB Treatment Period (Day 1 up to Day 28)||43
578975|NCT00563706|1410633|P8|STARTED|DB Treatment Period (Day 1 up to Day 28)||30
578976|NCT00563706|1410634|P7|STARTED|DB Treatment Period (Day 1 up to Day 28)||12
578977|NCT00563706|1410635|P6|STARTED|DB Treatment Period (Day 1 up to Day 28)||19
578978|NCT00563706|1410636|P5|STARTED|DB Treatment Period (Day 1 up to Day 28)||16
578979|NCT00563706|1410637|P4|STARTED|DB Treatment Period (Day 1 up to Day 28)||19
578980|NCT00563706|1410638|P3|STARTED|DB Treatment Period (Day 1 up to Day 28)||8
578981|NCT00563706|1410639|P2|STARTED|DB Treatment Period (Day 1 up to Day 28)||18
578982|NCT00563706|1410640|P1|STARTED|DB Treatment Period (Day 1 up to Day 28)||37
578983|NCT00563576|1410743|P2|NOT COMPLETED|Overall Study||14
578984|NCT00563576|1410744|P1|NOT COMPLETED|Overall Study||14
578985|NCT00563576|1410743|P2|COMPLETED|Overall Study||22
578986|NCT00563576|1410744|P1|COMPLETED|Overall Study||21
578987|NCT00563576|1410743|P2|STARTED|Overall Study||36
578988|NCT00563576|1410744|P1|STARTED|Overall Study||35
578989|NCT00563381|1410756|P2|NOT COMPLETED|Overall Study||648
578990|NCT00563381|1410757|P1|NOT COMPLETED|Overall Study||585
578991|NCT00563381|1410756|P2|COMPLETED|Overall Study|Completed treatment|3021
578992|NCT00563381|1410757|P1|COMPLETED|Overall Study|Completed treatment|3122
578993|NCT00563381|1410756|P2|STARTED|Overall Study|Started treatment|3669
578994|NCT00563381|1410757|P1|STARTED|Overall Study|Started treatment|3707
578995|NCT00563368|1410830|P7|NOT COMPLETED|Overall Study||33
578996|NCT00563368|1410831|P6|NOT COMPLETED|Overall Study||30
578997|NCT00563368|1410832|P5|NOT COMPLETED|Overall Study||28
578998|NCT00563368|1410833|P4|NOT COMPLETED|Overall Study||29
578999|NCT00563368|1410834|P3|NOT COMPLETED|Overall Study||30
579000|NCT00563368|1410835|P2|NOT COMPLETED|Overall Study||30
579001|NCT00563368|1410836|P1|NOT COMPLETED|Overall Study||35
579002|NCT00563368|1410830|P7|COMPLETED|Overall Study||75
579003|NCT00563368|1410831|P6|COMPLETED|Overall Study||77
579004|NCT00563368|1410832|P5|COMPLETED|Overall Study||80
579005|NCT00563368|1410833|P4|COMPLETED|Overall Study||78
579006|NCT00563368|1410834|P3|COMPLETED|Overall Study||78
579007|NCT00563368|1410835|P2|COMPLETED|Overall Study||79
579008|NCT00563368|1410836|P1|COMPLETED|Overall Study||74
579009|NCT00563368|1410830|P7|STARTED|Overall Study||108
579010|NCT00563368|1410831|P6|STARTED|Overall Study||107
579011|NCT00563368|1410832|P5|STARTED|Overall Study||108
579012|NCT00563368|1410833|P4|STARTED|Overall Study||107
579013|NCT00563368|1410834|P3|STARTED|Overall Study||108
579014|NCT00563368|1410835|P2|STARTED|Overall Study||109
579015|NCT00563368|1410836|P1|STARTED|Overall Study||109
579016|NCT00563316|1410859|P1|NOT COMPLETED|Overall Study||12
579017|NCT00563316|1410859|P1|COMPLETED|Overall Study||16
579018|NCT00563316|1410859|P1|Received Investigational Product|Overall Study||27
579019|NCT00563316|1410859|P1|STARTED|Overall Study||28
579020|NCT00563290|1410872|P2|NOT COMPLETED|Overall Study||0
579021|NCT00563290|1410873|P1|NOT COMPLETED|Overall Study||0
579022|NCT00563290|1410872|P2|COMPLETED|Overall Study||4
579023|NCT00563290|1410873|P1|COMPLETED|Overall Study||3
579024|NCT00563290|1410872|P2|STARTED|Overall Study||4
579025|NCT00563290|1410873|P1|STARTED|Overall Study||3
579026|NCT00562965|1410884|P2|NOT COMPLETED|Overall Study||6
579027|NCT00562965|1410885|P1|NOT COMPLETED|Overall Study||3
579028|NCT00562965|1410884|P2|COMPLETED|Overall Study||8
579029|NCT00562965|1410885|P1|COMPLETED|Overall Study||12
579030|NCT00562965|1410884|P2|Treated|Overall Study||13
579031|NCT00562965|1410885|P1|Treated|Overall Study||15
579032|NCT00562965|1410884|P2|STARTED|Overall Study||14
579033|NCT00562965|1410885|P1|STARTED|Overall Study||15
579034|NCT00562861|1410906|P2|NOT COMPLETED|Overall Study||11
579035|NCT00562861|1410907|P1|NOT COMPLETED|Overall Study||20
579036|NCT00562861|1410906|P2|COMPLETED|Overall Study||48
579037|NCT00562861|1410907|P1|COMPLETED|Overall Study||40
579038|NCT00562861|1410906|P2|STARTED|Overall Study||59
579039|NCT00562861|1410907|P1|STARTED|Overall Study||60
579040|NCT00562627|1410916|P3|NOT COMPLETED|Overall Study||1
579041|NCT00562627|1410917|P2|NOT COMPLETED|Overall Study||1
579042|NCT00562627|1410918|P1|NOT COMPLETED|Overall Study||1
579043|NCT00562627|1410916|P3|COMPLETED|Overall Study||33
579044|NCT00562627|1410917|P2|COMPLETED|Overall Study||33
579045|NCT00562627|1410918|P1|COMPLETED|Overall Study||33
579046|NCT00562627|1410916|P3|STARTED|Overall Study||34
579047|NCT00562627|1410917|P2|STARTED|Overall Study||34
579048|NCT00562627|1410918|P1|STARTED|Overall Study||34
579049|NCT00562588|1410934|P2|NOT COMPLETED|Overall Study||99
579050|NCT00562588|1410935|P1|NOT COMPLETED|Overall Study||92
579051|NCT00562588|1410934|P2|COMPLETED|Overall Study||184
579052|NCT00562588|1410935|P1|COMPLETED|Overall Study||168
579053|NCT00562588|1410934|P2|STARTED|Overall Study||283
579054|NCT00562588|1410935|P1|STARTED|Overall Study||260
579055|NCT00562484|1410965|P2|NOT COMPLETED|Overall Study||104
579056|NCT00562484|1410966|P1|NOT COMPLETED|Overall Study||206
579057|NCT00562484|1410965|P2|COMPLETED|Overall Study||4907
579058|NCT00562484|1410966|P1|COMPLETED|Overall Study||9827
579059|NCT00562484|1410965|P2|STARTED|Overall Study||5011
579060|NCT00562484|1410966|P1|STARTED|Overall Study||10033
579061|NCT00562354|1410998|P2|NOT COMPLETED|Overall Study||2
579062|NCT00562354|1410999|P1|NOT COMPLETED|Overall Study||0
579063|NCT00562354|1410998|P2|COMPLETED|Overall Study||135
579064|NCT00562354|1410999|P1|COMPLETED|Overall Study||134
579065|NCT00562354|1410998|P2|Evaluable Immunogenicity Population|Overall Study||134
579066|NCT00562354|1410999|P1|Evaluable Immunogenicity Population|Overall Study||134
579067|NCT00562354|1410998|P2|Received Study Treatment|Overall Study||136
579068|NCT00562354|1410999|P1|Received Study Treatment|Overall Study||134
579069|NCT00562354|1410998|P2|STARTED|Overall Study||137
579070|NCT00562354|1410999|P1|STARTED|Overall Study||134
579071|NCT00562328|1411040|P1|NOT COMPLETED|Overall Study||0
579072|NCT00562328|1411040|P1|COMPLETED|Overall Study||33
579073|NCT00562328|1411040|P1|STARTED|Overall Study||33
579074|NCT00562315|1411044|P1|NOT COMPLETED|Overall Study||0
579075|NCT00562315|1411044|P1|COMPLETED|Overall Study||93
579076|NCT00562315|1411044|P1|STARTED|Overall Study||93
579077|NCT00562302|1411061|P2|NOT COMPLETED|Overall Study||32
579078|NCT00562302|1411062|P1|NOT COMPLETED|Overall Study||20
579079|NCT00562302|1411061|P2|COMPLETED|Overall Study||137
579080|NCT00562302|1411062|P1|COMPLETED|Overall Study||150
579081|NCT00562302|1411061|P2|STARTED|Overall Study||169
579082|NCT00562302|1411062|P1|STARTED|Overall Study||170
579083|NCT00562159|1411084|P2|NOT COMPLETED|Overall Study||33
579084|NCT00562159|1411085|P1|NOT COMPLETED|Overall Study||38
579085|NCT00562159|1411084|P2|COMPLETED|Overall Study||192
579086|NCT00562159|1411085|P1|COMPLETED|Overall Study||175
579087|NCT00562159|1411084|P2|STARTED|Overall Study||225
579088|NCT00562159|1411085|P1|STARTED|Overall Study||213
579089|NCT00562120|1411097|P4|NOT COMPLETED|Fourth Intervention Period||0
579090|NCT00562120|1411098|P3|NOT COMPLETED|Fourth Intervention Period||0
579091|NCT00562120|1411099|P2|NOT COMPLETED|Fourth Intervention Period||0
579092|NCT00562120|1411100|P1|NOT COMPLETED|Fourth Intervention Period||0
579093|NCT00562120|1411097|P4|COMPLETED|Fourth Intervention Period||5
579094|NCT00562120|1411098|P3|COMPLETED|Fourth Intervention Period||5
579095|NCT00562120|1411099|P2|COMPLETED|Fourth Intervention Period||5
579096|NCT00562120|1411100|P1|COMPLETED|Fourth Intervention Period||4
579097|NCT00562120|1411097|P4|STARTED|Fourth Intervention Period||5
579098|NCT00562120|1411098|P3|STARTED|Fourth Intervention Period||5
579099|NCT00562120|1411099|P2|STARTED|Fourth Intervention Period||5
579100|NCT00562120|1411100|P1|STARTED|Fourth Intervention Period||4
579101|NCT00562120|1411097|P4|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
579102|NCT00562120|1411098|P3|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
579103|NCT00562120|1411099|P2|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
579104|NCT00562120|1411100|P1|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
579105|NCT00562120|1411097|P4|COMPLETED|Washout Period 3 (At Least 14 Days)||5
579106|NCT00562120|1411098|P3|COMPLETED|Washout Period 3 (At Least 14 Days)||5
579107|NCT00562120|1411099|P2|COMPLETED|Washout Period 3 (At Least 14 Days)||5
579108|NCT00562120|1411100|P1|COMPLETED|Washout Period 3 (At Least 14 Days)||4
579109|NCT00562120|1411097|P4|STARTED|Washout Period 3 (At Least 14 Days)||5
579110|NCT00562120|1411098|P3|STARTED|Washout Period 3 (At Least 14 Days)||5
579111|NCT00562120|1411099|P2|STARTED|Washout Period 3 (At Least 14 Days)||5
579112|NCT00562120|1411100|P1|STARTED|Washout Period 3 (At Least 14 Days)||4
579113|NCT00562120|1411097|P4|NOT COMPLETED|Third Intervention Period||0
579114|NCT00562120|1411098|P3|NOT COMPLETED|Third Intervention Period||0
579115|NCT00562120|1411099|P2|NOT COMPLETED|Third Intervention Period||0
579116|NCT00562120|1411100|P1|NOT COMPLETED|Third Intervention Period||0
579117|NCT00562120|1411097|P4|COMPLETED|Third Intervention Period||5
579118|NCT00562120|1411098|P3|COMPLETED|Third Intervention Period||5
579119|NCT00562120|1411099|P2|COMPLETED|Third Intervention Period||5
579120|NCT00562120|1411100|P1|COMPLETED|Third Intervention Period||4
579121|NCT00562120|1411097|P4|STARTED|Third Intervention Period||5
579122|NCT00562120|1411098|P3|STARTED|Third Intervention Period||5
579123|NCT00562120|1411099|P2|STARTED|Third Intervention Period||5
579124|NCT00562120|1411100|P1|STARTED|Third Intervention Period||4
579125|NCT00562120|1411097|P4|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
579126|NCT00562120|1411098|P3|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
579127|NCT00562120|1411099|P2|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
579128|NCT00562120|1411100|P1|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
579129|NCT00562120|1411097|P4|COMPLETED|Washout Period 2 (At Least 14 Days)||5
579130|NCT00562120|1411098|P3|COMPLETED|Washout Period 2 (At Least 14 Days)||5
579131|NCT00562120|1411099|P2|COMPLETED|Washout Period 2 (At Least 14 Days)||5
579132|NCT00562120|1411100|P1|COMPLETED|Washout Period 2 (At Least 14 Days)||4
579133|NCT00562120|1411097|P4|STARTED|Washout Period 2 (At Least 14 Days)||5
579134|NCT00562120|1411098|P3|STARTED|Washout Period 2 (At Least 14 Days)||5
579135|NCT00562120|1411099|P2|STARTED|Washout Period 2 (At Least 14 Days)||5
579136|NCT00562120|1411100|P1|STARTED|Washout Period 2 (At Least 14 Days)||4
579137|NCT00562120|1411097|P4|NOT COMPLETED|Second Intervention Period||0
579138|NCT00562120|1411098|P3|NOT COMPLETED|Second Intervention Period||0
579139|NCT00562120|1411099|P2|NOT COMPLETED|Second Intervention Period||0
579140|NCT00562120|1411100|P1|NOT COMPLETED|Second Intervention Period||0
579141|NCT00562120|1411097|P4|COMPLETED|Second Intervention Period||5
579142|NCT00562120|1411098|P3|COMPLETED|Second Intervention Period||5
579143|NCT00562120|1411099|P2|COMPLETED|Second Intervention Period||5
579144|NCT00562120|1411100|P1|COMPLETED|Second Intervention Period||4
579145|NCT00562120|1411097|P4|STARTED|Second Intervention Period||5
579146|NCT00562120|1411098|P3|STARTED|Second Intervention Period||5
579147|NCT00562120|1411099|P2|STARTED|Second Intervention Period||5
579148|NCT00562120|1411100|P1|STARTED|Second Intervention Period||4
579149|NCT00562120|1411097|P4|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
579150|NCT00562120|1411098|P3|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
579151|NCT00562120|1411099|P2|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
579152|NCT00562120|1411100|P1|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
579153|NCT00562120|1411097|P4|COMPLETED|Washout Period 1 (At Least 14 Days)||5
579154|NCT00562120|1411098|P3|COMPLETED|Washout Period 1 (At Least 14 Days)||5
579155|NCT00562120|1411099|P2|COMPLETED|Washout Period 1 (At Least 14 Days)||5
579156|NCT00562120|1411100|P1|COMPLETED|Washout Period 1 (At Least 14 Days)||4
579157|NCT00562120|1411097|P4|STARTED|Washout Period 1 (At Least 14 Days)||5
579158|NCT00562120|1411098|P3|STARTED|Washout Period 1 (At Least 14 Days)||5
579159|NCT00562120|1411099|P2|STARTED|Washout Period 1 (At Least 14 Days)||5
579160|NCT00562120|1411100|P1|STARTED|Washout Period 1 (At Least 14 Days)||4
579161|NCT00562120|1411097|P4|NOT COMPLETED|First Intervention Period||0
579162|NCT00562120|1411098|P3|NOT COMPLETED|First Intervention Period||0
579163|NCT00562120|1411099|P2|NOT COMPLETED|First Intervention Period||0
579164|NCT00562120|1411100|P1|NOT COMPLETED|First Intervention Period||2
579165|NCT00562120|1411097|P4|COMPLETED|First Intervention Period||5
579166|NCT00562120|1411098|P3|COMPLETED|First Intervention Period||5
579167|NCT00562120|1411099|P2|COMPLETED|First Intervention Period||5
579168|NCT00562120|1411100|P1|COMPLETED|First Intervention Period||4
579169|NCT00562120|1411097|P4|Treated|First Intervention Period||5
579170|NCT00562120|1411098|P3|Treated|First Intervention Period||5
579171|NCT00562120|1411099|P2|Treated|First Intervention Period||5
579172|NCT00562120|1411100|P1|Treated|First Intervention Period||5
579173|NCT00562120|1411097|P4|STARTED|First Intervention Period||5
579174|NCT00562120|1411098|P3|STARTED|First Intervention Period||5
579175|NCT00562120|1411099|P2|STARTED|First Intervention Period||5
579176|NCT00562120|1411100|P1|STARTED|First Intervention Period||6
579177|NCT00562094|1411132|P1|NOT COMPLETED|Overall Study||62
579178|NCT00562094|1411132|P1|COMPLETED|Overall Study||8554
579179|NCT00562094|1411132|P1|STARTED|Overall Study||8616
579180|NCT00561977|1411147|P3|NOT COMPLETED|Overall Study||2
579181|NCT00561977|1411148|P2|NOT COMPLETED|Overall Study||3
579182|NCT00561977|1411149|P1|NOT COMPLETED|Overall Study||0
579183|NCT00561977|1411147|P3|COMPLETED|Overall Study||10
579184|NCT00561977|1411148|P2|COMPLETED|Overall Study||9
579185|NCT00561977|1411149|P1|COMPLETED|Overall Study||12
579186|NCT00561977|1411147|P3|STARTED|Overall Study||12
579187|NCT00561977|1411148|P2|STARTED|Overall Study||12
579188|NCT00561977|1411149|P1|STARTED|Overall Study||12
579189|NCT00561951|1411175|P3|NOT COMPLETED|Overall Study||32
579190|NCT00561951|1411176|P2|NOT COMPLETED|Overall Study||34
579191|NCT00561951|1411177|P1|NOT COMPLETED|Overall Study||33
579192|NCT00561951|1411175|P3|COMPLETED|Overall Study||281
579193|NCT00561951|1411176|P2|COMPLETED|Overall Study||286
579194|NCT00561951|1411177|P1|COMPLETED|Overall Study||285
579195|NCT00561951|1411175|P3|STARTED|Overall Study||313
579196|NCT00561951|1411176|P2|STARTED|Overall Study||320
579197|NCT00561951|1411177|P1|STARTED|Overall Study||318
579198|NCT00561925|1411233|P5|NOT COMPLETED|Open-Label Extension Period||50
579199|NCT00561925|1411234|P4|NOT COMPLETED|Open-Label Extension Period||43
579200|NCT00561925|1411235|P3|NOT COMPLETED|Open-Label Extension Period||0
579201|NCT00561925|1411236|P2|NOT COMPLETED|Open-Label Extension Period||0
579202|NCT00561925|1411237|P1|NOT COMPLETED|Open-Label Extension Period||0
579203|NCT00561925|1411233|P5|COMPLETED|Open-Label Extension Period||328
579204|NCT00561925|1411234|P4|COMPLETED|Open-Label Extension Period||315
579205|NCT00561925|1411235|P3|COMPLETED|Open-Label Extension Period||0
579206|NCT00561925|1411236|P2|COMPLETED|Open-Label Extension Period||1
579207|NCT00561925|1411237|P1|COMPLETED|Open-Label Extension Period||0
579208|NCT00561925|1411233|P5|STARTED|Open-Label Extension Period||378
579209|NCT00561925|1411234|P4|STARTED|Open-Label Extension Period||358
579210|NCT00561925|1411235|P3|STARTED|Open-Label Extension Period||0
579211|NCT00561925|1411236|P2|STARTED|Open-Label Extension Period||1
579212|NCT00561925|1411237|P1|STARTED|Open-Label Extension Period||0
579213|NCT00561925|1411233|P5|NOT COMPLETED|144-week Double-blind, Double-dummy||0
579214|NCT00561925|1411234|P4|NOT COMPLETED|144-week Double-blind, Double-dummy||0
579215|NCT00561925|1411235|P3|NOT COMPLETED|144-week Double-blind, Double-dummy||127
579216|NCT00561925|1411236|P2|NOT COMPLETED|144-week Double-blind, Double-dummy||150
579217|NCT00561925|1411237|P1|NOT COMPLETED|144-week Double-blind, Double-dummy||0
579218|NCT00561925|1411233|P5|COMPLETED|144-week Double-blind, Double-dummy||0
579219|NCT00561925|1411234|P4|COMPLETED|144-week Double-blind, Double-dummy||0
579220|NCT00561925|1411235|P3|COMPLETED|144-week Double-blind, Double-dummy||378
579221|NCT00561925|1411236|P2|COMPLETED|144-week Double-blind, Double-dummy||358
579222|NCT00561925|1411237|P1|COMPLETED|144-week Double-blind, Double-dummy||0
579223|NCT00561925|1411233|P5|STARTED|144-week Double-blind, Double-dummy||0
579224|NCT00561925|1411234|P4|STARTED|144-week Double-blind, Double-dummy||0
579225|NCT00561925|1411235|P3|STARTED|144-week Double-blind, Double-dummy||505
579226|NCT00561925|1411236|P2|STARTED|144-week Double-blind, Double-dummy||508
579227|NCT00561925|1411237|P1|STARTED|144-week Double-blind, Double-dummy||0
579228|NCT00561925|1411233|P5|NOT COMPLETED|14 Day Lead-In Period||0
579229|NCT00561925|1411234|P4|NOT COMPLETED|14 Day Lead-In Period||0
579230|NCT00561925|1411235|P3|NOT COMPLETED|14 Day Lead-In Period||0
579231|NCT00561925|1411236|P2|NOT COMPLETED|14 Day Lead-In Period||0
579232|NCT00561925|1411237|P1|NOT COMPLETED|14 Day Lead-In Period||55
579233|NCT00561925|1411233|P5|COMPLETED|14 Day Lead-In Period||0
579234|NCT00561925|1411234|P4|COMPLETED|14 Day Lead-In Period||0
579235|NCT00561925|1411235|P3|COMPLETED|14 Day Lead-In Period||0
579236|NCT00561925|1411236|P2|COMPLETED|14 Day Lead-In Period||0
579237|NCT00561925|1411237|P1|COMPLETED|14 Day Lead-In Period||1013
579238|NCT00561925|1411233|P5|STARTED|14 Day Lead-In Period||0
579239|NCT00561925|1411234|P4|STARTED|14 Day Lead-In Period||0
579240|NCT00561925|1411235|P3|STARTED|14 Day Lead-In Period||0
579241|NCT00561925|1411236|P2|STARTED|14 Day Lead-In Period||0
579242|NCT00561925|1411237|P1|STARTED|14 Day Lead-In Period||1068
579243|NCT00561912|1411286|P1|NOT COMPLETED|Overall Study||1
579244|NCT00561912|1411286|P1|COMPLETED|Overall Study||1
579245|NCT00561912|1411286|P1|STARTED|Overall Study||2
579246|NCT00561834|1411290|P1|NOT COMPLETED|Overall Study||0
579247|NCT00561834|1411290|P1|COMPLETED|Overall Study||2
579248|NCT00561834|1411290|P1|STARTED|Overall Study||2
581892|NCT00546273|1419351|P2|STARTED|IV||0
579249|NCT00561821|1411298|P4|NOT COMPLETED|Overall Study||3
579250|NCT00561821|1411299|P3|NOT COMPLETED|Overall Study||2
579251|NCT00561821|1411300|P2|NOT COMPLETED|Overall Study||6
579252|NCT00561821|1411301|P1|NOT COMPLETED|Overall Study||5
579253|NCT00561821|1411298|P4|COMPLETED|Overall Study||133
579254|NCT00561821|1411299|P3|COMPLETED|Overall Study||132
579255|NCT00561821|1411300|P2|COMPLETED|Overall Study||130
579256|NCT00561821|1411301|P1|COMPLETED|Overall Study||127
579257|NCT00561821|1411298|P4|Treated|Overall Study||136
579258|NCT00561821|1411299|P3|Treated|Overall Study||133
579259|NCT00561821|1411300|P2|Treated|Overall Study||136
579260|NCT00561821|1411301|P1|Treated|Overall Study||132
579261|NCT00561821|1411298|P4|STARTED|Overall Study||136
579262|NCT00561821|1411299|P3|STARTED|Overall Study||134
579263|NCT00561821|1411300|P2|STARTED|Overall Study||136
579264|NCT00561821|1411301|P1|STARTED|Overall Study||132
579265|NCT00561795|1411377|P4|NOT COMPLETED|Overall Study||0
579266|NCT00561795|1411378|P3|NOT COMPLETED|Overall Study||0
579267|NCT00561795|1411379|P2|NOT COMPLETED|Overall Study||6
579268|NCT00561795|1411380|P1|NOT COMPLETED|Overall Study||4
579269|NCT00561795|1411377|P4|COMPLETED|Overall Study||0
579270|NCT00561795|1411378|P3|COMPLETED|Overall Study||0
579271|NCT00561795|1411379|P2|COMPLETED|Overall Study||0
579272|NCT00561795|1411380|P1|COMPLETED|Overall Study||2
579273|NCT00561795|1411377|P4|STARTED|Overall Study||0
579274|NCT00561795|1411378|P3|STARTED|Overall Study||0
579275|NCT00561795|1411379|P2|STARTED|Overall Study||6
579276|NCT00561795|1411380|P1|STARTED|Overall Study||6
579277|NCT00561730|1411400|P1|NOT COMPLETED|Overall Study||9
579278|NCT00561730|1411400|P1|COMPLETED|Overall Study||1986
579279|NCT00561730|1411400|P1|STARTED|Overall Study||1995
579280|NCT00561678|1411416|P2|NOT COMPLETED|Overall Study||6
579281|NCT00561678|1411417|P1|NOT COMPLETED|Overall Study||8
579282|NCT00561678|1411416|P2|COMPLETED|Overall Study||201
579283|NCT00561678|1411417|P1|COMPLETED|Overall Study||189
579284|NCT00561678|1411416|P2|STARTED|Overall Study||207
579285|NCT00561678|1411417|P1|STARTED|Overall Study||197
579286|NCT00561652|1411435|P2|NOT COMPLETED|Overall Study||1
579287|NCT00561652|1411436|P1|NOT COMPLETED|Overall Study||0
579288|NCT00561652|1411435|P2|COMPLETED|Overall Study||19
579289|NCT00561652|1411436|P1|COMPLETED|Overall Study||10
579290|NCT00561652|1411435|P2|STARTED|Overall Study||20
579291|NCT00561652|1411436|P1|STARTED|Overall Study||10
579292|NCT00561600|1411456|P2|NOT COMPLETED|Overall Study||16
579293|NCT00561600|1411457|P1|NOT COMPLETED|Overall Study||18
579294|NCT00561600|1411456|P2|COMPLETED|Overall Study||119
579295|NCT00561600|1411457|P1|COMPLETED|Overall Study||112
579296|NCT00561600|1411456|P2|STARTED|Overall Study||135
579297|NCT00561600|1411457|P1|STARTED|Overall Study||130
579298|NCT00561574|1411519|P2|NOT COMPLETED|Overall Study||58
579299|NCT00561574|1411520|P1|NOT COMPLETED|Overall Study||48
579300|NCT00561574|1411519|P2|COMPLETED|Overall Study||73
579301|NCT00561574|1411520|P1|COMPLETED|Overall Study||80
579302|NCT00561574|1411519|P2|STARTED|Overall Study||131
579303|NCT00561574|1411520|P1|STARTED|Overall Study||128
579304|NCT00561470|1411546|P2|NOT COMPLETED|Overall Study||612
579305|NCT00561470|1411547|P1|NOT COMPLETED|Overall Study||614
579306|NCT00561470|1411546|P2|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were ongoing treatment on the cutoff date|0
579307|NCT00561470|1411547|P1|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were ongoing treatment on the cutoff date|0
579308|NCT00561470|1411546|P2|ONGOING TREATMENT|Overall Study|Participants continuing treatment on the cutoff date of the final analysis|14
579309|NCT00561470|1411547|P1|ONGOING TREATMENT|Overall Study|Participants continuing treatment on the cutoff date of the final analysis|11
579310|NCT00561470|1411546|P2|SAFETY POPULATION|Overall Study|Treated participants including 4 from Placebo/FOLFIRI who received at least 1 dose of Aflibercept|611
579311|NCT00561470|1411547|P1|SAFETY POPULATION|Overall Study|Treated participants excluding 4 who received at least 1 dose of Aflibercept|605
579312|NCT00561470|1411546|P2|TREATED|Overall Study||607
579313|NCT00561470|1411547|P1|TREATED|Overall Study||609
579314|NCT00561470|1411546|P2|STARTED|Overall Study||612
579315|NCT00561470|1411547|P1|STARTED|Overall Study||614
579316|NCT00561457|1411561|P1|NOT COMPLETED|Overall Study||24
579317|NCT00561457|1411561|P1|COMPLETED|Overall Study||110
579318|NCT00561457|1411561|P1|STARTED|Overall Study||134
579319|NCT00561431|1411567|P2|NOT COMPLETED|Overall Study||0
579320|NCT00561431|1411568|P1|NOT COMPLETED|Overall Study||0
579321|NCT00561431|1411567|P2|COMPLETED|Overall Study||100
579322|NCT00561431|1411568|P1|COMPLETED|Overall Study||100
579323|NCT00561431|1411567|P2|STARTED|Overall Study||100
579324|NCT00561431|1411568|P1|STARTED|Overall Study||100
579325|NCT00561418|1411576|P1|NOT COMPLETED|Overall Study||0
579326|NCT00561418|1411576|P1|COMPLETED|Overall Study||23
579327|NCT00561418|1411576|P1|STARTED|Overall Study||23
579328|NCT00561392|1411583|P1|NOT COMPLETED|Overall Study||53
579329|NCT00561392|1411583|P1|COMPLETED|Overall Study||155
579330|NCT00561392|1411583|P1|STARTED|Overall Study||208
579331|NCT00561353|1411605|P10|NOT COMPLETED|Overall Study||2
579332|NCT00561353|1411606|P9|NOT COMPLETED|Overall Study||7
579333|NCT00561353|1411607|P8|NOT COMPLETED|Overall Study||4
579334|NCT00561353|1411608|P7|NOT COMPLETED|Overall Study||6
579335|NCT00561353|1411609|P6|NOT COMPLETED|Overall Study||6
579336|NCT00561353|1411610|P5|NOT COMPLETED|Overall Study||1
579337|NCT00561353|1411611|P4|NOT COMPLETED|Overall Study||6
579338|NCT00561353|1411612|P3|NOT COMPLETED|Overall Study||3
579339|NCT00561353|1411613|P2|NOT COMPLETED|Overall Study||3
579340|NCT00561353|1411614|P1|NOT COMPLETED|Overall Study||5
579341|NCT00561353|1411605|P10|COMPLETED|Overall Study||3
579342|NCT00561353|1411606|P9|COMPLETED|Overall Study||2
579343|NCT00561353|1411607|P8|COMPLETED|Overall Study||6
579344|NCT00561353|1411608|P7|COMPLETED|Overall Study||3
579345|NCT00561353|1411609|P6|COMPLETED|Overall Study||3
579346|NCT00561353|1411610|P5|COMPLETED|Overall Study||5
579347|NCT00561353|1411611|P4|COMPLETED|Overall Study||12
579348|NCT00561353|1411612|P3|COMPLETED|Overall Study||10
579349|NCT00561353|1411613|P2|COMPLETED|Overall Study||16
579350|NCT00561353|1411614|P1|COMPLETED|Overall Study||13
579351|NCT00561353|1411605|P10|STARTED|Overall Study||5
579352|NCT00561353|1411606|P9|STARTED|Overall Study||9
579353|NCT00561353|1411607|P8|STARTED|Overall Study||10
579354|NCT00561353|1411608|P7|STARTED|Overall Study||9
579355|NCT00561353|1411609|P6|STARTED|Overall Study||9
579356|NCT00561353|1411610|P5|STARTED|Overall Study||6
579357|NCT00561353|1411611|P4|STARTED|Overall Study||18
579358|NCT00561353|1411612|P3|STARTED|Overall Study||13
579359|NCT00561353|1411613|P2|STARTED|Overall Study||19
579360|NCT00561353|1411614|P1|STARTED|Overall Study||18
579361|NCT00561340|1411769|P2|NOT COMPLETED|Overall Study||0
579362|NCT00561340|1411770|P1|NOT COMPLETED|Overall Study||6
579363|NCT00561340|1411769|P2|COMPLETED|Overall Study||16
579364|NCT00561340|1411770|P1|COMPLETED|Overall Study||7
579365|NCT00561340|1411769|P2|STARTED|Overall Study||16
579366|NCT00561340|1411770|P1|STARTED|Overall Study||13
579367|NCT00561145|1411780|P2|NOT COMPLETED|Overall Study||0
579368|NCT00561145|1411781|P1|NOT COMPLETED|Overall Study||0
579369|NCT00561145|1411780|P2|COMPLETED|Overall Study||17
579370|NCT00561145|1411781|P1|COMPLETED|Overall Study||15
579371|NCT00561145|1411780|P2|STARTED|Overall Study||17
579372|NCT00561145|1411781|P1|STARTED|Overall Study||15
579373|NCT00561080|1411790|P3|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
579374|NCT00561080|1411791|P2|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
579375|NCT00561080|1411792|P1|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
579376|NCT00561080|1411790|P3|COMPLETED|36 Month Post Last Dose Follow-up||0
579377|NCT00561080|1411791|P2|COMPLETED|36 Month Post Last Dose Follow-up||0
579378|NCT00561080|1411792|P1|COMPLETED|36 Month Post Last Dose Follow-up||0
579379|NCT00561080|1411790|P3|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
579380|NCT00561080|1411791|P2|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
579381|NCT00561080|1411792|P1|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
579382|NCT00561080|1411790|P3|NOT COMPLETED|24-month Post Last Dose Follow-up||0
579383|NCT00561080|1411791|P2|NOT COMPLETED|24-month Post Last Dose Follow-up||0
579384|NCT00561080|1411792|P1|NOT COMPLETED|24-month Post Last Dose Follow-up||0
579385|NCT00561080|1411790|P3|COMPLETED|24-month Post Last Dose Follow-up||0
579386|NCT00561080|1411791|P2|COMPLETED|24-month Post Last Dose Follow-up||0
579387|NCT00561080|1411792|P1|COMPLETED|24-month Post Last Dose Follow-up||0
579388|NCT00561080|1411790|P3|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
579389|NCT00561080|1411791|P2|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
579390|NCT00561080|1411792|P1|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
579391|NCT00561080|1411790|P3|NOT COMPLETED|12-month Post Last Dose Follow-up||10
579392|NCT00561080|1411791|P2|NOT COMPLETED|12-month Post Last Dose Follow-up||9
579393|NCT00561080|1411792|P1|NOT COMPLETED|12-month Post Last Dose Follow-up||7
579394|NCT00561080|1411790|P3|COMPLETED|12-month Post Last Dose Follow-up||215
579395|NCT00561080|1411791|P2|COMPLETED|12-month Post Last Dose Follow-up||220
579396|NCT00561080|1411792|P1|COMPLETED|12-month Post Last Dose Follow-up||243
579397|NCT00561080|1411790|P3|STARTED|12-month Post Last Dose Follow-up||225
579398|NCT00561080|1411791|P2|STARTED|12-month Post Last Dose Follow-up||229
579399|NCT00561080|1411792|P1|STARTED|12-month Post Last Dose Follow-up||250
579400|NCT00561080|1411790|P3|NOT COMPLETED|Vaccination Period (up to Month 4)||26
579401|NCT00561080|1411791|P2|NOT COMPLETED|Vaccination Period (up to Month 4)||26
579402|NCT00561080|1411792|P1|NOT COMPLETED|Vaccination Period (up to Month 4)||3
579403|NCT00561080|1411790|P3|COMPLETED|Vaccination Period (up to Month 4)||225
579404|NCT00561080|1411791|P2|COMPLETED|Vaccination Period (up to Month 4)||229
579405|NCT00561080|1411792|P1|COMPLETED|Vaccination Period (up to Month 4)||250
579406|NCT00561080|1411790|P3|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||250
579407|NCT00561080|1411791|P2|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||254
579408|NCT00561080|1411792|P1|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||253
579409|NCT00561080|1411790|P3|STARTED|Vaccination Period (up to Month 4)||251
579410|NCT00561080|1411791|P2|STARTED|Vaccination Period (up to Month 4)||255
579411|NCT00561080|1411792|P1|STARTED|Vaccination Period (up to Month 4)||253
579412|NCT00561015|1411869|P6|NOT COMPLETED|Overall Study||3
579413|NCT00561015|1411870|P5|NOT COMPLETED|Overall Study||1
579414|NCT00561015|1411871|P4|NOT COMPLETED|Overall Study||1
579415|NCT00561015|1411872|P3|NOT COMPLETED|Overall Study||0
579416|NCT00561015|1411873|P2|NOT COMPLETED|Overall Study||0
579417|NCT00561015|1411874|P1|NOT COMPLETED|Overall Study||4
579418|NCT00561015|1411869|P6|COMPLETED|Overall Study||6
579419|NCT00561015|1411870|P5|COMPLETED|Overall Study||8
579420|NCT00561015|1411871|P4|COMPLETED|Overall Study||7
579421|NCT00561015|1411872|P3|COMPLETED|Overall Study||9
579422|NCT00561015|1411873|P2|COMPLETED|Overall Study||5
579423|NCT00561015|1411874|P1|COMPLETED|Overall Study||5
579424|NCT00561015|1411869|P6|STARTED|Overall Study||9
579425|NCT00561015|1411870|P5|STARTED|Overall Study||9
579426|NCT00561015|1411871|P4|STARTED|Overall Study||8
579427|NCT00561015|1411872|P3|STARTED|Overall Study||9
579428|NCT00561015|1411873|P2|STARTED|Overall Study||5
579429|NCT00561015|1411874|P1|STARTED|Overall Study||9
579430|NCT00561002|1411950|P2|NOT COMPLETED|Overall Study||0
579431|NCT00561002|1411951|P1|NOT COMPLETED|Overall Study||0
579432|NCT00561002|1411950|P2|COMPLETED|Overall Study||9
579433|NCT00561002|1411951|P1|COMPLETED|Overall Study||23
579434|NCT00561002|1411950|P2|STARTED|Overall Study||9
579435|NCT00561002|1411951|P1|STARTED|Overall Study||23
579436|NCT00560950|1411965|P2|NOT COMPLETED|Overall Study||0
579437|NCT00560950|1411966|P1|NOT COMPLETED|Overall Study||1
579438|NCT00560950|1411965|P2|COMPLETED|Overall Study||71
579439|NCT00560950|1411966|P1|COMPLETED|Overall Study||71
579440|NCT00560950|1411965|P2|STARTED|Overall Study||71
579441|NCT00560950|1411966|P1|STARTED|Overall Study||72
579442|NCT00560937|1412004|P2|NOT COMPLETED|Overall Study||2
579443|NCT00560937|1412005|P1|NOT COMPLETED|Overall Study||1
579444|NCT00560937|1412004|P2|COMPLETED|Overall Study||9
579445|NCT00560937|1412005|P1|COMPLETED|Overall Study|One participant was withdrawn after 6 weeks and data were carried forward|9
579446|NCT00560937|1412004|P2|STARTED|Overall Study||11
579447|NCT00560937|1412005|P1|STARTED|Overall Study||10
579448|NCT00560885|1412021|P1|NOT COMPLETED|Overall Study||8
579449|NCT00560885|1412021|P1|COMPLETED|Overall Study||47
579450|NCT00560885|1412021|P1|2 Year Follow-up|Overall Study||47
579451|NCT00560885|1412021|P1|12 Month Follow-up|Overall Study|48 pts available for 12 month follow-up, 46 pts assessed|48
579452|NCT00560885|1412021|P1|6 Month Follow-up|Overall Study|50 pts available for 6 month follow-up, 50 pts assessed|50
579453|NCT00560885|1412021|P1|3 Month Follow-up|Overall Study|51 pts available for 3 month follow-up, 48 pts assessed.|51
579454|NCT00560885|1412021|P1|30 Day Follow-up|Overall Study|53 pts available for 30 day follow-up, 52 pts assessed|53
579455|NCT00560885|1412021|P1|STARTED|Overall Study||55
579456|NCT00560859|1412030|P2|NOT COMPLETED|Overall Study||24
579457|NCT00560859|1412031|P1|NOT COMPLETED|Overall Study||32
579458|NCT00560859|1412030|P2|COMPLETED|Overall Study||203
579459|NCT00560859|1412031|P1|COMPLETED|Overall Study||194
579460|NCT00560859|1412030|P2|STARTED|Overall Study||227
579461|NCT00560859|1412031|P1|STARTED|Overall Study||226
579462|NCT00560833|1412046|P5|NOT COMPLETED|Overall Study||42
579463|NCT00560833|1412047|P4|NOT COMPLETED|Overall Study||31
579464|NCT00560833|1412048|P3|NOT COMPLETED|Overall Study||39
579465|NCT00560833|1412049|P2|NOT COMPLETED|Overall Study||26
579466|NCT00560833|1412050|P1|NOT COMPLETED|Overall Study||44
579467|NCT00560833|1412046|P5|COMPLETED|Overall Study||114
579468|NCT00560833|1412047|P4|COMPLETED|Overall Study||124
579469|NCT00560833|1412048|P3|COMPLETED|Overall Study||121
579470|NCT00560833|1412049|P2|COMPLETED|Overall Study||129
579471|NCT00560833|1412050|P1|COMPLETED|Overall Study||273
579472|NCT00560833|1412046|P5|Treated|Overall Study|One participant was randomized but not treated|155
579473|NCT00560833|1412047|P4|Treated|Overall Study||155
579474|NCT00560833|1412048|P3|Treated|Overall Study||160
579475|NCT00560833|1412049|P2|Treated|Overall Study|One participant was randomized but not treated|154
579476|NCT00560833|1412050|P1|Treated|Overall Study|One participant was not randomized but was treated with placebo|317
579477|NCT00560833|1412046|P5|STARTED|Overall Study||156
579478|NCT00560833|1412047|P4|STARTED|Overall Study||155
579479|NCT00560833|1412048|P3|STARTED|Overall Study||160
579480|NCT00560833|1412049|P2|STARTED|Overall Study||155
579481|NCT00560833|1412050|P1|STARTED|Overall Study||317
579482|NCT00560794|1412082|P1|NOT COMPLETED|Overall Study||11
579483|NCT00560794|1412082|P1|COMPLETED|Overall Study||10
579484|NCT00560794|1412082|P1|Completed 1 Treatment Cycle|Overall Study||20
579485|NCT00560794|1412082|P1|STARTED|Overall Study||21
579486|NCT00560755|1412099|P1|NOT COMPLETED|Overall Study||60
579487|NCT00560755|1412099|P1|COMPLETED|Overall Study||3328
579488|NCT00560755|1412099|P1|ProQuad® Dose 1 and Dose 2|Overall Study||3346
579489|NCT00560755|1412099|P1|STARTED|Overall Study|Vaccinated (at least one ProQuad® dose)|3388
579490|NCT00560703|1412120|P2|NOT COMPLETED|Overall Study||6
579491|NCT00560703|1412121|P1|NOT COMPLETED|Overall Study||0
579492|NCT00560703|1412120|P2|COMPLETED|Overall Study||18
579493|NCT00560703|1412121|P1|COMPLETED|Overall Study||46
579494|NCT00560703|1412120|P2|STARTED|Overall Study||24
579495|NCT00560703|1412121|P1|STARTED|Overall Study||46
579496|NCT00560612|1412131|P2|NOT COMPLETED|Overall Study||0
579497|NCT00560612|1412132|P1|NOT COMPLETED|Overall Study||0
579498|NCT00560612|1412131|P2|COMPLETED|Overall Study||7
579499|NCT00560612|1412132|P1|COMPLETED|Overall Study||5
579500|NCT00560612|1412131|P2|STARTED|Overall Study||7
579501|NCT00560612|1412132|P1|STARTED|Overall Study||5
579502|NCT00560573|1412138|P6|NOT COMPLETED|Overall Study||13
579503|NCT00560573|1412139|P5|NOT COMPLETED|Overall Study||7
579504|NCT00560573|1412140|P4|NOT COMPLETED|Overall Study||10
579505|NCT00560573|1412141|P3|NOT COMPLETED|Overall Study||6
579506|NCT00560573|1412142|P2|NOT COMPLETED|Overall Study||3
579507|NCT00560573|1412143|P1|NOT COMPLETED|Overall Study||6
579508|NCT00560573|1412138|P6|COMPLETED|Overall Study||0
579509|NCT00560573|1412139|P5|COMPLETED|Overall Study||1
579510|NCT00560573|1412140|P4|COMPLETED|Overall Study||0
579511|NCT00560573|1412141|P3|COMPLETED|Overall Study||0
579512|NCT00560573|1412142|P2|COMPLETED|Overall Study||0
579513|NCT00560573|1412143|P1|COMPLETED|Overall Study||0
579514|NCT00560573|1412138|P6|Treated|Overall Study||13
579515|NCT00560573|1412139|P5|Treated|Overall Study||7
579516|NCT00560573|1412140|P4|Treated|Overall Study||10
579517|NCT00560573|1412141|P3|Treated|Overall Study||6
579518|NCT00560573|1412142|P2|Treated|Overall Study||3
579519|NCT00560573|1412143|P1|Treated|Overall Study||6
579520|NCT00560573|1412138|P6|STARTED|Overall Study||13
579521|NCT00560573|1412139|P5|STARTED|Overall Study||8
579522|NCT00560573|1412140|P4|STARTED|Overall Study||10
579523|NCT00560573|1412141|P3|STARTED|Overall Study||6
579524|NCT00560573|1412142|P2|STARTED|Overall Study||3
579525|NCT00560573|1412143|P1|STARTED|Overall Study||6
579526|NCT00560560|1412197|P2|NOT COMPLETED|Overall Study||83
579527|NCT00560560|1412198|P1|NOT COMPLETED|Overall Study||85
579528|NCT00560560|1412197|P2|COMPLETED|Overall Study||0
579529|NCT00560560|1412198|P1|COMPLETED|Overall Study||0
579530|NCT00560560|1412197|P2|STARTED|Overall Study||83
579531|NCT00560560|1412198|P1|STARTED|Overall Study||85
579532|NCT00560508|1412220|P2|NOT COMPLETED|52-week Open-label Period Pramipexole ER||11
579533|NCT00560508|1412221|P1|NOT COMPLETED|52-week Open-label Period Pramipexole ER||8
579534|NCT00560508|1412220|P2|COMPLETED|52-week Open-label Period Pramipexole ER||42
579535|NCT00560508|1412221|P1|COMPLETED|52-week Open-label Period Pramipexole ER||43
579536|NCT00560508|1412220|P2|STARTED|52-week Open-label Period Pramipexole ER|all patients received Pramipexole ER for the 52-week open-label period|53
579537|NCT00560508|1412221|P1|STARTED|52-week Open-label Period Pramipexole ER|all patients received Pramipexole ER for the 52-week open-label period|51
579538|NCT00560508|1412220|P2|NOT COMPLETED|12 Week Double-blind Period||3
579539|NCT00560508|1412221|P1|NOT COMPLETED|12 Week Double-blind Period||5
579540|NCT00560508|1412220|P2|COMPLETED|12 Week Double-blind Period||53
579541|NCT00560508|1412221|P1|COMPLETED|12 Week Double-blind Period||51
579542|NCT00560508|1412220|P2|STARTED|12 Week Double-blind Period||56
579543|NCT00560508|1412221|P1|STARTED|12 Week Double-blind Period||56
579544|NCT00560417|1412280|P2|NOT COMPLETED|Overall Study||17
579545|NCT00560417|1412281|P1|NOT COMPLETED|Overall Study||17
579546|NCT00560417|1412280|P2|COMPLETED|Overall Study||151
579547|NCT00560417|1412281|P1|COMPLETED|Overall Study||154
579548|NCT00560417|1412280|P2|Intention to Treat (ITT) Population|Overall Study||167
579549|NCT00560417|1412281|P1|Intention to Treat (ITT) Population|Overall Study||170
579550|NCT00560417|1412280|P2|STARTED|Overall Study||168
579551|NCT00560417|1412281|P1|STARTED|Overall Study||171
579552|NCT00560404|1412309|P2|NOT COMPLETED|Overall Study||21
579553|NCT00560404|1412310|P1|NOT COMPLETED|Overall Study||36
579554|NCT00560404|1412309|P2|COMPLETED|Overall Study||100
579555|NCT00560404|1412310|P1|COMPLETED|Overall Study||76
579556|NCT00560404|1412309|P2|STARTED|Overall Study||121
579557|NCT00560404|1412310|P1|STARTED|Overall Study||112
579558|NCT00560391|1412357|P5|NOT COMPLETED|Overall Study||2
579559|NCT00560391|1412358|P4|NOT COMPLETED|Overall Study||1
579560|NCT00560391|1412359|P3|NOT COMPLETED|Overall Study||0
579561|NCT00560391|1412360|P2|NOT COMPLETED|Overall Study||0
579562|NCT00560391|1412361|P1|NOT COMPLETED|Overall Study||0
579563|NCT00560391|1412357|P5|COMPLETED|Overall Study|Completed=offtreatment;Disease progression-6;Study drug toxicity-7; Unrelated AE-1,Subject request-1|15
579564|NCT00560391|1412358|P4|COMPLETED|Overall Study|Completed=off treatment; Disease progression-2; Unrelated AE 1 and Subject request 2|5
579565|NCT00560391|1412359|P3|COMPLETED|Overall Study|Completed=off treatment; Disease progression-1;Maximum clinical benefit-1; Unrelated AE-1|3
579566|NCT00560391|1412360|P2|COMPLETED|Overall Study|Completed=off treatment; Disease progression-1;Death-1; Unrelated AE-1|3
579567|NCT00560391|1412361|P1|COMPLETED|Overall Study|Completed=off treatment;Disease progression-1;Death-1;Max. clinical benefit-2;Study drug toxicity-2|6
579568|NCT00560391|1412357|P5|STARTED|Overall Study|Participants who received treatment|17
579569|NCT00560391|1412358|P4|STARTED|Overall Study|Participants who received treatment|6
579570|NCT00560391|1412359|P3|STARTED|Overall Study|Participants who received treatment|3
579571|NCT00560391|1412360|P2|STARTED|Overall Study|Participants who received treatment|3
579572|NCT00560391|1412361|P1|STARTED|Overall Study|Participants who received treatment|6
579573|NCT00560352|1412417|P3|NOT COMPLETED|Overall Study||4
579574|NCT00560352|1412418|P2|NOT COMPLETED|Overall Study||3
579575|NCT00560352|1412419|P1|NOT COMPLETED|Overall Study||7
579576|NCT00560352|1412417|P3|COMPLETED|Overall Study||0
579577|NCT00560352|1412418|P2|COMPLETED|Overall Study||0
579578|NCT00560352|1412419|P1|COMPLETED|Overall Study||0
579579|NCT00560352|1412417|P3|STARTED|Overall Study||4
579580|NCT00560352|1412418|P2|STARTED|Overall Study||3
579581|NCT00560352|1412419|P1|STARTED|Overall Study||7
579582|NCT00560313|1412436|P1|NOT COMPLETED|Overall Study||6
579583|NCT00560313|1412436|P1|COMPLETED|Overall Study||48
579584|NCT00560313|1412436|P1|STARTED|Overall Study||54
579585|NCT00560235|1412463|P3|NOT COMPLETED|Phase 2||97
579586|NCT00560235|1412464|P2|NOT COMPLETED|Phase 2||0
579587|NCT00560235|1412465|P1|NOT COMPLETED|Phase 2||0
579588|NCT00560235|1412463|P3|COMPLETED|Phase 2||10
579589|NCT00560235|1412464|P2|COMPLETED|Phase 2||0
579590|NCT00560235|1412465|P1|COMPLETED|Phase 2||0
579591|NCT00560235|1412463|P3|STARTED|Phase 2||107
579592|NCT00560235|1412464|P2|STARTED|Phase 2||0
579593|NCT00560235|1412465|P1|STARTED|Phase 2||0
579594|NCT00560235|1412463|P3|NOT COMPLETED|Phase 1B||0
579595|NCT00560235|1412464|P2|NOT COMPLETED|Phase 1B||19
579596|NCT00560235|1412465|P1|NOT COMPLETED|Phase 1B||0
579597|NCT00560235|1412463|P3|COMPLETED|Phase 1B||0
579598|NCT00560235|1412464|P2|COMPLETED|Phase 1B||2
579599|NCT00560235|1412465|P1|COMPLETED|Phase 1B||0
579600|NCT00560235|1412463|P3|STARTED|Phase 1B||0
579601|NCT00560235|1412464|P2|STARTED|Phase 1B||21
579602|NCT00560235|1412465|P1|STARTED|Phase 1B||0
579603|NCT00560235|1412463|P3|NOT COMPLETED|Phase 1||0
579604|NCT00560235|1412464|P2|NOT COMPLETED|Phase 1||0
579605|NCT00560235|1412465|P1|NOT COMPLETED|Phase 1||8
579606|NCT00560235|1412463|P3|COMPLETED|Phase 1||0
579607|NCT00560235|1412464|P2|COMPLETED|Phase 1||0
579608|NCT00560235|1412465|P1|COMPLETED|Phase 1||2
579609|NCT00560235|1412463|P3|STARTED|Phase 1||0
579610|NCT00560235|1412464|P2|STARTED|Phase 1||0
579611|NCT00560235|1412465|P1|STARTED|Phase 1||10
579612|NCT00560105|1412496|P2|NOT COMPLETED|Overall Study||2
579613|NCT00560105|1412497|P1|NOT COMPLETED|Overall Study||1
579614|NCT00560105|1412496|P2|COMPLETED|Overall Study||18
579615|NCT00560105|1412497|P1|COMPLETED|Overall Study||19
579616|NCT00560105|1412496|P2|STARTED|Overall Study||20
579617|NCT00560105|1412497|P1|STARTED|Overall Study||20
579618|NCT00560066|1412511|P2|NOT COMPLETED|Overall Study||22
579619|NCT00560066|1412512|P1|NOT COMPLETED|Overall Study||6
579620|NCT00560066|1412511|P2|COMPLETED|Overall Study||980
579621|NCT00560066|1412512|P1|COMPLETED|Overall Study||390
579622|NCT00560066|1412511|P2|STARTED|Overall Study||1002
579623|NCT00560066|1412512|P1|STARTED|Overall Study||396
579624|NCT00559988|1412544|P2|NOT COMPLETED|Overall Study||352
579625|NCT00559988|1412545|P1|NOT COMPLETED|Overall Study||351
579626|NCT00559988|1412544|P2|COMPLETED|Overall Study||1009
579627|NCT00559988|1412545|P1|COMPLETED|Overall Study||1006
579628|NCT00559988|1412544|P2|STARTED|Overall Study||1361
579629|NCT00559988|1412545|P1|STARTED|Overall Study||1357
579630|NCT00559962|1412575|P8|NOT COMPLETED|Overall Study||4
579631|NCT00559962|1412576|P7|NOT COMPLETED|Overall Study||5
579632|NCT00559962|1412577|P6|NOT COMPLETED|Overall Study||5
579633|NCT00559962|1412578|P5|NOT COMPLETED|Overall Study||14
579634|NCT00559962|1412579|P4|NOT COMPLETED|Overall Study||5
579635|NCT00559962|1412580|P3|NOT COMPLETED|Overall Study||10
579636|NCT00559962|1412581|P2|NOT COMPLETED|Overall Study||9
579637|NCT00559962|1412582|P1|NOT COMPLETED|Overall Study||2
579638|NCT00559962|1412575|P8|COMPLETED|Overall Study||25
579639|NCT00559962|1412576|P7|COMPLETED|Overall Study||28
579640|NCT00559962|1412577|P6|COMPLETED|Overall Study||23
579641|NCT00559962|1412578|P5|COMPLETED|Overall Study||21
579642|NCT00559962|1412579|P4|COMPLETED|Overall Study||29
579643|NCT00559962|1412580|P3|COMPLETED|Overall Study||24
579644|NCT00559962|1412581|P2|COMPLETED|Overall Study||25
579645|NCT00559962|1412582|P1|COMPLETED|Overall Study||31
579646|NCT00559962|1412575|P8|STARTED|Overall Study||29
579647|NCT00559962|1412576|P7|STARTED|Overall Study||33
579648|NCT00559962|1412577|P6|STARTED|Overall Study||28
579649|NCT00559962|1412578|P5|STARTED|Overall Study||35
579650|NCT00559962|1412579|P4|STARTED|Overall Study||34
579651|NCT00559962|1412580|P3|STARTED|Overall Study||34
579652|NCT00559962|1412581|P2|STARTED|Overall Study||34
579653|NCT00559962|1412582|P1|STARTED|Overall Study||33
579654|NCT00559949|1412602|P1|NOT COMPLETED|Overall Study||7
579655|NCT00559949|1412602|P1|COMPLETED|Overall Study||32
579656|NCT00559949|1412602|P1|STARTED|Overall Study||39
579657|NCT00559936|1412609|P1|NOT COMPLETED|Overall Study||4
579658|NCT00559936|1412609|P1|COMPLETED|Overall Study||20
579659|NCT00559936|1412609|P1|STARTED|Overall Study||24
579660|NCT00559897|1412614|P1|NOT COMPLETED|Overall Study||0
579661|NCT00559897|1412614|P1|COMPLETED|Overall Study||6
579662|NCT00559897|1412614|P1|STARTED|Overall Study||6
579663|NCT00559845|1412618|P1|NOT COMPLETED|Overall Study||7
579664|NCT00559845|1412618|P1|COMPLETED|Overall Study||49
579665|NCT00559845|1412618|P1|STARTED|Overall Study||56
579666|NCT00559754|1412627|P1|NOT COMPLETED|Overall Study||11
579667|NCT00559754|1412627|P1|COMPLETED|Overall Study||61
579668|NCT00559754|1412627|P1|STARTED|Overall Study||72
579669|NCT00559637|1412651|P1|NOT COMPLETED|Overall Study||54
579670|NCT00559637|1412651|P1|COMPLETED|Overall Study||130
579671|NCT00559637|1412651|P1|STARTED|Overall Study||184
579672|NCT00559585|1412664|P2|NOT COMPLETED|Open Label LT Period Main + Sub-Study||0
579673|NCT00559585|1412665|P1|NOT COMPLETED|Open Label LT Period Main + Sub-Study||428
579674|NCT00559585|1412664|P2|COMPLETED|Open Label LT Period Main + Sub-Study||0
579675|NCT00559585|1412665|P1|COMPLETED|Open Label LT Period Main + Sub-Study||945
579676|NCT00559585|1412664|P2|STARTED|Open Label LT Period Main + Sub-Study|IV administration was discontinued and abatacept was only administered SC during LT Period.|0
579677|NCT00559585|1412665|P1|STARTED|Open Label LT Period Main + Sub-Study|1373 includes 15 participants from ST Period Sub-Study who rolled over into LT Period (6 SC + 9 IV).|1373
579678|NCT00559585|1412664|P2|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1
579679|NCT00559585|1412665|P1|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1
579680|NCT00559585|1412664|P2|COMPLETED|Anti-TNF Sub-Study in ST Period||9
579681|NCT00559585|1412665|P1|COMPLETED|Anti-TNF Sub-Study in ST Period||7
579682|NCT00559585|1412664|P2|STARTED|Anti-TNF Sub-Study in ST Period|9 completed Sub-Study ST Period and 9 chose to over into the LT Period.|10
579683|NCT00559585|1412665|P1|STARTED|Anti-TNF Sub-Study in ST Period|7 completed Sub-Study ST period and 6 chose to roll over into LT Period.|8
579684|NCT00559585|1412664|P2|NOT COMPLETED|Double Blind ST Period Main Study||45
579685|NCT00559585|1412665|P1|NOT COMPLETED|Double Blind ST Period Main Study||43
579686|NCT00559585|1412664|P2|COMPLETED|Double Blind ST Period Main Study||676
579687|NCT00559585|1412665|P1|COMPLETED|Double Blind ST Period Main Study||693
579688|NCT00559585|1412664|P2|STARTED|Double Blind ST Period Main Study|Randomized and treated|721
579689|NCT00559585|1412665|P1|STARTED|Double Blind ST Period Main Study|Randomized and treated|736
579690|NCT00559507|1412725|P1|NOT COMPLETED|Overall Study||3
579691|NCT00559507|1412725|P1|COMPLETED|Overall Study||9
579692|NCT00559507|1412725|P1|STARTED|Overall Study||12
579693|NCT00559377|1412731|P1|NOT COMPLETED|Overall Study||9
579694|NCT00559377|1412731|P1|COMPLETED|Overall Study||7
579695|NCT00559377|1412731|P1|STARTED|Overall Study||16
579696|NCT00559364|1412741|P2|NOT COMPLETED|Overall Study||0
579697|NCT00559364|1412742|P1|NOT COMPLETED|Overall Study||1
579698|NCT00559364|1412741|P2|COMPLETED|Overall Study||20
579699|NCT00559364|1412742|P1|COMPLETED|Overall Study||29
579700|NCT00559364|1412741|P2|STARTED|Overall Study||20
579701|NCT00559364|1412742|P1|STARTED|Overall Study||30
579702|NCT00559273|1412754|P2|NOT COMPLETED|Evaluation Period (8 Weeks)||5
579703|NCT00559273|1412755|P1|NOT COMPLETED|Evaluation Period (8 Weeks)||3
579704|NCT00559273|1412754|P2|COMPLETED|Evaluation Period (8 Weeks)||137
579705|NCT00559273|1412755|P1|COMPLETED|Evaluation Period (8 Weeks)||141
579706|NCT00559273|1412754|P2|STARTED|Evaluation Period (8 Weeks)||142
579707|NCT00559273|1412755|P1|STARTED|Evaluation Period (8 Weeks)||144
579708|NCT00559273|1412754|P2|NOT COMPLETED|Correction Period (20 Weeks)||12
579709|NCT00559273|1412755|P1|NOT COMPLETED|Correction Period (20 Weeks)||9
579710|NCT00559273|1412754|P2|COMPLETED|Correction Period (20 Weeks)||142
579711|NCT00559273|1412755|P1|COMPLETED|Correction Period (20 Weeks)||144
579712|NCT00559273|1412754|P2|Treated|Correction Period (20 Weeks)||154
579713|NCT00559273|1412755|P1|Treated|Correction Period (20 Weeks)||151
579714|NCT00559273|1412754|P2|STARTED|Correction Period (20 Weeks)||154
579715|NCT00559273|1412755|P1|STARTED|Correction Period (20 Weeks)||153
579716|NCT00559104|1412777|P2|NOT COMPLETED|Overall Study||0
579717|NCT00559104|1412778|P1|NOT COMPLETED|Overall Study||9
579718|NCT00559104|1412777|P2|COMPLETED|Overall Study||5
579719|NCT00559104|1412778|P1|COMPLETED|Overall Study|Progression was the reason for off-treatment for 9 of 9 patients who went off of treatment.|46
579720|NCT00559104|1412777|P2|STARTED|Overall Study||5
579721|NCT00559104|1412778|P1|STARTED|Overall Study||55
579722|NCT00559013|1412788|P1|NOT COMPLETED|Overall Study||0
579723|NCT00559013|1412788|P1|COMPLETED|Overall Study||38
579724|NCT00559013|1412788|P1|STARTED|Overall Study||38
579725|NCT00558896|1412799|P7|NOT COMPLETED|Overall Study||24
579726|NCT00558896|1412800|P6|NOT COMPLETED|Overall Study||52
579727|NCT00558896|1412801|P5|NOT COMPLETED|Overall Study||23
579728|NCT00558896|1412802|P4|NOT COMPLETED|Overall Study||12
579729|NCT00558896|1412803|P3|NOT COMPLETED|Overall Study||5
579730|NCT00558896|1412804|P2|NOT COMPLETED|Overall Study||7
579731|NCT00558896|1412805|P1|NOT COMPLETED|Overall Study||21
579732|NCT00558896|1412799|P7|COMPLETED|Overall Study||9
579733|NCT00558896|1412800|P6|COMPLETED|Overall Study||68
579734|NCT00558896|1412801|P5|COMPLETED|Overall Study||37
579735|NCT00558896|1412802|P4|COMPLETED|Overall Study||23
579736|NCT00558896|1412803|P3|COMPLETED|Overall Study||30
579737|NCT00558896|1412804|P2|COMPLETED|Overall Study||27
579738|NCT00558896|1412805|P1|COMPLETED|Overall Study||39
579739|NCT00558896|1412799|P7|STARTED|Overall Study||33
579740|NCT00558896|1412800|P6|STARTED|Overall Study||120
579741|NCT00558896|1412801|P5|STARTED|Overall Study||60
579742|NCT00558896|1412802|P4|STARTED|Overall Study||35
579743|NCT00558896|1412803|P3|STARTED|Overall Study||35
579744|NCT00558896|1412804|P2|STARTED|Overall Study||34
579745|NCT00558896|1412805|P1|STARTED|Overall Study||60
579746|NCT00558870|1412837|P2|NOT COMPLETED|Overall Study||0
579747|NCT00558870|1412838|P1|NOT COMPLETED|Overall Study||0
579748|NCT00558870|1412837|P2|COMPLETED|Overall Study||2
579749|NCT00558870|1412838|P1|COMPLETED|Overall Study||2
579750|NCT00558870|1412837|P2|STARTED|Overall Study||2
579751|NCT00558870|1412838|P1|STARTED|Overall Study||2
579752|NCT00558831|1412846|P1|NOT COMPLETED|Overall Study||1
579753|NCT00558831|1412846|P1|COMPLETED|Overall Study||10
579754|NCT00558831|1412846|P1|STARTED|Overall Study||11
579755|NCT00558792|1412855|P3|NOT COMPLETED|Overall Study||0
579756|NCT00558792|1412856|P2|NOT COMPLETED|Overall Study||0
579757|NCT00558792|1412857|P1|NOT COMPLETED|Overall Study||0
579758|NCT00558792|1412855|P3|COMPLETED|Overall Study||60
579759|NCT00558792|1412856|P2|COMPLETED|Overall Study||63
579760|NCT00558792|1412857|P1|COMPLETED|Overall Study||68
579761|NCT00558792|1412855|P3|STARTED|Overall Study||60
579762|NCT00558792|1412856|P2|STARTED|Overall Study||63
579763|NCT00558792|1412857|P1|STARTED|Overall Study||68
579764|NCT00558753|1412903|P2|NOT COMPLETED|Overall Study||7
579765|NCT00558753|1412904|P1|NOT COMPLETED|Overall Study||5
579766|NCT00558753|1412903|P2|COMPLETED|Overall Study||113
579767|NCT00558753|1412904|P1|COMPLETED|Overall Study||115
579768|NCT00558753|1412903|P2|STARTED|Overall Study||120
579769|NCT00558753|1412904|P1|STARTED|Overall Study||120
579770|NCT00558701|1412916|P2|NOT COMPLETED|Overall Study||4
579771|NCT00558701|1412917|P1|NOT COMPLETED|Overall Study||1
579772|NCT00558701|1412916|P2|COMPLETED|Overall Study||11
579773|NCT00558701|1412917|P1|COMPLETED|Overall Study||14
579774|NCT00558701|1412916|P2|STARTED|Overall Study||15
579775|NCT00558701|1412917|P1|STARTED|Overall Study||15
579776|NCT00558636|1412925|P2|NOT COMPLETED|Follow-up||7
579777|NCT00558636|1412926|P1|NOT COMPLETED|Follow-up||12
579778|NCT00558636|1412925|P2|COMPLETED|Follow-up|Study was prematurely terminated|0
579779|NCT00558636|1412926|P1|COMPLETED|Follow-up|Study was prematurely terminated|0
579780|NCT00558636|1412925|P2|STARTED|Follow-up|7 subjects entered Follow-up phase before they completed the treatment phase|7
579781|NCT00558636|1412926|P1|STARTED|Follow-up|12 subjects entered Follow-up phase before they completed the treatment phase|12
579782|NCT00558636|1412925|P2|NOT COMPLETED|Treatment||44
579783|NCT00558636|1412926|P1|NOT COMPLETED|Treatment||47
579784|NCT00558636|1412925|P2|COMPLETED|Treatment|Patients still on treatment did not enter follow-up because the study was prematurely terminated|0
579785|NCT00558636|1412926|P1|COMPLETED|Treatment|Patients still on treatment did not enter follow-up because the study was prematurely terminated|0
579786|NCT00558636|1412925|P2|Start of Maintenance Monotherapy|Treatment|Placebo taken as the single agent in the Maintenance Phase|2
579787|NCT00558636|1412926|P1|Start of Maintenance Monotherapy|Treatment|Sorafenib taken as the single agent in the Maintenance Phase|2
579788|NCT00558636|1412925|P2|STARTED|Treatment||44
579789|NCT00558636|1412926|P1|STARTED|Treatment|up to 6 cycles of combination therapy|47
579790|NCT00558571|1412948|P4|NOT COMPLETED|Overall Study||0
579791|NCT00558571|1412949|P3|NOT COMPLETED|Overall Study||0
579792|NCT00558571|1412950|P2|NOT COMPLETED|Overall Study||0
579793|NCT00558571|1412951|P1|NOT COMPLETED|Overall Study||0
579794|NCT00558571|1412948|P4|COMPLETED|Overall Study||30
579795|NCT00558571|1412949|P3|COMPLETED|Overall Study||16
579796|NCT00558571|1412950|P2|COMPLETED|Overall Study||16
579797|NCT00558571|1412951|P1|COMPLETED|Overall Study||16
579798|NCT00558571|1412948|P4|STARTED|Overall Study||30
579799|NCT00558571|1412949|P3|STARTED|Overall Study||16
579800|NCT00558571|1412950|P2|STARTED|Overall Study||16
579801|NCT00558571|1412951|P1|STARTED|Overall Study||16
579802|NCT00558558|1413026|P1|NOT COMPLETED|Overall Study||6
579803|NCT00558558|1413026|P1|COMPLETED|Overall Study||0
579804|NCT00558558|1413026|P1|STARTED|Overall Study||6
579805|NCT00558467|1413032|P2|NOT COMPLETED|Overall Study||4
579806|NCT00558467|1413033|P1|NOT COMPLETED|Overall Study||1
579807|NCT00558467|1413032|P2|COMPLETED|Overall Study||39
579808|NCT00558467|1413033|P1|COMPLETED|Overall Study||19
579809|NCT00558467|1413032|P2|STARTED|Overall Study||43
579810|NCT00558467|1413033|P1|STARTED|Overall Study||20
579811|NCT00558428|1413093|P4|NOT COMPLETED|Overall Study||11
579812|NCT00558428|1413094|P3|NOT COMPLETED|Overall Study||4
579813|NCT00558428|1413095|P2|NOT COMPLETED|Overall Study||24
579814|NCT00558428|1413096|P1|NOT COMPLETED|Overall Study||12
579815|NCT00558428|1413093|P4|COMPLETED|Overall Study||266
579816|NCT00558428|1413094|P3|COMPLETED|Overall Study||273
579817|NCT00558428|1413095|P2|COMPLETED|Overall Study||252
579818|NCT00558428|1413096|P1|COMPLETED|Overall Study||255
579819|NCT00558428|1413093|P4|STARTED|Overall Study||277
579820|NCT00558428|1413094|P3|STARTED|Overall Study||277
579821|NCT00558428|1413095|P2|STARTED|Overall Study||276
579822|NCT00558428|1413096|P1|STARTED|Overall Study||267
579823|NCT00558363|1413136|P2|NOT COMPLETED|Overall Study||36
579824|NCT00558363|1413137|P1|NOT COMPLETED|Overall Study||71
579825|NCT00558363|1413136|P2|COMPLETED|Overall Study||111
579826|NCT00558363|1413137|P1|COMPLETED|Overall Study||76
579827|NCT00558363|1413136|P2|STARTED|Overall Study||147
579828|NCT00558363|1413137|P1|STARTED|Overall Study||147
579829|NCT00558285|1413192|P5|NOT COMPLETED|Overall Study||4
579830|NCT00558285|1413193|P4|NOT COMPLETED|Overall Study||4
579831|NCT00558285|1413194|P3|NOT COMPLETED|Overall Study||5
579832|NCT00558285|1413195|P2|NOT COMPLETED|Overall Study||3
579833|NCT00558285|1413196|P1|NOT COMPLETED|Overall Study||6
579834|NCT00558285|1413192|P5|COMPLETED|Overall Study||49
579835|NCT00558285|1413193|P4|COMPLETED|Overall Study||48
579836|NCT00558285|1413194|P3|COMPLETED|Overall Study||46
579837|NCT00558285|1413195|P2|COMPLETED|Overall Study||48
579838|NCT00558285|1413196|P1|COMPLETED|Overall Study||44
579839|NCT00558285|1413192|P5|Safety: Received Study Drug|Overall Study||53
579840|NCT00558285|1413193|P4|Safety: Received Study Drug|Overall Study||51
579841|NCT00558285|1413194|P3|Safety: Received Study Drug|Overall Study||51
579842|NCT00558285|1413195|P2|Safety: Received Study Drug|Overall Study||51
579843|NCT00558285|1413196|P1|Safety: Received Study Drug|Overall Study||49
579844|NCT00558285|1413192|P5|STARTED|Overall Study||53
579845|NCT00558285|1413193|P4|STARTED|Overall Study||52
579846|NCT00558285|1413194|P3|STARTED|Overall Study||51
579847|NCT00558285|1413195|P2|STARTED|Overall Study||51
579848|NCT00558285|1413196|P1|STARTED|Overall Study||50
579849|NCT00558272|1413240|P2|NOT COMPLETED|Overall Study||2
579850|NCT00558272|1413241|P1|NOT COMPLETED|Overall Study||13
579851|NCT00558272|1413240|P2|COMPLETED|Overall Study|4-week treatment period|68
579852|NCT00558272|1413241|P1|COMPLETED|Overall Study|4-week treatment period|56
579853|NCT00558272|1413240|P2|30 Days Follow-up|Overall Study|30 days after last dose|67
579854|NCT00558272|1413241|P1|30 Days Follow-up|Overall Study|30 days after last dose|41
579855|NCT00558272|1413240|P2|STARTED|Overall Study|Randomised|70
579856|NCT00558272|1413241|P1|STARTED|Overall Study|Randomised|69
579857|NCT00558259|1413281|P2|NOT COMPLETED|Overall Study||99
579858|NCT00558259|1413282|P1|NOT COMPLETED|Overall Study||71
579859|NCT00558259|1413281|P2|COMPLETED|Overall Study|Completed treatment.|563
579860|NCT00558259|1413282|P1|COMPLETED|Overall Study|Completed treatment.|610
579861|NCT00558259|1413281|P2|STARTED|Overall Study|Number who started treatment. There were 6 patients randomised to placebo and not treated.|662
579862|NCT00558259|1413282|P1|STARTED|Overall Study|Number who started treatment. There were 4 patients randomised to Dabigatran and not treated.|681
579863|NCT00558246|1413302|P1|NOT COMPLETED|Overall Study||0
579864|NCT00558246|1413302|P1|COMPLETED|Overall Study||79
579865|NCT00558246|1413302|P1|STARTED|Overall Study||79
579866|NCT00558103|1413322|P6|NOT COMPLETED|Monotherapy Extension Phase||9
579867|NCT00558103|1413323|P5|NOT COMPLETED|Monotherapy Extension Phase||0
579868|NCT00558103|1413324|P4|NOT COMPLETED|Monotherapy Extension Phase||0
579869|NCT00558103|1413325|P3|NOT COMPLETED|Monotherapy Extension Phase||0
579870|NCT00558103|1413326|P2|NOT COMPLETED|Monotherapy Extension Phase||0
579871|NCT00558103|1413327|P1|NOT COMPLETED|Monotherapy Extension Phase||0
579872|NCT00558103|1413322|P6|COMPLETED|Monotherapy Extension Phase||0
579873|NCT00558103|1413323|P5|COMPLETED|Monotherapy Extension Phase||0
579874|NCT00558103|1413324|P4|COMPLETED|Monotherapy Extension Phase||0
579875|NCT00558103|1413325|P3|COMPLETED|Monotherapy Extension Phase||0
579876|NCT00558103|1413326|P2|COMPLETED|Monotherapy Extension Phase||0
579877|NCT00558103|1413327|P1|COMPLETED|Monotherapy Extension Phase||0
579878|NCT00558103|1413322|P6|STARTED|Monotherapy Extension Phase|9/11 participants completing pazopanib monotherapy elected to receive lapatinib monotherapy.|9
579879|NCT00558103|1413323|P5|STARTED|Monotherapy Extension Phase||0
579880|NCT00558103|1413324|P4|STARTED|Monotherapy Extension Phase||0
579881|NCT00558103|1413325|P3|STARTED|Monotherapy Extension Phase||0
579882|NCT00558103|1413326|P2|STARTED|Monotherapy Extension Phase||0
579883|NCT00558103|1413327|P1|STARTED|Monotherapy Extension Phase||0
579884|NCT00558103|1413322|P6|NOT COMPLETED|Randomized Treatment Phase||0
579885|NCT00558103|1413323|P5|NOT COMPLETED|Randomized Treatment Phase||5
579886|NCT00558103|1413324|P4|NOT COMPLETED|Randomized Treatment Phase||2
579887|NCT00558103|1413325|P3|NOT COMPLETED|Randomized Treatment Phase||3
579888|NCT00558103|1413326|P2|NOT COMPLETED|Randomized Treatment Phase||4
579889|NCT00558103|1413327|P1|NOT COMPLETED|Randomized Treatment Phase||5
579890|NCT00558103|1413322|P6|COMPLETED|Randomized Treatment Phase||0
579891|NCT00558103|1413323|P5|COMPLETED|Randomized Treatment Phase||33
579892|NCT00558103|1413324|P4|COMPLETED|Randomized Treatment Phase||11
579893|NCT00558103|1413325|P3|COMPLETED|Randomized Treatment Phase||33
579894|NCT00558103|1413326|P2|COMPLETED|Randomized Treatment Phase||34
579895|NCT00558103|1413327|P1|COMPLETED|Randomized Treatment Phase||33
579896|NCT00558103|1413322|P6|STARTED|Randomized Treatment Phase||0
579897|NCT00558103|1413323|P5|STARTED|Randomized Treatment Phase||38
579898|NCT00558103|1413324|P4|STARTED|Randomized Treatment Phase||13
579899|NCT00558103|1413325|P3|STARTED|Randomized Treatment Phase||36
579900|NCT00558103|1413326|P2|STARTED|Randomized Treatment Phase||38
579901|NCT00558103|1413327|P1|STARTED|Randomized Treatment Phase||38
579902|NCT00558064|1413357|P2|NOT COMPLETED|Overall Study||5
579903|NCT00558064|1413358|P1|NOT COMPLETED|Overall Study||5
579904|NCT00558064|1413357|P2|COMPLETED|Overall Study||257
579905|NCT00558064|1413358|P1|COMPLETED|Overall Study||264
579906|NCT00558064|1413357|P2|STARTED|Overall Study||262
579907|NCT00558064|1413358|P1|STARTED|Overall Study||269
579908|NCT00558025|1413380|P2|NOT COMPLETED|Overall Study||3
579909|NCT00558025|1413381|P1|NOT COMPLETED|Overall Study||4
579910|NCT00558025|1413380|P2|COMPLETED|Overall Study||49
579911|NCT00558025|1413381|P1|COMPLETED|Overall Study||100
579912|NCT00558025|1413380|P2|STARTED|Overall Study||52
579913|NCT00558025|1413381|P1|STARTED|Overall Study||104
579914|NCT00558012|1413405|P2|NOT COMPLETED|Overall Study||18
579915|NCT00558012|1413406|P1|NOT COMPLETED|Overall Study||25
579916|NCT00558012|1413405|P2|COMPLETED|Overall Study||74
579917|NCT00558012|1413406|P1|COMPLETED|Overall Study||64
579918|NCT00558012|1413405|P2|STARTED|Overall Study||92
579919|NCT00558012|1413406|P1|STARTED|Overall Study||89
579920|NCT00557947|1413412|P1|NOT COMPLETED|Overall Study||0
579921|NCT00557947|1413412|P1|COMPLETED|Overall Study||83
579922|NCT00557947|1413412|P1|STARTED|Overall Study||83
579923|NCT00557856|1413428|P9|NOT COMPLETED|Part 2: Exploratory Phase||24
579924|NCT00557856|1413429|P8|NOT COMPLETED|Part 2: Exploratory Phase||0
579925|NCT00557856|1413430|P7|NOT COMPLETED|Part 2: Exploratory Phase||0
579926|NCT00557856|1413431|P6|NOT COMPLETED|Part 2: Exploratory Phase||0
579927|NCT00557856|1413432|P5|NOT COMPLETED|Part 2: Exploratory Phase||0
579928|NCT00557856|1413433|P4|NOT COMPLETED|Part 2: Exploratory Phase||0
579929|NCT00557856|1413434|P3|NOT COMPLETED|Part 2: Exploratory Phase||0
579930|NCT00557856|1413435|P2|NOT COMPLETED|Part 2: Exploratory Phase||0
579931|NCT00557856|1413436|P1|NOT COMPLETED|Part 2: Exploratory Phase||0
579932|NCT00557856|1413428|P9|COMPLETED|Part 2: Exploratory Phase||0
579933|NCT00557856|1413429|P8|COMPLETED|Part 2: Exploratory Phase||0
579934|NCT00557856|1413430|P7|COMPLETED|Part 2: Exploratory Phase||0
579935|NCT00557856|1413431|P6|COMPLETED|Part 2: Exploratory Phase||0
579936|NCT00557856|1413432|P5|COMPLETED|Part 2: Exploratory Phase||0
579937|NCT00557856|1413433|P4|COMPLETED|Part 2: Exploratory Phase||0
579938|NCT00557856|1413434|P3|COMPLETED|Part 2: Exploratory Phase||0
579939|NCT00557856|1413435|P2|COMPLETED|Part 2: Exploratory Phase||0
579940|NCT00557856|1413436|P1|COMPLETED|Part 2: Exploratory Phase||0
579941|NCT00557856|1413428|P9|STARTED|Part 2: Exploratory Phase||24
579942|NCT00557856|1413429|P8|STARTED|Part 2: Exploratory Phase||0
579943|NCT00557856|1413430|P7|STARTED|Part 2: Exploratory Phase||0
579944|NCT00557856|1413431|P6|STARTED|Part 2: Exploratory Phase||0
579945|NCT00557856|1413432|P5|STARTED|Part 2: Exploratory Phase||0
579946|NCT00557856|1413433|P4|STARTED|Part 2: Exploratory Phase||0
579947|NCT00557856|1413434|P3|STARTED|Part 2: Exploratory Phase||0
579948|NCT00557856|1413435|P2|STARTED|Part 2: Exploratory Phase||0
579949|NCT00557856|1413436|P1|STARTED|Part 2: Exploratory Phase||0
579950|NCT00557856|1413428|P9|NOT COMPLETED|Part 1: Dose Escalation Phase||0
579951|NCT00557856|1413429|P8|NOT COMPLETED|Part 1: Dose Escalation Phase||6
579952|NCT00557856|1413430|P7|NOT COMPLETED|Part 1: Dose Escalation Phase||7
579953|NCT00557856|1413431|P6|NOT COMPLETED|Part 1: Dose Escalation Phase||8
579954|NCT00557856|1413432|P5|NOT COMPLETED|Part 1: Dose Escalation Phase||4
579955|NCT00557856|1413433|P4|NOT COMPLETED|Part 1: Dose Escalation Phase||3
579956|NCT00557856|1413434|P3|NOT COMPLETED|Part 1: Dose Escalation Phase||6
579957|NCT00557856|1413435|P2|NOT COMPLETED|Part 1: Dose Escalation Phase||5
579958|NCT00557856|1413436|P1|NOT COMPLETED|Part 1: Dose Escalation Phase||7
579959|NCT00557856|1413428|P9|COMPLETED|Part 1: Dose Escalation Phase||0
579960|NCT00557856|1413429|P8|COMPLETED|Part 1: Dose Escalation Phase||0
579961|NCT00557856|1413430|P7|COMPLETED|Part 1: Dose Escalation Phase||0
579962|NCT00557856|1413431|P6|COMPLETED|Part 1: Dose Escalation Phase||0
579963|NCT00557856|1413432|P5|COMPLETED|Part 1: Dose Escalation Phase||0
579964|NCT00557856|1413433|P4|COMPLETED|Part 1: Dose Escalation Phase||0
579965|NCT00557856|1413434|P3|COMPLETED|Part 1: Dose Escalation Phase||0
579966|NCT00557856|1413435|P2|COMPLETED|Part 1: Dose Escalation Phase||0
579967|NCT00557856|1413436|P1|COMPLETED|Part 1: Dose Escalation Phase||0
579968|NCT00557856|1413428|P9|Treated|Part 1: Dose Escalation Phase||0
579969|NCT00557856|1413429|P8|Treated|Part 1: Dose Escalation Phase||6
579970|NCT00557856|1413430|P7|Treated|Part 1: Dose Escalation Phase||7
579971|NCT00557856|1413431|P6|Treated|Part 1: Dose Escalation Phase||8
579972|NCT00557856|1413432|P5|Treated|Part 1: Dose Escalation Phase||4
579973|NCT00557856|1413433|P4|Treated|Part 1: Dose Escalation Phase||3
579974|NCT00557856|1413434|P3|Treated|Part 1: Dose Escalation Phase||6
579975|NCT00557856|1413435|P2|Treated|Part 1: Dose Escalation Phase||5
579976|NCT00557856|1413436|P1|Treated|Part 1: Dose Escalation Phase||5
579977|NCT00557856|1413428|P9|STARTED|Part 1: Dose Escalation Phase||0
579978|NCT00557856|1413429|P8|STARTED|Part 1: Dose Escalation Phase||6
579979|NCT00557856|1413430|P7|STARTED|Part 1: Dose Escalation Phase||7
579980|NCT00557856|1413431|P6|STARTED|Part 1: Dose Escalation Phase||8
579981|NCT00557856|1413432|P5|STARTED|Part 1: Dose Escalation Phase||4
579982|NCT00557856|1413433|P4|STARTED|Part 1: Dose Escalation Phase||3
579983|NCT00557856|1413434|P3|STARTED|Part 1: Dose Escalation Phase||6
579984|NCT00557856|1413435|P2|STARTED|Part 1: Dose Escalation Phase||5
579985|NCT00557856|1413436|P1|STARTED|Part 1: Dose Escalation Phase||7
579986|NCT00557830|1413635|P3|NOT COMPLETED|Treatment Phase||0
579987|NCT00557830|1413636|P2|NOT COMPLETED|Treatment Phase||0
579988|NCT00557830|1413637|P1|NOT COMPLETED|Treatment Phase||0
579989|NCT00557830|1413635|P3|COMPLETED|Treatment Phase||2
579990|NCT00557830|1413636|P2|COMPLETED|Treatment Phase||4
579991|NCT00557830|1413637|P1|COMPLETED|Treatment Phase||0
579992|NCT00557830|1413635|P3|STARTED|Treatment Phase||2
579993|NCT00557830|1413636|P2|STARTED|Treatment Phase||4
579994|NCT00557830|1413637|P1|STARTED|Treatment Phase||0
579995|NCT00557830|1413635|P3|NOT COMPLETED|Screening Treatment Phase||0
579996|NCT00557830|1413636|P2|NOT COMPLETED|Screening Treatment Phase||0
579997|NCT00557830|1413637|P1|NOT COMPLETED|Screening Treatment Phase||6
579998|NCT00557830|1413635|P3|COMPLETED|Screening Treatment Phase||0
579999|NCT00557830|1413636|P2|COMPLETED|Screening Treatment Phase||0
580000|NCT00557830|1413637|P1|COMPLETED|Screening Treatment Phase||6
580001|NCT00557830|1413635|P3|STARTED|Screening Treatment Phase||0
580002|NCT00557830|1413636|P2|STARTED|Screening Treatment Phase||0
580003|NCT00557830|1413637|P1|STARTED|Screening Treatment Phase||12
580004|NCT00557622|1413659|P2|NOT COMPLETED|12-Week Treatment Phase||1
580005|NCT00557622|1413660|P1|NOT COMPLETED|12-Week Treatment Phase||0
580006|NCT00557622|1413659|P2|COMPLETED|12-Week Treatment Phase||1
580007|NCT00557622|1413660|P1|COMPLETED|12-Week Treatment Phase||1
580008|NCT00557622|1413659|P2|STARTED|12-Week Treatment Phase||2
580009|NCT00557622|1413660|P1|STARTED|12-Week Treatment Phase||1
580010|NCT00557622|1413659|P2|NOT COMPLETED|4-Week Run-in Phase||0
580011|NCT00557622|1413660|P1|NOT COMPLETED|4-Week Run-in Phase||2
580012|NCT00557622|1413659|P2|COMPLETED|4-Week Run-in Phase||0
580013|NCT00557622|1413660|P1|COMPLETED|4-Week Run-in Phase||3
580014|NCT00557622|1413659|P2|STARTED|4-Week Run-in Phase||0
580015|NCT00557622|1413660|P1|STARTED|4-Week Run-in Phase||5
580016|NCT00557505|1413689|P9|NOT COMPLETED|Overall Study||17
580017|NCT00557505|1413690|P8|NOT COMPLETED|Overall Study||5
580018|NCT00557505|1413691|P7|NOT COMPLETED|Overall Study||3
580019|NCT00557505|1413692|P6|NOT COMPLETED|Overall Study||3
580020|NCT00557505|1413693|P5|NOT COMPLETED|Overall Study||2
580021|NCT00557505|1413694|P4|NOT COMPLETED|Overall Study||3
580022|NCT00557505|1413695|P3|NOT COMPLETED|Overall Study||4
580023|NCT00557505|1413696|P2|NOT COMPLETED|Overall Study||3
580024|NCT00557505|1413697|P1|NOT COMPLETED|Overall Study||3
580025|NCT00557505|1413689|P9|COMPLETED|Overall Study||0
580026|NCT00557505|1413690|P8|COMPLETED|Overall Study||0
580027|NCT00557505|1413691|P7|COMPLETED|Overall Study||0
580028|NCT00557505|1413692|P6|COMPLETED|Overall Study||0
580029|NCT00557505|1413693|P5|COMPLETED|Overall Study||0
580030|NCT00557505|1413694|P4|COMPLETED|Overall Study||0
580031|NCT00557505|1413695|P3|COMPLETED|Overall Study||0
580032|NCT00557505|1413696|P2|COMPLETED|Overall Study||0
580033|NCT00557505|1413697|P1|COMPLETED|Overall Study||0
580034|NCT00557505|1413689|P9|STARTED|Overall Study||17
580035|NCT00557505|1413690|P8|STARTED|Overall Study||5
580036|NCT00557505|1413691|P7|STARTED|Overall Study||3
580037|NCT00557505|1413692|P6|STARTED|Overall Study||3
580038|NCT00557505|1413693|P5|STARTED|Overall Study||2
580039|NCT00557505|1413694|P4|STARTED|Overall Study||3
580040|NCT00557505|1413695|P3|STARTED|Overall Study||4
580041|NCT00557505|1413696|P2|STARTED|Overall Study||3
580042|NCT00557505|1413697|P1|STARTED|Overall Study||3
580043|NCT00557492|1413861|P1|NOT COMPLETED|Overall Study||1
580044|NCT00557492|1413861|P1|COMPLETED|Overall Study|Evaluable for outcomes|58
580045|NCT00557492|1413861|P1|STARTED|Overall Study||59
580046|NCT00557466|1413879|P6|NOT COMPLETED|Overall Study||6
580047|NCT00557466|1413880|P5|NOT COMPLETED|Overall Study||3
580048|NCT00557466|1413881|P4|NOT COMPLETED|Overall Study||4
580049|NCT00557466|1413882|P3|NOT COMPLETED|Overall Study||6
580050|NCT00557466|1413883|P2|NOT COMPLETED|Overall Study||5
580051|NCT00557466|1413884|P1|NOT COMPLETED|Overall Study||4
580052|NCT00557466|1413879|P6|COMPLETED|Overall Study||85
580053|NCT00557466|1413880|P5|COMPLETED|Overall Study||87
580054|NCT00557466|1413881|P4|COMPLETED|Overall Study||92
580055|NCT00557466|1413882|P3|COMPLETED|Overall Study||95
580056|NCT00557466|1413883|P2|COMPLETED|Overall Study||87
580057|NCT00557466|1413884|P1|COMPLETED|Overall Study||94
580058|NCT00557466|1413879|P6|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|89
580059|NCT00557466|1413880|P5|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|87
580060|NCT00557466|1413881|P4|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|93
580061|NCT00557466|1413882|P3|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|98
580062|NCT00557466|1413883|P2|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|91
580063|NCT00557466|1413884|P1|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|98
580064|NCT00557466|1413879|P6|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|91
580065|NCT00557466|1413880|P5|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|90
580066|NCT00557466|1413881|P4|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|96
580067|NCT00557466|1413882|P3|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|101
580068|NCT00557466|1413883|P2|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|92
580069|NCT00557466|1413884|P1|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|98
580070|NCT00557466|1413879|P6|STARTED|Overall Study||91
580071|NCT00557466|1413880|P5|STARTED|Overall Study||90
580072|NCT00557466|1413881|P4|STARTED|Overall Study||96
580073|NCT00557466|1413882|P3|STARTED|Overall Study||101
580074|NCT00557466|1413883|P2|STARTED|Overall Study||92
580075|NCT00557466|1413884|P1|STARTED|Overall Study||98
580076|NCT00557440|1413937|P3|NOT COMPLETED|Treatment Period 3||0
580077|NCT00557440|1413938|P2|NOT COMPLETED|Treatment Period 3||0
580078|NCT00557440|1413939|P1|NOT COMPLETED|Treatment Period 3||0
580079|NCT00557440|1413937|P3|COMPLETED|Treatment Period 3||12
580080|NCT00557440|1413938|P2|COMPLETED|Treatment Period 3||12
580081|NCT00557440|1413939|P1|COMPLETED|Treatment Period 3||12
580082|NCT00557440|1413937|P3|STARTED|Treatment Period 3||12
580083|NCT00557440|1413938|P2|STARTED|Treatment Period 3||12
580084|NCT00557440|1413939|P1|STARTED|Treatment Period 3||12
580085|NCT00557440|1413937|P3|NOT COMPLETED|Treatment Period 2||0
580086|NCT00557440|1413938|P2|NOT COMPLETED|Treatment Period 2||0
580087|NCT00557440|1413939|P1|NOT COMPLETED|Treatment Period 2||0
580088|NCT00557440|1413937|P3|COMPLETED|Treatment Period 2||12
580089|NCT00557440|1413938|P2|COMPLETED|Treatment Period 2||12
580090|NCT00557440|1413939|P1|COMPLETED|Treatment Period 2||12
580091|NCT00557440|1413937|P3|STARTED|Treatment Period 2||12
580092|NCT00557440|1413938|P2|STARTED|Treatment Period 2||12
580093|NCT00557440|1413939|P1|STARTED|Treatment Period 2||12
580094|NCT00557440|1413937|P3|NOT COMPLETED|Treatment Period 1||1
580095|NCT00557440|1413938|P2|NOT COMPLETED|Treatment Period 1||0
580096|NCT00557440|1413939|P1|NOT COMPLETED|Treatment Period 1||0
580097|NCT00557440|1413937|P3|COMPLETED|Treatment Period 1||12
580098|NCT00557440|1413938|P2|COMPLETED|Treatment Period 1||12
580099|NCT00557440|1413939|P1|COMPLETED|Treatment Period 1||12
580100|NCT00557440|1413937|P3|STARTED|Treatment Period 1||13
580101|NCT00557440|1413938|P2|STARTED|Treatment Period 1||12
580102|NCT00557440|1413939|P1|STARTED|Treatment Period 1||12
580103|NCT00557362|1413963|P4|NOT COMPLETED|Overall Study||3
580104|NCT00557362|1413964|P3|NOT COMPLETED|Overall Study||4
580105|NCT00557362|1413965|P2|NOT COMPLETED|Overall Study||2
580106|NCT00557362|1413966|P1|NOT COMPLETED|Overall Study||2
580107|NCT00557362|1413963|P4|COMPLETED|Overall Study||27
580108|NCT00557362|1413964|P3|COMPLETED|Overall Study||26
580109|NCT00557362|1413965|P2|COMPLETED|Overall Study||28
580110|NCT00557362|1413966|P1|COMPLETED|Overall Study||28
580111|NCT00557362|1413963|P4|STARTED|Overall Study||30
580112|NCT00557362|1413964|P3|STARTED|Overall Study||30
580113|NCT00557362|1413965|P2|STARTED|Overall Study||30
580114|NCT00557362|1413966|P1|STARTED|Overall Study||30
580115|NCT00557349|1413984|P2|NOT COMPLETED|Overall Study||5
580116|NCT00557349|1413985|P1|NOT COMPLETED|Overall Study||5
580117|NCT00557349|1413984|P2|COMPLETED|Overall Study||13
580118|NCT00557349|1413985|P1|COMPLETED|Overall Study||17
580119|NCT00557349|1413984|P2|STARTED|Overall Study||18
580120|NCT00557349|1413985|P1|STARTED|Overall Study|omeprazole/bicarb|22
581893|NCT00546273|1419352|P1|STARTED|IV||0
580121|NCT00557323|1413993|P1|NOT COMPLETED|Overall Study||7
580122|NCT00557323|1413993|P1|COMPLETED|Overall Study||27
580123|NCT00557323|1413993|P1|STARTED|Overall Study||34
580124|NCT00557310|1413998|P1|NOT COMPLETED|Extension Phase (18 - 24 Months)||5
580125|NCT00557310|1413998|P1|COMPLETED|Extension Phase (18 - 24 Months)|One had a metal hip implant, a protocol violation, and was excluded from efficacy analyses.|25
580126|NCT00557310|1413998|P1|STARTED|Extension Phase (18 - 24 Months)||30
580127|NCT00557310|1413998|P1|NOT COMPLETED|Main Study (0 - 18 Months)||5
580128|NCT00557310|1413998|P1|COMPLETED|Main Study (0 - 18 Months)|One had a metal hip implant, a protocol violation, and was excluded from efficacy analyses.|30
580129|NCT00557310|1413998|P1|STARTED|Main Study (0 - 18 Months)||35
580130|NCT00557284|1414020|P2|NOT COMPLETED|Overall Study||0
580131|NCT00557284|1414021|P1|NOT COMPLETED|Overall Study||0
580132|NCT00557284|1414020|P2|COMPLETED|Overall Study||11
580133|NCT00557284|1414021|P1|COMPLETED|Overall Study||9
580134|NCT00557284|1414020|P2|STARTED|Overall Study||11
580135|NCT00557284|1414021|P1|STARTED|Overall Study||9
580136|NCT00557245|1414044|P3|NOT COMPLETED|Overall Study||12
580137|NCT00557245|1414045|P2|NOT COMPLETED|Overall Study||12
580138|NCT00557245|1414046|P1|NOT COMPLETED|Overall Study||12
580139|NCT00557245|1414044|P3|COMPLETED|Overall Study||1574
580140|NCT00557245|1414045|P2|COMPLETED|Overall Study||1571
580141|NCT00557245|1414046|P1|COMPLETED|Overall Study||1577
580142|NCT00557245|1414044|P3|STARTED|Overall Study||1586
580143|NCT00557245|1414045|P2|STARTED|Overall Study||1583
580144|NCT00557245|1414046|P1|STARTED|Overall Study||1589
580145|NCT00557076|1414086|P2|NOT COMPLETED|Overall Study||1
580146|NCT00557076|1414087|P1|NOT COMPLETED|Overall Study||0
580147|NCT00557076|1414086|P2|COMPLETED|Overall Study|One participant was withdrawn due to unblinding|7
580148|NCT00557076|1414087|P1|COMPLETED|Overall Study||8
580149|NCT00557076|1414086|P2|STARTED|Overall Study||8
580150|NCT00557076|1414087|P1|STARTED|Overall Study||8
580151|NCT00556998|1414095|P1|NOT COMPLETED|Voriconazole Oral||2
580152|NCT00556998|1414095|P1|COMPLETED|Voriconazole Oral||20
580153|NCT00556998|1414095|P1|STARTED|Voriconazole Oral|One participant received voriconazole 150 mg every 12 hours during oral phase.|22
580154|NCT00556998|1414095|P1|NOT COMPLETED|Voriconazole Intravenous (IV)||5
580155|NCT00556998|1414095|P1|COMPLETED|Voriconazole Intravenous (IV)|One participant received 2 days of oral; then received IV again before discontinuing from study.|21
580156|NCT00556998|1414095|P1|Treated|Voriconazole Intravenous (IV)||26
580157|NCT00556998|1414095|P1|STARTED|Voriconazole Intravenous (IV)||26
580158|NCT00556972|1414115|P1|NOT COMPLETED|Overall Study||0
580159|NCT00556972|1414115|P1|COMPLETED|Overall Study||4
580160|NCT00556972|1414115|P1|STARTED|Overall Study||4
580161|NCT00556946|1414122|P1|NOT COMPLETED|Overall Study||1
580162|NCT00556946|1414122|P1|COMPLETED|Overall Study||16
580163|NCT00556946|1414122|P1|STARTED|Overall Study||17
580164|NCT00556933|1414130|P4|NOT COMPLETED|CNI Withdrawal vs. Minimization||2
580165|NCT00556933|1414131|P3|NOT COMPLETED|CNI Withdrawal vs. Minimization||3
580166|NCT00556933|1414132|P2|NOT COMPLETED|CNI Withdrawal vs. Minimization||4
580167|NCT00556933|1414133|P1|NOT COMPLETED|CNI Withdrawal vs. Minimization||1
580168|NCT00556933|1414130|P4|COMPLETED|CNI Withdrawal vs. Minimization||41
580169|NCT00556933|1414131|P3|COMPLETED|CNI Withdrawal vs. Minimization||36
580170|NCT00556933|1414132|P2|COMPLETED|CNI Withdrawal vs. Minimization||33
580171|NCT00556933|1414133|P1|COMPLETED|CNI Withdrawal vs. Minimization||42
580172|NCT00556933|1414130|P4|STARTED|CNI Withdrawal vs. Minimization||43
580173|NCT00556933|1414131|P3|STARTED|CNI Withdrawal vs. Minimization||39
580174|NCT00556933|1414132|P2|STARTED|CNI Withdrawal vs. Minimization||37
580175|NCT00556933|1414133|P1|STARTED|CNI Withdrawal vs. Minimization||43
580176|NCT00556933|1414130|P4|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2
580177|NCT00556933|1414131|P3|NOT COMPLETED|Single vs. Divided-dose rATG Induction||6
580178|NCT00556933|1414132|P2|NOT COMPLETED|Single vs. Divided-dose rATG Induction||8
580179|NCT00556933|1414133|P1|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2
580180|NCT00556933|1414130|P4|COMPLETED|Single vs. Divided-dose rATG Induction||43
580181|NCT00556933|1414131|P3|COMPLETED|Single vs. Divided-dose rATG Induction||39
580182|NCT00556933|1414132|P2|COMPLETED|Single vs. Divided-dose rATG Induction||37
580183|NCT00556933|1414133|P1|COMPLETED|Single vs. Divided-dose rATG Induction||43
580184|NCT00556933|1414130|P4|STARTED|Single vs. Divided-dose rATG Induction||45
580185|NCT00556933|1414131|P3|STARTED|Single vs. Divided-dose rATG Induction||45
580186|NCT00556933|1414132|P2|STARTED|Single vs. Divided-dose rATG Induction||45
580187|NCT00556933|1414133|P1|STARTED|Single vs. Divided-dose rATG Induction||45
580188|NCT00556894|1414190|P3|NOT COMPLETED|Overall Study||19
580189|NCT00556894|1414191|P2|NOT COMPLETED|Overall Study||19
580190|NCT00556894|1414192|P1|NOT COMPLETED|Overall Study||16
580191|NCT00556894|1414190|P3|COMPLETED|Overall Study||65
580192|NCT00556894|1414191|P2|COMPLETED|Overall Study||68
580193|NCT00556894|1414192|P1|COMPLETED|Overall Study||66
580194|NCT00556894|1414190|P3|STARTED|Overall Study||84
580195|NCT00556894|1414191|P2|STARTED|Overall Study||87
580196|NCT00556894|1414192|P1|STARTED|Overall Study||82
580197|NCT00556712|1414202|P2|NOT COMPLETED|Overall Study||438
580198|NCT00556712|1414203|P1|NOT COMPLETED|Overall Study||451
580199|NCT00556712|1414202|P2|COMPLETED|Overall Study|Data cutoff date: 17 May 2008|0
580200|NCT00556712|1414203|P1|COMPLETED|Overall Study|Data cutoff date: 17 May 2008|0
580201|NCT00556712|1414202|P2|STARTED|Overall Study||438
580202|NCT00556712|1414203|P1|STARTED|Overall Study||451
580203|NCT00556673|1414281|P2|NOT COMPLETED|Overall Study||2
580204|NCT00556673|1414282|P1|NOT COMPLETED|Overall Study||3
580205|NCT00556673|1414281|P2|COMPLETED|Overall Study||13
580206|NCT00556673|1414282|P1|COMPLETED|Overall Study||13
580207|NCT00556673|1414281|P2|Pharmacodynamic (PD) Population|Overall Study|3 patients inadvertently unblinded were not included in PD analysis population.|12
580208|NCT00556673|1414282|P1|Pharmacodynamic (PD) Population|Overall Study|4 patients inadvertently unblinded were not included in PD analysis population.|12
580209|NCT00556673|1414281|P2|STARTED|Overall Study||15
580210|NCT00556673|1414282|P1|STARTED|Overall Study||16
580211|NCT00556543|1414318|P1|NOT COMPLETED|Overall Study||0
580212|NCT00556543|1414318|P1|COMPLETED|Overall Study|Subjects completed 180 days of study enrollment|10
580213|NCT00556543|1414318|P1|STARTED|Overall Study||10
580214|NCT00556504|1414336|P2|NOT COMPLETED|Overall Study||9
580215|NCT00556504|1414337|P1|NOT COMPLETED|Overall Study||8
580216|NCT00556504|1414336|P2|COMPLETED|Overall Study||33
580217|NCT00556504|1414337|P1|COMPLETED|Overall Study||34
580218|NCT00556504|1414336|P2|Safety Population|Overall Study||42
580219|NCT00556504|1414337|P1|Safety Population|Overall Study||41
580220|NCT00556504|1414336|P2|Intend-to Treat Population|Overall Study||42
580221|NCT00556504|1414337|P1|Intend-to Treat Population|Overall Study||42
580222|NCT00556504|1414336|P2|STARTED|Overall Study||42
580223|NCT00556504|1414337|P1|STARTED|Overall Study||42
580224|NCT00556491|1414357|P2|NOT COMPLETED|Overall Study||1
580225|NCT00556491|1414358|P1|NOT COMPLETED|Overall Study||1
580226|NCT00556491|1414357|P2|COMPLETED|Overall Study||19
580227|NCT00556491|1414358|P1|COMPLETED|Overall Study||19
580228|NCT00556491|1414357|P2|STARTED|Overall Study||20
580229|NCT00556491|1414358|P1|STARTED|Overall Study|January 2008|20
580230|NCT00556478|1414376|P2|NOT COMPLETED|Open-Label Phase||10
580231|NCT00556478|1414377|P1|NOT COMPLETED|Open-Label Phase||14
580232|NCT00556478|1414376|P2|COMPLETED|Open-Label Phase||67
580233|NCT00556478|1414377|P1|COMPLETED|Open-Label Phase||132
580234|NCT00556478|1414376|P2|Treated in Open-label|Open-Label Phase||71
580235|NCT00556478|1414377|P1|Treated in Open-label|Open-Label Phase||142
580236|NCT00556478|1414376|P2|STARTED|Open-Label Phase||77
580237|NCT00556478|1414377|P1|STARTED|Open-Label Phase||146
580238|NCT00556478|1414376|P2|NOT COMPLETED|Double-blind Phase||8
580239|NCT00556478|1414377|P1|NOT COMPLETED|Double-blind Phase||21
580240|NCT00556478|1414376|P2|COMPLETED|Double-blind Phase||77
580241|NCT00556478|1414377|P1|COMPLETED|Double-blind Phase||150
580242|NCT00556478|1414376|P2|ITT|Double-blind Phase||82
580243|NCT00556478|1414377|P1|ITT|Double-blind Phase||167
580244|NCT00556478|1414376|P2|STARTED|Double-blind Phase||85
580245|NCT00556478|1414377|P1|STARTED|Double-blind Phase||171
580246|NCT00556452|1414405|P3|NOT COMPLETED|Overall Study||0
580247|NCT00556452|1414406|P2|NOT COMPLETED|Overall Study||0
580248|NCT00556452|1414407|P1|NOT COMPLETED|Overall Study||0
580249|NCT00556452|1414405|P3|COMPLETED|Overall Study||19
580250|NCT00556452|1414406|P2|COMPLETED|Overall Study||21
580251|NCT00556452|1414407|P1|COMPLETED|Overall Study||6
580252|NCT00556452|1414405|P3|STARTED|Overall Study||19
580253|NCT00556452|1414406|P2|STARTED|Overall Study||21
580254|NCT00556452|1414407|P1|STARTED|Overall Study||6
580255|NCT00556439|1414418|P4|NOT COMPLETED|After Week 12 (Randomized Study Period)||1
580256|NCT00556439|1414419|P3|NOT COMPLETED|After Week 12 (Randomized Study Period)||0
580257|NCT00556439|1414420|P2|NOT COMPLETED|After Week 12 (Randomized Study Period)||4
580258|NCT00556439|1414421|P1|NOT COMPLETED|After Week 12 (Randomized Study Period)||3
580259|NCT00556439|1414418|P4|COMPLETED|After Week 12 (Randomized Study Period)||14
580260|NCT00556439|1414419|P3|COMPLETED|After Week 12 (Randomized Study Period)||11
580261|NCT00556439|1414420|P2|COMPLETED|After Week 12 (Randomized Study Period)||17
580262|NCT00556439|1414421|P1|COMPLETED|After Week 12 (Randomized Study Period)||17
580263|NCT00556439|1414418|P4|STARTED|After Week 12 (Randomized Study Period)||15
580264|NCT00556439|1414419|P3|STARTED|After Week 12 (Randomized Study Period)||11
580265|NCT00556439|1414420|P2|STARTED|After Week 12 (Randomized Study Period)||21
580266|NCT00556439|1414421|P1|STARTED|After Week 12 (Randomized Study Period)||20
580267|NCT00556439|1414418|P4|NOT COMPLETED|Study Entry to Week 12||0
580268|NCT00556439|1414419|P3|NOT COMPLETED|Study Entry to Week 12||8
580269|NCT00556439|1414420|P2|NOT COMPLETED|Study Entry to Week 12||0
580270|NCT00556439|1414421|P1|NOT COMPLETED|Study Entry to Week 12||8
580271|NCT00556439|1414418|P4|COMPLETED|Study Entry to Week 12||0
580272|NCT00556439|1414419|P3|COMPLETED|Study Entry to Week 12||26
580273|NCT00556439|1414420|P2|COMPLETED|Study Entry to Week 12||0
580274|NCT00556439|1414421|P1|COMPLETED|Study Entry to Week 12||41
580275|NCT00556439|1414418|P4|STARTED|Study Entry to Week 12|No participants received placebo until the Week 12 Randomization|0
580276|NCT00556439|1414419|P3|STARTED|Study Entry to Week 12|39 signed informed consent with 5 not being eligible. The remaining 34 received study drug.|34
580277|NCT00556439|1414420|P2|STARTED|Study Entry to Week 12|No participants received placebo until the Week 12 Randomization|0
580278|NCT00556439|1414421|P1|STARTED|Study Entry to Week 12|58 signed informed consent with 9 not being eligible. The remaining 49 received study drug.|49
580279|NCT00556426|1414431|P1|NOT COMPLETED|Overall Study||9
580280|NCT00556426|1414431|P1|COMPLETED|Overall Study||91
580281|NCT00556426|1414431|P1|STARTED|Overall Study||100
580282|NCT00556400|1414441|P2|NOT COMPLETED|Overall Study||0
580283|NCT00556400|1414442|P1|NOT COMPLETED|Overall Study||0
580284|NCT00556400|1414441|P2|COMPLETED|Overall Study||0
580285|NCT00556400|1414442|P1|COMPLETED|Overall Study||1
580286|NCT00556400|1414441|P2|STARTED|Overall Study||0
580287|NCT00556400|1414442|P1|STARTED|Overall Study||1
580288|NCT00556374|1414453|P2|NOT COMPLETED|Overall Study||220
580289|NCT00556374|1414454|P1|NOT COMPLETED|Overall Study||247
580290|NCT00556374|1414453|P2|COMPLETED|Overall Study|Indicates participants continuing study|1491
580291|NCT00556374|1414454|P1|COMPLETED|Overall Study|Indicates participants continuing study|1462
580292|NCT00556374|1414453|P2|Received Study Drug|Overall Study||1700
580293|NCT00556374|1414454|P1|Received Study Drug|Overall Study||1699
580294|NCT00556374|1414453|P2|STARTED|Overall Study||1711
580295|NCT00556374|1414454|P1|STARTED|Overall Study||1709
580296|NCT00556322|1414472|P2|NOT COMPLETED|Overall Study||203
580297|NCT00556322|1414473|P1|NOT COMPLETED|Overall Study||221
580298|NCT00556322|1414472|P2|COMPLETED|Overall Study|Data cutoff was 01 August 2010|0
580299|NCT00556322|1414473|P1|COMPLETED|Overall Study|Data cutoff was 01 August 2010|0
580300|NCT00556322|1414472|P2|STARTED|Overall Study||203
580301|NCT00556322|1414473|P1|STARTED|Overall Study||221
580302|NCT00556166|1414521|P1|NOT COMPLETED|Overall Study||1
580303|NCT00556166|1414521|P1|COMPLETED|Overall Study||3
580304|NCT00556166|1414521|P1|STARTED|Overall Study||4
580305|NCT00556140|1414526|P1|NOT COMPLETED|Overall Study||3
580306|NCT00556140|1414526|P1|COMPLETED|Overall Study||13
580307|NCT00556140|1414526|P1|STARTED|Overall Study||16
580308|NCT00556075|1414534|P3|NOT COMPLETED|Overall Study||8
580309|NCT00556075|1414535|P2|NOT COMPLETED|Overall Study||9
580310|NCT00556075|1414536|P1|NOT COMPLETED|Overall Study||13
580311|NCT00556075|1414534|P3|COMPLETED|Overall Study||15
580312|NCT00556075|1414535|P2|COMPLETED|Overall Study||13
580313|NCT00556075|1414536|P1|COMPLETED|Overall Study||9
580314|NCT00556075|1414534|P3|STARTED|Overall Study||23
580315|NCT00556075|1414535|P2|STARTED|Overall Study||22
580316|NCT00556075|1414536|P1|STARTED|Overall Study||22
580317|NCT00556049|1414559|P1|NOT COMPLETED|Overall Study||0
580318|NCT00556049|1414559|P1|COMPLETED|Overall Study||72
580319|NCT00556049|1414559|P1|STARTED|Overall Study||72
580320|NCT00555997|1414566|P4|NOT COMPLETED|Phase 2 SPCD||3
580321|NCT00555997|1414567|P3|NOT COMPLETED|Phase 2 SPCD||7
580322|NCT00555997|1414568|P2|NOT COMPLETED|Phase 2 SPCD||0
580323|NCT00555997|1414569|P1|NOT COMPLETED|Phase 2 SPCD||0
580324|NCT00555997|1414566|P4|COMPLETED|Phase 2 SPCD||22
580325|NCT00555997|1414567|P3|COMPLETED|Phase 2 SPCD||31
580326|NCT00555997|1414568|P2|COMPLETED|Phase 2 SPCD||0
580327|NCT00555997|1414569|P1|COMPLETED|Phase 2 SPCD||0
580328|NCT00555997|1414566|P4|STARTED|Phase 2 SPCD||25
580329|NCT00555997|1414567|P3|STARTED|Phase 2 SPCD||38
580330|NCT00555997|1414568|P2|STARTED|Phase 2 SPCD||0
580331|NCT00555997|1414569|P1|STARTED|Phase 2 SPCD||0
580332|NCT00555997|1414566|P4|NOT COMPLETED|Phase 1 SPCD||0
580333|NCT00555997|1414567|P3|NOT COMPLETED|Phase 1 SPCD||0
580334|NCT00555997|1414568|P2|NOT COMPLETED|Phase 1 SPCD||15
580335|NCT00555997|1414569|P1|NOT COMPLETED|Phase 1 SPCD||12
580336|NCT00555997|1414566|P4|COMPLETED|Phase 1 SPCD||0
580337|NCT00555997|1414567|P3|COMPLETED|Phase 1 SPCD||0
580338|NCT00555997|1414568|P2|COMPLETED|Phase 1 SPCD||76
580339|NCT00555997|1414569|P1|COMPLETED|Phase 1 SPCD||17
580340|NCT00555997|1414566|P4|STARTED|Phase 1 SPCD||0
580341|NCT00555997|1414567|P3|STARTED|Phase 1 SPCD||0
580342|NCT00555997|1414568|P2|STARTED|Phase 1 SPCD||91
580343|NCT00555997|1414569|P1|STARTED|Phase 1 SPCD||29
580344|NCT00555906|1414588|P5|NOT COMPLETED|Phase 2||32
580345|NCT00555906|1414589|P4|NOT COMPLETED|Phase 2||0
580346|NCT00555906|1414590|P3|NOT COMPLETED|Phase 2||0
580347|NCT00555906|1414591|P2|NOT COMPLETED|Phase 2||0
580348|NCT00555906|1414592|P1|NOT COMPLETED|Phase 2||0
580349|NCT00555906|1414588|P5|COMPLETED|Phase 2||0
580350|NCT00555906|1414589|P4|COMPLETED|Phase 2||0
580351|NCT00555906|1414590|P3|COMPLETED|Phase 2||0
580352|NCT00555906|1414591|P2|COMPLETED|Phase 2||0
580353|NCT00555906|1414592|P1|COMPLETED|Phase 2||0
580354|NCT00555906|1414588|P5|Treated|Phase 2||30
580355|NCT00555906|1414589|P4|Treated|Phase 2||0
580356|NCT00555906|1414590|P3|Treated|Phase 2||0
580357|NCT00555906|1414591|P2|Treated|Phase 2||0
580358|NCT00555906|1414592|P1|Treated|Phase 2||0
580359|NCT00555906|1414588|P5|STARTED|Phase 2||32
580360|NCT00555906|1414589|P4|STARTED|Phase 2||0
580361|NCT00555906|1414590|P3|STARTED|Phase 2||0
580362|NCT00555906|1414591|P2|STARTED|Phase 2||0
580363|NCT00555906|1414592|P1|STARTED|Phase 2||0
580364|NCT00555906|1414588|P5|NOT COMPLETED|Phase 1||0
580365|NCT00555906|1414589|P4|NOT COMPLETED|Phase 1||5
580366|NCT00555906|1414590|P3|NOT COMPLETED|Phase 1||7
580367|NCT00555906|1414591|P2|NOT COMPLETED|Phase 1||6
580368|NCT00555906|1414592|P1|NOT COMPLETED|Phase 1||3
580369|NCT00555906|1414588|P5|COMPLETED|Phase 1||0
580370|NCT00555906|1414589|P4|COMPLETED|Phase 1||0
580371|NCT00555906|1414590|P3|COMPLETED|Phase 1||0
580372|NCT00555906|1414591|P2|COMPLETED|Phase 1||0
580373|NCT00555906|1414592|P1|COMPLETED|Phase 1||0
580374|NCT00555906|1414588|P5|STARTED|Phase 1||0
580375|NCT00555906|1414589|P4|STARTED|Phase 1||5
580376|NCT00555906|1414590|P3|STARTED|Phase 1||7
580377|NCT00555906|1414591|P2|STARTED|Phase 1||6
580378|NCT00555906|1414592|P1|STARTED|Phase 1||3
580379|NCT00555893|1414624|P2|NOT COMPLETED|Overall Study||0
580380|NCT00555893|1414625|P1|NOT COMPLETED|Overall Study||0
580381|NCT00555893|1414624|P2|COMPLETED|Overall Study||63
580382|NCT00555893|1414625|P1|COMPLETED|Overall Study||130
580383|NCT00555893|1414624|P2|Final Analysis|Overall Study|n=12 excluded from number started because >119 hrs|51
580384|NCT00555893|1414625|P1|Final Analysis|Overall Study|n=16 excluded from number started because >119 hrs|114
580385|NCT00555893|1414624|P2|STARTED|Overall Study||63
580386|NCT00555893|1414625|P1|STARTED|Overall Study||130
580387|NCT00555880|1414635|P2|NOT COMPLETED|Treatment Period 2 (1 Day)||0
580388|NCT00555880|1414636|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
580389|NCT00555880|1414635|P2|COMPLETED|Treatment Period 2 (1 Day)||11
580390|NCT00555880|1414636|P1|COMPLETED|Treatment Period 2 (1 Day)||13
580391|NCT00555880|1414635|P2|STARTED|Treatment Period 2 (1 Day)||11
580392|NCT00555880|1414636|P1|STARTED|Treatment Period 2 (1 Day)||13
580393|NCT00555880|1414635|P2|NOT COMPLETED|Washout (1 Day)||0
580394|NCT00555880|1414636|P1|NOT COMPLETED|Washout (1 Day)||0
580395|NCT00555880|1414635|P2|COMPLETED|Washout (1 Day)||11
580396|NCT00555880|1414636|P1|COMPLETED|Washout (1 Day)||13
580397|NCT00555880|1414635|P2|STARTED|Washout (1 Day)||11
580398|NCT00555880|1414636|P1|STARTED|Washout (1 Day)||13
580399|NCT00555880|1414635|P2|NOT COMPLETED|Treatment Period 1 (1 Day)||0
580400|NCT00555880|1414636|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
580401|NCT00555880|1414635|P2|COMPLETED|Treatment Period 1 (1 Day)||11
580402|NCT00555880|1414636|P1|COMPLETED|Treatment Period 1 (1 Day)||13
580403|NCT00555880|1414635|P2|STARTED|Treatment Period 1 (1 Day)||11
580404|NCT00555880|1414636|P1|STARTED|Treatment Period 1 (1 Day)||13
580405|NCT00555750|1414675|P2|NOT COMPLETED|Overall Study||0
580406|NCT00555750|1414676|P1|NOT COMPLETED|Overall Study||0
580407|NCT00555750|1414675|P2|COMPLETED|Overall Study||10
580408|NCT00555750|1414676|P1|COMPLETED|Overall Study||10
580409|NCT00555750|1414675|P2|STARTED|Overall Study||10
580410|NCT00555750|1414676|P1|STARTED|Overall Study||10
580411|NCT00555672|1414708|P2|NOT COMPLETED|Overall Study||10
580412|NCT00555672|1414709|P1|NOT COMPLETED|Overall Study||24
580413|NCT00555672|1414708|P2|COMPLETED|Overall Study||0
580414|NCT00555672|1414709|P1|COMPLETED|Overall Study||0
580415|NCT00555672|1414708|P2|STARTED|Overall Study||10
580416|NCT00555672|1414709|P1|STARTED|Overall Study||24
580417|NCT00555620|1414734|P6|NOT COMPLETED|Overall Study||22
580418|NCT00555620|1414735|P5|NOT COMPLETED|Overall Study||3
580419|NCT00555620|1414736|P4|NOT COMPLETED|Overall Study||23
580420|NCT00555620|1414737|P3|NOT COMPLETED|Overall Study||15
580421|NCT00555620|1414738|P2|NOT COMPLETED|Overall Study||7
580422|NCT00555620|1414739|P1|NOT COMPLETED|Overall Study||6
580423|NCT00555620|1414734|P6|COMPLETED|Overall Study||0
580424|NCT00555620|1414735|P5|COMPLETED|Overall Study||0
580425|NCT00555620|1414736|P4|COMPLETED|Overall Study||0
580426|NCT00555620|1414737|P3|COMPLETED|Overall Study||0
580427|NCT00555620|1414738|P2|COMPLETED|Overall Study||0
580428|NCT00555620|1414739|P1|COMPLETED|Overall Study||0
580429|NCT00555620|1414734|P6|STARTED|Overall Study||22
580430|NCT00555620|1414735|P5|STARTED|Overall Study||3
580431|NCT00555620|1414736|P4|STARTED|Overall Study||23
580432|NCT00555620|1414737|P3|STARTED|Overall Study||15
580433|NCT00555620|1414738|P2|STARTED|Overall Study||7
580434|NCT00555620|1414739|P1|STARTED|Overall Study||6
580435|NCT00555581|1414851|P1|NOT COMPLETED|Overall Study||6
580436|NCT00555581|1414851|P1|COMPLETED|Overall Study||24
580437|NCT00555581|1414851|P1|STARTED|Overall Study||30
580438|NCT00555568|1414863|P3|NOT COMPLETED|Overall Study||16
580439|NCT00555568|1414864|P2|NOT COMPLETED|Overall Study||16
580440|NCT00555568|1414865|P1|NOT COMPLETED|Overall Study||26
580441|NCT00555568|1414863|P3|COMPLETED|Overall Study||84
580442|NCT00555568|1414864|P2|COMPLETED|Overall Study||82
580443|NCT00555568|1414865|P1|COMPLETED|Overall Study||74
580444|NCT00555568|1414863|P3|STARTED|Overall Study||100
580445|NCT00555568|1414864|P2|STARTED|Overall Study||98
580446|NCT00555568|1414865|P1|STARTED|Overall Study||100
580447|NCT00555477|1414887|P2|NOT COMPLETED|Overall Study||13
580448|NCT00555477|1414888|P1|NOT COMPLETED|Overall Study||2
580449|NCT00555477|1414887|P2|COMPLETED|Overall Study||32
580450|NCT00555477|1414888|P1|COMPLETED|Overall Study||12
580451|NCT00555477|1414887|P2|STARTED|Overall Study||45
580452|NCT00555477|1414888|P1|STARTED|Overall Study||14
580453|NCT00555464|1414895|P2|NOT COMPLETED|Overall Study||3
580454|NCT00555464|1414896|P1|NOT COMPLETED|Overall Study||0
580455|NCT00555464|1414895|P2|COMPLETED|Overall Study||1
580456|NCT00555464|1414896|P1|COMPLETED|Overall Study||4
580457|NCT00555464|1414895|P2|STARTED|Overall Study||4
580458|NCT00555464|1414896|P1|STARTED|Overall Study||4
580459|NCT00555438|1414904|P1|NOT COMPLETED|Between 10 Days and 30 Days Postoperativ||5
580460|NCT00555438|1414904|P1|COMPLETED|Between 10 Days and 30 Days Postoperativ||433
580461|NCT00555438|1414904|P1|STARTED|Between 10 Days and 30 Days Postoperativ||438
580462|NCT00555438|1414904|P1|NOT COMPLETED|10 Days Post-operative||4
580463|NCT00555438|1414904|P1|COMPLETED|10 Days Post-operative|438 patients attended the day 10 visit (four patients died during hospitalization)|438
580464|NCT00555438|1414904|P1|STARTED|10 Days Post-operative||442
580465|NCT00555425|1414914|P2|NOT COMPLETED|Overall Study||19
580466|NCT00555425|1414915|P1|NOT COMPLETED|Overall Study||51
580467|NCT00555425|1414914|P2|COMPLETED|Overall Study||37
580468|NCT00555425|1414915|P1|COMPLETED|Overall Study||6
580469|NCT00555425|1414914|P2|STARTED|Overall Study||56
580470|NCT00555425|1414915|P1|STARTED|Overall Study||57
580471|NCT00555360|1414935|P2|NOT COMPLETED|Overall Study||36
580472|NCT00555360|1414936|P1|NOT COMPLETED|Overall Study||27
580473|NCT00555360|1414935|P2|COMPLETED|Overall Study||153
580474|NCT00555360|1414936|P1|COMPLETED|Overall Study||156
580475|NCT00555360|1414935|P2|STARTED|Overall Study||189
580476|NCT00555360|1414936|P1|STARTED|Overall Study||183
580477|NCT00555321|1414951|P5|NOT COMPLETED|Long-term Extension Phase||26
580478|NCT00555321|1414952|P4|NOT COMPLETED|Long-term Extension Phase||38
580479|NCT00555321|1414953|P3|NOT COMPLETED|Long-term Extension Phase||24
580480|NCT00555321|1414954|P2|NOT COMPLETED|Long-term Extension Phase||27
580481|NCT00555321|1414955|P1|NOT COMPLETED|Long-term Extension Phase||30
580482|NCT00555321|1414951|P5|COMPLETED|Long-term Extension Phase||0
580483|NCT00555321|1414952|P4|COMPLETED|Long-term Extension Phase||0
580484|NCT00555321|1414953|P3|COMPLETED|Long-term Extension Phase||0
580485|NCT00555321|1414954|P2|COMPLETED|Long-term Extension Phase||0
580486|NCT00555321|1414955|P1|COMPLETED|Long-term Extension Phase||0
580487|NCT00555321|1414951|P5|STARTED|Long-term Extension Phase|6 participants did not enter LTE|26
580488|NCT00555321|1414952|P4|STARTED|Long-term Extension Phase|8 participants did not enter LTE|38
580489|NCT00555321|1414953|P3|STARTED|Long-term Extension Phase|2 participants did not enter LTE|24
580490|NCT00555321|1414954|P2|STARTED|Long-term Extension Phase|2 participants did not enter LTE|27
580491|NCT00555321|1414955|P1|STARTED|Long-term Extension Phase|1 participant did not enter LTE|30
580492|NCT00555321|1414951|P5|NOT COMPLETED|Treatment Phase up to 12-months||22
580493|NCT00555321|1414952|P4|NOT COMPLETED|Treatment Phase up to 12-months||7
580494|NCT00555321|1414953|P3|NOT COMPLETED|Treatment Phase up to 12-months||24
580495|NCT00555321|1414954|P2|NOT COMPLETED|Treatment Phase up to 12-months||22
580496|NCT00555321|1414955|P1|NOT COMPLETED|Treatment Phase up to 12-months||21
580497|NCT00555321|1414951|P5|COMPLETED|Treatment Phase up to 12-months||32
580498|NCT00555321|1414952|P4|COMPLETED|Treatment Phase up to 12-months||46
580499|NCT00555321|1414953|P3|COMPLETED|Treatment Phase up to 12-months||26
580500|NCT00555321|1414954|P2|COMPLETED|Treatment Phase up to 12-months||29
580501|NCT00555321|1414955|P1|COMPLETED|Treatment Phase up to 12-months||31
580502|NCT00555321|1414951|P5|Received Transplant and Treated|Treatment Phase up to 12-months||50
580503|NCT00555321|1414952|P4|Received Transplant and Treated|Treatment Phase up to 12-months||53
580504|NCT00555321|1414953|P3|Received Transplant and Treated|Treatment Phase up to 12-months||49
580505|NCT00555321|1414954|P2|Received Transplant and Treated|Treatment Phase up to 12-months||48
580506|NCT00555321|1414955|P1|Received Transplant and Treated|Treatment Phase up to 12-months||50
580507|NCT00555321|1414951|P5|STARTED|Treatment Phase up to 12-months||54
580508|NCT00555321|1414952|P4|STARTED|Treatment Phase up to 12-months||53
580509|NCT00555321|1414953|P3|STARTED|Treatment Phase up to 12-months||50
580510|NCT00555321|1414954|P2|STARTED|Treatment Phase up to 12-months||51
580511|NCT00555321|1414955|P1|STARTED|Treatment Phase up to 12-months||52
580512|NCT00555217|1415259|P2|NOT COMPLETED|Overall Study||68
580513|NCT00555217|1415260|P1|NOT COMPLETED|Overall Study||75
580514|NCT00555217|1415259|P2|COMPLETED|Overall Study||656
580515|NCT00555217|1415260|P1|COMPLETED|Overall Study||649
580516|NCT00555217|1415259|P2|STARTED|Overall Study||724
580517|NCT00555217|1415260|P1|STARTED|Overall Study||724
580518|NCT00555152|1415272|P4|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
580519|NCT00555152|1415273|P3|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
580520|NCT00555152|1415274|P2|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
580521|NCT00555152|1415275|P1|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
580522|NCT00555152|1415272|P4|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||9
580523|NCT00555152|1415273|P3|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
580524|NCT00555152|1415274|P2|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||10
580525|NCT00555152|1415275|P1|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
580526|NCT00555152|1415272|P4|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||9
580527|NCT00555152|1415273|P3|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||0
580528|NCT00555152|1415274|P2|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||10
580529|NCT00555152|1415275|P1|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14|Participants in initial and second study registration periods reported separately.|0
580530|NCT00555152|1415272|P4|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
580531|NCT00555152|1415273|P3|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
580532|NCT00555152|1415274|P2|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
580533|NCT00555152|1415275|P1|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
580534|NCT00555152|1415272|P4|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||1
580535|NCT00555152|1415273|P3|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
580536|NCT00555152|1415274|P2|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
580537|NCT00555152|1415275|P1|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||2
580538|NCT00555152|1415272|P4|STARTED|Period Open at BCM: 1/17/08-3/8/10||1
580539|NCT00555152|1415273|P3|STARTED|Period Open at BCM: 1/17/08-3/8/10||0
580540|NCT00555152|1415274|P2|STARTED|Period Open at BCM: 1/17/08-3/8/10|Participants in initial and second study registration periods reported separately.|0
580541|NCT00555152|1415275|P1|STARTED|Period Open at BCM: 1/17/08-3/8/10||2
580542|NCT00555061|1415297|P1|NOT COMPLETED|Overall Study||9
580543|NCT00555061|1415297|P1|COMPLETED|Overall Study||78
580544|NCT00555061|1415297|P1|STARTED|Overall Study|One participant did not receive study medication and was not included in the analysis population.|87
580545|NCT00555048|1415304|P1|NOT COMPLETED|Overall Study||0
580546|NCT00555048|1415304|P1|COMPLETED|Overall Study||1
580547|NCT00555048|1415304|P1|STARTED|Overall Study||1
580548|NCT00555009|1415316|P2|NOT COMPLETED|Overall Study||6
580549|NCT00555009|1415317|P1|NOT COMPLETED|Overall Study||2
580550|NCT00555009|1415316|P2|COMPLETED|Overall Study||0
580551|NCT00555009|1415317|P1|COMPLETED|Overall Study||2
580552|NCT00555009|1415316|P2|STARTED|Overall Study||6
580553|NCT00555009|1415317|P1|STARTED|Overall Study||4
580554|NCT00554996|1415339|P1|NOT COMPLETED|Overall Study||0
580555|NCT00554996|1415339|P1|COMPLETED|Overall Study||10
580556|NCT00554996|1415339|P1|STARTED|Overall Study||10
580557|NCT00554970|1415347|P4|NOT COMPLETED|Period 2||0
580558|NCT00554970|1415348|P3|NOT COMPLETED|Period 2||1
580559|NCT00554970|1415349|P2|NOT COMPLETED|Period 2||0
580560|NCT00554970|1415350|P1|NOT COMPLETED|Period 2||0
580561|NCT00554970|1415347|P4|COMPLETED|Period 2||8
580562|NCT00554970|1415348|P3|COMPLETED|Period 2||7
580563|NCT00554970|1415349|P2|COMPLETED|Period 2||8
580564|NCT00554970|1415350|P1|COMPLETED|Period 2||7
580565|NCT00554970|1415347|P4|STARTED|Period 2||8
580566|NCT00554970|1415348|P3|STARTED|Period 2||8
580567|NCT00554970|1415349|P2|STARTED|Period 2||8
580568|NCT00554970|1415350|P1|STARTED|Period 2||7
580569|NCT00554970|1415347|P4|NOT COMPLETED|Period 1||0
580570|NCT00554970|1415348|P3|NOT COMPLETED|Period 1||0
580571|NCT00554970|1415349|P2|NOT COMPLETED|Period 1||0
580572|NCT00554970|1415350|P1|NOT COMPLETED|Period 1||1
580573|NCT00554970|1415347|P4|COMPLETED|Period 1||8
580574|NCT00554970|1415348|P3|COMPLETED|Period 1||8
580575|NCT00554970|1415349|P2|COMPLETED|Period 1||8
580576|NCT00554970|1415350|P1|COMPLETED|Period 1||7
580577|NCT00554970|1415347|P4|STARTED|Period 1||8
580578|NCT00554970|1415348|P3|STARTED|Period 1||8
580579|NCT00554970|1415349|P2|STARTED|Period 1||8
580580|NCT00554970|1415350|P1|STARTED|Period 1||8
580581|NCT00554853|1415382|P2|NOT COMPLETED|Crossover Arm (3 Months)||2
580582|NCT00554853|1415383|P1|NOT COMPLETED|Crossover Arm (3 Months)||3
580583|NCT00554853|1415382|P2|COMPLETED|Crossover Arm (3 Months)||55
580584|NCT00554853|1415383|P1|COMPLETED|Crossover Arm (3 Months)||53
580585|NCT00554853|1415382|P2|STARTED|Crossover Arm (3 Months)||57
580586|NCT00554853|1415383|P1|STARTED|Crossover Arm (3 Months)||56
580587|NCT00554853|1415382|P2|NOT COMPLETED|Washout Period (2 Weeks)||7
580588|NCT00554853|1415383|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
580589|NCT00554853|1415382|P2|COMPLETED|Washout Period (2 Weeks)||57
580590|NCT00554853|1415383|P1|COMPLETED|Washout Period (2 Weeks)||56
580591|NCT00554853|1415382|P2|STARTED|Washout Period (2 Weeks)||64
580592|NCT00554853|1415383|P1|STARTED|Washout Period (2 Weeks)||56
580593|NCT00554853|1415382|P2|NOT COMPLETED|First Arm of Study||7
580594|NCT00554853|1415383|P1|NOT COMPLETED|First Arm of Study||16
580595|NCT00554853|1415382|P2|COMPLETED|First Arm of Study||64
580596|NCT00554853|1415383|P1|COMPLETED|First Arm of Study||56
580597|NCT00554853|1415382|P2|STARTED|First Arm of Study||71
580598|NCT00554853|1415383|P1|STARTED|First Arm of Study||72
580599|NCT00554840|1415397|P2|NOT COMPLETED|Overall Study||1
580600|NCT00554840|1415398|P1|NOT COMPLETED|Overall Study||0
580601|NCT00554840|1415397|P2|COMPLETED|Overall Study||4
580602|NCT00554840|1415398|P1|COMPLETED|Overall Study||4
580603|NCT00554840|1415397|P2|STARTED|Overall Study||5
580604|NCT00554840|1415398|P1|STARTED|Overall Study||4
580605|NCT00554801|1415416|P2|NOT COMPLETED|Overall Study||0
580606|NCT00554801|1415417|P1|NOT COMPLETED|Overall Study||19
580607|NCT00554801|1415416|P2|COMPLETED|Overall Study||29
580608|NCT00554801|1415417|P1|COMPLETED|Overall Study||36
580609|NCT00554801|1415416|P2|STARTED|Overall Study||29
580610|NCT00554801|1415417|P1|STARTED|Overall Study||55
580611|NCT00554749|1415423|P1|NOT COMPLETED|Overall Study||0
580612|NCT00554749|1415423|P1|COMPLETED|Overall Study||7
580613|NCT00554749|1415423|P1|STARTED|Overall Study||7
580614|NCT00554671|1415430|P2|NOT COMPLETED|Overall Study||16
580615|NCT00554671|1415431|P1|NOT COMPLETED|Overall Study||20
580616|NCT00554671|1415430|P2|COMPLETED|Overall Study||117
580617|NCT00554671|1415431|P1|COMPLETED|Overall Study||97
580618|NCT00554671|1415430|P2|STARTED|Overall Study||133
580619|NCT00554671|1415431|P1|STARTED|Overall Study||117
580620|NCT00554619|1415439|P1|NOT COMPLETED|Overall Study||3
580621|NCT00554619|1415439|P1|COMPLETED|Overall Study||18
580622|NCT00554619|1415439|P1|STARTED|Overall Study||21
580623|NCT00554515|1415451|P1|NOT COMPLETED|Overall Study||118
580624|NCT00554515|1415451|P1|COMPLETED|Overall Study||5
580625|NCT00554515|1415451|P1|Treated|Overall Study||120
580626|NCT00554515|1415451|P1|STARTED|Overall Study||123
580627|NCT00554463|1415480|P1|NOT COMPLETED|Overall Study||0
580628|NCT00554463|1415480|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|5
580629|NCT00554463|1415480|P1|STARTED|Overall Study||5
580630|NCT00554372|1415486|P2|NOT COMPLETED|Overall Study||0
580631|NCT00554372|1415487|P1|NOT COMPLETED|Overall Study||0
580632|NCT00554372|1415486|P2|COMPLETED|Overall Study||16
580633|NCT00554372|1415487|P1|COMPLETED|Overall Study||14
580634|NCT00554372|1415486|P2|STARTED|Overall Study||16
580635|NCT00554372|1415487|P1|STARTED|Overall Study||14
580636|NCT00554294|1415501|P2|NOT COMPLETED|Overall Study||80
580637|NCT00554294|1415502|P1|NOT COMPLETED|Overall Study||160
580638|NCT00554294|1415501|P2|COMPLETED|Overall Study||1641
580639|NCT00554294|1415502|P1|COMPLETED|Overall Study||1309
580640|NCT00554294|1415501|P2|STARTED|Overall Study||1721
580641|NCT00554294|1415502|P1|STARTED|Overall Study||1469
580642|NCT00554229|1415508|P2|NOT COMPLETED|Overall Study||225
580643|NCT00554229|1415509|P1|NOT COMPLETED|Overall Study||226
580644|NCT00554229|1415508|P2|COMPLETED|Overall Study||70
580645|NCT00554229|1415509|P1|COMPLETED|Overall Study||73
580646|NCT00554229|1415508|P2|Patients Who Received Treatment|Overall Study||295
580647|NCT00554229|1415509|P1|Patients Who Received Treatment|Overall Study||298
580648|NCT00554229|1415508|P2|STARTED|Overall Study||295
580649|NCT00554229|1415509|P1|STARTED|Overall Study||299
580650|NCT00554216|1415534|P3|NOT COMPLETED|Overall Study||172
580651|NCT00554216|1415535|P2|NOT COMPLETED|Overall Study||94
580652|NCT00554216|1415536|P1|NOT COMPLETED|Overall Study||242
580653|NCT00554216|1415534|P3|COMPLETED|Overall Study||340
580654|NCT00554216|1415535|P2|COMPLETED|Overall Study||147
580655|NCT00554216|1415536|P1|COMPLETED|Overall Study||272
580656|NCT00554216|1415534|P3|STARTED|Overall Study||512
580657|NCT00554216|1415535|P2|STARTED|Overall Study||241
580658|NCT00554216|1415536|P1|STARTED|Overall Study||514
580659|NCT00554190|1415547|P1|NOT COMPLETED|Overall Study||10
580660|NCT00554190|1415547|P1|COMPLETED|Overall Study|10 subjects did not complete the Termination Study Forms|19
580661|NCT00554190|1415547|P1|STARTED|Overall Study|29 subjects treated.|29
580662|NCT00554099|1415556|P3|NOT COMPLETED|Non-Treatment Phase (9 Months)||3
580663|NCT00554099|1415557|P2|NOT COMPLETED|Non-Treatment Phase (9 Months)||5
580664|NCT00554099|1415558|P1|NOT COMPLETED|Non-Treatment Phase (9 Months)||7
580665|NCT00554099|1415556|P3|COMPLETED|Non-Treatment Phase (9 Months)||24
580666|NCT00554099|1415557|P2|COMPLETED|Non-Treatment Phase (9 Months)||27
580667|NCT00554099|1415558|P1|COMPLETED|Non-Treatment Phase (9 Months)||22
580668|NCT00554099|1415556|P3|STARTED|Non-Treatment Phase (9 Months)||27
580669|NCT00554099|1415557|P2|STARTED|Non-Treatment Phase (9 Months)||32
580670|NCT00554099|1415558|P1|STARTED|Non-Treatment Phase (9 Months)||29
580671|NCT00554099|1415556|P3|NOT COMPLETED|Treatment Period (12 Weeks)||9
580672|NCT00554099|1415557|P2|NOT COMPLETED|Treatment Period (12 Weeks)||8
580673|NCT00554099|1415558|P1|NOT COMPLETED|Treatment Period (12 Weeks)||12
580674|NCT00554099|1415556|P3|COMPLETED|Treatment Period (12 Weeks)||27
580675|NCT00554099|1415557|P2|COMPLETED|Treatment Period (12 Weeks)||32
580676|NCT00554099|1415558|P1|COMPLETED|Treatment Period (12 Weeks)||29
580677|NCT00554099|1415556|P3|STARTED|Treatment Period (12 Weeks)||36
580678|NCT00554099|1415557|P2|STARTED|Treatment Period (12 Weeks)||40
580679|NCT00554099|1415558|P1|STARTED|Treatment Period (12 Weeks)||41
580680|NCT00553969|1415591|P4|NOT COMPLETED|Overall Study||1
580681|NCT00553969|1415592|P3|NOT COMPLETED|Overall Study||1
580682|NCT00553969|1415593|P2|NOT COMPLETED|Overall Study||0
580683|NCT00553969|1415594|P1|NOT COMPLETED|Overall Study||8
580684|NCT00553969|1415591|P4|COMPLETED|Overall Study||23
580685|NCT00553969|1415592|P3|COMPLETED|Overall Study||21
580686|NCT00553969|1415593|P2|COMPLETED|Overall Study||24
580687|NCT00553969|1415594|P1|COMPLETED|Overall Study||23
580688|NCT00553969|1415591|P4|STARTED|Overall Study||24
580689|NCT00553969|1415592|P3|STARTED|Overall Study||22
580690|NCT00553969|1415593|P2|STARTED|Overall Study||24
580691|NCT00553969|1415594|P1|STARTED|Overall Study||31
580692|NCT00553839|1415604|P1|NOT COMPLETED|Overall Study||0
580693|NCT00553839|1415604|P1|COMPLETED|Overall Study||21
580694|NCT00553839|1415604|P1|STARTED|Overall Study||21
580695|NCT00553787|1415613|P3|NOT COMPLETED|Overall Study||262
580696|NCT00553787|1415614|P2|NOT COMPLETED|Overall Study||124
580697|NCT00553787|1415615|P1|NOT COMPLETED|Overall Study||378
580698|NCT00553787|1415613|P3|COMPLETED|Overall Study||733
580699|NCT00553787|1415614|P2|COMPLETED|Overall Study||374
580700|NCT00553787|1415615|P1|COMPLETED|Overall Study||616
580701|NCT00553787|1415613|P3|STARTED|Overall Study||995
580702|NCT00553787|1415614|P2|STARTED|Overall Study||498
580703|NCT00553787|1415615|P1|STARTED|Overall Study||994
580704|NCT00553735|1415626|P1|NOT COMPLETED|Overall Study||7
580705|NCT00553735|1415626|P1|COMPLETED|Overall Study||1
580706|NCT00553735|1415626|P1|STARTED|Overall Study||8
580707|NCT00553696|1415647|P4|NOT COMPLETED|Overall Study||1
580708|NCT00553696|1415648|P3|NOT COMPLETED|Overall Study||6
580709|NCT00553696|1415649|P2|NOT COMPLETED|Overall Study||16
580710|NCT00553696|1415650|P1|NOT COMPLETED|Overall Study||4
580711|NCT00553696|1415647|P4|COMPLETED|Overall Study||0
580712|NCT00553696|1415648|P3|COMPLETED|Overall Study||0
580713|NCT00553696|1415649|P2|COMPLETED|Overall Study||0
580714|NCT00553696|1415650|P1|COMPLETED|Overall Study||0
580715|NCT00553696|1415647|P4|STARTED|Overall Study||1
580716|NCT00553696|1415648|P3|STARTED|Overall Study||6
580717|NCT00553696|1415649|P2|STARTED|Overall Study||16
580718|NCT00553696|1415650|P1|STARTED|Overall Study||4
580719|NCT00553644|1415688|P1|NOT COMPLETED|Overall Study||28
580720|NCT00553644|1415688|P1|COMPLETED|Overall Study||25
580721|NCT00553644|1415688|P1|STARTED|Overall Study||53
580722|NCT00553631|1415697|P2|NOT COMPLETED|Overall Study||1
580723|NCT00553631|1415698|P1|NOT COMPLETED|Overall Study||1
580724|NCT00553631|1415697|P2|COMPLETED|Overall Study||16
580725|NCT00553631|1415698|P1|COMPLETED|Overall Study||16
580726|NCT00553631|1415697|P2|STARTED|Overall Study|Intent-to-treat (ITT) population|17
580727|NCT00553631|1415698|P1|STARTED|Overall Study|Intent-to-treat (ITT) population|17
580728|NCT00553605|1415720|P2|NOT COMPLETED|Overall Study||3
580729|NCT00553605|1415721|P1|NOT COMPLETED|Overall Study||4
580730|NCT00553605|1415720|P2|COMPLETED|Overall Study||161
580731|NCT00553605|1415721|P1|COMPLETED|Overall Study||172
580732|NCT00553605|1415720|P2|Treated|Overall Study||164
580733|NCT00553605|1415721|P1|Treated|Overall Study||174
580734|NCT00553605|1415720|P2|STARTED|Overall Study||164
580735|NCT00553605|1415721|P1|STARTED|Overall Study||176
580736|NCT00553514|1415750|P5|NOT COMPLETED|Overall Study||7
580737|NCT00553514|1415751|P4|NOT COMPLETED|Overall Study||7
580738|NCT00553514|1415752|P3|NOT COMPLETED|Overall Study||6
580739|NCT00553514|1415753|P2|NOT COMPLETED|Overall Study||8
580740|NCT00553514|1415754|P1|NOT COMPLETED|Overall Study||8
580741|NCT00553514|1415750|P5|COMPLETED|Overall Study||8
580742|NCT00553514|1415751|P4|COMPLETED|Overall Study||6
580743|NCT00553514|1415752|P3|COMPLETED|Overall Study||9
580744|NCT00553514|1415753|P2|COMPLETED|Overall Study||6
580745|NCT00553514|1415754|P1|COMPLETED|Overall Study||6
580746|NCT00553514|1415750|P5|STARTED|Overall Study||15
580747|NCT00553514|1415751|P4|STARTED|Overall Study||13
580748|NCT00553514|1415752|P3|STARTED|Overall Study||15
580749|NCT00553514|1415753|P2|STARTED|Overall Study||14
580750|NCT00553514|1415754|P1|STARTED|Overall Study||14
580751|NCT00553501|1415791|P1|NOT COMPLETED|Overall Study||4
580752|NCT00553501|1415791|P1|COMPLETED|Overall Study||55
580753|NCT00553501|1415791|P1|STARTED|Overall Study||59
580754|NCT00553475|1415800|P3|NOT COMPLETED|Overall Study||13
580755|NCT00553475|1415801|P2|NOT COMPLETED|Overall Study||20
580756|NCT00553475|1415802|P1|NOT COMPLETED|Overall Study||16
580757|NCT00553475|1415800|P3|COMPLETED|Overall Study||32
580758|NCT00553475|1415801|P2|COMPLETED|Overall Study||114
580759|NCT00553475|1415802|P1|COMPLETED|Overall Study||119
580760|NCT00553475|1415800|P3|STARTED|Overall Study||45
580761|NCT00553475|1415801|P2|STARTED|Overall Study||134
580762|NCT00553475|1415802|P1|STARTED|Overall Study||135
580763|NCT00553462|1415924|P1|NOT COMPLETED|Overall Study||14
580764|NCT00553462|1415924|P1|COMPLETED|Overall Study||61
580765|NCT00553462|1415924|P1|STARTED|Overall Study||75
580766|NCT00553436|1415930|P1|NOT COMPLETED|Overall Study||1
580767|NCT00553436|1415930|P1|COMPLETED|Overall Study|09 April 2009|6
580768|NCT00553436|1415930|P1|STARTED|Overall Study|20 August 2007|7
580769|NCT00553358|1415939|P3|NOT COMPLETED|Overall Study||60
580770|NCT00553358|1415940|P2|NOT COMPLETED|Overall Study||12
580771|NCT00553358|1415941|P1|NOT COMPLETED|Overall Study||53
580772|NCT00553358|1415939|P3|COMPLETED|Overall Study||92
580773|NCT00553358|1415940|P2|COMPLETED|Overall Study||137
580774|NCT00553358|1415941|P1|COMPLETED|Overall Study||101
580775|NCT00553358|1415939|P3|STARTED|Overall Study||152
580776|NCT00553358|1415940|P2|STARTED|Overall Study||149
580777|NCT00553358|1415941|P1|STARTED|Overall Study||154
580778|NCT00553332|1415967|P1|NOT COMPLETED|Overall Study||1
580779|NCT00553332|1415967|P1|COMPLETED|Overall Study|evaluable for response|28
580780|NCT00553332|1415967|P1|STARTED|Overall Study||29
580781|NCT00553319|1415979|P3|NOT COMPLETED|Overall Study||9
580782|NCT00553319|1415980|P2|NOT COMPLETED|Overall Study||10
580783|NCT00553319|1415981|P1|NOT COMPLETED|Overall Study||14
580784|NCT00553319|1415979|P3|COMPLETED|Overall Study||34
580785|NCT00553319|1415980|P2|COMPLETED|Overall Study||30
580786|NCT00553319|1415981|P1|COMPLETED|Overall Study||29
580787|NCT00553319|1415979|P3|STARTED|Overall Study||43
580788|NCT00553319|1415980|P2|STARTED|Overall Study||40
580789|NCT00553319|1415981|P1|STARTED|Overall Study||43
580790|NCT00553280|1415992|P1|NOT COMPLETED|Overall Study||26
580791|NCT00553280|1415992|P1|COMPLETED|Overall Study||97
580792|NCT00553280|1415992|P1|STARTED|Overall Study||123
580793|NCT00553267|1416004|P3|NOT COMPLETED|Overall Study||10
580794|NCT00553267|1416005|P2|NOT COMPLETED|Overall Study||18
580795|NCT00553267|1416006|P1|NOT COMPLETED|Overall Study||14
580796|NCT00553267|1416004|P3|COMPLETED|Overall Study||307
580797|NCT00553267|1416005|P2|COMPLETED|Overall Study||297
580798|NCT00553267|1416006|P1|COMPLETED|Overall Study||301
580799|NCT00553267|1416004|P3|STARTED|Overall Study||317
580800|NCT00553267|1416005|P2|STARTED|Overall Study||315
580801|NCT00553267|1416006|P1|STARTED|Overall Study||315
580802|NCT00553202|1416041|P1|NOT COMPLETED|Overall Study||68
580803|NCT00553202|1416041|P1|COMPLETED|Overall Study||90
580804|NCT00553202|1416041|P1|STARTED|Overall Study||158
580805|NCT00553150|1416051|P4|NOT COMPLETED|Overall Study||4
580806|NCT00553150|1416052|P3|NOT COMPLETED|Overall Study||0
580807|NCT00553150|1416053|P2|NOT COMPLETED|Overall Study||0
580808|NCT00553150|1416054|P1|NOT COMPLETED|Overall Study||0
580809|NCT00553150|1416051|P4|COMPLETED|Overall Study||100
580810|NCT00553150|1416052|P3|COMPLETED|Overall Study||6
580811|NCT00553150|1416053|P2|COMPLETED|Overall Study||6
580812|NCT00553150|1416054|P1|COMPLETED|Overall Study||6
580813|NCT00553150|1416051|P4|STARTED|Overall Study||104
580814|NCT00553150|1416052|P3|STARTED|Overall Study||6
580815|NCT00553150|1416053|P2|STARTED|Overall Study||6
580816|NCT00553150|1416054|P1|STARTED|Overall Study||6
580817|NCT00553098|1416066|P1|NOT COMPLETED|Overall Study||1
580818|NCT00553098|1416066|P1|COMPLETED|Overall Study||28
580819|NCT00553098|1416066|P1|STARTED|Overall Study||29
580820|NCT00552812|1416080|P1|NOT COMPLETED|Overall Study||20
580821|NCT00552812|1416080|P1|COMPLETED|Overall Study|Some still remain inside the 2 year follow up window. 2 year follow up data is not yet complete.|85
580822|NCT00552812|1416080|P1|STARTED|Overall Study|168 consents, 57 failed cath criteria, 5 met criteria but received covered stent, 1 withdrew consent|105
580823|NCT00552786|1416088|P2|NOT COMPLETED|Second Intervention||0
580824|NCT00552786|1416089|P1|NOT COMPLETED|Second Intervention||0
580825|NCT00552786|1416088|P2|COMPLETED|Second Intervention||28
580826|NCT00552786|1416089|P1|COMPLETED|Second Intervention||25
580827|NCT00552786|1416088|P2|STARTED|Second Intervention||28
580828|NCT00552786|1416089|P1|STARTED|Second Intervention||25
580829|NCT00552786|1416088|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
580830|NCT00552786|1416089|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
580831|NCT00552786|1416088|P2|COMPLETED|Washout Period of 2 Weeks||28
580832|NCT00552786|1416089|P1|COMPLETED|Washout Period of 2 Weeks||25
580833|NCT00552786|1416088|P2|STARTED|Washout Period of 2 Weeks||28
580834|NCT00552786|1416089|P1|STARTED|Washout Period of 2 Weeks||25
580835|NCT00552786|1416088|P2|NOT COMPLETED|First Intervention||0
580836|NCT00552786|1416089|P1|NOT COMPLETED|First Intervention||0
580837|NCT00552786|1416088|P2|COMPLETED|First Intervention||28
580838|NCT00552786|1416089|P1|COMPLETED|First Intervention||25
580839|NCT00552786|1416088|P2|Medication and Hearing Evaluation|First Intervention||28
580840|NCT00552786|1416089|P1|Medication and Hearing Evaluation|First Intervention||25
580841|NCT00552786|1416088|P2|STARTED|First Intervention||28
580842|NCT00552786|1416089|P1|STARTED|First Intervention||25
580843|NCT00552760|1416099|P2|NOT COMPLETED|Overall Study||33
580844|NCT00552760|1416100|P1|NOT COMPLETED|Overall Study||26
580845|NCT00552760|1416099|P2|COMPLETED|Overall Study||8
580846|NCT00552760|1416100|P1|COMPLETED|Overall Study||16
580847|NCT00552760|1416099|P2|STARTED|Overall Study||41
580848|NCT00552760|1416100|P1|STARTED|Overall Study||42
580849|NCT00552695|1416116|P2|NOT COMPLETED|Overall Study||0
580850|NCT00552695|1416117|P1|NOT COMPLETED|Overall Study||0
580851|NCT00552695|1416116|P2|COMPLETED|Overall Study|September 2007|23
580852|NCT00552695|1416117|P1|COMPLETED|Overall Study|September 2007|22
580853|NCT00552695|1416116|P2|STARTED|Overall Study|August 2007|23
580854|NCT00552695|1416117|P1|STARTED|Overall Study|August 2007|22
580855|NCT00552669|1416127|P2|NOT COMPLETED|Overall Study||7
580856|NCT00552669|1416128|P1|NOT COMPLETED|Overall Study||3
580857|NCT00552669|1416127|P2|COMPLETED|Overall Study|All patients were followed for 18.3 +/- 7 months.|93
580858|NCT00552669|1416128|P1|COMPLETED|Overall Study|All patients were followed for 18.3 +/- 7 months.|97
580859|NCT00552669|1416127|P2|STARTED|Overall Study|patients|100
580860|NCT00552669|1416128|P1|STARTED|Overall Study|patients|100
580861|NCT00552578|1416140|P2|NOT COMPLETED|Overall Study||1
580862|NCT00552578|1416141|P1|NOT COMPLETED|Overall Study||1
580863|NCT00552578|1416140|P2|COMPLETED|Overall Study||5
580864|NCT00552578|1416141|P1|COMPLETED|Overall Study||5
580865|NCT00552578|1416140|P2|STARTED|Overall Study||6
580866|NCT00552578|1416141|P1|STARTED|Overall Study||6
580867|NCT00552513|1416153|P2|NOT COMPLETED|Overall Study||1
580868|NCT00552513|1416154|P1|NOT COMPLETED|Overall Study||5
580869|NCT00552513|1416153|P2|COMPLETED|Overall Study||1437
580870|NCT00552513|1416154|P1|COMPLETED|Overall Study||1588
580871|NCT00552513|1416153|P2|STARTED|Overall Study||1438
580872|NCT00552513|1416154|P1|STARTED|Overall Study||1593
580873|NCT00552448|1416166|P2|NOT COMPLETED|Overall Study||0
580874|NCT00552448|1416167|P1|NOT COMPLETED|Overall Study||1
580875|NCT00552448|1416166|P2|COMPLETED|Overall Study||16
580876|NCT00552448|1416167|P1|COMPLETED|Overall Study||19
580877|NCT00552448|1416166|P2|STARTED|Overall Study||16
580878|NCT00552448|1416167|P1|STARTED|Overall Study||20
580879|NCT00552422|1416179|P1|NOT COMPLETED|Overall Study||0
580880|NCT00552422|1416179|P1|COMPLETED|Overall Study||6
580881|NCT00552422|1416179|P1|STARTED|Overall Study||6
580882|NCT00552409|1416185|P2|NOT COMPLETED|Overall Study||2
580883|NCT00552409|1416186|P1|NOT COMPLETED|Overall Study||1
580884|NCT00552409|1416185|P2|COMPLETED|Overall Study||9
580885|NCT00552409|1416186|P1|COMPLETED|Overall Study||10
580886|NCT00552409|1416185|P2|STARTED|Overall Study||11
580887|NCT00552409|1416186|P1|STARTED|Overall Study||11
580888|NCT00552396|1416199|P7|NOT COMPLETED|Overall Study||9
580889|NCT00552396|1416200|P6|NOT COMPLETED|Overall Study||3
580890|NCT00552396|1416201|P5|NOT COMPLETED|Overall Study||3
580891|NCT00552396|1416202|P4|NOT COMPLETED|Overall Study||6
580892|NCT00552396|1416203|P3|NOT COMPLETED|Overall Study||3
580893|NCT00552396|1416204|P2|NOT COMPLETED|Overall Study||3
580894|NCT00552396|1416205|P1|NOT COMPLETED|Overall Study||3
580895|NCT00552396|1416199|P7|COMPLETED|Overall Study||1
580896|NCT00552396|1416200|P6|COMPLETED|Overall Study||0
580897|NCT00552396|1416201|P5|COMPLETED|Overall Study||0
580898|NCT00552396|1416202|P4|COMPLETED|Overall Study||0
580899|NCT00552396|1416203|P3|COMPLETED|Overall Study||0
580900|NCT00552396|1416204|P2|COMPLETED|Overall Study||0
580901|NCT00552396|1416205|P1|COMPLETED|Overall Study||1
580902|NCT00552396|1416199|P7|STARTED|Overall Study||10
580903|NCT00552396|1416200|P6|STARTED|Overall Study||3
580904|NCT00552396|1416201|P5|STARTED|Overall Study||3
580905|NCT00552396|1416202|P4|STARTED|Overall Study||6
580906|NCT00552396|1416203|P3|STARTED|Overall Study||3
580907|NCT00552396|1416204|P2|STARTED|Overall Study||3
580908|NCT00552396|1416205|P1|STARTED|Overall Study||4
580909|NCT00552344|1416242|P1|NOT COMPLETED|Overall Study||315
580910|NCT00552344|1416242|P1|COMPLETED|Overall Study||87
580911|NCT00552344|1416242|P1|STARTED|Overall Study||402
580912|NCT00552305|1416251|P1|NOT COMPLETED|Overall Study||250
580913|NCT00552305|1416251|P1|COMPLETED|Overall Study||120
580914|NCT00552305|1416251|P1|STARTED|Overall Study||370
580915|NCT00552279|1416261|P2|NOT COMPLETED|Overall Study||3
580916|NCT00552279|1416262|P1|NOT COMPLETED|Overall Study||14
580917|NCT00552279|1416261|P2|COMPLETED|Overall Study||398
580918|NCT00552279|1416262|P1|COMPLETED|Overall Study||389
580919|NCT00552279|1416261|P2|STARTED|Overall Study||401
580920|NCT00552279|1416262|P1|STARTED|Overall Study||403
580921|NCT00552240|1416288|P2|NOT COMPLETED|Overall Study||18
580922|NCT00552240|1416289|P1|NOT COMPLETED|Overall Study||24
580923|NCT00552240|1416288|P2|COMPLETED|Overall Study||59
580924|NCT00552240|1416289|P1|COMPLETED|Overall Study||51
580925|NCT00552240|1416288|P2|STARTED|Overall Study|Number in Full Analysis Set (FAS)|77
580926|NCT00552240|1416289|P1|STARTED|Overall Study|Number in Full Analysis Set (FAS)|75
580927|NCT00552188|1416391|P2|NOT COMPLETED|Overall Study||5
580928|NCT00552188|1416392|P1|NOT COMPLETED|Overall Study||2
580929|NCT00552188|1416391|P2|COMPLETED|Overall Study||21
580930|NCT00552188|1416392|P1|COMPLETED|Overall Study||24
580931|NCT00552188|1416391|P2|STARTED|Overall Study||26
580932|NCT00552188|1416392|P1|STARTED|Overall Study||26
580933|NCT00552175|1416403|P3|NOT COMPLETED|Overall Study||14
580934|NCT00552175|1416404|P2|NOT COMPLETED|Overall Study||13
580935|NCT00552175|1416405|P1|NOT COMPLETED|Overall Study||17
580936|NCT00552175|1416403|P3|COMPLETED|Overall Study||72
580937|NCT00552175|1416404|P2|COMPLETED|Overall Study||73
580938|NCT00552175|1416405|P1|COMPLETED|Overall Study||150
580939|NCT00552175|1416403|P3|Full Analysis Set Population|Overall Study||86
580940|NCT00552175|1416404|P2|Full Analysis Set Population|Overall Study||85
580941|NCT00552175|1416405|P1|Full Analysis Set Population|Overall Study||167
580942|NCT00552175|1416403|P3|STARTED|Overall Study||86
580943|NCT00552175|1416404|P2|STARTED|Overall Study||86
580944|NCT00552175|1416405|P1|STARTED|Overall Study||167
580945|NCT00552110|1416445|P5|NOT COMPLETED|Overall Study||9
580946|NCT00552110|1416446|P4|NOT COMPLETED|Overall Study||8
580947|NCT00552110|1416447|P3|NOT COMPLETED|Overall Study||2
580948|NCT00552110|1416448|P2|NOT COMPLETED|Overall Study||5
580949|NCT00552110|1416449|P1|NOT COMPLETED|Overall Study||4
580950|NCT00552110|1416445|P5|COMPLETED|Overall Study||133
580951|NCT00552110|1416446|P4|COMPLETED|Overall Study||133
580952|NCT00552110|1416447|P3|COMPLETED|Overall Study||137
580953|NCT00552110|1416448|P2|COMPLETED|Overall Study||134
580954|NCT00552110|1416449|P1|COMPLETED|Overall Study||142
580955|NCT00552110|1416445|P5|STARTED|Overall Study||142
580956|NCT00552110|1416446|P4|STARTED|Overall Study|One subject was excluded from the intent to treat population because there was no record of dosing.|141
580957|NCT00552110|1416447|P3|STARTED|Overall Study||139
580958|NCT00552110|1416448|P2|STARTED|Overall Study||139
580959|NCT00552110|1416449|P1|STARTED|Overall Study|One subject was excluded from the intent to treat population because there was no record of dosing.|146
580960|NCT00552084|1416468|P2|NOT COMPLETED|Overall Study||9
580961|NCT00552084|1416469|P1|NOT COMPLETED|Overall Study||8
580962|NCT00552084|1416468|P2|COMPLETED|Overall Study||55
580963|NCT00552084|1416469|P1|COMPLETED|Overall Study||118
580964|NCT00552084|1416468|P2|STARTED|Overall Study||64
580965|NCT00552084|1416469|P1|STARTED|Overall Study||126
580966|NCT00552058|1416477|P2|NOT COMPLETED|Overall Study||24
580967|NCT00552058|1416478|P1|NOT COMPLETED|Overall Study||16
580968|NCT00552058|1416477|P2|COMPLETED|Overall Study||192
580969|NCT00552058|1416478|P1|COMPLETED|Overall Study||207
580970|NCT00552058|1416477|P2|STARTED|Overall Study||216
580971|NCT00552058|1416478|P1|STARTED|Overall Study||223
580972|NCT00552032|1416518|P2|NOT COMPLETED|Overall Study||19
580973|NCT00552032|1416519|P1|NOT COMPLETED|Overall Study||17
580974|NCT00552032|1416518|P2|COMPLETED|Overall Study||47
580975|NCT00552032|1416519|P1|COMPLETED|Overall Study||49
580976|NCT00552032|1416518|P2|STARTED|Overall Study||66
580977|NCT00552032|1416519|P1|STARTED|Overall Study||66
580978|NCT00551759|1416563|P1|NOT COMPLETED|Overall Study||13
580979|NCT00551759|1416563|P1|COMPLETED|Overall Study||9
580980|NCT00551759|1416563|P1|Received Adjuvant Therapy|Overall Study||12
580981|NCT00551759|1416563|P1|Underwent Surgery|Overall Study||17
580982|NCT00551759|1416563|P1|Eligible and Began Treatment|Overall Study||21
580983|NCT00551759|1416563|P1|STARTED|Overall Study||22
580984|NCT00551746|1416569|P2|NOT COMPLETED|Overall Study||8
580985|NCT00551746|1416570|P1|NOT COMPLETED|Overall Study||11
580986|NCT00551746|1416569|P2|COMPLETED|Overall Study||26
580987|NCT00551746|1416570|P1|COMPLETED|Overall Study||25
580988|NCT00551746|1416569|P2|STARTED|Overall Study||34
580989|NCT00551746|1416570|P1|STARTED|Overall Study||36
580990|NCT00551707|1416581|P5|NOT COMPLETED|Overall Study||1
580991|NCT00551707|1416582|P4|NOT COMPLETED|Overall Study||4
580992|NCT00551707|1416583|P3|NOT COMPLETED|Overall Study||3
580993|NCT00551707|1416584|P2|NOT COMPLETED|Overall Study||6
580994|NCT00551707|1416585|P1|NOT COMPLETED|Overall Study||0
580995|NCT00551707|1416581|P5|COMPLETED|Overall Study||3
580996|NCT00551707|1416582|P4|COMPLETED|Overall Study||4
580997|NCT00551707|1416583|P3|COMPLETED|Overall Study||10
580998|NCT00551707|1416584|P2|COMPLETED|Overall Study||16
580999|NCT00551707|1416585|P1|COMPLETED|Overall Study||4
581000|NCT00551707|1416581|P5|STARTED|Overall Study||4
581001|NCT00551707|1416582|P4|STARTED|Overall Study||8
581002|NCT00551707|1416583|P3|STARTED|Overall Study||13
581003|NCT00551707|1416584|P2|STARTED|Overall Study||22
581004|NCT00551707|1416585|P1|STARTED|Overall Study||4
581005|NCT00551642|1416604|P2|NOT COMPLETED|Overall Study||63
581006|NCT00551642|1416605|P1|NOT COMPLETED|Overall Study||61
581007|NCT00551642|1416604|P2|COMPLETED|Overall Study||338
581008|NCT00551642|1416605|P1|COMPLETED|Overall Study||338
581009|NCT00551642|1416604|P2|STARTED|Overall Study||401
581010|NCT00551642|1416605|P1|STARTED|Overall Study||399
581011|NCT00551525|1416611|P1|NOT COMPLETED|Overall Study||5
581012|NCT00551525|1416611|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study|62
581013|NCT00551525|1416611|P1|STARTED|Overall Study||67
581014|NCT00551460|1416620|P1|NOT COMPLETED|Overall Study||18
581015|NCT00551460|1416620|P1|COMPLETED|Overall Study||60
581016|NCT00551460|1416620|P1|STARTED|Overall Study||78
581017|NCT00551421|1416626|P1|NOT COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||1
581018|NCT00551421|1416626|P1|COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||13
581019|NCT00551421|1416626|P1|STARTED|Amended Protocol (Cetuximab-refr. mCRC)||14
581020|NCT00551421|1416626|P1|NOT COMPLETED|Original Protocol, Dose Level 1||0
581021|NCT00551421|1416626|P1|COMPLETED|Original Protocol, Dose Level 1|1 subject developed Grade 3 diarrhea, all 3 subjects experienced significant skin toxicity.|3
581022|NCT00551421|1416626|P1|STARTED|Original Protocol, Dose Level 1||3
581023|NCT00551369|1416633|P1|NOT COMPLETED|Overall Study||7
581024|NCT00551369|1416633|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study|26
581025|NCT00551369|1416633|P1|STARTED|Overall Study||33
581026|NCT00551291|1416641|P1|NOT COMPLETED|Overall Study||1
581027|NCT00551291|1416641|P1|COMPLETED|Overall Study||9
581028|NCT00551291|1416641|P1|STARTED|Overall Study||10
581029|NCT00551213|1416649|P2|NOT COMPLETED|Overall Study||17
581030|NCT00551213|1416650|P1|NOT COMPLETED|Overall Study||50
581031|NCT00551213|1416649|P2|COMPLETED|Overall Study||0
581032|NCT00551213|1416650|P1|COMPLETED|Overall Study||0
581033|NCT00551213|1416649|P2|Treated|Overall Study||15
581034|NCT00551213|1416650|P1|Treated|Overall Study||49
581035|NCT00551213|1416649|P2|STARTED|Overall Study||17
581036|NCT00551213|1416650|P1|STARTED|Overall Study||50
581037|NCT00551200|1416666|P1|NOT COMPLETED|Overall Study||4
581038|NCT00551200|1416666|P1|COMPLETED|Overall Study||10
581039|NCT00551200|1416666|P1|STARTED|Overall Study||14
581040|NCT00551174|1416681|P2|NOT COMPLETED|Overall Study||6
581041|NCT00551174|1416682|P1|NOT COMPLETED|Overall Study||19
581042|NCT00551174|1416681|P2|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|394
581043|NCT00551174|1416682|P1|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|362
581044|NCT00551174|1416681|P2|STARTED|Overall Study||400
581045|NCT00551174|1416682|P1|STARTED|Overall Study||381
581046|NCT00551161|1416694|P1|NOT COMPLETED|Overall Study||1
581047|NCT00551161|1416694|P1|COMPLETED|Overall Study||11
581048|NCT00551161|1416694|P1|STARTED|Overall Study||12
581049|NCT00551135|1416702|P4|NOT COMPLETED|Overall Study||5
581050|NCT00551135|1416703|P3|NOT COMPLETED|Overall Study||5
581051|NCT00551135|1416704|P2|NOT COMPLETED|Overall Study||2
581052|NCT00551135|1416705|P1|NOT COMPLETED|Overall Study||5
581053|NCT00551135|1416702|P4|COMPLETED|Overall Study||103
581054|NCT00551135|1416703|P3|COMPLETED|Overall Study||98
581055|NCT00551135|1416704|P2|COMPLETED|Overall Study||104
581056|NCT00551135|1416705|P1|COMPLETED|Overall Study||103
581057|NCT00551135|1416702|P4|STARTED|Overall Study||108
581058|NCT00551135|1416703|P3|STARTED|Overall Study||103
581059|NCT00551135|1416704|P2|STARTED|Overall Study||106
581060|NCT00551135|1416705|P1|STARTED|Overall Study||108
581061|NCT00551070|1416819|P1|NOT COMPLETED|Overall Study||0
581062|NCT00551070|1416819|P1|COMPLETED|Overall Study||52
581063|NCT00551070|1416819|P1|STARTED|Overall Study||52
581064|NCT00551031|1416834|P5|NOT COMPLETED|Overall Study||1
581065|NCT00551031|1416835|P4|NOT COMPLETED|Overall Study||3
581066|NCT00551031|1416836|P3|NOT COMPLETED|Overall Study||2
581067|NCT00551031|1416837|P2|NOT COMPLETED|Overall Study||11
581068|NCT00551031|1416838|P1|NOT COMPLETED|Overall Study||2
581069|NCT00551031|1416834|P5|COMPLETED|Overall Study||185
581070|NCT00551031|1416835|P4|COMPLETED|Overall Study||317
581071|NCT00551031|1416836|P3|COMPLETED|Overall Study||317
581072|NCT00551031|1416837|P2|COMPLETED|Overall Study||625
581073|NCT00551031|1416838|P1|COMPLETED|Overall Study||635
581074|NCT00551031|1416834|P5|STARTED|Overall Study||186
581075|NCT00551031|1416835|P4|STARTED|Overall Study||320
581076|NCT00551031|1416836|P3|STARTED|Overall Study||319
581077|NCT00551031|1416837|P2|STARTED|Overall Study||636
581078|NCT00551031|1416838|P1|STARTED|Overall Study||637
581079|NCT00550953|1416867|P2|NOT COMPLETED|Overall Study||6
581080|NCT00550953|1416868|P1|NOT COMPLETED|Overall Study||6
581081|NCT00550953|1416867|P2|COMPLETED|Overall Study||152
581082|NCT00550953|1416868|P1|COMPLETED|Overall Study||150
581083|NCT00550953|1416867|P2|STARTED|Overall Study||158
581084|NCT00550953|1416868|P1|STARTED|Overall Study||156
581085|NCT00550862|1416892|P4|NOT COMPLETED|Overall Study||1
581086|NCT00550862|1416893|P3|NOT COMPLETED|Overall Study||16
581087|NCT00550862|1416894|P2|NOT COMPLETED|Overall Study||6
581088|NCT00550862|1416895|P1|NOT COMPLETED|Overall Study||6
581089|NCT00550862|1416892|P4|COMPLETED|Overall Study||37
581090|NCT00550862|1416893|P3|COMPLETED|Overall Study||25
581091|NCT00550862|1416894|P2|COMPLETED|Overall Study||42
581092|NCT00550862|1416895|P1|COMPLETED|Overall Study||32
581093|NCT00550862|1416892|P4|STARTED|Overall Study||38
581094|NCT00550862|1416893|P3|STARTED|Overall Study||41
581095|NCT00550862|1416894|P2|STARTED|Overall Study||48
581096|NCT00550862|1416895|P1|STARTED|Overall Study||38
581097|NCT00550836|1416915|P2|NOT COMPLETED|Overall Study||9
581098|NCT00550836|1416916|P1|NOT COMPLETED|Overall Study||3
581099|NCT00550836|1416915|P2|COMPLETED|Overall Study||46
581100|NCT00550836|1416916|P1|COMPLETED|Overall Study||46
581101|NCT00550836|1416915|P2|STARTED|Overall Study||55
581102|NCT00550836|1416916|P1|STARTED|Overall Study||49
581103|NCT00550771|1416932|P2|NOT COMPLETED|Overall Study||10
581104|NCT00550771|1416933|P1|NOT COMPLETED|Overall Study||17
581105|NCT00550771|1416932|P2|COMPLETED|Overall Study||50
581106|NCT00550771|1416933|P1|COMPLETED|Overall Study||104
581107|NCT00550771|1416932|P2|STARTED|Overall Study||60
581108|NCT00550771|1416933|P1|STARTED|Overall Study||121
581109|NCT00550745|1416947|P2|NOT COMPLETED|Overall Study||60
581110|NCT00550745|1416948|P1|NOT COMPLETED|Overall Study||87
581111|NCT00550745|1416947|P2|COMPLETED|Overall Study||5939
581112|NCT00550745|1416948|P1|COMPLETED|Overall Study||5913
581113|NCT00550745|1416947|P2|STARTED|Overall Study||5999
581114|NCT00550745|1416948|P1|STARTED|Overall Study||6000
581115|NCT00550732|1416956|P1|NOT COMPLETED|Overall Study||11
581116|NCT00550732|1416956|P1|COMPLETED|Overall Study||29
581117|NCT00550732|1416956|P1|STARTED|Overall Study||40
581118|NCT00550680|1416967|P1|NOT COMPLETED|Overall Study||56
581119|NCT00550680|1416967|P1|COMPLETED|Overall Study||152
581120|NCT00550680|1416967|P1|STARTED|Overall Study||208
581121|NCT00550654|1416976|P1|NOT COMPLETED|Overall Study||0
581122|NCT00550654|1416976|P1|COMPLETED|Overall Study||1
581123|NCT00550654|1416976|P1|STARTED|Overall Study||1
581124|NCT00550589|1416986|P1|NOT COMPLETED|Overall Study||0
581125|NCT00550589|1416986|P1|COMPLETED|Overall Study||33
581126|NCT00550589|1416986|P1|STARTED|Overall Study||33
581127|NCT00550550|1416999|P2|NOT COMPLETED|Overall Study||29
581128|NCT00550550|1417000|P1|NOT COMPLETED|Overall Study||34
581129|NCT00550550|1416999|P2|COMPLETED|Overall Study||140
581130|NCT00550550|1417000|P1|COMPLETED|Overall Study||142
581131|NCT00550550|1416999|P2|Number Treated|Overall Study||169
581132|NCT00550550|1417000|P1|Number Treated|Overall Study||175
581133|NCT00550550|1416999|P2|STARTED|Overall Study||169
581134|NCT00550550|1417000|P1|STARTED|Overall Study||176
581135|NCT00550537|1417012|P1|NOT COMPLETED|Overall Study||104
581136|NCT00550537|1417012|P1|COMPLETED|Overall Study||12
581137|NCT00550537|1417012|P1|STARTED|Overall Study||116
581138|NCT00550459|1417029|P2|NOT COMPLETED|Overall Study||3
581139|NCT00550459|1417030|P1|NOT COMPLETED|Overall Study||1
581140|NCT00550459|1417029|P2|COMPLETED|Overall Study||26
581141|NCT00550459|1417030|P1|COMPLETED|Overall Study||27
581142|NCT00550459|1417029|P2|STARTED|Overall Study||29
581143|NCT00550459|1417030|P1|STARTED|Overall Study||28
581144|NCT00550446|1417099|P11|NOT COMPLETED|Post Week 12||1
581145|NCT00550446|1417100|P10|NOT COMPLETED|Post Week 12||7
581146|NCT00550446|1417101|P9|NOT COMPLETED|Post Week 12||2
581147|NCT00550446|1417102|P8|NOT COMPLETED|Post Week 12||1
581148|NCT00550446|1417103|P7|NOT COMPLETED|Post Week 12||2
581149|NCT00550446|1417104|P6|NOT COMPLETED|Post Week 12||1
581150|NCT00550446|1417105|P5|NOT COMPLETED|Post Week 12||2
581151|NCT00550446|1417106|P4|NOT COMPLETED|Post Week 12||3
581152|NCT00550446|1417107|P3|NOT COMPLETED|Post Week 12||3
581153|NCT00550446|1417108|P2|NOT COMPLETED|Post Week 12||2
581154|NCT00550446|1417109|P1|NOT COMPLETED|Post Week 12||3
581155|NCT00550446|1417099|P11|COMPLETED|Post Week 12||24
581156|NCT00550446|1417100|P10|COMPLETED|Post Week 12||37
581157|NCT00550446|1417101|P9|COMPLETED|Post Week 12||15
581158|NCT00550446|1417102|P8|COMPLETED|Post Week 12||16
581159|NCT00550446|1417103|P7|COMPLETED|Post Week 12||19
581160|NCT00550446|1417104|P6|COMPLETED|Post Week 12||0
581161|NCT00550446|1417105|P5|COMPLETED|Post Week 12||52
581162|NCT00550446|1417106|P4|COMPLETED|Post Week 12||55
581163|NCT00550446|1417107|P3|COMPLETED|Post Week 12||43
581164|NCT00550446|1417108|P2|COMPLETED|Post Week 12||28
581165|NCT00550446|1417109|P1|COMPLETED|Post Week 12||24
581166|NCT00550446|1417099|P11|STARTED|Post Week 12||25
581167|NCT00550446|1417100|P10|STARTED|Post Week 12||44
581168|NCT00550446|1417101|P9|STARTED|Post Week 12||17
581169|NCT00550446|1417102|P8|STARTED|Post Week 12||17
581170|NCT00550446|1417103|P7|STARTED|Post Week 12||21
581171|NCT00550446|1417104|P6|STARTED|Post Week 12||1
581172|NCT00550446|1417105|P5|STARTED|Post Week 12||54
581173|NCT00550446|1417106|P4|STARTED|Post Week 12||58
581174|NCT00550446|1417107|P3|STARTED|Post Week 12||46
581175|NCT00550446|1417108|P2|STARTED|Post Week 12||30
581176|NCT00550446|1417109|P1|STARTED|Post Week 12||27
581177|NCT00550446|1417099|P11|NOT COMPLETED|Up To Week 12||0
581178|NCT00550446|1417100|P10|NOT COMPLETED|Up To Week 12||0
581179|NCT00550446|1417101|P9|NOT COMPLETED|Up To Week 12||0
581180|NCT00550446|1417102|P8|NOT COMPLETED|Up To Week 12||0
581181|NCT00550446|1417103|P7|NOT COMPLETED|Up To Week 12||13
581182|NCT00550446|1417104|P6|NOT COMPLETED|Up To Week 12||8
581183|NCT00550446|1417105|P5|NOT COMPLETED|Up To Week 12||3
581184|NCT00550446|1417106|P4|NOT COMPLETED|Up To Week 12||3
581185|NCT00550446|1417107|P3|NOT COMPLETED|Up To Week 12||4
581186|NCT00550446|1417108|P2|NOT COMPLETED|Up To Week 12||5
581187|NCT00550446|1417109|P1|NOT COMPLETED|Up To Week 12||10
581188|NCT00550446|1417099|P11|COMPLETED|Up To Week 12||0
581189|NCT00550446|1417100|P10|COMPLETED|Up To Week 12||0
581190|NCT00550446|1417101|P9|COMPLETED|Up To Week 12||0
581191|NCT00550446|1417102|P8|COMPLETED|Up To Week 12||0
581192|NCT00550446|1417103|P7|COMPLETED|Up To Week 12||46
581193|NCT00550446|1417104|P6|COMPLETED|Up To Week 12||45
581194|NCT00550446|1417105|P5|COMPLETED|Up To Week 12||54
581195|NCT00550446|1417106|P4|COMPLETED|Up To Week 12||58
581196|NCT00550446|1417107|P3|COMPLETED|Up To Week 12||46
581197|NCT00550446|1417108|P2|COMPLETED|Up To Week 12||47
581198|NCT00550446|1417109|P1|COMPLETED|Up To Week 12||44
581199|NCT00550446|1417099|P11|Treated|Up To Week 12||0
581200|NCT00550446|1417100|P10|Treated|Up To Week 12||0
581201|NCT00550446|1417101|P9|Treated|Up To Week 12||0
581202|NCT00550446|1417102|P8|Treated|Up To Week 12||0
581203|NCT00550446|1417103|P7|Treated|Up To Week 12||59
581204|NCT00550446|1417104|P6|Treated|Up To Week 12||53
581205|NCT00550446|1417105|P5|Treated|Up To Week 12||57
581206|NCT00550446|1417106|P4|Treated|Up To Week 12||61
581207|NCT00550446|1417107|P3|Treated|Up To Week 12||49
581208|NCT00550446|1417108|P2|Treated|Up To Week 12||51
581209|NCT00550446|1417109|P1|Treated|Up To Week 12||54
581210|NCT00550446|1417099|P11|STARTED|Up To Week 12||0
581211|NCT00550446|1417100|P10|STARTED|Up To Week 12||0
581212|NCT00550446|1417101|P9|STARTED|Up To Week 12||0
581213|NCT00550446|1417102|P8|STARTED|Up To Week 12||0
581214|NCT00550446|1417103|P7|STARTED|Up To Week 12||59
581215|NCT00550446|1417104|P6|STARTED|Up To Week 12||53
581216|NCT00550446|1417105|P5|STARTED|Up To Week 12||57
581217|NCT00550446|1417106|P4|STARTED|Up To Week 12||61
581218|NCT00550446|1417107|P3|STARTED|Up To Week 12||50
581219|NCT00550446|1417108|P2|STARTED|Up To Week 12||52
581220|NCT00550446|1417109|P1|STARTED|Up To Week 12||54
581221|NCT00550420|1417541|P1|NOT COMPLETED|Overall Study||305
581222|NCT00550420|1417541|P1|COMPLETED|Overall Study||26
581223|NCT00550420|1417541|P1|STARTED|Overall Study||331
581224|NCT00550407|1417564|P3|NOT COMPLETED|26-Week Randomized Phase||24
581225|NCT00550407|1417565|P2|NOT COMPLETED|26-Week Randomized Phase||43
581226|NCT00550407|1417566|P1|NOT COMPLETED|26-Week Randomized Phase||0
581227|NCT00550407|1417564|P3|COMPLETED|26-Week Randomized Phase||21
581228|NCT00550407|1417565|P2|COMPLETED|26-Week Randomized Phase||15
581229|NCT00550407|1417566|P1|COMPLETED|26-Week Randomized Phase||0
581230|NCT00550407|1417564|P3|STARTED|26-Week Randomized Phase||45
581231|NCT00550407|1417565|P2|STARTED|26-Week Randomized Phase||58
581232|NCT00550407|1417566|P1|STARTED|26-Week Randomized Phase||0
581233|NCT00550407|1417564|P3|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
581234|NCT00550407|1417565|P2|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
581235|NCT00550407|1417566|P1|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||112
581236|NCT00550407|1417564|P3|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
581237|NCT00550407|1417565|P2|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
581238|NCT00550407|1417566|P1|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||103
581239|NCT00550407|1417564|P3|STARTED|8-16 Week Preliminary (Open-Label) Phase||0
581240|NCT00550407|1417565|P2|STARTED|8-16 Week Preliminary (Open-Label) Phase||0
581241|NCT00550407|1417566|P1|STARTED|8-16 Week Preliminary (Open-Label) Phase||215
581242|NCT00550394|1417601|P2|NOT COMPLETED|Overall Study||13
581243|NCT00550394|1417602|P1|NOT COMPLETED|Overall Study||12
581244|NCT00550394|1417601|P2|COMPLETED|Overall Study||5
581245|NCT00550394|1417602|P1|COMPLETED|Overall Study||9
581246|NCT00550394|1417601|P2|STARTED|Overall Study||18
581247|NCT00550394|1417602|P1|STARTED|Overall Study||21
581248|NCT00550368|1417616|P2|NOT COMPLETED|Overall Study||0
581249|NCT00550368|1417617|P1|NOT COMPLETED|Overall Study||0
581250|NCT00550368|1417616|P2|COMPLETED|Overall Study||19
581251|NCT00550368|1417617|P1|COMPLETED|Overall Study||26
581252|NCT00550368|1417616|P2|STARTED|Overall Study||19
581253|NCT00550368|1417617|P1|STARTED|Overall Study||26
581254|NCT00550277|1417625|P1|NOT COMPLETED|Overall Study||9
581255|NCT00550277|1417625|P1|COMPLETED|Overall Study||11
581256|NCT00550277|1417625|P1|STARTED|Overall Study||20
581257|NCT00550173|1417632|P3|NOT COMPLETED|Overall Study||73
581258|NCT00550173|1417633|P2|NOT COMPLETED|Overall Study||63
581259|NCT00550173|1417634|P1|NOT COMPLETED|Overall Study||72
581260|NCT00550173|1417632|P3|COMPLETED|Overall Study||11
581261|NCT00550173|1417633|P2|COMPLETED|Overall Study||19
581262|NCT00550173|1417634|P1|COMPLETED|Overall Study||9
581263|NCT00550173|1417632|P3|Not Discontinued at 18 Months|Overall Study||11
581264|NCT00550173|1417633|P2|Not Discontinued at 18 Months|Overall Study||19
581265|NCT00550173|1417634|P1|Not Discontinued at 18 Months|Overall Study||9
581266|NCT00550173|1417632|P3|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|80
581267|NCT00550173|1417633|P2|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|82
581268|NCT00550173|1417634|P1|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|78
581269|NCT00550173|1417632|P3|STARTED|Overall Study||84
581270|NCT00550173|1417633|P2|STARTED|Overall Study||82
581271|NCT00550173|1417634|P1|STARTED|Overall Study||81
581272|NCT00550147|1417663|P1|NOT COMPLETED|Quetiapine Addition Treatment Period||6
581273|NCT00550147|1417663|P1|COMPLETED|Quetiapine Addition Treatment Period||18
581274|NCT00550147|1417663|P1|STARTED|Quetiapine Addition Treatment Period||24
581275|NCT00550147|1417663|P1|NOT COMPLETED|OROS Methylphenidate Monotherapy||6
581276|NCT00550147|1417663|P1|COMPLETED|OROS Methylphenidate Monotherapy||24
581277|NCT00550147|1417663|P1|STARTED|OROS Methylphenidate Monotherapy||30
581278|NCT00550043|1417686|P5|NOT COMPLETED|Overall Study||1
581279|NCT00550043|1417687|P4|NOT COMPLETED|Overall Study||2
581280|NCT00550043|1417688|P3|NOT COMPLETED|Overall Study||1
581281|NCT00550043|1417689|P2|NOT COMPLETED|Overall Study||3
581282|NCT00550043|1417690|P1|NOT COMPLETED|Overall Study||0
581283|NCT00550043|1417686|P5|COMPLETED|Overall Study||9
581284|NCT00550043|1417687|P4|COMPLETED|Overall Study||8
581285|NCT00550043|1417688|P3|COMPLETED|Overall Study||8
581286|NCT00550043|1417689|P2|COMPLETED|Overall Study||9
581287|NCT00550043|1417690|P1|COMPLETED|Overall Study||9
581288|NCT00550043|1417686|P5|STARTED|Overall Study||10
581289|NCT00550043|1417687|P4|STARTED|Overall Study||10
581290|NCT00550043|1417688|P3|STARTED|Overall Study||9
581291|NCT00550043|1417689|P2|STARTED|Overall Study||12
581292|NCT00550043|1417690|P1|STARTED|Overall Study||9
581293|NCT00549939|1417745|P3|NOT COMPLETED|40-week Open Label Treatment Period||5
581294|NCT00549939|1417746|P2|NOT COMPLETED|40-week Open Label Treatment Period||5
581295|NCT00549939|1417747|P1|NOT COMPLETED|40-week Open Label Treatment Period||0
581296|NCT00549939|1417745|P3|COMPLETED|40-week Open Label Treatment Period||78
581297|NCT00549939|1417746|P2|COMPLETED|40-week Open Label Treatment Period||75
581298|NCT00549939|1417747|P1|COMPLETED|40-week Open Label Treatment Period||0
581299|NCT00549939|1417745|P3|STARTED|40-week Open Label Treatment Period|55 patients continued Alfuzosin 0.2 mg/kg/day and 28 patients started Alfuzosin 0.2 mg/kg/day.|83
581300|NCT00549939|1417746|P2|STARTED|40-week Open Label Treatment Period|54 patients continued Alfuzosin 0.1 mg/kg/day and 26 patients started Alfuzosin 0.1 mg/kg/day.|80
581301|NCT00549939|1417747|P1|STARTED|40-week Open Label Treatment Period|54 patients continued and switched to Alfuzosin: 26 to 0.1 mg/kg/day and 28 to 0.2 mg/kg/day.|0
581302|NCT00549939|1417745|P3|NOT COMPLETED|12-week Double Blind Treatment Period||2
581303|NCT00549939|1417746|P2|NOT COMPLETED|12-week Double Blind Treatment Period||2
581304|NCT00549939|1417747|P1|NOT COMPLETED|12-week Double Blind Treatment Period||1
581305|NCT00549939|1417745|P3|COMPLETED|12-week Double Blind Treatment Period||56
581306|NCT00549939|1417746|P2|COMPLETED|12-week Double Blind Treatment Period||55
581307|NCT00549939|1417747|P1|COMPLETED|12-week Double Blind Treatment Period||56
581308|NCT00549939|1417745|P3|STARTED|12-week Double Blind Treatment Period||58
581309|NCT00549939|1417746|P2|STARTED|12-week Double Blind Treatment Period||57
581310|NCT00549939|1417747|P1|STARTED|12-week Double Blind Treatment Period|29 (Alfuzosin 0.1 mg/kg/day matching placebo) + 28 (Alfuzosin 0.2 mg/kg/day matching placebo)|57
581311|NCT00549900|1417774|P1|NOT COMPLETED|Overall Study||1
581312|NCT00549900|1417774|P1|COMPLETED|Overall Study||29
581313|NCT00549900|1417774|P1|STARTED|Overall Study||30
581314|NCT00549822|1417783|P1|NOT COMPLETED|Overall Study||0
581315|NCT00549822|1417783|P1|COMPLETED|Overall Study||3
581316|NCT00549822|1417783|P1|STARTED|Overall Study||3
581317|NCT00549783|1417791|P2|NOT COMPLETED|Overall Study||13
581318|NCT00549783|1417792|P1|NOT COMPLETED|Overall Study||8
581319|NCT00549783|1417791|P2|COMPLETED|Overall Study||122
581320|NCT00549783|1417792|P1|COMPLETED|Overall Study||131
581321|NCT00549783|1417791|P2|STARTED|Overall Study||135
581322|NCT00549783|1417792|P1|STARTED|Overall Study||139
581323|NCT00549770|1417830|P8|NOT COMPLETED|Overall Study||25
581324|NCT00549770|1417831|P7|NOT COMPLETED|Overall Study||14
581325|NCT00549770|1417832|P6|NOT COMPLETED|Overall Study||13
581326|NCT00549770|1417833|P5|NOT COMPLETED|Overall Study||17
581327|NCT00549770|1417834|P4|NOT COMPLETED|Overall Study||16
581328|NCT00549770|1417835|P3|NOT COMPLETED|Overall Study||10
581329|NCT00549770|1417836|P2|NOT COMPLETED|Overall Study||11
581330|NCT00549770|1417837|P1|NOT COMPLETED|Overall Study||7
581331|NCT00549770|1417830|P8|COMPLETED|Overall Study||148
581332|NCT00549770|1417831|P7|COMPLETED|Overall Study||151
581333|NCT00549770|1417832|P6|COMPLETED|Overall Study||151
581334|NCT00549770|1417833|P5|COMPLETED|Overall Study||149
581335|NCT00549770|1417834|P4|COMPLETED|Overall Study||147
581336|NCT00549770|1417835|P3|COMPLETED|Overall Study||162
581337|NCT00549770|1417836|P2|COMPLETED|Overall Study||158
581338|NCT00549770|1417837|P1|COMPLETED|Overall Study||149
581339|NCT00549770|1417830|P8|Ambulatory Blood Pressure Monitoring|Overall Study||57
581340|NCT00549770|1417831|P7|Ambulatory Blood Pressure Monitoring|Overall Study||50
581341|NCT00549770|1417832|P6|Ambulatory Blood Pressure Monitoring|Overall Study||54
581342|NCT00549770|1417833|P5|Ambulatory Blood Pressure Monitoring|Overall Study||49
581343|NCT00549770|1417834|P4|Ambulatory Blood Pressure Monitoring|Overall Study||55
581344|NCT00549770|1417835|P3|Ambulatory Blood Pressure Monitoring|Overall Study||53
581345|NCT00549770|1417836|P2|Ambulatory Blood Pressure Monitoring|Overall Study||61
581346|NCT00549770|1417837|P1|Ambulatory Blood Pressure Monitoring|Overall Study||48
581347|NCT00549770|1417830|P8|Intent-to-treat Population|Overall Study||172
581348|NCT00549770|1417831|P7|Intent-to-treat Population|Overall Study||164
581349|NCT00549770|1417832|P6|Intent-to-treat Population|Overall Study||163
581350|NCT00549770|1417833|P5|Intent-to-treat Population|Overall Study||163
581351|NCT00549770|1417834|P4|Intent-to-treat Population|Overall Study||163
581352|NCT00549770|1417835|P3|Intent-to-treat Population|Overall Study||170
581353|NCT00549770|1417836|P2|Intent-to-treat Population|Overall Study||168
581354|NCT00549770|1417837|P1|Intent-to-treat Population|Overall Study||154
581355|NCT00549770|1417830|P8|STARTED|Overall Study||173
581356|NCT00549770|1417831|P7|STARTED|Overall Study||165
581357|NCT00549770|1417832|P6|STARTED|Overall Study||164
581358|NCT00549770|1417833|P5|STARTED|Overall Study||166
581359|NCT00549770|1417834|P4|STARTED|Overall Study||163
581360|NCT00549770|1417835|P3|STARTED|Overall Study||172
581361|NCT00549770|1417836|P2|STARTED|Overall Study||169
581362|NCT00549770|1417837|P1|STARTED|Overall Study||156
581363|NCT00549757|1417921|P2|NOT COMPLETED|Extension Period (in Average 9 Months)||635
581364|NCT00549757|1417922|P1|NOT COMPLETED|Extension Period (in Average 9 Months)||625
581365|NCT00549757|1417921|P2|COMPLETED|Extension Period (in Average 9 Months)||3182
581366|NCT00549757|1417922|P1|COMPLETED|Extension Period (in Average 9 Months)||3148
581367|NCT00549757|1417921|P2|STARTED|Extension Period (in Average 9 Months)|"As explained in pre-assignment detail, follow up was made after drug discontinuation"|3817
581368|NCT00549757|1417922|P1|STARTED|Extension Period (in Average 9 Months)|"As explained in pre-assignment detail, follow up was made after drug discontinuation"|3773
581369|NCT00549757|1417921|P2|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4310
581370|NCT00549757|1417922|P1|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4296
581371|NCT00549757|1417921|P2|COMPLETED|Active Treatment Phase: Max. 50 Months||0
581372|NCT00549757|1417922|P1|COMPLETED|Active Treatment Phase: Max. 50 Months||0
581373|NCT00549757|1417921|P2|Safety Set|Active Treatment Phase: Max. 50 Months||4285
581374|NCT00549757|1417922|P1|Safety Set|Active Treatment Phase: Max. 50 Months||4272
581375|NCT00549757|1417921|P2|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4287
581376|NCT00549757|1417922|P1|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4274
581377|NCT00549757|1417921|P2|STARTED|Active Treatment Phase: Max. 50 Months||4310
581378|NCT00549757|1417922|P1|STARTED|Active Treatment Phase: Max. 50 Months|"Started indicates randomized patients."|4296
581379|NCT00549718|1417984|P4|NOT COMPLETED|Overall Study||55
581380|NCT00549718|1417985|P3|NOT COMPLETED|Overall Study||39
581381|NCT00549718|1417986|P2|NOT COMPLETED|Overall Study||37
581382|NCT00549718|1417987|P1|NOT COMPLETED|Overall Study||41
581383|NCT00549718|1417984|P4|COMPLETED|Overall Study||73
581384|NCT00549718|1417985|P3|COMPLETED|Overall Study||85
581385|NCT00549718|1417986|P2|COMPLETED|Overall Study||86
581386|NCT00549718|1417987|P1|COMPLETED|Overall Study||84
581387|NCT00549718|1417984|P4|STARTED|Overall Study||128
581388|NCT00549718|1417985|P3|STARTED|Overall Study||124
581389|NCT00549718|1417986|P2|STARTED|Overall Study||123
581390|NCT00549718|1417987|P1|STARTED|Overall Study||125
581391|NCT00549640|1418003|P2|NOT COMPLETED|Overall Study||16
581392|NCT00549640|1418004|P1|NOT COMPLETED|Overall Study||18
581393|NCT00549640|1418003|P2|COMPLETED|Overall Study||24
581394|NCT00549640|1418004|P1|COMPLETED|Overall Study|For the primary endpoint, subjects who discontinued participation were assumed to be smoking.|22
581395|NCT00549640|1418003|P2|STARTED|Overall Study||40
581396|NCT00549640|1418004|P1|STARTED|Overall Study||40
581397|NCT00549601|1418017|P3|NOT COMPLETED|Received Study Drug||4
581398|NCT00549601|1418018|P2|NOT COMPLETED|Received Study Drug||11
581399|NCT00549601|1418019|P1|NOT COMPLETED|Received Study Drug||7
581400|NCT00549601|1418017|P3|COMPLETED|Received Study Drug||45
581401|NCT00549601|1418018|P2|COMPLETED|Received Study Drug||36
581402|NCT00549601|1418019|P1|COMPLETED|Received Study Drug||36
581403|NCT00549601|1418017|P3|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|49
581404|NCT00549601|1418018|P2|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|47
581405|NCT00549601|1418019|P1|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|43
581406|NCT00549601|1418017|P3|NOT COMPLETED|Randomized||2
581407|NCT00549601|1418018|P2|NOT COMPLETED|Randomized||1
581408|NCT00549601|1418019|P1|NOT COMPLETED|Randomized||0
581409|NCT00549601|1418017|P3|COMPLETED|Randomized||49
581410|NCT00549601|1418018|P2|COMPLETED|Randomized||47
581411|NCT00549601|1418019|P1|COMPLETED|Randomized||43
581412|NCT00549601|1418017|P3|STARTED|Randomized||51
581413|NCT00549601|1418018|P2|STARTED|Randomized||48
581414|NCT00549601|1418019|P1|STARTED|Randomized||43
581415|NCT00549562|1418041|P1|NOT COMPLETED|Overall Study||2
581416|NCT00549562|1418041|P1|COMPLETED|Overall Study||23
581417|NCT00549562|1418041|P1|STARTED|Overall Study||25
581418|NCT00549549|1418053|P4|NOT COMPLETED|Overall Study||25
581419|NCT00549549|1418054|P3|NOT COMPLETED|Overall Study||17
581420|NCT00549549|1418055|P2|NOT COMPLETED|Overall Study||22
581421|NCT00549549|1418056|P1|NOT COMPLETED|Overall Study||24
581422|NCT00549549|1418053|P4|COMPLETED|Overall Study||78
581423|NCT00549549|1418054|P3|COMPLETED|Overall Study||82
581424|NCT00549549|1418055|P2|COMPLETED|Overall Study||77
581425|NCT00549549|1418056|P1|COMPLETED|Overall Study||77
581426|NCT00549549|1418053|P4|Treated|Overall Study||102
581427|NCT00549549|1418054|P3|Treated|Overall Study||98
581428|NCT00549549|1418055|P2|Treated|Overall Study||99
581429|NCT00549549|1418056|P1|Treated|Overall Study||101
581430|NCT00549549|1418053|P4|STARTED|Overall Study||103
581431|NCT00549549|1418054|P3|STARTED|Overall Study||99
581432|NCT00549549|1418055|P2|STARTED|Overall Study||99
581433|NCT00549549|1418056|P1|STARTED|Overall Study||101
581434|NCT00549445|1418124|P2|NOT COMPLETED|Overall Study||17
581435|NCT00549445|1418125|P1|NOT COMPLETED|Overall Study||15
581436|NCT00549445|1418124|P2|COMPLETED|Overall Study||13
581437|NCT00549445|1418125|P1|COMPLETED|Overall Study||8
581438|NCT00549445|1418124|P2|STARTED|Overall Study||30
581439|NCT00549445|1418125|P1|STARTED|Overall Study||23
581440|NCT00549393|1418133|P2|NOT COMPLETED|Period 3 (6 Months)||0
581441|NCT00549393|1418134|P1|NOT COMPLETED|Period 3 (6 Months)||0
581442|NCT00549393|1418133|P2|COMPLETED|Period 3 (6 Months)||1326
581443|NCT00549393|1418134|P1|COMPLETED|Period 3 (6 Months)||1103
581444|NCT00549393|1418133|P2|Per Protocol|Period 3 (6 Months)||1326
581445|NCT00549393|1418134|P1|Per Protocol|Period 3 (6 Months)||667
581446|NCT00549393|1418133|P2|STARTED|Period 3 (6 Months)|number not equal to period 1 due to unit cross over design|1326
581447|NCT00549393|1418134|P1|STARTED|Period 3 (6 Months)|number not equal to period 1 due to unit cross over design|1103
581448|NCT00549393|1418133|P2|NOT COMPLETED|Period 2 Washout (2 Weeks)||0
581449|NCT00549393|1418134|P1|NOT COMPLETED|Period 2 Washout (2 Weeks)||0
581450|NCT00549393|1418133|P2|COMPLETED|Period 2 Washout (2 Weeks)||0
581451|NCT00549393|1418134|P1|COMPLETED|Period 2 Washout (2 Weeks)||0
581452|NCT00549393|1418133|P2|STARTED|Period 2 Washout (2 Weeks)||0
581453|NCT00549393|1418134|P1|STARTED|Period 2 Washout (2 Weeks)||0
581454|NCT00549393|1418133|P2|NOT COMPLETED|Period 1 (6 Months)||0
581455|NCT00549393|1418134|P1|NOT COMPLETED|Period 1 (6 Months)||0
581456|NCT00549393|1418133|P2|COMPLETED|Period 1 (6 Months)||1199
581457|NCT00549393|1418134|P1|COMPLETED|Period 1 (6 Months)||1319
581458|NCT00549393|1418133|P2|Per Protocol|Period 1 (6 Months)||1199
581459|NCT00549393|1418134|P1|Per Protocol|Period 1 (6 Months)||880
581460|NCT00549393|1418133|P2|STARTED|Period 1 (6 Months)|ITT|1199
581461|NCT00549393|1418134|P1|STARTED|Period 1 (6 Months)|intention to treat (ITT)|1319
581462|NCT00549328|1418144|P1|NOT COMPLETED|Overall Study||14
581463|NCT00549328|1418144|P1|COMPLETED|Overall Study||0
581464|NCT00549328|1418144|P1|STARTED|Overall Study||14
581465|NCT00549302|1418155|P3|NOT COMPLETED|Open-Label||69
581466|NCT00549302|1418156|P2|NOT COMPLETED|Open-Label||0
581467|NCT00549302|1418157|P1|NOT COMPLETED|Open-Label||0
581468|NCT00549302|1418155|P3|COMPLETED|Open-Label|Another death occurred during the 30-day follow-up period after study drug discontinuation|217
581469|NCT00549302|1418156|P2|COMPLETED|Open-Label||0
581470|NCT00549302|1418157|P1|COMPLETED|Open-Label||0
581471|NCT00549302|1418155|P3|STARTED|Open-Label|7 participants who completed the Double-Blind Period did not enter the Open-Label Period.|286
581472|NCT00549302|1418156|P2|STARTED|Open-Label||0
581473|NCT00549302|1418157|P1|STARTED|Open-Label||0
581474|NCT00549302|1418155|P3|NOT COMPLETED|Double-Blind||0
581475|NCT00549302|1418156|P2|NOT COMPLETED|Double-Blind||53
581476|NCT00549302|1418157|P1|NOT COMPLETED|Double-Blind||11
581477|NCT00549302|1418155|P3|COMPLETED|Double-Blind||0
581478|NCT00549302|1418156|P2|COMPLETED|Double-Blind|Participants who completed the Double-Blind Period were eligible to enter the Open-Label Period.|241
581479|NCT00549302|1418157|P1|COMPLETED|Double-Blind|Participants who completed the Double-Blind Period were eligible to enter the Open-Label Period.|52
581480|NCT00549302|1418155|P3|Received at Least One Dose of Study Drug|Double-Blind||0
581481|NCT00549302|1418156|P2|Received at Least One Dose of Study Drug|Double-Blind||294
581482|NCT00549302|1418157|P1|Received at Least One Dose of Study Drug|Double-Blind||63
581483|NCT00549302|1418155|P3|STARTED|Double-Blind||0
581484|NCT00549302|1418156|P2|STARTED|Double-Blind||294
581485|NCT00549302|1418157|P1|STARTED|Double-Blind||63
581486|NCT00549198|1418169|P2|NOT COMPLETED|Overall Study||63
581487|NCT00549198|1418170|P1|NOT COMPLETED|Overall Study||80
581488|NCT00549198|1418169|P2|COMPLETED|Overall Study||134
581489|NCT00549198|1418170|P1|COMPLETED|Overall Study||115
581490|NCT00549198|1418169|P2|STARTED|Overall Study|Four participants were randomized but were not exposed to study drug (TDF/FTC).|197
581491|NCT00549198|1418170|P1|STARTED|Overall Study|Three participants were randomized but were not exposed to study drug (ABC/3TC).|195
581498|NCT00549055|1418307|P1|NOT COMPLETED|Overall Study||35
581499|NCT00549055|1418307|P1|COMPLETED|Overall Study||3
581500|NCT00549055|1418307|P1|STARTED|Overall Study||38
581501|NCT00548886|1418317|P1|NOT COMPLETED|Overall Study||0
581502|NCT00548886|1418317|P1|COMPLETED|Overall Study||7
581503|NCT00548886|1418317|P1|STARTED|Overall Study||7
581504|NCT00548860|1418324|P2|NOT COMPLETED|Overall Study||175
581505|NCT00548860|1418325|P1|NOT COMPLETED|Overall Study||136
581506|NCT00548860|1418324|P2|COMPLETED|Overall Study||847
581507|NCT00548860|1418325|P1|COMPLETED|Overall Study||860
581508|NCT00548860|1418324|P2|STARTED|Overall Study||1022
581509|NCT00548860|1418325|P1|STARTED|Overall Study||996
581510|NCT00548847|1418331|P1|NOT COMPLETED|Overall Study||7
581511|NCT00548847|1418331|P1|COMPLETED|Overall Study||8
581512|NCT00548847|1418331|P1|STARTED|Overall Study||15
581513|NCT00548808|1418338|P2|NOT COMPLETED|Overall Study||26
581514|NCT00548808|1418339|P1|NOT COMPLETED|Overall Study||42
581515|NCT00548808|1418338|P2|COMPLETED|Overall Study||186
581516|NCT00548808|1418339|P1|COMPLETED|Overall Study||172
581517|NCT00548808|1418338|P2|Per-Protocol Set|Overall Study||184
581518|NCT00548808|1418339|P1|Per-Protocol Set|Overall Study||177
581519|NCT00548808|1418338|P2|Full Analysis Set|Overall Study||212
581520|NCT00548808|1418339|P1|Full Analysis Set|Overall Study||211
581521|NCT00548808|1418338|P2|STARTED|Overall Study||212
581522|NCT00548808|1418339|P1|STARTED|Overall Study||214
581523|NCT00548717|1418363|P2|NOT COMPLETED|Overall Study||2
581524|NCT00548717|1418364|P1|NOT COMPLETED|Overall Study||9
581525|NCT00548717|1418363|P2|COMPLETED|Overall Study||0
581526|NCT00548717|1418364|P1|COMPLETED|Overall Study||4
581527|NCT00548717|1418363|P2|STARTED|Overall Study||2
581528|NCT00548717|1418364|P1|STARTED|Overall Study||13
581529|NCT00548691|1418383|P2|NOT COMPLETED|Overall Study||9
581530|NCT00548691|1418384|P1|NOT COMPLETED|Overall Study||7
581531|NCT00548691|1418383|P2|COMPLETED|Overall Study||250
581532|NCT00548691|1418384|P1|COMPLETED|Overall Study||251
581533|NCT00548691|1418383|P2|STARTED|Overall Study||259
581534|NCT00548691|1418384|P1|STARTED|Overall Study||258
581535|NCT00548548|1418392|P2|NOT COMPLETED|Overall Study||366
581536|NCT00548548|1418393|P1|NOT COMPLETED|Overall Study||362
581537|NCT00548548|1418392|P2|COMPLETED|Overall Study||21
581538|NCT00548548|1418393|P1|COMPLETED|Overall Study|Completed treatment discontinuation form was not completed; patient was counted alive on treatment.|25
581539|NCT00548548|1418392|P2|Safety Population|Overall Study||381
581540|NCT00548548|1418393|P1|Safety Population|Overall Study|Four patients randomized to placebo received single doses of bevacizumab in error.|386
581541|NCT00548548|1418392|P2|Treated|Overall Study||384
581542|NCT00548548|1418393|P1|Treated|Overall Study||383
581543|NCT00548548|1418392|P2|STARTED|Overall Study||387
581544|NCT00548548|1418393|P1|STARTED|Overall Study||387
581545|NCT00548470|1418413|P1|NOT COMPLETED|Overall Study||2
581546|NCT00548470|1418413|P1|COMPLETED|Overall Study||12
581547|NCT00548470|1418413|P1|STARTED|Overall Study||14
581548|NCT00548431|1418421|P1|NOT COMPLETED|Overall Study||0
581549|NCT00548431|1418421|P1|COMPLETED|Overall Study||38
581550|NCT00548431|1418421|P1|STARTED|Overall Study||38
581551|NCT00548418|1418425|P1|NOT COMPLETED|Overall Study||0
581552|NCT00548418|1418425|P1|COMPLETED|Overall Study||27
581553|NCT00548418|1418425|P1|STARTED|Overall Study||27
581554|NCT00548405|1418436|P3|NOT COMPLETED|Overall Study||9
581555|NCT00548405|1418437|P2|NOT COMPLETED|Overall Study||20
581556|NCT00548405|1418438|P1|NOT COMPLETED|Overall Study||56
581557|NCT00548405|1418436|P3|COMPLETED|Overall Study||164
581558|NCT00548405|1418437|P2|COMPLETED|Overall Study||416
581559|NCT00548405|1418438|P1|COMPLETED|Overall Study||175
581560|NCT00548405|1418436|P3|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|170
581561|NCT00548405|1418437|P2|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|426
581562|NCT00548405|1418438|P1|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|202
581563|NCT00548405|1418436|P3|STARTED|Overall Study|Randomized.|173
581564|NCT00548405|1418437|P2|STARTED|Overall Study|Randomized.|436
581565|NCT00548405|1418438|P1|STARTED|Overall Study|Randomized.|231
581566|NCT00548340|1418459|P3|NOT COMPLETED|Overall Study||9
581567|NCT00548340|1418460|P2|NOT COMPLETED|Overall Study||11
581568|NCT00548340|1418461|P1|NOT COMPLETED|Overall Study||8
581569|NCT00548340|1418459|P3|COMPLETED|Overall Study||95
581570|NCT00548340|1418460|P2|COMPLETED|Overall Study||98
581571|NCT00548340|1418461|P1|COMPLETED|Overall Study||101
581572|NCT00548340|1418459|P3|STARTED|Overall Study||104
581573|NCT00548340|1418460|P2|STARTED|Overall Study||109
581574|NCT00548340|1418461|P1|STARTED|Overall Study||109
581575|NCT00548327|1418480|P2|NOT COMPLETED|Overall Study||1
581576|NCT00548327|1418481|P1|NOT COMPLETED|Overall Study||0
581577|NCT00548327|1418480|P2|COMPLETED|Overall Study|Patient randomized to receive placebo first. While on placebo, Adverse Event lead to discontinuation|4
581578|NCT00548327|1418481|P1|COMPLETED|Overall Study||6
581579|NCT00548327|1418480|P2|STARTED|Overall Study||5
581580|NCT00548327|1418481|P1|STARTED|Overall Study||6
581581|NCT00548262|1418499|P1|NOT COMPLETED|Overall Study||32
581582|NCT00548262|1418499|P1|COMPLETED|Overall Study|1 N had D/C recorded as died and as lack of efficacy; reported as lack of efficacy in reason for D/C|22
581583|NCT00548262|1418499|P1|STARTED|Overall Study|1 participant (N) had death recorded twice; reported as 1 death in reason for discontinuation (D/C)|54
581584|NCT00548249|1418529|P5|NOT COMPLETED|Overall Study||21
581585|NCT00548249|1418530|P4|NOT COMPLETED|Overall Study||13
581586|NCT00548249|1418531|P3|NOT COMPLETED|Overall Study||20
581587|NCT00548249|1418532|P2|NOT COMPLETED|Overall Study||13
581588|NCT00548249|1418533|P1|NOT COMPLETED|Overall Study||16
581589|NCT00548249|1418529|P5|COMPLETED|Overall Study||7
581590|NCT00548249|1418530|P4|COMPLETED|Overall Study||9
581591|NCT00548249|1418531|P3|COMPLETED|Overall Study||9
581592|NCT00548249|1418532|P2|COMPLETED|Overall Study||13
581593|NCT00548249|1418533|P1|COMPLETED|Overall Study||10
581594|NCT00548249|1418529|P5|STARTED|Overall Study||28
581595|NCT00548249|1418530|P4|STARTED|Overall Study||22
581596|NCT00548249|1418531|P3|STARTED|Overall Study||29
581597|NCT00548249|1418532|P2|STARTED|Overall Study||26
581598|NCT00548249|1418533|P1|STARTED|Overall Study||26
581599|NCT00548184|1418570|P1|NOT COMPLETED|Overall Study||5
581600|NCT00548184|1418570|P1|COMPLETED|Overall Study|65 patients were on treatment. 5 did not complete due to adverse events or other reasons.|60
581601|NCT00548184|1418570|P1|STARTED|Overall Study||65
581602|NCT00548145|1418576|P2|NOT COMPLETED|Overall Study||4
581603|NCT00548145|1418577|P1|NOT COMPLETED|Overall Study||1
581604|NCT00548145|1418576|P2|COMPLETED|Overall Study||16
581605|NCT00548145|1418577|P1|COMPLETED|Overall Study||17
581606|NCT00548145|1418576|P2|STARTED|Overall Study||20
581607|NCT00548145|1418577|P1|STARTED|Overall Study||18
581608|NCT00548132|1418585|P2|NOT COMPLETED|Overall Study||0
581609|NCT00548132|1418586|P1|NOT COMPLETED|Overall Study||0
581610|NCT00548132|1418585|P2|COMPLETED|Overall Study||554
581611|NCT00548132|1418586|P1|COMPLETED|Overall Study||534
581612|NCT00548132|1418585|P2|Consented to Study|Overall Study||554
581613|NCT00548132|1418586|P1|Consented to Study|Overall Study||534
581614|NCT00548132|1418585|P2|STARTED|Overall Study||554
581615|NCT00548132|1418586|P1|STARTED|Overall Study||534
581616|NCT00548041|1418594|P1|NOT COMPLETED|Overall Study||0
581617|NCT00548041|1418594|P1|COMPLETED|Overall Study||100
581618|NCT00548041|1418594|P1|STARTED|Overall Study||100
581619|NCT00547911|1418602|P6|NOT COMPLETED|Overall Study||0
581620|NCT00547911|1418603|P5|NOT COMPLETED|Overall Study||0
581621|NCT00547911|1418604|P4|NOT COMPLETED|Overall Study||1
581622|NCT00547911|1418605|P3|NOT COMPLETED|Overall Study||0
581623|NCT00547911|1418606|P2|NOT COMPLETED|Overall Study||0
581624|NCT00547911|1418607|P1|NOT COMPLETED|Overall Study||0
581625|NCT00547911|1418602|P6|COMPLETED|Overall Study||3
581626|NCT00547911|1418603|P5|COMPLETED|Overall Study||3
581627|NCT00547911|1418604|P4|COMPLETED|Overall Study||1
581628|NCT00547911|1418605|P3|COMPLETED|Overall Study||2
581629|NCT00547911|1418606|P2|COMPLETED|Overall Study||2
581630|NCT00547911|1418607|P1|COMPLETED|Overall Study||2
581631|NCT00547911|1418602|P6|STARTED|Overall Study||3
581632|NCT00547911|1418603|P5|STARTED|Overall Study||3
581633|NCT00547911|1418604|P4|STARTED|Overall Study||2
581634|NCT00547911|1418605|P3|STARTED|Overall Study||2
581635|NCT00547911|1418606|P2|STARTED|Overall Study||2
581636|NCT00547911|1418607|P1|STARTED|Overall Study||2
581637|NCT00547703|1418638|P2|NOT COMPLETED|Overall Study||0
581638|NCT00547703|1418639|P1|NOT COMPLETED|Overall Study||1
581639|NCT00547703|1418638|P2|COMPLETED|Overall Study||1
581640|NCT00547703|1418639|P1|COMPLETED|Overall Study||3
581641|NCT00547703|1418638|P2|STARTED|Overall Study||1
581642|NCT00547703|1418639|P1|STARTED|Overall Study||4
581643|NCT00547638|1418647|P2|NOT COMPLETED|Overall Study||14
581644|NCT00547638|1418648|P1|NOT COMPLETED|Overall Study||24
581645|NCT00547638|1418647|P2|COMPLETED|Overall Study||59
581646|NCT00547638|1418648|P1|COMPLETED|Overall Study||119
581647|NCT00547638|1418647|P2|STARTED|Overall Study||73
581648|NCT00547638|1418648|P1|STARTED|Overall Study||143
581649|NCT00547534|1418664|P1|NOT COMPLETED|Overall Study||11
581650|NCT00547534|1418664|P1|COMPLETED|Overall Study|25 patients received at least 4 cycles. 29 patients were evaluable for response.|19
581651|NCT00547534|1418664|P1|STARTED|Overall Study|31 patients enrolled; one patient was determined to be ineligible, and did not receive any therapy.|30
581652|NCT00547521|1418672|P2|NOT COMPLETED|Long Term Extension (LTE) Study||31
581653|NCT00547521|1418673|P1|NOT COMPLETED|Long Term Extension (LTE) Study||0
581654|NCT00547521|1418672|P2|COMPLETED|Long Term Extension (LTE) Study||59
581655|NCT00547521|1418673|P1|COMPLETED|Long Term Extension (LTE) Study||0
581656|NCT00547521|1418672|P2|STARTED|Long Term Extension (LTE) Study|ST Study had 2 arms, LTE Study pooled all participants who had abatacept injection.|90
581657|NCT00547521|1418673|P1|STARTED|Long Term Extension (LTE) Study|ST Study had 2 arms, LTE Study pooled all participants who had abatacept injection.|0
581658|NCT00547521|1418672|P2|NOT COMPLETED|Short Term Study (4 Months)||4
581659|NCT00547521|1418673|P1|NOT COMPLETED|Short Term Study (4 Months)||1
581660|NCT00547521|1418672|P2|COMPLETED|Short Term Study (4 Months)||45
581661|NCT00547521|1418673|P1|COMPLETED|Short Term Study (4 Months)||50
581662|NCT00547521|1418672|P2|STARTED|Short Term Study (4 Months)|Number of participants treated.|49
581663|NCT00547521|1418673|P1|STARTED|Short Term Study (4 Months)|Number of participants treated.|51
581664|NCT00547456|1418743|P1|NOT COMPLETED|Overall Study||0
581665|NCT00547456|1418743|P1|COMPLETED|Overall Study||20
581666|NCT00547456|1418743|P1|STARTED|Overall Study||20
581667|NCT00547378|1418750|P3|NOT COMPLETED|All Implanted Cohort||70
581668|NCT00547378|1418751|P2|NOT COMPLETED|All Implanted Cohort||18
581669|NCT00547378|1418752|P1|NOT COMPLETED|All Implanted Cohort||15
581670|NCT00547378|1418750|P3|COMPLETED|All Implanted Cohort||111
581671|NCT00547378|1418751|P2|COMPLETED|All Implanted Cohort||22
581672|NCT00547378|1418752|P1|COMPLETED|All Implanted Cohort||36
581673|NCT00547378|1418750|P3|Month 60|All Implanted Cohort||114
581674|NCT00547378|1418751|P2|Month 60|All Implanted Cohort||23
581675|NCT00547378|1418752|P1|Month 60|All Implanted Cohort||36
581676|NCT00547378|1418750|P3|Month 48|All Implanted Cohort||136
581677|NCT00547378|1418751|P2|Month 48|All Implanted Cohort||27
581678|NCT00547378|1418752|P1|Month 48|All Implanted Cohort||38
581679|NCT00547378|1418750|P3|Month 36|All Implanted Cohort||146
581680|NCT00547378|1418751|P2|Month 36|All Implanted Cohort||29
581681|NCT00547378|1418752|P1|Month 36|All Implanted Cohort||42
581682|NCT00547378|1418750|P3|Month 24|All Implanted Cohort||161
581683|NCT00547378|1418751|P2|Month 24|All Implanted Cohort||30
581684|NCT00547378|1418752|P1|Month 24|All Implanted Cohort||42
581685|NCT00547378|1418750|P3|Month 12|All Implanted Cohort||175
581686|NCT00547378|1418751|P2|Month 12|All Implanted Cohort||32
581687|NCT00547378|1418752|P1|Month 12|All Implanted Cohort||48
581688|NCT00547378|1418750|P3|Month 6|All Implanted Cohort||178
581689|NCT00547378|1418751|P2|Month 6|All Implanted Cohort||36
581690|NCT00547378|1418752|P1|Month 6|All Implanted Cohort||50
581691|NCT00547378|1418750|P3|Month 3|All Implanted Cohort||178
581692|NCT00547378|1418751|P2|Month 3|All Implanted Cohort||39
581693|NCT00547378|1418752|P1|Month 3|All Implanted Cohort||51
581694|NCT00547378|1418750|P3|STARTED|All Implanted Cohort|This included subjects who received full system implant from non-randomized subjects.|181
581695|NCT00547378|1418751|P2|STARTED|All Implanted Cohort|This included SMT subjects who received full system implant after completing randomization period.|40
581696|NCT00547378|1418752|P1|STARTED|All Implanted Cohort|This included subjects who received full system implant after randomized to IST.|51
581697|NCT00547378|1418750|P3|NOT COMPLETED|Randomized Cohort||0
581698|NCT00547378|1418751|P2|NOT COMPLETED|Randomized Cohort||6
581699|NCT00547378|1418752|P1|NOT COMPLETED|Randomized Cohort||11
581700|NCT00547378|1418750|P3|COMPLETED|Randomized Cohort||0
581701|NCT00547378|1418751|P2|COMPLETED|Randomized Cohort||71
581702|NCT00547378|1418752|P1|COMPLETED|Randomized Cohort||59
581703|NCT00547378|1418750|P3|Month 6|Randomized Cohort||0
581704|NCT00547378|1418751|P2|Month 6|Randomized Cohort|This included SMT subjects who reached SMT Month 6 visit.|71
581705|NCT00547378|1418752|P1|Month 6|Randomized Cohort|This includes IST subjects reached Month 6 visit, regardless of implant or not.|59
581706|NCT00547378|1418750|P3|Month 3|Randomized Cohort||0
581707|NCT00547378|1418751|P2|Month 3|Randomized Cohort|This included SMT subjects who reached SMT Month 3 visit.|72
581708|NCT00547378|1418752|P1|Month 3|Randomized Cohort|This includes IST subjects reached Month 3 visit, regardless of implant or not.|62
581709|NCT00547378|1418750|P3|STARTED|Randomized Cohort||0
581710|NCT00547378|1418751|P2|STARTED|Randomized Cohort||77
581711|NCT00547378|1418752|P1|STARTED|Randomized Cohort||70
581712|NCT00547365|1418762|P1|NOT COMPLETED|Overall Study||8
581713|NCT00547365|1418762|P1|COMPLETED|Overall Study||2
581714|NCT00547365|1418762|P1|STARTED|Overall Study||10
581715|NCT00547157|1418769|P2|NOT COMPLETED|Overall Study||23
581716|NCT00547157|1418770|P1|NOT COMPLETED|Overall Study||49
581717|NCT00547157|1418769|P2|COMPLETED|Overall Study||39
581718|NCT00547157|1418770|P1|COMPLETED|Overall Study||41
581719|NCT00547157|1418769|P2|STARTED|Overall Study||62
581720|NCT00547157|1418770|P1|STARTED|Overall Study||90
581721|NCT00547118|1418788|P2|NOT COMPLETED|Overall Study||9
581722|NCT00547118|1418789|P1|NOT COMPLETED|Overall Study||8
581723|NCT00547118|1418788|P2|COMPLETED|Overall Study||0
581724|NCT00547118|1418789|P1|COMPLETED|Overall Study||0
581725|NCT00547118|1418788|P2|STARTED|Overall Study||9
581726|NCT00547118|1418789|P1|STARTED|Overall Study||8
581727|NCT00547105|1418821|P1|NOT COMPLETED|Overall Study||0
581728|NCT00547105|1418821|P1|COMPLETED|Overall Study||24
581729|NCT00547105|1418821|P1|STARTED|Overall Study||24
581730|NCT00546910|1418833|P2|NOT COMPLETED|Overall Study||11
581731|NCT00546910|1418834|P1|NOT COMPLETED|Overall Study||9
581732|NCT00546910|1418833|P2|COMPLETED|Overall Study||51
581733|NCT00546910|1418834|P1|COMPLETED|Overall Study||54
581734|NCT00546910|1418833|P2|STARTED|Overall Study||62
581735|NCT00546910|1418834|P1|STARTED|Overall Study||63
581736|NCT00546897|1418854|P2|NOT COMPLETED|Overall Study||0
581737|NCT00546897|1418855|P1|NOT COMPLETED|Overall Study||0
581738|NCT00546897|1418854|P2|COMPLETED|Overall Study||33
581739|NCT00546897|1418855|P1|COMPLETED|Overall Study||15
581740|NCT00546897|1418854|P2|STARTED|Overall Study||33
581741|NCT00546897|1418855|P1|STARTED|Overall Study||15
581742|NCT00546884|1418893|P2|NOT COMPLETED|Overall Study||0
581743|NCT00546884|1418894|P1|NOT COMPLETED|Overall Study||0
581744|NCT00546884|1418893|P2|COMPLETED|Overall Study||117
581745|NCT00546884|1418894|P1|COMPLETED|Overall Study||145
581746|NCT00546884|1418893|P2|STARTED|Overall Study||117
581747|NCT00546884|1418894|P1|STARTED|Overall Study||145
581748|NCT00546871|1418900|P2|NOT COMPLETED|Study Extension Period||1
581749|NCT00546871|1418901|P1|NOT COMPLETED|Study Extension Period||1
581750|NCT00546871|1418900|P2|COMPLETED|Study Extension Period||25
581751|NCT00546871|1418901|P1|COMPLETED|Study Extension Period||9
581752|NCT00546871|1418900|P2|STARTED|Study Extension Period|6 withdrawn after Part 3b|26
581753|NCT00546871|1418901|P1|STARTED|Study Extension Period|2 withdrawn after Part 3b|10
581754|NCT00546871|1418900|P2|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0
581755|NCT00546871|1418901|P1|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0
581756|NCT00546871|1418900|P2|COMPLETED|Part 3b - SC IGIV 12 Weeks||32
581757|NCT00546871|1418901|P1|COMPLETED|Part 3b - SC IGIV 12 Weeks||12
581758|NCT00546871|1418900|P2|STARTED|Part 3b - SC IGIV 12 Weeks||32
581759|NCT00546871|1418901|P1|STARTED|Part 3b - SC IGIV 12 Weeks||12
581760|NCT00546871|1418900|P2|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0
581761|NCT00546871|1418901|P1|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0
581762|NCT00546871|1418900|P2|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||32
581763|NCT00546871|1418901|P1|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||12
581764|NCT00546871|1418900|P2|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||32
581765|NCT00546871|1418901|P1|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||12
581766|NCT00546871|1418900|P2|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||3
581767|NCT00546871|1418901|P1|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||1
581768|NCT00546871|1418900|P2|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||32
581769|NCT00546871|1418901|P1|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||12
581770|NCT00546871|1418900|P2|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||35
581771|NCT00546871|1418901|P1|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||13
581772|NCT00546871|1418900|P2|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||0
581773|NCT00546871|1418901|P1|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||1
581774|NCT00546871|1418900|P2|COMPLETED|Part 1 - IV Infusions of IGIV, PK||35
581775|NCT00546871|1418901|P1|COMPLETED|Part 1 - IV Infusions of IGIV, PK||13
581776|NCT00546871|1418900|P2|STARTED|Part 1 - IV Infusions of IGIV, PK||35
581777|NCT00546871|1418901|P1|STARTED|Part 1 - IV Infusions of IGIV, PK||14
581778|NCT00546819|1419006|P2|NOT COMPLETED|Overall Study||6
581779|NCT00546819|1419007|P1|NOT COMPLETED|Overall Study||8
581780|NCT00546819|1419006|P2|COMPLETED|Overall Study||96
581781|NCT00546819|1419007|P1|COMPLETED|Overall Study||199
581782|NCT00546819|1419006|P2|VACCINATED|Overall Study||100
581783|NCT00546819|1419007|P1|VACCINATED|Overall Study||206
581784|NCT00546819|1419006|P2|STARTED|Overall Study||102
581785|NCT00546819|1419007|P1|STARTED|Overall Study||207
581786|NCT00546754|1419019|P2|NOT COMPLETED|Overall Study||49
581787|NCT00546754|1419020|P1|NOT COMPLETED|Overall Study||50
581788|NCT00546754|1419019|P2|COMPLETED|Overall Study||334
581789|NCT00546754|1419020|P1|COMPLETED|Overall Study||375
581790|NCT00546754|1419019|P2|Week 12|Overall Study||334
581791|NCT00546754|1419020|P1|Week 12|Overall Study||375
581792|NCT00546754|1419019|P2|Week 6|Overall Study||347
581793|NCT00546754|1419020|P1|Week 6|Overall Study||396
581794|NCT00546754|1419019|P2|Treated|Overall Study|Patients that received at least one dose of study medication and had 1 follow-up visit|373
581795|NCT00546754|1419020|P1|Treated|Overall Study|Patients that received at least one dose of study medication and had 1 follow-up visit|416
581796|NCT00546754|1419019|P2|STARTED|Overall Study|Number of patients enrolled and randomized|383
581797|NCT00546754|1419020|P1|STARTED|Overall Study|Number of patients enrolled and randomized|425
581798|NCT00546728|1419052|P2|NOT COMPLETED|Overall Study||0
581799|NCT00546728|1419053|P1|NOT COMPLETED|Overall Study||0
581800|NCT00546728|1419052|P2|COMPLETED|Overall Study||25
581801|NCT00546728|1419053|P1|COMPLETED|Overall Study||25
581802|NCT00546728|1419052|P2|STARTED|Overall Study||25
581803|NCT00546728|1419053|P1|STARTED|Overall Study||25
581804|NCT00546715|1419063|P4|NOT COMPLETED|Overall Study||0
581805|NCT00546715|1419064|P3|NOT COMPLETED|Overall Study||0
581806|NCT00546715|1419065|P2|NOT COMPLETED|Overall Study||1
581807|NCT00546715|1419066|P1|NOT COMPLETED|Overall Study||0
581808|NCT00546715|1419063|P4|COMPLETED|Overall Study||2
581809|NCT00546715|1419064|P3|COMPLETED|Overall Study||5
581810|NCT00546715|1419065|P2|COMPLETED|Overall Study||4
581811|NCT00546715|1419066|P1|COMPLETED|Overall Study||6
581812|NCT00546715|1419063|P4|STARTED|Overall Study||2
581813|NCT00546715|1419064|P3|STARTED|Overall Study||5
581814|NCT00546715|1419065|P2|STARTED|Overall Study||5
581815|NCT00546715|1419066|P1|STARTED|Overall Study||6
581816|NCT00546637|1419121|P2|NOT COMPLETED|Overall Study||49
581817|NCT00546637|1419122|P1|NOT COMPLETED|Overall Study||73
581818|NCT00546637|1419121|P2|COMPLETED|Overall Study||424
581819|NCT00546637|1419122|P1|COMPLETED|Overall Study||401
581820|NCT00546637|1419121|P2|Received Treatment|Overall Study||472
581821|NCT00546637|1419122|P1|Received Treatment|Overall Study||471
581822|NCT00546637|1419121|P2|STARTED|Overall Study||473
581823|NCT00546637|1419122|P1|STARTED|Overall Study||474
581824|NCT00546572|1419196|P2|NOT COMPLETED|Vax 2 / Year 1||2
581825|NCT00546572|1419197|P1|NOT COMPLETED|Vax 2 / Year 1||4
581826|NCT00546572|1419196|P2|COMPLETED|Vax 2 / Year 1||402
581827|NCT00546572|1419197|P1|COMPLETED|Vax 2 / Year 1||387
581828|NCT00546572|1419196|P2|Received Vax 2|Vax 2 / Year 1||404
581829|NCT00546572|1419197|P1|Received Vax 2|Vax 2 / Year 1||391
581830|NCT00546572|1419196|P2|STARTED|Vax 2 / Year 1||404
581831|NCT00546572|1419197|P1|STARTED|Vax 2 / Year 1||391
581832|NCT00546572|1419196|P2|NOT COMPLETED|Vax 1 / Year 0||70
581833|NCT00546572|1419197|P1|NOT COMPLETED|Vax 1 / Year 0||73
581834|NCT00546572|1419196|P2|COMPLETED|Vax 1 / Year 0||404
581835|NCT00546572|1419197|P1|COMPLETED|Vax 1 / Year 0||391
581836|NCT00546572|1419196|P2|Received Vax 1|Vax 1 / Year 0||473
581837|NCT00546572|1419197|P1|Received Vax 1|Vax 1 / Year 0||463
581838|NCT00546572|1419196|P2|STARTED|Vax 1 / Year 0||474
581839|NCT00546572|1419197|P1|STARTED|Vax 1 / Year 0||464
581840|NCT00546481|1419241|P3|NOT COMPLETED|Maintenance Phase (CERA)||4
581841|NCT00546481|1419242|P2|NOT COMPLETED|Maintenance Phase (CERA)||0
581842|NCT00546481|1419243|P1|NOT COMPLETED|Maintenance Phase (CERA)||0
581843|NCT00546481|1419241|P3|COMPLETED|Maintenance Phase (CERA)||50
581844|NCT00546481|1419242|P2|COMPLETED|Maintenance Phase (CERA)||0
581845|NCT00546481|1419243|P1|COMPLETED|Maintenance Phase (CERA)||0
581846|NCT00546481|1419241|P3|STARTED|Maintenance Phase (CERA)||54
581847|NCT00546481|1419242|P2|STARTED|Maintenance Phase (CERA)||0
581848|NCT00546481|1419243|P1|STARTED|Maintenance Phase (CERA)||0
581849|NCT00546481|1419241|P3|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||0
581850|NCT00546481|1419242|P2|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||5
581851|NCT00546481|1419243|P1|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||6
581852|NCT00546481|1419241|P3|COMPLETED|Correction Phase (CERA or Epoetin Beta)||0
581853|NCT00546481|1419242|P2|COMPLETED|Correction Phase (CERA or Epoetin Beta)||36
581854|NCT00546481|1419243|P1|COMPLETED|Correction Phase (CERA or Epoetin Beta)||33
581855|NCT00546481|1419241|P3|STARTED|Correction Phase (CERA or Epoetin Beta)||0
581856|NCT00546481|1419242|P2|STARTED|Correction Phase (CERA or Epoetin Beta)||41
581857|NCT00546481|1419243|P1|STARTED|Correction Phase (CERA or Epoetin Beta)||39
581858|NCT00546429|1419266|P1|NOT COMPLETED|Overall Study||30
581859|NCT00546429|1419266|P1|COMPLETED|Overall Study||32
581860|NCT00546429|1419266|P1|STARTED|Overall Study|2 subjects did not have a preoperative Merle D'Aubigne score.|62
581861|NCT00546377|1419270|P1|NOT COMPLETED|Overall Study||7
581862|NCT00546377|1419270|P1|COMPLETED|Overall Study||43
581863|NCT00546377|1419270|P1|STARTED|Overall Study||50
581864|NCT00546364|1419278|P3|NOT COMPLETED|Overall Study||17
581865|NCT00546364|1419279|P2|NOT COMPLETED|Overall Study||18
581866|NCT00546364|1419280|P1|NOT COMPLETED|Overall Study||17
581867|NCT00546364|1419278|P3|COMPLETED|Overall Study|Still on treatment|3
581868|NCT00546364|1419279|P2|COMPLETED|Overall Study|Still on treatment|4
581869|NCT00546364|1419280|P1|COMPLETED|Overall Study|Still on treatment|3
581870|NCT00546364|1419278|P3|Never Treated|Overall Study||0
581871|NCT00546364|1419279|P2|Never Treated|Overall Study||0
581872|NCT00546364|1419280|P1|Never Treated|Overall Study||0
581873|NCT00546364|1419278|P3|STARTED|Overall Study||20
581874|NCT00546364|1419279|P2|STARTED|Overall Study||22
581875|NCT00546364|1419280|P1|STARTED|Overall Study||20
581876|NCT00546351|1419315|P1|NOT COMPLETED|Overall Study||236
581877|NCT00546351|1419315|P1|COMPLETED|Overall Study||385
581878|NCT00546351|1419315|P1|STARTED|Overall Study||621
581879|NCT00546273|1419348|P5|NOT COMPLETED|IV||0
581880|NCT00546273|1419349|P4|NOT COMPLETED|IV||0
581881|NCT00546273|1419350|P3|NOT COMPLETED|IV||0
581882|NCT00546273|1419351|P2|NOT COMPLETED|IV||0
581883|NCT00546273|1419352|P1|NOT COMPLETED|IV||0
581884|NCT00546273|1419348|P5|COMPLETED|IV||2
581885|NCT00546273|1419349|P4|COMPLETED|IV||4
581886|NCT00546273|1419350|P3|COMPLETED|IV||0
581887|NCT00546273|1419351|P2|COMPLETED|IV||0
581888|NCT00546273|1419352|P1|COMPLETED|IV||0
581889|NCT00546273|1419348|P5|STARTED|IV||2
581890|NCT00546273|1419349|P4|STARTED|IV||4
581891|NCT00546273|1419350|P3|STARTED|IV||0
581894|NCT00546273|1419348|P5|NOT COMPLETED|III||0
581895|NCT00546273|1419349|P4|NOT COMPLETED|III||0
581896|NCT00546273|1419350|P3|NOT COMPLETED|III||0
581897|NCT00546273|1419351|P2|NOT COMPLETED|III||0
581898|NCT00546273|1419352|P1|NOT COMPLETED|III||0
581899|NCT00546273|1419348|P5|COMPLETED|III||2
581900|NCT00546273|1419349|P4|COMPLETED|III||0
581901|NCT00546273|1419350|P3|COMPLETED|III||4
581902|NCT00546273|1419351|P2|COMPLETED|III||0
581903|NCT00546273|1419352|P1|COMPLETED|III||0
581904|NCT00546273|1419348|P5|STARTED|III||2
581905|NCT00546273|1419349|P4|STARTED|III||0
581906|NCT00546273|1419350|P3|STARTED|III||4
581907|NCT00546273|1419351|P2|STARTED|III||0
581908|NCT00546273|1419352|P1|STARTED|III||0
581909|NCT00546273|1419348|P5|NOT COMPLETED|II||0
581910|NCT00546273|1419349|P4|NOT COMPLETED|II||0
581911|NCT00546273|1419350|P3|NOT COMPLETED|II||0
581912|NCT00546273|1419351|P2|NOT COMPLETED|II||0
581913|NCT00546273|1419352|P1|NOT COMPLETED|II||0
581914|NCT00546273|1419348|P5|COMPLETED|II||2
581915|NCT00546273|1419349|P4|COMPLETED|II||0
581916|NCT00546273|1419350|P3|COMPLETED|II||0
581917|NCT00546273|1419351|P2|COMPLETED|II||4
581918|NCT00546273|1419352|P1|COMPLETED|II||0
581919|NCT00546273|1419348|P5|STARTED|II||2
581920|NCT00546273|1419349|P4|STARTED|II||0
581921|NCT00546273|1419350|P3|STARTED|II||0
581922|NCT00546273|1419351|P2|STARTED|II||4
581923|NCT00546273|1419352|P1|STARTED|II||0
581924|NCT00546273|1419348|P5|NOT COMPLETED|I||0
581925|NCT00546273|1419349|P4|NOT COMPLETED|I||0
581926|NCT00546273|1419350|P3|NOT COMPLETED|I||0
581927|NCT00546273|1419351|P2|NOT COMPLETED|I||0
581928|NCT00546273|1419352|P1|NOT COMPLETED|I||0
581929|NCT00546273|1419348|P5|COMPLETED|I||2
581930|NCT00546273|1419349|P4|COMPLETED|I||0
581931|NCT00546273|1419350|P3|COMPLETED|I||0
581932|NCT00546273|1419351|P2|COMPLETED|I||0
581933|NCT00546273|1419352|P1|COMPLETED|I||4
581934|NCT00546273|1419348|P5|STARTED|I||2
581935|NCT00546273|1419349|P4|STARTED|I||0
581936|NCT00546273|1419350|P3|STARTED|I||0
581937|NCT00546273|1419351|P2|STARTED|I||0
581938|NCT00546273|1419352|P1|STARTED|I||4
581939|NCT00546260|1419361|P2|NOT COMPLETED|Overall Study||2
581940|NCT00546260|1419362|P1|NOT COMPLETED|Overall Study||8
581941|NCT00546260|1419361|P2|COMPLETED|Overall Study||32
581942|NCT00546260|1419362|P1|COMPLETED|Overall Study||28
581943|NCT00546260|1419361|P2|STARTED|Overall Study||34
581944|NCT00546260|1419362|P1|STARTED|Overall Study||36
581945|NCT00546156|1419374|P2|NOT COMPLETED|Overall Study||1
581946|NCT00546156|1419375|P1|NOT COMPLETED|Overall Study||14
581947|NCT00546156|1419374|P2|COMPLETED|Overall Study||19
581948|NCT00546156|1419375|P1|COMPLETED|Overall Study||70
581949|NCT00546156|1419374|P2|STARTED|Overall Study||20
581950|NCT00546156|1419375|P1|STARTED|Overall Study||84
581951|NCT00546117|1419384|P2|NOT COMPLETED|Overall Study||0
581952|NCT00546117|1419385|P1|NOT COMPLETED|Overall Study||4
581953|NCT00546117|1419384|P2|COMPLETED|Overall Study||7
581954|NCT00546117|1419385|P1|COMPLETED|Overall Study||5
581955|NCT00546117|1419384|P2|STARTED|Overall Study||7
581956|NCT00546117|1419385|P1|STARTED|Overall Study||9
581957|NCT00546104|1419399|P1|NOT COMPLETED|Overall Study||0
581958|NCT00546104|1419399|P1|COMPLETED|Overall Study||31
581959|NCT00546104|1419399|P1|STARTED|Overall Study||31
581960|NCT00546078|1419410|P2|NOT COMPLETED|Overall Study||7
581961|NCT00546078|1419411|P1|NOT COMPLETED|Overall Study||4
581962|NCT00546078|1419410|P2|COMPLETED|Overall Study||43
581963|NCT00546078|1419411|P1|COMPLETED|Overall Study||61
581964|NCT00546078|1419410|P2|Month 18|Overall Study||45
581965|NCT00546078|1419411|P1|Month 18|Overall Study||61
581966|NCT00546078|1419410|P2|STARTED|Overall Study||50
581967|NCT00546078|1419411|P1|STARTED|Overall Study||65
581968|NCT00546052|1419449|P1|NOT COMPLETED|Overall Study||227
581969|NCT00546052|1419449|P1|COMPLETED|Overall Study||1511
581970|NCT00546052|1419449|P1|Week 52|Overall Study||1511
581971|NCT00546052|1419449|P1|Week 32|Overall Study||1583
581972|NCT00546052|1419449|P1|Week 12|Overall Study||1650
581973|NCT00546052|1419449|P1|Week 8|Overall Study||1680
581974|NCT00546052|1419449|P1|Week 4|Overall Study||1714
581975|NCT00546052|1419449|P1|STARTED|Overall Study||1738
581976|NCT00546000|1419467|P1|NOT COMPLETED|Overall Study||4
581977|NCT00546000|1419467|P1|COMPLETED|Overall Study||52
581978|NCT00546000|1419467|P1|STARTED|Overall Study||56
581979|NCT00545974|1419474|P2|NOT COMPLETED|Overall Study||3
581980|NCT00545974|1419475|P1|NOT COMPLETED|Overall Study||2
581981|NCT00545974|1419474|P2|COMPLETED|Overall Study|subjects completed 26 weeks treatment in placebo cohort|39
581982|NCT00545974|1419475|P1|COMPLETED|Overall Study|subjects completed 26 weeks treatment in memantine cohort|37
581983|NCT00545974|1419474|P2|STARTED|Overall Study|subjects randomized to placebo cohort|42
581984|NCT00545974|1419475|P1|STARTED|Overall Study|subjects randomized to memantine cohort|39
581985|NCT00545948|1419486|P3|NOT COMPLETED|Overall Study||7
581986|NCT00545948|1419487|P2|NOT COMPLETED|Overall Study||1
581987|NCT00545948|1419488|P1|NOT COMPLETED|Overall Study||1
581988|NCT00545948|1419486|P3|COMPLETED|Overall Study||0
581989|NCT00545948|1419487|P2|COMPLETED|Overall Study|Patients who received pemetrexed + cisplatin protocol therapy.|14
581990|NCT00545948|1419488|P1|COMPLETED|Overall Study|Patients who received vinorelbine + cisplatin protocol therapy.|8
581991|NCT00545948|1419486|P3|Assigned Treatment|Overall Study||0
581992|NCT00545948|1419487|P2|Assigned Treatment|Overall Study||15
581993|NCT00545948|1419488|P1|Assigned Treatment|Overall Study||9
581994|NCT00545948|1419486|P3|STARTED|Overall Study|Registered patients who were not assigned to receive protocol therapy.|7
581995|NCT00545948|1419487|P2|STARTED|Overall Study|Registered patients assigned to receive pemetrexed + cisplatin protocol therapy.|15
581996|NCT00545948|1419488|P1|STARTED|Overall Study|Registered patients assigned to receive vinorelbine + cisplatin protocol therapy.|9
581997|NCT00545844|1419498|P1|NOT COMPLETED|Overall Study||12
581998|NCT00545844|1419498|P1|COMPLETED|Overall Study||301
581999|NCT00545844|1419498|P1|STARTED|Overall Study||313
582000|NCT00545792|1419512|P1|NOT COMPLETED|Overall Study||1
582001|NCT00545792|1419512|P1|COMPLETED|Overall Study||20
582002|NCT00545792|1419512|P1|STARTED|Overall Study||21
582003|NCT00545779|1419517|P1|NOT COMPLETED|Overall Study||44
582004|NCT00545779|1419517|P1|COMPLETED|Overall Study||633
582005|NCT00545779|1419517|P1|STARTED|Overall Study||677
582006|NCT00545766|1419530|P1|NOT COMPLETED|Overall Study||5
582007|NCT00545766|1419530|P1|COMPLETED|Overall Study||36
582008|NCT00545766|1419530|P1|STARTED|Overall Study||41
582009|NCT00545753|1419537|P3|NOT COMPLETED|Overall Study||26
582010|NCT00545753|1419538|P2|NOT COMPLETED|Overall Study||5
582011|NCT00545753|1419539|P1|NOT COMPLETED|Overall Study||16
582012|NCT00545753|1419537|P3|COMPLETED|Overall Study||230
582013|NCT00545753|1419538|P2|COMPLETED|Overall Study||54
582014|NCT00545753|1419539|P1|COMPLETED|Overall Study||227
582015|NCT00545753|1419537|P3|STARTED|Overall Study||256
582016|NCT00545753|1419538|P2|STARTED|Overall Study||59
582017|NCT00545753|1419539|P1|STARTED|Overall Study||243
582018|NCT00545740|1419552|P4|NOT COMPLETED|Overall Study||71
582019|NCT00545740|1419553|P3|NOT COMPLETED|Overall Study||96
582020|NCT00545740|1419554|P2|NOT COMPLETED|Overall Study||83
582021|NCT00545740|1419555|P1|NOT COMPLETED|Overall Study||75
582022|NCT00545740|1419552|P4|COMPLETED|Overall Study||78
582023|NCT00545740|1419553|P3|COMPLETED|Overall Study||55
582024|NCT00545740|1419554|P2|COMPLETED|Overall Study||62
582025|NCT00545740|1419555|P1|COMPLETED|Overall Study||70
582026|NCT00545740|1419552|P4|STARTED|Overall Study||149
582027|NCT00545740|1419553|P3|STARTED|Overall Study||151
582028|NCT00545740|1419554|P2|STARTED|Overall Study||145
582029|NCT00545740|1419555|P1|STARTED|Overall Study||145
582030|NCT00545688|1419593|P4|NOT COMPLETED|Follow-Up Period||27
582031|NCT00545688|1419594|P3|NOT COMPLETED|Follow-Up Period||20
582032|NCT00545688|1419595|P2|NOT COMPLETED|Follow-Up Period||19
582033|NCT00545688|1419596|P1|NOT COMPLETED|Follow-Up Period||21
582034|NCT00545688|1419593|P4|COMPLETED|Follow-Up Period||60
582035|NCT00545688|1419594|P3|COMPLETED|Follow-Up Period||78
582036|NCT00545688|1419595|P2|COMPLETED|Follow-Up Period||83
582037|NCT00545688|1419596|P1|COMPLETED|Follow-Up Period||77
582038|NCT00545688|1419593|P4|STARTED|Follow-Up Period||87
582039|NCT00545688|1419594|P3|STARTED|Follow-Up Period||98
582040|NCT00545688|1419595|P2|STARTED|Follow-Up Period||102
582041|NCT00545688|1419596|P1|STARTED|Follow-Up Period||98
582042|NCT00545688|1419593|P4|NOT COMPLETED|Adjuvant Treatment Period||14
582043|NCT00545688|1419594|P3|NOT COMPLETED|Adjuvant Treatment Period||4
582044|NCT00545688|1419595|P2|NOT COMPLETED|Adjuvant Treatment Period||8
582045|NCT00545688|1419596|P1|NOT COMPLETED|Adjuvant Treatment Period||5
582046|NCT00545688|1419593|P4|COMPLETED|Adjuvant Treatment Period||74
582047|NCT00545688|1419594|P3|COMPLETED|Adjuvant Treatment Period||90
582048|NCT00545688|1419595|P2|COMPLETED|Adjuvant Treatment Period||94
582049|NCT00545688|1419596|P1|COMPLETED|Adjuvant Treatment Period||98
582050|NCT00545688|1419593|P4|STARTED|Adjuvant Treatment Period||88
582051|NCT00545688|1419594|P3|STARTED|Adjuvant Treatment Period||94
582052|NCT00545688|1419595|P2|STARTED|Adjuvant Treatment Period||102
582053|NCT00545688|1419596|P1|STARTED|Adjuvant Treatment Period||103
582054|NCT00545688|1419593|P4|NOT COMPLETED|Neo-Adjuvant Treatment Period||6
582055|NCT00545688|1419594|P3|NOT COMPLETED|Neo-Adjuvant Treatment Period||14
582056|NCT00545688|1419595|P2|NOT COMPLETED|Neo-Adjuvant Treatment Period||5
582057|NCT00545688|1419596|P1|NOT COMPLETED|Neo-Adjuvant Treatment Period||4
582058|NCT00545688|1419593|P4|COMPLETED|Neo-Adjuvant Treatment Period||88
582059|NCT00545688|1419594|P3|COMPLETED|Neo-Adjuvant Treatment Period||94
582060|NCT00545688|1419595|P2|COMPLETED|Neo-Adjuvant Treatment Period||102
582061|NCT00545688|1419596|P1|COMPLETED|Neo-Adjuvant Treatment Period||103
582062|NCT00545688|1419593|P4|STARTED|Neo-Adjuvant Treatment Period||94
582063|NCT00545688|1419594|P3|STARTED|Neo-Adjuvant Treatment Period||108
582064|NCT00545688|1419595|P2|STARTED|Neo-Adjuvant Treatment Period||107
582065|NCT00545688|1419596|P1|STARTED|Neo-Adjuvant Treatment Period||107
582066|NCT00545662|1419668|P2|NOT COMPLETED|Overall Study||79
582067|NCT00545662|1419669|P1|NOT COMPLETED|Overall Study||85
582068|NCT00545662|1419668|P2|COMPLETED|Overall Study||528
582069|NCT00545662|1419669|P1|COMPLETED|Overall Study||521
582070|NCT00545662|1419668|P2|STARTED|Overall Study||607
582071|NCT00545662|1419669|P1|STARTED|Overall Study||606
582072|NCT00545623|1419679|P4|NOT COMPLETED|Overall Study||11
582073|NCT00545623|1419680|P3|NOT COMPLETED|Overall Study||13
582074|NCT00545623|1419681|P2|NOT COMPLETED|Overall Study||10
582075|NCT00545623|1419682|P1|NOT COMPLETED|Overall Study||7
582076|NCT00545623|1419679|P4|COMPLETED|Overall Study||23
582077|NCT00545623|1419680|P3|COMPLETED|Overall Study||20
582078|NCT00545623|1419681|P2|COMPLETED|Overall Study||21
582079|NCT00545623|1419682|P1|COMPLETED|Overall Study||25
582080|NCT00545623|1419679|P4|STARTED|Overall Study||34
582081|NCT00545623|1419680|P3|STARTED|Overall Study||33
582082|NCT00545623|1419681|P2|STARTED|Overall Study||31
582083|NCT00545623|1419682|P1|STARTED|Overall Study||32
582084|NCT00545584|1419695|P3|NOT COMPLETED|Overall Study||56
582085|NCT00545584|1419696|P2|NOT COMPLETED|Overall Study||80
582086|NCT00545584|1419697|P1|NOT COMPLETED|Overall Study||79
582087|NCT00545584|1419695|P3|COMPLETED|Overall Study||250
582088|NCT00545584|1419696|P2|COMPLETED|Overall Study||334
582089|NCT00545584|1419697|P1|COMPLETED|Overall Study||333
582090|NCT00545584|1419695|P3|STARTED|Overall Study|306 subjects were randomized but only 305 were treated.|306
582091|NCT00545584|1419696|P2|STARTED|Overall Study||414
582092|NCT00545584|1419697|P1|STARTED|Overall Study||412
582093|NCT00545571|1419708|P1|NOT COMPLETED|Overall Study||67
582094|NCT00545571|1419708|P1|COMPLETED|Overall Study||53
582095|NCT00545571|1419708|P1|STARTED|Overall Study||120
582096|NCT00545506|1419723|P2|NOT COMPLETED|Overall Study||0
582097|NCT00545506|1419724|P1|NOT COMPLETED|Overall Study||0
582098|NCT00545506|1419723|P2|COMPLETED|Overall Study||3
582099|NCT00545506|1419724|P1|COMPLETED|Overall Study||3
582100|NCT00545506|1419723|P2|STARTED|Overall Study||3
582101|NCT00545506|1419724|P1|STARTED|Overall Study||3
582102|NCT00545441|1419732|P2|NOT COMPLETED|Overall Study||16
582103|NCT00545441|1419733|P1|NOT COMPLETED|Overall Study||18
582104|NCT00545441|1419732|P2|COMPLETED|Overall Study||26
582105|NCT00545441|1419733|P1|COMPLETED|Overall Study||26
582106|NCT00545441|1419732|P2|STARTED|Overall Study||42
582107|NCT00545441|1419733|P1|STARTED|Overall Study||44
582108|NCT00545402|1419741|P2|NOT COMPLETED|Overall Study||29
582109|NCT00545402|1419742|P1|NOT COMPLETED|Overall Study||34
582110|NCT00545402|1419741|P2|COMPLETED|Overall Study||61
582111|NCT00545402|1419742|P1|COMPLETED|Overall Study||56
582112|NCT00545402|1419741|P2|STARTED|Overall Study||90
582113|NCT00545402|1419742|P1|STARTED|Overall Study||90
582114|NCT00545363|1419760|P2|NOT COMPLETED|Overall Study||15
582115|NCT00545363|1419761|P1|NOT COMPLETED|Overall Study||19
582116|NCT00545363|1419760|P2|COMPLETED|Overall Study||343
582117|NCT00545363|1419761|P1|COMPLETED|Overall Study||339
582118|NCT00545363|1419760|P2|Treated|Overall Study||357
582119|NCT00545363|1419761|P1|Treated|Overall Study||354
582120|NCT00545363|1419760|P2|STARTED|Overall Study||358
582121|NCT00545363|1419761|P1|STARTED|Overall Study||358
582122|NCT00545298|1419776|P3|NOT COMPLETED|Overall Study||1
582123|NCT00545298|1419777|P2|NOT COMPLETED|Overall Study||0
582124|NCT00545298|1419778|P1|NOT COMPLETED|Overall Study||2
582125|NCT00545298|1419776|P3|COMPLETED|Overall Study||0
582126|NCT00545298|1419777|P2|COMPLETED|Overall Study||1
582127|NCT00545298|1419778|P1|COMPLETED|Overall Study||0
582128|NCT00545298|1419776|P3|STARTED|Overall Study||1
582129|NCT00545298|1419777|P2|STARTED|Overall Study||1
582130|NCT00545298|1419778|P1|STARTED|Overall Study||2
582131|NCT00545272|1419795|P6|NOT COMPLETED|Overall Study||3
582132|NCT00545272|1419796|P5|NOT COMPLETED|Overall Study||2
582133|NCT00545272|1419797|P4|NOT COMPLETED|Overall Study||1
582134|NCT00545272|1419798|P3|NOT COMPLETED|Overall Study||1
582135|NCT00545272|1419799|P2|NOT COMPLETED|Overall Study||1
582136|NCT00545272|1419800|P1|NOT COMPLETED|Overall Study||0
582137|NCT00545272|1419795|P6|COMPLETED|Overall Study||59
582138|NCT00545272|1419796|P5|COMPLETED|Overall Study||62
582139|NCT00545272|1419797|P4|COMPLETED|Overall Study||71
582140|NCT00545272|1419798|P3|COMPLETED|Overall Study||64
582141|NCT00545272|1419799|P2|COMPLETED|Overall Study||67
582142|NCT00545272|1419800|P1|COMPLETED|Overall Study||61
582143|NCT00545272|1419795|P6|STARTED|Overall Study||62
582144|NCT00545272|1419796|P5|STARTED|Overall Study||64
582145|NCT00545272|1419797|P4|STARTED|Overall Study||72
582146|NCT00545272|1419798|P3|STARTED|Overall Study||65
582147|NCT00545272|1419799|P2|STARTED|Overall Study||68
582148|NCT00545272|1419800|P1|STARTED|Overall Study||61
582149|NCT00545233|1419852|P2|NOT COMPLETED|Overall Study||35
582150|NCT00545233|1419853|P1|NOT COMPLETED|Overall Study||46
582151|NCT00545233|1419852|P2|COMPLETED|Overall Study||41
582152|NCT00545233|1419853|P1|COMPLETED|Overall Study||33
582153|NCT00545233|1419852|P2|Intent-to-Treat (ITT)|Overall Study||73
582154|NCT00545233|1419853|P1|Intent-to-Treat (ITT)|Overall Study||77
582155|NCT00545233|1419852|P2|Safety Set|Overall Study||75
582156|NCT00545233|1419853|P1|Safety Set|Overall Study||77
582157|NCT00545233|1419852|P2|STARTED|Overall Study||76
582158|NCT00545233|1419853|P1|STARTED|Overall Study||79
582159|NCT00545181|1419902|P2|NOT COMPLETED|Overall Study||0
582160|NCT00545181|1419903|P1|NOT COMPLETED|Overall Study||0
582161|NCT00545181|1419902|P2|COMPLETED|Overall Study||25
582162|NCT00545181|1419903|P1|COMPLETED|Overall Study||29
582163|NCT00545181|1419902|P2|STARTED|Overall Study||25
582164|NCT00545181|1419903|P1|STARTED|Overall Study||29
582165|NCT00545168|1419912|P3|NOT COMPLETED|Overall Study||21
582166|NCT00545168|1419913|P2|NOT COMPLETED|Overall Study||5
582167|NCT00545168|1419914|P1|NOT COMPLETED|Overall Study||16
582168|NCT00545168|1419912|P3|COMPLETED|Overall Study||193
582169|NCT00545168|1419913|P2|COMPLETED|Overall Study||58
582170|NCT00545168|1419914|P1|COMPLETED|Overall Study||187
582171|NCT00545168|1419912|P3|STARTED|Overall Study||214
582172|NCT00545168|1419913|P2|STARTED|Overall Study||63
582173|NCT00545168|1419914|P1|STARTED|Overall Study||203
582174|NCT00545155|1419923|P1|NOT COMPLETED|Overall Study||0
582175|NCT00545155|1419923|P1|COMPLETED|Overall Study||187
582176|NCT00545155|1419923|P1|STARTED|Overall Study||187
582177|NCT00545103|1419940|P4|NOT COMPLETED|Overall Study||70
582178|NCT00545103|1419941|P3|NOT COMPLETED|Overall Study||76
582179|NCT00545103|1419942|P2|NOT COMPLETED|Overall Study||78
582180|NCT00545103|1419943|P1|NOT COMPLETED|Overall Study||75
582181|NCT00545103|1419940|P4|COMPLETED|Overall Study||76
582182|NCT00545103|1419941|P3|COMPLETED|Overall Study||74
582183|NCT00545103|1419942|P2|COMPLETED|Overall Study||70
582184|NCT00545103|1419943|P1|COMPLETED|Overall Study||73
582185|NCT00545103|1419940|P4|STARTED|Overall Study||146
582186|NCT00545103|1419941|P3|STARTED|Overall Study||150
582187|NCT00545103|1419942|P2|STARTED|Overall Study||148
582188|NCT00545103|1419943|P1|STARTED|Overall Study||148
582189|NCT00545064|1419977|P1|NOT COMPLETED|Overall Study||8
582190|NCT00545064|1419977|P1|COMPLETED|Overall Study||170
582191|NCT00545064|1419977|P1|Visit 3 (Week 8)|Overall Study|8 patients didn’t complete the 8-week period. 6 were retrieved and considered as Visit 3 (Week 8)|176
582192|NCT00545064|1419977|P1|Visit 2 (Week 4)|Overall Study||169
582193|NCT00545064|1419977|P1|Visit 1 (Baseline)|Overall Study||178
582194|NCT00545064|1419977|P1|STARTED|Overall Study||178
582195|NCT00545051|1419988|P2|NOT COMPLETED|Overall Study||7
582196|NCT00545051|1419989|P1|NOT COMPLETED|Overall Study||9
582197|NCT00545051|1419988|P2|COMPLETED|Overall Study||65
582198|NCT00545051|1419989|P1|COMPLETED|Overall Study||59
582199|NCT00545051|1419988|P2|STARTED|Overall Study||72
582200|NCT00545051|1419989|P1|STARTED|Overall Study||68
582201|NCT00545025|1420005|P2|NOT COMPLETED|Overall Study||0
582202|NCT00545025|1420006|P1|NOT COMPLETED|Overall Study||0
582203|NCT00545025|1420005|P2|COMPLETED|Overall Study||83
582204|NCT00545025|1420006|P1|COMPLETED|Overall Study||160
582205|NCT00545025|1420005|P2|STARTED|Overall Study||83
582206|NCT00545025|1420006|P1|STARTED|Overall Study||160
582207|NCT00544908|1420026|P1|NOT COMPLETED|Overall Study||0
582208|NCT00544908|1420026|P1|COMPLETED|Overall Study||7
582209|NCT00544908|1420026|P1|STARTED|Overall Study||7
582210|NCT00544882|1420033|P3|NOT COMPLETED|Cycle 3: Follow-up||0
582211|NCT00544882|1420034|P2|NOT COMPLETED|Cycle 3: Follow-up||2
582212|NCT00544882|1420035|P1|NOT COMPLETED|Cycle 3: Follow-up||0
582213|NCT00544882|1420033|P3|COMPLETED|Cycle 3: Follow-up|Completed 21 days of Cycle 3|28
582214|NCT00544882|1420034|P2|COMPLETED|Cycle 3: Follow-up|Completed 21 days of Cycle 3|26
582215|NCT00544882|1420035|P1|COMPLETED|Cycle 3: Follow-up||0
582216|NCT00544882|1420033|P3|STARTED|Cycle 3: Follow-up||28
582217|NCT00544882|1420034|P2|STARTED|Cycle 3: Follow-up||28
582218|NCT00544882|1420035|P1|STARTED|Cycle 3: Follow-up||0
582219|NCT00544882|1420033|P3|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1
582220|NCT00544882|1420034|P2|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1
582221|NCT00544882|1420035|P1|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||0
582222|NCT00544882|1420033|P3|COMPLETED|Cycle 2: Randomized Treatment Cycle||28
582223|NCT00544882|1420034|P2|COMPLETED|Cycle 2: Randomized Treatment Cycle||28
582224|NCT00544882|1420035|P1|COMPLETED|Cycle 2: Randomized Treatment Cycle||0
582225|NCT00544882|1420033|P3|Treated|Cycle 2: Randomized Treatment Cycle|One participant was dropped from the study due to noncompliance prior to treatment.|28
582226|NCT00544882|1420034|P2|Treated|Cycle 2: Randomized Treatment Cycle|One participant withdrew prior to treatment|28
582227|NCT00544882|1420035|P1|Treated|Cycle 2: Randomized Treatment Cycle||0
582228|NCT00544882|1420033|P3|STARTED|Cycle 2: Randomized Treatment Cycle||29
582229|NCT00544882|1420034|P2|STARTED|Cycle 2: Randomized Treatment Cycle||29
582230|NCT00544882|1420035|P1|STARTED|Cycle 2: Randomized Treatment Cycle||0
582231|NCT00544882|1420033|P3|NOT COMPLETED|Cycle 1: Run-in Cycle||0
582232|NCT00544882|1420034|P2|NOT COMPLETED|Cycle 1: Run-in Cycle||0
582233|NCT00544882|1420035|P1|NOT COMPLETED|Cycle 1: Run-in Cycle||3
582234|NCT00544882|1420033|P3|COMPLETED|Cycle 1: Run-in Cycle||0
582235|NCT00544882|1420034|P2|COMPLETED|Cycle 1: Run-in Cycle||0
582236|NCT00544882|1420035|P1|COMPLETED|Cycle 1: Run-in Cycle||58
582237|NCT00544882|1420033|P3|STARTED|Cycle 1: Run-in Cycle||0
582238|NCT00544882|1420034|P2|STARTED|Cycle 1: Run-in Cycle||0
582239|NCT00544882|1420035|P1|STARTED|Cycle 1: Run-in Cycle||61
582240|NCT00544869|1420060|P3|NOT COMPLETED|Overall Study||0
582241|NCT00544869|1420061|P2|NOT COMPLETED|Overall Study||2
582242|NCT00544869|1420062|P1|NOT COMPLETED|Overall Study||12
582243|NCT00544869|1420060|P3|COMPLETED|Overall Study||2
582244|NCT00544869|1420061|P2|COMPLETED|Overall Study||12
582245|NCT00544869|1420062|P1|COMPLETED|Overall Study||24
582246|NCT00544869|1420060|P3|STARTED|Overall Study||2
582247|NCT00544869|1420061|P2|STARTED|Overall Study||14
582248|NCT00544869|1420062|P1|STARTED|Overall Study||36
582249|NCT00544817|1420070|P1|NOT COMPLETED|Follow-up Systemic Therapy||19
582250|NCT00544817|1420070|P1|COMPLETED|Follow-up Systemic Therapy||9
582251|NCT00544817|1420070|P1|STARTED|Follow-up Systemic Therapy||28
582252|NCT00544817|1420070|P1|NOT COMPLETED|No Treatment Interval||12
582253|NCT00544817|1420070|P1|COMPLETED|No Treatment Interval||28
582254|NCT00544817|1420070|P1|STARTED|No Treatment Interval||40
582255|NCT00544817|1420070|P1|NOT COMPLETED|Combined Modality||7
582256|NCT00544817|1420070|P1|COMPLETED|Combined Modality||40
582257|NCT00544817|1420070|P1|STARTED|Combined Modality||47
582258|NCT00544778|1420076|P1|NOT COMPLETED|Overall Study||0
582259|NCT00544778|1420076|P1|COMPLETED|Overall Study||7
582260|NCT00544778|1420076|P1|STARTED|Overall Study||7
582261|NCT00544713|1420082|P2|NOT COMPLETED|Overall Study||5
582262|NCT00544713|1420083|P1|NOT COMPLETED|Overall Study||3
582263|NCT00544713|1420082|P2|COMPLETED|Overall Study||109
582264|NCT00544713|1420083|P1|COMPLETED|Overall Study||111
582265|NCT00544713|1420082|P2|STARTED|Overall Study||114
582266|NCT00544713|1420083|P1|STARTED|Overall Study||114
582267|NCT00544674|1420113|P1|NOT COMPLETED|Overall Study||1
582268|NCT00544674|1420113|P1|COMPLETED|Overall Study||4
582269|NCT00544674|1420113|P1|STARTED|Overall Study|1 subject registered and expired prior to dosing|5
582270|NCT00544648|1420119|P2|NOT COMPLETED|Overall Study||1
582271|NCT00544648|1420120|P1|NOT COMPLETED|Overall Study||3
582272|NCT00544648|1420119|P2|COMPLETED|Overall Study||1
582273|NCT00544648|1420120|P1|COMPLETED|Overall Study||8
582274|NCT00544648|1420119|P2|STARTED|Overall Study||2
582275|NCT00544648|1420120|P1|STARTED|Overall Study||11
582276|NCT00544557|1420134|P1|NOT COMPLETED|Overall Study||434
582277|NCT00544557|1420134|P1|COMPLETED|Overall Study||1251
582278|NCT00544557|1420134|P1|STARTED|Overall Study||1685
582279|NCT00544544|1420165|P1|NOT COMPLETED|Overall Study||3
582280|NCT00544544|1420165|P1|COMPLETED|Overall Study||11
582281|NCT00544544|1420165|P1|STARTED|Overall Study||14
582282|NCT00544440|1420169|P1|NOT COMPLETED|Overall Study||57
582283|NCT00544440|1420169|P1|COMPLETED|Overall Study||0
582284|NCT00544440|1420169|P1|STARTED|Overall Study||57
582285|NCT00544167|1420176|P1|NOT COMPLETED|Overall Study||29
582286|NCT00544167|1420176|P1|COMPLETED|Overall Study||16
582287|NCT00544167|1420176|P1|STARTED|Overall Study||45
582288|NCT00543985|1420180|P1|NOT COMPLETED|Overall Study||4
582289|NCT00543985|1420180|P1|COMPLETED|Overall Study||32
582290|NCT00543985|1420180|P1|STARTED|Overall Study||36
582291|NCT00543855|1420191|P4|NOT COMPLETED|Overall Study||4
582292|NCT00543855|1420192|P3|NOT COMPLETED|Overall Study||6
582293|NCT00543855|1420193|P2|NOT COMPLETED|Overall Study||2
582294|NCT00543855|1420194|P1|NOT COMPLETED|Overall Study||4
582295|NCT00543855|1420191|P4|COMPLETED|Overall Study||30
582296|NCT00543855|1420192|P3|COMPLETED|Overall Study||31
582297|NCT00543855|1420193|P2|COMPLETED|Overall Study||31
582298|NCT00543855|1420194|P1|COMPLETED|Overall Study||31
582299|NCT00543855|1420191|P4|STARTED|Overall Study||34
582300|NCT00543855|1420192|P3|STARTED|Overall Study||37
582301|NCT00543855|1420193|P2|STARTED|Overall Study||33
582302|NCT00543855|1420194|P1|STARTED|Overall Study||35
582303|NCT00543803|1420216|P1|NOT COMPLETED|Overall Study||142
582304|NCT00543803|1420216|P1|COMPLETED|Overall Study||192
582305|NCT00543803|1420216|P1|STARTED|Overall Study||334
582306|NCT00543764|1420235|P2|NOT COMPLETED|Overall Study||0
582307|NCT00543764|1420236|P1|NOT COMPLETED|Overall Study||0
582308|NCT00543764|1420235|P2|COMPLETED|Overall Study||50
582309|NCT00543764|1420236|P1|COMPLETED|Overall Study||100
582310|NCT00543764|1420235|P2|STARTED|Overall Study||50
582311|NCT00543764|1420236|P1|STARTED|Overall Study||100
582312|NCT00543725|1420244|P2|NOT COMPLETED|Overall Study||74
582313|NCT00543725|1420245|P1|NOT COMPLETED|Overall Study||68
582314|NCT00543725|1420244|P2|COMPLETED|Overall Study||264
582315|NCT00543725|1420245|P1|COMPLETED|Overall Study||272
582316|NCT00543725|1420244|P2|STARTED|Overall Study||338
582317|NCT00543725|1420245|P1|STARTED|Overall Study||340
582318|NCT00543569|1420271|P4|NOT COMPLETED|Overall Study||9
582319|NCT00543569|1420272|P3|NOT COMPLETED|Overall Study||20
582320|NCT00543569|1420273|P2|NOT COMPLETED|Overall Study||8
582321|NCT00543569|1420274|P1|NOT COMPLETED|Overall Study||12
582322|NCT00543569|1420271|P4|COMPLETED|Overall Study||72
582323|NCT00543569|1420272|P3|COMPLETED|Overall Study||60
582324|NCT00543569|1420273|P2|COMPLETED|Overall Study||72
582325|NCT00543569|1420274|P1|COMPLETED|Overall Study||70
582326|NCT00543569|1420271|P4|Received Treatment|Overall Study||78
582327|NCT00543569|1420272|P3|Received Treatment|Overall Study||75
582328|NCT00543569|1420273|P2|Received Treatment|Overall Study||77
582329|NCT00543569|1420274|P1|Received Treatment|Overall Study||79
582330|NCT00543569|1420271|P4|STARTED|Overall Study||81
582331|NCT00543569|1420272|P3|STARTED|Overall Study||80
582332|NCT00543569|1420273|P2|STARTED|Overall Study||80
582333|NCT00543569|1420274|P1|STARTED|Overall Study||82
582334|NCT00543543|1420380|P4|NOT COMPLETED|Extension Study||226
582335|NCT00543543|1420381|P3|NOT COMPLETED|Extension Study||0
582336|NCT00543543|1420382|P2|NOT COMPLETED|Extension Study||0
582337|NCT00543543|1420383|P1|NOT COMPLETED|Extension Study||0
582338|NCT00543543|1420380|P4|COMPLETED|Extension Study||2824
582339|NCT00543543|1420381|P3|COMPLETED|Extension Study||0
582340|NCT00543543|1420382|P2|COMPLETED|Extension Study||150
582341|NCT00543543|1420383|P1|COMPLETED|Extension Study||0
582342|NCT00543543|1420380|P4|STARTED|Extension Study|Cohort 2|3050
582343|NCT00543543|1420381|P3|STARTED|Extension Study|This group did not participate in the Extension Study|0
582344|NCT00543543|1420382|P2|STARTED|Extension Study|Cohort 1|150
582345|NCT00543543|1420383|P1|STARTED|Extension Study|This group did not participate in the Extension Study|0
582346|NCT00543543|1420380|P4|NOT COMPLETED|Base Study||1222
582347|NCT00543543|1420381|P3|NOT COMPLETED|Base Study||14
582348|NCT00543543|1420382|P2|NOT COMPLETED|Base Study||1252
582349|NCT00543543|1420383|P1|NOT COMPLETED|Base Study||20
582350|NCT00543543|1420380|P4|COMPLETED|Base Study|Follow-up was up to 54 months|5887
582351|NCT00543543|1420381|P3|COMPLETED|Base Study|Follow-up was up to 7 months|296
582352|NCT00543543|1420382|P2|COMPLETED|Base Study|Follow-up was up to 54 months|5854
582353|NCT00543543|1420383|P1|COMPLETED|Base Study|Follow-up was up to 7 months|295
582354|NCT00543543|1420380|P4|Completed 3 Vaccinations|Base Study||6934
582355|NCT00543543|1420381|P3|Completed 3 Vaccinations|Base Study||297
582356|NCT00543543|1420382|P2|Completed 3 Vaccinations|Base Study||6928
582357|NCT00543543|1420383|P1|Completed 3 Vaccinations|Base Study||300
582358|NCT00543543|1420380|P4|STARTED|Base Study||7109
582359|NCT00543543|1420381|P3|STARTED|Base Study||310
582360|NCT00543543|1420382|P2|STARTED|Base Study||7106
582361|NCT00543543|1420383|P1|STARTED|Base Study||315
582362|NCT00543400|1420428|P4|NOT COMPLETED|Overall Study||5
582363|NCT00543400|1420429|P3|NOT COMPLETED|Overall Study||4
582364|NCT00543400|1420430|P2|NOT COMPLETED|Overall Study||1
582365|NCT00543400|1420431|P1|NOT COMPLETED|Overall Study||5
582366|NCT00543400|1420428|P4|COMPLETED|Overall Study||151
582367|NCT00543400|1420429|P3|COMPLETED|Overall Study||148
582368|NCT00543400|1420430|P2|COMPLETED|Overall Study||43
582369|NCT00543400|1420431|P1|COMPLETED|Overall Study||146
582370|NCT00543400|1420428|P4|STARTED|Overall Study||156
582371|NCT00543400|1420429|P3|STARTED|Overall Study||152
582372|NCT00543400|1420430|P2|STARTED|Overall Study||44
582373|NCT00543400|1420431|P1|STARTED|Overall Study||151
582374|NCT00543309|1420444|P3|NOT COMPLETED|Overall Study||0
582375|NCT00543309|1420445|P2|NOT COMPLETED|Overall Study||1
582376|NCT00543309|1420446|P1|NOT COMPLETED|Overall Study||0
582377|NCT00543309|1420444|P3|COMPLETED|Overall Study||35
582378|NCT00543309|1420445|P2|COMPLETED|Overall Study||35
582379|NCT00543309|1420446|P1|COMPLETED|Overall Study||35
582380|NCT00543309|1420444|P3|STARTED|Overall Study||35
582381|NCT00543309|1420445|P2|STARTED|Overall Study||36
582382|NCT00543309|1420446|P1|STARTED|Overall Study||35
582383|NCT00543296|1420496|P1|NOT COMPLETED|Overall Study||7
582384|NCT00543296|1420496|P1|COMPLETED|Overall Study||14
582385|NCT00543296|1420496|P1|STARTED|Overall Study||21
582386|NCT00543140|1420503|P1|NOT COMPLETED|Overall Study||72
582387|NCT00543140|1420503|P1|COMPLETED|Overall Study||231
582388|NCT00543140|1420503|P1|STARTED|Overall Study||303
582389|NCT00543101|1420513|P2|NOT COMPLETED|Overall Study||0
582390|NCT00543101|1420514|P1|NOT COMPLETED|Overall Study||0
582391|NCT00543101|1420513|P2|COMPLETED|Overall Study||12
582392|NCT00543101|1420514|P1|COMPLETED|Overall Study||12
582393|NCT00543101|1420513|P2|STARTED|Overall Study||12
582394|NCT00543101|1420514|P1|STARTED|Overall Study||12
582395|NCT00542997|1420526|P1|NOT COMPLETED|Efficacy Period||3
582396|NCT00542997|1420526|P1|COMPLETED|Efficacy Period||43
582397|NCT00542997|1420526|P1|STARTED|Efficacy Period||46
582398|NCT00542997|1420526|P1|NOT COMPLETED|Wash in / Wash Out Period||5
582399|NCT00542997|1420526|P1|COMPLETED|Wash in / Wash Out Period||46
582400|NCT00542997|1420526|P1|STARTED|Wash in / Wash Out Period||51
582401|NCT00542971|1420541|P1|NOT COMPLETED|Overall Study||0
582402|NCT00542971|1420541|P1|COMPLETED|Overall Study||75
582403|NCT00542971|1420541|P1|STARTED|Overall Study||75
582404|NCT00542880|1420548|P2|NOT COMPLETED|Period 3||2
582405|NCT00542880|1420549|P1|NOT COMPLETED|Period 3||0
582406|NCT00542880|1420548|P2|COMPLETED|Period 3||201
582407|NCT00542880|1420549|P1|COMPLETED|Period 3||204
582408|NCT00542880|1420548|P2|STARTED|Period 3||203
582409|NCT00542880|1420549|P1|STARTED|Period 3||204
582410|NCT00542880|1420548|P2|NOT COMPLETED|Period 2||10
582411|NCT00542880|1420549|P1|NOT COMPLETED|Period 2||7
582412|NCT00542880|1420548|P2|COMPLETED|Period 2||203
582413|NCT00542880|1420549|P1|COMPLETED|Period 2||204
582414|NCT00542880|1420548|P2|STARTED|Period 2||213
582415|NCT00542880|1420549|P1|STARTED|Period 2||211
582416|NCT00542880|1420548|P2|NOT COMPLETED|Period 1||12
582417|NCT00542880|1420549|P1|NOT COMPLETED|Period 1||6
582418|NCT00542880|1420548|P2|COMPLETED|Period 1||213
582419|NCT00542880|1420549|P1|COMPLETED|Period 1||211
582420|NCT00542880|1420548|P2|STARTED|Period 1||225
582421|NCT00542880|1420549|P1|STARTED|Period 1|This was a cross-over study|217
582422|NCT00542828|1420585|P1|NOT COMPLETED|Overall Study||13
582423|NCT00542828|1420585|P1|COMPLETED|Overall Study|Number of participants who completed the 12-month study period.|3
582424|NCT00542828|1420585|P1|STARTED|Overall Study|Number of participants enrolled in the study; of the 16 enrolled, 14 received study treatment.|16
582425|NCT00542815|1420603|P3|NOT COMPLETED|Overall Study||32
582426|NCT00542815|1420604|P2|NOT COMPLETED|Overall Study||32
582427|NCT00542815|1420605|P1|NOT COMPLETED|Overall Study||106
582428|NCT00542815|1420603|P3|COMPLETED|Overall Study||92
582429|NCT00542815|1420604|P2|COMPLETED|Overall Study||44
582430|NCT00542815|1420605|P1|COMPLETED|Overall Study||326
582431|NCT00542815|1420603|P3|STARTED|Overall Study||124
582432|NCT00542815|1420604|P2|STARTED|Overall Study||76
582433|NCT00542815|1420605|P1|STARTED|Overall Study||432
582434|NCT00542789|1420618|P2|NOT COMPLETED|Overall Study||78
582435|NCT00542789|1420619|P1|NOT COMPLETED|Overall Study||41
582436|NCT00542789|1420618|P2|COMPLETED|Overall Study||90
582437|NCT00542789|1420619|P1|COMPLETED|Overall Study||134
582438|NCT00542789|1420618|P2|STARTED|Overall Study|Randomised|168
582439|NCT00542789|1420619|P1|STARTED|Overall Study|Randomised|175
582440|NCT00542750|1420629|P1|NOT COMPLETED|Overall Study||0
582441|NCT00542750|1420629|P1|COMPLETED|Overall Study||24
582442|NCT00542750|1420629|P1|STARTED|Overall Study||24
582443|NCT00542620|1420635|P2|NOT COMPLETED|Overall Study||0
582444|NCT00542620|1420636|P1|NOT COMPLETED|Overall Study||0
582445|NCT00542620|1420635|P2|COMPLETED|Overall Study||12
582446|NCT00542620|1420636|P1|COMPLETED|Overall Study||13
582447|NCT00542620|1420635|P2|Exposed to Drug|Overall Study|One subject randomly assigned to receive mixed injections, but received a separate injection mode|13
582448|NCT00542620|1420636|P1|Exposed to Drug|Overall Study|One subject randomly assigned to receive mixed injections, but received a separate injection mode|12
582449|NCT00542620|1420635|P2|STARTED|Overall Study||12
582450|NCT00542620|1420636|P1|STARTED|Overall Study||13
582451|NCT00542542|1420702|P2|NOT COMPLETED|Overall Study||0
582452|NCT00542542|1420703|P1|NOT COMPLETED|Overall Study||0
582453|NCT00542542|1420702|P2|COMPLETED|Overall Study||44
582454|NCT00542542|1420703|P1|COMPLETED|Overall Study||44
582455|NCT00542542|1420702|P2|STARTED|Overall Study||44
582456|NCT00542542|1420703|P1|STARTED|Overall Study||44
582457|NCT00542490|1420709|P1|NOT COMPLETED|Overall Study||2
582458|NCT00542490|1420709|P1|COMPLETED|Overall Study||21
582459|NCT00542490|1420709|P1|STARTED|Overall Study||23
582460|NCT00542425|1420719|P5|NOT COMPLETED|Extended 24 Weeks of Treatment||1
582461|NCT00542425|1420720|P4|NOT COMPLETED|Extended 24 Weeks of Treatment||1
582462|NCT00542425|1420721|P3|NOT COMPLETED|Extended 24 Weeks of Treatment||2
582463|NCT00542425|1420722|P2|NOT COMPLETED|Extended 24 Weeks of Treatment||2
582464|NCT00542425|1420723|P1|NOT COMPLETED|Extended 24 Weeks of Treatment||1
582465|NCT00542425|1420719|P5|COMPLETED|Extended 24 Weeks of Treatment||13
582466|NCT00542425|1420720|P4|COMPLETED|Extended 24 Weeks of Treatment||6
582467|NCT00542425|1420721|P3|COMPLETED|Extended 24 Weeks of Treatment||8
582468|NCT00542425|1420722|P2|COMPLETED|Extended 24 Weeks of Treatment||11
582469|NCT00542425|1420723|P1|COMPLETED|Extended 24 Weeks of Treatment||10
582470|NCT00542425|1420719|P5|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|14
582471|NCT00542425|1420720|P4|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|7
582472|NCT00542425|1420721|P3|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|10
582473|NCT00542425|1420722|P2|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|13
582474|NCT00542425|1420723|P1|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|11
582475|NCT00542425|1420719|P5|NOT COMPLETED|Initial 24 Weeks||6
582476|NCT00542425|1420720|P4|NOT COMPLETED|Initial 24 Weeks||11
582477|NCT00542425|1420721|P3|NOT COMPLETED|Initial 24 Weeks||7
582478|NCT00542425|1420722|P2|NOT COMPLETED|Initial 24 Weeks||10
582479|NCT00542425|1420723|P1|NOT COMPLETED|Initial 24 Weeks||4
582480|NCT00542425|1420719|P5|COMPLETED|Initial 24 Weeks||39
582481|NCT00542425|1420720|P4|COMPLETED|Initial 24 Weeks||34
582482|NCT00542425|1420721|P3|COMPLETED|Initial 24 Weeks||36
582483|NCT00542425|1420722|P2|COMPLETED|Initial 24 Weeks||33
582484|NCT00542425|1420723|P1|COMPLETED|Initial 24 Weeks||42
582485|NCT00542425|1420719|P5|STARTED|Initial 24 Weeks||45
582486|NCT00542425|1420720|P4|STARTED|Initial 24 Weeks||45
582487|NCT00542425|1420721|P3|STARTED|Initial 24 Weeks||43
582488|NCT00542425|1420722|P2|STARTED|Initial 24 Weeks||43
582489|NCT00542425|1420723|P1|STARTED|Initial 24 Weeks||46
582490|NCT00542386|1420761|P6|NOT COMPLETED|Overall Study||50
582491|NCT00542386|1420762|P5|NOT COMPLETED|Overall Study||40
582492|NCT00542386|1420763|P4|NOT COMPLETED|Overall Study||38
582493|NCT00542386|1420764|P3|NOT COMPLETED|Overall Study||33
582494|NCT00542386|1420765|P2|NOT COMPLETED|Overall Study||28
582495|NCT00542386|1420766|P1|NOT COMPLETED|Overall Study||43
582496|NCT00542386|1420761|P6|COMPLETED|Overall Study||82
582497|NCT00542386|1420762|P5|COMPLETED|Overall Study||62
582498|NCT00542386|1420763|P4|COMPLETED|Overall Study||65
582499|NCT00542386|1420764|P3|COMPLETED|Overall Study||66
582500|NCT00542386|1420765|P2|COMPLETED|Overall Study||74
582501|NCT00542386|1420766|P1|COMPLETED|Overall Study||61
582502|NCT00542386|1420761|P6|STARTED|Overall Study||132
582503|NCT00542386|1420762|P5|STARTED|Overall Study||102
582504|NCT00542386|1420763|P4|STARTED|Overall Study||103
582505|NCT00542386|1420764|P3|STARTED|Overall Study||99
582506|NCT00542386|1420765|P2|STARTED|Overall Study||102
582507|NCT00542386|1420766|P1|STARTED|Overall Study||104
582508|NCT00542321|1420788|P2|NOT COMPLETED|Overall Study||1
582509|NCT00542321|1420789|P1|NOT COMPLETED|Overall Study||0
582510|NCT00542321|1420788|P2|COMPLETED|Overall Study||7
582511|NCT00542321|1420789|P1|COMPLETED|Overall Study||8
582512|NCT00542321|1420788|P2|STARTED|Overall Study||8
582513|NCT00542321|1420789|P1|STARTED|Overall Study||8
582514|NCT00542308|1420803|P1|NOT COMPLETED|Overall Study||0
582515|NCT00542308|1420803|P1|COMPLETED|Overall Study||90
582516|NCT00542308|1420803|P1|STARTED|Overall Study||90
582517|NCT00542269|1420811|P3|NOT COMPLETED|Overall Study||6
582518|NCT00542269|1420812|P2|NOT COMPLETED|Overall Study||6
582519|NCT00542269|1420813|P1|NOT COMPLETED|Overall Study||13
582520|NCT00542269|1420811|P3|COMPLETED|Overall Study||51
582521|NCT00542269|1420812|P2|COMPLETED|Overall Study||54
582522|NCT00542269|1420813|P1|COMPLETED|Overall Study||48
582523|NCT00542269|1420811|P3|STARTED|Overall Study||57
582524|NCT00542269|1420812|P2|STARTED|Overall Study||60
582525|NCT00542269|1420813|P1|STARTED|Overall Study||61
582526|NCT00542178|1420848|P8|NOT COMPLETED|Overall Study||85
582527|NCT00542178|1420849|P7|NOT COMPLETED|Overall Study||87
582528|NCT00542178|1420850|P6|NOT COMPLETED|Overall Study||89
582529|NCT00542178|1420851|P5|NOT COMPLETED|Overall Study||64
582530|NCT00542178|1420852|P4|NOT COMPLETED|Overall Study||62
582531|NCT00542178|1420853|P3|NOT COMPLETED|Overall Study||74
582532|NCT00542178|1420854|P2|NOT COMPLETED|Overall Study||80
582533|NCT00542178|1420855|P1|NOT COMPLETED|Overall Study||75
582534|NCT00542178|1420848|P8|COMPLETED|Overall Study||381
582535|NCT00542178|1420849|P7|COMPLETED|Overall Study||406
582536|NCT00542178|1420850|P6|COMPLETED|Overall Study||406
582537|NCT00542178|1420851|P5|COMPLETED|Overall Study||400
582538|NCT00542178|1420852|P4|COMPLETED|Overall Study||308
582539|NCT00542178|1420853|P3|COMPLETED|Overall Study||308
582540|NCT00542178|1420854|P2|COMPLETED|Overall Study||332
582541|NCT00542178|1420855|P1|COMPLETED|Overall Study||315
582542|NCT00542178|1420848|P8|STARTED|Overall Study||466
582543|NCT00542178|1420849|P7|STARTED|Overall Study||493
582544|NCT00542178|1420850|P6|STARTED|Overall Study||495
582545|NCT00542178|1420851|P5|STARTED|Overall Study||464
582546|NCT00542178|1420852|P4|STARTED|Overall Study||370
582547|NCT00542178|1420853|P3|STARTED|Overall Study||382
582548|NCT00542178|1420854|P2|STARTED|Overall Study||412
582549|NCT00542178|1420855|P1|STARTED|Overall Study||390
582550|NCT00541970|1420873|P4|NOT COMPLETED|Month 60||72
582551|NCT00541970|1420874|P3|NOT COMPLETED|Month 60||82
582552|NCT00541970|1420875|P2|NOT COMPLETED|Month 60||77
582553|NCT00541970|1420876|P1|NOT COMPLETED|Month 60||78
582554|NCT00541970|1420873|P4|COMPLETED|Month 60||167
582555|NCT00541970|1420874|P3|COMPLETED|Month 60||158
582556|NCT00541970|1420875|P2|COMPLETED|Month 60||164
582557|NCT00541970|1420876|P1|COMPLETED|Month 60||162
582558|NCT00541970|1420873|P4|STARTED|Month 60||239
582559|NCT00541970|1420874|P3|STARTED|Month 60||240
582560|NCT00541970|1420875|P2|STARTED|Month 60||241
582561|NCT00541970|1420876|P1|STARTED|Month 60||240
582562|NCT00541970|1420873|P4|NOT COMPLETED|Month 48||75
582563|NCT00541970|1420874|P3|NOT COMPLETED|Month 48||73
582564|NCT00541970|1420875|P2|NOT COMPLETED|Month 48||73
582565|NCT00541970|1420876|P1|NOT COMPLETED|Month 48||71
582566|NCT00541970|1420873|P4|COMPLETED|Month 48||164
582567|NCT00541970|1420874|P3|COMPLETED|Month 48||167
582568|NCT00541970|1420875|P2|COMPLETED|Month 48||168
582569|NCT00541970|1420876|P1|COMPLETED|Month 48||169
582570|NCT00541970|1420873|P4|STARTED|Month 48||239
582571|NCT00541970|1420874|P3|STARTED|Month 48||240
582572|NCT00541970|1420875|P2|STARTED|Month 48||241
582573|NCT00541970|1420876|P1|STARTED|Month 48||240
582574|NCT00541970|1420873|P4|NOT COMPLETED|Month 36||60
582575|NCT00541970|1420874|P3|NOT COMPLETED|Month 36||66
582576|NCT00541970|1420875|P2|NOT COMPLETED|Month 36||66
582577|NCT00541970|1420876|P1|NOT COMPLETED|Month 36||61
582578|NCT00541970|1420873|P4|COMPLETED|Month 36||179
582579|NCT00541970|1420874|P3|COMPLETED|Month 36||174
582580|NCT00541970|1420875|P2|COMPLETED|Month 36||175
582581|NCT00541970|1420876|P1|COMPLETED|Month 36||179
582582|NCT00541970|1420873|P4|STARTED|Month 36||239
582583|NCT00541970|1420874|P3|STARTED|Month 36||240
582584|NCT00541970|1420875|P2|STARTED|Month 36||241
582585|NCT00541970|1420876|P1|STARTED|Month 36||240
582586|NCT00541970|1420873|P4|NOT COMPLETED|Month 24||22
582587|NCT00541970|1420874|P3|NOT COMPLETED|Month 24||32
582588|NCT00541970|1420875|P2|NOT COMPLETED|Month 24||32
582589|NCT00541970|1420876|P1|NOT COMPLETED|Month 24||29
582590|NCT00541970|1420873|P4|COMPLETED|Month 24||217
582591|NCT00541970|1420874|P3|COMPLETED|Month 24||208
582592|NCT00541970|1420875|P2|COMPLETED|Month 24||209
582593|NCT00541970|1420876|P1|COMPLETED|Month 24||211
582594|NCT00541970|1420873|P4|STARTED|Month 24||239
582595|NCT00541970|1420874|P3|STARTED|Month 24||240
582596|NCT00541970|1420875|P2|STARTED|Month 24||241
582597|NCT00541970|1420876|P1|STARTED|Month 24||240
582598|NCT00541970|1420873|P4|NOT COMPLETED|Month 18||17
582599|NCT00541970|1420874|P3|NOT COMPLETED|Month 18||25
582600|NCT00541970|1420875|P2|NOT COMPLETED|Month 18||24
582601|NCT00541970|1420876|P1|NOT COMPLETED|Month 18||14
582602|NCT00541970|1420873|P4|COMPLETED|Month 18||222
582603|NCT00541970|1420874|P3|COMPLETED|Month 18||215
582604|NCT00541970|1420875|P2|COMPLETED|Month 18||217
582605|NCT00541970|1420876|P1|COMPLETED|Month 18||226
582606|NCT00541970|1420873|P4|STARTED|Month 18||239
582607|NCT00541970|1420874|P3|STARTED|Month 18||240
582608|NCT00541970|1420875|P2|STARTED|Month 18||241
582609|NCT00541970|1420876|P1|STARTED|Month 18||240
582610|NCT00541970|1420873|P4|NOT COMPLETED|Month 12||16
582611|NCT00541970|1420874|P3|NOT COMPLETED|Month 12||21
582612|NCT00541970|1420875|P2|NOT COMPLETED|Month 12||22
582613|NCT00541970|1420876|P1|NOT COMPLETED|Month 12||12
582614|NCT00541970|1420873|P4|COMPLETED|Month 12||223
582615|NCT00541970|1420874|P3|COMPLETED|Month 12||219
582616|NCT00541970|1420875|P2|COMPLETED|Month 12||219
582617|NCT00541970|1420876|P1|COMPLETED|Month 12||228
582618|NCT00541970|1420873|P4|STARTED|Month 12||239
582619|NCT00541970|1420874|P3|STARTED|Month 12||240
582620|NCT00541970|1420875|P2|STARTED|Month 12||241
582621|NCT00541970|1420876|P1|STARTED|Month 12||240
582622|NCT00541970|1420873|P4|NOT COMPLETED|Month 7||5
582623|NCT00541970|1420874|P3|NOT COMPLETED|Month 7||11
582624|NCT00541970|1420875|P2|NOT COMPLETED|Month 7||13
582625|NCT00541970|1420876|P1|NOT COMPLETED|Month 7||9
582626|NCT00541970|1420873|P4|COMPLETED|Month 7||234
582627|NCT00541970|1420874|P3|COMPLETED|Month 7||229
582628|NCT00541970|1420875|P2|COMPLETED|Month 7||228
582629|NCT00541970|1420876|P1|COMPLETED|Month 7||231
582630|NCT00541970|1420873|P4|STARTED|Month 7||239
582631|NCT00541970|1420874|P3|STARTED|Month 7||240
582632|NCT00541970|1420875|P2|STARTED|Month 7||241
582633|NCT00541970|1420876|P1|STARTED|Month 7||240
582634|NCT00541931|1421027|P2|NOT COMPLETED|Overall Study||4
582635|NCT00541931|1421028|P1|NOT COMPLETED|Overall Study||5
582636|NCT00541931|1421027|P2|COMPLETED|Overall Study||11
582637|NCT00541931|1421028|P1|COMPLETED|Overall Study||17
582638|NCT00541931|1421027|P2|STARTED|Overall Study||15
582639|NCT00541931|1421028|P1|STARTED|Overall Study||22
582640|NCT00541866|1421041|P5|NOT COMPLETED|Overall Study||15
582641|NCT00541866|1421042|P4|NOT COMPLETED|Overall Study||16
582642|NCT00541866|1421043|P3|NOT COMPLETED|Overall Study||15
582643|NCT00541866|1421044|P2|NOT COMPLETED|Overall Study||18
582644|NCT00541866|1421045|P1|NOT COMPLETED|Overall Study||34
582645|NCT00541866|1421041|P5|COMPLETED|Overall Study||3
582646|NCT00541866|1421042|P4|COMPLETED|Overall Study||0
582647|NCT00541866|1421043|P3|COMPLETED|Overall Study||2
582648|NCT00541866|1421044|P2|COMPLETED|Overall Study||0
582649|NCT00541866|1421045|P1|COMPLETED|Overall Study||7
582650|NCT00541866|1421041|P5|STARTED|Overall Study||18
582651|NCT00541866|1421042|P4|STARTED|Overall Study||16
582652|NCT00541866|1421043|P3|STARTED|Overall Study||17
582653|NCT00541866|1421044|P2|STARTED|Overall Study||18
582654|NCT00541866|1421045|P1|STARTED|Overall Study|41 started, but only 39 treated|41
582655|NCT00541775|1421086|P3|NOT COMPLETED|Overall Study||8
582656|NCT00541775|1421087|P2|NOT COMPLETED|Overall Study||2
582657|NCT00541775|1421088|P1|NOT COMPLETED|Overall Study||9
582658|NCT00541775|1421086|P3|COMPLETED|Overall Study||84
582659|NCT00541775|1421087|P2|COMPLETED|Overall Study||85
582660|NCT00541775|1421088|P1|COMPLETED|Overall Study||85
582661|NCT00541775|1421086|P3|STARTED|Overall Study||92
582662|NCT00541775|1421087|P2|STARTED|Overall Study||87
582663|NCT00541775|1421088|P1|STARTED|Overall Study||94
582664|NCT00541671|1421104|P2|NOT COMPLETED|Overall Study||0
582665|NCT00541671|1421105|P1|NOT COMPLETED|Overall Study||0
582666|NCT00541671|1421104|P2|COMPLETED|Overall Study||12
582667|NCT00541671|1421105|P1|COMPLETED|Overall Study||13
582668|NCT00541671|1421104|P2|STARTED|Overall Study||12
582669|NCT00541671|1421105|P1|STARTED|Overall Study||13
582670|NCT00541658|1421114|P3|NOT COMPLETED|Overall Study||68
582671|NCT00541658|1421115|P2|NOT COMPLETED|Overall Study||73
582672|NCT00541658|1421116|P1|NOT COMPLETED|Overall Study||60
582673|NCT00541658|1421114|P3|COMPLETED|Overall Study||240
582674|NCT00541658|1421115|P2|COMPLETED|Overall Study||234
582675|NCT00541658|1421116|P1|COMPLETED|Overall Study||248
582676|NCT00541658|1421114|P3|ITT Population|Overall Study||308
582677|NCT00541658|1421115|P2|ITT Population|Overall Study||307
582678|NCT00541658|1421116|P1|ITT Population|Overall Study||307
582679|NCT00541658|1421114|P3|STARTED|Overall Study||308
582680|NCT00541658|1421115|P2|STARTED|Overall Study||307
582681|NCT00541658|1421116|P1|STARTED|Overall Study||308
582682|NCT00541593|1421273|P1|NOT COMPLETED|Overall Study||0
582683|NCT00541593|1421273|P1|COMPLETED|Overall Study||5
582684|NCT00541593|1421273|P1|STARTED|Overall Study||5
582685|NCT00541450|1421279|P2|NOT COMPLETED|Phase B||31
582686|NCT00541450|1421280|P1|NOT COMPLETED|Phase B||37
582687|NCT00541450|1421279|P2|COMPLETED|Phase B||200
582688|NCT00541450|1421280|P1|COMPLETED|Phase B||187
582689|NCT00541450|1421279|P2|STARTED|Phase B||231
582690|NCT00541450|1421280|P1|STARTED|Phase B||224
582691|NCT00541450|1421279|P2|NOT COMPLETED|Phase A||17
582692|NCT00541450|1421280|P1|NOT COMPLETED|Phase A||20
582693|NCT00541450|1421279|P2|COMPLETED|Phase A||231
582694|NCT00541450|1421280|P1|COMPLETED|Phase A||224
582695|NCT00541450|1421279|P2|STARTED|Phase A||248
582696|NCT00541450|1421280|P1|STARTED|Phase A||244
582697|NCT00541346|1421298|P1|NOT COMPLETED|Follow-up||1
582698|NCT00541346|1421298|P1|COMPLETED|Follow-up||15
582699|NCT00541346|1421298|P1|STARTED|Follow-up||16
582700|NCT00541346|1421298|P1|NOT COMPLETED|Baseline||0
582701|NCT00541346|1421298|P1|COMPLETED|Baseline||16
582702|NCT00541346|1421298|P1|STARTED|Baseline||16
582703|NCT00541307|1421312|P1|NOT COMPLETED|Overall Study||24
582704|NCT00541307|1421312|P1|COMPLETED|Overall Study||95
582705|NCT00541307|1421312|P1|STARTED|Overall Study||119
582706|NCT00541242|1421322|P2|NOT COMPLETED|Treatment Period 2||7
582707|NCT00541242|1421323|P1|NOT COMPLETED|Treatment Period 2||9
582708|NCT00541242|1421322|P2|COMPLETED|Treatment Period 2||266
582709|NCT00541242|1421323|P1|COMPLETED|Treatment Period 2||261
582710|NCT00541242|1421322|P2|STARTED|Treatment Period 2||273
582711|NCT00541242|1421323|P1|STARTED|Treatment Period 2||270
582712|NCT00541242|1421322|P2|NOT COMPLETED|Treatment Period 1||0
582713|NCT00541242|1421323|P1|NOT COMPLETED|Treatment Period 1||0
582714|NCT00541242|1421322|P2|COMPLETED|Treatment Period 1|43 of the 586 patients did not enter Treatment Period 2 (Randomized at Week 6)|586
582715|NCT00541242|1421323|P1|COMPLETED|Treatment Period 1||0
582716|NCT00541242|1421322|P2|STARTED|Treatment Period 1|586 patients were enrolled and received open-label latanoprost for 6 weeks|586
582717|NCT00541242|1421323|P1|STARTED|Treatment Period 1||0
582718|NCT00541229|1421337|P6|NOT COMPLETED|Treatment Period III (Week 11)||1
582719|NCT00541229|1421338|P5|NOT COMPLETED|Treatment Period III (Week 11)||1
582720|NCT00541229|1421339|P4|NOT COMPLETED|Treatment Period III (Week 11)||0
582721|NCT00541229|1421340|P3|NOT COMPLETED|Treatment Period III (Week 11)||1
582722|NCT00541229|1421341|P2|NOT COMPLETED|Treatment Period III (Week 11)||0
582723|NCT00541229|1421342|P1|NOT COMPLETED|Treatment Period III (Week 11)||0
582724|NCT00541229|1421337|P6|COMPLETED|Treatment Period III (Week 11)||4
582725|NCT00541229|1421338|P5|COMPLETED|Treatment Period III (Week 11)||6
582726|NCT00541229|1421339|P4|COMPLETED|Treatment Period III (Week 11)||8
582727|NCT00541229|1421340|P3|COMPLETED|Treatment Period III (Week 11)||9
582728|NCT00541229|1421341|P2|COMPLETED|Treatment Period III (Week 11)||8
582729|NCT00541229|1421342|P1|COMPLETED|Treatment Period III (Week 11)||7
582730|NCT00541229|1421337|P6|STARTED|Treatment Period III (Week 11)||5
582731|NCT00541229|1421338|P5|STARTED|Treatment Period III (Week 11)||7
582732|NCT00541229|1421339|P4|STARTED|Treatment Period III (Week 11)||8
582733|NCT00541229|1421340|P3|STARTED|Treatment Period III (Week 11)||10
582734|NCT00541229|1421341|P2|STARTED|Treatment Period III (Week 11)||8
582735|NCT00541229|1421342|P1|STARTED|Treatment Period III (Week 11)||7
582736|NCT00541229|1421337|P6|NOT COMPLETED|Washout Period II (Week 7-10)||3
582737|NCT00541229|1421338|P5|NOT COMPLETED|Washout Period II (Week 7-10)||4
582738|NCT00541229|1421339|P4|NOT COMPLETED|Washout Period II (Week 7-10)||4
582739|NCT00541229|1421340|P3|NOT COMPLETED|Washout Period II (Week 7-10)||2
582740|NCT00541229|1421341|P2|NOT COMPLETED|Washout Period II (Week 7-10)||4
582741|NCT00541229|1421342|P1|NOT COMPLETED|Washout Period II (Week 7-10)||4
582742|NCT00541229|1421337|P6|COMPLETED|Washout Period II (Week 7-10)||5
582743|NCT00541229|1421338|P5|COMPLETED|Washout Period II (Week 7-10)||7
582744|NCT00541229|1421339|P4|COMPLETED|Washout Period II (Week 7-10)||8
582745|NCT00541229|1421340|P3|COMPLETED|Washout Period II (Week 7-10)||10
582746|NCT00541229|1421341|P2|COMPLETED|Washout Period II (Week 7-10)||8
582747|NCT00541229|1421342|P1|COMPLETED|Washout Period II (Week 7-10)||7
582748|NCT00541229|1421337|P6|STARTED|Washout Period II (Week 7-10)||8
582749|NCT00541229|1421338|P5|STARTED|Washout Period II (Week 7-10)||11
582750|NCT00541229|1421339|P4|STARTED|Washout Period II (Week 7-10)||12
582751|NCT00541229|1421340|P3|STARTED|Washout Period II (Week 7-10)||12
582752|NCT00541229|1421341|P2|STARTED|Washout Period II (Week 7-10)||12
582753|NCT00541229|1421342|P1|STARTED|Washout Period II (Week 7-10)||11
582754|NCT00541229|1421337|P6|NOT COMPLETED|Treatment Period II (Week 6)||3
582755|NCT00541229|1421338|P5|NOT COMPLETED|Treatment Period II (Week 6)||2
582756|NCT00541229|1421339|P4|NOT COMPLETED|Treatment Period II (Week 6)||1
582757|NCT00541229|1421340|P3|NOT COMPLETED|Treatment Period II (Week 6)||1
582758|NCT00541229|1421341|P2|NOT COMPLETED|Treatment Period II (Week 6)||1
582759|NCT00541229|1421342|P1|NOT COMPLETED|Treatment Period II (Week 6)||2
582760|NCT00541229|1421337|P6|COMPLETED|Treatment Period II (Week 6)||8
582761|NCT00541229|1421338|P5|COMPLETED|Treatment Period II (Week 6)||11
582762|NCT00541229|1421339|P4|COMPLETED|Treatment Period II (Week 6)||12
582763|NCT00541229|1421340|P3|COMPLETED|Treatment Period II (Week 6)||12
582764|NCT00541229|1421341|P2|COMPLETED|Treatment Period II (Week 6)||12
582765|NCT00541229|1421342|P1|COMPLETED|Treatment Period II (Week 6)||11
582766|NCT00541229|1421337|P6|STARTED|Treatment Period II (Week 6)||11
582767|NCT00541229|1421338|P5|STARTED|Treatment Period II (Week 6)||13
582768|NCT00541229|1421339|P4|STARTED|Treatment Period II (Week 6)||13
582769|NCT00541229|1421340|P3|STARTED|Treatment Period II (Week 6)||13
582770|NCT00541229|1421341|P2|STARTED|Treatment Period II (Week 6)||13
582771|NCT00541229|1421342|P1|STARTED|Treatment Period II (Week 6)||13
582772|NCT00541229|1421337|P6|NOT COMPLETED|Washout Period I (Week 2-5)||5
582773|NCT00541229|1421338|P5|NOT COMPLETED|Washout Period I (Week 2-5)||1
582774|NCT00541229|1421339|P4|NOT COMPLETED|Washout Period I (Week 2-5)||4
582775|NCT00541229|1421340|P3|NOT COMPLETED|Washout Period I (Week 2-5)||4
582776|NCT00541229|1421341|P2|NOT COMPLETED|Washout Period I (Week 2-5)||2
582777|NCT00541229|1421342|P1|NOT COMPLETED|Washout Period I (Week 2-5)||4
582778|NCT00541229|1421337|P6|COMPLETED|Washout Period I (Week 2-5)||11
582779|NCT00541229|1421338|P5|COMPLETED|Washout Period I (Week 2-5)||13
582780|NCT00541229|1421339|P4|COMPLETED|Washout Period I (Week 2-5)||13
582781|NCT00541229|1421340|P3|COMPLETED|Washout Period I (Week 2-5)||13
582782|NCT00541229|1421341|P2|COMPLETED|Washout Period I (Week 2-5)||13
582783|NCT00541229|1421342|P1|COMPLETED|Washout Period I (Week 2-5)||13
582784|NCT00541229|1421337|P6|STARTED|Washout Period I (Week 2-5)||16
582785|NCT00541229|1421338|P5|STARTED|Washout Period I (Week 2-5)||14
582786|NCT00541229|1421339|P4|STARTED|Washout Period I (Week 2-5)||17
582787|NCT00541229|1421340|P3|STARTED|Washout Period I (Week 2-5)||17
582788|NCT00541229|1421341|P2|STARTED|Washout Period I (Week 2-5)||15
582789|NCT00541229|1421342|P1|STARTED|Washout Period I (Week 2-5)||17
582790|NCT00541229|1421337|P6|NOT COMPLETED|Treatment Period I (Week 1)||2
582791|NCT00541229|1421338|P5|NOT COMPLETED|Treatment Period I (Week 1)||0
582792|NCT00541229|1421339|P4|NOT COMPLETED|Treatment Period I (Week 1)||1
582793|NCT00541229|1421340|P3|NOT COMPLETED|Treatment Period I (Week 1)||3
582794|NCT00541229|1421341|P2|NOT COMPLETED|Treatment Period I (Week 1)||1
582795|NCT00541229|1421342|P1|NOT COMPLETED|Treatment Period I (Week 1)||0
582796|NCT00541229|1421337|P6|COMPLETED|Treatment Period I (Week 1)||16
582797|NCT00541229|1421338|P5|COMPLETED|Treatment Period I (Week 1)||14
582798|NCT00541229|1421339|P4|COMPLETED|Treatment Period I (Week 1)||17
582799|NCT00541229|1421340|P3|COMPLETED|Treatment Period I (Week 1)||17
582800|NCT00541229|1421341|P2|COMPLETED|Treatment Period I (Week 1)||15
582801|NCT00541229|1421342|P1|COMPLETED|Treatment Period I (Week 1)||17
582802|NCT00541229|1421337|P6|STARTED|Treatment Period I (Week 1)||18
582803|NCT00541229|1421338|P5|STARTED|Treatment Period I (Week 1)||14
582804|NCT00541229|1421339|P4|STARTED|Treatment Period I (Week 1)||18
582805|NCT00541229|1421340|P3|STARTED|Treatment Period I (Week 1)||20
582806|NCT00541229|1421341|P2|STARTED|Treatment Period I (Week 1)||16
582807|NCT00541229|1421342|P1|STARTED|Treatment Period I (Week 1)||17
582808|NCT00541190|1421352|P2|NOT COMPLETED|Overall Study||0
582809|NCT00541190|1421353|P1|NOT COMPLETED|Overall Study||0
582810|NCT00541190|1421352|P2|COMPLETED|Overall Study||11
582811|NCT00541190|1421353|P1|COMPLETED|Overall Study||10
582812|NCT00541190|1421352|P2|STARTED|Overall Study||11
582813|NCT00541190|1421353|P1|STARTED|Overall Study||10
582814|NCT00541099|1421361|P1|NOT COMPLETED|Overall Study||3
582815|NCT00541099|1421361|P1|COMPLETED|Overall Study||8
582816|NCT00541099|1421361|P1|STARTED|Overall Study||11
582817|NCT00541034|1421367|P1|NOT COMPLETED|Overall Study||3
582818|NCT00541034|1421367|P1|COMPLETED|Overall Study||46
582819|NCT00541034|1421367|P1|STARTED|Overall Study||49
582820|NCT00540969|1421373|P2|NOT COMPLETED|Overall Study||0
582821|NCT00540969|1421374|P1|NOT COMPLETED|Overall Study||0
582822|NCT00540969|1421373|P2|COMPLETED|Overall Study||1
582823|NCT00540969|1421374|P1|COMPLETED|Overall Study||2
582824|NCT00540969|1421373|P2|STARTED|Overall Study||1
582825|NCT00540969|1421374|P1|STARTED|Overall Study||2
582826|NCT00540722|1421384|P1|NOT COMPLETED|Overall Study||0
582827|NCT00540722|1421384|P1|COMPLETED|Overall Study||56
582828|NCT00540722|1421384|P1|STARTED|Overall Study||56
582829|NCT00540644|1421394|P2|NOT COMPLETED|Overall Study||9
582830|NCT00540644|1421395|P1|NOT COMPLETED|Overall Study||9
582831|NCT00540644|1421394|P2|COMPLETED|Overall Study||13
582832|NCT00540644|1421395|P1|COMPLETED|Overall Study||39
582833|NCT00540644|1421394|P2|STARTED|Overall Study||22
582834|NCT00540644|1421395|P1|STARTED|Overall Study||48
582835|NCT00540592|1421415|P10|NOT COMPLETED|Overall Study||2
582836|NCT00540592|1421416|P9|NOT COMPLETED|Overall Study||1
582837|NCT00540592|1421417|P8|NOT COMPLETED|Overall Study||1
582838|NCT00540592|1421418|P7|NOT COMPLETED|Overall Study||0
582839|NCT00540592|1421419|P6|NOT COMPLETED|Overall Study||0
582840|NCT00540592|1421420|P5|NOT COMPLETED|Overall Study||1
582841|NCT00540592|1421421|P4|NOT COMPLETED|Overall Study||1
582842|NCT00540592|1421422|P3|NOT COMPLETED|Overall Study||1
582843|NCT00540592|1421423|P2|NOT COMPLETED|Overall Study||1
582844|NCT00540592|1421424|P1|NOT COMPLETED|Overall Study||2
582845|NCT00540592|1421415|P10|COMPLETED|Overall Study||201
582846|NCT00540592|1421416|P9|COMPLETED|Overall Study||199
582847|NCT00540592|1421417|P8|COMPLETED|Overall Study||198
582848|NCT00540592|1421418|P7|COMPLETED|Overall Study||198
582849|NCT00540592|1421419|P6|COMPLETED|Overall Study||198
582850|NCT00540592|1421420|P5|COMPLETED|Overall Study||198
582851|NCT00540592|1421421|P4|COMPLETED|Overall Study||201
582852|NCT00540592|1421422|P3|COMPLETED|Overall Study||201
582853|NCT00540592|1421423|P2|COMPLETED|Overall Study||201
582854|NCT00540592|1421424|P1|COMPLETED|Overall Study||202
582855|NCT00540592|1421415|P10|Completed at Day 180|Overall Study||189
582856|NCT00540592|1421416|P9|Completed at Day 180|Overall Study||198
582857|NCT00540592|1421417|P8|Completed at Day 180|Overall Study||193
582858|NCT00540592|1421418|P7|Completed at Day 180|Overall Study||196
582859|NCT00540592|1421419|P6|Completed at Day 180|Overall Study||198
582860|NCT00540592|1421420|P5|Completed at Day 180|Overall Study||195
582861|NCT00540592|1421421|P4|Completed at Day 180|Overall Study||197
582862|NCT00540592|1421422|P3|Completed at Day 180|Overall Study||197
582863|NCT00540592|1421423|P2|Completed at Day 180|Overall Study||201
582864|NCT00540592|1421424|P1|Completed at Day 180|Overall Study||200
582865|NCT00540592|1421415|P10|STARTED|Overall Study||203
582866|NCT00540592|1421416|P9|STARTED|Overall Study||200
582867|NCT00540592|1421417|P8|STARTED|Overall Study||199
582868|NCT00540592|1421418|P7|STARTED|Overall Study||198
582869|NCT00540592|1421419|P6|STARTED|Overall Study||198
582870|NCT00540592|1421420|P5|STARTED|Overall Study||199
582871|NCT00540592|1421421|P4|STARTED|Overall Study||202
582872|NCT00540592|1421422|P3|STARTED|Overall Study||202
582873|NCT00540592|1421423|P2|STARTED|Overall Study||202
582874|NCT00540592|1421424|P1|STARTED|Overall Study||204
582875|NCT00540579|1421656|P1|NOT COMPLETED|Overall Study||0
582876|NCT00540579|1421656|P1|COMPLETED|Overall Study||23
582877|NCT00540579|1421656|P1|STARTED|Overall Study||23
582878|NCT00540514|1421663|P2|NOT COMPLETED|Overall Study||266
582879|NCT00540514|1421664|P1|NOT COMPLETED|Overall Study||246
582880|NCT00540514|1421663|P2|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease|265
582881|NCT00540514|1421664|P1|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease|275
582882|NCT00540514|1421663|P2|Biomarker Population|Overall Study||36
582883|NCT00540514|1421664|P1|Biomarker Population|Overall Study||35
582884|NCT00540514|1421663|P2|Treated|Overall Study||524
582885|NCT00540514|1421664|P1|Treated|Overall Study||514
582886|NCT00540514|1421663|P2|STARTED|Overall Study|Intent-to-treat Population: all randomized patients regardless of treatment received.|531
582887|NCT00540514|1421664|P1|STARTED|Overall Study|Intent-to-treat Population: all randomized patients regardless of treatment received.|521
582888|NCT00540449|1421696|P2|NOT COMPLETED|Overall Study||78
582889|NCT00540449|1421697|P1|NOT COMPLETED|Overall Study||84
582890|NCT00540449|1421696|P2|COMPLETED|Overall Study||266
582891|NCT00540449|1421697|P1|COMPLETED|Overall Study||262
582892|NCT00540449|1421696|P2|STARTED|Overall Study||344
582893|NCT00540449|1421697|P1|STARTED|Overall Study||346
582894|NCT00540436|1421719|P1|NOT COMPLETED|Second 12-Week Treatment Period||1
582895|NCT00540436|1421719|P1|COMPLETED|Second 12-Week Treatment Period||21
582896|NCT00540436|1421719|P1|STARTED|Second 12-Week Treatment Period||22
582897|NCT00540436|1421719|P1|NOT COMPLETED|First 12-Week Treatment Period||3
582898|NCT00540436|1421719|P1|COMPLETED|First 12-Week Treatment Period||22
582899|NCT00540436|1421719|P1|STARTED|First 12-Week Treatment Period||25
582900|NCT00540423|1421734|P3|NOT COMPLETED|Open-Label Treatment Period||2
582901|NCT00540423|1421735|P2|NOT COMPLETED|Open-Label Treatment Period||0
582902|NCT00540423|1421736|P1|NOT COMPLETED|Open-Label Treatment Period||0
582903|NCT00540423|1421734|P3|COMPLETED|Open-Label Treatment Period||20
582904|NCT00540423|1421735|P2|COMPLETED|Open-Label Treatment Period||0
582905|NCT00540423|1421736|P1|COMPLETED|Open-Label Treatment Period||0
582906|NCT00540423|1421734|P3|STARTED|Open-Label Treatment Period||22
582907|NCT00540423|1421735|P2|STARTED|Open-Label Treatment Period||0
582908|NCT00540423|1421736|P1|STARTED|Open-Label Treatment Period||0
582909|NCT00540423|1421734|P3|NOT COMPLETED|Double-Blind Treatment Period||0
582910|NCT00540423|1421735|P2|NOT COMPLETED|Double-Blind Treatment Period||1
582911|NCT00540423|1421736|P1|NOT COMPLETED|Double-Blind Treatment Period||0
582912|NCT00540423|1421734|P3|COMPLETED|Double-Blind Treatment Period||0
582913|NCT00540423|1421735|P2|COMPLETED|Double-Blind Treatment Period||14
582914|NCT00540423|1421736|P1|COMPLETED|Double-Blind Treatment Period||8
582915|NCT00540423|1421734|P3|STARTED|Double-Blind Treatment Period||0
582916|NCT00540423|1421735|P2|STARTED|Double-Blind Treatment Period||15
582917|NCT00540423|1421736|P1|STARTED|Double-Blind Treatment Period||8
582918|NCT00540293|1421786|P1|NOT COMPLETED|Overall Study||35
582919|NCT00540293|1421786|P1|COMPLETED|Overall Study||390
582920|NCT00540293|1421786|P1|STARTED|Overall Study||425
582921|NCT00540228|1421834|P5|NOT COMPLETED|Overall Study||0
582922|NCT00540228|1421835|P4|NOT COMPLETED|Overall Study||0
582923|NCT00540228|1421836|P3|NOT COMPLETED|Overall Study||0
582924|NCT00540228|1421837|P2|NOT COMPLETED|Overall Study||1
582925|NCT00540228|1421838|P1|NOT COMPLETED|Overall Study||3
582926|NCT00540228|1421834|P5|COMPLETED|Overall Study||202
582927|NCT00540228|1421835|P4|COMPLETED|Overall Study||202
582928|NCT00540228|1421836|P3|COMPLETED|Overall Study||204
582929|NCT00540228|1421837|P2|COMPLETED|Overall Study||197
582930|NCT00540228|1421838|P1|COMPLETED|Overall Study||197
582931|NCT00540228|1421834|P5|STARTED|Overall Study||202
582932|NCT00540228|1421835|P4|STARTED|Overall Study||202
582933|NCT00540228|1421836|P3|STARTED|Overall Study||204
582934|NCT00540228|1421837|P2|STARTED|Overall Study||198
582935|NCT00540228|1421838|P1|STARTED|Overall Study||200
582936|NCT00540124|1421908|P3|NOT COMPLETED|Overall Study||1
582937|NCT00540124|1421909|P2|NOT COMPLETED|Overall Study||3
582938|NCT00540124|1421910|P1|NOT COMPLETED|Overall Study||4
582939|NCT00540124|1421908|P3|COMPLETED|Overall Study||48
582940|NCT00540124|1421909|P2|COMPLETED|Overall Study||48
582941|NCT00540124|1421910|P1|COMPLETED|Overall Study||47
582942|NCT00540124|1421908|P3|STARTED|Overall Study||49
582943|NCT00540124|1421909|P2|STARTED|Overall Study||51
582944|NCT00540124|1421910|P1|STARTED|Overall Study||51
582945|NCT00540046|1421956|P2|NOT COMPLETED|Overall Study||23
582946|NCT00540046|1421957|P1|NOT COMPLETED|Overall Study||33
582947|NCT00540046|1421956|P2|COMPLETED|Overall Study||88
582948|NCT00540046|1421957|P1|COMPLETED|Overall Study||71
582949|NCT00540046|1421956|P2|STARTED|Overall Study||111
582950|NCT00540046|1421957|P1|STARTED|Overall Study||104
582951|NCT00540007|1421967|P2|NOT COMPLETED|Overall Study||0
582952|NCT00540007|1421968|P1|NOT COMPLETED|Overall Study||0
582953|NCT00540007|1421967|P2|COMPLETED|Overall Study||42
582954|NCT00540007|1421968|P1|COMPLETED|Overall Study||38
582955|NCT00540007|1421967|P2|STARTED|Overall Study||42
582956|NCT00540007|1421968|P1|STARTED|Overall Study||38
582957|NCT00539994|1421993|P3|NOT COMPLETED|Overall Study||2
582958|NCT00539994|1421994|P2|NOT COMPLETED|Overall Study||1
582959|NCT00539994|1421995|P1|NOT COMPLETED|Overall Study||3
582960|NCT00539994|1421993|P3|COMPLETED|Overall Study||13
582961|NCT00539994|1421994|P2|COMPLETED|Overall Study||18
582962|NCT00539994|1421995|P1|COMPLETED|Overall Study||20
582963|NCT00539994|1421993|P3|STARTED|Overall Study||15
582964|NCT00539994|1421994|P2|STARTED|Overall Study||19
582965|NCT00539994|1421995|P1|STARTED|Overall Study||23
582966|NCT00539942|1422034|P2|NOT COMPLETED|Overall Study||0
582967|NCT00539942|1422035|P1|NOT COMPLETED|Overall Study||0
582968|NCT00539942|1422034|P2|COMPLETED|Overall Study||3
582969|NCT00539942|1422035|P1|COMPLETED|Overall Study||4
582970|NCT00539942|1422034|P2|STARTED|Overall Study||3
582971|NCT00539942|1422035|P1|STARTED|Overall Study||4
582972|NCT00539864|1422045|P2|NOT COMPLETED|Overall Study||2
582973|NCT00539864|1422046|P1|NOT COMPLETED|Overall Study||1
582974|NCT00539864|1422045|P2|COMPLETED|Overall Study||300
582975|NCT00539864|1422046|P1|COMPLETED|Overall Study||299
582976|NCT00539864|1422045|P2|STARTED|Overall Study||302
582977|NCT00539864|1422046|P1|STARTED|Overall Study||300
582978|NCT00539734|1422058|P1|NOT COMPLETED|Overall Study||1
582979|NCT00539734|1422058|P1|COMPLETED|Overall Study||25
582980|NCT00539734|1422058|P1|STARTED|Overall Study||26
582981|NCT00539695|1422063|P1|NOT COMPLETED|Overall Study||13
582982|NCT00539695|1422063|P1|COMPLETED|Overall Study||12
582983|NCT00539695|1422063|P1|Evaluable Patients|Overall Study|Patients who received IL-2.|22
582984|NCT00539695|1422063|P1|STARTED|Overall Study||25
582985|NCT00539617|1422069|P1|NOT COMPLETED|Treatment Period||0
582986|NCT00539617|1422069|P1|COMPLETED|Treatment Period||3
582987|NCT00539617|1422069|P1|STARTED|Treatment Period||3
582988|NCT00539617|1422069|P1|NOT COMPLETED|Run-In Period||1
582989|NCT00539617|1422069|P1|COMPLETED|Run-In Period||3
582990|NCT00539617|1422069|P1|STARTED|Run-In Period||4
582991|NCT00539617|1422069|P1|NOT COMPLETED|Pre-screening Period||3
582992|NCT00539617|1422069|P1|COMPLETED|Pre-screening Period||4
582993|NCT00539617|1422069|P1|STARTED|Pre-screening Period||7
582994|NCT00539591|1422077|P3|NOT COMPLETED|Overall Study||3
582995|NCT00539591|1422078|P2|NOT COMPLETED|Overall Study||2
582996|NCT00539591|1422079|P1|NOT COMPLETED|Overall Study||5
582997|NCT00539591|1422077|P3|COMPLETED|Overall Study||1
582998|NCT00539591|1422078|P2|COMPLETED|Overall Study||0
582999|NCT00539591|1422079|P1|COMPLETED|Overall Study||18
583000|NCT00539591|1422077|P3|STARTED|Overall Study||4
583001|NCT00539591|1422078|P2|STARTED|Overall Study||2
583002|NCT00539591|1422079|P1|STARTED|Overall Study||23
583003|NCT00539539|1422189|P2|NOT COMPLETED|Overall Study||0
583004|NCT00539539|1422190|P1|NOT COMPLETED|Overall Study||0
583005|NCT00539539|1422189|P2|COMPLETED|Overall Study||771
583006|NCT00539539|1422190|P1|COMPLETED|Overall Study||815
583007|NCT00539539|1422189|P2|STARTED|Overall Study||771
583008|NCT00539539|1422190|P1|STARTED|Overall Study||815
583009|NCT00539526|1422213|P3|NOT COMPLETED|Overall Study||2
583010|NCT00539526|1422214|P2|NOT COMPLETED|Overall Study||2
583011|NCT00539526|1422215|P1|NOT COMPLETED|Overall Study||3
583012|NCT00539526|1422213|P3|COMPLETED|Overall Study||36
583013|NCT00539526|1422214|P2|COMPLETED|Overall Study||31
583014|NCT00539526|1422215|P1|COMPLETED|Overall Study||32
583015|NCT00539526|1422213|P3|STARTED|Overall Study||38
583016|NCT00539526|1422214|P2|STARTED|Overall Study||33
583017|NCT00539526|1422215|P1|STARTED|Overall Study||35
583018|NCT00539513|1422231|P2|NOT COMPLETED|Overall Study||2
583019|NCT00539513|1422232|P1|NOT COMPLETED|Overall Study||2
583020|NCT00539513|1422231|P2|COMPLETED|Overall Study||3
583021|NCT00539513|1422232|P1|COMPLETED|Overall Study||3
583022|NCT00539513|1422231|P2|Received Allocated Intervention|Overall Study||4
583023|NCT00539513|1422232|P1|Received Allocated Intervention|Overall Study||3
583024|NCT00539513|1422231|P2|STARTED|Overall Study||5
583025|NCT00539513|1422232|P1|STARTED|Overall Study||5
583026|NCT00539305|1422246|P2|NOT COMPLETED|Overall Study||2
583027|NCT00539305|1422247|P1|NOT COMPLETED|Overall Study||1
583028|NCT00539305|1422246|P2|COMPLETED|Overall Study||10
583029|NCT00539305|1422247|P1|COMPLETED|Overall Study||9
583030|NCT00539305|1422246|P2|STARTED|Overall Study||12
583031|NCT00539305|1422247|P1|STARTED|Overall Study||10
583032|NCT00539279|1422261|P2|NOT COMPLETED|6-Month Follow-Up Assessment||7
583033|NCT00539279|1422262|P1|NOT COMPLETED|6-Month Follow-Up Assessment||1
583034|NCT00539279|1422261|P2|COMPLETED|6-Month Follow-Up Assessment||22
583035|NCT00539279|1422262|P1|COMPLETED|6-Month Follow-Up Assessment||17
583036|NCT00539279|1422261|P2|STARTED|6-Month Follow-Up Assessment|Individuals eligible for 6-month assessment (includes all individuals randomized to RT)|29
583037|NCT00539279|1422262|P1|STARTED|6-Month Follow-Up Assessment|Individuals eligible for 6-month assessment (includes all individuals randomized to PE)|18
583038|NCT00539279|1422261|P2|NOT COMPLETED|Post-Treatment Assessment||9
583039|NCT00539279|1422262|P1|NOT COMPLETED|Post-Treatment Assessment||12
583040|NCT00539279|1422261|P2|COMPLETED|Post-Treatment Assessment||29
583041|NCT00539279|1422262|P1|COMPLETED|Post-Treatment Assessment||18
583042|NCT00539279|1422261|P2|STARTED|Post-Treatment Assessment|Individuals eligible for post-treatment assessment (includes all individuals randomized to RT)|38
583043|NCT00539279|1422262|P1|STARTED|Post-Treatment Assessment|Individuals eligible for post-treatment assessment (includes all individuals randomized to PE)|30
583044|NCT00539279|1422261|P2|NOT COMPLETED|Treatment||8
583045|NCT00539279|1422262|P1|NOT COMPLETED|Treatment||11
583046|NCT00539279|1422261|P2|COMPLETED|Treatment||38
583047|NCT00539279|1422262|P1|COMPLETED|Treatment||30
583048|NCT00539279|1422261|P2|STARTED|Treatment||46
583049|NCT00539279|1422262|P1|STARTED|Treatment||41
583050|NCT00539253|1422280|P1|NOT COMPLETED|Overall Study||26
583051|NCT00539253|1422280|P1|COMPLETED|Overall Study||19
583052|NCT00539253|1422280|P1|STARTED|Overall Study||45
583053|NCT00539240|1422288|P3|NOT COMPLETED|Overall Study||15
583054|NCT00539240|1422289|P2|NOT COMPLETED|Overall Study||7
583055|NCT00539240|1422290|P1|NOT COMPLETED|Overall Study||6
583056|NCT00539240|1422288|P3|COMPLETED|Overall Study||39
583057|NCT00539240|1422289|P2|COMPLETED|Overall Study||48
583058|NCT00539240|1422290|P1|COMPLETED|Overall Study||53
583059|NCT00539240|1422288|P3|STARTED|Overall Study||54
583060|NCT00539240|1422289|P2|STARTED|Overall Study||55
583061|NCT00539240|1422290|P1|STARTED|Overall Study||59
583062|NCT00539188|1422309|P2|NOT COMPLETED|Overall Study||1
583063|NCT00539188|1422310|P1|NOT COMPLETED|Overall Study||3
583064|NCT00539188|1422309|P2|COMPLETED|Overall Study||1
583065|NCT00539188|1422310|P1|COMPLETED|Overall Study||1
583066|NCT00539188|1422309|P2|Received Allocated Intervention|Overall Study||2
583067|NCT00539188|1422310|P1|Received Allocated Intervention|Overall Study||3
583068|NCT00539188|1422309|P2|STARTED|Overall Study||2
583069|NCT00539188|1422310|P1|STARTED|Overall Study||4
583070|NCT00539110|1422324|P2|NOT COMPLETED|Overall Study||0
583071|NCT00539110|1422325|P1|NOT COMPLETED|Overall Study||0
583072|NCT00539110|1422324|P2|COMPLETED|Overall Study||5
583073|NCT00539110|1422325|P1|COMPLETED|Overall Study||5
583074|NCT00539110|1422324|P2|STARTED|Overall Study||5
583075|NCT00539110|1422325|P1|STARTED|Overall Study||5
583076|NCT00539032|1422333|P2|NOT COMPLETED|Overall Study||1
583077|NCT00539032|1422334|P1|NOT COMPLETED|Overall Study||2
583078|NCT00539032|1422333|P2|COMPLETED|Overall Study||84
583079|NCT00539032|1422334|P1|COMPLETED|Overall Study||151
583080|NCT00539032|1422333|P2|STARTED|Overall Study||85
583081|NCT00539032|1422334|P1|STARTED|Overall Study||153
583082|NCT00539006|1422348|P4|NOT COMPLETED|Post-Study||0
583083|NCT00539006|1422349|P3|NOT COMPLETED|Post-Study||0
583084|NCT00539006|1422350|P2|NOT COMPLETED|Post-Study||0
583085|NCT00539006|1422351|P1|NOT COMPLETED|Post-Study||0
583086|NCT00539006|1422348|P4|COMPLETED|Post-Study||81
583087|NCT00539006|1422349|P3|COMPLETED|Post-Study||77
583088|NCT00539006|1422350|P2|COMPLETED|Post-Study||83
583089|NCT00539006|1422351|P1|COMPLETED|Post-Study||75
583090|NCT00539006|1422348|P4|STARTED|Post-Study||81
583091|NCT00539006|1422349|P3|STARTED|Post-Study||77
583092|NCT00539006|1422350|P2|STARTED|Post-Study||83
583093|NCT00539006|1422351|P1|STARTED|Post-Study||75
583094|NCT00539006|1422348|P4|NOT COMPLETED|Treatment Period 2||0
583095|NCT00539006|1422349|P3|NOT COMPLETED|Treatment Period 2||0
583096|NCT00539006|1422350|P2|NOT COMPLETED|Treatment Period 2||1
583097|NCT00539006|1422351|P1|NOT COMPLETED|Treatment Period 2||1
583098|NCT00539006|1422348|P4|COMPLETED|Treatment Period 2||81
583099|NCT00539006|1422349|P3|COMPLETED|Treatment Period 2||77
583100|NCT00539006|1422350|P2|COMPLETED|Treatment Period 2||83
583101|NCT00539006|1422351|P1|COMPLETED|Treatment Period 2||75
583102|NCT00539006|1422348|P4|STARTED|Treatment Period 2||81
583103|NCT00539006|1422349|P3|STARTED|Treatment Period 2||77
583104|NCT00539006|1422350|P2|STARTED|Treatment Period 2||84
583105|NCT00539006|1422351|P1|STARTED|Treatment Period 2||76
583106|NCT00539006|1422348|P4|NOT COMPLETED|Washout||9
583107|NCT00539006|1422349|P3|NOT COMPLETED|Washout||16
583108|NCT00539006|1422350|P2|NOT COMPLETED|Washout||10
583109|NCT00539006|1422351|P1|NOT COMPLETED|Washout||20
583110|NCT00539006|1422348|P4|COMPLETED|Washout||81
583111|NCT00539006|1422349|P3|COMPLETED|Washout||77
583112|NCT00539006|1422350|P2|COMPLETED|Washout||84
583113|NCT00539006|1422351|P1|COMPLETED|Washout||76
583114|NCT00539006|1422348|P4|STARTED|Washout||90
583115|NCT00539006|1422349|P3|STARTED|Washout||93
583116|NCT00539006|1422350|P2|STARTED|Washout||94
583117|NCT00539006|1422351|P1|STARTED|Washout||96
583118|NCT00539006|1422348|P4|NOT COMPLETED|Treatment Period 1||1
583119|NCT00539006|1422349|P3|NOT COMPLETED|Treatment Period 1||2
583120|NCT00539006|1422350|P2|NOT COMPLETED|Treatment Period 1||0
583121|NCT00539006|1422351|P1|NOT COMPLETED|Treatment Period 1||0
583122|NCT00539006|1422348|P4|COMPLETED|Treatment Period 1||90
583123|NCT00539006|1422349|P3|COMPLETED|Treatment Period 1||93
583124|NCT00539006|1422350|P2|COMPLETED|Treatment Period 1||94
583125|NCT00539006|1422351|P1|COMPLETED|Treatment Period 1||96
583126|NCT00539006|1422348|P4|STARTED|Treatment Period 1||91
583127|NCT00539006|1422349|P3|STARTED|Treatment Period 1||95
583128|NCT00539006|1422350|P2|STARTED|Treatment Period 1||94
583129|NCT00539006|1422351|P1|STARTED|Treatment Period 1||96
583130|NCT00539006|1422348|P4|NOT COMPLETED|Pre-treatment||0
583131|NCT00539006|1422349|P3|NOT COMPLETED|Pre-treatment||0
583132|NCT00539006|1422350|P2|NOT COMPLETED|Pre-treatment||1
583133|NCT00539006|1422351|P1|NOT COMPLETED|Pre-treatment||0
583134|NCT00539006|1422348|P4|COMPLETED|Pre-treatment||91
583135|NCT00539006|1422349|P3|COMPLETED|Pre-treatment||95
583136|NCT00539006|1422350|P2|COMPLETED|Pre-treatment||94
583137|NCT00539006|1422351|P1|COMPLETED|Pre-treatment||96
583138|NCT00539006|1422348|P4|STARTED|Pre-treatment||91
583139|NCT00539006|1422349|P3|STARTED|Pre-treatment||95
583140|NCT00539006|1422350|P2|STARTED|Pre-treatment||95
583141|NCT00539006|1422351|P1|STARTED|Pre-treatment||96
583142|NCT00538980|1422381|P1|NOT COMPLETED|Overall Study||10
583143|NCT00538980|1422381|P1|COMPLETED|Overall Study||0
583144|NCT00538980|1422381|P1|STARTED|Overall Study||10
583145|NCT00538915|1422389|P1|NOT COMPLETED|Overall Study||11
583146|NCT00538915|1422389|P1|COMPLETED|Overall Study||52
583147|NCT00538915|1422389|P1|STARTED|Overall Study||63
583148|NCT00538902|1422396|P3|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64
583149|NCT00538902|1422397|P2|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64
583150|NCT00538902|1422398|P1|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||36
583151|NCT00538902|1422396|P3|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||52
583152|NCT00538902|1422397|P2|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||55
583153|NCT00538902|1422398|P1|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||23
583154|NCT00538902|1422396|P3|STARTED|OL Wk 24 to End (Primary D/C Reasons)||116
583155|NCT00538902|1422397|P2|STARTED|OL Wk 24 to End (Primary D/C Reasons)||119
583156|NCT00538902|1422398|P1|STARTED|OL Wk 24 to End (Primary D/C Reasons)||59
583157|NCT00538902|1422396|P3|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||5
583158|NCT00538902|1422397|P2|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||2
583159|NCT00538902|1422398|P1|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||1
583160|NCT00538902|1422396|P3|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||116
583161|NCT00538902|1422397|P2|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||119
583162|NCT00538902|1422398|P1|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||59
583163|NCT00538902|1422396|P3|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121
583164|NCT00538902|1422397|P2|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121
583165|NCT00538902|1422398|P1|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||60
583166|NCT00538863|1422433|P1|NOT COMPLETED|Open-label Maintenance||106
583167|NCT00538863|1422433|P1|COMPLETED|Open-label Maintenance||163
583168|NCT00538863|1422433|P1|STARTED|Open-label Maintenance|Five participants who completed the titration period did not start the maintenance period.|269
583169|NCT00538863|1422433|P1|NOT COMPLETED|Open-label Titration||45
583170|NCT00538863|1422433|P1|COMPLETED|Open-label Titration||184
583171|NCT00538863|1422433|P1|STARTED|Open-label Titration||229
583172|NCT00538850|1422439|P3|NOT COMPLETED|Placebo - Double-blind||3
583173|NCT00538850|1422440|P2|NOT COMPLETED|Placebo - Double-blind||0
583174|NCT00538850|1422441|P1|NOT COMPLETED|Placebo - Double-blind||0
583175|NCT00538850|1422439|P3|COMPLETED|Placebo - Double-blind||95
583176|NCT00538850|1422440|P2|COMPLETED|Placebo - Double-blind||0
583177|NCT00538850|1422441|P1|COMPLETED|Placebo - Double-blind||0
583178|NCT00538850|1422439|P3|STARTED|Placebo - Double-blind||98
583179|NCT00538850|1422440|P2|STARTED|Placebo - Double-blind|There were no participants in this reporting group in the double-blind period.|0
583180|NCT00538850|1422441|P1|STARTED|Placebo - Double-blind|There were no participants in this reporting group in the double-blind period.|0
583181|NCT00538850|1422439|P3|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
583182|NCT00538850|1422440|P2|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||3
583183|NCT00538850|1422441|P1|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
583184|NCT00538850|1422439|P3|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
583185|NCT00538850|1422440|P2|COMPLETED|Fentanyl Sublingual Spray - Double-blind||95
583186|NCT00538850|1422441|P1|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
583187|NCT00538850|1422439|P3|STARTED|Fentanyl Sublingual Spray - Double-blind|There were no participants in this reporting group in the double-blind period.|0
583188|NCT00538850|1422440|P2|STARTED|Fentanyl Sublingual Spray - Double-blind||98
583189|NCT00538850|1422441|P1|STARTED|Fentanyl Sublingual Spray - Double-blind|There were no participants in this reporting group in the double-blind period.|0
583190|NCT00538850|1422439|P3|NOT COMPLETED|Titration Period||0
583191|NCT00538850|1422440|P2|NOT COMPLETED|Titration Period||0
583192|NCT00538850|1422441|P1|NOT COMPLETED|Titration Period||32
583193|NCT00538850|1422439|P3|COMPLETED|Titration Period||0
583194|NCT00538850|1422440|P2|COMPLETED|Titration Period||0
583195|NCT00538850|1422441|P1|COMPLETED|Titration Period||98
583196|NCT00538850|1422439|P3|STARTED|Titration Period|There were no participants in this reporting group in the titration period.|0
583197|NCT00538850|1422440|P2|STARTED|Titration Period|There were no participants in this reporting group in the titration period.|0
583198|NCT00538850|1422441|P1|STARTED|Titration Period||130
583199|NCT00538824|1422453|P1|NOT COMPLETED|Overall Study||0
583200|NCT00538824|1422453|P1|COMPLETED|Overall Study||5
583201|NCT00538824|1422453|P1|Progression of Disease|Overall Study||2
583202|NCT00538824|1422453|P1|STARTED|Overall Study||5
583203|NCT00538785|1422459|P2|NOT COMPLETED|Overall Study||17
583204|NCT00538785|1422460|P1|NOT COMPLETED|Overall Study||19
583205|NCT00538785|1422459|P2|COMPLETED|Overall Study||595
583206|NCT00538785|1422460|P1|COMPLETED|Overall Study||604
583207|NCT00538785|1422459|P2|STARTED|Overall Study||612
583208|NCT00538785|1422460|P1|STARTED|Overall Study|A subject was randomized without appropriate consent in France and is not included in the results.|623
583209|NCT00538733|1422481|P1|NOT COMPLETED|Overall Study||12
583210|NCT00538733|1422481|P1|COMPLETED|Overall Study||14
583211|NCT00538733|1422481|P1|Removed to Pursue Alternative Theray|Overall Study||2
583212|NCT00538733|1422481|P1|Removed to Pursue a Stem Cell Transplant|Overall Study||11
583213|NCT00538733|1422481|P1|Removed Due to Progression of Disease|Overall Study||1
583214|NCT00538733|1422481|P1|STARTED|Overall Study||26
583215|NCT00538642|1422490|P2|NOT COMPLETED|Overall Study||5
583216|NCT00538642|1422491|P1|NOT COMPLETED|Overall Study||1
583217|NCT00538642|1422490|P2|COMPLETED|Overall Study||9
583218|NCT00538642|1422491|P1|COMPLETED|Overall Study||9
583219|NCT00538642|1422490|P2|STARTED|Overall Study||14
583220|NCT00538642|1422491|P1|STARTED|Overall Study||10
583221|NCT00538629|1422531|P1|NOT COMPLETED|Overall Study||22
583222|NCT00538629|1422531|P1|COMPLETED|Overall Study||449
583223|NCT00538629|1422531|P1|STARTED|Overall Study||471
583224|NCT00538616|1422578|P2|NOT COMPLETED|Overall Study||0
583225|NCT00538616|1422579|P1|NOT COMPLETED|Overall Study||0
583226|NCT00538616|1422578|P2|COMPLETED|Overall Study||3
583227|NCT00538616|1422579|P1|COMPLETED|Overall Study||5
583228|NCT00538616|1422578|P2|STARTED|Overall Study||3
583229|NCT00538616|1422579|P1|STARTED|Overall Study||5
583230|NCT00538590|1422587|P2|NOT COMPLETED|Overall Study||0
583231|NCT00538590|1422588|P1|NOT COMPLETED|Overall Study||1
583232|NCT00538590|1422587|P2|COMPLETED|Overall Study||10
583233|NCT00538590|1422588|P1|COMPLETED|Overall Study|Deceased 8 months after surgery due to known cardiovascular co-morbidity.|9
583234|NCT00538590|1422587|P2|STARTED|Overall Study||10
583235|NCT00538590|1422588|P1|STARTED|Overall Study||10
583236|NCT00538512|1422605|P3|NOT COMPLETED|Overall Study||13
583237|NCT00538512|1422606|P2|NOT COMPLETED|Overall Study||30
583238|NCT00538512|1422607|P1|NOT COMPLETED|Overall Study||27
583239|NCT00538512|1422605|P3|COMPLETED|Overall Study||312
583240|NCT00538512|1422606|P2|COMPLETED|Overall Study||783
583241|NCT00538512|1422607|P1|COMPLETED|Overall Study||787
583242|NCT00538512|1422605|P3|STARTED|Overall Study||325
583243|NCT00538512|1422606|P2|STARTED|Overall Study||813
583244|NCT00538512|1422607|P1|STARTED|Overall Study||814
583245|NCT00538473|1422626|P2|NOT COMPLETED|Overall Study||0
583246|NCT00538473|1422627|P1|NOT COMPLETED|Overall Study||1
583247|NCT00538473|1422626|P2|COMPLETED|Overall Study||35
583248|NCT00538473|1422627|P1|COMPLETED|Overall Study||32
583249|NCT00538473|1422626|P2|STARTED|Overall Study||35
583250|NCT00538473|1422627|P1|STARTED|Overall Study||33
583251|NCT00538434|1422663|P4|NOT COMPLETED|Overall Study||6
583252|NCT00538434|1422664|P3|NOT COMPLETED|Overall Study||7
583253|NCT00538434|1422665|P2|NOT COMPLETED|Overall Study||11
583254|NCT00538434|1422666|P1|NOT COMPLETED|Overall Study||9
583255|NCT00538434|1422663|P4|COMPLETED|Overall Study|Completed all scheduled study visits|51
583256|NCT00538434|1422664|P3|COMPLETED|Overall Study|Completed all scheduled study visits|50
583257|NCT00538434|1422665|P2|COMPLETED|Overall Study|Completed all scheduled study visits|46
583258|NCT00538434|1422666|P1|COMPLETED|Overall Study|Completed all scheduled study visits|47
583259|NCT00538434|1422663|P4|Intent-to-treat (ITT) Population|Overall Study||57
583260|NCT00538434|1422664|P3|Intent-to-treat (ITT) Population|Overall Study||57
583261|NCT00538434|1422665|P2|Intent-to-treat (ITT) Population|Overall Study||57
583262|NCT00538434|1422666|P1|Intent-to-treat (ITT) Population|Overall Study|1 participant was randomized but not treated|55
583263|NCT00538434|1422663|P4|STARTED|Overall Study||57
583264|NCT00538434|1422664|P3|STARTED|Overall Study||57
583265|NCT00538434|1422665|P2|STARTED|Overall Study||57
583266|NCT00538434|1422666|P1|STARTED|Overall Study||56
583267|NCT00538304|1422690|P2|NOT COMPLETED|Overall Study||5
583268|NCT00538304|1422691|P1|NOT COMPLETED|Overall Study||7
583269|NCT00538304|1422690|P2|COMPLETED|Overall Study||66
583270|NCT00538304|1422691|P1|COMPLETED|Overall Study||144
583271|NCT00538304|1422690|P2|STARTED|Overall Study||71
583272|NCT00538304|1422691|P1|STARTED|Overall Study||151
583273|NCT00538291|1422707|P1|NOT COMPLETED|Overall Study||3
583274|NCT00538291|1422707|P1|COMPLETED|Overall Study||10
583275|NCT00538291|1422707|P1|STARTED|Overall Study||13
583276|NCT00538213|1422714|P3|NOT COMPLETED|Overall Study||0
583277|NCT00538213|1422715|P2|NOT COMPLETED|Overall Study||0
583278|NCT00538213|1422716|P1|NOT COMPLETED|Overall Study||0
583279|NCT00538213|1422714|P3|COMPLETED|Overall Study||38
583280|NCT00538213|1422715|P2|COMPLETED|Overall Study||40
583281|NCT00538213|1422716|P1|COMPLETED|Overall Study||55
583282|NCT00538213|1422714|P3|STARTED|Overall Study||38
583283|NCT00538213|1422715|P2|STARTED|Overall Study||40
583284|NCT00538213|1422716|P1|STARTED|Overall Study||55
583285|NCT00537979|1422765|P2|NOT COMPLETED|Overall Study||20
583286|NCT00537979|1422766|P1|NOT COMPLETED|Overall Study||6
583287|NCT00537979|1422765|P2|COMPLETED|Overall Study||89
583288|NCT00537979|1422766|P1|COMPLETED|Overall Study||32
583289|NCT00537979|1422765|P2|STARTED|Overall Study||109
583290|NCT00537979|1422766|P1|STARTED|Overall Study||38
583291|NCT00537940|1422782|P2|NOT COMPLETED|Overall Study||179
583292|NCT00537940|1422783|P1|NOT COMPLETED|Overall Study||183
583293|NCT00537940|1422782|P2|COMPLETED|Overall Study||62
583294|NCT00537940|1422783|P1|COMPLETED|Overall Study|2 participants had both treatment related and non-treatment related AE leading to discontinuation.|58
583295|NCT00537940|1422782|P2|Entered Opt Blinded Continuation Phase|Overall Study||139
583296|NCT00537940|1422783|P1|Entered Opt Blinded Continuation Phase|Overall Study||140
583297|NCT00537940|1422782|P2|Completed Maintenance Phase|Overall Study||172
583298|NCT00537940|1422783|P1|Completed Maintenance Phase|Overall Study||187
583299|NCT00537940|1422782|P2|Completed Titration Phase|Overall Study||210
583300|NCT00537940|1422783|P1|Completed Titration Phase|Overall Study||213
583301|NCT00537940|1422782|P2|STARTED|Overall Study||241
583302|NCT00537940|1422783|P1|STARTED|Overall Study||241
583303|NCT00537823|1422807|P2|NOT COMPLETED|Overall Study||0
583304|NCT00537823|1422808|P1|NOT COMPLETED|Overall Study||2
583305|NCT00537823|1422807|P2|COMPLETED|Overall Study||2
583306|NCT00537823|1422808|P1|COMPLETED|Overall Study||5
583307|NCT00537823|1422807|P2|STARTED|Overall Study||2
583308|NCT00537823|1422808|P1|STARTED|Overall Study||7
583309|NCT00537810|1422834|P4|NOT COMPLETED|Overall Study||4
583310|NCT00537810|1422835|P3|NOT COMPLETED|Overall Study||4
583311|NCT00537810|1422836|P2|NOT COMPLETED|Overall Study||13
583312|NCT00537810|1422837|P1|NOT COMPLETED|Overall Study||6
583313|NCT00537810|1422834|P4|COMPLETED|Overall Study||22
583314|NCT00537810|1422835|P3|COMPLETED|Overall Study||21
583315|NCT00537810|1422836|P2|COMPLETED|Overall Study||14
583316|NCT00537810|1422837|P1|COMPLETED|Overall Study||20
583317|NCT00537810|1422834|P4|STARTED|Overall Study||26
583318|NCT00537810|1422835|P3|STARTED|Overall Study||25
583319|NCT00537810|1422836|P2|STARTED|Overall Study||27
583320|NCT00537810|1422837|P1|STARTED|Overall Study||26
583321|NCT00537771|1422853|P2|NOT COMPLETED|Overall Study||61
583322|NCT00537771|1422854|P1|NOT COMPLETED|Overall Study||29
583323|NCT00537771|1422853|P2|COMPLETED|Overall Study||114
583324|NCT00537771|1422854|P1|COMPLETED|Overall Study||149
583325|NCT00537771|1422853|P2|STARTED|Overall Study||175
583326|NCT00537771|1422854|P1|STARTED|Overall Study||178
583327|NCT00537745|1422864|P1|NOT COMPLETED|Overall Study||5
583328|NCT00537745|1422864|P1|COMPLETED|Overall Study||9
583329|NCT00537745|1422864|P1|Began Intervention|Overall Study||11
583330|NCT00537745|1422864|P1|STARTED|Overall Study|There were three screen fails and two early terminations.|14
583331|NCT00537680|1422872|P3|NOT COMPLETED|Overall Study||0
583332|NCT00537680|1422873|P2|NOT COMPLETED|Overall Study||2
583333|NCT00537680|1422874|P1|NOT COMPLETED|Overall Study||0
583334|NCT00537680|1422872|P3|COMPLETED|Overall Study||24
583335|NCT00537680|1422873|P2|COMPLETED|Overall Study||22
583336|NCT00537680|1422874|P1|COMPLETED|Overall Study||22
583337|NCT00537680|1422872|P3|STARTED|Overall Study||24
583338|NCT00537680|1422873|P2|STARTED|Overall Study||24
583339|NCT00537680|1422874|P1|STARTED|Overall Study||22
583340|NCT00537511|1422882|P1|NOT COMPLETED|Maintenance Phase (Monotherapy)||8
583341|NCT00537511|1422882|P1|COMPLETED|Maintenance Phase (Monotherapy)||0
583342|NCT00537511|1422882|P1|STARTED|Maintenance Phase (Monotherapy)||8
583343|NCT00537511|1422882|P1|NOT COMPLETED|Recovery Period (Monotherapy)||8
583344|NCT00537511|1422882|P1|COMPLETED|Recovery Period (Monotherapy)||3
583345|NCT00537511|1422882|P1|STARTED|Recovery Period (Monotherapy)||11
583346|NCT00537511|1422882|P1|NOT COMPLETED|Extension Period (Combination)||6
583347|NCT00537511|1422882|P1|COMPLETED|Extension Period (Combination)||11
583348|NCT00537511|1422882|P1|STARTED|Extension Period (Combination)||17
583349|NCT00537511|1422882|P1|NOT COMPLETED|Treatment Period (Combination)||5
583350|NCT00537511|1422882|P1|COMPLETED|Treatment Period (Combination)||17
583351|NCT00537511|1422882|P1|Safety Population|Treatment Period (Combination)|Safety = All participants who took ≥1 dose of study treatment.|22
583352|NCT00537511|1422882|P1|Intent-to-Treat (ITT) Populaton|Treatment Period (Combination)|ITT = all participants enrolled in the study.|22
583353|NCT00537511|1422882|P1|STARTED|Treatment Period (Combination)||22
583354|NCT00537485|1422909|P2|NOT COMPLETED|Overall Study||10
583355|NCT00537485|1422910|P1|NOT COMPLETED|Overall Study||15
583356|NCT00537485|1422909|P2|COMPLETED|Overall Study||80
583357|NCT00537485|1422910|P1|COMPLETED|Overall Study||75
583358|NCT00537485|1422909|P2|STARTED|Overall Study||90
583359|NCT00537485|1422910|P1|STARTED|Overall Study||90
583360|NCT00537407|1422939|P5|NOT COMPLETED|Part 2 Weeks 5-48 or 72||7
583361|NCT00537407|1422940|P4|NOT COMPLETED|Part 2 Weeks 5-48 or 72||6
583362|NCT00537407|1422941|P3|NOT COMPLETED|Part 2 Weeks 5-48 or 72||9
583363|NCT00537407|1422942|P2|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8
583364|NCT00537407|1422943|P1|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8
583365|NCT00537407|1422939|P5|COMPLETED|Part 2 Weeks 5-48 or 72||3
583366|NCT00537407|1422940|P4|COMPLETED|Part 2 Weeks 5-48 or 72||4
583367|NCT00537407|1422941|P3|COMPLETED|Part 2 Weeks 5-48 or 72||2
583368|NCT00537407|1422942|P2|COMPLETED|Part 2 Weeks 5-48 or 72||1
583369|NCT00537407|1422943|P1|COMPLETED|Part 2 Weeks 5-48 or 72||2
583370|NCT00537407|1422939|P5|STARTED|Part 2 Weeks 5-48 or 72||10
583371|NCT00537407|1422940|P4|STARTED|Part 2 Weeks 5-48 or 72||10
583372|NCT00537407|1422941|P3|STARTED|Part 2 Weeks 5-48 or 72||11
583373|NCT00537407|1422942|P2|STARTED|Part 2 Weeks 5-48 or 72||9
583374|NCT00537407|1422943|P1|STARTED|Part 2 Weeks 5-48 or 72||10
583375|NCT00537407|1422939|P5|NOT COMPLETED|Part 1 Weeks 1-4||0
583376|NCT00537407|1422940|P4|NOT COMPLETED|Part 1 Weeks 1-4||0
583377|NCT00537407|1422941|P3|NOT COMPLETED|Part 1 Weeks 1-4||0
583378|NCT00537407|1422942|P2|NOT COMPLETED|Part 1 Weeks 1-4||0
583379|NCT00537407|1422943|P1|NOT COMPLETED|Part 1 Weeks 1-4||0
583380|NCT00537407|1422939|P5|COMPLETED|Part 1 Weeks 1-4||10
583381|NCT00537407|1422940|P4|COMPLETED|Part 1 Weeks 1-4||10
583382|NCT00537407|1422941|P3|COMPLETED|Part 1 Weeks 1-4||11
583383|NCT00537407|1422942|P2|COMPLETED|Part 1 Weeks 1-4||9
583384|NCT00537407|1422943|P1|COMPLETED|Part 1 Weeks 1-4||10
583385|NCT00537407|1422939|P5|STARTED|Part 1 Weeks 1-4||10
583386|NCT00537407|1422940|P4|STARTED|Part 1 Weeks 1-4||10
583387|NCT00537407|1422941|P3|STARTED|Part 1 Weeks 1-4||11
583388|NCT00537407|1422942|P2|STARTED|Part 1 Weeks 1-4||9
583389|NCT00537407|1422943|P1|STARTED|Part 1 Weeks 1-4||10
583390|NCT00537394|1422983|P3|NOT COMPLETED|2nd Year of Follow-up||6
583391|NCT00537394|1422984|P2|NOT COMPLETED|2nd Year of Follow-up||9
583392|NCT00537394|1422985|P1|NOT COMPLETED|2nd Year of Follow-up||11
583393|NCT00537394|1422983|P3|COMPLETED|2nd Year of Follow-up||44
583394|NCT00537394|1422984|P2|COMPLETED|2nd Year of Follow-up||159
583395|NCT00537394|1422985|P1|COMPLETED|2nd Year of Follow-up||158
583396|NCT00537394|1422983|P3|STARTED|2nd Year of Follow-up||50
583397|NCT00537394|1422984|P2|STARTED|2nd Year of Follow-up||168
583398|NCT00537394|1422985|P1|STARTED|2nd Year of Follow-up||169
583399|NCT00537394|1422983|P3|NOT COMPLETED|First Year of Follow-up||3
583400|NCT00537394|1422984|P2|NOT COMPLETED|First Year of Follow-up||11
583401|NCT00537394|1422985|P1|NOT COMPLETED|First Year of Follow-up||12
583402|NCT00537394|1422983|P3|COMPLETED|First Year of Follow-up||50
583403|NCT00537394|1422984|P2|COMPLETED|First Year of Follow-up|Completed refers to completing first 48 weeks of follow-up.|168
583404|NCT00537394|1422985|P1|COMPLETED|First Year of Follow-up|Completed refers to completing first 48 weeks of follow-up.|169
583405|NCT00537394|1422983|P3|STARTED|First Year of Follow-up||53
583406|NCT00537394|1422984|P2|STARTED|First Year of Follow-up||179
583407|NCT00537394|1422985|P1|STARTED|First Year of Follow-up||181
583408|NCT00537381|1423021|P2|NOT COMPLETED|Overall Study||62
583409|NCT00537381|1423022|P1|NOT COMPLETED|Overall Study||56
583410|NCT00537381|1423021|P2|COMPLETED|Overall Study||4
583411|NCT00537381|1423022|P1|COMPLETED|Overall Study||9
583412|NCT00537381|1423021|P2|STARTED|Overall Study||66
583413|NCT00537381|1423022|P1|STARTED|Overall Study|11 Participants after disease progression switched to intetumumab alone (2) or D+P+ Intetumumab (9).|65
583414|NCT00537329|1423042|P1|NOT COMPLETED|Overall Study||26
583415|NCT00537329|1423042|P1|COMPLETED|Overall Study||17
583416|NCT00537329|1423042|P1|STARTED|Overall Study||43
583417|NCT00537316|1423062|P7|NOT COMPLETED|Part 2||2
583418|NCT00537316|1423063|P6|NOT COMPLETED|Part 2||4
583419|NCT00537316|1423064|P5|NOT COMPLETED|Part 2||1
583420|NCT00537316|1423065|P4|NOT COMPLETED|Part 2||3
583421|NCT00537316|1423066|P3|NOT COMPLETED|Part 2||32
583422|NCT00537316|1423067|P2|NOT COMPLETED|Part 2||9
583423|NCT00537316|1423068|P1|NOT COMPLETED|Part 2||26
583424|NCT00537316|1423062|P7|COMPLETED|Part 2||0
583425|NCT00537316|1423063|P6|COMPLETED|Part 2||0
583426|NCT00537316|1423064|P5|COMPLETED|Part 2||1
583427|NCT00537316|1423065|P4|COMPLETED|Part 2||2
583428|NCT00537316|1423066|P3|COMPLETED|Part 2||16
583429|NCT00537316|1423067|P2|COMPLETED|Part 2||1
583430|NCT00537316|1423068|P1|COMPLETED|Part 2||11
583431|NCT00537316|1423062|P7|STARTED|Part 2||2
583432|NCT00537316|1423063|P6|STARTED|Part 2||4
583433|NCT00537316|1423064|P5|STARTED|Part 2||2
583434|NCT00537316|1423065|P4|STARTED|Part 2||5
583435|NCT00537316|1423066|P3|STARTED|Part 2||48
583436|NCT00537316|1423067|P2|STARTED|Part 2||10
583437|NCT00537316|1423068|P1|STARTED|Part 2||37
583438|NCT00537316|1423062|P7|NOT COMPLETED|Part 1||0
583439|NCT00537316|1423063|P6|NOT COMPLETED|Part 1||0
583440|NCT00537316|1423064|P5|NOT COMPLETED|Part 1||0
583441|NCT00537316|1423065|P4|NOT COMPLETED|Part 1||0
583442|NCT00537316|1423066|P3|NOT COMPLETED|Part 1||17
583443|NCT00537316|1423067|P2|NOT COMPLETED|Part 1||27
583444|NCT00537316|1423068|P1|NOT COMPLETED|Part 1||14
583445|NCT00537316|1423062|P7|COMPLETED|Part 1||0
583446|NCT00537316|1423063|P6|COMPLETED|Part 1||0
583447|NCT00537316|1423064|P5|COMPLETED|Part 1||0
583448|NCT00537316|1423065|P4|COMPLETED|Part 1||0
583449|NCT00537316|1423066|P3|COMPLETED|Part 1||63
583450|NCT00537316|1423067|P2|COMPLETED|Part 1||53
583451|NCT00537316|1423068|P1|COMPLETED|Part 1||65
583452|NCT00537316|1423062|P7|STARTED|Part 1||0
583453|NCT00537316|1423063|P6|STARTED|Part 1||0
583454|NCT00537316|1423064|P5|STARTED|Part 1||0
583455|NCT00537316|1423065|P4|STARTED|Part 1||0
583456|NCT00537316|1423066|P3|STARTED|Part 1||80
583457|NCT00537316|1423067|P2|STARTED|Part 1||80
583458|NCT00537316|1423068|P1|STARTED|Part 1||79
583459|NCT00537303|1423095|P2|NOT COMPLETED|Overall Study||25
583460|NCT00537303|1423096|P1|NOT COMPLETED|Overall Study||26
583461|NCT00537303|1423095|P2|COMPLETED|Overall Study||125
583462|NCT00537303|1423096|P1|COMPLETED|Overall Study||120
583463|NCT00537303|1423095|P2|STARTED|Overall Study||150
583464|NCT00537303|1423096|P1|STARTED|Overall Study||146
583465|NCT00537290|1423112|P1|NOT COMPLETED|Overall Study||0
583466|NCT00537290|1423112|P1|COMPLETED|Overall Study||19
583467|NCT00537290|1423112|P1|STARTED|Overall Study||19
583468|NCT00537277|1423117|P1|NOT COMPLETED|Overall Study||49
583469|NCT00537277|1423117|P1|COMPLETED|Overall Study||112
583470|NCT00537277|1423117|P1|Exposed to Trial Drug|Overall Study|One subject not exposed to trial drug, and thus not included in full analysis set (FAS)|160
583471|NCT00537277|1423117|P1|STARTED|Overall Study||161
583472|NCT00537238|1423128|P2|NOT COMPLETED|Overall Study||173
583473|NCT00537238|1423129|P1|NOT COMPLETED|Overall Study||174
583474|NCT00537238|1423128|P2|COMPLETED|Overall Study|Completed designates participants who completed the opt blinded continuation phase.|82
583475|NCT00537238|1423129|P1|COMPLETED|Overall Study|Completed designates participants who completed the opt blinded continuation phase.|80
583476|NCT00537238|1423128|P2|Entered Opt Blinded Continuation Phase|Overall Study|Participants who had clinical benefit were eligible to progress into opt blinded continuation phase.|195
583477|NCT00537238|1423129|P1|Entered Opt Blinded Continuation Phase|Overall Study|Participants who had clinical benefit were eligible to progress into opt blinded continuation phase.|185
583478|NCT00537238|1423128|P2|Completed Maintenance Phase|Overall Study|Primary analysis drawn from the population in the maintenance phase.|210
583479|NCT00537238|1423129|P1|Completed Maintenance Phase|Overall Study|Primary analysis drawn from the population in the maintenance phase.|208
583480|NCT00537238|1423128|P2|Completed Titration Phase|Overall Study||236
583481|NCT00537238|1423129|P1|Completed Titration Phase|Overall Study||226
583482|NCT00537238|1423128|P2|STARTED|Overall Study||255
583483|NCT00537238|1423129|P1|STARTED|Overall Study||254
583484|NCT00537199|1423149|P1|NOT COMPLETED|Overall Study||1
583485|NCT00537199|1423149|P1|COMPLETED|Overall Study||0
583486|NCT00537199|1423149|P1|STARTED|Overall Study||1
583487|NCT00537095|1423155|P2|NOT COMPLETED|Overall Study||57
583488|NCT00537095|1423156|P1|NOT COMPLETED|Overall Study||51
583489|NCT00537095|1423155|P2|COMPLETED|Overall Study||16
583490|NCT00537095|1423156|P1|COMPLETED|Overall Study||21
583491|NCT00537095|1423155|P2|STARTED|Overall Study||73
583492|NCT00537095|1423156|P1|STARTED|Overall Study||72
583493|NCT00537082|1423171|P3|NOT COMPLETED|Overall Study||6
583494|NCT00537082|1423172|P2|NOT COMPLETED|Overall Study||9
583495|NCT00537082|1423173|P1|NOT COMPLETED|Overall Study||9
583496|NCT00537082|1423171|P3|COMPLETED|Overall Study||51
583497|NCT00537082|1423172|P2|COMPLETED|Overall Study||48
583498|NCT00537082|1423173|P1|COMPLETED|Overall Study||48
583499|NCT00537082|1423171|P3|STARTED|Overall Study||57
583500|NCT00537082|1423172|P2|STARTED|Overall Study||57
583501|NCT00537082|1423173|P1|STARTED|Overall Study||57
583502|NCT00537056|1423190|P1|NOT COMPLETED|12-month Follow-up||0
583503|NCT00537056|1423190|P1|COMPLETED|12-month Follow-up||17
583504|NCT00537056|1423190|P1|STARTED|12-month Follow-up||17
583505|NCT00537056|1423190|P1|NOT COMPLETED|Interim PET/CT||5
583506|NCT00537056|1423190|P1|COMPLETED|Interim PET/CT||12
583507|NCT00537056|1423190|P1|STARTED|Interim PET/CT||17
583508|NCT00537056|1423190|P1|NOT COMPLETED|Baseline PET/CT||0
583509|NCT00537056|1423190|P1|COMPLETED|Baseline PET/CT||17
583510|NCT00537056|1423190|P1|STARTED|Baseline PET/CT||17
583511|NCT00537030|1423202|P1|NOT COMPLETED|Overall Study||16
583512|NCT00537030|1423202|P1|COMPLETED|Overall Study||43
583513|NCT00537030|1423202|P1|STARTED|Overall Study||59
583514|NCT00537017|1423206|P1|NOT COMPLETED|Follow-up Phase||9
583515|NCT00537017|1423206|P1|COMPLETED|Follow-up Phase||126
583516|NCT00537017|1423206|P1|STARTED|Follow-up Phase|All TP participants were eligible for FUP entry. 5 participants completing TP did not enter FUP.|135
583517|NCT00537017|1423206|P1|NOT COMPLETED|Treatment Phase||34
583518|NCT00537017|1423206|P1|COMPLETED|Treatment Phase||106
583519|NCT00537017|1423206|P1|STARTED|Treatment Phase||140
583520|NCT00536991|1423217|P1|NOT COMPLETED|Overall Study||13
583521|NCT00536991|1423217|P1|COMPLETED|Overall Study||38
583522|NCT00536991|1423217|P1|STARTED|Overall Study||51
583523|NCT00536978|1423224|P1|NOT COMPLETED|Overall Study||22
583524|NCT00536978|1423224|P1|COMPLETED|Overall Study||0
583525|NCT00536978|1423224|P1|STARTED|Overall Study||22
583526|NCT00536913|1423230|P2|NOT COMPLETED|Overall Study||0
583527|NCT00536913|1423231|P1|NOT COMPLETED|Overall Study||0
583528|NCT00536913|1423230|P2|COMPLETED|Overall Study||52
583529|NCT00536913|1423231|P1|COMPLETED|Overall Study||55
583530|NCT00536913|1423230|P2|STARTED|Overall Study||52
583531|NCT00536913|1423231|P1|STARTED|Overall Study||55
583532|NCT00536874|1423253|P1|NOT COMPLETED|Overall Study||4
583533|NCT00536874|1423253|P1|COMPLETED|Overall Study||35
583534|NCT00536874|1423253|P1|STARTED|Overall Study||39
583535|NCT00536809|1423263|P1|NOT COMPLETED|Phase II||2
583536|NCT00536809|1423263|P1|COMPLETED|Phase II||0
583537|NCT00536809|1423263|P1|STARTED|Phase II||2
583538|NCT00536809|1423263|P1|NOT COMPLETED|Phase I (Dose-finding Phase)||0
583539|NCT00536809|1423263|P1|COMPLETED|Phase I (Dose-finding Phase)||10
583540|NCT00536809|1423263|P1|STARTED|Phase I (Dose-finding Phase)||10
583541|NCT00536744|1423286|P2|NOT COMPLETED|Overall Study||28
583542|NCT00536744|1423287|P1|NOT COMPLETED|Overall Study||29
583543|NCT00536744|1423286|P2|COMPLETED|Overall Study||71
583544|NCT00536744|1423287|P1|COMPLETED|Overall Study||78
583545|NCT00536744|1423286|P2|STARTED|Overall Study||99
583546|NCT00536744|1423287|P1|STARTED|Overall Study||107
583547|NCT00536731|1423296|P3|NOT COMPLETED|Overall Study||5
583548|NCT00536731|1423297|P2|NOT COMPLETED|Overall Study||5
583549|NCT00536731|1423298|P1|NOT COMPLETED|Overall Study||4
583550|NCT00536731|1423296|P3|COMPLETED|Overall Study||238
583551|NCT00536731|1423297|P2|COMPLETED|Overall Study||241
583552|NCT00536731|1423298|P1|COMPLETED|Overall Study||249
583553|NCT00536731|1423296|P3|STARTED|Overall Study||243
583554|NCT00536731|1423297|P2|STARTED|Overall Study||246
583555|NCT00536731|1423298|P1|STARTED|Overall Study||253
583556|NCT00536575|1423342|P1|NOT COMPLETED|Overall Study||2
583557|NCT00536575|1423342|P1|COMPLETED|Overall Study||11
583558|NCT00536575|1423342|P1|STARTED|Overall Study||13
583559|NCT00536510|1423348|P2|NOT COMPLETED|Overall Study||29
583560|NCT00536510|1423349|P1|NOT COMPLETED|Overall Study||82
583561|NCT00536510|1423348|P2|COMPLETED|Overall Study||295
583562|NCT00536510|1423349|P1|COMPLETED|Overall Study||240
583563|NCT00536510|1423348|P2|STARTED|Overall Study||324
583564|NCT00536510|1423349|P1|STARTED|Overall Study||322
583565|NCT00536484|1423359|P2|NOT COMPLETED|Overall Study||56
583566|NCT00536484|1423360|P1|NOT COMPLETED|Overall Study||60
583567|NCT00536484|1423359|P2|COMPLETED|Overall Study|134 completed on 4mg dose and 248 on 8mg dose|382
583568|NCT00536484|1423360|P1|COMPLETED|Overall Study|88 completed on matched 4mg dose and 297 on matched 8mg dose|385
583569|NCT00536484|1423359|P2|STARTED|Overall Study|448 participants randomised; 10 not treated|438
583570|NCT00536484|1423360|P1|STARTED|Overall Study|448 participants randomised; 3 not treated|445
583571|NCT00536471|1423394|P4|NOT COMPLETED|Overall Study||74
583572|NCT00536471|1423395|P3|NOT COMPLETED|Overall Study||139
583573|NCT00536471|1423396|P2|NOT COMPLETED|Overall Study||84
583574|NCT00536471|1423397|P1|NOT COMPLETED|Overall Study||156
583575|NCT00536471|1423394|P4|COMPLETED|Overall Study||57
583576|NCT00536471|1423395|P3|COMPLETED|Overall Study||122
583577|NCT00536471|1423396|P2|COMPLETED|Overall Study||43
583578|NCT00536471|1423397|P1|COMPLETED|Overall Study||101
583579|NCT00536471|1423394|P4|STARTED|Overall Study||131
583580|NCT00536471|1423395|P3|STARTED|Overall Study||261
583581|NCT00536471|1423396|P2|STARTED|Overall Study||127
583582|NCT00536471|1423397|P1|STARTED|Overall Study||257
583583|NCT00536380|1423642|P3|NOT COMPLETED|Overall Study||10
583584|NCT00536380|1423643|P2|NOT COMPLETED|Overall Study||9
583585|NCT00536380|1423644|P1|NOT COMPLETED|Overall Study||12
583586|NCT00536380|1423642|P3|COMPLETED|Overall Study||94
583587|NCT00536380|1423643|P2|COMPLETED|Overall Study||95
583588|NCT00536380|1423644|P1|COMPLETED|Overall Study||94
583589|NCT00536380|1423642|P3|STARTED|Overall Study||104
583590|NCT00536380|1423643|P2|STARTED|Overall Study||104
583591|NCT00536380|1423644|P1|STARTED|Overall Study||106
583592|NCT00536341|1423654|P2|NOT COMPLETED|Overall Study||11
583593|NCT00536341|1423655|P1|NOT COMPLETED|Overall Study||5
583594|NCT00536341|1423654|P2|COMPLETED|Overall Study||43
583595|NCT00536341|1423655|P1|COMPLETED|Overall Study||5
583596|NCT00536341|1423654|P2|STARTED|Overall Study||54
583597|NCT00536341|1423655|P1|STARTED|Overall Study||10
583598|NCT00536263|1423668|P3|NOT COMPLETED|Overall Study||21
583599|NCT00536263|1423669|P2|NOT COMPLETED|Overall Study||14
583600|NCT00536263|1423670|P1|NOT COMPLETED|Overall Study||11
583601|NCT00536263|1423668|P3|COMPLETED|Overall Study||204
583602|NCT00536263|1423669|P2|COMPLETED|Overall Study||207
583603|NCT00536263|1423670|P1|COMPLETED|Overall Study||214
583604|NCT00536263|1423668|P3|STARTED|Overall Study|One (1) participant withdrawn from study for non-compliance.|225
583605|NCT00536263|1423669|P2|STARTED|Overall Study||221
583606|NCT00536263|1423670|P1|STARTED|Overall Study||225
583607|NCT00536198|1423710|P2|NOT COMPLETED|Overall Study||39
583608|NCT00536198|1423711|P1|NOT COMPLETED|Overall Study||37
583609|NCT00536198|1423710|P2|COMPLETED|Overall Study||88
583610|NCT00536198|1423711|P1|COMPLETED|Overall Study||88
583611|NCT00536198|1423710|P2|Cycle 6|Overall Study||88
583612|NCT00536198|1423711|P1|Cycle 6|Overall Study||88
583613|NCT00536198|1423710|P2|Cycle 5|Overall Study||85
583614|NCT00536198|1423711|P1|Cycle 5|Overall Study||88
583615|NCT00536198|1423710|P2|Cycle 4|Overall Study||98
583616|NCT00536198|1423711|P1|Cycle 4|Overall Study||95
583617|NCT00536198|1423710|P2|Cycle 3|Overall Study||101
583618|NCT00536198|1423711|P1|Cycle 3|Overall Study||100
583619|NCT00536198|1423710|P2|Cycle 2|Overall Study||112
583620|NCT00536198|1423711|P1|Cycle 2|Overall Study||104
583621|NCT00536198|1423710|P2|Cycle 1|Overall Study||123
583622|NCT00536198|1423711|P1|Cycle 1|Overall Study||110
583623|NCT00536198|1423710|P2|STARTED|Overall Study||127
583624|NCT00536198|1423711|P1|STARTED|Overall Study||125
583625|NCT00536172|1423741|P2|NOT COMPLETED|Overall Study||9
583626|NCT00536172|1423742|P1|NOT COMPLETED|Overall Study||14
583627|NCT00536172|1423741|P2|COMPLETED|Overall Study||65
583628|NCT00536172|1423742|P1|COMPLETED|Overall Study||60
583629|NCT00536172|1423741|P2|STARTED|Overall Study||74
583630|NCT00536172|1423742|P1|STARTED|Overall Study||74
583631|NCT00536120|1423750|P2|NOT COMPLETED|Overall Study||3
583632|NCT00536120|1423751|P1|NOT COMPLETED|Overall Study||6
583633|NCT00536120|1423750|P2|COMPLETED|Overall Study||27
583634|NCT00536120|1423751|P1|COMPLETED|Overall Study||24
583635|NCT00536120|1423750|P2|STARTED|Overall Study||30
583636|NCT00536120|1423751|P1|STARTED|Overall Study||30
583637|NCT00536107|1423765|P2|NOT COMPLETED|Overall Study||6
583638|NCT00536107|1423766|P1|NOT COMPLETED|Overall Study||8
583639|NCT00536107|1423765|P2|COMPLETED|Overall Study||0
583640|NCT00536107|1423766|P1|COMPLETED|Overall Study||0
583641|NCT00536107|1423765|P2|STARTED|Overall Study||6
583642|NCT00536107|1423766|P1|STARTED|Overall Study||8
583643|NCT00535938|1423776|P2|NOT COMPLETED|Overall Study||462
583644|NCT00535938|1423777|P1|NOT COMPLETED|Overall Study||391
583645|NCT00535938|1423776|P2|COMPLETED|Overall Study||404
583646|NCT00535938|1423777|P1|COMPLETED|Overall Study||115
583647|NCT00535938|1423776|P2|STARTED|Overall Study||866
583648|NCT00535938|1423777|P1|STARTED|Overall Study||506
583649|NCT00535873|1423813|P1|NOT COMPLETED|Overall Study||0
583650|NCT00535873|1423813|P1|COMPLETED|Overall Study||60
583651|NCT00535873|1423813|P1|STARTED|Overall Study||60
583652|NCT00535847|1423820|P3|NOT COMPLETED|Overall Study||2
583653|NCT00535847|1423821|P2|NOT COMPLETED|Overall Study||14
583654|NCT00535847|1423822|P1|NOT COMPLETED|Overall Study||22
583655|NCT00535847|1423820|P3|COMPLETED|Overall Study||0
583656|NCT00535847|1423821|P2|COMPLETED|Overall Study||20
583657|NCT00535847|1423822|P1|COMPLETED|Overall Study||59
583658|NCT00535847|1423820|P3|STARTED|Overall Study||2
583659|NCT00535847|1423821|P2|STARTED|Overall Study||34
583660|NCT00535847|1423822|P1|STARTED|Overall Study||81
583661|NCT00535821|1423848|P2|NOT COMPLETED|Overall Study||0
583662|NCT00535821|1423849|P1|NOT COMPLETED|Overall Study||0
583663|NCT00535821|1423848|P2|COMPLETED|Overall Study||3
583664|NCT00535821|1423849|P1|COMPLETED|Overall Study||2
583665|NCT00535821|1423848|P2|STARTED|Overall Study||3
583666|NCT00535821|1423849|P1|STARTED|Overall Study||2
583667|NCT00535782|1423857|P3|NOT COMPLETED|Part 2: 80-Week Open-label Period||26
583668|NCT00535782|1423858|P2|NOT COMPLETED|Part 2: 80-Week Open-label Period||0
583669|NCT00535782|1423859|P1|NOT COMPLETED|Part 2: 80-Week Open-label Period||0
583670|NCT00535782|1423857|P3|COMPLETED|Part 2: 80-Week Open-label Period||98
583671|NCT00535782|1423858|P2|COMPLETED|Part 2: 80-Week Open-label Period||0
583672|NCT00535782|1423859|P1|COMPLETED|Part 2: 80-Week Open-label Period||0
583673|NCT00535782|1423857|P3|STARTED|Part 2: 80-Week Open-label Period||124
583674|NCT00535782|1423858|P2|STARTED|Part 2: 80-Week Open-label Period||0
583675|NCT00535782|1423859|P1|STARTED|Part 2: 80-Week Open-label Period||0
583676|NCT00535782|1423857|P3|NOT COMPLETED|Part 1: 24-Week Double-blind Period||0
583677|NCT00535782|1423858|P2|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4
583678|NCT00535782|1423859|P1|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4
583679|NCT00535782|1423857|P3|COMPLETED|Part 1: 24-Week Double-blind Period||0
583680|NCT00535782|1423858|P2|COMPLETED|Part 1: 24-Week Double-blind Period||59
583681|NCT00535782|1423859|P1|COMPLETED|Part 1: 24-Week Double-blind Period||65
583682|NCT00535782|1423857|P3|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0
583683|NCT00535782|1423858|P2|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||62
583684|NCT00535782|1423859|P1|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0
583685|NCT00535782|1423857|P3|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||0
583686|NCT00535782|1423858|P2|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period|1 misrandomized patient received the TCZ in error, and 1 patient received TCZ as rescue therapy.|2
583687|NCT00535782|1423859|P1|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||69
583688|NCT00535782|1423857|P3|STARTED|Part 1: 24-Week Double-blind Period||0
583689|NCT00535782|1423858|P2|STARTED|Part 1: 24-Week Double-blind Period||63
583690|NCT00535782|1423859|P1|STARTED|Part 1: 24-Week Double-blind Period||69
583691|NCT00535769|1423876|P2|NOT COMPLETED|Overall Study||0
583692|NCT00535769|1423877|P1|NOT COMPLETED|Overall Study||0
583693|NCT00535769|1423876|P2|COMPLETED|Overall Study||35
583694|NCT00535769|1423877|P1|COMPLETED|Overall Study||35
583695|NCT00535769|1423876|P2|STARTED|Overall Study||35
583696|NCT00535769|1423877|P1|STARTED|Overall Study||35
583697|NCT00535730|1423888|P2|NOT COMPLETED|Overall Study||7
583698|NCT00535730|1423889|P1|NOT COMPLETED|Overall Study||2
583699|NCT00535730|1423888|P2|COMPLETED|Overall Study||230
583700|NCT00535730|1423889|P1|COMPLETED|Overall Study||234
583701|NCT00535730|1423888|P2|STARTED|Overall Study|Two subjects were allocated but not vaccinated making the number of subjects vaccinated 235|237
583702|NCT00535730|1423889|P1|STARTED|Overall Study||236
583703|NCT00535652|1423906|P1|NOT COMPLETED|Overall Study||3
583704|NCT00535652|1423906|P1|COMPLETED|Overall Study||20
583705|NCT00535652|1423906|P1|STARTED|Overall Study||23
583706|NCT00535626|1423910|P1|NOT COMPLETED|Overall Study||105
583707|NCT00535626|1423910|P1|COMPLETED|Overall Study||85
583708|NCT00535626|1423910|P1|STARTED|Overall Study||190
583709|NCT00535587|1423924|P4|NOT COMPLETED|Overall Study||13
583710|NCT00535587|1423925|P3|NOT COMPLETED|Overall Study||8
583711|NCT00535587|1423926|P2|NOT COMPLETED|Overall Study||11
583712|NCT00535587|1423927|P1|NOT COMPLETED|Overall Study||10
583713|NCT00535587|1423924|P4|COMPLETED|Overall Study||41
583714|NCT00535587|1423925|P3|COMPLETED|Overall Study||39
583715|NCT00535587|1423926|P2|COMPLETED|Overall Study||42
583716|NCT00535587|1423927|P1|COMPLETED|Overall Study||43
583717|NCT00535587|1423924|P4|STARTED|Overall Study||54
583718|NCT00535587|1423925|P3|STARTED|Overall Study||47
583719|NCT00535587|1423926|P2|STARTED|Overall Study||53
583720|NCT00535587|1423927|P1|STARTED|Overall Study||53
583721|NCT00535496|1423937|P4|NOT COMPLETED|Overall Study||0
583722|NCT00535496|1423938|P3|NOT COMPLETED|Overall Study||0
583723|NCT00535496|1423939|P2|NOT COMPLETED|Overall Study||2
583724|NCT00535496|1423940|P1|NOT COMPLETED|Overall Study||0
583725|NCT00535496|1423937|P4|COMPLETED|Overall Study||31
583726|NCT00535496|1423938|P3|COMPLETED|Overall Study||30
583727|NCT00535496|1423939|P2|COMPLETED|Overall Study||13
583728|NCT00535496|1423940|P1|COMPLETED|Overall Study||15
583729|NCT00535496|1423937|P4|All-Subjects-Treated (AST) Group|Overall Study||31
583730|NCT00535496|1423938|P3|All-Subjects-Treated (AST) Group|Overall Study||30
583731|NCT00535496|1423939|P2|All-Subjects-Treated (AST) Group|Overall Study||14
583732|NCT00535496|1423940|P1|All-Subjects-Treated (AST) Group|Overall Study||15
583733|NCT00535496|1423937|P4|STARTED|Overall Study||31
583734|NCT00535496|1423938|P3|STARTED|Overall Study||30
583735|NCT00535496|1423939|P2|STARTED|Overall Study||15
583736|NCT00535496|1423940|P1|STARTED|Overall Study||15
583737|NCT00535405|1423960|P5|NOT COMPLETED|Overall Study||16
583738|NCT00535405|1423961|P4|NOT COMPLETED|Overall Study||22
583739|NCT00535405|1423962|P3|NOT COMPLETED|Overall Study||18
583740|NCT00535405|1423963|P2|NOT COMPLETED|Overall Study||26
583741|NCT00535405|1423964|P1|NOT COMPLETED|Overall Study||17
583742|NCT00535405|1423960|P5|COMPLETED|Overall Study||241
583743|NCT00535405|1423961|P4|COMPLETED|Overall Study||235
583744|NCT00535405|1423962|P3|COMPLETED|Overall Study||241
583745|NCT00535405|1423963|P2|COMPLETED|Overall Study||233
583746|NCT00535405|1423964|P1|COMPLETED|Overall Study||240
583747|NCT00535405|1423960|P5|STARTED|Overall Study||257
583748|NCT00535405|1423961|P4|STARTED|Overall Study||257
583749|NCT00535405|1423962|P3|STARTED|Overall Study||259
583750|NCT00535405|1423963|P2|STARTED|Overall Study||259
583751|NCT00535405|1423964|P1|STARTED|Overall Study||257
583752|NCT00535392|1424001|P1|NOT COMPLETED|Overall Study||0
583753|NCT00535392|1424001|P1|COMPLETED|Overall Study||33
583754|NCT00535392|1424001|P1|STARTED|Overall Study||33
583755|NCT00535301|1424009|P2|NOT COMPLETED|Overall Study||5
583756|NCT00535301|1424010|P1|NOT COMPLETED|Overall Study||5
583757|NCT00535301|1424009|P2|COMPLETED|Overall Study||33
583758|NCT00535301|1424010|P1|COMPLETED|Overall Study||33
583759|NCT00535301|1424009|P2|STARTED|Overall Study||38
583760|NCT00535301|1424010|P1|STARTED|Overall Study||38
583761|NCT00535288|1424025|P5|NOT COMPLETED|Overall Study||42
583762|NCT00535288|1424026|P4|NOT COMPLETED|Overall Study||29
583763|NCT00535288|1424027|P3|NOT COMPLETED|Overall Study||33
583764|NCT00535288|1424028|P2|NOT COMPLETED|Overall Study||32
583765|NCT00535288|1424029|P1|NOT COMPLETED|Overall Study||54
583766|NCT00535288|1424025|P5|COMPLETED|Overall Study||116
583767|NCT00535288|1424026|P4|COMPLETED|Overall Study||122
583768|NCT00535288|1424027|P3|COMPLETED|Overall Study||127
583769|NCT00535288|1424028|P2|COMPLETED|Overall Study||130
583770|NCT00535288|1424029|P1|COMPLETED|Overall Study||260
583771|NCT00535288|1424025|P5|STARTED|Overall Study|One participant randomized to receive placebo received esmirtazapine 18 mg.|158
583772|NCT00535288|1424026|P4|STARTED|Overall Study||151
583773|NCT00535288|1424027|P3|STARTED|Overall Study||160
583774|NCT00535288|1424028|P2|STARTED|Overall Study||162
583775|NCT00535288|1424029|P1|STARTED|Overall Study|2 participants randomized to receive placebo did not receive placebo|314
583776|NCT00535262|1424106|P1|NOT COMPLETED|Overall Study||3
583777|NCT00535262|1424106|P1|COMPLETED|Overall Study|Pharmaceutical company withdrew supply of EmSam prematurely before protocol was complete.|0
583778|NCT00535262|1424106|P1|STARTED|Overall Study|3 patients were enrolled in the study. Data was collected for only two weeks before funding expired.|3
583779|NCT00535223|1424112|P2|NOT COMPLETED|Overall Study||1
583780|NCT00535223|1424113|P1|NOT COMPLETED|Overall Study||4
583781|NCT00535223|1424112|P2|COMPLETED|Overall Study||39
583782|NCT00535223|1424113|P1|COMPLETED|Overall Study||37
583783|NCT00535223|1424112|P2|STARTED|Overall Study|Patients were randomized in cohorts of ten.|40
583784|NCT00535223|1424113|P1|STARTED|Overall Study|Patients were randomized in cohorts of ten.|41
583785|NCT00535145|1424121|P1|NOT COMPLETED|Phase II||15
583786|NCT00535145|1424121|P1|COMPLETED|Phase II||69
583787|NCT00535145|1424121|P1|STARTED|Phase II|Of the 85 participants who completed Phase 1, 84 met the criteria to enroll into Phase 2|84
583788|NCT00535145|1424121|P1|NOT COMPLETED|Phase I||29
583789|NCT00535145|1424121|P1|COMPLETED|Phase I||85
583790|NCT00535145|1424121|P1|STARTED|Phase I||114
583791|NCT00535132|1424133|P2|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3
583792|NCT00535132|1424134|P1|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3
583793|NCT00535132|1424133|P2|COMPLETED|Intent-to-Treat (ITT) Analysis Set|Patients who received at least one dose of study drug and have some follow-up efficacy data.|96
583794|NCT00535132|1424134|P1|COMPLETED|Intent-to-Treat (ITT) Analysis Set|Patients who received at least one dose of study drug and have some follow-up efficacy data.|95
583795|NCT00535132|1424133|P2|STARTED|Intent-to-Treat (ITT) Analysis Set||99
583796|NCT00535132|1424134|P1|STARTED|Intent-to-Treat (ITT) Analysis Set||98
583797|NCT00535132|1424133|P2|NOT COMPLETED|Safety Analysis Set||2
583798|NCT00535132|1424134|P1|NOT COMPLETED|Safety Analysis Set||2
583799|NCT00535132|1424133|P2|COMPLETED|Safety Analysis Set|Two patients were randomized but not treated.|99
583800|NCT00535132|1424134|P1|COMPLETED|Safety Analysis Set|Two patients were randomized but not treated.|98
583801|NCT00535132|1424133|P2|STARTED|Safety Analysis Set||101
583802|NCT00535132|1424134|P1|STARTED|Safety Analysis Set||100
583803|NCT00535132|1424133|P2|NOT COMPLETED|Randomized Population||0
583804|NCT00535132|1424134|P1|NOT COMPLETED|Randomized Population||0
583805|NCT00535132|1424133|P2|COMPLETED|Randomized Population||101
583806|NCT00535132|1424134|P1|COMPLETED|Randomized Population||100
583807|NCT00535132|1424133|P2|STARTED|Randomized Population|Number of Subjects Randomized|101
583808|NCT00535132|1424134|P1|STARTED|Randomized Population|Number of Subjects Randomized|100
583809|NCT00535002|1424192|P8|NOT COMPLETED|Overall Study||0
583810|NCT00535002|1424193|P7|NOT COMPLETED|Overall Study||0
583811|NCT00535002|1424194|P6|NOT COMPLETED|Overall Study||0
583812|NCT00535002|1424195|P5|NOT COMPLETED|Overall Study||0
583813|NCT00535002|1424196|P4|NOT COMPLETED|Overall Study||0
583814|NCT00535002|1424197|P3|NOT COMPLETED|Overall Study||0
583815|NCT00535002|1424198|P2|NOT COMPLETED|Overall Study||0
583816|NCT00535002|1424199|P1|NOT COMPLETED|Overall Study||0
583817|NCT00535002|1424192|P8|COMPLETED|Overall Study||16
583818|NCT00535002|1424193|P7|COMPLETED|Overall Study||12
583819|NCT00535002|1424194|P6|COMPLETED|Overall Study||17
583820|NCT00535002|1424195|P5|COMPLETED|Overall Study||9
583821|NCT00535002|1424196|P4|COMPLETED|Overall Study||14
583822|NCT00535002|1424197|P3|COMPLETED|Overall Study||13
583823|NCT00535002|1424198|P2|COMPLETED|Overall Study||12
583824|NCT00535002|1424199|P1|COMPLETED|Overall Study||19
583825|NCT00535002|1424192|P8|STARTED|Overall Study||16
583826|NCT00535002|1424193|P7|STARTED|Overall Study||12
583827|NCT00535002|1424194|P6|STARTED|Overall Study||17
583828|NCT00535002|1424195|P5|STARTED|Overall Study||9
583829|NCT00535002|1424196|P4|STARTED|Overall Study||14
583830|NCT00535002|1424197|P3|STARTED|Overall Study||13
583831|NCT00535002|1424198|P2|STARTED|Overall Study||12
583832|NCT00535002|1424199|P1|STARTED|Overall Study||19
583833|NCT00534976|1424215|P2|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||0
583834|NCT00534976|1424216|P1|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||2
583835|NCT00534976|1424215|P2|COMPLETED|Period 3: Crossover Placebo/ Montelukast||32
583836|NCT00534976|1424216|P1|COMPLETED|Period 3: Crossover Placebo/ Montelukast||31
583837|NCT00534976|1424215|P2|STARTED|Period 3: Crossover Placebo/ Montelukast||32
583838|NCT00534976|1424216|P1|STARTED|Period 3: Crossover Placebo/ Montelukast||33
583839|NCT00534976|1424215|P2|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||1
583840|NCT00534976|1424216|P1|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||0
583841|NCT00534976|1424215|P2|COMPLETED|Period 2: Treatment Montelukast/ Placebo||32
583842|NCT00534976|1424216|P1|COMPLETED|Period 2: Treatment Montelukast/ Placebo||33
583843|NCT00534976|1424215|P2|STARTED|Period 2: Treatment Montelukast/ Placebo||33
583844|NCT00534976|1424216|P1|STARTED|Period 2: Treatment Montelukast/ Placebo||33
583845|NCT00534976|1424215|P2|NOT COMPLETED|Period 1: Placebo Run-in||0
583846|NCT00534976|1424216|P1|NOT COMPLETED|Period 1: Placebo Run-in||0
583847|NCT00534976|1424215|P2|COMPLETED|Period 1: Placebo Run-in||33
583848|NCT00534976|1424216|P1|COMPLETED|Period 1: Placebo Run-in||33
583849|NCT00534976|1424215|P2|STARTED|Period 1: Placebo Run-in||33
583850|NCT00534976|1424216|P1|STARTED|Period 1: Placebo Run-in||33
583851|NCT00534937|1424238|P2|NOT COMPLETED|Overall Study||12
583852|NCT00534937|1424239|P1|NOT COMPLETED|Overall Study||8
583853|NCT00534937|1424238|P2|COMPLETED|Overall Study||35
583854|NCT00534937|1424239|P1|COMPLETED|Overall Study||34
583855|NCT00534937|1424238|P2|STARTED|Overall Study||47
583856|NCT00534937|1424239|P1|STARTED|Overall Study||42
583857|NCT00534833|1424253|P2|NOT COMPLETED|Overall Study||0
583858|NCT00534833|1424254|P1|NOT COMPLETED|Overall Study||0
583859|NCT00534833|1424253|P2|COMPLETED|Overall Study||180
583860|NCT00534833|1424254|P1|COMPLETED|Overall Study||182
583861|NCT00534833|1424253|P2|STARTED|Overall Study||180
583862|NCT00534833|1424254|P1|STARTED|Overall Study||182
583863|NCT00534794|1424266|P2|NOT COMPLETED|Overall Study||0
583864|NCT00534794|1424267|P1|NOT COMPLETED|Overall Study||0
583865|NCT00534794|1424266|P2|COMPLETED|Overall Study||39
583866|NCT00534794|1424267|P1|COMPLETED|Overall Study||40
583867|NCT00534794|1424266|P2|STARTED|Overall Study||39
583868|NCT00534794|1424267|P1|STARTED|Overall Study||40
583869|NCT00534638|1424277|P2|NOT COMPLETED|Overall Study||11791
583870|NCT00534638|1424278|P1|NOT COMPLETED|Overall Study||6491
583871|NCT00534638|1424277|P2|COMPLETED|Overall Study||5547
583872|NCT00534638|1424278|P1|COMPLETED|Overall Study||8346
583873|NCT00534638|1424277|P2|STARTED|Overall Study||17338
583874|NCT00534638|1424278|P1|STARTED|Overall Study||14837
583875|NCT00534599|1424313|P2|NOT COMPLETED|Overall Study||32
583876|NCT00534599|1424314|P1|NOT COMPLETED|Overall Study||57
583877|NCT00534599|1424313|P2|COMPLETED|Overall Study||168
583878|NCT00534599|1424314|P1|COMPLETED|Overall Study||152
583879|NCT00534599|1424313|P2|STARTED|Overall Study|Randomized|200
583880|NCT00534599|1424314|P1|STARTED|Overall Study|Randomized|209
583881|NCT00534495|1424350|P3|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||11
583882|NCT00534495|1424351|P2|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0
583883|NCT00534495|1424352|P1|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0
583884|NCT00534495|1424350|P3|COMPLETED|Long Term Ext. Phase Week 24-month 21||29
583885|NCT00534495|1424351|P2|COMPLETED|Long Term Ext. Phase Week 24-month 21||0
583886|NCT00534495|1424352|P1|COMPLETED|Long Term Ext. Phase Week 24-month 21||0
583887|NCT00534495|1424350|P3|STARTED|Long Term Ext. Phase Week 24-month 21||40
583888|NCT00534495|1424351|P2|STARTED|Long Term Ext. Phase Week 24-month 21||0
583889|NCT00534495|1424352|P1|STARTED|Long Term Ext. Phase Week 24-month 21||0
583890|NCT00534495|1424350|P3|NOT COMPLETED|All Active Treatment Phase Week 4-24||0
583891|NCT00534495|1424351|P2|NOT COMPLETED|All Active Treatment Phase Week 4-24||9
583892|NCT00534495|1424352|P1|NOT COMPLETED|All Active Treatment Phase Week 4-24||4
583893|NCT00534495|1424350|P3|COMPLETED|All Active Treatment Phase Week 4-24||0
583894|NCT00534495|1424351|P2|COMPLETED|All Active Treatment Phase Week 4-24||25
583895|NCT00534495|1424352|P1|COMPLETED|All Active Treatment Phase Week 4-24||32
583896|NCT00534495|1424350|P3|STARTED|All Active Treatment Phase Week 4-24||0
583897|NCT00534495|1424351|P2|STARTED|All Active Treatment Phase Week 4-24||34
583898|NCT00534495|1424352|P1|STARTED|All Active Treatment Phase Week 4-24||36
583899|NCT00534495|1424350|P3|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0
583900|NCT00534495|1424351|P2|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||1
583901|NCT00534495|1424352|P1|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0
583902|NCT00534495|1424350|P3|COMPLETED|Double Blind Placebo Phase Week 0-4||0
583903|NCT00534495|1424351|P2|COMPLETED|Double Blind Placebo Phase Week 0-4||34
583904|NCT00534495|1424352|P1|COMPLETED|Double Blind Placebo Phase Week 0-4||36
583905|NCT00534495|1424350|P3|STARTED|Double Blind Placebo Phase Week 0-4||0
583906|NCT00534495|1424351|P2|STARTED|Double Blind Placebo Phase Week 0-4||35
583907|NCT00534495|1424352|P1|STARTED|Double Blind Placebo Phase Week 0-4||36
583908|NCT00534417|1424375|P1|NOT COMPLETED|Overall Study||0
583909|NCT00534417|1424375|P1|COMPLETED|Overall Study||41
583910|NCT00534417|1424375|P1|STARTED|Overall Study||41
583911|NCT00534404|1424390|P3|NOT COMPLETED|Overall Study||242
583912|NCT00534404|1424391|P2|NOT COMPLETED|Overall Study||143
583913|NCT00534404|1424392|P1|NOT COMPLETED|Overall Study||180
583914|NCT00534404|1424390|P3|COMPLETED|Overall Study||586
583915|NCT00534404|1424391|P2|COMPLETED|Overall Study||687
583916|NCT00534404|1424392|P1|COMPLETED|Overall Study||647
583917|NCT00534404|1424390|P3|3-month Follow up Completed|Overall Study||593
583918|NCT00534404|1424391|P2|3-month Follow up Completed|Overall Study||731
583919|NCT00534404|1424392|P1|3-month Follow up Completed|Overall Study||682
583920|NCT00534404|1424390|P3|1-month Follow up Completed|Overall Study||626
583921|NCT00534404|1424391|P2|1-month Follow up Completed|Overall Study||781
583922|NCT00534404|1424392|P1|1-month Follow up Completed|Overall Study||742
583923|NCT00534404|1424390|P3|Completed at Least 1 Counseling Call|Overall Study|There was no counseling offered in this arm|0
583924|NCT00534404|1424391|P2|Completed at Least 1 Counseling Call|Overall Study|There was no counseling offered in this arm|0
583925|NCT00534404|1424392|P1|Completed at Least 1 Counseling Call|Overall Study||813
583926|NCT00534404|1424390|P3|Completed Second NRT Order|Overall Study|NRT not available for this arm.|0
583927|NCT00534404|1424391|P2|Completed Second NRT Order|Overall Study||789
583928|NCT00534404|1424392|P1|Completed Second NRT Order|Overall Study||640
583929|NCT00534404|1424390|P3|Completed First NRT Order|Overall Study|NRT was not available for this arm|0
583930|NCT00534404|1424391|P2|Completed First NRT Order|Overall Study|Participants could order NRT without completing a web session|821
583931|NCT00534404|1424392|P1|Completed First NRT Order|Overall Study||765
583932|NCT00534404|1424390|P3|Completed at Least 1 Online Session|Overall Study||658
583933|NCT00534404|1424391|P2|Completed at Least 1 Online Session|Overall Study||813
583934|NCT00534404|1424392|P1|Completed at Least 1 Online Session|Overall Study||781
583935|NCT00534404|1424390|P3|STARTED|Overall Study||828
583936|NCT00534404|1424391|P2|STARTED|Overall Study||830
583937|NCT00534404|1424392|P1|STARTED|Overall Study||827
583938|NCT00534365|1424408|P2|NOT COMPLETED|Overall Study||7
583939|NCT00534365|1424409|P1|NOT COMPLETED|Overall Study||0
583940|NCT00534365|1424408|P2|COMPLETED|Overall Study||129
583941|NCT00534365|1424409|P1|COMPLETED|Overall Study||127
583942|NCT00534365|1424408|P2|Included in Intent to Treat Analysis|Overall Study||136
583943|NCT00534365|1424409|P1|Included in Intent to Treat Analysis|Overall Study||127
583944|NCT00534365|1424408|P2|Follow up at 12 Months or More|Overall Study||128
583945|NCT00534365|1424409|P1|Follow up at 12 Months or More|Overall Study||119
583946|NCT00534365|1424408|P2|Any Follow up|Overall Study||135
583947|NCT00534365|1424409|P1|Any Follow up|Overall Study||126
583948|NCT00534365|1424408|P2|Received Procedure|Overall Study|7 patients excluded due to receipt of sling other than mini-sling|129
583949|NCT00534365|1424409|P1|Received Procedure|Overall Study||127
583950|NCT00534365|1424408|P2|STARTED|Overall Study||136
583951|NCT00534365|1424409|P1|STARTED|Overall Study||127
583952|NCT00534352|1424423|P1|NOT COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||4
583953|NCT00534352|1424423|P1|COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||14
583954|NCT00534352|1424423|P1|STARTED|Optional Extension: DRV/Rtv + TDF/FTC||18
583955|NCT00534352|1424423|P1|NOT COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||1
583956|NCT00534352|1424423|P1|COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||20
583957|NCT00534352|1424423|P1|STARTED|Treatment C: DRV/Rtv + TDF/FTC||21
583958|NCT00534352|1424423|P1|NOT COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||0
583959|NCT00534352|1424423|P1|COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21
583960|NCT00534352|1424423|P1|STARTED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21
583961|NCT00534352|1424423|P1|NOT COMPLETED|Treatment A: TMC125 + TDF/FTC||2
583962|NCT00534352|1424423|P1|COMPLETED|Treatment A: TMC125 + TDF/FTC||21
583963|NCT00534352|1424423|P1|STARTED|Treatment A: TMC125 + TDF/FTC||23
583964|NCT00534313|1424467|P4|NOT COMPLETED|Long-term Period||33
583965|NCT00534313|1424468|P3|NOT COMPLETED|Long-term Period||43
583966|NCT00534313|1424469|P2|NOT COMPLETED|Long-term Period||34
583967|NCT00534313|1424470|P1|NOT COMPLETED|Long-term Period||37
583968|NCT00534313|1424467|P4|COMPLETED|Long-term Period||0
583969|NCT00534313|1424468|P3|COMPLETED|Long-term Period||0
583970|NCT00534313|1424469|P2|COMPLETED|Long-term Period||0
583971|NCT00534313|1424470|P1|COMPLETED|Long-term Period||0
583972|NCT00534313|1424467|P4|STARTED|Long-term Period||33
583973|NCT00534313|1424468|P3|STARTED|Long-term Period||43
583974|NCT00534313|1424469|P2|STARTED|Long-term Period||34
583975|NCT00534313|1424470|P1|STARTED|Long-term Period||37
583976|NCT00534313|1424467|P4|NOT COMPLETED|Short-term Period||9
583977|NCT00534313|1424468|P3|NOT COMPLETED|Short-term Period||2
583978|NCT00534313|1424469|P2|NOT COMPLETED|Short-term Period||6
583979|NCT00534313|1424470|P1|NOT COMPLETED|Short-term Period||6
583980|NCT00534313|1424467|P4|COMPLETED|Short-term Period|Completed the short-term study|33
583981|NCT00534313|1424468|P3|COMPLETED|Short-term Period|Completed the short-term study|43
583982|NCT00534313|1424469|P2|COMPLETED|Short-term Period|Completed the short-term study|34
583983|NCT00534313|1424470|P1|COMPLETED|Short-term Period|Completed the short-term study|37
583984|NCT00534313|1424467|P4|STARTED|Short-term Period||42
583985|NCT00534313|1424468|P3|STARTED|Short-term Period||45
583986|NCT00534313|1424469|P2|STARTED|Short-term Period||40
583987|NCT00534313|1424470|P1|STARTED|Short-term Period||43
583988|NCT00534248|1424565|P2|NOT COMPLETED|Overall Study||673
583989|NCT00534248|1424566|P1|NOT COMPLETED|Overall Study||661
583990|NCT00534248|1424565|P2|COMPLETED|Overall Study||10555
583991|NCT00534248|1424566|P1|COMPLETED|Overall Study||10550
583992|NCT00534248|1424565|P2|VACCINATED|Overall Study||11210
583993|NCT00534248|1424566|P1|VACCINATED|Overall Study||11186
583994|NCT00534248|1424565|P2|STARTED|Overall Study||11228
583995|NCT00534248|1424566|P1|STARTED|Overall Study||11211
583996|NCT00534209|1424576|P1|NOT COMPLETED|Overall Study||0
583997|NCT00534209|1424576|P1|COMPLETED|Overall Study||1
583998|NCT00534209|1424576|P1|STARTED|Overall Study||1
583999|NCT00534105|1424596|P2|NOT COMPLETED|Overall Study||39
584000|NCT00534105|1424597|P1|NOT COMPLETED|Overall Study||23
584001|NCT00534105|1424596|P2|COMPLETED|Overall Study||20
584002|NCT00534105|1424597|P1|COMPLETED|Overall Study||24
584003|NCT00534105|1424596|P2|STARTED|Overall Study||59
584004|NCT00534105|1424597|P1|STARTED|Overall Study||47
584005|NCT00534092|1424611|P2|NOT COMPLETED|Overall Study||0
584006|NCT00534092|1424612|P1|NOT COMPLETED|Overall Study||2
584007|NCT00534092|1424611|P2|COMPLETED|Overall Study||14
584008|NCT00534092|1424612|P1|COMPLETED|Overall Study||53
584009|NCT00534092|1424611|P2|STARTED|Overall Study||14
584010|NCT00534092|1424612|P1|STARTED|Overall Study||55
584011|NCT00534001|1424637|P2|NOT COMPLETED|Overall Study||4
584012|NCT00534001|1424638|P1|NOT COMPLETED|Overall Study||5
584013|NCT00534001|1424637|P2|COMPLETED|Overall Study||43
584014|NCT00534001|1424638|P1|COMPLETED|Overall Study||43
584015|NCT00534001|1424637|P2|STARTED|Overall Study||47
584016|NCT00534001|1424638|P1|STARTED|Overall Study||48
584017|NCT00533949|1424650|P4|NOT COMPLETED|Overall Study||10
584018|NCT00533949|1424651|P3|NOT COMPLETED|Overall Study||10
584019|NCT00533949|1424652|P2|NOT COMPLETED|Overall Study||14
584020|NCT00533949|1424653|P1|NOT COMPLETED|Overall Study||15
584021|NCT00533949|1424650|P4|COMPLETED|Overall Study||100
584022|NCT00533949|1424651|P3|COMPLETED|Overall Study||137
584023|NCT00533949|1424652|P2|COMPLETED|Overall Study||107
584024|NCT00533949|1424653|P1|COMPLETED|Overall Study||151
584025|NCT00533949|1424650|P4|STARTED|Overall Study||110
584026|NCT00533949|1424651|P3|STARTED|Overall Study||147
584027|NCT00533949|1424652|P2|STARTED|Overall Study||121
584028|NCT00533949|1424653|P1|STARTED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|166
584029|NCT00533897|1424684|P8|NOT COMPLETED|Long Term Extension (LTE)||25
584030|NCT00533897|1424685|P7|NOT COMPLETED|Long Term Extension (LTE)||13
584031|NCT00533897|1424686|P6|NOT COMPLETED|Long Term Extension (LTE)||0
584032|NCT00533897|1424687|P5|NOT COMPLETED|Long Term Extension (LTE)||0
584033|NCT00533897|1424688|P4|NOT COMPLETED|Long Term Extension (LTE)||0
584034|NCT00533897|1424689|P3|NOT COMPLETED|Long Term Extension (LTE)||0
584035|NCT00533897|1424690|P2|NOT COMPLETED|Long Term Extension (LTE)||0
584036|NCT00533897|1424691|P1|NOT COMPLETED|Long Term Extension (LTE)||0
584037|NCT00533897|1424684|P8|COMPLETED|Long Term Extension (LTE)|Participant continued until SC ABA was available in respective country or Sponsor ended study.|88
584038|NCT00533897|1424685|P7|COMPLETED|Long Term Extension (LTE)|Participant continued until SC ABA was available in respective country or Sponsor ended study.|24
584039|NCT00533897|1424686|P6|COMPLETED|Long Term Extension (LTE)||0
584040|NCT00533897|1424687|P5|COMPLETED|Long Term Extension (LTE)||0
584041|NCT00533897|1424688|P4|COMPLETED|Long Term Extension (LTE)||0
584042|NCT00533897|1424689|P3|COMPLETED|Long Term Extension (LTE)||0
584043|NCT00533897|1424690|P2|COMPLETED|Long Term Extension (LTE)||0
584044|NCT00533897|1424691|P1|COMPLETED|Long Term Extension (LTE)||0
584045|NCT00533897|1424684|P8|STARTED|Long Term Extension (LTE)|117 completed RI but 4 did not enter LTE: 1 lack of efficacy and 3 had their site closed.|113
584046|NCT00533897|1424685|P7|STARTED|Long Term Extension (LTE)|37 non-responders in Lead-In entered the LTE directly and didn't participate in DBW or RI Periods.|37
584047|NCT00533897|1424686|P6|STARTED|Long Term Extension (LTE)||0
584048|NCT00533897|1424687|P5|STARTED|Long Term Extension (LTE)||0
584049|NCT00533897|1424688|P4|STARTED|Long Term Extension (LTE)||0
584050|NCT00533897|1424689|P3|STARTED|Long Term Extension (LTE)||0
584051|NCT00533897|1424690|P2|STARTED|Long Term Extension (LTE)||0
584052|NCT00533897|1424691|P1|STARTED|Long Term Extension (LTE)||0
584053|NCT00533897|1424684|P8|NOT COMPLETED|Re-introduction (RI) Period 3||0
584054|NCT00533897|1424685|P7|NOT COMPLETED|Re-introduction (RI) Period 3||0
584055|NCT00533897|1424686|P6|NOT COMPLETED|Re-introduction (RI) Period 3||2
584056|NCT00533897|1424687|P5|NOT COMPLETED|Re-introduction (RI) Period 3||0
584057|NCT00533897|1424688|P4|NOT COMPLETED|Re-introduction (RI) Period 3||0
584058|NCT00533897|1424689|P3|NOT COMPLETED|Re-introduction (RI) Period 3||0
584059|NCT00533897|1424690|P2|NOT COMPLETED|Re-introduction (RI) Period 3||0
584060|NCT00533897|1424691|P1|NOT COMPLETED|Re-introduction (RI) Period 3||0
584061|NCT00533897|1424684|P8|COMPLETED|Re-introduction (RI) Period 3||0
584062|NCT00533897|1424685|P7|COMPLETED|Re-introduction (RI) Period 3||0
584063|NCT00533897|1424686|P6|COMPLETED|Re-introduction (RI) Period 3||42
584064|NCT00533897|1424687|P5|COMPLETED|Re-introduction (RI) Period 3||35
584065|NCT00533897|1424688|P4|COMPLETED|Re-introduction (RI) Period 3||40
584066|NCT00533897|1424689|P3|COMPLETED|Re-introduction (RI) Period 3||0
584067|NCT00533897|1424690|P2|COMPLETED|Re-introduction (RI) Period 3||0
584068|NCT00533897|1424691|P1|COMPLETED|Re-introduction (RI) Period 3||0
584069|NCT00533897|1424684|P8|STARTED|Re-introduction (RI) Period 3||0
584070|NCT00533897|1424685|P7|STARTED|Re-introduction (RI) Period 3||0
584071|NCT00533897|1424686|P6|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|44
584072|NCT00533897|1424687|P5|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|35
584073|NCT00533897|1424688|P4|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|40
584074|NCT00533897|1424689|P3|STARTED|Re-introduction (RI) Period 3||0
584075|NCT00533897|1424690|P2|STARTED|Re-introduction (RI) Period 3||0
584076|NCT00533897|1424691|P1|STARTED|Re-introduction (RI) Period 3||0
584077|NCT00533897|1424684|P8|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
584078|NCT00533897|1424685|P7|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
584079|NCT00533897|1424686|P6|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
584080|NCT00533897|1424687|P5|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
584081|NCT00533897|1424688|P4|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
584082|NCT00533897|1424689|P3|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||3
584083|NCT00533897|1424690|P2|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||1
584084|NCT00533897|1424691|P1|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
584085|NCT00533897|1424684|P8|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
584086|NCT00533897|1424685|P7|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
584087|NCT00533897|1424686|P6|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
584088|NCT00533897|1424687|P5|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
584089|NCT00533897|1424688|P4|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
584090|NCT00533897|1424689|P3|COMPLETED|Double-blind Withdrawal (DBW) Period 2|Two participants discontinued the DBW Period due to Lack of Efficacy to enter the RI Period early|77
584091|NCT00533897|1424690|P2|COMPLETED|Double-blind Withdrawal (DBW) Period 2|One participant discontinued the DBW Period due to Lack of Efficacy to enter the RI Period early|39
584092|NCT00533897|1424691|P1|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
584093|NCT00533897|1424684|P8|STARTED|Double-blind Withdrawal (DBW) Period 2||0
584094|NCT00533897|1424685|P7|STARTED|Double-blind Withdrawal (DBW) Period 2||0
584095|NCT00533897|1424686|P6|STARTED|Double-blind Withdrawal (DBW) Period 2||0
584096|NCT00533897|1424687|P5|STARTED|Double-blind Withdrawal (DBW) Period 2||0
584097|NCT00533897|1424688|P4|STARTED|Double-blind Withdrawal (DBW) Period 2||0
584098|NCT00533897|1424689|P3|STARTED|Double-blind Withdrawal (DBW) Period 2||80
584099|NCT00533897|1424690|P2|STARTED|Double-blind Withdrawal (DBW) Period 2||40
584100|NCT00533897|1424691|P1|STARTED|Double-blind Withdrawal (DBW) Period 2||0
584101|NCT00533897|1424684|P8|NOT COMPLETED|Lead-in (LI) Period 1||0
584102|NCT00533897|1424685|P7|NOT COMPLETED|Lead-in (LI) Period 1||0
584103|NCT00533897|1424686|P6|NOT COMPLETED|Lead-in (LI) Period 1||0
584104|NCT00533897|1424687|P5|NOT COMPLETED|Lead-in (LI) Period 1||0
584105|NCT00533897|1424688|P4|NOT COMPLETED|Lead-in (LI) Period 1||0
584106|NCT00533897|1424689|P3|NOT COMPLETED|Lead-in (LI) Period 1||0
584107|NCT00533897|1424690|P2|NOT COMPLETED|Lead-in (LI) Period 1||0
584108|NCT00533897|1424691|P1|NOT COMPLETED|Lead-in (LI) Period 1||10
584109|NCT00533897|1424684|P8|COMPLETED|Lead-in (LI) Period 1||0
584110|NCT00533897|1424685|P7|COMPLETED|Lead-in (LI) Period 1||0
584111|NCT00533897|1424686|P6|COMPLETED|Lead-in (LI) Period 1||0
584112|NCT00533897|1424687|P5|COMPLETED|Lead-in (LI) Period 1||0
584113|NCT00533897|1424688|P4|COMPLETED|Lead-in (LI) Period 1||0
584114|NCT00533897|1424689|P3|COMPLETED|Lead-in (LI) Period 1||0
584115|NCT00533897|1424690|P2|COMPLETED|Lead-in (LI) Period 1||0
584116|NCT00533897|1424691|P1|COMPLETED|Lead-in (LI) Period 1|37 participants entered the LTE directly and did not enter the DBW Period nor receive DBW treatment.|157
584117|NCT00533897|1424684|P8|STARTED|Lead-in (LI) Period 1||0
584118|NCT00533897|1424685|P7|STARTED|Lead-in (LI) Period 1||0
584119|NCT00533897|1424686|P6|STARTED|Lead-in (LI) Period 1||0
584120|NCT00533897|1424687|P5|STARTED|Lead-in (LI) Period 1||0
584121|NCT00533897|1424688|P4|STARTED|Lead-in (LI) Period 1||0
584122|NCT00533897|1424689|P3|STARTED|Lead-in (LI) Period 1||0
584123|NCT00533897|1424690|P2|STARTED|Lead-in (LI) Period 1||0
584124|NCT00533897|1424691|P1|STARTED|Lead-in (LI) Period 1||167
584125|NCT00533702|1424831|P2|NOT COMPLETED|Overall Study||2
584126|NCT00533702|1424832|P1|NOT COMPLETED|Overall Study||5
584127|NCT00533702|1424831|P2|COMPLETED|Overall Study||50
584128|NCT00533702|1424832|P1|COMPLETED|Overall Study||49
584129|NCT00533702|1424831|P2|Received Any Quantity of Study Drug|Overall Study||50
584130|NCT00533702|1424832|P1|Received Any Quantity of Study Drug|Overall Study||52
584131|NCT00533702|1424831|P2|STARTED|Overall Study||52
584132|NCT00533702|1424832|P1|STARTED|Overall Study||54
584133|NCT00533546|1424856|P1|NOT COMPLETED|Overall Study||0
584134|NCT00533546|1424856|P1|COMPLETED|Overall Study||12
584135|NCT00533546|1424856|P1|STARTED|Overall Study||12
584136|NCT00533507|1424863|P1|NOT COMPLETED|Overall Study||1
584137|NCT00533507|1424863|P1|COMPLETED|Overall Study||229
584138|NCT00533507|1424863|P1|STARTED|Overall Study||230
584139|NCT00533442|1424884|P2|NOT COMPLETED|Follow-up||10
584140|NCT00533442|1424885|P1|NOT COMPLETED|Follow-up||9
584141|NCT00533442|1424884|P2|COMPLETED|Follow-up||74
584142|NCT00533442|1424885|P1|COMPLETED|Follow-up||77
584143|NCT00533442|1424884|P2|STARTED|Follow-up|Ongoing Follow-up at 17-124 months (N=74); Lost to Follow-up (N=10, at 5-67 months).|84
584144|NCT00533442|1424885|P1|STARTED|Follow-up|Ongoing Follow-up at 13-123 months (N=77); Lost to Follow-up (N=9, at 5-100 months).|86
584145|NCT00533442|1424884|P2|NOT COMPLETED|Allocation and Intent to Treat Analysis||0
584146|NCT00533442|1424885|P1|NOT COMPLETED|Allocation and Intent to Treat Analysis||0
584147|NCT00533442|1424884|P2|COMPLETED|Allocation and Intent to Treat Analysis||84
584148|NCT00533442|1424885|P1|COMPLETED|Allocation and Intent to Treat Analysis||86
584149|NCT00533442|1424884|P2|STARTED|Allocation and Intent to Treat Analysis||84
584150|NCT00533442|1424885|P1|STARTED|Allocation and Intent to Treat Analysis||86
584151|NCT00533351|1424897|P2|NOT COMPLETED|Period 3||0
584152|NCT00533351|1424898|P1|NOT COMPLETED|Period 3||0
584153|NCT00533351|1424897|P2|COMPLETED|Period 3||0
584154|NCT00533351|1424898|P1|COMPLETED|Period 3||3
584155|NCT00533351|1424897|P2|STARTED|Period 3|No patients continued to Period 3|0
584156|NCT00533351|1424898|P1|STARTED|Period 3|Three out of the five patients who completed Period 2 continued to Period 3|3
584157|NCT00533351|1424897|P2|NOT COMPLETED|Period 2||0
584158|NCT00533351|1424898|P1|NOT COMPLETED|Period 2||0
584159|NCT00533351|1424897|P2|COMPLETED|Period 2||1
584160|NCT00533351|1424898|P1|COMPLETED|Period 2||5
584161|NCT00533351|1424897|P2|STARTED|Period 2||1
584162|NCT00533351|1424898|P1|STARTED|Period 2||5
584163|NCT00533351|1424897|P2|NOT COMPLETED|Period 1||1
584164|NCT00533351|1424898|P1|NOT COMPLETED|Period 1||2
584165|NCT00533351|1424897|P2|COMPLETED|Period 1||1
584166|NCT00533351|1424898|P1|COMPLETED|Period 1||5
584167|NCT00533351|1424897|P2|STARTED|Period 1||2
584168|NCT00533351|1424898|P1|STARTED|Period 1||7
584169|NCT00533273|1424908|P2|NOT COMPLETED|Open-label||0
584170|NCT00533273|1424909|P1|NOT COMPLETED|Open-label||6
584171|NCT00533273|1424908|P2|COMPLETED|Open-label||0
584172|NCT00533273|1424909|P1|COMPLETED|Open-label||58
584173|NCT00533273|1424908|P2|STARTED|Open-label|no placebo - this phase was open label|0
584174|NCT00533273|1424909|P1|STARTED|Open-label|open-label was extension of double-blind; 64 of 66 patients continued into open-label|64
584175|NCT00533273|1424908|P2|NOT COMPLETED|Double-blind||2
584176|NCT00533273|1424909|P1|NOT COMPLETED|Double-blind||0
584177|NCT00533273|1424908|P2|COMPLETED|Double-blind||19
584178|NCT00533273|1424909|P1|COMPLETED|Double-blind||45
584179|NCT00533273|1424908|P2|STARTED|Double-blind||21
584180|NCT00533273|1424909|P1|STARTED|Double-blind||45
584181|NCT00533117|1424944|P4|NOT COMPLETED|Overall Study||5
584182|NCT00533117|1424945|P3|NOT COMPLETED|Overall Study||6
584183|NCT00533117|1424946|P2|NOT COMPLETED|Overall Study||5
584184|NCT00533117|1424947|P1|NOT COMPLETED|Overall Study||4
584185|NCT00533117|1424944|P4|COMPLETED|Overall Study||13
584186|NCT00533117|1424945|P3|COMPLETED|Overall Study||14
584187|NCT00533117|1424946|P2|COMPLETED|Overall Study||14
584188|NCT00533117|1424947|P1|COMPLETED|Overall Study||14
584189|NCT00533117|1424944|P4|STARTED|Overall Study||18
584190|NCT00533117|1424945|P3|STARTED|Overall Study||20
584191|NCT00533117|1424946|P2|STARTED|Overall Study||19
584192|NCT00533117|1424947|P1|STARTED|Overall Study||18
584193|NCT00532948|1424958|P3|NOT COMPLETED|Overall Study||4
584194|NCT00532948|1424959|P2|NOT COMPLETED|Overall Study||5
584195|NCT00532948|1424960|P1|NOT COMPLETED|Overall Study||4
584196|NCT00532948|1424958|P3|COMPLETED|Overall Study||2
584197|NCT00532948|1424959|P2|COMPLETED|Overall Study||9
584198|NCT00532948|1424960|P1|COMPLETED|Overall Study||0
584199|NCT00532948|1424958|P3|STARTED|Overall Study||6
584200|NCT00532948|1424959|P2|STARTED|Overall Study||14
584201|NCT00532948|1424960|P1|STARTED|Overall Study||4
584202|NCT00532935|1424992|P2|NOT COMPLETED|Overall Study||52
584203|NCT00532935|1424993|P1|NOT COMPLETED|Overall Study||51
584204|NCT00532935|1424992|P2|COMPLETED|Overall Study||204
584205|NCT00532935|1424993|P1|COMPLETED|Overall Study||210
584206|NCT00532935|1424992|P2|STARTED|Overall Study|Excludes 1 patient who was randomized twice at different sites.|256
584207|NCT00532935|1424993|P1|STARTED|Overall Study|Excludes 1 patient who was randomized twice at different sites.|261
584208|NCT00532883|1425011|P4|NOT COMPLETED|Overall Study||5
584209|NCT00532883|1425012|P3|NOT COMPLETED|Overall Study||4
584210|NCT00532883|1425013|P2|NOT COMPLETED|Overall Study||7
584211|NCT00532883|1425014|P1|NOT COMPLETED|Overall Study||6
584212|NCT00532883|1425011|P4|COMPLETED|Overall Study|Study terminated early.|6
584213|NCT00532883|1425012|P3|COMPLETED|Overall Study|Study terminated early.|6
584214|NCT00532883|1425013|P2|COMPLETED|Overall Study|Study terminated early.|5
584215|NCT00532883|1425014|P1|COMPLETED|Overall Study|Study terminated early.|5
584216|NCT00532883|1425011|P4|STARTED|Overall Study||11
584217|NCT00532883|1425012|P3|STARTED|Overall Study||10
584218|NCT00532883|1425013|P2|STARTED|Overall Study||12
584219|NCT00532883|1425014|P1|STARTED|Overall Study||11
584220|NCT00532779|1425027|P3|NOT COMPLETED|Overall Study||291
584221|NCT00532779|1425028|P2|NOT COMPLETED|Overall Study||287
584222|NCT00532779|1425029|P1|NOT COMPLETED|Overall Study||294
584223|NCT00532779|1425027|P3|COMPLETED|Overall Study||290
584224|NCT00532779|1425028|P2|COMPLETED|Overall Study||296
584225|NCT00532779|1425029|P1|COMPLETED|Overall Study||284
584226|NCT00532779|1425027|P3|STARTED|Overall Study||581
584227|NCT00532779|1425028|P2|STARTED|Overall Study||583
584228|NCT00532779|1425029|P1|STARTED|Overall Study||578
584229|NCT00532493|1425090|P2|NOT COMPLETED|Overall Study||29
584230|NCT00532493|1425091|P1|NOT COMPLETED|Overall Study||30
584231|NCT00532493|1425090|P2|COMPLETED|Overall Study||123
584232|NCT00532493|1425091|P1|COMPLETED|Overall Study||122
584233|NCT00532493|1425090|P2|STARTED|Overall Study||152
584234|NCT00532493|1425091|P1|STARTED|Overall Study||152
584235|NCT00532480|1425121|P1|NOT COMPLETED|Overall Study||3
584236|NCT00532480|1425121|P1|COMPLETED|Overall Study||7
584237|NCT00532480|1425121|P1|STARTED|Overall Study||10
584238|NCT00532441|1425125|P2|NOT COMPLETED|Overall Study||0
584239|NCT00532441|1425126|P1|NOT COMPLETED|Overall Study||1
584240|NCT00532441|1425125|P2|COMPLETED|Overall Study||11
584241|NCT00532441|1425126|P1|COMPLETED|Overall Study||13
584242|NCT00532441|1425125|P2|STARTED|Overall Study||11
584243|NCT00532441|1425126|P1|STARTED|Overall Study||14
584244|NCT00532298|1425141|P6|NOT COMPLETED|Overall Study||2
584245|NCT00532298|1425142|P5|NOT COMPLETED|Overall Study||1
584246|NCT00532298|1425143|P4|NOT COMPLETED|Overall Study||0
584247|NCT00532298|1425144|P3|NOT COMPLETED|Overall Study||1
584248|NCT00532298|1425145|P2|NOT COMPLETED|Overall Study||1
584249|NCT00532298|1425146|P1|NOT COMPLETED|Overall Study||2
584250|NCT00532298|1425141|P6|COMPLETED|Overall Study||261
584251|NCT00532298|1425142|P5|COMPLETED|Overall Study||267
584252|NCT00532298|1425143|P4|COMPLETED|Overall Study||264
584253|NCT00532298|1425144|P3|COMPLETED|Overall Study||263
584254|NCT00532298|1425145|P2|COMPLETED|Overall Study||265
584255|NCT00532298|1425146|P1|COMPLETED|Overall Study||267
584256|NCT00532298|1425141|P6|STARTED|Overall Study||263
584257|NCT00532298|1425142|P5|STARTED|Overall Study||268
584258|NCT00532298|1425143|P4|STARTED|Overall Study||264
584259|NCT00532298|1425144|P3|STARTED|Overall Study||264
584260|NCT00532298|1425145|P2|STARTED|Overall Study||266
584261|NCT00532298|1425146|P1|STARTED|Overall Study||269
584262|NCT00532259|1425226|P1|NOT COMPLETED|Overall Study||32
584263|NCT00532259|1425226|P1|COMPLETED|Overall Study||40
584264|NCT00532259|1425226|P1|STARTED|Overall Study||72
584265|NCT00532155|1425233|P2|NOT COMPLETED|Overall Study||456
584266|NCT00532155|1425234|P1|NOT COMPLETED|Overall Study||457
584267|NCT00532155|1425233|P2|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria|0
584268|NCT00532155|1425234|P1|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria|0
584269|NCT00532155|1425233|P2|SAFETY POPULATION|Overall Study||450
584270|NCT00532155|1425234|P1|SAFETY POPULATION|Overall Study||455
584271|NCT00532155|1425233|P2|STARTED|Overall Study||456
584272|NCT00532155|1425234|P1|STARTED|Overall Study||457
584273|NCT00532129|1425248|P1|NOT COMPLETED|Follow-up Period||65
584274|NCT00532129|1425248|P1|COMPLETED|Follow-up Period||33
584275|NCT00532129|1425248|P1|STARTED|Follow-up Period||98
584276|NCT00532129|1425248|P1|NOT COMPLETED|Treatment Period||49
584277|NCT00532129|1425248|P1|COMPLETED|Treatment Period||51
584278|NCT00532129|1425248|P1|STARTED|Treatment Period||100
584279|NCT00531960|1425268|P2|NOT COMPLETED|Overall Study||63
584280|NCT00531960|1425269|P1|NOT COMPLETED|Overall Study||61
584281|NCT00531960|1425268|P2|COMPLETED|Overall Study||0
584282|NCT00531960|1425269|P1|COMPLETED|Overall Study||0
584283|NCT00531960|1425268|P2|STARTED|Overall Study||63
584284|NCT00531960|1425269|P1|STARTED|Overall Study||61
584285|NCT00531947|1425287|P2|NOT COMPLETED|Overall Study||51
584286|NCT00531947|1425288|P1|NOT COMPLETED|Overall Study||42
584287|NCT00531947|1425287|P2|COMPLETED|Overall Study||101
584288|NCT00531947|1425288|P1|COMPLETED|Overall Study||114
584289|NCT00531947|1425287|P2|STARTED|Overall Study|all randomized subjects who received at least one dose of EMSAM study medication|152
584290|NCT00531947|1425288|P1|STARTED|Overall Study|all randomized subjects who received at least one dose of placebo study medication|156
584291|NCT00531934|1425332|P2|NOT COMPLETED|Overall Study||63
584292|NCT00531934|1425333|P1|NOT COMPLETED|Overall Study||66
584293|NCT00531934|1425332|P2|COMPLETED|Overall Study||11
584294|NCT00531934|1425333|P1|COMPLETED|Overall Study||7
584295|NCT00531934|1425332|P2|STARTED|Overall Study||74
584296|NCT00531934|1425333|P1|STARTED|Overall Study||73
584297|NCT00531882|1425404|P3|NOT COMPLETED|Overall Study||0
584298|NCT00531882|1425405|P2|NOT COMPLETED|Overall Study||0
584299|NCT00531882|1425406|P1|NOT COMPLETED|Overall Study||0
584300|NCT00531882|1425404|P3|COMPLETED|Overall Study||5
584301|NCT00531882|1425405|P2|COMPLETED|Overall Study||10
584302|NCT00531882|1425406|P1|COMPLETED|Overall Study||10
584303|NCT00531882|1425404|P3|STARTED|Overall Study||5
584304|NCT00531882|1425405|P2|STARTED|Overall Study||10
584305|NCT00531882|1425406|P1|STARTED|Overall Study||10
584306|NCT00531843|1425416|P2|NOT COMPLETED|Overall Study||0
584307|NCT00531843|1425417|P1|NOT COMPLETED|Overall Study||0
584308|NCT00531843|1425416|P2|COMPLETED|Overall Study||6
584309|NCT00531843|1425417|P1|COMPLETED|Overall Study||81
584310|NCT00531843|1425416|P2|STARTED|Overall Study||6
584311|NCT00531843|1425417|P1|STARTED|Overall Study||81
584312|NCT00531817|1425429|P2|NOT COMPLETED|Entered Extended Treatment Period||57
584313|NCT00531817|1425430|P1|NOT COMPLETED|Entered Extended Treatment Period||137
584314|NCT00531817|1425429|P2|COMPLETED|Entered Extended Treatment Period||113
584315|NCT00531817|1425430|P1|COMPLETED|Entered Extended Treatment Period||206
584316|NCT00531817|1425429|P2|STARTED|Entered Extended Treatment Period|Eligible patients completing core study could participate in extension at investigator’s discretion.|170
584317|NCT00531817|1425430|P1|STARTED|Entered Extended Treatment Period|Eligible patients completing core study could participate in extension at investigator’s discretion.|343
584318|NCT00531817|1425429|P2|NOT COMPLETED|Randomized||34
584319|NCT00531817|1425430|P1|NOT COMPLETED|Randomized||59
584320|NCT00531817|1425429|P2|COMPLETED|Randomized||173
584321|NCT00531817|1425430|P1|COMPLETED|Randomized||353
584322|NCT00531817|1425429|P2|Received Study Drug in Core Study|Randomized|2 patients did not receive any study medication. Intent-to-treat population = 205.|205
584323|NCT00531817|1425430|P1|Received Study Drug in Core Study|Randomized|3 patients did not receive any study medication. Intent-to-treat population = 409.|409
584324|NCT00531817|1425429|P2|STARTED|Randomized||207
584325|NCT00531817|1425430|P1|STARTED|Randomized||412
584326|NCT00531752|1425461|P4|NOT COMPLETED|Second Double-blind Intervention Period||2
584327|NCT00531752|1425462|P3|NOT COMPLETED|Second Double-blind Intervention Period||0
584328|NCT00531752|1425463|P2|NOT COMPLETED|Second Double-blind Intervention Period||2
584329|NCT00531752|1425464|P1|NOT COMPLETED|Second Double-blind Intervention Period||2
584330|NCT00531752|1425461|P4|COMPLETED|Second Double-blind Intervention Period||11
584331|NCT00531752|1425462|P3|COMPLETED|Second Double-blind Intervention Period||9
584332|NCT00531752|1425463|P2|COMPLETED|Second Double-blind Intervention Period||11
584333|NCT00531752|1425464|P1|COMPLETED|Second Double-blind Intervention Period||9
584334|NCT00531752|1425461|P4|STARTED|Second Double-blind Intervention Period||13
584335|NCT00531752|1425462|P3|STARTED|Second Double-blind Intervention Period||9
584336|NCT00531752|1425463|P2|STARTED|Second Double-blind Intervention Period||13
584337|NCT00531752|1425464|P1|STARTED|Second Double-blind Intervention Period||11
584338|NCT00531752|1425461|P4|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
584339|NCT00531752|1425462|P3|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
584340|NCT00531752|1425463|P2|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
584341|NCT00531752|1425464|P1|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
584342|NCT00531752|1425461|P4|COMPLETED|Wash-out Period (at Least 7 Days)||13
584343|NCT00531752|1425462|P3|COMPLETED|Wash-out Period (at Least 7 Days)||9
584344|NCT00531752|1425463|P2|COMPLETED|Wash-out Period (at Least 7 Days)||13
584345|NCT00531752|1425464|P1|COMPLETED|Wash-out Period (at Least 7 Days)||11
584346|NCT00531752|1425461|P4|STARTED|Wash-out Period (at Least 7 Days)||13
584347|NCT00531752|1425462|P3|STARTED|Wash-out Period (at Least 7 Days)||9
584348|NCT00531752|1425463|P2|STARTED|Wash-out Period (at Least 7 Days)||13
584349|NCT00531752|1425464|P1|STARTED|Wash-out Period (at Least 7 Days)||11
584350|NCT00531752|1425461|P4|NOT COMPLETED|First Double-blind Intervention Period||3
584351|NCT00531752|1425462|P3|NOT COMPLETED|First Double-blind Intervention Period||7
584352|NCT00531752|1425463|P2|NOT COMPLETED|First Double-blind Intervention Period||4
584353|NCT00531752|1425464|P1|NOT COMPLETED|First Double-blind Intervention Period||6
584354|NCT00531752|1425461|P4|COMPLETED|First Double-blind Intervention Period||13
584355|NCT00531752|1425462|P3|COMPLETED|First Double-blind Intervention Period||9
584356|NCT00531752|1425463|P2|COMPLETED|First Double-blind Intervention Period||13
584357|NCT00531752|1425464|P1|COMPLETED|First Double-blind Intervention Period||11
584358|NCT00531752|1425461|P4|Treated|First Double-blind Intervention Period||16
584359|NCT00531752|1425462|P3|Treated|First Double-blind Intervention Period||16
584360|NCT00531752|1425463|P2|Treated|First Double-blind Intervention Period||17
584361|NCT00531752|1425464|P1|Treated|First Double-blind Intervention Period||16
584362|NCT00531752|1425461|P4|STARTED|First Double-blind Intervention Period||16
584363|NCT00531752|1425462|P3|STARTED|First Double-blind Intervention Period||16
584364|NCT00531752|1425463|P2|STARTED|First Double-blind Intervention Period||17
584365|NCT00531752|1425464|P1|STARTED|First Double-blind Intervention Period||17
584366|NCT00531661|1425543|P2|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||57
584367|NCT00531661|1425544|P1|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||58
584368|NCT00531661|1425543|P2|COMPLETED|Study Duration: 15 Months Avg. Follow-up||197
584369|NCT00531661|1425544|P1|COMPLETED|Study Duration: 15 Months Avg. Follow-up||186
584370|NCT00531661|1425543|P2|STARTED|Study Duration: 15 Months Avg. Follow-up||254
584371|NCT00531661|1425544|P1|STARTED|Study Duration: 15 Months Avg. Follow-up||244
584372|NCT00531661|1425543|P2|NOT COMPLETED|6 Months||26
584373|NCT00531661|1425544|P1|NOT COMPLETED|6 Months||26
584374|NCT00531661|1425543|P2|COMPLETED|6 Months||254
584375|NCT00531661|1425544|P1|COMPLETED|6 Months||244
584376|NCT00531661|1425543|P2|STARTED|6 Months||280
584377|NCT00531661|1425544|P1|STARTED|6 Months||270
584378|NCT00531518|1425566|P2|NOT COMPLETED|Overall Study||71
584379|NCT00531518|1425567|P1|NOT COMPLETED|Overall Study||32
584380|NCT00531518|1425566|P2|COMPLETED|Overall Study||134
584381|NCT00531518|1425567|P1|COMPLETED|Overall Study||55
584382|NCT00531518|1425566|P2|STARTED|Overall Study||205
584383|NCT00531518|1425567|P1|STARTED|Overall Study||87
584384|NCT00531479|1425575|P2|NOT COMPLETED|Overall Study||83
584385|NCT00531479|1425576|P1|NOT COMPLETED|Overall Study||76
584386|NCT00531479|1425575|P2|COMPLETED|Overall Study||146
584387|NCT00531479|1425576|P1|COMPLETED|Overall Study||154
584388|NCT00531479|1425575|P2|Treated|Overall Study||226
584389|NCT00531479|1425576|P1|Treated|Overall Study||228
584390|NCT00531479|1425575|P2|STARTED|Overall Study||229
584391|NCT00531479|1425576|P1|STARTED|Overall Study||230
584392|NCT00531453|1425596|P2|NOT COMPLETED|Overall Study||0
584393|NCT00531453|1425597|P1|NOT COMPLETED|Overall Study||0
584394|NCT00531453|1425596|P2|COMPLETED|Overall Study|10 April 2009|49
584395|NCT00531453|1425597|P1|COMPLETED|Overall Study|10 April 2009|49
584396|NCT00531453|1425596|P2|STARTED|Overall Study|02 October 2007|49
584397|NCT00531453|1425597|P1|STARTED|Overall Study|02 October 2007|49
584398|NCT00531427|1425607|P2|NOT COMPLETED|Overall Study||94
584399|NCT00531427|1425608|P1|NOT COMPLETED|Overall Study||73
584400|NCT00531427|1425607|P2|COMPLETED|Overall Study||191
584401|NCT00531427|1425608|P1|COMPLETED|Overall Study||209
584402|NCT00531427|1425607|P2|STARTED|Overall Study||285
584403|NCT00531427|1425608|P1|STARTED|Overall Study||282
584404|NCT00531284|1425636|P17|NOT COMPLETED|Overall Study||8
584405|NCT00531284|1425637|P16|NOT COMPLETED|Overall Study||12
584406|NCT00531284|1425638|P15|NOT COMPLETED|Overall Study||4
584407|NCT00531284|1425639|P14|NOT COMPLETED|Overall Study||3
584408|NCT00531284|1425640|P13|NOT COMPLETED|Overall Study||2
584409|NCT00531284|1425641|P12|NOT COMPLETED|Overall Study||24
584410|NCT00531284|1425642|P11|NOT COMPLETED|Overall Study||3
584411|NCT00531284|1425643|P10|NOT COMPLETED|Overall Study||4
584412|NCT00531284|1425644|P9|NOT COMPLETED|Overall Study||11
584413|NCT00531284|1425645|P8|NOT COMPLETED|Overall Study||10
584414|NCT00531284|1425646|P7|NOT COMPLETED|Overall Study||6
584415|NCT00531284|1425647|P6|NOT COMPLETED|Overall Study||7
584416|NCT00531284|1425648|P5|NOT COMPLETED|Overall Study||6
584417|NCT00531284|1425649|P4|NOT COMPLETED|Overall Study||63
584418|NCT00531284|1425650|P3|NOT COMPLETED|Overall Study||6
584419|NCT00531284|1425651|P2|NOT COMPLETED|Overall Study||4
584420|NCT00531284|1425652|P1|NOT COMPLETED|Overall Study||3
584421|NCT00531284|1425636|P17|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
584422|NCT00531284|1425637|P16|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|2
584423|NCT00531284|1425638|P15|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|3
584424|NCT00531284|1425639|P14|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
584425|NCT00531284|1425640|P13|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
584426|NCT00531284|1425641|P12|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
584427|NCT00531284|1425642|P11|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
584428|NCT00531284|1425643|P10|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
584429|NCT00531284|1425644|P9|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
584430|NCT00531284|1425645|P8|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
584431|NCT00531284|1425646|P7|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
584432|NCT00531284|1425647|P6|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
584433|NCT00531284|1425648|P5|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
584434|NCT00531284|1425649|P4|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|2
584435|NCT00531284|1425650|P3|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|1
584436|NCT00531284|1425651|P2|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|0
584437|NCT00531284|1425652|P1|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|0
584438|NCT00531284|1425636|P17|STARTED|Overall Study||8
584439|NCT00531284|1425637|P16|STARTED|Overall Study||14
584440|NCT00531284|1425638|P15|STARTED|Overall Study||7
584441|NCT00531284|1425639|P14|STARTED|Overall Study||3
584442|NCT00531284|1425640|P13|STARTED|Overall Study||2
584443|NCT00531284|1425641|P12|STARTED|Overall Study||24
584444|NCT00531284|1425642|P11|STARTED|Overall Study||3
584445|NCT00531284|1425643|P10|STARTED|Overall Study||4
584446|NCT00531284|1425644|P9|STARTED|Overall Study||11
584447|NCT00531284|1425645|P8|STARTED|Overall Study||10
584448|NCT00531284|1425646|P7|STARTED|Overall Study||6
584449|NCT00531284|1425647|P6|STARTED|Overall Study||7
584450|NCT00531284|1425648|P5|STARTED|Overall Study||6
584451|NCT00531284|1425649|P4|STARTED|Overall Study||65
584452|NCT00531284|1425650|P3|STARTED|Overall Study||7
584453|NCT00531284|1425651|P2|STARTED|Overall Study||4
584454|NCT00531284|1425652|P1|STARTED|Overall Study||3
584455|NCT00531206|1425802|P1|NOT COMPLETED|Overall Study||20
584456|NCT00531206|1425802|P1|COMPLETED|Overall Study||45
584457|NCT00531206|1425802|P1|STARTED|Overall Study||65
584458|NCT00531050|1425832|P6|NOT COMPLETED|Part 2: Period 3||1
584459|NCT00531050|1425833|P5|NOT COMPLETED|Part 2: Period 3||0
584460|NCT00531050|1425834|P4|NOT COMPLETED|Part 2: Period 3||0
584461|NCT00531050|1425835|P3|NOT COMPLETED|Part 2: Period 3||0
584462|NCT00531050|1425836|P2|NOT COMPLETED|Part 2: Period 3||0
584463|NCT00531050|1425837|P1|NOT COMPLETED|Part 2: Period 3||1
584464|NCT00531050|1425832|P6|COMPLETED|Part 2: Period 3||3
584465|NCT00531050|1425833|P5|COMPLETED|Part 2: Period 3||4
584466|NCT00531050|1425834|P4|COMPLETED|Part 2: Period 3||4
584467|NCT00531050|1425835|P3|COMPLETED|Part 2: Period 3||4
584468|NCT00531050|1425836|P2|COMPLETED|Part 2: Period 3||4
584469|NCT00531050|1425837|P1|COMPLETED|Part 2: Period 3||2
584470|NCT00531050|1425832|P6|STARTED|Part 2: Period 3||4
584471|NCT00531050|1425833|P5|STARTED|Part 2: Period 3||4
584472|NCT00531050|1425834|P4|STARTED|Part 2: Period 3||4
584473|NCT00531050|1425835|P3|STARTED|Part 2: Period 3||4
584474|NCT00531050|1425836|P2|STARTED|Part 2: Period 3||4
584475|NCT00531050|1425837|P1|STARTED|Part 2: Period 3||3
584476|NCT00531050|1425832|P6|NOT COMPLETED|Part 2: Period 2||0
584477|NCT00531050|1425833|P5|NOT COMPLETED|Part 2: Period 2||0
584478|NCT00531050|1425834|P4|NOT COMPLETED|Part 2: Period 2||0
584479|NCT00531050|1425835|P3|NOT COMPLETED|Part 2: Period 2||0
584480|NCT00531050|1425836|P2|NOT COMPLETED|Part 2: Period 2||0
584481|NCT00531050|1425837|P1|NOT COMPLETED|Part 2: Period 2||0
584482|NCT00531050|1425832|P6|COMPLETED|Part 2: Period 2||4
584483|NCT00531050|1425833|P5|COMPLETED|Part 2: Period 2||4
584484|NCT00531050|1425834|P4|COMPLETED|Part 2: Period 2||4
584485|NCT00531050|1425835|P3|COMPLETED|Part 2: Period 2||4
584486|NCT00531050|1425836|P2|COMPLETED|Part 2: Period 2||4
584487|NCT00531050|1425837|P1|COMPLETED|Part 2: Period 2||3
584488|NCT00531050|1425832|P6|STARTED|Part 2: Period 2||4
584489|NCT00531050|1425833|P5|STARTED|Part 2: Period 2||4
584490|NCT00531050|1425834|P4|STARTED|Part 2: Period 2||4
584491|NCT00531050|1425835|P3|STARTED|Part 2: Period 2||4
584492|NCT00531050|1425836|P2|STARTED|Part 2: Period 2||4
584493|NCT00531050|1425837|P1|STARTED|Part 2: Period 2||3
584494|NCT00531050|1425832|P6|NOT COMPLETED|Part 2: Period 1||1
584495|NCT00531050|1425833|P5|NOT COMPLETED|Part 2: Period 1||0
584496|NCT00531050|1425834|P4|NOT COMPLETED|Part 2: Period 1||0
584497|NCT00531050|1425835|P3|NOT COMPLETED|Part 2: Period 1||0
584498|NCT00531050|1425836|P2|NOT COMPLETED|Part 2: Period 1||0
584499|NCT00531050|1425837|P1|NOT COMPLETED|Part 2: Period 1||0
584500|NCT00531050|1425832|P6|COMPLETED|Part 2: Period 1||4
584501|NCT00531050|1425833|P5|COMPLETED|Part 2: Period 1||4
584502|NCT00531050|1425834|P4|COMPLETED|Part 2: Period 1||4
584503|NCT00531050|1425835|P3|COMPLETED|Part 2: Period 1||4
584504|NCT00531050|1425836|P2|COMPLETED|Part 2: Period 1||4
584505|NCT00531050|1425837|P1|COMPLETED|Part 2: Period 1||3
584506|NCT00531050|1425832|P6|STARTED|Part 2: Period 1||5
584507|NCT00531050|1425833|P5|STARTED|Part 2: Period 1||4
584508|NCT00531050|1425834|P4|STARTED|Part 2: Period 1||4
584509|NCT00531050|1425835|P3|STARTED|Part 2: Period 1||4
584510|NCT00531050|1425836|P2|STARTED|Part 2: Period 1||4
584511|NCT00531050|1425837|P1|STARTED|Part 2: Period 1||3
584512|NCT00531050|1425832|P6|NOT COMPLETED|Part 1: Period 3||0
584513|NCT00531050|1425833|P5|NOT COMPLETED|Part 1: Period 3||0
584514|NCT00531050|1425834|P4|NOT COMPLETED|Part 1: Period 3||0
584515|NCT00531050|1425835|P3|NOT COMPLETED|Part 1: Period 3||0
584516|NCT00531050|1425836|P2|NOT COMPLETED|Part 1: Period 3||0
584517|NCT00531050|1425837|P1|NOT COMPLETED|Part 1: Period 3||1
584518|NCT00531050|1425832|P6|COMPLETED|Part 1: Period 3||5
584519|NCT00531050|1425833|P5|COMPLETED|Part 1: Period 3||4
584520|NCT00531050|1425834|P4|COMPLETED|Part 1: Period 3||4
584521|NCT00531050|1425835|P3|COMPLETED|Part 1: Period 3||4
584522|NCT00531050|1425836|P2|COMPLETED|Part 1: Period 3||4
584523|NCT00531050|1425837|P1|COMPLETED|Part 1: Period 3||3
584524|NCT00531050|1425832|P6|STARTED|Part 1: Period 3||5
584525|NCT00531050|1425833|P5|STARTED|Part 1: Period 3||4
584526|NCT00531050|1425834|P4|STARTED|Part 1: Period 3||4
584527|NCT00531050|1425835|P3|STARTED|Part 1: Period 3||4
584528|NCT00531050|1425836|P2|STARTED|Part 1: Period 3||4
584529|NCT00531050|1425837|P1|STARTED|Part 1: Period 3||4
584530|NCT00531050|1425832|P6|NOT COMPLETED|Part 1: Period 2||0
584531|NCT00531050|1425833|P5|NOT COMPLETED|Part 1: Period 2||0
584532|NCT00531050|1425834|P4|NOT COMPLETED|Part 1: Period 2||0
584533|NCT00531050|1425835|P3|NOT COMPLETED|Part 1: Period 2||0
584534|NCT00531050|1425836|P2|NOT COMPLETED|Part 1: Period 2||0
584535|NCT00531050|1425837|P1|NOT COMPLETED|Part 1: Period 2||0
584536|NCT00531050|1425832|P6|COMPLETED|Part 1: Period 2||5
584537|NCT00531050|1425833|P5|COMPLETED|Part 1: Period 2||4
584538|NCT00531050|1425834|P4|COMPLETED|Part 1: Period 2||4
584539|NCT00531050|1425835|P3|COMPLETED|Part 1: Period 2||4
584540|NCT00531050|1425836|P2|COMPLETED|Part 1: Period 2||4
584541|NCT00531050|1425837|P1|COMPLETED|Part 1: Period 2||4
584542|NCT00531050|1425832|P6|STARTED|Part 1: Period 2||5
584543|NCT00531050|1425833|P5|STARTED|Part 1: Period 2||4
584544|NCT00531050|1425834|P4|STARTED|Part 1: Period 2||4
584545|NCT00531050|1425835|P3|STARTED|Part 1: Period 2||4
584546|NCT00531050|1425836|P2|STARTED|Part 1: Period 2||4
584547|NCT00531050|1425837|P1|STARTED|Part 1: Period 2||4
584548|NCT00531050|1425832|P6|NOT COMPLETED|Part 1: Period 1||0
584549|NCT00531050|1425833|P5|NOT COMPLETED|Part 1: Period 1||0
584550|NCT00531050|1425834|P4|NOT COMPLETED|Part 1: Period 1||1
584551|NCT00531050|1425835|P3|NOT COMPLETED|Part 1: Period 1||0
584552|NCT00531050|1425836|P2|NOT COMPLETED|Part 1: Period 1||1
584553|NCT00531050|1425837|P1|NOT COMPLETED|Part 1: Period 1||0
584554|NCT00531050|1425832|P6|COMPLETED|Part 1: Period 1||5
584555|NCT00531050|1425833|P5|COMPLETED|Part 1: Period 1||4
584556|NCT00531050|1425834|P4|COMPLETED|Part 1: Period 1||4
584557|NCT00531050|1425835|P3|COMPLETED|Part 1: Period 1||4
584558|NCT00531050|1425836|P2|COMPLETED|Part 1: Period 1||4
584559|NCT00531050|1425837|P1|COMPLETED|Part 1: Period 1||4
584560|NCT00531050|1425832|P6|STARTED|Part 1: Period 1||5
584561|NCT00531050|1425833|P5|STARTED|Part 1: Period 1||4
584562|NCT00531050|1425834|P4|STARTED|Part 1: Period 1||5
584563|NCT00531050|1425835|P3|STARTED|Part 1: Period 1||4
584564|NCT00531050|1425836|P2|STARTED|Part 1: Period 1||5
584565|NCT00531050|1425837|P1|STARTED|Part 1: Period 1||4
584566|NCT00531011|1425866|P2|NOT COMPLETED|Overall Study||7
584567|NCT00531011|1425867|P1|NOT COMPLETED|Overall Study||4
584568|NCT00531011|1425866|P2|COMPLETED|Overall Study||90
584569|NCT00531011|1425867|P1|COMPLETED|Overall Study||99
584570|NCT00531011|1425866|P2|STARTED|Overall Study||97
584571|NCT00531011|1425867|P1|STARTED|Overall Study||103
584572|NCT00530946|1425913|P4|NOT COMPLETED|Overall Study||2
584573|NCT00530946|1425914|P3|NOT COMPLETED|Overall Study||1
584574|NCT00530946|1425915|P2|NOT COMPLETED|Overall Study||2
584575|NCT00530946|1425916|P1|NOT COMPLETED|Overall Study||2
584576|NCT00530946|1425913|P4|COMPLETED|Overall Study||38
584577|NCT00530946|1425914|P3|COMPLETED|Overall Study||40
584578|NCT00530946|1425915|P2|COMPLETED|Overall Study||39
584579|NCT00530946|1425916|P1|COMPLETED|Overall Study||41
584580|NCT00530946|1425913|P4|STARTED|Overall Study||40
584581|NCT00530946|1425914|P3|STARTED|Overall Study||41
584582|NCT00530946|1425915|P2|STARTED|Overall Study||41
584583|NCT00530946|1425916|P1|STARTED|Overall Study||43
584584|NCT00530920|1425969|P3|NOT COMPLETED|Overall Study||4
584585|NCT00530920|1425970|P2|NOT COMPLETED|Overall Study||2
584586|NCT00530920|1425971|P1|NOT COMPLETED|Overall Study||0
584587|NCT00530920|1425969|P3|COMPLETED|Overall Study||24
584588|NCT00530920|1425970|P2|COMPLETED|Overall Study||25
584589|NCT00530920|1425971|P1|COMPLETED|Overall Study||30
584590|NCT00530920|1425969|P3|STARTED|Overall Study||28
584591|NCT00530920|1425970|P2|STARTED|Overall Study||27
584592|NCT00530920|1425971|P1|STARTED|Overall Study||30
584593|NCT00530894|1426031|P4|NOT COMPLETED|Overall Study||94
584594|NCT00530894|1426032|P3|NOT COMPLETED|Overall Study||55
584595|NCT00530894|1426033|P2|NOT COMPLETED|Overall Study||115
584596|NCT00530894|1426034|P1|NOT COMPLETED|Overall Study||88
584597|NCT00530894|1426031|P4|COMPLETED|Overall Study||85
584598|NCT00530894|1426032|P3|COMPLETED|Overall Study||124
584599|NCT00530894|1426033|P2|COMPLETED|Overall Study||236
584600|NCT00530894|1426034|P1|COMPLETED|Overall Study||260
584601|NCT00530894|1426031|P4|STARTED|Overall Study||179
584602|NCT00530894|1426032|P3|STARTED|Overall Study||179
584603|NCT00530894|1426033|P2|STARTED|Overall Study||351
584604|NCT00530894|1426034|P1|STARTED|Overall Study||348
584605|NCT00530855|1426062|P1|NOT COMPLETED|Overall Study||112
584606|NCT00530855|1426062|P1|COMPLETED|Overall Study||210
584607|NCT00530855|1426062|P1|STARTED|Overall Study||322
584608|NCT00530842|1426071|P2|NOT COMPLETED|Period 2||9
584609|NCT00530842|1426072|P1|NOT COMPLETED|Period 2||8
584610|NCT00530842|1426071|P2|COMPLETED|Period 2||151
584611|NCT00530842|1426072|P1|COMPLETED|Period 2||149
584612|NCT00530842|1426071|P2|STARTED|Period 2||160
584613|NCT00530842|1426072|P1|STARTED|Period 2||157
584614|NCT00530842|1426071|P2|NOT COMPLETED|Period 1||11
584615|NCT00530842|1426072|P1|NOT COMPLETED|Period 1||14
584616|NCT00530842|1426071|P2|COMPLETED|Period 1||161
584617|NCT00530842|1426072|P1|COMPLETED|Period 1||158
584618|NCT00530842|1426071|P2|STARTED|Period 1||172
584619|NCT00530842|1426072|P1|STARTED|Period 1||172
584620|NCT00530842|1426071|P2|NOT COMPLETED|Overall Study||21
584621|NCT00530842|1426072|P1|NOT COMPLETED|Overall Study||23
584622|NCT00530842|1426071|P2|COMPLETED|Overall Study||151
584623|NCT00530842|1426072|P1|COMPLETED|Overall Study||149
584624|NCT00530842|1426071|P2|STARTED|Overall Study||172
584625|NCT00530842|1426072|P1|STARTED|Overall Study||172
584626|NCT00530816|1426199|P3|NOT COMPLETED|Overall Study||41
584627|NCT00530816|1426200|P2|NOT COMPLETED|Overall Study||42
584628|NCT00530816|1426201|P1|NOT COMPLETED|Overall Study||26
584629|NCT00530816|1426199|P3|COMPLETED|Overall Study||29
584630|NCT00530816|1426200|P2|COMPLETED|Overall Study||17
584631|NCT00530816|1426201|P1|COMPLETED|Overall Study||9
584632|NCT00530816|1426199|P3|STARTED|Overall Study||70
584633|NCT00530816|1426200|P2|STARTED|Overall Study||59
584634|NCT00530816|1426201|P1|STARTED|Overall Study||35
584635|NCT00530790|1426227|P1|NOT COMPLETED|Overall Study||5
584636|NCT00530790|1426227|P1|COMPLETED|Overall Study||30
584637|NCT00530790|1426227|P1|STARTED|Overall Study||35
584638|NCT00530777|1426249|P2|NOT COMPLETED|Overall Study||5
584639|NCT00530777|1426250|P1|NOT COMPLETED|Overall Study||7
584640|NCT00530777|1426249|P2|COMPLETED|Overall Study||69
584641|NCT00530777|1426250|P1|COMPLETED|Overall Study||67
584642|NCT00530777|1426249|P2|STARTED|Overall Study||74
584643|NCT00530777|1426250|P1|STARTED|Overall Study||74
584644|NCT00530764|1426262|P4|NOT COMPLETED|Overall Study||25
584645|NCT00530764|1426263|P3|NOT COMPLETED|Overall Study||20
584646|NCT00530764|1426264|P2|NOT COMPLETED|Overall Study||21
584647|NCT00530764|1426265|P1|NOT COMPLETED|Overall Study||31
584648|NCT00530764|1426262|P4|COMPLETED|Overall Study||66
584649|NCT00530764|1426263|P3|COMPLETED|Overall Study||71
584650|NCT00530764|1426264|P2|COMPLETED|Overall Study||67
584651|NCT00530764|1426265|P1|COMPLETED|Overall Study||59
584652|NCT00530764|1426262|P4|STARTED|Overall Study||91
584653|NCT00530764|1426263|P3|STARTED|Overall Study||91
584654|NCT00530764|1426264|P2|STARTED|Overall Study||88
584655|NCT00530764|1426265|P1|STARTED|Overall Study||90
584656|NCT00530712|1426307|P1|NOT COMPLETED|12 Month Follow-up Visit||24
584657|NCT00530712|1426307|P1|COMPLETED|12 Month Follow-up Visit|Subjects that Completed 12-Month Follow-up Visit|263
584658|NCT00530712|1426307|P1|STARTED|12 Month Follow-up Visit|Subjects Expected for 12 Month Visit|287
584659|NCT00530712|1426307|P1|NOT COMPLETED|6 Month Follow-up Visit||12
584660|NCT00530712|1426307|P1|COMPLETED|6 Month Follow-up Visit|Subjects that Completed 6-Month Follow-up Visit|275
584661|NCT00530712|1426307|P1|STARTED|6 Month Follow-up Visit|Subjects Expected for 6-Month Visit|287
584662|NCT00530712|1426307|P1|NOT COMPLETED|30 Day Follow-up Visit||7
584663|NCT00530712|1426307|P1|COMPLETED|30 Day Follow-up Visit|Subjects that Completed 30-Day Follow-up Visit|280
584664|NCT00530712|1426307|P1|STARTED|30 Day Follow-up Visit|Subjects Expected for 30-Day Visit|287
584665|NCT00530712|1426307|P1|NOT COMPLETED|Enrollment||0
584666|NCT00530712|1426307|P1|COMPLETED|Enrollment|Subjects Available at Discharge|287
584667|NCT00530712|1426307|P1|STARTED|Enrollment|Total Enrolled Subjects|287
584668|NCT00530634|1426322|P1|NOT COMPLETED|Overall Study||0
584669|NCT00530634|1426322|P1|COMPLETED|Overall Study||3
584670|NCT00530634|1426322|P1|STARTED|Overall Study||3
584671|NCT00530504|1426326|P1|NOT COMPLETED|Overall Study||152
584672|NCT00530504|1426326|P1|COMPLETED|Overall Study||1348
584673|NCT00530504|1426326|P1|STARTED|Overall Study||1500
584674|NCT00530439|1426332|P2|NOT COMPLETED|Overall Study||26
584675|NCT00530439|1426333|P1|NOT COMPLETED|Overall Study||30
584676|NCT00530439|1426332|P2|COMPLETED|Overall Study||154
584677|NCT00530439|1426333|P1|COMPLETED|Overall Study||150
584678|NCT00530439|1426332|P2|STARTED|Overall Study||180
584679|NCT00530439|1426333|P1|STARTED|Overall Study||180
584680|NCT00530348|1426341|P2|NOT COMPLETED|Overall Study||19
584681|NCT00530348|1426342|P1|NOT COMPLETED|Overall Study||22
584682|NCT00530348|1426341|P2|COMPLETED|Overall Study||367
584683|NCT00530348|1426342|P1|COMPLETED|Overall Study||173
584684|NCT00530348|1426341|P2|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug.|376
584685|NCT00530348|1426342|P1|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug.|187
584686|NCT00530348|1426341|P2|STARTED|Overall Study|Randomized.|386
584687|NCT00530348|1426342|P1|STARTED|Overall Study|Randomized.|195
584688|NCT00530335|1426358|P1|NOT COMPLETED|Overall Study||6
584689|NCT00530335|1426358|P1|COMPLETED|Overall Study||39
584690|NCT00530335|1426358|P1|STARTED|Overall Study||45
584691|NCT00530270|1426375|P2|NOT COMPLETED|Overall Study||0
584692|NCT00530270|1426376|P1|NOT COMPLETED|Overall Study||1
584693|NCT00530270|1426375|P2|COMPLETED|Overall Study||6
584694|NCT00530270|1426376|P1|COMPLETED|Overall Study||5
584695|NCT00530270|1426375|P2|STARTED|Overall Study||6
584696|NCT00530270|1426376|P1|STARTED|Overall Study||6
584697|NCT00530257|1426390|P1|NOT COMPLETED|Overall Study||1
584698|NCT00530257|1426390|P1|COMPLETED|Overall Study||30
584699|NCT00530257|1426390|P1|STARTED|Overall Study||31
584700|NCT00530218|1426418|P1|NOT COMPLETED|Overall Study||25
584701|NCT00530218|1426418|P1|COMPLETED|Overall Study|CMV Reactivation Was Detected|36
584702|NCT00530218|1426418|P1|STARTED|Overall Study||61
584703|NCT00530088|1426425|P1|NOT COMPLETED|Overall Study||10
584704|NCT00530088|1426425|P1|COMPLETED|Overall Study||20
584705|NCT00530088|1426425|P1|STARTED|Overall Study||30
584706|NCT00530075|1426430|P1|NOT COMPLETED|Overall Study||7
584707|NCT00530075|1426430|P1|COMPLETED|Overall Study||38
584708|NCT00530075|1426430|P1|STARTED|Overall Study||45
584709|NCT00530023|1426443|P2|NOT COMPLETED|Overall Study||1
584710|NCT00530023|1426444|P1|NOT COMPLETED|Overall Study||0
584711|NCT00530023|1426443|P2|COMPLETED|Overall Study||14
584712|NCT00530023|1426444|P1|COMPLETED|Overall Study||14
584713|NCT00530023|1426443|P2|STARTED|Overall Study||15
584714|NCT00530023|1426444|P1|STARTED|Overall Study||14
584715|NCT00529802|1426458|P1|NOT COMPLETED|Evaluable for Secondary Endpoint||2
584716|NCT00529802|1426458|P1|COMPLETED|Evaluable for Secondary Endpoint||48
584717|NCT00529802|1426458|P1|STARTED|Evaluable for Secondary Endpoint||50
584718|NCT00529802|1426458|P1|NOT COMPLETED|Evaluable for Primary Endpoint||10
584719|NCT00529802|1426458|P1|COMPLETED|Evaluable for Primary Endpoint|Evaluable for primary endpoint|50
584720|NCT00529802|1426458|P1|STARTED|Evaluable for Primary Endpoint|60 patients started trial|60
584721|NCT00529789|1426464|P1|NOT COMPLETED|Study Period IV||6
584722|NCT00529789|1426464|P1|COMPLETED|Study Period IV|Includes 1 patient who withdrew at last visit; didn't enter Taper; however received 30 weeks of drug|42
584723|NCT00529789|1426464|P1|STARTED|Study Period IV||48
584724|NCT00529789|1426464|P1|NOT COMPLETED|Study Period II/III||24
584725|NCT00529789|1426464|P1|COMPLETED|Study Period II/III||48
584726|NCT00529789|1426464|P1|STARTED|Study Period II/III||72
584727|NCT00529763|1426489|P3|NOT COMPLETED|Overall Study||7
584728|NCT00529763|1426490|P2|NOT COMPLETED|Overall Study||33
584729|NCT00529763|1426491|P1|NOT COMPLETED|Overall Study||10
584730|NCT00529763|1426489|P3|COMPLETED|Overall Study|52 participants still on treatment; not completed = off treatment (n=7)|52
584731|NCT00529763|1426490|P2|COMPLETED|Overall Study|4 participants still on treatment; not completed = off treatment (n=33)|4
584732|NCT00529763|1426491|P1|COMPLETED|Overall Study|15 participants still on treatment; not completed = off treatment (n=10)|15
584733|NCT00529763|1426489|P3|STARTED|Overall Study||59
584734|NCT00529763|1426490|P2|STARTED|Overall Study|38 participants were enrolled; 37 were treated in this cohort|37
584735|NCT00529763|1426491|P1|STARTED|Overall Study||25
584736|NCT00529659|1426529|P2|NOT COMPLETED|Overall Study||23
584737|NCT00529659|1426530|P1|NOT COMPLETED|Overall Study||11
584738|NCT00529659|1426529|P2|COMPLETED|Overall Study||66
584739|NCT00529659|1426530|P1|COMPLETED|Overall Study||70
584740|NCT00529659|1426529|P2|STARTED|Overall Study||89
584741|NCT00529659|1426530|P1|STARTED|Overall Study||81
584742|NCT00529633|1426548|P2|NOT COMPLETED|Overall Study||1
584743|NCT00529633|1426549|P1|NOT COMPLETED|Overall Study||1
584744|NCT00529633|1426548|P2|COMPLETED|Overall Study||1
584745|NCT00529633|1426549|P1|COMPLETED|Overall Study||1
584746|NCT00529633|1426548|P2|STARTED|Overall Study||2
584747|NCT00529633|1426549|P1|STARTED|Overall Study||2
584748|NCT00529568|1426561|P3|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||102
584749|NCT00529568|1426562|P2|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||48
584750|NCT00529568|1426563|P1|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||0
584751|NCT00529568|1426561|P3|COMPLETED|Double-bilnd Antiviral Treatment Phase||404
584752|NCT00529568|1426562|P2|COMPLETED|Double-bilnd Antiviral Treatment Phase||205
584753|NCT00529568|1426563|P1|COMPLETED|Double-bilnd Antiviral Treatment Phase||0
584754|NCT00529568|1426561|P3|STARTED|Double-bilnd Antiviral Treatment Phase||506
584755|NCT00529568|1426562|P2|STARTED|Double-bilnd Antiviral Treatment Phase||253
584756|NCT00529568|1426563|P1|STARTED|Double-bilnd Antiviral Treatment Phase||0
584757|NCT00529568|1426561|P3|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
584758|NCT00529568|1426562|P2|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
584759|NCT00529568|1426563|P1|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||46
584760|NCT00529568|1426561|P3|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
584761|NCT00529568|1426562|P2|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
584762|NCT00529568|1426563|P1|COMPLETED|Open-label Pre-Antiviral Treatment Phase||759
584763|NCT00529568|1426561|P3|STARTED|Open-label Pre-Antiviral Treatment Phase||0
584764|NCT00529568|1426562|P2|STARTED|Open-label Pre-Antiviral Treatment Phase||0
584765|NCT00529568|1426563|P1|STARTED|Open-label Pre-Antiviral Treatment Phase||805
584766|NCT00529555|1426614|P3|NOT COMPLETED|Overall Study||26
584767|NCT00529555|1426615|P2|NOT COMPLETED|Overall Study||30
584768|NCT00529555|1426616|P1|NOT COMPLETED|Overall Study||29
584769|NCT00529555|1426614|P3|COMPLETED|Overall Study||174
584770|NCT00529555|1426615|P2|COMPLETED|Overall Study||172
584771|NCT00529555|1426616|P1|COMPLETED|Overall Study||171
584772|NCT00529555|1426614|P3|STARTED|Overall Study||200
584773|NCT00529555|1426615|P2|STARTED|Overall Study||202
584774|NCT00529555|1426616|P1|STARTED|Overall Study||200
584775|NCT00529542|1426626|P2|NOT COMPLETED|Overall Study||1
584776|NCT00529542|1426627|P1|NOT COMPLETED|Overall Study||1
584777|NCT00529542|1426626|P2|COMPLETED|Overall Study||10
584778|NCT00529542|1426627|P1|COMPLETED|Overall Study||8
584779|NCT00529542|1426626|P2|STARTED|Overall Study||11
584780|NCT00529542|1426627|P1|STARTED|Overall Study||9
584781|NCT00529529|1426670|P3|NOT COMPLETED|Overall Study||31
584782|NCT00529529|1426671|P2|NOT COMPLETED|Overall Study||43
584783|NCT00529529|1426672|P1|NOT COMPLETED|Overall Study||43
584784|NCT00529529|1426670|P3|COMPLETED|Overall Study||238
584785|NCT00529529|1426671|P2|COMPLETED|Overall Study||225
584786|NCT00529529|1426672|P1|COMPLETED|Overall Study||225
584787|NCT00529529|1426670|P3|STARTED|Overall Study||269
584788|NCT00529529|1426671|P2|STARTED|Overall Study||268
584789|NCT00529529|1426672|P1|STARTED|Overall Study||268
584790|NCT00529516|1426731|P3|NOT COMPLETED|Overall Study||1
584791|NCT00529516|1426732|P2|NOT COMPLETED|Overall Study||2
584792|NCT00529516|1426733|P1|NOT COMPLETED|Overall Study||3
584793|NCT00529516|1426731|P3|COMPLETED|Overall Study||288
584794|NCT00529516|1426732|P2|COMPLETED|Overall Study||486
584795|NCT00529516|1426733|P1|COMPLETED|Overall Study||472
584796|NCT00529516|1426731|P3|STARTED|Overall Study||289
584797|NCT00529516|1426732|P2|STARTED|Overall Study||488
584798|NCT00529516|1426733|P1|STARTED|Overall Study||475
584799|NCT00529464|1426804|P3|NOT COMPLETED|Overall Study||0
584800|NCT00529464|1426805|P2|NOT COMPLETED|Overall Study||0
584801|NCT00529464|1426806|P1|NOT COMPLETED|Overall Study||0
584802|NCT00529464|1426804|P3|COMPLETED|Overall Study||0
584803|NCT00529464|1426805|P2|COMPLETED|Overall Study||0
584804|NCT00529464|1426806|P1|COMPLETED|Overall Study||0
584805|NCT00529464|1426804|P3|STARTED|Overall Study||0
584806|NCT00529464|1426805|P2|STARTED|Overall Study||0
584807|NCT00529464|1426806|P1|STARTED|Overall Study||0
584808|NCT00529451|1426818|P4|NOT COMPLETED|Overall Study||31
584809|NCT00529451|1426819|P3|NOT COMPLETED|Overall Study||40
584810|NCT00529451|1426820|P2|NOT COMPLETED|Overall Study||48
584811|NCT00529451|1426821|P1|NOT COMPLETED|Overall Study||37
584812|NCT00529451|1426818|P4|COMPLETED|Overall Study||299
584813|NCT00529451|1426819|P3|COMPLETED|Overall Study||292
584814|NCT00529451|1426820|P2|COMPLETED|Overall Study||275
584815|NCT00529451|1426821|P1|COMPLETED|Overall Study||294
584816|NCT00529451|1426818|P4|STARTED|Overall Study||330
584817|NCT00529451|1426819|P3|STARTED|Overall Study||332
584818|NCT00529451|1426820|P2|STARTED|Overall Study||323
584819|NCT00529451|1426821|P1|STARTED|Overall Study||331
584820|NCT00529399|1426848|P3|NOT COMPLETED|Overall Study||2
584821|NCT00529399|1426849|P2|NOT COMPLETED|Overall Study||1
584822|NCT00529399|1426850|P1|NOT COMPLETED|Overall Study||2
584823|NCT00529399|1426848|P3|COMPLETED|Overall Study||46
584824|NCT00529399|1426849|P2|COMPLETED|Overall Study||48
584825|NCT00529399|1426850|P1|COMPLETED|Overall Study||46
584826|NCT00529399|1426848|P3|STARTED|Overall Study||48
584827|NCT00529399|1426849|P2|STARTED|Overall Study||49
584828|NCT00529399|1426850|P1|STARTED|Overall Study||48
584829|NCT00529308|1426860|P2|NOT COMPLETED|Overall Study||1
584830|NCT00529308|1426861|P1|NOT COMPLETED|Overall Study||1
584831|NCT00529308|1426860|P2|COMPLETED|Overall Study||10
584832|NCT00529308|1426861|P1|COMPLETED|Overall Study||8
584833|NCT00529308|1426860|P2|STARTED|Overall Study||11
584834|NCT00529308|1426861|P1|STARTED|Overall Study||9
584835|NCT00529282|1426877|P2|NOT COMPLETED|Overall Study||0
584836|NCT00529282|1426878|P1|NOT COMPLETED|Overall Study||0
584837|NCT00529282|1426877|P2|COMPLETED|Overall Study||2
584838|NCT00529282|1426878|P1|COMPLETED|Overall Study||0
584839|NCT00529282|1426877|P2|STARTED|Overall Study||2
584840|NCT00529282|1426878|P1|STARTED|Overall Study||0
584841|NCT00529243|1426890|P1|NOT COMPLETED|Overall Study||3
584842|NCT00529243|1426890|P1|COMPLETED|Overall Study||49
584843|NCT00529243|1426890|P1|STARTED|Overall Study||52
584844|NCT00529217|1426895|P1|NOT COMPLETED|Overall Study||4
584845|NCT00529217|1426895|P1|COMPLETED|Overall Study||8
584846|NCT00529217|1426895|P1|STARTED|Overall Study||12
584847|NCT00529204|1426900|P1|NOT COMPLETED|Overall Study||0
584848|NCT00529204|1426900|P1|COMPLETED|Overall Study||1
584849|NCT00529204|1426900|P1|STARTED|Overall Study||1
584850|NCT00529191|1426908|P2|NOT COMPLETED|Overall Study||0
584851|NCT00529191|1426909|P1|NOT COMPLETED|Overall Study||3
584852|NCT00529191|1426908|P2|COMPLETED|Overall Study||13
584853|NCT00529191|1426909|P1|COMPLETED|Overall Study||24
584854|NCT00529191|1426908|P2|STARTED|Overall Study||13
584855|NCT00529191|1426909|P1|STARTED|Overall Study||27
584856|NCT00529152|1426931|P1|NOT COMPLETED|Overall Study||5
584857|NCT00529152|1426931|P1|COMPLETED|Overall Study||95
584858|NCT00529152|1426931|P1|STARTED|Overall Study||100
584859|NCT00529126|1426939|P4|NOT COMPLETED|Overall Study||0
584860|NCT00529126|1426940|P3|NOT COMPLETED|Overall Study||0
584861|NCT00529126|1426941|P2|NOT COMPLETED|Overall Study||0
584862|NCT00529126|1426942|P1|NOT COMPLETED|Overall Study||0
584863|NCT00529126|1426939|P4|COMPLETED|Overall Study||26
584864|NCT00529126|1426940|P3|COMPLETED|Overall Study||24
584865|NCT00529126|1426941|P2|COMPLETED|Overall Study||25
584866|NCT00529126|1426942|P1|COMPLETED|Overall Study||25
584867|NCT00529126|1426939|P4|STARTED|Overall Study||26
584868|NCT00529126|1426940|P3|STARTED|Overall Study||24
584869|NCT00529126|1426941|P2|STARTED|Overall Study||25
584870|NCT00529126|1426942|P1|STARTED|Overall Study||25
584871|NCT00529100|1426955|P2|NOT COMPLETED|Overall Study||9
584872|NCT00529100|1426956|P1|NOT COMPLETED|Overall Study||0
584873|NCT00529100|1426955|P2|COMPLETED|Overall Study||24
584874|NCT00529100|1426956|P1|COMPLETED|Overall Study||16
584875|NCT00529100|1426955|P2|Received at Least 1 Dose of Study Drug|Overall Study||33
584876|NCT00529100|1426956|P1|Received at Least 1 Dose of Study Drug|Overall Study||16
584877|NCT00529100|1426955|P2|STARTED|Overall Study||33
584878|NCT00529100|1426956|P1|STARTED|Overall Study||16
584879|NCT00529087|1426973|P3|NOT COMPLETED|Overall Study||16
584880|NCT00529087|1426974|P2|NOT COMPLETED|Overall Study||28
584881|NCT00529087|1426975|P1|NOT COMPLETED|Overall Study||28
584882|NCT00529087|1426973|P3|COMPLETED|Overall Study||146
584883|NCT00529087|1426974|P2|COMPLETED|Overall Study||120
584884|NCT00529087|1426975|P1|COMPLETED|Overall Study||122
584885|NCT00529087|1426973|P3|STARTED|Overall Study||162
584886|NCT00529087|1426974|P2|STARTED|Overall Study||148
584887|NCT00529087|1426975|P1|STARTED|Overall Study||150
584888|NCT00529035|1427039|P1|NOT COMPLETED|Overall Study||1
584889|NCT00529035|1427039|P1|COMPLETED|Overall Study|28 evaluable, 1 patient withdrew participation and was not evaluable|28
584890|NCT00529035|1427039|P1|STARTED|Overall Study|29 enrolled|29
584891|NCT00528957|1427052|P2|NOT COMPLETED|Long-Term Extension (Week 336 and On)||17
584892|NCT00528957|1427053|P1|NOT COMPLETED|Long-Term Extension (Week 336 and On)||10
584893|NCT00528957|1427052|P2|COMPLETED|Long-Term Extension (Week 336 and On)||8
584894|NCT00528957|1427053|P1|COMPLETED|Long-Term Extension (Week 336 and On)||9
584895|NCT00528957|1427052|P2|STARTED|Long-Term Extension (Week 336 and On)|Two participants completed the third extension and did not enroll in the long-term extension.|25
584896|NCT00528957|1427053|P1|STARTED|Long-Term Extension (Week 336 and On)|Two participants completed the third extension and did not enroll in the long-term extension.|19
584897|NCT00528957|1427052|P2|NOT COMPLETED|Third Extension (Week 240 to Week 336)||10
584898|NCT00528957|1427053|P1|NOT COMPLETED|Third Extension (Week 240 to Week 336)||6
584899|NCT00528957|1427052|P2|COMPLETED|Third Extension (Week 240 to Week 336)||27
584900|NCT00528957|1427053|P1|COMPLETED|Third Extension (Week 240 to Week 336)||21
584901|NCT00528957|1427052|P2|STARTED|Third Extension (Week 240 to Week 336)||37
584902|NCT00528957|1427053|P1|STARTED|Third Extension (Week 240 to Week 336)||27
584903|NCT00528957|1427052|P2|NOT COMPLETED|Second Extension (Week 144 to Week 240)||3
584904|NCT00528957|1427053|P1|NOT COMPLETED|Second Extension (Week 144 to Week 240)||7
584905|NCT00528957|1427052|P2|COMPLETED|Second Extension (Week 144 to Week 240)||37
584906|NCT00528957|1427053|P1|COMPLETED|Second Extension (Week 144 to Week 240)||27
584907|NCT00528957|1427052|P2|STARTED|Second Extension (Week 144 to Week 240)||40
584908|NCT00528957|1427053|P1|STARTED|Second Extension (Week 144 to Week 240)|One participant completed the first extension and did not enroll in the second extension.|34
584909|NCT00528957|1427052|P2|NOT COMPLETED|First Extension (Week 48 to Week 144)||1
584910|NCT00528957|1427053|P1|NOT COMPLETED|First Extension (Week 48 to Week 144)||3
584911|NCT00528957|1427052|P2|COMPLETED|First Extension (Week 48 to Week 144)||40
584912|NCT00528957|1427053|P1|COMPLETED|First Extension (Week 48 to Week 144)||35
584913|NCT00528957|1427052|P2|STARTED|First Extension (Week 48 to Week 144)|Seven participants completed the 48-week randomized phase and did not enroll in the first extension.|41
584914|NCT00528957|1427053|P1|STARTED|First Extension (Week 48 to Week 144)|Six participants completed the 48-week randomized phase and did not enroll in the first extension.|38
584915|NCT00528957|1427052|P2|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||1
584916|NCT00528957|1427053|P1|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||4
584917|NCT00528957|1427052|P2|COMPLETED|Randomized Phase (Baseline to Week 48)||48
584918|NCT00528957|1427053|P1|COMPLETED|Randomized Phase (Baseline to Week 48)||44
584919|NCT00528957|1427052|P2|STARTED|Randomized Phase (Baseline to Week 48)||49
584920|NCT00528957|1427053|P1|STARTED|Randomized Phase (Baseline to Week 48)||48
584921|NCT00528931|1427194|P1|NOT COMPLETED|Overall Study||1
584922|NCT00528931|1427194|P1|COMPLETED|Overall Study||15
584923|NCT00528931|1427194|P1|STARTED|Overall Study||16
584924|NCT00528879|1427206|P4|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||24
584925|NCT00528879|1427207|P3|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||33
584926|NCT00528879|1427208|P2|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||38
584927|NCT00528879|1427209|P1|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||42
584928|NCT00528879|1427206|P4|COMPLETED|Long-term Period (Weeks 24 to 102)||95
584929|NCT00528879|1427207|P3|COMPLETED|Long-term Period (Weeks 24 to 102)||89
584930|NCT00528879|1427208|P2|COMPLETED|Long-term Period (Weeks 24 to 102)||82
584931|NCT00528879|1427209|P1|COMPLETED|Long-term Period (Weeks 24 to 102)||73
584932|NCT00528879|1427206|P4|STARTED|Long-term Period (Weeks 24 to 102)||119
584933|NCT00528879|1427207|P3|STARTED|Long-term Period (Weeks 24 to 102)||122
584934|NCT00528879|1427208|P2|STARTED|Long-term Period (Weeks 24 to 102)||120
584935|NCT00528879|1427209|P1|STARTED|Long-term Period (Weeks 24 to 102)||115
584936|NCT00528879|1427206|P4|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||16
584937|NCT00528879|1427207|P3|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||15
584938|NCT00528879|1427208|P2|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||17
584939|NCT00528879|1427209|P1|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||22
584940|NCT00528879|1427206|P4|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|119
584941|NCT00528879|1427207|P3|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|122
584942|NCT00528879|1427208|P2|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|120
584943|NCT00528879|1427209|P1|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|115
584944|NCT00528879|1427206|P4|Completed the Period|Short-term Period (Day 1 to Week 24)||121
584945|NCT00528879|1427207|P3|Completed the Period|Short-term Period (Day 1 to Week 24)||122
584946|NCT00528879|1427208|P2|Completed the Period|Short-term Period (Day 1 to Week 24)||121
584947|NCT00528879|1427209|P1|Completed the Period|Short-term Period (Day 1 to Week 24)||119
584948|NCT00528879|1427206|P4|STARTED|Short-term Period (Day 1 to Week 24)||135
584949|NCT00528879|1427207|P3|STARTED|Short-term Period (Day 1 to Week 24)||137
584950|NCT00528879|1427208|P2|STARTED|Short-term Period (Day 1 to Week 24)||137
584951|NCT00528879|1427209|P1|STARTED|Short-term Period (Day 1 to Week 24)||137
584952|NCT00528866|1427275|P1|NOT COMPLETED|Overall Study||6
584953|NCT00528866|1427275|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|74
584954|NCT00528866|1427275|P1|STARTED|Overall Study||80
584955|NCT00528840|1427287|P1|NOT COMPLETED|Overall Study||33
584956|NCT00528840|1427287|P1|COMPLETED|Overall Study||168
584957|NCT00528840|1427287|P1|STARTED|Overall Study||201
584958|NCT00528801|1427301|P2|NOT COMPLETED|Overall Study||11
584959|NCT00528801|1427302|P1|NOT COMPLETED|Overall Study||27
584960|NCT00528801|1427301|P2|COMPLETED|Overall Study||41
584961|NCT00528801|1427302|P1|COMPLETED|Overall Study||133
584962|NCT00528801|1427301|P2|STARTED|Overall Study||52
584963|NCT00528801|1427302|P1|STARTED|Overall Study||160
584964|NCT00528788|1427312|P1|NOT COMPLETED|Overall Study||4
584965|NCT00528788|1427312|P1|COMPLETED|Overall Study||20
584966|NCT00528788|1427312|P1|STARTED|Overall Study||24
584967|NCT00528775|1427316|P1|NOT COMPLETED|Overall Study||1
584968|NCT00528775|1427316|P1|COMPLETED|Overall Study||5
584969|NCT00528775|1427316|P1|STARTED|Overall Study||6
584970|NCT00528645|1427324|P1|NOT COMPLETED|Overall Study||3
584971|NCT00528645|1427324|P1|COMPLETED|Overall Study||20
584972|NCT00528645|1427324|P1|STARTED|Overall Study||23
584973|NCT00528606|1427333|P2|NOT COMPLETED|Overall Study||4
584974|NCT00528606|1427334|P1|NOT COMPLETED|Overall Study||13
584975|NCT00528606|1427333|P2|COMPLETED|Overall Study||100
584976|NCT00528606|1427334|P1|COMPLETED|Overall Study||191
584977|NCT00528606|1427333|P2|STARTED|Overall Study||104
584978|NCT00528606|1427334|P1|STARTED|Overall Study||204
584979|NCT00528580|1427358|P2|NOT COMPLETED|Overall Study||0
584980|NCT00528580|1427359|P1|NOT COMPLETED|Overall Study||0
584981|NCT00528580|1427358|P2|COMPLETED|Overall Study||34
584982|NCT00528580|1427359|P1|COMPLETED|Overall Study||34
584983|NCT00528580|1427358|P2|STARTED|Overall Study||34
584984|NCT00528580|1427359|P1|STARTED|Overall Study||34
584985|NCT00528567|1427367|P2|NOT COMPLETED|Overall Study||308
584986|NCT00528567|1427368|P1|NOT COMPLETED|Overall Study||431
584987|NCT00528567|1427367|P2|COMPLETED|Overall Study||982
584988|NCT00528567|1427368|P1|COMPLETED|Overall Study||870
584989|NCT00528567|1427367|P2|Safety Population|Overall Study||1271
584990|NCT00528567|1427368|P1|Safety Population|Overall Study||1288
584991|NCT00528567|1427367|P2|Intention to Treat|Overall Study||1290
584992|NCT00528567|1427368|P1|Intention to Treat|Overall Study||1301
584993|NCT00528567|1427367|P2|STARTED|Overall Study||1290
584994|NCT00528567|1427368|P1|STARTED|Overall Study||1301
584995|NCT00528541|1427408|P2|NOT COMPLETED|Overall Study||1
584996|NCT00528541|1427409|P1|NOT COMPLETED|Overall Study||2
584997|NCT00528541|1427408|P2|COMPLETED|Overall Study||69
584998|NCT00528541|1427409|P1|COMPLETED|Overall Study||73
584999|NCT00528541|1427408|P2|STARTED|Overall Study||70
585000|NCT00528541|1427409|P1|STARTED|Overall Study||75
585001|NCT00528528|1427435|P4|NOT COMPLETED|Overall Study||3
585002|NCT00528528|1427436|P3|NOT COMPLETED|Overall Study||3
585003|NCT00528528|1427437|P2|NOT COMPLETED|Overall Study||3
585004|NCT00528528|1427438|P1|NOT COMPLETED|Overall Study||3
585005|NCT00528528|1427435|P4|COMPLETED|Overall Study||36
585006|NCT00528528|1427436|P3|COMPLETED|Overall Study||37
585007|NCT00528528|1427437|P2|COMPLETED|Overall Study||39
585008|NCT00528528|1427438|P1|COMPLETED|Overall Study||37
585009|NCT00528528|1427435|P4|Ongoing at Time of Cut-off|Overall Study||0
585010|NCT00528528|1427436|P3|Ongoing at Time of Cut-off|Overall Study||1
585011|NCT00528528|1427437|P2|Ongoing at Time of Cut-off|Overall Study||0
585012|NCT00528528|1427438|P1|Ongoing at Time of Cut-off|Overall Study||0
585013|NCT00528528|1427435|P4|STARTED|Overall Study||39
585014|NCT00528528|1427436|P3|STARTED|Overall Study||40
585015|NCT00528528|1427437|P2|STARTED|Overall Study||42
585016|NCT00528528|1427438|P1|STARTED|Overall Study||40
585017|NCT00528450|1427472|P1|NOT COMPLETED|Overall Study||0
585018|NCT00528450|1427472|P1|COMPLETED|Overall Study||1
585019|NCT00528450|1427472|P1|STARTED|Overall Study||1
585020|NCT00528424|1427476|P1|NOT COMPLETED|Overall Study||29
585021|NCT00528424|1427476|P1|COMPLETED|Overall Study||257
585022|NCT00528424|1427476|P1|STARTED|Overall Study||286
585023|NCT00528411|1427491|P3|NOT COMPLETED|Overall Study||1
585024|NCT00528411|1427492|P2|NOT COMPLETED|Overall Study||3
585025|NCT00528411|1427493|P1|NOT COMPLETED|Overall Study||5
585026|NCT00528411|1427491|P3|COMPLETED|Overall Study||11
585027|NCT00528411|1427492|P2|COMPLETED|Overall Study||51
585028|NCT00528411|1427493|P1|COMPLETED|Overall Study||52
585029|NCT00528411|1427491|P3|STARTED|Overall Study||12
585030|NCT00528411|1427492|P2|STARTED|Overall Study||54
585031|NCT00528411|1427493|P1|STARTED|Overall Study||57
585032|NCT00528398|1427616|P1|NOT COMPLETED|Overall Study||0
585033|NCT00528398|1427616|P1|COMPLETED|Overall Study||111
585034|NCT00528398|1427616|P1|STARTED|Overall Study||111
585035|NCT00528372|1427630|P9|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6
585036|NCT00528372|1427631|P8|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6
585037|NCT00528372|1427632|P7|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||17
585038|NCT00528372|1427633|P6|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||15
585039|NCT00528372|1427634|P5|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||21
585040|NCT00528372|1427635|P4|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||14
585041|NCT00528372|1427636|P3|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||8
585042|NCT00528372|1427637|P2|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||19
585043|NCT00528372|1427638|P1|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||20
585044|NCT00528372|1427630|P9|COMPLETED|Long-term (LT) Period (Weeks 24-102)||27
585045|NCT00528372|1427631|P8|COMPLETED|Long-term (LT) Period (Weeks 24-102)||22
585046|NCT00528372|1427632|P7|COMPLETED|Long-term (LT) Period (Weeks 24-102)||48
585047|NCT00528372|1427633|P6|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
585048|NCT00528372|1427634|P5|COMPLETED|Long-term (LT) Period (Weeks 24-102)||37
585049|NCT00528372|1427635|P4|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
585050|NCT00528372|1427636|P3|COMPLETED|Long-term (LT) Period (Weeks 24-102)||43
585051|NCT00528372|1427637|P2|COMPLETED|Long-term (LT) Period (Weeks 24-102)||40
585052|NCT00528372|1427638|P1|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
585053|NCT00528372|1427630|P9|STARTED|Long-term (LT) Period (Weeks 24-102)|1 patient completed ST phase but withdrew for sponsor administrative reason before start of LT phase|33
585054|NCT00528372|1427631|P8|STARTED|Long-term (LT) Period (Weeks 24-102)||28
585055|NCT00528372|1427632|P7|STARTED|Long-term (LT) Period (Weeks 24-102)||65
585056|NCT00528372|1427633|P6|STARTED|Long-term (LT) Period (Weeks 24-102)||57
585057|NCT00528372|1427634|P5|STARTED|Long-term (LT) Period (Weeks 24-102)||58
585058|NCT00528372|1427635|P4|STARTED|Long-term (LT) Period (Weeks 24-102)||56
585059|NCT00528372|1427636|P3|STARTED|Long-term (LT) Period (Weeks 24-102)||51
585060|NCT00528372|1427637|P2|STARTED|Long-term (LT) Period (Weeks 24-102)||59
585061|NCT00528372|1427638|P1|STARTED|Long-term (LT) Period (Weeks 24-102)||62
585062|NCT00528372|1427630|P9|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5
585063|NCT00528372|1427631|P8|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||6
585064|NCT00528372|1427632|P7|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11
585065|NCT00528372|1427633|P6|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11
585066|NCT00528372|1427634|P5|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||9
585067|NCT00528372|1427635|P4|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||13
585068|NCT00528372|1427636|P3|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12
585069|NCT00528372|1427637|P2|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5
585070|NCT00528372|1427638|P1|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12
585071|NCT00528372|1427630|P9|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||34
585072|NCT00528372|1427631|P8|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||28
585073|NCT00528372|1427632|P7|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||65
585074|NCT00528372|1427633|P6|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57
585075|NCT00528372|1427634|P5|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||58
585076|NCT00528372|1427635|P4|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57
585077|NCT00528372|1427636|P3|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||52
585078|NCT00528372|1427637|P2|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||60
585079|NCT00528372|1427638|P1|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||63
585080|NCT00528372|1427630|P9|STARTED|Short-term (ST) Period (Day 1-Week 24)||39
585081|NCT00528372|1427631|P8|STARTED|Short-term (ST) Period (Day 1-Week 24)||34
585082|NCT00528372|1427632|P7|STARTED|Short-term (ST) Period (Day 1-Week 24)||76
585083|NCT00528372|1427633|P6|STARTED|Short-term (ST) Period (Day 1-Week 24)||68
585084|NCT00528372|1427634|P5|STARTED|Short-term (ST) Period (Day 1-Week 24)||67
585085|NCT00528372|1427635|P4|STARTED|Short-term (ST) Period (Day 1-Week 24)||70
585086|NCT00528372|1427636|P3|STARTED|Short-term (ST) Period (Day 1-Week 24)||64
585087|NCT00528372|1427637|P2|STARTED|Short-term (ST) Period (Day 1-Week 24)||65
585088|NCT00528372|1427638|P1|STARTED|Short-term (ST) Period (Day 1-Week 24)||75
585089|NCT00528268|1427752|P2|NOT COMPLETED|Overall Study||1
585090|NCT00528268|1427753|P1|NOT COMPLETED|Overall Study||1
585091|NCT00528268|1427752|P2|COMPLETED|Overall Study||7
585092|NCT00528268|1427753|P1|COMPLETED|Overall Study||5
585093|NCT00528268|1427752|P2|STARTED|Overall Study||8
585094|NCT00528268|1427753|P1|STARTED|Overall Study||6
585095|NCT00528190|1427761|P2|NOT COMPLETED|Overall Study||1
585096|NCT00528190|1427762|P1|NOT COMPLETED|Overall Study||0
585097|NCT00528190|1427761|P2|COMPLETED|Overall Study||16
585098|NCT00528190|1427762|P1|COMPLETED|Overall Study||18
585099|NCT00528190|1427761|P2|STARTED|Overall Study||17
585100|NCT00528190|1427762|P1|STARTED|Overall Study||18
585101|NCT00528112|1427770|P2|NOT COMPLETED|Extension Phase||157
585102|NCT00528112|1427771|P1|NOT COMPLETED|Extension Phase||0
585103|NCT00528112|1427770|P2|COMPLETED|Extension Phase||550
585104|NCT00528112|1427771|P1|COMPLETED|Extension Phase||0
585105|NCT00528112|1427770|P2|STARTED|Extension Phase||707
585106|NCT00528112|1427771|P1|STARTED|Extension Phase|Only subjects in the LCS16 groups could participate in the extension phase|0
585107|NCT00528112|1427770|P2|NOT COMPLETED|Treatment up to 3 Years||583
585108|NCT00528112|1427771|P1|NOT COMPLETED|Treatment up to 3 Years||613
585109|NCT00528112|1427770|P2|COMPLETED|Treatment up to 3 Years||870
585110|NCT00528112|1427771|P1|COMPLETED|Treatment up to 3 Years||819
585111|NCT00528112|1427770|P2|Participants Received Treatment|Treatment up to 3 Years|Full analysis set/Safety population|1452
585112|NCT00528112|1427771|P1|Participants Received Treatment|Treatment up to 3 Years|Full analysis set/Safety population|1432
585113|NCT00528112|1427770|P2|STARTED|Treatment up to 3 Years||1453
585114|NCT00528112|1427771|P1|STARTED|Treatment up to 3 Years||1432
585115|NCT00528021|1427829|P4|NOT COMPLETED|Overall Study||9
585116|NCT00528021|1427830|P3|NOT COMPLETED|Overall Study||7
585117|NCT00528021|1427831|P2|NOT COMPLETED|Overall Study||13
585118|NCT00528021|1427832|P1|NOT COMPLETED|Overall Study||17
585119|NCT00528021|1427829|P4|COMPLETED|Overall Study||47
585120|NCT00528021|1427830|P3|COMPLETED|Overall Study||49
585121|NCT00528021|1427831|P2|COMPLETED|Overall Study||46
585122|NCT00528021|1427832|P1|COMPLETED|Overall Study||42
585123|NCT00528021|1427829|P4|STARTED|Overall Study||56
585124|NCT00528021|1427830|P3|STARTED|Overall Study||56
585125|NCT00528021|1427831|P2|STARTED|Overall Study||59
585126|NCT00528021|1427832|P1|STARTED|Overall Study||59
585127|NCT00527982|1427844|P2|NOT COMPLETED|Overall Study||0
585128|NCT00527982|1427845|P1|NOT COMPLETED|Overall Study||1
585129|NCT00527982|1427844|P2|COMPLETED|Overall Study||0
585130|NCT00527982|1427845|P1|COMPLETED|Overall Study||0
585131|NCT00527982|1427844|P2|STARTED|Overall Study||0
585132|NCT00527982|1427845|P1|STARTED|Overall Study||1
585133|NCT00527943|1427853|P2|NOT COMPLETED|Overall Study||146
585134|NCT00527943|1427854|P1|NOT COMPLETED|Overall Study||160
585135|NCT00527943|1427853|P2|COMPLETED|Overall Study||6327
585136|NCT00527943|1427854|P1|COMPLETED|Overall Study||6311
585137|NCT00527943|1427853|P2|Received Treatment|Overall Study||6446
585138|NCT00527943|1427854|P1|Received Treatment|Overall Study||6441
585139|NCT00527943|1427853|P2|STARTED|Overall Study||6473
585140|NCT00527943|1427854|P1|STARTED|Overall Study||6471
585141|NCT00527904|1427886|P1|NOT COMPLETED|Overall Study||96
585142|NCT00527904|1427886|P1|COMPLETED|Overall Study||143
585143|NCT00527904|1427886|P1|STARTED|Overall Study||239
585144|NCT00527878|1427890|P2|NOT COMPLETED|Intervention 2||0
585145|NCT00527878|1427891|P1|NOT COMPLETED|Intervention 2||0
585146|NCT00527878|1427890|P2|COMPLETED|Intervention 2||4
585147|NCT00527878|1427891|P1|COMPLETED|Intervention 2||5
585148|NCT00527878|1427890|P2|STARTED|Intervention 2||4
585149|NCT00527878|1427891|P1|STARTED|Intervention 2||5
585150|NCT00527878|1427890|P2|NOT COMPLETED|Intervention 1||3
585151|NCT00527878|1427891|P1|NOT COMPLETED|Intervention 1||2
585152|NCT00527878|1427890|P2|COMPLETED|Intervention 1||4
585153|NCT00527878|1427891|P1|COMPLETED|Intervention 1||5
585154|NCT00527878|1427890|P2|STARTED|Intervention 1||7
585155|NCT00527878|1427891|P1|STARTED|Intervention 1||7
585156|NCT00527826|1427905|P2|NOT COMPLETED|Overall Study||26
585157|NCT00527826|1427906|P1|NOT COMPLETED|Overall Study||21
585158|NCT00527826|1427905|P2|COMPLETED|Overall Study||80
585159|NCT00527826|1427906|P1|COMPLETED|Overall Study||87
585160|NCT00527826|1427905|P2|STARTED|Overall Study||106
585161|NCT00527826|1427906|P1|STARTED|Overall Study|All Patients Population was used for Participant Flow section.|108
585162|NCT00527787|1427955|P2|NOT COMPLETED|Overall Study||63
585163|NCT00527787|1427956|P1|NOT COMPLETED|Overall Study||38
585164|NCT00527787|1427955|P2|COMPLETED|Overall Study||153
585165|NCT00527787|1427956|P1|COMPLETED|Overall Study||180
585166|NCT00527787|1427955|P2|STARTED|Overall Study|Safety and Intent-to-treat population (>=1 dose drug + no baseline ulcer) N=216|216
585167|NCT00527787|1427956|P1|STARTED|Overall Study||218
585168|NCT00527748|1427978|P1|NOT COMPLETED|Overall Study||3
585169|NCT00527748|1427978|P1|COMPLETED|Overall Study||23
585170|NCT00527748|1427978|P1|STARTED|Overall Study||26
585171|NCT00527735|1427985|P3|NOT COMPLETED|Overall Study||107
585172|NCT00527735|1427986|P2|NOT COMPLETED|Overall Study||107
585173|NCT00527735|1427987|P1|NOT COMPLETED|Overall Study||108
585174|NCT00527735|1427985|P3|COMPLETED|Overall Study|Still on treatment|2
585175|NCT00527735|1427986|P2|COMPLETED|Overall Study|Still on treatment|2
585176|NCT00527735|1427987|P1|COMPLETED|Overall Study|Still on treatment|5
585177|NCT00527735|1427985|P3|STARTED|Overall Study|Treated|109
585178|NCT00527735|1427986|P2|STARTED|Overall Study|Treated|109
585179|NCT00527735|1427987|P1|STARTED|Overall Study|Treated|113
585180|NCT00527722|1428061|P2|NOT COMPLETED|Overall Study||0
585181|NCT00527722|1428062|P1|NOT COMPLETED|Overall Study||0
585182|NCT00527722|1428061|P2|COMPLETED|Overall Study||25
585183|NCT00527722|1428062|P1|COMPLETED|Overall Study||22
585184|NCT00527722|1428061|P2|STARTED|Overall Study||25
585185|NCT00527722|1428062|P1|STARTED|Overall Study||22
585186|NCT00527644|1428068|P1|NOT COMPLETED|Overall Study||0
585187|NCT00527644|1428068|P1|COMPLETED|Overall Study||14
585188|NCT00527644|1428068|P1|STARTED|Overall Study||14
585189|NCT00527618|1428073|P2|NOT COMPLETED|Week 15-18 (Second Intervention)||3
585190|NCT00527618|1428074|P1|NOT COMPLETED|Week 15-18 (Second Intervention)||0
585191|NCT00527618|1428073|P2|COMPLETED|Week 15-18 (Second Intervention)|Acyclovir|13
585192|NCT00527618|1428074|P1|COMPLETED|Week 15-18 (Second Intervention)|Valacyclovir|12
585193|NCT00527618|1428073|P2|STARTED|Week 15-18 (Second Intervention)|Acyclovir|16
585194|NCT00527618|1428074|P1|STARTED|Week 15-18 (Second Intervention)|Valacyclovir|12
585195|NCT00527618|1428073|P2|NOT COMPLETED|Week 13-14 (Washout)||0
585196|NCT00527618|1428074|P1|NOT COMPLETED|Week 13-14 (Washout)||1
585197|NCT00527618|1428073|P2|COMPLETED|Week 13-14 (Washout)||16
585198|NCT00527618|1428074|P1|COMPLETED|Week 13-14 (Washout)||12
585199|NCT00527618|1428073|P2|STARTED|Week 13-14 (Washout)||16
585200|NCT00527618|1428074|P1|STARTED|Week 13-14 (Washout)||13
585201|NCT00527618|1428073|P2|NOT COMPLETED|Week 1-12 (First Intervention)||2
585202|NCT00527618|1428074|P1|NOT COMPLETED|Week 1-12 (First Intervention)||3
585203|NCT00527618|1428073|P2|COMPLETED|Week 1-12 (First Intervention)|Valacyclovir|16
585204|NCT00527618|1428074|P1|COMPLETED|Week 1-12 (First Intervention)|Acyclovir|13
585205|NCT00527618|1428073|P2|STARTED|Week 1-12 (First Intervention)|Valacyclovir; one participant was removed from the study due to urticaria after 2.5 weeks|18
585206|NCT00527618|1428074|P1|STARTED|Week 1-12 (First Intervention)|Acyclovir|16
585207|NCT00527605|1428089|P2|NOT COMPLETED|Overall Study||11
585208|NCT00527605|1428090|P1|NOT COMPLETED|Overall Study||13
585209|NCT00527605|1428089|P2|COMPLETED|Overall Study||116
585210|NCT00527605|1428090|P1|COMPLETED|Overall Study||113
585211|NCT00527605|1428089|P2|STARTED|Overall Study||127
585212|NCT00527605|1428090|P1|STARTED|Overall Study||126
585213|NCT00527592|1428126|P1|NOT COMPLETED|Overall Study||0
585214|NCT00527592|1428126|P1|COMPLETED|Overall Study||54
585215|NCT00527592|1428126|P1|STARTED|Overall Study||54
585216|NCT00527566|1428132|P1|NOT COMPLETED|Overall Study||0
585217|NCT00527566|1428132|P1|COMPLETED|Overall Study||10
585218|NCT00527566|1428132|P1|STARTED|Overall Study||10
585219|NCT00527514|1428141|P1|NOT COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||2
585220|NCT00527514|1428141|P1|COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||132
585221|NCT00527514|1428141|P1|STARTED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|158 -24 who met blood pressure goal = 134|134
585222|NCT00527514|1428141|P1|NOT COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||3
585223|NCT00527514|1428141|P1|COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||158
585224|NCT00527514|1428141|P1|STARTED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|178 -19 who met blood pressure goal + 2 who were mis-titrated = 161|161
585225|NCT00527514|1428141|P1|NOT COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||2
585226|NCT00527514|1428141|P1|COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||178
585227|NCT00527514|1428141|P1|STARTED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|184 -2 who were mis-titrated -2 who met blood pressure goal = 180|180
585228|NCT00527514|1428141|P1|NOT COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg||1
585229|NCT00527514|1428141|P1|COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg|1 participant dropped out. 2 participants were subsequently mis-titrated to the third regimen.|184
585230|NCT00527514|1428141|P1|STARTED|Weeks 1-3: Amlodipine (Aml) 5mg||185
585231|NCT00527488|1428157|P4|NOT COMPLETED|Overall Study||0
585232|NCT00527488|1428158|P3|NOT COMPLETED|Overall Study||1
585233|NCT00527488|1428159|P2|NOT COMPLETED|Overall Study||1
585234|NCT00527488|1428160|P1|NOT COMPLETED|Overall Study||0
585235|NCT00527488|1428157|P4|COMPLETED|Overall Study||13
585236|NCT00527488|1428158|P3|COMPLETED|Overall Study||12
585237|NCT00527488|1428159|P2|COMPLETED|Overall Study||12
585238|NCT00527488|1428160|P1|COMPLETED|Overall Study||13
585239|NCT00527488|1428157|P4|STARTED|Overall Study||13
585240|NCT00527488|1428158|P3|STARTED|Overall Study||13
585241|NCT00527488|1428159|P2|STARTED|Overall Study||13
585242|NCT00527488|1428160|P1|STARTED|Overall Study||13
585243|NCT00527475|1428236|P2|NOT COMPLETED|Overall Study||1
585244|NCT00527475|1428237|P1|NOT COMPLETED|Overall Study||3
585245|NCT00527475|1428236|P2|COMPLETED|Overall Study||29
585246|NCT00527475|1428237|P1|COMPLETED|Overall Study||27
585247|NCT00527475|1428236|P2|STARTED|Overall Study||30
585248|NCT00527475|1428237|P1|STARTED|Overall Study||30
585249|NCT00527423|1428243|P1|NOT COMPLETED|Overall Study||37
585250|NCT00527423|1428243|P1|COMPLETED|Overall Study||120
585251|NCT00527423|1428243|P1|STARTED|Overall Study||157
585252|NCT00527397|1428249|P1|NOT COMPLETED|Overall Study||24
585253|NCT00527397|1428249|P1|COMPLETED|Overall Study||0
585254|NCT00527397|1428249|P1|STARTED|Overall Study||24
585255|NCT00527332|1428275|P2|NOT COMPLETED|Overall Study||9
585256|NCT00527332|1428276|P1|NOT COMPLETED|Overall Study||9
585257|NCT00527332|1428275|P2|COMPLETED|Overall Study||80
585258|NCT00527332|1428276|P1|COMPLETED|Overall Study||82
585259|NCT00527332|1428275|P2|STARTED|Overall Study||89
585260|NCT00527332|1428276|P1|STARTED|Overall Study||91
585261|NCT00527319|1428285|P3|NOT COMPLETED|Overall Study||6
585262|NCT00527319|1428286|P2|NOT COMPLETED|Overall Study||4
585263|NCT00527319|1428287|P1|NOT COMPLETED|Overall Study||6
585264|NCT00527319|1428285|P3|COMPLETED|Overall Study||7
585265|NCT00527319|1428286|P2|COMPLETED|Overall Study||8
585266|NCT00527319|1428287|P1|COMPLETED|Overall Study||6
585267|NCT00527319|1428285|P3|STARTED|Overall Study||13
585268|NCT00527319|1428286|P2|STARTED|Overall Study||12
585269|NCT00527319|1428287|P1|STARTED|Overall Study||12
585270|NCT00527124|1428300|P2|NOT COMPLETED|Overall Study||0
585271|NCT00527124|1428301|P1|NOT COMPLETED|Overall Study||0
585272|NCT00527124|1428300|P2|COMPLETED|Overall Study||28
585273|NCT00527124|1428301|P1|COMPLETED|Overall Study||29
585274|NCT00527124|1428300|P2|STARTED|Overall Study||28
585275|NCT00527124|1428301|P1|STARTED|Overall Study||29
585276|NCT00527111|1428317|P2|NOT COMPLETED|Overall Study||22
585277|NCT00527111|1428318|P1|NOT COMPLETED|Overall Study||20
585278|NCT00527111|1428317|P2|COMPLETED|Overall Study||47
585279|NCT00527111|1428318|P1|COMPLETED|Overall Study||50
585280|NCT00527111|1428317|P2|STARTED|Overall Study||69
585281|NCT00527111|1428318|P1|STARTED|Overall Study||70
585282|NCT00527098|1428334|P2|NOT COMPLETED|Overall Study||0
585283|NCT00527098|1428335|P1|NOT COMPLETED|Overall Study||0
585284|NCT00527098|1428334|P2|COMPLETED|Overall Study||83
585285|NCT00527098|1428335|P1|COMPLETED|Overall Study||36
585286|NCT00527098|1428334|P2|STARTED|Overall Study||83
585287|NCT00527098|1428335|P1|STARTED|Overall Study||36
585288|NCT00527072|1428340|P1|NOT COMPLETED|Overall Study||36
585289|NCT00527072|1428340|P1|COMPLETED|Overall Study||179
585290|NCT00527072|1428340|P1|STARTED|Overall Study||215
585291|NCT00526994|1428349|P3|NOT COMPLETED|Overall Study||107
585292|NCT00526994|1428350|P2|NOT COMPLETED|Overall Study||121
585293|NCT00526994|1428351|P1|NOT COMPLETED|Overall Study||108
585294|NCT00526994|1428349|P3|COMPLETED|Overall Study||791
585295|NCT00526994|1428350|P2|COMPLETED|Overall Study||772
585296|NCT00526994|1428351|P1|COMPLETED|Overall Study||801
585297|NCT00526994|1428349|P3|STARTED|Overall Study||898
585298|NCT00526994|1428350|P2|STARTED|Overall Study||893
585299|NCT00526994|1428351|P1|STARTED|Overall Study||909
585300|NCT00526890|1428368|P1|NOT COMPLETED|Overall Study||2
585301|NCT00526890|1428368|P1|COMPLETED|Overall Study||14
585302|NCT00526890|1428368|P1|STARTED|Overall Study||16
585303|NCT00526799|1428380|P2|NOT COMPLETED|Overall Study||1
585304|NCT00526799|1428381|P1|NOT COMPLETED|Overall Study||1
585305|NCT00526799|1428380|P2|COMPLETED|Overall Study||13
585306|NCT00526799|1428381|P1|COMPLETED|Overall Study||15
585307|NCT00526799|1428380|P2|STARTED|Overall Study||14
585308|NCT00526799|1428381|P1|STARTED|Overall Study||16
585309|NCT00526669|1428389|P2|NOT COMPLETED|Combined Treatment Phase||8
585310|NCT00526669|1428390|P1|NOT COMPLETED|Combined Treatment Phase||0
585311|NCT00526669|1428389|P2|COMPLETED|Combined Treatment Phase||59
585312|NCT00526669|1428390|P1|COMPLETED|Combined Treatment Phase||0
585313|NCT00526669|1428389|P2|STARTED|Combined Treatment Phase||67
585314|NCT00526669|1428390|P1|STARTED|Combined Treatment Phase||0
585315|NCT00526669|1428389|P2|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
585316|NCT00526669|1428390|P1|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
585317|NCT00526669|1428389|P2|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
585318|NCT00526669|1428390|P1|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||67
585319|NCT00526669|1428389|P2|STARTED|7-Day Run-in Monotherapy Treatment Phase||0
585320|NCT00526669|1428390|P1|STARTED|7-Day Run-in Monotherapy Treatment Phase||67
585321|NCT00526630|1428419|P2|NOT COMPLETED|Second Intervention Period - 12 Weeks||1
585322|NCT00526630|1428420|P1|NOT COMPLETED|Second Intervention Period - 12 Weeks||2
585323|NCT00526630|1428419|P2|COMPLETED|Second Intervention Period - 12 Weeks||7
585324|NCT00526630|1428420|P1|COMPLETED|Second Intervention Period - 12 Weeks||10
585325|NCT00526630|1428419|P2|STARTED|Second Intervention Period - 12 Weeks||8
585326|NCT00526630|1428420|P1|STARTED|Second Intervention Period - 12 Weeks||12
585327|NCT00526630|1428419|P2|NOT COMPLETED|First Intervention Period - 12 Weeks||3
585328|NCT00526630|1428420|P1|NOT COMPLETED|First Intervention Period - 12 Weeks||0
585329|NCT00526630|1428419|P2|COMPLETED|First Intervention Period - 12 Weeks||8
585330|NCT00526630|1428420|P1|COMPLETED|First Intervention Period - 12 Weeks||12
585331|NCT00526630|1428419|P2|STARTED|First Intervention Period - 12 Weeks||11
585332|NCT00526630|1428420|P1|STARTED|First Intervention Period - 12 Weeks||12
585333|NCT00526474|1428450|P2|NOT COMPLETED|Overall Study||272
585334|NCT00526474|1428451|P1|NOT COMPLETED|Overall Study||292
585335|NCT00526474|1428450|P2|COMPLETED|Overall Study||12953
585336|NCT00526474|1428451|P1|COMPLETED|Overall Study||12932
585337|NCT00526474|1428450|P2|Received Study Drug|Overall Study||13186
585338|NCT00526474|1428451|P1|Received Study Drug|Overall Study||13166
585339|NCT00526474|1428450|P2|STARTED|Overall Study||13225
585340|NCT00526474|1428451|P1|STARTED|Overall Study||13224
585341|NCT00526331|1428519|P1|NOT COMPLETED|Overall Study||55
585342|NCT00526331|1428519|P1|COMPLETED|Overall Study||0
585343|NCT00526331|1428519|P1|STARTED|Overall Study||55
585344|NCT00526292|1428523|P1|NOT COMPLETED|Overall Study||0
585345|NCT00526292|1428523|P1|COMPLETED|Overall Study||6
585346|NCT00526292|1428523|P1|STARTED|Overall Study||6
585347|NCT00526227|1428527|P1|NOT COMPLETED|Overall Study||2
585348|NCT00526227|1428527|P1|COMPLETED|Overall Study||79
585349|NCT00526227|1428527|P1|STARTED|Overall Study||81
585350|NCT00526188|1428532|P1|NOT COMPLETED|Overall Study||0
585351|NCT00526188|1428532|P1|COMPLETED|Overall Study||234
585352|NCT00526188|1428532|P1|STARTED|Overall Study||234
585353|NCT00526162|1428538|P1|NOT COMPLETED|Overall Study||3
585354|NCT00526162|1428538|P1|COMPLETED|Overall Study||80
585355|NCT00526162|1428538|P1|STARTED|Overall Study||83
585356|NCT00526123|1428545|P2|NOT COMPLETED|Overall Study||246
585357|NCT00526123|1428546|P1|NOT COMPLETED|Overall Study||264
585358|NCT00526123|1428545|P2|COMPLETED|Overall Study||50
585359|NCT00526123|1428546|P1|COMPLETED|Overall Study||39
585360|NCT00526123|1428545|P2|STARTED|Overall Study|Intent-to-Treat population|296
585361|NCT00526123|1428546|P1|STARTED|Overall Study|Intent-to-Treat population|303
585362|NCT00526110|1428568|P2|NOT COMPLETED|Overall Study||41
585363|NCT00526110|1428569|P1|NOT COMPLETED|Overall Study||2
585364|NCT00526110|1428568|P2|COMPLETED|Overall Study||4
585365|NCT00526110|1428569|P1|COMPLETED|Overall Study||51
585366|NCT00526110|1428568|P2|STARTED|Overall Study||45
585367|NCT00526110|1428569|P1|STARTED|Overall Study||53
585368|NCT00526097|1428578|P2|NOT COMPLETED|Overall Study||56
585369|NCT00526097|1428579|P1|NOT COMPLETED|Overall Study||15
585370|NCT00526097|1428578|P2|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|191
585371|NCT00526097|1428579|P1|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|106
585372|NCT00526097|1428578|P2|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|247
585373|NCT00526097|1428579|P1|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|121
585374|NCT00526058|1428757|P2|NOT COMPLETED|Period: Second Intervention||0
585375|NCT00526058|1428758|P1|NOT COMPLETED|Period: Second Intervention||0
585376|NCT00526058|1428757|P2|COMPLETED|Period: Second Intervention||9
585377|NCT00526058|1428758|P1|COMPLETED|Period: Second Intervention||9
585378|NCT00526058|1428757|P2|STARTED|Period: Second Intervention||9
585379|NCT00526058|1428758|P1|STARTED|Period: Second Intervention||9
585380|NCT00526058|1428757|P2|NOT COMPLETED|Period: First Intervention||0
585381|NCT00526058|1428758|P1|NOT COMPLETED|Period: First Intervention||0
585382|NCT00526058|1428757|P2|COMPLETED|Period: First Intervention||9
585383|NCT00526058|1428758|P1|COMPLETED|Period: First Intervention||9
585384|NCT00526058|1428757|P2|STARTED|Period: First Intervention||9
585385|NCT00526058|1428758|P1|STARTED|Period: First Intervention||9
585386|NCT00525915|1428766|P2|NOT COMPLETED|Overall Study||9
585387|NCT00525915|1428767|P1|NOT COMPLETED|Overall Study||8
585388|NCT00525915|1428766|P2|COMPLETED|Overall Study||54
585389|NCT00525915|1428767|P1|COMPLETED|Overall Study|Participants who underwent surgery.|55
585390|NCT00525915|1428766|P2|STARTED|Overall Study||63
585391|NCT00525915|1428767|P1|STARTED|Overall Study||63
585392|NCT00525902|1428773|P1|NOT COMPLETED|Overall Study||1
585393|NCT00525902|1428773|P1|COMPLETED|Overall Study||30
585394|NCT00525902|1428773|P1|50 Weeks|Overall Study||12
585395|NCT00525902|1428773|P1|10 Weeks|Overall Study||30
585396|NCT00525902|1428773|P1|STARTED|Overall Study||31
585397|NCT00525876|1428780|P2|NOT COMPLETED|Overall Study||0
585398|NCT00525876|1428781|P1|NOT COMPLETED|Overall Study||0
585399|NCT00525876|1428780|P2|COMPLETED|Overall Study||20
585400|NCT00525876|1428781|P1|COMPLETED|Overall Study||16
585401|NCT00525876|1428780|P2|STARTED|Overall Study||20
585402|NCT00525876|1428781|P1|STARTED|Overall Study||16
585403|NCT00525837|1428787|P1|NOT COMPLETED|Overall Study||4
585404|NCT00525837|1428787|P1|COMPLETED|Overall Study||14
585405|NCT00525837|1428787|P1|STARTED|Overall Study||18
585406|NCT00525824|1428795|P4|NOT COMPLETED|Overall Study||15
585407|NCT00525824|1428796|P3|NOT COMPLETED|Overall Study||19
585408|NCT00525824|1428797|P2|NOT COMPLETED|Overall Study||28
585409|NCT00525824|1428798|P1|NOT COMPLETED|Overall Study||19
585410|NCT00525824|1428795|P4|COMPLETED|Overall Study||188
585411|NCT00525824|1428796|P3|COMPLETED|Overall Study||183
585412|NCT00525824|1428797|P2|COMPLETED|Overall Study||186
585413|NCT00525824|1428798|P1|COMPLETED|Overall Study||195
585414|NCT00525824|1428795|P4|STARTED|Overall Study|Randomized population|203
585415|NCT00525824|1428796|P3|STARTED|Overall Study|Randomized population|202
585416|NCT00525824|1428797|P2|STARTED|Overall Study|Randomized population|214
585417|NCT00525824|1428798|P1|STARTED|Overall Study|Randomized population|214
585418|NCT00525798|1428862|P2|NOT COMPLETED|Overall Study||599
585419|NCT00525798|1428863|P1|NOT COMPLETED|Overall Study||756
585420|NCT00525798|1428862|P2|COMPLETED|Overall Study||1732
585421|NCT00525798|1428863|P1|COMPLETED|Overall Study||1578
585422|NCT00525798|1428862|P2|STARTED|Overall Study||2331
585423|NCT00525798|1428863|P1|STARTED|Overall Study||2334
585424|NCT00525733|1428873|P2|NOT COMPLETED|Overall Study||3
585425|NCT00525733|1428874|P1|NOT COMPLETED|Overall Study||3
585426|NCT00525733|1428873|P2|COMPLETED|Overall Study||23
585427|NCT00525733|1428874|P1|COMPLETED|Overall Study||11
585428|NCT00525733|1428873|P2|STARTED|Overall Study||26
585429|NCT00525733|1428874|P1|STARTED|Overall Study||14
585430|NCT00525629|1428880|P2|NOT COMPLETED|Second Intervention||15
585431|NCT00525629|1428881|P1|NOT COMPLETED|Second Intervention||15
585432|NCT00525629|1428880|P2|COMPLETED|Second Intervention||0
585433|NCT00525629|1428881|P1|COMPLETED|Second Intervention||0
585434|NCT00525629|1428880|P2|STARTED|Second Intervention||15
585435|NCT00525629|1428881|P1|STARTED|Second Intervention||15
585436|NCT00525629|1428880|P2|NOT COMPLETED|Washout||0
585437|NCT00525629|1428881|P1|NOT COMPLETED|Washout||0
585438|NCT00525629|1428880|P2|COMPLETED|Washout||15
585439|NCT00525629|1428881|P1|COMPLETED|Washout||15
585440|NCT00525629|1428880|P2|STARTED|Washout||15
585441|NCT00525629|1428881|P1|STARTED|Washout||15
585442|NCT00525629|1428880|P2|NOT COMPLETED|First Intervention||5
585443|NCT00525629|1428881|P1|NOT COMPLETED|First Intervention||5
585444|NCT00525629|1428880|P2|COMPLETED|First Intervention||15
585445|NCT00525629|1428881|P1|COMPLETED|First Intervention||15
585446|NCT00525629|1428880|P2|STARTED|First Intervention||20
585447|NCT00525629|1428881|P1|STARTED|First Intervention||20
585448|NCT00525603|1428887|P1|NOT COMPLETED|Overall Study||0
585449|NCT00525603|1428887|P1|COMPLETED|Overall Study||60
585450|NCT00525603|1428887|P1|STARTED|Overall Study||60
585451|NCT00525525|1428893|P2|NOT COMPLETED|Overall Study||0
585452|NCT00525525|1428894|P1|NOT COMPLETED|Overall Study||0
585453|NCT00525525|1428893|P2|COMPLETED|Overall Study||15
585454|NCT00525525|1428894|P1|COMPLETED|Overall Study||59
585455|NCT00525525|1428893|P2|STARTED|Overall Study||15
585456|NCT00525525|1428894|P1|STARTED|Overall Study||59
585457|NCT00525512|1428903|P4|NOT COMPLETED|Open-Label Phase||5
585458|NCT00525512|1428904|P3|NOT COMPLETED|Open-Label Phase||6
585459|NCT00525512|1428905|P2|NOT COMPLETED|Open-Label Phase||0
585460|NCT00525512|1428906|P1|NOT COMPLETED|Open-Label Phase||0
585461|NCT00525512|1428903|P4|COMPLETED|Open-Label Phase||189
585462|NCT00525512|1428904|P3|COMPLETED|Open-Label Phase||158
585463|NCT00525512|1428905|P2|COMPLETED|Open-Label Phase||0
585464|NCT00525512|1428906|P1|COMPLETED|Open-Label Phase||0
585465|NCT00525512|1428903|P4|STARTED|Open-Label Phase||194
585466|NCT00525512|1428904|P3|STARTED|Open-Label Phase||164
585467|NCT00525512|1428905|P2|STARTED|Open-Label Phase||0
585468|NCT00525512|1428906|P1|STARTED|Open-Label Phase||0
585469|NCT00525512|1428903|P4|NOT COMPLETED|Double-Blind Phase||0
585470|NCT00525512|1428904|P3|NOT COMPLETED|Double-Blind Phase||0
585471|NCT00525512|1428905|P2|NOT COMPLETED|Double-Blind Phase||66
585472|NCT00525512|1428906|P1|NOT COMPLETED|Double-Blind Phase||96
585473|NCT00525512|1428903|P4|COMPLETED|Double-Blind Phase||0
585474|NCT00525512|1428904|P3|COMPLETED|Double-Blind Phase||0
585475|NCT00525512|1428905|P2|COMPLETED|Double-Blind Phase||194
585476|NCT00525512|1428906|P1|COMPLETED|Double-Blind Phase||163
585477|NCT00525512|1428903|P4|STARTED|Double-Blind Phase||0
585478|NCT00525512|1428904|P3|STARTED|Double-Blind Phase||0
585479|NCT00525512|1428905|P2|STARTED|Double-Blind Phase||260
585480|NCT00525512|1428906|P1|STARTED|Double-Blind Phase||259
585481|NCT00525499|1429048|P4|NOT COMPLETED|Overall Study||7
585482|NCT00525499|1429049|P3|NOT COMPLETED|Overall Study||7
585483|NCT00525499|1429050|P2|NOT COMPLETED|Overall Study||7
585484|NCT00525499|1429051|P1|NOT COMPLETED|Overall Study||7
585485|NCT00525499|1429048|P4|COMPLETED|Overall Study||39
585486|NCT00525499|1429049|P3|COMPLETED|Overall Study||40
585487|NCT00525499|1429050|P2|COMPLETED|Overall Study||39
585488|NCT00525499|1429051|P1|COMPLETED|Overall Study||40
585489|NCT00525499|1429048|P4|STARTED|Overall Study||46
585490|NCT00525499|1429049|P3|STARTED|Overall Study||47
585491|NCT00525499|1429050|P2|STARTED|Overall Study||46
585492|NCT00525499|1429051|P1|STARTED|Overall Study||47
585493|NCT00525421|1429067|P2|NOT COMPLETED|Overall Study||0
585494|NCT00525421|1429068|P1|NOT COMPLETED|Overall Study||0
585495|NCT00525421|1429067|P2|COMPLETED|Overall Study||10
585496|NCT00525421|1429068|P1|COMPLETED|Overall Study||10
585497|NCT00525421|1429067|P2|STARTED|Overall Study||10
585498|NCT00525421|1429068|P1|STARTED|Overall Study|Enrollment started october 2007|10
585499|NCT00525265|1429078|P2|NOT COMPLETED|Overall Study||0
585500|NCT00525265|1429079|P1|NOT COMPLETED|Overall Study||1
585501|NCT00525265|1429078|P2|COMPLETED|Overall Study||10
585502|NCT00525265|1429079|P1|COMPLETED|Overall Study||9
585503|NCT00525265|1429078|P2|STARTED|Overall Study||10
585504|NCT00525265|1429079|P1|STARTED|Overall Study||10
585505|NCT00525174|1429087|P2|NOT COMPLETED|Overall Study||8
585506|NCT00525174|1429088|P1|NOT COMPLETED|Overall Study||9
585507|NCT00525174|1429087|P2|COMPLETED|Overall Study||81
585508|NCT00525174|1429088|P1|COMPLETED|Overall Study||88
585509|NCT00525174|1429087|P2|STARTED|Overall Study||89
585510|NCT00525174|1429088|P1|STARTED|Overall Study||97
585511|NCT00525161|1429136|P1|NOT COMPLETED|Overall Study||1
585512|NCT00525161|1429136|P1|COMPLETED|Overall Study||10
585513|NCT00525161|1429136|P1|STARTED|Overall Study||11
585514|NCT00525148|1429146|P4|NOT COMPLETED|Overall Study||61
585515|NCT00525148|1429147|P3|NOT COMPLETED|Overall Study||7
585516|NCT00525148|1429148|P2|NOT COMPLETED|Overall Study||38
585517|NCT00525148|1429149|P1|NOT COMPLETED|Overall Study||23
585518|NCT00525148|1429146|P4|COMPLETED|Overall Study||0
585519|NCT00525148|1429147|P3|COMPLETED|Overall Study||0
585520|NCT00525148|1429148|P2|COMPLETED|Overall Study||0
585521|NCT00525148|1429149|P1|COMPLETED|Overall Study||0
585522|NCT00525148|1429146|P4|STARTED|Overall Study|entered and treated|61
585523|NCT00525148|1429147|P3|STARTED|Overall Study|entered and treated|7
585524|NCT00525148|1429148|P2|STARTED|Overall Study|entered and treated|38
585525|NCT00525148|1429149|P1|STARTED|Overall Study|entered and treated|23
585526|NCT00525135|1429167|P1|NOT COMPLETED|Overall Study||0
585527|NCT00525135|1429167|P1|COMPLETED|Overall Study||5
585528|NCT00525135|1429167|P1|STARTED|Overall Study||5
585529|NCT00525031|1429177|P2|NOT COMPLETED|Overall Study||1
585530|NCT00525031|1429178|P1|NOT COMPLETED|Overall Study||1
585531|NCT00525031|1429177|P2|COMPLETED|Overall Study||24
585532|NCT00525031|1429178|P1|COMPLETED|Overall Study||26
585533|NCT00525031|1429177|P2|STARTED|Overall Study||25
585534|NCT00525031|1429178|P1|STARTED|Overall Study||27
585535|NCT00524940|1429185|P1|NOT COMPLETED|Overall Study||0
585536|NCT00524940|1429185|P1|COMPLETED|Overall Study||124
585537|NCT00524940|1429185|P1|STARTED|Overall Study||124
585538|NCT00524771|1429192|P2|NOT COMPLETED|Overall Study||585
585539|NCT00524771|1429193|P1|NOT COMPLETED|Overall Study||220
585540|NCT00524771|1429192|P2|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 4.0 years.|16431
585541|NCT00524771|1429193|P1|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 4.0 years.|16864
585542|NCT00524771|1429192|P2|STARTED|Overall Study||17016
585543|NCT00524771|1429193|P1|STARTED|Overall Study||17084
585544|NCT00524745|1429207|P4|NOT COMPLETED|Overall Study||22
585545|NCT00524745|1429208|P3|NOT COMPLETED|Overall Study||29
585546|NCT00524745|1429209|P2|NOT COMPLETED|Overall Study||13
585547|NCT00524745|1429210|P1|NOT COMPLETED|Overall Study||34
585548|NCT00524745|1429207|P4|COMPLETED|Overall Study||205
585549|NCT00524745|1429208|P3|COMPLETED|Overall Study||212
585550|NCT00524745|1429209|P2|COMPLETED|Overall Study||193
585551|NCT00524745|1429210|P1|COMPLETED|Overall Study||195
585552|NCT00524745|1429207|P4|STARTED|Overall Study||227
585553|NCT00524745|1429208|P3|STARTED|Overall Study||241
585554|NCT00524745|1429209|P2|STARTED|Overall Study||206
585555|NCT00524745|1429210|P1|STARTED|Overall Study||229
585556|NCT00524680|1429236|P4|NOT COMPLETED|Overall Study||6
585557|NCT00524680|1429237|P3|NOT COMPLETED|Overall Study||3
585558|NCT00524680|1429238|P2|NOT COMPLETED|Overall Study||1
585559|NCT00524680|1429239|P1|NOT COMPLETED|Overall Study||3
585560|NCT00524680|1429236|P4|COMPLETED|Overall Study||34
585561|NCT00524680|1429237|P3|COMPLETED|Overall Study||33
585562|NCT00524680|1429238|P2|COMPLETED|Overall Study||34
585563|NCT00524680|1429239|P1|COMPLETED|Overall Study||34
585564|NCT00524680|1429236|P4|STARTED|Overall Study||40
585565|NCT00524680|1429237|P3|STARTED|Overall Study||36
585566|NCT00524680|1429238|P2|STARTED|Overall Study||35
585567|NCT00524680|1429239|P1|STARTED|Overall Study||37
585568|NCT00524589|1429261|P1|NOT COMPLETED|Overall Study||18
585569|NCT00524589|1429261|P1|COMPLETED|Overall Study||0
585570|NCT00524589|1429261|P1|STARTED|Overall Study||18
585571|NCT00524576|1429268|P2|NOT COMPLETED|Overall Study||0
585572|NCT00524576|1429269|P1|NOT COMPLETED|Overall Study||0
585573|NCT00524576|1429268|P2|COMPLETED|Overall Study||47
585574|NCT00524576|1429269|P1|COMPLETED|Overall Study||97
585575|NCT00524576|1429268|P2|STARTED|Overall Study||47
585576|NCT00524576|1429269|P1|STARTED|Overall Study||97
585577|NCT00524537|1429287|P1|NOT COMPLETED|Overall Study||2574
585578|NCT00524537|1429287|P1|COMPLETED|Overall Study|Still enrolled in study at the end of study|2451
585579|NCT00524537|1429287|P1|Discontinued After Re-enrollment|Overall Study|Discontinued from study after re-enrollment|102
585580|NCT00524537|1429287|P1|Re-enrolled|Overall Study|Discontinued from study and later re-enrolled in study|339
585581|NCT00524537|1429287|P1|Discontinued|Overall Study|Discontinued from study|2811
585582|NCT00524537|1429287|P1|STARTED|Overall Study|All Treated Population: All participants who received at least 1 injection of Humira in the registry|5025
585583|NCT00524511|1429303|P2|NOT COMPLETED|Overall Study||7
585584|NCT00524511|1429304|P1|NOT COMPLETED|Overall Study||4
585585|NCT00524511|1429303|P2|COMPLETED|Overall Study||61
585586|NCT00524511|1429304|P1|COMPLETED|Overall Study||64
585587|NCT00524511|1429303|P2|STARTED|Overall Study||68
585588|NCT00524511|1429304|P1|STARTED|Overall Study||68
585589|NCT00524485|1429312|P1|NOT COMPLETED|Overall Study||5
585590|NCT00524485|1429312|P1|COMPLETED|Overall Study||7
585591|NCT00524485|1429312|P1|STARTED|Overall Study||12
585592|NCT00524459|1429322|P1|NOT COMPLETED|Overall Study||2
585593|NCT00524459|1429322|P1|COMPLETED|Overall Study||4
585594|NCT00524459|1429322|P1|STARTED|Overall Study||6
585595|NCT00524420|1429332|P2|NOT COMPLETED|Overall Study||0
585596|NCT00524420|1429333|P1|NOT COMPLETED|Overall Study||1
585597|NCT00524420|1429332|P2|COMPLETED|Overall Study||11
585598|NCT00524420|1429333|P1|COMPLETED|Overall Study|1 dropped out after treatment 10 because of poor response and was included in the efficacy analyses.|7
585599|NCT00524420|1429332|P2|STARTED|Overall Study||11
585600|NCT00524420|1429333|P1|STARTED|Overall Study|One was incorrectly randomized;she did not have a BIRS of >7. Was excluded from efficacy analysis.|8
585601|NCT00524394|1429345|P1|NOT COMPLETED|Overall Study||1
585602|NCT00524394|1429345|P1|COMPLETED|Overall Study||1
585603|NCT00524394|1429345|P1|STARTED|Overall Study||2
585604|NCT00524368|1429351|P2|NOT COMPLETED|Overall Study||48
585605|NCT00524368|1429352|P1|NOT COMPLETED|Overall Study||41
585606|NCT00524368|1429351|P2|COMPLETED|Overall Study||248
585607|NCT00524368|1429352|P1|COMPLETED|Overall Study||253
585608|NCT00524368|1429351|P2|STARTED|Overall Study||296
585609|NCT00524368|1429352|P1|STARTED|Overall Study||294
585610|NCT00524342|1429380|P1|NOT COMPLETED|Overall Study||0
585611|NCT00524342|1429380|P1|COMPLETED|Overall Study||7
585612|NCT00524342|1429380|P1|STARTED|Overall Study||7
585613|NCT00524316|1429386|P1|NOT COMPLETED|Overall Study||16
585614|NCT00524316|1429386|P1|COMPLETED|Overall Study||0
585615|NCT00524316|1429386|P1|STARTED|Overall Study||16
585616|NCT00524303|1429398|P3|NOT COMPLETED|Overall Study||18
585617|NCT00524303|1429399|P2|NOT COMPLETED|Overall Study||10
585618|NCT00524303|1429400|P1|NOT COMPLETED|Overall Study||12
585619|NCT00524303|1429398|P3|COMPLETED|Overall Study||15
585620|NCT00524303|1429399|P2|COMPLETED|Overall Study||24
585621|NCT00524303|1429400|P1|COMPLETED|Overall Study||21
585622|NCT00524303|1429398|P3|STARTED|Overall Study||33
585623|NCT00524303|1429399|P2|STARTED|Overall Study||34
585624|NCT00524303|1429400|P1|STARTED|Overall Study||33
585625|NCT00524264|1429430|P2|NOT COMPLETED|Overall Study||27
585626|NCT00524264|1429431|P1|NOT COMPLETED|Overall Study||20
585627|NCT00524264|1429430|P2|COMPLETED|Overall Study||57
585628|NCT00524264|1429431|P1|COMPLETED|Overall Study||144
585629|NCT00524264|1429430|P2|STARTED|Overall Study||84
585630|NCT00524264|1429431|P1|STARTED|Overall Study||164
585631|NCT00524225|1429443|P1|NOT COMPLETED|Overall Study||0
585632|NCT00524225|1429443|P1|COMPLETED|Overall Study||3
585633|NCT00524225|1429443|P1|STARTED|Overall Study||3
585634|NCT00524173|1429452|P2|NOT COMPLETED|Overall Study||2
585635|NCT00524173|1429453|P1|NOT COMPLETED|Overall Study||5
585636|NCT00524173|1429452|P2|COMPLETED|Overall Study||13
585637|NCT00524173|1429453|P1|COMPLETED|Overall Study||12
585638|NCT00524173|1429452|P2|STARTED|Overall Study||15
585639|NCT00524173|1429453|P1|STARTED|Overall Study||17
585640|NCT00524134|1429465|P1|NOT COMPLETED|Overall Study||2
585641|NCT00524134|1429465|P1|COMPLETED|Overall Study||4
585642|NCT00524134|1429465|P1|STARTED|Overall Study||6
585643|NCT00524121|1429472|P1|NOT COMPLETED|Overall Study||19
585644|NCT00524121|1429472|P1|COMPLETED|Overall Study||3
585645|NCT00524121|1429472|P1|STARTED|Overall Study||22
585646|NCT00524043|1429492|P3|NOT COMPLETED|Overall Study||31
585647|NCT00524043|1429493|P2|NOT COMPLETED|Overall Study||28
585648|NCT00524043|1429494|P1|NOT COMPLETED|Overall Study||30
585649|NCT00524043|1429492|P3|COMPLETED|Overall Study||35
585650|NCT00524043|1429493|P2|COMPLETED|Overall Study||42
585651|NCT00524043|1429494|P1|COMPLETED|Overall Study||34
585652|NCT00524043|1429492|P3|STARTED|Overall Study||66
585653|NCT00524043|1429493|P2|STARTED|Overall Study||70
585654|NCT00524043|1429494|P1|STARTED|Overall Study|One patient was randomly assigned to treatment but did not receive placebo.|64
585655|NCT00524030|1429516|P2|NOT COMPLETED|Overall Study||59
585656|NCT00524030|1429517|P1|NOT COMPLETED|Overall Study||17
585657|NCT00524030|1429516|P2|COMPLETED|Overall Study||70
585658|NCT00524030|1429517|P1|COMPLETED|Overall Study||15
585659|NCT00524030|1429516|P2|Completed Taper/Titration Phase|Overall Study||70
585660|NCT00524030|1429517|P1|Completed Taper/Titration Phase|Overall Study||15
585661|NCT00524030|1429516|P2|Completed Double-Blind Treatment Phase|Overall Study||70
585662|NCT00524030|1429517|P1|Completed Double-Blind Treatment Phase|Overall Study||15
585663|NCT00524030|1429516|P2|STARTED|Overall Study||129
585664|NCT00524030|1429517|P1|STARTED|Overall Study||32
585665|NCT00523991|1429535|P2|NOT COMPLETED|Overall Study||27
585666|NCT00523991|1429536|P1|NOT COMPLETED|Overall Study||21
585667|NCT00523991|1429535|P2|COMPLETED|Overall Study||211
585668|NCT00523991|1429536|P1|COMPLETED|Overall Study||198
585669|NCT00523991|1429535|P2|STARTED|Overall Study||238
585670|NCT00523991|1429536|P1|STARTED|Overall Study||219
585671|NCT00523978|1429816|P2|NOT COMPLETED|Overall Study||8
585672|NCT00523978|1429817|P1|NOT COMPLETED|Overall Study||9
585673|NCT00523978|1429816|P2|COMPLETED|Overall Study||79
585674|NCT00523978|1429817|P1|COMPLETED|Overall Study||162
585675|NCT00523978|1429816|P2|STARTED|Overall Study||87
585676|NCT00523978|1429817|P1|STARTED|Overall Study||171
585677|NCT00523939|1429831|P2|NOT COMPLETED|Overall Study||0
585678|NCT00523939|1429832|P1|NOT COMPLETED|Overall Study||0
585679|NCT00523939|1429831|P2|COMPLETED|Overall Study||2
585680|NCT00523939|1429832|P1|COMPLETED|Overall Study||2
585681|NCT00523939|1429831|P2|STARTED|Overall Study||2
585682|NCT00523939|1429832|P1|STARTED|Overall Study||2
585683|NCT00523848|1429839|P1|NOT COMPLETED|Overall Study||24
585684|NCT00523848|1429839|P1|COMPLETED|Overall Study||22
585685|NCT00523848|1429839|P1|Treated With Study Therapy|Overall Study||44
585686|NCT00523848|1429839|P1|STARTED|Overall Study||46
585687|NCT00523809|1429845|P1|NOT COMPLETED|Overall Study||0
585688|NCT00523809|1429845|P1|COMPLETED|Overall Study||5
585689|NCT00523809|1429845|P1|STARTED|Overall Study||5
585690|NCT00523744|1429849|P1|NOT COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||0
585691|NCT00523744|1429849|P1|COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||91
585692|NCT00523744|1429849|P1|STARTED|Phase 3 - Amlodipine+Valsartan+HCTZ|Only patients with systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg at the end of Phase 2.|91
585693|NCT00523744|1429849|P1|NOT COMPLETED|Phase 2 - Amlodipine+Valsartan||3
585694|NCT00523744|1429849|P1|COMPLETED|Phase 2 - Amlodipine+Valsartan||173
585695|NCT00523744|1429849|P1|STARTED|Phase 2 - Amlodipine+Valsartan|Only patients with mean sitting diastolic BP ≥ 90 mmHg at the end of Phase 1 entered this phase.|176
585696|NCT00523744|1429849|P1|NOT COMPLETED|Phase 1 - Amlodipine+Olmesartan||6
585697|NCT00523744|1429849|P1|COMPLETED|Phase 1 - Amlodipine+Olmesartan||251
585698|NCT00523744|1429849|P1|STARTED|Phase 1 - Amlodipine+Olmesartan||257
585699|NCT00523718|1429868|P2|NOT COMPLETED|Overall Study||0
585700|NCT00523718|1429869|P1|NOT COMPLETED|Overall Study||3
585701|NCT00523718|1429868|P2|COMPLETED|Overall Study||18
585702|NCT00523718|1429869|P1|COMPLETED|Overall Study||17
585703|NCT00523718|1429868|P2|STARTED|Overall Study||18
585704|NCT00523718|1429869|P1|STARTED|Overall Study||20
585705|NCT00523705|1429883|P2|NOT COMPLETED|Overall Study||1
585706|NCT00523705|1429884|P1|NOT COMPLETED|Overall Study||0
585707|NCT00523705|1429883|P2|COMPLETED|Overall Study|1 withdrew due to no time|3
585708|NCT00523705|1429884|P1|COMPLETED|Overall Study||7
585709|NCT00523705|1429883|P2|STARTED|Overall Study||4
585710|NCT00523705|1429884|P1|STARTED|Overall Study||7
585711|NCT00523640|1429896|P1|NOT COMPLETED|Overall Study||1
585712|NCT00523640|1429896|P1|COMPLETED|Overall Study|1 patient died before starting treatment|29
585713|NCT00523640|1429896|P1|STARTED|Overall Study||30
585714|NCT00523614|1429904|P2|NOT COMPLETED|Overall Study||0
585715|NCT00523614|1429905|P1|NOT COMPLETED|Overall Study||0
585716|NCT00523614|1429904|P2|COMPLETED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|2720
585717|NCT00523614|1429905|P1|COMPLETED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|680
585718|NCT00523614|1429904|P2|STARTED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|2720
585719|NCT00523614|1429905|P1|STARTED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|680
585720|NCT00523549|1429913|P2|NOT COMPLETED|Overall Study||16
585721|NCT00523549|1429914|P1|NOT COMPLETED|Overall Study||19
585722|NCT00523549|1429913|P2|COMPLETED|Overall Study||99
585723|NCT00523549|1429914|P1|COMPLETED|Overall Study||95
585724|NCT00523549|1429913|P2|STARTED|Overall Study||115
585725|NCT00523549|1429914|P1|STARTED|Overall Study||114
585726|NCT00523419|1429932|P1|NOT COMPLETED|Overall Study||32
585727|NCT00523419|1429932|P1|COMPLETED|Overall Study||0
585728|NCT00523419|1429932|P1|STARTED|Overall Study||32
585729|NCT00523367|1429942|P1|NOT COMPLETED|Overall Study||23
585730|NCT00523367|1429942|P1|COMPLETED|Overall Study||2
585731|NCT00523367|1429942|P1|STARTED|Overall Study||25
585732|NCT00523341|1429948|P2|NOT COMPLETED|Overall Study||1000
585733|NCT00523341|1429949|P1|NOT COMPLETED|Overall Study||924
585734|NCT00523341|1429948|P2|COMPLETED|Overall Study||1343
585735|NCT00523341|1429949|P1|COMPLETED|Overall Study||1283
585736|NCT00523341|1429948|P2|Received Treatment|Overall Study||2343
585737|NCT00523341|1429949|P1|Received Treatment|Overall Study||2206
585738|NCT00523341|1429948|P2|STARTED|Overall Study||2343
585739|NCT00523341|1429949|P1|STARTED|Overall Study||2207
585740|NCT00523237|1430049|P1|NOT COMPLETED|Overall Study||0
585741|NCT00523237|1430049|P1|COMPLETED|Overall Study||14
585742|NCT00523237|1430049|P1|STARTED|Overall Study||14
585743|NCT00522951|1430053|P2|NOT COMPLETED|Period 2||1
585744|NCT00522951|1430054|P1|NOT COMPLETED|Period 2||2
585745|NCT00522951|1430053|P2|COMPLETED|Period 2||75
585746|NCT00522951|1430054|P1|COMPLETED|Period 2||84
585747|NCT00522951|1430053|P2|Subjects Received Treatment|Period 2||75
585748|NCT00522951|1430054|P1|Subjects Received Treatment|Period 2||84
585749|NCT00522951|1430053|P2|STARTED|Period 2||76
585750|NCT00522951|1430054|P1|STARTED|Period 2||86
585751|NCT00522951|1430053|P2|NOT COMPLETED|Washout Period||2
585752|NCT00522951|1430054|P1|NOT COMPLETED|Washout Period||0
585753|NCT00522951|1430053|P2|COMPLETED|Washout Period||76
585754|NCT00522951|1430054|P1|COMPLETED|Washout Period||86
585755|NCT00522951|1430053|P2|STARTED|Washout Period||78
585756|NCT00522951|1430054|P1|STARTED|Washout Period||86
585757|NCT00522951|1430053|P2|NOT COMPLETED|Period 1||1
585758|NCT00522951|1430054|P1|NOT COMPLETED|Period 1||0
585759|NCT00522951|1430053|P2|COMPLETED|Period 1||78
585760|NCT00522951|1430054|P1|COMPLETED|Period 1||86
585761|NCT00522951|1430053|P2|Received Treatment|Period 1||78
585762|NCT00522951|1430054|P1|Received Treatment|Period 1||86
585763|NCT00522951|1430053|P2|STARTED|Period 1||79
585764|NCT00522951|1430054|P1|STARTED|Period 1||86
585765|NCT00522925|1430097|P3|NOT COMPLETED|Overall Study||2
585766|NCT00522925|1430098|P2|NOT COMPLETED|Overall Study||1
585767|NCT00522925|1430099|P1|NOT COMPLETED|Overall Study||8
585768|NCT00522925|1430097|P3|COMPLETED|Overall Study||36
585769|NCT00522925|1430098|P2|COMPLETED|Overall Study||38
585770|NCT00522925|1430099|P1|COMPLETED|Overall Study||28
585771|NCT00522925|1430097|P3|STARTED|Overall Study||38
585772|NCT00522925|1430098|P2|STARTED|Overall Study||39
585773|NCT00522925|1430099|P1|STARTED|Overall Study||36
585774|NCT00522873|1430109|P2|NOT COMPLETED|Overall Study||44
585775|NCT00522873|1430110|P1|NOT COMPLETED|Overall Study||96
585776|NCT00522873|1430109|P2|COMPLETED|Overall Study|128 women completed study medication. 129 women completed the study.|128
585777|NCT00522873|1430110|P1|COMPLETED|Overall Study|394 women completed study medication. 398 women completed the study.|394
585778|NCT00522873|1430109|P2|Received Treatment|Overall Study||172
585779|NCT00522873|1430110|P1|Received Treatment|Overall Study||489
585780|NCT00522873|1430109|P2|STARTED|Overall Study||172
585781|NCT00522873|1430110|P1|STARTED|Overall Study||490
585782|NCT00522795|1430119|P1|NOT COMPLETED|Overall Study||0
585783|NCT00522795|1430119|P1|COMPLETED|Overall Study||40
585784|NCT00522795|1430119|P1|STARTED|Overall Study||40
585785|NCT00522626|1430123|P1|NOT COMPLETED|Overall Study||7
585786|NCT00522626|1430123|P1|COMPLETED|Overall Study||12
585787|NCT00522626|1430123|P1|STARTED|Overall Study||19
585788|NCT00522548|1430129|P2|NOT COMPLETED|Overall Study||4
585789|NCT00522548|1430130|P1|NOT COMPLETED|Overall Study||2
585790|NCT00522548|1430129|P2|COMPLETED|Overall Study||15
585791|NCT00522548|1430130|P1|COMPLETED|Overall Study||16
585792|NCT00522548|1430129|P2|Completed 2/2 PK Visits|Overall Study||5
585793|NCT00522548|1430130|P1|Completed 2/2 PK Visits|Overall Study||7
585794|NCT00522548|1430129|P2|Completed 1/2 PK Visits|Overall Study||1
585795|NCT00522548|1430130|P1|Completed 1/2 PK Visits|Overall Study||1
585796|NCT00522548|1430129|P2|Completed 0/2 PK Visits|Overall Study||4
585797|NCT00522548|1430130|P1|Completed 0/2 PK Visits|Overall Study||3
585798|NCT00522548|1430129|P2|Consented to Pharmacokinetic Study|Overall Study||10
585799|NCT00522548|1430130|P1|Consented to Pharmacokinetic Study|Overall Study||11
585800|NCT00522548|1430129|P2|STARTED|Overall Study||19
585801|NCT00522548|1430130|P1|STARTED|Overall Study||18
585802|NCT00522457|1430158|P1|NOT COMPLETED|Overall Study||18
585803|NCT00522457|1430158|P1|COMPLETED|Overall Study||1
585804|NCT00522457|1430158|P1|STARTED|Overall Study||19
585805|NCT00522431|1430164|P1|NOT COMPLETED|Overall Study||11
585806|NCT00522431|1430164|P1|COMPLETED|Overall Study||138
585807|NCT00522431|1430164|P1|STARTED|Overall Study||149
585808|NCT00522418|1430171|P2|NOT COMPLETED|Overall Study||58
585809|NCT00522418|1430172|P1|NOT COMPLETED|Overall Study||57
585810|NCT00522418|1430171|P2|COMPLETED|Overall Study|Completed 2-year follow-up|5
585811|NCT00522418|1430172|P1|COMPLETED|Overall Study|Completed 2-year follow-up|2
585812|NCT00522418|1430171|P2|Baseline and Month 12|Overall Study|Completed Baseline and Month 12|29
585813|NCT00522418|1430172|P1|Baseline and Month 12|Overall Study|Completed Baseline and Month 12|31
585814|NCT00522418|1430171|P2|Baseline and Month 9|Overall Study|Completed Baseline and Month 9|35
585815|NCT00522418|1430172|P1|Baseline and Month 9|Overall Study|Completed Baseline and Month 9|33
585816|NCT00522418|1430171|P2|Baseline and Month 6|Overall Study|Completed Baseline and Month 6|45
585817|NCT00522418|1430172|P1|Baseline and Month 6|Overall Study|Completed Baseline and Month 6|38
585818|NCT00522418|1430171|P2|Baseline and Month 3|Overall Study|Completed Baseline and Month 3|47
585819|NCT00522418|1430172|P1|Baseline and Month 3|Overall Study|Completed Baseline and Month 3|47
585820|NCT00522418|1430171|P2|Efficacy Set|Overall Study|10 pts. data excluded: exited prior to collection of baseline data & one postbaseline followup QOLIE|48
585821|NCT00522418|1430172|P1|Efficacy Set|Overall Study|6 pts. data excluded: exited prior to collection of baseline data & one postbaseline followup QOLIE|48
585822|NCT00522418|1430171|P2|Safety Set|Overall Study|Data of 5 randomized patients removed due to lack of ICF approval by site’s local ethics committee.|58
585823|NCT00522418|1430172|P1|Safety Set|Overall Study|Data of 5 randomized patients removed due to lack of ICF approval by site’s local ethics committee.|54
585824|NCT00522418|1430171|P2|STARTED|Overall Study||63
585825|NCT00522418|1430172|P1|STARTED|Overall Study||59
585826|NCT00522392|1430220|P2|NOT COMPLETED|Overall Study||13
585827|NCT00522392|1430221|P1|NOT COMPLETED|Overall Study||8
585828|NCT00522392|1430220|P2|COMPLETED|Overall Study||12
585829|NCT00522392|1430221|P1|COMPLETED|Overall Study||15
585830|NCT00522392|1430220|P2|Pts w/ QOL Assessments Complete|Overall Study||8
585831|NCT00522392|1430221|P1|Pts w/ QOL Assessments Complete|Overall Study||12
585832|NCT00522392|1430220|P2|Pts w/ Measurable Disease at Baseline|Overall Study||16
585833|NCT00522392|1430221|P1|Pts w/ Measurable Disease at Baseline|Overall Study||16
585834|NCT00522392|1430220|P2|STARTED|Overall Study||25
585835|NCT00522392|1430221|P1|STARTED|Overall Study||23
585836|NCT00522379|1430238|P5|NOT COMPLETED|Overall Study||27
585837|NCT00522379|1430239|P4|NOT COMPLETED|Overall Study||14
585838|NCT00522379|1430240|P3|NOT COMPLETED|Overall Study||22
585839|NCT00522379|1430241|P2|NOT COMPLETED|Overall Study||23
585840|NCT00522379|1430242|P1|NOT COMPLETED|Overall Study||22
585841|NCT00522379|1430238|P5|COMPLETED|Overall Study||81
585842|NCT00522379|1430239|P4|COMPLETED|Overall Study||80
585843|NCT00522379|1430240|P3|COMPLETED|Overall Study||82
585844|NCT00522379|1430241|P2|COMPLETED|Overall Study||84
585845|NCT00522379|1430242|P1|COMPLETED|Overall Study||79
585846|NCT00522379|1430238|P5|STARTED|Overall Study||108
585847|NCT00522379|1430239|P4|STARTED|Overall Study||94
585848|NCT00522379|1430240|P3|STARTED|Overall Study||104
585849|NCT00522379|1430241|P2|STARTED|Overall Study||107
585850|NCT00522379|1430242|P1|STARTED|Overall Study||101
585851|NCT00522301|1430344|P1|NOT COMPLETED|Overall Study||6
585852|NCT00522301|1430344|P1|COMPLETED|Overall Study||0
585853|NCT00522301|1430344|P1|STARTED|Overall Study||6
585854|NCT00522275|1430348|P1|NOT COMPLETED|Overall Study||170
585855|NCT00522275|1430348|P1|COMPLETED|Overall Study||138
585856|NCT00522275|1430348|P1|STARTED|Overall Study||308
585857|NCT00522171|1430358|P2|NOT COMPLETED|Overall Study||0
585858|NCT00522171|1430359|P1|NOT COMPLETED|Overall Study||0
585859|NCT00522171|1430358|P2|COMPLETED|Overall Study||15
585860|NCT00522171|1430359|P1|COMPLETED|Overall Study||15
585861|NCT00522171|1430358|P2|STARTED|Overall Study||15
585862|NCT00522171|1430359|P1|STARTED|Overall Study||15
585863|NCT00522041|1430369|P2|NOT COMPLETED|Overall Study||12
585864|NCT00522041|1430370|P1|NOT COMPLETED|Overall Study||17
585865|NCT00522041|1430369|P2|COMPLETED|Overall Study||113
585866|NCT00522041|1430370|P1|COMPLETED|Overall Study||106
585867|NCT00522041|1430369|P2|Received Treatment|Overall Study||124
585868|NCT00522041|1430370|P1|Received Treatment|Overall Study||123
585869|NCT00522041|1430369|P2|STARTED|Overall Study||125
585870|NCT00522041|1430370|P1|STARTED|Overall Study||123
585871|NCT00521989|1430385|P5|NOT COMPLETED|Overall Study||23
585872|NCT00521989|1430386|P4|NOT COMPLETED|Overall Study||12
585873|NCT00521989|1430387|P3|NOT COMPLETED|Overall Study||16
585874|NCT00521989|1430388|P2|NOT COMPLETED|Overall Study||17
585875|NCT00521989|1430389|P1|NOT COMPLETED|Overall Study||20
585876|NCT00521989|1430385|P5|COMPLETED|Overall Study||35
585877|NCT00521989|1430386|P4|COMPLETED|Overall Study||42
585878|NCT00521989|1430387|P3|COMPLETED|Overall Study||41
585879|NCT00521989|1430388|P2|COMPLETED|Overall Study||37
585880|NCT00521989|1430389|P1|COMPLETED|Overall Study||36
585881|NCT00521989|1430385|P5|STARTED|Overall Study||58
585882|NCT00521989|1430386|P4|STARTED|Overall Study||54
585883|NCT00521989|1430387|P3|STARTED|Overall Study||57
585884|NCT00521989|1430388|P2|STARTED|Overall Study||54
585885|NCT00521989|1430389|P1|STARTED|Overall Study||56
585886|NCT00521976|1430401|P1|NOT COMPLETED|Overall Study||0
585887|NCT00521976|1430401|P1|COMPLETED|Overall Study||871
585888|NCT00521976|1430401|P1|STARTED|Overall Study||871
585889|NCT00521924|1430408|P2|NOT COMPLETED|Overall Study||4
585890|NCT00521924|1430409|P1|NOT COMPLETED|Overall Study||4
585891|NCT00521924|1430408|P2|COMPLETED|Overall Study|At Early Termination, 3 patients completed Week 6 and 1 completed Week 22.|0
585892|NCT00521924|1430409|P1|COMPLETED|Overall Study|At Early Termination, 1 patient completed Week 2 and 2 patients completed Week 6.|0
585893|NCT00521924|1430408|P2|STARTED|Overall Study|Subjects randomized|4
585894|NCT00521924|1430409|P1|STARTED|Overall Study|Subjects randomized|4
585895|NCT00521885|1430417|P2|NOT COMPLETED|Overall Study||0
585896|NCT00521885|1430418|P1|NOT COMPLETED|Overall Study||0
585897|NCT00521885|1430417|P2|COMPLETED|Overall Study||0
585898|NCT00521885|1430418|P1|COMPLETED|Overall Study||0
585899|NCT00521885|1430417|P2|STARTED|Overall Study||0
585900|NCT00521885|1430418|P1|STARTED|Overall Study||0
585901|NCT00521599|1430429|P3|NOT COMPLETED|Overall Study||36
585902|NCT00521599|1430430|P2|NOT COMPLETED|Overall Study||29
585903|NCT00521599|1430431|P1|NOT COMPLETED|Overall Study||25
585904|NCT00521599|1430429|P3|COMPLETED|Overall Study||100
585905|NCT00521599|1430430|P2|COMPLETED|Overall Study||239
585906|NCT00521599|1430431|P1|COMPLETED|Overall Study||243
585907|NCT00521599|1430429|P3|STARTED|Overall Study||136
585908|NCT00521599|1430430|P2|STARTED|Overall Study||268
585909|NCT00521599|1430431|P1|STARTED|Overall Study||268
585910|NCT00521586|1430442|P2|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||12
585911|NCT00521586|1430443|P1|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||3
585912|NCT00521586|1430442|P2|COMPLETED|Revaccination With 13vPnC (Year 5)||351
585913|NCT00521586|1430443|P1|COMPLETED|Revaccination With 13vPnC (Year 5)||361
585914|NCT00521586|1430442|P2|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||351
585915|NCT00521586|1430443|P1|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||361
585916|NCT00521586|1430442|P2|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||359
585917|NCT00521586|1430443|P1|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||363
585918|NCT00521586|1430442|P2|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||363
585919|NCT00521586|1430443|P1|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||364
585920|NCT00521586|1430442|P2|STARTED|Revaccination With 13vPnC (Year 5)||363
585921|NCT00521586|1430443|P1|STARTED|Revaccination With 13vPnC (Year 5)||364
585922|NCT00521586|1430442|P2|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||170
585923|NCT00521586|1430443|P1|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||169
585924|NCT00521586|1430442|P2|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||363
585925|NCT00521586|1430443|P1|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||364
585926|NCT00521586|1430442|P2|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533
585927|NCT00521586|1430443|P1|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533
585928|NCT00521586|1430442|P2|NOT COMPLETED|Initial Vaccination (Year 0)||29
585929|NCT00521586|1430443|P1|NOT COMPLETED|Initial Vaccination (Year 0)||21
585930|NCT00521586|1430442|P2|COMPLETED|Initial Vaccination (Year 0)|6 additional participants initially reported to have withdrawn, actually completed follow-up(Year 0)|533
585931|NCT00521586|1430443|P1|COMPLETED|Initial Vaccination (Year 0)|6 additional participants initially reported to have withdrawn, actually completed follow-up(Year 0)|533
585932|NCT00521586|1430442|P2|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)|Initially 1060 participants were reported to complete follow-up(Year 0),but 1066 actually completed.|529
585933|NCT00521586|1430443|P1|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)|Initially 1060 participants were reported to complete follow-up(Year 0),but 1066 actually completed.|531
585934|NCT00521586|1430442|P2|Vaccinated Dose 2|Initial Vaccination (Year 0)||543
585935|NCT00521586|1430443|P1|Vaccinated Dose 2|Initial Vaccination (Year 0)||538
585936|NCT00521586|1430442|P2|Vaccinated Dose 1|Initial Vaccination (Year 0)||560
585937|NCT00521586|1430443|P1|Vaccinated Dose 1|Initial Vaccination (Year 0)||551
585938|NCT00521586|1430442|P2|STARTED|Initial Vaccination (Year 0)||562
585939|NCT00521586|1430443|P1|STARTED|Initial Vaccination (Year 0)||554
585940|NCT00521456|1430503|P2|NOT COMPLETED|Overall Study||28
585941|NCT00521456|1430504|P1|NOT COMPLETED|Overall Study||13
585942|NCT00521456|1430503|P2|COMPLETED|Overall Study||59
585943|NCT00521456|1430504|P1|COMPLETED|Overall Study||163
585944|NCT00521456|1430503|P2|STARTED|Overall Study||87
585945|NCT00521456|1430504|P1|STARTED|Overall Study||176
585946|NCT00521365|1430516|P1|NOT COMPLETED|Overall Study||20
585947|NCT00521365|1430516|P1|COMPLETED|Overall Study|68 participants completed the study and 68 completed without protocol deviations|68
585948|NCT00521365|1430516|P1|Safety Analysis Set|Overall Study|All participants who received study treatment|88
585949|NCT00521365|1430516|P1|Per Protocol (PP) Population|Overall Study|All participants without protocol deviations|68
586034|NCT00520975|1430669|P1|STARTED|Overall Study||48
586035|NCT00520936|1430701|P8|NOT COMPLETED|Overall Study||1
585950|NCT00521365|1430516|P1|Modified Intention to Treat (mITT)|Overall Study|Participants who have an YMRS assessment at inclusion, and at least one assessment after inclusion|88
585951|NCT00521365|1430516|P1|STARTED|Overall Study|98 participants were screened and obtain 88 patients who receive study treatment|88
585952|NCT00521352|1430535|P2|NOT COMPLETED|Overall Study||3
585953|NCT00521352|1430536|P1|NOT COMPLETED|Overall Study||1
585954|NCT00521352|1430535|P2|COMPLETED|Overall Study||10
585955|NCT00521352|1430536|P1|COMPLETED|Overall Study||11
585956|NCT00521352|1430535|P2|STARTED|Overall Study||13
585957|NCT00521352|1430536|P1|STARTED|Overall Study||12
585958|NCT00521339|1430546|P3|NOT COMPLETED|Observational Follow Up Phase||0
585959|NCT00521339|1430547|P2|NOT COMPLETED|Observational Follow Up Phase||0
585960|NCT00521339|1430548|P1|NOT COMPLETED|Observational Follow Up Phase||0
585961|NCT00521339|1430546|P3|COMPLETED|Observational Follow Up Phase||4
585962|NCT00521339|1430547|P2|COMPLETED|Observational Follow Up Phase||4
585963|NCT00521339|1430548|P1|COMPLETED|Observational Follow Up Phase||14
585964|NCT00521339|1430546|P3|STARTED|Observational Follow Up Phase||4
585965|NCT00521339|1430547|P2|STARTED|Observational Follow Up Phase||4
585966|NCT00521339|1430548|P1|STARTED|Observational Follow Up Phase||14
585967|NCT00521339|1430546|P3|NOT COMPLETED|Treatment Extension Phase||3
585968|NCT00521339|1430547|P2|NOT COMPLETED|Treatment Extension Phase||0
585969|NCT00521339|1430548|P1|NOT COMPLETED|Treatment Extension Phase||0
585970|NCT00521339|1430546|P3|COMPLETED|Treatment Extension Phase||4
585971|NCT00521339|1430547|P2|COMPLETED|Treatment Extension Phase||4
585972|NCT00521339|1430548|P1|COMPLETED|Treatment Extension Phase||0
585973|NCT00521339|1430546|P3|STARTED|Treatment Extension Phase|Some participants had completed the treatment phase prior to inception of extension phase|7
585974|NCT00521339|1430547|P2|STARTED|Treatment Extension Phase|Some participants had completed the treatment phase prior to inception of extension phase|4
585975|NCT00521339|1430548|P1|STARTED|Treatment Extension Phase||0
585976|NCT00521339|1430546|P3|NOT COMPLETED|Treatment Phase||0
585977|NCT00521339|1430547|P2|NOT COMPLETED|Treatment Phase||0
585978|NCT00521339|1430548|P1|NOT COMPLETED|Treatment Phase||12
585979|NCT00521339|1430546|P3|COMPLETED|Treatment Phase||0
585980|NCT00521339|1430547|P2|COMPLETED|Treatment Phase||0
585981|NCT00521339|1430548|P1|COMPLETED|Treatment Phase||19
585982|NCT00521339|1430546|P3|Received Apremilast|Treatment Phase||0
585983|NCT00521339|1430547|P2|Received Apremilast|Treatment Phase||0
585984|NCT00521339|1430548|P1|Received Apremilast|Treatment Phase|1 participant withdrew consent prior to first visit and was excluded from safety population|30
585985|NCT00521339|1430546|P3|STARTED|Treatment Phase||0
585986|NCT00521339|1430547|P2|STARTED|Treatment Phase||0
585987|NCT00521339|1430548|P1|STARTED|Treatment Phase||31
585988|NCT00521144|1430616|P5|NOT COMPLETED|Overall Study||7
585989|NCT00521144|1430617|P4|NOT COMPLETED|Overall Study||1
585990|NCT00521144|1430618|P3|NOT COMPLETED|Overall Study||2
585991|NCT00521144|1430619|P2|NOT COMPLETED|Overall Study||3
585992|NCT00521144|1430620|P1|NOT COMPLETED|Overall Study||4
585993|NCT00521144|1430616|P5|COMPLETED|Overall Study||0
585994|NCT00521144|1430617|P4|COMPLETED|Overall Study||0
585995|NCT00521144|1430618|P3|COMPLETED|Overall Study||1
585996|NCT00521144|1430619|P2|COMPLETED|Overall Study||2
585997|NCT00521144|1430620|P1|COMPLETED|Overall Study||2
585998|NCT00521144|1430616|P5|STARTED|Overall Study||7
585999|NCT00521144|1430617|P4|STARTED|Overall Study||1
586000|NCT00521144|1430618|P3|STARTED|Overall Study||3
586001|NCT00521144|1430619|P2|STARTED|Overall Study||5
586002|NCT00521144|1430620|P1|STARTED|Overall Study||6
586003|NCT00521079|1430634|P2|NOT COMPLETED|Overall Study||5
586004|NCT00521079|1430635|P1|NOT COMPLETED|Overall Study||14
586005|NCT00521079|1430634|P2|COMPLETED|Overall Study||97
586006|NCT00521079|1430635|P1|COMPLETED|Overall Study||178
586007|NCT00521079|1430634|P2|Surgical Roll-In|Overall Study||5
586008|NCT00521079|1430635|P1|Surgical Roll-In|Overall Study||9
586009|NCT00521079|1430634|P2|STARTED|Overall Study||102
586010|NCT00521079|1430635|P1|STARTED|Overall Study||192
586011|NCT00521053|1430645|P1|NOT COMPLETED|Observation Phase||68
586012|NCT00521053|1430645|P1|COMPLETED|Observation Phase||12
586013|NCT00521053|1430645|P1|STARTED|Observation Phase||80
586014|NCT00521053|1430645|P1|NOT COMPLETED|Treatment Phase||0
586015|NCT00521053|1430645|P1|COMPLETED|Treatment Phase||80
586016|NCT00521053|1430645|P1|Received 4 Cycles of PV-10|Treatment Phase||3
586017|NCT00521053|1430645|P1|Received 3 Cycles of PV-10|Treatment Phase||16
586018|NCT00521053|1430645|P1|Received 2 Cycles of PV-10|Treatment Phase||26
586019|NCT00521053|1430645|P1|Received 1 Cycle of PV-10|Treatment Phase||35
586020|NCT00521053|1430645|P1|STARTED|Treatment Phase||80
586021|NCT00521014|1430655|P1|NOT COMPLETED|Overall Study||1
586022|NCT00521014|1430655|P1|COMPLETED|Overall Study||13
586023|NCT00521014|1430655|P1|STARTED|Overall Study||14
586024|NCT00521001|1430659|P1|NOT COMPLETED|Overall Study||1
586025|NCT00521001|1430659|P1|COMPLETED|Overall Study||48
586026|NCT00521001|1430659|P1|STARTED|Overall Study||49
586027|NCT00520975|1430668|P2|NOT COMPLETED|Overall Study||48
586028|NCT00520975|1430669|P1|NOT COMPLETED|Overall Study||48
586029|NCT00520975|1430668|P2|COMPLETED|Overall Study|Treatment continued until progression or intolerable toxicity.|0
586030|NCT00520975|1430669|P1|COMPLETED|Overall Study|Treatment continued until progression or intolerable toxicity.|0
586031|NCT00520975|1430668|P2|Treated and Reported Adverse Events Data|Overall Study||45
586032|NCT00520975|1430669|P1|Treated and Reported Adverse Events Data|Overall Study||47
586033|NCT00520975|1430668|P2|STARTED|Overall Study||48
586036|NCT00520936|1430702|P7|NOT COMPLETED|Overall Study||4
586037|NCT00520936|1430703|P6|NOT COMPLETED|Overall Study||0
586038|NCT00520936|1430704|P5|NOT COMPLETED|Overall Study||1
586039|NCT00520936|1430705|P4|NOT COMPLETED|Overall Study||0
586040|NCT00520936|1430706|P3|NOT COMPLETED|Overall Study||2
586041|NCT00520936|1430707|P2|NOT COMPLETED|Overall Study||4
586042|NCT00520936|1430708|P1|NOT COMPLETED|Overall Study||0
586043|NCT00520936|1430701|P8|COMPLETED|Overall Study||9
586044|NCT00520936|1430702|P7|COMPLETED|Overall Study||7
586045|NCT00520936|1430703|P6|COMPLETED|Overall Study||10
586046|NCT00520936|1430704|P5|COMPLETED|Overall Study||5
586047|NCT00520936|1430705|P4|COMPLETED|Overall Study||5
586048|NCT00520936|1430706|P3|COMPLETED|Overall Study||7
586049|NCT00520936|1430707|P2|COMPLETED|Overall Study||7
586050|NCT00520936|1430708|P1|COMPLETED|Overall Study|Study completion defined as treated until disease progression. Completed=progressive disease.|10
586051|NCT00520936|1430701|P8|STARTED|Overall Study||10
586052|NCT00520936|1430702|P7|STARTED|Overall Study||11
586053|NCT00520936|1430703|P6|STARTED|Overall Study||10
586054|NCT00520936|1430704|P5|STARTED|Overall Study||6
586055|NCT00520936|1430705|P4|STARTED|Overall Study||5
586056|NCT00520936|1430706|P3|STARTED|Overall Study||9
586057|NCT00520936|1430707|P2|STARTED|Overall Study||11
586058|NCT00520936|1430708|P1|STARTED|Overall Study|75 participants entered the study and 72 were enrolled and received study drug.|10
586059|NCT00520845|1430735|P1|NOT COMPLETED|Overall Study||22
586060|NCT00520845|1430735|P1|COMPLETED|Overall Study||1
586061|NCT00520845|1430735|P1|STARTED|Overall Study||23
586062|NCT00520767|1430743|P1|NOT COMPLETED|Overall Study||2
586063|NCT00520767|1430743|P1|COMPLETED|Overall Study||33
586064|NCT00520767|1430743|P1|STARTED|Overall Study||35
586065|NCT00520741|1430749|P2|NOT COMPLETED|Overall Study||125
586066|NCT00520741|1430750|P1|NOT COMPLETED|Overall Study||37
586067|NCT00520741|1430749|P2|COMPLETED|Overall Study||194
586068|NCT00520741|1430750|P1|COMPLETED|Overall Study||69
586069|NCT00520741|1430749|P2|STARTED|Overall Study|One subject was randomized at 2 sites and excluded from the Safety Set.|319
586070|NCT00520741|1430750|P1|STARTED|Overall Study||106
586071|NCT00520676|1430768|P2|NOT COMPLETED|Overall Study||103
586072|NCT00520676|1430769|P1|NOT COMPLETED|Overall Study||101
586073|NCT00520676|1430768|P2|COMPLETED|Overall Study||29
586074|NCT00520676|1430769|P1|COMPLETED|Overall Study||27
586075|NCT00520676|1430768|P2|Qualified Intent-to-treat (Q-ITT)|Overall Study||105
586076|NCT00520676|1430769|P1|Qualified Intent-to-treat (Q-ITT)|Overall Study||106
586077|NCT00520676|1430768|P2|Received at Least 1 Dose of Study Drug|Overall Study||127
586078|NCT00520676|1430769|P1|Received at Least 1 Dose of Study Drug|Overall Study||118
586079|NCT00520676|1430768|P2|STARTED|Overall Study||132
586080|NCT00520676|1430769|P1|STARTED|Overall Study||128
586081|NCT00520572|1430795|P6|NOT COMPLETED|Overall Study||2
586082|NCT00520572|1430796|P5|NOT COMPLETED|Overall Study||12
586083|NCT00520572|1430797|P4|NOT COMPLETED|Overall Study||14
586084|NCT00520572|1430798|P3|NOT COMPLETED|Overall Study||15
586085|NCT00520572|1430799|P2|NOT COMPLETED|Overall Study||14
586086|NCT00520572|1430800|P1|NOT COMPLETED|Overall Study||12
586087|NCT00520572|1430795|P6|COMPLETED|Overall Study|Participants completed the study.|62
586088|NCT00520572|1430796|P5|COMPLETED|Overall Study|Participants completed the study.|53
586089|NCT00520572|1430797|P4|COMPLETED|Overall Study|Participants completed the study.|50
586090|NCT00520572|1430798|P3|COMPLETED|Overall Study|Participants completed the study.|49
586091|NCT00520572|1430799|P2|COMPLETED|Overall Study|Participants completed the study.|50
586092|NCT00520572|1430800|P1|COMPLETED|Overall Study|Participants completed the study.|52
586093|NCT00520572|1430795|P6|STARTED|Overall Study|Participants randomised.|64
586094|NCT00520572|1430796|P5|STARTED|Overall Study|Participants randomised.|65
586095|NCT00520572|1430797|P4|STARTED|Overall Study|Participants randomised.|64
586096|NCT00520572|1430798|P3|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|64
586097|NCT00520572|1430799|P2|STARTED|Overall Study|Participants randomised.|64
586098|NCT00520572|1430800|P1|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|64
586099|NCT00520546|1430838|P1|NOT COMPLETED|Overall Study||6
586100|NCT00520546|1430838|P1|COMPLETED|Overall Study||38
586101|NCT00520546|1430838|P1|STARTED|Overall Study||44
586102|NCT00520494|1430853|P1|NOT COMPLETED|Overall Study||1
586103|NCT00520494|1430853|P1|COMPLETED|Overall Study||17
586104|NCT00520494|1430853|P1|STARTED|Overall Study||18
586105|NCT00520468|1430876|P1|NOT COMPLETED|Overall Study||0
586106|NCT00520468|1430876|P1|COMPLETED|Overall Study||14
586107|NCT00520468|1430876|P1|STARTED|Overall Study||14
586108|NCT00520403|1430880|P1|NOT COMPLETED|Bevacizumab Monotherapy||2
586109|NCT00520403|1430880|P1|COMPLETED|Bevacizumab Monotherapy||0
586110|NCT00520403|1430880|P1|STARTED|Bevacizumab Monotherapy|2 of 7 participants completing Bevacizumab+IFN/vinblastine cycles initiated bevacizumab monotherapy|2
586111|NCT00520403|1430880|P1|NOT COMPLETED|Bevacizumab + IFN/Vinblastine||18
586112|NCT00520403|1430880|P1|COMPLETED|Bevacizumab + IFN/Vinblastine||7
586113|NCT00520403|1430880|P1|STARTED|Bevacizumab + IFN/Vinblastine||25
586114|NCT00520351|1430889|P2|NOT COMPLETED|Second Intervention||0
586115|NCT00520351|1430890|P1|NOT COMPLETED|Second Intervention||0
586116|NCT00520351|1430889|P2|COMPLETED|Second Intervention||14
586117|NCT00520351|1430890|P1|COMPLETED|Second Intervention||14
586118|NCT00520351|1430889|P2|STARTED|Second Intervention||14
586119|NCT00520351|1430890|P1|STARTED|Second Intervention||14
586120|NCT00520351|1430889|P2|NOT COMPLETED|First Intervention||1
586121|NCT00520351|1430890|P1|NOT COMPLETED|First Intervention||1
586122|NCT00520351|1430889|P2|COMPLETED|First Intervention|End date is Feb.25, 2008|14
586123|NCT00520351|1430890|P1|COMPLETED|First Intervention|End date is Feb.25, 2008|14
586124|NCT00520351|1430889|P2|STARTED|First Intervention|Start date is Sep.06, 2007|15
586125|NCT00520351|1430890|P1|STARTED|First Intervention|Start date is Sep.06, 2007|15
586126|NCT00520299|1430905|P3|NOT COMPLETED|Overall Study||6
586127|NCT00520299|1430906|P2|NOT COMPLETED|Overall Study||3
586128|NCT00520299|1430907|P1|NOT COMPLETED|Overall Study||0
586129|NCT00520299|1430905|P3|COMPLETED|Overall Study||13
586130|NCT00520299|1430906|P2|COMPLETED|Overall Study||3
586131|NCT00520299|1430907|P1|COMPLETED|Overall Study|Defined as completion of 1 treatment cycle|6
586132|NCT00520299|1430905|P3|STARTED|Overall Study||19
586133|NCT00520299|1430906|P2|STARTED|Overall Study||6
586134|NCT00520299|1430907|P1|STARTED|Overall Study||6
586135|NCT00520286|1430938|P2|NOT COMPLETED|Overall Study||32
586136|NCT00520286|1430939|P1|NOT COMPLETED|Overall Study||66
586137|NCT00520286|1430938|P2|COMPLETED|Overall Study||36
586138|NCT00520286|1430939|P1|COMPLETED|Overall Study||76
586139|NCT00520286|1430938|P2|STARTED|Overall Study||68
586140|NCT00520286|1430939|P1|STARTED|Overall Study||142
586141|NCT00520234|1430949|P2|NOT COMPLETED|Overall Study||2
586142|NCT00520234|1430950|P1|NOT COMPLETED|Overall Study||1
586143|NCT00520234|1430949|P2|COMPLETED|Overall Study||102
586144|NCT00520234|1430950|P1|COMPLETED|Overall Study||117
586145|NCT00520234|1430949|P2|STARTED|Overall Study||104
586146|NCT00520234|1430950|P1|STARTED|Overall Study||118
586147|NCT00520130|1430962|P2|NOT COMPLETED|Overall Study||1
586148|NCT00520130|1430963|P1|NOT COMPLETED|Overall Study||5
586149|NCT00520130|1430962|P2|COMPLETED|Overall Study||44
586150|NCT00520130|1430963|P1|COMPLETED|Overall Study||39
586151|NCT00520130|1430962|P2|STARTED|Overall Study||45
586152|NCT00520130|1430963|P1|STARTED|Overall Study||44
586153|NCT00520039|1431005|P2|NOT COMPLETED|Overall Study||5
586154|NCT00520039|1431006|P1|NOT COMPLETED|Overall Study||7
586155|NCT00520039|1431005|P2|COMPLETED|Overall Study||19
586156|NCT00520039|1431006|P1|COMPLETED|Overall Study||21
586157|NCT00520039|1431005|P2|STARTED|Overall Study||24
586158|NCT00520039|1431006|P1|STARTED|Overall Study||28
586159|NCT00520013|1431019|P3|NOT COMPLETED|Overall Study||11
586160|NCT00520013|1431020|P2|NOT COMPLETED|Overall Study||15
586161|NCT00520013|1431021|P1|NOT COMPLETED|Overall Study||12
586162|NCT00520013|1431019|P3|COMPLETED|Overall Study||0
586163|NCT00520013|1431020|P2|COMPLETED|Overall Study||10
586164|NCT00520013|1431021|P1|COMPLETED|Overall Study||11
586165|NCT00520013|1431019|P3|Treated|Overall Study||11
586166|NCT00520013|1431020|P2|Treated|Overall Study||25
586167|NCT00520013|1431021|P1|Treated|Overall Study||23
586168|NCT00520013|1431019|P3|STARTED|Overall Study|Excludes a pt who went off-study (on reg day) due to consent that may not have been informed (ESL).|11
586169|NCT00520013|1431020|P2|STARTED|Overall Study||25
586170|NCT00520013|1431021|P1|STARTED|Overall Study||23
586171|NCT00519896|1431031|P1|NOT COMPLETED|Overall Study||2
586172|NCT00519896|1431031|P1|COMPLETED|Overall Study||33
586173|NCT00519896|1431031|P1|STARTED|Overall Study||35
586174|NCT00519831|1431037|P1|NOT COMPLETED|Overall Study||3
586175|NCT00519831|1431037|P1|COMPLETED|Overall Study||13
586176|NCT00519831|1431037|P1|STARTED|Overall Study||16
586177|NCT00519818|1431044|P1|NOT COMPLETED|Overall Study||0
586178|NCT00519818|1431044|P1|COMPLETED|Overall Study||14
586179|NCT00519818|1431044|P1|STARTED|Overall Study||14
586180|NCT00519779|1431054|P2|NOT COMPLETED|Overall Study||1
586181|NCT00519779|1431055|P1|NOT COMPLETED|Overall Study||0
586182|NCT00519779|1431054|P2|COMPLETED|Overall Study||33
586183|NCT00519779|1431055|P1|COMPLETED|Overall Study||34
586184|NCT00519779|1431054|P2|STARTED|Overall Study||34
586185|NCT00519779|1431055|P1|STARTED|Overall Study||34
586186|NCT00519649|1431071|P1|NOT COMPLETED|Overall Study||1
586187|NCT00519649|1431071|P1|COMPLETED|Overall Study||299
586188|NCT00519649|1431071|P1|STARTED|Overall Study||300
586189|NCT00519636|1431084|P4|NOT COMPLETED|Post Study Period||1
586190|NCT00519636|1431085|P3|NOT COMPLETED|Post Study Period||0
586191|NCT00519636|1431086|P2|NOT COMPLETED|Post Study Period||0
586192|NCT00519636|1431087|P1|NOT COMPLETED|Post Study Period||0
586193|NCT00519636|1431084|P4|COMPLETED|Post Study Period||85
586194|NCT00519636|1431085|P3|COMPLETED|Post Study Period||74
586195|NCT00519636|1431086|P2|COMPLETED|Post Study Period||71
586196|NCT00519636|1431087|P1|COMPLETED|Post Study Period||69
586197|NCT00519636|1431084|P4|STARTED|Post Study Period||86
586198|NCT00519636|1431085|P3|STARTED|Post Study Period||74
586199|NCT00519636|1431086|P2|STARTED|Post Study Period||71
586200|NCT00519636|1431087|P1|STARTED|Post Study Period||69
586201|NCT00519636|1431084|P4|NOT COMPLETED|Treatment Period 2||2
586202|NCT00519636|1431085|P3|NOT COMPLETED|Treatment Period 2||1
586203|NCT00519636|1431086|P2|NOT COMPLETED|Treatment Period 2||1
586204|NCT00519636|1431087|P1|NOT COMPLETED|Treatment Period 2||0
586205|NCT00519636|1431084|P4|COMPLETED|Treatment Period 2||86
586206|NCT00519636|1431085|P3|COMPLETED|Treatment Period 2||74
586207|NCT00519636|1431086|P2|COMPLETED|Treatment Period 2||71
586208|NCT00519636|1431087|P1|COMPLETED|Treatment Period 2||69
586209|NCT00519636|1431084|P4|STARTED|Treatment Period 2||88
586210|NCT00519636|1431085|P3|STARTED|Treatment Period 2||75
586211|NCT00519636|1431086|P2|STARTED|Treatment Period 2||72
586212|NCT00519636|1431087|P1|STARTED|Treatment Period 2||69
586213|NCT00519636|1431084|P4|NOT COMPLETED|Washout Period||5
586214|NCT00519636|1431085|P3|NOT COMPLETED|Washout Period||14
586215|NCT00519636|1431086|P2|NOT COMPLETED|Washout Period||14
586216|NCT00519636|1431087|P1|NOT COMPLETED|Washout Period||20
586217|NCT00519636|1431084|P4|COMPLETED|Washout Period||88
586218|NCT00519636|1431085|P3|COMPLETED|Washout Period||75
586219|NCT00519636|1431086|P2|COMPLETED|Washout Period||72
586220|NCT00519636|1431087|P1|COMPLETED|Washout Period||69
586221|NCT00519636|1431084|P4|STARTED|Washout Period||93
586222|NCT00519636|1431085|P3|STARTED|Washout Period||89
586223|NCT00519636|1431086|P2|STARTED|Washout Period||86
586224|NCT00519636|1431087|P1|STARTED|Washout Period||89
586225|NCT00519636|1431084|P4|NOT COMPLETED|Treatment Period 1||0
586226|NCT00519636|1431085|P3|NOT COMPLETED|Treatment Period 1||1
586227|NCT00519636|1431086|P2|NOT COMPLETED|Treatment Period 1||0
586228|NCT00519636|1431087|P1|NOT COMPLETED|Treatment Period 1||2
586229|NCT00519636|1431084|P4|COMPLETED|Treatment Period 1||93
586230|NCT00519636|1431085|P3|COMPLETED|Treatment Period 1||89
586231|NCT00519636|1431086|P2|COMPLETED|Treatment Period 1||86
586232|NCT00519636|1431087|P1|COMPLETED|Treatment Period 1||89
586233|NCT00519636|1431084|P4|STARTED|Treatment Period 1||93
586234|NCT00519636|1431085|P3|STARTED|Treatment Period 1||90
586235|NCT00519636|1431086|P2|STARTED|Treatment Period 1||86
586236|NCT00519636|1431087|P1|STARTED|Treatment Period 1||91
586237|NCT00519623|1431117|P1|NOT COMPLETED|Overall Study||1
586238|NCT00519623|1431117|P1|COMPLETED|Overall Study||8
586239|NCT00519623|1431117|P1|STARTED|Overall Study||9
586240|NCT00519584|1431126|P4|NOT COMPLETED|Overall Study||0
586241|NCT00519584|1431127|P3|NOT COMPLETED|Overall Study||0
586242|NCT00519584|1431128|P2|NOT COMPLETED|Overall Study||0
586243|NCT00519584|1431129|P1|NOT COMPLETED|Overall Study||0
586244|NCT00519584|1431126|P4|COMPLETED|Overall Study||56
586245|NCT00519584|1431127|P3|COMPLETED|Overall Study||54
586246|NCT00519584|1431128|P2|COMPLETED|Overall Study||54
586247|NCT00519584|1431129|P1|COMPLETED|Overall Study||54
586248|NCT00519584|1431126|P4|STARTED|Overall Study||56
586249|NCT00519584|1431127|P3|STARTED|Overall Study||54
586250|NCT00519584|1431128|P2|STARTED|Overall Study||54
586251|NCT00519584|1431129|P1|STARTED|Overall Study||54
586252|NCT00519532|1431151|P1|NOT COMPLETED|Overall Study||18
586253|NCT00519532|1431151|P1|COMPLETED|Overall Study||66
586254|NCT00519532|1431151|P1|STARTED|Overall Study||84
586255|NCT00519428|1431161|P3|NOT COMPLETED|Overall Study||25
586256|NCT00519428|1431162|P2|NOT COMPLETED|Overall Study||15
586257|NCT00519428|1431163|P1|NOT COMPLETED|Overall Study||21
586258|NCT00519428|1431161|P3|COMPLETED|Overall Study||58
586259|NCT00519428|1431162|P2|COMPLETED|Overall Study||69
586260|NCT00519428|1431163|P1|COMPLETED|Overall Study||57
586261|NCT00519428|1431161|P3|STARTED|Overall Study||83
586262|NCT00519428|1431162|P2|STARTED|Overall Study||84
586263|NCT00519428|1431163|P1|STARTED|Overall Study||78
586264|NCT00519376|1431183|P16|NOT COMPLETED|Treatment Period 4||0
586265|NCT00519376|1431184|P15|NOT COMPLETED|Treatment Period 4||0
586266|NCT00519376|1431185|P14|NOT COMPLETED|Treatment Period 4||0
586267|NCT00519376|1431186|P13|NOT COMPLETED|Treatment Period 4||0
586268|NCT00519376|1431187|P12|NOT COMPLETED|Treatment Period 4||0
586269|NCT00519376|1431188|P11|NOT COMPLETED|Treatment Period 4||0
586270|NCT00519376|1431189|P10|NOT COMPLETED|Treatment Period 4||0
586271|NCT00519376|1431190|P9|NOT COMPLETED|Treatment Period 4||0
586272|NCT00519376|1431191|P8|NOT COMPLETED|Treatment Period 4||0
586273|NCT00519376|1431192|P7|NOT COMPLETED|Treatment Period 4||0
586274|NCT00519376|1431193|P6|NOT COMPLETED|Treatment Period 4||0
586275|NCT00519376|1431194|P5|NOT COMPLETED|Treatment Period 4||0
586276|NCT00519376|1431195|P4|NOT COMPLETED|Treatment Period 4||0
586277|NCT00519376|1431196|P3|NOT COMPLETED|Treatment Period 4||1
586278|NCT00519376|1431197|P2|NOT COMPLETED|Treatment Period 4||0
586279|NCT00519376|1431198|P1|NOT COMPLETED|Treatment Period 4||0
586280|NCT00519376|1431183|P16|COMPLETED|Treatment Period 4||1
586281|NCT00519376|1431184|P15|COMPLETED|Treatment Period 4||1
586282|NCT00519376|1431185|P14|COMPLETED|Treatment Period 4||1
586283|NCT00519376|1431186|P13|COMPLETED|Treatment Period 4||0
586284|NCT00519376|1431187|P12|COMPLETED|Treatment Period 4||1
586285|NCT00519376|1431188|P11|COMPLETED|Treatment Period 4||1
586286|NCT00519376|1431189|P10|COMPLETED|Treatment Period 4||1
586287|NCT00519376|1431190|P9|COMPLETED|Treatment Period 4||1
586288|NCT00519376|1431191|P8|COMPLETED|Treatment Period 4||1
586289|NCT00519376|1431192|P7|COMPLETED|Treatment Period 4||1
586290|NCT00519376|1431193|P6|COMPLETED|Treatment Period 4||1
586291|NCT00519376|1431194|P5|COMPLETED|Treatment Period 4||1
586292|NCT00519376|1431195|P4|COMPLETED|Treatment Period 4||2
586293|NCT00519376|1431196|P3|COMPLETED|Treatment Period 4||1
586294|NCT00519376|1431197|P2|COMPLETED|Treatment Period 4||2
586295|NCT00519376|1431198|P1|COMPLETED|Treatment Period 4||2
586296|NCT00519376|1431183|P16|STARTED|Treatment Period 4||1
586297|NCT00519376|1431184|P15|STARTED|Treatment Period 4||1
586298|NCT00519376|1431185|P14|STARTED|Treatment Period 4||1
586299|NCT00519376|1431186|P13|STARTED|Treatment Period 4||0
586300|NCT00519376|1431187|P12|STARTED|Treatment Period 4||1
586301|NCT00519376|1431188|P11|STARTED|Treatment Period 4||1
586302|NCT00519376|1431189|P10|STARTED|Treatment Period 4||1
586303|NCT00519376|1431190|P9|STARTED|Treatment Period 4||1
586304|NCT00519376|1431191|P8|STARTED|Treatment Period 4||1
586305|NCT00519376|1431192|P7|STARTED|Treatment Period 4||1
586306|NCT00519376|1431193|P6|STARTED|Treatment Period 4||1
586307|NCT00519376|1431194|P5|STARTED|Treatment Period 4||1
586308|NCT00519376|1431195|P4|STARTED|Treatment Period 4||2
586309|NCT00519376|1431196|P3|STARTED|Treatment Period 4||2
586310|NCT00519376|1431197|P2|STARTED|Treatment Period 4||2
586311|NCT00519376|1431198|P1|STARTED|Treatment Period 4||2
586312|NCT00519376|1431183|P16|NOT COMPLETED|Washout Period 3||0
586313|NCT00519376|1431184|P15|NOT COMPLETED|Washout Period 3||0
586314|NCT00519376|1431185|P14|NOT COMPLETED|Washout Period 3||0
586315|NCT00519376|1431186|P13|NOT COMPLETED|Washout Period 3||0
586316|NCT00519376|1431187|P12|NOT COMPLETED|Washout Period 3||0
586317|NCT00519376|1431188|P11|NOT COMPLETED|Washout Period 3||0
586318|NCT00519376|1431189|P10|NOT COMPLETED|Washout Period 3||0
586319|NCT00519376|1431190|P9|NOT COMPLETED|Washout Period 3||0
586320|NCT00519376|1431191|P8|NOT COMPLETED|Washout Period 3||0
586321|NCT00519376|1431192|P7|NOT COMPLETED|Washout Period 3||0
586322|NCT00519376|1431193|P6|NOT COMPLETED|Washout Period 3||0
586323|NCT00519376|1431194|P5|NOT COMPLETED|Washout Period 3||0
586324|NCT00519376|1431195|P4|NOT COMPLETED|Washout Period 3||0
586325|NCT00519376|1431196|P3|NOT COMPLETED|Washout Period 3||0
586326|NCT00519376|1431197|P2|NOT COMPLETED|Washout Period 3||0
586327|NCT00519376|1431198|P1|NOT COMPLETED|Washout Period 3||0
586328|NCT00519376|1431183|P16|COMPLETED|Washout Period 3||1
586329|NCT00519376|1431184|P15|COMPLETED|Washout Period 3||1
586330|NCT00519376|1431185|P14|COMPLETED|Washout Period 3||1
586331|NCT00519376|1431186|P13|COMPLETED|Washout Period 3||0
586332|NCT00519376|1431187|P12|COMPLETED|Washout Period 3||1
586333|NCT00519376|1431188|P11|COMPLETED|Washout Period 3||1
586334|NCT00519376|1431189|P10|COMPLETED|Washout Period 3||1
586335|NCT00519376|1431190|P9|COMPLETED|Washout Period 3||1
586336|NCT00519376|1431191|P8|COMPLETED|Washout Period 3||1
586337|NCT00519376|1431192|P7|COMPLETED|Washout Period 3||1
586338|NCT00519376|1431193|P6|COMPLETED|Washout Period 3||1
586339|NCT00519376|1431194|P5|COMPLETED|Washout Period 3||1
586340|NCT00519376|1431195|P4|COMPLETED|Washout Period 3||2
586341|NCT00519376|1431196|P3|COMPLETED|Washout Period 3||2
586342|NCT00519376|1431197|P2|COMPLETED|Washout Period 3||2
586343|NCT00519376|1431198|P1|COMPLETED|Washout Period 3||2
586344|NCT00519376|1431183|P16|STARTED|Washout Period 3||1
586345|NCT00519376|1431184|P15|STARTED|Washout Period 3||1
586346|NCT00519376|1431185|P14|STARTED|Washout Period 3||1
586347|NCT00519376|1431186|P13|STARTED|Washout Period 3||0
586348|NCT00519376|1431187|P12|STARTED|Washout Period 3||1
586349|NCT00519376|1431188|P11|STARTED|Washout Period 3||1
586350|NCT00519376|1431189|P10|STARTED|Washout Period 3||1
586351|NCT00519376|1431190|P9|STARTED|Washout Period 3||1
586352|NCT00519376|1431191|P8|STARTED|Washout Period 3||1
586353|NCT00519376|1431192|P7|STARTED|Washout Period 3||1
586354|NCT00519376|1431193|P6|STARTED|Washout Period 3||1
586355|NCT00519376|1431194|P5|STARTED|Washout Period 3||1
586356|NCT00519376|1431195|P4|STARTED|Washout Period 3||2
586357|NCT00519376|1431196|P3|STARTED|Washout Period 3||2
586358|NCT00519376|1431197|P2|STARTED|Washout Period 3||2
586359|NCT00519376|1431198|P1|STARTED|Washout Period 3||2
586360|NCT00519376|1431183|P16|NOT COMPLETED|Treatment Period 3||0
586361|NCT00519376|1431184|P15|NOT COMPLETED|Treatment Period 3||0
586362|NCT00519376|1431185|P14|NOT COMPLETED|Treatment Period 3||0
586363|NCT00519376|1431186|P13|NOT COMPLETED|Treatment Period 3||0
586364|NCT00519376|1431187|P12|NOT COMPLETED|Treatment Period 3||0
586365|NCT00519376|1431188|P11|NOT COMPLETED|Treatment Period 3||0
586366|NCT00519376|1431189|P10|NOT COMPLETED|Treatment Period 3||0
586367|NCT00519376|1431190|P9|NOT COMPLETED|Treatment Period 3||0
586368|NCT00519376|1431191|P8|NOT COMPLETED|Treatment Period 3||0
586369|NCT00519376|1431192|P7|NOT COMPLETED|Treatment Period 3||0
586370|NCT00519376|1431193|P6|NOT COMPLETED|Treatment Period 3||0
586371|NCT00519376|1431194|P5|NOT COMPLETED|Treatment Period 3||0
586372|NCT00519376|1431195|P4|NOT COMPLETED|Treatment Period 3||0
586373|NCT00519376|1431196|P3|NOT COMPLETED|Treatment Period 3||0
586374|NCT00519376|1431197|P2|NOT COMPLETED|Treatment Period 3||0
586375|NCT00519376|1431198|P1|NOT COMPLETED|Treatment Period 3||0
586376|NCT00519376|1431183|P16|COMPLETED|Treatment Period 3||1
586377|NCT00519376|1431184|P15|COMPLETED|Treatment Period 3||1
586378|NCT00519376|1431185|P14|COMPLETED|Treatment Period 3||1
586379|NCT00519376|1431186|P13|COMPLETED|Treatment Period 3||0
586380|NCT00519376|1431187|P12|COMPLETED|Treatment Period 3||1
586381|NCT00519376|1431188|P11|COMPLETED|Treatment Period 3||1
586382|NCT00519376|1431189|P10|COMPLETED|Treatment Period 3||1
586383|NCT00519376|1431190|P9|COMPLETED|Treatment Period 3||1
586384|NCT00519376|1431191|P8|COMPLETED|Treatment Period 3||1
586385|NCT00519376|1431192|P7|COMPLETED|Treatment Period 3||1
586386|NCT00519376|1431193|P6|COMPLETED|Treatment Period 3||1
586387|NCT00519376|1431194|P5|COMPLETED|Treatment Period 3||1
586388|NCT00519376|1431195|P4|COMPLETED|Treatment Period 3||2
586389|NCT00519376|1431196|P3|COMPLETED|Treatment Period 3||2
586390|NCT00519376|1431197|P2|COMPLETED|Treatment Period 3||2
586391|NCT00519376|1431198|P1|COMPLETED|Treatment Period 3||2
586392|NCT00519376|1431183|P16|STARTED|Treatment Period 3||1
586393|NCT00519376|1431184|P15|STARTED|Treatment Period 3||1
586394|NCT00519376|1431185|P14|STARTED|Treatment Period 3||1
586395|NCT00519376|1431186|P13|STARTED|Treatment Period 3||0
586396|NCT00519376|1431187|P12|STARTED|Treatment Period 3||1
586397|NCT00519376|1431188|P11|STARTED|Treatment Period 3||1
586398|NCT00519376|1431189|P10|STARTED|Treatment Period 3||1
586399|NCT00519376|1431190|P9|STARTED|Treatment Period 3||1
586400|NCT00519376|1431191|P8|STARTED|Treatment Period 3||1
586401|NCT00519376|1431192|P7|STARTED|Treatment Period 3||1
586402|NCT00519376|1431193|P6|STARTED|Treatment Period 3||1
586403|NCT00519376|1431194|P5|STARTED|Treatment Period 3||1
586404|NCT00519376|1431195|P4|STARTED|Treatment Period 3||2
586405|NCT00519376|1431196|P3|STARTED|Treatment Period 3||2
586406|NCT00519376|1431197|P2|STARTED|Treatment Period 3||2
586407|NCT00519376|1431198|P1|STARTED|Treatment Period 3||2
586408|NCT00519376|1431183|P16|NOT COMPLETED|Washout Period 2||0
586409|NCT00519376|1431184|P15|NOT COMPLETED|Washout Period 2||0
586410|NCT00519376|1431185|P14|NOT COMPLETED|Washout Period 2||0
586411|NCT00519376|1431186|P13|NOT COMPLETED|Washout Period 2||0
586412|NCT00519376|1431187|P12|NOT COMPLETED|Washout Period 2||0
586413|NCT00519376|1431188|P11|NOT COMPLETED|Washout Period 2||0
586414|NCT00519376|1431189|P10|NOT COMPLETED|Washout Period 2||0
586415|NCT00519376|1431190|P9|NOT COMPLETED|Washout Period 2||0
586416|NCT00519376|1431191|P8|NOT COMPLETED|Washout Period 2||0
586417|NCT00519376|1431192|P7|NOT COMPLETED|Washout Period 2||0
586418|NCT00519376|1431193|P6|NOT COMPLETED|Washout Period 2||0
586419|NCT00519376|1431194|P5|NOT COMPLETED|Washout Period 2||0
586420|NCT00519376|1431195|P4|NOT COMPLETED|Washout Period 2||0
586421|NCT00519376|1431196|P3|NOT COMPLETED|Washout Period 2||0
586422|NCT00519376|1431197|P2|NOT COMPLETED|Washout Period 2||0
586423|NCT00519376|1431198|P1|NOT COMPLETED|Washout Period 2||0
586424|NCT00519376|1431183|P16|COMPLETED|Washout Period 2||1
586425|NCT00519376|1431184|P15|COMPLETED|Washout Period 2||1
586426|NCT00519376|1431185|P14|COMPLETED|Washout Period 2||1
586427|NCT00519376|1431186|P13|COMPLETED|Washout Period 2||0
586428|NCT00519376|1431187|P12|COMPLETED|Washout Period 2||1
586429|NCT00519376|1431188|P11|COMPLETED|Washout Period 2||1
586430|NCT00519376|1431189|P10|COMPLETED|Washout Period 2||1
586431|NCT00519376|1431190|P9|COMPLETED|Washout Period 2||1
586432|NCT00519376|1431191|P8|COMPLETED|Washout Period 2||1
586433|NCT00519376|1431192|P7|COMPLETED|Washout Period 2||1
586434|NCT00519376|1431193|P6|COMPLETED|Washout Period 2||1
586435|NCT00519376|1431194|P5|COMPLETED|Washout Period 2||1
586436|NCT00519376|1431195|P4|COMPLETED|Washout Period 2||2
586437|NCT00519376|1431196|P3|COMPLETED|Washout Period 2||2
586438|NCT00519376|1431197|P2|COMPLETED|Washout Period 2||2
586439|NCT00519376|1431198|P1|COMPLETED|Washout Period 2||2
586440|NCT00519376|1431183|P16|STARTED|Washout Period 2||1
586441|NCT00519376|1431184|P15|STARTED|Washout Period 2||1
586442|NCT00519376|1431185|P14|STARTED|Washout Period 2||1
586443|NCT00519376|1431186|P13|STARTED|Washout Period 2||0
586444|NCT00519376|1431187|P12|STARTED|Washout Period 2||1
586445|NCT00519376|1431188|P11|STARTED|Washout Period 2||1
586446|NCT00519376|1431189|P10|STARTED|Washout Period 2||1
586447|NCT00519376|1431190|P9|STARTED|Washout Period 2||1
586448|NCT00519376|1431191|P8|STARTED|Washout Period 2||1
586449|NCT00519376|1431192|P7|STARTED|Washout Period 2||1
586450|NCT00519376|1431193|P6|STARTED|Washout Period 2||1
586451|NCT00519376|1431194|P5|STARTED|Washout Period 2||1
586452|NCT00519376|1431195|P4|STARTED|Washout Period 2||2
586453|NCT00519376|1431196|P3|STARTED|Washout Period 2||2
586454|NCT00519376|1431197|P2|STARTED|Washout Period 2||2
586455|NCT00519376|1431198|P1|STARTED|Washout Period 2||2
586456|NCT00519376|1431183|P16|NOT COMPLETED|Treatment Period 2||0
586457|NCT00519376|1431184|P15|NOT COMPLETED|Treatment Period 2||0
586458|NCT00519376|1431185|P14|NOT COMPLETED|Treatment Period 2||0
586459|NCT00519376|1431186|P13|NOT COMPLETED|Treatment Period 2||1
586460|NCT00519376|1431187|P12|NOT COMPLETED|Treatment Period 2||0
586461|NCT00519376|1431188|P11|NOT COMPLETED|Treatment Period 2||0
586462|NCT00519376|1431189|P10|NOT COMPLETED|Treatment Period 2||0
586463|NCT00519376|1431190|P9|NOT COMPLETED|Treatment Period 2||0
586464|NCT00519376|1431191|P8|NOT COMPLETED|Treatment Period 2||0
586465|NCT00519376|1431192|P7|NOT COMPLETED|Treatment Period 2||0
586466|NCT00519376|1431193|P6|NOT COMPLETED|Treatment Period 2||0
586467|NCT00519376|1431194|P5|NOT COMPLETED|Treatment Period 2||0
586468|NCT00519376|1431195|P4|NOT COMPLETED|Treatment Period 2||0
586469|NCT00519376|1431196|P3|NOT COMPLETED|Treatment Period 2||0
586470|NCT00519376|1431197|P2|NOT COMPLETED|Treatment Period 2||0
586471|NCT00519376|1431198|P1|NOT COMPLETED|Treatment Period 2||0
586472|NCT00519376|1431183|P16|COMPLETED|Treatment Period 2||1
586473|NCT00519376|1431184|P15|COMPLETED|Treatment Period 2||1
586474|NCT00519376|1431185|P14|COMPLETED|Treatment Period 2||1
586475|NCT00519376|1431186|P13|COMPLETED|Treatment Period 2||0
586476|NCT00519376|1431187|P12|COMPLETED|Treatment Period 2||1
586477|NCT00519376|1431188|P11|COMPLETED|Treatment Period 2||1
586478|NCT00519376|1431189|P10|COMPLETED|Treatment Period 2||1
586479|NCT00519376|1431190|P9|COMPLETED|Treatment Period 2||1
586480|NCT00519376|1431191|P8|COMPLETED|Treatment Period 2||1
586481|NCT00519376|1431192|P7|COMPLETED|Treatment Period 2||1
586482|NCT00519376|1431193|P6|COMPLETED|Treatment Period 2||1
586483|NCT00519376|1431194|P5|COMPLETED|Treatment Period 2||1
586484|NCT00519376|1431195|P4|COMPLETED|Treatment Period 2||2
586485|NCT00519376|1431196|P3|COMPLETED|Treatment Period 2||2
586486|NCT00519376|1431197|P2|COMPLETED|Treatment Period 2||2
586487|NCT00519376|1431198|P1|COMPLETED|Treatment Period 2||2
586488|NCT00519376|1431183|P16|STARTED|Treatment Period 2||1
586489|NCT00519376|1431184|P15|STARTED|Treatment Period 2||1
586490|NCT00519376|1431185|P14|STARTED|Treatment Period 2||1
586491|NCT00519376|1431186|P13|STARTED|Treatment Period 2||1
586492|NCT00519376|1431187|P12|STARTED|Treatment Period 2||1
586493|NCT00519376|1431188|P11|STARTED|Treatment Period 2||1
586494|NCT00519376|1431189|P10|STARTED|Treatment Period 2||1
586495|NCT00519376|1431190|P9|STARTED|Treatment Period 2||1
586496|NCT00519376|1431191|P8|STARTED|Treatment Period 2||1
586497|NCT00519376|1431192|P7|STARTED|Treatment Period 2||1
586498|NCT00519376|1431193|P6|STARTED|Treatment Period 2||1
586499|NCT00519376|1431194|P5|STARTED|Treatment Period 2||1
586500|NCT00519376|1431195|P4|STARTED|Treatment Period 2||2
586501|NCT00519376|1431196|P3|STARTED|Treatment Period 2||2
586502|NCT00519376|1431197|P2|STARTED|Treatment Period 2||2
586503|NCT00519376|1431198|P1|STARTED|Treatment Period 2||2
586504|NCT00519376|1431183|P16|NOT COMPLETED|Washout Period 1||0
586505|NCT00519376|1431184|P15|NOT COMPLETED|Washout Period 1||0
586506|NCT00519376|1431185|P14|NOT COMPLETED|Washout Period 1||0
586507|NCT00519376|1431186|P13|NOT COMPLETED|Washout Period 1||0
586508|NCT00519376|1431187|P12|NOT COMPLETED|Washout Period 1||0
586509|NCT00519376|1431188|P11|NOT COMPLETED|Washout Period 1||0
586510|NCT00519376|1431189|P10|NOT COMPLETED|Washout Period 1||0
586511|NCT00519376|1431190|P9|NOT COMPLETED|Washout Period 1||0
586512|NCT00519376|1431191|P8|NOT COMPLETED|Washout Period 1||0
586513|NCT00519376|1431192|P7|NOT COMPLETED|Washout Period 1||0
586514|NCT00519376|1431193|P6|NOT COMPLETED|Washout Period 1||0
586515|NCT00519376|1431194|P5|NOT COMPLETED|Washout Period 1||0
586516|NCT00519376|1431195|P4|NOT COMPLETED|Washout Period 1||0
586517|NCT00519376|1431196|P3|NOT COMPLETED|Washout Period 1||0
586518|NCT00519376|1431197|P2|NOT COMPLETED|Washout Period 1||0
586519|NCT00519376|1431198|P1|NOT COMPLETED|Washout Period 1||0
586520|NCT00519376|1431183|P16|COMPLETED|Washout Period 1||1
586521|NCT00519376|1431184|P15|COMPLETED|Washout Period 1||1
586522|NCT00519376|1431185|P14|COMPLETED|Washout Period 1||1
586523|NCT00519376|1431186|P13|COMPLETED|Washout Period 1||1
586524|NCT00519376|1431187|P12|COMPLETED|Washout Period 1||1
586525|NCT00519376|1431188|P11|COMPLETED|Washout Period 1||1
586526|NCT00519376|1431189|P10|COMPLETED|Washout Period 1||1
586527|NCT00519376|1431190|P9|COMPLETED|Washout Period 1||1
586528|NCT00519376|1431191|P8|COMPLETED|Washout Period 1||1
586529|NCT00519376|1431192|P7|COMPLETED|Washout Period 1||1
586530|NCT00519376|1431193|P6|COMPLETED|Washout Period 1||1
586531|NCT00519376|1431194|P5|COMPLETED|Washout Period 1||1
586532|NCT00519376|1431195|P4|COMPLETED|Washout Period 1||2
586533|NCT00519376|1431196|P3|COMPLETED|Washout Period 1||2
586534|NCT00519376|1431197|P2|COMPLETED|Washout Period 1||2
586535|NCT00519376|1431198|P1|COMPLETED|Washout Period 1||2
586536|NCT00519376|1431183|P16|STARTED|Washout Period 1||1
586537|NCT00519376|1431184|P15|STARTED|Washout Period 1||1
586538|NCT00519376|1431185|P14|STARTED|Washout Period 1||1
586539|NCT00519376|1431186|P13|STARTED|Washout Period 1||1
586540|NCT00519376|1431187|P12|STARTED|Washout Period 1||1
586541|NCT00519376|1431188|P11|STARTED|Washout Period 1||1
586542|NCT00519376|1431189|P10|STARTED|Washout Period 1||1
586543|NCT00519376|1431190|P9|STARTED|Washout Period 1||1
586544|NCT00519376|1431191|P8|STARTED|Washout Period 1||1
586545|NCT00519376|1431192|P7|STARTED|Washout Period 1||1
586546|NCT00519376|1431193|P6|STARTED|Washout Period 1||1
586547|NCT00519376|1431194|P5|STARTED|Washout Period 1||1
586548|NCT00519376|1431195|P4|STARTED|Washout Period 1||2
586549|NCT00519376|1431196|P3|STARTED|Washout Period 1||2
586550|NCT00519376|1431197|P2|STARTED|Washout Period 1||2
586551|NCT00519376|1431198|P1|STARTED|Washout Period 1||2
586552|NCT00519376|1431183|P16|NOT COMPLETED|Treatment Period 1||0
586553|NCT00519376|1431184|P15|NOT COMPLETED|Treatment Period 1||0
586554|NCT00519376|1431185|P14|NOT COMPLETED|Treatment Period 1||0
586555|NCT00519376|1431186|P13|NOT COMPLETED|Treatment Period 1||0
586556|NCT00519376|1431187|P12|NOT COMPLETED|Treatment Period 1||0
586557|NCT00519376|1431188|P11|NOT COMPLETED|Treatment Period 1||0
586558|NCT00519376|1431189|P10|NOT COMPLETED|Treatment Period 1||0
586559|NCT00519376|1431190|P9|NOT COMPLETED|Treatment Period 1||0
586560|NCT00519376|1431191|P8|NOT COMPLETED|Treatment Period 1||0
586561|NCT00519376|1431192|P7|NOT COMPLETED|Treatment Period 1||0
586562|NCT00519376|1431193|P6|NOT COMPLETED|Treatment Period 1||0
586563|NCT00519376|1431194|P5|NOT COMPLETED|Treatment Period 1||0
586564|NCT00519376|1431195|P4|NOT COMPLETED|Treatment Period 1||0
586565|NCT00519376|1431196|P3|NOT COMPLETED|Treatment Period 1||0
586566|NCT00519376|1431197|P2|NOT COMPLETED|Treatment Period 1||0
586567|NCT00519376|1431198|P1|NOT COMPLETED|Treatment Period 1||0
586568|NCT00519376|1431183|P16|COMPLETED|Treatment Period 1||1
586569|NCT00519376|1431184|P15|COMPLETED|Treatment Period 1||1
586570|NCT00519376|1431185|P14|COMPLETED|Treatment Period 1||1
586571|NCT00519376|1431186|P13|COMPLETED|Treatment Period 1||1
586572|NCT00519376|1431187|P12|COMPLETED|Treatment Period 1||1
586573|NCT00519376|1431188|P11|COMPLETED|Treatment Period 1||1
586574|NCT00519376|1431189|P10|COMPLETED|Treatment Period 1||1
586575|NCT00519376|1431190|P9|COMPLETED|Treatment Period 1||1
586576|NCT00519376|1431191|P8|COMPLETED|Treatment Period 1||1
586577|NCT00519376|1431192|P7|COMPLETED|Treatment Period 1||1
586578|NCT00519376|1431193|P6|COMPLETED|Treatment Period 1||1
586579|NCT00519376|1431194|P5|COMPLETED|Treatment Period 1||1
586580|NCT00519376|1431195|P4|COMPLETED|Treatment Period 1||2
586581|NCT00519376|1431196|P3|COMPLETED|Treatment Period 1||2
586582|NCT00519376|1431197|P2|COMPLETED|Treatment Period 1||2
586583|NCT00519376|1431198|P1|COMPLETED|Treatment Period 1||2
586584|NCT00519376|1431183|P16|STARTED|Treatment Period 1||1
586585|NCT00519376|1431184|P15|STARTED|Treatment Period 1||1
586586|NCT00519376|1431185|P14|STARTED|Treatment Period 1||1
586587|NCT00519376|1431186|P13|STARTED|Treatment Period 1||1
586588|NCT00519376|1431187|P12|STARTED|Treatment Period 1||1
586589|NCT00519376|1431188|P11|STARTED|Treatment Period 1||1
586590|NCT00519376|1431189|P10|STARTED|Treatment Period 1||1
586591|NCT00519376|1431190|P9|STARTED|Treatment Period 1||1
586592|NCT00519376|1431191|P8|STARTED|Treatment Period 1||1
586593|NCT00519376|1431192|P7|STARTED|Treatment Period 1||1
586594|NCT00519376|1431193|P6|STARTED|Treatment Period 1||1
586595|NCT00519376|1431194|P5|STARTED|Treatment Period 1||1
586596|NCT00519376|1431195|P4|STARTED|Treatment Period 1||2
586597|NCT00519376|1431196|P3|STARTED|Treatment Period 1||2
586598|NCT00519376|1431197|P2|STARTED|Treatment Period 1||2
586599|NCT00519376|1431198|P1|STARTED|Treatment Period 1||2
586600|NCT00519285|1431322|P2|NOT COMPLETED|Overall Study||612
586601|NCT00519285|1431323|P1|NOT COMPLETED|Overall Study||612
586602|NCT00519285|1431322|P2|COMPLETED|Overall Study||0
586603|NCT00519285|1431323|P1|COMPLETED|Overall Study|Participants were treated until progressive disease, unacceptable toxicity, or refusal of treatment|0
586604|NCT00519285|1431322|P2|Still Treated at Cut-off Date|Overall Study||2
586605|NCT00519285|1431323|P1|Still Treated at Cut-off Date|Overall Study|The cut-off date for analysis was defined as 07 February 2012, date at which 873 deaths has occurred|1
586606|NCT00519285|1431322|P2|TREATED|Overall Study|Received at least part of one dose of aflibercept|605
586607|NCT00519285|1431323|P1|TREATED|Overall Study|Received at least part of one dose of placebo|604
586608|NCT00519285|1431322|P2|STARTED|Overall Study|Randomized|612
586609|NCT00519285|1431323|P1|STARTED|Overall Study|Randomized|612
586610|NCT00519194|1431349|P1|NOT COMPLETED|Overall Study||21
586611|NCT00519194|1431349|P1|COMPLETED|Overall Study||91
586612|NCT00519194|1431349|P1|STARTED|Overall Study||112
586613|NCT00519090|1431355|P2|NOT COMPLETED|Overall Study||0
586614|NCT00519090|1431356|P1|NOT COMPLETED|Overall Study||0
586615|NCT00519090|1431355|P2|COMPLETED|Overall Study||4
586616|NCT00519090|1431356|P1|COMPLETED|Overall Study||2
586617|NCT00519090|1431355|P2|STARTED|Overall Study||4
586618|NCT00519090|1431356|P1|STARTED|Overall Study||2
586619|NCT00519077|1431364|P1|NOT COMPLETED|Overall Study||8
586620|NCT00519077|1431364|P1|COMPLETED|Overall Study||36
586621|NCT00519077|1431364|P1|STARTED|Overall Study||44
586622|NCT00518986|1431371|P2|NOT COMPLETED|Overall Study||26
586623|NCT00518986|1431372|P1|NOT COMPLETED|Overall Study||26
586624|NCT00518986|1431371|P2|COMPLETED|Overall Study||98
586625|NCT00518986|1431372|P1|COMPLETED|Overall Study||99
586626|NCT00518986|1431371|P2|STARTED|Overall Study||124
586627|NCT00518986|1431372|P1|STARTED|Overall Study|One subject discontinued before treatment, only 124 subjects in each treatment group were dosed.|125
586628|NCT00518882|1431498|P2|NOT COMPLETED|Open-Label Extension, Week 26-78||49
586629|NCT00518882|1431499|P1|NOT COMPLETED|Open-Label Extension, Week 26-78||41
586630|NCT00518882|1431498|P2|COMPLETED|Open-Label Extension, Week 26-78||138
586631|NCT00518882|1431499|P1|COMPLETED|Open-Label Extension, Week 26-78||161
586632|NCT00518882|1431498|P2|STARTED|Open-Label Extension, Week 26-78||187
586633|NCT00518882|1431499|P1|STARTED|Open-Label Extension, Week 26-78||202
586634|NCT00518882|1431498|P2|NOT COMPLETED|Double-Blind, Week 0-26||45
586635|NCT00518882|1431499|P1|NOT COMPLETED|Double-Blind, Week 0-26||33
586636|NCT00518882|1431498|P2|COMPLETED|Double-Blind, Week 0-26||187
586637|NCT00518882|1431499|P1|COMPLETED|Double-Blind, Week 0-26||202
586638|NCT00518882|1431498|P2|Randomised|Double-Blind, Week 0-26||231
586639|NCT00518882|1431499|P1|Randomised|Double-Blind, Week 0-26||233
586640|NCT00518882|1431498|P2|STARTED|Double-Blind, Week 0-26|1 subject exposed to study drug before randomisation. Subject only included in safety analysis set|232
586641|NCT00518882|1431499|P1|STARTED|Double-Blind, Week 0-26|2 subjects exposed to study drug before randomisation. Subjects only included in safety analysis set|235
586642|NCT00518713|1431617|P4|NOT COMPLETED|Overall Study||18
586643|NCT00518713|1431618|P3|NOT COMPLETED|Overall Study||18
586644|NCT00518713|1431619|P2|NOT COMPLETED|Overall Study||17
586645|NCT00518713|1431620|P1|NOT COMPLETED|Overall Study||8
586646|NCT00518713|1431617|P4|COMPLETED|Overall Study||41
586647|NCT00518713|1431618|P3|COMPLETED|Overall Study||41
586648|NCT00518713|1431619|P2|COMPLETED|Overall Study||45
586649|NCT00518713|1431620|P1|COMPLETED|Overall Study||50
586650|NCT00518713|1431617|P4|Modified Intent-to-Treat Population|Overall Study||57
586651|NCT00518713|1431618|P3|Modified Intent-to-Treat Population|Overall Study||49
586652|NCT00518713|1431619|P2|Modified Intent-to-Treat Population|Overall Study||58
586653|NCT00518713|1431620|P1|Modified Intent-to-Treat Population|Overall Study||53
586654|NCT00518713|1431617|P4|STARTED|Overall Study||59
586655|NCT00518713|1431618|P3|STARTED|Overall Study||59
586656|NCT00518713|1431619|P2|STARTED|Overall Study||62
586657|NCT00518713|1431620|P1|STARTED|Overall Study||58
586658|NCT00518687|1431680|P2|NOT COMPLETED|Overall Study||1420
586659|NCT00518687|1431681|P1|NOT COMPLETED|Overall Study||1437
586660|NCT00518687|1431680|P2|COMPLETED|Overall Study||2585
586661|NCT00518687|1431681|P1|COMPLETED|Overall Study||2568
586662|NCT00518687|1431680|P2|Vaccinated|Overall Study||3982
586663|NCT00518687|1431681|P1|Vaccinated|Overall Study||3981
586664|NCT00518687|1431680|P2|STARTED|Overall Study|An additional 11 participants were not analyzed because of questionable clinical practices at 1 site|4005
586665|NCT00518687|1431681|P1|STARTED|Overall Study|An additional 10 participants were not analyzed because of questionable clinical practices at 1 site|4005
586666|NCT00518622|1431701|P8|NOT COMPLETED|Overall Study||0
586667|NCT00518622|1431702|P7|NOT COMPLETED|Overall Study||0
586668|NCT00518622|1431703|P6|NOT COMPLETED|Overall Study||0
586669|NCT00518622|1431704|P5|NOT COMPLETED|Overall Study||0
586670|NCT00518622|1431705|P4|NOT COMPLETED|Overall Study||0
586671|NCT00518622|1431706|P3|NOT COMPLETED|Overall Study||1
586672|NCT00518622|1431707|P2|NOT COMPLETED|Overall Study||1
586673|NCT00518622|1431708|P1|NOT COMPLETED|Overall Study||0
586674|NCT00518622|1431701|P8|COMPLETED|Overall Study||5
586675|NCT00518622|1431702|P7|COMPLETED|Overall Study||4
586676|NCT00518622|1431703|P6|COMPLETED|Overall Study||5
586677|NCT00518622|1431704|P5|COMPLETED|Overall Study||6
586678|NCT00518622|1431705|P4|COMPLETED|Overall Study||5
586679|NCT00518622|1431706|P3|COMPLETED|Overall Study||5
586680|NCT00518622|1431707|P2|COMPLETED|Overall Study||5
586681|NCT00518622|1431708|P1|COMPLETED|Overall Study||3
586682|NCT00518622|1431701|P8|Discontinued Therapy|Overall Study||0
586683|NCT00518622|1431702|P7|Discontinued Therapy|Overall Study||0
586684|NCT00518622|1431703|P6|Discontinued Therapy|Overall Study||0
586685|NCT00518622|1431704|P5|Discontinued Therapy|Overall Study||0
586686|NCT00518622|1431705|P4|Discontinued Therapy|Overall Study||0
586687|NCT00518622|1431706|P3|Discontinued Therapy|Overall Study||0
586688|NCT00518622|1431707|P2|Discontinued Therapy|Overall Study||1
586689|NCT00518622|1431708|P1|Discontinued Therapy|Overall Study|Discontinued therapy defined if participant has not taken 8 days of medication per the protocol.|0
586690|NCT00518622|1431701|P8|Completed Therapy|Overall Study||5
586691|NCT00518622|1431702|P7|Completed Therapy|Overall Study||4
586692|NCT00518622|1431703|P6|Completed Therapy|Overall Study||5
586693|NCT00518622|1431704|P5|Completed Therapy|Overall Study||6
586694|NCT00518622|1431705|P4|Completed Therapy|Overall Study||5
586695|NCT00518622|1431706|P3|Completed Therapy|Overall Study||6
586696|NCT00518622|1431707|P2|Completed Therapy|Overall Study||5
586697|NCT00518622|1431708|P1|Completed Therapy|Overall Study|Completed therapy defined if participant has taken 8 days of study medication per the protocol.|3
586698|NCT00518622|1431701|P8|STARTED|Overall Study||5
586699|NCT00518622|1431702|P7|STARTED|Overall Study||4
586700|NCT00518622|1431703|P6|STARTED|Overall Study||5
586701|NCT00518622|1431704|P5|STARTED|Overall Study||6
586702|NCT00518622|1431705|P4|STARTED|Overall Study||5
586703|NCT00518622|1431706|P3|STARTED|Overall Study||6
586704|NCT00518622|1431707|P2|STARTED|Overall Study||6
586705|NCT00518622|1431708|P1|STARTED|Overall Study||3
586706|NCT00518531|1431736|P2|NOT COMPLETED|Treatment Period 2||20
586707|NCT00518531|1431737|P1|NOT COMPLETED|Treatment Period 2||3
586708|NCT00518531|1431736|P2|COMPLETED|Treatment Period 2||95
586709|NCT00518531|1431737|P1|COMPLETED|Treatment Period 2||103
586710|NCT00518531|1431736|P2|Received Treatment|Treatment Period 2||110
586711|NCT00518531|1431737|P1|Received Treatment|Treatment Period 2||106
586712|NCT00518531|1431736|P2|STARTED|Treatment Period 2|Participants can start Treatment Period 2 without completing Treatment Period 1.|115
586713|NCT00518531|1431737|P1|STARTED|Treatment Period 2||106
586714|NCT00518531|1431736|P2|NOT COMPLETED|Treatment Period 1||12
586715|NCT00518531|1431737|P1|NOT COMPLETED|Treatment Period 1||18
586716|NCT00518531|1431736|P2|COMPLETED|Treatment Period 1|Participants who completed Treatment Period 1 may choose not to start Treatment Period 2|114
586717|NCT00518531|1431737|P1|COMPLETED|Treatment Period 1||106
586718|NCT00518531|1431736|P2|Received Treatment|Treatment Period 1||124
586719|NCT00518531|1431737|P1|Received Treatment|Treatment Period 1||119
586720|NCT00518531|1431736|P2|STARTED|Treatment Period 1||126
586721|NCT00518531|1431737|P1|STARTED|Treatment Period 1||124
586722|NCT00518349|1431773|P2|NOT COMPLETED|Overall Study||0
586723|NCT00518349|1431774|P1|NOT COMPLETED|Overall Study||0
586724|NCT00518349|1431773|P2|COMPLETED|Overall Study||60
586725|NCT00518349|1431774|P1|COMPLETED|Overall Study||60
586726|NCT00518349|1431773|P2|STARTED|Overall Study||60
586727|NCT00518349|1431774|P1|STARTED|Overall Study||60
586728|NCT00518336|1431782|P2|NOT COMPLETED|Year 9||1
586729|NCT00518336|1431783|P1|NOT COMPLETED|Year 9||5
586730|NCT00518336|1431782|P2|COMPLETED|Year 9||212
586731|NCT00518336|1431783|P1|COMPLETED|Year 9||219
586732|NCT00518336|1431782|P2|STARTED|Year 9||213
586733|NCT00518336|1431783|P1|STARTED|Year 9|1 subject did not particpate at the previous timepoint, came back and was added in the Total cohort|224
586734|NCT00518336|1431782|P2|NOT COMPLETED|Year 8||2
586735|NCT00518336|1431783|P1|NOT COMPLETED|Year 8||1
586736|NCT00518336|1431782|P2|COMPLETED|Year 8||211
586737|NCT00518336|1431783|P1|COMPLETED|Year 8||222
586738|NCT00518336|1431782|P2|STARTED|Year 8|2 subjects withdrawn at Year 7 came back and were therefore no longer considered as withdrawn.|213
586739|NCT00518336|1431783|P1|STARTED|Year 8|1 subject withdrawn at Year 7 came back and was therefore no longer considered as withdrawn.|223
586740|NCT00518336|1431782|P2|NOT COMPLETED|Year 7||3
586741|NCT00518336|1431783|P1|NOT COMPLETED|Year 7||2
586742|NCT00518336|1431782|P2|COMPLETED|Year 7||208
586743|NCT00518336|1431783|P1|COMPLETED|Year 7||220
586744|NCT00518336|1431782|P2|STARTED|Year 7||211
586745|NCT00518336|1431783|P1|STARTED|Year 7||222
586746|NCT00518323|1431949|P4|NOT COMPLETED|Overall Study||25
586747|NCT00518323|1431950|P3|NOT COMPLETED|Overall Study||11
586748|NCT00518323|1431951|P2|NOT COMPLETED|Overall Study||8
586749|NCT00518323|1431952|P1|NOT COMPLETED|Overall Study||19
586750|NCT00518323|1431949|P4|COMPLETED|Overall Study||26
586751|NCT00518323|1431950|P3|COMPLETED|Overall Study||37
586752|NCT00518323|1431951|P2|COMPLETED|Overall Study||40
586753|NCT00518323|1431952|P1|COMPLETED|Overall Study||35
586754|NCT00518323|1431949|P4|STARTED|Overall Study||51
586755|NCT00518323|1431950|P3|STARTED|Overall Study||48
586756|NCT00518323|1431951|P2|STARTED|Overall Study||48
586757|NCT00518323|1431952|P1|STARTED|Overall Study||54
586758|NCT00518284|1431982|P4|NOT COMPLETED|Overall Study||2
586759|NCT00518284|1431983|P3|NOT COMPLETED|Overall Study||1
586760|NCT00518284|1431984|P2|NOT COMPLETED|Overall Study||3
586761|NCT00518284|1431985|P1|NOT COMPLETED|Overall Study||0
586762|NCT00518284|1431982|P4|COMPLETED|Overall Study||0
586763|NCT00518284|1431983|P3|COMPLETED|Overall Study||0
586764|NCT00518284|1431984|P2|COMPLETED|Overall Study||0
586765|NCT00518284|1431985|P1|COMPLETED|Overall Study||0
586766|NCT00518284|1431982|P4|STARTED|Overall Study||2
586767|NCT00518284|1431983|P3|STARTED|Overall Study||1
586768|NCT00518284|1431984|P2|STARTED|Overall Study||3
586769|NCT00518284|1431985|P1|STARTED|Overall Study||0
586770|NCT00518206|1432041|P2|NOT COMPLETED|Overall Study||6
586771|NCT00518206|1432042|P1|NOT COMPLETED|Overall Study||11
586772|NCT00518206|1432041|P2|COMPLETED|Overall Study||13
586773|NCT00518206|1432042|P1|COMPLETED|Overall Study||16
586774|NCT00518206|1432041|P2|STARTED|Overall Study||19
586775|NCT00518206|1432042|P1|STARTED|Overall Study||27
586776|NCT00518180|1432059|P3|NOT COMPLETED|Overall Study||82
586777|NCT00518180|1432060|P2|NOT COMPLETED|Overall Study||69
586778|NCT00518180|1432061|P1|NOT COMPLETED|Overall Study||65
586779|NCT00518180|1432059|P3|COMPLETED|Overall Study||457
586780|NCT00518180|1432060|P2|COMPLETED|Overall Study||472
586781|NCT00518180|1432061|P1|COMPLETED|Overall Study||475
586782|NCT00518180|1432059|P3|STARTED|Overall Study||539
586783|NCT00518180|1432060|P2|STARTED|Overall Study||541
586784|NCT00518180|1432061|P1|STARTED|Overall Study||540
586785|NCT00518115|1432113|P10|NOT COMPLETED|Overall Study||15
586786|NCT00518115|1432114|P9|NOT COMPLETED|Overall Study||5
586787|NCT00518115|1432115|P8|NOT COMPLETED|Overall Study||15
586788|NCT00518115|1432116|P7|NOT COMPLETED|Overall Study||8
586789|NCT00518115|1432117|P6|NOT COMPLETED|Overall Study||15
586790|NCT00518115|1432118|P5|NOT COMPLETED|Overall Study||10
586791|NCT00518115|1432119|P4|NOT COMPLETED|Overall Study||11
586792|NCT00518115|1432120|P3|NOT COMPLETED|Overall Study||17
586793|NCT00518115|1432121|P2|NOT COMPLETED|Overall Study||6
586794|NCT00518115|1432122|P1|NOT COMPLETED|Overall Study||12
586795|NCT00518115|1432113|P10|COMPLETED|Overall Study||20
586796|NCT00518115|1432114|P9|COMPLETED|Overall Study||30
586797|NCT00518115|1432115|P8|COMPLETED|Overall Study||20
586798|NCT00518115|1432116|P7|COMPLETED|Overall Study||25
586799|NCT00518115|1432117|P6|COMPLETED|Overall Study||19
586800|NCT00518115|1432118|P5|COMPLETED|Overall Study||21
586801|NCT00518115|1432119|P4|COMPLETED|Overall Study||24
586802|NCT00518115|1432120|P3|COMPLETED|Overall Study||19
586803|NCT00518115|1432121|P2|COMPLETED|Overall Study||29
586804|NCT00518115|1432122|P1|COMPLETED|Overall Study||40
586805|NCT00518115|1432113|P10|Safety Population|Overall Study|These participants received at least one dose of study drug.|34
586806|NCT00518115|1432114|P9|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
586807|NCT00518115|1432115|P8|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
586808|NCT00518115|1432116|P7|Safety Population|Overall Study|These participants received at least one dose of study drug.|32
586809|NCT00518115|1432117|P6|Safety Population|Overall Study|These participants received at least one dose of study drug.|33
586810|NCT00518115|1432118|P5|Safety Population|Overall Study|These participants received at least one dose of study drug.|31
586811|NCT00518115|1432119|P4|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
586812|NCT00518115|1432120|P3|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
586813|NCT00518115|1432121|P2|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
586814|NCT00518115|1432122|P1|Safety Population|Overall Study|These participants received at least one dose of study drug.|51
586815|NCT00518115|1432113|P10|STARTED|Overall Study||35
586816|NCT00518115|1432114|P9|STARTED|Overall Study||35
586817|NCT00518115|1432115|P8|STARTED|Overall Study||35
586818|NCT00518115|1432116|P7|STARTED|Overall Study||33
586819|NCT00518115|1432117|P6|STARTED|Overall Study||34
586820|NCT00518115|1432118|P5|STARTED|Overall Study||31
586821|NCT00518115|1432119|P4|STARTED|Overall Study||35
586822|NCT00518115|1432120|P3|STARTED|Overall Study||36
586823|NCT00518115|1432121|P2|STARTED|Overall Study||35
586824|NCT00518115|1432122|P1|STARTED|Overall Study||52
586825|NCT00518089|1432280|P2|NOT COMPLETED|Overall Study||31
586826|NCT00518089|1432281|P1|NOT COMPLETED|Overall Study||28
586827|NCT00518089|1432280|P2|COMPLETED|Overall Study||398
586828|NCT00518089|1432281|P1|COMPLETED|Overall Study||402
586829|NCT00518089|1432280|P2|STARTED|Overall Study||429
586830|NCT00518089|1432281|P1|STARTED|Overall Study||430
586831|NCT00518011|1432297|P2|NOT COMPLETED|Overall Study||8
586832|NCT00518011|1432298|P1|NOT COMPLETED|Overall Study||9
586833|NCT00518011|1432297|P2|COMPLETED|Overall Study||0
586834|NCT00518011|1432298|P1|COMPLETED|Overall Study||0
586835|NCT00518011|1432297|P2|STARTED|Overall Study||8
586836|NCT00518011|1432298|P1|STARTED|Overall Study||9
586837|NCT00517933|1432320|P2|NOT COMPLETED|Period 2||13
586838|NCT00517933|1432321|P1|NOT COMPLETED|Period 2||6
586839|NCT00517933|1432320|P2|COMPLETED|Period 2||70
586840|NCT00517933|1432321|P1|COMPLETED|Period 2||73
586841|NCT00517933|1432320|P2|STARTED|Period 2|2 patients terminated after completion of period one, but before starting period 2|83
586842|NCT00517933|1432321|P1|STARTED|Period 2|2 patients terminated after completion of period one, but before starting period 2|79
586843|NCT00517933|1432320|P2|NOT COMPLETED|Period 1||6
586844|NCT00517933|1432321|P1|NOT COMPLETED|Period 1||8
586845|NCT00517933|1432320|P2|COMPLETED|Period 1||85
586846|NCT00517933|1432321|P1|COMPLETED|Period 1||81
586847|NCT00517933|1432320|P2|STARTED|Period 1|Patients decreased due to death, adverse event and other (see below)|91
586848|NCT00517933|1432321|P1|STARTED|Period 1|Patients decreased due to death, adverse event, lost to follow up and other (see below)|89
586849|NCT00517881|1432385|P1|NOT COMPLETED|Overall Study||5
586850|NCT00517881|1432385|P1|COMPLETED|Overall Study||24
586851|NCT00517881|1432385|P1|STARTED|Overall Study||29
586852|NCT00517829|1432397|P2|NOT COMPLETED|Overall Study||75
586853|NCT00517829|1432398|P1|NOT COMPLETED|Overall Study||75
586854|NCT00517829|1432397|P2|COMPLETED|Overall Study||0
586855|NCT00517829|1432398|P1|COMPLETED|Overall Study||0
586856|NCT00517829|1432397|P2|STARTED|Overall Study||75
586857|NCT00517829|1432398|P1|STARTED|Overall Study||75
586858|NCT00517751|1432412|P1|NOT COMPLETED|Overall Study||129
586859|NCT00517751|1432412|P1|COMPLETED|Overall Study||33
586860|NCT00517751|1432412|P1|STARTED|Overall Study||162
586861|NCT00517699|1432435|P1|NOT COMPLETED|Overall Study||5
586862|NCT00517699|1432435|P1|COMPLETED|Overall Study||0
586863|NCT00517699|1432435|P1|STARTED|Overall Study||5
586864|NCT00517634|1432443|P6|NOT COMPLETED|Third Treatment Period||0
586865|NCT00517634|1432444|P5|NOT COMPLETED|Third Treatment Period||0
586866|NCT00517634|1432445|P4|NOT COMPLETED|Third Treatment Period||0
586867|NCT00517634|1432446|P3|NOT COMPLETED|Third Treatment Period||0
586868|NCT00517634|1432447|P2|NOT COMPLETED|Third Treatment Period||0
586869|NCT00517634|1432448|P1|NOT COMPLETED|Third Treatment Period||0
586870|NCT00517634|1432443|P6|COMPLETED|Third Treatment Period||4
586871|NCT00517634|1432444|P5|COMPLETED|Third Treatment Period||3
586872|NCT00517634|1432445|P4|COMPLETED|Third Treatment Period||3
586873|NCT00517634|1432446|P3|COMPLETED|Third Treatment Period||4
586874|NCT00517634|1432447|P2|COMPLETED|Third Treatment Period||4
586875|NCT00517634|1432448|P1|COMPLETED|Third Treatment Period||4
586876|NCT00517634|1432443|P6|STARTED|Third Treatment Period||4
586877|NCT00517634|1432444|P5|STARTED|Third Treatment Period||3
586878|NCT00517634|1432445|P4|STARTED|Third Treatment Period||3
586879|NCT00517634|1432446|P3|STARTED|Third Treatment Period||4
586880|NCT00517634|1432447|P2|STARTED|Third Treatment Period||4
586881|NCT00517634|1432448|P1|STARTED|Third Treatment Period||4
586882|NCT00517634|1432443|P6|NOT COMPLETED|Second Treatment Period||0
586883|NCT00517634|1432444|P5|NOT COMPLETED|Second Treatment Period||1
586884|NCT00517634|1432445|P4|NOT COMPLETED|Second Treatment Period||0
586885|NCT00517634|1432446|P3|NOT COMPLETED|Second Treatment Period||0
586886|NCT00517634|1432447|P2|NOT COMPLETED|Second Treatment Period||0
586887|NCT00517634|1432448|P1|NOT COMPLETED|Second Treatment Period||0
586888|NCT00517634|1432443|P6|COMPLETED|Second Treatment Period||4
586889|NCT00517634|1432444|P5|COMPLETED|Second Treatment Period||3
586890|NCT00517634|1432445|P4|COMPLETED|Second Treatment Period||3
586891|NCT00517634|1432446|P3|COMPLETED|Second Treatment Period||4
586892|NCT00517634|1432447|P2|COMPLETED|Second Treatment Period||4
586893|NCT00517634|1432448|P1|COMPLETED|Second Treatment Period||4
586894|NCT00517634|1432443|P6|STARTED|Second Treatment Period||4
586895|NCT00517634|1432444|P5|STARTED|Second Treatment Period||4
586896|NCT00517634|1432445|P4|STARTED|Second Treatment Period||3
586897|NCT00517634|1432446|P3|STARTED|Second Treatment Period||4
586898|NCT00517634|1432447|P2|STARTED|Second Treatment Period||4
586899|NCT00517634|1432448|P1|STARTED|Second Treatment Period||4
586900|NCT00517634|1432443|P6|NOT COMPLETED|First Treatment Period||0
586901|NCT00517634|1432444|P5|NOT COMPLETED|First Treatment Period||0
586902|NCT00517634|1432445|P4|NOT COMPLETED|First Treatment Period||0
586903|NCT00517634|1432446|P3|NOT COMPLETED|First Treatment Period||0
586904|NCT00517634|1432447|P2|NOT COMPLETED|First Treatment Period||0
586905|NCT00517634|1432448|P1|NOT COMPLETED|First Treatment Period||0
586906|NCT00517634|1432443|P6|COMPLETED|First Treatment Period||4
586907|NCT00517634|1432444|P5|COMPLETED|First Treatment Period||4
586908|NCT00517634|1432445|P4|COMPLETED|First Treatment Period||3
586909|NCT00517634|1432446|P3|COMPLETED|First Treatment Period||4
586910|NCT00517634|1432447|P2|COMPLETED|First Treatment Period||4
586911|NCT00517634|1432448|P1|COMPLETED|First Treatment Period||4
586912|NCT00517634|1432443|P6|STARTED|First Treatment Period||4
586913|NCT00517634|1432444|P5|STARTED|First Treatment Period||4
586914|NCT00517634|1432445|P4|STARTED|First Treatment Period||3
586915|NCT00517634|1432446|P3|STARTED|First Treatment Period||4
586916|NCT00517634|1432447|P2|STARTED|First Treatment Period||4
586917|NCT00517634|1432448|P1|STARTED|First Treatment Period||4
586918|NCT00517595|1432459|P1|NOT COMPLETED|Overall Study||0
586919|NCT00517595|1432459|P1|COMPLETED|Overall Study||48
586920|NCT00517595|1432459|P1|STARTED|Overall Study||48
586921|NCT00517556|1432470|P2|NOT COMPLETED|Overall Study||5
586922|NCT00517556|1432471|P1|NOT COMPLETED|Overall Study||4
586923|NCT00517556|1432470|P2|COMPLETED|Overall Study||14
586924|NCT00517556|1432471|P1|COMPLETED|Overall Study||15
586925|NCT00517556|1432470|P2|STARTED|Overall Study||19
586926|NCT00517556|1432471|P1|STARTED|Overall Study||19
586927|NCT00517530|1432484|P7|NOT COMPLETED|Overall Study||19
586928|NCT00517530|1432485|P6|NOT COMPLETED|Overall Study||19
586929|NCT00517530|1432486|P5|NOT COMPLETED|Overall Study||20
586930|NCT00517530|1432487|P4|NOT COMPLETED|Overall Study||21
586931|NCT00517530|1432488|P3|NOT COMPLETED|Overall Study||18
586932|NCT00517530|1432489|P2|NOT COMPLETED|Overall Study||13
586933|NCT00517530|1432490|P1|NOT COMPLETED|Overall Study||19
586934|NCT00517530|1432484|P7|COMPLETED|Overall Study||1
586935|NCT00517530|1432485|P6|COMPLETED|Overall Study||0
586936|NCT00517530|1432486|P5|COMPLETED|Overall Study||1
586937|NCT00517530|1432487|P4|COMPLETED|Overall Study||1
586938|NCT00517530|1432488|P3|COMPLETED|Overall Study||0
586939|NCT00517530|1432489|P2|COMPLETED|Overall Study||0
586940|NCT00517530|1432490|P1|COMPLETED|Overall Study||2
586941|NCT00517530|1432484|P7|Retreated Population|Overall Study||0
586942|NCT00517530|1432485|P6|Retreated Population|Overall Study||2
586943|NCT00517530|1432486|P5|Retreated Population|Overall Study||2
586944|NCT00517530|1432487|P4|Retreated Population|Overall Study||4
586945|NCT00517530|1432488|P3|Retreated Population|Overall Study||1
586946|NCT00517530|1432489|P2|Retreated Population|Overall Study||2
586947|NCT00517530|1432490|P1|Retreated Population|Overall Study||2
586948|NCT00517530|1432484|P7|Completed Follow-up|Overall Study||1
586949|NCT00517530|1432485|P6|Completed Follow-up|Overall Study||0
586950|NCT00517530|1432486|P5|Completed Follow-up|Overall Study||0
586951|NCT00517530|1432487|P4|Completed Follow-up|Overall Study||1
586952|NCT00517530|1432488|P3|Completed Follow-up|Overall Study||0
586953|NCT00517530|1432489|P2|Completed Follow-up|Overall Study||0
586954|NCT00517530|1432490|P1|Completed Follow-up|Overall Study||2
586955|NCT00517530|1432484|P7|Started Follow-up|Overall Study||19
586956|NCT00517530|1432485|P6|Started Follow-up|Overall Study||16
586957|NCT00517530|1432486|P5|Started Follow-up|Overall Study||17
586958|NCT00517530|1432487|P4|Started Follow-up|Overall Study||21
586959|NCT00517530|1432488|P3|Started Follow-up|Overall Study||17
586960|NCT00517530|1432489|P2|Started Follow-up|Overall Study||13
586961|NCT00517530|1432490|P1|Started Follow-up|Overall Study||20
586962|NCT00517530|1432484|P7|Completed Treatment|Overall Study||13
586963|NCT00517530|1432485|P6|Completed Treatment|Overall Study||9
586964|NCT00517530|1432486|P5|Completed Treatment|Overall Study||9
586965|NCT00517530|1432487|P4|Completed Treatment|Overall Study||18
586966|NCT00517530|1432488|P3|Completed Treatment|Overall Study||13
586967|NCT00517530|1432489|P2|Completed Treatment|Overall Study||13
586968|NCT00517530|1432490|P1|Completed Treatment|Overall Study||11
586969|NCT00517530|1432484|P7|STARTED|Overall Study||20
586970|NCT00517530|1432485|P6|STARTED|Overall Study||19
586971|NCT00517530|1432486|P5|STARTED|Overall Study||21
586972|NCT00517530|1432487|P4|STARTED|Overall Study||22
586973|NCT00517530|1432488|P3|STARTED|Overall Study||18
586974|NCT00517530|1432489|P2|STARTED|Overall Study||13
586975|NCT00517530|1432490|P1|STARTED|Overall Study||21
586976|NCT00517413|1432550|P1|NOT COMPLETED|Overall Study||61
586977|NCT00517413|1432550|P1|COMPLETED|Overall Study||102
586978|NCT00517413|1432550|P1|STARTED|Overall Study||163
586979|NCT00517361|1432571|P1|NOT COMPLETED|Overall Study||11
586980|NCT00517361|1432571|P1|COMPLETED|Overall Study|This study has been terminated due to poor accrual.|0
586981|NCT00517361|1432571|P1|STARTED|Overall Study||11
586982|NCT00517296|1432580|P2|NOT COMPLETED|Overall Study||0
586983|NCT00517296|1432581|P1|NOT COMPLETED|Overall Study||1
586984|NCT00517296|1432580|P2|COMPLETED|Overall Study||11
586985|NCT00517296|1432581|P1|COMPLETED|Overall Study||9
586986|NCT00517296|1432580|P2|STARTED|Overall Study||11
586987|NCT00517296|1432581|P1|STARTED|Overall Study||10
586988|NCT00517192|1432593|P2|NOT COMPLETED|Overall Study||20
586989|NCT00517192|1432594|P1|NOT COMPLETED|Overall Study||19
586990|NCT00517192|1432593|P2|COMPLETED|Overall Study||0
586991|NCT00517192|1432594|P1|COMPLETED|Overall Study||0
586992|NCT00517192|1432593|P2|STARTED|Overall Study||20
586993|NCT00517192|1432594|P1|STARTED|Overall Study||19
586994|NCT00517075|1432646|P4|NOT COMPLETED|Overall Study||0
586995|NCT00517075|1432647|P3|NOT COMPLETED|Overall Study||0
586996|NCT00517075|1432648|P2|NOT COMPLETED|Overall Study||0
586997|NCT00517075|1432649|P1|NOT COMPLETED|Overall Study||0
586998|NCT00517075|1432646|P4|COMPLETED|Overall Study||0
586999|NCT00517075|1432647|P3|COMPLETED|Overall Study||0
587000|NCT00517075|1432648|P2|COMPLETED|Overall Study||0
587001|NCT00517075|1432649|P1|COMPLETED|Overall Study||0
587002|NCT00517075|1432646|P4|STARTED|Overall Study||0
587003|NCT00517075|1432647|P3|STARTED|Overall Study||0
587004|NCT00517075|1432648|P2|STARTED|Overall Study||0
587005|NCT00517075|1432649|P1|STARTED|Overall Study||0
587006|NCT00517010|1432687|P1|NOT COMPLETED|Overall Study||1
587007|NCT00517010|1432687|P1|COMPLETED|Overall Study||5
587008|NCT00517010|1432687|P1|STARTED|Overall Study||6
587009|NCT00516919|1432692|P2|NOT COMPLETED|Overall Study||7
587010|NCT00516919|1432693|P1|NOT COMPLETED|Overall Study||10
587011|NCT00516919|1432692|P2|COMPLETED|Overall Study||32
587012|NCT00516919|1432693|P1|COMPLETED|Overall Study||30
587013|NCT00516919|1432692|P2|STARTED|Overall Study||39
587014|NCT00516919|1432693|P1|STARTED|Overall Study||40
587015|NCT00516906|1432701|P2|NOT COMPLETED|Overall Study||2
587016|NCT00516906|1432702|P1|NOT COMPLETED|Overall Study||6
587017|NCT00516906|1432701|P2|COMPLETED|Overall Study|Thirty patients were required to complete. Patients not completing were replaced.|30
587018|NCT00516906|1432702|P1|COMPLETED|Overall Study|Thirty patients were required to complete. Patients not completing were replaced.|30
587019|NCT00516906|1432701|P2|STARTED|Overall Study|33 patients were randomized but one patient was discharged prior to treatment.|32
587020|NCT00516906|1432702|P1|STARTED|Overall Study||36
587021|NCT00516893|1432712|P1|NOT COMPLETED|Overall Study||21
587022|NCT00516893|1432712|P1|COMPLETED|Overall Study||92
587023|NCT00516893|1432712|P1|Received Study Treatment|Overall Study||112
587024|NCT00516893|1432712|P1|STARTED|Overall Study||113
587025|NCT00516737|1432721|P2|NOT COMPLETED|Overall Study||8
587026|NCT00516737|1432722|P1|NOT COMPLETED|Overall Study||11
587027|NCT00516737|1432721|P2|COMPLETED|Overall Study||96
587028|NCT00516737|1432722|P1|COMPLETED|Overall Study||92
587029|NCT00516737|1432721|P2|STARTED|Overall Study||104
587030|NCT00516737|1432722|P1|STARTED|Overall Study||103
587031|NCT00516503|1432742|P2|NOT COMPLETED|Overall Study||0
587032|NCT00516503|1432743|P1|NOT COMPLETED|Overall Study||0
587033|NCT00516503|1432742|P2|COMPLETED|Overall Study||102
587034|NCT00516503|1432743|P1|COMPLETED|Overall Study||101
587035|NCT00516503|1432742|P2|STARTED|Overall Study||102
587036|NCT00516503|1432743|P1|STARTED|Overall Study||101
587037|NCT00516386|1432761|P1|NOT COMPLETED|Overall Study||6
587038|NCT00516386|1432761|P1|COMPLETED|Overall Study||10
587039|NCT00516386|1432761|P1|STARTED|Overall Study||16
587040|NCT00516321|1432768|P3|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||54
587041|NCT00516321|1432769|P2|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||35
587042|NCT00516321|1432770|P1|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||0
587043|NCT00516321|1432768|P3|COMPLETED|Double-blind (DB) Antiviral Treatment||396
587044|NCT00516321|1432769|P2|COMPLETED|Double-blind (DB) Antiviral Treatment||197
587045|NCT00516321|1432770|P1|COMPLETED|Double-blind (DB) Antiviral Treatment||0
587046|NCT00516321|1432768|P3|STARTED|Double-blind (DB) Antiviral Treatment||450
587047|NCT00516321|1432769|P2|STARTED|Double-blind (DB) Antiviral Treatment||232
587048|NCT00516321|1432770|P1|STARTED|Double-blind (DB) Antiviral Treatment||0
587049|NCT00516321|1432768|P3|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
587050|NCT00516321|1432769|P2|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
587051|NCT00516321|1432770|P1|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||33
587052|NCT00516321|1432768|P3|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
587053|NCT00516321|1432769|P2|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
587054|NCT00516321|1432770|P1|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||682
587055|NCT00516321|1432768|P3|STARTED|Open-label (OL) Pre-Antiviral Treatment||0
587056|NCT00516321|1432769|P2|STARTED|Open-label (OL) Pre-Antiviral Treatment||0
587057|NCT00516321|1432770|P1|STARTED|Open-label (OL) Pre-Antiviral Treatment||715
587058|NCT00516295|1432821|P3|NOT COMPLETED|Overall Study||0
587059|NCT00516295|1432822|P2|NOT COMPLETED|Overall Study||0
587060|NCT00516295|1432823|P1|NOT COMPLETED|Overall Study||3
587061|NCT00516295|1432821|P3|COMPLETED|Overall Study||0
587062|NCT00516295|1432822|P2|COMPLETED|Overall Study||0
587063|NCT00516295|1432823|P1|COMPLETED|Overall Study||4
587064|NCT00516295|1432821|P3|STARTED|Overall Study||0
587065|NCT00516295|1432822|P2|STARTED|Overall Study||0
587066|NCT00516295|1432823|P1|STARTED|Overall Study||7
587067|NCT00516269|1432836|P2|NOT COMPLETED|Overall Study||3
587068|NCT00516269|1432837|P1|NOT COMPLETED|Overall Study||2
587069|NCT00516269|1432836|P2|COMPLETED|Overall Study|2 patients did not complete the study and 1 randomized to placebo twice.|16
587070|NCT00516269|1432837|P1|COMPLETED|Overall Study|2 patients had an early termination|17
587071|NCT00516269|1432836|P2|STARTED|Overall Study||19
587072|NCT00516269|1432837|P1|STARTED|Overall Study||19
587073|NCT00516217|1432843|P1|NOT COMPLETED|Overall Study||0
587074|NCT00516217|1432843|P1|COMPLETED|Overall Study||29
587075|NCT00516217|1432843|P1|STARTED|Overall Study||29
587076|NCT00516165|1432849|P1|NOT COMPLETED|Overall Study||0
587077|NCT00516165|1432849|P1|COMPLETED|Overall Study||28
587078|NCT00516165|1432849|P1|STARTED|Overall Study||28
587079|NCT00516139|1432858|P1|NOT COMPLETED|Overall Study||38
587080|NCT00516139|1432858|P1|COMPLETED|Overall Study|Study completers completed Escalation, AM, and either AO or both Conversion and Monotherapy Phases.|84
587081|NCT00516139|1432858|P1|STARTED|Overall Study||122
587082|NCT00516074|1432889|P2|NOT COMPLETED|Overall Study||3
587083|NCT00516074|1432890|P1|NOT COMPLETED|Overall Study||6
587084|NCT00516074|1432889|P2|COMPLETED|Overall Study||23
587085|NCT00516074|1432890|P1|COMPLETED|Overall Study||22
587086|NCT00516074|1432889|P2|STARTED|Overall Study||26
587087|NCT00516074|1432890|P1|STARTED|Overall Study||28
587088|NCT00516048|1432908|P3|NOT COMPLETED|Overall Study||1
587089|NCT00516048|1432909|P2|NOT COMPLETED|Overall Study||2
587090|NCT00516048|1432910|P1|NOT COMPLETED|Overall Study||0
587091|NCT00516048|1432908|P3|COMPLETED|Overall Study||0
587092|NCT00516048|1432909|P2|COMPLETED|Overall Study||40
587093|NCT00516048|1432910|P1|COMPLETED|Overall Study||15
587094|NCT00516048|1432908|P3|STARTED|Overall Study||1
587095|NCT00516048|1432909|P2|STARTED|Overall Study||42
587096|NCT00516048|1432910|P1|STARTED|Overall Study||15
587097|NCT00515879|1432926|P2|NOT COMPLETED|Overall Study||20
587098|NCT00515879|1432927|P1|NOT COMPLETED|Overall Study||25
587099|NCT00515879|1432926|P2|COMPLETED|Overall Study||62
587100|NCT00515879|1432927|P1|COMPLETED|Overall Study||62
587101|NCT00515879|1432926|P2|STARTED|Overall Study||82
587102|NCT00515879|1432927|P1|STARTED|Overall Study||87
587103|NCT00515827|1432937|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
587104|NCT00515827|1432938|P1|NOT COMPLETED|Second Intervention (12 Weeks)||1
587105|NCT00515827|1432937|P2|COMPLETED|Second Intervention (12 Weeks)||25
587106|NCT00515827|1432938|P1|COMPLETED|Second Intervention (12 Weeks)||25
587107|NCT00515827|1432937|P2|STARTED|Second Intervention (12 Weeks)||25
587108|NCT00515827|1432938|P1|STARTED|Second Intervention (12 Weeks)||26
587109|NCT00515827|1432937|P2|NOT COMPLETED|First Intervention (12 Weeks)||1
587110|NCT00515827|1432938|P1|NOT COMPLETED|First Intervention (12 Weeks)||1
587111|NCT00515827|1432937|P2|COMPLETED|First Intervention (12 Weeks)||25
587112|NCT00515827|1432938|P1|COMPLETED|First Intervention (12 Weeks)||26
587113|NCT00515827|1432937|P2|STARTED|First Intervention (12 Weeks)||26
587114|NCT00515827|1432938|P1|STARTED|First Intervention (12 Weeks)||27
587115|NCT00515697|1432960|P1|NOT COMPLETED|Overall Study||0
587116|NCT00515697|1432960|P1|COMPLETED|Overall Study||39
587117|NCT00515697|1432960|P1|Received at Least 1 Dose of Study Drug|Overall Study||39
587118|NCT00515697|1432960|P1|STARTED|Overall Study||39
587119|NCT00515671|1432973|P2|NOT COMPLETED|Overall Study||17
587120|NCT00515671|1432974|P1|NOT COMPLETED|Overall Study||17
587121|NCT00515671|1432973|P2|COMPLETED|Overall Study||41
587122|NCT00515671|1432974|P1|COMPLETED|Overall Study||43
587123|NCT00515671|1432973|P2|STARTED|Overall Study||58
587124|NCT00515671|1432974|P1|STARTED|Overall Study||60
587125|NCT00515619|1432982|P1|NOT COMPLETED|Overall Study||216
587126|NCT00515619|1432982|P1|COMPLETED|Overall Study||160
587127|NCT00515619|1432982|P1|Safety Set|Overall Study||376
587128|NCT00515619|1432982|P1|STARTED|Overall Study||376
587129|NCT00515541|1432994|P4|NOT COMPLETED|Overall Study||5
587130|NCT00515541|1432995|P3|NOT COMPLETED|Overall Study||0
587131|NCT00515541|1432996|P2|NOT COMPLETED|Overall Study||5
587132|NCT00515541|1432997|P1|NOT COMPLETED|Overall Study||0
587133|NCT00515541|1432994|P4|COMPLETED|Overall Study||6
587134|NCT00515541|1432995|P3|COMPLETED|Overall Study|All subjects completed 24 weeks.|10
587135|NCT00515541|1432996|P2|COMPLETED|Overall Study||7
587136|NCT00515541|1432997|P1|COMPLETED|Overall Study|All subjects completed 24 weeks.|10
587137|NCT00515541|1432994|P4|24 Weeks (8 gm Lovaza)|Overall Study|Three subjects withdrew after 18 weeks (1 GI problem, 1 undefined medical problem, 1 no show)|6
587138|NCT00515541|1432995|P3|24 Weeks (8 gm Lovaza)|Overall Study||10
587139|NCT00515541|1432996|P2|24 Weeks (8 gm Lovaza)|Overall Study|Two subjects withdrew at 20 and 21 weeks due to nausea. Subjects were closed out early.|7
587140|NCT00515541|1432997|P1|24 Weeks (8 gm Lovaza)|Overall Study||10
587141|NCT00515541|1432994|P4|18 Weeks (4 gm Lovaza)|Overall Study|One subject withdrew at 14 weeks with GI problems.|9
587142|NCT00515541|1432995|P3|18 Weeks (4 gm Lovaza)|Overall Study||10
587143|NCT00515541|1432996|P2|18 Weeks (4 gm Lovaza)|Overall Study|One subject withdrew at 12 weeks due to acquired bleeding disorder present before enrolling.|9
587144|NCT00515541|1432997|P1|18 Weeks (4 gm Lovaza)|Overall Study||10
587145|NCT00515541|1432994|P4|12 Weeks (2 gm Lovaza)|Overall Study||10
587146|NCT00515541|1432995|P3|12 Weeks (2 gm Lovaza)|Overall Study||10
587147|NCT00515541|1432996|P2|12 Weeks (2 gm Lovaza)|Overall Study||10
587148|NCT00515541|1432997|P1|12 Weeks (2 gm Lovaza)|Overall Study||10
587149|NCT00515541|1432994|P4|6 Weeks (1 gm Lovaza)|Overall Study|One subject pulled due to no show for appt. after baseline.|10
587150|NCT00515541|1432995|P3|6 Weeks (1 gm Lovaza)|Overall Study||10
587151|NCT00515541|1432996|P2|6 Weeks (1 gm Lovaza)|Overall Study|One subject pulled after baseline. One subject pulled due to no show for appt.after baseline|10
587152|NCT00515541|1432997|P1|6 Weeks (1 gm Lovaza)|Overall Study||10
587153|NCT00515541|1432994|P4|STARTED|Overall Study||11
587154|NCT00515541|1432995|P3|STARTED|Overall Study||10
587155|NCT00515541|1432996|P2|STARTED|Overall Study||12
587156|NCT00515541|1432997|P1|STARTED|Overall Study||10
587157|NCT00515502|1433019|P12|NOT COMPLETED|Treatment Period 4||0
587158|NCT00515502|1433020|P11|NOT COMPLETED|Treatment Period 4||0
587159|NCT00515502|1433021|P10|NOT COMPLETED|Treatment Period 4||0
587160|NCT00515502|1433022|P9|NOT COMPLETED|Treatment Period 4||0
587161|NCT00515502|1433023|P8|NOT COMPLETED|Treatment Period 4||0
587162|NCT00515502|1433024|P7|NOT COMPLETED|Treatment Period 4||0
587163|NCT00515502|1433025|P6|NOT COMPLETED|Treatment Period 4||0
587164|NCT00515502|1433026|P5|NOT COMPLETED|Treatment Period 4||0
587165|NCT00515502|1433027|P4|NOT COMPLETED|Treatment Period 4||0
587166|NCT00515502|1433028|P3|NOT COMPLETED|Treatment Period 4||0
587167|NCT00515502|1433029|P2|NOT COMPLETED|Treatment Period 4||0
587168|NCT00515502|1433030|P1|NOT COMPLETED|Treatment Period 4||0
587169|NCT00515502|1433019|P12|COMPLETED|Treatment Period 4||0
587170|NCT00515502|1433020|P11|COMPLETED|Treatment Period 4||1
587171|NCT00515502|1433021|P10|COMPLETED|Treatment Period 4||2
587172|NCT00515502|1433022|P9|COMPLETED|Treatment Period 4||0
587173|NCT00515502|1433023|P8|COMPLETED|Treatment Period 4||1
587174|NCT00515502|1433024|P7|COMPLETED|Treatment Period 4||1
587175|NCT00515502|1433025|P6|COMPLETED|Treatment Period 4||1
587176|NCT00515502|1433026|P5|COMPLETED|Treatment Period 4||3
587177|NCT00515502|1433027|P4|COMPLETED|Treatment Period 4||3
587178|NCT00515502|1433028|P3|COMPLETED|Treatment Period 4||4
587179|NCT00515502|1433029|P2|COMPLETED|Treatment Period 4||3
587180|NCT00515502|1433030|P1|COMPLETED|Treatment Period 4||1
587181|NCT00515502|1433019|P12|STARTED|Treatment Period 4||0
587182|NCT00515502|1433020|P11|STARTED|Treatment Period 4||1
587183|NCT00515502|1433021|P10|STARTED|Treatment Period 4||2
587184|NCT00515502|1433022|P9|STARTED|Treatment Period 4||0
587185|NCT00515502|1433023|P8|STARTED|Treatment Period 4||1
587186|NCT00515502|1433024|P7|STARTED|Treatment Period 4||1
587187|NCT00515502|1433025|P6|STARTED|Treatment Period 4||1
587188|NCT00515502|1433026|P5|STARTED|Treatment Period 4||3
587189|NCT00515502|1433027|P4|STARTED|Treatment Period 4||3
587190|NCT00515502|1433028|P3|STARTED|Treatment Period 4||4
587191|NCT00515502|1433029|P2|STARTED|Treatment Period 4||3
587192|NCT00515502|1433030|P1|STARTED|Treatment Period 4||1
587193|NCT00515502|1433019|P12|NOT COMPLETED|Washout Period 3||0
587194|NCT00515502|1433020|P11|NOT COMPLETED|Washout Period 3||0
587195|NCT00515502|1433021|P10|NOT COMPLETED|Washout Period 3||0
587196|NCT00515502|1433022|P9|NOT COMPLETED|Washout Period 3||0
587197|NCT00515502|1433023|P8|NOT COMPLETED|Washout Period 3||0
587198|NCT00515502|1433024|P7|NOT COMPLETED|Washout Period 3||0
587199|NCT00515502|1433025|P6|NOT COMPLETED|Washout Period 3||0
587200|NCT00515502|1433026|P5|NOT COMPLETED|Washout Period 3||0
587201|NCT00515502|1433027|P4|NOT COMPLETED|Washout Period 3||0
587202|NCT00515502|1433028|P3|NOT COMPLETED|Washout Period 3||0
587203|NCT00515502|1433029|P2|NOT COMPLETED|Washout Period 3||0
587204|NCT00515502|1433030|P1|NOT COMPLETED|Washout Period 3||0
587205|NCT00515502|1433019|P12|COMPLETED|Washout Period 3||0
587206|NCT00515502|1433020|P11|COMPLETED|Washout Period 3||1
587207|NCT00515502|1433021|P10|COMPLETED|Washout Period 3||2
587208|NCT00515502|1433022|P9|COMPLETED|Washout Period 3||0
587209|NCT00515502|1433023|P8|COMPLETED|Washout Period 3||1
587210|NCT00515502|1433024|P7|COMPLETED|Washout Period 3||1
587211|NCT00515502|1433025|P6|COMPLETED|Washout Period 3||1
587212|NCT00515502|1433026|P5|COMPLETED|Washout Period 3||3
587213|NCT00515502|1433027|P4|COMPLETED|Washout Period 3||3
587214|NCT00515502|1433028|P3|COMPLETED|Washout Period 3||4
587215|NCT00515502|1433029|P2|COMPLETED|Washout Period 3||3
587216|NCT00515502|1433030|P1|COMPLETED|Washout Period 3||1
587217|NCT00515502|1433019|P12|STARTED|Washout Period 3||0
587218|NCT00515502|1433020|P11|STARTED|Washout Period 3||1
587219|NCT00515502|1433021|P10|STARTED|Washout Period 3||2
587220|NCT00515502|1433022|P9|STARTED|Washout Period 3||0
587221|NCT00515502|1433023|P8|STARTED|Washout Period 3||1
587222|NCT00515502|1433024|P7|STARTED|Washout Period 3||1
587223|NCT00515502|1433025|P6|STARTED|Washout Period 3||1
587224|NCT00515502|1433026|P5|STARTED|Washout Period 3||3
587225|NCT00515502|1433027|P4|STARTED|Washout Period 3||3
587226|NCT00515502|1433028|P3|STARTED|Washout Period 3||4
587227|NCT00515502|1433029|P2|STARTED|Washout Period 3||3
587228|NCT00515502|1433030|P1|STARTED|Washout Period 3||1
587229|NCT00515502|1433019|P12|NOT COMPLETED|Treatment Period 3||0
587230|NCT00515502|1433020|P11|NOT COMPLETED|Treatment Period 3||0
587231|NCT00515502|1433021|P10|NOT COMPLETED|Treatment Period 3||0
587232|NCT00515502|1433022|P9|NOT COMPLETED|Treatment Period 3||0
587233|NCT00515502|1433023|P8|NOT COMPLETED|Treatment Period 3||0
587234|NCT00515502|1433024|P7|NOT COMPLETED|Treatment Period 3||0
587235|NCT00515502|1433025|P6|NOT COMPLETED|Treatment Period 3||0
587236|NCT00515502|1433026|P5|NOT COMPLETED|Treatment Period 3||0
587237|NCT00515502|1433027|P4|NOT COMPLETED|Treatment Period 3||0
587238|NCT00515502|1433028|P3|NOT COMPLETED|Treatment Period 3||0
587239|NCT00515502|1433029|P2|NOT COMPLETED|Treatment Period 3||0
587240|NCT00515502|1433030|P1|NOT COMPLETED|Treatment Period 3||0
587241|NCT00515502|1433019|P12|COMPLETED|Treatment Period 3||0
587242|NCT00515502|1433020|P11|COMPLETED|Treatment Period 3||1
587243|NCT00515502|1433021|P10|COMPLETED|Treatment Period 3||2
587244|NCT00515502|1433022|P9|COMPLETED|Treatment Period 3||0
587245|NCT00515502|1433023|P8|COMPLETED|Treatment Period 3||1
587246|NCT00515502|1433024|P7|COMPLETED|Treatment Period 3||1
587247|NCT00515502|1433025|P6|COMPLETED|Treatment Period 3||1
587248|NCT00515502|1433026|P5|COMPLETED|Treatment Period 3||3
587249|NCT00515502|1433027|P4|COMPLETED|Treatment Period 3||3
587250|NCT00515502|1433028|P3|COMPLETED|Treatment Period 3||4
587251|NCT00515502|1433029|P2|COMPLETED|Treatment Period 3||3
587252|NCT00515502|1433030|P1|COMPLETED|Treatment Period 3||1
587253|NCT00515502|1433019|P12|STARTED|Treatment Period 3||0
587254|NCT00515502|1433020|P11|STARTED|Treatment Period 3||1
587255|NCT00515502|1433021|P10|STARTED|Treatment Period 3||2
587256|NCT00515502|1433022|P9|STARTED|Treatment Period 3||0
587257|NCT00515502|1433023|P8|STARTED|Treatment Period 3||1
587258|NCT00515502|1433024|P7|STARTED|Treatment Period 3||1
587259|NCT00515502|1433025|P6|STARTED|Treatment Period 3||1
587260|NCT00515502|1433026|P5|STARTED|Treatment Period 3||3
587261|NCT00515502|1433027|P4|STARTED|Treatment Period 3||3
587262|NCT00515502|1433028|P3|STARTED|Treatment Period 3||4
587263|NCT00515502|1433029|P2|STARTED|Treatment Period 3||3
587264|NCT00515502|1433030|P1|STARTED|Treatment Period 3||1
587265|NCT00515502|1433019|P12|NOT COMPLETED|Washout Period 2||0
587266|NCT00515502|1433020|P11|NOT COMPLETED|Washout Period 2||0
587267|NCT00515502|1433021|P10|NOT COMPLETED|Washout Period 2||0
587268|NCT00515502|1433022|P9|NOT COMPLETED|Washout Period 2||0
587269|NCT00515502|1433023|P8|NOT COMPLETED|Washout Period 2||0
587270|NCT00515502|1433024|P7|NOT COMPLETED|Washout Period 2||0
587271|NCT00515502|1433025|P6|NOT COMPLETED|Washout Period 2||0
587272|NCT00515502|1433026|P5|NOT COMPLETED|Washout Period 2||0
587273|NCT00515502|1433027|P4|NOT COMPLETED|Washout Period 2||0
587274|NCT00515502|1433028|P3|NOT COMPLETED|Washout Period 2||0
587275|NCT00515502|1433029|P2|NOT COMPLETED|Washout Period 2||0
587276|NCT00515502|1433030|P1|NOT COMPLETED|Washout Period 2||0
587277|NCT00515502|1433019|P12|COMPLETED|Washout Period 2||0
587278|NCT00515502|1433020|P11|COMPLETED|Washout Period 2||1
587279|NCT00515502|1433021|P10|COMPLETED|Washout Period 2||2
587280|NCT00515502|1433022|P9|COMPLETED|Washout Period 2||0
587281|NCT00515502|1433023|P8|COMPLETED|Washout Period 2||1
587282|NCT00515502|1433024|P7|COMPLETED|Washout Period 2||1
587283|NCT00515502|1433025|P6|COMPLETED|Washout Period 2||1
587284|NCT00515502|1433026|P5|COMPLETED|Washout Period 2||3
587285|NCT00515502|1433027|P4|COMPLETED|Washout Period 2||3
587286|NCT00515502|1433028|P3|COMPLETED|Washout Period 2||4
587287|NCT00515502|1433029|P2|COMPLETED|Washout Period 2||3
587288|NCT00515502|1433030|P1|COMPLETED|Washout Period 2||1
587289|NCT00515502|1433019|P12|STARTED|Washout Period 2||0
587290|NCT00515502|1433020|P11|STARTED|Washout Period 2||1
587291|NCT00515502|1433021|P10|STARTED|Washout Period 2||2
587292|NCT00515502|1433022|P9|STARTED|Washout Period 2||0
587293|NCT00515502|1433023|P8|STARTED|Washout Period 2||1
587294|NCT00515502|1433024|P7|STARTED|Washout Period 2||1
587295|NCT00515502|1433025|P6|STARTED|Washout Period 2||1
587296|NCT00515502|1433026|P5|STARTED|Washout Period 2||3
587297|NCT00515502|1433027|P4|STARTED|Washout Period 2||3
587298|NCT00515502|1433028|P3|STARTED|Washout Period 2||4
587299|NCT00515502|1433029|P2|STARTED|Washout Period 2||3
587300|NCT00515502|1433030|P1|STARTED|Washout Period 2||1
587301|NCT00515502|1433019|P12|NOT COMPLETED|Treatment Period 2||0
587302|NCT00515502|1433020|P11|NOT COMPLETED|Treatment Period 2||0
587303|NCT00515502|1433021|P10|NOT COMPLETED|Treatment Period 2||0
587304|NCT00515502|1433022|P9|NOT COMPLETED|Treatment Period 2||0
587305|NCT00515502|1433023|P8|NOT COMPLETED|Treatment Period 2||0
587306|NCT00515502|1433024|P7|NOT COMPLETED|Treatment Period 2||0
587307|NCT00515502|1433025|P6|NOT COMPLETED|Treatment Period 2||0
587308|NCT00515502|1433026|P5|NOT COMPLETED|Treatment Period 2||0
587309|NCT00515502|1433027|P4|NOT COMPLETED|Treatment Period 2||0
587310|NCT00515502|1433028|P3|NOT COMPLETED|Treatment Period 2||0
587311|NCT00515502|1433029|P2|NOT COMPLETED|Treatment Period 2||1
587312|NCT00515502|1433030|P1|NOT COMPLETED|Treatment Period 2||0
587313|NCT00515502|1433019|P12|COMPLETED|Treatment Period 2||0
587314|NCT00515502|1433020|P11|COMPLETED|Treatment Period 2||1
587315|NCT00515502|1433021|P10|COMPLETED|Treatment Period 2||2
587316|NCT00515502|1433022|P9|COMPLETED|Treatment Period 2||0
587317|NCT00515502|1433023|P8|COMPLETED|Treatment Period 2||1
587318|NCT00515502|1433024|P7|COMPLETED|Treatment Period 2||1
587319|NCT00515502|1433025|P6|COMPLETED|Treatment Period 2||1
587320|NCT00515502|1433026|P5|COMPLETED|Treatment Period 2||3
587321|NCT00515502|1433027|P4|COMPLETED|Treatment Period 2||3
587322|NCT00515502|1433028|P3|COMPLETED|Treatment Period 2||4
587323|NCT00515502|1433029|P2|COMPLETED|Treatment Period 2||3
587324|NCT00515502|1433030|P1|COMPLETED|Treatment Period 2||1
587325|NCT00515502|1433019|P12|STARTED|Treatment Period 2||0
587326|NCT00515502|1433020|P11|STARTED|Treatment Period 2||1
587327|NCT00515502|1433021|P10|STARTED|Treatment Period 2||2
587328|NCT00515502|1433022|P9|STARTED|Treatment Period 2||0
587329|NCT00515502|1433023|P8|STARTED|Treatment Period 2||1
587330|NCT00515502|1433024|P7|STARTED|Treatment Period 2||1
587331|NCT00515502|1433025|P6|STARTED|Treatment Period 2||1
587332|NCT00515502|1433026|P5|STARTED|Treatment Period 2||3
587333|NCT00515502|1433027|P4|STARTED|Treatment Period 2||3
587334|NCT00515502|1433028|P3|STARTED|Treatment Period 2||4
587335|NCT00515502|1433029|P2|STARTED|Treatment Period 2||4
587336|NCT00515502|1433030|P1|STARTED|Treatment Period 2||1
587337|NCT00515502|1433019|P12|NOT COMPLETED|Washout Period 1||0
587338|NCT00515502|1433020|P11|NOT COMPLETED|Washout Period 1||0
587339|NCT00515502|1433021|P10|NOT COMPLETED|Washout Period 1||0
587340|NCT00515502|1433022|P9|NOT COMPLETED|Washout Period 1||0
587341|NCT00515502|1433023|P8|NOT COMPLETED|Washout Period 1||0
587342|NCT00515502|1433024|P7|NOT COMPLETED|Washout Period 1||0
587343|NCT00515502|1433025|P6|NOT COMPLETED|Washout Period 1||0
587344|NCT00515502|1433026|P5|NOT COMPLETED|Washout Period 1||0
587345|NCT00515502|1433027|P4|NOT COMPLETED|Washout Period 1||0
587346|NCT00515502|1433028|P3|NOT COMPLETED|Washout Period 1||0
587347|NCT00515502|1433029|P2|NOT COMPLETED|Washout Period 1||0
587348|NCT00515502|1433030|P1|NOT COMPLETED|Washout Period 1||0
587349|NCT00515502|1433019|P12|COMPLETED|Washout Period 1||0
587350|NCT00515502|1433020|P11|COMPLETED|Washout Period 1||1
587351|NCT00515502|1433021|P10|COMPLETED|Washout Period 1||2
587352|NCT00515502|1433022|P9|COMPLETED|Washout Period 1||0
587353|NCT00515502|1433023|P8|COMPLETED|Washout Period 1||1
587354|NCT00515502|1433024|P7|COMPLETED|Washout Period 1||1
587355|NCT00515502|1433025|P6|COMPLETED|Washout Period 1||1
587356|NCT00515502|1433026|P5|COMPLETED|Washout Period 1||3
587357|NCT00515502|1433027|P4|COMPLETED|Washout Period 1||3
587358|NCT00515502|1433028|P3|COMPLETED|Washout Period 1||4
587359|NCT00515502|1433029|P2|COMPLETED|Washout Period 1||4
587360|NCT00515502|1433030|P1|COMPLETED|Washout Period 1||1
587361|NCT00515502|1433019|P12|STARTED|Washout Period 1||0
587362|NCT00515502|1433020|P11|STARTED|Washout Period 1||1
587363|NCT00515502|1433021|P10|STARTED|Washout Period 1||2
587364|NCT00515502|1433022|P9|STARTED|Washout Period 1||0
587365|NCT00515502|1433023|P8|STARTED|Washout Period 1||1
587366|NCT00515502|1433024|P7|STARTED|Washout Period 1||1
587367|NCT00515502|1433025|P6|STARTED|Washout Period 1||1
587368|NCT00515502|1433026|P5|STARTED|Washout Period 1||3
587369|NCT00515502|1433027|P4|STARTED|Washout Period 1||3
587370|NCT00515502|1433028|P3|STARTED|Washout Period 1||4
587371|NCT00515502|1433029|P2|STARTED|Washout Period 1||4
587372|NCT00515502|1433030|P1|STARTED|Washout Period 1||1
587373|NCT00515502|1433019|P12|NOT COMPLETED|Treatment Period 1||1
587374|NCT00515502|1433020|P11|NOT COMPLETED|Treatment Period 1||0
587375|NCT00515502|1433021|P10|NOT COMPLETED|Treatment Period 1||0
587376|NCT00515502|1433022|P9|NOT COMPLETED|Treatment Period 1||1
587377|NCT00515502|1433023|P8|NOT COMPLETED|Treatment Period 1||0
587378|NCT00515502|1433024|P7|NOT COMPLETED|Treatment Period 1||1
587379|NCT00515502|1433025|P6|NOT COMPLETED|Treatment Period 1||0
587380|NCT00515502|1433026|P5|NOT COMPLETED|Treatment Period 1||0
587381|NCT00515502|1433027|P4|NOT COMPLETED|Treatment Period 1||0
587382|NCT00515502|1433028|P3|NOT COMPLETED|Treatment Period 1||0
587383|NCT00515502|1433029|P2|NOT COMPLETED|Treatment Period 1||0
587384|NCT00515502|1433030|P1|NOT COMPLETED|Treatment Period 1||0
587385|NCT00515502|1433019|P12|COMPLETED|Treatment Period 1||0
587386|NCT00515502|1433020|P11|COMPLETED|Treatment Period 1||1
587387|NCT00515502|1433021|P10|COMPLETED|Treatment Period 1||2
587388|NCT00515502|1433022|P9|COMPLETED|Treatment Period 1||0
587389|NCT00515502|1433023|P8|COMPLETED|Treatment Period 1||1
587390|NCT00515502|1433024|P7|COMPLETED|Treatment Period 1||1
587391|NCT00515502|1433025|P6|COMPLETED|Treatment Period 1||1
587392|NCT00515502|1433026|P5|COMPLETED|Treatment Period 1||3
587393|NCT00515502|1433027|P4|COMPLETED|Treatment Period 1||3
587394|NCT00515502|1433028|P3|COMPLETED|Treatment Period 1||4
587395|NCT00515502|1433029|P2|COMPLETED|Treatment Period 1||4
587396|NCT00515502|1433030|P1|COMPLETED|Treatment Period 1||1
587397|NCT00515502|1433019|P12|STARTED|Treatment Period 1||1
587398|NCT00515502|1433020|P11|STARTED|Treatment Period 1||1
587399|NCT00515502|1433021|P10|STARTED|Treatment Period 1||2
587400|NCT00515502|1433022|P9|STARTED|Treatment Period 1||1
587401|NCT00515502|1433023|P8|STARTED|Treatment Period 1||1
587402|NCT00515502|1433024|P7|STARTED|Treatment Period 1||2
587403|NCT00515502|1433025|P6|STARTED|Treatment Period 1||1
587404|NCT00515502|1433026|P5|STARTED|Treatment Period 1||3
587405|NCT00515502|1433027|P4|STARTED|Treatment Period 1||3
587406|NCT00515502|1433028|P3|STARTED|Treatment Period 1||4
587407|NCT00515502|1433029|P2|STARTED|Treatment Period 1||4
587408|NCT00515502|1433030|P1|STARTED|Treatment Period 1||1
587409|NCT00515463|1433190|P2|NOT COMPLETED|Overall Study||14
587410|NCT00515463|1433191|P1|NOT COMPLETED|Overall Study||14
587411|NCT00515463|1433190|P2|COMPLETED|Overall Study||142
587412|NCT00515463|1433191|P1|COMPLETED|Overall Study||141
587413|NCT00515463|1433190|P2|Received Study Medication|Overall Study||156
587414|NCT00515463|1433191|P1|Received Study Medication|Overall Study||154
587415|NCT00515463|1433190|P2|STARTED|Overall Study||156
587416|NCT00515463|1433191|P1|STARTED|Overall Study||155
587417|NCT00515437|1433345|P4|NOT COMPLETED|Overall Study||1
587418|NCT00515437|1433346|P3|NOT COMPLETED|Overall Study||0
587419|NCT00515437|1433347|P2|NOT COMPLETED|Overall Study||0
587420|NCT00515437|1433348|P1|NOT COMPLETED|Overall Study||0
587421|NCT00515437|1433345|P4|COMPLETED|Overall Study||14
587422|NCT00515437|1433346|P3|COMPLETED|Overall Study||13
587423|NCT00515437|1433347|P2|COMPLETED|Overall Study||12
587424|NCT00515437|1433348|P1|COMPLETED|Overall Study||14
587425|NCT00515437|1433345|P4|STARTED|Overall Study||15
587426|NCT00515437|1433346|P3|STARTED|Overall Study||13
587427|NCT00515437|1433347|P2|STARTED|Overall Study||12
587428|NCT00515437|1433348|P1|STARTED|Overall Study||14
587429|NCT00515294|1433374|P4|NOT COMPLETED|Overall Study||4
587430|NCT00515294|1433375|P3|NOT COMPLETED|Overall Study||11
587431|NCT00515294|1433376|P2|NOT COMPLETED|Overall Study||3
587432|NCT00515294|1433377|P1|NOT COMPLETED|Overall Study||9
587433|NCT00515294|1433374|P4|COMPLETED|Overall Study||35
587434|NCT00515294|1433375|P3|COMPLETED|Overall Study||27
587435|NCT00515294|1433376|P2|COMPLETED|Overall Study||36
587436|NCT00515294|1433377|P1|COMPLETED|Overall Study||29
587437|NCT00515294|1433374|P4|STARTED|Overall Study||39
587438|NCT00515294|1433375|P3|STARTED|Overall Study||38
587439|NCT00515294|1433376|P2|STARTED|Overall Study||39
587440|NCT00515294|1433377|P1|STARTED|Overall Study||38
587441|NCT00515216|1433391|P1|NOT COMPLETED|Overall Study||1
587442|NCT00515216|1433391|P1|COMPLETED|Overall Study||25
587443|NCT00515216|1433391|P1|STARTED|Overall Study||26
587444|NCT00515203|1433415|P2|NOT COMPLETED|Overall Study||0
587445|NCT00515203|1433416|P1|NOT COMPLETED|Overall Study||0
587446|NCT00515203|1433415|P2|COMPLETED|Overall Study||5
587447|NCT00515203|1433416|P1|COMPLETED|Overall Study||17
587448|NCT00515203|1433415|P2|STARTED|Overall Study||5
587449|NCT00515203|1433416|P1|STARTED|Overall Study||17
587450|NCT00515177|1433434|P2|NOT COMPLETED|Overall Study||1
587451|NCT00515177|1433435|P1|NOT COMPLETED|Overall Study||2
587452|NCT00515177|1433434|P2|COMPLETED|Overall Study||9
587453|NCT00515177|1433435|P1|COMPLETED|Overall Study||18
587454|NCT00515177|1433434|P2|STARTED|Overall Study||10
587455|NCT00515177|1433435|P1|STARTED|Overall Study||20
587456|NCT00515112|1433453|P2|NOT COMPLETED|Overall Study||3
587457|NCT00515112|1433454|P1|NOT COMPLETED|Overall Study||3
587458|NCT00515112|1433453|P2|COMPLETED|Overall Study||0
587459|NCT00515112|1433454|P1|COMPLETED|Overall Study||0
587460|NCT00515112|1433453|P2|STARTED|Overall Study||3
587461|NCT00515112|1433454|P1|STARTED|Overall Study||3
587462|NCT00515099|1433464|P2|NOT COMPLETED|Overall Study||4
587463|NCT00515099|1433465|P1|NOT COMPLETED|Overall Study||3
587464|NCT00515099|1433464|P2|COMPLETED|Overall Study||16
587465|NCT00515099|1433465|P1|COMPLETED|Overall Study||35
587466|NCT00515099|1433464|P2|STARTED|Overall Study||20
587467|NCT00515099|1433465|P1|STARTED|Overall Study||38
587468|NCT00515086|1433487|P4|NOT COMPLETED|Overall Study||6
587469|NCT00515086|1433488|P3|NOT COMPLETED|Overall Study||5
587470|NCT00515086|1433489|P2|NOT COMPLETED|Overall Study||6
587471|NCT00515086|1433490|P1|NOT COMPLETED|Overall Study||24
587472|NCT00515086|1433487|P4|COMPLETED|Overall Study||0
587473|NCT00515086|1433488|P3|COMPLETED|Overall Study||0
587474|NCT00515086|1433489|P2|COMPLETED|Overall Study||0
587475|NCT00515086|1433490|P1|COMPLETED|Overall Study||0
587476|NCT00515086|1433487|P4|STARTED|Overall Study||6
587477|NCT00515086|1433488|P3|STARTED|Overall Study||5
587478|NCT00515086|1433489|P2|STARTED|Overall Study||6
587479|NCT00515086|1433490|P1|STARTED|Overall Study||24
587480|NCT00515073|1433517|P1|NOT COMPLETED|Overall Study||2
587481|NCT00515073|1433517|P1|COMPLETED|Overall Study||28
587482|NCT00515073|1433517|P1|STARTED|Overall Study||30
587483|NCT00515034|1433525|P4|NOT COMPLETED|Overall Study||5
587484|NCT00515034|1433526|P3|NOT COMPLETED|Overall Study||8
587485|NCT00515034|1433527|P2|NOT COMPLETED|Overall Study||2
587486|NCT00515034|1433528|P1|NOT COMPLETED|Overall Study||8
587487|NCT00515034|1433525|P4|COMPLETED|Overall Study||15
587488|NCT00515034|1433526|P3|COMPLETED|Overall Study||54
587489|NCT00515034|1433527|P2|COMPLETED|Overall Study||13
587490|NCT00515034|1433528|P1|COMPLETED|Overall Study||41
587491|NCT00515034|1433525|P4|TREATED|Overall Study||19
587492|NCT00515034|1433526|P3|TREATED|Overall Study||61
587493|NCT00515034|1433527|P2|TREATED|Overall Study||15
587494|NCT00515034|1433528|P1|TREATED|Overall Study||48
587495|NCT00515034|1433525|P4|STARTED|Overall Study||20
587496|NCT00515034|1433526|P3|STARTED|Overall Study||62
587497|NCT00515034|1433527|P2|STARTED|Overall Study||15
587498|NCT00515034|1433528|P1|STARTED|Overall Study||49
587499|NCT00515008|1433548|P2|NOT COMPLETED|Overall Study||4
587500|NCT00515008|1433549|P1|NOT COMPLETED|Overall Study||3
587501|NCT00515008|1433548|P2|COMPLETED|Overall Study||29
587502|NCT00515008|1433549|P1|COMPLETED|Overall Study||30
587503|NCT00515008|1433548|P2|Completed 12 Week Evaluation|Overall Study||29
587504|NCT00515008|1433549|P1|Completed 12 Week Evaluation|Overall Study||32
587505|NCT00515008|1433548|P2|STARTED|Overall Study||33
587506|NCT00515008|1433549|P1|STARTED|Overall Study||33
587507|NCT00514943|1433573|P2|NOT COMPLETED|Stage 2||36
587508|NCT00514943|1433574|P1|NOT COMPLETED|Stage 2||32
587509|NCT00514943|1433573|P2|COMPLETED|Stage 2||0
587510|NCT00514943|1433574|P1|COMPLETED|Stage 2||0
587511|NCT00514943|1433573|P2|STARTED|Stage 2||36
587512|NCT00514943|1433574|P1|STARTED|Stage 2||32
587513|NCT00514943|1433573|P2|NOT COMPLETED|Stage 1||26
587514|NCT00514943|1433574|P1|NOT COMPLETED|Stage 1||30
587515|NCT00514943|1433573|P2|COMPLETED|Stage 1||36
587516|NCT00514943|1433574|P1|COMPLETED|Stage 1||32
587517|NCT00514943|1433573|P2|STARTED|Stage 1|2 randomized patients were not treated|62
587518|NCT00514943|1433574|P1|STARTED|Stage 1|1 randomized patient was not treated|62
587519|NCT00514917|1433632|P2|NOT COMPLETED|Overall Study||115
587520|NCT00514917|1433633|P1|NOT COMPLETED|Overall Study||126
587521|NCT00514917|1433632|P2|COMPLETED|Overall Study||91
587522|NCT00514917|1433633|P1|COMPLETED|Overall Study||81
587523|NCT00514917|1433632|P2|Testosterone-Specific Evaluable|Overall Study||124
587524|NCT00514917|1433633|P1|Testosterone-Specific Evaluable|Overall Study||122
587525|NCT00514917|1433632|P2|Completed Study Treatment|Overall Study||182
587526|NCT00514917|1433633|P1|Completed Study Treatment|Overall Study||170
587527|NCT00514917|1433632|P2|Treated|Overall Study||204
587528|NCT00514917|1433633|P1|Treated|Overall Study||196
587529|NCT00514917|1433632|P2|STARTED|Overall Study||206
587530|NCT00514917|1433633|P1|STARTED|Overall Study||207
587531|NCT00514904|1433661|P2|NOT COMPLETED|Overall Study||5
587532|NCT00514904|1433662|P1|NOT COMPLETED|Overall Study||24
587533|NCT00514904|1433661|P2|COMPLETED|Overall Study||371
587534|NCT00514904|1433662|P1|COMPLETED|Overall Study||1101
587535|NCT00514904|1433661|P2|STARTED|Overall Study||376
587536|NCT00514904|1433662|P1|STARTED|Overall Study||1125
587537|NCT00514852|1433698|P2|NOT COMPLETED|Overall Study||5
587538|NCT00514852|1433699|P1|NOT COMPLETED|Overall Study||5
587539|NCT00514852|1433698|P2|COMPLETED|Overall Study||154
587540|NCT00514852|1433699|P1|COMPLETED|Overall Study||152
587541|NCT00514852|1433698|P2|STARTED|Overall Study||159
587542|NCT00514852|1433699|P1|STARTED|Overall Study||157
587543|NCT00514813|1433727|P4|NOT COMPLETED|Overall Study||4
587544|NCT00514813|1433728|P3|NOT COMPLETED|Overall Study||47
587545|NCT00514813|1433729|P2|NOT COMPLETED|Overall Study||86
587546|NCT00514813|1433730|P1|NOT COMPLETED|Overall Study||15
587547|NCT00514813|1433727|P4|COMPLETED|Overall Study||0
587548|NCT00514813|1433728|P3|COMPLETED|Overall Study||0
587549|NCT00514813|1433729|P2|COMPLETED|Overall Study||0
587550|NCT00514813|1433730|P1|COMPLETED|Overall Study||0
587551|NCT00514813|1433727|P4|STARTED|Overall Study||4
587552|NCT00514813|1433728|P3|STARTED|Overall Study||47
587553|NCT00514813|1433729|P2|STARTED|Overall Study||86
587554|NCT00514813|1433730|P1|STARTED|Overall Study||15
587555|NCT00514735|1433750|P2|NOT COMPLETED|Overall Study||6
587556|NCT00514735|1433751|P1|NOT COMPLETED|Overall Study||14
587557|NCT00514735|1433750|P2|COMPLETED|Overall Study||66
587558|NCT00514735|1433751|P1|COMPLETED|Overall Study||124
587559|NCT00514735|1433750|P2|STARTED|Overall Study||72
587560|NCT00514735|1433751|P1|STARTED|Overall Study||138
587561|NCT00514709|1433771|P2|NOT COMPLETED|Overall Study||0
587562|NCT00514709|1433772|P1|NOT COMPLETED|Overall Study||0
587563|NCT00514709|1433771|P2|COMPLETED|Overall Study||613
587564|NCT00514709|1433772|P1|COMPLETED|Overall Study||1230
587565|NCT00514709|1433771|P2|STARTED|Overall Study||613
587566|NCT00514709|1433772|P1|STARTED|Overall Study||1230
587567|NCT00514683|1433787|P5|NOT COMPLETED|Overall Study||33
587568|NCT00514683|1433788|P4|NOT COMPLETED|Overall Study||14
587569|NCT00514683|1433789|P3|NOT COMPLETED|Overall Study||18
587570|NCT00514683|1433790|P2|NOT COMPLETED|Overall Study||25
587571|NCT00514683|1433791|P1|NOT COMPLETED|Overall Study||26
587572|NCT00514683|1433787|P5|COMPLETED|Overall Study||53
587573|NCT00514683|1433788|P4|COMPLETED|Overall Study||72
587574|NCT00514683|1433789|P3|COMPLETED|Overall Study||68
587575|NCT00514683|1433790|P2|COMPLETED|Overall Study||62
587576|NCT00514683|1433791|P1|COMPLETED|Overall Study||61
587577|NCT00514683|1433787|P5|STARTED|Overall Study|Randomised|86
587578|NCT00514683|1433788|P4|STARTED|Overall Study|Randomised|86
587579|NCT00514683|1433789|P3|STARTED|Overall Study|Randomised|86
587580|NCT00514683|1433790|P2|STARTED|Overall Study|Randomised|87
587581|NCT00514683|1433791|P1|STARTED|Overall Study|Randomised|87
587582|NCT00514592|1433982|P1|NOT COMPLETED|Overall Study||0
587583|NCT00514592|1433982|P1|COMPLETED|Overall Study||230
587584|NCT00514592|1433982|P1|STARTED|Overall Study||230
587585|NCT00514514|1433990|P3|NOT COMPLETED|Extension - 4 Years||21
587586|NCT00514514|1433991|P2|NOT COMPLETED|Extension - 4 Years||22
587587|NCT00514514|1433992|P1|NOT COMPLETED|Extension - 4 Years||37
587588|NCT00514514|1433990|P3|COMPLETED|Extension - 4 Years||113
587589|NCT00514514|1433991|P2|COMPLETED|Extension - 4 Years||117
587590|NCT00514514|1433992|P1|COMPLETED|Extension - 4 Years||108
587591|NCT00514514|1433990|P3|Non-randomized (Followed)|Extension - 4 Years||0
587592|NCT00514514|1433991|P2|Non-randomized (Followed)|Extension - 4 Years||0
587593|NCT00514514|1433992|P1|Non-randomized (Followed)|Extension - 4 Years|Patients were not randomized but continued on standard regimen and entered follow up.|95
587594|NCT00514514|1433990|P3|STARTED|Extension - 4 Years||134
587595|NCT00514514|1433991|P2|STARTED|Extension - 4 Years||139
587596|NCT00514514|1433992|P1|STARTED|Extension - 4 Years||145
587597|NCT00514514|1433990|P3|NOT COMPLETED|Randomized - 9 Month||38
587598|NCT00514514|1433991|P2|NOT COMPLETED|Randomized - 9 Month||61
587599|NCT00514514|1433992|P1|NOT COMPLETED|Randomized - 9 Month||39
587600|NCT00514514|1433990|P3|COMPLETED|Randomized - 9 Month||124
587601|NCT00514514|1433991|P2|COMPLETED|Randomized - 9 Month||110
587602|NCT00514514|1433992|P1|COMPLETED|Randomized - 9 Month||127
587603|NCT00514514|1433990|P3|Randomized - Received Treatment|Randomized - 9 Month||161
587604|NCT00514514|1433991|P2|Randomized - Received Treatment|Randomized - 9 Month||171
587605|NCT00514514|1433992|P1|Randomized - Received Treatment|Randomized - 9 Month||165
587606|NCT00514514|1433990|P3|STARTED|Randomized - 9 Month||162
587607|NCT00514514|1433991|P2|STARTED|Randomized - 9 Month||171
587608|NCT00514514|1433992|P1|STARTED|Randomized - 9 Month||166
587609|NCT00514514|1433990|P3|NOT COMPLETED|Pre-phase||0
587610|NCT00514514|1433991|P2|NOT COMPLETED|Pre-phase||0
587611|NCT00514514|1433992|P1|NOT COMPLETED|Pre-phase||303
587612|NCT00514514|1433990|P3|COMPLETED|Pre-phase||0
587613|NCT00514514|1433991|P2|COMPLETED|Pre-phase||0
587614|NCT00514514|1433992|P1|COMPLETED|Pre-phase||499
587615|NCT00514514|1433990|P3|STARTED|Pre-phase||0
587616|NCT00514514|1433991|P2|STARTED|Pre-phase||0
587617|NCT00514514|1433992|P1|STARTED|Pre-phase|All enrolled patients received standard regimen for 3 months|802
587618|NCT00514501|1434036|P1|NOT COMPLETED|Overall Study||3
587619|NCT00514501|1434036|P1|COMPLETED|Overall Study||507
587620|NCT00514501|1434036|P1|STARTED|Overall Study||510
587621|NCT00514449|1434044|P2|NOT COMPLETED|Overall Study||4
587622|NCT00514449|1434045|P1|NOT COMPLETED|Overall Study||3
587623|NCT00514449|1434044|P2|COMPLETED|Overall Study||8
587624|NCT00514449|1434045|P1|COMPLETED|Overall Study||9
587625|NCT00514449|1434044|P2|STARTED|Overall Study||12
587626|NCT00514449|1434045|P1|STARTED|Overall Study||12
587627|NCT00514215|1434055|P1|NOT COMPLETED|Overall Study||0
587628|NCT00514215|1434055|P1|COMPLETED|Overall Study||8
587629|NCT00514215|1434055|P1|STARTED|Overall Study||8
587630|NCT00514137|1434059|P1|NOT COMPLETED|Overall Study||0
587631|NCT00514137|1434059|P1|COMPLETED|Overall Study||13
587632|NCT00514137|1434059|P1|STARTED|Overall Study||13
587633|NCT00514020|1434066|P1|NOT COMPLETED|Overall Study||28
587634|NCT00514020|1434066|P1|COMPLETED|Overall Study||5
587635|NCT00514020|1434066|P1|STARTED|Overall Study|two patients withdrew before treatment; one withdrew after treatment|33
587636|NCT00513799|1434074|P4|NOT COMPLETED|Four-Month Follow-Up||3
587637|NCT00513799|1434075|P3|NOT COMPLETED|Four-Month Follow-Up||7
587638|NCT00513799|1434076|P2|NOT COMPLETED|Four-Month Follow-Up||5
587639|NCT00513799|1434077|P1|NOT COMPLETED|Four-Month Follow-Up||0
587640|NCT00513799|1434074|P4|COMPLETED|Four-Month Follow-Up||51
587641|NCT00513799|1434075|P3|COMPLETED|Four-Month Follow-Up||57
587642|NCT00513799|1434076|P2|COMPLETED|Four-Month Follow-Up||57
587643|NCT00513799|1434077|P1|COMPLETED|Four-Month Follow-Up||64
587644|NCT00513799|1434074|P4|STARTED|Four-Month Follow-Up||54
587645|NCT00513799|1434075|P3|STARTED|Four-Month Follow-Up||64
587646|NCT00513799|1434076|P2|STARTED|Four-Month Follow-Up||62
587647|NCT00513799|1434077|P1|STARTED|Four-Month Follow-Up||64
587648|NCT00513799|1434074|P4|NOT COMPLETED|One-Month Follow-Up||21
587649|NCT00513799|1434075|P3|NOT COMPLETED|One-Month Follow-Up||11
587650|NCT00513799|1434076|P2|NOT COMPLETED|One-Month Follow-Up||13
587651|NCT00513799|1434077|P1|NOT COMPLETED|One-Month Follow-Up||11
587652|NCT00513799|1434074|P4|COMPLETED|One-Month Follow-Up||54
587653|NCT00513799|1434075|P3|COMPLETED|One-Month Follow-Up||64
587654|NCT00513799|1434076|P2|COMPLETED|One-Month Follow-Up||62
587655|NCT00513799|1434077|P1|COMPLETED|One-Month Follow-Up||64
587656|NCT00513799|1434074|P4|STARTED|One-Month Follow-Up||75
587657|NCT00513799|1434075|P3|STARTED|One-Month Follow-Up||75
587658|NCT00513799|1434076|P2|STARTED|One-Month Follow-Up||75
587659|NCT00513799|1434077|P1|STARTED|One-Month Follow-Up||75
587660|NCT00513708|1434098|P3|NOT COMPLETED|Overall Study||4
587661|NCT00513708|1434099|P2|NOT COMPLETED|Overall Study||4
587662|NCT00513708|1434100|P1|NOT COMPLETED|Overall Study||4
587663|NCT00513708|1434098|P3|COMPLETED|Overall Study||46
587664|NCT00513708|1434099|P2|COMPLETED|Overall Study||46
587665|NCT00513708|1434100|P1|COMPLETED|Overall Study||46
587666|NCT00513708|1434098|P3|STARTED|Overall Study||50
587667|NCT00513708|1434099|P2|STARTED|Overall Study||50
587668|NCT00513708|1434100|P1|STARTED|Overall Study||50
587669|NCT00513695|1434114|P1|NOT COMPLETED|Overall Study||5
587670|NCT00513695|1434114|P1|COMPLETED|Overall Study||63
587671|NCT00513695|1434114|P1|STARTED|Overall Study||68
587672|NCT00513682|1434123|P1|NOT COMPLETED|Treatment Phase||0
587673|NCT00513682|1434123|P1|COMPLETED|Treatment Phase||7
587674|NCT00513682|1434123|P1|STARTED|Treatment Phase||7
587675|NCT00513682|1434123|P1|NOT COMPLETED|Washout Phase||2
587676|NCT00513682|1434123|P1|COMPLETED|Washout Phase||7
587677|NCT00513682|1434123|P1|STARTED|Washout Phase||9
587678|NCT00513682|1434123|P1|NOT COMPLETED|Screening Phase||0
587679|NCT00513682|1434123|P1|COMPLETED|Screening Phase||9
587680|NCT00513682|1434123|P1|STARTED|Screening Phase||9
587681|NCT00513617|1434135|P3|NOT COMPLETED|Overall Study||8
587682|NCT00513617|1434136|P2|NOT COMPLETED|Overall Study||10
587683|NCT00513617|1434137|P1|NOT COMPLETED|Overall Study||11
587684|NCT00513617|1434135|P3|COMPLETED|Overall Study||30
587685|NCT00513617|1434136|P2|COMPLETED|Overall Study||25
587686|NCT00513617|1434137|P1|COMPLETED|Overall Study||25
587687|NCT00513617|1434135|P3|STARTED|Overall Study||38
587688|NCT00513617|1434136|P2|STARTED|Overall Study||35
587689|NCT00513617|1434137|P1|STARTED|Overall Study||36
587690|NCT00513604|1434153|P5|NOT COMPLETED|Overall Study||0
587691|NCT00513604|1434154|P4|NOT COMPLETED|Overall Study||0
587692|NCT00513604|1434155|P3|NOT COMPLETED|Overall Study||3
587693|NCT00513604|1434156|P2|NOT COMPLETED|Overall Study||3
587694|NCT00513604|1434157|P1|NOT COMPLETED|Overall Study||2
587695|NCT00513604|1434153|P5|COMPLETED|Overall Study||35
587696|NCT00513604|1434154|P4|COMPLETED|Overall Study||34
587697|NCT00513604|1434155|P3|COMPLETED|Overall Study||21
587698|NCT00513604|1434156|P2|COMPLETED|Overall Study||36
587699|NCT00513604|1434157|P1|COMPLETED|Overall Study||24
587700|NCT00513604|1434153|P5|STARTED|Overall Study|Cohort 5 = CD4+ depleted TIL-it is the SAME as cohort 2|35
587701|NCT00513604|1434154|P4|STARTED|Overall Study|Cohort 4 = unselected TIL - it is the SAME as cohort 1|34
587702|NCT00513604|1434155|P3|STARTED|Overall Study|Cohort 3 = CD4+ depleted (selected) TIL + 600Gy radiation|24
587703|NCT00513604|1434156|P2|STARTED|Overall Study|Cohort 2 = CD4+ depleted (selected) TIL|39
587704|NCT00513604|1434157|P1|STARTED|Overall Study|Cohort 1 = unselected TIL|26
587705|NCT00513526|1434174|P1|NOT COMPLETED|Overall Study||17
587706|NCT00513526|1434174|P1|COMPLETED|Overall Study||92
587707|NCT00513526|1434174|P1|STARTED|Overall Study||109
587708|NCT00513500|1434191|P2|NOT COMPLETED|Overall Study||54
587709|NCT00513500|1434192|P1|NOT COMPLETED|Overall Study||41
587710|NCT00513500|1434191|P2|COMPLETED|Overall Study||2054
587711|NCT00513500|1434192|P1|COMPLETED|Overall Study||976
587712|NCT00513500|1434191|P2|STARTED|Overall Study||2108
587713|NCT00513500|1434192|P1|STARTED|Overall Study||1017
587714|NCT00513474|1434204|P2|NOT COMPLETED|Overall Study||9
587715|NCT00513474|1434205|P1|NOT COMPLETED|Overall Study||7
587716|NCT00513474|1434204|P2|COMPLETED|Overall Study||12
587717|NCT00513474|1434205|P1|COMPLETED|Overall Study||18
587718|NCT00513474|1434204|P2|Received Rasburicase Per Protocol|Overall Study||0
587719|NCT00513474|1434205|P1|Received Rasburicase Per Protocol|Overall Study||24
587720|NCT00513474|1434204|P2|STARTED|Overall Study||21
587721|NCT00513474|1434205|P1|STARTED|Overall Study||25
587722|NCT00513435|1434217|P1|NOT COMPLETED|Overall Study||0
587723|NCT00513435|1434217|P1|COMPLETED|Overall Study||9
587724|NCT00513435|1434217|P1|STARTED|Overall Study||9
587725|NCT00513409|1434224|P2|NOT COMPLETED|Overall Study||6
587726|NCT00513409|1434225|P1|NOT COMPLETED|Overall Study||2
587727|NCT00513409|1434224|P2|COMPLETED|Overall Study||73
587728|NCT00513409|1434225|P1|COMPLETED|Overall Study||82
587729|NCT00513409|1434224|P2|STARTED|Overall Study||79
587730|NCT00513409|1434225|P1|STARTED|Overall Study||84
587731|NCT00513370|1434251|P1|NOT COMPLETED|Overall Study||24
587732|NCT00513370|1434251|P1|COMPLETED|Overall Study||179
587733|NCT00513370|1434251|P1|STARTED|Overall Study||203
587734|NCT00513357|1434281|P2|NOT COMPLETED|Overall Study||10
587735|NCT00513357|1434282|P1|NOT COMPLETED|Overall Study||15
587736|NCT00513357|1434281|P2|COMPLETED|Overall Study||25
587737|NCT00513357|1434282|P1|COMPLETED|Overall Study||23
587738|NCT00513357|1434281|P2|STARTED|Overall Study||35
587739|NCT00513357|1434282|P1|STARTED|Overall Study||38
587740|NCT00513344|1434288|P1|NOT COMPLETED|3rd Intervention 1 Day||0
587741|NCT00513344|1434288|P1|COMPLETED|3rd Intervention 1 Day||5
587742|NCT00513344|1434288|P1|STARTED|3rd Intervention 1 Day||5
587743|NCT00513344|1434288|P1|NOT COMPLETED|Washout Period 3 Days||0
587744|NCT00513344|1434288|P1|COMPLETED|Washout Period 3 Days||5
587745|NCT00513344|1434288|P1|STARTED|Washout Period 3 Days||5
587746|NCT00513344|1434288|P1|NOT COMPLETED|2nd Intervention 1 Day||0
587747|NCT00513344|1434288|P1|COMPLETED|2nd Intervention 1 Day||5
587748|NCT00513344|1434288|P1|STARTED|2nd Intervention 1 Day||5
587749|NCT00513344|1434288|P1|NOT COMPLETED|Washout Period 3 Days||0
587750|NCT00513344|1434288|P1|COMPLETED|Washout Period 3 Days||5
587751|NCT00513344|1434288|P1|STARTED|Washout Period 3 Days||5
587752|NCT00513344|1434288|P1|NOT COMPLETED|1st Intervention 1 Day||0
587753|NCT00513344|1434288|P1|COMPLETED|1st Intervention 1 Day||5
587754|NCT00513344|1434288|P1|STARTED|1st Intervention 1 Day||5
587755|NCT00513344|1434288|P1|NOT COMPLETED|Diet Restriction (3 Days)||0
587756|NCT00513344|1434288|P1|COMPLETED|Diet Restriction (3 Days)||5
587757|NCT00513344|1434288|P1|STARTED|Diet Restriction (3 Days)||5
587758|NCT00513305|1434301|P2|NOT COMPLETED|Overall Study||27
587759|NCT00513305|1434302|P1|NOT COMPLETED|Overall Study||28
587760|NCT00513305|1434301|P2|COMPLETED|Overall Study||7
587761|NCT00513305|1434302|P1|COMPLETED|Overall Study||5
587762|NCT00513305|1434301|P2|STARTED|Overall Study|One subject withdrew prior to receiving study medication|34
587763|NCT00513305|1434302|P1|STARTED|Overall Study||33
587764|NCT00513292|1434320|P2|NOT COMPLETED|Overall Study||0
587765|NCT00513292|1434321|P1|NOT COMPLETED|Overall Study||0
587766|NCT00513292|1434320|P2|COMPLETED|Overall Study||142
587767|NCT00513292|1434321|P1|COMPLETED|Overall Study||138
587768|NCT00513292|1434320|P2|STARTED|Overall Study||142
587769|NCT00513292|1434321|P1|STARTED|Overall Study||138
587770|NCT00513240|1434339|P2|NOT COMPLETED|Overall Study||7
587771|NCT00513240|1434340|P1|NOT COMPLETED|Overall Study||13
587772|NCT00513240|1434339|P2|COMPLETED|Overall Study|Competed 12 month neurodevelopmental exam, which are the only results published at this time.|20
587773|NCT00513240|1434340|P1|COMPLETED|Overall Study|Competed 12 month neurodevelopmental exam, which are the only results published at this time.|22
587774|NCT00513240|1434339|P2|Clinical Data Collection &Pre/Postop MRI|Overall Study||27
587775|NCT00513240|1434340|P1|Clinical Data Collection &Pre/Postop MRI|Overall Study|3 not having intended surgery are subtracted from original 35 subjects, leaving 32|32
587776|NCT00513240|1434339|P2|STARTED|Overall Study|25 had 3 doses; 1 had 1 dose due to rash; 1 had 2 doses and 1 dose of EPO due to pharmacy error|27
587777|NCT00513240|1434340|P1|STARTED|Overall Study|3 did not have intended surgery; 28 had all 3 doses; 4 had 1 dose but no more due to delayed surgery|35
587778|NCT00513071|1434347|P1|NOT COMPLETED|Overall Study||5
587779|NCT00513071|1434347|P1|COMPLETED|Overall Study||23
587780|NCT00513071|1434347|P1|STARTED|Overall Study||28
587781|NCT00513019|1434359|P2|NOT COMPLETED|Overall Study||5
587782|NCT00513019|1434360|P1|NOT COMPLETED|Overall Study||5
587783|NCT00513019|1434359|P2|COMPLETED|Overall Study||13
587784|NCT00513019|1434360|P1|COMPLETED|Overall Study||12
587785|NCT00513019|1434359|P2|STARTED|Overall Study||18
587786|NCT00513019|1434360|P1|STARTED|Overall Study||17
587787|NCT00512902|1434366|P1|NOT COMPLETED|Overall Study||8
587788|NCT00512902|1434366|P1|COMPLETED|Overall Study||12
587789|NCT00512902|1434366|P1|STARTED|Overall Study||20
587790|NCT00512876|1434374|P1|NOT COMPLETED|Overall Study||4
587791|NCT00512876|1434374|P1|COMPLETED|Overall Study||20
587792|NCT00512876|1434374|P1|STARTED|Overall Study||24
587793|NCT00512798|1434381|P2|NOT COMPLETED|Overall Study||27
587794|NCT00512798|1434382|P1|NOT COMPLETED|Overall Study||19
587795|NCT00512798|1434381|P2|COMPLETED|Overall Study||1
587796|NCT00512798|1434382|P1|COMPLETED|Overall Study||0
587797|NCT00512798|1434381|P2|STARTED|Overall Study||28
587798|NCT00512798|1434382|P1|STARTED|Overall Study||19
587799|NCT00512707|1434393|P2|NOT COMPLETED|Overall Study||12
587800|NCT00512707|1434394|P1|NOT COMPLETED|Overall Study||10
587801|NCT00512707|1434393|P2|COMPLETED|Overall Study||58
587802|NCT00512707|1434394|P1|COMPLETED|Overall Study||60
587803|NCT00512707|1434393|P2|STARTED|Overall Study||70
587804|NCT00512707|1434394|P1|STARTED|Overall Study||70
587805|NCT00512278|1434426|P2|NOT COMPLETED|Overall Study||17
587806|NCT00512278|1434427|P1|NOT COMPLETED|Overall Study||28
587807|NCT00512278|1434426|P2|COMPLETED|Overall Study||56
587808|NCT00512278|1434427|P1|COMPLETED|Overall Study||45
587809|NCT00512278|1434426|P2|STARTED|Overall Study||73
587810|NCT00512278|1434427|P1|STARTED|Overall Study||73
587811|NCT00512252|1434444|P3|NOT COMPLETED|Overall Study||3
587812|NCT00512252|1434445|P2|NOT COMPLETED|Overall Study||0
587813|NCT00512252|1434446|P1|NOT COMPLETED|Overall Study||0
587814|NCT00512252|1434444|P3|COMPLETED|Overall Study||43
587815|NCT00512252|1434445|P2|COMPLETED|Overall Study||3
587816|NCT00512252|1434446|P1|COMPLETED|Overall Study||3
587817|NCT00512252|1434444|P3|STARTED|Overall Study||46
587818|NCT00512252|1434445|P2|STARTED|Overall Study||3
587819|NCT00512252|1434446|P1|STARTED|Overall Study||3
587820|NCT00512148|1434474|P1|NOT COMPLETED|Long Term Follow Up Period||6
587821|NCT00512148|1434474|P1|COMPLETED|Long Term Follow Up Period|6 patients are being followed in long term follow up|0
587822|NCT00512148|1434474|P1|STARTED|Long Term Follow Up Period||6
587823|NCT00512148|1434474|P1|NOT COMPLETED|Primay Study Period||1
587824|NCT00512148|1434474|P1|COMPLETED|Primay Study Period||6
587825|NCT00512148|1434474|P1|STARTED|Primay Study Period||7
587826|NCT00512096|1434479|P1|NOT COMPLETED|Overall Study||7
587827|NCT00512096|1434479|P1|COMPLETED|Overall Study||23
587828|NCT00512096|1434479|P1|STARTED|Overall Study||30
587829|NCT00511992|1434483|P1|NOT COMPLETED|Overall Study||7
587830|NCT00511992|1434483|P1|COMPLETED|Overall Study||13
587831|NCT00511992|1434483|P1|STARTED|Overall Study||20
587832|NCT00511914|1434490|P2|NOT COMPLETED|Overall Study||0
587833|NCT00511914|1434491|P1|NOT COMPLETED|Overall Study||0
587834|NCT00511914|1434490|P2|COMPLETED|Overall Study||67
587835|NCT00511914|1434491|P1|COMPLETED|Overall Study||68
587836|NCT00511914|1434490|P2|STARTED|Overall Study||67
587837|NCT00511914|1434491|P1|STARTED|Overall Study||68
587838|NCT00511901|1434507|P2|NOT COMPLETED|Overall Study||3
587839|NCT00511901|1434508|P1|NOT COMPLETED|Overall Study||1
587840|NCT00511901|1434507|P2|COMPLETED|Overall Study||8
587841|NCT00511901|1434508|P1|COMPLETED|Overall Study||10
587842|NCT00511901|1434507|P2|STARTED|Overall Study||11
587843|NCT00511901|1434508|P1|STARTED|Overall Study||11
587844|NCT00511862|1434531|P3|NOT COMPLETED|Overall Study||0
587845|NCT00511862|1434532|P2|NOT COMPLETED|Overall Study||0
587846|NCT00511862|1434533|P1|NOT COMPLETED|Overall Study||0
587847|NCT00511862|1434531|P3|COMPLETED|Overall Study||47
587848|NCT00511862|1434532|P2|COMPLETED|Overall Study||43
587849|NCT00511862|1434533|P1|COMPLETED|Overall Study||61
587850|NCT00511862|1434531|P3|STARTED|Overall Study||47
587851|NCT00511862|1434532|P2|STARTED|Overall Study||43
587852|NCT00511862|1434533|P1|STARTED|Overall Study||61
587853|NCT00511836|1434546|P2|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||0
587854|NCT00511836|1434547|P1|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||16
587855|NCT00511836|1434546|P2|COMPLETED|Optional Open-label VIVITROL (2 Months)||0
587856|NCT00511836|1434547|P1|COMPLETED|Optional Open-label VIVITROL (2 Months)||6
587857|NCT00511836|1434546|P2|STARTED|Optional Open-label VIVITROL (2 Months)|Not all subjects from the double-blind phase entered the optional open-label extension.|0
587858|NCT00511836|1434547|P1|STARTED|Optional Open-label VIVITROL (2 Months)|Subjects who received placebo during Month 1 switched to VIVITROL for the optional extension phase.|22
587859|NCT00511836|1434546|P2|NOT COMPLETED|Double-blind Period||0
587860|NCT00511836|1434547|P1|NOT COMPLETED|Double-blind Period||1
587861|NCT00511836|1434546|P2|COMPLETED|Double-blind Period||15
587862|NCT00511836|1434547|P1|COMPLETED|Double-blind Period||15
587863|NCT00511836|1434546|P2|STARTED|Double-blind Period||15
587864|NCT00511836|1434547|P1|STARTED|Double-blind Period||16
587865|NCT00511810|1434564|P2|NOT COMPLETED|Overall Study||5
587866|NCT00511810|1434565|P1|NOT COMPLETED|Overall Study||1
587867|NCT00511810|1434564|P2|COMPLETED|Overall Study|2 terminated for worsening symptoms;1 refused a scan;2 lost to follow up (could not be contacted)|7
587868|NCT00511810|1434565|P1|COMPLETED|Overall Study||7
587869|NCT00511810|1434564|P2|STARTED|Overall Study||12
587870|NCT00511810|1434565|P1|STARTED|Overall Study||8
587871|NCT00511797|1434575|P4|NOT COMPLETED|Overall Study||15
587872|NCT00511797|1434576|P3|NOT COMPLETED|Overall Study||11
587873|NCT00511797|1434577|P2|NOT COMPLETED|Overall Study||8
587874|NCT00511797|1434578|P1|NOT COMPLETED|Overall Study||7
587875|NCT00511797|1434575|P4|COMPLETED|Overall Study||47
587876|NCT00511797|1434576|P3|COMPLETED|Overall Study||51
587877|NCT00511797|1434577|P2|COMPLETED|Overall Study||55
587878|NCT00511797|1434578|P1|COMPLETED|Overall Study||55
587879|NCT00511797|1434575|P4|Subjects Received Treatment|Overall Study|FAS|58
587880|NCT00511797|1434576|P3|Subjects Received Treatment|Overall Study|FAS|61
587881|NCT00511797|1434577|P2|Subjects Received Treatment|Overall Study|FAS|62
587882|NCT00511797|1434578|P1|Subjects Received Treatment|Overall Study|FAS|61
587883|NCT00511797|1434575|P4|Subjects Dispensed Drugs|Overall Study||59
587884|NCT00511797|1434576|P3|Subjects Dispensed Drugs|Overall Study||61
587885|NCT00511797|1434577|P2|Subjects Dispensed Drugs|Overall Study||63
587886|NCT00511797|1434578|P1|Subjects Dispensed Drugs|Overall Study||61
587887|NCT00511797|1434575|P4|STARTED|Overall Study||62
587888|NCT00511797|1434576|P3|STARTED|Overall Study||62
587889|NCT00511797|1434577|P2|STARTED|Overall Study||63
587890|NCT00511797|1434578|P1|STARTED|Overall Study||62
587891|NCT00511706|1434682|P2|NOT COMPLETED|Overall Study||5
587892|NCT00511706|1434683|P1|NOT COMPLETED|Overall Study||8
587893|NCT00511706|1434682|P2|COMPLETED|Overall Study||115
587894|NCT00511706|1434683|P1|COMPLETED|Overall Study||115
587895|NCT00511706|1434682|P2|STARTED|Overall Study||120
587896|NCT00511706|1434683|P1|STARTED|Overall Study||123
587897|NCT00511667|1434697|P2|NOT COMPLETED|Overall Study||3
587898|NCT00511667|1434698|P1|NOT COMPLETED|Overall Study||12
587899|NCT00511667|1434697|P2|COMPLETED|Overall Study||15
587900|NCT00511667|1434698|P1|COMPLETED|Overall Study||40
587901|NCT00511667|1434697|P2|STARTED|Overall Study||18
587902|NCT00511667|1434698|P1|STARTED|Overall Study||52
587903|NCT00511472|1434733|P2|NOT COMPLETED|Overall Study||6
587904|NCT00511472|1434734|P1|NOT COMPLETED|Overall Study||3
587905|NCT00511472|1434733|P2|COMPLETED|Overall Study||17
587906|NCT00511472|1434734|P1|COMPLETED|Overall Study||44
587907|NCT00511472|1434733|P2|STARTED|Overall Study||23
587908|NCT00511472|1434734|P1|STARTED|Overall Study||47
587909|NCT00511433|1434753|P2|NOT COMPLETED|Overall Study||1
587910|NCT00511433|1434754|P1|NOT COMPLETED|Overall Study||6
587911|NCT00511433|1434753|P2|COMPLETED|Overall Study||15
587912|NCT00511433|1434754|P1|COMPLETED|Overall Study||26
587913|NCT00511433|1434753|P2|STARTED|Overall Study||16
587914|NCT00511433|1434754|P1|STARTED|Overall Study||32
587915|NCT00511355|1434794|P2|NOT COMPLETED|Overall Study||9
587916|NCT00511355|1434795|P1|NOT COMPLETED|Overall Study||7
587917|NCT00511355|1434794|P2|COMPLETED|Overall Study||52
587918|NCT00511355|1434795|P1|COMPLETED|Overall Study||53
587919|NCT00511355|1434794|P2|STARTED|Overall Study||61
587920|NCT00511355|1434795|P1|STARTED|Overall Study||60
587921|NCT00511342|1434895|P2|NOT COMPLETED|Overall Study||22
587922|NCT00511342|1434896|P1|NOT COMPLETED|Overall Study||13
587923|NCT00511342|1434895|P2|COMPLETED|Overall Study||32
587924|NCT00511342|1434896|P1|COMPLETED|Overall Study||43
587925|NCT00511342|1434895|P2|STARTED|Overall Study||54
587926|NCT00511342|1434896|P1|STARTED|Overall Study||56
587927|NCT00511329|1434920|P1|NOT COMPLETED|Overall Study||0
587928|NCT00511329|1434920|P1|COMPLETED|Overall Study||0
587929|NCT00511329|1434920|P1|STARTED|Overall Study||0
587930|NCT00511238|1434927|P2|NOT COMPLETED|Overall Study||226
587931|NCT00511238|1434928|P1|NOT COMPLETED|Overall Study||42
587932|NCT00511238|1434927|P2|COMPLETED|Overall Study|Number of patients who completed 12 cycles of treatment|40
587933|NCT00511238|1434928|P1|COMPLETED|Overall Study|Number of patients who completed 12 cycles of treatment|4
587934|NCT00511238|1434927|P2|STARTED|Overall Study||266
587935|NCT00511238|1434928|P1|STARTED|Overall Study||46
587936|NCT00511199|1434947|P2|NOT COMPLETED|Overall Study||125
587937|NCT00511199|1434948|P1|NOT COMPLETED|Overall Study||449
587938|NCT00511199|1434947|P2|COMPLETED|Overall Study||410
587939|NCT00511199|1434948|P1|COMPLETED|Overall Study||1142
587940|NCT00511199|1434947|P2|STARTED|Overall Study||535
587941|NCT00511199|1434948|P1|STARTED|Overall Study||1591
587942|NCT00511173|1434972|P1|NOT COMPLETED|Overall Study||0
587943|NCT00511173|1434972|P1|COMPLETED|Overall Study||102
587944|NCT00511173|1434972|P1|STARTED|Overall Study||102
587945|NCT00511147|1434977|P1|NOT COMPLETED|Overall Study||7
587946|NCT00511147|1434977|P1|COMPLETED|Overall Study||57
587947|NCT00511147|1434977|P1|STARTED|Overall Study||64
587948|NCT00511134|1434986|P2|NOT COMPLETED|Overall Study||2
587949|NCT00511134|1434987|P1|NOT COMPLETED|Overall Study||0
587950|NCT00511134|1434986|P2|COMPLETED|Overall Study||1
587951|NCT00511134|1434987|P1|COMPLETED|Overall Study||1
587952|NCT00511134|1434986|P2|STARTED|Overall Study||3
587953|NCT00511134|1434987|P1|STARTED|Overall Study||1
587954|NCT00511108|1434999|P4|NOT COMPLETED|Overall Study||5
587955|NCT00511108|1435000|P3|NOT COMPLETED|Overall Study||5
587956|NCT00511108|1435001|P2|NOT COMPLETED|Overall Study||2
587957|NCT00511108|1435002|P1|NOT COMPLETED|Overall Study||6
587958|NCT00511108|1434999|P4|COMPLETED|Overall Study||48
587959|NCT00511108|1435000|P3|COMPLETED|Overall Study||47
587960|NCT00511108|1435001|P2|COMPLETED|Overall Study||52
587961|NCT00511108|1435002|P1|COMPLETED|Overall Study||46
587962|NCT00511108|1434999|P4|STARTED|Overall Study||53
587963|NCT00511108|1435000|P3|STARTED|Overall Study||52
587964|NCT00511108|1435001|P2|STARTED|Overall Study||54
587965|NCT00511108|1435002|P1|STARTED|Overall Study||52
587966|NCT00511095|1435020|P1|NOT COMPLETED|Overall Study||11
587967|NCT00511095|1435020|P1|COMPLETED|Overall Study||196
587968|NCT00511095|1435020|P1|STARTED|Overall Study||207
587969|NCT00511004|1435029|P3|NOT COMPLETED|Overall Study||4
587970|NCT00511004|1435030|P2|NOT COMPLETED|Overall Study||0
587971|NCT00511004|1435031|P1|NOT COMPLETED|Overall Study||0
587972|NCT00511004|1435029|P3|COMPLETED|Overall Study||10
587973|NCT00511004|1435030|P2|COMPLETED|Overall Study||13
587974|NCT00511004|1435031|P1|COMPLETED|Overall Study||13
587975|NCT00511004|1435029|P3|STARTED|Overall Study||14
587976|NCT00511004|1435030|P2|STARTED|Overall Study||13
587977|NCT00511004|1435031|P1|STARTED|Overall Study||13
587978|NCT00510952|1435050|P2|NOT COMPLETED|Overall Study||16
587979|NCT00510952|1435051|P1|NOT COMPLETED|Overall Study||26
587980|NCT00510952|1435050|P2|COMPLETED|Overall Study||220
587981|NCT00510952|1435051|P1|COMPLETED|Overall Study||209
587982|NCT00510952|1435050|P2|Full Analysis Set (Intent to Treat)|Overall Study||229
587983|NCT00510952|1435051|P1|Full Analysis Set (Intent to Treat)|Overall Study||229
587984|NCT00510952|1435050|P2|STARTED|Overall Study||236
587985|NCT00510952|1435051|P1|STARTED|Overall Study||235
587986|NCT00510887|1435077|P1|NOT COMPLETED|Overall Study||1
587987|NCT00510887|1435077|P1|COMPLETED|Overall Study||11
587988|NCT00510887|1435077|P1|STARTED|Overall Study||12
587989|NCT00510874|1435093|P7|NOT COMPLETED|Overall Study||1
587990|NCT00510874|1435094|P6|NOT COMPLETED|Overall Study||0
587991|NCT00510874|1435095|P5|NOT COMPLETED|Overall Study||7
587992|NCT00510874|1435096|P4|NOT COMPLETED|Overall Study||3
587993|NCT00510874|1435097|P3|NOT COMPLETED|Overall Study||1
587994|NCT00510874|1435098|P2|NOT COMPLETED|Overall Study||4
587995|NCT00510874|1435099|P1|NOT COMPLETED|Overall Study||3
587996|NCT00510874|1435093|P7|COMPLETED|Overall Study|Upto Day 182|49
587997|NCT00510874|1435094|P6|COMPLETED|Overall Study|Upto Day 182|50
587998|NCT00510874|1435095|P5|COMPLETED|Overall Study|Upto Day 182|141
587999|NCT00510874|1435096|P4|COMPLETED|Overall Study|Upto Day 182|148
588000|NCT00510874|1435097|P3|COMPLETED|Overall Study|Upto Day 182|150
588001|NCT00510874|1435098|P2|COMPLETED|Overall Study|Upto Day 182|148
588002|NCT00510874|1435099|P1|COMPLETED|Overall Study|Upto Day 182|75
588003|NCT00510874|1435093|P7|STARTED|Overall Study||50
588004|NCT00510874|1435094|P6|STARTED|Overall Study||50
588005|NCT00510874|1435095|P5|STARTED|Overall Study||148
588006|NCT00510874|1435096|P4|STARTED|Overall Study||151
588007|NCT00510874|1435097|P3|STARTED|Overall Study||151
588008|NCT00510874|1435098|P2|STARTED|Overall Study||152
588009|NCT00510874|1435099|P1|STARTED|Overall Study||78
588010|NCT00510835|1435202|P3|NOT COMPLETED|Overall Study||2
588011|NCT00510835|1435203|P2|NOT COMPLETED|Overall Study||2
588012|NCT00510835|1435204|P1|NOT COMPLETED|Overall Study||6
588013|NCT00510835|1435202|P3|COMPLETED|Overall Study||456
588014|NCT00510835|1435203|P2|COMPLETED|Overall Study||446
588015|NCT00510835|1435204|P1|COMPLETED|Overall Study||439
588016|NCT00510835|1435202|P3|STARTED|Overall Study||458
588017|NCT00510835|1435203|P2|STARTED|Overall Study||448
588018|NCT00510835|1435204|P1|STARTED|Overall Study||445
588019|NCT00510809|1435215|P3|NOT COMPLETED|Overall Study||0
588020|NCT00510809|1435216|P2|NOT COMPLETED|Overall Study||0
588021|NCT00510809|1435217|P1|NOT COMPLETED|Overall Study||0
588022|NCT00510809|1435215|P3|COMPLETED|Overall Study||18
588023|NCT00510809|1435216|P2|COMPLETED|Overall Study||18
588024|NCT00510809|1435217|P1|COMPLETED|Overall Study||18
588025|NCT00510809|1435215|P3|STARTED|Overall Study||18
588026|NCT00510809|1435216|P2|STARTED|Overall Study||18
588027|NCT00510809|1435217|P1|STARTED|Overall Study||18
588028|NCT00510783|1435230|P2|NOT COMPLETED|Overall Study||29
588029|NCT00510783|1435231|P1|NOT COMPLETED|Overall Study||31
588030|NCT00510783|1435230|P2|COMPLETED|Overall Study||47
588031|NCT00510783|1435231|P1|COMPLETED|Overall Study||51
588032|NCT00510783|1435230|P2|STARTED|Overall Study||76
588033|NCT00510783|1435231|P1|STARTED|Overall Study||82
588034|NCT00510744|1435237|P1|NOT COMPLETED|Overall Study||0
588035|NCT00510744|1435237|P1|COMPLETED|Overall Study||5
588036|NCT00510744|1435237|P1|STARTED|Overall Study||5
588037|NCT00510692|1435243|P2|NOT COMPLETED|Overall Study||3
588038|NCT00510692|1435244|P1|NOT COMPLETED|Overall Study||2
588039|NCT00510692|1435243|P2|COMPLETED|Overall Study||26
588040|NCT00510692|1435244|P1|COMPLETED|Overall Study||27
588041|NCT00510692|1435243|P2|STARTED|Overall Study||29
588042|NCT00510692|1435244|P1|STARTED|Overall Study||29
588043|NCT00510653|1435258|P1|NOT COMPLETED|Overall Study||11
588044|NCT00510653|1435258|P1|COMPLETED|Overall Study||13
588045|NCT00510653|1435258|P1|STARTED|Overall Study||24
588046|NCT00510510|1435265|P3|NOT COMPLETED|Overall Study||17
588047|NCT00510510|1435266|P2|NOT COMPLETED|Overall Study||9
588048|NCT00510510|1435267|P1|NOT COMPLETED|Overall Study||5
588049|NCT00510510|1435265|P3|COMPLETED|Overall Study||74
588050|NCT00510510|1435266|P2|COMPLETED|Overall Study||89
588051|NCT00510510|1435267|P1|COMPLETED|Overall Study||87
588052|NCT00510510|1435265|P3|STARTED|Overall Study||91
588053|NCT00510510|1435266|P2|STARTED|Overall Study||98
588054|NCT00510510|1435267|P1|STARTED|Overall Study||92
588055|NCT00510497|1435278|P1|NOT COMPLETED|Overall Study||3
588056|NCT00510497|1435278|P1|COMPLETED|Overall Study||8
588057|NCT00510497|1435278|P1|STARTED|Overall Study||11
588058|NCT00510484|1435285|P2|NOT COMPLETED|Period 2||0
588059|NCT00510484|1435286|P1|NOT COMPLETED|Period 2||0
588060|NCT00510484|1435285|P2|COMPLETED|Period 2||15
588061|NCT00510484|1435286|P1|COMPLETED|Period 2||16
588062|NCT00510484|1435285|P2|STARTED|Period 2||15
588063|NCT00510484|1435286|P1|STARTED|Period 2||16
588064|NCT00510484|1435285|P2|NOT COMPLETED|Wash-out Period||1
588065|NCT00510484|1435286|P1|NOT COMPLETED|Wash-out Period||0
588066|NCT00510484|1435285|P2|COMPLETED|Wash-out Period||15
588067|NCT00510484|1435286|P1|COMPLETED|Wash-out Period||16
588068|NCT00510484|1435285|P2|STARTED|Wash-out Period||16
588069|NCT00510484|1435286|P1|STARTED|Wash-out Period||16
588070|NCT00510484|1435285|P2|NOT COMPLETED|Period 1||0
588071|NCT00510484|1435286|P1|NOT COMPLETED|Period 1||0
588072|NCT00510484|1435285|P2|COMPLETED|Period 1||16
588073|NCT00510484|1435286|P1|COMPLETED|Period 1||16
588074|NCT00510484|1435285|P2|STARTED|Period 1||16
588075|NCT00510484|1435286|P1|STARTED|Period 1||16
588076|NCT00510458|1435306|P1|NOT COMPLETED|Overall Study||47
588077|NCT00510458|1435306|P1|COMPLETED|Overall Study||27
588078|NCT00510458|1435306|P1|STARTED|Overall Study||74
588079|NCT00510289|1435319|P1|NOT COMPLETED|Overall Study||12
588080|NCT00510289|1435319|P1|COMPLETED|Overall Study|Completed at least one cycle of study drug and had disease assessments|7
588081|NCT00510289|1435319|P1|Started Study Drug|Overall Study|3 patients progressed prior to starting study drug|16
588082|NCT00510289|1435319|P1|STARTED|Overall Study|All patients who consented|19
588083|NCT00510276|1435329|P2|NOT COMPLETED|Extension Open-Label Phase||48
588084|NCT00510276|1435330|P1|NOT COMPLETED|Extension Open-Label Phase||33
588085|NCT00510276|1435329|P2|COMPLETED|Extension Open-Label Phase||81
588086|NCT00510276|1435330|P1|COMPLETED|Extension Open-Label Phase||78
588087|NCT00510276|1435329|P2|STARTED|Extension Open-Label Phase|1 patient who completed acute phase did not participate in the optional atometine extension phase|129
588088|NCT00510276|1435330|P1|STARTED|Extension Open-Label Phase|4 patients who completed acute phase did not participate in the optional atomoxetine extension phase|111
588089|NCT00510276|1435329|P2|NOT COMPLETED|Acute Double-Blind Phase||95
588090|NCT00510276|1435330|P1|NOT COMPLETED|Acute Double-Blind Phase||105
588091|NCT00510276|1435329|P2|COMPLETED|Acute Double-Blind Phase||130
588092|NCT00510276|1435330|P1|COMPLETED|Acute Double-Blind Phase||115
588093|NCT00510276|1435329|P2|STARTED|Acute Double-Blind Phase||225
588094|NCT00510276|1435330|P1|STARTED|Acute Double-Blind Phase||220
588095|NCT00510224|1435415|P1|NOT COMPLETED|Overall Study||3
588096|NCT00510224|1435415|P1|COMPLETED|Overall Study||10
588097|NCT00510224|1435415|P1|STARTED|Overall Study||13
588098|NCT00510146|1435424|P2|NOT COMPLETED|Open-Label Treatment||26
588099|NCT00510146|1435425|P1|NOT COMPLETED|Open-Label Treatment||71
588100|NCT00510146|1435424|P2|COMPLETED|Open-Label Treatment||96
588101|NCT00510146|1435425|P1|COMPLETED|Open-Label Treatment||196
588102|NCT00510146|1435424|P2|STARTED|Open-Label Treatment||122
588103|NCT00510146|1435425|P1|STARTED|Open-Label Treatment||267
588104|NCT00510146|1435424|P2|NOT COMPLETED|Double-Blind Treatment||49
588105|NCT00510146|1435425|P1|NOT COMPLETED|Double-Blind Treatment||76
588106|NCT00510146|1435424|P2|COMPLETED|Double-Blind Treatment||122
588107|NCT00510146|1435425|P1|COMPLETED|Double-Blind Treatment||267
588108|NCT00510146|1435424|P2|STARTED|Double-Blind Treatment||171
588109|NCT00510146|1435425|P1|STARTED|Double-Blind Treatment||343
588110|NCT00510068|1435514|P2|NOT COMPLETED|Open-label Period||0
588111|NCT00510068|1435515|P1|NOT COMPLETED|Open-label Period||225
588112|NCT00510068|1435514|P2|COMPLETED|Open-label Period||0
588113|NCT00510068|1435515|P1|COMPLETED|Open-label Period||0
588114|NCT00510068|1435514|P2|STARTED|Open-label Period||0
588115|NCT00510068|1435515|P1|STARTED|Open-label Period|172 patients switched over from placebo & 53 who were initially randomized to Everolimus arm.|225
588116|NCT00510068|1435514|P2|NOT COMPLETED|Double-blind Period||203
588117|NCT00510068|1435515|P1|NOT COMPLETED|Double-blind Period||207
588118|NCT00510068|1435514|P2|COMPLETED|Double-blind Period||0
588119|NCT00510068|1435515|P1|COMPLETED|Double-blind Period||0
588120|NCT00510068|1435514|P2|Safety Population|Double-blind Period||203
588121|NCT00510068|1435515|P1|Safety Population|Double-blind Period||204
588122|NCT00510068|1435514|P2|STARTED|Double-blind Period||203
588123|NCT00510068|1435515|P1|STARTED|Double-blind Period||207
588124|NCT00509925|1435556|P2|NOT COMPLETED|Overall Study||1
588125|NCT00509925|1435557|P1|NOT COMPLETED|Overall Study||0
588126|NCT00509925|1435556|P2|COMPLETED|Overall Study||10
588127|NCT00509925|1435557|P1|COMPLETED|Overall Study||12
588128|NCT00509925|1435556|P2|STARTED|Overall Study||11
588129|NCT00509925|1435557|P1|STARTED|Overall Study||12
588130|NCT00509899|1435605|P8|NOT COMPLETED|Overall Study||1
588131|NCT00509899|1435606|P7|NOT COMPLETED|Overall Study||1
588132|NCT00509899|1435607|P6|NOT COMPLETED|Overall Study||10
588133|NCT00509899|1435608|P5|NOT COMPLETED|Overall Study||5
588134|NCT00509899|1435609|P4|NOT COMPLETED|Overall Study||4
588135|NCT00509899|1435610|P3|NOT COMPLETED|Overall Study||20
588136|NCT00509899|1435611|P2|NOT COMPLETED|Overall Study||9
588137|NCT00509899|1435612|P1|NOT COMPLETED|Overall Study||16
588138|NCT00509899|1435605|P8|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|2
588139|NCT00509899|1435606|P7|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|5
588140|NCT00509899|1435607|P6|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|12
588141|NCT00509899|1435608|P5|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|1
588142|NCT00509899|1435609|P4|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|1
588143|NCT00509899|1435610|P3|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|27
588144|NCT00509899|1435611|P2|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|26
588145|NCT00509899|1435612|P1|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|14
588146|NCT00509899|1435605|P8|STARTED|Overall Study||3
588147|NCT00509899|1435606|P7|STARTED|Overall Study||6
588148|NCT00509899|1435607|P6|STARTED|Overall Study||22
588149|NCT00509899|1435608|P5|STARTED|Overall Study||6
588150|NCT00509899|1435609|P4|STARTED|Overall Study||5
588151|NCT00509899|1435610|P3|STARTED|Overall Study||47
588152|NCT00509899|1435611|P2|STARTED|Overall Study||35
588153|NCT00509899|1435612|P1|STARTED|Overall Study||30
588154|NCT00509873|1435652|P2|NOT COMPLETED|Overall Study||15
588155|NCT00509873|1435653|P1|NOT COMPLETED|Overall Study||11
588156|NCT00509873|1435652|P2|COMPLETED|Overall Study||276
588157|NCT00509873|1435653|P1|COMPLETED|Overall Study||276
588158|NCT00509873|1435652|P2|STARTED|Overall Study||291
588159|NCT00509873|1435653|P1|STARTED|Overall Study||287
588160|NCT00509795|1435671|P4|NOT COMPLETED|Overall Study||27
588161|NCT00509795|1435672|P3|NOT COMPLETED|Overall Study||27
588162|NCT00509795|1435673|P2|NOT COMPLETED|Overall Study||11
588163|NCT00509795|1435674|P1|NOT COMPLETED|Overall Study||22
588164|NCT00509795|1435671|P4|COMPLETED|Overall Study||276
588165|NCT00509795|1435672|P3|COMPLETED|Overall Study||277
588166|NCT00509795|1435673|P2|COMPLETED|Overall Study||293
588167|NCT00509795|1435674|P1|COMPLETED|Overall Study||284
588168|NCT00509795|1435671|P4|Per Protocol Set (PPS) Population|Overall Study||265
588169|NCT00509795|1435672|P3|Per Protocol Set (PPS) Population|Overall Study||270
588170|NCT00509795|1435673|P2|Per Protocol Set (PPS) Population|Overall Study||285
588171|NCT00509795|1435674|P1|Per Protocol Set (PPS) Population|Overall Study||269
588172|NCT00509795|1435671|P4|Full Analysis Set (FAS) Population|Overall Study||301
588173|NCT00509795|1435672|P3|Full Analysis Set (FAS) Population|Overall Study||301
588174|NCT00509795|1435673|P2|Full Analysis Set (FAS) Population|Overall Study||304
588175|NCT00509795|1435674|P1|Full Analysis Set (FAS) Population|Overall Study||304
588176|NCT00509795|1435671|P4|Patients Received Treatment (SAF)|Overall Study||303
588177|NCT00509795|1435672|P3|Patients Received Treatment (SAF)|Overall Study||304
588178|NCT00509795|1435673|P2|Patients Received Treatment (SAF)|Overall Study||304
588179|NCT00509795|1435674|P1|Patients Received Treatment (SAF)|Overall Study||304
588180|NCT00509795|1435671|P4|STARTED|Overall Study||303
588181|NCT00509795|1435672|P3|STARTED|Overall Study||304
588182|NCT00509795|1435673|P2|STARTED|Overall Study||304
588183|NCT00509795|1435674|P1|STARTED|Overall Study||306
588184|NCT00509769|1435705|P1|NOT COMPLETED|Overall Study||91
588185|NCT00509769|1435705|P1|COMPLETED|Overall Study||21
588186|NCT00509769|1435705|P1|STARTED|Overall Study||112
588187|NCT00509600|1435714|P1|NOT COMPLETED|Overall Study||1
588188|NCT00509600|1435714|P1|COMPLETED|Overall Study||0
588189|NCT00509600|1435714|P1|STARTED|Overall Study||1
588190|NCT00509587|1435718|P1|NOT COMPLETED|Overall Study||0
588191|NCT00509587|1435718|P1|COMPLETED|Overall Study||21
588192|NCT00509587|1435718|P1|STARTED|Overall Study||21
588193|NCT00509496|1435728|P2|NOT COMPLETED|Overall Study||0
588194|NCT00509496|1435729|P1|NOT COMPLETED|Overall Study||0
588195|NCT00509496|1435728|P2|COMPLETED|Overall Study||2
588196|NCT00509496|1435729|P1|COMPLETED|Overall Study||19
588197|NCT00509496|1435728|P2|STARTED|Overall Study||2
588198|NCT00509496|1435729|P1|STARTED|Overall Study||19
588199|NCT00509392|1435739|P3|NOT COMPLETED|Overall Study||0
588200|NCT00509392|1435740|P2|NOT COMPLETED|Overall Study||0
588201|NCT00509392|1435741|P1|NOT COMPLETED|Overall Study||0
588202|NCT00509392|1435739|P3|COMPLETED|Overall Study||4
588203|NCT00509392|1435740|P2|COMPLETED|Overall Study||33
588204|NCT00509392|1435741|P1|COMPLETED|Overall Study||32
588205|NCT00509392|1435739|P3|STARTED|Overall Study||4
588206|NCT00509392|1435740|P2|STARTED|Overall Study||33
588207|NCT00509392|1435741|P1|STARTED|Overall Study||32
588208|NCT00509366|1435792|P5|NOT COMPLETED|Overall Study||0
588209|NCT00509366|1435793|P4|NOT COMPLETED|Overall Study||0
588210|NCT00509366|1435794|P3|NOT COMPLETED|Overall Study||1
588211|NCT00509366|1435795|P2|NOT COMPLETED|Overall Study||1
588212|NCT00509366|1435796|P1|NOT COMPLETED|Overall Study||1
588213|NCT00509366|1435792|P5|COMPLETED|Overall Study|Patients who were neither assigned nor treated with protocol-based therapy.|51
588214|NCT00509366|1435793|P4|COMPLETED|Overall Study|Patients assigned to treatment and treated with docetaxel/gemcitabine treatment combination.|2
588215|NCT00509366|1435794|P3|COMPLETED|Overall Study|Patients assigned to treatment and treated with pemetrexed/gemcitabine treatment combination.|21
588216|NCT00509366|1435795|P2|COMPLETED|Overall Study|Patients assigned to treatment and treated with cisplatin/pemetrexed treatment combination.|7
588217|NCT00509366|1435796|P1|COMPLETED|Overall Study|Patients assigned to treatment and treated with cisplatin/gemcitabine treatment combination.|17
588218|NCT00509366|1435792|P5|Assigned Treatment|Overall Study||0
588219|NCT00509366|1435793|P4|Assigned Treatment|Overall Study|Patients who were assigned to docetaxel/gemcitabine treatment arm.|2
588220|NCT00509366|1435794|P3|Assigned Treatment|Overall Study|Patients who were assigned to pemetrexed/gemcitabine treatment arm.|22
588221|NCT00509366|1435795|P2|Assigned Treatment|Overall Study|Patients who were assigned to cisplatin/pemetrexed treatment arm.|8
588222|NCT00509366|1435796|P1|Assigned Treatment|Overall Study|Patients who were assigned to cisplatin/gemcitabine treatment arm.|18
588223|NCT00509366|1435792|P5|STARTED|Overall Study|Registered patients who were neither assigned nor treated with protocol-based therapy.|51
588224|NCT00509366|1435793|P4|STARTED|Overall Study|Registered patients who were assigned docetaxel/gemcitabine treatment.|2
588225|NCT00509366|1435794|P3|STARTED|Overall Study|Registered patients who were assigned pemetrexed/gemcitabine treatment.|22
588226|NCT00509366|1435795|P2|STARTED|Overall Study|Registered patients who were assigned cisplatin/pemetrexed treatment.|8
588227|NCT00509366|1435796|P1|STARTED|Overall Study|Registered patients who were assigned cisplatin/gemcitabine treatment.|18
588228|NCT00509288|1435809|P2|NOT COMPLETED|Overall Study||0
588229|NCT00509288|1435810|P1|NOT COMPLETED|Overall Study||0
588230|NCT00509288|1435809|P2|COMPLETED|Overall Study||3
588231|NCT00509288|1435810|P1|COMPLETED|Overall Study||21
588232|NCT00509288|1435809|P2|STARTED|Overall Study||3
588233|NCT00509288|1435810|P1|STARTED|Overall Study||21
588234|NCT00509262|1435820|P2|NOT COMPLETED|Overall Study||42
588235|NCT00509262|1435821|P1|NOT COMPLETED|Overall Study||47
588236|NCT00509262|1435820|P2|COMPLETED|Overall Study||170
588237|NCT00509262|1435821|P1|COMPLETED|Overall Study||164
588238|NCT00509262|1435820|P2|STARTED|Overall Study||212
588239|NCT00509262|1435821|P1|STARTED|Overall Study||211
588240|NCT00509249|1435833|P1|NOT COMPLETED|Overall Study||0
588241|NCT00509249|1435833|P1|COMPLETED|Overall Study||18
588242|NCT00509249|1435833|P1|STARTED|Overall Study||18
588243|NCT00509236|1435839|P2|NOT COMPLETED|Overall Study||20
588244|NCT00509236|1435840|P1|NOT COMPLETED|Overall Study||17
588245|NCT00509236|1435839|P2|COMPLETED|Overall Study||45
588246|NCT00509236|1435840|P1|COMPLETED|Overall Study||47
588247|NCT00509236|1435839|P2|STARTED|Overall Study||65
588248|NCT00509236|1435840|P1|STARTED|Overall Study||64
588249|NCT00509223|1435855|P2|NOT COMPLETED|Overall Study||72
588250|NCT00509223|1435856|P1|NOT COMPLETED|Overall Study||88
588251|NCT00509223|1435855|P2|COMPLETED|Overall Study||137
588252|NCT00509223|1435856|P1|COMPLETED|Overall Study||119
588253|NCT00509223|1435855|P2|STARTED|Overall Study||209
588254|NCT00509223|1435856|P1|STARTED|Overall Study||207
588255|NCT00509197|1435864|P2|NOT COMPLETED|Overall Study||0
588256|NCT00509197|1435865|P1|NOT COMPLETED|Overall Study||0
588257|NCT00509197|1435864|P2|COMPLETED|Overall Study||6
588258|NCT00509197|1435865|P1|COMPLETED|Overall Study||6
588259|NCT00509197|1435864|P2|STARTED|Overall Study||6
588260|NCT00509197|1435865|P1|STARTED|Overall Study||6
588261|NCT00509106|1435879|P2|NOT COMPLETED|Overall Study||29
588262|NCT00509106|1435880|P1|NOT COMPLETED|Overall Study||31
588263|NCT00509106|1435879|P2|COMPLETED|Overall Study||278
588264|NCT00509106|1435880|P1|COMPLETED|Overall Study||284
588265|NCT00509106|1435879|P2|STARTED|Overall Study||307
588266|NCT00509106|1435880|P1|STARTED|Overall Study||315
588267|NCT00509067|1435888|P2|NOT COMPLETED|Overall Study||5
588268|NCT00509067|1435889|P1|NOT COMPLETED|Overall Study||4
588269|NCT00509067|1435888|P2|COMPLETED|Overall Study||19
588270|NCT00509067|1435889|P1|COMPLETED|Overall Study||15
588271|NCT00509067|1435888|P2|STARTED|Overall Study||24
588272|NCT00509067|1435889|P1|STARTED|Overall Study||19
588273|NCT00509041|1435899|P1|NOT COMPLETED|Overall Study||0
588274|NCT00509041|1435899|P1|COMPLETED|Overall Study||43
588275|NCT00509041|1435899|P1|STARTED|Overall Study||43
588276|NCT00509028|1435908|P2|NOT COMPLETED|Overall Study||7
588277|NCT00509028|1435909|P1|NOT COMPLETED|Overall Study||12
588278|NCT00509028|1435908|P2|COMPLETED|Overall Study||113
588279|NCT00509028|1435909|P1|COMPLETED|Overall Study||109
588280|NCT00509028|1435908|P2|STARTED|Overall Study||120
588281|NCT00509028|1435909|P1|STARTED|Overall Study||121
588282|NCT00509002|1435941|P1|NOT COMPLETED|Overall Study||0
588283|NCT00509002|1435941|P1|COMPLETED|Overall Study||37
588284|NCT00509002|1435941|P1|STARTED|Overall Study||37
588285|NCT00508924|1435949|P4|NOT COMPLETED|Overall Study||1
588286|NCT00508924|1435950|P3|NOT COMPLETED|Overall Study||1
588287|NCT00508924|1435951|P2|NOT COMPLETED|Overall Study||0
588288|NCT00508924|1435952|P1|NOT COMPLETED|Overall Study||0
588289|NCT00508924|1435949|P4|COMPLETED|Overall Study||33
588290|NCT00508924|1435950|P3|COMPLETED|Overall Study||31
588291|NCT00508924|1435951|P2|COMPLETED|Overall Study||38
588292|NCT00508924|1435952|P1|COMPLETED|Overall Study||36
588293|NCT00508924|1435949|P4|STARTED|Overall Study||34
588294|NCT00508924|1435950|P3|STARTED|Overall Study||32
588295|NCT00508924|1435951|P2|STARTED|Overall Study||38
588296|NCT00508924|1435952|P1|STARTED|Overall Study||36
588297|NCT00508872|1435966|P1|NOT COMPLETED|Overall Study||2
588298|NCT00508872|1435966|P1|COMPLETED|Overall Study||0
588299|NCT00508872|1435966|P1|STARTED|Overall Study||2
588300|NCT00508820|1435972|P2|NOT COMPLETED|Overall Study||64
588301|NCT00508820|1435973|P1|NOT COMPLETED|Overall Study||55
588302|NCT00508820|1435972|P2|COMPLETED|Overall Study||175
588303|NCT00508820|1435973|P1|COMPLETED|Overall Study||113
588304|NCT00508820|1435972|P2|STARTED|Overall Study||239
588305|NCT00508820|1435973|P1|STARTED|Overall Study||168
588306|NCT00508755|1435983|P1|NOT COMPLETED|Overall Study||1
588307|NCT00508755|1435983|P1|COMPLETED|Overall Study||5
588308|NCT00508755|1435983|P1|STARTED|Overall Study||6
588309|NCT00508742|1435991|P2|NOT COMPLETED|Period 3: Toddler Dose||15
588310|NCT00508742|1435992|P1|NOT COMPLETED|Period 3: Toddler Dose||25
588311|NCT00508742|1435991|P2|COMPLETED|Period 3: Toddler Dose||863
588312|NCT00508742|1435992|P1|COMPLETED|Period 3: Toddler Dose||858
588313|NCT00508742|1435991|P2|STARTED|Period 3: Toddler Dose||878
588314|NCT00508742|1435992|P1|STARTED|Period 3: Toddler Dose||883
588315|NCT00508742|1435991|P2|NOT COMPLETED|Period 2: After Infant Series||11
588316|NCT00508742|1435992|P1|NOT COMPLETED|Period 2: After Infant Series||7
588317|NCT00508742|1435991|P2|COMPLETED|Period 2: After Infant Series||878
588318|NCT00508742|1435992|P1|COMPLETED|Period 2: After Infant Series||883
588319|NCT00508742|1435991|P2|STARTED|Period 2: After Infant Series||889
588320|NCT00508742|1435992|P1|STARTED|Period 2: After Infant Series||890
588321|NCT00508742|1435991|P2|NOT COMPLETED|Period 1: Infant Series||45
588322|NCT00508742|1435992|P1|NOT COMPLETED|Period 1: Infant Series||42
588323|NCT00508742|1435991|P2|COMPLETED|Period 1: Infant Series||889
588324|NCT00508742|1435992|P1|COMPLETED|Period 1: Infant Series||890
588325|NCT00508742|1435991|P2|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||892
588326|NCT00508742|1435992|P1|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||898
588327|NCT00508742|1435991|P2|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||902
588328|NCT00508742|1435992|P1|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||904
588329|NCT00508742|1435991|P2|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||933
588330|NCT00508742|1435992|P1|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||930
588331|NCT00508742|1435991|P2|STARTED|Period 1: Infant Series||934
588332|NCT00508742|1435992|P1|STARTED|Period 1: Infant Series||932
588333|NCT00508716|1436008|P2|NOT COMPLETED|Overall Study||0
588334|NCT00508716|1436009|P1|NOT COMPLETED|Overall Study||0
588335|NCT00508716|1436008|P2|COMPLETED|Overall Study||63
588336|NCT00508716|1436009|P1|COMPLETED|Overall Study||61
588337|NCT00508716|1436008|P2|STARTED|Overall Study||63
588338|NCT00508716|1436009|P1|STARTED|Overall Study||61
588339|NCT00508651|1436017|P2|NOT COMPLETED|Overall Study||2
588340|NCT00508651|1436018|P1|NOT COMPLETED|Overall Study||4
588341|NCT00508651|1436017|P2|COMPLETED|Overall Study||8
588342|NCT00508651|1436018|P1|COMPLETED|Overall Study||16
588343|NCT00508651|1436017|P2|STARTED|Overall Study||10
588344|NCT00508651|1436018|P1|STARTED|Overall Study||20
588345|NCT00508521|1436092|P1|NOT COMPLETED|Overall Study||0
588346|NCT00508521|1436092|P1|COMPLETED|Overall Study||4
588347|NCT00508521|1436092|P1|STARTED|Overall Study||4
588348|NCT00508482|1436099|P3|NOT COMPLETED|at the 12th Week of Follow-up||0
588349|NCT00508482|1436100|P2|NOT COMPLETED|at the 12th Week of Follow-up||0
588350|NCT00508482|1436101|P1|NOT COMPLETED|at the 12th Week of Follow-up||0
588351|NCT00508482|1436099|P3|COMPLETED|at the 12th Week of Follow-up||98
588352|NCT00508482|1436100|P2|COMPLETED|at the 12th Week of Follow-up||96
588353|NCT00508482|1436101|P1|COMPLETED|at the 12th Week of Follow-up||196
588354|NCT00508482|1436099|P3|STARTED|at the 12th Week of Follow-up||98
588355|NCT00508482|1436100|P2|STARTED|at the 12th Week of Follow-up||96
588356|NCT00508482|1436101|P1|STARTED|at the 12th Week of Follow-up||196
588357|NCT00508482|1436099|P3|NOT COMPLETED|at the 4th Week of Follow-up||1
588358|NCT00508482|1436100|P2|NOT COMPLETED|at the 4th Week of Follow-up||6
588359|NCT00508482|1436101|P1|NOT COMPLETED|at the 4th Week of Follow-up||20
588360|NCT00508482|1436099|P3|COMPLETED|at the 4th Week of Follow-up||98
588361|NCT00508482|1436100|P2|COMPLETED|at the 4th Week of Follow-up||96
588362|NCT00508482|1436101|P1|COMPLETED|at the 4th Week of Follow-up||196
588363|NCT00508482|1436099|P3|STARTED|at the 4th Week of Follow-up||99
588364|NCT00508482|1436100|P2|STARTED|at the 4th Week of Follow-up||102
588365|NCT00508482|1436101|P1|STARTED|at the 4th Week of Follow-up||216
588366|NCT00508482|1436099|P3|NOT COMPLETED|Over 4 Weeks of Treatment||20
588367|NCT00508482|1436100|P2|NOT COMPLETED|Over 4 Weeks of Treatment||17
588368|NCT00508482|1436101|P1|NOT COMPLETED|Over 4 Weeks of Treatment||21
588369|NCT00508482|1436099|P3|COMPLETED|Over 4 Weeks of Treatment||99
588370|NCT00508482|1436100|P2|COMPLETED|Over 4 Weeks of Treatment||102
588371|NCT00508482|1436101|P1|COMPLETED|Over 4 Weeks of Treatment||216
588372|NCT00508482|1436099|P3|STARTED|Over 4 Weeks of Treatment||119
588373|NCT00508482|1436100|P2|STARTED|Over 4 Weeks of Treatment||119
588374|NCT00508482|1436101|P1|STARTED|Over 4 Weeks of Treatment||237
588375|NCT00508469|1436138|P2|NOT COMPLETED|Overall Study||10
588376|NCT00508469|1436139|P1|NOT COMPLETED|Overall Study||17
588377|NCT00508469|1436138|P2|COMPLETED|Overall Study||40
588378|NCT00508469|1436139|P1|COMPLETED|Overall Study||35
588379|NCT00508469|1436138|P2|STARTED|Overall Study||50
588380|NCT00508469|1436139|P1|STARTED|Overall Study||52
588381|NCT00508404|1436145|P1|NOT COMPLETED|Overall Study||42
588382|NCT00508404|1436145|P1|COMPLETED|Overall Study|Completion of safety follow-up visit conducted 8 weeks after last dose|112
588383|NCT00508404|1436145|P1|STARTED|Overall Study||154
588384|NCT00508391|1436172|P2|NOT COMPLETED|Second Treatment||0
588385|NCT00508391|1436173|P1|NOT COMPLETED|Second Treatment||2
588386|NCT00508391|1436172|P2|COMPLETED|Second Treatment||59
588387|NCT00508391|1436173|P1|COMPLETED|Second Treatment||52
588388|NCT00508391|1436172|P2|STARTED|Second Treatment||59
588389|NCT00508391|1436173|P1|STARTED|Second Treatment||54
588390|NCT00508391|1436172|P2|NOT COMPLETED|First Treatment||3
588391|NCT00508391|1436173|P1|NOT COMPLETED|First Treatment||6
588392|NCT00508391|1436172|P2|COMPLETED|First Treatment||59
588393|NCT00508391|1436173|P1|COMPLETED|First Treatment||54
588394|NCT00508391|1436172|P2|STARTED|First Treatment||62
588395|NCT00508391|1436173|P1|STARTED|First Treatment||60
588396|NCT00508274|1436184|P1|NOT COMPLETED|Overall Study||2
588397|NCT00508274|1436184|P1|COMPLETED|Overall Study||50
588398|NCT00508274|1436184|P1|STARTED|Overall Study||52
588399|NCT00508183|1436195|P2|NOT COMPLETED|Overall Study||8
588400|NCT00508183|1436196|P1|NOT COMPLETED|Overall Study||9
588401|NCT00508183|1436195|P2|COMPLETED|Overall Study||34
588402|NCT00508183|1436196|P1|COMPLETED|Overall Study||39
588403|NCT00508183|1436195|P2|STARTED|Overall Study||42
588404|NCT00508183|1436196|P1|STARTED|Overall Study||48
588405|NCT00508157|1436212|P2|NOT COMPLETED|Overall Study||3
588406|NCT00508157|1436213|P1|NOT COMPLETED|Overall Study||2
588407|NCT00508157|1436212|P2|COMPLETED|Overall Study||23
588408|NCT00508157|1436213|P1|COMPLETED|Overall Study||24
588409|NCT00508157|1436212|P2|Safety Sample|Overall Study|1 participant was withdrawn from study prior to receiving study drug & excluded from safety sample.|25
588410|NCT00508157|1436213|P1|Safety Sample|Overall Study||26
588411|NCT00508157|1436212|P2|Randomized Sample|Overall Study||26
588412|NCT00508157|1436213|P1|Randomized Sample|Overall Study||26
588413|NCT00508157|1436212|P2|STARTED|Overall Study||26
588414|NCT00508157|1436213|P1|STARTED|Overall Study||26
588415|NCT00508144|1436235|P1|NOT COMPLETED|Overall Study||11
588416|NCT00508144|1436235|P1|COMPLETED|Overall Study||53
588417|NCT00508144|1436235|P1|STARTED|Overall Study||64
588418|NCT00508118|1436241|P2|NOT COMPLETED|Overall Study||0
588419|NCT00508118|1436242|P1|NOT COMPLETED|Overall Study||0
588420|NCT00508118|1436241|P2|COMPLETED|Overall Study||4
588421|NCT00508118|1436242|P1|COMPLETED|Overall Study||3
588422|NCT00508118|1436241|P2|STARTED|Overall Study|Documentation is not available for the 7th subject and treatment arm.|4
588423|NCT00508118|1436242|P1|STARTED|Overall Study||3
588424|NCT00508027|1436261|P1|NOT COMPLETED|Dose Level 3||0
588425|NCT00508027|1436261|P1|COMPLETED|Dose Level 3||2
588426|NCT00508027|1436261|P1|STARTED|Dose Level 3|enrollment discontinued due to FDA recommendations regarding high dose (80mg/day) simvastatin|2
588427|NCT00508027|1436261|P1|NOT COMPLETED|Dose Level 2||4
588428|NCT00508027|1436261|P1|COMPLETED|Dose Level 2||16
588429|NCT00508027|1436261|P1|STARTED|Dose Level 2|The participants starting each dose period is a new cohort of subjects. 20 new subjects in dose 2|20
588430|NCT00508027|1436261|P1|NOT COMPLETED|Dose Level 1||8
588431|NCT00508027|1436261|P1|COMPLETED|Dose Level 1||12
588432|NCT00508027|1436261|P1|STARTED|Dose Level 1|The participants starting each dose period is a new cohort of subjects. 20 subjects started dose 1|20
588433|NCT00508001|1436302|P3|NOT COMPLETED|Overall Study||7
588434|NCT00508001|1436303|P2|NOT COMPLETED|Overall Study||12
588435|NCT00508001|1436304|P1|NOT COMPLETED|Overall Study||19
588436|NCT00508001|1436302|P3|COMPLETED|Overall Study||16
588437|NCT00508001|1436303|P2|COMPLETED|Overall Study||13
588438|NCT00508001|1436304|P1|COMPLETED|Overall Study||0
588439|NCT00508001|1436302|P3|Secondary Treatment Phase|Overall Study||16
588440|NCT00508001|1436303|P2|Secondary Treatment Phase|Overall Study||13
588441|NCT00508001|1436304|P1|Secondary Treatment Phase|Overall Study||0
588442|NCT00508001|1436302|P3|STARTED|Overall Study||23
588443|NCT00508001|1436303|P2|STARTED|Overall Study||25
588444|NCT00508001|1436304|P1|STARTED|Overall Study||19
588445|NCT00507819|1436321|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
588446|NCT00507819|1436322|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
588447|NCT00507819|1436321|P2|COMPLETED|Second Intervention (6 Weeks)||14
588448|NCT00507819|1436322|P1|COMPLETED|Second Intervention (6 Weeks)||13
588449|NCT00507819|1436321|P2|STARTED|Second Intervention (6 Weeks)||14
588450|NCT00507819|1436322|P1|STARTED|Second Intervention (6 Weeks)||13
588451|NCT00507819|1436321|P2|NOT COMPLETED|Washout (6 Weeks)||0
588452|NCT00507819|1436322|P1|NOT COMPLETED|Washout (6 Weeks)||1
588453|NCT00507819|1436321|P2|COMPLETED|Washout (6 Weeks)||14
588454|NCT00507819|1436322|P1|COMPLETED|Washout (6 Weeks)||13
588455|NCT00507819|1436321|P2|STARTED|Washout (6 Weeks)||14
588456|NCT00507819|1436322|P1|STARTED|Washout (6 Weeks)||14
588457|NCT00507819|1436321|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
588458|NCT00507819|1436322|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
588459|NCT00507819|1436321|P2|COMPLETED|First Intervention (6 Weeks)||14
588460|NCT00507819|1436322|P1|COMPLETED|First Intervention (6 Weeks)||14
588461|NCT00507819|1436321|P2|STARTED|First Intervention (6 Weeks)||14
588462|NCT00507819|1436322|P1|STARTED|First Intervention (6 Weeks)||14
588463|NCT00507767|1436334|P1|NOT COMPLETED|Overall Study||0
588464|NCT00507767|1436334|P1|COMPLETED|Overall Study||15
588465|NCT00507767|1436334|P1|STARTED|Overall Study||15
588466|NCT00507689|1436341|P2|NOT COMPLETED|Randomized Period||2
588467|NCT00507689|1436342|P1|NOT COMPLETED|Randomized Period||1
588468|NCT00507689|1436341|P2|COMPLETED|Randomized Period||16
588469|NCT00507689|1436342|P1|COMPLETED|Randomized Period||18
588470|NCT00507689|1436341|P2|STARTED|Randomized Period|18 of 37 participants who completed the pre-randomization period were randomized to FTC/TDF.|18
588471|NCT00507689|1436342|P1|STARTED|Randomized Period|19 of 37 participants who completed the pre-randomization period were randomized to FTC/TDF+HBIg.|19
588472|NCT00507689|1436341|P2|NOT COMPLETED|Pre-Randomization Period||0
588473|NCT00507689|1436342|P1|NOT COMPLETED|Pre-Randomization Period||3
588474|NCT00507689|1436341|P2|COMPLETED|Pre-Randomization Period||0
588475|NCT00507689|1436342|P1|COMPLETED|Pre-Randomization Period||37
588476|NCT00507689|1436341|P2|STARTED|Pre-Randomization Period||0
588477|NCT00507689|1436342|P1|STARTED|Pre-Randomization Period||40
588478|NCT00507559|1436359|P1|NOT COMPLETED|Overall Study||71
588479|NCT00507559|1436359|P1|COMPLETED|Overall Study||84
588480|NCT00507559|1436359|P1|STARTED|Overall Study||155
588481|NCT00507546|1436374|P2|NOT COMPLETED|Overall Study||1
588482|NCT00507546|1436375|P1|NOT COMPLETED|Overall Study||2
588483|NCT00507546|1436374|P2|COMPLETED|Overall Study||3
588484|NCT00507546|1436375|P1|COMPLETED|Overall Study||2
588485|NCT00507546|1436374|P2|STARTED|Overall Study||4
588486|NCT00507546|1436375|P1|STARTED|Overall Study||4
588487|NCT00507507|1436385|P2|NOT COMPLETED|24-week Treatment-free Follow-up Period||17
588488|NCT00507507|1436386|P1|NOT COMPLETED|24-week Treatment-free Follow-up Period||10
588489|NCT00507507|1436385|P2|COMPLETED|24-week Treatment-free Follow-up Period||12
588490|NCT00507507|1436386|P1|COMPLETED|24-week Treatment-free Follow-up Period||16
588491|NCT00507507|1436385|P2|STARTED|24-week Treatment-free Follow-up Period|Participants who discontinued treatment early may have entered the treatment-free follow-up period.|29
588492|NCT00507507|1436386|P1|STARTED|24-week Treatment-free Follow-up Period|Participants who discontinued treatment early may have entered the treatment-free follow-up period.|26
588493|NCT00507507|1436385|P2|NOT COMPLETED|Treatment Period||53
588494|NCT00507507|1436386|P1|NOT COMPLETED|Treatment Period||52
588495|NCT00507507|1436385|P2|COMPLETED|Treatment Period||9
588496|NCT00507507|1436386|P1|COMPLETED|Treatment Period||12
588497|NCT00507507|1436385|P2|Completed 192 Weeks of Treatment|Treatment Period||52
588498|NCT00507507|1436386|P1|Completed 192 Weeks of Treatment|Treatment Period||52
588499|NCT00507507|1436385|P2|STARTED|Treatment Period||62
588500|NCT00507507|1436386|P1|STARTED|Treatment Period||64
588501|NCT00507455|1436421|P3|NOT COMPLETED|Overall Study||12
588502|NCT00507455|1436422|P2|NOT COMPLETED|Overall Study||6
588503|NCT00507455|1436423|P1|NOT COMPLETED|Overall Study||12
588504|NCT00507455|1436421|P3|COMPLETED|Overall Study||62
588505|NCT00507455|1436422|P2|COMPLETED|Overall Study||68
588506|NCT00507455|1436423|P1|COMPLETED|Overall Study||62
588507|NCT00507455|1436421|P3|STARTED|Overall Study||74
588508|NCT00507455|1436422|P2|STARTED|Overall Study||74
588509|NCT00507455|1436423|P1|STARTED|Overall Study||74
588510|NCT00507442|1436486|P4|NOT COMPLETED|Overall Study||5
588511|NCT00507442|1436487|P3|NOT COMPLETED|Overall Study||15
588512|NCT00507442|1436488|P2|NOT COMPLETED|Overall Study||27
588513|NCT00507442|1436489|P1|NOT COMPLETED|Overall Study||16
588514|NCT00507442|1436486|P4|COMPLETED|Overall Study||12
588515|NCT00507442|1436487|P3|COMPLETED|Overall Study||18
588516|NCT00507442|1436488|P2|COMPLETED|Overall Study||39
588517|NCT00507442|1436489|P1|COMPLETED|Overall Study||26
588518|NCT00507442|1436486|P4|STARTED|Overall Study||17
588519|NCT00507442|1436487|P3|STARTED|Overall Study||33
588520|NCT00507442|1436488|P2|STARTED|Overall Study||66
588521|NCT00507442|1436489|P1|STARTED|Overall Study||42
588522|NCT00507429|1436541|P2|NOT COMPLETED|Maintenance Phase||0
588523|NCT00507429|1436542|P1|NOT COMPLETED|Maintenance Phase||14
588524|NCT00507429|1436541|P2|COMPLETED|Maintenance Phase||0
588525|NCT00507429|1436542|P1|COMPLETED|Maintenance Phase|14 subjects were withdrawn due to progressive disease, 2 subjects continued beyond data cut-off|2
588526|NCT00507429|1436541|P2|STARTED|Maintenance Phase|Control arm subjects followed for survival only; not enrolled in Maintenance period|0
588527|NCT00507429|1436542|P1|STARTED|Maintenance Phase|2 subjects did not enter maintenance: 1/18 progressive disease; 1/18 lost to follow-up.|16
588528|NCT00507429|1436541|P2|NOT COMPLETED|Treatment Phase||18
588529|NCT00507429|1436542|P1|NOT COMPLETED|Treatment Phase||37
588530|NCT00507429|1436541|P2|COMPLETED|Treatment Phase||7
588531|NCT00507429|1436542|P1|COMPLETED|Treatment Phase||18
588532|NCT00507429|1436541|P2|STARTED|Treatment Phase|Randomized|25
588533|NCT00507429|1436542|P1|STARTED|Treatment Phase|Randomized|55
588534|NCT00507416|1436553|P3|NOT COMPLETED|Overall Study||114
588535|NCT00507416|1436554|P2|NOT COMPLETED|Overall Study||125
588536|NCT00507416|1436555|P1|NOT COMPLETED|Overall Study||118
588537|NCT00507416|1436553|P3|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|53
588538|NCT00507416|1436554|P2|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|42
588539|NCT00507416|1436555|P1|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|50
588540|NCT00507416|1436553|P3|Completed 8 Treatment Cycles|Overall Study||69
588541|NCT00507416|1436554|P2|Completed 8 Treatment Cycles|Overall Study||60
588542|NCT00507416|1436555|P1|Completed 8 Treatment Cycles|Overall Study||82
588543|NCT00507416|1436553|P3|Treated (Safety Population)|Overall Study||163
588544|NCT00507416|1436554|P2|Treated (Safety Population)|Overall Study||158
588545|NCT00507416|1436555|P1|Treated (Safety Population)|Overall Study||165
588546|NCT00507416|1436553|P3|STARTED|Overall Study||167
588547|NCT00507416|1436554|P2|STARTED|Overall Study||167
588548|NCT00507416|1436555|P1|STARTED|Overall Study||168
588549|NCT00507208|1436586|P2|NOT COMPLETED|Overall Study||0
588550|NCT00507208|1436587|P1|NOT COMPLETED|Overall Study||0
588551|NCT00507208|1436586|P2|COMPLETED|Overall Study||26
588552|NCT00507208|1436587|P1|COMPLETED|Overall Study||27
588553|NCT00507208|1436586|P2|Received Dynasplint in Crossover|Overall Study||3
588554|NCT00507208|1436587|P1|Received Dynasplint in Crossover|Overall Study||0
588555|NCT00507208|1436586|P2|STARTED|Overall Study||26
588556|NCT00507208|1436587|P1|STARTED|Overall Study||27
588557|NCT00507130|1436597|P4|NOT COMPLETED|Overall Study||1
588558|NCT00507130|1436598|P3|NOT COMPLETED|Overall Study||1
588559|NCT00507130|1436599|P2|NOT COMPLETED|Overall Study||0
588560|NCT00507130|1436600|P1|NOT COMPLETED|Overall Study||1
588561|NCT00507130|1436597|P4|COMPLETED|Overall Study||8
588562|NCT00507130|1436598|P3|COMPLETED|Overall Study||8
588563|NCT00507130|1436599|P2|COMPLETED|Overall Study||9
588564|NCT00507130|1436600|P1|COMPLETED|Overall Study||8
588565|NCT00507130|1436597|P4|STARTED|Overall Study||9
588566|NCT00507130|1436598|P3|STARTED|Overall Study||9
588567|NCT00507130|1436599|P2|STARTED|Overall Study||9
588568|NCT00507130|1436600|P1|STARTED|Overall Study||9
588569|NCT00506948|1436642|P1|NOT COMPLETED|Overall Study||10
588570|NCT00506948|1436642|P1|COMPLETED|Overall Study||0
588571|NCT00506948|1436642|P1|STARTED|Overall Study||10
588572|NCT00506922|1436651|P5|NOT COMPLETED|Overall Study||1
588573|NCT00506922|1436652|P4|NOT COMPLETED|Overall Study||2
588574|NCT00506922|1436653|P3|NOT COMPLETED|Overall Study||0
588575|NCT00506922|1436654|P2|NOT COMPLETED|Overall Study||0
588576|NCT00506922|1436655|P1|NOT COMPLETED|Overall Study||0
588577|NCT00506922|1436651|P5|COMPLETED|Overall Study||10
588578|NCT00506922|1436652|P4|COMPLETED|Overall Study||61
588579|NCT00506922|1436653|P3|COMPLETED|Overall Study||29
588580|NCT00506922|1436654|P2|COMPLETED|Overall Study||10
588581|NCT00506922|1436655|P1|COMPLETED|Overall Study||37
588582|NCT00506922|1436651|P5|STARTED|Overall Study||11
588583|NCT00506922|1436652|P4|STARTED|Overall Study||63
588584|NCT00506922|1436653|P3|STARTED|Overall Study||29
588585|NCT00506922|1436654|P2|STARTED|Overall Study||10
588586|NCT00506922|1436655|P1|STARTED|Overall Study||37
588587|NCT00506883|1436666|P3|NOT COMPLETED|Overall Study||4
588588|NCT00506883|1436667|P2|NOT COMPLETED|Overall Study||3
588589|NCT00506883|1436668|P1|NOT COMPLETED|Overall Study||7
588590|NCT00506883|1436666|P3|COMPLETED|Overall Study||55
588591|NCT00506883|1436667|P2|COMPLETED|Overall Study||71
588592|NCT00506883|1436668|P1|COMPLETED|Overall Study||45
588593|NCT00506883|1436666|P3|STARTED|Overall Study||59
588594|NCT00506883|1436667|P2|STARTED|Overall Study||74
588595|NCT00506883|1436668|P1|STARTED|Overall Study||52
588596|NCT00506857|1436676|P1|NOT COMPLETED|Overall Study||0
588597|NCT00506857|1436676|P1|COMPLETED|Overall Study||80
588598|NCT00506857|1436676|P1|STARTED|Overall Study||80
588599|NCT00506831|1436681|P1|NOT COMPLETED|Overall Study||2
588600|NCT00506831|1436681|P1|COMPLETED|Overall Study||7
588601|NCT00506831|1436681|P1|STARTED|Overall Study||9
588602|NCT00506714|1436687|P2|NOT COMPLETED|Overall Study||0
588603|NCT00506714|1436688|P1|NOT COMPLETED|Overall Study||0
588604|NCT00506714|1436687|P2|COMPLETED|Overall Study||13
588605|NCT00506714|1436688|P1|COMPLETED|Overall Study||13
588606|NCT00506714|1436687|P2|STARTED|Overall Study||13
588607|NCT00506714|1436688|P1|STARTED|Overall Study||13
588608|NCT00506675|1436698|P2|NOT COMPLETED|Overall Study||0
588609|NCT00506675|1436699|P1|NOT COMPLETED|Overall Study||0
588610|NCT00506675|1436698|P2|COMPLETED|Overall Study||28
588611|NCT00506675|1436699|P1|COMPLETED|Overall Study||27
588612|NCT00506675|1436698|P2|STARTED|Overall Study||28
588613|NCT00506675|1436699|P1|STARTED|Overall Study||27
588614|NCT00506662|1436713|P2|NOT COMPLETED|Overall Study||28
588615|NCT00506662|1436714|P1|NOT COMPLETED|Overall Study||17
588616|NCT00506662|1436713|P2|COMPLETED|Overall Study||20
588617|NCT00506662|1436714|P1|COMPLETED|Overall Study||21
588618|NCT00506662|1436713|P2|STARTED|Overall Study||48
588619|NCT00506662|1436714|P1|STARTED|Overall Study||38
588620|NCT00506597|1436744|P1|NOT COMPLETED|Overall Study||0
588621|NCT00506597|1436744|P1|COMPLETED|Overall Study||33
588622|NCT00506597|1436744|P1|STARTED|Overall Study||33
588623|NCT00506493|1436748|P1|NOT COMPLETED|Overall Study||11
588624|NCT00506493|1436748|P1|COMPLETED|Overall Study||64
588625|NCT00506493|1436748|P1|STARTED|Overall Study||75
588626|NCT00506454|1436757|P2|NOT COMPLETED|Overall Study||1
588627|NCT00506454|1436758|P1|NOT COMPLETED|Overall Study||1
588628|NCT00506454|1436757|P2|COMPLETED|Overall Study||10
588629|NCT00506454|1436758|P1|COMPLETED|Overall Study||10
588630|NCT00506454|1436757|P2|STARTED|Overall Study||11
588631|NCT00506454|1436758|P1|STARTED|Overall Study||11
588632|NCT00506441|1436764|P2|NOT COMPLETED|Period 2; Double-blind Period||5
588633|NCT00506441|1436765|P1|NOT COMPLETED|Period 2; Double-blind Period||3
588634|NCT00506441|1436764|P2|COMPLETED|Period 2; Double-blind Period||79
588635|NCT00506441|1436765|P1|COMPLETED|Period 2; Double-blind Period||82
588636|NCT00506441|1436764|P2|STARTED|Period 2; Double-blind Period||84
588637|NCT00506441|1436765|P1|STARTED|Period 2; Double-blind Period||85
588638|NCT00506441|1436764|P2|NOT COMPLETED|Period 1; Open-label Period||0
588639|NCT00506441|1436765|P1|NOT COMPLETED|Period 1; Open-label Period||76
588640|NCT00506441|1436764|P2|COMPLETED|Period 1; Open-label Period||0
588641|NCT00506441|1436765|P1|COMPLETED|Period 1; Open-label Period||169
588642|NCT00506441|1436764|P2|STARTED|Period 1; Open-label Period||0
588643|NCT00506441|1436765|P1|STARTED|Period 1; Open-label Period||245
588644|NCT00506415|1436773|P4|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||62
588645|NCT00506415|1436774|P3|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
588646|NCT00506415|1436775|P2|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
588647|NCT00506415|1436776|P1|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
588648|NCT00506415|1436773|P4|COMPLETED|Extended Open Label (Maximum 48 Weeks)||395
588649|NCT00506415|1436774|P3|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
588650|NCT00506415|1436775|P2|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
588651|NCT00506415|1436776|P1|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
588652|NCT00506415|1436773|P4|STARTED|Extended Open Label (Maximum 48 Weeks)|Two participants did not receive study drug, hence excluded from this arm.|457
588653|NCT00506415|1436774|P3|STARTED|Extended Open Label (Maximum 48 Weeks)||0
588654|NCT00506415|1436775|P2|STARTED|Extended Open Label (Maximum 48 Weeks)||0
588655|NCT00506415|1436776|P1|STARTED|Extended Open Label (Maximum 48 Weeks)||0
588656|NCT00506415|1436773|P4|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0
588657|NCT00506415|1436774|P3|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||73
588658|NCT00506415|1436775|P2|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||83
588659|NCT00506415|1436776|P1|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0
588660|NCT00506415|1436773|P4|COMPLETED|Double Blind (Maximum 48 Weeks )||0
588661|NCT00506415|1436774|P3|COMPLETED|Double Blind (Maximum 48 Weeks )||207
588662|NCT00506415|1436775|P2|COMPLETED|Double Blind (Maximum 48 Weeks )||203
588663|NCT00506415|1436776|P1|COMPLETED|Double Blind (Maximum 48 Weeks )||0
588664|NCT00506415|1436773|P4|STARTED|Double Blind (Maximum 48 Weeks )||0
588665|NCT00506415|1436774|P3|STARTED|Double Blind (Maximum 48 Weeks )||280
588666|NCT00506415|1436775|P2|STARTED|Double Blind (Maximum 48 Weeks )|1 patient was randomized in error and did not receive study drug, hence excluded from this arm.|286
588667|NCT00506415|1436776|P1|STARTED|Double Blind (Maximum 48 Weeks )||0
588668|NCT00506415|1436773|P4|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
588669|NCT00506415|1436774|P3|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
588670|NCT00506415|1436775|P2|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
588671|NCT00506415|1436776|P1|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||499
588672|NCT00506415|1436773|P4|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
588673|NCT00506415|1436774|P3|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
588674|NCT00506415|1436775|P2|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
588675|NCT00506415|1436776|P1|COMPLETED|Initial Open Label (Maximum 48 Weeks)||1085
588676|NCT00506415|1436773|P4|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
588677|NCT00506415|1436774|P3|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
588678|NCT00506415|1436775|P2|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
588679|NCT00506415|1436776|P1|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||1582
588680|NCT00506415|1436773|P4|STARTED|Initial Open Label (Maximum 48 Weeks)||0
588681|NCT00506415|1436774|P3|STARTED|Initial Open Label (Maximum 48 Weeks)||0
588682|NCT00506415|1436775|P2|STARTED|Initial Open Label (Maximum 48 Weeks)||0
588683|NCT00506415|1436776|P1|STARTED|Initial Open Label (Maximum 48 Weeks)|Enrolled patients.|1584
588684|NCT00506389|1436801|P3|NOT COMPLETED|Follow-up Period||0
588685|NCT00506389|1436802|P2|NOT COMPLETED|Follow-up Period||0
588686|NCT00506389|1436803|P1|NOT COMPLETED|Follow-up Period||0
588687|NCT00506389|1436801|P3|COMPLETED|Follow-up Period||136
588688|NCT00506389|1436802|P2|COMPLETED|Follow-up Period||138
588689|NCT00506389|1436803|P1|COMPLETED|Follow-up Period||139
588690|NCT00506389|1436801|P3|STARTED|Follow-up Period|11 participants who discontinued treatment entered the Follow-up Period.|136
588691|NCT00506389|1436802|P2|STARTED|Follow-up Period|14 participants who discontinued treatment entered the Follow-up Period.|138
588692|NCT00506389|1436803|P1|STARTED|Follow-up Period|22 participants who discontinued treatment entered the Follow-up Period.|139
588693|NCT00506389|1436801|P3|NOT COMPLETED|In-treatment Period||12
588694|NCT00506389|1436802|P2|NOT COMPLETED|In-treatment Period||15
588695|NCT00506389|1436803|P1|NOT COMPLETED|In-treatment Period||26
588696|NCT00506389|1436801|P3|COMPLETED|In-treatment Period||125
588697|NCT00506389|1436802|P2|COMPLETED|In-treatment Period||124
588698|NCT00506389|1436803|P1|COMPLETED|In-treatment Period||117
588699|NCT00506389|1436801|P3|All Participants Treated|In-treatment Period||136
588700|NCT00506389|1436802|P2|All Participants Treated|In-treatment Period||138
588701|NCT00506389|1436803|P1|All Participants Treated|In-treatment Period||139
588702|NCT00506389|1436801|P3|STARTED|In-treatment Period||137
588703|NCT00506389|1436802|P2|STARTED|In-treatment Period||139
588704|NCT00506389|1436803|P1|STARTED|In-treatment Period||143
588705|NCT00506350|1436829|P9|NOT COMPLETED|Overall Study||5
588706|NCT00506350|1436830|P8|NOT COMPLETED|Overall Study||5
588707|NCT00506350|1436831|P7|NOT COMPLETED|Overall Study||2
588708|NCT00506350|1436832|P6|NOT COMPLETED|Overall Study||2
588709|NCT00506350|1436833|P5|NOT COMPLETED|Overall Study||10
588710|NCT00506350|1436834|P4|NOT COMPLETED|Overall Study||2
588711|NCT00506350|1436835|P3|NOT COMPLETED|Overall Study||6
588712|NCT00506350|1436836|P2|NOT COMPLETED|Overall Study||3
588713|NCT00506350|1436837|P1|NOT COMPLETED|Overall Study||3
588714|NCT00506350|1436829|P9|COMPLETED|Overall Study||30
588715|NCT00506350|1436830|P8|COMPLETED|Overall Study||36
588716|NCT00506350|1436831|P7|COMPLETED|Overall Study||33
588717|NCT00506350|1436832|P6|COMPLETED|Overall Study||38
588718|NCT00506350|1436833|P5|COMPLETED|Overall Study||40
588719|NCT00506350|1436834|P4|COMPLETED|Overall Study||34
588720|NCT00506350|1436835|P3|COMPLETED|Overall Study||31
588721|NCT00506350|1436836|P2|COMPLETED|Overall Study||37
588722|NCT00506350|1436837|P1|COMPLETED|Overall Study||33
588723|NCT00506350|1436829|P9|STARTED|Overall Study||35
588724|NCT00506350|1436830|P8|STARTED|Overall Study||41
588725|NCT00506350|1436831|P7|STARTED|Overall Study||35
588726|NCT00506350|1436832|P6|STARTED|Overall Study||40
588727|NCT00506350|1436833|P5|STARTED|Overall Study||50
588728|NCT00506350|1436834|P4|STARTED|Overall Study||36
588729|NCT00506350|1436835|P3|STARTED|Overall Study||37
588730|NCT00506350|1436836|P2|STARTED|Overall Study||40
588731|NCT00506350|1436837|P1|STARTED|Overall Study||36
588732|NCT00506285|1436984|P2|NOT COMPLETED|6-month Open Label Phase||12
588733|NCT00506285|1436985|P1|NOT COMPLETED|6-month Open Label Phase||10
588734|NCT00506285|1436984|P2|COMPLETED|6-month Open Label Phase||19
588735|NCT00506285|1436985|P1|COMPLETED|6-month Open Label Phase||10
588736|NCT00506285|1436984|P2|STARTED|6-month Open Label Phase||31
588737|NCT00506285|1436985|P1|STARTED|6-month Open Label Phase||20
588738|NCT00506285|1436984|P2|NOT COMPLETED|Double Blind Cross-Over Phase||5
588739|NCT00506285|1436985|P1|NOT COMPLETED|Double Blind Cross-Over Phase||9
588740|NCT00506285|1436984|P2|COMPLETED|Double Blind Cross-Over Phase||31
588741|NCT00506285|1436985|P1|COMPLETED|Double Blind Cross-Over Phase||20
588742|NCT00506285|1436984|P2|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||31
588743|NCT00506285|1436985|P1|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||29
588744|NCT00506285|1436984|P2|STARTED|Double Blind Cross-Over Phase||36
588745|NCT00506285|1436985|P1|STARTED|Double Blind Cross-Over Phase||29
588746|NCT00506285|1436984|P2|NOT COMPLETED|3 Week Screening Phase||10
588747|NCT00506285|1436985|P1|NOT COMPLETED|3 Week Screening Phase||17
588748|NCT00506285|1436984|P2|COMPLETED|3 Week Screening Phase||36
588749|NCT00506285|1436985|P1|COMPLETED|3 Week Screening Phase||29
588750|NCT00506285|1436984|P2|STARTED|3 Week Screening Phase||46
588751|NCT00506285|1436985|P1|STARTED|3 Week Screening Phase||46
588752|NCT00506155|1436993|P1|NOT COMPLETED|Overall Study||0
588753|NCT00506155|1436993|P1|COMPLETED|Overall Study||60
588754|NCT00506155|1436993|P1|STARTED|Overall Study||60
588755|NCT00506077|1437000|P2|NOT COMPLETED|Treatment Period 2||1
588756|NCT00506077|1437001|P1|NOT COMPLETED|Treatment Period 2||1
588757|NCT00506077|1437000|P2|COMPLETED|Treatment Period 2||23
588758|NCT00506077|1437001|P1|COMPLETED|Treatment Period 2||23
588759|NCT00506077|1437000|P2|STARTED|Treatment Period 2||24
588760|NCT00506077|1437001|P1|STARTED|Treatment Period 2||24
588761|NCT00506077|1437000|P2|NOT COMPLETED|Washout||0
588762|NCT00506077|1437001|P1|NOT COMPLETED|Washout||0
588763|NCT00506077|1437000|P2|COMPLETED|Washout||24
588764|NCT00506077|1437001|P1|COMPLETED|Washout||24
588765|NCT00506077|1437000|P2|STARTED|Washout||24
588766|NCT00506077|1437001|P1|STARTED|Washout||24
588767|NCT00506077|1437000|P2|NOT COMPLETED|Treatment Period 1||3
588768|NCT00506077|1437001|P1|NOT COMPLETED|Treatment Period 1||4
588769|NCT00506077|1437000|P2|COMPLETED|Treatment Period 1||24
588770|NCT00506077|1437001|P1|COMPLETED|Treatment Period 1||24
588771|NCT00506077|1437000|P2|STARTED|Treatment Period 1||27
588772|NCT00506077|1437001|P1|STARTED|Treatment Period 1||28
588773|NCT00506064|1437023|P2|NOT COMPLETED|Overall Study||0
588774|NCT00506064|1437024|P1|NOT COMPLETED|Overall Study||0
588775|NCT00506064|1437023|P2|COMPLETED|Overall Study||0
588776|NCT00506064|1437024|P1|COMPLETED|Overall Study||1
588777|NCT00506064|1437023|P2|STARTED|Overall Study||0
588778|NCT00506064|1437024|P1|STARTED|Overall Study||1
588779|NCT00506025|1437033|P3|NOT COMPLETED|Overall Study||0
588780|NCT00506025|1437034|P2|NOT COMPLETED|Overall Study||0
588781|NCT00506025|1437035|P1|NOT COMPLETED|Overall Study||0
588782|NCT00506025|1437033|P3|COMPLETED|Overall Study||8
588783|NCT00506025|1437034|P2|COMPLETED|Overall Study||9
588784|NCT00506025|1437035|P1|COMPLETED|Overall Study||10
588785|NCT00506025|1437033|P3|STARTED|Overall Study||8
588786|NCT00506025|1437034|P2|STARTED|Overall Study||9
588787|NCT00506025|1437035|P1|STARTED|Overall Study||10
588788|NCT00505934|1437043|P1|NOT COMPLETED|Overall Study||3
588789|NCT00505934|1437043|P1|COMPLETED|Overall Study||16
588790|NCT00505934|1437043|P1|STARTED|Overall Study|Of the 23 subjects screened, 19 were enrolled into the study and received levetiracetam IV (LEV IV).|19
588791|NCT00505921|1437049|P1|NOT COMPLETED|Overall Study||9
588792|NCT00505921|1437049|P1|COMPLETED|Overall Study||18
588793|NCT00505921|1437049|P1|STARTED|Overall Study||27
588794|NCT00505895|1437055|P2|NOT COMPLETED|Overall Study||0
588795|NCT00505895|1437056|P1|NOT COMPLETED|Overall Study||0
588796|NCT00505895|1437055|P2|COMPLETED|Overall Study||23
588797|NCT00505895|1437056|P1|COMPLETED|Overall Study||27
588798|NCT00505895|1437055|P2|STARTED|Overall Study||23
588799|NCT00505895|1437056|P1|STARTED|Overall Study||27
588800|NCT00505778|1437066|P2|NOT COMPLETED|Overall Study||135
588801|NCT00505778|1437067|P1|NOT COMPLETED|Overall Study||134
588802|NCT00505778|1437066|P2|COMPLETED|Overall Study||378
588803|NCT00505778|1437067|P1|COMPLETED|Overall Study||380
588804|NCT00505778|1437066|P2|Intent to Treat (ITT) Population|Overall Study||511
588805|NCT00505778|1437067|P1|Intent to Treat (ITT) Population|Overall Study||512
588806|NCT00505778|1437066|P2|STARTED|Overall Study||513
588807|NCT00505778|1437067|P1|STARTED|Overall Study||514
588808|NCT00505765|1437086|P3|NOT COMPLETED|Overall Study||3
588809|NCT00505765|1437087|P2|NOT COMPLETED|Overall Study||3
588810|NCT00505765|1437088|P1|NOT COMPLETED|Overall Study||2
588811|NCT00505765|1437086|P3|COMPLETED|Overall Study||19
588812|NCT00505765|1437087|P2|COMPLETED|Overall Study||17
588813|NCT00505765|1437088|P1|COMPLETED|Overall Study||19
588814|NCT00505765|1437086|P3|Mid-Point Assessment|Overall Study||21
588815|NCT00505765|1437087|P2|Mid-Point Assessment|Overall Study||19
588816|NCT00505765|1437088|P1|Mid-Point Assessment|Overall Study||20
588817|NCT00505765|1437086|P3|STARTED|Overall Study||22
588818|NCT00505765|1437087|P2|STARTED|Overall Study||20
588819|NCT00505765|1437088|P1|STARTED|Overall Study||21
588820|NCT00505752|1437115|P4|NOT COMPLETED|Overall Study||6
588821|NCT00505752|1437116|P3|NOT COMPLETED|Overall Study||8
588822|NCT00505752|1437117|P2|NOT COMPLETED|Overall Study||9
588823|NCT00505752|1437118|P1|NOT COMPLETED|Overall Study||6
588824|NCT00505752|1437115|P4|COMPLETED|Overall Study||126
588825|NCT00505752|1437116|P3|COMPLETED|Overall Study||120
588826|NCT00505752|1437117|P2|COMPLETED|Overall Study||119
588827|NCT00505752|1437118|P1|COMPLETED|Overall Study||126
588828|NCT00505752|1437115|P4|STARTED|Overall Study||132
588829|NCT00505752|1437116|P3|STARTED|Overall Study||128
588830|NCT00505752|1437117|P2|STARTED|Overall Study||128
588831|NCT00505752|1437118|P1|STARTED|Overall Study||132
588832|NCT00505687|1437132|P1|NOT COMPLETED|Overall Study||95
588833|NCT00505687|1437132|P1|COMPLETED|Overall Study||91
588834|NCT00505687|1437132|P1|STARTED|Overall Study||186
588835|NCT00505661|1437138|P1|NOT COMPLETED|Overall Study||4
588836|NCT00505661|1437138|P1|COMPLETED|Overall Study||12
588837|NCT00505661|1437138|P1|STARTED|Overall Study||16
588838|NCT00505635|1437142|P1|NOT COMPLETED|Overall Study||0
588839|NCT00505635|1437142|P1|COMPLETED|Overall Study||5
588840|NCT00505635|1437142|P1|STARTED|Overall Study||5
588841|NCT00505622|1437149|P3|NOT COMPLETED|Overall Study||96
588842|NCT00505622|1437150|P2|NOT COMPLETED|Overall Study||108
588843|NCT00505622|1437151|P1|NOT COMPLETED|Overall Study||121
588844|NCT00505622|1437149|P3|COMPLETED|Overall Study||0
588845|NCT00505622|1437150|P2|COMPLETED|Overall Study||0
588846|NCT00505622|1437151|P1|COMPLETED|Overall Study||0
588847|NCT00505622|1437149|P3|STARTED|Overall Study||96
588848|NCT00505622|1437150|P2|STARTED|Overall Study||108
588849|NCT00505622|1437151|P1|STARTED|Overall Study||121
588850|NCT00505518|1437168|P1|NOT COMPLETED|Overall Study||0
588851|NCT00505518|1437168|P1|COMPLETED|Overall Study||9
588852|NCT00505518|1437168|P1|STARTED|Overall Study||9
588853|NCT00505414|1437176|P5|NOT COMPLETED|Maintenance Phase||0
588854|NCT00505414|1437177|P4|NOT COMPLETED|Maintenance Phase||0
588855|NCT00505414|1437178|P3|NOT COMPLETED|Maintenance Phase||8
588856|NCT00505414|1437179|P2|NOT COMPLETED|Maintenance Phase||5
588857|NCT00505414|1437180|P1|NOT COMPLETED|Maintenance Phase||6
588858|NCT00505414|1437176|P5|COMPLETED|Maintenance Phase||0
588859|NCT00505414|1437177|P4|COMPLETED|Maintenance Phase||0
588860|NCT00505414|1437178|P3|COMPLETED|Maintenance Phase||6
588861|NCT00505414|1437179|P2|COMPLETED|Maintenance Phase||10
588862|NCT00505414|1437180|P1|COMPLETED|Maintenance Phase||12
588863|NCT00505414|1437176|P5|Did Not Qualify for Maintenance Phase|Maintenance Phase||1
588864|NCT00505414|1437177|P4|Did Not Qualify for Maintenance Phase|Maintenance Phase||3
588865|NCT00505414|1437178|P3|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
588866|NCT00505414|1437179|P2|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
588867|NCT00505414|1437180|P1|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
588868|NCT00505414|1437176|P5|STARTED|Maintenance Phase|18 of 19 participants completing the morphine titration phase were continued on morphine.|0
588869|NCT00505414|1437177|P4|STARTED|Maintenance Phase|29 of 32 participants were treated in the maintenance phase either with placebo or tapentadol|0
588870|NCT00505414|1437178|P3|STARTED|Maintenance Phase|14 of 32 tapentadol titration participants were treated with placebo in the maintenance phase.|14
588871|NCT00505414|1437179|P2|STARTED|Maintenance Phase|15 of 32 tapentadol titration participants continued with tapentadol in the maintenance phase|15
588872|NCT00505414|1437180|P1|STARTED|Maintenance Phase|18 of the 19 morphine participants continued with morphine in the maintenance phase.|18
588873|NCT00505414|1437176|P5|NOT COMPLETED|Titration Phase||12
588874|NCT00505414|1437177|P4|NOT COMPLETED|Titration Phase||30
588875|NCT00505414|1437178|P3|NOT COMPLETED|Titration Phase||0
588876|NCT00505414|1437179|P2|NOT COMPLETED|Titration Phase||0
588877|NCT00505414|1437180|P1|NOT COMPLETED|Titration Phase||0
588878|NCT00505414|1437176|P5|COMPLETED|Titration Phase||19
588879|NCT00505414|1437177|P4|COMPLETED|Titration Phase||32
588880|NCT00505414|1437178|P3|COMPLETED|Titration Phase||0
588881|NCT00505414|1437179|P2|COMPLETED|Titration Phase||0
588882|NCT00505414|1437180|P1|COMPLETED|Titration Phase||0
588883|NCT00505414|1437176|P5|STARTED|Titration Phase||31
588884|NCT00505414|1437177|P4|STARTED|Titration Phase||62
588885|NCT00505414|1437178|P3|STARTED|Titration Phase||0
588886|NCT00505414|1437179|P2|STARTED|Titration Phase||0
588887|NCT00505414|1437180|P1|STARTED|Titration Phase||0
588888|NCT00505375|1437197|P2|NOT COMPLETED|Overall Study||5
588889|NCT00505375|1437198|P1|NOT COMPLETED|Overall Study||4
588890|NCT00505375|1437197|P2|COMPLETED|Overall Study||30
588891|NCT00505375|1437198|P1|COMPLETED|Overall Study||73
588892|NCT00505375|1437197|P2|STARTED|Overall Study||35
588893|NCT00505375|1437198|P1|STARTED|Overall Study||77
588894|NCT00505362|1437206|P2|NOT COMPLETED|Overall Study||0
588895|NCT00505362|1437207|P1|NOT COMPLETED|Overall Study||0
588896|NCT00505362|1437206|P2|COMPLETED|Overall Study||28
588897|NCT00505362|1437207|P1|COMPLETED|Overall Study||35
588898|NCT00505362|1437206|P2|STARTED|Overall Study||28
588899|NCT00505362|1437207|P1|STARTED|Overall Study||35
588900|NCT00505284|1437220|P5|NOT COMPLETED|Overall Study||33
588901|NCT00505284|1437221|P4|NOT COMPLETED|Overall Study||19
588902|NCT00505284|1437222|P3|NOT COMPLETED|Overall Study||12
588903|NCT00505284|1437223|P2|NOT COMPLETED|Overall Study||16
588904|NCT00505284|1437224|P1|NOT COMPLETED|Overall Study||10
588905|NCT00505284|1437220|P5|COMPLETED|Overall Study||37
588906|NCT00505284|1437221|P4|COMPLETED|Overall Study||49
588907|NCT00505284|1437222|P3|COMPLETED|Overall Study||57
588908|NCT00505284|1437223|P2|COMPLETED|Overall Study||56
588909|NCT00505284|1437224|P1|COMPLETED|Overall Study||63
588910|NCT00505284|1437220|P5|STARTED|Overall Study||70
588911|NCT00505284|1437221|P4|STARTED|Overall Study||68
588912|NCT00505284|1437222|P3|STARTED|Overall Study||69
588913|NCT00505284|1437223|P2|STARTED|Overall Study||72
588914|NCT00505284|1437224|P1|STARTED|Overall Study||73
588915|NCT00505076|1437294|P3|NOT COMPLETED|Overall Study||5
588916|NCT00505076|1437295|P2|NOT COMPLETED|Overall Study||2
588917|NCT00505076|1437296|P1|NOT COMPLETED|Overall Study||3
588918|NCT00505076|1437294|P3|COMPLETED|Overall Study||17
588919|NCT00505076|1437295|P2|COMPLETED|Overall Study||17
588920|NCT00505076|1437296|P1|COMPLETED|Overall Study||19
588921|NCT00505076|1437294|P3|STARTED|Overall Study||22
588922|NCT00505076|1437295|P2|STARTED|Overall Study||19
588923|NCT00505076|1437296|P1|STARTED|Overall Study||22
588924|NCT00504985|1437310|P1|NOT COMPLETED|Overall Study||0
588925|NCT00504985|1437310|P1|COMPLETED|Overall Study||14
588926|NCT00504985|1437310|P1|STARTED|Overall Study||14
588927|NCT00504894|1437316|P2|NOT COMPLETED|Overall Study||0
588928|NCT00504894|1437317|P1|NOT COMPLETED|Overall Study||0
588929|NCT00504894|1437316|P2|COMPLETED|Overall Study||18
588930|NCT00504894|1437317|P1|COMPLETED|Overall Study||17
588931|NCT00504894|1437316|P2|STARTED|Overall Study||18
588932|NCT00504894|1437317|P1|STARTED|Overall Study||17
588933|NCT00504881|1437325|P2|NOT COMPLETED|Overall Study||36
588934|NCT00504881|1437326|P1|NOT COMPLETED|Overall Study||10
588935|NCT00504881|1437325|P2|COMPLETED|Overall Study||323
588936|NCT00504881|1437326|P1|COMPLETED|Overall Study||111
588937|NCT00504881|1437325|P2|STARTED|Overall Study||359
588938|NCT00504881|1437326|P1|STARTED|Overall Study||121
588939|NCT00504777|1437376|P1|NOT COMPLETED|Overall Study||1
588940|NCT00504777|1437376|P1|COMPLETED|Overall Study||35
588941|NCT00504777|1437376|P1|STARTED|Overall Study||36
588942|NCT00504751|1437383|P1|NOT COMPLETED|Overall Study||0
588943|NCT00504751|1437383|P1|COMPLETED|Overall Study||15
588944|NCT00504751|1437383|P1|STARTED|Overall Study||15
588945|NCT00504725|1437389|P2|NOT COMPLETED|Overall Study||0
588946|NCT00504725|1437390|P1|NOT COMPLETED|Overall Study||1
588947|NCT00504725|1437389|P2|COMPLETED|Overall Study||20
588948|NCT00504725|1437390|P1|COMPLETED|Overall Study|Prior to unblinding, one subject was discontinued due to elevated CRP levels at baseline.|20
588949|NCT00504725|1437389|P2|STARTED|Overall Study||20
588950|NCT00504725|1437390|P1|STARTED|Overall Study||21
588951|NCT00504660|1437402|P2|NOT COMPLETED|Overall Study||0
588952|NCT00504660|1437403|P1|NOT COMPLETED|Overall Study||0
588953|NCT00504660|1437402|P2|COMPLETED|Overall Study||43
588954|NCT00504660|1437403|P1|COMPLETED|Overall Study||31
588955|NCT00504660|1437402|P2|STARTED|Overall Study||43
588956|NCT00504660|1437403|P1|STARTED|Overall Study||31
588957|NCT00504595|1437413|P4|NOT COMPLETED|Overall Study||0
588958|NCT00504595|1437414|P3|NOT COMPLETED|Overall Study||2
588959|NCT00504595|1437415|P2|NOT COMPLETED|Overall Study||0
588960|NCT00504595|1437416|P1|NOT COMPLETED|Overall Study||1
588961|NCT00504595|1437413|P4|COMPLETED|Overall Study||10
588962|NCT00504595|1437414|P3|COMPLETED|Overall Study||8
588963|NCT00504595|1437415|P2|COMPLETED|Overall Study||10
588964|NCT00504595|1437416|P1|COMPLETED|Overall Study||49
588965|NCT00504595|1437413|P4|STARTED|Overall Study||10
588966|NCT00504595|1437414|P3|STARTED|Overall Study||10
588967|NCT00504595|1437415|P2|STARTED|Overall Study||10
588968|NCT00504595|1437416|P1|STARTED|Overall Study||50
588969|NCT00504556|1437433|P5|NOT COMPLETED|Overall Study||25
588970|NCT00504556|1437434|P4|NOT COMPLETED|Overall Study||128
588971|NCT00504556|1437435|P3|NOT COMPLETED|Overall Study||31
588972|NCT00504556|1437436|P2|NOT COMPLETED|Overall Study||38
588973|NCT00504556|1437437|P1|NOT COMPLETED|Overall Study||35
588974|NCT00504556|1437433|P5|COMPLETED|Overall Study||226
588975|NCT00504556|1437434|P4|COMPLETED|Overall Study||52
588976|NCT00504556|1437435|P3|COMPLETED|Overall Study||204
588977|NCT00504556|1437436|P2|COMPLETED|Overall Study||207
588978|NCT00504556|1437437|P1|COMPLETED|Overall Study||200
588979|NCT00504556|1437433|P5|Pharmacodynamic Analysis Set|Overall Study||244
588980|NCT00504556|1437434|P4|Pharmacodynamic Analysis Set|Overall Study||170
588981|NCT00504556|1437435|P3|Pharmacodynamic Analysis Set|Overall Study||228
588982|NCT00504556|1437436|P2|Pharmacodynamic Analysis Set|Overall Study||236
588983|NCT00504556|1437437|P1|Pharmacodynamic Analysis Set|Overall Study||230
588984|NCT00504556|1437433|P5|Per Protocol Analysis Set|Overall Study||250
588985|NCT00504556|1437434|P4|Per Protocol Analysis Set|Overall Study||180
588986|NCT00504556|1437435|P3|Per Protocol Analysis Set|Overall Study||234
588987|NCT00504556|1437436|P2|Per Protocol Analysis Set|Overall Study||243
588988|NCT00504556|1437437|P1|Per Protocol Analysis Set|Overall Study||235
588989|NCT00504556|1437433|P5|Safety Analysis Set|Overall Study||250
588990|NCT00504556|1437434|P4|Safety Analysis Set|Overall Study||180
588991|NCT00504556|1437435|P3|Safety Analysis Set|Overall Study||234
588992|NCT00504556|1437436|P2|Safety Analysis Set|Overall Study||244
588993|NCT00504556|1437437|P1|Safety Analysis Set|Overall Study||235
588994|NCT00504556|1437433|P5|STARTED|Overall Study||251
588995|NCT00504556|1437434|P4|STARTED|Overall Study||180
588996|NCT00504556|1437435|P3|STARTED|Overall Study||235
588997|NCT00504556|1437436|P2|STARTED|Overall Study||245
588998|NCT00504556|1437437|P1|STARTED|Overall Study||235
588999|NCT00504504|1437497|P1|NOT COMPLETED|Overall Study||0
589000|NCT00504504|1437497|P1|COMPLETED|Overall Study||82
589001|NCT00504504|1437497|P1|STARTED|Overall Study||82
589002|NCT00504426|1437505|P4|NOT COMPLETED|Overall Study||0
589003|NCT00504426|1437506|P3|NOT COMPLETED|Overall Study||4
589004|NCT00504426|1437507|P2|NOT COMPLETED|Overall Study||1
589005|NCT00504426|1437508|P1|NOT COMPLETED|Overall Study||3
589006|NCT00504426|1437505|P4|COMPLETED|Overall Study||24
589007|NCT00504426|1437506|P3|COMPLETED|Overall Study||18
589008|NCT00504426|1437507|P2|COMPLETED|Overall Study||22
589009|NCT00504426|1437508|P1|COMPLETED|Overall Study||29
589010|NCT00504426|1437505|P4|STARTED|Overall Study||24
589011|NCT00504426|1437506|P3|STARTED|Overall Study||22
589012|NCT00504426|1437507|P2|STARTED|Overall Study||23
589013|NCT00504426|1437508|P1|STARTED|Overall Study||32
589014|NCT00504309|1437528|P6|NOT COMPLETED|Overall Study||0
589015|NCT00504309|1437529|P5|NOT COMPLETED|Overall Study||1
589016|NCT00504309|1437530|P4|NOT COMPLETED|Overall Study||0
589017|NCT00504309|1437531|P3|NOT COMPLETED|Overall Study||1
589018|NCT00504309|1437532|P2|NOT COMPLETED|Overall Study||0
589019|NCT00504309|1437533|P1|NOT COMPLETED|Overall Study||0
589020|NCT00504309|1437528|P6|COMPLETED|Overall Study||3
589021|NCT00504309|1437529|P5|COMPLETED|Overall Study|Participant died during washout after 2nd period|7
589022|NCT00504309|1437530|P4|COMPLETED|Overall Study||3
589023|NCT00504309|1437531|P3|COMPLETED|Overall Study|Participant dropped out during second period|1
589024|NCT00504309|1437532|P2|COMPLETED|Overall Study||5
589025|NCT00504309|1437533|P1|COMPLETED|Overall Study||7
589026|NCT00504309|1437528|P6|STARTED|Overall Study||3
589027|NCT00504309|1437529|P5|STARTED|Overall Study||8
589028|NCT00504309|1437530|P4|STARTED|Overall Study||3
589029|NCT00504309|1437531|P3|STARTED|Overall Study||2
589030|NCT00504309|1437532|P2|STARTED|Overall Study||5
589031|NCT00504309|1437533|P1|STARTED|Overall Study||7
589032|NCT00504257|1437571|P1|NOT COMPLETED|Overall Study||4
589033|NCT00504257|1437571|P1|COMPLETED|Overall Study||41
589034|NCT00504257|1437571|P1|STARTED|Overall Study||45
589035|NCT00504231|1437583|P4|NOT COMPLETED|Overall Study||0
589036|NCT00504231|1437584|P3|NOT COMPLETED|Overall Study||1
589037|NCT00504231|1437585|P2|NOT COMPLETED|Overall Study||0
589038|NCT00504231|1437586|P1|NOT COMPLETED|Overall Study||0
589039|NCT00504231|1437583|P4|COMPLETED|Overall Study||65
589040|NCT00504231|1437584|P3|COMPLETED|Overall Study||63
589041|NCT00504231|1437585|P2|COMPLETED|Overall Study||64
589042|NCT00504231|1437586|P1|COMPLETED|Overall Study||65
589043|NCT00504231|1437583|P4|STARTED|Overall Study||65
589044|NCT00504231|1437584|P3|STARTED|Overall Study||64
589045|NCT00504231|1437585|P2|STARTED|Overall Study||64
589046|NCT00504231|1437586|P1|STARTED|Overall Study||65
589047|NCT00504166|1437606|P2|NOT COMPLETED|Overall Study||14
589048|NCT00504166|1437607|P1|NOT COMPLETED|Overall Study||6
589049|NCT00504166|1437606|P2|COMPLETED|Overall Study||13
589050|NCT00504166|1437607|P1|COMPLETED|Overall Study||20
589051|NCT00504166|1437606|P2|STARTED|Overall Study||27
589052|NCT00504166|1437607|P1|STARTED|Overall Study||26
589053|NCT00504153|1437613|P1|NOT COMPLETED|Overall Study||6
589054|NCT00504153|1437613|P1|COMPLETED|Overall Study||13
589055|NCT00504153|1437613|P1|STARTED|Overall Study||19
589056|NCT00504075|1437621|P1|NOT COMPLETED|Overall Study||8
589057|NCT00504075|1437621|P1|COMPLETED|Overall Study||27
589058|NCT00504075|1437621|P1|STARTED|Overall Study||35
589059|NCT00504023|1437627|P1|NOT COMPLETED|Overall Study||0
589060|NCT00504023|1437627|P1|COMPLETED|Overall Study||8
589061|NCT00504023|1437627|P1|STARTED|Overall Study||8
589062|NCT00503997|1437631|P1|NOT COMPLETED|Overall Study||8
589063|NCT00503997|1437631|P1|COMPLETED|Overall Study||34
589064|NCT00503997|1437631|P1|STARTED|Overall Study||42
589065|NCT00503984|1437637|P6|NOT COMPLETED|Overall Study||0
589066|NCT00503984|1437638|P5|NOT COMPLETED|Overall Study||1
589067|NCT00503984|1437639|P4|NOT COMPLETED|Overall Study||0
589068|NCT00503984|1437640|P3|NOT COMPLETED|Overall Study||0
589069|NCT00503984|1437641|P2|NOT COMPLETED|Overall Study||2
589070|NCT00503984|1437642|P1|NOT COMPLETED|Overall Study||0
589071|NCT00503984|1437637|P6|COMPLETED|Overall Study||1
589072|NCT00503984|1437638|P5|COMPLETED|Overall Study||5
589073|NCT00503984|1437639|P4|COMPLETED|Overall Study||6
589074|NCT00503984|1437640|P3|COMPLETED|Overall Study||3
589075|NCT00503984|1437641|P2|COMPLETED|Overall Study||1
589076|NCT00503984|1437642|P1|COMPLETED|Overall Study||3
589077|NCT00503984|1437637|P6|STARTED|Overall Study||1
589078|NCT00503984|1437638|P5|STARTED|Overall Study||6
589079|NCT00503984|1437639|P4|STARTED|Overall Study||6
589080|NCT00503984|1437640|P3|STARTED|Overall Study||3
589081|NCT00503984|1437641|P2|STARTED|Overall Study||3
589082|NCT00503984|1437642|P1|STARTED|Overall Study||3
589083|NCT00503906|1437668|P1|NOT COMPLETED|Overall Study||1
589084|NCT00503906|1437668|P1|COMPLETED|Overall Study||29
589085|NCT00503906|1437668|P1|STARTED|Overall Study||30
589086|NCT00503880|1437677|P5|NOT COMPLETED|Overall Study||0
589087|NCT00503880|1437678|P4|NOT COMPLETED|Overall Study||0
589088|NCT00503880|1437679|P3|NOT COMPLETED|Overall Study||0
589089|NCT00503880|1437680|P2|NOT COMPLETED|Overall Study||0
589090|NCT00503880|1437681|P1|NOT COMPLETED|Overall Study||2
589091|NCT00503880|1437677|P5|COMPLETED|Overall Study||0
589092|NCT00503880|1437678|P4|COMPLETED|Overall Study||0
589093|NCT00503880|1437679|P3|COMPLETED|Overall Study||0
589094|NCT00503880|1437680|P2|COMPLETED|Overall Study||0
589095|NCT00503880|1437681|P1|COMPLETED|Overall Study||0
589096|NCT00503880|1437677|P5|STARTED|Overall Study||0
589097|NCT00503880|1437678|P4|STARTED|Overall Study||0
589098|NCT00503880|1437679|P3|STARTED|Overall Study||0
589099|NCT00503880|1437680|P2|STARTED|Overall Study||0
589100|NCT00503880|1437681|P1|STARTED|Overall Study||2
589101|NCT00503841|1437690|P1|NOT COMPLETED|Overall Study||44
589102|NCT00503841|1437690|P1|COMPLETED|Overall Study||0
589103|NCT00503841|1437690|P1|STARTED|Overall Study||44
589104|NCT00503776|1437698|P4|NOT COMPLETED|Overall Study||2
589105|NCT00503776|1437699|P3|NOT COMPLETED|Overall Study||2
589106|NCT00503776|1437700|P2|NOT COMPLETED|Overall Study||0
589107|NCT00503776|1437701|P1|NOT COMPLETED|Overall Study||1
589108|NCT00503776|1437698|P4|COMPLETED|Overall Study||8
589109|NCT00503776|1437699|P3|COMPLETED|Overall Study||10
589110|NCT00503776|1437700|P2|COMPLETED|Overall Study||12
589111|NCT00503776|1437701|P1|COMPLETED|Overall Study||7
589112|NCT00503776|1437698|P4|STARTED|Overall Study|one patient withdrew before receiving protocol therapy|10
589113|NCT00503776|1437699|P3|STARTED|Overall Study|one patient withdrew before receiving protocol therapy|12
589114|NCT00503776|1437700|P2|STARTED|Overall Study||12
589115|NCT00503776|1437701|P1|STARTED|Overall Study||8
589116|NCT00503750|1437727|P1|NOT COMPLETED|Overall Study||0
589117|NCT00503750|1437727|P1|COMPLETED|Overall Study||27
589118|NCT00503750|1437727|P1|STARTED|Overall Study||27
589119|NCT00503698|1437734|P2|NOT COMPLETED|Overall Study||355
589120|NCT00503698|1437735|P1|NOT COMPLETED|Overall Study||357
589121|NCT00503698|1437734|P2|COMPLETED|Overall Study|Trial prematurely terminated|0
589122|NCT00503698|1437735|P1|COMPLETED|Overall Study|Trial prematurely terminated|0
589123|NCT00503698|1437734|P2|Exposed to Trial Drug|Overall Study|6 subjects randomised but not exposed to trial drug. Subjects not included in full analysis set.|349
589124|NCT00503698|1437735|P1|Exposed to Trial Drug|Overall Study|11 subjects randomised but not exposed to trial drug. Subjects not included in full analysis set.|346
589125|NCT00503698|1437734|P2|STARTED|Overall Study|Randomised|355
589126|NCT00503698|1437735|P1|STARTED|Overall Study|Randomised|357
589127|NCT00503685|1437752|P3|NOT COMPLETED|Overall Study||2
589128|NCT00503685|1437753|P2|NOT COMPLETED|Overall Study||3
589129|NCT00503685|1437754|P1|NOT COMPLETED|Overall Study||0
589130|NCT00503685|1437752|P3|COMPLETED|Overall Study||18
589131|NCT00503685|1437753|P2|COMPLETED|Overall Study||19
589132|NCT00503685|1437754|P1|COMPLETED|Overall Study||23
589133|NCT00503685|1437752|P3|Received at Least 1 Dose of Study Drug|Overall Study||20
589134|NCT00503685|1437753|P2|Received at Least 1 Dose of Study Drug|Overall Study||21
589135|NCT00503685|1437754|P1|Received at Least 1 Dose of Study Drug|Overall Study||23
589136|NCT00503685|1437752|P3|STARTED|Overall Study||20
589137|NCT00503685|1437753|P2|STARTED|Overall Study||22
589138|NCT00503685|1437754|P1|STARTED|Overall Study||23
589139|NCT00503425|1437796|P1|NOT COMPLETED|Overall Study||54
589140|NCT00503425|1437796|P1|COMPLETED|Overall Study||161
589141|NCT00503425|1437796|P1|STARTED|Overall Study||215
589142|NCT00503399|1437806|P2|NOT COMPLETED|Overall Study||8
589143|NCT00503399|1437807|P1|NOT COMPLETED|Overall Study||7
589144|NCT00503399|1437806|P2|COMPLETED|Overall Study||39
589145|NCT00503399|1437807|P1|COMPLETED|Overall Study||38
589146|NCT00503399|1437806|P2|STARTED|Overall Study||47
589147|NCT00503399|1437807|P1|STARTED|Overall Study||45
589148|NCT00503308|1437831|P2|NOT COMPLETED|Overall Study||1
589149|NCT00503308|1437832|P1|NOT COMPLETED|Overall Study||2
589150|NCT00503308|1437831|P2|COMPLETED|Overall Study||134
589151|NCT00503308|1437832|P1|COMPLETED|Overall Study||144
589152|NCT00503308|1437831|P2|STARTED|Overall Study||135
589153|NCT00503308|1437832|P1|STARTED|Overall Study||146
589154|NCT00503139|1437838|P1|NOT COMPLETED|Overall Study||8
589155|NCT00503139|1437838|P1|COMPLETED|Overall Study||676
589156|NCT00503139|1437838|P1|STARTED|Overall Study||684
589157|NCT00503113|1437852|P3|NOT COMPLETED|Overall Study||28
589158|NCT00503113|1437853|P2|NOT COMPLETED|Overall Study||28
589159|NCT00503113|1437854|P1|NOT COMPLETED|Overall Study||33
589160|NCT00503113|1437852|P3|COMPLETED|Overall Study||241
589161|NCT00503113|1437853|P2|COMPLETED|Overall Study||236
589162|NCT00503113|1437854|P1|COMPLETED|Overall Study||235
589163|NCT00503113|1437852|P3|Safety Population|Overall Study||267
589164|NCT00503113|1437853|P2|Safety Population|Overall Study||263
589165|NCT00503113|1437854|P1|Safety Population|Overall Study||263
589166|NCT00503113|1437852|P3|Per Protocol Population (PP)|Overall Study||241
589167|NCT00503113|1437853|P2|Per Protocol Population (PP)|Overall Study||243
589168|NCT00503113|1437854|P1|Per Protocol Population (PP)|Overall Study||246
589169|NCT00503113|1437852|P3|Intent to Treat Population (ITT)|Overall Study||268
589170|NCT00503113|1437853|P2|Intent to Treat Population (ITT)|Overall Study||261
589171|NCT00503113|1437854|P1|Intent to Treat Population (ITT)|Overall Study||262
589172|NCT00503113|1437852|P3|STARTED|Overall Study||269
589173|NCT00503113|1437853|P2|STARTED|Overall Study||264
589174|NCT00503113|1437854|P1|STARTED|Overall Study||268
589175|NCT00503009|1437886|P3|NOT COMPLETED|Overall Study||3
589176|NCT00503009|1437887|P2|NOT COMPLETED|Overall Study||2
589177|NCT00503009|1437888|P1|NOT COMPLETED|Overall Study||1
589178|NCT00503009|1437886|P3|COMPLETED|Overall Study||3
589179|NCT00503009|1437887|P2|COMPLETED|Overall Study||3
589180|NCT00503009|1437888|P1|COMPLETED|Overall Study||4
589181|NCT00503009|1437886|P3|STARTED|Overall Study||6
589182|NCT00503009|1437887|P2|STARTED|Overall Study||5
589183|NCT00503009|1437888|P1|STARTED|Overall Study||5
589184|NCT00502996|1437905|P1|NOT COMPLETED|Overall Study||44
589185|NCT00502996|1437905|P1|COMPLETED|Overall Study||188
589186|NCT00502996|1437905|P1|STARTED|Overall Study||232
589187|NCT00502944|1437931|P2|NOT COMPLETED|Overall Study||1766
589188|NCT00502944|1437932|P1|NOT COMPLETED|Overall Study||1064
589189|NCT00502944|1437931|P2|COMPLETED|Overall Study||643
589190|NCT00502944|1437932|P1|COMPLETED|Overall Study||1382
589191|NCT00502944|1437931|P2|STARTED|Overall Study||2409
589192|NCT00502944|1437932|P1|STARTED|Overall Study||2446
589193|NCT00502905|1437944|P1|NOT COMPLETED|Overall Study||0
589194|NCT00502905|1437944|P1|COMPLETED|Overall Study||196
589195|NCT00502905|1437944|P1|STARTED|Overall Study||196
589196|NCT00502853|1437948|P1|NOT COMPLETED|Overall Study||0
589197|NCT00502853|1437948|P1|COMPLETED|Overall Study||10
589198|NCT00502853|1437948|P1|STARTED|Overall Study||10
589199|NCT00502840|1437973|P1|NOT COMPLETED|Overall Study||100
589200|NCT00502840|1437973|P1|COMPLETED|Overall Study||93
589201|NCT00502840|1437973|P1|STARTED|Overall Study||193
589202|NCT00502801|1438001|P1|NOT COMPLETED|End of Therapy to Test of Cure||8
589203|NCT00502801|1438001|P1|COMPLETED|End of Therapy to Test of Cure||121
589204|NCT00502801|1438001|P1|STARTED|End of Therapy to Test of Cure||129
589205|NCT00502801|1438001|P1|NOT COMPLETED|Treatment Period||54
589206|NCT00502801|1438001|P1|COMPLETED|Treatment Period||129
589207|NCT00502801|1438001|P1|STARTED|Treatment Period||183
589208|NCT00502775|1438009|P3|NOT COMPLETED|Overall Study||13
589209|NCT00502775|1438010|P2|NOT COMPLETED|Overall Study||15
589210|NCT00502775|1438011|P1|NOT COMPLETED|Overall Study||10
589211|NCT00502775|1438009|P3|COMPLETED|Overall Study||214
589212|NCT00502775|1438010|P2|COMPLETED|Overall Study||209
589213|NCT00502775|1438011|P1|COMPLETED|Overall Study||219
589214|NCT00502775|1438009|P3|STARTED|Overall Study||227
589215|NCT00502775|1438010|P2|STARTED|Overall Study||224
589216|NCT00502775|1438011|P1|STARTED|Overall Study||229
589217|NCT00502697|1438054|P2|NOT COMPLETED|Overall Study||12
589218|NCT00502697|1438055|P1|NOT COMPLETED|Overall Study||13
589219|NCT00502697|1438054|P2|COMPLETED|Overall Study||102
589220|NCT00502697|1438055|P1|COMPLETED|Overall Study||109
589221|NCT00502697|1438054|P2|STARTED|Overall Study||114
589222|NCT00502697|1438055|P1|STARTED|Overall Study||122
589223|NCT00502671|1438063|P1|NOT COMPLETED|Overall Study||77
589224|NCT00502671|1438063|P1|COMPLETED|Overall Study||151
589225|NCT00502671|1438063|P1|STARTED|Overall Study||228
589226|NCT00502593|1438080|P12|NOT COMPLETED|Overall Study||0
589227|NCT00502593|1438081|P11|NOT COMPLETED|Overall Study||2
589228|NCT00502593|1438082|P10|NOT COMPLETED|Overall Study||0
589229|NCT00502593|1438083|P9|NOT COMPLETED|Overall Study||6
589230|NCT00502593|1438084|P8|NOT COMPLETED|Overall Study||0
589231|NCT00502593|1438085|P7|NOT COMPLETED|Overall Study||5
589232|NCT00502593|1438086|P6|NOT COMPLETED|Overall Study||0
589233|NCT00502593|1438087|P5|NOT COMPLETED|Overall Study||4
589234|NCT00502593|1438088|P4|NOT COMPLETED|Overall Study||4
589235|NCT00502593|1438089|P3|NOT COMPLETED|Overall Study||10
589236|NCT00502593|1438090|P2|NOT COMPLETED|Overall Study||2
589237|NCT00502593|1438091|P1|NOT COMPLETED|Overall Study||3
589238|NCT00502593|1438080|P12|COMPLETED|Overall Study||18
589239|NCT00502593|1438081|P11|COMPLETED|Overall Study||47
589240|NCT00502593|1438082|P10|COMPLETED|Overall Study||17
589241|NCT00502593|1438083|P9|COMPLETED|Overall Study||43
589242|NCT00502593|1438084|P8|COMPLETED|Overall Study||17
589243|NCT00502593|1438085|P7|COMPLETED|Overall Study||44
589244|NCT00502593|1438086|P6|COMPLETED|Overall Study||17
589245|NCT00502593|1438087|P5|COMPLETED|Overall Study||47
589246|NCT00502593|1438088|P4|COMPLETED|Overall Study||14
589247|NCT00502593|1438089|P3|COMPLETED|Overall Study||41
589248|NCT00502593|1438090|P2|COMPLETED|Overall Study||16
589249|NCT00502593|1438091|P1|COMPLETED|Overall Study||48
589250|NCT00502593|1438080|P12|STARTED|Overall Study||18
589251|NCT00502593|1438081|P11|STARTED|Overall Study||49
589252|NCT00502593|1438082|P10|STARTED|Overall Study||17
589253|NCT00502593|1438083|P9|STARTED|Overall Study||49
589254|NCT00502593|1438084|P8|STARTED|Overall Study||17
589255|NCT00502593|1438085|P7|STARTED|Overall Study||49
589256|NCT00502593|1438086|P6|STARTED|Overall Study||17
589257|NCT00502593|1438087|P5|STARTED|Overall Study||51
589258|NCT00502593|1438088|P4|STARTED|Overall Study||18
589259|NCT00502593|1438089|P3|STARTED|Overall Study||51
589260|NCT00502593|1438090|P2|STARTED|Overall Study||18
589261|NCT00502593|1438091|P1|STARTED|Overall Study||51
589262|NCT00502320|1438607|P2|NOT COMPLETED|Overall Study||7
589263|NCT00502320|1438608|P1|NOT COMPLETED|Overall Study||6
589264|NCT00502320|1438607|P2|COMPLETED|Overall Study||18
589265|NCT00502320|1438608|P1|COMPLETED|Overall Study||19
589266|NCT00502320|1438607|P2|Screening Visit|Overall Study|Participant signed informed consent but was a screen failure because she was nursing at the time.|24
589267|NCT00502320|1438608|P1|Screening Visit|Overall Study||25
589268|NCT00502320|1438607|P2|STARTED|Overall Study||25
589269|NCT00502320|1438608|P1|STARTED|Overall Study||25
589270|NCT00502242|1438620|P2|NOT COMPLETED|Overall Study||56
589271|NCT00502242|1438621|P1|NOT COMPLETED|Overall Study||51
589272|NCT00502242|1438620|P2|COMPLETED|Overall Study||84
589273|NCT00502242|1438621|P1|COMPLETED|Overall Study||104
589274|NCT00502242|1438620|P2|STARTED|Overall Study||140
589275|NCT00502242|1438621|P1|STARTED|Overall Study||155
589276|NCT00502216|1438674|P2|NOT COMPLETED|Overall Study||0
589277|NCT00502216|1438675|P1|NOT COMPLETED|Overall Study||0
589278|NCT00502216|1438674|P2|COMPLETED|Overall Study||19
589279|NCT00502216|1438675|P1|COMPLETED|Overall Study||21
589280|NCT00502216|1438674|P2|STARTED|Overall Study||19
589281|NCT00502216|1438675|P1|STARTED|Overall Study||21
589282|NCT00502203|1438685|P1|NOT COMPLETED|Overall Study||1
589283|NCT00502203|1438685|P1|COMPLETED|Overall Study||22
589284|NCT00502203|1438685|P1|STARTED|Overall Study||23
589285|NCT00501995|1438689|P1|NOT COMPLETED|Overall Study||1
589286|NCT00501995|1438689|P1|COMPLETED|Overall Study||5
589287|NCT00501995|1438689|P1|STARTED|Overall Study||6
589288|NCT00501969|1438694|P1|NOT COMPLETED|Overall Study||206
589289|NCT00501969|1438694|P1|COMPLETED|Overall Study||189
589290|NCT00501969|1438694|P1|STARTED|Overall Study||395
589291|NCT00501943|1438702|P2|NOT COMPLETED|Overall Study||3
589292|NCT00501943|1438703|P1|NOT COMPLETED|Overall Study||2
589293|NCT00501943|1438702|P2|COMPLETED|Overall Study||18
589294|NCT00501943|1438703|P1|COMPLETED|Overall Study||20
589295|NCT00501943|1438702|P2|STARTED|Overall Study||21
589296|NCT00501943|1438703|P1|STARTED|Overall Study||22
589297|NCT00501891|1438719|P1|NOT COMPLETED|Overall Study||0
589298|NCT00501891|1438719|P1|COMPLETED|Overall Study||32
589299|NCT00501891|1438719|P1|STARTED|Overall Study||32
589300|NCT00501852|1438726|P1|NOT COMPLETED|Overall Study||5
589301|NCT00501852|1438726|P1|COMPLETED|Overall Study||78
589302|NCT00501852|1438726|P1|Tiotropium|Overall Study||55
589303|NCT00501852|1438726|P1|Placebo|Overall Study||55
589304|NCT00501852|1438726|P1|NVA237 100µg|Overall Study||54
589305|NCT00501852|1438726|P1|NVA237 50µg|Overall Study||53
589306|NCT00501852|1438726|P1|NVA237 25µg|Overall Study||51
589307|NCT00501852|1438726|P1|NVA237 12.5µg|Overall Study||55
589308|NCT00501852|1438726|P1|STARTED|Overall Study||83
589309|NCT00501644|1438746|P1|NOT COMPLETED|Overall Study||5
589310|NCT00501644|1438746|P1|COMPLETED|Overall Study||54
589311|NCT00501644|1438746|P1|STARTED|Overall Study||59
589312|NCT00501631|1438752|P2|NOT COMPLETED|Part B (Open-label Period)||51
589313|NCT00501631|1438753|P1|NOT COMPLETED|Part B (Open-label Period)||53
589314|NCT00501631|1438752|P2|COMPLETED|Part B (Open-label Period)||48
589315|NCT00501631|1438753|P1|COMPLETED|Part B (Open-label Period)||37
589316|NCT00501631|1438752|P2|STARTED|Part B (Open-label Period)||99
589317|NCT00501631|1438753|P1|STARTED|Part B (Open-label Period)||90
589318|NCT00501631|1438752|P2|NOT COMPLETED|Part A (Double-blind Period)||49
589319|NCT00501631|1438753|P1|NOT COMPLETED|Part A (Double-blind Period)||62
589320|NCT00501631|1438752|P2|COMPLETED|Part A (Double-blind Period)||99
589321|NCT00501631|1438753|P1|COMPLETED|Part A (Double-blind Period)||90
589322|NCT00501631|1438752|P2|STARTED|Part A (Double-blind Period)||148
589323|NCT00501631|1438753|P1|STARTED|Part A (Double-blind Period)||152
589324|NCT00501592|1438762|P3|NOT COMPLETED|Overall Study||3
589325|NCT00501592|1438763|P2|NOT COMPLETED|Overall Study||5
589326|NCT00501592|1438764|P1|NOT COMPLETED|Overall Study||0
589327|NCT00501592|1438762|P3|COMPLETED|Overall Study||20
589328|NCT00501592|1438763|P2|COMPLETED|Overall Study||16
589329|NCT00501592|1438764|P1|COMPLETED|Overall Study||20
589330|NCT00501592|1438762|P3|STARTED|Overall Study||23
589331|NCT00501592|1438763|P2|STARTED|Overall Study||21
589332|NCT00501592|1438764|P1|STARTED|Overall Study||20
589333|NCT00501540|1438775|P1|NOT COMPLETED|Overall Study||5
589334|NCT00501540|1438775|P1|COMPLETED|Overall Study||10
589335|NCT00501540|1438775|P1|STARTED|Overall Study||15
589336|NCT00501345|1438781|P1|NOT COMPLETED|Overall Study||0
589337|NCT00501345|1438781|P1|COMPLETED|Overall Study||5
589338|NCT00501345|1438781|P1|STARTED|Overall Study||5
589339|NCT00501293|1438787|P2|NOT COMPLETED|Maintenance Period||28
589340|NCT00501293|1438788|P1|NOT COMPLETED|Maintenance Period||46
589341|NCT00501293|1438787|P2|COMPLETED|Maintenance Period||25
589342|NCT00501293|1438788|P1|COMPLETED|Maintenance Period||63
589343|NCT00501293|1438787|P2|STARTED|Maintenance Period||53
589344|NCT00501293|1438788|P1|STARTED|Maintenance Period||109
589345|NCT00501293|1438787|P2|NOT COMPLETED|Optimization Period||0
589346|NCT00501293|1438788|P1|NOT COMPLETED|Optimization Period||1
589347|NCT00501293|1438787|P2|COMPLETED|Optimization Period||53
589348|NCT00501293|1438788|P1|COMPLETED|Optimization Period||109
589349|NCT00501293|1438787|P2|STARTED|Optimization Period||53
589350|NCT00501293|1438788|P1|STARTED|Optimization Period||110
589351|NCT00501228|1438815|P1|NOT COMPLETED|Overall Study||1
589352|NCT00501228|1438815|P1|COMPLETED|Overall Study||1
589353|NCT00501228|1438815|P1|STARTED|Overall Study||2
589354|NCT00501085|1438819|P1|NOT COMPLETED|Overall Study||432
589355|NCT00501085|1438819|P1|COMPLETED|Overall Study|Number of participants completing 5 year follow-up visit.|83
589356|NCT00501085|1438819|P1|STARTED|Overall Study|Number of participants who were treated with the LAP-BAND System.|515
589357|NCT00501059|1438829|P2|NOT COMPLETED|Overall Study||1892
589358|NCT00501059|1438830|P1|NOT COMPLETED|Overall Study||1868
589359|NCT00501059|1438829|P2|COMPLETED|Overall Study||4384
589360|NCT00501059|1438830|P1|COMPLETED|Overall Study||4402
589361|NCT00501059|1438829|P2|STARTED|Overall Study||6276
589362|NCT00501059|1438830|P1|STARTED|Overall Study||6270
589363|NCT00501046|1438850|P2|NOT COMPLETED|Overall Study||294
589364|NCT00501046|1438851|P1|NOT COMPLETED|Overall Study||270
589365|NCT00501046|1438850|P2|COMPLETED|Overall Study||213
589366|NCT00501046|1438851|P1|COMPLETED|Overall Study||238
589367|NCT00501046|1438850|P2|STARTED|Overall Study||507
589368|NCT00501046|1438851|P1|STARTED|Overall Study||508
589369|NCT00501007|1438857|P2|NOT COMPLETED|Overall Study||25
589370|NCT00501007|1438858|P1|NOT COMPLETED|Overall Study||29
589371|NCT00501007|1438857|P2|COMPLETED|Overall Study||78
589372|NCT00501007|1438858|P1|COMPLETED|Overall Study||71
589373|NCT00501007|1438857|P2|STARTED|Overall Study||103
589374|NCT00501007|1438858|P1|STARTED|Overall Study||100
589375|NCT00500760|1438866|P2|NOT COMPLETED|Overall Study||24
589376|NCT00500760|1438867|P1|NOT COMPLETED|Overall Study||43
589377|NCT00500760|1438866|P2|COMPLETED|Overall Study||40
589378|NCT00500760|1438867|P1|COMPLETED|Overall Study||46
589379|NCT00500760|1438866|P2|Received Treatment|Overall Study||63
589380|NCT00500760|1438867|P1|Received Treatment|Overall Study||87
589381|NCT00500760|1438866|P2|STARTED|Overall Study||64
589382|NCT00500760|1438867|P1|STARTED|Overall Study||89
589383|NCT00500682|1438887|P2|NOT COMPLETED|Overall Study||287
589384|NCT00500682|1438888|P1|NOT COMPLETED|Overall Study||306
589385|NCT00500682|1438887|P2|COMPLETED|Overall Study||223
589386|NCT00500682|1438888|P1|COMPLETED|Overall Study||204
589387|NCT00500682|1438887|P2|STARTED|Overall Study||510
589388|NCT00500682|1438888|P1|STARTED|Overall Study||510
589389|NCT00500656|1438898|P4|NOT COMPLETED|Open Label Extension (OLE) Phase||2
589390|NCT00500656|1438899|P3|NOT COMPLETED|Open Label Extension (OLE) Phase||1
589391|NCT00500656|1438900|P2|NOT COMPLETED|Open Label Extension (OLE) Phase||12
589392|NCT00500656|1438901|P1|NOT COMPLETED|Open Label Extension (OLE) Phase||7
589393|NCT00500656|1438898|P4|COMPLETED|Open Label Extension (OLE) Phase||6
589394|NCT00500656|1438899|P3|COMPLETED|Open Label Extension (OLE) Phase||1
589395|NCT00500656|1438900|P2|COMPLETED|Open Label Extension (OLE) Phase||9
589396|NCT00500656|1438901|P1|COMPLETED|Open Label Extension (OLE) Phase||16
589397|NCT00500656|1438898|P4|STARTED|Open Label Extension (OLE) Phase|Subjects did not experience an angioedema attack during the controlled phase|8
589398|NCT00500656|1438899|P3|STARTED|Open Label Extension (OLE) Phase||2
589399|NCT00500656|1438900|P2|STARTED|Open Label Extension (OLE) Phase|7 Subjects did not experience an angioedema attack after their first attack in the controlled phase|21
589400|NCT00500656|1438901|P1|STARTED|Open Label Extension (OLE) Phase|3 Subjects did not experience an angioedema attack after their first attack in the controlled phase|23
589401|NCT00500656|1438898|P4|NOT COMPLETED|Controlled Phase||8
589402|NCT00500656|1438899|P3|NOT COMPLETED|Controlled Phase||1
589403|NCT00500656|1438900|P2|NOT COMPLETED|Controlled Phase||10
589404|NCT00500656|1438901|P1|NOT COMPLETED|Controlled Phase||10
589405|NCT00500656|1438898|P4|COMPLETED|Controlled Phase||0
589406|NCT00500656|1438899|P3|COMPLETED|Controlled Phase||2
589407|NCT00500656|1438900|P2|COMPLETED|Controlled Phase||28
589408|NCT00500656|1438901|P1|COMPLETED|Controlled Phase||26
589409|NCT00500656|1438898|P4|STARTED|Controlled Phase||8
589410|NCT00500656|1438899|P3|STARTED|Controlled Phase||3
589411|NCT00500656|1438900|P2|STARTED|Controlled Phase||38
589412|NCT00500656|1438901|P1|STARTED|Controlled Phase||36
589413|NCT00500578|1438915|P2|NOT COMPLETED|Overall Study||0
589414|NCT00500578|1438916|P1|NOT COMPLETED|Overall Study||0
589415|NCT00500578|1438915|P2|COMPLETED|Overall Study|All completed|32
589416|NCT00500578|1438916|P1|COMPLETED|Overall Study|All completed|18
589417|NCT00500578|1438915|P2|STARTED|Overall Study||32
589418|NCT00500578|1438916|P1|STARTED|Overall Study||18
589419|NCT00500539|1438922|P1|NOT COMPLETED|Follow-up Period (16 Weeks)||12
589420|NCT00500539|1438922|P1|COMPLETED|Follow-up Period (16 Weeks)||136
589421|NCT00500539|1438922|P1|STARTED|Follow-up Period (16 Weeks)|Participants could discontinue study drug and still enter the follow-up period.|148
589422|NCT00500539|1438922|P1|NOT COMPLETED|Treatment Period (24 Weeks)||15
589423|NCT00500539|1438922|P1|COMPLETED|Treatment Period (24 Weeks)||140
589424|NCT00500539|1438922|P1|STARTED|Treatment Period (24 Weeks)||155
589425|NCT00500448|1438931|P2|NOT COMPLETED|Overall Study||0
589426|NCT00500448|1438932|P1|NOT COMPLETED|Overall Study||0
589427|NCT00500448|1438931|P2|COMPLETED|Overall Study||16
589428|NCT00500448|1438932|P1|COMPLETED|Overall Study||14
589429|NCT00500448|1438931|P2|STARTED|Overall Study||16
589430|NCT00500448|1438932|P1|STARTED|Overall Study||14
589431|NCT00500370|1438948|P2|NOT COMPLETED|Overall Study||34
589432|NCT00500370|1438949|P1|NOT COMPLETED|Overall Study||33
589433|NCT00500370|1438948|P2|COMPLETED|Overall Study|COMPLETED = completion of treatment period (Week 24) plus follow-up visit 4 weeks later|49
589434|NCT00500370|1438949|P1|COMPLETED|Overall Study|COMPLETED = completion of treatment period (Week 24) plus follow-up visit 4 weeks later|47
589435|NCT00500370|1438948|P2|Treatment Complete (Week 24)|Overall Study||54
589436|NCT00500370|1438949|P1|Treatment Complete (Week 24)|Overall Study||48
589437|NCT00500370|1438948|P2|Treatment Start-Baseline (Week 0)|Overall Study||79
589438|NCT00500370|1438949|P1|Treatment Start-Baseline (Week 0)|Overall Study||73
589439|NCT00500370|1438948|P2|STARTED|Overall Study||83
589440|NCT00500370|1438949|P1|STARTED|Overall Study||80
589441|NCT00500357|1438985|P1|NOT COMPLETED|Overall Study||1
589442|NCT00500357|1438985|P1|COMPLETED|Overall Study||104
589443|NCT00500357|1438985|P1|Evaluable Immunogenicity Population|Overall Study|Administered Vax 1 and Vax 2 in study 6115A1-500; Vax 3 and at least 1 assay result in 6115A1-3009.|98
589444|NCT00500357|1438985|P1|Received 13vPnC (Vax 3)|Overall Study||105
589445|NCT00500357|1438985|P1|STARTED|Overall Study||105
589446|NCT00500331|1439011|P7|NOT COMPLETED|Overall Study||2
589447|NCT00500331|1439012|P6|NOT COMPLETED|Overall Study||5
589448|NCT00500331|1439013|P5|NOT COMPLETED|Overall Study||4
589449|NCT00500331|1439014|P4|NOT COMPLETED|Overall Study||10
589450|NCT00500331|1439015|P3|NOT COMPLETED|Overall Study||5
589451|NCT00500331|1439016|P2|NOT COMPLETED|Overall Study||5
589452|NCT00500331|1439017|P1|NOT COMPLETED|Overall Study||15
589453|NCT00500331|1439011|P7|COMPLETED|Overall Study||46
589454|NCT00500331|1439012|P6|COMPLETED|Overall Study||42
589455|NCT00500331|1439013|P5|COMPLETED|Overall Study||44
589456|NCT00500331|1439014|P4|COMPLETED|Overall Study||38
589457|NCT00500331|1439015|P3|COMPLETED|Overall Study||43
589458|NCT00500331|1439016|P2|COMPLETED|Overall Study||42
589459|NCT00500331|1439017|P1|COMPLETED|Overall Study||33
589460|NCT00500331|1439011|P7|STARTED|Overall Study||48
589461|NCT00500331|1439012|P6|STARTED|Overall Study||47
589462|NCT00500331|1439013|P5|STARTED|Overall Study||48
589463|NCT00500331|1439014|P4|STARTED|Overall Study||48
589464|NCT00500331|1439015|P3|STARTED|Overall Study||48
589465|NCT00500331|1439016|P2|STARTED|Overall Study||47
589466|NCT00500331|1439017|P1|STARTED|Overall Study||48
589467|NCT00500318|1439154|P2|NOT COMPLETED|Overall Study||17
589468|NCT00500318|1439155|P1|NOT COMPLETED|Overall Study||5
589469|NCT00500318|1439154|P2|COMPLETED|Overall Study||78
589470|NCT00500318|1439155|P1|COMPLETED|Overall Study||81
589471|NCT00500318|1439154|P2|STARTED|Overall Study||95
589472|NCT00500318|1439155|P1|STARTED|Overall Study||86
589473|NCT00500292|1439172|P3|NOT COMPLETED|Overall Study||27
589474|NCT00500292|1439173|P2|NOT COMPLETED|Overall Study||31
589475|NCT00500292|1439174|P1|NOT COMPLETED|Overall Study||25
589476|NCT00500292|1439172|P3|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|10
589477|NCT00500292|1439173|P2|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|4
589478|NCT00500292|1439174|P1|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|7
589479|NCT00500292|1439172|P3|STARTED|Overall Study|randomised patients|37
589480|NCT00500292|1439173|P2|STARTED|Overall Study|randomised patients|35
589481|NCT00500292|1439174|P1|STARTED|Overall Study|randomised patients|32
589482|NCT00500240|1439184|P2|NOT COMPLETED|Overall Study||0
589483|NCT00500240|1439185|P1|NOT COMPLETED|Overall Study||0
589484|NCT00500240|1439184|P2|COMPLETED|Overall Study||26
589485|NCT00500240|1439185|P1|COMPLETED|Overall Study||25
589486|NCT00500240|1439184|P2|STARTED|Overall Study||26
589487|NCT00500240|1439185|P1|STARTED|Overall Study||25
589488|NCT00500149|1439195|P2|NOT COMPLETED|Second Intervention (Cross-over Phase)||0
589489|NCT00500149|1439196|P1|NOT COMPLETED|Second Intervention (Cross-over Phase)||2
589490|NCT00500149|1439195|P2|COMPLETED|Second Intervention (Cross-over Phase)||57
589491|NCT00500149|1439196|P1|COMPLETED|Second Intervention (Cross-over Phase)||54
589492|NCT00500149|1439195|P2|STARTED|Second Intervention (Cross-over Phase)||57
589493|NCT00500149|1439196|P1|STARTED|Second Intervention (Cross-over Phase)||56
589494|NCT00500149|1439195|P2|NOT COMPLETED|First Intervention (Cross-over Phase)||2
589495|NCT00500149|1439196|P1|NOT COMPLETED|First Intervention (Cross-over Phase)||2
589496|NCT00500149|1439195|P2|COMPLETED|First Intervention (Cross-over Phase)||57
589497|NCT00500149|1439196|P1|COMPLETED|First Intervention (Cross-over Phase)||56
589498|NCT00500149|1439195|P2|STARTED|First Intervention (Cross-over Phase)||59
589499|NCT00500149|1439196|P1|STARTED|First Intervention (Cross-over Phase)||58
589500|NCT00500149|1439195|P2|NOT COMPLETED|Enrolled (Dose-optimization Phase)||0
589501|NCT00500149|1439196|P1|NOT COMPLETED|Enrolled (Dose-optimization Phase)||12
589502|NCT00500149|1439195|P2|COMPLETED|Enrolled (Dose-optimization Phase)||0
589503|NCT00500149|1439196|P1|COMPLETED|Enrolled (Dose-optimization Phase)||117
589504|NCT00500149|1439195|P2|STARTED|Enrolled (Dose-optimization Phase)||0
589505|NCT00500149|1439196|P1|STARTED|Enrolled (Dose-optimization Phase)||129
589506|NCT00500110|1439204|P1|NOT COMPLETED|Overall Study||3
589507|NCT00500110|1439204|P1|COMPLETED|Overall Study||36
589508|NCT00500110|1439204|P1|STARTED|Overall Study||39
589509|NCT00500071|1439208|P1|NOT COMPLETED|30-day Safety Follow-up||17
589510|NCT00500071|1439208|P1|COMPLETED|30-day Safety Follow-up||278
589511|NCT00500071|1439208|P1|STARTED|30-day Safety Follow-up||295
589512|NCT00500071|1439208|P1|NOT COMPLETED|Dose-optimization and Maintenance Phase||22
589513|NCT00500071|1439208|P1|COMPLETED|Dose-optimization and Maintenance Phase||295
589606|NCT00499460|1439471|P1|COMPLETED|Intervention 1 (30 Days)||6
589514|NCT00500071|1439208|P1|STARTED|Dose-optimization and Maintenance Phase|Safety population (i.e., received at least one dose of study medication)|317
589515|NCT00500071|1439208|P1|NOT COMPLETED|Screening and Washout Phase||1
589516|NCT00500071|1439208|P1|COMPLETED|Screening and Washout Phase||317
589517|NCT00500071|1439208|P1|STARTED|Screening and Washout Phase||318
589518|NCT00499915|1439219|P2|NOT COMPLETED|Overall Study||6
589519|NCT00499915|1439220|P1|NOT COMPLETED|Overall Study||15
589520|NCT00499915|1439219|P2|COMPLETED|Overall Study||76
589521|NCT00499915|1439220|P1|COMPLETED|Overall Study||68
589522|NCT00499915|1439219|P2|STARTED|Overall Study||82
589523|NCT00499915|1439220|P1|STARTED|Overall Study||83
589524|NCT00499889|1439226|P1|NOT COMPLETED|Overall Study||1
589525|NCT00499889|1439226|P1|COMPLETED|Overall Study||41
589526|NCT00499889|1439226|P1|STARTED|Overall Study||42
589527|NCT00499863|1439234|P2|NOT COMPLETED|Overall Study||43
589528|NCT00499863|1439235|P1|NOT COMPLETED|Overall Study||50
589529|NCT00499863|1439234|P2|COMPLETED|Overall Study||29
589530|NCT00499863|1439235|P1|COMPLETED|Overall Study||95
589531|NCT00499863|1439234|P2|STARTED|Overall Study||72
589532|NCT00499863|1439235|P1|STARTED|Overall Study||145
589533|NCT00500266|1439263|P1|NOT COMPLETED|Overall Study||13
589534|NCT00500266|1439263|P1|COMPLETED|Overall Study||1040
589535|NCT00500266|1439263|P1|Treated|Overall Study||1049
589536|NCT00500266|1439263|P1|STARTED|Overall Study||1053
589537|NCT00499746|1439270|P1|NOT COMPLETED|Phase 3 (9-14 One Day Sessions)||0
589538|NCT00499746|1439270|P1|COMPLETED|Phase 3 (9-14 One Day Sessions)||8
589539|NCT00499746|1439270|P1|STARTED|Phase 3 (9-14 One Day Sessions)||8
589540|NCT00499746|1439270|P1|NOT COMPLETED|Phase 2 (6-9 One Day Sessions)||0
589541|NCT00499746|1439270|P1|COMPLETED|Phase 2 (6-9 One Day Sessions)||8
589542|NCT00499746|1439270|P1|STARTED|Phase 2 (6-9 One Day Sessions)||8
589543|NCT00499746|1439270|P1|NOT COMPLETED|Phase 1(6-9 One Day Sessions)||12
589544|NCT00499746|1439270|P1|COMPLETED|Phase 1(6-9 One Day Sessions)||8
589545|NCT00499746|1439270|P1|STARTED|Phase 1(6-9 One Day Sessions)||20
589546|NCT00499694|1439339|P1|NOT COMPLETED|Overall Study||1
589547|NCT00499694|1439339|P1|COMPLETED|Overall Study||30
589548|NCT00499694|1439339|P1|STARTED|Overall Study||31
589549|NCT00499681|1439348|P2|NOT COMPLETED|Overall Study||2
589550|NCT00499681|1439349|P1|NOT COMPLETED|Overall Study||0
589551|NCT00499681|1439348|P2|COMPLETED|Overall Study||0
589552|NCT00499681|1439349|P1|COMPLETED|Overall Study||4
589553|NCT00499681|1439348|P2|STARTED|Overall Study||2
589554|NCT00499681|1439349|P1|STARTED|Overall Study||4
589555|NCT00499655|1439357|P2|NOT COMPLETED|Overall Study||0
589556|NCT00499655|1439358|P1|NOT COMPLETED|Overall Study||0
589557|NCT00499655|1439357|P2|COMPLETED|Overall Study||54
589558|NCT00499655|1439358|P1|COMPLETED|Overall Study||53
589559|NCT00499655|1439357|P2|STARTED|Overall Study||54
589560|NCT00499655|1439358|P1|STARTED|Overall Study||53
589561|NCT00499616|1439376|P4|NOT COMPLETED|Overall Study||57
589562|NCT00499616|1439377|P3|NOT COMPLETED|Overall Study||36
589563|NCT00499616|1439378|P2|NOT COMPLETED|Overall Study||28
589564|NCT00499616|1439379|P1|NOT COMPLETED|Overall Study||15
589565|NCT00499616|1439376|P4|COMPLETED|Overall Study||0
589566|NCT00499616|1439377|P3|COMPLETED|Overall Study||53
589567|NCT00499616|1439378|P2|COMPLETED|Overall Study||114
589568|NCT00499616|1439379|P1|COMPLETED|Overall Study||161
589569|NCT00499616|1439376|P4|STARTED|Overall Study||57
589570|NCT00499616|1439377|P3|STARTED|Overall Study||89
589571|NCT00499616|1439378|P2|STARTED|Overall Study||142
589572|NCT00499616|1439379|P1|STARTED|Overall Study||176
589573|NCT00499603|1439416|P2|NOT COMPLETED|Overall Study||1
589574|NCT00499603|1439417|P1|NOT COMPLETED|Overall Study||0
589575|NCT00499603|1439416|P2|COMPLETED|Overall Study||22
589576|NCT00499603|1439417|P1|COMPLETED|Overall Study||27
589577|NCT00499603|1439416|P2|STARTED|Overall Study||23
589578|NCT00499603|1439417|P1|STARTED|Overall Study||27
589579|NCT00499590|1439430|P3|NOT COMPLETED|Overall Study||113
589580|NCT00499590|1439431|P2|NOT COMPLETED|Overall Study||112
589581|NCT00499590|1439432|P1|NOT COMPLETED|Overall Study||113
589582|NCT00499590|1439430|P3|COMPLETED|Overall Study||0
589583|NCT00499590|1439431|P2|COMPLETED|Overall Study||0
589584|NCT00499590|1439432|P1|COMPLETED|Overall Study||0
589585|NCT00499590|1439430|P3|STARTED|Overall Study||113
589586|NCT00499590|1439431|P2|STARTED|Overall Study||112
589587|NCT00499590|1439432|P1|STARTED|Overall Study||113
589588|NCT00499486|1439443|P1|NOT COMPLETED|Overall Study||16
589589|NCT00499486|1439443|P1|COMPLETED|Overall Study||31
589590|NCT00499486|1439443|P1|STARTED|Overall Study||47
589591|NCT00499473|1439451|P2|NOT COMPLETED|Overall Study||0
589592|NCT00499473|1439452|P1|NOT COMPLETED|Overall Study||6
589593|NCT00499473|1439451|P2|COMPLETED|Overall Study||4
589594|NCT00499473|1439452|P1|COMPLETED|Overall Study|Patients evaluable|21
589595|NCT00499473|1439451|P2|STARTED|Overall Study||4
589596|NCT00499473|1439452|P1|STARTED|Overall Study||27
589597|NCT00499460|1439470|P2|NOT COMPLETED|Intervention 2 (30 Days)||1
589598|NCT00499460|1439471|P1|NOT COMPLETED|Intervention 2 (30 Days)||0
589599|NCT00499460|1439470|P2|COMPLETED|Intervention 2 (30 Days)||6
589600|NCT00499460|1439471|P1|COMPLETED|Intervention 2 (30 Days)||6
589601|NCT00499460|1439470|P2|STARTED|Intervention 2 (30 Days)||7
589602|NCT00499460|1439471|P1|STARTED|Intervention 2 (30 Days)||6
589603|NCT00499460|1439470|P2|NOT COMPLETED|Intervention 1 (30 Days)||0
589604|NCT00499460|1439471|P1|NOT COMPLETED|Intervention 1 (30 Days)||2
589605|NCT00499460|1439470|P2|COMPLETED|Intervention 1 (30 Days)||7
589607|NCT00499460|1439470|P2|STARTED|Intervention 1 (30 Days)||7
589608|NCT00499460|1439471|P1|STARTED|Intervention 1 (30 Days)||8
589609|NCT00499447|1439487|P1|NOT COMPLETED|Overall Study||0
589610|NCT00499447|1439487|P1|COMPLETED|Overall Study||13
589611|NCT00499447|1439487|P1|STARTED|Overall Study||13
589612|NCT00499408|1439491|P1|NOT COMPLETED|Overall Study||0
589613|NCT00499408|1439491|P1|COMPLETED|Overall Study|Three patients did not have adequate testing to be evaluable for a response.|26
589614|NCT00499408|1439491|P1|STARTED|Overall Study||26
589615|NCT00499369|1439500|P5|NOT COMPLETED|Overall Study||12
589616|NCT00499369|1439501|P4|NOT COMPLETED|Overall Study||9
589617|NCT00499369|1439502|P3|NOT COMPLETED|Overall Study||17
589618|NCT00499369|1439503|P2|NOT COMPLETED|Overall Study||18
589619|NCT00499369|1439504|P1|NOT COMPLETED|Overall Study||16
589620|NCT00499369|1439500|P5|COMPLETED|Overall Study||0
589621|NCT00499369|1439501|P4|COMPLETED|Overall Study||0
589622|NCT00499369|1439502|P3|COMPLETED|Overall Study||0
589623|NCT00499369|1439503|P2|COMPLETED|Overall Study||0
589624|NCT00499369|1439504|P1|COMPLETED|Overall Study||0
589625|NCT00499369|1439500|P5|Eligible|Overall Study||12
589626|NCT00499369|1439501|P4|Eligible|Overall Study||8
589627|NCT00499369|1439502|P3|Eligible|Overall Study||16
589628|NCT00499369|1439503|P2|Eligible|Overall Study||16
589629|NCT00499369|1439504|P1|Eligible|Overall Study||14
589630|NCT00499369|1439500|P5|STARTED|Overall Study||12
589631|NCT00499369|1439501|P4|STARTED|Overall Study||9
589632|NCT00499369|1439502|P3|STARTED|Overall Study||17
589633|NCT00499369|1439503|P2|STARTED|Overall Study||18
589634|NCT00499369|1439504|P1|STARTED|Overall Study||16
589635|NCT00499343|1439533|P2|NOT COMPLETED|Overall Study||0
589636|NCT00499343|1439534|P1|NOT COMPLETED|Overall Study||0
589637|NCT00499343|1439533|P2|COMPLETED|Overall Study||43
589638|NCT00499343|1439534|P1|COMPLETED|Overall Study||41
589639|NCT00499343|1439533|P2|STARTED|Overall Study||43
589640|NCT00499343|1439534|P1|STARTED|Overall Study||41
589641|NCT00499252|1439540|P1|NOT COMPLETED|Overall Study||12
589642|NCT00499252|1439540|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|39
589643|NCT00499252|1439540|P1|STARTED|Overall Study||51
589644|NCT00499122|1439550|P1|NOT COMPLETED|Overall Study||2
589645|NCT00499122|1439550|P1|COMPLETED|Overall Study||39
589646|NCT00499122|1439550|P1|STARTED|Overall Study||41
589647|NCT00499109|1439558|P2|NOT COMPLETED|Overall Study||7
589648|NCT00499109|1439559|P1|NOT COMPLETED|Overall Study||18
589649|NCT00499109|1439558|P2|COMPLETED|Overall Study||85
589650|NCT00499109|1439559|P1|COMPLETED|Overall Study||165
589651|NCT00499109|1439558|P2|STARTED|Overall Study||92
589652|NCT00499109|1439559|P1|STARTED|Overall Study||183
589653|NCT00499096|1439574|P2|NOT COMPLETED|Overall Study||20
589654|NCT00499096|1439575|P1|NOT COMPLETED|Overall Study||23
589655|NCT00499096|1439574|P2|COMPLETED|Overall Study||40
589656|NCT00499096|1439575|P1|COMPLETED|Overall Study||35
589657|NCT00499096|1439574|P2|STARTED|Overall Study||60
589658|NCT00499096|1439575|P1|STARTED|Overall Study||58
589659|NCT00499031|1439593|P1|NOT COMPLETED|Overall Study||3
589660|NCT00499031|1439593|P1|COMPLETED|Overall Study|Total number participants that are eligible and evaluable.|35
589661|NCT00499031|1439593|P1|STARTED|Overall Study|Total number participants enrolled on study|38
589662|NCT00498940|1439600|P2|NOT COMPLETED|Overall Study||0
589663|NCT00498940|1439601|P1|NOT COMPLETED|Overall Study||0
589664|NCT00498940|1439600|P2|COMPLETED|Overall Study||31
589665|NCT00498940|1439601|P1|COMPLETED|Overall Study||30
589666|NCT00498940|1439600|P2|STARTED|Overall Study||31
589667|NCT00498940|1439601|P1|STARTED|Overall Study||30
589668|NCT00498927|1439609|P1|NOT COMPLETED|Overall Study||0
589669|NCT00498927|1439609|P1|COMPLETED|Overall Study||47
589670|NCT00498927|1439609|P1|STARTED|Overall Study||47
589671|NCT00498797|1439616|P2|NOT COMPLETED|Overall Study||29
589672|NCT00498797|1439617|P1|NOT COMPLETED|Overall Study||38
589673|NCT00498797|1439616|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|14
589674|NCT00498797|1439617|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|5
589675|NCT00498797|1439616|P2|STARTED|Overall Study|randomised patients|43
589676|NCT00498797|1439617|P1|STARTED|Overall Study|randomised patients|43
589677|NCT00498706|1439627|P2|NOT COMPLETED|Overall Study||0
589678|NCT00498706|1439628|P1|NOT COMPLETED|Overall Study||0
589679|NCT00498706|1439627|P2|COMPLETED|Overall Study||162
589680|NCT00498706|1439628|P1|COMPLETED|Overall Study||163
589681|NCT00498706|1439627|P2|Post Treatment Week 18|Overall Study||162
589682|NCT00498706|1439628|P1|Post Treatment Week 18|Overall Study||163
589683|NCT00498706|1439627|P2|STARTED|Overall Study||162
589684|NCT00498706|1439628|P1|STARTED|Overall Study||163
589685|NCT00498628|1439642|P2|NOT COMPLETED|Overall Study||21
589686|NCT00498628|1439643|P1|NOT COMPLETED|Overall Study||15
589687|NCT00498628|1439642|P2|COMPLETED|Overall Study||92
589688|NCT00498628|1439643|P1|COMPLETED|Overall Study||90
589689|NCT00498628|1439642|P2|STARTED|Overall Study||113
589690|NCT00498628|1439643|P1|STARTED|Overall Study||105
589691|NCT00498615|1439649|P6|NOT COMPLETED|Placebo||0
589692|NCT00498615|1439650|P5|NOT COMPLETED|Placebo||0
589693|NCT00498615|1439651|P4|NOT COMPLETED|Placebo||0
589694|NCT00498615|1439652|P3|NOT COMPLETED|Placebo||0
589695|NCT00498615|1439653|P2|NOT COMPLETED|Placebo||0
589696|NCT00498615|1439654|P1|NOT COMPLETED|Placebo||0
589697|NCT00498615|1439649|P6|COMPLETED|Placebo||3
589698|NCT00498615|1439650|P5|COMPLETED|Placebo||3
589699|NCT00498615|1439651|P4|COMPLETED|Placebo||2
589700|NCT00498615|1439652|P3|COMPLETED|Placebo||3
589701|NCT00498615|1439653|P2|COMPLETED|Placebo||4
589702|NCT00498615|1439654|P1|COMPLETED|Placebo||2
589703|NCT00498615|1439649|P6|STARTED|Placebo||3
589704|NCT00498615|1439650|P5|STARTED|Placebo||3
589705|NCT00498615|1439651|P4|STARTED|Placebo||2
589706|NCT00498615|1439652|P3|STARTED|Placebo||3
589707|NCT00498615|1439653|P2|STARTED|Placebo||4
589708|NCT00498615|1439654|P1|STARTED|Placebo||2
589709|NCT00498615|1439649|P6|NOT COMPLETED|Fasudil 40mg||0
589710|NCT00498615|1439650|P5|NOT COMPLETED|Fasudil 40mg||0
589711|NCT00498615|1439651|P4|NOT COMPLETED|Fasudil 40mg||0
589712|NCT00498615|1439652|P3|NOT COMPLETED|Fasudil 40mg||0
589713|NCT00498615|1439653|P2|NOT COMPLETED|Fasudil 40mg||0
589714|NCT00498615|1439654|P1|NOT COMPLETED|Fasudil 40mg||0
589715|NCT00498615|1439649|P6|COMPLETED|Fasudil 40mg||3
589716|NCT00498615|1439650|P5|COMPLETED|Fasudil 40mg||3
589717|NCT00498615|1439651|P4|COMPLETED|Fasudil 40mg||2
589718|NCT00498615|1439652|P3|COMPLETED|Fasudil 40mg||3
589719|NCT00498615|1439653|P2|COMPLETED|Fasudil 40mg||4
589720|NCT00498615|1439654|P1|COMPLETED|Fasudil 40mg||2
589721|NCT00498615|1439649|P6|STARTED|Fasudil 40mg||3
589722|NCT00498615|1439650|P5|STARTED|Fasudil 40mg||3
589723|NCT00498615|1439651|P4|STARTED|Fasudil 40mg||2
589724|NCT00498615|1439652|P3|STARTED|Fasudil 40mg||3
589725|NCT00498615|1439653|P2|STARTED|Fasudil 40mg||4
589726|NCT00498615|1439654|P1|STARTED|Fasudil 40mg||2
589727|NCT00498615|1439649|P6|NOT COMPLETED|Fasudil 80mg||0
589728|NCT00498615|1439650|P5|NOT COMPLETED|Fasudil 80mg||0
589729|NCT00498615|1439651|P4|NOT COMPLETED|Fasudil 80mg||0
589730|NCT00498615|1439652|P3|NOT COMPLETED|Fasudil 80mg||0
589731|NCT00498615|1439653|P2|NOT COMPLETED|Fasudil 80mg||0
589732|NCT00498615|1439654|P1|NOT COMPLETED|Fasudil 80mg||0
589733|NCT00498615|1439649|P6|COMPLETED|Fasudil 80mg||3
589734|NCT00498615|1439650|P5|COMPLETED|Fasudil 80mg||3
589735|NCT00498615|1439651|P4|COMPLETED|Fasudil 80mg||2
589736|NCT00498615|1439652|P3|COMPLETED|Fasudil 80mg||3
589737|NCT00498615|1439653|P2|COMPLETED|Fasudil 80mg||4
589738|NCT00498615|1439654|P1|COMPLETED|Fasudil 80mg||2
589739|NCT00498615|1439649|P6|STARTED|Fasudil 80mg||3
589740|NCT00498615|1439650|P5|STARTED|Fasudil 80mg||3
589741|NCT00498615|1439651|P4|STARTED|Fasudil 80mg||2
589742|NCT00498615|1439652|P3|STARTED|Fasudil 80mg||3
589743|NCT00498615|1439653|P2|STARTED|Fasudil 80mg||4
589744|NCT00498615|1439654|P1|STARTED|Fasudil 80mg||2
589745|NCT00498602|1439675|P7|NOT COMPLETED|Overall Study||2
589746|NCT00498602|1439676|P6|NOT COMPLETED|Overall Study||13
589747|NCT00498602|1439677|P5|NOT COMPLETED|Overall Study||4
589748|NCT00498602|1439678|P4|NOT COMPLETED|Overall Study||5
589749|NCT00498602|1439679|P3|NOT COMPLETED|Overall Study||8
589750|NCT00498602|1439680|P2|NOT COMPLETED|Overall Study||10
589751|NCT00498602|1439681|P1|NOT COMPLETED|Overall Study||10
589752|NCT00498602|1439675|P7|COMPLETED|Overall Study||15
589753|NCT00498602|1439676|P6|COMPLETED|Overall Study||31
589754|NCT00498602|1439677|P5|COMPLETED|Overall Study||8
589755|NCT00498602|1439678|P4|COMPLETED|Overall Study||30
589756|NCT00498602|1439679|P3|COMPLETED|Overall Study||32
589757|NCT00498602|1439680|P2|COMPLETED|Overall Study||51
589758|NCT00498602|1439681|P1|COMPLETED|Overall Study||26
589759|NCT00498602|1439675|P7|Treated|Overall Study||17
589760|NCT00498602|1439676|P6|Treated|Overall Study||44
589761|NCT00498602|1439677|P5|Treated|Overall Study||12
589762|NCT00498602|1439678|P4|Treated|Overall Study||35
589763|NCT00498602|1439679|P3|Treated|Overall Study||40
589764|NCT00498602|1439680|P2|Treated|Overall Study|One participant discontinued due to an AE, with an outcome of death.|60
589765|NCT00498602|1439681|P1|Treated|Overall Study||36
589766|NCT00498602|1439675|P7|STARTED|Overall Study||17
589767|NCT00498602|1439676|P6|STARTED|Overall Study||44
589768|NCT00498602|1439677|P5|STARTED|Overall Study||12
589769|NCT00498602|1439678|P4|STARTED|Overall Study||35
589770|NCT00498602|1439679|P3|STARTED|Overall Study||40
589771|NCT00498602|1439680|P2|STARTED|Overall Study||61
589772|NCT00498602|1439681|P1|STARTED|Overall Study||36
589773|NCT00498550|1439720|P2|NOT COMPLETED|Overall Study||1
589774|NCT00498550|1439721|P1|NOT COMPLETED|Overall Study||0
589775|NCT00498550|1439720|P2|COMPLETED|Overall Study||15
589776|NCT00498550|1439721|P1|COMPLETED|Overall Study|13 of 15 received clozapine all 12 visits, two discontinued clozapine early but remained in study.|15
589777|NCT00498550|1439720|P2|STARTED|Overall Study||16
589778|NCT00498550|1439721|P1|STARTED|Overall Study||15
589779|NCT00498485|1439729|P2|NOT COMPLETED|Overall Study||5
589780|NCT00498485|1439730|P1|NOT COMPLETED|Overall Study||1
589781|NCT00498485|1439729|P2|COMPLETED|Overall Study||5
589782|NCT00498485|1439730|P1|COMPLETED|Overall Study||6
589783|NCT00498485|1439729|P2|STARTED|Overall Study||10
589784|NCT00498485|1439730|P1|STARTED|Overall Study||7
589785|NCT00498433|1439741|P3|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
589786|NCT00498433|1439742|P2|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
589787|NCT00498433|1439743|P1|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
589788|NCT00498433|1439741|P3|COMPLETED|Part 2: Double Blind (12 Weeks)||8
589789|NCT00498433|1439742|P2|COMPLETED|Part 2: Double Blind (12 Weeks)||8
589790|NCT00498433|1439743|P1|COMPLETED|Part 2: Double Blind (12 Weeks)||0
589791|NCT00498433|1439741|P3|STARTED|Part 2: Double Blind (12 Weeks)||8
589792|NCT00498433|1439742|P2|STARTED|Part 2: Double Blind (12 Weeks)||8
589793|NCT00498433|1439743|P1|STARTED|Part 2: Double Blind (12 Weeks)||0
589794|NCT00498433|1439741|P3|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
589795|NCT00498433|1439742|P2|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
589796|NCT00498433|1439743|P1|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||20
589797|NCT00498433|1439741|P3|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
589798|NCT00498433|1439742|P2|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
589799|NCT00498433|1439743|P1|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||16
589800|NCT00498433|1439741|P3|STARTED|Part 2: Placebo Run-in (2 Weeks)|For part 2, this arm belongs to randomized, double blind period.|0
589801|NCT00498433|1439742|P2|STARTED|Part 2: Placebo Run-in (2 Weeks)|For part 2, this arm belongs to randomized, double blind period.|0
589802|NCT00498433|1439743|P1|STARTED|Part 2: Placebo Run-in (2 Weeks)||36
589803|NCT00498433|1439741|P3|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
589804|NCT00498433|1439742|P2|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
589805|NCT00498433|1439743|P1|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
589806|NCT00498433|1439741|P3|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10
589807|NCT00498433|1439742|P2|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
589808|NCT00498433|1439743|P1|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
589809|NCT00498433|1439741|P3|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10
589810|NCT00498433|1439742|P2|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
589811|NCT00498433|1439743|P1|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
589812|NCT00498433|1439741|P3|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
589813|NCT00498433|1439742|P2|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
589814|NCT00498433|1439743|P1|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
589815|NCT00498433|1439741|P3|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
589816|NCT00498433|1439742|P2|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||10
589817|NCT00498433|1439743|P1|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
589818|NCT00498433|1439741|P3|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0
589819|NCT00498433|1439742|P2|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||10
589820|NCT00498433|1439743|P1|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0
589821|NCT00498433|1439741|P3|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
589822|NCT00498433|1439742|P2|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
589823|NCT00498433|1439743|P1|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
589824|NCT00498433|1439741|P3|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
589825|NCT00498433|1439742|P2|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
589826|NCT00498433|1439743|P1|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10
589827|NCT00498433|1439741|P3|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
589828|NCT00498433|1439742|P2|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
589829|NCT00498433|1439743|P1|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10
589830|NCT00498368|1439788|P2|NOT COMPLETED|Overall Study||2
589831|NCT00498368|1439789|P1|NOT COMPLETED|Overall Study||3
589832|NCT00498368|1439788|P2|COMPLETED|Overall Study||15
589833|NCT00498368|1439789|P1|COMPLETED|Overall Study||14
589834|NCT00498368|1439788|P2|STARTED|Overall Study||17
589835|NCT00498368|1439789|P1|STARTED|Overall Study||17
589836|NCT00498355|1439801|P1|NOT COMPLETED|Overall Study||1
589837|NCT00498355|1439801|P1|COMPLETED|Overall Study||6
589838|NCT00498355|1439801|P1|STARTED|Overall Study||7
589839|NCT00498186|1439809|P1|NOT COMPLETED|Overall Study||173
589840|NCT00498186|1439809|P1|COMPLETED|Overall Study||122
589841|NCT00498186|1439809|P1|STARTED|Overall Study||295
589842|NCT00498173|1439816|P3|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
589843|NCT00498173|1439817|P2|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
589844|NCT00498173|1439818|P1|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
589845|NCT00498173|1439816|P3|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||26
589846|NCT00498173|1439817|P2|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
589847|NCT00498173|1439818|P1|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
589848|NCT00498173|1439816|P3|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||26
589849|NCT00498173|1439817|P2|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
589850|NCT00498173|1439818|P1|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
589851|NCT00498173|1439816|P3|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||0
589852|NCT00498173|1439817|P2|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||1
589853|NCT00498173|1439818|P1|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||2
589854|NCT00498173|1439816|P3|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||0
589855|NCT00498173|1439817|P2|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||30
589856|NCT00498173|1439818|P1|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||27
589857|NCT00498173|1439816|P3|STARTED|Phase 1-Blinded Randomization (8 Weeks)||0
589858|NCT00498173|1439817|P2|STARTED|Phase 1-Blinded Randomization (8 Weeks)||31
589859|NCT00498173|1439818|P1|STARTED|Phase 1-Blinded Randomization (8 Weeks)||29
589860|NCT00497874|1439848|P2|NOT COMPLETED|Overall Study||116
589861|NCT00497874|1439849|P1|NOT COMPLETED|Overall Study||147
589862|NCT00497874|1439848|P2|COMPLETED|Overall Study||343
589863|NCT00497874|1439849|P1|COMPLETED|Overall Study||296
589864|NCT00497874|1439848|P2|STARTED|Overall Study||459
589865|NCT00497874|1439849|P1|STARTED|Overall Study||443
589866|NCT00497796|1439867|P2|NOT COMPLETED|Overall Study||59
589867|NCT00497796|1439868|P1|NOT COMPLETED|Overall Study||85
589868|NCT00497796|1439867|P2|COMPLETED|Overall Study||101
589869|NCT00497796|1439868|P1|COMPLETED|Overall Study||62
589870|NCT00497796|1439867|P2|STARTED|Overall Study||160
589871|NCT00497796|1439868|P1|STARTED|Overall Study||147
589872|NCT00497770|1439900|P4|NOT COMPLETED|Overall Study||0
589873|NCT00497770|1439901|P3|NOT COMPLETED|Overall Study||0
589874|NCT00497770|1439902|P2|NOT COMPLETED|Overall Study||0
589875|NCT00497770|1439903|P1|NOT COMPLETED|Overall Study||0
589876|NCT00497770|1439900|P4|COMPLETED|Overall Study||28
589877|NCT00497770|1439901|P3|COMPLETED|Overall Study||37
589878|NCT00497770|1439902|P2|COMPLETED|Overall Study||65
589879|NCT00497770|1439903|P1|COMPLETED|Overall Study||304
589880|NCT00497770|1439900|P4|STARTED|Overall Study||28
589881|NCT00497770|1439901|P3|STARTED|Overall Study||37
589882|NCT00497770|1439902|P2|STARTED|Overall Study||65
589883|NCT00497770|1439903|P1|STARTED|Overall Study||304
589884|NCT00497198|1439955|P2|NOT COMPLETED|Overall Study||5
589885|NCT00497198|1439956|P1|NOT COMPLETED|Overall Study||5
589886|NCT00497198|1439955|P2|COMPLETED|Overall Study||86
589887|NCT00497198|1439956|P1|COMPLETED|Overall Study||87
589888|NCT00497198|1439955|P2|STARTED|Overall Study||91
589889|NCT00497198|1439956|P1|STARTED|Overall Study||92
589890|NCT00497146|1439972|P2|NOT COMPLETED|Long-term Follow-up Period||6
589891|NCT00497146|1439973|P1|NOT COMPLETED|Long-term Follow-up Period||15
589892|NCT00497146|1439972|P2|COMPLETED|Long-term Follow-up Period||66
589893|NCT00497146|1439973|P1|COMPLETED|Long-term Follow-up Period||50
589894|NCT00497146|1439972|P2|STARTED|Long-term Follow-up Period||72
589895|NCT00497146|1439973|P1|STARTED|Long-term Follow-up Period||65
589896|NCT00497146|1439972|P2|NOT COMPLETED|Treatment Period||21
589897|NCT00497146|1439973|P1|NOT COMPLETED|Treatment Period||27
589898|NCT00497146|1439972|P2|COMPLETED|Treatment Period||91
589899|NCT00497146|1439973|P1|COMPLETED|Treatment Period||88
589900|NCT00497146|1439972|P2|STARTED|Treatment Period||112
589901|NCT00497146|1439973|P1|STARTED|Treatment Period||115
589902|NCT00497081|1440015|P2|NOT COMPLETED|Overall Study||2
589903|NCT00497081|1440016|P1|NOT COMPLETED|Overall Study||2
589904|NCT00497081|1440015|P2|COMPLETED|Overall Study||28
589905|NCT00497081|1440016|P1|COMPLETED|Overall Study||28
589906|NCT00497081|1440015|P2|STARTED|Overall Study||30
589907|NCT00497081|1440016|P1|STARTED|Overall Study||30
589908|NCT00497055|1440028|P2|NOT COMPLETED|Overall Study||5
589909|NCT00497055|1440029|P1|NOT COMPLETED|Overall Study||10
589910|NCT00497055|1440028|P2|COMPLETED|Overall Study||40
589911|NCT00497055|1440029|P1|COMPLETED|Overall Study||35
589912|NCT00497055|1440028|P2|STARTED|Overall Study||45
589913|NCT00497055|1440029|P1|STARTED|Overall Study||45
589914|NCT00496964|1440041|P2|NOT COMPLETED|Overall Study||1
589915|NCT00496964|1440042|P1|NOT COMPLETED|Overall Study||0
589916|NCT00496964|1440041|P2|COMPLETED|Overall Study||3
589917|NCT00496964|1440042|P1|COMPLETED|Overall Study||1
589918|NCT00496964|1440041|P2|STARTED|Overall Study||4
589919|NCT00496964|1440042|P1|STARTED|Overall Study||1
589920|NCT00496873|1440060|P1|NOT COMPLETED|Overall Study||7
589921|NCT00496873|1440060|P1|COMPLETED|Overall Study||78
589922|NCT00496873|1440060|P1|STARTED|Overall Study||85
589923|NCT00496860|1440069|P3|NOT COMPLETED|Overall Study||0
589924|NCT00496860|1440070|P2|NOT COMPLETED|Overall Study||1
589925|NCT00496860|1440071|P1|NOT COMPLETED|Overall Study||1
589926|NCT00496860|1440069|P3|COMPLETED|Overall Study||6
589927|NCT00496860|1440070|P2|COMPLETED|Overall Study||15
589928|NCT00496860|1440071|P1|COMPLETED|Overall Study||3
589929|NCT00496860|1440069|P3|STARTED|Overall Study||6
589930|NCT00496860|1440070|P2|STARTED|Overall Study||16
589931|NCT00496860|1440071|P1|STARTED|Overall Study||4
589932|NCT00496834|1440093|P2|NOT COMPLETED|Overall Study||13
589933|NCT00496834|1440094|P1|NOT COMPLETED|Overall Study||18
589934|NCT00496834|1440093|P2|COMPLETED|Overall Study||87
589935|NCT00496834|1440094|P1|COMPLETED|Overall Study||83
589936|NCT00496834|1440093|P2|STARTED|Overall Study||100
589937|NCT00496834|1440094|P1|STARTED|Overall Study||101
589938|NCT00496808|1440106|P1|NOT COMPLETED|Overall Study||0
589939|NCT00496808|1440106|P1|COMPLETED|Overall Study||69
589940|NCT00496808|1440106|P1|STARTED|Overall Study||69
589941|NCT00496782|1440113|P2|NOT COMPLETED|Overall Study||2
589942|NCT00496782|1440114|P1|NOT COMPLETED|Overall Study||1
589943|NCT00496782|1440113|P2|COMPLETED|Overall Study||5
589944|NCT00496782|1440114|P1|COMPLETED|Overall Study||8
589945|NCT00496782|1440113|P2|STARTED|Overall Study||7
589946|NCT00496782|1440114|P1|STARTED|Overall Study||9
589947|NCT00496769|1440148|P3|NOT COMPLETED|Open Label||1011
589948|NCT00496769|1440149|P2|NOT COMPLETED|Open Label||0
589949|NCT00496769|1440150|P1|NOT COMPLETED|Open Label||0
589950|NCT00496769|1440148|P3|COMPLETED|Open Label||2264
589951|NCT00496769|1440149|P2|COMPLETED|Open Label||0
589952|NCT00496769|1440150|P1|COMPLETED|Open Label||0
589953|NCT00496769|1440148|P3|STARTED|Open Label||3275
589954|NCT00496769|1440149|P2|STARTED|Open Label||0
589955|NCT00496769|1440150|P1|STARTED|Open Label||0
589956|NCT00496769|1440148|P3|NOT COMPLETED|Double Blind||0
589957|NCT00496769|1440149|P2|NOT COMPLETED|Double Blind||649
589958|NCT00496769|1440150|P1|NOT COMPLETED|Double Blind||558
589959|NCT00496769|1440148|P3|COMPLETED|Double Blind||0
589960|NCT00496769|1440149|P2|COMPLETED|Double Blind||2142
589961|NCT00496769|1440150|P1|COMPLETED|Double Blind||2249
589962|NCT00496769|1440148|P3|Received Treatment|Double Blind||0
589963|NCT00496769|1440149|P2|Received Treatment|Double Blind||2708
589964|NCT00496769|1440150|P1|Received Treatment|Double Blind||2798
589965|NCT00496769|1440148|P3|STARTED|Double Blind||0
589966|NCT00496769|1440149|P2|STARTED|Double Blind|Randomized|2791
589967|NCT00496769|1440150|P1|STARTED|Double Blind|Randomized|2807
589968|NCT00496730|1440175|P2|NOT COMPLETED|Overall Study||5
589969|NCT00496730|1440176|P1|NOT COMPLETED|Overall Study||6
589970|NCT00496730|1440175|P2|COMPLETED|Overall Study||121
589971|NCT00496730|1440176|P1|COMPLETED|Overall Study||124
589972|NCT00496730|1440175|P2|STARTED|Overall Study||126
589973|NCT00496730|1440176|P1|STARTED|Overall Study||130
589974|NCT00496626|1440188|P2|NOT COMPLETED|Overall Study||6
589975|NCT00496626|1440189|P1|NOT COMPLETED|Overall Study||6
589976|NCT00496626|1440188|P2|COMPLETED|Overall Study||292
589977|NCT00496626|1440189|P1|COMPLETED|Overall Study||296
589978|NCT00496626|1440188|P2|STARTED|Overall Study||298
589979|NCT00496626|1440189|P1|STARTED|Overall Study||302
589980|NCT00496587|1440201|P1|NOT COMPLETED|Overall Study||31
589981|NCT00496587|1440201|P1|COMPLETED|Overall Study||3
589982|NCT00496587|1440201|P1|STARTED|Overall Study||34
589983|NCT00496483|1440207|P1|NOT COMPLETED|Overall Study||12
589984|NCT00496483|1440207|P1|COMPLETED|Overall Study||48
589985|NCT00496483|1440207|P1|Dosed|Overall Study||51
589986|NCT00496483|1440207|P1|STARTED|Overall Study||60
589987|NCT00496470|1440224|P2|NOT COMPLETED|Overall Study||29
589988|NCT00496470|1440225|P1|NOT COMPLETED|Overall Study||26
589989|NCT00496470|1440224|P2|COMPLETED|Overall Study||302
589990|NCT00496470|1440225|P1|COMPLETED|Overall Study||303
589991|NCT00496470|1440224|P2|Received Study Medication|Overall Study||330
589992|NCT00496470|1440225|P1|Received Study Medication|Overall Study||329
589993|NCT00496470|1440224|P2|STARTED|Overall Study||331
589994|NCT00496470|1440225|P1|STARTED|Overall Study||329
589995|NCT00496379|1440303|P1|NOT COMPLETED|Overall Study||0
589996|NCT00496379|1440303|P1|COMPLETED|Overall Study||15
589997|NCT00496379|1440303|P1|STARTED|Overall Study||15
589998|NCT00496366|1440311|P1|NOT COMPLETED|Overall Study||1
589999|NCT00496366|1440311|P1|COMPLETED|Overall Study||10
590000|NCT00496366|1440311|P1|STARTED|Overall Study||11
590001|NCT00496340|1440316|P1|NOT COMPLETED|Overall Study||0
590002|NCT00496340|1440316|P1|COMPLETED|Overall Study||42
590003|NCT00496340|1440316|P1|STARTED|Overall Study||42
590004|NCT00496262|1440329|P1|NOT COMPLETED|Overall Study||0
590005|NCT00496262|1440329|P1|COMPLETED|Overall Study||15
590006|NCT00496262|1440329|P1|STARTED|Overall Study||15
590007|NCT00496197|1440342|P1|NOT COMPLETED|Overall Study||122
590008|NCT00496197|1440342|P1|COMPLETED|Overall Study||160
590009|NCT00496197|1440342|P1|STARTED|Overall Study||282
590010|NCT00496080|1440369|P1|NOT COMPLETED|Overall Study||27
590011|NCT00496080|1440369|P1|COMPLETED|Overall Study||60
590012|NCT00496080|1440369|P1|STARTED|Overall Study||87
590013|NCT00496054|1440379|P1|NOT COMPLETED|Overall Study||8
590014|NCT00496054|1440379|P1|COMPLETED|Overall Study||102
590015|NCT00496054|1440379|P1|STARTED|Overall Study||110
590016|NCT00495820|1440408|P2|NOT COMPLETED|Overall Study||1
590017|NCT00495820|1440409|P1|NOT COMPLETED|Overall Study||1
590018|NCT00495820|1440408|P2|COMPLETED|Overall Study||29
590019|NCT00495820|1440409|P1|COMPLETED|Overall Study||29
590020|NCT00495820|1440408|P2|STARTED|Overall Study||30
590021|NCT00495820|1440409|P1|STARTED|Overall Study||30
590022|NCT00495794|1440421|P2|NOT COMPLETED|Overall Study||0
590023|NCT00495794|1440422|P1|NOT COMPLETED|Overall Study||522
590024|NCT00495794|1440421|P2|COMPLETED|Overall Study||2303
590025|NCT00495794|1440422|P1|COMPLETED|Overall Study||1797
590026|NCT00495794|1440421|P2|STARTED|Overall Study||2303
590027|NCT00495794|1440422|P1|STARTED|Overall Study||2319
590028|NCT00495755|1440432|P1|NOT COMPLETED|Overall Study||3
590029|NCT00495755|1440432|P1|COMPLETED|Overall Study||10
590030|NCT00495755|1440432|P1|STARTED|Overall Study||13
590031|NCT00495677|1440444|P7|NOT COMPLETED|Stage 2 (25 Days)||0
590032|NCT00495677|1440445|P6|NOT COMPLETED|Stage 2 (25 Days)||0
590033|NCT00495677|1440446|P5|NOT COMPLETED|Stage 2 (25 Days)||0
590034|NCT00495677|1440447|P4|NOT COMPLETED|Stage 2 (25 Days)||0
590035|NCT00495677|1440448|P3|NOT COMPLETED|Stage 2 (25 Days)||0
590036|NCT00495677|1440449|P2|NOT COMPLETED|Stage 2 (25 Days)||0
590037|NCT00495677|1440450|P1|NOT COMPLETED|Stage 2 (25 Days)||0
590038|NCT00495677|1440444|P7|COMPLETED|Stage 2 (25 Days)||7
590039|NCT00495677|1440445|P6|COMPLETED|Stage 2 (25 Days)||8
590040|NCT00495677|1440446|P5|COMPLETED|Stage 2 (25 Days)||8
590041|NCT00495677|1440447|P4|COMPLETED|Stage 2 (25 Days)||0
590042|NCT00495677|1440448|P3|COMPLETED|Stage 2 (25 Days)||0
590043|NCT00495677|1440449|P2|COMPLETED|Stage 2 (25 Days)||0
590044|NCT00495677|1440450|P1|COMPLETED|Stage 2 (25 Days)||0
590045|NCT00495677|1440444|P7|STARTED|Stage 2 (25 Days)||7
590046|NCT00495677|1440445|P6|STARTED|Stage 2 (25 Days)||8
590047|NCT00495677|1440446|P5|STARTED|Stage 2 (25 Days)||8
590048|NCT00495677|1440447|P4|STARTED|Stage 2 (25 Days)||0
590049|NCT00495677|1440448|P3|STARTED|Stage 2 (25 Days)||0
590050|NCT00495677|1440449|P2|STARTED|Stage 2 (25 Days)||0
590051|NCT00495677|1440450|P1|STARTED|Stage 2 (25 Days)||0
590052|NCT00495677|1440444|P7|NOT COMPLETED|Stage 1 (25 Days)||0
590053|NCT00495677|1440445|P6|NOT COMPLETED|Stage 1 (25 Days)||0
590054|NCT00495677|1440446|P5|NOT COMPLETED|Stage 1 (25 Days)||0
590055|NCT00495677|1440447|P4|NOT COMPLETED|Stage 1 (25 Days)||0
590056|NCT00495677|1440448|P3|NOT COMPLETED|Stage 1 (25 Days)||1
590057|NCT00495677|1440449|P2|NOT COMPLETED|Stage 1 (25 Days)||0
590058|NCT00495677|1440450|P1|NOT COMPLETED|Stage 1 (25 Days)||0
590059|NCT00495677|1440444|P7|COMPLETED|Stage 1 (25 Days)||0
590060|NCT00495677|1440445|P6|COMPLETED|Stage 1 (25 Days)||0
590061|NCT00495677|1440446|P5|COMPLETED|Stage 1 (25 Days)||0
590062|NCT00495677|1440447|P4|COMPLETED|Stage 1 (25 Days)||6
590063|NCT00495677|1440448|P3|COMPLETED|Stage 1 (25 Days)||5
590064|NCT00495677|1440449|P2|COMPLETED|Stage 1 (25 Days)||6
590065|NCT00495677|1440450|P1|COMPLETED|Stage 1 (25 Days)||2
590066|NCT00495677|1440444|P7|STARTED|Stage 1 (25 Days)||0
590067|NCT00495677|1440445|P6|STARTED|Stage 1 (25 Days)||0
590068|NCT00495677|1440446|P5|STARTED|Stage 1 (25 Days)||0
590069|NCT00495677|1440447|P4|STARTED|Stage 1 (25 Days)||6
590070|NCT00495677|1440448|P3|STARTED|Stage 1 (25 Days)||6
590071|NCT00495677|1440449|P2|STARTED|Stage 1 (25 Days)||6
590072|NCT00495677|1440450|P1|STARTED|Stage 1 (25 Days)||2
590073|NCT00495625|1440505|P1|NOT COMPLETED|Overall Study||10
590074|NCT00495625|1440505|P1|COMPLETED|Overall Study||23
590075|NCT00495625|1440505|P1|STARTED|Overall Study||33
590076|NCT00495612|1440516|P2|NOT COMPLETED|Overall Study||0
590077|NCT00495612|1440517|P1|NOT COMPLETED|Overall Study||4
590078|NCT00495612|1440516|P2|COMPLETED|Overall Study||33
590079|NCT00495612|1440517|P1|COMPLETED|Overall Study||32
590080|NCT00495612|1440516|P2|STARTED|Overall Study||33
590081|NCT00495612|1440517|P1|STARTED|Overall Study||36
590082|NCT00495586|1440535|P2|NOT COMPLETED|Overall Study||4
590083|NCT00495586|1440536|P1|NOT COMPLETED|Overall Study||4
590084|NCT00495586|1440535|P2|COMPLETED|Overall Study||158
590085|NCT00495586|1440536|P1|COMPLETED|Overall Study||152
590086|NCT00495586|1440535|P2|STARTED|Overall Study||162
590087|NCT00495586|1440536|P1|STARTED|Overall Study||156
590088|NCT00495521|1440546|P2|NOT COMPLETED|Overall Study||1
590089|NCT00495521|1440547|P1|NOT COMPLETED|Overall Study||0
590090|NCT00495521|1440546|P2|COMPLETED|Overall Study||0
590091|NCT00495521|1440547|P1|COMPLETED|Overall Study||1
590092|NCT00495521|1440546|P2|STARTED|Overall Study||1
590093|NCT00495521|1440547|P1|STARTED|Overall Study||1
590094|NCT00495495|1440577|P1|NOT COMPLETED|Overall Study||99
590095|NCT00495495|1440577|P1|COMPLETED|Overall Study||295
590096|NCT00495495|1440577|P1|STARTED|Overall Study||394
590097|NCT00495469|1440597|P7|NOT COMPLETED|Overall Study||5
590098|NCT00495469|1440598|P6|NOT COMPLETED|Overall Study||5
590099|NCT00495469|1440599|P5|NOT COMPLETED|Overall Study||5
590100|NCT00495469|1440600|P4|NOT COMPLETED|Overall Study||4
590101|NCT00495469|1440601|P3|NOT COMPLETED|Overall Study||7
590102|NCT00495469|1440602|P2|NOT COMPLETED|Overall Study||7
590103|NCT00495469|1440603|P1|NOT COMPLETED|Overall Study||6
590104|NCT00495469|1440597|P7|COMPLETED|Overall Study||30
590105|NCT00495469|1440598|P6|COMPLETED|Overall Study||31
590106|NCT00495469|1440599|P5|COMPLETED|Overall Study||31
590107|NCT00495469|1440600|P4|COMPLETED|Overall Study||32
590108|NCT00495469|1440601|P3|COMPLETED|Overall Study||27
590109|NCT00495469|1440602|P2|COMPLETED|Overall Study||30
590110|NCT00495469|1440603|P1|COMPLETED|Overall Study||30
590111|NCT00495469|1440597|P7|STARTED|Overall Study||35
590112|NCT00495469|1440598|P6|STARTED|Overall Study||36
590113|NCT00495469|1440599|P5|STARTED|Overall Study||36
590114|NCT00495469|1440600|P4|STARTED|Overall Study||36
590115|NCT00495469|1440601|P3|STARTED|Overall Study||34
590116|NCT00495469|1440602|P2|STARTED|Overall Study||37
590117|NCT00495469|1440603|P1|STARTED|Overall Study||36
590118|NCT00495391|1440747|P2|NOT COMPLETED|Overall Study||21
590119|NCT00495391|1440748|P1|NOT COMPLETED|Overall Study||36
590120|NCT00495391|1440747|P2|COMPLETED|Overall Study||1
590121|NCT00495391|1440748|P1|COMPLETED|Overall Study||6
590122|NCT00495391|1440747|P2|From Baseline to End of Follow up|Overall Study||1
590123|NCT00495391|1440748|P1|From Baseline to End of Follow up|Overall Study||6
590124|NCT00495391|1440747|P2|From Baseline to End of Treatment|Overall Study||1
590125|NCT00495391|1440748|P1|From Baseline to End of Treatment|Overall Study||6
590126|NCT00495391|1440747|P2|From Baseline to Week 16|Overall Study||11
590127|NCT00495391|1440748|P1|From Baseline to Week 16|Overall Study||24
590128|NCT00495391|1440747|P2|From Baseline to Week 8|Overall Study||20
590129|NCT00495391|1440748|P1|From Baseline to Week 8|Overall Study||31
590130|NCT00495391|1440747|P2|STARTED|Overall Study||22
590131|NCT00495391|1440748|P1|STARTED|Overall Study||42
590132|NCT00495222|1440768|P1|NOT COMPLETED|Overall Study||0
590133|NCT00495222|1440768|P1|COMPLETED|Overall Study||9
590134|NCT00495222|1440768|P1|STARTED|Overall Study||9
590135|NCT00495157|1440774|P3|NOT COMPLETED|Overall Study||13
590136|NCT00495157|1440775|P2|NOT COMPLETED|Overall Study||23
590137|NCT00495157|1440776|P1|NOT COMPLETED|Overall Study||16
590138|NCT00495157|1440774|P3|COMPLETED|Overall Study||101
590139|NCT00495157|1440775|P2|COMPLETED|Overall Study||92
590140|NCT00495157|1440776|P1|COMPLETED|Overall Study||97
590141|NCT00495157|1440774|P3|STARTED|Overall Study||114
590142|NCT00495157|1440775|P2|STARTED|Overall Study||115
590143|NCT00495157|1440776|P1|STARTED|Overall Study||113
590144|NCT00495131|1440786|P2|NOT COMPLETED|Overall Study||6
590145|NCT00495131|1440787|P1|NOT COMPLETED|Overall Study||7
590146|NCT00495131|1440786|P2|COMPLETED|Overall Study||148
590147|NCT00495131|1440787|P1|COMPLETED|Overall Study||147
590148|NCT00495131|1440786|P2|STARTED|Overall Study||154
590149|NCT00495131|1440787|P1|STARTED|Overall Study||154
590150|NCT00495079|1440797|P1|NOT COMPLETED|Overall Study||0
590151|NCT00495079|1440797|P1|COMPLETED|Overall Study||65
590152|NCT00495079|1440797|P1|STARTED|Overall Study||65
590153|NCT00494975|1440806|P2|NOT COMPLETED|Overall Study||1
590154|NCT00494975|1440807|P1|NOT COMPLETED|Overall Study||2
590155|NCT00494975|1440806|P2|COMPLETED|Overall Study||10
590156|NCT00494975|1440807|P1|COMPLETED|Overall Study||8
590157|NCT00494975|1440806|P2|STARTED|Overall Study||11
590158|NCT00494975|1440807|P1|STARTED|Overall Study||10
590159|NCT00494871|1440815|P2|NOT COMPLETED|Follow-up (FU) Period||23
590160|NCT00494871|1440816|P1|NOT COMPLETED|Follow-up (FU) Period||29
590161|NCT00494871|1440815|P2|COMPLETED|Follow-up (FU) Period||616
590162|NCT00494871|1440816|P1|COMPLETED|Follow-up (FU) Period||610
590163|NCT00494871|1440815|P2|Entered FU and Valid for Safety|Follow-up (FU) Period|Safety population|630
590164|NCT00494871|1440816|P1|Entered FU and Valid for Safety|Follow-up (FU) Period|Safety population|628
590165|NCT00494871|1440815|P2|STARTED|Follow-up (FU) Period|All treated participants were to enter FU period, whether or not they completed the DB period|639
590166|NCT00494871|1440816|P1|STARTED|Follow-up (FU) Period|All treated participants were to enter FU period, whether or not they completed the DB period|639
590167|NCT00494871|1440815|P2|NOT COMPLETED|Double-blind (DB) Treatment Period||172
590168|NCT00494871|1440816|P1|NOT COMPLETED|Double-blind (DB) Treatment Period||160
590169|NCT00494871|1440815|P2|COMPLETED|Double-blind (DB) Treatment Period||468
590170|NCT00494871|1440816|P1|COMPLETED|Double-blind (DB) Treatment Period||480
590171|NCT00494871|1440815|P2|Started Treatment|Double-blind (DB) Treatment Period|Safety population|639
590172|NCT00494871|1440816|P1|Started Treatment|Double-blind (DB) Treatment Period|Safety population|639
590173|NCT00494871|1440815|P2|STARTED|Double-blind (DB) Treatment Period||640
590174|NCT00494871|1440816|P1|STARTED|Double-blind (DB) Treatment Period||640
590175|NCT00494806|1440848|P2|NOT COMPLETED|Overall Study||0
590176|NCT00494806|1440849|P1|NOT COMPLETED|Overall Study||0
590177|NCT00494806|1440848|P2|COMPLETED|Overall Study||32
590178|NCT00494806|1440849|P1|COMPLETED|Overall Study||34
590179|NCT00494806|1440848|P2|STARTED|Overall Study||32
590180|NCT00494806|1440849|P1|STARTED|Overall Study||34
590181|NCT00494780|1440857|P2|NOT COMPLETED|Overall Study||13
590182|NCT00494780|1440858|P1|NOT COMPLETED|Overall Study||11
590183|NCT00494780|1440857|P2|COMPLETED|Overall Study||17
590184|NCT00494780|1440858|P1|COMPLETED|Overall Study||18
590185|NCT00494780|1440857|P2|STARTED|Overall Study||30
590186|NCT00494780|1440858|P1|STARTED|Overall Study||29
590187|NCT00494676|1440896|P2|NOT COMPLETED|Second Intervention||1
590188|NCT00494676|1440897|P1|NOT COMPLETED|Second Intervention||1
590189|NCT00494676|1440896|P2|COMPLETED|Second Intervention||28
590190|NCT00494676|1440897|P1|COMPLETED|Second Intervention||33
590191|NCT00494676|1440896|P2|STARTED|Second Intervention||29
590192|NCT00494676|1440897|P1|STARTED|Second Intervention||34
590193|NCT00494676|1440896|P2|NOT COMPLETED|First Intervention||3
590194|NCT00494676|1440897|P1|NOT COMPLETED|First Intervention||1
590195|NCT00494676|1440896|P2|COMPLETED|First Intervention||29
590196|NCT00494676|1440897|P1|COMPLETED|First Intervention||34
590197|NCT00494676|1440896|P2|STARTED|First Intervention||32
590198|NCT00494676|1440897|P1|STARTED|First Intervention||35
590199|NCT00494676|1440896|P2|NOT COMPLETED|Allocation||4
590200|NCT00494676|1440897|P1|NOT COMPLETED|Allocation||2
590201|NCT00494676|1440896|P2|COMPLETED|Allocation||32
590202|NCT00494676|1440897|P1|COMPLETED|Allocation||35
590203|NCT00494676|1440896|P2|STARTED|Allocation||36
590204|NCT00494676|1440897|P1|STARTED|Allocation||37
590205|NCT00494585|1440904|P1|NOT COMPLETED|Overall Study||0
590206|NCT00494585|1440904|P1|COMPLETED|Overall Study||22
590207|NCT00494585|1440904|P1|STARTED|Overall Study||22
590208|NCT00494507|1440912|P4|NOT COMPLETED|Open-Label Phase||5
590209|NCT00494507|1440913|P3|NOT COMPLETED|Open-Label Phase||5
590210|NCT00494507|1440914|P2|NOT COMPLETED|Open-Label Phase||1
590211|NCT00494507|1440915|P1|NOT COMPLETED|Open-Label Phase||0
590212|NCT00494507|1440912|P4|COMPLETED|Open-Label Phase||14
590213|NCT00494507|1440913|P3|COMPLETED|Open-Label Phase||17
590214|NCT00494507|1440914|P2|COMPLETED|Open-Label Phase||7
590215|NCT00494507|1440915|P1|COMPLETED|Open-Label Phase||9
590216|NCT00494507|1440912|P4|STARTED|Open-Label Phase||19
590217|NCT00494507|1440913|P3|STARTED|Open-Label Phase||22
590218|NCT00494507|1440914|P2|STARTED|Open-Label Phase|1 subject randomized to Acetazolamide in this phase is not included-drug arm was removed from trial.|8
590219|NCT00494507|1440915|P1|STARTED|Open-Label Phase||9
590220|NCT00494507|1440912|P4|NOT COMPLETED|Double-Blind Phase||1
590221|NCT00494507|1440913|P3|NOT COMPLETED|Double-Blind Phase||2
590222|NCT00494507|1440914|P2|NOT COMPLETED|Double-Blind Phase||0
590223|NCT00494507|1440915|P1|NOT COMPLETED|Double-Blind Phase||3
590224|NCT00494507|1440912|P4|COMPLETED|Double-Blind Phase||19
590225|NCT00494507|1440913|P3|COMPLETED|Double-Blind Phase||22
590226|NCT00494507|1440914|P2|COMPLETED|Double-Blind Phase||9
590227|NCT00494507|1440915|P1|COMPLETED|Double-Blind Phase||9
590228|NCT00494507|1440912|P4|Reached Endpoint of Acute Worsening|Double-Blind Phase||5
590229|NCT00494507|1440913|P3|Reached Endpoint of Acute Worsening|Double-Blind Phase||0
590230|NCT00494507|1440914|P2|Reached Endpoint of Acute Worsening|Double-Blind Phase||2
590231|NCT00494507|1440915|P1|Reached Endpoint of Acute Worsening|Double-Blind Phase||0
590232|NCT00494507|1440912|P4|STARTED|Double-Blind Phase||20
590233|NCT00494507|1440913|P3|STARTED|Double-Blind Phase||24
590234|NCT00494507|1440914|P2|STARTED|Double-Blind Phase||9
590235|NCT00494507|1440915|P1|STARTED|Double-Blind Phase||12
590236|NCT00494494|1440965|P2|NOT COMPLETED|Overall Study||0
590237|NCT00494494|1440966|P1|NOT COMPLETED|Overall Study||0
590238|NCT00494494|1440965|P2|COMPLETED|Overall Study||39
590239|NCT00494494|1440966|P1|COMPLETED|Overall Study||40
590240|NCT00494494|1440965|P2|STARTED|Overall Study||39
590241|NCT00494494|1440966|P1|STARTED|Overall Study||40
590242|NCT00494481|1440982|P2|NOT COMPLETED|Overall Study||24
590243|NCT00494481|1440983|P1|NOT COMPLETED|Overall Study||29
590244|NCT00494481|1440982|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|5
590245|NCT00494481|1440983|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|6
590246|NCT00494481|1440982|P2|STARTED|Overall Study|randomised patients|29
590247|NCT00494481|1440983|P1|STARTED|Overall Study|randomised patients|35
590248|NCT00494442|1440991|P2|NOT COMPLETED|Overall Study||16
590249|NCT00494442|1440992|P1|NOT COMPLETED|Overall Study||17
590250|NCT00494442|1440991|P2|COMPLETED|Overall Study|Patients completed the full study schedule (168 days treatment)|17
590251|NCT00494442|1440992|P1|COMPLETED|Overall Study|Patients completed the full study schedule (168 days treatment)|7
590252|NCT00494442|1440991|P2|STARTED|Overall Study|Patients received treatment|33
590253|NCT00494442|1440992|P1|STARTED|Overall Study|Patients received treatment|24
590254|NCT00494299|1441008|P2|NOT COMPLETED|Overall Study||229
590255|NCT00494299|1441009|P1|NOT COMPLETED|Overall Study||229
590256|NCT00494299|1441008|P2|COMPLETED|Overall Study||0
590257|NCT00494299|1441009|P1|COMPLETED|Overall Study||0
590258|NCT00494299|1441008|P2|Received Treatment|Overall Study||227
590259|NCT00494299|1441009|P1|Received Treatment|Overall Study||229
590260|NCT00494299|1441008|P2|STARTED|Overall Study||229
590261|NCT00494299|1441009|P1|STARTED|Overall Study||229
590262|NCT00494234|1441021|P2|NOT COMPLETED|Overall Study||10
590263|NCT00494234|1441022|P1|NOT COMPLETED|Overall Study||15
590264|NCT00494234|1441021|P2|COMPLETED|Overall Study||17
590265|NCT00494234|1441022|P1|COMPLETED|Overall Study||12
590266|NCT00494234|1441021|P2|STARTED|Overall Study||27
590267|NCT00494234|1441022|P1|STARTED|Overall Study||27
590268|NCT00494221|1441041|P3|NOT COMPLETED|Overall Study||14
590269|NCT00494221|1441042|P2|NOT COMPLETED|Overall Study||11
590270|NCT00494221|1441043|P1|NOT COMPLETED|Overall Study||16
590271|NCT00494221|1441041|P3|COMPLETED|Overall Study||44
590272|NCT00494221|1441042|P2|COMPLETED|Overall Study||45
590273|NCT00494221|1441043|P1|COMPLETED|Overall Study||42
590274|NCT00494221|1441041|P3|STARTED|Overall Study||58
590275|NCT00494221|1441042|P2|STARTED|Overall Study||56
590276|NCT00494221|1441043|P1|STARTED|Overall Study||58
590277|NCT00494143|1441063|P6|NOT COMPLETED|Overall Study||0
590278|NCT00494143|1441064|P5|NOT COMPLETED|Overall Study||0
590279|NCT00494143|1441065|P4|NOT COMPLETED|Overall Study||0
590280|NCT00494143|1441066|P3|NOT COMPLETED|Overall Study||0
590281|NCT00494143|1441067|P2|NOT COMPLETED|Overall Study||0
590282|NCT00494143|1441068|P1|NOT COMPLETED|Overall Study||0
590283|NCT00494143|1441063|P6|COMPLETED|Overall Study||0
590284|NCT00494143|1441064|P5|COMPLETED|Overall Study||1
590285|NCT00494143|1441065|P4|COMPLETED|Overall Study||0
590286|NCT00494143|1441066|P3|COMPLETED|Overall Study||3
590287|NCT00494143|1441067|P2|COMPLETED|Overall Study||2
590288|NCT00494143|1441068|P1|COMPLETED|Overall Study||1
590289|NCT00494143|1441063|P6|STARTED|Overall Study||0
590290|NCT00494143|1441064|P5|STARTED|Overall Study||1
590291|NCT00494143|1441065|P4|STARTED|Overall Study||0
590292|NCT00494143|1441066|P3|STARTED|Overall Study||3
590293|NCT00494143|1441067|P2|STARTED|Overall Study||2
590294|NCT00494143|1441068|P1|STARTED|Overall Study||1
590295|NCT00494091|1441084|P2|NOT COMPLETED|Overall Study||76
590296|NCT00494091|1441085|P1|NOT COMPLETED|Overall Study||6
590297|NCT00494091|1441084|P2|COMPLETED|Overall Study||0
590298|NCT00494091|1441085|P1|COMPLETED|Overall Study||0
590299|NCT00494091|1441084|P2|STARTED|Overall Study||76
590300|NCT00494091|1441085|P1|STARTED|Overall Study||6
590301|NCT00494026|1441107|P1|NOT COMPLETED|Overall Study||4
590302|NCT00494026|1441107|P1|COMPLETED|Overall Study|2 patients did receive the full study treatment prior to the study being terminated.|0
590303|NCT00494026|1441107|P1|STARTED|Overall Study||4
590304|NCT00494013|1441117|P2|NOT COMPLETED|Overall Study||36
590305|NCT00494013|1441118|P1|NOT COMPLETED|Overall Study||30
590306|NCT00494013|1441117|P2|COMPLETED|Overall Study||183
590307|NCT00494013|1441118|P1|COMPLETED|Overall Study||193
590308|NCT00494013|1441117|P2|Full Analysis Set (Intent to Treat)|Overall Study||210
590309|NCT00494013|1441118|P1|Full Analysis Set (Intent to Treat)|Overall Study||219
590310|NCT00494013|1441117|P2|STARTED|Overall Study||219
590311|NCT00494013|1441118|P1|STARTED|Overall Study||223
590312|NCT00493974|1441148|P2|NOT COMPLETED|Overall Study||14
590313|NCT00493974|1441149|P1|NOT COMPLETED|Overall Study||13
590314|NCT00493974|1441148|P2|COMPLETED|Overall Study||45
590315|NCT00493974|1441149|P1|COMPLETED|Overall Study||47
590316|NCT00493974|1441148|P2|STARTED|Overall Study||59
590317|NCT00493974|1441149|P1|STARTED|Overall Study||60
590318|NCT00493805|1441167|P2|NOT COMPLETED|Overall Study||0
590319|NCT00493805|1441168|P1|NOT COMPLETED|Overall Study||0
590320|NCT00493805|1441167|P2|COMPLETED|Overall Study||42
590321|NCT00493805|1441168|P1|COMPLETED|Overall Study||17
590322|NCT00493805|1441167|P2|STARTED|Overall Study||42
590323|NCT00493805|1441168|P1|STARTED|Overall Study||17
590324|NCT00493779|1441176|P1|NOT COMPLETED|Overall Study||1
590325|NCT00493779|1441176|P1|COMPLETED|Overall Study|Completed follow-up phase|97
590326|NCT00493779|1441176|P1|STARTED|Overall Study|Number of subjects who had discontinued clopidogrel treatment and entered follow-up phase|98
590327|NCT00493649|1441183|P1|NOT COMPLETED|Overall Study||82
590328|NCT00493649|1441183|P1|COMPLETED|Overall Study||411
590329|NCT00493649|1441183|P1|STARTED|Overall Study||493
590330|NCT00493636|1441196|P2|NOT COMPLETED|Overall Study||2
590331|NCT00493636|1441197|P1|NOT COMPLETED|Overall Study||2
590332|NCT00493636|1441196|P2|COMPLETED|Overall Study||77
590333|NCT00493636|1441197|P1|COMPLETED|Overall Study||79
590334|NCT00493636|1441196|P2|STARTED|Overall Study||79
590335|NCT00493636|1441197|P1|STARTED|Overall Study||81
590336|NCT00493454|1441211|P1|NOT COMPLETED|Overall Study||1
590337|NCT00493454|1441211|P1|COMPLETED|Overall Study||5
590338|NCT00493454|1441211|P1|STARTED|Overall Study||6
590339|NCT00493311|1441217|P2|NOT COMPLETED|Overall Study||2
590340|NCT00493311|1441218|P1|NOT COMPLETED|Overall Study||2
590341|NCT00493311|1441217|P2|COMPLETED|Overall Study||29
590342|NCT00493311|1441218|P1|COMPLETED|Overall Study||27
590343|NCT00493311|1441217|P2|STARTED|Overall Study||31
590344|NCT00493311|1441218|P1|STARTED|Overall Study||29
590345|NCT00493285|1441238|P6|NOT COMPLETED|Overall Study||0
590346|NCT00493285|1441239|P5|NOT COMPLETED|Overall Study||1
590347|NCT00493285|1441240|P4|NOT COMPLETED|Overall Study||0
590348|NCT00493285|1441241|P3|NOT COMPLETED|Overall Study||0
590349|NCT00493285|1441242|P2|NOT COMPLETED|Overall Study||0
590350|NCT00493285|1441243|P1|NOT COMPLETED|Overall Study||0
590351|NCT00493285|1441238|P6|COMPLETED|Overall Study||5
590352|NCT00493285|1441239|P5|COMPLETED|Overall Study||9
590353|NCT00493285|1441240|P4|COMPLETED|Overall Study||6
590354|NCT00493285|1441241|P3|COMPLETED|Overall Study||9
590355|NCT00493285|1441242|P2|COMPLETED|Overall Study||6
590356|NCT00493285|1441243|P1|COMPLETED|Overall Study||13
590357|NCT00493285|1441238|P6|STARTED|Overall Study||5
590358|NCT00493285|1441239|P5|STARTED|Overall Study||10
590359|NCT00493285|1441240|P4|STARTED|Overall Study||6
590360|NCT00493285|1441241|P3|STARTED|Overall Study||9
590361|NCT00493285|1441242|P2|STARTED|Overall Study||6
590362|NCT00493285|1441243|P1|STARTED|Overall Study||13
590363|NCT00493246|1441475|P8|NOT COMPLETED|Overall Study||0
590364|NCT00493246|1441476|P7|NOT COMPLETED|Overall Study||1
590365|NCT00493246|1441477|P6|NOT COMPLETED|Overall Study||1
590366|NCT00493246|1441478|P5|NOT COMPLETED|Overall Study||1
590367|NCT00493246|1441479|P4|NOT COMPLETED|Overall Study||0
590368|NCT00493246|1441480|P3|NOT COMPLETED|Overall Study||0
590369|NCT00493246|1441481|P2|NOT COMPLETED|Overall Study||0
590370|NCT00493246|1441482|P1|NOT COMPLETED|Overall Study||0
590371|NCT00493246|1441475|P8|COMPLETED|Overall Study|Completed study 30 days after the last dose|10
590372|NCT00493246|1441476|P7|COMPLETED|Overall Study|Completed study 30 days after the last dose|11
590373|NCT00493246|1441477|P6|COMPLETED|Overall Study|Completed study 30 days after the last dose|15
590374|NCT00493246|1441478|P5|COMPLETED|Overall Study|Completed study 30 days after the last dose|8
590375|NCT00493246|1441479|P4|COMPLETED|Overall Study|Completed study 30 days after the last dose|13
590376|NCT00493246|1441480|P3|COMPLETED|Overall Study|Completed study 30 days after the last dose|12
590377|NCT00493246|1441481|P2|COMPLETED|Overall Study|Completed study 30 days after the last dose|1
590378|NCT00493246|1441482|P1|COMPLETED|Overall Study|Completed study 30 days after the last dose|2
590379|NCT00493246|1441475|P8|STARTED|Overall Study|All subjects who were randomized.|10
590380|NCT00493246|1441476|P7|STARTED|Overall Study|All subjects who were randomized.|12
590381|NCT00493246|1441477|P6|STARTED|Overall Study|All subjects who were randomized.|16
590382|NCT00493246|1441478|P5|STARTED|Overall Study|All subjects who were randomized.Excludes 1 subject who was randomized in error.|9
590383|NCT00493246|1441479|P4|STARTED|Overall Study||13
590384|NCT00493246|1441480|P3|STARTED|Overall Study||12
590385|NCT00493246|1441481|P2|STARTED|Overall Study||1
590386|NCT00493246|1441482|P1|STARTED|Overall Study||2
590387|NCT00493220|1441546|P6|NOT COMPLETED|Final 7-Day Safety Follow-up||0
590388|NCT00493220|1441547|P5|NOT COMPLETED|Final 7-Day Safety Follow-up||0
590389|NCT00493220|1441548|P4|NOT COMPLETED|Final 7-Day Safety Follow-up||0
590390|NCT00493220|1441549|P3|NOT COMPLETED|Final 7-Day Safety Follow-up||0
590391|NCT00493220|1441550|P2|NOT COMPLETED|Final 7-Day Safety Follow-up||0
590392|NCT00493220|1441551|P1|NOT COMPLETED|Final 7-Day Safety Follow-up||0
590393|NCT00493220|1441546|P6|COMPLETED|Final 7-Day Safety Follow-up||5
590394|NCT00493220|1441547|P5|COMPLETED|Final 7-Day Safety Follow-up||5
590395|NCT00493220|1441548|P4|COMPLETED|Final 7-Day Safety Follow-up||5
590396|NCT00493220|1441549|P3|COMPLETED|Final 7-Day Safety Follow-up||5
590397|NCT00493220|1441550|P2|COMPLETED|Final 7-Day Safety Follow-up||5
590398|NCT00493220|1441551|P1|COMPLETED|Final 7-Day Safety Follow-up||4
590399|NCT00493220|1441546|P6|STARTED|Final 7-Day Safety Follow-up||5
590400|NCT00493220|1441547|P5|STARTED|Final 7-Day Safety Follow-up||5
590401|NCT00493220|1441548|P4|STARTED|Final 7-Day Safety Follow-up||5
590402|NCT00493220|1441549|P3|STARTED|Final 7-Day Safety Follow-up||5
590403|NCT00493220|1441550|P2|STARTED|Final 7-Day Safety Follow-up||5
590404|NCT00493220|1441551|P1|STARTED|Final 7-Day Safety Follow-up||4
590405|NCT00493220|1441546|P6|NOT COMPLETED|Third Intervention||0
590406|NCT00493220|1441547|P5|NOT COMPLETED|Third Intervention||0
590407|NCT00493220|1441548|P4|NOT COMPLETED|Third Intervention||0
590408|NCT00493220|1441549|P3|NOT COMPLETED|Third Intervention||0
590409|NCT00493220|1441550|P2|NOT COMPLETED|Third Intervention||0
590410|NCT00493220|1441551|P1|NOT COMPLETED|Third Intervention||1
590411|NCT00493220|1441546|P6|COMPLETED|Third Intervention||5
590412|NCT00493220|1441547|P5|COMPLETED|Third Intervention||5
590413|NCT00493220|1441548|P4|COMPLETED|Third Intervention||5
590414|NCT00493220|1441549|P3|COMPLETED|Third Intervention||5
590415|NCT00493220|1441550|P2|COMPLETED|Third Intervention||5
590416|NCT00493220|1441551|P1|COMPLETED|Third Intervention||4
590417|NCT00493220|1441546|P6|STARTED|Third Intervention||5
590418|NCT00493220|1441547|P5|STARTED|Third Intervention||5
590419|NCT00493220|1441548|P4|STARTED|Third Intervention||5
590420|NCT00493220|1441549|P3|STARTED|Third Intervention||5
590421|NCT00493220|1441550|P2|STARTED|Third Intervention||5
590422|NCT00493220|1441551|P1|STARTED|Third Intervention||5
590423|NCT00493220|1441546|P6|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
590424|NCT00493220|1441547|P5|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
590425|NCT00493220|1441548|P4|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
590426|NCT00493220|1441549|P3|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
590427|NCT00493220|1441550|P2|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
590428|NCT00493220|1441551|P1|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
590429|NCT00493220|1441546|P6|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
590430|NCT00493220|1441547|P5|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
590431|NCT00493220|1441548|P4|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
590432|NCT00493220|1441549|P3|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
590433|NCT00493220|1441550|P2|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
590434|NCT00493220|1441551|P1|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
590435|NCT00493220|1441546|P6|STARTED|Second 7-Day Washout & Safety Follow-up||5
590436|NCT00493220|1441547|P5|STARTED|Second 7-Day Washout & Safety Follow-up||5
590437|NCT00493220|1441548|P4|STARTED|Second 7-Day Washout & Safety Follow-up||5
590438|NCT00493220|1441549|P3|STARTED|Second 7-Day Washout & Safety Follow-up||5
590439|NCT00493220|1441550|P2|STARTED|Second 7-Day Washout & Safety Follow-up||5
590440|NCT00493220|1441551|P1|STARTED|Second 7-Day Washout & Safety Follow-up||5
590441|NCT00493220|1441546|P6|NOT COMPLETED|Second Intervention||0
590442|NCT00493220|1441547|P5|NOT COMPLETED|Second Intervention||0
590443|NCT00493220|1441548|P4|NOT COMPLETED|Second Intervention||0
590444|NCT00493220|1441549|P3|NOT COMPLETED|Second Intervention||0
590445|NCT00493220|1441550|P2|NOT COMPLETED|Second Intervention||0
590446|NCT00493220|1441551|P1|NOT COMPLETED|Second Intervention||0
590447|NCT00493220|1441546|P6|COMPLETED|Second Intervention||5
590448|NCT00493220|1441547|P5|COMPLETED|Second Intervention||5
590449|NCT00493220|1441548|P4|COMPLETED|Second Intervention||5
590450|NCT00493220|1441549|P3|COMPLETED|Second Intervention||5
590451|NCT00493220|1441550|P2|COMPLETED|Second Intervention||5
590452|NCT00493220|1441551|P1|COMPLETED|Second Intervention||5
590453|NCT00493220|1441546|P6|STARTED|Second Intervention||5
590454|NCT00493220|1441547|P5|STARTED|Second Intervention||5
590455|NCT00493220|1441548|P4|STARTED|Second Intervention||5
590456|NCT00493220|1441549|P3|STARTED|Second Intervention||5
590457|NCT00493220|1441550|P2|STARTED|Second Intervention||5
590458|NCT00493220|1441551|P1|STARTED|Second Intervention||5
590459|NCT00493220|1441546|P6|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
590460|NCT00493220|1441547|P5|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
590461|NCT00493220|1441548|P4|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
590462|NCT00493220|1441549|P3|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
590463|NCT00493220|1441550|P2|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
590464|NCT00493220|1441551|P1|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
590465|NCT00493220|1441546|P6|COMPLETED|First 7-Day Washout & Safety Follow-up||5
590466|NCT00493220|1441547|P5|COMPLETED|First 7-Day Washout & Safety Follow-up||5
590467|NCT00493220|1441548|P4|COMPLETED|First 7-Day Washout & Safety Follow-up||5
590468|NCT00493220|1441549|P3|COMPLETED|First 7-Day Washout & Safety Follow-up||5
590469|NCT00493220|1441550|P2|COMPLETED|First 7-Day Washout & Safety Follow-up||5
590470|NCT00493220|1441551|P1|COMPLETED|First 7-Day Washout & Safety Follow-up||5
590471|NCT00493220|1441546|P6|STARTED|First 7-Day Washout & Safety Follow-up||5
590472|NCT00493220|1441547|P5|STARTED|First 7-Day Washout & Safety Follow-up||5
590473|NCT00493220|1441548|P4|STARTED|First 7-Day Washout & Safety Follow-up||5
590474|NCT00493220|1441549|P3|STARTED|First 7-Day Washout & Safety Follow-up||5
590475|NCT00493220|1441550|P2|STARTED|First 7-Day Washout & Safety Follow-up||5
590476|NCT00493220|1441551|P1|STARTED|First 7-Day Washout & Safety Follow-up||5
590477|NCT00493220|1441546|P6|NOT COMPLETED|First Intervention||0
590478|NCT00493220|1441547|P5|NOT COMPLETED|First Intervention||0
590479|NCT00493220|1441548|P4|NOT COMPLETED|First Intervention||0
590480|NCT00493220|1441549|P3|NOT COMPLETED|First Intervention||0
590481|NCT00493220|1441550|P2|NOT COMPLETED|First Intervention||0
590482|NCT00493220|1441551|P1|NOT COMPLETED|First Intervention||0
590483|NCT00493220|1441546|P6|COMPLETED|First Intervention||5
590484|NCT00493220|1441547|P5|COMPLETED|First Intervention||5
590485|NCT00493220|1441548|P4|COMPLETED|First Intervention||5
590486|NCT00493220|1441549|P3|COMPLETED|First Intervention||5
590487|NCT00493220|1441550|P2|COMPLETED|First Intervention||5
590488|NCT00493220|1441551|P1|COMPLETED|First Intervention||5
590489|NCT00493220|1441546|P6|STARTED|First Intervention||5
590490|NCT00493220|1441547|P5|STARTED|First Intervention||5
590491|NCT00493220|1441548|P4|STARTED|First Intervention||5
590492|NCT00493220|1441549|P3|STARTED|First Intervention||5
590493|NCT00493220|1441550|P2|STARTED|First Intervention||5
590494|NCT00493220|1441551|P1|STARTED|First Intervention||5
590495|NCT00493181|1441568|P1|NOT COMPLETED|Overall Study||0
590496|NCT00493181|1441568|P1|COMPLETED|Overall Study||8
590497|NCT00493181|1441568|P1|STARTED|Overall Study||8
590498|NCT00493038|1441574|P2|NOT COMPLETED|Follow-up||0
590499|NCT00493038|1441575|P1|NOT COMPLETED|Follow-up||1
590500|NCT00493038|1441574|P2|COMPLETED|Follow-up||126
590501|NCT00493038|1441575|P1|COMPLETED|Follow-up||122
590502|NCT00493038|1441574|P2|STARTED|Follow-up||126
590503|NCT00493038|1441575|P1|STARTED|Follow-up||123
590504|NCT00493038|1441574|P2|NOT COMPLETED|Treatment||20
590505|NCT00493038|1441575|P1|NOT COMPLETED|Treatment||24
590506|NCT00493038|1441574|P2|COMPLETED|Treatment||126
590507|NCT00493038|1441575|P1|COMPLETED|Treatment||123
590508|NCT00493038|1441574|P2|Test-of-Cure Visit|Treatment||126
590509|NCT00493038|1441575|P1|Test-of-Cure Visit|Treatment||123
590510|NCT00493038|1441574|P2|Treated With Study Medication|Treatment||142
590511|NCT00493038|1441575|P1|Treated With Study Medication|Treatment||145
590512|NCT00493038|1441574|P2|Randomization|Treatment||146
590513|NCT00493038|1441575|P1|Randomization|Treatment||147
590514|NCT00493038|1441574|P2|STARTED|Treatment||146
590515|NCT00493038|1441575|P1|STARTED|Treatment||147
590516|NCT00493012|1441591|P2|NOT COMPLETED|Overall Study||17
590517|NCT00493012|1441592|P1|NOT COMPLETED|Overall Study||18
590518|NCT00493012|1441591|P2|COMPLETED|Overall Study||83
590519|NCT00493012|1441592|P1|COMPLETED|Overall Study||82
590520|NCT00493012|1441591|P2|STARTED|Overall Study||100
590521|NCT00493012|1441592|P1|STARTED|Overall Study||100
590522|NCT00492973|1441620|P2|NOT COMPLETED|Overall Study||1
590523|NCT00492973|1441621|P1|NOT COMPLETED|Overall Study||0
590524|NCT00492973|1441620|P2|COMPLETED|Overall Study|One patient died of complications related to deep joint sepsis in the early postoperative period.|38
590525|NCT00492973|1441621|P1|COMPLETED|Overall Study||37
590526|NCT00492973|1441620|P2|STARTED|Overall Study||39
590527|NCT00492973|1441621|P1|STARTED|Overall Study||37
590528|NCT00492856|1441635|P4|NOT COMPLETED|Post-consolidation||1
590529|NCT00492856|1441636|P3|NOT COMPLETED|Post-consolidation||27
590530|NCT00492856|1441637|P2|NOT COMPLETED|Post-consolidation||12
590531|NCT00492856|1441638|P1|NOT COMPLETED|Post-consolidation||0
590532|NCT00492856|1441635|P4|COMPLETED|Post-consolidation||0
590533|NCT00492856|1441636|P3|COMPLETED|Post-consolidation||0
590534|NCT00492856|1441637|P2|COMPLETED|Post-consolidation||29
590535|NCT00492856|1441638|P1|COMPLETED|Post-consolidation||0
590536|NCT00492856|1441635|P4|STARTED|Post-consolidation||1
590537|NCT00492856|1441636|P3|STARTED|Post-consolidation||27
590538|NCT00492856|1441637|P2|STARTED|Post-consolidation||41
590539|NCT00492856|1441638|P1|STARTED|Post-consolidation|Patients who achieve CRm, are randomized to the treatment arm, and are eligible.|0
590540|NCT00492856|1441635|P4|NOT COMPLETED|Consolidation||0
590541|NCT00492856|1441636|P3|NOT COMPLETED|Consolidation||0
590542|NCT00492856|1441637|P2|NOT COMPLETED|Consolidation||0
590543|NCT00492856|1441638|P1|NOT COMPLETED|Consolidation||9
590544|NCT00492856|1441635|P4|COMPLETED|Consolidation||0
590545|NCT00492856|1441636|P3|COMPLETED|Consolidation||0
590546|NCT00492856|1441637|P2|COMPLETED|Consolidation||0
590547|NCT00492856|1441638|P1|COMPLETED|Consolidation||83
590548|NCT00492856|1441635|P4|STARTED|Consolidation||0
590549|NCT00492856|1441636|P3|STARTED|Consolidation||0
590550|NCT00492856|1441637|P2|STARTED|Consolidation||0
590551|NCT00492856|1441638|P1|STARTED|Consolidation|Patients in CR (CRm), CRi, or PR after induction, register for consolidation and are eligible.|92
590552|NCT00492856|1441635|P4|NOT COMPLETED|Induction||0
590553|NCT00492856|1441636|P3|NOT COMPLETED|Induction||0
590554|NCT00492856|1441637|P2|NOT COMPLETED|Induction||0
590555|NCT00492856|1441638|P1|NOT COMPLETED|Induction||6
590556|NCT00492856|1441635|P4|COMPLETED|Induction||0
590557|NCT00492856|1441636|P3|COMPLETED|Induction||0
590558|NCT00492856|1441637|P2|COMPLETED|Induction||0
590559|NCT00492856|1441638|P1|COMPLETED|Induction||99
590560|NCT00492856|1441635|P4|STARTED|Induction||0
590561|NCT00492856|1441636|P3|STARTED|Induction||0
590562|NCT00492856|1441637|P2|STARTED|Induction||0
590563|NCT00492856|1441638|P1|STARTED|Induction||105
590564|NCT00492752|1441652|P4|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||6
590565|NCT00492752|1441653|P3|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||47
590566|NCT00492752|1441654|P2|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||16
590567|NCT00492752|1441655|P1|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||86
590568|NCT00492752|1441652|P4|COMPLETED|Follow-up and/or Open Label Sorafenib||0
590569|NCT00492752|1441653|P3|COMPLETED|Follow-up and/or Open Label Sorafenib|20 participants were followed up until the end of this trial|20
590570|NCT00492752|1441654|P2|COMPLETED|Follow-up and/or Open Label Sorafenib||0
590571|NCT00492752|1441655|P1|COMPLETED|Follow-up and/or Open Label Sorafenib|1 participant completed all assessments, 33 were followed up until the end of this trial|34
590572|NCT00492752|1441652|P4|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||6
590573|NCT00492752|1441653|P3|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0
590574|NCT00492752|1441654|P2|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||16
590575|NCT00492752|1441655|P1|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0
590576|NCT00492752|1441652|P4|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0
590577|NCT00492752|1441653|P3|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||67
590578|NCT00492752|1441654|P2|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0
590579|NCT00492752|1441655|P1|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||120
590580|NCT00492752|1441652|P4|STARTED|Follow-up and/or Open Label Sorafenib||6
590581|NCT00492752|1441653|P3|STARTED|Follow-up and/or Open Label Sorafenib||67
590582|NCT00492752|1441654|P2|STARTED|Follow-up and/or Open Label Sorafenib||16
590583|NCT00492752|1441655|P1|STARTED|Follow-up and/or Open Label Sorafenib||120
590584|NCT00492752|1441652|P4|NOT COMPLETED|Double Blind Treatment||0
590585|NCT00492752|1441653|P3|NOT COMPLETED|Double Blind Treatment||3
590586|NCT00492752|1441654|P2|NOT COMPLETED|Double Blind Treatment||0
590587|NCT00492752|1441655|P1|NOT COMPLETED|Double Blind Treatment||14
590588|NCT00492752|1441652|P4|COMPLETED|Double Blind Treatment||6
590589|NCT00492752|1441653|P3|COMPLETED|Double Blind Treatment||67
590590|NCT00492752|1441654|P2|COMPLETED|Double Blind Treatment||16
590591|NCT00492752|1441655|P1|COMPLETED|Double Blind Treatment||120
590592|NCT00492752|1441652|P4|Received Treatment|Double Blind Treatment|Safety Population|6
590593|NCT00492752|1441653|P3|Received Treatment|Double Blind Treatment|Safety Population. 1 participant never received treatment due to protocol violation.|69
590594|NCT00492752|1441654|P2|Received Treatment|Double Blind Treatment|Safety Population|16
590595|NCT00492752|1441655|P1|Received Treatment|Double Blind Treatment|Safety Population. 1 participant never received treatment due to an Adverse Event.|133
590596|NCT00492752|1441652|P4|STARTED|Double Blind Treatment||6
590597|NCT00492752|1441653|P3|STARTED|Double Blind Treatment||70
590598|NCT00492752|1441654|P2|STARTED|Double Blind Treatment||16
590599|NCT00492752|1441655|P1|STARTED|Double Blind Treatment||134
590600|NCT00492726|1441690|P2|NOT COMPLETED|Overall Study||36
590601|NCT00492726|1441691|P1|NOT COMPLETED|Overall Study||50
590602|NCT00492726|1441690|P2|COMPLETED|Overall Study||358
590603|NCT00492726|1441691|P1|COMPLETED|Overall Study||360
590604|NCT00492726|1441690|P2|End of Study|Overall Study||358
590605|NCT00492726|1441691|P1|End of Study|Overall Study||360
590606|NCT00492726|1441690|P2|End of Treatment (EOT, Day 5 to 14)|Overall Study||377
590607|NCT00492726|1441691|P1|End of Treatment (EOT, Day 5 to 14)|Overall Study||387
590608|NCT00492726|1441690|P2|STARTED|Overall Study||394
590609|NCT00492726|1441691|P1|STARTED|Overall Study||410
590610|NCT00492622|1441715|P1|NOT COMPLETED|Overall Study||0
590611|NCT00492622|1441715|P1|COMPLETED|Overall Study||12
590612|NCT00492622|1441715|P1|STARTED|Overall Study|all subjects received the immediate release formulation|12
590613|NCT00492583|1441727|P2|NOT COMPLETED|Overall Study||0
590614|NCT00492583|1441728|P1|NOT COMPLETED|Overall Study||0
590615|NCT00492583|1441727|P2|COMPLETED|Overall Study||87
590616|NCT00492583|1441728|P1|COMPLETED|Overall Study||95
590617|NCT00492583|1441727|P2|STARTED|Overall Study||87
590618|NCT00492583|1441728|P1|STARTED|Overall Study||95
590619|NCT00492557|1441736|P2|NOT COMPLETED|Overall Study||23
590620|NCT00492557|1441737|P1|NOT COMPLETED|Overall Study||24
590621|NCT00492557|1441736|P2|COMPLETED|Overall Study||557
590622|NCT00492557|1441737|P1|COMPLETED|Overall Study||556
590623|NCT00492557|1441736|P2|Vaccinated Dose 2|Overall Study||558
590624|NCT00492557|1441737|P1|Vaccinated Dose 2|Overall Study||560
590625|NCT00492557|1441736|P2|Vaccinated Dose 1|Overall Study||575
590626|NCT00492557|1441737|P1|Vaccinated Dose 1|Overall Study||577
590627|NCT00492557|1441736|P2|STARTED|Overall Study||580
590628|NCT00492557|1441737|P1|STARTED|Overall Study||580
590629|NCT00492544|1441753|P1|NOT COMPLETED|Overall Study||0
590630|NCT00492544|1441753|P1|COMPLETED|Overall Study||100
590631|NCT00492544|1441753|P1|STARTED|Overall Study||100
590632|NCT00492531|1441767|P2|NOT COMPLETED|Overall Study||23
590633|NCT00492531|1441768|P1|NOT COMPLETED|Overall Study||22
590634|NCT00492531|1441767|P2|COMPLETED|Overall Study|Of 14 subjects who completed study, 13 were enrolled in Open label.|14
590635|NCT00492531|1441768|P1|COMPLETED|Overall Study|Of 15 subjects who completed study, 13 were enrolled in Open label.|15
590636|NCT00492531|1441767|P2|STARTED|Overall Study||37
590637|NCT00492531|1441768|P1|STARTED|Overall Study||37
590638|NCT00492401|1441780|P1|NOT COMPLETED|Overall Study||0
590639|NCT00492401|1441780|P1|COMPLETED|Overall Study||55
590640|NCT00492401|1441780|P1|STARTED|Overall Study||55
590641|NCT00492349|1441791|P2|NOT COMPLETED|Overall Study||7
590642|NCT00492349|1441792|P1|NOT COMPLETED|Overall Study||3
590643|NCT00492349|1441791|P2|COMPLETED|Overall Study||27
590644|NCT00492349|1441792|P1|COMPLETED|Overall Study||32
590645|NCT00492349|1441791|P2|Week 8|Overall Study||27
590646|NCT00492349|1441792|P1|Week 8|Overall Study||32
590647|NCT00492349|1441791|P2|Week 2|Overall Study||33
590648|NCT00492349|1441792|P1|Week 2|Overall Study||32
590649|NCT00492349|1441791|P2|STARTED|Overall Study||34
590650|NCT00492349|1441792|P1|STARTED|Overall Study||35
590651|NCT00492336|1441814|P2|NOT COMPLETED|Overall Study||6
590652|NCT00492336|1441815|P1|NOT COMPLETED|Overall Study||2
590653|NCT00492336|1441814|P2|COMPLETED|Overall Study||23
590654|NCT00492336|1441815|P1|COMPLETED|Overall Study||26
590655|NCT00492336|1441814|P2|STARTED|Overall Study||29
590656|NCT00492336|1441815|P1|STARTED|Overall Study||28
590657|NCT00492297|1441841|P1|NOT COMPLETED|Survival Only Follow-up||59
590658|NCT00492297|1441841|P1|COMPLETED|Survival Only Follow-up||0
590659|NCT00492297|1441841|P1|STARTED|Survival Only Follow-up||59
590660|NCT00492297|1441841|P1|NOT COMPLETED|Active Follow-up 30(+4) Days Duration||19
590661|NCT00492297|1441841|P1|COMPLETED|Active Follow-up 30(+4) Days Duration||59
590662|NCT00492297|1441841|P1|STARTED|Active Follow-up 30(+4) Days Duration|AFU is 30(+4) days duration for subjects withdrawn from sorafenib due to PD.|78
590663|NCT00492297|1441841|P1|NOT COMPLETED|Treatment||5
590664|NCT00492297|1441841|P1|COMPLETED|Treatment||78
590665|NCT00492297|1441841|P1|Second Stage of Simon Optimal Design|Treatment|Recruitment continued into the second stage. 51 of 83 subjects were treated in the second stage.|51
590666|NCT00492297|1441841|P1|First Stage of Simon Optimal Design|Treatment|32 subjects of 83 subjects enrolled were treated in first stage.|32
590667|NCT00492297|1441841|P1|STARTED|Treatment||83
590668|NCT00492284|1441859|P4|NOT COMPLETED|Overall Study||10
590669|NCT00492284|1441860|P3|NOT COMPLETED|Overall Study||6
590670|NCT00492284|1441861|P2|NOT COMPLETED|Overall Study||4
590671|NCT00492284|1441862|P1|NOT COMPLETED|Overall Study||1
590672|NCT00492284|1441859|P4|COMPLETED|Overall Study||31
590673|NCT00492284|1441860|P3|COMPLETED|Overall Study||37
590674|NCT00492284|1441861|P2|COMPLETED|Overall Study||35
590675|NCT00492284|1441862|P1|COMPLETED|Overall Study||38
590676|NCT00492284|1441859|P4|STARTED|Overall Study||41
590677|NCT00492284|1441860|P3|STARTED|Overall Study||43
590678|NCT00492284|1441861|P2|STARTED|Overall Study||39
590679|NCT00492284|1441862|P1|STARTED|Overall Study||39
590680|NCT00492232|1441906|P2|NOT COMPLETED|Open-Label Treatment||0
590681|NCT00492232|1441907|P1|NOT COMPLETED|Open-Label Treatment||1
590682|NCT00492232|1441906|P2|COMPLETED|Open-Label Treatment||0
590683|NCT00492232|1441907|P1|COMPLETED|Open-Label Treatment||88
590684|NCT00492232|1441906|P2|STARTED|Open-Label Treatment|All subjects received ramelteon in the OLTP.|0
590685|NCT00492232|1441907|P1|STARTED|Open-Label Treatment|In the previous DBTP, 45 and 44 subjects were randomized to ramelteon and placebo, respectively.|89
590686|NCT00492232|1441906|P2|NOT COMPLETED|Double-Blind Treatment||25
590687|NCT00492232|1441907|P1|NOT COMPLETED|Double-Blind Treatment||18
590688|NCT00492232|1441906|P2|COMPLETED|Double-Blind Treatment||45
590689|NCT00492232|1441907|P1|COMPLETED|Double-Blind Treatment||47
590690|NCT00492232|1441906|P2|STARTED|Double-Blind Treatment||70
590691|NCT00492232|1441907|P1|STARTED|Double-Blind Treatment||65
590692|NCT00492232|1441906|P2|NOT COMPLETED|Placebo Run-in||70
590693|NCT00492232|1441907|P1|NOT COMPLETED|Placebo Run-in||0
590694|NCT00492232|1441906|P2|COMPLETED|Placebo Run-in|These subjects successfully completed the placebo run-in period and were randomized to the DBTP.|135
590695|NCT00492232|1441907|P1|COMPLETED|Placebo Run-in||0
590696|NCT00492232|1441906|P2|STARTED|Placebo Run-in|All subjects received placebo in the placebo run-in period.|205
590697|NCT00492232|1441907|P1|STARTED|Placebo Run-in||0
590698|NCT00492206|1441939|P1|NOT COMPLETED|Overall Study||0
590699|NCT00492206|1441939|P1|COMPLETED|Overall Study||40
590700|NCT00492206|1441939|P1|STARTED|Overall Study||40
590701|NCT00492115|1441948|P2|NOT COMPLETED|Overall Study||4
590702|NCT00492115|1441949|P1|NOT COMPLETED|Overall Study||3
590703|NCT00492115|1441948|P2|COMPLETED|Overall Study|4 dropped due to not being able to tolerate CPAP|15
590704|NCT00492115|1441949|P1|COMPLETED|Overall Study|3 dropped due to anxiety or not being able to tolerate CPAP|16
590705|NCT00492115|1441948|P2|STARTED|Overall Study||19
590706|NCT00492115|1441949|P1|STARTED|Overall Study||19
590707|NCT00492089|1441959|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
590708|NCT00492089|1441960|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
590709|NCT00492089|1441959|P2|COMPLETED|Second Intervention (6 Weeks)||6
590710|NCT00492089|1441960|P1|COMPLETED|Second Intervention (6 Weeks)||5
590711|NCT00492089|1441959|P2|STARTED|Second Intervention (6 Weeks)||6
590712|NCT00492089|1441960|P1|STARTED|Second Intervention (6 Weeks)||5
590713|NCT00492089|1441959|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
590714|NCT00492089|1441960|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
590715|NCT00492089|1441959|P2|COMPLETED|First Intervention (6 Weeks)||6
590716|NCT00492089|1441960|P1|COMPLETED|First Intervention (6 Weeks)||5
590717|NCT00492089|1441959|P2|STARTED|First Intervention (6 Weeks)||6
590718|NCT00492089|1441960|P1|STARTED|First Intervention (6 Weeks)||5
590719|NCT00492063|1441970|P4|NOT COMPLETED|Overall Study||10
590720|NCT00492063|1441971|P3|NOT COMPLETED|Overall Study||11
590721|NCT00492063|1441972|P2|NOT COMPLETED|Overall Study||14
590722|NCT00492063|1441973|P1|NOT COMPLETED|Overall Study||10
590723|NCT00492063|1441970|P4|COMPLETED|Overall Study||666
590724|NCT00492063|1441971|P3|COMPLETED|Overall Study||667
590725|NCT00492063|1441972|P2|COMPLETED|Overall Study||634
590726|NCT00492063|1441973|P1|COMPLETED|Overall Study||642
590727|NCT00492063|1441970|P4|STARTED|Overall Study||676
590728|NCT00492063|1441971|P3|STARTED|Overall Study||678
590729|NCT00492063|1441972|P2|STARTED|Overall Study||648
590730|NCT00492063|1441973|P1|STARTED|Overall Study||652
590731|NCT00492024|1441997|P2|NOT COMPLETED|Follow up||2
590732|NCT00492024|1441998|P1|NOT COMPLETED|Follow up||1
590733|NCT00492024|1441997|P2|COMPLETED|Follow up||99
590734|NCT00492024|1441998|P1|COMPLETED|Follow up||221
590735|NCT00492024|1441997|P2|STARTED|Follow up||101
590736|NCT00492024|1441998|P1|STARTED|Follow up||222
590737|NCT00492024|1441997|P2|NOT COMPLETED|Treatment||22
590738|NCT00492024|1441998|P1|NOT COMPLETED|Treatment||29
590739|NCT00492024|1441997|P2|COMPLETED|Treatment||101
590740|NCT00492024|1441998|P1|COMPLETED|Treatment||222
590741|NCT00492024|1441997|P2|STARTED|Treatment||123
590742|NCT00492024|1441998|P1|STARTED|Treatment||251
590743|NCT00491894|1442014|P1|NOT COMPLETED|Overall Study||34
590744|NCT00491894|1442014|P1|COMPLETED|Overall Study||103
590745|NCT00491894|1442014|P1|STARTED|Overall Study||137
590746|NCT00491829|1442025|P3|NOT COMPLETED|Overall Study||75
590747|NCT00491829|1442026|P2|NOT COMPLETED|Overall Study||114
590748|NCT00491829|1442027|P1|NOT COMPLETED|Overall Study||95
590749|NCT00491829|1442025|P3|COMPLETED|Overall Study||243
590750|NCT00491829|1442026|P2|COMPLETED|Overall Study||202
590751|NCT00491829|1442027|P1|COMPLETED|Overall Study||216
590752|NCT00491829|1442025|P3|STARTED|Overall Study||318
590753|NCT00491829|1442026|P2|STARTED|Overall Study||316
590754|NCT00491829|1442027|P1|STARTED|Overall Study||311
590755|NCT00491764|1442041|P6|NOT COMPLETED|Overall Study||9
590756|NCT00491764|1442042|P5|NOT COMPLETED|Overall Study||3
590757|NCT00491764|1442043|P4|NOT COMPLETED|Overall Study||8
590758|NCT00491764|1442044|P3|NOT COMPLETED|Overall Study||8
590759|NCT00491764|1442045|P2|NOT COMPLETED|Overall Study||7
590760|NCT00491764|1442046|P1|NOT COMPLETED|Overall Study||5
590761|NCT00491764|1442041|P6|COMPLETED|Overall Study||27
590762|NCT00491764|1442042|P5|COMPLETED|Overall Study||33
590763|NCT00491764|1442043|P4|COMPLETED|Overall Study||28
590764|NCT00491764|1442044|P3|COMPLETED|Overall Study||28
590765|NCT00491764|1442045|P2|COMPLETED|Overall Study||30
590766|NCT00491764|1442046|P1|COMPLETED|Overall Study||32
590767|NCT00491764|1442041|P6|STARTED|Overall Study||36
590768|NCT00491764|1442042|P5|STARTED|Overall Study||36
590769|NCT00491764|1442043|P4|STARTED|Overall Study||36
590770|NCT00491764|1442044|P3|STARTED|Overall Study||36
590771|NCT00491764|1442045|P2|STARTED|Overall Study||37
590772|NCT00491764|1442046|P1|STARTED|Overall Study||37
590773|NCT00491738|1442074|P2|NOT COMPLETED|Overall Study||0
590774|NCT00491738|1442075|P1|NOT COMPLETED|Overall Study||0
590775|NCT00491738|1442074|P2|COMPLETED|Overall Study||9
590776|NCT00491738|1442075|P1|COMPLETED|Overall Study||7
590777|NCT00491738|1442074|P2|STARTED|Overall Study||9
590778|NCT00491738|1442075|P1|STARTED|Overall Study||7
590779|NCT00491608|1442079|P1|NOT COMPLETED|Overall Study||3
590780|NCT00491608|1442079|P1|COMPLETED|Overall Study||206
590781|NCT00491608|1442079|P1|STARTED|Overall Study|Participants who received treatment|209
590782|NCT00491556|1442090|P2|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||5
590783|NCT00491556|1442091|P1|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||24
590784|NCT00491556|1442090|P2|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||22
590785|NCT00491556|1442091|P1|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||25
590786|NCT00491556|1442090|P2|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||27
590787|NCT00491556|1442091|P1|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||49
590788|NCT00491556|1442090|P2|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||0
590789|NCT00491556|1442091|P1|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||26
590790|NCT00491556|1442090|P2|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||27
590791|NCT00491556|1442091|P1|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||49
590792|NCT00491556|1442090|P2|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||27
590793|NCT00491556|1442091|P1|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||53
590794|NCT00491556|1442090|P2|STARTED|Entry-Week (WK) 48: EXP/Standard Care||27
590795|NCT00491556|1442091|P1|STARTED|Entry-Week (WK) 48: EXP/Standard Care||75
590796|NCT00491530|1442150|P3|NOT COMPLETED|Overall Study||5
590797|NCT00491530|1442151|P2|NOT COMPLETED|Overall Study||6
590798|NCT00491530|1442152|P1|NOT COMPLETED|Overall Study||12
590799|NCT00491530|1442150|P3|COMPLETED|Overall Study||81
590800|NCT00491530|1442151|P2|COMPLETED|Overall Study||44
590801|NCT00491530|1442152|P1|COMPLETED|Overall Study||162
590802|NCT00491530|1442150|P3|STARTED|Overall Study||86
590803|NCT00491530|1442151|P2|STARTED|Overall Study||50
590804|NCT00491530|1442152|P1|STARTED|Overall Study||174
590805|NCT00491504|1442182|P4|NOT COMPLETED|Overall Study||4
590806|NCT00491504|1442183|P3|NOT COMPLETED|Overall Study||4
590807|NCT00491504|1442184|P2|NOT COMPLETED|Overall Study||1
590808|NCT00491504|1442185|P1|NOT COMPLETED|Overall Study||0
590809|NCT00491504|1442182|P4|COMPLETED|Overall Study||73
590810|NCT00491504|1442183|P3|COMPLETED|Overall Study||74
590811|NCT00491504|1442184|P2|COMPLETED|Overall Study||77
590812|NCT00491504|1442185|P1|COMPLETED|Overall Study||77
590813|NCT00491504|1442182|P4|STARTED|Overall Study|All subjects who received placebo on Day 1 through Day 7|77
590814|NCT00491504|1442183|P3|STARTED|Overall Study|All subjects who received MFNS on Day 1 through Day 7|78
590815|NCT00491504|1442184|P2|STARTED|Overall Study|All subjects who received placebo only on Day 1|78
590816|NCT00491504|1442185|P1|STARTED|Overall Study|All subjects who received MFNS only on Day 1|77
590817|NCT00491400|1442195|P2|NOT COMPLETED|Overall Study||4
590818|NCT00491400|1442196|P1|NOT COMPLETED|Overall Study||5
590819|NCT00491400|1442195|P2|COMPLETED|Overall Study||9
590820|NCT00491400|1442196|P1|COMPLETED|Overall Study||10
590821|NCT00491400|1442195|P2|Finished Second Treatment|Overall Study|None withdrew during fenofibrate treatment (second treatment)|9
590822|NCT00491400|1442196|P1|Finished Second Treatment|Overall Study|2 withdrew during atorvastatin treatment (second treatment)|10
590823|NCT00491400|1442195|P2|Started Second Treatment|Overall Study|None withdrew during the washout period|9
590824|NCT00491400|1442196|P1|Started Second Treatment|Overall Study|2 withdrew during washout period|12
590825|NCT00491400|1442195|P2|Completed First Treatment|Overall Study|4 withdrew during atorvastatin treatment (first treatment)|9
590826|NCT00491400|1442196|P1|Completed First Treatment|Overall Study|None withdrew during fenofibrate treatment (first treatment)|14
590827|NCT00491400|1442195|P2|Started First Treatment|Overall Study|None withdrew prior to starting atorvastatin|13
590828|NCT00491400|1442196|P1|Started First Treatment|Overall Study|1 withdrew prior to starting fenofibrate|14
590829|NCT00491400|1442195|P2|STARTED|Overall Study||13
590830|NCT00491400|1442196|P1|STARTED|Overall Study||15
590831|NCT00491387|1442204|P1|NOT COMPLETED|Overall Study||20
590832|NCT00491387|1442204|P1|COMPLETED|Overall Study||4
590833|NCT00491387|1442204|P1|Study Enrollment|Overall Study||24
590834|NCT00491387|1442204|P1|STARTED|Overall Study||24
590835|NCT00491374|1442210|P2|NOT COMPLETED|Overall Study||0
590836|NCT00491374|1442211|P1|NOT COMPLETED|Overall Study||0
590837|NCT00491374|1442210|P2|COMPLETED|Overall Study||0
590838|NCT00491374|1442211|P1|COMPLETED|Overall Study||0
590839|NCT00491374|1442210|P2|STARTED|Overall Study||0
590840|NCT00491374|1442211|P1|STARTED|Overall Study||0
590841|NCT00491322|1442219|P2|NOT COMPLETED|Overall Study||1
590842|NCT00491322|1442220|P1|NOT COMPLETED|Overall Study||1
590843|NCT00491322|1442219|P2|COMPLETED|Overall Study||50
590844|NCT00491322|1442220|P1|COMPLETED|Overall Study||40
590845|NCT00491322|1442219|P2|STARTED|Overall Study||51
590846|NCT00491322|1442220|P1|STARTED|Overall Study||41
590847|NCT00491244|1442228|P2|NOT COMPLETED|Overall Study||20
590848|NCT00491244|1442229|P1|NOT COMPLETED|Overall Study||27
590849|NCT00491244|1442228|P2|COMPLETED|Overall Study||168
590850|NCT00491244|1442229|P1|COMPLETED|Overall Study||162
590851|NCT00491244|1442228|P2|STARTED|Overall Study||188
590852|NCT00491244|1442229|P1|STARTED|Overall Study||189
590853|NCT00491179|1442239|P2|NOT COMPLETED|Overall Study||2
590854|NCT00491179|1442240|P1|NOT COMPLETED|Overall Study||7
590855|NCT00491179|1442239|P2|COMPLETED|Overall Study||8
590856|NCT00491179|1442240|P1|COMPLETED|Overall Study||18
590857|NCT00491179|1442239|P2|STARTED|Overall Study||10
590858|NCT00491179|1442240|P1|STARTED|Overall Study||25
590859|NCT00491075|1442248|P1|NOT COMPLETED|Overall Study||2
590860|NCT00491075|1442248|P1|COMPLETED|Overall Study||14
590861|NCT00491075|1442248|P1|STARTED|Overall Study||16
590862|NCT00490971|1442254|P5|NOT COMPLETED|Maintenance||39
590863|NCT00490971|1442255|P4|NOT COMPLETED|Maintenance||53
590864|NCT00490971|1442256|P3|NOT COMPLETED|Maintenance||51
590865|NCT00490971|1442257|P2|NOT COMPLETED|Maintenance||0
590866|NCT00490971|1442258|P1|NOT COMPLETED|Maintenance||0
590867|NCT00490971|1442254|P5|COMPLETED|Maintenance||44
590868|NCT00490971|1442255|P4|COMPLETED|Maintenance||96
590869|NCT00490971|1442256|P3|COMPLETED|Maintenance||96
590870|NCT00490971|1442257|P2|COMPLETED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
590871|NCT00490971|1442258|P1|COMPLETED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
590872|NCT00490971|1442254|P5|STARTED|Maintenance||83
590873|NCT00490971|1442255|P4|STARTED|Maintenance|152 participants were assigned to pali/pali, out of which 149 took the study medication.|149
590874|NCT00490971|1442256|P3|STARTED|Maintenance|148 participants were assigned to pali/placebo, out of which 147 took the study medication.|147
590875|NCT00490971|1442257|P2|STARTED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
590876|NCT00490971|1442258|P1|STARTED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
590877|NCT00490971|1442254|P5|NOT COMPLETED|Acute/Continuation||0
590878|NCT00490971|1442255|P4|NOT COMPLETED|Acute/Continuation||0
590879|NCT00490971|1442256|P3|NOT COMPLETED|Acute/Continuation||0
590880|NCT00490971|1442257|P2|NOT COMPLETED|Acute/Continuation||62
590881|NCT00490971|1442258|P1|NOT COMPLETED|Acute/Continuation||306
590882|NCT00490971|1442254|P5|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
590883|NCT00490971|1442255|P4|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
590884|NCT00490971|1442256|P3|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
590885|NCT00490971|1442257|P2|COMPLETED|Acute/Continuation||86
590886|NCT00490971|1442258|P1|COMPLETED|Acute/Continuation||308
590887|NCT00490971|1442254|P5|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
590888|NCT00490971|1442255|P4|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
590889|NCT00490971|1442256|P3|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
590890|NCT00490971|1442257|P2|STARTED|Acute/Continuation|149 participants were assigned to paliperidone, out of which 148 took the study medication.|148
590891|NCT00490971|1442258|P1|STARTED|Acute/Continuation|617 participants were assigned to paliperidone, out of which 614 took the study medication.|614
590892|NCT00490945|1442305|P5|NOT COMPLETED|Overall Study||0
590893|NCT00490945|1442306|P4|NOT COMPLETED|Overall Study||0
590894|NCT00490945|1442307|P3|NOT COMPLETED|Overall Study||0
590895|NCT00490945|1442308|P2|NOT COMPLETED|Overall Study||1
590896|NCT00490945|1442309|P1|NOT COMPLETED|Overall Study||0
590897|NCT00490945|1442305|P5|COMPLETED|Overall Study||7
590898|NCT00490945|1442306|P4|COMPLETED|Overall Study||7
590899|NCT00490945|1442307|P3|COMPLETED|Overall Study||8
590900|NCT00490945|1442308|P2|COMPLETED|Overall Study||8
590901|NCT00490945|1442309|P1|COMPLETED|Overall Study||8
590902|NCT00490945|1442305|P5|STARTED|Overall Study||7
590903|NCT00490945|1442306|P4|STARTED|Overall Study||7
590904|NCT00490945|1442307|P3|STARTED|Overall Study||8
590905|NCT00490945|1442308|P2|STARTED|Overall Study||9
590906|NCT00490945|1442309|P1|STARTED|Overall Study||8
590907|NCT00490919|1442345|P3|NOT COMPLETED|Double-blind Phase||84
590908|NCT00490919|1442346|P2|NOT COMPLETED|Double-blind Phase||86
590909|NCT00490919|1442347|P1|NOT COMPLETED|Double-blind Phase||0
590910|NCT00490919|1442345|P3|COMPLETED|Double-blind Phase||199
590911|NCT00490919|1442346|P2|COMPLETED|Double-blind Phase||170
590912|NCT00490919|1442347|P1|COMPLETED|Double-blind Phase||0
590913|NCT00490919|1442345|P3|STARTED|Double-blind Phase|1 subject had no safety data in DB phase; therefore is excluded from randomized safety population.|283
590914|NCT00490919|1442346|P2|STARTED|Double-blind Phase|1 subject had no safety data in DB phase; therefore is excluded from randomized safety population.|256
590915|NCT00490919|1442347|P1|STARTED|Double-blind Phase||0
590916|NCT00490919|1442345|P3|NOT COMPLETED|Open-label Run-in Period||0
590917|NCT00490919|1442346|P2|NOT COMPLETED|Open-label Run-in Period||0
590918|NCT00490919|1442347|P1|NOT COMPLETED|Open-label Run-in Period||483
590919|NCT00490919|1442345|P3|COMPLETED|Open-label Run-in Period||0
590920|NCT00490919|1442346|P2|COMPLETED|Open-label Run-in Period||0
590921|NCT00490919|1442347|P1|COMPLETED|Open-label Run-in Period|Completed run-in and randomized; however 2 had no safety data after randomization visit (N = 539)|541
590922|NCT00490919|1442345|P3|STARTED|Open-label Run-in Period||0
590923|NCT00490919|1442346|P2|STARTED|Open-label Run-in Period||0
590924|NCT00490919|1442347|P1|STARTED|Open-label Run-in Period||1024
590925|NCT00490841|1442358|P1|NOT COMPLETED|Overall Study||13
590926|NCT00490841|1442358|P1|COMPLETED|Overall Study||189
590927|NCT00490841|1442358|P1|STARTED|Overall Study||202
590928|NCT00490815|1442380|P2|NOT COMPLETED|Overall Study||9
590929|NCT00490815|1442381|P1|NOT COMPLETED|Overall Study||8
590930|NCT00490815|1442380|P2|COMPLETED|Overall Study||8
590931|NCT00490815|1442381|P1|COMPLETED|Overall Study||12
590932|NCT00490815|1442380|P2|STARTED|Overall Study||17
590933|NCT00490815|1442381|P1|STARTED|Overall Study||20
590934|NCT00490802|1442391|P2|NOT COMPLETED|Overall Study||2
590935|NCT00490802|1442392|P1|NOT COMPLETED|Overall Study||1
590936|NCT00490802|1442391|P2|COMPLETED|Overall Study||7
590937|NCT00490802|1442392|P1|COMPLETED|Overall Study||9
590938|NCT00490802|1442391|P2|STARTED|Overall Study||9
590939|NCT00490802|1442392|P1|STARTED|Overall Study||10
590940|NCT00490724|1442409|P3|NOT COMPLETED|Period II||3
590941|NCT00490724|1442410|P2|NOT COMPLETED|Period II||1
590942|NCT00490724|1442411|P1|NOT COMPLETED|Period II||3
590943|NCT00490724|1442409|P3|COMPLETED|Period II||16
590944|NCT00490724|1442410|P2|COMPLETED|Period II||19
590945|NCT00490724|1442411|P1|COMPLETED|Period II||18
590946|NCT00490724|1442409|P3|STARTED|Period II||19
590947|NCT00490724|1442410|P2|STARTED|Period II||20
590948|NCT00490724|1442411|P1|STARTED|Period II||21
590949|NCT00490724|1442409|P3|NOT COMPLETED|Period I||1
590950|NCT00490724|1442410|P2|NOT COMPLETED|Period I||0
590951|NCT00490724|1442411|P1|NOT COMPLETED|Period I||0
590952|NCT00490724|1442409|P3|COMPLETED|Period I||19
590953|NCT00490724|1442410|P2|COMPLETED|Period I||20
590954|NCT00490724|1442411|P1|COMPLETED|Period I||21
590955|NCT00490724|1442409|P3|STARTED|Period I||20
590956|NCT00490724|1442410|P2|STARTED|Period I||20
590957|NCT00490724|1442411|P1|STARTED|Period I||21
590958|NCT00490698|1442476|P1|NOT COMPLETED|Overall Study||10
590959|NCT00490698|1442476|P1|COMPLETED|Overall Study||1
590960|NCT00490698|1442476|P1|STARTED|Overall Study||11
590961|NCT00490646|1442482|P2|NOT COMPLETED|Overall Study||2
590962|NCT00490646|1442483|P1|NOT COMPLETED|Overall Study||2
590963|NCT00490646|1442482|P2|COMPLETED|Overall Study|Completed=Off-treatment (Major reasons: Disease progression=13; study drug toxicity=1)|23
590964|NCT00490646|1442483|P1|COMPLETED|Overall Study|Completed=Off-treatment (Major reasons: Disease progression=14; study drug toxicity=4)|23
590965|NCT00490646|1442482|P2|Treated|Overall Study||24
590966|NCT00490646|1442483|P1|Treated|Overall Study||24
590967|NCT00490646|1442482|P2|STARTED|Overall Study||25
590968|NCT00490646|1442483|P1|STARTED|Overall Study||25
590969|NCT00490568|1442503|P1|NOT COMPLETED|Overall Study||1364
590970|NCT00490568|1442503|P1|COMPLETED|Overall Study||97
590971|NCT00490568|1442503|P1|STARTED|Overall Study||1461
590972|NCT00490555|1442527|P4|NOT COMPLETED|Overall Study||0
590973|NCT00490555|1442528|P3|NOT COMPLETED|Overall Study||2
590974|NCT00490555|1442529|P2|NOT COMPLETED|Overall Study||0
590975|NCT00490555|1442530|P1|NOT COMPLETED|Overall Study||0
590976|NCT00490555|1442527|P4|COMPLETED|Overall Study||7
590977|NCT00490555|1442528|P3|COMPLETED|Overall Study||7
590978|NCT00490555|1442529|P2|COMPLETED|Overall Study||8
590979|NCT00490555|1442530|P1|COMPLETED|Overall Study||8
590980|NCT00490555|1442527|P4|STARTED|Overall Study||7
590981|NCT00490555|1442528|P3|STARTED|Overall Study||9
590982|NCT00490555|1442529|P2|STARTED|Overall Study||8
590983|NCT00490555|1442530|P1|STARTED|Overall Study||8
590984|NCT00490542|1442558|P2|NOT COMPLETED|Overall Study||4
590985|NCT00490542|1442559|P1|NOT COMPLETED|Overall Study||7
590986|NCT00490542|1442558|P2|COMPLETED|Overall Study||31
590987|NCT00490542|1442559|P1|COMPLETED|Overall Study||31
590988|NCT00490542|1442558|P2|STARTED|Overall Study||35
590989|NCT00490542|1442559|P1|STARTED|Overall Study||38
590990|NCT00490490|1442565|P1|NOT COMPLETED|Completed Assessment for TTP||3
590991|NCT00490490|1442565|P1|COMPLETED|Completed Assessment for TTP||5
590992|NCT00490490|1442565|P1|STARTED|Completed Assessment for TTP||8
590993|NCT00490490|1442565|P1|NOT COMPLETED|Completed Assessment for CR||0
590994|NCT00490490|1442565|P1|COMPLETED|Completed Assessment for CR||8
590995|NCT00490490|1442565|P1|STARTED|Completed Assessment for CR||8
590996|NCT00490477|1442573|P2|NOT COMPLETED|Overall Study||0
590997|NCT00490477|1442574|P1|NOT COMPLETED|Overall Study||0
590998|NCT00490477|1442573|P2|COMPLETED|Overall Study||8
590999|NCT00490477|1442574|P1|COMPLETED|Overall Study||8
591000|NCT00490477|1442573|P2|STARTED|Overall Study||8
591001|NCT00490477|1442574|P1|STARTED|Overall Study||8
591002|NCT00490451|1442582|P2|NOT COMPLETED|Overall Study||38
591003|NCT00490451|1442583|P1|NOT COMPLETED|Overall Study||63
591004|NCT00490451|1442582|P2|COMPLETED|Overall Study||0
591005|NCT00490451|1442583|P1|COMPLETED|Overall Study||0
591006|NCT00490451|1442582|P2|STARTED|Overall Study||38
591007|NCT00490451|1442583|P1|STARTED|Overall Study||63
591008|NCT00490269|1442605|P2|NOT COMPLETED|Placebo Then Dronabinol||0
591009|NCT00490269|1442606|P1|NOT COMPLETED|Placebo Then Dronabinol||0
591010|NCT00490269|1442605|P2|COMPLETED|Placebo Then Dronabinol||6
591011|NCT00490269|1442606|P1|COMPLETED|Placebo Then Dronabinol||6
591012|NCT00490269|1442605|P2|STARTED|Placebo Then Dronabinol||6
591013|NCT00490269|1442606|P1|STARTED|Placebo Then Dronabinol||6
591014|NCT00490269|1442605|P2|NOT COMPLETED|Dronabinol Then Placebo||0
591015|NCT00490269|1442606|P1|NOT COMPLETED|Dronabinol Then Placebo||0
591016|NCT00490269|1442605|P2|COMPLETED|Dronabinol Then Placebo||6
591017|NCT00490269|1442606|P1|COMPLETED|Dronabinol Then Placebo||6
591018|NCT00490269|1442605|P2|STARTED|Dronabinol Then Placebo||6
591019|NCT00490269|1442606|P1|STARTED|Dronabinol Then Placebo||6
591020|NCT00490256|1442614|P2|NOT COMPLETED|Overall Study||0
591021|NCT00490256|1442615|P1|NOT COMPLETED|Overall Study||0
591022|NCT00490256|1442614|P2|COMPLETED|Overall Study||7
591023|NCT00490256|1442615|P1|COMPLETED|Overall Study||7
591024|NCT00490256|1442614|P2|Intraoperative Portion of the Study|Overall Study|Intraoperative management|7
591025|NCT00490256|1442615|P1|Intraoperative Portion of the Study|Overall Study|Intraoperative management|7
591026|NCT00490256|1442614|P2|STARTED|Overall Study||7
591027|NCT00490256|1442615|P1|STARTED|Overall Study||7
591028|NCT00490139|1442625|P4|NOT COMPLETED|Overall Study||307
591029|NCT00490139|1442626|P3|NOT COMPLETED|Overall Study||434
591030|NCT00490139|1442627|P2|NOT COMPLETED|Overall Study||275
591031|NCT00490139|1442628|P1|NOT COMPLETED|Overall Study||308
591032|NCT00490139|1442625|P4|COMPLETED|Overall Study||1790
591033|NCT00490139|1442626|P3|COMPLETED|Overall Study||1666
591034|NCT00490139|1442627|P2|COMPLETED|Overall Study||1816
591035|NCT00490139|1442628|P1|COMPLETED|Overall Study||1785
591036|NCT00490139|1442625|P4|STARTED|Overall Study||2097
591037|NCT00490139|1442626|P3|STARTED|Overall Study||2100
591038|NCT00490139|1442627|P2|STARTED|Overall Study||2091
591039|NCT00490139|1442628|P1|STARTED|Overall Study||2093
591040|NCT00490100|1442658|P1|NOT COMPLETED|Overall Study||3
591041|NCT00490100|1442658|P1|COMPLETED|Overall Study||3
591042|NCT00490100|1442658|P1|STARTED|Overall Study||6
591043|NCT00490061|1442663|P1|NOT COMPLETED|Overall Study||1
591044|NCT00490061|1442663|P1|COMPLETED|Overall Study||16
591045|NCT00490061|1442663|P1|STARTED|Overall Study||17
591046|NCT00490035|1442672|P4|NOT COMPLETED|Overall Study||6
591047|NCT00490035|1442673|P3|NOT COMPLETED|Overall Study||12
591048|NCT00490035|1442674|P2|NOT COMPLETED|Overall Study||6
591049|NCT00490035|1442675|P1|NOT COMPLETED|Overall Study||8
591050|NCT00490035|1442672|P4|COMPLETED|Overall Study||94
591051|NCT00490035|1442673|P3|COMPLETED|Overall Study||88
591052|NCT00490035|1442674|P2|COMPLETED|Overall Study||93
591053|NCT00490035|1442675|P1|COMPLETED|Overall Study||92
591054|NCT00490035|1442672|P4|STARTED|Overall Study||100
591055|NCT00490035|1442673|P3|STARTED|Overall Study||100
591056|NCT00490035|1442674|P2|STARTED|Overall Study||99
591057|NCT00490035|1442675|P1|STARTED|Overall Study||100
591058|NCT00490022|1442775|P2|NOT COMPLETED|Overall Study||3
591059|NCT00490022|1442776|P1|NOT COMPLETED|Overall Study||1
591060|NCT00490022|1442775|P2|COMPLETED|Overall Study||12
591061|NCT00490022|1442776|P1|COMPLETED|Overall Study||15
591062|NCT00490022|1442775|P2|STARTED|Overall Study||15
591063|NCT00490022|1442776|P1|STARTED|Overall Study||16
591064|NCT00490009|1442784|P1|NOT COMPLETED|Overall Study||0
591065|NCT00490009|1442784|P1|COMPLETED|Overall Study||9
591066|NCT00490009|1442784|P1|STARTED|Overall Study||9
591067|NCT00489970|1442792|P2|NOT COMPLETED|Persistence Year 5||0
591068|NCT00489970|1442793|P1|NOT COMPLETED|Persistence Year 5||0
591069|NCT00489970|1442792|P2|COMPLETED|Persistence Year 5||401
591070|NCT00489970|1442793|P1|COMPLETED|Persistence Year 5||856
591071|NCT00489970|1442792|P2|STARTED|Persistence Year 5|Number of subjects who returned at Year 5|401
591072|NCT00489970|1442793|P1|STARTED|Persistence Year 5|Number of subjects who returned at Year 5|856
591073|NCT00489970|1442792|P2|NOT COMPLETED|Persistence Year 3||0
591074|NCT00489970|1442793|P1|NOT COMPLETED|Persistence Year 3||0
591075|NCT00489970|1442792|P2|COMPLETED|Persistence Year 3||486
591076|NCT00489970|1442793|P1|COMPLETED|Persistence Year 3||1019
591077|NCT00489970|1442792|P2|STARTED|Persistence Year 3|Number of subjects who returned at Year 3|486
591078|NCT00489970|1442793|P1|STARTED|Persistence Year 3|Number of subjects who returned at Year 3|1019
591079|NCT00489970|1442792|P2|NOT COMPLETED|Persistence Year 1||0
591080|NCT00489970|1442793|P1|NOT COMPLETED|Persistence Year 1||0
591081|NCT00489970|1442792|P2|COMPLETED|Persistence Year 1||523
591082|NCT00489970|1442793|P1|COMPLETED|Persistence Year 1||1069
591083|NCT00489970|1442792|P2|STARTED|Persistence Year 1||523
591084|NCT00489970|1442793|P1|STARTED|Persistence Year 1||1069
591085|NCT00489866|1442819|P2|NOT COMPLETED|Overall Study||0
591086|NCT00489866|1442820|P1|NOT COMPLETED|Overall Study||2
591087|NCT00489866|1442819|P2|COMPLETED|Overall Study||7
591088|NCT00489866|1442820|P1|COMPLETED|Overall Study||5
591089|NCT00489866|1442819|P2|STARTED|Overall Study||7
591090|NCT00489866|1442820|P1|STARTED|Overall Study||7
591091|NCT00489853|1442834|P3|NOT COMPLETED|Follow-up Period||0
591092|NCT00489853|1442835|P2|NOT COMPLETED|Follow-up Period||0
591093|NCT00489853|1442836|P1|NOT COMPLETED|Follow-up Period||0
591094|NCT00489853|1442834|P3|COMPLETED|Follow-up Period||33
591095|NCT00489853|1442835|P2|COMPLETED|Follow-up Period||29
591096|NCT00489853|1442836|P1|COMPLETED|Follow-up Period||29
591097|NCT00489853|1442834|P3|STARTED|Follow-up Period||33
591098|NCT00489853|1442835|P2|STARTED|Follow-up Period||29
591099|NCT00489853|1442836|P1|STARTED|Follow-up Period||29
591100|NCT00489853|1442834|P3|NOT COMPLETED|Treatment Period 3||0
591101|NCT00489853|1442835|P2|NOT COMPLETED|Treatment Period 3||1
591102|NCT00489853|1442836|P1|NOT COMPLETED|Treatment Period 3||0
591103|NCT00489853|1442834|P3|COMPLETED|Treatment Period 3||33
591104|NCT00489853|1442835|P2|COMPLETED|Treatment Period 3||29
591105|NCT00489853|1442836|P1|COMPLETED|Treatment Period 3||29
591106|NCT00489853|1442834|P3|STARTED|Treatment Period 3||33
591107|NCT00489853|1442835|P2|STARTED|Treatment Period 3||30
591108|NCT00489853|1442836|P1|STARTED|Treatment Period 3||29
591109|NCT00489853|1442834|P3|NOT COMPLETED|Wash-out Period 2||2
591110|NCT00489853|1442835|P2|NOT COMPLETED|Wash-out Period 2||3
591111|NCT00489853|1442836|P1|NOT COMPLETED|Wash-out Period 2||4
591112|NCT00489853|1442834|P3|COMPLETED|Wash-out Period 2||31
591113|NCT00489853|1442835|P2|COMPLETED|Wash-out Period 2||32
591114|NCT00489853|1442836|P1|COMPLETED|Wash-out Period 2||29
591115|NCT00489853|1442834|P3|STARTED|Wash-out Period 2||33
591116|NCT00489853|1442835|P2|STARTED|Wash-out Period 2||35
591117|NCT00489853|1442836|P1|STARTED|Wash-out Period 2||33
591118|NCT00489853|1442834|P3|NOT COMPLETED|Treatment Period 2||0
591119|NCT00489853|1442835|P2|NOT COMPLETED|Treatment Period 2||0
591120|NCT00489853|1442836|P1|NOT COMPLETED|Treatment Period 2||0
591121|NCT00489853|1442834|P3|COMPLETED|Treatment Period 2||33
591122|NCT00489853|1442835|P2|COMPLETED|Treatment Period 2||35
591123|NCT00489853|1442836|P1|COMPLETED|Treatment Period 2||33
591124|NCT00489853|1442834|P3|STARTED|Treatment Period 2||33
591125|NCT00489853|1442835|P2|STARTED|Treatment Period 2||35
591126|NCT00489853|1442836|P1|STARTED|Treatment Period 2||33
591127|NCT00489853|1442834|P3|NOT COMPLETED|Wash-out Period 1||6
591128|NCT00489853|1442835|P2|NOT COMPLETED|Wash-out Period 1||3
591129|NCT00489853|1442836|P1|NOT COMPLETED|Wash-out Period 1||1
591130|NCT00489853|1442834|P3|COMPLETED|Wash-out Period 1||32
591131|NCT00489853|1442835|P2|COMPLETED|Wash-out Period 1||34
591132|NCT00489853|1442836|P1|COMPLETED|Wash-out Period 1||35
591133|NCT00489853|1442834|P3|STARTED|Wash-out Period 1||38
591134|NCT00489853|1442835|P2|STARTED|Wash-out Period 1||37
591135|NCT00489853|1442836|P1|STARTED|Wash-out Period 1||36
591136|NCT00489853|1442834|P3|NOT COMPLETED|Treatment Period 1||0
591137|NCT00489853|1442835|P2|NOT COMPLETED|Treatment Period 1||0
591138|NCT00489853|1442836|P1|NOT COMPLETED|Treatment Period 1||0
591139|NCT00489853|1442834|P3|COMPLETED|Treatment Period 1||38
591140|NCT00489853|1442835|P2|COMPLETED|Treatment Period 1||37
591141|NCT00489853|1442836|P1|COMPLETED|Treatment Period 1||36
591142|NCT00489853|1442834|P3|STARTED|Treatment Period 1||38
591143|NCT00489853|1442835|P2|STARTED|Treatment Period 1||37
591144|NCT00489853|1442836|P1|STARTED|Treatment Period 1||36
591145|NCT00489736|1442933|P2|NOT COMPLETED|Overall Study||69
591146|NCT00489736|1442934|P1|NOT COMPLETED|Overall Study||96
591147|NCT00489736|1442933|P2|COMPLETED|Overall Study|completed study drug period|186
591148|NCT00489736|1442934|P1|COMPLETED|Overall Study|completed study drug period|153
591149|NCT00489736|1442933|P2|STARTED|Overall Study|Randomized and treated patients|255
591150|NCT00489736|1442934|P1|STARTED|Overall Study|Randomized and treated patients|249
591151|NCT00489554|1442944|P1|NOT COMPLETED|Overall Study||4
591152|NCT00489554|1442944|P1|COMPLETED|Overall Study||226
591153|NCT00489554|1442944|P1|STARTED|Overall Study||230
591154|NCT00489541|1442964|P2|NOT COMPLETED|9-Month Angiographic Follow-up||17
591155|NCT00489541|1442965|P1|NOT COMPLETED|9-Month Angiographic Follow-up||27
591156|NCT00489541|1442964|P2|COMPLETED|9-Month Angiographic Follow-up||108
591157|NCT00489541|1442965|P1|COMPLETED|9-Month Angiographic Follow-up||197
591158|NCT00489541|1442964|P2|STARTED|9-Month Angiographic Follow-up||125
591159|NCT00489541|1442965|P1|STARTED|9-Month Angiographic Follow-up||224
591160|NCT00489541|1442964|P2|NOT COMPLETED|12-Month Clinical Follow-up||5
591161|NCT00489541|1442965|P1|NOT COMPLETED|12-Month Clinical Follow-up||9
591162|NCT00489541|1442964|P2|COMPLETED|12-Month Clinical Follow-up||120
591163|NCT00489541|1442965|P1|COMPLETED|12-Month Clinical Follow-up||215
591164|NCT00489541|1442964|P2|STARTED|12-Month Clinical Follow-up||125
591165|NCT00489541|1442965|P1|STARTED|12-Month Clinical Follow-up||224
591166|NCT00489489|1442976|P3|NOT COMPLETED|Overall Study||3
591167|NCT00489489|1442977|P2|NOT COMPLETED|Overall Study||5
591168|NCT00489489|1442978|P1|NOT COMPLETED|Overall Study||3
591169|NCT00489489|1442976|P3|COMPLETED|Overall Study|completed treatment period|37
591170|NCT00489489|1442977|P2|COMPLETED|Overall Study|completed treatment period|32
591171|NCT00489489|1442978|P1|COMPLETED|Overall Study|completed treatment period|38
591172|NCT00489489|1442976|P3|Treated|Overall Study|One participant received teriflunomide 7 mg instead of teriflunomide 14 mg|39
591173|NCT00489489|1442977|P2|Treated|Overall Study||36
591174|NCT00489489|1442978|P1|Treated|Overall Study||41
591175|NCT00489489|1442976|P3|STARTED|Overall Study|randomized|40
591176|NCT00489489|1442977|P2|STARTED|Overall Study|randomized|37
591177|NCT00489489|1442978|P1|STARTED|Overall Study|randomized|41
591178|NCT00489476|1443010|P4|NOT COMPLETED|Overall Study||0
591179|NCT00489476|1443011|P3|NOT COMPLETED|Overall Study||0
591180|NCT00489476|1443012|P2|NOT COMPLETED|Overall Study||1
591181|NCT00489476|1443013|P1|NOT COMPLETED|Overall Study||0
591182|NCT00489476|1443010|P4|COMPLETED|Overall Study||43
591183|NCT00489476|1443011|P3|COMPLETED|Overall Study||43
591184|NCT00489476|1443012|P2|COMPLETED|Overall Study||42
591185|NCT00489476|1443013|P1|COMPLETED|Overall Study||39
591186|NCT00489476|1443010|P4|STARTED|Overall Study||43
591187|NCT00489476|1443011|P3|STARTED|Overall Study||43
591188|NCT00489476|1443012|P2|STARTED|Overall Study||43
591189|NCT00489476|1443013|P1|STARTED|Overall Study||39
591190|NCT00489424|1443034|P3|NOT COMPLETED|Overall Study||5
591191|NCT00489424|1443035|P2|NOT COMPLETED|Overall Study||5
591192|NCT00489424|1443036|P1|NOT COMPLETED|Overall Study||4
591193|NCT00489424|1443034|P3|COMPLETED|Overall Study||257
591194|NCT00489424|1443035|P2|COMPLETED|Overall Study||259
591195|NCT00489424|1443036|P1|COMPLETED|Overall Study||263
591196|NCT00489424|1443034|P3|STARTED|Overall Study||262
591197|NCT00489424|1443035|P2|STARTED|Overall Study||264
591198|NCT00489424|1443036|P1|STARTED|Overall Study||267
591199|NCT00489411|1443067|P2|NOT COMPLETED|Crossover Treatment Period (Weeks 8-12)||19
591200|NCT00489411|1443068|P1|NOT COMPLETED|Crossover Treatment Period (Weeks 8-12)||18
591201|NCT00489411|1443067|P2|COMPLETED|Crossover Treatment Period (Weeks 8-12)||74
591202|NCT00489411|1443068|P1|COMPLETED|Crossover Treatment Period (Weeks 8-12)||67
591203|NCT00489411|1443067|P2|STARTED|Crossover Treatment Period (Weeks 8-12)||93
591204|NCT00489411|1443068|P1|STARTED|Crossover Treatment Period (Weeks 8-12)||85
591205|NCT00489411|1443067|P2|NOT COMPLETED|Washout Period (Weeks 6-7)||1
591206|NCT00489411|1443068|P1|NOT COMPLETED|Washout Period (Weeks 6-7)||2
591207|NCT00489411|1443067|P2|COMPLETED|Washout Period (Weeks 6-7)||93
591208|NCT00489411|1443068|P1|COMPLETED|Washout Period (Weeks 6-7)||85
591209|NCT00489411|1443067|P2|STARTED|Washout Period (Weeks 6-7)||94
591210|NCT00489411|1443068|P1|STARTED|Washout Period (Weeks 6-7)||87
591211|NCT00489411|1443067|P2|NOT COMPLETED|Initial Treatment Period (Weeks 1-5)||22
591212|NCT00489411|1443068|P1|NOT COMPLETED|Initial Treatment Period (Weeks 1-5)||28
591213|NCT00489411|1443067|P2|COMPLETED|Initial Treatment Period (Weeks 1-5)||94
591214|NCT00489411|1443068|P1|COMPLETED|Initial Treatment Period (Weeks 1-5)||87
591215|NCT00489411|1443067|P2|STARTED|Initial Treatment Period (Weeks 1-5)||116
591216|NCT00489411|1443068|P1|STARTED|Initial Treatment Period (Weeks 1-5)||115
591217|NCT00489359|1443082|P2|NOT COMPLETED|Overall Study||29
591218|NCT00489359|1443083|P1|NOT COMPLETED|Overall Study||7
591219|NCT00489359|1443082|P2|COMPLETED|Overall Study|Received at least 6 cycles of therapy. Not completed implies participant received <6 cycles.|37
591220|NCT00489359|1443083|P1|COMPLETED|Overall Study|Received at least 6 cycles of therapy. Not completed implies participant received <6 cycles.|13
591221|NCT00489359|1443082|P2|STARTED|Overall Study||66
591222|NCT00489359|1443083|P1|STARTED|Overall Study||20
591223|NCT00489268|1443111|P5|NOT COMPLETED|Overall Study||20
591224|NCT00489268|1443112|P4|NOT COMPLETED|Overall Study||0
591225|NCT00489268|1443113|P3|NOT COMPLETED|Overall Study||1
591226|NCT00489268|1443114|P2|NOT COMPLETED|Overall Study||0
591227|NCT00489268|1443115|P1|NOT COMPLETED|Overall Study||0
591228|NCT00489268|1443111|P5|COMPLETED|Overall Study||50
591229|NCT00489268|1443112|P4|COMPLETED|Overall Study||11
591230|NCT00489268|1443113|P3|COMPLETED|Overall Study||9
591231|NCT00489268|1443114|P2|COMPLETED|Overall Study||10
591232|NCT00489268|1443115|P1|COMPLETED|Overall Study||1
591233|NCT00489268|1443111|P5|STARTED|Overall Study||70
591234|NCT00489268|1443112|P4|STARTED|Overall Study||11
591235|NCT00489268|1443113|P3|STARTED|Overall Study||10
591236|NCT00489268|1443114|P2|STARTED|Overall Study||10
591237|NCT00489268|1443115|P1|STARTED|Overall Study||1
591238|NCT00489255|1443144|P2|NOT COMPLETED|Period 3: Days 57 to 84||4
591239|NCT00489255|1443145|P1|NOT COMPLETED|Period 3: Days 57 to 84||4
591240|NCT00489255|1443144|P2|COMPLETED|Period 3: Days 57 to 84|Re-randomized participants is 27.Sample sizes differed due to withdrawal&re-randomization design.|78
591241|NCT00489255|1443145|P1|COMPLETED|Period 3: Days 57 to 84||24
591242|NCT00489255|1443144|P2|STARTED|Period 3: Days 57 to 84|Re-randomized participants is 30.Sample sizes differed due to withdrawal&re-randomization design.|82
591243|NCT00489255|1443145|P1|STARTED|Period 3: Days 57 to 84||28
591244|NCT00489255|1443144|P2|NOT COMPLETED|Period 2: Days 29 to 56||4
591245|NCT00489255|1443145|P1|NOT COMPLETED|Period 2: Days 29 to 56||3
591246|NCT00489255|1443144|P2|COMPLETED|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|55
591247|NCT00489255|1443145|P1|COMPLETED|Period 2: Days 29 to 56||61
591248|NCT00489255|1443144|P2|Completed But Discontinued Study|Period 2: Days 29 to 56|Re-randomized participants is 2.Sample sizes differed due to withdrawal&re-randomization design.|3
591249|NCT00489255|1443145|P1|Completed But Discontinued Study|Period 2: Days 29 to 56||3
591250|NCT00489255|1443144|P2|Completed and Follow Period 3|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|52
591251|NCT00489255|1443145|P1|Completed and Follow Period 3|Period 2: Days 29 to 56||58
591252|NCT00489255|1443144|P2|STARTED|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|59
591253|NCT00489255|1443145|P1|STARTED|Period 2: Days 29 to 56||64
591254|NCT00489255|1443144|P2|NOT COMPLETED|Period 1: Days 1 to 28||12
591255|NCT00489255|1443145|P1|NOT COMPLETED|Period 1: Days 1 to 28||29
591256|NCT00489255|1443144|P2|COMPLETED|Period 1: Days 1 to 28||34
591257|NCT00489255|1443145|P1|COMPLETED|Period 1: Days 1 to 28||107
591258|NCT00489255|1443144|P2|Completed But Discontinued Study|Period 1: Days 1 to 28||5
591259|NCT00489255|1443145|P1|Completed But Discontinued Study|Period 1: Days 1 to 28||13
591260|NCT00489255|1443144|P2|Completed and Follow Period 2|Period 1: Days 1 to 28||29
591261|NCT00489255|1443145|P1|Completed and Follow Period 2|Period 1: Days 1 to 28||94
591262|NCT00489255|1443144|P2|STARTED|Period 1: Days 1 to 28||46
591263|NCT00489255|1443145|P1|STARTED|Period 1: Days 1 to 28||136
591264|NCT00489255|1443144|P2|NOT COMPLETED|Screening and Initial Randomization||3
591265|NCT00489255|1443145|P1|NOT COMPLETED|Screening and Initial Randomization||9
591266|NCT00489255|1443144|P2|COMPLETED|Screening and Initial Randomization||46
591267|NCT00489255|1443145|P1|COMPLETED|Screening and Initial Randomization||136
591268|NCT00489255|1443144|P2|STARTED|Screening and Initial Randomization|Total randomized subjects to receive placebo|49
591269|NCT00489255|1443145|P1|STARTED|Screening and Initial Randomization|Total randomized subjects to receive Tigan|145
591270|NCT00489216|1443193|P1|NOT COMPLETED|Overall Study||1
591271|NCT00489216|1443193|P1|COMPLETED|Overall Study||1
591272|NCT00489216|1443193|P1|STARTED|Overall Study||2
591273|NCT00489086|1443202|P1|NOT COMPLETED|Overall Study||23
591274|NCT00489086|1443202|P1|COMPLETED|Overall Study|23 subjects completed 18 months|13
591275|NCT00489086|1443202|P1|STARTED|Overall Study||36
591276|NCT00488865|1443206|P1|NOT COMPLETED|Overall Study||0
591277|NCT00488865|1443206|P1|COMPLETED|Overall Study||100
591278|NCT00488865|1443206|P1|STARTED|Overall Study||100
591279|NCT00488826|1443215|P3|NOT COMPLETED|Overall Study||26
591280|NCT00488826|1443216|P2|NOT COMPLETED|Overall Study||52
591281|NCT00488826|1443217|P1|NOT COMPLETED|Overall Study||56
591282|NCT00488826|1443215|P3|COMPLETED|Overall Study||178
591283|NCT00488826|1443216|P2|COMPLETED|Overall Study||244
591284|NCT00488826|1443217|P1|COMPLETED|Overall Study||244
591285|NCT00488826|1443215|P3|STARTED|Overall Study||204
591286|NCT00488826|1443216|P2|STARTED|Overall Study||296
591287|NCT00488826|1443217|P1|STARTED|Overall Study||300
591288|NCT00488774|1443232|P4|NOT COMPLETED|Overall Study||3
591289|NCT00488774|1443233|P3|NOT COMPLETED|Overall Study||5
591290|NCT00488774|1443234|P2|NOT COMPLETED|Overall Study||5
591291|NCT00488774|1443235|P1|NOT COMPLETED|Overall Study||8
591292|NCT00488774|1443232|P4|COMPLETED|Overall Study||74
591293|NCT00488774|1443233|P3|COMPLETED|Overall Study||70
591294|NCT00488774|1443234|P2|COMPLETED|Overall Study||57
591295|NCT00488774|1443235|P1|COMPLETED|Overall Study||69
591296|NCT00488774|1443232|P4|STARTED|Overall Study||77
591297|NCT00488774|1443233|P3|STARTED|Overall Study||75
591298|NCT00488774|1443234|P2|STARTED|Overall Study||62
591299|NCT00488774|1443235|P1|STARTED|Overall Study||77
591300|NCT00488683|1443252|P3|NOT COMPLETED|Overall Study||2
591301|NCT00488683|1443253|P2|NOT COMPLETED|Overall Study||6
591302|NCT00488683|1443254|P1|NOT COMPLETED|Overall Study||12
591303|NCT00488683|1443252|P3|COMPLETED|Overall Study||52
591304|NCT00488683|1443253|P2|COMPLETED|Overall Study||48
591305|NCT00488683|1443254|P1|COMPLETED|Overall Study||96
591306|NCT00488683|1443252|P3|STARTED|Overall Study||54
591307|NCT00488683|1443253|P2|STARTED|Overall Study||54
591308|NCT00488683|1443254|P1|STARTED|Overall Study||108
591309|NCT00488644|1443313|P1|NOT COMPLETED|Overall Study||2
591310|NCT00488644|1443313|P1|COMPLETED|Overall Study||10
591311|NCT00488644|1443313|P1|STARTED|Overall Study||12
591312|NCT00488631|1443323|P10|NOT COMPLETED|Open Label Study Extension (Week 54-228)||3
591313|NCT00488631|1443324|P9|NOT COMPLETED|Open Label Study Extension (Week 54-228)||182
591314|NCT00488631|1443325|P8|NOT COMPLETED|Open Label Study Extension (Week 54-228)||27
591315|NCT00488631|1443326|P7|NOT COMPLETED|Open Label Study Extension (Week 54-228)||80
591316|NCT00488631|1443327|P6|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
591317|NCT00488631|1443328|P5|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
591318|NCT00488631|1443329|P4|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
591319|NCT00488631|1443330|P3|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
591320|NCT00488631|1443331|P2|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
591321|NCT00488631|1443332|P1|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
591322|NCT00488631|1443323|P10|COMPLETED|Open Label Study Extension (Week 54-228)||4
591323|NCT00488631|1443324|P9|COMPLETED|Open Label Study Extension (Week 54-228)||288
591324|NCT00488631|1443325|P8|COMPLETED|Open Label Study Extension (Week 54-228)||66
591325|NCT00488631|1443326|P7|COMPLETED|Open Label Study Extension (Week 54-228)||16
591326|NCT00488631|1443327|P6|COMPLETED|Open Label Study Extension (Week 54-228)||0
591327|NCT00488631|1443328|P5|COMPLETED|Open Label Study Extension (Week 54-228)||0
591328|NCT00488631|1443329|P4|COMPLETED|Open Label Study Extension (Week 54-228)||0
591329|NCT00488631|1443330|P3|COMPLETED|Open Label Study Extension (Week 54-228)||0
591330|NCT00488631|1443331|P2|COMPLETED|Open Label Study Extension (Week 54-228)||0
591331|NCT00488631|1443332|P1|COMPLETED|Open Label Study Extension (Week 54-228)||0
591332|NCT00488631|1443323|P10|STARTED|Open Label Study Extension (Week 54-228)||7
591333|NCT00488631|1443324|P9|STARTED|Open Label Study Extension (Week 54-228)||470
591334|NCT00488631|1443325|P8|STARTED|Open Label Study Extension (Week 54-228)||93
591335|NCT00488631|1443326|P7|STARTED|Open Label Study Extension (Week 54-228)||96
591336|NCT00488631|1443327|P6|STARTED|Open Label Study Extension (Week 54-228)||0
591337|NCT00488631|1443328|P5|STARTED|Open Label Study Extension (Week 54-228)||0
591338|NCT00488631|1443329|P4|STARTED|Open Label Study Extension (Week 54-228)||0
591339|NCT00488631|1443330|P3|STARTED|Open Label Study Extension (Week 54-228)||0
591340|NCT00488631|1443331|P2|STARTED|Open Label Study Extension (Week 54-228)||0
591341|NCT00488631|1443332|P1|STARTED|Open Label Study Extension (Week 54-228)||0
591342|NCT00488631|1443323|P10|NOT COMPLETED|Double Blind Period (Week 0-54)||0
591343|NCT00488631|1443324|P9|NOT COMPLETED|Double Blind Period (Week 0-54)||0
591344|NCT00488631|1443325|P8|NOT COMPLETED|Double Blind Period (Week 0-54)||0
591345|NCT00488631|1443326|P7|NOT COMPLETED|Double Blind Period (Week 0-54)||0
591346|NCT00488631|1443327|P6|NOT COMPLETED|Double Blind Period (Week 0-54)||216
591347|NCT00488631|1443328|P5|NOT COMPLETED|Double Blind Period (Week 0-54)||103
591348|NCT00488631|1443329|P4|NOT COMPLETED|Double Blind Period (Week 0-54)||41
591349|NCT00488631|1443330|P3|NOT COMPLETED|Double Blind Period (Week 0-54)||45
591350|NCT00488631|1443331|P2|NOT COMPLETED|Double Blind Period (Week 0-54)||43
591351|NCT00488631|1443332|P1|NOT COMPLETED|Double Blind Period (Week 0-54)||43
591352|NCT00488631|1443323|P10|COMPLETED|Double Blind Period (Week 0-54)||0
591353|NCT00488631|1443324|P9|COMPLETED|Double Blind Period (Week 0-54)||0
591354|NCT00488631|1443325|P8|COMPLETED|Double Blind Period (Week 0-54)||0
591355|NCT00488631|1443326|P7|COMPLETED|Double Blind Period (Week 0-54)||0
591356|NCT00488631|1443327|P6|COMPLETED|Double Blind Period (Week 0-54)||189
591357|NCT00488631|1443328|P5|COMPLETED|Double Blind Period (Week 0-54)||127
591358|NCT00488631|1443329|P4|COMPLETED|Double Blind Period (Week 0-54)||88
591359|NCT00488631|1443330|P3|COMPLETED|Double Blind Period (Week 0-54)||109
591360|NCT00488631|1443331|P2|COMPLETED|Double Blind Period (Week 0-54)||111
591361|NCT00488631|1443332|P1|COMPLETED|Double Blind Period (Week 0-54)||113
591362|NCT00488631|1443323|P10|STARTED|Double Blind Period (Week 0-54)||0
591363|NCT00488631|1443324|P9|STARTED|Double Blind Period (Week 0-54)||0
591364|NCT00488631|1443325|P8|STARTED|Double Blind Period (Week 0-54)||0
591365|NCT00488631|1443326|P7|STARTED|Double Blind Period (Week 0-54)||0
591366|NCT00488631|1443327|P6|STARTED|Double Blind Period (Week 0-54)||405
591367|NCT00488631|1443328|P5|STARTED|Double Blind Period (Week 0-54)||230
591368|NCT00488631|1443329|P4|STARTED|Double Blind Period (Week 0-54)||129
591369|NCT00488631|1443330|P3|STARTED|Double Blind Period (Week 0-54)||154
591370|NCT00488631|1443331|P2|STARTED|Double Blind Period (Week 0-54)||154
591371|NCT00488631|1443332|P1|STARTED|Double Blind Period (Week 0-54)||156
591372|NCT00488618|1443369|P2|NOT COMPLETED|Overall Study||43
591373|NCT00488618|1443370|P1|NOT COMPLETED|Overall Study||47
591374|NCT00488618|1443369|P2|COMPLETED|Overall Study||75
591375|NCT00488618|1443370|P1|COMPLETED|Overall Study||73
591376|NCT00488618|1443369|P2|Safety Population: Received Study Drug|Overall Study||118
591377|NCT00488618|1443370|P1|Safety Population: Received Study Drug|Overall Study||118
591378|NCT00488618|1443369|P2|STARTED|Overall Study||118
591379|NCT00488618|1443370|P1|STARTED|Overall Study||120
591380|NCT00488592|1443378|P1|NOT COMPLETED|Overall Study||3
591381|NCT00488592|1443378|P1|COMPLETED|Overall Study|7 completed the initial series of 6 vaccinations|7
591382|NCT00488592|1443378|P1|STARTED|Overall Study|10 subjects were accrued|10
591383|NCT00488514|1443382|P1|NOT COMPLETED|Overall Study||293
591384|NCT00488514|1443382|P1|COMPLETED|Overall Study||363
591385|NCT00488514|1443382|P1|STARTED|Overall Study||656
591386|NCT00488488|1443455|P1|NOT COMPLETED|Overall Study||268
591387|NCT00488488|1443455|P1|COMPLETED|Overall Study|Excludes 4 participants with missing information.|760
591388|NCT00488488|1443455|P1|Analyzed|Overall Study|3 participants were not analyzed due to retrospective documentation.|1025
591389|NCT00488488|1443455|P1|STARTED|Overall Study||1028
591390|NCT00488475|1443470|P1|NOT COMPLETED|Overall Study||1754
591391|NCT00488475|1443470|P1|COMPLETED|Overall Study||3191
591392|NCT00488475|1443470|P1|STARTED|Overall Study||4945
591393|NCT00488345|1443499|P3|NOT COMPLETED|Overall Study||3
591394|NCT00488345|1443500|P2|NOT COMPLETED|Overall Study||4
591395|NCT00488345|1443501|P1|NOT COMPLETED|Overall Study||0
591396|NCT00488345|1443499|P3|COMPLETED|Overall Study||17
591397|NCT00488345|1443500|P2|COMPLETED|Overall Study||17
591398|NCT00488345|1443501|P1|COMPLETED|Overall Study||17
591399|NCT00488345|1443499|P3|STARTED|Overall Study||20
591400|NCT00488345|1443500|P2|STARTED|Overall Study||21
591401|NCT00488345|1443501|P1|STARTED|Overall Study||17
591402|NCT00488319|1443527|P3|NOT COMPLETED|Overall Study||122
591403|NCT00488319|1443528|P2|NOT COMPLETED|Overall Study||43
591404|NCT00488319|1443529|P1|NOT COMPLETED|Overall Study||15
591405|NCT00488319|1443527|P3|COMPLETED|Overall Study||121
591406|NCT00488319|1443528|P2|COMPLETED|Overall Study||75
591407|NCT00488319|1443529|P1|COMPLETED|Overall Study||24
591408|NCT00488319|1443527|P3|STARTED|Overall Study||243
591409|NCT00488319|1443528|P2|STARTED|Overall Study||118
591410|NCT00488319|1443529|P1|STARTED|Overall Study||39
591411|NCT00488293|1443616|P2|NOT COMPLETED|Overall Study||30
591412|NCT00488293|1443617|P1|NOT COMPLETED|Overall Study||36
591413|NCT00488293|1443616|P2|COMPLETED|Overall Study||166
591414|NCT00488293|1443617|P1|COMPLETED|Overall Study||160
591415|NCT00488293|1443616|P2|STARTED|Overall Study||196
591416|NCT00488293|1443617|P1|STARTED|Overall Study||196
591417|NCT00488059|1443641|P3|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||4
591418|NCT00488059|1443642|P2|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
591419|NCT00488059|1443643|P1|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
591420|NCT00488059|1443641|P3|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||1
591421|NCT00488059|1443642|P2|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
591422|NCT00488059|1443643|P1|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
591423|NCT00488059|1443641|P3|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||5
591424|NCT00488059|1443642|P2|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0
591425|NCT00488059|1443643|P1|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0
591426|NCT00488059|1443641|P3|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
591427|NCT00488059|1443642|P2|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||2
591428|NCT00488059|1443643|P1|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
591429|NCT00488059|1443641|P3|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
591430|NCT00488059|1443642|P2|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||7
591431|NCT00488059|1443643|P1|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
591432|NCT00488059|1443641|P3|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0
591433|NCT00488059|1443642|P2|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||9
591434|NCT00488059|1443643|P1|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0
591435|NCT00488059|1443641|P3|NOT COMPLETED|Phase I: ENF 90mg SC BID||0
591436|NCT00488059|1443642|P2|NOT COMPLETED|Phase I: ENF 90mg SC BID||0
591437|NCT00488059|1443643|P1|NOT COMPLETED|Phase I: ENF 90mg SC BID||15
591438|NCT00488059|1443641|P3|COMPLETED|Phase I: ENF 90mg SC BID||0
591439|NCT00488059|1443642|P2|COMPLETED|Phase I: ENF 90mg SC BID||0
591440|NCT00488059|1443643|P1|COMPLETED|Phase I: ENF 90mg SC BID||14
591441|NCT00488059|1443641|P3|STARTED|Phase I: ENF 90mg SC BID||0
591442|NCT00488059|1443642|P2|STARTED|Phase I: ENF 90mg SC BID||0
591443|NCT00488059|1443643|P1|STARTED|Phase I: ENF 90mg SC BID||29
591444|NCT00488033|1443662|P2|NOT COMPLETED|Overall Study||0
591445|NCT00488033|1443663|P1|NOT COMPLETED|Overall Study||1
591446|NCT00488033|1443662|P2|COMPLETED|Overall Study||452
591447|NCT00488033|1443663|P1|COMPLETED|Overall Study||447
591448|NCT00488033|1443662|P2|STARTED|Overall Study||452
591449|NCT00488033|1443663|P1|STARTED|Overall Study||448
591450|NCT00487981|1443679|P1|NOT COMPLETED|Overall Study||1
591451|NCT00487981|1443679|P1|COMPLETED|Overall Study||0
591452|NCT00487981|1443679|P1|STARTED|Overall Study||1
591453|NCT00487942|1443687|P4|NOT COMPLETED|Overall Study||2
591454|NCT00487942|1443688|P3|NOT COMPLETED|Overall Study||3
591455|NCT00487942|1443689|P2|NOT COMPLETED|Overall Study||3
591456|NCT00487942|1443690|P1|NOT COMPLETED|Overall Study||3
591457|NCT00487942|1443687|P4|COMPLETED|Overall Study||13
591458|NCT00487942|1443688|P3|COMPLETED|Overall Study||12
591459|NCT00487942|1443689|P2|COMPLETED|Overall Study||12
591460|NCT00487942|1443690|P1|COMPLETED|Overall Study||12
591461|NCT00487942|1443687|P4|STARTED|Overall Study|One subject randomized to placebo discontinued prior to receiving any study drug, leaving 14.|15
591462|NCT00487942|1443688|P3|STARTED|Overall Study||15
591463|NCT00487942|1443689|P2|STARTED|Overall Study||15
591464|NCT00487942|1443690|P1|STARTED|Overall Study||15
591465|NCT00487825|1444074|P2|NOT COMPLETED|Overall Study||5
591466|NCT00487825|1444075|P1|NOT COMPLETED|Overall Study||6
591467|NCT00487825|1444074|P2|COMPLETED|Overall Study||21
591468|NCT00487825|1444075|P1|COMPLETED|Overall Study||46
591469|NCT00487825|1444074|P2|STARTED|Overall Study||26
591470|NCT00487825|1444075|P1|STARTED|Overall Study|"Started indicates Intent-to-treat population (ITT)"|52
591471|NCT00487747|1444087|P1|NOT COMPLETED|Overall Study||11
591472|NCT00487747|1444087|P1|COMPLETED|Overall Study||7
591473|NCT00487747|1444087|P1|STARTED|Overall Study||18
591474|NCT00487721|1444098|P2|NOT COMPLETED|Overall Study||0
591475|NCT00487721|1444099|P1|NOT COMPLETED|Overall Study||0
591476|NCT00487721|1444098|P2|COMPLETED|Overall Study||6
591477|NCT00487721|1444099|P1|COMPLETED|Overall Study||6
591478|NCT00487721|1444098|P2|STARTED|Overall Study||6
591479|NCT00487721|1444099|P1|STARTED|Overall Study||6
591480|NCT00487695|1444104|P2|NOT COMPLETED|Second Procedure||3
591481|NCT00487695|1444105|P1|NOT COMPLETED|Second Procedure||1
591482|NCT00487695|1444104|P2|COMPLETED|Second Procedure||20
591483|NCT00487695|1444105|P1|COMPLETED|Second Procedure||19
591484|NCT00487695|1444104|P2|STARTED|Second Procedure||23
591485|NCT00487695|1444105|P1|STARTED|Second Procedure||20
591486|NCT00487695|1444104|P2|NOT COMPLETED|First Procedure||0
591487|NCT00487695|1444105|P1|NOT COMPLETED|First Procedure||3
591488|NCT00487695|1444104|P2|COMPLETED|First Procedure||23
591489|NCT00487695|1444105|P1|COMPLETED|First Procedure||20
591490|NCT00487695|1444104|P2|STARTED|First Procedure||23
591491|NCT00487695|1444105|P1|STARTED|First Procedure||23
591492|NCT00487669|1444121|P1|NOT COMPLETED|Overall Study||0
591493|NCT00487669|1444121|P1|COMPLETED|Overall Study||12
591494|NCT00487669|1444121|P1|STARTED|Overall Study||12
591495|NCT00487578|1444133|P2|NOT COMPLETED|Overall Study||4
591496|NCT00487578|1444134|P1|NOT COMPLETED|Overall Study||1
591497|NCT00487578|1444133|P2|COMPLETED|Overall Study||5
591498|NCT00487578|1444134|P1|COMPLETED|Overall Study||2
591499|NCT00487578|1444133|P2|STARTED|Overall Study||9
591500|NCT00487578|1444134|P1|STARTED|Overall Study||3
591501|NCT00487565|1444150|P1|NOT COMPLETED|Overall Study||28
591502|NCT00487565|1444150|P1|COMPLETED|Overall Study||182
591503|NCT00487565|1444150|P1|STARTED|Overall Study||210
591504|NCT00487552|1444154|P1|NOT COMPLETED|Overall Study||6
591505|NCT00487552|1444154|P1|COMPLETED|Overall Study||12
591506|NCT00487552|1444154|P1|STARTED|Overall Study||18
591507|NCT00487539|1444163|P4|NOT COMPLETED|Overall Study||4
591508|NCT00487539|1444164|P3|NOT COMPLETED|Overall Study||3
591509|NCT00487539|1444165|P2|NOT COMPLETED|Overall Study||3
591510|NCT00487539|1444166|P1|NOT COMPLETED|Overall Study||7
591511|NCT00487539|1444163|P4|COMPLETED|Overall Study||327
591512|NCT00487539|1444164|P3|COMPLETED|Overall Study||328
591513|NCT00487539|1444165|P2|COMPLETED|Overall Study||69
591514|NCT00487539|1444166|P1|COMPLETED|Overall Study||324
591515|NCT00487539|1444163|P4|STARTED|Overall Study||331
591516|NCT00487539|1444164|P3|STARTED|Overall Study||331
591517|NCT00487539|1444165|P2|STARTED|Overall Study||72
591518|NCT00487539|1444166|P1|STARTED|Overall Study||331
591519|NCT00487461|1444187|P3|NOT COMPLETED|Overall Study||4
591520|NCT00487461|1444188|P2|NOT COMPLETED|Overall Study||2
591521|NCT00487461|1444189|P1|NOT COMPLETED|Overall Study||0
591522|NCT00487461|1444187|P3|COMPLETED|Overall Study||7
591523|NCT00487461|1444188|P2|COMPLETED|Overall Study||10
591524|NCT00487461|1444189|P1|COMPLETED|Overall Study||2
591525|NCT00487461|1444187|P3|STARTED|Overall Study||11
591526|NCT00487461|1444188|P2|STARTED|Overall Study||12
591527|NCT00487461|1444189|P1|STARTED|Overall Study||2
591528|NCT00487435|1444200|P1|NOT COMPLETED|Overall Study||485
591529|NCT00487435|1444200|P1|COMPLETED|Overall Study||669
591530|NCT00487435|1444200|P1|STARTED|Overall Study|Patients who received at least one dose of Tapentadol (CG5503) Extended Release (ER)|1154
591531|NCT00487396|1444205|P1|NOT COMPLETED|Overall Study||3
591532|NCT00487396|1444205|P1|COMPLETED|Overall Study||95
591533|NCT00487396|1444205|P1|STARTED|Overall Study||98
591534|NCT00487279|1444213|P2|NOT COMPLETED|Overall Study||2
591535|NCT00487279|1444214|P1|NOT COMPLETED|Overall Study||1
591536|NCT00487279|1444213|P2|COMPLETED|Overall Study||35
591537|NCT00487279|1444214|P1|COMPLETED|Overall Study||43
591538|NCT00487279|1444213|P2|STARTED|Overall Study||37
591539|NCT00487279|1444214|P1|STARTED|Overall Study||44
591540|NCT00487240|1444224|P2|NOT COMPLETED|Overall Study||26
591541|NCT00487240|1444225|P1|NOT COMPLETED|Overall Study||31
591542|NCT00487240|1444224|P2|COMPLETED|Overall Study||166
591543|NCT00487240|1444225|P1|COMPLETED|Overall Study||164
591544|NCT00487240|1444224|P2|Full Analysis Set (ITT Population)|Overall Study||189
591545|NCT00487240|1444225|P1|Full Analysis Set (ITT Population)|Overall Study||192
591546|NCT00487240|1444224|P2|STARTED|Overall Study||192
591547|NCT00487240|1444225|P1|STARTED|Overall Study||195
591548|NCT00487188|1444253|P3|NOT COMPLETED|Maintenance Phase||1
591549|NCT00487188|1444254|P2|NOT COMPLETED|Maintenance Phase||0
591550|NCT00487188|1444255|P1|NOT COMPLETED|Maintenance Phase||3
591551|NCT00487188|1444253|P3|COMPLETED|Maintenance Phase||8
591552|NCT00487188|1444254|P2|COMPLETED|Maintenance Phase||8
591553|NCT00487188|1444255|P1|COMPLETED|Maintenance Phase||7
591554|NCT00487188|1444253|P3|STARTED|Maintenance Phase||9
591555|NCT00487188|1444254|P2|STARTED|Maintenance Phase||8
591556|NCT00487188|1444255|P1|STARTED|Maintenance Phase||10
591557|NCT00487188|1444253|P3|NOT COMPLETED|Induction Phase||0
591558|NCT00487188|1444254|P2|NOT COMPLETED|Induction Phase||7
591559|NCT00487188|1444255|P1|NOT COMPLETED|Induction Phase||9
591560|NCT00487188|1444253|P3|COMPLETED|Induction Phase||0
591561|NCT00487188|1444254|P2|COMPLETED|Induction Phase||9
591562|NCT00487188|1444255|P1|COMPLETED|Induction Phase||22
591563|NCT00487188|1444253|P3|Safety Population|Induction Phase||0
591564|NCT00487188|1444254|P2|Safety Population|Induction Phase|2 patients randomized to ENF + HARRT only received treatment with HAART|18
591565|NCT00487188|1444255|P1|Safety Population|Induction Phase||29
591566|NCT00487188|1444253|P3|STARTED|Induction Phase|Participants were only randomized to this treatment arm in the Maintenance Phase|0
591567|NCT00487188|1444254|P2|STARTED|Induction Phase||16
591568|NCT00487188|1444255|P1|STARTED|Induction Phase||31
591569|NCT00487162|1444294|P2|NOT COMPLETED|Overall Study||5
591570|NCT00487162|1444295|P1|NOT COMPLETED|Overall Study||2
591571|NCT00487162|1444294|P2|COMPLETED|Overall Study||21
591572|NCT00487162|1444295|P1|COMPLETED|Overall Study||28
591573|NCT00487162|1444294|P2|STARTED|Overall Study||26
591574|NCT00487162|1444295|P1|STARTED|Overall Study||30
591575|NCT00487084|1444306|P3|NOT COMPLETED|Overall Study||5
591576|NCT00487084|1444307|P2|NOT COMPLETED|Overall Study||3
591577|NCT00487084|1444308|P1|NOT COMPLETED|Overall Study||4
591578|NCT00487084|1444306|P3|COMPLETED|Overall Study||28
591579|NCT00487084|1444307|P2|COMPLETED|Overall Study||30
591580|NCT00487084|1444308|P1|COMPLETED|Overall Study||29
591581|NCT00487084|1444306|P3|STARTED|Overall Study||33
591582|NCT00487084|1444307|P2|STARTED|Overall Study||33
591583|NCT00487084|1444308|P1|STARTED|Overall Study||33
591584|NCT00486954|1444329|P5|NOT COMPLETED|Randomized Part||14
591585|NCT00486954|1444330|P4|NOT COMPLETED|Randomized Part||20
591586|NCT00486954|1444331|P3|NOT COMPLETED|Randomized Part||0
591587|NCT00486954|1444332|P2|NOT COMPLETED|Randomized Part||0
591588|NCT00486954|1444333|P1|NOT COMPLETED|Randomized Part||0
591589|NCT00486954|1444329|P5|COMPLETED|Randomized Part||115
591590|NCT00486954|1444330|P4|COMPLETED|Randomized Part||112
591591|NCT00486954|1444331|P3|COMPLETED|Randomized Part||0
591592|NCT00486954|1444332|P2|COMPLETED|Randomized Part||0
591593|NCT00486954|1444333|P1|COMPLETED|Randomized Part||0
591594|NCT00486954|1444329|P5|STARTED|Randomized Part||129
591595|NCT00486954|1444330|P4|STARTED|Randomized Part||132
591596|NCT00486954|1444331|P3|STARTED|Randomized Part||0
591597|NCT00486954|1444332|P2|STARTED|Randomized Part||0
591598|NCT00486954|1444333|P1|STARTED|Randomized Part||0
591599|NCT00486954|1444329|P5|NOT COMPLETED|Pilot Part||0
591600|NCT00486954|1444330|P4|NOT COMPLETED|Pilot Part||0
591601|NCT00486954|1444331|P3|NOT COMPLETED|Pilot Part||6
591602|NCT00486954|1444332|P2|NOT COMPLETED|Pilot Part||0
591603|NCT00486954|1444333|P1|NOT COMPLETED|Pilot Part||6
591604|NCT00486954|1444329|P5|COMPLETED|Pilot Part||0
591605|NCT00486954|1444330|P4|COMPLETED|Pilot Part||0
591606|NCT00486954|1444331|P3|COMPLETED|Pilot Part||0
591607|NCT00486954|1444332|P2|COMPLETED|Pilot Part||0
591608|NCT00486954|1444333|P1|COMPLETED|Pilot Part||0
591609|NCT00486954|1444329|P5|STARTED|Pilot Part||0
591610|NCT00486954|1444330|P4|STARTED|Pilot Part||0
591611|NCT00486954|1444331|P3|STARTED|Pilot Part||6
591612|NCT00486954|1444332|P2|STARTED|Pilot Part||0
591613|NCT00486954|1444333|P1|STARTED|Pilot Part||6
591614|NCT00486902|1444431|P2|NOT COMPLETED|Overall Study||5
591615|NCT00486902|1444432|P1|NOT COMPLETED|Overall Study||9
591616|NCT00486902|1444431|P2|COMPLETED|Overall Study||89
591617|NCT00486902|1444432|P1|COMPLETED|Overall Study||85
591618|NCT00486902|1444431|P2|STARTED|Overall Study||94
591619|NCT00486902|1444432|P1|STARTED|Overall Study||94
591620|NCT00486863|1444454|P2|NOT COMPLETED|Overall Study||3
591621|NCT00486863|1444455|P1|NOT COMPLETED|Overall Study||1
591622|NCT00486863|1444454|P2|COMPLETED|Overall Study||183
591623|NCT00486863|1444455|P1|COMPLETED|Overall Study||183
591624|NCT00486863|1444454|P2|STARTED|Overall Study||186
591625|NCT00486863|1444455|P1|STARTED|Overall Study||184
591626|NCT00486837|1444499|P2|NOT COMPLETED|Overall Study||7
591627|NCT00486837|1444500|P1|NOT COMPLETED|Overall Study||9
591628|NCT00486837|1444499|P2|COMPLETED|Overall Study||28
591629|NCT00486837|1444500|P1|COMPLETED|Overall Study||28
591630|NCT00486837|1444499|P2|STARTED|Overall Study||35
591631|NCT00486837|1444500|P1|STARTED|Overall Study||37
591632|NCT00486811|1444519|P3|NOT COMPLETED|Overall Study||214
591633|NCT00486811|1444520|P2|NOT COMPLETED|Overall Study||141
591634|NCT00486811|1444521|P1|NOT COMPLETED|Overall Study||122
591635|NCT00486811|1444519|P3|COMPLETED|Overall Study||119
591636|NCT00486811|1444520|P2|COMPLETED|Overall Study||179
591637|NCT00486811|1444521|P1|COMPLETED|Overall Study||215
591638|NCT00486811|1444519|P3|STARTED|Overall Study|Two participants were not eligible to be dosed.|333
591639|NCT00486811|1444520|P2|STARTED|Overall Study|One participant was not eligible to be dosed.|320
591640|NCT00486811|1444521|P1|STARTED|Overall Study||337
591641|NCT00486759|1444564|P2|NOT COMPLETED|Safety Follow-up||118
591642|NCT00486759|1444565|P1|NOT COMPLETED|Safety Follow-up||139
591643|NCT00486759|1444564|P2|COMPLETED|Safety Follow-up||142
591644|NCT00486759|1444565|P1|COMPLETED|Safety Follow-up||64
591645|NCT00486759|1444564|P2|STARTED|Safety Follow-up||260
591646|NCT00486759|1444565|P1|STARTED|Safety Follow-up||203
591647|NCT00486759|1444564|P2|NOT COMPLETED|Treatment||137
591648|NCT00486759|1444565|P1|NOT COMPLETED|Treatment||187
591649|NCT00486759|1444564|P2|COMPLETED|Treatment||260
591650|NCT00486759|1444565|P1|COMPLETED|Treatment||203
591651|NCT00486759|1444564|P2|STARTED|Treatment||397
591652|NCT00486759|1444565|P1|STARTED|Treatment||390
591653|NCT00486720|1444577|P2|NOT COMPLETED|Overall Study||12
591654|NCT00486720|1444578|P1|NOT COMPLETED|Overall Study||10
591655|NCT00486720|1444577|P2|COMPLETED|Overall Study||0
591656|NCT00486720|1444578|P1|COMPLETED|Overall Study||0
591657|NCT00486720|1444577|P2|STARTED|Overall Study||12
591658|NCT00486720|1444578|P1|STARTED|Overall Study|1 randomized patient was discontinued before receiving treatment due to a protocol violation|10
591659|NCT00486642|1444588|P2|NOT COMPLETED|Overall Study||0
591660|NCT00486642|1444589|P1|NOT COMPLETED|Overall Study||0
591661|NCT00486642|1444588|P2|COMPLETED|Overall Study||13
591662|NCT00486642|1444589|P1|COMPLETED|Overall Study||10
591663|NCT00486642|1444588|P2|STARTED|Overall Study||13
591664|NCT00486642|1444589|P1|STARTED|Overall Study||10
591665|NCT00486525|1444613|P2|NOT COMPLETED|Overall Study||13
591666|NCT00486525|1444614|P1|NOT COMPLETED|Overall Study||6
591667|NCT00486525|1444613|P2|COMPLETED|Overall Study||87
591668|NCT00486525|1444614|P1|COMPLETED|Overall Study||94
591669|NCT00486525|1444613|P2|STARTED|Overall Study||100
591670|NCT00486525|1444614|P1|STARTED|Overall Study||100
591671|NCT00486447|1444630|P1|NOT COMPLETED|Overall Study||0
591672|NCT00486447|1444630|P1|COMPLETED|Overall Study||249
591673|NCT00486447|1444630|P1|STARTED|Overall Study||249
591674|NCT00486434|1444637|P2|NOT COMPLETED|Overall Study||134
591675|NCT00486434|1444638|P1|NOT COMPLETED|Overall Study||194
591676|NCT00486434|1444637|P2|COMPLETED|Overall Study||454
591677|NCT00486434|1444638|P1|COMPLETED|Overall Study||394
591678|NCT00486434|1444637|P2|STARTED|Overall Study||588
591679|NCT00486434|1444638|P1|STARTED|Overall Study||588
591680|NCT00486330|1444648|P1|NOT COMPLETED|Overall Study||2
591681|NCT00486330|1444648|P1|COMPLETED|Overall Study|Of the 12 subjects treated, two developed adverse events leading to study drug discontinuation.|10
591682|NCT00486330|1444648|P1|STARTED|Overall Study|Twelve subjects met inclusion/exclusion criteria|12
591683|NCT00486291|1444654|P2|NOT COMPLETED|Overall Study||29
591684|NCT00486291|1444655|P1|NOT COMPLETED|Overall Study||16
591685|NCT00486291|1444654|P2|COMPLETED|Overall Study||76
591686|NCT00486291|1444655|P1|COMPLETED|Overall Study||89
591687|NCT00486291|1444654|P2|STARTED|Overall Study|1 subject discontinued prior to first dose|105
591688|NCT00486291|1444655|P1|STARTED|Overall Study|3 subjects discontinued prior to first dose|105
591689|NCT00486278|1444663|P1|NOT COMPLETED|Overall Study||9
591690|NCT00486278|1444663|P1|COMPLETED|Overall Study||42
591691|NCT00486278|1444663|P1|STARTED|Overall Study|96 bleeds by 51 subjects, 77 were treated with vatreptacog alfa and 19 with rFVIIa|51
591692|NCT00486265|1444797|P1|NOT COMPLETED|Overall Study||9
591693|NCT00486265|1444797|P1|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until a discontinuation criterion is met|0
591694|NCT00486265|1444797|P1|STARTED|Overall Study|Partipants dosed on day 1.|9
591695|NCT00486252|1444801|P1|NOT COMPLETED|Overall Study||58
591696|NCT00486252|1444801|P1|COMPLETED|Overall Study||938
591697|NCT00486252|1444801|P1|STARTED|Overall Study||996
591698|NCT00486226|1444816|P1|NOT COMPLETED|Overall Study||13
591699|NCT00486226|1444816|P1|COMPLETED|Overall Study||92
591700|NCT00486226|1444816|P1|STARTED|Overall Study||105
591701|NCT00486044|1444826|P2|NOT COMPLETED|Overall Study||3
591702|NCT00486044|1444827|P1|NOT COMPLETED|Overall Study||2
591703|NCT00486044|1444826|P2|COMPLETED|Overall Study|21 completed MRI sub-study|46
591704|NCT00486044|1444827|P1|COMPLETED|Overall Study|27 completed MRI sub-study|49
591705|NCT00486044|1444826|P2|STARTED|Overall Study|23 in MRI sub-study|49
591706|NCT00486044|1444827|P1|STARTED|Overall Study|50 received assigned intervention (1 withdrew during baseline) 27 in MRI sub-study|51
591707|NCT00486031|1444839|P1|NOT COMPLETED|Overall Study||3
591708|NCT00486031|1444839|P1|COMPLETED|Overall Study||440
591709|NCT00486031|1444839|P1|STARTED|Overall Study||443
591710|NCT00486018|1444846|P3|NOT COMPLETED|Overall Study||6
591711|NCT00486018|1444847|P2|NOT COMPLETED|Overall Study||6
591712|NCT00486018|1444848|P1|NOT COMPLETED|Overall Study||9
591713|NCT00486018|1444846|P3|COMPLETED|Overall Study||125
591714|NCT00486018|1444847|P2|COMPLETED|Overall Study||128
591715|NCT00486018|1444848|P1|COMPLETED|Overall Study||123
591716|NCT00486018|1444846|P3|Received Drug (Safety Population)|Overall Study||130
591717|NCT00486018|1444847|P2|Received Drug (Safety Population)|Overall Study||134
591718|NCT00486018|1444848|P1|Received Drug (Safety Population)|Overall Study||131
591719|NCT00486018|1444846|P3|STARTED|Overall Study||131
591720|NCT00486018|1444847|P2|STARTED|Overall Study||134
591721|NCT00486018|1444848|P1|STARTED|Overall Study||132
591722|NCT00485953|1444876|P2|NOT COMPLETED|Overall Study||7
591723|NCT00485953|1444877|P1|NOT COMPLETED|Overall Study||7
591724|NCT00485953|1444876|P2|COMPLETED|Overall Study||47
591725|NCT00485953|1444877|P1|COMPLETED|Overall Study||48
591726|NCT00485953|1444876|P2|STARTED|Overall Study||54
591727|NCT00485953|1444877|P1|STARTED|Overall Study||55
591728|NCT00485836|1444890|P3|NOT COMPLETED|Overall Study||11
591729|NCT00485836|1444891|P2|NOT COMPLETED|Overall Study||3
591730|NCT00485836|1444892|P1|NOT COMPLETED|Overall Study||15
591731|NCT00485836|1444890|P3|COMPLETED|Overall Study||119
591732|NCT00485836|1444891|P2|COMPLETED|Overall Study||129
591733|NCT00485836|1444892|P1|COMPLETED|Overall Study||115
591734|NCT00485836|1444890|P3|Received Study Drug (Safety Population)|Overall Study||129
591735|NCT00485836|1444891|P2|Received Study Drug (Safety Population)|Overall Study||132
591736|NCT00485836|1444892|P1|Received Study Drug (Safety Population)|Overall Study||129
591737|NCT00485836|1444890|P3|STARTED|Overall Study||130
591738|NCT00485836|1444891|P2|STARTED|Overall Study||132
591739|NCT00485836|1444892|P1|STARTED|Overall Study||130
591740|NCT00485758|1444920|P2|NOT COMPLETED|Overall Study||65
591741|NCT00485758|1444921|P1|NOT COMPLETED|Overall Study||156
591742|NCT00485758|1444920|P2|COMPLETED|Overall Study||277
591743|NCT00485758|1444921|P1|COMPLETED|Overall Study||298
591744|NCT00485758|1444920|P2|STARTED|Overall Study||342
591745|NCT00485758|1444921|P1|STARTED|Overall Study||454
591746|NCT00485732|1444933|P2|NOT COMPLETED|Overall Study||9
591747|NCT00485732|1444934|P1|NOT COMPLETED|Overall Study||8
591748|NCT00485732|1444933|P2|COMPLETED|Overall Study||67
591749|NCT00485732|1444934|P1|COMPLETED|Overall Study||141
591750|NCT00485732|1444933|P2|STARTED|Overall Study||76
591751|NCT00485732|1444934|P1|STARTED|Overall Study||149
591752|NCT00485693|1444956|P2|NOT COMPLETED|Overall Study||0
591753|NCT00485693|1444957|P1|NOT COMPLETED|Overall Study||0
591754|NCT00485693|1444956|P2|COMPLETED|Overall Study||104
591755|NCT00485693|1444957|P1|COMPLETED|Overall Study||34
591756|NCT00485693|1444956|P2|STARTED|Overall Study||104
591757|NCT00485693|1444957|P1|STARTED|Overall Study||34
591758|NCT00485485|1444966|P1|NOT COMPLETED|Overall Study||0
591759|NCT00485485|1444966|P1|COMPLETED|Overall Study||7
591760|NCT00485485|1444966|P1|STARTED|Overall Study||7
591761|NCT00485472|1444972|P2|NOT COMPLETED|Overall Study||12
591762|NCT00485472|1444973|P1|NOT COMPLETED|Overall Study||16
591763|NCT00485472|1444972|P2|COMPLETED|Overall Study||64
591764|NCT00485472|1444973|P1|COMPLETED|Overall Study||57
591765|NCT00485472|1444972|P2|Entered Maintenance Phase|Overall Study||67
591766|NCT00485472|1444973|P1|Entered Maintenance Phase|Overall Study||65
591767|NCT00485472|1444972|P2|STARTED|Overall Study||76
591768|NCT00485472|1444973|P1|STARTED|Overall Study||73
591769|NCT00485433|1444999|P4|NOT COMPLETED|Overall Study||0
591770|NCT00485433|1445000|P3|NOT COMPLETED|Overall Study||0
591771|NCT00485433|1445001|P2|NOT COMPLETED|Overall Study||0
591772|NCT00485433|1445002|P1|NOT COMPLETED|Overall Study||0
591773|NCT00485433|1444999|P4|COMPLETED|Overall Study||25
591774|NCT00485433|1445000|P3|COMPLETED|Overall Study||24
591775|NCT00485433|1445001|P2|COMPLETED|Overall Study||25
591776|NCT00485433|1445002|P1|COMPLETED|Overall Study||24
591777|NCT00485433|1444999|P4|STARTED|Overall Study||25
591778|NCT00485433|1445000|P3|STARTED|Overall Study||24
591779|NCT00485433|1445001|P2|STARTED|Overall Study||25
591780|NCT00485433|1445002|P1|STARTED|Overall Study||24
591781|NCT00485303|1445010|P1|NOT COMPLETED|Overall Study||56
591782|NCT00485303|1445010|P1|COMPLETED|Overall Study||2
591783|NCT00485303|1445010|P1|STARTED|Overall Study||58
591784|NCT00485264|1445028|P6|NOT COMPLETED|Overall Study||7
591785|NCT00485264|1445029|P5|NOT COMPLETED|Overall Study||6
591786|NCT00485264|1445030|P4|NOT COMPLETED|Overall Study||4
591787|NCT00485264|1445031|P3|NOT COMPLETED|Overall Study||6
591788|NCT00485264|1445032|P2|NOT COMPLETED|Overall Study||7
591789|NCT00485264|1445033|P1|NOT COMPLETED|Overall Study||36
591790|NCT00485264|1445028|P6|COMPLETED|Overall Study||5
591791|NCT00485264|1445029|P5|COMPLETED|Overall Study||9
591792|NCT00485264|1445030|P4|COMPLETED|Overall Study||17
591793|NCT00485264|1445031|P3|COMPLETED|Overall Study||12
591794|NCT00485264|1445032|P2|COMPLETED|Overall Study||9
591795|NCT00485264|1445033|P1|COMPLETED|Overall Study||35
591796|NCT00485264|1445028|P6|Completed Week 24|Overall Study||11
591797|NCT00485264|1445029|P5|Completed Week 24|Overall Study||14
591798|NCT00485264|1445030|P4|Completed Week 24|Overall Study||21
591799|NCT00485264|1445031|P3|Completed Week 24|Overall Study||18
591800|NCT00485264|1445032|P2|Completed Week 24|Overall Study||16
591801|NCT00485264|1445033|P1|Completed Week 24|Overall Study||67
591802|NCT00485264|1445028|P6|STARTED|Overall Study||12
591803|NCT00485264|1445029|P5|STARTED|Overall Study||15
591804|NCT00485264|1445030|P4|STARTED|Overall Study||21
591805|NCT00485264|1445031|P3|STARTED|Overall Study||18
591806|NCT00485264|1445032|P2|STARTED|Overall Study||16
591807|NCT00485264|1445033|P1|STARTED|Overall Study||71
591808|NCT00485173|1445121|P2|NOT COMPLETED|Overall Study||64
591809|NCT00485173|1445122|P1|NOT COMPLETED|Overall Study||36
591810|NCT00485173|1445121|P2|COMPLETED|Overall Study|The number of completed participants is reported the number of subjects who had any 24-month data.|422
591811|NCT00485173|1445122|P1|COMPLETED|Overall Study|The number of completed participants is reported the number of subjects who had any 24-month data.|188
591812|NCT00485173|1445121|P2|STARTED|Overall Study||486
591813|NCT00485173|1445122|P1|STARTED|Overall Study||224
591814|NCT00485134|1445170|P8|NOT COMPLETED|Overall Study||1
591815|NCT00485134|1445171|P7|NOT COMPLETED|Overall Study||3
591816|NCT00485134|1445172|P6|NOT COMPLETED|Overall Study||4
591817|NCT00485134|1445173|P5|NOT COMPLETED|Overall Study||3
591818|NCT00485134|1445174|P4|NOT COMPLETED|Overall Study||1
591819|NCT00485134|1445175|P3|NOT COMPLETED|Overall Study||3
591820|NCT00485134|1445176|P2|NOT COMPLETED|Overall Study||2
591821|NCT00485134|1445177|P1|NOT COMPLETED|Overall Study||1
591822|NCT00485134|1445170|P8|COMPLETED|Overall Study||20
591823|NCT00485134|1445171|P7|COMPLETED|Overall Study||28
591824|NCT00485134|1445172|P6|COMPLETED|Overall Study||3
591825|NCT00485134|1445173|P5|COMPLETED|Overall Study||7
591826|NCT00485134|1445174|P4|COMPLETED|Overall Study||7
591827|NCT00485134|1445175|P3|COMPLETED|Overall Study||9
591828|NCT00485134|1445176|P2|COMPLETED|Overall Study||10
591829|NCT00485134|1445177|P1|COMPLETED|Overall Study||11
591830|NCT00485134|1445170|P8|STARTED|Overall Study||21
591831|NCT00485134|1445171|P7|STARTED|Overall Study||31
591832|NCT00485134|1445172|P6|STARTED|Overall Study||7
591833|NCT00485134|1445173|P5|STARTED|Overall Study||10
591834|NCT00485134|1445174|P4|STARTED|Overall Study||8
591835|NCT00485134|1445175|P3|STARTED|Overall Study||12
591836|NCT00485134|1445176|P2|STARTED|Overall Study||12
591837|NCT00485134|1445177|P1|STARTED|Overall Study||12
591838|NCT00485069|1445199|P2|NOT COMPLETED|Overall Study||12
591839|NCT00485069|1445200|P1|NOT COMPLETED|Overall Study||18
591840|NCT00485069|1445199|P2|COMPLETED|Overall Study||46
591841|NCT00485069|1445200|P1|COMPLETED|Overall Study||47
591842|NCT00485069|1445199|P2|STARTED|Overall Study||58
591843|NCT00485069|1445200|P1|STARTED|Overall Study||65
591844|NCT00484939|1445245|P2|NOT COMPLETED|Overall Study||140
591845|NCT00484939|1445246|P1|NOT COMPLETED|Overall Study||140
591846|NCT00484939|1445245|P2|COMPLETED|Overall Study||0
591847|NCT00484939|1445246|P1|COMPLETED|Overall Study||0
591848|NCT00484939|1445245|P2|STARTED|Overall Study||140
591849|NCT00484939|1445246|P1|STARTED|Overall Study||140
591853|NCT00484419|1445273|P3|NOT COMPLETED|Overall Study||11
591854|NCT00484419|1445274|P2|NOT COMPLETED|Overall Study||5
591855|NCT00484419|1445275|P1|NOT COMPLETED|Overall Study||12
591856|NCT00484419|1445273|P3|COMPLETED|Overall Study||45
591857|NCT00484419|1445274|P2|COMPLETED|Overall Study||51
591858|NCT00484419|1445275|P1|COMPLETED|Overall Study||45
591859|NCT00484419|1445273|P3|STARTED|Overall Study||56
591860|NCT00484419|1445274|P2|STARTED|Overall Study||56
591861|NCT00484419|1445275|P1|STARTED|Overall Study||57
591862|NCT00484393|1445333|P2|NOT COMPLETED|Overall Study||0
591863|NCT00484393|1445334|P1|NOT COMPLETED|Overall Study||0
591864|NCT00484393|1445333|P2|COMPLETED|Overall Study||3
591865|NCT00484393|1445334|P1|COMPLETED|Overall Study||4
591866|NCT00484393|1445333|P2|STARTED|Overall Study||3
591867|NCT00484393|1445334|P1|STARTED|Overall Study||4
591868|NCT00484315|1445342|P2|NOT COMPLETED|9-Month Angiographic Follow-up||13
591869|NCT00484315|1445343|P1|NOT COMPLETED|9-Month Angiographic Follow-up||28
591870|NCT00484315|1445342|P2|COMPLETED|9-Month Angiographic Follow-up||61
591871|NCT00484315|1445343|P1|COMPLETED|9-Month Angiographic Follow-up||228
591872|NCT00484315|1445342|P2|STARTED|9-Month Angiographic Follow-up||74
591873|NCT00484315|1445343|P1|STARTED|9-Month Angiographic Follow-up||256
591874|NCT00484315|1445342|P2|NOT COMPLETED|12-Month Clinical Follow-up||9
591875|NCT00484315|1445343|P1|NOT COMPLETED|12-Month Clinical Follow-up||28
591876|NCT00484315|1445342|P2|COMPLETED|12-Month Clinical Follow-up||311
591877|NCT00484315|1445343|P1|COMPLETED|12-Month Clinical Follow-up||914
591878|NCT00484315|1445342|P2|STARTED|12-Month Clinical Follow-up||320
591879|NCT00484315|1445343|P1|STARTED|12-Month Clinical Follow-up||942
591880|NCT00484289|1445354|P3|NOT COMPLETED|Post Marketing Phase||0
591881|NCT00484289|1445355|P2|NOT COMPLETED|Post Marketing Phase||1
591882|NCT00484289|1445356|P1|NOT COMPLETED|Post Marketing Phase||0
591883|NCT00484289|1445354|P3|COMPLETED|Post Marketing Phase||10
591884|NCT00484289|1445355|P2|COMPLETED|Post Marketing Phase||141
591885|NCT00484289|1445356|P1|COMPLETED|Post Marketing Phase||10
591886|NCT00484289|1445354|P3|STARTED|Post Marketing Phase||10
591887|NCT00484289|1445355|P2|STARTED|Post Marketing Phase||142
591888|NCT00484289|1445356|P1|STARTED|Post Marketing Phase||10
591889|NCT00484289|1445354|P3|NOT COMPLETED|Long Term Phase||16
591890|NCT00484289|1445355|P2|NOT COMPLETED|Long Term Phase||36
591891|NCT00484289|1445356|P1|NOT COMPLETED|Long Term Phase||3
591892|NCT00484289|1445354|P3|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|10
591893|NCT00484289|1445355|P2|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|142
591989|NCT00483548|1445669|P2|NOT COMPLETED|Overall Study||46
591894|NCT00484289|1445356|P1|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|10
591895|NCT00484289|1445354|P3|STARTED|Long Term Phase||26
591896|NCT00484289|1445355|P2|STARTED|Long Term Phase||178
591897|NCT00484289|1445356|P1|STARTED|Long Term Phase||13
591898|NCT00484185|1445428|P1|NOT COMPLETED|Overall Study||71
591899|NCT00484185|1445428|P1|COMPLETED|Overall Study||112
591900|NCT00484185|1445428|P1|Treated|Overall Study||178
591901|NCT00484185|1445428|P1|STARTED|Overall Study||183
591902|NCT00484159|1445450|P3|NOT COMPLETED|Overall Study||0
591903|NCT00484159|1445451|P2|NOT COMPLETED|Overall Study||1
591904|NCT00484159|1445452|P1|NOT COMPLETED|Overall Study||1
591905|NCT00484159|1445450|P3|COMPLETED|Overall Study||51
591906|NCT00484159|1445451|P2|COMPLETED|Overall Study||49
591907|NCT00484159|1445452|P1|COMPLETED|Overall Study||49
591908|NCT00484159|1445450|P3|STARTED|Overall Study||51
591909|NCT00484159|1445451|P2|STARTED|Overall Study||50
591910|NCT00484159|1445452|P1|STARTED|Overall Study||50
591911|NCT00484094|1445463|P1|NOT COMPLETED|Overall Study||42
591912|NCT00484094|1445463|P1|COMPLETED|Overall Study||167
591913|NCT00484094|1445463|P1|STARTED|Overall Study||209
591914|NCT00483938|1445479|P7|NOT COMPLETED|Overall Study||40
591915|NCT00483938|1445480|P6|NOT COMPLETED|Overall Study||8
591916|NCT00483938|1445481|P5|NOT COMPLETED|Overall Study||2
591917|NCT00483938|1445482|P4|NOT COMPLETED|Overall Study||6
591918|NCT00483938|1445483|P3|NOT COMPLETED|Overall Study||0
591919|NCT00483938|1445484|P2|NOT COMPLETED|Overall Study||19
591920|NCT00483938|1445485|P1|NOT COMPLETED|Overall Study||5
591921|NCT00483938|1445479|P7|COMPLETED|Overall Study||0
591922|NCT00483938|1445480|P6|COMPLETED|Overall Study||18
591923|NCT00483938|1445481|P5|COMPLETED|Overall Study||23
591924|NCT00483938|1445482|P4|COMPLETED|Overall Study||25
591925|NCT00483938|1445483|P3|COMPLETED|Overall Study||30
591926|NCT00483938|1445484|P2|COMPLETED|Overall Study||24
591927|NCT00483938|1445485|P1|COMPLETED|Overall Study||36
591928|NCT00483938|1445479|P7|STARTED|Overall Study||40
591929|NCT00483938|1445480|P6|STARTED|Overall Study||26
591930|NCT00483938|1445481|P5|STARTED|Overall Study||25
591931|NCT00483938|1445482|P4|STARTED|Overall Study||31
591932|NCT00483938|1445483|P3|STARTED|Overall Study||30
591933|NCT00483938|1445484|P2|STARTED|Overall Study||43
591934|NCT00483938|1445485|P1|STARTED|Overall Study||41
591935|NCT00483756|1445509|P3|NOT COMPLETED|Overall Study||52
591936|NCT00483756|1445510|P2|NOT COMPLETED|Overall Study||50
591937|NCT00483756|1445511|P1|NOT COMPLETED|Overall Study||33
591938|NCT00483756|1445509|P3|COMPLETED|Overall Study||59
591939|NCT00483756|1445510|P2|COMPLETED|Overall Study||60
591940|NCT00483756|1445511|P1|COMPLETED|Overall Study||77
591941|NCT00483756|1445509|P3|Treated|Overall Study||107
591942|NCT00483756|1445510|P2|Treated|Overall Study||106
591943|NCT00483756|1445511|P1|Treated|Overall Study||109
591944|NCT00483756|1445509|P3|STARTED|Overall Study||111
591945|NCT00483756|1445510|P2|STARTED|Overall Study||110
591946|NCT00483756|1445511|P1|STARTED|Overall Study||110
591947|NCT00483717|1445575|P2|NOT COMPLETED|Overall Study||21
591948|NCT00483717|1445576|P1|NOT COMPLETED|Overall Study||24
591949|NCT00483717|1445575|P2|COMPLETED|Overall Study||65
591950|NCT00483717|1445576|P1|COMPLETED|Overall Study||63
591951|NCT00483717|1445575|P2|STARTED|Overall Study||86
591952|NCT00483717|1445576|P1|STARTED|Overall Study||87
591953|NCT00483704|1445599|P3|NOT COMPLETED|Treatment||156
591954|NCT00483704|1445600|P2|NOT COMPLETED|Treatment||129
591955|NCT00483704|1445601|P1|NOT COMPLETED|Treatment||129
591956|NCT00483704|1445599|P3|COMPLETED|Treatment||399
591957|NCT00483704|1445600|P2|COMPLETED|Treatment||420
591958|NCT00483704|1445601|P1|COMPLETED|Treatment||444
591959|NCT00483704|1445599|P3|STARTED|Treatment||555
591960|NCT00483704|1445600|P2|STARTED|Treatment||549
591961|NCT00483704|1445601|P1|STARTED|Treatment||573
591962|NCT00483704|1445599|P3|NOT COMPLETED|Randomization||91
591963|NCT00483704|1445600|P2|NOT COMPLETED|Randomization||96
591964|NCT00483704|1445601|P1|NOT COMPLETED|Randomization||71
591965|NCT00483704|1445599|P3|COMPLETED|Randomization||555
591966|NCT00483704|1445600|P2|COMPLETED|Randomization||549
591967|NCT00483704|1445601|P1|COMPLETED|Randomization||573
591968|NCT00483704|1445599|P3|STARTED|Randomization||646
591969|NCT00483704|1445600|P2|STARTED|Randomization||645
591970|NCT00483704|1445601|P1|STARTED|Randomization||644
591971|NCT00483652|1445647|P2|NOT COMPLETED|Post-study Follow-up||0
591972|NCT00483652|1445648|P1|NOT COMPLETED|Post-study Follow-up||0
591973|NCT00483652|1445647|P2|COMPLETED|Post-study Follow-up||114
591974|NCT00483652|1445648|P1|COMPLETED|Post-study Follow-up||113
591975|NCT00483652|1445647|P2|STARTED|Post-study Follow-up||114
591976|NCT00483652|1445648|P1|STARTED|Post-study Follow-up||113
591977|NCT00483652|1445647|P2|NOT COMPLETED|Double-blind Treatment Period||5
591978|NCT00483652|1445648|P1|NOT COMPLETED|Double-blind Treatment Period||7
591979|NCT00483652|1445647|P2|COMPLETED|Double-blind Treatment Period||114
591980|NCT00483652|1445648|P1|COMPLETED|Double-blind Treatment Period||113
591981|NCT00483652|1445647|P2|STARTED|Double-blind Treatment Period||119
591982|NCT00483652|1445648|P1|STARTED|Double-blind Treatment Period||120
591983|NCT00483574|1445658|P2|NOT COMPLETED|Overall Study||13
591984|NCT00483574|1445659|P1|NOT COMPLETED|Overall Study||102
591985|NCT00483574|1445658|P2|COMPLETED|Overall Study||308
591986|NCT00483574|1445659|P1|COMPLETED|Overall Study||951
591987|NCT00483574|1445658|P2|STARTED|Overall Study||321
591988|NCT00483574|1445659|P1|STARTED|Overall Study||1053
591990|NCT00483548|1445670|P1|NOT COMPLETED|Overall Study||60
591991|NCT00483548|1445669|P2|COMPLETED|Overall Study||104
591992|NCT00483548|1445670|P1|COMPLETED|Overall Study||88
591993|NCT00483548|1445669|P2|Received Study Treatment|Overall Study|3 subjects randomized but not treated.|147
591994|NCT00483548|1445670|P1|Received Study Treatment|Overall Study|1 subject randomized but lost to follow up; no treatment data.|147
591995|NCT00483548|1445669|P2|STARTED|Overall Study||150
591996|NCT00483548|1445670|P1|STARTED|Overall Study||148
591997|NCT00483496|1445708|P1|NOT COMPLETED|Overall Study||1
591998|NCT00483496|1445708|P1|COMPLETED|Overall Study||15
591999|NCT00483496|1445708|P1|STARTED|Overall Study||16
592000|NCT00483405|1445720|P1|NOT COMPLETED|Overall Study||28
592001|NCT00483405|1445720|P1|COMPLETED|Overall Study||0
592002|NCT00483405|1445720|P1|STARTED|Overall Study||28
592003|NCT00483379|1445729|P2|NOT COMPLETED|Extension Period||0
592004|NCT00483379|1445730|P1|NOT COMPLETED|Extension Period||0
592005|NCT00483379|1445729|P2|COMPLETED|Extension Period||2
592006|NCT00483379|1445730|P1|COMPLETED|Extension Period||1
592007|NCT00483379|1445729|P2|STARTED|Extension Period|Extension allowed late-onset participants access to treatment until commercially available.|2
592008|NCT00483379|1445730|P1|STARTED|Extension Period|Extension allowed late-onset participants access to treatment until commercially available.|1
592009|NCT00483379|1445729|P2|NOT COMPLETED|Treatment Period||0
592010|NCT00483379|1445730|P1|NOT COMPLETED|Treatment Period||2
592011|NCT00483379|1445729|P2|COMPLETED|Treatment Period||7
592012|NCT00483379|1445730|P1|COMPLETED|Treatment Period||4
592013|NCT00483379|1445729|P2|STARTED|Treatment Period||7
592014|NCT00483379|1445730|P1|STARTED|Treatment Period||6
592015|NCT00483327|1445766|P1|NOT COMPLETED|Overall Study||10
592016|NCT00483327|1445766|P1|COMPLETED|Overall Study||20
592017|NCT00483327|1445766|P1|STARTED|Overall Study||30
592018|NCT00483262|1445777|P2|NOT COMPLETED|Overall Study||0
592019|NCT00483262|1445778|P1|NOT COMPLETED|Overall Study||0
592020|NCT00483262|1445777|P2|COMPLETED|Overall Study||43
592021|NCT00483262|1445778|P1|COMPLETED|Overall Study||20
592022|NCT00483262|1445777|P2|STARTED|Overall Study||43
592023|NCT00483262|1445778|P1|STARTED|Overall Study||20
592024|NCT00483223|1445788|P1|NOT COMPLETED|Overall Study||0
592025|NCT00483223|1445788|P1|COMPLETED|Overall Study||86
592026|NCT00483223|1445788|P1|STARTED|Overall Study||86
592027|NCT00483184|1445798|P3|NOT COMPLETED|Overall Study||3
592028|NCT00483184|1445799|P2|NOT COMPLETED|Overall Study||4
592029|NCT00483184|1445800|P1|NOT COMPLETED|Overall Study||5
592030|NCT00483184|1445798|P3|COMPLETED|Overall Study||23
592031|NCT00483184|1445799|P2|COMPLETED|Overall Study||27
592032|NCT00483184|1445800|P1|COMPLETED|Overall Study||22
592033|NCT00483184|1445798|P3|STARTED|Overall Study||26
592034|NCT00483184|1445799|P2|STARTED|Overall Study||31
592035|NCT00483184|1445800|P1|STARTED|Overall Study||27
592036|NCT00483119|1445810|P2|NOT COMPLETED|Overall Study||1
592037|NCT00483119|1445811|P1|NOT COMPLETED|Overall Study||1
592038|NCT00483119|1445810|P2|COMPLETED|Overall Study||3
592039|NCT00483119|1445811|P1|COMPLETED|Overall Study||4
592040|NCT00483119|1445810|P2|STARTED|Overall Study||4
592041|NCT00483119|1445811|P1|STARTED|Overall Study||5
592042|NCT00483041|1445825|P2|NOT COMPLETED|Overall Study||1
592043|NCT00483041|1445826|P1|NOT COMPLETED|Overall Study||0
592044|NCT00483041|1445825|P2|COMPLETED|Overall Study||5
592045|NCT00483041|1445826|P1|COMPLETED|Overall Study||5
592046|NCT00483041|1445825|P2|STARTED|Overall Study||6
592047|NCT00483041|1445826|P1|STARTED|Overall Study||5
592048|NCT00483002|1445856|P1|NOT COMPLETED|Overall Study||2554
592049|NCT00483002|1445856|P1|COMPLETED|Overall Study||1165
592050|NCT00483002|1445856|P1|STARTED|Overall Study||3719
592051|NCT00482911|1445864|P2|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
592052|NCT00482911|1445865|P1|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
592053|NCT00482911|1445864|P2|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun|5 stopped at Dose D-QOD, 2 stopped at Dose D-QD (1 after first increasing to Dose E-QD)|7
592054|NCT00482911|1445865|P1|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
592055|NCT00482911|1445864|P2|STARTED|Dosing Schedule 2: Len, Cyc, & Sun|All received Dose D-QD in cycle 1|7
592056|NCT00482911|1445865|P1|STARTED|Dosing Schedule 2: Len, Cyc, & Sun||0
592057|NCT00482911|1445864|P2|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0
592058|NCT00482911|1445865|P1|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0
592059|NCT00482911|1445864|P2|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun|1 stopped at Dose B-QD, 1 stopped at Dose C-QOD|2
592060|NCT00482911|1445865|P1|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun|1 stopped at Dose B-QD, 1 stopped at Dose C-QD, 1 stopped at Dose C-QOD|3
592061|NCT00482911|1445864|P2|STARTED|Dosing Schedule 1: Len, Cyc, & Sun|All received Dose B-QD in cycle 1|2
592062|NCT00482911|1445865|P1|STARTED|Dosing Schedule 1: Len, Cyc, & Sun|All received Dose B-QD in cycle 2|3
592063|NCT00482911|1445864|P2|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0
592064|NCT00482911|1445865|P1|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0
592065|NCT00482911|1445864|P2|COMPLETED|Dosing Schedule 1: Len & Cyc||0
592066|NCT00482911|1445865|P1|COMPLETED|Dosing Schedule 1: Len & Cyc||3
592067|NCT00482911|1445864|P2|STARTED|Dosing Schedule 1: Len & Cyc||0
592068|NCT00482911|1445865|P1|STARTED|Dosing Schedule 1: Len & Cyc|All received Dose A-QD in cycle 1|3
592069|NCT00482729|1445881|P2|NOT COMPLETED|Overall Study||218
592070|NCT00482729|1445882|P1|NOT COMPLETED|Overall Study||217
592071|NCT00482729|1445881|P2|COMPLETED|Overall Study||406
592072|NCT00482729|1445882|P1|COMPLETED|Overall Study||409
592073|NCT00482729|1445881|P2|Completed Phase B|Overall Study||406
592074|NCT00482729|1445882|P1|Completed Phase B|Overall Study||409
592075|NCT00482729|1445881|P2|Completed Phase A|Overall Study||482
592076|NCT00482729|1445882|P1|Completed Phase A|Overall Study||484
592077|NCT00482729|1445881|P2|STARTED|Overall Study|Site 079011301 was identified as non-compliant and 3 patients were excluded from all analysis|624
592078|NCT00482729|1445882|P1|STARTED|Overall Study|Site 079011301 was identified as non-compliant and 1 patient was excluded from all analysis|626
592079|NCT00482703|1445898|P2|NOT COMPLETED|Overall Study||0
592080|NCT00482703|1445899|P1|NOT COMPLETED|Overall Study||1
592081|NCT00482703|1445898|P2|COMPLETED|Overall Study||12
592082|NCT00482703|1445899|P1|COMPLETED|Overall Study||10
592083|NCT00482703|1445898|P2|STARTED|Overall Study|number enrolled, randomized and treated|12
592084|NCT00482703|1445899|P1|STARTED|Overall Study|number enrolled, randomized and treated|11
592085|NCT00482677|1445946|P2|NOT COMPLETED|Overall Study||0
592086|NCT00482677|1445947|P1|NOT COMPLETED|Overall Study||0
592087|NCT00482677|1445946|P2|COMPLETED|Overall Study||281
592088|NCT00482677|1445947|P1|COMPLETED|Overall Study||281
592089|NCT00482677|1445946|P2|STARTED|Overall Study||281
592090|NCT00482677|1445947|P1|STARTED|Overall Study||281
592091|NCT00482625|1445957|P1|NOT COMPLETED|Overall Study||0
592092|NCT00482625|1445957|P1|COMPLETED|Overall Study||6
592093|NCT00482625|1445957|P1|STARTED|Overall Study||6
592094|NCT00482612|1445970|P4|NOT COMPLETED|Follow-up Period||8
592095|NCT00482612|1445971|P3|NOT COMPLETED|Follow-up Period||22
592096|NCT00482612|1445972|P2|NOT COMPLETED|Follow-up Period||18
592097|NCT00482612|1445973|P1|NOT COMPLETED|Follow-up Period||14
592098|NCT00482612|1445970|P4|COMPLETED|Follow-up Period||127
592099|NCT00482612|1445971|P3|COMPLETED|Follow-up Period||106
592100|NCT00482612|1445972|P2|COMPLETED|Follow-up Period||107
592101|NCT00482612|1445973|P1|COMPLETED|Follow-up Period||123
592102|NCT00482612|1445970|P4|STARTED|Follow-up Period||135
592103|NCT00482612|1445971|P3|STARTED|Follow-up Period||128
592104|NCT00482612|1445972|P2|STARTED|Follow-up Period||125
592105|NCT00482612|1445973|P1|STARTED|Follow-up Period||137
592106|NCT00482612|1445970|P4|NOT COMPLETED|In-treatment Period||0
592107|NCT00482612|1445971|P3|NOT COMPLETED|In-treatment Period||1
592108|NCT00482612|1445972|P2|NOT COMPLETED|In-treatment Period||0
592109|NCT00482612|1445973|P1|NOT COMPLETED|In-treatment Period||0
592110|NCT00482612|1445970|P4|COMPLETED|In-treatment Period||135
592111|NCT00482612|1445971|P3|COMPLETED|In-treatment Period||128
592112|NCT00482612|1445972|P2|COMPLETED|In-treatment Period||125
592113|NCT00482612|1445973|P1|COMPLETED|In-treatment Period||137
592114|NCT00482612|1445970|P4|Treated|In-treatment Period||135
592115|NCT00482612|1445971|P3|Treated|In-treatment Period||128
592116|NCT00482612|1445972|P2|Treated|In-treatment Period||125
592117|NCT00482612|1445973|P1|Treated|In-treatment Period||137
592118|NCT00482612|1445970|P4|STARTED|In-treatment Period||135
592119|NCT00482612|1445971|P3|STARTED|In-treatment Period||129
592120|NCT00482612|1445972|P2|STARTED|In-treatment Period||125
592121|NCT00482612|1445973|P1|STARTED|In-treatment Period||137
592122|NCT00482547|1446001|P2|NOT COMPLETED|Overall Study||161
592123|NCT00482547|1446002|P1|NOT COMPLETED|Overall Study||173
592124|NCT00482547|1446001|P2|COMPLETED|Overall Study||428
592125|NCT00482547|1446002|P1|COMPLETED|Overall Study||426
592126|NCT00482547|1446001|P2|48 Hour Evaluation|Overall Study|428 went on to be included in the Silicone-coated 48 hour efficacy evaluable population.|428
592127|NCT00482547|1446002|P1|48 Hour Evaluation|Overall Study|426 went on to be included in the Silver-coated 48 hour efficacy evaluable population.|426
592128|NCT00482547|1446001|P2|Successful Catheterization|Overall Study|Out of the 589 SiCS catheter subjects 568 (96.4%) had a successful catheterization.|568
592129|NCT00482547|1446002|P1|Successful Catheterization|Overall Study|Out of the 599 AgCS subjects 565 (94.3%) had a successful catheterization.|565
592130|NCT00482547|1446001|P2|STARTED|Overall Study|589 subjects were enrolled in the silicone-coated catheter group.|589
592131|NCT00482547|1446002|P1|STARTED|Overall Study|599 subjects were enrolled in the silver-coated catheter group.|599
592132|NCT00482391|1446022|P1|NOT COMPLETED|Overall Study||3
592133|NCT00482391|1446022|P1|COMPLETED|Overall Study||92
592134|NCT00482391|1446022|P1|STARTED|Overall Study||95
592135|NCT00482274|1446027|P1|NOT COMPLETED|Overall Study||1
592136|NCT00482274|1446027|P1|COMPLETED|Overall Study||2
592137|NCT00482274|1446027|P1|STARTED|Overall Study||3
592138|NCT00482170|1446037|P2|NOT COMPLETED|Overall Study||20
592139|NCT00482170|1446038|P1|NOT COMPLETED|Overall Study||15
592140|NCT00482170|1446037|P2|COMPLETED|Overall Study||194
592141|NCT00482170|1446038|P1|COMPLETED|Overall Study||192
592142|NCT00482170|1446037|P2|Treated|Overall Study||211
592143|NCT00482170|1446038|P1|Treated|Overall Study||207
592144|NCT00482170|1446037|P2|STARTED|Overall Study||214
592145|NCT00482170|1446038|P1|STARTED|Overall Study||207
592146|NCT00482053|1446156|P1|NOT COMPLETED|Allogeneic Peripheral Stem Cells||0
592147|NCT00482053|1446156|P1|COMPLETED|Allogeneic Peripheral Stem Cells||2
592148|NCT00482053|1446156|P1|STARTED|Allogeneic Peripheral Stem Cells||2
592149|NCT00482053|1446156|P1|NOT COMPLETED|Inter-treatment Period||1
592150|NCT00482053|1446156|P1|COMPLETED|Inter-treatment Period||2
592151|NCT00482053|1446156|P1|STARTED|Inter-treatment Period||3
592152|NCT00482053|1446156|P1|NOT COMPLETED|Autologous Peripheral Stem Cells||0
592153|NCT00482053|1446156|P1|COMPLETED|Autologous Peripheral Stem Cells||3
592154|NCT00482053|1446156|P1|STARTED|Autologous Peripheral Stem Cells||3
592155|NCT00482014|1446170|P4|NOT COMPLETED|Overall Study||23
592156|NCT00482014|1446171|P3|NOT COMPLETED|Overall Study||11
592157|NCT00482014|1446172|P2|NOT COMPLETED|Overall Study||6
592158|NCT00482014|1446173|P1|NOT COMPLETED|Overall Study||7
592159|NCT00482014|1446170|P4|COMPLETED|Overall Study||29
592160|NCT00482014|1446171|P3|COMPLETED|Overall Study||35
592161|NCT00482014|1446172|P2|COMPLETED|Overall Study||7
592162|NCT00482014|1446173|P1|COMPLETED|Overall Study||2
592163|NCT00482014|1446170|P4|STARTED|Overall Study||52
592164|NCT00482014|1446171|P3|STARTED|Overall Study||46
592165|NCT00482014|1446172|P2|STARTED|Overall Study||13
592166|NCT00482014|1446173|P1|STARTED|Overall Study||9
592167|NCT00481988|1446197|P2|NOT COMPLETED|Overall Study||1
592168|NCT00481988|1446198|P1|NOT COMPLETED|Overall Study||1
592169|NCT00481988|1446197|P2|COMPLETED|Overall Study||8
592170|NCT00481988|1446198|P1|COMPLETED|Overall Study||11
592171|NCT00481988|1446197|P2|Crossover|Overall Study|patient dropped out of study after 5 sessions to illness unrelated to study|8
592172|NCT00481988|1446198|P1|Crossover|Overall Study|patient dropped out of study after 5 sessions to pursue other treatment options|11
592173|NCT00481988|1446197|P2|STARTED|Overall Study|one patient was dropped from the study before randomization|9
592174|NCT00481988|1446198|P1|STARTED|Overall Study||12
592175|NCT00481871|1446211|P5|NOT COMPLETED|Overall Study||0
592176|NCT00481871|1446212|P4|NOT COMPLETED|Overall Study||0
592177|NCT00481871|1446213|P3|NOT COMPLETED|Overall Study||1
592178|NCT00481871|1446214|P2|NOT COMPLETED|Overall Study||0
592179|NCT00481871|1446215|P1|NOT COMPLETED|Overall Study||0
592180|NCT00481871|1446211|P5|COMPLETED|Overall Study||34
592181|NCT00481871|1446212|P4|COMPLETED|Overall Study||38
592182|NCT00481871|1446213|P3|COMPLETED|Overall Study||17
592183|NCT00481871|1446214|P2|COMPLETED|Overall Study||10
592184|NCT00481871|1446215|P1|COMPLETED|Overall Study||7
592185|NCT00481871|1446211|P5|STARTED|Overall Study||34
592186|NCT00481871|1446212|P4|STARTED|Overall Study||38
592187|NCT00481871|1446213|P3|STARTED|Overall Study||18
592188|NCT00481871|1446214|P2|STARTED|Overall Study||10
592189|NCT00481871|1446215|P1|STARTED|Overall Study||7
592190|NCT00481845|1446231|P2|NOT COMPLETED|Overall Study||0
592191|NCT00481845|1446232|P1|NOT COMPLETED|Overall Study||0
592192|NCT00481845|1446231|P2|COMPLETED|Overall Study||0
592193|NCT00481845|1446232|P1|COMPLETED|Overall Study||1
592194|NCT00481845|1446231|P2|STARTED|Overall Study||0
592195|NCT00481845|1446232|P1|STARTED|Overall Study||1
592196|NCT00481832|1446240|P1|NOT COMPLETED|Allogenic Hematopoietic Cell Transplant||0
592197|NCT00481832|1446240|P1|COMPLETED|Allogenic Hematopoietic Cell Transplant||13
592198|NCT00481832|1446240|P1|STARTED|Allogenic Hematopoietic Cell Transplant||13
592199|NCT00481832|1446240|P1|NOT COMPLETED|Inter-transplant Period||27
592200|NCT00481832|1446240|P1|COMPLETED|Inter-transplant Period||13
592201|NCT00481832|1446240|P1|STARTED|Inter-transplant Period||40
592202|NCT00481832|1446240|P1|NOT COMPLETED|Autologous Hematopoietic Cell Transplant||0
592203|NCT00481832|1446240|P1|COMPLETED|Autologous Hematopoietic Cell Transplant||40
592204|NCT00481832|1446240|P1|STARTED|Autologous Hematopoietic Cell Transplant||40
592205|NCT00481832|1446240|P1|NOT COMPLETED|Enrollment||10
592206|NCT00481832|1446240|P1|COMPLETED|Enrollment||40
592207|NCT00481832|1446240|P1|STARTED|Enrollment||50
592208|NCT00481767|1446255|P2|NOT COMPLETED|Overall Study||21
592209|NCT00481767|1446256|P1|NOT COMPLETED|Overall Study||32
592210|NCT00481767|1446255|P2|COMPLETED|Overall Study||205
592211|NCT00481767|1446256|P1|COMPLETED|Overall Study||418
592212|NCT00481767|1446255|P2|STARTED|Overall Study||226
592213|NCT00481767|1446256|P1|STARTED|Overall Study||450
592214|NCT00481676|1446290|P2|NOT COMPLETED|Overall Study||5
592215|NCT00481676|1446291|P1|NOT COMPLETED|Overall Study||2
592216|NCT00481676|1446290|P2|COMPLETED|Overall Study||17
592217|NCT00481676|1446291|P1|COMPLETED|Overall Study||25
592218|NCT00481676|1446290|P2|STARTED|Overall Study||22
592219|NCT00481676|1446291|P1|STARTED|Overall Study||27
592220|NCT00481507|1446315|P2|NOT COMPLETED|Overall Study||0
592221|NCT00481507|1446316|P1|NOT COMPLETED|Overall Study||0
592222|NCT00481507|1446315|P2|COMPLETED|Overall Study||61
592223|NCT00481507|1446316|P1|COMPLETED|Overall Study||64
592224|NCT00481507|1446315|P2|STARTED|Overall Study||61
592225|NCT00481507|1446316|P1|STARTED|Overall Study||64
592226|NCT00481351|1446324|P2|NOT COMPLETED|Overall Study||0
592227|NCT00481351|1446325|P1|NOT COMPLETED|Overall Study||0
592228|NCT00481351|1446324|P2|COMPLETED|Overall Study||12
592229|NCT00481351|1446325|P1|COMPLETED|Overall Study||13
592230|NCT00481351|1446324|P2|STARTED|Overall Study||12
592231|NCT00481351|1446325|P1|STARTED|Overall Study||13
592232|NCT00481247|1446341|P2|NOT COMPLETED|Overall Study||260
592233|NCT00481247|1446342|P1|NOT COMPLETED|Overall Study||259
592234|NCT00481247|1446341|P2|COMPLETED|Overall Study||0
592235|NCT00481247|1446342|P1|COMPLETED|Overall Study||0
592236|NCT00481247|1446341|P2|Received Treatment|Overall Study||258
592237|NCT00481247|1446342|P1|Received Treatment|Overall Study||258
592238|NCT00481247|1446341|P2|STARTED|Overall Study|Randomized|260
592239|NCT00481247|1446342|P1|STARTED|Overall Study|Randomized|259
592240|NCT00481195|1446366|P2|NOT COMPLETED|Overall Study||39
592241|NCT00481195|1446367|P1|NOT COMPLETED|Overall Study||39
592242|NCT00481195|1446366|P2|COMPLETED|Overall Study||90
592243|NCT00481195|1446367|P1|COMPLETED|Overall Study||89
592244|NCT00481195|1446366|P2|STARTED|Overall Study|Four of these subjects were randomized but never received study medication.|129
592245|NCT00481195|1446367|P1|STARTED|Overall Study|Two of these subjects were randomized but never received study medication.|128
592246|NCT00481078|1446453|P2|NOT COMPLETED|Overall Study||20
592247|NCT00481078|1446454|P1|NOT COMPLETED|Overall Study||42
592248|NCT00481078|1446453|P2|COMPLETED|Overall Study||12
592249|NCT00481078|1446454|P1|COMPLETED|Overall Study||20
592250|NCT00481078|1446453|P2|STARTED|Overall Study||32
592251|NCT00481078|1446454|P1|STARTED|Overall Study||62
592252|NCT00481065|1446472|P8|NOT COMPLETED|Overall Study||19
592253|NCT00481065|1446473|P7|NOT COMPLETED|Overall Study||16
592254|NCT00481065|1446474|P6|NOT COMPLETED|Overall Study||24
592255|NCT00481065|1446475|P5|NOT COMPLETED|Overall Study||23
592256|NCT00481065|1446476|P4|NOT COMPLETED|Overall Study||15
592257|NCT00481065|1446477|P3|NOT COMPLETED|Overall Study||19
592258|NCT00481065|1446478|P2|NOT COMPLETED|Overall Study||17
592259|NCT00481065|1446479|P1|NOT COMPLETED|Overall Study||22
592260|NCT00481065|1446472|P8|COMPLETED|Overall Study||30
592261|NCT00481065|1446473|P7|COMPLETED|Overall Study||34
592262|NCT00481065|1446474|P6|COMPLETED|Overall Study||27
592263|NCT00481065|1446475|P5|COMPLETED|Overall Study||28
592264|NCT00481065|1446476|P4|COMPLETED|Overall Study||37
592265|NCT00481065|1446477|P3|COMPLETED|Overall Study||32
592266|NCT00481065|1446478|P2|COMPLETED|Overall Study||33
592267|NCT00481065|1446479|P1|COMPLETED|Overall Study||29
592268|NCT00481065|1446472|P8|STARTED|Overall Study||49
592269|NCT00481065|1446473|P7|STARTED|Overall Study||50
592270|NCT00481065|1446474|P6|STARTED|Overall Study||51
592271|NCT00481065|1446475|P5|STARTED|Overall Study||51
592272|NCT00481065|1446476|P4|STARTED|Overall Study||52
592273|NCT00481065|1446477|P3|STARTED|Overall Study||51
592274|NCT00481065|1446478|P2|STARTED|Overall Study||50
592275|NCT00481065|1446479|P1|STARTED|Overall Study||51
592276|NCT00480987|1446565|P1|NOT COMPLETED|Overall Study||0
592277|NCT00480987|1446565|P1|COMPLETED|Overall Study||27
592278|NCT00480987|1446565|P1|STARTED|Overall Study||27
592279|NCT00480857|1446569|P1|NOT COMPLETED|Overall Study||2
592280|NCT00480857|1446569|P1|COMPLETED|Overall Study||17
592281|NCT00480857|1446569|P1|STARTED|Overall Study||19
592282|NCT00480779|1446579|P2|NOT COMPLETED|Overall Study||3
592283|NCT00480779|1446580|P1|NOT COMPLETED|Overall Study||2
592284|NCT00480779|1446579|P2|COMPLETED|Overall Study||19
592285|NCT00480779|1446580|P1|COMPLETED|Overall Study||24
592286|NCT00480779|1446579|P2|STARTED|Overall Study||22
592287|NCT00480779|1446580|P1|STARTED|Overall Study||26
592288|NCT00480740|1446607|P3|NOT COMPLETED|Overall Study||0
592289|NCT00480740|1446608|P2|NOT COMPLETED|Overall Study||0
592290|NCT00480740|1446609|P1|NOT COMPLETED|Overall Study||0
592291|NCT00480740|1446607|P3|COMPLETED|Overall Study||6
592292|NCT00480740|1446608|P2|COMPLETED|Overall Study||9
592293|NCT00480740|1446609|P1|COMPLETED|Overall Study||26
592294|NCT00480740|1446607|P3|STARTED|Overall Study||6
592295|NCT00480740|1446608|P2|STARTED|Overall Study||9
592296|NCT00480740|1446609|P1|STARTED|Overall Study||26
592297|NCT00480636|1446617|P1|NOT COMPLETED|Overall Study||19
592298|NCT00480636|1446617|P1|COMPLETED|Overall Study||83
592299|NCT00480636|1446617|P1|STARTED|Overall Study||102
592300|NCT00480532|1446629|P4|NOT COMPLETED|Overall Study||1
592301|NCT00480532|1446630|P3|NOT COMPLETED|Overall Study||4
592302|NCT00480532|1446631|P2|NOT COMPLETED|Overall Study||4
592303|NCT00480532|1446632|P1|NOT COMPLETED|Overall Study||2
592304|NCT00480532|1446629|P4|COMPLETED|Overall Study||31
592305|NCT00480532|1446630|P3|COMPLETED|Overall Study||29
592306|NCT00480532|1446631|P2|COMPLETED|Overall Study||29
592307|NCT00480532|1446632|P1|COMPLETED|Overall Study||31
592308|NCT00480532|1446629|P4|STARTED|Overall Study||32
592309|NCT00480532|1446630|P3|STARTED|Overall Study||33
592310|NCT00480532|1446631|P2|STARTED|Overall Study||33
592311|NCT00480532|1446632|P1|STARTED|Overall Study||33
592312|NCT00480493|1446652|P2|NOT COMPLETED|Overall Study||7
592313|NCT00480493|1446653|P1|NOT COMPLETED|Overall Study||2
592314|NCT00480493|1446652|P2|COMPLETED|Overall Study||21
592315|NCT00480493|1446653|P1|COMPLETED|Overall Study||30
592316|NCT00480493|1446652|P2|Randomized|Overall Study||28
592317|NCT00480493|1446653|P1|Randomized|Overall Study||32
592318|NCT00480493|1446652|P2|STARTED|Overall Study||28
592319|NCT00480493|1446653|P1|STARTED|Overall Study||32
592320|NCT00480324|1446665|P2|NOT COMPLETED|Overall Study||16
592321|NCT00480324|1446666|P1|NOT COMPLETED|Overall Study||32
592322|NCT00480324|1446665|P2|COMPLETED|Overall Study||241
592323|NCT00480324|1446666|P1|COMPLETED|Overall Study||476
592324|NCT00480324|1446665|P2|STARTED|Overall Study||257
592325|NCT00480324|1446666|P1|STARTED|Overall Study||508
592326|NCT00479882|1446696|P4|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||18
592327|NCT00479882|1446697|P3|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||20
592328|NCT00479882|1446698|P2|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||21
592329|NCT00479882|1446699|P1|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||25
592330|NCT00479882|1446696|P4|COMPLETED|Crossover: Period III (Weeks 13-20)||447
592331|NCT00479882|1446697|P3|COMPLETED|Crossover: Period III (Weeks 13-20)||420
592332|NCT00479882|1446698|P2|COMPLETED|Crossover: Period III (Weeks 13-20)||419
592333|NCT00479882|1446699|P1|COMPLETED|Crossover: Period III (Weeks 13-20)||447
592334|NCT00479882|1446696|P4|STARTED|Crossover: Period III (Weeks 13-20)||465
592335|NCT00479882|1446697|P3|STARTED|Crossover: Period III (Weeks 13-20)||440
592336|NCT00479882|1446698|P2|STARTED|Crossover: Period III (Weeks 13-20)||440
592337|NCT00479882|1446699|P1|STARTED|Crossover: Period III (Weeks 13-20)||472
592338|NCT00479882|1446696|P4|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||140
592339|NCT00479882|1446697|P3|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||157
592340|NCT00479882|1446698|P2|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||162
592341|NCT00479882|1446699|P1|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||138
592342|NCT00479882|1446696|P4|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||465
592343|NCT00479882|1446697|P3|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440
592344|NCT00479882|1446698|P2|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440
592345|NCT00479882|1446699|P1|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||472
592346|NCT00479882|1446696|P4|STARTED|Precrossover: Periods I/II (Weeks 1-12)||605
592347|NCT00479882|1446697|P3|STARTED|Precrossover: Periods I/II (Weeks 1-12)||597
592348|NCT00479882|1446698|P2|STARTED|Precrossover: Periods I/II (Weeks 1-12)||602
592349|NCT00479882|1446699|P1|STARTED|Precrossover: Periods I/II (Weeks 1-12)||610
592350|NCT00479856|1446829|P1|NOT COMPLETED|Overall Study||3
592351|NCT00479856|1446829|P1|COMPLETED|Overall Study||6
592352|NCT00479856|1446829|P1|STARTED|Overall Study||9
592353|NCT00479765|1446838|P1|NOT COMPLETED|Overall Study||4
592354|NCT00479765|1446838|P1|COMPLETED|Overall Study||0
592355|NCT00479765|1446838|P1|STARTED|Overall Study||4
592356|NCT00479713|1446844|P2|NOT COMPLETED|Overall Study||9
592357|NCT00479713|1446845|P1|NOT COMPLETED|Overall Study||13
592358|NCT00479713|1446844|P2|COMPLETED|Overall Study||295
592359|NCT00479713|1446845|P1|COMPLETED|Overall Study||301
592360|NCT00479713|1446844|P2|STARTED|Overall Study||304
592361|NCT00479713|1446845|P1|STARTED|Overall Study||314
592362|NCT00479674|1446869|P1|NOT COMPLETED|Overall Study||41
592363|NCT00479674|1446869|P1|COMPLETED|Overall Study||0
592364|NCT00479674|1446869|P1|STARTED|Overall Study||41
592365|NCT00479557|1446884|P7|NOT COMPLETED|Overall Study||2
592366|NCT00479557|1446885|P6|NOT COMPLETED|Overall Study||13
592367|NCT00479557|1446886|P5|NOT COMPLETED|Overall Study||4
592368|NCT00479557|1446887|P4|NOT COMPLETED|Overall Study||5
592369|NCT00479557|1446888|P3|NOT COMPLETED|Overall Study||8
592370|NCT00479557|1446889|P2|NOT COMPLETED|Overall Study||10
592371|NCT00479557|1446890|P1|NOT COMPLETED|Overall Study||10
592372|NCT00479557|1446884|P7|COMPLETED|Overall Study||15
592373|NCT00479557|1446885|P6|COMPLETED|Overall Study||31
592374|NCT00479557|1446886|P5|COMPLETED|Overall Study||8
592375|NCT00479557|1446887|P4|COMPLETED|Overall Study||30
592376|NCT00479557|1446888|P3|COMPLETED|Overall Study||32
592377|NCT00479557|1446889|P2|COMPLETED|Overall Study||51
592378|NCT00479557|1446890|P1|COMPLETED|Overall Study||26
592379|NCT00479557|1446884|P7|Treated|Overall Study||17
592380|NCT00479557|1446885|P6|Treated|Overall Study||44
592381|NCT00479557|1446886|P5|Treated|Overall Study||12
592382|NCT00479557|1446887|P4|Treated|Overall Study||35
592383|NCT00479557|1446888|P3|Treated|Overall Study||40
592384|NCT00479557|1446889|P2|Treated|Overall Study|One participant discontinued due to an AE, with an outcome of death.|60
592385|NCT00479557|1446890|P1|Treated|Overall Study||36
592386|NCT00479557|1446884|P7|STARTED|Overall Study||17
592387|NCT00479557|1446885|P6|STARTED|Overall Study||44
592388|NCT00479557|1446886|P5|STARTED|Overall Study||12
592389|NCT00479557|1446887|P4|STARTED|Overall Study||35
592390|NCT00479557|1446888|P3|STARTED|Overall Study||40
592391|NCT00479557|1446889|P2|STARTED|Overall Study||61
592392|NCT00479557|1446890|P1|STARTED|Overall Study||36
592393|NCT00479466|1446933|P6|NOT COMPLETED|Overall Study||4
592394|NCT00479466|1446934|P5|NOT COMPLETED|Overall Study||8
592395|NCT00479466|1446935|P4|NOT COMPLETED|Overall Study||3
592396|NCT00479466|1446936|P3|NOT COMPLETED|Overall Study||3
592397|NCT00479466|1446937|P2|NOT COMPLETED|Overall Study||8
592398|NCT00479466|1446938|P1|NOT COMPLETED|Overall Study||13
592399|NCT00479466|1446933|P6|COMPLETED|Overall Study||53
592400|NCT00479466|1446934|P5|COMPLETED|Overall Study||48
592401|NCT00479466|1446935|P4|COMPLETED|Overall Study||55
592402|NCT00479466|1446936|P3|COMPLETED|Overall Study||54
592403|NCT00479466|1446937|P2|COMPLETED|Overall Study||49
592404|NCT00479466|1446938|P1|COMPLETED|Overall Study||44
592405|NCT00479466|1446933|P6|STARTED|Overall Study||57
592406|NCT00479466|1446934|P5|STARTED|Overall Study||56
592407|NCT00479466|1446935|P4|STARTED|Overall Study||58
592408|NCT00479466|1446936|P3|STARTED|Overall Study||57
592409|NCT00479466|1446937|P2|STARTED|Overall Study||57
592410|NCT00479466|1446938|P1|STARTED|Overall Study||57
592411|NCT00479401|1446967|P3|NOT COMPLETED|Overall Study||12
592412|NCT00479401|1446968|P2|NOT COMPLETED|Overall Study||37
592413|NCT00479401|1446969|P1|NOT COMPLETED|Overall Study||49
592414|NCT00479401|1446967|P3|COMPLETED|Overall Study||91
592415|NCT00479401|1446968|P2|COMPLETED|Overall Study||176
592416|NCT00479401|1446969|P1|COMPLETED|Overall Study||174
592417|NCT00479401|1446967|P3|STARTED|Overall Study||103
592418|NCT00479401|1446968|P2|STARTED|Overall Study||213
592419|NCT00479401|1446969|P1|STARTED|Overall Study||223
592420|NCT00479388|1447024|P2|NOT COMPLETED|Overall Study||73
592421|NCT00479388|1447025|P1|NOT COMPLETED|Overall Study||132
592422|NCT00479388|1447024|P2|COMPLETED|Overall Study||537
592423|NCT00479388|1447025|P1|COMPLETED|Overall Study||474
592424|NCT00479388|1447024|P2|STARTED|Overall Study||610
592425|NCT00479388|1447025|P1|STARTED|Overall Study||606
592426|NCT00479336|1447039|P4|NOT COMPLETED|Overall Study||5
592427|NCT00479336|1447040|P3|NOT COMPLETED|Overall Study||1
592428|NCT00479336|1447041|P2|NOT COMPLETED|Overall Study||6
592429|NCT00479336|1447042|P1|NOT COMPLETED|Overall Study||4
592430|NCT00479336|1447039|P4|COMPLETED|Overall Study||21
592431|NCT00479336|1447040|P3|COMPLETED|Overall Study||24
592432|NCT00479336|1447041|P2|COMPLETED|Overall Study||20
592433|NCT00479336|1447042|P1|COMPLETED|Overall Study||23
592434|NCT00479336|1447039|P4|STARTED|Overall Study||26
592435|NCT00479336|1447040|P3|STARTED|Overall Study||25
592436|NCT00479336|1447041|P2|STARTED|Overall Study||26
592437|NCT00479336|1447042|P1|STARTED|Overall Study||27
592438|NCT00479258|1447058|P2|NOT COMPLETED|Overall Study||0
592439|NCT00479258|1447059|P1|NOT COMPLETED|Overall Study||0
592440|NCT00479258|1447058|P2|COMPLETED|Overall Study||0
592441|NCT00479258|1447059|P1|COMPLETED|Overall Study||0
592442|NCT00479258|1447058|P2|STARTED|Overall Study||0
592443|NCT00479258|1447059|P1|STARTED|Overall Study||0
592444|NCT00479232|1447065|P6|NOT COMPLETED|Overall Study||30
592445|NCT00479232|1447066|P5|NOT COMPLETED|Overall Study||4
592446|NCT00479232|1447067|P4|NOT COMPLETED|Overall Study||3
592447|NCT00479232|1447068|P3|NOT COMPLETED|Overall Study||28
592448|NCT00479232|1447069|P2|NOT COMPLETED|Overall Study||3
592449|NCT00479232|1447070|P1|NOT COMPLETED|Overall Study||3
592450|NCT00479232|1447065|P6|COMPLETED|Overall Study||0
592451|NCT00479232|1447066|P5|COMPLETED|Overall Study||0
592452|NCT00479232|1447067|P4|COMPLETED|Overall Study||0
592453|NCT00479232|1447068|P3|COMPLETED|Overall Study||0
592454|NCT00479232|1447069|P2|COMPLETED|Overall Study||0
592455|NCT00479232|1447070|P1|COMPLETED|Overall Study||0
592456|NCT00479232|1447065|P6|STARTED|Overall Study||30
592457|NCT00479232|1447066|P5|STARTED|Overall Study||4
592458|NCT00479232|1447067|P4|STARTED|Overall Study||3
592459|NCT00479232|1447068|P3|STARTED|Overall Study||28
592460|NCT00479232|1447069|P2|STARTED|Overall Study||3
592461|NCT00479232|1447070|P1|STARTED|Overall Study||3
592462|NCT00479154|1447090|P2|NOT COMPLETED|Overall Study||0
592463|NCT00479154|1447091|P1|NOT COMPLETED|Overall Study||0
592464|NCT00479154|1447090|P2|COMPLETED|Overall Study||3
592465|NCT00479154|1447091|P1|COMPLETED|Overall Study||3
592466|NCT00479154|1447090|P2|STARTED|Overall Study||3
592467|NCT00479154|1447091|P1|STARTED|Overall Study||3
592468|NCT00479089|1447099|P2|NOT COMPLETED|Overall Study||0
592469|NCT00479089|1447100|P1|NOT COMPLETED|Overall Study||0
592470|NCT00479089|1447099|P2|COMPLETED|Overall Study||25
592471|NCT00479089|1447100|P1|COMPLETED|Overall Study||25
592472|NCT00479089|1447099|P2|STARTED|Overall Study||25
592473|NCT00479089|1447100|P1|STARTED|Overall Study||25
592474|NCT00479037|1447112|P2|NOT COMPLETED|Overall Study||6
592475|NCT00479037|1447113|P1|NOT COMPLETED|Overall Study||3
592476|NCT00479037|1447112|P2|COMPLETED|Overall Study||34
592477|NCT00479037|1447113|P1|COMPLETED|Overall Study||38
592478|NCT00479037|1447112|P2|STARTED|Overall Study||40
592479|NCT00479037|1447113|P1|STARTED|Overall Study||41
592480|NCT00478933|1447123|P1|NOT COMPLETED|Overall Study||78
592481|NCT00478933|1447123|P1|COMPLETED|Overall Study||1145
592482|NCT00478933|1447123|P1|STARTED|Overall Study||1223
592483|NCT00478881|1447149|P2|NOT COMPLETED|Overall Study||22
592484|NCT00478881|1447150|P1|NOT COMPLETED|Overall Study||39
592485|NCT00478881|1447149|P2|COMPLETED|Overall Study||176
592486|NCT00478881|1447150|P1|COMPLETED|Overall Study||160
592487|NCT00478881|1447149|P2|Received Medication|Overall Study||198
592488|NCT00478881|1447150|P1|Received Medication|Overall Study||198
592489|NCT00478881|1447149|P2|STARTED|Overall Study||198
592490|NCT00478881|1447150|P1|STARTED|Overall Study||199
592491|NCT00478777|1447174|P1|NOT COMPLETED|Overall Study||77
592492|NCT00478777|1447174|P1|COMPLETED|Overall Study|10 participants had >= 6 months and 63 participants < 6 months treatment prior to study termination.|73
592493|NCT00478777|1447174|P1|Safety and Full Analysis Set (FAS)|Overall Study|6 enrolled participants did not receive lenalidomide.|144
592494|NCT00478777|1447174|P1|STARTED|Overall Study||150
592495|NCT00478673|1447181|P1|NOT COMPLETED|12-Months Post-Procedure||64
592496|NCT00478673|1447181|P1|COMPLETED|12-Months Post-Procedure||231
592497|NCT00478673|1447181|P1|STARTED|12-Months Post-Procedure|3 participants who did not complete Period 1 due to death (2) and withdrawal (1) are not included.|295
592498|NCT00478673|1447181|P1|NOT COMPLETED|30-Days Post-Procedure||10
592499|NCT00478673|1447181|P1|COMPLETED|30-Days Post-Procedure|"7 participants who did not complete this Period due to Missed Visit still continued on to Period 2"|288
592500|NCT00478673|1447181|P1|STARTED|30-Days Post-Procedure||298
592501|NCT00478647|1447186|P1|NOT COMPLETED|Overall Study||2
592502|NCT00478647|1447186|P1|COMPLETED|Overall Study|Intent-to-Treat (ITT)=participants who have received at least 1 full or partial dose of study drug.|38
592503|NCT00478647|1447186|P1|STARTED|Overall Study||40
592504|NCT00478608|1447194|P1|NOT COMPLETED|Overall Study||20
592505|NCT00478608|1447194|P1|COMPLETED|Overall Study||59
592506|NCT00478608|1447194|P1|STARTED|Overall Study||79
592507|NCT00478569|1447202|P1|NOT COMPLETED|Overall Study||409
592508|NCT00478569|1447202|P1|COMPLETED|Overall Study||761
592509|NCT00478569|1447202|P1|STARTED|Overall Study||1170
592510|NCT00478556|1447218|P2|NOT COMPLETED|Overall Study||0
592511|NCT00478556|1447219|P1|NOT COMPLETED|Overall Study||0
592512|NCT00478556|1447218|P2|COMPLETED|Overall Study||149
592513|NCT00478556|1447219|P1|COMPLETED|Overall Study||151
592514|NCT00478556|1447218|P2|STARTED|Overall Study||149
592515|NCT00478556|1447219|P1|STARTED|Overall Study||151
592516|NCT00478335|1447229|P2|NOT COMPLETED|Period 2 (4 Days)||0
592517|NCT00478335|1447230|P1|NOT COMPLETED|Period 2 (4 Days)||0
592518|NCT00478335|1447229|P2|COMPLETED|Period 2 (4 Days)||2
592519|NCT00478335|1447230|P1|COMPLETED|Period 2 (4 Days)||2
592520|NCT00478335|1447229|P2|STARTED|Period 2 (4 Days)||2
592521|NCT00478335|1447230|P1|STARTED|Period 2 (4 Days)||2
592522|NCT00478335|1447229|P2|NOT COMPLETED|Period 1 (4 Days)||0
592523|NCT00478335|1447230|P1|NOT COMPLETED|Period 1 (4 Days)||0
592524|NCT00478335|1447229|P2|COMPLETED|Period 1 (4 Days)||2
592525|NCT00478335|1447230|P1|COMPLETED|Period 1 (4 Days)||2
592526|NCT00478335|1447229|P2|STARTED|Period 1 (4 Days)||2
592527|NCT00478335|1447230|P1|STARTED|Period 1 (4 Days)||2
592528|NCT00478257|1447238|P2|NOT COMPLETED|Overall Study||3
592529|NCT00478257|1447239|P1|NOT COMPLETED|Overall Study||8
592530|NCT00478257|1447238|P2|COMPLETED|Overall Study||13
592531|NCT00478257|1447239|P1|COMPLETED|Overall Study||15
592532|NCT00478257|1447238|P2|STARTED|Overall Study||16
592533|NCT00478257|1447239|P1|STARTED|Overall Study||23
592534|NCT00478244|1447245|P1|NOT COMPLETED|Overall Study||1
592535|NCT00478244|1447245|P1|COMPLETED|Overall Study||6
592536|NCT00478244|1447245|P1|STARTED|Overall Study||7
592537|NCT00478231|1447258|P1|NOT COMPLETED|Overall Study||84
592538|NCT00478231|1447258|P1|COMPLETED|Overall Study||125
592539|NCT00478231|1447258|P1|Treated|Overall Study||206
592540|NCT00478231|1447258|P1|STARTED|Overall Study||209
592541|NCT00478218|1447279|P2|NOT COMPLETED|Overall Study||0
592542|NCT00478218|1447280|P1|NOT COMPLETED|Overall Study||0
592543|NCT00478218|1447279|P2|COMPLETED|Overall Study||19
592544|NCT00478218|1447280|P1|COMPLETED|Overall Study||34
592545|NCT00478218|1447279|P2|STARTED|Overall Study||19
592546|NCT00478218|1447280|P1|STARTED|Overall Study||34
592547|NCT00478205|1447294|P2|NOT COMPLETED|Overall Study||87
592548|NCT00478205|1447295|P1|NOT COMPLETED|Overall Study||296
592549|NCT00478205|1447294|P2|COMPLETED|Overall Study||399
592550|NCT00478205|1447295|P1|COMPLETED|Overall Study||685
592551|NCT00478205|1447294|P2|STARTED|Overall Study||486
592552|NCT00478205|1447295|P1|STARTED|Overall Study||981
592553|NCT00478192|1447310|P3|NOT COMPLETED|Overall Study||2
592554|NCT00478192|1447311|P2|NOT COMPLETED|Overall Study||5
592555|NCT00478192|1447312|P1|NOT COMPLETED|Overall Study||4
592556|NCT00478192|1447310|P3|COMPLETED|Overall Study||8
592557|NCT00478192|1447311|P2|COMPLETED|Overall Study||15
592558|NCT00478192|1447312|P1|COMPLETED|Overall Study||16
592559|NCT00478192|1447310|P3|End of Treatment|Overall Study||8
592560|NCT00478192|1447311|P2|End of Treatment|Overall Study||16
592561|NCT00478192|1447312|P1|End of Treatment|Overall Study||18
592562|NCT00478192|1447310|P3|Full Analysis Set / Safety Analysis Set|Overall Study||9
592563|NCT00478192|1447311|P2|Full Analysis Set / Safety Analysis Set|Overall Study||20
592564|NCT00478192|1447312|P1|Full Analysis Set / Safety Analysis Set|Overall Study||20
592565|NCT00478192|1447310|P3|STARTED|Overall Study||10
592566|NCT00478192|1447311|P2|STARTED|Overall Study||20
592567|NCT00478192|1447312|P1|STARTED|Overall Study||20
592568|NCT00478140|1447339|P1|NOT COMPLETED|Overall Study||3
592569|NCT00478140|1447339|P1|COMPLETED|Overall Study||1
592570|NCT00478140|1447339|P1|STARTED|Overall Study||4
592571|NCT00478062|1447343|P1|NOT COMPLETED|Overall Study||0
592572|NCT00478062|1447343|P1|COMPLETED|Overall Study||1
592573|NCT00478062|1447343|P1|STARTED|Overall Study||1
592574|NCT00478036|1447353|P3|NOT COMPLETED|Overall Study||0
592575|NCT00478036|1447354|P2|NOT COMPLETED|Overall Study||0
592576|NCT00478036|1447355|P1|NOT COMPLETED|Overall Study||0
592577|NCT00478036|1447353|P3|COMPLETED|Overall Study||14
592578|NCT00478036|1447354|P2|COMPLETED|Overall Study||7
592579|NCT00478036|1447355|P1|COMPLETED|Overall Study||10
592580|NCT00478036|1447353|P3|STARTED|Overall Study||14
592581|NCT00478036|1447354|P2|STARTED|Overall Study||7
592582|NCT00478036|1447355|P1|STARTED|Overall Study||10
592583|NCT00478023|1447368|P5|NOT COMPLETED|Overall Study||55
592584|NCT00478023|1447369|P4|NOT COMPLETED|Overall Study||30
592585|NCT00478023|1447370|P3|NOT COMPLETED|Overall Study||20
592586|NCT00478023|1447371|P2|NOT COMPLETED|Overall Study||24
592587|NCT00478023|1447372|P1|NOT COMPLETED|Overall Study||35
592588|NCT00478023|1447368|P5|COMPLETED|Overall Study||114
592589|NCT00478023|1447369|P4|COMPLETED|Overall Study||146
592590|NCT00478023|1447370|P3|COMPLETED|Overall Study||151
592591|NCT00478023|1447371|P2|COMPLETED|Overall Study||144
592592|NCT00478023|1447372|P1|COMPLETED|Overall Study||135
592593|NCT00478023|1447368|P5|STARTED|Overall Study||169
592594|NCT00478023|1447369|P4|STARTED|Overall Study||176
592595|NCT00478023|1447370|P3|STARTED|Overall Study||171
592596|NCT00478023|1447371|P2|STARTED|Overall Study||168
592597|NCT00478023|1447372|P1|STARTED|Overall Study||170
592598|NCT00477971|1447391|P2|NOT COMPLETED|Overall Study||6
592599|NCT00477971|1447392|P1|NOT COMPLETED|Overall Study||17
592600|NCT00477971|1447391|P2|COMPLETED|Overall Study||49
592601|NCT00477971|1447392|P1|COMPLETED|Overall Study||17
592602|NCT00477971|1447391|P2|STARTED|Overall Study||55
592603|NCT00477971|1447392|P1|STARTED|Overall Study||34
592604|NCT00477750|1447404|P1|NOT COMPLETED|Overall Study||11
592605|NCT00477750|1447404|P1|COMPLETED|Overall Study||15
592606|NCT00477750|1447404|P1|STARTED|Overall Study||26
592607|NCT00477685|1447408|P1|NOT COMPLETED|Overall Study||0
592608|NCT00477685|1447408|P1|COMPLETED|Overall Study||10
592609|NCT00477685|1447408|P1|STARTED|Overall Study||10
592610|NCT00477672|1447416|P3|NOT COMPLETED|Overall Study||16
592611|NCT00477672|1447417|P2|NOT COMPLETED|Overall Study||16
592612|NCT00477672|1447418|P1|NOT COMPLETED|Overall Study||7
592613|NCT00477672|1447416|P3|COMPLETED|Overall Study||83
592614|NCT00477672|1447417|P2|COMPLETED|Overall Study||85
592615|NCT00477672|1447418|P1|COMPLETED|Overall Study||91
592616|NCT00477672|1447416|P3|STARTED|Overall Study||99
592617|NCT00477672|1447417|P2|STARTED|Overall Study||101
592618|NCT00477672|1447418|P1|STARTED|Overall Study||98
592619|NCT00477633|1447429|P1|NOT COMPLETED|Overall Study||709
592620|NCT00477633|1447429|P1|COMPLETED|Overall Study||991
592621|NCT00477633|1447429|P1|STARTED|Overall Study||1700
592622|NCT00477607|1447437|P2|NOT COMPLETED|Overall Study||7
592623|NCT00477607|1447438|P1|NOT COMPLETED|Overall Study||7
592624|NCT00477607|1447437|P2|COMPLETED|Overall Study||13
592625|NCT00477607|1447438|P1|COMPLETED|Overall Study||12
592626|NCT00477607|1447437|P2|STARTED|Overall Study||20
592627|NCT00477607|1447438|P1|STARTED|Overall Study||19
592628|NCT00477594|1447450|P2|NOT COMPLETED|Follow-up Period||1
592629|NCT00477594|1447451|P1|NOT COMPLETED|Follow-up Period||3
592630|NCT00477594|1447450|P2|COMPLETED|Follow-up Period||4
592631|NCT00477594|1447451|P1|COMPLETED|Follow-up Period||13
592632|NCT00477594|1447450|P2|STARTED|Follow-up Period||5
592633|NCT00477594|1447451|P1|STARTED|Follow-up Period||16
592634|NCT00477594|1447450|P2|NOT COMPLETED|Year 3||0
592635|NCT00477594|1447451|P1|NOT COMPLETED|Year 3||2
592636|NCT00477594|1447450|P2|COMPLETED|Year 3||0
592637|NCT00477594|1447451|P1|COMPLETED|Year 3||2
592638|NCT00477594|1447450|P2|STARTED|Year 3||0
592639|NCT00477594|1447451|P1|STARTED|Year 3||4
592640|NCT00477594|1447450|P2|NOT COMPLETED|Year 1 and Year 2||4
592641|NCT00477594|1447451|P1|NOT COMPLETED|Year 1 and Year 2||9
592642|NCT00477594|1447450|P2|COMPLETED|Year 1 and Year 2||1
592643|NCT00477594|1447451|P1|COMPLETED|Year 1 and Year 2||7
592644|NCT00477594|1447450|P2|STARTED|Year 1 and Year 2||5
592645|NCT00477594|1447451|P1|STARTED|Year 1 and Year 2||16
592646|NCT00477490|1447512|P9|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||8
592647|NCT00477490|1447513|P8|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5
592648|NCT00477490|1447514|P7|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5
592649|NCT00477490|1447515|P6|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||6
592650|NCT00477490|1447516|P5|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||20
592651|NCT00477490|1447517|P4|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||12
592652|NCT00477490|1447518|P3|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||15
592653|NCT00477490|1447519|P2|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||28
592654|NCT00477490|1447520|P1|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||0
592655|NCT00477490|1447512|P9|COMPLETED|Part II: Extension Week 5 up to Day 169||26
592656|NCT00477490|1447513|P8|COMPLETED|Part II: Extension Week 5 up to Day 169||29
592657|NCT00477490|1447514|P7|COMPLETED|Part II: Extension Week 5 up to Day 169||32
592658|NCT00477490|1447515|P6|COMPLETED|Part II: Extension Week 5 up to Day 169||25
592659|NCT00477490|1447516|P5|COMPLETED|Part II: Extension Week 5 up to Day 169||107
592660|NCT00477490|1447517|P4|COMPLETED|Part II: Extension Week 5 up to Day 169||120
592661|NCT00477490|1447518|P3|COMPLETED|Part II: Extension Week 5 up to Day 169||120
592662|NCT00477490|1447519|P2|COMPLETED|Part II: Extension Week 5 up to Day 169||107
592663|NCT00477490|1447520|P1|COMPLETED|Part II: Extension Week 5 up to Day 169||0
592664|NCT00477490|1447512|P9|STARTED|Part II: Extension Week 5 up to Day 169||34
592665|NCT00477490|1447513|P8|STARTED|Part II: Extension Week 5 up to Day 169||34
592666|NCT00477490|1447514|P7|STARTED|Part II: Extension Week 5 up to Day 169||37
592667|NCT00477490|1447515|P6|STARTED|Part II: Extension Week 5 up to Day 169||31
592668|NCT00477490|1447516|P5|STARTED|Part II: Extension Week 5 up to Day 169||127
592669|NCT00477490|1447517|P4|STARTED|Part II: Extension Week 5 up to Day 169||132
592670|NCT00477490|1447518|P3|STARTED|Part II: Extension Week 5 up to Day 169||135
592671|NCT00477490|1447519|P2|STARTED|Part II: Extension Week 5 up to Day 169||135
592672|NCT00477490|1447520|P1|STARTED|Part II: Extension Week 5 up to Day 169||0
592673|NCT00477490|1447512|P9|NOT COMPLETED|Part I: 4 Week Efficacy||0
592674|NCT00477490|1447513|P8|NOT COMPLETED|Part I: 4 Week Efficacy||0
592675|NCT00477490|1447514|P7|NOT COMPLETED|Part I: 4 Week Efficacy||0
592676|NCT00477490|1447515|P6|NOT COMPLETED|Part I: 4 Week Efficacy||0
592677|NCT00477490|1447516|P5|NOT COMPLETED|Part I: 4 Week Efficacy||25
592678|NCT00477490|1447517|P4|NOT COMPLETED|Part I: 4 Week Efficacy||20
592679|NCT00477490|1447518|P3|NOT COMPLETED|Part I: 4 Week Efficacy||10
592680|NCT00477490|1447519|P2|NOT COMPLETED|Part I: 4 Week Efficacy||19
592681|NCT00477490|1447520|P1|NOT COMPLETED|Part I: 4 Week Efficacy||15
592682|NCT00477490|1447512|P9|COMPLETED|Part I: 4 Week Efficacy||0
592683|NCT00477490|1447513|P8|COMPLETED|Part I: 4 Week Efficacy||0
592684|NCT00477490|1447514|P7|COMPLETED|Part I: 4 Week Efficacy||0
592685|NCT00477490|1447515|P6|COMPLETED|Part I: 4 Week Efficacy||0
592686|NCT00477490|1447516|P5|COMPLETED|Part I: 4 Week Efficacy||135
592687|NCT00477490|1447517|P4|COMPLETED|Part I: 4 Week Efficacy||138
592688|NCT00477490|1447518|P3|COMPLETED|Part I: 4 Week Efficacy||148
592689|NCT00477490|1447519|P2|COMPLETED|Part I: 4 Week Efficacy||144
592690|NCT00477490|1447520|P1|COMPLETED|Part I: 4 Week Efficacy||145
592691|NCT00477490|1447512|P9|ITT Population|Part I: 4 Week Efficacy||0
592692|NCT00477490|1447513|P8|ITT Population|Part I: 4 Week Efficacy||0
592693|NCT00477490|1447514|P7|ITT Population|Part I: 4 Week Efficacy||0
592694|NCT00477490|1447515|P6|ITT Population|Part I: 4 Week Efficacy||0
592695|NCT00477490|1447516|P5|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|146
592696|NCT00477490|1447517|P4|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|148
592697|NCT00477490|1447518|P3|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|152
592698|NCT00477490|1447519|P2|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|155
592699|NCT00477490|1447520|P1|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|156
592700|NCT00477490|1447512|P9|STARTED|Part I: 4 Week Efficacy||0
592701|NCT00477490|1447513|P8|STARTED|Part I: 4 Week Efficacy||0
592702|NCT00477490|1447514|P7|STARTED|Part I: 4 Week Efficacy||0
592703|NCT00477490|1447515|P6|STARTED|Part I: 4 Week Efficacy||0
592704|NCT00477490|1447516|P5|STARTED|Part I: 4 Week Efficacy||160
592705|NCT00477490|1447517|P4|STARTED|Part I: 4 Week Efficacy||158
592706|NCT00477490|1447518|P3|STARTED|Part I: 4 Week Efficacy||158
592707|NCT00477490|1447519|P2|STARTED|Part I: 4 Week Efficacy||163
592708|NCT00477490|1447520|P1|STARTED|Part I: 4 Week Efficacy||160
592709|NCT00477464|1447604|P1|NOT COMPLETED|Overall Study||51
592710|NCT00477464|1447604|P1|COMPLETED|Overall Study||0
592711|NCT00477464|1447604|P1|STARTED|Overall Study||51
592712|NCT00477451|1447631|P4|NOT COMPLETED|Overall Study||0
592713|NCT00477451|1447632|P3|NOT COMPLETED|Overall Study||0
592714|NCT00477451|1447633|P2|NOT COMPLETED|Overall Study||0
592715|NCT00477451|1447634|P1|NOT COMPLETED|Overall Study||0
592716|NCT00477451|1447631|P4|COMPLETED|Overall Study||2
592717|NCT00477451|1447632|P3|COMPLETED|Overall Study||7
592718|NCT00477451|1447633|P2|COMPLETED|Overall Study||20
592719|NCT00477451|1447634|P1|COMPLETED|Overall Study||20
592720|NCT00477451|1447631|P4|STARTED|Overall Study||2
592721|NCT00477451|1447632|P3|STARTED|Overall Study||7
592722|NCT00477451|1447633|P2|STARTED|Overall Study||20
592723|NCT00477451|1447634|P1|STARTED|Overall Study||20
592724|NCT00477386|1447648|P2|NOT COMPLETED|Overall Study||17
592725|NCT00477386|1447649|P1|NOT COMPLETED|Overall Study||11
592726|NCT00477386|1447648|P2|COMPLETED|Overall Study||0
592727|NCT00477386|1447649|P1|COMPLETED|Overall Study||0
592728|NCT00477386|1447648|P2|STARTED|Overall Study||17
592729|NCT00477386|1447649|P1|STARTED|Overall Study||11
592730|NCT00477334|1447659|P2|NOT COMPLETED|Overall Study||76
592731|NCT00477334|1447660|P1|NOT COMPLETED|Overall Study||170
592732|NCT00477334|1447659|P2|COMPLETED|Overall Study|Participants completing the first recurrence and follow-up.|75
592733|NCT00477334|1447660|P1|COMPLETED|Overall Study|Participants completing the first recurrence and follow-up.|142
592734|NCT00477334|1447659|P2|Modified Intent to Treat Population|Overall Study||78
592735|NCT00477334|1447660|P1|Modified Intent to Treat Population|Overall Study||152
592736|NCT00477334|1447659|P2|Participants Completing First Recurrence|Overall Study||92
592737|NCT00477334|1447660|P1|Participants Completing First Recurrence|Overall Study||187
592738|NCT00477334|1447659|P2|Intent to Treat Population|Overall Study||98
592739|NCT00477334|1447660|P1|Intent to Treat Population|Overall Study||201
592740|NCT00477334|1447659|P2|Randomized and Took Study Drug|Overall Study||98
592741|NCT00477334|1447660|P1|Randomized and Took Study Drug|Overall Study||206
592742|NCT00477334|1447659|P2|STARTED|Overall Study||151
592743|NCT00477334|1447660|P1|STARTED|Overall Study||312
592744|NCT00477295|1447686|P2|NOT COMPLETED|Overall Study||109
592745|NCT00477295|1447687|P1|NOT COMPLETED|Overall Study||121
592746|NCT00477295|1447686|P2|COMPLETED|Overall Study||192
592747|NCT00477295|1447687|P1|COMPLETED|Overall Study||161
592748|NCT00477295|1447686|P2|STARTED|Overall Study||301
592749|NCT00477295|1447687|P1|STARTED|Overall Study||282
592750|NCT00477269|1447715|P3|NOT COMPLETED|Open Label Extension||13
592751|NCT00477269|1447716|P2|NOT COMPLETED|Open Label Extension||0
592752|NCT00477269|1447717|P1|NOT COMPLETED|Open Label Extension||0
592753|NCT00477269|1447715|P3|COMPLETED|Open Label Extension||9
592754|NCT00477269|1447716|P2|COMPLETED|Open Label Extension|Arm in the Core study not extension|0
592755|NCT00477269|1447717|P1|COMPLETED|Open Label Extension|Arm in the Core study not extension|0
592756|NCT00477269|1447715|P3|STARTED|Open Label Extension||22
592757|NCT00477269|1447716|P2|STARTED|Open Label Extension|Arm in the Core study not extension|0
592758|NCT00477269|1447717|P1|STARTED|Open Label Extension|Arm in the Core study not extension|0
592759|NCT00477269|1447715|P3|NOT COMPLETED|Core Study||0
592760|NCT00477269|1447716|P2|NOT COMPLETED|Core Study||8
592761|NCT00477269|1447717|P1|NOT COMPLETED|Core Study||9
592762|NCT00477269|1447715|P3|COMPLETED|Core Study||0
592763|NCT00477269|1447716|P2|COMPLETED|Core Study||23
592764|NCT00477269|1447717|P1|COMPLETED|Core Study||19
592765|NCT00477269|1447715|P3|STARTED|Core Study||0
592766|NCT00477269|1447716|P2|STARTED|Core Study||31
592767|NCT00477269|1447717|P1|STARTED|Core Study||28
592768|NCT00477230|1447771|P2|NOT COMPLETED|Overall Study||31
592769|NCT00477230|1447772|P1|NOT COMPLETED|Overall Study||20
592770|NCT00477230|1447771|P2|COMPLETED|Overall Study||1
592771|NCT00477230|1447772|P1|COMPLETED|Overall Study||12
592772|NCT00477230|1447771|P2|STARTED|Overall Study||32
592773|NCT00477230|1447772|P1|STARTED|Overall Study||32
592774|NCT00477204|1447780|P2|NOT COMPLETED|Overall Study||0
592775|NCT00477204|1447781|P1|NOT COMPLETED|Overall Study||0
592776|NCT00477204|1447780|P2|COMPLETED|Overall Study||5
592777|NCT00477204|1447781|P1|COMPLETED|Overall Study||4
592778|NCT00477204|1447780|P2|STARTED|Overall Study||5
592779|NCT00477204|1447781|P1|STARTED|Overall Study||4
592780|NCT00477191|1447787|P1|NOT COMPLETED|Overall Study||5
592781|NCT00477191|1447787|P1|COMPLETED|Overall Study||13
592782|NCT00477191|1447787|P1|STARTED|Overall Study||18
592783|NCT00477165|1447796|P2|NOT COMPLETED|Overall Study||2
592784|NCT00477165|1447797|P1|NOT COMPLETED|Overall Study||7
592785|NCT00477165|1447796|P2|COMPLETED|Overall Study||25
592786|NCT00477165|1447797|P1|COMPLETED|Overall Study||20
592787|NCT00477165|1447796|P2|STARTED|Overall Study||27
592788|NCT00477165|1447797|P1|STARTED|Overall Study||27
592789|NCT00477152|1447809|P1|NOT COMPLETED|Overall Study||3
592790|NCT00477152|1447809|P1|COMPLETED|Overall Study|Two patients treated, but assessments incomplete. All available data included in analyses for these.|49
592791|NCT00477152|1447809|P1|STARTED|Overall Study|One patient withdrawn prior to treatment, so not included in analyses.|52
592792|NCT00477087|1447816|P1|NOT COMPLETED|Overall Study||0
592793|NCT00477087|1447816|P1|COMPLETED|Overall Study||10
592794|NCT00477087|1447816|P1|STARTED|Overall Study||10
592795|NCT00476957|1447824|P2|NOT COMPLETED|Overall Study||193
592796|NCT00476957|1447825|P1|NOT COMPLETED|Overall Study||176
592797|NCT00476957|1447824|P2|COMPLETED|Overall Study||4159
592798|NCT00476957|1447825|P1|COMPLETED|Overall Study||4181
592799|NCT00476957|1447824|P2|STARTED|Overall Study||4352
592800|NCT00476957|1447825|P1|STARTED|Overall Study||4357
592801|NCT00476827|1447839|P6|NOT COMPLETED|Overall Study||0
592802|NCT00476827|1447840|P5|NOT COMPLETED|Overall Study||0
592803|NCT00476827|1447841|P4|NOT COMPLETED|Overall Study||0
592804|NCT00476827|1447842|P3|NOT COMPLETED|Overall Study||0
592805|NCT00476827|1447843|P2|NOT COMPLETED|Overall Study||0
592806|NCT00476827|1447844|P1|NOT COMPLETED|Overall Study||0
592807|NCT00476827|1447839|P6|COMPLETED|Overall Study||2
592808|NCT00476827|1447840|P5|COMPLETED|Overall Study||2
592809|NCT00476827|1447841|P4|COMPLETED|Overall Study||0
592810|NCT00476827|1447842|P3|COMPLETED|Overall Study||1
592811|NCT00476827|1447843|P2|COMPLETED|Overall Study||0
592812|NCT00476827|1447844|P1|COMPLETED|Overall Study||3
592813|NCT00476827|1447839|P6|STARTED|Overall Study||2
592814|NCT00476827|1447840|P5|STARTED|Overall Study||2
592815|NCT00476827|1447841|P4|STARTED|Overall Study||0
592816|NCT00476827|1447842|P3|STARTED|Overall Study||1
592817|NCT00476827|1447843|P2|STARTED|Overall Study||0
592818|NCT00476827|1447844|P1|STARTED|Overall Study||3
592819|NCT00476788|1447874|P1|NOT COMPLETED|Overall Study||3
592820|NCT00476788|1447874|P1|COMPLETED|Overall Study||11
592821|NCT00476788|1447874|P1|STARTED|Overall Study||14
592822|NCT00476645|1447879|P1|NOT COMPLETED|Overall Study||0
592823|NCT00476645|1447879|P1|COMPLETED|Overall Study||10
592824|NCT00476645|1447879|P1|STARTED|Overall Study||10
592825|NCT00476593|1447889|P4|NOT COMPLETED|Overall Study||22
592826|NCT00476593|1447890|P3|NOT COMPLETED|Overall Study||8
592827|NCT00476593|1447891|P2|NOT COMPLETED|Overall Study||2
592828|NCT00476593|1447892|P1|NOT COMPLETED|Overall Study||10
592829|NCT00476593|1447889|P4|COMPLETED|Overall Study||107
592830|NCT00476593|1447890|P3|COMPLETED|Overall Study||30
592831|NCT00476593|1447891|P2|COMPLETED|Overall Study|all subjects completed treatment in one eye. However, bilateral OCT scans included only in 17 cases|17
592832|NCT00476593|1447892|P1|COMPLETED|Overall Study|all subjects completed treatment in one eye. However, bilateral OCT scans included only in 22 cases|22
592833|NCT00476593|1447889|P4|STARTED|Overall Study||129
592834|NCT00476593|1447890|P3|STARTED|Overall Study||38
592835|NCT00476593|1447891|P2|STARTED|Overall Study||19
592836|NCT00476593|1447892|P1|STARTED|Overall Study||32
592837|NCT00476476|1447904|P2|NOT COMPLETED|Overall Study||24
592838|NCT00476476|1447905|P1|NOT COMPLETED|Overall Study||2
592839|NCT00476476|1447904|P2|COMPLETED|Overall Study|Treatment was not of fixed duration and thus pts are not considered to have 'Completed' treatment.|0
592840|NCT00476476|1447905|P1|COMPLETED|Overall Study||15
592841|NCT00476476|1447904|P2|Response Evaluable|Overall Study|One woman was unevaluable due to an allergic reaction that developed after the 2nd dose.|23
592842|NCT00476476|1447905|P1|Response Evaluable|Overall Study||17
592843|NCT00476476|1447904|P2|STARTED|Overall Study||24
592844|NCT00476476|1447905|P1|STARTED|Overall Study||17
592845|NCT00476242|1447912|P2|NOT COMPLETED|Overall Study||16
592846|NCT00476242|1447913|P1|NOT COMPLETED|Overall Study||8
592847|NCT00476242|1447912|P2|COMPLETED|Overall Study||12
592848|NCT00476242|1447913|P1|COMPLETED|Overall Study||19
592849|NCT00476242|1447912|P2|STARTED|Overall Study||28
592850|NCT00476242|1447913|P1|STARTED|Overall Study||27
592851|NCT00476229|1447921|P1|NOT COMPLETED|Overall Study||1
592852|NCT00476229|1447921|P1|COMPLETED|Overall Study||19
592853|NCT00476229|1447921|P1|STARTED|Overall Study||20
592854|NCT00476151|1447927|P2|NOT COMPLETED|Overall Study||7
592855|NCT00476151|1447928|P1|NOT COMPLETED|Overall Study||3
592856|NCT00476151|1447927|P2|COMPLETED|Overall Study||107
592857|NCT00476151|1447928|P1|COMPLETED|Overall Study||109
592858|NCT00476151|1447927|P2|STARTED|Overall Study||114
592859|NCT00476151|1447928|P1|STARTED|Overall Study||112
592860|NCT00476086|1447934|P1|NOT COMPLETED|Overall Study||5
592861|NCT00476086|1447934|P1|COMPLETED|Overall Study||15
592862|NCT00476086|1447934|P1|Received Radiation|Overall Study||15
592863|NCT00476086|1447934|P1|Received Chemotherapy|Overall Study||19
592864|NCT00476086|1447934|P1|STARTED|Overall Study||20
592865|NCT00476047|1447940|P1|NOT COMPLETED|Overall Study||1
592866|NCT00476047|1447940|P1|COMPLETED|Overall Study||15
592867|NCT00476047|1447940|P1|Completed Treatment|Overall Study||16
592868|NCT00476047|1447940|P1|STARTED|Overall Study||16
592869|NCT00476021|1447949|P2|NOT COMPLETED|Overall Study||0
592870|NCT00476021|1447950|P1|NOT COMPLETED|Overall Study||0
592871|NCT00476021|1447949|P2|COMPLETED|Overall Study||51
592872|NCT00476021|1447950|P1|COMPLETED|Overall Study||51
592873|NCT00476021|1447949|P2|STARTED|Overall Study||51
592874|NCT00476021|1447950|P1|STARTED|Overall Study||51
592875|NCT00476008|1447966|P2|NOT COMPLETED|Overall Study||8
592876|NCT00476008|1447967|P1|NOT COMPLETED|Overall Study||9
592877|NCT00476008|1447966|P2|COMPLETED|Overall Study||13
592878|NCT00476008|1447967|P1|COMPLETED|Overall Study||13
592879|NCT00476008|1447966|P2|6 Month Testing|Overall Study||14
592880|NCT00476008|1447967|P1|6 Month Testing|Overall Study||15
592881|NCT00476008|1447966|P2|STARTED|Overall Study||21
592882|NCT00476008|1447967|P1|STARTED|Overall Study||22
592883|NCT00475904|1447994|P3|NOT COMPLETED|Overall Study||4
592884|NCT00475904|1447995|P2|NOT COMPLETED|Overall Study||13
592885|NCT00475904|1447996|P1|NOT COMPLETED|Overall Study||15
592886|NCT00475904|1447994|P3|COMPLETED|Overall Study||72
592887|NCT00475904|1447995|P2|COMPLETED|Overall Study||131
592888|NCT00475904|1447996|P1|COMPLETED|Overall Study||125
592889|NCT00475904|1447994|P3|STARTED|Overall Study||76
592890|NCT00475904|1447995|P2|STARTED|Overall Study||144
592891|NCT00475904|1447996|P1|STARTED|Overall Study||140
592892|NCT00475878|1448009|P2|NOT COMPLETED|Overall Study||0
592893|NCT00475878|1448010|P1|NOT COMPLETED|Overall Study||0
592894|NCT00475878|1448009|P2|COMPLETED|Overall Study||72
592895|NCT00475878|1448010|P1|COMPLETED|Overall Study||75
592896|NCT00475878|1448009|P2|STARTED|Overall Study||72
592897|NCT00475878|1448010|P1|STARTED|Overall Study||75
592898|NCT00475865|1448021|P3|NOT COMPLETED|Overall Study||6
592899|NCT00475865|1448022|P2|NOT COMPLETED|Overall Study||5
592900|NCT00475865|1448023|P1|NOT COMPLETED|Overall Study||2
592901|NCT00475865|1448021|P3|COMPLETED|Overall Study|completed treatment period|34
592902|NCT00475865|1448022|P2|COMPLETED|Overall Study|completed treatment period|37
592903|NCT00475865|1448023|P1|COMPLETED|Overall Study||39
592904|NCT00475865|1448021|P3|Treated|Overall Study||40
592905|NCT00475865|1448022|P2|Treated|Overall Study||42
592906|NCT00475865|1448023|P1|Treated|Overall Study|completed treatment period|41
592907|NCT00475865|1448021|P3|STARTED|Overall Study|randomized|40
592908|NCT00475865|1448022|P2|STARTED|Overall Study|randomized|42
592909|NCT00475865|1448023|P1|STARTED|Overall Study|randomized|41
592910|NCT00475852|1448053|P2|NOT COMPLETED|Overall Study||548
592911|NCT00475852|1448054|P1|NOT COMPLETED|Overall Study||517
592912|NCT00475852|1448053|P2|COMPLETED|Overall Study||3029
592913|NCT00475852|1448054|P1|COMPLETED|Overall Study||3047
592914|NCT00475852|1448053|P2|STARTED|Overall Study||3577
592915|NCT00475852|1448054|P1|STARTED|Overall Study||3564
592916|NCT00475787|1448084|P2|NOT COMPLETED|Overall Study||7
592917|NCT00475787|1448085|P1|NOT COMPLETED|Overall Study||8
592918|NCT00475787|1448084|P2|COMPLETED|Overall Study||60
592919|NCT00475787|1448085|P1|COMPLETED|Overall Study||61
592920|NCT00475787|1448084|P2|STARTED|Overall Study||67
592921|NCT00475787|1448085|P1|STARTED|Overall Study||69
592922|NCT00475735|1448105|P6|NOT COMPLETED|Treatment Period 2||1
592923|NCT00475735|1448106|P5|NOT COMPLETED|Treatment Period 2||1
592924|NCT00475735|1448107|P4|NOT COMPLETED|Treatment Period 2||2
592925|NCT00475735|1448108|P3|NOT COMPLETED|Treatment Period 2||0
592926|NCT00475735|1448109|P2|NOT COMPLETED|Treatment Period 2||1
592927|NCT00475735|1448110|P1|NOT COMPLETED|Treatment Period 2||0
592928|NCT00475735|1448105|P6|COMPLETED|Treatment Period 2||13
592929|NCT00475735|1448106|P5|COMPLETED|Treatment Period 2||15
592930|NCT00475735|1448107|P4|COMPLETED|Treatment Period 2||4
592931|NCT00475735|1448108|P3|COMPLETED|Treatment Period 2||7
592932|NCT00475735|1448109|P2|COMPLETED|Treatment Period 2||9
592933|NCT00475735|1448110|P1|COMPLETED|Treatment Period 2||10
592934|NCT00475735|1448105|P6|STARTED|Treatment Period 2||14
592935|NCT00475735|1448106|P5|STARTED|Treatment Period 2||16
592936|NCT00475735|1448107|P4|STARTED|Treatment Period 2||6
592937|NCT00475735|1448108|P3|STARTED|Treatment Period 2||7
592938|NCT00475735|1448109|P2|STARTED|Treatment Period 2||10
592939|NCT00475735|1448110|P1|STARTED|Treatment Period 2||10
592940|NCT00475735|1448105|P6|NOT COMPLETED|Treatment Washout||0
592941|NCT00475735|1448106|P5|NOT COMPLETED|Treatment Washout||0
592942|NCT00475735|1448107|P4|NOT COMPLETED|Treatment Washout||0
592943|NCT00475735|1448108|P3|NOT COMPLETED|Treatment Washout||0
592944|NCT00475735|1448109|P2|NOT COMPLETED|Treatment Washout||2
592945|NCT00475735|1448110|P1|NOT COMPLETED|Treatment Washout||0
592946|NCT00475735|1448105|P6|COMPLETED|Treatment Washout||14
592947|NCT00475735|1448106|P5|COMPLETED|Treatment Washout||16
592948|NCT00475735|1448107|P4|COMPLETED|Treatment Washout||6
592949|NCT00475735|1448108|P3|COMPLETED|Treatment Washout||7
592950|NCT00475735|1448109|P2|COMPLETED|Treatment Washout||10
592951|NCT00475735|1448110|P1|COMPLETED|Treatment Washout||10
592952|NCT00475735|1448105|P6|STARTED|Treatment Washout|Includes 2 patients that discontinued Treatment Period 1 but continued the Study.|14
592953|NCT00475735|1448106|P5|STARTED|Treatment Washout|Includes 2 patients that discontinued Treatment Period 1 but continued the Study.|16
592954|NCT00475735|1448107|P4|STARTED|Treatment Washout|Includes 1 patient that discontinued Treatment Period 1 but continued the Study.|6
592955|NCT00475735|1448108|P3|STARTED|Treatment Washout||7
592956|NCT00475735|1448109|P2|STARTED|Treatment Washout|Includes 1 patient that discontinued Treatment Period 1 but continued the Study.|12
592957|NCT00475735|1448110|P1|STARTED|Treatment Washout||10
592958|NCT00475735|1448105|P6|NOT COMPLETED|Treatment Period 1||3
592959|NCT00475735|1448106|P5|NOT COMPLETED|Treatment Period 1||2
592960|NCT00475735|1448107|P4|NOT COMPLETED|Treatment Period 1||2
592961|NCT00475735|1448108|P3|NOT COMPLETED|Treatment Period 1||0
592962|NCT00475735|1448109|P2|NOT COMPLETED|Treatment Period 1||2
592963|NCT00475735|1448110|P1|NOT COMPLETED|Treatment Period 1||4
592964|NCT00475735|1448105|P6|COMPLETED|Treatment Period 1||12
592965|NCT00475735|1448106|P5|COMPLETED|Treatment Period 1||14
592966|NCT00475735|1448107|P4|COMPLETED|Treatment Period 1||5
592967|NCT00475735|1448108|P3|COMPLETED|Treatment Period 1||7
592968|NCT00475735|1448109|P2|COMPLETED|Treatment Period 1||11
592969|NCT00475735|1448110|P1|COMPLETED|Treatment Period 1||10
592970|NCT00475735|1448105|P6|STARTED|Treatment Period 1||15
592971|NCT00475735|1448106|P5|STARTED|Treatment Period 1||16
592972|NCT00475735|1448107|P4|STARTED|Treatment Period 1||7
592973|NCT00475735|1448108|P3|STARTED|Treatment Period 1||7
592974|NCT00475735|1448109|P2|STARTED|Treatment Period 1||13
592975|NCT00475735|1448110|P1|STARTED|Treatment Period 1||14
592976|NCT00475722|1448123|P2|NOT COMPLETED|Overall Study||12
592977|NCT00475722|1448124|P1|NOT COMPLETED|Overall Study||15
592978|NCT00475722|1448123|P2|COMPLETED|Overall Study||47
592979|NCT00475722|1448124|P1|COMPLETED|Overall Study||46
592980|NCT00475722|1448123|P2|STARTED|Overall Study||59
592981|NCT00475722|1448124|P1|STARTED|Overall Study||61
592982|NCT00475709|1448130|P1|NOT COMPLETED|Overall Study||76
592983|NCT00475709|1448130|P1|COMPLETED|Overall Study||946
592984|NCT00475709|1448130|P1|Eligible of Analysis|Overall Study|Excludes eight ineligible subjects|1014
592985|NCT00475709|1448130|P1|STARTED|Overall Study||1022
592986|NCT00475670|1448138|P2|NOT COMPLETED|Overall Study||41
592987|NCT00475670|1448139|P1|NOT COMPLETED|Overall Study||3
592988|NCT00475670|1448138|P2|COMPLETED|Overall Study||0
592989|NCT00475670|1448139|P1|COMPLETED|Overall Study|This cohort was closed prematurely (with only 3 participants) because of enrollment difficulties.|0
592990|NCT00475670|1448138|P2|STARTED|Overall Study||41
592991|NCT00475670|1448139|P1|STARTED|Overall Study||3
592992|NCT00475657|1448163|P1|NOT COMPLETED|Overall Study||4
592993|NCT00475657|1448163|P1|COMPLETED|Overall Study||1
592994|NCT00475657|1448163|P1|STARTED|Overall Study||5
592995|NCT00475501|1448175|P4|NOT COMPLETED|Overall Study||4
592996|NCT00475501|1448176|P3|NOT COMPLETED|Overall Study||4
592997|NCT00475501|1448177|P2|NOT COMPLETED|Overall Study||5
592998|NCT00475501|1448178|P1|NOT COMPLETED|Overall Study||7
592999|NCT00475501|1448175|P4|COMPLETED|Overall Study||12
593000|NCT00475501|1448176|P3|COMPLETED|Overall Study||13
593001|NCT00475501|1448177|P2|COMPLETED|Overall Study||8
593002|NCT00475501|1448178|P1|COMPLETED|Overall Study||7
593003|NCT00475501|1448175|P4|STARTED|Overall Study||16
593004|NCT00475501|1448176|P3|STARTED|Overall Study||17
593005|NCT00475501|1448177|P2|STARTED|Overall Study||13
593006|NCT00475501|1448178|P1|STARTED|Overall Study||14
593007|NCT00475423|1448228|P1|NOT COMPLETED|Overall Study||32
593008|NCT00475423|1448228|P1|COMPLETED|Overall Study||90
593009|NCT00475423|1448228|P1|STARTED|Overall Study||122
593010|NCT00475332|1448249|P1|NOT COMPLETED|Overall Study||0
593011|NCT00475332|1448249|P1|COMPLETED|Overall Study||2
593012|NCT00475332|1448249|P1|STARTED|Overall Study||2
593013|NCT00475319|1448257|P3|NOT COMPLETED|Overall Study||4
593014|NCT00475319|1448258|P2|NOT COMPLETED|Overall Study||1
593015|NCT00475319|1448259|P1|NOT COMPLETED|Overall Study||2
593016|NCT00475319|1448257|P3|COMPLETED|Overall Study||99
593017|NCT00475319|1448258|P2|COMPLETED|Overall Study||101
593018|NCT00475319|1448259|P1|COMPLETED|Overall Study||101
593019|NCT00475319|1448257|P3|STARTED|Overall Study||103
593020|NCT00475319|1448258|P2|STARTED|Overall Study||102
593021|NCT00475319|1448259|P1|STARTED|Overall Study||103
593022|NCT00475306|1448274|P4|NOT COMPLETED|Overall Study||1
593023|NCT00475306|1448275|P3|NOT COMPLETED|Overall Study||0
593024|NCT00475306|1448276|P2|NOT COMPLETED|Overall Study||1
593025|NCT00475306|1448277|P1|NOT COMPLETED|Overall Study||1
593026|NCT00475306|1448274|P4|COMPLETED|Overall Study|1 patient's intravenous line infiltrated.|71
593027|NCT00475306|1448275|P3|COMPLETED|Overall Study||72
593028|NCT00475306|1448276|P2|COMPLETED|Overall Study|For 1 patient, data collection was incomplete and results could not be analyzed|71
593029|NCT00475306|1448277|P1|COMPLETED|Overall Study|1 patient had resolution of nausea prior and did not receive the investigational medication|72
593030|NCT00475306|1448274|P4|STARTED|Overall Study||72
593031|NCT00475306|1448275|P3|STARTED|Overall Study||72
593032|NCT00475306|1448276|P2|STARTED|Overall Study||72
593033|NCT00475306|1448277|P1|STARTED|Overall Study||73
593034|NCT00475241|1448293|P2|NOT COMPLETED|Overall Study||3
593035|NCT00475241|1448294|P1|NOT COMPLETED|Overall Study||7
593036|NCT00475241|1448293|P2|COMPLETED|Overall Study||15
593037|NCT00475241|1448294|P1|COMPLETED|Overall Study||11
593038|NCT00475241|1448293|P2|STARTED|Overall Study||18
593039|NCT00475241|1448294|P1|STARTED|Overall Study||18
593040|NCT00475228|1448302|P2|NOT COMPLETED|Overall Study||17
593041|NCT00475228|1448303|P1|NOT COMPLETED|Overall Study||17
593042|NCT00475228|1448302|P2|COMPLETED|Overall Study||27
593043|NCT00475228|1448303|P1|COMPLETED|Overall Study||27
593044|NCT00475228|1448302|P2|STARTED|Overall Study||44
593045|NCT00475228|1448303|P1|STARTED|Overall Study||44
593046|NCT00475176|1448313|P1|NOT COMPLETED|Overall Study||4
593047|NCT00475176|1448313|P1|COMPLETED|Overall Study||20
593048|NCT00475176|1448313|P1|STARTED|Overall Study||24
593049|NCT00475150|1448320|P2|NOT COMPLETED|Overall Study||0
593050|NCT00475150|1448321|P1|NOT COMPLETED|Overall Study||0
593051|NCT00475150|1448320|P2|COMPLETED|Overall Study||16
593052|NCT00475150|1448321|P1|COMPLETED|Overall Study||23
593053|NCT00475150|1448320|P2|STARTED|Overall Study||16
593054|NCT00475150|1448321|P1|STARTED|Overall Study||23
593055|NCT00475085|1448338|P4|NOT COMPLETED|Overall Study||20
593056|NCT00475085|1448339|P3|NOT COMPLETED|Overall Study||19
593057|NCT00475085|1448340|P2|NOT COMPLETED|Overall Study||20
593058|NCT00475085|1448341|P1|NOT COMPLETED|Overall Study||18
593059|NCT00475085|1448338|P4|COMPLETED|Overall Study||234
593060|NCT00475085|1448339|P3|COMPLETED|Overall Study||241
593061|NCT00475085|1448340|P2|COMPLETED|Overall Study||234
593062|NCT00475085|1448341|P1|COMPLETED|Overall Study||235
593063|NCT00475085|1448338|P4|STARTED|Overall Study||254
593064|NCT00475085|1448339|P3|STARTED|Overall Study||260
593065|NCT00475085|1448340|P2|STARTED|Overall Study||254
593066|NCT00475085|1448341|P1|STARTED|Overall Study||253
593067|NCT00475033|1448353|P2|NOT COMPLETED|Toddler Dose||0
593068|NCT00475033|1448354|P1|NOT COMPLETED|Toddler Dose||4
593069|NCT00475033|1448353|P2|COMPLETED|Toddler Dose||282
593070|NCT00475033|1448354|P1|COMPLETED|Toddler Dose||283
593071|NCT00475033|1448353|P2|STARTED|Toddler Dose|Vaccinated Toddler Dose|282
593072|NCT00475033|1448354|P1|STARTED|Toddler Dose|Vaccinated Toddler Dose|287
593073|NCT00475033|1448353|P2|NOT COMPLETED|After the Infant Series||8
593074|NCT00475033|1448354|P1|NOT COMPLETED|After the Infant Series||6
593075|NCT00475033|1448353|P2|COMPLETED|After the Infant Series||282
593076|NCT00475033|1448354|P1|COMPLETED|After the Infant Series||287
593077|NCT00475033|1448353|P2|Withdrawn After Infant Series|After the Infant Series||8
593078|NCT00475033|1448354|P1|Withdrawn After Infant Series|After the Infant Series||6
593079|NCT00475033|1448353|P2|STARTED|After the Infant Series||290
593080|NCT00475033|1448354|P1|STARTED|After the Infant Series||293
593081|NCT00475033|1448353|P2|NOT COMPLETED|Infant Series||13
593082|NCT00475033|1448354|P1|NOT COMPLETED|Infant Series||7
593083|NCT00475033|1448353|P2|COMPLETED|Infant Series||290
593084|NCT00475033|1448354|P1|COMPLETED|Infant Series||293
593085|NCT00475033|1448353|P2|Vaccinated Dose 3|Infant Series||294
593086|NCT00475033|1448354|P1|Vaccinated Dose 3|Infant Series||293
593087|NCT00475033|1448353|P2|Vaccinated Dose 2|Infant Series||296
593088|NCT00475033|1448354|P1|Vaccinated Dose 2|Infant Series||297
593089|NCT00475033|1448353|P2|Vaccinated Dose 1|Infant Series||303
593090|NCT00475033|1448354|P1|Vaccinated Dose 1|Infant Series||300
593091|NCT00475033|1448353|P2|STARTED|Infant Series||303
593092|NCT00475033|1448354|P1|STARTED|Infant Series||300
593093|NCT00474994|1448402|P1|NOT COMPLETED|Overall Study||5
593094|NCT00474994|1448402|P1|COMPLETED|Overall Study||48
593095|NCT00474994|1448402|P1|STARTED|Overall Study||53
593096|NCT00474968|1448408|P2|NOT COMPLETED|Overall Study||16
593097|NCT00474968|1448409|P1|NOT COMPLETED|Overall Study||18
593098|NCT00474968|1448408|P2|COMPLETED|Overall Study||355
593099|NCT00474968|1448409|P1|COMPLETED|Overall Study||348
593100|NCT00474968|1448408|P2|STARTED|Overall Study||371
593101|NCT00474968|1448409|P1|STARTED|Overall Study||366
593102|NCT00474955|1448419|P1|NOT COMPLETED|Overall Study||8
593103|NCT00474955|1448419|P1|COMPLETED|Overall Study||19
593104|NCT00474955|1448419|P1|STARTED|Overall Study||27
593105|NCT00474929|1448435|P5|NOT COMPLETED|Overall Study||0
593106|NCT00474929|1448436|P4|NOT COMPLETED|Overall Study||2
593107|NCT00474929|1448437|P3|NOT COMPLETED|Overall Study||2
593108|NCT00474929|1448438|P2|NOT COMPLETED|Overall Study||1
593109|NCT00474929|1448439|P1|NOT COMPLETED|Overall Study||0
593110|NCT00474929|1448435|P5|COMPLETED|Overall Study||77
593111|NCT00474929|1448436|P4|COMPLETED|Overall Study||5
593112|NCT00474929|1448437|P3|COMPLETED|Overall Study||5
593113|NCT00474929|1448438|P2|COMPLETED|Overall Study||5
593114|NCT00474929|1448439|P1|COMPLETED|Overall Study||6
593115|NCT00474929|1448435|P5|STARTED|Overall Study||77
593116|NCT00474929|1448436|P4|STARTED|Overall Study||7
593117|NCT00474929|1448437|P3|STARTED|Overall Study||7
593118|NCT00474929|1448438|P2|STARTED|Overall Study||6
593119|NCT00474929|1448439|P1|STARTED|Overall Study||6
593120|NCT00474903|1448456|P3|NOT COMPLETED|Overall Study||2
593121|NCT00474903|1448457|P2|NOT COMPLETED|Overall Study||5
593122|NCT00474903|1448458|P1|NOT COMPLETED|Overall Study||1
593123|NCT00474903|1448456|P3|COMPLETED|Overall Study||43
593124|NCT00474903|1448457|P2|COMPLETED|Overall Study||42
593125|NCT00474903|1448458|P1|COMPLETED|Overall Study||29
593126|NCT00474903|1448456|P3|STARTED|Overall Study||45
593127|NCT00474903|1448457|P2|STARTED|Overall Study||47
593128|NCT00474903|1448458|P1|STARTED|Overall Study||30
593129|NCT00474851|1448471|P2|NOT COMPLETED|Overall Study||11
593130|NCT00474851|1448472|P1|NOT COMPLETED|Overall Study||8
593131|NCT00474851|1448471|P2|COMPLETED|Overall Study||16
593132|NCT00474851|1448472|P1|COMPLETED|Overall Study||18
593133|NCT00474851|1448471|P2|Completed Baseline|Overall Study||26
593134|NCT00474851|1448472|P1|Completed Baseline|Overall Study||25
593135|NCT00474851|1448471|P2|STARTED|Overall Study||27
593136|NCT00474851|1448472|P1|STARTED|Overall Study||26
593137|NCT00474812|1448480|P1|NOT COMPLETED|Overall Study||7
593138|NCT00474812|1448480|P1|COMPLETED|Overall Study||44
593139|NCT00474812|1448480|P1|STARTED|Overall Study||51
593140|NCT00474786|1448490|P2|NOT COMPLETED|Overall Study||253
593141|NCT00474786|1448491|P1|NOT COMPLETED|Overall Study||259
593142|NCT00474786|1448490|P2|COMPLETED|Overall Study||0
593143|NCT00474786|1448491|P1|COMPLETED|Overall Study||0
593144|NCT00474786|1448490|P2|STARTED|Overall Study||253
593145|NCT00474786|1448491|P1|STARTED|Overall Study||259
593146|NCT00474760|1448516|P7|NOT COMPLETED|Overall Study||10
593147|NCT00474760|1448517|P6|NOT COMPLETED|Overall Study||29
593148|NCT00474760|1448518|P5|NOT COMPLETED|Overall Study||12
593149|NCT00474760|1448519|P4|NOT COMPLETED|Overall Study||3
593150|NCT00474760|1448520|P3|NOT COMPLETED|Overall Study||3
593151|NCT00474760|1448521|P2|NOT COMPLETED|Overall Study||3
593152|NCT00474760|1448522|P1|NOT COMPLETED|Overall Study||3
593153|NCT00474760|1448516|P7|COMPLETED|Overall Study||1
593154|NCT00474760|1448517|P6|COMPLETED|Overall Study||0
593155|NCT00474760|1448518|P5|COMPLETED|Overall Study||1
593156|NCT00474760|1448519|P4|COMPLETED|Overall Study||0
593157|NCT00474760|1448520|P3|COMPLETED|Overall Study||0
593158|NCT00474760|1448521|P2|COMPLETED|Overall Study||0
593159|NCT00474760|1448522|P1|COMPLETED|Overall Study||0
593160|NCT00474760|1448516|P7|STARTED|Overall Study||11
593161|NCT00474760|1448517|P6|STARTED|Overall Study||29
593162|NCT00474760|1448518|P5|STARTED|Overall Study||13
593163|NCT00474760|1448519|P4|STARTED|Overall Study||3
593164|NCT00474760|1448520|P3|STARTED|Overall Study||3
593165|NCT00474760|1448521|P2|STARTED|Overall Study||3
593166|NCT00474760|1448522|P1|STARTED|Overall Study||3
593167|NCT00474708|1448629|P2|NOT COMPLETED|Overall Study||25
593168|NCT00474708|1448630|P1|NOT COMPLETED|Overall Study||57
593169|NCT00474708|1448629|P2|COMPLETED|Overall Study||342
593170|NCT00474708|1448630|P1|COMPLETED|Overall Study||734
593171|NCT00474708|1448629|P2|STARTED|Overall Study||367
593172|NCT00474708|1448630|P1|STARTED|Overall Study||791
593173|NCT00474630|1448640|P2|NOT COMPLETED|Overall Study||70
593174|NCT00474630|1448641|P1|NOT COMPLETED|Overall Study||160
593175|NCT00474630|1448640|P2|COMPLETED|Overall Study||100
593176|NCT00474630|1448641|P1|COMPLETED|Overall Study||175
593177|NCT00474630|1448640|P2|STARTED|Overall Study||170
593178|NCT00474630|1448641|P1|STARTED|Overall Study||335
593179|NCT00474539|1448697|P2|NOT COMPLETED|Toddler Dose||0
593180|NCT00474539|1448698|P1|NOT COMPLETED|Toddler Dose||1
593181|NCT00474539|1448697|P2|COMPLETED|Toddler Dose||220
593182|NCT00474539|1448698|P1|COMPLETED|Toddler Dose||208
593183|NCT00474539|1448697|P2|STARTED|Toddler Dose||220
593184|NCT00474539|1448698|P1|STARTED|Toddler Dose||209
593185|NCT00474539|1448697|P2|NOT COMPLETED|After Infant Series||0
593186|NCT00474539|1448698|P1|NOT COMPLETED|After Infant Series||4
593187|NCT00474539|1448697|P2|COMPLETED|After Infant Series||220
593188|NCT00474539|1448698|P1|COMPLETED|After Infant Series||209
593189|NCT00474539|1448697|P2|STARTED|After Infant Series||220
593190|NCT00474539|1448698|P1|STARTED|After Infant Series||213
593191|NCT00474539|1448697|P2|NOT COMPLETED|Infant Series||6
593192|NCT00474539|1448698|P1|NOT COMPLETED|Infant Series||10
593193|NCT00474539|1448697|P2|COMPLETED|Infant Series||220
593194|NCT00474539|1448698|P1|COMPLETED|Infant Series||213
593195|NCT00474539|1448697|P2|Vaccinated Dose 3|Infant Series||221
593196|NCT00474539|1448698|P1|Vaccinated Dose 3|Infant Series||214
593197|NCT00474539|1448697|P2|Vaccinated Dose 2|Infant Series||222
593198|NCT00474539|1448698|P1|Vaccinated Dose 2|Infant Series||217
593199|NCT00474539|1448697|P2|Vaccinated Dose 1|Infant Series||226
593200|NCT00474539|1448698|P1|Vaccinated Dose 1|Infant Series||218
593201|NCT00474539|1448697|P2|STARTED|Infant Series|One participant was randomized to 7vPnC, but received 13vPnC.|226
593202|NCT00474539|1448698|P1|STARTED|Infant Series|One participant was randomized to 7vPnC, but received 13vPnC.|223
593203|NCT00474526|1448763|P17|NOT COMPLETED|Overall Study||9
593204|NCT00474526|1448764|P16|NOT COMPLETED|Overall Study||18
593205|NCT00474526|1448765|P15|NOT COMPLETED|Overall Study||77
593206|NCT00474526|1448766|P14|NOT COMPLETED|Overall Study||156
593207|NCT00474526|1448767|P13|NOT COMPLETED|Overall Study||15
593208|NCT00474526|1448768|P12|NOT COMPLETED|Overall Study||11
593209|NCT00474526|1448769|P11|NOT COMPLETED|Overall Study||10
593210|NCT00474526|1448770|P10|NOT COMPLETED|Overall Study||27
593211|NCT00474526|1448771|P9|NOT COMPLETED|Overall Study||6
593212|NCT00474526|1448772|P8|NOT COMPLETED|Overall Study||6
593213|NCT00474526|1448773|P7|NOT COMPLETED|Overall Study||25
593214|NCT00474526|1448774|P6|NOT COMPLETED|Overall Study||16
593215|NCT00474526|1448775|P5|NOT COMPLETED|Overall Study||68
593216|NCT00474526|1448776|P4|NOT COMPLETED|Overall Study||119
593217|NCT00474526|1448777|P3|NOT COMPLETED|Overall Study||49
593218|NCT00474526|1448778|P2|NOT COMPLETED|Overall Study||46
593219|NCT00474526|1448779|P1|NOT COMPLETED|Overall Study||33
593220|NCT00474526|1448763|P17|COMPLETED|Overall Study||174
593221|NCT00474526|1448764|P16|COMPLETED|Overall Study||152
593222|NCT00474526|1448765|P15|COMPLETED|Overall Study||281
593223|NCT00474526|1448766|P14|COMPLETED|Overall Study||1270
593224|NCT00474526|1448767|P13|COMPLETED|Overall Study||135
593225|NCT00474526|1448768|P12|COMPLETED|Overall Study||139
593226|NCT00474526|1448769|P11|COMPLETED|Overall Study||141
593227|NCT00474526|1448770|P10|COMPLETED|Overall Study||121
593228|NCT00474526|1448771|P9|COMPLETED|Overall Study||144
593229|NCT00474526|1448772|P8|COMPLETED|Overall Study||145
593230|NCT00474526|1448773|P7|COMPLETED|Overall Study||178
593231|NCT00474526|1448774|P6|COMPLETED|Overall Study||54
593232|NCT00474526|1448775|P5|COMPLETED|Overall Study||8
593233|NCT00474526|1448776|P4|COMPLETED|Overall Study||561
593234|NCT00474526|1448777|P3|COMPLETED|Overall Study||110
593235|NCT00474526|1448778|P2|COMPLETED|Overall Study||120
593236|NCT00474526|1448779|P1|COMPLETED|Overall Study||121
593237|NCT00474526|1448763|P17|STARTED|Overall Study||183
593238|NCT00474526|1448764|P16|STARTED|Overall Study||170
593239|NCT00474526|1448765|P15|STARTED|Overall Study||358
593240|NCT00474526|1448766|P14|STARTED|Overall Study||1426
593241|NCT00474526|1448767|P13|STARTED|Overall Study||150
593242|NCT00474526|1448768|P12|STARTED|Overall Study||150
593243|NCT00474526|1448769|P11|STARTED|Overall Study||151
593244|NCT00474526|1448770|P10|STARTED|Overall Study||148
593245|NCT00474526|1448771|P9|STARTED|Overall Study||150
593246|NCT00474526|1448772|P8|STARTED|Overall Study||151
593247|NCT00474526|1448773|P7|STARTED|Overall Study||203
593248|NCT00474526|1448774|P6|STARTED|Overall Study||70
593249|NCT00474526|1448775|P5|STARTED|Overall Study||76
593250|NCT00474526|1448776|P4|STARTED|Overall Study||680
593251|NCT00474526|1448777|P3|STARTED|Overall Study||159
593252|NCT00474526|1448778|P2|STARTED|Overall Study||166
593253|NCT00474526|1448779|P1|STARTED|Overall Study||154
593254|NCT00474487|1448944|P4|NOT COMPLETED|Overall Study||0
593255|NCT00474487|1448945|P3|NOT COMPLETED|Overall Study||14
593256|NCT00474487|1448946|P2|NOT COMPLETED|Overall Study||2
593257|NCT00474487|1448947|P1|NOT COMPLETED|Overall Study||30
593258|NCT00474487|1448944|P4|COMPLETED|Overall Study||109
593259|NCT00474487|1448945|P3|COMPLETED|Overall Study||885
593260|NCT00474487|1448946|P2|COMPLETED|Overall Study||215
593261|NCT00474487|1448947|P1|COMPLETED|Overall Study||1576
593262|NCT00474487|1448944|P4|STARTED|Overall Study||109
593263|NCT00474487|1448945|P3|STARTED|Overall Study||899
593264|NCT00474487|1448946|P2|STARTED|Overall Study||217
593265|NCT00474487|1448947|P1|STARTED|Overall Study||1606
593266|NCT00474383|1448967|P2|NOT COMPLETED|Extension||5
593267|NCT00474383|1448968|P1|NOT COMPLETED|Extension||0
593268|NCT00474383|1448967|P2|COMPLETED|Extension||0
593269|NCT00474383|1448968|P1|COMPLETED|Extension||0
593270|NCT00474383|1448967|P2|STARTED|Extension||5
593271|NCT00474383|1448968|P1|STARTED|Extension||0
593272|NCT00474383|1448967|P2|NOT COMPLETED|Between Main Study and Extension||0
593273|NCT00474383|1448968|P1|NOT COMPLETED|Between Main Study and Extension||6
593274|NCT00474383|1448967|P2|COMPLETED|Between Main Study and Extension||0
593275|NCT00474383|1448968|P1|COMPLETED|Between Main Study and Extension||5
593276|NCT00474383|1448967|P2|STARTED|Between Main Study and Extension||0
593277|NCT00474383|1448968|P1|STARTED|Between Main Study and Extension||11
593278|NCT00474383|1448967|P2|NOT COMPLETED|Main Study||0
593279|NCT00474383|1448968|P1|NOT COMPLETED|Main Study||36
593280|NCT00474383|1448967|P2|COMPLETED|Main Study||0
593281|NCT00474383|1448968|P1|COMPLETED|Main Study||11
593282|NCT00474383|1448967|P2|STARTED|Main Study||0
593283|NCT00474383|1448968|P1|STARTED|Main Study||47
593284|NCT00474266|1448983|P4|NOT COMPLETED|Overall Study||7
593285|NCT00474266|1448984|P3|NOT COMPLETED|Overall Study||4
593286|NCT00474266|1448985|P2|NOT COMPLETED|Overall Study||20
593287|NCT00474266|1448986|P1|NOT COMPLETED|Overall Study||7
593288|NCT00474266|1448983|P4|COMPLETED|Overall Study||118
593289|NCT00474266|1448984|P3|COMPLETED|Overall Study||122
593290|NCT00474266|1448985|P2|COMPLETED|Overall Study||354
593291|NCT00474266|1448986|P1|COMPLETED|Overall Study||368
593292|NCT00474266|1448983|P4|STARTED|Overall Study||125
593293|NCT00474266|1448984|P3|STARTED|Overall Study||126
593294|NCT00474266|1448985|P2|STARTED|Overall Study||374
593295|NCT00474266|1448986|P1|STARTED|Overall Study||375
593296|NCT00474240|1449094|P6|NOT COMPLETED|Overall Study||18
593297|NCT00474240|1449095|P5|NOT COMPLETED|Overall Study||8
593298|NCT00474240|1449096|P4|NOT COMPLETED|Overall Study||16
593299|NCT00474240|1449097|P3|NOT COMPLETED|Overall Study||9
593300|NCT00474240|1449098|P2|NOT COMPLETED|Overall Study||1
593301|NCT00474240|1449099|P1|NOT COMPLETED|Overall Study||1
593302|NCT00474240|1449094|P6|COMPLETED|Overall Study||8
593303|NCT00474240|1449095|P5|COMPLETED|Overall Study||18
593304|NCT00474240|1449096|P4|COMPLETED|Overall Study||10
593305|NCT00474240|1449097|P3|COMPLETED|Overall Study||17
593306|NCT00474240|1449098|P2|COMPLETED|Overall Study||25
593307|NCT00474240|1449099|P1|COMPLETED|Overall Study||26
593308|NCT00474240|1449094|P6|STARTED|Overall Study||26
593309|NCT00474240|1449095|P5|STARTED|Overall Study||26
593310|NCT00474240|1449096|P4|STARTED|Overall Study||26
593311|NCT00474240|1449097|P3|STARTED|Overall Study||26
593312|NCT00474240|1449098|P2|STARTED|Overall Study||26
593313|NCT00474240|1449099|P1|STARTED|Overall Study||27
593314|NCT00474201|1449119|P1|NOT COMPLETED|Overall Study||0
593315|NCT00474201|1449119|P1|COMPLETED|Overall Study||15
593316|NCT00474201|1449119|P1|STARTED|Overall Study||15
593317|NCT00474188|1449124|P1|NOT COMPLETED|Overall Study||6
593318|NCT00474188|1449124|P1|COMPLETED|Overall Study|Disease progression=15, adverse event=4, death=1|20
593319|NCT00474188|1449124|P1|STARTED|Overall Study||26
593320|NCT00474175|1449134|P3|NOT COMPLETED|Overall Study||4
593321|NCT00474175|1449135|P2|NOT COMPLETED|Overall Study||7
593322|NCT00474175|1449136|P1|NOT COMPLETED|Overall Study||1
593323|NCT00474175|1449134|P3|COMPLETED|Overall Study||225
593324|NCT00474175|1449135|P2|COMPLETED|Overall Study||226
593325|NCT00474175|1449136|P1|COMPLETED|Overall Study||114
593326|NCT00474175|1449134|P3|Treated|Overall Study||228
593327|NCT00474175|1449135|P2|Treated|Overall Study||233
593328|NCT00474175|1449136|P1|Treated|Overall Study||115
593329|NCT00474175|1449134|P3|STARTED|Overall Study||229
593330|NCT00474175|1449135|P2|STARTED|Overall Study||233
593331|NCT00474175|1449136|P1|STARTED|Overall Study||115
593332|NCT00474123|1449173|P2|NOT COMPLETED|Overall Study||0
593333|NCT00474123|1449174|P1|NOT COMPLETED|Overall Study||0
593334|NCT00474123|1449173|P2|COMPLETED|Overall Study||40
593335|NCT00474123|1449174|P1|COMPLETED|Overall Study||38
593336|NCT00474123|1449173|P2|STARTED|Overall Study||40
593337|NCT00474123|1449174|P1|STARTED|Overall Study||38
593338|NCT00474058|1449200|P2|NOT COMPLETED|Overall Study||17
593339|NCT00474058|1449201|P1|NOT COMPLETED|Overall Study||24
593340|NCT00474058|1449200|P2|COMPLETED|Overall Study||80
593341|NCT00474058|1449201|P1|COMPLETED|Overall Study||166
593342|NCT00474058|1449200|P2|STARTED|Overall Study||97
593343|NCT00474058|1449201|P1|STARTED|Overall Study||190
593344|NCT00474045|1449215|P2|NOT COMPLETED|Overall Study||101
593345|NCT00474045|1449216|P1|NOT COMPLETED|Overall Study||106
593346|NCT00474045|1449215|P2|COMPLETED|Overall Study||136
593347|NCT00474045|1449216|P1|COMPLETED|Overall Study||127
593348|NCT00474045|1449215|P2|Pregnancies (for Exposed-pregnant)|Overall Study|2 subjects had spontaneous abortion and became pregnant again|160
593349|NCT00474045|1449216|P1|Pregnancies (for Exposed-pregnant)|Overall Study||152
593350|NCT00474045|1449215|P2|Exposed-Pregnant Subjects|Overall Study|3 withdrawn before treatment initiation|158
593351|NCT00474045|1449216|P1|Exposed-Pregnant Subjects|Overall Study||152
593352|NCT00474045|1449215|P2|Exposed-All Subjects|Overall Study|5 withdrawn before treatment initiation|232
593353|NCT00474045|1449216|P1|Exposed-All Subjects|Overall Study||233
593354|NCT00474045|1449215|P2|STARTED|Overall Study||237
593355|NCT00474045|1449216|P1|STARTED|Overall Study||233
593356|NCT00473889|1449316|P2|NOT COMPLETED|Overall Study||64
593357|NCT00473889|1449317|P1|NOT COMPLETED|Overall Study||83
593358|NCT00473889|1449316|P2|COMPLETED|Overall Study||63
593359|NCT00473889|1449317|P1|COMPLETED|Overall Study||43
593360|NCT00473889|1449316|P2|STARTED|Overall Study||127
593361|NCT00473889|1449317|P1|STARTED|Overall Study||126
593362|NCT00473876|1449329|P2|NOT COMPLETED|Overall Study||1
593363|NCT00473876|1449330|P1|NOT COMPLETED|Overall Study||3
593364|NCT00473876|1449329|P2|COMPLETED|Overall Study||22
593365|NCT00473876|1449330|P1|COMPLETED|Overall Study||36
593366|NCT00473876|1449329|P2|STARTED|Overall Study||23
593367|NCT00473876|1449330|P1|STARTED|Overall Study||39
593368|NCT00473837|1449340|P2|NOT COMPLETED|Overall Study||3
593369|NCT00473837|1449341|P1|NOT COMPLETED|Overall Study||1
593370|NCT00473837|1449340|P2|COMPLETED|Overall Study||43
593371|NCT00473837|1449341|P1|COMPLETED|Overall Study||49
593372|NCT00473837|1449340|P2|STARTED|Overall Study||46
593373|NCT00473837|1449341|P1|STARTED|Overall Study||50
593374|NCT00473824|1449349|P2|NOT COMPLETED|Overall Study||0
593375|NCT00473824|1449350|P1|NOT COMPLETED|Overall Study||5
593376|NCT00473824|1449349|P2|COMPLETED|Overall Study|Study Completion/Early Termination Date|2
593377|NCT00473824|1449350|P1|COMPLETED|Overall Study|Study Completion/Early Termination Date|0
593378|NCT00473824|1449349|P2|STARTED|Overall Study||2
593379|NCT00473824|1449350|P1|STARTED|Overall Study||5
593380|NCT00473746|1449361|P5|NOT COMPLETED|Period 2 (Phase 2)||27
593381|NCT00473746|1449362|P4|NOT COMPLETED|Period 2 (Phase 2)||0
593382|NCT00473746|1449363|P3|NOT COMPLETED|Period 2 (Phase 2)||0
593383|NCT00473746|1449364|P2|NOT COMPLETED|Period 2 (Phase 2)||0
593384|NCT00473746|1449365|P1|NOT COMPLETED|Period 2 (Phase 2)||0
593385|NCT00473746|1449361|P5|COMPLETED|Period 2 (Phase 2)||6
593386|NCT00473746|1449362|P4|COMPLETED|Period 2 (Phase 2)||0
593387|NCT00473746|1449363|P3|COMPLETED|Period 2 (Phase 2)||0
593388|NCT00473746|1449364|P2|COMPLETED|Period 2 (Phase 2)||0
593389|NCT00473746|1449365|P1|COMPLETED|Period 2 (Phase 2)||0
593390|NCT00473746|1449361|P5|STARTED|Period 2 (Phase 2)||33
593391|NCT00473746|1449362|P4|STARTED|Period 2 (Phase 2)||0
593392|NCT00473746|1449363|P3|STARTED|Period 2 (Phase 2)||0
593393|NCT00473746|1449364|P2|STARTED|Period 2 (Phase 2)||0
593394|NCT00473746|1449365|P1|STARTED|Period 2 (Phase 2)||0
593395|NCT00473746|1449361|P5|NOT COMPLETED|Period 1 (Phase 1)||0
593396|NCT00473746|1449362|P4|NOT COMPLETED|Period 1 (Phase 1)||10
593397|NCT00473746|1449363|P3|NOT COMPLETED|Period 1 (Phase 1)||6
593398|NCT00473746|1449364|P2|NOT COMPLETED|Period 1 (Phase 1)||9
593399|NCT00473746|1449365|P1|NOT COMPLETED|Period 1 (Phase 1)||6
593400|NCT00473746|1449361|P5|COMPLETED|Period 1 (Phase 1)||0
593401|NCT00473746|1449362|P4|COMPLETED|Period 1 (Phase 1)|Treatment ongoing|2
593402|NCT00473746|1449363|P3|COMPLETED|Period 1 (Phase 1)||0
593403|NCT00473746|1449364|P2|COMPLETED|Period 1 (Phase 1)||0
593404|NCT00473746|1449365|P1|COMPLETED|Period 1 (Phase 1)||0
593405|NCT00473746|1449361|P5|STARTED|Period 1 (Phase 1)||0
593406|NCT00473746|1449362|P4|STARTED|Period 1 (Phase 1)||12
593407|NCT00473746|1449363|P3|STARTED|Period 1 (Phase 1)||6
593408|NCT00473746|1449364|P2|STARTED|Period 1 (Phase 1)||9
593409|NCT00473746|1449365|P1|STARTED|Period 1 (Phase 1)||6
593410|NCT00473668|1449413|P3|NOT COMPLETED|Overall Study||10
593411|NCT00473668|1449414|P2|NOT COMPLETED|Overall Study||11
593412|NCT00473668|1449415|P1|NOT COMPLETED|Overall Study||5
593413|NCT00473668|1449413|P3|COMPLETED|Overall Study||89
593414|NCT00473668|1449414|P2|COMPLETED|Overall Study||89
593415|NCT00473668|1449415|P1|COMPLETED|Overall Study||95
593416|NCT00473668|1449413|P3|STARTED|Overall Study||99
593417|NCT00473668|1449414|P2|STARTED|Overall Study||100
593418|NCT00473668|1449415|P1|STARTED|Overall Study||100
593419|NCT00473655|1449468|P3|NOT COMPLETED|Overall Study||8
593420|NCT00473655|1449469|P2|NOT COMPLETED|Overall Study||5
593421|NCT00473655|1449470|P1|NOT COMPLETED|Overall Study||9
593422|NCT00473655|1449468|P3|COMPLETED|Overall Study|8 participants were lost of follow up|103
593423|NCT00473655|1449469|P2|COMPLETED|Overall Study|5 participants were lost of follow up|107
593424|NCT00473655|1449470|P1|COMPLETED|Overall Study|9 participants were lost of follow up|102
593425|NCT00473655|1449468|P3|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|111
593426|NCT00473655|1449469|P2|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|112
593427|NCT00473655|1449470|P1|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|111
593428|NCT00473642|1449505|P3|NOT COMPLETED|Overall Study||2
593429|NCT00473642|1449506|P2|NOT COMPLETED|Overall Study||1
593430|NCT00473642|1449507|P1|NOT COMPLETED|Overall Study||2
593431|NCT00473642|1449505|P3|COMPLETED|Overall Study||8
593432|NCT00473642|1449506|P2|COMPLETED|Overall Study||10
593433|NCT00473642|1449507|P1|COMPLETED|Overall Study||8
593434|NCT00473642|1449505|P3|STARTED|Overall Study||10
593435|NCT00473642|1449506|P2|STARTED|Overall Study||11
593436|NCT00473642|1449507|P1|STARTED|Overall Study||10
593437|NCT00473590|1449517|P2|NOT COMPLETED|Overall Study||38
593438|NCT00473590|1449518|P1|NOT COMPLETED|Overall Study||45
593439|NCT00473590|1449517|P2|COMPLETED|Overall Study|Continuing on study as of the data cutoff date of 9 November 2009.|11
593440|NCT00473590|1449518|P1|COMPLETED|Overall Study|Continuing on study as of the data cutoff date of 9 November 2009.|8
593441|NCT00473590|1449517|P2|Safety Population|Overall Study||50
593442|NCT00473590|1449518|P1|Safety Population|Overall Study|2 patients received at least 1 bevacizumab dose & were analyzed as bevacizumab-treated patients|50
593443|NCT00473590|1449517|P2|Treated|Overall Study||48
593444|NCT00473590|1449518|P1|Treated|Overall Study||52
593445|NCT00473590|1449517|P2|STARTED|Overall Study||49
593446|NCT00473590|1449518|P1|STARTED|Overall Study||53
593447|NCT00473564|1449534|P1|NOT COMPLETED|Overall Study||23
593448|NCT00473564|1449534|P1|COMPLETED|Overall Study||147
593449|NCT00473564|1449534|P1|STARTED|Overall Study||170
593450|NCT00473512|1449544|P5|NOT COMPLETED|Period 2 (Phase 2)||2
593451|NCT00473512|1449545|P4|NOT COMPLETED|Period 2 (Phase 2)||23
593452|NCT00473512|1449546|P3|NOT COMPLETED|Period 2 (Phase 2)||2
593453|NCT00473512|1449547|P2|NOT COMPLETED|Period 2 (Phase 2)||2
593454|NCT00473512|1449548|P1|NOT COMPLETED|Period 2 (Phase 2)||1
593455|NCT00473512|1449544|P5|COMPLETED|Period 2 (Phase 2)||0
593456|NCT00473512|1449545|P4|COMPLETED|Period 2 (Phase 2)||0
593457|NCT00473512|1449546|P3|COMPLETED|Period 2 (Phase 2)||0
593458|NCT00473512|1449547|P2|COMPLETED|Period 2 (Phase 2)||0
593459|NCT00473512|1449548|P1|COMPLETED|Period 2 (Phase 2)||0
593460|NCT00473512|1449544|P5|STARTED|Period 2 (Phase 2)||2
593461|NCT00473512|1449545|P4|STARTED|Period 2 (Phase 2)|2 participants did not continue to Phase 2 of the study.|23
593462|NCT00473512|1449546|P3|STARTED|Period 2 (Phase 2)|1 participant did not continue to Phase 2 of the study.|2
593463|NCT00473512|1449547|P2|STARTED|Period 2 (Phase 2)||2
593464|NCT00473512|1449548|P1|STARTED|Period 2 (Phase 2)|1 participant did not continue to Phase 2 of the study.|1
593465|NCT00473512|1449544|P5|NOT COMPLETED|Period 1 (Phase 1)||1
593466|NCT00473512|1449545|P4|NOT COMPLETED|Period 1 (Phase 1)||17
593467|NCT00473512|1449546|P3|NOT COMPLETED|Period 1 (Phase 1)||0
593468|NCT00473512|1449547|P2|NOT COMPLETED|Period 1 (Phase 1)||1
593469|NCT00473512|1449548|P1|NOT COMPLETED|Period 1 (Phase 1)||1
593470|NCT00473512|1449544|P5|COMPLETED|Period 1 (Phase 1)||2
593471|NCT00473512|1449545|P4|COMPLETED|Period 1 (Phase 1)||25
593472|NCT00473512|1449546|P3|COMPLETED|Period 1 (Phase 1)||3
593473|NCT00473512|1449547|P2|COMPLETED|Period 1 (Phase 1)||2
593474|NCT00473512|1449548|P1|COMPLETED|Period 1 (Phase 1)||2
593475|NCT00473512|1449544|P5|STARTED|Period 1 (Phase 1)||3
593476|NCT00473512|1449545|P4|STARTED|Period 1 (Phase 1)||42
593477|NCT00473512|1449546|P3|STARTED|Period 1 (Phase 1)||3
593478|NCT00473512|1449547|P2|STARTED|Period 1 (Phase 1)||3
593479|NCT00473512|1449548|P1|STARTED|Period 1 (Phase 1)||3
593480|NCT00473434|1449606|P1|NOT COMPLETED|Overall Study||32
593481|NCT00473434|1449606|P1|COMPLETED|Overall Study||32
593482|NCT00473434|1449606|P1|STARTED|Overall Study||64
593483|NCT00473382|1449671|P3|NOT COMPLETED|Open-label Extension Through Month 60||82
593484|NCT00473382|1449672|P2|NOT COMPLETED|Open-label Extension Through Month 60||82
593485|NCT00473382|1449673|P1|NOT COMPLETED|Open-label Extension Through Month 60||86
593486|NCT00473382|1449671|P3|COMPLETED|Open-label Extension Through Month 60||2
593487|NCT00473382|1449672|P2|COMPLETED|Open-label Extension Through Month 60||1
593488|NCT00473382|1449673|P1|COMPLETED|Open-label Extension Through Month 60||2
593489|NCT00473382|1449671|P3|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|84
593490|NCT00473382|1449672|P2|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|83
593491|NCT00473382|1449673|P1|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|88
593492|NCT00473382|1449671|P3|NOT COMPLETED|Open-label Extension Through Month 48||47
593493|NCT00473382|1449672|P2|NOT COMPLETED|Open-label Extension Through Month 48||41
593494|NCT00473382|1449673|P1|NOT COMPLETED|Open-label Extension Through Month 48||50
593495|NCT00473382|1449671|P3|COMPLETED|Open-label Extension Through Month 48||37
593496|NCT00473382|1449672|P2|COMPLETED|Open-label Extension Through Month 48||42
593497|NCT00473382|1449673|P1|COMPLETED|Open-label Extension Through Month 48||38
593498|NCT00473382|1449671|P3|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|84
593499|NCT00473382|1449672|P2|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|83
593500|NCT00473382|1449673|P1|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|88
593501|NCT00473382|1449671|P3|NOT COMPLETED|Core Study||29
593502|NCT00473382|1449672|P2|NOT COMPLETED|Core Study||27
593503|NCT00473382|1449673|P1|NOT COMPLETED|Core Study||28
593504|NCT00473382|1449671|P3|COMPLETED|Core Study||98
593505|NCT00473382|1449672|P2|COMPLETED|Core Study||98
593506|NCT00473382|1449673|P1|COMPLETED|Core Study||102
593507|NCT00473382|1449671|P3|STARTED|Core Study||127
593508|NCT00473382|1449672|P2|STARTED|Core Study||125
593509|NCT00473382|1449673|P1|STARTED|Core Study||130
593510|NCT00473330|1449731|P3|NOT COMPLETED|Open-label Extension Through Month 60||77
593511|NCT00473330|1449732|P2|NOT COMPLETED|Open-label Extension Through Month 60||78
593512|NCT00473330|1449733|P1|NOT COMPLETED|Open-label Extension Through Month 60||88
593513|NCT00473330|1449731|P3|COMPLETED|Open-label Extension Through Month 60||0
593514|NCT00473330|1449732|P2|COMPLETED|Open-label Extension Through Month 60||1
593515|NCT00473330|1449733|P1|COMPLETED|Open-label Extension Through Month 60||1
593516|NCT00473330|1449731|P3|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|77
593517|NCT00473330|1449732|P2|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|79
593518|NCT00473330|1449733|P1|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|89
593519|NCT00473330|1449731|P3|NOT COMPLETED|Open-label Extension Through Month 48||27
593520|NCT00473330|1449732|P2|NOT COMPLETED|Open-label Extension Through Month 48||20
593521|NCT00473330|1449733|P1|NOT COMPLETED|Open-label Extension Through Month 48||26
593522|NCT00473330|1449731|P3|COMPLETED|Open-label Extension Through Month 48||50
593523|NCT00473330|1449732|P2|COMPLETED|Open-label Extension Through Month 48||59
593524|NCT00473330|1449733|P1|COMPLETED|Open-label Extension Through Month 48||63
593525|NCT00473330|1449731|P3|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|77
593526|NCT00473330|1449732|P2|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|79
593527|NCT00473330|1449733|P1|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|89
593528|NCT00473330|1449731|P3|NOT COMPLETED|Core Study||41
593529|NCT00473330|1449732|P2|NOT COMPLETED|Core Study||25
593530|NCT00473330|1449733|P1|NOT COMPLETED|Core Study||27
593531|NCT00473330|1449731|P3|COMPLETED|Core Study||86
593532|NCT00473330|1449732|P2|COMPLETED|Core Study||100
593533|NCT00473330|1449733|P1|COMPLETED|Core Study||98
593534|NCT00473330|1449731|P3|STARTED|Core Study||127
593535|NCT00473330|1449732|P2|STARTED|Core Study||125
593536|NCT00473330|1449733|P1|STARTED|Core Study||125
593537|NCT00473265|1449788|P1|NOT COMPLETED|Overall Study||20
593538|NCT00473265|1449788|P1|COMPLETED|Overall Study||48
593539|NCT00473265|1449788|P1|STARTED|Overall Study||68
593540|NCT00473083|1449800|P3|NOT COMPLETED|Overall Study||0
593541|NCT00473083|1449801|P2|NOT COMPLETED|Overall Study||0
593542|NCT00473083|1449802|P1|NOT COMPLETED|Overall Study||1
593543|NCT00473083|1449800|P3|COMPLETED|Overall Study||50
593544|NCT00473083|1449801|P2|COMPLETED|Overall Study||50
593545|NCT00473083|1449802|P1|COMPLETED|Overall Study|One patient (2%) from treatment arm 1 discontinued the study drug as a result of a TEAE (dizziness)|49
593546|NCT00473083|1449800|P3|STARTED|Overall Study||50
593547|NCT00473083|1449801|P2|STARTED|Overall Study||50
593548|NCT00473083|1449802|P1|STARTED|Overall Study||50
593549|NCT00472849|1449830|P2|NOT COMPLETED|Overall Study||0
593550|NCT00472849|1449831|P1|NOT COMPLETED|Overall Study||0
593551|NCT00472849|1449830|P2|COMPLETED|Overall Study||78
593552|NCT00472849|1449831|P1|COMPLETED|Overall Study||12
593553|NCT00472849|1449830|P2|STARTED|Overall Study||78
593554|NCT00472849|1449831|P1|STARTED|Overall Study||12
593555|NCT00472797|1449839|P2|NOT COMPLETED|Overall Study||1
593556|NCT00472797|1449840|P1|NOT COMPLETED|Overall Study||4
593557|NCT00472797|1449839|P2|COMPLETED|Overall Study||112
593558|NCT00472797|1449840|P1|COMPLETED|Overall Study||115
593559|NCT00472797|1449839|P2|STARTED|Overall Study||113
593560|NCT00472797|1449840|P1|STARTED|Overall Study||119
593561|NCT00472732|1449866|P2|NOT COMPLETED|Overall Study||0
593562|NCT00472732|1449867|P1|NOT COMPLETED|Overall Study||0
593563|NCT00472732|1449866|P2|COMPLETED|Overall Study||22
593564|NCT00472732|1449867|P1|COMPLETED|Overall Study||24
593565|NCT00472732|1449866|P2|STARTED|Overall Study||22
593566|NCT00472732|1449867|P1|STARTED|Overall Study||24
593567|NCT00472641|1449877|P1|NOT COMPLETED|Overall Study||7
593568|NCT00472641|1449877|P1|COMPLETED|Overall Study||18
593569|NCT00472641|1449877|P1|STARTED|Overall Study||25
593570|NCT00472576|1449884|P2|NOT COMPLETED|Second Intervention||0
593571|NCT00472576|1449885|P1|NOT COMPLETED|Second Intervention||0
593572|NCT00472576|1449884|P2|COMPLETED|Second Intervention||3
593573|NCT00472576|1449885|P1|COMPLETED|Second Intervention||2
593574|NCT00472576|1449884|P2|STARTED|Second Intervention||3
593575|NCT00472576|1449885|P1|STARTED|Second Intervention||2
593576|NCT00472576|1449884|P2|NOT COMPLETED|First Intervention||0
593577|NCT00472576|1449885|P1|NOT COMPLETED|First Intervention||0
593578|NCT00472576|1449884|P2|COMPLETED|First Intervention||3
593579|NCT00472576|1449885|P1|COMPLETED|First Intervention||2
593580|NCT00472576|1449884|P2|STARTED|First Intervention||3
593581|NCT00472576|1449885|P1|STARTED|First Intervention||2
593582|NCT00472446|1449897|P4|NOT COMPLETED|Overall Study||6
593583|NCT00472446|1449898|P3|NOT COMPLETED|Overall Study||7
593584|NCT00472446|1449899|P2|NOT COMPLETED|Overall Study||6
593585|NCT00472446|1449900|P1|NOT COMPLETED|Overall Study||5
593586|NCT00472446|1449897|P4|COMPLETED|Overall Study||39
593587|NCT00472446|1449898|P3|COMPLETED|Overall Study||38
593588|NCT00472446|1449899|P2|COMPLETED|Overall Study||41
593589|NCT00472446|1449900|P1|COMPLETED|Overall Study||41
593590|NCT00472446|1449897|P4|STARTED|Overall Study||45
593591|NCT00472446|1449898|P3|STARTED|Overall Study||45
593592|NCT00472446|1449899|P2|STARTED|Overall Study||47
593593|NCT00472446|1449900|P1|STARTED|Overall Study||46
593594|NCT00472420|1449930|P1|NOT COMPLETED|Follow-up Period||17
593595|NCT00472420|1449930|P1|COMPLETED|Follow-up Period||15
593596|NCT00472420|1449930|P1|STARTED|Follow-up Period||32
593597|NCT00472420|1449930|P1|NOT COMPLETED|Induction Treatment Period||16
593598|NCT00472420|1449930|P1|COMPLETED|Induction Treatment Period||32
593599|NCT00472420|1449930|P1|STARTED|Induction Treatment Period||48
593600|NCT00472303|1449938|P3|NOT COMPLETED|Maintenance Phase||17
593601|NCT00472303|1449939|P2|NOT COMPLETED|Maintenance Phase||16
593602|NCT00472303|1449940|P1|NOT COMPLETED|Maintenance Phase||17
593603|NCT00472303|1449938|P3|COMPLETED|Maintenance Phase||95
593604|NCT00472303|1449939|P2|COMPLETED|Maintenance Phase||93
593605|NCT00472303|1449940|P1|COMPLETED|Maintenance Phase||89
593606|NCT00472303|1449938|P3|STARTED|Maintenance Phase|112 of 218 participants in the tapentadol titration arm were re-randomized and treated.|112
593607|NCT00472303|1449939|P2|STARTED|Maintenance Phase||109
593608|NCT00472303|1449940|P1|STARTED|Maintenance Phase|106 of 218 participants in the tapentadol titration arm were re-randomized and treated.|106
593609|NCT00472303|1449938|P3|NOT COMPLETED|Discontinuations After Titration Phase||0
593610|NCT00472303|1449939|P2|NOT COMPLETED|Discontinuations After Titration Phase||20
593611|NCT00472303|1449940|P1|NOT COMPLETED|Discontinuations After Titration Phase||61
593612|NCT00472303|1449938|P3|COMPLETED|Discontinuations After Titration Phase||0
593613|NCT00472303|1449939|P2|COMPLETED|Discontinuations After Titration Phase|Participants meeting stabilization criteria on days 13-15 in the titration phase were re-randomized.|109
593614|NCT00472303|1449940|P1|COMPLETED|Discontinuations After Titration Phase|Participants meeting stabilization criteria on days 13-15 in the titration phase were re-randomized.|218
593615|NCT00472303|1449938|P3|STARTED|Discontinuations After Titration Phase||0
593616|NCT00472303|1449939|P2|STARTED|Discontinuations After Titration Phase||129
593617|NCT00472303|1449940|P1|STARTED|Discontinuations After Titration Phase||279
593618|NCT00472303|1449938|P3|NOT COMPLETED|Titration Phase||0
593619|NCT00472303|1449939|P2|NOT COMPLETED|Titration Phase||29
593620|NCT00472303|1449940|P1|NOT COMPLETED|Titration Phase||59
593621|NCT00472303|1449938|P3|COMPLETED|Titration Phase||0
593622|NCT00472303|1449939|P2|COMPLETED|Titration Phase||129
593623|NCT00472303|1449940|P1|COMPLETED|Titration Phase||279
593624|NCT00472303|1449938|P3|STARTED|Titration Phase|All participants in the titration phase were in the tapentadol arm during the titration phase.|0
593625|NCT00472303|1449939|P2|STARTED|Titration Phase||158
593626|NCT00472303|1449940|P1|STARTED|Titration Phase||338
593627|NCT00472290|1450003|P1|NOT COMPLETED|Overall Study||72
593628|NCT00472290|1450003|P1|COMPLETED|Overall Study||0
593629|NCT00472290|1450003|P1|STARTED|Overall Study||72
593630|NCT00472199|1450015|P2|NOT COMPLETED|Overall Study||60
593631|NCT00472199|1450016|P1|NOT COMPLETED|Overall Study||35
593632|NCT00472199|1450015|P2|COMPLETED|Overall Study||103
593633|NCT00472199|1450016|P1|COMPLETED|Overall Study||131
593634|NCT00472199|1450015|P2|STARTED|Overall Study||163
593635|NCT00472199|1450016|P1|STARTED|Overall Study||166
593636|NCT00472082|1450082|P1|NOT COMPLETED|Overall Study||5
593637|NCT00472082|1450082|P1|COMPLETED|Overall Study||0
593638|NCT00472082|1450082|P1|STARTED|Overall Study||5
593639|NCT00472056|1450091|P4|NOT COMPLETED|Overall Study||0
593640|NCT00472056|1450092|P3|NOT COMPLETED|Overall Study||0
593641|NCT00472056|1450093|P2|NOT COMPLETED|Overall Study||0
593642|NCT00472056|1450094|P1|NOT COMPLETED|Overall Study||0
593643|NCT00472056|1450091|P4|COMPLETED|Overall Study||17
593644|NCT00472056|1450092|P3|COMPLETED|Overall Study||32
593645|NCT00472056|1450093|P2|COMPLETED|Overall Study||19
593646|NCT00472056|1450094|P1|COMPLETED|Overall Study||25
593647|NCT00472056|1450091|P4|STARTED|Overall Study||17
593648|NCT00472056|1450092|P3|STARTED|Overall Study||32
593649|NCT00472056|1450093|P2|STARTED|Overall Study||19
593650|NCT00472056|1450094|P1|STARTED|Overall Study||25
593651|NCT00472030|1450104|P2|NOT COMPLETED|Overall Study||0
593652|NCT00472030|1450105|P1|NOT COMPLETED|Overall Study||1
593653|NCT00472030|1450104|P2|COMPLETED|Overall Study||0
593654|NCT00472030|1450105|P1|COMPLETED|Overall Study||1
593655|NCT00472030|1450104|P2|STARTED|Overall Study||0
593656|NCT00472030|1450105|P1|STARTED|Overall Study||2
593657|NCT00471822|1450121|P1|NOT COMPLETED|Overall Study||2
593658|NCT00471822|1450121|P1|COMPLETED|Overall Study||9705
593659|NCT00471822|1450121|P1|Treated|Overall Study||9705
593660|NCT00471822|1450121|P1|STARTED|Overall Study||9707
593661|NCT00471718|1450129|P1|NOT COMPLETED|Overall Study||27
593662|NCT00471718|1450129|P1|COMPLETED|Overall Study||0
593663|NCT00471718|1450129|P1|STARTED|Overall Study||27
593664|NCT00471705|1450141|P3|NOT COMPLETED|Overall Study||15
593665|NCT00471705|1450142|P2|NOT COMPLETED|Overall Study||22
593666|NCT00471705|1450143|P1|NOT COMPLETED|Overall Study||24
593667|NCT00471705|1450141|P3|COMPLETED|Overall Study||134
593668|NCT00471705|1450142|P2|COMPLETED|Overall Study||121
593669|NCT00471705|1450143|P1|COMPLETED|Overall Study||121
593670|NCT00471705|1450141|P3|STARTED|Overall Study||149
593671|NCT00471705|1450142|P2|STARTED|Overall Study||143
593672|NCT00471705|1450143|P1|STARTED|Overall Study||145
593673|NCT00471536|1450157|P1|NOT COMPLETED|Overall Study||1
593674|NCT00471536|1450157|P1|COMPLETED|Overall Study||18
593675|NCT00471536|1450157|P1|STARTED|Overall Study||19
593676|NCT00471497|1450169|P3|NOT COMPLETED|Overall Study||40
593677|NCT00471497|1450170|P2|NOT COMPLETED|Overall Study||35
593678|NCT00471497|1450171|P1|NOT COMPLETED|Overall Study||46
593679|NCT00471497|1450169|P3|COMPLETED|Overall Study|Completed means patient is on treatment in core phase of the study (ongoing) by data cut-off.|241
593680|NCT00471497|1450170|P2|COMPLETED|Overall Study|Completed means patient is on treatment in core phase of the study (ongoing) by data cut-off.|247
593681|NCT00471497|1450171|P1|COMPLETED|Overall Study|Completed means patient is on treatment in core phase of the study (ongoing) by data cut-off.|237
593682|NCT00471497|1450169|P3|SAFETY ANALYSIS SET|Overall Study|Safety set contained patients who received at least one dose of study medication.|277
593683|NCT00471497|1450170|P2|SAFETY ANALYSIS SET|Overall Study|Safety set contained patients who received at least one dose of study medication.|279
593684|NCT00471497|1450171|P1|SAFETY ANALYSIS SET|Overall Study|Safety set contained patients who received at least one dose of study medication.|280
593685|NCT00471497|1450169|P3|STARTED|Overall Study||281
593686|NCT00471497|1450170|P2|STARTED|Overall Study||282
593687|NCT00471497|1450171|P1|STARTED|Overall Study||283
593688|NCT00471445|1450181|P2|NOT COMPLETED|Overall Study||2
593689|NCT00471445|1450182|P1|NOT COMPLETED|Overall Study||2
593690|NCT00471445|1450181|P2|COMPLETED|Overall Study||231
593691|NCT00471445|1450182|P1|COMPLETED|Overall Study||227
593692|NCT00471445|1450181|P2|STARTED|Overall Study||233
593693|NCT00471445|1450182|P1|STARTED|Overall Study||229
593694|NCT00471380|1450188|P2|NOT COMPLETED|Third Intervention||2
593695|NCT00471380|1450189|P1|NOT COMPLETED|Third Intervention||1
593696|NCT00471380|1450188|P2|COMPLETED|Third Intervention||14
593697|NCT00471380|1450189|P1|COMPLETED|Third Intervention||17
593698|NCT00471380|1450188|P2|STARTED|Third Intervention||16
593699|NCT00471380|1450189|P1|STARTED|Third Intervention||18
593700|NCT00471380|1450188|P2|NOT COMPLETED|Second Intervention||4
593701|NCT00471380|1450189|P1|NOT COMPLETED|Second Intervention||0
593702|NCT00471380|1450188|P2|COMPLETED|Second Intervention||16
593703|NCT00471380|1450189|P1|COMPLETED|Second Intervention||18
593704|NCT00471380|1450188|P2|STARTED|Second Intervention||20
593705|NCT00471380|1450189|P1|STARTED|Second Intervention||18
593706|NCT00471380|1450188|P2|NOT COMPLETED|First Intervention||4
593707|NCT00471380|1450189|P1|NOT COMPLETED|First Intervention||4
593708|NCT00471380|1450188|P2|COMPLETED|First Intervention||20
593709|NCT00471380|1450189|P1|COMPLETED|First Intervention||18
593710|NCT00471380|1450188|P2|STARTED|First Intervention||24
593711|NCT00471380|1450189|P1|STARTED|First Intervention||22
593712|NCT00471354|1450195|P1|NOT COMPLETED|Overall Study||52
593713|NCT00471354|1450195|P1|COMPLETED|Overall Study||176
593714|NCT00471354|1450195|P1|STARTED|Overall Study||228
593715|NCT00471328|1450207|P2|NOT COMPLETED|Extension Phase||67
593716|NCT00471328|1450208|P1|NOT COMPLETED|Extension Phase||41
593717|NCT00471328|1450207|P2|COMPLETED|Extension Phase||0
593718|NCT00471328|1450208|P1|COMPLETED|Extension Phase||0
593719|NCT00471328|1450207|P2|Started:CrossOver During Extension|Extension Phase||10
593720|NCT00471328|1450208|P1|Started:CrossOver During Extension|Extension Phase||0
593721|NCT00471328|1450207|P2|Started:CrossOver After PrimaryAnalysis|Extension Phase||4
593722|NCT00471328|1450208|P1|Started:CrossOver After PrimaryAnalysis|Extension Phase||0
593723|NCT00471328|1450207|P2|Started:CrossOver Before PrimaryAnalysis|Extension Phase||53
593724|NCT00471328|1450208|P1|Started:CrossOver Before PrimaryAnalysis|Extension Phase||0
593725|NCT00471328|1450207|P2|STARTED|Extension Phase||67
593726|NCT00471328|1450208|P1|STARTED|Extension Phase|Out of 58 ongoing patients, 17 patients had progression or died before they could enter extension|41
593727|NCT00471328|1450207|P2|NOT COMPLETED|Core Phase||67
593728|NCT00471328|1450208|P1|NOT COMPLETED|Core Phase||107
593729|NCT00471328|1450207|P2|COMPLETED|Core Phase|Ongoing on treatment during completion of core|16
593730|NCT00471328|1450208|P1|COMPLETED|Core Phase|Ongoing on treatment during completion of core.|58
593731|NCT00471328|1450207|P2|Crossover to Nilotinib:Started Extension|Core Phase||53
593732|NCT00471328|1450208|P1|Crossover to Nilotinib:Started Extension|Core Phase||0
593733|NCT00471328|1450207|P2|STARTED|Core Phase||83
593734|NCT00471328|1450208|P1|STARTED|Core Phase||165
593735|NCT00471315|1450227|P1|NOT COMPLETED|Overall Study||8
593736|NCT00471315|1450227|P1|COMPLETED|Overall Study||10
593737|NCT00471315|1450227|P1|STARTED|Overall Study||18
593738|NCT00471276|1450232|P1|NOT COMPLETED|Overall Study||83
593739|NCT00471276|1450232|P1|COMPLETED|Overall Study||0
593740|NCT00471276|1450232|P1|STARTED|Overall Study||83
593741|NCT00471237|1450262|P7|NOT COMPLETED|Overall Study||3
593742|NCT00471237|1450263|P6|NOT COMPLETED|Overall Study||39
593743|NCT00471237|1450264|P5|NOT COMPLETED|Overall Study||41
593744|NCT00471237|1450265|P4|NOT COMPLETED|Overall Study||45
593745|NCT00471237|1450266|P3|NOT COMPLETED|Overall Study||34
593746|NCT00471237|1450267|P2|NOT COMPLETED|Overall Study||42
593747|NCT00471237|1450268|P1|NOT COMPLETED|Overall Study||41
593748|NCT00471237|1450262|P7|COMPLETED|Overall Study||38
593749|NCT00471237|1450263|P6|COMPLETED|Overall Study||50
593750|NCT00471237|1450264|P5|COMPLETED|Overall Study||46
593751|NCT00471237|1450265|P4|COMPLETED|Overall Study||43
593752|NCT00471237|1450266|P3|COMPLETED|Overall Study||48
593753|NCT00471237|1450267|P2|COMPLETED|Overall Study||45
593754|NCT00471237|1450268|P1|COMPLETED|Overall Study||49
593755|NCT00471237|1450262|P7|STARTED|Overall Study||41
593756|NCT00471237|1450263|P6|STARTED|Overall Study||89
593757|NCT00471237|1450264|P5|STARTED|Overall Study||87
593758|NCT00471237|1450265|P4|STARTED|Overall Study||88
593759|NCT00471237|1450266|P3|STARTED|Overall Study||82
593760|NCT00471237|1450267|P2|STARTED|Overall Study||87
593761|NCT00471237|1450268|P1|STARTED|Overall Study||90
593762|NCT00471146|1450418|P2|NOT COMPLETED|Overall Study||174
593763|NCT00471146|1450419|P1|NOT COMPLETED|Overall Study||172
593764|NCT00471146|1450418|P2|COMPLETED|Overall Study||142
593765|NCT00471146|1450419|P1|COMPLETED|Overall Study||142
593766|NCT00471146|1450418|P2|Treated|Overall Study||308
593767|NCT00471146|1450419|P1|Treated|Overall Study||305
593768|NCT00471146|1450418|P2|STARTED|Overall Study||316
593769|NCT00471146|1450419|P1|STARTED|Overall Study||314
593770|NCT00471107|1450444|P3|NOT COMPLETED|Overall Study||3
593771|NCT00471107|1450445|P2|NOT COMPLETED|Overall Study||1
593772|NCT00471107|1450446|P1|NOT COMPLETED|Overall Study||3
593773|NCT00471107|1450444|P3|COMPLETED|Overall Study||12
593774|NCT00471107|1450445|P2|COMPLETED|Overall Study||14
593775|NCT00471107|1450446|P1|COMPLETED|Overall Study||12
593776|NCT00471107|1450444|P3|STARTED|Overall Study||15
593777|NCT00471107|1450445|P2|STARTED|Overall Study||15
593778|NCT00471107|1450446|P1|STARTED|Overall Study||15
593779|NCT00471068|1450456|P2|NOT COMPLETED|Overall Study||1
593780|NCT00471068|1450457|P1|NOT COMPLETED|Overall Study||1
593781|NCT00471068|1450456|P2|COMPLETED|Overall Study||24
593782|NCT00471068|1450457|P1|COMPLETED|Overall Study||20
593783|NCT00471068|1450456|P2|STARTED|Overall Study||25
593784|NCT00471068|1450457|P1|STARTED|Overall Study||21
593785|NCT00470847|1450463|P1|NOT COMPLETED|Overall Study||1
593786|NCT00470847|1450463|P1|COMPLETED|Overall Study||34
593787|NCT00470847|1450463|P1|STARTED|Overall Study||35
593788|NCT00470834|1450476|P2|NOT COMPLETED|Extension Period (24 Months)||23
593789|NCT00470834|1450477|P1|NOT COMPLETED|Extension Period (24 Months)||15
593790|NCT00470834|1450476|P2|COMPLETED|Extension Period (24 Months)||7
593791|NCT00470834|1450477|P1|COMPLETED|Extension Period (24 Months)||11
593792|NCT00470834|1450476|P2|STARTED|Extension Period (24 Months)|One participant who completed the Treatment Period did not participate in the Extension Period.|30
593793|NCT00470834|1450477|P1|STARTED|Extension Period (24 Months)|One participant who completed the Treatment Period did not participate in the Extension Period.|26
593794|NCT00470834|1450476|P2|NOT COMPLETED|Treatment Period (18 Months)||31
593795|NCT00470834|1450477|P1|NOT COMPLETED|Treatment Period (18 Months)||38
593796|NCT00470834|1450476|P2|COMPLETED|Treatment Period (18 Months)||31
593797|NCT00470834|1450477|P1|COMPLETED|Treatment Period (18 Months)||27
593798|NCT00470834|1450476|P2|STARTED|Treatment Period (18 Months)||62
593799|NCT00470834|1450477|P1|STARTED|Treatment Period (18 Months)||65
593800|NCT00470626|1450491|P1|NOT COMPLETED|Overall Study||17
593801|NCT00470626|1450491|P1|COMPLETED|Overall Study||112
593802|NCT00470626|1450491|P1|STARTED|Overall Study||129
593803|NCT00470600|1450499|P2|NOT COMPLETED|Overall Study||0
593804|NCT00470600|1450500|P1|NOT COMPLETED|Overall Study||0
593805|NCT00470600|1450499|P2|COMPLETED|Overall Study|One subject was randomized to incorrect stratification categories (weight).|99
593806|NCT00470600|1450500|P1|COMPLETED|Overall Study|Two subjects were randomized to incorrect stratification categories (weight).|86
593807|NCT00470600|1450499|P2|STARTED|Overall Study||99
593808|NCT00470600|1450500|P1|STARTED|Overall Study||86
593809|NCT00470548|1450512|P4|NOT COMPLETED|Overall Study||0
593810|NCT00470548|1450513|P3|NOT COMPLETED|Overall Study||0
593811|NCT00470548|1450514|P2|NOT COMPLETED|Overall Study||0
593812|NCT00470548|1450515|P1|NOT COMPLETED|Overall Study||0
593813|NCT00470548|1450512|P4|COMPLETED|Overall Study||37
593814|NCT00470548|1450513|P3|COMPLETED|Overall Study||6
593815|NCT00470548|1450514|P2|COMPLETED|Overall Study||3
593816|NCT00470548|1450515|P1|COMPLETED|Overall Study||3
593817|NCT00470548|1450512|P4|STARTED|Overall Study||37
593818|NCT00470548|1450513|P3|STARTED|Overall Study||6
593819|NCT00470548|1450514|P2|STARTED|Overall Study||3
593820|NCT00470548|1450515|P1|STARTED|Overall Study||3
593821|NCT00470535|1450533|P1|NOT COMPLETED|Overall Study||18
593822|NCT00470535|1450533|P1|COMPLETED|Overall Study||0
593823|NCT00470535|1450533|P1|STARTED|Overall Study||18
593824|NCT00470470|1450542|P1|NOT COMPLETED|Overall Study||5
593825|NCT00470470|1450542|P1|COMPLETED|Overall Study||25
593826|NCT00470470|1450542|P1|STARTED|Overall Study||30
593827|NCT00470418|1450549|P2|NOT COMPLETED|Overall Study||0
593828|NCT00470418|1450550|P1|NOT COMPLETED|Overall Study||1
593829|NCT00470418|1450549|P2|COMPLETED|Overall Study||3
593830|NCT00470418|1450550|P1|COMPLETED|Overall Study||6
593831|NCT00470418|1450549|P2|STARTED|Overall Study||3
593832|NCT00470418|1450550|P1|STARTED|Overall Study||7
593833|NCT00470392|1450560|P2|NOT COMPLETED|Overall Study||0
593834|NCT00470392|1450561|P1|NOT COMPLETED|Overall Study||0
593835|NCT00470392|1450560|P2|COMPLETED|Overall Study||2
593836|NCT00470392|1450561|P1|COMPLETED|Overall Study||7
593837|NCT00470392|1450560|P2|STARTED|Overall Study|Number of subjects enrolled, passed screening and assigned to this arm.|2
593838|NCT00470392|1450561|P1|STARTED|Overall Study|Number of subjects enrolled, passed screening and assigned to this arm.|7
593839|NCT00470366|1450571|P1|NOT COMPLETED|Overall Study||4
593840|NCT00470366|1450571|P1|COMPLETED|Overall Study||56
593841|NCT00470366|1450571|P1|STARTED|Overall Study||60
593842|NCT00470301|1450578|P1|NOT COMPLETED|Overall Study||5
593843|NCT00470301|1450578|P1|COMPLETED|Overall Study||55
593844|NCT00470301|1450578|P1|STARTED|Overall Study||60
593845|NCT00470275|1450582|P1|NOT COMPLETED|Overall Study||10
593846|NCT00470275|1450582|P1|COMPLETED|Overall Study||0
593847|NCT00470275|1450582|P1|STARTED|Overall Study||10
593848|NCT00470262|1450588|P2|NOT COMPLETED|Overall Study||0
593849|NCT00470262|1450589|P1|NOT COMPLETED|Overall Study||2
593850|NCT00470262|1450588|P2|COMPLETED|Overall Study||12
593851|NCT00470262|1450589|P1|COMPLETED|Overall Study||13
593852|NCT00470262|1450588|P2|STARTED|Overall Study||12
593853|NCT00470262|1450589|P1|STARTED|Overall Study||15
593854|NCT00470184|1450597|P1|NOT COMPLETED|Overall Study||22
593855|NCT00470184|1450597|P1|COMPLETED|Overall Study||19
593856|NCT00470184|1450597|P1|Treated With Study Therapy|Overall Study||36
593857|NCT00470184|1450597|P1|STARTED|Overall Study||41
593858|NCT00470158|1450609|P5|NOT COMPLETED|Overall Study||6
593859|NCT00470158|1450610|P4|NOT COMPLETED|Overall Study||5
593860|NCT00470158|1450611|P3|NOT COMPLETED|Overall Study||8
593861|NCT00470158|1450612|P2|NOT COMPLETED|Overall Study||8
593862|NCT00470158|1450613|P1|NOT COMPLETED|Overall Study||8
593863|NCT00470158|1450609|P5|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|195
593864|NCT00470158|1450610|P4|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
593865|NCT00470158|1450611|P3|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
593866|NCT00470158|1450612|P2|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|191
593867|NCT00470158|1450613|P1|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
593868|NCT00470158|1450609|P5|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
593869|NCT00470158|1450610|P4|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|198
593870|NCT00470158|1450611|P3|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
593871|NCT00470158|1450612|P2|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|199
593872|NCT00470158|1450613|P1|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
593873|NCT00470106|1450629|P4|NOT COMPLETED|Overall Study||2
593874|NCT00470106|1450630|P3|NOT COMPLETED|Overall Study||7
593875|NCT00470106|1450631|P2|NOT COMPLETED|Overall Study||5
593876|NCT00470106|1450632|P1|NOT COMPLETED|Overall Study||3
593877|NCT00470106|1450629|P4|COMPLETED|Overall Study||19
593878|NCT00470106|1450630|P3|COMPLETED|Overall Study||14
593879|NCT00470106|1450631|P2|COMPLETED|Overall Study||19
593880|NCT00470106|1450632|P1|COMPLETED|Overall Study||16
593881|NCT00470106|1450629|P4|STARTED|Overall Study||21
593882|NCT00470106|1450630|P3|STARTED|Overall Study||21
593883|NCT00470106|1450631|P2|STARTED|Overall Study||24
593884|NCT00470106|1450632|P1|STARTED|Overall Study||19
593885|NCT00470067|1450646|P1|NOT COMPLETED|Overall Study||7
593886|NCT00470067|1450646|P1|COMPLETED|Overall Study||2
593887|NCT00470067|1450646|P1|STARTED|Overall Study||9
593888|NCT00470054|1450650|P1|NOT COMPLETED|Overall Study||1
593889|NCT00470054|1450650|P1|COMPLETED|Overall Study||43
593890|NCT00470054|1450650|P1|STARTED|Overall Study||44
593891|NCT00469898|1450658|P1|NOT COMPLETED|Overall Study||25
593892|NCT00469898|1450658|P1|COMPLETED|Overall Study||25
593893|NCT00469898|1450658|P1|STARTED|Overall Study||50
593894|NCT00469859|1450667|P2|NOT COMPLETED|Overall Study||2
593895|NCT00469859|1450668|P1|NOT COMPLETED|Overall Study||0
593896|NCT00469859|1450667|P2|COMPLETED|Overall Study||6
593897|NCT00469859|1450668|P1|COMPLETED|Overall Study||6
593898|NCT00469859|1450667|P2|STARTED|Overall Study||8
593899|NCT00469859|1450668|P1|STARTED|Overall Study||6
593900|NCT00469833|1450676|P1|NOT COMPLETED|Overall Study||2
593901|NCT00469833|1450676|P1|COMPLETED|Overall Study||15
593902|NCT00469833|1450676|P1|STARTED|Overall Study|17 subjects met inclusion criteria and consented for the study|17
593903|NCT00469508|1450688|P2|NOT COMPLETED|Overall Study||24
593904|NCT00469508|1450689|P1|NOT COMPLETED|Overall Study||20
593905|NCT00469508|1450688|P2|COMPLETED|Overall Study||13
593906|NCT00469508|1450689|P1|COMPLETED|Overall Study||14
593907|NCT00469508|1450688|P2|STARTED|Overall Study||37
593908|NCT00469508|1450689|P1|STARTED|Overall Study||34
593909|NCT00469456|1450703|P2|NOT COMPLETED|Overall Study||4
593910|NCT00469456|1450704|P1|NOT COMPLETED|Overall Study||9
593911|NCT00469456|1450703|P2|COMPLETED|Overall Study||131
593912|NCT00469456|1450704|P1|COMPLETED|Overall Study||120
593913|NCT00469456|1450703|P2|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug.|135
593914|NCT00469456|1450704|P1|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|129
593915|NCT00469391|1450714|P2|NOT COMPLETED|Overall Study||5
593916|NCT00469391|1450715|P1|NOT COMPLETED|Overall Study||14
593917|NCT00469391|1450714|P2|COMPLETED|Overall Study||24
593918|NCT00469391|1450715|P1|COMPLETED|Overall Study||13
593919|NCT00469391|1450714|P2|Patient Preference|Overall Study||1
593920|NCT00469391|1450715|P1|Patient Preference|Overall Study||0
593921|NCT00469391|1450714|P2|Lost to Follow up|Overall Study||1
593922|NCT00469391|1450715|P1|Lost to Follow up|Overall Study||0
593923|NCT00469391|1450714|P2|Adverse Event|Overall Study||0
593924|NCT00469391|1450715|P1|Adverse Event|Overall Study||8
593925|NCT00469391|1450714|P2|Unsuccessful Implant Procedure|Overall Study||0
593926|NCT00469391|1450715|P1|Unsuccessful Implant Procedure|Overall Study||4
593927|NCT00469391|1450714|P2|Discontinued Prior to Procedure|Overall Study||3
593928|NCT00469391|1450715|P1|Discontinued Prior to Procedure|Overall Study||2
593929|NCT00469391|1450714|P2|STARTED|Overall Study||29
593930|NCT00469391|1450715|P1|STARTED|Overall Study||27
593931|NCT00469274|1450723|P2|NOT COMPLETED|Overall Study||0
593932|NCT00469274|1450724|P1|NOT COMPLETED|Overall Study||0
593933|NCT00469274|1450723|P2|COMPLETED|Overall Study||42
593934|NCT00469274|1450724|P1|COMPLETED|Overall Study||44
593935|NCT00469274|1450723|P2|STARTED|Overall Study||42
593936|NCT00469274|1450724|P1|STARTED|Overall Study||44
593937|NCT00469209|1450733|P3|NOT COMPLETED|Overall Study||1
593938|NCT00469209|1450734|P2|NOT COMPLETED|Overall Study||0
593939|NCT00469209|1450735|P1|NOT COMPLETED|Overall Study||1
593940|NCT00469209|1450733|P3|COMPLETED|Overall Study||19
593941|NCT00469209|1450734|P2|COMPLETED|Overall Study||20
593942|NCT00469209|1450735|P1|COMPLETED|Overall Study||19
593943|NCT00469209|1450733|P3|STARTED|Overall Study||20
593944|NCT00469209|1450734|P2|STARTED|Overall Study||20
593945|NCT00469209|1450735|P1|STARTED|Overall Study||20
593946|NCT00469092|1450745|P2|NOT COMPLETED|Overall Study||21
593947|NCT00469092|1450746|P1|NOT COMPLETED|Overall Study||26
593948|NCT00469092|1450745|P2|COMPLETED|Overall Study||220
593949|NCT00469092|1450746|P1|COMPLETED|Overall Study||213
593950|NCT00469092|1450745|P2|Exposed to Study Drug|Overall Study||238
593951|NCT00469092|1450746|P1|Exposed to Study Drug|Overall Study||231
593952|NCT00469092|1450745|P2|STARTED|Overall Study||241
593953|NCT00469092|1450746|P1|STARTED|Overall Study||239
593954|NCT00469079|1450765|P3|NOT COMPLETED|Overall Study||19
593955|NCT00469079|1450766|P2|NOT COMPLETED|Overall Study||22
593956|NCT00469079|1450767|P1|NOT COMPLETED|Overall Study||9
593957|NCT00469079|1450765|P3|COMPLETED|Overall Study||32
593958|NCT00469079|1450766|P2|COMPLETED|Overall Study||30
593959|NCT00469079|1450767|P1|COMPLETED|Overall Study||18
593960|NCT00469079|1450765|P3|STARTED|Overall Study||51
593961|NCT00469079|1450766|P2|STARTED|Overall Study||52
593962|NCT00469079|1450767|P1|STARTED|Overall Study||27
593963|NCT00468910|1450786|P2|NOT COMPLETED|Overall Study||3
593964|NCT00468910|1450787|P1|NOT COMPLETED|Overall Study||4
593965|NCT00468910|1450786|P2|COMPLETED|Overall Study||36
593966|NCT00468910|1450787|P1|COMPLETED|Overall Study||36
593967|NCT00468910|1450786|P2|Follow-up|Overall Study||36
593968|NCT00468910|1450787|P1|Follow-up|Overall Study||36
593969|NCT00468910|1450786|P2|Post-Treatment Biopsy|Overall Study||36
593970|NCT00468910|1450787|P1|Post-Treatment Biopsy|Overall Study||36
593971|NCT00468910|1450786|P2|Treatment|Overall Study||36
593972|NCT00468910|1450787|P1|Treatment|Overall Study||36
593973|NCT00468910|1450786|P2|Randomization|Overall Study||39
593974|NCT00468910|1450787|P1|Randomization|Overall Study||40
593975|NCT00468910|1450786|P2|STARTED|Overall Study||39
593976|NCT00468910|1450787|P1|STARTED|Overall Study||40
593977|NCT00468858|1450806|P3|NOT COMPLETED|Overall Study||14
593978|NCT00468858|1450807|P2|NOT COMPLETED|Overall Study||10
593979|NCT00468858|1450808|P1|NOT COMPLETED|Overall Study||9
593980|NCT00468858|1450806|P3|COMPLETED|Overall Study||199
593981|NCT00468858|1450807|P2|COMPLETED|Overall Study||202
593982|NCT00468858|1450808|P1|COMPLETED|Overall Study||202
593983|NCT00468858|1450806|P3|STARTED|Overall Study||213
593984|NCT00468858|1450807|P2|STARTED|Overall Study||212
593985|NCT00468858|1450808|P1|STARTED|Overall Study||211
593986|NCT00468845|1450929|P3|NOT COMPLETED|Overall Study||30
593987|NCT00468845|1450930|P2|NOT COMPLETED|Overall Study||34
593988|NCT00468845|1450931|P1|NOT COMPLETED|Overall Study||21
593989|NCT00468845|1450929|P3|COMPLETED|Overall Study||139
593990|NCT00468845|1450930|P2|COMPLETED|Overall Study||136
593991|NCT00468845|1450931|P1|COMPLETED|Overall Study||141
593992|NCT00468845|1450929|P3|Received Treatment|Overall Study||167
593993|NCT00468845|1450930|P2|Received Treatment|Overall Study||166
593994|NCT00468845|1450931|P1|Received Treatment|Overall Study||161
593995|NCT00468845|1450929|P3|STARTED|Overall Study||169
593996|NCT00468845|1450930|P2|STARTED|Overall Study||170
593997|NCT00468845|1450931|P1|STARTED|Overall Study||162
593998|NCT00468819|1451068|P3|NOT COMPLETED|Overall Study||2
593999|NCT00468819|1451069|P2|NOT COMPLETED|Overall Study||0
594000|NCT00468819|1451070|P1|NOT COMPLETED|Overall Study||6
594001|NCT00468819|1451068|P3|COMPLETED|Overall Study||46
594002|NCT00468819|1451069|P2|COMPLETED|Overall Study||44
594003|NCT00468819|1451070|P1|COMPLETED|Overall Study||42
594004|NCT00468819|1451068|P3|Treatment Received/ Safety Follow-up|Overall Study|FAS|48
594005|NCT00468819|1451069|P2|Treatment Received/ Safety Follow-up|Overall Study|FAS|44
594006|NCT00468819|1451070|P1|Treatment Received/ Safety Follow-up|Overall Study|FAS (Full Analysis Set)|46
594007|NCT00468819|1451068|P3|STARTED|Overall Study|Enrolled participants|48
594008|NCT00468819|1451069|P2|STARTED|Overall Study|Enrolled participants|44
594009|NCT00468819|1451070|P1|STARTED|Overall Study|Enrolled participants|48
594010|NCT00468728|1451150|P2|NOT COMPLETED|Follow-up||31
594011|NCT00468728|1451151|P1|NOT COMPLETED|Follow-up||34
594012|NCT00468728|1451150|P2|COMPLETED|Follow-up||222
594013|NCT00468728|1451151|P1|COMPLETED|Follow-up||222
594014|NCT00468728|1451150|P2|STARTED|Follow-up||253
594015|NCT00468728|1451151|P1|STARTED|Follow-up||256
594016|NCT00468728|1451150|P2|NOT COMPLETED|Treatment||11
594017|NCT00468728|1451151|P1|NOT COMPLETED|Treatment||4
594018|NCT00468728|1451150|P2|COMPLETED|Treatment||253
594019|NCT00468728|1451151|P1|COMPLETED|Treatment||256
594020|NCT00468728|1451150|P2|STARTED|Treatment||264
594021|NCT00468728|1451151|P1|STARTED|Treatment||260
594022|NCT00468728|1451150|P2|NOT COMPLETED|Enrollment||7
594023|NCT00468728|1451151|P1|NOT COMPLETED|Enrollment||4
594024|NCT00468728|1451150|P2|COMPLETED|Enrollment|1 fidaxomicin subject received vancomycin, 11 subjects didn't take drug|264
594025|NCT00468728|1451151|P1|COMPLETED|Enrollment|1 fidaxomicin subject received vancomycin, 11 subjects didn't take drug|260
594026|NCT00468728|1451150|P2|STARTED|Enrollment||271
594027|NCT00468728|1451151|P1|STARTED|Enrollment||264
594028|NCT00468676|1451163|P2|NOT COMPLETED|Overall Study||12
594029|NCT00468676|1451164|P1|NOT COMPLETED|Overall Study||16
594030|NCT00468676|1451163|P2|COMPLETED|Overall Study||94
594031|NCT00468676|1451164|P1|COMPLETED|Overall Study||92
594032|NCT00468676|1451163|P2|STARTED|Overall Study||106
594033|NCT00468676|1451164|P1|STARTED|Overall Study||108
594034|NCT00468650|1451181|P1|NOT COMPLETED|Overall Study||7
594035|NCT00468650|1451181|P1|COMPLETED|Overall Study||110
594036|NCT00468650|1451181|P1|STARTED|Overall Study||117
594037|NCT00468585|1451229|P4|NOT COMPLETED|Overall Study||1
594038|NCT00468585|1451230|P3|NOT COMPLETED|Overall Study||5
594039|NCT00468585|1451231|P2|NOT COMPLETED|Overall Study||0
594040|NCT00468585|1451232|P1|NOT COMPLETED|Overall Study||1
594041|NCT00468585|1451229|P4|COMPLETED|Overall Study||5
594042|NCT00468585|1451230|P3|COMPLETED|Overall Study||45
594043|NCT00468585|1451231|P2|COMPLETED|Overall Study||3
594044|NCT00468585|1451232|P1|COMPLETED|Overall Study||3
594045|NCT00468585|1451229|P4|STARTED|Overall Study||6
594046|NCT00468585|1451230|P3|STARTED|Overall Study||50
594047|NCT00468585|1451231|P2|STARTED|Overall Study||3
594048|NCT00468585|1451232|P1|STARTED|Overall Study||4
594049|NCT00468559|1451244|P3|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||17
594050|NCT00468559|1451245|P2|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||10
594051|NCT00468559|1451246|P1|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||0
594052|NCT00468559|1451244|P3|COMPLETED|Double-blind, Treatment-withdrawal Phase||24
594053|NCT00468559|1451245|P2|COMPLETED|Double-blind, Treatment-withdrawal Phase||29
594054|NCT00468559|1451246|P1|COMPLETED|Double-blind, Treatment-withdrawal Phase||0
594055|NCT00468559|1451244|P3|STARTED|Double-blind, Treatment-withdrawal Phase||41
594056|NCT00468559|1451245|P2|STARTED|Double-blind, Treatment-withdrawal Phase||39
594057|NCT00468559|1451246|P1|STARTED|Double-blind, Treatment-withdrawal Phase||0
594058|NCT00468559|1451244|P3|NOT COMPLETED|Open-label Treatment Phase||0
594059|NCT00468559|1451245|P2|NOT COMPLETED|Open-label Treatment Phase||0
594060|NCT00468559|1451246|P1|NOT COMPLETED|Open-label Treatment Phase||18
594061|NCT00468559|1451244|P3|COMPLETED|Open-label Treatment Phase||0
594062|NCT00468559|1451245|P2|COMPLETED|Open-label Treatment Phase||0
594063|NCT00468559|1451246|P1|COMPLETED|Open-label Treatment Phase|18 patients discontinued (were not randomized into the double-blind treatment withdrawal phase)|80
594064|NCT00468559|1451244|P3|STARTED|Open-label Treatment Phase||0
594065|NCT00468559|1451245|P2|STARTED|Open-label Treatment Phase||0
594066|NCT00468559|1451246|P1|STARTED|Open-label Treatment Phase|All participants received open-label esomeprazole during this phase of the study|98
594067|NCT00468546|1451274|P2|NOT COMPLETED|Week 24 to Week 104 Analysis||225
594068|NCT00468546|1451275|P1|NOT COMPLETED|Week 24 to Week 104 Analysis||105
594069|NCT00468546|1451274|P2|COMPLETED|Week 24 to Week 104 Analysis||83
594070|NCT00468546|1451275|P1|COMPLETED|Week 24 to Week 104 Analysis||103
594071|NCT00468546|1451274|P2|STARTED|Week 24 to Week 104 Analysis|Participants who completed/not completed W24 analysis were entered in W24 to W104 analysis.|308
594072|NCT00468546|1451275|P1|STARTED|Week 24 to Week 104 Analysis|Participants who completed/not completed Week (W) 24 analysis were entered in W24 to W104 analysis.|208
594073|NCT00468546|1451274|P2|NOT COMPLETED|Week 24 Analysis||55
594074|NCT00468546|1451275|P1|NOT COMPLETED|Week 24 Analysis||97
594075|NCT00468546|1451274|P2|COMPLETED|Week 24 Analysis||253
594076|NCT00468546|1451275|P1|COMPLETED|Week 24 Analysis||111
594077|NCT00468546|1451274|P2|STARTED|Week 24 Analysis||308
594078|NCT00468546|1451275|P1|STARTED|Week 24 Analysis||208
594079|NCT00468481|1451305|P2|NOT COMPLETED|Overall Study||24
594080|NCT00468481|1451306|P1|NOT COMPLETED|Overall Study||88
594081|NCT00468481|1451305|P2|COMPLETED|Overall Study||70
594082|NCT00468481|1451306|P1|COMPLETED|Overall Study||203
594083|NCT00468481|1451305|P2|Subjects Treated|Overall Study||94
594084|NCT00468481|1451306|P1|Subjects Treated|Overall Study||285
594085|NCT00468481|1451305|P2|STARTED|Overall Study||94
594086|NCT00468481|1451306|P1|STARTED|Overall Study|6 of these randomized subjects did not take any study medication|291
594087|NCT00468312|1451406|P2|NOT COMPLETED|Overall Study||5
594088|NCT00468312|1451407|P1|NOT COMPLETED|Overall Study||4
594089|NCT00468312|1451406|P2|COMPLETED|Overall Study||204
594090|NCT00468312|1451407|P1|COMPLETED|Overall Study||216
594091|NCT00468312|1451406|P2|STARTED|Overall Study||209
594092|NCT00468312|1451407|P1|STARTED|Overall Study||220
594093|NCT00468299|1451423|P2|NOT COMPLETED|Overall Study||1
594094|NCT00468299|1451424|P1|NOT COMPLETED|Overall Study||0
594095|NCT00468299|1451423|P2|COMPLETED|Overall Study||7
594096|NCT00468299|1451424|P1|COMPLETED|Overall Study||9
594097|NCT00468299|1451423|P2|STARTED|Overall Study||8
594098|NCT00468299|1451424|P1|STARTED|Overall Study||9
594099|NCT00468286|1451434|P2|NOT COMPLETED|Overall Study||12
594100|NCT00468286|1451435|P1|NOT COMPLETED|Overall Study||7
594101|NCT00468286|1451434|P2|COMPLETED|Overall Study||54
594102|NCT00468286|1451435|P1|COMPLETED|Overall Study||60
594103|NCT00468286|1451434|P2|STARTED|Overall Study||66
594104|NCT00468286|1451435|P1|STARTED|Overall Study|Started=Intention to treat (ITT) population.|67
594105|NCT00468208|1451457|P1|NOT COMPLETED|Overall Study||0
594106|NCT00468208|1451457|P1|COMPLETED|Overall Study|All patients reached common closing or early termination|20
594107|NCT00468208|1451457|P1|STARTED|Overall Study||20
594108|NCT00468143|1451465|P2|NOT COMPLETED|Second Intervention (3 Weeks)||3
594109|NCT00468143|1451466|P1|NOT COMPLETED|Second Intervention (3 Weeks)||3
594110|NCT00468143|1451465|P2|COMPLETED|Second Intervention (3 Weeks)||24
594111|NCT00468143|1451466|P1|COMPLETED|Second Intervention (3 Weeks)||25
594112|NCT00468143|1451465|P2|STARTED|Second Intervention (3 Weeks)||27
594113|NCT00468143|1451466|P1|STARTED|Second Intervention (3 Weeks)||28
594114|NCT00468143|1451465|P2|NOT COMPLETED|First Intervention (3 Weeks)||4
594115|NCT00468143|1451466|P1|NOT COMPLETED|First Intervention (3 Weeks)||3
594116|NCT00468143|1451465|P2|COMPLETED|First Intervention (3 Weeks)||27
594117|NCT00468143|1451466|P1|COMPLETED|First Intervention (3 Weeks)||28
594118|NCT00468143|1451465|P2|STARTED|First Intervention (3 Weeks)||31
594119|NCT00468143|1451466|P1|STARTED|First Intervention (3 Weeks)||31
594120|NCT00468104|1451480|P2|NOT COMPLETED|Second Intervention||4
594121|NCT00468104|1451481|P1|NOT COMPLETED|Second Intervention||5
594122|NCT00468104|1451480|P2|COMPLETED|Second Intervention||37
594123|NCT00468104|1451481|P1|COMPLETED|Second Intervention||3
594124|NCT00468104|1451480|P2|STARTED|Second Intervention|4 patients responded to Placebo and did not go to the second intervention|41
594125|NCT00468104|1451481|P1|STARTED|Second Intervention|37 responded to Alteplase and did not go to the second intervention|8
594126|NCT00468104|1451480|P2|NOT COMPLETED|First Intervention||1
594127|NCT00468104|1451481|P1|NOT COMPLETED|First Intervention||9
594128|NCT00468104|1451480|P2|COMPLETED|First Intervention||45
594129|NCT00468104|1451481|P1|COMPLETED|First Intervention||45
594130|NCT00468104|1451480|P2|STARTED|First Intervention||46
594131|NCT00468104|1451481|P1|STARTED|First Intervention||54
594132|NCT00468052|1451498|P2|NOT COMPLETED|Overall Study||8
594133|NCT00468052|1451499|P1|NOT COMPLETED|Overall Study||7
594134|NCT00468052|1451498|P2|COMPLETED|Overall Study||61
594135|NCT00468052|1451499|P1|COMPLETED|Overall Study||61
594136|NCT00468052|1451498|P2|Target Enrollment|Overall Study||70
594137|NCT00468052|1451499|P1|Target Enrollment|Overall Study||70
594138|NCT00468052|1451498|P2|STARTED|Overall Study|One had an intraoperative complication and was withdrawn. 7 eliminated for a break in protocol.|69
594139|NCT00468052|1451499|P1|STARTED|Overall Study|1 subject withdrew consent.Surgery was cancelled for 2. 4 subjects eliminated for break in protocol|68
594140|NCT00467961|1451517|P1|NOT COMPLETED|Overall Study||7
594141|NCT00467961|1451517|P1|COMPLETED|Overall Study||24
594142|NCT00467961|1451517|P1|STARTED|Overall Study||31
594143|NCT00467896|1451521|P1|NOT COMPLETED|Overall Study||51
594144|NCT00467896|1451521|P1|COMPLETED|Overall Study||11
594145|NCT00467896|1451521|P1|STARTED|Overall Study||62
594146|NCT00467870|1451547|P6|NOT COMPLETED|Overall Study||2
594147|NCT00467870|1451548|P5|NOT COMPLETED|Overall Study||37
594148|NCT00467870|1451549|P4|NOT COMPLETED|Overall Study||33
594149|NCT00467870|1451550|P3|NOT COMPLETED|Overall Study||4
594150|NCT00467870|1451551|P2|NOT COMPLETED|Overall Study||43
594151|NCT00467870|1451552|P1|NOT COMPLETED|Overall Study||45
594152|NCT00467870|1451547|P6|COMPLETED|Overall Study||21
594153|NCT00467870|1451548|P5|COMPLETED|Overall Study||93
594154|NCT00467870|1451549|P4|COMPLETED|Overall Study||79
594155|NCT00467870|1451550|P3|COMPLETED|Overall Study||18
594156|NCT00467870|1451551|P2|COMPLETED|Overall Study||74
594157|NCT00467870|1451552|P1|COMPLETED|Overall Study||75
594158|NCT00467870|1451547|P6|STARTED|Overall Study||23
594159|NCT00467870|1451548|P5|STARTED|Overall Study||130
594160|NCT00467870|1451549|P4|STARTED|Overall Study||112
594161|NCT00467870|1451550|P3|STARTED|Overall Study||22
594162|NCT00467870|1451551|P2|STARTED|Overall Study||117
594163|NCT00467870|1451552|P1|STARTED|Overall Study||120
594164|NCT00467857|1451595|P2|NOT COMPLETED|Overall Study||8
594165|NCT00467857|1451596|P1|NOT COMPLETED|Overall Study||3
594166|NCT00467857|1451595|P2|COMPLETED|Overall Study||139
594167|NCT00467857|1451596|P1|COMPLETED|Overall Study||143
594168|NCT00467857|1451595|P2|STARTED|Overall Study||147
594169|NCT00467857|1451596|P1|STARTED|Overall Study||146
594170|NCT00467844|1451631|P3|NOT COMPLETED|Overall Study||14
594171|NCT00467844|1451632|P2|NOT COMPLETED|Overall Study||20
594172|NCT00467844|1451633|P1|NOT COMPLETED|Overall Study||19
594173|NCT00467844|1451631|P3|COMPLETED|Overall Study||38
594174|NCT00467844|1451632|P2|COMPLETED|Overall Study||34
594175|NCT00467844|1451633|P1|COMPLETED|Overall Study||34
594176|NCT00467844|1451631|P3|STARTED|Overall Study||52
594177|NCT00467844|1451632|P2|STARTED|Overall Study||54
594178|NCT00467844|1451633|P1|STARTED|Overall Study||53
594179|NCT00467831|1451644|P1|NOT COMPLETED|Overall Study||3
594180|NCT00467831|1451644|P1|COMPLETED|Overall Study||0
594181|NCT00467831|1451644|P1|STARTED|Overall Study||3
594182|NCT00467779|1451663|P15|NOT COMPLETED|Stage 3||17
594183|NCT00467779|1451664|P14|NOT COMPLETED|Stage 3||0
594184|NCT00467779|1451665|P13|NOT COMPLETED|Stage 3||0
594185|NCT00467779|1451666|P12|NOT COMPLETED|Stage 3||0
594186|NCT00467779|1451667|P11|NOT COMPLETED|Stage 3||0
594187|NCT00467779|1451668|P10|NOT COMPLETED|Stage 3||0
594188|NCT00467779|1451669|P9|NOT COMPLETED|Stage 3||0
594189|NCT00467779|1451670|P8|NOT COMPLETED|Stage 3||0
594190|NCT00467779|1451671|P7|NOT COMPLETED|Stage 3||0
594191|NCT00467779|1451672|P6|NOT COMPLETED|Stage 3||0
594192|NCT00467779|1451673|P5|NOT COMPLETED|Stage 3||0
594193|NCT00467779|1451674|P4|NOT COMPLETED|Stage 3||0
594194|NCT00467779|1451675|P3|NOT COMPLETED|Stage 3||0
594195|NCT00467779|1451676|P2|NOT COMPLETED|Stage 3||0
594196|NCT00467779|1451677|P1|NOT COMPLETED|Stage 3||0
594197|NCT00467779|1451663|P15|COMPLETED|Stage 3||3
594198|NCT00467779|1451664|P14|COMPLETED|Stage 3||0
594199|NCT00467779|1451665|P13|COMPLETED|Stage 3||0
594200|NCT00467779|1451666|P12|COMPLETED|Stage 3||0
594201|NCT00467779|1451667|P11|COMPLETED|Stage 3||0
594202|NCT00467779|1451668|P10|COMPLETED|Stage 3||0
594203|NCT00467779|1451669|P9|COMPLETED|Stage 3||0
594204|NCT00467779|1451670|P8|COMPLETED|Stage 3||0
594205|NCT00467779|1451671|P7|COMPLETED|Stage 3||0
594206|NCT00467779|1451672|P6|COMPLETED|Stage 3||0
594207|NCT00467779|1451673|P5|COMPLETED|Stage 3||0
594208|NCT00467779|1451674|P4|COMPLETED|Stage 3||0
594209|NCT00467779|1451675|P3|COMPLETED|Stage 3||0
594210|NCT00467779|1451676|P2|COMPLETED|Stage 3||0
594211|NCT00467779|1451677|P1|COMPLETED|Stage 3||0
594212|NCT00467779|1451663|P15|STARTED|Stage 3||20
594213|NCT00467779|1451664|P14|STARTED|Stage 3||0
594214|NCT00467779|1451665|P13|STARTED|Stage 3||0
594215|NCT00467779|1451666|P12|STARTED|Stage 3||0
594216|NCT00467779|1451667|P11|STARTED|Stage 3||0
594217|NCT00467779|1451668|P10|STARTED|Stage 3||0
594218|NCT00467779|1451669|P9|STARTED|Stage 3||0
594219|NCT00467779|1451670|P8|STARTED|Stage 3||0
594220|NCT00467779|1451671|P7|STARTED|Stage 3||0
594221|NCT00467779|1451672|P6|STARTED|Stage 3||0
594222|NCT00467779|1451673|P5|STARTED|Stage 3||0
594223|NCT00467779|1451674|P4|STARTED|Stage 3||0
594224|NCT00467779|1451675|P3|STARTED|Stage 3||0
594225|NCT00467779|1451676|P2|STARTED|Stage 3||0
594226|NCT00467779|1451677|P1|STARTED|Stage 3||0
594227|NCT00467779|1451663|P15|NOT COMPLETED|Stage 2A||0
594228|NCT00467779|1451664|P14|NOT COMPLETED|Stage 2A||21
594229|NCT00467779|1451665|P13|NOT COMPLETED|Stage 2A||0
594230|NCT00467779|1451666|P12|NOT COMPLETED|Stage 2A||0
594231|NCT00467779|1451667|P11|NOT COMPLETED|Stage 2A||0
594232|NCT00467779|1451668|P10|NOT COMPLETED|Stage 2A||0
594233|NCT00467779|1451669|P9|NOT COMPLETED|Stage 2A||0
594234|NCT00467779|1451670|P8|NOT COMPLETED|Stage 2A||0
594235|NCT00467779|1451671|P7|NOT COMPLETED|Stage 2A||0
594236|NCT00467779|1451672|P6|NOT COMPLETED|Stage 2A||0
594237|NCT00467779|1451673|P5|NOT COMPLETED|Stage 2A||0
594238|NCT00467779|1451674|P4|NOT COMPLETED|Stage 2A||0
594239|NCT00467779|1451675|P3|NOT COMPLETED|Stage 2A||0
594240|NCT00467779|1451676|P2|NOT COMPLETED|Stage 2A||0
594241|NCT00467779|1451677|P1|NOT COMPLETED|Stage 2A||0
594242|NCT00467779|1451663|P15|COMPLETED|Stage 2A||0
594243|NCT00467779|1451664|P14|COMPLETED|Stage 2A||1
594244|NCT00467779|1451665|P13|COMPLETED|Stage 2A||0
594245|NCT00467779|1451666|P12|COMPLETED|Stage 2A||0
594246|NCT00467779|1451667|P11|COMPLETED|Stage 2A||0
594247|NCT00467779|1451668|P10|COMPLETED|Stage 2A||0
594248|NCT00467779|1451669|P9|COMPLETED|Stage 2A||0
594249|NCT00467779|1451670|P8|COMPLETED|Stage 2A||0
594250|NCT00467779|1451671|P7|COMPLETED|Stage 2A||0
594251|NCT00467779|1451672|P6|COMPLETED|Stage 2A||0
594252|NCT00467779|1451673|P5|COMPLETED|Stage 2A||0
594253|NCT00467779|1451674|P4|COMPLETED|Stage 2A||0
594254|NCT00467779|1451675|P3|COMPLETED|Stage 2A||0
594255|NCT00467779|1451676|P2|COMPLETED|Stage 2A||0
594256|NCT00467779|1451677|P1|COMPLETED|Stage 2A||0
594257|NCT00467779|1451663|P15|STARTED|Stage 2A||0
594258|NCT00467779|1451664|P14|STARTED|Stage 2A||22
594259|NCT00467779|1451665|P13|STARTED|Stage 2A||0
594260|NCT00467779|1451666|P12|STARTED|Stage 2A||0
594261|NCT00467779|1451667|P11|STARTED|Stage 2A||0
594262|NCT00467779|1451668|P10|STARTED|Stage 2A||0
594263|NCT00467779|1451669|P9|STARTED|Stage 2A||0
594264|NCT00467779|1451670|P8|STARTED|Stage 2A||0
594265|NCT00467779|1451671|P7|STARTED|Stage 2A||0
594266|NCT00467779|1451672|P6|STARTED|Stage 2A||0
594267|NCT00467779|1451673|P5|STARTED|Stage 2A||0
594268|NCT00467779|1451674|P4|STARTED|Stage 2A||0
594269|NCT00467779|1451675|P3|STARTED|Stage 2A||0
594270|NCT00467779|1451676|P2|STARTED|Stage 2A||0
594271|NCT00467779|1451677|P1|STARTED|Stage 2A||0
594272|NCT00467779|1451663|P15|NOT COMPLETED|Stage 2||0
594273|NCT00467779|1451664|P14|NOT COMPLETED|Stage 2||0
594274|NCT00467779|1451665|P13|NOT COMPLETED|Stage 2||0
594275|NCT00467779|1451666|P12|NOT COMPLETED|Stage 2||0
594276|NCT00467779|1451667|P11|NOT COMPLETED|Stage 2||0
594277|NCT00467779|1451668|P10|NOT COMPLETED|Stage 2||0
594278|NCT00467779|1451669|P9|NOT COMPLETED|Stage 2||21
594279|NCT00467779|1451670|P8|NOT COMPLETED|Stage 2||0
594280|NCT00467779|1451671|P7|NOT COMPLETED|Stage 2||0
594281|NCT00467779|1451672|P6|NOT COMPLETED|Stage 2||0
594282|NCT00467779|1451673|P5|NOT COMPLETED|Stage 2||0
594283|NCT00467779|1451674|P4|NOT COMPLETED|Stage 2||0
594284|NCT00467779|1451675|P3|NOT COMPLETED|Stage 2||0
594285|NCT00467779|1451676|P2|NOT COMPLETED|Stage 2||0
594286|NCT00467779|1451677|P1|NOT COMPLETED|Stage 2||0
594287|NCT00467779|1451663|P15|COMPLETED|Stage 2||0
594288|NCT00467779|1451664|P14|COMPLETED|Stage 2||0
594289|NCT00467779|1451665|P13|COMPLETED|Stage 2||0
594290|NCT00467779|1451666|P12|COMPLETED|Stage 2||0
594291|NCT00467779|1451667|P11|COMPLETED|Stage 2||0
594292|NCT00467779|1451668|P10|COMPLETED|Stage 2||0
594293|NCT00467779|1451669|P9|COMPLETED|Stage 2||0
594294|NCT00467779|1451670|P8|COMPLETED|Stage 2||0
594295|NCT00467779|1451671|P7|COMPLETED|Stage 2||0
594296|NCT00467779|1451672|P6|COMPLETED|Stage 2||0
594297|NCT00467779|1451673|P5|COMPLETED|Stage 2||0
594298|NCT00467779|1451674|P4|COMPLETED|Stage 2||0
594299|NCT00467779|1451675|P3|COMPLETED|Stage 2||0
594300|NCT00467779|1451676|P2|COMPLETED|Stage 2||0
594301|NCT00467779|1451677|P1|COMPLETED|Stage 2||0
594302|NCT00467779|1451663|P15|STARTED|Stage 2||0
594303|NCT00467779|1451664|P14|STARTED|Stage 2||0
594304|NCT00467779|1451665|P13|STARTED|Stage 2||0
594305|NCT00467779|1451666|P12|STARTED|Stage 2||0
594306|NCT00467779|1451667|P11|STARTED|Stage 2||0
594307|NCT00467779|1451668|P10|STARTED|Stage 2||0
594308|NCT00467779|1451669|P9|STARTED|Stage 2||21
594309|NCT00467779|1451670|P8|STARTED|Stage 2||0
594310|NCT00467779|1451671|P7|STARTED|Stage 2||0
594311|NCT00467779|1451672|P6|STARTED|Stage 2||0
594312|NCT00467779|1451673|P5|STARTED|Stage 2||0
594313|NCT00467779|1451674|P4|STARTED|Stage 2||0
594314|NCT00467779|1451675|P3|STARTED|Stage 2||0
594315|NCT00467779|1451676|P2|STARTED|Stage 2||0
594316|NCT00467779|1451677|P1|STARTED|Stage 2||0
594317|NCT00467779|1451663|P15|NOT COMPLETED|Stage 1A||0
594318|NCT00467779|1451664|P14|NOT COMPLETED|Stage 1A||0
594319|NCT00467779|1451665|P13|NOT COMPLETED|Stage 1A||6
594320|NCT00467779|1451666|P12|NOT COMPLETED|Stage 1A||8
594321|NCT00467779|1451667|P11|NOT COMPLETED|Stage 1A||3
594322|NCT00467779|1451668|P10|NOT COMPLETED|Stage 1A||3
594323|NCT00467779|1451669|P9|NOT COMPLETED|Stage 1A||0
594324|NCT00467779|1451670|P8|NOT COMPLETED|Stage 1A||0
594325|NCT00467779|1451671|P7|NOT COMPLETED|Stage 1A||0
594326|NCT00467779|1451672|P6|NOT COMPLETED|Stage 1A||0
594327|NCT00467779|1451673|P5|NOT COMPLETED|Stage 1A||0
594328|NCT00467779|1451674|P4|NOT COMPLETED|Stage 1A||0
594329|NCT00467779|1451675|P3|NOT COMPLETED|Stage 1A||0
594330|NCT00467779|1451676|P2|NOT COMPLETED|Stage 1A||0
594331|NCT00467779|1451677|P1|NOT COMPLETED|Stage 1A||0
594332|NCT00467779|1451663|P15|COMPLETED|Stage 1A||0
594333|NCT00467779|1451664|P14|COMPLETED|Stage 1A||0
594334|NCT00467779|1451665|P13|COMPLETED|Stage 1A||0
594335|NCT00467779|1451666|P12|COMPLETED|Stage 1A||0
594336|NCT00467779|1451667|P11|COMPLETED|Stage 1A||0
594337|NCT00467779|1451668|P10|COMPLETED|Stage 1A||0
594338|NCT00467779|1451669|P9|COMPLETED|Stage 1A||0
594339|NCT00467779|1451670|P8|COMPLETED|Stage 1A||0
594340|NCT00467779|1451671|P7|COMPLETED|Stage 1A||0
594341|NCT00467779|1451672|P6|COMPLETED|Stage 1A||0
594342|NCT00467779|1451673|P5|COMPLETED|Stage 1A||0
594343|NCT00467779|1451674|P4|COMPLETED|Stage 1A||0
594344|NCT00467779|1451675|P3|COMPLETED|Stage 1A||0
594345|NCT00467779|1451676|P2|COMPLETED|Stage 1A||0
594346|NCT00467779|1451677|P1|COMPLETED|Stage 1A||0
594347|NCT00467779|1451663|P15|STARTED|Stage 1A||0
594348|NCT00467779|1451664|P14|STARTED|Stage 1A||0
594349|NCT00467779|1451665|P13|STARTED|Stage 1A||6
594350|NCT00467779|1451666|P12|STARTED|Stage 1A||8
594351|NCT00467779|1451667|P11|STARTED|Stage 1A||3
594352|NCT00467779|1451668|P10|STARTED|Stage 1A||3
594353|NCT00467779|1451669|P9|STARTED|Stage 1A||0
594354|NCT00467779|1451670|P8|STARTED|Stage 1A||0
594355|NCT00467779|1451671|P7|STARTED|Stage 1A||0
594356|NCT00467779|1451672|P6|STARTED|Stage 1A||0
594357|NCT00467779|1451673|P5|STARTED|Stage 1A||0
594358|NCT00467779|1451674|P4|STARTED|Stage 1A||0
594359|NCT00467779|1451675|P3|STARTED|Stage 1A||0
594360|NCT00467779|1451676|P2|STARTED|Stage 1A||0
594361|NCT00467779|1451677|P1|STARTED|Stage 1A||0
594362|NCT00467779|1451663|P15|NOT COMPLETED|Stage 1||0
594363|NCT00467779|1451664|P14|NOT COMPLETED|Stage 1||0
594364|NCT00467779|1451665|P13|NOT COMPLETED|Stage 1||0
594365|NCT00467779|1451666|P12|NOT COMPLETED|Stage 1||0
594366|NCT00467779|1451667|P11|NOT COMPLETED|Stage 1||0
594367|NCT00467779|1451668|P10|NOT COMPLETED|Stage 1||0
594368|NCT00467779|1451669|P9|NOT COMPLETED|Stage 1||0
594369|NCT00467779|1451670|P8|NOT COMPLETED|Stage 1||7
594370|NCT00467779|1451671|P7|NOT COMPLETED|Stage 1||7
594371|NCT00467779|1451672|P6|NOT COMPLETED|Stage 1||5
594372|NCT00467779|1451673|P5|NOT COMPLETED|Stage 1||3
594373|NCT00467779|1451674|P4|NOT COMPLETED|Stage 1||3
594374|NCT00467779|1451675|P3|NOT COMPLETED|Stage 1||3
594375|NCT00467779|1451676|P2|NOT COMPLETED|Stage 1||3
594376|NCT00467779|1451677|P1|NOT COMPLETED|Stage 1||4
594377|NCT00467779|1451663|P15|COMPLETED|Stage 1||0
594378|NCT00467779|1451664|P14|COMPLETED|Stage 1||0
594379|NCT00467779|1451665|P13|COMPLETED|Stage 1||0
594380|NCT00467779|1451666|P12|COMPLETED|Stage 1||0
594381|NCT00467779|1451667|P11|COMPLETED|Stage 1||0
594382|NCT00467779|1451668|P10|COMPLETED|Stage 1||0
594383|NCT00467779|1451669|P9|COMPLETED|Stage 1||0
594384|NCT00467779|1451670|P8|COMPLETED|Stage 1||0
594385|NCT00467779|1451671|P7|COMPLETED|Stage 1||0
594386|NCT00467779|1451672|P6|COMPLETED|Stage 1||1
594387|NCT00467779|1451673|P5|COMPLETED|Stage 1||0
594388|NCT00467779|1451674|P4|COMPLETED|Stage 1||0
594389|NCT00467779|1451675|P3|COMPLETED|Stage 1||0
594390|NCT00467779|1451676|P2|COMPLETED|Stage 1||0
594391|NCT00467779|1451677|P1|COMPLETED|Stage 1||0
594392|NCT00467779|1451663|P15|STARTED|Stage 1||0
594393|NCT00467779|1451664|P14|STARTED|Stage 1||0
594394|NCT00467779|1451665|P13|STARTED|Stage 1||0
594395|NCT00467779|1451666|P12|STARTED|Stage 1||0
594396|NCT00467779|1451667|P11|STARTED|Stage 1||0
594397|NCT00467779|1451668|P10|STARTED|Stage 1||0
594398|NCT00467779|1451669|P9|STARTED|Stage 1||0
594399|NCT00467779|1451670|P8|STARTED|Stage 1||7
594400|NCT00467779|1451671|P7|STARTED|Stage 1||7
594401|NCT00467779|1451672|P6|STARTED|Stage 1||6
594402|NCT00467779|1451673|P5|STARTED|Stage 1||3
594403|NCT00467779|1451674|P4|STARTED|Stage 1||3
594404|NCT00467779|1451675|P3|STARTED|Stage 1||3
594405|NCT00467779|1451676|P2|STARTED|Stage 1||3
594406|NCT00467779|1451677|P1|STARTED|Stage 1||4
594407|NCT00467753|1451851|P2|NOT COMPLETED|Overall Study||2
594408|NCT00467753|1451852|P1|NOT COMPLETED|Overall Study||3
594409|NCT00467753|1451851|P2|COMPLETED|Overall Study||0
594410|NCT00467753|1451852|P1|COMPLETED|Overall Study||0
594411|NCT00467753|1451851|P2|STARTED|Overall Study||2
594412|NCT00467753|1451852|P1|STARTED|Overall Study||3
594413|NCT00467740|1451863|P5|NOT COMPLETED|Overall Study||0
594414|NCT00467740|1451864|P4|NOT COMPLETED|Overall Study||1
594415|NCT00467740|1451865|P3|NOT COMPLETED|Overall Study||2
594416|NCT00467740|1451866|P2|NOT COMPLETED|Overall Study||3
594417|NCT00467740|1451867|P1|NOT COMPLETED|Overall Study||1
594418|NCT00467740|1451863|P5|COMPLETED|Overall Study||61
594419|NCT00467740|1451864|P4|COMPLETED|Overall Study||59
594420|NCT00467740|1451865|P3|COMPLETED|Overall Study||58
594421|NCT00467740|1451866|P2|COMPLETED|Overall Study||58
594422|NCT00467740|1451867|P1|COMPLETED|Overall Study||53
594423|NCT00467740|1451863|P5|STARTED|Overall Study||61
594424|NCT00467740|1451864|P4|STARTED|Overall Study||60
594425|NCT00467740|1451865|P3|STARTED|Overall Study||60
594426|NCT00467740|1451866|P2|STARTED|Overall Study||61
594427|NCT00467740|1451867|P1|STARTED|Overall Study||54
594428|NCT00467649|1452056|P6|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||1
594429|NCT00467649|1452057|P5|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
594430|NCT00467649|1452058|P4|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||2
594431|NCT00467649|1452059|P3|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
594432|NCT00467649|1452060|P2|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
594433|NCT00467649|1452061|P1|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
594434|NCT00467649|1452056|P6|COMPLETED|Phase 2 (Intent-to-Treat Population)||35
594435|NCT00467649|1452057|P5|COMPLETED|Phase 2 (Intent-to-Treat Population)||14
594436|NCT00467649|1452058|P4|COMPLETED|Phase 2 (Intent-to-Treat Population)||29
594437|NCT00467649|1452059|P3|COMPLETED|Phase 2 (Intent-to-Treat Population)||17
594438|NCT00467649|1452060|P2|COMPLETED|Phase 2 (Intent-to-Treat Population)||0
594439|NCT00467649|1452061|P1|COMPLETED|Phase 2 (Intent-to-Treat Population)||0
594440|NCT00467649|1452056|P6|STARTED|Phase 2 (Intent-to-Treat Population)||36
594441|NCT00467649|1452057|P5|STARTED|Phase 2 (Intent-to-Treat Population)||14
594442|NCT00467649|1452058|P4|STARTED|Phase 2 (Intent-to-Treat Population)||31
594443|NCT00467649|1452059|P3|STARTED|Phase 2 (Intent-to-Treat Population)||17
594444|NCT00467649|1452060|P2|STARTED|Phase 2 (Intent-to-Treat Population)||0
594445|NCT00467649|1452061|P1|STARTED|Phase 2 (Intent-to-Treat Population)||0
594446|NCT00467649|1452056|P6|NOT COMPLETED|Phase 1 (Randomized Population)||0
594447|NCT00467649|1452057|P5|NOT COMPLETED|Phase 1 (Randomized Population)||0
594448|NCT00467649|1452058|P4|NOT COMPLETED|Phase 1 (Randomized Population)||0
594449|NCT00467649|1452059|P3|NOT COMPLETED|Phase 1 (Randomized Population)||0
594450|NCT00467649|1452060|P2|NOT COMPLETED|Phase 1 (Randomized Population)||6
594451|NCT00467649|1452061|P1|NOT COMPLETED|Phase 1 (Randomized Population)||9
594452|NCT00467649|1452056|P6|COMPLETED|Phase 1 (Randomized Population)||0
594453|NCT00467649|1452057|P5|COMPLETED|Phase 1 (Randomized Population)||0
594454|NCT00467649|1452058|P4|COMPLETED|Phase 1 (Randomized Population)||0
594455|NCT00467649|1452059|P3|COMPLETED|Phase 1 (Randomized Population)||0
594456|NCT00467649|1452060|P2|COMPLETED|Phase 1 (Randomized Population)||50
594457|NCT00467649|1452061|P1|COMPLETED|Phase 1 (Randomized Population)||48
594458|NCT00467649|1452056|P6|Intent to Treat|Phase 1 (Randomized Population)||0
594459|NCT00467649|1452057|P5|Intent to Treat|Phase 1 (Randomized Population)||0
594460|NCT00467649|1452058|P4|Intent to Treat|Phase 1 (Randomized Population)||0
594461|NCT00467649|1452059|P3|Intent to Treat|Phase 1 (Randomized Population)||0
594462|NCT00467649|1452060|P2|Intent to Treat|Phase 1 (Randomized Population)||56
594463|NCT00467649|1452061|P1|Intent to Treat|Phase 1 (Randomized Population)||56
594464|NCT00467649|1452056|P6|STARTED|Phase 1 (Randomized Population)||0
594465|NCT00467649|1452057|P5|STARTED|Phase 1 (Randomized Population)||0
594466|NCT00467649|1452058|P4|STARTED|Phase 1 (Randomized Population)||0
594467|NCT00467649|1452059|P3|STARTED|Phase 1 (Randomized Population)||0
594468|NCT00467649|1452060|P2|STARTED|Phase 1 (Randomized Population)||56
594469|NCT00467649|1452061|P1|STARTED|Phase 1 (Randomized Population)|One patient randomized to the SYMLIN group withdrew consent prior to receiving the first dose|57
594470|NCT00467610|1452101|P1|NOT COMPLETED|Overall Study||1
594471|NCT00467610|1452101|P1|COMPLETED|Overall Study||5
594472|NCT00467610|1452101|P1|STARTED|Overall Study||6
594473|NCT00467597|1452112|P2|NOT COMPLETED|Overall Study||0
594474|NCT00467597|1452113|P1|NOT COMPLETED|Overall Study||2
594475|NCT00467597|1452112|P2|COMPLETED|Overall Study||6
594476|NCT00467597|1452113|P1|COMPLETED|Overall Study||24
594477|NCT00467597|1452112|P2|STARTED|Overall Study||6
594478|NCT00467597|1452113|P1|STARTED|Overall Study||26
594479|NCT00467584|1452126|P3|NOT COMPLETED|Overall Study||1
594480|NCT00467584|1452127|P2|NOT COMPLETED|Overall Study||5
594481|NCT00467584|1452128|P1|NOT COMPLETED|Overall Study||4
594482|NCT00467584|1452126|P3|COMPLETED|Overall Study||20
594483|NCT00467584|1452127|P2|COMPLETED|Overall Study||15
594484|NCT00467584|1452128|P1|COMPLETED|Overall Study||17
594485|NCT00467584|1452126|P3|STARTED|Overall Study||21
594486|NCT00467584|1452127|P2|STARTED|Overall Study||20
594487|NCT00467584|1452128|P1|STARTED|Overall Study||21
594488|NCT00467558|1452138|P2|NOT COMPLETED|Overall Study||0
594489|NCT00467558|1452139|P1|NOT COMPLETED|Overall Study||2
594490|NCT00467558|1452138|P2|COMPLETED|Overall Study||3
594491|NCT00467558|1452139|P1|COMPLETED|Overall Study||2
594492|NCT00467558|1452138|P2|STARTED|Overall Study||3
594493|NCT00467558|1452139|P1|STARTED|Overall Study||4
594494|NCT00467519|1452149|P2|NOT COMPLETED|Overall Study||23
594495|NCT00467519|1452150|P1|NOT COMPLETED|Overall Study||14
594496|NCT00467519|1452149|P2|COMPLETED|Overall Study||488
594497|NCT00467519|1452150|P1|COMPLETED|Overall Study||517
594498|NCT00467519|1452149|P2|STARTED|Overall Study||511
594499|NCT00467519|1452150|P1|STARTED|Overall Study||531
594500|NCT00467389|1452166|P2|NOT COMPLETED|Overall Study||0
594501|NCT00467389|1452167|P1|NOT COMPLETED|Overall Study||0
594502|NCT00467389|1452166|P2|COMPLETED|Overall Study||6
594503|NCT00467389|1452167|P1|COMPLETED|Overall Study||6
594504|NCT00467389|1452166|P2|STARTED|Overall Study||6
594505|NCT00467389|1452167|P1|STARTED|Overall Study||6
594506|NCT00467363|1452179|P2|NOT COMPLETED|Overall Study||70
594507|NCT00467363|1452180|P1|NOT COMPLETED|Overall Study||80
594508|NCT00467363|1452179|P2|COMPLETED|Overall Study||543
594509|NCT00467363|1452180|P1|COMPLETED|Overall Study||535
594510|NCT00467363|1452179|P2|STARTED|Overall Study||613
594511|NCT00467363|1452180|P1|STARTED|Overall Study||615
594512|NCT00467298|1452216|P2|NOT COMPLETED|Overall Study||6
594513|NCT00467298|1452217|P1|NOT COMPLETED|Overall Study||4
594514|NCT00467298|1452216|P2|COMPLETED|Overall Study||38
594515|NCT00467298|1452217|P1|COMPLETED|Overall Study||42
594516|NCT00467298|1452216|P2|STARTED|Overall Study||44
594517|NCT00467298|1452217|P1|STARTED|Overall Study||46
594518|NCT00467285|1452227|P2|NOT COMPLETED|Overall Study||4
594519|NCT00467285|1452228|P1|NOT COMPLETED|Overall Study||4
594520|NCT00467285|1452227|P2|COMPLETED|Overall Study||60
594521|NCT00467285|1452228|P1|COMPLETED|Overall Study||28
594522|NCT00467285|1452227|P2|STARTED|Overall Study||64
594523|NCT00467285|1452228|P1|STARTED|Overall Study||32
594524|NCT00467259|1452248|P2|NOT COMPLETED|Overall Study||242
594525|NCT00467259|1452249|P1|NOT COMPLETED|Overall Study||75
594526|NCT00467259|1452248|P2|COMPLETED|Overall Study||778
594527|NCT00467259|1452249|P1|COMPLETED|Overall Study||176
594528|NCT00467259|1452248|P2|ITT Population|Overall Study|One subject did not take any study medication and was excluded from ITT population.|1019
594529|NCT00467259|1452249|P1|ITT Population|Overall Study||251
594530|NCT00467259|1452248|P2|STARTED|Overall Study||1020
594531|NCT00467259|1452249|P1|STARTED|Overall Study||251
594532|NCT00467077|1452259|P1|NOT COMPLETED|Overall Study||0
594533|NCT00467077|1452259|P1|COMPLETED|Overall Study||21
594534|NCT00467077|1452259|P1|STARTED|Overall Study||21
594535|NCT00467051|1452266|P1|NOT COMPLETED|Overall Study||2
594536|NCT00467051|1452266|P1|COMPLETED|Overall Study||18
594537|NCT00467051|1452266|P1|STARTED|Overall Study||20
594538|NCT00467038|1452273|P2|NOT COMPLETED|Overall Study||0
594539|NCT00467038|1452274|P1|NOT COMPLETED|Overall Study||0
594540|NCT00467038|1452273|P2|COMPLETED|Overall Study||11
594541|NCT00467038|1452274|P1|COMPLETED|Overall Study||11
594542|NCT00467038|1452273|P2|STARTED|Overall Study||11
594543|NCT00467038|1452274|P1|STARTED|Overall Study||11
594544|NCT00466960|1452282|P1|NOT COMPLETED|Overall Study||0
594545|NCT00466960|1452282|P1|COMPLETED|Overall Study||21
594546|NCT00466960|1452282|P1|STARTED|Overall Study||21
594547|NCT00466947|1452293|P2|NOT COMPLETED|Study End Analysis Period||2534
594548|NCT00466947|1452294|P1|NOT COMPLETED|Study End Analysis Period||2496
594549|NCT00466947|1452293|P2|COMPLETED|Study End Analysis Period||9265
594550|NCT00466947|1452294|P1|COMPLETED|Study End Analysis Period||9302
594551|NCT00466947|1452293|P2|STARTED|Study End Analysis Period||11799
594552|NCT00466947|1452294|P1|STARTED|Study End Analysis Period||11798
594553|NCT00466947|1452293|P2|NOT COMPLETED|Primary Outcome Analysis Period||11863
594554|NCT00466947|1452294|P1|NOT COMPLETED|Primary Outcome Analysis Period||11875
594555|NCT00466947|1452293|P2|COMPLETED|Primary Outcome Analysis Period|No data on study completion and withdrawal were available at first analysis as the study was ongoing|0
594556|NCT00466947|1452294|P1|COMPLETED|Primary Outcome Analysis Period|No data on study completion and withdrawal were available at first analysis as the study was ongoing|0
594557|NCT00466947|1452293|P2|Ongoing|Primary Outcome Analysis Period||11863
594558|NCT00466947|1452294|P1|Ongoing|Primary Outcome Analysis Period||11875
594559|NCT00466947|1452293|P2|STARTED|Primary Outcome Analysis Period||11863
594560|NCT00466947|1452294|P1|STARTED|Primary Outcome Analysis Period||11875
594561|NCT00466882|1452416|P1|NOT COMPLETED|Overall Study||0
594562|NCT00466882|1452416|P1|COMPLETED|Overall Study||3
594563|NCT00466882|1452416|P1|STARTED|Overall Study||3
594564|NCT00466817|1452422|P2|NOT COMPLETED|Overall Study||4
594565|NCT00466817|1452423|P1|NOT COMPLETED|Overall Study||5
594566|NCT00466817|1452422|P2|COMPLETED|Overall Study||43
594567|NCT00466817|1452423|P1|COMPLETED|Overall Study||44
594568|NCT00466817|1452422|P2|STARTED|Overall Study||47
594569|NCT00466817|1452423|P1|STARTED|Overall Study||49
594570|NCT00466752|1452478|P2|NOT COMPLETED|Overall Study||0
594571|NCT00466752|1452479|P1|NOT COMPLETED|Overall Study||0
594572|NCT00466752|1452478|P2|COMPLETED|Overall Study||0
594573|NCT00466752|1452479|P1|COMPLETED|Overall Study||5
594574|NCT00466752|1452478|P2|STARTED|Overall Study||0
594575|NCT00466752|1452479|P1|STARTED|Overall Study||5
594576|NCT00466687|1452489|P1|NOT COMPLETED|Overall Study||34
594577|NCT00466687|1452489|P1|COMPLETED|Overall Study||0
594578|NCT00466687|1452489|P1|STARTED|Overall Study||34
594579|NCT00466505|1452496|P1|NOT COMPLETED|Overall Study||17
594580|NCT00466505|1452496|P1|COMPLETED|Overall Study||0
594581|NCT00466505|1452496|P1|STARTED|Overall Study||17
594582|NCT00466323|1452510|P2|NOT COMPLETED|Overall Study||23
594583|NCT00466323|1452511|P1|NOT COMPLETED|Overall Study||28
594584|NCT00466323|1452510|P2|COMPLETED|Overall Study||92
594585|NCT00466323|1452511|P1|COMPLETED|Overall Study||89
594586|NCT00466323|1452510|P2|STARTED|Overall Study||115
594587|NCT00466323|1452511|P1|STARTED|Overall Study||117
594588|NCT00466310|1452526|P3|NOT COMPLETED|Overall Study||0
594589|NCT00466310|1452527|P2|NOT COMPLETED|Overall Study||0
594590|NCT00466310|1452528|P1|NOT COMPLETED|Overall Study||0
594591|NCT00466310|1452526|P3|COMPLETED|Overall Study||31
594592|NCT00466310|1452527|P2|COMPLETED|Overall Study||20
594593|NCT00466310|1452528|P1|COMPLETED|Overall Study||20
594594|NCT00466310|1452526|P3|STARTED|Overall Study||31
594595|NCT00466310|1452527|P2|STARTED|Overall Study||20
594596|NCT00466310|1452528|P1|STARTED|Overall Study||20
594597|NCT00466206|1452536|P1|NOT COMPLETED|Overall Study||0
594598|NCT00466206|1452536|P1|COMPLETED|Overall Study|One of 10 patients withdrawn from study but completed treatment under Compassionate Use Designation|10
594599|NCT00466206|1452536|P1|STARTED|Overall Study||10
594600|NCT00466193|1452546|P2|NOT COMPLETED|Overall Study||8
594601|NCT00466193|1452547|P1|NOT COMPLETED|Overall Study||12
594602|NCT00466193|1452546|P2|COMPLETED|Overall Study|One patient did not report at least one Latency Sleep Onset following middle-of-the-night awakening.|137
594603|NCT00466193|1452547|P1|COMPLETED|Overall Study||138
594604|NCT00466193|1452546|P2|STARTED|Overall Study||145
594605|NCT00466193|1452547|P1|STARTED|Overall Study||150
594606|NCT00466167|1452574|P3|NOT COMPLETED|Overall Study||21
594607|NCT00466167|1452575|P2|NOT COMPLETED|Overall Study||12
594608|NCT00466167|1452576|P1|NOT COMPLETED|Overall Study||20
594609|NCT00466167|1452574|P3|COMPLETED|Overall Study||157
594610|NCT00466167|1452575|P2|COMPLETED|Overall Study||163
594611|NCT00466167|1452576|P1|COMPLETED|Overall Study||145
594612|NCT00466167|1452574|P3|STARTED|Overall Study||178
594613|NCT00466167|1452575|P2|STARTED|Overall Study||175
594614|NCT00466167|1452576|P1|STARTED|Overall Study||165
594615|NCT00465998|1452632|P1|NOT COMPLETED|Overall Study||0
594616|NCT00465998|1452632|P1|COMPLETED|Overall Study||275
594617|NCT00465998|1452632|P1|STARTED|Overall Study||275
594618|NCT00465985|1452637|P2|NOT COMPLETED|Part III - Open-label Treatment Period||0
594619|NCT00465985|1452638|P1|NOT COMPLETED|Part III - Open-label Treatment Period||2
594620|NCT00465985|1452637|P2|COMPLETED|Part III - Open-label Treatment Period||0
594621|NCT00465985|1452638|P1|COMPLETED|Part III - Open-label Treatment Period||29
594622|NCT00465985|1452637|P2|STARTED|Part III - Open-label Treatment Period||0
594623|NCT00465985|1452638|P1|STARTED|Part III - Open-label Treatment Period|All patients received treatment with ACZ885 in Part III of the study.|31
594624|NCT00465985|1452637|P2|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||12
594625|NCT00465985|1452638|P1|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||0
594626|NCT00465985|1452637|P2|COMPLETED|Part II - 1:1 ACZ885:Placebo||4
594627|NCT00465985|1452638|P1|COMPLETED|Part II - 1:1 ACZ885:Placebo||15
594628|NCT00465985|1452637|P2|STARTED|Part II - 1:1 ACZ885:Placebo||16
594629|NCT00465985|1452638|P1|STARTED|Part II - 1:1 ACZ885:Placebo|Patients with complete response to treatment entered Part II and were randomized to ACZ885 ,placebo.|15
594630|NCT00465985|1452637|P2|NOT COMPLETED|Part I - Open-label Treatment Period||0
594631|NCT00465985|1452638|P1|NOT COMPLETED|Part I - Open-label Treatment Period||4
594632|NCT00465985|1452637|P2|COMPLETED|Part I - Open-label Treatment Period||0
594633|NCT00465985|1452638|P1|COMPLETED|Part I - Open-label Treatment Period|Only patients with a complete response completed Part I and entered Part II of the study.|31
594634|NCT00465985|1452637|P2|STARTED|Part I - Open-label Treatment Period||0
594635|NCT00465985|1452638|P1|STARTED|Part I - Open-label Treatment Period|All patients received treatment with ACZ885 in Part I of the study.|35
594636|NCT00465972|1452661|P2|NOT COMPLETED|Overall Study||1
594637|NCT00465972|1452662|P1|NOT COMPLETED|Overall Study||2
594638|NCT00465972|1452661|P2|COMPLETED|Overall Study||23
594639|NCT00465972|1452662|P1|COMPLETED|Overall Study||18
594640|NCT00465972|1452661|P2|STARTED|Overall Study||24
594641|NCT00465972|1452662|P1|STARTED|Overall Study||20
594642|NCT00465894|1452672|P2|NOT COMPLETED|Overall Study||3
594643|NCT00465894|1452673|P1|NOT COMPLETED|Overall Study||5
594644|NCT00465894|1452672|P2|COMPLETED|Overall Study||25
594645|NCT00465894|1452673|P1|COMPLETED|Overall Study||25
594646|NCT00465894|1452672|P2|STARTED|Overall Study||28
594647|NCT00465894|1452673|P1|STARTED|Overall Study||30
594648|NCT00465816|1452682|P3|NOT COMPLETED|Overall Study||2
594649|NCT00465816|1452683|P2|NOT COMPLETED|Overall Study||0
594650|NCT00465816|1452684|P1|NOT COMPLETED|Overall Study||0
594651|NCT00465816|1452682|P3|COMPLETED|Overall Study||120
594652|NCT00465816|1452683|P2|COMPLETED|Overall Study||122
594653|NCT00465816|1452684|P1|COMPLETED|Overall Study||367
594654|NCT00465816|1452682|P3|STARTED|Overall Study||122
594655|NCT00465816|1452683|P2|STARTED|Overall Study||122
594656|NCT00465816|1452684|P1|STARTED|Overall Study||367
594657|NCT00465738|1452747|P2|NOT COMPLETED|Overall Study||6
594658|NCT00465738|1452748|P1|NOT COMPLETED|Overall Study||6
594659|NCT00465738|1452747|P2|COMPLETED|Overall Study||89
594660|NCT00465738|1452748|P1|COMPLETED|Overall Study||91
594661|NCT00465738|1452747|P2|STARTED|Overall Study||95
594662|NCT00465738|1452748|P1|STARTED|Overall Study||97
594663|NCT00465647|1452842|P4|NOT COMPLETED|Overall Study||13
594664|NCT00465647|1452843|P3|NOT COMPLETED|Overall Study||11
594665|NCT00465647|1452844|P2|NOT COMPLETED|Overall Study||8
594666|NCT00465647|1452845|P1|NOT COMPLETED|Overall Study||13
594667|NCT00465647|1452842|P4|COMPLETED|Overall Study||12
594668|NCT00465647|1452843|P3|COMPLETED|Overall Study||18
594669|NCT00465647|1452844|P2|COMPLETED|Overall Study||15
594670|NCT00465647|1452845|P1|COMPLETED|Overall Study||26
594671|NCT00465647|1452842|P4|STARTED|Overall Study||25
594672|NCT00465647|1452843|P3|STARTED|Overall Study||29
594673|NCT00465647|1452844|P2|STARTED|Overall Study||23
594674|NCT00465647|1452845|P1|STARTED|Overall Study||39
594675|NCT00465569|1452870|P2|NOT COMPLETED|Overall Study||0
594676|NCT00465569|1452871|P1|NOT COMPLETED|Overall Study||1
594677|NCT00465569|1452870|P2|COMPLETED|Overall Study||7
594678|NCT00465569|1452871|P1|COMPLETED|Overall Study||12
594679|NCT00465569|1452870|P2|STARTED|Overall Study||7
594680|NCT00465569|1452871|P1|STARTED|Overall Study||13
594681|NCT00465530|1452883|P2|NOT COMPLETED|Overall Study||4
594682|NCT00465530|1452884|P1|NOT COMPLETED|Overall Study||2
594683|NCT00465530|1452883|P2|COMPLETED|Overall Study||15
594684|NCT00465530|1452884|P1|COMPLETED|Overall Study||19
594685|NCT00465530|1452883|P2|STARTED|Overall Study||19
594686|NCT00465530|1452884|P1|STARTED|Overall Study||21
594687|NCT00465361|1452894|P1|NOT COMPLETED|Post-Intervention Assessment||0
594688|NCT00465361|1452894|P1|COMPLETED|Post-Intervention Assessment||3
594689|NCT00465361|1452894|P1|STARTED|Post-Intervention Assessment||3
594690|NCT00465361|1452894|P1|NOT COMPLETED|Baseline Assessment||4
594691|NCT00465361|1452894|P1|COMPLETED|Baseline Assessment||3
594692|NCT00465361|1452894|P1|STARTED|Baseline Assessment||7
594693|NCT00465179|1452898|P1|NOT COMPLETED|Overall Study||53
594694|NCT00465179|1452898|P1|COMPLETED|Overall Study||4
594695|NCT00465179|1452898|P1|STARTED|Overall Study||57
594696|NCT00465101|1452904|P1|NOT COMPLETED|Overall Study||59
594697|NCT00465101|1452904|P1|COMPLETED|Overall Study||91
594698|NCT00465101|1452904|P1|STARTED|Overall Study||150
594699|NCT00465088|1452939|P2|NOT COMPLETED|Overall Study||9
594700|NCT00465088|1452940|P1|NOT COMPLETED|Overall Study||32
594701|NCT00465088|1452939|P2|COMPLETED|Overall Study||70
594702|NCT00465088|1452940|P1|COMPLETED|Overall Study||82
594703|NCT00465088|1452939|P2|STARTED|Overall Study||79
594704|NCT00465088|1452940|P1|STARTED|Overall Study|For both arms, started means treated.|114
594705|NCT00464945|1452974|P2|NOT COMPLETED|Toddler Dose||1
594706|NCT00464945|1452975|P1|NOT COMPLETED|Toddler Dose||0
594707|NCT00464945|1452974|P2|COMPLETED|Toddler Dose||130
594708|NCT00464945|1452975|P1|COMPLETED|Toddler Dose||131
594709|NCT00464945|1452974|P2|STARTED|Toddler Dose||131
594710|NCT00464945|1452975|P1|STARTED|Toddler Dose||131
594711|NCT00464945|1452974|P2|NOT COMPLETED|After Infant Series||2
594712|NCT00464945|1452975|P1|NOT COMPLETED|After Infant Series||0
594713|NCT00464945|1452974|P2|COMPLETED|After Infant Series||131
594714|NCT00464945|1452975|P1|COMPLETED|After Infant Series||131
594715|NCT00464945|1452974|P2|STARTED|After Infant Series||133
594716|NCT00464945|1452975|P1|STARTED|After Infant Series||131
594717|NCT00464945|1452974|P2|NOT COMPLETED|Infant Series||1
594718|NCT00464945|1452975|P1|NOT COMPLETED|Infant Series||4
594719|NCT00464945|1452974|P2|COMPLETED|Infant Series||133
594720|NCT00464945|1452975|P1|COMPLETED|Infant Series||131
594721|NCT00464945|1452974|P2|Vaccinated Dose 3|Infant Series||133
594722|NCT00464945|1452975|P1|Vaccinated Dose 3|Infant Series||132
594723|NCT00464945|1452974|P2|Vaccinated Dose 2|Infant Series||133
594724|NCT00464945|1452975|P1|Vaccinated Dose 2|Infant Series||132
594725|NCT00464945|1452974|P2|Vaccinated Dose 1|Infant Series||134
594726|NCT00464945|1452975|P1|Vaccinated Dose 1|Infant Series||134
594727|NCT00464945|1452974|P2|STARTED|Infant Series||134
594728|NCT00464945|1452975|P1|STARTED|Infant Series||135
594729|NCT00464815|1453005|P2|NOT COMPLETED|Overall Study||3
594730|NCT00464815|1453006|P1|NOT COMPLETED|Overall Study||6
594731|NCT00464815|1453005|P2|COMPLETED|Overall Study||254
594732|NCT00464815|1453006|P1|COMPLETED|Overall Study||762
594733|NCT00464815|1453005|P2|STARTED|Overall Study||257
594734|NCT00464815|1453006|P1|STARTED|Overall Study||768
594735|NCT00464737|1453039|P3|NOT COMPLETED|Overall Study||55
594736|NCT00464737|1453040|P2|NOT COMPLETED|Overall Study||32
594737|NCT00464737|1453041|P1|NOT COMPLETED|Overall Study||32
594738|NCT00464737|1453039|P3|COMPLETED|Overall Study||19
594739|NCT00464737|1453040|P2|COMPLETED|Overall Study||42
594740|NCT00464737|1453041|P1|COMPLETED|Overall Study||50
594741|NCT00464737|1453039|P3|STARTED|Overall Study||74
594742|NCT00464737|1453040|P2|STARTED|Overall Study||74
594743|NCT00464737|1453041|P1|STARTED|Overall Study||82
594744|NCT00464711|1453088|P1|NOT COMPLETED|Overall Study||15
594745|NCT00464711|1453088|P1|COMPLETED|Overall Study||25
594746|NCT00464711|1453088|P1|STARTED|Overall Study||40
594747|NCT00464698|1453092|P1|NOT COMPLETED|Period 3: 120mg||2
594748|NCT00464698|1453092|P1|COMPLETED|Period 3: 120mg||12
594749|NCT00464698|1453092|P1|STARTED|Period 3: 120mg||14
594750|NCT00464698|1453092|P1|NOT COMPLETED|Period 2: 60 mg||0
594751|NCT00464698|1453092|P1|COMPLETED|Period 2: 60 mg||17
594752|NCT00464698|1453092|P1|STARTED|Period 2: 60 mg||17
594753|NCT00464698|1453092|P1|NOT COMPLETED|Period 1: 30 mg||3
594754|NCT00464698|1453092|P1|COMPLETED|Period 1: 30 mg||17
594755|NCT00464698|1453092|P1|STARTED|Period 1: 30 mg||20
594756|NCT00464685|1453104|P2|NOT COMPLETED|Overall Study||33
594757|NCT00464685|1453105|P1|NOT COMPLETED|Overall Study||23
594758|NCT00464685|1453104|P2|COMPLETED|Overall Study||94
594759|NCT00464685|1453105|P1|COMPLETED|Overall Study||103
594760|NCT00464685|1453104|P2|STARTED|Overall Study||127
594761|NCT00464685|1453105|P1|STARTED|Overall Study||126
594762|NCT00464672|1453121|P6|NOT COMPLETED|Overall Study||4
594763|NCT00464672|1453122|P5|NOT COMPLETED|Overall Study||10
594764|NCT00464672|1453123|P4|NOT COMPLETED|Overall Study||1
594765|NCT00464672|1453124|P3|NOT COMPLETED|Overall Study||0
594766|NCT00464672|1453125|P2|NOT COMPLETED|Overall Study||10
594767|NCT00464672|1453126|P1|NOT COMPLETED|Overall Study||25
594768|NCT00464672|1453121|P6|COMPLETED|Overall Study||195
594769|NCT00464672|1453122|P5|COMPLETED|Overall Study||392
594770|NCT00464672|1453123|P4|COMPLETED|Overall Study||199
594771|NCT00464672|1453124|P3|COMPLETED|Overall Study||400
594772|NCT00464672|1453125|P2|COMPLETED|Overall Study||222
594773|NCT00464672|1453126|P1|COMPLETED|Overall Study||435
594774|NCT00464672|1453121|P6|STARTED|Overall Study||199
594775|NCT00464672|1453122|P5|STARTED|Overall Study||402
594776|NCT00464672|1453123|P4|STARTED|Overall Study||200
594777|NCT00464672|1453124|P3|STARTED|Overall Study||400
594778|NCT00464672|1453125|P2|STARTED|Overall Study||232
594779|NCT00464672|1453126|P1|STARTED|Overall Study||460
594780|NCT00464646|1453198|P2|NOT COMPLETED|Overall Study||0
594781|NCT00464646|1453199|P1|NOT COMPLETED|Overall Study||0
594782|NCT00464646|1453198|P2|COMPLETED|Overall Study||29
594783|NCT00464646|1453199|P1|COMPLETED|Overall Study||76
594784|NCT00464646|1453198|P2|STARTED|Overall Study||29
594785|NCT00464646|1453199|P1|STARTED|Overall Study||76
594786|NCT00464568|1453205|P1|NOT COMPLETED|Overall Study||2
594787|NCT00464568|1453205|P1|COMPLETED|Overall Study||30
594788|NCT00464568|1453205|P1|STARTED|Overall Study||32
594789|NCT00464542|1453278|P1|NOT COMPLETED|Post-treatment||0
594790|NCT00464542|1453278|P1|COMPLETED|Post-treatment||10
594791|NCT00464542|1453278|P1|STARTED|Post-treatment||10
594792|NCT00464542|1453278|P1|NOT COMPLETED|Pre-treatment||2
594793|NCT00464542|1453278|P1|COMPLETED|Pre-treatment||10
594794|NCT00464542|1453278|P1|STARTED|Pre-treatment||12
594795|NCT00464490|1453285|P2|NOT COMPLETED|Overall Study||11
594796|NCT00464490|1453286|P1|NOT COMPLETED|Overall Study||11
594797|NCT00464490|1453285|P2|COMPLETED|Overall Study||10
594798|NCT00464490|1453286|P1|COMPLETED|Overall Study||10
594799|NCT00464490|1453285|P2|STARTED|Overall Study||21
594800|NCT00464490|1453286|P1|STARTED|Overall Study||21
594801|NCT00464464|1453294|P2|NOT COMPLETED|Overall Study||3
594802|NCT00464464|1453295|P1|NOT COMPLETED|Overall Study||5
594803|NCT00464464|1453294|P2|COMPLETED|Overall Study||36
594804|NCT00464464|1453295|P1|COMPLETED|Overall Study||36
594805|NCT00464464|1453294|P2|STARTED|Overall Study||39
594806|NCT00464464|1453295|P1|STARTED|Overall Study||41
594807|NCT00464438|1453309|P2|NOT COMPLETED|Overall Study||6
594808|NCT00464438|1453310|P1|NOT COMPLETED|Overall Study||2
594809|NCT00464438|1453309|P2|COMPLETED|Overall Study||80
594810|NCT00464438|1453310|P1|COMPLETED|Overall Study||83
594811|NCT00464438|1453309|P2|STARTED|Overall Study||86
594812|NCT00464438|1453310|P1|STARTED|Overall Study||85
594813|NCT00464334|1453333|P11|NOT COMPLETED|Overall Study||4
594814|NCT00464334|1453334|P10|NOT COMPLETED|Overall Study||1
594815|NCT00464334|1453335|P9|NOT COMPLETED|Overall Study||6
594816|NCT00464334|1453336|P8|NOT COMPLETED|Overall Study||1
594817|NCT00464334|1453337|P7|NOT COMPLETED|Overall Study||3
594818|NCT00464334|1453338|P6|NOT COMPLETED|Overall Study||4
594819|NCT00464334|1453339|P5|NOT COMPLETED|Overall Study||4
594820|NCT00464334|1453340|P4|NOT COMPLETED|Overall Study||4
594821|NCT00464334|1453341|P3|NOT COMPLETED|Overall Study||5
594822|NCT00464334|1453342|P2|NOT COMPLETED|Overall Study||8
594823|NCT00464334|1453343|P1|NOT COMPLETED|Overall Study||1
594824|NCT00464334|1453333|P11|COMPLETED|Overall Study||4
594825|NCT00464334|1453334|P10|COMPLETED|Overall Study||4
594826|NCT00464334|1453335|P9|COMPLETED|Overall Study||2
594827|NCT00464334|1453336|P8|COMPLETED|Overall Study||7
594828|NCT00464334|1453337|P7|COMPLETED|Overall Study||6
594829|NCT00464334|1453338|P6|COMPLETED|Overall Study||3
594830|NCT00464334|1453339|P5|COMPLETED|Overall Study||3
594831|NCT00464334|1453340|P4|COMPLETED|Overall Study||4
594832|NCT00464334|1453341|P3|COMPLETED|Overall Study||3
594833|NCT00464334|1453342|P2|COMPLETED|Overall Study||5
594834|NCT00464334|1453343|P1|COMPLETED|Overall Study||4
594835|NCT00464334|1453333|P11|STARTED|Overall Study||8
594836|NCT00464334|1453334|P10|STARTED|Overall Study||5
594837|NCT00464334|1453335|P9|STARTED|Overall Study||8
594838|NCT00464334|1453336|P8|STARTED|Overall Study||8
594839|NCT00464334|1453337|P7|STARTED|Overall Study||9
594840|NCT00464334|1453338|P6|STARTED|Overall Study||7
594841|NCT00464334|1453339|P5|STARTED|Overall Study||7
594842|NCT00464334|1453340|P4|STARTED|Overall Study||8
594843|NCT00464334|1453341|P3|STARTED|Overall Study||8
594844|NCT00464334|1453342|P2|STARTED|Overall Study||13
594845|NCT00464334|1453343|P1|STARTED|Overall Study||5
594846|NCT00464308|1453403|P3|NOT COMPLETED|Overall Study||59
594847|NCT00464308|1453404|P2|NOT COMPLETED|Overall Study||63
594848|NCT00464308|1453405|P1|NOT COMPLETED|Overall Study||69
594849|NCT00464308|1453403|P3|COMPLETED|Overall Study||400
594850|NCT00464308|1453404|P2|COMPLETED|Overall Study||406
594851|NCT00464308|1453405|P1|COMPLETED|Overall Study||395
594852|NCT00464308|1453403|P3|STARTED|Overall Study||459
594853|NCT00464308|1453404|P2|STARTED|Overall Study||469
594854|NCT00464308|1453405|P1|STARTED|Overall Study||464
594855|NCT00464269|1453435|P4|NOT COMPLETED|Overall Study||9
594856|NCT00464269|1453436|P3|NOT COMPLETED|Overall Study||7
594857|NCT00464269|1453437|P2|NOT COMPLETED|Overall Study||17
594858|NCT00464269|1453438|P1|NOT COMPLETED|Overall Study||6
594859|NCT00464269|1453435|P4|COMPLETED|Overall Study||93
594860|NCT00464269|1453436|P3|COMPLETED|Overall Study||93
594861|NCT00464269|1453437|P2|COMPLETED|Overall Study||82
594862|NCT00464269|1453438|P1|COMPLETED|Overall Study||93
594863|NCT00464269|1453435|P4|STARTED|Overall Study||102
594864|NCT00464269|1453436|P3|STARTED|Overall Study||100
594865|NCT00464269|1453437|P2|STARTED|Overall Study||99
594866|NCT00464269|1453438|P1|STARTED|Overall Study||99
594867|NCT00464204|1453538|P2|NOT COMPLETED|Overall Study||32
594868|NCT00464204|1453539|P1|NOT COMPLETED|Overall Study||49
594869|NCT00464204|1453538|P2|COMPLETED|Overall Study|Completed=no withdrawal until day 8.|64
594870|NCT00464204|1453539|P1|COMPLETED|Overall Study|Completed=no withdrawal until day 8.|51
594871|NCT00464204|1453538|P2|Withdrawal Due to Discharge From ICU|Overall Study||11
594872|NCT00464204|1453539|P1|Withdrawal Due to Discharge From ICU|Overall Study||18
594873|NCT00464204|1453538|P2|Day 90 Follow-up Performed|Overall Study||74
594874|NCT00464204|1453539|P1|Day 90 Follow-up Performed|Overall Study||69
594875|NCT00464204|1453538|P2|Day 30 Follow-up Performed|Overall Study||83
594876|NCT00464204|1453539|P1|Day 30 Follow-up Performed|Overall Study||89
594877|NCT00464204|1453538|P2|Completed Treatment|Overall Study||83
594878|NCT00464204|1453539|P1|Completed Treatment|Overall Study||81
594879|NCT00464204|1453538|P2|STARTED|Overall Study||96
594880|NCT00464204|1453539|P1|STARTED|Overall Study||100
594881|NCT00464087|1453576|P3|NOT COMPLETED|Overall Study||29
594882|NCT00464087|1453577|P2|NOT COMPLETED|Overall Study||0
594883|NCT00464087|1453578|P1|NOT COMPLETED|Overall Study||0
594884|NCT00464087|1453576|P3|COMPLETED|Overall Study||0
594885|NCT00464087|1453577|P2|COMPLETED|Overall Study||51
594886|NCT00464087|1453578|P1|COMPLETED|Overall Study||49
594887|NCT00464087|1453576|P3|STARTED|Overall Study||29
594888|NCT00464087|1453577|P2|STARTED|Overall Study||51
594889|NCT00464087|1453578|P1|STARTED|Overall Study||49
594890|NCT00463866|1453596|P2|NOT COMPLETED|Overall Study||340
594891|NCT00463866|1453597|P1|NOT COMPLETED|Overall Study||309
594892|NCT00463866|1453596|P2|COMPLETED|Overall Study||3705
594893|NCT00463866|1453597|P1|COMPLETED|Overall Study||3699
594894|NCT00463866|1453596|P2|STARTED|Overall Study|4221 participants randomised. Out of these, 176 had no efficacy data after randomisation.|4045
594895|NCT00463866|1453597|P1|STARTED|Overall Study|4203 participants randomised. Out of these, 195 had no efficacy data after randomisation.|4008
594896|NCT00463840|1453617|P1|NOT COMPLETED|Overall Study||12
594897|NCT00463840|1453617|P1|COMPLETED|Overall Study||12
594898|NCT00463840|1453617|P1|STARTED|Overall Study||24
594899|NCT00463801|1453622|P1|NOT COMPLETED|Overall Study||13
594900|NCT00463801|1453622|P1|COMPLETED|Overall Study||39
594901|NCT00463801|1453622|P1|STARTED|Overall Study||52
594902|NCT00463788|1453628|P2|NOT COMPLETED|Overall Study||54
594903|NCT00463788|1453629|P1|NOT COMPLETED|Overall Study||109
594904|NCT00463788|1453628|P2|COMPLETED|Overall Study||4
594905|NCT00463788|1453629|P1|COMPLETED|Overall Study||6
594906|NCT00463788|1453628|P2|Treated|Overall Study||57
594907|NCT00463788|1453629|P1|Treated|Overall Study||114
594908|NCT00463788|1453628|P2|STARTED|Overall Study||58
594909|NCT00463788|1453629|P1|STARTED|Overall Study||115
594910|NCT00463606|1453647|P3|NOT COMPLETED|Overall Study||20
594911|NCT00463606|1453648|P2|NOT COMPLETED|Overall Study||34
594912|NCT00463606|1453649|P1|NOT COMPLETED|Overall Study||41
594913|NCT00463606|1453647|P3|COMPLETED|Overall Study||231
594914|NCT00463606|1453648|P2|COMPLETED|Overall Study||220
594915|NCT00463606|1453649|P1|COMPLETED|Overall Study||212
594916|NCT00463606|1453647|P3|STARTED|Overall Study||251
594917|NCT00463606|1453648|P2|STARTED|Overall Study||254
594918|NCT00463606|1453649|P1|STARTED|Overall Study||253
594919|NCT00463580|1453674|P2|NOT COMPLETED|Overall Study||2
594920|NCT00463580|1453675|P1|NOT COMPLETED|Overall Study||3
594921|NCT00463580|1453674|P2|COMPLETED|Overall Study||28
594922|NCT00463580|1453675|P1|COMPLETED|Overall Study||27
594923|NCT00463580|1453674|P2|STARTED|Overall Study||30
594924|NCT00463580|1453675|P1|STARTED|Overall Study||30
594925|NCT00463567|1453690|P7|NOT COMPLETED|Overall Study||11
594926|NCT00463567|1453691|P6|NOT COMPLETED|Overall Study||21
594927|NCT00463567|1453692|P5|NOT COMPLETED|Overall Study||23
594928|NCT00463567|1453693|P4|NOT COMPLETED|Overall Study||131
594929|NCT00463567|1453694|P3|NOT COMPLETED|Overall Study||89
594930|NCT00463567|1453695|P2|NOT COMPLETED|Overall Study||77
594931|NCT00463567|1453696|P1|NOT COMPLETED|Overall Study||95
594932|NCT00463567|1453690|P7|COMPLETED|Overall Study||112
594933|NCT00463567|1453691|P6|COMPLETED|Overall Study||102
594934|NCT00463567|1453692|P5|COMPLETED|Overall Study||107
594935|NCT00463567|1453693|P4|COMPLETED|Overall Study||294
594936|NCT00463567|1453694|P3|COMPLETED|Overall Study||331
594937|NCT00463567|1453695|P2|COMPLETED|Overall Study||341
594938|NCT00463567|1453696|P1|COMPLETED|Overall Study||325
594939|NCT00463567|1453690|P7|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|122
594940|NCT00463567|1453691|P6|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|122
594941|NCT00463567|1453692|P5|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|127
594942|NCT00463567|1453693|P4|Safety Population: Received Study Drug|Overall Study||418
594943|NCT00463567|1453694|P3|Safety Population: Received Study Drug|Overall Study||415
594944|NCT00463567|1453695|P2|Safety Population: Received Study Drug|Overall Study||416
594945|NCT00463567|1453696|P1|Safety Population: Received Study Drug|Overall Study||416
594946|NCT00463567|1453690|P7|STARTED|Overall Study||123
594947|NCT00463567|1453691|P6|STARTED|Overall Study||123
594948|NCT00463567|1453692|P5|STARTED|Overall Study||130
594949|NCT00463567|1453693|P4|STARTED|Overall Study||425
594950|NCT00463567|1453694|P3|STARTED|Overall Study||420
594951|NCT00463567|1453695|P2|STARTED|Overall Study||418
594952|NCT00463567|1453696|P1|STARTED|Overall Study|Randomized Participants|420
594953|NCT00463437|1453731|P4|NOT COMPLETED|Overall Study||7
594954|NCT00463437|1453732|P3|NOT COMPLETED|Overall Study||6
594955|NCT00463437|1453733|P2|NOT COMPLETED|Overall Study||11
594956|NCT00463437|1453734|P1|NOT COMPLETED|Overall Study||4
594957|NCT00463437|1453731|P4|COMPLETED|Overall Study||350
594958|NCT00463437|1453732|P3|COMPLETED|Overall Study||352
594959|NCT00463437|1453733|P2|COMPLETED|Overall Study||352
594960|NCT00463437|1453734|P1|COMPLETED|Overall Study||355
594961|NCT00463437|1453731|P4|STARTED|Overall Study||357
594962|NCT00463437|1453732|P3|STARTED|Overall Study||358
594963|NCT00463437|1453733|P2|STARTED|Overall Study||363
594964|NCT00463437|1453734|P1|STARTED|Overall Study||359
594965|NCT00463385|1453800|P4|NOT COMPLETED|Overall Study||22
594966|NCT00463385|1453801|P3|NOT COMPLETED|Overall Study||22
594967|NCT00463385|1453802|P2|NOT COMPLETED|Overall Study||22
594968|NCT00463385|1453803|P1|NOT COMPLETED|Overall Study||22
594969|NCT00463385|1453800|P4|COMPLETED|Overall Study||0
594970|NCT00463385|1453801|P3|COMPLETED|Overall Study||0
594971|NCT00463385|1453802|P2|COMPLETED|Overall Study||0
594972|NCT00463385|1453803|P1|COMPLETED|Overall Study||0
594973|NCT00463385|1453800|P4|Treated|Overall Study||22
594974|NCT00463385|1453801|P3|Treated|Overall Study||19
594975|NCT00463385|1453802|P2|Treated|Overall Study||22
594976|NCT00463385|1453803|P1|Treated|Overall Study||22
594977|NCT00463385|1453800|P4|STARTED|Overall Study||22
594978|NCT00463385|1453801|P3|STARTED|Overall Study||22
594979|NCT00463385|1453802|P2|STARTED|Overall Study||22
594980|NCT00463385|1453803|P1|STARTED|Overall Study||22
594981|NCT00463346|1453855|P2|NOT COMPLETED|Overall Study||3
594982|NCT00463346|1453856|P1|NOT COMPLETED|Overall Study||3
594983|NCT00463346|1453855|P2|COMPLETED|Overall Study||8
594984|NCT00463346|1453856|P1|COMPLETED|Overall Study||9
594985|NCT00463346|1453855|P2|STARTED|Overall Study||11
594986|NCT00463346|1453856|P1|STARTED|Overall Study||12
594987|NCT00463229|1453866|P2|NOT COMPLETED|Overall Study||10
594988|NCT00463229|1453867|P1|NOT COMPLETED|Overall Study||9
594989|NCT00463229|1453866|P2|COMPLETED|Overall Study||39
594990|NCT00463229|1453867|P1|COMPLETED|Overall Study||43
594991|NCT00463229|1453866|P2|STARTED|Overall Study||49
594992|NCT00463229|1453867|P1|STARTED|Overall Study||52
594993|NCT00463047|1453873|P2|NOT COMPLETED|Double-Blind Treatment Period 2||2
594994|NCT00463047|1453874|P1|NOT COMPLETED|Double-Blind Treatment Period 2||1
594995|NCT00463047|1453873|P2|COMPLETED|Double-Blind Treatment Period 2||88
594996|NCT00463047|1453874|P1|COMPLETED|Double-Blind Treatment Period 2||92
594997|NCT00463047|1453873|P2|STARTED|Double-Blind Treatment Period 2||90
594998|NCT00463047|1453874|P1|STARTED|Double-Blind Treatment Period 2||93
594999|NCT00463047|1453873|P2|NOT COMPLETED|Double-Blind Treatment Period 1||4
595000|NCT00463047|1453874|P1|NOT COMPLETED|Double-Blind Treatment Period 1||3
595001|NCT00463047|1453873|P2|COMPLETED|Double-Blind Treatment Period 1||90
595002|NCT00463047|1453874|P1|COMPLETED|Double-Blind Treatment Period 1||93
595003|NCT00463047|1453873|P2|STARTED|Double-Blind Treatment Period 1|After completion of titration period subjects were re-randomized to these two treatment arms|94
595004|NCT00463047|1453874|P1|STARTED|Double-Blind Treatment Period 1|After completion of titration period subjects were re-randomized to these two treatment arms|96
595005|NCT00463047|1453873|P2|NOT COMPLETED|Titration Period 2||23
595006|NCT00463047|1453874|P1|NOT COMPLETED|Titration Period 2||30
595007|NCT00463047|1453873|P2|COMPLETED|Titration Period 2||98
595008|NCT00463047|1453874|P1|COMPLETED|Titration Period 2||93
595009|NCT00463047|1453873|P2|STARTED|Titration Period 2||121
595010|NCT00463047|1453874|P1|STARTED|Titration Period 2||123
595011|NCT00463047|1453873|P2|NOT COMPLETED|Titration Period 1||39
595012|NCT00463047|1453874|P1|NOT COMPLETED|Titration Period 1||37
595013|NCT00463047|1453873|P2|COMPLETED|Titration Period 1||121
595014|NCT00463047|1453874|P1|COMPLETED|Titration Period 1||123
595015|NCT00463047|1453873|P2|STARTED|Titration Period 1||160
595016|NCT00463047|1453874|P1|STARTED|Titration Period 1|323 subjects entered study period but 3 discontinued before being randomized to treatment|160
595017|NCT00462982|1453959|P1|NOT COMPLETED|Overall Study||3
595018|NCT00462982|1453959|P1|COMPLETED|Overall Study||5
595019|NCT00462982|1453959|P1|STARTED|Overall Study||8
595020|NCT00462943|1453966|P3|NOT COMPLETED|Overall Study||23
595021|NCT00462943|1453967|P2|NOT COMPLETED|Overall Study||30
595022|NCT00462943|1453968|P1|NOT COMPLETED|Overall Study||45
595023|NCT00462943|1453966|P3|COMPLETED|Overall Study||0
595024|NCT00462943|1453967|P2|COMPLETED|Overall Study||1
595025|NCT00462943|1453968|P1|COMPLETED|Overall Study||1
595026|NCT00462943|1453966|P3|STARTED|Overall Study||23
595027|NCT00462943|1453967|P2|STARTED|Overall Study||31
595028|NCT00462943|1453968|P1|STARTED|Overall Study||46
595029|NCT00462917|1454039|P4|NOT COMPLETED|Overall Study||11
595030|NCT00462917|1454040|P3|NOT COMPLETED|Overall Study||12
595031|NCT00462917|1454041|P2|NOT COMPLETED|Overall Study||10
595032|NCT00462917|1454042|P1|NOT COMPLETED|Overall Study||10
595033|NCT00462917|1454039|P4|COMPLETED|Overall Study||66
595034|NCT00462917|1454040|P3|COMPLETED|Overall Study||54
595035|NCT00462917|1454041|P2|COMPLETED|Overall Study||65
595036|NCT00462917|1454042|P1|COMPLETED|Overall Study||62
595037|NCT00462917|1454039|P4|Completed 6 Month Follow-up|Overall Study||66
595038|NCT00462917|1454040|P3|Completed 6 Month Follow-up|Overall Study||55
595039|NCT00462917|1454041|P2|Completed 6 Month Follow-up|Overall Study||68
595040|NCT00462917|1454042|P1|Completed 6 Month Follow-up|Overall Study||63
595041|NCT00462917|1454039|P4|Completed 6 Week Follow-up|Overall Study||68
595042|NCT00462917|1454040|P3|Completed 6 Week Follow-up|Overall Study||55
595043|NCT00462917|1454041|P2|Completed 6 Week Follow-up|Overall Study||70
595044|NCT00462917|1454042|P1|Completed 6 Week Follow-up|Overall Study||63
595045|NCT00462917|1454039|P4|Received Risk Information|Overall Study||68
595046|NCT00462917|1454040|P3|Received Risk Information|Overall Study||55
595047|NCT00462917|1454041|P2|Received Risk Information|Overall Study||70
595048|NCT00462917|1454042|P1|Received Risk Information|Overall Study||64
595049|NCT00462917|1454039|P4|Met With Genetic Counselor|Overall Study||71
595050|NCT00462917|1454040|P3|Met With Genetic Counselor|Overall Study||56
595051|NCT00462917|1454041|P2|Met With Genetic Counselor|Overall Study||71
595052|NCT00462917|1454042|P1|Met With Genetic Counselor|Overall Study||66
595053|NCT00462917|1454039|P4|STARTED|Overall Study||77
595054|NCT00462917|1454040|P3|STARTED|Overall Study||66
595055|NCT00462917|1454041|P2|STARTED|Overall Study||75
595056|NCT00462917|1454042|P1|STARTED|Overall Study||72
595057|NCT00462865|1454060|P1|NOT COMPLETED|Overall Study||1
595058|NCT00462865|1454060|P1|COMPLETED|Overall Study||17
595059|NCT00462865|1454060|P1|STARTED|Overall Study|18 pts enrolled,1 pt experienced a SAE infection normal ANC (gr 3) and did not begin study,see SAE|18
595060|NCT00462839|1454066|P2|NOT COMPLETED|Viewed Second||0
595061|NCT00462839|1454067|P1|NOT COMPLETED|Viewed Second||0
595062|NCT00462839|1454066|P2|COMPLETED|Viewed Second||53
595063|NCT00462839|1454067|P1|COMPLETED|Viewed Second||53
595064|NCT00462839|1454066|P2|STARTED|Viewed Second||53
595065|NCT00462839|1454067|P1|STARTED|Viewed Second||53
595066|NCT00462839|1454066|P2|NOT COMPLETED|Viewed First||0
595067|NCT00462839|1454067|P1|NOT COMPLETED|Viewed First||0
595068|NCT00462839|1454066|P2|COMPLETED|Viewed First||53
595069|NCT00462839|1454067|P1|COMPLETED|Viewed First||53
595070|NCT00462839|1454066|P2|STARTED|Viewed First||53
595071|NCT00462839|1454067|P1|STARTED|Viewed First||53
595072|NCT00462826|1454079|P1|NOT COMPLETED|Overall Study||5
595073|NCT00462826|1454079|P1|COMPLETED|Overall Study||44
595074|NCT00462826|1454079|P1|STARTED|Overall Study||49
595075|NCT00462748|1454095|P3|NOT COMPLETED|Overall Study||11
595076|NCT00462748|1454096|P2|NOT COMPLETED|Overall Study||11
595077|NCT00462748|1454097|P1|NOT COMPLETED|Overall Study||12
595078|NCT00462748|1454095|P3|COMPLETED|Overall Study||251
595079|NCT00462748|1454096|P2|COMPLETED|Overall Study||252
595080|NCT00462748|1454097|P1|COMPLETED|Overall Study||249
595081|NCT00462748|1454095|P3|STARTED|Overall Study||262
595082|NCT00462748|1454096|P2|STARTED|Overall Study||263
595083|NCT00462748|1454097|P1|STARTED|Overall Study||261
595084|NCT00462735|1454105|P1|NOT COMPLETED|Overall Study||0
595085|NCT00462735|1454105|P1|COMPLETED|Overall Study||33
595086|NCT00462735|1454105|P1|STARTED|Overall Study||33
595087|NCT00462722|1454116|P3|NOT COMPLETED|Overall Study||12
595088|NCT00462722|1454117|P2|NOT COMPLETED|Overall Study||4
595089|NCT00462722|1454118|P1|NOT COMPLETED|Overall Study||13
595090|NCT00462722|1454116|P3|COMPLETED|Overall Study||42
595091|NCT00462722|1454117|P2|COMPLETED|Overall Study||51
595092|NCT00462722|1454118|P1|COMPLETED|Overall Study||37
595093|NCT00462722|1454116|P3|STARTED|Overall Study||54
595094|NCT00462722|1454117|P2|STARTED|Overall Study||55
595095|NCT00462722|1454118|P1|STARTED|Overall Study||50
595096|NCT00462709|1454150|P1|NOT COMPLETED|Overall Study||67
595097|NCT00462709|1454150|P1|COMPLETED|Overall Study||79
595098|NCT00462709|1454150|P1|STARTED|Overall Study||146
595099|NCT00462670|1454159|P2|NOT COMPLETED|Overall Study||7
595100|NCT00462670|1454160|P1|NOT COMPLETED|Overall Study||5
595101|NCT00462670|1454159|P2|COMPLETED|Overall Study||46
595102|NCT00462670|1454160|P1|COMPLETED|Overall Study||52
595103|NCT00462670|1454159|P2|STARTED|Overall Study||53
595104|NCT00462670|1454160|P1|STARTED|Overall Study||57
595105|NCT00462644|1454170|P2|NOT COMPLETED|Overall Study||0
595106|NCT00462644|1454171|P1|NOT COMPLETED|Overall Study||0
595107|NCT00462644|1454170|P2|COMPLETED|Overall Study||12
595108|NCT00462644|1454171|P1|COMPLETED|Overall Study||18
595109|NCT00462644|1454170|P2|STARTED|Overall Study||12
595110|NCT00462644|1454171|P1|STARTED|Overall Study||18
595111|NCT00462605|1454189|P1|NOT COMPLETED|Overall Study||14
595112|NCT00462605|1454189|P1|COMPLETED|Overall Study||10
595113|NCT00462605|1454189|P1|STARTED|Overall Study||24
595114|NCT00462501|1454197|P1|NOT COMPLETED|Overall Study||5
595115|NCT00462501|1454197|P1|COMPLETED|Overall Study||30
595116|NCT00462501|1454197|P1|STARTED|Overall Study||35
595117|NCT00462462|1454203|P2|NOT COMPLETED|Overall Study||1
595118|NCT00462462|1454204|P1|NOT COMPLETED|Overall Study||0
595119|NCT00462462|1454203|P2|COMPLETED|Overall Study||13
595120|NCT00462462|1454204|P1|COMPLETED|Overall Study||17
595121|NCT00462462|1454203|P2|STARTED|Overall Study||14
595122|NCT00462462|1454204|P1|STARTED|Overall Study||17
595123|NCT00462449|1454214|P2|NOT COMPLETED|Overall Study||0
595124|NCT00462449|1454215|P1|NOT COMPLETED|Overall Study||0
595125|NCT00462449|1454214|P2|COMPLETED|Overall Study||10
595126|NCT00462449|1454215|P1|COMPLETED|Overall Study||13
595127|NCT00462449|1454214|P2|STARTED|Overall Study||10
595128|NCT00462449|1454215|P1|STARTED|Overall Study||13
595129|NCT00462423|1454225|P1|NOT COMPLETED|Overall Study||0
595130|NCT00462423|1454225|P1|COMPLETED|Overall Study||50
595131|NCT00462423|1454225|P1|STARTED|Overall Study||50
595132|NCT00462384|1454232|P1|NOT COMPLETED|Overall Study||9
595133|NCT00462384|1454232|P1|COMPLETED|Overall Study||30
595134|NCT00462384|1454232|P1|STARTED|Overall Study||39
595135|NCT00462345|1454240|P1|NOT COMPLETED|Overall Study||3
595136|NCT00462345|1454240|P1|COMPLETED|Overall Study||37
595137|NCT00462345|1454240|P1|Completed First Course|Overall Study||38
595138|NCT00462345|1454240|P1|STARTED|Overall Study||40
595139|NCT00462332|1454264|P2|NOT COMPLETED|Overall Study||0
595140|NCT00462332|1454265|P1|NOT COMPLETED|Overall Study||0
595141|NCT00462332|1454264|P2|COMPLETED|Overall Study||41
595142|NCT00462332|1454265|P1|COMPLETED|Overall Study||45
595143|NCT00462332|1454264|P2|STARTED|Overall Study||41
595144|NCT00462332|1454265|P1|STARTED|Overall Study||45
595145|NCT00462306|1454275|P2|NOT COMPLETED|Overall Study||13
595146|NCT00462306|1454276|P1|NOT COMPLETED|Overall Study||0
595147|NCT00462306|1454275|P2|COMPLETED|Overall Study||490
595148|NCT00462306|1454276|P1|COMPLETED|Overall Study||4074
595149|NCT00462306|1454275|P2|STARTED|Overall Study||503
595150|NCT00462306|1454276|P1|STARTED|Overall Study||4074
595151|NCT00462280|1454288|P4|NOT COMPLETED|Overall Study||3
595152|NCT00462280|1454289|P3|NOT COMPLETED|Overall Study||0
595153|NCT00462280|1454290|P2|NOT COMPLETED|Overall Study||7
595154|NCT00462280|1454291|P1|NOT COMPLETED|Overall Study||10
595155|NCT00462280|1454288|P4|COMPLETED|Overall Study||4
595156|NCT00462280|1454289|P3|COMPLETED|Overall Study||7
595157|NCT00462280|1454290|P2|COMPLETED|Overall Study||25
595158|NCT00462280|1454291|P1|COMPLETED|Overall Study||24
595159|NCT00462280|1454288|P4|STARTED|Overall Study||7
595160|NCT00462280|1454289|P3|STARTED|Overall Study||7
595161|NCT00462280|1454290|P2|STARTED|Overall Study||32
595162|NCT00462280|1454291|P1|STARTED|Overall Study||34
595163|NCT00462228|1454351|P1|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0
595164|NCT00462228|1454351|P1|COMPLETED|No Treatment (Washout) 4 Weeks||11
595165|NCT00462228|1454351|P1|STARTED|No Treatment (Washout) 4 Weeks||11
595166|NCT00462228|1454351|P1|NOT COMPLETED|Placebo or Memantine 12 Weeks||0
595167|NCT00462228|1454351|P1|COMPLETED|Placebo or Memantine 12 Weeks||11
595168|NCT00462228|1454351|P1|STARTED|Placebo or Memantine 12 Weeks||11
595169|NCT00462228|1454351|P1|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0
595170|NCT00462228|1454351|P1|COMPLETED|No Treatment (Washout) 4 Weeks||11
595171|NCT00462228|1454351|P1|STARTED|No Treatment (Washout) 4 Weeks||11
595172|NCT00462228|1454351|P1|NOT COMPLETED|Memantine or Placebo 12 Weeks||0
595173|NCT00462228|1454351|P1|COMPLETED|Memantine or Placebo 12 Weeks||11
595174|NCT00462228|1454351|P1|STARTED|Memantine or Placebo 12 Weeks||11
595175|NCT00462072|1454375|P3|NOT COMPLETED|Week 10||0
595176|NCT00462072|1454376|P2|NOT COMPLETED|Week 10||0
595177|NCT00462072|1454377|P1|NOT COMPLETED|Week 10||0
595178|NCT00462072|1454375|P3|COMPLETED|Week 10||9
595179|NCT00462072|1454376|P2|COMPLETED|Week 10||12
595180|NCT00462072|1454377|P1|COMPLETED|Week 10||10
595181|NCT00462072|1454375|P3|STARTED|Week 10||9
595182|NCT00462072|1454376|P2|STARTED|Week 10||12
595183|NCT00462072|1454377|P1|STARTED|Week 10||10
595184|NCT00462072|1454375|P3|NOT COMPLETED|Baseline (Week 0)||0
595185|NCT00462072|1454376|P2|NOT COMPLETED|Baseline (Week 0)||0
595186|NCT00462072|1454377|P1|NOT COMPLETED|Baseline (Week 0)||0
595187|NCT00462072|1454375|P3|COMPLETED|Baseline (Week 0)||9
595188|NCT00462072|1454376|P2|COMPLETED|Baseline (Week 0)||12
595189|NCT00462072|1454377|P1|COMPLETED|Baseline (Week 0)||10
595190|NCT00462072|1454375|P3|STARTED|Baseline (Week 0)||9
595191|NCT00462072|1454376|P2|STARTED|Baseline (Week 0)||12
595192|NCT00462072|1454377|P1|STARTED|Baseline (Week 0)||10
595193|NCT00462020|1454393|P2|NOT COMPLETED|Overall Study||0
595194|NCT00462020|1454394|P1|NOT COMPLETED|Overall Study||0
595195|NCT00462020|1454393|P2|COMPLETED|Overall Study||50
595196|NCT00462020|1454394|P1|COMPLETED|Overall Study||52
595197|NCT00462020|1454393|P2|STARTED|Overall Study||50
595198|NCT00462020|1454394|P1|STARTED|Overall Study||52
595199|NCT00461981|1454402|P2|NOT COMPLETED|Overall Study||9
595200|NCT00461981|1454403|P1|NOT COMPLETED|Overall Study||11
595201|NCT00461981|1454402|P2|COMPLETED|Overall Study||42
595202|NCT00461981|1454403|P1|COMPLETED|Overall Study||39
595203|NCT00461981|1454402|P2|STARTED|Overall Study||51
595204|NCT00461981|1454403|P1|STARTED|Overall Study||50
595205|NCT00461851|1454513|P1|NOT COMPLETED|Overall Study||0
595206|NCT00461851|1454513|P1|COMPLETED|Overall Study||17
595207|NCT00461851|1454513|P1|STARTED|Overall Study||17
595208|NCT00461812|1454519|P1|NOT COMPLETED|Overall Study||10
595209|NCT00461812|1454519|P1|COMPLETED|Overall Study||0
595210|NCT00461812|1454519|P1|STARTED|Overall Study||10
595211|NCT00461786|1454524|P1|NOT COMPLETED|Overall Study||3
595212|NCT00461786|1454524|P1|COMPLETED|Overall Study|Completed means the patient was evaluable for response.|48
595213|NCT00461786|1454524|P1|STARTED|Overall Study||51
595214|NCT00461734|1454534|P2|NOT COMPLETED|Overall Study||60
595215|NCT00461734|1454535|P1|NOT COMPLETED|Overall Study||58
595216|NCT00461734|1454534|P2|COMPLETED|Overall Study||60
595217|NCT00461734|1454535|P1|COMPLETED|Overall Study||62
595218|NCT00461734|1454534|P2|STARTED|Overall Study||120
595219|NCT00461734|1454535|P1|STARTED|Overall Study||120
595220|NCT00461708|1454569|P2|NOT COMPLETED|Overall Study||38
595221|NCT00461708|1454570|P1|NOT COMPLETED|Overall Study||115
595222|NCT00461708|1454569|P2|COMPLETED|Overall Study||0
595223|NCT00461708|1454570|P1|COMPLETED|Overall Study||0
595224|NCT00461708|1454569|P2|STARTED|Overall Study||38
595225|NCT00461708|1454570|P1|STARTED|Overall Study||115
595226|NCT00461682|1454596|P1|NOT COMPLETED|Overall Study||1
595227|NCT00461682|1454596|P1|COMPLETED|Overall Study||0
595228|NCT00461682|1454596|P1|STARTED|Overall Study||1
595229|NCT00461630|1454624|P2|NOT COMPLETED|Overall Study||827
595230|NCT00461630|1454625|P1|NOT COMPLETED|Overall Study||906
595231|NCT00461630|1454624|P2|COMPLETED|Overall Study||12008
595232|NCT00461630|1454625|P1|COMPLETED|Overall Study||11932
595233|NCT00461630|1454624|P2|STARTED|Overall Study||12835
595234|NCT00461630|1454625|P1|STARTED|Overall Study||12838
595235|NCT00461591|1454641|P2|NOT COMPLETED|Overall Study||85
595236|NCT00461591|1454642|P1|NOT COMPLETED|Overall Study||89
595237|NCT00461591|1454641|P2|COMPLETED|Overall Study||311
595238|NCT00461591|1454642|P1|COMPLETED|Overall Study||317
595239|NCT00461591|1454641|P2|STARTED|Overall Study||396
595240|NCT00461591|1454642|P1|STARTED|Overall Study||406
595241|NCT00461513|1454664|P2|NOT COMPLETED|Overall Study||27
595242|NCT00461513|1454665|P1|NOT COMPLETED|Overall Study||28
595243|NCT00461513|1454664|P2|COMPLETED|Overall Study||172
595244|NCT00461513|1454665|P1|COMPLETED|Overall Study||165
595245|NCT00461513|1454664|P2|STARTED|Overall Study||199
595246|NCT00461513|1454665|P1|STARTED|Overall Study||193
595247|NCT00461500|1454673|P2|NOT COMPLETED|Overall Study||6
595248|NCT00461500|1454674|P1|NOT COMPLETED|Overall Study||7
595249|NCT00461500|1454673|P2|COMPLETED|Overall Study||38
595250|NCT00461500|1454674|P1|COMPLETED|Overall Study||30
595251|NCT00461500|1454673|P2|STARTED|Overall Study||44
595252|NCT00461500|1454674|P1|STARTED|Overall Study||37
595253|NCT00461331|1454704|P2|NOT COMPLETED|Intervention 2||0
595254|NCT00461331|1454705|P1|NOT COMPLETED|Intervention 2||0
595255|NCT00461331|1454704|P2|COMPLETED|Intervention 2||10
595256|NCT00461331|1454705|P1|COMPLETED|Intervention 2||10
595257|NCT00461331|1454704|P2|STARTED|Intervention 2||10
595258|NCT00461331|1454705|P1|STARTED|Intervention 2||10
595259|NCT00461331|1454704|P2|NOT COMPLETED|Washout||0
595260|NCT00461331|1454705|P1|NOT COMPLETED|Washout||0
595261|NCT00461331|1454704|P2|COMPLETED|Washout||10
595262|NCT00461331|1454705|P1|COMPLETED|Washout||10
595263|NCT00461331|1454704|P2|STARTED|Washout||10
595264|NCT00461331|1454705|P1|STARTED|Washout||10
595265|NCT00461331|1454704|P2|NOT COMPLETED|Intervention 1||0
595266|NCT00461331|1454705|P1|NOT COMPLETED|Intervention 1||0
595267|NCT00461331|1454704|P2|COMPLETED|Intervention 1||10
595268|NCT00461331|1454705|P1|COMPLETED|Intervention 1||10
595269|NCT00461331|1454704|P2|STARTED|Intervention 1||10
595270|NCT00461331|1454705|P1|STARTED|Intervention 1||10
595271|NCT00461305|1454717|P2|NOT COMPLETED|Continued Treatment||0
595272|NCT00461305|1454718|P1|NOT COMPLETED|Continued Treatment||95
595273|NCT00461305|1454717|P2|COMPLETED|Continued Treatment||0
595274|NCT00461305|1454718|P1|COMPLETED|Continued Treatment||254
595275|NCT00461305|1454717|P2|STARTED|Continued Treatment|no participants were treated with the DRSP 3 mg/EE 30 μg combination beyond 6 cycles|0
595276|NCT00461305|1454718|P1|STARTED|Continued Treatment|FAS, participants from previous treatment who were available to continue treatment|349
595277|NCT00461305|1454717|P2|NOT COMPLETED|Treatment||9
595278|NCT00461305|1454718|P1|NOT COMPLETED|Treatment||101
595279|NCT00461305|1454717|P2|COMPLETED|Treatment||56
595280|NCT00461305|1454718|P1|COMPLETED|Treatment||254
595281|NCT00461305|1454717|P2|Subjects Received Treatment|Treatment|FAS, safety population|65
595282|NCT00461305|1454718|P1|Subjects Received Treatment|Treatment|FAS, safety population|349
595283|NCT00461305|1454717|P2|Subjects Dispensed Drugs|Treatment||65
595284|NCT00461305|1454718|P1|Subjects Dispensed Drugs|Treatment||350
595285|NCT00461305|1454717|P2|STARTED|Treatment|Enrolled|65
595286|NCT00461305|1454718|P1|STARTED|Treatment|Enrolled|355
595287|NCT00461292|1454781|P3|NOT COMPLETED|Treatment Cycle 2||0
595288|NCT00461292|1454782|P2|NOT COMPLETED|Treatment Cycle 2||2
595289|NCT00461292|1454783|P1|NOT COMPLETED|Treatment Cycle 2||5
595290|NCT00461292|1454781|P3|COMPLETED|Treatment Cycle 2||0
595291|NCT00461292|1454782|P2|COMPLETED|Treatment Cycle 2||72
595292|NCT00461292|1454783|P1|COMPLETED|Treatment Cycle 2||58
595293|NCT00461292|1454781|P3|STARTED|Treatment Cycle 2|Cycle 1 Placebo pts were randomized to receive 300U or 200 U in Cycle 2|0
595294|NCT00461292|1454782|P2|STARTED|Treatment Cycle 2|42 from the 200U group + 32 from the Placebo group entered Cycle 2|74
595295|NCT00461292|1454783|P1|STARTED|Treatment Cycle 2|32 from the 300U group + 31 from the Placebo group entered Cycle 2|63
595296|NCT00461292|1454781|P3|NOT COMPLETED|Treatment Cycle 1||11
595297|NCT00461292|1454782|P2|NOT COMPLETED|Treatment Cycle 1||12
595298|NCT00461292|1454783|P1|NOT COMPLETED|Treatment Cycle 1||15
595299|NCT00461292|1454781|P3|COMPLETED|Treatment Cycle 1||81
595300|NCT00461292|1454782|P2|COMPLETED|Treatment Cycle 1||80
595301|NCT00461292|1454783|P1|COMPLETED|Treatment Cycle 1||76
595302|NCT00461292|1454781|P3|STARTED|Treatment Cycle 1||92
595303|NCT00461292|1454782|P2|STARTED|Treatment Cycle 1||92
595304|NCT00461292|1454783|P1|STARTED|Treatment Cycle 1||91
595305|NCT00461253|1454802|P2|NOT COMPLETED|Overall Study||19798
595306|NCT00461253|1454803|P1|NOT COMPLETED|Overall Study||4980
595307|NCT00461253|1454802|P2|COMPLETED|Overall Study|Analyzed controls|20452
595308|NCT00461253|1454803|P1|COMPLETED|Overall Study|Analyzed cases|5113
595309|NCT00461253|1454802|P2|STARTED|Overall Study|Identified controls|40250
595310|NCT00461253|1454803|P1|STARTED|Overall Study|Identified cases|10093
595311|NCT00461175|1454811|P2|NOT COMPLETED|Overall Study||365
595312|NCT00461175|1454812|P1|NOT COMPLETED|Overall Study||522
595313|NCT00461175|1454811|P2|COMPLETED|Overall Study||18370
595314|NCT00461175|1454812|P1|COMPLETED|Overall Study||43078
595315|NCT00461175|1454811|P2|STARTED|Overall Study|859 patients could not be assigned to a cohort and are therefore missing in the participant flow.|18735
595316|NCT00461175|1454812|P1|STARTED|Overall Study|859 patients could not be assigned to a cohort and are therefore missing in the participant flow.|43600
595317|NCT00461123|1454822|P2|NOT COMPLETED|Overall Study||6
595318|NCT00461123|1454823|P1|NOT COMPLETED|Overall Study||6
595319|NCT00461123|1454822|P2|COMPLETED|Overall Study||19
595320|NCT00461123|1454823|P1|COMPLETED|Overall Study||19
595321|NCT00461123|1454822|P2|STARTED|Overall Study||25
595322|NCT00461123|1454823|P1|STARTED|Overall Study||25
595323|NCT00461097|1454839|P2|NOT COMPLETED|Overall Study||0
595324|NCT00461097|1454840|P1|NOT COMPLETED|Overall Study||0
595325|NCT00461097|1454839|P2|COMPLETED|Overall Study|Completed: Participants who were assessed for the primary outcome measure.|15
595326|NCT00461097|1454840|P1|COMPLETED|Overall Study|Completed: Participants who were assessed for the primary outcome measure and outcome measure #6.|40
595327|NCT00461097|1454839|P2|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||0
595328|NCT00461097|1454840|P1|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||7
595329|NCT00461097|1454839|P2|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||0
595330|NCT00461097|1454840|P1|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||16
595331|NCT00461097|1454839|P2|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||1
595332|NCT00461097|1454840|P1|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||34
595333|NCT00461097|1454839|P2|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||13
595334|NCT00461097|1454840|P1|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||35
595335|NCT00461097|1454839|P2|STARTED|Overall Study||15
595336|NCT00461097|1454840|P1|STARTED|Overall Study||40
595337|NCT00461045|1454856|P1|NOT COMPLETED|Overall Study||0
595338|NCT00461045|1454856|P1|COMPLETED|Overall Study||15
595339|NCT00461045|1454856|P1|STARTED|Overall Study||15
595340|NCT00461032|1454868|P2|NOT COMPLETED|Overall Study||44
595341|NCT00461032|1454869|P1|NOT COMPLETED|Overall Study||37
595342|NCT00461032|1454868|P2|COMPLETED|Overall Study||536
595343|NCT00461032|1454869|P1|COMPLETED|Overall Study||545
595344|NCT00461032|1454868|P2|STARTED|Overall Study||580
595345|NCT00461032|1454869|P1|STARTED|Overall Study||582
595346|NCT00460993|1454883|P2|NOT COMPLETED|Phase 2 (6 Days)||0
595347|NCT00460993|1454884|P1|NOT COMPLETED|Phase 2 (6 Days)||0
595348|NCT00460993|1454883|P2|COMPLETED|Phase 2 (6 Days)||17
595349|NCT00460993|1454884|P1|COMPLETED|Phase 2 (6 Days)||14
595350|NCT00460993|1454883|P2|STARTED|Phase 2 (6 Days)||17
595351|NCT00460993|1454884|P1|STARTED|Phase 2 (6 Days)||14
595352|NCT00460993|1454883|P2|NOT COMPLETED|Phase 1 (6 Days)||0
595353|NCT00460993|1454884|P1|NOT COMPLETED|Phase 1 (6 Days)||0
595354|NCT00460993|1454883|P2|COMPLETED|Phase 1 (6 Days)||17
595355|NCT00460993|1454884|P1|COMPLETED|Phase 1 (6 Days)||14
595356|NCT00460993|1454883|P2|STARTED|Phase 1 (6 Days)||17
595357|NCT00460993|1454884|P1|STARTED|Phase 1 (6 Days)||14
595358|NCT00460811|1454895|P5|NOT COMPLETED|Overall Study||20
595359|NCT00460811|1454896|P4|NOT COMPLETED|Overall Study||18
595360|NCT00460811|1454897|P3|NOT COMPLETED|Overall Study||14
595361|NCT00460811|1454898|P2|NOT COMPLETED|Overall Study||15
595362|NCT00460811|1454899|P1|NOT COMPLETED|Overall Study||16
595363|NCT00460811|1454895|P5|COMPLETED|Overall Study||65
595364|NCT00460811|1454896|P4|COMPLETED|Overall Study||71
595365|NCT00460811|1454897|P3|COMPLETED|Overall Study||71
595366|NCT00460811|1454898|P2|COMPLETED|Overall Study||67
595367|NCT00460811|1454899|P1|COMPLETED|Overall Study||63
595368|NCT00460811|1454895|P5|STARTED|Overall Study||85
595369|NCT00460811|1454896|P4|STARTED|Overall Study||89
595370|NCT00460811|1454897|P3|STARTED|Overall Study||85
595371|NCT00460811|1454898|P2|STARTED|Overall Study||82
595372|NCT00460811|1454899|P1|STARTED|Overall Study||79
595373|NCT00460798|1454941|P1|NOT COMPLETED|Overall Study||340
595374|NCT00460798|1454941|P1|COMPLETED|Overall Study||108
595375|NCT00460798|1454941|P1|Treated|Overall Study|Subjects with complete dosing information were recorded as 'Treated'|421
595376|NCT00460798|1454941|P1|STARTED|Overall Study||448
595377|NCT00460746|1454949|P1|NOT COMPLETED|Overall Study||2
595378|NCT00460746|1454949|P1|COMPLETED|Overall Study||8
595379|NCT00460746|1454949|P1|STARTED|Overall Study||10
595380|NCT00460655|1454964|P4|NOT COMPLETED|Open-Label Phase (36 Weeks)||9
595381|NCT00460655|1454965|P3|NOT COMPLETED|Open-Label Phase (36 Weeks)||7
595382|NCT00460655|1454966|P2|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
595383|NCT00460655|1454967|P1|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
595384|NCT00460655|1454964|P4|COMPLETED|Open-Label Phase (36 Weeks)||52
595385|NCT00460655|1454965|P3|COMPLETED|Open-Label Phase (36 Weeks)||45
595386|NCT00460655|1454966|P2|COMPLETED|Open-Label Phase (36 Weeks)||0
595387|NCT00460655|1454967|P1|COMPLETED|Open-Label Phase (36 Weeks)||0
595388|NCT00460655|1454964|P4|STARTED|Open-Label Phase (36 Weeks)||61
595389|NCT00460655|1454965|P3|STARTED|Open-Label Phase (36 Weeks)||52
595390|NCT00460655|1454966|P2|STARTED|Open-Label Phase (36 Weeks)||0
595391|NCT00460655|1454967|P1|STARTED|Open-Label Phase (36 Weeks)||0
595392|NCT00460655|1454964|P4|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
595393|NCT00460655|1454965|P3|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
595394|NCT00460655|1454966|P2|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1
595395|NCT00460655|1454967|P1|NOT COMPLETED|Double-Blind Phase (12 Weeks)||6
595396|NCT00460655|1454964|P4|COMPLETED|Double-Blind Phase (12 Weeks)||0
595397|NCT00460655|1454965|P3|COMPLETED|Double-Blind Phase (12 Weeks)||0
595398|NCT00460655|1454966|P2|COMPLETED|Double-Blind Phase (12 Weeks)||61
595399|NCT00460655|1454967|P1|COMPLETED|Double-Blind Phase (12 Weeks)||52
595400|NCT00460655|1454964|P4|STARTED|Double-Blind Phase (12 Weeks)||0
595401|NCT00460655|1454965|P3|STARTED|Double-Blind Phase (12 Weeks)||0
595402|NCT00460655|1454966|P2|STARTED|Double-Blind Phase (12 Weeks)||62
595403|NCT00460655|1454967|P1|STARTED|Double-Blind Phase (12 Weeks)||58
595404|NCT00460603|1455011|P12|NOT COMPLETED|Phase 2||41
595405|NCT00460603|1455012|P11|NOT COMPLETED|Phase 2||43
595406|NCT00460603|1455013|P10|NOT COMPLETED|Phase 2||42
595407|NCT00460603|1455014|P9|NOT COMPLETED|Phase 2||0
595408|NCT00460603|1455015|P8|NOT COMPLETED|Phase 2||0
595409|NCT00460603|1455016|P7|NOT COMPLETED|Phase 2||0
595410|NCT00460603|1455017|P6|NOT COMPLETED|Phase 2||0
595411|NCT00460603|1455018|P5|NOT COMPLETED|Phase 2||0
595412|NCT00460603|1455019|P4|NOT COMPLETED|Phase 2||0
595413|NCT00460603|1455020|P3|NOT COMPLETED|Phase 2||0
595414|NCT00460603|1455021|P2|NOT COMPLETED|Phase 2||0
595415|NCT00460603|1455022|P1|NOT COMPLETED|Phase 2||0
595416|NCT00460603|1455011|P12|COMPLETED|Phase 2||0
595417|NCT00460603|1455012|P11|COMPLETED|Phase 2||0
595418|NCT00460603|1455013|P10|COMPLETED|Phase 2||0
595419|NCT00460603|1455014|P9|COMPLETED|Phase 2||0
595420|NCT00460603|1455015|P8|COMPLETED|Phase 2||0
595421|NCT00460603|1455016|P7|COMPLETED|Phase 2||0
595422|NCT00460603|1455017|P6|COMPLETED|Phase 2||0
595423|NCT00460603|1455018|P5|COMPLETED|Phase 2||0
595424|NCT00460603|1455019|P4|COMPLETED|Phase 2||0
595425|NCT00460603|1455020|P3|COMPLETED|Phase 2||0
595426|NCT00460603|1455021|P2|COMPLETED|Phase 2||0
595427|NCT00460603|1455022|P1|COMPLETED|Phase 2||0
595428|NCT00460603|1455011|P12|Treated|Phase 2||41
595429|NCT00460603|1455012|P11|Treated|Phase 2||43
595430|NCT00460603|1455013|P10|Treated|Phase 2||39
595431|NCT00460603|1455014|P9|Treated|Phase 2||0
595432|NCT00460603|1455015|P8|Treated|Phase 2||0
595433|NCT00460603|1455016|P7|Treated|Phase 2||0
595434|NCT00460603|1455017|P6|Treated|Phase 2||0
595435|NCT00460603|1455018|P5|Treated|Phase 2||0
595436|NCT00460603|1455019|P4|Treated|Phase 2||0
595437|NCT00460603|1455020|P3|Treated|Phase 2||0
595438|NCT00460603|1455021|P2|Treated|Phase 2||0
595439|NCT00460603|1455022|P1|Treated|Phase 2||0
595440|NCT00460603|1455011|P12|STARTED|Phase 2||41
595441|NCT00460603|1455012|P11|STARTED|Phase 2||43
595442|NCT00460603|1455013|P10|STARTED|Phase 2||42
595443|NCT00460603|1455014|P9|STARTED|Phase 2||0
595444|NCT00460603|1455015|P8|STARTED|Phase 2||0
595445|NCT00460603|1455016|P7|STARTED|Phase 2||0
595446|NCT00460603|1455017|P6|STARTED|Phase 2||0
595447|NCT00460603|1455018|P5|STARTED|Phase 2||0
595448|NCT00460603|1455019|P4|STARTED|Phase 2||0
595449|NCT00460603|1455020|P3|STARTED|Phase 2||0
595450|NCT00460603|1455021|P2|STARTED|Phase 2||0
595451|NCT00460603|1455022|P1|STARTED|Phase 2||0
595452|NCT00460603|1455011|P12|NOT COMPLETED|Phase 1||0
595453|NCT00460603|1455012|P11|NOT COMPLETED|Phase 1||0
595454|NCT00460603|1455013|P10|NOT COMPLETED|Phase 1||0
595455|NCT00460603|1455014|P9|NOT COMPLETED|Phase 1||18
595456|NCT00460603|1455015|P8|NOT COMPLETED|Phase 1||3
595457|NCT00460603|1455016|P7|NOT COMPLETED|Phase 1||6
595458|NCT00460603|1455017|P6|NOT COMPLETED|Phase 1||4
595459|NCT00460603|1455018|P5|NOT COMPLETED|Phase 1||6
595460|NCT00460603|1455019|P4|NOT COMPLETED|Phase 1||8
595461|NCT00460603|1455020|P3|NOT COMPLETED|Phase 1||4
595462|NCT00460603|1455021|P2|NOT COMPLETED|Phase 1||6
595463|NCT00460603|1455022|P1|NOT COMPLETED|Phase 1||6
595464|NCT00460603|1455011|P12|COMPLETED|Phase 1||0
595465|NCT00460603|1455012|P11|COMPLETED|Phase 1||0
595466|NCT00460603|1455013|P10|COMPLETED|Phase 1||0
595467|NCT00460603|1455014|P9|COMPLETED|Phase 1||0
595468|NCT00460603|1455015|P8|COMPLETED|Phase 1||0
595469|NCT00460603|1455016|P7|COMPLETED|Phase 1||0
595470|NCT00460603|1455017|P6|COMPLETED|Phase 1||0
595471|NCT00460603|1455018|P5|COMPLETED|Phase 1||0
595472|NCT00460603|1455019|P4|COMPLETED|Phase 1||0
595473|NCT00460603|1455020|P3|COMPLETED|Phase 1||0
595474|NCT00460603|1455021|P2|COMPLETED|Phase 1||0
595475|NCT00460603|1455022|P1|COMPLETED|Phase 1||0
595476|NCT00460603|1455011|P12|STARTED|Phase 1||0
595477|NCT00460603|1455012|P11|STARTED|Phase 1||0
595478|NCT00460603|1455013|P10|STARTED|Phase 1||0
595479|NCT00460603|1455014|P9|STARTED|Phase 1||18
595480|NCT00460603|1455015|P8|STARTED|Phase 1||3
595481|NCT00460603|1455016|P7|STARTED|Phase 1||6
595482|NCT00460603|1455017|P6|STARTED|Phase 1||4
595483|NCT00460603|1455018|P5|STARTED|Phase 1||6
595484|NCT00460603|1455019|P4|STARTED|Phase 1||8
595485|NCT00460603|1455020|P3|STARTED|Phase 1||4
595486|NCT00460603|1455021|P2|STARTED|Phase 1||6
595487|NCT00460603|1455022|P1|STARTED|Phase 1||6
595488|NCT00460577|1455116|P2|NOT COMPLETED|Overall Study||6
595489|NCT00460577|1455117|P1|NOT COMPLETED|Overall Study||2
595490|NCT00460577|1455116|P2|COMPLETED|Overall Study||24
595491|NCT00460577|1455117|P1|COMPLETED|Overall Study||28
595492|NCT00460577|1455116|P2|STARTED|Overall Study||30
595493|NCT00460577|1455117|P1|STARTED|Overall Study|148 patients were screened; however, 22 did not consent and 66 did not meet inclusion/exclusion.|30
595494|NCT00460564|1455135|P8|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
595495|NCT00460564|1455136|P7|NOT COMPLETED|Open-Label Phase (36 Weeks)||2
595496|NCT00460564|1455137|P6|NOT COMPLETED|Open-Label Phase (36 Weeks)||6
595497|NCT00460564|1455138|P5|NOT COMPLETED|Open-Label Phase (36 Weeks)||9
595498|NCT00460564|1455139|P4|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
595499|NCT00460564|1455140|P3|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
595500|NCT00460564|1455141|P2|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
595501|NCT00460564|1455142|P1|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
595502|NCT00460564|1455135|P8|COMPLETED|Open-Label Phase (36 Weeks)||11
595503|NCT00460564|1455136|P7|COMPLETED|Open-Label Phase (36 Weeks)||19
595504|NCT00460564|1455137|P6|COMPLETED|Open-Label Phase (36 Weeks)||19
595505|NCT00460564|1455138|P5|COMPLETED|Open-Label Phase (36 Weeks)||38
595506|NCT00460564|1455139|P4|COMPLETED|Open-Label Phase (36 Weeks)||0
595507|NCT00460564|1455140|P3|COMPLETED|Open-Label Phase (36 Weeks)||0
595508|NCT00460564|1455141|P2|COMPLETED|Open-Label Phase (36 Weeks)||0
595509|NCT00460564|1455142|P1|COMPLETED|Open-Label Phase (36 Weeks)||0
595510|NCT00460564|1455135|P8|STARTED|Open-Label Phase (36 Weeks)||11
595511|NCT00460564|1455136|P7|STARTED|Open-Label Phase (36 Weeks)||21
595512|NCT00460564|1455137|P6|STARTED|Open-Label Phase (36 Weeks)||25
595513|NCT00460564|1455138|P5|STARTED|Open-Label Phase (36 Weeks)||47
595514|NCT00460564|1455139|P4|STARTED|Open-Label Phase (36 Weeks)||0
595515|NCT00460564|1455140|P3|STARTED|Open-Label Phase (36 Weeks)||0
595516|NCT00460564|1455141|P2|STARTED|Open-Label Phase (36 Weeks)||0
595517|NCT00460564|1455142|P1|STARTED|Open-Label Phase (36 Weeks)||0
595518|NCT00460564|1455135|P8|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
595519|NCT00460564|1455136|P7|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
595520|NCT00460564|1455137|P6|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
595521|NCT00460564|1455138|P5|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
595522|NCT00460564|1455139|P4|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
595523|NCT00460564|1455140|P3|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
595524|NCT00460564|1455141|P2|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1
595525|NCT00460564|1455142|P1|NOT COMPLETED|Double-Blind Phase (12 Weeks)||4
595526|NCT00460564|1455135|P8|COMPLETED|Double-Blind Phase (12 Weeks)||0
595527|NCT00460564|1455136|P7|COMPLETED|Double-Blind Phase (12 Weeks)||0
595528|NCT00460564|1455137|P6|COMPLETED|Double-Blind Phase (12 Weeks)||0
595529|NCT00460564|1455138|P5|COMPLETED|Double-Blind Phase (12 Weeks)||0
595530|NCT00460564|1455139|P4|COMPLETED|Double-Blind Phase (12 Weeks)||11
595531|NCT00460564|1455140|P3|COMPLETED|Double-Blind Phase (12 Weeks)||21
595532|NCT00460564|1455141|P2|COMPLETED|Double-Blind Phase (12 Weeks)||25
595533|NCT00460564|1455142|P1|COMPLETED|Double-Blind Phase (12 Weeks)||47
595534|NCT00460564|1455135|P8|STARTED|Double-Blind Phase (12 Weeks)||0
595535|NCT00460564|1455136|P7|STARTED|Double-Blind Phase (12 Weeks)||0
595536|NCT00460564|1455137|P6|STARTED|Double-Blind Phase (12 Weeks)||0
595537|NCT00460564|1455138|P5|STARTED|Double-Blind Phase (12 Weeks)||0
595538|NCT00460564|1455139|P4|STARTED|Double-Blind Phase (12 Weeks)||11
595539|NCT00460564|1455140|P3|STARTED|Double-Blind Phase (12 Weeks)||21
595540|NCT00460564|1455141|P2|STARTED|Double-Blind Phase (12 Weeks)||26
595541|NCT00460564|1455142|P1|STARTED|Double-Blind Phase (12 Weeks)||51
595542|NCT00460551|1455236|P1|NOT COMPLETED|Overall Study||0
595543|NCT00460551|1455236|P1|COMPLETED|Overall Study|The trial was terminated after Period 1A. Only safety was measured.|13
595544|NCT00460551|1455236|P1|STARTED|Overall Study||13
595545|NCT00460525|1455243|P2|NOT COMPLETED|Overall Study||5
595546|NCT00460525|1455244|P1|NOT COMPLETED|Overall Study||11
595547|NCT00460525|1455243|P2|COMPLETED|Overall Study||194
595548|NCT00460525|1455244|P1|COMPLETED|Overall Study||190
595549|NCT00460525|1455243|P2|STARTED|Overall Study||199
595550|NCT00460525|1455244|P1|STARTED|Overall Study||201
595551|NCT00460434|1455286|P2|NOT COMPLETED|Overall Study||7
595552|NCT00460434|1455287|P1|NOT COMPLETED|Overall Study||3
595553|NCT00460434|1455286|P2|COMPLETED|Overall Study||165
595554|NCT00460434|1455287|P1|COMPLETED|Overall Study||162
595555|NCT00460434|1455286|P2|12 Months|Overall Study||165
595556|NCT00460434|1455287|P1|12 Months|Overall Study||162
595557|NCT00460434|1455286|P2|3 Months|Overall Study||171
595558|NCT00460434|1455287|P1|3 Months|Overall Study||163
595559|NCT00460434|1455286|P2|STARTED|Overall Study||172
595560|NCT00460434|1455287|P1|STARTED|Overall Study||165
595561|NCT00460421|1455316|P3|NOT COMPLETED|Overall Study||0
595562|NCT00460421|1455317|P2|NOT COMPLETED|Overall Study||0
595563|NCT00460421|1455318|P1|NOT COMPLETED|Overall Study||0
595564|NCT00460421|1455316|P3|COMPLETED|Overall Study||9
595565|NCT00460421|1455317|P2|COMPLETED|Overall Study||9
595566|NCT00460421|1455318|P1|COMPLETED|Overall Study||9
595567|NCT00460421|1455316|P3|STARTED|Overall Study||9
595568|NCT00460421|1455317|P2|STARTED|Overall Study||9
595569|NCT00460421|1455318|P1|STARTED|Overall Study||9
595570|NCT00460408|1455366|P4|NOT COMPLETED|Overall Study||0
595571|NCT00460408|1455367|P3|NOT COMPLETED|Overall Study||6
595572|NCT00460408|1455368|P2|NOT COMPLETED|Overall Study||3
595573|NCT00460408|1455369|P1|NOT COMPLETED|Overall Study||67
595574|NCT00460408|1455366|P4|COMPLETED|Overall Study||7
595575|NCT00460408|1455367|P3|COMPLETED|Overall Study||69
595576|NCT00460408|1455368|P2|COMPLETED|Overall Study||13
595577|NCT00460408|1455369|P1|COMPLETED|Overall Study||336
595578|NCT00460408|1455366|P4|STARTED|Overall Study||7
595579|NCT00460408|1455367|P3|STARTED|Overall Study||75
595580|NCT00460408|1455368|P2|STARTED|Overall Study||16
595581|NCT00460408|1455369|P1|STARTED|Overall Study||403
595582|NCT00460265|1455406|P2|NOT COMPLETED|Overall Study||89
595583|NCT00460265|1455407|P1|NOT COMPLETED|Overall Study||85
595584|NCT00460265|1455406|P2|COMPLETED|Overall Study|Completed study=death|241
595585|NCT00460265|1455407|P1|COMPLETED|Overall Study|Completed study=death|243
595586|NCT00460265|1455406|P2|Received Study Medication|Overall Study||325
595587|NCT00460265|1455407|P1|Received Study Medication|Overall Study||325
595588|NCT00460265|1455406|P2|Randomized While Alive|Overall Study||330
595589|NCT00460265|1455407|P1|Randomized While Alive|Overall Study|1 subject was randomized by error after death|327
595590|NCT00460265|1455406|P2|STARTED|Overall Study||330
595591|NCT00460265|1455407|P1|STARTED|Overall Study||328
595592|NCT00460239|1455423|P9|NOT COMPLETED|Overall Study||0
595593|NCT00460239|1455424|P8|NOT COMPLETED|Overall Study||0
595594|NCT00460239|1455425|P7|NOT COMPLETED|Overall Study||0
595595|NCT00460239|1455426|P6|NOT COMPLETED|Overall Study||3
595596|NCT00460239|1455427|P5|NOT COMPLETED|Overall Study||0
595597|NCT00460239|1455428|P4|NOT COMPLETED|Overall Study||0
595598|NCT00460239|1455429|P3|NOT COMPLETED|Overall Study||0
595599|NCT00460239|1455430|P2|NOT COMPLETED|Overall Study||1
595600|NCT00460239|1455431|P1|NOT COMPLETED|Overall Study||0
595601|NCT00460239|1455423|P9|COMPLETED|Overall Study||1
595602|NCT00460239|1455424|P8|COMPLETED|Overall Study||1
595603|NCT00460239|1455425|P7|COMPLETED|Overall Study||1
595604|NCT00460239|1455426|P6|COMPLETED|Overall Study||1
595605|NCT00460239|1455427|P5|COMPLETED|Overall Study||1
595606|NCT00460239|1455428|P4|COMPLETED|Overall Study||0
595607|NCT00460239|1455429|P3|COMPLETED|Overall Study||1
595608|NCT00460239|1455430|P2|COMPLETED|Overall Study||2
595609|NCT00460239|1455431|P1|COMPLETED|Overall Study||0
595610|NCT00460239|1455423|P9|STARTED|Overall Study||1
595611|NCT00460239|1455424|P8|STARTED|Overall Study||1
595612|NCT00460239|1455425|P7|STARTED|Overall Study||1
595613|NCT00460239|1455426|P6|STARTED|Overall Study||4
595614|NCT00460239|1455427|P5|STARTED|Overall Study||1
595615|NCT00460239|1455428|P4|STARTED|Overall Study||0
595616|NCT00460239|1455429|P3|STARTED|Overall Study||1
595617|NCT00460239|1455430|P2|STARTED|Overall Study||3
595618|NCT00460239|1455431|P1|STARTED|Overall Study||0
595619|NCT00460109|1455500|P1|NOT COMPLETED|Overall Study||1
595620|NCT00460109|1455500|P1|COMPLETED|Overall Study||23
595621|NCT00460109|1455500|P1|STARTED|Overall Study||24
595622|NCT00460031|1455508|P1|NOT COMPLETED|Overall Study||11
595623|NCT00460031|1455508|P1|COMPLETED|Overall Study||23
595624|NCT00460031|1455508|P1|STARTED|Overall Study||34
595625|NCT00459979|1455516|P1|NOT COMPLETED|Overall Study||2
595626|NCT00459979|1455516|P1|COMPLETED|Overall Study||28
595627|NCT00459979|1455516|P1|STARTED|Overall Study||30
595628|NCT00459953|1455528|P2|NOT COMPLETED|Overall Study||1
595629|NCT00459953|1455529|P1|NOT COMPLETED|Overall Study||1
595630|NCT00459953|1455528|P2|COMPLETED|Overall Study||70
595631|NCT00459953|1455529|P1|COMPLETED|Overall Study||71
595632|NCT00459953|1455528|P2|STARTED|Overall Study||71
595633|NCT00459953|1455529|P1|STARTED|Overall Study||72
595634|NCT00459875|1455535|P1|NOT COMPLETED|Overall Study||3
595635|NCT00459875|1455535|P1|COMPLETED|Overall Study||21
595636|NCT00459875|1455535|P1|STARTED|Overall Study||24
595637|NCT00459862|1455539|P1|NOT COMPLETED|Overall Study||0
595638|NCT00459862|1455539|P1|COMPLETED|Overall Study||34
595639|NCT00459862|1455539|P1|STARTED|Overall Study||34
595640|NCT00459810|1455548|P1|NOT COMPLETED|Overall Study||0
595641|NCT00459810|1455548|P1|COMPLETED|Overall Study||21
595642|NCT00459810|1455548|P1|STARTED|Overall Study||21
595643|NCT00459732|1455558|P2|NOT COMPLETED|Overall Study||3
595644|NCT00459732|1455559|P1|NOT COMPLETED|Overall Study||4
595645|NCT00459732|1455558|P2|COMPLETED|Overall Study|3 on placebo dropped: 1 pregnant after 12 mo, 1 lost to followup, one died after 12 month timepoint|14
595646|NCT00459732|1455559|P1|COMPLETED|Overall Study|4 on zn dropped: 1 pregnant and 1 nausea after baseline, 1 lost to followup, 1 exited after 12 month|19
595647|NCT00459732|1455558|P2|STARTED|Overall Study||17
595648|NCT00459732|1455559|P1|STARTED|Overall Study||23
595649|NCT00459706|1455571|P2|NOT COMPLETED|Overall Study||21
595650|NCT00459706|1455572|P1|NOT COMPLETED|Overall Study||26
595651|NCT00459706|1455571|P2|COMPLETED|Overall Study||294
595652|NCT00459706|1455572|P1|COMPLETED|Overall Study||299
595653|NCT00459706|1455571|P2|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study|2 participants withdrew consent before the first injection|313
595654|NCT00459706|1455572|P1|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study|1 participant had no evaluation after the first injection|324
595655|NCT00459706|1455571|P2|STARTED|Overall Study||315
595656|NCT00459706|1455572|P1|STARTED|Overall Study||325
595657|NCT00459667|1455715|P3|NOT COMPLETED|Overall Study||20
595658|NCT00459667|1455716|P2|NOT COMPLETED|Overall Study||47
595659|NCT00459667|1455717|P1|NOT COMPLETED|Overall Study||38
595660|NCT00459667|1455715|P3|COMPLETED|Overall Study||161
595661|NCT00459667|1455716|P2|COMPLETED|Overall Study||600
595662|NCT00459667|1455717|P1|COMPLETED|Overall Study||554
595663|NCT00459667|1455715|P3|Started Treatment|Overall Study||180
595664|NCT00459667|1455716|P2|Started Treatment|Overall Study||644
595665|NCT00459667|1455717|P1|Started Treatment|Overall Study||586
595666|NCT00459667|1455715|P3|Study Medication Dispensed|Overall Study||180
595667|NCT00459667|1455716|P2|Study Medication Dispensed|Overall Study||645
595668|NCT00459667|1455717|P1|Study Medication Dispensed|Overall Study||586
595669|NCT00459667|1455715|P3|STARTED|Overall Study||181
595670|NCT00459667|1455716|P2|STARTED|Overall Study||647
595671|NCT00459667|1455717|P1|STARTED|Overall Study||592
595672|NCT00459537|1455739|P2|NOT COMPLETED|Overall Study||76
595673|NCT00459537|1455740|P1|NOT COMPLETED|Overall Study||66
595674|NCT00459537|1455739|P2|COMPLETED|Overall Study||446
595675|NCT00459537|1455740|P1|COMPLETED|Overall Study||441
595676|NCT00459537|1455739|P2|Safety Population|Overall Study||512
595677|NCT00459537|1455740|P1|Safety Population|Overall Study|Participants who had at least one dose of study drug and one post-baseline safety assessment.|493
595678|NCT00459537|1455739|P2|STARTED|Overall Study||522
595679|NCT00459537|1455740|P1|STARTED|Overall Study||507
595680|NCT00459381|1455754|P1|NOT COMPLETED|Overall Study||0
595681|NCT00459381|1455754|P1|COMPLETED|Overall Study||35
595682|NCT00459381|1455754|P1|STARTED|Overall Study||35
595683|NCT00459368|1455766|P2|NOT COMPLETED|Overall Study||329
595684|NCT00459368|1455767|P1|NOT COMPLETED|Overall Study||295
595685|NCT00459368|1455766|P2|COMPLETED|Overall Study||1034
595686|NCT00459368|1455767|P1|COMPLETED|Overall Study||1040
595687|NCT00459368|1455766|P2|STARTED|Overall Study||1363
595688|NCT00459368|1455767|P1|STARTED|Overall Study||1335
595689|NCT00459355|1455775|P2|NOT COMPLETED|Overall Study||18
595690|NCT00459355|1455776|P1|NOT COMPLETED|Overall Study||20
595691|NCT00459355|1455775|P2|COMPLETED|Overall Study|Includes 48 dyads, caregiver + care-recipient|96
595692|NCT00459355|1455776|P1|COMPLETED|Overall Study|Includes 60 dyads, caregiver + care-recipient|120
595693|NCT00459355|1455775|P2|STARTED|Overall Study|Includes 57 dyads, caregiver + care-recipient|114
595694|NCT00459355|1455776|P1|STARTED|Overall Study|Includes 70 dyads, caregiver/care-recipient|140
595695|NCT00459342|1455788|P1|NOT COMPLETED|Overall Study||1
595696|NCT00459342|1455788|P1|COMPLETED|Overall Study||34
595697|NCT00459342|1455788|P1|STARTED|Overall Study||35
595698|NCT00459316|1455797|P3|NOT COMPLETED|Step 3||1
595699|NCT00459316|1455798|P2|NOT COMPLETED|Step 3||0
595700|NCT00459316|1455799|P1|NOT COMPLETED|Step 3||3
595701|NCT00459316|1455797|P3|COMPLETED|Step 3||39
595702|NCT00459316|1455798|P2|COMPLETED|Step 3||0
595703|NCT00459316|1455799|P1|COMPLETED|Step 3||149
595704|NCT00459316|1455797|P3|STARTED|Step 3|Not all participants from Steps 1/2 were eligible for Step 3|40
595705|NCT00459316|1455798|P2|STARTED|Step 3|Group 2 participants were not eligible for Step 3|0
595706|NCT00459316|1455799|P1|STARTED|Step 3|Not all participants from Steps 1/2 were eligible for Step 3|152
595707|NCT00459316|1455797|P3|NOT COMPLETED|Steps 1 & 2||2
595708|NCT00459316|1455798|P2|NOT COMPLETED|Steps 1 & 2||7
595709|NCT00459316|1455799|P1|NOT COMPLETED|Steps 1 & 2||21
595710|NCT00459316|1455797|P3|COMPLETED|Steps 1 & 2||57
595711|NCT00459316|1455798|P2|COMPLETED|Steps 1 & 2||32
595712|NCT00459316|1455799|P1|COMPLETED|Steps 1 & 2||259
595713|NCT00459316|1455797|P3|STARTED|Steps 1 & 2||59
595714|NCT00459316|1455798|P2|STARTED|Steps 1 & 2||39
595715|NCT00459316|1455799|P1|STARTED|Steps 1 & 2||280
595716|NCT00459303|1455853|P1|NOT COMPLETED|Overall Study||0
595717|NCT00459303|1455853|P1|COMPLETED|Overall Study||20
595718|NCT00459303|1455853|P1|STARTED|Overall Study||20
595719|NCT00459290|1455864|P1|NOT COMPLETED|Overall Study||5
595720|NCT00459290|1455864|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|19
595721|NCT00459290|1455864|P1|STARTED|Overall Study||24
595722|NCT00459186|1455879|P1|NOT COMPLETED|Combination RAD001 + Docetaxel||0
595723|NCT00459186|1455879|P1|COMPLETED|Combination RAD001 + Docetaxel||15
595724|NCT00459186|1455879|P1|STARTED|Combination RAD001 + Docetaxel||15
595725|NCT00459186|1455879|P1|NOT COMPLETED|PET Imaging and Assessment||3
595726|NCT00459186|1455879|P1|COMPLETED|PET Imaging and Assessment||15
595727|NCT00459186|1455879|P1|STARTED|PET Imaging and Assessment||18
595728|NCT00459186|1455879|P1|NOT COMPLETED|Single Agent RAD001||1
595729|NCT00459186|1455879|P1|COMPLETED|Single Agent RAD001||18
595730|NCT00459186|1455879|P1|STARTED|Single Agent RAD001||19
595731|NCT00459134|1455886|P2|NOT COMPLETED|Overall Study||25
595732|NCT00459134|1455887|P1|NOT COMPLETED|Overall Study||23
595733|NCT00459134|1455886|P2|COMPLETED|Overall Study||67
595734|NCT00459134|1455887|P1|COMPLETED|Overall Study||71
595735|NCT00459134|1455886|P2|STARTED|Overall Study||92
595736|NCT00459134|1455887|P1|STARTED|Overall Study||94
595737|NCT00459121|1455895|P1|NOT COMPLETED|Overall Study||0
595738|NCT00459121|1455895|P1|COMPLETED|Overall Study||2
595739|NCT00459121|1455895|P1|STARTED|Overall Study||2
595740|NCT00459108|1455899|P1|NOT COMPLETED|Overall Study||11
595741|NCT00459108|1455899|P1|COMPLETED|Overall Study||14
595742|NCT00459108|1455899|P1|STARTED|Overall Study||25
595743|NCT00459056|1455909|P2|NOT COMPLETED|Second Intervention (Final Three Months)||0
595744|NCT00459056|1455910|P1|NOT COMPLETED|Second Intervention (Final Three Months)||0
595745|NCT00459056|1455909|P2|COMPLETED|Second Intervention (Final Three Months)||14
595746|NCT00459056|1455910|P1|COMPLETED|Second Intervention (Final Three Months)||9
595747|NCT00459056|1455909|P2|STARTED|Second Intervention (Final Three Months)||14
595748|NCT00459056|1455910|P1|STARTED|Second Intervention (Final Three Months)||9
595749|NCT00459056|1455909|P2|NOT COMPLETED|Washout (1 Month)||0
595750|NCT00459056|1455910|P1|NOT COMPLETED|Washout (1 Month)||0
595751|NCT00459056|1455909|P2|COMPLETED|Washout (1 Month)||14
595752|NCT00459056|1455910|P1|COMPLETED|Washout (1 Month)||9
595753|NCT00459056|1455909|P2|STARTED|Washout (1 Month)||14
595754|NCT00459056|1455910|P1|STARTED|Washout (1 Month)||9
595755|NCT00459056|1455909|P2|NOT COMPLETED|First Intervention (First Three Months)||1
595756|NCT00459056|1455910|P1|NOT COMPLETED|First Intervention (First Three Months)||1
595757|NCT00459056|1455909|P2|COMPLETED|First Intervention (First Three Months)||14
595758|NCT00459056|1455910|P1|COMPLETED|First Intervention (First Three Months)||9
595759|NCT00459056|1455909|P2|STARTED|First Intervention (First Three Months)||15
595760|NCT00459056|1455910|P1|STARTED|First Intervention (First Three Months)||10
595761|NCT00459043|1455918|P2|NOT COMPLETED|Overall Study||0
595762|NCT00459043|1455919|P1|NOT COMPLETED|Overall Study||1
595763|NCT00459043|1455918|P2|COMPLETED|Overall Study||15
595764|NCT00459043|1455919|P1|COMPLETED|Overall Study||14
595765|NCT00459043|1455918|P2|STARTED|Overall Study||15
595766|NCT00459043|1455919|P1|STARTED|Overall Study||15
595767|NCT00458952|1455931|P2|NOT COMPLETED|Overall Study||5
595768|NCT00458952|1455932|P1|NOT COMPLETED|Overall Study||2
595769|NCT00458952|1455931|P2|COMPLETED|Overall Study||9
595770|NCT00458952|1455932|P1|COMPLETED|Overall Study||5
595771|NCT00458952|1455931|P2|STARTED|Overall Study||14
595772|NCT00458952|1455932|P1|STARTED|Overall Study||7
595773|NCT00458822|1455936|P1|NOT COMPLETED|Overall Study||0
595774|NCT00458822|1455936|P1|COMPLETED|Overall Study||40
595775|NCT00458822|1455936|P1|STARTED|Overall Study||40
595776|NCT00458705|1455940|P1|NOT COMPLETED|Overall Study||5
595777|NCT00458705|1455940|P1|COMPLETED|Overall Study||40
595778|NCT00458705|1455940|P1|STARTED|Overall Study||45
595779|NCT00458536|1455944|P1|NOT COMPLETED|Overall Study||19
595780|NCT00458536|1455944|P1|COMPLETED|Overall Study||19
595781|NCT00458536|1455944|P1|STARTED|Overall Study||38
595782|NCT00458406|1455950|P2|NOT COMPLETED|Month 3||0
595783|NCT00458406|1455951|P1|NOT COMPLETED|Month 3||0
595784|NCT00458406|1455950|P2|COMPLETED|Month 3||13
595785|NCT00458406|1455951|P1|COMPLETED|Month 3||43
595786|NCT00458406|1455950|P2|STARTED|Month 3||13
595787|NCT00458406|1455951|P1|STARTED|Month 3||43
595788|NCT00458406|1455950|P2|NOT COMPLETED|Month 1||0
595789|NCT00458406|1455951|P1|NOT COMPLETED|Month 1||0
595790|NCT00458406|1455950|P2|COMPLETED|Month 1||13
595791|NCT00458406|1455951|P1|COMPLETED|Month 1||43
595792|NCT00458406|1455950|P2|STARTED|Month 1||13
595793|NCT00458406|1455951|P1|STARTED|Month 1||43
595794|NCT00458393|1455971|P2|NOT COMPLETED|Overall Study||295
595795|NCT00458393|1455972|P1|NOT COMPLETED|Overall Study||309
595796|NCT00458393|1455971|P2|COMPLETED|Overall Study||953
595797|NCT00458393|1455972|P1|COMPLETED|Overall Study||942
595798|NCT00458393|1455971|P2|STARTED|Overall Study||1248
595799|NCT00458393|1455972|P1|STARTED|Overall Study||1251
595800|NCT00458302|1456020|P2|NOT COMPLETED|Overall Study||24
595801|NCT00458302|1456021|P1|NOT COMPLETED|Overall Study||20
595802|NCT00458302|1456020|P2|COMPLETED|Overall Study||103
595803|NCT00458302|1456021|P1|COMPLETED|Overall Study||109
595804|NCT00458302|1456020|P2|STARTED|Overall Study||127
595805|NCT00458302|1456021|P1|STARTED|Overall Study||129
595806|NCT00458237|1456055|P3|NOT COMPLETED|Overall Study||0
595807|NCT00458237|1456056|P2|NOT COMPLETED|Overall Study||0
595808|NCT00458237|1456057|P1|NOT COMPLETED|Overall Study||0
595809|NCT00458237|1456055|P3|COMPLETED|Overall Study||5
595810|NCT00458237|1456056|P2|COMPLETED|Overall Study||3
595811|NCT00458237|1456057|P1|COMPLETED|Overall Study||3
595812|NCT00458237|1456055|P3|STARTED|Overall Study||5
595813|NCT00458237|1456056|P2|STARTED|Overall Study||3
595814|NCT00458237|1456057|P1|STARTED|Overall Study||3
595815|NCT00458211|1456066|P1|NOT COMPLETED|Overall Study||16
595816|NCT00458211|1456066|P1|COMPLETED|Overall Study|12 early termination 2 protocol violation 2 ( from Rochester) withdrawn from further analysis|24
595817|NCT00458211|1456066|P1|STARTED|Overall Study||40
595818|NCT00457977|1456079|P2|NOT COMPLETED|Overall Study||25
595819|NCT00457977|1456080|P1|NOT COMPLETED|Overall Study||28
595820|NCT00457977|1456079|P2|COMPLETED|Overall Study||66
595821|NCT00457977|1456080|P1|COMPLETED|Overall Study||62
595822|NCT00457977|1456079|P2|2-Year|Overall Study||66
595823|NCT00457977|1456080|P1|2-Year|Overall Study||62
595824|NCT00457977|1456079|P2|1-Year|Overall Study||76
595825|NCT00457977|1456080|P1|1-Year|Overall Study||69
595826|NCT00457977|1456079|P2|1-Month|Overall Study||87
595827|NCT00457977|1456080|P1|1-Month|Overall Study||88
595828|NCT00457977|1456079|P2|STARTED|Overall Study||91
595829|NCT00457977|1456080|P1|STARTED|Overall Study||90
595830|NCT00457951|1456091|P3|NOT COMPLETED|Overall Study||12
595831|NCT00457951|1456092|P2|NOT COMPLETED|Overall Study||16
595832|NCT00457951|1456093|P1|NOT COMPLETED|Overall Study||0
595833|NCT00457951|1456091|P3|COMPLETED|Overall Study||60
595834|NCT00457951|1456092|P2|COMPLETED|Overall Study||50
595835|NCT00457951|1456093|P1|COMPLETED|Overall Study||13
595836|NCT00457951|1456091|P3|STARTED|Overall Study||72
595837|NCT00457951|1456092|P2|STARTED|Overall Study||66
595838|NCT00457951|1456093|P1|STARTED|Overall Study||13
595839|NCT00457821|1456108|P8|NOT COMPLETED|Part 2||1
595840|NCT00457821|1456109|P7|NOT COMPLETED|Part 2||0
595841|NCT00457821|1456110|P6|NOT COMPLETED|Part 2||0
595842|NCT00457821|1456111|P5|NOT COMPLETED|Part 2||0
595843|NCT00457821|1456112|P4|NOT COMPLETED|Part 2||0
595844|NCT00457821|1456113|P3|NOT COMPLETED|Part 2||0
595845|NCT00457821|1456114|P2|NOT COMPLETED|Part 2||0
595846|NCT00457821|1456115|P1|NOT COMPLETED|Part 2||0
595847|NCT00457821|1456108|P8|COMPLETED|Part 2||4
595848|NCT00457821|1456109|P7|COMPLETED|Part 2||7
595849|NCT00457821|1456110|P6|COMPLETED|Part 2||8
595850|NCT00457821|1456111|P5|COMPLETED|Part 2||0
595851|NCT00457821|1456112|P4|COMPLETED|Part 2||0
595852|NCT00457821|1456113|P3|COMPLETED|Part 2||0
595853|NCT00457821|1456114|P2|COMPLETED|Part 2||0
595854|NCT00457821|1456115|P1|COMPLETED|Part 2||0
595855|NCT00457821|1456108|P8|Completed Study Drug Treatment|Part 2||4
595856|NCT00457821|1456109|P7|Completed Study Drug Treatment|Part 2|1 subject missed a 250-mg dose of ivacaftor on Day 28 of Part 2.|7
595857|NCT00457821|1456110|P6|Completed Study Drug Treatment|Part 2||8
595858|NCT00457821|1456111|P5|Completed Study Drug Treatment|Part 2||0
595859|NCT00457821|1456112|P4|Completed Study Drug Treatment|Part 2||0
595860|NCT00457821|1456113|P3|Completed Study Drug Treatment|Part 2||0
595861|NCT00457821|1456114|P2|Completed Study Drug Treatment|Part 2||0
595862|NCT00457821|1456115|P1|Completed Study Drug Treatment|Part 2||0
595863|NCT00457821|1456108|P8|STARTED|Part 2|All subjects who received at least 1 dose of study drug (placebo).|5
595864|NCT00457821|1456109|P7|STARTED|Part 2|All subjects who received at least 1 dose of study drug (ivacaftor).|7
595865|NCT00457821|1456110|P6|STARTED|Part 2|All subjects who received at least 1 dose of study drug (ivacaftor).|8
595866|NCT00457821|1456111|P5|STARTED|Part 2|Arm in Part 1 only|0
595867|NCT00457821|1456112|P4|STARTED|Part 2|Arm in Part 1 only|0
595868|NCT00457821|1456113|P3|STARTED|Part 2|Arm in Part 1 only|0
595869|NCT00457821|1456114|P2|STARTED|Part 2|Arm in Part 1 only|0
595870|NCT00457821|1456115|P1|STARTED|Part 2|Arm in Part 1 only|0
595871|NCT00457821|1456108|P8|NOT COMPLETED|Part 1||0
595872|NCT00457821|1456109|P7|NOT COMPLETED|Part 1||0
595873|NCT00457821|1456110|P6|NOT COMPLETED|Part 1||0
595874|NCT00457821|1456111|P5|NOT COMPLETED|Part 1||0
595875|NCT00457821|1456112|P4|NOT COMPLETED|Part 1||0
595876|NCT00457821|1456113|P3|NOT COMPLETED|Part 1||1
595877|NCT00457821|1456114|P2|NOT COMPLETED|Part 1||0
595878|NCT00457821|1456115|P1|NOT COMPLETED|Part 1||0
595879|NCT00457821|1456108|P8|COMPLETED|Part 1||0
595880|NCT00457821|1456109|P7|COMPLETED|Part 1||0
595881|NCT00457821|1456110|P6|COMPLETED|Part 1||0
595882|NCT00457821|1456111|P5|COMPLETED|Part 1||4
595883|NCT00457821|1456112|P4|COMPLETED|Part 1||4
595884|NCT00457821|1456113|P3|COMPLETED|Part 1||4
595885|NCT00457821|1456114|P2|COMPLETED|Part 1||4
595886|NCT00457821|1456115|P1|COMPLETED|Part 1||4
595887|NCT00457821|1456108|P8|STARTED|Part 1|Arm in Part 2 only|0
595888|NCT00457821|1456109|P7|STARTED|Part 1|Arm in Part 2 only|0
595889|NCT00457821|1456110|P6|STARTED|Part 1|Arm in Part 2 only|0
595890|NCT00457821|1456111|P5|STARTED|Part 1|Number of subjects randomized|4
595891|NCT00457821|1456112|P4|STARTED|Part 1|Number of subjects randomized|4
595892|NCT00457821|1456113|P3|STARTED|Part 1|Number of subjects randomized|5
595893|NCT00457821|1456114|P2|STARTED|Part 1|Number of subjects randomized|4
595894|NCT00457821|1456115|P1|STARTED|Part 1|Number of subjects randomized|4
595895|NCT00457795|1456144|P1|NOT COMPLETED|Overall Study||0
595896|NCT00457795|1456144|P1|COMPLETED|Overall Study||15
595897|NCT00457795|1456144|P1|STARTED|Overall Study||15
595898|NCT00457743|1456154|P3|NOT COMPLETED|Overall Study||3
595899|NCT00457743|1456155|P2|NOT COMPLETED|Overall Study||27
595900|NCT00457743|1456156|P1|NOT COMPLETED|Overall Study||3
595901|NCT00457743|1456154|P3|COMPLETED|Overall Study|However, all 3 subjects enrolled were included in analysis(Intent-to treat population).|0
595902|NCT00457743|1456155|P2|COMPLETED|Overall Study|However, all 30 subjects enrolled were included in analysis(Intent-to treat population).|3
595903|NCT00457743|1456156|P1|COMPLETED|Overall Study|However, all 3 subjects enrolled were included in analysis (Intent-to treat population).|0
595904|NCT00457743|1456154|P3|Enrolled in Phase 2|Overall Study|Three subjects who completed Phase 1 entered Phase 2.|3
595905|NCT00457743|1456155|P2|Enrolled in Phase 2|Overall Study|Six subjects who completed Phase 1 entered Phase 2, and 24 subjects were newly enrolled.|30
595906|NCT00457743|1456156|P1|Enrolled in Phase 2|Overall Study|Three subjects who completed Phase 1 entered Phase 2.|3
595907|NCT00457743|1456154|P3|Completed Phase 1|Overall Study||3
595908|NCT00457743|1456155|P2|Completed Phase 1|Overall Study||6
595909|NCT00457743|1456156|P1|Completed Phase 1|Overall Study||3
595910|NCT00457743|1456154|P3|Enrolled in Phase 1|Overall Study||3
595911|NCT00457743|1456155|P2|Enrolled in Phase 1|Overall Study||6
595912|NCT00457743|1456156|P1|Enrolled in Phase 1|Overall Study||3
595913|NCT00457743|1456154|P3|STARTED|Overall Study|Overall study|3
595914|NCT00457743|1456155|P2|STARTED|Overall Study|Overall study|30
595915|NCT00457743|1456156|P1|STARTED|Overall Study|Overall study|3
595916|NCT00457730|1456200|P2|NOT COMPLETED|Overall Study||1
595917|NCT00457730|1456201|P1|NOT COMPLETED|Overall Study||4
595918|NCT00457730|1456200|P2|COMPLETED|Overall Study||19
595919|NCT00457730|1456201|P1|COMPLETED|Overall Study||14
595920|NCT00457730|1456200|P2|STARTED|Overall Study||20
595921|NCT00457730|1456201|P1|STARTED|Overall Study||18
595922|NCT00457691|1456213|P2|NOT COMPLETED|Overall Study||382
595923|NCT00457691|1456214|P1|NOT COMPLETED|Overall Study||386
595924|NCT00457691|1456213|P2|COMPLETED|Overall Study||0
595925|NCT00457691|1456214|P1|COMPLETED|Overall Study||0
595926|NCT00457691|1456213|P2|STARTED|Overall Study||382
595927|NCT00457691|1456214|P1|STARTED|Overall Study||386
595928|NCT00457418|1456234|P1|NOT COMPLETED|Post PK Maintenance||28
595929|NCT00457418|1456234|P1|COMPLETED|Post PK Maintenance||3
595930|NCT00457418|1456234|P1|STARTED|Post PK Maintenance|4 participants didn't complete the PK sampling phase but continued to post PK maintenance treatment.|31
595931|NCT00457418|1456234|P1|NOT COMPLETED|Pharmacokinetic (PK) Sampling Phase||5
595932|NCT00457418|1456234|P1|COMPLETED|Pharmacokinetic (PK) Sampling Phase||27
595933|NCT00457418|1456234|P1|STARTED|Pharmacokinetic (PK) Sampling Phase||32
595934|NCT00457392|1456246|P2|NOT COMPLETED|Overall Study||480
595935|NCT00457392|1456247|P1|NOT COMPLETED|Overall Study||480
595936|NCT00457392|1456246|P2|COMPLETED|Overall Study||0
595937|NCT00457392|1456247|P1|COMPLETED|Overall Study||0
595938|NCT00457392|1456246|P2|Treated|Overall Study||477
595939|NCT00457392|1456247|P1|Treated|Overall Study||473
595940|NCT00457392|1456246|P2|STARTED|Overall Study||480
595941|NCT00457392|1456247|P1|STARTED|Overall Study||480
595942|NCT00457301|1456265|P2|NOT COMPLETED|Overall Study||24
595943|NCT00457301|1456266|P1|NOT COMPLETED|Overall Study||23
595944|NCT00457301|1456265|P2|COMPLETED|Overall Study||84
595945|NCT00457301|1456266|P1|COMPLETED|Overall Study||82
595946|NCT00457301|1456265|P2|STARTED|Overall Study||108
595947|NCT00457301|1456266|P1|STARTED|Overall Study||105
595948|NCT00457249|1456280|P2|NOT COMPLETED|Overall Study||2
595949|NCT00457249|1456281|P1|NOT COMPLETED|Overall Study||12
595950|NCT00457249|1456280|P2|COMPLETED|Overall Study||389
595951|NCT00457249|1456281|P1|COMPLETED|Overall Study||1158
595952|NCT00457249|1456280|P2|STARTED|Overall Study||391
595953|NCT00457249|1456281|P1|STARTED|Overall Study||1170
595954|NCT00457197|1456295|P2|NOT COMPLETED|Overall Study||1
595955|NCT00457197|1456296|P1|NOT COMPLETED|Overall Study||1
595956|NCT00457197|1456295|P2|COMPLETED|Overall Study||44
595957|NCT00457197|1456296|P1|COMPLETED|Overall Study||44
595958|NCT00457197|1456295|P2|STARTED|Overall Study||45
595959|NCT00457197|1456296|P1|STARTED|Overall Study||45
595960|NCT00457015|1456320|P2|NOT COMPLETED|Overall Study||1
595961|NCT00457015|1456321|P1|NOT COMPLETED|Overall Study||0
595962|NCT00457015|1456320|P2|COMPLETED|Overall Study||47
595963|NCT00457015|1456321|P1|COMPLETED|Overall Study||48
595964|NCT00457015|1456320|P2|STARTED|Overall Study||48
595965|NCT00457015|1456321|P1|STARTED|Overall Study||48
595966|NCT00457002|1456337|P2|NOT COMPLETED|Overall Study||757
595967|NCT00457002|1456338|P1|NOT COMPLETED|Overall Study||813
595968|NCT00457002|1456337|P2|COMPLETED|Overall Study||2516
595969|NCT00457002|1456338|P1|COMPLETED|Overall Study||2442
595970|NCT00457002|1456337|P2|STARTED|Overall Study||3273
595971|NCT00457002|1456338|P1|STARTED|Overall Study||3255
595972|NCT00456989|1456406|P1|NOT COMPLETED|Overall Study||0
595973|NCT00456989|1456406|P1|COMPLETED|Overall Study||39
595974|NCT00456989|1456406|P1|STARTED|Overall Study||39
595975|NCT00456885|1456410|P2|NOT COMPLETED|Second Treatment Period, 16 Weeks||0
595976|NCT00456885|1456411|P1|NOT COMPLETED|Second Treatment Period, 16 Weeks||1
595977|NCT00456885|1456410|P2|COMPLETED|Second Treatment Period, 16 Weeks||17
595978|NCT00456885|1456411|P1|COMPLETED|Second Treatment Period, 16 Weeks||23
595979|NCT00456885|1456410|P2|STARTED|Second Treatment Period, 16 Weeks||17
595980|NCT00456885|1456411|P1|STARTED|Second Treatment Period, 16 Weeks||24
595981|NCT00456885|1456410|P2|NOT COMPLETED|Washout, 3 Weeks||0
595982|NCT00456885|1456411|P1|NOT COMPLETED|Washout, 3 Weeks||0
595983|NCT00456885|1456410|P2|COMPLETED|Washout, 3 Weeks||17
595984|NCT00456885|1456411|P1|COMPLETED|Washout, 3 Weeks||24
595985|NCT00456885|1456410|P2|STARTED|Washout, 3 Weeks||17
595986|NCT00456885|1456411|P1|STARTED|Washout, 3 Weeks||24
595987|NCT00456885|1456410|P2|NOT COMPLETED|First Treatment Period, 16 Weeks||0
595988|NCT00456885|1456411|P1|NOT COMPLETED|First Treatment Period, 16 Weeks||0
595989|NCT00456885|1456410|P2|COMPLETED|First Treatment Period, 16 Weeks||17
595990|NCT00456885|1456411|P1|COMPLETED|First Treatment Period, 16 Weeks||24
595991|NCT00456885|1456410|P2|STARTED|First Treatment Period, 16 Weeks||17
595992|NCT00456885|1456411|P1|STARTED|First Treatment Period, 16 Weeks||24
595993|NCT00456846|1456442|P2|NOT COMPLETED|Overall Study||28
595994|NCT00456846|1456443|P1|NOT COMPLETED|Overall Study||16
595995|NCT00456846|1456442|P2|COMPLETED|Overall Study|Treatment considered completed upon disease progression|48
595996|NCT00456846|1456443|P1|COMPLETED|Overall Study|Treatment considered completed upon disease progression|31
595997|NCT00456846|1456442|P2|STARTED|Overall Study||76
595998|NCT00456846|1456443|P1|STARTED|Overall Study||47
595999|NCT00456807|1456465|P2|NOT COMPLETED|Overall Study||0
596000|NCT00456807|1456466|P1|NOT COMPLETED|Overall Study||1
596001|NCT00456807|1456465|P2|COMPLETED|Overall Study||47
596002|NCT00456807|1456466|P1|COMPLETED|Overall Study||52
596003|NCT00456807|1456465|P2|STARTED|Overall Study||47
596004|NCT00456807|1456466|P1|STARTED|Overall Study||53
596005|NCT00456755|1456484|P2|NOT COMPLETED|Overall Study||1
596006|NCT00456755|1456485|P1|NOT COMPLETED|Overall Study||2
596007|NCT00456755|1456484|P2|COMPLETED|Overall Study||62
596008|NCT00456755|1456485|P1|COMPLETED|Overall Study||61
596009|NCT00456755|1456484|P2|STARTED|Overall Study||63
596010|NCT00456755|1456485|P1|STARTED|Overall Study||63
596011|NCT00456625|1456493|P1|NOT COMPLETED|Overall Study||0
596012|NCT00456625|1456493|P1|COMPLETED|Overall Study||76
596013|NCT00456625|1456493|P1|STARTED|Overall Study||76
596014|NCT00456612|1456499|P1|NOT COMPLETED|Overall Study||3
596015|NCT00456612|1456499|P1|COMPLETED|Overall Study||1
596016|NCT00456612|1456499|P1|STARTED|Overall Study||4
596017|NCT00456599|1456504|P1|NOT COMPLETED|Overall Study||3
596018|NCT00456599|1456504|P1|COMPLETED|Overall Study||68
596019|NCT00456599|1456504|P1|Completed 4th Cycle of Chemotherapy|Overall Study|24 patients (63%) completed a fourth cycle of chemotherapy.|24
596020|NCT00456599|1456504|P1|Post-Surgery Adjuvent Therapy|Overall Study|After resection, 26 patients (68%) initiated adjuvant therapy.|26
596021|NCT00456599|1456504|P1|Completed Resection|Overall Study|43 patients underwent resection.|43
596022|NCT00456599|1456504|P1|Completed Protocol Surgery|Overall Study|Forty-eight patients (71%) underwent laparotomy according to the protocol.|48
596023|NCT00456599|1456504|P1|Initiated Cycle 2|Overall Study|5 patients were removed from study prior to initiation of a second cycle.|61
596024|NCT00456599|1456504|P1|Completed Cycle 1|Overall Study|Of the 71 patients, 1 was removed for noncompliance; 2 withdrew; 2 did not complete cycle 1.|66
596025|NCT00456599|1456504|P1|STARTED|Overall Study||71
596026|NCT00456547|1456512|P2|NOT COMPLETED|Overall Study||0
596027|NCT00456547|1456513|P1|NOT COMPLETED|Overall Study||0
596028|NCT00456547|1456512|P2|COMPLETED|Overall Study||12
596029|NCT00456547|1456513|P1|COMPLETED|Overall Study||12
596030|NCT00456547|1456512|P2|STARTED|Overall Study||12
596031|NCT00456547|1456513|P1|STARTED|Overall Study||12
596032|NCT00456521|1456527|P2|NOT COMPLETED|Overall Study||84
596033|NCT00456521|1456528|P1|NOT COMPLETED|Overall Study||249
596034|NCT00456521|1456527|P2|COMPLETED|Overall Study||118
596035|NCT00456521|1456528|P1|COMPLETED|Overall Study||342
596036|NCT00456521|1456527|P2|STARTED|Overall Study||202
596037|NCT00456521|1456528|P1|STARTED|Overall Study||591
596038|NCT00456508|1456568|P1|NOT COMPLETED|Overall Study||0
596039|NCT00456508|1456568|P1|COMPLETED|Overall Study||147
596040|NCT00456508|1456568|P1|STARTED|Overall Study||147
596041|NCT00456495|1456574|P1|NOT COMPLETED|Overall Study||2
596042|NCT00456495|1456574|P1|COMPLETED|Overall Study||3
596043|NCT00456495|1456574|P1|STARTED|Overall Study||5
596044|NCT00456365|1456581|P2|NOT COMPLETED|Overall Study||12
596045|NCT00456365|1456582|P1|NOT COMPLETED|Overall Study||7
596046|NCT00456365|1456581|P2|COMPLETED|Overall Study||42
596047|NCT00456365|1456582|P1|COMPLETED|Overall Study||49
596048|NCT00456365|1456581|P2|STARTED|Overall Study||54
596049|NCT00456365|1456582|P1|STARTED|Overall Study||56
596050|NCT00456261|1456596|P2|NOT COMPLETED|Maintenance Therapy||0
596051|NCT00456261|1456597|P1|NOT COMPLETED|Maintenance Therapy||0
596052|NCT00456261|1456596|P2|COMPLETED|Maintenance Therapy||29
596053|NCT00456261|1456597|P1|COMPLETED|Maintenance Therapy||3
596054|NCT00456261|1456596|P2|STARTED|Maintenance Therapy||29
596055|NCT00456261|1456597|P1|STARTED|Maintenance Therapy||3
596056|NCT00456261|1456596|P2|NOT COMPLETED|Combination Therapy||26
596057|NCT00456261|1456597|P1|NOT COMPLETED|Combination Therapy||52
596058|NCT00456261|1456596|P2|COMPLETED|Combination Therapy||29
596059|NCT00456261|1456597|P1|COMPLETED|Combination Therapy||3
596060|NCT00456261|1456596|P2|STARTED|Combination Therapy||55
596061|NCT00456261|1456597|P1|STARTED|Combination Therapy||55
596062|NCT00456014|1456607|P1|NOT COMPLETED|Tricyclic Phase||3
596063|NCT00456014|1456607|P1|COMPLETED|Tricyclic Phase||1
596064|NCT00456014|1456607|P1|STARTED|Tricyclic Phase|Only non-remitters from phase 1 were eligible for phase 2, and not all those eligible continued.|4
596065|NCT00456014|1456607|P1|NOT COMPLETED|SSRI Phase||9
596066|NCT00456014|1456607|P1|COMPLETED|SSRI Phase||28
596067|NCT00456014|1456607|P1|STARTED|SSRI Phase||37
596068|NCT00455975|1456615|P2|NOT COMPLETED|Overall Study||21
596069|NCT00455975|1456616|P1|NOT COMPLETED|Overall Study||18
596070|NCT00455975|1456615|P2|COMPLETED|Overall Study||40
596071|NCT00455975|1456616|P1|COMPLETED|Overall Study||40
596072|NCT00455975|1456615|P2|STARTED|Overall Study||61
596073|NCT00455975|1456616|P1|STARTED|Overall Study||58
596074|NCT00455962|1456630|P2|NOT COMPLETED|Overall Study||0
596075|NCT00455962|1456631|P1|NOT COMPLETED|Overall Study||0
596076|NCT00455962|1456630|P2|COMPLETED|Overall Study||13
596077|NCT00455962|1456631|P1|COMPLETED|Overall Study||10
596078|NCT00455962|1456630|P2|STARTED|Overall Study||13
596079|NCT00455962|1456631|P1|STARTED|Overall Study||10
596080|NCT00455923|1456639|P2|NOT COMPLETED|Overall Study||3
596081|NCT00455923|1456640|P1|NOT COMPLETED|Overall Study||3
596082|NCT00455923|1456639|P2|COMPLETED|Overall Study||47
596083|NCT00455923|1456640|P1|COMPLETED|Overall Study||47
596084|NCT00455923|1456639|P2|STARTED|Overall Study||50
596085|NCT00455923|1456640|P1|STARTED|Overall Study||50
596086|NCT00455858|1456656|P1|NOT COMPLETED|Overall Study||6
596087|NCT00455858|1456656|P1|COMPLETED|Overall Study||81
596088|NCT00455858|1456656|P1|STARTED|Overall Study|Enrolled in study and exposed to study drug|87
596089|NCT00455741|1456666|P2|NOT COMPLETED|Overall Study||1
596090|NCT00455741|1456667|P1|NOT COMPLETED|Overall Study||0
596091|NCT00455741|1456666|P2|COMPLETED|Overall Study||11
596092|NCT00455741|1456667|P1|COMPLETED|Overall Study||13
596093|NCT00455741|1456666|P2|STARTED|Overall Study||12
596094|NCT00455741|1456667|P1|STARTED|Overall Study||13
596095|NCT00455702|1456685|P2|NOT COMPLETED|Overall Study||3
596096|NCT00455702|1456686|P1|NOT COMPLETED|Overall Study||3
596097|NCT00455702|1456685|P2|COMPLETED|Overall Study||16
596098|NCT00455702|1456686|P1|COMPLETED|Overall Study||16
596099|NCT00455702|1456685|P2|STARTED|Overall Study||19
596100|NCT00455702|1456686|P1|STARTED|Overall Study||19
596101|NCT00455663|1456697|P3|NOT COMPLETED|Overall Study||3
596102|NCT00455663|1456698|P2|NOT COMPLETED|Overall Study||4
596103|NCT00455663|1456699|P1|NOT COMPLETED|Overall Study||3
596104|NCT00455663|1456697|P3|COMPLETED|Overall Study||29
596105|NCT00455663|1456698|P2|COMPLETED|Overall Study||32
596106|NCT00455663|1456699|P1|COMPLETED|Overall Study||34
596107|NCT00455663|1456697|P3|STARTED|Overall Study||32
596108|NCT00455663|1456698|P2|STARTED|Overall Study||36
596109|NCT00455663|1456699|P1|STARTED|Overall Study||37
596110|NCT00455650|1456718|P6|NOT COMPLETED|Week 3||0
596111|NCT00455650|1456719|P5|NOT COMPLETED|Week 3||0
596112|NCT00455650|1456720|P4|NOT COMPLETED|Week 3||0
596113|NCT00455650|1456721|P3|NOT COMPLETED|Week 3||0
596114|NCT00455650|1456722|P2|NOT COMPLETED|Week 3||0
596115|NCT00455650|1456723|P1|NOT COMPLETED|Week 3||0
596116|NCT00455650|1456718|P6|COMPLETED|Week 3||13
596117|NCT00455650|1456719|P5|COMPLETED|Week 3||14
596118|NCT00455650|1456720|P4|COMPLETED|Week 3||14
596119|NCT00455650|1456721|P3|COMPLETED|Week 3||10
596120|NCT00455650|1456722|P2|COMPLETED|Week 3||10
596121|NCT00455650|1456723|P1|COMPLETED|Week 3||10
596122|NCT00455650|1456718|P6|STARTED|Week 3||13
596123|NCT00455650|1456719|P5|STARTED|Week 3||14
596124|NCT00455650|1456720|P4|STARTED|Week 3||14
596125|NCT00455650|1456721|P3|STARTED|Week 3||10
596126|NCT00455650|1456722|P2|STARTED|Week 3||10
596127|NCT00455650|1456723|P1|STARTED|Week 3||10
596128|NCT00455650|1456718|P6|NOT COMPLETED|Week 2||0
596129|NCT00455650|1456719|P5|NOT COMPLETED|Week 2||0
596130|NCT00455650|1456720|P4|NOT COMPLETED|Week 2||0
596131|NCT00455650|1456721|P3|NOT COMPLETED|Week 2||0
596132|NCT00455650|1456722|P2|NOT COMPLETED|Week 2||0
596133|NCT00455650|1456723|P1|NOT COMPLETED|Week 2||0
596134|NCT00455650|1456718|P6|COMPLETED|Week 2||13
596135|NCT00455650|1456719|P5|COMPLETED|Week 2||14
596136|NCT00455650|1456720|P4|COMPLETED|Week 2||14
596137|NCT00455650|1456721|P3|COMPLETED|Week 2||10
596138|NCT00455650|1456722|P2|COMPLETED|Week 2||10
596139|NCT00455650|1456723|P1|COMPLETED|Week 2||10
596140|NCT00455650|1456718|P6|STARTED|Week 2||13
596141|NCT00455650|1456719|P5|STARTED|Week 2||14
596142|NCT00455650|1456720|P4|STARTED|Week 2||14
596143|NCT00455650|1456721|P3|STARTED|Week 2||10
596144|NCT00455650|1456722|P2|STARTED|Week 2||10
596145|NCT00455650|1456723|P1|STARTED|Week 2||10
596146|NCT00455650|1456718|P6|NOT COMPLETED|Week 1||0
596147|NCT00455650|1456719|P5|NOT COMPLETED|Week 1||0
596148|NCT00455650|1456720|P4|NOT COMPLETED|Week 1||0
596149|NCT00455650|1456721|P3|NOT COMPLETED|Week 1||0
596150|NCT00455650|1456722|P2|NOT COMPLETED|Week 1||0
596151|NCT00455650|1456723|P1|NOT COMPLETED|Week 1||0
596152|NCT00455650|1456718|P6|COMPLETED|Week 1||13
596153|NCT00455650|1456719|P5|COMPLETED|Week 1||14
596154|NCT00455650|1456720|P4|COMPLETED|Week 1||14
596155|NCT00455650|1456721|P3|COMPLETED|Week 1||10
596156|NCT00455650|1456722|P2|COMPLETED|Week 1||10
596157|NCT00455650|1456723|P1|COMPLETED|Week 1||10
596158|NCT00455650|1456718|P6|STARTED|Week 1||13
596159|NCT00455650|1456719|P5|STARTED|Week 1||14
596160|NCT00455650|1456720|P4|STARTED|Week 1||14
596161|NCT00455650|1456721|P3|STARTED|Week 1||10
596162|NCT00455650|1456722|P2|STARTED|Week 1||10
596163|NCT00455650|1456723|P1|STARTED|Week 1||10
596164|NCT00455533|1456753|P3|NOT COMPLETED|Period Two: Randomized Period||6
596165|NCT00455533|1456754|P2|NOT COMPLETED|Period Two: Randomized Period||6
596166|NCT00455533|1456755|P1|NOT COMPLETED|Period Two: Randomized Period||0
596167|NCT00455533|1456753|P3|COMPLETED|Period Two: Randomized Period||138
596168|NCT00455533|1456754|P2|COMPLETED|Period Two: Randomized Period||139
596169|NCT00455533|1456755|P1|COMPLETED|Period Two: Randomized Period||0
596170|NCT00455533|1456753|P3|STARTED|Period Two: Randomized Period|147 randomized, 144 randomized and treated with paclitaxel|144
596171|NCT00455533|1456754|P2|STARTED|Period Two: Randomized Period|148 randomized, 145 randomized and treated with ixabepilone|145
596172|NCT00455533|1456755|P1|STARTED|Period Two: Randomized Period||0
596173|NCT00455533|1456753|P3|NOT COMPLETED|Period One: Initial Chemotherapy||0
596174|NCT00455533|1456754|P2|NOT COMPLETED|Period One: Initial Chemotherapy||0
596175|NCT00455533|1456755|P1|NOT COMPLETED|Period One: Initial Chemotherapy||18
596176|NCT00455533|1456753|P3|COMPLETED|Period One: Initial Chemotherapy||0
596177|NCT00455533|1456754|P2|COMPLETED|Period One: Initial Chemotherapy||0
596178|NCT00455533|1456755|P1|COMPLETED|Period One: Initial Chemotherapy||295
596179|NCT00455533|1456753|P3|STARTED|Period One: Initial Chemotherapy||0
596180|NCT00455533|1456754|P2|STARTED|Period One: Initial Chemotherapy||0
596181|NCT00455533|1456755|P1|STARTED|Period One: Initial Chemotherapy||313
596182|NCT00455520|1456804|P2|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||62
596183|NCT00455520|1456805|P1|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||63
596184|NCT00455520|1456804|P2|COMPLETED|Double Blind Tapentadol ER vs Placebo||131
596185|NCT00455520|1456805|P1|COMPLETED|Double Blind Tapentadol ER vs Placebo||133
596186|NCT00455520|1456804|P2|STARTED|Double Blind Tapentadol ER vs Placebo|1 subject enrolled two separate times in this study, 2 subjects did not receive study medication|193
596187|NCT00455520|1456805|P1|STARTED|Double Blind Tapentadol ER vs Placebo|2 subjects enrolled two separate times in this study, 1 subject did not receive study medication|196
596188|NCT00455520|1456804|P2|NOT COMPLETED|Open Label Tapentadol Extended Release||0
596189|NCT00455520|1456805|P1|NOT COMPLETED|Open Label Tapentadol Extended Release||196
596190|NCT00455520|1456804|P2|COMPLETED|Open Label Tapentadol Extended Release||0
596191|NCT00455520|1456805|P1|COMPLETED|Open Label Tapentadol Extended Release||395
596192|NCT00455520|1456804|P2|STARTED|Open Label Tapentadol Extended Release||0
596193|NCT00455520|1456805|P1|STARTED|Open Label Tapentadol Extended Release||591
596194|NCT00455455|1456821|P2|NOT COMPLETED|Second Intervention||0
596195|NCT00455455|1456822|P1|NOT COMPLETED|Second Intervention||0
596196|NCT00455455|1456821|P2|COMPLETED|Second Intervention||24
596197|NCT00455455|1456822|P1|COMPLETED|Second Intervention||24
596198|NCT00455455|1456821|P2|STARTED|Second Intervention||24
596199|NCT00455455|1456822|P1|STARTED|Second Intervention||24
596200|NCT00455455|1456821|P2|NOT COMPLETED|Washout||0
596201|NCT00455455|1456822|P1|NOT COMPLETED|Washout||1
596202|NCT00455455|1456821|P2|COMPLETED|Washout||24
596203|NCT00455455|1456822|P1|COMPLETED|Washout||24
596204|NCT00455455|1456821|P2|STARTED|Washout||24
596205|NCT00455455|1456822|P1|STARTED|Washout||25
596206|NCT00455455|1456821|P2|NOT COMPLETED|First Intervention||0
596207|NCT00455455|1456822|P1|NOT COMPLETED|First Intervention||0
596208|NCT00455455|1456821|P2|COMPLETED|First Intervention||24
596209|NCT00455455|1456822|P1|COMPLETED|First Intervention||25
596210|NCT00455455|1456821|P2|STARTED|First Intervention||24
596211|NCT00455455|1456822|P1|STARTED|First Intervention||25
596212|NCT00455455|1456821|P2|NOT COMPLETED|Washout||1
596213|NCT00455455|1456822|P1|NOT COMPLETED|Washout||0
596214|NCT00455455|1456821|P2|COMPLETED|Washout||24
596215|NCT00455455|1456822|P1|COMPLETED|Washout||25
596216|NCT00455455|1456821|P2|STARTED|Washout||25
596217|NCT00455455|1456822|P1|STARTED|Washout||25
596218|NCT00455429|1456842|P4|NOT COMPLETED|Overall Study||14
596219|NCT00455429|1456843|P3|NOT COMPLETED|Overall Study||1
596220|NCT00455429|1456844|P2|NOT COMPLETED|Overall Study||5
596221|NCT00455429|1456845|P1|NOT COMPLETED|Overall Study||2
596222|NCT00455429|1456842|P4|COMPLETED|Overall Study||20
596223|NCT00455429|1456843|P3|COMPLETED|Overall Study||16
596224|NCT00455429|1456844|P2|COMPLETED|Overall Study||10
596225|NCT00455429|1456845|P1|COMPLETED|Overall Study||16
596226|NCT00455429|1456842|P4|Treated|Overall Study||32
596227|NCT00455429|1456843|P3|Treated|Overall Study||17
596228|NCT00455429|1456844|P2|Treated|Overall Study||15
596229|NCT00455429|1456845|P1|Treated|Overall Study||18
596230|NCT00455429|1456842|P4|STARTED|Overall Study||34
596231|NCT00455429|1456843|P3|STARTED|Overall Study||17
596232|NCT00455429|1456844|P2|STARTED|Overall Study||15
596233|NCT00455429|1456845|P1|STARTED|Overall Study||18
596234|NCT00455312|1456904|P2|NOT COMPLETED|Overall Study||1
596235|NCT00455312|1456905|P1|NOT COMPLETED|Overall Study||0
596236|NCT00455312|1456904|P2|COMPLETED|Overall Study||20
596237|NCT00455312|1456905|P1|COMPLETED|Overall Study||15
596238|NCT00455312|1456904|P2|STARTED|Overall Study||21
596239|NCT00455312|1456905|P1|STARTED|Overall Study||15
596240|NCT00455195|1456931|P2|NOT COMPLETED|Extension Study AGLU03206||0
596241|NCT00455195|1456932|P1|NOT COMPLETED|Extension Study AGLU03206||0
596242|NCT00455195|1456931|P2|COMPLETED|Extension Study AGLU03206||26
596243|NCT00455195|1456932|P1|COMPLETED|Extension Study AGLU03206||55
596244|NCT00455195|1456931|P2|STARTED|Extension Study AGLU03206|These 26 participants completed placebo double-blind treatment in the AGLU02704 (NCT00158600) study.|26
596245|NCT00455195|1456932|P1|STARTED|Extension Study AGLU03206||55
596246|NCT00455195|1456931|P2|NOT COMPLETED|Double-blind Study AGLU02704||4
596247|NCT00455195|1456932|P1|NOT COMPLETED|Double-blind Study AGLU02704||5
596248|NCT00455195|1456931|P2|COMPLETED|Double-blind Study AGLU02704||26
596249|NCT00455195|1456932|P1|COMPLETED|Double-blind Study AGLU02704||55
596250|NCT00455195|1456931|P2|STARTED|Double-blind Study AGLU02704|See study AGLU02704 (NCT00158600) for results while on placebo.|30
596251|NCT00455195|1456932|P1|STARTED|Double-blind Study AGLU02704|Patients randomized to alglucosidase alfa treatment group in AGLU02704 (NCT00158600).|60
596252|NCT00455013|1456949|P3|NOT COMPLETED|Long Term Extension (LTE)||7
596253|NCT00455013|1456950|P2|NOT COMPLETED|Long Term Extension (LTE)||3
596254|NCT00455013|1456951|P1|NOT COMPLETED|Long Term Extension (LTE)||2
596255|NCT00455013|1456949|P3|COMPLETED|Long Term Extension (LTE)||20
596256|NCT00455013|1456950|P2|COMPLETED|Long Term Extension (LTE)||16
596257|NCT00455013|1456951|P1|COMPLETED|Long Term Extension (LTE)||25
596258|NCT00455013|1456949|P3|STARTED|Long Term Extension (LTE)|1 Participant chose not to enter the LTE.|27
596259|NCT00455013|1456950|P2|STARTED|Long Term Extension (LTE)|2 Participants chose not to enter the LTE.|19
596260|NCT00455013|1456951|P1|STARTED|Long Term Extension (LTE)||27
596261|NCT00455013|1456949|P3|NOT COMPLETED|Short Term Period||2
596262|NCT00455013|1456950|P2|NOT COMPLETED|Short Term Period||5
596263|NCT00455013|1456951|P1|NOT COMPLETED|Short Term Period||6
596264|NCT00455013|1456949|P3|COMPLETED|Short Term Period|1 discontinued tacrolimus by Month 6 and 2 discontinued by Month 12 (1 more by Month 12)|28
596265|NCT00455013|1456950|P2|COMPLETED|Short Term Period|5 discontinued belatacept by Month 6; 10 additional switched from sirolimus to MMF.|21
596266|NCT00455013|1456951|P1|COMPLETED|Short Term Period|5 discontinued belatacept by Month 6 (1 more by Month 12), 2 switched from MMF to sirolimus.|27
596267|NCT00455013|1456949|P3|STARTED|Short Term Period|31 randomized, 30 transplanted and treated|30
596268|NCT00455013|1456950|P2|STARTED|Short Term Period|27 randomized, 26 transplanted and treated.|26
596269|NCT00455013|1456951|P1|STARTED|Short Term Period|35 randomized, 33 transplanted and treated.|33
596270|NCT00454987|1457019|P3|NOT COMPLETED|Year 4||0
596271|NCT00454987|1457020|P2|NOT COMPLETED|Year 4||0
596272|NCT00454987|1457021|P1|NOT COMPLETED|Year 4||0
596273|NCT00454987|1457019|P3|COMPLETED|Year 4||0
596274|NCT00454987|1457020|P2|COMPLETED|Year 4||62
596275|NCT00454987|1457021|P1|COMPLETED|Year 4||206
596276|NCT00454987|1457019|P3|STARTED|Year 4||0
596277|NCT00454987|1457020|P2|STARTED|Year 4||62
596278|NCT00454987|1457021|P1|STARTED|Year 4||206
596279|NCT00454987|1457019|P3|NOT COMPLETED|Year 2||0
596280|NCT00454987|1457020|P2|NOT COMPLETED|Year 2||0
596281|NCT00454987|1457021|P1|NOT COMPLETED|Year 2||0
596282|NCT00454987|1457019|P3|COMPLETED|Year 2||74
596283|NCT00454987|1457020|P2|COMPLETED|Year 2||77
596284|NCT00454987|1457021|P1|COMPLETED|Year 2||235
596285|NCT00454987|1457019|P3|STARTED|Year 2||74
596286|NCT00454987|1457020|P2|STARTED|Year 2||77
596287|NCT00454987|1457021|P1|STARTED|Year 2||235
596288|NCT00454987|1457019|P3|NOT COMPLETED|Year 1||0
596289|NCT00454987|1457020|P2|NOT COMPLETED|Year 1||0
596290|NCT00454987|1457021|P1|NOT COMPLETED|Year 1||0
596291|NCT00454987|1457019|P3|COMPLETED|Year 1||0
596292|NCT00454987|1457020|P2|COMPLETED|Year 1||67
596293|NCT00454987|1457021|P1|COMPLETED|Year 1||221
596294|NCT00454987|1457019|P3|STARTED|Year 1||0
596295|NCT00454987|1457020|P2|STARTED|Year 1||67
596296|NCT00454987|1457021|P1|STARTED|Year 1||221
596297|NCT00454987|1457019|P3|NOT COMPLETED|Booster Period||0
596298|NCT00454987|1457020|P2|NOT COMPLETED|Booster Period||1
596299|NCT00454987|1457021|P1|NOT COMPLETED|Booster Period||2
596300|NCT00454987|1457019|P3|COMPLETED|Booster Period||0
596301|NCT00454987|1457020|P2|COMPLETED|Booster Period||116
596302|NCT00454987|1457021|P1|COMPLETED|Booster Period||357
596303|NCT00454987|1457019|P3|STARTED|Booster Period||0
596304|NCT00454987|1457020|P2|STARTED|Booster Period||117
596305|NCT00454987|1457021|P1|STARTED|Booster Period||359
596306|NCT00454909|1457095|P3|NOT COMPLETED|Overall Study||2
596307|NCT00454909|1457096|P2|NOT COMPLETED|Overall Study||3
596308|NCT00454909|1457097|P1|NOT COMPLETED|Overall Study||7
596309|NCT00454909|1457095|P3|COMPLETED|Overall Study||86
596310|NCT00454909|1457096|P2|COMPLETED|Overall Study||194
596311|NCT00454909|1457097|P1|COMPLETED|Overall Study||580
596312|NCT00454909|1457095|P3|STARTED|Overall Study||88
596313|NCT00454909|1457096|P2|STARTED|Overall Study||197
596314|NCT00454909|1457097|P1|STARTED|Overall Study||587
596315|NCT00454857|1457135|P1|NOT COMPLETED|Overall Study||54
596316|NCT00454857|1457135|P1|COMPLETED|Overall Study||272
596317|NCT00454857|1457135|P1|Completed ≥1 Observational Study Visit|Overall Study||319
596318|NCT00454857|1457135|P1|Completed Retrospective Chart Review|Overall Study||324
596319|NCT00454857|1457135|P1|STARTED|Overall Study||326
596320|NCT00454818|1457160|P5|NOT COMPLETED|Phase 2: Randomized Double-blind||4
596321|NCT00454818|1457161|P4|NOT COMPLETED|Phase 2: Randomized Double-blind||1
596322|NCT00454818|1457162|P3|NOT COMPLETED|Phase 2: Randomized Double-blind||3
596323|NCT00454818|1457163|P2|NOT COMPLETED|Phase 2: Randomized Double-blind||2
596324|NCT00454818|1457164|P1|NOT COMPLETED|Phase 2: Randomized Double-blind||0
596325|NCT00454818|1457160|P5|COMPLETED|Phase 2: Randomized Double-blind||10
596326|NCT00454818|1457161|P4|COMPLETED|Phase 2: Randomized Double-blind||8
596327|NCT00454818|1457162|P3|COMPLETED|Phase 2: Randomized Double-blind||5
596328|NCT00454818|1457163|P2|COMPLETED|Phase 2: Randomized Double-blind||6
596329|NCT00454818|1457164|P1|COMPLETED|Phase 2: Randomized Double-blind||0
596330|NCT00454818|1457160|P5|STARTED|Phase 2: Randomized Double-blind||14
596331|NCT00454818|1457161|P4|STARTED|Phase 2: Randomized Double-blind||9
596332|NCT00454818|1457162|P3|STARTED|Phase 2: Randomized Double-blind||8
596333|NCT00454818|1457163|P2|STARTED|Phase 2: Randomized Double-blind||8
596334|NCT00454818|1457164|P1|STARTED|Phase 2: Randomized Double-blind||0
596335|NCT00454818|1457160|P5|NOT COMPLETED|Phase I: Open-label Dose-escalation||0
596336|NCT00454818|1457161|P4|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
596337|NCT00454818|1457162|P3|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
596338|NCT00454818|1457163|P2|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
596339|NCT00454818|1457164|P1|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
596340|NCT00454818|1457160|P5|COMPLETED|Phase I: Open-label Dose-escalation||0
596341|NCT00454818|1457161|P4|COMPLETED|Phase I: Open-label Dose-escalation||2
596342|NCT00454818|1457162|P3|COMPLETED|Phase I: Open-label Dose-escalation||2
596343|NCT00454818|1457163|P2|COMPLETED|Phase I: Open-label Dose-escalation||2
596344|NCT00454818|1457164|P1|COMPLETED|Phase I: Open-label Dose-escalation||2
596345|NCT00454818|1457160|P5|STARTED|Phase I: Open-label Dose-escalation||0
596346|NCT00454818|1457161|P4|STARTED|Phase I: Open-label Dose-escalation||3
596347|NCT00454818|1457162|P3|STARTED|Phase I: Open-label Dose-escalation||3
596348|NCT00454818|1457163|P2|STARTED|Phase I: Open-label Dose-escalation||3
596349|NCT00454818|1457164|P1|STARTED|Phase I: Open-label Dose-escalation||3
596350|NCT00454805|1457243|P2|NOT COMPLETED|Overall Study||23
596351|NCT00454805|1457244|P1|NOT COMPLETED|Overall Study||26
596352|NCT00454805|1457243|P2|COMPLETED|Overall Study|Ongoing at data cut-off|8
596353|NCT00454805|1457244|P1|COMPLETED|Overall Study|Ongoing at data cut-off|5
596354|NCT00454805|1457243|P2|STARTED|Overall Study|Randomised|31
596355|NCT00454805|1457244|P1|STARTED|Overall Study|Randomised|31
596356|NCT00454779|1457260|P2|NOT COMPLETED|Second-line Treatment Phase||3
596357|NCT00454779|1457261|P1|NOT COMPLETED|Second-line Treatment Phase||0
596358|NCT00454779|1457260|P2|COMPLETED|Second-line Treatment Phase|Disease progression (radiographically determined) or death|27
596359|NCT00454779|1457261|P1|COMPLETED|Second-line Treatment Phase|Disease progression (radiographically determined) or death|0
596360|NCT00454779|1457260|P2|STARTED|Second-line Treatment Phase|Second-line Panitumumab Monotherapy|30
596361|NCT00454779|1457261|P1|STARTED|Second-line Treatment Phase|Subjects in this arm do not have second-line treatment period|0
596362|NCT00454779|1457260|P2|NOT COMPLETED|First-line Treatment Phase||8
596363|NCT00454779|1457261|P1|NOT COMPLETED|First-line Treatment Phase||5
596364|NCT00454779|1457260|P2|COMPLETED|First-line Treatment Phase|Disease progression (radiographically determined) or death|49
596365|NCT00454779|1457261|P1|COMPLETED|First-line Treatment Phase|Disease progression (radiographically determined) or death|51
596366|NCT00454779|1457260|P2|Received Study Medication|First-line Treatment Phase||55
596367|NCT00454779|1457261|P1|Received Study Medication|First-line Treatment Phase||56
596368|NCT00454779|1457260|P2|STARTED|First-line Treatment Phase||57
596369|NCT00454779|1457261|P1|STARTED|First-line Treatment Phase||56
596370|NCT00454649|1457299|P10|NOT COMPLETED|Overall Study||5
596371|NCT00454649|1457300|P9|NOT COMPLETED|Overall Study||20
596372|NCT00454649|1457301|P8|NOT COMPLETED|Overall Study||19
596373|NCT00454649|1457302|P7|NOT COMPLETED|Overall Study||9
596374|NCT00454649|1457303|P6|NOT COMPLETED|Overall Study||7
596375|NCT00454649|1457304|P5|NOT COMPLETED|Overall Study||1
596376|NCT00454649|1457305|P4|NOT COMPLETED|Overall Study||6
596377|NCT00454649|1457306|P3|NOT COMPLETED|Overall Study||19
596378|NCT00454649|1457307|P2|NOT COMPLETED|Overall Study||4
596379|NCT00454649|1457308|P1|NOT COMPLETED|Overall Study||3
596380|NCT00454649|1457299|P10|COMPLETED|Overall Study||1
596381|NCT00454649|1457300|P9|COMPLETED|Overall Study||1
596382|NCT00454649|1457301|P8|COMPLETED|Overall Study||0
596383|NCT00454649|1457302|P7|COMPLETED|Overall Study||0
596384|NCT00454649|1457303|P6|COMPLETED|Overall Study||0
596385|NCT00454649|1457304|P5|COMPLETED|Overall Study||0
596386|NCT00454649|1457305|P4|COMPLETED|Overall Study||1
596387|NCT00454649|1457306|P3|COMPLETED|Overall Study||1
596388|NCT00454649|1457307|P2|COMPLETED|Overall Study||1
596389|NCT00454649|1457308|P1|COMPLETED|Overall Study||0
596390|NCT00454649|1457299|P10|STARTED|Overall Study||6
596391|NCT00454649|1457300|P9|STARTED|Overall Study||21
596392|NCT00454649|1457301|P8|STARTED|Overall Study||19
596393|NCT00454649|1457302|P7|STARTED|Overall Study||9
596394|NCT00454649|1457303|P6|STARTED|Overall Study||7
596395|NCT00454649|1457304|P5|STARTED|Overall Study||1
596396|NCT00454649|1457305|P4|STARTED|Overall Study||7
596397|NCT00454649|1457306|P3|STARTED|Overall Study||20
596398|NCT00454649|1457307|P2|STARTED|Overall Study||5
596399|NCT00454649|1457308|P1|STARTED|Overall Study||3
596400|NCT00454636|1457437|P4|NOT COMPLETED|Overall Study||32
596401|NCT00454636|1457438|P3|NOT COMPLETED|Overall Study||20
596402|NCT00454636|1457439|P2|NOT COMPLETED|Overall Study||23
596403|NCT00454636|1457440|P1|NOT COMPLETED|Overall Study||31
596404|NCT00454636|1457437|P4|COMPLETED|Overall Study||26
596405|NCT00454636|1457438|P3|COMPLETED|Overall Study||7
596406|NCT00454636|1457439|P2|COMPLETED|Overall Study||9
596407|NCT00454636|1457440|P1|COMPLETED|Overall Study||10
596408|NCT00454636|1457437|P4|STARTED|Overall Study||58
596409|NCT00454636|1457438|P3|STARTED|Overall Study||27
596410|NCT00454636|1457439|P2|STARTED|Overall Study||32
596411|NCT00454636|1457440|P1|STARTED|Overall Study||41
596412|NCT00454584|1457473|P6|NOT COMPLETED|After Controlled Period||32
596413|NCT00454584|1457474|P5|NOT COMPLETED|After Controlled Period||12
596414|NCT00454584|1457475|P4|NOT COMPLETED|After Controlled Period||26
596415|NCT00454584|1457476|P3|NOT COMPLETED|After Controlled Period||0
596416|NCT00454584|1457477|P2|NOT COMPLETED|After Controlled Period||0
596417|NCT00454584|1457478|P1|NOT COMPLETED|After Controlled Period||0
596418|NCT00454584|1457473|P6|COMPLETED|After Controlled Period||310
596419|NCT00454584|1457474|P5|COMPLETED|After Controlled Period||189
596420|NCT00454584|1457475|P4|COMPLETED|After Controlled Period||310
596421|NCT00454584|1457476|P3|COMPLETED|After Controlled Period||0
596422|NCT00454584|1457477|P2|COMPLETED|After Controlled Period||0
596423|NCT00454584|1457478|P1|COMPLETED|After Controlled Period||0
596424|NCT00454584|1457473|P6|STARTED|After Controlled Period||342
596425|NCT00454584|1457474|P5|STARTED|After Controlled Period||201
596426|NCT00454584|1457475|P4|STARTED|After Controlled Period||336
596427|NCT00454584|1457476|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
596428|NCT00454584|1457477|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
596429|NCT00454584|1457478|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
596430|NCT00454584|1457473|P6|NOT COMPLETED|Controlled Period||0
596431|NCT00454584|1457474|P5|NOT COMPLETED|Controlled Period||0
596432|NCT00454584|1457475|P4|NOT COMPLETED|Controlled Period||0
596433|NCT00454584|1457476|P3|NOT COMPLETED|Controlled Period||5
596434|NCT00454584|1457477|P2|NOT COMPLETED|Controlled Period||8
596435|NCT00454584|1457478|P1|NOT COMPLETED|Controlled Period||11
596436|NCT00454584|1457473|P6|COMPLETED|Controlled Period||0
596437|NCT00454584|1457474|P5|COMPLETED|Controlled Period||0
596438|NCT00454584|1457475|P4|COMPLETED|Controlled Period||0
596439|NCT00454584|1457476|P3|COMPLETED|Controlled Period||342
596440|NCT00454584|1457477|P2|COMPLETED|Controlled Period||201
596441|NCT00454584|1457478|P1|COMPLETED|Controlled Period||336
596442|NCT00454584|1457473|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
596443|NCT00454584|1457474|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
596444|NCT00454584|1457475|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
596445|NCT00454584|1457476|P3|STARTED|Controlled Period||347
596446|NCT00454584|1457477|P2|STARTED|Controlled Period||209
596447|NCT00454584|1457478|P1|STARTED|Controlled Period||347
596448|NCT00454571|1457500|P2|NOT COMPLETED|Overall Study||6
596449|NCT00454571|1457501|P1|NOT COMPLETED|Overall Study||13
596450|NCT00454571|1457500|P2|COMPLETED|Overall Study||13
596451|NCT00454571|1457501|P1|COMPLETED|Overall Study||5
596452|NCT00454571|1457500|P2|STARTED|Overall Study||19
596453|NCT00454571|1457501|P1|STARTED|Overall Study||18
596454|NCT00454532|1457513|P4|NOT COMPLETED|Overall Study||0
596455|NCT00454532|1457514|P3|NOT COMPLETED|Overall Study||0
596456|NCT00454532|1457515|P2|NOT COMPLETED|Overall Study||0
596457|NCT00454532|1457516|P1|NOT COMPLETED|Overall Study||0
596458|NCT00454532|1457513|P4|COMPLETED|Overall Study||7
596459|NCT00454532|1457514|P3|COMPLETED|Overall Study||3
596460|NCT00454532|1457515|P2|COMPLETED|Overall Study||6
596461|NCT00454532|1457516|P1|COMPLETED|Overall Study||11
596462|NCT00454532|1457513|P4|STARTED|Overall Study||7
596463|NCT00454532|1457514|P3|STARTED|Overall Study||3
596464|NCT00454532|1457515|P2|STARTED|Overall Study||6
596465|NCT00454532|1457516|P1|STARTED|Overall Study||11
596466|NCT00454363|1457536|P2|NOT COMPLETED|Overall Study||2
596467|NCT00454363|1457537|P1|NOT COMPLETED|Overall Study||5
596468|NCT00454363|1457536|P2|COMPLETED|Overall Study||29
596469|NCT00454363|1457537|P1|COMPLETED|Overall Study||15
596470|NCT00454363|1457536|P2|STARTED|Overall Study||31
596471|NCT00454363|1457537|P1|STARTED|Overall Study||20
596472|NCT00454324|1457546|P2|NOT COMPLETED|Overall Study||0
596473|NCT00454324|1457547|P1|NOT COMPLETED|Overall Study||0
596474|NCT00454324|1457546|P2|COMPLETED|Overall Study||13
596475|NCT00454324|1457547|P1|COMPLETED|Overall Study||14
596476|NCT00454324|1457546|P2|STARTED|Overall Study||13
596477|NCT00454324|1457547|P1|STARTED|Overall Study||14
596478|NCT00454246|1457562|P3|NOT COMPLETED|Overall Study||9
596479|NCT00454246|1457563|P2|NOT COMPLETED|Overall Study||29
596480|NCT00454246|1457564|P1|NOT COMPLETED|Overall Study||73
596481|NCT00454246|1457562|P3|COMPLETED|Overall Study||0
596482|NCT00454246|1457563|P2|COMPLETED|Overall Study||0
596483|NCT00454246|1457564|P1|COMPLETED|Overall Study||0
596484|NCT00454246|1457562|P3|STARTED|Overall Study||9
596485|NCT00454246|1457563|P2|STARTED|Overall Study||29
596486|NCT00454246|1457564|P1|STARTED|Overall Study||73
596487|NCT00454207|1457580|P2|NOT COMPLETED|Overall Study||2
596488|NCT00454207|1457581|P1|NOT COMPLETED|Overall Study||4
596489|NCT00454207|1457580|P2|COMPLETED|Overall Study||21
596490|NCT00454207|1457581|P1|COMPLETED|Overall Study|19 participants completed Part I period. 17 of 19 participants continued from part I into Part II.|17
596491|NCT00454207|1457580|P2|STARTED|Overall Study||23
596492|NCT00454207|1457581|P1|STARTED|Overall Study||21
596493|NCT00454194|1457626|P2|NOT COMPLETED|Overall Study||14
596494|NCT00454194|1457627|P1|NOT COMPLETED|Overall Study||22
596495|NCT00454194|1457626|P2|COMPLETED|Overall Study||37
596496|NCT00454194|1457627|P1|COMPLETED|Overall Study||25
596497|NCT00454194|1457626|P2|STARTED|Overall Study||51
596498|NCT00454194|1457627|P1|STARTED|Overall Study||47
596499|NCT00454181|1457645|P2|NOT COMPLETED|Overall Study||3
596500|NCT00454181|1457646|P1|NOT COMPLETED|Overall Study||15
596501|NCT00454181|1457645|P2|COMPLETED|Overall Study||11
596502|NCT00454181|1457646|P1|COMPLETED|Overall Study||30
596503|NCT00454181|1457645|P2|STARTED|Overall Study||14
596504|NCT00454181|1457646|P1|STARTED|Overall Study||45
596505|NCT00454142|1457662|P1|NOT COMPLETED|Overall Study||1
596506|NCT00454142|1457662|P1|COMPLETED|Overall Study||32
596507|NCT00454142|1457662|P1|STARTED|Overall Study||33
596508|NCT00454116|1457680|P3|NOT COMPLETED|Overall Study||28
596509|NCT00454116|1457681|P2|NOT COMPLETED|Overall Study||29
596510|NCT00454116|1457682|P1|NOT COMPLETED|Overall Study||27
596511|NCT00454116|1457680|P3|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
596512|NCT00454116|1457681|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
596513|NCT00454116|1457682|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|8
596514|NCT00454116|1457680|P3|STARTED|Overall Study|randomised patients|35
596515|NCT00454116|1457681|P2|STARTED|Overall Study|randomised patients|36
596516|NCT00454116|1457682|P1|STARTED|Overall Study|randomised patients|35
596517|NCT00454051|1457692|P2|NOT COMPLETED|Overall Study||3
596518|NCT00454051|1457693|P1|NOT COMPLETED|Overall Study||3
596519|NCT00454051|1457692|P2|COMPLETED|Overall Study||8
596520|NCT00454051|1457693|P1|COMPLETED|Overall Study||17
596521|NCT00454051|1457692|P2|STARTED|Overall Study||11
596522|NCT00454051|1457693|P1|STARTED|Overall Study||20
596523|NCT00453999|1457726|P3|NOT COMPLETED|Overall Study||3
596524|NCT00453999|1457727|P2|NOT COMPLETED|Overall Study||5
596525|NCT00453999|1457728|P1|NOT COMPLETED|Overall Study||5
596526|NCT00453999|1457726|P3|COMPLETED|Overall Study||43
596527|NCT00453999|1457727|P2|COMPLETED|Overall Study||41
596528|NCT00453999|1457728|P1|COMPLETED|Overall Study||40
596529|NCT00453999|1457726|P3|STARTED|Overall Study||46
596530|NCT00453999|1457727|P2|STARTED|Overall Study||46
596531|NCT00453999|1457728|P1|STARTED|Overall Study||45
596532|NCT00453986|1457756|P5|NOT COMPLETED|Overall Study||0
596533|NCT00453986|1457757|P4|NOT COMPLETED|Overall Study||2
596534|NCT00453986|1457758|P3|NOT COMPLETED|Overall Study||6
596535|NCT00453986|1457759|P2|NOT COMPLETED|Overall Study||5
596536|NCT00453986|1457760|P1|NOT COMPLETED|Overall Study||6
596537|NCT00453986|1457756|P5|COMPLETED|Overall Study||105
596538|NCT00453986|1457757|P4|COMPLETED|Overall Study||310
596539|NCT00453986|1457758|P3|COMPLETED|Overall Study||307
596540|NCT00453986|1457759|P2|COMPLETED|Overall Study||306
596541|NCT00453986|1457760|P1|COMPLETED|Overall Study||305
596542|NCT00453986|1457756|P5|STARTED|Overall Study||105
596543|NCT00453986|1457757|P4|STARTED|Overall Study||312
596544|NCT00453986|1457758|P3|STARTED|Overall Study||313
596545|NCT00453986|1457759|P2|STARTED|Overall Study||311
596546|NCT00453986|1457760|P1|STARTED|Overall Study||311
596547|NCT00453973|1457855|P2|NOT COMPLETED|Overall Study||48
596548|NCT00453973|1457856|P1|NOT COMPLETED|Overall Study||51
596549|NCT00453973|1457855|P2|COMPLETED|Overall Study||15
596550|NCT00453973|1457856|P1|COMPLETED|Overall Study||0
596551|NCT00453973|1457855|P2|STARTED|Overall Study||63
596552|NCT00453973|1457856|P1|STARTED|Overall Study||51
596553|NCT00453921|1457866|P4|NOT COMPLETED|Overall Study||1
596554|NCT00453921|1457867|P3|NOT COMPLETED|Overall Study||2
596555|NCT00453921|1457868|P2|NOT COMPLETED|Overall Study||1
596556|NCT00453921|1457869|P1|NOT COMPLETED|Overall Study||1
596557|NCT00453921|1457866|P4|COMPLETED|Overall Study||18
596558|NCT00453921|1457867|P3|COMPLETED|Overall Study||18
596559|NCT00453921|1457868|P2|COMPLETED|Overall Study||17
596560|NCT00453921|1457869|P1|COMPLETED|Overall Study||18
596561|NCT00453921|1457866|P4|STARTED|Overall Study||19
596562|NCT00453921|1457867|P3|STARTED|Overall Study||20
596563|NCT00453921|1457868|P2|STARTED|Overall Study||18
596564|NCT00453921|1457869|P1|STARTED|Overall Study||19
596565|NCT00453479|1457906|P3|NOT COMPLETED|Overall Study||0
596566|NCT00453479|1457907|P2|NOT COMPLETED|Overall Study||0
596567|NCT00453479|1457908|P1|NOT COMPLETED|Overall Study||0
596568|NCT00453479|1457906|P3|COMPLETED|Overall Study||8
596569|NCT00453479|1457907|P2|COMPLETED|Overall Study||9
596570|NCT00453479|1457908|P1|COMPLETED|Overall Study||6
596571|NCT00453479|1457906|P3|STARTED|Overall Study||8
596572|NCT00453479|1457907|P2|STARTED|Overall Study||9
596573|NCT00453479|1457908|P1|STARTED|Overall Study||6
596586|NCT00453362|1458008|P1|NOT COMPLETED|Overall Study||87
596587|NCT00453362|1458008|P1|COMPLETED|Overall Study||1
596588|NCT00453362|1458008|P1|FLT-PET Evaluable|Overall Study|Participants who completed all FLT-PET scans through day 56.|50
596589|NCT00453362|1458008|P1|FDG-PET Evaluable|Overall Study|Participants who completed all FDG-PET scans through day 56.|51
596590|NCT00453362|1458008|P1|Treated With Erlotinib|Overall Study||74
596591|NCT00453362|1458008|P1|STARTED|Overall Study|14 participants consented but did not receive drug and are not represented in the baseline data|88
596592|NCT00453349|1458034|P2|NOT COMPLETED|Completed Study||34
596593|NCT00453349|1458035|P1|NOT COMPLETED|Completed Study||27
596594|NCT00453349|1458034|P2|COMPLETED|Completed Study|had follow-up assessment or alternative antibiotic assessment|198
596595|NCT00453349|1458035|P1|COMPLETED|Completed Study|had follow-up assessment or alternative antibiotic assessment|201
596596|NCT00453349|1458034|P2|Completed Study Treatment|Completed Study|23 terminated prematurely|209
596597|NCT00453349|1458035|P1|Completed Study Treatment|Completed Study|25 terminated prematurely|203
596598|NCT00453349|1458034|P2|STARTED|Completed Study||232
596599|NCT00453349|1458035|P1|STARTED|Completed Study||228
596600|NCT00453349|1458034|P2|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||11
596601|NCT00453349|1458035|P1|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||10
596602|NCT00453349|1458034|P2|COMPLETED|Reaching of Primary Endpoint (TOC)||219
596603|NCT00453349|1458035|P1|COMPLETED|Reaching of Primary Endpoint (TOC)|All PP patients and ITT patients with a clinical response with no missing information|215
596604|NCT00453349|1458034|P2|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||190
596605|NCT00453349|1458035|P1|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||194
596606|NCT00453349|1458034|P2|STARTED|Reaching of Primary Endpoint (TOC)|i.e. the ITT population|230
596607|NCT00453349|1458035|P1|STARTED|Reaching of Primary Endpoint (TOC)|Subjects who attended the TOC visit or at least had a clinical evaluation at TOC|225
596608|NCT00453349|1458034|P2|NOT COMPLETED|Randomized||23
596609|NCT00453349|1458035|P1|NOT COMPLETED|Randomized||25
596610|NCT00453349|1458034|P2|COMPLETED|Randomized||209
596611|NCT00453349|1458035|P1|COMPLETED|Randomized||203
596612|NCT00453349|1458034|P2|STARTED|Randomized||232
596613|NCT00453349|1458035|P1|STARTED|Randomized||228
596614|NCT00453336|1458061|P1|NOT COMPLETED|Overall Study||0
596615|NCT00453336|1458061|P1|COMPLETED|Overall Study||45
596616|NCT00453336|1458061|P1|STARTED|Overall Study||45
596617|NCT00453310|1458066|P1|NOT COMPLETED|Overall Study||10
596618|NCT00453310|1458066|P1|COMPLETED|Overall Study||0
596619|NCT00453310|1458066|P1|STARTED|Overall Study||10
596620|NCT00453206|1458070|P1|NOT COMPLETED|Overall Study||1
596621|NCT00453206|1458070|P1|COMPLETED|Overall Study||65
596622|NCT00453206|1458070|P1|STARTED|Overall Study||66
596623|NCT00453193|1458074|P1|NOT COMPLETED|Overall Study||0
596624|NCT00453193|1458074|P1|COMPLETED|Overall Study||24
596625|NCT00453193|1458074|P1|STARTED|Overall Study||24
596626|NCT00453180|1458080|P2|NOT COMPLETED|Overall Study||3
596627|NCT00453180|1458081|P1|NOT COMPLETED|Overall Study||3
596628|NCT00453180|1458080|P2|COMPLETED|Overall Study||12
596629|NCT00453180|1458081|P1|COMPLETED|Overall Study||13
596630|NCT00453180|1458080|P2|STARTED|Overall Study||15
596631|NCT00453180|1458081|P1|STARTED|Overall Study||16
596632|NCT00453154|1458100|P4|NOT COMPLETED|Open Label Sunitinib Crossover||0
596633|NCT00453154|1458101|P3|NOT COMPLETED|Open Label Sunitinib Crossover||0
596634|NCT00453154|1458102|P2|NOT COMPLETED|Open Label Sunitinib Crossover||0
596635|NCT00453154|1458103|P1|NOT COMPLETED|Open Label Sunitinib Crossover||0
596636|NCT00453154|1458100|P4|COMPLETED|Open Label Sunitinib Crossover||0
596637|NCT00453154|1458101|P3|COMPLETED|Open Label Sunitinib Crossover||18
596638|NCT00453154|1458102|P2|COMPLETED|Open Label Sunitinib Crossover||0
596639|NCT00453154|1458103|P1|COMPLETED|Open Label Sunitinib Crossover||0
596640|NCT00453154|1458100|P4|STARTED|Open Label Sunitinib Crossover||0
596641|NCT00453154|1458101|P3|STARTED|Open Label Sunitinib Crossover||18
596642|NCT00453154|1458102|P2|STARTED|Open Label Sunitinib Crossover||0
596643|NCT00453154|1458103|P1|STARTED|Open Label Sunitinib Crossover||0
596644|NCT00453154|1458100|P4|NOT COMPLETED|Double BIind Maintenance||49
596645|NCT00453154|1458101|P3|NOT COMPLETED|Double BIind Maintenance||46
596646|NCT00453154|1458102|P2|NOT COMPLETED|Double BIind Maintenance||0
596647|NCT00453154|1458103|P1|NOT COMPLETED|Double BIind Maintenance||0
596648|NCT00453154|1458100|P4|COMPLETED|Double BIind Maintenance||0
596649|NCT00453154|1458101|P3|COMPLETED|Double BIind Maintenance||0
596650|NCT00453154|1458102|P2|COMPLETED|Double BIind Maintenance||0
596651|NCT00453154|1458103|P1|COMPLETED|Double BIind Maintenance||0
596652|NCT00453154|1458100|P4|STARTED|Double BIind Maintenance||49
596653|NCT00453154|1458101|P3|STARTED|Double BIind Maintenance||46
596654|NCT00453154|1458102|P2|STARTED|Double BIind Maintenance||0
596655|NCT00453154|1458103|P1|STARTED|Double BIind Maintenance||0
596656|NCT00453154|1458100|P4|NOT COMPLETED|Combination Chemotherapy||0
596657|NCT00453154|1458101|P3|NOT COMPLETED|Combination Chemotherapy||0
596658|NCT00453154|1458102|P2|NOT COMPLETED|Combination Chemotherapy||49
596659|NCT00453154|1458103|P1|NOT COMPLETED|Combination Chemotherapy||0
596660|NCT00453154|1458100|P4|COMPLETED|Combination Chemotherapy||0
596661|NCT00453154|1458101|P3|COMPLETED|Combination Chemotherapy||0
596662|NCT00453154|1458102|P2|COMPLETED|Combination Chemotherapy||95
596663|NCT00453154|1458103|P1|COMPLETED|Combination Chemotherapy||12
596664|NCT00453154|1458100|P4|STARTED|Combination Chemotherapy||0
596665|NCT00453154|1458101|P3|STARTED|Combination Chemotherapy||0
596666|NCT00453154|1458102|P2|STARTED|Combination Chemotherapy||144
596667|NCT00453154|1458103|P1|STARTED|Combination Chemotherapy||12
596668|NCT00453102|1458116|P1|NOT COMPLETED|Overall Study||2
596669|NCT00453102|1458116|P1|COMPLETED|Overall Study||16
596670|NCT00453102|1458116|P1|STARTED|Overall Study||18
596671|NCT00453063|1458127|P2|NOT COMPLETED|Overall Study||3
596672|NCT00453063|1458128|P1|NOT COMPLETED|Overall Study||3
596673|NCT00453063|1458127|P2|COMPLETED|Overall Study||212
596674|NCT00453063|1458128|P1|COMPLETED|Overall Study||208
596675|NCT00453063|1458127|P2|STARTED|Overall Study||215
596676|NCT00453063|1458128|P1|STARTED|Overall Study||211
596677|NCT00452868|1458142|P1|NOT COMPLETED|Overall Study||2
596678|NCT00452868|1458142|P1|COMPLETED|Overall Study||11
596679|NCT00452868|1458142|P1|STARTED|Overall Study||13
596680|NCT00452790|1458148|P2|NOT COMPLETED|Toddler Dose||2
596681|NCT00452790|1458149|P1|NOT COMPLETED|Toddler Dose||0
596682|NCT00452790|1458148|P2|COMPLETED|Toddler Dose||198
596683|NCT00452790|1458149|P1|COMPLETED|Toddler Dose||198
596684|NCT00452790|1458148|P2|STARTED|Toddler Dose||200
596685|NCT00452790|1458149|P1|STARTED|Toddler Dose||198
596686|NCT00452790|1458148|P2|NOT COMPLETED|After Infant Series||14
596687|NCT00452790|1458149|P1|NOT COMPLETED|After Infant Series||21
596688|NCT00452790|1458148|P2|COMPLETED|After Infant Series||200
596689|NCT00452790|1458149|P1|COMPLETED|After Infant Series||198
596690|NCT00452790|1458148|P2|STARTED|After Infant Series||214
596691|NCT00452790|1458149|P1|STARTED|After Infant Series||219
596692|NCT00452790|1458148|P2|NOT COMPLETED|Infant Series||141
596693|NCT00452790|1458149|P1|NOT COMPLETED|Infant Series||135
596694|NCT00452790|1458148|P2|COMPLETED|Infant Series||214
596695|NCT00452790|1458149|P1|COMPLETED|Infant Series||219
596696|NCT00452790|1458148|P2|Vaccinated Dose 3|Infant Series||218
596697|NCT00452790|1458149|P1|Vaccinated Dose 3|Infant Series||221
596698|NCT00452790|1458148|P2|Vaccinated Dose 2|Infant Series||300
596699|NCT00452790|1458149|P1|Vaccinated Dose 2|Infant Series||300
596700|NCT00452790|1458148|P2|Vaccinated Dose 1|Infant Series||353
596701|NCT00452790|1458149|P1|Vaccinated Dose 1|Infant Series||353
596702|NCT00452790|1458148|P2|STARTED|Infant Series||355
596703|NCT00452790|1458149|P1|STARTED|Infant Series||354
596704|NCT00452699|1458185|P2|NOT COMPLETED|Overall Study||73
596705|NCT00452699|1458186|P1|NOT COMPLETED|Overall Study||81
596706|NCT00452699|1458185|P2|COMPLETED|Overall Study||242
596707|NCT00452699|1458186|P1|COMPLETED|Overall Study||225
596708|NCT00452699|1458185|P2|STARTED|Overall Study||315
596709|NCT00452699|1458186|P1|STARTED|Overall Study||306
596710|NCT00452673|1458202|P5|NOT COMPLETED|Dose Expansion Period||21
596711|NCT00452673|1458203|P4|NOT COMPLETED|Dose Expansion Period||0
596712|NCT00452673|1458204|P3|NOT COMPLETED|Dose Expansion Period||0
596713|NCT00452673|1458205|P2|NOT COMPLETED|Dose Expansion Period||0
596714|NCT00452673|1458206|P1|NOT COMPLETED|Dose Expansion Period||0
596715|NCT00452673|1458202|P5|COMPLETED|Dose Expansion Period||0
596716|NCT00452673|1458203|P4|COMPLETED|Dose Expansion Period||0
596717|NCT00452673|1458204|P3|COMPLETED|Dose Expansion Period||0
596718|NCT00452673|1458205|P2|COMPLETED|Dose Expansion Period||0
596719|NCT00452673|1458206|P1|COMPLETED|Dose Expansion Period||0
596720|NCT00452673|1458202|P5|STARTED|Dose Expansion Period|The last dose level arm in the escalation period was selected for the dose expansion period.|21
596721|NCT00452673|1458203|P4|STARTED|Dose Expansion Period||0
596722|NCT00452673|1458204|P3|STARTED|Dose Expansion Period||0
596723|NCT00452673|1458205|P2|STARTED|Dose Expansion Period||0
596724|NCT00452673|1458206|P1|STARTED|Dose Expansion Period||0
596725|NCT00452673|1458202|P5|NOT COMPLETED|Dose Escalation Period||0
596726|NCT00452673|1458203|P4|NOT COMPLETED|Dose Escalation Period||9
596727|NCT00452673|1458204|P3|NOT COMPLETED|Dose Escalation Period||6
596728|NCT00452673|1458205|P2|NOT COMPLETED|Dose Escalation Period||9
596729|NCT00452673|1458206|P1|NOT COMPLETED|Dose Escalation Period||7
596730|NCT00452673|1458202|P5|COMPLETED|Dose Escalation Period||0
596731|NCT00452673|1458203|P4|COMPLETED|Dose Escalation Period||0
596732|NCT00452673|1458204|P3|COMPLETED|Dose Escalation Period||0
596733|NCT00452673|1458205|P2|COMPLETED|Dose Escalation Period||0
596734|NCT00452673|1458206|P1|COMPLETED|Dose Escalation Period||0
596735|NCT00452673|1458202|P5|STARTED|Dose Escalation Period||0
596736|NCT00452673|1458203|P4|STARTED|Dose Escalation Period||9
596737|NCT00452673|1458204|P3|STARTED|Dose Escalation Period||6
596738|NCT00452673|1458205|P2|STARTED|Dose Escalation Period||9
596739|NCT00452673|1458206|P1|STARTED|Dose Escalation Period||7
596740|NCT00452543|1458238|P2|NOT COMPLETED|Overall Study||6
596741|NCT00452543|1458239|P1|NOT COMPLETED|Overall Study||5
596742|NCT00452543|1458238|P2|COMPLETED|Overall Study||5
596743|NCT00452543|1458239|P1|COMPLETED|Overall Study||7
596744|NCT00452543|1458238|P2|STARTED|Overall Study||11
596745|NCT00452543|1458239|P1|STARTED|Overall Study||12
596746|NCT00452530|1458253|P2|NOT COMPLETED|Overall Study||136
596747|NCT00452530|1458254|P1|NOT COMPLETED|Overall Study||136
596748|NCT00452530|1458253|P2|COMPLETED|Overall Study||1393
596749|NCT00452530|1458254|P1|COMPLETED|Overall Study||1392
596750|NCT00452530|1458253|P2|Primary Participants|Overall Study||997
596751|NCT00452530|1458254|P1|Primary Participants|Overall Study||976
596752|NCT00452530|1458253|P2|Evaluable Participants|Overall Study||921
596753|NCT00452530|1458254|P1|Evaluable Participants|Overall Study||907
596754|NCT00452530|1458253|P2|Received Treatment|Overall Study||1508
596755|NCT00452530|1458254|P1|Received Treatment|Overall Study||1501
596756|NCT00452530|1458253|P2|STARTED|Overall Study|Randomized|1529
596757|NCT00452530|1458254|P1|STARTED|Overall Study|Randomized|1528
596758|NCT00452452|1458275|P3|NOT COMPLETED|Overall Study||1
596759|NCT00452452|1458276|P2|NOT COMPLETED|Overall Study||0
596760|NCT00452452|1458277|P1|NOT COMPLETED|Overall Study||2
596761|NCT00452452|1458275|P3|COMPLETED|Overall Study||152
596762|NCT00452452|1458276|P2|COMPLETED|Overall Study||112
596763|NCT00452452|1458277|P1|COMPLETED|Overall Study||88
596764|NCT00452452|1458275|P3|Vaccinated Dose 3|Overall Study||0
596765|NCT00452452|1458276|P2|Vaccinated Dose 3|Overall Study||0
596766|NCT00452452|1458277|P1|Vaccinated Dose 3|Overall Study||89
596767|NCT00452452|1458275|P3|Vaccinated Dose 2|Overall Study||0
596768|NCT00452452|1458276|P2|Vaccinated Dose 2|Overall Study||112
596769|NCT00452452|1458277|P1|Vaccinated Dose 2|Overall Study||90
596770|NCT00452452|1458275|P3|Vaccinated Dose 1|Overall Study||152
596771|NCT00452452|1458276|P2|Vaccinated Dose 1|Overall Study||112
596772|NCT00452452|1458277|P1|Vaccinated Dose 1|Overall Study||90
596773|NCT00452452|1458275|P3|STARTED|Overall Study||153
596774|NCT00452452|1458276|P2|STARTED|Overall Study||112
596775|NCT00452452|1458277|P1|STARTED|Overall Study||90
596776|NCT00452426|1458302|P2|NOT COMPLETED|Overall Study||11
596777|NCT00452426|1458303|P1|NOT COMPLETED|Overall Study||7
596778|NCT00452426|1458302|P2|COMPLETED|Overall Study||493
596779|NCT00452426|1458303|P1|COMPLETED|Overall Study||489
596780|NCT00452426|1458302|P2|STARTED|Overall Study||504
596781|NCT00452426|1458303|P1|STARTED|Overall Study||496
596782|NCT00452400|1458322|P5|NOT COMPLETED|Overall Study||3
596783|NCT00452400|1458323|P4|NOT COMPLETED|Overall Study||1
596784|NCT00452400|1458324|P3|NOT COMPLETED|Overall Study||7
596785|NCT00452400|1458325|P2|NOT COMPLETED|Overall Study||1
596786|NCT00452400|1458326|P1|NOT COMPLETED|Overall Study||5
596787|NCT00452400|1458322|P5|COMPLETED|Overall Study||76
596788|NCT00452400|1458323|P4|COMPLETED|Overall Study||85
596789|NCT00452400|1458324|P3|COMPLETED|Overall Study||73
596790|NCT00452400|1458325|P2|COMPLETED|Overall Study||80
596791|NCT00452400|1458326|P1|COMPLETED|Overall Study||74
596792|NCT00452400|1458322|P5|STARTED|Overall Study||79
596793|NCT00452400|1458323|P4|STARTED|Overall Study||86
596794|NCT00452400|1458324|P3|STARTED|Overall Study||80
596795|NCT00452400|1458325|P2|STARTED|Overall Study||81
596796|NCT00452400|1458326|P1|STARTED|Overall Study||79
596797|NCT00452387|1458498|P1|NOT COMPLETED|Overall Study||0
596798|NCT00452387|1458498|P1|COMPLETED|Overall Study||22
596799|NCT00452387|1458498|P1|STARTED|Overall Study||22
596800|NCT00452374|1458506|P1|NOT COMPLETED|Overall Study||0
596801|NCT00452374|1458506|P1|COMPLETED|Overall Study||48
596802|NCT00452374|1458506|P1|STARTED|Overall Study||48
596803|NCT00452361|1458513|P2|NOT COMPLETED|Overall Study||10
596804|NCT00452361|1458514|P1|NOT COMPLETED|Overall Study||21
596805|NCT00452361|1458513|P2|COMPLETED|Overall Study||0
596806|NCT00452361|1458514|P1|COMPLETED|Overall Study||0
596807|NCT00452361|1458513|P2|STARTED|Overall Study||10
596808|NCT00452361|1458514|P1|STARTED|Overall Study||21
596809|NCT00452348|1458558|P2|NOT COMPLETED|Overall Study||84
596810|NCT00452348|1458559|P1|NOT COMPLETED|Overall Study||79
596811|NCT00452348|1458558|P2|COMPLETED|Overall Study||234
596812|NCT00452348|1458559|P1|COMPLETED|Overall Study||231
596813|NCT00452348|1458558|P2|STARTED|Overall Study||318
596814|NCT00452348|1458559|P1|STARTED|Overall Study||310
596815|NCT00452335|1458574|P3|NOT COMPLETED|Overall Study||9
596816|NCT00452335|1458575|P2|NOT COMPLETED|Overall Study||4
596817|NCT00452335|1458576|P1|NOT COMPLETED|Overall Study||2
596818|NCT00452335|1458574|P3|COMPLETED|Overall Study||23
596819|NCT00452335|1458575|P2|COMPLETED|Overall Study||61
596820|NCT00452335|1458576|P1|COMPLETED|Overall Study||25
596821|NCT00452335|1458574|P3|STARTED|Overall Study||32
596822|NCT00452335|1458575|P2|STARTED|Overall Study||65
596823|NCT00452335|1458576|P1|STARTED|Overall Study||27
596824|NCT00452114|1458613|P2|NOT COMPLETED|Overall Study||3
596825|NCT00452114|1458614|P1|NOT COMPLETED|Overall Study||3
596826|NCT00452114|1458613|P2|COMPLETED|Overall Study||10
596827|NCT00452114|1458614|P1|COMPLETED|Overall Study||12
596828|NCT00452114|1458613|P2|STARTED|Overall Study||13
596829|NCT00452114|1458614|P1|STARTED|Overall Study||15
596830|NCT00451958|1458624|P5|NOT COMPLETED|CS21A (NCT00451958)||0
596831|NCT00451958|1458625|P4|NOT COMPLETED|CS21A (NCT00451958)||39
596832|NCT00451958|1458626|P3|NOT COMPLETED|CS21A (NCT00451958)||42
596833|NCT00451958|1458627|P2|NOT COMPLETED|CS21A (NCT00451958)||77
596834|NCT00451958|1458628|P1|NOT COMPLETED|CS21A (NCT00451958)||65
596835|NCT00451958|1458624|P5|COMPLETED|CS21A (NCT00451958)||0
596836|NCT00451958|1458625|P4|COMPLETED|CS21A (NCT00451958)||27
596837|NCT00451958|1458626|P3|COMPLETED|CS21A (NCT00451958)||27
596838|NCT00451958|1458627|P2|COMPLETED|CS21A (NCT00451958)||49
596839|NCT00451958|1458628|P1|COMPLETED|CS21A (NCT00451958)||60
596840|NCT00451958|1458624|P5|STARTED|CS21A (NCT00451958)|Participants were switched to the degarelix groups when CS21 was completed.|0
596841|NCT00451958|1458625|P4|STARTED|CS21A (NCT00451958)|One of the enrolled participants never received any treatment, i.e. the CS21A ITT population=65.|66
596842|NCT00451958|1458626|P3|STARTED|CS21A (NCT00451958)|CS21A ITT population.|69
596843|NCT00451958|1458627|P2|STARTED|CS21A (NCT00451958)|CS21A ITT population.|126
596844|NCT00451958|1458628|P1|STARTED|CS21A (NCT00451958)|CS21A intention-to-treat (ITT) population.|125
596845|NCT00451958|1458624|P5|NOT COMPLETED|CS21 (NCT00295750)||32
596846|NCT00451958|1458625|P4|NOT COMPLETED|CS21 (NCT00295750)||0
596847|NCT00451958|1458626|P3|NOT COMPLETED|CS21 (NCT00295750)||0
596848|NCT00451958|1458627|P2|NOT COMPLETED|CS21 (NCT00295750)||43
596849|NCT00451958|1458628|P1|NOT COMPLETED|CS21 (NCT00295750)||41
596850|NCT00451958|1458624|P5|COMPLETED|CS21 (NCT00295750)||172
596851|NCT00451958|1458625|P4|COMPLETED|CS21 (NCT00295750)||0
596852|NCT00451958|1458626|P3|COMPLETED|CS21 (NCT00295750)||0
596853|NCT00451958|1458627|P2|COMPLETED|CS21 (NCT00295750)||163
596854|NCT00451958|1458628|P1|COMPLETED|CS21 (NCT00295750)||169
596855|NCT00451958|1458624|P5|STARTED|CS21 (NCT00295750)||204
596856|NCT00451958|1458625|P4|STARTED|CS21 (NCT00295750)|Participants were switched from the leuprolide 7.5 mg group when CS21 was completed.|0
596857|NCT00451958|1458626|P3|STARTED|CS21 (NCT00295750)|Participants were switched from the leuprolide 7.5 mg group when CS21 was completed.|0
596858|NCT00451958|1458627|P2|STARTED|CS21 (NCT00295750)|CS21 ITT population.|206
596859|NCT00451958|1458628|P1|STARTED|CS21 (NCT00295750)|CS21 intention-to-treat (ITT) population.|210
596860|NCT00451906|1458658|P1|NOT COMPLETED|Overall Study||2239
596861|NCT00451906|1458658|P1|COMPLETED|Overall Study||13
596862|NCT00451906|1458658|P1|STARTED|Overall Study||2252
596863|NCT00451698|1458668|P2|NOT COMPLETED|Overall Study||0
596864|NCT00451698|1458669|P1|NOT COMPLETED|Overall Study||0
596865|NCT00451698|1458668|P2|COMPLETED|Overall Study||6
596866|NCT00451698|1458669|P1|COMPLETED|Overall Study||3
596867|NCT00451698|1458668|P2|STARTED|Overall Study||6
596868|NCT00451698|1458669|P1|STARTED|Overall Study||3
596869|NCT00451451|1458681|P4|NOT COMPLETED|Overall Study||58
596870|NCT00451451|1458682|P3|NOT COMPLETED|Overall Study||72
596871|NCT00451451|1458683|P2|NOT COMPLETED|Overall Study||75
596872|NCT00451451|1458684|P1|NOT COMPLETED|Overall Study||85
596873|NCT00451451|1458681|P4|COMPLETED|Overall Study||292
596874|NCT00451451|1458682|P3|COMPLETED|Overall Study||273
596875|NCT00451451|1458683|P2|COMPLETED|Overall Study||284
596876|NCT00451451|1458684|P1|COMPLETED|Overall Study||278
596877|NCT00451451|1458681|P4|STARTED|Overall Study|350 participants were dosed; 360 participants were randomized|350
596878|NCT00451451|1458682|P3|STARTED|Overall Study|345 participants were dosed; 345 participants were randomized|345
596879|NCT00451451|1458683|P2|STARTED|Overall Study|359 participants were dosed; 362 participants were randomized|359
596880|NCT00451451|1458684|P1|STARTED|Overall Study|363 participants were dosed; 363 participants were randomized|363
596881|NCT00451321|1458719|P8|NOT COMPLETED|Overall Study||6
596882|NCT00451321|1458720|P7|NOT COMPLETED|Overall Study||6
596883|NCT00451321|1458721|P6|NOT COMPLETED|Overall Study||9
596884|NCT00451321|1458722|P5|NOT COMPLETED|Overall Study||7
596885|NCT00451321|1458723|P4|NOT COMPLETED|Overall Study||12
596886|NCT00451321|1458724|P3|NOT COMPLETED|Overall Study||18
596887|NCT00451321|1458725|P2|NOT COMPLETED|Overall Study||5
596888|NCT00451321|1458726|P1|NOT COMPLETED|Overall Study||7
596889|NCT00451321|1458719|P8|COMPLETED|Overall Study||0
596890|NCT00451321|1458720|P7|COMPLETED|Overall Study||0
596891|NCT00451321|1458721|P6|COMPLETED|Overall Study||0
596892|NCT00451321|1458722|P5|COMPLETED|Overall Study||0
596893|NCT00451321|1458723|P4|COMPLETED|Overall Study||7
596894|NCT00451321|1458724|P3|COMPLETED|Overall Study||0
596895|NCT00451321|1458725|P2|COMPLETED|Overall Study||10
596896|NCT00451321|1458726|P1|COMPLETED|Overall Study||1
596897|NCT00451321|1458719|P8|STARTED|Overall Study||6
596898|NCT00451321|1458720|P7|STARTED|Overall Study||6
596899|NCT00451321|1458721|P6|STARTED|Overall Study||9
596900|NCT00451321|1458722|P5|STARTED|Overall Study||7
596901|NCT00451321|1458723|P4|STARTED|Overall Study||19
596902|NCT00451321|1458724|P3|STARTED|Overall Study||18
596903|NCT00451321|1458725|P2|STARTED|Overall Study||15
596904|NCT00451321|1458726|P1|STARTED|Overall Study||8
596905|NCT00451282|1458898|P2|NOT COMPLETED|Overall Study||5
596906|NCT00451282|1458899|P1|NOT COMPLETED|Overall Study||6
596907|NCT00451282|1458898|P2|COMPLETED|Overall Study||34
596908|NCT00451282|1458899|P1|COMPLETED|Overall Study||40
596909|NCT00451282|1458898|P2|STARTED|Overall Study||39
596910|NCT00451282|1458899|P1|STARTED|Overall Study||46
596911|NCT00451204|1458913|P2|NOT COMPLETED|Overall Study||20
596912|NCT00451204|1458914|P1|NOT COMPLETED|Overall Study||22
596913|NCT00451204|1458913|P2|COMPLETED|Overall Study||56
596914|NCT00451204|1458914|P1|COMPLETED|Overall Study|60 completed the study but 3 stopped study drug(s) early|60
596915|NCT00451204|1458913|P2|STARTED|Overall Study||76
596916|NCT00451204|1458914|P1|STARTED|Overall Study||82
596917|NCT00451191|1458932|P2|NOT COMPLETED|Overall Study||11
596918|NCT00451191|1458933|P1|NOT COMPLETED|Overall Study||15
596919|NCT00451191|1458932|P2|COMPLETED|Overall Study||55
596920|NCT00451191|1458933|P1|COMPLETED|Overall Study||53
596921|NCT00451191|1458932|P2|STARTED|Overall Study||66
596922|NCT00451191|1458933|P1|STARTED|Overall Study||68
596923|NCT00451048|1458939|P1|NOT COMPLETED|Overall Study||0
596924|NCT00451048|1458939|P1|COMPLETED|Overall Study||10
596925|NCT00451048|1458939|P1|STARTED|Overall Study||10
596926|NCT00450983|1458943|P1|NOT COMPLETED|Overall Study||0
596927|NCT00450983|1458943|P1|COMPLETED|Overall Study||1
596928|NCT00450983|1458943|P1|STARTED|Overall Study||1
596929|NCT00450866|1458955|P2|NOT COMPLETED|Overall Study||3
596930|NCT00450866|1458956|P1|NOT COMPLETED|Overall Study||7
596931|NCT00450866|1458955|P2|COMPLETED|Overall Study||7
596932|NCT00450866|1458956|P1|COMPLETED|Overall Study||38
596933|NCT00450866|1458955|P2|STARTED|Overall Study||10
596934|NCT00450866|1458956|P1|STARTED|Overall Study||45
596935|NCT00450801|1458966|P1|NOT COMPLETED|Overall Study||1
596936|NCT00450801|1458966|P1|COMPLETED|Overall Study||21
596937|NCT00450801|1458966|P1|STARTED|Overall Study||22
596938|NCT00450749|1458980|P3|NOT COMPLETED|Overall Study||2
596939|NCT00450749|1458981|P2|NOT COMPLETED|Overall Study||1
596940|NCT00450749|1458982|P1|NOT COMPLETED|Overall Study||0
596941|NCT00450749|1458980|P3|COMPLETED|Overall Study||2
596942|NCT00450749|1458981|P2|COMPLETED|Overall Study||2
596943|NCT00450749|1458982|P1|COMPLETED|Overall Study||3
596944|NCT00450749|1458980|P3|STARTED|Overall Study||4
596945|NCT00450749|1458981|P2|STARTED|Overall Study||3
596946|NCT00450749|1458982|P1|STARTED|Overall Study||3
596947|NCT00450723|1458990|P1|NOT COMPLETED|Overall Study||5
596948|NCT00450723|1458990|P1|COMPLETED|Overall Study||34
596949|NCT00450723|1458990|P1|STARTED|Overall Study||39
596950|NCT00450658|1458998|P2|NOT COMPLETED|Overall Study||90
596951|NCT00450658|1458999|P1|NOT COMPLETED|Overall Study||143
596952|NCT00450658|1458998|P2|COMPLETED|Overall Study||122
596953|NCT00450658|1458999|P1|COMPLETED|Overall Study||272
596954|NCT00450658|1458998|P2|STARTED|Overall Study||212
596955|NCT00450658|1458999|P1|STARTED|Overall Study||415
596956|NCT00450619|1459013|P2|NOT COMPLETED|Overall Study||1
596957|NCT00450619|1459014|P1|NOT COMPLETED|Overall Study||4
596958|NCT00450619|1459013|P2|COMPLETED|Overall Study||21
596959|NCT00450619|1459014|P1|COMPLETED|Overall Study||18
596960|NCT00450619|1459013|P2|STARTED|Overall Study||22
596961|NCT00450619|1459014|P1|STARTED|Overall Study||22
596962|NCT00450580|1459040|P2|NOT COMPLETED|Overall Study||16
596963|NCT00450580|1459041|P1|NOT COMPLETED|Overall Study||16
596964|NCT00450580|1459040|P2|COMPLETED|Overall Study||90
596965|NCT00450580|1459041|P1|COMPLETED|Overall Study||90
596966|NCT00450580|1459040|P2|STARTED|Overall Study||106
596967|NCT00450580|1459041|P1|STARTED|Overall Study||106
596968|NCT00450450|1459061|P2|NOT COMPLETED|Overall Study||3
596969|NCT00450450|1459062|P1|NOT COMPLETED|Overall Study||5
596970|NCT00450450|1459061|P2|COMPLETED|Overall Study||11
596971|NCT00450450|1459062|P1|COMPLETED|Overall Study||8
596972|NCT00450450|1459061|P2|STARTED|Overall Study||14
596973|NCT00450450|1459062|P1|STARTED|Overall Study||13
596974|NCT00450437|1459086|P4|NOT COMPLETED|Overall Study||11
596975|NCT00450437|1459087|P3|NOT COMPLETED|Overall Study||24
596976|NCT00450437|1459088|P2|NOT COMPLETED|Overall Study||16
596977|NCT00450437|1459089|P1|NOT COMPLETED|Overall Study||46
596978|NCT00450437|1459086|P4|COMPLETED|Overall Study||325
596979|NCT00450437|1459087|P3|COMPLETED|Overall Study||999
596980|NCT00450437|1459088|P2|COMPLETED|Overall Study||524
596981|NCT00450437|1459089|P1|COMPLETED|Overall Study||1594
596982|NCT00450437|1459086|P4|STARTED|Overall Study||336
596983|NCT00450437|1459087|P3|STARTED|Overall Study||1023
596984|NCT00450437|1459088|P2|STARTED|Overall Study||540
596985|NCT00450437|1459089|P1|STARTED|Overall Study||1640
596986|NCT00450424|1459113|P2|NOT COMPLETED|Overall Study||11
596987|NCT00450424|1459114|P1|NOT COMPLETED|Overall Study||20
596988|NCT00450424|1459113|P2|COMPLETED|Overall Study||106
596989|NCT00450424|1459114|P1|COMPLETED|Overall Study||102
596990|NCT00450424|1459113|P2|STARTED|Overall Study||117
596991|NCT00450424|1459114|P1|STARTED|Overall Study||122
596992|NCT00450411|1459120|P1|NOT COMPLETED|Overall Study||8
596993|NCT00450411|1459120|P1|COMPLETED|Overall Study||92
596994|NCT00450411|1459120|P1|STARTED|Overall Study||100
596995|NCT00450385|1459125|P1|NOT COMPLETED|Overall Study||13
596996|NCT00450385|1459125|P1|COMPLETED|Overall Study||44
596997|NCT00450385|1459125|P1|STARTED|Overall Study||57
596998|NCT00450372|1459134|P1|NOT COMPLETED|Overall Study||1
596999|NCT00450372|1459134|P1|COMPLETED|Overall Study||37
597000|NCT00450372|1459134|P1|STARTED|Overall Study||38
597001|NCT00450333|1459147|P4|NOT COMPLETED|Overall Study||28
597002|NCT00450333|1459148|P3|NOT COMPLETED|Overall Study||25
597003|NCT00450333|1459149|P2|NOT COMPLETED|Overall Study||63
597004|NCT00450333|1459150|P1|NOT COMPLETED|Overall Study||54
597005|NCT00450333|1459147|P4|COMPLETED|Overall Study||74
597006|NCT00450333|1459148|P3|COMPLETED|Overall Study||75
597007|NCT00450333|1459149|P2|COMPLETED|Overall Study||44
597008|NCT00450333|1459150|P1|COMPLETED|Overall Study||44
597009|NCT00450333|1459147|P4|STARTED|Overall Study||102
597010|NCT00450333|1459148|P3|STARTED|Overall Study||100
597011|NCT00450333|1459149|P2|STARTED|Overall Study||107
597012|NCT00450333|1459150|P1|STARTED|Overall Study||98
597013|NCT00450294|1459168|P1|NOT COMPLETED|Overall Study||0
597014|NCT00450294|1459168|P1|COMPLETED|Overall Study||10
597015|NCT00450294|1459168|P1|STARTED|Overall Study||10
597016|NCT00450255|1459173|P1|NOT COMPLETED|Overall Study||1
597017|NCT00450255|1459173|P1|COMPLETED|Overall Study||40
597018|NCT00450255|1459173|P1|STARTED|Overall Study||41
597019|NCT00450242|1459183|P2|NOT COMPLETED|Overall Study||1
597020|NCT00450242|1459184|P1|NOT COMPLETED|Overall Study||3
597021|NCT00450242|1459183|P2|COMPLETED|Overall Study||6
597022|NCT00450242|1459184|P1|COMPLETED|Overall Study||4
597023|NCT00450242|1459183|P2|STARTED|Overall Study||7
597024|NCT00450242|1459184|P1|STARTED|Overall Study||7
597025|NCT00450216|1459198|P2|NOT COMPLETED|Overall Study||129
597026|NCT00450216|1459199|P1|NOT COMPLETED|Overall Study||174
597027|NCT00450216|1459198|P2|COMPLETED|Overall Study||170
597028|NCT00450216|1459199|P1|COMPLETED|Overall Study||433
597029|NCT00450216|1459198|P2|STARTED|Overall Study||299
597030|NCT00450216|1459199|P1|STARTED|Overall Study||607
597031|NCT00450112|1459213|P2|NOT COMPLETED|Overall Study||6
597032|NCT00450112|1459214|P1|NOT COMPLETED|Overall Study||13
597033|NCT00450112|1459213|P2|COMPLETED|Overall Study||71
597034|NCT00450112|1459214|P1|COMPLETED|Overall Study||112
597035|NCT00450112|1459213|P2|Analyzed Participants|Overall Study||74
597036|NCT00450112|1459214|P1|Analyzed Participants|Overall Study|3 subjects removed from ITT analyses because of no post treatment data (pre-defined criteria).|122
597037|NCT00450112|1459213|P2|Received Injection|Overall Study||74
597038|NCT00450112|1459214|P1|Received Injection|Overall Study||125
597039|NCT00450112|1459213|P2|STARTED|Overall Study||77
597040|NCT00450112|1459214|P1|STARTED|Overall Study||125
597041|NCT00450073|1459239|P3|NOT COMPLETED|Overall Study||1
597042|NCT00450073|1459240|P2|NOT COMPLETED|Overall Study||0
597043|NCT00450073|1459241|P1|NOT COMPLETED|Overall Study||1
597044|NCT00450073|1459239|P3|COMPLETED|Overall Study||9
597045|NCT00450073|1459240|P2|COMPLETED|Overall Study||10
597046|NCT00450073|1459241|P1|COMPLETED|Overall Study||9
597047|NCT00450073|1459239|P3|STARTED|Overall Study||10
597048|NCT00450073|1459240|P2|STARTED|Overall Study||10
597049|NCT00450073|1459241|P1|STARTED|Overall Study||10
597050|NCT00449956|1459252|P3|NOT COMPLETED|Overall Study||9
597051|NCT00449956|1459253|P2|NOT COMPLETED|Overall Study||4
597052|NCT00449956|1459254|P1|NOT COMPLETED|Overall Study||10
597053|NCT00449956|1459252|P3|COMPLETED|Overall Study||184
597054|NCT00449956|1459253|P2|COMPLETED|Overall Study||88
597055|NCT00449956|1459254|P1|COMPLETED|Overall Study||179
597056|NCT00449956|1459252|P3|STARTED|Overall Study||193
597057|NCT00449956|1459253|P2|STARTED|Overall Study||92
597058|NCT00449956|1459254|P1|STARTED|Overall Study||189
597059|NCT00449930|1459270|P2|NOT COMPLETED|Overall Study||75
597060|NCT00449930|1459271|P1|NOT COMPLETED|Overall Study||61
597061|NCT00449930|1459270|P2|COMPLETED|Overall Study||447
597062|NCT00449930|1459271|P1|COMPLETED|Overall Study||467
597063|NCT00449930|1459270|P2|STARTED|Overall Study||522
597064|NCT00449930|1459271|P1|STARTED|Overall Study||528
597065|NCT00449865|1459287|P2|NOT COMPLETED|Overall Study||534
597066|NCT00449865|1459288|P1|NOT COMPLETED|Overall Study||522
597067|NCT00449865|1459287|P2|COMPLETED|Overall Study|477 Expected at Year 5|340
597068|NCT00449865|1459288|P1|COMPLETED|Overall Study|478 Expected at Year 5|345
597069|NCT00449865|1459287|P2|Completed Year 4|Overall Study|686 Expected at Year 4|523
597070|NCT00449865|1459288|P1|Completed Year 4|Overall Study|679 Expected at Year 4|521
597071|NCT00449865|1459287|P2|Completed Year 3|Overall Study|874 Expected at Year 3|715
597072|NCT00449865|1459288|P1|Completed Year 3|Overall Study|867 Expected at Year 3|719
597073|NCT00449865|1459287|P2|Completed Year 2|Overall Study|874 Expected at Year 2|766
597074|NCT00449865|1459288|P1|Completed Year 2|Overall Study|867 Expected at Year 2|768
597075|NCT00449865|1459287|P2|Completed Year 1|Overall Study|874 Expected at Year 1|822
597076|NCT00449865|1459288|P1|Completed Year 1|Overall Study|867 Expected at Year 1|802
597077|NCT00449865|1459287|P2|STARTED|Overall Study||874
597078|NCT00449865|1459288|P1|STARTED|Overall Study||867
597079|NCT00449787|1459296|P2|NOT COMPLETED|Overall Study||100
597080|NCT00449787|1459297|P1|NOT COMPLETED|Overall Study||105
597081|NCT00449787|1459296|P2|COMPLETED|Overall Study||98
597082|NCT00449787|1459297|P1|COMPLETED|Overall Study||98
597083|NCT00449787|1459296|P2|STARTED|Overall Study||198
597084|NCT00449787|1459297|P1|STARTED|Overall Study||203
597085|NCT00449748|1459307|P1|NOT COMPLETED|Overall Study||0
597086|NCT00449748|1459307|P1|COMPLETED|Overall Study||10
597087|NCT00449748|1459307|P1|STARTED|Overall Study||10
597088|NCT00449696|1459313|P2|NOT COMPLETED|Overall Study||9
597089|NCT00449696|1459314|P1|NOT COMPLETED|Overall Study||20
597090|NCT00449696|1459313|P2|COMPLETED|Overall Study||119
597091|NCT00449696|1459314|P1|COMPLETED|Overall Study||231
597092|NCT00449696|1459313|P2|Analyzed Participants|Overall Study||128
597093|NCT00449696|1459314|P1|Analyzed Participants|Overall Study|2 subjects removed from ITT analyses because of no post treatment data (pre-defined criteria).|247
597094|NCT00449696|1459313|P2|Received Injection|Overall Study||128
597095|NCT00449696|1459314|P1|Received Injection|Overall Study||249
597096|NCT00449696|1459313|P2|STARTED|Overall Study||128
597097|NCT00449696|1459314|P1|STARTED|Overall Study||251
597098|NCT00449644|1459340|P4|NOT COMPLETED|Overall Study||32
597099|NCT00449644|1459341|P3|NOT COMPLETED|Overall Study||29
597100|NCT00449644|1459342|P2|NOT COMPLETED|Overall Study||13
597101|NCT00449644|1459343|P1|NOT COMPLETED|Overall Study||10
597102|NCT00449644|1459340|P4|COMPLETED|Overall Study|After Week 24, 1 patient rolled over to treatment with TMC207 and was not completed or discontinued.|49
597103|NCT00449644|1459341|P3|COMPLETED|Overall Study||50
597104|NCT00449644|1459342|P2|COMPLETED|Overall Study||11
597105|NCT00449644|1459343|P1|COMPLETED|Overall Study||13
597106|NCT00449644|1459340|P4|Rollover|Overall Study||1
597107|NCT00449644|1459341|P3|Rollover|Overall Study||0
597108|NCT00449644|1459342|P2|Rollover|Overall Study||0
597109|NCT00449644|1459343|P1|Rollover|Overall Study||0
597110|NCT00449644|1459340|P4|STARTED|Overall Study||81
597111|NCT00449644|1459341|P3|STARTED|Overall Study||79
597112|NCT00449644|1459342|P2|STARTED|Overall Study||24
597113|NCT00449644|1459343|P1|STARTED|Overall Study||23
597114|NCT00449540|1459363|P3|NOT COMPLETED|Treatment Phase||17
597115|NCT00449540|1459364|P2|NOT COMPLETED|Treatment Phase||20
597116|NCT00449540|1459365|P1|NOT COMPLETED|Treatment Phase||0
597117|NCT00449540|1459363|P3|COMPLETED|Treatment Phase||82
597118|NCT00449540|1459364|P2|COMPLETED|Treatment Phase||82
597119|NCT00449540|1459365|P1|COMPLETED|Treatment Phase||0
597120|NCT00449540|1459363|P3|STARTED|Treatment Phase||99
597121|NCT00449540|1459364|P2|STARTED|Treatment Phase||102
597122|NCT00449540|1459365|P1|STARTED|Treatment Phase||0
597123|NCT00449540|1459363|P3|NOT COMPLETED|Pretreatment Phase||0
597124|NCT00449540|1459364|P2|NOT COMPLETED|Pretreatment Phase||0
597125|NCT00449540|1459365|P1|NOT COMPLETED|Pretreatment Phase||66
597126|NCT00449540|1459363|P3|COMPLETED|Pretreatment Phase||0
597127|NCT00449540|1459364|P2|COMPLETED|Pretreatment Phase||0
597128|NCT00449540|1459365|P1|COMPLETED|Pretreatment Phase||201
597129|NCT00449540|1459363|P3|STARTED|Pretreatment Phase||0
597130|NCT00449540|1459364|P2|STARTED|Pretreatment Phase||0
597131|NCT00449540|1459365|P1|STARTED|Pretreatment Phase||267
597132|NCT00449176|1459382|P3|NOT COMPLETED|Overall Study||167
597133|NCT00449176|1459383|P2|NOT COMPLETED|Overall Study||195
597134|NCT00449176|1459384|P1|NOT COMPLETED|Overall Study||152
597135|NCT00449176|1459382|P3|COMPLETED|Overall Study||152
597136|NCT00449176|1459383|P2|COMPLETED|Overall Study||133
597137|NCT00449176|1459384|P1|COMPLETED|Overall Study||166
597138|NCT00449176|1459382|P3|STARTED|Overall Study|5 randomly assigned to this group did not receive drug, 2 enrolled twice(of 326 subjects randomized)|319
597139|NCT00449176|1459383|P2|STARTED|Overall Study|6 randomly assigned to this treatment group did not take drug (of 334 subjects initially randomized)|328
597140|NCT00449176|1459384|P1|STARTED|Overall Study|3 randomly assigned to this treatment group did not take drug (of 321 subjects initially randomized)|318
597141|NCT00449163|1459410|P1|NOT COMPLETED|Overall Study||3
597142|NCT00449163|1459410|P1|COMPLETED|Overall Study||22
597143|NCT00449163|1459410|P1|STARTED|Overall Study||25
597144|NCT00449150|1459420|P3|NOT COMPLETED|Overall Study||47
597145|NCT00449150|1459421|P2|NOT COMPLETED|Overall Study||53
597146|NCT00449150|1459422|P1|NOT COMPLETED|Overall Study||46
597147|NCT00449150|1459420|P3|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|171
597148|NCT00449150|1459421|P2|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|177
597149|NCT00449150|1459422|P1|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|173
597150|NCT00449150|1459420|P3|STARTED|Overall Study||218
597151|NCT00449150|1459421|P2|STARTED|Overall Study||230
597152|NCT00449150|1459422|P1|STARTED|Overall Study||219
597153|NCT00449072|1459432|P2|NOT COMPLETED|Overall Study||42
597154|NCT00449072|1459433|P1|NOT COMPLETED|Overall Study||41
597155|NCT00449072|1459432|P2|COMPLETED|Overall Study||109
597156|NCT00449072|1459433|P1|COMPLETED|Overall Study||107
597157|NCT00449072|1459432|P2|STARTED|Overall Study||151
597158|NCT00449072|1459433|P1|STARTED|Overall Study||148
597159|NCT00449046|1459457|P1|NOT COMPLETED|Overall Study||0
597160|NCT00449046|1459457|P1|COMPLETED|Overall Study||40
597161|NCT00449046|1459457|P1|STARTED|Overall Study||40
597162|NCT00449033|1459470|P2|NOT COMPLETED|Follow-up Period||434
597163|NCT00449033|1459471|P1|NOT COMPLETED|Follow-up Period||425
597164|NCT00449033|1459470|P2|COMPLETED|Follow-up Period||0
597165|NCT00449033|1459471|P1|COMPLETED|Follow-up Period||0
597166|NCT00449033|1459470|P2|STARTED|Follow-up Period|434 entered, comprising 452 randomized less 12 deaths, 2 lost to follow-up & 4 ongoing on treatment|434
597167|NCT00449033|1459471|P1|STARTED|Follow-up Period|425 entered, comprising 452 randomized less 21 deaths & 6 ongoing on treatment|425
597168|NCT00449033|1459470|P2|NOT COMPLETED|Treatment Period||452
597169|NCT00449033|1459471|P1|NOT COMPLETED|Treatment Period||452
597170|NCT00449033|1459470|P2|COMPLETED|Treatment Period||0
597171|NCT00449033|1459471|P1|COMPLETED|Treatment Period||0
597172|NCT00449033|1459470|P2|Received Treatment|Treatment Period||449
597173|NCT00449033|1459471|P1|Received Treatment|Treatment Period||452
597174|NCT00449033|1459470|P2|STARTED|Treatment Period|Reasons for not treated: Adverse event (N=1); Consent withdrawn (N=1); Reason missing (N=1)|452
597175|NCT00449033|1459471|P1|STARTED|Treatment Period||452
597176|NCT00448916|1459509|P4|NOT COMPLETED|Overall Study||6
597177|NCT00448916|1459510|P3|NOT COMPLETED|Overall Study||6
597178|NCT00448916|1459511|P2|NOT COMPLETED|Overall Study||6
597179|NCT00448916|1459512|P1|NOT COMPLETED|Overall Study||7
597180|NCT00448916|1459509|P4|COMPLETED|Overall Study||5
597181|NCT00448916|1459510|P3|COMPLETED|Overall Study||6
597182|NCT00448916|1459511|P2|COMPLETED|Overall Study||9
597183|NCT00448916|1459512|P1|COMPLETED|Overall Study||9
597184|NCT00448916|1459509|P4|STARTED|Overall Study||11
597185|NCT00448916|1459510|P3|STARTED|Overall Study||12
597186|NCT00448916|1459511|P2|STARTED|Overall Study||15
597187|NCT00448916|1459512|P1|STARTED|Overall Study||16
597188|NCT00448864|1459586|P3|NOT COMPLETED|Overall Study||1
597189|NCT00448864|1459587|P2|NOT COMPLETED|Overall Study||5
597190|NCT00448864|1459588|P1|NOT COMPLETED|Overall Study||5
597191|NCT00448864|1459586|P3|COMPLETED|Overall Study||18
597192|NCT00448864|1459587|P2|COMPLETED|Overall Study||24
597193|NCT00448864|1459588|P1|COMPLETED|Overall Study||22
597283|NCT00448175|1459818|P2|COMPLETED|Continued PTNS Through 12 Months||0
597194|NCT00448864|1459586|P3|Completed Post-operative Period|Overall Study||18
597195|NCT00448864|1459587|P2|Completed Post-operative Period|Overall Study||25
597196|NCT00448864|1459588|P1|Completed Post-operative Period|Overall Study||26
597197|NCT00448864|1459586|P3|Started Post-operative Period|Overall Study||18
597198|NCT00448864|1459587|P2|Started Post-operative Period|Overall Study||25
597199|NCT00448864|1459588|P1|Started Post-operative Period|Overall Study||26
597200|NCT00448864|1459586|P3|Received at Least 1 Dose of Study Drug|Overall Study||18
597201|NCT00448864|1459587|P2|Received at Least 1 Dose of Study Drug|Overall Study||25
597202|NCT00448864|1459588|P1|Received at Least 1 Dose of Study Drug|Overall Study||26
597203|NCT00448864|1459586|P3|STARTED|Overall Study||19
597204|NCT00448864|1459587|P2|STARTED|Overall Study||29
597205|NCT00448864|1459588|P1|STARTED|Overall Study||27
597206|NCT00448760|1459604|P1|NOT COMPLETED|Overall Study||3
597207|NCT00448760|1459604|P1|COMPLETED|Overall Study||26
597208|NCT00448760|1459604|P1|STARTED|Overall Study||29
597209|NCT00448708|1459613|P2|NOT COMPLETED|Overall Study||31
597210|NCT00448708|1459614|P1|NOT COMPLETED|Overall Study||35
597211|NCT00448708|1459613|P2|COMPLETED|Overall Study||79
597212|NCT00448708|1459614|P1|COMPLETED|Overall Study||77
597213|NCT00448708|1459613|P2|STARTED|Overall Study||110
597214|NCT00448708|1459614|P1|STARTED|Overall Study||112
597215|NCT00448682|1459622|P1|NOT COMPLETED|Overall Study||0
597216|NCT00448682|1459622|P1|COMPLETED|Overall Study||25
597217|NCT00448682|1459622|P1|STARTED|Overall Study||25
597218|NCT00448630|1459628|P1|NOT COMPLETED|Overall Study||27
597219|NCT00448630|1459628|P1|COMPLETED|Overall Study|Number of patients who remained on same medication to end of study.|301
597220|NCT00448630|1459628|P1|STARTED|Overall Study||328
597221|NCT00448591|1459673|P1|NOT COMPLETED|Overall Study||2296
597222|NCT00448591|1459673|P1|COMPLETED|Overall Study||0
597223|NCT00448591|1459673|P1|STARTED|Overall Study||2296
597224|NCT00448539|1459684|P2|NOT COMPLETED|Overall Study||152
597225|NCT00448539|1459685|P1|NOT COMPLETED|Overall Study||134
597226|NCT00448539|1459684|P2|COMPLETED|Overall Study||0
597227|NCT00448539|1459685|P1|COMPLETED|Overall Study||0
597228|NCT00448539|1459684|P2|STARTED|Overall Study||152
597229|NCT00448539|1459685|P1|STARTED|Overall Study||134
597230|NCT00448448|1459693|P2|NOT COMPLETED|Overall Study||41
597231|NCT00448448|1459694|P1|NOT COMPLETED|Overall Study||100
597232|NCT00448448|1459693|P2|COMPLETED|Overall Study||96
597233|NCT00448448|1459694|P1|COMPLETED|Overall Study||146
597234|NCT00448448|1459693|P2|STARTED|Overall Study||137
597235|NCT00448448|1459694|P1|STARTED|Overall Study||246
597236|NCT00448435|1459700|P2|NOT COMPLETED|Extension Period - 20 Weeks||0
597237|NCT00448435|1459701|P1|NOT COMPLETED|Extension Period - 20 Weeks||0
597238|NCT00448435|1459700|P2|COMPLETED|Extension Period - 20 Weeks||0
597239|NCT00448435|1459701|P1|COMPLETED|Extension Period - 20 Weeks||50
597240|NCT00448435|1459700|P2|STARTED|Extension Period - 20 Weeks||0
597241|NCT00448435|1459701|P1|STARTED|Extension Period - 20 Weeks||50
597242|NCT00448435|1459700|P2|NOT COMPLETED|Treatment Period II - 4 Weeks||0
597243|NCT00448435|1459701|P1|NOT COMPLETED|Treatment Period II - 4 Weeks||0
597244|NCT00448435|1459700|P2|COMPLETED|Treatment Period II - 4 Weeks||25
597245|NCT00448435|1459701|P1|COMPLETED|Treatment Period II - 4 Weeks||25
597246|NCT00448435|1459700|P2|STARTED|Treatment Period II - 4 Weeks||25
597247|NCT00448435|1459701|P1|STARTED|Treatment Period II - 4 Weeks||25
597248|NCT00448435|1459700|P2|NOT COMPLETED|Washout Period - 2 Weeks||0
597249|NCT00448435|1459701|P1|NOT COMPLETED|Washout Period - 2 Weeks||1
597250|NCT00448435|1459700|P2|COMPLETED|Washout Period - 2 Weeks||25
597251|NCT00448435|1459701|P1|COMPLETED|Washout Period - 2 Weeks||25
597252|NCT00448435|1459700|P2|STARTED|Washout Period - 2 Weeks||25
597253|NCT00448435|1459701|P1|STARTED|Washout Period - 2 Weeks||26
597254|NCT00448435|1459700|P2|NOT COMPLETED|Treatment Period I - 4 Weeks||0
597255|NCT00448435|1459701|P1|NOT COMPLETED|Treatment Period I - 4 Weeks||0
597256|NCT00448435|1459700|P2|COMPLETED|Treatment Period I - 4 Weeks||25
597257|NCT00448435|1459701|P1|COMPLETED|Treatment Period I - 4 Weeks||26
597258|NCT00448435|1459700|P2|STARTED|Treatment Period I - 4 Weeks||25
597259|NCT00448435|1459701|P1|STARTED|Treatment Period I - 4 Weeks||26
597260|NCT00448357|1459727|P1|NOT COMPLETED|Overall Study||0
597261|NCT00448357|1459727|P1|COMPLETED|Overall Study||54
597262|NCT00448357|1459727|P1|STARTED|Overall Study||54
597263|NCT00448344|1459752|P2|NOT COMPLETED|Overall Study||36
597264|NCT00448344|1459753|P1|NOT COMPLETED|Overall Study||30
597265|NCT00448344|1459752|P2|COMPLETED|Overall Study||200
597266|NCT00448344|1459753|P1|COMPLETED|Overall Study||205
597267|NCT00448344|1459752|P2|STARTED|Overall Study||236
597268|NCT00448344|1459753|P1|STARTED|Overall Study||235
597269|NCT00448279|1459763|P2|NOT COMPLETED|Overall Study||29
597270|NCT00448279|1459764|P1|NOT COMPLETED|Overall Study||29
597271|NCT00448279|1459763|P2|COMPLETED|Overall Study||0
597272|NCT00448279|1459764|P1|COMPLETED|Overall Study||0
597273|NCT00448279|1459763|P2|STARTED|Overall Study||29
597274|NCT00448279|1459764|P1|STARTED|Overall Study||29
597275|NCT00448227|1459780|P1|NOT COMPLETED|Overall Study||0
597276|NCT00448227|1459780|P1|COMPLETED|Overall Study||18
597277|NCT00448227|1459780|P1|STARTED|Overall Study||18
597278|NCT00448201|1459807|P1|NOT COMPLETED|Overall Study||0
597279|NCT00448201|1459807|P1|COMPLETED|Overall Study||71
597280|NCT00448201|1459807|P1|STARTED|Overall Study||71
597281|NCT00448175|1459818|P2|NOT COMPLETED|Continued PTNS Through 12 Months||0
597282|NCT00448175|1459819|P1|NOT COMPLETED|Continued PTNS Through 12 Months||10
597284|NCT00448175|1459819|P1|COMPLETED|Continued PTNS Through 12 Months||25
597285|NCT00448175|1459818|P2|STARTED|Continued PTNS Through 12 Months||0
597286|NCT00448175|1459819|P1|STARTED|Continued PTNS Through 12 Months||35
597287|NCT00448175|1459818|P2|NOT COMPLETED|12 Weeks PTNS vs. Drug||7
597288|NCT00448175|1459819|P1|NOT COMPLETED|12 Weeks PTNS vs. Drug||9
597289|NCT00448175|1459818|P2|COMPLETED|12 Weeks PTNS vs. Drug||43
597290|NCT00448175|1459819|P1|COMPLETED|12 Weeks PTNS vs. Drug||41
597291|NCT00448175|1459818|P2|STARTED|12 Weeks PTNS vs. Drug||50
597292|NCT00448175|1459819|P1|STARTED|12 Weeks PTNS vs. Drug||50
597293|NCT00448136|1459827|P2|NOT COMPLETED|Overall Study||8
597294|NCT00448136|1459828|P1|NOT COMPLETED|Overall Study||4
597295|NCT00448136|1459827|P2|COMPLETED|Overall Study||41
597296|NCT00448136|1459828|P1|COMPLETED|Overall Study||30
597297|NCT00448136|1459827|P2|STARTED|Overall Study||49
597298|NCT00448136|1459828|P1|STARTED|Overall Study||34
597299|NCT00448123|1459866|P2|NOT COMPLETED|Overall Study||12
597300|NCT00448123|1459867|P1|NOT COMPLETED|Overall Study||15
597301|NCT00448123|1459866|P2|COMPLETED|Overall Study||53
597302|NCT00448123|1459867|P1|COMPLETED|Overall Study||47
597303|NCT00448123|1459866|P2|STARTED|Overall Study||65
597304|NCT00448123|1459867|P1|STARTED|Overall Study||62
597305|NCT00448019|1459877|P1|NOT COMPLETED|Overall Study||7
597306|NCT00448019|1459877|P1|COMPLETED|Overall Study||57
597307|NCT00448019|1459877|P1|STARTED|Overall Study||64
597308|NCT00447902|1459885|P2|NOT COMPLETED|Overall Study||6
597309|NCT00447902|1459886|P1|NOT COMPLETED|Overall Study||4
597310|NCT00447902|1459885|P2|COMPLETED|Overall Study||0
597311|NCT00447902|1459886|P1|COMPLETED|Overall Study||1
597312|NCT00447902|1459885|P2|STARTED|Overall Study||6
597313|NCT00447902|1459886|P1|STARTED|Overall Study||5
597314|NCT00447876|1459928|P2|NOT COMPLETED|Overall Study||4
597315|NCT00447876|1459929|P1|NOT COMPLETED|Overall Study||3
597316|NCT00447876|1459928|P2|COMPLETED|Overall Study||16
597317|NCT00447876|1459929|P1|COMPLETED|Overall Study||17
597318|NCT00447876|1459928|P2|STARTED|Overall Study||20
597319|NCT00447876|1459929|P1|STARTED|Overall Study||20
597320|NCT00447603|1459959|P3|NOT COMPLETED|Filter Period||15
597321|NCT00447603|1459960|P2|NOT COMPLETED|Filter Period||4
597322|NCT00447603|1459961|P1|NOT COMPLETED|Filter Period||0
597323|NCT00447603|1459959|P3|COMPLETED|Filter Period||0
597324|NCT00447603|1459960|P2|COMPLETED|Filter Period||0
597325|NCT00447603|1459961|P1|COMPLETED|Filter Period||0
597326|NCT00447603|1459959|P3|STARTED|Filter Period|The study was discontinued early; no participant entered treatment period|15
597327|NCT00447603|1459960|P2|STARTED|Filter Period|The study was discontinued early; no participant entered treatment period|4
597328|NCT00447603|1459961|P1|STARTED|Filter Period||0
597329|NCT00447603|1459959|P3|NOT COMPLETED|Screening||0
597330|NCT00447603|1459960|P2|NOT COMPLETED|Screening||0
597331|NCT00447603|1459961|P1|NOT COMPLETED|Screening||21
597332|NCT00447603|1459959|P3|COMPLETED|Screening||0
597333|NCT00447603|1459960|P2|COMPLETED|Screening||0
597334|NCT00447603|1459961|P1|COMPLETED|Screening||19
597335|NCT00447603|1459959|P3|STARTED|Screening||0
597336|NCT00447603|1459960|P2|STARTED|Screening||0
597337|NCT00447603|1459961|P1|STARTED|Screening||40
597338|NCT00447590|1459981|P1|NOT COMPLETED|Overall Study||60
597339|NCT00447590|1459981|P1|COMPLETED|Overall Study|Completing the study was defined as the number of participants in the study at month 60 (5 years).|93
597340|NCT00447590|1459981|P1|STARTED|Overall Study|153 participants were treated with the LAP-BAND System.|153
597341|NCT00447499|1459990|P1|NOT COMPLETED|Overall Study||7
597342|NCT00447499|1459990|P1|COMPLETED|Overall Study||52
597343|NCT00447499|1459990|P1|STARTED|Overall Study||59
597344|NCT00447421|1460000|P1|NOT COMPLETED|Overall Study||6
597345|NCT00447421|1460000|P1|COMPLETED|Overall Study||3
597346|NCT00447421|1460000|P1|STARTED|Overall Study||9
597347|NCT00447382|1460012|P2|NOT COMPLETED|Overall Study||6
597348|NCT00447382|1460013|P1|NOT COMPLETED|Overall Study||6
597349|NCT00447382|1460012|P2|COMPLETED|Overall Study||160
597350|NCT00447382|1460013|P1|COMPLETED|Overall Study||158
597351|NCT00447382|1460012|P2|STARTED|Overall Study||166
597352|NCT00447382|1460013|P1|STARTED|Overall Study||164
597353|NCT00447330|1460065|P1|NOT COMPLETED|Overall Study||2
597354|NCT00447330|1460065|P1|COMPLETED|Overall Study||58
597355|NCT00447330|1460065|P1|STARTED|Overall Study|2 subjects signed the ICF, but were withdrawn from study prior to receiving any study drug|60
597356|NCT00447278|1460074|P2|NOT COMPLETED|Period III (Optional 6 Month Extension)||15
597357|NCT00447278|1460075|P1|NOT COMPLETED|Period III (Optional 6 Month Extension)||30
597358|NCT00447278|1460074|P2|COMPLETED|Period III (Optional 6 Month Extension)||140
597359|NCT00447278|1460075|P1|COMPLETED|Period III (Optional 6 Month Extension)||109
597360|NCT00447278|1460074|P2|STARTED|Period III (Optional 6 Month Extension)|16 choose not to enter this optional period.|155
597361|NCT00447278|1460075|P1|STARTED|Period III (Optional 6 Month Extension)|18 choose not to enter this optional period.|139
597362|NCT00447278|1460074|P2|NOT COMPLETED|Period II (6 Month Open-Label)||29
597363|NCT00447278|1460075|P1|NOT COMPLETED|Period II (6 Month Open-Label)||42
597364|NCT00447278|1460074|P2|COMPLETED|Period II (6 Month Open-Label)||171
597365|NCT00447278|1460075|P1|COMPLETED|Period II (6 Month Open-Label)||157
597366|NCT00447278|1460074|P2|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)|1 patient withdrew due to parent/guardian decision prior to receiving study drug.|199
597367|NCT00447278|1460075|P1|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)||199
597368|NCT00447278|1460074|P2|STARTED|Period II (6 Month Open-Label)||200
597369|NCT00447278|1460075|P1|STARTED|Period II (6 Month Open-Label)||199
597370|NCT00447265|1460096|P2|NOT COMPLETED|Overall Study||0
597371|NCT00447265|1460097|P1|NOT COMPLETED|Overall Study||1
597372|NCT00447265|1460096|P2|COMPLETED|Overall Study||0
597373|NCT00447265|1460097|P1|COMPLETED|Overall Study|The participant completed treatment and discontinued follow-up at week 39 after randomization|0
597374|NCT00447265|1460096|P2|STARTED|Overall Study||0
597375|NCT00447265|1460097|P1|STARTED|Overall Study||1
597376|NCT00447226|1460110|P2|NOT COMPLETED|Double-blind Phase||3
597377|NCT00447226|1460111|P1|NOT COMPLETED|Double-blind Phase||4
597378|NCT00447226|1460110|P2|COMPLETED|Double-blind Phase||0
597379|NCT00447226|1460111|P1|COMPLETED|Double-blind Phase||0
597380|NCT00447226|1460110|P2|STARTED|Double-blind Phase||3
597381|NCT00447226|1460111|P1|STARTED|Double-blind Phase||4
597382|NCT00447226|1460110|P2|NOT COMPLETED|12-Week Open-label Phase||25
597383|NCT00447226|1460111|P1|NOT COMPLETED|12-Week Open-label Phase||0
597384|NCT00447226|1460110|P2|COMPLETED|12-Week Open-label Phase||7
597385|NCT00447226|1460111|P1|COMPLETED|12-Week Open-label Phase||0
597386|NCT00447226|1460110|P2|STARTED|12-Week Open-label Phase||32
597387|NCT00447226|1460111|P1|STARTED|12-Week Open-label Phase||0
597388|NCT00447122|1460129|P1|NOT COMPLETED|Overall Study||2
597389|NCT00447122|1460129|P1|COMPLETED|Overall Study|29 evaluable thus 29 represented in efficacy and safety portion|29
597390|NCT00447122|1460129|P1|STARTED|Overall Study||31
597391|NCT00447057|1460137|P4|NOT COMPLETED|Overall Study||26
597392|NCT00447057|1460138|P3|NOT COMPLETED|Overall Study||19
597393|NCT00447057|1460139|P2|NOT COMPLETED|Overall Study||73
597394|NCT00447057|1460140|P1|NOT COMPLETED|Overall Study||83
597395|NCT00447057|1460137|P4|COMPLETED|Overall Study||0
597396|NCT00447057|1460138|P3|COMPLETED|Overall Study||0
597397|NCT00447057|1460139|P2|COMPLETED|Overall Study||3
597398|NCT00447057|1460140|P1|COMPLETED|Overall Study||0
597399|NCT00447057|1460137|P4|STARTED|Overall Study||26
597400|NCT00447057|1460138|P3|STARTED|Overall Study||19
597401|NCT00447057|1460139|P2|STARTED|Overall Study||76
597402|NCT00447057|1460140|P1|STARTED|Overall Study||83
597403|NCT00447005|1460158|P1|NOT COMPLETED|Overall Study||12
597404|NCT00447005|1460158|P1|COMPLETED|Overall Study||0
597405|NCT00447005|1460158|P1|STARTED|Overall Study||12
597406|NCT00446992|1460172|P1|NOT COMPLETED|Overall Study||16
597407|NCT00446992|1460172|P1|COMPLETED|Overall Study|Intervention Completion|14
597408|NCT00446992|1460172|P1|STARTED|Overall Study|Beginning of Intervention|30
597409|NCT00446849|1460184|P1|NOT COMPLETED|Maintenance Phase||70
597410|NCT00446849|1460184|P1|COMPLETED|Maintenance Phase||138
597411|NCT00446849|1460184|P1|STARTED|Maintenance Phase||208
597412|NCT00446849|1460184|P1|NOT COMPLETED|Acute Phase||82
597413|NCT00446849|1460184|P1|COMPLETED|Acute Phase||56
597414|NCT00446849|1460184|P1|STARTED|Acute Phase||138
597415|NCT00446797|1460196|P2|NOT COMPLETED|Overall Study||12
597416|NCT00446797|1460197|P1|NOT COMPLETED|Overall Study||8
597417|NCT00446797|1460196|P2|COMPLETED|Overall Study||125
597418|NCT00446797|1460197|P1|COMPLETED|Overall Study||133
597419|NCT00446797|1460196|P2|STARTED|Overall Study||137
597420|NCT00446797|1460197|P1|STARTED|Overall Study||141
597421|NCT00446654|1460243|P2|NOT COMPLETED|Overall Study||0
597422|NCT00446654|1460244|P1|NOT COMPLETED|Overall Study||2
597423|NCT00446654|1460243|P2|COMPLETED|Overall Study||22
597424|NCT00446654|1460244|P1|COMPLETED|Overall Study||19
597425|NCT00446654|1460243|P2|STARTED|Overall Study||22
597426|NCT00446654|1460244|P1|STARTED|Overall Study||21
597427|NCT00446641|1460252|P2|NOT COMPLETED|Overall Study||10
597428|NCT00446641|1460253|P1|NOT COMPLETED|Overall Study||17
597429|NCT00446641|1460252|P2|COMPLETED|Overall Study||109
597430|NCT00446641|1460253|P1|COMPLETED|Overall Study||108
597431|NCT00446641|1460252|P2|STARTED|Overall Study||119
597432|NCT00446641|1460253|P1|STARTED|Overall Study||125
597433|NCT00446563|1460273|P2|NOT COMPLETED|Overall Study||9
597434|NCT00446563|1460274|P1|NOT COMPLETED|Overall Study||7
597435|NCT00446563|1460273|P2|COMPLETED|Overall Study||38
597436|NCT00446563|1460274|P1|COMPLETED|Overall Study||36
597437|NCT00446563|1460273|P2|STARTED|Overall Study||47
597438|NCT00446563|1460274|P1|STARTED|Overall Study||43
597439|NCT00446511|1460312|P4|NOT COMPLETED|Overall Study||6
597440|NCT00446511|1460313|P3|NOT COMPLETED|Overall Study||7
597441|NCT00446511|1460314|P2|NOT COMPLETED|Overall Study||2
597442|NCT00446511|1460315|P1|NOT COMPLETED|Overall Study||10
597443|NCT00446511|1460312|P4|COMPLETED|Overall Study||103
597444|NCT00446511|1460313|P3|COMPLETED|Overall Study||96
597445|NCT00446511|1460314|P2|COMPLETED|Overall Study||15
597446|NCT00446511|1460315|P1|COMPLETED|Overall Study||11
597447|NCT00446511|1460312|P4|STARTED|Overall Study||109
597448|NCT00446511|1460313|P3|STARTED|Overall Study||103
597449|NCT00446511|1460314|P2|STARTED|Overall Study||17
597450|NCT00446511|1460315|P1|STARTED|Overall Study||21
597451|NCT00446459|1460339|P1|NOT COMPLETED|12 Months||18
597452|NCT00446459|1460339|P1|COMPLETED|12 Months|4 subjects remained at month 12|4
597453|NCT00446459|1460339|P1|STARTED|12 Months|22 subjects remained on-study at month 8|22
597454|NCT00446459|1460339|P1|NOT COMPLETED|8 Months||12
597455|NCT00446459|1460339|P1|COMPLETED|8 Months|22 subjects were on study at month 8.|22
597456|NCT00446459|1460339|P1|STARTED|8 Months|34 subjects received any amount of MMF.|34
597457|NCT00446446|1460347|P1|NOT COMPLETED|Overall Study||24
597458|NCT00446446|1460347|P1|COMPLETED|Overall Study|Participants who completed the 60-day safety visit|28
597459|NCT00446446|1460347|P1|STARTED|Overall Study||52
597460|NCT00446290|1460358|P1|NOT COMPLETED|Overall Study||0
597461|NCT00446290|1460358|P1|COMPLETED|Overall Study||22
597462|NCT00446290|1460358|P1|STARTED|Overall Study||22
597463|NCT00446264|1460362|P1|NOT COMPLETED|Overall Study||0
597464|NCT00446264|1460362|P1|COMPLETED|Overall Study||14
597465|NCT00446264|1460362|P1|STARTED|Overall Study||14
597466|NCT00446251|1460371|P1|NOT COMPLETED|Overall Study||5
597467|NCT00446251|1460371|P1|COMPLETED|Overall Study||9
597468|NCT00446251|1460371|P1|STARTED|Overall Study|14 subjects were enrolled in this Rituximab-mycophenolic mofetil group.|14
597469|NCT00446199|1460381|P4|NOT COMPLETED|Overall Study||30
597470|NCT00446199|1460382|P3|NOT COMPLETED|Overall Study||27
597471|NCT00446199|1460383|P2|NOT COMPLETED|Overall Study||20
597472|NCT00446199|1460384|P1|NOT COMPLETED|Overall Study||23
597473|NCT00446199|1460381|P4|COMPLETED|Overall Study||153
597474|NCT00446199|1460382|P3|COMPLETED|Overall Study||158
597475|NCT00446199|1460383|P2|COMPLETED|Overall Study||164
597476|NCT00446199|1460384|P1|COMPLETED|Overall Study||160
597477|NCT00446199|1460381|P4|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|176
597478|NCT00446199|1460382|P3|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|179
597479|NCT00446199|1460383|P2|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|177
597480|NCT00446199|1460384|P1|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|178
597481|NCT00446199|1460381|P4|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|180
597482|NCT00446199|1460382|P3|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|182
597483|NCT00446199|1460383|P2|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|183
597484|NCT00446199|1460384|P1|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|181
597485|NCT00446199|1460381|P4|STARTED|Overall Study||183
597486|NCT00446199|1460382|P3|STARTED|Overall Study||185
597487|NCT00446199|1460383|P2|STARTED|Overall Study||184
597488|NCT00446199|1460384|P1|STARTED|Overall Study||183
597489|NCT00446147|1460464|P2|NOT COMPLETED|Overall Study||14
597490|NCT00446147|1460465|P1|NOT COMPLETED|Overall Study||15
597491|NCT00446147|1460464|P2|COMPLETED|Overall Study||180
597492|NCT00446147|1460465|P1|COMPLETED|Overall Study||180
597493|NCT00446147|1460464|P2|STARTED|Overall Study||194
597494|NCT00446147|1460465|P1|STARTED|Overall Study||195
597495|NCT00446134|1460477|P4|NOT COMPLETED|Overall Study||45
597496|NCT00446134|1460478|P3|NOT COMPLETED|Overall Study||43
597497|NCT00446134|1460479|P2|NOT COMPLETED|Overall Study||45
597498|NCT00446134|1460480|P1|NOT COMPLETED|Overall Study||34
597499|NCT00446134|1460477|P4|COMPLETED|Overall Study||25
597500|NCT00446134|1460478|P3|COMPLETED|Overall Study||26
597501|NCT00446134|1460479|P2|COMPLETED|Overall Study||25
597502|NCT00446134|1460480|P1|COMPLETED|Overall Study||35
597503|NCT00446134|1460477|P4|STARTED|Overall Study||70
597504|NCT00446134|1460478|P3|STARTED|Overall Study|Includes 1 patient who did not receive study drug and was not included in any other analysis|69
597505|NCT00446134|1460479|P2|STARTED|Overall Study||70
597506|NCT00446134|1460480|P1|STARTED|Overall Study|Includes 2 patients who did not receive study drug and was not included in any other analysis|69
597507|NCT00446095|1460507|P5|NOT COMPLETED|Phase I (28 Days)||3
597508|NCT00446095|1460508|P4|NOT COMPLETED|Phase I (28 Days)||1
597509|NCT00446095|1460509|P3|NOT COMPLETED|Phase I (28 Days)||0
597510|NCT00446095|1460510|P2|NOT COMPLETED|Phase I (28 Days)||0
597511|NCT00446095|1460511|P1|NOT COMPLETED|Phase I (28 Days)||0
597512|NCT00446095|1460507|P5|COMPLETED|Phase I (28 Days)||4
597513|NCT00446095|1460508|P4|COMPLETED|Phase I (28 Days)||5
597514|NCT00446095|1460509|P3|COMPLETED|Phase I (28 Days)||0
597515|NCT00446095|1460510|P2|COMPLETED|Phase I (28 Days)||0
597516|NCT00446095|1460511|P1|COMPLETED|Phase I (28 Days)||0
597517|NCT00446095|1460507|P5|STARTED|Phase I (28 Days)||7
597518|NCT00446095|1460508|P4|STARTED|Phase I (28 Days)||6
597519|NCT00446095|1460509|P3|STARTED|Phase I (28 Days)||0
597520|NCT00446095|1460510|P2|STARTED|Phase I (28 Days)||0
597521|NCT00446095|1460511|P1|STARTED|Phase I (28 Days)||0
597522|NCT00446095|1460507|P5|NOT COMPLETED|Phase II (8 Weeks)||0
597523|NCT00446095|1460508|P4|NOT COMPLETED|Phase II (8 Weeks)||0
597524|NCT00446095|1460509|P3|NOT COMPLETED|Phase II (8 Weeks)||3
597525|NCT00446095|1460510|P2|NOT COMPLETED|Phase II (8 Weeks)||3
597526|NCT00446095|1460511|P1|NOT COMPLETED|Phase II (8 Weeks)||12
597527|NCT00446095|1460507|P5|COMPLETED|Phase II (8 Weeks)||0
597528|NCT00446095|1460508|P4|COMPLETED|Phase II (8 Weeks)||0
597529|NCT00446095|1460509|P3|COMPLETED|Phase II (8 Weeks)||21
597530|NCT00446095|1460510|P2|COMPLETED|Phase II (8 Weeks)||18
597531|NCT00446095|1460511|P1|COMPLETED|Phase II (8 Weeks)||11
597532|NCT00446095|1460507|P5|STARTED|Phase II (8 Weeks)||0
597533|NCT00446095|1460508|P4|STARTED|Phase II (8 Weeks)||0
597534|NCT00446095|1460509|P3|STARTED|Phase II (8 Weeks)||24
597535|NCT00446095|1460510|P2|STARTED|Phase II (8 Weeks)||21
597536|NCT00446095|1460511|P1|STARTED|Phase II (8 Weeks)||23
597537|NCT00446030|1460534|P2|NOT COMPLETED|FOLLOW-UP (up to 2-years)||9
597538|NCT00446030|1460535|P1|NOT COMPLETED|FOLLOW-UP (up to 2-years)||30
597539|NCT00446030|1460534|P2|COMPLETED|FOLLOW-UP (up to 2-years)||25
597540|NCT00446030|1460535|P1|COMPLETED|FOLLOW-UP (up to 2-years)||63
597541|NCT00446030|1460534|P2|STARTED|FOLLOW-UP (up to 2-years)||34
597542|NCT00446030|1460535|P1|STARTED|FOLLOW-UP (up to 2-years)|All participants, including those who discontinued treatment, continued to the follow-up period.|93
597543|NCT00446030|1460534|P2|NOT COMPLETED|TREATMENT (up to 52 Weeks)||9
597544|NCT00446030|1460535|P1|NOT COMPLETED|TREATMENT (up to 52 Weeks)||44
597545|NCT00446030|1460534|P2|COMPLETED|TREATMENT (up to 52 Weeks)|Participants who completed treatment|25
597546|NCT00446030|1460535|P1|COMPLETED|TREATMENT (up to 52 Weeks)|Participants who completed treatment|49
597547|NCT00446030|1460534|P2|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||34
597548|NCT00446030|1460535|P1|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||92
597549|NCT00446030|1460534|P2|STARTED|TREATMENT (up to 52 Weeks)||34
597550|NCT00446030|1460535|P1|STARTED|TREATMENT (up to 52 Weeks)||93
597551|NCT00445939|1460546|P4|NOT COMPLETED|Period B - Week 4 - Week 8||1
597552|NCT00445939|1460547|P3|NOT COMPLETED|Period B - Week 4 - Week 8||0
597553|NCT00445939|1460548|P2|NOT COMPLETED|Period B - Week 4 - Week 8||0
597554|NCT00445939|1460549|P1|NOT COMPLETED|Period B - Week 4 - Week 8||2
597555|NCT00445939|1460546|P4|COMPLETED|Period B - Week 4 - Week 8||20
597556|NCT00445939|1460547|P3|COMPLETED|Period B - Week 4 - Week 8||0
597557|NCT00445939|1460548|P2|COMPLETED|Period B - Week 4 - Week 8||0
597558|NCT00445939|1460549|P1|COMPLETED|Period B - Week 4 - Week 8||14
597559|NCT00445939|1460546|P4|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 160/80 and 80/40 subjects allocated to 40/40 group.|21
597560|NCT00445939|1460547|P3|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous placebo subjects allocated to 160/80 mg group.|0
597561|NCT00445939|1460548|P2|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 80/40 mg subjects allocated to 40/40 mg group.|0
597562|NCT00445939|1460549|P1|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 16 placebo subjects allocated to 160/80 mg group.|16
597563|NCT00445939|1460546|P4|NOT COMPLETED|Period A - Week 0 - Week 4||0
597564|NCT00445939|1460547|P3|NOT COMPLETED|Period A - Week 0 - Week 4||0
597565|NCT00445939|1460548|P2|NOT COMPLETED|Period A - Week 0 - Week 4||2
597566|NCT00445939|1460549|P1|NOT COMPLETED|Period A - Week 0 - Week 4||1
597567|NCT00445939|1460546|P4|COMPLETED|Period A - Week 0 - Week 4||0
597568|NCT00445939|1460547|P3|COMPLETED|Period A - Week 0 - Week 4|7 rated as responders and 16 rated as non-responders in evaluation on Week 4.|23
597569|NCT00445939|1460548|P2|COMPLETED|Period A - Week 0 - Week 4|20 rated as responders and 12 rated as non-responders in evaluation on Week 4.|32
597570|NCT00445939|1460549|P1|COMPLETED|Period A - Week 0 - Week 4|23 rated as responders and 9 rated as non-responders in evaluation on Week 4.|32
597571|NCT00445939|1460546|P4|STARTED|Period A - Week 0 - Week 4||0
597572|NCT00445939|1460547|P3|STARTED|Period A - Week 0 - Week 4||23
597573|NCT00445939|1460548|P2|STARTED|Period A - Week 0 - Week 4||34
597574|NCT00445939|1460549|P1|STARTED|Period A - Week 0 - Week 4||33
597575|NCT00445887|1460574|P2|NOT COMPLETED|Overall Study||0
597576|NCT00445887|1460575|P1|NOT COMPLETED|Overall Study||0
597577|NCT00445887|1460574|P2|COMPLETED|Overall Study||31
597578|NCT00445887|1460575|P1|COMPLETED|Overall Study||33
597579|NCT00445887|1460574|P2|STARTED|Overall Study||31
597580|NCT00445887|1460575|P1|STARTED|Overall Study||33
597581|NCT00445848|1460597|P1|NOT COMPLETED|Overall Study||85
597582|NCT00445848|1460597|P1|COMPLETED|Overall Study||0
597583|NCT00445848|1460597|P1|STARTED|Overall Study||85
597584|NCT00445770|1460607|P3|NOT COMPLETED|Overall Study||31
597585|NCT00445770|1460608|P2|NOT COMPLETED|Overall Study||35
597586|NCT00445770|1460609|P1|NOT COMPLETED|Overall Study||53
597587|NCT00445770|1460607|P3|COMPLETED|Overall Study||151
597588|NCT00445770|1460608|P2|COMPLETED|Overall Study||157
597589|NCT00445770|1460609|P1|COMPLETED|Overall Study||123
597590|NCT00445770|1460607|P3|STARTED|Overall Study||182
597591|NCT00445770|1460608|P2|STARTED|Overall Study||192
597592|NCT00445770|1460609|P1|STARTED|Overall Study||176
597593|NCT00445744|1460676|P1|NOT COMPLETED|Overall Study||1
597594|NCT00445744|1460676|P1|COMPLETED|Overall Study||51
597595|NCT00445744|1460676|P1|STARTED|Overall Study||52
597596|NCT00445705|1460685|P4|NOT COMPLETED|Overall Study||14
597597|NCT00445705|1460686|P3|NOT COMPLETED|Overall Study||11
597598|NCT00445705|1460687|P2|NOT COMPLETED|Overall Study||11
597599|NCT00445705|1460688|P1|NOT COMPLETED|Overall Study||9
597600|NCT00445705|1460685|P4|COMPLETED|Overall Study||39
597601|NCT00445705|1460686|P3|COMPLETED|Overall Study||41
597602|NCT00445705|1460687|P2|COMPLETED|Overall Study||42
597603|NCT00445705|1460688|P1|COMPLETED|Overall Study||44
597604|NCT00445705|1460685|P4|STARTED|Overall Study||53
597605|NCT00445705|1460686|P3|STARTED|Overall Study||52
597606|NCT00445705|1460687|P2|STARTED|Overall Study||53
597607|NCT00445705|1460688|P1|STARTED|Overall Study||53
597608|NCT00445692|1460710|P1|NOT COMPLETED|Overall Study||16
597609|NCT00445692|1460710|P1|COMPLETED|Overall Study||15
597610|NCT00445692|1460710|P1|STARTED|Overall Study||31
597611|NCT00445679|1460720|P4|NOT COMPLETED|Overall Study||47
597612|NCT00445679|1460721|P3|NOT COMPLETED|Overall Study||66
597613|NCT00445679|1460722|P2|NOT COMPLETED|Overall Study||46
597614|NCT00445679|1460723|P1|NOT COMPLETED|Overall Study||48
597615|NCT00445679|1460720|P4|COMPLETED|Overall Study||149
597616|NCT00445679|1460721|P3|COMPLETED|Overall Study||139
597617|NCT00445679|1460722|P2|COMPLETED|Overall Study||157
597618|NCT00445679|1460723|P1|COMPLETED|Overall Study||155
597619|NCT00445679|1460720|P4|STARTED|Overall Study||196
597620|NCT00445679|1460721|P3|STARTED|Overall Study||205
597621|NCT00445679|1460722|P2|STARTED|Overall Study||203
597622|NCT00445679|1460723|P1|STARTED|Overall Study||203
597623|NCT00445601|1460759|P2|NOT COMPLETED|Overall Study||28
597624|NCT00445601|1460760|P1|NOT COMPLETED|Overall Study||33
597625|NCT00445601|1460759|P2|COMPLETED|Overall Study||177
597626|NCT00445601|1460760|P1|COMPLETED|Overall Study||168
597627|NCT00445601|1460759|P2|Received TURBT|Overall Study||193
597628|NCT00445601|1460760|P1|Received TURBT|Overall Study||190
597629|NCT00445601|1460759|P2|STARTED|Overall Study||205
597630|NCT00445601|1460760|P1|STARTED|Overall Study||201
597631|NCT00445588|1460772|P1|NOT COMPLETED|Overall Study||0
597632|NCT00445588|1460772|P1|COMPLETED|Overall Study||56
597633|NCT00445588|1460772|P1|STARTED|Overall Study||56
597634|NCT00445549|1460777|P1|NOT COMPLETED|Overall Study||12
597635|NCT00445549|1460777|P1|COMPLETED|Overall Study||0
597636|NCT00445549|1460777|P1|STARTED|Overall Study||12
597637|NCT00445484|1460784|P2|NOT COMPLETED|Overall Study||1
597638|NCT00445484|1460785|P1|NOT COMPLETED|Overall Study||4
597639|NCT00445484|1460784|P2|COMPLETED|Overall Study||10
597640|NCT00445484|1460785|P1|COMPLETED|Overall Study||7
597641|NCT00445484|1460784|P2|STARTED|Overall Study||11
597642|NCT00445484|1460785|P1|STARTED|Overall Study||11
597643|NCT00445458|1460801|P4|NOT COMPLETED|Overall Study||28
597644|NCT00445458|1460802|P3|NOT COMPLETED|Overall Study||68
597645|NCT00445458|1460803|P2|NOT COMPLETED|Overall Study||5
597646|NCT00445458|1460804|P1|NOT COMPLETED|Overall Study||3
597647|NCT00445458|1460801|P4|COMPLETED|Overall Study||3
597648|NCT00445458|1460802|P3|COMPLETED|Overall Study||3
597649|NCT00445458|1460803|P2|COMPLETED|Overall Study||0
597650|NCT00445458|1460804|P1|COMPLETED|Overall Study||0
597651|NCT00445458|1460801|P4|STARTED|Overall Study||31
597652|NCT00445458|1460802|P3|STARTED|Overall Study||71
597653|NCT00445458|1460803|P2|STARTED|Overall Study||5
597654|NCT00445458|1460804|P1|STARTED|Overall Study||3
597655|NCT00445432|1460822|P4|NOT COMPLETED|148 Weeks of Adalimumab Treatment||44
597656|NCT00445432|1460823|P3|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
597657|NCT00445432|1460824|P2|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
597658|NCT00445432|1460825|P1|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
597659|NCT00445432|1460822|P4|COMPLETED|148 Weeks of Adalimumab Treatment||35
597660|NCT00445432|1460823|P3|COMPLETED|148 Weeks of Adalimumab Treatment||0
597661|NCT00445432|1460824|P2|COMPLETED|148 Weeks of Adalimumab Treatment||0
597662|NCT00445432|1460825|P1|COMPLETED|148 Weeks of Adalimumab Treatment||0
597663|NCT00445432|1460822|P4|STARTED|148 Weeks of Adalimumab Treatment|3 participants discontinued while receiving double-blind placebo and never received any adalimumab|79
597664|NCT00445432|1460823|P3|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
597665|NCT00445432|1460824|P2|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
597666|NCT00445432|1460825|P1|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
597667|NCT00445432|1460822|P4|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0
597668|NCT00445432|1460823|P3|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||11
597669|NCT00445432|1460824|P2|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||23
597670|NCT00445432|1460825|P1|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||15
597671|NCT00445432|1460822|P4|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0
597672|NCT00445432|1460823|P3|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||21
597673|NCT00445432|1460824|P2|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||2
597674|NCT00445432|1460825|P1|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||10
597675|NCT00445432|1460822|P4|STARTED|Through Week 52 of NCT00445432 (M06-837)|This treatment group is not applicable for this period.|0
597676|NCT00445432|1460823|P3|STARTED|Through Week 52 of NCT00445432 (M06-837)||32
597677|NCT00445432|1460824|P2|STARTED|Through Week 52 of NCT00445432 (M06-837)||25
597678|NCT00445432|1460825|P1|STARTED|Through Week 52 of NCT00445432 (M06-837)||25
597679|NCT00445341|1460858|P1|NOT COMPLETED|Overall Study||2
597680|NCT00445341|1460858|P1|COMPLETED|Overall Study||26
597681|NCT00445341|1460858|P1|STARTED|Overall Study||28
597682|NCT00445328|1460865|P2|NOT COMPLETED|Overall Study||6
597683|NCT00445328|1460866|P1|NOT COMPLETED|Overall Study||3
597684|NCT00445328|1460865|P2|COMPLETED|Overall Study||36
597685|NCT00445328|1460866|P1|COMPLETED|Overall Study||39
597686|NCT00445328|1460865|P2|Received Treatment|Overall Study||42
597687|NCT00445328|1460866|P1|Received Treatment|Overall Study|1 subject discontinued after enrollment but prior to study treatment.|41
597688|NCT00445328|1460865|P2|STARTED|Overall Study||42
597689|NCT00445328|1460866|P1|STARTED|Overall Study||42
597690|NCT00445315|1460889|P5|NOT COMPLETED|Overall Study||0
597691|NCT00445315|1460890|P4|NOT COMPLETED|Overall Study||0
597692|NCT00445315|1460891|P3|NOT COMPLETED|Overall Study||0
597693|NCT00445315|1460892|P2|NOT COMPLETED|Overall Study||0
597694|NCT00445315|1460893|P1|NOT COMPLETED|Overall Study||0
597695|NCT00445315|1460889|P5|COMPLETED|Overall Study||8
597696|NCT00445315|1460890|P4|COMPLETED|Overall Study||6
597697|NCT00445315|1460891|P3|COMPLETED|Overall Study||6
597698|NCT00445315|1460892|P2|COMPLETED|Overall Study||6
597699|NCT00445315|1460893|P1|COMPLETED|Overall Study||6
597700|NCT00445315|1460889|P5|STARTED|Overall Study||8
597701|NCT00445315|1460890|P4|STARTED|Overall Study||6
597702|NCT00445315|1460891|P3|STARTED|Overall Study||6
597703|NCT00445315|1460892|P2|STARTED|Overall Study||6
597704|NCT00445315|1460893|P1|STARTED|Overall Study||6
597705|NCT00445302|1460987|P4|NOT COMPLETED|Overall Study||0
597706|NCT00445302|1460988|P3|NOT COMPLETED|Overall Study||0
597707|NCT00445302|1460989|P2|NOT COMPLETED|Overall Study||0
597708|NCT00445302|1460990|P1|NOT COMPLETED|Overall Study||0
597709|NCT00445302|1460987|P4|COMPLETED|Overall Study||6
597710|NCT00445302|1460988|P3|COMPLETED|Overall Study||6
597711|NCT00445302|1460989|P2|COMPLETED|Overall Study||5
597712|NCT00445302|1460990|P1|COMPLETED|Overall Study||6
597713|NCT00445302|1460987|P4|STARTED|Overall Study||6
597714|NCT00445302|1460988|P3|STARTED|Overall Study||6
597715|NCT00445302|1460989|P2|STARTED|Overall Study||5
597716|NCT00445302|1460990|P1|STARTED|Overall Study||6
597717|NCT00445263|1461018|P2|NOT COMPLETED|Overall Study||1
597718|NCT00445263|1461019|P1|NOT COMPLETED|Overall Study||0
597719|NCT00445263|1461018|P2|COMPLETED|Overall Study||86
597720|NCT00445263|1461019|P1|COMPLETED|Overall Study||83
597721|NCT00445263|1461018|P2|STARTED|Overall Study||87
597722|NCT00445263|1461019|P1|STARTED|Overall Study||83
597723|NCT00445224|1461027|P2|NOT COMPLETED|Combined Exercises||0
597724|NCT00445224|1461028|P1|NOT COMPLETED|Combined Exercises||0
597725|NCT00445224|1461027|P2|COMPLETED|Combined Exercises||13
597726|NCT00445224|1461028|P1|COMPLETED|Combined Exercises||13
597727|NCT00445224|1461027|P2|STARTED|Combined Exercises||13
597728|NCT00445224|1461028|P1|STARTED|Combined Exercises||13
597729|NCT00445224|1461027|P2|NOT COMPLETED|Specific Exercises||3
597730|NCT00445224|1461028|P1|NOT COMPLETED|Specific Exercises||4
597731|NCT00445224|1461027|P2|COMPLETED|Specific Exercises|No adverse event occurred|13
597732|NCT00445224|1461028|P1|COMPLETED|Specific Exercises|No adverse event occurred|13
597733|NCT00445224|1461027|P2|4 Weeks|Specific Exercises|Participants withdrew due to time conflicts|13
597734|NCT00445224|1461028|P1|4 Weeks|Specific Exercises|Participants withdrew due to time conflicts|14
597735|NCT00445224|1461027|P2|Baseline|Specific Exercises||16
597736|NCT00445224|1461028|P1|Baseline|Specific Exercises||17
597737|NCT00445224|1461027|P2|STARTED|Specific Exercises||16
597738|NCT00445224|1461028|P1|STARTED|Specific Exercises||17
597739|NCT00445211|1461040|P2|NOT COMPLETED|Overall Study||0
597740|NCT00445211|1461041|P1|NOT COMPLETED|Overall Study||0
597741|NCT00445211|1461040|P2|COMPLETED|Overall Study||23
597742|NCT00445211|1461041|P1|COMPLETED|Overall Study||23
597743|NCT00445211|1461040|P2|STARTED|Overall Study||23
597744|NCT00445211|1461041|P1|STARTED|Overall Study||23
597745|NCT00445146|1461055|P1|NOT COMPLETED|Overall Study||119
597746|NCT00445146|1461055|P1|COMPLETED|Overall Study||73
597747|NCT00445146|1461055|P1|STARTED|Overall Study||192
597748|NCT00445003|1461077|P3|NOT COMPLETED|Overall Study||4
597749|NCT00445003|1461078|P2|NOT COMPLETED|Overall Study||10
597750|NCT00445003|1461079|P1|NOT COMPLETED|Overall Study||5
597751|NCT00445003|1461077|P3|COMPLETED|Overall Study||105
597752|NCT00445003|1461078|P2|COMPLETED|Overall Study||103
597753|NCT00445003|1461079|P1|COMPLETED|Overall Study||118
597754|NCT00445003|1461077|P3|STARTED|Overall Study||109
597755|NCT00445003|1461078|P2|STARTED|Overall Study||113
597756|NCT00445003|1461079|P1|STARTED|Overall Study||123
597757|NCT00444951|1461111|P3|NOT COMPLETED|Overall Study||3
597758|NCT00444951|1461112|P2|NOT COMPLETED|Overall Study||6
597759|NCT00444951|1461113|P1|NOT COMPLETED|Overall Study||5
597760|NCT00444951|1461111|P3|COMPLETED|Overall Study||160
597761|NCT00444951|1461112|P2|COMPLETED|Overall Study||136
597762|NCT00444951|1461113|P1|COMPLETED|Overall Study||140
597763|NCT00444951|1461111|P3|STARTED|Overall Study||163
597764|NCT00444951|1461112|P2|STARTED|Overall Study||142
597765|NCT00444951|1461113|P1|STARTED|Overall Study||145
597766|NCT00444925|1461130|P3|NOT COMPLETED|Double-blind Treatment Period||81
597767|NCT00444925|1461131|P2|NOT COMPLETED|Double-blind Treatment Period||56
597768|NCT00444925|1461132|P1|NOT COMPLETED|Double-blind Treatment Period||30
597769|NCT00444925|1461130|P3|COMPLETED|Double-blind Treatment Period||598
597770|NCT00444925|1461131|P2|COMPLETED|Double-blind Treatment Period||628
597771|NCT00444925|1461132|P1|COMPLETED|Double-blind Treatment Period||304
597772|NCT00444925|1461130|P3|STARTED|Double-blind Treatment Period||679
597773|NCT00444925|1461131|P2|STARTED|Double-blind Treatment Period||684
597774|NCT00444925|1461132|P1|STARTED|Double-blind Treatment Period||334
597775|NCT00444925|1461130|P3|NOT COMPLETED|Randomized to Double-blind Treatment||6
597776|NCT00444925|1461131|P2|NOT COMPLETED|Randomized to Double-blind Treatment||6
597777|NCT00444925|1461132|P1|NOT COMPLETED|Randomized to Double-blind Treatment||3
597778|NCT00444925|1461130|P3|COMPLETED|Randomized to Double-blind Treatment||679
597779|NCT00444925|1461131|P2|COMPLETED|Randomized to Double-blind Treatment||684
597780|NCT00444925|1461132|P1|COMPLETED|Randomized to Double-blind Treatment||334
597781|NCT00444925|1461130|P3|STARTED|Randomized to Double-blind Treatment||685
597782|NCT00444925|1461131|P2|STARTED|Randomized to Double-blind Treatment||690
597783|NCT00444925|1461132|P1|STARTED|Randomized to Double-blind Treatment||337
597784|NCT00444925|1461130|P3|NOT COMPLETED|Single-blind Placebo Run-In Period||0
597785|NCT00444925|1461131|P2|NOT COMPLETED|Single-blind Placebo Run-In Period||0
597786|NCT00444925|1461132|P1|NOT COMPLETED|Single-blind Placebo Run-In Period||734
597787|NCT00444925|1461130|P3|COMPLETED|Single-blind Placebo Run-In Period||0
597788|NCT00444925|1461131|P2|COMPLETED|Single-blind Placebo Run-In Period||0
597789|NCT00444925|1461132|P1|COMPLETED|Single-blind Placebo Run-In Period|progressed to randomization in double-blind treatment period|1712
597790|NCT00444925|1461130|P3|STARTED|Single-blind Placebo Run-In Period||0
597791|NCT00444925|1461131|P2|STARTED|Single-blind Placebo Run-In Period||0
597792|NCT00444925|1461132|P1|STARTED|Single-blind Placebo Run-In Period||2446
597793|NCT00444912|1461196|P2|NOT COMPLETED|Overall Study||2
597794|NCT00444912|1461197|P1|NOT COMPLETED|Overall Study||3
597795|NCT00444912|1461196|P2|COMPLETED|Overall Study||13
597796|NCT00444912|1461197|P1|COMPLETED|Overall Study||12
597797|NCT00444912|1461196|P2|Received Transplant|Overall Study||14
597798|NCT00444912|1461197|P1|Received Transplant|Overall Study||14
597799|NCT00444912|1461196|P2|Received Plerixafor|Overall Study||15
597800|NCT00444912|1461197|P1|Received Plerixafor|Overall Study||15
597801|NCT00444912|1461196|P2|STARTED|Overall Study||15
597802|NCT00444912|1461197|P1|STARTED|Overall Study||15
597803|NCT00444821|1461227|P2|NOT COMPLETED|Overall Study||366
597804|NCT00444821|1461228|P1|NOT COMPLETED|Overall Study||362
597805|NCT00444821|1461227|P2|COMPLETED|Overall Study||0
597806|NCT00444821|1461228|P1|COMPLETED|Overall Study||0
597807|NCT00444821|1461227|P2|Received AAA Repair|Overall Study|Underwent AAA repair per protocol|326
597808|NCT00444821|1461228|P1|Received AAA Repair|Overall Study|Crossed over to AAA repair|122
597809|NCT00444821|1461227|P2|STARTED|Overall Study||366
597810|NCT00444821|1461228|P1|STARTED|Overall Study||362
597811|NCT00444795|1461238|P1|NOT COMPLETED|Overall Study||3
597812|NCT00444795|1461238|P1|COMPLETED|Overall Study|Refer to the Safety Analysis Set.|617
597813|NCT00444795|1461238|P1|STARTED|Overall Study||620
597814|NCT00444626|1461243|P1|NOT COMPLETED|Repeat Treatment Period||0
597815|NCT00444626|1461243|P1|COMPLETED|Repeat Treatment Period||105
597816|NCT00444626|1461243|P1|STARTED|Repeat Treatment Period|23 subjects withdrew after completing the Initial Treatment and did not enter the Repeat Treatment|105
597817|NCT00444626|1461243|P1|NOT COMPLETED|Initial Treatment Period||12
597818|NCT00444626|1461243|P1|COMPLETED|Initial Treatment Period||128
597819|NCT00444626|1461243|P1|STARTED|Initial Treatment Period||140
597820|NCT00444600|1461273|P4|NOT COMPLETED|Overall Study||10
597821|NCT00444600|1461274|P3|NOT COMPLETED|Overall Study||10
597822|NCT00444600|1461275|P2|NOT COMPLETED|Overall Study||16
597823|NCT00444600|1461276|P1|NOT COMPLETED|Overall Study||19
597824|NCT00444600|1461273|P4|COMPLETED|Overall Study|Number of eyes|176
597825|NCT00444600|1461274|P3|COMPLETED|Overall Study|Number of eyes|178
597826|NCT00444600|1461275|P2|COMPLETED|Overall Study|Number of eyes|171
597827|NCT00444600|1461276|P1|COMPLETED|Overall Study|Number of eyes|274
597828|NCT00444600|1461273|P4|STARTED|Overall Study|Number of eyes|186
597829|NCT00444600|1461274|P3|STARTED|Overall Study|Number of eyes|188
597830|NCT00444600|1461275|P2|STARTED|Overall Study|Number of eyes|187
597831|NCT00444600|1461276|P1|STARTED|Overall Study|Number of eyes|293
597832|NCT00444587|1461368|P2|NOT COMPLETED|Overall Study||15
597833|NCT00444587|1461369|P1|NOT COMPLETED|Overall Study||83
597834|NCT00444587|1461368|P2|COMPLETED|Overall Study||1
597835|NCT00444587|1461369|P1|COMPLETED|Overall Study||10
597836|NCT00444587|1461368|P2|STARTED|Overall Study||16
597837|NCT00444587|1461369|P1|STARTED|Overall Study||93
597838|NCT00444535|1461390|P1|NOT COMPLETED|Overall Study||24
597839|NCT00444535|1461390|P1|COMPLETED|Overall Study||28
597840|NCT00444535|1461390|P1|STARTED|Overall Study||52
597841|NCT00444457|1461401|P4|NOT COMPLETED|Toddler Dose||8
597842|NCT00444457|1461402|P3|NOT COMPLETED|Toddler Dose||4
597843|NCT00444457|1461403|P2|NOT COMPLETED|Toddler Dose||6
597844|NCT00444457|1461404|P1|NOT COMPLETED|Toddler Dose||7
597845|NCT00444457|1461401|P4|COMPLETED|Toddler Dose||200
597846|NCT00444457|1461402|P3|COMPLETED|Toddler Dose||404
597847|NCT00444457|1461403|P2|COMPLETED|Toddler Dose||391
597848|NCT00444457|1461404|P1|COMPLETED|Toddler Dose||408
597849|NCT00444457|1461401|P4|STARTED|Toddler Dose|Vaccinated toddler dose|208
597850|NCT00444457|1461402|P3|STARTED|Toddler Dose|Vaccinated toddler dose|408
597851|NCT00444457|1461403|P2|STARTED|Toddler Dose|Vaccinated toddler dose|397
597852|NCT00444457|1461404|P1|STARTED|Toddler Dose|Vaccinated toddler dose|415
597853|NCT00444457|1461401|P4|NOT COMPLETED|After Infant Series||10
597854|NCT00444457|1461402|P3|NOT COMPLETED|After Infant Series||19
597855|NCT00444457|1461403|P2|NOT COMPLETED|After Infant Series||30
597856|NCT00444457|1461404|P1|NOT COMPLETED|After Infant Series||20
597857|NCT00444457|1461401|P4|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|208
597858|NCT00444457|1461402|P3|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|408
597859|NCT00444457|1461403|P2|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|397
597860|NCT00444457|1461404|P1|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|415
597861|NCT00444457|1461401|P4|STARTED|After Infant Series||218
597862|NCT00444457|1461402|P3|STARTED|After Infant Series||427
597863|NCT00444457|1461403|P2|STARTED|After Infant Series||427
597864|NCT00444457|1461404|P1|STARTED|After Infant Series||435
597865|NCT00444457|1461401|P4|NOT COMPLETED|Infant Series||28
597866|NCT00444457|1461402|P3|NOT COMPLETED|Infant Series||61
597867|NCT00444457|1461403|P2|NOT COMPLETED|Infant Series||61
597868|NCT00444457|1461404|P1|NOT COMPLETED|Infant Series||54
597869|NCT00444457|1461401|P4|COMPLETED|Infant Series||218
597870|NCT00444457|1461402|P3|COMPLETED|Infant Series||428
597871|NCT00444457|1461403|P2|COMPLETED|Infant Series||427
597872|NCT00444457|1461404|P1|COMPLETED|Infant Series||435
597873|NCT00444457|1461401|P4|Vaccinated Dose 3|Infant Series||225
597874|NCT00444457|1461402|P3|Vaccinated Dose 3|Infant Series||438
597875|NCT00444457|1461403|P2|Vaccinated Dose 3|Infant Series||435
597876|NCT00444457|1461404|P1|Vaccinated Dose 3|Infant Series||442
597877|NCT00444457|1461401|P4|Vaccinated Dose 2|Infant Series||228
597878|NCT00444457|1461402|P3|Vaccinated Dose 2|Infant Series||455
597879|NCT00444457|1461403|P2|Vaccinated Dose 2|Infant Series||447
597880|NCT00444457|1461404|P1|Vaccinated Dose 2|Infant Series||455
597881|NCT00444457|1461401|P4|Vaccinated Dose 1|Infant Series||244
597882|NCT00444457|1461402|P3|Vaccinated Dose 1|Infant Series||485
597883|NCT00444457|1461403|P2|Vaccinated Dose 1|Infant Series||484
597884|NCT00444457|1461404|P1|Vaccinated Dose 1|Infant Series||486
597885|NCT00444457|1461401|P4|STARTED|Infant Series||246
597886|NCT00444457|1461402|P3|STARTED|Infant Series||489
597887|NCT00444457|1461403|P2|STARTED|Infant Series||488
597888|NCT00444457|1461404|P1|STARTED|Infant Series||489
597889|NCT00444275|1461469|P5|NOT COMPLETED|Maintenance Treatment Phase||179
597890|NCT00444275|1461470|P4|NOT COMPLETED|Maintenance Treatment Phase||133
597891|NCT00444275|1461471|P3|NOT COMPLETED|Maintenance Treatment Phase||161
597892|NCT00444275|1461472|P2|NOT COMPLETED|Maintenance Treatment Phase||0
597893|NCT00444275|1461473|P1|NOT COMPLETED|Maintenance Treatment Phase||0
597894|NCT00444275|1461469|P5|COMPLETED|Maintenance Treatment Phase||701
597895|NCT00444275|1461470|P4|COMPLETED|Maintenance Treatment Phase||764
597896|NCT00444275|1461471|P3|COMPLETED|Maintenance Treatment Phase||747
597897|NCT00444275|1461472|P2|COMPLETED|Maintenance Treatment Phase||0
597898|NCT00444275|1461473|P1|COMPLETED|Maintenance Treatment Phase||0
597899|NCT00444275|1461469|P5|STARTED|Maintenance Treatment Phase||880
597900|NCT00444275|1461470|P4|STARTED|Maintenance Treatment Phase||897
597901|NCT00444275|1461471|P3|STARTED|Maintenance Treatment Phase||908
597902|NCT00444275|1461472|P2|STARTED|Maintenance Treatment Phase||0
597903|NCT00444275|1461473|P1|STARTED|Maintenance Treatment Phase||0
597904|NCT00444275|1461469|P5|NOT COMPLETED|Initial Treatment Phase||0
597905|NCT00444275|1461470|P4|NOT COMPLETED|Initial Treatment Phase||0
597906|NCT00444275|1461471|P3|NOT COMPLETED|Initial Treatment Phase||0
597907|NCT00444275|1461472|P2|NOT COMPLETED|Initial Treatment Phase||96
597908|NCT00444275|1461473|P1|NOT COMPLETED|Initial Treatment Phase||248
597909|NCT00444275|1461469|P5|COMPLETED|Initial Treatment Phase||0
597910|NCT00444275|1461470|P4|COMPLETED|Initial Treatment Phase||0
597911|NCT00444275|1461471|P3|COMPLETED|Initial Treatment Phase||0
597912|NCT00444275|1461472|P2|COMPLETED|Initial Treatment Phase||777
597913|NCT00444275|1461473|P1|COMPLETED|Initial Treatment Phase||1908
597914|NCT00444275|1461469|P5|STARTED|Initial Treatment Phase||0
597915|NCT00444275|1461470|P4|STARTED|Initial Treatment Phase||0
597916|NCT00444275|1461471|P3|STARTED|Initial Treatment Phase||0
597917|NCT00444275|1461472|P2|STARTED|Initial Treatment Phase||873
597918|NCT00444275|1461473|P1|STARTED|Initial Treatment Phase||2156
597919|NCT00444145|1461523|P1|NOT COMPLETED|Overall Study||19
597920|NCT00444145|1461523|P1|COMPLETED|Overall Study||19
597921|NCT00444145|1461523|P1|STARTED|Overall Study||38
597922|NCT00444106|1461530|P3|NOT COMPLETED|Overall Study||1
597923|NCT00444106|1461531|P2|NOT COMPLETED|Overall Study||1
597924|NCT00444106|1461532|P1|NOT COMPLETED|Overall Study||2
597925|NCT00444106|1461530|P3|COMPLETED|Overall Study||52
597926|NCT00444106|1461531|P2|COMPLETED|Overall Study||52
597927|NCT00444106|1461532|P1|COMPLETED|Overall Study||157
597928|NCT00444106|1461530|P3|Completed Treatment Period|Overall Study||53
597929|NCT00444106|1461531|P2|Completed Treatment Period|Overall Study||53
597930|NCT00444106|1461532|P1|Completed Treatment Period|Overall Study||159
597931|NCT00444106|1461530|P3|STARTED|Overall Study||53
597932|NCT00444106|1461531|P2|STARTED|Overall Study||53
597933|NCT00444106|1461532|P1|STARTED|Overall Study||159
597934|NCT00444067|1461549|P2|NOT COMPLETED|Overall Study||1
597935|NCT00444067|1461550|P1|NOT COMPLETED|Overall Study||0
597936|NCT00444067|1461549|P2|COMPLETED|Overall Study||23
597937|NCT00444067|1461550|P1|COMPLETED|Overall Study||74
597938|NCT00444067|1461549|P2|STARTED|Overall Study||24
597939|NCT00444067|1461550|P1|STARTED|Overall Study||74
597940|NCT00443898|1461564|P4|NOT COMPLETED|Overall Study||18
597941|NCT00443898|1461565|P3|NOT COMPLETED|Overall Study||29
597942|NCT00443898|1461566|P2|NOT COMPLETED|Overall Study||25
597943|NCT00443898|1461567|P1|NOT COMPLETED|Overall Study||24
597944|NCT00443898|1461564|P4|COMPLETED|Overall Study||110
597945|NCT00443898|1461565|P3|COMPLETED|Overall Study||107
597946|NCT00443898|1461566|P2|COMPLETED|Overall Study||103
597947|NCT00443898|1461567|P1|COMPLETED|Overall Study||102
597948|NCT00443898|1461564|P4|STARTED|Overall Study||128
597949|NCT00443898|1461565|P3|STARTED|Overall Study||136
597950|NCT00443898|1461566|P2|STARTED|Overall Study||128
597951|NCT00443898|1461567|P1|STARTED|Overall Study||126
597952|NCT00443872|1461589|P1|NOT COMPLETED|Overall Study||17
597953|NCT00443872|1461589|P1|COMPLETED|Overall Study||60
597954|NCT00443872|1461589|P1|STARTED|Overall Study||77
597955|NCT00443846|1461604|P2|NOT COMPLETED|Overall Study||6
597956|NCT00443846|1461605|P1|NOT COMPLETED|Overall Study||11
597957|NCT00443846|1461604|P2|COMPLETED|Overall Study||117
597958|NCT00443846|1461605|P1|COMPLETED|Overall Study||113
597959|NCT00443846|1461604|P2|Vaccinated|Overall Study||123
597960|NCT00443846|1461605|P1|Vaccinated|Overall Study||116
597961|NCT00443846|1461604|P2|STARTED|Overall Study||123
597962|NCT00443846|1461605|P1|STARTED|Overall Study||124
597963|NCT00443820|1461615|P4|NOT COMPLETED|Overall Study||17
597964|NCT00443820|1461616|P3|NOT COMPLETED|Overall Study||18
597965|NCT00443820|1461617|P2|NOT COMPLETED|Overall Study||19
597966|NCT00443820|1461618|P1|NOT COMPLETED|Overall Study||21
597967|NCT00443820|1461615|P4|COMPLETED|Overall Study||111
597968|NCT00443820|1461616|P3|COMPLETED|Overall Study||117
597969|NCT00443820|1461617|P2|COMPLETED|Overall Study|A participant from this gr. discont'ed due to renal failure, was counted as an AE and also as a SAE.|111
597970|NCT00443820|1461618|P1|COMPLETED|Overall Study||112
597971|NCT00443820|1461615|P4|Safety Population|Overall Study||126
597972|NCT00443820|1461616|P3|Safety Population|Overall Study||134
597973|NCT00443820|1461617|P2|Safety Population|Overall Study||129
597974|NCT00443820|1461618|P1|Safety Population|Overall Study|Participants who received study drug and had at least one post-baseline safety assessment.|131
597975|NCT00443820|1461615|P4|STARTED|Overall Study||128
597976|NCT00443820|1461616|P3|STARTED|Overall Study||135
597977|NCT00443820|1461617|P2|STARTED|Overall Study||130
597978|NCT00443820|1461618|P1|STARTED|Overall Study||133
597979|NCT00443781|1461640|P1|NOT COMPLETED|Overall Study||25
597980|NCT00443781|1461640|P1|COMPLETED|Overall Study||37
597981|NCT00443781|1461640|P1|STARTED|Overall Study||62
597982|NCT00443755|1461646|P2|NOT COMPLETED|Overall Study||1
597983|NCT00443755|1461647|P1|NOT COMPLETED|Overall Study||2
597984|NCT00443755|1461646|P2|COMPLETED|Overall Study||13
597985|NCT00443755|1461647|P1|COMPLETED|Overall Study||12
597986|NCT00443755|1461646|P2|STARTED|Overall Study||14
597987|NCT00443755|1461647|P1|STARTED|Overall Study||14
597988|NCT00443729|1461681|P2|NOT COMPLETED|Overall Study||7
597989|NCT00443729|1461682|P1|NOT COMPLETED|Overall Study||10
597990|NCT00443729|1461681|P2|COMPLETED|Overall Study||172
597991|NCT00443729|1461682|P1|COMPLETED|Overall Study||166
597992|NCT00443729|1461681|P2|Treated|Overall Study||178
597993|NCT00443729|1461682|P1|Treated|Overall Study||176
597994|NCT00443729|1461681|P2|STARTED|Overall Study||179
597995|NCT00443729|1461682|P1|STARTED|Overall Study||176
597996|NCT00443703|1461730|P2|NOT COMPLETED|Overall Study||18
597997|NCT00443703|1461731|P1|NOT COMPLETED|Overall Study||28
597998|NCT00443703|1461730|P2|COMPLETED|Overall Study||157
597999|NCT00443703|1461731|P1|COMPLETED|Overall Study||149
598000|NCT00443703|1461730|P2|Treated|Overall Study||174
598001|NCT00443703|1461731|P1|Treated|Overall Study||174
598002|NCT00443703|1461730|P2|STARTED|Overall Study||175
598003|NCT00443703|1461731|P1|STARTED|Overall Study||177
598004|NCT00443651|1461783|P2|NOT COMPLETED|Overall Study||58
598005|NCT00443651|1461784|P1|NOT COMPLETED|Overall Study||95
598006|NCT00443651|1461783|P2|COMPLETED|Overall Study|Completed the study or the safety follow-up period.|118
598007|NCT00443651|1461784|P1|COMPLETED|Overall Study|Completed the study or the safety follow-up period.|306
598008|NCT00443651|1461783|P2|Week 48|Overall Study||134
598009|NCT00443651|1461784|P1|Week 48|Overall Study||338
598010|NCT00443651|1461783|P2|Week 24|Overall Study||160
598011|NCT00443651|1461784|P1|Week 24|Overall Study||376
598012|NCT00443651|1461783|P2|STARTED|Overall Study||176
598013|NCT00443651|1461784|P1|STARTED|Overall Study||401
598014|NCT00443599|1461804|P2|NOT COMPLETED|Overall Study||3
598015|NCT00443599|1461805|P1|NOT COMPLETED|Overall Study||6
598016|NCT00443599|1461804|P2|COMPLETED|Overall Study|Included in per-protocol analysis|490
598017|NCT00443599|1461805|P1|COMPLETED|Overall Study|Included in per-protocol analysis|490
598018|NCT00443599|1461804|P2|STARTED|Overall Study|Randomly Assigned to Standard Care|493
598019|NCT00443599|1461805|P1|STARTED|Overall Study|Randomly Assigned to Tight Glycemic Control|496
598020|NCT00443560|1461839|P2|NOT COMPLETED|Overall Study||30
598021|NCT00443560|1461840|P1|NOT COMPLETED|Overall Study||60
598022|NCT00443560|1461839|P2|COMPLETED|Overall Study||1051
598023|NCT00443560|1461840|P1|COMPLETED|Overall Study||1021
598024|NCT00443560|1461839|P2|STARTED|Overall Study||1081
598025|NCT00443560|1461840|P1|STARTED|Overall Study||1081
598026|NCT00443534|1461850|P1|NOT COMPLETED|Overall Study||123
598027|NCT00443534|1461850|P1|COMPLETED|Overall Study||0
598028|NCT00443534|1461850|P1|Treated|Overall Study||122
598029|NCT00443534|1461850|P1|STARTED|Overall Study||123
598030|NCT00443456|1461857|P1|NOT COMPLETED|Overall Study||18
598031|NCT00443456|1461857|P1|COMPLETED|Overall Study||116
598032|NCT00443456|1461857|P1|STARTED|Overall Study||134
598033|NCT00443430|1461892|P2|NOT COMPLETED|Overall Study||4
598034|NCT00443430|1461893|P1|NOT COMPLETED|Overall Study||4
598035|NCT00443430|1461892|P2|COMPLETED|Overall Study||38
598036|NCT00443430|1461893|P1|COMPLETED|Overall Study||39
598037|NCT00443430|1461892|P2|STARTED|Overall Study||42
598038|NCT00443430|1461893|P1|STARTED|Overall Study||43
598039|NCT00443352|1461903|P1|NOT COMPLETED|Overall Study||5
598040|NCT00443352|1461903|P1|COMPLETED|Overall Study||22
598041|NCT00443352|1461903|P1|STARTED|Overall Study||27
598042|NCT00443261|1461907|P1|NOT COMPLETED|Overall Study||1
598043|NCT00443261|1461907|P1|COMPLETED|Overall Study|Study terminated due to poor accrual and only patient enrolled died|0
598044|NCT00443261|1461907|P1|Accrual in 10 Months|Overall Study|Patient died due to progressive disease after cycle 1 of treatment|1
598045|NCT00443261|1461907|P1|STARTED|Overall Study||1
598046|NCT00443209|1461913|P2|NOT COMPLETED|Months 13 to 18 Treatment Period||47
598047|NCT00443209|1461914|P1|NOT COMPLETED|Months 13 to 18 Treatment Period||99
598048|NCT00443209|1461913|P2|COMPLETED|Months 13 to 18 Treatment Period|Trial terminated used for participants not completing 18 months of treatment due to trial completion|39
598049|NCT00443209|1461914|P1|COMPLETED|Months 13 to 18 Treatment Period|Trial terminated used for participants not completing 18 months of treatment due to trial completion|87
598050|NCT00443209|1461913|P2|STARTED|Months 13 to 18 Treatment Period|The Months 13 to 18 Treatment Period was optional. 116 participants chose not to continue.|86
598051|NCT00443209|1461914|P1|STARTED|Months 13 to 18 Treatment Period|The Months 13 to 18 Treatment Period.was optional. 181 participants chose not to continue.|186
598052|NCT00443209|1461913|P2|NOT COMPLETED|Months 1 to 12 Treatment Period||154
598053|NCT00443209|1461914|P1|NOT COMPLETED|Months 1 to 12 Treatment Period||345
598054|NCT00443209|1461913|P2|COMPLETED|Months 1 to 12 Treatment Period|Trial terminated used for participants not completing 12 months of treatment due to trial completion|202
598055|NCT00443209|1461914|P1|COMPLETED|Months 1 to 12 Treatment Period|Trial terminated used for participants not completing 12 months of treatment due to trial completion|367
598056|NCT00443209|1461913|P2|Treated|Months 1 to 12 Treatment Period||313
598057|NCT00443209|1461914|P1|Treated|Months 1 to 12 Treatment Period||641
598058|NCT00443209|1461913|P2|STARTED|Months 1 to 12 Treatment Period||356
598059|NCT00443209|1461914|P1|STARTED|Months 1 to 12 Treatment Period||712
598060|NCT00443118|1461931|P3|NOT COMPLETED|Overall Study||0
598061|NCT00443118|1461932|P2|NOT COMPLETED|Overall Study||1
598062|NCT00443118|1461933|P1|NOT COMPLETED|Overall Study||4
598063|NCT00443118|1461931|P3|COMPLETED|Overall Study||226
598064|NCT00443118|1461932|P2|COMPLETED|Overall Study||290
598065|NCT00443118|1461933|P1|COMPLETED|Overall Study||511
598066|NCT00443118|1461931|P3|STARTED|Overall Study||226
598067|NCT00443118|1461932|P2|STARTED|Overall Study||291
598068|NCT00443118|1461933|P1|STARTED|Overall Study||515
598069|NCT00443053|1461982|P2|NOT COMPLETED|Overall Study||33
598070|NCT00443053|1461983|P1|NOT COMPLETED|Overall Study||21
598071|NCT00443053|1461982|P2|COMPLETED|Overall Study||1467
598072|NCT00443053|1461983|P1|COMPLETED|Overall Study||1481
598073|NCT00443053|1461982|P2|STARTED|Overall Study||1500
598074|NCT00443053|1461983|P1|STARTED|Overall Study||1502
598075|NCT00443040|1462004|P3|NOT COMPLETED|Overall Study||1
598076|NCT00443040|1462005|P2|NOT COMPLETED|Overall Study||0
598077|NCT00443040|1462006|P1|NOT COMPLETED|Overall Study||4
598078|NCT00443040|1462004|P3|COMPLETED|Overall Study||9
598079|NCT00443040|1462005|P2|COMPLETED|Overall Study||11
598080|NCT00443040|1462006|P1|COMPLETED|Overall Study||10
598081|NCT00443040|1462004|P3|STARTED|Overall Study||10
598082|NCT00443040|1462005|P2|STARTED|Overall Study||11
598083|NCT00443040|1462006|P1|STARTED|Overall Study||14
598084|NCT00442962|1462014|P1|NOT COMPLETED|Overall Study||8
598085|NCT00442962|1462014|P1|COMPLETED|Overall Study|Completed 48 weeks of follow-up.|46
598086|NCT00442962|1462014|P1|Primary Outcome Evaluation|Overall Study|Primary outcome evaluation at week 24.|52
598087|NCT00442962|1462014|P1|STARTED|Overall Study||54
598088|NCT00442936|1462032|P4|NOT COMPLETED|Overall Study||1
598089|NCT00442936|1462033|P3|NOT COMPLETED|Overall Study||1
598090|NCT00442936|1462034|P2|NOT COMPLETED|Overall Study||0
598091|NCT00442936|1462035|P1|NOT COMPLETED|Overall Study||1
598092|NCT00442936|1462032|P4|COMPLETED|Overall Study||347
598093|NCT00442936|1462033|P3|COMPLETED|Overall Study||344
598094|NCT00442936|1462034|P2|COMPLETED|Overall Study||354
598095|NCT00442936|1462035|P1|COMPLETED|Overall Study||332
598096|NCT00442936|1462032|P4|STARTED|Overall Study||348
598097|NCT00442936|1462033|P3|STARTED|Overall Study||345
598098|NCT00442936|1462034|P2|STARTED|Overall Study||354
598099|NCT00442936|1462035|P1|STARTED|Overall Study||333
598100|NCT00442897|1462083|P2|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6
598101|NCT00442897|1462084|P1|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6
598102|NCT00442897|1462083|P2|COMPLETED|24 Weeks Follow-up (3 Centers)||28
598103|NCT00442897|1462084|P1|COMPLETED|24 Weeks Follow-up (3 Centers)||29
598104|NCT00442897|1462083|P2|STARTED|24 Weeks Follow-up (3 Centers)|65 Patients did not continue in the additional 12 week extension, for the 24 weeks follow-up period.|34
598105|NCT00442897|1462084|P1|STARTED|24 Weeks Follow-up (3 Centers)|66 Patients did not continue in the additional 12 week extension, for the 24 weeks follow-up period.|35
598106|NCT00442897|1462083|P2|NOT COMPLETED|Base Study (12 Week Follow-up)||12
598107|NCT00442897|1462084|P1|NOT COMPLETED|Base Study (12 Week Follow-up)||17
598108|NCT00442897|1462083|P2|COMPLETED|Base Study (12 Week Follow-up)||99
598109|NCT00442897|1462084|P1|COMPLETED|Base Study (12 Week Follow-up)||101
598110|NCT00442897|1462083|P2|STARTED|Base Study (12 Week Follow-up)||111
598111|NCT00442897|1462084|P1|STARTED|Base Study (12 Week Follow-up)||118
598112|NCT00442702|1462094|P2|NOT COMPLETED|Evaluation Period||4
598113|NCT00442702|1462095|P1|NOT COMPLETED|Evaluation Period||5
598114|NCT00442702|1462094|P2|COMPLETED|Evaluation Period||107
598115|NCT00442702|1462095|P1|COMPLETED|Evaluation Period||97
598116|NCT00442702|1462094|P2|STARTED|Evaluation Period||111
598117|NCT00442702|1462095|P1|STARTED|Evaluation Period||102
598118|NCT00442702|1462094|P2|NOT COMPLETED|Titration Period||3
598119|NCT00442702|1462095|P1|NOT COMPLETED|Titration Period||12
598120|NCT00442702|1462094|P2|COMPLETED|Titration Period||111
598121|NCT00442702|1462095|P1|COMPLETED|Titration Period||102
598122|NCT00442702|1462094|P2|Safety Population|Titration Period||113
598123|NCT00442702|1462095|P1|Safety Population|Titration Period|One patient was randomized to darbepoetin alfa but treated by mistake with Mircera|115
598124|NCT00442702|1462094|P2|STARTED|Titration Period||114
598125|NCT00442702|1462095|P1|STARTED|Titration Period||114
598126|NCT00442689|1462110|P3|NOT COMPLETED|Overall Study||9
598127|NCT00442689|1462111|P2|NOT COMPLETED|Overall Study||11
598128|NCT00442689|1462112|P1|NOT COMPLETED|Overall Study||10
598129|NCT00442689|1462110|P3|COMPLETED|Overall Study||13
598130|NCT00442689|1462111|P2|COMPLETED|Overall Study||13
598131|NCT00442689|1462112|P1|COMPLETED|Overall Study||11
598132|NCT00442689|1462110|P3|STARTED|Overall Study||22
598133|NCT00442689|1462111|P2|STARTED|Overall Study||24
598134|NCT00442689|1462112|P1|STARTED|Overall Study||21
598135|NCT00442611|1462140|P2|NOT COMPLETED|Overall Study||0
598136|NCT00442611|1462141|P1|NOT COMPLETED|Overall Study||1
598137|NCT00442611|1462140|P2|COMPLETED|Overall Study||3
598138|NCT00442611|1462141|P1|COMPLETED|Overall Study||6
598139|NCT00442611|1462140|P2|STARTED|Overall Study||3
598140|NCT00442611|1462141|P1|STARTED|Overall Study||7
598141|NCT00442598|1462160|P3|NOT COMPLETED|Overall Study||0
598142|NCT00442598|1462161|P2|NOT COMPLETED|Overall Study||8
598143|NCT00442598|1462162|P1|NOT COMPLETED|Overall Study||6
598144|NCT00442598|1462160|P3|COMPLETED|Overall Study||0
598145|NCT00442598|1462161|P2|COMPLETED|Overall Study||2
598146|NCT00442598|1462162|P1|COMPLETED|Overall Study||1
598147|NCT00442598|1462160|P3|Two Cycles|Overall Study||0
598148|NCT00442598|1462161|P2|Two Cycles|Overall Study||6
598149|NCT00442598|1462162|P1|Two Cycles|Overall Study||5
598150|NCT00442598|1462160|P3|STARTED|Overall Study||0
598151|NCT00442598|1462161|P2|STARTED|Overall Study||10
598152|NCT00442598|1462162|P1|STARTED|Overall Study||7
598153|NCT00442572|1462180|P2|NOT COMPLETED|Overall Study||3
598154|NCT00442572|1462181|P1|NOT COMPLETED|Overall Study||8
598155|NCT00442572|1462180|P2|COMPLETED|Overall Study||1
598156|NCT00442572|1462181|P1|COMPLETED|Overall Study||9
598157|NCT00442572|1462180|P2|STARTED|Overall Study||4
598158|NCT00442572|1462181|P1|STARTED|Overall Study||17
598159|NCT00442559|1462221|P2|NOT COMPLETED|Overall Study||35
598160|NCT00442559|1462222|P1|NOT COMPLETED|Overall Study||34
598161|NCT00442559|1462221|P2|COMPLETED|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|56
598162|NCT00442559|1462222|P1|COMPLETED|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|66
598163|NCT00442559|1462221|P2|12 Weeks After Randomization|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|60
598164|NCT00442559|1462222|P1|12 Weeks After Randomization|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|68
598165|NCT00442559|1462221|P2|STARTED|Overall Study||91
598166|NCT00442559|1462222|P1|STARTED|Overall Study||100
598167|NCT00442546|1462237|P3|NOT COMPLETED|Overall Study||33
598168|NCT00442546|1462238|P2|NOT COMPLETED|Overall Study||37
598169|NCT00442546|1462239|P1|NOT COMPLETED|Overall Study||26
598170|NCT00442546|1462237|P3|COMPLETED|Overall Study||71
598171|NCT00442546|1462238|P2|COMPLETED|Overall Study||63
598172|NCT00442546|1462239|P1|COMPLETED|Overall Study||77
598173|NCT00442546|1462237|P3|Received Treatment|Overall Study||98
598174|NCT00442546|1462238|P2|Received Treatment|Overall Study||96
598175|NCT00442546|1462239|P1|Received Treatment|Overall Study||98
598176|NCT00442546|1462237|P3|STARTED|Overall Study||104
598177|NCT00442546|1462238|P2|STARTED|Overall Study||100
598178|NCT00442546|1462239|P1|STARTED|Overall Study||103
598179|NCT00442507|1462361|P1|NOT COMPLETED|Overall Study||0
598180|NCT00442507|1462361|P1|COMPLETED|Overall Study||6
598181|NCT00442507|1462361|P1|STARTED|Overall Study||6
598182|NCT00442468|1462368|P1|NOT COMPLETED|Overall Study||183
598183|NCT00442468|1462368|P1|COMPLETED|Overall Study||1100
598184|NCT00442468|1462368|P1|STARTED|Overall Study||1283
598185|NCT00442416|1462398|P2|NOT COMPLETED|Overall Study||39
598186|NCT00442416|1462399|P1|NOT COMPLETED|Overall Study||37
598187|NCT00442416|1462398|P2|COMPLETED|Overall Study||2
598188|NCT00442416|1462399|P1|COMPLETED|Overall Study||2
598189|NCT00442416|1462398|P2|STARTED|Overall Study||41
598190|NCT00442416|1462399|P1|STARTED|Overall Study||39
598191|NCT00442364|1462432|P1|NOT COMPLETED|Overall Study||0
598192|NCT00442364|1462432|P1|COMPLETED|Overall Study||60
598193|NCT00442364|1462432|P1|STARTED|Overall Study||60
598194|NCT00442351|1462438|P2|NOT COMPLETED|Overall Study||6
598195|NCT00442351|1462439|P1|NOT COMPLETED|Overall Study||7
598196|NCT00442351|1462438|P2|COMPLETED|Overall Study||3
598197|NCT00442351|1462439|P1|COMPLETED|Overall Study||10
598198|NCT00442351|1462438|P2|STARTED|Overall Study||9
598199|NCT00442351|1462439|P1|STARTED|Overall Study|Due to poor enrollment and a high screening failure rate, this study was terminated early.|17
598200|NCT00442338|1462448|P3|NOT COMPLETED|Overall Study||0
598201|NCT00442338|1462449|P2|NOT COMPLETED|Overall Study||0
598202|NCT00442338|1462450|P1|NOT COMPLETED|Overall Study||0
598203|NCT00442338|1462448|P3|COMPLETED|Overall Study||31
598204|NCT00442338|1462449|P2|COMPLETED|Overall Study||30
598205|NCT00442338|1462450|P1|COMPLETED|Overall Study||30
598206|NCT00442338|1462448|P3|STARTED|Overall Study||31
598207|NCT00442338|1462449|P2|STARTED|Overall Study||30
598208|NCT00442338|1462450|P1|STARTED|Overall Study||30
598209|NCT00442286|1462461|P2|NOT COMPLETED|Overall Study||2
598210|NCT00442286|1462462|P1|NOT COMPLETED|Overall Study||7
598211|NCT00442286|1462461|P2|COMPLETED|Overall Study||82
598212|NCT00442286|1462462|P1|COMPLETED|Overall Study||174
598213|NCT00442286|1462461|P2|12 Months|Overall Study||82
598214|NCT00442286|1462462|P1|12 Months|Overall Study||174
598215|NCT00442286|1462461|P2|6 Months|Overall Study||83
598216|NCT00442286|1462462|P1|6 Months|Overall Study||177
598217|NCT00442286|1462461|P2|STARTED|Overall Study||84
598218|NCT00442286|1462462|P1|STARTED|Overall Study||181
598219|NCT00442169|1462479|P6|NOT COMPLETED|Part 2||0
598220|NCT00442169|1462480|P5|NOT COMPLETED|Part 2||0
598221|NCT00442169|1462481|P4|NOT COMPLETED|Part 2||0
598222|NCT00442169|1462482|P3|NOT COMPLETED|Part 2||0
598223|NCT00442169|1462483|P2|NOT COMPLETED|Part 2||0
598224|NCT00442169|1462484|P1|NOT COMPLETED|Part 2||0
598225|NCT00442169|1462479|P6|COMPLETED|Part 2||57
598226|NCT00442169|1462480|P5|COMPLETED|Part 2||25
598227|NCT00442169|1462481|P4|COMPLETED|Part 2||0
598228|NCT00442169|1462482|P3|COMPLETED|Part 2||0
598229|NCT00442169|1462483|P2|COMPLETED|Part 2||0
598230|NCT00442169|1462484|P1|COMPLETED|Part 2||0
598231|NCT00442169|1462479|P6|STARTED|Part 2||57
598232|NCT00442169|1462480|P5|STARTED|Part 2||25
598233|NCT00442169|1462481|P4|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
598234|NCT00442169|1462482|P3|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
598235|NCT00442169|1462483|P2|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
598236|NCT00442169|1462484|P1|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
598237|NCT00442169|1462479|P6|NOT COMPLETED|Part 1||0
598238|NCT00442169|1462480|P5|NOT COMPLETED|Part 1||0
598239|NCT00442169|1462481|P4|NOT COMPLETED|Part 1||0
598240|NCT00442169|1462482|P3|NOT COMPLETED|Part 1||0
598241|NCT00442169|1462483|P2|NOT COMPLETED|Part 1||0
598242|NCT00442169|1462484|P1|NOT COMPLETED|Part 1||0
598243|NCT00442169|1462479|P6|COMPLETED|Part 1||0
598244|NCT00442169|1462480|P5|COMPLETED|Part 1||0
598245|NCT00442169|1462481|P4|COMPLETED|Part 1||31
598246|NCT00442169|1462482|P3|COMPLETED|Part 1||40
598247|NCT00442169|1462483|P2|COMPLETED|Part 1||24
598248|NCT00442169|1462484|P1|COMPLETED|Part 1||17
598249|NCT00442169|1462479|P6|STARTED|Part 1|Participants in Part 2 are not the same as those in Part 1|0
598250|NCT00442169|1462480|P5|STARTED|Part 1|Participants in Part 2 are not the same as those in Part 1|0
598251|NCT00442169|1462481|P4|STARTED|Part 1||31
598252|NCT00442169|1462482|P3|STARTED|Part 1||40
598253|NCT00442169|1462483|P2|STARTED|Part 1||24
598254|NCT00442169|1462484|P1|STARTED|Part 1||17
598255|NCT00442117|1462524|P2|NOT COMPLETED|Overall Study||38
598256|NCT00442117|1462525|P1|NOT COMPLETED|Overall Study||38
598257|NCT00442117|1462524|P2|COMPLETED|Overall Study||49
598258|NCT00442117|1462525|P1|COMPLETED|Overall Study||47
598259|NCT00442117|1462524|P2|STARTED|Overall Study||87
598260|NCT00442117|1462525|P1|STARTED|Overall Study||85
598261|NCT00442013|1462539|P2|NOT COMPLETED|Overall Study||17
598262|NCT00442013|1462540|P1|NOT COMPLETED|Overall Study||26
598263|NCT00442013|1462539|P2|COMPLETED|Overall Study||132
598264|NCT00442013|1462540|P1|COMPLETED|Overall Study||131
598265|NCT00442013|1462539|P2|STARTED|Overall Study||149
598266|NCT00442013|1462540|P1|STARTED|Overall Study||157
598267|NCT00441974|1462556|P1|NOT COMPLETED|Overall Study||128
598268|NCT00441974|1462556|P1|COMPLETED|Overall Study||1342
598269|NCT00441974|1462556|P1|STARTED|Overall Study||1470
598270|NCT00441792|1462572|P2|NOT COMPLETED|Overall Study||2
598271|NCT00441792|1462573|P1|NOT COMPLETED|Overall Study||0
598272|NCT00441792|1462572|P2|COMPLETED|Overall Study|2 patients lost to follow up in Etomidate arm due to transfer to outside hospital.|61
598273|NCT00441792|1462573|P1|COMPLETED|Overall Study||59
598274|NCT00441792|1462572|P2|STARTED|Overall Study||63
598275|NCT00441792|1462573|P1|STARTED|Overall Study||59
598276|NCT00441766|1462585|P4|NOT COMPLETED|Overall Study||6
598277|NCT00441766|1462586|P3|NOT COMPLETED|Overall Study||9
598278|NCT00441766|1462587|P2|NOT COMPLETED|Overall Study||7
598279|NCT00441766|1462588|P1|NOT COMPLETED|Overall Study||14
598280|NCT00441766|1462585|P4|COMPLETED|Overall Study||48
598281|NCT00441766|1462586|P3|COMPLETED|Overall Study||44
598282|NCT00441766|1462587|P2|COMPLETED|Overall Study||46
598283|NCT00441766|1462588|P1|COMPLETED|Overall Study||39
598284|NCT00441766|1462585|P4|STARTED|Overall Study||54
598285|NCT00441766|1462586|P3|STARTED|Overall Study||53
598286|NCT00441766|1462587|P2|STARTED|Overall Study||53
598287|NCT00441766|1462588|P1|STARTED|Overall Study||53
598288|NCT00441727|1462613|P3|NOT COMPLETED|Overall Study||168
598289|NCT00441727|1462614|P2|NOT COMPLETED|Overall Study||118
598290|NCT00441727|1462615|P1|NOT COMPLETED|Overall Study||106
598291|NCT00441727|1462613|P3|COMPLETED|Overall Study|ITT/randomised|637
598292|NCT00441727|1462614|P2|COMPLETED|Overall Study|ITT/randomised|686
598293|NCT00441727|1462615|P1|COMPLETED|Overall Study|ITT/randomised|711
598294|NCT00441727|1462613|P3|STARTED|Overall Study|ITT/randomised|805
598295|NCT00441727|1462614|P2|STARTED|Overall Study|ITT/randomised|804
598296|NCT00441727|1462615|P1|STARTED|Overall Study|ITT/randomised|817
598297|NCT00441701|1462648|P10|NOT COMPLETED|Overall Study||0
598298|NCT00441701|1462649|P9|NOT COMPLETED|Overall Study||0
598299|NCT00441701|1462650|P8|NOT COMPLETED|Overall Study||0
598300|NCT00441701|1462651|P7|NOT COMPLETED|Overall Study||0
598301|NCT00441701|1462652|P6|NOT COMPLETED|Overall Study||3
598302|NCT00441701|1462653|P5|NOT COMPLETED|Overall Study||2
598303|NCT00441701|1462654|P4|NOT COMPLETED|Overall Study||3
598304|NCT00441701|1462655|P3|NOT COMPLETED|Overall Study||4
598305|NCT00441701|1462656|P2|NOT COMPLETED|Overall Study||4
598306|NCT00441701|1462657|P1|NOT COMPLETED|Overall Study||5
598307|NCT00441701|1462648|P10|COMPLETED|Overall Study||0
598308|NCT00441701|1462649|P9|COMPLETED|Overall Study||0
598309|NCT00441701|1462650|P8|COMPLETED|Overall Study||0
598310|NCT00441701|1462651|P7|COMPLETED|Overall Study||0
598311|NCT00441701|1462652|P6|COMPLETED|Overall Study||8
598312|NCT00441701|1462653|P5|COMPLETED|Overall Study||20
598313|NCT00441701|1462654|P4|COMPLETED|Overall Study||8
598314|NCT00441701|1462655|P3|COMPLETED|Overall Study||18
598315|NCT00441701|1462656|P2|COMPLETED|Overall Study||7
598316|NCT00441701|1462657|P1|COMPLETED|Overall Study||17
598317|NCT00441701|1462648|P10|STARTED|Overall Study||0
598318|NCT00441701|1462649|P9|STARTED|Overall Study||0
598319|NCT00441701|1462650|P8|STARTED|Overall Study||0
598320|NCT00441701|1462651|P7|STARTED|Overall Study||0
598321|NCT00441701|1462652|P6|STARTED|Overall Study||11
598322|NCT00441701|1462653|P5|STARTED|Overall Study||22
598323|NCT00441701|1462654|P4|STARTED|Overall Study||11
598324|NCT00441701|1462655|P3|STARTED|Overall Study||22
598325|NCT00441701|1462656|P2|STARTED|Overall Study||11
598326|NCT00441701|1462657|P1|STARTED|Overall Study||22
598327|NCT00441584|1462739|P1|NOT COMPLETED|Overall Study||105
598328|NCT00441584|1462739|P1|COMPLETED|Overall Study||12
598329|NCT00441584|1462739|P1|STARTED|Overall Study||117
598330|NCT00441558|1462743|P1|NOT COMPLETED|Overall Study||1056
598331|NCT00441558|1462743|P1|COMPLETED|Overall Study||667
598332|NCT00441558|1462743|P1|STARTED|Overall Study||1723
598333|NCT00441545|1462747|P2|NOT COMPLETED|Second Intervention||7
598334|NCT00441545|1462748|P1|NOT COMPLETED|Second Intervention||12
598335|NCT00441545|1462747|P2|COMPLETED|Second Intervention||68
598336|NCT00441545|1462748|P1|COMPLETED|Second Intervention||65
598337|NCT00441545|1462747|P2|STARTED|Second Intervention||75
598338|NCT00441545|1462748|P1|STARTED|Second Intervention||77
598339|NCT00441545|1462747|P2|NOT COMPLETED|Washout||0
598340|NCT00441545|1462748|P1|NOT COMPLETED|Washout||0
598341|NCT00441545|1462747|P2|COMPLETED|Washout||75
598342|NCT00441545|1462748|P1|COMPLETED|Washout||77
598343|NCT00441545|1462747|P2|STARTED|Washout||75
598344|NCT00441545|1462748|P1|STARTED|Washout||77
598345|NCT00441545|1462747|P2|NOT COMPLETED|First Intervention||12
598346|NCT00441545|1462748|P1|NOT COMPLETED|First Intervention||18
598347|NCT00441545|1462747|P2|COMPLETED|First Intervention||75
598348|NCT00441545|1462748|P1|COMPLETED|First Intervention||77
598349|NCT00441545|1462747|P2|STARTED|First Intervention||87
598350|NCT00441545|1462748|P1|STARTED|First Intervention||95
598351|NCT00441480|1462762|P2|NOT COMPLETED|Overall Study||4
598352|NCT00441480|1462763|P1|NOT COMPLETED|Overall Study||3
598353|NCT00441480|1462762|P2|COMPLETED|Overall Study||41
598354|NCT00441480|1462763|P1|COMPLETED|Overall Study||43
598355|NCT00441480|1462762|P2|STARTED|Overall Study||45
598356|NCT00441480|1462763|P1|STARTED|Overall Study||46
598357|NCT00441467|1462795|P1|NOT COMPLETED|Overall Study||18
598358|NCT00441467|1462795|P1|COMPLETED|Overall Study||4
598359|NCT00441467|1462795|P1|4 Cycles|Overall Study||7
598360|NCT00441467|1462795|P1|2 Cycles|Overall Study||17
598361|NCT00441467|1462795|P1|STARTED|Overall Study||22
598362|NCT00441441|1462803|P2|NOT COMPLETED|Overall Study||14
598363|NCT00441441|1462804|P1|NOT COMPLETED|Overall Study||11
598364|NCT00441441|1462803|P2|COMPLETED|Overall Study||163
598365|NCT00441441|1462804|P1|COMPLETED|Overall Study||162
598366|NCT00441441|1462803|P2|STARTED|Overall Study||177
598367|NCT00441441|1462804|P1|STARTED|Overall Study||173
598368|NCT00441363|1462864|P2|NOT COMPLETED|Overall Study||15
598369|NCT00441363|1462865|P1|NOT COMPLETED|Overall Study||17
598370|NCT00441363|1462864|P2|COMPLETED|Overall Study||19
598371|NCT00441363|1462865|P1|COMPLETED|Overall Study|no subject withdrew early since the trial was terminated|15
598372|NCT00441363|1462864|P2|STARTED|Overall Study||34
598373|NCT00441363|1462865|P1|STARTED|Overall Study||32
598374|NCT00441337|1462877|P4|NOT COMPLETED|Overall Study||21
598375|NCT00441337|1462878|P3|NOT COMPLETED|Overall Study||6
598376|NCT00441337|1462879|P2|NOT COMPLETED|Overall Study||6
598377|NCT00441337|1462880|P1|NOT COMPLETED|Overall Study||6
598378|NCT00441337|1462877|P4|COMPLETED|Overall Study||0
598379|NCT00441337|1462878|P3|COMPLETED|Overall Study||0
598380|NCT00441337|1462879|P2|COMPLETED|Overall Study||0
598381|NCT00441337|1462880|P1|COMPLETED|Overall Study||0
598382|NCT00441337|1462877|P4|STARTED|Overall Study||21
598383|NCT00441337|1462878|P3|STARTED|Overall Study||6
598384|NCT00441337|1462879|P2|STARTED|Overall Study||6
598385|NCT00441337|1462880|P1|STARTED|Overall Study||6
598386|NCT00441285|1462963|P5|NOT COMPLETED|Overall Study||0
598387|NCT00441285|1462964|P4|NOT COMPLETED|Overall Study||0
598388|NCT00441285|1462965|P3|NOT COMPLETED|Overall Study||0
598389|NCT00441285|1462966|P2|NOT COMPLETED|Overall Study||0
598390|NCT00441285|1462967|P1|NOT COMPLETED|Overall Study||0
598391|NCT00441285|1462963|P5|COMPLETED|Overall Study||43
598392|NCT00441285|1462964|P4|COMPLETED|Overall Study||40
598393|NCT00441285|1462965|P3|COMPLETED|Overall Study||41
598394|NCT00441285|1462966|P2|COMPLETED|Overall Study||16
598395|NCT00441285|1462967|P1|COMPLETED|Overall Study||16
598396|NCT00441285|1462963|P5|STARTED|Overall Study||43
598397|NCT00441285|1462964|P4|STARTED|Overall Study||40
598398|NCT00441285|1462965|P3|STARTED|Overall Study||41
598399|NCT00441285|1462966|P2|STARTED|Overall Study||16
598400|NCT00441285|1462967|P1|STARTED|Overall Study||16
598401|NCT00441272|1462993|P2|NOT COMPLETED|Overall Study||25
598402|NCT00441272|1462994|P1|NOT COMPLETED|Overall Study||25
598403|NCT00441272|1462993|P2|COMPLETED|Overall Study|Study terminated prior to enrollment.|0
598404|NCT00441272|1462994|P1|COMPLETED|Overall Study|Study terminated prior to enrollment.|0
598405|NCT00441272|1462993|P2|STARTED|Overall Study||25
598406|NCT00441272|1462994|P1|STARTED|Overall Study||25
598407|NCT00441259|1463002|P2|NOT COMPLETED|Overall Study||0
598408|NCT00441259|1463003|P1|NOT COMPLETED|Overall Study||0
598409|NCT00441259|1463002|P2|COMPLETED|Overall Study||48
598410|NCT00441259|1463003|P1|COMPLETED|Overall Study||48
598411|NCT00441259|1463002|P2|STARTED|Overall Study||48
598412|NCT00441259|1463003|P1|STARTED|Overall Study||48
598413|NCT00441168|1463021|P2|NOT COMPLETED|Follow-up Period||9
598414|NCT00441168|1463022|P1|NOT COMPLETED|Follow-up Period||12
598415|NCT00441168|1463021|P2|COMPLETED|Follow-up Period||4
598416|NCT00441168|1463022|P1|COMPLETED|Follow-up Period||5
598417|NCT00441168|1463021|P2|STARTED|Follow-up Period|Subjects who did not complete the treatment period could be entered into the follow-up period|13
598418|NCT00441168|1463022|P1|STARTED|Follow-up Period|Subjects who did not complete the treatment period could be entered into the follow-up period|17
598419|NCT00441168|1463021|P2|NOT COMPLETED|Treatment Period||6
598420|NCT00441168|1463022|P1|NOT COMPLETED|Treatment Period||11
598421|NCT00441168|1463021|P2|COMPLETED|Treatment Period||7
598422|NCT00441168|1463022|P1|COMPLETED|Treatment Period||6
598423|NCT00441168|1463021|P2|TREATED|Treatment Period||13
598424|NCT00441168|1463022|P1|TREATED|Treatment Period||16
598425|NCT00441168|1463021|P2|STARTED|Treatment Period||13
598426|NCT00441168|1463022|P1|STARTED|Treatment Period||17
598427|NCT00441142|1463036|P4|NOT COMPLETED|Overall Study||68
598428|NCT00441142|1463037|P3|NOT COMPLETED|Overall Study||22
598429|NCT00441142|1463038|P2|NOT COMPLETED|Overall Study||7
598430|NCT00441142|1463039|P1|NOT COMPLETED|Overall Study||6
598431|NCT00441142|1463036|P4|COMPLETED|Overall Study||1
598432|NCT00441142|1463037|P3|COMPLETED|Overall Study||7
598433|NCT00441142|1463038|P2|COMPLETED|Overall Study||0
598434|NCT00441142|1463039|P1|COMPLETED|Overall Study||0
598435|NCT00441142|1463036|P4|STARTED|Overall Study||69
598436|NCT00441142|1463037|P3|STARTED|Overall Study||29
598437|NCT00441142|1463038|P2|STARTED|Overall Study||7
598438|NCT00441142|1463039|P1|STARTED|Overall Study||6
598439|NCT00441116|1463057|P2|NOT COMPLETED|Overall Study||2
598440|NCT00441116|1463058|P1|NOT COMPLETED|Overall Study||3
598441|NCT00441116|1463057|P2|COMPLETED|Overall Study||75
598442|NCT00441116|1463058|P1|COMPLETED|Overall Study||73
598443|NCT00441116|1463057|P2|STARTED|Overall Study||77
598444|NCT00441116|1463058|P1|STARTED|Overall Study||76
598445|NCT00441103|1463126|P2|NOT COMPLETED|Overall Study||4
598446|NCT00441103|1463127|P1|NOT COMPLETED|Overall Study||11
598447|NCT00441103|1463126|P2|COMPLETED|Overall Study||56
598448|NCT00441103|1463127|P1|COMPLETED|Overall Study||109
598449|NCT00441103|1463126|P2|STARTED|Overall Study|Intent to treat (ITT) population: all participants who received at least one dose of study drug.|60
598450|NCT00441103|1463127|P1|STARTED|Overall Study|Intent to treat (ITT) population: all participants who received at least one dose of study drug.|120
598451|NCT00441090|1463143|P5|NOT COMPLETED|Overall Study||0
598452|NCT00441090|1463144|P4|NOT COMPLETED|Overall Study||2
598453|NCT00441090|1463145|P3|NOT COMPLETED|Overall Study||2
598454|NCT00441090|1463146|P2|NOT COMPLETED|Overall Study||1
598455|NCT00441090|1463147|P1|NOT COMPLETED|Overall Study||2
598456|NCT00441090|1463143|P5|COMPLETED|Overall Study||5
598457|NCT00441090|1463144|P4|COMPLETED|Overall Study||13
598458|NCT00441090|1463145|P3|COMPLETED|Overall Study||12
598459|NCT00441090|1463146|P2|COMPLETED|Overall Study||14
598460|NCT00441090|1463147|P1|COMPLETED|Overall Study||13
598461|NCT00441090|1463143|P5|STARTED|Overall Study||5
598462|NCT00441090|1463144|P4|STARTED|Overall Study||15
598463|NCT00441090|1463145|P3|STARTED|Overall Study||14
598464|NCT00441090|1463146|P2|STARTED|Overall Study||15
598465|NCT00441090|1463147|P1|STARTED|Overall Study||15
598466|NCT00441064|1463191|P2|NOT COMPLETED|Overall Study||7
598467|NCT00441064|1463192|P1|NOT COMPLETED|Overall Study||10
598468|NCT00441064|1463191|P2|COMPLETED|Overall Study||56
598469|NCT00441064|1463192|P1|COMPLETED|Overall Study||59
598470|NCT00441064|1463191|P2|Intent-to-treat (ITT) Population|Overall Study||57
598471|NCT00441064|1463192|P1|Intent-to-treat (ITT) Population|Overall Study||61
598472|NCT00441064|1463191|P2|Safety Population (SP)|Overall Study||63
598473|NCT00441064|1463192|P1|Safety Population (SP)|Overall Study||69
598474|NCT00441064|1463191|P2|STARTED|Overall Study||63
598475|NCT00441064|1463192|P1|STARTED|Overall Study||69
598476|NCT00441012|1463204|P2|NOT COMPLETED|Overall Study||13
598477|NCT00441012|1463205|P1|NOT COMPLETED|Overall Study||18
598478|NCT00441012|1463204|P2|COMPLETED|Overall Study||263
598479|NCT00441012|1463205|P1|COMPLETED|Overall Study||252
598480|NCT00441012|1463204|P2|Vaccination Visit 3|Overall Study||269
598481|NCT00441012|1463205|P1|Vaccination Visit 3|Overall Study||265
598482|NCT00441012|1463204|P2|Vaccination Visit 2|Overall Study||272
598483|NCT00441012|1463205|P1|Vaccination Visit 2|Overall Study||267
598484|NCT00441012|1463204|P2|Vaccination Visit 1|Overall Study|3 participants were vaccinated but were never randomized in the COMVAX™ group|276
598485|NCT00441012|1463205|P1|Vaccination Visit 1|Overall Study|1 participant was randomized but not vaccinated in the Modified Process Vaccine group|269
598486|NCT00441012|1463204|P2|STARTED|Overall Study||276
598487|NCT00441012|1463205|P1|STARTED|Overall Study||270
598488|NCT00440947|1463219|P5|NOT COMPLETED|Optional 60-Week Extension Phase||26
598489|NCT00440947|1463220|P4|NOT COMPLETED|Optional 60-Week Extension Phase||29
598490|NCT00440947|1463221|P3|NOT COMPLETED|Optional 60-Week Extension Phase||0
598491|NCT00440947|1463222|P2|NOT COMPLETED|Optional 60-Week Extension Phase||0
598492|NCT00440947|1463223|P1|NOT COMPLETED|Optional 60-Week Extension Phase||0
598493|NCT00440947|1463219|P5|COMPLETED|Optional 60-Week Extension Phase||154
598494|NCT00440947|1463220|P4|COMPLETED|Optional 60-Week Extension Phase||160
598495|NCT00440947|1463221|P3|COMPLETED|Optional 60-Week Extension Phase||0
598496|NCT00440947|1463222|P2|COMPLETED|Optional 60-Week Extension Phase||0
598497|NCT00440947|1463223|P1|COMPLETED|Optional 60-Week Extension Phase||0
598498|NCT00440947|1463219|P5|STARTED|Optional 60-Week Extension Phase||180
598499|NCT00440947|1463220|P4|STARTED|Optional 60-Week Extension Phase||189
598500|NCT00440947|1463221|P3|STARTED|Optional 60-Week Extension Phase||0
598501|NCT00440947|1463222|P2|STARTED|Optional 60-Week Extension Phase||0
598502|NCT00440947|1463223|P1|STARTED|Optional 60-Week Extension Phase||0
598503|NCT00440947|1463219|P5|NOT COMPLETED|48-Week Randomization Phase||0
598504|NCT00440947|1463220|P4|NOT COMPLETED|48-Week Randomization Phase||0
598505|NCT00440947|1463221|P3|NOT COMPLETED|48-Week Randomization Phase||24
598506|NCT00440947|1463222|P2|NOT COMPLETED|48-Week Randomization Phase||16
598507|NCT00440947|1463223|P1|NOT COMPLETED|48-Week Randomization Phase||0
598508|NCT00440947|1463219|P5|COMPLETED|48-Week Randomization Phase||0
598509|NCT00440947|1463220|P4|COMPLETED|48-Week Randomization Phase||0
598510|NCT00440947|1463221|P3|COMPLETED|48-Week Randomization Phase||185
598511|NCT00440947|1463222|P2|COMPLETED|48-Week Randomization Phase||194
598512|NCT00440947|1463223|P1|COMPLETED|48-Week Randomization Phase||0
598513|NCT00440947|1463219|P5|STARTED|48-Week Randomization Phase||0
598514|NCT00440947|1463220|P4|STARTED|48-Week Randomization Phase||0
598515|NCT00440947|1463221|P3|STARTED|48-Week Randomization Phase||209
598516|NCT00440947|1463222|P2|STARTED|48-Week Randomization Phase||210
598517|NCT00440947|1463223|P1|STARTED|48-Week Randomization Phase||0
598518|NCT00440947|1463219|P5|NOT COMPLETED|36-Week Induction Phase||0
598519|NCT00440947|1463220|P4|NOT COMPLETED|36-Week Induction Phase||0
598520|NCT00440947|1463221|P3|NOT COMPLETED|36-Week Induction Phase||0
598521|NCT00440947|1463222|P2|NOT COMPLETED|36-Week Induction Phase||0
598522|NCT00440947|1463223|P1|NOT COMPLETED|36-Week Induction Phase||73
598523|NCT00440947|1463219|P5|COMPLETED|36-Week Induction Phase||0
598524|NCT00440947|1463220|P4|COMPLETED|36-Week Induction Phase||0
598525|NCT00440947|1463221|P3|COMPLETED|36-Week Induction Phase||0
598526|NCT00440947|1463222|P2|COMPLETED|36-Week Induction Phase||0
598527|NCT00440947|1463223|P1|COMPLETED|36-Week Induction Phase|23 PAR without confirmed HIV-RNA<50c/mL prior to Wk 36 couldn’t be randomized but weren’t withdrawn.|442
598528|NCT00440947|1463219|P5|STARTED|36-Week Induction Phase||0
598529|NCT00440947|1463220|P4|STARTED|36-Week Induction Phase||0
598530|NCT00440947|1463221|P3|STARTED|36-Week Induction Phase||0
598531|NCT00440947|1463222|P2|STARTED|36-Week Induction Phase||0
598532|NCT00440947|1463223|P1|STARTED|36-Week Induction Phase||515
598533|NCT00440830|1463278|P4|NOT COMPLETED|Overall Study||0
598534|NCT00440830|1463279|P3|NOT COMPLETED|Overall Study||0
598535|NCT00440830|1463280|P2|NOT COMPLETED|Overall Study||0
598536|NCT00440830|1463281|P1|NOT COMPLETED|Overall Study||0
598537|NCT00440830|1463278|P4|COMPLETED|Overall Study||10
598538|NCT00440830|1463279|P3|COMPLETED|Overall Study||30
598539|NCT00440830|1463280|P2|COMPLETED|Overall Study||8
598540|NCT00440830|1463281|P1|COMPLETED|Overall Study||20
598541|NCT00440830|1463278|P4|STARTED|Overall Study||10
598542|NCT00440830|1463279|P3|STARTED|Overall Study||30
598543|NCT00440830|1463280|P2|STARTED|Overall Study||8
598544|NCT00440830|1463281|P1|STARTED|Overall Study||20
598545|NCT00440700|1463298|P3|NOT COMPLETED|Overall Study||4
598546|NCT00440700|1463299|P2|NOT COMPLETED|Overall Study||8
598547|NCT00440700|1463300|P1|NOT COMPLETED|Overall Study||8
598548|NCT00440700|1463298|P3|COMPLETED|Overall Study||120
598549|NCT00440700|1463299|P2|COMPLETED|Overall Study||110
598550|NCT00440700|1463300|P1|COMPLETED|Overall Study||114
598551|NCT00440700|1463298|P3|STARTED|Overall Study||124
598552|NCT00440700|1463299|P2|STARTED|Overall Study||118
598553|NCT00440700|1463300|P1|STARTED|Overall Study||122
598554|NCT00440557|1463323|P3|NOT COMPLETED|Overall Study||35
598555|NCT00440557|1463324|P2|NOT COMPLETED|Overall Study||29
598556|NCT00440557|1463325|P1|NOT COMPLETED|Overall Study||25
598557|NCT00440557|1463323|P3|COMPLETED|Overall Study||90
598558|NCT00440557|1463324|P2|COMPLETED|Overall Study||96
598559|NCT00440557|1463325|P1|COMPLETED|Overall Study||98
598560|NCT00440557|1463323|P3|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|125
598561|NCT00440557|1463324|P2|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|125
598562|NCT00440557|1463325|P1|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|123
598563|NCT00440531|1463357|P3|NOT COMPLETED|Overall Study||7
598564|NCT00440531|1463358|P2|NOT COMPLETED|Overall Study||5
598565|NCT00440531|1463359|P1|NOT COMPLETED|Overall Study||10
598566|NCT00440531|1463357|P3|COMPLETED|Overall Study||165
598567|NCT00440531|1463358|P2|COMPLETED|Overall Study||178
598568|NCT00440531|1463359|P1|COMPLETED|Overall Study||175
598569|NCT00440531|1463357|P3|Vaccination 3|Overall Study||166
598570|NCT00440531|1463358|P2|Vaccination 3|Overall Study||178
598571|NCT00440531|1463359|P1|Vaccination 3|Overall Study||176
598572|NCT00440531|1463357|P3|Vaccination 2|Overall Study||171
598573|NCT00440531|1463358|P2|Vaccination 2|Overall Study||182
598574|NCT00440531|1463359|P1|Vaccination 2|Overall Study||181
598575|NCT00440531|1463357|P3|Vaccination 1|Overall Study||172
598576|NCT00440531|1463358|P2|Vaccination 1|Overall Study||183
598577|NCT00440531|1463359|P1|Vaccination 1|Overall Study||183
598578|NCT00440531|1463357|P3|STARTED|Overall Study||172
598579|NCT00440531|1463358|P2|STARTED|Overall Study||183
598580|NCT00440531|1463359|P1|STARTED|Overall Study||185
598581|NCT00440518|1463376|P3|NOT COMPLETED|Maintenance and Safety Follow-up Periods||15
598582|NCT00440518|1463377|P2|NOT COMPLETED|Maintenance and Safety Follow-up Periods||12
598583|NCT00440518|1463378|P1|NOT COMPLETED|Maintenance and Safety Follow-up Periods||7
598584|NCT00440518|1463376|P3|COMPLETED|Maintenance and Safety Follow-up Periods||55
598585|NCT00440518|1463377|P2|COMPLETED|Maintenance and Safety Follow-up Periods||51
598586|NCT00440518|1463378|P1|COMPLETED|Maintenance and Safety Follow-up Periods||52
598587|NCT00440518|1463376|P3|STARTED|Maintenance and Safety Follow-up Periods||70
598588|NCT00440518|1463377|P2|STARTED|Maintenance and Safety Follow-up Periods||63
598589|NCT00440518|1463378|P1|STARTED|Maintenance and Safety Follow-up Periods||59
598590|NCT00440518|1463376|P3|NOT COMPLETED|Randomized /Titration Period||4
598591|NCT00440518|1463377|P2|NOT COMPLETED|Randomized /Titration Period||9
598592|NCT00440518|1463378|P1|NOT COMPLETED|Randomized /Titration Period||13
598593|NCT00440518|1463376|P3|COMPLETED|Randomized /Titration Period||70
598594|NCT00440518|1463377|P2|COMPLETED|Randomized /Titration Period||63
598595|NCT00440518|1463378|P1|COMPLETED|Randomized /Titration Period||59
598596|NCT00440518|1463376|P3|STARTED|Randomized /Titration Period||74
598597|NCT00440518|1463377|P2|STARTED|Randomized /Titration Period||72
598598|NCT00440518|1463378|P1|STARTED|Randomized /Titration Period||72
598599|NCT00440505|1463398|P6|NOT COMPLETED|Third Intervention||0
598600|NCT00440505|1463399|P5|NOT COMPLETED|Third Intervention||0
598601|NCT00440505|1463400|P4|NOT COMPLETED|Third Intervention||1
598602|NCT00440505|1463401|P3|NOT COMPLETED|Third Intervention||0
598603|NCT00440505|1463402|P2|NOT COMPLETED|Third Intervention||0
598604|NCT00440505|1463403|P1|NOT COMPLETED|Third Intervention||0
598605|NCT00440505|1463398|P6|COMPLETED|Third Intervention||5
598606|NCT00440505|1463399|P5|COMPLETED|Third Intervention||5
598607|NCT00440505|1463400|P4|COMPLETED|Third Intervention||1
598608|NCT00440505|1463401|P3|COMPLETED|Third Intervention||1
598609|NCT00440505|1463402|P2|COMPLETED|Third Intervention||2
598610|NCT00440505|1463403|P1|COMPLETED|Third Intervention||5
598611|NCT00440505|1463398|P6|STARTED|Third Intervention||5
598612|NCT00440505|1463399|P5|STARTED|Third Intervention||5
598613|NCT00440505|1463400|P4|STARTED|Third Intervention||2
598614|NCT00440505|1463401|P3|STARTED|Third Intervention||1
598615|NCT00440505|1463402|P2|STARTED|Third Intervention||2
598616|NCT00440505|1463403|P1|STARTED|Third Intervention||5
598617|NCT00440505|1463398|P6|NOT COMPLETED|Second Intervention||0
598618|NCT00440505|1463399|P5|NOT COMPLETED|Second Intervention||0
598619|NCT00440505|1463400|P4|NOT COMPLETED|Second Intervention||0
598620|NCT00440505|1463401|P3|NOT COMPLETED|Second Intervention||0
598621|NCT00440505|1463402|P2|NOT COMPLETED|Second Intervention||0
598622|NCT00440505|1463403|P1|NOT COMPLETED|Second Intervention||0
598623|NCT00440505|1463398|P6|COMPLETED|Second Intervention||5
598624|NCT00440505|1463399|P5|COMPLETED|Second Intervention||5
598625|NCT00440505|1463400|P4|COMPLETED|Second Intervention||2
598626|NCT00440505|1463401|P3|COMPLETED|Second Intervention||1
598627|NCT00440505|1463402|P2|COMPLETED|Second Intervention||2
598628|NCT00440505|1463403|P1|COMPLETED|Second Intervention||5
598629|NCT00440505|1463398|P6|STARTED|Second Intervention||5
598630|NCT00440505|1463399|P5|STARTED|Second Intervention||5
598631|NCT00440505|1463400|P4|STARTED|Second Intervention||2
598632|NCT00440505|1463401|P3|STARTED|Second Intervention||1
598633|NCT00440505|1463402|P2|STARTED|Second Intervention||2
598634|NCT00440505|1463403|P1|STARTED|Second Intervention||5
598635|NCT00440505|1463398|P6|NOT COMPLETED|First Intervention||0
598636|NCT00440505|1463399|P5|NOT COMPLETED|First Intervention||0
598637|NCT00440505|1463400|P4|NOT COMPLETED|First Intervention||0
598638|NCT00440505|1463401|P3|NOT COMPLETED|First Intervention||0
598639|NCT00440505|1463402|P2|NOT COMPLETED|First Intervention||0
598640|NCT00440505|1463403|P1|NOT COMPLETED|First Intervention||0
598641|NCT00440505|1463398|P6|COMPLETED|First Intervention||5
598642|NCT00440505|1463399|P5|COMPLETED|First Intervention||5
598643|NCT00440505|1463400|P4|COMPLETED|First Intervention||2
598644|NCT00440505|1463401|P3|COMPLETED|First Intervention||1
598645|NCT00440505|1463402|P2|COMPLETED|First Intervention||2
598646|NCT00440505|1463403|P1|COMPLETED|First Intervention||5
598647|NCT00440505|1463398|P6|STARTED|First Intervention||5
598648|NCT00440505|1463399|P5|STARTED|First Intervention||5
598649|NCT00440505|1463400|P4|STARTED|First Intervention||2
598650|NCT00440505|1463401|P3|STARTED|First Intervention||1
598651|NCT00440505|1463402|P2|STARTED|First Intervention||2
598652|NCT00440505|1463403|P1|STARTED|First Intervention||5
598653|NCT00440466|1463423|P3|NOT COMPLETED|Overall Study||41
598654|NCT00440466|1463424|P2|NOT COMPLETED|Overall Study||15
598655|NCT00440466|1463425|P1|NOT COMPLETED|Overall Study||13
598656|NCT00440466|1463423|P3|COMPLETED|Overall Study||174
598657|NCT00440466|1463424|P2|COMPLETED|Overall Study||92
598658|NCT00440466|1463425|P1|COMPLETED|Overall Study||95
598659|NCT00440466|1463423|P3|STARTED|Overall Study||215
598660|NCT00440466|1463424|P2|STARTED|Overall Study||107
598661|NCT00440466|1463425|P1|STARTED|Overall Study||108
598662|NCT00440401|1463459|P2|NOT COMPLETED|Overall Study||6
598663|NCT00440401|1463460|P1|NOT COMPLETED|Overall Study||4
598664|NCT00440401|1463459|P2|COMPLETED|Overall Study||54
598665|NCT00440401|1463460|P1|COMPLETED|Overall Study||55
598666|NCT00440401|1463459|P2|STARTED|Overall Study||60
598667|NCT00440401|1463460|P1|STARTED|Overall Study||59
598668|NCT00440310|1463470|P2|NOT COMPLETED|Overall Study||30
598669|NCT00440310|1463471|P1|NOT COMPLETED|Overall Study||28
598670|NCT00440310|1463470|P2|COMPLETED|Overall Study||209
598671|NCT00440310|1463471|P1|COMPLETED|Overall Study||216
598672|NCT00440310|1463470|P2|Treated|Overall Study||232
598673|NCT00440310|1463471|P1|Treated|Overall Study||222
598674|NCT00440310|1463470|P2|STARTED|Overall Study||239
598675|NCT00440310|1463471|P1|STARTED|Overall Study||244
598676|NCT00440297|1463479|P2|NOT COMPLETED|Overall Study||18
598677|NCT00440297|1463480|P1|NOT COMPLETED|Overall Study||23
598678|NCT00440297|1463479|P2|COMPLETED|Overall Study||120
598679|NCT00440297|1463480|P1|COMPLETED|Overall Study||116
598680|NCT00440297|1463479|P2|Vaccination Visit 4|Overall Study||122
598681|NCT00440297|1463480|P1|Vaccination Visit 4|Overall Study||116
598682|NCT00440297|1463479|P2|Vaccination Visit 3|Overall Study||125
598683|NCT00440297|1463480|P1|Vaccination Visit 3|Overall Study||124
598684|NCT00440297|1463479|P2|Vaccination Visit 2|Overall Study||134
598685|NCT00440297|1463480|P1|Vaccination Visit 2|Overall Study||136
598686|NCT00440297|1463479|P2|Vaccination Visit 1|Overall Study||138
598687|NCT00440297|1463480|P1|Vaccination Visit 1|Overall Study||138
598688|NCT00440297|1463479|P2|STARTED|Overall Study||138
598689|NCT00440297|1463480|P1|STARTED|Overall Study||139
598690|NCT00440271|1463496|P2|NOT COMPLETED|Overall Study||15
598691|NCT00440271|1463497|P1|NOT COMPLETED|Overall Study||12
598692|NCT00440271|1463496|P2|COMPLETED|Overall Study||3
598693|NCT00440271|1463497|P1|COMPLETED|Overall Study||3
598694|NCT00440271|1463496|P2|STARTED|Overall Study||18
598695|NCT00440271|1463497|P1|STARTED|Overall Study||15
598696|NCT00440232|1463531|P2|NOT COMPLETED|Overall Study||4
598697|NCT00440232|1463532|P1|NOT COMPLETED|Overall Study||3
598698|NCT00440232|1463531|P2|COMPLETED|Overall Study||34
598699|NCT00440232|1463532|P1|COMPLETED|Overall Study||33
598700|NCT00440232|1463531|P2|STARTED|Overall Study||38
598701|NCT00440232|1463532|P1|STARTED|Overall Study||36
598702|NCT00440193|1463542|P2|NOT COMPLETED|Observational Period||38
598703|NCT00440193|1463543|P1|NOT COMPLETED|Observational Period||45
598704|NCT00440193|1463542|P2|COMPLETED|Observational Period||1369
598705|NCT00440193|1463543|P1|COMPLETED|Observational Period||1380
598706|NCT00440193|1463542|P2|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|1407
598707|NCT00440193|1463543|P1|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|1425
598708|NCT00440193|1463542|P2|NOT COMPLETED|Treatment Period||351
598709|NCT00440193|1463543|P1|NOT COMPLETED|Treatment Period||305
598710|NCT00440193|1463542|P2|COMPLETED|Treatment Period||1367
598711|NCT00440193|1463543|P1|COMPLETED|Treatment Period||1426
598712|NCT00440193|1463542|P2|Participants Received Treatment|Treatment Period||1711
598713|NCT00440193|1463543|P1|Participants Received Treatment|Treatment Period||1718
598714|NCT00440193|1463542|P2|STARTED|Treatment Period||1718
598715|NCT00440193|1463543|P1|STARTED|Treatment Period||1731
598716|NCT00440180|1463579|P2|NOT COMPLETED|Overall Study||0
598717|NCT00440180|1463580|P1|NOT COMPLETED|Overall Study||0
598718|NCT00440180|1463579|P2|COMPLETED|Overall Study||10
598719|NCT00440180|1463580|P1|COMPLETED|Overall Study||10
598720|NCT00440180|1463579|P2|STARTED|Overall Study||10
598721|NCT00440180|1463580|P1|STARTED|Overall Study||10
598722|NCT00440115|1463589|P3|NOT COMPLETED|Overall Study||6
598723|NCT00440115|1463590|P2|NOT COMPLETED|Overall Study||11
598724|NCT00440115|1463591|P1|NOT COMPLETED|Overall Study||7
598725|NCT00440115|1463589|P3|COMPLETED|Overall Study||244
598726|NCT00440115|1463590|P2|COMPLETED|Overall Study||238
598727|NCT00440115|1463591|P1|COMPLETED|Overall Study||244
598728|NCT00440115|1463589|P3|STARTED|Overall Study||250
598729|NCT00440115|1463590|P2|STARTED|Overall Study||249
598730|NCT00440115|1463591|P1|STARTED|Overall Study||251
598731|NCT00440050|1463607|P2|NOT COMPLETED|Overall Study||67
598732|NCT00440050|1463608|P1|NOT COMPLETED|Overall Study||40
598733|NCT00440050|1463607|P2|COMPLETED|Overall Study||171
598734|NCT00440050|1463608|P1|COMPLETED|Overall Study||124
598735|NCT00440050|1463607|P2|STARTED|Overall Study||238
598736|NCT00440050|1463608|P1|STARTED|Overall Study||164
598737|NCT00440011|1463622|P2|NOT COMPLETED|Overall Study||3
598738|NCT00440011|1463623|P1|NOT COMPLETED|Overall Study||4
598739|NCT00440011|1463622|P2|COMPLETED|Overall Study||132
598740|NCT00440011|1463623|P1|COMPLETED|Overall Study||127
598741|NCT00440011|1463622|P2|STARTED|Overall Study||135
598742|NCT00440011|1463623|P1|STARTED|Overall Study||131
598743|NCT00439946|1463631|P1|NOT COMPLETED|Overall Study||0
598744|NCT00439946|1463631|P1|COMPLETED|Overall Study||8
598745|NCT00439946|1463631|P1|STARTED|Overall Study||8
598746|NCT00439777|1463650|P2|NOT COMPLETED|Observational Period||41
598747|NCT00439777|1463651|P1|NOT COMPLETED|Observational Period||41
598748|NCT00439777|1463650|P2|COMPLETED|Observational Period||2156
598749|NCT00439777|1463651|P1|COMPLETED|Observational Period||2165
598750|NCT00439777|1463650|P2|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|2197
598751|NCT00439777|1463651|P1|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|2206
598752|NCT00439777|1463650|P2|NOT COMPLETED|Treatment Period||459
598753|NCT00439777|1463651|P1|NOT COMPLETED|Treatment Period||419
598754|NCT00439777|1463650|P2|COMPLETED|Treatment Period||1954
598755|NCT00439777|1463651|P1|COMPLETED|Treatment Period||2001
598756|NCT00439777|1463650|P2|Participants Received Treatment|Treatment Period||2405
598757|NCT00439777|1463651|P1|Participants Received Treatment|Treatment Period||2412
598758|NCT00439777|1463650|P2|STARTED|Treatment Period||2413
598759|NCT00439777|1463651|P1|STARTED|Treatment Period||2420
598760|NCT00439738|1463689|P2|NOT COMPLETED|Overall Study||28
598761|NCT00439738|1463690|P1|NOT COMPLETED|Overall Study||36
598762|NCT00439738|1463689|P2|COMPLETED|Overall Study||178
598763|NCT00439738|1463690|P1|COMPLETED|Overall Study||170
598764|NCT00439738|1463689|P2|STARTED|Overall Study||206
598765|NCT00439738|1463690|P1|STARTED|Overall Study||206
598766|NCT00439725|1463708|P2|NOT COMPLETED|Observational Period||7
598767|NCT00439725|1463709|P1|NOT COMPLETED|Observational Period||8
598768|NCT00439725|1463708|P2|COMPLETED|Observational Period||553
598769|NCT00439725|1463709|P1|COMPLETED|Observational Period||569
598770|NCT00439725|1463708|P2|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|560
598771|NCT00439725|1463709|P1|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|577
598772|NCT00439725|1463708|P2|NOT COMPLETED|Treatment Period||246
598773|NCT00439725|1463709|P1|NOT COMPLETED|Treatment Period||236
598774|NCT00439725|1463708|P2|COMPLETED|Treatment Period||349
598775|NCT00439725|1463709|P1|COMPLETED|Treatment Period||366
598776|NCT00439725|1463708|P2|Participants Received Treatment|Treatment Period|Safety population|590
598777|NCT00439725|1463709|P1|Participants Received Treatment|Treatment Period|Safety population|598
598778|NCT00439725|1463708|P2|STARTED|Treatment Period||595
598779|NCT00439725|1463709|P1|STARTED|Treatment Period||602
598780|NCT00439647|1463755|P2|NOT COMPLETED|Overall Study||71
598781|NCT00439647|1463756|P1|NOT COMPLETED|Overall Study||58
598782|NCT00439647|1463755|P2|COMPLETED|Overall Study||540
598783|NCT00439647|1463756|P1|COMPLETED|Overall Study||530
598784|NCT00439647|1463755|P2|Modified Intent to Treat (mITT)|Overall Study||574
598785|NCT00439647|1463756|P1|Modified Intent to Treat (mITT)|Overall Study||553
598786|NCT00439647|1463755|P2|STARTED|Overall Study||611
598787|NCT00439647|1463756|P1|STARTED|Overall Study|"Started indicates intent to treat (ITT) and safety set."|588
598788|NCT00439608|1463788|P1|NOT COMPLETED|Overall Study||0
598789|NCT00439608|1463788|P1|COMPLETED|Overall Study||60
598790|NCT00439608|1463788|P1|STARTED|Overall Study||60
598791|NCT00439569|1463792|P1|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||1
598792|NCT00439569|1463792|P1|COMPLETED|Cohort 2 (500 mg/kg/Day)||1
598793|NCT00439569|1463792|P1|STARTED|Cohort 2 (500 mg/kg/Day)|2 new subjects in Cohort 2 were enrolled into the study after Cohort 1 completed the study.|2
598794|NCT00439569|1463792|P1|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||4
598795|NCT00439569|1463792|P1|COMPLETED|Cohort 1 (500 mg/kg/Day)||3
598796|NCT00439569|1463792|P1|STARTED|Cohort 1 (500 mg/kg/Day)||7
598797|NCT00439517|1463805|P2|NOT COMPLETED|Overall Study||0
598798|NCT00439517|1463806|P1|NOT COMPLETED|Overall Study||2
598799|NCT00439517|1463805|P2|COMPLETED|Overall Study||150
598800|NCT00439517|1463806|P1|COMPLETED|Overall Study||150
598801|NCT00439517|1463805|P2|STARTED|Overall Study||150
598802|NCT00439517|1463806|P1|STARTED|Overall Study||152
598803|NCT00439413|1463830|P2|NOT COMPLETED|Overall Study||37
598804|NCT00439413|1463831|P1|NOT COMPLETED|Overall Study||31
598805|NCT00439413|1463830|P2|COMPLETED|Overall Study||88
598806|NCT00439413|1463831|P1|COMPLETED|Overall Study||90
598807|NCT00439413|1463830|P2|STARTED|Overall Study||125
598808|NCT00439413|1463831|P1|STARTED|Overall Study||121
598809|NCT00439335|1463841|P2|NOT COMPLETED|Overall Study||0
598810|NCT00439335|1463842|P1|NOT COMPLETED|Overall Study||2
598811|NCT00439335|1463841|P2|COMPLETED|Overall Study||114
598812|NCT00439335|1463842|P1|COMPLETED|Overall Study||111
598813|NCT00439335|1463841|P2|STARTED|Overall Study||114
598814|NCT00439335|1463842|P1|STARTED|Overall Study||113
598815|NCT00439309|1463874|P2|NOT COMPLETED|Follow-Up||2
598816|NCT00439309|1463875|P1|NOT COMPLETED|Follow-Up||3
598817|NCT00439309|1463874|P2|COMPLETED|Follow-Up||13
598818|NCT00439309|1463875|P1|COMPLETED|Follow-Up||51
598819|NCT00439309|1463874|P2|STARTED|Follow-Up||15
598820|NCT00439309|1463875|P1|STARTED|Follow-Up||54
598821|NCT00439309|1463874|P2|NOT COMPLETED|Treatment||0
598822|NCT00439309|1463875|P1|NOT COMPLETED|Treatment||0
598823|NCT00439309|1463874|P2|COMPLETED|Treatment||15
598824|NCT00439309|1463875|P1|COMPLETED|Treatment||54
598825|NCT00439309|1463874|P2|STARTED|Treatment||15
598826|NCT00439309|1463875|P1|STARTED|Treatment||54
598827|NCT00439270|1463894|P5|NOT COMPLETED|Phase 2 (51.6 Months)||0
598828|NCT00439270|1463895|P4|NOT COMPLETED|Phase 2 (51.6 Months)||34
598829|NCT00439270|1463896|P3|NOT COMPLETED|Phase 2 (51.6 Months)||0
598830|NCT00439270|1463897|P2|NOT COMPLETED|Phase 2 (51.6 Months)||0
598831|NCT00439270|1463898|P1|NOT COMPLETED|Phase 2 (51.6 Months)||0
598832|NCT00439270|1463894|P5|COMPLETED|Phase 2 (51.6 Months)||0
598833|NCT00439270|1463895|P4|COMPLETED|Phase 2 (51.6 Months)||0
598834|NCT00439270|1463896|P3|COMPLETED|Phase 2 (51.6 Months)||0
598835|NCT00439270|1463897|P2|COMPLETED|Phase 2 (51.6 Months)||0
598836|NCT00439270|1463898|P1|COMPLETED|Phase 2 (51.6 Months)||0
598837|NCT00439270|1463894|P5|STARTED|Phase 2 (51.6 Months)||0
598838|NCT00439270|1463895|P4|STARTED|Phase 2 (51.6 Months)|Includes 4 patients who completed Phase 1|34
598839|NCT00439270|1463896|P3|STARTED|Phase 2 (51.6 Months)||0
598840|NCT00439270|1463897|P2|STARTED|Phase 2 (51.6 Months)||0
598841|NCT00439270|1463898|P1|STARTED|Phase 2 (51.6 Months)||0
598842|NCT00439270|1463894|P5|NOT COMPLETED|Phase 1 (18.1 Months)||3
598843|NCT00439270|1463895|P4|NOT COMPLETED|Phase 1 (18.1 Months)||0
598844|NCT00439270|1463896|P3|NOT COMPLETED|Phase 1 (18.1 Months)||3
598845|NCT00439270|1463897|P2|NOT COMPLETED|Phase 1 (18.1 Months)||3
598846|NCT00439270|1463898|P1|NOT COMPLETED|Phase 1 (18.1 Months)||3
598847|NCT00439270|1463894|P5|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
598848|NCT00439270|1463895|P4|COMPLETED|Phase 1 (18.1 Months)|Remained on study|4
598849|NCT00439270|1463896|P3|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
598850|NCT00439270|1463897|P2|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
598851|NCT00439270|1463898|P1|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
598852|NCT00439270|1463894|P5|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
598853|NCT00439270|1463895|P4|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|4
598854|NCT00439270|1463896|P3|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
598855|NCT00439270|1463897|P2|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
598856|NCT00439270|1463898|P1|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
598857|NCT00439244|1463940|P3|NOT COMPLETED|Overall Study||7
598858|NCT00439244|1463941|P2|NOT COMPLETED|Overall Study||6
598859|NCT00439244|1463942|P1|NOT COMPLETED|Overall Study||11
598860|NCT00439244|1463940|P3|COMPLETED|Overall Study||131
598861|NCT00439244|1463941|P2|COMPLETED|Overall Study||131
598862|NCT00439244|1463942|P1|COMPLETED|Overall Study||126
598863|NCT00439244|1463940|P3|Safety Population|Overall Study||137
598864|NCT00439244|1463941|P2|Safety Population|Overall Study||137
598865|NCT00439244|1463942|P1|Safety Population|Overall Study|Total safety population is 411. One patient was randomized, but never received any study medication.|137
598866|NCT00439244|1463940|P3|STARTED|Overall Study||138
598867|NCT00439244|1463941|P2|STARTED|Overall Study||137
598868|NCT00439244|1463942|P1|STARTED|Overall Study|"Started indicates randomized as well as intent to treat (ITT) population enrolled to study."|137
598869|NCT00439231|1463962|P1|NOT COMPLETED|Overall Study||28
598870|NCT00439231|1463962|P1|COMPLETED|Overall Study|5 subjects had a partial response, 0 complete response, 28 completed off study,|5
598871|NCT00439231|1463962|P1|STARTED|Overall Study||33
598872|NCT00439218|1463966|P1|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||0
598873|NCT00439218|1463966|P1|COMPLETED|Cohort 2 (500 mg/kg/Day)||1
598874|NCT00439218|1463966|P1|STARTED|Cohort 2 (500 mg/kg/Day)|One new subject was enrolled into the study after Cohort 1 completed the study.|1
598875|NCT00439218|1463966|P1|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||1
598876|NCT00439218|1463966|P1|COMPLETED|Cohort 1 (500 mg/kg/Day)|3 subjects completed the study in Cohort 1. Cohort 2 was then opened for new enrollments.|3
598877|NCT00439218|1463966|P1|STARTED|Cohort 1 (500 mg/kg/Day)||4
598878|NCT00439179|1463981|P4|NOT COMPLETED|Overall Study||0
598879|NCT00439179|1463982|P3|NOT COMPLETED|Overall Study||0
598880|NCT00439179|1463983|P2|NOT COMPLETED|Overall Study||2
598881|NCT00439179|1463984|P1|NOT COMPLETED|Overall Study||0
598882|NCT00439179|1463981|P4|COMPLETED|Overall Study||5
598883|NCT00439179|1463982|P3|COMPLETED|Overall Study||6
598884|NCT00439179|1463983|P2|COMPLETED|Overall Study||11
598885|NCT00439179|1463984|P1|COMPLETED|Overall Study||3
598886|NCT00439179|1463981|P4|STARTED|Overall Study|2 with biliry|5
598887|NCT00439179|1463982|P3|STARTED|Overall Study|2 with biliary|6
598888|NCT00439179|1463983|P2|STARTED|Overall Study|2 with biliary|13
598889|NCT00439179|1463984|P1|STARTED|Overall Study|1 with biliary|3
598890|NCT00439140|1464001|P3|NOT COMPLETED|Treatment Cycle 2||0
598891|NCT00439140|1464002|P2|NOT COMPLETED|Treatment Cycle 2||1
598892|NCT00439140|1464003|P1|NOT COMPLETED|Treatment Cycle 2||2
598893|NCT00439140|1464001|P3|COMPLETED|Treatment Cycle 2||0
598894|NCT00439140|1464002|P2|COMPLETED|Treatment Cycle 2||6
598895|NCT00439140|1464003|P1|COMPLETED|Treatment Cycle 2||11
598896|NCT00439140|1464001|P3|STARTED|Treatment Cycle 2|No patients received placebo in Cycle 2.|0
598897|NCT00439140|1464002|P2|STARTED|Treatment Cycle 2|6 patients from the 300U arm plus 1 patient from the placebo arm in Cycle 1 entered Cycle 2.|7
598898|NCT00439140|1464003|P1|STARTED|Treatment Cycle 2|8 patients from the 200U arm plus 5 patients from the placebo arm in Cycle 1 entered Cycle 2.|13
598899|NCT00439140|1464001|P3|NOT COMPLETED|Treatment Cycle 1||1
598900|NCT00439140|1464002|P2|NOT COMPLETED|Treatment Cycle 1||4
598901|NCT00439140|1464003|P1|NOT COMPLETED|Treatment Cycle 1||1
598902|NCT00439140|1464001|P3|COMPLETED|Treatment Cycle 1|5 patients did not enter Cycle 2. 6 patients received botulinum toxin Type A in Cycle 2.|11
598903|NCT00439140|1464002|P2|COMPLETED|Treatment Cycle 1||10
598904|NCT00439140|1464003|P1|COMPLETED|Treatment Cycle 1||14
598905|NCT00439140|1464001|P3|STARTED|Treatment Cycle 1||12
598906|NCT00439140|1464002|P2|STARTED|Treatment Cycle 1||14
598907|NCT00439140|1464003|P1|STARTED|Treatment Cycle 1||15
598908|NCT00438971|1464032|P1|NOT COMPLETED|Overall Study||2
598909|NCT00438971|1464032|P1|COMPLETED|Overall Study||15
598910|NCT00438971|1464032|P1|STARTED|Overall Study||17
598911|NCT00438932|1464047|P4|NOT COMPLETED|Overall Study||0
598912|NCT00438932|1464048|P3|NOT COMPLETED|Overall Study||0
598913|NCT00438932|1464049|P2|NOT COMPLETED|Overall Study||0
598914|NCT00438932|1464050|P1|NOT COMPLETED|Overall Study||0
598915|NCT00438932|1464047|P4|COMPLETED|Overall Study||4
598916|NCT00438932|1464048|P3|COMPLETED|Overall Study||4
598917|NCT00438932|1464049|P2|COMPLETED|Overall Study||4
598918|NCT00438932|1464050|P1|COMPLETED|Overall Study||4
598919|NCT00438932|1464047|P4|STARTED|Overall Study||4
598920|NCT00438932|1464048|P3|STARTED|Overall Study||4
598921|NCT00438932|1464049|P2|STARTED|Overall Study||4
598922|NCT00438932|1464050|P1|STARTED|Overall Study||4
598923|NCT00438880|1464066|P2|NOT COMPLETED|Overall Study||0
598924|NCT00438880|1464067|P1|NOT COMPLETED|Overall Study||0
598925|NCT00438880|1464066|P2|COMPLETED|Overall Study||8
598926|NCT00438880|1464067|P1|COMPLETED|Overall Study||30
598927|NCT00438880|1464066|P2|STARTED|Overall Study||8
598928|NCT00438880|1464067|P1|STARTED|Overall Study||30
598929|NCT00438854|1464079|P1|NOT COMPLETED|Overall Study||0
598930|NCT00438854|1464079|P1|COMPLETED|Overall Study||15
598931|NCT00438854|1464079|P1|STARTED|Overall Study||15
598932|NCT00438815|1464086|P1|NOT COMPLETED|Overall Study||70
598933|NCT00438815|1464086|P1|COMPLETED|Overall Study||43
598934|NCT00438815|1464086|P1|STARTED|Overall Study||113
598935|NCT00438802|1464099|P3|NOT COMPLETED|Overall Study||0
598936|NCT00438802|1464100|P2|NOT COMPLETED|Overall Study||0
598937|NCT00438802|1464101|P1|NOT COMPLETED|Overall Study||0
598938|NCT00438802|1464099|P3|COMPLETED|Overall Study||9
598939|NCT00438802|1464100|P2|COMPLETED|Overall Study||8
598940|NCT00438802|1464101|P1|COMPLETED|Overall Study||6
598941|NCT00438802|1464099|P3|STARTED|Overall Study||9
598942|NCT00438802|1464100|P2|STARTED|Overall Study||8
598943|NCT00438802|1464101|P1|STARTED|Overall Study||6
598944|NCT00438750|1464115|P2|NOT COMPLETED|Overall Study||9
598945|NCT00438750|1464116|P1|NOT COMPLETED|Overall Study||9
598946|NCT00438750|1464115|P2|COMPLETED|Overall Study||37
598947|NCT00438750|1464116|P1|COMPLETED|Overall Study||39
598948|NCT00438750|1464115|P2|STARTED|Overall Study||46
598949|NCT00438750|1464116|P1|STARTED|Overall Study||48
598950|NCT00438672|1464136|P2|NOT COMPLETED|Overall Study||9
598951|NCT00438672|1464137|P1|NOT COMPLETED|Overall Study||7
598952|NCT00438672|1464136|P2|COMPLETED|Overall Study||24
598953|NCT00438672|1464137|P1|COMPLETED|Overall Study||24
598954|NCT00438672|1464136|P2|STARTED|Overall Study||33
598955|NCT00438672|1464137|P1|STARTED|Overall Study||31
598956|NCT00438659|1464147|P2|NOT COMPLETED|Overall Study||4
598957|NCT00438659|1464148|P1|NOT COMPLETED|Overall Study||6
598958|NCT00438659|1464147|P2|COMPLETED|Overall Study||82
598959|NCT00438659|1464148|P1|COMPLETED|Overall Study||84
598960|NCT00438659|1464147|P2|STARTED|Overall Study||86
598961|NCT00438659|1464148|P1|STARTED|Overall Study||90
598962|NCT00438490|1464172|P2|NOT COMPLETED|Overall Study||0
598963|NCT00438490|1464173|P1|NOT COMPLETED|Overall Study||0
598964|NCT00438490|1464172|P2|COMPLETED|Overall Study||9
598965|NCT00438490|1464173|P1|COMPLETED|Overall Study||12
598966|NCT00438490|1464172|P2|STARTED|Overall Study||9
598967|NCT00438490|1464173|P1|STARTED|Overall Study||12
598968|NCT00438464|1464187|P2|NOT COMPLETED|Overall Study||7
598969|NCT00438464|1464188|P1|NOT COMPLETED|Overall Study||14
598970|NCT00438464|1464187|P2|COMPLETED|Overall Study||94
598971|NCT00438464|1464188|P1|COMPLETED|Overall Study||89
598972|NCT00438464|1464187|P2|Received Assigned Intervention|Overall Study||94
598973|NCT00438464|1464188|P1|Received Assigned Intervention|Overall Study||89
598974|NCT00438464|1464187|P2|STARTED|Overall Study||101
598975|NCT00438464|1464188|P1|STARTED|Overall Study||103
598976|NCT00438451|1464243|P3|NOT COMPLETED|Overall Study||53
598977|NCT00438451|1464244|P2|NOT COMPLETED|Overall Study||66
598978|NCT00438451|1464245|P1|NOT COMPLETED|Overall Study||47
598979|NCT00438451|1464243|P3|COMPLETED|Overall Study||65
598980|NCT00438451|1464244|P2|COMPLETED|Overall Study||55
598981|NCT00438451|1464245|P1|COMPLETED|Overall Study||75
598982|NCT00438451|1464243|P3|Maintenance Phase (Week 7-58)|Overall Study||93
598983|NCT00438451|1464244|P2|Maintenance Phase (Week 7-58)|Overall Study||89
598984|NCT00438451|1464245|P1|Maintenance Phase (Week 7-58)|Overall Study||93
598985|NCT00438451|1464243|P3|ITT Population|Overall Study||117
598986|NCT00438451|1464244|P2|ITT Population|Overall Study||120
598987|NCT00438451|1464245|P1|ITT Population|Overall Study||122
598988|NCT00438451|1464243|P3|Safety Population|Overall Study||117
598989|NCT00438451|1464244|P2|Safety Population|Overall Study||121
598990|NCT00438451|1464245|P1|Safety Population|Overall Study||122
598991|NCT00438451|1464243|P3|STARTED|Overall Study||118
598992|NCT00438451|1464244|P2|STARTED|Overall Study||121
598993|NCT00438451|1464245|P1|STARTED|Overall Study||122
598994|NCT00438399|1464289|P6|NOT COMPLETED|Overall Study||6
598995|NCT00438399|1464290|P5|NOT COMPLETED|Overall Study||3
598996|NCT00438399|1464291|P4|NOT COMPLETED|Overall Study||4
598997|NCT00438399|1464292|P3|NOT COMPLETED|Overall Study||7
598998|NCT00438399|1464293|P2|NOT COMPLETED|Overall Study||8
598999|NCT00438399|1464294|P1|NOT COMPLETED|Overall Study||8
599000|NCT00438399|1464289|P6|COMPLETED|Overall Study||31
599001|NCT00438399|1464290|P5|COMPLETED|Overall Study||30
599002|NCT00438399|1464291|P4|COMPLETED|Overall Study||32
599003|NCT00438399|1464292|P3|COMPLETED|Overall Study||28
599004|NCT00438399|1464293|P2|COMPLETED|Overall Study||32
599005|NCT00438399|1464294|P1|COMPLETED|Overall Study||30
599006|NCT00438399|1464289|P6|TREATED & ANALYZED|Overall Study||31
599007|NCT00438399|1464290|P5|TREATED & ANALYZED|Overall Study||30
599008|NCT00438399|1464291|P4|TREATED & ANALYZED|Overall Study||32
599009|NCT00438399|1464292|P3|TREATED & ANALYZED|Overall Study||28
599010|NCT00438399|1464293|P2|TREATED & ANALYZED|Overall Study||32
599011|NCT00438399|1464294|P1|TREATED & ANALYZED|Overall Study||30
599012|NCT00438399|1464289|P6|STARTED|Overall Study||37
599013|NCT00438399|1464290|P5|STARTED|Overall Study||33
599014|NCT00438399|1464291|P4|STARTED|Overall Study||36
599015|NCT00438399|1464292|P3|STARTED|Overall Study||35
599016|NCT00438399|1464293|P2|STARTED|Overall Study||40
599017|NCT00438399|1464294|P1|STARTED|Overall Study||38
599018|NCT00438360|1464305|P2|NOT COMPLETED|Overall Study||43
599019|NCT00438360|1464306|P1|NOT COMPLETED|Overall Study||72
599020|NCT00438360|1464305|P2|COMPLETED|Overall Study||38
599021|NCT00438360|1464306|P1|COMPLETED|Overall Study||90
599022|NCT00438360|1464305|P2|Intention to Treat (ITT) Population|Overall Study||79
599023|NCT00438360|1464306|P1|Intention to Treat (ITT) Population|Overall Study|These numbers are different from those started (randomized) as 2 pts from each arm never took drug.|160
599024|NCT00438360|1464305|P2|STARTED|Overall Study||81
599025|NCT00438360|1464306|P1|STARTED|Overall Study|"Started indicates randomized patients."|162
599026|NCT00438204|1464320|P1|NOT COMPLETED|Overall Study||0
599027|NCT00438204|1464320|P1|COMPLETED|Overall Study||39
599028|NCT00438204|1464320|P1|STARTED|Overall Study||39
599029|NCT00438191|1464330|P2|NOT COMPLETED|Overall Study||14
599030|NCT00438191|1464331|P1|NOT COMPLETED|Overall Study||11
599031|NCT00438191|1464330|P2|COMPLETED|Overall Study||26
599032|NCT00438191|1464331|P1|COMPLETED|Overall Study||32
599033|NCT00438191|1464330|P2|STARTED|Overall Study||40
599034|NCT00438191|1464331|P1|STARTED|Overall Study||43
599035|NCT00438100|1464345|P2|NOT COMPLETED|Overall Study||4
599036|NCT00438100|1464346|P1|NOT COMPLETED|Overall Study||2
599037|NCT00438100|1464345|P2|COMPLETED|Overall Study||65
599038|NCT00438100|1464346|P1|COMPLETED|Overall Study||71
599039|NCT00438100|1464345|P2|STARTED|Overall Study||69
599040|NCT00438100|1464346|P1|STARTED|Overall Study||73
599041|NCT00437983|1464354|P2|NOT COMPLETED|Overall Study||13
599042|NCT00437983|1464355|P1|NOT COMPLETED|Overall Study||13
599043|NCT00437983|1464354|P2|COMPLETED|Overall Study||65
599044|NCT00437983|1464355|P1|COMPLETED|Overall Study||66
599045|NCT00437983|1464354|P2|STARTED|Overall Study||78
599046|NCT00437983|1464355|P1|STARTED|Overall Study||79
599047|NCT00437645|1464367|P2|NOT COMPLETED|Overall Study||115
599048|NCT00437645|1464368|P1|NOT COMPLETED|Overall Study||35
599049|NCT00437645|1464367|P2|COMPLETED|Overall Study||476
599050|NCT00437645|1464368|P1|COMPLETED|Overall Study||557
599051|NCT00437645|1464367|P2|STARTED|Overall Study||591
599052|NCT00437645|1464368|P1|STARTED|Overall Study||592
599053|NCT00437489|1464384|P2|NOT COMPLETED|Overall Study||22
599054|NCT00437489|1464385|P1|NOT COMPLETED|Overall Study||23
599055|NCT00437489|1464384|P2|COMPLETED|Overall Study|2 subjects completed prior to study termination.|2
599056|NCT00437489|1464385|P1|COMPLETED|Overall Study|2 subjects completed prior to study termination.|2
599057|NCT00437489|1464384|P2|STARTED|Overall Study||24
599058|NCT00437489|1464385|P1|STARTED|Overall Study||25
599059|NCT00437398|1464397|P1|NOT COMPLETED|Overall Study||0
599060|NCT00437398|1464397|P1|COMPLETED|Overall Study||2
599061|NCT00437398|1464397|P1|STARTED|Overall Study||2
599062|NCT00437281|1464422|P20|NOT COMPLETED|Overall Study||1
599063|NCT00437281|1464423|P19|NOT COMPLETED|Overall Study||1
599064|NCT00437281|1464424|P18|NOT COMPLETED|Overall Study||0
599065|NCT00437281|1464425|P17|NOT COMPLETED|Overall Study||0
599066|NCT00437281|1464426|P16|NOT COMPLETED|Overall Study||0
599067|NCT00437281|1464427|P15|NOT COMPLETED|Overall Study||1
599068|NCT00437281|1464428|P14|NOT COMPLETED|Overall Study||1
599069|NCT00437281|1464429|P13|NOT COMPLETED|Overall Study||0
599070|NCT00437281|1464430|P12|NOT COMPLETED|Overall Study||0
599071|NCT00437281|1464431|P11|NOT COMPLETED|Overall Study||0
599072|NCT00437281|1464432|P10|NOT COMPLETED|Overall Study||1
599073|NCT00437281|1464433|P9|NOT COMPLETED|Overall Study||0
599074|NCT00437281|1464434|P8|NOT COMPLETED|Overall Study||0
599075|NCT00437281|1464435|P7|NOT COMPLETED|Overall Study||0
599076|NCT00437281|1464436|P6|NOT COMPLETED|Overall Study||1
599077|NCT00437281|1464437|P5|NOT COMPLETED|Overall Study||0
599078|NCT00437281|1464438|P4|NOT COMPLETED|Overall Study||1
599079|NCT00437281|1464439|P3|NOT COMPLETED|Overall Study||0
599080|NCT00437281|1464440|P2|NOT COMPLETED|Overall Study||0
599081|NCT00437281|1464441|P1|NOT COMPLETED|Overall Study||0
599082|NCT00437281|1464422|P20|COMPLETED|Overall Study||2
599083|NCT00437281|1464423|P19|COMPLETED|Overall Study||1
599084|NCT00437281|1464424|P18|COMPLETED|Overall Study||4
599085|NCT00437281|1464425|P17|COMPLETED|Overall Study||3
599086|NCT00437281|1464426|P16|COMPLETED|Overall Study||3
599087|NCT00437281|1464427|P15|COMPLETED|Overall Study||4
599088|NCT00437281|1464428|P14|COMPLETED|Overall Study||2
599089|NCT00437281|1464429|P13|COMPLETED|Overall Study||2
599090|NCT00437281|1464430|P12|COMPLETED|Overall Study||3
599091|NCT00437281|1464431|P11|COMPLETED|Overall Study||3
599092|NCT00437281|1464432|P10|COMPLETED|Overall Study||4
599093|NCT00437281|1464433|P9|COMPLETED|Overall Study||3
599094|NCT00437281|1464434|P8|COMPLETED|Overall Study||3
599095|NCT00437281|1464435|P7|COMPLETED|Overall Study||3
599096|NCT00437281|1464436|P6|COMPLETED|Overall Study||3
599097|NCT00437281|1464437|P5|COMPLETED|Overall Study||4
599098|NCT00437281|1464438|P4|COMPLETED|Overall Study||2
599099|NCT00437281|1464439|P3|COMPLETED|Overall Study||3
599100|NCT00437281|1464440|P2|COMPLETED|Overall Study||3
599101|NCT00437281|1464441|P1|COMPLETED|Overall Study||3
599102|NCT00437281|1464422|P20|STARTED|Overall Study||3
599103|NCT00437281|1464423|P19|STARTED|Overall Study||2
599104|NCT00437281|1464424|P18|STARTED|Overall Study||4
599105|NCT00437281|1464425|P17|STARTED|Overall Study||3
599106|NCT00437281|1464426|P16|STARTED|Overall Study||3
599107|NCT00437281|1464427|P15|STARTED|Overall Study||5
599108|NCT00437281|1464428|P14|STARTED|Overall Study||3
599109|NCT00437281|1464429|P13|STARTED|Overall Study||2
599110|NCT00437281|1464430|P12|STARTED|Overall Study||3
599111|NCT00437281|1464431|P11|STARTED|Overall Study||3
599112|NCT00437281|1464432|P10|STARTED|Overall Study||5
599113|NCT00437281|1464433|P9|STARTED|Overall Study||3
599114|NCT00437281|1464434|P8|STARTED|Overall Study||3
599115|NCT00437281|1464435|P7|STARTED|Overall Study||3
599116|NCT00437281|1464436|P6|STARTED|Overall Study||4
599117|NCT00437281|1464437|P5|STARTED|Overall Study||4
599118|NCT00437281|1464438|P4|STARTED|Overall Study||3
599119|NCT00437281|1464439|P3|STARTED|Overall Study||3
599120|NCT00437281|1464440|P2|STARTED|Overall Study||3
599121|NCT00437281|1464441|P1|STARTED|Overall Study||3
599122|NCT00437203|1464745|P10|NOT COMPLETED|Overall Study||4
599123|NCT00437203|1464746|P9|NOT COMPLETED|Overall Study||3
599124|NCT00437203|1464747|P8|NOT COMPLETED|Overall Study||3
599125|NCT00437203|1464748|P7|NOT COMPLETED|Overall Study||7
599126|NCT00437203|1464749|P6|NOT COMPLETED|Overall Study||3
599127|NCT00437203|1464750|P5|NOT COMPLETED|Overall Study||3
599128|NCT00437203|1464751|P4|NOT COMPLETED|Overall Study||3
599129|NCT00437203|1464752|P3|NOT COMPLETED|Overall Study||3
599130|NCT00437203|1464753|P2|NOT COMPLETED|Overall Study||8
599131|NCT00437203|1464754|P1|NOT COMPLETED|Overall Study||6
599132|NCT00437203|1464745|P10|COMPLETED|Overall Study||0
599133|NCT00437203|1464746|P9|COMPLETED|Overall Study||0
599134|NCT00437203|1464747|P8|COMPLETED|Overall Study||0
599135|NCT00437203|1464748|P7|COMPLETED|Overall Study||0
599136|NCT00437203|1464749|P6|COMPLETED|Overall Study||0
599137|NCT00437203|1464750|P5|COMPLETED|Overall Study||0
599138|NCT00437203|1464751|P4|COMPLETED|Overall Study||0
599139|NCT00437203|1464752|P3|COMPLETED|Overall Study||0
599140|NCT00437203|1464753|P2|COMPLETED|Overall Study||0
599141|NCT00437203|1464754|P1|COMPLETED|Overall Study||0
599142|NCT00437203|1464745|P10|STARTED|Overall Study||4
599143|NCT00437203|1464746|P9|STARTED|Overall Study||3
599144|NCT00437203|1464747|P8|STARTED|Overall Study||3
599145|NCT00437203|1464748|P7|STARTED|Overall Study||7
599146|NCT00437203|1464749|P6|STARTED|Overall Study||3
599147|NCT00437203|1464750|P5|STARTED|Overall Study||3
599148|NCT00437203|1464751|P4|STARTED|Overall Study||3
599149|NCT00437203|1464752|P3|STARTED|Overall Study||3
599150|NCT00437203|1464753|P2|STARTED|Overall Study||8
599151|NCT00437203|1464754|P1|STARTED|Overall Study||6
599152|NCT00437125|1464858|P1|NOT COMPLETED|Overall Study||32
599153|NCT00437125|1464858|P1|COMPLETED|Overall Study||119
599154|NCT00437125|1464858|P1|STARTED|Overall Study||151
599155|NCT00437073|1464879|P2|NOT COMPLETED|Overall Study||1
599156|NCT00437073|1464880|P1|NOT COMPLETED|Overall Study||1
599157|NCT00437073|1464879|P2|COMPLETED|Overall Study||8
599158|NCT00437073|1464880|P1|COMPLETED|Overall Study||12
599159|NCT00437073|1464879|P2|STARTED|Overall Study||9
599160|NCT00437073|1464880|P1|STARTED|Overall Study||13
599161|NCT00437034|1464908|P1|NOT COMPLETED|Overall Study||6
599162|NCT00437034|1464908|P1|COMPLETED|Overall Study||0
599163|NCT00437034|1464908|P1|STARTED|Overall Study||6
599164|NCT00436982|1464914|P2|NOT COMPLETED|Overall Study||4
599165|NCT00436982|1464915|P1|NOT COMPLETED|Overall Study||4
599166|NCT00436982|1464914|P2|COMPLETED|Overall Study||26
599167|NCT00436982|1464915|P1|COMPLETED|Overall Study||26
599168|NCT00436982|1464914|P2|STARTED|Overall Study||30
599169|NCT00436982|1464915|P1|STARTED|Overall Study||30
599170|NCT00436969|1464937|P2|NOT COMPLETED|Overall Study||52
599171|NCT00436969|1464938|P1|NOT COMPLETED|Overall Study||22
599172|NCT00436969|1464937|P2|COMPLETED|Overall Study||134
599173|NCT00436969|1464938|P1|COMPLETED|Overall Study||66
599174|NCT00436969|1464937|P2|Randomized But Not Treated|Overall Study||3
599175|NCT00436969|1464938|P1|Randomized But Not Treated|Overall Study||1
599176|NCT00436969|1464937|P2|STARTED|Overall Study||186
599177|NCT00436969|1464938|P1|STARTED|Overall Study||88
599178|NCT00436956|1464986|P2|NOT COMPLETED|Overall Study||0
599179|NCT00436956|1464987|P1|NOT COMPLETED|Overall Study||1
599180|NCT00436956|1464986|P2|COMPLETED|Overall Study||23
599181|NCT00436956|1464987|P1|COMPLETED|Overall Study|One pt was not evaluable due to a cord compression on day 2 of therapy; was removed from the trial.|35
599182|NCT00436956|1464986|P2|STARTED|Overall Study||23
599183|NCT00436956|1464987|P1|STARTED|Overall Study||36
599184|NCT00436917|1464996|P1|NOT COMPLETED|Overall Study||54
599185|NCT00436917|1464996|P1|COMPLETED|Overall Study||0
599186|NCT00436917|1464996|P1|STARTED|Overall Study|6 participants with cancellation, protocol violation and ineligible were excluded from all analysis.|54
599187|NCT00436904|1465000|P1|NOT COMPLETED|Overall Study||0
599188|NCT00436904|1465000|P1|COMPLETED|Overall Study||30
599189|NCT00436904|1465000|P1|STARTED|Overall Study||30
599190|NCT00436852|1465011|P2|NOT COMPLETED|Overall Study||45
599191|NCT00436852|1465012|P1|NOT COMPLETED|Overall Study||35
599192|NCT00436852|1465011|P2|COMPLETED|Overall Study||2
599193|NCT00436852|1465012|P1|COMPLETED|Overall Study||10
599194|NCT00436852|1465011|P2|STARTED|Overall Study||47
599195|NCT00436852|1465012|P1|STARTED|Overall Study||45
599196|NCT00436826|1465022|P6|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||7
599197|NCT00436826|1465023|P5|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||51
599198|NCT00436826|1465024|P4|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
599199|NCT00436826|1465025|P3|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
599200|NCT00436826|1465026|P2|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
599201|NCT00436826|1465027|P1|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
599202|NCT00436826|1465022|P6|COMPLETED|Ext. Period (No Cladribine Treatment)||0
599203|NCT00436826|1465023|P5|COMPLETED|Ext. Period (No Cladribine Treatment)||1
599204|NCT00436826|1465024|P4|COMPLETED|Ext. Period (No Cladribine Treatment)||0
599205|NCT00436826|1465025|P3|COMPLETED|Ext. Period (No Cladribine Treatment)||0
599206|NCT00436826|1465026|P2|COMPLETED|Ext. Period (No Cladribine Treatment)||0
599207|NCT00436826|1465027|P1|COMPLETED|Ext. Period (No Cladribine Treatment)||0
599208|NCT00436826|1465022|P6|STARTED|Ext. Period (No Cladribine Treatment)||7
599209|NCT00436826|1465023|P5|STARTED|Ext. Period (No Cladribine Treatment)||52
599210|NCT00436826|1465024|P4|STARTED|Ext. Period (No Cladribine Treatment)||0
599211|NCT00436826|1465025|P3|STARTED|Ext. Period (No Cladribine Treatment)||0
599212|NCT00436826|1465026|P2|STARTED|Ext. Period (No Cladribine Treatment)||0
599213|NCT00436826|1465027|P1|STARTED|Ext. Period (No Cladribine Treatment)||0
599214|NCT00436826|1465022|P6|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
599215|NCT00436826|1465023|P5|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
599216|NCT00436826|1465024|P4|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||24
599217|NCT00436826|1465025|P3|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||44
599218|NCT00436826|1465026|P2|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
599219|NCT00436826|1465027|P1|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
599220|NCT00436826|1465022|P6|COMPLETED|Ext. Period (With Cladribine Treatment)||0
599221|NCT00436826|1465023|P5|COMPLETED|Ext. Period (With Cladribine Treatment)||0
599222|NCT00436826|1465024|P4|COMPLETED|Ext. Period (With Cladribine Treatment)||4
599223|NCT00436826|1465025|P3|COMPLETED|Ext. Period (With Cladribine Treatment)||3
599224|NCT00436826|1465026|P2|COMPLETED|Ext. Period (With Cladribine Treatment)||0
599225|NCT00436826|1465027|P1|COMPLETED|Ext. Period (With Cladribine Treatment)||0
599226|NCT00436826|1465022|P6|STARTED|Ext. Period (With Cladribine Treatment)||0
599227|NCT00436826|1465023|P5|STARTED|Ext. Period (With Cladribine Treatment)||0
599228|NCT00436826|1465024|P4|STARTED|Ext. Period (With Cladribine Treatment)||28
599229|NCT00436826|1465025|P3|STARTED|Ext. Period (With Cladribine Treatment)||47
599230|NCT00436826|1465026|P2|STARTED|Ext. Period (With Cladribine Treatment)||0
599231|NCT00436826|1465027|P1|STARTED|Ext. Period (With Cladribine Treatment)||0
599232|NCT00436826|1465022|P6|NOT COMPLETED|Double Blind Period||0
599233|NCT00436826|1465023|P5|NOT COMPLETED|Double Blind Period||0
599234|NCT00436826|1465024|P4|NOT COMPLETED|Double Blind Period||0
599235|NCT00436826|1465025|P3|NOT COMPLETED|Double Blind Period||0
599236|NCT00436826|1465026|P2|NOT COMPLETED|Double Blind Period||11
599237|NCT00436826|1465027|P1|NOT COMPLETED|Double Blind Period||13
599238|NCT00436826|1465022|P6|COMPLETED|Double Blind Period||0
599239|NCT00436826|1465023|P5|COMPLETED|Double Blind Period||0
599240|NCT00436826|1465024|P4|COMPLETED|Double Blind Period||0
599241|NCT00436826|1465025|P3|COMPLETED|Double Blind Period||0
599242|NCT00436826|1465026|P2|COMPLETED|Double Blind Period||37
599243|NCT00436826|1465027|P1|COMPLETED|Double Blind Period||111
599244|NCT00436826|1465022|P6|STARTED|Double Blind Period||0
599245|NCT00436826|1465023|P5|STARTED|Double Blind Period||0
599246|NCT00436826|1465024|P4|STARTED|Double Blind Period||0
599247|NCT00436826|1465025|P3|STARTED|Double Blind Period||0
599248|NCT00436826|1465026|P2|STARTED|Double Blind Period||48
599249|NCT00436826|1465027|P1|STARTED|Double Blind Period||124
599250|NCT00436748|1465049|P2|NOT COMPLETED|Overall Study||12
599251|NCT00436748|1465050|P1|NOT COMPLETED|Overall Study||11
599252|NCT00436748|1465049|P2|COMPLETED|Overall Study||45
599253|NCT00436748|1465050|P1|COMPLETED|Overall Study||48
599254|NCT00436748|1465049|P2|Received Treatment|Overall Study||56
599255|NCT00436748|1465050|P1|Received Treatment|Overall Study||58
599256|NCT00436748|1465049|P2|STARTED|Overall Study||57
599257|NCT00436748|1465050|P1|STARTED|Overall Study||59
599258|NCT00436644|1465084|P1|NOT COMPLETED|Overall Study||3
599259|NCT00436644|1465084|P1|COMPLETED|Overall Study||15
599260|NCT00436644|1465084|P1|STARTED|Overall Study||18
599261|NCT00436618|1465094|P3|NOT COMPLETED|Overall Study||61
599262|NCT00436618|1465095|P2|NOT COMPLETED|Overall Study||27
599263|NCT00436618|1465096|P1|NOT COMPLETED|Overall Study||30
599264|NCT00436618|1465094|P3|COMPLETED|Overall Study||46
599265|NCT00436618|1465095|P2|COMPLETED|Overall Study||28
599266|NCT00436618|1465096|P1|COMPLETED|Overall Study||84
599267|NCT00436618|1465094|P3|STARTED|Overall Study||107
599268|NCT00436618|1465095|P2|STARTED|Overall Study||55
599269|NCT00436618|1465096|P1|STARTED|Overall Study||114
599270|NCT00436605|1465113|P1|NOT COMPLETED|Overall Study||3
599271|NCT00436605|1465113|P1|COMPLETED|Overall Study||36
599272|NCT00436605|1465113|P1|STARTED|Overall Study||39
599273|NCT00436566|1465118|P1|NOT COMPLETED|Overall Study||3
599274|NCT00436566|1465118|P1|COMPLETED|Overall Study||109
599275|NCT00436566|1465118|P1|STARTED|Overall Study||112
599276|NCT00436553|1465125|P3|NOT COMPLETED|Overall Study||10
599277|NCT00436553|1465126|P2|NOT COMPLETED|Overall Study||12
599278|NCT00436553|1465127|P1|NOT COMPLETED|Overall Study||13
599279|NCT00436553|1465125|P3|COMPLETED|Overall Study||102
599280|NCT00436553|1465126|P2|COMPLETED|Overall Study||93
599281|NCT00436553|1465127|P1|COMPLETED|Overall Study|Completed the 12 month study phase.|91
599282|NCT00436553|1465125|P3|STARTED|Overall Study||112
599283|NCT00436553|1465126|P2|STARTED|Overall Study||105
599284|NCT00436553|1465127|P1|STARTED|Overall Study|"The table shows 12 month data. Started indicates Randomized set of population."|104
599285|NCT00436501|1465148|P2|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||3
599286|NCT00436501|1465149|P1|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0
599287|NCT00436501|1465148|P2|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||46
599288|NCT00436501|1465149|P1|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0
599289|NCT00436501|1465148|P2|STARTED|Phase 2: MTD VEGF Trap + Docetaxel|After toxicity observations Phase 2 opened June 4, 2008 and closed to entry September 27, 2010.|49
599290|NCT00436501|1465149|P1|STARTED|Phase 2: MTD VEGF Trap + Docetaxel||0
599291|NCT00436501|1465148|P2|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
599292|NCT00436501|1465149|P1|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
599293|NCT00436501|1465148|P2|COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
599294|NCT00436501|1465149|P1|COMPLETED|Phase 1: VEGF Trap Escalating Dose||9
599295|NCT00436501|1465148|P2|STARTED|Phase 1: VEGF Trap Escalating Dose|Participants registered in next period.|0
599296|NCT00436501|1465149|P1|STARTED|Phase 1: VEGF Trap Escalating Dose|Phase 1 opened on January 17, 2007 and closed to new patient entry on March 7, 2008.|9
599297|NCT00436501|1465148|P2|NOT COMPLETED|Complete Study Participation||0
599298|NCT00436501|1465149|P1|NOT COMPLETED|Complete Study Participation||0
599299|NCT00436501|1465148|P2|COMPLETED|Complete Study Participation||49
599300|NCT00436501|1465149|P1|COMPLETED|Complete Study Participation||9
599301|NCT00436501|1465148|P2|STARTED|Complete Study Participation|After toxicity observations, Phase 2 opened June 4, 2008 and closed September 27, 2010.|49
599302|NCT00436501|1465149|P1|STARTED|Complete Study Participation|Phase 1 opened on January 17, 2007 and closed to new patient entry on March 7, 2008.|9
599303|NCT00436436|1465160|P1|NOT COMPLETED|Overall Study||12
599304|NCT00436436|1465160|P1|COMPLETED|Overall Study||0
599305|NCT00436436|1465160|P1|STARTED|Overall Study||12
599306|NCT00436345|1465171|P2|NOT COMPLETED|Overall Study||0
599307|NCT00436345|1465172|P1|NOT COMPLETED|Overall Study||3
599308|NCT00436345|1465171|P2|COMPLETED|Overall Study||18
599309|NCT00436345|1465172|P1|COMPLETED|Overall Study||18
599310|NCT00436345|1465171|P2|STARTED|Overall Study||18
599311|NCT00436345|1465172|P1|STARTED|Overall Study||21
599312|NCT00436332|1465225|P1|NOT COMPLETED|Overall Study||83
599313|NCT00436332|1465225|P1|COMPLETED|Overall Study||1
599314|NCT00436332|1465225|P1|Eligible and Began Protocol Therapy|Overall Study||79
599315|NCT00436332|1465225|P1|Eligible|Overall Study||82
599316|NCT00436332|1465225|P1|STARTED|Overall Study||84
599317|NCT00436215|1465232|P1|NOT COMPLETED|Overall Study||4
599318|NCT00436215|1465232|P1|COMPLETED|Overall Study||51
599319|NCT00436215|1465232|P1|STARTED|Overall Study||55
599320|NCT00436163|1465238|P1|NOT COMPLETED|Overall Study||3
599321|NCT00436163|1465238|P1|COMPLETED|Overall Study||36
599322|NCT00436163|1465238|P1|STARTED|Overall Study||39
599323|NCT00436046|1465252|P3|NOT COMPLETED|Overall Study||0
599324|NCT00436046|1465253|P2|NOT COMPLETED|Overall Study||0
599325|NCT00436046|1465254|P1|NOT COMPLETED|Overall Study||0
599326|NCT00436046|1465252|P3|COMPLETED|Overall Study||31
599327|NCT00436046|1465253|P2|COMPLETED|Overall Study||32
599328|NCT00436046|1465254|P1|COMPLETED|Overall Study||32
599329|NCT00436046|1465252|P3|STARTED|Overall Study||31
599330|NCT00436046|1465253|P2|STARTED|Overall Study||32
599331|NCT00436046|1465254|P1|STARTED|Overall Study||32
599332|NCT00436007|1465286|P3|NOT COMPLETED|Overall Study||23
599333|NCT00436007|1465287|P2|NOT COMPLETED|Overall Study||14
599334|NCT00436007|1465288|P1|NOT COMPLETED|Overall Study||19
599335|NCT00436007|1465286|P3|COMPLETED|Overall Study||148
599336|NCT00436007|1465287|P2|COMPLETED|Overall Study||156
599337|NCT00436007|1465288|P1|COMPLETED|Overall Study||151
599338|NCT00436007|1465286|P3|STARTED|Overall Study||171
599339|NCT00436007|1465287|P2|STARTED|Overall Study||170
599340|NCT00436007|1465288|P1|STARTED|Overall Study||170
599341|NCT00435994|1465336|P3|NOT COMPLETED|Overall Study||0
599342|NCT00435994|1465337|P2|NOT COMPLETED|Overall Study||0
599343|NCT00435994|1465338|P1|NOT COMPLETED|Overall Study||7
599344|NCT00435994|1465336|P3|COMPLETED|Overall Study||12
599345|NCT00435994|1465337|P2|COMPLETED|Overall Study||25
599346|NCT00435994|1465338|P1|COMPLETED|Overall Study|7 of the subjects were consented and did not complete the study procedures.|15
599347|NCT00435994|1465336|P3|STARTED|Overall Study||12
599348|NCT00435994|1465337|P2|STARTED|Overall Study||25
599349|NCT00435994|1465338|P1|STARTED|Overall Study||22
599350|NCT00435942|1465349|P2|NOT COMPLETED|Overall Study||27
599351|NCT00435942|1465350|P1|NOT COMPLETED|Overall Study||23
599352|NCT00435942|1465349|P2|COMPLETED|Overall Study||33
599353|NCT00435942|1465350|P1|COMPLETED|Overall Study||97
599354|NCT00435942|1465349|P2|STARTED|Overall Study||60
599355|NCT00435942|1465350|P1|STARTED|Overall Study||120
599356|NCT00435929|1465359|P2|NOT COMPLETED|Overall Study||0
599357|NCT00435929|1465360|P1|NOT COMPLETED|Overall Study||0
599358|NCT00435929|1465359|P2|COMPLETED|Overall Study||9
599359|NCT00435929|1465360|P1|COMPLETED|Overall Study||7
599360|NCT00435929|1465359|P2|STARTED|Overall Study||9
599361|NCT00435929|1465360|P1|STARTED|Overall Study||7
599362|NCT00435825|1465390|P4|NOT COMPLETED|Overall Study||16
599363|NCT00435825|1465391|P3|NOT COMPLETED|Overall Study||11
599364|NCT00435825|1465392|P2|NOT COMPLETED|Overall Study||12
599365|NCT00435825|1465393|P1|NOT COMPLETED|Overall Study||18
599366|NCT00435825|1465390|P4|COMPLETED|Overall Study||120
599367|NCT00435825|1465391|P3|COMPLETED|Overall Study||127
599368|NCT00435825|1465392|P2|COMPLETED|Overall Study||124
599369|NCT00435825|1465393|P1|COMPLETED|Overall Study|Completed is the number of participants who received study treatment and completed follow-up.|123
599370|NCT00435825|1465390|P4|Completed 48 Weeks Treatment|Overall Study||117
599371|NCT00435825|1465391|P3|Completed 48 Weeks Treatment|Overall Study||124
599372|NCT00435825|1465392|P2|Completed 48 Weeks Treatment|Overall Study||0
599373|NCT00435825|1465393|P1|Completed 48 Weeks Treatment|Overall Study||0
599374|NCT00435825|1465390|P4|Completed 24 Weeks Treatment|Overall Study||131
599375|NCT00435825|1465391|P3|Completed 24 Weeks Treatment|Overall Study||134
599376|NCT00435825|1465392|P2|Completed 24 Weeks Treatment|Overall Study||126
599377|NCT00435825|1465393|P1|Completed 24 Weeks Treatment|Overall Study||128
599378|NCT00435825|1465390|P4|Entered Follow-up|Overall Study||133
599379|NCT00435825|1465391|P3|Entered Follow-up|Overall Study||135
599380|NCT00435825|1465392|P2|Entered Follow-up|Overall Study||132
599381|NCT00435825|1465393|P1|Entered Follow-up|Overall Study||140
599382|NCT00435825|1465390|P4|Received Study Drug|Overall Study||136
599383|NCT00435825|1465391|P3|Received Study Drug|Overall Study||136
599384|NCT00435825|1465392|P2|Received Study Drug|Overall Study||136
599385|NCT00435825|1465393|P1|Received Study Drug|Overall Study||140
599386|NCT00435825|1465390|P4|STARTED|Overall Study||136
599387|NCT00435825|1465391|P3|STARTED|Overall Study||138
599388|NCT00435825|1465392|P2|STARTED|Overall Study||136
599389|NCT00435825|1465393|P1|STARTED|Overall Study||141
599390|NCT00435812|1465449|P2|NOT COMPLETED|Overall Study||18
599391|NCT00435812|1465450|P1|NOT COMPLETED|Overall Study||63
599392|NCT00435812|1465449|P2|COMPLETED|Overall Study||590
599393|NCT00435812|1465450|P1|COMPLETED|Overall Study||1757
599394|NCT00435812|1465449|P2|STARTED|Overall Study||608
599395|NCT00435812|1465450|P1|STARTED|Overall Study||1820
599396|NCT00435591|1465462|P4|NOT COMPLETED|Overall Study||11
599397|NCT00435591|1465463|P3|NOT COMPLETED|Overall Study||5
599398|NCT00435591|1465464|P2|NOT COMPLETED|Overall Study||4
599399|NCT00435591|1465465|P1|NOT COMPLETED|Overall Study||7
599400|NCT00435591|1465462|P4|COMPLETED|Overall Study||19
599401|NCT00435591|1465463|P3|COMPLETED|Overall Study||25
599402|NCT00435591|1465464|P2|COMPLETED|Overall Study||27
599403|NCT00435591|1465465|P1|COMPLETED|Overall Study||23
599404|NCT00435591|1465462|P4|End of Treatment|Overall Study||23
599405|NCT00435591|1465463|P3|End of Treatment|Overall Study||27
599406|NCT00435591|1465464|P2|End of Treatment|Overall Study||27
599407|NCT00435591|1465465|P1|End of Treatment|Overall Study||25
599408|NCT00435591|1465462|P4|Full Analysis Set|Overall Study||29
599409|NCT00435591|1465463|P3|Full Analysis Set|Overall Study||30
599410|NCT00435591|1465464|P2|Full Analysis Set|Overall Study||29
599411|NCT00435591|1465465|P1|Full Analysis Set|Overall Study||28
599412|NCT00435591|1465462|P4|Safety Analysis Set|Overall Study||29
599413|NCT00435591|1465463|P3|Safety Analysis Set|Overall Study||30
599414|NCT00435591|1465464|P2|Safety Analysis Set|Overall Study||30
599415|NCT00435591|1465465|P1|Safety Analysis Set|Overall Study||28
599416|NCT00435591|1465462|P4|STARTED|Overall Study||30
599417|NCT00435591|1465463|P3|STARTED|Overall Study||30
599418|NCT00435591|1465464|P2|STARTED|Overall Study||31
599419|NCT00435591|1465465|P1|STARTED|Overall Study||30
599420|NCT00435539|1465495|P5|NOT COMPLETED|Overall Study||0
599421|NCT00435539|1465496|P4|NOT COMPLETED|Overall Study||0
599422|NCT00435539|1465497|P3|NOT COMPLETED|Overall Study||0
599423|NCT00435539|1465498|P2|NOT COMPLETED|Overall Study||0
599424|NCT00435539|1465499|P1|NOT COMPLETED|Overall Study||0
599425|NCT00435539|1465495|P5|COMPLETED|Overall Study||12
599426|NCT00435539|1465496|P4|COMPLETED|Overall Study||12
599427|NCT00435539|1465497|P3|COMPLETED|Overall Study||11
599428|NCT00435539|1465498|P2|COMPLETED|Overall Study||13
599429|NCT00435539|1465499|P1|COMPLETED|Overall Study||12
599430|NCT00435539|1465495|P5|STARTED|Overall Study||12
599431|NCT00435539|1465496|P4|STARTED|Overall Study||12
599432|NCT00435539|1465497|P3|STARTED|Overall Study||11
599433|NCT00435539|1465498|P2|STARTED|Overall Study||13
599434|NCT00435539|1465499|P1|STARTED|Overall Study||12
599435|NCT00435487|1465516|P2|NOT COMPLETED|Overall Study||15
599436|NCT00435487|1465517|P1|NOT COMPLETED|Overall Study||12
599437|NCT00435487|1465516|P2|COMPLETED|Overall Study||71
599438|NCT00435487|1465517|P1|COMPLETED|Overall Study||76
599439|NCT00435487|1465516|P2|TREATED|Overall Study|One subject was mistakenly treated with Dalteparin, two subjects withdrew consent before treatment.|83
599440|NCT00435487|1465517|P1|TREATED|Overall Study|One additional subject originally randomized to Unfractioned Heparin was treated with Dalteparin.|88
599441|NCT00435487|1465516|P2|STARTED|Overall Study||86
599442|NCT00435487|1465517|P1|STARTED|Overall Study|87 subjects were randomized however one additional subject originally randomized to UFH was treated.|88
599443|NCT00435461|1465536|P3|NOT COMPLETED|Overall Study||24
599444|NCT00435461|1465537|P2|NOT COMPLETED|Overall Study||14
599445|NCT00435461|1465538|P1|NOT COMPLETED|Overall Study||23
599446|NCT00435461|1465536|P3|COMPLETED|Overall Study||287
599447|NCT00435461|1465537|P2|COMPLETED|Overall Study||298
599448|NCT00435461|1465538|P1|COMPLETED|Overall Study||290
599449|NCT00435461|1465536|P3|STARTED|Overall Study||311
599450|NCT00435461|1465537|P2|STARTED|Overall Study||312
599451|NCT00435461|1465538|P1|STARTED|Overall Study||313
599452|NCT00435409|1465575|P3|NOT COMPLETED|Overall Study||78
599453|NCT00435409|1465576|P2|NOT COMPLETED|Overall Study||143
599454|NCT00435409|1465577|P1|NOT COMPLETED|Overall Study||221
599455|NCT00435409|1465575|P3|COMPLETED|Overall Study||0
599456|NCT00435409|1465576|P2|COMPLETED|Overall Study||0
599457|NCT00435409|1465577|P1|COMPLETED|Overall Study||0
599458|NCT00435409|1465575|P3|Treated|Overall Study||78
599459|NCT00435409|1465576|P2|Treated|Overall Study||139
599460|NCT00435409|1465577|P1|Treated|Overall Study||217
599461|NCT00435409|1465575|P3|STARTED|Overall Study||78
599462|NCT00435409|1465576|P2|STARTED|Overall Study||143
599463|NCT00435409|1465577|P1|STARTED|Overall Study||221
599464|NCT00435370|1465599|P2|NOT COMPLETED|Overall Study||20
599465|NCT00435370|1465600|P1|NOT COMPLETED|Overall Study||22
599466|NCT00435370|1465599|P2|COMPLETED|Overall Study|The entire recruitment has been completed in December, 2011.|69
599467|NCT00435370|1465600|P1|COMPLETED|Overall Study||68
599468|NCT00435370|1465599|P2|STARTED|Overall Study|The recruitment restarted in August, 2010.|89
599469|NCT00435370|1465600|P1|STARTED|Overall Study||90
599470|NCT00435188|1465608|P2|NOT COMPLETED|Overall Study||23
599471|NCT00435188|1465609|P1|NOT COMPLETED|Overall Study||22
599472|NCT00435188|1465608|P2|COMPLETED|Overall Study||176
599473|NCT00435188|1465609|P1|COMPLETED|Overall Study||177
599474|NCT00435188|1465608|P2|STARTED|Overall Study||199
599475|NCT00435188|1465609|P1|STARTED|Overall Study||199
599476|NCT00435162|1465652|P6|NOT COMPLETED|Period 2 (2 Weeks)||0
599477|NCT00435162|1465653|P5|NOT COMPLETED|Period 2 (2 Weeks)||0
599478|NCT00435162|1465654|P4|NOT COMPLETED|Period 2 (2 Weeks)||0
599479|NCT00435162|1465655|P3|NOT COMPLETED|Period 2 (2 Weeks)||0
599480|NCT00435162|1465656|P2|NOT COMPLETED|Period 2 (2 Weeks)||1
599481|NCT00435162|1465657|P1|NOT COMPLETED|Period 2 (2 Weeks)||0
599482|NCT00435162|1465652|P6|COMPLETED|Period 2 (2 Weeks)||15
599483|NCT00435162|1465653|P5|COMPLETED|Period 2 (2 Weeks)||15
599484|NCT00435162|1465654|P4|COMPLETED|Period 2 (2 Weeks)||8
599485|NCT00435162|1465655|P3|COMPLETED|Period 2 (2 Weeks)||6
599486|NCT00435162|1465656|P2|COMPLETED|Period 2 (2 Weeks)||14
599487|NCT00435162|1465657|P1|COMPLETED|Period 2 (2 Weeks)||15
599488|NCT00435162|1465652|P6|STARTED|Period 2 (2 Weeks)||15
599489|NCT00435162|1465653|P5|STARTED|Period 2 (2 Weeks)||15
599490|NCT00435162|1465654|P4|STARTED|Period 2 (2 Weeks)||8
599491|NCT00435162|1465655|P3|STARTED|Period 2 (2 Weeks)||6
599492|NCT00435162|1465656|P2|STARTED|Period 2 (2 Weeks)||15
599493|NCT00435162|1465657|P1|STARTED|Period 2 (2 Weeks)||15
599494|NCT00435162|1465652|P6|NOT COMPLETED|Period 1 (6 Weeks)||0
599495|NCT00435162|1465653|P5|NOT COMPLETED|Period 1 (6 Weeks)||0
599496|NCT00435162|1465654|P4|NOT COMPLETED|Period 1 (6 Weeks)||0
599497|NCT00435162|1465655|P3|NOT COMPLETED|Period 1 (6 Weeks)||0
599498|NCT00435162|1465656|P2|NOT COMPLETED|Period 1 (6 Weeks)||0
599499|NCT00435162|1465657|P1|NOT COMPLETED|Period 1 (6 Weeks)||0
599500|NCT00435162|1465652|P6|COMPLETED|Period 1 (6 Weeks)||15
599501|NCT00435162|1465653|P5|COMPLETED|Period 1 (6 Weeks)||15
599502|NCT00435162|1465654|P4|COMPLETED|Period 1 (6 Weeks)||8
599503|NCT00435162|1465655|P3|COMPLETED|Period 1 (6 Weeks)||6
599504|NCT00435162|1465656|P2|COMPLETED|Period 1 (6 Weeks)||15
599505|NCT00435162|1465657|P1|COMPLETED|Period 1 (6 Weeks)||15
599506|NCT00435162|1465652|P6|STARTED|Period 1 (6 Weeks)||15
599507|NCT00435162|1465653|P5|STARTED|Period 1 (6 Weeks)||15
599508|NCT00435162|1465654|P4|STARTED|Period 1 (6 Weeks)||8
599509|NCT00435162|1465655|P3|STARTED|Period 1 (6 Weeks)||6
599510|NCT00435162|1465656|P2|STARTED|Period 1 (6 Weeks)||15
599511|NCT00435162|1465657|P1|STARTED|Period 1 (6 Weeks)||15
599512|NCT00435045|1465677|P2|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||2
599513|NCT00435045|1465678|P1|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||5
599514|NCT00435045|1465677|P2|COMPLETED|Weeks 13-16 / 40mg Dose Level||111
599515|NCT00435045|1465678|P1|COMPLETED|Weeks 13-16 / 40mg Dose Level||108
599516|NCT00435045|1465677|P2|STARTED|Weeks 13-16 / 40mg Dose Level||113
599517|NCT00435045|1465678|P1|STARTED|Weeks 13-16 / 40mg Dose Level||113
599518|NCT00435045|1465677|P2|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5
599519|NCT00435045|1465678|P1|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5
599520|NCT00435045|1465677|P2|COMPLETED|Weeks 9-12 / 20mg Dose Level||113
599521|NCT00435045|1465678|P1|COMPLETED|Weeks 9-12 / 20mg Dose Level||113
599522|NCT00435045|1465677|P2|STARTED|Weeks 9-12 / 20mg Dose Level||118
599523|NCT00435045|1465678|P1|STARTED|Weeks 9-12 / 20mg Dose Level||118
599524|NCT00435045|1465677|P2|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||4
599525|NCT00435045|1465678|P1|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||5
599526|NCT00435045|1465677|P2|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118
599527|NCT00435045|1465678|P1|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118
599528|NCT00435045|1465677|P2|STARTED|Weeks 1-8 / 10 mg Dose Level||122
599529|NCT00435045|1465678|P1|STARTED|Weeks 1-8 / 10 mg Dose Level||123
599530|NCT00435019|1465734|P2|NOT COMPLETED|Overall Study||10
599531|NCT00435019|1465735|P1|NOT COMPLETED|Overall Study||13
599532|NCT00435019|1465734|P2|COMPLETED|Overall Study||161
599533|NCT00435019|1465735|P1|COMPLETED|Overall Study||164
599534|NCT00435019|1465734|P2|Exposed to Study Drug|Overall Study|One subject withdrew before receiving study drug, and thus not included in the full analysis set.|170
599535|NCT00435019|1465735|P1|Exposed to Study Drug|Overall Study||177
599536|NCT00435019|1465734|P2|STARTED|Overall Study|Randomised|171
599537|NCT00435019|1465735|P1|STARTED|Overall Study|Randomised|177
599538|NCT00434993|1465747|P2|NOT COMPLETED|Overall Study||0
599539|NCT00434993|1465748|P1|NOT COMPLETED|Overall Study||0
599540|NCT00434993|1465747|P2|COMPLETED|Overall Study||130
599541|NCT00434993|1465748|P1|COMPLETED|Overall Study||152
599542|NCT00434993|1465747|P2|STARTED|Overall Study||130
599543|NCT00434993|1465748|P1|STARTED|Overall Study||152
599544|NCT00434967|1465776|P4|NOT COMPLETED|Overall Study||14
599545|NCT00434967|1465777|P3|NOT COMPLETED|Overall Study||9
599546|NCT00434967|1465778|P2|NOT COMPLETED|Overall Study||8
599547|NCT00434967|1465779|P1|NOT COMPLETED|Overall Study||7
599548|NCT00434967|1465776|P4|COMPLETED|Overall Study||478
599549|NCT00434967|1465777|P3|COMPLETED|Overall Study||461
599550|NCT00434967|1465778|P2|COMPLETED|Overall Study||457
599551|NCT00434967|1465779|P1|COMPLETED|Overall Study||90
599552|NCT00434967|1465776|P4|STARTED|Overall Study||492
599553|NCT00434967|1465777|P3|STARTED|Overall Study||470
599554|NCT00434967|1465778|P2|STARTED|Overall Study||465
599555|NCT00434967|1465779|P1|STARTED|Overall Study||97
599556|NCT00434954|1465799|P2|NOT COMPLETED|Overall Study||71
599557|NCT00434954|1465800|P1|NOT COMPLETED|Overall Study||82
599558|NCT00434954|1465799|P2|COMPLETED|Overall Study||175
599559|NCT00434954|1465800|P1|COMPLETED|Overall Study||166
599560|NCT00434954|1465799|P2|Completed - Previous Treatment MET + SU|Overall Study||38
599561|NCT00434954|1465800|P1|Completed - Previous Treatment MET + SU|Overall Study||31
599562|NCT00434954|1465799|P2|Completed - Previous Treatment MET Only|Overall Study||137
599563|NCT00434954|1465800|P1|Completed - Previous Treatment MET Only|Overall Study||135
599564|NCT00434954|1465799|P2|FAS - Previous Treatment MET + SU|Overall Study||60
599565|NCT00434954|1465800|P1|FAS - Previous Treatment MET + SU|Overall Study||66
599566|NCT00434954|1465799|P2|FAS - Previous Treatment MET Only|Overall Study|"Baseline and efficacy data reported for FAS-Previous Treatment MET Only group."|173
599567|NCT00434954|1465800|P1|FAS - Previous Treatment MET Only|Overall Study|"Baseline and efficacy data reported for FAS-Previous Treatment MET Only group."|181
599568|NCT00434954|1465799|P2|Full Analysis Set (FAS) Overall|Overall Study|FAS=received >=1 dose of study drug. Adverse event data reported for Overall FAS.|233
599569|NCT00434954|1465800|P1|Full Analysis Set (FAS) Overall|Overall Study|FAS=received >=1 dose of study drug. Adverse event data reported for Overall FAS.|247
599570|NCT00434954|1465799|P2|Started - Previous Treatment MET + SU|Overall Study||65
599571|NCT00434954|1465800|P1|Started - Previous Treatment MET + SU|Overall Study||66
599572|NCT00434954|1465799|P2|Started - Previous Treatment MET Only|Overall Study||181
599573|NCT00434954|1465800|P1|Started - Previous Treatment MET Only|Overall Study||182
599574|NCT00434954|1465799|P2|STARTED|Overall Study||246
599575|NCT00434954|1465800|P1|STARTED|Overall Study||248
599576|NCT00434876|1465830|P2|NOT COMPLETED|Overall Study||1
599577|NCT00434876|1465831|P1|NOT COMPLETED|Overall Study||1
599578|NCT00434876|1465830|P2|COMPLETED|Overall Study||10
599579|NCT00434876|1465831|P1|COMPLETED|Overall Study||10
599580|NCT00434876|1465830|P2|STARTED|Overall Study||11
599581|NCT00434876|1465831|P1|STARTED|Overall Study||11
599582|NCT00434759|1465845|P2|NOT COMPLETED|Overall Study||5
599583|NCT00434759|1465846|P1|NOT COMPLETED|Overall Study||24
599584|NCT00434759|1465845|P2|COMPLETED|Overall Study||38
599585|NCT00434759|1465846|P1|COMPLETED|Overall Study||22
599586|NCT00434759|1465845|P2|STARTED|Overall Study||43
599587|NCT00434759|1465846|P1|STARTED|Overall Study||46
599588|NCT00434642|1465862|P2|NOT COMPLETED|Open-label Treatment Phase||11
599589|NCT00434642|1465863|P1|NOT COMPLETED|Open-label Treatment Phase||0
599590|NCT00434642|1465862|P2|COMPLETED|Open-label Treatment Phase||1
599591|NCT00434642|1465863|P1|COMPLETED|Open-label Treatment Phase||0
599592|NCT00434642|1465862|P2|STARTED|Open-label Treatment Phase|One participant did not continue into the open-label treatment phase.|12
599593|NCT00434642|1465863|P1|STARTED|Open-label Treatment Phase||0
599594|NCT00434642|1465862|P2|NOT COMPLETED|Blinded Treatment Phase||229
599595|NCT00434642|1465863|P1|NOT COMPLETED|Blinded Treatment Phase||242
599596|NCT00434642|1465862|P2|COMPLETED|Blinded Treatment Phase||13
599597|NCT00434642|1465863|P1|COMPLETED|Blinded Treatment Phase||0
599598|NCT00434642|1465862|P2|STARTED|Blinded Treatment Phase||242
599599|NCT00434642|1465863|P1|STARTED|Blinded Treatment Phase||242
599600|NCT00434590|1465881|P2|NOT COMPLETED|Overall Study||5
599601|NCT00434590|1465882|P1|NOT COMPLETED|Overall Study||5
599602|NCT00434590|1465881|P2|COMPLETED|Overall Study||0
599603|NCT00434590|1465882|P1|COMPLETED|Overall Study|All patients randomized had study discontinued because of premature study termination.|0
599604|NCT00434590|1465881|P2|STARTED|Overall Study||5
599605|NCT00434590|1465882|P1|STARTED|Overall Study||5
599606|NCT00434434|1465891|P3|NOT COMPLETED|Overall Study||1
599607|NCT00434434|1465892|P2|NOT COMPLETED|Overall Study||0
599608|NCT00434434|1465893|P1|NOT COMPLETED|Overall Study||2
599609|NCT00434434|1465891|P3|COMPLETED|Overall Study||13
599610|NCT00434434|1465892|P2|COMPLETED|Overall Study||24
599611|NCT00434434|1465893|P1|COMPLETED|Overall Study||21
599612|NCT00434434|1465891|P3|STARTED|Overall Study||14
599613|NCT00434434|1465892|P2|STARTED|Overall Study||24
599614|NCT00434434|1465893|P1|STARTED|Overall Study||23
599615|NCT00434421|1465904|P1|NOT COMPLETED|Overall Study||2
599616|NCT00434421|1465904|P1|COMPLETED|Overall Study||26
599617|NCT00434421|1465904|P1|STARTED|Overall Study||28
599618|NCT00434356|1465910|P2|NOT COMPLETED|Overall Study||23
599619|NCT00434356|1465911|P1|NOT COMPLETED|Overall Study||23
599620|NCT00434356|1465910|P2|COMPLETED|Overall Study||0
599621|NCT00434356|1465911|P1|COMPLETED|Overall Study||0
599622|NCT00434356|1465910|P2|STARTED|Overall Study||23
599623|NCT00434356|1465911|P1|STARTED|Overall Study||23
599624|NCT00434330|1465932|P6|NOT COMPLETED|Overall Study||1
599625|NCT00434330|1465933|P5|NOT COMPLETED|Overall Study||1
599626|NCT00434330|1465934|P4|NOT COMPLETED|Overall Study||2
599627|NCT00434330|1465935|P3|NOT COMPLETED|Overall Study||3
599628|NCT00434330|1465936|P2|NOT COMPLETED|Overall Study||0
599629|NCT00434330|1465937|P1|NOT COMPLETED|Overall Study||1
599630|NCT00434330|1465932|P6|COMPLETED|Overall Study||14
599631|NCT00434330|1465933|P5|COMPLETED|Overall Study||14
599632|NCT00434330|1465934|P4|COMPLETED|Overall Study||13
599633|NCT00434330|1465935|P3|COMPLETED|Overall Study||13
599634|NCT00434330|1465936|P2|COMPLETED|Overall Study||15
599635|NCT00434330|1465937|P1|COMPLETED|Overall Study||14
599636|NCT00434330|1465932|P6|STARTED|Overall Study||15
599637|NCT00434330|1465933|P5|STARTED|Overall Study||15
599638|NCT00434330|1465934|P4|STARTED|Overall Study||15
599639|NCT00434330|1465935|P3|STARTED|Overall Study||16
599640|NCT00434330|1465936|P2|STARTED|Overall Study||15
599641|NCT00434330|1465937|P1|STARTED|Overall Study||15
599642|NCT00434304|1465969|P1|NOT COMPLETED|Overall Study||20
599643|NCT00434304|1465969|P1|COMPLETED|Overall Study||42
599644|NCT00434304|1465969|P1|STARTED|Overall Study||62
599645|NCT00434278|1466007|P2|NOT COMPLETED|Overall Study||0
599646|NCT00434278|1466008|P1|NOT COMPLETED|Overall Study||2
599647|NCT00434278|1466007|P2|COMPLETED|Overall Study||13
599648|NCT00434278|1466008|P1|COMPLETED|Overall Study||12
599649|NCT00434278|1466007|P2|STARTED|Overall Study||13
599650|NCT00434278|1466008|P1|STARTED|Overall Study||14
599651|NCT00434252|1466018|P2|NOT COMPLETED|Overall Study||131
599652|NCT00434252|1466019|P1|NOT COMPLETED|Overall Study||64
599653|NCT00434252|1466018|P2|COMPLETED|Overall Study|Continuing study drug treatment at the time of the data cutoff.|12
599654|NCT00434252|1466019|P1|COMPLETED|Overall Study|Continuing study drug treatment at the time of the data cutoff.|7
599655|NCT00434252|1466018|P2|Treated|Overall Study||143
599656|NCT00434252|1466019|P1|Treated|Overall Study|One patient died and one patient withdrew prior to receiving study treatment|69
599657|NCT00434252|1466018|P2|STARTED|Overall Study||143
599658|NCT00434252|1466019|P1|STARTED|Overall Study||71
599659|NCT00434226|1466041|P2|NOT COMPLETED|Overall Study||26
599660|NCT00434226|1466042|P1|NOT COMPLETED|Overall Study||30
599661|NCT00434226|1466041|P2|COMPLETED|Overall Study||0
599662|NCT00434226|1466042|P1|COMPLETED|Overall Study||0
599663|NCT00434226|1466041|P2|STARTED|Overall Study||26
599664|NCT00434226|1466042|P1|STARTED|Overall Study||30
599665|NCT00434213|1466053|P1|NOT COMPLETED|Overall Study||49
599666|NCT00434213|1466053|P1|COMPLETED|Overall Study||260
599667|NCT00434213|1466053|P1|STARTED|Overall Study||309
599668|NCT00434161|1466061|P3|NOT COMPLETED|Overall Study||11
599669|NCT00434161|1466062|P2|NOT COMPLETED|Overall Study||3
599670|NCT00434161|1466063|P1|NOT COMPLETED|Overall Study||10
599671|NCT00434161|1466061|P3|COMPLETED|Overall Study||104
599672|NCT00434161|1466062|P2|COMPLETED|Overall Study||54
599673|NCT00434161|1466063|P1|COMPLETED|Overall Study||99
599674|NCT00434161|1466061|P3|STARTED|Overall Study||115
599675|NCT00434161|1466062|P2|STARTED|Overall Study||57
599676|NCT00434161|1466063|P1|STARTED|Overall Study||109
599677|NCT00434148|1466107|P2|NOT COMPLETED|Overall Study||73
599678|NCT00434148|1466108|P1|NOT COMPLETED|Overall Study||69
599679|NCT00434148|1466107|P2|COMPLETED|Overall Study||7
599680|NCT00434148|1466108|P1|COMPLETED|Overall Study||13
599681|NCT00434148|1466107|P2|Completed Month 12; Entered Extension|Overall Study||32
599682|NCT00434148|1466108|P1|Completed Month 12; Entered Extension|Overall Study||26
599683|NCT00434148|1466107|P2|Completed m. 12; Did Not Enter Extension|Overall Study||7
599684|NCT00434148|1466108|P1|Completed m. 12; Did Not Enter Extension|Overall Study||13
599685|NCT00434148|1466107|P2|Completed Month 12|Overall Study||39
599686|NCT00434148|1466108|P1|Completed Month 12|Overall Study||39
599687|NCT00434148|1466107|P2|STARTED|Overall Study||80
599688|NCT00434148|1466108|P1|STARTED|Overall Study|"Started indicates Full Analysis Set. Patients randomized and treated."|82
599689|NCT00434122|1466144|P2|NOT COMPLETED|Overall Study||7
599690|NCT00434122|1466145|P1|NOT COMPLETED|Overall Study||6
599691|NCT00434122|1466144|P2|COMPLETED|Overall Study||36
599692|NCT00434122|1466145|P1|COMPLETED|Overall Study||36
599693|NCT00434122|1466144|P2|Intention-to-treat (ITT) Population|Overall Study|All randomised and exposed subjects not withdrawn before Stimulation Day 1.|39
599694|NCT00434122|1466145|P1|Intention-to-treat (ITT) Population|Overall Study|All randomised and exposed subjects not withdrawn before Stimulation Day 1.|39
599695|NCT00434122|1466144|P2|STARTED|Overall Study|Randomised|43
599696|NCT00434122|1466145|P1|STARTED|Overall Study|Randomised|42
599697|NCT00434109|1466154|P1|NOT COMPLETED|Overall Study||18
599698|NCT00434109|1466154|P1|COMPLETED|Overall Study|Patients completing the maximum eight cycles of sunitinib.|21
599699|NCT00434109|1466154|P1|STARTED|Overall Study||39
599700|NCT00434057|1466163|P1|NOT COMPLETED|Overall Study||1
599701|NCT00434057|1466163|P1|COMPLETED|Overall Study|One patient withdrew from the study after signing the Informed Consent Form|1382
599702|NCT00434057|1466163|P1|STARTED|Overall Study||1383
599703|NCT00434018|1466169|P2|NOT COMPLETED|Overall Study||12
599704|NCT00434018|1466170|P1|NOT COMPLETED|Overall Study||17
599705|NCT00434018|1466169|P2|COMPLETED|Overall Study||57
599706|NCT00434018|1466170|P1|COMPLETED|Overall Study||52
599707|NCT00434018|1466169|P2|STARTED|Overall Study||69
599708|NCT00434018|1466170|P1|STARTED|Overall Study||69
599709|NCT00433992|1466188|P2|NOT COMPLETED|Overall Study||8
599710|NCT00433992|1466189|P1|NOT COMPLETED|Overall Study||9
599711|NCT00433992|1466188|P2|COMPLETED|Overall Study||20
599712|NCT00433992|1466189|P1|COMPLETED|Overall Study||19
599713|NCT00433992|1466188|P2|STARTED|Overall Study||28
599714|NCT00433992|1466189|P1|STARTED|Overall Study||28
599715|NCT00433966|1466201|P4|NOT COMPLETED|Stent Intervention/Randomization||62
599716|NCT00433966|1466202|P3|NOT COMPLETED|Stent Intervention/Randomization||154
599717|NCT00433966|1466203|P2|NOT COMPLETED|Stent Intervention/Randomization||0
599718|NCT00433966|1466204|P1|NOT COMPLETED|Stent Intervention/Randomization||0
599719|NCT00433966|1466201|P4|COMPLETED|Stent Intervention/Randomization||687
599720|NCT00433966|1466202|P3|COMPLETED|Stent Intervention/Randomization||2103
599721|NCT00433966|1466203|P2|COMPLETED|Stent Intervention/Randomization||0
599722|NCT00433966|1466204|P1|COMPLETED|Stent Intervention/Randomization||0
599723|NCT00433966|1466201|P4|3-Year Follow-up|Stent Intervention/Randomization||687
599724|NCT00433966|1466202|P3|3-Year Follow-up|Stent Intervention/Randomization||2103
599725|NCT00433966|1466203|P2|3-Year Follow-up|Stent Intervention/Randomization||0
599726|NCT00433966|1466204|P1|3-Year Follow-up|Stent Intervention/Randomization||0
599727|NCT00433966|1466201|P4|1-Year Follow-up|Stent Intervention/Randomization||715
599728|NCT00433966|1466202|P3|1-Year Follow-up|Stent Intervention/Randomization||2186
599729|NCT00433966|1466203|P2|1-Year Follow-up|Stent Intervention/Randomization||0
599730|NCT00433966|1466204|P1|1-Year Follow-up|Stent Intervention/Randomization||0
599731|NCT00433966|1466201|P4|STARTED|Stent Intervention/Randomization||749
599732|NCT00433966|1466202|P3|STARTED|Stent Intervention/Randomization||2257
599733|NCT00433966|1466203|P2|STARTED|Stent Intervention/Randomization||0
599734|NCT00433966|1466204|P1|STARTED|Stent Intervention/Randomization||0
599735|NCT00433966|1466201|P4|NOT COMPLETED|Pharmacology Intervention/Randomization||0
599736|NCT00433966|1466202|P3|NOT COMPLETED|Pharmacology Intervention/Randomization||0
599737|NCT00433966|1466203|P2|NOT COMPLETED|Pharmacology Intervention/Randomization||174
599738|NCT00433966|1466204|P1|NOT COMPLETED|Pharmacology Intervention/Randomization||166
599739|NCT00433966|1466201|P4|COMPLETED|Pharmacology Intervention/Randomization||0
599740|NCT00433966|1466202|P3|COMPLETED|Pharmacology Intervention/Randomization||0
599741|NCT00433966|1466203|P2|COMPLETED|Pharmacology Intervention/Randomization||1628
599742|NCT00433966|1466204|P1|COMPLETED|Pharmacology Intervention/Randomization||1634
599743|NCT00433966|1466201|P4|3-Year Follow-up|Pharmacology Intervention/Randomization||0
599744|NCT00433966|1466202|P3|3-Year Follow-up|Pharmacology Intervention/Randomization||0
599745|NCT00433966|1466203|P2|3-Year Follow-up|Pharmacology Intervention/Randomization||1628
599746|NCT00433966|1466204|P1|3-Year Follow-up|Pharmacology Intervention/Randomization||1634
599747|NCT00433966|1466201|P4|1-Year Follow-up|Pharmacology Intervention/Randomization||0
599748|NCT00433966|1466202|P3|1-Year Follow-up|Pharmacology Intervention/Randomization||0
599749|NCT00433966|1466203|P2|1-Year Follow-up|Pharmacology Intervention/Randomization||1702
599750|NCT00433966|1466204|P1|1-Year Follow-up|Pharmacology Intervention/Randomization||1696
599751|NCT00433966|1466201|P4|30-Day Follow-up|Pharmacology Intervention/Randomization||0
599752|NCT00433966|1466202|P3|30-Day Follow-up|Pharmacology Intervention/Randomization||0
599753|NCT00433966|1466203|P2|30-Day Follow-up|Pharmacology Intervention/Randomization||1791
599754|NCT00433966|1466204|P1|30-Day Follow-up|Pharmacology Intervention/Randomization||1787
599755|NCT00433966|1466201|P4|STARTED|Pharmacology Intervention/Randomization||0
599756|NCT00433966|1466202|P3|STARTED|Pharmacology Intervention/Randomization||0
599757|NCT00433966|1466203|P2|STARTED|Pharmacology Intervention/Randomization||1802
599758|NCT00433966|1466204|P1|STARTED|Pharmacology Intervention/Randomization||1800
599759|NCT00433914|1466226|P2|NOT COMPLETED|Overall Study||3
599760|NCT00433914|1466227|P1|NOT COMPLETED|Overall Study||0
599761|NCT00433914|1466226|P2|COMPLETED|Overall Study||27
599762|NCT00433914|1466227|P1|COMPLETED|Overall Study||30
599763|NCT00433914|1466226|P2|STARTED|Overall Study||30
599764|NCT00433914|1466227|P1|STARTED|Overall Study||30
599765|NCT00433836|1466247|P2|NOT COMPLETED|Overall Study||6
599766|NCT00433836|1466248|P1|NOT COMPLETED|Overall Study||13
599767|NCT00433836|1466247|P2|COMPLETED|Overall Study||143
599768|NCT00433836|1466248|P1|COMPLETED|Overall Study||138
599769|NCT00433836|1466247|P2|STARTED|Overall Study||149
599770|NCT00433836|1466248|P1|STARTED|Overall Study||151
599771|NCT00433771|1466260|P1|NOT COMPLETED|Overall Study||19
599772|NCT00433771|1466260|P1|COMPLETED|Overall Study|55 out of 58 patients were evaluable(had a stent placed and had at least 1 week of follow up)|55
599773|NCT00433771|1466260|P1|STARTED|Overall Study|74 enrolled patients(signed an Informed Consent Form)were screened.58 were eligible(intent to treat)|74
599774|NCT00433745|1466276|P1|NOT COMPLETED|Overall Study||0
599775|NCT00433745|1466276|P1|COMPLETED|Overall Study||4
599776|NCT00433745|1466276|P1|STARTED|Overall Study||4
599777|NCT00433654|1466283|P2|NOT COMPLETED|Overall Study||5
599778|NCT00433654|1466284|P1|NOT COMPLETED|Overall Study||15
599779|NCT00433654|1466283|P2|COMPLETED|Overall Study|Subjects completing the 4-month follow-up.|201
599780|NCT00433654|1466284|P1|COMPLETED|Overall Study|Subjects completing the 4-month follow-up.|243
599781|NCT00433654|1466283|P2|STARTED|Overall Study||206
599782|NCT00433654|1466284|P1|STARTED|Overall Study||258
599783|NCT00433550|1466318|P3|NOT COMPLETED|Overall Study||0
599784|NCT00433550|1466319|P2|NOT COMPLETED|Overall Study||0
599785|NCT00433550|1466320|P1|NOT COMPLETED|Overall Study||0
599786|NCT00433550|1466318|P3|COMPLETED|Overall Study||6
599787|NCT00433550|1466319|P2|COMPLETED|Overall Study||10
599788|NCT00433550|1466320|P1|COMPLETED|Overall Study||17
599789|NCT00433550|1466318|P3|STARTED|Overall Study||6
599790|NCT00433550|1466319|P2|STARTED|Overall Study||10
599791|NCT00433550|1466320|P1|STARTED|Overall Study||17
599792|NCT00433537|1466330|P3|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
599793|NCT00433537|1466331|P2|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
599794|NCT00433537|1466332|P1|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||16
599795|NCT00433537|1466330|P3|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
599796|NCT00433537|1466331|P2|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||22
599797|NCT00433537|1466332|P1|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||29
599798|NCT00433537|1466330|P3|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||0
599799|NCT00433537|1466331|P2|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||22
599800|NCT00433537|1466332|P1|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||44
599801|NCT00433537|1466330|P3|STARTED|Step 2 - Maintenance Rituximab or ASCT|One patient completed VcR-CVAD and then withdrew from the study.|0
599802|NCT00433537|1466331|P2|STARTED|Step 2 - Maintenance Rituximab or ASCT||22
599803|NCT00433537|1466332|P1|STARTED|Step 2 - Maintenance Rituximab or ASCT|This included all treated patients regardless of eligibility.|45
599804|NCT00433537|1466330|P3|NOT COMPLETED|Step 1 - VcR-CVAD Induction||9
599805|NCT00433537|1466331|P2|NOT COMPLETED|Step 1 - VcR-CVAD Induction||0
599806|NCT00433537|1466332|P1|NOT COMPLETED|Step 1 - VcR-CVAD Induction||1
599807|NCT00433537|1466330|P3|COMPLETED|Step 1 - VcR-CVAD Induction||1
599808|NCT00433537|1466331|P2|COMPLETED|Step 1 - VcR-CVAD Induction||22
599809|NCT00433537|1466332|P1|COMPLETED|Step 1 - VcR-CVAD Induction||44
599810|NCT00433537|1466330|P3|Eligible and Treated|Step 1 - VcR-CVAD Induction||9
599811|NCT00433537|1466331|P2|Eligible and Treated|Step 1 - VcR-CVAD Induction||22
599812|NCT00433537|1466332|P1|Eligible and Treated|Step 1 - VcR-CVAD Induction||44
599813|NCT00433537|1466330|P3|STARTED|Step 1 - VcR-CVAD Induction||10
599814|NCT00433537|1466331|P2|STARTED|Step 1 - VcR-CVAD Induction||22
599815|NCT00433537|1466332|P1|STARTED|Step 1 - VcR-CVAD Induction||45
599816|NCT00433446|1466341|P1|NOT COMPLETED|Overall Study||61
599817|NCT00433446|1466341|P1|COMPLETED|Overall Study||1
599818|NCT00433446|1466341|P1|Eligible and Began Protocol Therapy|Overall Study||53
599819|NCT00433446|1466341|P1|Eligible|Overall Study||53
599820|NCT00433446|1466341|P1|STARTED|Overall Study||62
599821|NCT00433381|1466351|P2|NOT COMPLETED|Overall Study||3
599822|NCT00433381|1466352|P1|NOT COMPLETED|Overall Study||5
599823|NCT00433381|1466351|P2|COMPLETED|Overall Study||57
599824|NCT00433381|1466352|P1|COMPLETED|Overall Study|Evaluated for 6-month progression-free survival. (Applies to both arms).|58
599825|NCT00433381|1466351|P2|STARTED|Overall Study||60
599826|NCT00433381|1466352|P1|STARTED|Overall Study||63
599827|NCT00433329|1466358|P1|NOT COMPLETED|Overall Study||21
599828|NCT00433329|1466358|P1|COMPLETED|Overall Study||79
599829|NCT00433329|1466358|P1|STARTED|Overall Study||100
599830|NCT00433290|1466364|P2|NOT COMPLETED|Overall Study||17
599831|NCT00433290|1466365|P1|NOT COMPLETED|Overall Study||35
599832|NCT00433290|1466364|P2|COMPLETED|Overall Study||111
599833|NCT00433290|1466365|P1|COMPLETED|Overall Study||93
599834|NCT00433290|1466364|P2|STARTED|Overall Study||128
599835|NCT00433290|1466365|P1|STARTED|Overall Study||128
599836|NCT00433199|1466434|P2|NOT COMPLETED|Open-Label Period||34
599837|NCT00433199|1466435|P1|NOT COMPLETED|Open-Label Period||0
599838|NCT00433199|1466434|P2|COMPLETED|Open-Label Period||185
599839|NCT00433199|1466435|P1|COMPLETED|Open-Label Period||0
599840|NCT00433199|1466434|P2|STARTED|Open-Label Period||219
599841|NCT00433199|1466435|P1|STARTED|Open-Label Period||0
599842|NCT00433199|1466434|P2|NOT COMPLETED|Double-Blind Period||66
599843|NCT00433199|1466435|P1|NOT COMPLETED|Double-Blind Period||12
599844|NCT00433199|1466434|P2|COMPLETED|Double-Blind Period||168
599845|NCT00433199|1466435|P1|COMPLETED|Double-Blind Period||28
599846|NCT00433199|1466434|P2|STARTED|Double-Blind Period||234
599847|NCT00433199|1466435|P1|STARTED|Double-Blind Period||40
599848|NCT00433160|1466455|P2|NOT COMPLETED|104 Weeks, 28-Week OL Period||3
599849|NCT00433160|1466456|P1|NOT COMPLETED|104 Weeks, 28-Week OL Period||10
599850|NCT00433160|1466455|P2|COMPLETED|104 Weeks, 28-Week OL Period||47
599851|NCT00433160|1466456|P1|COMPLETED|104 Weeks, 28-Week OL Period||92
599852|NCT00433160|1466455|P2|Received Treatment|104 Weeks, 28-Week OL Period||50
599853|NCT00433160|1466456|P1|Received Treatment|104 Weeks, 28-Week OL Period||102
599854|NCT00433160|1466455|P2|STARTED|104 Weeks, 28-Week OL Period|Five participants withdrew at end of first OL period and did not continue on to second OL period.|50
599855|NCT00433160|1466456|P1|STARTED|104 Weeks, 28-Week OL Period|Eleven participants withdrew at end of first OL period and did not continue on to second OL period.|102
599856|NCT00433160|1466455|P2|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||4
599857|NCT00433160|1466456|P1|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||6
599858|NCT00433160|1466455|P2|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||55
599859|NCT00433160|1466456|P1|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||113
599860|NCT00433160|1466455|P2|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||59
599861|NCT00433160|1466456|P1|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||119
599862|NCT00433160|1466455|P2|STARTED|76 Weeks, 24-Week Open Label (OL) Period|One participant did not continue to first OL period due to adverse event after completing DB period.|59
599863|NCT00433160|1466456|P1|STARTED|76 Weeks, 24-Week Open Label (OL) Period|One participant did not continue to first OL period due to adverse event after completing DB period.|119
599864|NCT00433160|1466455|P2|NOT COMPLETED|52-Week Double-Blind (DB) Period||10
599865|NCT00433160|1466456|P1|NOT COMPLETED|52-Week Double-Blind (DB) Period||17
599866|NCT00433160|1466455|P2|COMPLETED|52-Week Double-Blind (DB) Period||60
599867|NCT00433160|1466456|P1|COMPLETED|52-Week Double-Blind (DB) Period||120
599868|NCT00433160|1466455|P2|Received Treatment|52-Week Double-Blind (DB) Period||68
599869|NCT00433160|1466456|P1|Received Treatment|52-Week Double-Blind (DB) Period||136
599870|NCT00433160|1466455|P2|STARTED|52-Week Double-Blind (DB) Period||70
599871|NCT00433160|1466456|P1|STARTED|52-Week Double-Blind (DB) Period||137
599872|NCT00433017|1466506|P2|NOT COMPLETED|Overall Study||101
599873|NCT00433017|1466507|P1|NOT COMPLETED|Overall Study||96
599874|NCT00433017|1466506|P2|COMPLETED|Overall Study||32
599875|NCT00433017|1466507|P1|COMPLETED|Overall Study||26
599876|NCT00433017|1466506|P2|Completed 12 Month Phase|Overall Study||126
599877|NCT00433017|1466507|P1|Completed 12 Month Phase|Overall Study||114
599878|NCT00433017|1466506|P2|STARTED|Overall Study||133
599879|NCT00433017|1466507|P1|STARTED|Overall Study||122
599880|NCT00433004|1466523|P2|NOT COMPLETED|Overall Study||7
599881|NCT00433004|1466524|P1|NOT COMPLETED|Overall Study||5
599882|NCT00433004|1466523|P2|COMPLETED|Overall Study||16
599883|NCT00433004|1466524|P1|COMPLETED|Overall Study||22
599884|NCT00433004|1466523|P2|STARTED|Overall Study||23
599885|NCT00433004|1466524|P1|STARTED|Overall Study||27
599886|NCT00432991|1466536|P2|NOT COMPLETED|Overall Study||12
599887|NCT00432991|1466537|P1|NOT COMPLETED|Overall Study||7
599888|NCT00432991|1466536|P2|COMPLETED|Overall Study||19
599889|NCT00432991|1466537|P1|COMPLETED|Overall Study||15
599890|NCT00432991|1466536|P2|STARTED|Overall Study||31
599891|NCT00432991|1466537|P1|STARTED|Overall Study||22
599892|NCT00432965|1466549|P2|NOT COMPLETED|Overall Study||86
599893|NCT00432965|1466550|P1|NOT COMPLETED|Overall Study||94
599894|NCT00432965|1466549|P2|COMPLETED|Overall Study||80
599895|NCT00432965|1466550|P1|COMPLETED|Overall Study||75
599896|NCT00432965|1466549|P2|STARTED|Overall Study||166
599897|NCT00432965|1466550|P1|STARTED|Overall Study||169
599898|NCT00432835|1466558|P2|NOT COMPLETED|Overall Study||7
599899|NCT00432835|1466559|P1|NOT COMPLETED|Overall Study||6
599900|NCT00432835|1466558|P2|COMPLETED|Overall Study|These 23 patients completed the entire 8 day protocol.|23
599901|NCT00432835|1466559|P1|COMPLETED|Overall Study|These 22 patients completed the entire 8 day protocol.|22
599902|NCT00432835|1466558|P2|Completed 2nd Intervention|Overall Study||23
599903|NCT00432835|1466559|P1|Completed 2nd Intervention|Overall Study||22
599904|NCT00432835|1466558|P2|Completed 1st Intervention|Overall Study||23
599905|NCT00432835|1466559|P1|Completed 1st Intervention|Overall Study||22
599906|NCT00432835|1466558|P2|STARTED|Overall Study||30
599907|NCT00432835|1466559|P1|STARTED|Overall Study||28
599908|NCT00432809|1466572|P3|NOT COMPLETED|2 Year Sub-study||1
599909|NCT00432809|1466573|P2|NOT COMPLETED|2 Year Sub-study||2
599910|NCT00432809|1466574|P1|NOT COMPLETED|2 Year Sub-study||3
599911|NCT00432809|1466572|P3|COMPLETED|2 Year Sub-study||19
599912|NCT00432809|1466573|P2|COMPLETED|2 Year Sub-study||18
599913|NCT00432809|1466574|P1|COMPLETED|2 Year Sub-study||17
599914|NCT00432809|1466572|P3|STARTED|2 Year Sub-study||20
599915|NCT00432809|1466573|P2|STARTED|2 Year Sub-study||20
599916|NCT00432809|1466574|P1|STARTED|2 Year Sub-study||20
599917|NCT00432809|1466572|P3|NOT COMPLETED|1 Year Follow-up||1
599918|NCT00432809|1466573|P2|NOT COMPLETED|1 Year Follow-up||0
599919|NCT00432809|1466574|P1|NOT COMPLETED|1 Year Follow-up||9
599920|NCT00432809|1466572|P3|COMPLETED|1 Year Follow-up||49
599921|NCT00432809|1466573|P2|COMPLETED|1 Year Follow-up||50
599922|NCT00432809|1466574|P1|COMPLETED|1 Year Follow-up||41
599923|NCT00432809|1466572|P3|STARTED|1 Year Follow-up||50
599924|NCT00432809|1466573|P2|STARTED|1 Year Follow-up||50
599925|NCT00432809|1466574|P1|STARTED|1 Year Follow-up||50
599926|NCT00432744|1466647|P2|NOT COMPLETED|Months 7 - 12||1
599927|NCT00432744|1466648|P1|NOT COMPLETED|Months 7 - 12||1
599928|NCT00432744|1466647|P2|COMPLETED|Months 7 - 12||7
599929|NCT00432744|1466648|P1|COMPLETED|Months 7 - 12||6
599930|NCT00432744|1466647|P2|STARTED|Months 7 - 12||8
599931|NCT00432744|1466648|P1|STARTED|Months 7 - 12||7
599932|NCT00432744|1466647|P2|NOT COMPLETED|Months 0-6||4
599933|NCT00432744|1466648|P1|NOT COMPLETED|Months 0-6||5
599934|NCT00432744|1466647|P2|COMPLETED|Months 0-6|"One patient in period 1 other reason for loss became too disabled to complete the 6 month test."|8
599935|NCT00432744|1466648|P1|COMPLETED|Months 0-6||7
599936|NCT00432744|1466647|P2|STARTED|Months 0-6||12
599937|NCT00432744|1466648|P1|STARTED|Months 0-6||12
599938|NCT00432666|1466660|P2|NOT COMPLETED|Open-Label Extension Period||0
599939|NCT00432666|1466661|P1|NOT COMPLETED|Open-Label Extension Period||25
599940|NCT00432666|1466660|P2|COMPLETED|Open-Label Extension Period||0
599941|NCT00432666|1466661|P1|COMPLETED|Open-Label Extension Period||120
599942|NCT00432666|1466660|P2|STARTED|Open-Label Extension Period|In the Open-Label Extension Period no placebo treatment arm was given.|0
599943|NCT00432666|1466661|P1|STARTED|Open-Label Extension Period||145
599944|NCT00432666|1466660|P2|NOT COMPLETED|Main Period||1
599945|NCT00432666|1466661|P1|NOT COMPLETED|Main Period||2
599946|NCT00432666|1466660|P2|COMPLETED|Main Period||74
599947|NCT00432666|1466661|P1|COMPLETED|Main Period||71
599948|NCT00432666|1466660|P2|STARTED|Main Period||75
599949|NCT00432666|1466661|P1|STARTED|Main Period||73
599950|NCT00432601|1466825|P2|NOT COMPLETED|Time 2 to Time 3||22
599951|NCT00432601|1466826|P1|NOT COMPLETED|Time 2 to Time 3||19
599952|NCT00432601|1466825|P2|COMPLETED|Time 2 to Time 3||122
599953|NCT00432601|1466826|P1|COMPLETED|Time 2 to Time 3||122
599954|NCT00432601|1466825|P2|STARTED|Time 2 to Time 3||144
599955|NCT00432601|1466826|P1|STARTED|Time 2 to Time 3||141
599956|NCT00432601|1466825|P2|NOT COMPLETED|Time 1 to Time 2||368
599957|NCT00432601|1466826|P1|NOT COMPLETED|Time 1 to Time 2||369
599958|NCT00432601|1466825|P2|COMPLETED|Time 1 to Time 2|There is large drop-off as only one-third of subjects enrolled were eligible to continue the study|144
599959|NCT00432601|1466826|P1|COMPLETED|Time 1 to Time 2|There is large drop-off as only one-third of subjects enrolled were eligible to continue the study|141
599960|NCT00432601|1466825|P2|STARTED|Time 1 to Time 2||512
599961|NCT00432601|1466826|P1|STARTED|Time 1 to Time 2||510
599962|NCT00432562|1466834|P2|NOT COMPLETED|Overall Study||0
599963|NCT00432562|1466835|P1|NOT COMPLETED|Overall Study||3
599964|NCT00432562|1466834|P2|COMPLETED|Overall Study||15
599965|NCT00432562|1466835|P1|COMPLETED|Overall Study||13
599966|NCT00432562|1466834|P2|STARTED|Overall Study||15
599967|NCT00432562|1466835|P1|STARTED|Overall Study||16
599968|NCT00432458|1466861|P2|NOT COMPLETED|Overall Study||1
599969|NCT00432458|1466862|P1|NOT COMPLETED|Overall Study||5
599970|NCT00432458|1466861|P2|COMPLETED|Overall Study||32
599971|NCT00432458|1466862|P1|COMPLETED|Overall Study||30
599972|NCT00432458|1466861|P2|STARTED|Overall Study||33
599973|NCT00432458|1466862|P1|STARTED|Overall Study||35
599974|NCT00432445|1466880|P1|NOT COMPLETED|Overall Study||0
599975|NCT00432445|1466880|P1|COMPLETED|Overall Study||2
599976|NCT00432445|1466880|P1|STARTED|Overall Study||2
599977|NCT00432380|1466887|P3|NOT COMPLETED|Overall Study||1
599978|NCT00432380|1466888|P2|NOT COMPLETED|Overall Study||4
599979|NCT00432380|1466889|P1|NOT COMPLETED|Overall Study||4
599980|NCT00432380|1466887|P3|COMPLETED|Overall Study||74
599981|NCT00432380|1466888|P2|COMPLETED|Overall Study||146
599982|NCT00432380|1466889|P1|COMPLETED|Overall Study||146
599983|NCT00432380|1466887|P3|STARTED|Overall Study||75
599984|NCT00432380|1466888|P2|STARTED|Overall Study||150
599985|NCT00432380|1466889|P1|STARTED|Overall Study||150
599986|NCT00432341|1466915|P2|NOT COMPLETED|Overall Study||0
599987|NCT00432341|1466916|P1|NOT COMPLETED|Overall Study||0
599988|NCT00432341|1466915|P2|COMPLETED|Overall Study||30
599989|NCT00432341|1466916|P1|COMPLETED|Overall Study||24
599990|NCT00432341|1466915|P2|STARTED|Overall Study||30
599991|NCT00432341|1466916|P1|STARTED|Overall Study||24
599992|NCT00432276|1466942|P2|NOT COMPLETED|Overall Study||156
599993|NCT00432276|1466943|P1|NOT COMPLETED|Overall Study||121
599994|NCT00432276|1466942|P2|COMPLETED|Overall Study||243
599995|NCT00432276|1466943|P1|COMPLETED|Overall Study||283
599996|NCT00432276|1466942|P2|Per Protocol Set|Overall Study||306
599997|NCT00432276|1466943|P1|Per Protocol Set|Overall Study|Patients who received at least 1 dose of study medication and who had no major protocol violations.|303
599998|NCT00432276|1466942|P2|STARTED|Overall Study||399
599999|NCT00432276|1466943|P1|STARTED|Overall Study||404
600000|NCT00432237|1467033|P4|NOT COMPLETED|Overall Study||124
600001|NCT00432237|1467034|P3|NOT COMPLETED|Overall Study||109
600002|NCT00432237|1467035|P2|NOT COMPLETED|Overall Study||101
600003|NCT00432237|1467036|P1|NOT COMPLETED|Overall Study||67
600004|NCT00432237|1467033|P4|COMPLETED|Overall Study||366
600005|NCT00432237|1467034|P3|COMPLETED|Overall Study||375
600006|NCT00432237|1467035|P2|COMPLETED|Overall Study||384
600007|NCT00432237|1467036|P1|COMPLETED|Overall Study||177
600008|NCT00432237|1467033|P4|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|1
600009|NCT00432237|1467034|P3|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|5
600010|NCT00432237|1467035|P2|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|3
600011|NCT00432237|1467036|P1|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|1
600012|NCT00432237|1467033|P4|Completed--With Data|Overall Study||365
600013|NCT00432237|1467034|P3|Completed--With Data|Overall Study||370
600014|NCT00432237|1467035|P2|Completed--With Data|Overall Study||381
600015|NCT00432237|1467036|P1|Completed--With Data|Overall Study||176
600016|NCT00432237|1467033|P4|STARTED|Overall Study||490
600017|NCT00432237|1467034|P3|STARTED|Overall Study|1 patient in the MK0974 300 mg group was treated but withdrew consent.|484
600018|NCT00432237|1467035|P2|STARTED|Overall Study||485
600019|NCT00432237|1467036|P1|STARTED|Overall Study|1 patient in the MK0974 50 mg group was treated but withdrew consent.|244
600020|NCT00432159|1467079|P5|NOT COMPLETED|Overall Study||10
600021|NCT00432159|1467080|P4|NOT COMPLETED|Overall Study||5
600022|NCT00432159|1467081|P3|NOT COMPLETED|Overall Study||4
600023|NCT00432159|1467082|P2|NOT COMPLETED|Overall Study||30
600024|NCT00432159|1467083|P1|NOT COMPLETED|Overall Study||22
600025|NCT00432159|1467079|P5|COMPLETED|Overall Study|Actual (Complete efficacy)|79
600026|NCT00432159|1467080|P4|COMPLETED|Overall Study|Actual (Complete efficacy)|15
600027|NCT00432159|1467081|P3|COMPLETED|Overall Study|Actual (Complete efficacy)|35
600028|NCT00432159|1467082|P2|COMPLETED|Overall Study|Actual (Complete efficacy)|137
600029|NCT00432159|1467083|P1|COMPLETED|Overall Study|Actual (Complete efficacy)|163
600030|NCT00432159|1467079|P5|STARTED|Overall Study||89
600031|NCT00432159|1467080|P4|STARTED|Overall Study||20
600032|NCT00432159|1467081|P3|STARTED|Overall Study||39
600033|NCT00432159|1467082|P2|STARTED|Overall Study||167
600034|NCT00432159|1467083|P1|STARTED|Overall Study||185
600035|NCT00432042|1467190|P3|NOT COMPLETED|Overall Study||2
600036|NCT00432042|1467191|P2|NOT COMPLETED|Overall Study||1
600037|NCT00432042|1467192|P1|NOT COMPLETED|Overall Study||7
600038|NCT00432042|1467190|P3|COMPLETED|Overall Study||239
600039|NCT00432042|1467191|P2|COMPLETED|Overall Study||234
600040|NCT00432042|1467192|P1|COMPLETED|Overall Study||472
600041|NCT00432042|1467190|P3|Vaccinated|Overall Study||240
600042|NCT00432042|1467191|P2|Vaccinated|Overall Study||235
600043|NCT00432042|1467192|P1|Vaccinated|Overall Study||477
600044|NCT00432042|1467190|P3|STARTED|Overall Study|Number randomized.|241
600045|NCT00432042|1467191|P2|STARTED|Overall Study|Number randomized.|235
600046|NCT00432042|1467192|P1|STARTED|Overall Study|Number randomized.|479
600047|NCT00431964|1467205|P2|NOT COMPLETED|Overall Study||8
600048|NCT00431964|1467206|P1|NOT COMPLETED|Overall Study||6
600049|NCT00431964|1467205|P2|COMPLETED|Overall Study||124
600050|NCT00431964|1467206|P1|COMPLETED|Overall Study||125
600051|NCT00431964|1467205|P2|Withdrew From Study|Overall Study||5
600052|NCT00431964|1467206|P1|Withdrew From Study|Overall Study||6
600053|NCT00431964|1467205|P2|Did Not Receive Drug|Overall Study||3
600054|NCT00431964|1467206|P1|Did Not Receive Drug|Overall Study||0
600055|NCT00431964|1467205|P2|Randomized/Received Drug|Overall Study||129
600056|NCT00431964|1467206|P1|Randomized/Received Drug|Overall Study||131
600057|NCT00431964|1467205|P2|STARTED|Overall Study||132
600058|NCT00431964|1467206|P1|STARTED|Overall Study||131
600059|NCT00431951|1467216|P4|NOT COMPLETED|Overall Study||2
600060|NCT00431951|1467217|P3|NOT COMPLETED|Overall Study||2
600061|NCT00431951|1467218|P2|NOT COMPLETED|Overall Study||2
600062|NCT00431951|1467219|P1|NOT COMPLETED|Overall Study||1
600063|NCT00431951|1467216|P4|COMPLETED|Overall Study||4
600064|NCT00431951|1467217|P3|COMPLETED|Overall Study||6
600065|NCT00431951|1467218|P2|COMPLETED|Overall Study||6
600066|NCT00431951|1467219|P1|COMPLETED|Overall Study||7
600067|NCT00431951|1467216|P4|STARTED|Overall Study||6
600068|NCT00431951|1467217|P3|STARTED|Overall Study||8
600069|NCT00431951|1467218|P2|STARTED|Overall Study||8
600070|NCT00431951|1467219|P1|STARTED|Overall Study||8
600071|NCT00431847|1467281|P5|NOT COMPLETED|Overall Study||1
600072|NCT00431847|1467282|P4|NOT COMPLETED|Overall Study||14
600073|NCT00431847|1467283|P3|NOT COMPLETED|Overall Study||4
600074|NCT00431847|1467284|P2|NOT COMPLETED|Overall Study||3
600075|NCT00431847|1467285|P1|NOT COMPLETED|Overall Study||6
600076|NCT00431847|1467281|P5|COMPLETED|Overall Study||0
600077|NCT00431847|1467282|P4|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|170
600078|NCT00431847|1467283|P3|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|20
600079|NCT00431847|1467284|P2|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|42
600080|NCT00431847|1467285|P1|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|126
600081|NCT00431847|1467281|P5|STARTED|Overall Study||1
600082|NCT00431847|1467282|P4|STARTED|Overall Study||184
600083|NCT00431847|1467283|P3|STARTED|Overall Study||24
600084|NCT00431847|1467284|P2|STARTED|Overall Study||45
600085|NCT00431847|1467285|P1|STARTED|Overall Study||132
600086|NCT00431834|1467359|P1|NOT COMPLETED|Overall Study||13
600087|NCT00431834|1467359|P1|COMPLETED|Overall Study||62
600088|NCT00431834|1467359|P1|STARTED|Overall Study||75
600089|NCT00431626|1467368|P2|NOT COMPLETED|Overall Study||0
600090|NCT00431626|1467369|P1|NOT COMPLETED|Overall Study||0
600091|NCT00431626|1467368|P2|COMPLETED|Overall Study||0
600092|NCT00431626|1467369|P1|COMPLETED|Overall Study||4
600093|NCT00431626|1467368|P2|STARTED|Overall Study||0
600094|NCT00431626|1467369|P1|STARTED|Overall Study||4
600095|NCT00431496|1467375|P1|NOT COMPLETED|Overall Study||11
600096|NCT00431496|1467375|P1|COMPLETED|Overall Study||60
600097|NCT00431496|1467375|P1|STARTED|Overall Study||71
600098|NCT00431444|1467386|P2|NOT COMPLETED|Overall Study||7
600099|NCT00431444|1467387|P1|NOT COMPLETED|Overall Study||5
600100|NCT00431444|1467386|P2|COMPLETED|Overall Study||46
600101|NCT00431444|1467387|P1|COMPLETED|Overall Study||51
600102|NCT00431444|1467386|P2|STARTED|Overall Study|"Initially 110 randomized, 1 participant of Raloxifene group never took study drug."|53
600103|NCT00431444|1467387|P1|STARTED|Overall Study||56
600104|NCT00431184|1467413|P2|NOT COMPLETED|Second Intervention (Day 2)||0
600105|NCT00431184|1467414|P1|NOT COMPLETED|Second Intervention (Day 2)||0
600106|NCT00431184|1467413|P2|COMPLETED|Second Intervention (Day 2)||9
600107|NCT00431184|1467414|P1|COMPLETED|Second Intervention (Day 2)||10
600108|NCT00431184|1467413|P2|STARTED|Second Intervention (Day 2)||9
600109|NCT00431184|1467414|P1|STARTED|Second Intervention (Day 2)||10
600110|NCT00431184|1467413|P2|NOT COMPLETED|1st Intervention (Day 1)||0
600111|NCT00431184|1467414|P1|NOT COMPLETED|1st Intervention (Day 1)||0
600112|NCT00431184|1467413|P2|COMPLETED|1st Intervention (Day 1)||9
600113|NCT00431184|1467414|P1|COMPLETED|1st Intervention (Day 1)||10
600114|NCT00431184|1467413|P2|STARTED|1st Intervention (Day 1)||9
600115|NCT00431184|1467414|P1|STARTED|1st Intervention (Day 1)||10
600116|NCT00431132|1467422|P1|NOT COMPLETED|Overall Study||44
600117|NCT00431132|1467422|P1|COMPLETED|Overall Study||292
600118|NCT00431132|1467422|P1|STARTED|Overall Study||336
600119|NCT00431067|1467427|P1|NOT COMPLETED|Overall Study||41
600120|NCT00431067|1467427|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (22-Sep-2009)|0
600121|NCT00431067|1467427|P1|STARTED|Overall Study|52 patients screened, 41 treated|41
600122|NCT00431041|1467437|P2|NOT COMPLETED|Overall Study||24
600123|NCT00431041|1467438|P1|NOT COMPLETED|Overall Study||16
600124|NCT00431041|1467437|P2|COMPLETED|Overall Study||40
600125|NCT00431041|1467438|P1|COMPLETED|Overall Study||52
600126|NCT00431041|1467437|P2|STARTED|Overall Study|Data represents ITT Population: All randomized subjects|64
600127|NCT00431041|1467438|P1|STARTED|Overall Study|Data represents Intention To Treat(ITT) Population: All randomized subjects|68
600128|NCT00430950|1467452|P2|NOT COMPLETED|Overall Study||13
600129|NCT00430950|1467453|P1|NOT COMPLETED|Overall Study||13
600130|NCT00430950|1467452|P2|COMPLETED|Overall Study||495
600131|NCT00430950|1467453|P1|COMPLETED|Overall Study||489
600132|NCT00430950|1467452|P2|STARTED|Overall Study||508
600133|NCT00430950|1467453|P1|STARTED|Overall Study||502
600134|NCT00430937|1467467|P2|NOT COMPLETED|Overall Study||28
600135|NCT00430937|1467468|P1|NOT COMPLETED|Overall Study||27
600136|NCT00430937|1467467|P2|COMPLETED|Overall Study||64
600137|NCT00430937|1467468|P1|COMPLETED|Overall Study||70
600138|NCT00430937|1467467|P2|STARTED|Overall Study||92
600139|NCT00430937|1467468|P1|STARTED|Overall Study|Additional 5 participants were randomized; however, they were not exposed to study drug by mistake.|97
600140|NCT00430781|1467479|P3|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||20
600141|NCT00430781|1467480|P2|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||18
600142|NCT00430781|1467481|P1|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||24
600143|NCT00430781|1467479|P3|COMPLETED|End-of-Study Analysis; 28 July 2011||54
600144|NCT00430781|1467480|P2|COMPLETED|End-of-Study Analysis; 28 July 2011||59
600145|NCT00430781|1467481|P1|COMPLETED|End-of-Study Analysis; 28 July 2011||53
600146|NCT00430781|1467479|P3|STARTED|End-of-Study Analysis; 28 July 2011||74
600147|NCT00430781|1467480|P2|STARTED|End-of-Study Analysis; 28 July 2011|1 participant randomized to lapatinib (final analysis table) actually received combination therapy.|77
600148|NCT00430781|1467481|P1|STARTED|End-of-Study Analysis; 28 July 2011|Enrollment continued in this arm after data cut for Interim Analysis and before arm closed.|77
600149|NCT00430781|1467479|P3|NOT COMPLETED|Final Analysis; 31 July 2008||48
600150|NCT00430781|1467480|P2|NOT COMPLETED|Final Analysis; 31 July 2008||39
600151|NCT00430781|1467481|P1|NOT COMPLETED|Final Analysis; 31 July 2008||0
600152|NCT00430781|1467479|P3|COMPLETED|Final Analysis; 31 July 2008||26
600153|NCT00430781|1467480|P2|COMPLETED|Final Analysis; 31 July 2008||39
600154|NCT00430781|1467481|P1|COMPLETED|Final Analysis; 31 July 2008||0
600155|NCT00430781|1467479|P3|Ongoing|Final Analysis; 31 July 2008||32
600156|NCT00430781|1467480|P2|Ongoing|Final Analysis; 31 July 2008||29
600157|NCT00430781|1467481|P1|Ongoing|Final Analysis; 31 July 2008||0
600158|NCT00430781|1467479|P3|STARTED|Final Analysis; 31 July 2008||74
600159|NCT00430781|1467480|P2|STARTED|Final Analysis; 31 July 2008||78
600160|NCT00430781|1467481|P1|STARTED|Final Analysis; 31 July 2008||0
600161|NCT00430781|1467479|P3|NOT COMPLETED|Interim Analysis; 11 February 2008||60
600162|NCT00430781|1467480|P2|NOT COMPLETED|Interim Analysis; 11 February 2008||58
600163|NCT00430781|1467481|P1|NOT COMPLETED|Interim Analysis; 11 February 2008||59
600164|NCT00430781|1467479|P3|COMPLETED|Interim Analysis; 11 February 2008||0
600165|NCT00430781|1467480|P2|COMPLETED|Interim Analysis; 11 February 2008||0
600166|NCT00430781|1467481|P1|COMPLETED|Interim Analysis; 11 February 2008||0
600167|NCT00430781|1467479|P3|Ongoing|Interim Analysis; 11 February 2008||25
600168|NCT00430781|1467480|P2|Ongoing|Interim Analysis; 11 February 2008||20
600169|NCT00430781|1467481|P1|Ongoing|Interim Analysis; 11 February 2008||23
600170|NCT00430781|1467479|P3|STARTED|Interim Analysis; 11 February 2008||60
600171|NCT00430781|1467480|P2|STARTED|Interim Analysis; 11 February 2008||58
600172|NCT00430781|1467481|P1|STARTED|Interim Analysis; 11 February 2008||59
600173|NCT00430768|1467507|P3|NOT COMPLETED|Overall Study||0
600174|NCT00430768|1467508|P2|NOT COMPLETED|Overall Study||0
600175|NCT00430768|1467509|P1|NOT COMPLETED|Overall Study||0
600176|NCT00430768|1467507|P3|COMPLETED|Overall Study||3
600177|NCT00430768|1467508|P2|COMPLETED|Overall Study||3
600178|NCT00430768|1467509|P1|COMPLETED|Overall Study||3
600179|NCT00430768|1467507|P3|STARTED|Overall Study||3
600180|NCT00430768|1467508|P2|STARTED|Overall Study||3
600181|NCT00430768|1467509|P1|STARTED|Overall Study||3
600182|NCT00430755|1467523|P1|NOT COMPLETED|Overall Study||53
600183|NCT00430755|1467523|P1|COMPLETED|Overall Study||45
600184|NCT00430755|1467523|P1|STARTED|Overall Study||98
600185|NCT00430716|1467530|P3|NOT COMPLETED|Open Label Phase||7
600186|NCT00430716|1467531|P2|NOT COMPLETED|Open Label Phase||7
600187|NCT00430716|1467532|P1|NOT COMPLETED|Open Label Phase||9
600188|NCT00430716|1467530|P3|COMPLETED|Open Label Phase||32
600189|NCT00430716|1467531|P2|COMPLETED|Open Label Phase||31
600190|NCT00430716|1467532|P1|COMPLETED|Open Label Phase||27
600191|NCT00430716|1467530|P3|STARTED|Open Label Phase||39
600192|NCT00430716|1467531|P2|STARTED|Open Label Phase||38
600193|NCT00430716|1467532|P1|STARTED|Open Label Phase||36
600194|NCT00430716|1467530|P3|NOT COMPLETED|Double Blind Phase||6
600195|NCT00430716|1467531|P2|NOT COMPLETED|Double Blind Phase||5
600196|NCT00430716|1467532|P1|NOT COMPLETED|Double Blind Phase||6
600197|NCT00430716|1467530|P3|COMPLETED|Double Blind Phase||39
600198|NCT00430716|1467531|P2|COMPLETED|Double Blind Phase||38
600199|NCT00430716|1467532|P1|COMPLETED|Double Blind Phase||36
600200|NCT00430716|1467530|P3|Treated|Double Blind Phase||45
600201|NCT00430716|1467531|P2|Treated|Double Blind Phase||43
600202|NCT00430716|1467532|P1|Treated|Double Blind Phase||41
600203|NCT00430716|1467530|P3|STARTED|Double Blind Phase||45
600204|NCT00430716|1467531|P2|STARTED|Double Blind Phase||43
600205|NCT00430716|1467532|P1|STARTED|Double Blind Phase||42
600206|NCT00430677|1467564|P3|NOT COMPLETED|Long-term Extension Period||63
600207|NCT00430677|1467565|P2|NOT COMPLETED|Long-term Extension Period||58
600208|NCT00430677|1467566|P1|NOT COMPLETED|Long-term Extension Period||60
600209|NCT00430677|1467564|P3|COMPLETED|Long-term Extension Period|Completed the long-term extension period|11
600210|NCT00430677|1467565|P2|COMPLETED|Long-term Extension Period|Completed the long-term extension period|9
600211|NCT00430677|1467566|P1|COMPLETED|Long-term Extension Period|Completed the long-term extension period|10
600212|NCT00430677|1467564|P3|STARTED|Long-term Extension Period||74
600213|NCT00430677|1467565|P2|STARTED|Long-term Extension Period||67
600214|NCT00430677|1467566|P1|STARTED|Long-term Extension Period||70
600215|NCT00430677|1467564|P3|NOT COMPLETED|Short-term Period||22
600216|NCT00430677|1467565|P2|NOT COMPLETED|Short-term Period||25
600217|NCT00430677|1467566|P1|NOT COMPLETED|Short-term Period||23
600218|NCT00430677|1467564|P3|COMPLETED|Short-term Period|Completed the short-term period|78
600219|NCT00430677|1467565|P2|COMPLETED|Short-term Period|Completed the short-term period|74
600220|NCT00430677|1467566|P1|COMPLETED|Short-term Period|Completed the short-term period|76
600221|NCT00430677|1467564|P3|STARTED|Short-term Period||100
600222|NCT00430677|1467565|P2|STARTED|Short-term Period|1 participant took infliximab on day 1 and was discontinued before receiving study medication.|99
600223|NCT00430677|1467566|P1|STARTED|Short-term Period|1 participant died before receiving the first dose of study medication|99
600224|NCT00430638|1467689|P2|NOT COMPLETED|Overall Study||48
600225|NCT00430638|1467690|P1|NOT COMPLETED|Overall Study||78
600226|NCT00430638|1467689|P2|COMPLETED|Overall Study||92
600227|NCT00430638|1467690|P1|COMPLETED|Overall Study||60
600228|NCT00430638|1467689|P2|STARTED|Overall Study|2 participants were erroneously assigned to olmesartan 40 mg instead of 20 mg|140
600229|NCT00430638|1467690|P1|STARTED|Overall Study||138
600230|NCT00430625|1467708|P2|NOT COMPLETED|Overall Study||0
600231|NCT00430625|1467709|P1|NOT COMPLETED|Overall Study||0
600232|NCT00430625|1467708|P2|COMPLETED|Overall Study||12
600233|NCT00430625|1467709|P1|COMPLETED|Overall Study||13
600234|NCT00430625|1467708|P2|STARTED|Overall Study||12
600235|NCT00430625|1467709|P1|STARTED|Overall Study||13
600236|NCT00430573|1467725|P1|NOT COMPLETED|Overall Study||5
600237|NCT00430573|1467725|P1|COMPLETED|Overall Study|Only 5 took study drug on at least one occasion and 8 completed the baseline ASI.|5
600238|NCT00430573|1467725|P1|STARTED|Overall Study||10
600239|NCT00430508|1467734|P4|NOT COMPLETED|Overall Study||5
600240|NCT00430508|1467735|P3|NOT COMPLETED|Overall Study||13
600241|NCT00430508|1467736|P2|NOT COMPLETED|Overall Study||6
600242|NCT00430508|1467737|P1|NOT COMPLETED|Overall Study||3
600243|NCT00430508|1467734|P4|COMPLETED|Overall Study||269
600244|NCT00430508|1467735|P3|COMPLETED|Overall Study||266
600245|NCT00430508|1467736|P2|COMPLETED|Overall Study||272
600246|NCT00430508|1467737|P1|COMPLETED|Overall Study||137
600247|NCT00430508|1467734|P4|STARTED|Overall Study||274
600248|NCT00430508|1467735|P3|STARTED|Overall Study||279
600249|NCT00430508|1467736|P2|STARTED|Overall Study||278
600250|NCT00430508|1467737|P1|STARTED|Overall Study||140
600251|NCT00430495|1467775|P4|NOT COMPLETED|Overall Study||4
600252|NCT00430495|1467776|P3|NOT COMPLETED|Overall Study||13
600253|NCT00430495|1467777|P2|NOT COMPLETED|Overall Study||7
600254|NCT00430495|1467778|P1|NOT COMPLETED|Overall Study||14
600255|NCT00430495|1467775|P4|COMPLETED|Overall Study||60
600256|NCT00430495|1467776|P3|COMPLETED|Overall Study||49
600257|NCT00430495|1467777|P2|COMPLETED|Overall Study||59
600258|NCT00430495|1467778|P1|COMPLETED|Overall Study||50
600259|NCT00430495|1467775|P4|Treated|Overall Study||64
600260|NCT00430495|1467776|P3|Treated|Overall Study||62
600261|NCT00430495|1467777|P2|Treated|Overall Study||66
600262|NCT00430495|1467778|P1|Treated|Overall Study||62
600263|NCT00430495|1467775|P4|STARTED|Overall Study||64
600264|NCT00430495|1467776|P3|STARTED|Overall Study||62
600265|NCT00430495|1467777|P2|STARTED|Overall Study||66
600266|NCT00430495|1467778|P1|STARTED|Overall Study||64
600267|NCT00430352|1467816|P1|NOT COMPLETED|Overall Study||138
600268|NCT00430352|1467816|P1|COMPLETED|Overall Study||407
600269|NCT00430352|1467816|P1|STARTED|Overall Study||545
600270|NCT00430300|1467834|P4|NOT COMPLETED|Overall Study||2
600271|NCT00430300|1467835|P3|NOT COMPLETED|Overall Study||6
600272|NCT00430300|1467836|P2|NOT COMPLETED|Overall Study||2
600273|NCT00430300|1467837|P1|NOT COMPLETED|Overall Study||2
600274|NCT00430300|1467834|P4|COMPLETED|Overall Study||15
600275|NCT00430300|1467835|P3|COMPLETED|Overall Study||29
600276|NCT00430300|1467836|P2|COMPLETED|Overall Study||16
600277|NCT00430300|1467837|P1|COMPLETED|Overall Study||15
600278|NCT00430300|1467834|P4|STARTED|Overall Study||17
600279|NCT00430300|1467835|P3|STARTED|Overall Study||35
600280|NCT00430300|1467836|P2|STARTED|Overall Study||18
600281|NCT00430300|1467837|P1|STARTED|Overall Study||17
600282|NCT00430248|1467942|P3|NOT COMPLETED|Overall Study||135
600283|NCT00430248|1467943|P2|NOT COMPLETED|Overall Study||158
600284|NCT00430248|1467944|P1|NOT COMPLETED|Overall Study||125
600285|NCT00430248|1467942|P3|COMPLETED|Overall Study||621
600286|NCT00430248|1467943|P2|COMPLETED|Overall Study||598
600287|NCT00430248|1467944|P1|COMPLETED|Overall Study||632
600288|NCT00430248|1467942|P3|STARTED|Overall Study||756
600289|NCT00430248|1467943|P2|STARTED|Overall Study||756
600290|NCT00430248|1467944|P1|STARTED|Overall Study||757
600291|NCT00430092|1468003|P3|NOT COMPLETED|Overall Study||57
600292|NCT00430092|1468004|P2|NOT COMPLETED|Overall Study||4
600293|NCT00430092|1468005|P1|NOT COMPLETED|Overall Study||6
600294|NCT00430092|1468003|P3|COMPLETED|Overall Study||56
600295|NCT00430092|1468004|P2|COMPLETED|Overall Study||48
600296|NCT00430092|1468005|P1|COMPLETED|Overall Study||48
600297|NCT00430092|1468003|P3|STARTED|Overall Study||113
600298|NCT00430092|1468004|P2|STARTED|Overall Study||52
600299|NCT00430092|1468005|P1|STARTED|Overall Study||54
600300|NCT00430027|1468010|P1|NOT COMPLETED|Overall Study||8
600301|NCT00430027|1468010|P1|COMPLETED|Overall Study||0
600302|NCT00430027|1468010|P1|STARTED|Overall Study||8
600303|NCT00429949|1468014|P1|NOT COMPLETED|Overall Study||0
600304|NCT00429949|1468014|P1|COMPLETED|Overall Study||21
600305|NCT00429949|1468014|P1|STARTED|Overall Study||21
600306|NCT00429923|1468027|P3|NOT COMPLETED|Overall Study||39
600307|NCT00429923|1468028|P2|NOT COMPLETED|Overall Study||4
600308|NCT00429923|1468029|P1|NOT COMPLETED|Overall Study||5
600309|NCT00429923|1468027|P3|COMPLETED|Overall Study||68
600310|NCT00429923|1468028|P2|COMPLETED|Overall Study||51
600311|NCT00429923|1468029|P1|COMPLETED|Overall Study||52
600312|NCT00429923|1468027|P3|STARTED|Overall Study||107
600313|NCT00429923|1468028|P2|STARTED|Overall Study||55
600314|NCT00429923|1468029|P1|STARTED|Overall Study||57
600315|NCT00429793|1468034|P1|NOT COMPLETED|Overall Study||6
600316|NCT00429793|1468034|P1|COMPLETED|Overall Study||54
600317|NCT00429793|1468034|P1|STARTED|Overall Study||60
600318|NCT00429702|1468050|P2|NOT COMPLETED|Overall Study||0
600319|NCT00429702|1468051|P1|NOT COMPLETED|Overall Study||0
600320|NCT00429702|1468050|P2|COMPLETED|Overall Study||4
600321|NCT00429702|1468051|P1|COMPLETED|Overall Study||3
600322|NCT00429702|1468050|P2|STARTED|Overall Study||4
600323|NCT00429702|1468051|P1|STARTED|Overall Study||3
600324|NCT00429663|1468061|P2|NOT COMPLETED|Overall Study||39
600325|NCT00429663|1468062|P1|NOT COMPLETED|Overall Study||36
600326|NCT00429663|1468061|P2|COMPLETED|Overall Study||41
600327|NCT00429663|1468062|P1|COMPLETED|Overall Study||40
600328|NCT00429663|1468061|P2|STARTED|Overall Study||80
600329|NCT00429663|1468062|P1|STARTED|Overall Study||76
600330|NCT00429572|1468076|P1|NOT COMPLETED|Overall Study||1
600331|NCT00429572|1468076|P1|COMPLETED|Overall Study||18
600332|NCT00429572|1468076|P1|STARTED|Overall Study||19
600333|NCT00429507|1468084|P1|NOT COMPLETED|Overall Study||0
600334|NCT00429507|1468084|P1|COMPLETED|Overall Study||12
600335|NCT00429507|1468084|P1|STARTED|Overall Study||12
600336|NCT00429494|1468088|P1|NOT COMPLETED|Overall Study||15
600337|NCT00429494|1468088|P1|COMPLETED|Overall Study||44
600338|NCT00429494|1468088|P1|STARTED|Overall Study||59
600339|NCT00429416|1468092|P1|NOT COMPLETED|Overall Study||1
600340|NCT00429416|1468092|P1|COMPLETED|Overall Study||13
600341|NCT00429416|1468092|P1|STARTED|Overall Study||14
600342|NCT00429403|1468102|P2|NOT COMPLETED|Overall Study||0
600343|NCT00429403|1468103|P1|NOT COMPLETED|Overall Study||0
600344|NCT00429403|1468102|P2|COMPLETED|Overall Study||0
600345|NCT00429403|1468103|P1|COMPLETED|Overall Study||1
600346|NCT00429403|1468102|P2|STARTED|Overall Study||0
600347|NCT00429403|1468103|P1|STARTED|Overall Study||1
600348|NCT00429364|1468111|P2|NOT COMPLETED|Overall Study||33
600349|NCT00429364|1468112|P1|NOT COMPLETED|Overall Study||32
600350|NCT00429364|1468111|P2|COMPLETED|Overall Study||272
600351|NCT00429364|1468112|P1|COMPLETED|Overall Study||271
600352|NCT00429364|1468111|P2|STARTED|Overall Study||305
600353|NCT00429364|1468112|P1|STARTED|Overall Study||303
600354|NCT00429299|1468171|P3|NOT COMPLETED|Overall Study||4
600355|NCT00429299|1468172|P2|NOT COMPLETED|Overall Study||7
600356|NCT00429299|1468173|P1|NOT COMPLETED|Overall Study||4
600357|NCT00429299|1468171|P3|COMPLETED|Overall Study||42
600358|NCT00429299|1468172|P2|COMPLETED|Overall Study||32
600359|NCT00429299|1468173|P1|COMPLETED|Overall Study||32
600360|NCT00429299|1468171|P3|STARTED|Overall Study||46
600361|NCT00429299|1468172|P2|STARTED|Overall Study||39
600362|NCT00429299|1468173|P1|STARTED|Overall Study||36
600363|NCT00429273|1468205|P3|NOT COMPLETED|Overall Study||9
600364|NCT00429273|1468206|P2|NOT COMPLETED|Overall Study||8
600365|NCT00429273|1468207|P1|NOT COMPLETED|Overall Study||8
600366|NCT00429273|1468205|P3|COMPLETED|Overall Study||61
600367|NCT00429273|1468206|P2|COMPLETED|Overall Study||61
600368|NCT00429273|1468207|P1|COMPLETED|Overall Study||60
600369|NCT00429273|1468205|P3|STARTED|Overall Study||70
600370|NCT00429273|1468206|P2|STARTED|Overall Study||69
600371|NCT00429273|1468207|P1|STARTED|Overall Study||68
600372|NCT00429182|1468215|P1|NOT COMPLETED|Overall Study||7
600373|NCT00429182|1468215|P1|COMPLETED|Overall Study||25
600374|NCT00429182|1468215|P1|STARTED|Overall Study||32
600375|NCT00429169|1468222|P2|NOT COMPLETED|Overall Study||2
600376|NCT00429169|1468223|P1|NOT COMPLETED|Overall Study||2
600377|NCT00429169|1468222|P2|COMPLETED|Overall Study|2 subjects excluded: re-diagnosis/ineligibility (1), and did not return after randomization (1).|38
600378|NCT00429169|1468223|P1|COMPLETED|Overall Study|2 subjects excluded due to re-diagnosis/ineligibility.|36
600379|NCT00429169|1468222|P2|STARTED|Overall Study||40
600380|NCT00429169|1468223|P1|STARTED|Overall Study||38
600381|NCT00429143|1468233|P1|NOT COMPLETED|Overall Study||0
600382|NCT00429143|1468233|P1|COMPLETED|Overall Study||27
600383|NCT00429143|1468233|P1|STARTED|Overall Study||27
600384|NCT00429104|1468241|P1|NOT COMPLETED|Overall Study||1
600385|NCT00429104|1468241|P1|COMPLETED|Overall Study||17
600386|NCT00429104|1468241|P1|STARTED|Overall Study||18
600387|NCT00429026|1468246|P1|NOT COMPLETED|Overall Study||40
600388|NCT00429026|1468246|P1|COMPLETED|Overall Study||0
600389|NCT00429026|1468246|P1|STARTED|Overall Study||40
600390|NCT00428974|1468254|P4|NOT COMPLETED|Overall Study||3
600391|NCT00428974|1468255|P3|NOT COMPLETED|Overall Study||1
600392|NCT00428974|1468256|P2|NOT COMPLETED|Overall Study||0
600393|NCT00428974|1468257|P1|NOT COMPLETED|Overall Study||8
600394|NCT00428974|1468254|P4|COMPLETED|Overall Study||16
600395|NCT00428974|1468255|P3|COMPLETED|Overall Study||14
600396|NCT00428974|1468256|P2|COMPLETED|Overall Study||17
600397|NCT00428974|1468257|P1|COMPLETED|Overall Study||17
600398|NCT00428974|1468254|P4|STARTED|Overall Study||19
600399|NCT00428974|1468255|P3|STARTED|Overall Study||15
600400|NCT00428974|1468256|P2|STARTED|Overall Study||17
600401|NCT00428974|1468257|P1|STARTED|Overall Study|one patient was randomized but never received study treatment|25
600402|NCT00428948|1468273|P2|NOT COMPLETED|Overall Study||67
600403|NCT00428948|1468274|P1|NOT COMPLETED|Overall Study||221
600404|NCT00428948|1468273|P2|COMPLETED|Overall Study||417
600405|NCT00428948|1468274|P1|COMPLETED|Overall Study||740
600406|NCT00428948|1468273|P2|Received Treatment|Overall Study||483
600407|NCT00428948|1468274|P1|Received Treatment|Overall Study||961
600408|NCT00428948|1468273|P2|STARTED|Overall Study||484
600409|NCT00428948|1468274|P1|STARTED|Overall Study||961
600410|NCT00428922|1468292|P1|NOT COMPLETED|Overall Study||0
600411|NCT00428922|1468292|P1|COMPLETED|Overall Study||26
600412|NCT00428922|1468292|P1|STARTED|Overall Study||26
600413|NCT00428844|1468302|P3|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2
600414|NCT00428844|1468303|P2|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2
600415|NCT00428844|1468304|P1|NOT COMPLETED|Completed Test of Cure (TOC) Visit||3
600416|NCT00428844|1468302|P3|COMPLETED|Completed Test of Cure (TOC) Visit||17
600417|NCT00428844|1468303|P2|COMPLETED|Completed Test of Cure (TOC) Visit||16
600418|NCT00428844|1468304|P1|COMPLETED|Completed Test of Cure (TOC) Visit||20
600419|NCT00428844|1468302|P3|STARTED|Completed Test of Cure (TOC) Visit||19
600420|NCT00428844|1468303|P2|STARTED|Completed Test of Cure (TOC) Visit||18
600421|NCT00428844|1468304|P1|STARTED|Completed Test of Cure (TOC) Visit||23
600422|NCT00428844|1468302|P3|NOT COMPLETED|Completed Study Drug Treatment||7
600423|NCT00428844|1468303|P2|NOT COMPLETED|Completed Study Drug Treatment||6
600424|NCT00428844|1468304|P1|NOT COMPLETED|Completed Study Drug Treatment||2
600425|NCT00428844|1468302|P3|COMPLETED|Completed Study Drug Treatment||19
600426|NCT00428844|1468303|P2|COMPLETED|Completed Study Drug Treatment||18
600427|NCT00428844|1468304|P1|COMPLETED|Completed Study Drug Treatment||23
600428|NCT00428844|1468302|P3|Received First Dose|Completed Study Drug Treatment||25
600429|NCT00428844|1468303|P2|Received First Dose|Completed Study Drug Treatment||24
600430|NCT00428844|1468304|P1|Received First Dose|Completed Study Drug Treatment||25
600431|NCT00428844|1468302|P3|STARTED|Completed Study Drug Treatment||26
600432|NCT00428844|1468303|P2|STARTED|Completed Study Drug Treatment||24
600433|NCT00428844|1468304|P1|STARTED|Completed Study Drug Treatment||25
600434|NCT00428792|1468327|P2|NOT COMPLETED|Overall Study||4
600435|NCT00428792|1468328|P1|NOT COMPLETED|Overall Study||1
600436|NCT00428792|1468327|P2|COMPLETED|Overall Study|Information is not available during which cross-over period patients discontinued.|66
600437|NCT00428792|1468328|P1|COMPLETED|Overall Study|Information is not available during which cross-over period patients discontinued.|79
600438|NCT00428792|1468327|P2|STARTED|Overall Study||70
600439|NCT00428792|1468328|P1|STARTED|Overall Study||80
600440|NCT00428610|1468355|P3|NOT COMPLETED|Overall Study||32
600441|NCT00428610|1468356|P2|NOT COMPLETED|Overall Study||18
600442|NCT00428610|1468357|P1|NOT COMPLETED|Overall Study||53
600443|NCT00428610|1468355|P3|COMPLETED|Overall Study||0
600444|NCT00428610|1468356|P2|COMPLETED|Overall Study||0
600445|NCT00428610|1468357|P1|COMPLETED|Overall Study||0
600446|NCT00428610|1468355|P3|Received at Least One Dose of Study Drug|Overall Study||32
600447|NCT00428610|1468356|P2|Received at Least One Dose of Study Drug|Overall Study||18
600448|NCT00428610|1468357|P1|Received at Least One Dose of Study Drug|Overall Study||53
600449|NCT00428610|1468355|P3|STARTED|Overall Study||32
600450|NCT00428610|1468356|P2|STARTED|Overall Study||18
600451|NCT00428610|1468357|P1|STARTED|Overall Study||53
600452|NCT00428597|1468391|P2|NOT COMPLETED|Overall Study||85
600453|NCT00428597|1468392|P1|NOT COMPLETED|Overall Study||86
600454|NCT00428597|1468391|P2|COMPLETED|Overall Study||0
600455|NCT00428597|1468392|P1|COMPLETED|Overall Study||0
600456|NCT00428597|1468391|P2|Received Treatment|Overall Study||82
600457|NCT00428597|1468392|P1|Received Treatment|Overall Study||83
600458|NCT00428597|1468391|P2|STARTED|Overall Study||85
600459|NCT00428597|1468392|P1|STARTED|Overall Study||86
600460|NCT00428584|1468434|P2|NOT COMPLETED|Extension Phase||29
600461|NCT00428584|1468435|P1|NOT COMPLETED|Extension Phase||21
600462|NCT00428584|1468434|P2|COMPLETED|Extension Phase||34
600463|NCT00428584|1468435|P1|COMPLETED|Extension Phase||35
600464|NCT00428584|1468434|P2|STARTED|Extension Phase||63
600465|NCT00428584|1468435|P1|STARTED|Extension Phase|Extension Phase - new formulation of rebif to new formulation of rebif|56
600466|NCT00428584|1468434|P2|NOT COMPLETED|Comparative Phase||1
600467|NCT00428584|1468435|P1|NOT COMPLETED|Comparative Phase||9
600468|NCT00428584|1468434|P2|COMPLETED|Comparative Phase||63
600469|NCT00428584|1468435|P1|COMPLETED|Comparative Phase|Comparator Phase - new formulation of rebif and Betaseron|56
600470|NCT00428584|1468434|P2|STARTED|Comparative Phase||64
600471|NCT00428584|1468435|P1|STARTED|Comparative Phase||65
600472|NCT00428441|1468459|P1|NOT COMPLETED|Overall Study||1
600473|NCT00428441|1468459|P1|COMPLETED|Overall Study||74
600474|NCT00428441|1468459|P1|STARTED|Overall Study||75
600475|NCT00428389|1468465|P2|NOT COMPLETED|Extension Phase||26
600476|NCT00428389|1468466|P1|NOT COMPLETED|Extension Phase||32
600477|NCT00428389|1468465|P2|COMPLETED|Extension Phase||91
600478|NCT00428389|1468466|P1|COMPLETED|Extension Phase||85
600479|NCT00428389|1468465|P2|STARTED|Extension Phase||117
600480|NCT00428389|1468466|P1|STARTED|Extension Phase|Participants were required to sign a separate informed consent prior to entering the extension phase|117
600481|NCT00428389|1468465|P2|NOT COMPLETED|Core Phase||11
600482|NCT00428389|1468466|P1|NOT COMPLETED|Core Phase||11
600483|NCT00428389|1468465|P2|COMPLETED|Core Phase||120
600484|NCT00428389|1468466|P1|COMPLETED|Core Phase||120
600485|NCT00428389|1468465|P2|Intent-to-treat Population|Core Phase|1 patient was discontinued from the study the same day as randomization & excluded from all analyses|130
600486|NCT00428389|1468466|P1|Intent-to-treat Population|Core Phase||131
600487|NCT00428389|1468465|P2|STARTED|Core Phase||131
600488|NCT00428389|1468466|P1|STARTED|Core Phase||131
600489|NCT00428298|1468486|P2|NOT COMPLETED|Overall Study||11
600490|NCT00428298|1468487|P1|NOT COMPLETED|Overall Study||14
600491|NCT00428298|1468486|P2|COMPLETED|Overall Study||19
600492|NCT00428298|1468487|P1|COMPLETED|Overall Study||16
600493|NCT00428298|1468486|P2|Second RBANS at Study Exit|Overall Study||3
600494|NCT00428298|1468487|P1|Second RBANS at Study Exit|Overall Study||3
600495|NCT00428298|1468486|P2|STARTED|Overall Study||30
600496|NCT00428298|1468487|P1|STARTED|Overall Study||30
600497|NCT00428246|1468500|P3|NOT COMPLETED|Overall Study||1
600498|NCT00428246|1468501|P2|NOT COMPLETED|Overall Study||0
600499|NCT00428246|1468502|P1|NOT COMPLETED|Overall Study||1
600500|NCT00428246|1468500|P3|COMPLETED|Overall Study||7
600501|NCT00428246|1468501|P2|COMPLETED|Overall Study||8
600502|NCT00428246|1468502|P1|COMPLETED|Overall Study||7
600503|NCT00428246|1468500|P3|STARTED|Overall Study||8
600504|NCT00428246|1468501|P2|STARTED|Overall Study||8
600505|NCT00428246|1468502|P1|STARTED|Overall Study||8
600506|NCT00428220|1468510|P1|NOT COMPLETED|Overall Study||223
600507|NCT00428220|1468510|P1|COMPLETED|Overall Study||0
600508|NCT00428220|1468510|P1|STARTED|Overall Study||223
600509|NCT00428207|1468526|P2|NOT COMPLETED|Overall Study||0
600510|NCT00428207|1468527|P1|NOT COMPLETED|Overall Study||0
600511|NCT00428207|1468526|P2|COMPLETED|Overall Study||2
600512|NCT00428207|1468527|P1|COMPLETED|Overall Study||2
600513|NCT00428207|1468526|P2|STARTED|Overall Study||2
600514|NCT00428207|1468527|P1|STARTED|Overall Study||2
600515|NCT00428116|1468535|P2|NOT COMPLETED|Overall Study||0
600516|NCT00428116|1468536|P1|NOT COMPLETED|Overall Study||3
600517|NCT00428116|1468535|P2|COMPLETED|Overall Study||21
600518|NCT00428116|1468536|P1|COMPLETED|Overall Study||18
600519|NCT00428116|1468535|P2|STARTED|Overall Study||21
600520|NCT00428116|1468536|P1|STARTED|Overall Study||21
600521|NCT00428090|1468548|P4|NOT COMPLETED|Overall Study||28
600522|NCT00428090|1468549|P3|NOT COMPLETED|Overall Study||38
600523|NCT00428090|1468550|P2|NOT COMPLETED|Overall Study||31
600524|NCT00428090|1468551|P1|NOT COMPLETED|Overall Study||34
600525|NCT00428090|1468548|P4|COMPLETED|Overall Study||55
600526|NCT00428090|1468549|P3|COMPLETED|Overall Study||127
600527|NCT00428090|1468550|P2|COMPLETED|Overall Study||135
600528|NCT00428090|1468551|P1|COMPLETED|Overall Study||131
600529|NCT00428090|1468548|P4|STARTED|Overall Study||83
600530|NCT00428090|1468549|P3|STARTED|Overall Study||165
600531|NCT00428090|1468550|P2|STARTED|Overall Study||166
600532|NCT00428090|1468551|P1|STARTED|Overall Study||165
600533|NCT00428077|1468665|P1|NOT COMPLETED|Overall Study||0
600534|NCT00428077|1468665|P1|COMPLETED|Overall Study||4
600535|NCT00428077|1468665|P1|STARTED|Overall Study||4
600536|NCT00427999|1468669|P1|NOT COMPLETED|Overall Study||32
600537|NCT00427999|1468669|P1|COMPLETED|Overall Study||33
600538|NCT00427999|1468669|P1|Extension Follow-up|Overall Study||19
600539|NCT00427999|1468669|P1|Intent to Treat (ITT)|Overall Study||61
600540|NCT00427999|1468669|P1|STARTED|Overall Study||65
600541|NCT00427973|1468678|P1|NOT COMPLETED|Overall Study||0
600542|NCT00427973|1468678|P1|COMPLETED|Overall Study||17
600543|NCT00427973|1468678|P1|STARTED|Overall Study||17
600544|NCT00427960|1468687|P2|NOT COMPLETED|Overall Study||4
600545|NCT00427960|1468688|P1|NOT COMPLETED|Overall Study||2
600546|NCT00427960|1468687|P2|COMPLETED|Overall Study||21
600547|NCT00427960|1468688|P1|COMPLETED|Overall Study||28
600548|NCT00427960|1468687|P2|STARTED|Overall Study||25
600549|NCT00427960|1468688|P1|STARTED|Overall Study||30
600550|NCT00427934|1468726|P4|NOT COMPLETED|Overall Study||15
600551|NCT00427934|1468727|P3|NOT COMPLETED|Overall Study||23
600552|NCT00427934|1468728|P2|NOT COMPLETED|Overall Study||0
600553|NCT00427934|1468729|P1|NOT COMPLETED|Overall Study||1
600554|NCT00427934|1468726|P4|COMPLETED|Overall Study||19
600555|NCT00427934|1468727|P3|COMPLETED|Overall Study||55
600556|NCT00427934|1468728|P2|COMPLETED|Overall Study||8
600557|NCT00427934|1468729|P1|COMPLETED|Overall Study||7
600558|NCT00427934|1468726|P4|Treated|Overall Study||33
600559|NCT00427934|1468727|P3|Treated|Overall Study||77
600560|NCT00427934|1468728|P2|Treated|Overall Study||8
600561|NCT00427934|1468729|P1|Treated|Overall Study||8
600562|NCT00427934|1468726|P4|STARTED|Overall Study||34
600563|NCT00427934|1468727|P3|STARTED|Overall Study||78
600564|NCT00427934|1468728|P2|STARTED|Overall Study||8
600565|NCT00427934|1468729|P1|STARTED|Overall Study||8
600566|NCT00427921|1468797|P1|NOT COMPLETED|Overall Study||50
600567|NCT00427921|1468797|P1|COMPLETED|Overall Study||254
600568|NCT00427921|1468797|P1|STARTED|Overall Study||304
600569|NCT00427908|1468820|P4|NOT COMPLETED|Persistence Phase Year 5||0
600570|NCT00427908|1468821|P3|NOT COMPLETED|Persistence Phase Year 5||0
600571|NCT00427908|1468822|P2|NOT COMPLETED|Persistence Phase Year 5||0
600572|NCT00427908|1468823|P1|NOT COMPLETED|Persistence Phase Year 5||0
600573|NCT00427908|1468820|P4|COMPLETED|Persistence Phase Year 5||13
600574|NCT00427908|1468821|P3|COMPLETED|Persistence Phase Year 5||12
600575|NCT00427908|1468822|P2|COMPLETED|Persistence Phase Year 5||99
600576|NCT00427908|1468823|P1|COMPLETED|Persistence Phase Year 5||52
600577|NCT00427908|1468820|P4|STARTED|Persistence Phase Year 5||13
600578|NCT00427908|1468821|P3|STARTED|Persistence Phase Year 5||12
600579|NCT00427908|1468822|P2|STARTED|Persistence Phase Year 5||99
600580|NCT00427908|1468823|P1|STARTED|Persistence Phase Year 5||52
600581|NCT00427908|1468820|P4|NOT COMPLETED|Persistence Phase Year 4||0
600582|NCT00427908|1468821|P3|NOT COMPLETED|Persistence Phase Year 4||0
600583|NCT00427908|1468822|P2|NOT COMPLETED|Persistence Phase Year 4||0
600584|NCT00427908|1468823|P1|NOT COMPLETED|Persistence Phase Year 4||0
600585|NCT00427908|1468820|P4|COMPLETED|Persistence Phase Year 4||32
600586|NCT00427908|1468821|P3|COMPLETED|Persistence Phase Year 4||34
600587|NCT00427908|1468822|P2|COMPLETED|Persistence Phase Year 4||192
600588|NCT00427908|1468823|P1|COMPLETED|Persistence Phase Year 4||165
600589|NCT00427908|1468820|P4|STARTED|Persistence Phase Year 4||32
600590|NCT00427908|1468821|P3|STARTED|Persistence Phase Year 4||34
600591|NCT00427908|1468822|P2|STARTED|Persistence Phase Year 4||192
600592|NCT00427908|1468823|P1|STARTED|Persistence Phase Year 4||165
600593|NCT00427908|1468820|P4|NOT COMPLETED|Persistence Phase Year 3||0
600594|NCT00427908|1468821|P3|NOT COMPLETED|Persistence Phase Year 3||0
600595|NCT00427908|1468822|P2|NOT COMPLETED|Persistence Phase Year 3||0
600596|NCT00427908|1468823|P1|NOT COMPLETED|Persistence Phase Year 3||0
600597|NCT00427908|1468820|P4|COMPLETED|Persistence Phase Year 3||38
600598|NCT00427908|1468821|P3|COMPLETED|Persistence Phase Year 3||38
600599|NCT00427908|1468822|P2|COMPLETED|Persistence Phase Year 3||201
600600|NCT00427908|1468823|P1|COMPLETED|Persistence Phase Year 3||185
600601|NCT00427908|1468820|P4|STARTED|Persistence Phase Year 3||38
600602|NCT00427908|1468821|P3|STARTED|Persistence Phase Year 3||38
600603|NCT00427908|1468822|P2|STARTED|Persistence Phase Year 3||201
600604|NCT00427908|1468823|P1|STARTED|Persistence Phase Year 3||185
600605|NCT00427908|1468820|P4|NOT COMPLETED|Persistence Phase Year 2||0
600606|NCT00427908|1468821|P3|NOT COMPLETED|Persistence Phase Year 2||0
600607|NCT00427908|1468822|P2|NOT COMPLETED|Persistence Phase Year 2||0
600608|NCT00427908|1468823|P1|NOT COMPLETED|Persistence Phase Year 2||0
600609|NCT00427908|1468820|P4|COMPLETED|Persistence Phase Year 2||61
600610|NCT00427908|1468821|P3|COMPLETED|Persistence Phase Year 2||53
600611|NCT00427908|1468822|P2|COMPLETED|Persistence Phase Year 2||215
600612|NCT00427908|1468823|P1|COMPLETED|Persistence Phase Year 2||208
600613|NCT00427908|1468820|P4|STARTED|Persistence Phase Year 2||61
600614|NCT00427908|1468821|P3|STARTED|Persistence Phase Year 2||53
600615|NCT00427908|1468822|P2|STARTED|Persistence Phase Year 2||215
600616|NCT00427908|1468823|P1|STARTED|Persistence Phase Year 2||208
600617|NCT00427908|1468820|P4|NOT COMPLETED|Persistence Phase Year 1||0
600618|NCT00427908|1468821|P3|NOT COMPLETED|Persistence Phase Year 1||0
600619|NCT00427908|1468822|P2|NOT COMPLETED|Persistence Phase Year 1||0
600620|NCT00427908|1468823|P1|NOT COMPLETED|Persistence Phase Year 1||0
600621|NCT00427908|1468820|P4|COMPLETED|Persistence Phase Year 1||78
600622|NCT00427908|1468821|P3|COMPLETED|Persistence Phase Year 1||71
600623|NCT00427908|1468822|P2|COMPLETED|Persistence Phase Year 1||221
600624|NCT00427908|1468823|P1|COMPLETED|Persistence Phase Year 1||222
600625|NCT00427908|1468820|P4|STARTED|Persistence Phase Year 1||78
600626|NCT00427908|1468821|P3|STARTED|Persistence Phase Year 1||71
600627|NCT00427908|1468822|P2|STARTED|Persistence Phase Year 1||221
600628|NCT00427908|1468823|P1|STARTED|Persistence Phase Year 1||222
600629|NCT00427908|1468820|P4|NOT COMPLETED|Primary Phase||0
600630|NCT00427908|1468821|P3|NOT COMPLETED|Primary Phase||3
600631|NCT00427908|1468822|P2|NOT COMPLETED|Primary Phase||3
600632|NCT00427908|1468823|P1|NOT COMPLETED|Primary Phase||5
600633|NCT00427908|1468820|P4|COMPLETED|Primary Phase||78
600634|NCT00427908|1468821|P3|COMPLETED|Primary Phase||72
600635|NCT00427908|1468822|P2|COMPLETED|Primary Phase||228
600636|NCT00427908|1468823|P1|COMPLETED|Primary Phase||224
600637|NCT00427908|1468820|P4|STARTED|Primary Phase||78
600638|NCT00427908|1468821|P3|STARTED|Primary Phase||75
600639|NCT00427908|1468822|P2|STARTED|Primary Phase||231
600640|NCT00427908|1468823|P1|STARTED|Primary Phase||229
600641|NCT00427895|1469023|P8|NOT COMPLETED|Vax 2/Year 3 to 4||2
600642|NCT00427895|1469024|P7|NOT COMPLETED|Vax 2/Year 3 to 4||0
600643|NCT00427895|1469025|P6|NOT COMPLETED|Vax 2/Year 3 to 4||0
600644|NCT00427895|1469026|P5|NOT COMPLETED|Vax 2/Year 3 to 4||1
600645|NCT00427895|1469027|P4|NOT COMPLETED|Vax 2/Year 3 to 4||0
600646|NCT00427895|1469028|P3|NOT COMPLETED|Vax 2/Year 3 to 4||0
600647|NCT00427895|1469029|P2|NOT COMPLETED|Vax 2/Year 3 to 4||0
600648|NCT00427895|1469030|P1|NOT COMPLETED|Vax 2/Year 3 to 4||0
600649|NCT00427895|1469023|P8|COMPLETED|Vax 2/Year 3 to 4||212
600650|NCT00427895|1469024|P7|COMPLETED|Vax 2/Year 3 to 4||189
600651|NCT00427895|1469025|P6|COMPLETED|Vax 2/Year 3 to 4||108
600652|NCT00427895|1469026|P5|COMPLETED|Vax 2/Year 3 to 4||107
600653|NCT00427895|1469027|P4|COMPLETED|Vax 2/Year 3 to 4||0
600654|NCT00427895|1469028|P3|COMPLETED|Vax 2/Year 3 to 4||0
600655|NCT00427895|1469029|P2|COMPLETED|Vax 2/Year 3 to 4||0
600656|NCT00427895|1469030|P1|COMPLETED|Vax 2/Year 3 to 4||0
600657|NCT00427895|1469023|P8|STARTED|Vax 2/Year 3 to 4||214
600658|NCT00427895|1469024|P7|STARTED|Vax 2/Year 3 to 4||189
600659|NCT00427895|1469025|P6|STARTED|Vax 2/Year 3 to 4||108
600660|NCT00427895|1469026|P5|STARTED|Vax 2/Year 3 to 4||108
600661|NCT00427895|1469027|P4|STARTED|Vax 2/Year 3 to 4||0
600662|NCT00427895|1469028|P3|STARTED|Vax 2/Year 3 to 4||0
600663|NCT00427895|1469029|P2|STARTED|Vax 2/Year 3 to 4||0
600664|NCT00427895|1469030|P1|STARTED|Vax 2/Year 3 to 4||0
600665|NCT00427895|1469023|P8|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
600666|NCT00427895|1469024|P7|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
600667|NCT00427895|1469025|P6|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
600668|NCT00427895|1469026|P5|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
600669|NCT00427895|1469027|P4|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||469
600670|NCT00427895|1469028|P3|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||159
600671|NCT00427895|1469029|P2|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||207
600672|NCT00427895|1469030|P1|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||188
600673|NCT00427895|1469023|P8|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
600674|NCT00427895|1469024|P7|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
600675|NCT00427895|1469025|P6|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
600676|NCT00427895|1469026|P5|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
600677|NCT00427895|1469027|P4|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
600678|NCT00427895|1469028|P3|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||214
600679|NCT00427895|1469029|P2|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||189
600680|NCT00427895|1469030|P1|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||216
600681|NCT00427895|1469023|P8|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
600682|NCT00427895|1469024|P7|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
600683|NCT00427895|1469025|P6|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
600684|NCT00427895|1469026|P5|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
600685|NCT00427895|1469027|P4|STARTED|Between Year 1 - Vax 2/Year 3 to 4||469
600686|NCT00427895|1469028|P3|STARTED|Between Year 1 - Vax 2/Year 3 to 4||373
600687|NCT00427895|1469029|P2|STARTED|Between Year 1 - Vax 2/Year 3 to 4||396
600688|NCT00427895|1469030|P1|STARTED|Between Year 1 - Vax 2/Year 3 to 4||404
600689|NCT00427895|1469023|P8|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
600690|NCT00427895|1469024|P7|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
600691|NCT00427895|1469025|P6|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
600692|NCT00427895|1469026|P5|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
600693|NCT00427895|1469027|P4|NOT COMPLETED|Vax 1/Year 1 Follow-up||33
600694|NCT00427895|1469028|P3|NOT COMPLETED|Vax 1/Year 1 Follow-up||19
600695|NCT00427895|1469029|P2|NOT COMPLETED|Vax 1/Year 1 Follow-up||15
600696|NCT00427895|1469030|P1|NOT COMPLETED|Vax 1/Year 1 Follow-up||7
600697|NCT00427895|1469023|P8|COMPLETED|Vax 1/Year 1 Follow-up||0
600698|NCT00427895|1469024|P7|COMPLETED|Vax 1/Year 1 Follow-up||0
600699|NCT00427895|1469025|P6|COMPLETED|Vax 1/Year 1 Follow-up||0
600700|NCT00427895|1469026|P5|COMPLETED|Vax 1/Year 1 Follow-up||0
600701|NCT00427895|1469027|P4|COMPLETED|Vax 1/Year 1 Follow-up||469
600702|NCT00427895|1469028|P3|COMPLETED|Vax 1/Year 1 Follow-up||373
600703|NCT00427895|1469029|P2|COMPLETED|Vax 1/Year 1 Follow-up||396
600704|NCT00427895|1469030|P1|COMPLETED|Vax 1/Year 1 Follow-up||404
600705|NCT00427895|1469023|P8|STARTED|Vax 1/Year 1 Follow-up||0
600706|NCT00427895|1469024|P7|STARTED|Vax 1/Year 1 Follow-up||0
600707|NCT00427895|1469025|P6|STARTED|Vax 1/Year 1 Follow-up||0
600708|NCT00427895|1469026|P5|STARTED|Vax 1/Year 1 Follow-up||0
600709|NCT00427895|1469027|P4|STARTED|Vax 1/Year 1 Follow-up||502
600710|NCT00427895|1469028|P3|STARTED|Vax 1/Year 1 Follow-up||392
600711|NCT00427895|1469029|P2|STARTED|Vax 1/Year 1 Follow-up||411
600712|NCT00427895|1469030|P1|STARTED|Vax 1/Year 1 Follow-up||411
600713|NCT00427895|1469023|P8|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
600714|NCT00427895|1469024|P7|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
600715|NCT00427895|1469025|P6|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
600716|NCT00427895|1469026|P5|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
600717|NCT00427895|1469027|P4|NOT COMPLETED|Between 6-Month Follow-up - Year 1||352
600718|NCT00427895|1469028|P3|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
600719|NCT00427895|1469029|P2|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
600720|NCT00427895|1469030|P1|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
600721|NCT00427895|1469023|P8|COMPLETED|Between 6-Month Follow-up - Year 1||0
600722|NCT00427895|1469024|P7|COMPLETED|Between 6-Month Follow-up - Year 1||0
600723|NCT00427895|1469025|P6|COMPLETED|Between 6-Month Follow-up - Year 1||0
600724|NCT00427895|1469026|P5|COMPLETED|Between 6-Month Follow-up - Year 1||0
600725|NCT00427895|1469027|P4|COMPLETED|Between 6-Month Follow-up - Year 1||502
600726|NCT00427895|1469028|P3|COMPLETED|Between 6-Month Follow-up - Year 1||392
600727|NCT00427895|1469029|P2|COMPLETED|Between 6-Month Follow-up - Year 1||411
600728|NCT00427895|1469030|P1|COMPLETED|Between 6-Month Follow-up - Year 1||411
600729|NCT00427895|1469023|P8|STARTED|Between 6-Month Follow-up - Year 1||0
600730|NCT00427895|1469024|P7|STARTED|Between 6-Month Follow-up - Year 1||0
600731|NCT00427895|1469025|P6|STARTED|Between 6-Month Follow-up - Year 1||0
600732|NCT00427895|1469026|P5|STARTED|Between 6-Month Follow-up - Year 1||0
600733|NCT00427895|1469027|P4|STARTED|Between 6-Month Follow-up - Year 1||854
600734|NCT00427895|1469028|P3|STARTED|Between 6-Month Follow-up - Year 1||392
600735|NCT00427895|1469029|P2|STARTED|Between 6-Month Follow-up - Year 1||411
600736|NCT00427895|1469030|P1|STARTED|Between 6-Month Follow-up - Year 1||411
600737|NCT00427895|1469023|P8|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
600738|NCT00427895|1469024|P7|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
600739|NCT00427895|1469025|P6|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
600740|NCT00427895|1469026|P5|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
600741|NCT00427895|1469027|P4|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||46
600742|NCT00427895|1469028|P3|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||14
600743|NCT00427895|1469029|P2|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||6
600744|NCT00427895|1469030|P1|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||7
600745|NCT00427895|1469023|P8|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
600746|NCT00427895|1469024|P7|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
600747|NCT00427895|1469025|P6|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
600748|NCT00427895|1469026|P5|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
600749|NCT00427895|1469027|P4|COMPLETED|Vax 1 Baseline/6-Month Follow-up||854
600750|NCT00427895|1469028|P3|COMPLETED|Vax 1 Baseline/6-Month Follow-up||392
600751|NCT00427895|1469029|P2|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411
600752|NCT00427895|1469030|P1|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411
600753|NCT00427895|1469023|P8|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
600754|NCT00427895|1469024|P7|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
600755|NCT00427895|1469025|P6|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
600756|NCT00427895|1469026|P5|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
600757|NCT00427895|1469027|P4|Vaccinated|Vax 1 Baseline/6-Month Follow-up||899
600758|NCT00427895|1469028|P3|Vaccinated|Vax 1 Baseline/6-Month Follow-up||404
600759|NCT00427895|1469029|P2|Vaccinated|Vax 1 Baseline/6-Month Follow-up||414
600760|NCT00427895|1469030|P1|Vaccinated|Vax 1 Baseline/6-Month Follow-up||417
600761|NCT00427895|1469023|P8|STARTED|Vax 1 Baseline/6-Month Follow-up||0
600762|NCT00427895|1469024|P7|STARTED|Vax 1 Baseline/6-Month Follow-up||0
600763|NCT00427895|1469025|P6|STARTED|Vax 1 Baseline/6-Month Follow-up||0
600764|NCT00427895|1469026|P5|STARTED|Vax 1 Baseline/6-Month Follow-up||0
600765|NCT00427895|1469027|P4|STARTED|Vax 1 Baseline/6-Month Follow-up||900
600766|NCT00427895|1469028|P3|STARTED|Vax 1 Baseline/6-Month Follow-up||406
600767|NCT00427895|1469029|P2|STARTED|Vax 1 Baseline/6-Month Follow-up||417
600768|NCT00427895|1469030|P1|STARTED|Vax 1 Baseline/6-Month Follow-up||418
600769|NCT00427804|1469087|P2|NOT COMPLETED|Overall Study||0
600770|NCT00427804|1469088|P1|NOT COMPLETED|Overall Study||0
600771|NCT00427804|1469087|P2|COMPLETED|Overall Study||5
600772|NCT00427804|1469088|P1|COMPLETED|Overall Study||4
600773|NCT00427804|1469087|P2|STARTED|Overall Study||5
600774|NCT00427804|1469088|P1|STARTED|Overall Study||4
600775|NCT00427791|1469096|P2|NOT COMPLETED|Overall Study||0
600776|NCT00427791|1469097|P1|NOT COMPLETED|Overall Study||0
600777|NCT00427791|1469096|P2|COMPLETED|Overall Study||13
600778|NCT00427791|1469097|P1|COMPLETED|Overall Study||10
600779|NCT00427791|1469096|P2|STARTED|Overall Study||13
600780|NCT00427791|1469097|P1|STARTED|Overall Study||10
600781|NCT00427778|1469105|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
600782|NCT00427778|1469106|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
600783|NCT00427778|1469105|P2|COMPLETED|Second Intervention (4 Weeks)||14
600784|NCT00427778|1469106|P1|COMPLETED|Second Intervention (4 Weeks)||10
600785|NCT00427778|1469105|P2|STARTED|Second Intervention (4 Weeks)||14
600786|NCT00427778|1469106|P1|STARTED|Second Intervention (4 Weeks)||10
600787|NCT00427778|1469105|P2|NOT COMPLETED|Wash Out (2 Weeks)||0
600788|NCT00427778|1469106|P1|NOT COMPLETED|Wash Out (2 Weeks)||0
600789|NCT00427778|1469105|P2|COMPLETED|Wash Out (2 Weeks)||14
600790|NCT00427778|1469106|P1|COMPLETED|Wash Out (2 Weeks)||10
600791|NCT00427778|1469105|P2|STARTED|Wash Out (2 Weeks)||14
600792|NCT00427778|1469106|P1|STARTED|Wash Out (2 Weeks)||10
600793|NCT00427778|1469105|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
600794|NCT00427778|1469106|P1|NOT COMPLETED|First Intervention (4 Weeks)||4
600795|NCT00427778|1469105|P2|COMPLETED|First Intervention (4 Weeks)||14
600796|NCT00427778|1469106|P1|COMPLETED|First Intervention (4 Weeks)||10
600797|NCT00427778|1469105|P2|STARTED|First Intervention (4 Weeks)||15
600798|NCT00427778|1469106|P1|STARTED|First Intervention (4 Weeks)||14
600799|NCT00427765|1469125|P1|NOT COMPLETED|Overall Study||0
600800|NCT00427765|1469125|P1|COMPLETED|Overall Study||164
600801|NCT00427765|1469125|P1|STARTED|Overall Study||164
600802|NCT00427700|1469131|P2|NOT COMPLETED|Overall Study||11
600803|NCT00427700|1469132|P1|NOT COMPLETED|Overall Study||3
600804|NCT00427700|1469131|P2|COMPLETED|Overall Study||31
600805|NCT00427700|1469132|P1|COMPLETED|Overall Study||37
600806|NCT00427700|1469131|P2|STARTED|Overall Study||42
600807|NCT00427700|1469132|P1|STARTED|Overall Study||40
600808|NCT00427661|1469140|P1|NOT COMPLETED|Overall Study||0
600809|NCT00427661|1469140|P1|COMPLETED|Overall Study||8
600810|NCT00427661|1469140|P1|STARTED|Overall Study||8
600811|NCT00427635|1469148|P2|NOT COMPLETED|Study Completion to Safety Follow-up||1
600812|NCT00427635|1469149|P1|NOT COMPLETED|Study Completion to Safety Follow-up||0
600813|NCT00427635|1469148|P2|COMPLETED|Study Completion to Safety Follow-up|One participant lost to follow-up|25
600814|NCT00427635|1469149|P1|COMPLETED|Study Completion to Safety Follow-up||25
600815|NCT00427635|1469148|P2|STARTED|Study Completion to Safety Follow-up||26
600816|NCT00427635|1469149|P1|STARTED|Study Completion to Safety Follow-up||25
600817|NCT00427635|1469148|P2|NOT COMPLETED|Treatment Phase||0
600818|NCT00427635|1469149|P1|NOT COMPLETED|Treatment Phase||1
600819|NCT00427635|1469148|P2|COMPLETED|Treatment Phase|ITT population|26
600820|NCT00427635|1469149|P1|COMPLETED|Treatment Phase|ITT population. One voluntary discontinuation by parent/guardian|25
600821|NCT00427635|1469148|P2|STARTED|Treatment Phase|Randomised|26
600822|NCT00427635|1469149|P1|STARTED|Treatment Phase|Randomised|26
600823|NCT00427557|1469177|P1|NOT COMPLETED|Overall Study||0
600824|NCT00427557|1469177|P1|COMPLETED|Overall Study||30
600825|NCT00427557|1469177|P1|STARTED|Overall Study||30
600826|NCT00427349|1469181|P1|NOT COMPLETED|Overall Study||46
600827|NCT00427349|1469181|P1|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity|0
600828|NCT00427349|1469181|P1|Eligible and Treated|Overall Study||44
600829|NCT00427349|1469181|P1|Treated|Overall Study||45
600830|NCT00427349|1469181|P1|Eligible|Overall Study||45
600831|NCT00427349|1469181|P1|STARTED|Overall Study||46
600832|NCT00427336|1469187|P1|NOT COMPLETED|Overall Study||0
600833|NCT00427336|1469187|P1|COMPLETED|Overall Study||9
600834|NCT00427336|1469187|P1|STARTED|Overall Study||9
600835|NCT00427037|1469193|P2|NOT COMPLETED|Overall Study||7
600836|NCT00427037|1469194|P1|NOT COMPLETED|Overall Study||7
600837|NCT00427037|1469193|P2|COMPLETED|Overall Study||10
600838|NCT00427037|1469194|P1|COMPLETED|Overall Study||10
600839|NCT00427037|1469193|P2|STARTED|Overall Study||17
600840|NCT00427037|1469194|P1|STARTED|Overall Study||17
600841|NCT00427011|1469202|P1|NOT COMPLETED|Overall Study||25
600842|NCT00427011|1469202|P1|COMPLETED|Overall Study||0
600843|NCT00427011|1469202|P1|STARTED|Overall Study||25
600844|NCT00426855|1469213|P1|NOT COMPLETED|Overall Study||0
600845|NCT00426855|1469213|P1|COMPLETED|Overall Study||12
600846|NCT00426855|1469213|P1|STARTED|Overall Study||12
600847|NCT00426842|1469217|P1|NOT COMPLETED|Overall Study||1
600848|NCT00426842|1469217|P1|COMPLETED|Overall Study||10
600849|NCT00426842|1469217|P1|STARTED|Overall Study||11
600850|NCT00426764|1469223|P1|NOT COMPLETED|Overall Study||98
600851|NCT00426764|1469223|P1|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6 (data cutoff of October 31 2010).|33
600852|NCT00426764|1469223|P1|Received 6 or More Treatment Cycles|Overall Study||36
600853|NCT00426764|1469223|P1|Received 4 or More Treatment Cycles|Overall Study||50
600854|NCT00426764|1469223|P1|Histopathologically-Confirmed Population|Overall Study|Central histologic confirmation of peripheral T-cell lymphoma (PTCL).|130
600855|NCT00426764|1469223|P1|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|131
600856|NCT00426751|1469239|P2|NOT COMPLETED|Overall Study||20
600857|NCT00426751|1469240|P1|NOT COMPLETED|Overall Study||22
600858|NCT00426751|1469239|P2|COMPLETED|Overall Study||183
600859|NCT00426751|1469240|P1|COMPLETED|Overall Study||204
600860|NCT00426751|1469239|P2|STARTED|Overall Study||203
600861|NCT00426751|1469240|P1|STARTED|Overall Study||226
600862|NCT00426660|1469284|P1|NOT COMPLETED|Overall Study||131
600863|NCT00426660|1469284|P1|COMPLETED|Overall Study||916
600864|NCT00426660|1469284|P1|Safety Analysis Set|Overall Study||1032
600865|NCT00426660|1469284|P1|Treated|Overall Study||1032
600866|NCT00426660|1469284|P1|STARTED|Overall Study||1047
600867|NCT00426556|1469315|P4|NOT COMPLETED|Phase II - Extension Phase||23
600868|NCT00426556|1469316|P3|NOT COMPLETED|Phase II - Extension Phase||0
600869|NCT00426556|1469317|P2|NOT COMPLETED|Phase II - Extension Phase||0
600870|NCT00426556|1469318|P1|NOT COMPLETED|Phase II - Extension Phase||0
600871|NCT00426556|1469315|P4|COMPLETED|Phase II - Extension Phase|Completed means 'Ongoing'|1
600872|NCT00426556|1469316|P3|COMPLETED|Phase II - Extension Phase||0
600873|NCT00426556|1469317|P2|COMPLETED|Phase II - Extension Phase||0
600874|NCT00426556|1469318|P1|COMPLETED|Phase II - Extension Phase||0
600875|NCT00426556|1469315|P4|STARTED|Phase II - Extension Phase|4 patients did not enter the Extension phase.|24
600876|NCT00426556|1469316|P3|STARTED|Phase II - Extension Phase||0
600877|NCT00426556|1469317|P2|STARTED|Phase II - Extension Phase||0
600878|NCT00426556|1469318|P1|STARTED|Phase II - Extension Phase||0
600879|NCT00426556|1469315|P4|NOT COMPLETED|Phase II - Core Phase||27
600880|NCT00426556|1469316|P3|NOT COMPLETED|Phase II - Core Phase||0
600881|NCT00426556|1469317|P2|NOT COMPLETED|Phase II - Core Phase||0
600882|NCT00426556|1469318|P1|NOT COMPLETED|Phase II - Core Phase||0
600883|NCT00426556|1469315|P4|COMPLETED|Phase II - Core Phase||28
600884|NCT00426556|1469316|P3|COMPLETED|Phase II - Core Phase||0
600885|NCT00426556|1469317|P2|COMPLETED|Phase II - Core Phase||0
600886|NCT00426556|1469318|P1|COMPLETED|Phase II - Core Phase||0
600887|NCT00426556|1469315|P4|STARTED|Phase II - Core Phase||55
600888|NCT00426556|1469316|P3|STARTED|Phase II - Core Phase||0
600889|NCT00426556|1469317|P2|STARTED|Phase II - Core Phase||0
600890|NCT00426556|1469318|P1|STARTED|Phase II - Core Phase||0
600891|NCT00426556|1469315|P4|NOT COMPLETED|Phase I - Extension Phase||0
600892|NCT00426556|1469316|P3|NOT COMPLETED|Phase I - Extension Phase||7
600893|NCT00426556|1469317|P2|NOT COMPLETED|Phase I - Extension Phase||6
600894|NCT00426556|1469318|P1|NOT COMPLETED|Phase I - Extension Phase||5
600895|NCT00426556|1469315|P4|COMPLETED|Phase I - Extension Phase||0
600896|NCT00426556|1469316|P3|COMPLETED|Phase I - Extension Phase||0
600897|NCT00426556|1469317|P2|COMPLETED|Phase I - Extension Phase||1
600898|NCT00426556|1469318|P1|COMPLETED|Phase I - Extension Phase||0
600899|NCT00426556|1469315|P4|STARTED|Phase I - Extension Phase||0
600900|NCT00426556|1469316|P3|STARTED|Phase I - Extension Phase||7
600901|NCT00426556|1469317|P2|STARTED|Phase I - Extension Phase||7
600902|NCT00426556|1469318|P1|STARTED|Phase I - Extension Phase||5
600903|NCT00426556|1469315|P4|NOT COMPLETED|Phase I - Core Phase||0
600904|NCT00426556|1469316|P3|NOT COMPLETED|Phase I - Core Phase||3
600905|NCT00426556|1469317|P2|NOT COMPLETED|Phase I - Core Phase||10
600906|NCT00426556|1469318|P1|NOT COMPLETED|Phase I - Core Phase||1
600907|NCT00426556|1469315|P4|COMPLETED|Phase I - Core Phase||0
600908|NCT00426556|1469316|P3|COMPLETED|Phase I - Core Phase||7
600909|NCT00426556|1469317|P2|COMPLETED|Phase I - Core Phase||7
600910|NCT00426556|1469318|P1|COMPLETED|Phase I - Core Phase||5
600911|NCT00426556|1469315|P4|STARTED|Phase I - Core Phase||0
600912|NCT00426556|1469316|P3|STARTED|Phase I - Core Phase||10
600913|NCT00426556|1469317|P2|STARTED|Phase I - Core Phase||17
600914|NCT00426556|1469318|P1|STARTED|Phase I - Core Phase||6
600915|NCT00426361|1469343|P3|NOT COMPLETED|Overall Study||5
600916|NCT00426361|1469344|P2|NOT COMPLETED|Overall Study||5
600917|NCT00426361|1469345|P1|NOT COMPLETED|Overall Study||4
600918|NCT00426361|1469343|P3|COMPLETED|Overall Study||243
600919|NCT00426361|1469344|P2|COMPLETED|Overall Study||250
600920|NCT00426361|1469345|P1|COMPLETED|Overall Study||244
600921|NCT00426361|1469343|P3|STARTED|Overall Study||248
600922|NCT00426361|1469344|P2|STARTED|Overall Study||255
600923|NCT00426361|1469345|P1|STARTED|Overall Study||248
600924|NCT00426283|1469397|P2|NOT COMPLETED|Overall Study||1
600925|NCT00426283|1469398|P1|NOT COMPLETED|Overall Study||5
600926|NCT00426283|1469397|P2|COMPLETED|Overall Study||13
600927|NCT00426283|1469398|P1|COMPLETED|Overall Study||23
600928|NCT00426283|1469397|P2|STARTED|Overall Study||14
600929|NCT00426283|1469398|P1|STARTED|Overall Study||28
600930|NCT00426270|1469404|P1|NOT COMPLETED|Overall Study||6
600931|NCT00426270|1469404|P1|COMPLETED|Overall Study||110
600932|NCT00426270|1469404|P1|STARTED|Overall Study||116
600933|NCT00426231|1469414|P2|NOT COMPLETED|Overall Study||12
600934|NCT00426231|1469415|P1|NOT COMPLETED|Overall Study||9
600935|NCT00426231|1469414|P2|COMPLETED|Overall Study|For the 6-month endpoint|25
600936|NCT00426231|1469415|P1|COMPLETED|Overall Study|For the 6 month endpoint|27
600937|NCT00426231|1469414|P2|STARTED|Overall Study||37
600938|NCT00426231|1469415|P1|STARTED|Overall Study||36
600939|NCT00426153|1469425|P2|NOT COMPLETED|Overall Study||0
600940|NCT00426153|1469426|P1|NOT COMPLETED|Overall Study||0
600941|NCT00426153|1469425|P2|COMPLETED|Overall Study||14
600942|NCT00426153|1469426|P1|COMPLETED|Overall Study||28
600943|NCT00426153|1469425|P2|STARTED|Overall Study||14
600944|NCT00426153|1469426|P1|STARTED|Overall Study|Participants were randomized in a 2:1 ratio, Octreotide LAR depot: Placebo|28
600945|NCT00426127|1469438|P1|NOT COMPLETED|Overall Study||2
600946|NCT00426127|1469438|P1|COMPLETED|Overall Study||0
600947|NCT00426127|1469438|P1|STARTED|Overall Study||2
600948|NCT00425945|1469446|P2|NOT COMPLETED|Overall Study||5
600949|NCT00425945|1469447|P1|NOT COMPLETED|Overall Study||4
600950|NCT00425945|1469446|P2|COMPLETED|Overall Study||61
600951|NCT00425945|1469447|P1|COMPLETED|Overall Study||60
600952|NCT00425945|1469446|P2|STARTED|Overall Study||66
600953|NCT00425945|1469447|P1|STARTED|Overall Study||64
600954|NCT00425854|1469485|P2|NOT COMPLETED|Overall Study||21
600955|NCT00425854|1469486|P1|NOT COMPLETED|Overall Study||29
600956|NCT00425854|1469485|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date (30 Sep 2009)|0
600957|NCT00425854|1469486|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (30 Sep 2009)|0
600958|NCT00425854|1469485|P2|STARTED|Overall Study|Treated|21
600959|NCT00425854|1469486|P1|STARTED|Overall Study|Treated|29
600960|NCT00425802|1469507|P1|NOT COMPLETED|Overall Study||0
600961|NCT00425802|1469507|P1|COMPLETED|Overall Study||61
600962|NCT00425802|1469507|P1|STARTED|Overall Study||61
600963|NCT00425750|1469519|P1|NOT COMPLETED|Overall Study||25
600964|NCT00425750|1469519|P1|COMPLETED|Overall Study||0
600965|NCT00425750|1469519|P1|STARTED|Overall Study||25
600966|NCT00425698|1469527|P2|NOT COMPLETED|Overall Study||2
600967|NCT00425698|1469528|P1|NOT COMPLETED|Overall Study||3
600968|NCT00425698|1469527|P2|COMPLETED|Overall Study||42
600969|NCT00425698|1469528|P1|COMPLETED|Overall Study||41
600970|NCT00425698|1469527|P2|STARTED|Overall Study||44
600971|NCT00425698|1469528|P1|STARTED|Overall Study||44
600972|NCT00425672|1469534|P1|NOT COMPLETED|Overall Study||1
600973|NCT00425672|1469534|P1|COMPLETED|Overall Study||14
600974|NCT00425672|1469534|P1|STARTED|Overall Study||15
600975|NCT00425607|1469543|P1|NOT COMPLETED|Overall Study||2
600976|NCT00425607|1469543|P1|COMPLETED|Overall Study||27
600977|NCT00425607|1469543|P1|Received Treatment|Overall Study||28
600978|NCT00425607|1469543|P1|STARTED|Overall Study||29
600979|NCT00425503|1469547|P1|NOT COMPLETED|Overall Study||3
600980|NCT00425503|1469547|P1|COMPLETED|Overall Study||37
600981|NCT00425503|1469547|P1|STARTED|Overall Study||40
600982|NCT00425438|1469553|P2|NOT COMPLETED|Overall Study||27
600983|NCT00425438|1469554|P1|NOT COMPLETED|Overall Study||25
600984|NCT00425438|1469553|P2|COMPLETED|Overall Study||0
600985|NCT00425438|1469554|P1|COMPLETED|Overall Study||0
600986|NCT00425438|1469553|P2|STARTED|Overall Study||27
600987|NCT00425438|1469554|P1|STARTED|Overall Study||25
600988|NCT00425386|1469570|P1|NOT COMPLETED|Overall Study||3
600989|NCT00425386|1469570|P1|COMPLETED|Overall Study||43
600990|NCT00425386|1469570|P1|STARTED|Overall Study||46
600991|NCT00425373|1469588|P9|NOT COMPLETED|Overall Study||18
600992|NCT00425373|1469589|P8|NOT COMPLETED|Overall Study||10
600993|NCT00425373|1469590|P7|NOT COMPLETED|Overall Study||7
600994|NCT00425373|1469591|P6|NOT COMPLETED|Overall Study||9
600995|NCT00425373|1469592|P5|NOT COMPLETED|Overall Study||10
600996|NCT00425373|1469593|P4|NOT COMPLETED|Overall Study||2
600997|NCT00425373|1469594|P3|NOT COMPLETED|Overall Study||3
600998|NCT00425373|1469595|P2|NOT COMPLETED|Overall Study||3
600999|NCT00425373|1469596|P1|NOT COMPLETED|Overall Study||5
601000|NCT00425373|1469588|P9|COMPLETED|Overall Study||148
601001|NCT00425373|1469589|P8|COMPLETED|Overall Study||151
601002|NCT00425373|1469590|P7|COMPLETED|Overall Study||154
601003|NCT00425373|1469591|P6|COMPLETED|Overall Study||154
601004|NCT00425373|1469592|P5|COMPLETED|Overall Study||159
601005|NCT00425373|1469593|P4|COMPLETED|Overall Study||160
601006|NCT00425373|1469594|P3|COMPLETED|Overall Study||157
601007|NCT00425373|1469595|P2|COMPLETED|Overall Study||164
601008|NCT00425373|1469596|P1|COMPLETED|Overall Study||154
601009|NCT00425373|1469588|P9|STARTED|Overall Study||166
601010|NCT00425373|1469589|P8|STARTED|Overall Study||161
601011|NCT00425373|1469590|P7|STARTED|Overall Study||161
601012|NCT00425373|1469591|P6|STARTED|Overall Study||163
601013|NCT00425373|1469592|P5|STARTED|Overall Study||169
601014|NCT00425373|1469593|P4|STARTED|Overall Study||162
601015|NCT00425373|1469594|P3|STARTED|Overall Study||160
601016|NCT00425373|1469595|P2|STARTED|Overall Study||167
601017|NCT00425373|1469596|P1|STARTED|Overall Study||159
601018|NCT00425308|1469654|P2|NOT COMPLETED|Overall Study||1
601019|NCT00425308|1469655|P1|NOT COMPLETED|Overall Study||4
601020|NCT00425308|1469654|P2|COMPLETED|Overall Study||14
601021|NCT00425308|1469655|P1|COMPLETED|Overall Study||11
601022|NCT00425308|1469654|P2|STARTED|Overall Study||15
601023|NCT00425308|1469655|P1|STARTED|Overall Study||15
601024|NCT00425269|1469685|P2|NOT COMPLETED|Overall Study||20
601025|NCT00425269|1469686|P1|NOT COMPLETED|Overall Study||19
601026|NCT00425269|1469685|P2|COMPLETED|Overall Study||77
601027|NCT00425269|1469686|P1|COMPLETED|Overall Study||82
601028|NCT00425269|1469685|P2|STARTED|Overall Study||97
601029|NCT00425269|1469686|P1|STARTED|Overall Study||101
601030|NCT00425113|1469764|P2|NOT COMPLETED|Overall Study||2
601031|NCT00425113|1469765|P1|NOT COMPLETED|Overall Study||2
601032|NCT00425113|1469764|P2|COMPLETED|Overall Study|Included in modified intent-to-treat analysis|16
601033|NCT00425113|1469765|P1|COMPLETED|Overall Study|Included in modified intent-to-treat analysis|15
601034|NCT00425113|1469764|P2|Exposed to Study Drug|Overall Study||17
601035|NCT00425113|1469765|P1|Exposed to Study Drug|Overall Study||16
601036|NCT00425113|1469764|P2|STARTED|Overall Study||18
601037|NCT00425113|1469765|P1|STARTED|Overall Study||17
601038|NCT00425100|1469773|P1|NOT COMPLETED|Overall Study||53
601039|NCT00425100|1469773|P1|COMPLETED|Overall Study||463
601040|NCT00425100|1469773|P1|STARTED|Overall Study||516
601041|NCT00425061|1469817|P7|NOT COMPLETED|Overall Study||19
601042|NCT00425061|1469818|P6|NOT COMPLETED|Overall Study||4
601043|NCT00425061|1469819|P5|NOT COMPLETED|Overall Study||26
601044|NCT00425061|1469820|P4|NOT COMPLETED|Overall Study||2
601045|NCT00425061|1469821|P3|NOT COMPLETED|Overall Study||0
601046|NCT00425061|1469822|P2|NOT COMPLETED|Overall Study||2
601047|NCT00425061|1469823|P1|NOT COMPLETED|Overall Study||2
601048|NCT00425061|1469817|P7|COMPLETED|Overall Study||26
601049|NCT00425061|1469818|P6|COMPLETED|Overall Study||0
601050|NCT00425061|1469819|P5|COMPLETED|Overall Study||19
601051|NCT00425061|1469820|P4|COMPLETED|Overall Study||14
601052|NCT00425061|1469821|P3|COMPLETED|Overall Study||16
601053|NCT00425061|1469822|P2|COMPLETED|Overall Study||15
601054|NCT00425061|1469823|P1|COMPLETED|Overall Study||14
601055|NCT00425061|1469817|P7|STARTED|Overall Study||45
601056|NCT00425061|1469818|P6|STARTED|Overall Study||4
601057|NCT00425061|1469819|P5|STARTED|Overall Study||45
601058|NCT00425061|1469820|P4|STARTED|Overall Study||16
601059|NCT00425061|1469821|P3|STARTED|Overall Study||16
601060|NCT00425061|1469822|P2|STARTED|Overall Study||17
601061|NCT00425061|1469823|P1|STARTED|Overall Study||16
601062|NCT00424827|1469939|P1|NOT COMPLETED|Overall Study||1
601063|NCT00424827|1469939|P1|COMPLETED|Overall Study||10
601064|NCT00424827|1469939|P1|STARTED|Overall Study||11
601065|NCT00424775|1469947|P2|NOT COMPLETED|Overall Study||0
601066|NCT00424775|1469948|P1|NOT COMPLETED|Overall Study||3
601067|NCT00424775|1469947|P2|COMPLETED|Overall Study||0
601068|NCT00424775|1469948|P1|COMPLETED|Overall Study||0
601069|NCT00424775|1469947|P2|STARTED|Overall Study||0
601070|NCT00424775|1469948|P1|STARTED|Overall Study||3
601071|NCT00424762|1469958|P2|NOT COMPLETED|Overall Study||22
601072|NCT00424762|1469959|P1|NOT COMPLETED|Overall Study||20
601073|NCT00424762|1469958|P2|COMPLETED|Overall Study||54
601074|NCT00424762|1469959|P1|COMPLETED|Overall Study||54
601075|NCT00424762|1469958|P2|STARTED|Overall Study||76
601076|NCT00424762|1469959|P1|STARTED|Overall Study||74
601077|NCT00424749|1469969|P1|NOT COMPLETED|Overall Study||1
601078|NCT00424749|1469969|P1|COMPLETED|Overall Study||3
601079|NCT00424749|1469969|P1|STARTED|Overall Study||4
601080|NCT00424645|1469976|P2|NOT COMPLETED|Overall Study||0
601081|NCT00424645|1469977|P1|NOT COMPLETED|Overall Study||1
601082|NCT00424645|1469976|P2|COMPLETED|Overall Study||0
601083|NCT00424645|1469977|P1|COMPLETED|Overall Study||2
601084|NCT00424645|1469976|P2|STARTED|Overall Study||0
601085|NCT00424645|1469977|P1|STARTED|Overall Study||3
601086|NCT00424632|1469985|P10|NOT COMPLETED|Overall Study||6
601087|NCT00424632|1469986|P9|NOT COMPLETED|Overall Study||16
601088|NCT00424632|1469987|P8|NOT COMPLETED|Overall Study||3
601089|NCT00424632|1469988|P7|NOT COMPLETED|Overall Study||7
601090|NCT00424632|1469989|P6|NOT COMPLETED|Overall Study||15
601091|NCT00424632|1469990|P5|NOT COMPLETED|Overall Study||3
601092|NCT00424632|1469991|P4|NOT COMPLETED|Overall Study||4
601093|NCT00424632|1469992|P3|NOT COMPLETED|Overall Study||1
601094|NCT00424632|1469993|P2|NOT COMPLETED|Overall Study||1
601095|NCT00424632|1469994|P1|NOT COMPLETED|Overall Study||1
601096|NCT00424632|1469985|P10|COMPLETED|Overall Study||0
601097|NCT00424632|1469986|P9|COMPLETED|Overall Study||0
601098|NCT00424632|1469987|P8|COMPLETED|Overall Study||0
601099|NCT00424632|1469988|P7|COMPLETED|Overall Study||0
601100|NCT00424632|1469989|P6|COMPLETED|Overall Study||0
601101|NCT00424632|1469990|P5|COMPLETED|Overall Study||0
601102|NCT00424632|1469991|P4|COMPLETED|Overall Study||0
601103|NCT00424632|1469992|P3|COMPLETED|Overall Study||0
601104|NCT00424632|1469993|P2|COMPLETED|Overall Study||0
601105|NCT00424632|1469994|P1|COMPLETED|Overall Study||0
601106|NCT00424632|1469985|P10|STARTED|Overall Study||6
601107|NCT00424632|1469986|P9|STARTED|Overall Study||16
601108|NCT00424632|1469987|P8|STARTED|Overall Study||3
601109|NCT00424632|1469988|P7|STARTED|Overall Study||7
601110|NCT00424632|1469989|P6|STARTED|Overall Study||15
601111|NCT00424632|1469990|P5|STARTED|Overall Study||3
601112|NCT00424632|1469991|P4|STARTED|Overall Study||4
601113|NCT00424632|1469992|P3|STARTED|Overall Study||1
601114|NCT00424632|1469993|P2|STARTED|Overall Study||1
601115|NCT00424632|1469994|P1|STARTED|Overall Study||1
601116|NCT00424619|1470128|P3|NOT COMPLETED|3 Month||0
601117|NCT00424619|1470129|P2|NOT COMPLETED|3 Month||0
601118|NCT00424619|1470130|P1|NOT COMPLETED|3 Month||0
601119|NCT00424619|1470128|P3|COMPLETED|3 Month||17
601120|NCT00424619|1470129|P2|COMPLETED|3 Month||18
601121|NCT00424619|1470130|P1|COMPLETED|3 Month||12
601122|NCT00424619|1470128|P3|STARTED|3 Month||17
601123|NCT00424619|1470129|P2|STARTED|3 Month||18
601124|NCT00424619|1470130|P1|STARTED|3 Month||12
601125|NCT00424619|1470128|P3|NOT COMPLETED|4 Week||0
601126|NCT00424619|1470129|P2|NOT COMPLETED|4 Week||0
601127|NCT00424619|1470130|P1|NOT COMPLETED|4 Week||0
601128|NCT00424619|1470128|P3|COMPLETED|4 Week||17
601129|NCT00424619|1470129|P2|COMPLETED|4 Week||17
601130|NCT00424619|1470130|P1|COMPLETED|4 Week||18
601131|NCT00424619|1470128|P3|STARTED|4 Week||17
601132|NCT00424619|1470129|P2|STARTED|4 Week||17
601133|NCT00424619|1470130|P1|STARTED|4 Week||18
601134|NCT00424619|1470128|P3|NOT COMPLETED|Baseline||1
601135|NCT00424619|1470129|P2|NOT COMPLETED|Baseline||0
601136|NCT00424619|1470130|P1|NOT COMPLETED|Baseline||0
601137|NCT00424619|1470128|P3|COMPLETED|Baseline||20
601138|NCT00424619|1470129|P2|COMPLETED|Baseline||22
601139|NCT00424619|1470130|P1|COMPLETED|Baseline||22
601140|NCT00424619|1470128|P3|STARTED|Baseline|n=21 but one participant was lost as a screen failure|21
601141|NCT00424619|1470129|P2|STARTED|Baseline||22
601142|NCT00424619|1470130|P1|STARTED|Baseline||22
601143|NCT00424593|1470164|P2|NOT COMPLETED|Dose-Blind Extension Period||0
601144|NCT00424593|1470165|P1|NOT COMPLETED|Dose-Blind Extension Period||64
601145|NCT00424593|1470164|P2|COMPLETED|Dose-Blind Extension Period||0
601146|NCT00424593|1470165|P1|COMPLETED|Dose-Blind Extension Period||117
601147|NCT00424593|1470164|P2|STARTED|Dose-Blind Extension Period|98 placebo patients from acute phase entered dose-blind period and received duloxetine.|0
601148|NCT00424593|1470165|P1|STARTED|Dose-Blind Extension Period|83 duloxetine patients from the acute phase entered the dose-blind period.|181
601149|NCT00424593|1470164|P2|NOT COMPLETED|Acute Double-Blind Period||23
601150|NCT00424593|1470165|P1|NOT COMPLETED|Acute Double-Blind Period||31
601151|NCT00424593|1470164|P2|COMPLETED|Acute Double-Blind Period||98
601152|NCT00424593|1470165|P1|COMPLETED|Acute Double-Blind Period||84
601153|NCT00424593|1470164|P2|STARTED|Acute Double-Blind Period||121
601154|NCT00424593|1470165|P1|STARTED|Acute Double-Blind Period||115
601155|NCT00424554|1470211|P2|NOT COMPLETED|Overall Study||0
601156|NCT00424554|1470212|P1|NOT COMPLETED|Overall Study||0
601157|NCT00424554|1470211|P2|COMPLETED|Overall Study||6
601158|NCT00424554|1470212|P1|COMPLETED|Overall Study||34
601159|NCT00424554|1470211|P2|STARTED|Overall Study||6
601160|NCT00424554|1470212|P1|STARTED|Overall Study||34
601161|NCT00424528|1470229|P3|NOT COMPLETED|Overall Study||4
601162|NCT00424528|1470230|P2|NOT COMPLETED|Overall Study||4
601163|NCT00424528|1470231|P1|NOT COMPLETED|Overall Study||5
601164|NCT00424528|1470229|P3|COMPLETED|Overall Study||74
601165|NCT00424528|1470230|P2|COMPLETED|Overall Study||76
601166|NCT00424528|1470231|P1|COMPLETED|Overall Study||71
601167|NCT00424528|1470229|P3|STARTED|Overall Study||78
601168|NCT00424528|1470230|P2|STARTED|Overall Study||80
601169|NCT00424528|1470231|P1|STARTED|Overall Study||76
601170|NCT00424515|1470286|P2|NOT COMPLETED|Overall Study||13
601171|NCT00424515|1470287|P1|NOT COMPLETED|Overall Study||11
601172|NCT00424515|1470286|P2|COMPLETED|Overall Study||0
601173|NCT00424515|1470287|P1|COMPLETED|Overall Study||0
601174|NCT00424515|1470286|P2|STARTED|Overall Study||13
601175|NCT00424515|1470287|P1|STARTED|Overall Study||11
601176|NCT00424502|1470297|P1|NOT COMPLETED|Overall Study||0
601177|NCT00424502|1470297|P1|COMPLETED|Overall Study||20
601178|NCT00424502|1470297|P1|STARTED|Overall Study||20
601179|NCT00424476|1470309|P3|NOT COMPLETED|Overall Study||49
601180|NCT00424476|1470310|P2|NOT COMPLETED|Overall Study||48
601181|NCT00424476|1470311|P1|NOT COMPLETED|Overall Study||61
601182|NCT00424476|1470309|P3|COMPLETED|Overall Study||241
601183|NCT00424476|1470310|P2|COMPLETED|Overall Study||240
601184|NCT00424476|1470311|P1|COMPLETED|Overall Study||226
601185|NCT00424476|1470309|P3|STARTED|Overall Study||290
601186|NCT00424476|1470310|P2|STARTED|Overall Study||288
601187|NCT00424476|1470311|P1|STARTED|Overall Study||287
601188|NCT00424463|1470337|P3|NOT COMPLETED|Overall Study||16
601189|NCT00424463|1470338|P2|NOT COMPLETED|Overall Study||14
601190|NCT00424463|1470339|P1|NOT COMPLETED|Overall Study||7
601191|NCT00424463|1470337|P3|COMPLETED|Overall Study||72
601192|NCT00424463|1470338|P2|COMPLETED|Overall Study||34
601193|NCT00424463|1470339|P1|COMPLETED|Overall Study||38
601194|NCT00424463|1470337|P3|STARTED|Overall Study||88
601195|NCT00424463|1470338|P2|STARTED|Overall Study||48
601196|NCT00424463|1470339|P1|STARTED|Overall Study||45
601197|NCT00424398|1470368|P3|NOT COMPLETED|Overall Study||0
601198|NCT00424398|1470369|P2|NOT COMPLETED|Overall Study||1
601199|NCT00424398|1470370|P1|NOT COMPLETED|Overall Study||3
601200|NCT00424398|1470368|P3|COMPLETED|Overall Study||36
601201|NCT00424398|1470369|P2|COMPLETED|Overall Study||35
601202|NCT00424398|1470370|P1|COMPLETED|Overall Study||32
601203|NCT00424398|1470368|P3|STARTED|Overall Study||36
601204|NCT00424398|1470369|P2|STARTED|Overall Study||36
601205|NCT00424398|1470370|P1|STARTED|Overall Study||35
601206|NCT00424385|1470414|P1|NOT COMPLETED|Cohort 1||1
601207|NCT00424385|1470414|P1|COMPLETED|Cohort 1||4
601208|NCT00424385|1470414|P1|STARTED|Cohort 1||5
601209|NCT00424385|1470414|P1|NOT COMPLETED|Cohort 0||6
601210|NCT00424385|1470414|P1|COMPLETED|Cohort 0||6
601211|NCT00424385|1470414|P1|STARTED|Cohort 0||12
601212|NCT00424372|1470421|P1|NOT COMPLETED|Overall Study||31
601213|NCT00424372|1470421|P1|COMPLETED|Overall Study||95
601214|NCT00424372|1470421|P1|STARTED|Overall Study||126
601215|NCT00424346|1470433|P4|NOT COMPLETED|Extension Phase||55
601216|NCT00424346|1470434|P3|NOT COMPLETED|Extension Phase||55
601217|NCT00424346|1470435|P2|NOT COMPLETED|Extension Phase||102
601218|NCT00424346|1470436|P1|NOT COMPLETED|Extension Phase||0
601219|NCT00424346|1470433|P4|COMPLETED|Extension Phase||3
601220|NCT00424346|1470434|P3|COMPLETED|Extension Phase||4
601221|NCT00424346|1470435|P2|COMPLETED|Extension Phase||8
601222|NCT00424346|1470436|P1|COMPLETED|Extension Phase||0
601223|NCT00424346|1470433|P4|STARTED|Extension Phase||58
601224|NCT00424346|1470434|P3|STARTED|Extension Phase||59
601225|NCT00424346|1470435|P2|STARTED|Extension Phase|Includes participants who completed the Core phase in the Canakinumab 600 mg IV + 300 mg q2wk group.|110
601226|NCT00424346|1470436|P1|STARTED|Extension Phase|Participants are represented in the Canakinumab 300 mg q2wk treatment group.|0
601227|NCT00424346|1470433|P4|NOT COMPLETED|Core Study||7
601228|NCT00424346|1470434|P3|NOT COMPLETED|Core Study||4
601229|NCT00424346|1470435|P2|NOT COMPLETED|Core Study||8
601230|NCT00424346|1470436|P1|NOT COMPLETED|Core Study||9
601231|NCT00424346|1470433|P4|COMPLETED|Core Study||63
601232|NCT00424346|1470434|P3|COMPLETED|Core Study||65
601233|NCT00424346|1470435|P2|COMPLETED|Core Study||56
601234|NCT00424346|1470436|P1|COMPLETED|Core Study||62
601235|NCT00424346|1470433|P4|STARTED|Core Study||70
601236|NCT00424346|1470434|P3|STARTED|Core Study||69
601237|NCT00424346|1470435|P2|STARTED|Core Study||64
601238|NCT00424346|1470436|P1|STARTED|Core Study||71
601239|NCT00424294|1470551|P2|NOT COMPLETED|Overall Study||15
601240|NCT00424294|1470552|P1|NOT COMPLETED|Overall Study||8
601241|NCT00424294|1470551|P2|COMPLETED|Overall Study||19
601242|NCT00424294|1470552|P1|COMPLETED|Overall Study||28
601243|NCT00424294|1470551|P2|Treated|Overall Study||34
601244|NCT00424294|1470552|P1|Treated|Overall Study||35
601245|NCT00424294|1470551|P2|STARTED|Overall Study||34
601246|NCT00424294|1470552|P1|STARTED|Overall Study||36
601247|NCT00424268|1470602|P2|NOT COMPLETED|Overall Study||39
601248|NCT00424268|1470603|P1|NOT COMPLETED|Overall Study||62
601249|NCT00424268|1470602|P2|COMPLETED|Overall Study||333
601250|NCT00424268|1470603|P1|COMPLETED|Overall Study||309
601251|NCT00424268|1470602|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|372
601252|NCT00424268|1470603|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|371
601253|NCT00424255|1470619|P2|NOT COMPLETED|Overall Study||346
601254|NCT00424255|1470620|P1|NOT COMPLETED|Overall Study||342
601255|NCT00424255|1470619|P2|COMPLETED|Overall Study||0
601256|NCT00424255|1470620|P1|COMPLETED|Overall Study||0
601257|NCT00424255|1470619|P2|STARTED|Overall Study||346
601258|NCT00424255|1470620|P1|STARTED|Overall Study||342
601259|NCT00424190|1470668|P2|NOT COMPLETED|Overall Study||30
601260|NCT00424190|1470669|P1|NOT COMPLETED|Overall Study||22
601261|NCT00424190|1470668|P2|COMPLETED|Overall Study||317
601262|NCT00424190|1470669|P1|COMPLETED|Overall Study||329
601263|NCT00424190|1470668|P2|STARTED|Overall Study||347
601264|NCT00424190|1470669|P1|STARTED|Overall Study||351
601265|NCT00424177|1470675|P1|NOT COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||3
601266|NCT00424177|1470675|P1|COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||48
601267|NCT00424177|1470675|P1|STARTED|Cycle 3: Eltrombopag 50 or 75 mg||51
601268|NCT00424177|1470675|P1|NOT COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||4
601269|NCT00424177|1470675|P1|COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||51
601270|NCT00424177|1470675|P1|STARTED|Cycle 2: Eltrombopag 50 or 75 mg||55
601271|NCT00424177|1470675|P1|NOT COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||11
601272|NCT00424177|1470675|P1|COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||55
601273|NCT00424177|1470675|P1|STARTED|Cycle 1: Eltrombopag 50 mg Starting Dose||66
601274|NCT00424047|1470704|P2|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||8
601275|NCT00424047|1470705|P1|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||21
601276|NCT00424047|1470704|P2|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0
601277|NCT00424047|1470705|P1|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0
601278|NCT00424047|1470704|P2|STARTED|Long Term Extension (Up to 25 Jun 2013)|2 participants opted to receive dex alone, 3 crossed over to Len/Dex and 3 added Len at a later date|8
601279|NCT00424047|1470705|P1|STARTED|Long Term Extension (Up to 25 Jun 2013)||21
601280|NCT00424047|1470704|P2|NOT COMPLETED|On Study at Time of Unblinding||167
601281|NCT00424047|1470705|P1|NOT COMPLETED|On Study at Time of Unblinding||155
601282|NCT00424047|1470704|P2|COMPLETED|On Study at Time of Unblinding|Participants completed = those continuing on long term dexamethasone|8
601283|NCT00424047|1470705|P1|COMPLETED|On Study at Time of Unblinding|Participants completed = those continuing on long term Lenalidomide and dexamethasone|21
601284|NCT00424047|1470704|P2|STARTED|On Study at Time of Unblinding||175
601285|NCT00424047|1470705|P1|STARTED|On Study at Time of Unblinding|Refers to original treatment group assignment in the study.|176
601286|NCT00424047|1470704|P2|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||156
601287|NCT00424047|1470705|P1|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||122
601288|NCT00424047|1470704|P2|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)|Ongoing and includes 15 participants who crossed over to lenalidomide/dexamethasone after unblinding|19
601289|NCT00424047|1470705|P1|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)|54 participants ongoing and continuing on lenalidomide/dexamethasone treatment|54
601290|NCT00424047|1470704|P2|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)|4 participants excluded because they had no baseline M-protein assessment|171
601291|NCT00424047|1470705|P1|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)|1 participant excluded because they had no baseline M-protein assessment|175
601292|NCT00424047|1470704|P2|Safety Population|Blinded Treatment (Up to 03 Aug 2005)|Includes those who took at least one dose of study medication regimen|175
601293|NCT00424047|1470705|P1|Safety Population|Blinded Treatment (Up to 03 Aug 2005)|Includes those who took at least one dose of study medication regimen|176
601294|NCT00424047|1470704|P2|STARTED|Blinded Treatment (Up to 03 Aug 2005)||175
601295|NCT00424047|1470705|P1|STARTED|Blinded Treatment (Up to 03 Aug 2005)||176
601296|NCT00424021|1470737|P4|NOT COMPLETED|AMB-220-E Study Period||10
601297|NCT00424021|1470738|P3|NOT COMPLETED|AMB-220-E Study Period||5
601298|NCT00424021|1470739|P2|NOT COMPLETED|AMB-220-E Study Period||2
601299|NCT00424021|1470740|P1|NOT COMPLETED|AMB-220-E Study Period||1
601300|NCT00424021|1470737|P4|COMPLETED|AMB-220-E Study Period||16
601301|NCT00424021|1470738|P3|COMPLETED|AMB-220-E Study Period||14
601302|NCT00424021|1470739|P2|COMPLETED|AMB-220-E Study Period||5
601303|NCT00424021|1470740|P1|COMPLETED|AMB-220-E Study Period||1
601304|NCT00424021|1470737|P4|STARTED|AMB-220-E Study Period||26
601305|NCT00424021|1470738|P3|STARTED|AMB-220-E Study Period||19
601306|NCT00424021|1470739|P2|STARTED|AMB-220-E Study Period||7
601307|NCT00424021|1470740|P1|STARTED|AMB-220-E Study Period||2
601308|NCT00424021|1470737|P4|NOT COMPLETED|NCT00046319 Study Period||1
601309|NCT00424021|1470738|P3|NOT COMPLETED|NCT00046319 Study Period||1
601310|NCT00424021|1470739|P2|NOT COMPLETED|NCT00046319 Study Period||3
601311|NCT00424021|1470740|P1|NOT COMPLETED|NCT00046319 Study Period||1
601312|NCT00424021|1470737|P4|COMPLETED|NCT00046319 Study Period||12
601313|NCT00424021|1470738|P3|COMPLETED|NCT00046319 Study Period||15
601314|NCT00424021|1470739|P2|COMPLETED|NCT00046319 Study Period||16
601315|NCT00424021|1470740|P1|COMPLETED|NCT00046319 Study Period||15
601316|NCT00424021|1470737|P4|STARTED|NCT00046319 Study Period||13
601317|NCT00424021|1470738|P3|STARTED|NCT00046319 Study Period||16
601318|NCT00424021|1470739|P2|STARTED|NCT00046319 Study Period||19
601319|NCT00424021|1470740|P1|STARTED|NCT00046319 Study Period||16
601320|NCT00424008|1470783|P2|NOT COMPLETED|Overall Study||335
601321|NCT00424008|1470784|P1|NOT COMPLETED|Overall Study||349
601322|NCT00424008|1470783|P2|COMPLETED|Overall Study||16
601323|NCT00424008|1470784|P1|COMPLETED|Overall Study||22
601324|NCT00424008|1470783|P2|STARTED|Overall Study||351
601325|NCT00424008|1470784|P1|STARTED|Overall Study||371
601326|NCT00423943|1470799|P2|NOT COMPLETED|Overall Study||1
601327|NCT00423943|1470800|P1|NOT COMPLETED|Overall Study||3
601328|NCT00423943|1470799|P2|COMPLETED|Overall Study||13
601329|NCT00423943|1470800|P1|COMPLETED|Overall Study||16
601330|NCT00423943|1470799|P2|STARTED|Overall Study||14
601331|NCT00423943|1470800|P1|STARTED|Overall Study||19
601332|NCT00423930|1470814|P1|NOT COMPLETED|Overall Study||2
601333|NCT00423930|1470814|P1|COMPLETED|Overall Study||42
601334|NCT00423930|1470814|P1|STARTED|Overall Study||44
601335|NCT00423917|1470819|P1|NOT COMPLETED|Overall Study||3
601336|NCT00423917|1470819|P1|COMPLETED|Overall Study||33
601337|NCT00423917|1470819|P1|STARTED|Overall Study||36
601338|NCT00423891|1470832|P3|NOT COMPLETED|Post-Dosing Follow Up||2
601339|NCT00423891|1470833|P2|NOT COMPLETED|Post-Dosing Follow Up||3
601340|NCT00423891|1470834|P1|NOT COMPLETED|Post-Dosing Follow Up||2
601341|NCT00423891|1470832|P3|COMPLETED|Post-Dosing Follow Up||3
601342|NCT00423891|1470833|P2|COMPLETED|Post-Dosing Follow Up||15
601343|NCT00423891|1470834|P1|COMPLETED|Post-Dosing Follow Up||20
601344|NCT00423891|1470832|P3|STARTED|Post-Dosing Follow Up||5
601345|NCT00423891|1470833|P2|STARTED|Post-Dosing Follow Up||18
601346|NCT00423891|1470834|P1|STARTED|Post-Dosing Follow Up||22
601347|NCT00423891|1470832|P3|NOT COMPLETED|Treatment||0
601348|NCT00423891|1470833|P2|NOT COMPLETED|Treatment||0
601349|NCT00423891|1470834|P1|NOT COMPLETED|Treatment||2
601350|NCT00423891|1470832|P3|COMPLETED|Treatment||5
601351|NCT00423891|1470833|P2|COMPLETED|Treatment||19
601352|NCT00423891|1470834|P1|COMPLETED|Treatment||22
601353|NCT00423891|1470832|P3|STARTED|Treatment||5
601354|NCT00423891|1470833|P2|STARTED|Treatment||19
601355|NCT00423891|1470834|P1|STARTED|Treatment||24
601356|NCT00423891|1470832|P3|NOT COMPLETED|Enrolled||3
601357|NCT00423891|1470833|P2|NOT COMPLETED|Enrolled||2
601358|NCT00423891|1470834|P1|NOT COMPLETED|Enrolled||11
601359|NCT00423891|1470832|P3|COMPLETED|Enrolled||5
601360|NCT00423891|1470833|P2|COMPLETED|Enrolled||19
601361|NCT00423891|1470834|P1|COMPLETED|Enrolled||24
601362|NCT00423891|1470832|P3|STARTED|Enrolled||8
601363|NCT00423891|1470833|P2|STARTED|Enrolled||21
601364|NCT00423891|1470834|P1|STARTED|Enrolled||35
601365|NCT00423878|1470903|P2|NOT COMPLETED|Overall Study||8
601366|NCT00423878|1470904|P1|NOT COMPLETED|Overall Study||20
601367|NCT00423878|1470903|P2|COMPLETED|Overall Study||98
601368|NCT00423878|1470904|P1|COMPLETED|Overall Study||89
601369|NCT00423878|1470903|P2|STARTED|Overall Study||106
601370|NCT00423878|1470904|P1|STARTED|Overall Study||109
601371|NCT00423852|1470912|P1|NOT COMPLETED|Overall Study||3
601372|NCT00423852|1470912|P1|COMPLETED|Overall Study||23
601373|NCT00423852|1470912|P1|STARTED|Overall Study||26
601374|NCT00423813|1470920|P3|NOT COMPLETED|Overall Study||74
601375|NCT00423813|1470921|P2|NOT COMPLETED|Overall Study||66
601376|NCT00423813|1470922|P1|NOT COMPLETED|Overall Study||57
601377|NCT00423813|1470920|P3|COMPLETED|Overall Study||116
601378|NCT00423813|1470921|P2|COMPLETED|Overall Study||129
601379|NCT00423813|1470922|P1|COMPLETED|Overall Study||131
601380|NCT00423813|1470920|P3|Treated|Overall Study||189
601381|NCT00423813|1470921|P2|Treated|Overall Study||194
601382|NCT00423813|1470922|P1|Treated|Overall Study||188
601383|NCT00423813|1470920|P3|STARTED|Overall Study||190
601384|NCT00423813|1470921|P2|STARTED|Overall Study||195
601385|NCT00423813|1470922|P1|STARTED|Overall Study||188
601386|NCT00423800|1470932|P2|NOT COMPLETED|Overall Study||1
601387|NCT00423800|1470933|P1|NOT COMPLETED|Overall Study||0
601388|NCT00423800|1470932|P2|COMPLETED|Overall Study||1
601389|NCT00423800|1470933|P1|COMPLETED|Overall Study||3
601390|NCT00423800|1470932|P2|STARTED|Overall Study||2
601391|NCT00423800|1470933|P1|STARTED|Overall Study||3
601392|NCT00423735|1470945|P3|NOT COMPLETED|Overall Study||0
601393|NCT00423735|1470946|P2|NOT COMPLETED|Overall Study||6
601394|NCT00423735|1470947|P1|NOT COMPLETED|Overall Study||8
601395|NCT00423735|1470945|P3|COMPLETED|Overall Study||0
601396|NCT00423735|1470946|P2|COMPLETED|Overall Study||29
601397|NCT00423735|1470947|P1|COMPLETED|Overall Study||21
601398|NCT00423735|1470945|P3|STARTED|Overall Study||0
601399|NCT00423735|1470946|P2|STARTED|Overall Study||35
601400|NCT00423735|1470947|P1|STARTED|Overall Study||29
601401|NCT00423722|1470970|P2|NOT COMPLETED|Overall Study||13
601402|NCT00423722|1470971|P1|NOT COMPLETED|Overall Study||14
601403|NCT00423722|1470970|P2|COMPLETED|Overall Study||53
601404|NCT00423722|1470971|P1|COMPLETED|Overall Study||49
601405|NCT00423722|1470970|P2|STARTED|Overall Study||66
601406|NCT00423722|1470971|P1|STARTED|Overall Study||63
601407|NCT00423683|1470993|P2|NOT COMPLETED|Overall Study||0
601408|NCT00423683|1470994|P1|NOT COMPLETED|Overall Study||1
601409|NCT00423683|1470993|P2|COMPLETED|Overall Study||33
601410|NCT00423683|1470994|P1|COMPLETED|Overall Study||30
601411|NCT00423683|1470993|P2|STARTED|Overall Study||33
601412|NCT00423683|1470994|P1|STARTED|Overall Study||31
601413|NCT00423670|1471013|P8|NOT COMPLETED|Follow-up Period||3
601414|NCT00423670|1471014|P7|NOT COMPLETED|Follow-up Period||9
601415|NCT00423670|1471015|P6|NOT COMPLETED|Follow-up Period||0
601416|NCT00423670|1471016|P5|NOT COMPLETED|Follow-up Period||2
601417|NCT00423670|1471017|P4|NOT COMPLETED|Follow-up Period||5
601418|NCT00423670|1471018|P3|NOT COMPLETED|Follow-up Period||11
601419|NCT00423670|1471019|P2|NOT COMPLETED|Follow-up Period||16
601420|NCT00423670|1471020|P1|NOT COMPLETED|Follow-up Period||3
601421|NCT00423670|1471013|P8|COMPLETED|Follow-up Period||32
601422|NCT00423670|1471014|P7|COMPLETED|Follow-up Period||41
601423|NCT00423670|1471015|P6|COMPLETED|Follow-up Period||14
601424|NCT00423670|1471016|P5|COMPLETED|Follow-up Period||89
601425|NCT00423670|1471017|P4|COMPLETED|Follow-up Period||91
601426|NCT00423670|1471018|P3|COMPLETED|Follow-up Period||85
601427|NCT00423670|1471019|P2|COMPLETED|Follow-up Period||84
601428|NCT00423670|1471020|P1|COMPLETED|Follow-up Period||94
601429|NCT00423670|1471013|P8|STARTED|Follow-up Period||35
601430|NCT00423670|1471014|P7|STARTED|Follow-up Period||50
601431|NCT00423670|1471015|P6|STARTED|Follow-up Period||14
601432|NCT00423670|1471016|P5|STARTED|Follow-up Period||91
601433|NCT00423670|1471017|P4|STARTED|Follow-up Period||96
601434|NCT00423670|1471018|P3|STARTED|Follow-up Period||96
601435|NCT00423670|1471019|P2|STARTED|Follow-up Period||100
601436|NCT00423670|1471020|P1|STARTED|Follow-up Period||97
601437|NCT00423670|1471013|P8|NOT COMPLETED|Treatment Period||21
601438|NCT00423670|1471014|P7|NOT COMPLETED|Treatment Period||31
601439|NCT00423670|1471015|P6|NOT COMPLETED|Treatment Period||8
601440|NCT00423670|1471016|P5|NOT COMPLETED|Treatment Period||27
601441|NCT00423670|1471017|P4|NOT COMPLETED|Treatment Period||40
601442|NCT00423670|1471018|P3|NOT COMPLETED|Treatment Period||27
601443|NCT00423670|1471019|P2|NOT COMPLETED|Treatment Period||30
601444|NCT00423670|1471020|P1|NOT COMPLETED|Treatment Period||52
601445|NCT00423670|1471013|P8|COMPLETED|Treatment Period||15
601446|NCT00423670|1471014|P7|COMPLETED|Treatment Period||28
601447|NCT00423670|1471015|P6|COMPLETED|Treatment Period||8
601448|NCT00423670|1471016|P5|COMPLETED|Treatment Period||76
601449|NCT00423670|1471017|P4|COMPLETED|Treatment Period||63
601450|NCT00423670|1471018|P3|COMPLETED|Treatment Period||76
601451|NCT00423670|1471019|P2|COMPLETED|Treatment Period||77
601452|NCT00423670|1471020|P1|COMPLETED|Treatment Period||52
601453|NCT00423670|1471013|P8|STARTED|Treatment Period|Arm 8 were Arm 1 participants that were positive for HCV-RNA at TW 24 and had the option to switch.|36
601454|NCT00423670|1471014|P7|STARTED|Treatment Period||59
601455|NCT00423670|1471015|P6|STARTED|Treatment Period||16
601456|NCT00423670|1471016|P5|STARTED|Treatment Period||103
601457|NCT00423670|1471017|P4|STARTED|Treatment Period||103
601458|NCT00423670|1471018|P3|STARTED|Treatment Period||103
601459|NCT00423670|1471019|P2|STARTED|Treatment Period||107
601460|NCT00423670|1471020|P1|STARTED|Treatment Period||104
601461|NCT00423657|1471078|P2|NOT COMPLETED|Overall Study||25
601462|NCT00423657|1471079|P1|NOT COMPLETED|Overall Study||26
601463|NCT00423657|1471078|P2|COMPLETED|Overall Study||313
601464|NCT00423657|1471079|P1|COMPLETED|Overall Study||316
601465|NCT00423657|1471078|P2|STARTED|Overall Study||338
601466|NCT00423657|1471079|P1|STARTED|Overall Study||342
601467|NCT00423605|1471085|P1|NOT COMPLETED|Overall Study||241
601468|NCT00423605|1471085|P1|COMPLETED|Overall Study||319
601469|NCT00423605|1471085|P1|STARTED|Overall Study||560
601470|NCT00423592|1471089|P1|NOT COMPLETED|Overall Study||7
601471|NCT00423592|1471089|P1|COMPLETED|Overall Study|Completed study|29
601472|NCT00423592|1471089|P1|Completed Preliminary Analysis Cut-off|Overall Study|Preliminary analysis cut-off at Week 12 for primary/secondary endpoint analysis|34
601473|NCT00423592|1471089|P1|STARTED|Overall Study|Enrolled|36
601474|NCT00423579|1471110|P2|NOT COMPLETED|Overall Study||4
601475|NCT00423579|1471111|P1|NOT COMPLETED|Overall Study||4
601476|NCT00423579|1471110|P2|COMPLETED|Overall Study|These 56 subjects were the Intent-to-Treat population. Analysis based on ITT population.|56
601477|NCT00423579|1471111|P1|COMPLETED|Overall Study|These 56 subjects were the Intent-to-Treat population. Analysis based on ITT population.|56
601478|NCT00423579|1471110|P2|STARTED|Overall Study||60
601479|NCT00423579|1471111|P1|STARTED|Overall Study|61 enrolled, however one subject was ineligible and was removed.|60
601486|NCT00423449|1471126|P5|NOT COMPLETED|Overall Study||7
601487|NCT00423449|1471127|P4|NOT COMPLETED|Overall Study||22
601488|NCT00423449|1471128|P3|NOT COMPLETED|Overall Study||15
601489|NCT00423449|1471129|P2|NOT COMPLETED|Overall Study||4
601490|NCT00423449|1471130|P1|NOT COMPLETED|Overall Study||3
601491|NCT00423449|1471126|P5|COMPLETED|Overall Study||0
601492|NCT00423449|1471127|P4|COMPLETED|Overall Study||5
601493|NCT00423449|1471128|P3|COMPLETED|Overall Study||2
601494|NCT00423449|1471129|P2|COMPLETED|Overall Study||2
601495|NCT00423449|1471130|P1|COMPLETED|Overall Study||1
601496|NCT00423449|1471126|P5|STARTED|Overall Study||7
601497|NCT00423449|1471127|P4|STARTED|Overall Study||27
601498|NCT00423449|1471128|P3|STARTED|Overall Study||17
601499|NCT00423449|1471129|P2|STARTED|Overall Study||6
601500|NCT00423449|1471130|P1|STARTED|Overall Study||4
601501|NCT00423436|1471155|P2|NOT COMPLETED|Overall Study||0
601502|NCT00423436|1471156|P1|NOT COMPLETED|Overall Study||0
601503|NCT00423436|1471155|P2|COMPLETED|Overall Study||33
601504|NCT00423436|1471156|P1|COMPLETED|Overall Study||35
601505|NCT00423436|1471155|P2|STARTED|Overall Study||33
601506|NCT00423436|1471156|P1|STARTED|Overall Study||35
601507|NCT00423358|1471164|P2|NOT COMPLETED|Overall Study||0
601508|NCT00423358|1471165|P1|NOT COMPLETED|Overall Study||0
601509|NCT00423358|1471164|P2|COMPLETED|Overall Study||11
601510|NCT00423358|1471165|P1|COMPLETED|Overall Study||11
601511|NCT00423358|1471164|P2|STARTED|Overall Study||11
601512|NCT00423358|1471165|P1|STARTED|Overall Study||11
601513|NCT00423332|1471177|P2|NOT COMPLETED|Overall Study||7
601514|NCT00423332|1471178|P1|NOT COMPLETED|Overall Study||9
601515|NCT00423332|1471177|P2|COMPLETED|Overall Study|Number completing 12 weeks blinded randomised treatment|11
601516|NCT00423332|1471178|P1|COMPLETED|Overall Study|Number completing 12 weeks blinded randomised treatment|44
601517|NCT00423332|1471177|P2|Ongoing at Data Cut Off (8th March 2009)|Overall Study|Number ongoing at data cut off (8th March 2009)|4
601518|NCT00423332|1471178|P1|Ongoing at Data Cut Off (8th March 2009)|Overall Study|Number ongoing at data cut off (8th March 2009)|22
601519|NCT00423332|1471177|P2|Continuing After Unblinding|Overall Study|Number starting/ continuing AZD2171 after unblinding|14
601520|NCT00423332|1471178|P1|Continuing After Unblinding|Overall Study|Number starting/ continuing AZD2171 after unblinding|44
601521|NCT00423332|1471177|P2|STARTED|Overall Study|Number randomised|18
601522|NCT00423332|1471178|P1|STARTED|Overall Study|Randomised|53
601523|NCT00423319|1471197|P2|NOT COMPLETED|Overall Study||252
601524|NCT00423319|1471198|P1|NOT COMPLETED|Overall Study||224
601525|NCT00423319|1471197|P2|COMPLETED|Overall Study||2447
601526|NCT00423319|1471198|P1|COMPLETED|Overall Study||2484
601527|NCT00423319|1471197|P2|Participants Who Received Treatment|Overall Study||2659
601528|NCT00423319|1471198|P1|Participants Who Received Treatment|Overall Study||2673
601529|NCT00423319|1471197|P2|STARTED|Overall Study|Randomized|2699
601530|NCT00423319|1471198|P1|STARTED|Overall Study|Randomized|2708
601531|NCT00423293|1471230|P1|NOT COMPLETED|Overall Study||11
601532|NCT00423293|1471230|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52
601533|NCT00423293|1471230|P1|STARTED|Overall Study||63
601534|NCT00423267|1471236|P2|NOT COMPLETED|Period B||0
601535|NCT00423267|1471237|P1|NOT COMPLETED|Period B||0
601536|NCT00423267|1471236|P2|COMPLETED|Period B||0
601537|NCT00423267|1471237|P1|COMPLETED|Period B||12
601538|NCT00423267|1471236|P2|STARTED|Period B||0
601539|NCT00423267|1471237|P1|STARTED|Period B||12
601540|NCT00423267|1471236|P2|NOT COMPLETED|Period A||1
601541|NCT00423267|1471237|P1|NOT COMPLETED|Period A||2
601542|NCT00423267|1471236|P2|COMPLETED|Period A||6
601543|NCT00423267|1471237|P1|COMPLETED|Period A||7
601544|NCT00423267|1471236|P2|STARTED|Period A||7
601545|NCT00423267|1471237|P1|STARTED|Period A||9
601546|NCT00423189|1471257|P3|NOT COMPLETED|Overall Study||0
601547|NCT00423189|1471258|P2|NOT COMPLETED|Overall Study||1
601548|NCT00423189|1471259|P1|NOT COMPLETED|Overall Study||0
601549|NCT00423189|1471257|P3|COMPLETED|Overall Study||2
601550|NCT00423189|1471258|P2|COMPLETED|Overall Study||2
601551|NCT00423189|1471259|P1|COMPLETED|Overall Study||2
601552|NCT00423189|1471257|P3|STARTED|Overall Study||2
601553|NCT00423189|1471258|P2|STARTED|Overall Study||3
601554|NCT00423189|1471259|P1|STARTED|Overall Study||2
601555|NCT00423176|1471281|P2|NOT COMPLETED|Overall Study||29
601556|NCT00423176|1471282|P1|NOT COMPLETED|Overall Study||16
601557|NCT00423176|1471281|P2|COMPLETED|Overall Study||94
601558|NCT00423176|1471282|P1|COMPLETED|Overall Study||98
601559|NCT00423176|1471281|P2|STARTED|Overall Study||123
601560|NCT00423176|1471282|P1|STARTED|Overall Study||114
601561|NCT00423150|1471290|P1|NOT COMPLETED|Overall Study||86
601562|NCT00423150|1471290|P1|COMPLETED|Overall Study||0
601563|NCT00423150|1471290|P1|STARTED|Overall Study||86
601564|NCT00423098|1471296|P2|NOT COMPLETED|Overall Study||4
601565|NCT00423098|1471297|P1|NOT COMPLETED|Overall Study||3
601566|NCT00423098|1471296|P2|COMPLETED|Overall Study||35
601567|NCT00423098|1471297|P1|COMPLETED|Overall Study|Completed 24 weeks of study medication.|39
601568|NCT00423098|1471296|P2|STARTED|Overall Study||39
601569|NCT00423098|1471297|P1|STARTED|Overall Study|Total number of patients screened was 90, but the total number of randomized patients was 81.|42
601570|NCT00423085|1471324|P4|NOT COMPLETED|52-Week Open-Label Extension Phase||163
601571|NCT00423085|1471325|P3|NOT COMPLETED|52-Week Open-Label Extension Phase||0
601572|NCT00423085|1471326|P2|NOT COMPLETED|52-Week Open-Label Extension Phase||0
601573|NCT00423085|1471327|P1|NOT COMPLETED|52-Week Open-Label Extension Phase||0
601574|NCT00423085|1471324|P4|COMPLETED|52-Week Open-Label Extension Phase||474
601575|NCT00423085|1471325|P3|COMPLETED|52-Week Open-Label Extension Phase||0
601576|NCT00423085|1471326|P2|COMPLETED|52-Week Open-Label Extension Phase||0
601577|NCT00423085|1471327|P1|COMPLETED|52-Week Open-Label Extension Phase||0
601578|NCT00423085|1471324|P4|STARTED|52-Week Open-Label Extension Phase|Patients who completed the 24-wk treatment phase were eligible to enroll in the open-label extension|637
601579|NCT00423085|1471325|P3|STARTED|52-Week Open-Label Extension Phase||0
601580|NCT00423085|1471326|P2|STARTED|52-Week Open-Label Extension Phase||0
601581|NCT00423085|1471327|P1|STARTED|52-Week Open-Label Extension Phase||0
601582|NCT00423085|1471324|P4|NOT COMPLETED|24-Week Double-Blind Treatment Phase||0
601583|NCT00423085|1471325|P3|NOT COMPLETED|24-Week Double-Blind Treatment Phase||59
601584|NCT00423085|1471326|P2|NOT COMPLETED|24-Week Double-Blind Treatment Phase||64
601585|NCT00423085|1471327|P1|NOT COMPLETED|24-Week Double-Blind Treatment Phase||46
601586|NCT00423085|1471324|P4|COMPLETED|24-Week Double-Blind Treatment Phase||0
601587|NCT00423085|1471325|P3|COMPLETED|24-Week Double-Blind Treatment Phase||228
601588|NCT00423085|1471326|P2|COMPLETED|24-Week Double-Blind Treatment Phase||220
601589|NCT00423085|1471327|P1|COMPLETED|24-Week Double-Blind Treatment Phase||242
601590|NCT00423085|1471324|P4|STARTED|24-Week Double-Blind Treatment Phase||0
601591|NCT00423085|1471325|P3|STARTED|24-Week Double-Blind Treatment Phase||287
601592|NCT00423085|1471326|P2|STARTED|24-Week Double-Blind Treatment Phase||284
601593|NCT00423085|1471327|P1|STARTED|24-Week Double-Blind Treatment Phase||288
601594|NCT00423046|1471356|P2|NOT COMPLETED|Overall Study||345
601595|NCT00423046|1471357|P1|NOT COMPLETED|Overall Study||340
601596|NCT00423046|1471356|P2|COMPLETED|Overall Study|Completed until Month 60|208
601597|NCT00423046|1471357|P1|COMPLETED|Overall Study|Completed until Month 60|213
601598|NCT00423046|1471356|P2|STARTED|Overall Study||553
601599|NCT00423046|1471357|P1|STARTED|Overall Study||553
601600|NCT00422942|1471423|P1|NOT COMPLETED|Overall Study||3
601601|NCT00422942|1471423|P1|COMPLETED|Overall Study||0
601602|NCT00422942|1471423|P1|STARTED|Overall Study||3
601603|NCT00422903|1471442|P2|NOT COMPLETED|Overall Study||5
601604|NCT00422903|1471443|P1|NOT COMPLETED|Overall Study||4
601605|NCT00422903|1471442|P2|COMPLETED|Overall Study||38
601606|NCT00422903|1471443|P1|COMPLETED|Overall Study||45
601607|NCT00422903|1471442|P2|STARTED|Overall Study||43
601608|NCT00422903|1471443|P1|STARTED|Overall Study||49
601609|NCT00422812|1471471|P4|NOT COMPLETED|Overall Study||2
601610|NCT00422812|1471472|P3|NOT COMPLETED|Overall Study||2
601611|NCT00422812|1471473|P2|NOT COMPLETED|Overall Study||1
601612|NCT00422812|1471474|P1|NOT COMPLETED|Overall Study||0
601613|NCT00422812|1471471|P4|COMPLETED|Overall Study||103
601614|NCT00422812|1471472|P3|COMPLETED|Overall Study||91
601615|NCT00422812|1471473|P2|COMPLETED|Overall Study||103
601616|NCT00422812|1471474|P1|COMPLETED|Overall Study||98
601617|NCT00422812|1471471|P4|STARTED|Overall Study||105
601618|NCT00422812|1471472|P3|STARTED|Overall Study||93
601619|NCT00422812|1471473|P2|STARTED|Overall Study||104
601620|NCT00422812|1471474|P1|STARTED|Overall Study||98
601621|NCT00422799|1471492|P1|NOT COMPLETED|Overall Study||13
601622|NCT00422799|1471492|P1|COMPLETED|Overall Study||50
601623|NCT00422799|1471492|P1|STARTED|Overall Study||63
601624|NCT00422734|1471501|P2|NOT COMPLETED|Overall Study||21
601625|NCT00422734|1471502|P1|NOT COMPLETED|Overall Study||14
601626|NCT00422734|1471501|P2|COMPLETED|Overall Study||243
601627|NCT00422734|1471502|P1|COMPLETED|Overall Study||64
601628|NCT00422734|1471501|P2|STARTED|Overall Study||264
601629|NCT00422734|1471502|P1|STARTED|Overall Study||78
601630|NCT00422695|1471536|P2|NOT COMPLETED|Overall Study||0
601631|NCT00422695|1471537|P1|NOT COMPLETED|Overall Study||0
601632|NCT00422695|1471536|P2|COMPLETED|Overall Study||38
601633|NCT00422695|1471537|P1|COMPLETED|Overall Study||105
601634|NCT00422695|1471536|P2|STARTED|Overall Study||38
601635|NCT00422695|1471537|P1|STARTED|Overall Study||105
601636|NCT00422669|1471548|P3|NOT COMPLETED|Overall Study||7
601637|NCT00422669|1471549|P2|NOT COMPLETED|Overall Study||100
601638|NCT00422669|1471550|P1|NOT COMPLETED|Overall Study||98
601639|NCT00422669|1471548|P3|COMPLETED|Overall Study||0
601640|NCT00422669|1471549|P2|COMPLETED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|0
601641|NCT00422669|1471550|P1|COMPLETED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|0
601642|NCT00422669|1471548|P3|STARTED|Overall Study||7
601643|NCT00422669|1471549|P2|STARTED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|100
601644|NCT00422669|1471550|P1|STARTED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|98
601645|NCT00422656|1471571|P1|NOT COMPLETED|Overall Study||0
601646|NCT00422656|1471571|P1|COMPLETED|Overall Study||37
601647|NCT00422656|1471571|P1|STARTED|Overall Study||37
601648|NCT00422591|1471578|P1|NOT COMPLETED|Overall Study||6
601649|NCT00422591|1471578|P1|COMPLETED|Overall Study||169
601650|NCT00422591|1471578|P1|STARTED|Overall Study||175
601651|NCT00422513|1471586|P2|NOT COMPLETED|Overall Study||106
601652|NCT00422513|1471587|P1|NOT COMPLETED|Overall Study||107
601653|NCT00422513|1471586|P2|COMPLETED|Overall Study||24
601654|NCT00422513|1471587|P1|COMPLETED|Overall Study||23
601655|NCT00422513|1471586|P2|STARTED|Overall Study||130
601656|NCT00422513|1471587|P1|STARTED|Overall Study||130
601657|NCT00422448|1471599|P1|NOT COMPLETED|Overall Study||0
601658|NCT00422448|1471599|P1|COMPLETED|Overall Study||43
601659|NCT00422448|1471599|P1|STARTED|Overall Study|22 prospectively enrolled during study period and 21 retrospectively enrolled|43
601660|NCT00422422|1471604|P1|NOT COMPLETED|Overall Study||10
601661|NCT00422422|1471604|P1|COMPLETED|Overall Study||90
601662|NCT00422422|1471604|P1|STARTED|Overall Study||100
601663|NCT00422383|1471621|P5|NOT COMPLETED|Overall Study||3
601664|NCT00422383|1471622|P4|NOT COMPLETED|Overall Study||2
601665|NCT00422383|1471623|P3|NOT COMPLETED|Overall Study||4
601666|NCT00422383|1471624|P2|NOT COMPLETED|Overall Study||14
601667|NCT00422383|1471625|P1|NOT COMPLETED|Overall Study||15
601668|NCT00422383|1471621|P5|COMPLETED|Overall Study||22
601669|NCT00422383|1471622|P4|COMPLETED|Overall Study||4
601670|NCT00422383|1471623|P3|COMPLETED|Overall Study||89
601671|NCT00422383|1471624|P2|COMPLETED|Overall Study||106
601672|NCT00422383|1471625|P1|COMPLETED|Overall Study||119
601673|NCT00422383|1471621|P5|STARTED|Overall Study||25
601674|NCT00422383|1471622|P4|STARTED|Overall Study||6
601675|NCT00422383|1471623|P3|STARTED|Overall Study||93
601676|NCT00422383|1471624|P2|STARTED|Overall Study||120
601677|NCT00422383|1471625|P1|STARTED|Overall Study||134
601678|NCT00422292|1471768|P4|NOT COMPLETED|Overall Study||24
601679|NCT00422292|1471769|P3|NOT COMPLETED|Overall Study||22
601680|NCT00422292|1471770|P2|NOT COMPLETED|Overall Study||66
601681|NCT00422292|1471771|P1|NOT COMPLETED|Overall Study||18
601682|NCT00422292|1471768|P4|COMPLETED|Overall Study||452
601683|NCT00422292|1471769|P3|COMPLETED|Overall Study||224
601684|NCT00422292|1471770|P2|COMPLETED|Overall Study||598
601685|NCT00422292|1471771|P1|COMPLETED|Overall Study||239
601686|NCT00422292|1471768|P4|STARTED|Overall Study||476
601687|NCT00422292|1471769|P3|STARTED|Overall Study||246
601688|NCT00422292|1471770|P2|STARTED|Overall Study||664
601689|NCT00422292|1471771|P1|STARTED|Overall Study||257
601690|NCT00422279|1471799|P2|NOT COMPLETED|Overall Study||0
601691|NCT00422279|1471800|P1|NOT COMPLETED|Overall Study||0
601692|NCT00422279|1471799|P2|COMPLETED|Overall Study||2
601693|NCT00422279|1471800|P1|COMPLETED|Overall Study||2
601694|NCT00422279|1471799|P2|24 Month After Loading Period|Overall Study||2
601695|NCT00422279|1471800|P1|24 Month After Loading Period|Overall Study||2
601696|NCT00422279|1471799|P2|STARTED|Overall Study||2
601697|NCT00422279|1471800|P1|STARTED|Overall Study||2
601698|NCT00422227|1471810|P2|NOT COMPLETED|Overall Study||15
601699|NCT00422227|1471811|P1|NOT COMPLETED|Overall Study||4
601700|NCT00422227|1471810|P2|COMPLETED|Overall Study||88
601701|NCT00422227|1471811|P1|COMPLETED|Overall Study||193
601702|NCT00422227|1471810|P2|STARTED|Overall Study||103
601703|NCT00422227|1471811|P1|STARTED|Overall Study||197
601704|NCT00422201|1471835|P1|NOT COMPLETED|Overall Study||11
601705|NCT00422201|1471835|P1|COMPLETED|Overall Study||7
601706|NCT00422201|1471835|P1|STARTED|Overall Study||18
601707|NCT00422162|1471841|P2|NOT COMPLETED|Overall Study||30
601708|NCT00422162|1471842|P1|NOT COMPLETED|Overall Study||24
601709|NCT00422162|1471841|P2|COMPLETED|Overall Study||142
601710|NCT00422162|1471842|P1|COMPLETED|Overall Study||143
601711|NCT00422162|1471841|P2|Received Treatment|Overall Study||171
601712|NCT00422162|1471842|P1|Received Treatment|Overall Study||167
601713|NCT00422162|1471841|P2|STARTED|Overall Study||172
601714|NCT00422162|1471842|P1|STARTED|Overall Study||167
601715|NCT00422097|1471902|P8|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
601716|NCT00422097|1471903|P7|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
601717|NCT00422097|1471904|P6|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
601718|NCT00422097|1471905|P5|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
601719|NCT00422097|1471906|P4|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
601720|NCT00422097|1471907|P3|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
601721|NCT00422097|1471908|P2|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
601722|NCT00422097|1471909|P1|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
601723|NCT00422097|1471902|P8|COMPLETED|Ixabepilone With Famotidine or Food||7
601724|NCT00422097|1471903|P7|COMPLETED|Ixabepilone With Famotidine or Food||8
601725|NCT00422097|1471904|P6|COMPLETED|Ixabepilone With Famotidine or Food||0
601726|NCT00422097|1471905|P5|COMPLETED|Ixabepilone With Famotidine or Food||0
601727|NCT00422097|1471906|P4|COMPLETED|Ixabepilone With Famotidine or Food||0
601728|NCT00422097|1471907|P3|COMPLETED|Ixabepilone With Famotidine or Food||0
601729|NCT00422097|1471908|P2|COMPLETED|Ixabepilone With Famotidine or Food||0
601730|NCT00422097|1471909|P1|COMPLETED|Ixabepilone With Famotidine or Food||0
601731|NCT00422097|1471902|P8|STARTED|Ixabepilone With Famotidine or Food||7
601732|NCT00422097|1471903|P7|STARTED|Ixabepilone With Famotidine or Food||8
601733|NCT00422097|1471904|P6|STARTED|Ixabepilone With Famotidine or Food||0
601734|NCT00422097|1471905|P5|STARTED|Ixabepilone With Famotidine or Food||0
601735|NCT00422097|1471906|P4|STARTED|Ixabepilone With Famotidine or Food||0
601736|NCT00422097|1471907|P3|STARTED|Ixabepilone With Famotidine or Food||0
601737|NCT00422097|1471908|P2|STARTED|Ixabepilone With Famotidine or Food||0
601738|NCT00422097|1471909|P1|STARTED|Ixabepilone With Famotidine or Food||0
601739|NCT00422097|1471902|P8|NOT COMPLETED|Dose Level 6||0
601740|NCT00422097|1471903|P7|NOT COMPLETED|Dose Level 6||0
601741|NCT00422097|1471904|P6|NOT COMPLETED|Dose Level 6||0
601742|NCT00422097|1471905|P5|NOT COMPLETED|Dose Level 6||0
601743|NCT00422097|1471906|P4|NOT COMPLETED|Dose Level 6||0
601744|NCT00422097|1471907|P3|NOT COMPLETED|Dose Level 6||0
601745|NCT00422097|1471908|P2|NOT COMPLETED|Dose Level 6||0
601746|NCT00422097|1471909|P1|NOT COMPLETED|Dose Level 6||0
601747|NCT00422097|1471902|P8|COMPLETED|Dose Level 6||0
601748|NCT00422097|1471903|P7|COMPLETED|Dose Level 6||0
601749|NCT00422097|1471904|P6|COMPLETED|Dose Level 6||6
601750|NCT00422097|1471905|P5|COMPLETED|Dose Level 6||0
601751|NCT00422097|1471906|P4|COMPLETED|Dose Level 6||0
601752|NCT00422097|1471907|P3|COMPLETED|Dose Level 6||0
601753|NCT00422097|1471908|P2|COMPLETED|Dose Level 6||0
601754|NCT00422097|1471909|P1|COMPLETED|Dose Level 6||0
601755|NCT00422097|1471902|P8|STARTED|Dose Level 6||0
601756|NCT00422097|1471903|P7|STARTED|Dose Level 6||0
601757|NCT00422097|1471904|P6|STARTED|Dose Level 6||6
601758|NCT00422097|1471905|P5|STARTED|Dose Level 6||0
601759|NCT00422097|1471906|P4|STARTED|Dose Level 6||0
601760|NCT00422097|1471907|P3|STARTED|Dose Level 6||0
601761|NCT00422097|1471908|P2|STARTED|Dose Level 6||0
601762|NCT00422097|1471909|P1|STARTED|Dose Level 6||0
601763|NCT00422097|1471902|P8|NOT COMPLETED|Dose Level 5||0
601764|NCT00422097|1471903|P7|NOT COMPLETED|Dose Level 5||0
601765|NCT00422097|1471904|P6|NOT COMPLETED|Dose Level 5||0
601766|NCT00422097|1471905|P5|NOT COMPLETED|Dose Level 5||0
601767|NCT00422097|1471906|P4|NOT COMPLETED|Dose Level 5||0
601768|NCT00422097|1471907|P3|NOT COMPLETED|Dose Level 5||0
601769|NCT00422097|1471908|P2|NOT COMPLETED|Dose Level 5||0
601770|NCT00422097|1471909|P1|NOT COMPLETED|Dose Level 5||0
601771|NCT00422097|1471902|P8|COMPLETED|Dose Level 5||0
601772|NCT00422097|1471903|P7|COMPLETED|Dose Level 5||0
601773|NCT00422097|1471904|P6|COMPLETED|Dose Level 5||0
601774|NCT00422097|1471905|P5|COMPLETED|Dose Level 5||23
601775|NCT00422097|1471906|P4|COMPLETED|Dose Level 5||0
601776|NCT00422097|1471907|P3|COMPLETED|Dose Level 5||0
601777|NCT00422097|1471908|P2|COMPLETED|Dose Level 5||0
601778|NCT00422097|1471909|P1|COMPLETED|Dose Level 5||0
601779|NCT00422097|1471902|P8|STARTED|Dose Level 5||0
601780|NCT00422097|1471903|P7|STARTED|Dose Level 5||0
601781|NCT00422097|1471904|P6|STARTED|Dose Level 5||0
601782|NCT00422097|1471905|P5|STARTED|Dose Level 5||23
601783|NCT00422097|1471906|P4|STARTED|Dose Level 5||0
601784|NCT00422097|1471907|P3|STARTED|Dose Level 5||0
601785|NCT00422097|1471908|P2|STARTED|Dose Level 5||0
601786|NCT00422097|1471909|P1|STARTED|Dose Level 5||0
601787|NCT00422097|1471902|P8|NOT COMPLETED|Dose Level 4||0
601788|NCT00422097|1471903|P7|NOT COMPLETED|Dose Level 4||0
601789|NCT00422097|1471904|P6|NOT COMPLETED|Dose Level 4||0
601790|NCT00422097|1471905|P5|NOT COMPLETED|Dose Level 4||0
601791|NCT00422097|1471906|P4|NOT COMPLETED|Dose Level 4||0
601792|NCT00422097|1471907|P3|NOT COMPLETED|Dose Level 4||0
601793|NCT00422097|1471908|P2|NOT COMPLETED|Dose Level 4||0
601794|NCT00422097|1471909|P1|NOT COMPLETED|Dose Level 4||0
601795|NCT00422097|1471902|P8|COMPLETED|Dose Level 4||0
601796|NCT00422097|1471903|P7|COMPLETED|Dose Level 4||0
601797|NCT00422097|1471904|P6|COMPLETED|Dose Level 4||0
601798|NCT00422097|1471905|P5|COMPLETED|Dose Level 4||0
601799|NCT00422097|1471906|P4|COMPLETED|Dose Level 4||3
601800|NCT00422097|1471907|P3|COMPLETED|Dose Level 4||0
601801|NCT00422097|1471908|P2|COMPLETED|Dose Level 4||0
601802|NCT00422097|1471909|P1|COMPLETED|Dose Level 4||0
601803|NCT00422097|1471902|P8|STARTED|Dose Level 4||0
601804|NCT00422097|1471903|P7|STARTED|Dose Level 4||0
601805|NCT00422097|1471904|P6|STARTED|Dose Level 4||0
601806|NCT00422097|1471905|P5|STARTED|Dose Level 4||0
601807|NCT00422097|1471906|P4|STARTED|Dose Level 4||3
601808|NCT00422097|1471907|P3|STARTED|Dose Level 4||0
601809|NCT00422097|1471908|P2|STARTED|Dose Level 4||0
601810|NCT00422097|1471909|P1|STARTED|Dose Level 4||0
601811|NCT00422097|1471902|P8|NOT COMPLETED|Dose Level 3||0
601812|NCT00422097|1471903|P7|NOT COMPLETED|Dose Level 3||0
601813|NCT00422097|1471904|P6|NOT COMPLETED|Dose Level 3||0
601814|NCT00422097|1471905|P5|NOT COMPLETED|Dose Level 3||0
601815|NCT00422097|1471906|P4|NOT COMPLETED|Dose Level 3||0
601816|NCT00422097|1471907|P3|NOT COMPLETED|Dose Level 3||0
601817|NCT00422097|1471908|P2|NOT COMPLETED|Dose Level 3||0
601818|NCT00422097|1471909|P1|NOT COMPLETED|Dose Level 3||0
601819|NCT00422097|1471902|P8|COMPLETED|Dose Level 3||0
601820|NCT00422097|1471903|P7|COMPLETED|Dose Level 3||0
601821|NCT00422097|1471904|P6|COMPLETED|Dose Level 3||0
601822|NCT00422097|1471905|P5|COMPLETED|Dose Level 3||0
601823|NCT00422097|1471906|P4|COMPLETED|Dose Level 3||0
601824|NCT00422097|1471907|P3|COMPLETED|Dose Level 3||3
601825|NCT00422097|1471908|P2|COMPLETED|Dose Level 3||0
601826|NCT00422097|1471909|P1|COMPLETED|Dose Level 3||0
601827|NCT00422097|1471902|P8|STARTED|Dose Level 3||0
601828|NCT00422097|1471903|P7|STARTED|Dose Level 3||0
601829|NCT00422097|1471904|P6|STARTED|Dose Level 3||0
601830|NCT00422097|1471905|P5|STARTED|Dose Level 3||0
601831|NCT00422097|1471906|P4|STARTED|Dose Level 3||0
601832|NCT00422097|1471907|P3|STARTED|Dose Level 3||3
601833|NCT00422097|1471908|P2|STARTED|Dose Level 3||0
601834|NCT00422097|1471909|P1|STARTED|Dose Level 3||0
601835|NCT00422097|1471902|P8|NOT COMPLETED|Dose Level 2||0
601836|NCT00422097|1471903|P7|NOT COMPLETED|Dose Level 2||0
601837|NCT00422097|1471904|P6|NOT COMPLETED|Dose Level 2||0
601838|NCT00422097|1471905|P5|NOT COMPLETED|Dose Level 2||0
601839|NCT00422097|1471906|P4|NOT COMPLETED|Dose Level 2||0
601840|NCT00422097|1471907|P3|NOT COMPLETED|Dose Level 2||0
601841|NCT00422097|1471908|P2|NOT COMPLETED|Dose Level 2||1
601842|NCT00422097|1471909|P1|NOT COMPLETED|Dose Level 2||0
601843|NCT00422097|1471902|P8|COMPLETED|Dose Level 2||0
601844|NCT00422097|1471903|P7|COMPLETED|Dose Level 2||0
601845|NCT00422097|1471904|P6|COMPLETED|Dose Level 2||0
601846|NCT00422097|1471905|P5|COMPLETED|Dose Level 2||0
601847|NCT00422097|1471906|P4|COMPLETED|Dose Level 2||0
601848|NCT00422097|1471907|P3|COMPLETED|Dose Level 2||0
601849|NCT00422097|1471908|P2|COMPLETED|Dose Level 2||5
601850|NCT00422097|1471909|P1|COMPLETED|Dose Level 2||0
601851|NCT00422097|1471902|P8|STARTED|Dose Level 2||0
601852|NCT00422097|1471903|P7|STARTED|Dose Level 2||0
601853|NCT00422097|1471904|P6|STARTED|Dose Level 2||0
601854|NCT00422097|1471905|P5|STARTED|Dose Level 2||0
601855|NCT00422097|1471906|P4|STARTED|Dose Level 2||0
601856|NCT00422097|1471907|P3|STARTED|Dose Level 2||0
601857|NCT00422097|1471908|P2|STARTED|Dose Level 2||6
601858|NCT00422097|1471909|P1|STARTED|Dose Level 2||0
601859|NCT00422097|1471902|P8|NOT COMPLETED|Dose Level 1||0
601860|NCT00422097|1471903|P7|NOT COMPLETED|Dose Level 1||0
601861|NCT00422097|1471904|P6|NOT COMPLETED|Dose Level 1||0
601862|NCT00422097|1471905|P5|NOT COMPLETED|Dose Level 1||0
601863|NCT00422097|1471906|P4|NOT COMPLETED|Dose Level 1||0
601864|NCT00422097|1471907|P3|NOT COMPLETED|Dose Level 1||0
601865|NCT00422097|1471908|P2|NOT COMPLETED|Dose Level 1||0
601866|NCT00422097|1471909|P1|NOT COMPLETED|Dose Level 1||0
601867|NCT00422097|1471902|P8|COMPLETED|Dose Level 1||0
601868|NCT00422097|1471903|P7|COMPLETED|Dose Level 1||0
601869|NCT00422097|1471904|P6|COMPLETED|Dose Level 1||0
601870|NCT00422097|1471905|P5|COMPLETED|Dose Level 1||0
601871|NCT00422097|1471906|P4|COMPLETED|Dose Level 1||0
601872|NCT00422097|1471907|P3|COMPLETED|Dose Level 1||0
601873|NCT00422097|1471908|P2|COMPLETED|Dose Level 1||0
601874|NCT00422097|1471909|P1|COMPLETED|Dose Level 1||3
601875|NCT00422097|1471902|P8|STARTED|Dose Level 1||0
601876|NCT00422097|1471903|P7|STARTED|Dose Level 1||0
601877|NCT00422097|1471904|P6|STARTED|Dose Level 1||0
601878|NCT00422097|1471905|P5|STARTED|Dose Level 1||0
601879|NCT00422097|1471906|P4|STARTED|Dose Level 1||0
601880|NCT00422097|1471907|P3|STARTED|Dose Level 1||0
601881|NCT00422097|1471908|P2|STARTED|Dose Level 1||0
601882|NCT00422097|1471909|P1|STARTED|Dose Level 1||3
601883|NCT00422058|1471974|P6|NOT COMPLETED|Open-Label Extension, Week 20-104||34
601884|NCT00422058|1471975|P5|NOT COMPLETED|Open-Label Extension, Week 20-104||35
601885|NCT00422058|1471976|P4|NOT COMPLETED|Open-Label Extension, Week 20-104||28
601886|NCT00422058|1471977|P3|NOT COMPLETED|Open-Label Extension, Week 20-104||36
601887|NCT00422058|1471978|P2|NOT COMPLETED|Open-Label Extension, Week 20-104||39
601888|NCT00422058|1471979|P1|NOT COMPLETED|Open-Label Extension, Week 20-104||32
601889|NCT00422058|1471974|P6|COMPLETED|Open-Label Extension, Week 20-104||45
601890|NCT00422058|1471975|P5|COMPLETED|Open-Label Extension, Week 20-104||47
601891|NCT00422058|1471976|P4|COMPLETED|Open-Label Extension, Week 20-104||45
601892|NCT00422058|1471977|P3|COMPLETED|Open-Label Extension, Week 20-104||38
601893|NCT00422058|1471978|P2|COMPLETED|Open-Label Extension, Week 20-104||46
601894|NCT00422058|1471979|P1|COMPLETED|Open-Label Extension, Week 20-104||47
601895|NCT00422058|1471974|P6|Enrolled in Extension|Open-Label Extension, Week 20-104||67
601896|NCT00422058|1471975|P5|Enrolled in Extension|Open-Label Extension, Week 20-104||72
601897|NCT00422058|1471976|P4|Enrolled in Extension|Open-Label Extension, Week 20-104||65
601898|NCT00422058|1471977|P3|Enrolled in Extension|Open-Label Extension, Week 20-104||59
601899|NCT00422058|1471978|P2|Enrolled in Extension|Open-Label Extension, Week 20-104||68
601900|NCT00422058|1471979|P1|Enrolled in Extension|Open-Label Extension, Week 20-104||67
601901|NCT00422058|1471974|P6|STARTED|Open-Label Extension, Week 20-104||79
601902|NCT00422058|1471975|P5|STARTED|Open-Label Extension, Week 20-104||82
601903|NCT00422058|1471976|P4|STARTED|Open-Label Extension, Week 20-104||73
601904|NCT00422058|1471977|P3|STARTED|Open-Label Extension, Week 20-104||74
601905|NCT00422058|1471978|P2|STARTED|Open-Label Extension, Week 20-104||85
601906|NCT00422058|1471979|P1|STARTED|Open-Label Extension, Week 20-104||79
601907|NCT00422058|1471974|P6|NOT COMPLETED|Double-Blind, Week 0-20||16
601908|NCT00422058|1471975|P5|NOT COMPLETED|Double-Blind, Week 0-20||11
601909|NCT00422058|1471976|P4|NOT COMPLETED|Double-Blind, Week 0-20||20
601910|NCT00422058|1471977|P3|NOT COMPLETED|Double-Blind, Week 0-20||16
601911|NCT00422058|1471978|P2|NOT COMPLETED|Double-Blind, Week 0-20||10
601912|NCT00422058|1471979|P1|NOT COMPLETED|Double-Blind, Week 0-20||19
601913|NCT00422058|1471974|P6|COMPLETED|Double-Blind, Week 0-20||79
601914|NCT00422058|1471975|P5|COMPLETED|Double-Blind, Week 0-20||82
601915|NCT00422058|1471976|P4|COMPLETED|Double-Blind, Week 0-20||73
601916|NCT00422058|1471977|P3|COMPLETED|Double-Blind, Week 0-20||74
601917|NCT00422058|1471978|P2|COMPLETED|Double-Blind, Week 0-20||85
601918|NCT00422058|1471979|P1|COMPLETED|Double-Blind, Week 0-20||79
601919|NCT00422058|1471974|P6|STARTED|Double-Blind, Week 0-20||95
601920|NCT00422058|1471975|P5|STARTED|Double-Blind, Week 0-20||93
601921|NCT00422058|1471976|P4|STARTED|Double-Blind, Week 0-20||93
601922|NCT00422058|1471977|P3|STARTED|Double-Blind, Week 0-20||90
601923|NCT00422058|1471978|P2|STARTED|Double-Blind, Week 0-20||95
601924|NCT00422058|1471979|P1|STARTED|Double-Blind, Week 0-20||98
601925|NCT00422032|1472109|P2|NOT COMPLETED|Overall Study||0
601926|NCT00422032|1472110|P1|NOT COMPLETED|Overall Study||0
601927|NCT00422032|1472109|P2|COMPLETED|Overall Study||21
601928|NCT00422032|1472110|P1|COMPLETED|Overall Study||37
601929|NCT00422032|1472109|P2|STARTED|Overall Study||21
601930|NCT00422032|1472110|P1|STARTED|Overall Study||37
601931|NCT00421993|1472120|P4|NOT COMPLETED|Overall Study||57
601932|NCT00421993|1472121|P3|NOT COMPLETED|Overall Study||52
601933|NCT00421993|1472122|P2|NOT COMPLETED|Overall Study||49
601934|NCT00421993|1472123|P1|NOT COMPLETED|Overall Study||53
601935|NCT00421993|1472120|P4|COMPLETED|Overall Study||361
601936|NCT00421993|1472121|P3|COMPLETED|Overall Study||363
601937|NCT00421993|1472122|P2|COMPLETED|Overall Study||369
601938|NCT00421993|1472123|P1|COMPLETED|Overall Study||366
601939|NCT00421993|1472120|P4|STARTED|Overall Study||418
601940|NCT00421993|1472121|P3|STARTED|Overall Study||415
601941|NCT00421993|1472122|P2|STARTED|Overall Study||418
601942|NCT00421993|1472123|P1|STARTED|Overall Study||419
601943|NCT00421954|1472153|P1|NOT COMPLETED|Overall Study||0
601944|NCT00421954|1472153|P1|COMPLETED|Overall Study||0
601945|NCT00421954|1472153|P1|STARTED|Overall Study||0
601946|NCT00421928|1472160|P3|NOT COMPLETED|Overall Study||134
601947|NCT00421928|1472161|P2|NOT COMPLETED|Overall Study||224
601948|NCT00421928|1472162|P1|NOT COMPLETED|Overall Study||163
601949|NCT00421928|1472160|P3|COMPLETED|Overall Study||203
601950|NCT00421928|1472161|P2|COMPLETED|Overall Study||118
601951|NCT00421928|1472162|P1|COMPLETED|Overall Study||181
601952|NCT00421928|1472160|P3|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug|337
601953|NCT00421928|1472161|P2|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug. One subject was enrolled twice.|342
601954|NCT00421928|1472162|P1|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug|344
601955|NCT00421889|1472197|P9|NOT COMPLETED|Overall Study||11
601956|NCT00421889|1472198|P8|NOT COMPLETED|Overall Study||2
601957|NCT00421889|1472199|P7|NOT COMPLETED|Overall Study||4
601958|NCT00421889|1472200|P6|NOT COMPLETED|Overall Study||35
601959|NCT00421889|1472201|P5|NOT COMPLETED|Overall Study||6
601960|NCT00421889|1472202|P4|NOT COMPLETED|Overall Study||4
601961|NCT00421889|1472203|P3|NOT COMPLETED|Overall Study||3
601962|NCT00421889|1472204|P2|NOT COMPLETED|Overall Study||5
601963|NCT00421889|1472205|P1|NOT COMPLETED|Overall Study||5
601964|NCT00421889|1472197|P9|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 4.27|4
601965|NCT00421889|1472198|P8|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 3.33|1
601966|NCT00421889|1472199|P7|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.50|0
601967|NCT00421889|1472200|P6|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 7.69|0
601968|NCT00421889|1472201|P5|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.00|0
601969|NCT00421889|1472202|P4|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 9.25|0
601970|NCT00421889|1472203|P3|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 3.33|0
601971|NCT00421889|1472204|P2|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 8.20|0
601972|NCT00421889|1472205|P1|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.20|0
601973|NCT00421889|1472197|P9|STARTED|Overall Study||15
601974|NCT00421889|1472198|P8|STARTED|Overall Study||3
601975|NCT00421889|1472199|P7|STARTED|Overall Study||4
601976|NCT00421889|1472200|P6|STARTED|Overall Study||35
601977|NCT00421889|1472201|P5|STARTED|Overall Study||6
601978|NCT00421889|1472202|P4|STARTED|Overall Study||4
601979|NCT00421889|1472203|P3|STARTED|Overall Study||3
601980|NCT00421889|1472204|P2|STARTED|Overall Study||5
601981|NCT00421889|1472205|P1|STARTED|Overall Study||5
601982|NCT00421733|1472250|P3|NOT COMPLETED|Overall Study||20
601983|NCT00421733|1472251|P2|NOT COMPLETED|Overall Study||26
601984|NCT00421733|1472252|P1|NOT COMPLETED|Overall Study||15
601985|NCT00421733|1472250|P3|COMPLETED|Overall Study||73
601986|NCT00421733|1472251|P2|COMPLETED|Overall Study||69
601987|NCT00421733|1472252|P1|COMPLETED|Overall Study||78
601988|NCT00421733|1472250|P3|STARTED|Overall Study||93
601989|NCT00421733|1472251|P2|STARTED|Overall Study||95
601990|NCT00421733|1472252|P1|STARTED|Overall Study||93
601991|NCT00421707|1472272|P2|NOT COMPLETED|Period 3:Treatment Period 2||3
601992|NCT00421707|1472273|P1|NOT COMPLETED|Period 3:Treatment Period 2||2
601993|NCT00421707|1472272|P2|COMPLETED|Period 3:Treatment Period 2||49
601994|NCT00421707|1472273|P1|COMPLETED|Period 3:Treatment Period 2||53
601995|NCT00421707|1472272|P2|STARTED|Period 3:Treatment Period 2||52
601996|NCT00421707|1472273|P1|STARTED|Period 3:Treatment Period 2||55
601997|NCT00421707|1472272|P2|NOT COMPLETED|Period 2: Washout||4
601998|NCT00421707|1472273|P1|NOT COMPLETED|Period 2: Washout||1
601999|NCT00421707|1472272|P2|COMPLETED|Period 2: Washout||52
602000|NCT00421707|1472273|P1|COMPLETED|Period 2: Washout||55
602001|NCT00421707|1472272|P2|STARTED|Period 2: Washout||56
602002|NCT00421707|1472273|P1|STARTED|Period 2: Washout||56
602003|NCT00421707|1472272|P2|NOT COMPLETED|Period 1: Treatment Period 1||9
602004|NCT00421707|1472273|P1|NOT COMPLETED|Period 1: Treatment Period 1||11
602005|NCT00421707|1472272|P2|COMPLETED|Period 1: Treatment Period 1||56
602006|NCT00421707|1472273|P1|COMPLETED|Period 1: Treatment Period 1||56
602007|NCT00421707|1472272|P2|STARTED|Period 1: Treatment Period 1||65
602008|NCT00421707|1472273|P1|STARTED|Period 1: Treatment Period 1||67
602009|NCT00421603|1472315|P2|NOT COMPLETED|Overall Study||12
602010|NCT00421603|1472316|P1|NOT COMPLETED|Overall Study||11
602011|NCT00421603|1472315|P2|COMPLETED|Overall Study|Completed all 14 week sof trial|30
602012|NCT00421603|1472316|P1|COMPLETED|Overall Study|Completed all 14 week sof trial|28
602013|NCT00421603|1472315|P2|STARTED|Overall Study||42
602014|NCT00421603|1472316|P1|STARTED|Overall Study||39
602015|NCT00421408|1472324|P2|NOT COMPLETED|Overall Study||45
602016|NCT00421408|1472325|P1|NOT COMPLETED|Overall Study||42
602017|NCT00421408|1472324|P2|COMPLETED|Overall Study||61
602018|NCT00421408|1472325|P1|COMPLETED|Overall Study||60
602019|NCT00421408|1472324|P2|STARTED|Overall Study||106
602020|NCT00421408|1472325|P1|STARTED|Overall Study||102
602021|NCT00421343|1472343|P1|NOT COMPLETED|Overall Study||6
602022|NCT00421343|1472343|P1|COMPLETED|Overall Study||23
602023|NCT00421343|1472343|P1|STARTED|Overall Study||29
602024|NCT00421174|1472349|P2|NOT COMPLETED|Overall Study||1
602025|NCT00421174|1472350|P1|NOT COMPLETED|Overall Study||2
602026|NCT00421174|1472349|P2|COMPLETED|Overall Study||18
602027|NCT00421174|1472350|P1|COMPLETED|Overall Study||16
602028|NCT00421174|1472349|P2|STARTED|Overall Study||19
602029|NCT00421174|1472350|P1|STARTED|Overall Study||18
602030|NCT00420992|1472380|P2|NOT COMPLETED|Maintenance Phase||75
602031|NCT00420992|1472381|P1|NOT COMPLETED|Maintenance Phase||61
602032|NCT00420992|1472380|P2|COMPLETED|Maintenance Phase||98
602033|NCT00420992|1472381|P1|COMPLETED|Maintenance Phase||110
602034|NCT00420992|1472380|P2|STARTED|Maintenance Phase||173
602035|NCT00420992|1472381|P1|STARTED|Maintenance Phase||171
602036|NCT00420992|1472380|P2|NOT COMPLETED|Titration Phase||0
602037|NCT00420992|1472381|P1|NOT COMPLETED|Titration Phase||203
602038|NCT00420992|1472380|P2|COMPLETED|Titration Phase||0
602039|NCT00420992|1472381|P1|COMPLETED|Titration Phase||344
602040|NCT00420992|1472380|P2|STARTED|Titration Phase||0
602041|NCT00420992|1472381|P1|STARTED|Titration Phase|All patients received ALO-01 during open-label titration phase|547
602042|NCT00420927|1472395|P7|NOT COMPLETED|Period 2||53
602043|NCT00420927|1472396|P6|NOT COMPLETED|Period 2||15
602044|NCT00420927|1472397|P5|NOT COMPLETED|Period 2||43
602045|NCT00420927|1472398|P4|NOT COMPLETED|Period 2||10
602046|NCT00420927|1472399|P3|NOT COMPLETED|Period 2||13
602047|NCT00420927|1472400|P2|NOT COMPLETED|Period 2||0
602048|NCT00420927|1472401|P1|NOT COMPLETED|Period 2||0
602049|NCT00420927|1472395|P7|COMPLETED|Period 2||295
602050|NCT00420927|1472396|P6|COMPLETED|Period 2||97
602051|NCT00420927|1472397|P5|COMPLETED|Period 2||216
602052|NCT00420927|1472398|P4|COMPLETED|Period 2||95
602053|NCT00420927|1472399|P3|COMPLETED|Period 2||89
602054|NCT00420927|1472400|P2|COMPLETED|Period 2||0
602055|NCT00420927|1472401|P1|COMPLETED|Period 2||0
602056|NCT00420927|1472395|P7|STARTED|Period 2||348
602057|NCT00420927|1472396|P6|STARTED|Period 2||112
602058|NCT00420927|1472397|P5|STARTED|Period 2||259
602059|NCT00420927|1472398|P4|STARTED|Period 2||105
602060|NCT00420927|1472399|P3|STARTED|Period 2||102
602061|NCT00420927|1472400|P2|STARTED|Period 2|This treatment group is not relevant to Period 2.|0
602062|NCT00420927|1472401|P1|STARTED|Period 2|This treatment group is not relevant to Period 2.|0
602063|NCT00420927|1472395|P7|NOT COMPLETED|Period 1||0
602064|NCT00420927|1472396|P6|NOT COMPLETED|Period 1||0
602065|NCT00420927|1472397|P5|NOT COMPLETED|Period 1||0
602066|NCT00420927|1472398|P4|NOT COMPLETED|Period 1||0
602067|NCT00420927|1472399|P3|NOT COMPLETED|Period 1||0
602068|NCT00420927|1472400|P2|NOT COMPLETED|Period 1||57
602069|NCT00420927|1472401|P1|NOT COMPLETED|Period 1||49
602070|NCT00420927|1472395|P7|COMPLETED|Period 1||0
602071|NCT00420927|1472396|P6|COMPLETED|Period 1||0
602072|NCT00420927|1472397|P5|COMPLETED|Period 1||0
602073|NCT00420927|1472398|P4|COMPLETED|Period 1||0
602074|NCT00420927|1472399|P3|COMPLETED|Period 1||0
602075|NCT00420927|1472400|P2|COMPLETED|Period 1||460
602076|NCT00420927|1472401|P1|COMPLETED|Period 1||466
602077|NCT00420927|1472395|P7|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
602078|NCT00420927|1472396|P6|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
602079|NCT00420927|1472397|P5|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
602080|NCT00420927|1472398|P4|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
602081|NCT00420927|1472399|P3|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
602082|NCT00420927|1472400|P2|STARTED|Period 1||517
602083|NCT00420927|1472401|P1|STARTED|Period 1||515
602084|NCT00420849|1472505|P1|NOT COMPLETED|Overall Study||331
602085|NCT00420849|1472505|P1|COMPLETED|Overall Study|Participants completed the study upon commercial availability of lenalidomide|256
602086|NCT00420849|1472505|P1|STARTED|Overall Study||587
602087|NCT00420784|1472574|P4|NOT COMPLETED|Overall Study||78
602088|NCT00420784|1472575|P3|NOT COMPLETED|Overall Study||53
602089|NCT00420784|1472576|P2|NOT COMPLETED|Overall Study||58
602090|NCT00420784|1472577|P1|NOT COMPLETED|Overall Study||29
602091|NCT00420784|1472574|P4|COMPLETED|Overall Study||36
602092|NCT00420784|1472575|P3|COMPLETED|Overall Study||58
602093|NCT00420784|1472576|P2|COMPLETED|Overall Study||55
602094|NCT00420784|1472577|P1|COMPLETED|Overall Study||86
602095|NCT00420784|1472574|P4|STARTED|Overall Study||114
602096|NCT00420784|1472575|P3|STARTED|Overall Study||111
602097|NCT00420784|1472576|P2|STARTED|Overall Study||113
602098|NCT00420784|1472577|P1|STARTED|Overall Study||115
602099|NCT00420745|1472606|P2|NOT COMPLETED|Overall Study||6
602100|NCT00420745|1472607|P1|NOT COMPLETED|Overall Study||15
602101|NCT00420745|1472606|P2|COMPLETED|Overall Study||333
602102|NCT00420745|1472607|P1|COMPLETED|Overall Study||655
602103|NCT00420745|1472606|P2|STARTED|Overall Study||339
602104|NCT00420745|1472607|P1|STARTED|Overall Study||670
602105|NCT00420641|1472626|P3|NOT COMPLETED|Overall Study||44
602106|NCT00420641|1472627|P2|NOT COMPLETED|Overall Study||72
602107|NCT00420641|1472628|P1|NOT COMPLETED|Overall Study||45
602108|NCT00420641|1472626|P3|COMPLETED|Overall Study||128
602109|NCT00420641|1472627|P2|COMPLETED|Overall Study||100
602110|NCT00420641|1472628|P1|COMPLETED|Overall Study||115
602111|NCT00420641|1472626|P3|STARTED|Overall Study||172
602112|NCT00420641|1472627|P2|STARTED|Overall Study||172
602113|NCT00420641|1472628|P1|STARTED|Overall Study||160
602114|NCT00420628|1472704|P2|NOT COMPLETED|Overall Study||4
602115|NCT00420628|1472705|P1|NOT COMPLETED|Overall Study||9
602116|NCT00420628|1472704|P2|COMPLETED|Overall Study||32
602117|NCT00420628|1472705|P1|COMPLETED|Overall Study||63
602118|NCT00420628|1472704|P2|STARTED|Overall Study||36
602119|NCT00420628|1472705|P1|STARTED|Overall Study||72
602120|NCT00420511|1472721|P2|NOT COMPLETED|Overall Study||1
602121|NCT00420511|1472722|P1|NOT COMPLETED|Overall Study||2
602122|NCT00420511|1472721|P2|COMPLETED|Overall Study||10
602123|NCT00420511|1472722|P1|COMPLETED|Overall Study||8
602124|NCT00420511|1472721|P2|STARTED|Overall Study||11
602125|NCT00420511|1472722|P1|STARTED|Overall Study||10
602126|NCT00420459|1472732|P1|NOT COMPLETED|Overall Study||0
602127|NCT00420459|1472732|P1|COMPLETED|Overall Study||12
602128|NCT00420459|1472732|P1|STARTED|Overall Study||12
602129|NCT00420420|1472743|P2|NOT COMPLETED|Overall Study||4
602130|NCT00420420|1472744|P1|NOT COMPLETED|Overall Study||8
602131|NCT00420420|1472743|P2|COMPLETED|Overall Study||67
602132|NCT00420420|1472744|P1|COMPLETED|Overall Study|One patient from the MK-0249 arm discontinued the trial due to an AE prior to receiving study drug.|65
602133|NCT00420420|1472743|P2|STARTED|Overall Study|Number of patients randomized.|71
602134|NCT00420420|1472744|P1|STARTED|Overall Study|Number of patients randomized.|73
602135|NCT00420407|1472762|P2|NOT COMPLETED|Overall Study||6
602136|NCT00420407|1472763|P1|NOT COMPLETED|Overall Study||4
602137|NCT00420407|1472762|P2|COMPLETED|Overall Study||34
602138|NCT00420407|1472763|P1|COMPLETED|Overall Study||37
602139|NCT00420407|1472762|P2|STARTED|Overall Study||40
602140|NCT00420407|1472763|P1|STARTED|Overall Study||41
602141|NCT00420342|1472772|P3|NOT COMPLETED|Overall Study||1
602142|NCT00420342|1472773|P2|NOT COMPLETED|Overall Study||2
602143|NCT00420342|1472774|P1|NOT COMPLETED|Overall Study||1
602144|NCT00420342|1472772|P3|COMPLETED|Overall Study||28
602145|NCT00420342|1472773|P2|COMPLETED|Overall Study||31
602146|NCT00420342|1472774|P1|COMPLETED|Overall Study||29
602147|NCT00420342|1472772|P3|Received Treatment|Overall Study||29
602148|NCT00420342|1472773|P2|Received Treatment|Overall Study|1 subject did not confirm if she ever took the study medication.|32
602149|NCT00420342|1472774|P1|Received Treatment|Overall Study|1 subject did not confirm if she ever took the study medication.|29
602150|NCT00420342|1472772|P3|STARTED|Overall Study||29
602151|NCT00420342|1472773|P2|STARTED|Overall Study||33
602152|NCT00420342|1472774|P1|STARTED|Overall Study||30
602153|NCT00420316|1472817|P2|NOT COMPLETED|Overall Study||9
602154|NCT00420316|1472818|P1|NOT COMPLETED|Overall Study||12
602155|NCT00420316|1472817|P2|COMPLETED|Overall Study||522
602156|NCT00420316|1472818|P1|COMPLETED|Overall Study||1070
602157|NCT00420316|1472817|P2|STARTED|Overall Study||531
602158|NCT00420316|1472818|P1|STARTED|Overall Study||1082
602159|NCT00420303|1472842|P2|NOT COMPLETED|Overall Study||4
602160|NCT00420303|1472843|P1|NOT COMPLETED|Overall Study||1
602161|NCT00420303|1472842|P2|COMPLETED|Overall Study||8
602162|NCT00420303|1472843|P1|COMPLETED|Overall Study||11
602163|NCT00420303|1472842|P2|STARTED|Overall Study||12
602164|NCT00420303|1472843|P1|STARTED|Overall Study||12
602165|NCT00420290|1472855|P2|NOT COMPLETED|Overall Study||4
602166|NCT00420290|1472856|P1|NOT COMPLETED|Overall Study||4
602167|NCT00420290|1472855|P2|COMPLETED|Overall Study||7
602168|NCT00420290|1472856|P1|COMPLETED|Overall Study||7
602169|NCT00420290|1472855|P2|STARTED|Overall Study||11
602170|NCT00420290|1472856|P1|STARTED|Overall Study||11
602171|NCT00420238|1472872|P2|NOT COMPLETED|12 Week Open-Label Treatment Period 2||1
602172|NCT00420238|1472873|P1|NOT COMPLETED|12 Week Open-Label Treatment Period 2||2
602173|NCT00420238|1472872|P2|COMPLETED|12 Week Open-Label Treatment Period 2||38
602174|NCT00420238|1472873|P1|COMPLETED|12 Week Open-Label Treatment Period 2||36
602175|NCT00420238|1472872|P2|STARTED|12 Week Open-Label Treatment Period 2||39
602176|NCT00420238|1472873|P1|STARTED|12 Week Open-Label Treatment Period 2||38
602177|NCT00420238|1472872|P2|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||4
602178|NCT00420238|1472873|P1|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||1
602179|NCT00420238|1472872|P2|COMPLETED|12 Week Double-Blind Treatment Period 1||39
602180|NCT00420238|1472873|P1|COMPLETED|12 Week Double-Blind Treatment Period 1||38
602181|NCT00420238|1472872|P2|STARTED|12 Week Double-Blind Treatment Period 1||43
602182|NCT00420238|1472873|P1|STARTED|12 Week Double-Blind Treatment Period 1||39
602183|NCT00420212|1473012|P3|NOT COMPLETED|Overall Study||96
602184|NCT00420212|1473013|P2|NOT COMPLETED|Overall Study||95
602185|NCT00420212|1473014|P1|NOT COMPLETED|Overall Study||91
602186|NCT00420212|1473012|P3|COMPLETED|Overall Study||320
602187|NCT00420212|1473013|P2|COMPLETED|Overall Study||315
602188|NCT00420212|1473014|P1|COMPLETED|Overall Study||317
602189|NCT00420212|1473012|P3|STARTED|Overall Study|416 participants were dosed; 416 participants were randomized|416
602190|NCT00420212|1473013|P2|STARTED|Overall Study|410 participants were dosed; 411 participants were randomized|410
602191|NCT00420212|1473014|P1|STARTED|Overall Study|408 participants were dosed; 410 participants were randomized|408
602192|NCT00420199|1473040|P2|NOT COMPLETED|Overall Study||0
602193|NCT00420199|1473041|P1|NOT COMPLETED|Overall Study||1
602194|NCT00420199|1473040|P2|COMPLETED|Overall Study||23
602195|NCT00420199|1473041|P1|COMPLETED|Overall Study||26
602196|NCT00420199|1473040|P2|STARTED|Overall Study||23
602197|NCT00420199|1473041|P1|STARTED|Overall Study||27
602198|NCT00420147|1473096|P2|NOT COMPLETED|Overall Study||0
602199|NCT00420147|1473097|P1|NOT COMPLETED|Overall Study||0
602200|NCT00420147|1473096|P2|COMPLETED|Overall Study||19
602201|NCT00420147|1473097|P1|COMPLETED|Overall Study||19
602202|NCT00420147|1473096|P2|STARTED|Overall Study||19
602203|NCT00420147|1473097|P1|STARTED|Overall Study||19
602204|NCT00420095|1473107|P2|NOT COMPLETED|Overall Study||1
602205|NCT00420095|1473108|P1|NOT COMPLETED|Overall Study||3
602206|NCT00420095|1473107|P2|COMPLETED|Overall Study||59
602207|NCT00420095|1473108|P1|COMPLETED|Overall Study||54
602208|NCT00420095|1473107|P2|STARTED|Overall Study||60
602209|NCT00420095|1473108|P1|STARTED|Overall Study||57
602210|NCT00420056|1473126|P1|NOT COMPLETED|Overall Study||17
602211|NCT00420056|1473126|P1|COMPLETED|Overall Study||0
602212|NCT00420056|1473126|P1|STARTED|Overall Study||17
602213|NCT00420017|1473150|P2|NOT COMPLETED|Overall Study||0
602214|NCT00420017|1473151|P1|NOT COMPLETED|Overall Study||2
602215|NCT00420017|1473150|P2|COMPLETED|Overall Study||40
602216|NCT00420017|1473151|P1|COMPLETED|Overall Study|40 completed analysis|38
602217|NCT00420017|1473150|P2|STARTED|Overall Study||40
602218|NCT00420017|1473151|P1|STARTED|Overall Study||40
602219|NCT00420004|1473166|P3|NOT COMPLETED|Overall Study||32
602220|NCT00420004|1473167|P2|NOT COMPLETED|Overall Study||71
602221|NCT00420004|1473168|P1|NOT COMPLETED|Overall Study||129
602222|NCT00420004|1473166|P3|COMPLETED|Overall Study||30
602223|NCT00420004|1473167|P2|COMPLETED|Overall Study||67
602224|NCT00420004|1473168|P1|COMPLETED|Overall Study||140
602225|NCT00420004|1473166|P3|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|54
602226|NCT00420004|1473167|P2|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|122
602227|NCT00420004|1473168|P1|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|249
602228|NCT00420004|1473166|P3|STARTED|Overall Study||62
602229|NCT00420004|1473167|P2|STARTED|Overall Study||138
602230|NCT00420004|1473168|P1|STARTED|Overall Study||269
602231|NCT00419952|1473233|P2|NOT COMPLETED|Overall Study||125
602232|NCT00419952|1473234|P1|NOT COMPLETED|Overall Study||149
602233|NCT00419952|1473233|P2|COMPLETED|Overall Study||240
602234|NCT00419952|1473234|P1|COMPLETED|Overall Study||228
602235|NCT00419952|1473233|P2|STARTED|Overall Study||365
602236|NCT00419952|1473234|P1|STARTED|Overall Study||377
602237|NCT00419926|1473268|P2|NOT COMPLETED|Overall Study||10
602238|NCT00419926|1473269|P1|NOT COMPLETED|Overall Study||14
602239|NCT00419926|1473268|P2|COMPLETED|Overall Study||148
602240|NCT00419926|1473269|P1|COMPLETED|Overall Study||141
602241|NCT00419926|1473268|P2|STARTED|Overall Study|Intention to treat population, 154 is safety population.|158
602242|NCT00419926|1473269|P1|STARTED|Overall Study|Intention to treat population, 150 is safety population.|155
602243|NCT00419770|1473285|P2|NOT COMPLETED|Overall Study||1
602244|NCT00419770|1473286|P1|NOT COMPLETED|Overall Study||5
602245|NCT00419770|1473285|P2|COMPLETED|Overall Study||8
602246|NCT00419770|1473286|P1|COMPLETED|Overall Study||6
602247|NCT00419770|1473285|P2|STARTED|Overall Study||9
602248|NCT00419770|1473286|P1|STARTED|Overall Study||11
602249|NCT00419757|1473294|P2|NOT COMPLETED|Overall Study||21
602250|NCT00419757|1473295|P1|NOT COMPLETED|Overall Study||18
602251|NCT00419757|1473294|P2|COMPLETED|Overall Study|Randomized patients|102
602252|NCT00419757|1473295|P1|COMPLETED|Overall Study|Randomized patients|109
602253|NCT00419757|1473294|P2|STARTED|Overall Study|Randomized patients|123
602254|NCT00419757|1473295|P1|STARTED|Overall Study|Randomized patients|127
602255|NCT00419744|1473334|P3|NOT COMPLETED|Overall Study||133
602256|NCT00419744|1473335|P2|NOT COMPLETED|Overall Study||118
602257|NCT00419744|1473336|P1|NOT COMPLETED|Overall Study||117
602258|NCT00419744|1473334|P3|COMPLETED|Overall Study||271
602259|NCT00419744|1473335|P2|COMPLETED|Overall Study||290
602260|NCT00419744|1473336|P1|COMPLETED|Overall Study||290
602261|NCT00419744|1473334|P3|STARTED|Overall Study||404
602262|NCT00419744|1473335|P2|STARTED|Overall Study||408
602263|NCT00419744|1473336|P1|STARTED|Overall Study||407
602264|NCT00419445|1473368|P3|NOT COMPLETED|Overall Study||1
602265|NCT00419445|1473369|P2|NOT COMPLETED|Overall Study||2
602266|NCT00419445|1473370|P1|NOT COMPLETED|Overall Study||1
602267|NCT00419445|1473368|P3|COMPLETED|Overall Study||7
602268|NCT00419445|1473369|P2|COMPLETED|Overall Study||14
602269|NCT00419445|1473370|P1|COMPLETED|Overall Study||7
602270|NCT00419445|1473368|P3|STARTED|Overall Study||8
602271|NCT00419445|1473369|P2|STARTED|Overall Study||16
602272|NCT00419445|1473370|P1|STARTED|Overall Study||8
602273|NCT00419393|1473378|P1|NOT COMPLETED|Overall Study||24
602274|NCT00419393|1473378|P1|COMPLETED|Overall Study||166
602275|NCT00419393|1473378|P1|STARTED|Overall Study|One subject did not receive medication|190
602276|NCT00419380|1473388|P2|NOT COMPLETED|Overall Study||10
602277|NCT00419380|1473389|P1|NOT COMPLETED|Overall Study||1
602278|NCT00419380|1473388|P2|COMPLETED|Overall Study||12
602279|NCT00419380|1473389|P1|COMPLETED|Overall Study||18
602280|NCT00419380|1473388|P2|STARTED|Overall Study||22
602281|NCT00419380|1473389|P1|STARTED|Overall Study||19
602282|NCT00419341|1473397|P1|NOT COMPLETED|Efficacy Period||10
602283|NCT00419341|1473397|P1|COMPLETED|Efficacy Period||28
602284|NCT00419341|1473397|P1|STARTED|Efficacy Period||38
602285|NCT00419341|1473397|P1|NOT COMPLETED|Wash in/Wash Out Period||11
602286|NCT00419341|1473397|P1|COMPLETED|Wash in/Wash Out Period||38
602287|NCT00419341|1473397|P1|STARTED|Wash in/Wash Out Period||49
602288|NCT00419315|1473420|P2|NOT COMPLETED|Overall Study||0
602289|NCT00419315|1473421|P1|NOT COMPLETED|Overall Study||0
602290|NCT00419315|1473420|P2|COMPLETED|Overall Study||78
602291|NCT00419315|1473421|P1|COMPLETED|Overall Study||85
602292|NCT00419315|1473420|P2|STARTED|Overall Study||78
602293|NCT00419315|1473421|P1|STARTED|Overall Study||85
602294|NCT00419263|1473432|P3|NOT COMPLETED|Overall Study||3
602295|NCT00419263|1473433|P2|NOT COMPLETED|Overall Study||2
602296|NCT00419263|1473434|P1|NOT COMPLETED|Overall Study||3
602297|NCT00419263|1473432|P3|COMPLETED|Overall Study||112
602298|NCT00419263|1473433|P2|COMPLETED|Overall Study||112
602299|NCT00419263|1473434|P1|COMPLETED|Overall Study||112
602300|NCT00419263|1473432|P3|STARTED|Overall Study||115
602301|NCT00419263|1473433|P2|STARTED|Overall Study||114
602302|NCT00419263|1473434|P1|STARTED|Overall Study||115
602303|NCT00419159|1473463|P2|NOT COMPLETED|Overall Study||100
602304|NCT00419159|1473464|P1|NOT COMPLETED|Overall Study||99
602305|NCT00419159|1473463|P2|COMPLETED|Overall Study||0
602306|NCT00419159|1473464|P1|COMPLETED|Overall Study||0
602307|NCT00419159|1473463|P2|STARTED|Overall Study||100
602308|NCT00419159|1473464|P1|STARTED|Overall Study|Full Analysis Set|99
602309|NCT00419120|1473478|P1|NOT COMPLETED|Long Term Follow up Period||10
602310|NCT00419120|1473478|P1|COMPLETED|Long Term Follow up Period||0
602311|NCT00419120|1473478|P1|STARTED|Long Term Follow up Period|10 patients are being followed in long term follow up.|10
602312|NCT00419120|1473478|P1|NOT COMPLETED|Primary Study Period||0
602313|NCT00419120|1473478|P1|COMPLETED|Primary Study Period||10
602314|NCT00419120|1473478|P1|STARTED|Primary Study Period||10
602315|NCT00419094|1473485|P2|NOT COMPLETED|Overall Study||30
602316|NCT00419094|1473486|P1|NOT COMPLETED|Overall Study||7
602317|NCT00419094|1473485|P2|COMPLETED|Overall Study||141
602318|NCT00419094|1473486|P1|COMPLETED|Overall Study||50
602319|NCT00419094|1473485|P2|STARTED|Overall Study||171
602320|NCT00419094|1473486|P1|STARTED|Overall Study|Number started refers to number randomized; 303 subjects were screened/enrolled and 228 randomized.|57
602321|NCT00419003|1473500|P2|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||0
602322|NCT00419003|1473501|P1|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||1
602323|NCT00419003|1473500|P2|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||8
602324|NCT00419003|1473501|P1|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||5
602325|NCT00419003|1473500|P2|STARTED|Phase 2, Riluzole/Placebo Follow-Up|14 completers of phase I didn’t split up evenly (same way as phase I) in the riluzole/placebo phase.|8
602326|NCT00419003|1473501|P1|STARTED|Phase 2, Riluzole/Placebo Follow-Up|14 completers of phase I didn’t split up evenly (same way as phase I) in the riluzole/placebo phase.|6
602327|NCT00419003|1473500|P2|NOT COMPLETED|Phase I, Ketamine Infusion||6
602328|NCT00419003|1473501|P1|NOT COMPLETED|Phase I, Ketamine Infusion||6
602329|NCT00419003|1473500|P2|COMPLETED|Phase I, Ketamine Infusion||7
602330|NCT00419003|1473501|P1|COMPLETED|Phase I, Ketamine Infusion||7
602331|NCT00419003|1473500|P2|STARTED|Phase I, Ketamine Infusion||13
602332|NCT00419003|1473501|P1|STARTED|Phase I, Ketamine Infusion||13
602333|NCT00418977|1473512|P2|NOT COMPLETED|Overall Study||3
602334|NCT00418977|1473513|P1|NOT COMPLETED|Overall Study||3
602335|NCT00418977|1473512|P2|COMPLETED|Overall Study||13
602336|NCT00418977|1473513|P1|COMPLETED|Overall Study||40
602337|NCT00418977|1473512|P2|STARTED|Overall Study||16
602338|NCT00418977|1473513|P1|STARTED|Overall Study||43
602339|NCT00418964|1473530|P3|NOT COMPLETED|Overall Study||6
602340|NCT00418964|1473531|P2|NOT COMPLETED|Overall Study||3
602341|NCT00418964|1473532|P1|NOT COMPLETED|Overall Study||1
602342|NCT00418964|1473530|P3|COMPLETED|Overall Study||14
602343|NCT00418964|1473531|P2|COMPLETED|Overall Study||17
602344|NCT00418964|1473532|P1|COMPLETED|Overall Study||21
602345|NCT00418964|1473530|P3|STARTED|Overall Study||20
602346|NCT00418964|1473531|P2|STARTED|Overall Study||20
602347|NCT00418964|1473532|P1|STARTED|Overall Study||22
602348|NCT00418951|1473543|P3|NOT COMPLETED|Overall Study||0
602349|NCT00418951|1473544|P2|NOT COMPLETED|Overall Study||0
602350|NCT00418951|1473545|P1|NOT COMPLETED|Overall Study||0
602351|NCT00418951|1473543|P3|COMPLETED|Overall Study||40
602352|NCT00418951|1473544|P2|COMPLETED|Overall Study||33
602353|NCT00418951|1473545|P1|COMPLETED|Overall Study||39
602354|NCT00418951|1473543|P3|STARTED|Overall Study||40
602355|NCT00418951|1473544|P2|STARTED|Overall Study||33
602356|NCT00418951|1473545|P1|STARTED|Overall Study||39
602357|NCT00418938|1473555|P2|NOT COMPLETED|Overall Study||23
602358|NCT00418938|1473556|P1|NOT COMPLETED|Overall Study||24
602359|NCT00418938|1473555|P2|COMPLETED|Overall Study||108
602360|NCT00418938|1473556|P1|COMPLETED|Overall Study||109
602361|NCT00418938|1473555|P2|STARTED|Overall Study||131
602362|NCT00418938|1473556|P1|STARTED|Overall Study||133
602363|NCT00418886|1473576|P2|NOT COMPLETED|Overall Study||255
602364|NCT00418886|1473577|P1|NOT COMPLETED|Overall Study||226
602365|NCT00418886|1473576|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|23
602366|NCT00418886|1473577|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|30
602367|NCT00418886|1473576|P2|STARTED|Overall Study|randomised patients|278
602368|NCT00418886|1473577|P1|STARTED|Overall Study|randomised patients|256
602369|NCT00418834|1473603|P2|NOT COMPLETED|Overall Study||20
602370|NCT00418834|1473604|P1|NOT COMPLETED|Overall Study||23
602371|NCT00418834|1473603|P2|COMPLETED|Overall Study||507
602372|NCT00418834|1473604|P1|COMPLETED|Overall Study||503
602373|NCT00418834|1473603|P2|STARTED|Overall Study||527
602374|NCT00418834|1473604|P1|STARTED|Overall Study||526
602375|NCT00418717|1473664|P1|NOT COMPLETED|Treatment Period B - Weeks 5-12||2
602376|NCT00418717|1473664|P1|COMPLETED|Treatment Period B - Weeks 5-12||39
602377|NCT00418717|1473664|P1|STARTED|Treatment Period B - Weeks 5-12||41
602378|NCT00418717|1473664|P1|NOT COMPLETED|Treatment Period A - Weeks 1-4||1
602379|NCT00418717|1473664|P1|COMPLETED|Treatment Period A - Weeks 1-4||41
602380|NCT00418717|1473664|P1|STARTED|Treatment Period A - Weeks 1-4||42
602381|NCT00418691|1473672|P3|NOT COMPLETED|Overall Study||5
602382|NCT00418691|1473673|P2|NOT COMPLETED|Overall Study||2
602383|NCT00418691|1473674|P1|NOT COMPLETED|Overall Study||2
602384|NCT00418691|1473672|P3|COMPLETED|Overall Study||5
602385|NCT00418691|1473673|P2|COMPLETED|Overall Study||10
602386|NCT00418691|1473674|P1|COMPLETED|Overall Study||9
602387|NCT00418691|1473672|P3|STARTED|Overall Study||10
602388|NCT00418691|1473673|P2|STARTED|Overall Study||12
602389|NCT00418691|1473674|P1|STARTED|Overall Study||11
602390|NCT00418665|1473685|P3|NOT COMPLETED|Treatment Extension||2
602391|NCT00418665|1473686|P2|NOT COMPLETED|Treatment Extension||4
602392|NCT00418665|1473687|P1|NOT COMPLETED|Treatment Extension||6
602393|NCT00418665|1473685|P3|COMPLETED|Treatment Extension||7
602394|NCT00418665|1473686|P2|COMPLETED|Treatment Extension||4
602395|NCT00418665|1473687|P1|COMPLETED|Treatment Extension||1
602396|NCT00418665|1473685|P3|STARTED|Treatment Extension||9
602397|NCT00418665|1473686|P2|STARTED|Treatment Extension||8
602398|NCT00418665|1473687|P1|STARTED|Treatment Extension||7
602399|NCT00418665|1473685|P3|NOT COMPLETED|Treatment Period||4
602400|NCT00418665|1473686|P2|NOT COMPLETED|Treatment Period||6
602401|NCT00418665|1473687|P1|NOT COMPLETED|Treatment Period||5
602402|NCT00418665|1473685|P3|COMPLETED|Treatment Period||9
602403|NCT00418665|1473686|P2|COMPLETED|Treatment Period||8
602404|NCT00418665|1473687|P1|COMPLETED|Treatment Period||7
602405|NCT00418665|1473685|P3|Received Study Medication|Treatment Period||13
602406|NCT00418665|1473686|P2|Received Study Medication|Treatment Period||13
602407|NCT00418665|1473687|P1|Received Study Medication|Treatment Period||11
602408|NCT00418665|1473685|P3|STARTED|Treatment Period||13
602409|NCT00418665|1473686|P2|STARTED|Treatment Period||14
602410|NCT00418665|1473687|P1|STARTED|Treatment Period||12
602411|NCT00418574|1473706|P2|NOT COMPLETED|Overall Study||23
602412|NCT00418574|1473707|P1|NOT COMPLETED|Overall Study||48
602413|NCT00418574|1473706|P2|COMPLETED|Overall Study||272
602414|NCT00418574|1473707|P1|COMPLETED|Overall Study||545
602415|NCT00418574|1473706|P2|TREATED|Overall Study||294
602416|NCT00418574|1473707|P1|TREATED|Overall Study||592
602417|NCT00418574|1473706|P2|STARTED|Overall Study||295
602418|NCT00418574|1473707|P1|STARTED|Overall Study||593
602419|NCT00418561|1473721|P3|NOT COMPLETED|Overall Study||0
602420|NCT00418561|1473722|P2|NOT COMPLETED|Overall Study||1
602421|NCT00418561|1473723|P1|NOT COMPLETED|Overall Study||0
602422|NCT00418561|1473721|P3|COMPLETED|Overall Study||4
602423|NCT00418561|1473722|P2|COMPLETED|Overall Study||4
602424|NCT00418561|1473723|P1|COMPLETED|Overall Study||4
602425|NCT00418561|1473721|P3|STARTED|Overall Study||4
602426|NCT00418561|1473722|P2|STARTED|Overall Study||5
602427|NCT00418561|1473723|P1|STARTED|Overall Study||4
602428|NCT00418522|1473793|P2|NOT COMPLETED|Overall Study||42
602429|NCT00418522|1473794|P1|NOT COMPLETED|Overall Study||83
602430|NCT00418522|1473793|P2|COMPLETED|Overall Study||152
602431|NCT00418522|1473794|P1|COMPLETED|Overall Study||136
602432|NCT00418522|1473793|P2|Received Treatment|Overall Study||190
602433|NCT00418522|1473794|P1|Received Treatment|Overall Study||212
602434|NCT00418522|1473793|P2|STARTED|Overall Study||194
602435|NCT00418522|1473794|P1|STARTED|Overall Study||219
602436|NCT00418379|1473841|P3|NOT COMPLETED|Year 5||3
602437|NCT00418379|1473842|P2|NOT COMPLETED|Year 5||5
602438|NCT00418379|1473843|P1|NOT COMPLETED|Year 5||2
602439|NCT00418379|1473841|P3|COMPLETED|Year 5||131
602440|NCT00418379|1473842|P2|COMPLETED|Year 5||115
602441|NCT00418379|1473843|P1|COMPLETED|Year 5||126
602442|NCT00418379|1473841|P3|STARTED|Year 5|20 patients withdrew between Year 4 and Year 5 study periods.|134
602443|NCT00418379|1473842|P2|STARTED|Year 5|16 patients withdrew between Year 4 and Year 5 study periods.|120
602444|NCT00418379|1473843|P1|STARTED|Year 5|14 patients withdrew between Year 4 and Year 5 study periods.|128
602445|NCT00418379|1473841|P3|NOT COMPLETED|Year 4||2
602446|NCT00418379|1473842|P2|NOT COMPLETED|Year 4||5
602447|NCT00418379|1473843|P1|NOT COMPLETED|Year 4||3
602448|NCT00418379|1473841|P3|COMPLETED|Year 4||154
602449|NCT00418379|1473842|P2|COMPLETED|Year 4||136
602450|NCT00418379|1473843|P1|COMPLETED|Year 4||142
602451|NCT00418379|1473841|P3|STARTED|Year 4|7 patients withdrew between Year 3 and Year 4 study periods.|156
602452|NCT00418379|1473842|P2|STARTED|Year 4|5 patients withdrew between Year 3 and Year 4 study periods.|141
602453|NCT00418379|1473843|P1|STARTED|Year 4|3 patients withdrew between Year 3 and Year 4 study periods.|145
602454|NCT00418379|1473841|P3|NOT COMPLETED|Year 3||3
602455|NCT00418379|1473842|P2|NOT COMPLETED|Year 3||2
602456|NCT00418379|1473843|P1|NOT COMPLETED|Year 3||3
602457|NCT00418379|1473841|P3|COMPLETED|Year 3||163
602458|NCT00418379|1473842|P2|COMPLETED|Year 3||146
602459|NCT00418379|1473843|P1|COMPLETED|Year 3||148
602460|NCT00418379|1473841|P3|STARTED|Year 3|6 patients withdrew between Year 2 and Year 3 treatment periods.|166
602461|NCT00418379|1473842|P2|STARTED|Year 3|7 patients withdrew between Year 2 and Year 3 treatment periods.|148
602462|NCT00418379|1473843|P1|STARTED|Year 3|8 patients withdrew between Year 2 and Year 3 treatment periods.|151
602463|NCT00418379|1473841|P3|NOT COMPLETED|Year 2||10
602464|NCT00418379|1473842|P2|NOT COMPLETED|Year 2||4
602465|NCT00418379|1473843|P1|NOT COMPLETED|Year 2||8
602466|NCT00418379|1473841|P3|COMPLETED|Year 2||172
602467|NCT00418379|1473842|P2|COMPLETED|Year 2||155
602468|NCT00418379|1473843|P1|COMPLETED|Year 2||159
602469|NCT00418379|1473841|P3|STARTED|Year 2|22 patients withdrew between Year 1 and Year 2 treatment periods.|182
602470|NCT00418379|1473842|P2|STARTED|Year 2|20 patients withdrew between Year 1 and Year 2 treatment periods.|159
602471|NCT00418379|1473843|P1|STARTED|Year 2|22 patients withdrew between Year 1 and Year 2 treatment periods.|167
602472|NCT00418379|1473841|P3|NOT COMPLETED|Year 1||15
602473|NCT00418379|1473842|P2|NOT COMPLETED|Year 1||28
602474|NCT00418379|1473843|P1|NOT COMPLETED|Year 1||18
602475|NCT00418379|1473841|P3|COMPLETED|Year 1||204
602476|NCT00418379|1473842|P2|COMPLETED|Year 1||179
602477|NCT00418379|1473843|P1|COMPLETED|Year 1||189
602478|NCT00418379|1473841|P3|STARTED|Year 1||219
602479|NCT00418379|1473842|P2|STARTED|Year 1||207
602480|NCT00418379|1473843|P1|STARTED|Year 1||207
602481|NCT00418314|1473853|P2|NOT COMPLETED|Overall Study||2
602482|NCT00418314|1473854|P1|NOT COMPLETED|Overall Study||1
602483|NCT00418314|1473853|P2|COMPLETED|Overall Study||828
602484|NCT00418314|1473854|P1|COMPLETED|Overall Study||816
602485|NCT00418314|1473853|P2|STARTED|Overall Study||830
602486|NCT00418314|1473854|P1|STARTED|Overall Study||817
602487|NCT00418262|1473864|P1|NOT COMPLETED|Visits 8 Thru 10||5
602488|NCT00418262|1473864|P1|COMPLETED|Visits 8 Thru 10||11
602489|NCT00418262|1473864|P1|STARTED|Visits 8 Thru 10||16
602490|NCT00418262|1473864|P1|NOT COMPLETED|Visits 5 Thru 8||9
602491|NCT00418262|1473864|P1|COMPLETED|Visits 5 Thru 8||16
602492|NCT00418262|1473864|P1|STARTED|Visits 5 Thru 8||25
602493|NCT00418262|1473864|P1|NOT COMPLETED|Visits 1 (Baseline) Thru 5||2
602494|NCT00418262|1473864|P1|COMPLETED|Visits 1 (Baseline) Thru 5||25
602495|NCT00418262|1473864|P1|STARTED|Visits 1 (Baseline) Thru 5||27
602496|NCT00418184|1473884|P2|NOT COMPLETED|Open-label Phase||5
602497|NCT00418184|1473885|P1|NOT COMPLETED|Open-label Phase||5
602498|NCT00418184|1473884|P2|COMPLETED|Open-label Phase|5 dropped out|43
602499|NCT00418184|1473885|P1|COMPLETED|Open-label Phase|5 dropped out|97
602500|NCT00418184|1473884|P2|STARTED|Open-label Phase|1 was not included due to low compliance in the double blind phase, 3 didn't want to participate.|48
602501|NCT00418184|1473885|P1|STARTED|Open-label Phase|3 were not included due to low compliance in the double blind phase, 5 didn't want to participate.|102
602502|NCT00418184|1473884|P2|NOT COMPLETED|Double-blind Phase||11
602503|NCT00418184|1473885|P1|NOT COMPLETED|Double-blind Phase||27
602504|NCT00418184|1473884|P2|COMPLETED|Double-blind Phase||52
602505|NCT00418184|1473885|P1|COMPLETED|Double-blind Phase||110
602506|NCT00418184|1473884|P2|STARTED|Double-blind Phase||63
602507|NCT00418184|1473885|P1|STARTED|Double-blind Phase||137
602508|NCT00418145|1473893|P1|NOT COMPLETED|Overall Study||6
602509|NCT00418145|1473893|P1|COMPLETED|Overall Study||10
602510|NCT00418145|1473893|P1|STARTED|Overall Study||16
602511|NCT00418093|1473905|P1|NOT COMPLETED|Overall Study||0
602512|NCT00418093|1473905|P1|COMPLETED|Overall Study||19
602513|NCT00418093|1473905|P1|Completed Study|Overall Study||19
602514|NCT00418093|1473905|P1|STARTED|Overall Study||19
602515|NCT00418028|1473914|P2|NOT COMPLETED|Overall Study||1
602516|NCT00418028|1473915|P1|NOT COMPLETED|Overall Study||2
602517|NCT00418028|1473914|P2|COMPLETED|Overall Study||97
602518|NCT00418028|1473915|P1|COMPLETED|Overall Study||95
602519|NCT00418028|1473914|P2|STARTED|Overall Study||98
602520|NCT00418028|1473915|P1|STARTED|Overall Study||97
602521|NCT00418015|1473937|P4|NOT COMPLETED|Overall Study||0
602522|NCT00418015|1473938|P3|NOT COMPLETED|Overall Study||0
602523|NCT00418015|1473939|P2|NOT COMPLETED|Overall Study||0
602524|NCT00418015|1473940|P1|NOT COMPLETED|Overall Study||0
602525|NCT00418015|1473937|P4|COMPLETED|Overall Study||25
602526|NCT00418015|1473938|P3|COMPLETED|Overall Study||78
602527|NCT00418015|1473939|P2|COMPLETED|Overall Study||46
602528|NCT00418015|1473940|P1|COMPLETED|Overall Study||144
602529|NCT00418015|1473937|P4|STARTED|Overall Study||25
602530|NCT00418015|1473938|P3|STARTED|Overall Study||78
602531|NCT00418015|1473939|P2|STARTED|Overall Study||46
602532|NCT00418015|1473940|P1|STARTED|Overall Study||144
602533|NCT00417989|1473968|P2|NOT COMPLETED|Overall Study||22
602534|NCT00417989|1473969|P1|NOT COMPLETED|Overall Study||20
602535|NCT00417989|1473968|P2|COMPLETED|Overall Study||219
602536|NCT00417989|1473969|P1|COMPLETED|Overall Study||224
602537|NCT00417989|1473968|P2|STARTED|Overall Study||241
602538|NCT00417989|1473969|P1|STARTED|Overall Study|Intent to Treat include safety population & subjects with baseline & 1 post baseline A1C measurement|244
602539|NCT00417976|1473991|P1|NOT COMPLETED|Overall Study||3
602540|NCT00417976|1473991|P1|COMPLETED|Overall Study||39
602541|NCT00417976|1473991|P1|STARTED|Overall Study||42
602542|NCT00417963|1473996|P1|NOT COMPLETED|Overall Study||41
602543|NCT00417963|1473996|P1|COMPLETED|Overall Study|79 subjects completed in the roll-in cohort and 371 in the pivotal cohort.|445
602544|NCT00417963|1473996|P1|STARTED|Overall Study|79 participants were enrolled in the roll-in cohort and 407 in the pivotal cohort.|486
602545|NCT00417885|1474013|P1|NOT COMPLETED|Overall Study||6
602546|NCT00417885|1474013|P1|COMPLETED|Overall Study||0
602547|NCT00417885|1474013|P1|STARTED|Overall Study||6
602548|NCT00417612|1474024|P2|NOT COMPLETED|Overall Study||3
602549|NCT00417612|1474025|P1|NOT COMPLETED|Overall Study||3
602550|NCT00417612|1474024|P2|COMPLETED|Overall Study||8
602551|NCT00417612|1474025|P1|COMPLETED|Overall Study||19
602552|NCT00417612|1474024|P2|STARTED|Overall Study||11
602553|NCT00417612|1474025|P1|STARTED|Overall Study||22
602554|NCT00417482|1474051|P3|NOT COMPLETED|Phase B 2nd 16 Weeks||3
602555|NCT00417482|1474052|P2|NOT COMPLETED|Phase B 2nd 16 Weeks||13
602556|NCT00417482|1474053|P1|NOT COMPLETED|Phase B 2nd 16 Weeks||3
602557|NCT00417482|1474051|P3|COMPLETED|Phase B 2nd 16 Weeks||10
602558|NCT00417482|1474052|P2|COMPLETED|Phase B 2nd 16 Weeks||14
602559|NCT00417482|1474053|P1|COMPLETED|Phase B 2nd 16 Weeks||10
602560|NCT00417482|1474051|P3|STARTED|Phase B 2nd 16 Weeks|Placebo for 16 weeks.|13
602561|NCT00417482|1474052|P2|STARTED|Phase B 2nd 16 Weeks|Placebo for 16 weeks.|27
602562|NCT00417482|1474053|P1|STARTED|Phase B 2nd 16 Weeks|Risperidone for 16 weeks.|13
602563|NCT00417482|1474051|P3|NOT COMPLETED|Phase B 1st 16 Weeks||27
602564|NCT00417482|1474052|P2|NOT COMPLETED|Phase B 1st 16 Weeks||11
602565|NCT00417482|1474053|P1|NOT COMPLETED|Phase B 1st 16 Weeks||19
602566|NCT00417482|1474051|P3|COMPLETED|Phase B 1st 16 Weeks||13
602567|NCT00417482|1474052|P2|COMPLETED|Phase B 1st 16 Weeks||27
602568|NCT00417482|1474053|P1|COMPLETED|Phase B 1st 16 Weeks||13
602569|NCT00417482|1474051|P3|STARTED|Phase B 1st 16 Weeks|Placebo 16 weeks.|40
602570|NCT00417482|1474052|P2|STARTED|Phase B 1st 16 Weeks|Risperidone 16 weeks.|38
602571|NCT00417482|1474053|P1|STARTED|Phase B 1st 16 Weeks|Risperidone 16 weeks.|32
602572|NCT00417417|1474079|P2|NOT COMPLETED|Overall Study||0
602573|NCT00417417|1474080|P1|NOT COMPLETED|Overall Study||0
602574|NCT00417417|1474079|P2|COMPLETED|Overall Study||6
602575|NCT00417417|1474080|P1|COMPLETED|Overall Study||4
602576|NCT00417417|1474079|P2|STARTED|Overall Study||6
602577|NCT00417417|1474080|P1|STARTED|Overall Study||4
602578|NCT00417274|1474088|P1|NOT COMPLETED|Overall Study||0
602579|NCT00417274|1474088|P1|COMPLETED|Overall Study||31
602580|NCT00417274|1474088|P1|STARTED|Overall Study||31
602581|NCT00417248|1474092|P1|NOT COMPLETED|Overall Study||8
602582|NCT00417248|1474092|P1|COMPLETED|Overall Study||0
602583|NCT00417248|1474092|P1|STARTED|Overall Study||8
602584|NCT00417170|1474099|P2|NOT COMPLETED|Overall Study||3
602585|NCT00417170|1474100|P1|NOT COMPLETED|Overall Study||2
602586|NCT00417170|1474099|P2|COMPLETED|Overall Study||22
602587|NCT00417170|1474100|P1|COMPLETED|Overall Study||21
602588|NCT00417170|1474099|P2|Pharmacodynamics Population|Overall Study||23
602589|NCT00417170|1474100|P1|Pharmacodynamics Population|Overall Study||21
602590|NCT00417170|1474099|P2|STARTED|Overall Study||25
602591|NCT00417170|1474100|P1|STARTED|Overall Study|"Started indicates Safety population."|23
602592|NCT00417079|1474116|P2|NOT COMPLETED|Overall Study||273
602593|NCT00417079|1474117|P1|NOT COMPLETED|Overall Study||331
602594|NCT00417079|1474116|P2|COMPLETED|Overall Study|Randomized patients|105
602595|NCT00417079|1474117|P1|COMPLETED|Overall Study|Randomized patients|46
602596|NCT00417079|1474116|P2|STARTED|Overall Study|Randomized patients|378
602597|NCT00417079|1474117|P1|STARTED|Overall Study|Randomized patients|377
602598|NCT00417027|1474140|P3|NOT COMPLETED|Overall Study||5
602599|NCT00417027|1474141|P2|NOT COMPLETED|Overall Study||5
602600|NCT00417027|1474142|P1|NOT COMPLETED|Overall Study||0
602601|NCT00417027|1474140|P3|COMPLETED|Overall Study||54
602602|NCT00417027|1474141|P2|COMPLETED|Overall Study||60
602603|NCT00417027|1474142|P1|COMPLETED|Overall Study||66
602604|NCT00417027|1474140|P3|STARTED|Overall Study||59
602605|NCT00417027|1474141|P2|STARTED|Overall Study||65
602606|NCT00417027|1474142|P1|STARTED|Overall Study||66
602607|NCT00416884|1474168|P1|NOT COMPLETED|Overall Study||1
602608|NCT00416884|1474168|P1|COMPLETED|Overall Study||0
602609|NCT00416884|1474168|P1|STARTED|Overall Study||1
602610|NCT00416793|1474172|P1|NOT COMPLETED|Overall Study||0
602611|NCT00416793|1474172|P1|COMPLETED|Overall Study||9
602612|NCT00416793|1474172|P1|STARTED|Overall Study||9
602613|NCT00416715|1474176|P1|NOT COMPLETED|Overall Study||15
602614|NCT00416715|1474176|P1|COMPLETED|Overall Study||85
602615|NCT00416715|1474176|P1|STARTED|Overall Study||100
602616|NCT00416624|1474187|P4|NOT COMPLETED|Overall Study||17
602617|NCT00416624|1474188|P3|NOT COMPLETED|Overall Study||18
602618|NCT00416624|1474189|P2|NOT COMPLETED|Overall Study||27
602619|NCT00416624|1474190|P1|NOT COMPLETED|Overall Study||22
602620|NCT00416624|1474187|P4|COMPLETED|Overall Study||40
602621|NCT00416624|1474188|P3|COMPLETED|Overall Study||40
602622|NCT00416624|1474189|P2|COMPLETED|Overall Study||33
602623|NCT00416624|1474190|P1|COMPLETED|Overall Study||39
602624|NCT00416624|1474187|P4|STARTED|Overall Study||57
602625|NCT00416624|1474188|P3|STARTED|Overall Study||58
602626|NCT00416624|1474189|P2|STARTED|Overall Study||60
602627|NCT00416624|1474190|P1|STARTED|Overall Study||61
602628|NCT00416598|1474244|P1|NOT COMPLETED|Decitabine Maintenance||72
602629|NCT00416598|1474244|P1|COMPLETED|Decitabine Maintenance||62
602630|NCT00416598|1474244|P1|STARTED|Decitabine Maintenance||134
602631|NCT00416598|1474244|P1|NOT COMPLETED|Induction & Intensification||412
602632|NCT00416598|1474244|P1|COMPLETED|Induction & Intensification||134
602633|NCT00416598|1474244|P1|STARTED|Induction & Intensification||546
602634|NCT00416572|1474252|P3|NOT COMPLETED|Overall Study||8
602635|NCT00416572|1474253|P2|NOT COMPLETED|Overall Study||7
602636|NCT00416572|1474254|P1|NOT COMPLETED|Overall Study||13
602637|NCT00416572|1474252|P3|COMPLETED|Overall Study||76
602638|NCT00416572|1474253|P2|COMPLETED|Overall Study||78
602639|NCT00416572|1474254|P1|COMPLETED|Overall Study||70
602640|NCT00416572|1474252|P3|STARTED|Overall Study||84
602641|NCT00416572|1474253|P2|STARTED|Overall Study||85
602642|NCT00416572|1474254|P1|STARTED|Overall Study||83
602643|NCT00416520|1474270|P4|NOT COMPLETED|Placebo-controlled Withdrawal Period||5
602644|NCT00416520|1474271|P3|NOT COMPLETED|Placebo-controlled Withdrawal Period||1
602645|NCT00416520|1474272|P2|NOT COMPLETED|Placebo-controlled Withdrawal Period||0
602646|NCT00416520|1474273|P1|NOT COMPLETED|Placebo-controlled Withdrawal Period||0
602647|NCT00416520|1474270|P4|COMPLETED|Placebo-controlled Withdrawal Period||49
602648|NCT00416520|1474271|P3|COMPLETED|Placebo-controlled Withdrawal Period||49
602649|NCT00416520|1474272|P2|COMPLETED|Placebo-controlled Withdrawal Period||0
602650|NCT00416520|1474273|P1|COMPLETED|Placebo-controlled Withdrawal Period||0
602651|NCT00416520|1474270|P4|STARTED|Placebo-controlled Withdrawal Period||54
602652|NCT00416520|1474271|P3|STARTED|Placebo-controlled Withdrawal Period||50
602653|NCT00416520|1474272|P2|STARTED|Placebo-controlled Withdrawal Period||0
602654|NCT00416520|1474273|P1|STARTED|Placebo-controlled Withdrawal Period||0
602655|NCT00416520|1474270|P4|NOT COMPLETED|Open-label Period||0
602656|NCT00416520|1474271|P3|NOT COMPLETED|Open-label Period||0
602657|NCT00416520|1474272|P2|NOT COMPLETED|Open-label Period||32
602658|NCT00416520|1474273|P1|NOT COMPLETED|Open-label Period||60
602659|NCT00416520|1474270|P4|COMPLETED|Open-label Period||0
602660|NCT00416520|1474271|P3|COMPLETED|Open-label Period||0
602661|NCT00416520|1474272|P2|COMPLETED|Open-label Period||139
602662|NCT00416520|1474273|P1|COMPLETED|Open-label Period||105
602663|NCT00416520|1474270|P4|STARTED|Open-label Period||0
602664|NCT00416520|1474271|P3|STARTED|Open-label Period||0
602665|NCT00416520|1474272|P2|STARTED|Open-label Period||171
602666|NCT00416520|1474273|P1|STARTED|Open-label Period||165
602667|NCT00416494|1474285|P2|NOT COMPLETED|Overall Study||0
602668|NCT00416494|1474286|P1|NOT COMPLETED|Overall Study||0
602669|NCT00416494|1474285|P2|COMPLETED|Overall Study||31
602670|NCT00416494|1474286|P1|COMPLETED|Overall Study||19
602671|NCT00416494|1474285|P2|STARTED|Overall Study||31
602672|NCT00416494|1474286|P1|STARTED|Overall Study||19
602673|NCT00416455|1474302|P2|NOT COMPLETED|Overall Study||8
602674|NCT00416455|1474303|P1|NOT COMPLETED|Overall Study||16
602675|NCT00416455|1474302|P2|COMPLETED|Overall Study|Number of patients with adequate imaging and pathology|207
602676|NCT00416455|1474303|P1|COMPLETED|Overall Study|Number of patients with adequate imaging and pathology|153
602677|NCT00416455|1474302|P2|STARTED|Overall Study|This is a diagnostic imaging study.|215
602678|NCT00416455|1474303|P1|STARTED|Overall Study|This is a diagnostic imaging study.|169
602679|NCT00416195|1474317|P2|NOT COMPLETED|Overall Study||4
602680|NCT00416195|1474318|P1|NOT COMPLETED|Overall Study||2
602681|NCT00416195|1474317|P2|COMPLETED|Overall Study||34
602682|NCT00416195|1474318|P1|COMPLETED|Overall Study||8
602683|NCT00416195|1474317|P2|STARTED|Overall Study||38
602684|NCT00416195|1474318|P1|STARTED|Overall Study||10
602685|NCT00416182|1474328|P2|NOT COMPLETED|Overall Study||2
602686|NCT00416182|1474329|P1|NOT COMPLETED|Overall Study||3
602687|NCT00416182|1474328|P2|COMPLETED|Overall Study||6
602688|NCT00416182|1474329|P1|COMPLETED|Overall Study||5
602689|NCT00416182|1474328|P2|STARTED|Overall Study||8
602690|NCT00416182|1474329|P1|STARTED|Overall Study||8
602691|NCT00416078|1474343|P2|NOT COMPLETED|Overall Study||8
602692|NCT00416078|1474344|P1|NOT COMPLETED|Overall Study||11
602693|NCT00416078|1474343|P2|COMPLETED|Overall Study||16
602694|NCT00416078|1474344|P1|COMPLETED|Overall Study||18
602695|NCT00416078|1474343|P2|STARTED|Overall Study||24
602696|NCT00416078|1474344|P1|STARTED|Overall Study||29
602697|NCT00415909|1474360|P1|NOT COMPLETED|Overall Study||3
602698|NCT00415909|1474360|P1|COMPLETED|Overall Study||0
602699|NCT00415909|1474360|P1|STARTED|Overall Study||3
602700|NCT00415870|1474366|P2|NOT COMPLETED|Overall Study||7
602701|NCT00415870|1474367|P1|NOT COMPLETED|Overall Study||6
602702|NCT00415870|1474366|P2|COMPLETED|Overall Study||26
602703|NCT00415870|1474367|P1|COMPLETED|Overall Study||26
602704|NCT00415870|1474366|P2|STARTED|Overall Study||33
602705|NCT00415870|1474367|P1|STARTED|Overall Study||32
602706|NCT00415857|1474375|P2|NOT COMPLETED|Overall Study||0
602707|NCT00415857|1474376|P1|NOT COMPLETED|Overall Study||0
602708|NCT00415857|1474375|P2|COMPLETED|Overall Study||3
602709|NCT00415857|1474376|P1|COMPLETED|Overall Study||2
602710|NCT00415857|1474375|P2|STARTED|Overall Study||3
602711|NCT00415857|1474376|P1|STARTED|Overall Study||2
602712|NCT00415623|1474386|P2|NOT COMPLETED|Overall Study||5
602713|NCT00415623|1474387|P1|NOT COMPLETED|Overall Study||5
602714|NCT00415623|1474386|P2|COMPLETED|Overall Study||146
602715|NCT00415623|1474387|P1|COMPLETED|Overall Study||149
602716|NCT00415623|1474386|P2|STARTED|Overall Study||151
602717|NCT00415623|1474387|P1|STARTED|Overall Study||154
602718|NCT00415610|1474414|P3|NOT COMPLETED|Overall Study||5
602719|NCT00415610|1474415|P2|NOT COMPLETED|Overall Study||2
602720|NCT00415610|1474416|P1|NOT COMPLETED|Overall Study||3
602721|NCT00415610|1474414|P3|COMPLETED|Overall Study||17
602722|NCT00415610|1474415|P2|COMPLETED|Overall Study||18
602723|NCT00415610|1474416|P1|COMPLETED|Overall Study||15
602724|NCT00415610|1474414|P3|STARTED|Overall Study||22
602725|NCT00415610|1474415|P2|STARTED|Overall Study||20
602726|NCT00415610|1474416|P1|STARTED|Overall Study||18
602727|NCT00415597|1474436|P1|NOT COMPLETED|Treatment||305
602728|NCT00415597|1474436|P1|COMPLETED|Treatment||160
602729|NCT00415597|1474436|P1|STARTED|Treatment||465
602730|NCT00415597|1474436|P1|NOT COMPLETED|Enrollment||2
602731|NCT00415597|1474436|P1|COMPLETED|Enrollment||465
602732|NCT00415597|1474436|P1|STARTED|Enrollment||467
602733|NCT00415532|1474444|P2|NOT COMPLETED|Safety Follow Up Period||12
602734|NCT00415532|1474445|P1|NOT COMPLETED|Safety Follow Up Period||9
602735|NCT00415532|1474444|P2|COMPLETED|Safety Follow Up Period||18
602736|NCT00415532|1474445|P1|COMPLETED|Safety Follow Up Period||34
602737|NCT00415532|1474444|P2|STARTED|Safety Follow Up Period|Participants who completed the treatment period were not required to participate in this follow-up|30
602738|NCT00415532|1474445|P1|STARTED|Safety Follow Up Period|Participants who completed the treatment period were not required to participate in this follow-up|43
602739|NCT00415532|1474444|P2|NOT COMPLETED|Treatment Period||15
602740|NCT00415532|1474445|P1|NOT COMPLETED|Treatment Period||17
602741|NCT00415532|1474444|P2|COMPLETED|Treatment Period||142
602742|NCT00415532|1474445|P1|COMPLETED|Treatment Period||60
602743|NCT00415532|1474444|P2|Switched to Romiplostim Group|Treatment Period||0
602744|NCT00415532|1474445|P1|Switched to Romiplostim Group|Treatment Period||2
602745|NCT00415532|1474444|P2|Received Treatment|Treatment Period||154
602746|NCT00415532|1474445|P1|Received Treatment|Treatment Period||75
602747|NCT00415532|1474444|P2|STARTED|Treatment Period||157
602748|NCT00415532|1474445|P1|STARTED|Treatment Period||77
602749|NCT00415519|1474467|P2|NOT COMPLETED|Overall Study||0
602750|NCT00415519|1474468|P1|NOT COMPLETED|Overall Study||4
602751|NCT00415519|1474467|P2|COMPLETED|Overall Study||12
602752|NCT00415519|1474468|P1|COMPLETED|Overall Study||9
602753|NCT00415519|1474467|P2|STARTED|Overall Study||12
602754|NCT00415519|1474468|P1|STARTED|Overall Study||13
602755|NCT00415506|1474488|P2|NOT COMPLETED|Overall Study||1
602756|NCT00415506|1474489|P1|NOT COMPLETED|Overall Study||3
602757|NCT00415506|1474488|P2|COMPLETED|Overall Study||9
602758|NCT00415506|1474489|P1|COMPLETED|Overall Study||9
602759|NCT00415506|1474488|P2|STARTED|Overall Study||10
602760|NCT00415506|1474489|P1|STARTED|Overall Study||12
602761|NCT00415493|1474499|P2|NOT COMPLETED|Overall Study||0
602762|NCT00415493|1474500|P1|NOT COMPLETED|Overall Study||0
602763|NCT00415493|1474499|P2|COMPLETED|Overall Study||12
602764|NCT00415493|1474500|P1|COMPLETED|Overall Study||12
602765|NCT00415493|1474499|P2|STARTED|Overall Study||12
602766|NCT00415493|1474500|P1|STARTED|Overall Study||12
602767|NCT00415194|1474508|P2|NOT COMPLETED|Overall Study||342
602768|NCT00415194|1474509|P1|NOT COMPLETED|Overall Study||328
602769|NCT00415194|1474508|P2|COMPLETED|Overall Study||55
602770|NCT00415194|1474509|P1|COMPLETED|Overall Study||70
602771|NCT00415194|1474508|P2|Received at Least 1 Dose of Study Drug|Overall Study||385
602772|NCT00415194|1474509|P1|Received at Least 1 Dose of Study Drug|Overall Study||392
602773|NCT00415194|1474508|P2|STARTED|Overall Study||397
602774|NCT00415194|1474509|P1|STARTED|Overall Study||398
602775|NCT00415168|1474525|P1|NOT COMPLETED|Overall Study||52
602776|NCT00415168|1474525|P1|COMPLETED|Overall Study||1
602777|NCT00415168|1474525|P1|Completed Treatment|Overall Study||15
602778|NCT00415168|1474525|P1|STARTED|Overall Study||53
602779|NCT00415051|1474535|P1|NOT COMPLETED|Overall Study||1
602780|NCT00415051|1474535|P1|COMPLETED|Overall Study||19
602781|NCT00415051|1474535|P1|STARTED|Overall Study||20
602782|NCT00414973|1474546|P4|NOT COMPLETED|Overall Study||0
602783|NCT00414973|1474547|P3|NOT COMPLETED|Overall Study||3
602784|NCT00414973|1474548|P2|NOT COMPLETED|Overall Study||10
602785|NCT00414973|1474549|P1|NOT COMPLETED|Overall Study||28
602786|NCT00414973|1474546|P4|COMPLETED|Overall Study||11
602787|NCT00414973|1474547|P3|COMPLETED|Overall Study||21
602788|NCT00414973|1474548|P2|COMPLETED|Overall Study||99
602789|NCT00414973|1474549|P1|COMPLETED|Overall Study||190
602790|NCT00414973|1474546|P4|STARTED|Overall Study||11
602791|NCT00414973|1474547|P3|STARTED|Overall Study||24
602792|NCT00414973|1474548|P2|STARTED|Overall Study||109
602793|NCT00414973|1474549|P1|STARTED|Overall Study||218
602794|NCT00414908|1474569|P2|NOT COMPLETED|Overall Study||1
602795|NCT00414908|1474570|P1|NOT COMPLETED|Overall Study||1
602796|NCT00414908|1474569|P2|COMPLETED|Overall Study||28
602797|NCT00414908|1474570|P1|COMPLETED|Overall Study||24
602798|NCT00414908|1474569|P2|STARTED|Overall Study||29
602799|NCT00414908|1474570|P1|STARTED|Overall Study||25
602800|NCT00414817|1474594|P2|NOT COMPLETED|Overall Study||3016
602801|NCT00414817|1474595|P1|NOT COMPLETED|Overall Study||3130
602802|NCT00414817|1474594|P2|COMPLETED|Overall Study|Qualified for primary analysis (3260 prior ICS users) or secondary analysis (755 new users) samples.|4015
602803|NCT00414817|1474595|P1|COMPLETED|Overall Study|Qualified for primary analysis (3171 prior ICS users) or secondary analysis (732 new users) samples.|3903
602804|NCT00414817|1474594|P2|<3 Months Follow-up|Overall Study|qualified for analysis sample, but excluded since follow-up too short to assess adherence reliably.|184
602805|NCT00414817|1474595|P1|<3 Months Follow-up|Overall Study|qualified for analysis sample, but excluded since follow-up too short to assess adherence reliably.|175
602806|NCT00414817|1474594|P2|Daily Oral Steroid User|Overall Study|qualified for analysis sample, but excluded due to subsequent determination of oral steroid use.|123
602807|NCT00414817|1474595|P1|Daily Oral Steroid User|Overall Study|qualified for analysis sample, but excluded due to subsequent determination of oral steroid use.|117
602808|NCT00414817|1474594|P2|Adherent ICS User|Overall Study|Fully adherent ICS users who never qualified for an intervention call.|900
602809|NCT00414817|1474595|P1|Adherent ICS User|Overall Study|Fully adherent ICS users who never qualified for an intervention call.|922
602810|NCT00414817|1474594|P2|Died or Left Health Plan|Overall Study|These individuals died or terminated Health Plan membership prior to ever qualifying for a call.|417
602811|NCT00414817|1474595|P1|Died or Left Health Plan|Overall Study|These individuals died or terminated Health Plan membership prior to ever qualifying for a call.|451
602812|NCT00414817|1474594|P2|Never Started on ICS|Overall Study|Not initial users of ICS and not starting during study, hence don't qualify for analysis sample.|1392
602813|NCT00414817|1474595|P1|Never Started on ICS|Overall Study|Not initial users of ICS and not starting during study, hence don't qualify for analysis sample.|1465
602814|NCT00414817|1474594|P2|STARTED|Overall Study||7031
602815|NCT00414817|1474595|P1|STARTED|Overall Study||7033
602816|NCT00414726|1474607|P2|NOT COMPLETED|Overall Study||1
602817|NCT00414726|1474608|P1|NOT COMPLETED|Overall Study||0
602818|NCT00414726|1474607|P2|COMPLETED|Overall Study||41
602819|NCT00414726|1474608|P1|COMPLETED|Overall Study||43
602820|NCT00414726|1474607|P2|STARTED|Overall Study||42
602821|NCT00414726|1474608|P1|STARTED|Overall Study||43
602822|NCT00414700|1474618|P2|NOT COMPLETED|Overall Study||3
602823|NCT00414700|1474619|P1|NOT COMPLETED|Overall Study||6
602824|NCT00414700|1474618|P2|COMPLETED|Overall Study||58
602825|NCT00414700|1474619|P1|COMPLETED|Overall Study||51
602826|NCT00414700|1474618|P2|STARTED|Overall Study||61
602827|NCT00414700|1474619|P1|STARTED|Overall Study||57
602828|NCT00414661|1474643|P4|NOT COMPLETED|Overall Study||3
602829|NCT00414661|1474644|P3|NOT COMPLETED|Overall Study||2
602830|NCT00414661|1474645|P2|NOT COMPLETED|Overall Study||14
602831|NCT00414661|1474646|P1|NOT COMPLETED|Overall Study||14
602832|NCT00414661|1474643|P4|COMPLETED|Overall Study||0
602833|NCT00414661|1474644|P3|COMPLETED|Overall Study||20
602834|NCT00414661|1474645|P2|COMPLETED|Overall Study||75
602835|NCT00414661|1474646|P1|COMPLETED|Overall Study||34
602836|NCT00414661|1474643|P4|STARTED|Overall Study||3
602837|NCT00414661|1474644|P3|STARTED|Overall Study||22
602838|NCT00414661|1474645|P2|STARTED|Overall Study||89
602839|NCT00414661|1474646|P1|STARTED|Overall Study||48
602840|NCT00414635|1474670|P2|NOT COMPLETED|Overall Study||2
602841|NCT00414635|1474671|P1|NOT COMPLETED|Overall Study||5
602842|NCT00414635|1474670|P2|COMPLETED|Overall Study||28
602843|NCT00414635|1474671|P1|COMPLETED|Overall Study||25
602844|NCT00414635|1474670|P2|STARTED|Overall Study||30
602845|NCT00414635|1474671|P1|STARTED|Overall Study||30
602846|NCT00414609|1474691|P3|NOT COMPLETED|Extension Study||57
602847|NCT00414609|1474692|P2|NOT COMPLETED|Extension Study||0
602848|NCT00414609|1474693|P1|NOT COMPLETED|Extension Study||0
602849|NCT00414609|1474691|P3|COMPLETED|Extension Study||365
602850|NCT00414609|1474692|P2|COMPLETED|Extension Study||0
602851|NCT00414609|1474693|P1|COMPLETED|Extension Study||0
602852|NCT00414609|1474691|P3|Echocardiogram (ECHO) Analysis Set|Extension Study||400
602853|NCT00414609|1474692|P2|Echocardiogram (ECHO) Analysis Set|Extension Study||0
602854|NCT00414609|1474693|P1|Echocardiogram (ECHO) Analysis Set|Extension Study||0
602855|NCT00414609|1474691|P3|STARTED|Extension Study|Patients of both core arms who completed core study and signed informed consent form for extension.|422
602856|NCT00414609|1474692|P2|STARTED|Extension Study||0
602857|NCT00414609|1474693|P1|STARTED|Extension Study||0
602858|NCT00414609|1474691|P3|NOT COMPLETED|Core Study||0
602859|NCT00414609|1474692|P2|NOT COMPLETED|Core Study||45
602860|NCT00414609|1474693|P1|NOT COMPLETED|Core Study||34
602861|NCT00414609|1474691|P3|COMPLETED|Core Study||0
602862|NCT00414609|1474692|P2|COMPLETED|Core Study||378
602863|NCT00414609|1474693|P1|COMPLETED|Core Study||363
602864|NCT00414609|1474691|P3|Echocardiogram Evaluable Set|Core Study||0
602865|NCT00414609|1474692|P2|Echocardiogram Evaluable Set|Core Study||343
602866|NCT00414609|1474693|P1|Echocardiogram Evaluable Set|Core Study||330
602867|NCT00414609|1474691|P3|Received Study Drug|Core Study||0
602868|NCT00414609|1474692|P2|Received Study Drug|Core Study||422
602869|NCT00414609|1474693|P1|Received Study Drug|Core Study||397
602870|NCT00414609|1474691|P3|STARTED|Core Study||0
602871|NCT00414609|1474692|P2|STARTED|Core Study||423
602872|NCT00414609|1474693|P1|STARTED|Core Study||397
602873|NCT00414596|1474716|P1|NOT COMPLETED|Overall Study||2
602874|NCT00414596|1474716|P1|COMPLETED|Overall Study|April 2007|18
602875|NCT00414596|1474716|P1|STARTED|Overall Study|December 2006|20
602876|NCT00414544|1474725|P1|NOT COMPLETED|Overall Study||14
602877|NCT00414544|1474725|P1|COMPLETED|Overall Study||131
602878|NCT00414544|1474725|P1|STARTED|Overall Study||145
602879|NCT00414518|1474733|P2|NOT COMPLETED|Overall Study||0
602880|NCT00414518|1474734|P1|NOT COMPLETED|Overall Study||0
602881|NCT00414518|1474733|P2|COMPLETED|Overall Study||9
602882|NCT00414518|1474734|P1|COMPLETED|Overall Study||7
602883|NCT00414518|1474733|P2|STARTED|Overall Study||9
602884|NCT00414518|1474734|P1|STARTED|Overall Study||7
602885|NCT00414466|1474748|P4|NOT COMPLETED|Overall Study||1
602886|NCT00414466|1474749|P3|NOT COMPLETED|Overall Study||1
602887|NCT00414466|1474750|P2|NOT COMPLETED|Overall Study||0
602888|NCT00414466|1474751|P1|NOT COMPLETED|Overall Study||2
602889|NCT00414466|1474748|P4|COMPLETED|Overall Study||42
602890|NCT00414466|1474749|P3|COMPLETED|Overall Study||40
602891|NCT00414466|1474750|P2|COMPLETED|Overall Study||42
602892|NCT00414466|1474751|P1|COMPLETED|Overall Study||42
602893|NCT00414466|1474748|P4|STARTED|Overall Study||43
602894|NCT00414466|1474749|P3|STARTED|Overall Study||41
602895|NCT00414466|1474750|P2|STARTED|Overall Study||42
602896|NCT00414466|1474751|P1|STARTED|Overall Study||44
602897|NCT00414453|1474769|P1|NOT COMPLETED|Overall Study||16
602898|NCT00414453|1474769|P1|COMPLETED|Overall Study||3
602899|NCT00414453|1474769|P1|STARTED|Overall Study||19
602900|NCT00414440|1474817|P2|NOT COMPLETED|Extension Period||140
602901|NCT00414440|1474818|P1|NOT COMPLETED|Extension Period||150
602902|NCT00414440|1474817|P2|COMPLETED|Extension Period|Extension|77
602903|NCT00414440|1474818|P1|COMPLETED|Extension Period|Extension|64
602904|NCT00414440|1474817|P2|STARTED|Extension Period|Extension|217
602905|NCT00414440|1474818|P1|STARTED|Extension Period|Extension|214
602906|NCT00414440|1474817|P2|NOT COMPLETED|Core Period||32
602907|NCT00414440|1474818|P1|NOT COMPLETED|Core Period||70
602908|NCT00414440|1474817|P2|COMPLETED|Core Period|Core period|185
602909|NCT00414440|1474818|P1|COMPLETED|Core Period|Core period|144
602910|NCT00414440|1474817|P2|STARTED|Core Period|Core period|217
602911|NCT00414440|1474818|P1|STARTED|Core Period|Core period|214
602912|NCT00414388|1474832|P1|NOT COMPLETED|Overall Study||1
602913|NCT00414388|1474832|P1|COMPLETED|Overall Study||21
602914|NCT00414388|1474832|P1|STARTED|Overall Study||22
602915|NCT00414310|1474840|P2|NOT COMPLETED|Overall Study||0
602916|NCT00414310|1474841|P1|NOT COMPLETED|Overall Study||1
602917|NCT00414310|1474840|P2|COMPLETED|Overall Study||79
602918|NCT00414310|1474841|P1|COMPLETED|Overall Study||70
602919|NCT00414310|1474840|P2|STARTED|Overall Study||79
602920|NCT00414310|1474841|P1|STARTED|Overall Study||71
602921|NCT00414206|1474850|P3|NOT COMPLETED|Overall Study||55
602922|NCT00414206|1474851|P2|NOT COMPLETED|Overall Study||56
602923|NCT00414206|1474852|P1|NOT COMPLETED|Overall Study||58
602924|NCT00414206|1474850|P3|COMPLETED|Overall Study||59
602925|NCT00414206|1474851|P2|COMPLETED|Overall Study||58
602926|NCT00414206|1474852|P1|COMPLETED|Overall Study||57
602927|NCT00414206|1474850|P3|STARTED|Overall Study||114
602928|NCT00414206|1474851|P2|STARTED|Overall Study||114
602929|NCT00414206|1474852|P1|STARTED|Overall Study||115
602930|NCT00414167|1474862|P2|NOT COMPLETED|Overall Study||3
602931|NCT00414167|1474863|P1|NOT COMPLETED|Overall Study||4
602932|NCT00414167|1474862|P2|COMPLETED|Overall Study||27
602933|NCT00414167|1474863|P1|COMPLETED|Overall Study||27
602934|NCT00414167|1474862|P2|STARTED|Overall Study||30
602935|NCT00414167|1474863|P1|STARTED|Overall Study||31
602936|NCT00414050|1474875|P4|NOT COMPLETED|Overall Study||8
602937|NCT00414050|1474876|P3|NOT COMPLETED|Overall Study||6
602938|NCT00414050|1474877|P2|NOT COMPLETED|Overall Study||8
602939|NCT00414050|1474878|P1|NOT COMPLETED|Overall Study||9
602940|NCT00414050|1474875|P4|COMPLETED|Overall Study||423
602941|NCT00414050|1474876|P3|COMPLETED|Overall Study||423
602942|NCT00414050|1474877|P2|COMPLETED|Overall Study||419
602943|NCT00414050|1474878|P1|COMPLETED|Overall Study||422
602944|NCT00414050|1474875|P4|Received Vaccination 3|Overall Study||424
602945|NCT00414050|1474876|P3|Received Vaccination 3|Overall Study||425
602946|NCT00414050|1474877|P2|Received Vaccination 3|Overall Study||419
602947|NCT00414050|1474878|P1|Received Vaccination 3|Overall Study||424
602948|NCT00414050|1474875|P4|Received Vaccination 2|Overall Study||425
602949|NCT00414050|1474876|P3|Received Vaccination 2|Overall Study||425
602950|NCT00414050|1474877|P2|Received Vaccination 2|Overall Study||421
602951|NCT00414050|1474878|P1|Received Vaccination 2|Overall Study||425
602952|NCT00414050|1474875|P4|Received Vaccination 1|Overall Study||431
602953|NCT00414050|1474876|P3|Received Vaccination 1|Overall Study||429
602954|NCT00414050|1474877|P2|Received Vaccination 1|Overall Study||426
602955|NCT00414050|1474878|P1|Received Vaccination 1|Overall Study||431
602956|NCT00414050|1474875|P4|STARTED|Overall Study||431
602957|NCT00414050|1474876|P3|STARTED|Overall Study||429
602958|NCT00414050|1474877|P2|STARTED|Overall Study||427
602959|NCT00414050|1474878|P1|STARTED|Overall Study||431
602960|NCT00414011|1474892|P1|NOT COMPLETED|Overall Study||5
602961|NCT00414011|1474892|P1|COMPLETED|Overall Study||35
602962|NCT00414011|1474892|P1|STARTED|Overall Study||40
602963|NCT00413972|1474901|P4|NOT COMPLETED|Overall Study||3
602964|NCT00413972|1474902|P3|NOT COMPLETED|Overall Study||10
602965|NCT00413972|1474903|P2|NOT COMPLETED|Overall Study||8
602966|NCT00413972|1474904|P1|NOT COMPLETED|Overall Study||7
602967|NCT00413972|1474901|P4|COMPLETED|Overall Study||95
602968|NCT00413972|1474902|P3|COMPLETED|Overall Study||88
602969|NCT00413972|1474903|P2|COMPLETED|Overall Study||90
602970|NCT00413972|1474904|P1|COMPLETED|Overall Study||91
602971|NCT00413972|1474901|P4|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
602972|NCT00413972|1474902|P3|STARTED|Overall Study||98
602973|NCT00413972|1474903|P2|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
602974|NCT00413972|1474904|P1|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
602975|NCT00413959|1474914|P1|NOT COMPLETED|Overall Study||1
602976|NCT00413959|1474914|P1|COMPLETED|Overall Study||11
602977|NCT00413959|1474914|P1|STARTED|Overall Study||12
602978|NCT00413920|1474921|P2|NOT COMPLETED|Overall Study||28
602979|NCT00413920|1474922|P1|NOT COMPLETED|Overall Study||28
602980|NCT00413920|1474921|P2|COMPLETED|Overall Study||82
602981|NCT00413920|1474922|P1|COMPLETED|Overall Study||84
602982|NCT00413920|1474921|P2|STARTED|Overall Study||110
602983|NCT00413920|1474922|P1|STARTED|Overall Study||112
602984|NCT00413894|1474937|P1|NOT COMPLETED|Overall Study||80
602985|NCT00413894|1474937|P1|COMPLETED|Overall Study||344
602986|NCT00413894|1474937|P1|STARTED|Overall Study||424
602987|NCT00413777|1474954|P2|NOT COMPLETED|Extension Period||0
602988|NCT00413777|1474955|P1|NOT COMPLETED|Extension Period||0
602989|NCT00413777|1474954|P2|COMPLETED|Extension Period||18
602990|NCT00413777|1474955|P1|COMPLETED|Extension Period||17
602991|NCT00413777|1474954|P2|STARTED|Extension Period||18
602992|NCT00413777|1474955|P1|STARTED|Extension Period||17
602993|NCT00413777|1474954|P2|NOT COMPLETED|Fixed-dose Period||3
602994|NCT00413777|1474955|P1|NOT COMPLETED|Fixed-dose Period||4
602995|NCT00413777|1474954|P2|COMPLETED|Fixed-dose Period||21
602996|NCT00413777|1474955|P1|COMPLETED|Fixed-dose Period||18
602997|NCT00413777|1474954|P2|STARTED|Fixed-dose Period||24
602998|NCT00413777|1474955|P1|STARTED|Fixed-dose Period||22
602999|NCT00413699|1475003|P2|NOT COMPLETED|Overall Study||1705
603000|NCT00413699|1475004|P1|NOT COMPLETED|Overall Study||639
603001|NCT00413699|1475003|P2|COMPLETED|Overall Study||1653
603002|NCT00413699|1475004|P1|COMPLETED|Overall Study||484
603003|NCT00413699|1475003|P2|STARTED|Overall Study||3358
603004|NCT00413699|1475004|P1|STARTED|Overall Study||1123
603005|NCT00413660|1475078|P11|NOT COMPLETED|Post Week 12||1
603006|NCT00413660|1475079|P10|NOT COMPLETED|Post Week 12||1
603007|NCT00413660|1475080|P9|NOT COMPLETED|Post Week 12||0
603008|NCT00413660|1475081|P8|NOT COMPLETED|Post Week 12||0
603009|NCT00413660|1475082|P7|NOT COMPLETED|Post Week 12||3
603010|NCT00413660|1475083|P6|NOT COMPLETED|Post Week 12||3
603011|NCT00413660|1475084|P5|NOT COMPLETED|Post Week 12||6
603012|NCT00413660|1475085|P4|NOT COMPLETED|Post Week 12||1
603013|NCT00413660|1475086|P3|NOT COMPLETED|Post Week 12||8
603014|NCT00413660|1475087|P2|NOT COMPLETED|Post Week 12||4
603015|NCT00413660|1475088|P1|NOT COMPLETED|Post Week 12||3
603016|NCT00413660|1475078|P11|COMPLETED|Post Week 12||17
603017|NCT00413660|1475079|P10|COMPLETED|Post Week 12||12
603018|NCT00413660|1475080|P9|COMPLETED|Post Week 12||13
603019|NCT00413660|1475081|P8|COMPLETED|Post Week 12||21
603020|NCT00413660|1475082|P7|COMPLETED|Post Week 12||37
603021|NCT00413660|1475083|P6|COMPLETED|Post Week 12||54
603022|NCT00413660|1475084|P5|COMPLETED|Post Week 12||60
603023|NCT00413660|1475085|P4|COMPLETED|Post Week 12||66
603024|NCT00413660|1475086|P3|COMPLETED|Post Week 12||56
603025|NCT00413660|1475087|P2|COMPLETED|Post Week 12||44
603026|NCT00413660|1475088|P1|COMPLETED|Post Week 12||40
603027|NCT00413660|1475078|P11|STARTED|Post Week 12||18
603028|NCT00413660|1475079|P10|STARTED|Post Week 12||13
603029|NCT00413660|1475080|P9|STARTED|Post Week 12||13
603030|NCT00413660|1475081|P8|STARTED|Post Week 12||21
603031|NCT00413660|1475082|P7|STARTED|Post Week 12||40
603032|NCT00413660|1475083|P6|STARTED|Post Week 12||57
603033|NCT00413660|1475084|P5|STARTED|Post Week 12||66
603034|NCT00413660|1475085|P4|STARTED|Post Week 12||67
603035|NCT00413660|1475086|P3|STARTED|Post Week 12||64
603036|NCT00413660|1475087|P2|STARTED|Post Week 12||48
603037|NCT00413660|1475088|P1|STARTED|Post Week 12||43
603038|NCT00413660|1475078|P11|NOT COMPLETED|Up To Week 12||0
603039|NCT00413660|1475079|P10|NOT COMPLETED|Up To Week 12||0
603040|NCT00413660|1475080|P9|NOT COMPLETED|Up To Week 12||0
603041|NCT00413660|1475081|P8|NOT COMPLETED|Up To Week 12||0
603042|NCT00413660|1475082|P7|NOT COMPLETED|Up To Week 12||11
603043|NCT00413660|1475083|P6|NOT COMPLETED|Up To Week 12||10
603044|NCT00413660|1475084|P5|NOT COMPLETED|Up To Week 12||9
603045|NCT00413660|1475085|P4|NOT COMPLETED|Up To Week 12||8
603046|NCT00413660|1475086|P3|NOT COMPLETED|Up To Week 12||7
603047|NCT00413660|1475087|P2|NOT COMPLETED|Up To Week 12||7
603048|NCT00413660|1475088|P1|NOT COMPLETED|Up To Week 12||7
603049|NCT00413660|1475078|P11|COMPLETED|Up To Week 12||0
603050|NCT00413660|1475079|P10|COMPLETED|Up To Week 12||0
603051|NCT00413660|1475080|P9|COMPLETED|Up To Week 12||0
603052|NCT00413660|1475081|P8|COMPLETED|Up To Week 12||0
603053|NCT00413660|1475082|P7|COMPLETED|Up To Week 12||58
603054|NCT00413660|1475083|P6|COMPLETED|Up To Week 12||70
603055|NCT00413660|1475084|P5|COMPLETED|Up To Week 12||66
603056|NCT00413660|1475085|P4|COMPLETED|Up To Week 12||67
603057|NCT00413660|1475086|P3|COMPLETED|Up To Week 12||64
603058|NCT00413660|1475087|P2|COMPLETED|Up To Week 12||61
603059|NCT00413660|1475088|P1|COMPLETED|Up To Week 12||64
603060|NCT00413660|1475078|P11|Treated|Up To Week 12||0
603061|NCT00413660|1475079|P10|Treated|Up To Week 12||0
603062|NCT00413660|1475080|P9|Treated|Up To Week 12||0
603063|NCT00413660|1475081|P8|Treated|Up To Week 12||0
603064|NCT00413660|1475082|P7|Treated|Up To Week 12||69
603065|NCT00413660|1475083|P6|Treated|Up To Week 12||80
603066|NCT00413660|1475084|P5|Treated|Up To Week 12||75
603067|NCT00413660|1475085|P4|Treated|Up To Week 12||74
603068|NCT00413660|1475086|P3|Treated|Up To Week 12||71
603069|NCT00413660|1475087|P2|Treated|Up To Week 12||68
603070|NCT00413660|1475088|P1|Treated|Up To Week 12||70
603071|NCT00413660|1475078|P11|STARTED|Up To Week 12||0
603072|NCT00413660|1475079|P10|STARTED|Up To Week 12||0
603073|NCT00413660|1475080|P9|STARTED|Up To Week 12||0
603074|NCT00413660|1475081|P8|STARTED|Up To Week 12||0
603075|NCT00413660|1475082|P7|STARTED|Up To Week 12||69
603076|NCT00413660|1475083|P6|STARTED|Up To Week 12||80
603077|NCT00413660|1475084|P5|STARTED|Up To Week 12||75
603078|NCT00413660|1475085|P4|STARTED|Up To Week 12||75
603079|NCT00413660|1475086|P3|STARTED|Up To Week 12||71
603080|NCT00413660|1475087|P2|STARTED|Up To Week 12||68
603081|NCT00413660|1475088|P1|STARTED|Up To Week 12||71
603082|NCT00413634|1475436|P2|NOT COMPLETED|Overall Study||0
603083|NCT00413634|1475437|P1|NOT COMPLETED|Overall Study||0
603084|NCT00413634|1475436|P2|COMPLETED|Overall Study||12
603085|NCT00413634|1475437|P1|COMPLETED|Overall Study||12
603086|NCT00413634|1475436|P2|STARTED|Overall Study||12
603087|NCT00413634|1475437|P1|STARTED|Overall Study||12
603088|NCT00413582|1475475|P2|NOT COMPLETED|Overall Study||0
603089|NCT00413582|1475476|P1|NOT COMPLETED|Overall Study||0
603090|NCT00413582|1475475|P2|COMPLETED|Overall Study|all enrolled completed|55
603091|NCT00413582|1475476|P1|COMPLETED|Overall Study|all enrolled completed|55
603092|NCT00413582|1475475|P2|Completion of Study|Overall Study|all enrolled completed|55
603093|NCT00413582|1475476|P1|Completion of Study|Overall Study|all enrolled completed|55
603094|NCT00413582|1475475|P2|STARTED|Overall Study|all enrolled completed|55
603095|NCT00413582|1475476|P1|STARTED|Overall Study|all enrolled completed|55
603096|NCT00413478|1475484|P1|NOT COMPLETED|Overall Study||0
603097|NCT00413478|1475484|P1|COMPLETED|Overall Study||9
603098|NCT00413478|1475484|P1|STARTED|Overall Study||9
603099|NCT00413413|1475491|P3|NOT COMPLETED|Double-Blind||18
603100|NCT00413413|1475492|P2|NOT COMPLETED|Double-Blind||14
603101|NCT00413413|1475493|P1|NOT COMPLETED|Double-Blind||15
603102|NCT00413413|1475491|P3|COMPLETED|Double-Blind||285
603103|NCT00413413|1475492|P2|COMPLETED|Double-Blind||293
603104|NCT00413413|1475493|P1|COMPLETED|Double-Blind||293
603105|NCT00413413|1475491|P3|STARTED|Double-Blind||303
603106|NCT00413413|1475492|P2|STARTED|Double-Blind||307
603107|NCT00413413|1475493|P1|STARTED|Double-Blind||308
603108|NCT00413413|1475491|P3|NOT COMPLETED|Single-Blind||0
603109|NCT00413413|1475492|P2|NOT COMPLETED|Single-Blind||216
603110|NCT00413413|1475493|P1|NOT COMPLETED|Single-Blind||0
603111|NCT00413413|1475491|P3|COMPLETED|Single-Blind||0
603112|NCT00413413|1475492|P2|COMPLETED|Single-Blind||918
603113|NCT00413413|1475493|P1|COMPLETED|Single-Blind||0
603114|NCT00413413|1475491|P3|STARTED|Single-Blind|In single-blind period participants were only enrolled to Valsartan 80 mg arm.|0
603115|NCT00413413|1475492|P2|STARTED|Single-Blind||1134
603116|NCT00413413|1475493|P1|STARTED|Single-Blind|In single-blind period participants were only enrolled to Valsartan 80 mg arm.|0
603117|NCT00413400|1475515|P2|NOT COMPLETED|Overall Study||4
603118|NCT00413400|1475516|P1|NOT COMPLETED|Overall Study||2
603119|NCT00413400|1475515|P2|COMPLETED|Overall Study||12
603120|NCT00413400|1475516|P1|COMPLETED|Overall Study||22
603121|NCT00413400|1475515|P2|3 Month Visit|Overall Study||12
603122|NCT00413400|1475516|P1|3 Month Visit|Overall Study||22
603123|NCT00413400|1475515|P2|STARTED|Overall Study||16
603124|NCT00413400|1475516|P1|STARTED|Overall Study||24
603125|NCT00413374|1475546|P2|NOT COMPLETED|Overall Study||0
603126|NCT00413374|1475547|P1|NOT COMPLETED|Overall Study||6
603127|NCT00413374|1475546|P2|COMPLETED|Overall Study||80
603128|NCT00413374|1475547|P1|COMPLETED|Overall Study||34
603129|NCT00413374|1475546|P2|STARTED|Overall Study||80
603130|NCT00413374|1475547|P1|STARTED|Overall Study||40
603131|NCT00413335|1475559|P2|NOT COMPLETED|Overall Study||0
603132|NCT00413335|1475560|P1|NOT COMPLETED|Overall Study||0
603133|NCT00413335|1475559|P2|COMPLETED|Overall Study||9
603134|NCT00413335|1475560|P1|COMPLETED|Overall Study||12
603135|NCT00413335|1475559|P2|STARTED|Overall Study||9
603136|NCT00413335|1475560|P1|STARTED|Overall Study||12
603137|NCT00413283|1475578|P4|NOT COMPLETED|Overall Study||4
603138|NCT00413283|1475579|P3|NOT COMPLETED|Overall Study||2
603139|NCT00413283|1475580|P2|NOT COMPLETED|Overall Study||3
603140|NCT00413283|1475581|P1|NOT COMPLETED|Overall Study||1
603141|NCT00413283|1475578|P4|COMPLETED|Overall Study||13
603142|NCT00413283|1475579|P3|COMPLETED|Overall Study||16
603143|NCT00413283|1475580|P2|COMPLETED|Overall Study||13
603144|NCT00413283|1475581|P1|COMPLETED|Overall Study||11
603145|NCT00413283|1475578|P4|Received Study Drug|Overall Study||16
603146|NCT00413283|1475579|P3|Received Study Drug|Overall Study||18
603147|NCT00413283|1475580|P2|Received Study Drug|Overall Study||16
603148|NCT00413283|1475581|P1|Received Study Drug|Overall Study||12
603149|NCT00413283|1475578|P4|STARTED|Overall Study||17
603150|NCT00413283|1475579|P3|STARTED|Overall Study||18
603151|NCT00413283|1475580|P2|STARTED|Overall Study||16
603152|NCT00413283|1475581|P1|STARTED|Overall Study||12
603153|NCT00413244|1475613|P2|NOT COMPLETED|Overall Study||1
603154|NCT00413244|1475614|P1|NOT COMPLETED|Overall Study||10
603155|NCT00413244|1475613|P2|COMPLETED|Overall Study||19
603156|NCT00413244|1475614|P1|COMPLETED|Overall Study||21
603157|NCT00413244|1475613|P2|STARTED|Overall Study||20
603158|NCT00413244|1475614|P1|STARTED|Overall Study||31
603159|NCT00413231|1475642|P1|NOT COMPLETED|365-day to 60-month Post Treatment||46
603160|NCT00413231|1475642|P1|COMPLETED|365-day to 60-month Post Treatment||93
603161|NCT00413231|1475642|P1|STARTED|365-day to 60-month Post Treatment||139
603162|NCT00413231|1475642|P1|NOT COMPLETED|30-day to 365-day Post Treatment||13
603163|NCT00413231|1475642|P1|COMPLETED|30-day to 365-day Post Treatment||139
603164|NCT00413231|1475642|P1|STARTED|30-day to 365-day Post Treatment||152
603165|NCT00413231|1475642|P1|NOT COMPLETED|0 to 30-day Post Treatment||8
603166|NCT00413231|1475642|P1|COMPLETED|0 to 30-day Post Treatment||152
603167|NCT00413231|1475642|P1|STARTED|0 to 30-day Post Treatment||160
603168|NCT00413218|1475674|P2|NOT COMPLETED|Overall Study||96
603169|NCT00413218|1475675|P1|NOT COMPLETED|Overall Study||103
603170|NCT00413218|1475674|P2|COMPLETED|Overall Study||131
603171|NCT00413218|1475675|P1|COMPLETED|Overall Study||120
603172|NCT00413218|1475674|P2|Intent to Treat Population (ITT)|Overall Study||219
603173|NCT00413218|1475675|P1|Intent to Treat Population (ITT)|Overall Study||221
603174|NCT00413218|1475674|P2|STARTED|Overall Study||227
603175|NCT00413218|1475675|P1|STARTED|Overall Study||223
603176|NCT00413192|1475701|P4|NOT COMPLETED|Overall Study||32
603177|NCT00413192|1475702|P3|NOT COMPLETED|Overall Study||19
603178|NCT00413192|1475703|P2|NOT COMPLETED|Overall Study||40
603179|NCT00413192|1475704|P1|NOT COMPLETED|Overall Study||37
603180|NCT00413192|1475701|P4|COMPLETED|Overall Study||0
603181|NCT00413192|1475702|P3|COMPLETED|Overall Study||0
603182|NCT00413192|1475703|P2|COMPLETED|Overall Study||0
603183|NCT00413192|1475704|P1|COMPLETED|Overall Study||0
603184|NCT00413192|1475701|P4|STARTED|Overall Study||32
603185|NCT00413192|1475702|P3|STARTED|Overall Study||19
603186|NCT00413192|1475703|P2|STARTED|Overall Study||40
603187|NCT00413192|1475704|P1|STARTED|Overall Study||37
603188|NCT00413153|1475744|P2|NOT COMPLETED|Overall Study||1
603189|NCT00413153|1475745|P1|NOT COMPLETED|Overall Study||2
603190|NCT00413153|1475744|P2|COMPLETED|Overall Study||7
603191|NCT00413153|1475745|P1|COMPLETED|Overall Study||5
603192|NCT00413153|1475744|P2|STARTED|Overall Study||8
603193|NCT00413153|1475745|P1|STARTED|Overall Study||7
603194|NCT00413062|1475769|P2|NOT COMPLETED|Overall Study||210
603195|NCT00413062|1475770|P1|NOT COMPLETED|Overall Study||678
603196|NCT00413062|1475769|P2|COMPLETED|Overall Study||344
603197|NCT00413062|1475770|P1|COMPLETED|Overall Study||988
603198|NCT00413062|1475769|P2|STARTED|Overall Study||554
603199|NCT00413062|1475770|P1|STARTED|Overall Study||1666
603200|NCT00413049|1475796|P2|NOT COMPLETED|Overall Study||18
603201|NCT00413049|1475797|P1|NOT COMPLETED|Overall Study||24
603202|NCT00413049|1475796|P2|COMPLETED|Overall Study||331
603203|NCT00413049|1475797|P1|COMPLETED|Overall Study||325
603204|NCT00413049|1475796|P2|STARTED|Overall Study||349
603205|NCT00413049|1475797|P1|STARTED|Overall Study||349
603206|NCT00413036|1475813|P1|NOT COMPLETED|Overall Study||217
603207|NCT00413036|1475813|P1|COMPLETED|Overall Study|Participants remain on study drug until progressive disease or unacceptable adverse events develop.|0
603208|NCT00413036|1475813|P1|STARTED|Overall Study||217
603209|NCT00413010|1475823|P2|NOT COMPLETED|Overall Study||63
603210|NCT00413010|1475824|P1|NOT COMPLETED|Overall Study||72
603211|NCT00413010|1475823|P2|COMPLETED|Overall Study||113
603212|NCT00413010|1475824|P1|COMPLETED|Overall Study||108
603213|NCT00413010|1475823|P2|STARTED|Overall Study||176
603214|NCT00413010|1475824|P1|STARTED|Overall Study||180
603215|NCT00412984|1475846|P2|NOT COMPLETED|Overall Study||2493
603216|NCT00412984|1475847|P1|NOT COMPLETED|Overall Study||2310
603217|NCT00412984|1475846|P2|COMPLETED|Overall Study||6588
603218|NCT00412984|1475847|P1|COMPLETED|Overall Study||6810
603219|NCT00412984|1475846|P2|STARTED|Overall Study|Randomized participants|9081
603220|NCT00412984|1475847|P1|STARTED|Overall Study|Randomized participants|9120
603221|NCT00412971|1475891|P2|NOT COMPLETED|Overall Study||10
603222|NCT00412971|1475892|P1|NOT COMPLETED|Overall Study||30
603223|NCT00412971|1475891|P2|COMPLETED|Overall Study||108
603224|NCT00412971|1475892|P1|COMPLETED|Overall Study||85
603225|NCT00412971|1475891|P2|STARTED|Overall Study||118
603226|NCT00412971|1475892|P1|STARTED|Overall Study||115
603227|NCT00412958|1475905|P4|NOT COMPLETED|Overall Study||1
603228|NCT00412958|1475906|P3|NOT COMPLETED|Overall Study||0
603229|NCT00412958|1475907|P2|NOT COMPLETED|Overall Study||4
603230|NCT00412958|1475908|P1|NOT COMPLETED|Overall Study||3
603231|NCT00412958|1475905|P4|COMPLETED|Overall Study||30
603232|NCT00412958|1475906|P3|COMPLETED|Overall Study||32
603233|NCT00412958|1475907|P2|COMPLETED|Overall Study||29
603234|NCT00412958|1475908|P1|COMPLETED|Overall Study||26
603235|NCT00412958|1475905|P4|STARTED|Overall Study||31
603236|NCT00412958|1475906|P3|STARTED|Overall Study||32
603237|NCT00412958|1475907|P2|STARTED|Overall Study||33
603238|NCT00412958|1475908|P1|STARTED|Overall Study||29
603239|NCT00412932|1475918|P1|NOT COMPLETED|Olm+ Hydrochlorothiazide 25 mg||2
603240|NCT00412932|1475918|P1|COMPLETED|Olm+ Hydrochlorothiazide 25 mg||123
603241|NCT00412932|1475918|P1|STARTED|Olm+ Hydrochlorothiazide 25 mg|153 -28 met their blood pressure goal (stayed on olmesartan 40/hydrochlorothiazide 12.5) = 125|125
603242|NCT00412932|1475918|P1|NOT COMPLETED|Olm+Hydrochlorothiazide 12.5 mg||6
603243|NCT00412932|1475918|P1|COMPLETED|Olm+Hydrochlorothiazide 12.5 mg||153
603244|NCT00412932|1475918|P1|STARTED|Olm+Hydrochlorothiazide 12.5 mg|161 -2 met blood pressure goal (stayed on olmesartan 40) = 159|159
603245|NCT00412932|1475918|P1|NOT COMPLETED|Olmesartan 40 mg||8
603246|NCT00412932|1475918|P1|COMPLETED|Olmesartan 40 mg||161
603247|NCT00412932|1475918|P1|STARTED|Olmesartan 40 mg|171 -1 met blood pressure goal (stayed on olmesartan 20) -1 who erroneously skipped this step = 169.|169
603248|NCT00412932|1475918|P1|NOT COMPLETED|Olmesartan (Olm) 20 mg||7
603249|NCT00412932|1475918|P1|COMPLETED|Olmesartan (Olm) 20 mg||171
603250|NCT00412932|1475918|P1|STARTED|Olmesartan (Olm) 20 mg||178
603251|NCT00412893|1475929|P2|NOT COMPLETED|Overall Study||144
603252|NCT00412893|1475930|P1|NOT COMPLETED|Overall Study||145
603253|NCT00412893|1475929|P2|COMPLETED|Overall Study|Defined as completed treatment|120
603254|NCT00412893|1475930|P1|COMPLETED|Overall Study|Defined as completed treatment|118
603255|NCT00412893|1475929|P2|Received Treatment|Overall Study||258
603256|NCT00412893|1475930|P1|Received Treatment|Overall Study|One participant randomized to this group received voriconazole treatment for the first 7 days|258
603257|NCT00412893|1475929|P2|STARTED|Overall Study||264
603258|NCT00412893|1475930|P1|STARTED|Overall Study||263
603259|NCT00412867|1475956|P1|NOT COMPLETED|Overall Study||0
603260|NCT00412867|1475956|P1|COMPLETED|Overall Study||58
603261|NCT00412867|1475956|P1|STARTED|Overall Study||58
603262|NCT00412854|1475968|P2|NOT COMPLETED|Overall Study||16
603263|NCT00412854|1475969|P1|NOT COMPLETED|Overall Study||14
603264|NCT00412854|1475968|P2|COMPLETED|Overall Study||314
603265|NCT00412854|1475969|P1|COMPLETED|Overall Study||316
603266|NCT00412854|1475968|P2|STARTED|Overall Study||330
603267|NCT00412854|1475969|P1|STARTED|Overall Study||330
603268|NCT00412841|1475997|P2|NOT COMPLETED|Overall Study||5
603269|NCT00412841|1475998|P1|NOT COMPLETED|Overall Study||10
603270|NCT00412841|1475997|P2|COMPLETED|Overall Study||16
603271|NCT00412841|1475998|P1|COMPLETED|Overall Study||12
603272|NCT00412841|1475997|P2|STARTED|Overall Study||21
603273|NCT00412841|1475998|P1|STARTED|Overall Study||22
603274|NCT00412750|1476009|P3|NOT COMPLETED|Overall Study||23
603275|NCT00412750|1476010|P2|NOT COMPLETED|Overall Study||21
603276|NCT00412750|1476011|P1|NOT COMPLETED|Overall Study||31
603277|NCT00412750|1476009|P3|COMPLETED|Overall Study||31
603278|NCT00412750|1476010|P2|COMPLETED|Overall Study||34
603279|NCT00412750|1476011|P1|COMPLETED|Overall Study||19
603280|NCT00412750|1476009|P3|STARTED|Overall Study||54
603281|NCT00412750|1476010|P2|STARTED|Overall Study||55
603282|NCT00412750|1476011|P1|STARTED|Overall Study||50
603283|NCT00412737|1476036|P2|NOT COMPLETED|Overall Study||6
603284|NCT00412737|1476037|P1|NOT COMPLETED|Overall Study||16
603285|NCT00412737|1476036|P2|COMPLETED|Overall Study||232
603286|NCT00412737|1476037|P1|COMPLETED|Overall Study||221
603287|NCT00412737|1476036|P2|STARTED|Overall Study||238
603288|NCT00412737|1476037|P1|STARTED|Overall Study||237
603289|NCT00412607|1476055|P1|NOT COMPLETED|Overall Study||104
603290|NCT00412607|1476055|P1|COMPLETED|Overall Study||145
603291|NCT00412607|1476055|P1|Started Study Catheter|Overall Study||233
603292|NCT00412607|1476055|P1|STARTED|Overall Study||249
603293|NCT00412542|1476068|P2|NOT COMPLETED|Overall Study||3
603294|NCT00412542|1476069|P1|NOT COMPLETED|Overall Study||0
603295|NCT00412542|1476068|P2|COMPLETED|Overall Study||42
603296|NCT00412542|1476069|P1|COMPLETED|Overall Study||33
603297|NCT00412542|1476068|P2|STARTED|Overall Study||45
603298|NCT00412542|1476069|P1|STARTED|Overall Study||33
603299|NCT00412529|1476075|P2|NOT COMPLETED|Overall Study||0
603300|NCT00412529|1476076|P1|NOT COMPLETED|Overall Study||0
603301|NCT00412529|1476075|P2|COMPLETED|Overall Study||21
603302|NCT00412529|1476076|P1|COMPLETED|Overall Study||23
603303|NCT00412529|1476075|P2|STARTED|Overall Study||21
603304|NCT00412529|1476076|P1|STARTED|Overall Study||23
603305|NCT00412516|1476099|P3|NOT COMPLETED|Overall Study||0
603306|NCT00412516|1476100|P2|NOT COMPLETED|Overall Study||0
603307|NCT00412516|1476101|P1|NOT COMPLETED|Overall Study||0
603308|NCT00412516|1476099|P3|COMPLETED|Overall Study||214
603309|NCT00412516|1476100|P2|COMPLETED|Overall Study||212
603310|NCT00412516|1476101|P1|COMPLETED|Overall Study||93
603311|NCT00412516|1476099|P3|STARTED|Overall Study||214
603312|NCT00412516|1476100|P2|STARTED|Overall Study||212
603313|NCT00412516|1476101|P1|STARTED|Overall Study||93
603314|NCT00412464|1476118|P1|NOT COMPLETED|Overall Study||0
603315|NCT00412464|1476118|P1|COMPLETED|Overall Study|Age Groups: 1-5 Years (10); 6-12 Years (7); 13-18 years (7)|24
603316|NCT00412464|1476118|P1|STARTED|Overall Study|Age Groups: 1-5 Years (10); 6-12 Years (7); 13-18 years (7)|24
603317|NCT00412451|1476130|P4|NOT COMPLETED|Overall Study||2
603318|NCT00412451|1476131|P3|NOT COMPLETED|Overall Study||1
603319|NCT00412451|1476132|P2|NOT COMPLETED|Overall Study||0
603320|NCT00412451|1476133|P1|NOT COMPLETED|Overall Study||0
603321|NCT00412451|1476130|P4|COMPLETED|Overall Study||11
603322|NCT00412451|1476131|P3|COMPLETED|Overall Study||14
603323|NCT00412451|1476132|P2|COMPLETED|Overall Study||15
603324|NCT00412451|1476133|P1|COMPLETED|Overall Study||8
603325|NCT00412451|1476130|P4|STARTED|Overall Study||13
603326|NCT00412451|1476131|P3|STARTED|Overall Study||15
603327|NCT00412451|1476132|P2|STARTED|Overall Study||15
603328|NCT00412451|1476133|P1|STARTED|Overall Study||8
603329|NCT00412425|1476145|P2|NOT COMPLETED|Overall Study||0
603330|NCT00412425|1476146|P1|NOT COMPLETED|Overall Study||0
603331|NCT00412425|1476145|P2|COMPLETED|Overall Study||15
603332|NCT00412425|1476146|P1|COMPLETED|Overall Study||15
603333|NCT00412425|1476145|P2|STARTED|Overall Study||15
603334|NCT00412425|1476146|P1|STARTED|Overall Study||15
603335|NCT00412373|1476154|P2|NOT COMPLETED|Overall Study||77
603336|NCT00412373|1476155|P1|NOT COMPLETED|Overall Study||41
603337|NCT00412373|1476154|P2|COMPLETED|Overall Study|Number of Subjects Who Completed Double-Blind Treatment..|134
603338|NCT00412373|1476155|P1|COMPLETED|Overall Study|Number of Subjects Who Completed Double-Blind Treatment.|52
603339|NCT00412373|1476154|P2|STARTED|Overall Study|Number of Subjects Intent-to-Treat Analysis Set.|211
603340|NCT00412373|1476155|P1|STARTED|Overall Study|Number of Subjects in Intent-to-Treat Analysis Set.|93
603341|NCT00412360|1476197|P2|NOT COMPLETED|Overall Study||3
603342|NCT00412360|1476198|P1|NOT COMPLETED|Overall Study||1
603343|NCT00412360|1476197|P2|COMPLETED|Overall Study||108
603344|NCT00412360|1476198|P1|COMPLETED|Overall Study||112
603345|NCT00412360|1476197|P2|STARTED|Overall Study||111
603346|NCT00412360|1476198|P1|STARTED|Overall Study||113
603347|NCT00412243|1476222|P1|NOT COMPLETED|Overall Study||0
603348|NCT00412243|1476222|P1|COMPLETED|Overall Study||50
603349|NCT00412243|1476222|P1|STARTED|Overall Study||50
603350|NCT00412217|1476228|P2|NOT COMPLETED|Overall Study||48
603351|NCT00412217|1476229|P1|NOT COMPLETED|Overall Study||46
603352|NCT00412217|1476228|P2|COMPLETED|Overall Study||0
603353|NCT00412217|1476229|P1|COMPLETED|Overall Study||0
603354|NCT00412217|1476228|P2|STARTED|Overall Study||48
603355|NCT00412217|1476229|P1|STARTED|Overall Study||46
603356|NCT00412113|1476243|P2|NOT COMPLETED|Overall Study||15
603357|NCT00412113|1476244|P1|NOT COMPLETED|Overall Study||12
603358|NCT00412113|1476243|P2|COMPLETED|Overall Study|15-April-2008|107
603359|NCT00412113|1476244|P1|COMPLETED|Overall Study|15-April-2008|111
603360|NCT00412113|1476243|P2|Received Treatment|Overall Study||122
603361|NCT00412113|1476244|P1|Received Treatment|Overall Study|One subject assigned to Norvasc and TLC did not receive treatment and was excluded from all analyses|122
603362|NCT00412113|1476243|P2|STARTED|Overall Study|15-January-2007|122
603363|NCT00412113|1476244|P1|STARTED|Overall Study|15-January-2007|123
603364|NCT00412087|1476298|P2|NOT COMPLETED|Overall Study||65
603365|NCT00412087|1476299|P1|NOT COMPLETED|Overall Study||62
603366|NCT00412087|1476298|P2|COMPLETED|Overall Study||66
603367|NCT00412087|1476299|P1|COMPLETED|Overall Study||72
603368|NCT00412087|1476298|P2|STARTED|Overall Study||131
603369|NCT00412087|1476299|P1|STARTED|Overall Study||134
603370|NCT00412074|1476310|P3|NOT COMPLETED|Overall Study||67
603371|NCT00412074|1476311|P2|NOT COMPLETED|Overall Study||22
603372|NCT00412074|1476312|P1|NOT COMPLETED|Overall Study||77
603373|NCT00412074|1476310|P3|COMPLETED|Overall Study||128
603374|NCT00412074|1476311|P2|COMPLETED|Overall Study||44
603375|NCT00412074|1476312|P1|COMPLETED|Overall Study||122
603376|NCT00412074|1476310|P3|STARTED|Overall Study||195
603377|NCT00412074|1476311|P2|STARTED|Overall Study||66
603378|NCT00412074|1476312|P1|STARTED|Overall Study||199
603379|NCT00412061|1476328|P2|NOT COMPLETED|Open Label Phase||170
603380|NCT00412061|1476329|P1|NOT COMPLETED|Open Label Phase||0
603381|NCT00412061|1476328|P2|COMPLETED|Open Label Phase||0
603382|NCT00412061|1476329|P1|COMPLETED|Open Label Phase||0
603383|NCT00412061|1476328|P2|STARTED|Open Label Phase||170
603384|NCT00412061|1476329|P1|STARTED|Open Label Phase||0
603385|NCT00412061|1476328|P2|NOT COMPLETED|Double Blind Phase||213
603386|NCT00412061|1476329|P1|NOT COMPLETED|Double Blind Phase||216
603387|NCT00412061|1476328|P2|COMPLETED|Double Blind Phase||0
603388|NCT00412061|1476329|P1|COMPLETED|Double Blind Phase||0
603389|NCT00412061|1476328|P2|Safety Set|Double Blind Phase|1 pt randomized never took drug Another randomized did not have valid post BL safety assessment|211
603390|NCT00412061|1476329|P1|Safety Set|Double Blind Phase|1 patient did not provide at laest one valid post baseline safety assessment.|215
603391|NCT00412061|1476328|P2|STARTED|Double Blind Phase||213
603392|NCT00412061|1476329|P1|STARTED|Double Blind Phase||216
603393|NCT00411788|1476347|P1|NOT COMPLETED|Overall Study||2
603394|NCT00411788|1476347|P1|COMPLETED|Overall Study||9
603395|NCT00411788|1476347|P1|STARTED|Overall Study||11
603396|NCT00411762|1476356|P1|NOT COMPLETED|Overall Study||5
603397|NCT00411762|1476356|P1|COMPLETED|Overall Study||20
603398|NCT00411762|1476356|P1|STARTED|Overall Study||25
603399|NCT00411749|1476363|P2|NOT COMPLETED|Overall Study||0
603400|NCT00411749|1476364|P1|NOT COMPLETED|Overall Study||0
603401|NCT00411749|1476363|P2|COMPLETED|Overall Study|Completed at 1 month after vaccination series (Month 7). Subjects were followed until Month 7|25
603402|NCT00411749|1476364|P1|COMPLETED|Overall Study|Completed at 24 month after vaccination series (Month 30). Subjects were followed until Month 30|82
603403|NCT00411749|1476363|P2|Vaccinated|Overall Study||25
603404|NCT00411749|1476364|P1|Vaccinated|Overall Study||82
603405|NCT00411749|1476363|P2|STARTED|Overall Study||25
603406|NCT00411749|1476364|P1|STARTED|Overall Study||82
603407|NCT00411671|1476380|P1|NOT COMPLETED|Overall Study||20
603408|NCT00411671|1476380|P1|COMPLETED|Overall Study||85
603409|NCT00411671|1476380|P1|STARTED|Overall Study||105
603410|NCT00411645|1476388|P2|NOT COMPLETED|Overall Study||164
603411|NCT00411645|1476389|P1|NOT COMPLETED|Overall Study||81
603412|NCT00411645|1476388|P2|COMPLETED|Overall Study||290
603413|NCT00411645|1476389|P1|COMPLETED|Overall Study||146
603414|NCT00411645|1476388|P2|STARTED|Overall Study||454
603415|NCT00411645|1476389|P1|STARTED|Overall Study||227
603416|NCT00411619|1476413|P1|NOT COMPLETED|Overall Study||6
603417|NCT00411619|1476413|P1|COMPLETED|Overall Study||22
603418|NCT00411619|1476413|P1|STARTED|Overall Study||28
603419|NCT00411554|1476420|P2|NOT COMPLETED|Overall Study||9
603420|NCT00411554|1476421|P1|NOT COMPLETED|Overall Study||8
603421|NCT00411554|1476420|P2|COMPLETED|Overall Study||147
603422|NCT00411554|1476421|P1|COMPLETED|Overall Study||155
603423|NCT00411554|1476420|P2|STARTED|Overall Study|Study enrolled slightly more than the target of N=155|156
603424|NCT00411554|1476421|P1|STARTED|Overall Study|Study enrolled slightly more than the target of N=155|163
603425|NCT00411463|1476433|P2|NOT COMPLETED|Overall Study||3
603426|NCT00411463|1476434|P1|NOT COMPLETED|Overall Study||3
603427|NCT00411463|1476433|P2|COMPLETED|Overall Study||8
603428|NCT00411463|1476434|P1|COMPLETED|Overall Study||11
603429|NCT00411463|1476433|P2|STARTED|Overall Study||11
603430|NCT00411463|1476434|P1|STARTED|Overall Study||14
603431|NCT00411450|1476447|P1|NOT COMPLETED|Overall Study||3
603432|NCT00411450|1476447|P1|COMPLETED|Overall Study|Ended second-line treatment|113
603433|NCT00411450|1476447|P1|Received Treatment|Overall Study||115
603434|NCT00411450|1476447|P1|STARTED|Overall Study||116
603435|NCT00411411|1476475|P2|NOT COMPLETED|Overall Study||0
603436|NCT00411411|1476476|P1|NOT COMPLETED|Overall Study||0
603437|NCT00411411|1476475|P2|COMPLETED|Overall Study||25
603438|NCT00411411|1476476|P1|COMPLETED|Overall Study||24
603439|NCT00411411|1476475|P2|STARTED|Overall Study||25
603440|NCT00411411|1476476|P1|STARTED|Overall Study||24
603441|NCT00411398|1476484|P1|NOT COMPLETED|Overall Study||5
603442|NCT00411398|1476484|P1|COMPLETED|Overall Study||10
603443|NCT00411398|1476484|P1|STARTED|Overall Study||15
603444|NCT00411216|1476490|P2|NOT COMPLETED|Overall Study||2
603445|NCT00411216|1476491|P1|NOT COMPLETED|Overall Study||0
603446|NCT00411216|1476490|P2|COMPLETED|Overall Study||8
603447|NCT00411216|1476491|P1|COMPLETED|Overall Study||13
603448|NCT00411216|1476490|P2|STARTED|Overall Study||10
603449|NCT00411216|1476491|P1|STARTED|Overall Study||13
603450|NCT00411151|1476497|P1|NOT COMPLETED|Overall Study||47
603451|NCT00411151|1476497|P1|COMPLETED|Overall Study||5
603452|NCT00411151|1476497|P1|STARTED|Overall Study||52
603453|NCT00411086|1476507|P1|NOT COMPLETED|Overall Study||0
603454|NCT00411086|1476507|P1|COMPLETED|Overall Study||52
603455|NCT00411086|1476507|P1|STARTED|Overall Study||52
603456|NCT00410904|1476515|P2|NOT COMPLETED|Overall Study||0
603457|NCT00410904|1476516|P1|NOT COMPLETED|Overall Study||0
603458|NCT00410904|1476515|P2|COMPLETED|Overall Study||20
603459|NCT00410904|1476516|P1|COMPLETED|Overall Study||40
603460|NCT00410904|1476515|P2|STARTED|Overall Study||20
603461|NCT00410904|1476516|P1|STARTED|Overall Study||40
603462|NCT00410891|1476524|P1|NOT COMPLETED|Overall Study||0
603463|NCT00410891|1476524|P1|COMPLETED|Overall Study||129
603464|NCT00410891|1476524|P1|STARTED|Overall Study||129
603465|NCT00410826|1476530|P2|NOT COMPLETED|Overall Study||4
603466|NCT00410826|1476531|P1|NOT COMPLETED|Overall Study||9
603467|NCT00410826|1476530|P2|COMPLETED|Overall Study||95
603468|NCT00410826|1476531|P1|COMPLETED|Overall Study||96
603469|NCT00410826|1476530|P2|STARTED|Overall Study||99
603470|NCT00410826|1476531|P1|STARTED|Overall Study||105
603471|NCT00410813|1476541|P2|NOT COMPLETED|Overall Study||42
603472|NCT00410813|1476542|P1|NOT COMPLETED|Overall Study||43
603473|NCT00410813|1476541|P2|COMPLETED|Overall Study||0
603474|NCT00410813|1476542|P1|COMPLETED|Overall Study|Patients treated until progression.|0
603475|NCT00410813|1476541|P2|Eligible|Overall Study||38
603476|NCT00410813|1476542|P1|Eligible|Overall Study||41
603477|NCT00410813|1476541|P2|STARTED|Overall Study||42
603478|NCT00410813|1476542|P1|STARTED|Overall Study||43
603479|NCT00410761|1476579|P2|NOT COMPLETED|Overall Study||72
603480|NCT00410761|1476580|P1|NOT COMPLETED|Overall Study||120
603481|NCT00410761|1476579|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|28
603482|NCT00410761|1476580|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|111
603483|NCT00410761|1476579|P2|STARTED|Overall Study|randomised patients|100
603484|NCT00410761|1476580|P1|STARTED|Overall Study|randomised patients|231
603485|NCT00410605|1476600|P1|NOT COMPLETED|Overall Study||25
603486|NCT00410605|1476600|P1|COMPLETED|Overall Study||14
603487|NCT00410605|1476600|P1|STARTED|Overall Study||39
603488|NCT00410514|1476612|P3|NOT COMPLETED|Overall Study||7
603489|NCT00410514|1476613|P2|NOT COMPLETED|Overall Study||3
603490|NCT00410514|1476614|P1|NOT COMPLETED|Overall Study||2
603491|NCT00410514|1476612|P3|COMPLETED|Overall Study||58
603492|NCT00410514|1476613|P2|COMPLETED|Overall Study||67
603493|NCT00410514|1476614|P1|COMPLETED|Overall Study||63
603494|NCT00410514|1476612|P3|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|58
603495|NCT00410514|1476613|P2|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|64
603496|NCT00410514|1476614|P1|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|63
603497|NCT00410514|1476612|P3|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|65
603498|NCT00410514|1476613|P2|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|70
603499|NCT00410514|1476614|P1|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|65
603500|NCT00410514|1476612|P3|STARTED|Overall Study||65
603501|NCT00410514|1476613|P2|STARTED|Overall Study||70
603502|NCT00410514|1476614|P1|STARTED|Overall Study||65
603503|NCT00410488|1476675|P2|NOT COMPLETED|Overall Study||0
603504|NCT00410488|1476676|P1|NOT COMPLETED|Overall Study||0
603505|NCT00410488|1476675|P2|COMPLETED|Overall Study||34
603506|NCT00410488|1476676|P1|COMPLETED|Overall Study||16
603507|NCT00410488|1476675|P2|STARTED|Overall Study||34
603508|NCT00410488|1476676|P1|STARTED|Overall Study||16
603509|NCT00410423|1476681|P4|NOT COMPLETED|Phase 2||0
603510|NCT00410423|1476682|P3|NOT COMPLETED|Phase 2||0
603511|NCT00410423|1476683|P2|NOT COMPLETED|Phase 2||0
603512|NCT00410423|1476684|P1|NOT COMPLETED|Phase 2||0
603513|NCT00410423|1476681|P4|COMPLETED|Phase 2||44
603514|NCT00410423|1476682|P3|COMPLETED|Phase 2||0
603515|NCT00410423|1476683|P2|COMPLETED|Phase 2||0
603516|NCT00410423|1476684|P1|COMPLETED|Phase 2||0
603517|NCT00410423|1476681|P4|STARTED|Phase 2||44
603518|NCT00410423|1476682|P3|STARTED|Phase 2||0
603519|NCT00410423|1476683|P2|STARTED|Phase 2||0
603520|NCT00410423|1476684|P1|STARTED|Phase 2||0
603521|NCT00410423|1476681|P4|NOT COMPLETED|Phase 1 - Dose Level 3||0
603522|NCT00410423|1476682|P3|NOT COMPLETED|Phase 1 - Dose Level 3||0
603523|NCT00410423|1476683|P2|NOT COMPLETED|Phase 1 - Dose Level 3||0
603524|NCT00410423|1476684|P1|NOT COMPLETED|Phase 1 - Dose Level 3||0
603525|NCT00410423|1476681|P4|COMPLETED|Phase 1 - Dose Level 3||0
603526|NCT00410423|1476682|P3|COMPLETED|Phase 1 - Dose Level 3||3
603527|NCT00410423|1476683|P2|COMPLETED|Phase 1 - Dose Level 3||0
603528|NCT00410423|1476684|P1|COMPLETED|Phase 1 - Dose Level 3||0
603529|NCT00410423|1476681|P4|STARTED|Phase 1 - Dose Level 3||0
603530|NCT00410423|1476682|P3|STARTED|Phase 1 - Dose Level 3||3
603531|NCT00410423|1476683|P2|STARTED|Phase 1 - Dose Level 3||0
603532|NCT00410423|1476684|P1|STARTED|Phase 1 - Dose Level 3||0
603533|NCT00410423|1476681|P4|NOT COMPLETED|Phase 1 - Dose Level 2||0
603534|NCT00410423|1476682|P3|NOT COMPLETED|Phase 1 - Dose Level 2||0
603535|NCT00410423|1476683|P2|NOT COMPLETED|Phase 1 - Dose Level 2||0
603536|NCT00410423|1476684|P1|NOT COMPLETED|Phase 1 - Dose Level 2||0
603537|NCT00410423|1476681|P4|COMPLETED|Phase 1 - Dose Level 2||0
603538|NCT00410423|1476682|P3|COMPLETED|Phase 1 - Dose Level 2||0
603539|NCT00410423|1476683|P2|COMPLETED|Phase 1 - Dose Level 2||5
603540|NCT00410423|1476684|P1|COMPLETED|Phase 1 - Dose Level 2||0
603541|NCT00410423|1476681|P4|STARTED|Phase 1 - Dose Level 2||0
603542|NCT00410423|1476682|P3|STARTED|Phase 1 - Dose Level 2||0
603543|NCT00410423|1476683|P2|STARTED|Phase 1 - Dose Level 2||5
603544|NCT00410423|1476684|P1|STARTED|Phase 1 - Dose Level 2||0
603545|NCT00410423|1476681|P4|NOT COMPLETED|Phase 1 - Dose Level 1||0
603546|NCT00410423|1476682|P3|NOT COMPLETED|Phase 1 - Dose Level 1||0
603547|NCT00410423|1476683|P2|NOT COMPLETED|Phase 1 - Dose Level 1||0
603548|NCT00410423|1476684|P1|NOT COMPLETED|Phase 1 - Dose Level 1||0
603549|NCT00410423|1476681|P4|COMPLETED|Phase 1 - Dose Level 1||0
603550|NCT00410423|1476682|P3|COMPLETED|Phase 1 - Dose Level 1||0
603551|NCT00410423|1476683|P2|COMPLETED|Phase 1 - Dose Level 1||0
603552|NCT00410423|1476684|P1|COMPLETED|Phase 1 - Dose Level 1||3
603553|NCT00410423|1476681|P4|STARTED|Phase 1 - Dose Level 1||0
603554|NCT00410423|1476682|P3|STARTED|Phase 1 - Dose Level 1||0
603555|NCT00410423|1476683|P2|STARTED|Phase 1 - Dose Level 1||0
603556|NCT00410423|1476684|P1|STARTED|Phase 1 - Dose Level 1||3
603557|NCT00410410|1476697|P9|NOT COMPLETED|Open-Label Period (OL)||349
603558|NCT00410410|1476698|P8|NOT COMPLETED|Open-Label Period (OL)||0
603559|NCT00410410|1476699|P7|NOT COMPLETED|Open-Label Period (OL)||0
603560|NCT00410410|1476700|P6|NOT COMPLETED|Open-Label Period (OL)||0
603561|NCT00410410|1476701|P5|NOT COMPLETED|Open-Label Period (OL)||0
603562|NCT00410410|1476702|P4|NOT COMPLETED|Open-Label Period (OL)||0
603563|NCT00410410|1476703|P3|NOT COMPLETED|Open-Label Period (OL)||0
603564|NCT00410410|1476704|P2|NOT COMPLETED|Open-Label Period (OL)||0
603565|NCT00410410|1476705|P1|NOT COMPLETED|Open-Label Period (OL)||0
603566|NCT00410410|1476697|P9|COMPLETED|Open-Label Period (OL)||0
603567|NCT00410410|1476698|P8|COMPLETED|Open-Label Period (OL)||0
603568|NCT00410410|1476699|P7|COMPLETED|Open-Label Period (OL)||0
603569|NCT00410410|1476700|P6|COMPLETED|Open-Label Period (OL)||0
603570|NCT00410410|1476701|P5|COMPLETED|Open-Label Period (OL)||0
603571|NCT00410410|1476702|P4|COMPLETED|Open-Label Period (OL)||0
603572|NCT00410410|1476703|P3|COMPLETED|Open-Label Period (OL)||0
603573|NCT00410410|1476704|P2|COMPLETED|Open-Label Period (OL)||0
603574|NCT00410410|1476705|P1|COMPLETED|Open-Label Period (OL)||0
603575|NCT00410410|1476697|P9|STARTED|Open-Label Period (OL)|349 entered OL (those who completed IP but failed response criteria, or completed/relapsed on MP).|349
603576|NCT00410410|1476698|P8|STARTED|Open-Label Period (OL)||0
603577|NCT00410410|1476699|P7|STARTED|Open-Label Period (OL)||0
603578|NCT00410410|1476700|P6|STARTED|Open-Label Period (OL)||0
603579|NCT00410410|1476701|P5|STARTED|Open-Label Period (OL)||0
603580|NCT00410410|1476702|P4|STARTED|Open-Label Period (OL)||0
603581|NCT00410410|1476703|P3|STARTED|Open-Label Period (OL)||0
603582|NCT00410410|1476704|P2|STARTED|Open-Label Period (OL)||0
603583|NCT00410410|1476705|P1|STARTED|Open-Label Period (OL)||0
603584|NCT00410410|1476697|P9|NOT COMPLETED|Maintenance Period (MP)||0
603585|NCT00410410|1476698|P8|NOT COMPLETED|Maintenance Period (MP)||55
603586|NCT00410410|1476699|P7|NOT COMPLETED|Maintenance Period (MP)||50
603587|NCT00410410|1476700|P6|NOT COMPLETED|Maintenance Period (MP)||0
603588|NCT00410410|1476701|P5|NOT COMPLETED|Maintenance Period (MP)||0
603589|NCT00410410|1476702|P4|NOT COMPLETED|Maintenance Period (MP)||0
603590|NCT00410410|1476703|P3|NOT COMPLETED|Maintenance Period (MP)||0
603591|NCT00410410|1476704|P2|NOT COMPLETED|Maintenance Period (MP)||0
603592|NCT00410410|1476705|P1|NOT COMPLETED|Maintenance Period (MP)||0
603593|NCT00410410|1476697|P9|COMPLETED|Maintenance Period (MP)||0
603594|NCT00410410|1476698|P8|COMPLETED|Maintenance Period (MP)||11
603595|NCT00410410|1476699|P7|COMPLETED|Maintenance Period (MP)||15
603596|NCT00410410|1476700|P6|COMPLETED|Maintenance Period (MP)||0
603597|NCT00410410|1476701|P5|COMPLETED|Maintenance Period (MP)||0
603598|NCT00410410|1476702|P4|COMPLETED|Maintenance Period (MP)||0
603599|NCT00410410|1476703|P3|COMPLETED|Maintenance Period (MP)||0
603600|NCT00410410|1476704|P2|COMPLETED|Maintenance Period (MP)||0
603601|NCT00410410|1476705|P1|COMPLETED|Maintenance Period (MP)||0
603602|NCT00410410|1476697|P9|STARTED|Maintenance Period (MP)||0
603603|NCT00410410|1476698|P8|STARTED|Maintenance Period (MP)|At end of IP, 66 participants met response criteria and were randomly assigned to placebo in MP.|66
603604|NCT00410410|1476699|P7|STARTED|Maintenance Period (MP)|At end of IP, 65 participants met response criteria and were randomly assigned to abatacept in MP.|65
603605|NCT00410410|1476700|P6|STARTED|Maintenance Period (MP)||0
603606|NCT00410410|1476701|P5|STARTED|Maintenance Period (MP)||0
603607|NCT00410410|1476702|P4|STARTED|Maintenance Period (MP)||0
603608|NCT00410410|1476703|P3|STARTED|Maintenance Period (MP)||0
603609|NCT00410410|1476704|P2|STARTED|Maintenance Period (MP)||0
603610|NCT00410410|1476705|P1|STARTED|Maintenance Period (MP)||0
603611|NCT00410410|1476697|P9|NOT COMPLETED|Induction Period (IP)||0
603612|NCT00410410|1476698|P8|NOT COMPLETED|Induction Period (IP)||0
603613|NCT00410410|1476699|P7|NOT COMPLETED|Induction Period (IP)||0
603614|NCT00410410|1476700|P6|NOT COMPLETED|Induction Period (IP)||29
603615|NCT00410410|1476701|P5|NOT COMPLETED|Induction Period (IP)||32
603616|NCT00410410|1476702|P4|NOT COMPLETED|Induction Period (IP)||20
603617|NCT00410410|1476703|P3|NOT COMPLETED|Induction Period (IP)||17
603618|NCT00410410|1476704|P2|NOT COMPLETED|Induction Period (IP)||35
603619|NCT00410410|1476705|P1|NOT COMPLETED|Induction Period (IP)||35
603620|NCT00410410|1476697|P9|COMPLETED|Induction Period (IP)||0
603621|NCT00410410|1476698|P8|COMPLETED|Induction Period (IP)||0
603622|NCT00410410|1476699|P7|COMPLETED|Induction Period (IP)||0
603623|NCT00410410|1476700|P6|COMPLETED|Induction Period (IP)||21
603624|NCT00410410|1476701|P5|COMPLETED|Induction Period (IP)||19
603625|NCT00410410|1476702|P4|COMPLETED|Induction Period (IP)||120
603626|NCT00410410|1476703|P3|COMPLETED|Induction Period (IP)||53
603627|NCT00410410|1476704|P2|COMPLETED|Induction Period (IP)||104
603628|NCT00410410|1476705|P1|COMPLETED|Induction Period (IP)||106
603629|NCT00410410|1476697|P9|STARTED|Induction Period (IP)||0
603630|NCT00410410|1476698|P8|STARTED|Induction Period (IP)||0
603631|NCT00410410|1476699|P7|STARTED|Induction Period (IP)||0
603632|NCT00410410|1476700|P6|STARTED|Induction Period (IP)||50
603633|NCT00410410|1476701|P5|STARTED|Induction Period (IP)||51
603634|NCT00410410|1476702|P4|STARTED|Induction Period (IP)||140
603635|NCT00410410|1476703|P3|STARTED|Induction Period (IP)||70
603636|NCT00410410|1476704|P2|STARTED|Induction Period (IP)||139
603637|NCT00410410|1476705|P1|STARTED|Induction Period (IP)||141
603638|NCT00410384|1476866|P3|NOT COMPLETED|Overall Study||82
603639|NCT00410384|1476867|P2|NOT COMPLETED|Overall Study||72
603640|NCT00410384|1476868|P1|NOT COMPLETED|Overall Study||89
603641|NCT00410384|1476866|P3|COMPLETED|Overall Study||191
603642|NCT00410384|1476867|P2|COMPLETED|Overall Study||199
603643|NCT00410384|1476868|P1|COMPLETED|Overall Study||186
603644|NCT00410384|1476866|P3|STARTED|Overall Study||273
603645|NCT00410384|1476867|P2|STARTED|Overall Study||271
603646|NCT00410384|1476868|P1|STARTED|Overall Study||275
603647|NCT00410280|1476896|P2|NOT COMPLETED|Overall Study||0
603648|NCT00410280|1476897|P1|NOT COMPLETED|Overall Study||0
603649|NCT00410280|1476896|P2|COMPLETED|Overall Study||13
603650|NCT00410280|1476897|P1|COMPLETED|Overall Study||14
603651|NCT00410280|1476896|P2|STARTED|Overall Study||13
603652|NCT00410280|1476897|P1|STARTED|Overall Study||14
603653|NCT00410202|1476941|P3|NOT COMPLETED|Off-treatment Follow up||12
603654|NCT00410202|1476942|P2|NOT COMPLETED|Off-treatment Follow up||8
603655|NCT00410202|1476943|P1|NOT COMPLETED|Off-treatment Follow up||14
603656|NCT00410202|1476941|P3|COMPLETED|Off-treatment Follow up||2
603657|NCT00410202|1476942|P2|COMPLETED|Off-treatment Follow up||0
603658|NCT00410202|1476943|P1|COMPLETED|Off-treatment Follow up||1
603659|NCT00410202|1476941|P3|STARTED|Off-treatment Follow up||14
603660|NCT00410202|1476942|P2|STARTED|Off-treatment Follow up||8
603661|NCT00410202|1476943|P1|STARTED|Off-treatment Follow up||15
603662|NCT00410202|1476941|P3|NOT COMPLETED|On-Treatment||71
603663|NCT00410202|1476942|P2|NOT COMPLETED|On-Treatment||79
603664|NCT00410202|1476943|P1|NOT COMPLETED|On-Treatment||75
603665|NCT00410202|1476941|P3|COMPLETED|On-Treatment|Completed the 100 week dosing|66
603666|NCT00410202|1476942|P2|COMPLETED|On-Treatment|Completed the 100 week dosing|61
603667|NCT00410202|1476943|P1|COMPLETED|On-Treatment|Completed the 100 week dosing|63
603668|NCT00410202|1476941|P3|Discontinued at or After Week 48 Visit|On-Treatment||3
603669|NCT00410202|1476942|P2|Discontinued at or After Week 48 Visit|On-Treatment||6
603670|NCT00410202|1476943|P1|Discontinued at or After Week 48 Visit|On-Treatment||2
603671|NCT00410202|1476941|P3|Discontinued Prior to Week 48 Visit|On-Treatment||2
603672|NCT00410202|1476942|P2|Discontinued Prior to Week 48 Visit|On-Treatment||2
603673|NCT00410202|1476943|P1|Discontinued Prior to Week 48 Visit|On-Treatment||4
603674|NCT00410202|1476941|P3|STARTED|On-Treatment||137
603675|NCT00410202|1476942|P2|STARTED|On-Treatment||140
603676|NCT00410202|1476943|P1|STARTED|On-Treatment||138
603677|NCT00410189|1477023|P1|NOT COMPLETED|Overall Study||0
603678|NCT00410189|1477023|P1|COMPLETED|Overall Study||54
603679|NCT00410189|1477023|P1|STARTED|Overall Study||54
603680|NCT00410163|1477030|P2|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
603681|NCT00410163|1477031|P1|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
603682|NCT00410163|1477030|P2|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||11
603683|NCT00410163|1477031|P1|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
603684|NCT00410163|1477030|P2|STARTED|Extended Follow-up (FU) Phase (2-5 Years|Participants who withdrew from the Treatment Phase were eligible to enter the Extended FU Phase.|21
603685|NCT00410163|1477031|P1|STARTED|Extended Follow-up (FU) Phase (2-5 Years|Participants who withdrew from the Treatment Phase were eligible to enter the Extended FU Phase.|20
603686|NCT00410163|1477030|P2|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||11
603687|NCT00410163|1477031|P1|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||12
603688|NCT00410163|1477030|P2|COMPLETED|Treatment and Follow-up Phase (2 Years)||19
603689|NCT00410163|1477031|P1|COMPLETED|Treatment and Follow-up Phase (2 Years)||19
603690|NCT00410163|1477030|P2|STARTED|Treatment and Follow-up Phase (2 Years)||30
603691|NCT00410163|1477031|P1|STARTED|Treatment and Follow-up Phase (2 Years)||31
603692|NCT00410150|1477075|P2|NOT COMPLETED|Overall Study||3
603693|NCT00410150|1477076|P1|NOT COMPLETED|Overall Study||2
603694|NCT00410150|1477075|P2|COMPLETED|Overall Study|3 study withdrawals (analyzed by intention-to-treat0|17
603695|NCT00410150|1477076|P1|COMPLETED|Overall Study|2 study withdrawals (analyzed by intention-to-treat)|20
603696|NCT00410150|1477075|P2|STARTED|Overall Study||20
603697|NCT00410150|1477076|P1|STARTED|Overall Study||22
603698|NCT00410124|1477084|P2|NOT COMPLETED|Extension Phase - Open Label (45 Months)||111
603699|NCT00410124|1477085|P1|NOT COMPLETED|Extension Phase - Open Label (45 Months)||67
603700|NCT00410124|1477084|P2|COMPLETED|Extension Phase - Open Label (45 Months)||0
603701|NCT00410124|1477085|P1|COMPLETED|Extension Phase - Open Label (45 Months)||0
603702|NCT00410124|1477084|P2|STARTED|Extension Phase - Open Label (45 Months)|Patients on placebo in core received RAD001 in extension phase.|111
603703|NCT00410124|1477085|P1|STARTED|Extension Phase - Open Label (45 Months)||67
603704|NCT00410124|1477084|P2|NOT COMPLETED|Core Phase Double Blind (15 Months)||133
603705|NCT00410124|1477085|P1|NOT COMPLETED|Core Phase Double Blind (15 Months)||202
603706|NCT00410124|1477084|P2|COMPLETED|Core Phase Double Blind (15 Months)|All patients ongoing/completed/not completed in core had option to enter extension taking RAD001.|6
603791|NCT00409682|1477378|P3|NOT COMPLETED|Open-label Induction Period||0
603707|NCT00410124|1477085|P1|COMPLETED|Core Phase Double Blind (15 Months)|Patients ongoing/completed double blind phase had option entering extension phase continuing RAD001.|75
603708|NCT00410124|1477084|P2|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||2
603709|NCT00410124|1477085|P1|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||62
603710|NCT00410124|1477084|P2|Ongoing|Core Phase Double Blind (15 Months)||4
603711|NCT00410124|1477085|P1|Ongoing|Core Phase Double Blind (15 Months)||13
603712|NCT00410124|1477084|P2|STARTED|Core Phase Double Blind (15 Months)||139
603713|NCT00410124|1477085|P1|STARTED|Core Phase Double Blind (15 Months)|Started indicates randomized (FAS) and treated|277
603714|NCT00410072|1477116|P2|NOT COMPLETED|After Week 48 to Week 96||11
603715|NCT00410072|1477117|P1|NOT COMPLETED|After Week 48 to Week 96||6
603716|NCT00410072|1477116|P2|COMPLETED|After Week 48 to Week 96||174
603717|NCT00410072|1477117|P1|COMPLETED|After Week 48 to Week 96||170
603718|NCT00410072|1477116|P2|STARTED|After Week 48 to Week 96||185
603719|NCT00410072|1477117|P1|STARTED|After Week 48 to Week 96||176
603720|NCT00410072|1477116|P2|NOT COMPLETED|Day 1 to Week 48||12
603721|NCT00410072|1477117|P1|NOT COMPLETED|Day 1 to Week 48||6
603722|NCT00410072|1477116|P2|COMPLETED|Day 1 to Week 48||185
603723|NCT00410072|1477117|P1|COMPLETED|Day 1 to Week 48||176
603724|NCT00410072|1477116|P2|STARTED|Day 1 to Week 48|Number of participants randomized and treated; 1 more was randomized but not treated.|197
603725|NCT00410072|1477117|P1|STARTED|Day 1 to Week 48|Number of participants randomized and treated; 4 more were randomized but not treated.|182
603726|NCT00410059|1477153|P1|NOT COMPLETED|Overall Study||0
603727|NCT00410059|1477153|P1|COMPLETED|Overall Study||59
603728|NCT00410059|1477153|P1|STARTED|Overall Study||59
603729|NCT00410046|1477157|P1|NOT COMPLETED|Overall Study||5
603730|NCT00410046|1477157|P1|COMPLETED|Overall Study||79
603731|NCT00410046|1477157|P1|STARTED|Overall Study||84
603732|NCT00409838|1477188|P2|NOT COMPLETED|Long-term Extension Period||0
603733|NCT00409838|1477189|P1|NOT COMPLETED|Long-term Extension Period||18
603734|NCT00409838|1477188|P2|COMPLETED|Long-term Extension Period||0
603735|NCT00409838|1477189|P1|COMPLETED|Long-term Extension Period||87
603736|NCT00409838|1477188|P2|STARTED|Long-term Extension Period||0
603737|NCT00409838|1477189|P1|STARTED|Long-term Extension Period||105
603738|NCT00409838|1477188|P2|NOT COMPLETED|Short-term Period||5
603739|NCT00409838|1477189|P1|NOT COMPLETED|Short-term Period||3
603740|NCT00409838|1477188|P2|COMPLETED|Short-term Period|Participants who received placebo in this period received abatacept in next period.|52
603741|NCT00409838|1477189|P1|COMPLETED|Short-term Period||53
603742|NCT00409838|1477188|P2|Treated (Baseline) Population|Short-term Period||57
603743|NCT00409838|1477189|P1|Treated (Baseline) Population|Short-term Period||55
603744|NCT00409838|1477188|P2|STARTED|Short-term Period|Randomized|57
603745|NCT00409838|1477189|P1|STARTED|Short-term Period|Randomized|56
603746|NCT00409825|1477250|P1|NOT COMPLETED|Overall Study||0
603747|NCT00409825|1477250|P1|COMPLETED|Overall Study||61
603748|NCT00409825|1477250|P1|STARTED|Overall Study||61
603749|NCT00409786|1477254|P1|NOT COMPLETED|Overall Study||3
603750|NCT00409786|1477254|P1|COMPLETED|Overall Study||47
603751|NCT00409786|1477254|P1|STARTED|Overall Study||50
603752|NCT00409773|1477263|P5|NOT COMPLETED|Overall Study||10
603753|NCT00409773|1477264|P4|NOT COMPLETED|Overall Study||12
603754|NCT00409773|1477265|P3|NOT COMPLETED|Overall Study||9
603755|NCT00409773|1477266|P2|NOT COMPLETED|Overall Study||7
603756|NCT00409773|1477267|P1|NOT COMPLETED|Overall Study||9
603757|NCT00409773|1477263|P5|COMPLETED|Overall Study||218
603758|NCT00409773|1477264|P4|COMPLETED|Overall Study||216
603759|NCT00409773|1477265|P3|COMPLETED|Overall Study||220
603760|NCT00409773|1477266|P2|COMPLETED|Overall Study||222
603761|NCT00409773|1477267|P1|COMPLETED|Overall Study||220
603762|NCT00409773|1477263|P5|STARTED|Overall Study||228
603763|NCT00409773|1477264|P4|STARTED|Overall Study||228
603764|NCT00409773|1477265|P3|STARTED|Overall Study||229
603765|NCT00409773|1477266|P2|STARTED|Overall Study||229
603766|NCT00409773|1477267|P1|STARTED|Overall Study||229
603767|NCT00409747|1477349|P1|NOT COMPLETED|Overall Study||1
603768|NCT00409747|1477349|P1|COMPLETED|Overall Study||10
603769|NCT00409747|1477349|P1|STARTED|Overall Study||11
603770|NCT00409708|1477356|P2|NOT COMPLETED|Washout||10
603771|NCT00409708|1477357|P1|NOT COMPLETED|Washout||21
603772|NCT00409708|1477356|P2|COMPLETED|Washout||29
603773|NCT00409708|1477357|P1|COMPLETED|Washout||17
603774|NCT00409708|1477356|P2|STARTED|Washout||39
603775|NCT00409708|1477357|P1|STARTED|Washout||38
603776|NCT00409708|1477356|P2|NOT COMPLETED|Treatment||17
603777|NCT00409708|1477357|P1|NOT COMPLETED|Treatment||15
603778|NCT00409708|1477356|P2|COMPLETED|Treatment||39
603779|NCT00409708|1477357|P1|COMPLETED|Treatment||38
603780|NCT00409708|1477356|P2|STARTED|Treatment||56
603781|NCT00409708|1477357|P1|STARTED|Treatment|A total of 142 participants were screened for the study but only 109 were randomized to treatment|53
603782|NCT00409682|1477378|P3|NOT COMPLETED|EOW Double-blind Maintenance Period||27
603783|NCT00409682|1477379|P2|NOT COMPLETED|EOW Double-blind Maintenance Period||37
603784|NCT00409682|1477380|P1|NOT COMPLETED|EOW Double-blind Maintenance Period||0
603785|NCT00409682|1477378|P3|COMPLETED|EOW Double-blind Maintenance Period||66
603786|NCT00409682|1477379|P2|COMPLETED|EOW Double-blind Maintenance Period||58
603787|NCT00409682|1477380|P1|COMPLETED|EOW Double-blind Maintenance Period||0
603788|NCT00409682|1477378|P3|STARTED|EOW Double-blind Maintenance Period||93
603789|NCT00409682|1477379|P2|STARTED|EOW Double-blind Maintenance Period||95
603790|NCT00409682|1477380|P1|STARTED|EOW Double-blind Maintenance Period||0
603792|NCT00409682|1477379|P2|NOT COMPLETED|Open-label Induction Period||0
603793|NCT00409682|1477380|P1|NOT COMPLETED|Open-label Induction Period||4
603794|NCT00409682|1477378|P3|COMPLETED|Open-label Induction Period||0
603795|NCT00409682|1477379|P2|COMPLETED|Open-label Induction Period||0
603796|NCT00409682|1477380|P1|COMPLETED|Open-label Induction Period||188
603797|NCT00409682|1477378|P3|STARTED|Open-label Induction Period||0
603798|NCT00409682|1477379|P2|STARTED|Open-label Induction Period||0
603799|NCT00409682|1477380|P1|STARTED|Open-label Induction Period||192
603800|NCT00409617|1477397|P1|NOT COMPLETED|Overall Study||160
603801|NCT00409617|1477397|P1|COMPLETED|Overall Study||785
603802|NCT00409617|1477397|P1|STARTED|Overall Study||945
603803|NCT00409578|1477413|P4|NOT COMPLETED|Overall Study||67
603804|NCT00409578|1477414|P3|NOT COMPLETED|Overall Study||54
603805|NCT00409578|1477415|P2|NOT COMPLETED|Overall Study||70
603806|NCT00409578|1477416|P1|NOT COMPLETED|Overall Study||52
603807|NCT00409578|1477413|P4|COMPLETED|Overall Study||214
603808|NCT00409578|1477414|P3|COMPLETED|Overall Study||215
603809|NCT00409578|1477415|P2|COMPLETED|Overall Study||201
603810|NCT00409578|1477416|P1|COMPLETED|Overall Study||228
603811|NCT00409578|1477413|P4|STARTED|Overall Study||281
603812|NCT00409578|1477414|P3|STARTED|Overall Study||269
603813|NCT00409578|1477415|P2|STARTED|Overall Study||271
603814|NCT00409578|1477416|P1|STARTED|Overall Study||280
603815|NCT00409565|1477438|P1|NOT COMPLETED|Overall Study||1
603816|NCT00409565|1477438|P1|COMPLETED|Overall Study||45
603817|NCT00409565|1477438|P1|Overall Response Rate|Overall Study||7
603818|NCT00409565|1477438|P1|STARTED|Overall Study||46
603819|NCT00409539|1477451|P5|NOT COMPLETED|Overall Study||25
603820|NCT00409539|1477452|P4|NOT COMPLETED|Overall Study||12
603821|NCT00409539|1477453|P3|NOT COMPLETED|Overall Study||14
603822|NCT00409539|1477454|P2|NOT COMPLETED|Overall Study||11
603823|NCT00409539|1477455|P1|NOT COMPLETED|Overall Study||11
603824|NCT00409539|1477451|P5|COMPLETED|Overall Study||85
603825|NCT00409539|1477452|P4|COMPLETED|Overall Study||97
603826|NCT00409539|1477453|P3|COMPLETED|Overall Study||95
603827|NCT00409539|1477454|P2|COMPLETED|Overall Study||100
603828|NCT00409539|1477455|P1|COMPLETED|Overall Study||100
603829|NCT00409539|1477451|P5|STARTED|Overall Study||110
603830|NCT00409539|1477452|P4|STARTED|Overall Study||109
603831|NCT00409539|1477453|P3|STARTED|Overall Study||109
603832|NCT00409539|1477454|P2|STARTED|Overall Study||111
603833|NCT00409539|1477455|P1|STARTED|Overall Study||111
603834|NCT00409409|1477474|P2|NOT COMPLETED|Overall Study||4
603835|NCT00409409|1477475|P1|NOT COMPLETED|Overall Study||8
603836|NCT00409409|1477474|P2|COMPLETED|Overall Study||135
603837|NCT00409409|1477475|P1|COMPLETED|Overall Study||131
603838|NCT00409409|1477474|P2|STARTED|Overall Study||139
603839|NCT00409409|1477475|P1|STARTED|Overall Study||139
603840|NCT00409344|1477483|P2|NOT COMPLETED|Overall Study||0
603841|NCT00409344|1477484|P1|NOT COMPLETED|Overall Study||0
603842|NCT00409344|1477483|P2|COMPLETED|Overall Study|No participants were enrolled to completion|0
603843|NCT00409344|1477484|P1|COMPLETED|Overall Study|No participants were enrolled to completion|0
603844|NCT00409344|1477483|P2|STARTED|Overall Study|No participants enrolled|0
603845|NCT00409344|1477484|P1|STARTED|Overall Study|No participants enrolled|0
603846|NCT00409331|1477502|P1|NOT COMPLETED|Overall Study||1
603847|NCT00409331|1477502|P1|COMPLETED|Overall Study||0
603848|NCT00409331|1477502|P1|STARTED|Overall Study||1
603849|NCT00409292|1477506|P1|NOT COMPLETED|Overall Study||0
603850|NCT00409292|1477506|P1|COMPLETED|Overall Study||33
603851|NCT00409292|1477506|P1|STARTED|Overall Study||33
603852|NCT00409240|1477515|P2|NOT COMPLETED|Overall Study||1
603853|NCT00409240|1477516|P1|NOT COMPLETED|Overall Study||3
603854|NCT00409240|1477515|P2|COMPLETED|Overall Study||49
603855|NCT00409240|1477516|P1|COMPLETED|Overall Study||50
603856|NCT00409240|1477515|P2|STARTED|Overall Study||50
603857|NCT00409240|1477516|P1|STARTED|Overall Study||53
603858|NCT00409188|1477524|P2|NOT COMPLETED|Overall Study||175
603859|NCT00409188|1477525|P1|NOT COMPLETED|Overall Study||383
603860|NCT00409188|1477524|P2|COMPLETED|Overall Study||332
603861|NCT00409188|1477525|P1|COMPLETED|Overall Study||623
603862|NCT00409188|1477524|P2|STARTED|Overall Study||507
603863|NCT00409188|1477525|P1|STARTED|Overall Study||1006
603864|NCT00409175|1477541|P2|NOT COMPLETED|Overall Study||19
603865|NCT00409175|1477542|P1|NOT COMPLETED|Overall Study||18
603866|NCT00409175|1477541|P2|COMPLETED|Overall Study||44
603867|NCT00409175|1477542|P1|COMPLETED|Overall Study||47
603868|NCT00409175|1477541|P2|STARTED|Overall Study||63
603869|NCT00409175|1477542|P1|STARTED|Overall Study||65
603870|NCT00409006|1477568|P2|NOT COMPLETED|Overall Study||12
603871|NCT00409006|1477569|P1|NOT COMPLETED|Overall Study||20
603872|NCT00409006|1477568|P2|COMPLETED|Overall Study||19
603873|NCT00409006|1477569|P1|COMPLETED|Overall Study||19
603874|NCT00409006|1477568|P2|STARTED|Overall Study||31
603875|NCT00409006|1477569|P1|STARTED|Overall Study||39
603876|NCT00408993|1477585|P2|NOT COMPLETED|Overall Study||17
603877|NCT00408993|1477586|P1|NOT COMPLETED|Overall Study||19
603878|NCT00408993|1477585|P2|COMPLETED|Overall Study||92
603879|NCT00408993|1477586|P1|COMPLETED|Overall Study||87
603880|NCT00408993|1477585|P2|STARTED|Overall Study||109
603881|NCT00408993|1477586|P1|STARTED|Overall Study||106
603882|NCT00408928|1477618|P1|NOT COMPLETED|Overall Study||3
603883|NCT00408928|1477618|P1|COMPLETED|Overall Study||8
603884|NCT00408928|1477618|P1|STARTED|Overall Study||11
603885|NCT00408902|1477623|P1|NOT COMPLETED|Overall Study||10
603886|NCT00408902|1477623|P1|COMPLETED|Overall Study||0
603887|NCT00408902|1477623|P1|STARTED|Overall Study||10
603888|NCT00408876|1477633|P4|NOT COMPLETED|Overall Study||35
603889|NCT00408876|1477634|P3|NOT COMPLETED|Overall Study||50
603890|NCT00408876|1477635|P2|NOT COMPLETED|Overall Study||36
603891|NCT00408876|1477636|P1|NOT COMPLETED|Overall Study||16
603892|NCT00408876|1477633|P4|COMPLETED|Overall Study||82
603893|NCT00408876|1477634|P3|COMPLETED|Overall Study||62
603894|NCT00408876|1477635|P2|COMPLETED|Overall Study||80
603895|NCT00408876|1477636|P1|COMPLETED|Overall Study||43
603896|NCT00408876|1477633|P4|STARTED|Overall Study||117
603897|NCT00408876|1477634|P3|STARTED|Overall Study||112
603898|NCT00408876|1477635|P2|STARTED|Overall Study||116
603899|NCT00408876|1477636|P1|STARTED|Overall Study||59
603900|NCT00408694|1477886|P1|NOT COMPLETED|Overall Study||2
603901|NCT00408694|1477886|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
603902|NCT00408694|1477886|P1|STARTED|Overall Study||46
603903|NCT00408681|1477898|P1|NOT COMPLETED|Overall Study||9
603904|NCT00408681|1477898|P1|COMPLETED|Overall Study|Completion was defined as administration of the study product for at least 28 days.|11
603905|NCT00408681|1477898|P1|STARTED|Overall Study||20
603906|NCT00408629|1477917|P2|NOT COMPLETED|Overall Study||125
603907|NCT00408629|1477918|P1|NOT COMPLETED|Overall Study||97
603908|NCT00408629|1477917|P2|COMPLETED|Overall Study||135
603909|NCT00408629|1477918|P1|COMPLETED|Overall Study|1 ADA recipient did not receive study drug and discontinued due to other reasons.|161
603910|NCT00408629|1477917|P2|STARTED|Overall Study|14 PLB recipients from 3 noncompliant clinical sites in Safety, but not in Efficacy analyses (246).|260
603911|NCT00408629|1477918|P1|STARTED|Overall Study|10 ADA recipients from 3 noncompliant clinical sites in Safety, but not in Efficacy analyses (248).|258
603912|NCT00408603|1477960|P3|NOT COMPLETED|Overall Study||40
603913|NCT00408603|1477961|P2|NOT COMPLETED|Overall Study||2
603914|NCT00408603|1477962|P1|NOT COMPLETED|Overall Study||4
603915|NCT00408603|1477960|P3|COMPLETED|Overall Study||35
603916|NCT00408603|1477961|P2|COMPLETED|Overall Study||37
603917|NCT00408603|1477962|P1|COMPLETED|Overall Study||65
603918|NCT00408603|1477960|P3|STARTED|Overall Study||75
603919|NCT00408603|1477961|P2|STARTED|Overall Study||39
603920|NCT00408603|1477962|P1|STARTED|Overall Study||69
603921|NCT00408590|1477978|P9|NOT COMPLETED|Overall Study||0
603922|NCT00408590|1477979|P8|NOT COMPLETED|Overall Study||0
603923|NCT00408590|1477980|P7|NOT COMPLETED|Overall Study||0
603924|NCT00408590|1477981|P6|NOT COMPLETED|Overall Study||0
603925|NCT00408590|1477982|P5|NOT COMPLETED|Overall Study||0
603926|NCT00408590|1477983|P4|NOT COMPLETED|Overall Study||0
603927|NCT00408590|1477984|P3|NOT COMPLETED|Overall Study||0
603928|NCT00408590|1477985|P2|NOT COMPLETED|Overall Study||0
603929|NCT00408590|1477986|P1|NOT COMPLETED|Overall Study||0
603930|NCT00408590|1477978|P9|COMPLETED|Overall Study||13
603931|NCT00408590|1477979|P8|COMPLETED|Overall Study||3
603932|NCT00408590|1477980|P7|COMPLETED|Overall Study||3
603933|NCT00408590|1477981|P6|COMPLETED|Overall Study||3
603934|NCT00408590|1477982|P5|COMPLETED|Overall Study||3
603935|NCT00408590|1477983|P4|COMPLETED|Overall Study||3
603936|NCT00408590|1477984|P3|COMPLETED|Overall Study||3
603937|NCT00408590|1477985|P2|COMPLETED|Overall Study||3
603938|NCT00408590|1477986|P1|COMPLETED|Overall Study||3
603939|NCT00408590|1477978|P9|STARTED|Overall Study||13
603940|NCT00408590|1477979|P8|STARTED|Overall Study||3
603941|NCT00408590|1477980|P7|STARTED|Overall Study||3
603942|NCT00408590|1477981|P6|STARTED|Overall Study||3
603943|NCT00408590|1477982|P5|STARTED|Overall Study||3
603944|NCT00408590|1477983|P4|STARTED|Overall Study||3
603945|NCT00408590|1477984|P3|STARTED|Overall Study||3
603946|NCT00408590|1477985|P2|STARTED|Overall Study||3
603947|NCT00408590|1477986|P1|STARTED|Overall Study||3
603948|NCT00408499|1478005|P5|NOT COMPLETED|Phase II- MTD Expansion||20
603949|NCT00408499|1478006|P4|NOT COMPLETED|Phase II- MTD Expansion||0
603950|NCT00408499|1478007|P3|NOT COMPLETED|Phase II- MTD Expansion||0
603951|NCT00408499|1478008|P2|NOT COMPLETED|Phase II- MTD Expansion||0
603952|NCT00408499|1478009|P1|NOT COMPLETED|Phase II- MTD Expansion||0
603953|NCT00408499|1478005|P5|COMPLETED|Phase II- MTD Expansion||24
603954|NCT00408499|1478006|P4|COMPLETED|Phase II- MTD Expansion||0
603955|NCT00408499|1478007|P3|COMPLETED|Phase II- MTD Expansion||0
603956|NCT00408499|1478008|P2|COMPLETED|Phase II- MTD Expansion||0
603957|NCT00408499|1478009|P1|COMPLETED|Phase II- MTD Expansion||0
603958|NCT00408499|1478005|P5|STARTED|Phase II- MTD Expansion||44
603959|NCT00408499|1478006|P4|STARTED|Phase II- MTD Expansion||0
603960|NCT00408499|1478007|P3|STARTED|Phase II- MTD Expansion||0
603961|NCT00408499|1478008|P2|STARTED|Phase II- MTD Expansion||0
603962|NCT00408499|1478009|P1|STARTED|Phase II- MTD Expansion||0
603963|NCT00408499|1478005|P5|NOT COMPLETED|Phase 1: Dose Levels 1-4||0
603964|NCT00408499|1478006|P4|NOT COMPLETED|Phase 1: Dose Levels 1-4||0
603965|NCT00408499|1478007|P3|NOT COMPLETED|Phase 1: Dose Levels 1-4||1
603966|NCT00408499|1478008|P2|NOT COMPLETED|Phase 1: Dose Levels 1-4||2
603967|NCT00408499|1478009|P1|NOT COMPLETED|Phase 1: Dose Levels 1-4||2
603968|NCT00408499|1478005|P5|COMPLETED|Phase 1: Dose Levels 1-4||0
603969|NCT00408499|1478006|P4|COMPLETED|Phase 1: Dose Levels 1-4||6
603970|NCT00408499|1478007|P3|COMPLETED|Phase 1: Dose Levels 1-4||2
603971|NCT00408499|1478008|P2|COMPLETED|Phase 1: Dose Levels 1-4||5
603972|NCT00408499|1478009|P1|COMPLETED|Phase 1: Dose Levels 1-4||2
603973|NCT00408499|1478005|P5|STARTED|Phase 1: Dose Levels 1-4||0
603974|NCT00408499|1478006|P4|STARTED|Phase 1: Dose Levels 1-4||6
603975|NCT00408499|1478007|P3|STARTED|Phase 1: Dose Levels 1-4||3
603976|NCT00408499|1478008|P2|STARTED|Phase 1: Dose Levels 1-4||7
603977|NCT00408499|1478009|P1|STARTED|Phase 1: Dose Levels 1-4||4
603978|NCT00408460|1478018|P1|NOT COMPLETED|Overall Study||0
603979|NCT00408460|1478018|P1|COMPLETED|Overall Study||34
603980|NCT00408460|1478018|P1|STARTED|Overall Study||34
603981|NCT00408421|1478026|P3|NOT COMPLETED|Treatment Re-Randomization||5
603982|NCT00408421|1478027|P2|NOT COMPLETED|Treatment Re-Randomization||7
603983|NCT00408421|1478028|P1|NOT COMPLETED|Treatment Re-Randomization||7
603984|NCT00408421|1478026|P3|COMPLETED|Treatment Re-Randomization||38
603985|NCT00408421|1478027|P2|COMPLETED|Treatment Re-Randomization||39
603986|NCT00408421|1478028|P1|COMPLETED|Treatment Re-Randomization||96
603987|NCT00408421|1478026|P3|STARTED|Treatment Re-Randomization||43
603988|NCT00408421|1478027|P2|STARTED|Treatment Re-Randomization||46
603989|NCT00408421|1478028|P1|STARTED|Treatment Re-Randomization||103
603990|NCT00408421|1478026|P3|NOT COMPLETED|Treatment Initial Randomization||0
603991|NCT00408421|1478027|P2|NOT COMPLETED|Treatment Initial Randomization||22
603992|NCT00408421|1478028|P1|NOT COMPLETED|Treatment Initial Randomization||17
603993|NCT00408421|1478026|P3|COMPLETED|Treatment Initial Randomization|Patients weren't randomized to Duloxetine 120 mg until Visit 4.|0
603994|NCT00408421|1478027|P2|COMPLETED|Treatment Initial Randomization|Pre-Re-Randomization (Visit 4)|89
603995|NCT00408421|1478028|P1|COMPLETED|Treatment Initial Randomization|Pre-Re-Randomization (Visit 4)|103
603996|NCT00408421|1478026|P3|STARTED|Treatment Initial Randomization||0
603997|NCT00408421|1478027|P2|STARTED|Treatment Initial Randomization||111
603998|NCT00408421|1478028|P1|STARTED|Treatment Initial Randomization||120
603999|NCT00408408|1478108|P6|NOT COMPLETED|Overall Study||3
604000|NCT00408408|1478109|P5|NOT COMPLETED|Overall Study||5
604001|NCT00408408|1478110|P4|NOT COMPLETED|Overall Study||7
604002|NCT00408408|1478111|P3|NOT COMPLETED|Overall Study||0
604003|NCT00408408|1478112|P2|NOT COMPLETED|Overall Study||3
604004|NCT00408408|1478113|P1|NOT COMPLETED|Overall Study||2
604005|NCT00408408|1478108|P6|COMPLETED|Overall Study||201
604006|NCT00408408|1478109|P5|COMPLETED|Overall Study||192
604007|NCT00408408|1478110|P4|COMPLETED|Overall Study||194
604008|NCT00408408|1478111|P3|COMPLETED|Overall Study||204
604009|NCT00408408|1478112|P2|COMPLETED|Overall Study||196
604010|NCT00408408|1478113|P1|COMPLETED|Overall Study||199
604011|NCT00408408|1478108|P6|STARTED|Overall Study||204
604012|NCT00408408|1478109|P5|STARTED|Overall Study||197
604013|NCT00408408|1478110|P4|STARTED|Overall Study||201
604014|NCT00408408|1478111|P3|STARTED|Overall Study||204
604015|NCT00408408|1478112|P2|STARTED|Overall Study||199
604016|NCT00408408|1478113|P1|STARTED|Overall Study||201
604017|NCT00408317|1478175|P2|NOT COMPLETED|Second Intervention Period||2
604018|NCT00408317|1478176|P1|NOT COMPLETED|Second Intervention Period||2
604019|NCT00408317|1478175|P2|COMPLETED|Second Intervention Period||14
604020|NCT00408317|1478176|P1|COMPLETED|Second Intervention Period||12
604021|NCT00408317|1478175|P2|STARTED|Second Intervention Period||16
604022|NCT00408317|1478176|P1|STARTED|Second Intervention Period||14
604023|NCT00408317|1478175|P2|NOT COMPLETED|First Intervention Period||1
604024|NCT00408317|1478176|P1|NOT COMPLETED|First Intervention Period||0
604025|NCT00408317|1478175|P2|COMPLETED|First Intervention Period||16
604026|NCT00408317|1478176|P1|COMPLETED|First Intervention Period||14
604027|NCT00408317|1478175|P2|STARTED|First Intervention Period||17
604028|NCT00408317|1478176|P1|STARTED|First Intervention Period||14
604029|NCT00408200|1478190|P2|NOT COMPLETED|Overall Study||0
604030|NCT00408200|1478191|P1|NOT COMPLETED|Overall Study||0
604031|NCT00408200|1478190|P2|COMPLETED|Overall Study||53
604032|NCT00408200|1478191|P1|COMPLETED|Overall Study||57
604033|NCT00408200|1478190|P2|STARTED|Overall Study||53
604034|NCT00408200|1478191|P1|STARTED|Overall Study||57
604035|NCT00408070|1478199|P1|NOT COMPLETED|Overall Study||0
604036|NCT00408070|1478199|P1|COMPLETED|Overall Study||5
604037|NCT00408070|1478199|P1|STARTED|Overall Study||5
604038|NCT00407966|1478207|P1|NOT COMPLETED|Overall Study||0
604039|NCT00407966|1478207|P1|COMPLETED|Overall Study||45
604040|NCT00407966|1478207|P1|CR|Overall Study||30
604041|NCT00407966|1478207|P1|STARTED|Overall Study||45
604042|NCT00407888|1478211|P1|NOT COMPLETED|Overall Study||0
604043|NCT00407888|1478211|P1|COMPLETED|Overall Study||60
604044|NCT00407888|1478211|P1|STARTED|Overall Study||60
604045|NCT00407797|1478219|P1|NOT COMPLETED|Overall Study||18
604046|NCT00407797|1478219|P1|COMPLETED|Overall Study||118
604047|NCT00407797|1478219|P1|Full Analysis Set|Overall Study|At least 1 dose of study medication and had a baseline and at least 1 post-baseline measurement.|135
604048|NCT00407797|1478219|P1|STARTED|Overall Study||136
604049|NCT00407758|1478234|P1|NOT COMPLETED|Overall Study||1
604050|NCT00407758|1478234|P1|COMPLETED|Overall Study||27
604051|NCT00407758|1478234|P1|STARTED|Overall Study||28
604052|NCT00407745|1478247|P2|NOT COMPLETED|Overall Study||17
604053|NCT00407745|1478248|P1|NOT COMPLETED|Overall Study||19
604054|NCT00407745|1478247|P2|COMPLETED|Overall Study||91
604055|NCT00407745|1478248|P1|COMPLETED|Overall Study||93
604056|NCT00407745|1478247|P2|Treated|Overall Study||107
604057|NCT00407745|1478248|P1|Treated|Overall Study||112
604058|NCT00407745|1478247|P2|STARTED|Overall Study||108
604059|NCT00407745|1478248|P1|STARTED|Overall Study||112
604060|NCT00407654|1478320|P1|NOT COMPLETED|Overall Study||0
604061|NCT00407654|1478320|P1|COMPLETED|Overall Study||75
604062|NCT00407654|1478320|P1|STARTED|Overall Study||75
604063|NCT00407563|1478332|P1|NOT COMPLETED|Overall Study||1
604064|NCT00407563|1478332|P1|COMPLETED|Overall Study|One patient remains on study treatment.|47
604065|NCT00407563|1478332|P1|STARTED|Overall Study||48
604066|NCT00407550|1478342|P2|NOT COMPLETED|Overall Study||4
604067|NCT00407550|1478343|P1|NOT COMPLETED|Overall Study||3
604068|NCT00407550|1478342|P2|COMPLETED|Overall Study||5
604069|NCT00407550|1478343|P1|COMPLETED|Overall Study||7
604070|NCT00407550|1478342|P2|STARTED|Overall Study||9
604071|NCT00407550|1478343|P1|STARTED|Overall Study||10
604072|NCT00407537|1478351|P2|NOT COMPLETED|Overall Study||44
604073|NCT00407537|1478352|P1|NOT COMPLETED|Overall Study||93
604074|NCT00407537|1478351|P2|COMPLETED|Overall Study||638
604075|NCT00407537|1478352|P1|COMPLETED|Overall Study||686
604076|NCT00407537|1478351|P2|Eligible for Efficacy Analysis|Overall Study||657
604077|NCT00407537|1478352|P1|Eligible for Efficacy Analysis|Overall Study||760
604078|NCT00407537|1478351|P2|STARTED|Overall Study|4 participants assigned to Caduet treatment received usual care only during the study|682
604079|NCT00407537|1478352|P1|STARTED|Overall Study||779
604080|NCT00407511|1478400|P1|NOT COMPLETED|Overall Study||22
604081|NCT00407511|1478400|P1|COMPLETED|Overall Study||99
604082|NCT00407511|1478400|P1|STARTED|Overall Study||121
604083|NCT00407485|1478414|P1|NOT COMPLETED|Overall Study||0
604084|NCT00407485|1478414|P1|COMPLETED|Overall Study||22
604085|NCT00407485|1478414|P1|STARTED|Overall Study||22
604086|NCT00407381|1478422|P3|NOT COMPLETED|Overall Study||2
604087|NCT00407381|1478423|P2|NOT COMPLETED|Overall Study||4
604088|NCT00407381|1478424|P1|NOT COMPLETED|Overall Study||3
604089|NCT00407381|1478422|P3|COMPLETED|Overall Study||40
604090|NCT00407381|1478423|P2|COMPLETED|Overall Study||38
604091|NCT00407381|1478424|P1|COMPLETED|Overall Study||39
604092|NCT00407381|1478422|P3|STARTED|Overall Study||42
604093|NCT00407381|1478423|P2|STARTED|Overall Study||42
604094|NCT00407381|1478424|P1|STARTED|Overall Study||42
604095|NCT00407355|1478434|P2|NOT COMPLETED|Overall Study||11
604096|NCT00407355|1478435|P1|NOT COMPLETED|Overall Study||10
604097|NCT00407355|1478434|P2|COMPLETED|Overall Study||9
604098|NCT00407355|1478435|P1|COMPLETED|Overall Study||10
604099|NCT00407355|1478434|P2|STARTED|Overall Study||20
604100|NCT00407355|1478435|P1|STARTED|Overall Study||20
604101|NCT00407030|1478446|P3|NOT COMPLETED|Extension Period - up to 68 Weeks||0
604102|NCT00407030|1478447|P2|NOT COMPLETED|Extension Period - up to 68 Weeks||29
604103|NCT00407030|1478448|P1|NOT COMPLETED|Extension Period - up to 68 Weeks||27
604104|NCT00407030|1478446|P3|COMPLETED|Extension Period - up to 68 Weeks||0
604105|NCT00407030|1478447|P2|COMPLETED|Extension Period - up to 68 Weeks||74
604106|NCT00407030|1478448|P1|COMPLETED|Extension Period - up to 68 Weeks||84
604107|NCT00407030|1478446|P3|STARTED|Extension Period - up to 68 Weeks|After the Main Period all patients were randomly assigned to the 2 active treatment arms.|0
604108|NCT00407030|1478447|P2|STARTED|Extension Period - up to 68 Weeks|2 subjects did not enter the Ext. Period, 3 subjects never expressed any need for a new injection|103
604109|NCT00407030|1478448|P1|STARTED|Extension Period - up to 68 Weeks|2 subjects did not enter the Ext. Period, 3 subjects never expressed any need for a new injection|111
604110|NCT00407030|1478446|P3|NOT COMPLETED|Main Period - 8 to 20 Weeks||6
604111|NCT00407030|1478447|P2|NOT COMPLETED|Main Period - 8 to 20 Weeks||3
604112|NCT00407030|1478448|P1|NOT COMPLETED|Main Period - 8 to 20 Weeks||5
604113|NCT00407030|1478446|P3|COMPLETED|Main Period - 8 to 20 Weeks||68
604114|NCT00407030|1478447|P2|COMPLETED|Main Period - 8 to 20 Weeks||75
604115|NCT00407030|1478448|P1|COMPLETED|Main Period - 8 to 20 Weeks||76
604116|NCT00407030|1478446|P3|STARTED|Main Period - 8 to 20 Weeks||74
604117|NCT00407030|1478447|P2|STARTED|Main Period - 8 to 20 Weeks||78
604118|NCT00407030|1478448|P1|STARTED|Main Period - 8 to 20 Weeks||81
604119|NCT00406848|1478476|P2|NOT COMPLETED|Overall Study||54
604120|NCT00406848|1478477|P1|NOT COMPLETED|Overall Study||93
604121|NCT00406848|1478476|P2|COMPLETED|Overall Study||67
604122|NCT00406848|1478477|P1|COMPLETED|Overall Study||156
604123|NCT00406848|1478476|P2|STARTED|Overall Study|Represents full safety analysis population. Efficacy analysis population (c,d,e) N=95.|121
604124|NCT00406848|1478477|P1|STARTED|Overall Study|Represents full safety analysis population. Efficacy analysis population (c,d,e) N=204.|249
604125|NCT00406783|1478541|P2|NOT COMPLETED|Overall Study||15
604126|NCT00406783|1478542|P1|NOT COMPLETED|Overall Study||14
604127|NCT00406783|1478541|P2|COMPLETED|Overall Study||256
604128|NCT00406783|1478542|P1|COMPLETED|Overall Study||262
604129|NCT00406783|1478541|P2|STARTED|Overall Study||271
604130|NCT00406783|1478542|P1|STARTED|Overall Study||276
604131|NCT00406718|1478557|P3|NOT COMPLETED|Overall Study||8
604132|NCT00406718|1478558|P2|NOT COMPLETED|Overall Study||14
604133|NCT00406718|1478559|P1|NOT COMPLETED|Overall Study||4
604134|NCT00406718|1478557|P3|COMPLETED|Overall Study||39
604135|NCT00406718|1478558|P2|COMPLETED|Overall Study||34
604136|NCT00406718|1478559|P1|COMPLETED|Overall Study||43
604137|NCT00406718|1478557|P3|STARTED|Overall Study||47
604138|NCT00406718|1478558|P2|STARTED|Overall Study||48
604139|NCT00406718|1478559|P1|STARTED|Overall Study||47
604140|NCT00406692|1478573|P1|NOT COMPLETED|Overall Study||7
604141|NCT00406692|1478573|P1|COMPLETED|Overall Study||9
604142|NCT00406692|1478573|P1|STARTED|Overall Study||16
604143|NCT00406653|1478583|P7|NOT COMPLETED|Open-Label Period||324
604144|NCT00406653|1478584|P6|NOT COMPLETED|Open-Label Period||0
604145|NCT00406653|1478585|P5|NOT COMPLETED|Open-Label Period||0
604146|NCT00406653|1478586|P4|NOT COMPLETED|Open-Label Period||0
604147|NCT00406653|1478587|P3|NOT COMPLETED|Open-Label Period||0
604148|NCT00406653|1478588|P2|NOT COMPLETED|Open-Label Period||0
604149|NCT00406653|1478589|P1|NOT COMPLETED|Open-Label Period||0
604150|NCT00406653|1478583|P7|COMPLETED|Open-Label Period||0
604151|NCT00406653|1478584|P6|COMPLETED|Open-Label Period||0
604152|NCT00406653|1478585|P5|COMPLETED|Open-Label Period||0
604153|NCT00406653|1478586|P4|COMPLETED|Open-Label Period||0
604154|NCT00406653|1478587|P3|COMPLETED|Open-Label Period||0
604155|NCT00406653|1478588|P2|COMPLETED|Open-Label Period||0
604156|NCT00406653|1478589|P1|COMPLETED|Open-Label Period||0
604157|NCT00406653|1478583|P7|STARTED|Open-Label Period|All completing IP but failing response criteria and those completing or relapsing on MP entered OL.|324
604158|NCT00406653|1478584|P6|STARTED|Open-Label Period||0
604159|NCT00406653|1478585|P5|STARTED|Open-Label Period||0
604160|NCT00406653|1478586|P4|STARTED|Open-Label Period||0
604161|NCT00406653|1478587|P3|STARTED|Open-Label Period||0
604162|NCT00406653|1478588|P2|STARTED|Open-Label Period||0
604163|NCT00406653|1478589|P1|STARTED|Open-Label Period||0
604164|NCT00406653|1478583|P7|NOT COMPLETED|Maintenance Period||0
604165|NCT00406653|1478584|P6|NOT COMPLETED|Maintenance Period||36
604166|NCT00406653|1478585|P5|NOT COMPLETED|Maintenance Period||30
604167|NCT00406653|1478586|P4|NOT COMPLETED|Maintenance Period||0
604168|NCT00406653|1478587|P3|NOT COMPLETED|Maintenance Period||0
604169|NCT00406653|1478588|P2|NOT COMPLETED|Maintenance Period||0
604170|NCT00406653|1478589|P1|NOT COMPLETED|Maintenance Period||0
604171|NCT00406653|1478583|P7|COMPLETED|Maintenance Period||0
604172|NCT00406653|1478584|P6|COMPLETED|Maintenance Period||10
604173|NCT00406653|1478585|P5|COMPLETED|Maintenance Period||14
604174|NCT00406653|1478586|P4|COMPLETED|Maintenance Period||0
604175|NCT00406653|1478587|P3|COMPLETED|Maintenance Period||0
604176|NCT00406653|1478588|P2|COMPLETED|Maintenance Period||0
604177|NCT00406653|1478589|P1|COMPLETED|Maintenance Period||0
604178|NCT00406653|1478583|P7|STARTED|Maintenance Period||0
604179|NCT00406653|1478584|P6|STARTED|Maintenance Period|At end of IP, 46 participants met response criteria and were randomly assigned to placebo in MP.|46
604180|NCT00406653|1478585|P5|STARTED|Maintenance Period|At end of IP, 44 participants met response criteria and were randomly assigned to abatacept in MP.|44
604181|NCT00406653|1478586|P4|STARTED|Maintenance Period||0
604182|NCT00406653|1478587|P3|STARTED|Maintenance Period||0
604183|NCT00406653|1478588|P2|STARTED|Maintenance Period||0
604184|NCT00406653|1478589|P1|STARTED|Maintenance Period||0
604185|NCT00406653|1478583|P7|NOT COMPLETED|Induction Period||0
604186|NCT00406653|1478584|P6|NOT COMPLETED|Induction Period||0
604187|NCT00406653|1478585|P5|NOT COMPLETED|Induction Period||0
604188|NCT00406653|1478586|P4|NOT COMPLETED|Induction Period||26
604189|NCT00406653|1478587|P3|NOT COMPLETED|Induction Period||18
604190|NCT00406653|1478588|P2|NOT COMPLETED|Induction Period||34
604191|NCT00406653|1478589|P1|NOT COMPLETED|Induction Period||15
604192|NCT00406653|1478583|P7|COMPLETED|Induction Period||0
604193|NCT00406653|1478584|P6|COMPLETED|Induction Period||0
604194|NCT00406653|1478585|P5|COMPLETED|Induction Period||0
604195|NCT00406653|1478586|P4|COMPLETED|Induction Period||102
604196|NCT00406653|1478587|P3|COMPLETED|Induction Period||112
604197|NCT00406653|1478588|P2|COMPLETED|Induction Period||94
604198|NCT00406653|1478589|P1|COMPLETED|Induction Period||50
604199|NCT00406653|1478583|P7|STARTED|Induction Period||0
604200|NCT00406653|1478584|P6|STARTED|Induction Period||0
604201|NCT00406653|1478585|P5|STARTED|Induction Period||0
604202|NCT00406653|1478586|P4|STARTED|Induction Period||128
604203|NCT00406653|1478587|P3|STARTED|Induction Period||130
604204|NCT00406653|1478588|P2|STARTED|Induction Period||128
604205|NCT00406653|1478589|P1|STARTED|Induction Period||65
604206|NCT00406640|1478670|P2|NOT COMPLETED|OL Extension Phase for Non-Responders||24
604207|NCT00406640|1478671|P1|NOT COMPLETED|OL Extension Phase for Non-Responders||22
604208|NCT00406640|1478670|P2|COMPLETED|OL Extension Phase for Non-Responders||36
604209|NCT00406640|1478671|P1|COMPLETED|OL Extension Phase for Non-Responders||47
604210|NCT00406640|1478670|P2|STARTED|OL Extension Phase for Non-Responders||60
604211|NCT00406640|1478671|P1|STARTED|OL Extension Phase for Non-Responders||69
604212|NCT00406640|1478670|P2|NOT COMPLETED|DB Continuation Phase for Responders||37
604213|NCT00406640|1478671|P1|NOT COMPLETED|DB Continuation Phase for Responders||33
604214|NCT00406640|1478670|P2|COMPLETED|DB Continuation Phase for Responders||151
604215|NCT00406640|1478671|P1|COMPLETED|DB Continuation Phase for Responders||139
604216|NCT00406640|1478670|P2|STARTED|DB Continuation Phase for Responders||188
604217|NCT00406640|1478671|P1|STARTED|DB Continuation Phase for Responders||172
604218|NCT00406640|1478670|P2|NOT COMPLETED|Acute Phase||43
604219|NCT00406640|1478671|P1|NOT COMPLETED|Acute Phase||51
604220|NCT00406640|1478670|P2|COMPLETED|Acute Phase||256
604221|NCT00406640|1478671|P1|COMPLETED|Acute Phase||245
604222|NCT00406640|1478670|P2|STARTED|Acute Phase||299
604223|NCT00406640|1478671|P1|STARTED|Acute Phase||296
604224|NCT00406393|1478703|P2|NOT COMPLETED|Overall Study||1
604225|NCT00406393|1478704|P1|NOT COMPLETED|Overall Study||2
604226|NCT00406393|1478703|P2|COMPLETED|Overall Study||152
604227|NCT00406393|1478704|P1|COMPLETED|Overall Study||149
604228|NCT00406393|1478703|P2|STARTED|Overall Study||153
604229|NCT00406393|1478704|P1|STARTED|Overall Study||151
604230|NCT00406367|1478734|P2|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0
604231|NCT00406367|1478735|P1|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||20
604232|NCT00406367|1478734|P2|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0
604233|NCT00406367|1478735|P1|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||82
604234|NCT00406367|1478734|P2|STARTED|Open-Label Ext. Period - up to 68 Weeks|In the Open-Label Extension Period no placebo treatment arm was given.|0
604235|NCT00406367|1478735|P1|STARTED|Open-Label Ext. Period - up to 68 Weeks||102
604236|NCT00406367|1478734|P2|NOT COMPLETED|Main Period - 6 to 20 Weeks||2
604237|NCT00406367|1478735|P1|NOT COMPLETED|Main Period - 6 to 20 Weeks||5
604238|NCT00406367|1478734|P2|COMPLETED|Main Period - 6 to 20 Weeks||32
604239|NCT00406367|1478735|P1|COMPLETED|Main Period - 6 to 20 Weeks||70
604240|NCT00406367|1478734|P2|STARTED|Main Period - 6 to 20 Weeks||34
604241|NCT00406367|1478735|P1|STARTED|Main Period - 6 to 20 Weeks||75
604242|NCT00406354|1478750|P3|NOT COMPLETED|All Randomized and Treated Patients||22
604243|NCT00406354|1478751|P2|NOT COMPLETED|All Randomized and Treated Patients||13
604244|NCT00406354|1478752|P1|NOT COMPLETED|All Randomized and Treated Patients||16
604245|NCT00406354|1478750|P3|COMPLETED|All Randomized and Treated Patients||37
604246|NCT00406354|1478751|P2|COMPLETED|All Randomized and Treated Patients||48
604247|NCT00406354|1478752|P1|COMPLETED|All Randomized and Treated Patients||44
604248|NCT00406354|1478750|P3|STARTED|All Randomized and Treated Patients||59
604249|NCT00406354|1478751|P2|STARTED|All Randomized and Treated Patients||61
604250|NCT00406354|1478752|P1|STARTED|All Randomized and Treated Patients||60
604251|NCT00406354|1478750|P3|NOT COMPLETED|All Randomized Patients||1
604252|NCT00406354|1478751|P2|NOT COMPLETED|All Randomized Patients||0
604253|NCT00406354|1478752|P1|NOT COMPLETED|All Randomized Patients||0
604254|NCT00406354|1478750|P3|COMPLETED|All Randomized Patients|One patient was randomized but never received study treatment.|59
604255|NCT00406354|1478751|P2|COMPLETED|All Randomized Patients||61
604256|NCT00406354|1478752|P1|COMPLETED|All Randomized Patients||60
604257|NCT00406354|1478750|P3|STARTED|All Randomized Patients||60
604258|NCT00406354|1478751|P2|STARTED|All Randomized Patients||61
604259|NCT00406354|1478752|P1|STARTED|All Randomized Patients||60
604260|NCT00406315|1478823|P1|NOT COMPLETED|Overall Study||141
604261|NCT00406315|1478823|P1|COMPLETED|Overall Study||100
604262|NCT00406315|1478823|P1|STARTED|Overall Study|Started = Treated|241
604263|NCT00406276|1478841|P1|NOT COMPLETED|Overall Study||4
604264|NCT00406276|1478841|P1|COMPLETED|Overall Study||24
604265|NCT00406276|1478841|P1|STARTED|Overall Study||28
604266|NCT00406133|1478850|P4|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0
604267|NCT00406133|1478851|P3|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0
604268|NCT00406133|1478852|P2|NOT COMPLETED|Phase 2 (Second 26 Week Period)||3
604269|NCT00406133|1478853|P1|NOT COMPLETED|Phase 2 (Second 26 Week Period)||2
604270|NCT00406133|1478850|P4|COMPLETED|Phase 2 (Second 26 Week Period)||60
604271|NCT00406133|1478851|P3|COMPLETED|Phase 2 (Second 26 Week Period)||67
604272|NCT00406133|1478852|P2|COMPLETED|Phase 2 (Second 26 Week Period)||152
604273|NCT00406133|1478853|P1|COMPLETED|Phase 2 (Second 26 Week Period)||157
604274|NCT00406133|1478850|P4|STARTED|Phase 2 (Second 26 Week Period)||60
604275|NCT00406133|1478851|P3|STARTED|Phase 2 (Second 26 Week Period)||67
604276|NCT00406133|1478852|P2|STARTED|Phase 2 (Second 26 Week Period)||155
604277|NCT00406133|1478853|P1|STARTED|Phase 2 (Second 26 Week Period)|3 subjects completed phase 1 but elected not to go into phase 2.|159
604278|NCT00406133|1478850|P4|NOT COMPLETED|Phase 1 (First 26 Week Period)||2
604279|NCT00406133|1478851|P3|NOT COMPLETED|Phase 1 (First 26 Week Period)||0
604280|NCT00406133|1478852|P2|NOT COMPLETED|Phase 1 (First 26 Week Period)||2
604281|NCT00406133|1478853|P1|NOT COMPLETED|Phase 1 (First 26 Week Period)||3
604282|NCT00406133|1478850|P4|COMPLETED|Phase 1 (First 26 Week Period)||60
604283|NCT00406133|1478851|P3|COMPLETED|Phase 1 (First 26 Week Period)||67
604284|NCT00406133|1478852|P2|COMPLETED|Phase 1 (First 26 Week Period)||155
604285|NCT00406133|1478853|P1|COMPLETED|Phase 1 (First 26 Week Period)||162
604286|NCT00406133|1478850|P4|STARTED|Phase 1 (First 26 Week Period)||62
604287|NCT00406133|1478851|P3|STARTED|Phase 1 (First 26 Week Period)||67
604288|NCT00406133|1478852|P2|STARTED|Phase 1 (First 26 Week Period)||157
604289|NCT00406133|1478853|P1|STARTED|Phase 1 (First 26 Week Period)||165
604290|NCT00406107|1478917|P2|NOT COMPLETED|Overall Study||1
604291|NCT00406107|1478918|P1|NOT COMPLETED|Overall Study||1
604292|NCT00406107|1478917|P2|COMPLETED|Overall Study||4
604293|NCT00406107|1478918|P1|COMPLETED|Overall Study||14
604294|NCT00406107|1478917|P2|STARTED|Overall Study||5
604295|NCT00406107|1478918|P1|STARTED|Overall Study||15
604296|NCT00406029|1478933|P5|NOT COMPLETED|Overall Study||8
604297|NCT00406029|1478934|P4|NOT COMPLETED|Overall Study||17
604298|NCT00406029|1478935|P3|NOT COMPLETED|Overall Study||10
604299|NCT00406029|1478936|P2|NOT COMPLETED|Overall Study||8
604300|NCT00406029|1478937|P1|NOT COMPLETED|Overall Study||16
604301|NCT00406029|1478933|P5|COMPLETED|Overall Study||41
604302|NCT00406029|1478934|P4|COMPLETED|Overall Study||40
604303|NCT00406029|1478935|P3|COMPLETED|Overall Study||39
604304|NCT00406029|1478936|P2|COMPLETED|Overall Study||41
604305|NCT00406029|1478937|P1|COMPLETED|Overall Study||33
604306|NCT00406029|1478933|P5|Treated|Overall Study||47
604307|NCT00406029|1478934|P4|Treated|Overall Study||54
604308|NCT00406029|1478935|P3|Treated|Overall Study||47
604309|NCT00406029|1478936|P2|Treated|Overall Study||49
604310|NCT00406029|1478937|P1|Treated|Overall Study||49
604311|NCT00406029|1478933|P5|STARTED|Overall Study||49
604312|NCT00406029|1478934|P4|STARTED|Overall Study||57
604313|NCT00406029|1478935|P3|STARTED|Overall Study||49
604314|NCT00406029|1478936|P2|STARTED|Overall Study||49
604315|NCT00406029|1478937|P1|STARTED|Overall Study||49
604316|NCT00405964|1479041|P2|NOT COMPLETED|Overall Study||95
604317|NCT00405964|1479042|P1|NOT COMPLETED|Overall Study||59
604318|NCT00405964|1479041|P2|COMPLETED|Overall Study||261
604319|NCT00405964|1479042|P1|COMPLETED|Overall Study||301
604320|NCT00405964|1479041|P2|STARTED|Overall Study||356
604321|NCT00405964|1479042|P1|STARTED|Overall Study||360
604322|NCT00405938|1479054|P2|NOT COMPLETED|Overall Study||0
604323|NCT00405938|1479055|P1|NOT COMPLETED|Overall Study||0
604324|NCT00405938|1479054|P2|COMPLETED|Overall Study||41
604325|NCT00405938|1479055|P1|COMPLETED|Overall Study||38
604326|NCT00405938|1479054|P2|STARTED|Overall Study||41
604327|NCT00405938|1479055|P1|STARTED|Overall Study||38
604328|NCT00405912|1479064|P3|NOT COMPLETED|Overall Study||16
604329|NCT00405912|1479065|P2|NOT COMPLETED|Overall Study||19
604330|NCT00405912|1479066|P1|NOT COMPLETED|Overall Study||16
604331|NCT00405912|1479064|P3|COMPLETED|Overall Study||23
604332|NCT00405912|1479065|P2|COMPLETED|Overall Study||21
604333|NCT00405912|1479066|P1|COMPLETED|Overall Study||23
604334|NCT00405912|1479064|P3|STARTED|Overall Study||39
604335|NCT00405912|1479065|P2|STARTED|Overall Study||40
604336|NCT00405912|1479066|P1|STARTED|Overall Study||39
604337|NCT00405821|1479079|P2|NOT COMPLETED|Overall Study||22
604338|NCT00405821|1479080|P1|NOT COMPLETED|Overall Study||22
604339|NCT00405821|1479079|P2|COMPLETED|Overall Study||198
604340|NCT00405821|1479080|P1|COMPLETED|Overall Study||198
604341|NCT00405821|1479079|P2|STARTED|Overall Study||220
604342|NCT00405821|1479080|P1|STARTED|Overall Study||220
604343|NCT00405756|1479093|P3|NOT COMPLETED|Follow-up||88
604344|NCT00405756|1479094|P2|NOT COMPLETED|Follow-up||90
604345|NCT00405756|1479095|P1|NOT COMPLETED|Follow-up||75
604346|NCT00405756|1479093|P3|COMPLETED|Follow-up||0
604347|NCT00405756|1479094|P2|COMPLETED|Follow-up||0
604348|NCT00405756|1479095|P1|COMPLETED|Follow-up||0
604349|NCT00405756|1479093|P3|STARTED|Follow-up|52 participants from the Double-blind and 36 from the Open Label Extension|88
604350|NCT00405756|1479094|P2|STARTED|Follow-up|65 participants from the Double-blind and 25 from the Open Label Extension|90
604351|NCT00405756|1479095|P1|STARTED|Follow-up|66 participants from Double-blind and 9 from the Open Label Extension|75
604352|NCT00405756|1479093|P3|NOT COMPLETED|Open-label Extension||72
604353|NCT00405756|1479094|P2|NOT COMPLETED|Open-label Extension||47
604354|NCT00405756|1479095|P1|NOT COMPLETED|Open-label Extension||19
604355|NCT00405756|1479093|P3|COMPLETED|Open-label Extension||0
604356|NCT00405756|1479094|P2|COMPLETED|Open-label Extension||0
604357|NCT00405756|1479095|P1|COMPLETED|Open-label Extension|Participants continue until disease progression or other reason for discontinuing.|0
604358|NCT00405756|1479093|P3|STARTED|Open-label Extension||72
604359|NCT00405756|1479094|P2|STARTED|Open-label Extension||47
604360|NCT00405756|1479095|P1|STARTED|Open-label Extension||19
604361|NCT00405756|1479093|P3|NOT COMPLETED|Double-blind Treatment||154
604362|NCT00405756|1479094|P2|NOT COMPLETED|Double-blind Treatment||153
604363|NCT00405756|1479095|P1|NOT COMPLETED|Double-blind Treatment||152
604364|NCT00405756|1479093|P3|COMPLETED|Double-blind Treatment||0
604365|NCT00405756|1479094|P2|COMPLETED|Double-blind Treatment||0
604366|NCT00405756|1479095|P1|COMPLETED|Double-blind Treatment|Double-blind Treatment Period had no defined completion.|0
604367|NCT00405756|1479093|P3|Safety Population|Double-blind Treatment||153
604368|NCT00405756|1479094|P2|Safety Population|Double-blind Treatment||152
604369|NCT00405756|1479095|P1|Safety Population|Double-blind Treatment|Participants who took at least one dose of study drug.|150
604370|NCT00405756|1479093|P3|STARTED|Double-blind Treatment||154
604371|NCT00405756|1479094|P2|STARTED|Double-blind Treatment||153
604372|NCT00405756|1479095|P1|STARTED|Double-blind Treatment|Intent to treat population of all randomized participants|152
604373|NCT00405704|1479185|P2|NOT COMPLETED|Overall Study||46
604374|NCT00405704|1479186|P1|NOT COMPLETED|Overall Study||41
604375|NCT00405704|1479185|P2|COMPLETED|Overall Study||259
604376|NCT00405704|1479186|P1|COMPLETED|Overall Study||261
604377|NCT00405704|1479185|P2|Recurrent UTI With TMP-SMZ Panel|Overall Study||69
604378|NCT00405704|1479186|P1|Recurrent UTI With TMP-SMZ Panel|Overall Study||38
604379|NCT00405704|1479185|P2|Recurrent UTI With E. Coli|Overall Study||57
604380|NCT00405704|1479186|P1|Recurrent UTI With E. Coli|Overall Study||30
604381|NCT00405704|1479185|P2|Outcome Stool Assessed|Overall Study||210
604382|NCT00405704|1479186|P1|Outcome Stool Assessed|Overall Study||203
604383|NCT00405704|1479185|P2|Completed Assessments for New Scarring|Overall Study||227
604384|NCT00405704|1479186|P1|Completed Assessments for New Scarring|Overall Study||220
604385|NCT00405704|1479185|P2|Completed Outcome Renal Scan|Overall Study||235
604386|NCT00405704|1479186|P1|Completed Outcome Renal Scan|Overall Study||227
604387|NCT00405704|1479185|P2|STARTED|Overall Study||305
604388|NCT00405704|1479186|P1|STARTED|Overall Study||302
604389|NCT00405652|1479206|P1|NOT COMPLETED|Overall Study||4
604390|NCT00405652|1479206|P1|COMPLETED|Overall Study||30
604391|NCT00405652|1479206|P1|STARTED|Overall Study||34
604392|NCT00405639|1479213|P2|NOT COMPLETED|Overall Study||0
604393|NCT00405639|1479214|P1|NOT COMPLETED|Overall Study||3
604394|NCT00405639|1479213|P2|COMPLETED|Overall Study||12
604395|NCT00405639|1479214|P1|COMPLETED|Overall Study||22
604396|NCT00405639|1479213|P2|STARTED|Overall Study||12
604397|NCT00405639|1479214|P1|STARTED|Overall Study||25
604398|NCT00405587|1479230|P4|NOT COMPLETED|Overall Study||20
604399|NCT00405587|1479231|P3|NOT COMPLETED|Overall Study||22
604400|NCT00405587|1479232|P2|NOT COMPLETED|Overall Study||28
604401|NCT00405587|1479233|P1|NOT COMPLETED|Overall Study||26
604402|NCT00405587|1479230|P4|COMPLETED|Overall Study||1
604403|NCT00405587|1479231|P3|COMPLETED|Overall Study||10
604404|NCT00405587|1479232|P2|COMPLETED|Overall Study||2
604405|NCT00405587|1479233|P1|COMPLETED|Overall Study||0
604406|NCT00405587|1479230|P4|STARTED|Overall Study||21
604407|NCT00405587|1479231|P3|STARTED|Overall Study||32
604408|NCT00405587|1479232|P2|STARTED|Overall Study||30
604409|NCT00405587|1479233|P1|STARTED|Overall Study||26
604410|NCT00405548|1479351|P2|NOT COMPLETED|Overall Study||1
604411|NCT00405548|1479352|P1|NOT COMPLETED|Overall Study||4
604412|NCT00405548|1479351|P2|COMPLETED|Overall Study||12
604413|NCT00405548|1479352|P1|COMPLETED|Overall Study||24
604414|NCT00405548|1479351|P2|STARTED|Overall Study||13
604415|NCT00405548|1479352|P1|STARTED|Overall Study||28
604416|NCT00405509|1479366|P2|NOT COMPLETED|Overall Study||0
604417|NCT00405509|1479367|P1|NOT COMPLETED|Overall Study||0
604418|NCT00405509|1479366|P2|COMPLETED|Overall Study||22
604419|NCT00405509|1479367|P1|COMPLETED|Overall Study||11
604420|NCT00405509|1479366|P2|STARTED|Overall Study||22
604421|NCT00405509|1479367|P1|STARTED|Overall Study||11
604422|NCT00405392|1479383|P2|NOT COMPLETED|Overall Study||27
604423|NCT00405392|1479384|P1|NOT COMPLETED|Overall Study||30
604424|NCT00405392|1479383|P2|COMPLETED|Overall Study||155
604425|NCT00405392|1479384|P1|COMPLETED|Overall Study||153
604426|NCT00405392|1479383|P2|STARTED|Overall Study||182
604427|NCT00405392|1479384|P1|STARTED|Overall Study||183
604428|NCT00405288|1479396|P2|NOT COMPLETED|Overall Study||0
604429|NCT00405288|1479397|P1|NOT COMPLETED|Overall Study||0
604430|NCT00405288|1479396|P2|COMPLETED|Overall Study||204
604431|NCT00405288|1479397|P1|COMPLETED|Overall Study||204
604432|NCT00405288|1479396|P2|STARTED|Overall Study||204
604433|NCT00405288|1479397|P1|STARTED|Overall Study||204
604434|NCT00405275|1479427|P2|NOT COMPLETED|Overall Study||19
604435|NCT00405275|1479428|P1|NOT COMPLETED|Overall Study||23
604436|NCT00405275|1479427|P2|COMPLETED|Overall Study||156
604437|NCT00405275|1479428|P1|COMPLETED|Overall Study||155
604438|NCT00405275|1479427|P2|24 Week (Switch)|Overall Study||44
604439|NCT00405275|1479428|P1|24 Week (Switch)|Overall Study||44
604440|NCT00405275|1479427|P2|24 Week (no Switch)|Overall Study||121
604441|NCT00405275|1479428|P1|24 Week (no Switch)|Overall Study||119
604442|NCT00405275|1479427|P2|24 Weeks (Total)|Overall Study||165
604443|NCT00405275|1479428|P1|24 Weeks (Total)|Overall Study||163
604444|NCT00405275|1479427|P2|STARTED|Overall Study||175
604445|NCT00405275|1479428|P1|STARTED|Overall Study||178
604446|NCT00405067|1479437|P3|NOT COMPLETED|Overall Study||5
604447|NCT00405067|1479438|P2|NOT COMPLETED|Overall Study||9
604448|NCT00405067|1479439|P1|NOT COMPLETED|Overall Study||4
604449|NCT00405067|1479437|P3|COMPLETED|Overall Study||24
604450|NCT00405067|1479438|P2|COMPLETED|Overall Study||19
604451|NCT00405067|1479439|P1|COMPLETED|Overall Study||24
604452|NCT00405067|1479437|P3|STARTED|Overall Study||29
604453|NCT00405067|1479438|P2|STARTED|Overall Study||28
604454|NCT00405067|1479439|P1|STARTED|Overall Study||28
604455|NCT00404924|1479476|P2|NOT COMPLETED|Overall Study||306
604456|NCT00404924|1479477|P1|NOT COMPLETED|Overall Study||603
604457|NCT00404924|1479476|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|1
604458|NCT00404924|1479477|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|14
604459|NCT00404924|1479476|P2|STARTED|Overall Study|randomised patients|307
604460|NCT00404924|1479477|P1|STARTED|Overall Study|randomised patients|617
604461|NCT00404820|1479495|P2|NOT COMPLETED|Overall Study||24
604462|NCT00404820|1479496|P1|NOT COMPLETED|Overall Study||19
604463|NCT00404820|1479495|P2|COMPLETED|Overall Study||172
604464|NCT00404820|1479496|P1|COMPLETED|Overall Study||389
604465|NCT00404820|1479495|P2|Started Treatment|Overall Study|The reason why 2 patients did not start treatment is unavailable.|194
604466|NCT00404820|1479496|P1|Started Treatment|Overall Study||408
604467|NCT00404820|1479495|P2|STARTED|Overall Study||196
604468|NCT00404820|1479496|P1|STARTED|Overall Study||408
604469|NCT00404768|1479518|P4|NOT COMPLETED|Part C||14
604470|NCT00404768|1479519|P3|NOT COMPLETED|Part C||8
604471|NCT00404768|1479520|P2|NOT COMPLETED|Part C||0
604472|NCT00404768|1479521|P1|NOT COMPLETED|Part C||0
604473|NCT00404768|1479518|P4|COMPLETED|Part C||20
604474|NCT00404768|1479519|P3|COMPLETED|Part C||22
604475|NCT00404768|1479520|P2|COMPLETED|Part C||0
604476|NCT00404768|1479521|P1|COMPLETED|Part C||0
604477|NCT00404768|1479518|P4|STARTED|Part C||34
604478|NCT00404768|1479519|P3|STARTED|Part C||30
604479|NCT00404768|1479520|P2|STARTED|Part C||0
604480|NCT00404768|1479521|P1|STARTED|Part C||0
604481|NCT00404768|1479518|P4|NOT COMPLETED|Part A and B||0
604482|NCT00404768|1479519|P3|NOT COMPLETED|Part A and B||0
604483|NCT00404768|1479520|P2|NOT COMPLETED|Part A and B||1
604484|NCT00404768|1479521|P1|NOT COMPLETED|Part A and B||1
604485|NCT00404768|1479518|P4|COMPLETED|Part A and B||0
604486|NCT00404768|1479519|P3|COMPLETED|Part A and B||0
604487|NCT00404768|1479520|P2|COMPLETED|Part A and B||8
604488|NCT00404768|1479521|P1|COMPLETED|Part A and B||19
604489|NCT00404768|1479518|P4|STARTED|Part A and B||0
604490|NCT00404768|1479519|P3|STARTED|Part A and B||0
604491|NCT00404768|1479520|P2|STARTED|Part A and B||9
604492|NCT00404768|1479521|P1|STARTED|Part A and B||20
604493|NCT00404755|1479582|P1|NOT COMPLETED|Phase III (Imipramine)||0
604494|NCT00404755|1479582|P1|COMPLETED|Phase III (Imipramine)||3
604495|NCT00404755|1479582|P1|STARTED|Phase III (Imipramine)||3
604496|NCT00404755|1479582|P1|NOT COMPLETED|Phase II (Escitalopram)||2
604497|NCT00404755|1479582|P1|COMPLETED|Phase II (Escitalopram)||9
604498|NCT00404755|1479582|P1|STARTED|Phase II (Escitalopram)||11
604499|NCT00404755|1479582|P1|NOT COMPLETED|Phase I (Bupropion)||4
604500|NCT00404755|1479582|P1|COMPLETED|Phase I (Bupropion)||13
604501|NCT00404755|1479582|P1|STARTED|Phase I (Bupropion)|3 went directly into Phase II (intolerant of bupropion), 1 withdrew consent and 4 did not return|17
604502|NCT00404651|1479597|P4|NOT COMPLETED|Overall Study||21
604503|NCT00404651|1479598|P3|NOT COMPLETED|Overall Study||45
604504|NCT00404651|1479599|P2|NOT COMPLETED|Overall Study||28
604505|NCT00404651|1479600|P1|NOT COMPLETED|Overall Study||39
604506|NCT00404651|1479597|P4|COMPLETED|Overall Study||146
604507|NCT00404651|1479598|P3|COMPLETED|Overall Study||294
604508|NCT00404651|1479599|P2|COMPLETED|Overall Study||315
604509|NCT00404651|1479600|P1|COMPLETED|Overall Study||301
604510|NCT00404651|1479597|P4|STARTED|Overall Study||167
604511|NCT00404651|1479598|P3|STARTED|Overall Study||339
604512|NCT00404651|1479599|P2|STARTED|Overall Study||343
604513|NCT00404651|1479600|P1|STARTED|Overall Study||340
604514|NCT00404547|1479628|P2|NOT COMPLETED|Overall Study||25
604515|NCT00404547|1479629|P1|NOT COMPLETED|Overall Study||90
604516|NCT00404547|1479628|P2|COMPLETED|Overall Study||334
604517|NCT00404547|1479629|P1|COMPLETED|Overall Study||672
604518|NCT00404547|1479628|P2|STARTED|Overall Study||359
604519|NCT00404547|1479629|P1|STARTED|Overall Study||762
604520|NCT00404495|1479639|P2|NOT COMPLETED|Overall Study||11
604521|NCT00404495|1479640|P1|NOT COMPLETED|Overall Study||44
604522|NCT00404495|1479639|P2|COMPLETED|Overall Study||6
604523|NCT00404495|1479640|P1|COMPLETED|Overall Study||22
604524|NCT00404495|1479639|P2|STARTED|Overall Study||17
604525|NCT00404495|1479640|P1|STARTED|Overall Study||66
604526|NCT00404352|1479659|P9|NOT COMPLETED|Open Label Extension (up to 36 Months)||2
604527|NCT00404352|1479660|P8|NOT COMPLETED|Open Label Extension (up to 36 Months)||1
604528|NCT00404352|1479661|P7|NOT COMPLETED|Open Label Extension (up to 36 Months)||1
604529|NCT00404352|1479662|P6|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
604530|NCT00404352|1479663|P5|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
604531|NCT00404352|1479664|P4|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
604532|NCT00404352|1479665|P3|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
604533|NCT00404352|1479666|P2|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
604534|NCT00404352|1479667|P1|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
604535|NCT00404352|1479659|P9|COMPLETED|Open Label Extension (up to 36 Months)||9
604536|NCT00404352|1479660|P8|COMPLETED|Open Label Extension (up to 36 Months)||4
604537|NCT00404352|1479661|P7|COMPLETED|Open Label Extension (up to 36 Months)||3
604538|NCT00404352|1479662|P6|COMPLETED|Open Label Extension (up to 36 Months)||0
604539|NCT00404352|1479663|P5|COMPLETED|Open Label Extension (up to 36 Months)||0
604540|NCT00404352|1479664|P4|COMPLETED|Open Label Extension (up to 36 Months)||0
604541|NCT00404352|1479665|P3|COMPLETED|Open Label Extension (up to 36 Months)||0
604542|NCT00404352|1479666|P2|COMPLETED|Open Label Extension (up to 36 Months)||0
604543|NCT00404352|1479667|P1|COMPLETED|Open Label Extension (up to 36 Months)||0
604544|NCT00404352|1479659|P9|STARTED|Open Label Extension (up to 36 Months)|11 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|11
604545|NCT00404352|1479660|P8|STARTED|Open Label Extension (up to 36 Months)|5 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|5
604546|NCT00404352|1479661|P7|STARTED|Open Label Extension (up to 36 Months)|4 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|4
604547|NCT00404352|1479662|P6|STARTED|Open Label Extension (up to 36 Months)||0
604548|NCT00404352|1479663|P5|STARTED|Open Label Extension (up to 36 Months)||0
604549|NCT00404352|1479664|P4|STARTED|Open Label Extension (up to 36 Months)||0
604550|NCT00404352|1479665|P3|STARTED|Open Label Extension (up to 36 Months)||0
604551|NCT00404352|1479666|P2|STARTED|Open Label Extension (up to 36 Months)||0
604552|NCT00404352|1479667|P1|STARTED|Open Label Extension (up to 36 Months)||0
604553|NCT00404352|1479659|P9|NOT COMPLETED|Open Label (up to 24 Month)||0
604554|NCT00404352|1479660|P8|NOT COMPLETED|Open Label (up to 24 Month)||0
604555|NCT00404352|1479661|P7|NOT COMPLETED|Open Label (up to 24 Month)||0
604556|NCT00404352|1479662|P6|NOT COMPLETED|Open Label (up to 24 Month)||7
604557|NCT00404352|1479663|P5|NOT COMPLETED|Open Label (up to 24 Month)||2
604558|NCT00404352|1479664|P4|NOT COMPLETED|Open Label (up to 24 Month)||3
604559|NCT00404352|1479665|P3|NOT COMPLETED|Open Label (up to 24 Month)||0
604560|NCT00404352|1479666|P2|NOT COMPLETED|Open Label (up to 24 Month)||0
604561|NCT00404352|1479667|P1|NOT COMPLETED|Open Label (up to 24 Month)||0
604562|NCT00404352|1479659|P9|COMPLETED|Open Label (up to 24 Month)||0
604563|NCT00404352|1479660|P8|COMPLETED|Open Label (up to 24 Month)||0
604564|NCT00404352|1479661|P7|COMPLETED|Open Label (up to 24 Month)||0
604565|NCT00404352|1479662|P6|COMPLETED|Open Label (up to 24 Month)||52
604566|NCT00404352|1479663|P5|COMPLETED|Open Label (up to 24 Month)||28
604567|NCT00404352|1479664|P4|COMPLETED|Open Label (up to 24 Month)||28
604568|NCT00404352|1479665|P3|COMPLETED|Open Label (up to 24 Month)||0
604569|NCT00404352|1479666|P2|COMPLETED|Open Label (up to 24 Month)||0
604570|NCT00404352|1479667|P1|COMPLETED|Open Label (up to 24 Month)||0
604571|NCT00404352|1479659|P9|STARTED|Open Label (up to 24 Month)||0
604572|NCT00404352|1479660|P8|STARTED|Open Label (up to 24 Month)||0
604573|NCT00404352|1479661|P7|STARTED|Open Label (up to 24 Month)||0
604574|NCT00404352|1479662|P6|STARTED|Open Label (up to 24 Month)|From DB period, 59 participants converted to CDMS and switched to OL period in this study|59
604575|NCT00404352|1479663|P5|STARTED|Open Label (up to 24 Month)|From DB period, 30 participants converted to CDMS and switched to OL period in this study|30
604576|NCT00404352|1479664|P4|STARTED|Open Label (up to 24 Month)|From DB period, 31 participants converted to CDMS and switched to OL period in this study|31
604577|NCT00404352|1479665|P3|STARTED|Open Label (up to 24 Month)||0
604578|NCT00404352|1479666|P2|STARTED|Open Label (up to 24 Month)||0
604579|NCT00404352|1479667|P1|STARTED|Open Label (up to 24 Month)||0
604580|NCT00404352|1479659|P9|NOT COMPLETED|Double Blind (up to 24 Month)||0
604581|NCT00404352|1479660|P8|NOT COMPLETED|Double Blind (up to 24 Month)||0
604582|NCT00404352|1479661|P7|NOT COMPLETED|Double Blind (up to 24 Month)||0
604583|NCT00404352|1479662|P6|NOT COMPLETED|Double Blind (up to 24 Month)||0
604584|NCT00404352|1479663|P5|NOT COMPLETED|Double Blind (up to 24 Month)||0
604585|NCT00404352|1479664|P4|NOT COMPLETED|Double Blind (up to 24 Month)||0
604586|NCT00404352|1479665|P3|NOT COMPLETED|Double Blind (up to 24 Month)||79
604587|NCT00404352|1479666|P2|NOT COMPLETED|Double Blind (up to 24 Month)||47
604588|NCT00404352|1479667|P1|NOT COMPLETED|Double Blind (up to 24 Month)||52
604589|NCT00404352|1479659|P9|COMPLETED|Double Blind (up to 24 Month)||0
604590|NCT00404352|1479660|P8|COMPLETED|Double Blind (up to 24 Month)||0
604591|NCT00404352|1479661|P7|COMPLETED|Double Blind (up to 24 Month)||0
604592|NCT00404352|1479662|P6|COMPLETED|Double Blind (up to 24 Month)||0
604593|NCT00404352|1479663|P5|COMPLETED|Double Blind (up to 24 Month)||0
604594|NCT00404352|1479664|P4|COMPLETED|Double Blind (up to 24 Month)||0
604595|NCT00404352|1479665|P3|COMPLETED|Double Blind (up to 24 Month)||92
604596|NCT00404352|1479666|P2|COMPLETED|Double Blind (up to 24 Month)||128
604597|NCT00404352|1479667|P1|COMPLETED|Double Blind (up to 24 Month)||119
604598|NCT00404352|1479659|P9|Treated|Double Blind (up to 24 Month)||0
604599|NCT00404352|1479660|P8|Treated|Double Blind (up to 24 Month)||0
604600|NCT00404352|1479661|P7|Treated|Double Blind (up to 24 Month)||0
604601|NCT00404352|1479662|P6|Treated|Double Blind (up to 24 Month)||0
604602|NCT00404352|1479663|P5|Treated|Double Blind (up to 24 Month)||0
604603|NCT00404352|1479664|P4|Treated|Double Blind (up to 24 Month)||0
604604|NCT00404352|1479665|P3|Treated|Double Blind (up to 24 Month)||171
604605|NCT00404352|1479666|P2|Treated|Double Blind (up to 24 Month)||173
604606|NCT00404352|1479667|P1|Treated|Double Blind (up to 24 Month)||171
604607|NCT00404352|1479659|P9|STARTED|Double Blind (up to 24 Month)||0
604608|NCT00404352|1479660|P8|STARTED|Double Blind (up to 24 Month)||0
604609|NCT00404352|1479661|P7|STARTED|Double Blind (up to 24 Month)||0
604610|NCT00404352|1479662|P6|STARTED|Double Blind (up to 24 Month)||0
604611|NCT00404352|1479663|P5|STARTED|Double Blind (up to 24 Month)||0
604612|NCT00404352|1479664|P4|STARTED|Double Blind (up to 24 Month)||0
604613|NCT00404352|1479665|P3|STARTED|Double Blind (up to 24 Month)||171
604614|NCT00404352|1479666|P2|STARTED|Double Blind (up to 24 Month)||175
604615|NCT00404352|1479667|P1|STARTED|Double Blind (up to 24 Month)||171
604616|NCT00404248|1479702|P9|NOT COMPLETED|Overall Study||0
604617|NCT00404248|1479703|P8|NOT COMPLETED|Overall Study||0
604618|NCT00404248|1479704|P7|NOT COMPLETED|Overall Study||0
604619|NCT00404248|1479705|P6|NOT COMPLETED|Overall Study||0
604620|NCT00404248|1479706|P5|NOT COMPLETED|Overall Study||0
604621|NCT00404248|1479707|P4|NOT COMPLETED|Overall Study||0
604622|NCT00404248|1479708|P3|NOT COMPLETED|Overall Study||0
604623|NCT00404248|1479709|P2|NOT COMPLETED|Overall Study||1
604624|NCT00404248|1479710|P1|NOT COMPLETED|Overall Study||0
604625|NCT00404248|1479702|P9|COMPLETED|Overall Study||3
604626|NCT00404248|1479703|P8|COMPLETED|Overall Study||6
604627|NCT00404248|1479704|P7|COMPLETED|Overall Study||6
604628|NCT00404248|1479705|P6|COMPLETED|Overall Study||3
604629|NCT00404248|1479706|P5|COMPLETED|Overall Study||3
604630|NCT00404248|1479707|P4|COMPLETED|Overall Study||2
604631|NCT00404248|1479708|P3|COMPLETED|Overall Study||5
604632|NCT00404248|1479709|P2|COMPLETED|Overall Study||3
604633|NCT00404248|1479710|P1|COMPLETED|Overall Study||3
604634|NCT00404248|1479702|P9|STARTED|Overall Study||3
604635|NCT00404248|1479703|P8|STARTED|Overall Study||6
604636|NCT00404248|1479704|P7|STARTED|Overall Study||6
604637|NCT00404248|1479705|P6|STARTED|Overall Study||3
604638|NCT00404248|1479706|P5|STARTED|Overall Study||3
604639|NCT00404248|1479707|P4|STARTED|Overall Study||2
604640|NCT00404248|1479708|P3|STARTED|Overall Study||5
604641|NCT00404248|1479709|P2|STARTED|Overall Study||4
604642|NCT00404248|1479710|P1|STARTED|Overall Study||3
604643|NCT00404092|1479745|P4|NOT COMPLETED|Overall Study||0
604644|NCT00404092|1479746|P3|NOT COMPLETED|Overall Study||1
604645|NCT00404092|1479747|P2|NOT COMPLETED|Overall Study||0
604646|NCT00404092|1479748|P1|NOT COMPLETED|Overall Study||1
604647|NCT00404092|1479745|P4|COMPLETED|Overall Study||20
604648|NCT00404092|1479746|P3|COMPLETED|Overall Study||8
604649|NCT00404092|1479747|P2|COMPLETED|Overall Study||8
604650|NCT00404092|1479748|P1|COMPLETED|Overall Study||8
604651|NCT00404092|1479745|P4|STARTED|Overall Study||20
604652|NCT00404092|1479746|P3|STARTED|Overall Study||9
604653|NCT00404092|1479747|P2|STARTED|Overall Study||8
604654|NCT00404092|1479748|P1|STARTED|Overall Study||9
604655|NCT00404079|1479764|P2|NOT COMPLETED|Overall Study||20
604656|NCT00404079|1479765|P1|NOT COMPLETED|Overall Study||22
604657|NCT00404079|1479764|P2|COMPLETED|Overall Study||105
604658|NCT00404079|1479765|P1|COMPLETED|Overall Study||103
604659|NCT00404079|1479764|P2|STARTED|Overall Study||125
604660|NCT00404079|1479765|P1|STARTED|Overall Study||125
604661|NCT00404066|1479771|P1|NOT COMPLETED|Overall Study||3
604662|NCT00404066|1479771|P1|COMPLETED|Overall Study||18
604751|NCT00403754|1479829|P3|STARTED|Core Treatment Period 3||8
604663|NCT00404066|1479771|P1|STARTED|Overall Study|1 subject started but withdrew after adriamycin+cytoxan, but before study drugs lapatinib+docetaxel.|21
604664|NCT00403845|1479776|P4|NOT COMPLETED|Treatment Period 4||0
604665|NCT00403845|1479777|P3|NOT COMPLETED|Treatment Period 4||0
604666|NCT00403845|1479778|P2|NOT COMPLETED|Treatment Period 4||0
604667|NCT00403845|1479779|P1|NOT COMPLETED|Treatment Period 4||0
604668|NCT00403845|1479776|P4|COMPLETED|Treatment Period 4||11
604669|NCT00403845|1479777|P3|COMPLETED|Treatment Period 4||11
604670|NCT00403845|1479778|P2|COMPLETED|Treatment Period 4||13
604671|NCT00403845|1479779|P1|COMPLETED|Treatment Period 4||10
604672|NCT00403845|1479776|P4|STARTED|Treatment Period 4||11
604673|NCT00403845|1479777|P3|STARTED|Treatment Period 4||11
604674|NCT00403845|1479778|P2|STARTED|Treatment Period 4||13
604675|NCT00403845|1479779|P1|STARTED|Treatment Period 4||10
604676|NCT00403845|1479776|P4|NOT COMPLETED|Treatment Period 3||2
604677|NCT00403845|1479777|P3|NOT COMPLETED|Treatment Period 3||0
604678|NCT00403845|1479778|P2|NOT COMPLETED|Treatment Period 3||0
604679|NCT00403845|1479779|P1|NOT COMPLETED|Treatment Period 3||0
604680|NCT00403845|1479776|P4|COMPLETED|Treatment Period 3||11
604681|NCT00403845|1479777|P3|COMPLETED|Treatment Period 3||11
604682|NCT00403845|1479778|P2|COMPLETED|Treatment Period 3||13
604683|NCT00403845|1479779|P1|COMPLETED|Treatment Period 3||10
604684|NCT00403845|1479776|P4|STARTED|Treatment Period 3||13
604685|NCT00403845|1479777|P3|STARTED|Treatment Period 3||11
604686|NCT00403845|1479778|P2|STARTED|Treatment Period 3||13
604687|NCT00403845|1479779|P1|STARTED|Treatment Period 3||10
604688|NCT00403845|1479776|P4|NOT COMPLETED|Treatment Period 2||0
604689|NCT00403845|1479777|P3|NOT COMPLETED|Treatment Period 2||0
604690|NCT00403845|1479778|P2|NOT COMPLETED|Treatment Period 2||0
604691|NCT00403845|1479779|P1|NOT COMPLETED|Treatment Period 2||1
604692|NCT00403845|1479776|P4|COMPLETED|Treatment Period 2||13
604693|NCT00403845|1479777|P3|COMPLETED|Treatment Period 2||11
604694|NCT00403845|1479778|P2|COMPLETED|Treatment Period 2||13
604695|NCT00403845|1479779|P1|COMPLETED|Treatment Period 2||10
604696|NCT00403845|1479776|P4|STARTED|Treatment Period 2||13
604697|NCT00403845|1479777|P3|STARTED|Treatment Period 2||11
604698|NCT00403845|1479778|P2|STARTED|Treatment Period 2||13
604699|NCT00403845|1479779|P1|STARTED|Treatment Period 2||11
604700|NCT00403845|1479776|P4|NOT COMPLETED|Treatment Period 1||1
604701|NCT00403845|1479777|P3|NOT COMPLETED|Treatment Period 1||0
604702|NCT00403845|1479778|P2|NOT COMPLETED|Treatment Period 1||0
604703|NCT00403845|1479779|P1|NOT COMPLETED|Treatment Period 1||1
604704|NCT00403845|1479776|P4|COMPLETED|Treatment Period 1||13
604705|NCT00403845|1479777|P3|COMPLETED|Treatment Period 1||11
604706|NCT00403845|1479778|P2|COMPLETED|Treatment Period 1||13
604707|NCT00403845|1479779|P1|COMPLETED|Treatment Period 1||11
604708|NCT00403845|1479776|P4|STARTED|Treatment Period 1||14
604709|NCT00403845|1479777|P3|STARTED|Treatment Period 1||11
604710|NCT00403845|1479778|P2|STARTED|Treatment Period 1||13
604711|NCT00403845|1479779|P1|STARTED|Treatment Period 1||12
604712|NCT00403767|1479803|P2|NOT COMPLETED|Overall Study||2468
604713|NCT00403767|1479804|P1|NOT COMPLETED|Overall Study||2520
604714|NCT00403767|1479803|P2|COMPLETED|Overall Study||4657
604715|NCT00403767|1479804|P1|COMPLETED|Overall Study||4591
604716|NCT00403767|1479803|P2|STARTED|Overall Study||7125
604717|NCT00403767|1479804|P1|STARTED|Overall Study||7111
604718|NCT00403754|1479828|P4|NOT COMPLETED|Open Label: Salmeterol||0
604719|NCT00403754|1479829|P3|NOT COMPLETED|Open Label: Salmeterol||0
604720|NCT00403754|1479830|P2|NOT COMPLETED|Open Label: Salmeterol||0
604721|NCT00403754|1479831|P1|NOT COMPLETED|Open Label: Salmeterol||0
604722|NCT00403754|1479828|P4|COMPLETED|Open Label: Salmeterol||11
604723|NCT00403754|1479829|P3|COMPLETED|Open Label: Salmeterol||8
604724|NCT00403754|1479830|P2|COMPLETED|Open Label: Salmeterol||9
604725|NCT00403754|1479831|P1|COMPLETED|Open Label: Salmeterol||11
604726|NCT00403754|1479828|P4|STARTED|Open Label: Salmeterol||11
604727|NCT00403754|1479829|P3|STARTED|Open Label: Salmeterol||8
604728|NCT00403754|1479830|P2|STARTED|Open Label: Salmeterol||9
604729|NCT00403754|1479831|P1|STARTED|Open Label: Salmeterol||11
604730|NCT00403754|1479828|P4|NOT COMPLETED|Core Treatment Period 4||0
604731|NCT00403754|1479829|P3|NOT COMPLETED|Core Treatment Period 4||0
604732|NCT00403754|1479830|P2|NOT COMPLETED|Core Treatment Period 4||0
604733|NCT00403754|1479831|P1|NOT COMPLETED|Core Treatment Period 4||0
604734|NCT00403754|1479828|P4|COMPLETED|Core Treatment Period 4||11
604735|NCT00403754|1479829|P3|COMPLETED|Core Treatment Period 4||8
604736|NCT00403754|1479830|P2|COMPLETED|Core Treatment Period 4||9
604737|NCT00403754|1479831|P1|COMPLETED|Core Treatment Period 4||11
604738|NCT00403754|1479828|P4|STARTED|Core Treatment Period 4||11
604739|NCT00403754|1479829|P3|STARTED|Core Treatment Period 4||8
604740|NCT00403754|1479830|P2|STARTED|Core Treatment Period 4||9
604741|NCT00403754|1479831|P1|STARTED|Core Treatment Period 4||11
604742|NCT00403754|1479828|P4|NOT COMPLETED|Core Treatment Period 3||0
604743|NCT00403754|1479829|P3|NOT COMPLETED|Core Treatment Period 3||0
604744|NCT00403754|1479830|P2|NOT COMPLETED|Core Treatment Period 3||0
604745|NCT00403754|1479831|P1|NOT COMPLETED|Core Treatment Period 3||0
604746|NCT00403754|1479828|P4|COMPLETED|Core Treatment Period 3||11
604747|NCT00403754|1479829|P3|COMPLETED|Core Treatment Period 3||8
604748|NCT00403754|1479830|P2|COMPLETED|Core Treatment Period 3||9
604749|NCT00403754|1479831|P1|COMPLETED|Core Treatment Period 3||11
604750|NCT00403754|1479828|P4|STARTED|Core Treatment Period 3||11
604752|NCT00403754|1479830|P2|STARTED|Core Treatment Period 3||9
604753|NCT00403754|1479831|P1|STARTED|Core Treatment Period 3||11
604754|NCT00403754|1479828|P4|NOT COMPLETED|Core Treatment Period 2||0
604755|NCT00403754|1479829|P3|NOT COMPLETED|Core Treatment Period 2||1
604756|NCT00403754|1479830|P2|NOT COMPLETED|Core Treatment Period 2||0
604757|NCT00403754|1479831|P1|NOT COMPLETED|Core Treatment Period 2||0
604758|NCT00403754|1479828|P4|COMPLETED|Core Treatment Period 2||11
604759|NCT00403754|1479829|P3|COMPLETED|Core Treatment Period 2||8
604760|NCT00403754|1479830|P2|COMPLETED|Core Treatment Period 2||9
604761|NCT00403754|1479831|P1|COMPLETED|Core Treatment Period 2||11
604762|NCT00403754|1479828|P4|STARTED|Core Treatment Period 2||11
604763|NCT00403754|1479829|P3|STARTED|Core Treatment Period 2||9
604764|NCT00403754|1479830|P2|STARTED|Core Treatment Period 2||9
604765|NCT00403754|1479831|P1|STARTED|Core Treatment Period 2||11
604766|NCT00403754|1479828|P4|NOT COMPLETED|Core Treatment Period 1||0
604767|NCT00403754|1479829|P3|NOT COMPLETED|Core Treatment Period 1||0
604768|NCT00403754|1479830|P2|NOT COMPLETED|Core Treatment Period 1||1
604769|NCT00403754|1479831|P1|NOT COMPLETED|Core Treatment Period 1||0
604770|NCT00403754|1479828|P4|COMPLETED|Core Treatment Period 1||11
604771|NCT00403754|1479829|P3|COMPLETED|Core Treatment Period 1||9
604772|NCT00403754|1479830|P2|COMPLETED|Core Treatment Period 1||9
604773|NCT00403754|1479831|P1|COMPLETED|Core Treatment Period 1||11
604774|NCT00403754|1479828|P4|STARTED|Core Treatment Period 1||11
604775|NCT00403754|1479829|P3|STARTED|Core Treatment Period 1||9
604776|NCT00403754|1479830|P2|STARTED|Core Treatment Period 1||10
604777|NCT00403754|1479831|P1|STARTED|Core Treatment Period 1||11
604778|NCT00403585|1479858|P1|NOT COMPLETED|Open-Label Phase; Extension Study||6
604779|NCT00403585|1479858|P1|COMPLETED|Open-Label Phase; Extension Study||74
604780|NCT00403585|1479858|P1|STARTED|Open-Label Phase; Extension Study|80 of 102 participants completing Study 103814 enrolled in extension (22 didn't continue medication)|80
604781|NCT00403585|1479858|P1|NOT COMPLETED|Initial Treatment Phase||2
604782|NCT00403585|1479858|P1|COMPLETED|Initial Treatment Phase||102
604783|NCT00403585|1479858|P1|STARTED|Initial Treatment Phase||104
604784|NCT00403546|1479869|P3|NOT COMPLETED|Randomized Trial||16
604785|NCT00403546|1479870|P2|NOT COMPLETED|Randomized Trial||17
604786|NCT00403546|1479871|P1|NOT COMPLETED|Randomized Trial||0
604787|NCT00403546|1479869|P3|COMPLETED|Randomized Trial||21
604788|NCT00403546|1479870|P2|COMPLETED|Randomized Trial||21
604789|NCT00403546|1479871|P1|COMPLETED|Randomized Trial||0
604790|NCT00403546|1479869|P3|STARTED|Randomized Trial||37
604791|NCT00403546|1479870|P2|STARTED|Randomized Trial||38
604792|NCT00403546|1479871|P1|STARTED|Randomized Trial|All participants who completed Screening were randomized to the High-Dose and Placebo arms.|0
604793|NCT00403546|1479869|P3|NOT COMPLETED|Screening Phase||0
604794|NCT00403546|1479870|P2|NOT COMPLETED|Screening Phase||0
604795|NCT00403546|1479871|P1|NOT COMPLETED|Screening Phase||28
604796|NCT00403546|1479869|P3|COMPLETED|Screening Phase||0
604797|NCT00403546|1479870|P2|COMPLETED|Screening Phase||0
604798|NCT00403546|1479871|P1|COMPLETED|Screening Phase|All participants who completed Screening were randomized to the High-Dose and Placebo arms.|75
604799|NCT00403546|1479869|P3|STARTED|Screening Phase||0
604800|NCT00403546|1479870|P2|STARTED|Screening Phase||0
604801|NCT00403546|1479871|P1|STARTED|Screening Phase||103
604802|NCT00403546|1479869|P3|NOT COMPLETED|Signed Informed Consent/Open-Label||0
604803|NCT00403546|1479870|P2|NOT COMPLETED|Signed Informed Consent/Open-Label||0
604804|NCT00403546|1479871|P1|NOT COMPLETED|Signed Informed Consent/Open-Label||28
604805|NCT00403546|1479869|P3|COMPLETED|Signed Informed Consent/Open-Label||0
604806|NCT00403546|1479870|P2|COMPLETED|Signed Informed Consent/Open-Label||0
604807|NCT00403546|1479871|P1|COMPLETED|Signed Informed Consent/Open-Label||103
604808|NCT00403546|1479869|P3|STARTED|Signed Informed Consent/Open-Label||0
604809|NCT00403546|1479870|P2|STARTED|Signed Informed Consent/Open-Label||0
604810|NCT00403546|1479871|P1|STARTED|Signed Informed Consent/Open-Label||131
604811|NCT00403481|1479911|P1|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||2
604812|NCT00403481|1479911|P1|COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||142
604813|NCT00403481|1479911|P1|STARTED|Olm 40 mg + Hydrochlorothiazide 25 mg|168 -24 met their blood pressure goal (remained on olmesartan 40 mg/hydrochlorothiazide 12.5mg)= 144|144
604814|NCT00403481|1479911|P1|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||5
604815|NCT00403481|1479911|P1|COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||168
604816|NCT00403481|1479911|P1|STARTED|Olm 40 mg + Hydrochlorothiazide 12.5 mg|177 -4 met their blood pressure goal (remained on olmesartan 40 mg)= 173|173
604817|NCT00403481|1479911|P1|NOT COMPLETED|Olm 40 mg||5
604818|NCT00403481|1479911|P1|COMPLETED|Olm 40 mg||177
604819|NCT00403481|1479911|P1|STARTED|Olm 40 mg|186 -4 met their blood pressure goal (remained on olmesartan 20 mg) = 182|182
604820|NCT00403481|1479911|P1|NOT COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||6
604821|NCT00403481|1479911|P1|COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||186
604822|NCT00403481|1479911|P1|STARTED|Olmesartan Medoxomil (Olm) 20 mg||192
604823|NCT00403455|1479926|P1|NOT COMPLETED|Overall Study||1
604824|NCT00403455|1479926|P1|COMPLETED|Overall Study||37
604825|NCT00403455|1479926|P1|STARTED|Overall Study||38
604826|NCT00403403|1479932|P2|NOT COMPLETED|Overall Study||0
604827|NCT00403403|1479933|P1|NOT COMPLETED|Overall Study||0
604828|NCT00403403|1479932|P2|COMPLETED|Overall Study||52
604829|NCT00403403|1479933|P1|COMPLETED|Overall Study||50
604830|NCT00403403|1479932|P2|Safety-Evaluable Patients|Overall Study||51
604831|NCT00403403|1479933|P1|Safety-Evaluable Patients|Overall Study||47
604832|NCT00403403|1479932|P2|STARTED|Overall Study||52
604833|NCT00403403|1479933|P1|STARTED|Overall Study||50
604834|NCT00403390|1479949|P2|NOT COMPLETED|Overall Study||0
604835|NCT00403390|1479950|P1|NOT COMPLETED|Overall Study||3
604836|NCT00403390|1479949|P2|COMPLETED|Overall Study||18
604837|NCT00403390|1479950|P1|COMPLETED|Overall Study||13
604838|NCT00403390|1479949|P2|STARTED|Overall Study||18
604839|NCT00403390|1479950|P1|STARTED|Overall Study||16
604840|NCT00403273|1479958|P2|NOT COMPLETED|Overall Study||4
604841|NCT00403273|1479959|P1|NOT COMPLETED|Overall Study||3
604842|NCT00403273|1479958|P2|COMPLETED|Overall Study||25
604843|NCT00403273|1479959|P1|COMPLETED|Overall Study||22
604844|NCT00403273|1479958|P2|STARTED|Overall Study||29
604845|NCT00403273|1479959|P1|STARTED|Overall Study||25
604846|NCT00403234|1480001|P4|NOT COMPLETED|Overall Study||0
604847|NCT00403234|1480002|P3|NOT COMPLETED|Overall Study||1
604848|NCT00403234|1480003|P2|NOT COMPLETED|Overall Study||1
604849|NCT00403234|1480004|P1|NOT COMPLETED|Overall Study||1
604850|NCT00403234|1480001|P4|COMPLETED|Overall Study||2
604851|NCT00403234|1480002|P3|COMPLETED|Overall Study||2
604852|NCT00403234|1480003|P2|COMPLETED|Overall Study||2
604853|NCT00403234|1480004|P1|COMPLETED|Overall Study||1
604854|NCT00403234|1480001|P4|STARTED|Overall Study||2
604855|NCT00403234|1480002|P3|STARTED|Overall Study||3
604856|NCT00403234|1480003|P2|STARTED|Overall Study||3
604857|NCT00403234|1480004|P1|STARTED|Overall Study||2
604858|NCT00403130|1480014|P1|NOT COMPLETED|Overall Study||5
604859|NCT00403130|1480014|P1|COMPLETED|Overall Study||26
604860|NCT00403130|1480014|P1|STARTED|Overall Study||31
604861|NCT00403117|1480021|P1|NOT COMPLETED|Overall Study||20
604862|NCT00403117|1480021|P1|COMPLETED|Overall Study||29
604863|NCT00403117|1480021|P1|STARTED|Overall Study||49
604864|NCT00402987|1480067|P4|NOT COMPLETED|Overall Study||0
604865|NCT00402987|1480068|P3|NOT COMPLETED|Overall Study||1
604866|NCT00402987|1480069|P2|NOT COMPLETED|Overall Study||0
604867|NCT00402987|1480070|P1|NOT COMPLETED|Overall Study||0
604868|NCT00402987|1480067|P4|COMPLETED|Overall Study||89
604869|NCT00402987|1480068|P3|COMPLETED|Overall Study||44
604870|NCT00402987|1480069|P2|COMPLETED|Overall Study||45
604871|NCT00402987|1480070|P1|COMPLETED|Overall Study||90
604872|NCT00402987|1480067|P4|STARTED|Overall Study||89
604873|NCT00402987|1480068|P3|STARTED|Overall Study||45
604874|NCT00402987|1480069|P2|STARTED|Overall Study||45
604875|NCT00402987|1480070|P1|STARTED|Overall Study||90
604876|NCT00402896|1480232|P1|NOT COMPLETED|Overall Study||0
604877|NCT00402896|1480232|P1|COMPLETED|Overall Study||20
604878|NCT00402896|1480232|P1|STARTED|Overall Study||20
604879|NCT00402883|1480236|P1|NOT COMPLETED|Maintenance Therapy||0
604880|NCT00402883|1480236|P1|COMPLETED|Maintenance Therapy|All 5 patients received limited maintenance therapy due to early trial closure.|5
604881|NCT00402883|1480236|P1|STARTED|Maintenance Therapy||5
604882|NCT00402883|1480236|P1|NOT COMPLETED|Consolidation Therapy||0
604883|NCT00402883|1480236|P1|COMPLETED|Consolidation Therapy||5
604884|NCT00402883|1480236|P1|STARTED|Consolidation Therapy||5
604885|NCT00402883|1480236|P1|NOT COMPLETED|Induction Therapy||0
604886|NCT00402883|1480236|P1|COMPLETED|Induction Therapy||5
604887|NCT00402883|1480236|P1|STARTED|Induction Therapy||5
604888|NCT00402740|1480240|P1|NOT COMPLETED|Overall Study||80
604889|NCT00402740|1480240|P1|COMPLETED|Overall Study||242
604890|NCT00402740|1480240|P1|STARTED|Overall Study||322
604891|NCT00402727|1480252|P2|NOT COMPLETED|Overall Study||34
604892|NCT00402727|1480253|P1|NOT COMPLETED|Overall Study||42
604893|NCT00402727|1480252|P2|COMPLETED|Overall Study||347
604894|NCT00402727|1480253|P1|COMPLETED|Overall Study||390
604895|NCT00402727|1480252|P2|Achieving Test Of Cure (TOC)|Overall Study||347
604896|NCT00402727|1480253|P1|Achieving Test Of Cure (TOC)|Overall Study||390
604897|NCT00402727|1480252|P2|Achieving End Of Treatment (EOT)|Overall Study||355
604898|NCT00402727|1480253|P1|Achieving End Of Treatment (EOT)|Overall Study||408
604899|NCT00402727|1480252|P2|STARTED|Overall Study||381
604900|NCT00402727|1480253|P1|STARTED|Overall Study||432
604901|NCT00402714|1480283|P2|NOT COMPLETED|Overall Study||0
604902|NCT00402714|1480284|P1|NOT COMPLETED|Overall Study||0
604903|NCT00402714|1480283|P2|COMPLETED|Overall Study||11
604904|NCT00402714|1480284|P1|COMPLETED|Overall Study||3
604905|NCT00402714|1480283|P2|STARTED|Overall Study||11
604906|NCT00402714|1480284|P1|STARTED|Overall Study||3
604907|NCT00402688|1480295|P3|NOT COMPLETED|Overall Study||15
604908|NCT00402688|1480296|P2|NOT COMPLETED|Overall Study||16
604909|NCT00402688|1480297|P1|NOT COMPLETED|Overall Study||21
604910|NCT00402688|1480295|P3|COMPLETED|Overall Study||65
604911|NCT00402688|1480296|P2|COMPLETED|Overall Study||65
604912|NCT00402688|1480297|P1|COMPLETED|Overall Study||60
604913|NCT00402688|1480295|P3|STARTED|Overall Study||80
604914|NCT00402688|1480296|P2|STARTED|Overall Study||81
604915|NCT00402688|1480297|P1|STARTED|Overall Study||81
604916|NCT00402649|1480320|P1|NOT COMPLETED|Overall Study||2
604917|NCT00402649|1480320|P1|COMPLETED|Overall Study||33
604918|NCT00402649|1480320|P1|STARTED|Overall Study||35
604919|NCT00402597|1480335|P5|NOT COMPLETED|Overall Study||124
604920|NCT00402597|1480336|P4|NOT COMPLETED|Overall Study||74
604921|NCT00402597|1480337|P3|NOT COMPLETED|Overall Study||212
604922|NCT00402597|1480338|P2|NOT COMPLETED|Overall Study||46
604923|NCT00402597|1480339|P1|NOT COMPLETED|Overall Study||191
604924|NCT00402597|1480335|P5|COMPLETED|Overall Study||479
604925|NCT00402597|1480336|P4|COMPLETED|Overall Study||279
604926|NCT00402597|1480337|P3|COMPLETED|Overall Study||834
604927|NCT00402597|1480338|P2|COMPLETED|Overall Study||261
604928|NCT00402597|1480339|P1|COMPLETED|Overall Study||962
604929|NCT00402597|1480335|P5|STARTED|Overall Study||603
604930|NCT00402597|1480336|P4|STARTED|Overall Study||353
604931|NCT00402597|1480337|P3|STARTED|Overall Study||1046
604932|NCT00402597|1480338|P2|STARTED|Overall Study||307
604933|NCT00402597|1480339|P1|STARTED|Overall Study||1153
604934|NCT00402363|1480380|P4|NOT COMPLETED|Overall Study||10
604935|NCT00402363|1480381|P3|NOT COMPLETED|Overall Study||6
604936|NCT00402363|1480382|P2|NOT COMPLETED|Overall Study||30
604937|NCT00402363|1480383|P1|NOT COMPLETED|Overall Study||33
604938|NCT00402363|1480380|P4|COMPLETED|Overall Study||45
604939|NCT00402363|1480381|P3|COMPLETED|Overall Study||60
604940|NCT00402363|1480382|P2|COMPLETED|Overall Study||246
604941|NCT00402363|1480383|P1|COMPLETED|Overall Study||233
604942|NCT00402363|1480380|P4|STARTED|Overall Study||55
604943|NCT00402363|1480381|P3|STARTED|Overall Study||66
604944|NCT00402363|1480382|P2|STARTED|Overall Study||276
604945|NCT00402363|1480383|P1|STARTED|Overall Study||266
604946|NCT00402337|1480446|P5|NOT COMPLETED|Overall Study||8
604947|NCT00402337|1480447|P4|NOT COMPLETED|Overall Study||12
604948|NCT00402337|1480448|P3|NOT COMPLETED|Overall Study||4
604949|NCT00402337|1480449|P2|NOT COMPLETED|Overall Study||6
604950|NCT00402337|1480450|P1|NOT COMPLETED|Overall Study||5
604951|NCT00402337|1480446|P5|COMPLETED|Overall Study||61
604952|NCT00402337|1480447|P4|COMPLETED|Overall Study||51
604953|NCT00402337|1480448|P3|COMPLETED|Overall Study||58
604954|NCT00402337|1480449|P2|COMPLETED|Overall Study||51
604955|NCT00402337|1480450|P1|COMPLETED|Overall Study||54
604956|NCT00402337|1480446|P5|STARTED|Overall Study||69
604957|NCT00402337|1480447|P4|STARTED|Overall Study||63
604958|NCT00402337|1480448|P3|STARTED|Overall Study||62
604959|NCT00402337|1480449|P2|STARTED|Overall Study||57
604960|NCT00402337|1480450|P1|STARTED|Overall Study||59
604961|NCT00402324|1480489|P2|NOT COMPLETED|Overall Study||41
604962|NCT00402324|1480490|P1|NOT COMPLETED|Overall Study||43
604963|NCT00402324|1480489|P2|COMPLETED|Overall Study||60
604964|NCT00402324|1480490|P1|COMPLETED|Overall Study||58
604965|NCT00402324|1480489|P2|STARTED|Overall Study||101
604966|NCT00402324|1480490|P1|STARTED|Overall Study||101
604967|NCT00402285|1480523|P3|NOT COMPLETED|Overall Study||2
604968|NCT00402285|1480524|P2|NOT COMPLETED|Overall Study||6
604969|NCT00402285|1480525|P1|NOT COMPLETED|Overall Study||7
604970|NCT00402285|1480523|P3|COMPLETED|Overall Study||26
604971|NCT00402285|1480524|P2|COMPLETED|Overall Study||21
604972|NCT00402285|1480525|P1|COMPLETED|Overall Study||22
604973|NCT00402285|1480523|P3|STARTED|Overall Study||28
604974|NCT00402285|1480524|P2|STARTED|Overall Study||27
604975|NCT00402285|1480525|P1|STARTED|Overall Study||29
604976|NCT00402246|1480533|P2|NOT COMPLETED|Overall Study||234
604977|NCT00402246|1480534|P1|NOT COMPLETED|Overall Study||220
604978|NCT00402246|1480533|P2|COMPLETED|Overall Study||749
604979|NCT00402246|1480534|P1|COMPLETED|Overall Study||794
604980|NCT00402246|1480533|P2|STARTED|Overall Study||983
604981|NCT00402246|1480534|P1|STARTED|Overall Study||1014
604982|NCT00402233|1480568|P4|NOT COMPLETED|Overall Study||11
604983|NCT00402233|1480569|P3|NOT COMPLETED|Overall Study||11
604984|NCT00402233|1480570|P2|NOT COMPLETED|Overall Study||10
604985|NCT00402233|1480571|P1|NOT COMPLETED|Overall Study||5
604986|NCT00402233|1480568|P4|COMPLETED|Overall Study||62
604987|NCT00402233|1480569|P3|COMPLETED|Overall Study||70
604988|NCT00402233|1480570|P2|COMPLETED|Overall Study||70
604989|NCT00402233|1480571|P1|COMPLETED|Overall Study||72
604990|NCT00402233|1480568|P4|STARTED|Overall Study||73
604991|NCT00402233|1480569|P3|STARTED|Overall Study||81
604992|NCT00402233|1480570|P2|STARTED|Overall Study||80
604993|NCT00402233|1480571|P1|STARTED|Overall Study||77
604994|NCT00402194|1480595|P2|NOT COMPLETED|Overall Study||0
604995|NCT00402194|1480596|P1|NOT COMPLETED|Overall Study||0
604996|NCT00402194|1480595|P2|COMPLETED|Overall Study||8
604997|NCT00402194|1480596|P1|COMPLETED|Overall Study||9
604998|NCT00402194|1480595|P2|STARTED|Overall Study||8
604999|NCT00402194|1480596|P1|STARTED|Overall Study||9
605000|NCT00402168|1480606|P2|NOT COMPLETED|Switched From CNI to Belatacept in LT||0
605001|NCT00402168|1480607|P1|NOT COMPLETED|Switched From CNI to Belatacept in LT||6
605002|NCT00402168|1480606|P2|COMPLETED|Switched From CNI to Belatacept in LT||0
605003|NCT00402168|1480607|P1|COMPLETED|Switched From CNI to Belatacept in LT||32
605004|NCT00402168|1480606|P2|STARTED|Switched From CNI to Belatacept in LT|Out of 81 starting LT period in CNI group, 38 switched from CNI to Belatacept during the LT period.|0
605005|NCT00402168|1480607|P1|STARTED|Switched From CNI to Belatacept in LT|Participants switched from CNI to Belatacept during LT period.|38
605006|NCT00402168|1480606|P2|NOT COMPLETED|Long Term (LT)||17
605007|NCT00402168|1480607|P1|NOT COMPLETED|Long Term (LT)||11
605008|NCT00402168|1480606|P2|COMPLETED|Long Term (LT)||64
605009|NCT00402168|1480607|P1|COMPLETED|Long Term (LT)||70
605010|NCT00402168|1480606|P2|STARTED|Long Term (LT)|5 completed 12 months, did not enter long term: 1 AE, 1 lack of efficacy, 3 other(non-specified).|81
605011|NCT00402168|1480607|P1|STARTED|Long Term (LT)||81
605012|NCT00402168|1480606|P2|NOT COMPLETED|Treatment (up to 12 Months)||2
605013|NCT00402168|1480607|P1|NOT COMPLETED|Treatment (up to 12 Months)||2
605014|NCT00402168|1480606|P2|COMPLETED|Treatment (up to 12 Months)||86
605015|NCT00402168|1480607|P1|COMPLETED|Treatment (up to 12 Months)||81
605016|NCT00402168|1480606|P2|STARTED|Treatment (up to 12 Months)||88
605017|NCT00402168|1480607|P1|STARTED|Treatment (up to 12 Months)||83
605018|NCT00402168|1480606|P2|NOT COMPLETED|Randomized||1
605019|NCT00402168|1480607|P1|NOT COMPLETED|Randomized||1
605020|NCT00402168|1480606|P2|COMPLETED|Randomized||88
605021|NCT00402168|1480607|P1|COMPLETED|Randomized||83
605022|NCT00402168|1480606|P2|STARTED|Randomized||89
605023|NCT00402168|1480607|P1|STARTED|Randomized||84
605024|NCT00402103|1480664|P2|NOT COMPLETED|Overall Study||13
605025|NCT00402103|1480665|P1|NOT COMPLETED|Overall Study||91
605026|NCT00402103|1480664|P2|COMPLETED|Overall Study||73
605027|NCT00402103|1480665|P1|COMPLETED|Overall Study||379
605028|NCT00402103|1480664|P2|STARTED|Overall Study||86
605029|NCT00402103|1480665|P1|STARTED|Overall Study||470
605030|NCT00402051|1480681|P2|NOT COMPLETED|Overall Study||35
605031|NCT00402051|1480682|P1|NOT COMPLETED|Overall Study||38
605032|NCT00402051|1480681|P2|COMPLETED|Overall Study|Completed 6 treatment cycles and 30 days of follow-up after last dose of study drug|32
605033|NCT00402051|1480682|P1|COMPLETED|Overall Study|Completed 6 treatment cycles and 30 days of follow-up after last dose of study drug|28
605034|NCT00402051|1480681|P2|Received Treatment|Overall Study||65
605035|NCT00402051|1480682|P1|Received Treatment|Overall Study||65
605036|NCT00402051|1480681|P2|STARTED|Overall Study||67
605037|NCT00402051|1480682|P1|STARTED|Overall Study||66
605038|NCT00402025|1480699|P3|NOT COMPLETED|Overall Study||10
605039|NCT00402025|1480700|P2|NOT COMPLETED|Overall Study||3
605040|NCT00402025|1480701|P1|NOT COMPLETED|Overall Study||2
605041|NCT00402025|1480699|P3|COMPLETED|Overall Study||0
605042|NCT00402025|1480700|P2|COMPLETED|Overall Study||1
605043|NCT00402025|1480701|P1|COMPLETED|Overall Study||1
605044|NCT00402025|1480699|P3|STARTED|Overall Study||10
605045|NCT00402025|1480700|P2|STARTED|Overall Study||4
605046|NCT00402025|1480701|P1|STARTED|Overall Study||3
605047|NCT00401973|1480727|P3|NOT COMPLETED|Overall Study||23
605048|NCT00401973|1480728|P2|NOT COMPLETED|Overall Study||26
605049|NCT00401973|1480729|P1|NOT COMPLETED|Overall Study||11
605050|NCT00401973|1480727|P3|COMPLETED|Overall Study||50
605051|NCT00401973|1480728|P2|COMPLETED|Overall Study||50
605052|NCT00401973|1480729|P1|COMPLETED|Overall Study||39
605053|NCT00401973|1480727|P3|STARTED|Overall Study||73
605054|NCT00401973|1480728|P2|STARTED|Overall Study||76
605055|NCT00401973|1480729|P1|STARTED|Overall Study||50
605056|NCT00401960|1480768|P2|NOT COMPLETED|Overall Study||0
605057|NCT00401960|1480769|P1|NOT COMPLETED|Overall Study||5
605058|NCT00401960|1480768|P2|COMPLETED|Overall Study||1
605059|NCT00401960|1480769|P1|COMPLETED|Overall Study||0
605060|NCT00401960|1480768|P2|STARTED|Overall Study||1
605061|NCT00401960|1480769|P1|STARTED|Overall Study||5
605062|NCT00401882|1480779|P2|NOT COMPLETED|Overall Study||0
605063|NCT00401882|1480780|P1|NOT COMPLETED|Overall Study||0
605064|NCT00401882|1480779|P2|COMPLETED|Overall Study||5
605065|NCT00401882|1480780|P1|COMPLETED|Overall Study||2
605066|NCT00401882|1480779|P2|STARTED|Overall Study||5
605067|NCT00401882|1480780|P1|STARTED|Overall Study||2
605068|NCT00401843|1480799|P3|NOT COMPLETED|Overall Study||142
605069|NCT00401843|1480800|P2|NOT COMPLETED|Overall Study||144
605070|NCT00401843|1480801|P1|NOT COMPLETED|Overall Study||21
605071|NCT00401843|1480799|P3|COMPLETED|Overall Study||0
605072|NCT00401843|1480800|P2|COMPLETED|Overall Study||0
605073|NCT00401843|1480801|P1|COMPLETED|Overall Study||0
605074|NCT00401843|1480799|P3|Treated|Overall Study||139
605075|NCT00401843|1480800|P2|Treated|Overall Study||142
605076|NCT00401843|1480801|P1|Treated|Overall Study||21
605077|NCT00401843|1480799|P3|STARTED|Overall Study||142
605078|NCT00401843|1480800|P2|STARTED|Overall Study||144
605079|NCT00401843|1480801|P1|STARTED|Overall Study||21
605080|NCT00401830|1480819|P2|NOT COMPLETED|Overall Study||32
605081|NCT00401830|1480820|P1|NOT COMPLETED|Overall Study||31
605082|NCT00401830|1480819|P2|COMPLETED|Overall Study||46
605083|NCT00401830|1480820|P1|COMPLETED|Overall Study||50
605084|NCT00401830|1480819|P2|STARTED|Overall Study||78
605085|NCT00401830|1480820|P1|STARTED|Overall Study||81
605086|NCT00401817|1480852|P1|NOT COMPLETED|Overall Study||0
605087|NCT00401817|1480852|P1|COMPLETED|Overall Study||11
605088|NCT00401817|1480852|P1|STARTED|Overall Study||11
605089|NCT00401778|1480862|P3|NOT COMPLETED|Overall Study||1
605090|NCT00401778|1480863|P2|NOT COMPLETED|Overall Study||1
605091|NCT00401778|1480864|P1|NOT COMPLETED|Overall Study||1
605092|NCT00401778|1480862|P3|COMPLETED|Overall Study||10
605093|NCT00401778|1480863|P2|COMPLETED|Overall Study||11
605094|NCT00401778|1480864|P1|COMPLETED|Overall Study||9
605095|NCT00401778|1480862|P3|STARTED|Overall Study||11
605096|NCT00401778|1480863|P2|STARTED|Overall Study||12
605097|NCT00401778|1480864|P1|STARTED|Overall Study||10
605098|NCT00401752|1480878|P2|NOT COMPLETED|Overall Study||18
605099|NCT00401752|1480879|P1|NOT COMPLETED|Overall Study||10
605100|NCT00401752|1480878|P2|COMPLETED|Overall Study||94
605101|NCT00401752|1480879|P1|COMPLETED|Overall Study||97
605102|NCT00401752|1480878|P2|Patients Included in Per-Protocol Popula|Overall Study||99
605103|NCT00401752|1480879|P1|Patients Included in Per-Protocol Popula|Overall Study||100
605104|NCT00401752|1480878|P2|Patients Included in Safety Population|Overall Study||110
605105|NCT00401752|1480879|P1|Patients Included in Safety Population|Overall Study||107
605106|NCT00401752|1480878|P2|Patients Included in ITT Population|Overall Study||111
605107|NCT00401752|1480879|P1|Patients Included in ITT Population|Overall Study||106
605108|NCT00401752|1480878|P2|Number of Patients Received Treatment|Overall Study||111
605109|NCT00401752|1480879|P1|Number of Patients Received Treatment|Overall Study||107
605110|NCT00401752|1480878|P2|STARTED|Overall Study||112
605111|NCT00401752|1480879|P1|STARTED|Overall Study||107
605112|NCT00401726|1480897|P2|NOT COMPLETED|Overall Study||112
605113|NCT00401726|1480898|P1|NOT COMPLETED|Overall Study||97
605114|NCT00401726|1480897|P2|COMPLETED|Overall Study||156
605115|NCT00401726|1480898|P1|COMPLETED|Overall Study||172
605116|NCT00401726|1480897|P2|STARTED|Overall Study||268
605117|NCT00401726|1480898|P1|STARTED|Overall Study||269
605118|NCT00401622|1480920|P2|NOT COMPLETED|Overall Study||43
605119|NCT00401622|1480921|P1|NOT COMPLETED|Overall Study||34
605120|NCT00401622|1480920|P2|COMPLETED|Overall Study||117
605121|NCT00401622|1480921|P1|COMPLETED|Overall Study||126
605122|NCT00401622|1480920|P2|STARTED|Overall Study||160
605123|NCT00401622|1480921|P1|STARTED|Overall Study||160
605124|NCT00401544|1480933|P4|NOT COMPLETED|Overall Study||16
605125|NCT00401544|1480934|P3|NOT COMPLETED|Overall Study||12
605126|NCT00401544|1480935|P2|NOT COMPLETED|Overall Study||18
605127|NCT00401544|1480936|P1|NOT COMPLETED|Overall Study||18
605128|NCT00401544|1480933|P4|COMPLETED|Overall Study||44
605129|NCT00401544|1480934|P3|COMPLETED|Overall Study||48
605130|NCT00401544|1480935|P2|COMPLETED|Overall Study||44
605131|NCT00401544|1480936|P1|COMPLETED|Overall Study||38
605132|NCT00401544|1480933|P4|STARTED|Overall Study|Randomized and treated|60
605133|NCT00401544|1480934|P3|STARTED|Overall Study|Randomized and treated|60
605134|NCT00401544|1480935|P2|STARTED|Overall Study|Randomized and treated|62
605135|NCT00401544|1480936|P1|STARTED|Overall Study|Randomized and treated|56
605136|NCT00401531|1480976|P2|NOT COMPLETED|Overall Study||10
605137|NCT00401531|1480977|P1|NOT COMPLETED|Overall Study||9
605138|NCT00401531|1480976|P2|COMPLETED|Overall Study||196
605139|NCT00401531|1480977|P1|COMPLETED|Overall Study||197
605140|NCT00401531|1480976|P2|STARTED|Overall Study||206
605141|NCT00401531|1480977|P1|STARTED|Overall Study||206
605142|NCT00401414|1480996|P3|NOT COMPLETED|Overall Study||0
605143|NCT00401414|1480997|P2|NOT COMPLETED|Overall Study||0
605144|NCT00401414|1480998|P1|NOT COMPLETED|Overall Study||0
605145|NCT00401414|1480996|P3|COMPLETED|Overall Study||79
605146|NCT00401414|1480997|P2|COMPLETED|Overall Study||147
605147|NCT00401414|1480998|P1|COMPLETED|Overall Study||118
605148|NCT00401414|1480996|P3|STARTED|Overall Study||79
605149|NCT00401414|1480997|P2|STARTED|Overall Study||147
605150|NCT00401414|1480998|P1|STARTED|Overall Study||118
605151|NCT00401401|1481022|P4|NOT COMPLETED|Overall Study||3
605152|NCT00401401|1481023|P3|NOT COMPLETED|Overall Study||1
605153|NCT00401401|1481024|P2|NOT COMPLETED|Overall Study||0
605154|NCT00401401|1481025|P1|NOT COMPLETED|Overall Study||0
605155|NCT00401401|1481022|P4|COMPLETED|Overall Study||9
605156|NCT00401401|1481023|P3|COMPLETED|Overall Study||5
605157|NCT00401401|1481024|P2|COMPLETED|Overall Study||6
605158|NCT00401401|1481025|P1|COMPLETED|Overall Study||6
605159|NCT00401401|1481022|P4|STARTED|Overall Study||12
605160|NCT00401401|1481023|P3|STARTED|Overall Study||6
605161|NCT00401401|1481024|P2|STARTED|Overall Study||6
605162|NCT00401401|1481025|P1|STARTED|Overall Study||6
605163|NCT00401258|1481047|P1|NOT COMPLETED|Overall Study||7
605164|NCT00401258|1481047|P1|COMPLETED|Overall Study||8
605165|NCT00401258|1481047|P1|STARTED|Overall Study||15
605166|NCT00401245|1481062|P8|NOT COMPLETED|Double Blind Tapering Phase||7
605167|NCT00401245|1481063|P7|NOT COMPLETED|Double Blind Tapering Phase||7
605168|NCT00401245|1481064|P6|NOT COMPLETED|Double Blind Tapering Phase||4
605169|NCT00401245|1481065|P5|NOT COMPLETED|Double Blind Tapering Phase||4
605170|NCT00401245|1481066|P4|NOT COMPLETED|Double Blind Tapering Phase||0
605171|NCT00401245|1481067|P3|NOT COMPLETED|Double Blind Tapering Phase||0
605172|NCT00401245|1481068|P2|NOT COMPLETED|Double Blind Tapering Phase||0
605173|NCT00401245|1481069|P1|NOT COMPLETED|Double Blind Tapering Phase||0
605174|NCT00401245|1481062|P8|COMPLETED|Double Blind Tapering Phase||95
605175|NCT00401245|1481063|P7|COMPLETED|Double Blind Tapering Phase||80
605176|NCT00401245|1481064|P6|COMPLETED|Double Blind Tapering Phase||90
605177|NCT00401245|1481065|P5|COMPLETED|Double Blind Tapering Phase||97
605178|NCT00401245|1481066|P4|COMPLETED|Double Blind Tapering Phase||0
605179|NCT00401245|1481067|P3|COMPLETED|Double Blind Tapering Phase||0
605180|NCT00401245|1481068|P2|COMPLETED|Double Blind Tapering Phase||0
605181|NCT00401245|1481069|P1|COMPLETED|Double Blind Tapering Phase||0
605182|NCT00401245|1481062|P8|STARTED|Double Blind Tapering Phase||102
605183|NCT00401245|1481063|P7|STARTED|Double Blind Tapering Phase||87
605184|NCT00401245|1481064|P6|STARTED|Double Blind Tapering Phase||94
605185|NCT00401245|1481065|P5|STARTED|Double Blind Tapering Phase||101
605186|NCT00401245|1481066|P4|STARTED|Double Blind Tapering Phase||0
605187|NCT00401245|1481067|P3|STARTED|Double Blind Tapering Phase||0
605188|NCT00401245|1481068|P2|STARTED|Double Blind Tapering Phase||0
605189|NCT00401245|1481069|P1|STARTED|Double Blind Tapering Phase||0
605190|NCT00401245|1481062|P8|NOT COMPLETED|Open Label Phase||0
605191|NCT00401245|1481063|P7|NOT COMPLETED|Open Label Phase||0
605192|NCT00401245|1481064|P6|NOT COMPLETED|Open Label Phase||0
605193|NCT00401245|1481065|P5|NOT COMPLETED|Open Label Phase||0
605194|NCT00401245|1481066|P4|NOT COMPLETED|Open Label Phase||21
605195|NCT00401245|1481067|P3|NOT COMPLETED|Open Label Phase||23
605196|NCT00401245|1481068|P2|NOT COMPLETED|Open Label Phase||35
605197|NCT00401245|1481069|P1|NOT COMPLETED|Open Label Phase||21
605198|NCT00401245|1481062|P8|COMPLETED|Open Label Phase||0
605199|NCT00401245|1481063|P7|COMPLETED|Open Label Phase||0
605200|NCT00401245|1481064|P6|COMPLETED|Open Label Phase||0
605201|NCT00401245|1481065|P5|COMPLETED|Open Label Phase||0
605202|NCT00401245|1481066|P4|COMPLETED|Open Label Phase||84
605203|NCT00401245|1481067|P3|COMPLETED|Open Label Phase||95
605204|NCT00401245|1481068|P2|COMPLETED|Open Label Phase||81
605205|NCT00401245|1481069|P1|COMPLETED|Open Label Phase||101
605206|NCT00401245|1481062|P8|STARTED|Open Label Phase||0
605207|NCT00401245|1481063|P7|STARTED|Open Label Phase||0
605208|NCT00401245|1481064|P6|STARTED|Open Label Phase||0
605209|NCT00401245|1481065|P5|STARTED|Open Label Phase||0
605210|NCT00401245|1481066|P4|STARTED|Open Label Phase||105
605211|NCT00401245|1481067|P3|STARTED|Open Label Phase||118
605212|NCT00401245|1481068|P2|STARTED|Open Label Phase||116
605213|NCT00401245|1481069|P1|STARTED|Open Label Phase||122
605214|NCT00401245|1481062|P8|NOT COMPLETED|Between Titration and Open Label Phase||0
605215|NCT00401245|1481063|P7|NOT COMPLETED|Between Titration and Open Label Phase||0
605216|NCT00401245|1481064|P6|NOT COMPLETED|Between Titration and Open Label Phase||0
605217|NCT00401245|1481065|P5|NOT COMPLETED|Between Titration and Open Label Phase||0
605218|NCT00401245|1481066|P4|NOT COMPLETED|Between Titration and Open Label Phase||2
605219|NCT00401245|1481067|P3|NOT COMPLETED|Between Titration and Open Label Phase||0
605220|NCT00401245|1481068|P2|NOT COMPLETED|Between Titration and Open Label Phase||2
605221|NCT00401245|1481069|P1|NOT COMPLETED|Between Titration and Open Label Phase||0
605222|NCT00401245|1481062|P8|COMPLETED|Between Titration and Open Label Phase||0
605223|NCT00401245|1481063|P7|COMPLETED|Between Titration and Open Label Phase||0
605224|NCT00401245|1481064|P6|COMPLETED|Between Titration and Open Label Phase||0
605225|NCT00401245|1481065|P5|COMPLETED|Between Titration and Open Label Phase||0
605226|NCT00401245|1481066|P4|COMPLETED|Between Titration and Open Label Phase||105
605227|NCT00401245|1481067|P3|COMPLETED|Between Titration and Open Label Phase||118
605228|NCT00401245|1481068|P2|COMPLETED|Between Titration and Open Label Phase||116
605229|NCT00401245|1481069|P1|COMPLETED|Between Titration and Open Label Phase||122
605230|NCT00401245|1481062|P8|STARTED|Between Titration and Open Label Phase||0
605231|NCT00401245|1481063|P7|STARTED|Between Titration and Open Label Phase||0
605232|NCT00401245|1481064|P6|STARTED|Between Titration and Open Label Phase||0
605233|NCT00401245|1481065|P5|STARTED|Between Titration and Open Label Phase||0
605234|NCT00401245|1481066|P4|STARTED|Between Titration and Open Label Phase||107
605235|NCT00401245|1481067|P3|STARTED|Between Titration and Open Label Phase||118
605236|NCT00401245|1481068|P2|STARTED|Between Titration and Open Label Phase||118
605237|NCT00401245|1481069|P1|STARTED|Between Titration and Open Label Phase||122
605238|NCT00401245|1481062|P8|NOT COMPLETED|Double Blind Titration Phase||0
605239|NCT00401245|1481063|P7|NOT COMPLETED|Double Blind Titration Phase||0
605240|NCT00401245|1481064|P6|NOT COMPLETED|Double Blind Titration Phase||0
605241|NCT00401245|1481065|P5|NOT COMPLETED|Double Blind Titration Phase||0
605242|NCT00401245|1481066|P4|NOT COMPLETED|Double Blind Titration Phase||15
605243|NCT00401245|1481067|P3|NOT COMPLETED|Double Blind Titration Phase||6
605244|NCT00401245|1481068|P2|NOT COMPLETED|Double Blind Titration Phase||3
605245|NCT00401245|1481069|P1|NOT COMPLETED|Double Blind Titration Phase||4
605246|NCT00401245|1481062|P8|COMPLETED|Double Blind Titration Phase||0
605247|NCT00401245|1481063|P7|COMPLETED|Double Blind Titration Phase||0
605248|NCT00401245|1481064|P6|COMPLETED|Double Blind Titration Phase||0
605249|NCT00401245|1481065|P5|COMPLETED|Double Blind Titration Phase||0
605250|NCT00401245|1481066|P4|COMPLETED|Double Blind Titration Phase||107
605251|NCT00401245|1481067|P3|COMPLETED|Double Blind Titration Phase||118
605252|NCT00401245|1481068|P2|COMPLETED|Double Blind Titration Phase||118
605253|NCT00401245|1481069|P1|COMPLETED|Double Blind Titration Phase||122
605254|NCT00401245|1481062|P8|STARTED|Double Blind Titration Phase||0
605255|NCT00401245|1481063|P7|STARTED|Double Blind Titration Phase||0
605256|NCT00401245|1481064|P6|STARTED|Double Blind Titration Phase||0
605257|NCT00401245|1481065|P5|STARTED|Double Blind Titration Phase||0
605258|NCT00401245|1481066|P4|STARTED|Double Blind Titration Phase||122
605259|NCT00401245|1481067|P3|STARTED|Double Blind Titration Phase||124
605260|NCT00401245|1481068|P2|STARTED|Double Blind Titration Phase||121
605261|NCT00401245|1481069|P1|STARTED|Double Blind Titration Phase||126
605262|NCT00401193|1481137|P3|NOT COMPLETED|Overall Study||6
605263|NCT00401193|1481138|P2|NOT COMPLETED|Overall Study||11
605264|NCT00401193|1481139|P1|NOT COMPLETED|Overall Study||15
605265|NCT00401193|1481137|P3|COMPLETED|Overall Study||63
605266|NCT00401193|1481138|P2|COMPLETED|Overall Study||106
605267|NCT00401193|1481139|P1|COMPLETED|Overall Study||103
605268|NCT00401193|1481137|P3|Modified Intent to Treat Population|Overall Study||67
605269|NCT00401193|1481138|P2|Modified Intent to Treat Population|Overall Study||115
605270|NCT00401193|1481139|P1|Modified Intent to Treat Population|Overall Study||112
605271|NCT00401193|1481137|P3|Intent to Treat Population|Overall Study||67
605272|NCT00401193|1481138|P2|Intent to Treat Population|Overall Study||115
605273|NCT00401193|1481139|P1|Intent to Treat Population|Overall Study||115
605274|NCT00401193|1481137|P3|STARTED|Overall Study||69
605275|NCT00401193|1481138|P2|STARTED|Overall Study||117
605276|NCT00401193|1481139|P1|STARTED|Overall Study||118
605277|NCT00401102|1481153|P1|NOT COMPLETED|Overall Study||7
605278|NCT00401102|1481153|P1|COMPLETED|Overall Study||5
605279|NCT00401102|1481153|P1|STARTED|Overall Study||12
605280|NCT00400946|1481162|P5|NOT COMPLETED|Overall Study||38
605281|NCT00400946|1481163|P4|NOT COMPLETED|Overall Study||47
605282|NCT00400946|1481164|P3|NOT COMPLETED|Overall Study||2
605283|NCT00400946|1481165|P2|NOT COMPLETED|Overall Study||11
605284|NCT00400946|1481166|P1|NOT COMPLETED|Overall Study||14
605285|NCT00400946|1481162|P5|COMPLETED|Overall Study||206
605286|NCT00400946|1481163|P4|COMPLETED|Overall Study||4
605287|NCT00400946|1481164|P3|COMPLETED|Overall Study||40
605288|NCT00400946|1481165|P2|COMPLETED|Overall Study||221
605289|NCT00400946|1481166|P1|COMPLETED|Overall Study||217
605290|NCT00400946|1481162|P5|Eligible and Treated|Overall Study||243
605291|NCT00400946|1481163|P4|Eligible and Treated|Overall Study||46
605292|NCT00400946|1481164|P3|Eligible and Treated|Overall Study||42
605293|NCT00400946|1481165|P2|Eligible and Treated|Overall Study||232
605294|NCT00400946|1481166|P1|Eligible and Treated|Overall Study||231
605295|NCT00400946|1481162|P5|Evaluable for Day 32 MRD|Overall Study||168
605296|NCT00400946|1481163|P4|Evaluable for Day 32 MRD|Overall Study||12
605297|NCT00400946|1481164|P3|Evaluable for Day 32 MRD|Overall Study||33
605298|NCT00400946|1481165|P2|Evaluable for Day 32 MRD|Overall Study||167
605299|NCT00400946|1481166|P1|Evaluable for Day 32 MRD|Overall Study||166
605300|NCT00400946|1481162|P5|Evaluable for Day 18 Marrow Morphology|Overall Study||152
605301|NCT00400946|1481163|P4|Evaluable for Day 18 Marrow Morphology|Overall Study||13
605302|NCT00400946|1481164|P3|Evaluable for Day 18 Marrow Morphology|Overall Study||19
605303|NCT00400946|1481165|P2|Evaluable for Day 18 Marrow Morphology|Overall Study||161
605304|NCT00400946|1481166|P1|Evaluable for Day 18 Marrow Morphology|Overall Study||158
605305|NCT00400946|1481162|P5|Evaluable for CNS Directed-Treatment|Overall Study||227
605306|NCT00400946|1481163|P4|Evaluable for CNS Directed-Treatment|Overall Study||21
605307|NCT00400946|1481164|P3|Evaluable for CNS Directed-Treatment|Overall Study||42
605308|NCT00400946|1481165|P2|Evaluable for CNS Directed-Treatment|Overall Study||232
605309|NCT00400946|1481166|P1|Evaluable for CNS Directed-Treatment|Overall Study||231
605310|NCT00400946|1481162|P5|STARTED|Overall Study||244
605311|NCT00400946|1481163|P4|STARTED|Overall Study||51
605312|NCT00400946|1481164|P3|STARTED|Overall Study||42
605313|NCT00400946|1481165|P2|STARTED|Overall Study||232
605314|NCT00400946|1481166|P1|STARTED|Overall Study||231
605315|NCT00400881|1481194|P2|NOT COMPLETED|Overall Study||0
605316|NCT00400881|1481195|P1|NOT COMPLETED|Overall Study||0
605317|NCT00400881|1481194|P2|COMPLETED|Overall Study||60
605318|NCT00400881|1481195|P1|COMPLETED|Overall Study||62
605319|NCT00400881|1481194|P2|STARTED|Overall Study||60
605320|NCT00400881|1481195|P1|STARTED|Overall Study||62
605321|NCT00400829|1481203|P1|NOT COMPLETED|Overall Study||0
605322|NCT00400829|1481203|P1|COMPLETED|Overall Study||66
605323|NCT00400829|1481203|P1|STARTED|Overall Study||66
605324|NCT00400803|1481209|P1|NOT COMPLETED|Overall Study||0
605325|NCT00400803|1481209|P1|COMPLETED|Overall Study||35
605326|NCT00400803|1481209|P1|STARTED|Overall Study||35
605327|NCT00400764|1481225|P5|NOT COMPLETED|Phase II||11
605328|NCT00400764|1481226|P4|NOT COMPLETED|Phase II||26
605329|NCT00400764|1481227|P3|NOT COMPLETED|Phase II||23
605330|NCT00400764|1481228|P2|NOT COMPLETED|Phase II||0
605331|NCT00400764|1481229|P1|NOT COMPLETED|Phase II||0
605332|NCT00400764|1481225|P5|COMPLETED|Phase II||0
605333|NCT00400764|1481226|P4|COMPLETED|Phase II||0
605334|NCT00400764|1481227|P3|COMPLETED|Phase II||0
605335|NCT00400764|1481228|P2|COMPLETED|Phase II||0
605336|NCT00400764|1481229|P1|COMPLETED|Phase II||0
605337|NCT00400764|1481225|P5|Treated|Phase II||11
605338|NCT00400764|1481226|P4|Treated|Phase II||26
605339|NCT00400764|1481227|P3|Treated|Phase II|One patient in the Rituximab arm withdrew prior to treatment|22
605340|NCT00400764|1481228|P2|Treated|Phase II||0
605341|NCT00400764|1481229|P1|Treated|Phase II||0
605342|NCT00400764|1481225|P5|STARTED|Phase II||11
605343|NCT00400764|1481226|P4|STARTED|Phase II||26
605344|NCT00400764|1481227|P3|STARTED|Phase II||23
605345|NCT00400764|1481228|P2|STARTED|Phase II||0
605346|NCT00400764|1481229|P1|STARTED|Phase II||0
605347|NCT00400764|1481225|P5|NOT COMPLETED|Phase Ib||0
605348|NCT00400764|1481226|P4|NOT COMPLETED|Phase Ib||0
605349|NCT00400764|1481227|P3|NOT COMPLETED|Phase Ib||0
605350|NCT00400764|1481228|P2|NOT COMPLETED|Phase Ib||4
605351|NCT00400764|1481229|P1|NOT COMPLETED|Phase Ib||6
605352|NCT00400764|1481225|P5|COMPLETED|Phase Ib||0
605353|NCT00400764|1481226|P4|COMPLETED|Phase Ib||0
605354|NCT00400764|1481227|P3|COMPLETED|Phase Ib||0
605355|NCT00400764|1481228|P2|COMPLETED|Phase Ib||2
605356|NCT00400764|1481229|P1|COMPLETED|Phase Ib|One patient reported as discontinued due to an AE should have been reported as death.|0
605357|NCT00400764|1481225|P5|Treated|Phase Ib||0
605358|NCT00400764|1481226|P4|Treated|Phase Ib||0
605359|NCT00400764|1481227|P3|Treated|Phase Ib||0
605360|NCT00400764|1481228|P2|Treated|Phase Ib||6
605361|NCT00400764|1481229|P1|Treated|Phase Ib||6
605362|NCT00400764|1481225|P5|STARTED|Phase Ib||0
605363|NCT00400764|1481226|P4|STARTED|Phase Ib||0
605364|NCT00400764|1481227|P3|STARTED|Phase Ib||0
605365|NCT00400764|1481228|P2|STARTED|Phase Ib||6
605366|NCT00400764|1481229|P1|STARTED|Phase Ib||6
605367|NCT00400712|1481282|P2|NOT COMPLETED|Overall Study||16
605368|NCT00400712|1481283|P1|NOT COMPLETED|Overall Study||17
605369|NCT00400712|1481282|P2|COMPLETED|Overall Study||35
605370|NCT00400712|1481283|P1|COMPLETED|Overall Study||35
605371|NCT00400712|1481282|P2|STARTED|Overall Study||51
605372|NCT00400712|1481283|P1|STARTED|Overall Study||52
605373|NCT00400686|1481301|P1|NOT COMPLETED|Overall Study||0
605374|NCT00400686|1481301|P1|COMPLETED|Overall Study||31
605375|NCT00400686|1481301|P1|STARTED|Overall Study||31
605376|NCT00400634|1481309|P2|NOT COMPLETED|Overall Study||1
605377|NCT00400634|1481310|P1|NOT COMPLETED|Overall Study||4
605378|NCT00400634|1481309|P2|COMPLETED|Overall Study||19
605379|NCT00400634|1481310|P1|COMPLETED|Overall Study||34
605380|NCT00400634|1481309|P2|STARTED|Overall Study||20
605381|NCT00400634|1481310|P1|STARTED|Overall Study||38
605382|NCT00400569|1481318|P1|NOT COMPLETED|Overall Study||1
605383|NCT00400569|1481318|P1|COMPLETED|Overall Study||47
605384|NCT00400569|1481318|P1|STARTED|Overall Study||48
605385|NCT00400400|1481331|P2|NOT COMPLETED|Overall Study||15
605386|NCT00400400|1481332|P1|NOT COMPLETED|Overall Study||14
605387|NCT00400400|1481331|P2|COMPLETED|Overall Study||185
605388|NCT00400400|1481332|P1|COMPLETED|Overall Study||186
605389|NCT00400400|1481331|P2|Intent-to-Treat Population|Overall Study||197
605390|NCT00400400|1481332|P1|Intent-to-Treat Population|Overall Study|Participants who received study drug.|199
605391|NCT00400400|1481331|P2|STARTED|Overall Study||200
605392|NCT00400400|1481332|P1|STARTED|Overall Study||200
605393|NCT00400205|1481350|P1|NOT COMPLETED|Overall Study||5
605394|NCT00400205|1481350|P1|COMPLETED|Overall Study||9
605395|NCT00400205|1481350|P1|STARTED|Overall Study||14
605396|NCT00400179|1481357|P2|NOT COMPLETED|Overall Study||18
605397|NCT00400179|1481358|P1|NOT COMPLETED|Overall Study||6
605398|NCT00400179|1481357|P2|COMPLETED|Overall Study||508
605399|NCT00400179|1481358|P1|COMPLETED|Overall Study|Received Treatment|521
605400|NCT00400179|1481357|P2|STARTED|Overall Study||526
605401|NCT00400179|1481358|P1|STARTED|Overall Study|Signed informed consent form and randomized|527
605402|NCT00400153|1481375|P3|NOT COMPLETED|Overall Study||61
605403|NCT00400153|1481376|P2|NOT COMPLETED|Overall Study||55
605404|NCT00400153|1481377|P1|NOT COMPLETED|Overall Study||48
605405|NCT00400153|1481375|P3|COMPLETED|Overall Study||422
605406|NCT00400153|1481376|P2|COMPLETED|Overall Study||436
605407|NCT00400153|1481377|P1|COMPLETED|Overall Study||438
605408|NCT00400153|1481375|P3|STARTED|Overall Study||483
605409|NCT00400153|1481376|P2|STARTED|Overall Study||491
605410|NCT00400153|1481377|P1|STARTED|Overall Study||486
605411|NCT00399893|1481624|P2|NOT COMPLETED|Overall Study||0
605412|NCT00399893|1481625|P1|NOT COMPLETED|Overall Study||1
605413|NCT00399893|1481624|P2|COMPLETED|Overall Study||3
605414|NCT00399893|1481625|P1|COMPLETED|Overall Study|Participant withdrew after 3 months but was included in results|1
605415|NCT00399893|1481624|P2|STARTED|Overall Study||3
605416|NCT00399893|1481625|P1|STARTED|Overall Study||2
605417|NCT00399880|1481653|P2|NOT COMPLETED|Overall Study||0
605418|NCT00399880|1481654|P1|NOT COMPLETED|Overall Study||0
605419|NCT00399880|1481653|P2|COMPLETED|Overall Study||65
605420|NCT00399880|1481654|P1|COMPLETED|Overall Study||65
605421|NCT00399880|1481653|P2|STARTED|Overall Study||65
605422|NCT00399880|1481654|P1|STARTED|Overall Study||65
605423|NCT00399802|1481664|P2|NOT COMPLETED|Overall Study||3
605424|NCT00399802|1481665|P1|NOT COMPLETED|Overall Study||0
605425|NCT00399802|1481664|P2|COMPLETED|Overall Study||26
605426|NCT00399802|1481665|P1|COMPLETED|Overall Study||14
605427|NCT00399802|1481664|P2|STARTED|Overall Study||29
605428|NCT00399802|1481665|P1|STARTED|Overall Study||14
605429|NCT00399763|1481679|P2|NOT COMPLETED|Overall Study||3
605430|NCT00399763|1481680|P1|NOT COMPLETED|Overall Study||2
605431|NCT00399763|1481679|P2|COMPLETED|Overall Study||32
605432|NCT00399763|1481680|P1|COMPLETED|Overall Study||33
605433|NCT00399763|1481679|P2|STARTED|Overall Study||35
605434|NCT00399763|1481680|P1|STARTED|Overall Study||35
605435|NCT00399568|1481692|P2|NOT COMPLETED|Overall Study||9
605436|NCT00399568|1481693|P1|NOT COMPLETED|Overall Study||12
605437|NCT00399568|1481692|P2|COMPLETED|Overall Study||156
605438|NCT00399568|1481693|P1|COMPLETED|Overall Study||154
605439|NCT00399568|1481692|P2|STARTED|Overall Study||165
605440|NCT00399568|1481693|P1|STARTED|Overall Study||166
605441|NCT00399542|1481707|P2|NOT COMPLETED|Overall Study||43
605442|NCT00399542|1481708|P1|NOT COMPLETED|Overall Study||84
605443|NCT00399542|1481707|P2|COMPLETED|Overall Study||151
605444|NCT00399542|1481708|P1|COMPLETED|Overall Study||303
605445|NCT00399542|1481707|P2|STARTED|Overall Study||194
605446|NCT00399542|1481708|P1|STARTED|Overall Study||387
605447|NCT00399516|1481770|P1|NOT COMPLETED|Overall Study||2
605448|NCT00399516|1481770|P1|COMPLETED|Overall Study||19
605449|NCT00399516|1481770|P1|STARTED|Overall Study||21
605450|NCT00399360|1481778|P4|NOT COMPLETED|Overall Study||6
605451|NCT00399360|1481779|P3|NOT COMPLETED|Overall Study||3
605452|NCT00399360|1481780|P2|NOT COMPLETED|Overall Study||3
605453|NCT00399360|1481781|P1|NOT COMPLETED|Overall Study||2
605454|NCT00399360|1481778|P4|COMPLETED|Overall Study||9
605455|NCT00399360|1481779|P3|COMPLETED|Overall Study||10
605456|NCT00399360|1481780|P2|COMPLETED|Overall Study||8
605457|NCT00399360|1481781|P1|COMPLETED|Overall Study||9
605458|NCT00399360|1481778|P4|STARTED|Overall Study||15
605459|NCT00399360|1481779|P3|STARTED|Overall Study||13
605460|NCT00399360|1481780|P2|STARTED|Overall Study||11
605461|NCT00399360|1481781|P1|STARTED|Overall Study||11
605462|NCT00399308|1481830|P3|NOT COMPLETED|Overall Study||1
605463|NCT00399308|1481831|P2|NOT COMPLETED|Overall Study||0
605464|NCT00399308|1481832|P1|NOT COMPLETED|Overall Study||0
605465|NCT00399308|1481830|P3|COMPLETED|Overall Study|One patient withdrew: did not want to comply with study requirements|11
605466|NCT00399308|1481831|P2|COMPLETED|Overall Study||15
605467|NCT00399308|1481832|P1|COMPLETED|Overall Study||13
605468|NCT00399308|1481830|P3|STARTED|Overall Study||12
605469|NCT00399308|1481831|P2|STARTED|Overall Study||15
605470|NCT00399308|1481832|P1|STARTED|Overall Study||13
605471|NCT00399035|1481852|P3|NOT COMPLETED|Overall Study||252
605472|NCT00399035|1481853|P2|NOT COMPLETED|Overall Study||158
605473|NCT00399035|1481854|P1|NOT COMPLETED|Overall Study||313
605474|NCT00399035|1481852|P3|COMPLETED|Overall Study||106
605475|NCT00399035|1481853|P2|COMPLETED|Overall Study||58
605476|NCT00399035|1481854|P1|COMPLETED|Overall Study||189
605477|NCT00399035|1481852|P3|STARTED|Overall Study||358
605478|NCT00399035|1481853|P2|STARTED|Overall Study||216
605479|NCT00399035|1481854|P1|STARTED|Overall Study||502
605480|NCT00398983|1481875|P2|NOT COMPLETED|Overall Study||0
605481|NCT00398983|1481876|P1|NOT COMPLETED|Overall Study||0
605482|NCT00398983|1481875|P2|COMPLETED|Overall Study||25
605483|NCT00398983|1481876|P1|COMPLETED|Overall Study||20
605484|NCT00398983|1481875|P2|STARTED|Overall Study||25
605485|NCT00398983|1481876|P1|STARTED|Overall Study||20
605486|NCT00398918|1481882|P1|NOT COMPLETED|Overall Study||0
605487|NCT00398918|1481882|P1|COMPLETED|Overall Study||10
605488|NCT00398918|1481882|P1|STARTED|Overall Study||10
605489|NCT00398866|1481890|P3|NOT COMPLETED|Overall Study||8
605490|NCT00398866|1481891|P2|NOT COMPLETED|Overall Study||8
605491|NCT00398866|1481892|P1|NOT COMPLETED|Overall Study||14
605492|NCT00398866|1481890|P3|COMPLETED|Overall Study||58
605493|NCT00398866|1481891|P2|COMPLETED|Overall Study||60
605494|NCT00398866|1481892|P1|COMPLETED|Overall Study||52
605495|NCT00398866|1481890|P3|STARTED|Overall Study||66
605496|NCT00398866|1481891|P2|STARTED|Overall Study||68
605497|NCT00398866|1481892|P1|STARTED|Overall Study||66
605498|NCT00398632|1481903|P1|NOT COMPLETED|Overall Study||2
605499|NCT00398632|1481903|P1|COMPLETED|Overall Study|2/6 subjects withdrew at end of week 6; 1 for lack of efficacy, 1 because of time constraints.|4
605500|NCT00398632|1481903|P1|STARTED|Overall Study||6
605501|NCT00398567|1481911|P3|NOT COMPLETED|Overall Study||34
605502|NCT00398567|1481912|P2|NOT COMPLETED|Overall Study||4
605503|NCT00398567|1481913|P1|NOT COMPLETED|Overall Study||4
605504|NCT00398567|1481911|P3|COMPLETED|Overall Study||3
605505|NCT00398567|1481912|P2|COMPLETED|Overall Study||0
605506|NCT00398567|1481913|P1|COMPLETED|Overall Study||0
605507|NCT00398567|1481911|P3|STARTED|Overall Study||37
605508|NCT00398567|1481912|P2|STARTED|Overall Study||4
605509|NCT00398567|1481913|P1|STARTED|Overall Study||4
605510|NCT00398476|1481925|P2|NOT COMPLETED|Treatment Period 2||0
605511|NCT00398476|1481926|P1|NOT COMPLETED|Treatment Period 2||0
605512|NCT00398476|1481925|P2|COMPLETED|Treatment Period 2||64
605513|NCT00398476|1481926|P1|COMPLETED|Treatment Period 2||63
605514|NCT00398476|1481925|P2|STARTED|Treatment Period 2||64
605515|NCT00398476|1481926|P1|STARTED|Treatment Period 2||63
605516|NCT00398476|1481925|P2|NOT COMPLETED|Washout Period (20 Minutes)||0
605517|NCT00398476|1481926|P1|NOT COMPLETED|Washout Period (20 Minutes)||0
605518|NCT00398476|1481925|P2|COMPLETED|Washout Period (20 Minutes)||64
605519|NCT00398476|1481926|P1|COMPLETED|Washout Period (20 Minutes)||63
605520|NCT00398476|1481925|P2|STARTED|Washout Period (20 Minutes)||64
605521|NCT00398476|1481926|P1|STARTED|Washout Period (20 Minutes)||63
605522|NCT00398476|1481925|P2|NOT COMPLETED|Treatment Period 1||0
605523|NCT00398476|1481926|P1|NOT COMPLETED|Treatment Period 1||0
605524|NCT00398476|1481925|P2|COMPLETED|Treatment Period 1||64
605525|NCT00398476|1481926|P1|COMPLETED|Treatment Period 1||63
605526|NCT00398476|1481925|P2|STARTED|Treatment Period 1||64
605527|NCT00398476|1481926|P1|STARTED|Treatment Period 1||63
605528|NCT00398411|1481967|P2|NOT COMPLETED|Overall Study||1
605529|NCT00398411|1481968|P1|NOT COMPLETED|Overall Study||0
605530|NCT00398411|1481967|P2|COMPLETED|Overall Study||31
605531|NCT00398411|1481968|P1|COMPLETED|Overall Study||34
605532|NCT00398411|1481967|P2|STARTED|Overall Study||32
605533|NCT00398411|1481968|P1|STARTED|Overall Study||34
605534|NCT00398398|1481984|P1|NOT COMPLETED|Overall Study||0
605535|NCT00398398|1481984|P1|COMPLETED|Overall Study||44
605536|NCT00398398|1481984|P1|STARTED|Overall Study||44
605537|NCT00398320|1481991|P1|NOT COMPLETED|Overall Study||6
605538|NCT00398320|1481991|P1|COMPLETED|Overall Study||34
605539|NCT00398320|1481991|P1|STARTED|Overall Study||40
605540|NCT00398216|1482004|P5|NOT COMPLETED|Overall Study||15
605541|NCT00398216|1482005|P4|NOT COMPLETED|Overall Study||22
605542|NCT00398216|1482006|P3|NOT COMPLETED|Overall Study||21
605543|NCT00398216|1482007|P2|NOT COMPLETED|Overall Study||19
605544|NCT00398216|1482008|P1|NOT COMPLETED|Overall Study||11
605545|NCT00398216|1482004|P5|COMPLETED|Overall Study||157
605546|NCT00398216|1482005|P4|COMPLETED|Overall Study||155
605547|NCT00398216|1482006|P3|COMPLETED|Overall Study||164
605548|NCT00398216|1482007|P2|COMPLETED|Overall Study||151
605549|NCT00398216|1482008|P1|COMPLETED|Overall Study||181
605550|NCT00398216|1482004|P5|STARTED|Overall Study||172
605551|NCT00398216|1482005|P4|STARTED|Overall Study||177
605552|NCT00398216|1482006|P3|STARTED|Overall Study||185
605553|NCT00398216|1482007|P2|STARTED|Overall Study||170
605554|NCT00398216|1482008|P1|STARTED|Overall Study||192
605555|NCT00398138|1482035|P1|NOT COMPLETED|Overall Study||2
605556|NCT00398138|1482035|P1|COMPLETED|Overall Study||10
605557|NCT00398138|1482035|P1|STARTED|Overall Study||12
605558|NCT00398112|1482040|P1|NOT COMPLETED|Overall Study||18
605559|NCT00398112|1482040|P1|COMPLETED|Overall Study||0
605560|NCT00398112|1482040|P1|STARTED|Overall Study||18
605561|NCT00398086|1482051|P3|NOT COMPLETED|Overall Study||2
605562|NCT00398086|1482052|P2|NOT COMPLETED|Overall Study||23
605563|NCT00398086|1482053|P1|NOT COMPLETED|Overall Study||9
605656|NCT00397215|1482334|P3|COMPLETED|Month 24 (Day 720)||117
605564|NCT00398086|1482051|P3|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|1
605565|NCT00398086|1482052|P2|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|21
605566|NCT00398086|1482053|P1|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|11
605567|NCT00398086|1482051|P3|Phase 1, Dose Escalation Population|Overall Study||3
605568|NCT00398086|1482052|P2|Phase 1, Dose Escalation Population|Overall Study||7
605569|NCT00398086|1482053|P1|Phase 1, Dose Escalation Population|Overall Study||20
605570|NCT00398086|1482051|P3|STARTED|Overall Study||3
605571|NCT00398086|1482052|P2|STARTED|Overall Study||44
605572|NCT00398086|1482053|P1|STARTED|Overall Study||20
605573|NCT00398073|1482087|P2|NOT COMPLETED|Overall Study||0
605574|NCT00398073|1482088|P1|NOT COMPLETED|Overall Study||1
605575|NCT00398073|1482087|P2|COMPLETED|Overall Study||17
605576|NCT00398073|1482088|P1|COMPLETED|Overall Study||17
605577|NCT00398073|1482087|P2|STARTED|Overall Study||17
605578|NCT00398073|1482088|P1|STARTED|Overall Study||18
605579|NCT00398047|1482098|P1|NOT COMPLETED|Overall Study||3
605580|NCT00398047|1482098|P1|COMPLETED|Overall Study|all three patients progressed before completing|0
605581|NCT00398047|1482098|P1|STARTED|Overall Study||3
605582|NCT00397982|1482108|P1|NOT COMPLETED|Overall Study||4
605583|NCT00397982|1482108|P1|COMPLETED|Overall Study||13
605584|NCT00397982|1482108|P1|STARTED|Overall Study||17
605585|NCT00397930|1482119|P2|NOT COMPLETED|Overall Study||51
605586|NCT00397930|1482120|P1|NOT COMPLETED|Overall Study||38
605587|NCT00397930|1482119|P2|COMPLETED|Overall Study||153
605588|NCT00397930|1482120|P1|COMPLETED|Overall Study||168
605589|NCT00397930|1482119|P2|STARTED|Overall Study||204
605590|NCT00397930|1482120|P1|STARTED|Overall Study||206
605591|NCT00397904|1482126|P1|NOT COMPLETED|Overall Study||0
605592|NCT00397904|1482126|P1|COMPLETED|Overall Study||16
605593|NCT00397904|1482126|P1|STARTED|Overall Study||16
605594|NCT00397891|1482135|P5|NOT COMPLETED|Overall Study||1
605595|NCT00397891|1482136|P4|NOT COMPLETED|Overall Study||0
605596|NCT00397891|1482137|P3|NOT COMPLETED|Overall Study||0
605597|NCT00397891|1482138|P2|NOT COMPLETED|Overall Study||0
605598|NCT00397891|1482139|P1|NOT COMPLETED|Overall Study||1
605599|NCT00397891|1482135|P5|COMPLETED|Overall Study||7
605600|NCT00397891|1482136|P4|COMPLETED|Overall Study||6
605601|NCT00397891|1482137|P3|COMPLETED|Overall Study||6
605602|NCT00397891|1482138|P2|COMPLETED|Overall Study||6
605603|NCT00397891|1482139|P1|COMPLETED|Overall Study||5
605604|NCT00397891|1482135|P5|STARTED|Overall Study||8
605605|NCT00397891|1482136|P4|STARTED|Overall Study||6
605606|NCT00397891|1482137|P3|STARTED|Overall Study||6
605607|NCT00397891|1482138|P2|STARTED|Overall Study||6
605608|NCT00397891|1482139|P1|STARTED|Overall Study||6
605609|NCT00397878|1482237|P1|NOT COMPLETED|Overall Study||0
605610|NCT00397878|1482237|P1|COMPLETED|Overall Study||10
605611|NCT00397878|1482237|P1|STARTED|Overall Study||10
605612|NCT00397839|1482243|P2|NOT COMPLETED|Overall Study||18
605613|NCT00397839|1482244|P1|NOT COMPLETED|Overall Study||7
605614|NCT00397839|1482243|P2|COMPLETED|Overall Study||69
605615|NCT00397839|1482244|P1|COMPLETED|Overall Study||41
605616|NCT00397839|1482243|P2|STARTED|Overall Study||87
605617|NCT00397839|1482244|P1|STARTED|Overall Study||48
605618|NCT00397631|1482260|P2|NOT COMPLETED|Overall Study||44
605619|NCT00397631|1482261|P1|NOT COMPLETED|Overall Study||30
605620|NCT00397631|1482260|P2|COMPLETED|Overall Study||215
605621|NCT00397631|1482261|P1|COMPLETED|Overall Study||231
605622|NCT00397631|1482260|P2|STARTED|Overall Study||259
605623|NCT00397631|1482261|P1|STARTED|Overall Study|Randomization ratio was 1:1|261
605624|NCT00397540|1482273|P2|NOT COMPLETED|Overall Study||0
605625|NCT00397540|1482274|P1|NOT COMPLETED|Overall Study||1
605626|NCT00397540|1482273|P2|COMPLETED|Overall Study||85
605627|NCT00397540|1482274|P1|COMPLETED|Overall Study||59
605628|NCT00397540|1482273|P2|STARTED|Overall Study||85
605629|NCT00397540|1482274|P1|STARTED|Overall Study||60
605630|NCT00397514|1482280|P1|NOT COMPLETED|Overall Study||9
605631|NCT00397514|1482280|P1|COMPLETED|Overall Study||25
605632|NCT00397514|1482280|P1|STARTED|Overall Study||34
605633|NCT00397488|1482290|P1|NOT COMPLETED|Overall Study||7
605634|NCT00397488|1482290|P1|COMPLETED|Overall Study||71
605635|NCT00397488|1482290|P1|STARTED|Overall Study||78
605636|NCT00397462|1482297|P3|NOT COMPLETED|Overall Study||0
605637|NCT00397462|1482298|P2|NOT COMPLETED|Overall Study||0
605638|NCT00397462|1482299|P1|NOT COMPLETED|Overall Study||0
605639|NCT00397462|1482297|P3|COMPLETED|Overall Study||15
605640|NCT00397462|1482298|P2|COMPLETED|Overall Study||13
605641|NCT00397462|1482299|P1|COMPLETED|Overall Study||16
605642|NCT00397462|1482297|P3|STARTED|Overall Study||15
605643|NCT00397462|1482298|P2|STARTED|Overall Study||13
605644|NCT00397462|1482299|P1|STARTED|Overall Study||16
605645|NCT00397254|1482310|P2|NOT COMPLETED|Overall Study||2
605646|NCT00397254|1482311|P1|NOT COMPLETED|Overall Study||2
605647|NCT00397254|1482310|P2|COMPLETED|Overall Study||74
605648|NCT00397254|1482311|P1|COMPLETED|Overall Study||77
605649|NCT00397254|1482310|P2|STARTED|Overall Study||76
605650|NCT00397254|1482311|P1|STARTED|Overall Study||79
605651|NCT00397215|1482333|P4|NOT COMPLETED|Month 24 (Day 720)||0
605652|NCT00397215|1482334|P3|NOT COMPLETED|Month 24 (Day 720)||0
605653|NCT00397215|1482335|P2|NOT COMPLETED|Month 24 (Day 720)||0
605654|NCT00397215|1482336|P1|NOT COMPLETED|Month 24 (Day 720)||0
605655|NCT00397215|1482333|P4|COMPLETED|Month 24 (Day 720)||36
605657|NCT00397215|1482335|P2|COMPLETED|Month 24 (Day 720)||45
605658|NCT00397215|1482336|P1|COMPLETED|Month 24 (Day 720)||122
605659|NCT00397215|1482333|P4|STARTED|Month 24 (Day 720)||36
605660|NCT00397215|1482334|P3|STARTED|Month 24 (Day 720)||117
605661|NCT00397215|1482335|P2|STARTED|Month 24 (Day 720)||45
605662|NCT00397215|1482336|P1|STARTED|Month 24 (Day 720)||122
605663|NCT00397215|1482333|P4|NOT COMPLETED|Month 12 (Day 360)||0
605664|NCT00397215|1482334|P3|NOT COMPLETED|Month 12 (Day 360)||0
605665|NCT00397215|1482335|P2|NOT COMPLETED|Month 12 (Day 360)||0
605666|NCT00397215|1482336|P1|NOT COMPLETED|Month 12 (Day 360)||0
605667|NCT00397215|1482333|P4|COMPLETED|Month 12 (Day 360)||42
605668|NCT00397215|1482334|P3|COMPLETED|Month 12 (Day 360)||125
605669|NCT00397215|1482335|P2|COMPLETED|Month 12 (Day 360)||48
605670|NCT00397215|1482336|P1|COMPLETED|Month 12 (Day 360)||130
605671|NCT00397215|1482333|P4|STARTED|Month 12 (Day 360)||42
605672|NCT00397215|1482334|P3|STARTED|Month 12 (Day 360)||125
605673|NCT00397215|1482335|P2|STARTED|Month 12 (Day 360)||48
605674|NCT00397215|1482336|P1|STARTED|Month 12 (Day 360)||130
605675|NCT00397215|1482333|P4|NOT COMPLETED|Month 6 (Day 180)||0
605676|NCT00397215|1482334|P3|NOT COMPLETED|Month 6 (Day 180)||5
605677|NCT00397215|1482335|P2|NOT COMPLETED|Month 6 (Day 180)||3
605678|NCT00397215|1482336|P1|NOT COMPLETED|Month 6 (Day 180)||2
605679|NCT00397215|1482333|P4|COMPLETED|Month 6 (Day 180)||51
605680|NCT00397215|1482334|P3|COMPLETED|Month 6 (Day 180)||153
605681|NCT00397215|1482335|P2|COMPLETED|Month 6 (Day 180)||55
605682|NCT00397215|1482336|P1|COMPLETED|Month 6 (Day 180)||162
605683|NCT00397215|1482333|P4|STARTED|Month 6 (Day 180)||51
605684|NCT00397215|1482334|P3|STARTED|Month 6 (Day 180)||158
605685|NCT00397215|1482335|P2|STARTED|Month 6 (Day 180)||58
605686|NCT00397215|1482336|P1|STARTED|Month 6 (Day 180)||164
605687|NCT00397215|1482333|P4|NOT COMPLETED|Month 0 (Day 0)||4
605688|NCT00397215|1482334|P3|NOT COMPLETED|Month 0 (Day 0)||6
605689|NCT00397215|1482335|P2|NOT COMPLETED|Month 0 (Day 0)||5
605690|NCT00397215|1482336|P1|NOT COMPLETED|Month 0 (Day 0)||7
605691|NCT00397215|1482333|P4|COMPLETED|Month 0 (Day 0)||48
605692|NCT00397215|1482334|P3|COMPLETED|Month 0 (Day 0)||153
605693|NCT00397215|1482335|P2|COMPLETED|Month 0 (Day 0)||56
605694|NCT00397215|1482336|P1|COMPLETED|Month 0 (Day 0)||158
605695|NCT00397215|1482333|P4|STARTED|Month 0 (Day 0)||52
605696|NCT00397215|1482334|P3|STARTED|Month 0 (Day 0)||159
605697|NCT00397215|1482335|P2|STARTED|Month 0 (Day 0)||61
605698|NCT00397215|1482336|P1|STARTED|Month 0 (Day 0)||165
605699|NCT00397189|1482472|P2|NOT COMPLETED|Extension Period||43
605700|NCT00397189|1482473|P1|NOT COMPLETED|Extension Period||113
605701|NCT00397189|1482472|P2|COMPLETED|Extension Period||134
605702|NCT00397189|1482473|P1|COMPLETED|Extension Period||421
605703|NCT00397189|1482472|P2|STARTED|Extension Period|Please note randomization ratio in extension is 3:1|177
605704|NCT00397189|1482473|P1|STARTED|Extension Period|Not all completers continued to extension as only patients who wished to proceed were randomized.|534
605705|NCT00397189|1482472|P2|NOT COMPLETED|3 Weeks Period||22
605706|NCT00397189|1482473|P1|NOT COMPLETED|3 Weeks Period||21
605707|NCT00397189|1482472|P2|COMPLETED|3 Weeks Period|out of 373, 362 were included in the ITT population detailed in the Baseline Characteristics|373
605708|NCT00397189|1482473|P1|COMPLETED|3 Weeks Period|out of 373, 360 were included in the ITT population detailed in the Baseline Characteristics.|373
605709|NCT00397189|1482472|P2|STARTED|3 Weeks Period||395
605710|NCT00397189|1482473|P1|STARTED|3 Weeks Period||394
605711|NCT00397150|1482483|P2|NOT COMPLETED|Overall Study||145
605712|NCT00397150|1482484|P1|NOT COMPLETED|Overall Study||135
605713|NCT00397150|1482483|P2|COMPLETED|Overall Study||1111
605714|NCT00397150|1482484|P1|COMPLETED|Overall Study||1188
605715|NCT00397150|1482483|P2|STARTED|Overall Study||1256
605716|NCT00397150|1482484|P1|STARTED|Overall Study||1323
605717|NCT00397046|1482500|P4|NOT COMPLETED|Overall Study||5
605718|NCT00397046|1482501|P3|NOT COMPLETED|Overall Study||10
605719|NCT00397046|1482502|P2|NOT COMPLETED|Overall Study||3
605720|NCT00397046|1482503|P1|NOT COMPLETED|Overall Study||3
605721|NCT00397046|1482500|P4|COMPLETED|Overall Study||0
605722|NCT00397046|1482501|P3|COMPLETED|Overall Study||0
605723|NCT00397046|1482502|P2|COMPLETED|Overall Study||0
605724|NCT00397046|1482503|P1|COMPLETED|Overall Study||0
605725|NCT00397046|1482500|P4|STARTED|Overall Study||5
605726|NCT00397046|1482501|P3|STARTED|Overall Study||10
605727|NCT00397046|1482502|P2|STARTED|Overall Study||3
605728|NCT00397046|1482503|P1|STARTED|Overall Study||3
605729|NCT00397033|1482524|P3|NOT COMPLETED|Overall Study||23
605730|NCT00397033|1482525|P2|NOT COMPLETED|Overall Study||37
605731|NCT00397033|1482526|P1|NOT COMPLETED|Overall Study||44
605732|NCT00397033|1482524|P3|COMPLETED|Overall Study||77
605733|NCT00397033|1482525|P2|COMPLETED|Overall Study||72
605734|NCT00397033|1482526|P1|COMPLETED|Overall Study||63
605735|NCT00397033|1482524|P3|ITT Population|Overall Study||98
605736|NCT00397033|1482525|P2|ITT Population|Overall Study||105
605737|NCT00397033|1482526|P1|ITT Population|Overall Study||107
605738|NCT00397033|1482524|P3|Safety Population: >= 1 Dose of Drug|Overall Study||98
605739|NCT00397033|1482525|P2|Safety Population: >= 1 Dose of Drug|Overall Study||108
605740|NCT00397033|1482526|P1|Safety Population: >= 1 Dose of Drug|Overall Study||107
605741|NCT00397033|1482524|P3|STARTED|Overall Study||100
605742|NCT00397033|1482525|P2|STARTED|Overall Study||109
605743|NCT00397033|1482526|P1|STARTED|Overall Study||107
605744|NCT00396981|1482587|P2|NOT COMPLETED|Overall Study||9
605745|NCT00396981|1482588|P1|NOT COMPLETED|Overall Study||15
605746|NCT00396981|1482587|P2|COMPLETED|Overall Study||306
605747|NCT00396981|1482588|P1|COMPLETED|Overall Study||296
605748|NCT00396981|1482587|P2|STARTED|Overall Study||315
605749|NCT00396981|1482588|P1|STARTED|Overall Study||311
605750|NCT00396877|1482608|P2|NOT COMPLETED|Overall Study||8
605751|NCT00396877|1482609|P1|NOT COMPLETED|Overall Study||6
605752|NCT00396877|1482608|P2|COMPLETED|Overall Study|Completed follow-up|459
605753|NCT00396877|1482609|P1|COMPLETED|Overall Study|Completed follow-up|433
605754|NCT00396877|1482608|P2|Completed Treatment|Overall Study||352
605755|NCT00396877|1482609|P1|Completed Treatment|Overall Study||356
605756|NCT00396877|1482608|P2|Treated|Overall Study||464
605757|NCT00396877|1482609|P1|Treated|Overall Study||436
605758|NCT00396877|1482608|P2|STARTED|Overall Study|Randomized|467
605759|NCT00396877|1482609|P1|STARTED|Overall Study|Randomized|439
605760|NCT00396812|1482619|P1|NOT COMPLETED|Overall Study||1
605761|NCT00396812|1482619|P1|COMPLETED|Overall Study|4 subjects completed treatment, but 1 subject terminated early due to disease progression|3
605762|NCT00396812|1482619|P1|STARTED|Overall Study||4
605763|NCT00396656|1482631|P2|NOT COMPLETED|Second Treatment Period||1
605764|NCT00396656|1482632|P1|NOT COMPLETED|Second Treatment Period||0
605765|NCT00396656|1482631|P2|COMPLETED|Second Treatment Period||12
605766|NCT00396656|1482632|P1|COMPLETED|Second Treatment Period||15
605767|NCT00396656|1482631|P2|STARTED|Second Treatment Period||13
605768|NCT00396656|1482632|P1|STARTED|Second Treatment Period||15
605769|NCT00396656|1482631|P2|NOT COMPLETED|First Treatment Period||2
605770|NCT00396656|1482632|P1|NOT COMPLETED|First Treatment Period||0
605771|NCT00396656|1482631|P2|COMPLETED|First Treatment Period||13
605772|NCT00396656|1482632|P1|COMPLETED|First Treatment Period||15
605773|NCT00396656|1482631|P2|STARTED|First Treatment Period||15
605774|NCT00396656|1482632|P1|STARTED|First Treatment Period||15
605775|NCT00396630|1482650|P2|NOT COMPLETED|Overall Study||5
605776|NCT00396630|1482651|P1|NOT COMPLETED|Overall Study||5
605777|NCT00396630|1482650|P2|COMPLETED|Overall Study|Completed Visit 4 (Week 17).|95
605778|NCT00396630|1482651|P1|COMPLETED|Overall Study|Completed Visit 4 (Week 17).|95
605779|NCT00396630|1482650|P2|STARTED|Overall Study||100
605780|NCT00396630|1482651|P1|STARTED|Overall Study||100
605781|NCT00396591|1482671|P1|NOT COMPLETED|Overall Study||16
605782|NCT00396591|1482671|P1|COMPLETED|Overall Study||0
605783|NCT00396591|1482671|P1|STARTED|Overall Study||16
605784|NCT00396565|1482684|P3|NOT COMPLETED|Overall Study||17
605785|NCT00396565|1482685|P2|NOT COMPLETED|Overall Study||91
605786|NCT00396565|1482686|P1|NOT COMPLETED|Overall Study||48
605787|NCT00396565|1482684|P3|COMPLETED|Overall Study||30
605788|NCT00396565|1482685|P2|COMPLETED|Overall Study||47
605789|NCT00396565|1482686|P1|COMPLETED|Overall Study||88
605790|NCT00396565|1482684|P3|STARTED|Overall Study||47
605791|NCT00396565|1482685|P2|STARTED|Overall Study||138
605792|NCT00396565|1482686|P1|STARTED|Overall Study||136
605793|NCT00396409|1482711|P2|NOT COMPLETED|Period 2 - 2008||2
605794|NCT00396409|1482712|P1|NOT COMPLETED|Period 2 - 2008||7
605795|NCT00396409|1482711|P2|COMPLETED|Period 2 - 2008||53
605796|NCT00396409|1482712|P1|COMPLETED|Period 2 - 2008||52
605797|NCT00396409|1482711|P2|STARTED|Period 2 - 2008||55
605798|NCT00396409|1482712|P1|STARTED|Period 2 - 2008||59
605799|NCT00396409|1482711|P2|NOT COMPLETED|Between Period 1 and Period 2||2
605800|NCT00396409|1482712|P1|NOT COMPLETED|Between Period 1 and Period 2||3
605801|NCT00396409|1482711|P2|COMPLETED|Between Period 1 and Period 2||55
605802|NCT00396409|1482712|P1|COMPLETED|Between Period 1 and Period 2||59
605803|NCT00396409|1482711|P2|STARTED|Between Period 1 and Period 2||57
605804|NCT00396409|1482712|P1|STARTED|Between Period 1 and Period 2||62
605805|NCT00396409|1482711|P2|NOT COMPLETED|Period 1 - 2007||6
605806|NCT00396409|1482712|P1|NOT COMPLETED|Period 1 - 2007||3
605807|NCT00396409|1482711|P2|COMPLETED|Period 1 - 2007||57
605808|NCT00396409|1482712|P1|COMPLETED|Period 1 - 2007||62
605809|NCT00396409|1482711|P2|STARTED|Period 1 - 2007||63
605810|NCT00396409|1482712|P1|STARTED|Period 1 - 2007||65
605811|NCT00396383|1482742|P1|NOT COMPLETED|Overall Study||3
605812|NCT00396383|1482742|P1|COMPLETED|Overall Study||6
605813|NCT00396383|1482742|P1|STARTED|Overall Study||9
605814|NCT00396331|1482755|P1|NOT COMPLETED|Overall Study||32
605815|NCT00396331|1482755|P1|COMPLETED|Overall Study||68
605816|NCT00396331|1482755|P1|Number of Participants Transplanted|Overall Study|7 participants had two transplants|87
605817|NCT00396331|1482755|P1|Number of Participants Treated|Overall Study||100
605818|NCT00396331|1482755|P1|STARTED|Overall Study||100
605819|NCT00396318|1482808|P1|NOT COMPLETED|7-Day Post-Treatment Contact||1
605820|NCT00396318|1482808|P1|COMPLETED|7-Day Post-Treatment Contact||240
605821|NCT00396318|1482808|P1|STARTED|7-Day Post-Treatment Contact||241
605822|NCT00396318|1482808|P1|NOT COMPLETED|48- to 96-Hour Follow-Up Period||5
605823|NCT00396318|1482808|P1|COMPLETED|48- to 96-Hour Follow-Up Period||241
605824|NCT00396318|1482808|P1|STARTED|48- to 96-Hour Follow-Up Period||246
605825|NCT00396318|1482808|P1|NOT COMPLETED|At Least One Dose of Tenecteplase (MITT)||5
605826|NCT00396318|1482808|P1|COMPLETED|At Least One Dose of Tenecteplase (MITT)||241
605827|NCT00396318|1482808|P1|STARTED|At Least One Dose of Tenecteplase (MITT)||246
605828|NCT00396292|1482821|P2|NOT COMPLETED|Overall Study||16
605829|NCT00396292|1482822|P1|NOT COMPLETED|Overall Study||9
605830|NCT00396292|1482821|P2|COMPLETED|Overall Study||162
605831|NCT00396292|1482822|P1|COMPLETED|Overall Study||165
605832|NCT00396292|1482821|P2|STARTED|Overall Study||178
605833|NCT00396292|1482822|P1|STARTED|Overall Study||174
605834|NCT00396279|1482828|P1|NOT COMPLETED|Overall Study||30
605835|NCT00396279|1482828|P1|COMPLETED|Overall Study|Defined as participants with a complete resection|7
605836|NCT00396279|1482828|P1|STARTED|Overall Study||37
605837|NCT00396266|1482839|P2|NOT COMPLETED|Overall Study||0
605838|NCT00396266|1482840|P1|NOT COMPLETED|Overall Study||0
605839|NCT00396266|1482839|P2|COMPLETED|Overall Study||14
605840|NCT00396266|1482840|P1|COMPLETED|Overall Study||8
605841|NCT00396266|1482839|P2|STARTED|Overall Study||14
605842|NCT00396266|1482840|P1|STARTED|Overall Study||8
605843|NCT00396253|1482861|P1|NOT COMPLETED|Overall Study||13
605844|NCT00396253|1482861|P1|COMPLETED|Overall Study||210
605845|NCT00396253|1482861|P1|STARTED|Overall Study||223
605846|NCT00396201|1482873|P1|NOT COMPLETED|Follow-up Period||0
605847|NCT00396201|1482873|P1|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|21
605848|NCT00396201|1482873|P1|STARTED|Follow-up Period|Participants who had transplants. One had insufficient collection of cells so no transplant.|21
605849|NCT00396201|1482873|P1|NOT COMPLETED|Treatment Period||0
605850|NCT00396201|1482873|P1|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|22
605851|NCT00396201|1482873|P1|STARTED|Treatment Period||22
605852|NCT00396162|1482892|P2|NOT COMPLETED|Overall Study||3
605853|NCT00396162|1482893|P1|NOT COMPLETED|Overall Study||2
605854|NCT00396162|1482892|P2|COMPLETED|Overall Study||35
605855|NCT00396162|1482893|P1|COMPLETED|Overall Study||37
605856|NCT00396162|1482892|P2|STARTED|Overall Study||38
605857|NCT00396162|1482893|P1|STARTED|Overall Study||39
605858|NCT00396136|1482905|P1|NOT COMPLETED|Overall Study||125
605859|NCT00396136|1482905|P1|COMPLETED|Overall Study||96
605860|NCT00396136|1482905|P1|STARTED|Overall Study||221
605861|NCT00396097|1482912|P2|NOT COMPLETED|Overall Study||46
605862|NCT00396097|1482913|P1|NOT COMPLETED|Overall Study||26
605863|NCT00396097|1482912|P2|COMPLETED|Overall Study||156
605864|NCT00396097|1482913|P1|COMPLETED|Overall Study||88
605865|NCT00396097|1482912|P2|STARTED|Overall Study||202
605866|NCT00396097|1482913|P1|STARTED|Overall Study|4 participants randomized to Individualized Dose, received Standard Dose throughout the study.|114
605867|NCT00396084|1482941|P6|NOT COMPLETED|Overall Study||2
605868|NCT00396084|1482942|P5|NOT COMPLETED|Overall Study||1
605869|NCT00396084|1482943|P4|NOT COMPLETED|Overall Study||1
605870|NCT00396084|1482944|P3|NOT COMPLETED|Overall Study||0
605871|NCT00396084|1482945|P2|NOT COMPLETED|Overall Study||0
605872|NCT00396084|1482946|P1|NOT COMPLETED|Overall Study||0
605873|NCT00396084|1482941|P6|COMPLETED|Overall Study||18
605874|NCT00396084|1482942|P5|COMPLETED|Overall Study||9
605875|NCT00396084|1482943|P4|COMPLETED|Overall Study||9
605876|NCT00396084|1482944|P3|COMPLETED|Overall Study||10
605877|NCT00396084|1482945|P2|COMPLETED|Overall Study||10
605878|NCT00396084|1482946|P1|COMPLETED|Overall Study||10
605879|NCT00396084|1482941|P6|STARTED|Overall Study||20
605880|NCT00396084|1482942|P5|STARTED|Overall Study||10
605881|NCT00396084|1482943|P4|STARTED|Overall Study||10
605882|NCT00396084|1482944|P3|STARTED|Overall Study||10
605883|NCT00396084|1482945|P2|STARTED|Overall Study||10
605884|NCT00396084|1482946|P1|STARTED|Overall Study||10
605885|NCT00396032|1483021|P2|NOT COMPLETED|Overall Study||5
605886|NCT00396032|1483022|P1|NOT COMPLETED|Overall Study||4
605887|NCT00396032|1483021|P2|COMPLETED|Overall Study||71
605888|NCT00396032|1483022|P1|COMPLETED|Overall Study||70
605889|NCT00396032|1483021|P2|STARTED|Overall Study||76
605890|NCT00396032|1483022|P1|STARTED|Overall Study||74
605891|NCT00396019|1483039|P3|NOT COMPLETED|Overall Study||1
605892|NCT00396019|1483040|P2|NOT COMPLETED|Overall Study||3
605893|NCT00396019|1483041|P1|NOT COMPLETED|Overall Study||0
605894|NCT00396019|1483039|P3|COMPLETED|Overall Study||29
605895|NCT00396019|1483040|P2|COMPLETED|Overall Study||26
605896|NCT00396019|1483041|P1|COMPLETED|Overall Study||27
605897|NCT00396019|1483039|P3|STARTED|Overall Study||30
605898|NCT00396019|1483040|P2|STARTED|Overall Study||29
605899|NCT00396019|1483041|P1|STARTED|Overall Study||27
605900|NCT00396006|1483051|P1|NOT COMPLETED|Overall Study||0
605901|NCT00396006|1483051|P1|COMPLETED|Overall Study||13
605902|NCT00396006|1483051|P1|STARTED|Overall Study||13
605903|NCT00395993|1483068|P2|NOT COMPLETED|Overall Study||19
605904|NCT00395993|1483069|P1|NOT COMPLETED|Overall Study||35
605905|NCT00395993|1483068|P2|COMPLETED|Overall Study||212
605906|NCT00395993|1483069|P1|COMPLETED|Overall Study||211
605907|NCT00395993|1483068|P2|STARTED|Overall Study||231
605908|NCT00395993|1483069|P1|STARTED|Overall Study||246
605909|NCT00395967|1483075|P1|NOT COMPLETED|Follow-up Period||2
605910|NCT00395967|1483075|P1|COMPLETED|Follow-up Period||3
605911|NCT00395967|1483075|P1|STARTED|Follow-up Period|Participants who had transplants.|5
605912|NCT00395967|1483075|P1|NOT COMPLETED|Treatment Period||1
605913|NCT00395967|1483075|P1|COMPLETED|Treatment Period|Failed mobilization due to <2 fold yield after one day of plerixafor treatment|4
605914|NCT00395967|1483075|P1|STARTED|Treatment Period||5
605915|NCT00395876|1483086|P2|NOT COMPLETED|Overall Study||0
605916|NCT00395876|1483087|P1|NOT COMPLETED|Overall Study||3
605917|NCT00395876|1483086|P2|COMPLETED|Overall Study||50
605918|NCT00395876|1483087|P1|COMPLETED|Overall Study||47
605919|NCT00395876|1483086|P2|STARTED|Overall Study||50
605920|NCT00395876|1483087|P1|STARTED|Overall Study||50
605921|NCT00395863|1483115|P2|NOT COMPLETED|Overall Study||3
605922|NCT00395863|1483116|P1|NOT COMPLETED|Overall Study||2
605923|NCT00395863|1483115|P2|COMPLETED|Overall Study||20
605924|NCT00395863|1483116|P1|COMPLETED|Overall Study||21
605925|NCT00395863|1483115|P2|STARTED|Overall Study||23
605926|NCT00395863|1483116|P1|STARTED|Overall Study||23
605927|NCT00395850|1483151|P4|NOT COMPLETED|Disulfiram/Placebo Treatment||13
605928|NCT00395850|1483152|P3|NOT COMPLETED|Disulfiram/Placebo Treatment||19
605929|NCT00395850|1483153|P2|NOT COMPLETED|Disulfiram/Placebo Treatment||14
605930|NCT00395850|1483154|P1|NOT COMPLETED|Disulfiram/Placebo Treatment||9
605931|NCT00395850|1483151|P4|COMPLETED|Disulfiram/Placebo Treatment||8
605932|NCT00395850|1483152|P3|COMPLETED|Disulfiram/Placebo Treatment||5
605933|NCT00395850|1483153|P2|COMPLETED|Disulfiram/Placebo Treatment||9
605934|NCT00395850|1483154|P1|COMPLETED|Disulfiram/Placebo Treatment||11
605935|NCT00395850|1483151|P4|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|21
605936|NCT00395850|1483152|P3|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|24
605937|NCT00395850|1483153|P2|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|23
605938|NCT00395850|1483154|P1|STARTED|Disulfiram/Placebo Treatment|Received >= 1 disulfiram dose. Two baseline/randomized subjects dropped out before receiving disulf|20
605939|NCT00395850|1483151|P4|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||4
605940|NCT00395850|1483152|P3|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||6
605941|NCT00395850|1483153|P2|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||2
605942|NCT00395850|1483154|P1|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||5
605943|NCT00395850|1483151|P4|COMPLETED|Randomization to Disulfiram/ Pre-admin||21
605944|NCT00395850|1483152|P3|COMPLETED|Randomization to Disulfiram/ Pre-admin||24
605945|NCT00395850|1483153|P2|COMPLETED|Randomization to Disulfiram/ Pre-admin||23
605946|NCT00395850|1483154|P1|COMPLETED|Randomization to Disulfiram/ Pre-admin||22
605947|NCT00395850|1483151|P4|STARTED|Randomization to Disulfiram/ Pre-admin||25
605948|NCT00395850|1483152|P3|STARTED|Randomization to Disulfiram/ Pre-admin||30
605949|NCT00395850|1483153|P2|STARTED|Randomization to Disulfiram/ Pre-admin||25
605950|NCT00395850|1483154|P1|STARTED|Randomization to Disulfiram/ Pre-admin||27
605951|NCT00395850|1483151|P4|NOT COMPLETED|Pre-randomization Baseline/Induction||0
605952|NCT00395850|1483152|P3|NOT COMPLETED|Pre-randomization Baseline/Induction||0
605953|NCT00395850|1483153|P2|NOT COMPLETED|Pre-randomization Baseline/Induction||0
605954|NCT00395850|1483154|P1|NOT COMPLETED|Pre-randomization Baseline/Induction||11
605955|NCT00395850|1483151|P4|COMPLETED|Pre-randomization Baseline/Induction||0
605956|NCT00395850|1483152|P3|COMPLETED|Pre-randomization Baseline/Induction||0
605957|NCT00395850|1483153|P2|COMPLETED|Pre-randomization Baseline/Induction||0
605958|NCT00395850|1483154|P1|COMPLETED|Pre-randomization Baseline/Induction||107
605959|NCT00395850|1483151|P4|STARTED|Pre-randomization Baseline/Induction||0
605960|NCT00395850|1483152|P3|STARTED|Pre-randomization Baseline/Induction||0
605961|NCT00395850|1483153|P2|STARTED|Pre-randomization Baseline/Induction||0
605962|NCT00395850|1483154|P1|STARTED|Pre-randomization Baseline/Induction|Pre-randomization and disulfiram (disulf) administration|118
605963|NCT00395746|1483171|P3|NOT COMPLETED|Overall Study||22
605964|NCT00395746|1483172|P2|NOT COMPLETED|Overall Study||4
605965|NCT00395746|1483173|P1|NOT COMPLETED|Overall Study||10
605966|NCT00395746|1483171|P3|COMPLETED|Overall Study|Completed 52 weeks treatment|66
605967|NCT00395746|1483172|P2|COMPLETED|Overall Study|Completed 52 weeks treatment|84
605968|NCT00395746|1483173|P1|COMPLETED|Overall Study|Completed 52 weeks treatment|78
605969|NCT00395746|1483171|P3|STARTED|Overall Study|Exposed to study drug|88
605970|NCT00395746|1483172|P2|STARTED|Overall Study|Exposed to study drug|88
605971|NCT00395746|1483173|P1|STARTED|Overall Study|Exposed to study drug|88
605972|NCT00395733|1483219|P2|NOT COMPLETED|Period 2||5
605973|NCT00395733|1483220|P1|NOT COMPLETED|Period 2||2
605974|NCT00395733|1483219|P2|COMPLETED|Period 2||37
605975|NCT00395733|1483220|P1|COMPLETED|Period 2||39
605976|NCT00395733|1483219|P2|STARTED|Period 2||42
605977|NCT00395733|1483220|P1|STARTED|Period 2||41
605978|NCT00395733|1483219|P2|NOT COMPLETED|Period 1||0
605979|NCT00395733|1483220|P1|NOT COMPLETED|Period 1||0
605980|NCT00395733|1483219|P2|COMPLETED|Period 1||42
605981|NCT00395733|1483220|P1|COMPLETED|Period 1||41
605982|NCT00395733|1483219|P2|STARTED|Period 1||42
605983|NCT00395733|1483220|P1|STARTED|Period 1||41
605984|NCT00395694|1483244|P2|NOT COMPLETED|Continuation Phase||13
605985|NCT00395694|1483245|P1|NOT COMPLETED|Continuation Phase||15
605986|NCT00395694|1483244|P2|COMPLETED|Continuation Phase||35
605987|NCT00395694|1483245|P1|COMPLETED|Continuation Phase||34
605988|NCT00395694|1483244|P2|STARTED|Continuation Phase|One participant completing the Escalation/Maintenance Phase did not start the Continuation Phase.|48
605989|NCT00395694|1483245|P1|STARTED|Continuation Phase|One participant completing the Escalation/Maintenance Phase did not start the Continuation Phase.|49
605990|NCT00395694|1483244|P2|NOT COMPLETED|Escalation Phase + Maintenance Phase||2
605991|NCT00395694|1483245|P1|NOT COMPLETED|Escalation Phase + Maintenance Phase||1
605992|NCT00395694|1483244|P2|COMPLETED|Escalation Phase + Maintenance Phase||49
605993|NCT00395694|1483245|P1|COMPLETED|Escalation Phase + Maintenance Phase||50
605994|NCT00395694|1483244|P2|STARTED|Escalation Phase + Maintenance Phase||51
605995|NCT00395694|1483245|P1|STARTED|Escalation Phase + Maintenance Phase||51
605996|NCT00395642|1483276|P1|NOT COMPLETED|Overall Study||13
605997|NCT00395642|1483276|P1|COMPLETED|Overall Study||53
605998|NCT00395642|1483276|P1|STARTED|Overall Study||66
605999|NCT00395629|1483283|P3|NOT COMPLETED|Extension Study||3
606000|NCT00395629|1483284|P2|NOT COMPLETED|Extension Study||0
606001|NCT00395629|1483285|P1|NOT COMPLETED|Extension Study||0
606002|NCT00395629|1483283|P3|COMPLETED|Extension Study||8
606003|NCT00395629|1483284|P2|COMPLETED|Extension Study||6
606004|NCT00395629|1483285|P1|COMPLETED|Extension Study||9
606005|NCT00395629|1483283|P3|STARTED|Extension Study||11
606006|NCT00395629|1483284|P2|STARTED|Extension Study||6
606007|NCT00395629|1483285|P1|STARTED|Extension Study||9
606008|NCT00395629|1483283|P3|NOT COMPLETED|Core Study||7
606009|NCT00395629|1483284|P2|NOT COMPLETED|Core Study||4
606010|NCT00395629|1483285|P1|NOT COMPLETED|Core Study||1
606011|NCT00395629|1483283|P3|COMPLETED|Core Study||16
606012|NCT00395629|1483284|P2|COMPLETED|Core Study||11
606013|NCT00395629|1483285|P1|COMPLETED|Core Study||10
606014|NCT00395629|1483283|P3|STARTED|Core Study||23
606015|NCT00395629|1483284|P2|STARTED|Core Study||15
606016|NCT00395629|1483285|P1|STARTED|Core Study||11
606017|NCT00395512|1483303|P4|NOT COMPLETED|Overall Study||38
606018|NCT00395512|1483304|P3|NOT COMPLETED|Overall Study||28
606019|NCT00395512|1483305|P2|NOT COMPLETED|Overall Study||37
606020|NCT00395512|1483306|P1|NOT COMPLETED|Overall Study||38
606021|NCT00395512|1483303|P4|COMPLETED|Overall Study||126
606022|NCT00395512|1483304|P3|COMPLETED|Overall Study||136
606023|NCT00395512|1483305|P2|COMPLETED|Overall Study||126
606024|NCT00395512|1483306|P1|COMPLETED|Overall Study||126
606025|NCT00395512|1483303|P4|Safety Set|Overall Study|1 participant was lost to follow-up post visit 1. It is unknown if they took any study medication.|163
606026|NCT00395512|1483304|P3|Safety Set|Overall Study||164
606027|NCT00395512|1483305|P2|Safety Set|Overall Study||163
606028|NCT00395512|1483306|P1|Safety Set|Overall Study||164
606029|NCT00395512|1483303|P4|STARTED|Overall Study||164
606030|NCT00395512|1483304|P3|STARTED|Overall Study||164
606031|NCT00395512|1483305|P2|STARTED|Overall Study||163
606032|NCT00395512|1483306|P1|STARTED|Overall Study||164
606033|NCT00395486|1483478|P2|NOT COMPLETED|Overall Study||5
606034|NCT00395486|1483479|P1|NOT COMPLETED|Overall Study||6
606035|NCT00395486|1483478|P2|COMPLETED|Overall Study|Completed subjects|121
606036|NCT00395486|1483479|P1|COMPLETED|Overall Study|Completed subjects|126
606037|NCT00395486|1483478|P2|STARTED|Overall Study|Randomized subjects|126
606038|NCT00395486|1483479|P1|STARTED|Overall Study|Randomized subjects|132
606039|NCT00395460|1483509|P2|NOT COMPLETED|Overall Study||0
606040|NCT00395460|1483510|P1|NOT COMPLETED|Overall Study||1
606041|NCT00395460|1483509|P2|COMPLETED|Overall Study||75
606042|NCT00395460|1483510|P1|COMPLETED|Overall Study||71
606043|NCT00395460|1483509|P2|Received Treatment|Overall Study||75
606044|NCT00395460|1483510|P1|Received Treatment|Overall Study|1 participant withdrew consent prior to study drug injection and did not receive any study drug.|71
606045|NCT00395460|1483509|P2|STARTED|Overall Study||75
606046|NCT00395460|1483510|P1|STARTED|Overall Study||72
606047|NCT00395447|1483534|P2|NOT COMPLETED|Overall Study||111
606048|NCT00395447|1483535|P1|NOT COMPLETED|Overall Study||121
606049|NCT00395447|1483534|P2|COMPLETED|Overall Study||602
606050|NCT00395447|1483535|P1|COMPLETED|Overall Study||910
606051|NCT00395447|1483534|P2|STARTED|Overall Study||713
606052|NCT00395447|1483535|P1|STARTED|Overall Study||1031
606053|NCT00395343|1483543|P2|NOT COMPLETED|Overall Study||36
606054|NCT00395343|1483544|P1|NOT COMPLETED|Overall Study||41
606055|NCT00395343|1483543|P2|COMPLETED|Overall Study||283
606056|NCT00395343|1483544|P1|COMPLETED|Overall Study||281
606057|NCT00395343|1483543|P2|STARTED|Overall Study||319
606058|NCT00395343|1483544|P1|STARTED|Overall Study||322
606059|NCT00395304|1483562|P6|NOT COMPLETED|Treatment Period 3||1
606060|NCT00395304|1483563|P5|NOT COMPLETED|Treatment Period 3||0
606061|NCT00395304|1483564|P4|NOT COMPLETED|Treatment Period 3||2
606062|NCT00395304|1483565|P3|NOT COMPLETED|Treatment Period 3||0
606063|NCT00395304|1483566|P2|NOT COMPLETED|Treatment Period 3||2
606064|NCT00395304|1483567|P1|NOT COMPLETED|Treatment Period 3||1
606065|NCT00395304|1483562|P6|COMPLETED|Treatment Period 3||27
606066|NCT00395304|1483563|P5|COMPLETED|Treatment Period 3||27
606067|NCT00395304|1483564|P4|COMPLETED|Treatment Period 3||25
606068|NCT00395304|1483565|P3|COMPLETED|Treatment Period 3||29
606069|NCT00395304|1483566|P2|COMPLETED|Treatment Period 3||20
606070|NCT00395304|1483567|P1|COMPLETED|Treatment Period 3||29
606071|NCT00395304|1483562|P6|STARTED|Treatment Period 3||28
606072|NCT00395304|1483563|P5|STARTED|Treatment Period 3||27
606073|NCT00395304|1483564|P4|STARTED|Treatment Period 3||27
606074|NCT00395304|1483565|P3|STARTED|Treatment Period 3||29
606075|NCT00395304|1483566|P2|STARTED|Treatment Period 3||22
606076|NCT00395304|1483567|P1|STARTED|Treatment Period 3||30
606077|NCT00395304|1483562|P6|NOT COMPLETED|Treatment Period 2||2
606078|NCT00395304|1483563|P5|NOT COMPLETED|Treatment Period 2||0
606079|NCT00395304|1483564|P4|NOT COMPLETED|Treatment Period 2||1
606080|NCT00395304|1483565|P3|NOT COMPLETED|Treatment Period 2||1
606081|NCT00395304|1483566|P2|NOT COMPLETED|Treatment Period 2||4
606082|NCT00395304|1483567|P1|NOT COMPLETED|Treatment Period 2||0
606083|NCT00395304|1483562|P6|COMPLETED|Treatment Period 2||28
606084|NCT00395304|1483563|P5|COMPLETED|Treatment Period 2||27
606085|NCT00395304|1483564|P4|COMPLETED|Treatment Period 2||27
606086|NCT00395304|1483565|P3|COMPLETED|Treatment Period 2||29
606087|NCT00395304|1483566|P2|COMPLETED|Treatment Period 2||22
606088|NCT00395304|1483567|P1|COMPLETED|Treatment Period 2||30
606089|NCT00395304|1483562|P6|STARTED|Treatment Period 2||30
606090|NCT00395304|1483563|P5|STARTED|Treatment Period 2||27
606091|NCT00395304|1483564|P4|STARTED|Treatment Period 2||28
606092|NCT00395304|1483565|P3|STARTED|Treatment Period 2||30
606093|NCT00395304|1483566|P2|STARTED|Treatment Period 2||26
606094|NCT00395304|1483567|P1|STARTED|Treatment Period 2||30
606095|NCT00395304|1483562|P6|NOT COMPLETED|Treatment Period 1||2
606096|NCT00395304|1483563|P5|NOT COMPLETED|Treatment Period 1||1
606097|NCT00395304|1483564|P4|NOT COMPLETED|Treatment Period 1||3
606098|NCT00395304|1483565|P3|NOT COMPLETED|Treatment Period 1||0
606099|NCT00395304|1483566|P2|NOT COMPLETED|Treatment Period 1||4
606100|NCT00395304|1483567|P1|NOT COMPLETED|Treatment Period 1||1
606101|NCT00395304|1483562|P6|COMPLETED|Treatment Period 1||30
606102|NCT00395304|1483563|P5|COMPLETED|Treatment Period 1||27
606103|NCT00395304|1483564|P4|COMPLETED|Treatment Period 1||28
606104|NCT00395304|1483565|P3|COMPLETED|Treatment Period 1||30
606105|NCT00395304|1483566|P2|COMPLETED|Treatment Period 1||26
606106|NCT00395304|1483567|P1|COMPLETED|Treatment Period 1||30
606107|NCT00395304|1483562|P6|STARTED|Treatment Period 1||32
606108|NCT00395304|1483563|P5|STARTED|Treatment Period 1||28
606109|NCT00395304|1483564|P4|STARTED|Treatment Period 1||31
606110|NCT00395304|1483565|P3|STARTED|Treatment Period 1||30
606111|NCT00395304|1483566|P2|STARTED|Treatment Period 1||30
606112|NCT00395304|1483567|P1|STARTED|Treatment Period 1||31
606113|NCT00395291|1483610|P2|NOT COMPLETED|Second Intervention||0
606114|NCT00395291|1483611|P1|NOT COMPLETED|Second Intervention||0
606115|NCT00395291|1483610|P2|COMPLETED|Second Intervention||9
606116|NCT00395291|1483611|P1|COMPLETED|Second Intervention||13
606117|NCT00395291|1483610|P2|STARTED|Second Intervention||9
606118|NCT00395291|1483611|P1|STARTED|Second Intervention||13
606119|NCT00395291|1483610|P2|NOT COMPLETED|Washout Period for 30 Days||0
606120|NCT00395291|1483611|P1|NOT COMPLETED|Washout Period for 30 Days||2
606121|NCT00395291|1483610|P2|COMPLETED|Washout Period for 30 Days||9
606122|NCT00395291|1483611|P1|COMPLETED|Washout Period for 30 Days||13
606123|NCT00395291|1483610|P2|STARTED|Washout Period for 30 Days||9
606124|NCT00395291|1483611|P1|STARTED|Washout Period for 30 Days||15
606125|NCT00395291|1483610|P2|NOT COMPLETED|First Intervention||0
606126|NCT00395291|1483611|P1|NOT COMPLETED|First Intervention||2
606127|NCT00395291|1483610|P2|COMPLETED|First Intervention||9
606128|NCT00395291|1483611|P1|COMPLETED|First Intervention||15
606129|NCT00395291|1483610|P2|STARTED|First Intervention||9
606130|NCT00395291|1483611|P1|STARTED|First Intervention||17
606131|NCT00395226|1483643|P2|NOT COMPLETED|Overall Study||5
606132|NCT00395226|1483644|P1|NOT COMPLETED|Overall Study||4
606133|NCT00395226|1483643|P2|COMPLETED|Overall Study||22
606134|NCT00395226|1483644|P1|COMPLETED|Overall Study||22
606135|NCT00395226|1483643|P2|STARTED|Overall Study||27
606136|NCT00395226|1483644|P1|STARTED|Overall Study||26
606137|NCT00395161|1483652|P2|NOT COMPLETED|Overall Study||0
606138|NCT00395161|1483653|P1|NOT COMPLETED|Overall Study||0
606139|NCT00395161|1483652|P2|COMPLETED|Overall Study||144
606140|NCT00395161|1483653|P1|COMPLETED|Overall Study||149
606141|NCT00395161|1483652|P2|STARTED|Overall Study||144
606142|NCT00395161|1483653|P1|STARTED|Overall Study||149
606143|NCT00395135|1483669|P5|NOT COMPLETED|Year 2||190
606144|NCT00395135|1483670|P4|NOT COMPLETED|Year 2||88
606145|NCT00395135|1483671|P3|NOT COMPLETED|Year 2||147
606146|NCT00395135|1483672|P2|NOT COMPLETED|Year 2||0
606147|NCT00395135|1483673|P1|NOT COMPLETED|Year 2||0
606148|NCT00395135|1483669|P5|COMPLETED|Year 2||507
606149|NCT00395135|1483670|P4|COMPLETED|Year 2||195
606150|NCT00395135|1483671|P3|COMPLETED|Year 2||426
606151|NCT00395135|1483672|P2|COMPLETED|Year 2||0
606152|NCT00395135|1483673|P1|COMPLETED|Year 2||0
606153|NCT00395135|1483669|P5|STARTED|Year 2||697
606154|NCT00395135|1483670|P4|STARTED|Year 2||283
606155|NCT00395135|1483671|P3|STARTED|Year 2||573
606156|NCT00395135|1483672|P2|STARTED|Year 2||0
606157|NCT00395135|1483673|P1|STARTED|Year 2||0
606158|NCT00395135|1483669|P5|NOT COMPLETED|Year 1||0
606159|NCT00395135|1483670|P4|NOT COMPLETED|Year 1||0
606160|NCT00395135|1483671|P3|NOT COMPLETED|Year 1||0
606161|NCT00395135|1483672|P2|NOT COMPLETED|Year 1||871
606162|NCT00395135|1483673|P1|NOT COMPLETED|Year 1||712
606163|NCT00395135|1483669|P5|COMPLETED|Year 1||0
606164|NCT00395135|1483670|P4|COMPLETED|Year 1||0
606165|NCT00395135|1483671|P3|COMPLETED|Year 1||0
606166|NCT00395135|1483672|P2|COMPLETED|Year 1||716
606167|NCT00395135|1483673|P1|COMPLETED|Year 1||883
606168|NCT00395135|1483669|P5|STARTED|Year 1||0
606169|NCT00395135|1483670|P4|STARTED|Year 1||0
606170|NCT00395135|1483671|P3|STARTED|Year 1||0
606171|NCT00395135|1483672|P2|STARTED|Year 1||1587
606172|NCT00395135|1483673|P1|STARTED|Year 1||1595
606173|NCT00395083|1483691|P2|NOT COMPLETED|Overall Study||8
606174|NCT00395083|1483692|P1|NOT COMPLETED|Overall Study||10
606175|NCT00395083|1483691|P2|COMPLETED|Overall Study||201
606176|NCT00395083|1483692|P1|COMPLETED|Overall Study||207
606177|NCT00395083|1483691|P2|STARTED|Overall Study||209
606178|NCT00395083|1483692|P1|STARTED|Overall Study||217
606179|NCT00395057|1483708|P4|NOT COMPLETED|Overall Study||33
606180|NCT00395057|1483709|P3|NOT COMPLETED|Overall Study||33
606181|NCT00395057|1483710|P2|NOT COMPLETED|Overall Study||34
606182|NCT00395057|1483711|P1|NOT COMPLETED|Overall Study||32
606183|NCT00395057|1483708|P4|COMPLETED|Overall Study||1
606184|NCT00395057|1483709|P3|COMPLETED|Overall Study||2
606185|NCT00395057|1483710|P2|COMPLETED|Overall Study||1
606186|NCT00395057|1483711|P1|COMPLETED|Overall Study||2
606187|NCT00395057|1483708|P4|STARTED|Overall Study||34
606188|NCT00395057|1483709|P3|STARTED|Overall Study||35
606189|NCT00395057|1483710|P2|STARTED|Overall Study||35
606190|NCT00395057|1483711|P1|STARTED|Overall Study||34
606191|NCT00395044|1483739|P2|NOT COMPLETED|Overall Study||14
606192|NCT00395044|1483740|P1|NOT COMPLETED|Overall Study||18
606193|NCT00395044|1483739|P2|COMPLETED|Overall Study||11
606194|NCT00395044|1483740|P1|COMPLETED|Overall Study||7
606195|NCT00395044|1483739|P2|STARTED|Overall Study||25
606196|NCT00395044|1483740|P1|STARTED|Overall Study||25
606197|NCT00395018|1483758|P1|NOT COMPLETED|Off-Treatment Follow-up||4
606198|NCT00395018|1483758|P1|COMPLETED|Off-Treatment Follow-up|"Completed means completed the study"|1
606199|NCT00395018|1483758|P1|STARTED|Off-Treatment Follow-up|Treated participants who discontinued =<72 weeks and did not start other anti-HBV therapy|5
606200|NCT00395018|1483758|P1|NOT COMPLETED|On-Treatment||10
606201|NCT00395018|1483758|P1|COMPLETED|On-Treatment|"Completed means received treatment through Week 72"|55
606202|NCT00395018|1483758|P1|DISCONTINUED AT OR AFTER WEEK 72 VISIT|On-Treatment||0
606203|NCT00395018|1483758|P1|DISCONTINUED PRIOR TO WEEK 72 VISIT|On-Treatment||10
606204|NCT00395018|1483758|P1|STARTED|On-Treatment|Started = treated (participants who received at least 1 dose of study therapy)|65
606205|NCT00394953|1483779|P2|NOT COMPLETED|Second Treatment Period||74
606206|NCT00394953|1483780|P1|NOT COMPLETED|Second Treatment Period||29
606207|NCT00394953|1483779|P2|COMPLETED|Second Treatment Period||148
606208|NCT00394953|1483780|P1|COMPLETED|Second Treatment Period||187
606209|NCT00394953|1483779|P2|STARTED|Second Treatment Period||222
606210|NCT00394953|1483780|P1|STARTED|Second Treatment Period||216
606211|NCT00394953|1483779|P2|NOT COMPLETED|First Treatment Period||22
606212|NCT00394953|1483780|P1|NOT COMPLETED|First Treatment Period||29
606213|NCT00394953|1483779|P2|COMPLETED|First Treatment Period||222
606214|NCT00394953|1483780|P1|COMPLETED|First Treatment Period||216
606215|NCT00394953|1483779|P2|STARTED|First Treatment Period||244
606216|NCT00394953|1483780|P1|STARTED|First Treatment Period||245
606217|NCT00394914|1483798|P3|NOT COMPLETED|Treatment Period||6
606218|NCT00394914|1483799|P2|NOT COMPLETED|Treatment Period||10
606219|NCT00394914|1483800|P1|NOT COMPLETED|Treatment Period||0
606220|NCT00394914|1483798|P3|COMPLETED|Treatment Period||151
606221|NCT00394914|1483799|P2|COMPLETED|Treatment Period||144
606222|NCT00394914|1483800|P1|COMPLETED|Treatment Period||0
606223|NCT00394914|1483798|P3|STARTED|Treatment Period||157
606224|NCT00394914|1483799|P2|STARTED|Treatment Period||154
606225|NCT00394914|1483800|P1|STARTED|Treatment Period||0
606226|NCT00394914|1483798|P3|NOT COMPLETED|Pre-exposure Period||0
606227|NCT00394914|1483799|P2|NOT COMPLETED|Pre-exposure Period||0
606228|NCT00394914|1483800|P1|NOT COMPLETED|Pre-exposure Period||0
606229|NCT00394914|1483798|P3|COMPLETED|Pre-exposure Period||0
606230|NCT00394914|1483799|P2|COMPLETED|Pre-exposure Period||0
606231|NCT00394914|1483800|P1|COMPLETED|Pre-exposure Period||311
606232|NCT00394914|1483798|P3|STARTED|Pre-exposure Period||0
606233|NCT00394914|1483799|P2|STARTED|Pre-exposure Period||0
606234|NCT00394914|1483800|P1|STARTED|Pre-exposure Period||311
606235|NCT00394914|1483798|P3|NOT COMPLETED|Screening Period||0
606236|NCT00394914|1483799|P2|NOT COMPLETED|Screening Period||0
606237|NCT00394914|1483800|P1|NOT COMPLETED|Screening Period||0
606238|NCT00394914|1483798|P3|COMPLETED|Screening Period||0
606239|NCT00394914|1483799|P2|COMPLETED|Screening Period||0
606240|NCT00394914|1483800|P1|COMPLETED|Screening Period||311
606241|NCT00394914|1483798|P3|STARTED|Screening Period||0
606242|NCT00394914|1483799|P2|STARTED|Screening Period||0
606243|NCT00394914|1483800|P1|STARTED|Screening Period||311
606244|NCT00394901|1483828|P4|NOT COMPLETED|Double-blind Phase||27
606245|NCT00394901|1483829|P3|NOT COMPLETED|Double-blind Phase||18
606246|NCT00394901|1483830|P2|NOT COMPLETED|Double-blind Phase||14
606247|NCT00394901|1483831|P1|NOT COMPLETED|Double-blind Phase||15
606248|NCT00394901|1483828|P4|COMPLETED|Double-blind Phase||70
606249|NCT00394901|1483829|P3|COMPLETED|Double-blind Phase||71
606250|NCT00394901|1483830|P2|COMPLETED|Double-blind Phase||73
606251|NCT00394901|1483831|P1|COMPLETED|Double-blind Phase||83
606252|NCT00394901|1483828|P4|STARTED|Double-blind Phase|Subjects treated with the study drug.|97
606253|NCT00394901|1483829|P3|STARTED|Double-blind Phase|Subjects treated with the study drug.|89
606254|NCT00394901|1483830|P2|STARTED|Double-blind Phase|Subjects treated with the study drug.|87
606255|NCT00394901|1483831|P1|STARTED|Double-blind Phase|Subjects treated with the study drug.|98
606256|NCT00394901|1483828|P4|NOT COMPLETED|Baseline Phase||0
606257|NCT00394901|1483829|P3|NOT COMPLETED|Baseline Phase||1
606258|NCT00394901|1483830|P2|NOT COMPLETED|Baseline Phase||0
606259|NCT00394901|1483831|P1|NOT COMPLETED|Baseline Phase||0
606260|NCT00394901|1483828|P4|COMPLETED|Baseline Phase||97
606261|NCT00394901|1483829|P3|COMPLETED|Baseline Phase||89
606262|NCT00394901|1483830|P2|COMPLETED|Baseline Phase||87
606263|NCT00394901|1483831|P1|COMPLETED|Baseline Phase||98
606264|NCT00394901|1483828|P4|STARTED|Baseline Phase|Subjects randomized|97
606265|NCT00394901|1483829|P3|STARTED|Baseline Phase|Subjects randomized|90
606266|NCT00394901|1483830|P2|STARTED|Baseline Phase|Subjects randomized|87
606267|NCT00394901|1483831|P1|STARTED|Baseline Phase|Subjects randomized|98
606268|NCT00394888|1484059|P3|NOT COMPLETED|Overall Study||0
606269|NCT00394888|1484060|P2|NOT COMPLETED|Overall Study||0
606270|NCT00394888|1484061|P1|NOT COMPLETED|Overall Study||0
606271|NCT00394888|1484059|P3|COMPLETED|Overall Study||201
606272|NCT00394888|1484060|P2|COMPLETED|Overall Study||48
606273|NCT00394888|1484061|P1|COMPLETED|Overall Study||108
606274|NCT00394888|1484059|P3|STARTED|Overall Study||201
606275|NCT00394888|1484060|P2|STARTED|Overall Study||48
606276|NCT00394888|1484061|P1|STARTED|Overall Study||108
606277|NCT00394836|1484074|P2|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||53
606278|NCT00394836|1484075|P1|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||20
606279|NCT00394836|1484074|P2|COMPLETED|Extended Follow-up Phase (2-5 Years)||5
606280|NCT00394836|1484075|P1|COMPLETED|Extended Follow-up Phase (2-5 Years)||0
606281|NCT00394836|1484074|P2|STARTED|Extended Follow-up Phase (2-5 Years)|Not all participants went into extended follow up per protocol.|58
606282|NCT00394836|1484075|P1|STARTED|Extended Follow-up Phase (2-5 Years)|Not all participants went into extended follow up per protocol.|20
606283|NCT00394836|1484074|P2|NOT COMPLETED|Teatment or Follow-up Phase||78
606284|NCT00394836|1484075|P1|NOT COMPLETED|Teatment or Follow-up Phase||28
606285|NCT00394836|1484074|P2|COMPLETED|Teatment or Follow-up Phase||8
606286|NCT00394836|1484075|P1|COMPLETED|Teatment or Follow-up Phase||2
606287|NCT00394836|1484074|P2|Early Follow-up Entry|Teatment or Follow-up Phase|Did not complete treatment.|8
606288|NCT00394836|1484075|P1|Early Follow-up Entry|Teatment or Follow-up Phase|Did not complete treatment.|4
606289|NCT00394836|1484074|P2|STARTED|Teatment or Follow-up Phase||86
606290|NCT00394836|1484075|P1|STARTED|Teatment or Follow-up Phase||30
606291|NCT00394771|1484121|P4|NOT COMPLETED|Overall Study||39
606292|NCT00394771|1484122|P3|NOT COMPLETED|Overall Study||47
606293|NCT00394771|1484123|P2|NOT COMPLETED|Overall Study||34
606294|NCT00394771|1484124|P1|NOT COMPLETED|Overall Study||41
606295|NCT00394771|1484121|P4|COMPLETED|Overall Study||109
606296|NCT00394771|1484122|P3|COMPLETED|Overall Study||96
606297|NCT00394771|1484123|P2|COMPLETED|Overall Study||102
606298|NCT00394771|1484124|P1|COMPLETED|Overall Study||99
606299|NCT00394771|1484121|P4|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|120
606300|NCT00394771|1484122|P3|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|108
606301|NCT00394771|1484123|P2|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|110
606302|NCT00394771|1484124|P1|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|110
606303|NCT00394771|1484121|P4|STARTED|Overall Study|Safety population of treated participants|148
606304|NCT00394771|1484122|P3|STARTED|Overall Study|Safety population of treated participants|143
606305|NCT00394771|1484123|P2|STARTED|Overall Study|Safety population of treated participants|136
606306|NCT00394771|1484124|P1|STARTED|Overall Study|Safety population of treated participants|140
606307|NCT00394706|1484194|P8|NOT COMPLETED|Overall Study||0
606308|NCT00394706|1484195|P7|NOT COMPLETED|Overall Study||3
606309|NCT00394706|1484196|P6|NOT COMPLETED|Overall Study||7
606310|NCT00394706|1484197|P5|NOT COMPLETED|Overall Study||2
606311|NCT00394706|1484198|P4|NOT COMPLETED|Overall Study||1
606312|NCT00394706|1484199|P3|NOT COMPLETED|Overall Study||9
606313|NCT00394706|1484200|P2|NOT COMPLETED|Overall Study||2
606314|NCT00394706|1484201|P1|NOT COMPLETED|Overall Study||4
606315|NCT00394706|1484194|P8|COMPLETED|Overall Study||851
606316|NCT00394706|1484195|P7|COMPLETED|Overall Study||926
606317|NCT00394706|1484196|P6|COMPLETED|Overall Study||1377
606318|NCT00394706|1484197|P5|COMPLETED|Overall Study||1634
606319|NCT00394706|1484198|P4|COMPLETED|Overall Study||1632
606320|NCT00394706|1484199|P3|COMPLETED|Overall Study||1615
606321|NCT00394706|1484200|P2|COMPLETED|Overall Study||1860
606322|NCT00394706|1484201|P1|COMPLETED|Overall Study||1815
606323|NCT00394706|1484194|P8|STARTED|Overall Study||851
606324|NCT00394706|1484195|P7|STARTED|Overall Study||929
606325|NCT00394706|1484196|P6|STARTED|Overall Study||1384
606326|NCT00394706|1484197|P5|STARTED|Overall Study||1636
606327|NCT00394706|1484198|P4|STARTED|Overall Study||1633
606328|NCT00394706|1484199|P3|STARTED|Overall Study||1624
606329|NCT00394706|1484200|P2|STARTED|Overall Study||1862
606330|NCT00394706|1484201|P1|STARTED|Overall Study||1819
606331|NCT00394654|1484221|P2|NOT COMPLETED|Overall Study||0
606332|NCT00394654|1484222|P1|NOT COMPLETED|Overall Study||2
606333|NCT00394654|1484221|P2|COMPLETED|Overall Study||15
606334|NCT00394654|1484222|P1|COMPLETED|Overall Study||13
606335|NCT00394654|1484221|P2|STARTED|Overall Study||15
606336|NCT00394654|1484222|P1|STARTED|Overall Study||15
606337|NCT00394589|1484287|P3|NOT COMPLETED|Overall Study||7
606338|NCT00394589|1484288|P2|NOT COMPLETED|Overall Study||3
606339|NCT00394589|1484289|P1|NOT COMPLETED|Overall Study||8
606340|NCT00394589|1484287|P3|COMPLETED|Overall Study||11
606341|NCT00394589|1484288|P2|COMPLETED|Overall Study||8
606342|NCT00394589|1484289|P1|COMPLETED|Overall Study||6
606343|NCT00394589|1484287|P3|STARTED|Overall Study||18
606344|NCT00394589|1484288|P2|STARTED|Overall Study||11
606345|NCT00394589|1484289|P1|STARTED|Overall Study||14
606346|NCT00394524|1484299|P2|NOT COMPLETED|Overall Study||10
606347|NCT00394524|1484300|P1|NOT COMPLETED|Overall Study||11
606348|NCT00394524|1484299|P2|COMPLETED|Overall Study||68
606349|NCT00394524|1484300|P1|COMPLETED|Overall Study||68
606350|NCT00394524|1484299|P2|STARTED|Overall Study||78
606351|NCT00394524|1484300|P1|STARTED|Overall Study||79
606352|NCT00394472|1484312|P2|NOT COMPLETED|Overall Study||11
606353|NCT00394472|1484313|P1|NOT COMPLETED|Overall Study||9
606354|NCT00394472|1484312|P2|COMPLETED|Overall Study||111
606355|NCT00394472|1484313|P1|COMPLETED|Overall Study||113
606356|NCT00394472|1484312|P2|STARTED|Overall Study||122
606357|NCT00394472|1484313|P1|STARTED|Overall Study||122
606358|NCT00394433|1484321|P1|NOT COMPLETED|Overall Study||3
606359|NCT00394433|1484321|P1|COMPLETED|Overall Study||35
606360|NCT00394433|1484321|P1|Evaluable and Treated|Overall Study||35
606361|NCT00394433|1484321|P1|STARTED|Overall Study||38
606362|NCT00394355|1484332|P4|NOT COMPLETED|Overall Study||31
606363|NCT00394355|1484333|P3|NOT COMPLETED|Overall Study||38
606364|NCT00394355|1484334|P2|NOT COMPLETED|Overall Study||34
606365|NCT00394355|1484335|P1|NOT COMPLETED|Overall Study||35
606366|NCT00394355|1484332|P4|COMPLETED|Overall Study||111
606367|NCT00394355|1484333|P3|COMPLETED|Overall Study||109
606368|NCT00394355|1484334|P2|COMPLETED|Overall Study||103
606369|NCT00394355|1484335|P1|COMPLETED|Overall Study||105
606370|NCT00394355|1484332|P4|STARTED|Overall Study||142
606371|NCT00394355|1484333|P3|STARTED|Overall Study||147
606372|NCT00394355|1484334|P2|STARTED|Overall Study||137
606373|NCT00394355|1484335|P1|STARTED|Overall Study||140
606374|NCT00394329|1484361|P4|NOT COMPLETED|Overall Study||24
606375|NCT00394329|1484362|P3|NOT COMPLETED|Overall Study||13
606376|NCT00394329|1484363|P2|NOT COMPLETED|Overall Study||9
606377|NCT00394329|1484364|P1|NOT COMPLETED|Overall Study||8
606378|NCT00394329|1484361|P4|COMPLETED|Overall Study||50
606379|NCT00394329|1484362|P3|COMPLETED|Overall Study||58
606380|NCT00394329|1484363|P2|COMPLETED|Overall Study||63
606381|NCT00394329|1484364|P1|COMPLETED|Overall Study||63
606382|NCT00394329|1484361|P4|STARTED|Overall Study||74
606383|NCT00394329|1484362|P3|STARTED|Overall Study||71
606384|NCT00394329|1484363|P2|STARTED|Overall Study||72
606385|NCT00394329|1484364|P1|STARTED|Overall Study||71
606386|NCT00394277|1484414|P4|NOT COMPLETED|Overall Study||125
606387|NCT00394277|1484415|P3|NOT COMPLETED|Overall Study||120
606388|NCT00394277|1484416|P2|NOT COMPLETED|Overall Study||60
606389|NCT00394277|1484417|P1|NOT COMPLETED|Overall Study||58
606390|NCT00394277|1484414|P4|COMPLETED|Overall Study||266
606391|NCT00394277|1484415|P3|COMPLETED|Overall Study||273
606392|NCT00394277|1484416|P2|COMPLETED|Overall Study||136
606393|NCT00394277|1484417|P1|COMPLETED|Overall Study||137
606394|NCT00394277|1484414|P4|STARTED|Overall Study||391
606395|NCT00394277|1484415|P3|STARTED|Overall Study||393
606396|NCT00394277|1484416|P2|STARTED|Overall Study||196
606397|NCT00394277|1484417|P1|STARTED|Overall Study||195
606398|NCT00394251|1484441|P2|NOT COMPLETED|Overall Study||38
606399|NCT00394251|1484442|P1|NOT COMPLETED|Overall Study||37
606400|NCT00394251|1484441|P2|COMPLETED|Overall Study||61
606401|NCT00394251|1484442|P1|COMPLETED|Overall Study||61
606402|NCT00394251|1484441|P2|At Least One Dose of Taxane|Overall Study||93
606403|NCT00394251|1484442|P1|At Least One Dose of Taxane|Overall Study||93
606404|NCT00394251|1484441|P2|STARTED|Overall Study||99
606405|NCT00394251|1484442|P1|STARTED|Overall Study||98
606406|NCT00394212|1484470|P2|NOT COMPLETED|Overall Study||1
606407|NCT00394212|1484471|P1|NOT COMPLETED|Overall Study||7
606408|NCT00394212|1484470|P2|COMPLETED|Overall Study||26
606409|NCT00394212|1484471|P1|COMPLETED|Overall Study||43
606410|NCT00394212|1484470|P2|6 Month Follow-up|Overall Study||26
606411|NCT00394212|1484471|P1|6 Month Follow-up|Overall Study||43
606412|NCT00394212|1484470|P2|3 Month Follow-up|Overall Study||26
606413|NCT00394212|1484471|P1|3 Month Follow-up|Overall Study||45
606414|NCT00394212|1484470|P2|6 Week Follow-up|Overall Study||26
606415|NCT00394212|1484471|P1|6 Week Follow-up|Overall Study||45
606416|NCT00394212|1484470|P2|STARTED|Overall Study||27
606417|NCT00394212|1484471|P1|STARTED|Overall Study|2 subjects assigned to suturing underwent sham procedure, results based on Intent-To-Treat (ITT)|50
606418|NCT00394095|1484485|P2|NOT COMPLETED|Overall Study||0
606419|NCT00394095|1484486|P1|NOT COMPLETED|Overall Study||1
606420|NCT00394095|1484485|P2|COMPLETED|Overall Study||14
606421|NCT00394095|1484486|P1|COMPLETED|Overall Study||16
606422|NCT00394095|1484485|P2|Screened|Overall Study||14
606423|NCT00394095|1484486|P1|Screened|Overall Study||17
606424|NCT00394095|1484485|P2|STARTED|Overall Study||14
606425|NCT00394095|1484486|P1|STARTED|Overall Study||17
606426|NCT00394082|1484494|P1|NOT COMPLETED|Overall Study||26
606427|NCT00394082|1484494|P1|COMPLETED|Overall Study|Treatment completed upon disease progression|24
606428|NCT00394082|1484494|P1|At Least One Response Assessment|Overall Study||43
606429|NCT00394082|1484494|P1|STARTED|Overall Study||50
606430|NCT00393978|1484505|P2|NOT COMPLETED|Overall Study||20
606431|NCT00393978|1484506|P1|NOT COMPLETED|Overall Study||16
606432|NCT00393978|1484505|P2|COMPLETED|Overall Study||18
606433|NCT00393978|1484506|P1|COMPLETED|Overall Study||21
606434|NCT00393978|1484505|P2|STARTED|Overall Study||38
606435|NCT00393978|1484506|P1|STARTED|Overall Study||37
606436|NCT00393939|1484516|P2|NOT COMPLETED|Overall Study||297
606437|NCT00393939|1484517|P1|NOT COMPLETED|Overall Study||296
606438|NCT00393939|1484516|P2|COMPLETED|Overall Study||0
606439|NCT00393939|1484517|P1|COMPLETED|Overall Study||0
606440|NCT00393939|1484516|P2|Treated|Overall Study||293
606441|NCT00393939|1484517|P1|Treated|Overall Study||295
606442|NCT00393939|1484516|P2|STARTED|Overall Study||297
606443|NCT00393939|1484517|P1|STARTED|Overall Study||296
606444|NCT00393913|1484535|P1|NOT COMPLETED|CPAP Withdrawal||0
606445|NCT00393913|1484535|P1|COMPLETED|CPAP Withdrawal||42
606446|NCT00393913|1484535|P1|CPAP Compliance|CPAP Withdrawal|Only subjects with sufficient CPAP complaince (>4 hrs/night) were included.|42
606447|NCT00393913|1484535|P1|STARTED|CPAP Withdrawal|Includes only subjects with good CPAP adherence|42
606448|NCT00393913|1484535|P1|NOT COMPLETED|CPAP||7
606449|NCT00393913|1484535|P1|COMPLETED|CPAP||93
606450|NCT00393913|1484535|P1|STARTED|CPAP|Excludes normal volunteers without OSA|100
606451|NCT00393913|1484535|P1|NOT COMPLETED|Initial Assessment||37
606452|NCT00393913|1484535|P1|COMPLETED|Initial Assessment||107
606453|NCT00393913|1484535|P1|STARTED|Initial Assessment||144
606454|NCT00393887|1484543|P2|NOT COMPLETED|Overall Study||9
606455|NCT00393887|1484544|P1|NOT COMPLETED|Overall Study||16
606456|NCT00393887|1484543|P2|COMPLETED|Overall Study||41
606457|NCT00393887|1484544|P1|COMPLETED|Overall Study||34
606458|NCT00393887|1484543|P2|1 Year|Overall Study||50
606459|NCT00393887|1484544|P1|1 Year|Overall Study||45
606460|NCT00393887|1484543|P2|STARTED|Overall Study||50
606461|NCT00393887|1484544|P1|STARTED|Overall Study||50
606462|NCT00393874|1484553|P3|NOT COMPLETED|Overall Study||2
606463|NCT00393874|1484554|P2|NOT COMPLETED|Overall Study||4
606464|NCT00393874|1484555|P1|NOT COMPLETED|Overall Study||3
606465|NCT00393874|1484553|P3|COMPLETED|Overall Study||13
606466|NCT00393874|1484554|P2|COMPLETED|Overall Study||13
606467|NCT00393874|1484555|P1|COMPLETED|Overall Study||15
606468|NCT00393874|1484553|P3|STARTED|Overall Study||15
606469|NCT00393874|1484554|P2|STARTED|Overall Study||17
606470|NCT00393874|1484555|P1|STARTED|Overall Study||18
606471|NCT00393861|1484572|P1|NOT COMPLETED|Overall Study||26
606472|NCT00393861|1484572|P1|COMPLETED|Overall Study||3
606473|NCT00393861|1484572|P1|STARTED|Overall Study||29
606474|NCT00393848|1484583|P4|NOT COMPLETED|Overall Study||1
606475|NCT00393848|1484584|P3|NOT COMPLETED|Overall Study||2
606476|NCT00393848|1484585|P2|NOT COMPLETED|Overall Study||0
606477|NCT00393848|1484586|P1|NOT COMPLETED|Overall Study||0
606478|NCT00393848|1484583|P4|COMPLETED|Overall Study||8
606479|NCT00393848|1484584|P3|COMPLETED|Overall Study||4
606480|NCT00393848|1484585|P2|COMPLETED|Overall Study||9
606481|NCT00393848|1484586|P1|COMPLETED|Overall Study||16
606482|NCT00393848|1484583|P4|STARTED|Overall Study||9
606483|NCT00393848|1484584|P3|STARTED|Overall Study||6
606484|NCT00393848|1484585|P2|STARTED|Overall Study||9
606485|NCT00393848|1484586|P1|STARTED|Overall Study||16
606486|NCT00393796|1484600|P2|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0
606487|NCT00393796|1484601|P1|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0
606488|NCT00393796|1484600|P2|COMPLETED|Open Label Period - Placebo to SUTENT||16
606489|NCT00393796|1484601|P1|COMPLETED|Open Label Period - Placebo to SUTENT||0
606490|NCT00393796|1484600|P2|STARTED|Open Label Period - Placebo to SUTENT||16
606491|NCT00393796|1484601|P1|STARTED|Open Label Period - Placebo to SUTENT||0
606492|NCT00393796|1484600|P2|NOT COMPLETED|Double Blind Period||0
606493|NCT00393796|1484601|P1|NOT COMPLETED|Double Blind Period||0
606494|NCT00393796|1484600|P2|COMPLETED|Double Blind Period||28
606495|NCT00393796|1484601|P1|COMPLETED|Double Blind Period||26
606496|NCT00393796|1484600|P2|STARTED|Double Blind Period||28
606497|NCT00393796|1484601|P1|STARTED|Double Blind Period||26
606498|NCT00393718|1484609|P2|NOT COMPLETED|Overall Study||22
606499|NCT00393718|1484610|P1|NOT COMPLETED|Overall Study||43
606500|NCT00393718|1484609|P2|COMPLETED|Overall Study||110
606501|NCT00393718|1484610|P1|COMPLETED|Overall Study||225
606502|NCT00393718|1484609|P2|STARTED|Overall Study||132
606503|NCT00393718|1484610|P1|STARTED|Overall Study||268
606504|NCT00393705|1484642|P2|NOT COMPLETED|Overall Study||23
606505|NCT00393705|1484643|P1|NOT COMPLETED|Overall Study||23
606506|NCT00393705|1484642|P2|COMPLETED|Overall Study||128
606507|NCT00393705|1484643|P1|COMPLETED|Overall Study||128
606508|NCT00393705|1484642|P2|Received at Least One Dose of Study Drug|Overall Study||139
606509|NCT00393705|1484643|P1|Received at Least One Dose of Study Drug|Overall Study||139
606510|NCT00393705|1484642|P2|STARTED|Overall Study||151
606511|NCT00393705|1484643|P1|STARTED|Overall Study||151
606512|NCT00393523|1484672|P5|NOT COMPLETED|Overall Study||1
606513|NCT00393523|1484673|P4|NOT COMPLETED|Overall Study||6
606514|NCT00393523|1484674|P3|NOT COMPLETED|Overall Study||4
606515|NCT00393523|1484675|P2|NOT COMPLETED|Overall Study||9
606516|NCT00393523|1484676|P1|NOT COMPLETED|Overall Study||12
606517|NCT00393523|1484672|P5|COMPLETED|Overall Study||19
606518|NCT00393523|1484673|P4|COMPLETED|Overall Study||348
606519|NCT00393523|1484674|P3|COMPLETED|Overall Study||349
606520|NCT00393523|1484675|P2|COMPLETED|Overall Study||366
606521|NCT00393523|1484676|P1|COMPLETED|Overall Study||364
606522|NCT00393523|1484672|P5|Vaccination Visit 1|Overall Study||20
606523|NCT00393523|1484673|P4|Vaccination Visit 1|Overall Study||352
606524|NCT00393523|1484674|P3|Vaccination Visit 1|Overall Study||349
606525|NCT00393523|1484675|P2|Vaccination Visit 1|Overall Study||375
606526|NCT00393523|1484676|P1|Vaccination Visit 1|Overall Study||374
606527|NCT00393523|1484672|P5|STARTED|Overall Study||20
606528|NCT00393523|1484673|P4|STARTED|Overall Study||354
606529|NCT00393523|1484674|P3|STARTED|Overall Study||353
606530|NCT00393523|1484675|P2|STARTED|Overall Study||375
606531|NCT00393523|1484676|P1|STARTED|Overall Study||376
606532|NCT00393510|1484693|P2|NOT COMPLETED|Overall Study||9
606533|NCT00393510|1484694|P1|NOT COMPLETED|Overall Study||3
606534|NCT00393510|1484693|P2|COMPLETED|Overall Study||31
606535|NCT00393510|1484694|P1|COMPLETED|Overall Study||37
606536|NCT00393510|1484693|P2|STARTED|Overall Study||40
606537|NCT00393510|1484694|P1|STARTED|Overall Study||40
606538|NCT00393484|1484706|P2|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||23
606539|NCT00393484|1484707|P1|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||8
606540|NCT00393484|1484706|P2|COMPLETED|Open-label Period (Weeks 96 to 240)||21
606541|NCT00393484|1484707|P1|COMPLETED|Open-label Period (Weeks 96 to 240)||40
606542|NCT00393484|1484706|P2|Lack of Efficacy|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|2
606543|NCT00393484|1484707|P1|Lack of Efficacy|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|0
606544|NCT00393484|1484706|P2|Withdrew Consent|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|6
606718|NCT00392392|1485125|P1|COMPLETED|Overall Study||9
606545|NCT00393484|1484707|P1|Withdrew Consent|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|6
606546|NCT00393484|1484706|P2|STARTED|Open-label Period (Weeks 96 to 240)||44
606547|NCT00393484|1484707|P1|STARTED|Open-label Period (Weeks 96 to 240)||48
606548|NCT00393484|1484706|P2|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||12
606549|NCT00393484|1484707|P1|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||2
606550|NCT00393484|1484706|P2|COMPLETED|Double-blind Period (Day 1 to Week 96)||52
606551|NCT00393484|1484707|P1|COMPLETED|Double-blind Period (Day 1 to Week 96)||54
606552|NCT00393484|1484706|P2|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1
606553|NCT00393484|1484707|P1|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1
606554|NCT00393484|1484706|P2|STARTED|Double-blind Period (Day 1 to Week 96)|Number treated|64
606555|NCT00393484|1484707|P1|STARTED|Double-blind Period (Day 1 to Week 96)|Number treated|56
606556|NCT00393458|1484743|P4|NOT COMPLETED|Overall Study||137
606557|NCT00393458|1484744|P3|NOT COMPLETED|Overall Study||112
606558|NCT00393458|1484745|P2|NOT COMPLETED|Overall Study||102
606559|NCT00393458|1484746|P1|NOT COMPLETED|Overall Study||99
606560|NCT00393458|1484743|P4|COMPLETED|Overall Study||295
606561|NCT00393458|1484744|P3|COMPLETED|Overall Study||323
606562|NCT00393458|1484745|P2|COMPLETED|Overall Study||326
606563|NCT00393458|1484746|P1|COMPLETED|Overall Study||338
606564|NCT00393458|1484743|P4|Exposed to Study Medication or Placebo|Overall Study||432
606565|NCT00393458|1484744|P3|Exposed to Study Medication or Placebo|Overall Study||434
606566|NCT00393458|1484745|P2|Exposed to Study Medication or Placebo|Overall Study||425
606567|NCT00393458|1484746|P1|Exposed to Study Medication or Placebo|Overall Study||437
606568|NCT00393458|1484743|P4|STARTED|Overall Study||432
606569|NCT00393458|1484744|P3|STARTED|Overall Study||435
606570|NCT00393458|1484745|P2|STARTED|Overall Study||428
606571|NCT00393458|1484746|P1|STARTED|Overall Study||437
606572|NCT00393380|1484760|P1|NOT COMPLETED|Overall Study||0
606573|NCT00393380|1484760|P1|COMPLETED|Overall Study||13
606574|NCT00393380|1484760|P1|STARTED|Overall Study||13
606575|NCT00393367|1484773|P2|NOT COMPLETED|Overall Study||7
606576|NCT00393367|1484774|P1|NOT COMPLETED|Overall Study||2
606577|NCT00393367|1484773|P2|COMPLETED|Overall Study||81
606578|NCT00393367|1484774|P1|COMPLETED|Overall Study||89
606579|NCT00393367|1484773|P2|STARTED|Overall Study||88
606580|NCT00393367|1484774|P1|STARTED|Overall Study||91
606581|NCT00393094|1484802|P1|NOT COMPLETED|Disease Progression After Trtmt: Onstudy||1
606582|NCT00393094|1484802|P1|COMPLETED|Disease Progression After Trtmt: Onstudy||29
606583|NCT00393094|1484802|P1|STARTED|Disease Progression After Trtmt: Onstudy||30
606584|NCT00393094|1484802|P1|NOT COMPLETED|Period1Bevacizumab & Irinotecan Patients||1
606585|NCT00393094|1484802|P1|COMPLETED|Period1Bevacizumab & Irinotecan Patients||30
606586|NCT00393094|1484802|P1|STARTED|Period1Bevacizumab & Irinotecan Patients||31
606587|NCT00393068|1484809|P1|NOT COMPLETED|Overall Study||18
606588|NCT00393068|1484809|P1|COMPLETED|Overall Study||44
606589|NCT00393068|1484809|P1|STARTED|Overall Study||62
606590|NCT00393042|1484813|P2|NOT COMPLETED|Second Intervetion||8
606591|NCT00393042|1484814|P1|NOT COMPLETED|Second Intervetion||2
606592|NCT00393042|1484813|P2|COMPLETED|Second Intervetion||19
606593|NCT00393042|1484814|P1|COMPLETED|Second Intervetion||24
606594|NCT00393042|1484813|P2|Completed 25/30 mg Dosage|Second Intervetion||20
606595|NCT00393042|1484814|P1|Completed 25/30 mg Dosage|Second Intervetion||24
606596|NCT00393042|1484813|P2|Completed the 20mg Dosage|Second Intervetion||21
606597|NCT00393042|1484814|P1|Completed the 20mg Dosage|Second Intervetion||24
606598|NCT00393042|1484813|P2|Completed 10 mg Dosage|Second Intervetion||24
606599|NCT00393042|1484814|P1|Completed 10 mg Dosage|Second Intervetion||26
606600|NCT00393042|1484813|P2|Completed Placebo Dosage|Second Intervetion||21
606601|NCT00393042|1484814|P1|Completed Placebo Dosage|Second Intervetion||25
606602|NCT00393042|1484813|P2|STARTED|Second Intervetion||27
606603|NCT00393042|1484814|P1|STARTED|Second Intervetion||26
606604|NCT00393042|1484813|P2|NOT COMPLETED|First Intervention||6
606605|NCT00393042|1484814|P1|NOT COMPLETED|First Intervention||5
606606|NCT00393042|1484813|P2|COMPLETED|First Intervention||27
606607|NCT00393042|1484814|P1|COMPLETED|First Intervention||26
606608|NCT00393042|1484813|P2|Completed 25/30mg Dosage|First Intervention||27
606609|NCT00393042|1484814|P1|Completed 25/30mg Dosage|First Intervention||27
606610|NCT00393042|1484813|P2|Completed 20 mg Dosage|First Intervention||28
606611|NCT00393042|1484814|P1|Completed 20 mg Dosage|First Intervention||26
606612|NCT00393042|1484813|P2|Completed 10mg Dosage|First Intervention||29
606613|NCT00393042|1484814|P1|Completed 10mg Dosage|First Intervention||29
606614|NCT00393042|1484813|P2|Completed the Placebo Dosage|First Intervention||29
606615|NCT00393042|1484814|P1|Completed the Placebo Dosage|First Intervention||27
606616|NCT00393042|1484813|P2|STARTED|First Intervention||33
606617|NCT00393042|1484814|P1|STARTED|First Intervention||31
606618|NCT00393029|1484886|P2|NOT COMPLETED|Overall Study||1
606619|NCT00393029|1484887|P1|NOT COMPLETED|Overall Study||0
606620|NCT00393029|1484886|P2|COMPLETED|Overall Study||9
606621|NCT00393029|1484887|P1|COMPLETED|Overall Study||2
606622|NCT00393029|1484886|P2|STARTED|Overall Study||10
606623|NCT00393029|1484887|P1|STARTED|Overall Study||2
606624|NCT00392951|1484896|P1|NOT COMPLETED|Overall Study||0
606625|NCT00392951|1484896|P1|COMPLETED|Overall Study||30
606626|NCT00392951|1484896|P1|STARTED|Overall Study||30
606627|NCT00392925|1484908|P4|NOT COMPLETED|Randomization to Treatment Group Period||18
606628|NCT00392925|1484909|P3|NOT COMPLETED|Randomization to Treatment Group Period||19
606629|NCT00392925|1484910|P2|NOT COMPLETED|Randomization to Treatment Group Period||8
606630|NCT00392925|1484911|P1|NOT COMPLETED|Randomization to Treatment Group Period||0
606631|NCT00392925|1484908|P4|COMPLETED|Randomization to Treatment Group Period|At Week 20|38
606632|NCT00392925|1484909|P3|COMPLETED|Randomization to Treatment Group Period|At Week 20|37
606633|NCT00392925|1484910|P2|COMPLETED|Randomization to Treatment Group Period|AT Week 20|19
606634|NCT00392925|1484911|P1|COMPLETED|Randomization to Treatment Group Period||0
606635|NCT00392925|1484908|P4|STARTED|Randomization to Treatment Group Period||56
606636|NCT00392925|1484909|P3|STARTED|Randomization to Treatment Group Period||56
606637|NCT00392925|1484910|P2|STARTED|Randomization to Treatment Group Period||27
606638|NCT00392925|1484911|P1|STARTED|Randomization to Treatment Group Period||0
606639|NCT00392925|1484908|P4|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
606640|NCT00392925|1484909|P3|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
606641|NCT00392925|1484910|P2|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
606642|NCT00392925|1484911|P1|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||38
606643|NCT00392925|1484908|P4|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
606644|NCT00392925|1484909|P3|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
606645|NCT00392925|1484910|P2|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
606646|NCT00392925|1484911|P1|COMPLETED|4 Week Lead-In Period - Non-Randomized||139
606647|NCT00392925|1484908|P4|STARTED|4 Week Lead-In Period - Non-Randomized||0
606648|NCT00392925|1484909|P3|STARTED|4 Week Lead-In Period - Non-Randomized||0
606649|NCT00392925|1484910|P2|STARTED|4 Week Lead-In Period - Non-Randomized||0
606650|NCT00392925|1484911|P1|STARTED|4 Week Lead-In Period - Non-Randomized||177
606651|NCT00392860|1484999|P3|NOT COMPLETED|Overall Study||0
606652|NCT00392860|1485000|P2|NOT COMPLETED|Overall Study||0
606653|NCT00392860|1485001|P1|NOT COMPLETED|Overall Study||0
606654|NCT00392860|1484999|P3|COMPLETED|Overall Study||1
606655|NCT00392860|1485000|P2|COMPLETED|Overall Study||0
606656|NCT00392860|1485001|P1|COMPLETED|Overall Study||3
606657|NCT00392860|1484999|P3|STARTED|Overall Study||1
606658|NCT00392860|1485000|P2|STARTED|Overall Study||0
606659|NCT00392860|1485001|P1|STARTED|Overall Study||3
606660|NCT00392834|1485009|P2|NOT COMPLETED|Overall Study||0
606661|NCT00392834|1485010|P1|NOT COMPLETED|Overall Study||0
606662|NCT00392834|1485009|P2|COMPLETED|Overall Study||32
606663|NCT00392834|1485010|P1|COMPLETED|Overall Study||2
606664|NCT00392834|1485009|P2|STARTED|Overall Study||32
606665|NCT00392834|1485010|P1|STARTED|Overall Study||2
606666|NCT00392821|1485016|P1|NOT COMPLETED|Overall Study||19
606667|NCT00392821|1485016|P1|COMPLETED|Overall Study||59
606668|NCT00392821|1485016|P1|STARTED|Overall Study||78
606669|NCT00392808|1485025|P4|NOT COMPLETED|Overall Study||4
606670|NCT00392808|1485026|P3|NOT COMPLETED|Overall Study||2
606671|NCT00392808|1485027|P2|NOT COMPLETED|Overall Study||3
606672|NCT00392808|1485028|P1|NOT COMPLETED|Overall Study||6
606673|NCT00392808|1485025|P4|COMPLETED|Overall Study||100
606674|NCT00392808|1485026|P3|COMPLETED|Overall Study||107
606675|NCT00392808|1485027|P2|COMPLETED|Overall Study||86
606676|NCT00392808|1485028|P1|COMPLETED|Overall Study||81
606677|NCT00392808|1485025|P4|STARTED|Overall Study||104
606678|NCT00392808|1485026|P3|STARTED|Overall Study||109
606679|NCT00392808|1485027|P2|STARTED|Overall Study||89
606680|NCT00392808|1485028|P1|STARTED|Overall Study||87
606681|NCT00392782|1485042|P1|NOT COMPLETED|Overall Study||0
606682|NCT00392782|1485042|P1|COMPLETED|Overall Study||24
606683|NCT00392782|1485042|P1|STARTED|Overall Study||24
606684|NCT00392769|1485052|P1|NOT COMPLETED|Overall Study||10
606685|NCT00392769|1485052|P1|COMPLETED|Overall Study||23
606686|NCT00392769|1485052|P1|STARTED|Overall Study||33
606687|NCT00392704|1485056|P1|NOT COMPLETED|Combined Modality Therapy||5
606688|NCT00392704|1485056|P1|COMPLETED|Combined Modality Therapy||49
606689|NCT00392704|1485056|P1|STARTED|Combined Modality Therapy||54
606690|NCT00392704|1485056|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||6
606691|NCT00392704|1485056|P1|COMPLETED|Neoadjuvant Chemotherapy||54
606692|NCT00392704|1485056|P1|STARTED|Neoadjuvant Chemotherapy||60
606693|NCT00392678|1485065|P4|NOT COMPLETED|Overall Study||1
606694|NCT00392678|1485066|P3|NOT COMPLETED|Overall Study||2
606695|NCT00392678|1485067|P2|NOT COMPLETED|Overall Study||1
606696|NCT00392678|1485068|P1|NOT COMPLETED|Overall Study||0
606697|NCT00392678|1485065|P4|COMPLETED|Overall Study||26
606698|NCT00392678|1485066|P3|COMPLETED|Overall Study||25
606699|NCT00392678|1485067|P2|COMPLETED|Overall Study||26
606700|NCT00392678|1485068|P1|COMPLETED|Overall Study||27
606701|NCT00392678|1485065|P4|STARTED|Overall Study||27
606702|NCT00392678|1485066|P3|STARTED|Overall Study||27
606703|NCT00392678|1485067|P2|STARTED|Overall Study||27
606704|NCT00392678|1485068|P1|STARTED|Overall Study||27
606705|NCT00392665|1485104|P2|NOT COMPLETED|Overall Study||15
606706|NCT00392665|1485105|P1|NOT COMPLETED|Overall Study||17
606707|NCT00392665|1485104|P2|COMPLETED|Overall Study||3
606708|NCT00392665|1485105|P1|COMPLETED|Overall Study||1
606709|NCT00392665|1485104|P2|STARTED|Overall Study||18
606710|NCT00392665|1485105|P1|STARTED|Overall Study||18
606711|NCT00392496|1485117|P1|NOT COMPLETED|Overall Study||0
606712|NCT00392496|1485117|P1|COMPLETED|Overall Study||19
606713|NCT00392496|1485117|P1|STARTED|Overall Study||19
606714|NCT00392444|1485121|P1|NOT COMPLETED|Overall Study||0
606715|NCT00392444|1485121|P1|COMPLETED|Overall Study||39
606716|NCT00392444|1485121|P1|STARTED|Overall Study||39
606717|NCT00392392|1485125|P1|NOT COMPLETED|Overall Study||20
606719|NCT00392392|1485125|P1|STARTED|Overall Study||29
606720|NCT00392379|1485131|P2|NOT COMPLETED|Overall Study||38
606721|NCT00392379|1485132|P1|NOT COMPLETED|Overall Study||22
606722|NCT00392379|1485131|P2|COMPLETED|Overall Study|Medication period|96
606723|NCT00392379|1485132|P1|COMPLETED|Overall Study|Medication period|114
606724|NCT00392379|1485131|P2|STARTED|Overall Study|Medication period|134
606725|NCT00392379|1485132|P1|STARTED|Overall Study|Medication period|136
606726|NCT00392288|1485145|P3|NOT COMPLETED|Overall Study||17
606727|NCT00392288|1485146|P2|NOT COMPLETED|Overall Study||22
606728|NCT00392288|1485147|P1|NOT COMPLETED|Overall Study||32
606729|NCT00392288|1485145|P3|COMPLETED|Overall Study|ITT set = 172 patients|159
606730|NCT00392288|1485146|P2|COMPLETED|Overall Study|ITT set = 166 patients|155
606731|NCT00392288|1485147|P1|COMPLETED|Overall Study|ITT set = 163 patients|143
606732|NCT00392288|1485145|P3|Treatment Period|Overall Study||175
606733|NCT00392288|1485146|P2|Treatment Period|Overall Study||174
606734|NCT00392288|1485147|P1|Treatment Period|Overall Study||172
606735|NCT00392288|1485145|P3|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|176
606736|NCT00392288|1485146|P2|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|177
606737|NCT00392288|1485147|P1|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|175
606738|NCT00392236|1485163|P2|NOT COMPLETED|Overall Study||6
606739|NCT00392236|1485164|P1|NOT COMPLETED|Overall Study||12
606740|NCT00392236|1485163|P2|COMPLETED|Overall Study|Defined as having adherence data for month 6 of the study.|12
606741|NCT00392236|1485164|P1|COMPLETED|Overall Study|Defined as having adherence data for month 6 of the study.|8
606742|NCT00392236|1485163|P2|STARTED|Overall Study|1 subject post randomization was found to not meet inclusion criteria|18
606743|NCT00392236|1485164|P1|STARTED|Overall Study|1 subject post randomization was found to not meet inclusion criteria|20
606744|NCT00392223|1485172|P2|NOT COMPLETED|Overall Study||13
606745|NCT00392223|1485173|P1|NOT COMPLETED|Overall Study||9
606746|NCT00392223|1485172|P2|COMPLETED|Overall Study||47
606747|NCT00392223|1485173|P1|COMPLETED|Overall Study||49
606748|NCT00392223|1485172|P2|STARTED|Overall Study||60
606749|NCT00392223|1485173|P1|STARTED|Overall Study||58
606750|NCT00392210|1485191|P2|NOT COMPLETED|Second Voiding Trial||0
606751|NCT00392210|1485192|P1|NOT COMPLETED|Second Voiding Trial||0
606752|NCT00392210|1485191|P2|COMPLETED|Second Voiding Trial||31
606753|NCT00392210|1485192|P1|COMPLETED|Second Voiding Trial||34
606754|NCT00392210|1485191|P2|STARTED|Second Voiding Trial||31
606755|NCT00392210|1485192|P1|STARTED|Second Voiding Trial||34
606756|NCT00392210|1485191|P2|NOT COMPLETED|First Voiding Trial||2
606757|NCT00392210|1485192|P1|NOT COMPLETED|First Voiding Trial||2
606758|NCT00392210|1485191|P2|COMPLETED|First Voiding Trial||31
606759|NCT00392210|1485192|P1|COMPLETED|First Voiding Trial||34
606760|NCT00392210|1485191|P2|STARTED|First Voiding Trial||33
606761|NCT00392210|1485192|P1|STARTED|First Voiding Trial||36
606762|NCT00392197|1485200|P2|NOT COMPLETED|Overall Study||30
606763|NCT00392197|1485201|P1|NOT COMPLETED|Overall Study||21
606764|NCT00392197|1485200|P2|COMPLETED|Overall Study||33
606765|NCT00392197|1485201|P1|COMPLETED|Overall Study||27
606766|NCT00392197|1485200|P2|STARTED|Overall Study||63
606767|NCT00392197|1485201|P1|STARTED|Overall Study||48
606768|NCT00392171|1485209|P1|NOT COMPLETED|Overall Study||105
606769|NCT00392171|1485209|P1|COMPLETED|Overall Study||15
606770|NCT00392171|1485209|P1|STARTED|Overall Study||120
606771|NCT00391989|1485213|P1|NOT COMPLETED|Overall Study||2
606772|NCT00391989|1485213|P1|COMPLETED|Overall Study||53
606773|NCT00391989|1485213|P1|STARTED|Overall Study||55
606774|NCT00391976|1485220|P3|NOT COMPLETED|Overall Study||35
606775|NCT00391976|1485221|P2|NOT COMPLETED|Overall Study||25
606776|NCT00391976|1485222|P1|NOT COMPLETED|Overall Study||27
606777|NCT00391976|1485220|P3|COMPLETED|Overall Study||0
606778|NCT00391976|1485221|P2|COMPLETED|Overall Study||18
606779|NCT00391976|1485222|P1|COMPLETED|Overall Study||18
606780|NCT00391976|1485220|P3|Safety Population|Overall Study||35
606781|NCT00391976|1485221|P2|Safety Population|Overall Study||43
606782|NCT00391976|1485222|P1|Safety Population|Overall Study|Patients who were enrolled and received at least one dose of study medication.|44
606783|NCT00391976|1485220|P3|Randomized|Overall Study||0
606784|NCT00391976|1485221|P2|Randomized|Overall Study||43
606785|NCT00391976|1485222|P1|Randomized|Overall Study|Randomization occurred after 28 days of treatment & negative antibody test aeruginosa antibody test|45
606786|NCT00391976|1485220|P3|STARTED|Overall Study||35
606787|NCT00391976|1485221|P2|STARTED|Overall Study||43
606788|NCT00391976|1485222|P1|STARTED|Overall Study|Started indicates all patients who were enrolled at Visit 1|45
606789|NCT00391898|1485246|P2|NOT COMPLETED|Overall Study||10
606790|NCT00391898|1485247|P1|NOT COMPLETED|Overall Study||11
606791|NCT00391898|1485246|P2|COMPLETED|Overall Study||39
606792|NCT00391898|1485247|P1|COMPLETED|Overall Study||35
606793|NCT00391898|1485246|P2|STARTED|Overall Study||49
606794|NCT00391898|1485247|P1|STARTED|Overall Study|Safety population for Levodopa/carbidopa/entacapone is 45, for Levodopa/carbidopa, per randomized.|46
606795|NCT00391872|1485267|P2|NOT COMPLETED|Overall Study||255
606796|NCT00391872|1485268|P1|NOT COMPLETED|Overall Study||307
606797|NCT00391872|1485267|P2|COMPLETED|Overall Study||9036
606798|NCT00391872|1485268|P1|COMPLETED|Overall Study||9026
606799|NCT00391872|1485267|P2|STARTED|Overall Study||9291
606800|NCT00391872|1485268|P1|STARTED|Overall Study||9333
606801|NCT00391846|1485306|P2|NOT COMPLETED|Overall Study||7
606802|NCT00391846|1485307|P1|NOT COMPLETED|Overall Study||8
606803|NCT00391846|1485306|P2|COMPLETED|Overall Study|118 completed patients includes 5 CV related deaths|118
606804|NCT00391846|1485307|P1|COMPLETED|Overall Study|119 completed patients includes 4 CV related deaths|119
606805|NCT00391846|1485306|P2|STARTED|Overall Study|Of th 125 randomised patients 7 were discontinued|125
606806|NCT00391846|1485307|P1|STARTED|Overall Study|Of the 127 randomised patients 8 were discontinued|127
606807|NCT00391807|1485327|P1|NOT COMPLETED|Overall Study||715
606808|NCT00391807|1485327|P1|COMPLETED|Overall Study||968
606809|NCT00391807|1485327|P1|STARTED|Overall Study||1683
606810|NCT00391768|1485354|P7|NOT COMPLETED|Overall Study||4
606811|NCT00391768|1485355|P6|NOT COMPLETED|Overall Study||3
606812|NCT00391768|1485356|P5|NOT COMPLETED|Overall Study||2
606813|NCT00391768|1485357|P4|NOT COMPLETED|Overall Study||1
606814|NCT00391768|1485358|P3|NOT COMPLETED|Overall Study||1
606815|NCT00391768|1485359|P2|NOT COMPLETED|Overall Study||0
606816|NCT00391768|1485360|P1|NOT COMPLETED|Overall Study||0
606817|NCT00391768|1485354|P7|COMPLETED|Overall Study||19
606818|NCT00391768|1485355|P6|COMPLETED|Overall Study||7
606819|NCT00391768|1485356|P5|COMPLETED|Overall Study||22
606820|NCT00391768|1485357|P4|COMPLETED|Overall Study||7
606821|NCT00391768|1485358|P3|COMPLETED|Overall Study||6
606822|NCT00391768|1485359|P2|COMPLETED|Overall Study||3
606823|NCT00391768|1485360|P1|COMPLETED|Overall Study||12
606824|NCT00391768|1485354|P7|STARTED|Overall Study||23
606825|NCT00391768|1485355|P6|STARTED|Overall Study||10
606826|NCT00391768|1485356|P5|STARTED|Overall Study||24
606827|NCT00391768|1485357|P4|STARTED|Overall Study||8
606828|NCT00391768|1485358|P3|STARTED|Overall Study||7
606829|NCT00391768|1485359|P2|STARTED|Overall Study||3
606830|NCT00391768|1485360|P1|STARTED|Overall Study||12
606831|NCT00391716|1485428|P3|NOT COMPLETED|Overall Study||19
606832|NCT00391716|1485429|P2|NOT COMPLETED|Overall Study||19
606833|NCT00391716|1485430|P1|NOT COMPLETED|Overall Study||27
606834|NCT00391716|1485428|P3|COMPLETED|Overall Study||30
606835|NCT00391716|1485429|P2|COMPLETED|Overall Study||28
606836|NCT00391716|1485430|P1|COMPLETED|Overall Study||27
606837|NCT00391716|1485428|P3|STARTED|Overall Study||49
606838|NCT00391716|1485429|P2|STARTED|Overall Study||47
606839|NCT00391716|1485430|P1|STARTED|Overall Study||54
606840|NCT00391625|1485447|P1|NOT COMPLETED|Month 84||0
606841|NCT00391625|1485447|P1|COMPLETED|Month 84||8
606842|NCT00391625|1485447|P1|STARTED|Month 84||8
606843|NCT00391625|1485447|P1|NOT COMPLETED|Month 50||1
606844|NCT00391625|1485447|P1|COMPLETED|Month 50||8
606845|NCT00391625|1485447|P1|STARTED|Month 50||9
606846|NCT00391625|1485447|P1|NOT COMPLETED|Month 14||1
606847|NCT00391625|1485447|P1|COMPLETED|Month 14||9
606848|NCT00391625|1485447|P1|STARTED|Month 14||10
606849|NCT00391625|1485447|P1|NOT COMPLETED|Baseline||0
606850|NCT00391625|1485447|P1|COMPLETED|Baseline||10
606851|NCT00391625|1485447|P1|STARTED|Baseline||10
606852|NCT00391599|1485489|P2|NOT COMPLETED|Overall Study||0
606853|NCT00391599|1485490|P1|NOT COMPLETED|Overall Study||0
606854|NCT00391599|1485489|P2|COMPLETED|Overall Study||65
606855|NCT00391599|1485490|P1|COMPLETED|Overall Study||65
606856|NCT00391599|1485489|P2|STARTED|Overall Study||65
606857|NCT00391599|1485490|P1|STARTED|Overall Study||65
606858|NCT00391586|1485500|P1|NOT COMPLETED|Overall Study||24
606859|NCT00391586|1485500|P1|COMPLETED|Overall Study|These patients received at least 2 cycles of erlotinib|21
606860|NCT00391586|1485500|P1|Received Platinum-based Chemotherapy|Overall Study|Total number of patients who received platinum-based chemotherapy after erlotinib treatment|10
606861|NCT00391586|1485500|P1|Received First-line Erlotinib|Overall Study|These patients received at least one dose of on-study first-line erlotinib|43
606862|NCT00391586|1485500|P1|STARTED|Overall Study||45
606863|NCT00391469|1485509|P2|NOT COMPLETED|Overall Study||0
606864|NCT00391469|1485510|P1|NOT COMPLETED|Overall Study||0
606865|NCT00391469|1485509|P2|COMPLETED|Overall Study||671
606866|NCT00391469|1485510|P1|COMPLETED|Overall Study|5 patients were found to be incarcerated at time of randomization, thus data was not included|688
606867|NCT00391469|1485509|P2|STARTED|Overall Study||671
606868|NCT00391469|1485510|P1|STARTED|Overall Study||688
606869|NCT00391443|1485524|P2|NOT COMPLETED|Overall Study||0
606870|NCT00391443|1485525|P1|NOT COMPLETED|Overall Study||0
606871|NCT00391443|1485524|P2|COMPLETED|Overall Study||407
606872|NCT00391443|1485525|P1|COMPLETED|Overall Study||209
606873|NCT00391443|1485524|P2|STARTED|Overall Study||407
606874|NCT00391443|1485525|P1|STARTED|Overall Study|1 patient in the bosentan arm did not receive treatment & was excluded from the Safety Population.|209
606875|NCT00391391|1485537|P4|NOT COMPLETED|Overall Study||19
606876|NCT00391391|1485538|P3|NOT COMPLETED|Overall Study||23
606877|NCT00391391|1485539|P2|NOT COMPLETED|Overall Study||10
606878|NCT00391391|1485540|P1|NOT COMPLETED|Overall Study||9
606879|NCT00391391|1485537|P4|COMPLETED|Overall Study||145
606880|NCT00391391|1485538|P3|COMPLETED|Overall Study||138
606881|NCT00391391|1485539|P2|COMPLETED|Overall Study||87
606882|NCT00391391|1485540|P1|COMPLETED|Overall Study||89
606883|NCT00391391|1485537|P4|STARTED|Overall Study|1 participant was not vaccinated.|164
606884|NCT00391391|1485538|P3|STARTED|Overall Study|1 participant was not vaccinated.|161
606885|NCT00391391|1485539|P2|STARTED|Overall Study||97
606886|NCT00391391|1485540|P1|STARTED|Overall Study|1 participant was not vaccinated.|98
606887|NCT00391365|1485572|P2|NOT COMPLETED|Overall Study||19
606888|NCT00391365|1485573|P1|NOT COMPLETED|Overall Study||25
606889|NCT00391365|1485572|P2|COMPLETED|Overall Study||151
606890|NCT00391365|1485573|P1|COMPLETED|Overall Study||78
606891|NCT00391365|1485572|P2|STARTED|Overall Study||170
606892|NCT00391365|1485573|P1|STARTED|Overall Study||103
606893|NCT00391274|1485585|P2|NOT COMPLETED|Overall Study||57
606894|NCT00391274|1485586|P1|NOT COMPLETED|Overall Study||61
606895|NCT00391274|1485585|P2|COMPLETED|Overall Study||47
606896|NCT00391274|1485586|P1|COMPLETED|Overall Study||46
606897|NCT00391274|1485585|P2|Received at Least One Dose of Study Drug|Overall Study||102
606898|NCT00391274|1485586|P1|Received at Least One Dose of Study Drug|Overall Study||106
606899|NCT00391274|1485585|P2|STARTED|Overall Study||104
606900|NCT00391274|1485586|P1|STARTED|Overall Study||107
606901|NCT00391222|1485605|P4|NOT COMPLETED|Period III (Double-Blind Treatment)||0
606902|NCT00391222|1485606|P3|NOT COMPLETED|Period III (Double-Blind Treatment)||23
606903|NCT00391222|1485607|P2|NOT COMPLETED|Period III (Double-Blind Treatment)||22
606904|NCT00391222|1485608|P1|NOT COMPLETED|Period III (Double-Blind Treatment)||28
606905|NCT00391222|1485605|P4|COMPLETED|Period III (Double-Blind Treatment)||0
606906|NCT00391222|1485606|P3|COMPLETED|Period III (Double-Blind Treatment)||108
606907|NCT00391222|1485607|P2|COMPLETED|Period III (Double-Blind Treatment)||113
606908|NCT00391222|1485608|P1|COMPLETED|Period III (Double-Blind Treatment)||104
606909|NCT00391222|1485605|P4|STARTED|Period III (Double-Blind Treatment)||0
606910|NCT00391222|1485606|P3|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|131
606911|NCT00391222|1485607|P2|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|135
606912|NCT00391222|1485608|P1|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|132
606913|NCT00391222|1485605|P4|NOT COMPLETED|Period II (Open-label Risperidone LAI)||162
606914|NCT00391222|1485606|P3|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
606915|NCT00391222|1485607|P2|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
606916|NCT00391222|1485608|P1|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
606917|NCT00391222|1485605|P4|COMPLETED|Period II (Open-label Risperidone LAI)||398
606918|NCT00391222|1485606|P3|COMPLETED|Period II (Open-label Risperidone LAI)||0
606919|NCT00391222|1485607|P2|COMPLETED|Period II (Open-label Risperidone LAI)||0
606920|NCT00391222|1485608|P1|COMPLETED|Period II (Open-label Risperidone LAI)||0
606921|NCT00391222|1485605|P4|STARTED|Period II (Open-label Risperidone LAI)|The 25 patients at the site of Dr. Parikh were excluded from the analysis due to GCP non-compliance|560
606922|NCT00391222|1485606|P3|STARTED|Period II (Open-label Risperidone LAI)||0
606923|NCT00391222|1485607|P2|STARTED|Period II (Open-label Risperidone LAI)||0
606924|NCT00391222|1485608|P1|STARTED|Period II (Open-label Risperidone LAI)||0
606925|NCT00391092|1485634|P2|NOT COMPLETED|Overall Study||216
606926|NCT00391092|1485635|P1|NOT COMPLETED|Overall Study||208
606927|NCT00391092|1485634|P2|COMPLETED|Overall Study|This was using a data cutoff of 30 June 2011.|0
606928|NCT00391092|1485635|P1|COMPLETED|Overall Study|This was using a data cutoff of 30 June 2011.|0
606929|NCT00391092|1485634|P2|Received Treatment|Overall Study||215
606930|NCT00391092|1485635|P1|Received Treatment|Overall Study||206
606931|NCT00391092|1485634|P2|STARTED|Overall Study||216
606932|NCT00391092|1485635|P1|STARTED|Overall Study||208
606933|NCT00391079|1485655|P2|NOT COMPLETED|Overall Study||16
606934|NCT00391079|1485656|P1|NOT COMPLETED|Overall Study||26
606935|NCT00391079|1485655|P2|COMPLETED|Overall Study||156
606936|NCT00391079|1485656|P1|COMPLETED|Overall Study||141
606937|NCT00391079|1485655|P2|STARTED|Overall Study||172
606938|NCT00391079|1485656|P1|STARTED|Overall Study||167
606939|NCT00391053|1485678|P4|NOT COMPLETED|Overall Study||10
606940|NCT00391053|1485679|P3|NOT COMPLETED|Overall Study||2
606941|NCT00391053|1485680|P2|NOT COMPLETED|Overall Study||1
606942|NCT00391053|1485681|P1|NOT COMPLETED|Overall Study||9
606943|NCT00391053|1485678|P4|COMPLETED|Overall Study||1252
606944|NCT00391053|1485679|P3|COMPLETED|Overall Study||868
606945|NCT00391053|1485680|P2|COMPLETED|Overall Study||847
606946|NCT00391053|1485681|P1|COMPLETED|Overall Study||848
606947|NCT00391053|1485678|P4|STARTED|Overall Study||1262
606948|NCT00391053|1485679|P3|STARTED|Overall Study||870
606949|NCT00391053|1485680|P2|STARTED|Overall Study||848
606950|NCT00391053|1485681|P1|STARTED|Overall Study||857
606951|NCT00391027|1485705|P2|NOT COMPLETED|Overall Study||12
606952|NCT00391027|1485706|P1|NOT COMPLETED|Overall Study||25
606953|NCT00391027|1485705|P2|COMPLETED|Overall Study||110
606954|NCT00391027|1485706|P1|COMPLETED|Overall Study||110
606955|NCT00391027|1485705|P2|STARTED|Overall Study|Full Analysis Set = 121; 1 subject excluded; missing a baseline or postbaseline HbA1c measurement.|122
606956|NCT00391027|1485706|P1|STARTED|Overall Study|Full Analysis Set = 134; 1 subject excluded; missing a baseline or postbaseline HbA1c measurement.|135
606957|NCT00390884|1485746|P2|NOT COMPLETED|Overall Study||2
606958|NCT00390884|1485747|P1|NOT COMPLETED|Overall Study||2
606959|NCT00390884|1485746|P2|COMPLETED|Overall Study||55
606960|NCT00390884|1485747|P1|COMPLETED|Overall Study||114
606961|NCT00390884|1485746|P2|STARTED|Overall Study||57
606962|NCT00390884|1485747|P1|STARTED|Overall Study||116
606963|NCT00390858|1485759|P2|NOT COMPLETED|Overall Study||7
606964|NCT00390858|1485760|P1|NOT COMPLETED|Overall Study||9
606965|NCT00390858|1485759|P2|COMPLETED|Overall Study|13 Participants completed the Extension Study|13
606966|NCT00390858|1485760|P1|COMPLETED|Overall Study|11 participants Completed the Extension Study|11
606967|NCT00390858|1485759|P2|Completed Core & Entered Extension Study|Overall Study||20
606968|NCT00390858|1485760|P1|Completed Core & Entered Extension Study|Overall Study||19
606969|NCT00390858|1485759|P2|STARTED|Overall Study|20 Participants started the Core Study|20
606970|NCT00390858|1485760|P1|STARTED|Overall Study|20 participants started the Core Study|20
606971|NCT00390806|1485774|P2|NOT COMPLETED|Overall Study||32
606972|NCT00390806|1485775|P1|NOT COMPLETED|Overall Study||30
606973|NCT00390806|1485774|P2|COMPLETED|Overall Study||204
606974|NCT00390806|1485775|P1|COMPLETED|Overall Study||206
606975|NCT00390806|1485774|P2|Ongoing|Overall Study||2
606976|NCT00390806|1485775|P1|Ongoing|Overall Study||4
606977|NCT00390806|1485774|P2|STARTED|Overall Study||236
606978|NCT00390806|1485775|P1|STARTED|Overall Study||236
606979|NCT00390780|1485843|P2|NOT COMPLETED|Overall Study||27
606980|NCT00390780|1485844|P1|NOT COMPLETED|Overall Study||23
606981|NCT00390780|1485843|P2|COMPLETED|Overall Study||260
606982|NCT00390780|1485844|P1|COMPLETED|Overall Study||268
606983|NCT00390780|1485843|P2|Treatment|Overall Study||287
606984|NCT00390780|1485844|P1|Treatment|Overall Study|One patient randomized to miconazole lost study drug, never started treatment, and was discontinued.|290
606985|NCT00390780|1485843|P2|STARTED|Overall Study||287
606986|NCT00390780|1485844|P1|STARTED|Overall Study||291
606987|NCT00390689|1485877|P3|NOT COMPLETED|Overall Study||3
606988|NCT00390689|1485878|P2|NOT COMPLETED|Overall Study||5
606989|NCT00390689|1485879|P1|NOT COMPLETED|Overall Study||5
606990|NCT00390689|1485877|P3|COMPLETED|Overall Study||50
606991|NCT00390689|1485878|P2|COMPLETED|Overall Study||48
606992|NCT00390689|1485879|P1|COMPLETED|Overall Study||43
606993|NCT00390689|1485877|P3|STARTED|Overall Study||53
606994|NCT00390689|1485878|P2|STARTED|Overall Study||53
606995|NCT00390689|1485879|P1|STARTED|Overall Study||48
606996|NCT00390611|1485939|P2|NOT COMPLETED|Maintenance Sorafenib to Month 12||0
606997|NCT00390611|1485940|P1|NOT COMPLETED|Maintenance Sorafenib to Month 12||10
606998|NCT00390611|1485939|P2|COMPLETED|Maintenance Sorafenib to Month 12||0
606999|NCT00390611|1485940|P1|COMPLETED|Maintenance Sorafenib to Month 12||13
607000|NCT00390611|1485939|P2|STARTED|Maintenance Sorafenib to Month 12|Patients in the Paclitaxel/carboplatin arm did not recieve maintenance sorafenib|0
607001|NCT00390611|1485940|P1|STARTED|Maintenance Sorafenib to Month 12|11 patients came off-study between the end of cycle 6 and the start of maintenance|23
607002|NCT00390611|1485939|P2|NOT COMPLETED|6 Cycles of Study Treatment||5
607003|NCT00390611|1485940|P1|NOT COMPLETED|6 Cycles of Study Treatment||9
607004|NCT00390611|1485939|P2|COMPLETED|6 Cycles of Study Treatment||37
607005|NCT00390611|1485940|P1|COMPLETED|6 Cycles of Study Treatment||34
607006|NCT00390611|1485939|P2|STARTED|6 Cycles of Study Treatment||42
607007|NCT00390611|1485940|P1|STARTED|6 Cycles of Study Treatment||43
607008|NCT00390572|1485954|P2|NOT COMPLETED|Overall Study||5
607009|NCT00390572|1485955|P1|NOT COMPLETED|Overall Study||8
607010|NCT00390572|1485954|P2|COMPLETED|Overall Study||64
607011|NCT00390572|1485955|P1|COMPLETED|Overall Study||60
607012|NCT00390572|1485954|P2|STARTED|Overall Study||69
607013|NCT00390572|1485955|P1|STARTED|Overall Study||68
607014|NCT00390559|1485969|P1|NOT COMPLETED|Overall Study||44
607015|NCT00390559|1485969|P1|COMPLETED|Overall Study||80
607016|NCT00390559|1485969|P1|ActiveP/PlaceboC|Overall Study||90
607017|NCT00390559|1485969|P1|PlaceboP/PlaceboC|Overall Study||93
607018|NCT00390559|1485969|P1|ActiveP/ActiveC|Overall Study||87
607019|NCT00390559|1485969|P1|Received PlaceboP/Active C|Overall Study||93
607020|NCT00390559|1485969|P1|STARTED|Overall Study||124
607021|NCT00390546|1485981|P2|NOT COMPLETED|Overall Study||5
607022|NCT00390546|1485982|P1|NOT COMPLETED|Overall Study||6
607023|NCT00390546|1485981|P2|COMPLETED|Overall Study||34
607024|NCT00390546|1485982|P1|COMPLETED|Overall Study||27
607025|NCT00390546|1485981|P2|STARTED|Overall Study||39
607026|NCT00390546|1485982|P1|STARTED|Overall Study||33
607027|NCT00390468|1485992|P1|NOT COMPLETED|Overall Study||3
607028|NCT00390468|1485992|P1|COMPLETED|Overall Study||15
607029|NCT00390468|1485992|P1|STARTED|Overall Study||18
607030|NCT00390455|1485998|P2|NOT COMPLETED|Overall Study||23
607031|NCT00390455|1485999|P1|NOT COMPLETED|Overall Study||32
607032|NCT00390455|1485998|P2|COMPLETED|Overall Study||124
607033|NCT00390455|1485999|P1|COMPLETED|Overall Study||116
607034|NCT00390455|1485998|P2|STARTED|Overall Study||147
607035|NCT00390455|1485999|P1|STARTED|Overall Study||148
607036|NCT00390429|1486020|P4|NOT COMPLETED|Overall Study||0
607037|NCT00390429|1486021|P3|NOT COMPLETED|Overall Study||0
607038|NCT00390429|1486022|P2|NOT COMPLETED|Overall Study||0
607039|NCT00390429|1486023|P1|NOT COMPLETED|Overall Study||0
607040|NCT00390429|1486020|P4|COMPLETED|Overall Study||39
607041|NCT00390429|1486021|P3|COMPLETED|Overall Study||25
607042|NCT00390429|1486022|P2|COMPLETED|Overall Study||12
607043|NCT00390429|1486023|P1|COMPLETED|Overall Study||5
607044|NCT00390429|1486020|P4|STARTED|Overall Study||39
607045|NCT00390429|1486021|P3|STARTED|Overall Study||25
607046|NCT00390429|1486022|P2|STARTED|Overall Study||12
607047|NCT00390429|1486023|P1|STARTED|Overall Study||5
607048|NCT00390416|1486039|P1|NOT COMPLETED|Overall Study||4
607049|NCT00390416|1486039|P1|COMPLETED|Overall Study||44
607050|NCT00390416|1486039|P1|STARTED|Overall Study||48
607051|NCT00390364|1486045|P1|NOT COMPLETED|Overall Study||0
607052|NCT00390364|1486045|P1|COMPLETED|Overall Study||1
607053|NCT00390364|1486045|P1|STARTED|Overall Study||1
607054|NCT00390234|1486049|P1|NOT COMPLETED|Overall Study||0
607055|NCT00390234|1486049|P1|COMPLETED|Overall Study||63
607056|NCT00390234|1486049|P1|STARTED|Overall Study||63
607057|NCT00390221|1486060|P3|NOT COMPLETED|Overall Study||15
607058|NCT00390221|1486061|P2|NOT COMPLETED|Overall Study||20
607059|NCT00390221|1486062|P1|NOT COMPLETED|Overall Study||18
607060|NCT00390221|1486060|P3|COMPLETED|Overall Study||194
607061|NCT00390221|1486061|P2|COMPLETED|Overall Study||188
607062|NCT00390221|1486062|P1|COMPLETED|Overall Study||186
607063|NCT00390221|1486060|P3|STARTED|Overall Study||209
607064|NCT00390221|1486061|P2|STARTED|Overall Study||208
607065|NCT00390221|1486062|P1|STARTED|Overall Study||204
607066|NCT00390182|1486083|P1|NOT COMPLETED|Overall Study||5
607067|NCT00390182|1486083|P1|COMPLETED|Overall Study||33
607068|NCT00390182|1486083|P1|STARTED|Overall Study||38
607069|NCT00390013|1486092|P4|NOT COMPLETED|Phase 2 Second Treatment||0
607070|NCT00390013|1486093|P3|NOT COMPLETED|Phase 2 Second Treatment||0
607071|NCT00390013|1486094|P2|NOT COMPLETED|Phase 2 Second Treatment||0
607072|NCT00390013|1486095|P1|NOT COMPLETED|Phase 2 Second Treatment||0
607073|NCT00390013|1486092|P4|COMPLETED|Phase 2 Second Treatment||0
607074|NCT00390013|1486093|P3|COMPLETED|Phase 2 Second Treatment||0
607075|NCT00390013|1486094|P2|COMPLETED|Phase 2 Second Treatment||1
607076|NCT00390013|1486095|P1|COMPLETED|Phase 2 Second Treatment||2
607077|NCT00390013|1486092|P4|STARTED|Phase 2 Second Treatment||0
607078|NCT00390013|1486093|P3|STARTED|Phase 2 Second Treatment||0
607079|NCT00390013|1486094|P2|STARTED|Phase 2 Second Treatment||1
607080|NCT00390013|1486095|P1|STARTED|Phase 2 Second Treatment||2
607081|NCT00390013|1486092|P4|NOT COMPLETED|Phase 2 First Treatment||0
607082|NCT00390013|1486093|P3|NOT COMPLETED|Phase 2 First Treatment||0
607083|NCT00390013|1486094|P2|NOT COMPLETED|Phase 2 First Treatment||1
607084|NCT00390013|1486095|P1|NOT COMPLETED|Phase 2 First Treatment||1
607085|NCT00390013|1486092|P4|COMPLETED|Phase 2 First Treatment||0
607086|NCT00390013|1486093|P3|COMPLETED|Phase 2 First Treatment||0
607087|NCT00390013|1486094|P2|COMPLETED|Phase 2 First Treatment||1
607088|NCT00390013|1486095|P1|COMPLETED|Phase 2 First Treatment||2
607089|NCT00390013|1486092|P4|STARTED|Phase 2 First Treatment||0
607090|NCT00390013|1486093|P3|STARTED|Phase 2 First Treatment||0
607091|NCT00390013|1486094|P2|STARTED|Phase 2 First Treatment||2
607092|NCT00390013|1486095|P1|STARTED|Phase 2 First Treatment||3
607093|NCT00390013|1486092|P4|NOT COMPLETED|Phase 1||1
607094|NCT00390013|1486093|P3|NOT COMPLETED|Phase 1||0
607095|NCT00390013|1486094|P2|NOT COMPLETED|Phase 1||0
607096|NCT00390013|1486095|P1|NOT COMPLETED|Phase 1||0
607097|NCT00390013|1486092|P4|COMPLETED|Phase 1||1
607098|NCT00390013|1486093|P3|COMPLETED|Phase 1||2
607099|NCT00390013|1486094|P2|COMPLETED|Phase 1||0
607100|NCT00390013|1486095|P1|COMPLETED|Phase 1||0
607101|NCT00390013|1486092|P4|STARTED|Phase 1||2
607102|NCT00390013|1486093|P3|STARTED|Phase 1||2
607103|NCT00390013|1486094|P2|STARTED|Phase 1||0
607104|NCT00390013|1486095|P1|STARTED|Phase 1||0
607105|NCT00389974|1486101|P1|NOT COMPLETED|Overall Study||0
607106|NCT00389974|1486101|P1|COMPLETED|Overall Study||19
607107|NCT00389974|1486101|P1|STARTED|Overall Study||19
607108|NCT00389857|1486107|P2|NOT COMPLETED|Overall Study||0
607109|NCT00389857|1486108|P1|NOT COMPLETED|Overall Study||0
607110|NCT00389857|1486107|P2|COMPLETED|Overall Study||17
607111|NCT00389857|1486108|P1|COMPLETED|Overall Study||14
607112|NCT00389857|1486107|P2|STARTED|Overall Study||17
607113|NCT00389857|1486108|P1|STARTED|Overall Study||14
607114|NCT00389831|1486120|P2|NOT COMPLETED|Overall Study||7
607115|NCT00389831|1486121|P1|NOT COMPLETED|Overall Study||0
607116|NCT00389831|1486120|P2|COMPLETED|Overall Study||27
607117|NCT00389831|1486121|P1|COMPLETED|Overall Study||10
607118|NCT00389831|1486120|P2|STARTED|Overall Study||34
607119|NCT00389831|1486121|P1|STARTED|Overall Study||10
607120|NCT00389818|1486147|P1|NOT COMPLETED|Overall Study||3
607121|NCT00389818|1486147|P1|COMPLETED|Overall Study||40
607122|NCT00389818|1486147|P1|STARTED|Overall Study||43
607123|NCT00389805|1486153|P2|NOT COMPLETED|Phase II||0
607124|NCT00389805|1486154|P1|NOT COMPLETED|Phase II||0
607125|NCT00389805|1486153|P2|COMPLETED|Phase II||0
607126|NCT00389805|1486154|P1|COMPLETED|Phase II||0
607127|NCT00389805|1486153|P2|STARTED|Phase II|The Phase II study was not conducted.|0
607128|NCT00389805|1486154|P1|STARTED|Phase II|The Phase II study was not conducted.|0
607129|NCT00389805|1486153|P2|NOT COMPLETED|Phase I||0
607130|NCT00389805|1486154|P1|NOT COMPLETED|Phase I||0
607131|NCT00389805|1486153|P2|COMPLETED|Phase I||12
607132|NCT00389805|1486154|P1|COMPLETED|Phase I||15
607133|NCT00389805|1486153|P2|STARTED|Phase I||12
607134|NCT00389805|1486154|P1|STARTED|Phase I||15
607135|NCT00389597|1486184|P4|NOT COMPLETED|Overall Study||6
607136|NCT00389597|1486185|P3|NOT COMPLETED|Overall Study||4
607137|NCT00389597|1486186|P2|NOT COMPLETED|Overall Study||6
607138|NCT00389597|1486187|P1|NOT COMPLETED|Overall Study||8
607139|NCT00389597|1486184|P4|COMPLETED|Overall Study||99
607140|NCT00389597|1486185|P3|COMPLETED|Overall Study||221
607141|NCT00389597|1486186|P2|COMPLETED|Overall Study||75
607142|NCT00389597|1486187|P1|COMPLETED|Overall Study||156
607143|NCT00389597|1486184|P4|24 mo|Overall Study||99
607144|NCT00389597|1486185|P3|24 mo|Overall Study||221
607145|NCT00389597|1486186|P2|24 mo|Overall Study||75
607146|NCT00389597|1486187|P1|24 mo|Overall Study||156
607147|NCT00389597|1486184|P4|STARTED|Overall Study||105
607148|NCT00389597|1486185|P3|STARTED|Overall Study||225
607149|NCT00389597|1486186|P2|STARTED|Overall Study||81
607150|NCT00389597|1486187|P1|STARTED|Overall Study||164
607151|NCT00389532|1486199|P2|NOT COMPLETED|Overall Study||0
607152|NCT00389532|1486200|P1|NOT COMPLETED|Overall Study||0
607153|NCT00389532|1486199|P2|COMPLETED|Overall Study||56
607154|NCT00389532|1486200|P1|COMPLETED|Overall Study|3 of the participants did not have valid post-vaccination serological results|60
607155|NCT00389532|1486199|P2|STARTED|Overall Study||56
607156|NCT00389532|1486200|P1|STARTED|Overall Study||60
607157|NCT00389519|1486212|P4|NOT COMPLETED|Treated||4
607158|NCT00389519|1486213|P3|NOT COMPLETED|Treated||0
607159|NCT00389519|1486214|P2|NOT COMPLETED|Treated||1
607160|NCT00389519|1486215|P1|NOT COMPLETED|Treated||2
607161|NCT00389519|1486212|P4|COMPLETED|Treated||76
607162|NCT00389519|1486213|P3|COMPLETED|Treated||40
607163|NCT00389519|1486214|P2|COMPLETED|Treated||40
607164|NCT00389519|1486215|P1|COMPLETED|Treated||79
607165|NCT00389519|1486212|P4|STARTED|Treated||80
607166|NCT00389519|1486213|P3|STARTED|Treated||40
607167|NCT00389519|1486214|P2|STARTED|Treated||41
607168|NCT00389519|1486215|P1|STARTED|Treated||81
607169|NCT00389519|1486212|P4|NOT COMPLETED|Randomized||0
607170|NCT00389519|1486213|P3|NOT COMPLETED|Randomized||0
607171|NCT00389519|1486214|P2|NOT COMPLETED|Randomized||0
607172|NCT00389519|1486215|P1|NOT COMPLETED|Randomized||2
607173|NCT00389519|1486212|P4|COMPLETED|Randomized||80
607174|NCT00389519|1486213|P3|COMPLETED|Randomized||40
607175|NCT00389519|1486214|P2|COMPLETED|Randomized||41
607176|NCT00389519|1486215|P1|COMPLETED|Randomized||81
607177|NCT00389519|1486212|P4|STARTED|Randomized||80
607178|NCT00389519|1486213|P3|STARTED|Randomized||40
607179|NCT00389519|1486214|P2|STARTED|Randomized||41
607180|NCT00389519|1486215|P1|STARTED|Randomized||83
607181|NCT00389519|1486212|P4|NOT COMPLETED|Placebo Run-In||0
607182|NCT00389519|1486213|P3|NOT COMPLETED|Placebo Run-In||0
607183|NCT00389519|1486214|P2|NOT COMPLETED|Placebo Run-In||0
607184|NCT00389519|1486215|P1|NOT COMPLETED|Placebo Run-In||178
607185|NCT00389519|1486212|P4|COMPLETED|Placebo Run-In||0
607186|NCT00389519|1486213|P3|COMPLETED|Placebo Run-In||0
607187|NCT00389519|1486214|P2|COMPLETED|Placebo Run-In||0
607188|NCT00389519|1486215|P1|COMPLETED|Placebo Run-In||244
607189|NCT00389519|1486212|P4|STARTED|Placebo Run-In||0
607190|NCT00389519|1486213|P3|STARTED|Placebo Run-In||0
607191|NCT00389519|1486214|P2|STARTED|Placebo Run-In||0
607192|NCT00389519|1486215|P1|STARTED|Placebo Run-In||422
607193|NCT00389493|1486244|P3|NOT COMPLETED|Overall Study||3
607194|NCT00389493|1486245|P2|NOT COMPLETED|Overall Study||8
607195|NCT00389493|1486246|P1|NOT COMPLETED|Overall Study||3
607196|NCT00389493|1486244|P3|COMPLETED|Overall Study||17
607197|NCT00389493|1486245|P2|COMPLETED|Overall Study||32
607198|NCT00389493|1486246|P1|COMPLETED|Overall Study||37
607199|NCT00389493|1486244|P3|STARTED|Overall Study||20
607200|NCT00389493|1486245|P2|STARTED|Overall Study||40
607201|NCT00389493|1486246|P1|STARTED|Overall Study||40
607202|NCT00389467|1486270|P4|NOT COMPLETED|Overall Study||0
607203|NCT00389467|1486271|P3|NOT COMPLETED|Overall Study||0
607204|NCT00389467|1486272|P2|NOT COMPLETED|Overall Study||0
607205|NCT00389467|1486273|P1|NOT COMPLETED|Overall Study||0
607206|NCT00389467|1486270|P4|COMPLETED|Overall Study||20
607207|NCT00389467|1486271|P3|COMPLETED|Overall Study||30
607208|NCT00389467|1486272|P2|COMPLETED|Overall Study||34
607209|NCT00389467|1486273|P1|COMPLETED|Overall Study||34
607210|NCT00389467|1486270|P4|STARTED|Overall Study||20
607211|NCT00389467|1486271|P3|STARTED|Overall Study||30
607212|NCT00389467|1486272|P2|STARTED|Overall Study||34
607213|NCT00389467|1486273|P1|STARTED|Overall Study||34
607214|NCT00389441|1486292|P1|NOT COMPLETED|Overall Study||52
607215|NCT00389441|1486292|P1|COMPLETED|Overall Study||0
607216|NCT00389441|1486292|P1|STARTED|Overall Study||52
607217|NCT00389324|1486301|P1|NOT COMPLETED|Subcutaneous Phase||7
607218|NCT00389324|1486301|P1|COMPLETED|Subcutaneous Phase||25
607219|NCT00389324|1486301|P1|STARTED|Subcutaneous Phase||32
607220|NCT00389324|1486301|P1|NOT COMPLETED|Intravenous Phase||0
607221|NCT00389324|1486301|P1|COMPLETED|Intravenous Phase||32
607222|NCT00389324|1486301|P1|STARTED|Intravenous Phase|18 subjects entered from the Run-in Phase and 14 new participants entered directly|32
607223|NCT00389324|1486301|P1|NOT COMPLETED|Run-In Phase||3
607224|NCT00389324|1486301|P1|COMPLETED|Run-In Phase||18
607225|NCT00389324|1486301|P1|STARTED|Run-In Phase||21
607226|NCT00389207|1486311|P3|NOT COMPLETED|Overall Study||41
607227|NCT00389207|1486312|P2|NOT COMPLETED|Overall Study||72
607228|NCT00389207|1486313|P1|NOT COMPLETED|Overall Study||63
607229|NCT00389207|1486311|P3|COMPLETED|Overall Study||152
607230|NCT00389207|1486312|P2|COMPLETED|Overall Study||116
607231|NCT00389207|1486313|P1|COMPLETED|Overall Study||125
607232|NCT00389207|1486311|P3|STARTED|Overall Study||193
607233|NCT00389207|1486312|P2|STARTED|Overall Study|4 patients were randomized to NVP BID but not treated and so are not part of the FAS|188
607234|NCT00389207|1486313|P1|STARTED|Overall Study|3 patients were randomized to NVP QD but not treated and so not part of the Full Analysis Set (FAS)|188
607235|NCT00389168|1486417|P2|NOT COMPLETED|Overall Study||5
607236|NCT00389168|1486418|P1|NOT COMPLETED|Overall Study||9
607237|NCT00389168|1486417|P2|COMPLETED|Overall Study||53
607238|NCT00389168|1486418|P1|COMPLETED|Overall Study||47
607239|NCT00389168|1486417|P2|STARTED|Overall Study||58
607240|NCT00389168|1486418|P1|STARTED|Overall Study||56
607241|NCT00389064|1486436|P2|NOT COMPLETED|Overall Study||59
607242|NCT00389064|1486437|P1|NOT COMPLETED|Overall Study||45
607243|NCT00389064|1486436|P2|COMPLETED|Overall Study||168
607244|NCT00389064|1486437|P1|COMPLETED|Overall Study||178
607245|NCT00389064|1486436|P2|STARTED|Overall Study||227
607246|NCT00389064|1486437|P1|STARTED|Overall Study||223
607247|NCT00388973|1486465|P2|NOT COMPLETED|Overall Study||58
607248|NCT00388973|1486466|P1|NOT COMPLETED|Overall Study||56
607249|NCT00388973|1486465|P2|COMPLETED|Overall Study|Completed 9-week treatment and 2 week follow-up|114
607250|NCT00388973|1486466|P1|COMPLETED|Overall Study|Completed 9-week treatment and 2 week follow-up|110
607251|NCT00388973|1486465|P2|Completed Study|Overall Study||114
607252|NCT00388973|1486466|P1|Completed Study|Overall Study||110
607253|NCT00388973|1486465|P2|STARTED|Overall Study|Randomized|172
607254|NCT00388973|1486466|P1|STARTED|Overall Study|Randomized|166
607255|NCT00388947|1486486|P1|NOT COMPLETED|Overall Study||47
607256|NCT00388947|1486486|P1|COMPLETED|Overall Study|47 patients excluded because no AMS prolapse device was noted.|1543
607257|NCT00388947|1486486|P1|STARTED|Overall Study||1590
607258|NCT00388804|1486493|P2|NOT COMPLETED|Overall Study||0
607259|NCT00388804|1486494|P1|NOT COMPLETED|Overall Study||0
607260|NCT00388804|1486493|P2|COMPLETED|Overall Study||21
607261|NCT00388804|1486494|P1|COMPLETED|Overall Study||17
607262|NCT00388804|1486493|P2|STARTED|Overall Study||21
607263|NCT00388804|1486494|P1|STARTED|Overall Study||17
607264|NCT00388726|1486502|P2|NOT COMPLETED|Overall Study||244
607265|NCT00388726|1486503|P1|NOT COMPLETED|Overall Study||484
607266|NCT00388726|1486502|P2|COMPLETED|Overall Study||10
607267|NCT00388726|1486503|P1|COMPLETED|Overall Study||24
607268|NCT00388726|1486502|P2|STARTED|Overall Study||254
607269|NCT00388726|1486503|P1|STARTED|Overall Study||508
607270|NCT00388583|1486517|P2|NOT COMPLETED|Overall Study||4
607271|NCT00388583|1486518|P1|NOT COMPLETED|Overall Study||6
607272|NCT00388583|1486517|P2|COMPLETED|Overall Study||406
607273|NCT00388583|1486518|P1|COMPLETED|Overall Study||401
607274|NCT00388583|1486517|P2|STARTED|Overall Study||410
607275|NCT00388583|1486518|P1|STARTED|Overall Study||407
607276|NCT00388505|1486532|P2|NOT COMPLETED|Overall Study||38
607277|NCT00388505|1486533|P1|NOT COMPLETED|Overall Study||83
607278|NCT00388505|1486532|P2|COMPLETED|Overall Study||171
607279|NCT00388505|1486533|P1|COMPLETED|Overall Study||225
607280|NCT00388505|1486532|P2|STARTED|Overall Study|Randomized patients who received any amount of study medication|209
607281|NCT00388505|1486533|P1|STARTED|Overall Study|Randomized patients who received any amount of study medication|308
607282|NCT00388453|1486558|P3|NOT COMPLETED|Overall Study||0
607283|NCT00388453|1486559|P2|NOT COMPLETED|Overall Study||0
607284|NCT00388453|1486560|P1|NOT COMPLETED|Overall Study||0
607285|NCT00388453|1486558|P3|COMPLETED|Overall Study||10
607286|NCT00388453|1486559|P2|COMPLETED|Overall Study||17
607287|NCT00388453|1486560|P1|COMPLETED|Overall Study||20
607288|NCT00388453|1486558|P3|STARTED|Overall Study||10
607289|NCT00388453|1486559|P2|STARTED|Overall Study||17
607290|NCT00388453|1486560|P1|STARTED|Overall Study||20
607291|NCT00388414|1486579|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
607292|NCT00388414|1486580|P1|NOT COMPLETED|Second Intervention (8 Weeks)||0
607293|NCT00388414|1486579|P2|COMPLETED|Second Intervention (8 Weeks)||7
607294|NCT00388414|1486580|P1|COMPLETED|Second Intervention (8 Weeks)||7
607295|NCT00388414|1486579|P2|STARTED|Second Intervention (8 Weeks)||7
607296|NCT00388414|1486580|P1|STARTED|Second Intervention (8 Weeks)||7
607297|NCT00388414|1486579|P2|NOT COMPLETED|Washout (1 Week)||0
607298|NCT00388414|1486580|P1|NOT COMPLETED|Washout (1 Week)||0
607299|NCT00388414|1486579|P2|COMPLETED|Washout (1 Week)||7
607300|NCT00388414|1486580|P1|COMPLETED|Washout (1 Week)||7
607301|NCT00388414|1486579|P2|STARTED|Washout (1 Week)||7
607302|NCT00388414|1486580|P1|STARTED|Washout (1 Week)||7
607303|NCT00388414|1486579|P2|NOT COMPLETED|First Intervention (8 Weeks)||0
607304|NCT00388414|1486580|P1|NOT COMPLETED|First Intervention (8 Weeks)||0
607305|NCT00388414|1486579|P2|COMPLETED|First Intervention (8 Weeks)||7
607306|NCT00388414|1486580|P1|COMPLETED|First Intervention (8 Weeks)||7
607307|NCT00388414|1486579|P2|STARTED|First Intervention (8 Weeks)||7
607308|NCT00388414|1486580|P1|STARTED|First Intervention (8 Weeks)||7
607309|NCT00388362|1486588|P1|NOT COMPLETED|Remained on Study Median of 514 Days||2
607310|NCT00388362|1486588|P1|COMPLETED|Remained on Study Median of 514 Days||21
607311|NCT00388362|1486588|P1|STARTED|Remained on Study Median of 514 Days||23
607312|NCT00388362|1486588|P1|NOT COMPLETED|Enrolled||13
607313|NCT00388362|1486588|P1|COMPLETED|Enrolled||23
607314|NCT00388362|1486588|P1|STARTED|Enrolled||36
607315|NCT00388349|1486593|P2|NOT COMPLETED|Phase 2 Dose Expansion||0
607316|NCT00388349|1486594|P1|NOT COMPLETED|Phase 2 Dose Expansion||0
607317|NCT00388349|1486593|P2|COMPLETED|Phase 2 Dose Expansion||0
607318|NCT00388349|1486594|P1|COMPLETED|Phase 2 Dose Expansion||139
607319|NCT00388349|1486593|P2|STARTED|Phase 2 Dose Expansion|No participants were treated in Phase 2 at 1500 mg/m2 gemcitabine (MTD exceeded)|0
607320|NCT00388349|1486594|P1|STARTED|Phase 2 Dose Expansion|Includes the three phase 1 participants who received 1250 mg/m2 gemcitabine (MTD)|139
607321|NCT00388349|1486593|P2|NOT COMPLETED|Phase I Dose Escalation||3
607322|NCT00388349|1486594|P1|NOT COMPLETED|Phase I Dose Escalation||0
607323|NCT00388349|1486593|P2|COMPLETED|Phase I Dose Escalation||1
607324|NCT00388349|1486594|P1|COMPLETED|Phase I Dose Escalation||3
607325|NCT00388349|1486593|P2|STARTED|Phase I Dose Escalation||4
607326|NCT00388349|1486594|P1|STARTED|Phase I Dose Escalation||3
607327|NCT00388154|1486603|P1|NOT COMPLETED|Overall Study||1
607328|NCT00388154|1486603|P1|COMPLETED|Overall Study||20
607329|NCT00388154|1486603|P1|STARTED|Overall Study||21
607330|NCT00388037|1486608|P1|NOT COMPLETED|Overall Study||1
607331|NCT00388037|1486608|P1|COMPLETED|Overall Study||30
607332|NCT00388037|1486608|P1|STARTED|Overall Study||31
607333|NCT00387959|1486612|P1|NOT COMPLETED|Overall Study||1
607334|NCT00387959|1486612|P1|COMPLETED|Overall Study||16
607335|NCT00387959|1486612|P1|STARTED|Overall Study||17
607336|NCT00387894|1486616|P1|NOT COMPLETED|Overall Study||1
607337|NCT00387894|1486616|P1|COMPLETED|Overall Study||5
607338|NCT00387894|1486616|P1|STARTED|Overall Study||6
607339|NCT00387881|1486623|P2|NOT COMPLETED|Overall Study||102
607340|NCT00387881|1486624|P1|NOT COMPLETED|Overall Study||89
607341|NCT00387881|1486623|P2|COMPLETED|Overall Study||243
607342|NCT00387881|1486624|P1|COMPLETED|Overall Study||245
607343|NCT00387881|1486623|P2|STARTED|Overall Study||345
607344|NCT00387881|1486624|P1|STARTED|Overall Study||334
607345|NCT00387829|1486648|P2|NOT COMPLETED|Intent-to-treat Population||30
607346|NCT00387829|1486649|P1|NOT COMPLETED|Intent-to-treat Population||38
607347|NCT00387829|1486648|P2|COMPLETED|Intent-to-treat Population||136
607348|NCT00387829|1486649|P1|COMPLETED|Intent-to-treat Population||139
607349|NCT00387829|1486648|P2|STARTED|Intent-to-treat Population||166
607350|NCT00387829|1486649|P1|STARTED|Intent-to-treat Population||177
607351|NCT00387829|1486648|P2|NOT COMPLETED|Safety Population||33
607352|NCT00387829|1486649|P1|NOT COMPLETED|Safety Population||39
607353|NCT00387829|1486648|P2|COMPLETED|Safety Population||136
607354|NCT00387829|1486649|P1|COMPLETED|Safety Population||139
607355|NCT00387829|1486648|P2|STARTED|Safety Population||169
607356|NCT00387829|1486649|P1|STARTED|Safety Population||178
607357|NCT00387790|1486657|P1|NOT COMPLETED|Overall Study||14
607358|NCT00387790|1486657|P1|COMPLETED|Overall Study||50
607359|NCT00387790|1486657|P1|STARTED|Overall Study||64
607360|NCT00387764|1486663|P1|NOT COMPLETED|Overall Study||31
607361|NCT00387764|1486663|P1|COMPLETED|Overall Study|Participants completed treatment (until disease progression), but may not have completed the study.|49
607362|NCT00387764|1486663|P1|STARTED|Overall Study||80
607363|NCT00387751|1486681|P1|NOT COMPLETED|Overall Study||0
607364|NCT00387751|1486681|P1|COMPLETED|Overall Study||14
607365|NCT00387751|1486681|P1|STARTED|Overall Study||14
607366|NCT00387725|1486691|P4|NOT COMPLETED|Overall Study||2
607367|NCT00387725|1486692|P3|NOT COMPLETED|Overall Study||2
607368|NCT00387725|1486693|P2|NOT COMPLETED|Overall Study||1
607369|NCT00387725|1486694|P1|NOT COMPLETED|Overall Study||1
607370|NCT00387725|1486691|P4|COMPLETED|Overall Study||43
607371|NCT00387725|1486692|P3|COMPLETED|Overall Study||43
607372|NCT00387725|1486693|P2|COMPLETED|Overall Study||15
607373|NCT00387725|1486694|P1|COMPLETED|Overall Study||20
607374|NCT00387725|1486691|P4|STARTED|Overall Study||45
607375|NCT00387725|1486692|P3|STARTED|Overall Study||45
607376|NCT00387725|1486693|P2|STARTED|Overall Study||16
607377|NCT00387725|1486694|P1|STARTED|Overall Study||21
607378|NCT00387712|1486714|P2|NOT COMPLETED|Overall Study||36
607379|NCT00387712|1486715|P1|NOT COMPLETED|Overall Study||29
607380|NCT00387712|1486714|P2|COMPLETED|Overall Study||16
607381|NCT00387712|1486715|P1|COMPLETED|Overall Study||18
607382|NCT00387712|1486714|P2|STARTED|Overall Study||52
607383|NCT00387712|1486715|P1|STARTED|Overall Study||47
607384|NCT00387673|1486725|P3|NOT COMPLETED|Overall Study||0
607385|NCT00387673|1486726|P2|NOT COMPLETED|Overall Study||0
607386|NCT00387673|1486727|P1|NOT COMPLETED|Overall Study||0
607387|NCT00387673|1486725|P3|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
607388|NCT00387673|1486726|P2|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
607389|NCT00387673|1486727|P1|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
607390|NCT00387673|1486725|P3|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
607391|NCT00387673|1486726|P2|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
607392|NCT00387673|1486727|P1|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
607393|NCT00387660|1486735|P2|NOT COMPLETED|Overall Study||0
607394|NCT00387660|1486736|P1|NOT COMPLETED|Overall Study||0
607395|NCT00387660|1486735|P2|COMPLETED|Overall Study||40
607396|NCT00387660|1486736|P1|COMPLETED|Overall Study||40
607397|NCT00387660|1486735|P2|STARTED|Overall Study||40
607398|NCT00387660|1486736|P1|STARTED|Overall Study||40
607399|NCT00387647|1486746|P1|NOT COMPLETED|Overall Study||18
607400|NCT00387647|1486746|P1|COMPLETED|Overall Study||6
607401|NCT00387647|1486746|P1|STARTED|Overall Study||24
607402|NCT00387621|1486755|P2|NOT COMPLETED|Second Intervention||0
607403|NCT00387621|1486756|P1|NOT COMPLETED|Second Intervention||0
607404|NCT00387621|1486755|P2|COMPLETED|Second Intervention||29
607405|NCT00387621|1486756|P1|COMPLETED|Second Intervention||29
607406|NCT00387621|1486755|P2|STARTED|Second Intervention||29
607407|NCT00387621|1486756|P1|STARTED|Second Intervention||29
607408|NCT00387621|1486755|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
607409|NCT00387621|1486756|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
607410|NCT00387621|1486755|P2|COMPLETED|Washout Period of 2 Weeks||29
607411|NCT00387621|1486756|P1|COMPLETED|Washout Period of 2 Weeks||29
607412|NCT00387621|1486755|P2|STARTED|Washout Period of 2 Weeks||29
607413|NCT00387621|1486756|P1|STARTED|Washout Period of 2 Weeks||29
607414|NCT00387621|1486755|P2|NOT COMPLETED|First Intervention||0
607415|NCT00387621|1486756|P1|NOT COMPLETED|First Intervention||0
607416|NCT00387621|1486755|P2|COMPLETED|First Intervention||29
607417|NCT00387621|1486756|P1|COMPLETED|First Intervention||29
607418|NCT00387621|1486755|P2|STARTED|First Intervention||29
607419|NCT00387621|1486756|P1|STARTED|First Intervention||29
607420|NCT00387426|1486786|P1|NOT COMPLETED|Overall Study||14
607421|NCT00387426|1486786|P1|COMPLETED|Overall Study||0
607422|NCT00387426|1486786|P1|STARTED|Overall Study||14
607423|NCT00387348|1486793|P3|NOT COMPLETED|Overall Study||4
607424|NCT00387348|1486794|P2|NOT COMPLETED|Overall Study||3
607425|NCT00387348|1486795|P1|NOT COMPLETED|Overall Study||3
607426|NCT00387348|1486793|P3|COMPLETED|Overall Study||7
607427|NCT00387348|1486794|P2|COMPLETED|Overall Study||2
607428|NCT00387348|1486795|P1|COMPLETED|Overall Study||5
607429|NCT00387348|1486793|P3|STARTED|Overall Study||11
607430|NCT00387348|1486794|P2|STARTED|Overall Study||5
607431|NCT00387348|1486795|P1|STARTED|Overall Study||8
607432|NCT00387335|1486811|P2|NOT COMPLETED|Overall Study||0
607433|NCT00387335|1486812|P1|NOT COMPLETED|Overall Study||0
607434|NCT00387335|1486811|P2|COMPLETED|Overall Study||7
607435|NCT00387335|1486812|P1|COMPLETED|Overall Study||15
607436|NCT00387335|1486811|P2|STARTED|Overall Study||7
607437|NCT00387335|1486812|P1|STARTED|Overall Study||15
607438|NCT00387153|1486824|P1|NOT COMPLETED|Overall Study||8
607439|NCT00387153|1486824|P1|COMPLETED|Overall Study||0
607440|NCT00387153|1486824|P1|STARTED|Overall Study||8
607441|NCT00387127|1486830|P2|NOT COMPLETED|Overall Study||34
607442|NCT00387127|1486831|P1|NOT COMPLETED|Overall Study||33
607443|NCT00387127|1486830|P2|COMPLETED|Overall Study||0
607444|NCT00387127|1486831|P1|COMPLETED|Overall Study||0
607445|NCT00387127|1486830|P2|STARTED|Overall Study||34
607446|NCT00387127|1486831|P1|STARTED|Overall Study||33
607447|NCT00387088|1486873|P2|NOT COMPLETED|Overall Study||373
607448|NCT00387088|1486874|P1|NOT COMPLETED|Overall Study||318
607449|NCT00387088|1486873|P2|COMPLETED|Overall Study||1629
607450|NCT00387088|1486874|P1|COMPLETED|Overall Study||1671
607451|NCT00387088|1486873|P2|STARTED|Overall Study||2002
607452|NCT00387088|1486874|P1|STARTED|Overall Study||1989
607453|NCT00387036|1486918|P2|NOT COMPLETED|2-Week Crossover Second Intervention||0
607454|NCT00387036|1486919|P1|NOT COMPLETED|2-Week Crossover Second Intervention||0
607455|NCT00387036|1486918|P2|COMPLETED|2-Week Crossover Second Intervention||6
607456|NCT00387036|1486919|P1|COMPLETED|2-Week Crossover Second Intervention||6
607457|NCT00387036|1486918|P2|STARTED|2-Week Crossover Second Intervention||6
607458|NCT00387036|1486919|P1|STARTED|2-Week Crossover Second Intervention||6
607459|NCT00387036|1486918|P2|NOT COMPLETED|2-Week Placebo Washout||0
607460|NCT00387036|1486919|P1|NOT COMPLETED|2-Week Placebo Washout||0
607461|NCT00387036|1486918|P2|COMPLETED|2-Week Placebo Washout||6
607462|NCT00387036|1486919|P1|COMPLETED|2-Week Placebo Washout||6
607463|NCT00387036|1486918|P2|STARTED|2-Week Placebo Washout||6
607464|NCT00387036|1486919|P1|STARTED|2-Week Placebo Washout||6
607465|NCT00387036|1486918|P2|NOT COMPLETED|2-Week First Intervention||0
607466|NCT00387036|1486919|P1|NOT COMPLETED|2-Week First Intervention||0
607467|NCT00387036|1486918|P2|COMPLETED|2-Week First Intervention||6
607468|NCT00387036|1486919|P1|COMPLETED|2-Week First Intervention||6
607469|NCT00387036|1486918|P2|STARTED|2-Week First Intervention||6
607470|NCT00387036|1486919|P1|STARTED|2-Week First Intervention||6
607471|NCT00387023|1486927|P1|NOT COMPLETED|Overall Study||0
607472|NCT00387023|1486927|P1|COMPLETED|Overall Study||12
607473|NCT00387023|1486927|P1|STARTED|Overall Study||12
607474|NCT00387010|1486931|P1|NOT COMPLETED|Treatment Period||11
607475|NCT00387010|1486931|P1|COMPLETED|Treatment Period||169
607476|NCT00387010|1486931|P1|Full Analysis Set|Treatment Period|FAS: treated patients with at least 1 paired baseline and post baseline efficacy assessment|175
607477|NCT00387010|1486931|P1|STARTED|Treatment Period||180
607478|NCT00387010|1486931|P1|NOT COMPLETED|Dose Titration Period||38
607479|NCT00387010|1486931|P1|COMPLETED|Dose Titration Period||180
607480|NCT00387010|1486931|P1|STARTED|Dose Titration Period||218
607481|NCT00386880|1486952|P2|NOT COMPLETED|Overall Study||0
607482|NCT00386880|1486953|P1|NOT COMPLETED|Overall Study||0
607483|NCT00386880|1486952|P2|COMPLETED|Overall Study||8
607484|NCT00386880|1486953|P1|COMPLETED|Overall Study||30
607485|NCT00386880|1486952|P2|STARTED|Overall Study||8
607486|NCT00386880|1486953|P1|STARTED|Overall Study||30
607487|NCT00386776|1486958|P1|NOT COMPLETED|Overall Study||8
607488|NCT00386776|1486958|P1|COMPLETED|Overall Study||32
607489|NCT00386776|1486958|P1|STARTED|Overall Study||40
607490|NCT00386607|1486968|P2|NOT COMPLETED|Extension||17
607491|NCT00386607|1486969|P1|NOT COMPLETED|Extension||0
607492|NCT00386607|1486968|P2|COMPLETED|Extension||145
607493|NCT00386607|1486969|P1|COMPLETED|Extension||0
607494|NCT00386607|1486968|P2|STARTED|Extension||162
607495|NCT00386607|1486969|P1|STARTED|Extension||0
607496|NCT00386607|1486968|P2|NOT COMPLETED|Core||0
607497|NCT00386607|1486969|P1|NOT COMPLETED|Core||115
607498|NCT00386607|1486968|P2|COMPLETED|Core||0
607499|NCT00386607|1486969|P1|COMPLETED|Core||486
607500|NCT00386607|1486968|P2|STARTED|Core||0
607501|NCT00386607|1486969|P1|STARTED|Core||601
607502|NCT00386477|1486987|P2|NOT COMPLETED|Overall Study||0
607503|NCT00386477|1486988|P1|NOT COMPLETED|Overall Study||0
607504|NCT00386477|1486987|P2|COMPLETED|Overall Study||145
607505|NCT00386477|1486988|P1|COMPLETED|Overall Study||155
607506|NCT00386477|1486987|P2|STARTED|Overall Study||145
607507|NCT00386477|1486988|P1|STARTED|Overall Study||155
607508|NCT00386425|1486997|P3|NOT COMPLETED|Overall Study||0
607509|NCT00386425|1486998|P2|NOT COMPLETED|Overall Study||1
607510|NCT00386425|1486999|P1|NOT COMPLETED|Overall Study||3
607511|NCT00386425|1486997|P3|COMPLETED|Overall Study||53
607512|NCT00386425|1486998|P2|COMPLETED|Overall Study|33 severe protein C deficiency; 172 moderate protein C deficiency|205
607513|NCT00386425|1486999|P1|COMPLETED|Overall Study|51 severe protein C deficiency; 173 moderate protein C deficiency|224
607514|NCT00386425|1486997|P3|Received Study Drug|Overall Study||53
607515|NCT00386425|1486998|P2|Received Study Drug|Overall Study||206
607516|NCT00386425|1486999|P1|Received Study Drug|Overall Study||227
607517|NCT00386425|1486997|P3|STARTED|Overall Study||53
607518|NCT00386425|1486998|P2|STARTED|Overall Study|33 severe protein C deficiency; 173 moderate protein C deficiency|206
607519|NCT00386425|1486999|P1|STARTED|Overall Study|51 severe protein C deficiency; 176 moderate protein C deficiency|227
607520|NCT00386360|1487025|P2|NOT COMPLETED|Overall Study||17
607521|NCT00386360|1487026|P1|NOT COMPLETED|Overall Study||9
607522|NCT00386360|1487025|P2|COMPLETED|Overall Study||95
607523|NCT00386360|1487026|P1|COMPLETED|Overall Study||40
607524|NCT00386360|1487025|P2|Primary Efficacy|Overall Study||77
607525|NCT00386360|1487026|P1|Primary Efficacy|Overall Study|Per-protocol patients with evaluable BVTV (trabecular bone volume/tissue volume) at baseline & M12.|36
607526|NCT00386360|1487025|P2|Intent to Treat Population (ITT)|Overall Study||110
607527|NCT00386360|1487026|P1|Intent to Treat Population (ITT)|Overall Study|Includes all patients randomized and took at least one dose of study drug.|49
607528|NCT00386360|1487025|P2|STARTED|Overall Study||112
607529|NCT00386360|1487026|P1|STARTED|Overall Study||49
607530|NCT00386334|1487060|P2|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||1
607531|NCT00386334|1487061|P1|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||3
607532|NCT00386334|1487060|P2|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||144
607533|NCT00386334|1487061|P1|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||143
607534|NCT00386334|1487060|P2|STARTED|Follow up:2 Week Placebo, 2 Week no Drug|Two subjects withdrew consent prior to starting the follow up period.|145
607535|NCT00386334|1487061|P1|STARTED|Follow up:2 Week Placebo, 2 Week no Drug|Two subjects withdrew consent prior to starting the follow up period.|146
607536|NCT00386334|1487060|P2|NOT COMPLETED|Double Blind Period||47
607537|NCT00386334|1487061|P1|NOT COMPLETED|Double Blind Period||46
607538|NCT00386334|1487060|P2|COMPLETED|Double Blind Period||147
607539|NCT00386334|1487061|P1|COMPLETED|Double Blind Period||148
607540|NCT00386334|1487060|P2|STARTED|Double Blind Period||194
607541|NCT00386334|1487061|P1|STARTED|Double Blind Period||194
607542|NCT00386308|1487205|P2|NOT COMPLETED|Overall Study||19
607543|NCT00386308|1487206|P1|NOT COMPLETED|Overall Study||29
607544|NCT00386308|1487205|P2|COMPLETED|Overall Study||54
607545|NCT00386308|1487206|P1|COMPLETED|Overall Study||94
607546|NCT00386308|1487205|P2|Modified Intent to Treat Population|Overall Study||72
607547|NCT00386308|1487206|P1|Modified Intent to Treat Population|Overall Study||115
607548|NCT00386308|1487205|P2|Intent to Treat Population|Overall Study||72
607549|NCT00386308|1487206|P1|Intent to Treat Population|Overall Study||117
607550|NCT00386308|1487205|P2|STARTED|Overall Study||73
607551|NCT00386308|1487206|P1|STARTED|Overall Study||123
607552|NCT00386256|1487222|P4|NOT COMPLETED|Overall Study||0
607553|NCT00386256|1487223|P3|NOT COMPLETED|Overall Study||0
607554|NCT00386256|1487224|P2|NOT COMPLETED|Overall Study||0
607555|NCT00386256|1487225|P1|NOT COMPLETED|Overall Study||0
607556|NCT00386256|1487222|P4|COMPLETED|Overall Study||3
607557|NCT00386256|1487223|P3|COMPLETED|Overall Study||4
607558|NCT00386256|1487224|P2|COMPLETED|Overall Study||15
607559|NCT00386256|1487225|P1|COMPLETED|Overall Study||16
607560|NCT00386256|1487222|P4|STARTED|Overall Study||3
607561|NCT00386256|1487223|P3|STARTED|Overall Study||4
607562|NCT00386256|1487224|P2|STARTED|Overall Study||15
607563|NCT00386256|1487225|P1|STARTED|Overall Study||16
607564|NCT00386243|1487241|P2|NOT COMPLETED|Overall Study||13
607565|NCT00386243|1487242|P1|NOT COMPLETED|Overall Study||7
607566|NCT00386243|1487241|P2|COMPLETED|Overall Study||108
607567|NCT00386243|1487242|P1|COMPLETED|Overall Study||114
607568|NCT00386243|1487241|P2|STARTED|Overall Study||121
607569|NCT00386243|1487242|P1|STARTED|Overall Study||121
607570|NCT00386152|1487253|P3|NOT COMPLETED|Overall Study||33
607571|NCT00386152|1487254|P2|NOT COMPLETED|Overall Study||40
607572|NCT00386152|1487255|P1|NOT COMPLETED|Overall Study||44
607573|NCT00386152|1487253|P3|COMPLETED|Overall Study||42
607574|NCT00386152|1487254|P2|COMPLETED|Overall Study||37
607575|NCT00386152|1487255|P1|COMPLETED|Overall Study||31
607576|NCT00386152|1487253|P3|STARTED|Overall Study|number of subjects treated|75
607577|NCT00386152|1487254|P2|STARTED|Overall Study|number of subjects treated|77
607578|NCT00386152|1487255|P1|STARTED|Overall Study|number of subjects treated|75
607579|NCT00386100|1487274|P2|NOT COMPLETED|Overall Study||131
607580|NCT00386100|1487275|P1|NOT COMPLETED|Overall Study||154
607581|NCT00386100|1487274|P2|COMPLETED|Overall Study||217
607582|NCT00386100|1487275|P1|COMPLETED|Overall Study||186
607583|NCT00386100|1487274|P2|STARTED|Overall Study||348
607584|NCT00386100|1487275|P1|STARTED|Overall Study||340
607585|NCT00386022|1487339|P2|NOT COMPLETED|Plus Estrogen||1
607586|NCT00386022|1487340|P1|NOT COMPLETED|Plus Estrogen||2
607587|NCT00386022|1487339|P2|COMPLETED|Plus Estrogen||8
607588|NCT00386022|1487340|P1|COMPLETED|Plus Estrogen||8
607589|NCT00386022|1487339|P2|All Doses GnRH|Plus Estrogen||8
607590|NCT00386022|1487340|P1|All Doses GnRH|Plus Estrogen||8
607591|NCT00386022|1487339|P2|Estrogen Patch|Plus Estrogen||9
607592|NCT00386022|1487340|P1|Estrogen Patch|Plus Estrogen||8
607593|NCT00386022|1487339|P2|STARTED|Plus Estrogen||9
607594|NCT00386022|1487340|P1|STARTED|Plus Estrogen||10
607595|NCT00386022|1487339|P2|NOT COMPLETED|Baseline||0
607596|NCT00386022|1487340|P1|NOT COMPLETED|Baseline||0
607597|NCT00386022|1487339|P2|COMPLETED|Baseline||9
607598|NCT00386022|1487340|P1|COMPLETED|Baseline||10
607599|NCT00386022|1487339|P2|All Doses of GnRH|Baseline||9
607600|NCT00386022|1487340|P1|All Doses of GnRH|Baseline||10
607601|NCT00386022|1487339|P2|STARTED|Baseline||9
607602|NCT00386022|1487340|P1|STARTED|Baseline||10
607603|NCT00386009|1487350|P2|NOT COMPLETED|Overall Study||10
607604|NCT00386009|1487351|P1|NOT COMPLETED|Overall Study||9
607605|NCT00386009|1487350|P2|COMPLETED|Overall Study||89
607606|NCT00386009|1487351|P1|COMPLETED|Overall Study||92
607607|NCT00386009|1487350|P2|STARTED|Overall Study||99
607608|NCT00386009|1487351|P1|STARTED|Overall Study||101
607609|NCT00385996|1487389|P1|NOT COMPLETED|Overall Study||0
607610|NCT00385996|1487389|P1|COMPLETED|Overall Study||22
607611|NCT00385996|1487389|P1|STARTED|Overall Study||22
607612|NCT00385944|1487396|P3|NOT COMPLETED|2nd Maintenance Dose Period||0
607613|NCT00385944|1487397|P2|NOT COMPLETED|2nd Maintenance Dose Period||3
607614|NCT00385944|1487398|P1|NOT COMPLETED|2nd Maintenance Dose Period||2
607615|NCT00385944|1487396|P3|COMPLETED|2nd Maintenance Dose Period||0
607616|NCT00385944|1487397|P2|COMPLETED|2nd Maintenance Dose Period||19
607617|NCT00385944|1487398|P1|COMPLETED|2nd Maintenance Dose Period||22
607618|NCT00385944|1487396|P3|STARTED|2nd Maintenance Dose Period||0
607619|NCT00385944|1487397|P2|STARTED|2nd Maintenance Dose Period|2 patients discontinued prior to the 2nd MD Period (Sponsor decision due to early study termination)|22
607620|NCT00385944|1487398|P1|STARTED|2nd Maintenance Dose Period|1 patient discontinued prior to the 2nd MD Period (Sponsor decision due to early study termination)|24
607621|NCT00385944|1487396|P3|NOT COMPLETED|1st Maintenance Dose Period||0
607622|NCT00385944|1487397|P2|NOT COMPLETED|1st Maintenance Dose Period||1
607623|NCT00385944|1487398|P1|NOT COMPLETED|1st Maintenance Dose Period||4
607624|NCT00385944|1487396|P3|COMPLETED|1st Maintenance Dose Period||0
607625|NCT00385944|1487397|P2|COMPLETED|1st Maintenance Dose Period||24
607626|NCT00385944|1487398|P1|COMPLETED|1st Maintenance Dose Period||25
607627|NCT00385944|1487396|P3|STARTED|1st Maintenance Dose Period||0
607628|NCT00385944|1487397|P2|STARTED|1st Maintenance Dose Period|Two patients withdrew from the study after randomization but prior to receiving the 1st MD.|25
607629|NCT00385944|1487398|P1|STARTED|1st Maintenance Dose Period||29
607630|NCT00385944|1487396|P3|NOT COMPLETED|Loading Dose||0
607631|NCT00385944|1487397|P2|NOT COMPLETED|Loading Dose||0
607632|NCT00385944|1487398|P1|NOT COMPLETED|Loading Dose||0
607633|NCT00385944|1487396|P3|COMPLETED|Loading Dose||56
607634|NCT00385944|1487397|P2|COMPLETED|Loading Dose||0
607635|NCT00385944|1487398|P1|COMPLETED|Loading Dose||0
607636|NCT00385944|1487396|P3|STARTED|Loading Dose||56
607637|NCT00385944|1487397|P2|STARTED|Loading Dose||0
607638|NCT00385944|1487398|P1|STARTED|Loading Dose||0
607639|NCT00385918|1487441|P3|NOT COMPLETED|Intervention Phase After Randomization||0
607640|NCT00385918|1487442|P2|NOT COMPLETED|Intervention Phase After Randomization||0
607641|NCT00385918|1487443|P1|NOT COMPLETED|Intervention Phase After Randomization||3
607642|NCT00385918|1487441|P3|COMPLETED|Intervention Phase After Randomization||0
607643|NCT00385918|1487442|P2|COMPLETED|Intervention Phase After Randomization|Participants completed the 3-month home-base intervention|6
607644|NCT00385918|1487443|P1|COMPLETED|Intervention Phase After Randomization|Participants completed the 3-month training intervention|12
607645|NCT00385918|1487441|P3|STARTED|Intervention Phase After Randomization||0
607646|NCT00385918|1487442|P2|STARTED|Intervention Phase After Randomization|Participants successfully completed screening; this is the number in the home stretching arm.|6
607647|NCT00385918|1487443|P1|STARTED|Intervention Phase After Randomization|Participant successfully completed screening; this is the number in the Lokomat training arm.|15
607648|NCT00385918|1487441|P3|NOT COMPLETED|Feasibility & Baseline Measurement Phase||14
607649|NCT00385918|1487442|P2|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0
607650|NCT00385918|1487443|P1|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0
607651|NCT00385918|1487441|P3|COMPLETED|Feasibility & Baseline Measurement Phase||21
607652|NCT00385918|1487442|P2|COMPLETED|Feasibility & Baseline Measurement Phase||0
607653|NCT00385918|1487443|P1|COMPLETED|Feasibility & Baseline Measurement Phase||0
607654|NCT00385918|1487441|P3|Completed Baseline Tests|Feasibility & Baseline Measurement Phase|6 subjects did not complete all baseline tests.|21
607655|NCT00385918|1487442|P2|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0
607656|NCT00385918|1487443|P1|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0
607657|NCT00385918|1487441|P3|Number Eligible|Feasibility & Baseline Measurement Phase|8 subjects failed screening.|27
607658|NCT00385918|1487442|P2|Number Eligible|Feasibility & Baseline Measurement Phase||0
607659|NCT00385918|1487443|P1|Number Eligible|Feasibility & Baseline Measurement Phase||0
607660|NCT00385918|1487441|P3|STARTED|Feasibility & Baseline Measurement Phase|Total # of subjects screened.The screening occurred before randomization.|35
607661|NCT00385918|1487442|P2|STARTED|Feasibility & Baseline Measurement Phase||0
607662|NCT00385918|1487443|P1|STARTED|Feasibility & Baseline Measurement Phase||0
607663|NCT00385840|1487467|P2|NOT COMPLETED|Overall Study||14
607664|NCT00385840|1487468|P1|NOT COMPLETED|Overall Study||4
607665|NCT00385840|1487467|P2|COMPLETED|Overall Study||531
607666|NCT00385840|1487468|P1|COMPLETED|Overall Study||129
607667|NCT00385840|1487467|P2|STARTED|Overall Study||545
607668|NCT00385840|1487468|P1|STARTED|Overall Study||133
607669|NCT00385827|1487491|P3|NOT COMPLETED|Part 2||48
607670|NCT00385827|1487492|P2|NOT COMPLETED|Part 2||33
607671|NCT00385827|1487493|P1|NOT COMPLETED|Part 2||0
607672|NCT00385827|1487491|P3|COMPLETED|Part 2||0
607673|NCT00385827|1487492|P2|COMPLETED|Part 2||16
607674|NCT00385827|1487493|P1|COMPLETED|Part 2||0
607675|NCT00385827|1487491|P3|Treated|Part 2||46
607676|NCT00385827|1487492|P2|Treated|Part 2||47
607677|NCT00385827|1487493|P1|Treated|Part 2||0
607678|NCT00385827|1487491|P3|STARTED|Part 2||48
607679|NCT00385827|1487492|P2|STARTED|Part 2||49
607680|NCT00385827|1487493|P1|STARTED|Part 2||0
607681|NCT00385827|1487491|P3|NOT COMPLETED|Part 1||0
607682|NCT00385827|1487492|P2|NOT COMPLETED|Part 1||0
607683|NCT00385827|1487493|P1|NOT COMPLETED|Part 1||9
607684|NCT00385827|1487491|P3|COMPLETED|Part 1||0
607685|NCT00385827|1487492|P2|COMPLETED|Part 1||0
607686|NCT00385827|1487493|P1|COMPLETED|Part 1||0
607687|NCT00385827|1487491|P3|Treated|Part 1||0
607688|NCT00385827|1487492|P2|Treated|Part 1||0
607689|NCT00385827|1487493|P1|Treated|Part 1||9
607690|NCT00385827|1487491|P3|STARTED|Part 1||0
607691|NCT00385827|1487492|P2|STARTED|Part 1||0
607692|NCT00385827|1487493|P1|STARTED|Part 1||9
607693|NCT00385801|1487515|P2|NOT COMPLETED|Overall Study||8
607694|NCT00385801|1487516|P1|NOT COMPLETED|Overall Study||9
607695|NCT00385801|1487515|P2|COMPLETED|Overall Study||8
607696|NCT00385801|1487516|P1|COMPLETED|Overall Study||6
607697|NCT00385801|1487515|P2|STARTED|Overall Study||16
607698|NCT00385801|1487516|P1|STARTED|Overall Study||15
607699|NCT00385788|1487530|P2|NOT COMPLETED|Overall Study||0
607700|NCT00385788|1487531|P1|NOT COMPLETED|Overall Study||0
607701|NCT00385788|1487530|P2|COMPLETED|Overall Study||40
607702|NCT00385788|1487531|P1|COMPLETED|Overall Study||12
607703|NCT00385788|1487530|P2|STARTED|Overall Study||40
607704|NCT00385788|1487531|P1|STARTED|Overall Study||12
607705|NCT00385762|1487537|P1|NOT COMPLETED|Overall Study||2
607706|NCT00385762|1487537|P1|COMPLETED|Overall Study||33
607707|NCT00385762|1487537|P1|STARTED|Overall Study||35
607708|NCT00385736|1487547|P3|NOT COMPLETED|Safety Analysis Set||80
607709|NCT00385736|1487548|P2|NOT COMPLETED|Safety Analysis Set||44
607710|NCT00385736|1487549|P1|NOT COMPLETED|Safety Analysis Set||70
607711|NCT00385736|1487547|P3|COMPLETED|Safety Analysis Set||143
607712|NCT00385736|1487548|P2|COMPLETED|Safety Analysis Set||86
607713|NCT00385736|1487549|P1|COMPLETED|Safety Analysis Set||153
607714|NCT00385736|1487547|P3|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|223
607715|NCT00385736|1487548|P2|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|130
607716|NCT00385736|1487549|P1|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|223
607717|NCT00385736|1487547|P3|NOT COMPLETED|Efficacy Analysis Set - Maintenance||80
607718|NCT00385736|1487548|P2|NOT COMPLETED|Efficacy Analysis Set - Maintenance||44
607719|NCT00385736|1487549|P1|NOT COMPLETED|Efficacy Analysis Set - Maintenance||69
607720|NCT00385736|1487547|P3|COMPLETED|Efficacy Analysis Set - Maintenance||143
607721|NCT00385736|1487548|P2|COMPLETED|Efficacy Analysis Set - Maintenance||86
607722|NCT00385736|1487549|P1|COMPLETED|Efficacy Analysis Set - Maintenance||153
607723|NCT00385736|1487547|P3|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|223
607724|NCT00385736|1487548|P2|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|130
607725|NCT00385736|1487549|P1|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|222
607726|NCT00385736|1487547|P3|NOT COMPLETED|Efficacy Analysis Set - Induction||9
607727|NCT00385736|1487548|P2|NOT COMPLETED|Efficacy Analysis Set - Induction||12
607728|NCT00385736|1487549|P1|NOT COMPLETED|Efficacy Analysis Set - Induction||9
607729|NCT00385736|1487547|P3|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|121
607730|NCT00385736|1487548|P2|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|118
607731|NCT00385736|1487549|P1|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|121
607732|NCT00385736|1487547|P3|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
607733|NCT00385736|1487548|P2|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
607734|NCT00385736|1487549|P1|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
607735|NCT00385723|1487594|P3|NOT COMPLETED|Overall Study||2
607736|NCT00385723|1487595|P2|NOT COMPLETED|Overall Study||1
607737|NCT00385723|1487596|P1|NOT COMPLETED|Overall Study||2
607738|NCT00385723|1487594|P3|COMPLETED|Overall Study||44
607739|NCT00385723|1487595|P2|COMPLETED|Overall Study||45
607740|NCT00385723|1487596|P1|COMPLETED|Overall Study||44
607741|NCT00385723|1487594|P3|STARTED|Overall Study||46
607742|NCT00385723|1487595|P2|STARTED|Overall Study||46
607743|NCT00385723|1487596|P1|STARTED|Overall Study||46
607744|NCT00385684|1487610|P2|NOT COMPLETED|PHASE B||0
607745|NCT00385684|1487611|P1|NOT COMPLETED|PHASE B||0
607746|NCT00385684|1487610|P2|COMPLETED|PHASE B||3
607747|NCT00385684|1487611|P1|COMPLETED|PHASE B||5
607748|NCT00385684|1487610|P2|STARTED|PHASE B||3
607749|NCT00385684|1487611|P1|STARTED|PHASE B||5
607750|NCT00385684|1487610|P2|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||2
607751|NCT00385684|1487611|P1|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||0
607752|NCT00385684|1487610|P2|COMPLETED|SECOND INTERVENTION OF PHASE A||3
607753|NCT00385684|1487611|P1|COMPLETED|SECOND INTERVENTION OF PHASE A||5
607754|NCT00385684|1487610|P2|STARTED|SECOND INTERVENTION OF PHASE A||5
607755|NCT00385684|1487611|P1|STARTED|SECOND INTERVENTION OF PHASE A||5
607756|NCT00385684|1487610|P2|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||0
607757|NCT00385684|1487611|P1|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||1
607758|NCT00385684|1487610|P2|COMPLETED|FIRST INTERVENTION OF PHASE A||5
607759|NCT00385684|1487611|P1|COMPLETED|FIRST INTERVENTION OF PHASE A||5
607760|NCT00385684|1487610|P2|STARTED|FIRST INTERVENTION OF PHASE A||5
607761|NCT00385684|1487611|P1|STARTED|FIRST INTERVENTION OF PHASE A||6
607762|NCT00385671|1487620|P3|NOT COMPLETED|Overall Study||36
607763|NCT00385671|1487621|P2|NOT COMPLETED|Overall Study||51
607764|NCT00385671|1487622|P1|NOT COMPLETED|Overall Study||38
607765|NCT00385671|1487620|P3|COMPLETED|Overall Study||99
607766|NCT00385671|1487621|P2|COMPLETED|Overall Study||87
607767|NCT00385671|1487622|P1|COMPLETED|Overall Study||96
607768|NCT00385671|1487620|P3|STARTED|Overall Study||135
607769|NCT00385671|1487621|P2|STARTED|Overall Study||138
607770|NCT00385671|1487622|P1|STARTED|Overall Study||134
607771|NCT00385593|1487778|P2|NOT COMPLETED|Overall Study||37
607772|NCT00385593|1487779|P1|NOT COMPLETED|Overall Study||58
607773|NCT00385593|1487778|P2|COMPLETED|Overall Study||289
607774|NCT00385593|1487779|P1|COMPLETED|Overall Study||270
607775|NCT00385593|1487778|P2|STARTED|Overall Study||326
607776|NCT00385593|1487779|P1|STARTED|Overall Study||328
607777|NCT00385580|1487797|P2|NOT COMPLETED|Overall Study||0
607778|NCT00385580|1487798|P1|NOT COMPLETED|Overall Study||0
607779|NCT00385580|1487797|P2|COMPLETED|Overall Study|Completed=off study. Major reasons for being off study are disease progression, and study toxicity.|47
607780|NCT00385580|1487798|P1|COMPLETED|Overall Study|Completed=off study. Major reasons for being off study are disease progression, and study toxicity.|48
607781|NCT00385580|1487797|P2|STARTED|Overall Study|Number of participants treated.|47
607782|NCT00385580|1487798|P1|STARTED|Overall Study|Number of participants treated.|48
607783|NCT00385541|1487889|P2|NOT COMPLETED|Overall Study||1
607784|NCT00385541|1487890|P1|NOT COMPLETED|Overall Study||0
607785|NCT00385541|1487889|P2|COMPLETED|Overall Study||24
607786|NCT00385541|1487890|P1|COMPLETED|Overall Study||25
607787|NCT00385541|1487889|P2|STARTED|Overall Study||25
607788|NCT00385541|1487890|P1|STARTED|Overall Study||25
607789|NCT00385515|1487906|P2|NOT COMPLETED|Overall Study||3
607790|NCT00385515|1487907|P1|NOT COMPLETED|Overall Study||4
607791|NCT00385515|1487906|P2|COMPLETED|Overall Study||21
607792|NCT00385515|1487907|P1|COMPLETED|Overall Study||53
607793|NCT00385515|1487906|P2|STARTED|Overall Study||24
607794|NCT00385515|1487907|P1|STARTED|Overall Study||57
607795|NCT00385268|1487915|P2|NOT COMPLETED|Overall Study||8
607796|NCT00385268|1487916|P1|NOT COMPLETED|Overall Study||16
607797|NCT00385268|1487915|P2|COMPLETED|Overall Study||18
607798|NCT00385268|1487916|P1|COMPLETED|Overall Study||18
607799|NCT00385268|1487915|P2|STARTED|Overall Study||26
607800|NCT00385268|1487916|P1|STARTED|Overall Study||34
607801|NCT00385216|1487922|P2|NOT COMPLETED|Second Intervention||0
607802|NCT00385216|1487923|P1|NOT COMPLETED|Second Intervention||0
607803|NCT00385216|1487922|P2|COMPLETED|Second Intervention||9
607804|NCT00385216|1487923|P1|COMPLETED|Second Intervention||11
607805|NCT00385216|1487922|P2|STARTED|Second Intervention||9
607806|NCT00385216|1487923|P1|STARTED|Second Intervention||11
607807|NCT00385216|1487922|P2|NOT COMPLETED|First Intervention||0
607808|NCT00385216|1487923|P1|NOT COMPLETED|First Intervention||0
607809|NCT00385216|1487922|P2|COMPLETED|First Intervention||9
607810|NCT00385216|1487923|P1|COMPLETED|First Intervention||11
607811|NCT00385216|1487922|P2|STARTED|First Intervention||9
607812|NCT00385216|1487923|P1|STARTED|First Intervention||11
607813|NCT00385203|1487937|P2|NOT COMPLETED|Overall Study||7
607814|NCT00385203|1487938|P1|NOT COMPLETED|Overall Study||26
607815|NCT00385203|1487937|P2|COMPLETED|Overall Study||3
607816|NCT00385203|1487938|P1|COMPLETED|Overall Study||0
607817|NCT00385203|1487937|P2|STARTED|Overall Study||10
607818|NCT00385203|1487938|P1|STARTED|Overall Study||26
607819|NCT00385138|1487958|P2|NOT COMPLETED|Overall Study||28
607820|NCT00385138|1487959|P1|NOT COMPLETED|Overall Study||30
607821|NCT00385138|1487958|P2|COMPLETED|Overall Study|"Completed means patient completed scheduled visits or developed a primary endpoint event."|2641
607822|NCT00385138|1487959|P1|COMPLETED|Overall Study|"Completed means patient completed scheduled visits or developed a primary endpoint event."|2665
607823|NCT00385138|1487958|P2|Safety Population|Overall Study|Includes all randomized patients who received at least one dose of study drug.|2650
607824|NCT00385138|1487959|P1|Safety Population|Overall Study|Includes all randomized patients who received at least one dose of study drug.|2662
607825|NCT00385138|1487958|P2|Modified Intent-to-treat (mITT)|Overall Study|Excludes 24 patients who either did not received study drug or have PCI.|2645
607826|NCT00385138|1487959|P1|Modified Intent-to-treat (mITT)|Overall Study|Excludes 37 patients who either did not receive study drug or have PCI.|2656
607827|NCT00385138|1487958|P2|Intent-to-treat (ITT)|Overall Study||2669
607828|NCT00385138|1487959|P1|Intent-to-treat (ITT)|Overall Study|All patients randomized excluding two (2) who withdrew consent for using study data.|2693
607829|NCT00385138|1487958|P2|STARTED|Overall Study||2669
607830|NCT00385138|1487959|P1|STARTED|Overall Study||2695
607831|NCT00385008|1488005|P2|NOT COMPLETED|Overall Study||0
607832|NCT00385008|1488006|P1|NOT COMPLETED|Overall Study||0
607833|NCT00385008|1488005|P2|COMPLETED|Overall Study||10
607834|NCT00385008|1488006|P1|COMPLETED|Overall Study||10
607835|NCT00385008|1488005|P2|In Presence of Migraine|Overall Study||5
607836|NCT00385008|1488006|P1|In Presence of Migraine|Overall Study||5
607837|NCT00385008|1488005|P2|In Absence of Migraine|Overall Study||10
607838|NCT00385008|1488006|P1|In Absence of Migraine|Overall Study||10
607839|NCT00385008|1488005|P2|STARTED|Overall Study||10
607840|NCT00385008|1488006|P1|STARTED|Overall Study||10
607841|NCT00384956|1488026|P1|NOT COMPLETED|Overall Study||3
607842|NCT00384956|1488026|P1|COMPLETED|Overall Study||22
607843|NCT00384956|1488026|P1|STARTED|Overall Study||25
607844|NCT00384930|1488043|P5|NOT COMPLETED|Overall Study||47
607845|NCT00384930|1488044|P4|NOT COMPLETED|Overall Study||41
607846|NCT00384930|1488045|P3|NOT COMPLETED|Overall Study||30
607847|NCT00384930|1488046|P2|NOT COMPLETED|Overall Study||27
607848|NCT00384930|1488047|P1|NOT COMPLETED|Overall Study||27
607849|NCT00384930|1488043|P5|COMPLETED|Overall Study||162
607850|NCT00384930|1488044|P4|COMPLETED|Overall Study||175
607851|NCT00384930|1488045|P3|COMPLETED|Overall Study||182
607852|NCT00384930|1488046|P2|COMPLETED|Overall Study||182
607853|NCT00384930|1488047|P1|COMPLETED|Overall Study||185
607854|NCT00384930|1488043|P5|Received Double-Blind Study Drug|Overall Study||209
607855|NCT00384930|1488044|P4|Received Double-Blind Study Drug|Overall Study||216
607856|NCT00384930|1488045|P3|Received Double-Blind Study Drug|Overall Study||212
607857|NCT00384930|1488046|P2|Received Double-Blind Study Drug|Overall Study||208
607858|NCT00384930|1488047|P1|Received Double-Blind Study Drug|Overall Study||211
607859|NCT00384930|1488043|P5|STARTED|Overall Study||209
607860|NCT00384930|1488044|P4|STARTED|Overall Study||216
607861|NCT00384930|1488045|P3|STARTED|Overall Study||212
607862|NCT00384930|1488046|P2|STARTED|Overall Study||209
607863|NCT00384930|1488047|P1|STARTED|Overall Study||212
607864|NCT00384865|1488105|P4|NOT COMPLETED|Overall Study||0
607865|NCT00384865|1488106|P3|NOT COMPLETED|Overall Study||0
607866|NCT00384865|1488107|P2|NOT COMPLETED|Overall Study||0
607867|NCT00384865|1488108|P1|NOT COMPLETED|Overall Study||0
607868|NCT00384865|1488105|P4|COMPLETED|Overall Study||16
607869|NCT00384865|1488106|P3|COMPLETED|Overall Study||16
607870|NCT00384865|1488107|P2|COMPLETED|Overall Study||16
607871|NCT00384865|1488108|P1|COMPLETED|Overall Study||16
607872|NCT00384865|1488105|P4|Completed Six Month Assessment|Overall Study||11
607873|NCT00384865|1488106|P3|Completed Six Month Assessment|Overall Study||15
607874|NCT00384865|1488107|P2|Completed Six Month Assessment|Overall Study||12
607875|NCT00384865|1488108|P1|Completed Six Month Assessment|Overall Study||11
607876|NCT00384865|1488105|P4|STARTED|Overall Study||16
607877|NCT00384865|1488106|P3|STARTED|Overall Study||16
607878|NCT00384865|1488107|P2|STARTED|Overall Study||16
607879|NCT00384865|1488108|P1|STARTED|Overall Study||16
607880|NCT00384813|1488128|P2|NOT COMPLETED|Overall Study||0
607881|NCT00384813|1488129|P1|NOT COMPLETED|Overall Study||2
607882|NCT00384813|1488128|P2|COMPLETED|Overall Study||20
607883|NCT00384813|1488129|P1|COMPLETED|Overall Study||21
607884|NCT00384813|1488128|P2|STARTED|Overall Study||20
607885|NCT00384813|1488129|P1|STARTED|Overall Study||23
607886|NCT00384748|1488137|P2|NOT COMPLETED|Overall Study||0
607887|NCT00384748|1488138|P1|NOT COMPLETED|Overall Study||0
607888|NCT00384748|1488137|P2|COMPLETED|Overall Study||23
607889|NCT00384748|1488138|P1|COMPLETED|Overall Study||25
607890|NCT00384748|1488137|P2|STARTED|Overall Study||23
607891|NCT00384748|1488138|P1|STARTED|Overall Study||25
607892|NCT00384670|1488144|P1|NOT COMPLETED|Overall Study||0
607893|NCT00384670|1488144|P1|COMPLETED|Overall Study||7
607894|NCT00384670|1488144|P1|STARTED|Overall Study||7
607895|NCT00384397|1488157|P3|NOT COMPLETED|Overall Study||33
607896|NCT00384397|1488158|P2|NOT COMPLETED|Overall Study||46
607897|NCT00384397|1488159|P1|NOT COMPLETED|Overall Study||32
607898|NCT00384397|1488157|P3|COMPLETED|Overall Study||385
607899|NCT00384397|1488158|P2|COMPLETED|Overall Study||247
607900|NCT00384397|1488159|P1|COMPLETED|Overall Study||375
607901|NCT00384397|1488157|P3|STARTED|Overall Study||418
607902|NCT00384397|1488158|P2|STARTED|Overall Study||293
607903|NCT00384397|1488159|P1|STARTED|Overall Study||407
607904|NCT00384332|1488178|P2|NOT COMPLETED|Overall Study||0
607905|NCT00384332|1488179|P1|NOT COMPLETED|Overall Study||4
607906|NCT00384332|1488178|P2|COMPLETED|Overall Study||10
607907|NCT00384332|1488179|P1|COMPLETED|Overall Study||9
607908|NCT00384332|1488178|P2|STARTED|Overall Study||10
607909|NCT00384332|1488179|P1|STARTED|Overall Study||13
607910|NCT00384293|1488189|P3|NOT COMPLETED|Post-randomization Period||219
607911|NCT00384293|1488190|P2|NOT COMPLETED|Post-randomization Period||214
607912|NCT00384293|1488191|P1|NOT COMPLETED|Post-randomization Period||0
607913|NCT00384293|1488189|P3|COMPLETED|Post-randomization Period||0
607914|NCT00384293|1488190|P2|COMPLETED|Post-randomization Period||0
607915|NCT00384293|1488191|P1|COMPLETED|Post-randomization Period||0
607916|NCT00384293|1488189|P3|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||218
607917|NCT00384293|1488190|P2|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period|Received at least one dose of randomized study drug (All Patients as Treated Population)|214
607918|NCT00384293|1488191|P1|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||0
607919|NCT00384293|1488189|P3|STARTED|Post-randomization Period||219
607920|NCT00384293|1488190|P2|STARTED|Post-randomization Period||214
607921|NCT00384293|1488191|P1|STARTED|Post-randomization Period||0
607922|NCT00384293|1488189|P3|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0
607923|NCT00384293|1488190|P2|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0
607924|NCT00384293|1488191|P1|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||504
607925|NCT00384293|1488189|P3|COMPLETED|MK0524A Active Run-In, Pre-randomization||0
607926|NCT00384293|1488190|P2|COMPLETED|MK0524A Active Run-In, Pre-randomization||0
607927|NCT00384293|1488191|P1|COMPLETED|MK0524A Active Run-In, Pre-randomization||433
607928|NCT00384293|1488189|P3|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0
607929|NCT00384293|1488190|P2|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0
607930|NCT00384293|1488191|P1|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization|MK0524A dose increased to 2 g in active run-in period|813
607931|NCT00384293|1488189|P3|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0
607932|NCT00384293|1488190|P2|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0
607933|NCT00384293|1488191|P1|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization|Entered active run-in period and received MK0524A 1 g|937
607934|NCT00384293|1488189|P3|STARTED|MK0524A Active Run-In, Pre-randomization||0
607935|NCT00384293|1488190|P2|STARTED|MK0524A Active Run-In, Pre-randomization||0
607936|NCT00384293|1488191|P1|STARTED|MK0524A Active Run-In, Pre-randomization||937
607937|NCT00384241|1488204|P2|NOT COMPLETED|Overall Study||0
607938|NCT00384241|1488205|P1|NOT COMPLETED|Overall Study||0
607939|NCT00384241|1488204|P2|COMPLETED|Overall Study||599
607940|NCT00384241|1488205|P1|COMPLETED|Overall Study||500
607941|NCT00384241|1488204|P2|STARTED|Overall Study||599
607942|NCT00384241|1488205|P1|STARTED|Overall Study||500
607943|NCT00384189|1488215|P4|NOT COMPLETED|Overall Study||40
607944|NCT00384189|1488216|P3|NOT COMPLETED|Overall Study||58
607945|NCT00384189|1488217|P2|NOT COMPLETED|Overall Study||57
607946|NCT00384189|1488218|P1|NOT COMPLETED|Overall Study||50
607947|NCT00384189|1488215|P4|COMPLETED|Overall Study||110
607948|NCT00384189|1488216|P3|COMPLETED|Overall Study||255
607949|NCT00384189|1488217|P2|COMPLETED|Overall Study||255
607950|NCT00384189|1488218|P1|COMPLETED|Overall Study||255
607951|NCT00384189|1488215|P4|Actual Treatment Received|Overall Study||146
607952|NCT00384189|1488216|P3|Actual Treatment Received|Overall Study|1 participants in the 160 μg arm actually received 40 μg and is moved to that arm.|310
607953|NCT00384189|1488217|P2|Actual Treatment Received|Overall Study||312
607954|NCT00384189|1488218|P1|Actual Treatment Received|Overall Study|1 participant randomized to 160 μg who actually received 40 μg is included.|305
607955|NCT00384189|1488215|P4|Randomized, Not Treated|Overall Study||4
607956|NCT00384189|1488216|P3|Randomized, Not Treated|Overall Study||2
607957|NCT00384189|1488217|P2|Randomized, Not Treated|Overall Study||0
607958|NCT00384189|1488218|P1|Randomized, Not Treated|Overall Study||1
607959|NCT00384189|1488215|P4|STARTED|Overall Study||150
607960|NCT00384189|1488216|P3|STARTED|Overall Study||313
607961|NCT00384189|1488217|P2|STARTED|Overall Study||312
607962|NCT00384189|1488218|P1|STARTED|Overall Study||305
607963|NCT00384176|1488279|P3|NOT COMPLETED|Overall Study||132
607964|NCT00384176|1488280|P2|NOT COMPLETED|Overall Study||319
607965|NCT00384176|1488281|P1|NOT COMPLETED|Overall Study||312
607966|NCT00384176|1488279|P3|COMPLETED|Overall Study||60
607967|NCT00384176|1488280|P2|COMPLETED|Overall Study||394
607968|NCT00384176|1488281|P1|COMPLETED|Overall Study||397
607969|NCT00384176|1488279|P3|STARTED|Overall Study||192
607970|NCT00384176|1488280|P2|STARTED|Overall Study||713
607971|NCT00384176|1488281|P1|STARTED|Overall Study||709
607972|NCT00384085|1488307|P3|NOT COMPLETED|Overall Study||56
607973|NCT00384085|1488308|P2|NOT COMPLETED|Overall Study||46
607974|NCT00384085|1488309|P1|NOT COMPLETED|Overall Study||39
607975|NCT00384085|1488307|P3|COMPLETED|Overall Study|Based on the entire ITT population|141
607976|NCT00384085|1488308|P2|COMPLETED|Overall Study|Based on the entire ITT population|150
607977|NCT00384085|1488309|P1|COMPLETED|Overall Study|Based on the entire ITT population|156
607978|NCT00384085|1488307|P3|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||189
607979|NCT00384085|1488308|P2|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||186
607980|NCT00384085|1488309|P1|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||187
607981|NCT00384085|1488307|P3|Treated (Safety Population)|Overall Study||194
607982|NCT00384085|1488308|P2|Treated (Safety Population)|Overall Study||194
607983|NCT00384085|1488309|P1|Treated (Safety Population)|Overall Study||194
607984|NCT00384085|1488307|P3|Intent-To-Treat (ITT)|Overall Study||197
607985|NCT00384085|1488308|P2|Intent-To-Treat (ITT)|Overall Study||196
607986|NCT00384085|1488309|P1|Intent-To-Treat (ITT)|Overall Study||195
607987|NCT00384085|1488307|P3|STARTED|Overall Study|Randomized|197
607988|NCT00384085|1488308|P2|STARTED|Overall Study|Randomized|196
607989|NCT00384085|1488309|P1|STARTED|Overall Study|Randomized|195
607990|NCT00384059|1488335|P2|NOT COMPLETED|Toddler Dose||2
607991|NCT00384059|1488336|P1|NOT COMPLETED|Toddler Dose||1
607992|NCT00384059|1488335|P2|COMPLETED|Toddler Dose||120
607993|NCT00384059|1488336|P1|COMPLETED|Toddler Dose||130
607994|NCT00384059|1488335|P2|STARTED|Toddler Dose||122
607995|NCT00384059|1488336|P1|STARTED|Toddler Dose||131
607996|NCT00384059|1488335|P2|NOT COMPLETED|After Infant Series||10
607997|NCT00384059|1488336|P1|NOT COMPLETED|After Infant Series||4
607998|NCT00384059|1488335|P2|COMPLETED|After Infant Series||122
607999|NCT00384059|1488336|P1|COMPLETED|After Infant Series||131
608000|NCT00384059|1488335|P2|STARTED|After Infant Series||132
608001|NCT00384059|1488336|P1|STARTED|After Infant Series||135
608002|NCT00384059|1488335|P2|NOT COMPLETED|Infant Series||13
608003|NCT00384059|1488336|P1|NOT COMPLETED|Infant Series||6
608004|NCT00384059|1488335|P2|COMPLETED|Infant Series||132
608005|NCT00384059|1488336|P1|COMPLETED|Infant Series||135
608006|NCT00384059|1488335|P2|Vaccinated Dose 2|Infant Series||135
608007|NCT00384059|1488336|P1|Vaccinated Dose 2|Infant Series||136
608008|NCT00384059|1488335|P2|Vaccinated Dose 1|Infant Series||139
608009|NCT00384059|1488336|P1|Vaccinated Dose 1|Infant Series||139
608010|NCT00384059|1488335|P2|STARTED|Infant Series||145
608011|NCT00384059|1488336|P1|STARTED|Infant Series||141
608012|NCT00384033|1488386|P4|NOT COMPLETED|Overall Study||40
608013|NCT00384033|1488387|P3|NOT COMPLETED|Overall Study||43
608014|NCT00384033|1488388|P2|NOT COMPLETED|Overall Study||35
608015|NCT00384033|1488389|P1|NOT COMPLETED|Overall Study||41
608016|NCT00384033|1488386|P4|COMPLETED|Overall Study||119
608017|NCT00384033|1488387|P3|COMPLETED|Overall Study||117
608018|NCT00384033|1488388|P2|COMPLETED|Overall Study||120
608019|NCT00384033|1488389|P1|COMPLETED|Overall Study||123
608020|NCT00384033|1488386|P4|Treated|Overall Study||157
608021|NCT00384033|1488387|P3|Treated|Overall Study||150
608022|NCT00384033|1488388|P2|Treated|Overall Study||148
608023|NCT00384033|1488389|P1|Treated|Overall Study||161
608024|NCT00384033|1488386|P4|STARTED|Overall Study||159
608025|NCT00384033|1488387|P3|STARTED|Overall Study||160
608026|NCT00384033|1488388|P2|STARTED|Overall Study||155
608027|NCT00384033|1488389|P1|STARTED|Overall Study||164
608028|NCT00383942|1488433|P2|NOT COMPLETED|Overall Study||0
608029|NCT00383942|1488434|P1|NOT COMPLETED|Overall Study||0
608030|NCT00383942|1488433|P2|COMPLETED|Overall Study||40
608031|NCT00383942|1488434|P1|COMPLETED|Overall Study||40
608032|NCT00383942|1488433|P2|STARTED|Overall Study||40
608033|NCT00383942|1488434|P1|STARTED|Overall Study||40
608034|NCT00383786|1488442|P2|NOT COMPLETED|Overall Study||12
608035|NCT00383786|1488443|P1|NOT COMPLETED|Overall Study||4
608036|NCT00383786|1488442|P2|COMPLETED|Overall Study||13
608037|NCT00383786|1488443|P1|COMPLETED|Overall Study||18
608038|NCT00383786|1488442|P2|STARTED|Overall Study||25
608039|NCT00383786|1488443|P1|STARTED|Overall Study||22
608040|NCT00383760|1488449|P1|NOT COMPLETED|Overall Study||0
608041|NCT00383760|1488449|P1|COMPLETED|Overall Study||15
608042|NCT00383760|1488449|P1|STARTED|Overall Study||15
608043|NCT00383747|1488465|P4|NOT COMPLETED|Visit 2||0
608044|NCT00383747|1488466|P3|NOT COMPLETED|Visit 2||0
608045|NCT00383747|1488467|P2|NOT COMPLETED|Visit 2||0
608046|NCT00383747|1488468|P1|NOT COMPLETED|Visit 2||0
608047|NCT00383747|1488465|P4|COMPLETED|Visit 2||16
608048|NCT00383747|1488466|P3|COMPLETED|Visit 2||16
608049|NCT00383747|1488467|P2|COMPLETED|Visit 2||14
608050|NCT00383747|1488468|P1|COMPLETED|Visit 2||14
608051|NCT00383747|1488465|P4|STARTED|Visit 2||16
608052|NCT00383747|1488466|P3|STARTED|Visit 2||16
608053|NCT00383747|1488467|P2|STARTED|Visit 2||14
608054|NCT00383747|1488468|P1|STARTED|Visit 2||14
608055|NCT00383747|1488465|P4|NOT COMPLETED|Visit 1||0
608056|NCT00383747|1488466|P3|NOT COMPLETED|Visit 1||0
608057|NCT00383747|1488467|P2|NOT COMPLETED|Visit 1||0
608058|NCT00383747|1488468|P1|NOT COMPLETED|Visit 1||0
608059|NCT00383747|1488465|P4|COMPLETED|Visit 1||16
608060|NCT00383747|1488466|P3|COMPLETED|Visit 1||16
608061|NCT00383747|1488467|P2|COMPLETED|Visit 1||14
608062|NCT00383747|1488468|P1|COMPLETED|Visit 1||14
608063|NCT00383747|1488465|P4|STARTED|Visit 1||16
608064|NCT00383747|1488466|P3|STARTED|Visit 1||16
608065|NCT00383747|1488467|P2|STARTED|Visit 1||14
608066|NCT00383747|1488468|P1|STARTED|Visit 1||14
608067|NCT00383721|1488493|P5|NOT COMPLETED|26-Week Treatment Safety Extension||0
608068|NCT00383721|1488494|P4|NOT COMPLETED|26-Week Treatment Safety Extension||17
608069|NCT00383721|1488495|P3|NOT COMPLETED|26-Week Treatment Safety Extension||23
608070|NCT00383721|1488496|P2|NOT COMPLETED|26-Week Treatment Safety Extension||17
608071|NCT00383721|1488497|P1|NOT COMPLETED|26-Week Treatment Safety Extension||19
608072|NCT00383721|1488493|P5|COMPLETED|26-Week Treatment Safety Extension||8
608073|NCT00383721|1488494|P4|COMPLETED|26-Week Treatment Safety Extension||131
608074|NCT00383721|1488495|P3|COMPLETED|26-Week Treatment Safety Extension||126
608075|NCT00383721|1488496|P2|COMPLETED|26-Week Treatment Safety Extension||136
608076|NCT00383721|1488497|P1|COMPLETED|26-Week Treatment Safety Extension||126
608077|NCT00383721|1488493|P5|STARTED|26-Week Treatment Safety Extension||8
608078|NCT00383721|1488494|P4|STARTED|26-Week Treatment Safety Extension||148
608079|NCT00383721|1488495|P3|STARTED|26-Week Treatment Safety Extension||149
608080|NCT00383721|1488496|P2|STARTED|26-Week Treatment Safety Extension||153
608081|NCT00383721|1488497|P1|STARTED|26-Week Treatment Safety Extension||145
608082|NCT00383721|1488493|P5|NOT COMPLETED|26-Week Double-Blind Treatment Period||67
608083|NCT00383721|1488494|P4|NOT COMPLETED|26-Week Double-Blind Treatment Period||50
608084|NCT00383721|1488495|P3|NOT COMPLETED|26-Week Double-Blind Treatment Period||51
608085|NCT00383721|1488496|P2|NOT COMPLETED|26-Week Double-Blind Treatment Period||37
608086|NCT00383721|1488497|P1|NOT COMPLETED|26-Week Double-Blind Treatment Period||35
608087|NCT00383721|1488493|P5|COMPLETED|26-Week Double-Blind Treatment Period||169
608088|NCT00383721|1488494|P4|COMPLETED|26-Week Double-Blind Treatment Period||193
608089|NCT00383721|1488495|P3|COMPLETED|26-Week Double-Blind Treatment Period||202
608090|NCT00383721|1488496|P2|COMPLETED|26-Week Double-Blind Treatment Period||202
608091|NCT00383721|1488497|P1|COMPLETED|26-Week Double-Blind Treatment Period|1 participant listed as “ongoing” since the participant status could not be formally confirmed.|190
608092|NCT00383721|1488493|P5|STARTED|26-Week Double-Blind Treatment Period||236
608093|NCT00383721|1488494|P4|STARTED|26-Week Double-Blind Treatment Period||243
608094|NCT00383721|1488495|P3|STARTED|26-Week Double-Blind Treatment Period||253
608095|NCT00383721|1488496|P2|STARTED|26-Week Double-Blind Treatment Period||239
608096|NCT00383721|1488497|P1|STARTED|26-Week Double-Blind Treatment Period||225
608097|NCT00383643|1488537|P3|NOT COMPLETED|Overall Study||1
608098|NCT00383643|1488538|P2|NOT COMPLETED|Overall Study||1
608099|NCT00383643|1488539|P1|NOT COMPLETED|Overall Study||1
608100|NCT00383643|1488537|P3|COMPLETED|Overall Study||13
608101|NCT00383643|1488538|P2|COMPLETED|Overall Study||15
608102|NCT00383643|1488539|P1|COMPLETED|Overall Study||17
608103|NCT00383643|1488537|P3|STARTED|Overall Study||14
608104|NCT00383643|1488538|P2|STARTED|Overall Study||16
608105|NCT00383643|1488539|P1|STARTED|Overall Study||18
608106|NCT00383565|1488559|P1|NOT COMPLETED|Overall Study||0
608107|NCT00383565|1488559|P1|COMPLETED|Overall Study||9
608108|NCT00383565|1488559|P1|STARTED|Overall Study||9
608109|NCT00383552|1488569|P4|NOT COMPLETED|Overall Study||72
608110|NCT00383552|1488570|P3|NOT COMPLETED|Overall Study||61
608111|NCT00383552|1488571|P2|NOT COMPLETED|Overall Study||41
608112|NCT00383552|1488572|P1|NOT COMPLETED|Overall Study||36
608113|NCT00383552|1488569|P4|COMPLETED|Overall Study||116
608114|NCT00383552|1488570|P3|COMPLETED|Overall Study||127
608115|NCT00383552|1488571|P2|COMPLETED|Overall Study||147
608116|NCT00383552|1488572|P1|COMPLETED|Overall Study||146
608117|NCT00383552|1488569|P4|STARTED|Overall Study||188
608118|NCT00383552|1488570|P3|STARTED|Overall Study||188
608119|NCT00383552|1488571|P2|STARTED|Overall Study||188
608120|NCT00383552|1488572|P1|STARTED|Overall Study||182
608121|NCT00383500|1488614|P3|NOT COMPLETED|Overall Study||2
608122|NCT00383500|1488615|P2|NOT COMPLETED|Overall Study||3
608123|NCT00383500|1488616|P1|NOT COMPLETED|Overall Study||8
608124|NCT00383500|1488614|P3|COMPLETED|Overall Study||22
608125|NCT00383500|1488615|P2|COMPLETED|Overall Study||21
608126|NCT00383500|1488616|P1|COMPLETED|Overall Study||19
608127|NCT00383500|1488614|P3|STARTED|Overall Study||24
608128|NCT00383500|1488615|P2|STARTED|Overall Study||24
608129|NCT00383500|1488616|P1|STARTED|Overall Study||27
608130|NCT00383435|1488632|P5|NOT COMPLETED|26-Week Treatment Safety Extension||3
608131|NCT00383435|1488633|P4|NOT COMPLETED|26-Week Treatment Safety Extension||15
608132|NCT00383435|1488634|P3|NOT COMPLETED|26-Week Treatment Safety Extension||16
608133|NCT00383435|1488635|P2|NOT COMPLETED|26-Week Treatment Safety Extension||9
608134|NCT00383435|1488636|P1|NOT COMPLETED|26-Week Treatment Safety Extension||14
608135|NCT00383435|1488632|P5|COMPLETED|26-Week Treatment Safety Extension||10
608136|NCT00383435|1488633|P4|COMPLETED|26-Week Treatment Safety Extension||116
608137|NCT00383435|1488634|P3|COMPLETED|26-Week Treatment Safety Extension||108
608138|NCT00383435|1488635|P2|COMPLETED|26-Week Treatment Safety Extension||121
608139|NCT00383435|1488636|P1|COMPLETED|26-Week Treatment Safety Extension||117
608140|NCT00383435|1488632|P5|STARTED|26-Week Treatment Safety Extension||13
608141|NCT00383435|1488633|P4|STARTED|26-Week Treatment Safety Extension||131
608142|NCT00383435|1488634|P3|STARTED|26-Week Treatment Safety Extension||124
608143|NCT00383435|1488635|P2|STARTED|26-Week Treatment Safety Extension||130
608144|NCT00383435|1488636|P1|STARTED|26-Week Treatment Safety Extension||131
608145|NCT00383435|1488632|P5|NOT COMPLETED|26-Week Double-Blind Treatment Period||53
608146|NCT00383435|1488633|P4|NOT COMPLETED|26-Week Double-Blind Treatment Period||37
608147|NCT00383435|1488634|P3|NOT COMPLETED|26-Week Double-Blind Treatment Period||46
608148|NCT00383435|1488635|P2|NOT COMPLETED|26-Week Double-Blind Treatment Period||38
608149|NCT00383435|1488636|P1|NOT COMPLETED|26-Week Double-Blind Treatment Period||41
608150|NCT00383435|1488632|P5|COMPLETED|26-Week Double-Blind Treatment Period||159
608151|NCT00383435|1488633|P4|COMPLETED|26-Week Double-Blind Treatment Period||172
608152|NCT00383435|1488634|P3|COMPLETED|26-Week Double-Blind Treatment Period||164
608153|NCT00383435|1488635|P2|COMPLETED|26-Week Double-Blind Treatment Period||169
608154|NCT00383435|1488636|P1|COMPLETED|26-Week Double-Blind Treatment Period||176
608155|NCT00383435|1488632|P5|STARTED|26-Week Double-Blind Treatment Period||212
608156|NCT00383435|1488633|P4|STARTED|26-Week Double-Blind Treatment Period||209
608157|NCT00383435|1488634|P3|STARTED|26-Week Double-Blind Treatment Period||210
608158|NCT00383435|1488635|P2|STARTED|26-Week Double-Blind Treatment Period||207
608159|NCT00383435|1488636|P1|STARTED|26-Week Double-Blind Treatment Period||217
608160|NCT00383331|1488675|P2|NOT COMPLETED|Overall Study||1
608161|NCT00383331|1488676|P1|NOT COMPLETED|Overall Study||0
608162|NCT00383331|1488675|P2|COMPLETED|Overall Study||8
608163|NCT00383331|1488676|P1|COMPLETED|Overall Study||10
608164|NCT00383331|1488675|P2|STARTED|Overall Study||9
608165|NCT00383331|1488676|P1|STARTED|Overall Study||10
608166|NCT00383292|1488695|P3|NOT COMPLETED|Overall Study||8
608167|NCT00383292|1488696|P2|NOT COMPLETED|Overall Study||6
608168|NCT00383292|1488697|P1|NOT COMPLETED|Overall Study||15
608169|NCT00383292|1488695|P3|COMPLETED|Overall Study||22
608170|NCT00383292|1488696|P2|COMPLETED|Overall Study||26
608171|NCT00383292|1488697|P1|COMPLETED|Overall Study||53
608172|NCT00383292|1488695|P3|Received at Least One Dose of Study Drug|Overall Study||30
608173|NCT00383292|1488696|P2|Received at Least One Dose of Study Drug|Overall Study||32
608174|NCT00383292|1488697|P1|Received at Least One Dose of Study Drug|Overall Study||68
608175|NCT00383292|1488695|P3|STARTED|Overall Study||30
608176|NCT00383292|1488696|P2|STARTED|Overall Study||32
608177|NCT00383292|1488697|P1|STARTED|Overall Study||68
608178|NCT00383266|1488725|P1|NOT COMPLETED|Overall Study||0
608179|NCT00383266|1488725|P1|COMPLETED|Overall Study||9
608180|NCT00383266|1488725|P1|STARTED|Overall Study||9
608181|NCT00383240|1488738|P4|NOT COMPLETED|Overall Study||77
608182|NCT00383240|1488739|P3|NOT COMPLETED|Overall Study||85
608183|NCT00383240|1488740|P2|NOT COMPLETED|Overall Study||33
608184|NCT00383240|1488741|P1|NOT COMPLETED|Overall Study||35
608185|NCT00383240|1488738|P4|COMPLETED|Overall Study||119
608186|NCT00383240|1488739|P3|COMPLETED|Overall Study||117
608187|NCT00383240|1488740|P2|COMPLETED|Overall Study||159
608188|NCT00383240|1488741|P1|COMPLETED|Overall Study||156
608189|NCT00383240|1488738|P4|STARTED|Overall Study||196
608190|NCT00383240|1488739|P3|STARTED|Overall Study||202
608191|NCT00383240|1488740|P2|STARTED|Overall Study||192
608192|NCT00383240|1488741|P1|STARTED|Overall Study||191
608193|NCT00383162|1488772|P2|NOT COMPLETED|Migraine Attack 2 (Period 2)||7
608194|NCT00383162|1488773|P1|NOT COMPLETED|Migraine Attack 2 (Period 2)||2
608195|NCT00383162|1488772|P2|COMPLETED|Migraine Attack 2 (Period 2)||66
608196|NCT00383162|1488773|P1|COMPLETED|Migraine Attack 2 (Period 2)||65
608197|NCT00383162|1488772|P2|STARTED|Migraine Attack 2 (Period 2)||73
608198|NCT00383162|1488773|P1|STARTED|Migraine Attack 2 (Period 2)||67
608199|NCT00383162|1488772|P2|NOT COMPLETED|Migraine Attack 1 (Period 1)||13
608200|NCT00383162|1488773|P1|NOT COMPLETED|Migraine Attack 1 (Period 1)||20
608201|NCT00383162|1488772|P2|COMPLETED|Migraine Attack 1 (Period 1)|Participants not completing did not take investigational product.|73
608202|NCT00383162|1488773|P1|COMPLETED|Migraine Attack 1 (Period 1)|Participants completing a period treated a migraine with investigational product.|67
608203|NCT00383162|1488772|P2|STARTED|Migraine Attack 1 (Period 1)||86
608204|NCT00383162|1488773|P1|STARTED|Migraine Attack 1 (Period 1)||87
608205|NCT00383149|1488815|P1|NOT COMPLETED|Overall Study||54
608206|NCT00383149|1488815|P1|COMPLETED|Overall Study||0
608207|NCT00383149|1488815|P1|STARTED|Overall Study||54
608208|NCT00383123|1488834|P2|NOT COMPLETED|Overall Study||86
608209|NCT00383123|1488835|P1|NOT COMPLETED|Overall Study||111
608210|NCT00383123|1488834|P2|COMPLETED|Overall Study||1124
608211|NCT00383123|1488835|P1|COMPLETED|Overall Study||2004
608212|NCT00383123|1488834|P2|STARTED|Overall Study||1210
608213|NCT00383123|1488835|P1|STARTED|Overall Study||2115
608214|NCT00383110|1488857|P2|NOT COMPLETED|Overall Study||0
608215|NCT00383110|1488858|P1|NOT COMPLETED|Overall Study||0
608216|NCT00383110|1488857|P2|COMPLETED|Overall Study||150
608217|NCT00383110|1488858|P1|COMPLETED|Overall Study||150
608218|NCT00383110|1488857|P2|STARTED|Overall Study||150
608219|NCT00383110|1488858|P1|STARTED|Overall Study||150
608220|NCT00383084|1488876|P2|NOT COMPLETED|Overall Study||10
608221|NCT00383084|1488877|P1|NOT COMPLETED|Overall Study||12
608222|NCT00383084|1488876|P2|COMPLETED|Overall Study||28
608223|NCT00383084|1488877|P1|COMPLETED|Overall Study||34
608224|NCT00383084|1488876|P2|STARTED|Overall Study||38
608225|NCT00383084|1488877|P1|STARTED|Overall Study||46
608226|NCT00383071|1488893|P4|NOT COMPLETED|Overall Study||3
608227|NCT00383071|1488894|P3|NOT COMPLETED|Overall Study||7
608228|NCT00383071|1488895|P2|NOT COMPLETED|Overall Study||4
608229|NCT00383071|1488896|P1|NOT COMPLETED|Overall Study||0
608230|NCT00383071|1488893|P4|COMPLETED|Overall Study||22
608231|NCT00383071|1488894|P3|COMPLETED|Overall Study||44
608232|NCT00383071|1488895|P2|COMPLETED|Overall Study||21
608233|NCT00383071|1488896|P1|COMPLETED|Overall Study||25
608234|NCT00383071|1488893|P4|STARTED|Overall Study||25
608235|NCT00383071|1488894|P3|STARTED|Overall Study||51
608236|NCT00383071|1488895|P2|STARTED|Overall Study||25
608237|NCT00383071|1488896|P1|STARTED|Overall Study||25
608238|NCT00383019|1488908|P2|NOT COMPLETED|Overall Study||2
608239|NCT00383019|1488909|P1|NOT COMPLETED|Overall Study||5
608240|NCT00383019|1488908|P2|COMPLETED|Overall Study||143
608241|NCT00383019|1488909|P1|COMPLETED|Overall Study||139
608242|NCT00383019|1488908|P2|STARTED|Overall Study||145
608243|NCT00383019|1488909|P1|STARTED|Overall Study||144
608244|NCT00382993|1488931|P2|NOT COMPLETED|Migraine Attack 2 (Period 2)||4
608245|NCT00382993|1488932|P1|NOT COMPLETED|Migraine Attack 2 (Period 2)||2
608246|NCT00382993|1488931|P2|COMPLETED|Migraine Attack 2 (Period 2)||63
608247|NCT00382993|1488932|P1|COMPLETED|Migraine Attack 2 (Period 2)||68
608248|NCT00382993|1488931|P2|STARTED|Migraine Attack 2 (Period 2)||67
608249|NCT00382993|1488932|P1|STARTED|Migraine Attack 2 (Period 2)||70
608250|NCT00382993|1488931|P2|NOT COMPLETED|Migraine Attack 1 (Period 1)||18
608251|NCT00382993|1488932|P1|NOT COMPLETED|Migraine Attack 1 (Period 1)||14
608252|NCT00382993|1488931|P2|COMPLETED|Migraine Attack 1 (Period 1)||67
608253|NCT00382993|1488932|P1|COMPLETED|Migraine Attack 1 (Period 1)|Participant considered to have completed period if treated a migraine with investigational product.|70
608254|NCT00382993|1488931|P2|STARTED|Migraine Attack 1 (Period 1)||85
608255|NCT00382993|1488932|P1|STARTED|Migraine Attack 1 (Period 1)||84
608256|NCT00382967|1488976|P2|NOT COMPLETED|Overall Study||1
608257|NCT00382967|1488977|P1|NOT COMPLETED|Overall Study||1
608258|NCT00382967|1488976|P2|COMPLETED|Overall Study|Subject dosed in error, should not have received Datscan product|137
608259|NCT00382967|1488977|P1|COMPLETED|Overall Study|Patient lost to followup and the data was not recorded.|121
608260|NCT00382967|1488976|P2|STARTED|Overall Study||138
608261|NCT00382967|1488977|P1|STARTED|Overall Study|135 subjects enrolled at the start of the study, however, 13 subjects withdrew prior to dosing.|122
608262|NCT00382928|1488987|P2|NOT COMPLETED|Overall Study||0
608263|NCT00382928|1488988|P1|NOT COMPLETED|Overall Study||0
608264|NCT00382928|1488987|P2|COMPLETED|Overall Study||95
608265|NCT00382928|1488988|P1|COMPLETED|Overall Study||97
608266|NCT00382928|1488987|P2|STARTED|Overall Study||95
608267|NCT00382928|1488988|P1|STARTED|Overall Study||97
608268|NCT00382863|1489002|P2|NOT COMPLETED|Overall Study||36
608269|NCT00382863|1489003|P1|NOT COMPLETED|Overall Study||15
608270|NCT00382863|1489002|P2|COMPLETED|Overall Study||78
608271|NCT00382863|1489003|P1|COMPLETED|Overall Study||81
608272|NCT00382863|1489002|P2|STARTED|Overall Study||114
608273|NCT00382863|1489003|P1|STARTED|Overall Study||96
608274|NCT00382785|1489059|P2|NOT COMPLETED|Overall Study||0
608275|NCT00382785|1489060|P1|NOT COMPLETED|Overall Study||0
608276|NCT00382785|1489059|P2|COMPLETED|Overall Study||26
608277|NCT00382785|1489060|P1|COMPLETED|Overall Study||25
608278|NCT00382785|1489059|P2|STARTED|Overall Study||26
608279|NCT00382785|1489060|P1|STARTED|Overall Study||25
608280|NCT00382733|1489070|P5|NOT COMPLETED|Overall Study||0
608281|NCT00382733|1489071|P4|NOT COMPLETED|Overall Study||0
608282|NCT00382733|1489072|P3|NOT COMPLETED|Overall Study||0
608283|NCT00382733|1489073|P2|NOT COMPLETED|Overall Study||1
608284|NCT00382733|1489074|P1|NOT COMPLETED|Overall Study||0
608285|NCT00382733|1489070|P5|COMPLETED|Overall Study||2
608286|NCT00382733|1489071|P4|COMPLETED|Overall Study||14
608287|NCT00382733|1489072|P3|COMPLETED|Overall Study||3
608288|NCT00382733|1489073|P2|COMPLETED|Overall Study|1 subject withdrew consent before completing Cycle 1 - that subject was replaced|3
608289|NCT00382733|1489074|P1|COMPLETED|Overall Study||3
608290|NCT00382733|1489070|P5|STARTED|Overall Study||2
608291|NCT00382733|1489071|P4|STARTED|Overall Study||14
608292|NCT00382733|1489072|P3|STARTED|Overall Study||3
608293|NCT00382733|1489073|P2|STARTED|Overall Study||4
608294|NCT00382733|1489074|P1|STARTED|Overall Study||3
608295|NCT00382720|1489095|P3|NOT COMPLETED|Overall Study||86
608296|NCT00382720|1489096|P2|NOT COMPLETED|Overall Study||89
608297|NCT00382720|1489097|P1|NOT COMPLETED|Overall Study||79
608298|NCT00382720|1489095|P3|COMPLETED|Overall Study||0
608299|NCT00382720|1489096|P2|COMPLETED|Overall Study||0
608300|NCT00382720|1489097|P1|COMPLETED|Overall Study||0
608301|NCT00382720|1489095|P3|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|82
608302|NCT00382720|1489096|P2|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|88
608303|NCT00382720|1489097|P1|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|78
608304|NCT00382720|1489095|P3|Administered Optimal Dose (Parts I & II)|Overall Study||82
608305|NCT00382720|1489096|P2|Administered Optimal Dose (Parts I & II)|Overall Study||88
608306|NCT00382720|1489097|P1|Administered Optimal Dose (Parts I & II)|Overall Study||78
608307|NCT00382720|1489095|P3|Administered Non-Optimal Dose (Part I)|Overall Study||0
608308|NCT00382720|1489096|P2|Administered Non-Optimal Dose (Part I)|Overall Study||11
608309|NCT00382720|1489097|P1|Administered Non-Optimal Dose (Part I)|Overall Study||10
608310|NCT00382720|1489095|P3|STARTED|Overall Study||86
608311|NCT00382720|1489096|P2|STARTED|Overall Study||89
608312|NCT00382720|1489097|P1|STARTED|Overall Study||79
608313|NCT00382590|1489113|P2|NOT COMPLETED|Overall Study||0
608314|NCT00382590|1489114|P1|NOT COMPLETED|Overall Study||0
608315|NCT00382590|1489113|P2|COMPLETED|Overall Study||6
608316|NCT00382590|1489114|P1|COMPLETED|Overall Study||4
608317|NCT00382590|1489113|P2|STARTED|Overall Study||6
608318|NCT00382590|1489114|P1|STARTED|Overall Study||4
608319|NCT00382408|1489122|P2|NOT COMPLETED|Overall Study||54
608320|NCT00382408|1489123|P1|NOT COMPLETED|Overall Study||144
608321|NCT00382408|1489122|P2|COMPLETED|Overall Study||955
608322|NCT00382408|1489123|P1|COMPLETED|Overall Study||2887
608323|NCT00382408|1489122|P2|STARTED|Overall Study||1009
608324|NCT00382408|1489123|P1|STARTED|Overall Study||3031
608325|NCT00382291|1489150|P3|NOT COMPLETED|Overall Study||8
608326|NCT00382291|1489151|P2|NOT COMPLETED|Overall Study||7
608327|NCT00382291|1489152|P1|NOT COMPLETED|Overall Study||4
608328|NCT00382291|1489150|P3|COMPLETED|Overall Study||13
608329|NCT00382291|1489151|P2|COMPLETED|Overall Study||10
608330|NCT00382291|1489152|P1|COMPLETED|Overall Study||14
608331|NCT00382291|1489150|P3|STARTED|Overall Study||21
608332|NCT00382291|1489151|P2|STARTED|Overall Study||17
608333|NCT00382291|1489152|P1|STARTED|Overall Study||18
608334|NCT00382174|1489165|P3|NOT COMPLETED|Overall Study||21
608335|NCT00382174|1489166|P2|NOT COMPLETED|Overall Study||17
608336|NCT00382174|1489167|P1|NOT COMPLETED|Overall Study||4
608337|NCT00382174|1489165|P3|COMPLETED|Overall Study||51
608338|NCT00382174|1489166|P2|COMPLETED|Overall Study||37
608339|NCT00382174|1489167|P1|COMPLETED|Overall Study||14
608340|NCT00382174|1489165|P3|STARTED|Overall Study||72
608341|NCT00382174|1489166|P2|STARTED|Overall Study||54
608342|NCT00382174|1489167|P1|STARTED|Overall Study||18
608343|NCT00382148|1489180|P2|NOT COMPLETED|Overall Study||0
608344|NCT00382148|1489181|P1|NOT COMPLETED|Overall Study||1
608345|NCT00382148|1489180|P2|COMPLETED|Overall Study||7
608346|NCT00382148|1489181|P1|COMPLETED|Overall Study||3
608347|NCT00382148|1489180|P2|STARTED|Overall Study||7
608348|NCT00382148|1489181|P1|STARTED|Overall Study||4
608349|NCT00382109|1489195|P2|NOT COMPLETED|Overall Study||4
608350|NCT00382109|1489196|P1|NOT COMPLETED|Overall Study||12
608351|NCT00382109|1489195|P2|COMPLETED|Overall Study||66
608352|NCT00382109|1489196|P1|COMPLETED|Overall Study||64
608353|NCT00382109|1489195|P2|STARTED|Overall Study||70
608354|NCT00382109|1489196|P1|STARTED|Overall Study||76
608355|NCT00382031|1489218|P2|NOT COMPLETED|Overall Study||0
608356|NCT00382031|1489219|P1|NOT COMPLETED|Overall Study||0
608357|NCT00382031|1489218|P2|COMPLETED|Overall Study||95
608358|NCT00382031|1489219|P1|COMPLETED|Overall Study||191
608359|NCT00382031|1489218|P2|STARTED|Overall Study|Of the 95 randomized patients 94 attended Visit2.|95
608360|NCT00382031|1489219|P1|STARTED|Overall Study|Of the 191 randomized patients 189 received at least one infusion of zalutumumab|191
608361|NCT00382018|1489235|P4|NOT COMPLETED|Overall Study||59
608362|NCT00382018|1489236|P3|NOT COMPLETED|Overall Study||64
608363|NCT00382018|1489237|P2|NOT COMPLETED|Overall Study||165
608364|NCT00382018|1489238|P1|NOT COMPLETED|Overall Study||0
608365|NCT00382018|1489235|P4|COMPLETED|Overall Study||0
608366|NCT00382018|1489236|P3|COMPLETED|Overall Study||0
608367|NCT00382018|1489237|P2|COMPLETED|Overall Study||0
608368|NCT00382018|1489238|P1|COMPLETED|Overall Study|This group of patients did not receive protocol treatment.|276
608369|NCT00382018|1489235|P4|STARTED|Overall Study||59
608370|NCT00382018|1489236|P3|STARTED|Overall Study||64
608371|NCT00382018|1489237|P2|STARTED|Overall Study||165
608372|NCT00382018|1489238|P1|STARTED|Overall Study||276
608376|NCT00381940|1489261|P1|NOT COMPLETED|Overall Study||5
608377|NCT00381940|1489261|P1|COMPLETED|Overall Study||21
608378|NCT00381940|1489261|P1|STARTED|Overall Study||26
608379|NCT00381888|1489265|P1|NOT COMPLETED|Overall Study||17
608380|NCT00381888|1489265|P1|COMPLETED|Overall Study||27
608381|NCT00381888|1489265|P1|STARTED|Overall Study||44
608382|NCT00381862|1489270|P1|NOT COMPLETED|Overall Study||10
608383|NCT00381862|1489270|P1|COMPLETED|Overall Study||44
608384|NCT00381862|1489270|P1|STARTED|Overall Study||54
608385|NCT00381849|1489276|P2|NOT COMPLETED|Open-label||0
608386|NCT00381849|1489277|P1|NOT COMPLETED|Open-label||0
608387|NCT00381849|1489276|P2|COMPLETED|Open-label||9
608388|NCT00381849|1489277|P1|COMPLETED|Open-label||10
608389|NCT00381849|1489276|P2|STARTED|Open-label||9
608390|NCT00381849|1489277|P1|STARTED|Open-label||10
608391|NCT00381849|1489276|P2|NOT COMPLETED|Second Intervention||0
608392|NCT00381849|1489277|P1|NOT COMPLETED|Second Intervention||0
608393|NCT00381849|1489276|P2|COMPLETED|Second Intervention||9
608394|NCT00381849|1489277|P1|COMPLETED|Second Intervention||10
608395|NCT00381849|1489276|P2|STARTED|Second Intervention||9
608396|NCT00381849|1489277|P1|STARTED|Second Intervention||10
608397|NCT00381849|1489276|P2|NOT COMPLETED|Wash Out||1
608398|NCT00381849|1489277|P1|NOT COMPLETED|Wash Out||0
608399|NCT00381849|1489276|P2|COMPLETED|Wash Out||9
608400|NCT00381849|1489277|P1|COMPLETED|Wash Out||10
608401|NCT00381849|1489276|P2|STARTED|Wash Out||10
608402|NCT00381849|1489277|P1|STARTED|Wash Out||10
608403|NCT00381849|1489276|P2|NOT COMPLETED|First Intervention||0
608404|NCT00381849|1489277|P1|NOT COMPLETED|First Intervention||0
608405|NCT00381849|1489276|P2|COMPLETED|First Intervention||10
608406|NCT00381849|1489277|P1|COMPLETED|First Intervention||10
608407|NCT00381849|1489276|P2|STARTED|First Intervention||10
608408|NCT00381849|1489277|P1|STARTED|First Intervention||10
608409|NCT00381810|1489295|P1|NOT COMPLETED|B Cell Follow-up||7
608410|NCT00381810|1489295|P1|COMPLETED|B Cell Follow-up||0
608411|NCT00381810|1489295|P1|STARTED|B Cell Follow-up|Participants only entered the B cell follow-up period if their peripheral B cells were depleted.|7
608412|NCT00381810|1489295|P1|NOT COMPLETED|Treatment and Safety Follow-up||15
608413|NCT00381810|1489295|P1|COMPLETED|Treatment and Safety Follow-up||16
608414|NCT00381810|1489295|P1|STARTED|Treatment and Safety Follow-up||31
608415|NCT00381797|1489304|P5|NOT COMPLETED|Overall Study||2
608416|NCT00381797|1489305|P4|NOT COMPLETED|Overall Study||1
608417|NCT00381797|1489306|P3|NOT COMPLETED|Overall Study||0
608418|NCT00381797|1489307|P2|NOT COMPLETED|Overall Study||1
608419|NCT00381797|1489308|P1|NOT COMPLETED|Overall Study||1
608420|NCT00381797|1489304|P5|COMPLETED|Overall Study||35
608421|NCT00381797|1489305|P4|COMPLETED|Overall Study||14
608422|NCT00381797|1489306|P3|COMPLETED|Overall Study||10
608423|NCT00381797|1489307|P2|COMPLETED|Overall Study||16
608424|NCT00381797|1489308|P1|COMPLETED|Overall Study||17
608425|NCT00381797|1489304|P5|STARTED|Overall Study||37
608426|NCT00381797|1489305|P4|STARTED|Overall Study||15
608427|NCT00381797|1489306|P3|STARTED|Overall Study||10
608428|NCT00381797|1489307|P2|STARTED|Overall Study||17
608429|NCT00381797|1489308|P1|STARTED|Overall Study||18
608430|NCT00381706|1489383|P3|NOT COMPLETED|Overall Study||1
608431|NCT00381706|1489384|P2|NOT COMPLETED|Overall Study||2
608432|NCT00381706|1489385|P1|NOT COMPLETED|Overall Study||7
608433|NCT00381706|1489383|P3|COMPLETED|Overall Study||79
608434|NCT00381706|1489384|P2|COMPLETED|Overall Study||81
608435|NCT00381706|1489385|P1|COMPLETED|Overall Study||75
608436|NCT00381706|1489383|P3|STARTED|Overall Study||80
608437|NCT00381706|1489384|P2|STARTED|Overall Study||83
608438|NCT00381706|1489385|P1|STARTED|Overall Study||82
608439|NCT00381693|1489408|P1|NOT COMPLETED|Overall Study||8
608440|NCT00381693|1489408|P1|COMPLETED|Overall Study||2
608441|NCT00381693|1489408|P1|STARTED|Overall Study||10
608442|NCT00381680|1489417|P2|NOT COMPLETED|Overall Study||50
608443|NCT00381680|1489418|P1|NOT COMPLETED|Overall Study||125
608444|NCT00381680|1489417|P2|COMPLETED|Overall Study||19
608445|NCT00381680|1489418|P1|COMPLETED|Overall Study||81
608446|NCT00381680|1489417|P2|STARTED|Overall Study||69
608447|NCT00381680|1489418|P1|STARTED|Overall Study||206
608448|NCT00381641|1489435|P2|NOT COMPLETED|Overall Study||2
608449|NCT00381641|1489436|P1|NOT COMPLETED|Overall Study||0
608450|NCT00381641|1489435|P2|COMPLETED|Overall Study||23
608451|NCT00381641|1489436|P1|COMPLETED|Overall Study||38
608452|NCT00381641|1489435|P2|STARTED|Overall Study||25
608453|NCT00381641|1489436|P1|STARTED|Overall Study||38
608454|NCT00381628|1489452|P4|NOT COMPLETED|Overall Study||0
608455|NCT00381628|1489453|P3|NOT COMPLETED|Overall Study||0
608456|NCT00381628|1489454|P2|NOT COMPLETED|Overall Study||0
608457|NCT00381628|1489455|P1|NOT COMPLETED|Overall Study||0
608458|NCT00381628|1489452|P4|COMPLETED|Overall Study||14
608459|NCT00381628|1489453|P3|COMPLETED|Overall Study||0
608460|NCT00381628|1489454|P2|COMPLETED|Overall Study||27
608461|NCT00381628|1489455|P1|COMPLETED|Overall Study||18
608462|NCT00381628|1489452|P4|STARTED|Overall Study||14
608463|NCT00381628|1489453|P3|STARTED|Overall Study||0
608464|NCT00381628|1489454|P2|STARTED|Overall Study||27
608465|NCT00381628|1489455|P1|STARTED|Overall Study||18
608466|NCT00381615|1489469|P4|NOT COMPLETED|Overall Study||2
608467|NCT00381615|1489470|P3|NOT COMPLETED|Overall Study||1
608468|NCT00381615|1489471|P2|NOT COMPLETED|Overall Study||5
608469|NCT00381615|1489472|P1|NOT COMPLETED|Overall Study||4
608470|NCT00381615|1489469|P4|COMPLETED|Overall Study||22
608471|NCT00381615|1489470|P3|COMPLETED|Overall Study||24
608472|NCT00381615|1489471|P2|COMPLETED|Overall Study||45
608473|NCT00381615|1489472|P1|COMPLETED|Overall Study||44
608474|NCT00381615|1489469|P4|STARTED|Overall Study||24
608475|NCT00381615|1489470|P3|STARTED|Overall Study||25
608476|NCT00381615|1489471|P2|STARTED|Overall Study||50
608477|NCT00381615|1489472|P1|STARTED|Overall Study||48
608478|NCT00381563|1489524|P2|NOT COMPLETED|Overall Study||6
608479|NCT00381563|1489525|P1|NOT COMPLETED|Overall Study||7
608480|NCT00381563|1489524|P2|COMPLETED|Overall Study||33
608481|NCT00381563|1489525|P1|COMPLETED|Overall Study||34
608482|NCT00381563|1489524|P2|STARTED|Overall Study||39
608483|NCT00381563|1489525|P1|STARTED|Overall Study||41
608484|NCT00381550|1489532|P1|NOT COMPLETED|Overall Study||0
608485|NCT00381550|1489532|P1|COMPLETED|Overall Study||35
608486|NCT00381550|1489532|P1|STARTED|Overall Study||35
608487|NCT00381485|1489540|P4|NOT COMPLETED|Double-Blind Treatment Period||33
608488|NCT00381485|1489541|P3|NOT COMPLETED|Double-Blind Treatment Period||25
608489|NCT00381485|1489542|P2|NOT COMPLETED|Double-Blind Treatment Period||27
608490|NCT00381485|1489543|P1|NOT COMPLETED|Double-Blind Treatment Period||0
608491|NCT00381485|1489540|P4|COMPLETED|Double-Blind Treatment Period||207
608492|NCT00381485|1489541|P3|COMPLETED|Double-Blind Treatment Period||208
608493|NCT00381485|1489542|P2|COMPLETED|Double-Blind Treatment Period||228
608494|NCT00381485|1489543|P1|COMPLETED|Double-Blind Treatment Period||0
608495|NCT00381485|1489540|P4|STARTED|Double-Blind Treatment Period||240
608496|NCT00381485|1489541|P3|STARTED|Double-Blind Treatment Period||233
608497|NCT00381485|1489542|P2|STARTED|Double-Blind Treatment Period||255
608498|NCT00381485|1489543|P1|STARTED|Double-Blind Treatment Period||0
608499|NCT00381485|1489540|P4|NOT COMPLETED|Open-Label Run-In Period||0
608500|NCT00381485|1489541|P3|NOT COMPLETED|Open-Label Run-In Period||0
608501|NCT00381485|1489542|P2|NOT COMPLETED|Open-Label Run-In Period||0
608502|NCT00381485|1489543|P1|NOT COMPLETED|Open-Label Run-In Period||106
608503|NCT00381485|1489540|P4|COMPLETED|Open-Label Run-In Period||0
608504|NCT00381485|1489541|P3|COMPLETED|Open-Label Run-In Period||0
608505|NCT00381485|1489542|P2|COMPLETED|Open-Label Run-In Period||0
608506|NCT00381485|1489543|P1|COMPLETED|Open-Label Run-In Period||728
608507|NCT00381485|1489540|P4|STARTED|Open-Label Run-In Period||0
608508|NCT00381485|1489541|P3|STARTED|Open-Label Run-In Period||0
608509|NCT00381485|1489542|P2|STARTED|Open-Label Run-In Period||0
608510|NCT00381485|1489543|P1|STARTED|Open-Label Run-In Period||834
608511|NCT00381381|1489561|P1|NOT COMPLETED|Overall Study||64
608512|NCT00381381|1489561|P1|COMPLETED|Overall Study||135
608513|NCT00381381|1489561|P1|STARTED|Overall Study||199
608514|NCT00381303|1489570|P2|NOT COMPLETED|Overall Study||33
608515|NCT00381303|1489571|P1|NOT COMPLETED|Overall Study||94
608516|NCT00381303|1489570|P2|COMPLETED|Overall Study||109
608517|NCT00381303|1489571|P1|COMPLETED|Overall Study||193
608518|NCT00381303|1489570|P2|STARTED|Overall Study||142
608519|NCT00381303|1489571|P1|STARTED|Overall Study||287
608520|NCT00381238|1489631|P1|NOT COMPLETED|Overall Study||12
608521|NCT00381238|1489631|P1|COMPLETED|Overall Study||21
608522|NCT00381238|1489631|P1|STARTED|Overall Study||33
608523|NCT00381095|1489647|P2|NOT COMPLETED|Overall Study||21
608524|NCT00381095|1489648|P1|NOT COMPLETED|Overall Study||13
608525|NCT00381095|1489647|P2|COMPLETED|Overall Study||59
608526|NCT00381095|1489648|P1|COMPLETED|Overall Study||59
608527|NCT00381095|1489647|P2|STARTED|Overall Study||80
608528|NCT00381095|1489648|P1|STARTED|Overall Study||72
608529|NCT00381043|1489680|P2|NOT COMPLETED|Overall Study||8
608530|NCT00381043|1489681|P1|NOT COMPLETED|Overall Study||12
608531|NCT00381043|1489680|P2|COMPLETED|Overall Study||41
608532|NCT00381043|1489681|P1|COMPLETED|Overall Study||39
608533|NCT00381043|1489680|P2|STARTED|Overall Study||49
608534|NCT00381043|1489681|P1|STARTED|Overall Study||51
608535|NCT00381004|1489699|P1|NOT COMPLETED|Overall Study||0
608536|NCT00381004|1489699|P1|COMPLETED|Overall Study||60
608537|NCT00381004|1489699|P1|STARTED|Overall Study||60
608538|NCT00380978|1489707|P2|NOT COMPLETED|Overall Study||10
608539|NCT00380978|1489708|P1|NOT COMPLETED|Overall Study||2
608540|NCT00380978|1489707|P2|COMPLETED|Overall Study||400
608541|NCT00380978|1489708|P1|COMPLETED|Overall Study||406
608542|NCT00380978|1489707|P2|STARTED|Overall Study||410
608543|NCT00380978|1489708|P1|STARTED|Overall Study||408
608544|NCT00380874|1489730|P2|NOT COMPLETED|Overall Study||10
608545|NCT00380874|1489731|P1|NOT COMPLETED|Overall Study||13
608546|NCT00380874|1489730|P2|COMPLETED|Overall Study||19
608547|NCT00380874|1489731|P1|COMPLETED|Overall Study||19
608548|NCT00380874|1489730|P2|STARTED|Overall Study||29
608549|NCT00380874|1489731|P1|STARTED|Overall Study||32
608550|NCT00380861|1489749|P2|NOT COMPLETED|Overall Study||17
608551|NCT00380861|1489750|P1|NOT COMPLETED|Overall Study||18
608552|NCT00380861|1489749|P2|COMPLETED|Overall Study||74
608553|NCT00380861|1489750|P1|COMPLETED|Overall Study||75
608643|NCT00379808|1490197|P2|COMPLETED|Intervention Period 2 (4 Weeks)||10
608554|NCT00380861|1489749|P2|STARTED|Overall Study|Two subjects received the PFC Sigma RP-F device but not the RP and their results are not included.|91
608555|NCT00380861|1489750|P1|STARTED|Overall Study||93
608556|NCT00380718|1489756|P1|NOT COMPLETED|Overall Study||18
608557|NCT00380718|1489756|P1|COMPLETED|Overall Study||15
608558|NCT00380718|1489756|P1|Received Escalated Dose in Cycle 2|Overall Study||25
608559|NCT00380718|1489756|P1|Received at Least One Dose of Study Drug|Overall Study||33
608560|NCT00380718|1489756|P1|STARTED|Overall Study||33
608561|NCT00380692|1489768|P2|NOT COMPLETED|Study Period III - Open Label||12
608562|NCT00380692|1489769|P1|NOT COMPLETED|Study Period III - Open Label||6
608563|NCT00380692|1489768|P2|COMPLETED|Study Period III - Open Label||34
608564|NCT00380692|1489769|P1|COMPLETED|Study Period III - Open Label||36
608565|NCT00380692|1489768|P2|STARTED|Study Period III - Open Label||46
608566|NCT00380692|1489769|P1|STARTED|Study Period III - Open Label|One patient who completed Study Period II did not enter Study Period III.|42
608567|NCT00380692|1489768|P2|NOT COMPLETED|Study Period II - Double Blind||3
608568|NCT00380692|1489769|P1|NOT COMPLETED|Study Period II - Double Blind||5
608569|NCT00380692|1489768|P2|COMPLETED|Study Period II - Double Blind||46
608570|NCT00380692|1489769|P1|COMPLETED|Study Period II - Double Blind||43
608571|NCT00380692|1489768|P2|STARTED|Study Period II - Double Blind||49
608572|NCT00380692|1489769|P1|STARTED|Study Period II - Double Blind||48
608573|NCT00380588|1489817|P2|NOT COMPLETED|Overall Study||40
608574|NCT00380588|1489818|P1|NOT COMPLETED|Overall Study||39
608575|NCT00380588|1489817|P2|COMPLETED|Overall Study|Treatment period reached 48 week maximum.|2
608576|NCT00380588|1489818|P1|COMPLETED|Overall Study|Treatment period reached 48 week maximum.|3
608577|NCT00380588|1489817|P2|Received at Least One Dose of Study Drug|Overall Study||42
608578|NCT00380588|1489818|P1|Received at Least One Dose of Study Drug|Overall Study||41
608579|NCT00380588|1489817|P2|STARTED|Overall Study||42
608580|NCT00380588|1489818|P1|STARTED|Overall Study||42
608581|NCT00380367|1489830|P1|NOT COMPLETED|Overall Study||2
608582|NCT00380367|1489830|P1|COMPLETED|Overall Study||108
608583|NCT00380367|1489830|P1|STARTED|Overall Study||110
608584|NCT00380250|1489837|P2|NOT COMPLETED|Overall Study||55
608585|NCT00380250|1489838|P1|NOT COMPLETED|Overall Study||99
608586|NCT00380250|1489837|P2|COMPLETED|Overall Study||139
608587|NCT00380250|1489838|P1|COMPLETED|Overall Study||297
608588|NCT00380250|1489837|P2|STARTED|Overall Study||194
608589|NCT00380250|1489838|P1|STARTED|Overall Study||396
608590|NCT00380081|1489906|P6|NOT COMPLETED|Overall Study||1
608591|NCT00380081|1489907|P5|NOT COMPLETED|Overall Study||1
608592|NCT00380081|1489908|P4|NOT COMPLETED|Overall Study||0
608593|NCT00380081|1489909|P3|NOT COMPLETED|Overall Study||0
608594|NCT00380081|1489910|P2|NOT COMPLETED|Overall Study||0
608595|NCT00380081|1489911|P1|NOT COMPLETED|Overall Study||0
608596|NCT00380081|1489906|P6|COMPLETED|Overall Study||13
608597|NCT00380081|1489907|P5|COMPLETED|Overall Study||12
608598|NCT00380081|1489908|P4|COMPLETED|Overall Study||15
608599|NCT00380081|1489909|P3|COMPLETED|Overall Study||13
608600|NCT00380081|1489910|P2|COMPLETED|Overall Study||13
608601|NCT00380081|1489911|P1|COMPLETED|Overall Study||14
608602|NCT00380081|1489906|P6|STARTED|Overall Study||14
608603|NCT00380081|1489907|P5|STARTED|Overall Study||13
608604|NCT00380081|1489908|P4|STARTED|Overall Study||15
608605|NCT00380081|1489909|P3|STARTED|Overall Study||13
608606|NCT00380081|1489910|P2|STARTED|Overall Study||13
608607|NCT00380081|1489911|P1|STARTED|Overall Study||14
608608|NCT00380068|1489961|P1|NOT COMPLETED|Overall Study||69
608609|NCT00380068|1489961|P1|COMPLETED|Overall Study||155
608610|NCT00380068|1489961|P1|STARTED|Overall Study||224
608611|NCT00380029|1489981|P1|NOT COMPLETED|Overall Study||0
608612|NCT00380029|1489981|P1|COMPLETED|Overall Study||20
608613|NCT00380029|1489981|P1|STARTED|Overall Study||20
608614|NCT00379912|1489993|P2|NOT COMPLETED|Overall Study||0
608615|NCT00379912|1489994|P1|NOT COMPLETED|Overall Study||1
608616|NCT00379912|1489993|P2|COMPLETED|Overall Study||8
608617|NCT00379912|1489994|P1|COMPLETED|Overall Study||6
608618|NCT00379912|1489993|P2|STARTED|Overall Study||8
608619|NCT00379912|1489994|P1|STARTED|Overall Study||7
608620|NCT00379899|1490016|P2|NOT COMPLETED|Overall Study||40
608621|NCT00379899|1490017|P1|NOT COMPLETED|Overall Study||40
608622|NCT00379899|1490016|P2|COMPLETED|Overall Study||140
608623|NCT00379899|1490017|P1|COMPLETED|Overall Study||140
608624|NCT00379899|1490016|P2|STARTED|Overall Study||180
608625|NCT00379899|1490017|P1|STARTED|Overall Study||180
608626|NCT00379834|1490045|P1|NOT COMPLETED|Overall Study||2
608627|NCT00379834|1490045|P1|COMPLETED|Overall Study||8
608628|NCT00379834|1490045|P1|STARTED|Overall Study||10
608629|NCT00379821|1490053|P4|NOT COMPLETED|Overall Study||79
608630|NCT00379821|1490054|P3|NOT COMPLETED|Overall Study||67
608631|NCT00379821|1490055|P2|NOT COMPLETED|Overall Study||89
608632|NCT00379821|1490056|P1|NOT COMPLETED|Overall Study||73
608633|NCT00379821|1490053|P4|COMPLETED|Overall Study||81
608634|NCT00379821|1490054|P3|COMPLETED|Overall Study||93
608635|NCT00379821|1490055|P2|COMPLETED|Overall Study||71
608636|NCT00379821|1490056|P1|COMPLETED|Overall Study||87
608637|NCT00379821|1490053|P4|STARTED|Overall Study||160
608638|NCT00379821|1490054|P3|STARTED|Overall Study||160
608639|NCT00379821|1490055|P2|STARTED|Overall Study||160
608640|NCT00379821|1490056|P1|STARTED|Overall Study||160
608641|NCT00379808|1490197|P2|NOT COMPLETED|Intervention Period 2 (4 Weeks)||1
608642|NCT00379808|1490198|P1|NOT COMPLETED|Intervention Period 2 (4 Weeks)||0
608644|NCT00379808|1490198|P1|COMPLETED|Intervention Period 2 (4 Weeks)||11
608645|NCT00379808|1490197|P2|STARTED|Intervention Period 2 (4 Weeks)||11
608646|NCT00379808|1490198|P1|STARTED|Intervention Period 2 (4 Weeks)||11
608647|NCT00379808|1490197|P2|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0
608648|NCT00379808|1490198|P1|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0
608649|NCT00379808|1490197|P2|COMPLETED|Intervention Period 1 (4 Weeks)||11
608650|NCT00379808|1490198|P1|COMPLETED|Intervention Period 1 (4 Weeks)||11
608651|NCT00379808|1490197|P2|STARTED|Intervention Period 1 (4 Weeks)||11
608652|NCT00379808|1490198|P1|STARTED|Intervention Period 1 (4 Weeks)||11
608653|NCT00379795|1490219|P5|NOT COMPLETED|Overall Study||49
608654|NCT00379795|1490220|P4|NOT COMPLETED|Overall Study||68
608655|NCT00379795|1490221|P3|NOT COMPLETED|Overall Study||93
608656|NCT00379795|1490222|P2|NOT COMPLETED|Overall Study||51
608657|NCT00379795|1490223|P1|NOT COMPLETED|Overall Study||476
608658|NCT00379795|1490219|P5|COMPLETED|Overall Study||14
608659|NCT00379795|1490220|P4|COMPLETED|Overall Study||6
608660|NCT00379795|1490221|P3|COMPLETED|Overall Study||23
608661|NCT00379795|1490222|P2|COMPLETED|Overall Study||23
608662|NCT00379795|1490223|P1|COMPLETED|Overall Study||50
608663|NCT00379795|1490219|P5|Received Ranibizumab in Extension Study|Overall Study||0
608664|NCT00379795|1490220|P4|Received Ranibizumab in Extension Study|Overall Study||55
608665|NCT00379795|1490221|P3|Received Ranibizumab in Extension Study|Overall Study||113
608666|NCT00379795|1490222|P2|Received Ranibizumab in Extension Study|Overall Study||41
608667|NCT00379795|1490223|P1|Received Ranibizumab in Extension Study|Overall Study||377
608668|NCT00379795|1490219|P5|STARTED|Overall Study||63
608669|NCT00379795|1490220|P4|STARTED|Overall Study||74
608670|NCT00379795|1490221|P3|STARTED|Overall Study||116
608671|NCT00379795|1490222|P2|STARTED|Overall Study||74
608672|NCT00379795|1490223|P1|STARTED|Overall Study||526
608673|NCT00379769|1490253|P6|NOT COMPLETED|Observational Follow-up||148
608674|NCT00379769|1490254|P5|NOT COMPLETED|Observational Follow-up||149
608675|NCT00379769|1490255|P4|NOT COMPLETED|Observational Follow-up||0
608676|NCT00379769|1490256|P3|NOT COMPLETED|Observational Follow-up||0
608677|NCT00379769|1490257|P2|NOT COMPLETED|Observational Follow-up||0
608678|NCT00379769|1490258|P1|NOT COMPLETED|Observational Follow-up||0
608679|NCT00379769|1490253|P6|COMPLETED|Observational Follow-up||1102
608680|NCT00379769|1490254|P5|COMPLETED|Observational Follow-up||1131
608681|NCT00379769|1490255|P4|COMPLETED|Observational Follow-up||0
608682|NCT00379769|1490256|P3|COMPLETED|Observational Follow-up||0
608683|NCT00379769|1490257|P2|COMPLETED|Observational Follow-up||0
608684|NCT00379769|1490258|P1|COMPLETED|Observational Follow-up||0
608685|NCT00379769|1490253|P6|STARTED|Observational Follow-up|647 from “SU in Addition to Background MET” arm; 603 from “MET in Addition to Background SU” arm.|1250
608686|NCT00379769|1490254|P5|STARTED|Observational Follow-up|665 from “RSG in Addition to Background MET” arm; 615 from “RGS in Addition to Background SU” arm.|1280
608687|NCT00379769|1490255|P4|STARTED|Observational Follow-up||0
608688|NCT00379769|1490256|P3|STARTED|Observational Follow-up||0
608689|NCT00379769|1490257|P2|STARTED|Observational Follow-up||0
608690|NCT00379769|1490258|P1|STARTED|Observational Follow-up||0
608691|NCT00379769|1490253|P6|NOT COMPLETED|Main Study||0
608692|NCT00379769|1490254|P5|NOT COMPLETED|Main Study||0
608693|NCT00379769|1490255|P4|NOT COMPLETED|Main Study||230
608694|NCT00379769|1490256|P3|NOT COMPLETED|Main Study||207
608695|NCT00379769|1490257|P2|NOT COMPLETED|Main Study||199
608696|NCT00379769|1490258|P1|NOT COMPLETED|Main Study||178
608697|NCT00379769|1490253|P6|COMPLETED|Main Study||0
608698|NCT00379769|1490254|P5|COMPLETED|Main Study||0
608699|NCT00379769|1490255|P4|COMPLETED|Main Study||892
608700|NCT00379769|1490256|P3|COMPLETED|Main Study||896
608701|NCT00379769|1490257|P2|COMPLETED|Main Study||906
608702|NCT00379769|1490258|P1|COMPLETED|Main Study||939
608703|NCT00379769|1490253|P6|STARTED|Main Study||0
608704|NCT00379769|1490254|P5|STARTED|Main Study||0
608705|NCT00379769|1490255|P4|STARTED|Main Study||1122
608706|NCT00379769|1490256|P3|STARTED|Main Study||1103
608707|NCT00379769|1490257|P2|STARTED|Main Study||1105
608708|NCT00379769|1490258|P1|STARTED|Main Study||1117
608709|NCT00379639|1490417|P5|NOT COMPLETED|Overall Study||6
608710|NCT00379639|1490418|P4|NOT COMPLETED|Overall Study||6
608711|NCT00379639|1490419|P3|NOT COMPLETED|Overall Study||9
608712|NCT00379639|1490420|P2|NOT COMPLETED|Overall Study||5
608713|NCT00379639|1490421|P1|NOT COMPLETED|Overall Study||3
608714|NCT00379639|1490417|P5|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|0
608715|NCT00379639|1490418|P4|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|0
608716|NCT00379639|1490419|P3|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|1
608717|NCT00379639|1490420|P2|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|2
608718|NCT00379639|1490421|P1|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|4
608719|NCT00379639|1490417|P5|Completed 6 Cycles of Therapy|Overall Study||0
608720|NCT00379639|1490418|P4|Completed 6 Cycles of Therapy|Overall Study||0
608721|NCT00379639|1490419|P3|Completed 6 Cycles of Therapy|Overall Study||1
608722|NCT00379639|1490420|P2|Completed 6 Cycles of Therapy|Overall Study||2
608723|NCT00379639|1490421|P1|Completed 6 Cycles of Therapy|Overall Study||4
608724|NCT00379639|1490417|P5|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|3
608725|NCT00379639|1490418|P4|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|4
608726|NCT00379639|1490419|P3|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|7
608727|NCT00379639|1490420|P2|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|7
608728|NCT00379639|1490421|P1|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|6
608729|NCT00379639|1490417|P5|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|6
608730|NCT00379639|1490418|P4|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|6
608731|NCT00379639|1490419|P3|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|10
608732|NCT00379639|1490420|P2|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|7
608733|NCT00379639|1490421|P1|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|7
608734|NCT00379587|1490443|P1|NOT COMPLETED|Overall Study||2
608735|NCT00379587|1490443|P1|COMPLETED|Overall Study||63
608736|NCT00379587|1490443|P1|STARTED|Overall Study||65
608737|NCT00379574|1490450|P1|NOT COMPLETED|Overall Study||0
608738|NCT00379574|1490450|P1|COMPLETED|Overall Study|Phase I (9) + Phase II (40)|49
608739|NCT00379574|1490450|P1|STARTED|Overall Study|Phase I (9) + Phase II (40)|49
608740|NCT00379353|1490457|P2|NOT COMPLETED|Overall Study||6
608741|NCT00379353|1490458|P1|NOT COMPLETED|Overall Study||11
608742|NCT00379353|1490457|P2|COMPLETED|Overall Study||9
608743|NCT00379353|1490458|P1|COMPLETED|Overall Study||5
608744|NCT00379353|1490457|P2|STARTED|Overall Study||15
608745|NCT00379353|1490458|P1|STARTED|Overall Study||16
608746|NCT00379340|1490493|P5|NOT COMPLETED|Overall Study||14
608747|NCT00379340|1490494|P4|NOT COMPLETED|Overall Study||13
608748|NCT00379340|1490495|P3|NOT COMPLETED|Overall Study||2
608749|NCT00379340|1490496|P2|NOT COMPLETED|Overall Study||3
608750|NCT00379340|1490497|P1|NOT COMPLETED|Overall Study||13
608751|NCT00379340|1490493|P5|COMPLETED|Overall Study||9
608752|NCT00379340|1490494|P4|COMPLETED|Overall Study||37
608753|NCT00379340|1490495|P3|COMPLETED|Overall Study||50
608754|NCT00379340|1490496|P2|COMPLETED|Overall Study||132
608755|NCT00379340|1490497|P1|COMPLETED|Overall Study||107
608756|NCT00379340|1490493|P5|STARTED|Overall Study||23
608757|NCT00379340|1490494|P4|STARTED|Overall Study||50
608758|NCT00379340|1490495|P3|STARTED|Overall Study||52
608759|NCT00379340|1490496|P2|STARTED|Overall Study||135
608760|NCT00379340|1490497|P1|STARTED|Overall Study||120
608761|NCT00379288|1490514|P4|NOT COMPLETED|Overall Study||8
608762|NCT00379288|1490515|P3|NOT COMPLETED|Overall Study||10
608763|NCT00379288|1490516|P2|NOT COMPLETED|Overall Study||22
608764|NCT00379288|1490517|P1|NOT COMPLETED|Overall Study||19
608765|NCT00379288|1490514|P4|COMPLETED|Overall Study||57
608766|NCT00379288|1490515|P3|COMPLETED|Overall Study||58
608767|NCT00379288|1490516|P2|COMPLETED|Overall Study||108
608768|NCT00379288|1490517|P1|COMPLETED|Overall Study||122
608769|NCT00379288|1490514|P4|STARTED|Overall Study||65
608770|NCT00379288|1490515|P3|STARTED|Overall Study||68
608771|NCT00379288|1490516|P2|STARTED|Overall Study||130
608772|NCT00379288|1490517|P1|STARTED|Overall Study||141
608773|NCT00379236|1490529|P3|NOT COMPLETED|Open-label Extension||55
608774|NCT00379236|1490530|P2|NOT COMPLETED|Open-label Extension||0
608775|NCT00379236|1490531|P1|NOT COMPLETED|Open-label Extension||0
608776|NCT00379236|1490529|P3|COMPLETED|Open-label Extension||378
608777|NCT00379236|1490530|P2|COMPLETED|Open-label Extension||0
608778|NCT00379236|1490531|P1|COMPLETED|Open-label Extension||0
608779|NCT00379236|1490529|P3|STARTED|Open-label Extension||433
608780|NCT00379236|1490530|P2|STARTED|Open-label Extension||0
608781|NCT00379236|1490531|P1|STARTED|Open-label Extension||0
608782|NCT00379236|1490529|P3|NOT COMPLETED|Double-blind||0
608783|NCT00379236|1490530|P2|NOT COMPLETED|Double-blind||36
608784|NCT00379236|1490531|P1|NOT COMPLETED|Double-blind||36
608785|NCT00379236|1490529|P3|COMPLETED|Double-blind||0
608786|NCT00379236|1490530|P2|COMPLETED|Double-blind|Data could not be retrieved for two participants|259
608787|NCT00379236|1490531|P1|COMPLETED|Double-blind|Data could not be retrieved for two participants|257
608788|NCT00379236|1490529|P3|STARTED|Double-blind||0
608789|NCT00379236|1490530|P2|STARTED|Double-blind||295
608790|NCT00379236|1490531|P1|STARTED|Double-blind||293
608791|NCT00379210|1490576|P2|NOT COMPLETED|Overall Study||7
608792|NCT00379210|1490577|P1|NOT COMPLETED|Overall Study||10
608793|NCT00379210|1490576|P2|COMPLETED|Overall Study||23
608794|NCT00379210|1490577|P1|COMPLETED|Overall Study||20
608795|NCT00379210|1490576|P2|STARTED|Overall Study||30
608796|NCT00379210|1490577|P1|STARTED|Overall Study||30
608797|NCT00379197|1490583|P1|NOT COMPLETED|Overall Study||5
608798|NCT00379197|1490583|P1|COMPLETED|Overall Study||8
608799|NCT00379197|1490583|P1|STARTED|Overall Study||13
608800|NCT00379145|1490588|P1|NOT COMPLETED|Overall Study||0
608801|NCT00379145|1490588|P1|COMPLETED|Overall Study||20
608802|NCT00379145|1490588|P1|STARTED|Overall Study||20
608803|NCT00379080|1490600|P3|NOT COMPLETED|Overall Study||0
608804|NCT00379080|1490601|P2|NOT COMPLETED|Overall Study||4
608805|NCT00379080|1490602|P1|NOT COMPLETED|Overall Study||0
608806|NCT00379080|1490600|P3|COMPLETED|Overall Study||31
608807|NCT00379080|1490601|P2|COMPLETED|Overall Study||15
608808|NCT00379080|1490602|P1|COMPLETED|Overall Study||6
608809|NCT00379080|1490600|P3|STARTED|Overall Study||31
608810|NCT00379080|1490601|P2|STARTED|Overall Study||19
608811|NCT00379080|1490602|P1|STARTED|Overall Study||6
608812|NCT00378898|1490647|P2|NOT COMPLETED|Overall Study||6
608813|NCT00378898|1490648|P1|NOT COMPLETED|Overall Study||11
608814|NCT00378898|1490647|P2|COMPLETED|Overall Study||11
608815|NCT00378898|1490648|P1|COMPLETED|Overall Study||11
608816|NCT00378898|1490647|P2|STARTED|Overall Study||17
608817|NCT00378898|1490648|P1|STARTED|Overall Study||22
608818|NCT00378703|1490660|P4|NOT COMPLETED|Overall Study||91
608819|NCT00378703|1490661|P3|NOT COMPLETED|Overall Study||90
608820|NCT00378703|1490662|P2|NOT COMPLETED|Overall Study||91
608821|NCT00378703|1490663|P1|NOT COMPLETED|Overall Study||89
608822|NCT00378703|1490660|P4|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
608823|NCT00378703|1490661|P3|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
608824|NCT00378703|1490662|P2|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
608825|NCT00378703|1490663|P1|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
608826|NCT00378703|1490660|P4|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|84
608827|NCT00378703|1490661|P3|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|83
608828|NCT00378703|1490662|P2|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|80
608829|NCT00378703|1490663|P1|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|84
608830|NCT00378703|1490660|P4|Treated|Overall Study|Number of patients included in the toxicity analysis.|91
608831|NCT00378703|1490661|P3|Treated|Overall Study|Number of patients included in the toxicity analysis.|90
608832|NCT00378703|1490662|P2|Treated|Overall Study|Number of patients included in the toxicity analysis.|86
608833|NCT00378703|1490663|P1|Treated|Overall Study|Number of patients included in the toxicity analysis.|88
608834|NCT00378703|1490660|P4|STARTED|Overall Study|Number of patients randomized to this treatment arm.|91
608835|NCT00378703|1490661|P3|STARTED|Overall Study|Number of patients randomized to this treatment arm.|90
608836|NCT00378703|1490662|P2|STARTED|Overall Study|Number of patients randomized to this treatment arm.|91
608837|NCT00378703|1490663|P1|STARTED|Overall Study|Number of patients randomized to this treatment arm.|89
608838|NCT00378599|1490685|P1|NOT COMPLETED|Overall Study||52
608839|NCT00378599|1490685|P1|COMPLETED|Overall Study||73
608840|NCT00378599|1490685|P1|STARTED|Overall Study||125
608841|NCT00378573|1490689|P1|NOT COMPLETED|Follow-up||14
608842|NCT00378573|1490689|P1|COMPLETED|Follow-up||3
608843|NCT00378573|1490689|P1|STARTED|Follow-up||17
608844|NCT00378573|1490689|P1|NOT COMPLETED|Treatment Period||17
608845|NCT00378573|1490689|P1|COMPLETED|Treatment Period|Patients who did not complete treatment moved directly to the follow-up phase of the study.|0
608846|NCT00378573|1490689|P1|STARTED|Treatment Period||17
608847|NCT00378560|1490697|P2|NOT COMPLETED|Overall Study||58
608848|NCT00378560|1490698|P1|NOT COMPLETED|Overall Study||56
608849|NCT00378560|1490697|P2|COMPLETED|Overall Study||454
608850|NCT00378560|1490698|P1|COMPLETED|Overall Study||453
608851|NCT00378560|1490697|P2|Vaccinated|Overall Study||512
608852|NCT00378560|1490698|P1|Vaccinated|Overall Study||509
608853|NCT00378560|1490697|P2|STARTED|Overall Study||512
608854|NCT00378560|1490698|P1|STARTED|Overall Study||509
608855|NCT00378534|1490712|P1|NOT COMPLETED|Overall Study||60
608856|NCT00378534|1490712|P1|COMPLETED|Overall Study|Transplantation Recipients|55
608857|NCT00378534|1490712|P1|STARTED|Overall Study||115
608858|NCT00378508|1490718|P2|NOT COMPLETED|Overall Study||3
608859|NCT00378508|1490719|P1|NOT COMPLETED|Overall Study||2
608860|NCT00378508|1490718|P2|COMPLETED|Overall Study||31
608861|NCT00378508|1490719|P1|COMPLETED|Overall Study||27
608862|NCT00378508|1490718|P2|Received Intervention/Placebo|Overall Study||31
608863|NCT00378508|1490719|P1|Received Intervention/Placebo|Overall Study||28
608864|NCT00378508|1490718|P2|Randomized|Overall Study||34
608865|NCT00378508|1490719|P1|Randomized|Overall Study||29
608866|NCT00378508|1490718|P2|STARTED|Overall Study||34
608867|NCT00378508|1490719|P1|STARTED|Overall Study||29
608868|NCT00378378|1490738|P3|NOT COMPLETED|Overall Study||2
608869|NCT00378378|1490739|P2|NOT COMPLETED|Overall Study||1
608870|NCT00378378|1490740|P1|NOT COMPLETED|Overall Study||0
608871|NCT00378378|1490738|P3|COMPLETED|Overall Study||24
608872|NCT00378378|1490739|P2|COMPLETED|Overall Study||49
608873|NCT00378378|1490740|P1|COMPLETED|Overall Study||51
608874|NCT00378378|1490738|P3|STARTED|Overall Study||26
608875|NCT00378378|1490739|P2|STARTED|Overall Study||50
608876|NCT00378378|1490740|P1|STARTED|Overall Study||51
608877|NCT00378352|1490753|P6|NOT COMPLETED|Efficacy Phase||7
608878|NCT00378352|1490754|P5|NOT COMPLETED|Efficacy Phase||11
608879|NCT00378352|1490755|P4|NOT COMPLETED|Efficacy Phase||0
608880|NCT00378352|1490756|P3|NOT COMPLETED|Efficacy Phase||0
608881|NCT00378352|1490757|P2|NOT COMPLETED|Efficacy Phase||0
608882|NCT00378352|1490758|P1|NOT COMPLETED|Efficacy Phase||0
608883|NCT00378352|1490753|P6|COMPLETED|Efficacy Phase||59
608884|NCT00378352|1490754|P5|COMPLETED|Efficacy Phase||54
608885|NCT00378352|1490755|P4|COMPLETED|Efficacy Phase||0
608886|NCT00378352|1490756|P3|COMPLETED|Efficacy Phase||0
608887|NCT00378352|1490757|P2|COMPLETED|Efficacy Phase||0
608888|NCT00378352|1490758|P1|COMPLETED|Efficacy Phase||0
608889|NCT00378352|1490753|P6|Safety Analysis|Efficacy Phase||64
608890|NCT00378352|1490754|P5|Safety Analysis|Efficacy Phase|Two participants randomized to placebo received 60,000 units Epoetin alfa|67
608891|NCT00378352|1490755|P4|Safety Analysis|Efficacy Phase||0
608892|NCT00378352|1490756|P3|Safety Analysis|Efficacy Phase||0
608893|NCT00378352|1490757|P2|Safety Analysis|Efficacy Phase||0
608894|NCT00378352|1490758|P1|Safety Analysis|Efficacy Phase||0
608895|NCT00378352|1490753|P6|STARTED|Efficacy Phase||66
608896|NCT00378352|1490754|P5|STARTED|Efficacy Phase||65
608897|NCT00378352|1490755|P4|STARTED|Efficacy Phase||0
608898|NCT00378352|1490756|P3|STARTED|Efficacy Phase||0
608899|NCT00378352|1490757|P2|STARTED|Efficacy Phase||0
608900|NCT00378352|1490758|P1|STARTED|Efficacy Phase||0
608901|NCT00378352|1490753|P6|NOT COMPLETED|Dose Escalation 60,000 Units||0
608902|NCT00378352|1490754|P5|NOT COMPLETED|Dose Escalation 60,000 Units||0
608903|NCT00378352|1490755|P4|NOT COMPLETED|Dose Escalation 60,000 Units||1
608904|NCT00378352|1490756|P3|NOT COMPLETED|Dose Escalation 60,000 Units||3
608905|NCT00378352|1490757|P2|NOT COMPLETED|Dose Escalation 60,000 Units||0
608906|NCT00378352|1490758|P1|NOT COMPLETED|Dose Escalation 60,000 Units||0
608907|NCT00378352|1490753|P6|COMPLETED|Dose Escalation 60,000 Units||0
608908|NCT00378352|1490754|P5|COMPLETED|Dose Escalation 60,000 Units||0
608909|NCT00378352|1490755|P4|COMPLETED|Dose Escalation 60,000 Units||10
608910|NCT00378352|1490756|P3|COMPLETED|Dose Escalation 60,000 Units||17
608911|NCT00378352|1490757|P2|COMPLETED|Dose Escalation 60,000 Units||0
608912|NCT00378352|1490758|P1|COMPLETED|Dose Escalation 60,000 Units||0
608913|NCT00378352|1490753|P6|Safety Analysis|Dose Escalation 60,000 Units||0
608914|NCT00378352|1490754|P5|Safety Analysis|Dose Escalation 60,000 Units||0
608915|NCT00378352|1490755|P4|Safety Analysis|Dose Escalation 60,000 Units||11
608916|NCT00378352|1490756|P3|Safety Analysis|Dose Escalation 60,000 Units||19
608917|NCT00378352|1490757|P2|Safety Analysis|Dose Escalation 60,000 Units||0
608918|NCT00378352|1490758|P1|Safety Analysis|Dose Escalation 60,000 Units||0
608919|NCT00378352|1490753|P6|STARTED|Dose Escalation 60,000 Units||0
608920|NCT00378352|1490754|P5|STARTED|Dose Escalation 60,000 Units||0
608921|NCT00378352|1490755|P4|STARTED|Dose Escalation 60,000 Units||11
608922|NCT00378352|1490756|P3|STARTED|Dose Escalation 60,000 Units||20
608923|NCT00378352|1490757|P2|STARTED|Dose Escalation 60,000 Units||0
608924|NCT00378352|1490758|P1|STARTED|Dose Escalation 60,000 Units||0
608925|NCT00378352|1490753|P6|NOT COMPLETED|Dose Escalation 30,000 Units||0
608926|NCT00378352|1490754|P5|NOT COMPLETED|Dose Escalation 30,000 Units||0
608927|NCT00378352|1490755|P4|NOT COMPLETED|Dose Escalation 30,000 Units||2
608928|NCT00378352|1490756|P3|NOT COMPLETED|Dose Escalation 30,000 Units||0
608929|NCT00378352|1490757|P2|NOT COMPLETED|Dose Escalation 30,000 Units||3
608930|NCT00378352|1490758|P1|NOT COMPLETED|Dose Escalation 30,000 Units||0
608931|NCT00378352|1490753|P6|COMPLETED|Dose Escalation 30,000 Units||0
608932|NCT00378352|1490754|P5|COMPLETED|Dose Escalation 30,000 Units||0
608933|NCT00378352|1490755|P4|COMPLETED|Dose Escalation 30,000 Units||9
608934|NCT00378352|1490756|P3|COMPLETED|Dose Escalation 30,000 Units||0
608935|NCT00378352|1490757|P2|COMPLETED|Dose Escalation 30,000 Units||16
608936|NCT00378352|1490758|P1|COMPLETED|Dose Escalation 30,000 Units||0
608937|NCT00378352|1490753|P6|Safety Analysis|Dose Escalation 30,000 Units||0
608938|NCT00378352|1490754|P5|Safety Analysis|Dose Escalation 30,000 Units||0
608939|NCT00378352|1490755|P4|Safety Analysis|Dose Escalation 30,000 Units||11
608940|NCT00378352|1490756|P3|Safety Analysis|Dose Escalation 30,000 Units||0
608941|NCT00378352|1490757|P2|Safety Analysis|Dose Escalation 30,000 Units|One participant randomized to 60,000 units received 30,000 units|20
608942|NCT00378352|1490758|P1|Safety Analysis|Dose Escalation 30,000 Units||0
608943|NCT00378352|1490753|P6|STARTED|Dose Escalation 30,000 Units||0
608944|NCT00378352|1490754|P5|STARTED|Dose Escalation 30,000 Units||0
608945|NCT00378352|1490755|P4|STARTED|Dose Escalation 30,000 Units||11
608946|NCT00378352|1490756|P3|STARTED|Dose Escalation 30,000 Units||0
608947|NCT00378352|1490757|P2|STARTED|Dose Escalation 30,000 Units||19
608948|NCT00378352|1490758|P1|STARTED|Dose Escalation 30,000 Units||0
608949|NCT00378352|1490753|P6|NOT COMPLETED|Dose Escalation 15,000 Units||0
608950|NCT00378352|1490754|P5|NOT COMPLETED|Dose Escalation 15,000 Units||0
608951|NCT00378352|1490755|P4|NOT COMPLETED|Dose Escalation 15,000 Units||1
608952|NCT00378352|1490756|P3|NOT COMPLETED|Dose Escalation 15,000 Units||0
608953|NCT00378352|1490757|P2|NOT COMPLETED|Dose Escalation 15,000 Units||0
608954|NCT00378352|1490758|P1|NOT COMPLETED|Dose Escalation 15,000 Units||5
608955|NCT00378352|1490753|P6|COMPLETED|Dose Escalation 15,000 Units||0
608956|NCT00378352|1490754|P5|COMPLETED|Dose Escalation 15,000 Units||0
608957|NCT00378352|1490755|P4|COMPLETED|Dose Escalation 15,000 Units||10
608958|NCT00378352|1490756|P3|COMPLETED|Dose Escalation 15,000 Units||0
608959|NCT00378352|1490757|P2|COMPLETED|Dose Escalation 15,000 Units||0
608960|NCT00378352|1490758|P1|COMPLETED|Dose Escalation 15,000 Units||15
608961|NCT00378352|1490753|P6|Safety Analysis|Dose Escalation 15,000 Units||0
608962|NCT00378352|1490754|P5|Safety Analysis|Dose Escalation 15,000 Units||0
608963|NCT00378352|1490755|P4|Safety Analysis|Dose Escalation 15,000 Units||11
608964|NCT00378352|1490756|P3|Safety Analysis|Dose Escalation 15,000 Units||0
608965|NCT00378352|1490757|P2|Safety Analysis|Dose Escalation 15,000 Units||0
608966|NCT00378352|1490758|P1|Safety Analysis|Dose Escalation 15,000 Units||19
608967|NCT00378352|1490753|P6|STARTED|Dose Escalation 15,000 Units||0
608968|NCT00378352|1490754|P5|STARTED|Dose Escalation 15,000 Units||0
608969|NCT00378352|1490755|P4|STARTED|Dose Escalation 15,000 Units||11
608970|NCT00378352|1490756|P3|STARTED|Dose Escalation 15,000 Units||0
608971|NCT00378352|1490757|P2|STARTED|Dose Escalation 15,000 Units||0
608972|NCT00378352|1490758|P1|STARTED|Dose Escalation 15,000 Units||20
608973|NCT00378326|1490780|P1|NOT COMPLETED|Overall Study||0
608974|NCT00378326|1490780|P1|COMPLETED|Overall Study||26
608975|NCT00378326|1490780|P1|STARTED|Overall Study||26
608976|NCT00378209|1490786|P1|NOT COMPLETED|Overall Study||22
608977|NCT00378209|1490786|P1|COMPLETED|Overall Study|This included patients who completed at least 8 cycles of combination therapy with all drugs.|42
608978|NCT00378209|1490786|P1|STARTED|Overall Study|1 patient who never started treatment was excluded in the analysis.|64
608979|NCT00378105|1490796|P2|NOT COMPLETED|Overall Study||30
608980|NCT00378105|1490797|P1|NOT COMPLETED|Overall Study||20
608981|NCT00378105|1490796|P2|COMPLETED|Overall Study||5
608982|NCT00378105|1490797|P1|COMPLETED|Overall Study||11
608983|NCT00378105|1490796|P2|STARTED|Overall Study||35
608984|NCT00378105|1490797|P1|STARTED|Overall Study|Out of 33 enrolled, two patients went off study before start of therapy.|31
608985|NCT00378079|1490809|P3|NOT COMPLETED|Overall Study||0
608986|NCT00378079|1490810|P2|NOT COMPLETED|Overall Study||1
608987|NCT00378079|1490811|P1|NOT COMPLETED|Overall Study||6
608988|NCT00378079|1490809|P3|COMPLETED|Overall Study||71
608989|NCT00378079|1490810|P2|COMPLETED|Overall Study||69
608990|NCT00378079|1490811|P1|COMPLETED|Overall Study||64
608991|NCT00378079|1490809|P3|STARTED|Overall Study||71
608992|NCT00378079|1490810|P2|STARTED|Overall Study||70
608993|NCT00378079|1490811|P1|STARTED|Overall Study||70
608994|NCT00378014|1490833|P2|NOT COMPLETED|Extension (Month 12 to Month 59)||14
608995|NCT00378014|1490834|P1|NOT COMPLETED|Extension (Month 12 to Month 59)||14
608996|NCT00378014|1490833|P2|COMPLETED|Extension (Month 12 to Month 59)||26
608997|NCT00378014|1490834|P1|COMPLETED|Extension (Month 12 to Month 59)||27
608998|NCT00378014|1490833|P2|STARTED|Extension (Month 12 to Month 59)||40
608999|NCT00378014|1490834|P1|STARTED|Extension (Month 12 to Month 59)||41
609000|NCT00378014|1490833|P2|NOT COMPLETED|Core (Randomization to Month 11)||12
609001|NCT00378014|1490834|P1|NOT COMPLETED|Core (Randomization to Month 11)||14
609002|NCT00378014|1490833|P2|COMPLETED|Core (Randomization to Month 11)||90
609003|NCT00378014|1490834|P1|COMPLETED|Core (Randomization to Month 11)||87
609004|NCT00378014|1490833|P2|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)|ITT contained all randomized patients who had at least one post baseline GFR measurement.|98
609005|NCT00378014|1490834|P1|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)|ITT contained all randomized patients who had at least one post baseline GFR measurement.|96
609006|NCT00378014|1490833|P2|STARTED|Core (Randomization to Month 11)||102
609007|NCT00378014|1490834|P1|STARTED|Core (Randomization to Month 11)||101
609008|NCT00377962|1490860|P2|NOT COMPLETED|Extension Study: 12-24 Months||4
609009|NCT00377962|1490861|P1|NOT COMPLETED|Extension Study: 12-24 Months||10
609010|NCT00377962|1490860|P2|COMPLETED|Extension Study: 12-24 Months||123
609011|NCT00377962|1490861|P1|COMPLETED|Extension Study: 12-24 Months||98
609012|NCT00377962|1490860|P2|STARTED|Extension Study: 12-24 Months||127
609013|NCT00377962|1490861|P1|STARTED|Extension Study: 12-24 Months||108
609014|NCT00377962|1490860|P2|NOT COMPLETED|Core Study: 0-12 Months||9
609015|NCT00377962|1490861|P1|NOT COMPLETED|Core Study: 0-12 Months||28
609016|NCT00377962|1490860|P2|COMPLETED|Core Study: 0-12 Months||133
609017|NCT00377962|1490861|P1|COMPLETED|Core Study: 0-12 Months||112
609018|NCT00377962|1490860|P2|STARTED|Core Study: 0-12 Months||142
609019|NCT00377962|1490861|P1|STARTED|Core Study: 0-12 Months||140
609020|NCT00377858|1490897|P2|NOT COMPLETED|Overall Study||27
609021|NCT00377858|1490898|P1|NOT COMPLETED|Overall Study||31
609022|NCT00377858|1490897|P2|COMPLETED|Overall Study||215
609023|NCT00377858|1490898|P1|COMPLETED|Overall Study||211
609024|NCT00377858|1490897|P2|Had at Least One Post-Baseline Value|Overall Study||240
609025|NCT00377858|1490898|P1|Had at Least One Post-Baseline Value|Overall Study||239
609026|NCT00377858|1490897|P2|STARTED|Overall Study||242
609027|NCT00377858|1490898|P1|STARTED|Overall Study||242
609028|NCT00377832|1490928|P2|NOT COMPLETED|Overall Study||0
609029|NCT00377832|1490929|P1|NOT COMPLETED|Overall Study||0
609030|NCT00377832|1490928|P2|COMPLETED|Overall Study||6
609031|NCT00377832|1490929|P1|COMPLETED|Overall Study||7
609032|NCT00377832|1490928|P2|STARTED|Overall Study||6
609033|NCT00377832|1490929|P1|STARTED|Overall Study||7
609034|NCT00377819|1490951|P2|NOT COMPLETED|Overall Study||10
609035|NCT00377819|1490952|P1|NOT COMPLETED|Overall Study||13
609036|NCT00377819|1490951|P2|COMPLETED|Overall Study||243
609037|NCT00377819|1490952|P1|COMPLETED|Overall Study||238
609038|NCT00377819|1490951|P2|Received Study Medication|Overall Study||253
609039|NCT00377819|1490952|P1|Received Study Medication|Overall Study||249
609040|NCT00377819|1490951|P2|STARTED|Overall Study||253
609041|NCT00377819|1490952|P1|STARTED|Overall Study||251
609042|NCT00377741|1490964|P2|NOT COMPLETED|Overall Study||0
609043|NCT00377741|1490965|P1|NOT COMPLETED|Overall Study||0
609044|NCT00377741|1490964|P2|COMPLETED|Overall Study||15
609045|NCT00377741|1490965|P1|COMPLETED|Overall Study||16
609046|NCT00377741|1490964|P2|STARTED|Overall Study||15
609047|NCT00377741|1490965|P1|STARTED|Overall Study||16
609048|NCT00377676|1490981|P2|NOT COMPLETED|Overall Study||322
609049|NCT00377676|1490982|P1|NOT COMPLETED|Overall Study||961
609050|NCT00377676|1490981|P2|COMPLETED|Overall Study||694
609051|NCT00377676|1490982|P1|COMPLETED|Overall Study||1093
609052|NCT00377676|1490981|P2|STARTED|Overall Study||1016
609053|NCT00377676|1490982|P1|STARTED|Overall Study|25 subjects did not receive study drug - thus 3070 were randomized and received drug|2054
609054|NCT00377637|1490998|P4|NOT COMPLETED|Maintenance Phase||57
609055|NCT00377637|1490999|P3|NOT COMPLETED|Maintenance Phase||43
609056|NCT00377637|1491000|P2|NOT COMPLETED|Maintenance Phase||0
609057|NCT00377637|1491001|P1|NOT COMPLETED|Maintenance Phase||0
609058|NCT00377637|1490998|P4|COMPLETED|Maintenance Phase||54
609059|NCT00377637|1490999|P3|COMPLETED|Maintenance Phase||73
609060|NCT00377637|1491000|P2|COMPLETED|Maintenance Phase||0
609061|NCT00377637|1491001|P1|COMPLETED|Maintenance Phase||0
609062|NCT00377637|1490998|P4|STARTED|Maintenance Phase||111
609063|NCT00377637|1490999|P3|STARTED|Maintenance Phase||116
609064|NCT00377637|1491000|P2|STARTED|Maintenance Phase||0
609065|NCT00377637|1491001|P1|STARTED|Maintenance Phase||0
609066|NCT00377637|1490998|P4|NOT COMPLETED|Induction Phase||0
609067|NCT00377637|1490999|P3|NOT COMPLETED|Induction Phase||0
609068|NCT00377637|1491000|P2|NOT COMPLETED|Induction Phase||35
609069|NCT00377637|1491001|P1|NOT COMPLETED|Induction Phase||29
609070|NCT00377637|1490998|P4|COMPLETED|Induction Phase||0
609071|NCT00377637|1490999|P3|COMPLETED|Induction Phase||0
609072|NCT00377637|1491000|P2|COMPLETED|Induction Phase||150
609073|NCT00377637|1491001|P1|COMPLETED|Induction Phase||156
609074|NCT00377637|1490998|P4|Safety Population|Induction Phase||0
609075|NCT00377637|1490999|P3|Safety Population|Induction Phase||0
609076|NCT00377637|1491000|P2|Safety Population|Induction Phase||184
609077|NCT00377637|1491001|P1|Safety Population|Induction Phase||180
609078|NCT00377637|1490998|P4|STARTED|Induction Phase||0
609079|NCT00377637|1490999|P3|STARTED|Induction Phase||0
609080|NCT00377637|1491000|P2|STARTED|Induction Phase|Intent-To-Treat|185
609081|NCT00377637|1491001|P1|STARTED|Induction Phase|Intent-To-Treat|185
609082|NCT00377572|1491037|P2|NOT COMPLETED|Overall Study||54
609083|NCT00377572|1491038|P1|NOT COMPLETED|Overall Study||53
609084|NCT00377572|1491037|P2|COMPLETED|Overall Study||157
609085|NCT00377572|1491038|P1|COMPLETED|Overall Study||155
609086|NCT00377572|1491037|P2|STARTED|Overall Study||211
609087|NCT00377572|1491038|P1|STARTED|Overall Study||208
609088|NCT00377520|1491076|P1|NOT COMPLETED|Overall Study||1
609089|NCT00377520|1491076|P1|COMPLETED|Overall Study|Completed means the patient was evaluable for response.|26
609090|NCT00377520|1491076|P1|STARTED|Overall Study||27
609091|NCT00377455|1491081|P1|NOT COMPLETED|Overall Study||1
609092|NCT00377455|1491081|P1|COMPLETED|Overall Study||4
609093|NCT00377455|1491081|P1|STARTED|Overall Study||5
609094|NCT00377429|1491089|P1|NOT COMPLETED|Overall Study||15
609095|NCT00377429|1491089|P1|COMPLETED|Overall Study|Completed main study|32
609096|NCT00377429|1491089|P1|STARTED|Overall Study|Treated|47
609097|NCT00377403|1491100|P2|NOT COMPLETED|Overall Study||7
609098|NCT00377403|1491101|P1|NOT COMPLETED|Overall Study||4
609099|NCT00377403|1491100|P2|COMPLETED|Overall Study|The number varied by day of follow-up from 71 to 77 in the symptomatic treatment only group.|74
609100|NCT00377403|1491101|P1|COMPLETED|Overall Study|The number varied by day of follow-up from 80 to 82 in the intervention group.|81
609101|NCT00377403|1491100|P2|Day 28 Assessment|Overall Study||77
609102|NCT00377403|1491101|P1|Day 28 Assessment|Overall Study||82
609103|NCT00377403|1491100|P2|Day 10 Assessment|Overall Study||71
609104|NCT00377403|1491101|P1|Day 10 Assessment|Overall Study||81
609105|NCT00377403|1491100|P2|Day 7 Assessment|Overall Study||75
609106|NCT00377403|1491101|P1|Day 7 Assessment|Overall Study||80
609107|NCT00377403|1491100|P2|Day -3 Assessment|Overall Study||74
609108|NCT00377403|1491101|P1|Day -3 Assessment|Overall Study||81
609109|NCT00377403|1491100|P2|STARTED|Overall Study||81
609110|NCT00377403|1491101|P1|STARTED|Overall Study||85
609111|NCT00377364|1491109|P2|NOT COMPLETED|Overall Study||0
609112|NCT00377364|1491110|P1|NOT COMPLETED|Overall Study||2
609113|NCT00377364|1491109|P2|COMPLETED|Overall Study||14
609114|NCT00377364|1491110|P1|COMPLETED|Overall Study||14
609115|NCT00377364|1491109|P2|STARTED|Overall Study||14
609116|NCT00377364|1491110|P1|STARTED|Overall Study||16
609117|NCT00377312|1491136|P2|NOT COMPLETED|Overall Study||1
609118|NCT00377312|1491137|P1|NOT COMPLETED|Overall Study||1
609119|NCT00377312|1491136|P2|COMPLETED|Overall Study||4
609120|NCT00377312|1491137|P1|COMPLETED|Overall Study||5
609121|NCT00377312|1491136|P2|STARTED|Overall Study||5
609122|NCT00377312|1491137|P1|STARTED|Overall Study||6
609123|NCT00377299|1491169|P2|NOT COMPLETED|Overall Study||24
609124|NCT00377299|1491170|P1|NOT COMPLETED|Overall Study||19
609125|NCT00377299|1491169|P2|COMPLETED|Overall Study||4
609126|NCT00377299|1491170|P1|COMPLETED|Overall Study||13
609127|NCT00377299|1491169|P2|STARTED|Overall Study||28
609128|NCT00377299|1491170|P1|STARTED|Overall Study||32
609129|NCT00377260|1491186|P2|NOT COMPLETED|Overall Study||5
609130|NCT00377260|1491187|P1|NOT COMPLETED|Overall Study||2
609131|NCT00377260|1491186|P2|COMPLETED|Overall Study|A child is considered a completer if he/she had at least one visit after the end of therapy.|142
609132|NCT00377260|1491187|P1|COMPLETED|Overall Study|A child is considered a completer if he/she had at least one visit after the end of therapy.|142
609133|NCT00377260|1491186|P2|STARTED|Overall Study||147
609134|NCT00377260|1491187|P1|STARTED|Overall Study||144
609135|NCT00377234|1491241|P2|NOT COMPLETED|Overall Study||31
609136|NCT00377234|1491242|P1|NOT COMPLETED|Overall Study||34
609137|NCT00377234|1491241|P2|COMPLETED|Overall Study||145
609138|NCT00377234|1491242|P1|COMPLETED|Overall Study||146
609139|NCT00377234|1491241|P2|Safety Analysis Set: Risedronate|Overall Study||174
609140|NCT00377234|1491242|P1|Safety Analysis Set: Risedronate|Overall Study||153
609141|NCT00377234|1491241|P2|Safety Analysis Set: Ibandronate|Overall Study||150
609142|NCT00377234|1491242|P1|Safety Analysis Set: Ibandronate|Overall Study||177
609143|NCT00377234|1491241|P2|Safety Analysis Set: Period 2|Overall Study||150
609144|NCT00377234|1491242|P1|Safety Analysis Set: Period 2|Overall Study||153
609145|NCT00377234|1491241|P2|Safety Analysis Set: Period 1|Overall Study||174
609146|NCT00377234|1491242|P1|Safety Analysis Set: Period 1|Overall Study||177
609147|NCT00377234|1491241|P2|Received Treatment|Overall Study||174
609148|NCT00377234|1491242|P1|Received Treatment|Overall Study||177
609149|NCT00377234|1491241|P2|Did Not Receive Study Treatment|Overall Study||2
609150|NCT00377234|1491242|P1|Did Not Receive Study Treatment|Overall Study||3
609151|NCT00377234|1491241|P2|Randomized|Overall Study||176
609152|NCT00377234|1491242|P1|Randomized|Overall Study||180
609153|NCT00377234|1491241|P2|STARTED|Overall Study||176
609154|NCT00377234|1491242|P1|STARTED|Overall Study||180
609155|NCT00377156|1491260|P2|NOT COMPLETED|Overall Study||54
609156|NCT00377156|1491261|P1|NOT COMPLETED|Overall Study||48
609157|NCT00377156|1491260|P2|COMPLETED|Overall Study||48
609158|NCT00377156|1491261|P1|COMPLETED|Overall Study||63
609159|NCT00377156|1491260|P2|STARTED|Overall Study||102
609160|NCT00377156|1491261|P1|STARTED|Overall Study||111
609161|NCT00376961|1491275|P2|NOT COMPLETED|Maintenance||23
609162|NCT00376961|1491276|P1|NOT COMPLETED|Maintenance||0
609163|NCT00376961|1491275|P2|COMPLETED|Maintenance||27
609164|NCT00376961|1491276|P1|COMPLETED|Maintenance||0
609165|NCT00376961|1491275|P2|Eligible|Maintenance||47
609166|NCT00376961|1491276|P1|Eligible|Maintenance||0
609167|NCT00376961|1491275|P2|STARTED|Maintenance||50
609168|NCT00376961|1491276|P1|STARTED|Maintenance||0
609169|NCT00376961|1491275|P2|NOT COMPLETED|Initial Registration||0
609170|NCT00376961|1491276|P1|NOT COMPLETED|Initial Registration||7
609171|NCT00376961|1491275|P2|COMPLETED|Initial Registration||0
609172|NCT00376961|1491276|P1|COMPLETED|Initial Registration||61
609173|NCT00376961|1491275|P2|Eligible|Initial Registration||0
609174|NCT00376961|1491276|P1|Eligible|Initial Registration||65
609175|NCT00376961|1491275|P2|STARTED|Initial Registration||0
609176|NCT00376961|1491276|P1|STARTED|Initial Registration||68
609177|NCT00376948|1491285|P1|NOT COMPLETED|Overall Study||0
609178|NCT00376948|1491285|P1|COMPLETED|Overall Study||20
609179|NCT00376948|1491285|P1|STARTED|Overall Study||20
609180|NCT00376935|1491294|P4|NOT COMPLETED|Overall Study||0
609181|NCT00376935|1491295|P3|NOT COMPLETED|Overall Study||0
609182|NCT00376935|1491296|P2|NOT COMPLETED|Overall Study||0
609183|NCT00376935|1491297|P1|NOT COMPLETED|Overall Study||0
609184|NCT00376935|1491294|P4|COMPLETED|Overall Study||24
609185|NCT00376935|1491295|P3|COMPLETED|Overall Study||25
609186|NCT00376935|1491296|P2|COMPLETED|Overall Study||25
609187|NCT00376935|1491297|P1|COMPLETED|Overall Study||25
609188|NCT00376935|1491294|P4|STARTED|Overall Study||24
609189|NCT00376935|1491295|P3|STARTED|Overall Study||25
609190|NCT00376935|1491296|P2|STARTED|Overall Study||25
609191|NCT00376935|1491297|P1|STARTED|Overall Study||25
609192|NCT00376805|1491335|P1|NOT COMPLETED|Overall Study||0
609193|NCT00376805|1491335|P1|COMPLETED|Overall Study||6
609194|NCT00376805|1491335|P1|STARTED|Overall Study||6
609195|NCT00376688|1491342|P1|NOT COMPLETED|Overall Study||4
609196|NCT00376688|1491342|P1|COMPLETED|Overall Study||27
609197|NCT00376688|1491342|P1|STARTED|Overall Study||31
609198|NCT00376675|1491348|P2|NOT COMPLETED|Overall Study||14
609199|NCT00376675|1491349|P1|NOT COMPLETED|Overall Study||20
609200|NCT00376675|1491348|P2|COMPLETED|Overall Study||56
609201|NCT00376675|1491349|P1|COMPLETED|Overall Study||49
609202|NCT00376675|1491348|P2|STARTED|Overall Study||70
609203|NCT00376675|1491349|P1|STARTED|Overall Study||69
609204|NCT00376597|1491373|P2|NOT COMPLETED|Overall Study||3
609205|NCT00376597|1491374|P1|NOT COMPLETED|Overall Study||11
609206|NCT00376597|1491373|P2|COMPLETED|Overall Study||312
609207|NCT00376597|1491374|P1|COMPLETED|Overall Study||242
609208|NCT00376597|1491373|P2|STARTED|Overall Study||315
609209|NCT00376597|1491374|P1|STARTED|Overall Study||253
609210|NCT00376558|1491388|P2|NOT COMPLETED|Overall Study||0
609211|NCT00376558|1491389|P1|NOT COMPLETED|Overall Study||0
609212|NCT00376558|1491388|P2|COMPLETED|Overall Study||25
609213|NCT00376558|1491389|P1|COMPLETED|Overall Study||25
609214|NCT00376558|1491388|P2|STARTED|Overall Study||25
609215|NCT00376558|1491389|P1|STARTED|Overall Study||25
609216|NCT00376532|1491398|P2|NOT COMPLETED|Overall Study||6
609217|NCT00376532|1491399|P1|NOT COMPLETED|Overall Study||6
609218|NCT00376532|1491398|P2|COMPLETED|Overall Study|Last non-event subject enrolled 3/18/2008.|26
609219|NCT00376532|1491399|P1|COMPLETED|Overall Study|Last event subject enrolled 2/22/2008|25
609220|NCT00376532|1491398|P2|STARTED|Overall Study|Subjects without an event were enrolled beginning 09/15/2006.|32
609221|NCT00376532|1491399|P1|STARTED|Overall Study|Subjects with an event were enrolled beginning 09/14/2006.|31
609222|NCT00376506|1491409|P2|NOT COMPLETED|Overall Study||2
609223|NCT00376506|1491410|P1|NOT COMPLETED|Overall Study||0
609224|NCT00376506|1491409|P2|COMPLETED|Overall Study||4
609225|NCT00376506|1491410|P1|COMPLETED|Overall Study||4
609226|NCT00376506|1491409|P2|STARTED|Overall Study||6
609227|NCT00376506|1491410|P1|STARTED|Overall Study||4
609228|NCT00376363|1491428|P2|NOT COMPLETED|Overall Study||46
609229|NCT00376363|1491429|P1|NOT COMPLETED|Overall Study||56
609230|NCT00376363|1491428|P2|COMPLETED|Overall Study||87
609231|NCT00376363|1491429|P1|COMPLETED|Overall Study||87
609232|NCT00376363|1491428|P2|STARTED|Overall Study||133
609233|NCT00376363|1491429|P1|STARTED|Overall Study||143
609234|NCT00376259|1491441|P2|NOT COMPLETED|Overall Study||21
609235|NCT00376259|1491442|P1|NOT COMPLETED|Overall Study||22
609236|NCT00376259|1491441|P2|COMPLETED|Overall Study||0
609237|NCT00376259|1491442|P1|COMPLETED|Overall Study||0
609238|NCT00376259|1491441|P2|Received Study Drug|Overall Study||21
609239|NCT00376259|1491442|P1|Received Study Drug|Overall Study||21
609240|NCT00376259|1491441|P2|STARTED|Overall Study||21
609241|NCT00376259|1491442|P1|STARTED|Overall Study||22
609242|NCT00376220|1491456|P2|NOT COMPLETED|Overall Study||12
609243|NCT00376220|1491457|P1|NOT COMPLETED|Overall Study||10
609244|NCT00376220|1491456|P2|COMPLETED|Overall Study||35
609245|NCT00376220|1491457|P1|COMPLETED|Overall Study||37
609246|NCT00376220|1491456|P2|STARTED|Overall Study||47
609247|NCT00376220|1491457|P1|STARTED|Overall Study||47
609248|NCT00376168|1491465|P2|NOT COMPLETED|Overall Study||1
609249|NCT00376168|1491466|P1|NOT COMPLETED|Overall Study||2
609250|NCT00376168|1491465|P2|COMPLETED|Overall Study||15
609251|NCT00376168|1491466|P1|COMPLETED|Overall Study||14
609252|NCT00376168|1491465|P2|STARTED|Overall Study|One patient randomized but not treated|16
609253|NCT00376168|1491466|P1|STARTED|Overall Study||16
609254|NCT00375999|1491480|P1|NOT COMPLETED|Overall Study||2
609255|NCT00375999|1491480|P1|COMPLETED|Overall Study||32
609256|NCT00375999|1491480|P1|STARTED|Overall Study||34
609257|NCT00375973|1491486|P2|NOT COMPLETED|Overall Study||2
609258|NCT00375973|1491487|P1|NOT COMPLETED|Overall Study||10
609259|NCT00375973|1491486|P2|COMPLETED|Overall Study||28
609260|NCT00375973|1491487|P1|COMPLETED|Overall Study||20
609261|NCT00375973|1491486|P2|STARTED|Overall Study||30
609262|NCT00375973|1491487|P1|STARTED|Overall Study||30
609263|NCT00375934|1491507|P2|NOT COMPLETED|Overall Study||6
609264|NCT00375934|1491508|P1|NOT COMPLETED|Overall Study||3
609265|NCT00375934|1491507|P2|COMPLETED|Overall Study||95
609266|NCT00375934|1491508|P1|COMPLETED|Overall Study||96
609267|NCT00375934|1491507|P2|STARTED|Overall Study||101
609268|NCT00375934|1491508|P1|STARTED|Overall Study||99
609269|NCT00375752|1491536|P2|NOT COMPLETED|Overall Study||15
609270|NCT00375752|1491537|P1|NOT COMPLETED|Overall Study||12
609271|NCT00375752|1491536|P2|COMPLETED|Overall Study||74
609272|NCT00375752|1491537|P1|COMPLETED|Overall Study||67
609273|NCT00375752|1491536|P2|STARTED|Overall Study||89
609274|NCT00375752|1491537|P1|STARTED|Overall Study||79
609275|NCT00375713|1491553|P2|NOT COMPLETED|Overall Study||23
609276|NCT00375713|1491554|P1|NOT COMPLETED|Overall Study||20
609277|NCT00375713|1491553|P2|COMPLETED|Overall Study|23 Patients were not treated or discontinued after randomization in Cetirizine group.|211
609278|NCT00375713|1491554|P1|COMPLETED|Overall Study|20 Patients were not treated or discontinued after randomization in Levocetirizine group.|212
609279|NCT00375713|1491553|P2|STARTED|Overall Study|Randomized population (N=234).|234
609280|NCT00375713|1491554|P1|STARTED|Overall Study|Randomized population (N=232).|232
609281|NCT00375674|1491568|P2|NOT COMPLETED|Overall Study||115
609282|NCT00375674|1491569|P1|NOT COMPLETED|Overall Study||123
609283|NCT00375674|1491568|P2|COMPLETED|Overall Study||191
609284|NCT00375674|1491569|P1|COMPLETED|Overall Study||186
609285|NCT00375674|1491568|P2|As-Treated Population|Overall Study|2 were randomized but not treated: 1 was screening failure & 1 discontinued due to new liver lesions|304
609286|NCT00375674|1491569|P1|As-Treated Population|Overall Study|3 were randomized but not treated: 2 refused treatment & 1 withdrew before receiving study drug|306
609287|NCT00375674|1491568|P2|Intent-to-Treat Population|Overall Study||306
609288|NCT00375674|1491569|P1|Intent-to-Treat Population|Overall Study||309
609289|NCT00375674|1491568|P2|STARTED|Overall Study||306
609290|NCT00375674|1491569|P1|STARTED|Overall Study||309
609291|NCT00375609|1491598|P3|NOT COMPLETED|Overall Study||1
609292|NCT00375609|1491599|P2|NOT COMPLETED|Overall Study||7
609293|NCT00375609|1491600|P1|NOT COMPLETED|Overall Study||4
609294|NCT00375609|1491598|P3|COMPLETED|Overall Study||42
609295|NCT00375609|1491599|P2|COMPLETED|Overall Study||77
609296|NCT00375609|1491600|P1|COMPLETED|Overall Study||84
609297|NCT00375609|1491598|P3|STARTED|Overall Study||43
609298|NCT00375609|1491599|P2|STARTED|Overall Study||84
609299|NCT00375609|1491600|P1|STARTED|Overall Study||88
609300|NCT00375518|1491616|P2|NOT COMPLETED|Overall Study||17
609301|NCT00375518|1491617|P1|NOT COMPLETED|Overall Study||8
609302|NCT00375518|1491616|P2|COMPLETED|Overall Study||65
609303|NCT00375518|1491617|P1|COMPLETED|Overall Study||72
609304|NCT00375518|1491616|P2|STARTED|Overall Study||82
609305|NCT00375518|1491617|P1|STARTED|Overall Study||80
609306|NCT00375505|1491625|P2|NOT COMPLETED|Overall Study||2
609307|NCT00375505|1491626|P1|NOT COMPLETED|Overall Study||1
609308|NCT00375505|1491625|P2|COMPLETED|Overall Study||32
609309|NCT00375505|1491626|P1|COMPLETED|Overall Study||35
609310|NCT00375505|1491625|P2|STARTED|Overall Study||34
609311|NCT00375505|1491626|P1|STARTED|Overall Study||36
609312|NCT00375492|1491670|P2|NOT COMPLETED|Overall Study||26
609313|NCT00375492|1491671|P1|NOT COMPLETED|Overall Study||26
609314|NCT00375492|1491670|P2|COMPLETED|Overall Study||72
609315|NCT00375492|1491671|P1|COMPLETED|Overall Study||70
609316|NCT00375492|1491670|P2|STARTED|Overall Study||98
609317|NCT00375492|1491671|P1|STARTED|Overall Study||96
609318|NCT00375427|1491701|P2|NOT COMPLETED|Overall Study||74
609319|NCT00375427|1491702|P1|NOT COMPLETED|Overall Study||60
609320|NCT00375427|1491701|P2|COMPLETED|Overall Study||142
609321|NCT00375427|1491702|P1|COMPLETED|Overall Study||149
609322|NCT00375427|1491701|P2|STARTED|Overall Study||216
609323|NCT00375427|1491702|P1|STARTED|Overall Study|Total enrollment was 430 but five patients were screened but not treated.|209
609324|NCT00375219|1491727|P3|NOT COMPLETED|Overall Study||21
609325|NCT00375219|1491728|P2|NOT COMPLETED|Overall Study||20
609326|NCT00375219|1491729|P1|NOT COMPLETED|Overall Study||59
609327|NCT00375219|1491727|P3|COMPLETED|Overall Study||0
609328|NCT00375219|1491728|P2|COMPLETED|Overall Study||0
609329|NCT00375219|1491729|P1|COMPLETED|Overall Study||3
609330|NCT00375219|1491727|P3|STARTED|Overall Study||21
609331|NCT00375219|1491728|P2|STARTED|Overall Study||20
609332|NCT00375219|1491729|P1|STARTED|Overall Study||62
609333|NCT00374907|1491797|P2|NOT COMPLETED|116-Week Short-term + Long-term Period||14
609334|NCT00374907|1491798|P1|NOT COMPLETED|116-Week Short-term + Long-term Period||13
609335|NCT00374907|1491797|P2|COMPLETED|116-Week Short-term + Long-term Period||2
609336|NCT00374907|1491798|P1|COMPLETED|116-Week Short-term + Long-term Period||7
609337|NCT00374907|1491797|P2|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||15
609338|NCT00374907|1491798|P1|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||17
609339|NCT00374907|1491797|P2|STARTED|116-Week Short-term + Long-term Period||16
609340|NCT00374907|1491798|P1|STARTED|116-Week Short-term + Long-term Period||20
609341|NCT00374907|1491797|P2|NOT COMPLETED|12-Week Short-term Period||1
609342|NCT00374907|1491798|P1|NOT COMPLETED|12-Week Short-term Period||3
609343|NCT00374907|1491797|P2|COMPLETED|12-Week Short-term Period||15
609344|NCT00374907|1491798|P1|COMPLETED|12-Week Short-term Period||17
609345|NCT00374907|1491797|P2|STARTED|12-Week Short-term Period||16
609346|NCT00374907|1491798|P1|STARTED|12-Week Short-term Period||20
609347|NCT00374868|1491810|P1|NOT COMPLETED|Overall Study||36
609348|NCT00374868|1491810|P1|COMPLETED|Overall Study||2
609349|NCT00374868|1491810|P1|STARTED|Overall Study||38
609350|NCT00374842|1491824|P3|NOT COMPLETED|Overall Study||0
609351|NCT00374842|1491825|P2|NOT COMPLETED|Overall Study||0
609352|NCT00374842|1491826|P1|NOT COMPLETED|Overall Study||0
609353|NCT00374842|1491824|P3|COMPLETED|Overall Study||100
609354|NCT00374842|1491825|P2|COMPLETED|Overall Study||100
609355|NCT00374842|1491826|P1|COMPLETED|Overall Study||100
609356|NCT00374842|1491824|P3|STARTED|Overall Study||100
609357|NCT00374842|1491825|P2|STARTED|Overall Study||100
609358|NCT00374842|1491826|P1|STARTED|Overall Study||100
609359|NCT00374803|1491857|P2|NOT COMPLETED|Overall Study||0
609360|NCT00374803|1491858|P1|NOT COMPLETED|Overall Study||0
609361|NCT00374803|1491857|P2|COMPLETED|Overall Study||23
609362|NCT00374803|1491858|P1|COMPLETED|Overall Study||22
609363|NCT00374803|1491857|P2|STARTED|Overall Study||23
609364|NCT00374803|1491858|P1|STARTED|Overall Study||22
609365|NCT00374556|1491874|P2|NOT COMPLETED|Overall Study||1
609366|NCT00374556|1491875|P1|NOT COMPLETED|Overall Study||1
609367|NCT00374556|1491874|P2|COMPLETED|Overall Study||15
609368|NCT00374556|1491875|P1|COMPLETED|Overall Study||13
609369|NCT00374556|1491874|P2|STARTED|Overall Study||16
609370|NCT00374556|1491875|P1|STARTED|Overall Study||14
609371|NCT00374543|1491927|P2|NOT COMPLETED|Overall Study||0
609372|NCT00374543|1491928|P1|NOT COMPLETED|Overall Study||0
609373|NCT00374543|1491927|P2|COMPLETED|Overall Study||1
609374|NCT00374543|1491928|P1|COMPLETED|Overall Study||2
609375|NCT00374543|1491927|P2|STARTED|Overall Study||1
609376|NCT00374543|1491928|P1|STARTED|Overall Study||2
609377|NCT00374452|1491936|P2|NOT COMPLETED|Overall Study||5
609378|NCT00374452|1491937|P1|NOT COMPLETED|Overall Study||5
609379|NCT00374452|1491936|P2|COMPLETED|Overall Study||43
609380|NCT00374452|1491937|P1|COMPLETED|Overall Study||29
609381|NCT00374452|1491936|P2|Intervention Started|Overall Study||46
609382|NCT00374452|1491937|P1|Intervention Started|Overall Study||30
609383|NCT00374452|1491936|P2|STARTED|Overall Study||48
609384|NCT00374452|1491937|P1|STARTED|Overall Study||34
609385|NCT00374335|1491943|P1|NOT COMPLETED|Overall Study||0
609386|NCT00374335|1491943|P1|COMPLETED|Overall Study||261
609387|NCT00374335|1491943|P1|STARTED|Overall Study||261
609388|NCT00374322|1491950|P2|NOT COMPLETED|Overall Study||1304
609389|NCT00374322|1491951|P1|NOT COMPLETED|Overall Study||1257
609390|NCT00374322|1491950|P2|COMPLETED|Overall Study||278
609391|NCT00374322|1491951|P1|COMPLETED|Overall Study||322
609392|NCT00374322|1491950|P2|Received >=1 Dose of Study Treatment|Overall Study||1576
609393|NCT00374322|1491951|P1|Received >=1 Dose of Study Treatment|Overall Study||1571
609394|NCT00374322|1491950|P2|STARTED|Overall Study||1582
609395|NCT00374322|1491951|P1|STARTED|Overall Study||1579
609396|NCT00374244|1491989|P2|NOT COMPLETED|Overall Study||0
609397|NCT00374244|1491990|P1|NOT COMPLETED|Overall Study||0
609398|NCT00374244|1491989|P2|COMPLETED|Overall Study||14
609399|NCT00374244|1491990|P1|COMPLETED|Overall Study||14
609400|NCT00374244|1491989|P2|STARTED|Overall Study||14
609401|NCT00374244|1491990|P1|STARTED|Overall Study||14
609402|NCT00374231|1492036|P1|NOT COMPLETED|Overall Study||0
609403|NCT00374231|1492036|P1|COMPLETED|Overall Study||40
609404|NCT00374231|1492036|P1|STARTED|Overall Study||40
609405|NCT00374140|1492042|P1|NOT COMPLETED|Overall Study||2
609406|NCT00374140|1492042|P1|COMPLETED|Overall Study||38
609407|NCT00374140|1492042|P1|STARTED|Overall Study||40
609408|NCT00374127|1492049|P1|NOT COMPLETED|Overall Study||11
609409|NCT00374127|1492049|P1|COMPLETED|Overall Study||24
609410|NCT00374127|1492049|P1|STARTED|Overall Study||35
609411|NCT00374088|1492085|P2|NOT COMPLETED|Overall Study||1
609412|NCT00374088|1492086|P1|NOT COMPLETED|Overall Study||1
609413|NCT00374088|1492085|P2|COMPLETED|Overall Study||10
609414|NCT00374088|1492086|P1|COMPLETED|Overall Study||9
609415|NCT00374088|1492085|P2|STARTED|Overall Study||11
609416|NCT00374088|1492086|P1|STARTED|Overall Study||10
609417|NCT00373958|1492098|P2|NOT COMPLETED|Toddler Dose||38
609418|NCT00373958|1492099|P1|NOT COMPLETED|Toddler Dose||30
609419|NCT00373958|1492098|P2|COMPLETED|Toddler Dose||252
609420|NCT00373958|1492099|P1|COMPLETED|Toddler Dose||264
609421|NCT00373958|1492098|P2|Vaccinated Toddler Dose|Toddler Dose||265
609422|NCT00373958|1492099|P1|Vaccinated Toddler Dose|Toddler Dose||272
609423|NCT00373958|1492098|P2|Withdrawn After Infant Series|Toddler Dose||25
609424|NCT00373958|1492099|P1|Withdrawn After Infant Series|Toddler Dose||22
609425|NCT00373958|1492098|P2|STARTED|Toddler Dose||290
609426|NCT00373958|1492099|P1|STARTED|Toddler Dose||294
609427|NCT00373958|1492098|P2|NOT COMPLETED|Infant Series||42
609428|NCT00373958|1492099|P1|NOT COMPLETED|Infant Series||40
609429|NCT00373958|1492098|P2|COMPLETED|Infant Series||290
609430|NCT00373958|1492099|P1|COMPLETED|Infant Series||294
609431|NCT00373958|1492098|P2|Vaccinated Dose 3|Infant Series||300
609432|NCT00373958|1492099|P1|Vaccinated Dose 3|Infant Series||298
609433|NCT00373958|1492098|P2|Vaccinated Dose 2|Infant Series||305
609434|NCT00373958|1492099|P1|Vaccinated Dose 2|Infant Series||309
609435|NCT00373958|1492098|P2|Vaccinated Dose 1|Infant Series||331
609436|NCT00373958|1492099|P1|Vaccinated Dose 1|Infant Series||332
609437|NCT00373958|1492098|P2|STARTED|Infant Series||332
609438|NCT00373958|1492099|P1|STARTED|Infant Series|One participant was prerandomized but not consented.|334
609439|NCT00373880|1492147|P1|NOT COMPLETED|Overall Study||18
609440|NCT00373880|1492147|P1|COMPLETED|Overall Study||8
609441|NCT00373880|1492147|P1|STARTED|Overall Study||26
609442|NCT00373698|1492177|P2|NOT COMPLETED|Overall Study||0
609443|NCT00373698|1492178|P1|NOT COMPLETED|Overall Study||11
609444|NCT00373698|1492177|P2|COMPLETED|Overall Study||99
609445|NCT00373698|1492178|P1|COMPLETED|Overall Study||85
609446|NCT00373698|1492177|P2|STARTED|Overall Study||99
609447|NCT00373698|1492178|P1|STARTED|Overall Study||96
609448|NCT00373685|1492192|P2|NOT COMPLETED|Overall Study||1421
609449|NCT00373685|1492193|P1|NOT COMPLETED|Overall Study||1439
609450|NCT00373685|1492192|P2|COMPLETED|Overall Study||2611
609451|NCT00373685|1492193|P1|COMPLETED|Overall Study||2596
609452|NCT00373685|1492192|P2|Treated|Overall Study||3955
609453|NCT00373685|1492193|P1|Treated|Overall Study||3984
609454|NCT00373685|1492192|P2|STARTED|Overall Study||4032
609455|NCT00373685|1492193|P1|STARTED|Overall Study||4035
609456|NCT00373529|1492227|P1|NOT COMPLETED|Overall Study||108
609457|NCT00373529|1492227|P1|COMPLETED|Overall Study|Completed: initiated full 6 cycles of treatment. Not Completed: initiated <6 cycles of treatment|8
609458|NCT00373529|1492227|P1|Full Analysis Set|Overall Study|3 Failed Independent Confirmation of AML; 1 consent violation|112
609459|NCT00373529|1492227|P1|STARTED|Overall Study||116
609460|NCT00373490|1492239|P2|NOT COMPLETED|Overall Study||6
609461|NCT00373490|1492240|P1|NOT COMPLETED|Overall Study||9
609462|NCT00373490|1492239|P2|COMPLETED|Overall Study||0
609463|NCT00373490|1492240|P1|COMPLETED|Overall Study||1
609464|NCT00373490|1492239|P2|STARTED|Overall Study||6
609465|NCT00373490|1492240|P1|STARTED|Overall Study||10
609466|NCT00373425|1492263|P5|NOT COMPLETED|Overall Study||72
609467|NCT00373425|1492264|P4|NOT COMPLETED|Overall Study||11
609468|NCT00373425|1492265|P3|NOT COMPLETED|Overall Study||134
609469|NCT00373425|1492266|P2|NOT COMPLETED|Overall Study||153
609470|NCT00373425|1492267|P1|NOT COMPLETED|Overall Study||370
609471|NCT00373425|1492263|P5|COMPLETED|Overall Study|Completed 2 years of study treatment|60
609472|NCT00373425|1492264|P4|COMPLETED|Overall Study|Completed 2 years of study treatment|0
609473|NCT00373425|1492265|P3|COMPLETED|Overall Study|Completed 2 years of study treatment|0
609474|NCT00373425|1492266|P2|COMPLETED|Overall Study|Completed 2 years of study treatment|197
609475|NCT00373425|1492267|P1|COMPLETED|Overall Study|Completed 2 years of study treatment|253
609476|NCT00373425|1492263|P5|Received Treatment|Overall Study||132
609477|NCT00373425|1492264|P4|Received Treatment|Overall Study||7
609478|NCT00373425|1492265|P3|Received Treatment|Overall Study||134
609479|NCT00373425|1492266|P2|Received Treatment|Overall Study||342
609480|NCT00373425|1492267|P1|Received Treatment|Overall Study||612
609481|NCT00373425|1492263|P5|STARTED|Overall Study||132
609482|NCT00373425|1492264|P4|STARTED|Overall Study||11
609483|NCT00373425|1492265|P3|STARTED|Overall Study||134
609484|NCT00373425|1492266|P2|STARTED|Overall Study||350
609485|NCT00373425|1492267|P1|STARTED|Overall Study||623
609486|NCT00373386|1492292|P1|NOT COMPLETED|Overall Study||0
609487|NCT00373386|1492292|P1|COMPLETED|Overall Study||9
609488|NCT00373386|1492292|P1|STARTED|Overall Study||9
609489|NCT00373360|1492302|P1|NOT COMPLETED|Overall Study||0
609490|NCT00373360|1492302|P1|COMPLETED|Overall Study||10
609491|NCT00373360|1492302|P1|STARTED|Overall Study||10
609492|NCT00373334|1492333|P3|NOT COMPLETED|Overall Study||13
609493|NCT00373334|1492334|P2|NOT COMPLETED|Overall Study||18
609494|NCT00373334|1492335|P1|NOT COMPLETED|Overall Study||10
609495|NCT00373334|1492333|P3|COMPLETED|Overall Study||32
609496|NCT00373334|1492334|P2|COMPLETED|Overall Study||32
609497|NCT00373334|1492335|P1|COMPLETED|Overall Study||33
609498|NCT00373334|1492333|P3|STARTED|Overall Study||45
609499|NCT00373334|1492334|P2|STARTED|Overall Study||50
609500|NCT00373334|1492335|P1|STARTED|Overall Study||43
609501|NCT00373295|1492349|P6|NOT COMPLETED|Intervention 3 (8 Days)||0
609502|NCT00373295|1492350|P5|NOT COMPLETED|Intervention 3 (8 Days)||0
609503|NCT00373295|1492351|P4|NOT COMPLETED|Intervention 3 (8 Days)||0
609504|NCT00373295|1492352|P3|NOT COMPLETED|Intervention 3 (8 Days)||0
609505|NCT00373295|1492353|P2|NOT COMPLETED|Intervention 3 (8 Days)||0
609506|NCT00373295|1492354|P1|NOT COMPLETED|Intervention 3 (8 Days)||0
609507|NCT00373295|1492349|P6|COMPLETED|Intervention 3 (8 Days)||2
609508|NCT00373295|1492350|P5|COMPLETED|Intervention 3 (8 Days)||2
609509|NCT00373295|1492351|P4|COMPLETED|Intervention 3 (8 Days)||2
609510|NCT00373295|1492352|P3|COMPLETED|Intervention 3 (8 Days)||1
609511|NCT00373295|1492353|P2|COMPLETED|Intervention 3 (8 Days)||1
609512|NCT00373295|1492354|P1|COMPLETED|Intervention 3 (8 Days)||2
609513|NCT00373295|1492349|P6|STARTED|Intervention 3 (8 Days)||2
609514|NCT00373295|1492350|P5|STARTED|Intervention 3 (8 Days)||2
609515|NCT00373295|1492351|P4|STARTED|Intervention 3 (8 Days)||2
609516|NCT00373295|1492352|P3|STARTED|Intervention 3 (8 Days)||1
609517|NCT00373295|1492353|P2|STARTED|Intervention 3 (8 Days)||1
609518|NCT00373295|1492354|P1|STARTED|Intervention 3 (8 Days)||2
609519|NCT00373295|1492349|P6|NOT COMPLETED|Intervention 2 (8 Days)||0
609520|NCT00373295|1492350|P5|NOT COMPLETED|Intervention 2 (8 Days)||0
609521|NCT00373295|1492351|P4|NOT COMPLETED|Intervention 2 (8 Days)||0
609522|NCT00373295|1492352|P3|NOT COMPLETED|Intervention 2 (8 Days)||0
609523|NCT00373295|1492353|P2|NOT COMPLETED|Intervention 2 (8 Days)||0
609524|NCT00373295|1492354|P1|NOT COMPLETED|Intervention 2 (8 Days)||0
609525|NCT00373295|1492349|P6|COMPLETED|Intervention 2 (8 Days)||2
609526|NCT00373295|1492350|P5|COMPLETED|Intervention 2 (8 Days)||2
609527|NCT00373295|1492351|P4|COMPLETED|Intervention 2 (8 Days)||2
609528|NCT00373295|1492352|P3|COMPLETED|Intervention 2 (8 Days)||1
609529|NCT00373295|1492353|P2|COMPLETED|Intervention 2 (8 Days)||1
609530|NCT00373295|1492354|P1|COMPLETED|Intervention 2 (8 Days)||2
609531|NCT00373295|1492349|P6|STARTED|Intervention 2 (8 Days)||2
609532|NCT00373295|1492350|P5|STARTED|Intervention 2 (8 Days)||2
609533|NCT00373295|1492351|P4|STARTED|Intervention 2 (8 Days)||2
609534|NCT00373295|1492352|P3|STARTED|Intervention 2 (8 Days)||1
609535|NCT00373295|1492353|P2|STARTED|Intervention 2 (8 Days)||1
609536|NCT00373295|1492354|P1|STARTED|Intervention 2 (8 Days)||2
609537|NCT00373295|1492349|P6|NOT COMPLETED|Intervention 1 (8 Days)||0
609538|NCT00373295|1492350|P5|NOT COMPLETED|Intervention 1 (8 Days)||1
609539|NCT00373295|1492351|P4|NOT COMPLETED|Intervention 1 (8 Days)||0
609540|NCT00373295|1492352|P3|NOT COMPLETED|Intervention 1 (8 Days)||0
609541|NCT00373295|1492353|P2|NOT COMPLETED|Intervention 1 (8 Days)||2
609542|NCT00373295|1492354|P1|NOT COMPLETED|Intervention 1 (8 Days)||0
609543|NCT00373295|1492349|P6|COMPLETED|Intervention 1 (8 Days)||2
609544|NCT00373295|1492350|P5|COMPLETED|Intervention 1 (8 Days)||2
609545|NCT00373295|1492351|P4|COMPLETED|Intervention 1 (8 Days)||2
609546|NCT00373295|1492352|P3|COMPLETED|Intervention 1 (8 Days)||1
609547|NCT00373295|1492353|P2|COMPLETED|Intervention 1 (8 Days)||1
609548|NCT00373295|1492354|P1|COMPLETED|Intervention 1 (8 Days)||2
609549|NCT00373295|1492349|P6|STARTED|Intervention 1 (8 Days)||2
609550|NCT00373295|1492350|P5|STARTED|Intervention 1 (8 Days)||3
609551|NCT00373295|1492351|P4|STARTED|Intervention 1 (8 Days)||2
609552|NCT00373295|1492352|P3|STARTED|Intervention 1 (8 Days)||1
609553|NCT00373295|1492353|P2|STARTED|Intervention 1 (8 Days)||3
609554|NCT00373295|1492354|P1|STARTED|Intervention 1 (8 Days)||2
609555|NCT00373269|1492364|P2|NOT COMPLETED|Overall Study||0
609556|NCT00373269|1492365|P1|NOT COMPLETED|Overall Study||0
609557|NCT00373269|1492364|P2|COMPLETED|Overall Study||10
609558|NCT00373269|1492365|P1|COMPLETED|Overall Study||11
609559|NCT00373269|1492364|P2|STARTED|Overall Study||10
609560|NCT00373269|1492365|P1|STARTED|Overall Study||11
609561|NCT00373256|1492375|P2|NOT COMPLETED|Overall Study||247
609562|NCT00373256|1492376|P1|NOT COMPLETED|Overall Study||241
609563|NCT00373256|1492375|P2|COMPLETED|Overall Study||0
609564|NCT00373256|1492376|P1|COMPLETED|Overall Study||0
609565|NCT00373256|1492375|P2|Treated|Overall Study||236
609566|NCT00373256|1492376|P1|Treated|Overall Study||235
609567|NCT00373256|1492375|P2|STARTED|Overall Study||247
609568|NCT00373256|1492376|P1|STARTED|Overall Study||241
609569|NCT00373113|1492402|P2|NOT COMPLETED|Overall Study||244
609570|NCT00373113|1492403|P1|NOT COMPLETED|Overall Study||238
609571|NCT00373113|1492402|P2|COMPLETED|Overall Study||0
609572|NCT00373113|1492403|P1|COMPLETED|Overall Study||0
609573|NCT00373113|1492402|P2|Received Treatment|Overall Study||240
609574|NCT00373113|1492403|P1|Received Treatment|Overall Study||238
609575|NCT00373113|1492402|P2|STARTED|Overall Study||244
609576|NCT00373113|1492403|P1|STARTED|Overall Study||238
609577|NCT00372996|1492425|P4|NOT COMPLETED|Overall Study||20
609578|NCT00372996|1492426|P3|NOT COMPLETED|Overall Study||28
609579|NCT00372996|1492427|P2|NOT COMPLETED|Overall Study||14
609580|NCT00372996|1492428|P1|NOT COMPLETED|Overall Study||37
609581|NCT00372996|1492425|P4|COMPLETED|Overall Study||23
609582|NCT00372996|1492426|P3|COMPLETED|Overall Study||33
609583|NCT00372996|1492427|P2|COMPLETED|Overall Study||22
609584|NCT00372996|1492428|P1|COMPLETED|Overall Study||42
609585|NCT00372996|1492425|P4|STARTED|Overall Study||43
609586|NCT00372996|1492426|P3|STARTED|Overall Study||61
609587|NCT00372996|1492427|P2|STARTED|Overall Study||36
609588|NCT00372996|1492428|P1|STARTED|Overall Study||79
609589|NCT00372970|1492454|P2|NOT COMPLETED|Overall Study||0
609590|NCT00372970|1492455|P1|NOT COMPLETED|Overall Study||0
609591|NCT00372970|1492454|P2|COMPLETED|Overall Study||16
609592|NCT00372970|1492455|P1|COMPLETED|Overall Study||16
609593|NCT00372970|1492454|P2|STARTED|Overall Study||16
609594|NCT00372970|1492455|P1|STARTED|Overall Study||16
609595|NCT00372957|1492464|P3|NOT COMPLETED|Overall Study||0
609596|NCT00372957|1492465|P2|NOT COMPLETED|Overall Study||0
609597|NCT00372957|1492466|P1|NOT COMPLETED|Overall Study||0
609598|NCT00372957|1492464|P3|COMPLETED|Overall Study||10
609599|NCT00372957|1492465|P2|COMPLETED|Overall Study||10
609600|NCT00372957|1492466|P1|COMPLETED|Overall Study||10
609601|NCT00372957|1492464|P3|STARTED|Overall Study||10
609602|NCT00372957|1492465|P2|STARTED|Overall Study||10
609603|NCT00372957|1492466|P1|STARTED|Overall Study||10
609604|NCT00372775|1492513|P1|NOT COMPLETED|Overall Study||63
609605|NCT00372775|1492513|P1|COMPLETED|Overall Study||3
609606|NCT00372775|1492513|P1|Received Treatment|Overall Study||64
609607|NCT00372775|1492513|P1|STARTED|Overall Study||66
609608|NCT00372697|1492535|P2|NOT COMPLETED|Overall Study||1
609609|NCT00372697|1492536|P1|NOT COMPLETED|Overall Study||1
609610|NCT00372697|1492535|P2|COMPLETED|Overall Study||11
609611|NCT00372697|1492536|P1|COMPLETED|Overall Study||15
609612|NCT00372697|1492535|P2|STARTED|Overall Study||12
609613|NCT00372697|1492536|P1|STARTED|Overall Study||16
609614|NCT00372619|1492561|P7|NOT COMPLETED|Overall Study||0
609615|NCT00372619|1492562|P6|NOT COMPLETED|Overall Study||3
609616|NCT00372619|1492563|P5|NOT COMPLETED|Overall Study||0
609617|NCT00372619|1492564|P4|NOT COMPLETED|Overall Study||0
609618|NCT00372619|1492565|P3|NOT COMPLETED|Overall Study||0
609619|NCT00372619|1492566|P2|NOT COMPLETED|Overall Study||0
609620|NCT00372619|1492567|P1|NOT COMPLETED|Overall Study||0
609621|NCT00372619|1492561|P7|COMPLETED|Overall Study||2
609622|NCT00372619|1492562|P6|COMPLETED|Overall Study||39
609623|NCT00372619|1492563|P5|COMPLETED|Overall Study||7
609624|NCT00372619|1492564|P4|COMPLETED|Overall Study||10
609625|NCT00372619|1492565|P3|COMPLETED|Overall Study||3
609626|NCT00372619|1492566|P2|COMPLETED|Overall Study||2
609627|NCT00372619|1492567|P1|COMPLETED|Overall Study||8
609628|NCT00372619|1492561|P7|STARTED|Overall Study||2
609629|NCT00372619|1492562|P6|STARTED|Overall Study||42
609630|NCT00372619|1492563|P5|STARTED|Overall Study||7
609631|NCT00372619|1492564|P4|STARTED|Overall Study||10
609632|NCT00372619|1492565|P3|STARTED|Overall Study||3
609633|NCT00372619|1492566|P2|STARTED|Overall Study||2
609634|NCT00372619|1492567|P1|STARTED|Overall Study||8
609635|NCT00372593|1492600|P3|NOT COMPLETED|Overall Study||4
609636|NCT00372593|1492601|P2|NOT COMPLETED|Overall Study||198
609637|NCT00372593|1492602|P1|NOT COMPLETED|Overall Study||204
609638|NCT00372593|1492600|P3|COMPLETED|Overall Study||3
609639|NCT00372593|1492601|P2|COMPLETED|Overall Study||334
609640|NCT00372593|1492602|P1|COMPLETED|Overall Study||327
609641|NCT00372593|1492600|P3|STARTED|Overall Study||7
609642|NCT00372593|1492601|P2|STARTED|Overall Study||532
609643|NCT00372593|1492602|P1|STARTED|Overall Study||531
609644|NCT00372567|1492631|P3|NOT COMPLETED|Phase 3 Study||12
609645|NCT00372567|1492632|P2|NOT COMPLETED|Phase 3 Study||26
609646|NCT00372567|1492633|P1|NOT COMPLETED|Phase 3 Study||31
609647|NCT00372567|1492631|P3|COMPLETED|Phase 3 Study||0
609648|NCT00372567|1492632|P2|COMPLETED|Phase 3 Study||0
609649|NCT00372567|1492633|P1|COMPLETED|Phase 3 Study||0
609650|NCT00372567|1492631|P3|Received Treatment|Phase 3 Study||12
609651|NCT00372567|1492632|P2|Received Treatment|Phase 3 Study||25
609652|NCT00372567|1492633|P1|Received Treatment|Phase 3 Study||31
609653|NCT00372567|1492631|P3|STARTED|Phase 3 Study||12
609654|NCT00372567|1492632|P2|STARTED|Phase 3 Study||26
609655|NCT00372567|1492633|P1|STARTED|Phase 3 Study||31
609656|NCT00372567|1492631|P3|NOT COMPLETED|Phase 1 Sub-study||0
609657|NCT00372567|1492632|P2|NOT COMPLETED|Phase 1 Sub-study||0
609658|NCT00372567|1492633|P1|NOT COMPLETED|Phase 1 Sub-study||0
609659|NCT00372567|1492631|P3|COMPLETED|Phase 1 Sub-study||12
609660|NCT00372567|1492632|P2|COMPLETED|Phase 1 Sub-study||0
609661|NCT00372567|1492633|P1|COMPLETED|Phase 1 Sub-study||0
609662|NCT00372567|1492631|P3|STARTED|Phase 1 Sub-study||12
609663|NCT00372567|1492632|P2|STARTED|Phase 1 Sub-study||0
609664|NCT00372567|1492633|P1|STARTED|Phase 1 Sub-study||0
609665|NCT00372528|1492661|P1|NOT COMPLETED|Overall Study||21
609666|NCT00372528|1492661|P1|COMPLETED|Overall Study||0
609667|NCT00372528|1492661|P1|STARTED|Overall Study||21
609668|NCT00372489|1492666|P1|NOT COMPLETED|Overall Study||79
609669|NCT00372489|1492666|P1|COMPLETED|Overall Study||2
609670|NCT00372489|1492666|P1|STARTED|Overall Study||81
609671|NCT00372424|1492670|P1|NOT COMPLETED|Overall Study||26
609672|NCT00372424|1492670|P1|COMPLETED|Overall Study||0
609673|NCT00372424|1492670|P1|Treated|Overall Study||25
609674|NCT00372424|1492670|P1|STARTED|Overall Study||26
609675|NCT00372411|1492684|P3|NOT COMPLETED|Overall Study||3
609676|NCT00372411|1492685|P2|NOT COMPLETED|Overall Study||8
609677|NCT00372411|1492686|P1|NOT COMPLETED|Overall Study||5
609678|NCT00372411|1492684|P3|COMPLETED|Overall Study||25
609679|NCT00372411|1492685|P2|COMPLETED|Overall Study||42
609680|NCT00372411|1492686|P1|COMPLETED|Overall Study||44
609681|NCT00372411|1492684|P3|STARTED|Overall Study||28
609682|NCT00372411|1492685|P2|STARTED|Overall Study||50
609683|NCT00372411|1492686|P1|STARTED|Overall Study||49
609684|NCT00372385|1492710|P4|NOT COMPLETED|Overall Study||8
609685|NCT00372385|1492711|P3|NOT COMPLETED|Overall Study||10
609686|NCT00372385|1492712|P2|NOT COMPLETED|Overall Study||20
609687|NCT00372385|1492713|P1|NOT COMPLETED|Overall Study||33
609688|NCT00372385|1492710|P4|COMPLETED|Overall Study||70
609689|NCT00372385|1492711|P3|COMPLETED|Overall Study||72
609690|NCT00372385|1492712|P2|COMPLETED|Overall Study||61
609691|NCT00372385|1492713|P1|COMPLETED|Overall Study||49
609692|NCT00372385|1492710|P4|STARTED|Overall Study||78
609693|NCT00372385|1492711|P3|STARTED|Overall Study||82
609694|NCT00372385|1492712|P2|STARTED|Overall Study||81
609695|NCT00372385|1492713|P1|STARTED|Overall Study||82
609696|NCT00372190|1492742|P2|NOT COMPLETED|Overall Study||1
609697|NCT00372190|1492743|P1|NOT COMPLETED|Overall Study||3
609698|NCT00372190|1492742|P2|COMPLETED|Overall Study||96
609699|NCT00372190|1492743|P1|COMPLETED|Overall Study||90
609700|NCT00372190|1492742|P2|STARTED|Overall Study|99 were allocated to conventional arm, however 2 never underwent any surgery|97
609701|NCT00372190|1492743|P1|STARTED|Overall Study|95 were allocated to mesh group, however 2 never underwent any surgery|93
609702|NCT00372112|1492759|P4|NOT COMPLETED|Overall Study||4
609703|NCT00372112|1492760|P3|NOT COMPLETED|Overall Study||4
609704|NCT00372112|1492761|P2|NOT COMPLETED|Overall Study||1
609705|NCT00372112|1492762|P1|NOT COMPLETED|Overall Study||1
609706|NCT00372112|1492759|P4|COMPLETED|Overall Study||14
609707|NCT00372112|1492760|P3|COMPLETED|Overall Study||13
609708|NCT00372112|1492761|P2|COMPLETED|Overall Study||15
609709|NCT00372112|1492762|P1|COMPLETED|Overall Study||16
609710|NCT00372112|1492759|P4|STARTED|Overall Study||18
609711|NCT00372112|1492760|P3|STARTED|Overall Study||17
609712|NCT00372112|1492761|P2|STARTED|Overall Study||16
609713|NCT00372112|1492762|P1|STARTED|Overall Study||17
609714|NCT00372060|1492893|P2|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||8
609715|NCT00372060|1492894|P1|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||14
609716|NCT00372060|1492893|P2|COMPLETED|Period II - Open-label (Weeks 12-52)||59
609717|NCT00372060|1492894|P1|COMPLETED|Period II - Open-label (Weeks 12-52)||49
609718|NCT00372060|1492893|P2|STARTED|Period II - Open-label (Weeks 12-52)||67
609719|NCT00372060|1492894|P1|STARTED|Period II - Open-label (Weeks 12-52)||63
609720|NCT00372060|1492893|P2|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||1
609721|NCT00372060|1492894|P1|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||3
609722|NCT00372060|1492893|P2|COMPLETED|Period I - Double-blind (Weeks 0-12)||67
609723|NCT00372060|1492894|P1|COMPLETED|Period I - Double-blind (Weeks 0-12)||63
609724|NCT00372060|1492893|P2|STARTED|Period I - Double-blind (Weeks 0-12)||68
609725|NCT00372060|1492894|P1|STARTED|Period I - Double-blind (Weeks 0-12)|The planned number of enrolled patients was 130. The actual number of enrolled patients was 134.|66
609726|NCT00371865|1492909|P2|NOT COMPLETED|Overall Study||14
609727|NCT00371865|1492910|P1|NOT COMPLETED|Overall Study||15
609728|NCT00371865|1492909|P2|COMPLETED|Overall Study|8 withdrew before starting the intervention. 6 withdrew after starting the intervention.|43
609729|NCT00371865|1492910|P1|COMPLETED|Overall Study|7 withdrew before starting the intervention. 8 withdrew after starting the intervention.|42
609730|NCT00371865|1492909|P2|STARTED|Overall Study||57
609731|NCT00371865|1492910|P1|STARTED|Overall Study||57
609732|NCT00371839|1492927|P3|NOT COMPLETED|Overall Study||2
609733|NCT00371839|1492928|P2|NOT COMPLETED|Overall Study||7
609734|NCT00371839|1492929|P1|NOT COMPLETED|Overall Study||17
609735|NCT00371839|1492927|P3|COMPLETED|Overall Study||7
609736|NCT00371839|1492928|P2|COMPLETED|Overall Study||13
609737|NCT00371839|1492929|P1|COMPLETED|Overall Study||32
609738|NCT00371839|1492927|P3|STARTED|Overall Study||9
609739|NCT00371839|1492928|P2|STARTED|Overall Study||20
609740|NCT00371839|1492929|P1|STARTED|Overall Study||49
609741|NCT00371826|1492938|P3|NOT COMPLETED|Extension Phase (24 Months)||2
609742|NCT00371826|1492939|P2|NOT COMPLETED|Extension Phase (24 Months)||10
609743|NCT00371826|1492940|P1|NOT COMPLETED|Extension Phase (24 Months)||5
609744|NCT00371826|1492938|P3|COMPLETED|Extension Phase (24 Months)||3
609745|NCT00371826|1492939|P2|COMPLETED|Extension Phase (24 Months)||29
609746|NCT00371826|1492940|P1|COMPLETED|Extension Phase (24 Months)||18
609747|NCT00371826|1492938|P3|Safety Set|Extension Phase (24 Months)|Patient withdrawn as per DMC suggestion had no efficacy data, but was included in safety set.|5
609748|NCT00371826|1492939|P2|Safety Set|Extension Phase (24 Months)|One patient mis-randomised to 1st arm but treated in this arm, evaluated for safety in this arm.|40
609749|NCT00371826|1492940|P1|Safety Set|Extension Phase (24 Months)|One patient randomized to this arm, was treated with the control regimen (CNI+MPA+Steroid)|22
609750|NCT00371826|1492938|P3|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)|One patient entered extension, was withdrawn (no efficacy data in extension) due to DMC suggestion|4
609751|NCT00371826|1492939|P2|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||39
609752|NCT00371826|1492940|P1|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||23
609753|NCT00371826|1492938|P3|STARTED|Extension Phase (24 Months)|One patient completed core, did not wish to continue to extension.|5
609754|NCT00371826|1492939|P2|STARTED|Extension Phase (24 Months)||39
609755|NCT00371826|1492940|P1|STARTED|Extension Phase (24 Months)|2 patients who completed 12 month core did not wish to continue in extension.|23
609756|NCT00371826|1492938|P3|NOT COMPLETED|Core Phase (12 Months)||24
609757|NCT00371826|1492939|P2|NOT COMPLETED|Core Phase (12 Months)||8
609758|NCT00371826|1492940|P1|NOT COMPLETED|Core Phase (12 Months)||24
609759|NCT00371826|1492938|P3|COMPLETED|Core Phase (12 Months)||6
609760|NCT00371826|1492939|P2|COMPLETED|Core Phase (12 Months)||39
609761|NCT00371826|1492940|P1|COMPLETED|Core Phase (12 Months)|"Completed means patients were still on study medication by month 12."|25
609762|NCT00371826|1492938|P3|Modified Intent to Treat (mITT)|Core Phase (12 Months)||6
609763|NCT00371826|1492939|P2|Modified Intent to Treat (mITT)|Core Phase (12 Months)||39
609764|NCT00371826|1492940|P1|Modified Intent to Treat (mITT)|Core Phase (12 Months)||27
609765|NCT00371826|1492938|P3|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||20
609766|NCT00371826|1492939|P2|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||44
609767|NCT00371826|1492940|P1|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||46
609768|NCT00371826|1492938|P3|STARTED|Core Phase (12 Months)||30
609769|NCT00371826|1492939|P2|STARTED|Core Phase (12 Months)||47
609861|NCT00371397|1493274|P6|COMPLETED|Session 3||4
609862|NCT00371397|1493275|P5|COMPLETED|Session 3||3
609770|NCT00371826|1492940|P1|STARTED|Core Phase (12 Months)|"Started indicates patients in Randomized, Intent to treat (ITT) and Safety set."|49
609771|NCT00371787|1493064|P2|NOT COMPLETED|Overall Study||1
609772|NCT00371787|1493065|P1|NOT COMPLETED|Overall Study||3
609773|NCT00371787|1493064|P2|COMPLETED|Overall Study||11
609774|NCT00371787|1493065|P1|COMPLETED|Overall Study||23
609775|NCT00371787|1493064|P2|STARTED|Overall Study||12
609776|NCT00371787|1493065|P1|STARTED|Overall Study||26
609777|NCT00371761|1493079|P2|NOT COMPLETED|Overall Study||10
609778|NCT00371761|1493080|P1|NOT COMPLETED|Overall Study||8
609779|NCT00371761|1493079|P2|COMPLETED|Overall Study||2
609780|NCT00371761|1493080|P1|COMPLETED|Overall Study||5
609781|NCT00371761|1493079|P2|STARTED|Overall Study||12
609782|NCT00371761|1493080|P1|STARTED|Overall Study||13
609783|NCT00371683|1493088|P2|NOT COMPLETED|Follow-Up Period - Randomized Patients||72
609784|NCT00371683|1493089|P1|NOT COMPLETED|Follow-Up Period - Randomized Patients||61
609785|NCT00371683|1493088|P2|COMPLETED|Follow-Up Period - Randomized Patients||1461
609786|NCT00371683|1493089|P1|COMPLETED|Follow-Up Period - Randomized Patients||1492
609787|NCT00371683|1493088|P2|STARTED|Follow-Up Period - Randomized Patients||1533
609788|NCT00371683|1493089|P1|STARTED|Follow-Up Period - Randomized Patients||1553
609789|NCT00371683|1493088|P2|NOT COMPLETED|DB Treatment Period-Randomized Patients||107
609790|NCT00371683|1493089|P1|NOT COMPLETED|DB Treatment Period-Randomized Patients||90
609791|NCT00371683|1493088|P2|COMPLETED|DB Treatment Period-Randomized Patients||1489
609792|NCT00371683|1493089|P1|COMPLETED|DB Treatment Period-Randomized Patients||1509
609793|NCT00371683|1493088|P2|STARTED|DB Treatment Period-Randomized Patients||1596
609794|NCT00371683|1493089|P1|STARTED|DB Treatment Period-Randomized Patients||1599
609795|NCT00371644|1493143|P2|NOT COMPLETED|Overall Study||13
609796|NCT00371644|1493144|P1|NOT COMPLETED|Overall Study||28
609797|NCT00371644|1493143|P2|COMPLETED|Overall Study||44
609798|NCT00371644|1493144|P1|COMPLETED|Overall Study||44
609799|NCT00371644|1493143|P2|STARTED|Overall Study||57
609800|NCT00371644|1493144|P1|STARTED|Overall Study||72
609801|NCT00371631|1493150|P1|NOT COMPLETED|Overall Study||0
609802|NCT00371631|1493150|P1|COMPLETED|Overall Study||13
609803|NCT00371631|1493150|P1|STARTED|Overall Study||13
609804|NCT00371566|1493157|P2|NOT COMPLETED|Follow Up Phase||7
609805|NCT00371566|1493158|P1|NOT COMPLETED|Follow Up Phase||3
609806|NCT00371566|1493157|P2|COMPLETED|Follow Up Phase||58
609807|NCT00371566|1493158|P1|COMPLETED|Follow Up Phase||28
609808|NCT00371566|1493157|P2|STARTED|Follow Up Phase||65
609809|NCT00371566|1493158|P1|STARTED|Follow Up Phase||31
609810|NCT00371566|1493157|P2|NOT COMPLETED|Chemoradiation Phase||3
609811|NCT00371566|1493158|P1|NOT COMPLETED|Chemoradiation Phase||5
609812|NCT00371566|1493157|P2|COMPLETED|Chemoradiation Phase||65
609813|NCT00371566|1493158|P1|COMPLETED|Chemoradiation Phase||31
609814|NCT00371566|1493157|P2|STARTED|Chemoradiation Phase||68
609815|NCT00371566|1493158|P1|STARTED|Chemoradiation Phase||36
609816|NCT00371566|1493157|P2|NOT COMPLETED|Treatment Phase||3
609817|NCT00371566|1493158|P1|NOT COMPLETED|Treatment Phase||0
609818|NCT00371566|1493157|P2|COMPLETED|Treatment Phase|1 screen failure included in the ITT population|68
609819|NCT00371566|1493158|P1|COMPLETED|Treatment Phase||36
609820|NCT00371566|1493157|P2|STARTED|Treatment Phase||71
609821|NCT00371566|1493158|P1|STARTED|Treatment Phase||36
609822|NCT00371540|1493230|P2|NOT COMPLETED|Overall Study||9
609823|NCT00371540|1493231|P1|NOT COMPLETED|Overall Study||10
609824|NCT00371540|1493230|P2|COMPLETED|Overall Study||87
609825|NCT00371540|1493231|P1|COMPLETED|Overall Study||102
609826|NCT00371540|1493230|P2|STARTED|Overall Study||96
609827|NCT00371540|1493231|P1|STARTED|Overall Study||112
609828|NCT00371462|1493243|P2|NOT COMPLETED|Overall Study||8
609829|NCT00371462|1493244|P1|NOT COMPLETED|Overall Study||8
609830|NCT00371462|1493243|P2|COMPLETED|Overall Study||27
609831|NCT00371462|1493244|P1|COMPLETED|Overall Study||27
609832|NCT00371462|1493243|P2|STARTED|Overall Study||35
609833|NCT00371462|1493244|P1|STARTED|Overall Study||35
609834|NCT00371449|1493250|P1|NOT COMPLETED|Overall Study||0
609835|NCT00371449|1493250|P1|COMPLETED|Overall Study||120
609836|NCT00371449|1493250|P1|STARTED|Overall Study||120
609837|NCT00371436|1493261|P2|NOT COMPLETED|Overall Study||21
609838|NCT00371436|1493262|P1|NOT COMPLETED|Overall Study||34
609839|NCT00371436|1493261|P2|COMPLETED|Overall Study||68
609840|NCT00371436|1493262|P1|COMPLETED|Overall Study||58
609841|NCT00371436|1493261|P2|STARTED|Overall Study||89
609842|NCT00371436|1493262|P1|STARTED|Overall Study||92
609843|NCT00371397|1493268|P12|NOT COMPLETED|Session 3||0
609844|NCT00371397|1493269|P11|NOT COMPLETED|Session 3||0
609845|NCT00371397|1493270|P10|NOT COMPLETED|Session 3||0
609846|NCT00371397|1493271|P9|NOT COMPLETED|Session 3||0
609847|NCT00371397|1493272|P8|NOT COMPLETED|Session 3||0
609848|NCT00371397|1493273|P7|NOT COMPLETED|Session 3||0
609849|NCT00371397|1493274|P6|NOT COMPLETED|Session 3||0
609850|NCT00371397|1493275|P5|NOT COMPLETED|Session 3||0
609851|NCT00371397|1493276|P4|NOT COMPLETED|Session 3||0
609852|NCT00371397|1493277|P3|NOT COMPLETED|Session 3||0
609853|NCT00371397|1493278|P2|NOT COMPLETED|Session 3||0
609854|NCT00371397|1493279|P1|NOT COMPLETED|Session 3||0
609855|NCT00371397|1493268|P12|COMPLETED|Session 3||2
609856|NCT00371397|1493269|P11|COMPLETED|Session 3||4
609857|NCT00371397|1493270|P10|COMPLETED|Session 3||5
609858|NCT00371397|1493271|P9|COMPLETED|Session 3||6
609859|NCT00371397|1493272|P8|COMPLETED|Session 3||4
609860|NCT00371397|1493273|P7|COMPLETED|Session 3||4
609863|NCT00371397|1493276|P4|COMPLETED|Session 3||2
609864|NCT00371397|1493277|P3|COMPLETED|Session 3||5
609865|NCT00371397|1493278|P2|COMPLETED|Session 3||7
609866|NCT00371397|1493279|P1|COMPLETED|Session 3||4
609867|NCT00371397|1493268|P12|STARTED|Session 3||2
609868|NCT00371397|1493269|P11|STARTED|Session 3||4
609869|NCT00371397|1493270|P10|STARTED|Session 3||5
609870|NCT00371397|1493271|P9|STARTED|Session 3||6
609871|NCT00371397|1493272|P8|STARTED|Session 3||4
609872|NCT00371397|1493273|P7|STARTED|Session 3||4
609873|NCT00371397|1493274|P6|STARTED|Session 3||4
609874|NCT00371397|1493275|P5|STARTED|Session 3||3
609875|NCT00371397|1493276|P4|STARTED|Session 3||2
609876|NCT00371397|1493277|P3|STARTED|Session 3||5
609877|NCT00371397|1493278|P2|STARTED|Session 3||7
609878|NCT00371397|1493279|P1|STARTED|Session 3||4
609879|NCT00371397|1493268|P12|NOT COMPLETED|Session 2||0
609880|NCT00371397|1493269|P11|NOT COMPLETED|Session 2||0
609881|NCT00371397|1493270|P10|NOT COMPLETED|Session 2||0
609882|NCT00371397|1493271|P9|NOT COMPLETED|Session 2||0
609883|NCT00371397|1493272|P8|NOT COMPLETED|Session 2||0
609884|NCT00371397|1493273|P7|NOT COMPLETED|Session 2||0
609885|NCT00371397|1493274|P6|NOT COMPLETED|Session 2||0
609886|NCT00371397|1493275|P5|NOT COMPLETED|Session 2||0
609887|NCT00371397|1493276|P4|NOT COMPLETED|Session 2||0
609888|NCT00371397|1493277|P3|NOT COMPLETED|Session 2||0
609889|NCT00371397|1493278|P2|NOT COMPLETED|Session 2||0
609890|NCT00371397|1493279|P1|NOT COMPLETED|Session 2||0
609891|NCT00371397|1493268|P12|COMPLETED|Session 2||2
609892|NCT00371397|1493269|P11|COMPLETED|Session 2||4
609893|NCT00371397|1493270|P10|COMPLETED|Session 2||5
609894|NCT00371397|1493271|P9|COMPLETED|Session 2||6
609895|NCT00371397|1493272|P8|COMPLETED|Session 2||4
609896|NCT00371397|1493273|P7|COMPLETED|Session 2||4
609897|NCT00371397|1493274|P6|COMPLETED|Session 2||4
609898|NCT00371397|1493275|P5|COMPLETED|Session 2||3
609899|NCT00371397|1493276|P4|COMPLETED|Session 2||2
609900|NCT00371397|1493277|P3|COMPLETED|Session 2||5
609901|NCT00371397|1493278|P2|COMPLETED|Session 2||7
609902|NCT00371397|1493279|P1|COMPLETED|Session 2||4
609903|NCT00371397|1493268|P12|STARTED|Session 2||2
609904|NCT00371397|1493269|P11|STARTED|Session 2||4
609905|NCT00371397|1493270|P10|STARTED|Session 2||5
609906|NCT00371397|1493271|P9|STARTED|Session 2||6
609907|NCT00371397|1493272|P8|STARTED|Session 2||4
609908|NCT00371397|1493273|P7|STARTED|Session 2||4
609909|NCT00371397|1493274|P6|STARTED|Session 2||4
609910|NCT00371397|1493275|P5|STARTED|Session 2||3
609911|NCT00371397|1493276|P4|STARTED|Session 2||2
609912|NCT00371397|1493277|P3|STARTED|Session 2||5
609913|NCT00371397|1493278|P2|STARTED|Session 2||7
609914|NCT00371397|1493279|P1|STARTED|Session 2||4
609915|NCT00371397|1493268|P12|NOT COMPLETED|Session 1||0
609916|NCT00371397|1493269|P11|NOT COMPLETED|Session 1||0
609917|NCT00371397|1493270|P10|NOT COMPLETED|Session 1||0
609918|NCT00371397|1493271|P9|NOT COMPLETED|Session 1||0
609919|NCT00371397|1493272|P8|NOT COMPLETED|Session 1||1
609920|NCT00371397|1493273|P7|NOT COMPLETED|Session 1||0
609921|NCT00371397|1493274|P6|NOT COMPLETED|Session 1||0
609922|NCT00371397|1493275|P5|NOT COMPLETED|Session 1||0
609923|NCT00371397|1493276|P4|NOT COMPLETED|Session 1||0
609924|NCT00371397|1493277|P3|NOT COMPLETED|Session 1||0
609925|NCT00371397|1493278|P2|NOT COMPLETED|Session 1||0
609926|NCT00371397|1493279|P1|NOT COMPLETED|Session 1||1
609927|NCT00371397|1493268|P12|COMPLETED|Session 1||2
609928|NCT00371397|1493269|P11|COMPLETED|Session 1||4
609929|NCT00371397|1493270|P10|COMPLETED|Session 1||5
609930|NCT00371397|1493271|P9|COMPLETED|Session 1||6
609931|NCT00371397|1493272|P8|COMPLETED|Session 1||4
609932|NCT00371397|1493273|P7|COMPLETED|Session 1||4
609933|NCT00371397|1493274|P6|COMPLETED|Session 1||4
609934|NCT00371397|1493275|P5|COMPLETED|Session 1||3
609935|NCT00371397|1493276|P4|COMPLETED|Session 1||2
609936|NCT00371397|1493277|P3|COMPLETED|Session 1||5
609937|NCT00371397|1493278|P2|COMPLETED|Session 1||7
609938|NCT00371397|1493279|P1|COMPLETED|Session 1||4
609939|NCT00371397|1493268|P12|STARTED|Session 1||2
609940|NCT00371397|1493269|P11|STARTED|Session 1||4
609941|NCT00371397|1493270|P10|STARTED|Session 1||5
609942|NCT00371397|1493271|P9|STARTED|Session 1||6
609943|NCT00371397|1493272|P8|STARTED|Session 1||5
609944|NCT00371397|1493273|P7|STARTED|Session 1||4
609945|NCT00371397|1493274|P6|STARTED|Session 1||4
609946|NCT00371397|1493275|P5|STARTED|Session 1||3
609947|NCT00371397|1493276|P4|STARTED|Session 1||2
609948|NCT00371397|1493277|P3|STARTED|Session 1||5
609949|NCT00371397|1493278|P2|STARTED|Session 1||7
609950|NCT00371397|1493279|P1|STARTED|Session 1||5
609951|NCT00371345|1493287|P2|NOT COMPLETED|Overall Study||46
609952|NCT00371345|1493288|P1|NOT COMPLETED|Overall Study||24
609953|NCT00371345|1493287|P2|COMPLETED|Overall Study||0
609954|NCT00371345|1493288|P1|COMPLETED|Overall Study||0
609955|NCT00371345|1493287|P2|STARTED|Overall Study||46
609956|NCT00371345|1493288|P1|STARTED|Overall Study||24
609957|NCT00371293|1493348|P3|NOT COMPLETED|Overall Study||16
609958|NCT00371293|1493349|P2|NOT COMPLETED|Overall Study||19
609959|NCT00371293|1493350|P1|NOT COMPLETED|Overall Study||10
609960|NCT00371293|1493348|P3|COMPLETED|Overall Study||46
609961|NCT00371293|1493349|P2|COMPLETED|Overall Study||42
609962|NCT00371293|1493350|P1|COMPLETED|Overall Study||48
609963|NCT00371293|1493348|P3|STARTED|Overall Study||62
609964|NCT00371293|1493349|P2|STARTED|Overall Study||61
609965|NCT00371293|1493350|P1|STARTED|Overall Study||58
609966|NCT00371267|1493372|P2|NOT COMPLETED|Overall Study||18
609967|NCT00371267|1493373|P1|NOT COMPLETED|Overall Study||9
609968|NCT00371267|1493372|P2|COMPLETED|Overall Study||32
609969|NCT00371267|1493373|P1|COMPLETED|Overall Study||39
609970|NCT00371267|1493372|P2|STARTED|Overall Study||50
609971|NCT00371267|1493373|P1|STARTED|Overall Study||48
609972|NCT00371254|1493389|P2|NOT COMPLETED|Overall Study||21
609973|NCT00371254|1493390|P1|NOT COMPLETED|Overall Study||23
609974|NCT00371254|1493389|P2|COMPLETED|Overall Study|Number of participants remained on study till the study drug could be tolerated|0
609975|NCT00371254|1493390|P1|COMPLETED|Overall Study|Number of participants remained on study till the study drug could be tolerated|0
609976|NCT00371254|1493389|P2|STARTED|Overall Study|Number of participants treated|21
609977|NCT00371254|1493390|P1|STARTED|Overall Study|Number of participants treated|23
609978|NCT00371176|1493442|P2|NOT COMPLETED|Overall Study||8
609979|NCT00371176|1493443|P1|NOT COMPLETED|Overall Study||5
609980|NCT00371176|1493442|P2|COMPLETED|Overall Study||5
609981|NCT00371176|1493443|P1|COMPLETED|Overall Study||8
609982|NCT00371176|1493442|P2|Completed Treatment|Overall Study||9
609983|NCT00371176|1493443|P1|Completed Treatment|Overall Study||10
609984|NCT00371176|1493442|P2|STARTED|Overall Study||13
609985|NCT00371176|1493443|P1|STARTED|Overall Study||13
609986|NCT00371150|1493473|P2|NOT COMPLETED|Overall Study||2
609987|NCT00371150|1493474|P1|NOT COMPLETED|Overall Study||3
609988|NCT00371150|1493473|P2|COMPLETED|Overall Study|"Completion of treatment” means received treatment through Week 52"|4
609989|NCT00371150|1493474|P1|COMPLETED|Overall Study|"Completion of treatment” means received treatment through Week 52"|37
609990|NCT00371150|1493473|P2|Discontinued at or After Week 48 Visit|Overall Study||1
609991|NCT00371150|1493474|P1|Discontinued at or After Week 48 Visit|Overall Study||2
609992|NCT00371150|1493473|P2|Discontinued Prior to Week 48 Visit|Overall Study||1
609993|NCT00371150|1493474|P1|Discontinued Prior to Week 48 Visit|Overall Study||1
609994|NCT00371150|1493473|P2|STARTED|Overall Study||6
609995|NCT00371150|1493474|P1|STARTED|Overall Study||40
609996|NCT00371137|1493509|P3|NOT COMPLETED|Overall Study||79
609997|NCT00371137|1493510|P2|NOT COMPLETED|Overall Study||63
609998|NCT00371137|1493511|P1|NOT COMPLETED|Overall Study||72
609999|NCT00371137|1493509|P3|COMPLETED|Overall Study||104
610000|NCT00371137|1493510|P2|COMPLETED|Overall Study||119
610001|NCT00371137|1493511|P1|COMPLETED|Overall Study||111
610002|NCT00371137|1493509|P3|Treated|Overall Study||182
610003|NCT00371137|1493510|P2|Treated|Overall Study||182
610004|NCT00371137|1493511|P1|Treated|Overall Study||183
610005|NCT00371137|1493509|P3|STARTED|Overall Study||183
610006|NCT00371137|1493510|P2|STARTED|Overall Study||182
610007|NCT00371137|1493511|P1|STARTED|Overall Study||183
610008|NCT00370994|1493521|P2|NOT COMPLETED|Overall Study||0
610009|NCT00370994|1493522|P1|NOT COMPLETED|Overall Study||0
610010|NCT00370994|1493521|P2|COMPLETED|Overall Study||60
610011|NCT00370994|1493522|P1|COMPLETED|Overall Study||60
610012|NCT00370994|1493521|P2|STARTED|Overall Study||60
610013|NCT00370994|1493522|P1|STARTED|Overall Study|Sample size was 200, due to the difficulties of recruiting we changed to 120|60
610014|NCT00370838|1493532|P2|NOT COMPLETED|Taper||0
610015|NCT00370838|1493533|P1|NOT COMPLETED|Taper||0
610016|NCT00370838|1493532|P2|COMPLETED|Taper||3
610017|NCT00370838|1493533|P1|COMPLETED|Taper||7
610018|NCT00370838|1493532|P2|STARTED|Taper||3
610019|NCT00370838|1493533|P1|STARTED|Taper||7
610020|NCT00370838|1493532|P2|NOT COMPLETED|Period 2 (Days 65-107)||0
610021|NCT00370838|1493533|P1|NOT COMPLETED|Period 2 (Days 65-107)||0
610022|NCT00370838|1493532|P2|COMPLETED|Period 2 (Days 65-107)||3
610023|NCT00370838|1493533|P1|COMPLETED|Period 2 (Days 65-107)||7
610024|NCT00370838|1493532|P2|STARTED|Period 2 (Days 65-107)||3
610025|NCT00370838|1493533|P1|STARTED|Period 2 (Days 65-107)||7
610026|NCT00370838|1493532|P2|NOT COMPLETED|Washout (Days 51-64)||0
610027|NCT00370838|1493533|P1|NOT COMPLETED|Washout (Days 51-64)||0
610028|NCT00370838|1493532|P2|COMPLETED|Washout (Days 51-64)||3
610029|NCT00370838|1493533|P1|COMPLETED|Washout (Days 51-64)||7
610030|NCT00370838|1493532|P2|STARTED|Washout (Days 51-64)||3
610031|NCT00370838|1493533|P1|STARTED|Washout (Days 51-64)||7
610032|NCT00370838|1493532|P2|NOT COMPLETED|Period 1 (Days 8-50)||0
610033|NCT00370838|1493533|P1|NOT COMPLETED|Period 1 (Days 8-50)||0
610034|NCT00370838|1493532|P2|COMPLETED|Period 1 (Days 8-50)||3
610035|NCT00370838|1493533|P1|COMPLETED|Period 1 (Days 8-50)||7
610036|NCT00370838|1493532|P2|STARTED|Period 1 (Days 8-50)||3
610037|NCT00370838|1493533|P1|STARTED|Period 1 (Days 8-50)||7
610038|NCT00370682|1493554|P3|NOT COMPLETED|Overall Study||1
610039|NCT00370682|1493555|P2|NOT COMPLETED|Overall Study||3
610040|NCT00370682|1493556|P1|NOT COMPLETED|Overall Study||0
610041|NCT00370682|1493554|P3|COMPLETED|Overall Study||39
610042|NCT00370682|1493555|P2|COMPLETED|Overall Study||37
610043|NCT00370682|1493556|P1|COMPLETED|Overall Study||40
610044|NCT00370682|1493554|P3|STARTED|Overall Study||40
610045|NCT00370682|1493555|P2|STARTED|Overall Study||40
610046|NCT00370682|1493556|P1|STARTED|Overall Study||40
610047|NCT00370552|1493598|P3|NOT COMPLETED|Overall Study||32
610048|NCT00370552|1493599|P2|NOT COMPLETED|Overall Study||45
610049|NCT00370552|1493600|P1|NOT COMPLETED|Overall Study||46
610050|NCT00370552|1493598|P3|COMPLETED|Overall Study||0
610051|NCT00370552|1493599|P2|COMPLETED|Overall Study||0
610052|NCT00370552|1493600|P1|COMPLETED|Overall Study||0
610053|NCT00370552|1493598|P3|STARTED|Overall Study|Randomized|32
610054|NCT00370552|1493599|P2|STARTED|Overall Study|Randomized|45
610055|NCT00370552|1493600|P1|STARTED|Overall Study|Randomized|46
610056|NCT00370331|1493640|P2|NOT COMPLETED|Overall Study||23
610057|NCT00370331|1493641|P1|NOT COMPLETED|Overall Study||7
610058|NCT00370331|1493640|P2|COMPLETED|Overall Study||112
610059|NCT00370331|1493641|P1|COMPLETED|Overall Study||55
610060|NCT00370331|1493640|P2|STARTED|Overall Study||135
610061|NCT00370331|1493641|P1|STARTED|Overall Study||62
610062|NCT00370292|1493667|P1|NOT COMPLETED|Overall Study||13
610063|NCT00370292|1493667|P1|COMPLETED|Overall Study||6
610064|NCT00370292|1493667|P1|STARTED|Overall Study||19
610065|NCT00370149|1493680|P2|NOT COMPLETED|Overall Study||19
610066|NCT00370149|1493681|P1|NOT COMPLETED|Overall Study||19
610067|NCT00370149|1493680|P2|COMPLETED|Overall Study||142
610068|NCT00370149|1493681|P1|COMPLETED|Overall Study||146
610069|NCT00370149|1493680|P2|STARTED|Overall Study||161
610070|NCT00370149|1493681|P1|STARTED|Overall Study||165
610071|NCT00370071|1493691|P1|NOT COMPLETED|Overall Study||2
610072|NCT00370071|1493691|P1|COMPLETED|Overall Study||37
610073|NCT00370071|1493691|P1|STARTED|Overall Study||39
610074|NCT00370032|1493708|P2|NOT COMPLETED|Follow-up Period||0
610075|NCT00370032|1493709|P1|NOT COMPLETED|Follow-up Period||1
610076|NCT00370032|1493708|P2|COMPLETED|Follow-up Period||22
610077|NCT00370032|1493709|P1|COMPLETED|Follow-up Period||22
610078|NCT00370032|1493708|P2|STARTED|Follow-up Period||22
610079|NCT00370032|1493709|P1|STARTED|Follow-up Period||23
610080|NCT00370032|1493708|P2|NOT COMPLETED|Treatment Period 2||0
610081|NCT00370032|1493709|P1|NOT COMPLETED|Treatment Period 2||0
610082|NCT00370032|1493708|P2|COMPLETED|Treatment Period 2||22
610083|NCT00370032|1493709|P1|COMPLETED|Treatment Period 2||23
610084|NCT00370032|1493708|P2|STARTED|Treatment Period 2||22
610085|NCT00370032|1493709|P1|STARTED|Treatment Period 2||23
610086|NCT00370032|1493708|P2|NOT COMPLETED|Washout Period||2
610087|NCT00370032|1493709|P1|NOT COMPLETED|Washout Period||1
610088|NCT00370032|1493708|P2|COMPLETED|Washout Period||22
610089|NCT00370032|1493709|P1|COMPLETED|Washout Period||23
610090|NCT00370032|1493708|P2|STARTED|Washout Period||24
610091|NCT00370032|1493709|P1|STARTED|Washout Period||24
610092|NCT00370032|1493708|P2|NOT COMPLETED|Treatment Period 1||1
610093|NCT00370032|1493709|P1|NOT COMPLETED|Treatment Period 1||0
610094|NCT00370032|1493708|P2|COMPLETED|Treatment Period 1||24
610095|NCT00370032|1493709|P1|COMPLETED|Treatment Period 1||24
610096|NCT00370032|1493708|P2|STARTED|Treatment Period 1|Safety Population - all subjects who took at least one dose of study medication.|25
610097|NCT00370032|1493709|P1|STARTED|Treatment Period 1|Safety Population - all subjects who took at least one dose of study medication.|24
610098|NCT00369967|1493729|P2|NOT COMPLETED|Overall Study||12
610099|NCT00369967|1493730|P1|NOT COMPLETED|Overall Study||23
610100|NCT00369967|1493729|P2|COMPLETED|Overall Study||5
610101|NCT00369967|1493730|P1|COMPLETED|Overall Study||8
610102|NCT00369967|1493729|P2|STARTED|Overall Study||17
610103|NCT00369967|1493730|P1|STARTED|Overall Study||31
610104|NCT00369941|1493748|P2|NOT COMPLETED|Overall Study||100
610105|NCT00369941|1493749|P1|NOT COMPLETED|Overall Study||72
610106|NCT00369941|1493748|P2|COMPLETED|Overall Study||184
610107|NCT00369941|1493749|P1|COMPLETED|Overall Study||210
610108|NCT00369941|1493748|P2|Treated|Overall Study||282
610109|NCT00369941|1493749|P1|Treated|Overall Study||281
610110|NCT00369941|1493748|P2|STARTED|Overall Study||284
610111|NCT00369941|1493749|P1|STARTED|Overall Study||282
610112|NCT00369928|1493902|P3|NOT COMPLETED|Overall Study||20
610113|NCT00369928|1493903|P2|NOT COMPLETED|Overall Study||16
610114|NCT00369928|1493904|P1|NOT COMPLETED|Overall Study||8
610115|NCT00369928|1493902|P3|COMPLETED|Overall Study||66
610116|NCT00369928|1493903|P2|COMPLETED|Overall Study||69
610117|NCT00369928|1493904|P1|COMPLETED|Overall Study||77
610118|NCT00369928|1493902|P3|STARTED|Overall Study||86
610119|NCT00369928|1493903|P2|STARTED|Overall Study||85
610120|NCT00369928|1493904|P1|STARTED|Overall Study||85
610121|NCT00369915|1493914|P2|NOT COMPLETED|Overall Study||3
610122|NCT00369915|1493915|P1|NOT COMPLETED|Overall Study||6
610123|NCT00369915|1493914|P2|COMPLETED|Overall Study||4
610124|NCT00369915|1493915|P1|COMPLETED|Overall Study||4
610125|NCT00369915|1493914|P2|STARTED|Overall Study||7
610126|NCT00369915|1493915|P1|STARTED|Overall Study||10
610127|NCT00369824|1493929|P6|NOT COMPLETED|Overall Study||11
610128|NCT00369824|1493930|P5|NOT COMPLETED|Overall Study||18
610129|NCT00369824|1493931|P4|NOT COMPLETED|Overall Study||15
610130|NCT00369824|1493932|P3|NOT COMPLETED|Overall Study||12
610131|NCT00369824|1493933|P2|NOT COMPLETED|Overall Study||19
610132|NCT00369824|1493934|P1|NOT COMPLETED|Overall Study||15
610133|NCT00369824|1493929|P6|COMPLETED|Overall Study||204
610134|NCT00369824|1493930|P5|COMPLETED|Overall Study||196
610135|NCT00369824|1493931|P4|COMPLETED|Overall Study||199
610136|NCT00369824|1493932|P3|COMPLETED|Overall Study||202
610137|NCT00369824|1493933|P2|COMPLETED|Overall Study||195
610138|NCT00369824|1493934|P1|COMPLETED|Overall Study||197
610139|NCT00369824|1493929|P6|STARTED|Overall Study||215
610140|NCT00369824|1493930|P5|STARTED|Overall Study||214
610141|NCT00369824|1493931|P4|STARTED|Overall Study||214
610142|NCT00369824|1493932|P3|STARTED|Overall Study||214
610143|NCT00369824|1493933|P2|STARTED|Overall Study||214
610144|NCT00369824|1493934|P1|STARTED|Overall Study||212
610145|NCT00369785|1494034|P2|NOT COMPLETED|Overall Study||25
610146|NCT00369785|1494035|P1|NOT COMPLETED|Overall Study||27
610147|NCT00369785|1494034|P2|COMPLETED|Overall Study||74
610148|NCT00369785|1494035|P1|COMPLETED|Overall Study||72
610149|NCT00369785|1494034|P2|STARTED|Overall Study||99
610150|NCT00369785|1494035|P1|STARTED|Overall Study||99
610151|NCT00369746|1494045|P2|NOT COMPLETED|Overall Study||0
610152|NCT00369746|1494046|P1|NOT COMPLETED|Overall Study||0
610153|NCT00369746|1494045|P2|COMPLETED|Overall Study||536
610154|NCT00369746|1494046|P1|COMPLETED|Overall Study||138
610155|NCT00369746|1494045|P2|STARTED|Overall Study||536
610156|NCT00369746|1494046|P1|STARTED|Overall Study||138
610157|NCT00369681|1494056|P1|NOT COMPLETED|Overall Study||1
610158|NCT00369681|1494056|P1|COMPLETED|Overall Study||49
610159|NCT00369681|1494056|P1|STARTED|Overall Study||50
610160|NCT00369668|1494065|P3|NOT COMPLETED|Overall Study||7
610161|NCT00369668|1494066|P2|NOT COMPLETED|Overall Study||5
610162|NCT00369668|1494067|P1|NOT COMPLETED|Overall Study||4
610163|NCT00369668|1494065|P3|COMPLETED|Overall Study||3
610164|NCT00369668|1494066|P2|COMPLETED|Overall Study||5
610165|NCT00369668|1494067|P1|COMPLETED|Overall Study||6
610166|NCT00369668|1494065|P3|STARTED|Overall Study||10
610167|NCT00369668|1494066|P2|STARTED|Overall Study||10
610168|NCT00369668|1494067|P1|STARTED|Overall Study|Original number of participants to be recruited for each group.|10
610169|NCT00369655|1494081|P1|NOT COMPLETED|Overall Study||2
610170|NCT00369655|1494081|P1|COMPLETED|Overall Study||19
610171|NCT00369655|1494081|P1|STARTED|Overall Study||21
610172|NCT00369590|1494092|P2|NOT COMPLETED|Overall Study||0
610173|NCT00369590|1494093|P1|NOT COMPLETED|Overall Study||0
610174|NCT00369590|1494092|P2|COMPLETED|Overall Study||42
610175|NCT00369590|1494093|P1|COMPLETED|Overall Study||16
610176|NCT00369590|1494092|P2|STARTED|Overall Study||42
610177|NCT00369590|1494093|P1|STARTED|Overall Study||16
610178|NCT00369577|1494111|P3|NOT COMPLETED|Overall Study||1
610179|NCT00369577|1494112|P2|NOT COMPLETED|Overall Study||0
610180|NCT00369577|1494113|P1|NOT COMPLETED|Overall Study||0
610181|NCT00369577|1494111|P3|COMPLETED|Overall Study||40
610182|NCT00369577|1494112|P2|COMPLETED|Overall Study||45
610183|NCT00369577|1494113|P1|COMPLETED|Overall Study||43
610184|NCT00369577|1494111|P3|STARTED|Overall Study||41
610185|NCT00369577|1494112|P2|STARTED|Overall Study||45
610186|NCT00369577|1494113|P1|STARTED|Overall Study||43
610187|NCT00369564|1494132|P2|NOT COMPLETED|Overall Study||23
610188|NCT00369564|1494133|P1|NOT COMPLETED|Overall Study||43
610189|NCT00369564|1494132|P2|COMPLETED|Overall Study||100
610190|NCT00369564|1494133|P1|COMPLETED|Overall Study||84
610191|NCT00369564|1494132|P2|STARTED|Overall Study||123
610192|NCT00369564|1494133|P1|STARTED|Overall Study||127
610193|NCT00369512|1494139|P1|NOT COMPLETED|Overall Study||0
610194|NCT00369512|1494139|P1|COMPLETED|Overall Study||15
610195|NCT00369512|1494139|P1|STARTED|Overall Study||15
610196|NCT00369486|1494150|P5|NOT COMPLETED|34-Week Visit||3
610197|NCT00369486|1494151|P4|NOT COMPLETED|34-Week Visit||3
610198|NCT00369486|1494152|P3|NOT COMPLETED|34-Week Visit||1
610199|NCT00369486|1494153|P2|NOT COMPLETED|34-Week Visit||1
610200|NCT00369486|1494154|P1|NOT COMPLETED|34-Week Visit||0
610201|NCT00369486|1494150|P5|COMPLETED|34-Week Visit|Number of eyes|22
610202|NCT00369486|1494151|P4|COMPLETED|34-Week Visit|Number of eyes|19
610203|NCT00369486|1494152|P3|COMPLETED|34-Week Visit|Number of eyes|22
610204|NCT00369486|1494153|P2|COMPLETED|34-Week Visit|Number of eyes|20
610205|NCT00369486|1494154|P1|COMPLETED|34-Week Visit|Number of eyes|38
610206|NCT00369486|1494150|P5|STARTED|34-Week Visit|Number of eyes that|25
610207|NCT00369486|1494151|P4|STARTED|34-Week Visit|Number of eyes|22
610208|NCT00369486|1494152|P3|STARTED|34-Week Visit|Number of eyes|23
610209|NCT00369486|1494153|P2|STARTED|34-Week Visit|Number of eyes|21
610210|NCT00369486|1494154|P1|STARTED|34-Week Visit|Number of eyes|38
610211|NCT00369486|1494150|P5|NOT COMPLETED|17-Week Visit||1
610212|NCT00369486|1494151|P4|NOT COMPLETED|17-Week Visit||1
610213|NCT00369486|1494152|P3|NOT COMPLETED|17-Week Visit||1
610214|NCT00369486|1494153|P2|NOT COMPLETED|17-Week Visit||0
610215|NCT00369486|1494154|P1|NOT COMPLETED|17-Week Visit||0
610216|NCT00369486|1494150|P5|COMPLETED|17-Week Visit|Number of eyes|24
610217|NCT00369486|1494151|P4|COMPLETED|17-Week Visit|Number of eyes|21
610218|NCT00369486|1494152|P3|COMPLETED|17-Week Visit|Number of eyes|22
610219|NCT00369486|1494153|P2|COMPLETED|17-Week Visit|Number of eyes|21
610220|NCT00369486|1494154|P1|COMPLETED|17-Week Visit|Number of eyes|38
610221|NCT00369486|1494150|P5|STARTED|17-Week Visit|Number of eyes|25
610222|NCT00369486|1494151|P4|STARTED|17-Week Visit|Number of eyes|22
610223|NCT00369486|1494152|P3|STARTED|17-Week Visit|Number of eyes|23
610224|NCT00369486|1494153|P2|STARTED|17-Week Visit|Number of eyes|21
610225|NCT00369486|1494154|P1|STARTED|17-Week Visit|Number of eyes|38
610226|NCT00369486|1494150|P5|NOT COMPLETED|8-Week Visit||1
610227|NCT00369486|1494151|P4|NOT COMPLETED|8-Week Visit||1
610228|NCT00369486|1494152|P3|NOT COMPLETED|8-Week Visit||0
610229|NCT00369486|1494153|P2|NOT COMPLETED|8-Week Visit||1
610230|NCT00369486|1494154|P1|NOT COMPLETED|8-Week Visit||0
610231|NCT00369486|1494150|P5|COMPLETED|8-Week Visit|Number of eyes|24
610232|NCT00369486|1494151|P4|COMPLETED|8-Week Visit|Number of eyes|21
610233|NCT00369486|1494152|P3|COMPLETED|8-Week Visit|Number of eyes|22
610234|NCT00369486|1494153|P2|COMPLETED|8-Week Visit|Number of eyes|20
610235|NCT00369486|1494154|P1|COMPLETED|8-Week Visit|Number of eyes|38
610236|NCT00369486|1494150|P5|STARTED|8-Week Visit|Number of eyes|25
610237|NCT00369486|1494151|P4|STARTED|8-Week Visit|Number of eyes|22
610238|NCT00369486|1494152|P3|STARTED|8-Week Visit|Number of eyes|22
610239|NCT00369486|1494153|P2|STARTED|8-Week Visit|Number of eyes|21
610240|NCT00369486|1494154|P1|STARTED|8-Week Visit|Number of eyes|38
610241|NCT00369486|1494150|P5|NOT COMPLETED|4-Week Visit||1
610242|NCT00369486|1494151|P4|NOT COMPLETED|4-Week Visit||2
610243|NCT00369486|1494152|P3|NOT COMPLETED|4-Week Visit||1
610244|NCT00369486|1494153|P2|NOT COMPLETED|4-Week Visit||2
610245|NCT00369486|1494154|P1|NOT COMPLETED|4-Week Visit||2
610246|NCT00369486|1494150|P5|COMPLETED|4-Week Visit|Number of eyes|24
610247|NCT00369486|1494151|P4|COMPLETED|4-Week Visit|Number of eyes|20
610248|NCT00369486|1494152|P3|COMPLETED|4-Week Visit|Number of eyes|22
610249|NCT00369486|1494153|P2|COMPLETED|4-Week Visit|Number of eyes;|19
610250|NCT00369486|1494154|P1|COMPLETED|4-Week Visit|Number of eyes|36
610251|NCT00369486|1494150|P5|STARTED|4-Week Visit|Number of eyes|25
610252|NCT00369486|1494151|P4|STARTED|4-Week Visit|Number of eyes|22
610253|NCT00369486|1494152|P3|STARTED|4-Week Visit|Number of eyes|23
610254|NCT00369486|1494153|P2|STARTED|4-Week Visit|Number of eyes|21
610255|NCT00369486|1494154|P1|STARTED|4-Week Visit|Number of eyes|38
610256|NCT00369382|1494193|P2|NOT COMPLETED|Overall Study||3
610257|NCT00369382|1494194|P1|NOT COMPLETED|Overall Study||10
610258|NCT00369382|1494193|P2|COMPLETED|Overall Study||54
610259|NCT00369382|1494194|P1|COMPLETED|Overall Study||49
610260|NCT00369382|1494193|P2|Completed Assigned Treatment Regimen|Overall Study||33
610261|NCT00369382|1494194|P1|Completed Assigned Treatment Regimen|Overall Study||48
610262|NCT00369382|1494193|P2|Received Treatment|Overall Study||57
610263|NCT00369382|1494194|P1|Received Treatment|Overall Study||57
610264|NCT00369382|1494193|P2|STARTED|Overall Study||57
610265|NCT00369382|1494194|P1|STARTED|Overall Study||59
610266|NCT00369343|1494227|P2|NOT COMPLETED|Open-label Phase||30
610267|NCT00369343|1494228|P1|NOT COMPLETED|Open-label Phase||57
610268|NCT00369343|1494227|P2|COMPLETED|Open-label Phase||79
610269|NCT00369343|1494228|P1|COMPLETED|Open-label Phase||155
610270|NCT00369343|1494227|P2|STARTED|Open-label Phase||109
610271|NCT00369343|1494228|P1|STARTED|Open-label Phase||212
610272|NCT00369343|1494227|P2|NOT COMPLETED|Double-blind Phase||16
610273|NCT00369343|1494228|P1|NOT COMPLETED|Double-blind Phase||44
610274|NCT00369343|1494227|P2|COMPLETED|Double-blind Phase||109
610275|NCT00369343|1494228|P1|COMPLETED|Double-blind Phase||212
610276|NCT00369343|1494227|P2|STARTED|Double-blind Phase||125
610277|NCT00369343|1494228|P1|STARTED|Double-blind Phase||256
610278|NCT00369317|1494261|P1|NOT COMPLETED|Overall Study||20
610279|NCT00369317|1494261|P1|COMPLETED|Overall Study||185
610280|NCT00369317|1494261|P1|STARTED|Overall Study||205
610281|NCT00369278|1494277|P2|NOT COMPLETED|Overall Study||21
610282|NCT00369278|1494278|P1|NOT COMPLETED|Overall Study||24
610283|NCT00369278|1494277|P2|COMPLETED|Overall Study||44
610284|NCT00369278|1494278|P1|COMPLETED|Overall Study||39
610285|NCT00369278|1494277|P2|STARTED|Overall Study||65
610286|NCT00369278|1494278|P1|STARTED|Overall Study||63
610287|NCT00369265|1494294|P2|NOT COMPLETED|Overall Study||7
610288|NCT00369265|1494295|P1|NOT COMPLETED|Overall Study||4
610289|NCT00369265|1494294|P2|COMPLETED|Overall Study||0
610290|NCT00369265|1494295|P1|COMPLETED|Overall Study||0
610291|NCT00369265|1494294|P2|STARTED|Overall Study||7
610292|NCT00369265|1494295|P1|STARTED|Overall Study||4
610293|NCT00369226|1494303|P2|NOT COMPLETED|Phase II (45 Days)||0
610294|NCT00369226|1494304|P1|NOT COMPLETED|Phase II (45 Days)||0
610295|NCT00369226|1494303|P2|COMPLETED|Phase II (45 Days)|This includes 10 patients treated at candidate MTD in Phase I.|32
610296|NCT00369226|1494304|P1|COMPLETED|Phase II (45 Days)||0
610297|NCT00369226|1494303|P2|STARTED|Phase II (45 Days)||32
610298|NCT00369226|1494304|P1|STARTED|Phase II (45 Days)||0
610299|NCT00369226|1494303|P2|NOT COMPLETED|Phase I (45 Days)||0
610300|NCT00369226|1494304|P1|NOT COMPLETED|Phase I (45 Days)||0
610301|NCT00369226|1494303|P2|COMPLETED|Phase I (45 Days)||0
610302|NCT00369226|1494304|P1|COMPLETED|Phase I (45 Days)|Once MTD established, additional 10 patients were accrued at MTD to better estimate toxicity.|13
610303|NCT00369226|1494303|P2|STARTED|Phase I (45 Days)||0
610304|NCT00369226|1494304|P1|STARTED|Phase I (45 Days)||13
610305|NCT00369161|1494316|P2|NOT COMPLETED|Overall Study||24
610306|NCT00369161|1494317|P1|NOT COMPLETED|Overall Study||27
610307|NCT00369161|1494316|P2|COMPLETED|Overall Study||95
610308|NCT00369161|1494317|P1|COMPLETED|Overall Study||82
610309|NCT00369161|1494316|P2|Intention to Treat (ITT)|Overall Study||117
610310|NCT00369161|1494317|P1|Intention to Treat (ITT)|Overall Study||107
610311|NCT00369161|1494316|P2|STARTED|Overall Study||119
610312|NCT00369161|1494317|P1|STARTED|Overall Study|"Started indicates randomized and safety population."|109
610313|NCT00369122|1494327|P1|NOT COMPLETED|Overall Study||11
610314|NCT00369122|1494327|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|49
610315|NCT00369122|1494327|P1|STARTED|Overall Study||60
610316|NCT00368992|1494334|P1|NOT COMPLETED|Overall Study||110
610317|NCT00368992|1494334|P1|COMPLETED|Overall Study||0
610318|NCT00368992|1494334|P1|STARTED|Overall Study||110
610319|NCT00368979|1494343|P2|NOT COMPLETED|Overall Study||30
610320|NCT00368979|1494344|P1|NOT COMPLETED|Overall Study||25
610321|NCT00368979|1494343|P2|COMPLETED|Overall Study||163
610322|NCT00368979|1494344|P1|COMPLETED|Overall Study||160
610323|NCT00368979|1494343|P2|STARTED|Overall Study||193
610324|NCT00368979|1494344|P1|STARTED|Overall Study||185
610325|NCT00368966|1494360|P2|NOT COMPLETED|Toddler Dose||3
610326|NCT00368966|1494361|P1|NOT COMPLETED|Toddler Dose||1
610327|NCT00368966|1494360|P2|COMPLETED|Toddler Dose||286
610328|NCT00368966|1494361|P1|COMPLETED|Toddler Dose||292
610329|NCT00368966|1494360|P2|STARTED|Toddler Dose||289
610330|NCT00368966|1494361|P1|STARTED|Toddler Dose||293
610331|NCT00368966|1494360|P2|NOT COMPLETED|After Infant||5
610332|NCT00368966|1494361|P1|NOT COMPLETED|After Infant||6
610333|NCT00368966|1494360|P2|COMPLETED|After Infant||289
610334|NCT00368966|1494361|P1|COMPLETED|After Infant||293
610335|NCT00368966|1494360|P2|STARTED|After Infant||294
610336|NCT00368966|1494361|P1|STARTED|After Infant||299
610337|NCT00368966|1494360|P2|NOT COMPLETED|Infant Series||10
610338|NCT00368966|1494361|P1|NOT COMPLETED|Infant Series||16
610339|NCT00368966|1494360|P2|COMPLETED|Infant Series||294
610340|NCT00368966|1494361|P1|COMPLETED|Infant Series||299
610341|NCT00368966|1494360|P2|Vaccinated Dose 3|Infant Series|1 randomized but incorrectly given 13vPnC|296
610342|NCT00368966|1494361|P1|Vaccinated Dose 3|Infant Series||301
610343|NCT00368966|1494360|P2|Vaccinated Dose 2|Infant Series||298
610344|NCT00368966|1494361|P1|Vaccinated Dose 2|Infant Series|1 randomized but incorrectly given 7vPnC|307
610345|NCT00368966|1494360|P2|Vaccinated Dose 1|Infant Series|1 randomized to 7vPnC but given 13vPnC vaccine; 1 was withdrawn before receiving 7vPnC vaccine|302
610346|NCT00368966|1494361|P1|Vaccinated Dose 1|Infant Series||314
610347|NCT00368966|1494360|P2|STARTED|Infant Series||304
610348|NCT00368966|1494361|P1|STARTED|Infant Series||315
610349|NCT00368940|1494417|P2|NOT COMPLETED|Completed 12-wk Treatment||5
610350|NCT00368940|1494418|P1|NOT COMPLETED|Completed 12-wk Treatment||6
610351|NCT00368940|1494417|P2|COMPLETED|Completed 12-wk Treatment||32
610352|NCT00368940|1494418|P1|COMPLETED|Completed 12-wk Treatment||31
610353|NCT00368940|1494417|P2|STARTED|Completed 12-wk Treatment||37
610354|NCT00368940|1494418|P1|STARTED|Completed 12-wk Treatment||37
610355|NCT00368940|1494417|P2|NOT COMPLETED|Intention-to-Treat||0
610356|NCT00368940|1494418|P1|NOT COMPLETED|Intention-to-Treat||0
610357|NCT00368940|1494417|P2|COMPLETED|Intention-to-Treat||37
610358|NCT00368940|1494418|P1|COMPLETED|Intention-to-Treat||37
610359|NCT00368940|1494417|P2|STARTED|Intention-to-Treat||37
610360|NCT00368940|1494418|P1|STARTED|Intention-to-Treat||37
610361|NCT00368927|1494432|P2|NOT COMPLETED|Overall Study||3
610362|NCT00368927|1494433|P1|NOT COMPLETED|Overall Study||5
610363|NCT00368927|1494432|P2|COMPLETED|Overall Study||27
610364|NCT00368927|1494433|P1|COMPLETED|Overall Study||26
610365|NCT00368927|1494432|P2|STARTED|Overall Study||30
610366|NCT00368927|1494433|P1|STARTED|Overall Study||31
610367|NCT00368875|1494441|P2|NOT COMPLETED|Overall Study||48
610368|NCT00368875|1494442|P1|NOT COMPLETED|Overall Study||6
610369|NCT00368875|1494441|P2|COMPLETED|Overall Study||0
610370|NCT00368875|1494442|P1|COMPLETED|Overall Study||0
610371|NCT00368875|1494441|P2|STARTED|Overall Study||48
610372|NCT00368875|1494442|P1|STARTED|Overall Study||6
610373|NCT00368849|1494450|P2|NOT COMPLETED|Overall Study||2
610374|NCT00368849|1494451|P1|NOT COMPLETED|Overall Study||0
610375|NCT00368849|1494450|P2|COMPLETED|Overall Study||8
610376|NCT00368849|1494451|P1|COMPLETED|Overall Study||10
610377|NCT00368849|1494450|P2|STARTED|Overall Study||10
610378|NCT00368849|1494451|P1|STARTED|Overall Study||10
610379|NCT00368745|1494467|P2|NOT COMPLETED|Double-blind Treatment Period||31
610380|NCT00368745|1494468|P1|NOT COMPLETED|Double-blind Treatment Period||26
610381|NCT00368745|1494467|P2|COMPLETED|Double-blind Treatment Period||19
610382|NCT00368745|1494468|P1|COMPLETED|Double-blind Treatment Period||30
610383|NCT00368745|1494467|P2|STARTED|Double-blind Treatment Period||50
610384|NCT00368745|1494468|P1|STARTED|Double-blind Treatment Period||56
610385|NCT00368745|1494467|P2|NOT COMPLETED|Randomized to Double-blind Treatment||1
610386|NCT00368745|1494468|P1|NOT COMPLETED|Randomized to Double-blind Treatment||1
610387|NCT00368745|1494467|P2|COMPLETED|Randomized to Double-blind Treatment|One subject did not want to participate in study.|50
610388|NCT00368745|1494468|P1|COMPLETED|Randomized to Double-blind Treatment|One subject did not return following randomization; study drug not dispensed.|56
610389|NCT00368745|1494467|P2|STARTED|Randomized to Double-blind Treatment||51
610390|NCT00368745|1494468|P1|STARTED|Randomized to Double-blind Treatment||57
610391|NCT00368654|1494502|P4|NOT COMPLETED|Overall Study||3
610392|NCT00368654|1494503|P3|NOT COMPLETED|Overall Study||3
610393|NCT00368654|1494504|P2|NOT COMPLETED|Overall Study||3
610394|NCT00368654|1494505|P1|NOT COMPLETED|Overall Study||3
610395|NCT00368654|1494502|P4|COMPLETED|Overall Study||0
610396|NCT00368654|1494503|P3|COMPLETED|Overall Study||0
610397|NCT00368654|1494504|P2|COMPLETED|Overall Study||0
610398|NCT00368654|1494505|P1|COMPLETED|Overall Study||0
610399|NCT00368654|1494502|P4|STARTED|Overall Study||3
610400|NCT00368654|1494503|P3|STARTED|Overall Study||3
610401|NCT00368654|1494504|P2|STARTED|Overall Study||3
610402|NCT00368654|1494505|P1|STARTED|Overall Study||3
610403|NCT00368641|1494521|P2|NOT COMPLETED|Overall Study||6
610404|NCT00368641|1494522|P1|NOT COMPLETED|Overall Study||6
610405|NCT00368641|1494521|P2|COMPLETED|Overall Study|study was terminated prior to completion of treatment period|0
610406|NCT00368641|1494522|P1|COMPLETED|Overall Study|study was terminated prior to completion of treatment period|0
610407|NCT00368641|1494521|P2|STARTED|Overall Study||6
610408|NCT00368641|1494522|P1|STARTED|Overall Study||6
610409|NCT00368550|1494530|P2|NOT COMPLETED|Overall Study||23
610410|NCT00368550|1494531|P1|NOT COMPLETED|Overall Study||28
610411|NCT00368550|1494530|P2|COMPLETED|Overall Study||48
610412|NCT00368550|1494531|P1|COMPLETED|Overall Study||35
610413|NCT00368550|1494530|P2|STARTED|Overall Study||71
610414|NCT00368550|1494531|P1|STARTED|Overall Study||63
610415|NCT00368537|1494543|P2|NOT COMPLETED|Baseline Participants||24
610416|NCT00368537|1494544|P1|NOT COMPLETED|Baseline Participants||24
610417|NCT00368537|1494543|P2|COMPLETED|Baseline Participants||239
610418|NCT00368537|1494544|P1|COMPLETED|Baseline Participants||244
610419|NCT00368537|1494543|P2|STARTED|Baseline Participants||263
610420|NCT00368537|1494544|P1|STARTED|Baseline Participants||268
610421|NCT00368537|1494543|P2|NOT COMPLETED|Randomization||6
610422|NCT00368537|1494544|P1|NOT COMPLETED|Randomization||13
610423|NCT00368537|1494543|P2|COMPLETED|Randomization||263
610424|NCT00368537|1494544|P1|COMPLETED|Randomization||268
610425|NCT00368537|1494543|P2|STARTED|Randomization||269
610426|NCT00368537|1494544|P1|STARTED|Randomization||281
610427|NCT00368472|1494558|P1|NOT COMPLETED|Overall Study||105
610428|NCT00368472|1494558|P1|COMPLETED|Overall Study||33
610429|NCT00368472|1494558|P1|STARTED|Overall Study||138
610430|NCT00368459|1494566|P2|NOT COMPLETED|Overall Study||1
610431|NCT00368459|1494567|P1|NOT COMPLETED|Overall Study||2
610432|NCT00368459|1494566|P2|COMPLETED|Overall Study||20
610433|NCT00368459|1494567|P1|COMPLETED|Overall Study||19
610434|NCT00368459|1494566|P2|STARTED|Overall Study||21
610435|NCT00368459|1494567|P1|STARTED|Overall Study||21
610436|NCT00368316|1494593|P2|NOT COMPLETED|Overall Study||46
610437|NCT00368316|1494594|P1|NOT COMPLETED|Overall Study||42
610438|NCT00368316|1494593|P2|COMPLETED|Overall Study||1319
610439|NCT00368316|1494594|P1|COMPLETED|Overall Study||1392
610440|NCT00368316|1494593|P2|STARTED|Overall Study||1365
610441|NCT00368316|1494594|P1|STARTED|Overall Study||1434
610442|NCT00368290|1494606|P2|NOT COMPLETED|Overall Study||10
610443|NCT00368290|1494607|P1|NOT COMPLETED|Overall Study||13
610444|NCT00368290|1494606|P2|COMPLETED|Overall Study||37
610445|NCT00368290|1494607|P1|COMPLETED|Overall Study||34
610446|NCT00368290|1494606|P2|STARTED|Overall Study||47
610447|NCT00368290|1494607|P1|STARTED|Overall Study||47
610448|NCT00368277|1494617|P2|NOT COMPLETED|Overall Study||108
610449|NCT00368277|1494618|P1|NOT COMPLETED|Overall Study||113
610450|NCT00368277|1494617|P2|COMPLETED|Overall Study||336
610451|NCT00368277|1494618|P1|COMPLETED|Overall Study||344
610452|NCT00368277|1494617|P2|STARTED|Overall Study||444
610453|NCT00368277|1494618|P1|STARTED|Overall Study||457
610454|NCT00368251|1494633|P3|NOT COMPLETED|Overall Study||1
610455|NCT00368251|1494634|P2|NOT COMPLETED|Overall Study||0
610456|NCT00368251|1494635|P1|NOT COMPLETED|Overall Study||1
610457|NCT00368251|1494633|P3|COMPLETED|Overall Study||17
610458|NCT00368251|1494634|P2|COMPLETED|Overall Study||20
610459|NCT00368251|1494635|P1|COMPLETED|Overall Study||17
610460|NCT00368251|1494633|P3|STARTED|Overall Study||18
610461|NCT00368251|1494634|P2|STARTED|Overall Study||20
610462|NCT00368251|1494635|P1|STARTED|Overall Study||18
610463|NCT00368108|1494658|P3|NOT COMPLETED|Overall Study||68
610464|NCT00368108|1494659|P2|NOT COMPLETED|Overall Study||53
610465|NCT00368108|1494660|P1|NOT COMPLETED|Overall Study||64
610466|NCT00368108|1494658|P3|COMPLETED|Overall Study||182
610467|NCT00368108|1494659|P2|COMPLETED|Overall Study||198
610468|NCT00368108|1494660|P1|COMPLETED|Overall Study||187
610469|NCT00368108|1494658|P3|STARTED|Overall Study||250
610470|NCT00368108|1494659|P2|STARTED|Overall Study||251
610471|NCT00368108|1494660|P1|STARTED|Overall Study|One subject had stopped medication prior to notifying staff. Remaining results will have 250.|251
610472|NCT00368069|1494679|P2|NOT COMPLETED|Overall Study||7
610473|NCT00368069|1494680|P1|NOT COMPLETED|Overall Study||8
610474|NCT00368069|1494679|P2|COMPLETED|Overall Study||72
610475|NCT00368069|1494680|P1|COMPLETED|Overall Study||71
610476|NCT00368069|1494679|P2|STARTED|Overall Study||79
610477|NCT00368069|1494680|P1|STARTED|Overall Study||79
610478|NCT00367991|1494698|P2|NOT COMPLETED|Overall Study||2
610479|NCT00367991|1494699|P1|NOT COMPLETED|Overall Study||2
610480|NCT00367991|1494698|P2|COMPLETED|Overall Study||13
610481|NCT00367991|1494699|P1|COMPLETED|Overall Study||27
610482|NCT00367991|1494698|P2|STARTED|Overall Study||15
610483|NCT00367991|1494699|P1|STARTED|Overall Study||29
610484|NCT00367835|1494717|P2|NOT COMPLETED|Overall Study||31
610485|NCT00367835|1494718|P1|NOT COMPLETED|Overall Study||29
610486|NCT00367835|1494717|P2|COMPLETED|Overall Study||48
610487|NCT00367835|1494718|P1|COMPLETED|Overall Study||109
610488|NCT00367835|1494717|P2|STARTED|Overall Study||79
610489|NCT00367835|1494718|P1|STARTED|Overall Study||138
610490|NCT00367770|1494744|P1|NOT COMPLETED|Overall Study||2
610491|NCT00367770|1494744|P1|COMPLETED|Overall Study||35
610492|NCT00367770|1494744|P1|STARTED|Overall Study||37
610493|NCT00367744|1494752|P2|NOT COMPLETED|Overall Study||5
610494|NCT00367744|1494753|P1|NOT COMPLETED|Overall Study||4
610495|NCT00367744|1494752|P2|COMPLETED|Overall Study||32
610496|NCT00367744|1494753|P1|COMPLETED|Overall Study||30
610497|NCT00367744|1494752|P2|STARTED|Overall Study||37
610498|NCT00367744|1494753|P1|STARTED|Overall Study||34
610499|NCT00367679|1494761|P1|NOT COMPLETED|Overall Study||0
610500|NCT00367679|1494761|P1|COMPLETED|Overall Study||35
610501|NCT00367679|1494761|P1|STARTED|Overall Study||35
610502|NCT00367640|1494782|P4|NOT COMPLETED|Overall Study||10
610503|NCT00367640|1494783|P3|NOT COMPLETED|Overall Study||19
610504|NCT00367640|1494784|P2|NOT COMPLETED|Overall Study||22
610505|NCT00367640|1494785|P1|NOT COMPLETED|Overall Study||18
610506|NCT00367640|1494782|P4|COMPLETED|Overall Study||146
610507|NCT00367640|1494783|P3|COMPLETED|Overall Study||141
610508|NCT00367640|1494784|P2|COMPLETED|Overall Study||133
610509|NCT00367640|1494785|P1|COMPLETED|Overall Study||139
610510|NCT00367640|1494782|P4|STARTED|Overall Study||156
610511|NCT00367640|1494783|P3|STARTED|Overall Study||160
610512|NCT00367640|1494784|P2|STARTED|Overall Study||155
610513|NCT00367640|1494785|P1|STARTED|Overall Study||157
610514|NCT00367601|1494795|P1|NOT COMPLETED|Overall Study||0
610515|NCT00367601|1494795|P1|COMPLETED|Overall Study||25
610516|NCT00367601|1494795|P1|STARTED|Overall Study||25
610517|NCT00367484|1494801|P1|NOT COMPLETED|Overall Study||17
610518|NCT00367484|1494801|P1|COMPLETED|Overall Study|Safety population = 460 Intent To Treat (ITT) population = 458|443
610519|NCT00367484|1494801|P1|STARTED|Overall Study||460
610520|NCT00367432|1494805|P2|NOT COMPLETED|Second Period (up to 54 Months)||16
610521|NCT00367432|1494806|P1|NOT COMPLETED|Second Period (up to 54 Months)||87
610522|NCT00367432|1494805|P2|COMPLETED|Second Period (up to 54 Months)||69
610523|NCT00367432|1494806|P1|COMPLETED|Second Period (up to 54 Months)||188
610524|NCT00367432|1494805|P2|STARTED|Second Period (up to 54 Months)|85 subjects from N01020 [NCT00160615] entered Second Period of N01222|85
610525|NCT00367432|1494806|P1|STARTED|Second Period (up to 54 Months)|275 subjects from N01221 [NCT00280696] completed First Period and entered Second Period of N01222|275
610526|NCT00367432|1494805|P2|NOT COMPLETED|First Period (16 Weeks)||0
610527|NCT00367432|1494806|P1|NOT COMPLETED|First Period (16 Weeks)||38
610528|NCT00367432|1494805|P2|COMPLETED|First Period (16 Weeks)||0
610529|NCT00367432|1494806|P1|COMPLETED|First Period (16 Weeks)||275
610530|NCT00367432|1494805|P2|STARTED|First Period (16 Weeks)||0
610531|NCT00367432|1494806|P1|STARTED|First Period (16 Weeks)|Eligible subjects from preceding study N01221 [NCT00280696] entered the First Period of N01222|313
610532|NCT00367380|1494821|P3|NOT COMPLETED|Overall Study||0
610533|NCT00367380|1494822|P2|NOT COMPLETED|Overall Study||0
610534|NCT00367380|1494823|P1|NOT COMPLETED|Overall Study||0
610535|NCT00367380|1494821|P3|COMPLETED|Overall Study||6
610536|NCT00367380|1494822|P2|COMPLETED|Overall Study||6
610537|NCT00367380|1494823|P1|COMPLETED|Overall Study||6
610538|NCT00367380|1494821|P3|STARTED|Overall Study||6
610539|NCT00367380|1494822|P2|STARTED|Overall Study||6
610540|NCT00367380|1494823|P1|STARTED|Overall Study||6
610541|NCT00367341|1494833|P2|NOT COMPLETED|Overall Study||0
610542|NCT00367341|1494834|P1|NOT COMPLETED|Overall Study||2
610543|NCT00367341|1494833|P2|COMPLETED|Overall Study||40
610544|NCT00367341|1494834|P1|COMPLETED|Overall Study||40
610545|NCT00367341|1494833|P2|STARTED|Overall Study||40
610546|NCT00367341|1494834|P1|STARTED|Overall Study||42
610547|NCT00367237|1494844|P2|NOT COMPLETED|Overall Study||11
610548|NCT00367237|1494845|P1|NOT COMPLETED|Overall Study||10
610549|NCT00367237|1494844|P2|COMPLETED|Overall Study||47
610550|NCT00367237|1494845|P1|COMPLETED|Overall Study||47
610551|NCT00367237|1494844|P2|STARTED|Overall Study|Number of subjects randomized|58
610552|NCT00367237|1494845|P1|STARTED|Overall Study|Number of subjects randomized|57
610553|NCT00367133|1494854|P3|NOT COMPLETED|3 Years||18
610554|NCT00367133|1494855|P2|NOT COMPLETED|3 Years||23
610555|NCT00367133|1494856|P1|NOT COMPLETED|3 Years||28
610556|NCT00367133|1494854|P3|COMPLETED|3 Years||98
610557|NCT00367133|1494855|P2|COMPLETED|3 Years||93
610558|NCT00367133|1494856|P1|COMPLETED|3 Years||115
610559|NCT00367133|1494854|P3|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|116
610560|NCT00367133|1494855|P2|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|116
610561|NCT00367133|1494856|P1|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|143
610562|NCT00367133|1494854|P3|NOT COMPLETED|2 Years||49
610563|NCT00367133|1494855|P2|NOT COMPLETED|2 Years||36
610564|NCT00367133|1494856|P1|NOT COMPLETED|2 Years||58
610565|NCT00367133|1494854|P3|COMPLETED|2 Years||205
610566|NCT00367133|1494855|P2|COMPLETED|2 Years||220
610567|NCT00367133|1494856|P1|COMPLETED|2 Years||272
610568|NCT00367133|1494854|P3|STARTED|2 Years|Number of Eyes|254
610569|NCT00367133|1494855|P2|STARTED|2 Years|Number of Eyes|256
610570|NCT00367133|1494856|P1|STARTED|2 Years|Number of Eyes|330
610571|NCT00367055|1494908|P2|NOT COMPLETED|Overall Study||11
610572|NCT00367055|1494909|P1|NOT COMPLETED|Overall Study||11
610573|NCT00367055|1494908|P2|COMPLETED|Overall Study||30
610574|NCT00367055|1494909|P1|COMPLETED|Overall Study||32
610575|NCT00367055|1494908|P2|STARTED|Overall Study||41
610576|NCT00367055|1494909|P1|STARTED|Overall Study||43
610577|NCT00366899|1494925|P2|NOT COMPLETED|Toddler Dose||1
610578|NCT00366899|1494926|P1|NOT COMPLETED|Toddler Dose||2
610579|NCT00366899|1494925|P2|COMPLETED|Toddler Dose||281
610580|NCT00366899|1494926|P1|COMPLETED|Toddler Dose||285
610581|NCT00366899|1494925|P2|STARTED|Toddler Dose||282
610582|NCT00366899|1494926|P1|STARTED|Toddler Dose||287
610583|NCT00366899|1494925|P2|NOT COMPLETED|After Infant Series||9
610584|NCT00366899|1494926|P1|NOT COMPLETED|After Infant Series||7
610585|NCT00366899|1494925|P2|COMPLETED|After Infant Series||282
610586|NCT00366899|1494926|P1|COMPLETED|After Infant Series||287
610587|NCT00366899|1494925|P2|STARTED|After Infant Series||291
610588|NCT00366899|1494926|P1|STARTED|After Infant Series||294
610589|NCT00366899|1494925|P2|NOT COMPLETED|Infant Series||12
610590|NCT00366899|1494926|P1|NOT COMPLETED|Infant Series||9
610591|NCT00366899|1494925|P2|COMPLETED|Infant Series||291
610592|NCT00366899|1494926|P1|COMPLETED|Infant Series||294
610593|NCT00366899|1494925|P2|Vaccinated Dose 2|Infant Series||293
610594|NCT00366899|1494926|P1|Vaccinated Dose 2|Infant Series|1 participant randomized to 13vPnC, incorrectly received 7vPnC|296
610595|NCT00366899|1494925|P2|Vaccinated Dose 1|Infant Series||302
610686|NCT00366444|1495131|P2|NOT COMPLETED|Overall Study||2
610596|NCT00366899|1494926|P1|Vaccinated Dose 1|Infant Series|2 participants randomized to 13vPnC, incorrectly received 7vPnC|302
610597|NCT00366899|1494925|P2|STARTED|Infant Series|1 participant randomized to 7vPnC but never vaccinated|303
610598|NCT00366899|1494926|P1|STARTED|Infant Series|1 participant was counted twice, 1 participant randomized to 13vPnC, incorrectly received 7vPnC|303
610599|NCT00366678|1494986|P3|NOT COMPLETED|Toddler Dose||0
610600|NCT00366678|1494987|P2|NOT COMPLETED|Toddler Dose||1
610601|NCT00366678|1494988|P1|NOT COMPLETED|Toddler Dose||5
610602|NCT00366678|1494986|P3|COMPLETED|Toddler Dose||137
610603|NCT00366678|1494987|P2|COMPLETED|Toddler Dose||151
610604|NCT00366678|1494988|P1|COMPLETED|Toddler Dose||268
610605|NCT00366678|1494986|P3|STARTED|Toddler Dose||137
610606|NCT00366678|1494987|P2|STARTED|Toddler Dose||152
610607|NCT00366678|1494988|P1|STARTED|Toddler Dose||273
610608|NCT00366678|1494986|P3|NOT COMPLETED|After Infant||0
610609|NCT00366678|1494987|P2|NOT COMPLETED|After Infant||10
610610|NCT00366678|1494988|P1|NOT COMPLETED|After Infant||17
610611|NCT00366678|1494986|P3|COMPLETED|After Infant||0
610612|NCT00366678|1494987|P2|COMPLETED|After Infant||289
610613|NCT00366678|1494988|P1|COMPLETED|After Infant||273
610614|NCT00366678|1494986|P3|STARTED|After Infant||0
610615|NCT00366678|1494987|P2|STARTED|After Infant||299
610616|NCT00366678|1494988|P1|STARTED|After Infant||290
610617|NCT00366678|1494986|P3|NOT COMPLETED|Infant Series||0
610618|NCT00366678|1494987|P2|NOT COMPLETED|Infant Series||10
610619|NCT00366678|1494988|P1|NOT COMPLETED|Infant Series||14
610620|NCT00366678|1494986|P3|COMPLETED|Infant Series||0
610621|NCT00366678|1494987|P2|COMPLETED|Infant Series||299
610622|NCT00366678|1494988|P1|COMPLETED|Infant Series||290
610623|NCT00366678|1494986|P3|Vaccinated Dose 3|Infant Series||0
610624|NCT00366678|1494987|P2|Vaccinated Dose 3|Infant Series||302
610625|NCT00366678|1494988|P1|Vaccinated Dose 3|Infant Series||291
610626|NCT00366678|1494986|P3|Vaccinated Dose 2|Infant Series||0
610627|NCT00366678|1494987|P2|Vaccinated Dose 2|Infant Series||304
610628|NCT00366678|1494988|P1|Vaccinated Dose 2|Infant Series||295
610629|NCT00366678|1494986|P3|Vaccinated Dose 1|Infant Series||0
610630|NCT00366678|1494987|P2|Vaccinated Dose 1|Infant Series||309
610631|NCT00366678|1494988|P1|Vaccinated Dose 1|Infant Series||302
610632|NCT00366678|1494986|P3|STARTED|Infant Series||0
610633|NCT00366678|1494987|P2|STARTED|Infant Series||309
610634|NCT00366678|1494988|P1|STARTED|Infant Series||304
610635|NCT00366626|1495055|P2|NOT COMPLETED|Overall Study||0
610636|NCT00366626|1495056|P1|NOT COMPLETED|Overall Study||0
610637|NCT00366626|1495055|P2|COMPLETED|Overall Study||45
610638|NCT00366626|1495056|P1|COMPLETED|Overall Study||38
610639|NCT00366626|1495055|P2|STARTED|Overall Study||45
610640|NCT00366626|1495056|P1|STARTED|Overall Study||38
610641|NCT00366548|1495070|P2|NOT COMPLETED|Toddler Dose||0
610642|NCT00366548|1495071|P1|NOT COMPLETED|Toddler Dose||0
610643|NCT00366548|1495070|P2|COMPLETED|Toddler Dose||244
610644|NCT00366548|1495071|P1|COMPLETED|Toddler Dose||240
610645|NCT00366548|1495070|P2|STARTED|Toddler Dose||244
610646|NCT00366548|1495071|P1|STARTED|Toddler Dose||240
610647|NCT00366548|1495070|P2|NOT COMPLETED|After Infant Series||1
610648|NCT00366548|1495071|P1|NOT COMPLETED|After Infant Series||6
610649|NCT00366548|1495070|P2|COMPLETED|After Infant Series||244
610650|NCT00366548|1495071|P1|COMPLETED|After Infant Series||240
610651|NCT00366548|1495070|P2|STARTED|After Infant Series||245
610652|NCT00366548|1495071|P1|STARTED|After Infant Series||246
610653|NCT00366548|1495070|P2|NOT COMPLETED|Infant Series||5
610654|NCT00366548|1495071|P1|NOT COMPLETED|Infant Series||4
610655|NCT00366548|1495070|P2|COMPLETED|Infant Series||245
610656|NCT00366548|1495071|P1|COMPLETED|Infant Series||246
610657|NCT00366548|1495070|P2|Vaccinated Dose 3|Infant Series||247
610658|NCT00366548|1495071|P1|Vaccinated Dose 3|Infant Series||246
610659|NCT00366548|1495070|P2|Vaccinated Dose 2|Infant Series||249
610660|NCT00366548|1495071|P1|Vaccinated Dose 2|Infant Series||246
610661|NCT00366548|1495070|P2|Vaccinated Dose 1|Infant Series||250
610662|NCT00366548|1495071|P1|Vaccinated Dose 1|Infant Series||250
610663|NCT00366548|1495070|P2|STARTED|Infant Series||250
610664|NCT00366548|1495071|P1|STARTED|Infant Series||250
610665|NCT00366535|1495107|P2|NOT COMPLETED|Second Phase: 12 Weeks||3
610666|NCT00366535|1495108|P1|NOT COMPLETED|Second Phase: 12 Weeks||3
610667|NCT00366535|1495107|P2|COMPLETED|Second Phase: 12 Weeks||18
610668|NCT00366535|1495108|P1|COMPLETED|Second Phase: 12 Weeks||21
610669|NCT00366535|1495107|P2|STARTED|Second Phase: 12 Weeks||21
610670|NCT00366535|1495108|P1|STARTED|Second Phase: 12 Weeks||24
610671|NCT00366535|1495107|P2|NOT COMPLETED|Washout Period (at Least a Week)||0
610672|NCT00366535|1495108|P1|NOT COMPLETED|Washout Period (at Least a Week)||0
610673|NCT00366535|1495107|P2|COMPLETED|Washout Period (at Least a Week)||21
610674|NCT00366535|1495108|P1|COMPLETED|Washout Period (at Least a Week)||24
610675|NCT00366535|1495107|P2|STARTED|Washout Period (at Least a Week)||21
610676|NCT00366535|1495108|P1|STARTED|Washout Period (at Least a Week)||24
610677|NCT00366535|1495107|P2|NOT COMPLETED|First Phase: 12 Weeks||8
610678|NCT00366535|1495108|P1|NOT COMPLETED|First Phase: 12 Weeks||3
610679|NCT00366535|1495107|P2|COMPLETED|First Phase: 12 Weeks||21
610680|NCT00366535|1495108|P1|COMPLETED|First Phase: 12 Weeks||24
610681|NCT00366535|1495107|P2|STARTED|First Phase: 12 Weeks||29
610682|NCT00366535|1495108|P1|STARTED|First Phase: 12 Weeks||27
610683|NCT00366457|1495122|P1|NOT COMPLETED|Overall Study||2
610684|NCT00366457|1495122|P1|COMPLETED|Overall Study||30
610685|NCT00366457|1495122|P1|STARTED|Overall Study||32
610687|NCT00366444|1495132|P1|NOT COMPLETED|Overall Study||1
610688|NCT00366444|1495131|P2|COMPLETED|Overall Study||97
610689|NCT00366444|1495132|P1|COMPLETED|Overall Study||101
610690|NCT00366444|1495131|P2|STARTED|Overall Study||99
610691|NCT00366444|1495132|P1|STARTED|Overall Study||102
610692|NCT00366340|1495160|P2|NOT COMPLETED|Toddler Dose||1
610693|NCT00366340|1495161|P1|NOT COMPLETED|Toddler Dose||1
610694|NCT00366340|1495160|P2|COMPLETED|Toddler Dose||286
610695|NCT00366340|1495161|P1|COMPLETED|Toddler Dose||289
610696|NCT00366340|1495160|P2|STARTED|Toddler Dose||287
610697|NCT00366340|1495161|P1|STARTED|Toddler Dose||290
610698|NCT00366340|1495160|P2|NOT COMPLETED|After the Infant Series||6
610699|NCT00366340|1495161|P1|NOT COMPLETED|After the Infant Series||3
610700|NCT00366340|1495160|P2|COMPLETED|After the Infant Series||287
610701|NCT00366340|1495161|P1|COMPLETED|After the Infant Series||290
610702|NCT00366340|1495160|P2|STARTED|After the Infant Series||293
610703|NCT00366340|1495161|P1|STARTED|After the Infant Series||293
610704|NCT00366340|1495160|P2|NOT COMPLETED|Infant Series||10
610705|NCT00366340|1495161|P1|NOT COMPLETED|Infant Series||8
610706|NCT00366340|1495160|P2|COMPLETED|Infant Series||293
610707|NCT00366340|1495161|P1|COMPLETED|Infant Series||293
610708|NCT00366340|1495160|P2|Vaccinated Dose 3|Infant Series||293
610709|NCT00366340|1495161|P1|Vaccinated Dose 3|Infant Series||294
610710|NCT00366340|1495160|P2|Vaccinated Dose 2|Infant Series||297
610711|NCT00366340|1495161|P1|Vaccinated Dose 2|Infant Series||296
610712|NCT00366340|1495160|P2|Vaccinated Dose 1|Infant Series||303
610713|NCT00366340|1495161|P1|Vaccinated Dose 1|Infant Series||300
610714|NCT00366340|1495160|P2|STARTED|Infant Series||303
610715|NCT00366340|1495161|P1|STARTED|Infant Series||301
610716|NCT00366301|1495219|P4|NOT COMPLETED|Overall Study||8
610717|NCT00366301|1495220|P3|NOT COMPLETED|Overall Study||4
610718|NCT00366301|1495221|P2|NOT COMPLETED|Overall Study||6
610719|NCT00366301|1495222|P1|NOT COMPLETED|Overall Study||8
610720|NCT00366301|1495219|P4|COMPLETED|Overall Study||116
610721|NCT00366301|1495220|P3|COMPLETED|Overall Study||122
610722|NCT00366301|1495221|P2|COMPLETED|Overall Study||120
610723|NCT00366301|1495222|P1|COMPLETED|Overall Study||116
610724|NCT00366301|1495219|P4|Either 6W or 14W CRP Obtained|Overall Study||119
610725|NCT00366301|1495220|P3|Either 6W or 14W CRP Obtained|Overall Study||124
610726|NCT00366301|1495221|P2|Either 6W or 14W CRP Obtained|Overall Study||124
610727|NCT00366301|1495222|P1|Either 6W or 14W CRP Obtained|Overall Study||120
610728|NCT00366301|1495219|P4|STARTED|Overall Study||124
610729|NCT00366301|1495220|P3|STARTED|Overall Study||126
610730|NCT00366301|1495221|P2|STARTED|Overall Study||126
610731|NCT00366301|1495222|P1|STARTED|Overall Study||124
610732|NCT00366275|1495232|P1|NOT COMPLETED|Overall Study||6
610733|NCT00366275|1495232|P1|COMPLETED|Overall Study||58
610734|NCT00366275|1495232|P1|STARTED|Overall Study||64
610735|NCT00366249|1495238|P2|NOT COMPLETED|Overall Study||78
610736|NCT00366249|1495239|P1|NOT COMPLETED|Overall Study||131
610737|NCT00366249|1495238|P2|COMPLETED|Overall Study||430
610738|NCT00366249|1495239|P1|COMPLETED|Overall Study||422
610739|NCT00366249|1495238|P2|STARTED|Overall Study||508
610740|NCT00366249|1495239|P1|STARTED|Overall Study||553
610741|NCT00366106|1495253|P1|NOT COMPLETED|Overall Study||0
610742|NCT00366106|1495253|P1|COMPLETED|Overall Study||32
610743|NCT00366106|1495253|P1|STARTED|Overall Study||32
610744|NCT00366028|1495262|P2|NOT COMPLETED|Overall Study||0
610745|NCT00366028|1495263|P1|NOT COMPLETED|Overall Study||0
610746|NCT00366028|1495262|P2|COMPLETED|Overall Study||735
610747|NCT00366028|1495263|P1|COMPLETED|Overall Study||889
610748|NCT00366028|1495262|P2|STARTED|Overall Study||735
610749|NCT00366028|1495263|P1|STARTED|Overall Study||889
610750|NCT00365976|1495273|P2|NOT COMPLETED|Overall Study||5
610751|NCT00365976|1495274|P1|NOT COMPLETED|Overall Study||1
610752|NCT00365976|1495273|P2|COMPLETED|Overall Study||20
610753|NCT00365976|1495274|P1|COMPLETED|Overall Study||32
610754|NCT00365976|1495273|P2|STARTED|Overall Study||25
610755|NCT00365976|1495274|P1|STARTED|Overall Study||33
610756|NCT00365872|1495305|P3|NOT COMPLETED|Overall Study||0
610757|NCT00365872|1495306|P2|NOT COMPLETED|Overall Study||0
610758|NCT00365872|1495307|P1|NOT COMPLETED|Overall Study||0
610759|NCT00365872|1495305|P3|COMPLETED|Overall Study||6
610760|NCT00365872|1495306|P2|COMPLETED|Overall Study||6
610761|NCT00365872|1495307|P1|COMPLETED|Overall Study||5
610762|NCT00365872|1495305|P3|STARTED|Overall Study||6
610763|NCT00365872|1495306|P2|STARTED|Overall Study||6
610764|NCT00365872|1495307|P1|STARTED|Overall Study||5
610765|NCT00365859|1495320|P4|NOT COMPLETED|Overall Study||131
610766|NCT00365859|1495321|P3|NOT COMPLETED|Overall Study||67
610767|NCT00365859|1495322|P2|NOT COMPLETED|Overall Study||33
610768|NCT00365859|1495323|P1|NOT COMPLETED|Overall Study||31
610769|NCT00365859|1495320|P4|COMPLETED|Overall Study||199
610770|NCT00365859|1495321|P3|COMPLETED|Overall Study||107
610771|NCT00365859|1495322|P2|COMPLETED|Overall Study||37
610772|NCT00365859|1495323|P1|COMPLETED|Overall Study||55
610773|NCT00365859|1495320|P4|Efficacy Population|Overall Study||322
610774|NCT00365859|1495321|P3|Efficacy Population|Overall Study|3 lost to follow-up, 1 not included due to mild increased appetite, 1 to family emergency (total=5)|169
610775|NCT00365859|1495322|P2|Efficacy Population|Overall Study|1 not included due to increased alanine aminotransferase (ALT) prior to treatment with aripiprazole|69
610776|NCT00365859|1495323|P1|Efficacy Population|Overall Study|1 patient was lost to follow-up and 1 not included due to moderate sedation (total=2)|84
610777|NCT00365859|1495320|P4|Safety Population|Overall Study||330
610778|NCT00365859|1495321|P3|Safety Population|Overall Study||174
610779|NCT00365859|1495322|P2|Safety Population|Overall Study||70
610780|NCT00365859|1495323|P1|Safety Population|Overall Study||86
610781|NCT00365859|1495320|P4|STARTED|Overall Study||330
610782|NCT00365859|1495321|P3|STARTED|Overall Study||174
610783|NCT00365859|1495322|P2|STARTED|Overall Study||70
610784|NCT00365859|1495323|P1|STARTED|Overall Study||86
610785|NCT00365846|1495412|P1|NOT COMPLETED|Overall Study||1
610786|NCT00365846|1495412|P1|COMPLETED|Overall Study||28
610787|NCT00365846|1495412|P1|STARTED|Overall Study||29
610788|NCT00365768|1495423|P2|NOT COMPLETED|Overall Study||0
610789|NCT00365768|1495424|P1|NOT COMPLETED|Overall Study||0
610790|NCT00365768|1495423|P2|COMPLETED|Overall Study||25
610791|NCT00365768|1495424|P1|COMPLETED|Overall Study||24
610792|NCT00365768|1495423|P2|STARTED|Overall Study||25
610793|NCT00365768|1495424|P1|STARTED|Overall Study||24
610794|NCT00365716|1495437|P7|NOT COMPLETED|Extension 2||10
610795|NCT00365716|1495438|P6|NOT COMPLETED|Extension 2||0
610796|NCT00365716|1495439|P5|NOT COMPLETED|Extension 2||0
610797|NCT00365716|1495440|P4|NOT COMPLETED|Extension 2||0
610798|NCT00365716|1495441|P3|NOT COMPLETED|Extension 2||0
610799|NCT00365716|1495442|P2|NOT COMPLETED|Extension 2||0
610800|NCT00365716|1495443|P1|NOT COMPLETED|Extension 2||0
610801|NCT00365716|1495437|P7|COMPLETED|Extension 2||7
610802|NCT00365716|1495438|P6|COMPLETED|Extension 2||0
610803|NCT00365716|1495439|P5|COMPLETED|Extension 2||0
610804|NCT00365716|1495440|P4|COMPLETED|Extension 2||0
610805|NCT00365716|1495441|P3|COMPLETED|Extension 2||0
610806|NCT00365716|1495442|P2|COMPLETED|Extension 2||0
610807|NCT00365716|1495443|P1|COMPLETED|Extension 2||0
610808|NCT00365716|1495437|P7|STARTED|Extension 2|17 Participants continued into Extension 2 from Extension 1|17
610809|NCT00365716|1495438|P6|STARTED|Extension 2||0
610810|NCT00365716|1495439|P5|STARTED|Extension 2||0
610811|NCT00365716|1495440|P4|STARTED|Extension 2||0
610812|NCT00365716|1495441|P3|STARTED|Extension 2||0
610813|NCT00365716|1495442|P2|STARTED|Extension 2||0
610814|NCT00365716|1495443|P1|STARTED|Extension 2||0
610815|NCT00365716|1495437|P7|NOT COMPLETED|Extension 1||0
610816|NCT00365716|1495438|P6|NOT COMPLETED|Extension 1||22
610817|NCT00365716|1495439|P5|NOT COMPLETED|Extension 1||0
610818|NCT00365716|1495440|P4|NOT COMPLETED|Extension 1||0
610819|NCT00365716|1495441|P3|NOT COMPLETED|Extension 1||0
610820|NCT00365716|1495442|P2|NOT COMPLETED|Extension 1||0
610821|NCT00365716|1495443|P1|NOT COMPLETED|Extension 1||0
610822|NCT00365716|1495437|P7|COMPLETED|Extension 1||0
610823|NCT00365716|1495438|P6|COMPLETED|Extension 1||219
610824|NCT00365716|1495439|P5|COMPLETED|Extension 1||0
610825|NCT00365716|1495440|P4|COMPLETED|Extension 1||0
610826|NCT00365716|1495441|P3|COMPLETED|Extension 1||0
610827|NCT00365716|1495442|P2|COMPLETED|Extension 1||0
610828|NCT00365716|1495443|P1|COMPLETED|Extension 1||0
610829|NCT00365716|1495437|P7|STARTED|Extension 1||0
610830|NCT00365716|1495438|P6|STARTED|Extension 1||241
610831|NCT00365716|1495439|P5|STARTED|Extension 1||0
610832|NCT00365716|1495440|P4|STARTED|Extension 1||0
610833|NCT00365716|1495441|P3|STARTED|Extension 1||0
610834|NCT00365716|1495442|P2|STARTED|Extension 1||0
610835|NCT00365716|1495443|P1|STARTED|Extension 1||0
610836|NCT00365716|1495437|P7|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
610837|NCT00365716|1495438|P6|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
610838|NCT00365716|1495439|P5|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||82
610839|NCT00365716|1495440|P4|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||79
610840|NCT00365716|1495441|P3|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||20
610841|NCT00365716|1495442|P2|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||15
610842|NCT00365716|1495443|P1|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||132
610843|NCT00365716|1495437|P7|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
610844|NCT00365716|1495438|P6|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
610845|NCT00365716|1495439|P5|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57
610846|NCT00365716|1495440|P4|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57
610847|NCT00365716|1495441|P3|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||251
610848|NCT00365716|1495442|P2|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||245
610849|NCT00365716|1495443|P1|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||137
610850|NCT00365716|1495437|P7|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0
610851|NCT00365716|1495438|P6|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0
610852|NCT00365716|1495439|P5|STARTED|Long Term Follow-up (Month 7 toMonth 36)||139
610853|NCT00365716|1495440|P4|STARTED|Long Term Follow-up (Month 7 toMonth 36)||136
610854|NCT00365716|1495441|P3|STARTED|Long Term Follow-up (Month 7 toMonth 36)||271
610855|NCT00365716|1495442|P2|STARTED|Long Term Follow-up (Month 7 toMonth 36)||260
610856|NCT00365716|1495443|P1|STARTED|Long Term Follow-up (Month 7 toMonth 36)||269
610857|NCT00365716|1495437|P7|NOT COMPLETED|Base Study (Day 1 to Month 7)||0
610858|NCT00365716|1495438|P6|NOT COMPLETED|Base Study (Day 1 to Month 7)||0
610859|NCT00365716|1495439|P5|NOT COMPLETED|Base Study (Day 1 to Month 7)||7
610860|NCT00365716|1495440|P4|NOT COMPLETED|Base Study (Day 1 to Month 7)||10
610861|NCT00365716|1495441|P3|NOT COMPLETED|Base Study (Day 1 to Month 7)||21
610862|NCT00365716|1495442|P2|NOT COMPLETED|Base Study (Day 1 to Month 7)||24
610863|NCT00365716|1495443|P1|NOT COMPLETED|Base Study (Day 1 to Month 7)||21
610864|NCT00365716|1495437|P7|COMPLETED|Base Study (Day 1 to Month 7)||0
610865|NCT00365716|1495438|P6|COMPLETED|Base Study (Day 1 to Month 7)||0
610866|NCT00365716|1495439|P5|COMPLETED|Base Study (Day 1 to Month 7)||139
610867|NCT00365716|1495440|P4|COMPLETED|Base Study (Day 1 to Month 7)||136
610868|NCT00365716|1495441|P3|COMPLETED|Base Study (Day 1 to Month 7)||271
610869|NCT00365716|1495442|P2|COMPLETED|Base Study (Day 1 to Month 7)||260
610870|NCT00365716|1495443|P1|COMPLETED|Base Study (Day 1 to Month 7)||269
610871|NCT00365716|1495437|P7|STARTED|Base Study (Day 1 to Month 7)||0
610872|NCT00365716|1495438|P6|STARTED|Base Study (Day 1 to Month 7)||0
610873|NCT00365716|1495439|P5|STARTED|Base Study (Day 1 to Month 7)||146
610874|NCT00365716|1495440|P4|STARTED|Base Study (Day 1 to Month 7)||146
610875|NCT00365716|1495441|P3|STARTED|Base Study (Day 1 to Month 7)||292
610876|NCT00365716|1495442|P2|STARTED|Base Study (Day 1 to Month 7)||284
610877|NCT00365716|1495443|P1|STARTED|Base Study (Day 1 to Month 7)||290
610878|NCT00365599|1495458|P1|NOT COMPLETED|Overall Study||0
610879|NCT00365599|1495458|P1|COMPLETED|Overall Study||43
610880|NCT00365599|1495458|P1|STARTED|Overall Study||43
610881|NCT00365547|1495464|P1|NOT COMPLETED|Overall Study||3
610882|NCT00365547|1495464|P1|COMPLETED|Overall Study||43
610883|NCT00365547|1495464|P1|STARTED|Overall Study||46
610884|NCT00365508|1495474|P2|NOT COMPLETED|Overall Study||154
610885|NCT00365508|1495475|P1|NOT COMPLETED|Overall Study||139
610886|NCT00365508|1495474|P2|COMPLETED|Overall Study||167
610887|NCT00365508|1495475|P1|COMPLETED|Overall Study||182
610888|NCT00365508|1495474|P2|STARTED|Overall Study||321
610889|NCT00365508|1495475|P1|STARTED|Overall Study||321
610890|NCT00365456|1495483|P2|NOT COMPLETED|Trial Period III (12 Months)||5
610891|NCT00365456|1495484|P1|NOT COMPLETED|Trial Period III (12 Months)||18
610892|NCT00365456|1495483|P2|COMPLETED|Trial Period III (12 Months)||127
610893|NCT00365456|1495484|P1|COMPLETED|Trial Period III (12 Months)||118
610894|NCT00365456|1495483|P2|STARTED|Trial Period III (12 Months)||132
610895|NCT00365456|1495484|P1|STARTED|Trial Period III (12 Months)||136
610896|NCT00365456|1495483|P2|NOT COMPLETED|Trial Period II (12 Months)||14
610897|NCT00365456|1495484|P1|NOT COMPLETED|Trial Period II (12 Months)||0
610898|NCT00365456|1495483|P2|COMPLETED|Trial Period II (12 Months)||268
610899|NCT00365456|1495484|P1|COMPLETED|Trial Period II (12 Months)||0
610900|NCT00365456|1495483|P2|STARTED|Trial Period II (12 Months)||282
610901|NCT00365456|1495484|P1|STARTED|Trial Period II (12 Months)||0
610902|NCT00365456|1495483|P2|NOT COMPLETED|Trial Period I (12 Months)||0
610903|NCT00365456|1495484|P1|NOT COMPLETED|Trial Period I (12 Months)||125
610904|NCT00365456|1495483|P2|COMPLETED|Trial Period I (12 Months)||0
610905|NCT00365456|1495484|P1|COMPLETED|Trial Period I (12 Months)||282
610906|NCT00365456|1495483|P2|STARTED|Trial Period I (12 Months)||0
610907|NCT00365456|1495484|P1|STARTED|Trial Period I (12 Months)||407
610908|NCT00365417|1495490|P1|NOT COMPLETED|Overall Study||0
610909|NCT00365417|1495490|P1|COMPLETED|Overall Study||45
610910|NCT00365417|1495490|P1|STARTED|Overall Study||45
610911|NCT00365391|1495496|P1|NOT COMPLETED|Overall Study||0
610912|NCT00365391|1495496|P1|COMPLETED|Overall Study||27
610913|NCT00365391|1495496|P1|STARTED|Overall Study||27
610914|NCT00365378|1495506|P3|NOT COMPLETED|Extension||197
610915|NCT00365378|1495507|P2|NOT COMPLETED|Extension||0
610916|NCT00365378|1495508|P1|NOT COMPLETED|Extension||0
610917|NCT00365378|1495506|P3|COMPLETED|Extension||203
610918|NCT00365378|1495507|P2|COMPLETED|Extension||0
610919|NCT00365378|1495508|P1|COMPLETED|Extension||0
610920|NCT00365378|1495506|P3|STARTED|Extension||400
610921|NCT00365378|1495507|P2|STARTED|Extension||0
610922|NCT00365378|1495508|P1|STARTED|Extension||0
610923|NCT00365378|1495506|P3|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||0
610924|NCT00365378|1495507|P2|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||202
610925|NCT00365378|1495508|P1|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||158
610926|NCT00365378|1495506|P3|COMPLETED|Follow-up (Month 7 Though Month 48)||0
610927|NCT00365378|1495507|P2|COMPLETED|Follow-up (Month 7 Though Month 48)||836
610928|NCT00365378|1495508|P1|COMPLETED|Follow-up (Month 7 Though Month 48)||835
610929|NCT00365378|1495506|P3|STARTED|Follow-up (Month 7 Though Month 48)||0
610930|NCT00365378|1495507|P2|STARTED|Follow-up (Month 7 Though Month 48)||1038
610931|NCT00365378|1495508|P1|STARTED|Follow-up (Month 7 Though Month 48)||993
610932|NCT00365378|1495506|P3|NOT COMPLETED|Vaccination (Day 1 to Month 7)||0
610933|NCT00365378|1495507|P2|NOT COMPLETED|Vaccination (Day 1 to Month 7)||167
610934|NCT00365378|1495508|P1|NOT COMPLETED|Vaccination (Day 1 to Month 7)||211
610935|NCT00365378|1495506|P3|COMPLETED|Vaccination (Day 1 to Month 7)||0
610936|NCT00365378|1495507|P2|COMPLETED|Vaccination (Day 1 to Month 7)||1038
610937|NCT00365378|1495508|P1|COMPLETED|Vaccination (Day 1 to Month 7)||993
610938|NCT00365378|1495506|P3|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||0
610939|NCT00365378|1495507|P2|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1198
610940|NCT00365378|1495508|P1|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1193
610941|NCT00365378|1495506|P3|STARTED|Vaccination (Day 1 to Month 7)||0
610942|NCT00365378|1495507|P2|STARTED|Vaccination (Day 1 to Month 7)||1205
610943|NCT00365378|1495508|P1|STARTED|Vaccination (Day 1 to Month 7)||1204
610944|NCT00365365|1495522|P3|NOT COMPLETED|Overall Study||15
610945|NCT00365365|1495523|P2|NOT COMPLETED|Overall Study||36
610946|NCT00365365|1495524|P1|NOT COMPLETED|Overall Study||34
610947|NCT00365365|1495522|P3|COMPLETED|Overall Study||44
610948|NCT00365365|1495523|P2|COMPLETED|Overall Study||41
610949|NCT00365365|1495524|P1|COMPLETED|Overall Study||44
610950|NCT00365365|1495522|P3|COMPLETED TREATMENT|Overall Study||45
610951|NCT00365365|1495523|P2|COMPLETED TREATMENT|Overall Study||36
610952|NCT00365365|1495524|P1|COMPLETED TREATMENT|Overall Study||38
610953|NCT00365365|1495522|P3|TREATED (SAFETY POPULATION)|Overall Study||59
610954|NCT00365365|1495523|P2|TREATED (SAFETY POPULATION)|Overall Study||75
610955|NCT00365365|1495524|P1|TREATED (SAFETY POPULATION)|Overall Study||78
610956|NCT00365365|1495522|P3|STARTED|Overall Study||59
610957|NCT00365365|1495523|P2|STARTED|Overall Study||77
610958|NCT00365365|1495524|P1|STARTED|Overall Study||78
610959|NCT00365352|1495541|P3|NOT COMPLETED|Overall Study||15
610960|NCT00365352|1495542|P2|NOT COMPLETED|Overall Study||11
610961|NCT00365352|1495543|P1|NOT COMPLETED|Overall Study||20
610962|NCT00365352|1495541|P3|COMPLETED|Overall Study||98
610963|NCT00365352|1495542|P2|COMPLETED|Overall Study||104
610964|NCT00365352|1495543|P1|COMPLETED|Overall Study||77
610965|NCT00365352|1495541|P3|Modified Intent-to-Treat Population|Overall Study||111
610966|NCT00365352|1495542|P2|Modified Intent-to-Treat Population|Overall Study||114
610967|NCT00365352|1495543|P1|Modified Intent-to-Treat Population|Overall Study||96
610968|NCT00365352|1495541|P3|Safety Population|Overall Study||111
610969|NCT00365352|1495542|P2|Safety Population|Overall Study||115
610970|NCT00365352|1495543|P1|Safety Population|Overall Study||96
610971|NCT00365352|1495541|P3|STARTED|Overall Study||113
610972|NCT00365352|1495542|P2|STARTED|Overall Study||115
610973|NCT00365352|1495543|P1|STARTED|Overall Study||97
610974|NCT00365300|1495627|P2|NOT COMPLETED|Double-blind Phase||9
610975|NCT00365300|1495628|P1|NOT COMPLETED|Double-blind Phase||11
610976|NCT00365300|1495627|P2|COMPLETED|Double-blind Phase||45
610977|NCT00365300|1495628|P1|COMPLETED|Double-blind Phase||43
610978|NCT00365300|1495627|P2|STARTED|Double-blind Phase||54
610979|NCT00365300|1495628|P1|STARTED|Double-blind Phase||54
610980|NCT00365300|1495627|P2|NOT COMPLETED|Open-label Phase||0
610981|NCT00365300|1495628|P1|NOT COMPLETED|Open-label Phase||22
610982|NCT00365300|1495627|P2|COMPLETED|Open-label Phase||0
610983|NCT00365300|1495628|P1|COMPLETED|Open-label Phase||107
610984|NCT00365300|1495627|P2|STARTED|Open-label Phase||0
610985|NCT00365300|1495628|P1|STARTED|Open-label Phase||129
610986|NCT00365274|1495637|P1|NOT COMPLETED|Overall Study||0
610987|NCT00365274|1495637|P1|COMPLETED|Overall Study||6
610988|NCT00365274|1495637|P1|STARTED|Overall Study||6
610989|NCT00365261|1495643|P2|NOT COMPLETED|Overall Study||3
610990|NCT00365261|1495644|P1|NOT COMPLETED|Overall Study||3
610991|NCT00365261|1495643|P2|COMPLETED|Overall Study||19
610992|NCT00365261|1495644|P1|COMPLETED|Overall Study||20
610993|NCT00365261|1495643|P2|STARTED|Overall Study||22
610994|NCT00365261|1495644|P1|STARTED|Overall Study||23
610995|NCT00365209|1495654|P1|NOT COMPLETED|Stage 2: Receiving 4g Curcumin||2
610996|NCT00365209|1495654|P1|COMPLETED|Stage 2: Receiving 4g Curcumin||19
610997|NCT00365209|1495654|P1|STARTED|Stage 2: Receiving 4g Curcumin||21
610998|NCT00365209|1495654|P1|NOT COMPLETED|Stage 1: Receiving 2g Curcumin||2
610999|NCT00365209|1495654|P1|COMPLETED|Stage 1: Receiving 2g Curcumin||21
611000|NCT00365209|1495654|P1|STARTED|Stage 1: Receiving 2g Curcumin||23
611001|NCT00365144|1495683|P1|NOT COMPLETED|Overall Study||0
611002|NCT00365144|1495683|P1|COMPLETED|Overall Study||36
611003|NCT00365144|1495683|P1|STARTED|Overall Study||36
611004|NCT00365105|1495693|P2|NOT COMPLETED|Overall Study||4
611005|NCT00365105|1495694|P1|NOT COMPLETED|Overall Study||6
611006|NCT00365105|1495693|P2|COMPLETED|Overall Study||128
611007|NCT00365105|1495694|P1|COMPLETED|Overall Study||123
611008|NCT00365105|1495693|P2|STARTED|Overall Study||132
611009|NCT00365105|1495694|P1|STARTED|Overall Study||129
611010|NCT00365053|1495700|P1|NOT COMPLETED|Overall Study||0
611011|NCT00365053|1495700|P1|COMPLETED|Overall Study||13
611012|NCT00365053|1495700|P1|STARTED|Overall Study||13
611013|NCT00364949|1495711|P2|NOT COMPLETED|Overall Study||0
611014|NCT00364949|1495712|P1|NOT COMPLETED|Overall Study||0
611015|NCT00364949|1495711|P2|COMPLETED|Overall Study||39
611016|NCT00364949|1495712|P1|COMPLETED|Overall Study||31
611017|NCT00364949|1495711|P2|STARTED|Overall Study||39
611018|NCT00364949|1495712|P1|STARTED|Overall Study||31
611019|NCT00364923|1495730|P1|NOT COMPLETED|Survival Follow-up, After Pralatrexate||24
611020|NCT00364923|1495730|P1|COMPLETED|Survival Follow-up, After Pralatrexate|Pts who completed follow-up either died, were followed for 24 months, or withdrew|83
611021|NCT00364923|1495730|P1|STARTED|Survival Follow-up, After Pralatrexate|Patients (pts) who stop treatment with pralatrexate are followed for survival|107
611022|NCT00364923|1495730|P1|NOT COMPLETED|Treatment With Pralatrexate||4
611023|NCT00364923|1495730|P1|COMPLETED|Treatment With Pralatrexate|Treatment duration not limited. After treatment ends, patients attend survival follow-up visits.|107
611024|NCT00364923|1495730|P1|STARTED|Treatment With Pralatrexate|Received at least one dose of pralatrexate.|111
611025|NCT00364858|1495739|P2|NOT COMPLETED|Overall Study||22
611026|NCT00364858|1495740|P1|NOT COMPLETED|Overall Study||7
611027|NCT00364858|1495739|P2|COMPLETED|Overall Study||40
611028|NCT00364858|1495740|P1|COMPLETED|Overall Study||26
611029|NCT00364858|1495739|P2|STARTED|Overall Study||62
611030|NCT00364858|1495740|P1|STARTED|Overall Study||33
611031|NCT00364845|1495755|P2|NOT COMPLETED|Overall Study||11
611032|NCT00364845|1495756|P1|NOT COMPLETED|Overall Study||11
611033|NCT00364845|1495755|P2|COMPLETED|Overall Study|Completed 36-week titration/treatment phase|12
611034|NCT00364845|1495756|P1|COMPLETED|Overall Study|Completed 36-week titration/treatment phase|17
611035|NCT00364845|1495755|P2|STARTED|Overall Study||23
611036|NCT00364845|1495756|P1|STARTED|Overall Study||28
611037|NCT00364832|1495777|P12|NOT COMPLETED|Extension Year 2||3
611038|NCT00364832|1495778|P11|NOT COMPLETED|Extension Year 2||5
611039|NCT00364832|1495779|P10|NOT COMPLETED|Extension Year 2||5
611040|NCT00364832|1495780|P9|NOT COMPLETED|Extension Year 2||0
611041|NCT00364832|1495781|P8|NOT COMPLETED|Extension Year 2||0
611042|NCT00364832|1495782|P7|NOT COMPLETED|Extension Year 2||0
611043|NCT00364832|1495783|P6|NOT COMPLETED|Extension Year 2||0
611044|NCT00364832|1495784|P5|NOT COMPLETED|Extension Year 2||0
611045|NCT00364832|1495785|P4|NOT COMPLETED|Extension Year 2||0
611046|NCT00364832|1495786|P3|NOT COMPLETED|Extension Year 2||0
611047|NCT00364832|1495787|P2|NOT COMPLETED|Extension Year 2||0
611048|NCT00364832|1495788|P1|NOT COMPLETED|Extension Year 2||0
611049|NCT00364832|1495777|P12|COMPLETED|Extension Year 2||11
611050|NCT00364832|1495778|P11|COMPLETED|Extension Year 2||9
611051|NCT00364832|1495779|P10|COMPLETED|Extension Year 2||9
611052|NCT00364832|1495780|P9|COMPLETED|Extension Year 2||0
611053|NCT00364832|1495781|P8|COMPLETED|Extension Year 2||0
611054|NCT00364832|1495782|P7|COMPLETED|Extension Year 2||0
611055|NCT00364832|1495783|P6|COMPLETED|Extension Year 2||0
611056|NCT00364832|1495784|P5|COMPLETED|Extension Year 2||0
611057|NCT00364832|1495785|P4|COMPLETED|Extension Year 2||0
611058|NCT00364832|1495786|P3|COMPLETED|Extension Year 2||0
611059|NCT00364832|1495787|P2|COMPLETED|Extension Year 2||0
611060|NCT00364832|1495788|P1|COMPLETED|Extension Year 2||0
611061|NCT00364832|1495777|P12|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
611062|NCT00364832|1495778|P11|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
611063|NCT00364832|1495779|P10|STARTED|Extension Year 2||14
611064|NCT00364832|1495780|P9|STARTED|Extension Year 2||0
611065|NCT00364832|1495781|P8|STARTED|Extension Year 2||0
611066|NCT00364832|1495782|P7|STARTED|Extension Year 2||0
611067|NCT00364832|1495783|P6|STARTED|Extension Year 2||0
611068|NCT00364832|1495784|P5|STARTED|Extension Year 2||0
611069|NCT00364832|1495785|P4|STARTED|Extension Year 2||0
611070|NCT00364832|1495786|P3|STARTED|Extension Year 2||0
611071|NCT00364832|1495787|P2|STARTED|Extension Year 2||0
611072|NCT00364832|1495788|P1|STARTED|Extension Year 2||0
611073|NCT00364832|1495777|P12|NOT COMPLETED|Extension Year 1||10
611074|NCT00364832|1495778|P11|NOT COMPLETED|Extension Year 1||2
611075|NCT00364832|1495779|P10|NOT COMPLETED|Extension Year 1||4
611076|NCT00364832|1495780|P9|NOT COMPLETED|Extension Year 1||0
611077|NCT00364832|1495781|P8|NOT COMPLETED|Extension Year 1||0
611078|NCT00364832|1495782|P7|NOT COMPLETED|Extension Year 1||0
611079|NCT00364832|1495783|P6|NOT COMPLETED|Extension Year 1||0
611080|NCT00364832|1495784|P5|NOT COMPLETED|Extension Year 1||0
611081|NCT00364832|1495785|P4|NOT COMPLETED|Extension Year 1||0
611082|NCT00364832|1495786|P3|NOT COMPLETED|Extension Year 1||0
611083|NCT00364832|1495787|P2|NOT COMPLETED|Extension Year 1||0
611084|NCT00364832|1495788|P1|NOT COMPLETED|Extension Year 1||0
611085|NCT00364832|1495777|P12|COMPLETED|Extension Year 1||17
611086|NCT00364832|1495778|P11|COMPLETED|Extension Year 1||15
611087|NCT00364832|1495779|P10|COMPLETED|Extension Year 1||14
611088|NCT00364832|1495780|P9|COMPLETED|Extension Year 1||0
611089|NCT00364832|1495781|P8|COMPLETED|Extension Year 1||0
611090|NCT00364832|1495782|P7|COMPLETED|Extension Year 1||0
611091|NCT00364832|1495783|P6|COMPLETED|Extension Year 1||0
611092|NCT00364832|1495784|P5|COMPLETED|Extension Year 1||0
611093|NCT00364832|1495785|P4|COMPLETED|Extension Year 1||0
611094|NCT00364832|1495786|P3|COMPLETED|Extension Year 1||0
611095|NCT00364832|1495787|P2|COMPLETED|Extension Year 1||0
611096|NCT00364832|1495788|P1|COMPLETED|Extension Year 1||0
611097|NCT00364832|1495777|P12|STARTED|Extension Year 1|Participants (Cohorts C, F, and I) who completed core, entered extension period (entry optional).|27
611098|NCT00364832|1495778|P11|STARTED|Extension Year 1|Participants (Cohorts B, E, and H) who completed core, entered extension period (entry optional).|17
611099|NCT00364832|1495779|P10|STARTED|Extension Year 1|Participants (Cohorts A, D, and G) who completed core, entered extension period (entry optional).|18
611100|NCT00364832|1495780|P9|STARTED|Extension Year 1||0
611101|NCT00364832|1495781|P8|STARTED|Extension Year 1||0
611102|NCT00364832|1495782|P7|STARTED|Extension Year 1||0
611103|NCT00364832|1495783|P6|STARTED|Extension Year 1||0
611104|NCT00364832|1495784|P5|STARTED|Extension Year 1||0
611105|NCT00364832|1495785|P4|STARTED|Extension Year 1||0
611106|NCT00364832|1495786|P3|STARTED|Extension Year 1||0
611107|NCT00364832|1495787|P2|STARTED|Extension Year 1||0
611108|NCT00364832|1495788|P1|STARTED|Extension Year 1||0
611109|NCT00364832|1495777|P12|NOT COMPLETED|Core Period||0
611110|NCT00364832|1495778|P11|NOT COMPLETED|Core Period||0
611111|NCT00364832|1495779|P10|NOT COMPLETED|Core Period||0
611112|NCT00364832|1495780|P9|NOT COMPLETED|Core Period||0
611113|NCT00364832|1495781|P8|NOT COMPLETED|Core Period||1
611114|NCT00364832|1495782|P7|NOT COMPLETED|Core Period||4
611115|NCT00364832|1495783|P6|NOT COMPLETED|Core Period||0
611116|NCT00364832|1495784|P5|NOT COMPLETED|Core Period||0
611117|NCT00364832|1495785|P4|NOT COMPLETED|Core Period||1
611118|NCT00364832|1495786|P3|NOT COMPLETED|Core Period||1
611119|NCT00364832|1495787|P2|NOT COMPLETED|Core Period||2
611120|NCT00364832|1495788|P1|NOT COMPLETED|Core Period||2
611121|NCT00364832|1495777|P12|COMPLETED|Core Period||0
611122|NCT00364832|1495778|P11|COMPLETED|Core Period||0
611123|NCT00364832|1495779|P10|COMPLETED|Core Period||0
611124|NCT00364832|1495780|P9|COMPLETED|Core Period||16
611125|NCT00364832|1495781|P8|COMPLETED|Core Period||14
611126|NCT00364832|1495782|P7|COMPLETED|Core Period||12
611127|NCT00364832|1495783|P6|COMPLETED|Core Period||12
611128|NCT00364832|1495784|P5|COMPLETED|Core Period||16
611129|NCT00364832|1495785|P4|COMPLETED|Core Period||15
611130|NCT00364832|1495786|P3|COMPLETED|Core Period||14
611131|NCT00364832|1495787|P2|COMPLETED|Core Period||13
611132|NCT00364832|1495788|P1|COMPLETED|Core Period||14
611133|NCT00364832|1495777|P12|STARTED|Core Period||0
611134|NCT00364832|1495778|P11|STARTED|Core Period||0
611135|NCT00364832|1495779|P10|STARTED|Core Period||0
611136|NCT00364832|1495780|P9|STARTED|Core Period||16
611137|NCT00364832|1495781|P8|STARTED|Core Period||15
611138|NCT00364832|1495782|P7|STARTED|Core Period||16
611139|NCT00364832|1495783|P6|STARTED|Core Period||12
611140|NCT00364832|1495784|P5|STARTED|Core Period||16
611141|NCT00364832|1495785|P4|STARTED|Core Period||16
611142|NCT00364832|1495786|P3|STARTED|Core Period||15
611143|NCT00364832|1495787|P2|STARTED|Core Period||15
611144|NCT00364832|1495788|P1|STARTED|Core Period||16
611145|NCT00364819|1495841|P1|NOT COMPLETED|Overall Study||0
611146|NCT00364819|1495841|P1|COMPLETED|Overall Study||6
611147|NCT00364819|1495841|P1|STARTED|Overall Study||6
611148|NCT00364793|1495853|P4|NOT COMPLETED|Overall Study||3
611149|NCT00364793|1495854|P3|NOT COMPLETED|Overall Study||4
611150|NCT00364793|1495855|P2|NOT COMPLETED|Overall Study||5
611151|NCT00364793|1495856|P1|NOT COMPLETED|Overall Study||8
611152|NCT00364793|1495853|P4|COMPLETED|Overall Study||5
611153|NCT00364793|1495854|P3|COMPLETED|Overall Study||0
611154|NCT00364793|1495855|P2|COMPLETED|Overall Study||5
611155|NCT00364793|1495856|P1|COMPLETED|Overall Study||7
611156|NCT00364793|1495853|P4|STARTED|Overall Study||8
611157|NCT00364793|1495854|P3|STARTED|Overall Study||4
611158|NCT00364793|1495855|P2|STARTED|Overall Study||10
611159|NCT00364793|1495856|P1|STARTED|Overall Study||15
611160|NCT00364611|1495992|P2|NOT COMPLETED|Overall Study||21
611161|NCT00364611|1495993|P1|NOT COMPLETED|Overall Study||51
611162|NCT00364611|1495992|P2|COMPLETED|Overall Study||0
611163|NCT00364611|1495993|P1|COMPLETED|Overall Study|Ongoing treatment (June 2011-initial analysis). Continued treatment till March 2012 (study closed).|1
611164|NCT00364611|1495992|P2|TREATED (SAFTEY POPULATION)|Overall Study|Received at least one dose of study medication|20
611165|NCT00364611|1495993|P1|TREATED (SAFTEY POPULATION)|Overall Study|Received at least one dose of study medication|52
611166|NCT00364611|1495992|P2|STARTED|Overall Study||21
611167|NCT00364611|1495993|P1|STARTED|Overall Study||52
611168|NCT00364533|1496016|P5|NOT COMPLETED|Overall Study||51
611169|NCT00364533|1496017|P4|NOT COMPLETED|Overall Study||31
611170|NCT00364533|1496018|P3|NOT COMPLETED|Overall Study||45
611171|NCT00364533|1496019|P2|NOT COMPLETED|Overall Study||40
611172|NCT00364533|1496020|P1|NOT COMPLETED|Overall Study||42
611173|NCT00364533|1496016|P5|COMPLETED|Overall Study||24
611174|NCT00364533|1496017|P4|COMPLETED|Overall Study||36
611175|NCT00364533|1496018|P3|COMPLETED|Overall Study||30
611176|NCT00364533|1496019|P2|COMPLETED|Overall Study||31
611177|NCT00364533|1496020|P1|COMPLETED|Overall Study||35
611178|NCT00364533|1496016|P5|STARTED|Overall Study||75
611179|NCT00364533|1496017|P4|STARTED|Overall Study||67
611180|NCT00364533|1496018|P3|STARTED|Overall Study||75
611181|NCT00364533|1496019|P2|STARTED|Overall Study||71
611182|NCT00364533|1496020|P1|STARTED|Overall Study||77
611183|NCT00364377|1496044|P2|NOT COMPLETED|Overall Study||0
611184|NCT00364377|1496045|P1|NOT COMPLETED|Overall Study||0
611185|NCT00364377|1496044|P2|COMPLETED|Overall Study||11
611186|NCT00364377|1496045|P1|COMPLETED|Overall Study||11
611187|NCT00364377|1496044|P2|STARTED|Overall Study||11
611188|NCT00364377|1496045|P1|STARTED|Overall Study||11
611189|NCT00364351|1496053|P2|NOT COMPLETED|Overall Study||583
611190|NCT00364351|1496054|P1|NOT COMPLETED|Overall Study||592
611191|NCT00364351|1496053|P2|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 26 Sep 2008.|34
611192|NCT00364351|1496054|P1|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 26 Sep 2008.|31
611193|NCT00364351|1496053|P2|STARTED|Overall Study|randomised patients|617
611194|NCT00364351|1496054|P1|STARTED|Overall Study|randomised patients|623
611195|NCT00364286|1496072|P1|NOT COMPLETED|Overall Study||3
611196|NCT00364286|1496072|P1|COMPLETED|Overall Study||14
611197|NCT00364286|1496072|P1|STARTED|Overall Study||17
611198|NCT00364182|1496079|P3|NOT COMPLETED|Fourth Intervention||0
611199|NCT00364182|1496080|P2|NOT COMPLETED|Fourth Intervention||0
611200|NCT00364182|1496081|P1|NOT COMPLETED|Fourth Intervention||0
611201|NCT00364182|1496079|P3|COMPLETED|Fourth Intervention||22
611202|NCT00364182|1496080|P2|COMPLETED|Fourth Intervention||19
611203|NCT00364182|1496081|P1|COMPLETED|Fourth Intervention||0
611204|NCT00364182|1496079|P3|STARTED|Fourth Intervention||22
611205|NCT00364182|1496080|P2|STARTED|Fourth Intervention||19
611206|NCT00364182|1496081|P1|STARTED|Fourth Intervention||0
611207|NCT00364182|1496079|P3|NOT COMPLETED|Third Intervention||1
611208|NCT00364182|1496080|P2|NOT COMPLETED|Third Intervention||1
611209|NCT00364182|1496081|P1|NOT COMPLETED|Third Intervention||0
611210|NCT00364182|1496079|P3|COMPLETED|Third Intervention||22
611211|NCT00364182|1496080|P2|COMPLETED|Third Intervention||19
611212|NCT00364182|1496081|P1|COMPLETED|Third Intervention||0
611213|NCT00364182|1496079|P3|STARTED|Third Intervention||23
611214|NCT00364182|1496080|P2|STARTED|Third Intervention||20
611215|NCT00364182|1496081|P1|STARTED|Third Intervention||0
611216|NCT00364182|1496079|P3|NOT COMPLETED|Second Intervention||2
611217|NCT00364182|1496080|P2|NOT COMPLETED|Second Intervention||2
611218|NCT00364182|1496081|P1|NOT COMPLETED|Second Intervention||0
611219|NCT00364182|1496079|P3|COMPLETED|Second Intervention||23
611220|NCT00364182|1496080|P2|COMPLETED|Second Intervention||20
611221|NCT00364182|1496081|P1|COMPLETED|Second Intervention||0
611222|NCT00364182|1496079|P3|Randomized|Second Intervention||25
611223|NCT00364182|1496080|P2|Randomized|Second Intervention||22
611224|NCT00364182|1496081|P1|Randomized|Second Intervention||0
611225|NCT00364182|1496079|P3|STARTED|Second Intervention||25
611226|NCT00364182|1496080|P2|STARTED|Second Intervention||22
611227|NCT00364182|1496081|P1|STARTED|Second Intervention||0
611228|NCT00364182|1496079|P3|NOT COMPLETED|First Intervention||0
611229|NCT00364182|1496080|P2|NOT COMPLETED|First Intervention||0
611230|NCT00364182|1496081|P1|NOT COMPLETED|First Intervention||3
611231|NCT00364182|1496079|P3|COMPLETED|First Intervention||25
611232|NCT00364182|1496080|P2|COMPLETED|First Intervention||22
611233|NCT00364182|1496081|P1|COMPLETED|First Intervention||0
611234|NCT00364182|1496079|P3|STARTED|First Intervention||25
611235|NCT00364182|1496080|P2|STARTED|First Intervention||22
611236|NCT00364182|1496081|P1|STARTED|First Intervention||3
611237|NCT00364156|1496115|P2|NOT COMPLETED|Overall Study||81
611238|NCT00364156|1496116|P1|NOT COMPLETED|Overall Study||79
611239|NCT00364156|1496115|P2|COMPLETED|Overall Study||205
611240|NCT00364156|1496116|P1|COMPLETED|Overall Study||203
611241|NCT00364156|1496115|P2|STARTED|Overall Study||286
611242|NCT00364156|1496116|P1|STARTED|Overall Study||282
611243|NCT00364130|1496124|P2|NOT COMPLETED|Post Intervention Follow-up Period||11
611244|NCT00364130|1496125|P1|NOT COMPLETED|Post Intervention Follow-up Period||5
611245|NCT00364130|1496124|P2|COMPLETED|Post Intervention Follow-up Period||50
611246|NCT00364130|1496125|P1|COMPLETED|Post Intervention Follow-up Period||55
611247|NCT00364130|1496124|P2|STARTED|Post Intervention Follow-up Period||61
611248|NCT00364130|1496125|P1|STARTED|Post Intervention Follow-up Period||60
611249|NCT00364130|1496124|P2|NOT COMPLETED|Intervention Period||8
611250|NCT00364130|1496125|P1|NOT COMPLETED|Intervention Period||9
611251|NCT00364130|1496124|P2|COMPLETED|Intervention Period||61
611252|NCT00364130|1496125|P1|COMPLETED|Intervention Period||60
611253|NCT00364130|1496124|P2|STARTED|Intervention Period||69
611254|NCT00364130|1496125|P1|STARTED|Intervention Period||69
611255|NCT00364013|1496147|P2|NOT COMPLETED|Overall Study||95
611256|NCT00364013|1496148|P1|NOT COMPLETED|Overall Study||101
611257|NCT00364013|1496147|P2|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|495
611258|NCT00364013|1496148|P1|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|492
611259|NCT00364013|1496147|P2|Received Study Drug|Overall Study||583
611260|NCT00364013|1496148|P1|Received Study Drug|Overall Study|One participant randomized to this group did not receive any panitumumab|586
611261|NCT00364013|1496147|P2|STARTED|Overall Study||590
611262|NCT00364013|1496148|P1|STARTED|Overall Study||593
611263|NCT00363896|1496176|P2|NOT COMPLETED|Overall Study||47
611264|NCT00363896|1496177|P1|NOT COMPLETED|Overall Study||89
611265|NCT00363896|1496176|P2|COMPLETED|Overall Study||169
611266|NCT00363896|1496177|P1|COMPLETED|Overall Study||538
611267|NCT00363896|1496176|P2|STARTED|Overall Study||216
611268|NCT00363896|1496177|P1|STARTED|Overall Study||627
611269|NCT00363883|1496189|P1|NOT COMPLETED|Overall Study||0
611270|NCT00363883|1496189|P1|COMPLETED|Overall Study||14
611271|NCT00363883|1496189|P1|STARTED|Overall Study||14
611272|NCT00363805|1496198|P3|NOT COMPLETED|Overall Study||3
611273|NCT00363805|1496199|P2|NOT COMPLETED|Overall Study||6
611274|NCT00363805|1496200|P1|NOT COMPLETED|Overall Study||4
611275|NCT00363805|1496198|P3|COMPLETED|Overall Study||70
611276|NCT00363805|1496199|P2|COMPLETED|Overall Study||57
611277|NCT00363805|1496200|P1|COMPLETED|Overall Study||38
611278|NCT00363805|1496198|P3|STARTED|Overall Study||73
611279|NCT00363805|1496199|P2|STARTED|Overall Study||63
611280|NCT00363805|1496200|P1|STARTED|Overall Study||42
611281|NCT00363779|1496211|P1|NOT COMPLETED|Overall Study||0
611282|NCT00363779|1496211|P1|COMPLETED|Overall Study||5
611283|NCT00363779|1496211|P1|STARTED|Overall Study||5
611284|NCT00363675|1496216|P1|NOT COMPLETED|Overall Study||0
611285|NCT00363675|1496216|P1|COMPLETED|Overall Study||3
611286|NCT00363675|1496216|P1|Completed Testing|Overall Study||3
611287|NCT00363675|1496216|P1|STARTED|Overall Study||3
611288|NCT00363545|1496225|P2|NOT COMPLETED|Overall Study||57
611289|NCT00363545|1496226|P1|NOT COMPLETED|Overall Study||44
611290|NCT00363545|1496225|P2|COMPLETED|Overall Study||581
611291|NCT00363545|1496226|P1|COMPLETED|Overall Study||592
611292|NCT00363545|1496225|P2|STARTED|Overall Study||638
611293|NCT00363545|1496226|P1|STARTED|Overall Study||636
611294|NCT00363480|1496244|P1|NOT COMPLETED|Overall Study||17
611295|NCT00363480|1496244|P1|COMPLETED|Overall Study||204
611296|NCT00363480|1496244|P1|STARTED|Overall Study||221
611297|NCT00363467|1496264|P1|NOT COMPLETED|Overall Study||1
611298|NCT00363467|1496264|P1|COMPLETED|Overall Study||2
611299|NCT00363467|1496264|P1|STARTED|Overall Study||3
611300|NCT00363415|1496274|P2|NOT COMPLETED|Overall Study||249
611301|NCT00363415|1496275|P1|NOT COMPLETED|Overall Study||361
611302|NCT00363415|1496274|P2|COMPLETED|Overall Study||206
611303|NCT00363415|1496275|P1|COMPLETED|Overall Study||92
611304|NCT00363415|1496274|P2|Received at Least One Dose of Study Drug|Overall Study||447
611305|NCT00363415|1496275|P1|Received at Least One Dose of Study Drug|Overall Study||433
611306|NCT00363415|1496274|P2|STARTED|Overall Study||455
611307|NCT00363415|1496275|P1|STARTED|Overall Study||453
611308|NCT00363311|1496293|P2|NOT COMPLETED|Overall Study||45
611309|NCT00363311|1496294|P1|NOT COMPLETED|Overall Study||76
611310|NCT00363311|1496293|P2|COMPLETED|Overall Study||102
611311|NCT00363311|1496294|P1|COMPLETED|Overall Study||79
611312|NCT00363311|1496293|P2|STARTED|Overall Study||147
611313|NCT00363311|1496294|P1|STARTED|Overall Study||155
611314|NCT00363298|1496360|P2|NOT COMPLETED|4-week Study Continuation Phase||0
611315|NCT00363298|1496361|P1|NOT COMPLETED|4-week Study Continuation Phase||1
611316|NCT00363298|1496360|P2|COMPLETED|4-week Study Continuation Phase||7
611317|NCT00363298|1496361|P1|COMPLETED|4-week Study Continuation Phase||5
611318|NCT00363298|1496360|P2|STARTED|4-week Study Continuation Phase||7
611319|NCT00363298|1496361|P1|STARTED|4-week Study Continuation Phase||6
611320|NCT00363298|1496360|P2|NOT COMPLETED|First Study Week||5
611321|NCT00363298|1496361|P1|NOT COMPLETED|First Study Week||6
611322|NCT00363298|1496360|P2|COMPLETED|First Study Week|At end of week 1, 7/12 subjects met Y-BOCS response criterion and began 4-week continuation phase|7
611323|NCT00363298|1496361|P1|COMPLETED|First Study Week|At end of week 1, 6/12 subjects met Y-BOCS response criterion and began 4-week continuation phase|6
611324|NCT00363298|1496360|P2|STARTED|First Study Week||12
611325|NCT00363298|1496361|P1|STARTED|First Study Week||12
611326|NCT00363246|1496369|P1|NOT COMPLETED|Overall Study||97
611327|NCT00363246|1496369|P1|COMPLETED|Overall Study||669
611328|NCT00363246|1496369|P1|STARTED|Overall Study||766
611329|NCT00363168|1496376|P2|NOT COMPLETED|Overall Study||0
611330|NCT00363168|1496377|P1|NOT COMPLETED|Overall Study||0
611331|NCT00363168|1496376|P2|COMPLETED|Overall Study||2
611332|NCT00363168|1496377|P1|COMPLETED|Overall Study||5
611333|NCT00363168|1496376|P2|STARTED|Overall Study||2
611334|NCT00363168|1496377|P1|STARTED|Overall Study||5
611335|NCT00363142|1496387|P2|NOT COMPLETED|Overall Study||3
611336|NCT00363142|1496388|P1|NOT COMPLETED|Overall Study||7
611337|NCT00363142|1496387|P2|COMPLETED|Overall Study||66
611338|NCT00363142|1496388|P1|COMPLETED|Overall Study||133
611339|NCT00363142|1496387|P2|STARTED|Overall Study||69
611340|NCT00363142|1496388|P1|STARTED|Overall Study||140
611341|NCT00363129|1496417|P2|NOT COMPLETED|Overall Study||33
611342|NCT00363129|1496418|P1|NOT COMPLETED|Overall Study||29
611343|NCT00363129|1496417|P2|COMPLETED|Overall Study||60
611344|NCT00363129|1496418|P1|COMPLETED|Overall Study||67
611345|NCT00363129|1496417|P2|STARTED|Overall Study||93
611346|NCT00363129|1496418|P1|STARTED|Overall Study||96
611347|NCT00363077|1496434|P2|NOT COMPLETED|Overall Study||0
611348|NCT00363077|1496435|P1|NOT COMPLETED|Overall Study||0
611349|NCT00363077|1496434|P2|COMPLETED|Overall Study||75
611350|NCT00363077|1496435|P1|COMPLETED|Overall Study||75
611351|NCT00363077|1496434|P2|STARTED|Overall Study||75
611352|NCT00363077|1496435|P1|STARTED|Overall Study||75
611353|NCT00363051|1496461|P2|NOT COMPLETED|Overall Study||22
611354|NCT00363051|1496462|P1|NOT COMPLETED|Overall Study||38
611355|NCT00363051|1496461|P2|COMPLETED|Overall Study||23
611356|NCT00363051|1496462|P1|COMPLETED|Overall Study|Patients with documented disease progression per RECIST criteria|77
611357|NCT00363051|1496461|P2|STARTED|Overall Study||45
611358|NCT00363051|1496462|P1|STARTED|Overall Study||115
611359|NCT00363038|1496479|P1|NOT COMPLETED|Overall Study||0
611360|NCT00363038|1496479|P1|COMPLETED|Overall Study||16
611361|NCT00363038|1496479|P1|STARTED|Overall Study||16
611362|NCT00362882|1496485|P2|NOT COMPLETED|Overall Study||0
611363|NCT00362882|1496486|P1|NOT COMPLETED|Overall Study||0
611364|NCT00362882|1496485|P2|COMPLETED|Overall Study||41
611365|NCT00362882|1496486|P1|COMPLETED|Overall Study||40
611366|NCT00362882|1496485|P2|STARTED|Overall Study||41
611367|NCT00362882|1496486|P1|STARTED|Overall Study||40
611368|NCT00362817|1496498|P1|NOT COMPLETED|Overall Study||0
611369|NCT00362817|1496498|P1|COMPLETED|Overall Study||17
611370|NCT00362817|1496498|P1|STARTED|Overall Study||17
611371|NCT00362648|1496511|P4|NOT COMPLETED|Overall Study||11
611372|NCT00362648|1496512|P3|NOT COMPLETED|Overall Study||9
611373|NCT00362648|1496513|P2|NOT COMPLETED|Overall Study||134
611374|NCT00362648|1496514|P1|NOT COMPLETED|Overall Study||126
611375|NCT00362648|1496511|P4|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|1007
611376|NCT00362648|1496512|P3|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|1009
611377|NCT00362648|1496513|P2|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|2601
611378|NCT00362648|1496514|P1|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|2607
611379|NCT00362648|1496511|P4|Vaccinated at Visit 3|Overall Study||1007
611380|NCT00362648|1496512|P3|Vaccinated at Visit 3|Overall Study||1009
611381|NCT00362648|1496513|P2|Vaccinated at Visit 3|Overall Study||2612
611382|NCT00362648|1496514|P1|Vaccinated at Visit 3|Overall Study||2613
611383|NCT00362648|1496511|P4|Vaccinated at Visit 2|Overall Study||1009
611384|NCT00362648|1496512|P3|Vaccinated at Visit 2|Overall Study||1013
611385|NCT00362648|1496513|P2|Vaccinated at Visit 2|Overall Study||2666
611386|NCT00362648|1496514|P1|Vaccinated at Visit 2|Overall Study||2657
611387|NCT00362648|1496511|P4|Vaccinated at Visit 1|Overall Study||1018
611388|NCT00362648|1496512|P3|Vaccinated at Visit 1|Overall Study||1018
611389|NCT00362648|1496513|P2|Vaccinated at Visit 1|Overall Study||2735
611390|NCT00362648|1496514|P1|Vaccinated at Visit 1|Overall Study||2733
611391|NCT00362648|1496511|P4|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|1018
611392|NCT00362648|1496512|P3|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|1018
611393|NCT00362648|1496513|P2|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|2735
611394|NCT00362648|1496514|P1|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|2733
611395|NCT00362609|1496532|P2|NOT COMPLETED|Overall Study||2
611396|NCT00362609|1496533|P1|NOT COMPLETED|Overall Study||0
611397|NCT00362609|1496532|P2|COMPLETED|Overall Study||38
611398|NCT00362609|1496533|P1|COMPLETED|Overall Study||19
611399|NCT00362609|1496532|P2|STARTED|Overall Study||40
611400|NCT00362609|1496533|P1|STARTED|Overall Study||19
611401|NCT00362466|1496547|P2|NOT COMPLETED|Overall Study||0
611402|NCT00362466|1496548|P1|NOT COMPLETED|Overall Study||0
611403|NCT00362466|1496547|P2|COMPLETED|Overall Study||1
611404|NCT00362466|1496548|P1|COMPLETED|Overall Study||2
611405|NCT00362466|1496547|P2|STARTED|Overall Study||1
611406|NCT00362466|1496548|P1|STARTED|Overall Study||2
611407|NCT00362453|1496570|P2|NOT COMPLETED|Overall Study||0
611408|NCT00362453|1496571|P1|NOT COMPLETED|Overall Study||0
611409|NCT00362453|1496570|P2|COMPLETED|Overall Study|No patient withdrew from the study (20/20 participants completed follow-ups at 12, 24 and 48 weeks).|20
611410|NCT00362453|1496571|P1|COMPLETED|Overall Study|No patient withdrew from the study (20/20 participants completed follow-ups at 12, 24 and 48 weeks).|20
611411|NCT00362453|1496570|P2|STARTED|Overall Study||20
611412|NCT00362453|1496571|P1|STARTED|Overall Study||20
611413|NCT00362440|1496603|P2|NOT COMPLETED|Overall Study||1
611414|NCT00362440|1496604|P1|NOT COMPLETED|Overall Study||2
611415|NCT00362440|1496603|P2|COMPLETED|Overall Study||3
611416|NCT00362440|1496604|P1|COMPLETED|Overall Study||3
611417|NCT00362440|1496603|P2|STARTED|Overall Study||4
611418|NCT00362440|1496604|P1|STARTED|Overall Study||5
611419|NCT00362414|1496614|P1|NOT COMPLETED|Overall Study||3
611420|NCT00362414|1496614|P1|COMPLETED|Overall Study||12
611421|NCT00362414|1496614|P1|STARTED|Overall Study||15
611422|NCT00362401|1496634|P3|NOT COMPLETED|Overall Study||0
611423|NCT00362401|1496635|P2|NOT COMPLETED|Overall Study||0
611424|NCT00362401|1496636|P1|NOT COMPLETED|Overall Study||0
611425|NCT00362401|1496634|P3|COMPLETED|Overall Study||40
611426|NCT00362401|1496635|P2|COMPLETED|Overall Study||29
611427|NCT00362401|1496636|P1|COMPLETED|Overall Study||15
611428|NCT00362401|1496634|P3|STARTED|Overall Study||40
611429|NCT00362401|1496635|P2|STARTED|Overall Study||29
611430|NCT00362401|1496636|P1|STARTED|Overall Study||15
611431|NCT00362375|1496643|P2|NOT COMPLETED|Overall Study||35
611432|NCT00362375|1496644|P1|NOT COMPLETED|Overall Study||40
611433|NCT00362375|1496643|P2|COMPLETED|Overall Study|Number completed 6-month follow-up assessment|117
611434|NCT00362375|1496644|P1|COMPLETED|Overall Study|Number completed 6-month follow-up assessment|121
611435|NCT00362375|1496643|P2|STARTED|Overall Study|Number eligible and randomized|152
611436|NCT00362375|1496644|P1|STARTED|Overall Study|Number eligible and randomized|161
611437|NCT00362336|1496661|P3|NOT COMPLETED|Overall Study||3
611438|NCT00362336|1496662|P2|NOT COMPLETED|Overall Study||7
611439|NCT00362336|1496663|P1|NOT COMPLETED|Overall Study||10
611440|NCT00362336|1496661|P3|COMPLETED|Overall Study||134
611441|NCT00362336|1496662|P2|COMPLETED|Overall Study||235
611442|NCT00362336|1496663|P1|COMPLETED|Overall Study||233
611443|NCT00362336|1496661|P3|STARTED|Overall Study||137
611444|NCT00362336|1496662|P2|STARTED|Overall Study||242
611445|NCT00362336|1496663|P1|STARTED|Overall Study||243
611446|NCT00362297|1496691|P2|NOT COMPLETED|Arm 2 (Cross-over to Other Dose)||0
611447|NCT00362297|1496692|P1|NOT COMPLETED|Arm 2 (Cross-over to Other Dose)||0
611448|NCT00362297|1496691|P2|COMPLETED|Arm 2 (Cross-over to Other Dose)||11
611449|NCT00362297|1496692|P1|COMPLETED|Arm 2 (Cross-over to Other Dose)||16
611450|NCT00362297|1496691|P2|STARTED|Arm 2 (Cross-over to Other Dose)||11
611451|NCT00362297|1496692|P1|STARTED|Arm 2 (Cross-over to Other Dose)||16
611452|NCT00362297|1496691|P2|NOT COMPLETED|Arm 1 (Initial Drug Assignment)||4
611453|NCT00362297|1496692|P1|NOT COMPLETED|Arm 1 (Initial Drug Assignment)||0
611454|NCT00362297|1496691|P2|COMPLETED|Arm 1 (Initial Drug Assignment)||11
611455|NCT00362297|1496692|P1|COMPLETED|Arm 1 (Initial Drug Assignment)||16
611456|NCT00362297|1496691|P2|STARTED|Arm 1 (Initial Drug Assignment)||15
611457|NCT00362297|1496692|P1|STARTED|Arm 1 (Initial Drug Assignment)||16
611458|NCT00362232|1496700|P2|NOT COMPLETED|Follow-up (30 (+ 5) Days)||39
611459|NCT00362232|1496701|P1|NOT COMPLETED|Follow-up (30 (+ 5) Days)||38
611460|NCT00362232|1496700|P2|COMPLETED|Follow-up (30 (+ 5) Days)||1416
611461|NCT00362232|1496701|P1|COMPLETED|Follow-up (30 (+ 5) Days)||1433
611462|NCT00362232|1496700|P2|STARTED|Follow-up (30 (+ 5) Days)||1455
611463|NCT00362232|1496701|P1|STARTED|Follow-up (30 (+ 5) Days)||1471
611464|NCT00362232|1496700|P2|NOT COMPLETED|Treatment (12 +/- 2 Days)||151
611465|NCT00362232|1496701|P1|NOT COMPLETED|Treatment (12 +/- 2 Days)||159
611466|NCT00362232|1496700|P2|COMPLETED|Treatment (12 +/- 2 Days)||1413
611467|NCT00362232|1496701|P1|COMPLETED|Treatment (12 +/- 2 Days)||1425
611468|NCT00362232|1496700|P2|Received Treatment|Treatment (12 +/- 2 Days)|Safety population|1508
611469|NCT00362232|1496701|P1|Received Treatment|Treatment (12 +/- 2 Days)|Safety population|1526
611470|NCT00362232|1496700|P2|STARTED|Treatment (12 +/- 2 Days)||1564
611471|NCT00362232|1496701|P1|STARTED|Treatment (12 +/- 2 Days)||1584
611472|NCT00362180|1496746|P9|NOT COMPLETED|20 Week Safety Follow-up||0
611473|NCT00362180|1496747|P8|NOT COMPLETED|20 Week Safety Follow-up||0
611474|NCT00362180|1496748|P7|NOT COMPLETED|20 Week Safety Follow-up||0
611475|NCT00362180|1496749|P6|NOT COMPLETED|20 Week Safety Follow-up||0
611476|NCT00362180|1496750|P5|NOT COMPLETED|20 Week Safety Follow-up||0
611477|NCT00362180|1496751|P4|NOT COMPLETED|20 Week Safety Follow-up||0
611478|NCT00362180|1496752|P3|NOT COMPLETED|20 Week Safety Follow-up||0
611479|NCT00362180|1496753|P2|NOT COMPLETED|20 Week Safety Follow-up||0
611480|NCT00362180|1496754|P1|NOT COMPLETED|20 Week Safety Follow-up||0
611481|NCT00362180|1496746|P9|COMPLETED|20 Week Safety Follow-up||1
611482|NCT00362180|1496747|P8|COMPLETED|20 Week Safety Follow-up||3
611483|NCT00362180|1496748|P7|COMPLETED|20 Week Safety Follow-up||0
611484|NCT00362180|1496749|P6|COMPLETED|20 Week Safety Follow-up||9
611485|NCT00362180|1496750|P5|COMPLETED|20 Week Safety Follow-up||11
611486|NCT00362180|1496751|P4|COMPLETED|20 Week Safety Follow-up||0
611487|NCT00362180|1496752|P3|COMPLETED|20 Week Safety Follow-up||1
611488|NCT00362180|1496753|P2|COMPLETED|20 Week Safety Follow-up||2
611489|NCT00362180|1496754|P1|COMPLETED|20 Week Safety Follow-up||3
611490|NCT00362180|1496746|P9|STARTED|20 Week Safety Follow-up||1
611491|NCT00362180|1496747|P8|STARTED|20 Week Safety Follow-up||3
611492|NCT00362180|1496748|P7|STARTED|20 Week Safety Follow-up|This observational cohort did not include a safety follow-up period.|0
611493|NCT00362180|1496749|P6|STARTED|20 Week Safety Follow-up||9
611494|NCT00362180|1496750|P5|STARTED|20 Week Safety Follow-up||11
611495|NCT00362180|1496751|P4|STARTED|20 Week Safety Follow-up||0
611496|NCT00362180|1496752|P3|STARTED|20 Week Safety Follow-up||1
611497|NCT00362180|1496753|P2|STARTED|20 Week Safety Follow-up||2
611498|NCT00362180|1496754|P1|STARTED|20 Week Safety Follow-up||3
611499|NCT00362180|1496746|P9|NOT COMPLETED|Treated Period||0
611500|NCT00362180|1496747|P8|NOT COMPLETED|Treated Period||1
611501|NCT00362180|1496748|P7|NOT COMPLETED|Treated Period||0
611502|NCT00362180|1496749|P6|NOT COMPLETED|Treated Period||1
611503|NCT00362180|1496750|P5|NOT COMPLETED|Treated Period||0
611504|NCT00362180|1496751|P4|NOT COMPLETED|Treated Period||0
611505|NCT00362180|1496752|P3|NOT COMPLETED|Treated Period||0
611506|NCT00362180|1496753|P2|NOT COMPLETED|Treated Period||0
611507|NCT00362180|1496754|P1|NOT COMPLETED|Treated Period||1
611508|NCT00362180|1496746|P9|COMPLETED|Treated Period||1
611509|NCT00362180|1496747|P8|COMPLETED|Treated Period||2
611510|NCT00362180|1496748|P7|COMPLETED|Treated Period||6
611511|NCT00362180|1496749|P6|COMPLETED|Treated Period||9
611512|NCT00362180|1496750|P5|COMPLETED|Treated Period||11
611513|NCT00362180|1496751|P4|COMPLETED|Treated Period||0
611514|NCT00362180|1496752|P3|COMPLETED|Treated Period||1
611515|NCT00362180|1496753|P2|COMPLETED|Treated Period||2
611516|NCT00362180|1496754|P1|COMPLETED|Treated Period||3
611517|NCT00362180|1496746|P9|STARTED|Treated Period||1
611518|NCT00362180|1496747|P8|STARTED|Treated Period||3
611519|NCT00362180|1496748|P7|STARTED|Treated Period||6
611520|NCT00362180|1496749|P6|STARTED|Treated Period||10
611521|NCT00362180|1496750|P5|STARTED|Treated Period||11
611522|NCT00362180|1496751|P4|STARTED|Treated Period||0
611523|NCT00362180|1496752|P3|STARTED|Treated Period||1
611524|NCT00362180|1496753|P2|STARTED|Treated Period||2
611525|NCT00362180|1496754|P1|STARTED|Treated Period||4
611526|NCT00362128|1496815|P1|NOT COMPLETED|Overall Study||0
611527|NCT00362128|1496815|P1|COMPLETED|Overall Study|Enrollment was completed in October 2009.|2072
611528|NCT00362128|1496815|P1|STARTED|Overall Study|Enrollment was initiated in 2007.|2072
611529|NCT00362115|1496826|P7|NOT COMPLETED|Overall Study||12
611530|NCT00362115|1496827|P6|NOT COMPLETED|Overall Study||7
611531|NCT00362115|1496828|P5|NOT COMPLETED|Overall Study||7
611532|NCT00362115|1496829|P4|NOT COMPLETED|Overall Study||4
611533|NCT00362115|1496830|P3|NOT COMPLETED|Overall Study||7
611534|NCT00362115|1496831|P2|NOT COMPLETED|Overall Study||6
611535|NCT00362115|1496832|P1|NOT COMPLETED|Overall Study||2
611536|NCT00362115|1496826|P7|COMPLETED|Overall Study||52
611537|NCT00362115|1496827|P6|COMPLETED|Overall Study||57
611538|NCT00362115|1496828|P5|COMPLETED|Overall Study||57
611539|NCT00362115|1496829|P4|COMPLETED|Overall Study||59
611540|NCT00362115|1496830|P3|COMPLETED|Overall Study||57
611541|NCT00362115|1496831|P2|COMPLETED|Overall Study||59
611542|NCT00362115|1496832|P1|COMPLETED|Overall Study||63
611543|NCT00362115|1496826|P7|STARTED|Overall Study|1 participant failed to receive double-blind medication.|64
611544|NCT00362115|1496827|P6|STARTED|Overall Study|1 participant failed to receive double-blind medication.|64
611545|NCT00362115|1496828|P5|STARTED|Overall Study||64
611546|NCT00362115|1496829|P4|STARTED|Overall Study|1 participant failed to receive double-blind medication.|63
611547|NCT00362115|1496830|P3|STARTED|Overall Study||64
611548|NCT00362115|1496831|P2|STARTED|Overall Study|1 participant failed to receive double-blind medication.|65
611549|NCT00362115|1496832|P1|STARTED|Overall Study||65
611550|NCT00361972|1496983|P2|NOT COMPLETED|Overall Study||0
611551|NCT00361972|1496984|P1|NOT COMPLETED|Overall Study||0
611552|NCT00361972|1496983|P2|COMPLETED|Overall Study||9
611553|NCT00361972|1496984|P1|COMPLETED|Overall Study||8
611554|NCT00361972|1496983|P2|STARTED|Overall Study||9
611555|NCT00361972|1496984|P1|STARTED|Overall Study||8
611556|NCT00361712|1496994|P2|NOT COMPLETED|Overall Study||0
611557|NCT00361712|1496995|P1|NOT COMPLETED|Overall Study||0
611558|NCT00361712|1496994|P2|COMPLETED|Overall Study||21
611559|NCT00361712|1496995|P1|COMPLETED|Overall Study||20
611560|NCT00361712|1496994|P2|STARTED|Overall Study||21
611561|NCT00361712|1496995|P1|STARTED|Overall Study||20
611562|NCT00361634|1497005|P1|NOT COMPLETED|Overall Study||2
611563|NCT00361634|1497005|P1|COMPLETED|Overall Study||12
611564|NCT00361634|1497005|P1|Treated|Overall Study|The safety analysis set consisted of all patients who received at least one dose of etanercept.|13
611565|NCT00361634|1497005|P1|STARTED|Overall Study||14
611566|NCT00361595|1497023|P1|NOT COMPLETED|Overall Study||0
611567|NCT00361595|1497023|P1|COMPLETED|Overall Study||35
611568|NCT00361595|1497023|P1|STARTED|Overall Study||35
611569|NCT00361569|1497034|P4|NOT COMPLETED|Overall Study||21
611570|NCT00361569|1497035|P3|NOT COMPLETED|Overall Study||18
611571|NCT00361569|1497036|P2|NOT COMPLETED|Overall Study||11
611572|NCT00361569|1497037|P1|NOT COMPLETED|Overall Study||12
611573|NCT00361569|1497034|P4|COMPLETED|Overall Study||135
611574|NCT00361569|1497035|P3|COMPLETED|Overall Study||137
611575|NCT00361569|1497036|P2|COMPLETED|Overall Study||150
611576|NCT00361569|1497037|P1|COMPLETED|Overall Study||138
611577|NCT00361569|1497034|P4|STARTED|Overall Study||156
611578|NCT00361569|1497035|P3|STARTED|Overall Study||155
611579|NCT00361569|1497036|P2|STARTED|Overall Study||161
611580|NCT00361569|1497037|P1|STARTED|Overall Study||150
611581|NCT00361504|1497061|P2|NOT COMPLETED|Overall Study||145
611582|NCT00361504|1497062|P1|NOT COMPLETED|Overall Study||481
611583|NCT00361504|1497061|P2|COMPLETED|Overall Study||78
611584|NCT00361504|1497062|P1|COMPLETED|Overall Study||413
611585|NCT00361504|1497061|P2|STARTED|Overall Study|Number of participants who received at least 1 dose of study medication|223
611586|NCT00361504|1497062|P1|STARTED|Overall Study|Number of participants who received at least 1 dose of study medication|894
611587|NCT00361439|1497072|P2|NOT COMPLETED|Overall Study||0
611588|NCT00361439|1497073|P1|NOT COMPLETED|Overall Study||0
611589|NCT00361439|1497072|P2|COMPLETED|Overall Study||9
611590|NCT00361439|1497073|P1|COMPLETED|Overall Study||8
611591|NCT00361439|1497072|P2|STARTED|Overall Study||9
611592|NCT00361439|1497073|P1|STARTED|Overall Study||8
611593|NCT00361374|1497088|P3|NOT COMPLETED|Overall Study||12
611594|NCT00361374|1497089|P2|NOT COMPLETED|Overall Study||15
611595|NCT00361374|1497090|P1|NOT COMPLETED|Overall Study||15
611596|NCT00361374|1497088|P3|COMPLETED|Overall Study||53
611597|NCT00361374|1497089|P2|COMPLETED|Overall Study||50
611598|NCT00361374|1497090|P1|COMPLETED|Overall Study||51
611599|NCT00361374|1497088|P3|STARTED|Overall Study||65
611600|NCT00361374|1497089|P2|STARTED|Overall Study||65
611601|NCT00361374|1497090|P1|STARTED|Overall Study||66
611602|NCT00361335|1497103|P7|NOT COMPLETED|SC Period: Week E0 to Week E24||9
611603|NCT00361335|1497104|P6|NOT COMPLETED|SC Period: Week E0 to Week E24||1
611604|NCT00361335|1497105|P5|NOT COMPLETED|SC Period: Week E0 to Week E24||0
611605|NCT00361335|1497106|P4|NOT COMPLETED|SC Period: Week E0 to Week E24||4
611606|NCT00361335|1497107|P3|NOT COMPLETED|SC Period: Week E0 to Week E24||5
611607|NCT00361335|1497108|P2|NOT COMPLETED|SC Period: Week E0 to Week E24||3
611608|NCT00361335|1497109|P1|NOT COMPLETED|SC Period: Week E0 to Week E24||2
611609|NCT00361335|1497103|P7|COMPLETED|SC Period: Week E0 to Week E24||164
611610|NCT00361335|1497104|P6|COMPLETED|SC Period: Week E0 to Week E24||23
611611|NCT00361335|1497105|P5|COMPLETED|SC Period: Week E0 to Week E24||3
611612|NCT00361335|1497106|P4|COMPLETED|SC Period: Week E0 to Week E24||59
611613|NCT00361335|1497107|P3|COMPLETED|SC Period: Week E0 to Week E24||99
611614|NCT00361335|1497108|P2|COMPLETED|SC Period: Week E0 to Week E24||56
611615|NCT00361335|1497109|P1|COMPLETED|SC Period: Week E0 to Week E24||80
611616|NCT00361335|1497103|P7|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|173
611617|NCT00361335|1497104|P6|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|24
611618|NCT00361335|1497105|P5|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|3
611619|NCT00361335|1497106|P4|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|63
611620|NCT00361335|1497107|P3|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|104
611621|NCT00361335|1497108|P2|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|59
611622|NCT00361335|1497109|P1|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|82
611623|NCT00361335|1497103|P7|NOT COMPLETED|IV Period: Baseline to E0||0
611624|NCT00361335|1497104|P6|NOT COMPLETED|IV Period: Baseline to E0||0
611625|NCT00361335|1497105|P5|NOT COMPLETED|IV Period: Baseline to E0||24
611626|NCT00361335|1497106|P4|NOT COMPLETED|IV Period: Baseline to E0||27
611627|NCT00361335|1497107|P3|NOT COMPLETED|IV Period: Baseline to E0||21
611628|NCT00361335|1497108|P2|NOT COMPLETED|IV Period: Baseline to E0||29
611629|NCT00361335|1497109|P1|NOT COMPLETED|IV Period: Baseline to E0||20
611630|NCT00361335|1497103|P7|COMPLETED|IV Period: Baseline to E0||0
611631|NCT00361335|1497104|P6|COMPLETED|IV Period: Baseline to E0||0
611632|NCT00361335|1497105|P5|COMPLETED|IV Period: Baseline to E0||105
611633|NCT00361335|1497106|P4|COMPLETED|IV Period: Baseline to E0||102
611634|NCT00361335|1497107|P3|COMPLETED|IV Period: Baseline to E0||107
611635|NCT00361335|1497108|P2|COMPLETED|IV Period: Baseline to E0||99
611636|NCT00361335|1497109|P1|COMPLETED|IV Period: Baseline to E0||109
611637|NCT00361335|1497103|P7|STARTED|IV Period: Baseline to E0|"0 in column indicates this reporting group is not relevant to the IV Period."|0
611638|NCT00361335|1497104|P6|STARTED|IV Period: Baseline to E0|"0 in column indicates this reporting group is not relevant to the IV Period."|0
611639|NCT00361335|1497105|P5|STARTED|IV Period: Baseline to E0||129
611640|NCT00361335|1497106|P4|STARTED|IV Period: Baseline to E0||129
611641|NCT00361335|1497107|P3|STARTED|IV Period: Baseline to E0||128
611642|NCT00361335|1497108|P2|STARTED|IV Period: Baseline to E0||128
611643|NCT00361335|1497109|P1|STARTED|IV Period: Baseline to E0||129
611644|NCT00361283|1497153|P1|NOT COMPLETED|Overall Study||27
611645|NCT00361283|1497153|P1|COMPLETED|Overall Study||81
611646|NCT00361283|1497153|P1|STARTED|Overall Study||108
611647|NCT00361270|1497161|P4|NOT COMPLETED|Overall Study||13
611648|NCT00361270|1497162|P3|NOT COMPLETED|Overall Study||10
611649|NCT00361270|1497163|P2|NOT COMPLETED|Overall Study||14
611650|NCT00361270|1497164|P1|NOT COMPLETED|Overall Study||24
611651|NCT00361270|1497161|P4|COMPLETED|Overall Study||25
611652|NCT00361270|1497162|P3|COMPLETED|Overall Study||25
611653|NCT00361270|1497163|P2|COMPLETED|Overall Study||25
611654|NCT00361270|1497164|P1|COMPLETED|Overall Study||25
611655|NCT00361270|1497161|P4|STARTED|Overall Study||38
611656|NCT00361270|1497162|P3|STARTED|Overall Study||35
611657|NCT00361270|1497163|P2|STARTED|Overall Study||39
611658|NCT00361270|1497164|P1|STARTED|Overall Study||49
611659|NCT00361257|1497184|P2|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15
611660|NCT00361257|1497185|P1|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15
611661|NCT00361257|1497184|P2|COMPLETED|Step 2: Minocycline(Open Label) for All||19
611662|NCT00361257|1497185|P1|COMPLETED|Step 2: Minocycline(Open Label) for All||13
611663|NCT00361257|1497184|P2|STARTED|Step 2: Minocycline(Open Label) for All|43 participants completed Step 1; however, 9 decided not to enroll Step 2,so 43-9=34 started Step 2.|34
611664|NCT00361257|1497185|P1|STARTED|Step 2: Minocycline(Open Label) for All|40 participants completed Step 1; however,12 decided not to enroll Step 2,so 40-12=28 started Step 2|28
611665|NCT00361257|1497184|P2|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12
611666|NCT00361257|1497185|P1|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12
611667|NCT00361257|1497184|P2|COMPLETED|Step 1: Minocycline vs. Placebo||43
611668|NCT00361257|1497185|P1|COMPLETED|Step 1: Minocycline vs. Placebo||40
611669|NCT00361257|1497184|P2|STARTED|Step 1: Minocycline vs. Placebo||55
611670|NCT00361257|1497185|P1|STARTED|Step 1: Minocycline vs. Placebo||52
611671|NCT00361231|1497237|P1|NOT COMPLETED|Overall Study||34
611672|NCT00361231|1497237|P1|COMPLETED|Overall Study||1
611673|NCT00361231|1497237|P1|STARTED|Overall Study||35
611674|NCT00361218|1497242|P1|NOT COMPLETED|Overall Study||23
611675|NCT00361218|1497242|P1|COMPLETED|Overall Study||30
611676|NCT00361218|1497242|P1|Completed Baseline Assessment|Overall Study||47
611677|NCT00361218|1497242|P1|STARTED|Overall Study|met eligibility criteria and enrolled in the study|53
611678|NCT00361140|1497250|P3|NOT COMPLETED|Overall Study||0
611679|NCT00361140|1497251|P2|NOT COMPLETED|Overall Study||0
611680|NCT00361140|1497252|P1|NOT COMPLETED|Overall Study||0
611681|NCT00361140|1497250|P3|COMPLETED|Overall Study||3
611682|NCT00361140|1497251|P2|COMPLETED|Overall Study||29
611683|NCT00361140|1497252|P1|COMPLETED|Overall Study||40
611684|NCT00361140|1497250|P3|STARTED|Overall Study||3
611685|NCT00361140|1497251|P2|STARTED|Overall Study||29
611686|NCT00361140|1497252|P1|STARTED|Overall Study||40
611687|NCT00360971|1497265|P2|NOT COMPLETED|Overall Study||0
611688|NCT00360971|1497266|P1|NOT COMPLETED|Overall Study||0
611689|NCT00360971|1497265|P2|COMPLETED|Overall Study|Subjects with data for planned primary analysis are considered to have completed the study.|11
611690|NCT00360971|1497266|P1|COMPLETED|Overall Study|Subjects with data for planned primary analysis are considered to have completed the study.|10
611691|NCT00360971|1497265|P2|STARTED|Overall Study||11
611692|NCT00360971|1497266|P1|STARTED|Overall Study||10
611693|NCT00360828|1497282|P1|NOT COMPLETED|Overall Study||1
611694|NCT00360828|1497282|P1|COMPLETED|Overall Study||9
611695|NCT00360828|1497282|P1|STARTED|Overall Study||10
611696|NCT00360724|1497292|P2|NOT COMPLETED|Overall Study||4
611697|NCT00360724|1497293|P1|NOT COMPLETED|Overall Study||4
611698|NCT00360724|1497292|P2|COMPLETED|Overall Study||28
611699|NCT00360724|1497293|P1|COMPLETED|Overall Study||29
611700|NCT00360724|1497292|P2|STARTED|Overall Study||32
611701|NCT00360724|1497293|P1|STARTED|Overall Study||33
611702|NCT00360698|1497321|P2|NOT COMPLETED|Treatment Period||1
611703|NCT00360698|1497322|P1|NOT COMPLETED|Treatment Period||1
611704|NCT00360698|1497321|P2|COMPLETED|Treatment Period||56
611705|NCT00360698|1497322|P1|COMPLETED|Treatment Period||48
611706|NCT00360698|1497321|P2|STARTED|Treatment Period||57
611707|NCT00360698|1497322|P1|STARTED|Treatment Period||49
611708|NCT00360698|1497321|P2|NOT COMPLETED|Run-In||10
611709|NCT00360698|1497322|P1|NOT COMPLETED|Run-In||0
611710|NCT00360698|1497321|P2|COMPLETED|Run-In|19 patients completed the run-in but were not eligible for randomization in the treatment period|125
611711|NCT00360698|1497322|P1|COMPLETED|Run-In||0
611712|NCT00360698|1497321|P2|STARTED|Run-In||135
611713|NCT00360698|1497322|P1|STARTED|Run-In||0
611714|NCT00360685|1497350|P2|NOT COMPLETED|Overall Study||0
611715|NCT00360685|1497351|P1|NOT COMPLETED|Overall Study||0
611716|NCT00360685|1497350|P2|COMPLETED|Overall Study||42
611717|NCT00360685|1497351|P1|COMPLETED|Overall Study||47
611718|NCT00360685|1497350|P2|STARTED|Overall Study||42
611719|NCT00360685|1497351|P1|STARTED|Overall Study||47
611720|NCT00360672|1497361|P1|NOT COMPLETED|Overall Study||0
611721|NCT00360672|1497361|P1|COMPLETED|Overall Study||27
611722|NCT00360672|1497361|P1|STARTED|Overall Study||27
611723|NCT00360568|1497367|P2|NOT COMPLETED|Overall Study||5
611724|NCT00360568|1497368|P1|NOT COMPLETED|Overall Study||2
611725|NCT00360568|1497367|P2|COMPLETED|Overall Study||24
611726|NCT00360568|1497368|P1|COMPLETED|Overall Study||31
611727|NCT00360568|1497367|P2|STARTED|Overall Study||29
611728|NCT00360568|1497368|P1|STARTED|Overall Study||33
611729|NCT00360555|1497479|P4|NOT COMPLETED|Overall Study||112
611730|NCT00360555|1497480|P3|NOT COMPLETED|Overall Study||145
611731|NCT00360555|1497481|P2|NOT COMPLETED|Overall Study||134
611732|NCT00360555|1497482|P1|NOT COMPLETED|Overall Study||122
611733|NCT00360555|1497479|P4|COMPLETED|Overall Study||287
611734|NCT00360555|1497480|P3|COMPLETED|Overall Study||251
611735|NCT00360555|1497481|P2|COMPLETED|Overall Study||259
611736|NCT00360555|1497482|P1|COMPLETED|Overall Study||274
611737|NCT00360555|1497479|P4|STARTED|Overall Study||399
611738|NCT00360555|1497480|P3|STARTED|Overall Study||396
611739|NCT00360555|1497481|P2|STARTED|Overall Study||393
611740|NCT00360555|1497482|P1|STARTED|Overall Study||396
611741|NCT00360529|1497499|P3|NOT COMPLETED|Overall Study||91
611742|NCT00360529|1497500|P2|NOT COMPLETED|Overall Study||65
611743|NCT00360529|1497501|P1|NOT COMPLETED|Overall Study||61
611744|NCT00360529|1497499|P3|COMPLETED|Overall Study||199
611745|NCT00360529|1497500|P2|COMPLETED|Overall Study||230
611746|NCT00360529|1497501|P1|COMPLETED|Overall Study||234
611747|NCT00360529|1497499|P3|STARTED|Overall Study||290
611748|NCT00360529|1497500|P2|STARTED|Overall Study||295
611749|NCT00360529|1497501|P1|STARTED|Overall Study||295
611750|NCT00360490|1497529|P2|NOT COMPLETED|Overall Study||11
611751|NCT00360490|1497530|P1|NOT COMPLETED|Overall Study||9
611752|NCT00360490|1497529|P2|COMPLETED|Overall Study||72
611753|NCT00360490|1497530|P1|COMPLETED|Overall Study||73
611754|NCT00360490|1497529|P2|STARTED|Overall Study||83
611755|NCT00360490|1497530|P1|STARTED|Overall Study||82
611756|NCT00360412|1497565|P2|NOT COMPLETED|Overall Study||662
611757|NCT00360412|1497566|P1|NOT COMPLETED|Overall Study||333
611758|NCT00360412|1497565|P2|COMPLETED|Overall Study||2
611759|NCT00360412|1497566|P1|COMPLETED|Overall Study||0
611760|NCT00360412|1497565|P2|STARTED|Overall Study||664
611761|NCT00360412|1497566|P1|STARTED|Overall Study||333
611762|NCT00360399|1497581|P3|NOT COMPLETED|Overall Study||46
611763|NCT00360399|1497582|P2|NOT COMPLETED|Overall Study||36
611764|NCT00360399|1497583|P1|NOT COMPLETED|Overall Study||28
611765|NCT00360399|1497581|P3|COMPLETED|Overall Study||69
611766|NCT00360399|1497582|P2|COMPLETED|Overall Study||79
611767|NCT00360399|1497583|P1|COMPLETED|Overall Study||86
611768|NCT00360399|1497581|P3|Had Post-randomization Assessment|Overall Study||105
611769|NCT00360399|1497582|P2|Had Post-randomization Assessment|Overall Study||106
611770|NCT00360399|1497583|P1|Had Post-randomization Assessment|Overall Study||105
611771|NCT00360399|1497581|P3|STARTED|Overall Study||115
611772|NCT00360399|1497582|P2|STARTED|Overall Study||115
611773|NCT00360399|1497583|P1|STARTED|Overall Study||114
611774|NCT00360360|1497606|P1|NOT COMPLETED|Overall Study||6
611775|NCT00360360|1497606|P1|COMPLETED|Overall Study||54
611776|NCT00360360|1497606|P1|STARTED|Overall Study||60
611777|NCT00360334|1497613|P2|NOT COMPLETED|Overall Study||13
611778|NCT00360334|1497614|P1|NOT COMPLETED|Overall Study||19
611779|NCT00360334|1497613|P2|COMPLETED|Overall Study||104
611780|NCT00360334|1497614|P1|COMPLETED|Overall Study||99
611781|NCT00360334|1497613|P2|Full Analysis Set (FAS)|Overall Study|FAS = received ≥ 1 dose of study drug|116
611782|NCT00360334|1497614|P1|Full Analysis Set (FAS)|Overall Study|FAS = received ≥ 1 dose of study drug|118
611783|NCT00360334|1497613|P2|STARTED|Overall Study||117
611784|NCT00360334|1497614|P1|STARTED|Overall Study||118
611785|NCT00360308|1497677|P3|NOT COMPLETED|Overall Study||88
611786|NCT00360308|1497678|P2|NOT COMPLETED|Overall Study||79
611787|NCT00360308|1497679|P1|NOT COMPLETED|Overall Study||76
611788|NCT00360308|1497677|P3|COMPLETED|Overall Study||154
611789|NCT00360308|1497678|P2|COMPLETED|Overall Study||155
611790|NCT00360308|1497679|P1|COMPLETED|Overall Study||171
611791|NCT00360308|1497677|P3|STARTED|Overall Study||242
611792|NCT00360308|1497678|P2|STARTED|Overall Study||234
611793|NCT00360308|1497679|P1|STARTED|Overall Study||247
611794|NCT00360282|1497696|P4|NOT COMPLETED|Second Intervention||0
611795|NCT00360282|1497697|P3|NOT COMPLETED|Second Intervention||0
611796|NCT00360282|1497698|P2|NOT COMPLETED|Second Intervention||1
611797|NCT00360282|1497699|P1|NOT COMPLETED|Second Intervention||0
611798|NCT00360282|1497696|P4|COMPLETED|Second Intervention||6
611799|NCT00360282|1497697|P3|COMPLETED|Second Intervention||6
611800|NCT00360282|1497698|P2|COMPLETED|Second Intervention||7
611801|NCT00360282|1497699|P1|COMPLETED|Second Intervention||6
611802|NCT00360282|1497696|P4|STARTED|Second Intervention||6
611803|NCT00360282|1497697|P3|STARTED|Second Intervention||6
611804|NCT00360282|1497698|P2|STARTED|Second Intervention||8
611805|NCT00360282|1497699|P1|STARTED|Second Intervention||6
611806|NCT00360282|1497696|P4|NOT COMPLETED|Washout 1-3 Weeks||0
611807|NCT00360282|1497697|P3|NOT COMPLETED|Washout 1-3 Weeks||1
611808|NCT00360282|1497698|P2|NOT COMPLETED|Washout 1-3 Weeks||0
611809|NCT00360282|1497699|P1|NOT COMPLETED|Washout 1-3 Weeks||0
611810|NCT00360282|1497696|P4|COMPLETED|Washout 1-3 Weeks||6
611811|NCT00360282|1497697|P3|COMPLETED|Washout 1-3 Weeks||6
611812|NCT00360282|1497698|P2|COMPLETED|Washout 1-3 Weeks||8
611813|NCT00360282|1497699|P1|COMPLETED|Washout 1-3 Weeks||6
611814|NCT00360282|1497696|P4|STARTED|Washout 1-3 Weeks||6
611815|NCT00360282|1497697|P3|STARTED|Washout 1-3 Weeks||7
611816|NCT00360282|1497698|P2|STARTED|Washout 1-3 Weeks||8
611817|NCT00360282|1497699|P1|STARTED|Washout 1-3 Weeks||6
611818|NCT00360282|1497696|P4|NOT COMPLETED|First Intervention||0
611819|NCT00360282|1497697|P3|NOT COMPLETED|First Intervention||0
611820|NCT00360282|1497698|P2|NOT COMPLETED|First Intervention||0
611821|NCT00360282|1497699|P1|NOT COMPLETED|First Intervention||0
611822|NCT00360282|1497696|P4|COMPLETED|First Intervention||6
611823|NCT00360282|1497697|P3|COMPLETED|First Intervention||7
611824|NCT00360282|1497698|P2|COMPLETED|First Intervention||8
611825|NCT00360282|1497699|P1|COMPLETED|First Intervention||6
611826|NCT00360282|1497696|P4|STARTED|First Intervention||6
611827|NCT00360282|1497697|P3|STARTED|First Intervention||7
611828|NCT00360282|1497698|P2|STARTED|First Intervention||8
611829|NCT00360282|1497699|P1|STARTED|First Intervention||6
611830|NCT00360269|1497711|P2|NOT COMPLETED|Overall Study||12
611831|NCT00360269|1497712|P1|NOT COMPLETED|Overall Study||10
611832|NCT00360269|1497711|P2|COMPLETED|Overall Study||7
611833|NCT00360269|1497712|P1|COMPLETED|Overall Study||9
611834|NCT00360269|1497711|P2|STARTED|Overall Study||19
611835|NCT00360269|1497712|P1|STARTED|Overall Study||19
611836|NCT00360243|1497730|P4|NOT COMPLETED|Overall Study||125
611837|NCT00360243|1497731|P3|NOT COMPLETED|Overall Study||156
611838|NCT00360243|1497732|P2|NOT COMPLETED|Overall Study||120
611839|NCT00360243|1497733|P1|NOT COMPLETED|Overall Study||102
611840|NCT00360243|1497730|P4|COMPLETED|Overall Study||224
611841|NCT00360243|1497731|P3|COMPLETED|Overall Study||180
611842|NCT00360243|1497732|P2|COMPLETED|Overall Study||243
611843|NCT00360243|1497733|P1|COMPLETED|Overall Study||235
611844|NCT00360243|1497730|P4|STARTED|Overall Study||349
611845|NCT00360243|1497731|P3|STARTED|Overall Study||336
611846|NCT00360243|1497732|P2|STARTED|Overall Study||363
611847|NCT00360243|1497733|P1|STARTED|Overall Study||337
611848|NCT00360230|1497754|P7|NOT COMPLETED|Overall Study||2
611849|NCT00360230|1497755|P6|NOT COMPLETED|Overall Study||4
611850|NCT00360230|1497756|P5|NOT COMPLETED|Overall Study||5
611851|NCT00360230|1497757|P4|NOT COMPLETED|Overall Study||2
611852|NCT00360230|1497758|P3|NOT COMPLETED|Overall Study||3
611853|NCT00360230|1497759|P2|NOT COMPLETED|Overall Study||3
611854|NCT00360230|1497760|P1|NOT COMPLETED|Overall Study||6
611855|NCT00360230|1497754|P7|COMPLETED|Overall Study||43
611856|NCT00360230|1497755|P6|COMPLETED|Overall Study||86
611857|NCT00360230|1497756|P5|COMPLETED|Overall Study||85
611858|NCT00360230|1497757|P4|COMPLETED|Overall Study||88
611859|NCT00360230|1497758|P3|COMPLETED|Overall Study||42
611860|NCT00360230|1497759|P2|COMPLETED|Overall Study||87
611861|NCT00360230|1497760|P1|COMPLETED|Overall Study||84
611862|NCT00360230|1497754|P7|STARTED|Overall Study||45
611863|NCT00360230|1497755|P6|STARTED|Overall Study||90
611864|NCT00360230|1497756|P5|STARTED|Overall Study||90
611865|NCT00360230|1497757|P4|STARTED|Overall Study||90
611866|NCT00360230|1497758|P3|STARTED|Overall Study||45
611867|NCT00360230|1497759|P2|STARTED|Overall Study||90
611868|NCT00360230|1497760|P1|STARTED|Overall Study||90
611869|NCT00360126|1497811|P1|NOT COMPLETED|Overall Study||0
611870|NCT00360126|1497811|P1|COMPLETED|Overall Study||11
611871|NCT00360126|1497811|P1|STARTED|Overall Study||11
611872|NCT00360009|1497818|P3|NOT COMPLETED|Overall Study||3
611873|NCT00360009|1497819|P2|NOT COMPLETED|Overall Study||4
611874|NCT00360009|1497820|P1|NOT COMPLETED|Overall Study||0
611875|NCT00360009|1497818|P3|COMPLETED|Overall Study||23
611876|NCT00360009|1497819|P2|COMPLETED|Overall Study||22
611877|NCT00360009|1497820|P1|COMPLETED|Overall Study||10
611878|NCT00360009|1497818|P3|STARTED|Overall Study||26
611879|NCT00360009|1497819|P2|STARTED|Overall Study||26
611880|NCT00360009|1497820|P1|STARTED|Overall Study||10
611881|NCT00359983|1497861|P3|NOT COMPLETED|Year 5 Persistence Follow-up||0
611882|NCT00359983|1497862|P2|NOT COMPLETED|Year 5 Persistence Follow-up||0
611883|NCT00359983|1497863|P1|NOT COMPLETED|Year 5 Persistence Follow-up||0
611884|NCT00359983|1497861|P3|COMPLETED|Year 5 Persistence Follow-up||42
611885|NCT00359983|1497862|P2|COMPLETED|Year 5 Persistence Follow-up||44
611886|NCT00359983|1497863|P1|COMPLETED|Year 5 Persistence Follow-up||95
611887|NCT00359983|1497861|P3|STARTED|Year 5 Persistence Follow-up||42
611888|NCT00359983|1497862|P2|STARTED|Year 5 Persistence Follow-up||44
611889|NCT00359983|1497863|P1|STARTED|Year 5 Persistence Follow-up||95
611890|NCT00359983|1497861|P3|NOT COMPLETED|Year 3 Persistence Follow-up||0
611891|NCT00359983|1497862|P2|NOT COMPLETED|Year 3 Persistence Follow-up||0
611892|NCT00359983|1497863|P1|NOT COMPLETED|Year 3 Persistence Follow-up||0
611893|NCT00359983|1497861|P3|COMPLETED|Year 3 Persistence Follow-up||51
611894|NCT00359983|1497862|P2|COMPLETED|Year 3 Persistence Follow-up||47
611895|NCT00359983|1497863|P1|COMPLETED|Year 3 Persistence Follow-up||103
611896|NCT00359983|1497861|P3|STARTED|Year 3 Persistence Follow-up||51
611897|NCT00359983|1497862|P2|STARTED|Year 3 Persistence Follow-up||47
611898|NCT00359983|1497863|P1|STARTED|Year 3 Persistence Follow-up||103
611899|NCT00359983|1497861|P3|NOT COMPLETED|Year 1 Persistence Follow-up||0
611900|NCT00359983|1497862|P2|NOT COMPLETED|Year 1 Persistence Follow-up||0
611901|NCT00359983|1497863|P1|NOT COMPLETED|Year 1 Persistence Follow-up||0
611902|NCT00359983|1497861|P3|COMPLETED|Year 1 Persistence Follow-up||62
611903|NCT00359983|1497862|P2|COMPLETED|Year 1 Persistence Follow-up||70
611904|NCT00359983|1497863|P1|COMPLETED|Year 1 Persistence Follow-up||138
611905|NCT00359983|1497861|P3|STARTED|Year 1 Persistence Follow-up||62
611906|NCT00359983|1497862|P2|STARTED|Year 1 Persistence Follow-up||70
611907|NCT00359983|1497863|P1|STARTED|Year 1 Persistence Follow-up||138
611908|NCT00359944|1497898|P3|NOT COMPLETED|Overall Study||19
611909|NCT00359944|1497899|P2|NOT COMPLETED|Overall Study||19
611910|NCT00359944|1497900|P1|NOT COMPLETED|Overall Study||16
611911|NCT00359944|1497898|P3|COMPLETED|Overall Study||38
611912|NCT00359944|1497899|P2|COMPLETED|Overall Study||28
611913|NCT00359944|1497900|P1|COMPLETED|Overall Study||34
611914|NCT00359944|1497898|P3|STARTED|Overall Study||57
611915|NCT00359944|1497899|P2|STARTED|Overall Study||47
611916|NCT00359944|1497900|P1|STARTED|Overall Study||50
611917|NCT00359801|1497916|P2|NOT COMPLETED|Overall Study||220
611918|NCT00359801|1497917|P1|NOT COMPLETED|Overall Study||305
611919|NCT00359801|1497916|P2|COMPLETED|Overall Study|4 additional subjects had missing data and final status (completed/discontinued) is unknown.|769
611920|NCT00359801|1497917|P1|COMPLETED|Overall Study|7 additional subjects had missing data and final status (completed/discontinued) is unknown.|682
611921|NCT00359801|1497916|P2|STARTED|Overall Study||989
611922|NCT00359801|1497917|P1|STARTED|Overall Study||987
611923|NCT00359788|1497951|P2|NOT COMPLETED|Overall Study||17
611924|NCT00359788|1497952|P1|NOT COMPLETED|Overall Study||23
611925|NCT00359788|1497951|P2|COMPLETED|Overall Study||159
611926|NCT00359788|1497952|P1|COMPLETED|Overall Study||150
611927|NCT00359788|1497951|P2|STARTED|Overall Study||176
611928|NCT00359788|1497952|P1|STARTED|Overall Study||173
611929|NCT00359762|1498186|P5|NOT COMPLETED|Period I||0
611930|NCT00359762|1498187|P4|NOT COMPLETED|Period I||0
611931|NCT00359762|1498188|P3|NOT COMPLETED|Period I||0
611932|NCT00359762|1498189|P2|NOT COMPLETED|Period I||0
611933|NCT00359762|1498190|P1|NOT COMPLETED|Period I||0
611934|NCT00359762|1498186|P5|COMPLETED|Period I||0
611935|NCT00359762|1498187|P4|COMPLETED|Period I||0
611936|NCT00359762|1498188|P3|COMPLETED|Period I||0
611937|NCT00359762|1498189|P2|COMPLETED|Period I||0
611938|NCT00359762|1498190|P1|COMPLETED|Period I||0
611939|NCT00359762|1498186|P5|STARTED|Period I||0
611940|NCT00359762|1498187|P4|STARTED|Period I||0
611941|NCT00359762|1498188|P3|STARTED|Period I||0
611942|NCT00359762|1498189|P2|STARTED|Period I||0
611943|NCT00359762|1498190|P1|STARTED|Period I||0
611944|NCT00359762|1498186|P5|NOT COMPLETED|Period III||0
611945|NCT00359762|1498187|P4|NOT COMPLETED|Period III||65
611946|NCT00359762|1498188|P3|NOT COMPLETED|Period III||30
611947|NCT00359762|1498189|P2|NOT COMPLETED|Period III||29
611948|NCT00359762|1498190|P1|NOT COMPLETED|Period III||0
611949|NCT00359762|1498186|P5|COMPLETED|Period III||0
611950|NCT00359762|1498187|P4|COMPLETED|Period III||101
611951|NCT00359762|1498188|P3|COMPLETED|Period III||47
611952|NCT00359762|1498189|P2|COMPLETED|Period III||48
611953|NCT00359762|1498190|P1|COMPLETED|Period III||0
611954|NCT00359762|1498186|P5|Extension ITT Efficacy Population|Period III||0
611955|NCT00359762|1498187|P4|Extension ITT Efficacy Population|Period III||164
611956|NCT00359762|1498188|P3|Extension ITT Efficacy Population|Period III||75
611957|NCT00359762|1498189|P2|Extension ITT Efficacy Population|Period III||73
611958|NCT00359762|1498190|P1|Extension ITT Efficacy Population|Period III||0
611959|NCT00359762|1498186|P5|Extension ITT Safety Population|Period III||0
611960|NCT00359762|1498187|P4|Extension ITT Safety Population|Period III||166
611961|NCT00359762|1498188|P3|Extension ITT Safety Population|Period III||76
611962|NCT00359762|1498189|P2|Extension ITT Safety Population|Period III||74
611963|NCT00359762|1498190|P1|Extension ITT Safety Population|Period III||0
611964|NCT00359762|1498186|P5|STARTED|Period III||0
611965|NCT00359762|1498187|P4|STARTED|Period III||166
611966|NCT00359762|1498188|P3|STARTED|Period III||77
611967|NCT00359762|1498189|P2|STARTED|Period III||77
611968|NCT00359762|1498190|P1|STARTED|Period III||0
611969|NCT00359762|1498186|P5|NOT COMPLETED|Period II||174
611970|NCT00359762|1498187|P4|NOT COMPLETED|Period II||0
611971|NCT00359762|1498188|P3|NOT COMPLETED|Period II||0
611972|NCT00359762|1498189|P2|NOT COMPLETED|Period II||0
611973|NCT00359762|1498190|P1|NOT COMPLETED|Period II||128
611974|NCT00359762|1498186|P5|COMPLETED|Period II||341
611975|NCT00359762|1498187|P4|COMPLETED|Period II||0
611976|NCT00359762|1498188|P3|COMPLETED|Period II||0
611977|NCT00359762|1498189|P2|COMPLETED|Period II||0
611978|NCT00359762|1498190|P1|COMPLETED|Period II||386
611979|NCT00359762|1498186|P5|Without Treatment Failure|Period II||138
611980|NCT00359762|1498187|P4|Without Treatment Failure|Period II||0
611981|NCT00359762|1498188|P3|Without Treatment Failure|Period II||0
611982|NCT00359762|1498189|P2|Without Treatment Failure|Period II||0
611983|NCT00359762|1498190|P1|Without Treatment Failure|Period II||124
611984|NCT00359762|1498186|P5|Met Primary Endpoint|Period II||203
611985|NCT00359762|1498187|P4|Met Primary Endpoint|Period II||0
611986|NCT00359762|1498188|P3|Met Primary Endpoint|Period II||0
611987|NCT00359762|1498189|P2|Met Primary Endpoint|Period II||0
611988|NCT00359762|1498190|P1|Met Primary Endpoint|Period II||262
611989|NCT00359762|1498186|P5|ITT Efficacy Population|Period II||490
611990|NCT00359762|1498187|P4|ITT Efficacy Population|Period II||0
611991|NCT00359762|1498188|P3|ITT Efficacy Population|Period II||0
611992|NCT00359762|1498189|P2|ITT Efficacy Population|Period II||0
611993|NCT00359762|1498190|P1|ITT Efficacy Population|Period II||487
611994|NCT00359762|1498186|P5|Intent to Treat (ITT) Safety Population|Period II||511
611995|NCT00359762|1498187|P4|Intent to Treat (ITT) Safety Population|Period II||0
611996|NCT00359762|1498188|P3|Intent to Treat (ITT) Safety Population|Period II||0
611997|NCT00359762|1498189|P2|Intent to Treat (ITT) Safety Population|Period II||0
611998|NCT00359762|1498190|P1|Intent to Treat (ITT) Safety Population|Period II||508
611999|NCT00359762|1498186|P5|STARTED|Period II||515
612000|NCT00359762|1498187|P4|STARTED|Period II||0
612001|NCT00359762|1498188|P3|STARTED|Period II||0
612002|NCT00359762|1498189|P2|STARTED|Period II||0
612003|NCT00359762|1498190|P1|STARTED|Period II||514
612004|NCT00359736|1498253|P2|NOT COMPLETED|Overall Study||0
612005|NCT00359736|1498254|P1|NOT COMPLETED|Overall Study||0
612006|NCT00359736|1498253|P2|COMPLETED|Overall Study||15
612007|NCT00359736|1498254|P1|COMPLETED|Overall Study||14
612008|NCT00359736|1498253|P2|STARTED|Overall Study||15
612009|NCT00359736|1498254|P1|STARTED|Overall Study||14
612010|NCT00359632|1498264|P2|NOT COMPLETED|Overall Study||0
612011|NCT00359632|1498265|P1|NOT COMPLETED|Overall Study||4
612012|NCT00359632|1498264|P2|COMPLETED|Overall Study||9
612013|NCT00359632|1498265|P1|COMPLETED|Overall Study||20
612014|NCT00359632|1498264|P2|STARTED|Overall Study||9
612015|NCT00359632|1498265|P1|STARTED|Overall Study||24
612016|NCT00359619|1498279|P7|NOT COMPLETED|Overall Study||4
612017|NCT00359619|1498280|P6|NOT COMPLETED|Overall Study||5
612018|NCT00359619|1498281|P5|NOT COMPLETED|Overall Study||3
612019|NCT00359619|1498282|P4|NOT COMPLETED|Overall Study||3
612020|NCT00359619|1498283|P3|NOT COMPLETED|Overall Study||7
612021|NCT00359619|1498284|P2|NOT COMPLETED|Overall Study||5
612022|NCT00359619|1498285|P1|NOT COMPLETED|Overall Study||8
612023|NCT00359619|1498279|P7|COMPLETED|Overall Study||46
612024|NCT00359619|1498280|P6|COMPLETED|Overall Study||45
612025|NCT00359619|1498281|P5|COMPLETED|Overall Study||45
612026|NCT00359619|1498282|P4|COMPLETED|Overall Study||45
612027|NCT00359619|1498283|P3|COMPLETED|Overall Study||42
612028|NCT00359619|1498284|P2|COMPLETED|Overall Study||45
612029|NCT00359619|1498285|P1|COMPLETED|Overall Study||80
612030|NCT00359619|1498279|P7|STARTED|Overall Study||50
612031|NCT00359619|1498280|P6|STARTED|Overall Study||50
612032|NCT00359619|1498281|P5|STARTED|Overall Study||48
612033|NCT00359619|1498282|P4|STARTED|Overall Study||48
612034|NCT00359619|1498283|P3|STARTED|Overall Study||49
612035|NCT00359619|1498284|P2|STARTED|Overall Study||50
612036|NCT00359619|1498285|P1|STARTED|Overall Study||88
612037|NCT00359424|1498415|P2|NOT COMPLETED|Overall Study||67
612038|NCT00359424|1498416|P1|NOT COMPLETED|Overall Study||130
612039|NCT00359424|1498415|P2|COMPLETED|Overall Study||155
612040|NCT00359424|1498416|P1|COMPLETED|Overall Study||304
612041|NCT00359424|1498415|P2|270 Day Follow up|Overall Study||159
612042|NCT00359424|1498416|P1|270 Day Follow up|Overall Study||313
612043|NCT00359424|1498415|P2|180 Day Follow up|Overall Study||167
612044|NCT00359424|1498416|P1|180 Day Follow up|Overall Study||325
612045|NCT00359424|1498415|P2|90 Day Follow up|Overall Study||172
612046|NCT00359424|1498416|P1|90 Day Follow up|Overall Study||343
612047|NCT00359424|1498415|P2|STARTED|Overall Study||222
612048|NCT00359424|1498416|P1|STARTED|Overall Study||434
612049|NCT00359281|1498455|P9|NOT COMPLETED|Overall Study||0
612050|NCT00359281|1498456|P8|NOT COMPLETED|Overall Study||0
612051|NCT00359281|1498457|P7|NOT COMPLETED|Overall Study||2
612052|NCT00359281|1498458|P6|NOT COMPLETED|Overall Study||0
612053|NCT00359281|1498459|P5|NOT COMPLETED|Overall Study||0
612054|NCT00359281|1498460|P4|NOT COMPLETED|Overall Study||0
612055|NCT00359281|1498461|P3|NOT COMPLETED|Overall Study||0
612056|NCT00359281|1498462|P2|NOT COMPLETED|Overall Study||0
612057|NCT00359281|1498463|P1|NOT COMPLETED|Overall Study||1
612058|NCT00359281|1498455|P9|COMPLETED|Overall Study||20
612059|NCT00359281|1498456|P8|COMPLETED|Overall Study||15
612060|NCT00359281|1498457|P7|COMPLETED|Overall Study||16
612061|NCT00359281|1498458|P6|COMPLETED|Overall Study||15
612062|NCT00359281|1498459|P5|COMPLETED|Overall Study||10
612063|NCT00359281|1498460|P4|COMPLETED|Overall Study||10
612064|NCT00359281|1498461|P3|COMPLETED|Overall Study||10
612065|NCT00359281|1498462|P2|COMPLETED|Overall Study||15
612066|NCT00359281|1498463|P1|COMPLETED|Overall Study||15
612067|NCT00359281|1498455|P9|STARTED|Overall Study||20
612068|NCT00359281|1498456|P8|STARTED|Overall Study||15
612069|NCT00359281|1498457|P7|STARTED|Overall Study||18
612070|NCT00359281|1498458|P6|STARTED|Overall Study||15
612071|NCT00359281|1498459|P5|STARTED|Overall Study||10
612072|NCT00359281|1498460|P4|STARTED|Overall Study||10
612073|NCT00359281|1498461|P3|STARTED|Overall Study||10
612074|NCT00359281|1498462|P2|STARTED|Overall Study||15
612075|NCT00359281|1498463|P1|STARTED|Overall Study||16
612076|NCT00359216|1498495|P2|NOT COMPLETED|Overall Study||1
612077|NCT00359216|1498496|P1|NOT COMPLETED|Overall Study||0
612078|NCT00359216|1498495|P2|COMPLETED|Overall Study|Completed treatment but simultaneously partaking in other study,final study procedures not performed|9
612079|NCT00359216|1498496|P1|COMPLETED|Overall Study||20
612080|NCT00359216|1498495|P2|STARTED|Overall Study||10
612081|NCT00359216|1498496|P1|STARTED|Overall Study||20
612082|NCT00359203|1498504|P2|NOT COMPLETED|Overall Study||0
612083|NCT00359203|1498505|P1|NOT COMPLETED|Overall Study||0
612084|NCT00359203|1498504|P2|COMPLETED|Overall Study||38
612085|NCT00359203|1498505|P1|COMPLETED|Overall Study||39
612086|NCT00359203|1498504|P2|STARTED|Overall Study||38
612087|NCT00359203|1498505|P1|STARTED|Overall Study||39
612088|NCT00359138|1498514|P3|NOT COMPLETED|Overall Study||0
612089|NCT00359138|1498515|P2|NOT COMPLETED|Overall Study||0
612090|NCT00359138|1498516|P1|NOT COMPLETED|Overall Study||0
612091|NCT00359138|1498514|P3|COMPLETED|Overall Study||12
612092|NCT00359138|1498515|P2|COMPLETED|Overall Study||12
612093|NCT00359138|1498516|P1|COMPLETED|Overall Study||12
612094|NCT00359138|1498514|P3|STARTED|Overall Study||12
612095|NCT00359138|1498515|P2|STARTED|Overall Study||12
612096|NCT00359138|1498516|P1|STARTED|Overall Study||12
612097|NCT00359073|1498526|P2|NOT COMPLETED|Overall Study||2
612098|NCT00359073|1498527|P1|NOT COMPLETED|Overall Study||4
612099|NCT00359073|1498526|P2|COMPLETED|Overall Study||11
612100|NCT00359073|1498527|P1|COMPLETED|Overall Study||8
612101|NCT00359073|1498526|P2|STARTED|Overall Study||13
612102|NCT00359073|1498527|P1|STARTED|Overall Study||12
612103|NCT00359021|1498539|P2|NOT COMPLETED|Overall Study||52
612104|NCT00359021|1498540|P1|NOT COMPLETED|Overall Study||81
612105|NCT00359021|1498539|P2|COMPLETED|Overall Study||195
612106|NCT00359021|1498540|P1|COMPLETED|Overall Study||175
612107|NCT00359021|1498539|P2|STARTED|Overall Study||247
612108|NCT00359021|1498540|P1|STARTED|Overall Study||256
612109|NCT00358956|1498552|P1|NOT COMPLETED|Overall Study||8
612110|NCT00358956|1498552|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|11
612111|NCT00358956|1498552|P1|STARTED|Overall Study||19
612112|NCT00358917|1498564|P2|NOT COMPLETED|Overall Study||69
612113|NCT00358917|1498565|P1|NOT COMPLETED|Overall Study||66
612114|NCT00358917|1498564|P2|COMPLETED|Overall Study||230
612115|NCT00358917|1498565|P1|COMPLETED|Overall Study||234
612116|NCT00358917|1498564|P2|STARTED|Overall Study||299
612117|NCT00358917|1498565|P1|STARTED|Overall Study||300
612118|NCT00358826|1498583|P8|NOT COMPLETED|MDCT Substudy||0
612119|NCT00358826|1498584|P7|NOT COMPLETED|MDCT Substudy||0
612120|NCT00358826|1498585|P6|NOT COMPLETED|MDCT Substudy||2
612121|NCT00358826|1498586|P5|NOT COMPLETED|MDCT Substudy||1
612122|NCT00358826|1498587|P4|NOT COMPLETED|MDCT Substudy||0
612123|NCT00358826|1498588|P3|NOT COMPLETED|MDCT Substudy||0
612124|NCT00358826|1498589|P2|NOT COMPLETED|MDCT Substudy||0
612125|NCT00358826|1498590|P1|NOT COMPLETED|MDCT Substudy||0
612126|NCT00358826|1498583|P8|COMPLETED|MDCT Substudy||27
612127|NCT00358826|1498584|P7|COMPLETED|MDCT Substudy||19
612128|NCT00358826|1498585|P6|COMPLETED|MDCT Substudy||20
612129|NCT00358826|1498586|P5|COMPLETED|MDCT Substudy||24
612130|NCT00358826|1498587|P4|COMPLETED|MDCT Substudy||0
612131|NCT00358826|1498588|P3|COMPLETED|MDCT Substudy||0
612132|NCT00358826|1498589|P2|COMPLETED|MDCT Substudy||0
612133|NCT00358826|1498590|P1|COMPLETED|MDCT Substudy||0
612134|NCT00358826|1498583|P8|STARTED|MDCT Substudy||27
612135|NCT00358826|1498584|P7|STARTED|MDCT Substudy||19
612136|NCT00358826|1498585|P6|STARTED|MDCT Substudy||22
612137|NCT00358826|1498586|P5|STARTED|MDCT Substudy||25
612138|NCT00358826|1498587|P4|STARTED|MDCT Substudy||0
612139|NCT00358826|1498588|P3|STARTED|MDCT Substudy||0
612140|NCT00358826|1498589|P2|STARTED|MDCT Substudy||0
612141|NCT00358826|1498590|P1|STARTED|MDCT Substudy||0
612142|NCT00358826|1498583|P8|NOT COMPLETED|Core Study||0
612143|NCT00358826|1498584|P7|NOT COMPLETED|Core Study||0
612144|NCT00358826|1498585|P6|NOT COMPLETED|Core Study||0
612145|NCT00358826|1498586|P5|NOT COMPLETED|Core Study||0
612146|NCT00358826|1498587|P4|NOT COMPLETED|Core Study||2
612147|NCT00358826|1498588|P3|NOT COMPLETED|Core Study||2
612148|NCT00358826|1498589|P2|NOT COMPLETED|Core Study||5
612149|NCT00358826|1498590|P1|NOT COMPLETED|Core Study||3
612150|NCT00358826|1498583|P8|COMPLETED|Core Study||0
612151|NCT00358826|1498584|P7|COMPLETED|Core Study||0
612152|NCT00358826|1498585|P6|COMPLETED|Core Study||0
612153|NCT00358826|1498586|P5|COMPLETED|Core Study||0
612154|NCT00358826|1498587|P4|COMPLETED|Core Study||50
612155|NCT00358826|1498588|P3|COMPLETED|Core Study||42
612156|NCT00358826|1498589|P2|COMPLETED|Core Study||41
612157|NCT00358826|1498590|P1|COMPLETED|Core Study||46
612158|NCT00358826|1498583|P8|STARTED|Core Study||0
612159|NCT00358826|1498584|P7|STARTED|Core Study||0
612160|NCT00358826|1498585|P6|STARTED|Core Study||0
612161|NCT00358826|1498586|P5|STARTED|Core Study||0
612162|NCT00358826|1498587|P4|STARTED|Core Study||52
612163|NCT00358826|1498588|P3|STARTED|Core Study||44
612164|NCT00358826|1498589|P2|STARTED|Core Study||46
612165|NCT00358826|1498590|P1|STARTED|Core Study||49
612166|NCT00358735|1498626|P2|NOT COMPLETED|Overall Study||17
612167|NCT00358735|1498627|P1|NOT COMPLETED|Overall Study||8
612168|NCT00358735|1498626|P2|COMPLETED|Overall Study|Efficacy|190
612169|NCT00358735|1498627|P1|COMPLETED|Overall Study|Efficacy|196
612170|NCT00358735|1498626|P2|Not Completed Safety|Overall Study||13
612171|NCT00358735|1498627|P1|Not Completed Safety|Overall Study||6
612172|NCT00358735|1498626|P2|Completed Safety|Overall Study||194
612173|NCT00358735|1498627|P1|Completed Safety|Overall Study||198
612174|NCT00358735|1498626|P2|STARTED|Overall Study||207
612175|NCT00358735|1498627|P1|STARTED|Overall Study||204
612176|NCT00358670|1498657|P2|NOT COMPLETED|Overall Study||219
612177|NCT00358670|1498658|P1|NOT COMPLETED|Overall Study||222
612178|NCT00358670|1498657|P2|COMPLETED|Overall Study||0
612179|NCT00358670|1498658|P1|COMPLETED|Overall Study||0
612180|NCT00358670|1498657|P2|STARTED|Overall Study||219
612181|NCT00358670|1498658|P1|STARTED|Overall Study||222
612182|NCT00358644|1498672|P1|NOT COMPLETED|Overall Study||50
612183|NCT00358644|1498672|P1|COMPLETED|Overall Study||5
612184|NCT00358644|1498672|P1|STARTED|Overall Study||55
612185|NCT00358579|1498678|P2|NOT COMPLETED|Overall Study||0
612186|NCT00358579|1498679|P1|NOT COMPLETED|Overall Study||0
612187|NCT00358579|1498678|P2|COMPLETED|Overall Study||374
612188|NCT00358579|1498679|P1|COMPLETED|Overall Study||353
612189|NCT00358579|1498678|P2|STARTED|Overall Study||374
612190|NCT00358579|1498679|P1|STARTED|Overall Study||353
612191|NCT00358527|1498695|P2|NOT COMPLETED|Overall Study||3
612192|NCT00358527|1498696|P1|NOT COMPLETED|Overall Study||13
612193|NCT00358527|1498695|P2|COMPLETED|Overall Study||131
612194|NCT00358527|1498696|P1|COMPLETED|Overall Study||254
612195|NCT00358527|1498695|P2|STARTED|Overall Study||134
612196|NCT00358527|1498696|P1|STARTED|Overall Study||267
612197|NCT00358501|1498706|P2|NOT COMPLETED|Overall Study||0
612198|NCT00358501|1498707|P1|NOT COMPLETED|Overall Study||0
612199|NCT00358501|1498706|P2|COMPLETED|Overall Study||32
612200|NCT00358501|1498707|P1|COMPLETED|Overall Study||102
612201|NCT00358501|1498706|P2|STARTED|Overall Study||32
612202|NCT00358501|1498707|P1|STARTED|Overall Study||102
612203|NCT00358462|1498722|P2|NOT COMPLETED|Overall Study||64
612204|NCT00358462|1498723|P1|NOT COMPLETED|Overall Study||59
612205|NCT00358462|1498722|P2|COMPLETED|Overall Study||238
612206|NCT00358462|1498723|P1|COMPLETED|Overall Study||245
612207|NCT00358462|1498722|P2|STARTED|Overall Study||302
612208|NCT00358462|1498723|P1|STARTED|Overall Study||304
612209|NCT00358449|1498734|P3|NOT COMPLETED|Overall Study||2
612210|NCT00358449|1498735|P2|NOT COMPLETED|Overall Study||1
612211|NCT00358449|1498736|P1|NOT COMPLETED|Overall Study||4
612212|NCT00358449|1498734|P3|COMPLETED|Overall Study||18
612213|NCT00358449|1498735|P2|COMPLETED|Overall Study||19
612214|NCT00358449|1498736|P1|COMPLETED|Overall Study||15
612215|NCT00358449|1498734|P3|STARTED|Overall Study||20
612216|NCT00358449|1498735|P2|STARTED|Overall Study||20
612217|NCT00358449|1498736|P1|STARTED|Overall Study||19
612218|NCT00358436|1498839|P2|NOT COMPLETED|Overall Study||86
612219|NCT00358436|1498840|P1|NOT COMPLETED|Overall Study||154
612220|NCT00358436|1498839|P2|COMPLETED|Overall Study||118
612221|NCT00358436|1498840|P1|COMPLETED|Overall Study||446
612222|NCT00358436|1498839|P2|STARTED|Overall Study||204
612223|NCT00358436|1498840|P1|STARTED|Overall Study||600
612224|NCT00358332|1498856|P4|NOT COMPLETED|Overall Study||0
612225|NCT00358332|1498857|P3|NOT COMPLETED|Overall Study||1
612226|NCT00358332|1498858|P2|NOT COMPLETED|Overall Study||3
612227|NCT00358332|1498859|P1|NOT COMPLETED|Overall Study||0
612228|NCT00358332|1498856|P4|COMPLETED|Overall Study||25
612229|NCT00358332|1498857|P3|COMPLETED|Overall Study||29
612230|NCT00358332|1498858|P2|COMPLETED|Overall Study||27
612231|NCT00358332|1498859|P1|COMPLETED|Overall Study||15
612232|NCT00358332|1498856|P4|STARTED|Overall Study||25
612233|NCT00358332|1498857|P3|STARTED|Overall Study||30
612234|NCT00358332|1498858|P2|STARTED|Overall Study||30
612235|NCT00358332|1498859|P1|STARTED|Overall Study||15
612236|NCT00358215|1498911|P2|NOT COMPLETED|Overall Study||652
612237|NCT00358215|1498912|P1|NOT COMPLETED|Overall Study||679
612238|NCT00358215|1498911|P2|COMPLETED|Overall Study|Participants who completed investigational product|484
612239|NCT00358215|1498912|P1|COMPLETED|Overall Study|Participants who completed investigational product|463
612240|NCT00358215|1498911|P2|Received Investigational Product|Overall Study||1133
612241|NCT00358215|1498912|P1|Received Investigational Product|Overall Study||1140
612242|NCT00358215|1498911|P2|STARTED|Overall Study||1136
612243|NCT00358215|1498912|P1|STARTED|Overall Study||1142
612244|NCT00358150|1498926|P1|NOT COMPLETED|Overall Study||7
612245|NCT00358150|1498926|P1|COMPLETED|Overall Study||19
612246|NCT00358150|1498926|P1|STARTED|Overall Study||26
612247|NCT00358007|1498948|P1|NOT COMPLETED|Overall Study||2
612248|NCT00358007|1498948|P1|COMPLETED|Overall Study||28
612249|NCT00358007|1498948|P1|STARTED|Overall Study||30
612250|NCT00357994|1498955|P2|NOT COMPLETED|Overall Study||3
612251|NCT00357994|1498956|P1|NOT COMPLETED|Overall Study||2
612252|NCT00357994|1498955|P2|COMPLETED|Overall Study||31
612253|NCT00357994|1498956|P1|COMPLETED|Overall Study||35
612254|NCT00357994|1498955|P2|STARTED|Overall Study||34
612255|NCT00357994|1498956|P1|STARTED|Overall Study||37
612256|NCT00357968|1499010|P2|NOT COMPLETED|Crossover Maintenance Dose Phase||0
612257|NCT00357968|1499011|P1|NOT COMPLETED|Crossover Maintenance Dose Phase||0
612258|NCT00357968|1499010|P2|COMPLETED|Crossover Maintenance Dose Phase||55
612259|NCT00357968|1499011|P1|COMPLETED|Crossover Maintenance Dose Phase||54
612260|NCT00357968|1499010|P2|STARTED|Crossover Maintenance Dose Phase||55
612261|NCT00357968|1499011|P1|STARTED|Crossover Maintenance Dose Phase|1 subject discontinued study drug-did not take clopidogrel during the 2nd phase but completed study|54
612262|NCT00357968|1499010|P2|NOT COMPLETED|First Maintenance Dose Phase||44
612263|NCT00357968|1499011|P1|NOT COMPLETED|First Maintenance Dose Phase||48
612264|NCT00357968|1499010|P2|COMPLETED|First Maintenance Dose Phase||55
612265|NCT00357968|1499011|P1|COMPLETED|First Maintenance Dose Phase||54
612266|NCT00357968|1499010|P2|Started Maintenance Dose|First Maintenance Dose Phase||55
612267|NCT00357968|1499011|P1|Started Maintenance Dose|First Maintenance Dose Phase||55
612268|NCT00357968|1499010|P2|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||57
612269|NCT00357968|1499011|P1|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||55
612270|NCT00357968|1499010|P2|Received Loading Dose|First Maintenance Dose Phase||99
612271|NCT00357968|1499011|P1|Received Loading Dose|First Maintenance Dose Phase||102
612272|NCT00357968|1499010|P2|STARTED|First Maintenance Dose Phase||99
612273|NCT00357968|1499011|P1|STARTED|First Maintenance Dose Phase||102
612274|NCT00357955|1499055|P2|NOT COMPLETED|Overall Study||3
612275|NCT00357955|1499056|P1|NOT COMPLETED|Overall Study||6
612276|NCT00357955|1499055|P2|COMPLETED|Overall Study||51
612277|NCT00357955|1499056|P1|COMPLETED|Overall Study||58
612278|NCT00357955|1499055|P2|STARTED|Overall Study||54
612279|NCT00357955|1499056|P1|STARTED|Overall Study||64
612280|NCT00357903|1499064|P2|NOT COMPLETED|Overall Study||43
612281|NCT00357903|1499065|P1|NOT COMPLETED|Overall Study||363
612282|NCT00357903|1499064|P2|COMPLETED|Overall Study||15
612283|NCT00357903|1499065|P1|COMPLETED|Overall Study||218
612284|NCT00357903|1499064|P2|STARTED|Overall Study||58
612285|NCT00357903|1499065|P1|STARTED|Overall Study||581
612286|NCT00357877|1499105|P2|NOT COMPLETED|Overall Study||30
612287|NCT00357877|1499106|P1|NOT COMPLETED|Overall Study||26
612288|NCT00357877|1499105|P2|COMPLETED|Overall Study||460
612289|NCT00357877|1499106|P1|COMPLETED|Overall Study||467
612290|NCT00357877|1499105|P2|STARTED|Overall Study||490
612291|NCT00357877|1499106|P1|STARTED|Overall Study||493
612292|NCT00357760|1499120|P2|NOT COMPLETED|Overall Study||35
612293|NCT00357760|1499121|P1|NOT COMPLETED|Overall Study||59
612294|NCT00357760|1499120|P2|COMPLETED|Overall Study|Patients continued receiving protocol treatment until progressive disease or unacceptable toxicity.|0
612295|NCT00357760|1499121|P1|COMPLETED|Overall Study|Patients continued receiving protocol treatment until progressive disease or unacceptable toxicity.|0
612296|NCT00357760|1499120|P2|Patients Who Undergo Dose Escalation|Overall Study||16
612297|NCT00357760|1499121|P1|Patients Who Undergo Dose Escalation|Overall Study|Only patients who progressed on the low dose (Arm B) had the opportunity to undergo dose escalation.|0
612298|NCT00357760|1499120|P2|Eligible and Treated Patients|Overall Study||32
612299|NCT00357760|1499121|P1|Eligible and Treated Patients|Overall Study||57
612300|NCT00357760|1499120|P2|Patients Who Started Treatment|Overall Study||34
612301|NCT00357760|1499121|P1|Patients Who Started Treatment|Overall Study||57
612302|NCT00357760|1499120|P2|STARTED|Overall Study||35
612303|NCT00357760|1499121|P1|STARTED|Overall Study||59
612304|NCT00357734|1499131|P1|NOT COMPLETED|Overall Study||4
612305|NCT00357734|1499131|P1|COMPLETED|Overall Study||10
612306|NCT00357734|1499131|P1|Patient Received 500 mg of ZD1839|Overall Study||1
612307|NCT00357734|1499131|P1|Patients Received 250 mg of ZD1839|Overall Study||13
612308|NCT00357734|1499131|P1|STARTED|Overall Study||14
612309|NCT00357656|1499142|P2|NOT COMPLETED|Overall Study||3
612310|NCT00357656|1499143|P1|NOT COMPLETED|Overall Study||0
612311|NCT00357656|1499142|P2|COMPLETED|Overall Study||29
612312|NCT00357656|1499143|P1|COMPLETED|Overall Study||31
612313|NCT00357656|1499142|P2|STARTED|Overall Study||32
612314|NCT00357656|1499143|P1|STARTED|Overall Study||31
612315|NCT00357552|1499194|P1|NOT COMPLETED|Weeks 24 to 104||5
612316|NCT00357552|1499194|P1|COMPLETED|Weeks 24 to 104||117
612317|NCT00357552|1499194|P1|STARTED|Weeks 24 to 104||122
612318|NCT00357552|1499194|P1|NOT COMPLETED|Weeks 0 to 24||1
612319|NCT00357552|1499194|P1|COMPLETED|Weeks 0 to 24|One subject died prior to week 24.|122
612320|NCT00357552|1499194|P1|STARTED|Weeks 0 to 24||123
612321|NCT00357552|1499194|P1|NOT COMPLETED|Screening||84
612322|NCT00357552|1499194|P1|COMPLETED|Screening|The number of participants who completed this period, is the number of participants who enrolled.|123
612323|NCT00357552|1499194|P1|STARTED|Screening|The number of participants who started this period, is the number of participants who screened.|207
612324|NCT00357500|1499209|P1|NOT COMPLETED|Overall Study||77
612325|NCT00357500|1499209|P1|COMPLETED|Overall Study||24
612326|NCT00357500|1499209|P1|Began Protocol Therapy|Overall Study|4 pts did not start treatment due either to removal of consent or inability to get insurance.|97
612327|NCT00357500|1499209|P1|STARTED|Overall Study||101
612328|NCT00357396|1499218|P2|NOT COMPLETED|Overall Study||0
612329|NCT00357396|1499219|P1|NOT COMPLETED|Overall Study||1
612330|NCT00357396|1499218|P2|COMPLETED|Overall Study||4
612331|NCT00357396|1499219|P1|COMPLETED|Overall Study||5
612332|NCT00357396|1499218|P2|STARTED|Overall Study||4
612333|NCT00357396|1499219|P1|STARTED|Overall Study||6
612334|NCT00357370|1499227|P3|NOT COMPLETED|Cohort 2||2
612335|NCT00357370|1499228|P2|NOT COMPLETED|Cohort 2||7
612336|NCT00357370|1499229|P1|NOT COMPLETED|Cohort 2||2
612337|NCT00357370|1499227|P3|COMPLETED|Cohort 2||22
612338|NCT00357370|1499228|P2|COMPLETED|Cohort 2||16
612339|NCT00357370|1499229|P1|COMPLETED|Cohort 2||22
612340|NCT00357370|1499227|P3|STARTED|Cohort 2||24
612341|NCT00357370|1499228|P2|STARTED|Cohort 2||23
612342|NCT00357370|1499229|P1|STARTED|Cohort 2||24
612343|NCT00357370|1499227|P3|NOT COMPLETED|Cohort 1||0
612344|NCT00357370|1499228|P2|NOT COMPLETED|Cohort 1||0
612345|NCT00357370|1499229|P1|NOT COMPLETED|Cohort 1||0
612346|NCT00357370|1499227|P3|COMPLETED|Cohort 1||0
612347|NCT00357370|1499228|P2|COMPLETED|Cohort 1||0
612348|NCT00357370|1499229|P1|COMPLETED|Cohort 1||4
612349|NCT00357370|1499227|P3|STARTED|Cohort 1||0
612350|NCT00357370|1499228|P2|STARTED|Cohort 1||0
612351|NCT00357370|1499229|P1|STARTED|Cohort 1||4
612352|NCT00357331|1499254|P2|NOT COMPLETED|Overall Study||0
612353|NCT00357331|1499255|P1|NOT COMPLETED|Overall Study||0
612354|NCT00357331|1499254|P2|COMPLETED|Overall Study||41
612355|NCT00357331|1499255|P1|COMPLETED|Overall Study||42
612356|NCT00357331|1499254|P2|STARTED|Overall Study||41
612357|NCT00357331|1499255|P1|STARTED|Overall Study||42
612358|NCT00357162|1499265|P1|NOT COMPLETED|Overall Study||0
612359|NCT00357162|1499265|P1|COMPLETED|Overall Study||21
612360|NCT00357162|1499265|P1|STARTED|Overall Study||21
612361|NCT00357110|1499275|P2|NOT COMPLETED|Overall Study||5
612362|NCT00357110|1499276|P1|NOT COMPLETED|Overall Study||5
612363|NCT00357110|1499275|P2|COMPLETED|Overall Study||2
612364|NCT00357110|1499276|P1|COMPLETED|Overall Study||1
612365|NCT00357110|1499275|P2|STARTED|Overall Study||7
612366|NCT00357110|1499276|P1|STARTED|Overall Study||6
612367|NCT00357097|1499284|P2|NOT COMPLETED|Overall Study||29
612368|NCT00357097|1499285|P1|NOT COMPLETED|Overall Study||54
612369|NCT00357097|1499284|P2|COMPLETED|Overall Study||38
612370|NCT00357097|1499285|P1|COMPLETED|Overall Study||145
612371|NCT00357097|1499284|P2|STARTED|Overall Study||67
612372|NCT00357097|1499285|P1|STARTED|Overall Study|199 were randomized. Only 198 took investigational product.|199
612373|NCT00357032|1499329|P1|NOT COMPLETED|Overall Study||0
612374|NCT00357032|1499329|P1|COMPLETED|Overall Study||12
612375|NCT00357032|1499329|P1|STARTED|Overall Study||12
612376|NCT00357006|1499339|P3|NOT COMPLETED|Overall Study||3
612377|NCT00357006|1499340|P2|NOT COMPLETED|Overall Study||5
612378|NCT00357006|1499341|P1|NOT COMPLETED|Overall Study||2
612379|NCT00357006|1499339|P3|COMPLETED|Overall Study||59
612380|NCT00357006|1499340|P2|COMPLETED|Overall Study||51
612381|NCT00357006|1499341|P1|COMPLETED|Overall Study||60
612382|NCT00357006|1499339|P3|STARTED|Overall Study||62
612383|NCT00357006|1499340|P2|STARTED|Overall Study||56
612384|NCT00357006|1499341|P1|STARTED|Overall Study||62
612385|NCT00356915|1499352|P3|NOT COMPLETED|Overall Study||42
612386|NCT00356915|1499353|P2|NOT COMPLETED|Overall Study||94
612387|NCT00356915|1499354|P1|NOT COMPLETED|Overall Study||76
612388|NCT00356915|1499352|P3|COMPLETED|Overall Study||156
612389|NCT00356915|1499353|P2|COMPLETED|Overall Study||496
612390|NCT00356915|1499354|P1|COMPLETED|Overall Study||517
612391|NCT00356915|1499352|P3|STARTED|Overall Study||198
612392|NCT00356915|1499353|P2|STARTED|Overall Study||590
612393|NCT00356915|1499354|P1|STARTED|Overall Study||593
612394|NCT00356889|1499371|P1|NOT COMPLETED|Overall Study||3
612395|NCT00356889|1499371|P1|COMPLETED|Overall Study||53
612396|NCT00356889|1499371|P1|STARTED|Overall Study||56
612397|NCT00356863|1499380|P2|NOT COMPLETED|Overall Study||75
612398|NCT00356863|1499381|P1|NOT COMPLETED|Overall Study||92
612399|NCT00356863|1499380|P2|COMPLETED|Overall Study||445
612400|NCT00356863|1499381|P1|COMPLETED|Overall Study||412
612401|NCT00356863|1499380|P2|STARTED|Overall Study||520
612402|NCT00356863|1499381|P1|STARTED|Overall Study||504
612403|NCT00356811|1499407|P1|NOT COMPLETED|Overall Study||49
612404|NCT00356811|1499407|P1|COMPLETED|Overall Study||8
612405|NCT00356811|1499407|P1|STARTED|Overall Study||57
612406|NCT00356603|1499422|P2|NOT COMPLETED|Overall Study||3
612407|NCT00356603|1499423|P1|NOT COMPLETED|Overall Study||6
612408|NCT00356603|1499422|P2|COMPLETED|Overall Study||33
612409|NCT00356603|1499423|P1|COMPLETED|Overall Study||33
612410|NCT00356603|1499422|P2|STARTED|Overall Study||36
612411|NCT00356603|1499423|P1|STARTED|Overall Study||39
612412|NCT00356590|1499437|P1|NOT COMPLETED|Overall Study||274
612413|NCT00356590|1499437|P1|COMPLETED|Overall Study||194
612414|NCT00356590|1499437|P1|STARTED|Overall Study||468
612415|NCT00356525|1499473|P4|NOT COMPLETED|Overall Study||9
612416|NCT00356525|1499474|P3|NOT COMPLETED|Overall Study||7
612417|NCT00356525|1499475|P2|NOT COMPLETED|Overall Study||11
612418|NCT00356525|1499476|P1|NOT COMPLETED|Overall Study||14
612419|NCT00356525|1499473|P4|COMPLETED|Overall Study||0
612420|NCT00356525|1499474|P3|COMPLETED|Overall Study||0
612421|NCT00356525|1499475|P2|COMPLETED|Overall Study||0
612422|NCT00356525|1499476|P1|COMPLETED|Overall Study||0
612423|NCT00356525|1499473|P4|STARTED|Overall Study||9
612424|NCT00356525|1499474|P3|STARTED|Overall Study||7
612425|NCT00356525|1499475|P2|STARTED|Overall Study||11
612426|NCT00356525|1499476|P1|STARTED|Overall Study||14
612427|NCT00356434|1499504|P2|NOT COMPLETED|Overall Study||0
612428|NCT00356434|1499505|P1|NOT COMPLETED|Overall Study||0
612429|NCT00356434|1499504|P2|COMPLETED|Overall Study||7
612430|NCT00356434|1499505|P1|COMPLETED|Overall Study||4
612431|NCT00356434|1499504|P2|STARTED|Overall Study||7
612432|NCT00356434|1499505|P1|STARTED|Overall Study||4
612433|NCT00356421|1499517|P2|NOT COMPLETED|Overall Study||17
612434|NCT00356421|1499518|P1|NOT COMPLETED|Overall Study||32
612435|NCT00356421|1499517|P2|COMPLETED|Overall Study||3
612436|NCT00356421|1499518|P1|COMPLETED|Overall Study||6
612437|NCT00356421|1499517|P2|STARTED|Overall Study||20
612438|NCT00356421|1499518|P1|STARTED|Overall Study||38
612439|NCT00356408|1499558|P1|NOT COMPLETED|Overall Study||60
612440|NCT00356408|1499558|P1|COMPLETED|Overall Study||43
612441|NCT00356408|1499558|P1|STARTED|Overall Study|106 subjects enrolled, however only 103 were included in the Intent to Treat (ITT) population.|103
612442|NCT00356369|1499575|P2|NOT COMPLETED|Year 5||0
612443|NCT00356369|1499576|P1|NOT COMPLETED|Year 5||0
612444|NCT00356369|1499575|P2|COMPLETED|Year 5||105
612445|NCT00356369|1499576|P1|COMPLETED|Year 5||299
612446|NCT00356369|1499575|P2|STARTED|Year 5||105
612447|NCT00356369|1499576|P1|STARTED|Year 5||299
612448|NCT00356369|1499575|P2|NOT COMPLETED|Year 4||0
612449|NCT00356369|1499576|P1|NOT COMPLETED|Year 4||0
612450|NCT00356369|1499575|P2|COMPLETED|Year 4||109
612451|NCT00356369|1499576|P1|COMPLETED|Year 4||317
612452|NCT00356369|1499575|P2|STARTED|Year 4||109
612453|NCT00356369|1499576|P1|STARTED|Year 4||317
612454|NCT00356369|1499575|P2|NOT COMPLETED|Year 3||0
612455|NCT00356369|1499576|P1|NOT COMPLETED|Year 3||0
612456|NCT00356369|1499575|P2|COMPLETED|Year 3||116
612457|NCT00356369|1499576|P1|COMPLETED|Year 3||344
612458|NCT00356369|1499575|P2|STARTED|Year 3||116
612459|NCT00356369|1499576|P1|STARTED|Year 3||344
612460|NCT00356369|1499575|P2|NOT COMPLETED|Year 2||0
612461|NCT00356369|1499576|P1|NOT COMPLETED|Year 2||0
612462|NCT00356369|1499575|P2|COMPLETED|Year 2||117
612463|NCT00356369|1499576|P1|COMPLETED|Year 2||354
612464|NCT00356369|1499575|P2|STARTED|Year 2||117
612465|NCT00356369|1499576|P1|STARTED|Year 2||354
612466|NCT00356369|1499575|P2|NOT COMPLETED|Year 1||0
612467|NCT00356369|1499576|P1|NOT COMPLETED|Year 1||0
612468|NCT00356369|1499575|P2|COMPLETED|Year 1||121
612469|NCT00356369|1499576|P1|COMPLETED|Year 1||364
612470|NCT00356369|1499575|P2|STARTED|Year 1||121
612471|NCT00356369|1499576|P1|STARTED|Year 1||364
612472|NCT00356369|1499575|P2|NOT COMPLETED|Active Phase||1
612473|NCT00356369|1499576|P1|NOT COMPLETED|Active Phase||2
612474|NCT00356369|1499575|P2|COMPLETED|Active Phase||125
612475|NCT00356369|1499576|P1|COMPLETED|Active Phase||372
612476|NCT00356369|1499575|P2|STARTED|Active Phase||126
612477|NCT00356369|1499576|P1|STARTED|Active Phase||374
612478|NCT00356304|1499646|P2|NOT COMPLETED|Overall Study||4
612479|NCT00356304|1499647|P1|NOT COMPLETED|Overall Study||2
612480|NCT00356304|1499646|P2|COMPLETED|Overall Study||20
612481|NCT00356304|1499647|P1|COMPLETED|Overall Study||24
612482|NCT00356304|1499646|P2|STARTED|Overall Study||24
612483|NCT00356304|1499647|P1|STARTED|Overall Study||26
612484|NCT00356278|1499658|P3|NOT COMPLETED|Overall Study||19
612485|NCT00356278|1499659|P2|NOT COMPLETED|Overall Study||15
612486|NCT00356278|1499660|P1|NOT COMPLETED|Overall Study||25
612487|NCT00356278|1499658|P3|COMPLETED|Overall Study||34
612488|NCT00356278|1499659|P2|COMPLETED|Overall Study||35
612489|NCT00356278|1499660|P1|COMPLETED|Overall Study||28
612490|NCT00356278|1499658|P3|STARTED|Overall Study||53
612491|NCT00356278|1499659|P2|STARTED|Overall Study||50
612492|NCT00356278|1499660|P1|STARTED|Overall Study||53
612493|NCT00356265|1499698|P3|NOT COMPLETED|Overall Study||1
612494|NCT00356265|1499699|P2|NOT COMPLETED|Overall Study||0
612495|NCT00356265|1499700|P1|NOT COMPLETED|Overall Study||0
612496|NCT00356265|1499698|P3|COMPLETED|Overall Study||5
612497|NCT00356265|1499699|P2|COMPLETED|Overall Study||2
612498|NCT00356265|1499700|P1|COMPLETED|Overall Study||7
612499|NCT00356265|1499698|P3|STARTED|Overall Study||6
612500|NCT00356265|1499699|P2|STARTED|Overall Study||2
612501|NCT00356265|1499700|P1|STARTED|Overall Study||7
612502|NCT00356200|1499712|P2|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||2
612503|NCT00356200|1499713|P1|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0
612504|NCT00356200|1499712|P2|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||3
612505|NCT00356200|1499713|P1|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0
612506|NCT00356200|1499712|P2|STARTED|Cohort 2: 100 ug/ml (New Patients)||5
612507|NCT00356200|1499713|P1|STARTED|Cohort 2: 100 ug/ml (New Patients)||0
612508|NCT00356200|1499712|P2|NOT COMPLETED|Cohort 1: 10 ug/ml||0
612509|NCT00356200|1499713|P1|NOT COMPLETED|Cohort 1: 10 ug/ml||1
612510|NCT00356200|1499712|P2|COMPLETED|Cohort 1: 10 ug/ml||0
612511|NCT00356200|1499713|P1|COMPLETED|Cohort 1: 10 ug/ml||4
612512|NCT00356200|1499712|P2|STARTED|Cohort 1: 10 ug/ml||0
612513|NCT00356200|1499713|P1|STARTED|Cohort 1: 10 ug/ml||5
612514|NCT00356187|1499727|P2|NOT COMPLETED|Overall Study||0
612515|NCT00356187|1499728|P1|NOT COMPLETED|Overall Study||0
612516|NCT00356187|1499727|P2|COMPLETED|Overall Study||0
612517|NCT00356187|1499728|P1|COMPLETED|Overall Study||0
612518|NCT00356187|1499727|P2|STARTED|Overall Study||0
612519|NCT00356187|1499728|P1|STARTED|Overall Study||0
612520|NCT00356148|1499742|P2|NOT COMPLETED|Overall Study||1
612521|NCT00356148|1499743|P1|NOT COMPLETED|Overall Study||2
612522|NCT00356148|1499742|P2|COMPLETED|Overall Study||182
612523|NCT00356148|1499743|P1|COMPLETED|Overall Study||187
612524|NCT00356148|1499742|P2|STARTED|Overall Study||183
612525|NCT00356148|1499743|P1|STARTED|Overall Study||189
612526|NCT00356135|1499754|P3|NOT COMPLETED|Overall Study||5
612527|NCT00356135|1499755|P2|NOT COMPLETED|Overall Study||2
612528|NCT00356135|1499756|P1|NOT COMPLETED|Overall Study||4
612529|NCT00356135|1499754|P3|COMPLETED|Overall Study||39
612530|NCT00356135|1499755|P2|COMPLETED|Overall Study||46
612531|NCT00356135|1499756|P1|COMPLETED|Overall Study||43
612532|NCT00356135|1499754|P3|STARTED|Overall Study||44
612533|NCT00356135|1499755|P2|STARTED|Overall Study||48
612534|NCT00356135|1499756|P1|STARTED|Overall Study||47
612535|NCT00356122|1499778|P1|NOT COMPLETED|FOLLOW-UP||41
612536|NCT00356122|1499778|P1|COMPLETED|FOLLOW-UP||12
612537|NCT00356122|1499778|P1|STARTED|FOLLOW-UP||53
612538|NCT00356122|1499778|P1|NOT COMPLETED|TREATMENT||45
612539|NCT00356122|1499778|P1|COMPLETED|TREATMENT||8
612540|NCT00356122|1499778|P1|STARTED|TREATMENT||53
612541|NCT00356057|1499789|P3|NOT COMPLETED|Overall Study||12
612542|NCT00356057|1499790|P2|NOT COMPLETED|Overall Study||14
612543|NCT00356057|1499791|P1|NOT COMPLETED|Overall Study||13
612544|NCT00356057|1499789|P3|COMPLETED|Overall Study||22
612545|NCT00356057|1499790|P2|COMPLETED|Overall Study||47
612546|NCT00356057|1499791|P1|COMPLETED|Overall Study||45
612547|NCT00356057|1499789|P3|IMPLANTED|Overall Study||25
612548|NCT00356057|1499790|P2|IMPLANTED|Overall Study||52
612549|NCT00356057|1499791|P1|IMPLANTED|Overall Study||49
612550|NCT00356057|1499789|P3|STARTED|Overall Study||34
612551|NCT00356057|1499790|P2|STARTED|Overall Study||61
612552|NCT00356057|1499791|P1|STARTED|Overall Study||58
612553|NCT00356031|1499829|P1|NOT COMPLETED|Overall Study||0
612554|NCT00356031|1499829|P1|COMPLETED|Overall Study||20
612555|NCT00356031|1499829|P1|STARTED|Overall Study||20
612556|NCT00355914|1499840|P2|NOT COMPLETED|Overall Study||0
612557|NCT00355914|1499841|P1|NOT COMPLETED|Overall Study||0
612558|NCT00355914|1499840|P2|COMPLETED|Overall Study||60
612559|NCT00355914|1499841|P1|COMPLETED|Overall Study||60
612560|NCT00355914|1499840|P2|STARTED|Overall Study||60
612561|NCT00355914|1499841|P1|STARTED|Overall Study||60
612562|NCT00355797|1499852|P3|NOT COMPLETED|Overall Study||142
612563|NCT00355797|1499853|P2|NOT COMPLETED|Overall Study||148
612564|NCT00355797|1499854|P1|NOT COMPLETED|Overall Study||240
612565|NCT00355797|1499852|P3|COMPLETED|Overall Study||239
612566|NCT00355797|1499853|P2|COMPLETED|Overall Study||221
612567|NCT00355797|1499854|P1|COMPLETED|Overall Study||501
612568|NCT00355797|1499852|P3|STARTED|Overall Study||381
612569|NCT00355797|1499853|P2|STARTED|Overall Study||369
612570|NCT00355797|1499854|P1|STARTED|Overall Study||741
612571|NCT00355784|1499886|P3|NOT COMPLETED|Overall Study||2
612572|NCT00355784|1499887|P2|NOT COMPLETED|Overall Study||0
612573|NCT00355784|1499888|P1|NOT COMPLETED|Overall Study||0
612574|NCT00355784|1499886|P3|COMPLETED|Overall Study||5
612575|NCT00355784|1499887|P2|COMPLETED|Overall Study||8
612576|NCT00355784|1499888|P1|COMPLETED|Overall Study||9
612577|NCT00355784|1499886|P3|STARTED|Overall Study||7
612578|NCT00355784|1499887|P2|STARTED|Overall Study||8
612579|NCT00355784|1499888|P1|STARTED|Overall Study||9
612580|NCT00355706|1499922|P2|NOT COMPLETED|Overall Study||0
612581|NCT00355706|1499923|P1|NOT COMPLETED|Overall Study||0
612582|NCT00355706|1499922|P2|COMPLETED|Overall Study||50
612583|NCT00355706|1499923|P1|COMPLETED|Overall Study||50
612584|NCT00355706|1499922|P2|STARTED|Overall Study||50
612585|NCT00355706|1499923|P1|STARTED|Overall Study||50
612586|NCT00355615|1499937|P5|NOT COMPLETED|40-week Rosuvastatin Open Label Period||9
612587|NCT00355615|1499938|P4|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
612588|NCT00355615|1499939|P3|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
612589|NCT00355615|1499940|P2|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
612590|NCT00355615|1499941|P1|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
612591|NCT00355615|1499937|P5|COMPLETED|40-week Rosuvastatin Open Label Period||164
612592|NCT00355615|1499938|P4|COMPLETED|40-week Rosuvastatin Open Label Period||0
612593|NCT00355615|1499939|P3|COMPLETED|40-week Rosuvastatin Open Label Period||0
612594|NCT00355615|1499940|P2|COMPLETED|40-week Rosuvastatin Open Label Period||0
612595|NCT00355615|1499941|P1|COMPLETED|40-week Rosuvastatin Open Label Period||0
612596|NCT00355615|1499937|P5|STARTED|40-week Rosuvastatin Open Label Period||173
612597|NCT00355615|1499938|P4|STARTED|40-week Rosuvastatin Open Label Period||0
612598|NCT00355615|1499939|P3|STARTED|40-week Rosuvastatin Open Label Period||0
612599|NCT00355615|1499940|P2|STARTED|40-week Rosuvastatin Open Label Period||0
612600|NCT00355615|1499941|P1|STARTED|40-week Rosuvastatin Open Label Period||0
612601|NCT00355615|1499937|P5|NOT COMPLETED|Randomized Double Blind Period||0
612602|NCT00355615|1499938|P4|NOT COMPLETED|Randomized Double Blind Period||1
612603|NCT00355615|1499939|P3|NOT COMPLETED|Randomized Double Blind Period||1
612604|NCT00355615|1499940|P2|NOT COMPLETED|Randomized Double Blind Period||0
612605|NCT00355615|1499941|P1|NOT COMPLETED|Randomized Double Blind Period||1
612606|NCT00355615|1499937|P5|COMPLETED|Randomized Double Blind Period||0
612607|NCT00355615|1499938|P4|COMPLETED|Randomized Double Blind Period|1 dropped out due to an adverse event|45
612608|NCT00355615|1499939|P3|COMPLETED|Randomized Double Blind Period|45 were randomized but 1 never received drug|44
612609|NCT00355615|1499940|P2|COMPLETED|Randomized Double Blind Period||44
612610|NCT00355615|1499941|P1|COMPLETED|Randomized Double Blind Period|1 dropped out due to adverse event|41
612611|NCT00355615|1499937|P5|STARTED|Randomized Double Blind Period|open label phase followed the randomized phase|0
612612|NCT00355615|1499938|P4|STARTED|Randomized Double Blind Period||46
612613|NCT00355615|1499939|P3|STARTED|Randomized Double Blind Period||45
612614|NCT00355615|1499940|P2|STARTED|Randomized Double Blind Period||44
612615|NCT00355615|1499941|P1|STARTED|Randomized Double Blind Period||42
612616|NCT00355472|1500000|P1|NOT COMPLETED|Overall Study||1
612617|NCT00355472|1500000|P1|COMPLETED|Overall Study||15
612618|NCT00355472|1500000|P1|STARTED|Overall Study||16
612619|NCT00355394|1500027|P2|NOT COMPLETED|Overall Study||0
612620|NCT00355394|1500028|P1|NOT COMPLETED|Overall Study||0
612621|NCT00355394|1500027|P2|COMPLETED|Overall Study||16
612622|NCT00355394|1500028|P1|COMPLETED|Overall Study||15
612623|NCT00355394|1500027|P2|STARTED|Overall Study||16
612624|NCT00355394|1500028|P1|STARTED|Overall Study||15
612625|NCT00355368|1500046|P2|NOT COMPLETED|Overall Study||9
612626|NCT00355368|1500047|P1|NOT COMPLETED|Overall Study||10
612627|NCT00355368|1500046|P2|COMPLETED|Overall Study||201
612628|NCT00355368|1500047|P1|COMPLETED|Overall Study||200
612629|NCT00355368|1500046|P2|STARTED|Overall Study||210
612630|NCT00355368|1500047|P1|STARTED|Overall Study||210
612631|NCT00355342|1500061|P2|NOT COMPLETED|Overall Study||36
612632|NCT00355342|1500062|P1|NOT COMPLETED|Overall Study||39
612633|NCT00355342|1500061|P2|COMPLETED|Overall Study||56
612634|NCT00355342|1500062|P1|COMPLETED|Overall Study||55
612635|NCT00355342|1500061|P2|STARTED|Overall Study||92
612636|NCT00355342|1500062|P1|STARTED|Overall Study||94
612637|NCT00355199|1500072|P2|NOT COMPLETED|Overall Study||4
612638|NCT00355199|1500073|P1|NOT COMPLETED|Overall Study||7
612639|NCT00355199|1500072|P2|COMPLETED|Overall Study||122
612640|NCT00355199|1500073|P1|COMPLETED|Overall Study||113
612641|NCT00355199|1500072|P2|STARTED|Overall Study||126
612642|NCT00355199|1500073|P1|STARTED|Overall Study||120
612643|NCT00355147|1500089|P2|NOT COMPLETED|Overall Study||20
612644|NCT00355147|1500090|P1|NOT COMPLETED|Overall Study||18
612645|NCT00355147|1500089|P2|COMPLETED|Overall Study||67
612646|NCT00355147|1500090|P1|COMPLETED|Overall Study||69
612647|NCT00355147|1500089|P2|STARTED|Overall Study||87
612648|NCT00355147|1500090|P1|STARTED|Overall Study||87
612649|NCT00355134|1500109|P5|NOT COMPLETED|Extension Phase||19
612650|NCT00355134|1500110|P4|NOT COMPLETED|Extension Phase||16
612651|NCT00355134|1500111|P3|NOT COMPLETED|Extension Phase||0
612652|NCT00355134|1500112|P2|NOT COMPLETED|Extension Phase||37
612653|NCT00355134|1500113|P1|NOT COMPLETED|Extension Phase||31
612654|NCT00355134|1500109|P5|COMPLETED|Extension Phase||88
612655|NCT00355134|1500110|P4|COMPLETED|Extension Phase||89
612656|NCT00355134|1500111|P3|COMPLETED|Extension Phase||0
612657|NCT00355134|1500112|P2|COMPLETED|Extension Phase||180
612658|NCT00355134|1500113|P1|COMPLETED|Extension Phase||172
612659|NCT00355134|1500109|P5|STARTED|Extension Phase||107
612660|NCT00355134|1500110|P4|STARTED|Extension Phase||105
612661|NCT00355134|1500111|P3|STARTED|Extension Phase||0
612662|NCT00355134|1500112|P2|STARTED|Extension Phase||217
612663|NCT00355134|1500113|P1|STARTED|Extension Phase||203
612664|NCT00355134|1500109|P5|NOT COMPLETED|Core Phase||0
612665|NCT00355134|1500110|P4|NOT COMPLETED|Core Phase||0
612666|NCT00355134|1500111|P3|NOT COMPLETED|Core Phase||100
612667|NCT00355134|1500112|P2|NOT COMPLETED|Core Phase||86
612668|NCT00355134|1500113|P1|NOT COMPLETED|Core Phase||119
612669|NCT00355134|1500109|P5|COMPLETED|Core Phase||0
612670|NCT00355134|1500110|P4|COMPLETED|Core Phase||0
612671|NCT00355134|1500111|P3|COMPLETED|Core Phase||255
612672|NCT00355134|1500112|P2|COMPLETED|Core Phase||272
612673|NCT00355134|1500113|P1|COMPLETED|Core Phase||251
612674|NCT00355134|1500109|P5|STARTED|Core Phase||0
612675|NCT00355134|1500110|P4|STARTED|Core Phase||0
612676|NCT00355134|1500111|P3|STARTED|Core Phase||355
612677|NCT00355134|1500112|P2|STARTED|Core Phase||358
612678|NCT00355134|1500113|P1|STARTED|Core Phase||370
612679|NCT00355121|1500156|P3|NOT COMPLETED|Overall Study||5
612680|NCT00355121|1500157|P2|NOT COMPLETED|Overall Study||29
612681|NCT00355121|1500158|P1|NOT COMPLETED|Overall Study||21
612682|NCT00355121|1500156|P3|COMPLETED|Overall Study||170
612683|NCT00355121|1500157|P2|COMPLETED|Overall Study||324
612684|NCT00355121|1500158|P1|COMPLETED|Overall Study||332
612685|NCT00355121|1500156|P3|STARTED|Overall Study||175
612686|NCT00355121|1500157|P2|STARTED|Overall Study||353
612687|NCT00355121|1500158|P1|STARTED|Overall Study||353
612688|NCT00355082|1500189|P3|NOT COMPLETED|Continuation Phase||3
612689|NCT00355082|1500190|P2|NOT COMPLETED|Continuation Phase||0
612690|NCT00355082|1500191|P1|NOT COMPLETED|Continuation Phase||24
612691|NCT00355082|1500189|P3|COMPLETED|Continuation Phase||8
612692|NCT00355082|1500190|P2|COMPLETED|Continuation Phase||0
612693|NCT00355082|1500191|P1|COMPLETED|Continuation Phase||160
612694|NCT00355082|1500189|P3|STARTED|Continuation Phase|"See Pre-assign. Details for reasons why number starting CP does not equal number completing TP."|11
612695|NCT00355082|1500190|P2|STARTED|Continuation Phase||0
612696|NCT00355082|1500191|P1|STARTED|Continuation Phase|83 and 101 participants from the 250 and 300 mg groups (DB Phase), respectively, entered the CP.|184
612697|NCT00355082|1500189|P3|NOT COMPLETED|Double-Blind (DB) Treatment Phase||0
612698|NCT00355082|1500190|P2|NOT COMPLETED|Double-Blind (DB) Treatment Phase||34
612699|NCT00355082|1500191|P1|NOT COMPLETED|Double-Blind (DB) Treatment Phase||19
612700|NCT00355082|1500189|P3|COMPLETED|Double-Blind (DB) Treatment Phase||0
612701|NCT00355082|1500190|P2|COMPLETED|Double-Blind (DB) Treatment Phase||79
612702|NCT00355082|1500191|P1|COMPLETED|Double-Blind (DB) Treatment Phase||94
612703|NCT00355082|1500189|P3|STARTED|Double-Blind (DB) Treatment Phase||0
612704|NCT00355082|1500190|P2|STARTED|Double-Blind (DB) Treatment Phase|111 participants have baseline data; 2 participants did not receive study drug.|113
612705|NCT00355082|1500191|P1|STARTED|Double-Blind (DB) Treatment Phase|112 participants have baseline data; 1 participant did not receive study drug.|113
612706|NCT00355030|1500213|P2|NOT COMPLETED|Study Period 2 Long Term Follow-Up||2
612707|NCT00355030|1500214|P1|NOT COMPLETED|Study Period 2 Long Term Follow-Up||1
612708|NCT00355030|1500213|P2|COMPLETED|Study Period 2 Long Term Follow-Up||17
612709|NCT00355030|1500214|P1|COMPLETED|Study Period 2 Long Term Follow-Up||19
612710|NCT00355030|1500213|P2|STARTED|Study Period 2 Long Term Follow-Up|Participants from France were given the option to re-consent for Study Period 2.|19
612711|NCT00355030|1500214|P1|STARTED|Study Period 2 Long Term Follow-Up|Participants from France were given the option to re-consent for Study Period 2.|20
612712|NCT00355030|1500213|P2|NOT COMPLETED|Study Period 1 Treatment||44
612713|NCT00355030|1500214|P1|NOT COMPLETED|Study Period 1 Treatment||45
612714|NCT00355030|1500213|P2|COMPLETED|Study Period 1 Treatment|Participants from the Netherlands exited the study after Study Period 1.|1
612715|NCT00355030|1500214|P1|COMPLETED|Study Period 1 Treatment|Participants from the Netherlands exited the study after Study Period 1.|1
612716|NCT00355030|1500213|P2|Received At Least One Dose of Study Drug|Study Period 1 Treatment|2 non-eligible participants received somatropin from previous control group|43
612717|NCT00355030|1500214|P1|Received At Least One Dose of Study Drug|Study Period 1 Treatment|1 non-eligible participant received somatropin from previous control group|45
612718|NCT00355030|1500213|P2|STARTED|Study Period 1 Treatment||45
612719|NCT00355030|1500214|P1|STARTED|Study Period 1 Treatment||46
612720|NCT00354978|1500236|P1|NOT COMPLETED|Overall Study||0
612721|NCT00354978|1500236|P1|COMPLETED|Overall Study||43
612722|NCT00354978|1500236|P1|STARTED|Overall Study||43
612723|NCT00354913|1500240|P1|NOT COMPLETED|Overall Study||0
612724|NCT00354913|1500240|P1|COMPLETED|Overall Study||21
612725|NCT00354913|1500240|P1|STARTED|Overall Study||21
612726|NCT00354887|1500247|P1|NOT COMPLETED|Overall Study||1
612727|NCT00354887|1500247|P1|COMPLETED|Overall Study||29
612728|NCT00354887|1500247|P1|STARTED|Overall Study||30
612729|NCT00354835|1500253|P2|NOT COMPLETED|Overall Study||61
612730|NCT00354835|1500254|P1|NOT COMPLETED|Overall Study||52
612731|NCT00354835|1500253|P2|COMPLETED|Overall Study||181
612732|NCT00354835|1500254|P1|COMPLETED|Overall Study||187
612733|NCT00354835|1500253|P2|STARTED|Overall Study||242
612734|NCT00354835|1500254|P1|STARTED|Overall Study||239
612735|NCT00354770|1500286|P2|NOT COMPLETED|Overall Study||3
612736|NCT00354770|1500287|P1|NOT COMPLETED|Overall Study||3
612737|NCT00354770|1500286|P2|COMPLETED|Overall Study||22
612738|NCT00354770|1500287|P1|COMPLETED|Overall Study||22
612739|NCT00354770|1500286|P2|STARTED|Overall Study||25
612740|NCT00354770|1500287|P1|STARTED|Overall Study||25
612741|NCT00354744|1500293|P1|NOT COMPLETED|Overall Study||42
612742|NCT00354744|1500293|P1|COMPLETED|Overall Study||67
612743|NCT00354744|1500293|P1|STARTED|Overall Study||109
612744|NCT00354679|1500298|P1|NOT COMPLETED|Overall Study||1
612745|NCT00354679|1500298|P1|COMPLETED|Overall Study||33
612746|NCT00354679|1500298|P1|STARTED|Overall Study||34
612747|NCT00354640|1500302|P1|NOT COMPLETED|Overall Study||0
612748|NCT00354640|1500302|P1|COMPLETED|Overall Study||11
612749|NCT00354640|1500302|P1|STARTED|Overall Study||11
612750|NCT00354614|1500307|P1|NOT COMPLETED|Overall Study||28
612751|NCT00354614|1500307|P1|COMPLETED|Overall Study||53
612752|NCT00354614|1500307|P1|STARTED|Overall Study||81
612753|NCT00354601|1500311|P1|NOT COMPLETED|Overall Study||2
612754|NCT00354601|1500311|P1|COMPLETED|Overall Study||0
612755|NCT00354601|1500311|P1|STARTED|Overall Study||2
612756|NCT00354484|1500320|P2|NOT COMPLETED|Overall Study||3
612757|NCT00354484|1500321|P1|NOT COMPLETED|Overall Study||4
612758|NCT00354484|1500320|P2|COMPLETED|Overall Study||144
612759|NCT00354484|1500321|P1|COMPLETED|Overall Study||138
612760|NCT00354484|1500320|P2|STARTED|Overall Study||147
612761|NCT00354484|1500321|P1|STARTED|Overall Study||142
612762|NCT00354432|1500331|P4|NOT COMPLETED|Overall Study||10
612763|NCT00354432|1500332|P3|NOT COMPLETED|Overall Study||10
612764|NCT00354432|1500333|P2|NOT COMPLETED|Overall Study||8
612765|NCT00354432|1500334|P1|NOT COMPLETED|Overall Study||6
612766|NCT00354432|1500331|P4|COMPLETED|Overall Study||20
612767|NCT00354432|1500332|P3|COMPLETED|Overall Study||20
612768|NCT00354432|1500333|P2|COMPLETED|Overall Study||22
612769|NCT00354432|1500334|P1|COMPLETED|Overall Study||24
612770|NCT00354432|1500331|P4|STARTED|Overall Study||30
612771|NCT00354432|1500332|P3|STARTED|Overall Study||30
612772|NCT00354432|1500333|P2|STARTED|Overall Study||30
612773|NCT00354432|1500334|P1|STARTED|Overall Study||30
612774|NCT00354341|1500350|P2|NOT COMPLETED|Overall Study||7
612775|NCT00354341|1500351|P1|NOT COMPLETED|Overall Study||3
612776|NCT00354341|1500350|P2|COMPLETED|Overall Study||75
612777|NCT00354341|1500351|P1|COMPLETED|Overall Study||85
612778|NCT00354341|1500350|P2|STARTED|Overall Study||82
612779|NCT00354341|1500351|P1|STARTED|Overall Study||88
612780|NCT00354172|1500367|P1|NOT COMPLETED|Overall Study||1
612781|NCT00354172|1500367|P1|COMPLETED|Overall Study|1 patient did not reach umbilical cord blood transplant|15
612782|NCT00354172|1500367|P1|STARTED|Overall Study||16
612783|NCT00354159|1500387|P2|NOT COMPLETED|Long-term Follow-up||176
612784|NCT00354159|1500388|P1|NOT COMPLETED|Long-term Follow-up||180
612785|NCT00354159|1500387|P2|COMPLETED|Long-term Follow-up|All subjects were exited at the time of study closure|0
612786|NCT00354159|1500388|P1|COMPLETED|Long-term Follow-up|All subjects were exited at the time of study closure|0
612787|NCT00354159|1500387|P2|STARTED|Long-term Follow-up|Number entering post 12-month non-randomized long-term follow-up period|176
612788|NCT00354159|1500388|P1|STARTED|Long-term Follow-up|Number entering post 12-month non-randomized long-term follow-up period|180
612789|NCT00354159|1500387|P2|NOT COMPLETED|Randomized Study Period||22
612790|NCT00354159|1500388|P1|NOT COMPLETED|Randomized Study Period||22
612791|NCT00354159|1500387|P2|COMPLETED|Randomized Study Period||176
612792|NCT00354159|1500388|P1|COMPLETED|Randomized Study Period||180
612793|NCT00354159|1500387|P2|STARTED|Randomized Study Period||198
612794|NCT00354159|1500388|P1|STARTED|Randomized Study Period||202
612795|NCT00354107|1500431|P1|NOT COMPLETED|Overall Study||5
612796|NCT00354107|1500431|P1|COMPLETED|Overall Study||0
612797|NCT00354107|1500431|P1|STARTED|Overall Study||5
612798|NCT00354029|1500441|P2|NOT COMPLETED|Overall Study||2
612799|NCT00354029|1500442|P1|NOT COMPLETED|Overall Study||4
612800|NCT00354029|1500441|P2|COMPLETED|Overall Study||38
612801|NCT00354029|1500442|P1|COMPLETED|Overall Study||39
612802|NCT00354029|1500441|P2|STARTED|Overall Study||40
612803|NCT00354029|1500442|P1|STARTED|Overall Study||43
612804|NCT00353977|1500448|P1|NOT COMPLETED|Overall Study||0
612805|NCT00353977|1500448|P1|COMPLETED|Overall Study||38
612806|NCT00353977|1500448|P1|STARTED|Overall Study||38
612807|NCT00353873|1500454|P2|NOT COMPLETED|Overall Study||3
612808|NCT00353873|1500455|P1|NOT COMPLETED|Overall Study||6
612809|NCT00353873|1500454|P2|COMPLETED|Overall Study||147
612810|NCT00353873|1500455|P1|COMPLETED|Overall Study||147
612811|NCT00353873|1500454|P2|STARTED|Overall Study||150
612812|NCT00353873|1500455|P1|STARTED|Overall Study||153
612813|NCT00353834|1500469|P2|NOT COMPLETED|Overall Study||0
612814|NCT00353834|1500470|P1|NOT COMPLETED|Overall Study||0
612815|NCT00353834|1500469|P2|COMPLETED|Overall Study||27
612816|NCT00353834|1500470|P1|COMPLETED|Overall Study||26
612817|NCT00353834|1500469|P2|STARTED|Overall Study||27
612818|NCT00353834|1500470|P1|STARTED|Overall Study||26
612819|NCT00353795|1500478|P1|NOT COMPLETED|Overall Study||0
612820|NCT00353795|1500478|P1|COMPLETED|Overall Study||179
612821|NCT00353795|1500478|P1|STARTED|Overall Study||179
612822|NCT00353704|1500484|P2|NOT COMPLETED|Overall Study||1
612823|NCT00353704|1500485|P1|NOT COMPLETED|Overall Study||3
612824|NCT00353704|1500484|P2|COMPLETED|Overall Study||24
612825|NCT00353704|1500485|P1|COMPLETED|Overall Study||22
612826|NCT00353704|1500484|P2|STARTED|Overall Study||25
612827|NCT00353704|1500485|P1|STARTED|Overall Study||25
612828|NCT00353652|1500499|P6|NOT COMPLETED|Overall Study||5
612829|NCT00353652|1500500|P5|NOT COMPLETED|Overall Study||5
612830|NCT00353652|1500501|P4|NOT COMPLETED|Overall Study||0
612831|NCT00353652|1500502|P3|NOT COMPLETED|Overall Study||0
612832|NCT00353652|1500503|P2|NOT COMPLETED|Overall Study||0
612833|NCT00353652|1500504|P1|NOT COMPLETED|Overall Study||0
612834|NCT00353652|1500499|P6|COMPLETED|Overall Study||18
612835|NCT00353652|1500500|P5|COMPLETED|Overall Study||18
612836|NCT00353652|1500501|P4|COMPLETED|Overall Study||7
612837|NCT00353652|1500502|P3|COMPLETED|Overall Study||17
612838|NCT00353652|1500503|P2|COMPLETED|Overall Study||17
612839|NCT00353652|1500504|P1|COMPLETED|Overall Study||17
612840|NCT00353652|1500499|P6|STARTED|Overall Study||23
612841|NCT00353652|1500500|P5|STARTED|Overall Study||23
612842|NCT00353652|1500501|P4|STARTED|Overall Study||7
612843|NCT00353652|1500502|P3|STARTED|Overall Study||17
612844|NCT00353652|1500503|P2|STARTED|Overall Study||17
612845|NCT00353652|1500504|P1|STARTED|Overall Study||17
612846|NCT00353496|1500520|P2|NOT COMPLETED|Overall Study||17
612847|NCT00353496|1500521|P1|NOT COMPLETED|Overall Study||16
612848|NCT00353496|1500520|P2|COMPLETED|Overall Study||86
612849|NCT00353496|1500521|P1|COMPLETED|Overall Study|Patients who completed specified assessments or met primary efficacy endpoint criteria for an event.|85
612850|NCT00353496|1500520|P2|STARTED|Overall Study||103
612851|NCT00353496|1500521|P1|STARTED|Overall Study||101
612852|NCT00353431|1500538|P2|NOT COMPLETED|Overall Study||0
612853|NCT00353431|1500539|P1|NOT COMPLETED|Overall Study||0
612854|NCT00353431|1500538|P2|COMPLETED|Overall Study||67
612855|NCT00353431|1500539|P1|COMPLETED|Overall Study||63
612856|NCT00353431|1500538|P2|STARTED|Overall Study||67
612857|NCT00353431|1500539|P1|STARTED|Overall Study||63
612858|NCT00353418|1500555|P2|NOT COMPLETED|Overall Study||158
612859|NCT00353418|1500556|P1|NOT COMPLETED|Overall Study||83
612860|NCT00353418|1500555|P2|COMPLETED|Overall Study||119
612861|NCT00353418|1500556|P1|COMPLETED|Overall Study||55
612862|NCT00353418|1500555|P2|STARTED|Overall Study||277
612863|NCT00353418|1500556|P1|STARTED|Overall Study||138
612864|NCT00353366|1500574|P1|NOT COMPLETED|Overall Study||143
612865|NCT00353366|1500574|P1|COMPLETED|Overall Study||1289
612866|NCT00353366|1500574|P1|STARTED|Overall Study||1432
612867|NCT00353301|1500581|P1|NOT COMPLETED|Overall Study||0
612868|NCT00353301|1500581|P1|COMPLETED|Overall Study||25
612869|NCT00353301|1500581|P1|STARTED|Overall Study||25
612870|NCT00353275|1500588|P2|NOT COMPLETED|Overall Study||0
612871|NCT00353275|1500589|P1|NOT COMPLETED|Overall Study||0
612872|NCT00353275|1500588|P2|COMPLETED|Overall Study||3
612873|NCT00353275|1500589|P1|COMPLETED|Overall Study||2
612874|NCT00353275|1500588|P2|STARTED|Overall Study||3
612875|NCT00353275|1500589|P1|STARTED|Overall Study||2
612876|NCT00353262|1500595|P1|NOT COMPLETED|Overall Study||29
612877|NCT00353262|1500595|P1|COMPLETED|Overall Study||7
612878|NCT00353262|1500595|P1|STARTED|Overall Study||36
612879|NCT00353119|1500614|P2|NOT COMPLETED|Second Intervention Week 12 to Week 28||0
612880|NCT00353119|1500615|P1|NOT COMPLETED|Second Intervention Week 12 to Week 28||0
612881|NCT00353119|1500614|P2|COMPLETED|Second Intervention Week 12 to Week 28||10
612882|NCT00353119|1500615|P1|COMPLETED|Second Intervention Week 12 to Week 28||5
612883|NCT00353119|1500614|P2|STARTED|Second Intervention Week 12 to Week 28||10
612884|NCT00353119|1500615|P1|STARTED|Second Intervention Week 12 to Week 28||5
612885|NCT00353119|1500614|P2|NOT COMPLETED|First Intervention Day 0 to Week 12||0
612886|NCT00353119|1500615|P1|NOT COMPLETED|First Intervention Day 0 to Week 12||0
612887|NCT00353119|1500614|P2|COMPLETED|First Intervention Day 0 to Week 12||10
612888|NCT00353119|1500615|P1|COMPLETED|First Intervention Day 0 to Week 12||5
612889|NCT00353119|1500614|P2|STARTED|First Intervention Day 0 to Week 12||10
612890|NCT00353119|1500615|P1|STARTED|First Intervention Day 0 to Week 12||5
612891|NCT00352911|1500627|P2|NOT COMPLETED|300mg Twice Daily (14 Days)||0
612892|NCT00352911|1500628|P1|NOT COMPLETED|300mg Twice Daily (14 Days)||1
612893|NCT00352911|1500627|P2|COMPLETED|300mg Twice Daily (14 Days)||3
612894|NCT00352911|1500628|P1|COMPLETED|300mg Twice Daily (14 Days)||15
612895|NCT00352911|1500627|P2|STARTED|300mg Twice Daily (14 Days)||3
612896|NCT00352911|1500628|P1|STARTED|300mg Twice Daily (14 Days)||16
612897|NCT00352911|1500627|P2|NOT COMPLETED|150mg Twice Daily (14 Days)||0
612898|NCT00352911|1500628|P1|NOT COMPLETED|150mg Twice Daily (14 Days)||0
612899|NCT00352911|1500627|P2|COMPLETED|150mg Twice Daily (14 Days)||3
612900|NCT00352911|1500628|P1|COMPLETED|150mg Twice Daily (14 Days)||16
612901|NCT00352911|1500627|P2|STARTED|150mg Twice Daily (14 Days)||3
612902|NCT00352911|1500628|P1|STARTED|150mg Twice Daily (14 Days)||16
612903|NCT00352885|1500636|P2|NOT COMPLETED|Overall Study||8
612904|NCT00352885|1500637|P1|NOT COMPLETED|Overall Study||5
612905|NCT00352885|1500636|P2|COMPLETED|Overall Study||3
612906|NCT00352885|1500637|P1|COMPLETED|Overall Study||4
612907|NCT00352885|1500636|P2|STARTED|Overall Study||11
612908|NCT00352885|1500637|P1|STARTED|Overall Study||9
612909|NCT00352846|1500645|P2|NOT COMPLETED|Overall Study||13
612910|NCT00352846|1500646|P1|NOT COMPLETED|Overall Study||8
612911|NCT00352846|1500645|P2|COMPLETED|Overall Study||24
612912|NCT00352846|1500646|P1|COMPLETED|Overall Study||29
612913|NCT00352846|1500645|P2|STARTED|Overall Study||37
612914|NCT00352846|1500646|P1|STARTED|Overall Study||37
612915|NCT00352781|1500652|P1|NOT COMPLETED|Overall Study||883
612916|NCT00352781|1500652|P1|COMPLETED|Overall Study||884
612917|NCT00352781|1500652|P1|STARTED|Overall Study||1767
612918|NCT00352755|1500657|P1|NOT COMPLETED|Overall Study||2
612919|NCT00352755|1500657|P1|COMPLETED|Overall Study||16
612920|NCT00352755|1500657|P1|STARTED|Overall Study||18
612921|NCT00352690|1500667|P2|NOT COMPLETED|Overall Study||0
612922|NCT00352690|1500668|P1|NOT COMPLETED|Overall Study||2
612923|NCT00352690|1500667|P2|COMPLETED|Overall Study||0
612924|NCT00352690|1500668|P1|COMPLETED|Overall Study||8
612925|NCT00352690|1500667|P2|STARTED|Overall Study||0
612926|NCT00352690|1500668|P1|STARTED|Overall Study||10
612927|NCT00352664|1500688|P2|NOT COMPLETED|Overall Study||0
612928|NCT00352664|1500689|P1|NOT COMPLETED|Overall Study||7
612929|NCT00352664|1500688|P2|COMPLETED|Overall Study||0
612930|NCT00352664|1500689|P1|COMPLETED|Overall Study||20
612931|NCT00352664|1500688|P2|STARTED|Overall Study||0
612932|NCT00352664|1500689|P1|STARTED|Overall Study||27
612933|NCT00352612|1500697|P2|NOT COMPLETED|Overall Study||0
612934|NCT00352612|1500698|P1|NOT COMPLETED|Overall Study||0
612935|NCT00352612|1500697|P2|COMPLETED|Overall Study||100
612936|NCT00352612|1500698|P1|COMPLETED|Overall Study||100
612937|NCT00352612|1500697|P2|STARTED|Overall Study||100
612938|NCT00352612|1500698|P1|STARTED|Overall Study||100
612939|NCT00352534|1500706|P7|NOT COMPLETED|Final Risk Group Assignment||39
612940|NCT00352534|1500707|P6|NOT COMPLETED|Final Risk Group Assignment||45
612941|NCT00352534|1500708|P5|NOT COMPLETED|Final Risk Group Assignment||1
612942|NCT00352534|1500709|P4|NOT COMPLETED|Final Risk Group Assignment||3
612943|NCT00352534|1500710|P3|NOT COMPLETED|Final Risk Group Assignment||3
612944|NCT00352534|1500711|P2|NOT COMPLETED|Final Risk Group Assignment||0
612945|NCT00352534|1500712|P1|NOT COMPLETED|Final Risk Group Assignment||0
612946|NCT00352534|1500706|P7|COMPLETED|Final Risk Group Assignment||1
612947|NCT00352534|1500707|P6|COMPLETED|Final Risk Group Assignment||503
612948|NCT00352534|1500708|P5|COMPLETED|Final Risk Group Assignment||31
612949|NCT00352534|1500709|P4|COMPLETED|Final Risk Group Assignment||49
612950|NCT00352534|1500710|P3|COMPLETED|Final Risk Group Assignment||116
612951|NCT00352534|1500711|P2|COMPLETED|Final Risk Group Assignment||0
612952|NCT00352534|1500712|P1|COMPLETED|Final Risk Group Assignment||0
612953|NCT00352534|1500706|P7|STARTED|Final Risk Group Assignment||40
612954|NCT00352534|1500707|P6|STARTED|Final Risk Group Assignment||548
612955|NCT00352534|1500708|P5|STARTED|Final Risk Group Assignment||32
612956|NCT00352534|1500709|P4|STARTED|Final Risk Group Assignment||52
612957|NCT00352534|1500710|P3|STARTED|Final Risk Group Assignment||119
612958|NCT00352534|1500711|P2|STARTED|Final Risk Group Assignment||0
612959|NCT00352534|1500712|P1|STARTED|Final Risk Group Assignment||0
612960|NCT00352534|1500706|P7|NOT COMPLETED|Initial Staging||0
612961|NCT00352534|1500707|P6|NOT COMPLETED|Initial Staging||0
612962|NCT00352534|1500708|P5|NOT COMPLETED|Initial Staging||0
612963|NCT00352534|1500709|P4|NOT COMPLETED|Initial Staging||0
612964|NCT00352534|1500710|P3|NOT COMPLETED|Initial Staging||0
612965|NCT00352534|1500711|P2|NOT COMPLETED|Initial Staging||9
612966|NCT00352534|1500712|P1|NOT COMPLETED|Initial Staging||8
612967|NCT00352534|1500706|P7|COMPLETED|Initial Staging||0
612968|NCT00352534|1500707|P6|COMPLETED|Initial Staging||0
612969|NCT00352534|1500708|P5|COMPLETED|Initial Staging||0
612970|NCT00352534|1500709|P4|COMPLETED|Initial Staging||0
612971|NCT00352534|1500710|P3|COMPLETED|Initial Staging||0
612972|NCT00352534|1500711|P2|COMPLETED|Initial Staging||588
612973|NCT00352534|1500712|P1|COMPLETED|Initial Staging||203
612974|NCT00352534|1500706|P7|STARTED|Initial Staging||0
612975|NCT00352534|1500707|P6|STARTED|Initial Staging||0
612976|NCT00352534|1500708|P5|STARTED|Initial Staging||0
612977|NCT00352534|1500709|P4|STARTED|Initial Staging||0
612978|NCT00352534|1500710|P3|STARTED|Initial Staging||0
612979|NCT00352534|1500711|P2|STARTED|Initial Staging||597
612980|NCT00352534|1500712|P1|STARTED|Initial Staging||211
612981|NCT00352417|1500729|P2|NOT COMPLETED|Overall Study||5
612982|NCT00352417|1500730|P1|NOT COMPLETED|Overall Study||5
612983|NCT00352417|1500729|P2|COMPLETED|Overall Study||21
612984|NCT00352417|1500730|P1|COMPLETED|Overall Study||19
612985|NCT00352417|1500729|P2|STARTED|Overall Study||26
612986|NCT00352417|1500730|P1|STARTED|Overall Study||24
612987|NCT00352365|1500744|P1|NOT COMPLETED|Maintenance Therapy||12
612988|NCT00352365|1500744|P1|COMPLETED|Maintenance Therapy||0
612989|NCT00352365|1500744|P1|Eligible and Began Protocol Therapy|Maintenance Therapy||8
612990|NCT00352365|1500744|P1|STARTED|Maintenance Therapy||12
612991|NCT00352365|1500744|P1|NOT COMPLETED|Induction Therapy||27
612992|NCT00352365|1500744|P1|COMPLETED|Induction Therapy||14
612993|NCT00352365|1500744|P1|Eligible and Began Protocol Therapy|Induction Therapy||37
612994|NCT00352365|1500744|P1|Eligible|Induction Therapy||38
612995|NCT00352365|1500744|P1|STARTED|Induction Therapy||41
612996|NCT00352118|1500754|P1|NOT COMPLETED|Overall Study||4
612997|NCT00352118|1500754|P1|COMPLETED|Overall Study||0
612998|NCT00352118|1500754|P1|STARTED|Overall Study||4
612999|NCT00352105|1500764|P1|NOT COMPLETED|Overall Study||40
613000|NCT00352105|1500764|P1|COMPLETED|Overall Study||20
613001|NCT00352105|1500764|P1|STARTED|Overall Study||60
613002|NCT00352053|1500775|P2|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||2
613003|NCT00352053|1500776|P1|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||1
613004|NCT00352053|1500775|P2|COMPLETED|Third Extension Phase (Weeks 240-294)||2
613005|NCT00352053|1500776|P1|COMPLETED|Third Extension Phase (Weeks 240-294)||0
613006|NCT00352053|1500775|P2|STARTED|Third Extension Phase (Weeks 240-294)|5 participants completed the 2nd extension phase but did not enroll in the 3rd extension phase.|4
613007|NCT00352053|1500776|P1|STARTED|Third Extension Phase (Weeks 240-294)|3 participants completed the 2nd extension phase but did not enroll in the 3rd extension phase.|1
613008|NCT00352053|1500775|P2|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5
613009|NCT00352053|1500776|P1|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5
613010|NCT00352053|1500775|P2|COMPLETED|Second Extension Phase (Weeks 144-240)||9
613011|NCT00352053|1500776|P1|COMPLETED|Second Extension Phase (Weeks 144-240)||4
613012|NCT00352053|1500775|P2|STARTED|Second Extension Phase (Weeks 144-240)|5 participants completed the 1st extension phase but did not enroll in the 2nd extension phase.|14
613013|NCT00352053|1500776|P1|STARTED|Second Extension Phase (Weeks 144-240)|3 participants completed the 1st extension phase but did not enroll in the 2nd extension phase.|9
613014|NCT00352053|1500775|P2|NOT COMPLETED|First Extension Phase (Weeks 48-144)||17
613015|NCT00352053|1500776|P1|NOT COMPLETED|First Extension Phase (Weeks 48-144)||12
613016|NCT00352053|1500775|P2|COMPLETED|First Extension Phase (Weeks 48-144)||19
613017|NCT00352053|1500776|P1|COMPLETED|First Extension Phase (Weeks 48-144)||12
613018|NCT00352053|1500775|P2|STARTED|First Extension Phase (Weeks 48-144)|3 participants completed the double-blind phase but did not enroll in the 1st extension phase.|36
613019|NCT00352053|1500776|P1|STARTED|First Extension Phase (Weeks 48-144)|3 participants completed the double-blind phase but did not enroll in the 1st extension phase.|24
613020|NCT00352053|1500775|P2|NOT COMPLETED|Double-Blind Phase (Through Week 48)||13
613021|NCT00352053|1500776|P1|NOT COMPLETED|Double-Blind Phase (Through Week 48)||18
613022|NCT00352053|1500775|P2|COMPLETED|Double-Blind Phase (Through Week 48)|The 10 participants discontinued for virologic failure enrolled early in the open-label extension.|29
613023|NCT00352053|1500776|P1|COMPLETED|Double-Blind Phase (Through Week 48)||27
613024|NCT00352053|1500775|P2|STARTED|Double-Blind Phase (Through Week 48)||42
613025|NCT00352053|1500776|P1|STARTED|Double-Blind Phase (Through Week 48)||45
613026|NCT00352027|1500943|P1|NOT COMPLETED|Overall Study||3
613027|NCT00352027|1500943|P1|COMPLETED|Overall Study||77
613028|NCT00352027|1500943|P1|STARTED|Overall Study||80
613029|NCT00351936|1501212|P1|NOT COMPLETED|Overall Study||0
613030|NCT00351936|1501212|P1|COMPLETED|Overall Study||15
613031|NCT00351936|1501212|P1|STARTED|Overall Study||15
613032|NCT00351819|1501231|P2|NOT COMPLETED|Overall Study||12
613033|NCT00351819|1501232|P1|NOT COMPLETED|Overall Study||7
613034|NCT00351819|1501231|P2|COMPLETED|Overall Study||29
613035|NCT00351819|1501232|P1|COMPLETED|Overall Study||36
613036|NCT00351819|1501231|P2|STARTED|Overall Study||41
613037|NCT00351819|1501232|P1|STARTED|Overall Study||43
613038|NCT00351741|1501282|P2|NOT COMPLETED|Overall Study||0
613039|NCT00351741|1501283|P1|NOT COMPLETED|Overall Study||0
613040|NCT00351741|1501282|P2|COMPLETED|Overall Study||31
613041|NCT00351741|1501283|P1|COMPLETED|Overall Study||31
613042|NCT00351741|1501282|P2|STARTED|Overall Study||31
613043|NCT00351741|1501283|P1|STARTED|Overall Study||31
613044|NCT00351533|1501303|P2|NOT COMPLETED|Overall Study||5
613045|NCT00351533|1501304|P1|NOT COMPLETED|Overall Study||2
613046|NCT00351533|1501303|P2|COMPLETED|Overall Study|Pts did not undergo BALs if not intubated|44
613047|NCT00351533|1501304|P1|COMPLETED|Overall Study|Pts did not undergo BALs if not intubated|39
613048|NCT00351533|1501303|P2|STARTED|Overall Study||49
613049|NCT00351533|1501304|P1|STARTED|Overall Study||41
613050|NCT00351468|1501364|P1|NOT COMPLETED|Overall Study||167
613051|NCT00351468|1501364|P1|COMPLETED|Overall Study||135
613052|NCT00351468|1501364|P1|Unknown - Not From Previous Trial|Overall Study|Mistakenly enrolled (not in any of the 3 trials) On 50 mg/d eltrombopag for 18 days and withdrawn|1
613053|NCT00351468|1501364|P1|Subjects From TRA108057 Repeat|Overall Study||43
613054|NCT00351468|1501364|P1|Subjects From TRA102537 Raise|Overall Study||146
613055|NCT00351468|1501364|P1|Subjects From TRA100773B|Overall Study||61
613056|NCT00351468|1501364|P1|Subjects From TRA100773A|Overall Study||51
613057|NCT00351468|1501364|P1|STARTED|Overall Study||302
613058|NCT00351416|1501381|P2|NOT COMPLETED|Overall Study||0
613059|NCT00351416|1501382|P1|NOT COMPLETED|Overall Study||0
613060|NCT00351416|1501381|P2|COMPLETED|Overall Study||9
613061|NCT00351416|1501382|P1|COMPLETED|Overall Study||6
613062|NCT00351416|1501381|P2|STARTED|Overall Study||9
613063|NCT00351416|1501382|P1|STARTED|Overall Study||6
613064|NCT00351377|1501388|P1|NOT COMPLETED|Overall Study||7
613065|NCT00351377|1501388|P1|COMPLETED|Overall Study||104
613066|NCT00351377|1501388|P1|STARTED|Overall Study||111
613067|NCT00351351|1501402|P2|NOT COMPLETED|Overall Study||4
613068|NCT00351351|1501403|P1|NOT COMPLETED|Overall Study||9
613069|NCT00351351|1501402|P2|COMPLETED|Overall Study||32
613070|NCT00351351|1501403|P1|COMPLETED|Overall Study||25
613071|NCT00351351|1501402|P2|STARTED|Overall Study||36
613072|NCT00351351|1501403|P1|STARTED|Overall Study||34
613073|NCT00351299|1501411|P2|NOT COMPLETED|Overall Study||0
613074|NCT00351299|1501412|P1|NOT COMPLETED|Overall Study||0
613075|NCT00351299|1501411|P2|COMPLETED|Overall Study||28
613076|NCT00351299|1501412|P1|COMPLETED|Overall Study||25
613077|NCT00351299|1501411|P2|STARTED|Overall Study||28
613078|NCT00351299|1501412|P1|STARTED|Overall Study||25
613079|NCT00351273|1501429|P3|NOT COMPLETED|Overall Study||5
613080|NCT00351273|1501430|P2|NOT COMPLETED|Overall Study||2
613081|NCT00351273|1501431|P1|NOT COMPLETED|Overall Study||1
613082|NCT00351273|1501429|P3|COMPLETED|Overall Study||10
613083|NCT00351273|1501430|P2|COMPLETED|Overall Study||10
613084|NCT00351273|1501431|P1|COMPLETED|Overall Study||14
613085|NCT00351273|1501429|P3|STARTED|Overall Study||15
613086|NCT00351273|1501430|P2|STARTED|Overall Study||12
613087|NCT00351273|1501431|P1|STARTED|Overall Study||15
613088|NCT00351039|1501439|P1|NOT COMPLETED|Overall Study||0
613089|NCT00351039|1501439|P1|COMPLETED|Overall Study|The study was halted before Phase II was initiated.|8
613090|NCT00351039|1501439|P1|STARTED|Overall Study||8
613091|NCT00351000|1501448|P1|NOT COMPLETED|Overall Study||3
613092|NCT00351000|1501448|P1|COMPLETED|Overall Study||21
613093|NCT00351000|1501448|P1|STARTED|Overall Study||24
613094|NCT00350870|1501459|P4|NOT COMPLETED|Overall Study||15
613095|NCT00350870|1501460|P3|NOT COMPLETED|Overall Study||16
613096|NCT00350870|1501461|P2|NOT COMPLETED|Overall Study||17
613097|NCT00350870|1501462|P1|NOT COMPLETED|Overall Study||22
613098|NCT00350870|1501459|P4|COMPLETED|Overall Study||7
613099|NCT00350870|1501460|P3|COMPLETED|Overall Study||6
613100|NCT00350870|1501461|P2|COMPLETED|Overall Study||11
613101|NCT00350870|1501462|P1|COMPLETED|Overall Study||5
613102|NCT00350870|1501459|P4|Had at Least 1 Day of Med|Overall Study||19
613103|NCT00350870|1501460|P3|Had at Least 1 Day of Med|Overall Study||18
613104|NCT00350870|1501461|P2|Had at Least 1 Day of Med|Overall Study||24
613105|NCT00350870|1501462|P1|Had at Least 1 Day of Med|Overall Study||19
613106|NCT00350870|1501459|P4|STARTED|Overall Study||22
613107|NCT00350870|1501460|P3|STARTED|Overall Study||22
613108|NCT00350870|1501461|P2|STARTED|Overall Study||28
613109|NCT00350870|1501462|P1|STARTED|Overall Study||27
613110|NCT00350844|1501476|P1|NOT COMPLETED|Overall Study||1
613111|NCT00350844|1501476|P1|COMPLETED|Overall Study||5
613112|NCT00350844|1501476|P1|STARTED|Overall Study||6
613113|NCT00350792|1501480|P1|NOT COMPLETED|Overall Study||33
613114|NCT00350792|1501480|P1|COMPLETED|Overall Study||29
613115|NCT00350792|1501480|P1|STARTED|Overall Study||62
613116|NCT00350779|1501490|P2|NOT COMPLETED|Overall Study||21
613117|NCT00350779|1501491|P1|NOT COMPLETED|Overall Study||22
613118|NCT00350779|1501490|P2|COMPLETED|Overall Study||71
613119|NCT00350779|1501491|P1|COMPLETED|Overall Study||148
613120|NCT00350779|1501490|P2|STARTED|Overall Study||92
613121|NCT00350779|1501491|P1|STARTED|Overall Study||170
613122|NCT00350727|1501512|P3|NOT COMPLETED|Phase II||22
613123|NCT00350727|1501513|P2|NOT COMPLETED|Phase II||19
613124|NCT00350727|1501514|P1|NOT COMPLETED|Phase II||0
613125|NCT00350727|1501512|P3|COMPLETED|Phase II||0
613126|NCT00350727|1501513|P2|COMPLETED|Phase II||0
613127|NCT00350727|1501514|P1|COMPLETED|Phase II||0
613128|NCT00350727|1501512|P3|STARTED|Phase II||22
613129|NCT00350727|1501513|P2|STARTED|Phase II||19
613130|NCT00350727|1501514|P1|STARTED|Phase II||0
613131|NCT00350727|1501512|P3|NOT COMPLETED|Phase I: Dose Escalation||0
613132|NCT00350727|1501513|P2|NOT COMPLETED|Phase I: Dose Escalation||0
613133|NCT00350727|1501514|P1|NOT COMPLETED|Phase I: Dose Escalation||34
613134|NCT00350727|1501512|P3|COMPLETED|Phase I: Dose Escalation||0
613135|NCT00350727|1501513|P2|COMPLETED|Phase I: Dose Escalation||0
613136|NCT00350727|1501514|P1|COMPLETED|Phase I: Dose Escalation||0
613137|NCT00350727|1501512|P3|STARTED|Phase I: Dose Escalation||0
613138|NCT00350727|1501513|P2|STARTED|Phase I: Dose Escalation||0
613139|NCT00350727|1501514|P1|STARTED|Phase I: Dose Escalation||34
613140|NCT00350636|1501658|P2|NOT COMPLETED|Overall Study||45
613141|NCT00350636|1501659|P1|NOT COMPLETED|Overall Study||43
613142|NCT00350636|1501658|P2|COMPLETED|Overall Study||355
613143|NCT00350636|1501659|P1|COMPLETED|Overall Study||346
613144|NCT00350636|1501658|P2|STARTED|Overall Study||400
613145|NCT00350636|1501659|P1|STARTED|Overall Study||389
613146|NCT00350623|1501678|P3|NOT COMPLETED|Overall Study||6
613147|NCT00350623|1501679|P2|NOT COMPLETED|Overall Study||4
613148|NCT00350623|1501680|P1|NOT COMPLETED|Overall Study||8
613149|NCT00350623|1501678|P3|COMPLETED|Overall Study||62
613150|NCT00350623|1501679|P2|COMPLETED|Overall Study||67
613151|NCT00350623|1501680|P1|COMPLETED|Overall Study||63
613152|NCT00350623|1501678|P3|STARTED|Overall Study||68
613153|NCT00350623|1501679|P2|STARTED|Overall Study||71
613154|NCT00350623|1501680|P1|STARTED|Overall Study||71
613155|NCT00350545|1501688|P1|NOT COMPLETED|Overall Study||2
613156|NCT00350545|1501688|P1|COMPLETED|Overall Study||35
613157|NCT00350545|1501688|P1|STARTED|Overall Study||37
613158|NCT00350532|1501698|P2|NOT COMPLETED|Overall Study||0
613159|NCT00350532|1501699|P1|NOT COMPLETED|Overall Study||0
613160|NCT00350532|1501698|P2|COMPLETED|Overall Study||19
613161|NCT00350532|1501699|P1|COMPLETED|Overall Study||24
613162|NCT00350532|1501698|P2|STARTED|Overall Study||19
613163|NCT00350532|1501699|P1|STARTED|Overall Study||24
613164|NCT00350519|1501707|P2|NOT COMPLETED|Overall Study||6
613165|NCT00350519|1501708|P1|NOT COMPLETED|Overall Study||4
613166|NCT00350519|1501707|P2|COMPLETED|Overall Study||13
613167|NCT00350519|1501708|P1|COMPLETED|Overall Study||14
613168|NCT00350519|1501707|P2|STARTED|Overall Study||19
613169|NCT00350519|1501708|P1|STARTED|Overall Study||18
613170|NCT00350402|1501722|P2|NOT COMPLETED|Overall Study||1
613171|NCT00350402|1501723|P1|NOT COMPLETED|Overall Study||1
613172|NCT00350402|1501722|P2|COMPLETED|Overall Study||20
613173|NCT00350402|1501723|P1|COMPLETED|Overall Study||20
613174|NCT00350402|1501722|P2|STARTED|Overall Study||21
613175|NCT00350402|1501723|P1|STARTED|Overall Study||21
613176|NCT00350363|1501735|P1|NOT COMPLETED|Overall Study||0
613177|NCT00350363|1501735|P1|COMPLETED|Overall Study||60
613178|NCT00350363|1501735|P1|STARTED|Overall Study||60
613179|NCT00350272|1501741|P2|NOT COMPLETED|Open-Label 84 Week Treatment||8
613180|NCT00350272|1501742|P1|NOT COMPLETED|Open-Label 84 Week Treatment||9
613181|NCT00350272|1501741|P2|COMPLETED|Open-Label 84 Week Treatment||27
613182|NCT00350272|1501742|P1|COMPLETED|Open-Label 84 Week Treatment||21
613183|NCT00350272|1501741|P2|STARTED|Open-Label 84 Week Treatment||35
613184|NCT00350272|1501742|P1|STARTED|Open-Label 84 Week Treatment||30
613185|NCT00350272|1501741|P2|NOT COMPLETED|Blinded 12 Week Treatment||2
613186|NCT00350272|1501742|P1|NOT COMPLETED|Blinded 12 Week Treatment||9
613187|NCT00350272|1501741|P2|COMPLETED|Blinded 12 Week Treatment||35
613188|NCT00350272|1501742|P1|COMPLETED|Blinded 12 Week Treatment||30
613189|NCT00350272|1501741|P2|STARTED|Blinded 12 Week Treatment||37
613190|NCT00350272|1501742|P1|STARTED|Blinded 12 Week Treatment||39
613191|NCT00350220|1501752|P2|NOT COMPLETED|Overall Study||0
613192|NCT00350220|1501753|P1|NOT COMPLETED|Overall Study||0
613193|NCT00350220|1501752|P2|COMPLETED|Overall Study||30
613194|NCT00350220|1501753|P1|COMPLETED|Overall Study||30
613195|NCT00350220|1501752|P2|STARTED|Overall Study||30
613196|NCT00350220|1501753|P1|STARTED|Overall Study||30
613197|NCT00350207|1501764|P3|NOT COMPLETED|Overall Study||7
613198|NCT00350207|1501765|P2|NOT COMPLETED|Overall Study||6
613199|NCT00350207|1501766|P1|NOT COMPLETED|Overall Study||8
613200|NCT00350207|1501764|P3|COMPLETED|Overall Study||119
613201|NCT00350207|1501765|P2|COMPLETED|Overall Study||128
613202|NCT00350207|1501766|P1|COMPLETED|Overall Study||120
613203|NCT00350207|1501764|P3|STARTED|Overall Study||126
613204|NCT00350207|1501765|P2|STARTED|Overall Study||134
613205|NCT00350207|1501766|P1|STARTED|Overall Study||128
613206|NCT00350142|1501960|P1|NOT COMPLETED|Overall Study||0
613207|NCT00350142|1501960|P1|COMPLETED|Overall Study||20
613208|NCT00350142|1501960|P1|STARTED|Overall Study||20
613209|NCT00350025|1501967|P2|NOT COMPLETED|Overall Study||2
613210|NCT00350025|1501968|P1|NOT COMPLETED|Overall Study||0
613211|NCT00350025|1501967|P2|COMPLETED|Overall Study||28
613212|NCT00350025|1501968|P1|COMPLETED|Overall Study||11
613213|NCT00350025|1501967|P2|STARTED|Overall Study||30
613214|NCT00350025|1501968|P1|STARTED|Overall Study||11
613215|NCT00349921|1501980|P4|NOT COMPLETED|Second Spinal Injection||0
613216|NCT00349921|1501981|P3|NOT COMPLETED|Second Spinal Injection||0
613217|NCT00349921|1501982|P2|NOT COMPLETED|Second Spinal Injection||0
613218|NCT00349921|1501983|P1|NOT COMPLETED|Second Spinal Injection||0
613219|NCT00349921|1501980|P4|COMPLETED|Second Spinal Injection||1
613220|NCT00349921|1501981|P3|COMPLETED|Second Spinal Injection||0
613221|NCT00349921|1501982|P2|COMPLETED|Second Spinal Injection||10
613222|NCT00349921|1501983|P1|COMPLETED|Second Spinal Injection||9
613223|NCT00349921|1501980|P4|STARTED|Second Spinal Injection||1
613224|NCT00349921|1501981|P3|STARTED|Second Spinal Injection||0
613225|NCT00349921|1501982|P2|STARTED|Second Spinal Injection||10
613226|NCT00349921|1501983|P1|STARTED|Second Spinal Injection|One patient experienced an adverse event after period one and did not participate in period two|9
613227|NCT00349921|1501980|P4|NOT COMPLETED|First Spinal Injection||0
613228|NCT00349921|1501981|P3|NOT COMPLETED|First Spinal Injection||1
613229|NCT00349921|1501982|P2|NOT COMPLETED|First Spinal Injection||0
613230|NCT00349921|1501983|P1|NOT COMPLETED|First Spinal Injection||1
613231|NCT00349921|1501980|P4|COMPLETED|First Spinal Injection||1
613232|NCT00349921|1501981|P3|COMPLETED|First Spinal Injection||0
613233|NCT00349921|1501982|P2|COMPLETED|First Spinal Injection||10
613234|NCT00349921|1501983|P1|COMPLETED|First Spinal Injection||9
613235|NCT00349921|1501980|P4|STARTED|First Spinal Injection||1
613236|NCT00349921|1501981|P3|STARTED|First Spinal Injection||1
613237|NCT00349921|1501982|P2|STARTED|First Spinal Injection||10
613238|NCT00349921|1501983|P1|STARTED|First Spinal Injection||10
613239|NCT00349908|1501994|P2|NOT COMPLETED|Overall Study||4
613240|NCT00349908|1501995|P1|NOT COMPLETED|Overall Study||0
613241|NCT00349908|1501994|P2|COMPLETED|Overall Study|9 returned for 30 day follow-up, 7 returned for 6 month and 6/7 had 6 month angiogram|6
613242|NCT00349908|1501995|P1|COMPLETED|Overall Study||10
613243|NCT00349908|1501994|P2|STARTED|Overall Study||10
613244|NCT00349908|1501995|P1|STARTED|Overall Study||10
613245|NCT00349778|1502013|P1|NOT COMPLETED|Overall Study||0
613246|NCT00349778|1502013|P1|COMPLETED|Overall Study||102
613247|NCT00349778|1502013|P1|STARTED|Overall Study||102
613248|NCT00349752|1502021|P2|NOT COMPLETED|Overall Study||64
613249|NCT00349752|1502022|P1|NOT COMPLETED|Overall Study||59
613250|NCT00349752|1502021|P2|COMPLETED|Overall Study||23
613251|NCT00349752|1502022|P1|COMPLETED|Overall Study||28
613252|NCT00349752|1502021|P2|STARTED|Overall Study||87
613253|NCT00349752|1502022|P1|STARTED|Overall Study||87
613254|NCT00349713|1502051|P3|NOT COMPLETED|Overall Study||0
613255|NCT00349713|1502052|P2|NOT COMPLETED|Overall Study||0
613256|NCT00349713|1502053|P1|NOT COMPLETED|Overall Study||0
613257|NCT00349713|1502051|P3|COMPLETED|Overall Study||20
613258|NCT00349713|1502052|P2|COMPLETED|Overall Study||20
613259|NCT00349713|1502053|P1|COMPLETED|Overall Study||20
613260|NCT00349713|1502051|P3|STARTED|Overall Study||20
613261|NCT00349713|1502052|P2|STARTED|Overall Study||20
613262|NCT00349713|1502053|P1|STARTED|Overall Study||20
613263|NCT00349622|1502075|P2|NOT COMPLETED|Overall Study||96
613264|NCT00349622|1502076|P1|NOT COMPLETED|Overall Study||178
613265|NCT00349622|1502075|P2|COMPLETED|Overall Study||77
613266|NCT00349622|1502076|P1|COMPLETED|Overall Study||162
613267|NCT00349622|1502075|P2|STARTED|Overall Study||173
613268|NCT00349622|1502076|P1|STARTED|Overall Study||340
613269|NCT00349466|1502094|P2|NOT COMPLETED|Overall Study||3
613270|NCT00349466|1502095|P1|NOT COMPLETED|Overall Study||9
613271|NCT00349466|1502094|P2|COMPLETED|Overall Study||35
613272|NCT00349466|1502095|P1|COMPLETED|Overall Study||33
613273|NCT00349466|1502094|P2|STARTED|Overall Study||38
613274|NCT00349466|1502095|P1|STARTED|Overall Study||42
613275|NCT00349388|1502103|P2|NOT COMPLETED|Overall Study||0
613276|NCT00349388|1502104|P1|NOT COMPLETED|Overall Study||0
613277|NCT00349388|1502103|P2|COMPLETED|Overall Study||1
613278|NCT00349388|1502104|P1|COMPLETED|Overall Study|no patients enrolled , therefore no patients completed|0
613279|NCT00349388|1502103|P2|STARTED|Overall Study||1
613280|NCT00349388|1502104|P1|STARTED|Overall Study|no patients enrolled|0
613281|NCT00349349|1502113|P3|NOT COMPLETED|Overall Study||6
613282|NCT00349349|1502114|P2|NOT COMPLETED|Overall Study||62
613283|NCT00349349|1502115|P1|NOT COMPLETED|Overall Study||53
613284|NCT00349349|1502113|P3|COMPLETED|Overall Study||10
613285|NCT00349349|1502114|P2|COMPLETED|Overall Study||50
613286|NCT00349349|1502115|P1|COMPLETED|Overall Study||42
613287|NCT00349349|1502113|P3|STARTED|Overall Study||16
613288|NCT00349349|1502114|P2|STARTED|Overall Study||112
613289|NCT00349349|1502115|P1|STARTED|Overall Study||95
613290|NCT00349336|1502181|P2|NOT COMPLETED|Overall Study||14
613291|NCT00349336|1502182|P1|NOT COMPLETED|Overall Study||13
613292|NCT00349336|1502181|P2|COMPLETED|Overall Study||18
613293|NCT00349336|1502182|P1|COMPLETED|Overall Study||19
613294|NCT00349336|1502181|P2|STARTED|Overall Study||32
613295|NCT00349336|1502182|P1|STARTED|Overall Study||32
613296|NCT00348933|1502204|P1|NOT COMPLETED|Overall Study||25
613297|NCT00348933|1502204|P1|COMPLETED|Overall Study||65
613298|NCT00348933|1502204|P1|STARTED|Overall Study||90
613299|NCT00348881|1502212|P2|NOT COMPLETED|Overall Study||12
613300|NCT00348881|1502213|P1|NOT COMPLETED|Overall Study||17
613301|NCT00348881|1502212|P2|COMPLETED|Overall Study||697
613302|NCT00348881|1502213|P1|COMPLETED|Overall Study||1407
613303|NCT00348881|1502212|P2|STARTED|Overall Study||709
613304|NCT00348881|1502213|P1|STARTED|Overall Study||1424
613305|NCT00348816|1502225|P1|NOT COMPLETED|Overall Study||1
613306|NCT00348816|1502225|P1|COMPLETED|Overall Study||19
613307|NCT00348816|1502225|P1|STARTED|Overall Study||20
613308|NCT00348790|1502232|P1|NOT COMPLETED|Completed Treatment||25
613309|NCT00348790|1502232|P1|COMPLETED|Completed Treatment||0
613310|NCT00348790|1502232|P1|STARTED|Completed Treatment||25
613311|NCT00348790|1502232|P1|NOT COMPLETED|Began Treatment||0
613312|NCT00348790|1502232|P1|COMPLETED|Began Treatment||25
613313|NCT00348790|1502232|P1|STARTED|Began Treatment||25
613314|NCT00348686|1502237|P1|NOT COMPLETED|Overall Study||66
613315|NCT00348686|1502237|P1|COMPLETED|Overall Study||249
613316|NCT00348686|1502237|P1|STARTED|Overall Study||315
613317|NCT00348673|1502254|P9|NOT COMPLETED|Stage 2||0
613318|NCT00348673|1502255|P8|NOT COMPLETED|Stage 2||0
613319|NCT00348673|1502256|P7|NOT COMPLETED|Stage 2||0
613320|NCT00348673|1502257|P6|NOT COMPLETED|Stage 2||0
613321|NCT00348673|1502258|P5|NOT COMPLETED|Stage 2||0
613322|NCT00348673|1502259|P4|NOT COMPLETED|Stage 2||0
613323|NCT00348673|1502260|P3|NOT COMPLETED|Stage 2||0
613324|NCT00348673|1502261|P2|NOT COMPLETED|Stage 2||0
613325|NCT00348673|1502262|P1|NOT COMPLETED|Stage 2||0
613326|NCT00348673|1502254|P9|COMPLETED|Stage 2||2
613327|NCT00348673|1502255|P8|COMPLETED|Stage 2||6
613328|NCT00348673|1502256|P7|COMPLETED|Stage 2||6
613329|NCT00348673|1502257|P6|COMPLETED|Stage 2||6
613330|NCT00348673|1502258|P5|COMPLETED|Stage 2||0
613331|NCT00348673|1502259|P4|COMPLETED|Stage 2||0
613332|NCT00348673|1502260|P3|COMPLETED|Stage 2||0
613333|NCT00348673|1502261|P2|COMPLETED|Stage 2||0
613334|NCT00348673|1502262|P1|COMPLETED|Stage 2||0
613335|NCT00348673|1502254|P9|STARTED|Stage 2||2
613336|NCT00348673|1502255|P8|STARTED|Stage 2||6
613337|NCT00348673|1502256|P7|STARTED|Stage 2||6
613338|NCT00348673|1502257|P6|STARTED|Stage 2||6
613339|NCT00348673|1502258|P5|STARTED|Stage 2||0
613340|NCT00348673|1502259|P4|STARTED|Stage 2||0
613341|NCT00348673|1502260|P3|STARTED|Stage 2||0
613342|NCT00348673|1502261|P2|STARTED|Stage 2||0
613343|NCT00348673|1502262|P1|STARTED|Stage 2||0
613344|NCT00348673|1502254|P9|NOT COMPLETED|Stage 1||0
613345|NCT00348673|1502255|P8|NOT COMPLETED|Stage 1||0
613346|NCT00348673|1502256|P7|NOT COMPLETED|Stage 1||0
613347|NCT00348673|1502257|P6|NOT COMPLETED|Stage 1||0
613348|NCT00348673|1502258|P5|NOT COMPLETED|Stage 1||0
613349|NCT00348673|1502259|P4|NOT COMPLETED|Stage 1||0
613350|NCT00348673|1502260|P3|NOT COMPLETED|Stage 1||1
613351|NCT00348673|1502261|P2|NOT COMPLETED|Stage 1||0
613352|NCT00348673|1502262|P1|NOT COMPLETED|Stage 1||0
613353|NCT00348673|1502254|P9|COMPLETED|Stage 1||0
613354|NCT00348673|1502255|P8|COMPLETED|Stage 1||0
613355|NCT00348673|1502256|P7|COMPLETED|Stage 1||0
613356|NCT00348673|1502257|P6|COMPLETED|Stage 1||0
613357|NCT00348673|1502258|P5|COMPLETED|Stage 1||4
613358|NCT00348673|1502259|P4|COMPLETED|Stage 1||6
613359|NCT00348673|1502260|P3|COMPLETED|Stage 1||6
613360|NCT00348673|1502261|P2|COMPLETED|Stage 1||6
613361|NCT00348673|1502262|P1|COMPLETED|Stage 1||6
613362|NCT00348673|1502254|P9|Treated|Stage 1||0
613363|NCT00348673|1502255|P8|Treated|Stage 1||0
613364|NCT00348673|1502256|P7|Treated|Stage 1||0
613365|NCT00348673|1502257|P6|Treated|Stage 1||0
613366|NCT00348673|1502258|P5|Treated|Stage 1||4
613367|NCT00348673|1502259|P4|Treated|Stage 1||6
613368|NCT00348673|1502260|P3|Treated|Stage 1||6
613369|NCT00348673|1502261|P2|Treated|Stage 1||6
613370|NCT00348673|1502262|P1|Treated|Stage 1||6
613371|NCT00348673|1502254|P9|STARTED|Stage 1||0
613372|NCT00348673|1502255|P8|STARTED|Stage 1||0
613373|NCT00348673|1502256|P7|STARTED|Stage 1||0
613374|NCT00348673|1502257|P6|STARTED|Stage 1||0
613375|NCT00348673|1502258|P5|STARTED|Stage 1||4
613376|NCT00348673|1502259|P4|STARTED|Stage 1||6
613377|NCT00348673|1502260|P3|STARTED|Stage 1||7
613378|NCT00348673|1502261|P2|STARTED|Stage 1||6
613379|NCT00348673|1502262|P1|STARTED|Stage 1||6
613380|NCT00348556|1502309|P1|NOT COMPLETED|Overall Study||1
613381|NCT00348556|1502309|P1|COMPLETED|Overall Study||3
613382|NCT00348556|1502309|P1|STARTED|Overall Study||4
613383|NCT00348374|1502316|P2|NOT COMPLETED|Overall Study||32
613384|NCT00348374|1502317|P1|NOT COMPLETED|Overall Study||19
613385|NCT00348374|1502316|P2|COMPLETED|Overall Study||71
613386|NCT00348374|1502317|P1|COMPLETED|Overall Study||69
613387|NCT00348374|1502316|P2|Received Study Treatment|Overall Study||96
613388|NCT00348374|1502317|P1|Received Study Treatment|Overall Study||88
613389|NCT00348374|1502316|P2|STARTED|Overall Study||103
613390|NCT00348374|1502317|P1|STARTED|Overall Study||88
613391|NCT00348348|1502364|P2|NOT COMPLETED|Overall Study||27
613392|NCT00348348|1502365|P1|NOT COMPLETED|Overall Study||25
613393|NCT00348348|1502364|P2|COMPLETED|Overall Study||555
613394|NCT00348348|1502365|P1|COMPLETED|Overall Study||554
613395|NCT00348348|1502364|P2|STARTED|Overall Study|Received at least one drop of study medication(Safety Population)|582
613396|NCT00348348|1502365|P1|STARTED|Overall Study|Received at least one drop of study medication (Safety Population)|579
613397|NCT00348309|1502380|P3|NOT COMPLETED|Overall Study||143
613398|NCT00348309|1502381|P2|NOT COMPLETED|Overall Study||98
613399|NCT00348309|1502382|P1|NOT COMPLETED|Overall Study||134
613400|NCT00348309|1502380|P3|COMPLETED|Overall Study||346
613401|NCT00348309|1502381|P2|COMPLETED|Overall Study||396
613402|NCT00348309|1502382|P1|COMPLETED|Overall Study||362
613403|NCT00348309|1502380|P3|STARTED|Overall Study||489
613404|NCT00348309|1502381|P2|STARTED|Overall Study||494
613405|NCT00348309|1502382|P1|STARTED|Overall Study||496
613406|NCT00348283|1502455|P2|NOT COMPLETED|Open Label||34
613407|NCT00348283|1502456|P1|NOT COMPLETED|Open Label||0
613408|NCT00348283|1502455|P2|COMPLETED|Open Label||66
613409|NCT00348283|1502456|P1|COMPLETED|Open Label||0
613410|NCT00348283|1502455|P2|STARTED|Open Label|14 subjects completed the Double Blind portion of the study but did not enter the Open Label period.|100
613411|NCT00348283|1502456|P1|STARTED|Open Label|No comparator was used in the Open Label portion of the study.|0
613412|NCT00348283|1502455|P2|NOT COMPLETED|Double Blind||10
613413|NCT00348283|1502456|P1|NOT COMPLETED|Double Blind||5
613414|NCT00348283|1502455|P2|COMPLETED|Double Blind||54
613415|NCT00348283|1502456|P1|COMPLETED|Double Blind||60
613416|NCT00348283|1502455|P2|STARTED|Double Blind|At Week 4, subjects were randomized to either adalimumab 40 mg eow or placebo eow.|64
613417|NCT00348283|1502456|P1|STARTED|Double Blind|At Week 4, subjects were randomized to either adalimumab 40 mg eow or placebo eow.|65
613418|NCT00348283|1502455|P2|NOT COMPLETED|Induction||6
613419|NCT00348283|1502456|P1|NOT COMPLETED|Induction||0
613420|NCT00348283|1502455|P2|COMPLETED|Induction|Subjects provided more than one reason for discontinuing during induction.|129
613421|NCT00348283|1502456|P1|COMPLETED|Induction||0
613422|NCT00348283|1502455|P2|STARTED|Induction|Subjects received an open- label dose of 80 mg adalimumab at Week 2 (induction dose).|135
613423|NCT00348283|1502456|P1|STARTED|Induction||0
613424|NCT00348140|1502475|P3|NOT COMPLETED|Overall Study||163
613425|NCT00348140|1502476|P2|NOT COMPLETED|Overall Study||139
613426|NCT00348140|1502477|P1|NOT COMPLETED|Overall Study||126
613427|NCT00348140|1502475|P3|COMPLETED|Overall Study||328
613428|NCT00348140|1502476|P2|COMPLETED|Overall Study||351
613429|NCT00348140|1502477|P1|COMPLETED|Overall Study||361
613430|NCT00348140|1502475|P3|STARTED|Overall Study||491
613431|NCT00348140|1502476|P2|STARTED|Overall Study||490
613432|NCT00348140|1502477|P1|STARTED|Overall Study||487
613433|NCT00347958|1502575|P1|NOT COMPLETED|Overall Study||4
613434|NCT00347958|1502575|P1|COMPLETED|Overall Study||540
613435|NCT00347958|1502575|P1|STARTED|Overall Study||544
613436|NCT00347932|1502584|P2|NOT COMPLETED|Overall Study||52
613437|NCT00347932|1502585|P1|NOT COMPLETED|Overall Study||31
613438|NCT00347932|1502584|P2|COMPLETED|Overall Study||430
613439|NCT00347932|1502585|P1|COMPLETED|Overall Study||444
613440|NCT00347932|1502584|P2|STARTED|Overall Study|As Randomized Population - received at least one dose of study medication|482
613441|NCT00347932|1502585|P1|STARTED|Overall Study|As Randomized population - received at least one dose of study medication|475
613442|NCT00347919|1502600|P3|NOT COMPLETED|Overall Study||38
613443|NCT00347919|1502601|P2|NOT COMPLETED|Overall Study||76
613444|NCT00347919|1502602|P1|NOT COMPLETED|Overall Study||71
613445|NCT00347919|1502600|P3|COMPLETED|Overall Study||2
613446|NCT00347919|1502601|P2|COMPLETED|Overall Study||0
613447|NCT00347919|1502602|P1|COMPLETED|Overall Study||2
613448|NCT00347919|1502600|P3|STARTED|Overall Study|Safety Population|40
613449|NCT00347919|1502601|P2|STARTED|Overall Study|Safety Population|76
613450|NCT00347919|1502602|P1|STARTED|Overall Study|Safety Population|73
613451|NCT00347776|1502625|P3|NOT COMPLETED|12 Month Follow-up||19
613452|NCT00347776|1502626|P2|NOT COMPLETED|12 Month Follow-up||16
613453|NCT00347776|1502627|P1|NOT COMPLETED|12 Month Follow-up||23
613454|NCT00347776|1502625|P3|COMPLETED|12 Month Follow-up||436
613455|NCT00347776|1502626|P2|COMPLETED|12 Month Follow-up||446
613456|NCT00347776|1502627|P1|COMPLETED|12 Month Follow-up||425
613457|NCT00347776|1502625|P3|STARTED|12 Month Follow-up||455
613458|NCT00347776|1502626|P2|STARTED|12 Month Follow-up||462
613459|NCT00347776|1502627|P1|STARTED|12 Month Follow-up||448
613460|NCT00347776|1502625|P3|NOT COMPLETED|6 Month Follow-up||18
613461|NCT00347776|1502626|P2|NOT COMPLETED|6 Month Follow-up||13
613462|NCT00347776|1502627|P1|NOT COMPLETED|6 Month Follow-up||22
613463|NCT00347776|1502625|P3|COMPLETED|6 Month Follow-up|452 had no recurrence.3 were lost to follow-up but were still eligible for follow-up at next visits|455
613553|NCT00346775|1502900|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
613464|NCT00347776|1502626|P2|COMPLETED|6 Month Follow-up|459 had no recurrence.3 were lost to follow-up but were still eligible for follow-up at next visits|462
613465|NCT00347776|1502627|P1|COMPLETED|6 Month Follow-up|440 had no recurrence.8 were lost to follow-up but were still eligible for follow-up at next visits|448
613466|NCT00347776|1502625|P3|STARTED|6 Month Follow-up||473
613467|NCT00347776|1502626|P2|STARTED|6 Month Follow-up||475
613468|NCT00347776|1502627|P1|STARTED|6 Month Follow-up||470
613469|NCT00347776|1502625|P3|NOT COMPLETED|1.5 Month Follow-up||12
613470|NCT00347776|1502626|P2|NOT COMPLETED|1.5 Month Follow-up||8
613471|NCT00347776|1502627|P1|NOT COMPLETED|1.5 Month Follow-up||14
613472|NCT00347776|1502625|P3|COMPLETED|1.5 Month Follow-up|472 had no recurrence.1 was lost to follow-up but was still eligible for follow-up at next visits|473
613473|NCT00347776|1502626|P2|COMPLETED|1.5 Month Follow-up|473 had no recurrence.2 were lost to follow-up but were still eligible for follow-up at next visits|475
613474|NCT00347776|1502627|P1|COMPLETED|1.5 Month Follow-up||470
613475|NCT00347776|1502625|P3|STARTED|1.5 Month Follow-up||485
613476|NCT00347776|1502626|P2|STARTED|1.5 Month Follow-up||483
613477|NCT00347776|1502627|P1|STARTED|1.5 Month Follow-up||484
613478|NCT00347438|1502639|P1|NOT COMPLETED|Overall Study||2
613479|NCT00347438|1502639|P1|COMPLETED|Overall Study||16
613480|NCT00347438|1502639|P1|STARTED|Overall Study||18
613481|NCT00347360|1502661|P15|NOT COMPLETED|Overall Study||4
613482|NCT00347360|1502662|P14|NOT COMPLETED|Overall Study||8
613483|NCT00347360|1502663|P13|NOT COMPLETED|Overall Study||10
613484|NCT00347360|1502664|P12|NOT COMPLETED|Overall Study||6
613485|NCT00347360|1502665|P11|NOT COMPLETED|Overall Study||5
613486|NCT00347360|1502666|P10|NOT COMPLETED|Overall Study||9
613487|NCT00347360|1502667|P9|NOT COMPLETED|Overall Study||6
613488|NCT00347360|1502668|P8|NOT COMPLETED|Overall Study||3
613489|NCT00347360|1502669|P7|NOT COMPLETED|Overall Study||7
613490|NCT00347360|1502670|P6|NOT COMPLETED|Overall Study||8
613491|NCT00347360|1502671|P5|NOT COMPLETED|Overall Study||5
613492|NCT00347360|1502672|P4|NOT COMPLETED|Overall Study||13
613493|NCT00347360|1502673|P3|NOT COMPLETED|Overall Study||6
613494|NCT00347360|1502674|P2|NOT COMPLETED|Overall Study||8
613495|NCT00347360|1502675|P1|NOT COMPLETED|Overall Study||5
613496|NCT00347360|1502661|P15|COMPLETED|Overall Study||39
613497|NCT00347360|1502662|P14|COMPLETED|Overall Study||36
613498|NCT00347360|1502663|P13|COMPLETED|Overall Study||34
613499|NCT00347360|1502664|P12|COMPLETED|Overall Study||37
613500|NCT00347360|1502665|P11|COMPLETED|Overall Study||39
613501|NCT00347360|1502666|P10|COMPLETED|Overall Study||35
613502|NCT00347360|1502667|P9|COMPLETED|Overall Study||38
613503|NCT00347360|1502668|P8|COMPLETED|Overall Study||40
613504|NCT00347360|1502669|P7|COMPLETED|Overall Study||37
613505|NCT00347360|1502670|P6|COMPLETED|Overall Study||36
613506|NCT00347360|1502671|P5|COMPLETED|Overall Study||39
613507|NCT00347360|1502672|P4|COMPLETED|Overall Study||30
613508|NCT00347360|1502673|P3|COMPLETED|Overall Study||37
613509|NCT00347360|1502674|P2|COMPLETED|Overall Study||35
613510|NCT00347360|1502675|P1|COMPLETED|Overall Study||39
613511|NCT00347360|1502661|P15|STARTED|Overall Study||43
613512|NCT00347360|1502662|P14|STARTED|Overall Study||44
613513|NCT00347360|1502663|P13|STARTED|Overall Study||44
613514|NCT00347360|1502664|P12|STARTED|Overall Study||43
613515|NCT00347360|1502665|P11|STARTED|Overall Study||44
613516|NCT00347360|1502666|P10|STARTED|Overall Study||44
613517|NCT00347360|1502667|P9|STARTED|Overall Study||44
613518|NCT00347360|1502668|P8|STARTED|Overall Study||43
613519|NCT00347360|1502669|P7|STARTED|Overall Study||44
613520|NCT00347360|1502670|P6|STARTED|Overall Study||44
613521|NCT00347360|1502671|P5|STARTED|Overall Study||44
613522|NCT00347360|1502672|P4|STARTED|Overall Study||43
613523|NCT00347360|1502673|P3|STARTED|Overall Study||43
613524|NCT00347360|1502674|P2|STARTED|Overall Study||43
613525|NCT00347360|1502675|P1|STARTED|Overall Study||44
613526|NCT00347308|1502857|P1|NOT COMPLETED|Overall Study||0
613527|NCT00347308|1502857|P1|COMPLETED|Overall Study||40
613528|NCT00347308|1502857|P1|STARTED|Overall Study||40
613529|NCT00347269|1502863|P2|NOT COMPLETED|Overall Study||106
613530|NCT00347269|1502864|P1|NOT COMPLETED|Overall Study||94
613531|NCT00347269|1502863|P2|COMPLETED|Overall Study||395
613532|NCT00347269|1502864|P1|COMPLETED|Overall Study||409
613533|NCT00347269|1502863|P2|STARTED|Overall Study||501
613534|NCT00347269|1502864|P1|STARTED|Overall Study||503
613535|NCT00347022|1502872|P2|NOT COMPLETED|Overall Study||5
613536|NCT00347022|1502873|P1|NOT COMPLETED|Overall Study||12
613537|NCT00347022|1502872|P2|COMPLETED|Overall Study||66
613538|NCT00347022|1502873|P1|COMPLETED|Overall Study||62
613539|NCT00347022|1502872|P2|STARTED|Overall Study||71
613540|NCT00347022|1502873|P1|STARTED|Overall Study||74
613541|NCT00347009|1502879|P1|NOT COMPLETED|Overall Study||27
613542|NCT00347009|1502879|P1|COMPLETED|Overall Study||128
613543|NCT00347009|1502879|P1|STARTED|Overall Study||155
613544|NCT00346905|1502896|P1|NOT COMPLETED|Overall Study||4
613545|NCT00346905|1502896|P1|COMPLETED|Overall Study||12
613546|NCT00346905|1502896|P1|STARTED|Overall Study||16
613547|NCT00346775|1502900|P2|NOT COMPLETED|Period 3: Intervention Period 2||0
613548|NCT00346775|1502901|P1|NOT COMPLETED|Period 3: Intervention Period 2||0
613549|NCT00346775|1502900|P2|COMPLETED|Period 3: Intervention Period 2||45
613550|NCT00346775|1502901|P1|COMPLETED|Period 3: Intervention Period 2||44
613551|NCT00346775|1502900|P2|STARTED|Period 3: Intervention Period 2||45
613552|NCT00346775|1502901|P1|STARTED|Period 3: Intervention Period 2||44
613554|NCT00346775|1502901|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
613555|NCT00346775|1502900|P2|COMPLETED|Period 2: Washout Period (7 Days)||45
613556|NCT00346775|1502901|P1|COMPLETED|Period 2: Washout Period (7 Days)||44
613557|NCT00346775|1502900|P2|STARTED|Period 2: Washout Period (7 Days)||45
613558|NCT00346775|1502901|P1|STARTED|Period 2: Washout Period (7 Days)||44
613559|NCT00346775|1502900|P2|NOT COMPLETED|Period 1: Intervention Period 1||3
613560|NCT00346775|1502901|P1|NOT COMPLETED|Period 1: Intervention Period 1||5
613561|NCT00346775|1502900|P2|COMPLETED|Period 1: Intervention Period 1||45
613562|NCT00346775|1502901|P1|COMPLETED|Period 1: Intervention Period 1||44
613563|NCT00346775|1502900|P2|STARTED|Period 1: Intervention Period 1||48
613564|NCT00346775|1502901|P1|STARTED|Period 1: Intervention Period 1||49
613565|NCT00346697|1502913|P2|NOT COMPLETED|Overall Study||1
613566|NCT00346697|1502914|P1|NOT COMPLETED|Overall Study||0
613567|NCT00346697|1502913|P2|COMPLETED|Overall Study||23
613568|NCT00346697|1502914|P1|COMPLETED|Overall Study||24
613569|NCT00346697|1502913|P2|STARTED|Overall Study||24
613570|NCT00346697|1502914|P1|STARTED|Overall Study||24
613571|NCT00346632|1502950|P10|NOT COMPLETED|Overall Study||3
613572|NCT00346632|1502951|P9|NOT COMPLETED|Overall Study||4
613573|NCT00346632|1502952|P8|NOT COMPLETED|Overall Study||4
613574|NCT00346632|1502953|P7|NOT COMPLETED|Overall Study||5
613575|NCT00346632|1502954|P6|NOT COMPLETED|Overall Study||2
613576|NCT00346632|1502955|P5|NOT COMPLETED|Overall Study||4
613577|NCT00346632|1502956|P4|NOT COMPLETED|Overall Study||3
613578|NCT00346632|1502957|P3|NOT COMPLETED|Overall Study||6
613579|NCT00346632|1502958|P2|NOT COMPLETED|Overall Study||3
613580|NCT00346632|1502959|P1|NOT COMPLETED|Overall Study||3
613581|NCT00346632|1502950|P10|COMPLETED|Overall Study||0
613582|NCT00346632|1502951|P9|COMPLETED|Overall Study||0
613583|NCT00346632|1502952|P8|COMPLETED|Overall Study||0
613584|NCT00346632|1502953|P7|COMPLETED|Overall Study||0
613585|NCT00346632|1502954|P6|COMPLETED|Overall Study||0
613586|NCT00346632|1502955|P5|COMPLETED|Overall Study||0
613587|NCT00346632|1502956|P4|COMPLETED|Overall Study||0
613588|NCT00346632|1502957|P3|COMPLETED|Overall Study||0
613589|NCT00346632|1502958|P2|COMPLETED|Overall Study||0
613590|NCT00346632|1502959|P1|COMPLETED|Overall Study||0
613591|NCT00346632|1502950|P10|STARTED|Overall Study||3
613592|NCT00346632|1502951|P9|STARTED|Overall Study||4
613593|NCT00346632|1502952|P8|STARTED|Overall Study||4
613594|NCT00346632|1502953|P7|STARTED|Overall Study||5
613595|NCT00346632|1502954|P6|STARTED|Overall Study||2
613596|NCT00346632|1502955|P5|STARTED|Overall Study||4
613597|NCT00346632|1502956|P4|STARTED|Overall Study||3
613598|NCT00346632|1502957|P3|STARTED|Overall Study||6
613599|NCT00346632|1502958|P2|STARTED|Overall Study||3
613600|NCT00346632|1502959|P1|STARTED|Overall Study||3
613601|NCT00346476|1503102|P1|NOT COMPLETED|Overall Study||0
613602|NCT00346476|1503102|P1|COMPLETED|Overall Study||1250
613603|NCT00346476|1503102|P1|STARTED|Overall Study||1250
613604|NCT00346398|1503109|P2|NOT COMPLETED|Overall Study||2
613605|NCT00346398|1503110|P1|NOT COMPLETED|Overall Study||3
613606|NCT00346398|1503109|P2|COMPLETED|Overall Study||24
613607|NCT00346398|1503110|P1|COMPLETED|Overall Study||22
613608|NCT00346398|1503109|P2|STARTED|Overall Study||26
613609|NCT00346398|1503110|P1|STARTED|Overall Study||25
613610|NCT00346333|1503122|P2|NOT COMPLETED|Overall Study||8
613611|NCT00346333|1503123|P1|NOT COMPLETED|Overall Study||5
613612|NCT00346333|1503122|P2|COMPLETED|Overall Study||111
613613|NCT00346333|1503123|P1|COMPLETED|Overall Study||116
613614|NCT00346333|1503122|P2|STARTED|Overall Study||119
613615|NCT00346333|1503123|P1|STARTED|Overall Study||121
613616|NCT00346268|1503139|P2|NOT COMPLETED|Overall Study||3
613617|NCT00346268|1503140|P1|NOT COMPLETED|Overall Study||2
613618|NCT00346268|1503139|P2|COMPLETED|Overall Study||50
613619|NCT00346268|1503140|P1|COMPLETED|Overall Study||50
613620|NCT00346268|1503139|P2|STARTED|Overall Study||53
613621|NCT00346268|1503140|P1|STARTED|Overall Study||52
613622|NCT00346216|1503175|P3|NOT COMPLETED|Overall Study||2348
613623|NCT00346216|1503176|P2|NOT COMPLETED|Overall Study||2460
613624|NCT00346216|1503177|P1|NOT COMPLETED|Overall Study||2408
613625|NCT00346216|1503175|P3|COMPLETED|Overall Study||5621
613626|NCT00346216|1503176|P2|COMPLETED|Overall Study||5580
613627|NCT00346216|1503177|P1|COMPLETED|Overall Study||5664
613628|NCT00346216|1503175|P3|STARTED|Overall Study||7969
613629|NCT00346216|1503176|P2|STARTED|Overall Study||8040
613630|NCT00346216|1503177|P1|STARTED|Overall Study||8072
613631|NCT00346164|1503198|P4|NOT COMPLETED|Overall Study||106
613632|NCT00346164|1503199|P3|NOT COMPLETED|Overall Study||26
613633|NCT00346164|1503200|P2|NOT COMPLETED|Overall Study||7
613634|NCT00346164|1503201|P1|NOT COMPLETED|Overall Study||17
613635|NCT00346164|1503198|P4|COMPLETED|Overall Study||117
613636|NCT00346164|1503199|P3|COMPLETED|Overall Study||96
613637|NCT00346164|1503200|P2|COMPLETED|Overall Study||14
613638|NCT00346164|1503201|P1|COMPLETED|Overall Study||205
613639|NCT00346164|1503198|P4|STARTED|Overall Study||223
613640|NCT00346164|1503199|P3|STARTED|Overall Study||122
613641|NCT00346164|1503200|P2|STARTED|Overall Study||21
613642|NCT00346164|1503201|P1|STARTED|Overall Study||222
613643|NCT00346151|1503236|P1|NOT COMPLETED|Overall Study||3
613644|NCT00346151|1503236|P1|COMPLETED|Overall Study||2
613645|NCT00346151|1503236|P1|STARTED|Overall Study||5
613646|NCT00346034|1503254|P1|NOT COMPLETED|Overall Study||57
613647|NCT00346034|1503254|P1|COMPLETED|Overall Study||300
613648|NCT00346034|1503254|P1|STARTED|Overall Study||357
613649|NCT00345969|1503261|P2|NOT COMPLETED|Overall Study||2
613650|NCT00345969|1503262|P1|NOT COMPLETED|Overall Study||1
613651|NCT00345969|1503261|P2|COMPLETED|Overall Study||11
613652|NCT00345969|1503262|P1|COMPLETED|Overall Study||11
613653|NCT00345969|1503261|P2|STARTED|Overall Study||13
613654|NCT00345969|1503262|P1|STARTED|Overall Study||12
613655|NCT00345878|1503294|P2|NOT COMPLETED|Overall Study||1
613656|NCT00345878|1503295|P1|NOT COMPLETED|Overall Study||4
613657|NCT00345878|1503294|P2|COMPLETED|Overall Study||135
613658|NCT00345878|1503295|P1|COMPLETED|Overall Study||131
613659|NCT00345878|1503294|P2|STARTED|Overall Study||136
613660|NCT00345878|1503295|P1|STARTED|Overall Study||135
613661|NCT00345839|1503313|P2|NOT COMPLETED|Overall Study||159
613662|NCT00345839|1503314|P1|NOT COMPLETED|Overall Study||149
613663|NCT00345839|1503313|P2|COMPLETED|Overall Study|Participants who completed study includes those with ended study due to death.|1776
613664|NCT00345839|1503314|P1|COMPLETED|Overall Study|Participants who completed study includes those with ended study due to death.|1799
613665|NCT00345839|1503313|P2|STARTED|Overall Study|Randomized to placebo|1935
613666|NCT00345839|1503314|P1|STARTED|Overall Study|Randomized to cinacalcet|1948
613667|NCT00345683|1503340|P2|NOT COMPLETED|Overall Study||9
613668|NCT00345683|1503341|P1|NOT COMPLETED|Overall Study||25
613669|NCT00345683|1503340|P2|COMPLETED|Overall Study||1001
613670|NCT00345683|1503341|P1|COMPLETED|Overall Study||2985
613671|NCT00345683|1503340|P2|STARTED|Overall Study||1010
613672|NCT00345683|1503341|P1|STARTED|Overall Study||3010
613673|NCT00345631|1503364|P3|NOT COMPLETED|Overall Study||6
613674|NCT00345631|1503365|P2|NOT COMPLETED|Overall Study||8
613675|NCT00345631|1503366|P1|NOT COMPLETED|Overall Study||4
613676|NCT00345631|1503364|P3|COMPLETED|Overall Study||128
613677|NCT00345631|1503365|P2|COMPLETED|Overall Study||259
613678|NCT00345631|1503366|P1|COMPLETED|Overall Study||83
613679|NCT00345631|1503364|P3|STARTED|Overall Study||134
613680|NCT00345631|1503365|P2|STARTED|Overall Study||267
613681|NCT00345631|1503366|P1|STARTED|Overall Study||87
613682|NCT00345605|1503398|P2|NOT COMPLETED|Arm 2, Opposite Treatment||0
613683|NCT00345605|1503399|P1|NOT COMPLETED|Arm 2, Opposite Treatment||1
613684|NCT00345605|1503398|P2|COMPLETED|Arm 2, Opposite Treatment||6
613685|NCT00345605|1503399|P1|COMPLETED|Arm 2, Opposite Treatment||5
613686|NCT00345605|1503398|P2|STARTED|Arm 2, Opposite Treatment||6
613687|NCT00345605|1503399|P1|STARTED|Arm 2, Opposite Treatment||6
613688|NCT00345605|1503398|P2|NOT COMPLETED|Crossover Wash-out||0
613689|NCT00345605|1503399|P1|NOT COMPLETED|Crossover Wash-out||0
613690|NCT00345605|1503398|P2|COMPLETED|Crossover Wash-out||6
613691|NCT00345605|1503399|P1|COMPLETED|Crossover Wash-out||6
613692|NCT00345605|1503398|P2|STARTED|Crossover Wash-out||6
613693|NCT00345605|1503399|P1|STARTED|Crossover Wash-out||6
613694|NCT00345605|1503398|P2|NOT COMPLETED|Interval||0
613695|NCT00345605|1503399|P1|NOT COMPLETED|Interval||0
613696|NCT00345605|1503398|P2|COMPLETED|Interval||6
613697|NCT00345605|1503399|P1|COMPLETED|Interval||6
613698|NCT00345605|1503398|P2|STARTED|Interval||6
613699|NCT00345605|1503399|P1|STARTED|Interval||6
613700|NCT00345605|1503398|P2|NOT COMPLETED|Arm 1||1
613701|NCT00345605|1503399|P1|NOT COMPLETED|Arm 1||0
613702|NCT00345605|1503398|P2|COMPLETED|Arm 1||5
613703|NCT00345605|1503399|P1|COMPLETED|Arm 1||6
613704|NCT00345605|1503398|P2|STARTED|Arm 1||6
613705|NCT00345605|1503399|P1|STARTED|Arm 1||6
613706|NCT00345605|1503398|P2|NOT COMPLETED|Initial Washout||0
613707|NCT00345605|1503399|P1|NOT COMPLETED|Initial Washout||0
613708|NCT00345605|1503398|P2|COMPLETED|Initial Washout||6
613709|NCT00345605|1503399|P1|COMPLETED|Initial Washout||6
613710|NCT00345605|1503398|P2|STARTED|Initial Washout||6
613711|NCT00345605|1503399|P1|STARTED|Initial Washout||6
613712|NCT00345592|1503419|P2|NOT COMPLETED|Overall Study||24
613713|NCT00345592|1503420|P1|NOT COMPLETED|Overall Study||25
613714|NCT00345592|1503419|P2|COMPLETED|Overall Study||173
613715|NCT00345592|1503420|P1|COMPLETED|Overall Study||174
613716|NCT00345592|1503419|P2|STARTED|Overall Study||197
613717|NCT00345592|1503420|P1|STARTED|Overall Study||199
613718|NCT00345579|1503428|P2|NOT COMPLETED|Overall Study||65
613719|NCT00345579|1503429|P1|NOT COMPLETED|Overall Study||164
613720|NCT00345579|1503428|P2|COMPLETED|Overall Study||1048
613721|NCT00345579|1503429|P1|COMPLETED|Overall Study||3114
613722|NCT00345579|1503428|P2|STARTED|Overall Study||1113
613723|NCT00345579|1503429|P1|STARTED|Overall Study||3278
613724|NCT00345540|1503449|P1|NOT COMPLETED|Overall Study||1
613725|NCT00345540|1503449|P1|COMPLETED|Overall Study||15
613726|NCT00345540|1503449|P1|STARTED|Overall Study|1 subject enrolled but not treated (off-trial for patient discretion)|16
613727|NCT00345397|1503455|P1|NOT COMPLETED|Overall Study||1
613728|NCT00345397|1503455|P1|COMPLETED|Overall Study||6
613729|NCT00345397|1503455|P1|STARTED|Overall Study||7
613730|NCT00345384|1503462|P2|NOT COMPLETED|Overall Study||0
613731|NCT00345384|1503463|P1|NOT COMPLETED|Overall Study||0
613732|NCT00345384|1503462|P2|COMPLETED|Overall Study||19
613733|NCT00345384|1503463|P1|COMPLETED|Overall Study||19
613734|NCT00345384|1503462|P2|STARTED|Overall Study||19
613735|NCT00345384|1503463|P1|STARTED|Overall Study||19
613736|NCT00345371|1503473|P2|NOT COMPLETED|Overall Study||33
613737|NCT00345371|1503474|P1|NOT COMPLETED|Overall Study||30
613738|NCT00345371|1503473|P2|COMPLETED|Overall Study||38
613739|NCT00345371|1503474|P1|COMPLETED|Overall Study||39
613740|NCT00345371|1503473|P2|STARTED|Overall Study||71
613741|NCT00345371|1503474|P1|STARTED|Overall Study||69
613742|NCT00345332|1503484|P2|NOT COMPLETED|Overall Study||0
613743|NCT00345332|1503485|P1|NOT COMPLETED|Overall Study||0
613744|NCT00345332|1503484|P2|COMPLETED|Overall Study||20
613745|NCT00345332|1503485|P1|COMPLETED|Overall Study||11
613746|NCT00345332|1503484|P2|STARTED|Overall Study||20
613747|NCT00345332|1503485|P1|STARTED|Overall Study||11
613748|NCT00345293|1503493|P2|NOT COMPLETED|Overall Study||0
613749|NCT00345293|1503494|P1|NOT COMPLETED|Overall Study||2
613750|NCT00345293|1503493|P2|COMPLETED|Overall Study||3
613751|NCT00345293|1503494|P1|COMPLETED|Overall Study||8
613752|NCT00345293|1503493|P2|STARTED|Overall Study||3
613753|NCT00345293|1503494|P1|STARTED|Overall Study||10
613754|NCT00345254|1503503|P2|NOT COMPLETED|Overall Study||0
613755|NCT00345254|1503504|P1|NOT COMPLETED|Overall Study||0
613756|NCT00345254|1503503|P2|COMPLETED|Overall Study||30
613757|NCT00345254|1503504|P1|COMPLETED|Overall Study||30
613758|NCT00345254|1503503|P2|STARTED|Overall Study||30
613759|NCT00345254|1503504|P1|STARTED|Overall Study||30
613760|NCT00345176|1503514|P4|NOT COMPLETED|Overall Study||10
613761|NCT00345176|1503515|P3|NOT COMPLETED|Overall Study||6
613762|NCT00345176|1503516|P2|NOT COMPLETED|Overall Study||6
613763|NCT00345176|1503517|P1|NOT COMPLETED|Overall Study||5
613764|NCT00345176|1503514|P4|COMPLETED|Overall Study||1069
613765|NCT00345176|1503515|P3|COMPLETED|Overall Study||1062
613766|NCT00345176|1503516|P2|COMPLETED|Overall Study||1038
613767|NCT00345176|1503517|P1|COMPLETED|Overall Study||1007
613768|NCT00345176|1503514|P4|STARTED|Overall Study||1079
613769|NCT00345176|1503515|P3|STARTED|Overall Study||1068
613770|NCT00345176|1503516|P2|STARTED|Overall Study||1044
613771|NCT00345176|1503517|P1|STARTED|Overall Study||1012
613772|NCT00345046|1503540|P3|NOT COMPLETED|Overall Study||2
613773|NCT00345046|1503541|P2|NOT COMPLETED|Overall Study||1
613774|NCT00345046|1503542|P1|NOT COMPLETED|Overall Study||1
613775|NCT00345046|1503540|P3|COMPLETED|Overall Study||14
613776|NCT00345046|1503541|P2|COMPLETED|Overall Study||21
613777|NCT00345046|1503542|P1|COMPLETED|Overall Study||17
613778|NCT00345046|1503540|P3|STARTED|Overall Study||16
613779|NCT00345046|1503541|P2|STARTED|Overall Study||22
613780|NCT00345046|1503542|P1|STARTED|Overall Study||18
613781|NCT00345033|1503552|P2|NOT COMPLETED|Overall Study||4
613782|NCT00345033|1503553|P1|NOT COMPLETED|Overall Study||4
613783|NCT00345033|1503552|P2|COMPLETED|Overall Study||14
613784|NCT00345033|1503553|P1|COMPLETED|Overall Study||16
613785|NCT00345033|1503552|P2|STARTED|Overall Study||18
613786|NCT00345033|1503553|P1|STARTED|Overall Study||20
613787|NCT00344968|1503572|P3|NOT COMPLETED|Overall Study||116
613788|NCT00344968|1503573|P2|NOT COMPLETED|Overall Study||102
613789|NCT00344968|1503574|P1|NOT COMPLETED|Overall Study||59
613790|NCT00344968|1503572|P3|COMPLETED|Overall Study||279
613791|NCT00344968|1503573|P2|COMPLETED|Overall Study||274
613792|NCT00344968|1503574|P1|COMPLETED|Overall Study||126
613793|NCT00344968|1503572|P3|STARTED|Overall Study||395
613794|NCT00344968|1503573|P2|STARTED|Overall Study||376
613795|NCT00344968|1503574|P1|STARTED|Overall Study||185
613796|NCT00344773|1503585|P1|NOT COMPLETED|Overall Study||21
613797|NCT00344773|1503585|P1|COMPLETED|Overall Study||25
613798|NCT00344773|1503585|P1|STARTED|Overall Study||46
613799|NCT00344682|1503593|P2|NOT COMPLETED|Overall Study||1
613800|NCT00344682|1503594|P1|NOT COMPLETED|Overall Study||4
613801|NCT00344682|1503593|P2|COMPLETED|Overall Study||14
613802|NCT00344682|1503594|P1|COMPLETED|Overall Study||12
613803|NCT00344682|1503593|P2|STARTED|Overall Study||15
613804|NCT00344682|1503594|P1|STARTED|Overall Study||16
613805|NCT00344500|1503608|P3|NOT COMPLETED|Overall Study||2
613806|NCT00344500|1503609|P2|NOT COMPLETED|Overall Study||35
613807|NCT00344500|1503610|P1|NOT COMPLETED|Overall Study||23
613808|NCT00344500|1503608|P3|COMPLETED|Overall Study||12
613809|NCT00344500|1503609|P2|COMPLETED|Overall Study||25
613810|NCT00344500|1503610|P1|COMPLETED|Overall Study||25
613811|NCT00344500|1503608|P3|STARTED|Overall Study||14
613812|NCT00344500|1503609|P2|STARTED|Overall Study||60
613813|NCT00344500|1503610|P1|STARTED|Overall Study||48
613814|NCT00344487|1503621|P1|NOT COMPLETED|Overall Study||1
613815|NCT00344487|1503621|P1|COMPLETED|Overall Study|One subject was withdrawn at month 9 because he was considered an immunologic failure on study.|2
613816|NCT00344487|1503621|P1|STARTED|Overall Study||3
613817|NCT00344461|1503625|P1|NOT COMPLETED|Overall Study||21
613818|NCT00344461|1503625|P1|COMPLETED|Overall Study||33
613819|NCT00344461|1503625|P1|STARTED|Overall Study||54
613820|NCT00344448|1503636|P2|NOT COMPLETED|Open Label||1
613821|NCT00344448|1503637|P1|NOT COMPLETED|Open Label||2
613822|NCT00344448|1503636|P2|COMPLETED|Open Label||2
613823|NCT00344448|1503637|P1|COMPLETED|Open Label||2
613824|NCT00344448|1503636|P2|STARTED|Open Label||3
613825|NCT00344448|1503637|P1|STARTED|Open Label||4
613826|NCT00344448|1503636|P2|NOT COMPLETED|Double Blind, Placebo Controlled||0
613827|NCT00344448|1503637|P1|NOT COMPLETED|Double Blind, Placebo Controlled||2
613828|NCT00344448|1503636|P2|COMPLETED|Double Blind, Placebo Controlled||3
613829|NCT00344448|1503637|P1|COMPLETED|Double Blind, Placebo Controlled||4
613830|NCT00344448|1503636|P2|STARTED|Double Blind, Placebo Controlled||3
613831|NCT00344448|1503637|P1|STARTED|Double Blind, Placebo Controlled||6
613832|NCT00344448|1503636|P2|NOT COMPLETED|Screening||1
613833|NCT00344448|1503637|P1|NOT COMPLETED|Screening||0
613834|NCT00344448|1503636|P2|COMPLETED|Screening||3
613835|NCT00344448|1503637|P1|COMPLETED|Screening||6
613836|NCT00344448|1503636|P2|STARTED|Screening||4
613837|NCT00344448|1503637|P1|STARTED|Screening|No randomization during the screening phase|6
613838|NCT00344370|1503645|P2|NOT COMPLETED|Overall Study||3
613839|NCT00344370|1503646|P1|NOT COMPLETED|Overall Study||15
613840|NCT00344370|1503645|P2|COMPLETED|Overall Study||68
613841|NCT00344370|1503646|P1|COMPLETED|Overall Study||128
613842|NCT00344370|1503645|P2|STARTED|Overall Study||71
613843|NCT00344370|1503646|P1|STARTED|Overall Study||143
613844|NCT00344305|1503656|P2|NOT COMPLETED|Overall Study||1
613845|NCT00344305|1503657|P1|NOT COMPLETED|Overall Study||2
613846|NCT00344305|1503656|P2|COMPLETED|Overall Study||99
613847|NCT00344305|1503657|P1|COMPLETED|Overall Study||98
613848|NCT00344305|1503656|P2|STARTED|Overall Study||100
613849|NCT00344305|1503657|P1|STARTED|Overall Study||100
613850|NCT00344175|1503694|P2|NOT COMPLETED|Overall Study||10
613851|NCT00344175|1503695|P1|NOT COMPLETED|Overall Study||12
613852|NCT00344175|1503694|P2|COMPLETED|Overall Study||47
613853|NCT00344175|1503695|P1|COMPLETED|Overall Study||109
613854|NCT00344175|1503694|P2|STARTED|Overall Study||57
613855|NCT00344175|1503695|P1|STARTED|Overall Study||121
613856|NCT00344032|1503707|P2|NOT COMPLETED|Overall Study||10
613857|NCT00344032|1503708|P1|NOT COMPLETED|Overall Study||14
613858|NCT00344032|1503707|P2|COMPLETED|Overall Study||168
613859|NCT00344032|1503708|P1|COMPLETED|Overall Study||162
613860|NCT00344032|1503707|P2|STARTED|Overall Study||178
613861|NCT00344032|1503708|P1|STARTED|Overall Study||176
613862|NCT00344019|1503727|P3|NOT COMPLETED|Overall Study||74
613863|NCT00344019|1503728|P2|NOT COMPLETED|Overall Study||0
613864|NCT00344019|1503729|P1|NOT COMPLETED|Overall Study||0
613865|NCT00344019|1503727|P3|COMPLETED|Overall Study||0
613866|NCT00344019|1503728|P2|COMPLETED|Overall Study||11
613867|NCT00344019|1503729|P1|COMPLETED|Overall Study||12
613868|NCT00344019|1503727|P3|STARTED|Overall Study||74
613869|NCT00344019|1503728|P2|STARTED|Overall Study||11
613870|NCT00344019|1503729|P1|STARTED|Overall Study||12
613871|NCT00343915|1503747|P2|NOT COMPLETED|Month 66 Follow-up||0
613872|NCT00343915|1503748|P1|NOT COMPLETED|Month 66 Follow-up||0
613873|NCT00343915|1503747|P2|COMPLETED|Month 66 Follow-up||76
613874|NCT00343915|1503748|P1|COMPLETED|Month 66 Follow-up||158
613875|NCT00343915|1503747|P2|STARTED|Month 66 Follow-up||76
613876|NCT00343915|1503748|P1|STARTED|Month 66 Follow-up|Subjects, previously vaccinated, that returned for the Month 66 follow-up.|158
613877|NCT00343915|1503747|P2|NOT COMPLETED|Month 54 Follow-up||0
613878|NCT00343915|1503748|P1|NOT COMPLETED|Month 54 Follow-up||0
613879|NCT00343915|1503747|P2|COMPLETED|Month 54 Follow-up||79
613880|NCT00343915|1503748|P1|COMPLETED|Month 54 Follow-up||166
613881|NCT00343915|1503747|P2|STARTED|Month 54 Follow-up||79
613882|NCT00343915|1503748|P1|STARTED|Month 54 Follow-up|Subjects, previously vaccinated, that returned for the Month 54 follow-up.|166
613883|NCT00343915|1503747|P2|NOT COMPLETED|Month 42 Follow-up||0
613884|NCT00343915|1503748|P1|NOT COMPLETED|Month 42 Follow-up||0
613885|NCT00343915|1503747|P2|COMPLETED|Month 42 Follow-up||84
613886|NCT00343915|1503748|P1|COMPLETED|Month 42 Follow-up||174
613887|NCT00343915|1503747|P2|STARTED|Month 42 Follow-up||84
613888|NCT00343915|1503748|P1|STARTED|Month 42 Follow-up|Subjects, previously vaccinated, that returned for the Month 42 follow-up.|174
613889|NCT00343915|1503747|P2|NOT COMPLETED|Month 30 Follow-up||0
613890|NCT00343915|1503748|P1|NOT COMPLETED|Month 30 Follow-up||0
613891|NCT00343915|1503747|P2|COMPLETED|Month 30 Follow-up||88
613892|NCT00343915|1503748|P1|COMPLETED|Month 30 Follow-up||179
613893|NCT00343915|1503747|P2|STARTED|Month 30 Follow-up||88
613894|NCT00343915|1503748|P1|STARTED|Month 30 Follow-up|Subjects, previously vaccinated, that returned for the Month 30 follow-up.|179
613895|NCT00343915|1503747|P2|NOT COMPLETED|Primary Study||3
613896|NCT00343915|1503748|P1|NOT COMPLETED|Primary Study||4
613897|NCT00343915|1503747|P2|COMPLETED|Primary Study||123
613898|NCT00343915|1503748|P1|COMPLETED|Primary Study||254
613899|NCT00343915|1503747|P2|STARTED|Primary Study||126
613900|NCT00343915|1503748|P1|STARTED|Primary Study||258
613901|NCT00343889|1503774|P2|NOT COMPLETED|Overall Study||1
613902|NCT00343889|1503775|P1|NOT COMPLETED|Overall Study||3
613903|NCT00343889|1503774|P2|COMPLETED|Overall Study||188
613904|NCT00343889|1503775|P1|COMPLETED|Overall Study||187
613905|NCT00343889|1503774|P2|STARTED|Overall Study||189
613906|NCT00343889|1503775|P1|STARTED|Overall Study||190
613907|NCT00343863|1503793|P2|NOT COMPLETED|Overall Study||0
613908|NCT00343863|1503794|P1|NOT COMPLETED|Overall Study||0
613909|NCT00343863|1503793|P2|COMPLETED|Overall Study||34
613910|NCT00343863|1503794|P1|COMPLETED|Overall Study||7
613911|NCT00343863|1503793|P2|STARTED|Overall Study||34
613912|NCT00343863|1503794|P1|STARTED|Overall Study||7
613913|NCT00343785|1503816|P1|NOT COMPLETED|Overall Study||0
613914|NCT00343785|1503816|P1|COMPLETED|Overall Study||21
613915|NCT00343785|1503816|P1|STARTED|Overall Study||21
613916|NCT00343564|1503833|P11|NOT COMPLETED|Overall Study||0
613917|NCT00343564|1503834|P10|NOT COMPLETED|Overall Study||0
613918|NCT00343564|1503835|P9|NOT COMPLETED|Overall Study||0
613919|NCT00343564|1503836|P8|NOT COMPLETED|Overall Study||0
613920|NCT00343564|1503837|P7|NOT COMPLETED|Overall Study||0
613921|NCT00343564|1503838|P6|NOT COMPLETED|Overall Study||0
613922|NCT00343564|1503839|P5|NOT COMPLETED|Overall Study||0
613923|NCT00343564|1503840|P4|NOT COMPLETED|Overall Study||0
613924|NCT00343564|1503841|P3|NOT COMPLETED|Overall Study||0
613925|NCT00343564|1503842|P2|NOT COMPLETED|Overall Study||0
613926|NCT00343564|1503843|P1|NOT COMPLETED|Overall Study||0
613927|NCT00343564|1503833|P11|COMPLETED|Overall Study||8
613928|NCT00343564|1503834|P10|COMPLETED|Overall Study||8
613929|NCT00343564|1503835|P9|COMPLETED|Overall Study||3
613930|NCT00343564|1503836|P8|COMPLETED|Overall Study||3
613931|NCT00343564|1503837|P7|COMPLETED|Overall Study||4
613932|NCT00343564|1503838|P6|COMPLETED|Overall Study||9
613933|NCT00343564|1503839|P5|COMPLETED|Overall Study||10
613934|NCT00343564|1503840|P4|COMPLETED|Overall Study||7
613935|NCT00343564|1503841|P3|COMPLETED|Overall Study||3
613936|NCT00343564|1503842|P2|COMPLETED|Overall Study||7
613937|NCT00343564|1503843|P1|COMPLETED|Overall Study||6
613938|NCT00343564|1503833|P11|STARTED|Overall Study||8
613939|NCT00343564|1503834|P10|STARTED|Overall Study||8
613940|NCT00343564|1503835|P9|STARTED|Overall Study||3
613941|NCT00343564|1503836|P8|STARTED|Overall Study||3
613942|NCT00343564|1503837|P7|STARTED|Overall Study||4
613943|NCT00343564|1503838|P6|STARTED|Overall Study||9
613944|NCT00343564|1503839|P5|STARTED|Overall Study||10
613945|NCT00343564|1503840|P4|STARTED|Overall Study||7
613946|NCT00343564|1503841|P3|STARTED|Overall Study||3
613947|NCT00343564|1503842|P2|STARTED|Overall Study||7
613948|NCT00343564|1503843|P1|STARTED|Overall Study||6
613949|NCT00343512|1503858|P1|NOT COMPLETED|Overall Study||2
613950|NCT00343512|1503858|P1|COMPLETED|Overall Study||32
613951|NCT00343512|1503858|P1|STARTED|Overall Study||34
613952|NCT00343460|1503870|P3|NOT COMPLETED|Cycle 2 - 4||0
613953|NCT00343460|1503871|P2|NOT COMPLETED|Cycle 2 - 4||50
613954|NCT00343460|1503872|P1|NOT COMPLETED|Cycle 2 - 4||56
613955|NCT00343460|1503870|P3|COMPLETED|Cycle 2 - 4||0
613956|NCT00343460|1503871|P2|COMPLETED|Cycle 2 - 4||515
613957|NCT00343460|1503872|P1|COMPLETED|Cycle 2 - 4||528
613958|NCT00343460|1503870|P3|STARTED|Cycle 2 - 4||0
613959|NCT00343460|1503871|P2|STARTED|Cycle 2 - 4||565
613960|NCT00343460|1503872|P1|STARTED|Cycle 2 - 4||584
613961|NCT00343460|1503870|P3|NOT COMPLETED|Cycle 1||18
613962|NCT00343460|1503871|P2|NOT COMPLETED|Cycle 1||22
613963|NCT00343460|1503872|P1|NOT COMPLETED|Cycle 1||22
613964|NCT00343460|1503870|P3|COMPLETED|Cycle 1||454
613965|NCT00343460|1503871|P2|COMPLETED|Cycle 1||459
613966|NCT00343460|1503872|P1|COMPLETED|Cycle 1||453
613967|NCT00343460|1503870|P3|STARTED|Cycle 1||472
613968|NCT00343460|1503871|P2|STARTED|Cycle 1||481
613969|NCT00343460|1503872|P1|STARTED|Cycle 1||475
613970|NCT00343382|1503946|P3|NOT COMPLETED|Overall Study||17
613971|NCT00343382|1503947|P2|NOT COMPLETED|Overall Study||14
613972|NCT00343382|1503948|P1|NOT COMPLETED|Overall Study||4
613973|NCT00343382|1503946|P3|COMPLETED|Overall Study||49
613974|NCT00343382|1503947|P2|COMPLETED|Overall Study||51
613975|NCT00343382|1503948|P1|COMPLETED|Overall Study||60
613976|NCT00343382|1503946|P3|STARTED|Overall Study||66
613977|NCT00343382|1503947|P2|STARTED|Overall Study||65
613978|NCT00343382|1503948|P1|STARTED|Overall Study||64
613979|NCT00343291|1503967|P2|NOT COMPLETED|Overall Study||56
613980|NCT00343291|1503968|P1|NOT COMPLETED|Overall Study||57
613981|NCT00343291|1503967|P2|COMPLETED|Overall Study|Participants completed 6 cycles of treatment. Did not start subsequent weekly cetuximab monotherapy.|5
613982|NCT00343291|1503968|P1|COMPLETED|Overall Study|Participants completed 6 cycles of treatment. Did not start subsequent weekly cetuximab monotherapy.|3
613983|NCT00343291|1503967|P2|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58
613984|NCT00343291|1503968|P1|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58
613985|NCT00343291|1503967|P2|STARTED|Overall Study||61
613986|NCT00343291|1503968|P1|STARTED|Overall Study||60
613987|NCT00343252|1503984|P2|NOT COMPLETED|18 Months (All Treated Participants)||81
613988|NCT00343252|1503985|P1|NOT COMPLETED|18 Months (All Treated Participants)||101
613989|NCT00343252|1503984|P2|COMPLETED|18 Months (All Treated Participants)||269
613990|NCT00343252|1503985|P1|COMPLETED|18 Months (All Treated Participants)||259
613991|NCT00343252|1503984|P2|STARTED|18 Months (All Treated Participants)||350
613992|NCT00343252|1503985|P1|STARTED|18 Months (All Treated Participants)||360
613993|NCT00343252|1503984|P2|NOT COMPLETED|12 Months (All Treated Participants)||69
613994|NCT00343252|1503985|P1|NOT COMPLETED|12 Months (All Treated Participants)||86
613995|NCT00343252|1503984|P2|COMPLETED|12 Months (All Treated Participants)|Completed 12 Months.|281
613996|NCT00343252|1503985|P1|COMPLETED|12 Months (All Treated Participants)|Completed 12 Months.|274
613997|NCT00343252|1503984|P2|STARTED|12 Months (All Treated Participants)|351 participants were randomized but 1 did not receive study drug and was not analyzed.|350
613998|NCT00343252|1503985|P1|STARTED|12 Months (All Treated Participants)|361 participants were randomized but 1 did not receive study drug and was not analyzed.|360
613999|NCT00343252|1503984|P2|NOT COMPLETED|6 Months (All Treated Participants)||44
614000|NCT00343252|1503985|P1|NOT COMPLETED|6 Months (All Treated Participants)||56
614001|NCT00343252|1503984|P2|COMPLETED|6 Months (All Treated Participants)||306
614002|NCT00343252|1503985|P1|COMPLETED|6 Months (All Treated Participants)||304
614003|NCT00343252|1503984|P2|STARTED|6 Months (All Treated Participants)|351 participants were randomized but 1 did not receive study drug and was not analyzed.|350
614004|NCT00343252|1503985|P1|STARTED|6 Months (All Treated Participants)|361 participants were randomized but 1 did not receive study drug and was not analyzed.|360
614005|NCT00343252|1503984|P2|NOT COMPLETED|All Randomized Participants||82
614006|NCT00343252|1503985|P1|NOT COMPLETED|All Randomized Participants||102
614007|NCT00343252|1503984|P2|COMPLETED|All Randomized Participants||269
614008|NCT00343252|1503985|P1|COMPLETED|All Randomized Participants||259
614009|NCT00343252|1503984|P2|STARTED|All Randomized Participants||351
614010|NCT00343252|1503985|P1|STARTED|All Randomized Participants||361
614011|NCT00343083|1504031|P1|NOT COMPLETED|Overall Study||21
614012|NCT00343083|1504031|P1|COMPLETED|Overall Study||22
614013|NCT00343083|1504031|P1|STARTED|Overall Study||43
614014|NCT00343044|1504040|P1|NOT COMPLETED|Overall Study||0
614015|NCT00343044|1504040|P1|COMPLETED|Overall Study||40
614016|NCT00343044|1504040|P1|STARTED|Overall Study||40
614017|NCT00342628|1504050|P3|NOT COMPLETED|Overall Study||19
614018|NCT00342628|1504051|P2|NOT COMPLETED|Overall Study||21
614019|NCT00342628|1504052|P1|NOT COMPLETED|Overall Study||20
614020|NCT00342628|1504050|P3|COMPLETED|Overall Study|97 completed 3 injections of DTP alone, 16 were lost-to-followup for blood drawing at 12 months.|81
614021|NCT00342628|1504051|P2|COMPLETED|Overall Study|83 completed 4 injections, 3 were lost-to-followup after 4th injection|80
614022|NCT00342628|1504052|P1|COMPLETED|Overall Study|84 completed 4 injections, 4 were lost-to-followup after the 4th injection|80
614023|NCT00342628|1504050|P3|STARTED|Overall Study||100
614024|NCT00342628|1504051|P2|STARTED|Overall Study||101
614025|NCT00342628|1504052|P1|STARTED|Overall Study||100
614026|NCT00342563|1504073|P4|NOT COMPLETED|Overall Study||6
614027|NCT00342563|1504074|P3|NOT COMPLETED|Overall Study||14
614028|NCT00342563|1504075|P2|NOT COMPLETED|Overall Study||8
614029|NCT00342563|1504076|P1|NOT COMPLETED|Overall Study||6
614030|NCT00342563|1504073|P4|COMPLETED|Overall Study||22
614031|NCT00342563|1504074|P3|COMPLETED|Overall Study||26
614032|NCT00342563|1504075|P2|COMPLETED|Overall Study||19
614033|NCT00342563|1504076|P1|COMPLETED|Overall Study||35
614034|NCT00342563|1504073|P4|STARTED|Overall Study||28
614035|NCT00342563|1504074|P3|STARTED|Overall Study||40
614036|NCT00342563|1504075|P2|STARTED|Overall Study||27
614037|NCT00342563|1504076|P1|STARTED|Overall Study||41
614038|NCT00342355|1504096|P4|NOT COMPLETED|Overall Study||0
614039|NCT00342355|1504097|P3|NOT COMPLETED|Overall Study||0
614040|NCT00342355|1504098|P2|NOT COMPLETED|Overall Study||0
614041|NCT00342355|1504099|P1|NOT COMPLETED|Overall Study||0
614042|NCT00342355|1504096|P4|COMPLETED|Overall Study||443
614043|NCT00342355|1504097|P3|COMPLETED|Overall Study||444
614044|NCT00342355|1504098|P2|COMPLETED|Overall Study||440
614045|NCT00342355|1504099|P1|COMPLETED|Overall Study||444
614046|NCT00342355|1504096|P4|STARTED|Overall Study||443
614047|NCT00342355|1504097|P3|STARTED|Overall Study||444
614048|NCT00342355|1504098|P2|STARTED|Overall Study||440
614049|NCT00342355|1504099|P1|STARTED|Overall Study||444
614050|NCT00340834|1504118|P5|NOT COMPLETED|Extension Phase of Study||44
614051|NCT00340834|1504119|P4|NOT COMPLETED|Extension Phase of Study||53
614052|NCT00340834|1504120|P3|NOT COMPLETED|Extension Phase of Study||0
614053|NCT00340834|1504121|P2|NOT COMPLETED|Extension Phase of Study||76
614054|NCT00340834|1504122|P1|NOT COMPLETED|Extension Phase of Study||85
614055|NCT00340834|1504118|P5|COMPLETED|Extension Phase of Study||123
614056|NCT00340834|1504119|P4|COMPLETED|Extension Phase of Study||123
614057|NCT00340834|1504120|P3|COMPLETED|Extension Phase of Study||0
614058|NCT00340834|1504121|P2|COMPLETED|Extension Phase of Study||281
614059|NCT00340834|1504122|P1|COMPLETED|Extension Phase of Study||245
614060|NCT00340834|1504118|P5|Received Study Drug|Extension Phase of Study||167
614061|NCT00340834|1504119|P4|Received Study Drug|Extension Phase of Study||174
614062|NCT00340834|1504120|P3|Received Study Drug|Extension Phase of Study||0
614063|NCT00340834|1504121|P2|Received Study Drug|Extension Phase of Study||356
614064|NCT00340834|1504122|P1|Received Study Drug|Extension Phase of Study||330
614065|NCT00340834|1504118|P5|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|167
614066|NCT00340834|1504119|P4|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|176
614067|NCT00340834|1504120|P3|STARTED|Extension Phase of Study|This group did not exist in the extension phase of the study.|0
614068|NCT00340834|1504121|P2|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|357
614069|NCT00340834|1504122|P1|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|330
614070|NCT00340834|1504118|P5|NOT COMPLETED|Core Phase of Study||0
614071|NCT00340834|1504119|P4|NOT COMPLETED|Core Phase of Study||0
614072|NCT00340834|1504120|P3|NOT COMPLETED|Core Phase of Study||49
614073|NCT00340834|1504121|P2|NOT COMPLETED|Core Phase of Study||33
614074|NCT00340834|1504122|P1|NOT COMPLETED|Core Phase of Study||57
614075|NCT00340834|1504118|P5|COMPLETED|Core Phase of Study||0
614076|NCT00340834|1504119|P4|COMPLETED|Core Phase of Study||0
614077|NCT00340834|1504120|P3|COMPLETED|Core Phase of Study|On study drug: 380, Off study drug: 6|386
614078|NCT00340834|1504121|P2|COMPLETED|Core Phase of Study|On study drug: 385, Off study drug: 13|398
614079|NCT00340834|1504122|P1|COMPLETED|Core Phase of Study|On study drug: 358, Off study drug: 11|369
614080|NCT00340834|1504118|P5|STARTED|Core Phase of Study|This group was formed at the beginning of the extension phase of the study.|0
614081|NCT00340834|1504119|P4|STARTED|Core Phase of Study|This group was formed at the beginning of the extension phase of the study.|0
614082|NCT00340834|1504120|P3|STARTED|Core Phase of Study||435
614083|NCT00340834|1504121|P2|STARTED|Core Phase of Study||431
614084|NCT00340834|1504122|P1|STARTED|Core Phase of Study||426
614085|NCT00340704|1504156|P9|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||29
614086|NCT00340704|1504157|P8|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||12
614087|NCT00340704|1504158|P7|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||53
614088|NCT00340704|1504159|P6|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||7
614089|NCT00340704|1504160|P5|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||5
614090|NCT00340704|1504161|P4|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||2
614268|NCT00338455|1504630|P2|NOT COMPLETED|Overall Study||1
614091|NCT00340704|1504162|P3|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
614092|NCT00340704|1504163|P2|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
614093|NCT00340704|1504164|P1|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
614094|NCT00340704|1504156|P9|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
614095|NCT00340704|1504157|P8|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1
614096|NCT00340704|1504158|P7|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1
614097|NCT00340704|1504159|P6|COMPLETED|Group D- Denovo & 527.51 Rollover Study||30
614098|NCT00340704|1504160|P5|COMPLETED|Group D- Denovo & 527.51 Rollover Study||16
614099|NCT00340704|1504161|P4|COMPLETED|Group D- Denovo & 527.51 Rollover Study||27
614100|NCT00340704|1504162|P3|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
614101|NCT00340704|1504163|P2|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
614102|NCT00340704|1504164|P1|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
614103|NCT00340704|1504156|P9|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
614104|NCT00340704|1504157|P8|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
614105|NCT00340704|1504158|P7|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
614106|NCT00340704|1504159|P6|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||18
614107|NCT00340704|1504160|P5|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||5
614108|NCT00340704|1504161|P4|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||7
614109|NCT00340704|1504162|P3|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
614110|NCT00340704|1504163|P2|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
614111|NCT00340704|1504164|P1|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
614112|NCT00340704|1504156|P9|STARTED|Group D- Denovo & 527.51 Rollover Study||29
614113|NCT00340704|1504157|P8|STARTED|Group D- Denovo & 527.51 Rollover Study||13
614114|NCT00340704|1504158|P7|STARTED|Group D- Denovo & 527.51 Rollover Study||54
614115|NCT00340704|1504159|P6|STARTED|Group D- Denovo & 527.51 Rollover Study||37
614116|NCT00340704|1504160|P5|STARTED|Group D- Denovo & 527.51 Rollover Study||21
614117|NCT00340704|1504161|P4|STARTED|Group D- Denovo & 527.51 Rollover Study||29
614118|NCT00340704|1504162|P3|STARTED|Group D- Denovo & 527.51 Rollover Study||0
614119|NCT00340704|1504163|P2|STARTED|Group D- Denovo & 527.51 Rollover Study||0
614120|NCT00340704|1504164|P1|STARTED|Group D- Denovo & 527.51 Rollover Study||0
614121|NCT00340704|1504156|P9|NOT COMPLETED|PK Study||0
614122|NCT00340704|1504157|P8|NOT COMPLETED|PK Study||0
614123|NCT00340704|1504158|P7|NOT COMPLETED|PK Study||0
614124|NCT00340704|1504159|P6|NOT COMPLETED|PK Study||0
614125|NCT00340704|1504160|P5|NOT COMPLETED|PK Study||0
614126|NCT00340704|1504161|P4|NOT COMPLETED|PK Study||0
614127|NCT00340704|1504162|P3|NOT COMPLETED|PK Study||1
614128|NCT00340704|1504163|P2|NOT COMPLETED|PK Study||1
614129|NCT00340704|1504164|P1|NOT COMPLETED|PK Study||0
614130|NCT00340704|1504156|P9|COMPLETED|PK Study||0
614131|NCT00340704|1504157|P8|COMPLETED|PK Study||0
614132|NCT00340704|1504158|P7|COMPLETED|PK Study||0
614133|NCT00340704|1504159|P6|COMPLETED|PK Study||0
614134|NCT00340704|1504160|P5|COMPLETED|PK Study||0
614135|NCT00340704|1504161|P4|COMPLETED|PK Study||0
614136|NCT00340704|1504162|P3|COMPLETED|PK Study||10
614137|NCT00340704|1504163|P2|COMPLETED|PK Study||9
614138|NCT00340704|1504164|P1|COMPLETED|PK Study||10
614139|NCT00340704|1504156|P9|STARTED|PK Study||0
614140|NCT00340704|1504157|P8|STARTED|PK Study||0
614141|NCT00340704|1504158|P7|STARTED|PK Study||0
614142|NCT00340704|1504159|P6|STARTED|PK Study||0
614143|NCT00340704|1504160|P5|STARTED|PK Study||0
614144|NCT00340704|1504161|P4|STARTED|PK Study||0
614145|NCT00340704|1504162|P3|STARTED|PK Study||11
614146|NCT00340704|1504163|P2|STARTED|PK Study||10
614147|NCT00340704|1504164|P1|STARTED|PK Study||10
614148|NCT00340678|1504270|P4|NOT COMPLETED|Overall Study||0
614149|NCT00340678|1504271|P3|NOT COMPLETED|Overall Study||0
614150|NCT00340678|1504272|P2|NOT COMPLETED|Overall Study||0
614151|NCT00340678|1504273|P1|NOT COMPLETED|Overall Study||1
614152|NCT00340678|1504270|P4|COMPLETED|Overall Study||39
614153|NCT00340678|1504271|P3|COMPLETED|Overall Study||39
614154|NCT00340678|1504272|P2|COMPLETED|Overall Study||46
614155|NCT00340678|1504273|P1|COMPLETED|Overall Study||45
614156|NCT00340678|1504270|P4|STARTED|Overall Study||39
614157|NCT00340678|1504271|P3|STARTED|Overall Study||39
614158|NCT00340678|1504272|P2|STARTED|Overall Study||46
614159|NCT00340678|1504273|P1|STARTED|Overall Study||46
614160|NCT00340379|1504287|P2|NOT COMPLETED|Overall Study||9
614161|NCT00340379|1504288|P1|NOT COMPLETED|Overall Study||8
614162|NCT00340379|1504287|P2|COMPLETED|Overall Study||28
614163|NCT00340379|1504288|P1|COMPLETED|Overall Study||27
614164|NCT00340379|1504287|P2|STARTED|Overall Study||37
614165|NCT00340379|1504288|P1|STARTED|Overall Study||35
614166|NCT00339833|1504300|P2|NOT COMPLETED|Overall Study||8
614167|NCT00339833|1504301|P1|NOT COMPLETED|Overall Study||6
614168|NCT00339833|1504300|P2|COMPLETED|Overall Study||18
614169|NCT00339833|1504301|P1|COMPLETED|Overall Study||22
614170|NCT00339833|1504300|P2|STARTED|Overall Study||26
614171|NCT00339833|1504301|P1|STARTED|Overall Study||28
614172|NCT00339183|1504311|P2|NOT COMPLETED|Overall Study||105
614173|NCT00339183|1504312|P1|NOT COMPLETED|Overall Study||121
614174|NCT00339183|1504311|P2|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|490
614269|NCT00338455|1504631|P1|NOT COMPLETED|Overall Study||3
614175|NCT00339183|1504312|P1|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|470
614176|NCT00339183|1504311|P2|Received Study Drug|Overall Study||593
614177|NCT00339183|1504312|P1|Received Study Drug|Overall Study|Includes one participant who received FOLFIRI Alone|588
614178|NCT00339183|1504311|P2|STARTED|Overall Study||595
614179|NCT00339183|1504312|P1|STARTED|Overall Study||591
614180|NCT00339144|1504341|P3|NOT COMPLETED|Overall Study||4
614181|NCT00339144|1504342|P2|NOT COMPLETED|Overall Study||3
614182|NCT00339144|1504343|P1|NOT COMPLETED|Overall Study||9
614183|NCT00339144|1504341|P3|COMPLETED|Overall Study||0
614184|NCT00339144|1504342|P2|COMPLETED|Overall Study||0
614185|NCT00339144|1504343|P1|COMPLETED|Overall Study||0
614186|NCT00339144|1504341|P3|STARTED|Overall Study|Number of participants enrolled and treated|4
614187|NCT00339144|1504342|P2|STARTED|Overall Study|Number of participants enrolled and treated|3
614188|NCT00339144|1504343|P1|STARTED|Overall Study|Number of participants enrolled and treated|9
614189|NCT00339079|1504429|P4|NOT COMPLETED|Overall Study||24
614190|NCT00339079|1504430|P3|NOT COMPLETED|Overall Study||18
614191|NCT00339079|1504431|P2|NOT COMPLETED|Overall Study||23
614192|NCT00339079|1504432|P1|NOT COMPLETED|Overall Study||33
614193|NCT00339079|1504429|P4|COMPLETED|Overall Study||29
614194|NCT00339079|1504430|P3|COMPLETED|Overall Study||27
614195|NCT00339079|1504431|P2|COMPLETED|Overall Study||21
614196|NCT00339079|1504432|P1|COMPLETED|Overall Study||20
614197|NCT00339079|1504429|P4|STARTED|Overall Study||53
614198|NCT00339079|1504430|P3|STARTED|Overall Study||45
614199|NCT00339079|1504431|P2|STARTED|Overall Study||44
614200|NCT00339079|1504432|P1|STARTED|Overall Study||53
614201|NCT00339040|1504448|P2|NOT COMPLETED|Stage II||2
614202|NCT00339040|1504449|P1|NOT COMPLETED|Stage II||10
614203|NCT00339040|1504448|P2|COMPLETED|Stage II||27
614204|NCT00339040|1504449|P1|COMPLETED|Stage II||84
614205|NCT00339040|1504448|P2|Vaccination 6 at Week 120|Stage II||27
614206|NCT00339040|1504449|P1|Vaccination 6 at Week 120|Stage II||0
614207|NCT00339040|1504448|P2|Vaccination 5 at Week 104|Stage II||28
614208|NCT00339040|1504449|P1|Vaccination 5 at Week 104|Stage II||0
614209|NCT00339040|1504448|P2|Vaccination 4 at Week 96|Stage II||29
614210|NCT00339040|1504449|P1|Vaccination 4 at Week 96|Stage II||84
614211|NCT00339040|1504448|P2|STARTED|Stage II||29
614212|NCT00339040|1504449|P1|STARTED|Stage II||94
614213|NCT00339040|1504448|P2|NOT COMPLETED|Stage I||1
614214|NCT00339040|1504449|P1|NOT COMPLETED|Stage I||2
614215|NCT00339040|1504448|P2|COMPLETED|Stage I||29
614216|NCT00339040|1504449|P1|COMPLETED|Stage I||94
614217|NCT00339040|1504448|P2|Vaccination 3 at Week 24|Stage I||30
614218|NCT00339040|1504449|P1|Vaccination 3 at Week 24|Stage I||94
614219|NCT00339040|1504448|P2|Vaccination 2 at Week 8|Stage I||30
614220|NCT00339040|1504449|P1|Vaccination 2 at Week 8|Stage I||95
614221|NCT00339040|1504448|P2|Vaccination 1 at Week 0|Stage I||30
614222|NCT00339040|1504449|P1|Vaccination 1 at Week 0|Stage I||96
614223|NCT00339040|1504448|P2|STARTED|Stage I||30
614224|NCT00339040|1504449|P1|STARTED|Stage I||96
614225|NCT00338988|1504467|P1|NOT COMPLETED|Overall Study||1
614226|NCT00338988|1504467|P1|COMPLETED|Overall Study||43
614227|NCT00338988|1504467|P1|STARTED|Overall Study||44
614228|NCT00338962|1504476|P4|NOT COMPLETED|Overall Study||3
614229|NCT00338962|1504477|P3|NOT COMPLETED|Overall Study||6
614230|NCT00338962|1504478|P2|NOT COMPLETED|Overall Study||4
614231|NCT00338962|1504479|P1|NOT COMPLETED|Overall Study||8
614232|NCT00338962|1504476|P4|COMPLETED|Overall Study||21
614233|NCT00338962|1504477|P3|COMPLETED|Overall Study||16
614234|NCT00338962|1504478|P2|COMPLETED|Overall Study||16
614235|NCT00338962|1504479|P1|COMPLETED|Overall Study||14
614236|NCT00338962|1504476|P4|STARTED|Overall Study||24
614237|NCT00338962|1504477|P3|STARTED|Overall Study||22
614238|NCT00338962|1504478|P2|STARTED|Overall Study||20
614239|NCT00338962|1504479|P1|STARTED|Overall Study||22
614240|NCT00338884|1504501|P1|NOT COMPLETED|Overall Study||78
614241|NCT00338884|1504501|P1|COMPLETED|Overall Study||42
614242|NCT00338884|1504501|P1|Received Treatment|Overall Study||119
614243|NCT00338884|1504501|P1|STARTED|Overall Study||120
614244|NCT00338806|1504535|P2|NOT COMPLETED|Follow-up||3
614245|NCT00338806|1504536|P1|NOT COMPLETED|Follow-up||1
614246|NCT00338806|1504535|P2|COMPLETED|Follow-up||1
614247|NCT00338806|1504536|P1|COMPLETED|Follow-up||1
614248|NCT00338806|1504535|P2|STARTED|Follow-up||4
614249|NCT00338806|1504536|P1|STARTED|Follow-up||2
614250|NCT00338806|1504535|P2|NOT COMPLETED|Acute Phase||1
614251|NCT00338806|1504536|P1|NOT COMPLETED|Acute Phase||0
614252|NCT00338806|1504535|P2|COMPLETED|Acute Phase||4
614253|NCT00338806|1504536|P1|COMPLETED|Acute Phase||2
614254|NCT00338806|1504535|P2|STARTED|Acute Phase||5
614255|NCT00338806|1504536|P1|STARTED|Acute Phase||2
614256|NCT00338741|1504598|P2|NOT COMPLETED|Overall Study||0
614257|NCT00338741|1504599|P1|NOT COMPLETED|Overall Study||2
614258|NCT00338741|1504598|P2|COMPLETED|Overall Study||2
614259|NCT00338741|1504599|P1|COMPLETED|Overall Study||32
614260|NCT00338741|1504598|P2|STARTED|Overall Study||2
614261|NCT00338741|1504599|P1|STARTED|Overall Study|2 subjects signed a consent form but no data were received for either subject|34
614262|NCT00338598|1504609|P2|NOT COMPLETED|Overall Study||2
614263|NCT00338598|1504610|P1|NOT COMPLETED|Overall Study||0
614264|NCT00338598|1504609|P2|COMPLETED|Overall Study||8
614265|NCT00338598|1504610|P1|COMPLETED|Overall Study||10
614266|NCT00338598|1504609|P2|STARTED|Overall Study||10
614267|NCT00338598|1504610|P1|STARTED|Overall Study||10
614270|NCT00338455|1504630|P2|COMPLETED|Overall Study||6
614271|NCT00338455|1504631|P1|COMPLETED|Overall Study||6
614272|NCT00338455|1504630|P2|Administered Study Drug|Overall Study||7
614273|NCT00338455|1504631|P1|Administered Study Drug|Overall Study||8
614274|NCT00338455|1504630|P2|STARTED|Overall Study||7
614275|NCT00338455|1504631|P1|STARTED|Overall Study||9
614276|NCT00338286|1504645|P2|NOT COMPLETED|Overall Study||213
614277|NCT00338286|1504646|P1|NOT COMPLETED|Overall Study||233
614278|NCT00338286|1504645|P2|COMPLETED|Overall Study||837
614279|NCT00338286|1504646|P1|COMPLETED|Overall Study||815
614280|NCT00338286|1504645|P2|STARTED|Overall Study||1050
614281|NCT00338286|1504646|P1|STARTED|Overall Study||1048
614282|NCT00338104|1504663|P3|NOT COMPLETED|Overall Study||3
614283|NCT00338104|1504664|P2|NOT COMPLETED|Overall Study||1
614284|NCT00338104|1504665|P1|NOT COMPLETED|Overall Study||2
614285|NCT00338104|1504663|P3|COMPLETED|Overall Study||22
614286|NCT00338104|1504664|P2|COMPLETED|Overall Study||24
614287|NCT00338104|1504665|P1|COMPLETED|Overall Study||23
614288|NCT00338104|1504663|P3|STARTED|Overall Study||25
614289|NCT00338104|1504664|P2|STARTED|Overall Study||25
614290|NCT00338104|1504665|P1|STARTED|Overall Study||25
614291|NCT00338039|1504676|P1|NOT COMPLETED|Overall Study||0
614292|NCT00338039|1504676|P1|COMPLETED|Overall Study||69
614293|NCT00338039|1504676|P1|STARTED|Overall Study||69
614294|NCT00337987|1504681|P1|NOT COMPLETED|Overall Study||0
614295|NCT00337987|1504681|P1|COMPLETED|Overall Study||49
614296|NCT00337987|1504681|P1|STARTED|Overall Study||49
614297|NCT00337935|1504688|P2|NOT COMPLETED|Overall Study||27
614298|NCT00337935|1504689|P1|NOT COMPLETED|Overall Study||10
614299|NCT00337935|1504688|P2|COMPLETED|Overall Study||91
614300|NCT00337935|1504689|P1|COMPLETED|Overall Study||29
614301|NCT00337935|1504688|P2|STARTED|Overall Study||118
614302|NCT00337935|1504689|P1|STARTED|Overall Study||39
614303|NCT00337818|1504702|P3|NOT COMPLETED|Overall Study||107
614304|NCT00337818|1504703|P2|NOT COMPLETED|Overall Study||91
614305|NCT00337818|1504704|P1|NOT COMPLETED|Overall Study||289
614306|NCT00337818|1504702|P3|COMPLETED|Overall Study||51
614307|NCT00337818|1504703|P2|COMPLETED|Overall Study||63
614308|NCT00337818|1504704|P1|COMPLETED|Overall Study||169
614309|NCT00337818|1504702|P3|STARTED|Overall Study||158
614310|NCT00337818|1504703|P2|STARTED|Overall Study||154
614311|NCT00337818|1504704|P1|STARTED|Overall Study||458
614312|NCT00337779|1504726|P2|NOT COMPLETED|Overall Study||79
614313|NCT00337779|1504727|P1|NOT COMPLETED|Overall Study||52
614314|NCT00337779|1504726|P2|COMPLETED|Overall Study||490
614315|NCT00337779|1504727|P1|COMPLETED|Overall Study||534
614316|NCT00337779|1504726|P2|STARTED|Overall Study||569
614317|NCT00337779|1504727|P1|STARTED|Overall Study||586
614318|NCT00337727|1504739|P2|NOT COMPLETED|Overall Study||12
614319|NCT00337727|1504740|P1|NOT COMPLETED|Overall Study||18
614320|NCT00337727|1504739|P2|COMPLETED|Overall Study||406
614321|NCT00337727|1504740|P1|COMPLETED|Overall Study||412
614322|NCT00337727|1504739|P2|STARTED|Overall Study||418
614323|NCT00337727|1504740|P1|STARTED|Overall Study||430
614324|NCT00337675|1504751|P3|NOT COMPLETED|Overall Study||99
614325|NCT00337675|1504752|P2|NOT COMPLETED|Overall Study||103
614326|NCT00337675|1504753|P1|NOT COMPLETED|Overall Study||97
614327|NCT00337675|1504751|P3|COMPLETED|Overall Study||492
614328|NCT00337675|1504752|P2|COMPLETED|Overall Study||488
614329|NCT00337675|1504753|P1|COMPLETED|Overall Study||492
614330|NCT00337675|1504751|P3|STARTED|Overall Study||591
614331|NCT00337675|1504752|P2|STARTED|Overall Study||591
614332|NCT00337675|1504753|P1|STARTED|Overall Study||589
614333|NCT00337662|1504770|P4|NOT COMPLETED|Study Period III||0
614334|NCT00337662|1504771|P3|NOT COMPLETED|Study Period III||44
614335|NCT00337662|1504772|P2|NOT COMPLETED|Study Period III||58
614336|NCT00337662|1504773|P1|NOT COMPLETED|Study Period III||60
614337|NCT00337662|1504770|P4|COMPLETED|Study Period III||0
614338|NCT00337662|1504771|P3|COMPLETED|Study Period III||100
614339|NCT00337662|1504772|P2|COMPLETED|Study Period III||134
614340|NCT00337662|1504773|P1|COMPLETED|Study Period III||126
614341|NCT00337662|1504770|P4|STARTED|Study Period III||0
614342|NCT00337662|1504771|P3|STARTED|Study Period III||144
614343|NCT00337662|1504772|P2|STARTED|Study Period III||192
614344|NCT00337662|1504773|P1|STARTED|Study Period III||186
614345|NCT00337662|1504770|P4|NOT COMPLETED|Study Period II||106
614346|NCT00337662|1504771|P3|NOT COMPLETED|Study Period II||0
614347|NCT00337662|1504772|P2|NOT COMPLETED|Study Period II||0
614348|NCT00337662|1504773|P1|NOT COMPLETED|Study Period II||0
614349|NCT00337662|1504770|P4|COMPLETED|Study Period II||522
614350|NCT00337662|1504771|P3|COMPLETED|Study Period II||0
614351|NCT00337662|1504772|P2|COMPLETED|Study Period II||0
614352|NCT00337662|1504773|P1|COMPLETED|Study Period II||0
614353|NCT00337662|1504770|P4|STARTED|Study Period II||628
614354|NCT00337662|1504771|P3|STARTED|Study Period II||0
614355|NCT00337662|1504772|P2|STARTED|Study Period II||0
614356|NCT00337662|1504773|P1|STARTED|Study Period II||0
614357|NCT00337610|1504827|P2|NOT COMPLETED|Overall Study||14
614358|NCT00337610|1504828|P1|NOT COMPLETED|Overall Study||17
614359|NCT00337610|1504827|P2|COMPLETED|Overall Study||80
614360|NCT00337610|1504828|P1|COMPLETED|Overall Study||79
614361|NCT00337610|1504827|P2|Completed Week 18|Overall Study||82
614362|NCT00337610|1504828|P1|Completed Week 18|Overall Study||89
614363|NCT00337610|1504827|P2|STARTED|Overall Study||94
614364|NCT00337610|1504828|P1|STARTED|Overall Study||96
614365|NCT00337571|1504844|P4|NOT COMPLETED|Overall Study||7
614366|NCT00337571|1504845|P3|NOT COMPLETED|Overall Study||10
614367|NCT00337571|1504846|P2|NOT COMPLETED|Overall Study||9
614368|NCT00337571|1504847|P1|NOT COMPLETED|Overall Study||14
614369|NCT00337571|1504844|P4|COMPLETED|Overall Study||47
614370|NCT00337571|1504845|P3|COMPLETED|Overall Study||49
614371|NCT00337571|1504846|P2|COMPLETED|Overall Study||44
614372|NCT00337571|1504847|P1|COMPLETED|Overall Study||38
614373|NCT00337571|1504844|P4|STARTED|Overall Study||54
614374|NCT00337571|1504845|P3|STARTED|Overall Study||59
614375|NCT00337571|1504846|P2|STARTED|Overall Study||53
614376|NCT00337571|1504847|P1|STARTED|Overall Study||52
614377|NCT00337467|1504885|P1|NOT COMPLETED|Overall Study||10
614378|NCT00337467|1504885|P1|COMPLETED|Overall Study||51
614379|NCT00337467|1504885|P1|Discontinued Prior to Week 96|Overall Study|5 of these participants discontinued prior to Week 48|10
614380|NCT00337467|1504885|P1|STARTED|Overall Study||61
614381|NCT00337428|1504904|P2|NOT COMPLETED|Overall Study||3
614382|NCT00337428|1504905|P1|NOT COMPLETED|Overall Study||4
614383|NCT00337428|1504904|P2|COMPLETED|Overall Study||421
614384|NCT00337428|1504905|P1|COMPLETED|Overall Study||415
614385|NCT00337428|1504904|P2|STARTED|Overall Study||424
614386|NCT00337428|1504905|P1|STARTED|Overall Study||419
614387|NCT00337350|1504945|P2|NOT COMPLETED|Overall Study||1
614388|NCT00337350|1504946|P1|NOT COMPLETED|Overall Study||1
614389|NCT00337350|1504945|P2|COMPLETED|Overall Study||10
614390|NCT00337350|1504946|P1|COMPLETED|Overall Study||8
614391|NCT00337350|1504945|P2|STARTED|Overall Study||11
614392|NCT00337350|1504946|P1|STARTED|Overall Study||9
614393|NCT00337285|1504956|P1|NOT COMPLETED|Overall Study||158
614394|NCT00337285|1504956|P1|COMPLETED|Overall Study||191
614395|NCT00337285|1504956|P1|STARTED|Overall Study||349
614396|NCT00337272|1504964|P2|NOT COMPLETED|Withdrawal Period||1
614397|NCT00337272|1504965|P1|NOT COMPLETED|Withdrawal Period||0
614398|NCT00337272|1504964|P2|COMPLETED|Withdrawal Period||6
614399|NCT00337272|1504965|P1|COMPLETED|Withdrawal Period||6
614400|NCT00337272|1504964|P2|STARTED|Withdrawal Period|Subjects in both groups received placebo for one week.|7
614401|NCT00337272|1504965|P1|STARTED|Withdrawal Period|Subjects in both groups received placebo for one week.|6
614402|NCT00337272|1504964|P2|NOT COMPLETED|Treatment Period||2
614403|NCT00337272|1504965|P1|NOT COMPLETED|Treatment Period||1
614404|NCT00337272|1504964|P2|COMPLETED|Treatment Period||7
614405|NCT00337272|1504965|P1|COMPLETED|Treatment Period||6
614406|NCT00337272|1504964|P2|Randomization|Treatment Period||9
614407|NCT00337272|1504965|P1|Randomization|Treatment Period||7
614408|NCT00337272|1504964|P2|STARTED|Treatment Period|16 subjects were randomized to either placebo or ramelteon before starting treatment period.|9
614409|NCT00337272|1504965|P1|STARTED|Treatment Period|16 subjects were randomized to either placebo or ramelteon before starting treatment period.|7
614410|NCT00337272|1504964|P2|NOT COMPLETED|Screening Period (Pre-randomization)||0
614411|NCT00337272|1504965|P1|NOT COMPLETED|Screening Period (Pre-randomization)||6
614412|NCT00337272|1504964|P2|COMPLETED|Screening Period (Pre-randomization)||0
614413|NCT00337272|1504965|P1|COMPLETED|Screening Period (Pre-randomization)|16 subjects completed the screening period and were eligible for randomization.|16
614414|NCT00337272|1504964|P2|STARTED|Screening Period (Pre-randomization)||0
614415|NCT00337272|1504965|P1|STARTED|Screening Period (Pre-randomization)|22 subjects were consented. All subjects received placebo during the 2 week screening period.|22
614416|NCT00337207|1504985|P1|NOT COMPLETED|Overall Study||3
614417|NCT00337207|1504985|P1|COMPLETED|Overall Study||52
614418|NCT00337207|1504985|P1|STARTED|Overall Study||55
614419|NCT00337194|1504991|P2|NOT COMPLETED|Overall Study||4
614420|NCT00337194|1504992|P1|NOT COMPLETED|Overall Study||12
614421|NCT00337194|1504991|P2|COMPLETED|Overall Study||3
614422|NCT00337194|1504992|P1|COMPLETED|Overall Study||11
614423|NCT00337194|1504991|P2|STARTED|Overall Study||7
614424|NCT00337194|1504992|P1|STARTED|Overall Study||23
614425|NCT00337168|1505007|P1|NOT COMPLETED|Overall Study||8
614426|NCT00337168|1505007|P1|COMPLETED|Overall Study||29
614427|NCT00337168|1505007|P1|Eligible and Treated|Overall Study||36
614428|NCT00337168|1505007|P1|Eligible|Overall Study||37
614429|NCT00337168|1505007|P1|STARTED|Overall Study||37
614430|NCT00337129|1505014|P1|NOT COMPLETED|Overall Study||40
614431|NCT00337129|1505014|P1|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until discontinuation criterion is met.|0
614432|NCT00337129|1505014|P1|STARTED|Overall Study||40
614433|NCT00337103|1505023|P2|NOT COMPLETED|Overall Study||543
614434|NCT00337103|1505024|P1|NOT COMPLETED|Overall Study||549
614435|NCT00337103|1505023|P2|COMPLETED|Overall Study||5
614436|NCT00337103|1505024|P1|COMPLETED|Overall Study||5
614437|NCT00337103|1505023|P2|STARTED|Overall Study||548
614438|NCT00337103|1505024|P1|STARTED|Overall Study||554
614439|NCT00337077|1505035|P3|NOT COMPLETED|Overall Study||25
614440|NCT00337077|1505036|P2|NOT COMPLETED|Overall Study||53
614441|NCT00337077|1505037|P1|NOT COMPLETED|Overall Study||43
614442|NCT00337077|1505035|P3|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
614443|NCT00337077|1505036|P2|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
614444|NCT00337077|1505037|P1|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
614445|NCT00337077|1505035|P3|Patients With Measurable Disease|Overall Study||13
614446|NCT00337077|1505036|P2|Patients With Measurable Disease|Overall Study||38
614447|NCT00337077|1505037|P1|Patients With Measurable Disease|Overall Study||26
614448|NCT00337077|1505035|P3|Eligible and Treated|Overall Study||24
614449|NCT00337077|1505036|P2|Eligible and Treated|Overall Study||51
614450|NCT00337077|1505037|P1|Eligible and Treated|Overall Study||41
614451|NCT00337077|1505035|P3|Toxicity Assessed|Overall Study||25
614452|NCT00337077|1505036|P2|Toxicity Assessed|Overall Study||51
614453|NCT00337077|1505037|P1|Toxicity Assessed|Overall Study||42
614454|NCT00337077|1505035|P3|Treated|Overall Study||25
614455|NCT00337077|1505036|P2|Treated|Overall Study||52
614456|NCT00337077|1505037|P1|Treated|Overall Study||42
614457|NCT00337077|1505035|P3|STARTED|Overall Study||25
614458|NCT00337077|1505036|P2|STARTED|Overall Study||53
614459|NCT00337077|1505037|P1|STARTED|Overall Study||43
614460|NCT00336973|1505046|P1|NOT COMPLETED|Overall Study||33
614461|NCT00336973|1505046|P1|COMPLETED|Overall Study||33
614462|NCT00336973|1505046|P1|STARTED|Overall Study||66
614463|NCT00336895|1505052|P1|NOT COMPLETED|Overall Study||4
614464|NCT00336895|1505052|P1|COMPLETED|Overall Study||26
614465|NCT00336895|1505052|P1|STARTED|Overall Study||30
614466|NCT00336856|1505058|P1|NOT COMPLETED|Overall Study||4
614467|NCT00336856|1505058|P1|COMPLETED|Overall Study||31
614468|NCT00336856|1505058|P1|STARTED|Overall Study|Number of patients consented and registered for the study|35
614469|NCT00336817|1505066|P2|NOT COMPLETED|Overall Study||2
614470|NCT00336817|1505067|P1|NOT COMPLETED|Overall Study||1
614471|NCT00336817|1505066|P2|COMPLETED|Overall Study||13
614472|NCT00336817|1505067|P1|COMPLETED|Overall Study||14
614473|NCT00336817|1505066|P2|STARTED|Overall Study||15
614474|NCT00336817|1505067|P1|STARTED|Overall Study||15
614475|NCT00336700|1505097|P1|NOT COMPLETED|Overall Study||0
614476|NCT00336700|1505097|P1|COMPLETED|Overall Study||25
614477|NCT00336700|1505097|P1|STARTED|Overall Study||25
614478|NCT00336583|1505106|P1|NOT COMPLETED|Overall Study||2
614479|NCT00336583|1505106|P1|COMPLETED|Overall Study||25
614480|NCT00336583|1505106|P1|STARTED|Overall Study||27
614481|NCT00336544|1505113|P2|NOT COMPLETED|Overall Study||22
614482|NCT00336544|1505114|P1|NOT COMPLETED|Overall Study||19
614483|NCT00336544|1505113|P2|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|238
614484|NCT00336544|1505114|P1|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|242
614485|NCT00336544|1505113|P2|STARTED|Overall Study|All subjects who were randomized and dosed.|260
614486|NCT00336544|1505114|P1|STARTED|Overall Study|All subjects who were randomized and dosed.|261
614487|NCT00336505|1505128|P2|NOT COMPLETED|Overall Study||27
614488|NCT00336505|1505129|P1|NOT COMPLETED|Overall Study||37
614489|NCT00336505|1505128|P2|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|264
614490|NCT00336505|1505129|P1|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|254
614491|NCT00336505|1505128|P2|STARTED|Overall Study|All subjects who were randomized and dosed.|291
614492|NCT00336505|1505129|P1|STARTED|Overall Study|All subjects who were randomized and dosed.|291
614493|NCT00336492|1505144|P3|NOT COMPLETED|Overall Study||11
614494|NCT00336492|1505145|P2|NOT COMPLETED|Overall Study||4
614495|NCT00336492|1505146|P1|NOT COMPLETED|Overall Study||15
614496|NCT00336492|1505144|P3|COMPLETED|Overall Study||12
614497|NCT00336492|1505145|P2|COMPLETED|Overall Study||18
614498|NCT00336492|1505146|P1|COMPLETED|Overall Study||0
614499|NCT00336492|1505144|P3|STARTED|Overall Study||23
614500|NCT00336492|1505145|P2|STARTED|Overall Study||22
614501|NCT00336492|1505146|P1|STARTED|Overall Study||15
614502|NCT00336479|1505158|P4|NOT COMPLETED|Overall Study||4
614503|NCT00336479|1505159|P3|NOT COMPLETED|Overall Study||26
614504|NCT00336479|1505160|P2|NOT COMPLETED|Overall Study||25
614505|NCT00336479|1505161|P1|NOT COMPLETED|Overall Study||37
614506|NCT00336479|1505158|P4|COMPLETED|Overall Study||13
614507|NCT00336479|1505159|P3|COMPLETED|Overall Study||53
614508|NCT00336479|1505160|P2|COMPLETED|Overall Study||54
614509|NCT00336479|1505161|P1|COMPLETED|Overall Study||38
614510|NCT00336479|1505158|P4|STARTED|Overall Study||17
614511|NCT00336479|1505159|P3|STARTED|Overall Study||79
614512|NCT00336479|1505160|P2|STARTED|Overall Study||79
614513|NCT00336479|1505161|P1|STARTED|Overall Study||75
614514|NCT00336323|1505189|P5|NOT COMPLETED|Overall Study||3
614515|NCT00336323|1505190|P4|NOT COMPLETED|Overall Study||0
614516|NCT00336323|1505191|P3|NOT COMPLETED|Overall Study||1
614517|NCT00336323|1505192|P2|NOT COMPLETED|Overall Study||1
614518|NCT00336323|1505193|P1|NOT COMPLETED|Overall Study||0
614519|NCT00336323|1505189|P5|COMPLETED|Overall Study||19
614520|NCT00336323|1505190|P4|COMPLETED|Overall Study||22
614521|NCT00336323|1505191|P3|COMPLETED|Overall Study||23
614522|NCT00336323|1505192|P2|COMPLETED|Overall Study||21
614523|NCT00336323|1505193|P1|COMPLETED|Overall Study||19
614524|NCT00336323|1505189|P5|24 Week Visit|Overall Study||19
614525|NCT00336323|1505190|P4|24 Week Visit|Overall Study||22
614526|NCT00336323|1505191|P3|24 Week Visit|Overall Study|1 patient was dropped from the study|22
614527|NCT00336323|1505192|P2|24 Week Visit|Overall Study|1 patient was dropped from the study|20
614528|NCT00336323|1505193|P1|24 Week Visit|Overall Study||18
614529|NCT00336323|1505189|P5|18 Week Visit|Overall Study|1 patient was dropped from the study|18
614530|NCT00336323|1505190|P4|18 Week Visit|Overall Study||21
614531|NCT00336323|1505191|P3|18 Week Visit|Overall Study||23
614532|NCT00336323|1505192|P2|18 Week Visit|Overall Study||22
614533|NCT00336323|1505193|P1|18 Week Visit|Overall Study||19
614534|NCT00336323|1505189|P5|12 Week Visit|Overall Study|1 patient was dropped from study|20
614535|NCT00336323|1505190|P4|12 Week Visit|Overall Study||22
614536|NCT00336323|1505191|P3|12 Week Visit|Overall Study||24
614537|NCT00336323|1505192|P2|12 Week Visit|Overall Study||21
614538|NCT00336323|1505193|P1|12 Week Visit|Overall Study||19
614539|NCT00336323|1505189|P5|9 Week Visit|Overall Study||19
614540|NCT00336323|1505190|P4|9 Week Visit|Overall Study||21
614541|NCT00336323|1505191|P3|9 Week Visit|Overall Study||23
614542|NCT00336323|1505192|P2|9 Week Visit|Overall Study||21
614543|NCT00336323|1505193|P1|9 Week Visit|Overall Study||18
614544|NCT00336323|1505189|P5|6 Week Visit|Overall Study|1 patient was dropped - injection was given late at 9 wks for one patient|20
614545|NCT00336323|1505190|P4|6 Week Visit|Overall Study||22
614546|NCT00336323|1505191|P3|6 Week Visit|Overall Study||24
614547|NCT00336323|1505192|P2|6 Week Visit|Overall Study||22
614548|NCT00336323|1505193|P1|6 Week Visit|Overall Study||18
614549|NCT00336323|1505189|P5|3 Week Visit|Overall Study|Laser given late at six weeks for one patient|20
614550|NCT00336323|1505190|P4|3 Week Visit|Overall Study||22
614551|NCT00336323|1505191|P3|3 Week Visit|Overall Study||24
614552|NCT00336323|1505192|P2|3 Week Visit|Overall Study||21
614553|NCT00336323|1505193|P1|3 Week Visit|Overall Study||18
614554|NCT00336323|1505189|P5|STARTED|Overall Study||22
614555|NCT00336323|1505190|P4|STARTED|Overall Study||22
614556|NCT00336323|1505191|P3|STARTED|Overall Study||24
614557|NCT00336323|1505192|P2|STARTED|Overall Study||22
614558|NCT00336323|1505193|P1|STARTED|Overall Study||19
614559|NCT00336284|1505250|P2|NOT COMPLETED|Overall Study||151
614560|NCT00336284|1505251|P1|NOT COMPLETED|Overall Study||236
614561|NCT00336284|1505250|P2|COMPLETED|Overall Study||322
614562|NCT00336284|1505251|P1|COMPLETED|Overall Study||741
614563|NCT00336284|1505250|P2|STARTED|Overall Study||473
614564|NCT00336284|1505251|P1|STARTED|Overall Study||977
614565|NCT00336232|1505263|P1|NOT COMPLETED|High Vitamin K (500mcg Daily)||0
614566|NCT00336232|1505263|P1|COMPLETED|High Vitamin K (500mcg Daily)||42
614567|NCT00336232|1505263|P1|STARTED|High Vitamin K (500mcg Daily)||42
614568|NCT00336232|1505263|P1|NOT COMPLETED|Low Vitamin K (10mcg Daily)||0
614569|NCT00336232|1505263|P1|COMPLETED|Low Vitamin K (10mcg Daily)||42
614570|NCT00336232|1505263|P1|STARTED|Low Vitamin K (10mcg Daily)||42
614571|NCT00336232|1505263|P1|NOT COMPLETED|Baseline (200mcg Daily)||17
614572|NCT00336232|1505263|P1|COMPLETED|Baseline (200mcg Daily)||42
614573|NCT00336232|1505263|P1|STARTED|Baseline (200mcg Daily)||59
614574|NCT00335972|1505269|P2|NOT COMPLETED|Overall Study||3
614575|NCT00335972|1505270|P1|NOT COMPLETED|Overall Study||0
614576|NCT00335972|1505269|P2|COMPLETED|Overall Study||68
614577|NCT00335972|1505270|P1|COMPLETED|Overall Study||71
614578|NCT00335972|1505269|P2|STARTED|Overall Study||71
614579|NCT00335972|1505270|P1|STARTED|Overall Study||71
614580|NCT00335959|1505280|P1|NOT COMPLETED|Overall Study||3
614581|NCT00335959|1505280|P1|COMPLETED|Overall Study||4
614582|NCT00335959|1505280|P1|Eligible and Began Protocol Therapy|Overall Study||6
614583|NCT00335959|1505280|P1|Eligible|Overall Study||6
614584|NCT00335959|1505280|P1|STARTED|Overall Study||7
614585|NCT00335829|1505285|P1|NOT COMPLETED|Overall Study||3
614586|NCT00335829|1505285|P1|COMPLETED|Overall Study||23
614587|NCT00335829|1505285|P1|Received First TACE|Overall Study|1 patient left after receiving bevacizumab but prior to first TACE|25
614588|NCT00335829|1505285|P1|Received Bevacizumab|Overall Study||26
614589|NCT00335829|1505285|P1|STARTED|Overall Study||26
614590|NCT00335777|1505299|P1|NOT COMPLETED|Treated 2 Headaches Per Protocol||13
614591|NCT00335777|1505299|P1|COMPLETED|Treated 2 Headaches Per Protocol||22
614592|NCT00335777|1505299|P1|STARTED|Treated 2 Headaches Per Protocol||35
614593|NCT00335777|1505299|P1|NOT COMPLETED|Enrolled and Dispensed Study Medication||29
614594|NCT00335777|1505299|P1|COMPLETED|Enrolled and Dispensed Study Medication||35
614595|NCT00335777|1505299|P1|STARTED|Enrolled and Dispensed Study Medication|64 subjects enrolled. 35 treated 2 headaches, but 22/35 at appropriate times, as per protocol.|64
614596|NCT00335738|1505306|P2|NOT COMPLETED|Overall Study||4
614597|NCT00335738|1505307|P1|NOT COMPLETED|Overall Study||11
614598|NCT00335738|1505306|P2|COMPLETED|Overall Study||219
614599|NCT00335738|1505307|P1|COMPLETED|Overall Study||97
614600|NCT00335738|1505306|P2|STARTED|Overall Study||223
614601|NCT00335738|1505307|P1|STARTED|Overall Study||108
614602|NCT00335725|1505324|P2|NOT COMPLETED|Overall Study||5
614603|NCT00335725|1505325|P1|NOT COMPLETED|Overall Study||4
614604|NCT00335725|1505324|P2|COMPLETED|Overall Study||71
614605|NCT00335725|1505325|P1|COMPLETED|Overall Study||71
614606|NCT00335725|1505324|P2|STARTED|Overall Study||76
614607|NCT00335725|1505325|P1|STARTED|Overall Study||75
614608|NCT00335556|1505339|P6|NOT COMPLETED|Overall Study||1
614609|NCT00335556|1505340|P5|NOT COMPLETED|Overall Study||1
614610|NCT00335556|1505341|P4|NOT COMPLETED|Overall Study||5
614611|NCT00335556|1505342|P3|NOT COMPLETED|Overall Study||5
614612|NCT00335556|1505343|P2|NOT COMPLETED|Overall Study||34
614613|NCT00335556|1505344|P1|NOT COMPLETED|Overall Study||2
614614|NCT00335556|1505339|P6|COMPLETED|Overall Study||29
614615|NCT00335556|1505340|P5|COMPLETED|Overall Study||77
614616|NCT00335556|1505341|P4|COMPLETED|Overall Study||5
614617|NCT00335556|1505342|P3|COMPLETED|Overall Study||2
614618|NCT00335556|1505343|P2|COMPLETED|Overall Study||64
614619|NCT00335556|1505344|P1|COMPLETED|Overall Study||66
614620|NCT00335556|1505339|P6|STARTED|Overall Study||30
614621|NCT00335556|1505340|P5|STARTED|Overall Study||78
614622|NCT00335556|1505341|P4|STARTED|Overall Study||10
614623|NCT00335556|1505342|P3|STARTED|Overall Study||7
614624|NCT00335556|1505343|P2|STARTED|Overall Study||98
614625|NCT00335556|1505344|P1|STARTED|Overall Study||68
614626|NCT00335517|1505365|P1|NOT COMPLETED|Overall Study||2
614627|NCT00335517|1505365|P1|COMPLETED|Overall Study|Due to pharmacy error two patients were enolled and recieved EREM, but were not included in analysis|98
614628|NCT00335517|1505365|P1|STARTED|Overall Study||100
614629|NCT00335504|1505373|P4|NOT COMPLETED|Overall Study||0
614630|NCT00335504|1505374|P3|NOT COMPLETED|Overall Study||0
614631|NCT00335504|1505375|P2|NOT COMPLETED|Overall Study||0
614632|NCT00335504|1505376|P1|NOT COMPLETED|Overall Study||0
614633|NCT00335504|1505373|P4|COMPLETED|Overall Study||22
614634|NCT00335504|1505374|P3|COMPLETED|Overall Study||20
614635|NCT00335504|1505375|P2|COMPLETED|Overall Study||21
614636|NCT00335504|1505376|P1|COMPLETED|Overall Study||22
614637|NCT00335504|1505373|P4|STARTED|Overall Study||22
614638|NCT00335504|1505374|P3|STARTED|Overall Study||20
614639|NCT00335504|1505375|P2|STARTED|Overall Study||21
614640|NCT00335504|1505376|P1|STARTED|Overall Study||22
614641|NCT00335478|1505398|P1|NOT COMPLETED|Overall Study||24
614642|NCT00335478|1505398|P1|COMPLETED|Overall Study||30
614643|NCT00335478|1505398|P1|STARTED|Overall Study||54
614644|NCT00335452|1505406|P4|NOT COMPLETED|Overall Study||131
614645|NCT00335452|1505407|P3|NOT COMPLETED|Overall Study||159
614646|NCT00335452|1505408|P2|NOT COMPLETED|Overall Study||147
614647|NCT00335452|1505409|P1|NOT COMPLETED|Overall Study||158
614648|NCT00335452|1505406|P4|COMPLETED|Overall Study|Completed 30 days follow-up period|6122
614649|NCT00335452|1505407|P3|COMPLETED|Overall Study|Completed 30 days follow-up period|6108
614650|NCT00335452|1505408|P2|COMPLETED|Overall Study|Completed 30 days follow-up period|6107
614651|NCT00335452|1505409|P1|COMPLETED|Overall Study|Completed 30 days follow-up period|6154
614652|NCT00335452|1505406|P4|TREATED WITH ASA|Overall Study||6247
614653|NCT00335452|1505407|P3|TREATED WITH ASA|Overall Study||6261
614654|NCT00335452|1505408|P2|TREATED WITH ASA|Overall Study||6251
614655|NCT00335452|1505409|P1|TREATED WITH ASA|Overall Study||6302
614656|NCT00335452|1505406|P4|TREATED WITH CLOPIDOGREL|Overall Study||6217
614657|NCT00335452|1505407|P3|TREATED WITH CLOPIDOGREL|Overall Study||6228
614658|NCT00335452|1505408|P2|TREATED WITH CLOPIDOGREL|Overall Study||6218
614659|NCT00335452|1505409|P1|TREATED WITH CLOPIDOGREL|Overall Study||6271
614660|NCT00335452|1505406|P4|STARTED|Overall Study|Randomized|6253
614661|NCT00335452|1505407|P3|STARTED|Overall Study|Randomized|6267
614662|NCT00335452|1505408|P2|STARTED|Overall Study|Randomized|6254
614663|NCT00335452|1505409|P1|STARTED|Overall Study|Randomized|6312
614664|NCT00335322|1505434|P3|NOT COMPLETED|Overall Study||2
614665|NCT00335322|1505435|P2|NOT COMPLETED|Overall Study||2
614666|NCT00335322|1505436|P1|NOT COMPLETED|Overall Study||1
614667|NCT00335322|1505434|P3|COMPLETED|Overall Study||103
614668|NCT00335322|1505435|P2|COMPLETED|Overall Study||105
614669|NCT00335322|1505436|P1|COMPLETED|Overall Study||114
614670|NCT00335322|1505434|P3|STARTED|Overall Study||105
614671|NCT00335322|1505435|P2|STARTED|Overall Study||107
614672|NCT00335322|1505436|P1|STARTED|Overall Study||115
614673|NCT00335283|1505446|P2|NOT COMPLETED|Overall Study||5
614674|NCT00335283|1505447|P1|NOT COMPLETED|Overall Study||6
614675|NCT00335283|1505446|P2|COMPLETED|Overall Study||34
614676|NCT00335283|1505447|P1|COMPLETED|Overall Study||30
614677|NCT00335283|1505446|P2|STARTED|Overall Study||39
614678|NCT00335283|1505447|P1|STARTED|Overall Study||36
614679|NCT00335257|1505462|P3|NOT COMPLETED|Overall Study||0
614680|NCT00335257|1505463|P2|NOT COMPLETED|Overall Study||0
614681|NCT00335257|1505464|P1|NOT COMPLETED|Overall Study||0
614682|NCT00335257|1505462|P3|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 6.0 years.|60190
614683|NCT00335257|1505463|P2|COMPLETED|Overall Study||9377
614684|NCT00335257|1505464|P1|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 6.0 years.|15542
614685|NCT00335257|1505462|P3|STARTED|Overall Study||60190
614686|NCT00335257|1505463|P2|STARTED|Overall Study||9377
614687|NCT00335257|1505464|P1|STARTED|Overall Study||15542
614688|NCT00335153|1505481|P1|NOT COMPLETED|Post-PEG-J Long-Term Treatment Period||52
614689|NCT00335153|1505481|P1|COMPLETED|Post-PEG-J Long-Term Treatment Period||272
614690|NCT00335153|1505481|P1|STARTED|Post-PEG-J Long-Term Treatment Period||324
614691|NCT00335153|1505481|P1|NOT COMPLETED|Nasojejunal (NJ) Test Period||30
614692|NCT00335153|1505481|P1|COMPLETED|Nasojejunal (NJ) Test Period||324
614693|NCT00335153|1505481|P1|STARTED|Nasojejunal (NJ) Test Period||354
614694|NCT00335140|1505518|P1|NOT COMPLETED|Overall Study||1
614695|NCT00335140|1505518|P1|COMPLETED|Overall Study||25
614696|NCT00335140|1505518|P1|Treated|Overall Study||25
614697|NCT00335140|1505518|P1|Eligible|Overall Study||25
614698|NCT00335140|1505518|P1|STARTED|Overall Study||26
614699|NCT00334958|1505524|P2|NOT COMPLETED|Overall Study||24
614700|NCT00334958|1505525|P1|NOT COMPLETED|Overall Study||37
614701|NCT00334958|1505524|P2|COMPLETED|Overall Study||156
614702|NCT00334958|1505525|P1|COMPLETED|Overall Study||139
614703|NCT00334958|1505524|P2|STARTED|Overall Study|1 subject withdrawn prior to study drug dosing due to not obtaining labs|180
614704|NCT00334958|1505525|P1|STARTED|Overall Study||176
614705|NCT00334893|1505539|P2|NOT COMPLETED|Overall Study||0
614706|NCT00334893|1505540|P1|NOT COMPLETED|Overall Study||1
614707|NCT00334893|1505539|P2|COMPLETED|Overall Study||37
614708|NCT00334893|1505540|P1|COMPLETED|Overall Study||36
614709|NCT00334893|1505539|P2|STARTED|Overall Study||37
614710|NCT00334893|1505540|P1|STARTED|Overall Study||37
614711|NCT00334815|1505550|P2|NOT COMPLETED|Overall Study||10
614712|NCT00334815|1505551|P1|NOT COMPLETED|Overall Study||7
614713|NCT00334815|1505550|P2|COMPLETED|Overall Study||3
614714|NCT00334815|1505551|P1|COMPLETED|Overall Study||9
614715|NCT00334815|1505550|P2|STARTED|Overall Study||13
614716|NCT00334815|1505551|P1|STARTED|Overall Study||16
614717|NCT00334802|1505565|P2|NOT COMPLETED|Overall Study||40
614718|NCT00334802|1505566|P1|NOT COMPLETED|Overall Study||6
614719|NCT00334802|1505565|P2|COMPLETED|Overall Study||16
614720|NCT00334802|1505566|P1|COMPLETED|Overall Study||0
614721|NCT00334802|1505565|P2|STARTED|Overall Study||56
614722|NCT00334802|1505566|P1|STARTED|Overall Study||6
614723|NCT00334633|1505586|P3|NOT COMPLETED|Overall Study||82
614724|NCT00334633|1505587|P2|NOT COMPLETED|Overall Study||82
614725|NCT00334633|1505588|P1|NOT COMPLETED|Overall Study||80
614726|NCT00334633|1505586|P3|COMPLETED|Overall Study||114
614727|NCT00334633|1505587|P2|COMPLETED|Overall Study||118
614728|NCT00334633|1505588|P1|COMPLETED|Overall Study||117
614729|NCT00334633|1505586|P3|STARTED|Overall Study||196
614730|NCT00334633|1505587|P2|STARTED|Overall Study||200
614731|NCT00334633|1505588|P1|STARTED|Overall Study||197
614732|NCT00334542|1505599|P1|NOT COMPLETED|Overall Study||5
614733|NCT00334542|1505599|P1|COMPLETED|Overall Study||45
614734|NCT00334542|1505599|P1|STARTED|Overall Study||50
614735|NCT00334295|1505604|P1|NOT COMPLETED|Overall Study||5
614736|NCT00334295|1505604|P1|COMPLETED|Overall Study||30
614737|NCT00334295|1505604|P1|STARTED|Overall Study||35
614738|NCT00334282|1505614|P2|NOT COMPLETED|Overall Study||108
614739|NCT00334282|1505615|P1|NOT COMPLETED|Overall Study||222
614740|NCT00334282|1505614|P2|COMPLETED|Overall Study||37
614741|NCT00334282|1505615|P1|COMPLETED|Overall Study||68
614742|NCT00334282|1505614|P2|STARTED|Overall Study||145
614743|NCT00334282|1505615|P1|STARTED|Overall Study||290
614744|NCT00334204|1505638|P1|NOT COMPLETED|Overall Study||2
614745|NCT00334204|1505638|P1|COMPLETED|Overall Study||56
614746|NCT00334204|1505638|P1|STARTED|Overall Study||58
614747|NCT00334113|1505646|P2|NOT COMPLETED|Overall Study||3
614748|NCT00334113|1505647|P1|NOT COMPLETED|Overall Study||2
614749|NCT00334113|1505646|P2|COMPLETED|Overall Study||31
614750|NCT00334113|1505647|P1|COMPLETED|Overall Study||30
614751|NCT00334113|1505646|P2|STARTED|Overall Study||34
614752|NCT00334113|1505647|P1|STARTED|Overall Study||32
614753|NCT00334074|1505653|P1|NOT COMPLETED|Overall Study||0
614754|NCT00334074|1505653|P1|COMPLETED|Overall Study||30
614755|NCT00334074|1505653|P1|STARTED|Overall Study||30
614756|NCT00334061|1505658|P1|NOT COMPLETED|Overall Study||0
614757|NCT00334061|1505658|P1|COMPLETED|Overall Study|November 2007|125
614758|NCT00334061|1505658|P1|STARTED|Overall Study|June 2006|125
614759|NCT00333983|1505670|P3|NOT COMPLETED|Overall Study||2
614760|NCT00333983|1505671|P2|NOT COMPLETED|Overall Study||5
614761|NCT00333983|1505672|P1|NOT COMPLETED|Overall Study||3
614762|NCT00333983|1505670|P3|COMPLETED|Overall Study||19
614763|NCT00333983|1505671|P2|COMPLETED|Overall Study||16
614764|NCT00333983|1505672|P1|COMPLETED|Overall Study||17
614765|NCT00333983|1505670|P3|STARTED|Overall Study||21
614766|NCT00333983|1505671|P2|STARTED|Overall Study||21
614767|NCT00333983|1505672|P1|STARTED|Overall Study||20
614768|NCT00333970|1505682|P2|NOT COMPLETED|Overall Study||7
614769|NCT00333970|1505683|P1|NOT COMPLETED|Overall Study||13
614770|NCT00333970|1505682|P2|COMPLETED|Overall Study||18
614771|NCT00333970|1505683|P1|COMPLETED|Overall Study||37
614772|NCT00333970|1505682|P2|STARTED|Overall Study||25
614773|NCT00333970|1505683|P1|STARTED|Overall Study||50
614774|NCT00333879|1505689|P1|NOT COMPLETED|Overall Study||0
614775|NCT00333879|1505689|P1|COMPLETED|Overall Study||4
614776|NCT00333879|1505689|P1|STARTED|Overall Study||4
614777|NCT00333866|1505698|P4|NOT COMPLETED|Overall Study||66
614778|NCT00333866|1505699|P3|NOT COMPLETED|Overall Study||51
614779|NCT00333866|1505700|P2|NOT COMPLETED|Overall Study||64
614780|NCT00333866|1505701|P1|NOT COMPLETED|Overall Study||48
614781|NCT00333866|1505698|P4|COMPLETED|Overall Study||121
614782|NCT00333866|1505699|P3|COMPLETED|Overall Study||133
614783|NCT00333866|1505700|P2|COMPLETED|Overall Study||123
614784|NCT00333866|1505701|P1|COMPLETED|Overall Study||141
614785|NCT00333866|1505698|P4|TREATED|Overall Study||186
614786|NCT00333866|1505699|P3|TREATED|Overall Study||182
614787|NCT00333866|1505700|P2|TREATED|Overall Study||184
614788|NCT00333866|1505701|P1|TREATED|Overall Study||184
614789|NCT00333866|1505698|P4|STARTED|Overall Study||187
614790|NCT00333866|1505699|P3|STARTED|Overall Study||184
614791|NCT00333866|1505700|P2|STARTED|Overall Study||187
614792|NCT00333866|1505701|P1|STARTED|Overall Study||189
614793|NCT00333840|1505761|P4|NOT COMPLETED|Second-line Treatment Period||188
614794|NCT00333840|1505762|P3|NOT COMPLETED|Second-line Treatment Period||14
614795|NCT00333840|1505763|P2|NOT COMPLETED|Second-line Treatment Period||0
614796|NCT00333840|1505764|P1|NOT COMPLETED|Second-line Treatment Period||0
614797|NCT00333840|1505761|P4|COMPLETED|Second-line Treatment Period||175
614798|NCT00333840|1505762|P3|COMPLETED|Second-line Treatment Period||0
614799|NCT00333840|1505763|P2|COMPLETED|Second-line Treatment Period||0
614800|NCT00333840|1505764|P1|COMPLETED|Second-line Treatment Period||0
614801|NCT00333840|1505761|P4|STARTED|Second-line Treatment Period||363
614802|NCT00333840|1505762|P3|STARTED|Second-line Treatment Period||14
614803|NCT00333840|1505763|P2|STARTED|Second-line Treatment Period||0
614804|NCT00333840|1505764|P1|STARTED|Second-line Treatment Period||0
614805|NCT00333840|1505761|P4|NOT COMPLETED|First-line Treatment Period||0
614806|NCT00333840|1505762|P3|NOT COMPLETED|First-line Treatment Period||0
614807|NCT00333840|1505763|P2|NOT COMPLETED|First-line Treatment Period||546
614808|NCT00333840|1505764|P1|NOT COMPLETED|First-line Treatment Period||286
614809|NCT00333840|1505761|P4|COMPLETED|First-line Treatment Period||0
614810|NCT00333840|1505762|P3|COMPLETED|First-line Treatment Period||0
614811|NCT00333840|1505763|P2|COMPLETED|First-line Treatment Period||7
614812|NCT00333840|1505764|P1|COMPLETED|First-line Treatment Period||267
614813|NCT00333840|1505761|P4|Safety Population; Received Study Drug|First-line Treatment Period||0
614814|NCT00333840|1505762|P3|Safety Population; Received Study Drug|First-line Treatment Period||0
614815|NCT00333840|1505763|P2|Safety Population; Received Study Drug|First-line Treatment Period||533
614816|NCT00333840|1505764|P1|Safety Population; Received Study Drug|First-line Treatment Period||551
614817|NCT00333840|1505761|P4|STARTED|First-line Treatment Period||0
614818|NCT00333840|1505762|P3|STARTED|First-line Treatment Period||0
614819|NCT00333840|1505763|P2|STARTED|First-line Treatment Period||553
614820|NCT00333840|1505764|P1|STARTED|First-line Treatment Period||553
614821|NCT00333814|1505792|P3|NOT COMPLETED|Overall Study||5
614822|NCT00333814|1505793|P2|NOT COMPLETED|Overall Study||4
614823|NCT00333814|1505794|P1|NOT COMPLETED|Overall Study||3
614824|NCT00333814|1505792|P3|COMPLETED|Overall Study||71
614825|NCT00333814|1505793|P2|COMPLETED|Overall Study||73
614826|NCT00333814|1505794|P1|COMPLETED|Overall Study||73
614827|NCT00333814|1505792|P3|STARTED|Overall Study||76
614828|NCT00333814|1505793|P2|STARTED|Overall Study||77
614829|NCT00333814|1505794|P1|STARTED|Overall Study||76
614830|NCT00333801|1505810|P2|NOT COMPLETED|Overall Study||6
614831|NCT00333801|1505811|P1|NOT COMPLETED|Overall Study||8
614832|NCT00333801|1505810|P2|COMPLETED|Overall Study||36
614833|NCT00333801|1505811|P1|COMPLETED|Overall Study||35
614834|NCT00333801|1505810|P2|STARTED|Overall Study||42
614835|NCT00333801|1505811|P1|STARTED|Overall Study||43
614836|NCT00333788|1505829|P1|NOT COMPLETED|Overall Study||162
614837|NCT00333788|1505829|P1|COMPLETED|Overall Study||71
614838|NCT00333788|1505829|P1|STARTED|Overall Study|Participant flow based on All Subjects population; Baseline characteristics based on ITT population.|233
614839|NCT00333775|1505859|P3|NOT COMPLETED|Overall Study||247
614840|NCT00333775|1505860|P2|NOT COMPLETED|Overall Study||248
614841|NCT00333775|1505861|P1|NOT COMPLETED|Overall Study||241
614842|NCT00333775|1505859|P3|COMPLETED|Overall Study||0
614843|NCT00333775|1505860|P2|COMPLETED|Overall Study||0
614844|NCT00333775|1505861|P1|COMPLETED|Overall Study||0
614845|NCT00333775|1505859|P3|Received Treatment|Overall Study||245
614846|NCT00333775|1505860|P2|Received Treatment|Overall Study||247
614847|NCT00333775|1505861|P1|Received Treatment|Overall Study||238
614848|NCT00333775|1505859|P3|STARTED|Overall Study||247
614849|NCT00333775|1505860|P2|STARTED|Overall Study||248
614850|NCT00333775|1505861|P1|STARTED|Overall Study||241
614851|NCT00333762|1505881|P1|NOT COMPLETED|Overall Study||4
614852|NCT00333762|1505881|P1|COMPLETED|Overall Study||0
614853|NCT00333762|1505881|P1|STARTED|Overall Study||4
614854|NCT00333710|1505888|P3|NOT COMPLETED|Overall Study||1
614855|NCT00333710|1505889|P2|NOT COMPLETED|Overall Study||4
614856|NCT00333710|1505890|P1|NOT COMPLETED|Overall Study||11
614857|NCT00333710|1505888|P3|COMPLETED|Overall Study||15
614858|NCT00333710|1505889|P2|COMPLETED|Overall Study||14
614859|NCT00333710|1505890|P1|COMPLETED|Overall Study||8
614860|NCT00333710|1505888|P3|STARTED|Overall Study||16
614861|NCT00333710|1505889|P2|STARTED|Overall Study||18
614862|NCT00333710|1505890|P1|STARTED|Overall Study||19
614863|NCT00333619|1505900|P2|NOT COMPLETED|Overall Study||10
614864|NCT00333619|1505901|P1|NOT COMPLETED|Overall Study||21
614865|NCT00333619|1505900|P2|COMPLETED|Overall Study||99
614866|NCT00333619|1505901|P1|COMPLETED|Overall Study||89
614867|NCT00333619|1505900|P2|3-month Follow-up|Overall Study||105
614868|NCT00333619|1505901|P1|3-month Follow-up|Overall Study||101
614869|NCT00333619|1505900|P2|Post-treatment|Overall Study||109
614870|NCT00333619|1505901|P1|Post-treatment|Overall Study||109
614871|NCT00333619|1505900|P2|STARTED|Overall Study||109
614872|NCT00333619|1505901|P1|STARTED|Overall Study||110
614873|NCT00333437|1505909|P1|NOT COMPLETED|Overall Study||0
614874|NCT00333437|1505909|P1|COMPLETED|Overall Study||7
614875|NCT00333437|1505909|P1|STARTED|Overall Study||7
614876|NCT00333359|1505919|P2|NOT COMPLETED|Overall Study||122
614877|NCT00333359|1505920|P1|NOT COMPLETED|Overall Study||73
614878|NCT00333359|1505919|P2|COMPLETED|Overall Study||260
614879|NCT00333359|1505920|P1|COMPLETED|Overall Study||126
614880|NCT00333359|1505919|P2|STARTED|Overall Study||382
614881|NCT00333359|1505920|P1|STARTED|Overall Study||199
614882|NCT00333229|1505963|P2|NOT COMPLETED|Overall Study||1
614883|NCT00333229|1505964|P1|NOT COMPLETED|Overall Study||0
614884|NCT00333229|1505963|P2|COMPLETED|Overall Study||4
614885|NCT00333229|1505964|P1|COMPLETED|Overall Study||6
614886|NCT00333229|1505963|P2|STARTED|Overall Study||5
614887|NCT00333229|1505964|P1|STARTED|Overall Study||6
614888|NCT00333138|1505981|P3|NOT COMPLETED|Extension Study (Month6 to End of Study)||43
614889|NCT00333138|1505982|P2|NOT COMPLETED|Extension Study (Month6 to End of Study)||42
614890|NCT00333138|1505983|P1|NOT COMPLETED|Extension Study (Month6 to End of Study)||43
614891|NCT00333138|1505981|P3|COMPLETED|Extension Study (Month6 to End of Study)||37
614892|NCT00333138|1505982|P2|COMPLETED|Extension Study (Month6 to End of Study)||45
614893|NCT00333138|1505983|P1|COMPLETED|Extension Study (Month6 to End of Study)||40
614894|NCT00333138|1505981|P3|STARTED|Extension Study (Month6 to End of Study)||80
614895|NCT00333138|1505982|P2|STARTED|Extension Study (Month6 to End of Study)||87
614896|NCT00333138|1505983|P1|STARTED|Extension Study (Month6 to End of Study)||83
614897|NCT00333138|1505981|P3|NOT COMPLETED|Core Study (6 Months)||12
614898|NCT00333138|1505982|P2|NOT COMPLETED|Core Study (6 Months)||6
614899|NCT00333138|1505983|P1|NOT COMPLETED|Core Study (6 Months)||7
614900|NCT00333138|1505981|P3|COMPLETED|Core Study (6 Months)||82
614901|NCT00333138|1505982|P2|COMPLETED|Core Study (6 Months)||88
614902|NCT00333138|1505983|P1|COMPLETED|Core Study (6 Months)||86
614903|NCT00333138|1505981|P3|STARTED|Core Study (6 Months)||94
614904|NCT00333138|1505982|P2|STARTED|Core Study (6 Months)||94
614905|NCT00333138|1505983|P1|STARTED|Core Study (6 Months)||93
614906|NCT00332839|1506022|P2|NOT COMPLETED|Follow-up (Months 12 - 60)||3
614907|NCT00332839|1506023|P1|NOT COMPLETED|Follow-up (Months 12 - 60)||4
614908|NCT00332839|1506022|P2|COMPLETED|Follow-up (Months 12 - 60)||31
614909|NCT00332839|1506023|P1|COMPLETED|Follow-up (Months 12 - 60)||29
614910|NCT00332839|1506022|P2|STARTED|Follow-up (Months 12 - 60)|Follow-up included core participants (completed or discontinued) who wished to be followed.|34
614911|NCT00332839|1506023|P1|STARTED|Follow-up (Months 12 - 60)|Follow-up included core participants (completed or discontinued) who wished to be followed.|33
614912|NCT00332839|1506022|P2|NOT COMPLETED|Core (Months 0 - 12)||18
614913|NCT00332839|1506023|P1|NOT COMPLETED|Core (Months 0 - 12)||10
614914|NCT00332839|1506022|P2|COMPLETED|Core (Months 0 - 12)||28
614915|NCT00332839|1506023|P1|COMPLETED|Core (Months 0 - 12)||37
614916|NCT00332839|1506022|P2|Safety Set|Core (Months 0 - 12)||46
614917|NCT00332839|1506023|P1|Safety Set|Core (Months 0 - 12)||47
614918|NCT00332839|1506022|P2|STARTED|Core (Months 0 - 12)||46
614919|NCT00332839|1506023|P1|STARTED|Core (Months 0 - 12)||47
614920|NCT00332722|1506043|P2|NOT COMPLETED|Overall Study||0
614921|NCT00332722|1506044|P1|NOT COMPLETED|Overall Study||0
614922|NCT00332722|1506043|P2|COMPLETED|Overall Study||60
614923|NCT00332722|1506044|P1|COMPLETED|Overall Study||60
614924|NCT00332722|1506043|P2|STARTED|Overall Study||60
614925|NCT00332722|1506044|P1|STARTED|Overall Study||60
614926|NCT00332709|1506054|P2|NOT COMPLETED|Overall Study||20
614927|NCT00332709|1506055|P1|NOT COMPLETED|Overall Study||16
614928|NCT00332709|1506054|P2|COMPLETED|Overall Study||21
614929|NCT00332709|1506055|P1|COMPLETED|Overall Study||24
614930|NCT00332709|1506054|P2|STARTED|Overall Study||41
614931|NCT00332709|1506055|P1|STARTED|Overall Study||40
614932|NCT00332696|1506079|P2|NOT COMPLETED|Overall Study||30
614933|NCT00332696|1506080|P1|NOT COMPLETED|Overall Study||30
614934|NCT00332696|1506079|P2|COMPLETED|Overall Study||2
614935|NCT00332696|1506080|P1|COMPLETED|Overall Study|Completed Month 3 Visit|2
614936|NCT00332696|1506079|P2|Completed Day 14 Visit|Overall Study||15
614937|NCT00332696|1506080|P1|Completed Day 14 Visit|Overall Study|Primary Endpoint|21
614938|NCT00332696|1506079|P2|STARTED|Overall Study||32
614939|NCT00332696|1506080|P1|STARTED|Overall Study||32
614940|NCT00332644|1506112|P6|NOT COMPLETED|Overall Study||15
614941|NCT00332644|1506113|P5|NOT COMPLETED|Overall Study||12
614942|NCT00332644|1506114|P4|NOT COMPLETED|Overall Study||20
614943|NCT00332644|1506115|P3|NOT COMPLETED|Overall Study||9
614944|NCT00332644|1506116|P2|NOT COMPLETED|Overall Study||22
614945|NCT00332644|1506117|P1|NOT COMPLETED|Overall Study||12
614946|NCT00332644|1506112|P6|COMPLETED|Overall Study||174
614947|NCT00332644|1506113|P5|COMPLETED|Overall Study||250
614948|NCT00332644|1506114|P4|COMPLETED|Overall Study||244
614949|NCT00332644|1506115|P3|COMPLETED|Overall Study||258
614950|NCT00332644|1506116|P2|COMPLETED|Overall Study||238
614951|NCT00332644|1506117|P1|COMPLETED|Overall Study||250
614952|NCT00332644|1506112|P6|STARTED|Overall Study||189
614953|NCT00332644|1506113|P5|STARTED|Overall Study||262
614954|NCT00332644|1506114|P4|STARTED|Overall Study||264
614955|NCT00332644|1506115|P3|STARTED|Overall Study||267
614956|NCT00332644|1506116|P2|STARTED|Overall Study||260
614957|NCT00332644|1506117|P1|STARTED|Overall Study||262
614958|NCT00332605|1506134|P3|NOT COMPLETED|Overall Study||8
614959|NCT00332605|1506135|P2|NOT COMPLETED|Overall Study||2
614960|NCT00332605|1506136|P1|NOT COMPLETED|Overall Study||2
614961|NCT00332605|1506134|P3|COMPLETED|Overall Study||9
614962|NCT00332605|1506135|P2|COMPLETED|Overall Study||12
614963|NCT00332605|1506136|P1|COMPLETED|Overall Study||12
614964|NCT00332605|1506134|P3|STARTED|Overall Study||17
614965|NCT00332605|1506135|P2|STARTED|Overall Study||14
614966|NCT00332605|1506136|P1|STARTED|Overall Study||14
614967|NCT00332579|1506146|P2|NOT COMPLETED|Overall Study||1
614968|NCT00332579|1506147|P1|NOT COMPLETED|Overall Study||1
614969|NCT00332579|1506146|P2|COMPLETED|Overall Study||12
614970|NCT00332579|1506147|P1|COMPLETED|Overall Study||11
614971|NCT00332579|1506146|P2|STARTED|Overall Study||13
614972|NCT00332579|1506147|P1|STARTED|Overall Study||12
614973|NCT00332488|1506156|P3|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||21
614974|NCT00332488|1506157|P2|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||2
614975|NCT00332488|1506158|P1|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||2
614976|NCT00332488|1506156|P3|COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||233
614977|NCT00332488|1506157|P2|COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||70
614978|NCT00332488|1506158|P1|COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||27
614979|NCT00332488|1506156|P3|STARTED|Transfer Treatment Phase (Weeks 12 – 24)|Subjects in this arm who met HbA1c criteria + subjects from other arms who did not|254
614980|NCT00332488|1506157|P2|STARTED|Transfer Treatment Phase (Weeks 12 – 24)|Subjects on treatment who achieved an HbA1c < 7.5% or had an HbA1c decrease from baseline >= 1.0%|72
614981|NCT00332488|1506158|P1|STARTED|Transfer Treatment Phase (Weeks 12 – 24)|Subjects on TI who achieved an HbA1c < 7.5% or had an HbA1c decrease from baseline >= 1.0%|29
614982|NCT00332488|1506156|P3|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||56
614983|NCT00332488|1506157|P2|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||18
614984|NCT00332488|1506158|P1|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||50
614985|NCT00332488|1506156|P3|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||119
614986|NCT00332488|1506157|P2|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||152
614987|NCT00332488|1506158|P1|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||133
614988|NCT00332488|1506156|P3|STARTED|Initial Treatment Phase (Weeks 0 - 12)||175
614989|NCT00332488|1506157|P2|STARTED|Initial Treatment Phase (Weeks 0 - 12)||170
614990|NCT00332488|1506158|P1|STARTED|Initial Treatment Phase (Weeks 0 - 12)||183
614991|NCT00332462|1506170|P1|NOT COMPLETED|Overall Study||16
614992|NCT00332462|1506170|P1|COMPLETED|Overall Study||18
614993|NCT00332462|1506170|P1|Patients Treated With Sandimmun® Optoral|Overall Study||29
614994|NCT00332462|1506170|P1|Patients Treated With Sandimmun® i.v.|Overall Study||34
614995|NCT00332462|1506170|P1|STARTED|Overall Study|Safety and Intention to treat population.|34
614996|NCT00332332|1506177|P1|NOT COMPLETED|Overall Study||68
614997|NCT00332332|1506177|P1|COMPLETED|Overall Study||178
614998|NCT00332332|1506177|P1|Received Study Medication|Overall Study||230
614999|NCT00332332|1506177|P1|STARTED|Overall Study||246
615000|NCT00332241|1506186|P2|NOT COMPLETED|Overall Study||8
615001|NCT00332241|1506187|P1|NOT COMPLETED|Overall Study||15
615002|NCT00332241|1506186|P2|COMPLETED|Overall Study||39
615003|NCT00332241|1506187|P1|COMPLETED|Overall Study||36
615004|NCT00332241|1506186|P2|STARTED|Overall Study||47
615005|NCT00332241|1506187|P1|STARTED|Overall Study||51
615006|NCT00332189|1506207|P1|NOT COMPLETED|Overall Study||21
615007|NCT00332189|1506207|P1|COMPLETED|Overall Study|Subjects in this extension study continued until there was market approval in their region.|90
615008|NCT00332189|1506207|P1|STARTED|Overall Study||111
615009|NCT00332163|1506214|P2|NOT COMPLETED|Overall Study||0
615010|NCT00332163|1506215|P1|NOT COMPLETED|Overall Study||0
615011|NCT00332163|1506214|P2|COMPLETED|Overall Study||47
615012|NCT00332163|1506215|P1|COMPLETED|Overall Study||48
615013|NCT00332163|1506214|P2|Received Treatment|Overall Study||47
615014|NCT00332163|1506215|P1|Received Treatment|Overall Study||48
615015|NCT00332163|1506214|P2|STARTED|Overall Study||47
615016|NCT00332163|1506215|P1|STARTED|Overall Study||48
615017|NCT00331864|1506249|P2|NOT COMPLETED|Overall Study||4
615018|NCT00331864|1506250|P1|NOT COMPLETED|Overall Study||58
615019|NCT00331864|1506249|P2|COMPLETED|Overall Study||14
615020|NCT00331864|1506250|P1|COMPLETED|Overall Study||455
615021|NCT00331864|1506249|P2|STARTED|Overall Study||18
615022|NCT00331864|1506250|P1|STARTED|Overall Study||513
615023|NCT00331799|1506269|P1|NOT COMPLETED|Overall Study||3
615024|NCT00331799|1506269|P1|COMPLETED|Overall Study||15
615025|NCT00331799|1506269|P1|STARTED|Overall Study||18
615026|NCT00331773|1506275|P2|NOT COMPLETED|Overall Study||7
615027|NCT00331773|1506276|P1|NOT COMPLETED|Overall Study||16
615028|NCT00331773|1506275|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|550
615029|NCT00331773|1506276|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|542
615030|NCT00331773|1506275|P2|STARTED|Overall Study||557
615031|NCT00331773|1506276|P1|STARTED|Overall Study||558
615032|NCT00331760|1506304|P2|NOT COMPLETED|Overall Study||8
615033|NCT00331760|1506305|P1|NOT COMPLETED|Overall Study||15
615034|NCT00331760|1506304|P2|COMPLETED|Overall Study||40
615035|NCT00331760|1506305|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|43
615036|NCT00331760|1506304|P2|STARTED|Overall Study||48
615037|NCT00331760|1506305|P1|STARTED|Overall Study||58
615038|NCT00331682|1506311|P1|NOT COMPLETED|Overall Study||1
615039|NCT00331682|1506311|P1|COMPLETED|Overall Study||9
615040|NCT00331682|1506311|P1|STARTED|Overall Study||10
615041|NCT00331552|1506319|P2|NOT COMPLETED|Period 3: Phase II||0
615042|NCT00331552|1506320|P1|NOT COMPLETED|Period 3: Phase II||2
615043|NCT00331552|1506319|P2|COMPLETED|Period 3: Phase II||0
615044|NCT00331552|1506320|P1|COMPLETED|Period 3: Phase II||22
615045|NCT00331552|1506319|P2|STARTED|Period 3: Phase II||0
615046|NCT00331552|1506320|P1|STARTED|Period 3: Phase II||24
615047|NCT00331552|1506319|P2|NOT COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
615048|NCT00331552|1506320|P1|NOT COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
615049|NCT00331552|1506319|P2|COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||3
615050|NCT00331552|1506320|P1|COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
615051|NCT00331552|1506319|P2|STARTED|Period 2: Doxil 35 mg/m^2 (Phase I)||3
615052|NCT00331552|1506320|P1|STARTED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
615053|NCT00331552|1506319|P2|NOT COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
615054|NCT00331552|1506320|P1|NOT COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
615055|NCT00331552|1506319|P2|COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
615056|NCT00331552|1506320|P1|COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||3
615057|NCT00331552|1506319|P2|STARTED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
615058|NCT00331552|1506320|P1|STARTED|Period 1: Doxil 30 mg/m^2 (Phase I)||3
615059|NCT00331422|1506334|P1|NOT COMPLETED|Overall Study||5
615060|NCT00331422|1506334|P1|COMPLETED|Overall Study|Completed all 6 courses of chemotherapy and had surgery to remove all tumor lesions.|2
615061|NCT00331422|1506334|P1|STARTED|Overall Study|Patients who met study criteria and received at least one dose of study drug.|7
615062|NCT00331409|1506343|P1|NOT COMPLETED|Overall Study||4
615154|NCT00330876|1506434|P1|COMPLETED|Overall Study||378
615155|NCT00330876|1506433|P2|STARTED|Overall Study||90
615063|NCT00331409|1506343|P1|COMPLETED|Overall Study|15 patients accrued to the first stage;if>9 were progression-free at 3 months,enrollment continued.|15
615064|NCT00331409|1506343|P1|STARTED|Overall Study|19 patients were enrolled in the first stage due to 4 patients who withdrew early.|19
615065|NCT00331344|1506351|P9|NOT COMPLETED|Phase II||4
615066|NCT00331344|1506352|P8|NOT COMPLETED|Phase II||0
615067|NCT00331344|1506353|P7|NOT COMPLETED|Phase II||0
615068|NCT00331344|1506354|P6|NOT COMPLETED|Phase II||0
615069|NCT00331344|1506355|P5|NOT COMPLETED|Phase II||0
615070|NCT00331344|1506356|P4|NOT COMPLETED|Phase II||0
615071|NCT00331344|1506357|P3|NOT COMPLETED|Phase II||0
615072|NCT00331344|1506358|P2|NOT COMPLETED|Phase II||0
615073|NCT00331344|1506359|P1|NOT COMPLETED|Phase II||0
615074|NCT00331344|1506351|P9|COMPLETED|Phase II||48
615075|NCT00331344|1506352|P8|COMPLETED|Phase II||6
615076|NCT00331344|1506353|P7|COMPLETED|Phase II||0
615077|NCT00331344|1506354|P6|COMPLETED|Phase II||0
615078|NCT00331344|1506355|P5|COMPLETED|Phase II||0
615079|NCT00331344|1506356|P4|COMPLETED|Phase II||0
615080|NCT00331344|1506357|P3|COMPLETED|Phase II||0
615081|NCT00331344|1506358|P2|COMPLETED|Phase II||0
615082|NCT00331344|1506359|P1|COMPLETED|Phase II||0
615083|NCT00331344|1506351|P9|STARTED|Phase II|Protocol enrollment (63) minus 11 ineligible prior to receiving treatment.|52
615084|NCT00331344|1506352|P8|STARTED|Phase II|6 patients in Phase I Group VIa continued to the Phase II period.|6
615085|NCT00331344|1506353|P7|STARTED|Phase II||0
615086|NCT00331344|1506354|P6|STARTED|Phase II||0
615087|NCT00331344|1506355|P5|STARTED|Phase II||0
615088|NCT00331344|1506356|P4|STARTED|Phase II||0
615089|NCT00331344|1506357|P3|STARTED|Phase II||0
615090|NCT00331344|1506358|P2|STARTED|Phase II||0
615091|NCT00331344|1506359|P1|STARTED|Phase II||0
615092|NCT00331344|1506351|P9|NOT COMPLETED|Phase I||0
615093|NCT00331344|1506352|P8|NOT COMPLETED|Phase I||1
615094|NCT00331344|1506353|P7|NOT COMPLETED|Phase I||0
615095|NCT00331344|1506354|P6|NOT COMPLETED|Phase I||2
615096|NCT00331344|1506355|P5|NOT COMPLETED|Phase I||2
615097|NCT00331344|1506356|P4|NOT COMPLETED|Phase I||1
615098|NCT00331344|1506357|P3|NOT COMPLETED|Phase I||0
615099|NCT00331344|1506358|P2|NOT COMPLETED|Phase I||0
615100|NCT00331344|1506359|P1|NOT COMPLETED|Phase I||0
615101|NCT00331344|1506351|P9|COMPLETED|Phase I||0
615102|NCT00331344|1506352|P8|COMPLETED|Phase I|1 participant reached dose limiting toxicity|5
615103|NCT00331344|1506353|P7|COMPLETED|Phase I||4
615104|NCT00331344|1506354|P6|COMPLETED|Phase I|2 participants reached dose limiting toxicity|3
615105|NCT00331344|1506355|P5|COMPLETED|Phase I|2 participants reached dose limiting toxicity|4
615106|NCT00331344|1506356|P4|COMPLETED|Phase I|1 participant reached dose limiting toxicity|5
615107|NCT00331344|1506357|P3|COMPLETED|Phase I||3
615108|NCT00331344|1506358|P2|COMPLETED|Phase I||3
615109|NCT00331344|1506359|P1|COMPLETED|Phase I||3
615110|NCT00331344|1506351|P9|STARTED|Phase I||0
615111|NCT00331344|1506352|P8|STARTED|Phase I|1 participant who was enrolled died prior to initiating protocol therapy.|6
615112|NCT00331344|1506353|P7|STARTED|Phase I||4
615113|NCT00331344|1506354|P6|STARTED|Phase I||5
615114|NCT00331344|1506355|P5|STARTED|Phase I||6
615115|NCT00331344|1506356|P4|STARTED|Phase I||6
615116|NCT00331344|1506357|P3|STARTED|Phase I||3
615117|NCT00331344|1506358|P2|STARTED|Phase I||3
615118|NCT00331344|1506359|P1|STARTED|Phase I||3
615119|NCT00331162|1506375|P2|NOT COMPLETED|Overall Study||0
615120|NCT00331162|1506376|P1|NOT COMPLETED|Overall Study||0
615121|NCT00331162|1506375|P2|COMPLETED|Overall Study||109
615122|NCT00331162|1506376|P1|COMPLETED|Overall Study||113
615123|NCT00331162|1506375|P2|STARTED|Overall Study||109
615124|NCT00331162|1506376|P1|STARTED|Overall Study||113
615125|NCT00331006|1506396|P1|NOT COMPLETED|Follow-Up Phase II||3
615126|NCT00331006|1506396|P1|COMPLETED|Follow-Up Phase II||11
615127|NCT00331006|1506396|P1|STARTED|Follow-Up Phase II||14
615128|NCT00331006|1506396|P1|NOT COMPLETED|Follow-Up Phase I||1
615129|NCT00331006|1506396|P1|COMPLETED|Follow-Up Phase I||14
615130|NCT00331006|1506396|P1|STARTED|Follow-Up Phase I||15
615131|NCT00331006|1506396|P1|NOT COMPLETED|Treatment Phase||1
615132|NCT00331006|1506396|P1|COMPLETED|Treatment Phase||15
615133|NCT00331006|1506396|P1|STARTED|Treatment Phase||16
615134|NCT00331006|1506396|P1|NOT COMPLETED|Screening Phase||7
615135|NCT00331006|1506396|P1|COMPLETED|Screening Phase|subjects eligible for the treatment phase if inhibitor titer following Factor VIII was at least 5 BU|16
615136|NCT00331006|1506396|P1|STARTED|Screening Phase||23
615137|NCT00330967|1506409|P2|NOT COMPLETED|Overall Study||14
615138|NCT00330967|1506410|P1|NOT COMPLETED|Overall Study||0
615139|NCT00330967|1506409|P2|COMPLETED|Overall Study||11
615140|NCT00330967|1506410|P1|COMPLETED|Overall Study||0
615141|NCT00330967|1506409|P2|STARTED|Overall Study||25
615142|NCT00330967|1506410|P1|STARTED|Overall Study||0
615143|NCT00330928|1506421|P1|NOT COMPLETED|Overall Study||17
615144|NCT00330928|1506421|P1|COMPLETED|Overall Study||89
615145|NCT00330928|1506421|P1|1 Year Phone Contact|Overall Study||89
615146|NCT00330928|1506421|P1|7 Day Phone Contact|Overall Study||99
615147|NCT00330928|1506421|P1|STARTED|Overall Study|Subjects that signed consent and were subject to research procedures.|106
615148|NCT00330915|1506426|P1|NOT COMPLETED|Overall Study||0
615149|NCT00330915|1506426|P1|COMPLETED|Overall Study||37
615150|NCT00330915|1506426|P1|STARTED|Overall Study||37
615151|NCT00330876|1506433|P2|NOT COMPLETED|Overall Study||13
615152|NCT00330876|1506434|P1|NOT COMPLETED|Overall Study||71
615153|NCT00330876|1506433|P2|COMPLETED|Overall Study||77
615156|NCT00330876|1506434|P1|STARTED|Overall Study||449
615157|NCT00330759|1506444|P2|NOT COMPLETED|Overall Study||706
615158|NCT00330759|1506445|P1|NOT COMPLETED|Overall Study||712
615159|NCT00330759|1506444|P2|COMPLETED|Overall Study||180
615160|NCT00330759|1506445|P1|COMPLETED|Overall Study||178
615161|NCT00330759|1506444|P2|Received Investigational Product|Overall Study||878
615162|NCT00330759|1506445|P1|Received Investigational Product|Overall Study||878
615163|NCT00330759|1506444|P2|STARTED|Overall Study||886
615164|NCT00330759|1506445|P1|STARTED|Overall Study||890
615165|NCT00330733|1506457|P2|NOT COMPLETED|Overall Study||5
615166|NCT00330733|1506458|P1|NOT COMPLETED|Overall Study||7
615167|NCT00330733|1506457|P2|COMPLETED|Overall Study||29
615168|NCT00330733|1506458|P1|COMPLETED|Overall Study||30
615169|NCT00330733|1506457|P2|Received Study Medication|Overall Study||34
615170|NCT00330733|1506458|P1|Received Study Medication|Overall Study||36
615171|NCT00330733|1506457|P2|STARTED|Overall Study||34
615172|NCT00330733|1506458|P1|STARTED|Overall Study||37
615173|NCT00330681|1506466|P2|NOT COMPLETED|Overall Study||14
615174|NCT00330681|1506467|P1|NOT COMPLETED|Overall Study||9
615175|NCT00330681|1506466|P2|COMPLETED|Overall Study||90
615176|NCT00330681|1506467|P1|COMPLETED|Overall Study||93
615177|NCT00330681|1506466|P2|STARTED|Overall Study||104
615178|NCT00330681|1506467|P1|STARTED|Overall Study||102
615179|NCT00330668|1506489|P1|NOT COMPLETED|Overall Study||114
615180|NCT00330668|1506489|P1|COMPLETED|Overall Study||0
615181|NCT00330668|1506489|P1|STARTED|Overall Study||114
615182|NCT00330616|1506496|P1|NOT COMPLETED|Overall Study||21
615183|NCT00330616|1506496|P1|COMPLETED|Overall Study||14
615184|NCT00330616|1506496|P1|STARTED|Overall Study||35
615185|NCT00330564|1506515|P1|NOT COMPLETED|Overall Study||0
615186|NCT00330564|1506515|P1|COMPLETED|Overall Study||15
615187|NCT00330564|1506515|P1|STARTED|Overall Study||15
615188|NCT00330460|1506522|P2|NOT COMPLETED|Overall Study||33
615189|NCT00330460|1506523|P1|NOT COMPLETED|Overall Study||42
615190|NCT00330460|1506522|P2|COMPLETED|Overall Study||561
615191|NCT00330460|1506523|P1|COMPLETED|Overall Study||553
615192|NCT00330460|1506522|P2|STARTED|Overall Study||594
615193|NCT00330460|1506523|P1|STARTED|Overall Study||595
615194|NCT00330421|1506537|P2|NOT COMPLETED|Overall Study||0
615195|NCT00330421|1506538|P1|NOT COMPLETED|Overall Study||0
615196|NCT00330421|1506537|P2|COMPLETED|Overall Study||0
615197|NCT00330421|1506538|P1|COMPLETED|Overall Study||15
615198|NCT00330421|1506537|P2|STARTED|Overall Study||0
615199|NCT00330421|1506538|P1|STARTED|Overall Study||15
615200|NCT00330382|1506544|P2|NOT COMPLETED|Overall Study||17
615201|NCT00330382|1506545|P1|NOT COMPLETED|Overall Study||24
615202|NCT00330382|1506544|P2|COMPLETED|Overall Study||48
615203|NCT00330382|1506545|P1|COMPLETED|Overall Study||43
615204|NCT00330382|1506544|P2|STARTED|Overall Study||65
615205|NCT00330382|1506545|P1|STARTED|Overall Study||67
615206|NCT00330343|1506566|P1|NOT COMPLETED|Overall Study||5
615207|NCT00330343|1506566|P1|COMPLETED|Overall Study||59
615208|NCT00330343|1506566|P1|STARTED|Overall Study||64
615209|NCT00330174|1506572|P2|NOT COMPLETED|Overall Study||19
615210|NCT00330174|1506573|P1|NOT COMPLETED|Overall Study||22
615211|NCT00330174|1506572|P2|COMPLETED|Overall Study||26
615212|NCT00330174|1506573|P1|COMPLETED|Overall Study||23
615213|NCT00330174|1506572|P2|STARTED|Overall Study||45
615214|NCT00330174|1506573|P1|STARTED|Overall Study||45
615215|NCT00330161|1506585|P1|NOT COMPLETED|Overall Study||0
615216|NCT00330161|1506585|P1|COMPLETED|Overall Study||29
615217|NCT00330161|1506585|P1|STARTED|Overall Study||29
615218|NCT00329901|1506597|P3|NOT COMPLETED|Overall Study||4
615219|NCT00329901|1506598|P2|NOT COMPLETED|Overall Study||5
615220|NCT00329901|1506599|P1|NOT COMPLETED|Overall Study||9
615221|NCT00329901|1506597|P3|COMPLETED|Overall Study||353
615222|NCT00329901|1506598|P2|COMPLETED|Overall Study||349
615223|NCT00329901|1506599|P1|COMPLETED|Overall Study||352
615224|NCT00329901|1506597|P3|STARTED|Overall Study||357
615225|NCT00329901|1506598|P2|STARTED|Overall Study||354
615226|NCT00329901|1506599|P1|STARTED|Overall Study||361
615227|NCT00329849|1506629|P2|NOT COMPLETED|Overall Study||4
615228|NCT00329849|1506630|P1|NOT COMPLETED|Overall Study||6
615229|NCT00329849|1506629|P2|COMPLETED|Overall Study||546
615230|NCT00329849|1506630|P1|COMPLETED|Overall Study||944
615231|NCT00329849|1506629|P2|STARTED|Overall Study||550
615232|NCT00329849|1506630|P1|STARTED|Overall Study||950
615233|NCT00329836|1506650|P1|NOT COMPLETED|Overall Study||0
615234|NCT00329836|1506650|P1|COMPLETED|Overall Study||41
615235|NCT00329836|1506650|P1|STARTED|Overall Study||41
615236|NCT00329797|1506656|P2|NOT COMPLETED|Overall Study||6
615237|NCT00329797|1506657|P1|NOT COMPLETED|Overall Study||7
615238|NCT00329797|1506656|P2|COMPLETED|Overall Study||46
615239|NCT00329797|1506657|P1|COMPLETED|Overall Study||50
615240|NCT00329797|1506656|P2|STARTED|Overall Study||52
615241|NCT00329797|1506657|P1|STARTED|Overall Study||57
615242|NCT00329784|1506673|P4|NOT COMPLETED|Overall Study||0
615243|NCT00329784|1506674|P3|NOT COMPLETED|Overall Study||0
615244|NCT00329784|1506675|P2|NOT COMPLETED|Overall Study||5
615245|NCT00329784|1506676|P1|NOT COMPLETED|Overall Study||5
615246|NCT00329784|1506673|P4|COMPLETED|Overall Study||47
615247|NCT00329784|1506674|P3|COMPLETED|Overall Study||51
615248|NCT00329784|1506675|P2|COMPLETED|Overall Study||267
615249|NCT00329784|1506676|P1|COMPLETED|Overall Study||265
615250|NCT00329784|1506673|P4|STARTED|Overall Study||47
615251|NCT00329784|1506674|P3|STARTED|Overall Study||51
615252|NCT00329784|1506675|P2|STARTED|Overall Study||272
615253|NCT00329784|1506676|P1|STARTED|Overall Study||270
615254|NCT00329771|1506698|P1|NOT COMPLETED|Overall Study||3
615255|NCT00329771|1506698|P1|COMPLETED|Overall Study|3 subjects withdrew or were lost to follow-up|25
615256|NCT00329771|1506698|P1|STARTED|Overall Study||28
615257|NCT00329745|1506704|P2|NOT COMPLETED|Overall Study||102
615258|NCT00329745|1506705|P1|NOT COMPLETED|Overall Study||87
615259|NCT00329745|1506704|P2|COMPLETED|Overall Study||4226
615260|NCT00329745|1506705|P1|COMPLETED|Overall Study||4272
615261|NCT00329745|1506704|P2|STARTED|Overall Study||4328
615262|NCT00329745|1506705|P1|STARTED|Overall Study||4359
615263|NCT00329732|1506715|P2|NOT COMPLETED|Overall Study||0
615264|NCT00329732|1506716|P1|NOT COMPLETED|Overall Study||0
615265|NCT00329732|1506715|P2|COMPLETED|Overall Study||0
615266|NCT00329732|1506716|P1|COMPLETED|Overall Study||2
615267|NCT00329732|1506715|P2|STARTED|Overall Study||0
615268|NCT00329732|1506716|P1|STARTED|Overall Study||2
615269|NCT00329719|1506725|P4|NOT COMPLETED|Overall Study||1
615270|NCT00329719|1506726|P3|NOT COMPLETED|Overall Study||0
615271|NCT00329719|1506727|P2|NOT COMPLETED|Overall Study||0
615272|NCT00329719|1506728|P1|NOT COMPLETED|Overall Study||0
615273|NCT00329719|1506725|P4|COMPLETED|Overall Study||44
615274|NCT00329719|1506726|P3|COMPLETED|Overall Study||9
615275|NCT00329719|1506727|P2|COMPLETED|Overall Study||49
615276|NCT00329719|1506728|P1|COMPLETED|Overall Study||12
615277|NCT00329719|1506725|P4|STARTED|Overall Study||45
615278|NCT00329719|1506726|P3|STARTED|Overall Study||9
615279|NCT00329719|1506727|P2|STARTED|Overall Study||49
615280|NCT00329719|1506728|P1|STARTED|Overall Study||12
615281|NCT00329641|1506750|P1|NOT COMPLETED|Overall Study||6
615282|NCT00329641|1506750|P1|COMPLETED|Overall Study||19
615283|NCT00329641|1506750|P1|Eligible and Received Treatment|Overall Study||24
615284|NCT00329641|1506750|P1|Eligible|Overall Study||25
615285|NCT00329641|1506750|P1|STARTED|Overall Study||25
615286|NCT00329602|1506759|P3|NOT COMPLETED|40-Week Open-Label Treatment Phase||36
615287|NCT00329602|1506760|P2|NOT COMPLETED|40-Week Open-Label Treatment Phase||0
615288|NCT00329602|1506761|P1|NOT COMPLETED|40-Week Open-Label Treatment Phase||0
615289|NCT00329602|1506759|P3|COMPLETED|40-Week Open-Label Treatment Phase||233
615290|NCT00329602|1506760|P2|COMPLETED|40-Week Open-Label Treatment Phase||0
615291|NCT00329602|1506761|P1|COMPLETED|40-Week Open-Label Treatment Phase||0
615292|NCT00329602|1506759|P3|STARTED|40-Week Open-Label Treatment Phase|148 and 121 par. randomized to DB placebo and ropinirole IR, respectively, entered the OL phase.|269
615293|NCT00329602|1506760|P2|STARTED|40-Week Open-Label Treatment Phase||0
615294|NCT00329602|1506761|P1|STARTED|40-Week Open-Label Treatment Phase||0
615295|NCT00329602|1506759|P3|NOT COMPLETED|26-Week Double-Blind Treatment Phase||0
615296|NCT00329602|1506760|P2|NOT COMPLETED|26-Week Double-Blind Treatment Phase||99
615297|NCT00329602|1506761|P1|NOT COMPLETED|26-Week Double-Blind Treatment Phase||119
615298|NCT00329602|1506759|P3|COMPLETED|26-Week Double-Blind Treatment Phase||0
615299|NCT00329602|1506760|P2|COMPLETED|26-Week Double-Blind Treatment Phase||98
615300|NCT00329602|1506761|P1|COMPLETED|26-Week Double-Blind Treatment Phase||88
615301|NCT00329602|1506759|P3|STARTED|26-Week Double-Blind Treatment Phase||0
615302|NCT00329602|1506760|P2|STARTED|26-Week Double-Blind Treatment Phase||197
615303|NCT00329602|1506761|P1|STARTED|26-Week Double-Blind Treatment Phase|"Numbers of participants in the Participant Flow section are based on the Safety Population."|207
615304|NCT00329550|1506799|P3|NOT COMPLETED|Overall Study||4
615305|NCT00329550|1506800|P2|NOT COMPLETED|Overall Study||4
615306|NCT00329550|1506801|P1|NOT COMPLETED|Overall Study||4
615307|NCT00329550|1506799|P3|COMPLETED|Overall Study||12
615308|NCT00329550|1506800|P2|COMPLETED|Overall Study||11
615309|NCT00329550|1506801|P1|COMPLETED|Overall Study||5
615310|NCT00329550|1506799|P3|STARTED|Overall Study|1 subject in Safety Set is not in Full Analysis Set due to Good Clinical Practice non-compliance.|16
615311|NCT00329550|1506800|P2|STARTED|Overall Study||15
615312|NCT00329550|1506801|P1|STARTED|Overall Study||9
615313|NCT00329524|1507048|P1|NOT COMPLETED|Overall Study||0
615314|NCT00329524|1507048|P1|COMPLETED|Overall Study||5
615315|NCT00329524|1507048|P1|STARTED|Overall Study||5
615316|NCT00329433|1507056|P2|NOT COMPLETED|Overall Study||0
615317|NCT00329433|1507057|P1|NOT COMPLETED|Overall Study||0
615318|NCT00329433|1507056|P2|COMPLETED|Overall Study||59
615319|NCT00329433|1507057|P1|COMPLETED|Overall Study||61
615320|NCT00329433|1507056|P2|STARTED|Overall Study||59
615321|NCT00329433|1507057|P1|STARTED|Overall Study||61
615322|NCT00329420|1507066|P3|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||1
615323|NCT00329420|1507067|P2|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||2
615324|NCT00329420|1507068|P1|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||4
615325|NCT00329420|1507066|P3|COMPLETED|4-weekly Dosing Phase (Responders Only)||6
615326|NCT00329420|1507067|P2|COMPLETED|4-weekly Dosing Phase (Responders Only)||5
615327|NCT00329420|1507068|P1|COMPLETED|4-weekly Dosing Phase (Responders Only)||8
615328|NCT00329420|1507066|P3|STARTED|4-weekly Dosing Phase (Responders Only)||7
615329|NCT00329420|1507067|P2|STARTED|4-weekly Dosing Phase (Responders Only)||7
615330|NCT00329420|1507068|P1|STARTED|4-weekly Dosing Phase (Responders Only)||12
615331|NCT00329420|1507066|P3|NOT COMPLETED|Re-induction Phase||8
615332|NCT00329420|1507067|P2|NOT COMPLETED|Re-induction Phase||6
615333|NCT00329420|1507068|P1|NOT COMPLETED|Re-induction Phase||6
615334|NCT00329420|1507066|P3|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|7
615335|NCT00329420|1507067|P2|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|7
615336|NCT00329420|1507068|P1|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|12
615337|NCT00329420|1507066|P3|STARTED|Re-induction Phase||15
615338|NCT00329420|1507067|P2|STARTED|Re-induction Phase||13
615339|NCT00329420|1507068|P1|STARTED|Re-induction Phase||18
615340|NCT00329407|1507447|P1|NOT COMPLETED|Overall Study||1
615341|NCT00329407|1507447|P1|COMPLETED|Overall Study||9
615342|NCT00329407|1507447|P1|STARTED|Overall Study||10
615343|NCT00329238|1507454|P2|NOT COMPLETED|Overall Study||281
615344|NCT00329238|1507455|P1|NOT COMPLETED|Overall Study||276
615345|NCT00329238|1507454|P2|COMPLETED|Overall Study||1145
615346|NCT00329238|1507455|P1|COMPLETED|Overall Study||1154
615347|NCT00329238|1507454|P2|STARTED|Overall Study|2866 were randomized. A total of ten did not receive treatment resulting in 2856 starting study.|1426
615348|NCT00329238|1507455|P1|STARTED|Overall Study|2866 were randomized. A total of ten did not receive treatment resulting in 2856 starting study.|1430
615349|NCT00329160|1507491|P1|NOT COMPLETED|Overall Study||88
615350|NCT00329160|1507491|P1|COMPLETED|Overall Study||126
615351|NCT00329160|1507491|P1|Treatment Period|Overall Study||214
615352|NCT00329160|1507491|P1|Observation Period|Overall Study||214
615353|NCT00329160|1507491|P1|STARTED|Overall Study||214
615354|NCT00329108|1507500|P2|NOT COMPLETED|Overall Study||12
615355|NCT00329108|1507501|P1|NOT COMPLETED|Overall Study||10
615356|NCT00329108|1507500|P2|COMPLETED|Overall Study||2
615357|NCT00329108|1507501|P1|COMPLETED|Overall Study||5
615358|NCT00329108|1507500|P2|STARTED|Overall Study|study terminated due to poor recruitment|14
615359|NCT00329108|1507501|P1|STARTED|Overall Study|study terminated due to poor recruitment|15
615360|NCT00329030|1507509|P2|NOT COMPLETED|Overall Study||6
615361|NCT00329030|1507510|P1|NOT COMPLETED|Overall Study||8
615362|NCT00329030|1507509|P2|COMPLETED|Overall Study||107
615363|NCT00329030|1507510|P1|COMPLETED|Overall Study||103
615364|NCT00329030|1507509|P2|STARTED|Overall Study||113
615365|NCT00329030|1507510|P1|STARTED|Overall Study||111
615366|NCT00328926|1507541|P3|NOT COMPLETED|Overall Study||2
615367|NCT00328926|1507542|P2|NOT COMPLETED|Overall Study||3
615368|NCT00328926|1507543|P1|NOT COMPLETED|Overall Study||2
615369|NCT00328926|1507541|P3|COMPLETED|Overall Study||1
615370|NCT00328926|1507542|P2|COMPLETED|Overall Study||0
615371|NCT00328926|1507543|P1|COMPLETED|Overall Study||3
615372|NCT00328926|1507541|P3|STARTED|Overall Study||3
615373|NCT00328926|1507542|P2|STARTED|Overall Study||3
615374|NCT00328926|1507543|P1|STARTED|Overall Study||5
615375|NCT00328861|1507559|P2|NOT COMPLETED|Overall Study||0
615376|NCT00328861|1507560|P1|NOT COMPLETED|Overall Study||0
615377|NCT00328861|1507559|P2|COMPLETED|Overall Study||1
615378|NCT00328861|1507560|P1|COMPLETED|Overall Study||7
615379|NCT00328861|1507559|P2|STARTED|Overall Study||1
615380|NCT00328861|1507560|P1|STARTED|Overall Study||7
615381|NCT00328783|1507568|P1|NOT COMPLETED|Overall Study||26
615382|NCT00328783|1507568|P1|COMPLETED|Overall Study||86
615383|NCT00328783|1507568|P1|STARTED|Overall Study||112
615384|NCT00328770|1507576|P1|NOT COMPLETED|Overall Study||0
615385|NCT00328770|1507576|P1|COMPLETED|Overall Study||70
615386|NCT00328770|1507576|P1|STARTED|Overall Study||70
615387|NCT00328627|1507594|P12|NOT COMPLETED|Overall Study||16
615388|NCT00328627|1507595|P11|NOT COMPLETED|Overall Study||18
615389|NCT00328627|1507596|P10|NOT COMPLETED|Overall Study||32
615390|NCT00328627|1507597|P9|NOT COMPLETED|Overall Study||17
615391|NCT00328627|1507598|P8|NOT COMPLETED|Overall Study||14
615392|NCT00328627|1507599|P7|NOT COMPLETED|Overall Study||35
615393|NCT00328627|1507600|P6|NOT COMPLETED|Overall Study||20
615394|NCT00328627|1507601|P5|NOT COMPLETED|Overall Study||15
615395|NCT00328627|1507602|P4|NOT COMPLETED|Overall Study||37
615396|NCT00328627|1507603|P3|NOT COMPLETED|Overall Study||28
615397|NCT00328627|1507604|P2|NOT COMPLETED|Overall Study||31
615398|NCT00328627|1507605|P1|NOT COMPLETED|Overall Study||59
615399|NCT00328627|1507594|P12|COMPLETED|Overall Study||114
615400|NCT00328627|1507595|P11|COMPLETED|Overall Study||112
615401|NCT00328627|1507596|P10|COMPLETED|Overall Study||97
615402|NCT00328627|1507597|P9|COMPLETED|Overall Study||113
615403|NCT00328627|1507598|P8|COMPLETED|Overall Study||116
615404|NCT00328627|1507599|P7|COMPLETED|Overall Study||94
615405|NCT00328627|1507600|P6|COMPLETED|Overall Study||110
615406|NCT00328627|1507601|P5|COMPLETED|Overall Study||115
615407|NCT00328627|1507602|P4|COMPLETED|Overall Study||93
615408|NCT00328627|1507603|P3|COMPLETED|Overall Study||101
615409|NCT00328627|1507604|P2|COMPLETED|Overall Study||97
615410|NCT00328627|1507605|P1|COMPLETED|Overall Study||70
615411|NCT00328627|1507594|P12|Safety Set|Overall Study||130
615412|NCT00328627|1507595|P11|Safety Set|Overall Study||130
615413|NCT00328627|1507596|P10|Safety Set|Overall Study||129
615414|NCT00328627|1507597|P9|Safety Set|Overall Study||130
615415|NCT00328627|1507598|P8|Safety Set|Overall Study||130
615416|NCT00328627|1507599|P7|Safety Set|Overall Study||129
615417|NCT00328627|1507600|P6|Safety Set|Overall Study||130
615418|NCT00328627|1507601|P5|Safety Set|Overall Study||130
615419|NCT00328627|1507602|P4|Safety Set|Overall Study||129
615420|NCT00328627|1507603|P3|Safety Set|Overall Study||129
615421|NCT00328627|1507604|P2|Safety Set|Overall Study||128
615422|NCT00328627|1507605|P1|Safety Set|Overall Study|All patients who took at least 1 dose of double-blind study drug.|129
615423|NCT00328627|1507594|P12|STARTED|Overall Study||130
615424|NCT00328627|1507595|P11|STARTED|Overall Study||130
615425|NCT00328627|1507596|P10|STARTED|Overall Study||129
615426|NCT00328627|1507597|P9|STARTED|Overall Study||130
615427|NCT00328627|1507598|P8|STARTED|Overall Study||130
615428|NCT00328627|1507599|P7|STARTED|Overall Study||129
615429|NCT00328627|1507600|P6|STARTED|Overall Study||130
615430|NCT00328627|1507601|P5|STARTED|Overall Study||130
615431|NCT00328627|1507602|P4|STARTED|Overall Study||130
615432|NCT00328627|1507603|P3|STARTED|Overall Study||129
615433|NCT00328627|1507604|P2|STARTED|Overall Study||128
615434|NCT00328627|1507605|P1|STARTED|Overall Study||129
615435|NCT00328614|1509128|P6|NOT COMPLETED|Overall Study||1
615436|NCT00328614|1509129|P5|NOT COMPLETED|Overall Study||1
615437|NCT00328614|1509130|P4|NOT COMPLETED|Overall Study||1
615438|NCT00328614|1509131|P3|NOT COMPLETED|Overall Study||0
615439|NCT00328614|1509132|P2|NOT COMPLETED|Overall Study||0
615440|NCT00328614|1509133|P1|NOT COMPLETED|Overall Study||0
615441|NCT00328614|1509128|P6|COMPLETED|Overall Study||5
615442|NCT00328614|1509129|P5|COMPLETED|Overall Study||5
615443|NCT00328614|1509130|P4|COMPLETED|Overall Study||5
615444|NCT00328614|1509131|P3|COMPLETED|Overall Study||6
615445|NCT00328614|1509132|P2|COMPLETED|Overall Study||4
615446|NCT00328614|1509133|P1|COMPLETED|Overall Study||4
615447|NCT00328614|1509128|P6|STARTED|Overall Study||6
615448|NCT00328614|1509129|P5|STARTED|Overall Study||6
615449|NCT00328614|1509130|P4|STARTED|Overall Study||6
615450|NCT00328614|1509131|P3|STARTED|Overall Study||6
615451|NCT00328614|1509132|P2|STARTED|Overall Study||4
615452|NCT00328614|1509133|P1|STARTED|Overall Study||4
615453|NCT00328562|1509142|P1|NOT COMPLETED|Overall Study||1
615454|NCT00328562|1509142|P1|COMPLETED|Overall Study||12
615455|NCT00328562|1509142|P1|STARTED|Overall Study||13
615456|NCT00328510|1509151|P2|NOT COMPLETED|Overall Study||4
615457|NCT00328510|1509152|P1|NOT COMPLETED|Overall Study||10
615458|NCT00328510|1509151|P2|COMPLETED|Overall Study||37
615459|NCT00328510|1509152|P1|COMPLETED|Overall Study||32
615460|NCT00328510|1509151|P2|STARTED|Overall Study||41
615461|NCT00328510|1509152|P1|STARTED|Overall Study||42
615462|NCT00328263|1509160|P2|NOT COMPLETED|Overall Study||4
615463|NCT00328263|1509161|P1|NOT COMPLETED|Overall Study||3
615464|NCT00328263|1509160|P2|COMPLETED|Overall Study|4 deaths occured during the study. None of the deaths were causally related to the study product.|217
615465|NCT00328263|1509161|P1|COMPLETED|Overall Study|3 deaths occured during the study. None of the deaths were causally related to the study product.|213
615466|NCT00328263|1509160|P2|STARTED|Overall Study||221
615467|NCT00328263|1509161|P1|STARTED|Overall Study||216
615468|NCT00328198|1509167|P1|NOT COMPLETED|Follow-up||35
615469|NCT00328198|1509167|P1|COMPLETED|Follow-up||43
615470|NCT00328198|1509167|P1|STARTED|Follow-up|Eight participants did not enter Follow-up|78
615471|NCT00328198|1509167|P1|NOT COMPLETED|Treatment||38
615472|NCT00328198|1509167|P1|COMPLETED|Treatment|Depending upon protocol version, completed treatment was either 12 or 18 weeks in duration.|48
615473|NCT00328198|1509167|P1|STARTED|Treatment|16 participants escalated the dose. 70 participants started at the 30 mg target dose.|86
615474|NCT00328172|1509182|P5|NOT COMPLETED|Overall Study||5
615475|NCT00328172|1509183|P4|NOT COMPLETED|Overall Study||13
615476|NCT00328172|1509184|P3|NOT COMPLETED|Overall Study||10
615477|NCT00328172|1509185|P2|NOT COMPLETED|Overall Study||14
615478|NCT00328172|1509186|P1|NOT COMPLETED|Overall Study||22
615479|NCT00328172|1509182|P5|COMPLETED|Overall Study||60
615480|NCT00328172|1509183|P4|COMPLETED|Overall Study||42
615481|NCT00328172|1509184|P3|COMPLETED|Overall Study||47
615482|NCT00328172|1509185|P2|COMPLETED|Overall Study||44
615483|NCT00328172|1509186|P1|COMPLETED|Overall Study||45
615484|NCT00328172|1509182|P5|STARTED|Overall Study||65
615485|NCT00328172|1509183|P4|STARTED|Overall Study||55
615486|NCT00328172|1509184|P3|STARTED|Overall Study||57
615487|NCT00328172|1509185|P2|STARTED|Overall Study||58
615488|NCT00328172|1509186|P1|STARTED|Overall Study||67
615489|NCT00328094|1509210|P2|NOT COMPLETED|Overall Study||3
615490|NCT00328094|1509211|P1|NOT COMPLETED|Overall Study||3
615491|NCT00328094|1509210|P2|COMPLETED|Overall Study|3 did not receive interevention. 1 post induction arrest. 1 case cancelled.|122
615492|NCT00328094|1509211|P1|COMPLETED|Overall Study|2 did not receive intervention. 1 patient refusal|114
615493|NCT00328094|1509210|P2|STARTED|Overall Study||125
615494|NCT00328094|1509211|P1|STARTED|Overall Study||117
615495|NCT00328042|1509221|P2|NOT COMPLETED|Overall Study||2
615496|NCT00328042|1509222|P1|NOT COMPLETED|Overall Study||0
615497|NCT00328042|1509221|P2|COMPLETED|Overall Study||63
615498|NCT00328042|1509222|P1|COMPLETED|Overall Study||69
615499|NCT00328042|1509221|P2|STARTED|Overall Study||65
615500|NCT00328042|1509222|P1|STARTED|Overall Study||69
615501|NCT00328016|1509232|P2|NOT COMPLETED|Overall Study||0
615502|NCT00328016|1509233|P1|NOT COMPLETED|Overall Study||0
615503|NCT00328016|1509232|P2|COMPLETED|Overall Study||21
615504|NCT00328016|1509233|P1|COMPLETED|Overall Study||23
615505|NCT00328016|1509232|P2|STARTED|Overall Study||21
615506|NCT00328016|1509233|P1|STARTED|Overall Study||23
615507|NCT00327717|1509245|P2|NOT COMPLETED|Overall Study||14
615508|NCT00327717|1509246|P1|NOT COMPLETED|Overall Study||9
615509|NCT00327717|1509245|P2|COMPLETED|Overall Study||106
615510|NCT00327717|1509246|P1|COMPLETED|Overall Study||111
615511|NCT00327717|1509245|P2|STARTED|Overall Study||120
615512|NCT00327717|1509246|P1|STARTED|Overall Study||120
615513|NCT00327470|1509272|P2|NOT COMPLETED|Overall Study||63
615514|NCT00327470|1509273|P1|NOT COMPLETED|Overall Study||29
615515|NCT00327470|1509272|P2|COMPLETED|Overall Study||118
615516|NCT00327470|1509273|P1|COMPLETED|Overall Study||78
615517|NCT00327470|1509272|P2|Treated|Overall Study||179
615518|NCT00327470|1509273|P1|Treated|Overall Study||107
615519|NCT00327470|1509272|P2|STARTED|Overall Study||181
615520|NCT00327470|1509273|P1|STARTED|Overall Study||107
615521|NCT00327444|1509293|P2|NOT COMPLETED|Open Label Treatment (OL) Period||10
615522|NCT00327444|1509294|P1|NOT COMPLETED|Open Label Treatment (OL) Period||11
615523|NCT00327444|1509293|P2|COMPLETED|Open Label Treatment (OL) Period|All participants were treated till they met treatment discontinuation criteria|0
615524|NCT00327444|1509294|P1|COMPLETED|Open Label Treatment (OL) Period|All participants were treated till they met treatment discontinuation criteria|0
615525|NCT00327444|1509293|P2|ONGOING TREATMENT|Open Label Treatment (OL) Period||0
615526|NCT00327444|1509294|P1|ONGOING TREATMENT|Open Label Treatment (OL) Period||1
615527|NCT00327444|1509293|P2|STARTED|Open Label Treatment (OL) Period||10
615528|NCT00327444|1509294|P1|STARTED|Open Label Treatment (OL) Period||11
615529|NCT00327444|1509293|P2|NOT COMPLETED|Double Blind Treatment (DB) Period||29
615530|NCT00327444|1509294|P1|NOT COMPLETED|Double Blind Treatment (DB) Period||26
615531|NCT00327444|1509293|P2|COMPLETED|Double Blind Treatment (DB) Period||0
615532|NCT00327444|1509294|P1|COMPLETED|Double Blind Treatment (DB) Period||0
615533|NCT00327444|1509293|P2|SAFETY|Double Blind Treatment (DB) Period|Includes 1 from Placebo who received aflibercept in DB period|30
615534|NCT00327444|1509294|P1|SAFETY|Double Blind Treatment (DB) Period|Excludes one participant from the Placebo arm who received aflibercept in error in the DB period.|25
615535|NCT00327444|1509293|P2|STARTED|Double Blind Treatment (DB) Period||29
615536|NCT00327444|1509294|P1|STARTED|Double Blind Treatment (DB) Period||26
615537|NCT00327392|1509306|P1|NOT COMPLETED|Overall Study||0
615538|NCT00327392|1509306|P1|COMPLETED|Overall Study||123
615539|NCT00327392|1509306|P1|STARTED|Overall Study||123
615540|NCT00327340|1509312|P2|NOT COMPLETED|Overall Study||30
615541|NCT00327340|1509313|P1|NOT COMPLETED|Overall Study||15
615542|NCT00327340|1509312|P2|COMPLETED|Overall Study||16
615543|NCT00327340|1509313|P1|COMPLETED|Overall Study||8
615544|NCT00327340|1509312|P2|STARTED|Overall Study||46
615545|NCT00327340|1509313|P1|STARTED|Overall Study||23
615546|NCT00327171|1509327|P2|NOT COMPLETED|Overall Study||109
615547|NCT00327171|1509328|P1|NOT COMPLETED|Overall Study||108
615548|NCT00327171|1509327|P2|COMPLETED|Overall Study|Participants received treatment until they met treatment discontinuation criteria|0
615549|NCT00327171|1509328|P1|COMPLETED|Overall Study|Participants received treatment until they met treatment discontinuation criteria|1
615550|NCT00327171|1509327|P2|STARTED|Overall Study||109
615551|NCT00327171|1509328|P1|STARTED|Overall Study||109
615552|NCT00327015|1509360|P4|NOT COMPLETED|Overall Study||109
615553|NCT00327015|1509361|P3|NOT COMPLETED|Overall Study||126
615554|NCT00327015|1509362|P2|NOT COMPLETED|Overall Study||92
615555|NCT00327015|1509363|P1|NOT COMPLETED|Overall Study||91
615556|NCT00327015|1509360|P4|COMPLETED|Overall Study||219
615557|NCT00327015|1509361|P3|COMPLETED|Overall Study||209
615558|NCT00327015|1509362|P2|COMPLETED|Overall Study||231
615559|NCT00327015|1509363|P1|COMPLETED|Overall Study||229
615560|NCT00327015|1509360|P4|Completed Study Without Being Rescued|Overall Study||144
615561|NCT00327015|1509361|P3|Completed Study Without Being Rescued|Overall Study||113
615562|NCT00327015|1509362|P2|Completed Study Without Being Rescued|Overall Study||177
615563|NCT00327015|1509363|P1|Completed Study Without Being Rescued|Overall Study||179
615564|NCT00327015|1509360|P4|STARTED|Overall Study||328
615565|NCT00327015|1509361|P3|STARTED|Overall Study||335
615566|NCT00327015|1509362|P2|STARTED|Overall Study||323
615567|NCT00327015|1509363|P1|STARTED|Overall Study||320
615568|NCT00326963|1509405|P1|NOT COMPLETED|Overall Study||33
615569|NCT00326963|1509405|P1|COMPLETED|Overall Study||107
615570|NCT00326963|1509405|P1|STARTED|Overall Study||140
615571|NCT00326950|1509425|P1|NOT COMPLETED|Overall Study||1
615572|NCT00326950|1509425|P1|COMPLETED|Overall Study||14
615573|NCT00326950|1509425|P1|STARTED|Overall Study||15
615574|NCT00326924|1509432|P2|NOT COMPLETED|Overall Study||1
615575|NCT00326924|1509433|P1|NOT COMPLETED|Overall Study||1
615576|NCT00326924|1509432|P2|COMPLETED|Overall Study||188
615577|NCT00326924|1509433|P1|COMPLETED|Overall Study||187
615578|NCT00326924|1509432|P2|STARTED|Overall Study||189
615579|NCT00326924|1509433|P1|STARTED|Overall Study||188
615580|NCT00326911|1509447|P2|NOT COMPLETED|Overall Study||2
615581|NCT00326911|1509448|P1|NOT COMPLETED|Overall Study||1
615582|NCT00326911|1509447|P2|COMPLETED|Overall Study|This number reflects all treated patients.|29
615583|NCT00326911|1509448|P1|COMPLETED|Overall Study|This number reflects all treated patients.|29
615584|NCT00326911|1509447|P2|STARTED|Overall Study|This number reflects all randomized patients.|31
615585|NCT00326911|1509448|P1|STARTED|Overall Study|This number reflects all randomized patients.|30
615586|NCT00326898|1509501|P3|NOT COMPLETED|Overall Study||203
615587|NCT00326898|1509502|P2|NOT COMPLETED|Overall Study||343
615588|NCT00326898|1509503|P1|NOT COMPLETED|Overall Study||351
615589|NCT00326898|1509501|P3|COMPLETED|Overall Study||444
615590|NCT00326898|1509502|P2|COMPLETED|Overall Study||306
615591|NCT00326898|1509503|P1|COMPLETED|Overall Study||296
615592|NCT00326898|1509501|P3|Patients With >=1 Follow-up MUGA Scan|Overall Study||580
615593|NCT00326898|1509502|P2|Patients With >=1 Follow-up MUGA Scan|Overall Study||510
615594|NCT00326898|1509503|P1|Patients With >=1 Follow-up MUGA Scan|Overall Study||513
615595|NCT00326898|1509501|P3|Patients With Clear Cell Histology|Overall Study||540
615596|NCT00326898|1509502|P2|Patients With Clear Cell Histology|Overall Study||540
615597|NCT00326898|1509503|P1|Patients With Clear Cell Histology|Overall Study||542
615598|NCT00326898|1509501|P3|Patients With Toxicity Data|Overall Study||626
615599|NCT00326898|1509502|P2|Patients With Toxicity Data|Overall Study||628
615600|NCT00326898|1509503|P1|Patients With Toxicity Data|Overall Study||625
615601|NCT00326898|1509501|P3|STARTED|Overall Study||647
615602|NCT00326898|1509502|P2|STARTED|Overall Study||649
615603|NCT00326898|1509503|P1|STARTED|Overall Study||647
615604|NCT00326885|1509520|P1|NOT COMPLETED|Overall Study||7
615605|NCT00326885|1509520|P1|COMPLETED|Overall Study||25
615606|NCT00326885|1509520|P1|STARTED|Overall Study||32
615607|NCT00326872|1509529|P1|NOT COMPLETED|Overall Study||0
615608|NCT00326872|1509529|P1|COMPLETED|Overall Study||26
615609|NCT00326872|1509529|P1|STARTED|Overall Study||26
615610|NCT00326781|1509540|P2|NOT COMPLETED|Overall Study||32
615611|NCT00326781|1509541|P1|NOT COMPLETED|Overall Study||42
615612|NCT00326781|1509540|P2|COMPLETED|Overall Study||298
615613|NCT00326781|1509541|P1|COMPLETED|Overall Study||302
615614|NCT00326781|1509540|P2|STARTED|Overall Study||330
615615|NCT00326781|1509541|P1|STARTED|Overall Study||344
615616|NCT00326716|1509551|P4|NOT COMPLETED|Infants||0
615617|NCT00326716|1509552|P3|NOT COMPLETED|Infants||0
615618|NCT00326716|1509553|P2|NOT COMPLETED|Infants||0
615619|NCT00326716|1509554|P1|NOT COMPLETED|Infants||0
615620|NCT00326716|1509551|P4|COMPLETED|Infants||20
615621|NCT00326716|1509552|P3|COMPLETED|Infants||20
615622|NCT00326716|1509553|P2|COMPLETED|Infants||0
615623|NCT00326716|1509554|P1|COMPLETED|Infants||0
615624|NCT00326716|1509551|P4|STARTED|Infants|All infants were followed. One mother withdrew consent pre-delivery and her infant was not followed.|20
615625|NCT00326716|1509552|P3|STARTED|Infants|All infants were followed.|20
615626|NCT00326716|1509553|P2|STARTED|Infants||0
615627|NCT00326716|1509554|P1|STARTED|Infants||0
615628|NCT00326716|1509551|P4|NOT COMPLETED|Pre-Natal Mothers||0
615629|NCT00326716|1509552|P3|NOT COMPLETED|Pre-Natal Mothers||0
615630|NCT00326716|1509553|P2|NOT COMPLETED|Pre-Natal Mothers||2
615631|NCT00326716|1509554|P1|NOT COMPLETED|Pre-Natal Mothers||1
615632|NCT00326716|1509551|P4|COMPLETED|Pre-Natal Mothers|Completion was defined as completing all follow up visits through 6 months.|0
615633|NCT00326716|1509552|P3|COMPLETED|Pre-Natal Mothers|Completion was defined as completing all follow up visits through 6 months.|0
615634|NCT00326716|1509553|P2|COMPLETED|Pre-Natal Mothers|Completion was defined as completing the study.|19
615635|NCT00326716|1509554|P1|COMPLETED|Pre-Natal Mothers|Completion was defined as completing the study.|19
615636|NCT00326716|1509551|P4|STARTED|Pre-Natal Mothers||0
615637|NCT00326716|1509552|P3|STARTED|Pre-Natal Mothers||0
615638|NCT00326716|1509553|P2|STARTED|Pre-Natal Mothers||21
615639|NCT00326716|1509554|P1|STARTED|Pre-Natal Mothers||20
615640|NCT00326612|1509626|P2|NOT COMPLETED|Overall Study||137
615641|NCT00326612|1509627|P1|NOT COMPLETED|Overall Study||129
615642|NCT00326612|1509626|P2|COMPLETED|Overall Study||42
615643|NCT00326612|1509627|P1|COMPLETED|Overall Study||50
615644|NCT00326612|1509626|P2|STARTED|Overall Study||179
615645|NCT00326612|1509627|P1|STARTED|Overall Study||179
615646|NCT00326599|1509649|P4|NOT COMPLETED|Overall Study||19
615647|NCT00326599|1509650|P3|NOT COMPLETED|Overall Study||53
615648|NCT00326599|1509651|P2|NOT COMPLETED|Overall Study||1
615649|NCT00326599|1509652|P1|NOT COMPLETED|Overall Study||6
615650|NCT00326599|1509649|P4|COMPLETED|Overall Study||10
615651|NCT00326599|1509650|P3|COMPLETED|Overall Study||5
615652|NCT00326599|1509651|P2|COMPLETED|Overall Study||2
615653|NCT00326599|1509652|P1|COMPLETED|Overall Study||0
615654|NCT00326599|1509649|P4|STARTED|Overall Study||29
615655|NCT00326599|1509650|P3|STARTED|Overall Study||58
615656|NCT00326599|1509651|P2|STARTED|Overall Study||3
615657|NCT00326599|1509652|P1|STARTED|Overall Study||6
615658|NCT00326495|1509671|P1|NOT COMPLETED|Overall Study||5
615659|NCT00326495|1509671|P1|COMPLETED|Overall Study||46
615660|NCT00326495|1509671|P1|STARTED|Overall Study||51
615661|NCT00326417|1509678|P4|NOT COMPLETED|Overall Study||3
615662|NCT00326417|1509679|P3|NOT COMPLETED|Overall Study||1
615663|NCT00326417|1509680|P2|NOT COMPLETED|Overall Study||0
615664|NCT00326417|1509681|P1|NOT COMPLETED|Overall Study||14
615665|NCT00326417|1509678|P4|COMPLETED|Overall Study|Arm was closed to accrual after 3 patients experienced graft failure.|0
615666|NCT00326417|1509679|P3|COMPLETED|Overall Study||38
615667|NCT00326417|1509680|P2|COMPLETED|Overall Study||41
615668|NCT00326417|1509681|P1|COMPLETED|Overall Study|Dose level was closed for excessive toxicity after 8 patients in Phase II accrued.|0
615669|NCT00326417|1509678|P4|Phase II|Overall Study||0
615670|NCT00326417|1509679|P3|Phase II|Overall Study||33
615671|NCT00326417|1509680|P2|Phase II|Overall Study||35
615672|NCT00326417|1509681|P1|Phase II|Overall Study||8
615673|NCT00326417|1509678|P4|Phase I|Overall Study||3
615674|NCT00326417|1509679|P3|Phase I|Overall Study||6
615675|NCT00326417|1509680|P2|Phase I|Overall Study||6
615676|NCT00326417|1509681|P1|Phase I|Overall Study||6
615677|NCT00326417|1509678|P4|STARTED|Overall Study||3
615678|NCT00326417|1509679|P3|STARTED|Overall Study||39
615679|NCT00326417|1509680|P2|STARTED|Overall Study||41
615680|NCT00326417|1509681|P1|STARTED|Overall Study||14
615681|NCT00326196|1509699|P2|NOT COMPLETED|Overall Study||0
615682|NCT00326196|1509700|P1|NOT COMPLETED|Overall Study||0
615683|NCT00326196|1509699|P2|COMPLETED|Overall Study||97
615684|NCT00326196|1509700|P1|COMPLETED|Overall Study||101
615685|NCT00326196|1509699|P2|STARTED|Overall Study||97
615686|NCT00326196|1509700|P1|STARTED|Overall Study||101
615687|NCT00326183|1509708|P2|NOT COMPLETED|Overall Study||83
615688|NCT00326183|1509709|P1|NOT COMPLETED|Overall Study||200
615689|NCT00326183|1509708|P2|COMPLETED|Overall Study||264
615690|NCT00326183|1509709|P1|COMPLETED|Overall Study||1253
615691|NCT00326183|1509708|P2|Postvaccination 2 Post-safety Follow-up|Overall Study||271
615692|NCT00326183|1509709|P1|Postvaccination 2 Post-safety Follow-up|Overall Study||1265
615693|NCT00326183|1509708|P2|Vaccination 2 + Safety Follow-up|Overall Study||292
615694|NCT00326183|1509709|P1|Vaccination 2 + Safety Follow-up|Overall Study||1301
615695|NCT00326183|1509708|P2|Postvaccination 1 Post-safety Follow-up|Overall Study||325
615696|NCT00326183|1509709|P1|Postvaccination 1 Post-safety Follow-up|Overall Study||1393
615697|NCT00326183|1509708|P2|Vaccination 1 + Safety Follow-up|Overall Study||347
615698|NCT00326183|1509709|P1|Vaccination 1 + Safety Follow-up|Overall Study||1453
615699|NCT00326183|1509708|P2|STARTED|Overall Study||347
615700|NCT00326183|1509709|P1|STARTED|Overall Study||1453
615701|NCT00326170|1509735|P1|NOT COMPLETED|Overall Study||0
615702|NCT00326170|1509735|P1|COMPLETED|Overall Study||34
615703|NCT00326170|1509735|P1|STARTED|Overall Study||34
615704|NCT00326118|1509741|P2|NOT COMPLETED|Year 5 Follow up||0
615705|NCT00326118|1509742|P1|NOT COMPLETED|Year 5 Follow up||0
615706|NCT00326118|1509741|P2|COMPLETED|Year 5 Follow up||78
615707|NCT00326118|1509742|P1|COMPLETED|Year 5 Follow up||217
615708|NCT00326118|1509741|P2|STARTED|Year 5 Follow up||78
615709|NCT00326118|1509742|P1|STARTED|Year 5 Follow up||217
615710|NCT00326118|1509741|P2|NOT COMPLETED|Year 4 Follow-up||0
615711|NCT00326118|1509742|P1|NOT COMPLETED|Year 4 Follow-up||0
615712|NCT00326118|1509741|P2|COMPLETED|Year 4 Follow-up||80
615713|NCT00326118|1509742|P1|COMPLETED|Year 4 Follow-up||228
615714|NCT00326118|1509741|P2|STARTED|Year 4 Follow-up||80
615715|NCT00326118|1509742|P1|STARTED|Year 4 Follow-up||228
615716|NCT00326118|1509741|P2|NOT COMPLETED|Year 3 Follow-up||0
615717|NCT00326118|1509742|P1|NOT COMPLETED|Year 3 Follow-up||0
615718|NCT00326118|1509741|P2|COMPLETED|Year 3 Follow-up||89
615719|NCT00326118|1509742|P1|COMPLETED|Year 3 Follow-up||256
615720|NCT00326118|1509741|P2|STARTED|Year 3 Follow-up||89
615721|NCT00326118|1509742|P1|STARTED|Year 3 Follow-up||256
615722|NCT00326118|1509741|P2|NOT COMPLETED|Year 2 Follow-up||0
615723|NCT00326118|1509742|P1|NOT COMPLETED|Year 2 Follow-up||0
615724|NCT00326118|1509741|P2|COMPLETED|Year 2 Follow-up||92
615725|NCT00326118|1509742|P1|COMPLETED|Year 2 Follow-up||270
615726|NCT00326118|1509741|P2|STARTED|Year 2 Follow-up||92
615727|NCT00326118|1509742|P1|STARTED|Year 2 Follow-up||270
615728|NCT00326118|1509741|P2|NOT COMPLETED|Year 1 Follow-up||0
615729|NCT00326118|1509742|P1|NOT COMPLETED|Year 1 Follow-up||0
615730|NCT00326118|1509741|P2|COMPLETED|Year 1 Follow-up||100
615731|NCT00326118|1509742|P1|COMPLETED|Year 1 Follow-up||295
615732|NCT00326118|1509741|P2|STARTED|Year 1 Follow-up||100
615733|NCT00326118|1509742|P1|STARTED|Year 1 Follow-up||295
615734|NCT00326118|1509741|P2|NOT COMPLETED|Active Phase||1
615735|NCT00326118|1509742|P1|NOT COMPLETED|Active Phase||4
615736|NCT00326118|1509741|P2|COMPLETED|Active Phase||108
615737|NCT00326118|1509742|P1|COMPLETED|Active Phase||320
615738|NCT00326118|1509741|P2|STARTED|Active Phase||109
615739|NCT00326118|1509742|P1|STARTED|Active Phase||324
615740|NCT00326001|1509778|P2|NOT COMPLETED|Overall Study||8
615741|NCT00326001|1509779|P1|NOT COMPLETED|Overall Study||7
615742|NCT00326001|1509778|P2|COMPLETED|Overall Study||219
615743|NCT00326001|1509779|P1|COMPLETED|Overall Study||229
615744|NCT00326001|1509778|P2|STARTED|Overall Study||227
615745|NCT00326001|1509779|P1|STARTED|Overall Study||236
615746|NCT00325897|1509793|P2|NOT COMPLETED|Overall Study||13
615747|NCT00325897|1509794|P1|NOT COMPLETED|Overall Study||12
615748|NCT00325897|1509793|P2|COMPLETED|Overall Study||559
615749|NCT00325897|1509794|P1|COMPLETED|Overall Study||558
615750|NCT00325897|1509793|P2|STARTED|Overall Study||572
615751|NCT00325897|1509794|P1|STARTED|Overall Study||570
615752|NCT00325819|1509814|P2|NOT COMPLETED|Overall Study||13
615753|NCT00325819|1509815|P1|NOT COMPLETED|Overall Study||9
615754|NCT00325819|1509814|P2|COMPLETED|Overall Study||176
615755|NCT00325819|1509815|P1|COMPLETED|Overall Study||176
615756|NCT00325819|1509814|P2|STARTED|Overall Study||189
615757|NCT00325819|1509815|P1|STARTED|Overall Study||185
615758|NCT00325780|1509835|P1|NOT COMPLETED|Overall Study||155
615759|NCT00325780|1509835|P1|COMPLETED|Overall Study||1200
615760|NCT00325780|1509835|P1|Safety Population|Overall Study|Patients who received at least one dose of study treatment in this extension study.|1353
615761|NCT00325780|1509835|P1|STARTED|Overall Study||1355
615762|NCT00325754|1509842|P2|NOT COMPLETED|Overall Study||1
615763|NCT00325754|1509843|P1|NOT COMPLETED|Overall Study||4
615764|NCT00325754|1509842|P2|COMPLETED|Overall Study||10
615765|NCT00325754|1509843|P1|COMPLETED|Overall Study||7
615766|NCT00325754|1509842|P2|STARTED|Overall Study||11
615767|NCT00325754|1509843|P1|STARTED|Overall Study||11
615768|NCT00325598|1509859|P2|NOT COMPLETED|Overall Study||0
615769|NCT00325598|1509860|P1|NOT COMPLETED|Overall Study||0
615770|NCT00325598|1509859|P2|COMPLETED|Overall Study||50
615771|NCT00325598|1509860|P1|COMPLETED|Overall Study||50
615772|NCT00325598|1509859|P2|STARTED|Overall Study||50
615773|NCT00325598|1509860|P1|STARTED|Overall Study||50
615774|NCT00325468|1509889|P5|NOT COMPLETED|Overall Study||8
615775|NCT00325468|1509890|P4|NOT COMPLETED|Overall Study||34
615776|NCT00325468|1509891|P3|NOT COMPLETED|Overall Study||4
615777|NCT00325468|1509892|P2|NOT COMPLETED|Overall Study||5
615778|NCT00325468|1509893|P1|NOT COMPLETED|Overall Study||11
615779|NCT00325468|1509889|P5|COMPLETED|Overall Study||14
615780|NCT00325468|1509890|P4|COMPLETED|Overall Study||90
615781|NCT00325468|1509891|P3|COMPLETED|Overall Study||10
615782|NCT00325468|1509892|P2|COMPLETED|Overall Study||12
615783|NCT00325468|1509893|P1|COMPLETED|Overall Study||12
615784|NCT00325468|1509889|P5|STARTED|Overall Study||22
615785|NCT00325468|1509890|P4|STARTED|Overall Study||124
615786|NCT00325468|1509891|P3|STARTED|Overall Study||14
615787|NCT00325468|1509892|P2|STARTED|Overall Study||17
615788|NCT00325468|1509893|P1|STARTED|Overall Study||23
615789|NCT00325442|1509928|P2|NOT COMPLETED|Overall Study||21
615790|NCT00325442|1509929|P1|NOT COMPLETED|Overall Study||9
615791|NCT00325442|1509928|P2|COMPLETED|Overall Study||153
615792|NCT00325442|1509929|P1|COMPLETED|Overall Study||167
615793|NCT00325442|1509928|P2|STARTED|Overall Study||174
615794|NCT00325442|1509929|P1|STARTED|Overall Study||176
615795|NCT00325416|1509976|P2|NOT COMPLETED|Phase II: Treatment at MTD||2
615796|NCT00325416|1509977|P1|NOT COMPLETED|Phase II: Treatment at MTD||0
615797|NCT00325416|1509976|P2|COMPLETED|Phase II: Treatment at MTD||40
615798|NCT00325416|1509977|P1|COMPLETED|Phase II: Treatment at MTD||78
615799|NCT00325416|1509976|P2|Enrolled During Phase II|Phase II: Treatment at MTD||8
615800|NCT00325416|1509977|P1|Enrolled During Phase II|Phase II: Treatment at MTD||40
615801|NCT00325416|1509976|P2|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||34
615802|NCT00325416|1509977|P1|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||38
615803|NCT00325416|1509976|P2|STARTED|Phase II: Treatment at MTD||42
615804|NCT00325416|1509977|P1|STARTED|Phase II: Treatment at MTD||78
615805|NCT00325416|1509976|P2|NOT COMPLETED|Phase I: Dose Escalation||16
615806|NCT00325416|1509977|P1|NOT COMPLETED|Phase I: Dose Escalation||22
615807|NCT00325416|1509976|P2|COMPLETED|Phase I: Dose Escalation||44
615808|NCT00325416|1509977|P1|COMPLETED|Phase I: Dose Escalation||48
615809|NCT00325416|1509976|P2|STARTED|Phase I: Dose Escalation||60
615810|NCT00325416|1509977|P1|STARTED|Phase I: Dose Escalation||70
615811|NCT00325403|1509991|P2|NOT COMPLETED|Overall Study||51
615812|NCT00325403|1509992|P1|NOT COMPLETED|Overall Study||18
615813|NCT00325403|1509991|P2|COMPLETED|Overall Study|182 subjects receiving oral treprostinil completed the study on study drug|182
615814|NCT00325403|1509992|P1|COMPLETED|Overall Study|98 subjects receiving placebo completed the study on study drug|98
615815|NCT00325403|1509991|P2|STARTED|Overall Study||233
615816|NCT00325403|1509992|P1|STARTED|Overall Study||116
615817|NCT00325234|1510030|P2|NOT COMPLETED|Overall Study||66
615818|NCT00325234|1510031|P1|NOT COMPLETED|Overall Study||69
615819|NCT00325234|1510030|P2|COMPLETED|Overall Study||0
615820|NCT00325234|1510031|P1|COMPLETED|Overall Study||0
615821|NCT00325234|1510030|P2|Received At Least 1 Dose of Study Drug|Overall Study||66
615822|NCT00325234|1510031|P1|Received At Least 1 Dose of Study Drug|Overall Study||65
615823|NCT00325234|1510030|P2|STARTED|Overall Study||66
615824|NCT00325234|1510031|P1|STARTED|Overall Study||69
615825|NCT00325195|1510050|P3|NOT COMPLETED|Received Intervention: ITT Population||4
615826|NCT00325195|1510051|P2|NOT COMPLETED|Received Intervention: ITT Population||25
615827|NCT00325195|1510052|P1|NOT COMPLETED|Received Intervention: ITT Population||26
615828|NCT00325195|1510050|P3|COMPLETED|Received Intervention: ITT Population||39
615829|NCT00325195|1510051|P2|COMPLETED|Received Intervention: ITT Population||59
615830|NCT00325195|1510052|P1|COMPLETED|Received Intervention: ITT Population||59
615831|NCT00325195|1510050|P3|STARTED|Received Intervention: ITT Population||43
615832|NCT00325195|1510051|P2|STARTED|Received Intervention: ITT Population||84
615833|NCT00325195|1510052|P1|STARTED|Received Intervention: ITT Population||85
615834|NCT00325195|1510050|P3|NOT COMPLETED|Randomized||3
615835|NCT00325195|1510051|P2|NOT COMPLETED|Randomized||5
615836|NCT00325195|1510052|P1|NOT COMPLETED|Randomized||5
615837|NCT00325195|1510050|P3|COMPLETED|Randomized||43
615838|NCT00325195|1510051|P2|COMPLETED|Randomized||84
615839|NCT00325195|1510052|P1|COMPLETED|Randomized||85
615840|NCT00325195|1510050|P3|STARTED|Randomized||46
615841|NCT00325195|1510051|P2|STARTED|Randomized||89
615842|NCT00325195|1510052|P1|STARTED|Randomized||90
615843|NCT00325156|1510075|P1|NOT COMPLETED|Overall Study||112
615844|NCT00325156|1510075|P1|COMPLETED|Overall Study||2478
615845|NCT00325156|1510075|P1|STARTED|Overall Study||2590
615846|NCT00325143|1510082|P1|NOT COMPLETED|Overall Study||26
615847|NCT00325143|1510082|P1|COMPLETED|Overall Study||676
615848|NCT00325143|1510082|P1|STARTED|Overall Study||702
615849|NCT00325130|1510092|P2|NOT COMPLETED|Overall Study||30
615850|NCT00325130|1510093|P1|NOT COMPLETED|Overall Study||19
615851|NCT00325130|1510092|P2|COMPLETED|Overall Study||494
615852|NCT00325130|1510093|P1|COMPLETED|Overall Study||499
615853|NCT00325130|1510092|P2|STARTED|Overall Study||524
615854|NCT00325130|1510093|P1|STARTED|Overall Study||518
615855|NCT00325078|1510136|P3|NOT COMPLETED|Overall Study||2
615856|NCT00325078|1510137|P2|NOT COMPLETED|Overall Study||5
615857|NCT00325078|1510138|P1|NOT COMPLETED|Overall Study||5
615858|NCT00325078|1510136|P3|COMPLETED|Overall Study||23
615859|NCT00325078|1510137|P2|COMPLETED|Overall Study||2
615860|NCT00325078|1510138|P1|COMPLETED|Overall Study||3
615861|NCT00325078|1510136|P3|STARTED|Overall Study||25
615862|NCT00325078|1510137|P2|STARTED|Overall Study||7
615863|NCT00325078|1510138|P1|STARTED|Overall Study||8
615864|NCT00325039|1510150|P2|NOT COMPLETED|Overall Study||14
615865|NCT00325039|1510151|P1|NOT COMPLETED|Overall Study||18
615866|NCT00325039|1510150|P2|COMPLETED|Overall Study||285
615867|NCT00325039|1510151|P1|COMPLETED|Overall Study||280
615868|NCT00325039|1510150|P2|STARTED|Overall Study||299
615869|NCT00325039|1510151|P1|STARTED|Overall Study||298
615870|NCT00324987|1510167|P2|NOT COMPLETED|Overall Study||6
615871|NCT00324987|1510168|P1|NOT COMPLETED|Overall Study||6
615872|NCT00324987|1510167|P2|COMPLETED|Overall Study|Patients were to be treated until progression|0
615873|NCT00324987|1510168|P1|COMPLETED|Overall Study|Patients were to be treated until progression|0
615874|NCT00324987|1510167|P2|STARTED|Overall Study||6
615875|NCT00324987|1510168|P1|STARTED|Overall Study||6
615876|NCT00324961|1510182|P1|NOT COMPLETED|Overall Study||43
615877|NCT00324961|1510182|P1|COMPLETED|Overall Study||490
615878|NCT00324961|1510182|P1|STARTED|Overall Study||533
615879|NCT00324896|1510197|P2|NOT COMPLETED|Overall Study||8
615880|NCT00324896|1510198|P1|NOT COMPLETED|Overall Study||3
615881|NCT00324896|1510197|P2|COMPLETED|Overall Study||7
615882|NCT00324896|1510198|P1|COMPLETED|Overall Study||12
615883|NCT00324896|1510197|P2|STARTED|Overall Study||15
615884|NCT00324896|1510198|P1|STARTED|Overall Study||15
615885|NCT00324870|1510206|P1|NOT COMPLETED|Overall Study||0
615886|NCT00324870|1510206|P1|COMPLETED|Overall Study||37
615887|NCT00324870|1510206|P1|STARTED|Overall Study||37
615888|NCT00324857|1510214|P4|NOT COMPLETED|Overall Study||5
615889|NCT00324857|1510215|P3|NOT COMPLETED|Overall Study||7
615890|NCT00324857|1510216|P2|NOT COMPLETED|Overall Study||6
615891|NCT00324857|1510217|P1|NOT COMPLETED|Overall Study||6
615892|NCT00324857|1510214|P4|COMPLETED|Overall Study||158
615893|NCT00324857|1510215|P3|COMPLETED|Overall Study||158
615894|NCT00324857|1510216|P2|COMPLETED|Overall Study||162
615895|NCT00324857|1510217|P1|COMPLETED|Overall Study||161
615896|NCT00324857|1510214|P4|STARTED|Overall Study||163
615897|NCT00324857|1510215|P3|STARTED|Overall Study||165
615898|NCT00324857|1510216|P2|STARTED|Overall Study||168
615899|NCT00324857|1510217|P1|STARTED|Overall Study||167
615900|NCT00324805|1510229|P2|NOT COMPLETED|Overall Study||483
615901|NCT00324805|1510230|P1|NOT COMPLETED|Overall Study||150
615902|NCT00324805|1510229|P2|COMPLETED|Overall Study||269
615903|NCT00324805|1510230|P1|COMPLETED|Overall Study||599
615904|NCT00324805|1510229|P2|Started Assigned Therapy|Overall Study||735
615905|NCT00324805|1510230|P1|Started Assigned Therapy|Overall Study||737
615906|NCT00324805|1510229|P2|STARTED|Overall Study||752
615907|NCT00324805|1510230|P1|STARTED|Overall Study||749
615908|NCT00324740|1510242|P3|NOT COMPLETED|Overall Study||1
615909|NCT00324740|1510243|P2|NOT COMPLETED|Overall Study||0
615910|NCT00324740|1510244|P1|NOT COMPLETED|Overall Study||1
615911|NCT00324740|1510242|P3|COMPLETED|Overall Study||3
615912|NCT00324740|1510243|P2|COMPLETED|Overall Study||3
615913|NCT00324740|1510244|P1|COMPLETED|Overall Study||6
615914|NCT00324740|1510242|P3|STARTED|Overall Study||4
615915|NCT00324740|1510243|P2|STARTED|Overall Study||3
615916|NCT00324740|1510244|P1|STARTED|Overall Study||7
615917|NCT00324701|1510253|P2|NOT COMPLETED|Overall Study||17
615918|NCT00324701|1510254|P1|NOT COMPLETED|Overall Study||20
615919|NCT00324701|1510253|P2|COMPLETED|Overall Study||104
615920|NCT00324701|1510254|P1|COMPLETED|Overall Study||100
615921|NCT00324701|1510253|P2|Week 8 Assessment|Overall Study||107
615922|NCT00324701|1510254|P1|Week 8 Assessment|Overall Study||108
615923|NCT00324701|1510253|P2|STARTED|Overall Study||121
615924|NCT00324701|1510254|P1|STARTED|Overall Study||120
615925|NCT00324675|1510264|P2|NOT COMPLETED|Overall Study||0
615926|NCT00324675|1510265|P1|NOT COMPLETED|Overall Study||1
615927|NCT00324675|1510264|P2|COMPLETED|Overall Study||14
615928|NCT00324675|1510265|P1|COMPLETED|Overall Study||13
615929|NCT00324675|1510264|P2|STARTED|Overall Study||14
615930|NCT00324675|1510265|P1|STARTED|Overall Study||14
615931|NCT00324649|1510273|P2|NOT COMPLETED|Overall Study||5
615932|NCT00324649|1510274|P1|NOT COMPLETED|Overall Study||2
615933|NCT00324649|1510273|P2|COMPLETED|Overall Study||36
615934|NCT00324649|1510274|P1|COMPLETED|Overall Study||37
615935|NCT00324649|1510273|P2|STARTED|Overall Study||41
615936|NCT00324649|1510274|P1|STARTED|Overall Study||39
615937|NCT00324415|1510314|P1|NOT COMPLETED|Overall Study||0
615938|NCT00324415|1510314|P1|COMPLETED|Overall Study||45
615939|NCT00324415|1510314|P1|STARTED|Overall Study||45
615940|NCT00324350|1510329|P2|NOT COMPLETED|Overall Study||0
615941|NCT00324350|1510330|P1|NOT COMPLETED|Overall Study||0
615942|NCT00324350|1510329|P2|COMPLETED|Overall Study||3632
615943|NCT00324350|1510330|P1|COMPLETED|Overall Study||3655
615944|NCT00324350|1510329|P2|Falls Follow-Up|Overall Study||3418
615945|NCT00324350|1510330|P1|Falls Follow-Up|Overall Study||3364
615946|NCT00324350|1510329|P2|Non-Vertebral Fracture Follow-Up|Overall Study||3632
615947|NCT00324350|1510330|P1|Non-Vertebral Fracture Follow-Up|Overall Study||3655
615948|NCT00324350|1510329|P2|STARTED|Overall Study||3632
615949|NCT00324350|1510330|P1|STARTED|Overall Study||3655
615950|NCT00324272|1510344|P4|NOT COMPLETED|Overall Study||0
615951|NCT00324272|1510345|P3|NOT COMPLETED|Overall Study||0
615952|NCT00324272|1510346|P2|NOT COMPLETED|Overall Study||0
615953|NCT00324272|1510347|P1|NOT COMPLETED|Overall Study||0
615954|NCT00324272|1510344|P4|COMPLETED|Overall Study||18
615955|NCT00324272|1510345|P3|COMPLETED|Overall Study||18
615956|NCT00324272|1510346|P2|COMPLETED|Overall Study||20
615957|NCT00324272|1510347|P1|COMPLETED|Overall Study||18
615958|NCT00324272|1510344|P4|STARTED|Overall Study||18
615959|NCT00324272|1510345|P3|STARTED|Overall Study||18
615960|NCT00324272|1510346|P2|STARTED|Overall Study||20
615961|NCT00324272|1510347|P1|STARTED|Overall Study||18
615962|NCT00324259|1510383|P2|NOT COMPLETED|Overall Study||0
615963|NCT00324259|1510384|P1|NOT COMPLETED|Overall Study||0
615964|NCT00324259|1510383|P2|COMPLETED|Overall Study||32
615965|NCT00324259|1510384|P1|COMPLETED|Overall Study||34
615966|NCT00324259|1510383|P2|STARTED|Overall Study||32
615967|NCT00324259|1510384|P1|STARTED|Overall Study||34
615968|NCT00324233|1510405|P2|NOT COMPLETED|Second Period||7
615969|NCT00324233|1510406|P1|NOT COMPLETED|Second Period||5
615970|NCT00324233|1510405|P2|COMPLETED|Second Period||11
615971|NCT00324233|1510406|P1|COMPLETED|Second Period||12
615972|NCT00324233|1510405|P2|STARTED|Second Period||18
615973|NCT00324233|1510406|P1|STARTED|Second Period||17
615974|NCT00324233|1510405|P2|NOT COMPLETED|First Period||0
615975|NCT00324233|1510406|P1|NOT COMPLETED|First Period||1
615976|NCT00324233|1510405|P2|COMPLETED|First Period||18
615977|NCT00324233|1510406|P1|COMPLETED|First Period||17
615978|NCT00324233|1510405|P2|STARTED|First Period||18
615979|NCT00324233|1510406|P1|STARTED|First Period||18
615980|NCT00324168|1510414|P2|NOT COMPLETED|Overall Study||30
615981|NCT00324168|1510415|P1|NOT COMPLETED|Overall Study||28
615982|NCT00324168|1510414|P2|COMPLETED|Overall Study||220
615983|NCT00324168|1510415|P1|COMPLETED|Overall Study||222
615984|NCT00324168|1510414|P2|STARTED|Overall Study||250
615985|NCT00324168|1510415|P1|STARTED|Overall Study||250
615986|NCT00324155|1510443|P2|NOT COMPLETED|Follow-up Phase||6
615987|NCT00324155|1510444|P1|NOT COMPLETED|Follow-up Phase||11
615988|NCT00324155|1510443|P2|COMPLETED|Follow-up Phase||245
615989|NCT00324155|1510444|P1|COMPLETED|Follow-up Phase||236
615990|NCT00324155|1510443|P2|STARTED|Follow-up Phase|All participants received study drug. Follow-up was performed for those leaving earlier phases.|251
615991|NCT00324155|1510444|P1|STARTED|Follow-up Phase|All participants received study drug. Follow-up was performed for those leaving earlier phases.|247
615992|NCT00324155|1510443|P2|NOT COMPLETED|Received Treatment in Maintenance Phase||47
615993|NCT00324155|1510444|P1|NOT COMPLETED|Received Treatment in Maintenance Phase||32
615994|NCT00324155|1510443|P2|COMPLETED|Received Treatment in Maintenance Phase|Study is in closure. 6 participants in Maintenance Phase not yet summarized.|6
615995|NCT00324155|1510444|P1|COMPLETED|Received Treatment in Maintenance Phase|Study is in closure at this time. 11 in Maintenance Phase not yet summarized.|11
615996|NCT00324155|1510443|P2|STARTED|Received Treatment in Maintenance Phase|1 completed Induction Phase but did not enter Maintenance Phase|53
615997|NCT00324155|1510444|P1|STARTED|Received Treatment in Maintenance Phase|2 completed Induction Phase but did not enter Maintenance Phase|43
615998|NCT00324155|1510443|P2|NOT COMPLETED|Received Treatment in Induction Phase||197
615999|NCT00324155|1510444|P1|NOT COMPLETED|Received Treatment in Induction Phase||202
616000|NCT00324155|1510443|P2|COMPLETED|Received Treatment in Induction Phase|54 participants on treatment at end of Induction Phase. Study undergoing closure.|54
616001|NCT00324155|1510444|P1|COMPLETED|Received Treatment in Induction Phase|45 participants on treatment at end of Induction Phase. Study undergoing closure.|45
616002|NCT00324155|1510443|P2|STARTED|Received Treatment in Induction Phase||251
616003|NCT00324155|1510444|P1|STARTED|Received Treatment in Induction Phase||247
616004|NCT00324155|1510443|P2|NOT COMPLETED|Enrolled and Randomized||1
616005|NCT00324155|1510444|P1|NOT COMPLETED|Enrolled and Randomized||3
616006|NCT00324155|1510443|P2|COMPLETED|Enrolled and Randomized|1 randomized but who did not receive treatment (lost to follow-up).|251
616007|NCT00324155|1510444|P1|COMPLETED|Enrolled and Randomized|3 randomized but who did not receive treatment (no longer met study criteria).|247
616008|NCT00324155|1510443|P2|STARTED|Enrolled and Randomized||252
616009|NCT00324155|1510444|P1|STARTED|Enrolled and Randomized||250
616010|NCT00324116|1510474|P1|NOT COMPLETED|Overall Study||32
616011|NCT00324116|1510474|P1|COMPLETED|Overall Study||49
616012|NCT00324116|1510474|P1|STARTED|Overall Study|subjects received treatment|81
616013|NCT00324038|1510486|P2|NOT COMPLETED|Overall Study||51
616014|NCT00324038|1510487|P1|NOT COMPLETED|Overall Study||49
616015|NCT00324038|1510486|P2|COMPLETED|Overall Study||58
616016|NCT00324038|1510487|P1|COMPLETED|Overall Study||61
616017|NCT00324038|1510486|P2|STARTED|Overall Study||109
616018|NCT00324038|1510487|P1|STARTED|Overall Study||110
616019|NCT00323882|1510498|P5|NOT COMPLETED|Overall Study||32
616020|NCT00323882|1510499|P4|NOT COMPLETED|Overall Study||7
616021|NCT00323882|1510500|P3|NOT COMPLETED|Overall Study||13
616022|NCT00323882|1510501|P2|NOT COMPLETED|Overall Study||6
616023|NCT00323882|1510502|P1|NOT COMPLETED|Overall Study||8
616024|NCT00323882|1510498|P5|COMPLETED|Overall Study||2
616025|NCT00323882|1510499|P4|COMPLETED|Overall Study||0
616026|NCT00323882|1510500|P3|COMPLETED|Overall Study||3
616027|NCT00323882|1510501|P2|COMPLETED|Overall Study||0
616028|NCT00323882|1510502|P1|COMPLETED|Overall Study||0
616029|NCT00323882|1510498|P5|STARTED|Overall Study||34
616030|NCT00323882|1510499|P4|STARTED|Overall Study||7
616031|NCT00323882|1510500|P3|STARTED|Overall Study||16
616032|NCT00323882|1510501|P2|STARTED|Overall Study||6
616033|NCT00323882|1510502|P1|STARTED|Overall Study||8
616034|NCT00323869|1510573|P1|NOT COMPLETED|Overall Study||1
616035|NCT00323869|1510573|P1|COMPLETED|Overall Study||47
616036|NCT00323869|1510573|P1|Treatment Initiation|Overall Study|One participant died before receiving therapy, not included in analysis|47
616037|NCT00323869|1510573|P1|STARTED|Overall Study|Enrollment|48
616038|NCT00323739|1510585|P1|NOT COMPLETED|Overall Study||0
616039|NCT00323739|1510585|P1|COMPLETED|Overall Study||80
616040|NCT00323739|1510585|P1|STARTED|Overall Study||80
616041|NCT00323635|1510592|P2|NOT COMPLETED|Overall Study||0
616042|NCT00323635|1510593|P1|NOT COMPLETED|Overall Study||0
616043|NCT00323635|1510592|P2|COMPLETED|Overall Study||9
616044|NCT00323635|1510593|P1|COMPLETED|Overall Study||10
616045|NCT00323635|1510592|P2|STARTED|Overall Study||9
616046|NCT00323635|1510593|P1|STARTED|Overall Study||10
616047|NCT00323622|1510629|P8|NOT COMPLETED|Overall Study||15
616048|NCT00323622|1510630|P7|NOT COMPLETED|Overall Study||5
616049|NCT00323622|1510631|P6|NOT COMPLETED|Overall Study||74
616050|NCT00323622|1510632|P5|NOT COMPLETED|Overall Study||39
616051|NCT00323622|1510633|P4|NOT COMPLETED|Overall Study||12
616052|NCT00323622|1510634|P3|NOT COMPLETED|Overall Study||4
616053|NCT00323622|1510635|P2|NOT COMPLETED|Overall Study||92
616054|NCT00323622|1510636|P1|NOT COMPLETED|Overall Study||31
616055|NCT00323622|1510629|P8|COMPLETED|Overall Study||125
616056|NCT00323622|1510630|P7|COMPLETED|Overall Study||38
616057|NCT00323622|1510631|P6|COMPLETED|Overall Study||454
616058|NCT00323622|1510632|P5|COMPLETED|Overall Study||120
616059|NCT00323622|1510633|P4|COMPLETED|Overall Study||122
616060|NCT00323622|1510634|P3|COMPLETED|Overall Study||38
616061|NCT00323622|1510635|P2|COMPLETED|Overall Study||423
616062|NCT00323622|1510636|P1|COMPLETED|Overall Study||145
616063|NCT00323622|1510629|P8|STARTED|Overall Study||140
616064|NCT00323622|1510630|P7|STARTED|Overall Study||43
616065|NCT00323622|1510631|P6|STARTED|Overall Study||528
616066|NCT00323622|1510632|P5|STARTED|Overall Study||159
616067|NCT00323622|1510633|P4|STARTED|Overall Study||134
616068|NCT00323622|1510634|P3|STARTED|Overall Study||42
616069|NCT00323622|1510635|P2|STARTED|Overall Study||515
616070|NCT00323622|1510636|P1|STARTED|Overall Study||176
616071|NCT00323609|1510678|P4|NOT COMPLETED|Overall Study||15
616072|NCT00323609|1510679|P3|NOT COMPLETED|Overall Study||8
616073|NCT00323609|1510680|P2|NOT COMPLETED|Overall Study||99
616074|NCT00323609|1510681|P1|NOT COMPLETED|Overall Study||91
616075|NCT00323609|1510678|P4|COMPLETED|Overall Study||0
616076|NCT00323609|1510679|P3|COMPLETED|Overall Study||0
616077|NCT00323609|1510680|P2|COMPLETED|Overall Study|Revision retains subjects with follow-up data in a visit window when terminated in same visit window|91
616078|NCT00323609|1510681|P1|COMPLETED|Overall Study|Revision retains subjects with follow-up data in a visit window when terminated in same visit window|100
616079|NCT00323609|1510678|P4|STARTED|Overall Study||15
616080|NCT00323609|1510679|P3|STARTED|Overall Study||8
616081|NCT00323609|1510680|P2|STARTED|Overall Study||190
616082|NCT00323609|1510681|P1|STARTED|Overall Study||191
616083|NCT00323557|1510717|P2|NOT COMPLETED|Overall Study||0
616084|NCT00323557|1510718|P1|NOT COMPLETED|Overall Study||1
616085|NCT00323557|1510717|P2|COMPLETED|Overall Study||7
616086|NCT00323557|1510718|P1|COMPLETED|Overall Study||24
616087|NCT00323557|1510717|P2|STARTED|Overall Study||7
616088|NCT00323557|1510718|P1|STARTED|Overall Study|GM-CSF pre and post vaccine.|25
616089|NCT00323492|1510727|P3|NOT COMPLETED|Study Phase 2||1
616090|NCT00323492|1510728|P2|NOT COMPLETED|Study Phase 2||1
616091|NCT00323492|1510729|P1|NOT COMPLETED|Study Phase 2||4
616092|NCT00323492|1510727|P3|COMPLETED|Study Phase 2||24
616093|NCT00323492|1510728|P2|COMPLETED|Study Phase 2||17
616094|NCT00323492|1510729|P1|COMPLETED|Study Phase 2||40
616095|NCT00323492|1510727|P3|STARTED|Study Phase 2|N=25 switched to Truvada in Phase 2.|25
616096|NCT00323492|1510728|P2|STARTED|Study Phase 2|2/45 subjects completed Phase 1 but did not start Phase 2. Week 48 ITT N=20 (no switch to Truvada)|18
616097|NCT00323492|1510729|P1|STARTED|Study Phase 2|1/45 subjects completed Phase 1 but did not start Phase 2. Week 48 ITT N=46|44
616098|NCT00323492|1510727|P3|NOT COMPLETED|Study Phase 1||0
616099|NCT00323492|1510728|P2|NOT COMPLETED|Study Phase 1||0
616100|NCT00323492|1510729|P1|NOT COMPLETED|Study Phase 1||2
616101|NCT00323492|1510727|P3|COMPLETED|Study Phase 1||0
616102|NCT00323492|1510728|P2|COMPLETED|Study Phase 1||45
616103|NCT00323492|1510729|P1|COMPLETED|Study Phase 1||45
616104|NCT00323492|1510727|P3|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||0
616105|NCT00323492|1510728|P2|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||45
616106|NCT00323492|1510729|P1|Intent-to-Treat (ITT) Analysis Set|Study Phase 1|One subject was excluded from ITT analysis set due to protocol violation.|46
616107|NCT00323492|1510727|P3|STARTED|Study Phase 1|Not applicable to Phase 1.|0
616108|NCT00323492|1510728|P2|STARTED|Study Phase 1||45
616109|NCT00323492|1510729|P1|STARTED|Study Phase 1||47
616110|NCT00323479|1510760|P1|NOT COMPLETED|Overall Study||8
616111|NCT00323479|1510760|P1|COMPLETED|Overall Study|with at least 1 evaluation for primary efficacy endpoint|106
616112|NCT00323479|1510760|P1|Safety Population|Overall Study|Patients who taken at least one dose of treatment|110
616113|NCT00323479|1510760|P1|STARTED|Overall Study||114
616114|NCT00323427|1510771|P2|NOT COMPLETED|Overall Study||23
616115|NCT00323427|1510772|P1|NOT COMPLETED|Overall Study||31
616116|NCT00323427|1510771|P2|COMPLETED|Overall Study||43
616117|NCT00323427|1510772|P1|COMPLETED|Overall Study||38
616118|NCT00323427|1510771|P2|STARTED|Overall Study||66
616119|NCT00323427|1510772|P1|STARTED|Overall Study||69
616120|NCT00323414|1510784|P2|NOT COMPLETED|Overall Study||1
616121|NCT00323414|1510785|P1|NOT COMPLETED|Overall Study||0
616122|NCT00323414|1510784|P2|COMPLETED|Overall Study||18
616123|NCT00323414|1510785|P1|COMPLETED|Overall Study||18
616124|NCT00323414|1510784|P2|STARTED|Overall Study||19
616125|NCT00323414|1510785|P1|STARTED|Overall Study||18
616126|NCT00323362|1510801|P1|NOT COMPLETED|Overall Study||0
616127|NCT00323362|1510801|P1|COMPLETED|Overall Study||17
616128|NCT00323362|1510801|P1|STARTED|Overall Study||17
616129|NCT00323310|1510807|P1|NOT COMPLETED|Overall Study||3
616130|NCT00323310|1510807|P1|COMPLETED|Overall Study||89
616131|NCT00323310|1510807|P1|STARTED|Overall Study||92
616132|NCT00323297|1510822|P2|NOT COMPLETED|Part B (Open-label)||12
616133|NCT00323297|1510823|P1|NOT COMPLETED|Part B (Open-label)||9
616134|NCT00323297|1510822|P2|COMPLETED|Part B (Open-label)||31
616135|NCT00323297|1510823|P1|COMPLETED|Part B (Open-label)||39
616136|NCT00323297|1510822|P2|STARTED|Part B (Open-label)||43
616137|NCT00323297|1510823|P1|STARTED|Part B (Open-label)||48
616138|NCT00323297|1510822|P2|NOT COMPLETED|Part A (Double Blind Randomized)||7
616139|NCT00323297|1510823|P1|NOT COMPLETED|Part A (Double Blind Randomized)||5
616140|NCT00323297|1510822|P2|COMPLETED|Part A (Double Blind Randomized)||43
616141|NCT00323297|1510823|P1|COMPLETED|Part A (Double Blind Randomized)||48
616142|NCT00323297|1510822|P2|STARTED|Part A (Double Blind Randomized)||50
616143|NCT00323297|1510823|P1|STARTED|Part A (Double Blind Randomized)||53
616144|NCT00323284|1510841|P2|NOT COMPLETED|24 Months Follow-up||22
616145|NCT00323284|1510842|P1|NOT COMPLETED|24 Months Follow-up||18
616146|NCT00323284|1510841|P2|COMPLETED|24 Months Follow-up||101
616147|NCT00323284|1510842|P1|COMPLETED|24 Months Follow-up||98
616148|NCT00323284|1510841|P2|STARTED|24 Months Follow-up||123
616149|NCT00323284|1510842|P1|STARTED|24 Months Follow-up||116
616150|NCT00323284|1510841|P2|NOT COMPLETED|12 Months Follow-up||9
616151|NCT00323284|1510842|P1|NOT COMPLETED|12 Months Follow-up||5
616152|NCT00323284|1510841|P2|COMPLETED|12 Months Follow-up||114
616153|NCT00323284|1510842|P1|COMPLETED|12 Months Follow-up||111
616154|NCT00323284|1510841|P2|STARTED|12 Months Follow-up||123
616155|NCT00323284|1510842|P1|STARTED|12 Months Follow-up||116
616156|NCT00323271|1510852|P2|NOT COMPLETED|Overall Study||3
616157|NCT00323271|1510853|P1|NOT COMPLETED|Overall Study||2
616158|NCT00323271|1510852|P2|COMPLETED|Overall Study||9
616159|NCT00323271|1510853|P1|COMPLETED|Overall Study||11
616160|NCT00323271|1510852|P2|STARTED|Overall Study||12
616161|NCT00323271|1510853|P1|STARTED|Overall Study||13
616162|NCT00323258|1510863|P2|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14
616163|NCT00323258|1510864|P1|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14
616164|NCT00323258|1510863|P2|COMPLETED|Secondary Outcome (6 Mon Refill Records)||58
616165|NCT00323258|1510864|P1|COMPLETED|Secondary Outcome (6 Mon Refill Records)||57
616166|NCT00323258|1510863|P2|STARTED|Secondary Outcome (6 Mon Refill Records)||72
616167|NCT00323258|1510864|P1|STARTED|Secondary Outcome (6 Mon Refill Records)||71
616168|NCT00323258|1510863|P2|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||19
616169|NCT00323258|1510864|P1|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||16
616170|NCT00323258|1510863|P2|COMPLETED|Primary Outcome (Phone Call at 6 Months)||53
616171|NCT00323258|1510864|P1|COMPLETED|Primary Outcome (Phone Call at 6 Months)||55
616172|NCT00323258|1510863|P2|STARTED|Primary Outcome (Phone Call at 6 Months)||72
616173|NCT00323258|1510864|P1|STARTED|Primary Outcome (Phone Call at 6 Months)||71
616174|NCT00323193|1510880|P2|NOT COMPLETED|Overall Study||15
616175|NCT00323193|1510881|P1|NOT COMPLETED|Overall Study||23
616176|NCT00323193|1510880|P2|COMPLETED|Overall Study||41
616177|NCT00323193|1510881|P1|COMPLETED|Overall Study||30
616178|NCT00323193|1510880|P2|STARTED|Overall Study||56
616179|NCT00323193|1510881|P1|STARTED|Overall Study||53
616180|NCT00323115|1510889|P1|NOT COMPLETED|Adjuvant Therapy & Survival Follow-Up||8
616181|NCT00323115|1510889|P1|COMPLETED|Adjuvant Therapy & Survival Follow-Up||2
616182|NCT00323115|1510889|P1|STARTED|Adjuvant Therapy & Survival Follow-Up||10
616183|NCT00323115|1510889|P1|NOT COMPLETED|Vaccine Administration||1
616184|NCT00323115|1510889|P1|COMPLETED|Vaccine Administration||10
616185|NCT00323115|1510889|P1|STARTED|Vaccine Administration||11
616186|NCT00323063|1510896|P2|NOT COMPLETED|Overall Study||0
616187|NCT00323063|1510897|P1|NOT COMPLETED|Overall Study||2
616188|NCT00323063|1510896|P2|COMPLETED|Overall Study||23
616189|NCT00323063|1510897|P1|COMPLETED|Overall Study||24
616190|NCT00323063|1510896|P2|STARTED|Overall Study||23
616191|NCT00323063|1510897|P1|STARTED|Overall Study||26
616192|NCT00323037|1510909|P2|NOT COMPLETED|Overall Study||27
616193|NCT00323037|1510910|P1|NOT COMPLETED|Overall Study||33
616194|NCT00323037|1510909|P2|COMPLETED|Overall Study||126
616195|NCT00323037|1510910|P1|COMPLETED|Overall Study||132
616196|NCT00323037|1510909|P2|STARTED|Overall Study|Number randomized|153
616197|NCT00323037|1510910|P1|STARTED|Overall Study|Number randomized|165
616198|NCT00322881|1510914|P1|NOT COMPLETED|Overall Study||5
616199|NCT00322881|1510914|P1|COMPLETED|Overall Study||7
616200|NCT00322881|1510914|P1|STARTED|Overall Study||12
616201|NCT00322868|1510918|P1|NOT COMPLETED|Overall Study||1
616202|NCT00322868|1510918|P1|COMPLETED|Overall Study||20
616203|NCT00322868|1510918|P1|STARTED|Overall Study||21
616204|NCT00322855|1510937|P1|NOT COMPLETED|Overall Study||0
616205|NCT00322855|1510937|P1|COMPLETED|Overall Study||1
616206|NCT00322855|1510937|P1|STARTED|Overall Study||1
616207|NCT00322842|1510943|P2|NOT COMPLETED|Overall Study||2
616208|NCT00322842|1510944|P1|NOT COMPLETED|Overall Study||2
616209|NCT00322842|1510943|P2|COMPLETED|Overall Study|One participant d/c treatment early, received a transplant, and was lost to follow-up after 6 months|29
616210|NCT00322842|1510944|P1|COMPLETED|Overall Study|One participant discontinued (d/c) treatment early, received a transplant, and completed the study.|2
616211|NCT00322842|1510943|P2|STARTED|Overall Study||31
616212|NCT00322842|1510944|P1|STARTED|Overall Study||4
616213|NCT00322777|1510971|P2|NOT COMPLETED|Overall Study||0
616214|NCT00322777|1510972|P1|NOT COMPLETED|Overall Study||0
616215|NCT00322777|1510971|P2|COMPLETED|Overall Study||45
616216|NCT00322777|1510972|P1|COMPLETED|Overall Study||39
616217|NCT00322777|1510971|P2|Data Collection at Week 24|Overall Study||45
616218|NCT00322777|1510972|P1|Data Collection at Week 24|Overall Study||39
616219|NCT00322777|1510971|P2|Data Collection at Week 16|Overall Study||45
616220|NCT00322777|1510972|P1|Data Collection at Week 16|Overall Study||39
616221|NCT00322777|1510971|P2|Data Collection at Week 8|Overall Study||45
616222|NCT00322777|1510972|P1|Data Collection at Week 8|Overall Study||39
616223|NCT00322777|1510971|P2|"Data Collection at BASELINE|"|Overall Study||45
616224|NCT00322777|1510972|P1|"Data Collection at BASELINE|"|Overall Study||39
616225|NCT00322777|1510971|P2|STARTED|Overall Study||45
616226|NCT00322777|1510972|P1|STARTED|Overall Study||39
616227|NCT00322712|1510982|P1|NOT COMPLETED|Overall Study||1
616228|NCT00322712|1510982|P1|COMPLETED|Overall Study||11
616229|NCT00322712|1510982|P1|STARTED|Overall Study||12
616230|NCT00322621|1510986|P3|NOT COMPLETED|Period III - Maintenance / Rescue Phase||36
616231|NCT00322621|1510987|P2|NOT COMPLETED|Period III - Maintenance / Rescue Phase||29
616232|NCT00322621|1510988|P1|NOT COMPLETED|Period III - Maintenance / Rescue Phase||0
616233|NCT00322621|1510986|P3|COMPLETED|Period III - Maintenance / Rescue Phase||33
616234|NCT00322621|1510987|P2|COMPLETED|Period III - Maintenance / Rescue Phase||86
616235|NCT00322621|1510988|P1|COMPLETED|Period III - Maintenance / Rescue Phase||0
616236|NCT00322621|1510986|P3|STARTED|Period III - Maintenance / Rescue Phase||69
616237|NCT00322621|1510987|P2|STARTED|Period III - Maintenance / Rescue Phase||115
616238|NCT00322621|1510988|P1|STARTED|Period III - Maintenance / Rescue Phase||0
616239|NCT00322621|1510986|P3|NOT COMPLETED|Period II - Acute Therapy Phase||0
616240|NCT00322621|1510987|P2|NOT COMPLETED|Period II - Acute Therapy Phase||0
616241|NCT00322621|1510988|P1|NOT COMPLETED|Period II - Acute Therapy Phase||32
616242|NCT00322621|1510986|P3|COMPLETED|Period II - Acute Therapy Phase||0
616243|NCT00322621|1510987|P2|COMPLETED|Period II - Acute Therapy Phase||0
616244|NCT00322621|1510988|P1|COMPLETED|Period II - Acute Therapy Phase||184
616245|NCT00322621|1510986|P3|STARTED|Period II - Acute Therapy Phase||0
616246|NCT00322621|1510987|P2|STARTED|Period II - Acute Therapy Phase||0
616247|NCT00322621|1510988|P1|STARTED|Period II - Acute Therapy Phase||216
616248|NCT00322556|1511040|P1|NOT COMPLETED|Overall Study||12
616249|NCT00322556|1511040|P1|COMPLETED|Overall Study||43
616250|NCT00322556|1511040|P1|STARTED|Overall Study||55
616251|NCT00322491|1511056|P2|NOT COMPLETED|Overall Study||2
616252|NCT00322491|1511057|P1|NOT COMPLETED|Overall Study||2
616253|NCT00322491|1511056|P2|COMPLETED|Overall Study||24
616254|NCT00322491|1511057|P1|COMPLETED|Overall Study||21
616255|NCT00322491|1511056|P2|STARTED|Overall Study||26
616256|NCT00322491|1511057|P1|STARTED|Overall Study||23
616257|NCT00322465|1511083|P4|NOT COMPLETED|Overall Study||26
616258|NCT00322465|1511084|P3|NOT COMPLETED|Overall Study||26
616259|NCT00322465|1511085|P2|NOT COMPLETED|Overall Study||24
616260|NCT00322465|1511086|P1|NOT COMPLETED|Overall Study||20
616261|NCT00322465|1511083|P4|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|53
616262|NCT00322465|1511084|P3|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|51
616263|NCT00322465|1511085|P2|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|49
616264|NCT00322465|1511086|P1|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|56
616265|NCT00322465|1511083|P4|STARTED|Overall Study|Randomized|79
616266|NCT00322465|1511084|P3|STARTED|Overall Study|Randomized|77
616267|NCT00322465|1511085|P2|STARTED|Overall Study|Randomized|73
616268|NCT00322465|1511086|P1|STARTED|Overall Study|Randomized|76
616269|NCT00322452|1511147|P2|NOT COMPLETED|Overall Study||276
616270|NCT00322452|1511148|P1|NOT COMPLETED|Overall Study||247
616271|NCT00322452|1511147|P2|COMPLETED|Overall Study|Patients still in study at PFS Data Cut Off (14 April 2008), 84 remained at OS DCO (14 June 2010)|332
616272|NCT00322452|1511148|P1|COMPLETED|Overall Study|Patients still in study at PFS Data Cut Off (14 April 2008), 97 remained at OS DCO (14 June 2010)|362
616273|NCT00322452|1511147|P2|STARTED|Overall Study|Number of patients randomized|608
616274|NCT00322452|1511148|P1|STARTED|Overall Study|Number of patients randomized|609
616275|NCT00322439|1511184|P1|NOT COMPLETED|Overall Study||1056
616276|NCT00322439|1511184|P1|COMPLETED|Overall Study||1455
616277|NCT00322439|1511184|P1|Received at Least 1 Dose of Etanercept|Overall Study||2510
616278|NCT00322439|1511184|P1|STARTED|Overall Study||2511
616279|NCT00322387|1511199|P2|NOT COMPLETED|Follow-up Period||3
616280|NCT00322387|1511200|P1|NOT COMPLETED|Follow-up Period||2
616281|NCT00322387|1511199|P2|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|23
616282|NCT00322387|1511200|P1|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|12
616283|NCT00322387|1511199|P2|STARTED|Follow-up Period|Participants who had transplants. One participant did not complete therapy but had a transplant.|26
616284|NCT00322387|1511200|P1|STARTED|Follow-up Period|Participants who had transplants|14
616285|NCT00322387|1511199|P2|NOT COMPLETED|Treatment Period||1
616286|NCT00322387|1511200|P1|NOT COMPLETED|Treatment Period||0
616287|NCT00322387|1511199|P2|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|25
616288|NCT00322387|1511200|P1|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|14
616289|NCT00322387|1511199|P2|STARTED|Treatment Period|Plerixafor PM=12, Plerixafor AM=9, Low CD34+ Count/Plerixafor PM=1, and Plerixafor After Chemo=4|26
616290|NCT00322387|1511200|P1|STARTED|Treatment Period|Plerixafor PM=7, Plerixafor AM=6, Low CD34+ Count/Plerixafor PM=0, and Plerixafor After Chemo=1|14
616291|NCT00322374|1511234|P4|NOT COMPLETED|Second Escalation||0
616292|NCT00322374|1511235|P3|NOT COMPLETED|Second Escalation||6
616293|NCT00322374|1511236|P2|NOT COMPLETED|Second Escalation||0
616294|NCT00322374|1511237|P1|NOT COMPLETED|Second Escalation||0
616295|NCT00322374|1511234|P4|COMPLETED|Second Escalation||0
616296|NCT00322374|1511235|P3|COMPLETED|Second Escalation||0
616297|NCT00322374|1511236|P2|COMPLETED|Second Escalation||0
616298|NCT00322374|1511237|P1|COMPLETED|Second Escalation||0
616299|NCT00322374|1511234|P4|STARTED|Second Escalation||0
616300|NCT00322374|1511235|P3|STARTED|Second Escalation||6
616301|NCT00322374|1511236|P2|STARTED|Second Escalation||0
616302|NCT00322374|1511237|P1|STARTED|Second Escalation||0
616303|NCT00322374|1511234|P4|NOT COMPLETED|First Escalation||0
616304|NCT00322374|1511235|P3|NOT COMPLETED|First Escalation||0
616305|NCT00322374|1511236|P2|NOT COMPLETED|First Escalation||30
616306|NCT00322374|1511237|P1|NOT COMPLETED|First Escalation||0
616307|NCT00322374|1511234|P4|COMPLETED|First Escalation||0
616308|NCT00322374|1511235|P3|COMPLETED|First Escalation||0
616309|NCT00322374|1511236|P2|COMPLETED|First Escalation||0
616310|NCT00322374|1511237|P1|COMPLETED|First Escalation||0
616311|NCT00322374|1511234|P4|STARTED|First Escalation||0
616312|NCT00322374|1511235|P3|STARTED|First Escalation||0
616313|NCT00322374|1511236|P2|STARTED|First Escalation||30
616314|NCT00322374|1511237|P1|STARTED|First Escalation||0
616315|NCT00322374|1511234|P4|NOT COMPLETED|Starting Dose||0
616316|NCT00322374|1511235|P3|NOT COMPLETED|Starting Dose||0
616317|NCT00322374|1511236|P2|NOT COMPLETED|Starting Dose||0
616318|NCT00322374|1511237|P1|NOT COMPLETED|Starting Dose||6
616319|NCT00322374|1511234|P4|COMPLETED|Starting Dose||0
616320|NCT00322374|1511235|P3|COMPLETED|Starting Dose||0
616321|NCT00322374|1511236|P2|COMPLETED|Starting Dose||0
616322|NCT00322374|1511237|P1|COMPLETED|Starting Dose||0
616323|NCT00322374|1511234|P4|STARTED|Starting Dose||0
616324|NCT00322374|1511235|P3|STARTED|Starting Dose||0
616325|NCT00322374|1511236|P2|STARTED|Starting Dose||0
616326|NCT00322374|1511237|P1|STARTED|Starting Dose||6
616327|NCT00322374|1511234|P4|NOT COMPLETED|Enrollment||0
616328|NCT00322374|1511235|P3|NOT COMPLETED|Enrollment||0
616329|NCT00322374|1511236|P2|NOT COMPLETED|Enrollment||0
616330|NCT00322374|1511237|P1|NOT COMPLETED|Enrollment||0
616331|NCT00322374|1511234|P4|COMPLETED|Enrollment||42
616332|NCT00322374|1511235|P3|COMPLETED|Enrollment||0
616333|NCT00322374|1511236|P2|COMPLETED|Enrollment||0
616334|NCT00322374|1511237|P1|COMPLETED|Enrollment||0
616335|NCT00322374|1511234|P4|STARTED|Enrollment||42
616336|NCT00322374|1511235|P3|STARTED|Enrollment||0
616337|NCT00322374|1511236|P2|STARTED|Enrollment||0
616338|NCT00322374|1511237|P1|STARTED|Enrollment||0
616339|NCT00322348|1511287|P2|NOT COMPLETED|Overall Study||33
616340|NCT00322348|1511288|P1|NOT COMPLETED|Overall Study||37
616341|NCT00322348|1511287|P2|COMPLETED|Overall Study|Number of participants completed up to Week 96|16
616342|NCT00322348|1511288|P1|COMPLETED|Overall Study|Number of participants completed up to Week 96|12
616343|NCT00322348|1511287|P2|Received Study Treatment|Overall Study||48
616344|NCT00322348|1511288|P1|Received Study Treatment|Overall Study||50
616345|NCT00322348|1511287|P2|STARTED|Overall Study||49
616346|NCT00322348|1511288|P1|STARTED|Overall Study||49
616347|NCT00322335|1511307|P3|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
616348|NCT00322335|1511308|P2|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
616349|NCT00322335|1511309|P1|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
616350|NCT00322335|1511307|P3|COMPLETED|Subjects 66 Months After Booster Dose||53
616351|NCT00322335|1511308|P2|COMPLETED|Subjects 66 Months After Booster Dose||104
616352|NCT00322335|1511309|P1|COMPLETED|Subjects 66 Months After Booster Dose||48
616353|NCT00322335|1511307|P3|STARTED|Subjects 66 Months After Booster Dose||53
616354|NCT00322335|1511308|P2|STARTED|Subjects 66 Months After Booster Dose||104
616355|NCT00322335|1511309|P1|STARTED|Subjects 66 Months After Booster Dose||48
616356|NCT00322335|1511307|P3|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
616357|NCT00322335|1511308|P2|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
616358|NCT00322335|1511309|P1|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
616359|NCT00322335|1511307|P3|COMPLETED|Subjects 54 Months After Booster Dose||56
616360|NCT00322335|1511308|P2|COMPLETED|Subjects 54 Months After Booster Dose||108
616361|NCT00322335|1511309|P1|COMPLETED|Subjects 54 Months After Booster Dose||50
616362|NCT00322335|1511307|P3|STARTED|Subjects 54 Months After Booster Dose||56
616363|NCT00322335|1511308|P2|STARTED|Subjects 54 Months After Booster Dose||108
616364|NCT00322335|1511309|P1|STARTED|Subjects 54 Months After Booster Dose||50
616365|NCT00322335|1511307|P3|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
616366|NCT00322335|1511308|P2|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
616367|NCT00322335|1511309|P1|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
616368|NCT00322335|1511307|P3|COMPLETED|Subjects 42 Months After Booster Dose||56
616369|NCT00322335|1511308|P2|COMPLETED|Subjects 42 Months After Booster Dose||113
616370|NCT00322335|1511309|P1|COMPLETED|Subjects 42 Months After Booster Dose||51
616371|NCT00322335|1511307|P3|STARTED|Subjects 42 Months After Booster Dose||56
616372|NCT00322335|1511308|P2|STARTED|Subjects 42 Months After Booster Dose||113
616373|NCT00322335|1511309|P1|STARTED|Subjects 42 Months After Booster Dose||51
616374|NCT00322335|1511307|P3|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
616375|NCT00322335|1511308|P2|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
616376|NCT00322335|1511309|P1|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
616377|NCT00322335|1511307|P3|COMPLETED|Subjects 30 Months After Booster Dose||57
616378|NCT00322335|1511308|P2|COMPLETED|Subjects 30 Months After Booster Dose||119
616379|NCT00322335|1511309|P1|COMPLETED|Subjects 30 Months After Booster Dose||54
616468|NCT00321906|1511548|P1|STARTED|Overall Study||94
616380|NCT00322335|1511307|P3|STARTED|Subjects 30 Months After Booster Dose|Subjects eliminated from previous timepoint were included again from this timepoint onwards|57
616381|NCT00322335|1511308|P2|STARTED|Subjects 30 Months After Booster Dose||119
616382|NCT00322335|1511309|P1|STARTED|Subjects 30 Months After Booster Dose||54
616383|NCT00322335|1511307|P3|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
616384|NCT00322335|1511308|P2|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
616385|NCT00322335|1511309|P1|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
616386|NCT00322335|1511307|P3|COMPLETED|Subjects 18 Months After Booster Dose||3
616387|NCT00322335|1511308|P2|COMPLETED|Subjects 18 Months After Booster Dose||123
616388|NCT00322335|1511309|P1|COMPLETED|Subjects 18 Months After Booster Dose||58
616389|NCT00322335|1511307|P3|STARTED|Subjects 18 Months After Booster Dose|Subjects who received Meningitec booster outside scope study NCT00323050 eliminated from this period|3
616390|NCT00322335|1511308|P2|STARTED|Subjects 18 Months After Booster Dose||123
616391|NCT00322335|1511309|P1|STARTED|Subjects 18 Months After Booster Dose||58
616392|NCT00322309|1511349|P2|NOT COMPLETED|Overall Study||4
616393|NCT00322309|1511350|P1|NOT COMPLETED|Overall Study||2
616394|NCT00322309|1511349|P2|COMPLETED|Overall Study||9
616395|NCT00322309|1511350|P1|COMPLETED|Overall Study||9
616396|NCT00322309|1511349|P2|STARTED|Overall Study||13
616397|NCT00322309|1511350|P1|STARTED|Overall Study||11
616398|NCT00322231|1511366|P2|NOT COMPLETED|Period 2||0
616399|NCT00322231|1511367|P1|NOT COMPLETED|Period 2||0
616400|NCT00322231|1511366|P2|COMPLETED|Period 2||49
616401|NCT00322231|1511367|P1|COMPLETED|Period 2||51
616402|NCT00322231|1511366|P2|STARTED|Period 2|One participant was lost between Period 1 and Period 2|49
616403|NCT00322231|1511367|P1|STARTED|Period 2||51
616404|NCT00322231|1511366|P2|NOT COMPLETED|Period 1||0
616405|NCT00322231|1511367|P1|NOT COMPLETED|Period 1||0
616406|NCT00322231|1511366|P2|COMPLETED|Period 1||50
616407|NCT00322231|1511367|P1|COMPLETED|Period 1||51
616408|NCT00322231|1511366|P2|STARTED|Period 1||50
616409|NCT00322231|1511367|P1|STARTED|Period 1||51
616410|NCT00322153|1511379|P2|NOT COMPLETED|Overall Study||69
616411|NCT00322153|1511380|P1|NOT COMPLETED|Overall Study||63
616412|NCT00322153|1511379|P2|COMPLETED|Overall Study||273
616413|NCT00322153|1511380|P1|COMPLETED|Overall Study||272
616414|NCT00322153|1511379|P2|SAFETY POPULATION|Overall Study|Safety population: one patient was randomized but did not receive double-blind study drug.|341
616415|NCT00322153|1511380|P1|SAFETY POPULATION|Overall Study|Safety population defined as all patients who took at least one dose of double-blind study drug.|335
616416|NCT00322153|1511379|P2|STARTED|Overall Study|Randomized to Memantine ER|342
616417|NCT00322153|1511380|P1|STARTED|Overall Study|Randomized to placebo|335
616418|NCT00322101|1511392|P2|NOT COMPLETED|Overall Study||0
616419|NCT00322101|1511393|P1|NOT COMPLETED|Overall Study||0
616420|NCT00322101|1511392|P2|COMPLETED|Overall Study||11
616421|NCT00322101|1511393|P1|COMPLETED|Overall Study||14
616422|NCT00322101|1511392|P2|STARTED|Overall Study||11
616423|NCT00322101|1511393|P1|STARTED|Overall Study||14
616424|NCT00322049|1511413|P4|NOT COMPLETED|Overall Study||1
616425|NCT00322049|1511414|P3|NOT COMPLETED|Overall Study||0
616426|NCT00322049|1511415|P2|NOT COMPLETED|Overall Study||1
616427|NCT00322049|1511416|P1|NOT COMPLETED|Overall Study||0
616428|NCT00322049|1511413|P4|COMPLETED|Overall Study||16
616429|NCT00322049|1511414|P3|COMPLETED|Overall Study||20
616430|NCT00322049|1511415|P2|COMPLETED|Overall Study||9
616431|NCT00322049|1511416|P1|COMPLETED|Overall Study||4
616432|NCT00322049|1511413|P4|STARTED|Overall Study||17
616433|NCT00322049|1511414|P3|STARTED|Overall Study||20
616434|NCT00322049|1511415|P2|STARTED|Overall Study||10
616435|NCT00322049|1511416|P1|STARTED|Overall Study||4
616436|NCT00321984|1511449|P3|NOT COMPLETED|Overall Study||26
616437|NCT00321984|1511450|P2|NOT COMPLETED|Overall Study||21
616438|NCT00321984|1511451|P1|NOT COMPLETED|Overall Study||27
616439|NCT00321984|1511449|P3|COMPLETED|Overall Study||289
616440|NCT00321984|1511450|P2|COMPLETED|Overall Study||294
616441|NCT00321984|1511451|P1|COMPLETED|Overall Study||290
616442|NCT00321984|1511449|P3|STARTED|Overall Study||315
616443|NCT00321984|1511450|P2|STARTED|Overall Study||315
616444|NCT00321984|1511451|P1|STARTED|Overall Study||317
616445|NCT00321971|1511470|P2|NOT COMPLETED|Overall Study||11
616446|NCT00321971|1511471|P1|NOT COMPLETED|Overall Study||8
616447|NCT00321971|1511470|P2|COMPLETED|Overall Study||26
616448|NCT00321971|1511471|P1|COMPLETED|Overall Study||28
616449|NCT00321971|1511470|P2|STARTED|Overall Study||37
616450|NCT00321971|1511471|P1|STARTED|Overall Study|Subject recruitment began in February 2007 and ended in December 2011|36
616451|NCT00321932|1511479|P2|NOT COMPLETED|Overall Study||21
616452|NCT00321932|1511480|P1|NOT COMPLETED|Overall Study||10
616453|NCT00321932|1511479|P2|COMPLETED|Overall Study||11
616454|NCT00321932|1511480|P1|COMPLETED|Overall Study||19
616455|NCT00321932|1511479|P2|STARTED|Overall Study||32
616456|NCT00321932|1511480|P1|STARTED|Overall Study||29
616457|NCT00321919|1511504|P2|NOT COMPLETED|Overall Study||52
616458|NCT00321919|1511505|P1|NOT COMPLETED|Overall Study||75
616459|NCT00321919|1511504|P2|COMPLETED|Overall Study||250
616460|NCT00321919|1511505|P1|COMPLETED|Overall Study||226
616461|NCT00321919|1511504|P2|STARTED|Overall Study||302
616462|NCT00321919|1511505|P1|STARTED|Overall Study||301
616463|NCT00321906|1511547|P2|NOT COMPLETED|Overall Study||56
616464|NCT00321906|1511548|P1|NOT COMPLETED|Overall Study||46
616465|NCT00321906|1511547|P2|COMPLETED|Overall Study||31
616466|NCT00321906|1511548|P1|COMPLETED|Overall Study||48
616467|NCT00321906|1511547|P2|STARTED|Overall Study||87
616469|NCT00321893|1511570|P2|NOT COMPLETED|Overall Study||14
616470|NCT00321893|1511571|P1|NOT COMPLETED|Overall Study||24
616471|NCT00321893|1511570|P2|COMPLETED|Overall Study||87
616472|NCT00321893|1511571|P1|COMPLETED|Overall Study||77
616473|NCT00321893|1511570|P2|STARTED|Overall Study||101
616474|NCT00321893|1511571|P1|STARTED|Overall Study||101
616475|NCT00321854|1511585|P2|NOT COMPLETED|Overall Study||82
616476|NCT00321854|1511586|P1|NOT COMPLETED|Overall Study||63
616477|NCT00321854|1511585|P2|COMPLETED|Overall Study||192
616478|NCT00321854|1511586|P1|COMPLETED|Overall Study||198
616479|NCT00321854|1511585|P2|STARTED|Overall Study||274
616480|NCT00321854|1511586|P1|STARTED|Overall Study||261
616481|NCT00321828|1511704|P1|NOT COMPLETED|Overall Study||4
616482|NCT00321828|1511704|P1|COMPLETED|Overall Study||86
616483|NCT00321828|1511704|P1|STARTED|Overall Study||90
616484|NCT00321789|1511710|P2|NOT COMPLETED|Overall Study||16
616485|NCT00321789|1511711|P1|NOT COMPLETED|Overall Study||15
616486|NCT00321789|1511710|P2|COMPLETED|Overall Study||112
616487|NCT00321789|1511711|P1|COMPLETED|Overall Study||112
616488|NCT00321789|1511710|P2|STARTED|Overall Study||128
616489|NCT00321789|1511711|P1|STARTED|Overall Study||127
616490|NCT00321763|1511743|P4|NOT COMPLETED|Overall Study||5
616491|NCT00321763|1511744|P3|NOT COMPLETED|Overall Study||6
616492|NCT00321763|1511745|P2|NOT COMPLETED|Overall Study||2
616493|NCT00321763|1511746|P1|NOT COMPLETED|Overall Study||6
616494|NCT00321763|1511743|P4|COMPLETED|Overall Study||565
616495|NCT00321763|1511744|P3|COMPLETED|Overall Study||848
616496|NCT00321763|1511745|P2|COMPLETED|Overall Study||848
616497|NCT00321763|1511746|P1|COMPLETED|Overall Study||844
616498|NCT00321763|1511743|P4|STARTED|Overall Study||570
616499|NCT00321763|1511744|P3|STARTED|Overall Study||854
616500|NCT00321763|1511745|P2|STARTED|Overall Study||850
616501|NCT00321763|1511746|P1|STARTED|Overall Study||850
616502|NCT00321737|1511806|P3|NOT COMPLETED|Overall Study||54
616503|NCT00321737|1511807|P2|NOT COMPLETED|Overall Study||48
616504|NCT00321737|1511808|P1|NOT COMPLETED|Overall Study||122
616505|NCT00321737|1511806|P3|COMPLETED|Overall Study||104
616506|NCT00321737|1511807|P2|COMPLETED|Overall Study||92
616507|NCT00321737|1511808|P1|COMPLETED|Overall Study||25
616508|NCT00321737|1511806|P3|STARTED|Overall Study||158
616509|NCT00321737|1511807|P2|STARTED|Overall Study||140
616510|NCT00321737|1511808|P1|STARTED|Overall Study||147
616511|NCT00321711|1511836|P5|NOT COMPLETED|Part B||5
616512|NCT00321711|1511837|P4|NOT COMPLETED|Part B||6
616513|NCT00321711|1511838|P3|NOT COMPLETED|Part B||0
616514|NCT00321711|1511839|P2|NOT COMPLETED|Part B||0
616515|NCT00321711|1511840|P1|NOT COMPLETED|Part B||0
616516|NCT00321711|1511836|P5|COMPLETED|Part B||10
616517|NCT00321711|1511837|P4|COMPLETED|Part B||8
616518|NCT00321711|1511838|P3|COMPLETED|Part B||0
616519|NCT00321711|1511839|P2|COMPLETED|Part B||0
616520|NCT00321711|1511840|P1|COMPLETED|Part B||0
616521|NCT00321711|1511836|P5|STARTED|Part B||15
616522|NCT00321711|1511837|P4|STARTED|Part B||14
616523|NCT00321711|1511838|P3|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
616524|NCT00321711|1511839|P2|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
616525|NCT00321711|1511840|P1|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
616526|NCT00321711|1511836|P5|NOT COMPLETED|Part A||0
616527|NCT00321711|1511837|P4|NOT COMPLETED|Part A||0
616528|NCT00321711|1511838|P3|NOT COMPLETED|Part A||11
616529|NCT00321711|1511839|P2|NOT COMPLETED|Part A||10
616530|NCT00321711|1511840|P1|NOT COMPLETED|Part A||5
616531|NCT00321711|1511836|P5|COMPLETED|Part A||0
616532|NCT00321711|1511837|P4|COMPLETED|Part A||0
616533|NCT00321711|1511838|P3|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|3
616534|NCT00321711|1511839|P2|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|3
616535|NCT00321711|1511840|P1|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|8
616536|NCT00321711|1511836|P5|STARTED|Part A||0
616537|NCT00321711|1511837|P4|STARTED|Part A||0
616538|NCT00321711|1511838|P3|STARTED|Part A||14
616539|NCT00321711|1511839|P2|STARTED|Part A||13
616540|NCT00321711|1511840|P1|STARTED|Part A||13
616541|NCT00321698|1511872|P5|NOT COMPLETED|Phase II, MTD Dose||0
616542|NCT00321698|1511873|P4|NOT COMPLETED|Phase II, MTD Dose||0
616543|NCT00321698|1511874|P3|NOT COMPLETED|Phase II, MTD Dose||0
616544|NCT00321698|1511875|P2|NOT COMPLETED|Phase II, MTD Dose||0
616545|NCT00321698|1511876|P1|NOT COMPLETED|Phase II, MTD Dose||0
616546|NCT00321698|1511872|P5|COMPLETED|Phase II, MTD Dose||13
616547|NCT00321698|1511873|P4|COMPLETED|Phase II, MTD Dose||0
616548|NCT00321698|1511874|P3|COMPLETED|Phase II, MTD Dose||0
616549|NCT00321698|1511875|P2|COMPLETED|Phase II, MTD Dose||0
616550|NCT00321698|1511876|P1|COMPLETED|Phase II, MTD Dose||0
616551|NCT00321698|1511872|P5|STARTED|Phase II, MTD Dose|+1 screen failure|13
616552|NCT00321698|1511873|P4|STARTED|Phase II, MTD Dose||0
616553|NCT00321698|1511874|P3|STARTED|Phase II, MTD Dose||0
616554|NCT00321698|1511875|P2|STARTED|Phase II, MTD Dose||0
616555|NCT00321698|1511876|P1|STARTED|Phase II, MTD Dose||0
616556|NCT00321698|1511872|P5|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
616557|NCT00321698|1511873|P4|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
616558|NCT00321698|1511874|P3|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
616559|NCT00321698|1511875|P2|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
616560|NCT00321698|1511876|P1|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
616561|NCT00321698|1511872|P5|COMPLETED|Phase I, Rad Only & Dose 1-3||0
616562|NCT00321698|1511873|P4|COMPLETED|Phase I, Rad Only & Dose 1-3||3
616563|NCT00321698|1511874|P3|COMPLETED|Phase I, Rad Only & Dose 1-3||3
616564|NCT00321698|1511875|P2|COMPLETED|Phase I, Rad Only & Dose 1-3||3
616565|NCT00321698|1511876|P1|COMPLETED|Phase I, Rad Only & Dose 1-3||3
616566|NCT00321698|1511872|P5|STARTED|Phase I, Rad Only & Dose 1-3||0
616567|NCT00321698|1511873|P4|STARTED|Phase I, Rad Only & Dose 1-3||3
616568|NCT00321698|1511874|P3|STARTED|Phase I, Rad Only & Dose 1-3||3
616569|NCT00321698|1511875|P2|STARTED|Phase I, Rad Only & Dose 1-3||3
616570|NCT00321698|1511876|P1|STARTED|Phase I, Rad Only & Dose 1-3||3
616571|NCT00321685|1511890|P1|NOT COMPLETED|Overall Study||39
616572|NCT00321685|1511890|P1|COMPLETED|Overall Study||18
616573|NCT00321685|1511890|P1|Eligible and Treated|Overall Study||53
616574|NCT00321685|1511890|P1|Started Protocol Therapy|Overall Study||55
616575|NCT00321685|1511890|P1|Eligible|Overall Study||55
616576|NCT00321685|1511890|P1|STARTED|Overall Study||57
616577|NCT00321672|1511902|P4|NOT COMPLETED|Overall Study||2
616578|NCT00321672|1511903|P3|NOT COMPLETED|Overall Study||11
616579|NCT00321672|1511904|P2|NOT COMPLETED|Overall Study||8
616580|NCT00321672|1511905|P1|NOT COMPLETED|Overall Study||12
616581|NCT00321672|1511902|P4|COMPLETED|Overall Study||71
616582|NCT00321672|1511903|P3|COMPLETED|Overall Study||156
616583|NCT00321672|1511904|P2|COMPLETED|Overall Study||81
616584|NCT00321672|1511905|P1|COMPLETED|Overall Study||153
616585|NCT00321672|1511902|P4|STARTED|Overall Study|One randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety.|73
616586|NCT00321672|1511903|P3|STARTED|Overall Study||167
616587|NCT00321672|1511904|P2|STARTED|Overall Study|One randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety.|89
616588|NCT00321672|1511905|P1|STARTED|Overall Study||165
616589|NCT00321646|1511931|P1|NOT COMPLETED|Prostatectomy||0
616590|NCT00321646|1511931|P1|COMPLETED|Prostatectomy||37
616591|NCT00321646|1511931|P1|STARTED|Prostatectomy||37
616592|NCT00321646|1511931|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||4
616593|NCT00321646|1511931|P1|COMPLETED|Neoadjuvant Chemotherapy|1 pt withdrew before start of therapy, 38 completed 6 cycles neoadjuvant therapy.|38
616594|NCT00321646|1511931|P1|STARTED|Neoadjuvant Chemotherapy||42
616595|NCT00321620|1511938|P2|NOT COMPLETED|Overall Study||722
616596|NCT00321620|1511939|P1|NOT COMPLETED|Overall Study||743
616597|NCT00321620|1511938|P2|COMPLETED|Overall Study||228
616598|NCT00321620|1511939|P1|COMPLETED|Overall Study||208
616599|NCT00321620|1511938|P2|Received Investigational Product|Overall Study||942
616600|NCT00321620|1511939|P1|Received Investigational Product|Overall Study||946
616601|NCT00321620|1511938|P2|STARTED|Overall Study||950
616602|NCT00321620|1511939|P1|STARTED|Overall Study||951
616603|NCT00321594|1511951|P5|NOT COMPLETED|Phase II, MTD Dose||0
616604|NCT00321594|1511952|P4|NOT COMPLETED|Phase II, MTD Dose||0
616605|NCT00321594|1511953|P3|NOT COMPLETED|Phase II, MTD Dose||0
616606|NCT00321594|1511954|P2|NOT COMPLETED|Phase II, MTD Dose||0
616607|NCT00321594|1511955|P1|NOT COMPLETED|Phase II, MTD Dose||0
616608|NCT00321594|1511951|P5|COMPLETED|Phase II, MTD Dose||36
616609|NCT00321594|1511952|P4|COMPLETED|Phase II, MTD Dose||6
616610|NCT00321594|1511953|P3|COMPLETED|Phase II, MTD Dose||0
616611|NCT00321594|1511954|P2|COMPLETED|Phase II, MTD Dose||0
616612|NCT00321594|1511955|P1|COMPLETED|Phase II, MTD Dose||0
616613|NCT00321594|1511951|P5|STARTED|Phase II, MTD Dose|last six patients in Phase I, Level 4 include in Phase II MTD Dose total number = 6 + 36 = 42|36
616614|NCT00321594|1511952|P4|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|6
616615|NCT00321594|1511953|P3|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
616616|NCT00321594|1511954|P2|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
616617|NCT00321594|1511955|P1|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
616618|NCT00321594|1511951|P5|NOT COMPLETED|Phase I, Level 1-4||0
616619|NCT00321594|1511952|P4|NOT COMPLETED|Phase I, Level 1-4||0
616620|NCT00321594|1511953|P3|NOT COMPLETED|Phase I, Level 1-4||0
616621|NCT00321594|1511954|P2|NOT COMPLETED|Phase I, Level 1-4||0
616622|NCT00321594|1511955|P1|NOT COMPLETED|Phase I, Level 1-4||0
616623|NCT00321594|1511951|P5|COMPLETED|Phase I, Level 1-4||0
616624|NCT00321594|1511952|P4|COMPLETED|Phase I, Level 1-4||6
616625|NCT00321594|1511953|P3|COMPLETED|Phase I, Level 1-4||6
616626|NCT00321594|1511954|P2|COMPLETED|Phase I, Level 1-4||3
616627|NCT00321594|1511955|P1|COMPLETED|Phase I, Level 1-4||3
616628|NCT00321594|1511951|P5|STARTED|Phase I, Level 1-4||0
616629|NCT00321594|1511952|P4|STARTED|Phase I, Level 1-4||6
616630|NCT00321594|1511953|P3|STARTED|Phase I, Level 1-4||6
616631|NCT00321594|1511954|P2|STARTED|Phase I, Level 1-4||3
616632|NCT00321594|1511955|P1|STARTED|Phase I, Level 1-4||3
616633|NCT00321464|1511969|P2|NOT COMPLETED|Overall Study||558
616634|NCT00321464|1511970|P1|NOT COMPLETED|Overall Study||559
616635|NCT00321464|1511969|P2|COMPLETED|Overall Study||468
616636|NCT00321464|1511970|P1|COMPLETED|Overall Study||461
616637|NCT00321464|1511969|P2|Received Investigational Product|Overall Study||1019
616638|NCT00321464|1511970|P1|Received Investigational Product|Overall Study||1014
616639|NCT00321464|1511969|P2|STARTED|Overall Study||1026
616640|NCT00321464|1511970|P1|STARTED|Overall Study||1020
616641|NCT00321373|1511983|P3|NOT COMPLETED|Overall Study||3
616642|NCT00321373|1511984|P2|NOT COMPLETED|Overall Study||0
616643|NCT00321373|1511985|P1|NOT COMPLETED|Overall Study||2
616644|NCT00321373|1511983|P3|COMPLETED|Overall Study||404
616645|NCT00321373|1511984|P2|COMPLETED|Overall Study||406
616646|NCT00321373|1511985|P1|COMPLETED|Overall Study||405
616647|NCT00321373|1511983|P3|STARTED|Overall Study||407
616648|NCT00321373|1511984|P2|STARTED|Overall Study||406
616649|NCT00321373|1511985|P1|STARTED|Overall Study||407
616650|NCT00321321|1512008|P1|NOT COMPLETED|Overall Study||0
616651|NCT00321321|1512008|P1|COMPLETED|Overall Study||12
616652|NCT00321321|1512008|P1|STARTED|Overall Study||12
616653|NCT00321269|1512014|P2|NOT COMPLETED|Overall Study||6
616654|NCT00321269|1512015|P1|NOT COMPLETED|Overall Study||8
616655|NCT00321269|1512014|P2|COMPLETED|Overall Study||68
616656|NCT00321269|1512015|P1|COMPLETED|Overall Study||66
616657|NCT00321269|1512014|P2|STARTED|Overall Study||74
616658|NCT00321269|1512015|P1|STARTED|Overall Study||74
616659|NCT00320801|1512025|P4|NOT COMPLETED|Extension Phase||48
616660|NCT00320801|1512026|P3|NOT COMPLETED|Extension Phase||0
616661|NCT00320801|1512027|P2|NOT COMPLETED|Extension Phase||0
616662|NCT00320801|1512028|P1|NOT COMPLETED|Extension Phase||0
616663|NCT00320801|1512025|P4|COMPLETED|Extension Phase||7
616664|NCT00320801|1512026|P3|COMPLETED|Extension Phase||0
616665|NCT00320801|1512027|P2|COMPLETED|Extension Phase||0
616666|NCT00320801|1512028|P1|COMPLETED|Extension Phase||0
616667|NCT00320801|1512025|P4|STARTED|Extension Phase||55
616668|NCT00320801|1512026|P3|STARTED|Extension Phase||0
616669|NCT00320801|1512027|P2|STARTED|Extension Phase||0
616670|NCT00320801|1512028|P1|STARTED|Extension Phase||0
616671|NCT00320801|1512025|P4|NOT COMPLETED|Double-blind Phase||0
616672|NCT00320801|1512026|P3|NOT COMPLETED|Double-blind Phase||14
616673|NCT00320801|1512027|P2|NOT COMPLETED|Double-blind Phase||11
616674|NCT00320801|1512028|P1|NOT COMPLETED|Double-blind Phase||0
616675|NCT00320801|1512025|P4|COMPLETED|Double-blind Phase||0
616676|NCT00320801|1512026|P3|COMPLETED|Double-blind Phase||35
616677|NCT00320801|1512027|P2|COMPLETED|Double-blind Phase||36
616678|NCT00320801|1512028|P1|COMPLETED|Double-blind Phase||0
616679|NCT00320801|1512025|P4|STARTED|Double-blind Phase||0
616680|NCT00320801|1512026|P3|STARTED|Double-blind Phase||49
616681|NCT00320801|1512027|P2|STARTED|Double-blind Phase||47
616682|NCT00320801|1512028|P1|STARTED|Double-blind Phase||0
616683|NCT00320801|1512025|P4|NOT COMPLETED|Open-label Run-in Period||0
616684|NCT00320801|1512026|P3|NOT COMPLETED|Open-label Run-in Period||0
616685|NCT00320801|1512027|P2|NOT COMPLETED|Open-label Run-in Period||0
616686|NCT00320801|1512028|P1|NOT COMPLETED|Open-label Run-in Period||92
616687|NCT00320801|1512025|P4|COMPLETED|Open-label Run-in Period||0
616688|NCT00320801|1512026|P3|COMPLETED|Open-label Run-in Period||0
616689|NCT00320801|1512027|P2|COMPLETED|Open-label Run-in Period||0
616690|NCT00320801|1512028|P1|COMPLETED|Open-label Run-in Period||96
616691|NCT00320801|1512025|P4|STARTED|Open-label Run-in Period||0
616692|NCT00320801|1512026|P3|STARTED|Open-label Run-in Period||0
616693|NCT00320801|1512027|P2|STARTED|Open-label Run-in Period||0
616694|NCT00320801|1512028|P1|STARTED|Open-label Run-in Period||188
616695|NCT00320788|1512043|P5|NOT COMPLETED|Overall Study||5
616696|NCT00320788|1512044|P4|NOT COMPLETED|Overall Study||5
616697|NCT00320788|1512045|P3|NOT COMPLETED|Overall Study||3
616698|NCT00320788|1512046|P2|NOT COMPLETED|Overall Study||6
616699|NCT00320788|1512047|P1|NOT COMPLETED|Overall Study||6
616700|NCT00320788|1512043|P5|COMPLETED|Overall Study||26
616701|NCT00320788|1512044|P4|COMPLETED|Overall Study||27
616702|NCT00320788|1512045|P3|COMPLETED|Overall Study||29
616703|NCT00320788|1512046|P2|COMPLETED|Overall Study||26
616704|NCT00320788|1512047|P1|COMPLETED|Overall Study||26
616705|NCT00320788|1512043|P5|Participants Received Treatment (SAF)|Overall Study||31
616706|NCT00320788|1512044|P4|Participants Received Treatment (SAF)|Overall Study|One participant in this group did not receive treatment and was not included in the SAF and FAS|31
616707|NCT00320788|1512045|P3|Participants Received Treatment (SAF)|Overall Study|One participant in this group did not receive treatment and was not included in the SAF and FAS|31
616708|NCT00320788|1512046|P2|Participants Received Treatment (SAF)|Overall Study||32
616709|NCT00320788|1512047|P1|Participants Received Treatment (SAF)|Overall Study||32
616710|NCT00320788|1512043|P5|STARTED|Overall Study||31
616711|NCT00320788|1512044|P4|STARTED|Overall Study|Participants Randomized|32
616712|NCT00320788|1512045|P3|STARTED|Overall Study||32
616713|NCT00320788|1512046|P2|STARTED|Overall Study||32
616714|NCT00320788|1512047|P1|STARTED|Overall Study||32
616715|NCT00320749|1512090|P3|NOT COMPLETED|Overall Study||9
616716|NCT00320749|1512091|P2|NOT COMPLETED|Overall Study||2
616717|NCT00320749|1512092|P1|NOT COMPLETED|Overall Study||0
616718|NCT00320749|1512090|P3|COMPLETED|Overall Study||1
616719|NCT00320749|1512091|P2|COMPLETED|Overall Study||6
616720|NCT00320749|1512092|P1|COMPLETED|Overall Study||3
616721|NCT00320749|1512090|P3|STARTED|Overall Study||10
616722|NCT00320749|1512091|P2|STARTED|Overall Study||8
616723|NCT00320749|1512092|P1|STARTED|Overall Study||3
616724|NCT00320710|1512101|P3|NOT COMPLETED|Overall Study||5
616725|NCT00320710|1512102|P2|NOT COMPLETED|Overall Study||76
616726|NCT00320710|1512103|P1|NOT COMPLETED|Overall Study||94
616727|NCT00320710|1512101|P3|COMPLETED|Overall Study||8
616728|NCT00320710|1512102|P2|COMPLETED|Overall Study||127
616729|NCT00320710|1512103|P1|COMPLETED|Overall Study||106
616730|NCT00320710|1512101|P3|Treated (Safety Set)|Overall Study||13
616731|NCT00320710|1512102|P2|Treated (Safety Set)|Overall Study||202
616732|NCT00320710|1512103|P1|Treated (Safety Set)|Overall Study||198
616733|NCT00320710|1512101|P3|STARTED|Overall Study||13
616734|NCT00320710|1512102|P2|STARTED|Overall Study||203
616735|NCT00320710|1512103|P1|STARTED|Overall Study||200
616736|NCT00320671|1512126|P2|NOT COMPLETED|Overall Study||38
616737|NCT00320671|1512127|P1|NOT COMPLETED|Overall Study||33
616738|NCT00320671|1512126|P2|COMPLETED|Overall Study||58
616739|NCT00320671|1512127|P1|COMPLETED|Overall Study||69
616740|NCT00320671|1512126|P2|STARTED|Overall Study||96
616741|NCT00320671|1512127|P1|STARTED|Overall Study||102
616742|NCT00320606|1512133|P1|NOT COMPLETED|Overall Study||14
616743|NCT00320606|1512133|P1|COMPLETED|Overall Study|2 discontinued early, 12 ongoing in study|6
616744|NCT00320606|1512133|P1|STARTED|Overall Study||20
616745|NCT00320593|1512139|P2|NOT COMPLETED|Overall Study||1
616746|NCT00320593|1512140|P1|NOT COMPLETED|Overall Study||7
616747|NCT00320593|1512139|P2|COMPLETED|Overall Study|Completed defined as completing the 3 year primary outcome exam|58
616748|NCT00320593|1512140|P1|COMPLETED|Overall Study|Completed defined as completing the 3 year primary outcome exam|52
616749|NCT00320593|1512139|P2|STARTED|Overall Study||59
616750|NCT00320593|1512140|P1|STARTED|Overall Study||59
616751|NCT00320541|1512164|P2|NOT COMPLETED|Overall Study||57
616752|NCT00320541|1512165|P1|NOT COMPLETED|Overall Study||50
616753|NCT00320541|1512164|P2|COMPLETED|Overall Study||36
616754|NCT00320541|1512165|P1|COMPLETED|Overall Study||44
616755|NCT00320541|1512164|P2|STARTED|Overall Study||93
616756|NCT00320541|1512165|P1|STARTED|Overall Study||94
616757|NCT00320528|1512192|P3|NOT COMPLETED|Study Period III||106
616758|NCT00320528|1512193|P2|NOT COMPLETED|Study Period III||31
616759|NCT00320528|1512194|P1|NOT COMPLETED|Study Period III||87
616760|NCT00320528|1512192|P3|COMPLETED|Study Period III||2
616761|NCT00320528|1512193|P2|COMPLETED|Study Period III||0
616762|NCT00320528|1512194|P1|COMPLETED|Study Period III||0
616763|NCT00320528|1512192|P3|STARTED|Study Period III||108
616764|NCT00320528|1512193|P2|STARTED|Study Period III||31
616765|NCT00320528|1512194|P1|STARTED|Study Period III||87
616766|NCT00320528|1512192|P3|NOT COMPLETED|Study Period II||22
616767|NCT00320528|1512193|P2|NOT COMPLETED|Study Period II||10
616768|NCT00320528|1512194|P1|NOT COMPLETED|Study Period II||11
616769|NCT00320528|1512192|P3|COMPLETED|Study Period II||108
616770|NCT00320528|1512193|P2|COMPLETED|Study Period II||31
616771|NCT00320528|1512194|P1|COMPLETED|Study Period II||87
616772|NCT00320528|1512192|P3|Received at Least One Dose of Study Drug|Study Period II||128
616773|NCT00320528|1512193|P2|Received at Least One Dose of Study Drug|Study Period II||38
616774|NCT00320528|1512194|P1|Received at Least One Dose of Study Drug|Study Period II||97
616775|NCT00320528|1512192|P3|STARTED|Study Period II||130
616776|NCT00320528|1512193|P2|STARTED|Study Period II||41
616777|NCT00320528|1512194|P1|STARTED|Study Period II||98
616778|NCT00320515|1512229|P1|NOT COMPLETED|Overall Study||49
616779|NCT00320515|1512229|P1|COMPLETED|Overall Study||20
616780|NCT00320515|1512229|P1|STARTED|Overall Study||69
616781|NCT00320489|1512238|P2|NOT COMPLETED|Overall Study||136
616782|NCT00320489|1512239|P1|NOT COMPLETED|Overall Study||145
616783|NCT00320489|1512238|P2|COMPLETED|Overall Study||124
616784|NCT00320489|1512239|P1|COMPLETED|Overall Study||119
616785|NCT00320489|1512238|P2|STARTED|Overall Study||260
616786|NCT00320489|1512239|P1|STARTED|Overall Study||264
616787|NCT00320424|1512295|P1|NOT COMPLETED|Overall Study||6
616788|NCT00320424|1512295|P1|COMPLETED|Overall Study||42
616789|NCT00320424|1512295|P1|STARTED|Overall Study||48
616790|NCT00320411|1512309|P1|NOT COMPLETED|Overall Study||4
616791|NCT00320411|1512309|P1|COMPLETED|Overall Study||58
616792|NCT00320411|1512309|P1|STARTED|Overall Study||62
616793|NCT00320398|1512332|P2|NOT COMPLETED|Overall Study||4
616794|NCT00320398|1512333|P1|NOT COMPLETED|Overall Study||2
616795|NCT00320398|1512332|P2|COMPLETED|Overall Study||52
616796|NCT00320398|1512333|P1|COMPLETED|Overall Study||56
616797|NCT00320398|1512332|P2|STARTED|Overall Study||56
616798|NCT00320398|1512333|P1|STARTED|Overall Study||58
616799|NCT00320385|1512361|P2|NOT COMPLETED|Overall Study||22
616800|NCT00320385|1512362|P1|NOT COMPLETED|Overall Study||18
616801|NCT00320385|1512361|P2|COMPLETED|Overall Study||126
616802|NCT00320385|1512362|P1|COMPLETED|Overall Study||130
616803|NCT00320385|1512361|P2|STARTED|Overall Study||148
616804|NCT00320385|1512362|P1|STARTED|Overall Study||148
616805|NCT00320372|1512385|P2|NOT COMPLETED|Overall Study||163
616806|NCT00320372|1512386|P1|NOT COMPLETED|Overall Study||195
616807|NCT00320372|1512385|P2|COMPLETED|Overall Study||138
616808|NCT00320372|1512386|P1|COMPLETED|Overall Study||299
616809|NCT00320372|1512385|P2|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||0
616810|NCT00320372|1512386|P1|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||159
616811|NCT00320372|1512385|P2|VNS Therapy D-23 Original|Overall Study||0
616812|NCT00320372|1512386|P1|VNS Therapy D-23 Original|Overall Study||335
616813|NCT00320372|1512385|P2|STARTED|Overall Study||301
616814|NCT00320372|1512386|P1|STARTED|Overall Study||494
616815|NCT00320281|1512413|P2|NOT COMPLETED|Overall Study||0
616816|NCT00320281|1512414|P1|NOT COMPLETED|Overall Study||0
616817|NCT00320281|1512413|P2|COMPLETED|Overall Study||9
616818|NCT00320281|1512414|P1|COMPLETED|Overall Study||10
616819|NCT00320281|1512413|P2|STARTED|Overall Study||9
616820|NCT00320281|1512414|P1|STARTED|Overall Study||10
616821|NCT00320255|1512426|P6|NOT COMPLETED|Overall Study||0
616822|NCT00320255|1512427|P5|NOT COMPLETED|Overall Study||0
616823|NCT00320255|1512428|P4|NOT COMPLETED|Overall Study||8
616824|NCT00320255|1512429|P3|NOT COMPLETED|Overall Study||6
616825|NCT00320255|1512430|P2|NOT COMPLETED|Overall Study||7
616826|NCT00320255|1512431|P1|NOT COMPLETED|Overall Study||11
616827|NCT00320255|1512426|P6|COMPLETED|Overall Study||3
616828|NCT00320255|1512427|P5|COMPLETED|Overall Study||2
616829|NCT00320255|1512428|P4|COMPLETED|Overall Study||25
616830|NCT00320255|1512429|P3|COMPLETED|Overall Study||24
616831|NCT00320255|1512430|P2|COMPLETED|Overall Study||25
616832|NCT00320255|1512431|P1|COMPLETED|Overall Study||19
616833|NCT00320255|1512426|P6|Received Treatment|Overall Study||3
616834|NCT00320255|1512427|P5|Received Treatment|Overall Study||2
616835|NCT00320255|1512428|P4|Received Treatment|Overall Study||32
616836|NCT00320255|1512429|P3|Received Treatment|Overall Study||29
616837|NCT00320255|1512430|P2|Received Treatment|Overall Study||32
616838|NCT00320255|1512431|P1|Received Treatment|Overall Study||29
616839|NCT00320255|1512426|P6|STARTED|Overall Study||3
616840|NCT00320255|1512427|P5|STARTED|Overall Study||2
616841|NCT00320255|1512428|P4|STARTED|Overall Study||33
616842|NCT00320255|1512429|P3|STARTED|Overall Study||30
616843|NCT00320255|1512430|P2|STARTED|Overall Study||32
616844|NCT00320255|1512431|P1|STARTED|Overall Study||30
616845|NCT00320242|1512511|P2|NOT COMPLETED|Overall Study||4
616846|NCT00320242|1512512|P1|NOT COMPLETED|Overall Study||2
616847|NCT00320242|1512511|P2|COMPLETED|Overall Study||12
616848|NCT00320242|1512512|P1|COMPLETED|Overall Study||14
616849|NCT00320242|1512511|P2|STARTED|Overall Study||16
616850|NCT00320242|1512512|P1|STARTED|Overall Study||16
616851|NCT00320216|1512524|P5|NOT COMPLETED|Overall Study||6
616852|NCT00320216|1512525|P4|NOT COMPLETED|Overall Study||3
616853|NCT00320216|1512526|P3|NOT COMPLETED|Overall Study||6
616854|NCT00320216|1512527|P2|NOT COMPLETED|Overall Study||10
616855|NCT00320216|1512528|P1|NOT COMPLETED|Overall Study||16
616856|NCT00320216|1512524|P5|COMPLETED|Overall Study||58
616857|NCT00320216|1512525|P4|COMPLETED|Overall Study||61
616858|NCT00320216|1512526|P3|COMPLETED|Overall Study||58
616859|NCT00320216|1512527|P2|COMPLETED|Overall Study||54
616860|NCT00320216|1512528|P1|COMPLETED|Overall Study||48
616861|NCT00320216|1512524|P5|STARTED|Overall Study||64
616862|NCT00320216|1512525|P4|STARTED|Overall Study||64
616863|NCT00320216|1512526|P3|STARTED|Overall Study|1 patient randomized but not treated was included as discontinued due to Other reason.|64
616864|NCT00320216|1512527|P2|STARTED|Overall Study|1 patient randomized but not treated was included as discontinued due to Other reason.|64
616865|NCT00320216|1512528|P1|STARTED|Overall Study||64
616866|NCT00320190|1512562|P2|NOT COMPLETED|Long-term (12-month) Extension||2
616867|NCT00320190|1512563|P1|NOT COMPLETED|Long-term (12-month) Extension||9
616868|NCT00320190|1512562|P2|COMPLETED|Long-term (12-month) Extension||1
616869|NCT00320190|1512563|P1|COMPLETED|Long-term (12-month) Extension||2
616870|NCT00320190|1512562|P2|STARTED|Long-term (12-month) Extension||3
616871|NCT00320190|1512563|P1|STARTED|Long-term (12-month) Extension||11
616872|NCT00320190|1512562|P2|NOT COMPLETED|First 12 Months||10
616873|NCT00320190|1512563|P1|NOT COMPLETED|First 12 Months||8
616874|NCT00320190|1512562|P2|COMPLETED|First 12 Months||3
616875|NCT00320190|1512563|P1|COMPLETED|First 12 Months||11
616876|NCT00320190|1512562|P2|STARTED|First 12 Months||13
616877|NCT00320190|1512563|P1|STARTED|First 12 Months||19
616878|NCT00320112|1512583|P2|NOT COMPLETED|Overall Study||5
616879|NCT00320112|1512584|P1|NOT COMPLETED|Overall Study||8
616880|NCT00320112|1512583|P2|COMPLETED|Overall Study||114
616881|NCT00320112|1512584|P1|COMPLETED|Overall Study||117
616882|NCT00320112|1512583|P2|STARTED|Overall Study||119
616883|NCT00320112|1512584|P1|STARTED|Overall Study||125
616884|NCT00319982|1512598|P2|NOT COMPLETED|Overall Study||0
616885|NCT00319982|1512599|P1|NOT COMPLETED|Overall Study||1
616886|NCT00319982|1512598|P2|COMPLETED|Overall Study||20
616887|NCT00319982|1512599|P1|COMPLETED|Overall Study||18
616888|NCT00319982|1512598|P2|STARTED|Overall Study||20
616889|NCT00319982|1512599|P1|STARTED|Overall Study||19
616890|NCT00319956|1512619|P2|NOT COMPLETED|Overall Study||24
616891|NCT00319956|1512620|P1|NOT COMPLETED|Overall Study||20
616892|NCT00319956|1512619|P2|COMPLETED|Overall Study||85
616893|NCT00319956|1512620|P1|COMPLETED|Overall Study||91
616894|NCT00319956|1512619|P2|STARTED|Overall Study||109
616895|NCT00319956|1512620|P1|STARTED|Overall Study||111
616896|NCT00319839|1512632|P1|NOT COMPLETED|Overall Study||6
616897|NCT00319839|1512632|P1|COMPLETED|Overall Study||1
616898|NCT00319839|1512632|P1|STARTED|Overall Study||7
616899|NCT00319748|1512638|P1|NOT COMPLETED|Overall Study||0
616900|NCT00319748|1512638|P1|COMPLETED|Overall Study||13
616901|NCT00319748|1512638|P1|STARTED|Overall Study||13
616902|NCT00319735|1512648|P1|NOT COMPLETED|Overall Study||2
616903|NCT00319735|1512648|P1|COMPLETED|Overall Study||39
616904|NCT00319735|1512648|P1|STARTED|Overall Study||41
616905|NCT00319696|1512661|P1|NOT COMPLETED|Overall Study||60
616906|NCT00319696|1512661|P1|COMPLETED|Overall Study||56
616907|NCT00319696|1512661|P1|STARTED|Overall Study||116
616908|NCT00319644|1512687|P2|NOT COMPLETED|Overall Study||0
616909|NCT00319644|1512688|P1|NOT COMPLETED|Overall Study||0
616910|NCT00319644|1512687|P2|COMPLETED|Overall Study||16
616911|NCT00319644|1512688|P1|COMPLETED|Overall Study||21
616912|NCT00319644|1512687|P2|STARTED|Overall Study||16
616913|NCT00319644|1512688|P1|STARTED|Overall Study||21
616914|NCT00319592|1512698|P2|NOT COMPLETED|Overall Study||1
616915|NCT00319592|1512699|P1|NOT COMPLETED|Overall Study||1
616916|NCT00319592|1512698|P2|COMPLETED|Overall Study||29
616917|NCT00319592|1512699|P1|COMPLETED|Overall Study||29
616918|NCT00319592|1512698|P2|STARTED|Overall Study||30
616919|NCT00319592|1512699|P1|STARTED|Overall Study||30
616920|NCT00319553|1512715|P2|NOT COMPLETED|Overall Study||4
616921|NCT00319553|1512716|P1|NOT COMPLETED|Overall Study||4
616922|NCT00319553|1512715|P2|COMPLETED|Overall Study||317
616923|NCT00319553|1512716|P1|COMPLETED|Overall Study||319
616924|NCT00319553|1512715|P2|STARTED|Overall Study||321
616925|NCT00319553|1512716|P1|STARTED|Overall Study||323
616926|NCT00319501|1512730|P2|NOT COMPLETED|Open-label Extension Period||0
616927|NCT00319501|1512731|P1|NOT COMPLETED|Open-label Extension Period||51
616928|NCT00319501|1512730|P2|COMPLETED|Open-label Extension Period||0
616929|NCT00319501|1512731|P1|COMPLETED|Open-label Extension Period||0
616930|NCT00319501|1512730|P2|Received Treatment|Open-label Extension Period||0
616931|NCT00319501|1512731|P1|Received Treatment|Open-label Extension Period||33
616932|NCT00319501|1512730|P2|STARTED|Open-label Extension Period||0
616933|NCT00319501|1512731|P1|STARTED|Open-label Extension Period|Eligible participants who chose to continue treatment|51
616934|NCT00319501|1512730|P2|NOT COMPLETED|Open-label Period||0
616935|NCT00319501|1512731|P1|NOT COMPLETED|Open-label Period||116
616936|NCT00319501|1512730|P2|COMPLETED|Open-label Period||0
616937|NCT00319501|1512731|P1|COMPLETED|Open-label Period|Competed=continuing treatment|45
616938|NCT00319501|1512730|P2|Received Treatment|Open-label Period||0
616939|NCT00319501|1512731|P1|Received Treatment|Open-label Period||128
616940|NCT00319501|1512730|P2|STARTED|Open-label Period||0
616941|NCT00319501|1512731|P1|STARTED|Open-label Period|Participants who continued to meet eligibility requirements|161
616942|NCT00319501|1512730|P2|NOT COMPLETED|Double-blind Period||32
616943|NCT00319501|1512731|P1|NOT COMPLETED|Double-blind Period||43
616944|NCT00319501|1512730|P2|COMPLETED|Double-blind Period||78
616945|NCT00319501|1512731|P1|COMPLETED|Double-blind Period||81
616946|NCT00319501|1512730|P2|Received Treatment|Double-blind Period||81
616947|NCT00319501|1512731|P1|Received Treatment|Double-blind Period||82
616948|NCT00319501|1512730|P2|STARTED|Double-blind Period|Randomized participants|110
616949|NCT00319501|1512731|P1|STARTED|Double-blind Period|Randomized participants|124
616950|NCT00319449|1512757|P2|NOT COMPLETED|Overall Study||0
616951|NCT00319449|1512758|P1|NOT COMPLETED|Overall Study||2
616952|NCT00319449|1512757|P2|COMPLETED|Overall Study||12
616953|NCT00319449|1512758|P1|COMPLETED|Overall Study||8
616954|NCT00319449|1512757|P2|STARTED|Overall Study||12
616955|NCT00319449|1512758|P1|STARTED|Overall Study||10
616956|NCT00319436|1512770|P2|NOT COMPLETED|Overall Study||7
616957|NCT00319436|1512771|P1|NOT COMPLETED|Overall Study||6
616958|NCT00319436|1512770|P2|COMPLETED|Overall Study||17
616959|NCT00319436|1512771|P1|COMPLETED|Overall Study||17
616960|NCT00319436|1512770|P2|STARTED|Overall Study||24
616961|NCT00319436|1512771|P1|STARTED|Overall Study||23
616962|NCT00319254|1512789|P1|NOT COMPLETED|Overall Study||54
616963|NCT00319254|1512789|P1|COMPLETED|Overall Study||21
616964|NCT00319254|1512789|P1|Treated|Overall Study||73
616965|NCT00319254|1512789|P1|STARTED|Overall Study||75
616966|NCT00319111|1512802|P1|NOT COMPLETED|Overall Study||47
616967|NCT00319111|1512802|P1|COMPLETED|Overall Study||104
616968|NCT00319111|1512802|P1|STARTED|Overall Study|148 patients enrolled in BENEFIT OL & 3 prematurely discontinued from BENEFIT (NCT00313222)|151
616969|NCT00319098|1512816|P2|NOT COMPLETED|Overall Study||32
616970|NCT00319098|1512817|P1|NOT COMPLETED|Overall Study||135
616971|NCT00319098|1512816|P2|COMPLETED|Overall Study||1237
616972|NCT00319098|1512817|P1|COMPLETED|Overall Study||3667
616973|NCT00319098|1512816|P2|STARTED|Overall Study||1269
616974|NCT00319098|1512817|P1|STARTED|Overall Study||3802
616975|NCT00319046|1512875|P1|NOT COMPLETED|Overall Study||8
616976|NCT00319046|1512875|P1|COMPLETED|Overall Study||34
616977|NCT00319046|1512875|P1|STARTED|Overall Study|One patient was excluded from analysis as the baseline liver volume not available|42
616978|NCT00319020|1512884|P2|NOT COMPLETED|Overall Study||13
616979|NCT00319020|1512885|P1|NOT COMPLETED|Overall Study||7
616980|NCT00319020|1512884|P2|COMPLETED|Overall Study||8
616981|NCT00319020|1512885|P1|COMPLETED|Overall Study||8
616982|NCT00319020|1512884|P2|Enrollment in FUTURE 2 (F-2)|Overall Study||20
616983|NCT00319020|1512885|P1|Enrollment in FUTURE 2 (F-2)|Overall Study||13
616984|NCT00319020|1512884|P2|STARTED|Overall Study||21
616985|NCT00319020|1512885|P1|STARTED|Overall Study||15
616986|NCT00318929|1512914|P1|NOT COMPLETED|Overall Study||0
616987|NCT00318929|1512914|P1|COMPLETED|Overall Study||14
616988|NCT00318929|1512914|P1|STARTED|Overall Study||14
616989|NCT00318812|1512923|P2|NOT COMPLETED|Overall Study||0
616990|NCT00318812|1512924|P1|NOT COMPLETED|Overall Study||0
616991|NCT00318812|1512923|P2|COMPLETED|Overall Study||22
616992|NCT00318812|1512924|P1|COMPLETED|Overall Study||18
616993|NCT00318812|1512923|P2|STARTED|Overall Study||22
616994|NCT00318812|1512924|P1|STARTED|Overall Study||18
616995|NCT00318708|1512936|P2|NOT COMPLETED|Overall Study||5
616996|NCT00318708|1512937|P1|NOT COMPLETED|Overall Study||8
616997|NCT00318708|1512936|P2|COMPLETED|Overall Study||40
616998|NCT00318708|1512937|P1|COMPLETED|Overall Study||39
616999|NCT00318708|1512936|P2|8-week Milestone|Overall Study||42
617000|NCT00318708|1512937|P1|8-week Milestone|Overall Study||42
617001|NCT00318708|1512936|P2|STARTED|Overall Study||45
617002|NCT00318708|1512937|P1|STARTED|Overall Study||47
617003|NCT00318656|1512957|P2|NOT COMPLETED|Overall Study||2
617004|NCT00318656|1512958|P1|NOT COMPLETED|Overall Study||0
617005|NCT00318656|1512957|P2|COMPLETED|Overall Study|1 patient received by error avandamet treatment and 1 patient did not receive any treatment.|9
617006|NCT00318656|1512958|P1|COMPLETED|Overall Study||12
617007|NCT00318656|1512957|P2|STARTED|Overall Study||11
617008|NCT00318656|1512958|P1|STARTED|Overall Study||12
617009|NCT00318591|1512996|P2|NOT COMPLETED|Overall Study||45
617010|NCT00318591|1512997|P1|NOT COMPLETED|Overall Study||60
617011|NCT00318591|1512996|P2|COMPLETED|Overall Study||69
617012|NCT00318591|1512997|P1|COMPLETED|Overall Study||45
617013|NCT00318591|1512996|P2|STARTED|Overall Study||114
617014|NCT00318591|1512997|P1|STARTED|Overall Study||105
617015|NCT00318565|1513015|P1|NOT COMPLETED|Overall Study||24
617016|NCT00318565|1513015|P1|COMPLETED|Overall Study||267
617017|NCT00318565|1513015|P1|STARTED|Overall Study||291
617018|NCT00318474|1513022|P2|NOT COMPLETED|Overall Study||17
617019|NCT00318474|1513023|P1|NOT COMPLETED|Overall Study||18
617020|NCT00318474|1513022|P2|COMPLETED|Overall Study||10
617021|NCT00318474|1513023|P1|COMPLETED|Overall Study||7
617022|NCT00318474|1513022|P2|STARTED|Overall Study||27
617023|NCT00318474|1513023|P1|STARTED|Overall Study||25
617024|NCT00318461|1513034|P5|NOT COMPLETED|Open-Label Extension, 18 Months||97
617025|NCT00318461|1513035|P4|NOT COMPLETED|Open-Label Extension, 18 Months||43
617026|NCT00318461|1513036|P3|NOT COMPLETED|Open-Label Extension, 18 Months||73
617027|NCT00318461|1513037|P2|NOT COMPLETED|Open-Label Extension, 18 Months||60
617028|NCT00318461|1513038|P1|NOT COMPLETED|Open-Label Extension, 18 Months||78
617029|NCT00318461|1513034|P5|COMPLETED|Open-Label Extension, 18 Months||113
617030|NCT00318461|1513035|P4|COMPLETED|Open-Label Extension, 18 Months||31
617031|NCT00318461|1513036|P3|COMPLETED|Open-Label Extension, 18 Months||118
617032|NCT00318461|1513037|P2|COMPLETED|Open-Label Extension, 18 Months||137
617033|NCT00318461|1513038|P1|COMPLETED|Open-Label Extension, 18 Months||130
617034|NCT00318461|1513034|P5|STARTED|Open-Label Extension, 18 Months||210
617035|NCT00318461|1513035|P4|STARTED|Open-Label Extension, 18 Months||74
617036|NCT00318461|1513036|P3|STARTED|Open-Label Extension, 18 Months||191
617037|NCT00318461|1513037|P2|STARTED|Open-Label Extension, 18 Months||197
617038|NCT00318461|1513038|P1|STARTED|Open-Label Extension, 18 Months||208
617039|NCT00318461|1513034|P5|NOT COMPLETED|Double-Blind, 6 Months||34
617040|NCT00318461|1513035|P4|NOT COMPLETED|Double-Blind, 6 Months||48
617041|NCT00318461|1513036|P3|NOT COMPLETED|Double-Blind, 6 Months||51
617042|NCT00318461|1513037|P2|NOT COMPLETED|Double-Blind, 6 Months||44
617043|NCT00318461|1513038|P1|NOT COMPLETED|Double-Blind, 6 Months||34
617044|NCT00318461|1513034|P5|COMPLETED|Double-Blind, 6 Months||210
617045|NCT00318461|1513035|P4|COMPLETED|Double-Blind, 6 Months||74
617046|NCT00318461|1513036|P3|COMPLETED|Double-Blind, 6 Months||191
617047|NCT00318461|1513037|P2|COMPLETED|Double-Blind, 6 Months||197
617048|NCT00318461|1513038|P1|COMPLETED|Double-Blind, 6 Months||208
617049|NCT00318461|1513034|P5|Exposed to Study Drug|Double-Blind, 6 Months|Subjects withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|242
617050|NCT00318461|1513035|P4|Exposed to Study Drug|Double-Blind, 6 Months|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|121
617051|NCT00318461|1513036|P3|Exposed to Study Drug|Double-Blind, 6 Months||242
617052|NCT00318461|1513037|P2|Exposed to Study Drug|Double-Blind, 6 Months|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|240
617053|NCT00318461|1513038|P1|Exposed to Study Drug|Double-Blind, 6 Months||242
617054|NCT00318461|1513034|P5|STARTED|Double-Blind, 6 Months|Randomised|244
617055|NCT00318461|1513035|P4|STARTED|Double-Blind, 6 Months|Randomised|122
617056|NCT00318461|1513036|P3|STARTED|Double-Blind, 6 Months|Randomised|242
617057|NCT00318461|1513037|P2|STARTED|Double-Blind, 6 Months|Randomised|241
617058|NCT00318461|1513038|P1|STARTED|Double-Blind, 6 Months|Randomised|242
617059|NCT00318409|1513117|P2|NOT COMPLETED|Overall Study||1
617060|NCT00318409|1513118|P1|NOT COMPLETED|Overall Study||2
617061|NCT00318409|1513117|P2|COMPLETED|Overall Study||9
617062|NCT00318409|1513118|P1|COMPLETED|Overall Study||18
617063|NCT00318409|1513117|P2|STARTED|Overall Study||10
617064|NCT00318409|1513118|P1|STARTED|Overall Study||20
617065|NCT00318370|1513137|P3|NOT COMPLETED|Period 3||33
617066|NCT00318370|1513138|P2|NOT COMPLETED|Period 3||0
617067|NCT00318370|1513139|P1|NOT COMPLETED|Period 3||0
617068|NCT00318370|1513137|P3|COMPLETED|Period 3||3
617069|NCT00318370|1513138|P2|COMPLETED|Period 3||0
617070|NCT00318370|1513139|P1|COMPLETED|Period 3||0
617071|NCT00318370|1513137|P3|STARTED|Period 3||36
617072|NCT00318370|1513138|P2|STARTED|Period 3||0
617073|NCT00318370|1513139|P1|STARTED|Period 3||0
617074|NCT00318370|1513137|P3|NOT COMPLETED|Period 2||0
617075|NCT00318370|1513138|P2|NOT COMPLETED|Period 2||11
617076|NCT00318370|1513139|P1|NOT COMPLETED|Period 2||0
617077|NCT00318370|1513137|P3|COMPLETED|Period 2||0
617078|NCT00318370|1513138|P2|COMPLETED|Period 2||36
617079|NCT00318370|1513139|P1|COMPLETED|Period 2||0
617080|NCT00318370|1513137|P3|STARTED|Period 2||0
617081|NCT00318370|1513138|P2|STARTED|Period 2|26 participants enrolled directly into Chemo Plus Far plus 21 participants from Far Only.|47
617082|NCT00318370|1513139|P1|STARTED|Period 2||0
617083|NCT00318370|1513137|P3|NOT COMPLETED|Period 1||0
617084|NCT00318370|1513138|P2|NOT COMPLETED|Period 1||0
617085|NCT00318370|1513139|P1|NOT COMPLETED|Period 1||7
617086|NCT00318370|1513137|P3|COMPLETED|Period 1||0
617087|NCT00318370|1513138|P2|COMPLETED|Period 1||0
617088|NCT00318370|1513139|P1|COMPLETED|Period 1|21 participants proceeded from Far Only to Chemo Plus Far.|21
617089|NCT00318370|1513137|P3|STARTED|Period 1||0
617090|NCT00318370|1513138|P2|STARTED|Period 1||0
617091|NCT00318370|1513139|P1|STARTED|Period 1||28
617092|NCT00318292|1513151|P2|NOT COMPLETED|Overall Study||0
617093|NCT00318292|1513152|P1|NOT COMPLETED|Overall Study||0
617094|NCT00318292|1513151|P2|COMPLETED|Overall Study||45
617095|NCT00318292|1513152|P1|COMPLETED|Overall Study||45
617096|NCT00318292|1513151|P2|STARTED|Overall Study||45
617097|NCT00318292|1513152|P1|STARTED|Overall Study||45
617098|NCT00318136|1513158|P1|NOT COMPLETED|Overall Study||45
617099|NCT00318136|1513158|P1|COMPLETED|Overall Study||2
617100|NCT00318136|1513158|P1|STARTED|Overall Study||47
617101|NCT00317941|1513167|P3|NOT COMPLETED|Overall Study||8
617102|NCT00317941|1513168|P2|NOT COMPLETED|Overall Study||5
617103|NCT00317941|1513169|P1|NOT COMPLETED|Overall Study||7
617104|NCT00317941|1513167|P3|COMPLETED|Overall Study||60
617105|NCT00317941|1513168|P2|COMPLETED|Overall Study||74
617106|NCT00317941|1513169|P1|COMPLETED|Overall Study||66
617107|NCT00317941|1513167|P3|Fulfilled Requirements PP Population|Overall Study||63
617108|NCT00317941|1513168|P2|Fulfilled Requirements PP Population|Overall Study||76
617109|NCT00317941|1513169|P1|Fulfilled Requirements PP Population|Overall Study||66
617110|NCT00317941|1513167|P3|Fulfilled Requirement Safety Population|Overall Study||65
617111|NCT00317941|1513168|P2|Fulfilled Requirement Safety Population|Overall Study||77
617112|NCT00317941|1513169|P1|Fulfilled Requirement Safety Population|Overall Study||73
617113|NCT00317941|1513167|P3|Participants Received Treatment|Overall Study||68
617114|NCT00317941|1513168|P2|Participants Received Treatment|Overall Study||79
617115|NCT00317941|1513169|P1|Participants Received Treatment|Overall Study||73
617116|NCT00317941|1513167|P3|STARTED|Overall Study||68
617117|NCT00317941|1513168|P2|STARTED|Overall Study||79
617118|NCT00317941|1513169|P1|STARTED|Overall Study||73
617119|NCT00317720|1513210|P2|NOT COMPLETED|Overall Study||0
617120|NCT00317720|1513211|P1|NOT COMPLETED|Overall Study||0
617121|NCT00317720|1513210|P2|COMPLETED|Overall Study||7
617122|NCT00317720|1513211|P1|COMPLETED|Overall Study||40
617123|NCT00317720|1513210|P2|STARTED|Overall Study||7
617124|NCT00317720|1513211|P1|STARTED|Overall Study||40
617125|NCT00317642|1513218|P2|NOT COMPLETED|Overall Study||135
617126|NCT00317642|1513219|P1|NOT COMPLETED|Overall Study||122
617127|NCT00317642|1513218|P2|COMPLETED|Overall Study|achieved remission and completed consolidation|28
617128|NCT00317642|1513219|P1|COMPLETED|Overall Study|achieved remission and completed consolidation|41
617129|NCT00317642|1513218|P2|Received >= 1 Study Drug (Safety Set)|Overall Study||155
617130|NCT00317642|1513219|P1|Received >= 1 Study Drug (Safety Set)|Overall Study||161
617131|NCT00317642|1513218|P2|Full Analysis Set|Overall Study|AML Centrally Confirmed|158
617132|NCT00317642|1513219|P1|Full Analysis Set|Overall Study|AML Centrally Confirmed|162
617133|NCT00317642|1513218|P2|STARTED|Overall Study||163
617134|NCT00317642|1513219|P1|STARTED|Overall Study||163
617135|NCT00317473|1513298|P6|NOT COMPLETED|Overall Study||3
617136|NCT00317473|1513299|P5|NOT COMPLETED|Overall Study||8
617137|NCT00317473|1513300|P4|NOT COMPLETED|Overall Study||2
617138|NCT00317473|1513301|P3|NOT COMPLETED|Overall Study||3
617139|NCT00317473|1513302|P2|NOT COMPLETED|Overall Study||3
617140|NCT00317473|1513303|P1|NOT COMPLETED|Overall Study||4
617141|NCT00317473|1513298|P6|COMPLETED|Overall Study||12
617142|NCT00317473|1513299|P5|COMPLETED|Overall Study||22
617143|NCT00317473|1513300|P4|COMPLETED|Overall Study||13
617144|NCT00317473|1513301|P3|COMPLETED|Overall Study||27
617145|NCT00317473|1513302|P2|COMPLETED|Overall Study||12
617146|NCT00317473|1513303|P1|COMPLETED|Overall Study||26
617147|NCT00317473|1513298|P6|STARTED|Overall Study||15
617148|NCT00317473|1513299|P5|STARTED|Overall Study||30
617149|NCT00317473|1513300|P4|STARTED|Overall Study||15
617150|NCT00317473|1513301|P3|STARTED|Overall Study||30
617151|NCT00317473|1513302|P2|STARTED|Overall Study||15
617152|NCT00317473|1513303|P1|STARTED|Overall Study||30
617153|NCT00317239|1513329|P2|NOT COMPLETED|Overall Study||19
617154|NCT00317239|1513330|P1|NOT COMPLETED|Overall Study||13
617155|NCT00317239|1513329|P2|COMPLETED|Overall Study||84
617156|NCT00317239|1513330|P1|COMPLETED|Overall Study||134
617157|NCT00317239|1513329|P2|STARTED|Overall Study||103
617158|NCT00317239|1513330|P1|STARTED|Overall Study||147
617159|NCT00317226|1513336|P1|NOT COMPLETED|Overall Study||23
617160|NCT00317226|1513336|P1|COMPLETED|Overall Study||104
617161|NCT00317226|1513336|P1|STARTED|Overall Study||127
617162|NCT00317109|1513342|P2|NOT COMPLETED|Overall Study||0
617163|NCT00317109|1513343|P1|NOT COMPLETED|Overall Study||3
617164|NCT00317109|1513342|P2|COMPLETED|Overall Study||84
617165|NCT00317109|1513343|P1|COMPLETED|Overall Study||81
617166|NCT00317109|1513342|P2|STARTED|Overall Study||84
617167|NCT00317109|1513343|P1|STARTED|Overall Study||84
617168|NCT00317044|1513380|P3|NOT COMPLETED|Overall Study||45
617169|NCT00317044|1513381|P2|NOT COMPLETED|Overall Study||40
617170|NCT00317044|1513382|P1|NOT COMPLETED|Overall Study||48
617171|NCT00317044|1513380|P3|COMPLETED|Overall Study||283
617172|NCT00317044|1513381|P2|COMPLETED|Overall Study||273
617173|NCT00317044|1513382|P1|COMPLETED|Overall Study||272
617174|NCT00317044|1513380|P3|STARTED|Overall Study||328
617175|NCT00317044|1513381|P2|STARTED|Overall Study||313
617176|NCT00317044|1513382|P1|STARTED|Overall Study||320
617177|NCT00316914|1513428|P2|NOT COMPLETED|Overall Study||36
617178|NCT00316914|1513429|P1|NOT COMPLETED|Overall Study||33
617179|NCT00316914|1513428|P2|COMPLETED|Overall Study||16
617180|NCT00316914|1513429|P1|COMPLETED|Overall Study||17
617181|NCT00316914|1513428|P2|STARTED|Overall Study||52
617182|NCT00316914|1513429|P1|STARTED|Overall Study||50
617183|NCT00316888|1513459|P2|NOT COMPLETED|Overall Study||8
617184|NCT00316888|1513460|P1|NOT COMPLETED|Overall Study||6
617185|NCT00316888|1513459|P2|COMPLETED|Overall Study||27
617186|NCT00316888|1513460|P1|COMPLETED|Overall Study||22
617187|NCT00316888|1513459|P2|Started Chemo+Radiation+Cetuximab|Overall Study||34
617188|NCT00316888|1513460|P1|Started Chemo+Radiation+Cetuximab|Overall Study|One patient did not start chemo+radiation therapy after completing induction therapy|27
617189|NCT00316888|1513459|P2|Started Induction Chemotherapy|Overall Study|Induction chemotherapy was removed for patients on this arm|0
617190|NCT00316888|1513460|P1|Started Induction Chemotherapy|Overall Study||28
617191|NCT00316888|1513459|P2|Treated|Overall Study||34
617192|NCT00316888|1513460|P1|Treated|Overall Study|Received induction and/or chemo+radiation therapy|28
617193|NCT00316888|1513459|P2|Eligible|Overall Study||35
617194|NCT00316888|1513460|P1|Eligible|Overall Study||28
617195|NCT00316888|1513459|P2|STARTED|Overall Study||35
617196|NCT00316888|1513460|P1|STARTED|Overall Study||28
617197|NCT00316862|1513474|P1|NOT COMPLETED|Overall Study||0
617198|NCT00316862|1513474|P1|COMPLETED|Overall Study||82
617199|NCT00316862|1513474|P1|STARTED|Overall Study||82
617200|NCT00316719|1513482|P2|NOT COMPLETED|Overall Study||6
617201|NCT00316719|1513483|P1|NOT COMPLETED|Overall Study||2
617202|NCT00316719|1513482|P2|COMPLETED|Overall Study||47
617203|NCT00316719|1513483|P1|COMPLETED|Overall Study||50
617204|NCT00316719|1513482|P2|STARTED|Overall Study||53
617205|NCT00316719|1513483|P1|STARTED|Overall Study||52
617206|NCT00316706|1513509|P2|NOT COMPLETED|Overall Study||48
617207|NCT00316706|1513510|P1|NOT COMPLETED|Overall Study||38
617208|NCT00316706|1513509|P2|COMPLETED|Overall Study|Subjects in Havrix group that completed the study at Month 24|571
617209|NCT00316706|1513510|P1|COMPLETED|Overall Study|Subjects in Cervarix group that completed the study at Month 48|588
617210|NCT00316706|1513509|P2|STARTED|Overall Study||619
617211|NCT00316706|1513510|P1|STARTED|Overall Study||626
617212|NCT00316693|1513526|P2|NOT COMPLETED|Overall Study||85
617213|NCT00316693|1513527|P1|NOT COMPLETED|Overall Study||77
617214|NCT00316693|1513526|P2|COMPLETED|Overall Study||436
617215|NCT00316693|1513527|P1|COMPLETED|Overall Study||442
617216|NCT00316693|1513526|P2|STARTED|Overall Study||521
617217|NCT00316693|1513527|P1|STARTED|Overall Study||519
617218|NCT00316355|1513569|P2|NOT COMPLETED|Overall Study||7
617219|NCT00316355|1513570|P1|NOT COMPLETED|Overall Study||5
617220|NCT00316355|1513569|P2|COMPLETED|Overall Study||12
617221|NCT00316355|1513570|P1|COMPLETED|Overall Study||10
617222|NCT00316355|1513569|P2|Started Treatment|Overall Study||18
617223|NCT00316355|1513570|P1|Started Treatment|Overall Study||12
617224|NCT00316355|1513569|P2|STARTED|Overall Study||19
617225|NCT00316355|1513570|P1|STARTED|Overall Study||15
617226|NCT00316303|1513580|P2|NOT COMPLETED|Overall Study||16
617227|NCT00316303|1513581|P1|NOT COMPLETED|Overall Study||11
617228|NCT00316303|1513580|P2|COMPLETED|Overall Study||102
617229|NCT00316303|1513581|P1|COMPLETED|Overall Study||107
617230|NCT00316303|1513580|P2|STARTED|Overall Study||118
617231|NCT00316303|1513581|P1|STARTED|Overall Study||118
617232|NCT00316277|1513597|P2|NOT COMPLETED|Phase 2 (24 Weeks)||19
617233|NCT00316277|1513598|P1|NOT COMPLETED|Phase 2 (24 Weeks)||19
617234|NCT00316277|1513597|P2|COMPLETED|Phase 2 (24 Weeks)||161
617235|NCT00316277|1513598|P1|COMPLETED|Phase 2 (24 Weeks)||161
617236|NCT00316277|1513597|P2|STARTED|Phase 2 (24 Weeks)||180
617237|NCT00316277|1513598|P1|STARTED|Phase 2 (24 Weeks)||180
617238|NCT00316277|1513597|P2|NOT COMPLETED|Phase 1 (12 Weeks)||300
617239|NCT00316277|1513598|P1|NOT COMPLETED|Phase 1 (12 Weeks)||310
617240|NCT00316277|1513597|P2|COMPLETED|Phase 1 (12 Weeks)||24
617241|NCT00316277|1513598|P1|COMPLETED|Phase 1 (12 Weeks)||19
617242|NCT00316277|1513597|P2|STARTED|Phase 1 (12 Weeks)||324
617243|NCT00316277|1513598|P1|STARTED|Phase 1 (12 Weeks)||329
617244|NCT00316264|1513619|P3|NOT COMPLETED|Overall Study||6
617245|NCT00316264|1513620|P2|NOT COMPLETED|Overall Study||7
617246|NCT00316264|1513621|P1|NOT COMPLETED|Overall Study||6
617247|NCT00316264|1513619|P3|COMPLETED|Overall Study||87
617248|NCT00316264|1513620|P2|COMPLETED|Overall Study||77
617249|NCT00316264|1513621|P1|COMPLETED|Overall Study||77
617250|NCT00316264|1513619|P3|STARTED|Overall Study||93
617251|NCT00316264|1513620|P2|STARTED|Overall Study||84
617252|NCT00316264|1513621|P1|STARTED|Overall Study||83
617253|NCT00316225|1513689|P1|NOT COMPLETED|Overall Study||25
617254|NCT00316225|1513689|P1|COMPLETED|Overall Study||6
617255|NCT00316225|1513689|P1|STARTED|Overall Study||31
617256|NCT00316199|1513698|P1|NOT COMPLETED|Overall Study||12
617257|NCT00316199|1513698|P1|COMPLETED|Overall Study||48
617258|NCT00316199|1513698|P1|STARTED|Overall Study||60
617259|NCT00316186|1513706|P1|NOT COMPLETED|Overall Study||12
617260|NCT00316186|1513706|P1|COMPLETED|Overall Study||21
617261|NCT00316186|1513706|P1|STARTED|Overall Study||33
617262|NCT00316173|1513720|P2|NOT COMPLETED|Treatment Phase||42
617263|NCT00316173|1513721|P1|NOT COMPLETED|Treatment Phase||0
617264|NCT00316173|1513720|P2|COMPLETED|Treatment Phase||13
617265|NCT00316173|1513721|P1|COMPLETED|Treatment Phase||0
617266|NCT00316173|1513720|P2|STARTED|Treatment Phase||55
617267|NCT00316173|1513721|P1|STARTED|Treatment Phase||0
617268|NCT00316173|1513720|P2|NOT COMPLETED|Run-in Phase||0
617269|NCT00316173|1513721|P1|NOT COMPLETED|Run-in Phase||7
617270|NCT00316173|1513720|P2|COMPLETED|Run-in Phase||0
617271|NCT00316173|1513721|P1|COMPLETED|Run-in Phase||15
617272|NCT00316173|1513720|P2|STARTED|Run-in Phase||0
617273|NCT00316173|1513721|P1|STARTED|Run-in Phase||22
617274|NCT00316121|1513734|P2|NOT COMPLETED|Overall Study||9
617275|NCT00316121|1513735|P1|NOT COMPLETED|Overall Study||22
617276|NCT00316121|1513734|P2|COMPLETED|Overall Study||37
617277|NCT00316121|1513735|P1|COMPLETED|Overall Study||70
617278|NCT00316121|1513734|P2|STARTED|Overall Study||46
617279|NCT00316121|1513735|P1|STARTED|Overall Study||92
617280|NCT00316082|1513746|P5|NOT COMPLETED|Overall Study||26
617281|NCT00316082|1513747|P4|NOT COMPLETED|Overall Study||26
617282|NCT00316082|1513748|P3|NOT COMPLETED|Overall Study||27
617283|NCT00316082|1513749|P2|NOT COMPLETED|Overall Study||22
617284|NCT00316082|1513750|P1|NOT COMPLETED|Overall Study||33
617285|NCT00316082|1513746|P5|COMPLETED|Overall Study||48
617286|NCT00316082|1513747|P4|COMPLETED|Overall Study||46
617287|NCT00316082|1513748|P3|COMPLETED|Overall Study||44
617288|NCT00316082|1513749|P2|COMPLETED|Overall Study||52
617289|NCT00316082|1513750|P1|COMPLETED|Overall Study||41
617290|NCT00316082|1513746|P5|Completed Study Without Being Rescued|Overall Study||31
617291|NCT00316082|1513747|P4|Completed Study Without Being Rescued|Overall Study||27
617292|NCT00316082|1513748|P3|Completed Study Without Being Rescued|Overall Study||29
617293|NCT00316082|1513749|P2|Completed Study Without Being Rescued|Overall Study||35
617294|NCT00316082|1513750|P1|Completed Study Without Being Rescued|Overall Study||25
617295|NCT00316082|1513746|P5|STARTED|Overall Study||74
617296|NCT00316082|1513747|P4|STARTED|Overall Study||72
617297|NCT00316082|1513748|P3|STARTED|Overall Study||71
617298|NCT00316082|1513749|P2|STARTED|Overall Study||74
617299|NCT00316082|1513750|P1|STARTED|Overall Study||74
617300|NCT00316017|1513781|P3|NOT COMPLETED|Overall Study||19
617301|NCT00316017|1513782|P2|NOT COMPLETED|Overall Study||13
617302|NCT00316017|1513783|P1|NOT COMPLETED|Overall Study||11
617303|NCT00316017|1513781|P3|COMPLETED|Overall Study||376
617304|NCT00316017|1513782|P2|COMPLETED|Overall Study||256
617305|NCT00316017|1513783|P1|COMPLETED|Overall Study||220
617306|NCT00316017|1513781|P3|STARTED|Overall Study|19 of 19 not complete due to BONG|395
617307|NCT00316017|1513782|P2|STARTED|Overall Study|12 of 13 not completed due to BONG; 1 not completed was a prisoner who was excluded|269
617308|NCT00316017|1513783|P1|STARTED|Overall Study|"11 of 11 not completed due to Bag Opened Not Given (BONG)"|231
617309|NCT00316004|1513857|P3|NOT COMPLETED|Overall Study||21
617310|NCT00316004|1513858|P2|NOT COMPLETED|Overall Study||14
617311|NCT00316004|1513859|P1|NOT COMPLETED|Overall Study||14
617312|NCT00316004|1513857|P3|COMPLETED|Overall Study||582
617313|NCT00316004|1513858|P2|COMPLETED|Overall Study||341
617314|NCT00316004|1513859|P1|COMPLETED|Overall Study||359
617315|NCT00316004|1513857|P3|STARTED|Overall Study||603
617316|NCT00316004|1513858|P2|STARTED|Overall Study||355
617317|NCT00316004|1513859|P1|STARTED|Overall Study||373
617318|NCT00315939|1513914|P2|NOT COMPLETED|Admission 3 (3 Months)||2
617319|NCT00315939|1513915|P1|NOT COMPLETED|Admission 3 (3 Months)||4
617320|NCT00315939|1513914|P2|COMPLETED|Admission 3 (3 Months)||49
617321|NCT00315939|1513915|P1|COMPLETED|Admission 3 (3 Months)||48
617322|NCT00315939|1513914|P2|STARTED|Admission 3 (3 Months)||51
617323|NCT00315939|1513915|P1|STARTED|Admission 3 (3 Months)||52
617324|NCT00315939|1513914|P2|NOT COMPLETED|Admission 2 (3 Months)||4
617325|NCT00315939|1513915|P1|NOT COMPLETED|Admission 2 (3 Months)||4
617326|NCT00315939|1513914|P2|COMPLETED|Admission 2 (3 Months)||51
617327|NCT00315939|1513915|P1|COMPLETED|Admission 2 (3 Months)||52
617328|NCT00315939|1513914|P2|STARTED|Admission 2 (3 Months)||55
617329|NCT00315939|1513915|P1|STARTED|Admission 2 (3 Months)||56
617330|NCT00315939|1513914|P2|NOT COMPLETED|Admission 1 (3 Months)||6
617331|NCT00315939|1513915|P1|NOT COMPLETED|Admission 1 (3 Months)||3
617332|NCT00315939|1513914|P2|COMPLETED|Admission 1 (3 Months)||55
617333|NCT00315939|1513915|P1|COMPLETED|Admission 1 (3 Months)||56
617334|NCT00315939|1513914|P2|STARTED|Admission 1 (3 Months)||61
617335|NCT00315939|1513915|P1|STARTED|Admission 1 (3 Months)||59
617336|NCT00315822|1513923|P2|NOT COMPLETED|Overall Study||0
617337|NCT00315822|1513924|P1|NOT COMPLETED|Overall Study||0
617338|NCT00315822|1513923|P2|COMPLETED|Overall Study||202
617339|NCT00315822|1513924|P1|COMPLETED|Overall Study||198
617340|NCT00315822|1513923|P2|STARTED|Overall Study||202
617341|NCT00315822|1513924|P1|STARTED|Overall Study||198
617342|NCT00315731|1513930|P1|NOT COMPLETED|Overall Study||6
617343|NCT00315731|1513930|P1|COMPLETED|Overall Study||9
617344|NCT00315731|1513930|P1|STARTED|Overall Study||15
617345|NCT00315705|1513958|P1|NOT COMPLETED|Phase 2||25
617346|NCT00315705|1513958|P1|COMPLETED|Phase 2|No Phase 2 participants completed the treatment period (i.e. all 8 cycles and follow-up)|0
617347|NCT00315705|1513958|P1|STARTED|Phase 2|Phase 1 and phase 2 are separate populations|25
617348|NCT00315705|1513958|P1|NOT COMPLETED|Phase 1||25
617349|NCT00315705|1513958|P1|COMPLETED|Phase 1|No Phase 1 participants completed the treatment period (i.e. all 8 cycles and follow-up)|0
617350|NCT00315705|1513958|P1|STARTED|Phase 1||25
617351|NCT00315627|1513995|P1|NOT COMPLETED|Overall Study||0
617352|NCT00315627|1513995|P1|COMPLETED|Overall Study||3
617353|NCT00315627|1513995|P1|STARTED|Overall Study||3
617354|NCT00315614|1514003|P1|NOT COMPLETED|Overall Study||0
617355|NCT00315614|1514003|P1|COMPLETED|Overall Study||3
617356|NCT00315614|1514003|P1|STARTED|Overall Study||3
617357|NCT00315588|1514010|P1|NOT COMPLETED|Overall Study||0
617358|NCT00315588|1514010|P1|COMPLETED|Overall Study||7
617359|NCT00315588|1514010|P1|STARTED|Overall Study||7
617360|NCT00315458|1514019|P4|NOT COMPLETED|Overall Study||29
617361|NCT00315458|1514020|P3|NOT COMPLETED|Overall Study||52
617362|NCT00315458|1514021|P2|NOT COMPLETED|Overall Study||12
617363|NCT00315458|1514022|P1|NOT COMPLETED|Overall Study||3
617364|NCT00315458|1514019|P4|COMPLETED|Overall Study||10
617365|NCT00315458|1514020|P3|COMPLETED|Overall Study||107
617366|NCT00315458|1514021|P2|COMPLETED|Overall Study||44
617367|NCT00315458|1514022|P1|COMPLETED|Overall Study||48
617368|NCT00315458|1514019|P4|STARTED|Overall Study||39
617369|NCT00315458|1514020|P3|STARTED|Overall Study||159
617370|NCT00315458|1514021|P2|STARTED|Overall Study||56
617371|NCT00315458|1514022|P1|STARTED|Overall Study||51
617372|NCT00315445|1514035|P3|NOT COMPLETED|Overall Study||24
617373|NCT00315445|1514036|P2|NOT COMPLETED|Overall Study||16
617374|NCT00315445|1514037|P1|NOT COMPLETED|Overall Study||27
617375|NCT00315445|1514035|P3|COMPLETED|Overall Study||22
617376|NCT00315445|1514036|P2|COMPLETED|Overall Study||27
617377|NCT00315445|1514037|P1|COMPLETED|Overall Study||18
617378|NCT00315445|1514035|P3|STARTED|Overall Study||46
617379|NCT00315445|1514036|P2|STARTED|Overall Study||43
617380|NCT00315445|1514037|P1|STARTED|Overall Study||45
617381|NCT00315341|1514110|P2|NOT COMPLETED|Overall Study||138
617382|NCT00315341|1514111|P1|NOT COMPLETED|Overall Study||400
617383|NCT00315341|1514110|P2|COMPLETED|Overall Study||391
617384|NCT00315341|1514111|P1|COMPLETED|Overall Study||340
617385|NCT00315341|1514110|P2|STARTED|Overall Study||529
617386|NCT00315341|1514111|P1|STARTED|Overall Study||740
617387|NCT00315328|1514121|P4|NOT COMPLETED|Overall Study||2
617388|NCT00315328|1514122|P3|NOT COMPLETED|Overall Study||5
617389|NCT00315328|1514123|P2|NOT COMPLETED|Overall Study||7
617390|NCT00315328|1514124|P1|NOT COMPLETED|Overall Study||14
617391|NCT00315328|1514121|P4|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|20
617392|NCT00315328|1514122|P3|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|13
617393|NCT00315328|1514123|P2|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|88
617394|NCT00315328|1514124|P1|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|84
617395|NCT00315328|1514121|P4|5 Week Visit|Overall Study||19
617396|NCT00315328|1514122|P3|5 Week Visit|Overall Study||17
617397|NCT00315328|1514123|P2|5 Week Visit|Overall Study||89
617398|NCT00315328|1514124|P1|5 Week Visit|Overall Study||91
617399|NCT00315328|1514121|P4|STARTED|Overall Study|Includes subjects with severe amblyopia only (20/125 to 20/400 at baseline)|22
617400|NCT00315328|1514122|P3|STARTED|Overall Study|Includes subjects with severe amblyopia only (20/125 to 20/400 at baseline)|18
617401|NCT00315328|1514123|P2|STARTED|Overall Study|Includes subjects with moderate amblyopia only (20/40 to 20/100 at baseline)|95
617402|NCT00315328|1514124|P1|STARTED|Overall Study|Includes subjects with moderate amblyopia only (20/40 to 20/100 at baseline)|98
617403|NCT00315302|1514194|P4|NOT COMPLETED|Overall Study||3
617404|NCT00315302|1514195|P3|NOT COMPLETED|Overall Study||2
617405|NCT00315302|1514196|P2|NOT COMPLETED|Overall Study||2
617406|NCT00315302|1514197|P1|NOT COMPLETED|Overall Study||6
617407|NCT00315302|1514194|P4|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|31
617408|NCT00315302|1514195|P3|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|24
617409|NCT00315302|1514196|P2|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|88
617410|NCT00315302|1514197|P1|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|84
617411|NCT00315302|1514194|P4|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|11
617412|NCT00315302|1514195|P3|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|9
617413|NCT00315302|1514196|P2|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|13
617414|NCT00315302|1514197|P1|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|16
617415|NCT00315302|1514194|P4|18 Week Primary Outcome Visit|Overall Study|Can be higher as includes subjects who may have missed the 10 week or other visit|31
617416|NCT00315302|1514195|P3|18 Week Primary Outcome Visit|Overall Study||24
617417|NCT00315302|1514196|P2|18 Week Primary Outcome Visit|Overall Study|Can be higher as includes subjects who may have missed the 10 week or other visit|88
617418|NCT00315302|1514197|P1|18 Week Primary Outcome Visit|Overall Study||84
617419|NCT00315302|1514194|P4|10 Week Visit|Overall Study||29
617420|NCT00315302|1514195|P3|10 Week Visit|Overall Study||24
617421|NCT00315302|1514196|P2|10 Week Visit|Overall Study||85
617422|NCT00315302|1514197|P1|10 Week Visit|Overall Study|Can be higher as includes subjects who may have missed the 5 week visit|86
617423|NCT00315302|1514194|P4|5 Week Visit|Overall Study||30
617424|NCT00315302|1514195|P3|5 Week Visit|Overall Study||26
617425|NCT00315302|1514196|P2|5 Week Visit|Overall Study||86
617426|NCT00315302|1514197|P1|5 Week Visit|Overall Study||85
617427|NCT00315302|1514194|P4|STARTED|Overall Study||34
617428|NCT00315302|1514195|P3|STARTED|Overall Study||26
617429|NCT00315302|1514196|P2|STARTED|Overall Study||90
617430|NCT00315302|1514197|P1|STARTED|Overall Study||90
617431|NCT00315146|1514243|P4|NOT COMPLETED|Overall Study||0
617432|NCT00315146|1514244|P3|NOT COMPLETED|Overall Study||2
617433|NCT00315146|1514245|P2|NOT COMPLETED|Overall Study||3
617434|NCT00315146|1514246|P1|NOT COMPLETED|Overall Study||2
617435|NCT00315146|1514243|P4|COMPLETED|Overall Study||22
617436|NCT00315146|1514244|P3|COMPLETED|Overall Study||20
617437|NCT00315146|1514245|P2|COMPLETED|Overall Study||19
617438|NCT00315146|1514246|P1|COMPLETED|Overall Study||20
617439|NCT00315146|1514243|P4|STARTED|Overall Study||22
617440|NCT00315146|1514244|P3|STARTED|Overall Study||22
617441|NCT00315146|1514245|P2|STARTED|Overall Study||22
617442|NCT00315146|1514246|P1|STARTED|Overall Study||22
617443|NCT00315120|1514264|P4|NOT COMPLETED|Overall Study||0
617444|NCT00315120|1514265|P3|NOT COMPLETED|Overall Study||0
617445|NCT00315120|1514266|P2|NOT COMPLETED|Overall Study||0
617446|NCT00315120|1514267|P1|NOT COMPLETED|Overall Study||0
617447|NCT00315120|1514264|P4|COMPLETED|Overall Study||107
617448|NCT00315120|1514265|P3|COMPLETED|Overall Study||115
617449|NCT00315120|1514266|P2|COMPLETED|Overall Study||118
617450|NCT00315120|1514267|P1|COMPLETED|Overall Study||115
617451|NCT00315120|1514264|P4|STARTED|Overall Study||107
617452|NCT00315120|1514265|P3|STARTED|Overall Study||115
617453|NCT00315120|1514266|P2|STARTED|Overall Study||118
617454|NCT00315120|1514267|P1|STARTED|Overall Study||115
617455|NCT00315055|1514327|P2|NOT COMPLETED|Overall Study||5
617456|NCT00315055|1514328|P1|NOT COMPLETED|Overall Study||3
617457|NCT00315055|1514327|P2|COMPLETED|Overall Study||150
617458|NCT00315055|1514328|P1|COMPLETED|Overall Study||152
617459|NCT00315055|1514327|P2|STARTED|Overall Study||155
617460|NCT00315055|1514328|P1|STARTED|Overall Study||155
617461|NCT00314951|1514346|P2|NOT COMPLETED|Follow-up||34
617462|NCT00314951|1514347|P1|NOT COMPLETED|Follow-up||44
617463|NCT00314951|1514346|P2|COMPLETED|Follow-up||255
617464|NCT00314951|1514347|P1|COMPLETED|Follow-up||263
617465|NCT00314951|1514346|P2|STARTED|Follow-up||289
617466|NCT00314951|1514347|P1|STARTED|Follow-up||307
617467|NCT00314951|1514346|P2|NOT COMPLETED|Treatment||11
617468|NCT00314951|1514347|P1|NOT COMPLETED|Treatment||16
617469|NCT00314951|1514346|P2|COMPLETED|Treatment||289
617470|NCT00314951|1514347|P1|COMPLETED|Treatment||307
617471|NCT00314951|1514346|P2|STARTED|Treatment||300
617472|NCT00314951|1514347|P1|STARTED|Treatment||323
617473|NCT00314951|1514346|P2|NOT COMPLETED|Enrollment||6
617474|NCT00314951|1514347|P1|NOT COMPLETED|Enrollment||0
617475|NCT00314951|1514346|P2|COMPLETED|Enrollment|6 subjects took incorrect treatment assignment, 6 subjects didn't take drug|300
617476|NCT00314951|1514347|P1|COMPLETED|Enrollment|6 subjects took incorrect treatment assignment, 6 subjects didn't take drug|323
617477|NCT00314951|1514346|P2|STARTED|Enrollment||306
617478|NCT00314951|1514347|P1|STARTED|Enrollment||323
617479|NCT00314808|1514357|P1|NOT COMPLETED|Overall Study||8
617480|NCT00314808|1514357|P1|COMPLETED|Overall Study|Completed 2 cycles of Dronabinol or terminated early due to treatment-related adverse events (AE)|25
617481|NCT00314808|1514357|P1|STARTED|Overall Study||33
617482|NCT00314574|1514367|P2|NOT COMPLETED|Overall Study||83
617483|NCT00314574|1514368|P1|NOT COMPLETED|Overall Study||94
617484|NCT00314574|1514367|P2|COMPLETED|Overall Study||344
617485|NCT00314574|1514368|P1|COMPLETED|Overall Study||329
617486|NCT00314574|1514367|P2|Safety Population|Overall Study||428
617487|NCT00314574|1514368|P1|Safety Population|Overall Study|1 patient in the placebo arm received Xolair and was added to the Xolair arm for Safety analyses.|420
617488|NCT00314574|1514367|P2|Received at Least One Dose of Study Drug|Overall Study||427
617489|NCT00314574|1514368|P1|Received at Least One Dose of Study Drug|Overall Study||421
617490|NCT00314574|1514367|P2|STARTED|Overall Study||427
617491|NCT00314574|1514368|P1|STARTED|Overall Study||423
617492|NCT00314366|1514384|P2|NOT COMPLETED|Overall Study||0
617493|NCT00314366|1514385|P1|NOT COMPLETED|Overall Study||1
617494|NCT00314366|1514384|P2|COMPLETED|Overall Study||10
617495|NCT00314366|1514385|P1|COMPLETED|Overall Study||10
617496|NCT00314366|1514384|P2|STARTED|Overall Study||10
617497|NCT00314366|1514385|P1|STARTED|Overall Study||11
617498|NCT00314353|1514415|P2|NOT COMPLETED|Follow-up||0
617499|NCT00314353|1514416|P1|NOT COMPLETED|Follow-up||0
617500|NCT00314353|1514415|P2|COMPLETED|Follow-up||0
617501|NCT00314353|1514416|P1|COMPLETED|Follow-up||3
617502|NCT00314353|1514415|P2|STARTED|Follow-up||0
617503|NCT00314353|1514416|P1|STARTED|Follow-up|2 participants who completed 8 cycles plus 1 participant who did not complete 8 cycles therapy.|3
617504|NCT00314353|1514415|P2|NOT COMPLETED|Protocol Therapy (8 Cycles)||3
617505|NCT00314353|1514416|P1|NOT COMPLETED|Protocol Therapy (8 Cycles)||2
617506|NCT00314353|1514415|P2|COMPLETED|Protocol Therapy (8 Cycles)|COMPLETED refers to the participants completing 8 cycles of therapy.|0
617507|NCT00314353|1514416|P1|COMPLETED|Protocol Therapy (8 Cycles)|COMPLETED refers to the participants completing 8 cycles of therapy.|2
617508|NCT00314353|1514415|P2|STARTED|Protocol Therapy (8 Cycles)||3
617509|NCT00314353|1514416|P1|STARTED|Protocol Therapy (8 Cycles)||4
617510|NCT00314340|1514430|P1|NOT COMPLETED|Overall Study||1
617511|NCT00314340|1514430|P1|COMPLETED|Overall Study||11
617512|NCT00314340|1514430|P1|Placebo|Overall Study||12
617513|NCT00314340|1514430|P1|Hydrocodone Plus APAP|Overall Study||12
617514|NCT00314340|1514430|P1|ER Morphine|Overall Study||11
617515|NCT00314340|1514430|P1|STARTED|Overall Study||12
617516|NCT00314327|1514436|P1|NOT COMPLETED|Overall Study||1
617517|NCT00314327|1514436|P1|COMPLETED|Overall Study||0
617518|NCT00314327|1514436|P1|STARTED|Overall Study||1
617519|NCT00314262|1514441|P1|NOT COMPLETED|Overall Study||5
617520|NCT00314262|1514441|P1|COMPLETED|Overall Study||7
617521|NCT00314262|1514441|P1|STARTED|Overall Study||12
617522|NCT00314249|1514449|P2|NOT COMPLETED|Overall Study||163
617523|NCT00314249|1514450|P1|NOT COMPLETED|Overall Study||152
617524|NCT00314249|1514449|P2|COMPLETED|Overall Study||353
617525|NCT00314249|1514450|P1|COMPLETED|Overall Study||357
617526|NCT00314249|1514449|P2|STARTED|Overall Study||516
617527|NCT00314249|1514450|P1|STARTED|Overall Study||509
617528|NCT00314236|1514468|P2|NOT COMPLETED|Overall Study||2
617529|NCT00314236|1514469|P1|NOT COMPLETED|Overall Study||0
617530|NCT00314236|1514468|P2|COMPLETED|Overall Study||37
617531|NCT00314236|1514469|P1|COMPLETED|Overall Study||41
617532|NCT00314236|1514468|P2|STARTED|Overall Study||39
617533|NCT00314236|1514469|P1|STARTED|Overall Study||41
617534|NCT00314145|1514483|P2|NOT COMPLETED|Overall Study||29
617535|NCT00314145|1514484|P1|NOT COMPLETED|Overall Study||21
617536|NCT00314145|1514483|P2|COMPLETED|Overall Study||381
617537|NCT00314145|1514484|P1|COMPLETED|Overall Study||389
617538|NCT00314145|1514483|P2|STARTED|Overall Study||410
617539|NCT00314145|1514484|P1|STARTED|Overall Study||410
617540|NCT00314132|1514498|P2|NOT COMPLETED|Overall Study||18
617541|NCT00314132|1514499|P1|NOT COMPLETED|Overall Study||8
617542|NCT00314132|1514498|P2|COMPLETED|Overall Study||1583
617543|NCT00314132|1514499|P1|COMPLETED|Overall Study||395
617544|NCT00314132|1514498|P2|STARTED|Overall Study||1601
617545|NCT00314132|1514499|P1|STARTED|Overall Study||403
617546|NCT00314106|1514509|P2|NOT COMPLETED|Overall Study||0
617547|NCT00314106|1514510|P1|NOT COMPLETED|Overall Study||0
617548|NCT00314106|1514509|P2|COMPLETED|Overall Study||8
617549|NCT00314106|1514510|P1|COMPLETED|Overall Study||18
617550|NCT00314106|1514509|P2|STARTED|Overall Study||8
617551|NCT00314106|1514510|P1|STARTED|Overall Study||18
617552|NCT00313911|1514520|P2|NOT COMPLETED|Overall Study||41
617553|NCT00313911|1514521|P1|NOT COMPLETED|Overall Study||94
617554|NCT00313911|1514520|P2|COMPLETED|Overall Study||670
617555|NCT00313911|1514521|P1|COMPLETED|Overall Study||1328
617556|NCT00313911|1514520|P2|STARTED|Overall Study|A participant in this group mistakenly got Group 1 vaccine. N in outcomes adjusted accordingly.|711
617557|NCT00313911|1514521|P1|STARTED|Overall Study|N for outcomes adjusted to include participant in Group 2 that got vaccine assigned to this group.|1422
617558|NCT00313846|1514535|P2|NOT COMPLETED|Overall Study||11
617559|NCT00313846|1514536|P1|NOT COMPLETED|Overall Study||5
617560|NCT00313846|1514535|P2|COMPLETED|Overall Study||153
617561|NCT00313846|1514536|P1|COMPLETED|Overall Study||157
617562|NCT00313846|1514535|P2|STARTED|Overall Study|327 subjects were randomized: 1 subject was lost to follow-up (N = 326).|164
617563|NCT00313846|1514536|P1|STARTED|Overall Study||162
617564|NCT00313820|1514547|P2|NOT COMPLETED|Pregabalin or Placebo Treatment Period||19
617565|NCT00313820|1514548|P1|NOT COMPLETED|Pregabalin or Placebo Treatment Period||17
617566|NCT00313820|1514547|P2|COMPLETED|Pregabalin or Placebo Treatment Period||90
617567|NCT00313820|1514548|P1|COMPLETED|Pregabalin or Placebo Treatment Period||93
617568|NCT00313820|1514547|P2|STARTED|Pregabalin or Placebo Treatment Period||109
617569|NCT00313820|1514548|P1|STARTED|Pregabalin or Placebo Treatment Period||110
617570|NCT00313820|1514547|P2|NOT COMPLETED|Assigned to Treatment||0
617571|NCT00313820|1514548|P1|NOT COMPLETED|Assigned to Treatment||1
617572|NCT00313820|1514547|P2|COMPLETED|Assigned to Treatment||109
617573|NCT00313820|1514548|P1|COMPLETED|Assigned to Treatment||110
617574|NCT00313820|1514547|P2|STARTED|Assigned to Treatment||109
617575|NCT00313820|1514548|P1|STARTED|Assigned to Treatment||111
617576|NCT00313781|1514586|P3|NOT COMPLETED|After Crossover||27
617577|NCT00313781|1514587|P2|NOT COMPLETED|After Crossover||0
617578|NCT00313781|1514588|P1|NOT COMPLETED|After Crossover||0
617579|NCT00313781|1514586|P3|COMPLETED|After Crossover||10
617580|NCT00313781|1514587|P2|COMPLETED|After Crossover||0
617581|NCT00313781|1514588|P1|COMPLETED|After Crossover||0
617582|NCT00313781|1514586|P3|STARTED|After Crossover||37
617583|NCT00313781|1514587|P2|STARTED|After Crossover||0
617584|NCT00313781|1514588|P1|STARTED|After Crossover||0
617585|NCT00313781|1514586|P3|NOT COMPLETED|Before Crossover||0
617586|NCT00313781|1514587|P2|NOT COMPLETED|Before Crossover||79
617587|NCT00313781|1514588|P1|NOT COMPLETED|Before Crossover||75
617588|NCT00313781|1514586|P3|COMPLETED|Before Crossover||0
617589|NCT00313781|1514587|P2|COMPLETED|Before Crossover||23
617590|NCT00313781|1514588|P1|COMPLETED|Before Crossover||27
617591|NCT00313781|1514586|P3|Treated|Before Crossover||0
617592|NCT00313781|1514587|P2|Treated|Before Crossover||102
617593|NCT00313781|1514588|P1|Treated|Before Crossover||97
617594|NCT00313781|1514586|P3|STARTED|Before Crossover||0
617595|NCT00313781|1514587|P2|STARTED|Before Crossover||102
617596|NCT00313781|1514588|P1|STARTED|Before Crossover||102
617597|NCT00313716|1514628|P6|NOT COMPLETED|Overall Study||13
617598|NCT00313716|1514629|P5|NOT COMPLETED|Overall Study||6
617599|NCT00313716|1514630|P4|NOT COMPLETED|Overall Study||4
617600|NCT00313716|1514631|P3|NOT COMPLETED|Overall Study||12
617601|NCT00313716|1514632|P2|NOT COMPLETED|Overall Study||8
617602|NCT00313716|1514633|P1|NOT COMPLETED|Overall Study||5
617603|NCT00313716|1514628|P6|COMPLETED|Overall Study||35
617604|NCT00313716|1514629|P5|COMPLETED|Overall Study||27
617605|NCT00313716|1514630|P4|COMPLETED|Overall Study||16
617606|NCT00313716|1514631|P3|COMPLETED|Overall Study||38
617607|NCT00313716|1514632|P2|COMPLETED|Overall Study||23
617608|NCT00313716|1514633|P1|COMPLETED|Overall Study||13
617609|NCT00313716|1514628|P6|STARTED|Overall Study||48
617610|NCT00313716|1514629|P5|STARTED|Overall Study||33
617611|NCT00313716|1514630|P4|STARTED|Overall Study||20
617612|NCT00313716|1514631|P3|STARTED|Overall Study||50
617613|NCT00313716|1514632|P2|STARTED|Overall Study||31
617614|NCT00313716|1514633|P1|STARTED|Overall Study||18
617615|NCT00313703|1514660|P4|NOT COMPLETED|Overall Study||12
617616|NCT00313703|1514661|P3|NOT COMPLETED|Overall Study||5
617617|NCT00313703|1514662|P2|NOT COMPLETED|Overall Study||2
617618|NCT00313703|1514663|P1|NOT COMPLETED|Overall Study||11
617619|NCT00313703|1514660|P4|COMPLETED|Overall Study|Outcomes not reported due to heterogeneity of this group|0
617620|NCT00313703|1514661|P3|COMPLETED|Overall Study|Some subjects lost-to-follow-up|72
617621|NCT00313703|1514662|P2|COMPLETED|Overall Study|Some subjects lost-to follow-up|32
617622|NCT00313703|1514663|P1|COMPLETED|Overall Study|Some subjects lost to follow-up|175
617623|NCT00313703|1514660|P4|STARTED|Overall Study||12
617624|NCT00313703|1514661|P3|STARTED|Overall Study||77
617625|NCT00313703|1514662|P2|STARTED|Overall Study||34
617626|NCT00313703|1514663|P1|STARTED|Overall Study||186
617627|NCT00313612|1514679|P2|NOT COMPLETED|Overall Study||1
617628|NCT00313612|1514680|P1|NOT COMPLETED|Overall Study||0
617629|NCT00313612|1514679|P2|COMPLETED|Overall Study||19
617630|NCT00313612|1514680|P1|COMPLETED|Overall Study||19
617631|NCT00313612|1514679|P2|STARTED|Overall Study||20
617632|NCT00313612|1514680|P1|STARTED|Overall Study||19
617633|NCT00313586|1514692|P4|NOT COMPLETED|Overall Study||23
617634|NCT00313586|1514693|P3|NOT COMPLETED|Overall Study||24
617635|NCT00313586|1514694|P2|NOT COMPLETED|Overall Study||70
617636|NCT00313586|1514695|P1|NOT COMPLETED|Overall Study||70
617637|NCT00313586|1514692|P4|COMPLETED|Overall Study||0
617638|NCT00313586|1514693|P3|COMPLETED|Overall Study||0
617639|NCT00313586|1514694|P2|COMPLETED|Overall Study||5
617640|NCT00313586|1514695|P1|COMPLETED|Overall Study||5
617641|NCT00313586|1514692|P4|Treated|Overall Study||23
617642|NCT00313586|1514693|P3|Treated|Overall Study||24
617643|NCT00313586|1514694|P2|Treated|Overall Study||75
617644|NCT00313586|1514695|P1|Treated|Overall Study||74
617645|NCT00313586|1514692|P4|STARTED|Overall Study||23
617646|NCT00313586|1514693|P3|STARTED|Overall Study||24
617647|NCT00313586|1514694|P2|STARTED|Overall Study||75
617648|NCT00313586|1514695|P1|STARTED|Overall Study||75
617649|NCT00313443|1514703|P1|NOT COMPLETED|Overall Study||0
617650|NCT00313443|1514703|P1|COMPLETED|Overall Study||30
617651|NCT00313443|1514703|P1|STARTED|Overall Study||30
617652|NCT00313313|1514714|P3|NOT COMPLETED|Overall Study||82
617653|NCT00313313|1514715|P2|NOT COMPLETED|Overall Study||66
617654|NCT00313313|1514716|P1|NOT COMPLETED|Overall Study||63
617655|NCT00313313|1514714|P3|COMPLETED|Overall Study|26 subjects completed the study without being rescued|185
617656|NCT00313313|1514715|P2|COMPLETED|Overall Study|55 subjects completed the study without being rescued|187
617657|NCT00313313|1514716|P1|COMPLETED|Overall Study|61 subjects completed the study without being rescued|185
617658|NCT00313313|1514714|P3|STARTED|Overall Study||267
617659|NCT00313313|1514715|P2|STARTED|Overall Study||253
617660|NCT00313313|1514716|P1|STARTED|Overall Study||248
617661|NCT00313300|1514738|P5|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2
617662|NCT00313300|1514739|P4|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||5
617663|NCT00313300|1514740|P3|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2
617664|NCT00313300|1514741|P2|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||0
617665|NCT00313300|1514742|P1|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||3
617666|NCT00313300|1514738|P5|COMPLETED|Follow-Up(30days)-Randomized Phase B||199
617667|NCT00313300|1514739|P4|COMPLETED|Follow-Up(30days)-Randomized Phase B||217
617668|NCT00313300|1514740|P3|COMPLETED|Follow-Up(30days)-Randomized Phase B||117
617669|NCT00313300|1514741|P2|COMPLETED|Follow-Up(30days)-Randomized Phase B||123
617670|NCT00313300|1514742|P1|COMPLETED|Follow-Up(30days)-Randomized Phase B||380
617671|NCT00313300|1514738|P5|STARTED|Follow-Up(30days)-Randomized Phase B||201
617672|NCT00313300|1514739|P4|STARTED|Follow-Up(30days)-Randomized Phase B||222
617673|NCT00313300|1514740|P3|STARTED|Follow-Up(30days)-Randomized Phase B||119
617674|NCT00313300|1514741|P2|STARTED|Follow-Up(30days)-Randomized Phase B||123
617675|NCT00313300|1514742|P1|STARTED|Follow-Up(30days)-Randomized Phase B||383
617676|NCT00313300|1514738|P5|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0
617677|NCT00313300|1514739|P4|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0
617678|NCT00313300|1514740|P3|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||2
617679|NCT00313300|1514741|P2|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||6
617680|NCT00313300|1514742|P1|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||5
617681|NCT00313300|1514738|P5|COMPLETED|Follow-Up(30days)-Randomized Phase A||0
617682|NCT00313300|1514739|P4|COMPLETED|Follow-Up(30days)-Randomized Phase A||0
617683|NCT00313300|1514740|P3|COMPLETED|Follow-Up(30days)-Randomized Phase A||172
617684|NCT00313300|1514741|P2|COMPLETED|Follow-Up(30days)-Randomized Phase A||156
617685|NCT00313300|1514742|P1|COMPLETED|Follow-Up(30days)-Randomized Phase A||158
617686|NCT00313300|1514738|P5|STARTED|Follow-Up(30days)-Randomized Phase A||0
617687|NCT00313300|1514739|P4|STARTED|Follow-Up(30days)-Randomized Phase A||0
617688|NCT00313300|1514740|P3|STARTED|Follow-Up(30days)-Randomized Phase A||174
617689|NCT00313300|1514741|P2|STARTED|Follow-Up(30days)-Randomized Phase A||162
617690|NCT00313300|1514742|P1|STARTED|Follow-Up(30days)-Randomized Phase A||163
617691|NCT00313300|1514738|P5|NOT COMPLETED|Randomized in Phase B (26 Weeks)||208
617692|NCT00313300|1514739|P4|NOT COMPLETED|Randomized in Phase B (26 Weeks)||233
617693|NCT00313300|1514740|P3|NOT COMPLETED|Randomized in Phase B (26 Weeks)||40
617694|NCT00313300|1514741|P2|NOT COMPLETED|Randomized in Phase B (26 Weeks)||33
617695|NCT00313300|1514742|P1|NOT COMPLETED|Randomized in Phase B (26 Weeks)||94
617696|NCT00313300|1514738|P5|COMPLETED|Randomized in Phase B (26 Weeks)||13
617697|NCT00313300|1514739|P4|COMPLETED|Randomized in Phase B (26 Weeks)||15
617698|NCT00313300|1514740|P3|COMPLETED|Randomized in Phase B (26 Weeks)||94
617699|NCT00313300|1514741|P2|COMPLETED|Randomized in Phase B (26 Weeks)||105
617700|NCT00313300|1514742|P1|COMPLETED|Randomized in Phase B (26 Weeks)||333
617701|NCT00313300|1514738|P5|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||221
617702|NCT00313300|1514739|P4|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||248
617703|NCT00313300|1514740|P3|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||110
617704|NCT00313300|1514741|P2|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||120
617705|NCT00313300|1514742|P1|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||368
617706|NCT00313300|1514738|P5|STARTED|Randomized in Phase B (26 Weeks)||221
617707|NCT00313300|1514739|P4|STARTED|Randomized in Phase B (26 Weeks)||248
617708|NCT00313300|1514740|P3|STARTED|Randomized in Phase B (26 Weeks)||134
617709|NCT00313300|1514741|P2|STARTED|Randomized in Phase B (26 Weeks)||138
617710|NCT00313300|1514742|P1|STARTED|Randomized in Phase B (26 Weeks)||427
617711|NCT00313300|1514738|P5|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0
617712|NCT00313300|1514739|P4|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0
617713|NCT00313300|1514740|P3|NOT COMPLETED|Randomized in Phase A (26 Weeks)||35
617714|NCT00313300|1514741|P2|NOT COMPLETED|Randomized in Phase A (26 Weeks)||39
617715|NCT00313300|1514742|P1|NOT COMPLETED|Randomized in Phase A (26 Weeks)||54
617716|NCT00313300|1514738|P5|COMPLETED|Randomized in Phase A (26 Weeks)||0
617717|NCT00313300|1514739|P4|COMPLETED|Randomized in Phase A (26 Weeks)||0
617718|NCT00313300|1514740|P3|COMPLETED|Randomized in Phase A (26 Weeks)||149
617719|NCT00313300|1514741|P2|COMPLETED|Randomized in Phase A (26 Weeks)||140
617720|NCT00313300|1514742|P1|COMPLETED|Randomized in Phase A (26 Weeks)||130
617721|NCT00313300|1514738|P5|STARTED|Randomized in Phase A (26 Weeks)||0
617722|NCT00313300|1514739|P4|STARTED|Randomized in Phase A (26 Weeks)||0
617723|NCT00313300|1514740|P3|STARTED|Randomized in Phase A (26 Weeks)||184
617724|NCT00313300|1514741|P2|STARTED|Randomized in Phase A (26 Weeks)||179
617725|NCT00313300|1514742|P1|STARTED|Randomized in Phase A (26 Weeks)||184
617726|NCT00313209|1514794|P2|NOT COMPLETED|Overall Study||82
617727|NCT00313209|1514795|P1|NOT COMPLETED|Overall Study||107
617728|NCT00313209|1514794|P2|COMPLETED|Overall Study||385
617729|NCT00313209|1514795|P1|COMPLETED|Overall Study||359
617730|NCT00313209|1514794|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|467
617731|NCT00313209|1514795|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|466
617732|NCT00313170|1514812|P3|NOT COMPLETED|Overall Study||32
617733|NCT00313170|1514813|P2|NOT COMPLETED|Overall Study||34
617734|NCT00313170|1514814|P1|NOT COMPLETED|Overall Study||36
617735|NCT00313170|1514812|P3|COMPLETED|Overall Study||14
617736|NCT00313170|1514813|P2|COMPLETED|Overall Study||16
617737|NCT00313170|1514814|P1|COMPLETED|Overall Study||11
617738|NCT00313170|1514812|P3|STARTED|Overall Study||46
617739|NCT00313170|1514813|P2|STARTED|Overall Study||50
617740|NCT00313170|1514814|P1|STARTED|Overall Study||47
617741|NCT00313144|1514830|P1|NOT COMPLETED|Overall Study||110
617742|NCT00313144|1514830|P1|COMPLETED|Overall Study||17
617743|NCT00313144|1514830|P1|STARTED|Overall Study||127
617744|NCT00313014|1514917|P3|NOT COMPLETED|Overall Study||61
617745|NCT00313014|1514918|P2|NOT COMPLETED|Overall Study||73
617746|NCT00313014|1514919|P1|NOT COMPLETED|Overall Study||93
617747|NCT00313014|1514917|P3|COMPLETED|Overall Study||159
617748|NCT00313014|1514918|P2|COMPLETED|Overall Study||146
617749|NCT00313014|1514919|P1|COMPLETED|Overall Study||128
617750|NCT00313014|1514917|P3|STARTED|Overall Study||220
617751|NCT00313014|1514918|P2|STARTED|Overall Study||219
617752|NCT00313014|1514919|P1|STARTED|Overall Study||221
617753|NCT00312923|1514939|P2|NOT COMPLETED|Overall Study||6
617754|NCT00312923|1514940|P1|NOT COMPLETED|Overall Study||9
617755|NCT00312923|1514939|P2|COMPLETED|Overall Study||20
617756|NCT00312923|1514940|P1|COMPLETED|Overall Study||19
617757|NCT00312923|1514939|P2|STARTED|Overall Study||26
617758|NCT00312923|1514940|P1|STARTED|Overall Study||28
617759|NCT00312897|1514950|P2|NOT COMPLETED|Overall Study||6
617760|NCT00312897|1514951|P1|NOT COMPLETED|Overall Study||6
617761|NCT00312897|1514950|P2|COMPLETED|Overall Study||18
617762|NCT00312897|1514951|P1|COMPLETED|Overall Study||21
617763|NCT00312897|1514950|P2|STARTED|Overall Study||24
617764|NCT00312897|1514951|P1|STARTED|Overall Study||27
617765|NCT00312884|1514961|P2|NOT COMPLETED|Overall Study||12
617766|NCT00312884|1514962|P1|NOT COMPLETED|Overall Study||17
617767|NCT00312884|1514961|P2|COMPLETED|Overall Study||79
617768|NCT00312884|1514962|P1|COMPLETED|Overall Study||74
617769|NCT00312884|1514961|P2|STARTED|Overall Study||91
617770|NCT00312884|1514962|P1|STARTED|Overall Study||91
617771|NCT00312858|1514976|P2|NOT COMPLETED|Overall Study||93
617772|NCT00312858|1514977|P1|NOT COMPLETED|Overall Study||68
617773|NCT00312858|1514976|P2|COMPLETED|Overall Study||230
617774|NCT00312858|1514977|P1|COMPLETED|Overall Study||262
617775|NCT00312858|1514976|P2|Visit 4|Overall Study||240
617776|NCT00312858|1514977|P1|Visit 4|Overall Study||262
617777|NCT00312858|1514976|P2|Visit 3|Overall Study||261
617778|NCT00312858|1514977|P1|Visit 3|Overall Study||273
617779|NCT00312858|1514976|P2|Visit 2|Overall Study||294
617780|NCT00312858|1514977|P1|Visit 2|Overall Study||305
617781|NCT00312858|1514976|P2|Visit 1|Overall Study||323
617782|NCT00312858|1514977|P1|Visit 1|Overall Study||330
617783|NCT00312858|1514976|P2|STARTED|Overall Study||323
617784|NCT00312858|1514977|P1|STARTED|Overall Study||330
617785|NCT00312845|1515031|P2|NOT COMPLETED|Overall Study||95
617786|NCT00312845|1515032|P1|NOT COMPLETED|Overall Study||99
617787|NCT00312845|1515031|P2|COMPLETED|Overall Study||245
617788|NCT00312845|1515032|P1|COMPLETED|Overall Study||237
617789|NCT00312845|1515031|P2|STARTED|Overall Study||340
617790|NCT00312845|1515032|P1|STARTED|Overall Study||336
617791|NCT00312728|1515040|P1|NOT COMPLETED|Overall Study||110
617792|NCT00312728|1515040|P1|COMPLETED|Overall Study||5
617793|NCT00312728|1515040|P1|STARTED|Overall Study||115
617794|NCT00312572|1515051|P2|NOT COMPLETED|Overall Study||21
617795|NCT00312572|1515052|P1|NOT COMPLETED|Overall Study||16
617796|NCT00312572|1515051|P2|COMPLETED|Overall Study||82
617797|NCT00312572|1515052|P1|COMPLETED|Overall Study||85
617798|NCT00312572|1515051|P2|STARTED|Overall Study||103
617799|NCT00312572|1515052|P1|STARTED|Overall Study||101
617800|NCT00312494|1515063|P3|NOT COMPLETED|Overall Study||43
617801|NCT00312494|1515064|P2|NOT COMPLETED|Overall Study||58
617802|NCT00312494|1515065|P1|NOT COMPLETED|Overall Study||71
617803|NCT00312494|1515063|P3|COMPLETED|Overall Study||179
617804|NCT00312494|1515064|P2|COMPLETED|Overall Study||168
617805|NCT00312494|1515065|P1|COMPLETED|Overall Study|1 subject randomized to higher dose; received lower dose baseline and/or week 1; higher dose week 2.|161
617806|NCT00312494|1515063|P3|Received Study Treatment|Overall Study||217
617807|NCT00312494|1515064|P2|Received Study Treatment|Overall Study||216
617808|NCT00312494|1515065|P1|Received Study Treatment|Overall Study|1 subject randomized to higher dose; received lower dose at baseline, higher dose weeks 1 and 2.|223
617809|NCT00312494|1515063|P3|STARTED|Overall Study||222
617810|NCT00312494|1515064|P2|STARTED|Overall Study||226
617811|NCT00312494|1515065|P1|STARTED|Overall Study||232
617812|NCT00312377|1515099|P2|NOT COMPLETED|Overall Study||668
617813|NCT00312377|1515100|P1|NOT COMPLETED|Overall Study||644
617814|NCT00312377|1515099|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|29
617815|NCT00312377|1515100|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|50
617816|NCT00312377|1515099|P2|STARTED|Overall Study|randomised patients|697
617817|NCT00312377|1515100|P1|STARTED|Overall Study|randomised patients|694
617818|NCT00312338|1515124|P2|NOT COMPLETED|Overall Study||3
617819|NCT00312338|1515125|P1|NOT COMPLETED|Overall Study||22
617820|NCT00312338|1515124|P2|COMPLETED|Overall Study||54
617821|NCT00312338|1515125|P1|COMPLETED|Overall Study||83
617822|NCT00312338|1515124|P2|STARTED|Overall Study||57
617823|NCT00312338|1515125|P1|STARTED|Overall Study||105
617824|NCT00312221|1515138|P4|NOT COMPLETED|Double-blind Phase||70
617825|NCT00312221|1515139|P3|NOT COMPLETED|Double-blind Phase||72
617826|NCT00312221|1515140|P2|NOT COMPLETED|Double-blind Phase||59
617827|NCT00312221|1515141|P1|NOT COMPLETED|Double-blind Phase||0
617828|NCT00312221|1515138|P4|COMPLETED|Double-blind Phase||63
617829|NCT00312221|1515139|P3|COMPLETED|Double-blind Phase||77
617830|NCT00312221|1515140|P2|COMPLETED|Double-blind Phase||77
617831|NCT00312221|1515141|P1|COMPLETED|Double-blind Phase||0
617832|NCT00312221|1515138|P4|STARTED|Double-blind Phase||133
617833|NCT00312221|1515139|P3|STARTED|Double-blind Phase||149
617834|NCT00312221|1515140|P2|STARTED|Double-blind Phase||136
617835|NCT00312221|1515141|P1|STARTED|Double-blind Phase||0
617836|NCT00312221|1515138|P4|NOT COMPLETED|Open-label Run-in Period||0
617837|NCT00312221|1515139|P3|NOT COMPLETED|Open-label Run-in Period||0
617838|NCT00312221|1515140|P2|NOT COMPLETED|Open-label Run-in Period||0
617839|NCT00312221|1515141|P1|NOT COMPLETED|Open-label Run-in Period||234
617840|NCT00312221|1515138|P4|COMPLETED|Open-label Run-in Period||0
617841|NCT00312221|1515139|P3|COMPLETED|Open-label Run-in Period||0
617842|NCT00312221|1515140|P2|COMPLETED|Open-label Run-in Period||0
617843|NCT00312221|1515141|P1|COMPLETED|Open-label Run-in Period||418
617844|NCT00312221|1515138|P4|STARTED|Open-label Run-in Period||0
617845|NCT00312221|1515139|P3|STARTED|Open-label Run-in Period||0
617846|NCT00312221|1515140|P2|STARTED|Open-label Run-in Period||0
617847|NCT00312221|1515141|P1|STARTED|Open-label Run-in Period||652
617848|NCT00312208|1515161|P2|NOT COMPLETED|Overall Study||123
617849|NCT00312208|1515162|P1|NOT COMPLETED|Overall Study||172
617850|NCT00312208|1515161|P2|COMPLETED|Overall Study||1526
617851|NCT00312208|1515162|P1|COMPLETED|Overall Study||1477
617852|NCT00312208|1515161|P2|STARTED|Overall Study|1649 patients randomized 1635 patients treated|1649
617853|NCT00312208|1515162|P1|STARTED|Overall Study|1649 patients randomized, 1634 patients treated|1649
617854|NCT00312195|1515172|P2|NOT COMPLETED|Overall Study||6
617855|NCT00312195|1515173|P1|NOT COMPLETED|Overall Study||6
617856|NCT00312195|1515172|P2|COMPLETED|Overall Study||123
617857|NCT00312195|1515173|P1|COMPLETED|Overall Study||132
617858|NCT00312195|1515172|P2|STARTED|Overall Study||129
617859|NCT00312195|1515173|P1|STARTED|Overall Study||138
617860|NCT00311766|1515189|P2|NOT COMPLETED|Overall Study||5
617861|NCT00311766|1515190|P1|NOT COMPLETED|Overall Study||0
617862|NCT00311766|1515189|P2|COMPLETED|Overall Study||17
617863|NCT00311766|1515190|P1|COMPLETED|Overall Study||8
617864|NCT00311766|1515189|P2|STARTED|Overall Study||22
617865|NCT00311766|1515190|P1|STARTED|Overall Study||8
617866|NCT00311584|1515200|P2|NOT COMPLETED|Overall Study||23
617867|NCT00311584|1515201|P1|NOT COMPLETED|Overall Study||20
617868|NCT00311584|1515200|P2|COMPLETED|Overall Study||7
617869|NCT00311584|1515201|P1|COMPLETED|Overall Study||9
617870|NCT00311584|1515200|P2|STARTED|Overall Study||30
617871|NCT00311584|1515201|P1|STARTED|Overall Study||29
617872|NCT00311402|1515209|P2|NOT COMPLETED|Overall Study||177
617873|NCT00311402|1515210|P1|NOT COMPLETED|Overall Study||210
617874|NCT00311402|1515209|P2|COMPLETED|Overall Study||462
617875|NCT00311402|1515210|P1|COMPLETED|Overall Study||445
617876|NCT00311402|1515209|P2|STARTED|Overall Study||639
617877|NCT00311402|1515210|P1|STARTED|Overall Study||655
617878|NCT00311376|1515237|P3|NOT COMPLETED|Treatment Cycle 2||0
617879|NCT00311376|1515238|P2|NOT COMPLETED|Treatment Cycle 2||13
617880|NCT00311376|1515239|P1|NOT COMPLETED|Treatment Cycle 2||9
617881|NCT00311376|1515237|P3|COMPLETED|Treatment Cycle 2||0
617882|NCT00311376|1515238|P2|COMPLETED|Treatment Cycle 2||112
617883|NCT00311376|1515239|P1|COMPLETED|Treatment Cycle 2||106
617884|NCT00311376|1515237|P3|STARTED|Treatment Cycle 2|Cycle 1 Placebo pts were randomized to receive 300U or 200U in Cycle 2|0
617885|NCT00311376|1515238|P2|STARTED|Treatment Cycle 2|74 from the 200U group + 51 from the Placebo group entered Cycle 2|125
617886|NCT00311376|1515239|P1|STARTED|Treatment Cycle 2|69 from the 300U group + 46 from the Placebo group entered Cycle 2|115
617887|NCT00311376|1515237|P3|NOT COMPLETED|Treatment Cycle 1||17
617888|NCT00311376|1515238|P2|NOT COMPLETED|Treatment Cycle 1||17
617889|NCT00311376|1515239|P1|NOT COMPLETED|Treatment Cycle 1||27
617890|NCT00311376|1515237|P3|COMPLETED|Treatment Cycle 1||132
617891|NCT00311376|1515238|P2|COMPLETED|Treatment Cycle 1||118
617892|NCT00311376|1515239|P1|COMPLETED|Treatment Cycle 1||105
617893|NCT00311376|1515237|P3|STARTED|Treatment Cycle 1||149
617894|NCT00311376|1515238|P2|STARTED|Treatment Cycle 1||135
617895|NCT00311376|1515239|P1|STARTED|Treatment Cycle 1||132
617896|NCT00311363|1515259|P3|NOT COMPLETED|12-Week Double-Blind Treatment Period||12
617897|NCT00311363|1515260|P2|NOT COMPLETED|12-Week Double-Blind Treatment Period||14
617898|NCT00311363|1515261|P1|NOT COMPLETED|12-Week Double-Blind Treatment Period||0
617899|NCT00311363|1515259|P3|COMPLETED|12-Week Double-Blind Treatment Period||84
617900|NCT00311363|1515260|P2|COMPLETED|12-Week Double-Blind Treatment Period||84
617901|NCT00311363|1515261|P1|COMPLETED|12-Week Double-Blind Treatment Period||0
617902|NCT00311363|1515259|P3|STARTED|12-Week Double-Blind Treatment Period||96
617903|NCT00311363|1515260|P2|STARTED|12-Week Double-Blind Treatment Period||98
617904|NCT00311363|1515261|P1|STARTED|12-Week Double-Blind Treatment Period||0
617905|NCT00311363|1515259|P3|NOT COMPLETED|24-Week Single-Blind Treatment Period||0
617906|NCT00311363|1515260|P2|NOT COMPLETED|24-Week Single-Blind Treatment Period||0
617907|NCT00311363|1515261|P1|NOT COMPLETED|24-Week Single-Blind Treatment Period||106
617908|NCT00311363|1515259|P3|COMPLETED|24-Week Single-Blind Treatment Period||0
617909|NCT00311363|1515260|P2|COMPLETED|24-Week Single-Blind Treatment Period||0
617910|NCT00311363|1515261|P1|COMPLETED|24-Week Single-Blind Treatment Period||221
617911|NCT00311363|1515259|P3|STARTED|24-Week Single-Blind Treatment Period||0
617912|NCT00311363|1515260|P2|STARTED|24-Week Single-Blind Treatment Period||0
617913|NCT00311363|1515261|P1|STARTED|24-Week Single-Blind Treatment Period||327
617914|NCT00311311|1515321|P2|NOT COMPLETED|Overall Study||9
617915|NCT00311311|1515322|P1|NOT COMPLETED|Overall Study||8
617916|NCT00311311|1515321|P2|COMPLETED|Overall Study||26
617917|NCT00311311|1515322|P1|COMPLETED|Overall Study||29
617918|NCT00311311|1515321|P2|STARTED|Overall Study||35
617919|NCT00311311|1515322|P1|STARTED|Overall Study||37
617920|NCT00311181|1515372|P1|NOT COMPLETED|Overall Study||96
617921|NCT00311181|1515372|P1|COMPLETED|Overall Study||121
617922|NCT00311181|1515372|P1|STARTED|Overall Study||217
617923|NCT00311155|1515378|P1|NOT COMPLETED|Overall Study||93
617924|NCT00311155|1515378|P1|COMPLETED|Overall Study|Some participants had multiple reasons for discontinuation|601
617925|NCT00311155|1515378|P1|STARTED|Overall Study||694
617926|NCT00310856|1515390|P3|NOT COMPLETED|Overall Study||8
617927|NCT00310856|1515391|P2|NOT COMPLETED|Overall Study||5
617928|NCT00310856|1515392|P1|NOT COMPLETED|Overall Study||5
617929|NCT00310856|1515390|P3|COMPLETED|Overall Study||42
617930|NCT00310856|1515391|P2|COMPLETED|Overall Study||56
617931|NCT00310856|1515392|P1|COMPLETED|Overall Study||59
617932|NCT00310856|1515390|P3|STARTED|Overall Study||50
617933|NCT00310856|1515391|P2|STARTED|Overall Study||61
617934|NCT00310856|1515392|P1|STARTED|Overall Study||64
617935|NCT00310817|1515416|P4|NOT COMPLETED|Overall Study||8
617936|NCT00310817|1515417|P3|NOT COMPLETED|Overall Study||8
617937|NCT00310817|1515418|P2|NOT COMPLETED|Overall Study||8
617938|NCT00310817|1515419|P1|NOT COMPLETED|Overall Study||11
617939|NCT00310817|1515416|P4|COMPLETED|Overall Study||74
617940|NCT00310817|1515417|P3|COMPLETED|Overall Study||120
617941|NCT00310817|1515418|P2|COMPLETED|Overall Study||198
617942|NCT00310817|1515419|P1|COMPLETED|Overall Study||196
617943|NCT00310817|1515416|P4|STARTED|Overall Study||82
617944|NCT00310817|1515417|P3|STARTED|Overall Study||128
617945|NCT00310817|1515418|P2|STARTED|Overall Study||206
617946|NCT00310817|1515419|P1|STARTED|Overall Study||207
617947|NCT00310804|1515507|P2|NOT COMPLETED|Overall Study||0
617948|NCT00310804|1515508|P1|NOT COMPLETED|Overall Study||5
617949|NCT00310804|1515507|P2|COMPLETED|Overall Study||171
617950|NCT00310804|1515508|P1|COMPLETED|Overall Study||1024
617951|NCT00310804|1515507|P2|STARTED|Overall Study||171
617952|NCT00310804|1515508|P1|STARTED|Overall Study||1029
617953|NCT00310791|1515543|P2|NOT COMPLETED|Overall Study||10
617954|NCT00310791|1515544|P1|NOT COMPLETED|Overall Study||10
617955|NCT00310791|1515543|P2|COMPLETED|Overall Study||30
617956|NCT00310791|1515544|P1|COMPLETED|Overall Study||30
617957|NCT00310791|1515543|P2|STARTED|Overall Study||40
617958|NCT00310791|1515544|P1|STARTED|Overall Study||40
617959|NCT00310466|1515552|P2|NOT COMPLETED|Overall Study||12
617960|NCT00310466|1515553|P1|NOT COMPLETED|Overall Study||18
617961|NCT00310466|1515552|P2|COMPLETED|Overall Study||101
617962|NCT00310466|1515553|P1|COMPLETED|Overall Study||95
617963|NCT00310466|1515552|P2|STARTED|Overall Study||113
617964|NCT00310466|1515553|P1|STARTED|Overall Study||113
617965|NCT00310440|1515567|P2|NOT COMPLETED|Overall Study||13
617966|NCT00310440|1515568|P1|NOT COMPLETED|Overall Study||26
617967|NCT00310440|1515567|P2|COMPLETED|Overall Study||141
617968|NCT00310440|1515568|P1|COMPLETED|Overall Study||139
617969|NCT00310440|1515567|P2|STARTED|Overall Study||154
617970|NCT00310440|1515568|P1|STARTED|Overall Study||165
617971|NCT00310427|1515594|P2|NOT COMPLETED|Overall Study||1
617972|NCT00310427|1515595|P1|NOT COMPLETED|Overall Study||2
617973|NCT00310427|1515594|P2|COMPLETED|Overall Study||25
617974|NCT00310427|1515595|P1|COMPLETED|Overall Study||25
617975|NCT00310427|1515594|P2|STARTED|Overall Study||26
617976|NCT00310427|1515595|P1|STARTED|Overall Study||27
617977|NCT00310401|1515617|P2|NOT COMPLETED|Overall Study||0
617978|NCT00310401|1515618|P1|NOT COMPLETED|Overall Study||0
617979|NCT00310401|1515617|P2|COMPLETED|Overall Study||246
617980|NCT00310401|1515618|P1|COMPLETED|Overall Study||260
617981|NCT00310401|1515617|P2|STARTED|Overall Study||246
617982|NCT00310401|1515618|P1|STARTED|Overall Study||260
617983|NCT00310388|1515632|P1|NOT COMPLETED|Overall Study||346
617984|NCT00310388|1515632|P1|COMPLETED|Overall Study||30
617985|NCT00310388|1515632|P1|STARTED|Overall Study||376
617986|NCT00310375|1515670|P3|NOT COMPLETED|Safety Follow-up Continuation Phase||1
617987|NCT00310375|1515671|P2|NOT COMPLETED|Safety Follow-up Continuation Phase||0
617988|NCT00310375|1515672|P1|NOT COMPLETED|Safety Follow-up Continuation Phase||0
617989|NCT00310375|1515670|P3|COMPLETED|Safety Follow-up Continuation Phase|Met the protocol defined stopping criteria|18
617990|NCT00310375|1515671|P2|COMPLETED|Safety Follow-up Continuation Phase||0
617991|NCT00310375|1515672|P1|COMPLETED|Safety Follow-up Continuation Phase||0
617992|NCT00310375|1515670|P3|STARTED|Safety Follow-up Continuation Phase||19
617993|NCT00310375|1515671|P2|STARTED|Safety Follow-up Continuation Phase||0
617994|NCT00310375|1515672|P1|STARTED|Safety Follow-up Continuation Phase||0
617995|NCT00310375|1515670|P3|NOT COMPLETED|Primary Reporting Phase||0
617996|NCT00310375|1515671|P2|NOT COMPLETED|Primary Reporting Phase||68
617997|NCT00310375|1515672|P1|NOT COMPLETED|Primary Reporting Phase||91
617998|NCT00310375|1515670|P3|COMPLETED|Primary Reporting Phase||0
617999|NCT00310375|1515671|P2|COMPLETED|Primary Reporting Phase||11
618000|NCT00310375|1515672|P1|COMPLETED|Primary Reporting Phase||11
618001|NCT00310375|1515670|P3|STARTED|Primary Reporting Phase||0
618002|NCT00310375|1515671|P2|STARTED|Primary Reporting Phase||79
618003|NCT00310375|1515672|P1|STARTED|Primary Reporting Phase||102
618004|NCT00310362|1515717|P3|NOT COMPLETED|Overall Study||0
618005|NCT00310362|1515718|P2|NOT COMPLETED|Overall Study||0
618006|NCT00310362|1515719|P1|NOT COMPLETED|Overall Study||0
618007|NCT00310362|1515717|P3|COMPLETED|Overall Study||1206
618008|NCT00310362|1515718|P2|COMPLETED|Overall Study||1205
618009|NCT00310362|1515719|P1|COMPLETED|Overall Study||1199
618010|NCT00310362|1515717|P3|STARTED|Overall Study||1206
618011|NCT00310362|1515718|P2|STARTED|Overall Study||1205
618012|NCT00310362|1515719|P1|STARTED|Overall Study||1199
618013|NCT00310310|1515729|P2|NOT COMPLETED|Overall Study||20
618014|NCT00310310|1515730|P1|NOT COMPLETED|Overall Study||30
618015|NCT00310310|1515729|P2|COMPLETED|Overall Study||100
618016|NCT00310310|1515730|P1|COMPLETED|Overall Study||90
618017|NCT00310310|1515729|P2|STARTED|Overall Study||120
618018|NCT00310310|1515730|P1|STARTED|Overall Study||120
618019|NCT00310076|1515754|P1|NOT COMPLETED|Overall Study||3
618020|NCT00310076|1515754|P1|COMPLETED|Overall Study||26
618021|NCT00310076|1515754|P1|STARTED|Overall Study||29
618022|NCT00309985|1515760|P2|NOT COMPLETED|Overall Study||1
618023|NCT00309985|1515761|P1|NOT COMPLETED|Overall Study||62
618024|NCT00309985|1515760|P2|COMPLETED|Overall Study|"Arm B tx info was not collected so only 1 patient w/o follow-up data was considered not completed."|392
618025|NCT00309985|1515761|P1|COMPLETED|Overall Study||335
618026|NCT00309985|1515760|P2|Both Baseline and 3-month FACT-P Evals|Overall Study||299
618027|NCT00309985|1515761|P1|Both Baseline and 3-month FACT-P Evals|Overall Study||334
618028|NCT00309985|1515760|P2|Toxicity Analysis|Overall Study||392
618029|NCT00309985|1515761|P1|Toxicity Analysis|Overall Study||390
618030|NCT00309985|1515760|P2|STARTED|Overall Study||393
618031|NCT00309985|1515761|P1|STARTED|Overall Study||397
618032|NCT00309946|1515777|P1|NOT COMPLETED|Overall Study||1
618033|NCT00309946|1515777|P1|COMPLETED|Overall Study||50
618034|NCT00309946|1515777|P1|STARTED|Overall Study||51
618035|NCT00309907|1515783|P1|NOT COMPLETED|Overall Study||20
618036|NCT00309907|1515783|P1|COMPLETED|Overall Study||19
618037|NCT00309907|1515783|P1|STARTED|Overall Study||39
618038|NCT00309777|1515796|P4|NOT COMPLETED|Overall Study||4
618039|NCT00309777|1515797|P3|NOT COMPLETED|Overall Study||19
618040|NCT00309777|1515798|P2|NOT COMPLETED|Overall Study||9
618041|NCT00309777|1515799|P1|NOT COMPLETED|Overall Study||23
618042|NCT00309777|1515796|P4|COMPLETED|Overall Study||107
618043|NCT00309777|1515797|P3|COMPLETED|Overall Study||304
618044|NCT00309777|1515798|P2|COMPLETED|Overall Study||99
618045|NCT00309777|1515799|P1|COMPLETED|Overall Study||292
618046|NCT00309777|1515796|P4|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|110
618047|NCT00309777|1515797|P3|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|320
618048|NCT00309777|1515798|P2|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|107
618049|NCT00309777|1515799|P1|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|311
618050|NCT00309777|1515796|P4|STARTED|Overall Study||111
618051|NCT00309777|1515797|P3|STARTED|Overall Study||323
618052|NCT00309777|1515798|P2|STARTED|Overall Study||108
618053|NCT00309777|1515799|P1|STARTED|Overall Study||315
618054|NCT00309751|1515815|P2|NOT COMPLETED|Overall Study||15
618055|NCT00309751|1515816|P1|NOT COMPLETED|Overall Study||31
618056|NCT00309751|1515815|P2|COMPLETED|Overall Study||124
618057|NCT00309751|1515816|P1|COMPLETED|Overall Study||248
618058|NCT00309751|1515815|P2|Safety Population|Overall Study|Subjects who received at least 1 dose of study drug|137
618059|NCT00309751|1515816|P1|Safety Population|Overall Study|Subjects who received at least 1 dose of study drug|275
618060|NCT00309751|1515815|P2|STARTED|Overall Study||139
618061|NCT00309751|1515816|P1|STARTED|Overall Study||279
618062|NCT00309738|1515826|P2|NOT COMPLETED|Overall Study||12
618063|NCT00309738|1515827|P1|NOT COMPLETED|Overall Study||13
618064|NCT00309738|1515826|P2|COMPLETED|Overall Study||107
618065|NCT00309738|1515827|P1|COMPLETED|Overall Study||223
618066|NCT00309738|1515826|P2|Safety Population|Overall Study|Subjects who received at least one dose of study medication|119
618067|NCT00309738|1515827|P1|Safety Population|Overall Study|Subjects who received at least one dose of study medication|233
618068|NCT00309738|1515826|P2|STARTED|Overall Study||119
618069|NCT00309738|1515827|P1|STARTED|Overall Study||236
618070|NCT00309608|1515840|P5|NOT COMPLETED|Overall Study||4
618071|NCT00309608|1515841|P4|NOT COMPLETED|Overall Study||6
618072|NCT00309608|1515842|P3|NOT COMPLETED|Overall Study||10
618073|NCT00309608|1515843|P2|NOT COMPLETED|Overall Study||13
618074|NCT00309608|1515844|P1|NOT COMPLETED|Overall Study||14
618075|NCT00309608|1515840|P5|COMPLETED|Overall Study||61
618076|NCT00309608|1515841|P4|COMPLETED|Overall Study||60
618077|NCT00309608|1515842|P3|COMPLETED|Overall Study||56
618078|NCT00309608|1515843|P2|COMPLETED|Overall Study||52
618079|NCT00309608|1515844|P1|COMPLETED|Overall Study||57
618080|NCT00309608|1515840|P5|STARTED|Overall Study||65
618081|NCT00309608|1515841|P4|STARTED|Overall Study||66
618082|NCT00309608|1515842|P3|STARTED|Overall Study||66
618083|NCT00309608|1515843|P2|STARTED|Overall Study||65
618084|NCT00309608|1515844|P1|STARTED|Overall Study||71
618085|NCT00309465|1515871|P6|NOT COMPLETED|Overall Study||0
618086|NCT00309465|1515872|P5|NOT COMPLETED|Overall Study||0
618087|NCT00309465|1515873|P4|NOT COMPLETED|Overall Study||1
618088|NCT00309465|1515874|P3|NOT COMPLETED|Overall Study||0
618089|NCT00309465|1515875|P2|NOT COMPLETED|Overall Study||0
618090|NCT00309465|1515876|P1|NOT COMPLETED|Overall Study||0
618091|NCT00309465|1515871|P6|COMPLETED|Overall Study||76
618092|NCT00309465|1515872|P5|COMPLETED|Overall Study||76
618093|NCT00309465|1515873|P4|COMPLETED|Overall Study|One subject was excluded due to eligibility error.|75
618094|NCT00309465|1515874|P3|COMPLETED|Overall Study||58
618095|NCT00309465|1515875|P2|COMPLETED|Overall Study||58
618096|NCT00309465|1515876|P1|COMPLETED|Overall Study||58
618097|NCT00309465|1515871|P6|STARTED|Overall Study||76
618098|NCT00309465|1515872|P5|STARTED|Overall Study||76
618099|NCT00309465|1515873|P4|STARTED|Overall Study||76
618100|NCT00309465|1515874|P3|STARTED|Overall Study||58
618101|NCT00309465|1515875|P2|STARTED|Overall Study||58
618102|NCT00309465|1515876|P1|STARTED|Overall Study||58
618103|NCT00309452|1515892|P2|NOT COMPLETED|Overall Study||0
618104|NCT00309452|1515893|P1|NOT COMPLETED|Overall Study||3
618105|NCT00309452|1515892|P2|COMPLETED|Overall Study||60
618106|NCT00309452|1515893|P1|COMPLETED|Overall Study||57
618107|NCT00309452|1515892|P2|STARTED|Overall Study||60
618108|NCT00309452|1515893|P1|STARTED|Overall Study||60
618109|NCT00309387|1515921|P2|NOT COMPLETED|Overall Study||159
618110|NCT00309387|1515922|P1|NOT COMPLETED|Overall Study||142
618111|NCT00309387|1515921|P2|COMPLETED|Overall Study||351
618112|NCT00309387|1515922|P1|COMPLETED|Overall Study||368
618113|NCT00309387|1515921|P2|STARTED|Overall Study||510
618114|NCT00309387|1515922|P1|STARTED|Overall Study||510
618115|NCT00309244|1515940|P2|NOT COMPLETED|Overall Study||97
618116|NCT00309244|1515941|P1|NOT COMPLETED|Overall Study||118
618117|NCT00309244|1515940|P2|COMPLETED|Overall Study||246
618118|NCT00309244|1515941|P1|COMPLETED|Overall Study||216
618119|NCT00309244|1515940|P2|STARTED|Overall Study||343
618120|NCT00309244|1515941|P1|STARTED|Overall Study||334
618121|NCT00308997|1515963|P2|NOT COMPLETED|Overall Study||1
618122|NCT00308997|1515964|P1|NOT COMPLETED|Overall Study||1
618123|NCT00308997|1515963|P2|COMPLETED|Overall Study||28
618124|NCT00308997|1515964|P1|COMPLETED|Overall Study||55
618125|NCT00308997|1515963|P2|STARTED|Overall Study||29
618126|NCT00308997|1515964|P1|STARTED|Overall Study||56
618127|NCT00308737|1515983|P3|NOT COMPLETED|Overall Study||37
618128|NCT00308737|1515984|P2|NOT COMPLETED|Overall Study||289
618129|NCT00308737|1515985|P1|NOT COMPLETED|Overall Study||463
618130|NCT00308737|1515983|P3|COMPLETED|Overall Study||127
618131|NCT00308737|1515984|P2|COMPLETED|Overall Study||662
618132|NCT00308737|1515985|P1|COMPLETED|Overall Study||475
618133|NCT00308737|1515983|P3|STARTED|Overall Study||164
618134|NCT00308737|1515984|P2|STARTED|Overall Study||951
618135|NCT00308737|1515985|P1|STARTED|Overall Study||938
618136|NCT00308711|1516025|P3|NOT COMPLETED|Overall Study||5
618137|NCT00308711|1516026|P2|NOT COMPLETED|Overall Study||4
618138|NCT00308711|1516027|P1|NOT COMPLETED|Overall Study||2
618139|NCT00308711|1516025|P3|COMPLETED|Overall Study||431
618140|NCT00308711|1516026|P2|COMPLETED|Overall Study||440
618141|NCT00308711|1516027|P1|COMPLETED|Overall Study||426
618142|NCT00308711|1516025|P3|STARTED|Overall Study||436
618143|NCT00308711|1516026|P2|STARTED|Overall Study||444
618144|NCT00308711|1516027|P1|STARTED|Overall Study||428
618145|NCT00308620|1516062|P3|NOT COMPLETED|Overall Study||1
618146|NCT00308620|1516063|P2|NOT COMPLETED|Overall Study||1
618147|NCT00308620|1516064|P1|NOT COMPLETED|Overall Study||1
618148|NCT00308620|1516062|P3|COMPLETED|Overall Study||5
618149|NCT00308620|1516063|P2|COMPLETED|Overall Study||3
618150|NCT00308620|1516064|P1|COMPLETED|Overall Study||2
618151|NCT00308620|1516062|P3|STARTED|Overall Study||6
618152|NCT00308620|1516063|P2|STARTED|Overall Study||4
618153|NCT00308620|1516064|P1|STARTED|Overall Study||3
618154|NCT00308581|1516073|P3|NOT COMPLETED|Randomized Maintenance Phase||0
618155|NCT00308581|1516074|P2|NOT COMPLETED|Randomized Maintenance Phase||103
618156|NCT00308581|1516075|P1|NOT COMPLETED|Randomized Maintenance Phase||105
618157|NCT00308581|1516073|P3|COMPLETED|Randomized Maintenance Phase||0
618158|NCT00308581|1516074|P2|COMPLETED|Randomized Maintenance Phase||83
618159|NCT00308581|1516075|P1|COMPLETED|Randomized Maintenance Phase||82
618160|NCT00308581|1516073|P3|STARTED|Randomized Maintenance Phase||0
618161|NCT00308581|1516074|P2|STARTED|Randomized Maintenance Phase||186
618162|NCT00308581|1516075|P1|STARTED|Randomized Maintenance Phase||187
618163|NCT00308581|1516073|P3|NOT COMPLETED|Induction Phase||166
618164|NCT00308581|1516074|P2|NOT COMPLETED|Induction Phase||0
618165|NCT00308581|1516075|P1|NOT COMPLETED|Induction Phase||0
618166|NCT00308581|1516073|P3|COMPLETED|Induction Phase||373
618167|NCT00308581|1516074|P2|COMPLETED|Induction Phase|Not applicable in this period|0
618168|NCT00308581|1516075|P1|COMPLETED|Induction Phase|Not applicable in this period|0
618169|NCT00308581|1516073|P3|STARTED|Induction Phase||539
618170|NCT00308581|1516074|P2|STARTED|Induction Phase|Not applicable in this period|0
618171|NCT00308581|1516075|P1|STARTED|Induction Phase|Not applicable in this period|0
618172|NCT00308555|1516201|P2|NOT COMPLETED|Overall Study||0
618173|NCT00308555|1516202|P1|NOT COMPLETED|Overall Study||3
618174|NCT00308555|1516201|P2|COMPLETED|Overall Study||11
618175|NCT00308555|1516202|P1|COMPLETED|Overall Study||10
618176|NCT00308555|1516201|P2|STARTED|Overall Study||11
618177|NCT00308555|1516202|P1|STARTED|Overall Study||13
618178|NCT00308516|1516210|P2|NOT COMPLETED|Overall Study||21
618179|NCT00308516|1516211|P1|NOT COMPLETED|Overall Study||29
618180|NCT00308516|1516210|P2|COMPLETED|Overall Study||10
618181|NCT00308516|1516211|P1|COMPLETED|Overall Study||6
618182|NCT00308516|1516210|P2|STARTED|Overall Study||31
618183|NCT00308516|1516211|P1|STARTED|Overall Study||35
618184|NCT00308308|1516219|P2|NOT COMPLETED|Overall Study||68
618185|NCT00308308|1516220|P1|NOT COMPLETED|Overall Study||103
618186|NCT00308308|1516219|P2|COMPLETED|Overall Study||220
618187|NCT00308308|1516220|P1|COMPLETED|Overall Study||198
618188|NCT00308308|1516219|P2|STARTED|Overall Study||288
618189|NCT00308308|1516220|P1|STARTED|Overall Study||301
618190|NCT00308230|1516243|P3|NOT COMPLETED|Overall Study||0
618191|NCT00308230|1516244|P2|NOT COMPLETED|Overall Study||0
618192|NCT00308230|1516245|P1|NOT COMPLETED|Overall Study||0
618193|NCT00308230|1516243|P3|COMPLETED|Overall Study||20
618194|NCT00308230|1516244|P2|COMPLETED|Overall Study||8
618195|NCT00308230|1516245|P1|COMPLETED|Overall Study||6
618196|NCT00308230|1516243|P3|STARTED|Overall Study||20
618197|NCT00308230|1516244|P2|STARTED|Overall Study||8
618198|NCT00308230|1516245|P1|STARTED|Overall Study||6
618199|NCT00308139|1516255|P2|NOT COMPLETED|Overall Study||87
618200|NCT00308139|1516256|P1|NOT COMPLETED|Overall Study||94
618201|NCT00308139|1516255|P2|COMPLETED|Overall Study|Subjects who completed 364 weeks of assessment|64
618202|NCT00308139|1516256|P1|COMPLETED|Overall Study|Subjects who completed 364 weeks of assessment|58
618203|NCT00308139|1516255|P2|30-Week Completed|Overall Study|Subjects who completed 30 weeks of assessment|130
618204|NCT00308139|1516256|P1|30-Week Completed|Overall Study|Subjects who completed 30 weeks of assessment|128
618205|NCT00308139|1516255|P2|Evaluable Meal Tolerance Cohort|Overall Study||24
618206|NCT00308139|1516256|P1|Evaluable Meal Tolerance Cohort|Overall Study||27
618207|NCT00308139|1516255|P2|Pharmacokinetics Population|Overall Study||0
618208|NCT00308139|1516256|P1|Pharmacokinetics Population|Overall Study||129
618209|NCT00308139|1516255|P2|ITT in the 30-Week Assessment|Overall Study|ITT Subjects who received at least one injection of randomized dose.|145
618210|NCT00308139|1516256|P1|ITT in the 30-Week Assessment|Overall Study|ITT Subjects who received at least one injection of randomized dose.|148
618211|NCT00308139|1516255|P2|Intent to Treat (ITT)|Overall Study|Subjects who received at least one injection of lead-in exenatide 5 mcg.|147
618212|NCT00308139|1516256|P1|Intent to Treat (ITT)|Overall Study|Subjects who received at least one injection of lead-in exenatide 5 mcg.|148
618213|NCT00308139|1516255|P2|STARTED|Overall Study||151
618214|NCT00308139|1516256|P1|STARTED|Overall Study||152
618215|NCT00308113|1516330|P4|NOT COMPLETED|Overall Study||1
618216|NCT00308113|1516331|P3|NOT COMPLETED|Overall Study||0
618217|NCT00308113|1516332|P2|NOT COMPLETED|Overall Study||0
618218|NCT00308113|1516333|P1|NOT COMPLETED|Overall Study||0
618219|NCT00308113|1516330|P4|COMPLETED|Overall Study||1
618220|NCT00308113|1516331|P3|COMPLETED|Overall Study||1
618221|NCT00308113|1516332|P2|COMPLETED|Overall Study||0
618222|NCT00308113|1516333|P1|COMPLETED|Overall Study||0
618223|NCT00308113|1516330|P4|STARTED|Overall Study||2
618224|NCT00308113|1516331|P3|STARTED|Overall Study||1
618225|NCT00308113|1516332|P2|STARTED|Overall Study||0
618226|NCT00308113|1516333|P1|STARTED|Overall Study||0
618227|NCT00308087|1516353|P2|NOT COMPLETED|Overall Study||37
618228|NCT00308087|1516354|P1|NOT COMPLETED|Overall Study||36
618229|NCT00308087|1516353|P2|COMPLETED|Overall Study|Completers finished treatment and the 24 month follow-up.|1
618230|NCT00308087|1516354|P1|COMPLETED|Overall Study|Completers finished treatment and the 24 month follow-up.|1
618231|NCT00308087|1516353|P2|STARTED|Overall Study||38
618232|NCT00308087|1516354|P1|STARTED|Overall Study||37
618233|NCT00308074|1516370|P1|NOT COMPLETED|Overall Study||1
618234|NCT00308074|1516370|P1|COMPLETED|Overall Study||13
618235|NCT00308074|1516370|P1|STARTED|Overall Study||14
618236|NCT00308061|1516379|P2|NOT COMPLETED|Overall Study||0
618237|NCT00308061|1516380|P1|NOT COMPLETED|Overall Study||0
618238|NCT00308061|1516379|P2|COMPLETED|Overall Study||20
618239|NCT00308061|1516380|P1|COMPLETED|Overall Study||20
618240|NCT00308061|1516379|P2|STARTED|Overall Study||20
618241|NCT00308061|1516380|P1|STARTED|Overall Study||20
618242|NCT00307931|1516387|P1|NOT COMPLETED|Overall Study||1
618243|NCT00307931|1516387|P1|COMPLETED|Overall Study|Number of subjects who completed the Week 12 visit|15
618244|NCT00307931|1516387|P1|STARTED|Overall Study|Number of subjects who entered the study and have been treated|16
618245|NCT00307801|1516404|P2|NOT COMPLETED|Overall Study||17
618246|NCT00307801|1516405|P1|NOT COMPLETED|Overall Study||32
618247|NCT00307801|1516404|P2|COMPLETED|Overall Study||65
618248|NCT00307801|1516405|P1|COMPLETED|Overall Study||117
618249|NCT00307801|1516404|P2|Cycle 7, Treatment Day 196|Overall Study|Includes subjects that prematurely discontinued the study and may not be counted in earlier visits.|77
618250|NCT00307801|1516405|P1|Cycle 7, Treatment Day 196|Overall Study|Includes subjects that prematurely discontinued the study and may not be counted in earlier visits.|141
618251|NCT00307801|1516404|P2|Cycle 3, Visit 7, Treatment Day 84|Overall Study||71
618252|NCT00307801|1516405|P1|Cycle 3, Visit 7, Treatment Day 84|Overall Study||130
618253|NCT00307801|1516404|P2|Cycle 1, Visit 5, Baseline|Overall Study||81
618254|NCT00307801|1516405|P1|Cycle 1, Visit 5, Baseline|Overall Study||145
618255|NCT00307801|1516404|P2|Subjects Received Treatment|Overall Study||81
618256|NCT00307801|1516405|P1|Subjects Received Treatment|Overall Study||145
618257|NCT00307801|1516404|P2|STARTED|Overall Study||82
618258|NCT00307801|1516405|P1|STARTED|Overall Study||149
618259|NCT00307736|1516517|P4|NOT COMPLETED|Overall Study||3
618260|NCT00307736|1516518|P3|NOT COMPLETED|Overall Study||3
618261|NCT00307736|1516519|P2|NOT COMPLETED|Overall Study||0
618262|NCT00307736|1516520|P1|NOT COMPLETED|Overall Study||0
618263|NCT00307736|1516517|P4|COMPLETED|Overall Study||20
618264|NCT00307736|1516518|P3|COMPLETED|Overall Study||0
618265|NCT00307736|1516519|P2|COMPLETED|Overall Study||3
618266|NCT00307736|1516520|P1|COMPLETED|Overall Study||3
618267|NCT00307736|1516517|P4|STARTED|Overall Study||23
618268|NCT00307736|1516518|P3|STARTED|Overall Study||3
618269|NCT00307736|1516519|P2|STARTED|Overall Study||3
618270|NCT00307736|1516520|P1|STARTED|Overall Study||3
618271|NCT00307684|1516531|P3|NOT COMPLETED|Double Blind Phase||0
618272|NCT00307684|1516532|P2|NOT COMPLETED|Double Blind Phase||5
618273|NCT00307684|1516533|P1|NOT COMPLETED|Double Blind Phase||2
618274|NCT00307684|1516531|P3|COMPLETED|Double Blind Phase||0
618275|NCT00307684|1516532|P2|COMPLETED|Double Blind Phase||17
618276|NCT00307684|1516533|P1|COMPLETED|Double Blind Phase||21
618277|NCT00307684|1516531|P3|STARTED|Double Blind Phase||0
618278|NCT00307684|1516532|P2|STARTED|Double Blind Phase||22
618279|NCT00307684|1516533|P1|STARTED|Double Blind Phase||23
618280|NCT00307684|1516531|P3|NOT COMPLETED|Open Label Phase||56
618281|NCT00307684|1516532|P2|NOT COMPLETED|Open Label Phase||0
618282|NCT00307684|1516533|P1|NOT COMPLETED|Open Label Phase||0
618283|NCT00307684|1516531|P3|COMPLETED|Open Label Phase||99
618284|NCT00307684|1516532|P2|COMPLETED|Open Label Phase||0
618285|NCT00307684|1516533|P1|COMPLETED|Open Label Phase||0
618286|NCT00307684|1516531|P3|STARTED|Open Label Phase|1 screening failure|155
618287|NCT00307684|1516532|P2|STARTED|Open Label Phase||0
618288|NCT00307684|1516533|P1|STARTED|Open Label Phase||0
618289|NCT00307489|1516561|P2|NOT COMPLETED|Week 48 Through Week 168||6
618290|NCT00307489|1516562|P1|NOT COMPLETED|Week 48 Through Week 168||6
618291|NCT00307489|1516561|P2|COMPLETED|Week 48 Through Week 168|5 of the 44 subjects switched to open-label FTC/TDF prior to Week 168.|44
618292|NCT00307489|1516562|P1|COMPLETED|Week 48 Through Week 168|11 of the 46 subjects switched to open-label FTC/TDF prior to Week 168.|46
618293|NCT00307489|1516561|P2|STARTED|Week 48 Through Week 168||50
618294|NCT00307489|1516562|P1|STARTED|Week 48 Through Week 168||52
618295|NCT00307489|1516561|P2|NOT COMPLETED|Baseline Through Week 48||2
618296|NCT00307489|1516562|P1|NOT COMPLETED|Baseline Through Week 48||1
618297|NCT00307489|1516561|P2|COMPLETED|Baseline Through Week 48|9 of the 50 subjects switched to open-label FTC/TDF prior to Week 48.|50
618298|NCT00307489|1516562|P1|COMPLETED|Baseline Through Week 48|16 of the 52 subjects switched to open-label FTC/TDF prior to Week 48.|52
618299|NCT00307489|1516561|P2|STARTED|Baseline Through Week 48||52
618300|NCT00307489|1516562|P1|STARTED|Baseline Through Week 48||53
618301|NCT00307437|1516607|P7|NOT COMPLETED|After Controlled Period||113
618302|NCT00307437|1516608|P6|NOT COMPLETED|After Controlled Period||122
618303|NCT00307437|1516609|P5|NOT COMPLETED|After Controlled Period||55
618304|NCT00307437|1516610|P4|NOT COMPLETED|After Controlled Period||58
618305|NCT00307437|1516611|P3|NOT COMPLETED|After Controlled Period||0
618306|NCT00307437|1516612|P2|NOT COMPLETED|After Controlled Period||0
618307|NCT00307437|1516613|P1|NOT COMPLETED|After Controlled Period||0
618308|NCT00307437|1516607|P7|COMPLETED|After Controlled Period||289
618309|NCT00307437|1516608|P6|COMPLETED|After Controlled Period||281
618310|NCT00307437|1516609|P5|COMPLETED|After Controlled Period||140
618311|NCT00307437|1516610|P4|COMPLETED|After Controlled Period||139
618312|NCT00307437|1516611|P3|COMPLETED|After Controlled Period||0
618313|NCT00307437|1516612|P2|COMPLETED|After Controlled Period||0
618314|NCT00307437|1516613|P1|COMPLETED|After Controlled Period||0
618315|NCT00307437|1516607|P7|STARTED|After Controlled Period||402
618316|NCT00307437|1516608|P6|STARTED|After Controlled Period||403
618317|NCT00307437|1516609|P5|STARTED|After Controlled Period|2 participants from placebo group in CP did not crossover to this group after CP.|195
618318|NCT00307437|1516610|P4|STARTED|After Controlled Period||197
618319|NCT00307437|1516611|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
618320|NCT00307437|1516612|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
618321|NCT00307437|1516613|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
618322|NCT00307437|1516607|P7|NOT COMPLETED|Controlled Period||0
618323|NCT00307437|1516608|P6|NOT COMPLETED|Controlled Period||0
618324|NCT00307437|1516609|P5|NOT COMPLETED|Controlled Period||0
618325|NCT00307437|1516610|P4|NOT COMPLETED|Controlled Period||0
618326|NCT00307437|1516611|P3|NOT COMPLETED|Controlled Period||9
618327|NCT00307437|1516612|P2|NOT COMPLETED|Controlled Period||6
618328|NCT00307437|1516613|P1|NOT COMPLETED|Controlled Period||16
618329|NCT00307437|1516607|P7|COMPLETED|Controlled Period||0
618330|NCT00307437|1516608|P6|COMPLETED|Controlled Period||0
618331|NCT00307437|1516609|P5|COMPLETED|Controlled Period||0
618332|NCT00307437|1516610|P4|COMPLETED|Controlled Period||0
618333|NCT00307437|1516611|P3|COMPLETED|Controlled Period||402
618334|NCT00307437|1516612|P2|COMPLETED|Controlled Period||403
618335|NCT00307437|1516613|P1|COMPLETED|Controlled Period||394
618336|NCT00307437|1516607|P7|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
618337|NCT00307437|1516608|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
618338|NCT00307437|1516609|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
618339|NCT00307437|1516610|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
618340|NCT00307437|1516611|P3|STARTED|Controlled Period||411
618341|NCT00307437|1516612|P2|STARTED|Controlled Period||409
618342|NCT00307437|1516613|P1|STARTED|Controlled Period||410
618343|NCT00307333|1516639|P2|NOT COMPLETED|Overall Study||3
618344|NCT00307333|1516640|P1|NOT COMPLETED|Overall Study||11
618345|NCT00307333|1516639|P2|COMPLETED|Overall Study||1489
618346|NCT00307333|1516640|P1|COMPLETED|Overall Study||1500
618347|NCT00307333|1516639|P2|STARTED|Overall Study||1492
618348|NCT00307333|1516640|P1|STARTED|Overall Study||1511
618349|NCT00307294|1516652|P1|NOT COMPLETED|Overall Study||1
618350|NCT00307294|1516652|P1|COMPLETED|Overall Study||39
618351|NCT00307294|1516652|P1|STARTED|Overall Study||40
618352|NCT00307164|1516661|P2|NOT COMPLETED|Overall Study||14
618353|NCT00307164|1516662|P1|NOT COMPLETED|Overall Study||15
618354|NCT00307164|1516661|P2|COMPLETED|Overall Study||68
618355|NCT00307164|1516662|P1|COMPLETED|Overall Study||68
618356|NCT00307164|1516661|P2|STARTED|Overall Study||82
618357|NCT00307164|1516662|P1|STARTED|Overall Study||83
618358|NCT00307151|1516702|P4|NOT COMPLETED|Overall Study||11
618359|NCT00307151|1516703|P3|NOT COMPLETED|Overall Study||20
618360|NCT00307151|1516704|P2|NOT COMPLETED|Overall Study||7
618361|NCT00307151|1516705|P1|NOT COMPLETED|Overall Study||11
618362|NCT00307151|1516702|P4|COMPLETED|Overall Study|Results are through date DSMB recommended Cohort II results be unblinded (October 27, 2010)|129
618363|NCT00307151|1516703|P3|COMPLETED|Overall Study|Results are through date DSMB recommended Cohort II results be unblinded (October 27, 2010)|127
618364|NCT00307151|1516704|P2|COMPLETED|Overall Study|Results are through date DSMB closed Cohort I to accrual (April 20, 2009)|75
618365|NCT00307151|1516705|P1|COMPLETED|Overall Study|Results are through date DSMB closed Cohort I to accrual (April 20, 2009)|71
618366|NCT00307151|1516702|P4|STARTED|Overall Study|One participant never started treatment, were not followed and not included in analysis.|140
618367|NCT00307151|1516703|P3|STARTED|Overall Study||147
618368|NCT00307151|1516704|P2|STARTED|Overall Study||82
618369|NCT00307151|1516705|P1|STARTED|Overall Study||82
618370|NCT00307125|1516749|P3|NOT COMPLETED|Pilot Phase||1
618371|NCT00307125|1516750|P2|NOT COMPLETED|Pilot Phase||2
618372|NCT00307125|1516751|P1|NOT COMPLETED|Pilot Phase||0
618373|NCT00307125|1516749|P3|COMPLETED|Pilot Phase|1 participant had reduced follow-up|6
618374|NCT00307125|1516750|P2|COMPLETED|Pilot Phase|2 participants had reduced follow-up|13
618375|NCT00307125|1516751|P1|COMPLETED|Pilot Phase||0
618376|NCT00307125|1516749|P3|STARTED|Pilot Phase||7
618377|NCT00307125|1516750|P2|STARTED|Pilot Phase||15
618378|NCT00307125|1516751|P1|STARTED|Pilot Phase||0
618379|NCT00307125|1516749|P3|NOT COMPLETED|Screening Phase||0
618380|NCT00307125|1516750|P2|NOT COMPLETED|Screening Phase||0
618381|NCT00307125|1516751|P1|NOT COMPLETED|Screening Phase||454
618382|NCT00307125|1516749|P3|COMPLETED|Screening Phase||0
618383|NCT00307125|1516750|P2|COMPLETED|Screening Phase||0
618384|NCT00307125|1516751|P1|COMPLETED|Screening Phase||303
618385|NCT00307125|1516749|P3|STARTED|Screening Phase||0
618386|NCT00307125|1516750|P2|STARTED|Screening Phase||0
618387|NCT00307125|1516751|P1|STARTED|Screening Phase||757
618388|NCT00307086|1516773|P1|NOT COMPLETED|Overall Study||5
618389|NCT00307086|1516773|P1|COMPLETED|Overall Study||25
618390|NCT00307086|1516773|P1|STARTED|Overall Study||30
618391|NCT00307047|1516779|P2|NOT COMPLETED|Overall Study||49
618392|NCT00307047|1516780|P1|NOT COMPLETED|Overall Study||69
618393|NCT00307047|1516779|P2|COMPLETED|Overall Study||1180
618394|NCT00307047|1516780|P1|COMPLETED|Overall Study||2389
618395|NCT00307047|1516779|P2|STARTED|Overall Study||1229
618396|NCT00307047|1516780|P1|STARTED|Overall Study||2458
618397|NCT00307034|1516918|P2|NOT COMPLETED|Overall Study||7
618398|NCT00307034|1516919|P1|NOT COMPLETED|Overall Study||2
618399|NCT00307034|1516918|P2|COMPLETED|Overall Study||169
618400|NCT00307034|1516919|P1|COMPLETED|Overall Study||173
618401|NCT00307034|1516918|P2|STARTED|Overall Study||176
618402|NCT00307034|1516919|P1|STARTED|Overall Study||175
618403|NCT00306917|1516959|P2|NOT COMPLETED|Overall Study||109
618404|NCT00306917|1516960|P1|NOT COMPLETED|Overall Study||108
618405|NCT00306917|1516959|P2|COMPLETED|Overall Study||15
618406|NCT00306917|1516960|P1|COMPLETED|Overall Study||13
618407|NCT00306917|1516959|P2|60 Month Follow up|Overall Study||15
618408|NCT00306917|1516960|P1|60 Month Follow up|Overall Study||13
618409|NCT00306917|1516959|P2|48 Month Follow up|Overall Study||22
618410|NCT00306917|1516960|P1|48 Month Follow up|Overall Study||29
618411|NCT00306917|1516959|P2|36 Month Follow up|Overall Study||42
618412|NCT00306917|1516960|P1|36 Month Follow up|Overall Study||56
618413|NCT00306917|1516959|P2|24 Month Follow up|Overall Study||71
618414|NCT00306917|1516960|P1|24 Month Follow up|Overall Study||60
618415|NCT00306917|1516959|P2|12 Month Follow|Overall Study||94
618416|NCT00306917|1516960|P1|12 Month Follow|Overall Study||86
618417|NCT00306917|1516959|P2|Postoperative to 6 Month Follow up|Overall Study||100
618418|NCT00306917|1516960|P1|Postoperative to 6 Month Follow up|Overall Study||93
618419|NCT00306917|1516959|P2|STARTED|Overall Study|400 subjects were to be followed for 5 years; due to slow enrollment study closed early with 245.|124
618420|NCT00306917|1516960|P1|STARTED|Overall Study|400 subjects were to be followed for 5 years; due to slow enrollment study closed early with 245.|121
618421|NCT00306891|1516970|P4|NOT COMPLETED|Part B||17
618422|NCT00306891|1516971|P3|NOT COMPLETED|Part B||11
618423|NCT00306891|1516972|P2|NOT COMPLETED|Part B||0
618424|NCT00306891|1516973|P1|NOT COMPLETED|Part B||0
618425|NCT00306891|1516970|P4|COMPLETED|Part B||14
618426|NCT00306891|1516971|P3|COMPLETED|Part B||5
618427|NCT00306891|1516972|P2|COMPLETED|Part B||0
618428|NCT00306891|1516973|P1|COMPLETED|Part B||0
618429|NCT00306891|1516970|P4|STARTED|Part B|in Part B: Cediranib Dose Escalation 11 new patients were randomized.|31
618430|NCT00306891|1516971|P3|STARTED|Part B|In Part B: Cediranib 45 mg Fixed Dose 4 new patients were randomized|16
618431|NCT00306891|1516972|P2|STARTED|Part B||0
618432|NCT00306891|1516973|P1|STARTED|Part B||0
618433|NCT00306891|1516970|P4|NOT COMPLETED|Part A||0
618434|NCT00306891|1516971|P3|NOT COMPLETED|Part A||0
618435|NCT00306891|1516972|P2|NOT COMPLETED|Part A||6
618436|NCT00306891|1516973|P1|NOT COMPLETED|Part A||5
618437|NCT00306891|1516970|P4|COMPLETED|Part A||0
618438|NCT00306891|1516971|P3|COMPLETED|Part A||0
618439|NCT00306891|1516972|P2|COMPLETED|Part A||16
618440|NCT00306891|1516973|P1|COMPLETED|Part A||18
618441|NCT00306891|1516970|P4|STARTED|Part A||0
618442|NCT00306891|1516971|P3|STARTED|Part A||0
618443|NCT00306891|1516972|P2|STARTED|Part A||22
618444|NCT00306891|1516973|P1|STARTED|Part A||23
618445|NCT00306852|1516996|P2|NOT COMPLETED|Overall Study||38
618446|NCT00306852|1516997|P1|NOT COMPLETED|Overall Study||29
618447|NCT00306852|1516996|P2|COMPLETED|Overall Study||69
618448|NCT00306852|1516997|P1|COMPLETED|Overall Study||76
618449|NCT00306852|1516996|P2|STARTED|Overall Study||107
618450|NCT00306852|1516997|P1|STARTED|Overall Study||105
618451|NCT00306787|1517015|P2|NOT COMPLETED|Overall Study||241
618452|NCT00306787|1517016|P1|NOT COMPLETED|Overall Study||234
618453|NCT00306787|1517015|P2|COMPLETED|Overall Study||359
618454|NCT00306787|1517016|P1|COMPLETED|Overall Study||345
618455|NCT00306787|1517015|P2|Intent to Treat (ITT) Population|Overall Study||381
618456|NCT00306787|1517016|P1|Intent to Treat (ITT) Population|Overall Study||370
618457|NCT00306787|1517015|P2|Received Study Drug (Safety Population)|Overall Study||385
618458|NCT00306787|1517016|P1|Received Study Drug (Safety Population)|Overall Study||371
618459|NCT00306787|1517015|P2|STARTED|Overall Study||600
618460|NCT00306787|1517016|P1|STARTED|Overall Study||579
618461|NCT00306670|1517034|P2|NOT COMPLETED|Overall Study||2
618462|NCT00306670|1517035|P1|NOT COMPLETED|Overall Study||0
618463|NCT00306670|1517034|P2|COMPLETED|Overall Study|2 patients recruited; Genentech, the study sponsor, discontinued study before treatment initiated|0
618464|NCT00306670|1517035|P1|COMPLETED|Overall Study|no patients recruited; Genentech, the study sponsor, pulled funding and discontinued the protocol|0
618465|NCT00306670|1517034|P2|STARTED|Overall Study|2 patients recruited; Genentech, the study sponsor, discontinued trial before treatment started|2
618466|NCT00306670|1517035|P1|STARTED|Overall Study|no patients recruited; Genentech, the study sponsor, pulled funding and discontinued the protocol|0
618467|NCT00306592|1517041|P2|NOT COMPLETED|Overall Study||58
618468|NCT00306592|1517042|P1|NOT COMPLETED|Overall Study||31
618469|NCT00306592|1517041|P2|COMPLETED|Overall Study||632
618470|NCT00306592|1517042|P1|COMPLETED|Overall Study||373
618471|NCT00306592|1517041|P2|Entered 101-MS-321 Extension Study|Overall Study|pertains to participants transitioning from 101-MS-322 (NCT00306592) study only|0
618472|NCT00306592|1517042|P1|Entered 101-MS-321 Extension Study|Overall Study||22
618473|NCT00306592|1517041|P2|Completed at 48 Weeks|Overall Study||632
618474|NCT00306592|1517042|P1|Completed at 48 Weeks|Overall Study||81
618475|NCT00306592|1517041|P2|Completed Between 24 and 48 Weeks|Overall Study||0
618476|NCT00306592|1517042|P1|Completed Between 24 and 48 Weeks|Overall Study||85
618477|NCT00306592|1517041|P2|Completed at 24 Weeks|Overall Study||0
618478|NCT00306592|1517042|P1|Completed at 24 Weeks|Overall Study||207
618479|NCT00306592|1517041|P2|STARTED|Overall Study||690
618480|NCT00306592|1517042|P1|STARTED|Overall Study||404
618481|NCT00306527|1517052|P4|NOT COMPLETED|Overall Study||6
618482|NCT00306527|1517053|P3|NOT COMPLETED|Overall Study||5
618483|NCT00306527|1517054|P2|NOT COMPLETED|Overall Study||7
618484|NCT00306527|1517055|P1|NOT COMPLETED|Overall Study||6
618485|NCT00306527|1517052|P4|COMPLETED|Overall Study||590
618486|NCT00306527|1517053|P3|COMPLETED|Overall Study|Additional death has been reported post study. Please refer to outcome measure-2.|567
618487|NCT00306527|1517054|P2|COMPLETED|Overall Study||527
618488|NCT00306527|1517055|P1|COMPLETED|Overall Study||527
618489|NCT00306527|1517052|P4|STARTED|Overall Study||596
618490|NCT00306527|1517053|P3|STARTED|Overall Study||572
618491|NCT00306527|1517054|P2|STARTED|Overall Study||534
618492|NCT00306527|1517055|P1|STARTED|Overall Study||533
618493|NCT00306488|1517109|P2|NOT COMPLETED|Overall Study||1
618494|NCT00306488|1517110|P1|NOT COMPLETED|Overall Study||1
618495|NCT00306488|1517109|P2|COMPLETED|Overall Study||10
618496|NCT00306488|1517110|P1|COMPLETED|Overall Study||10
618497|NCT00306488|1517109|P2|STARTED|Overall Study||11
618498|NCT00306488|1517110|P1|STARTED|Overall Study||11
618499|NCT00306384|1517124|P3|NOT COMPLETED|Overall Study||277
618500|NCT00306384|1517125|P2|NOT COMPLETED|Overall Study||508
618501|NCT00306384|1517126|P1|NOT COMPLETED|Overall Study||542
618502|NCT00306384|1517124|P3|COMPLETED|Overall Study||251
618503|NCT00306384|1517125|P2|COMPLETED|Overall Study||891
618504|NCT00306384|1517126|P1|COMPLETED|Overall Study||854
618505|NCT00306384|1517124|P3|Safety Set|Overall Study|Patients who received at least one dose of study drug|527
618506|NCT00306384|1517125|P2|Safety Set|Overall Study|Patients who received at least one dose of study drug|1398
618507|NCT00306384|1517126|P1|Safety Set|Overall Study|Patients who received at least one dose of study drug|1395
618508|NCT00306384|1517124|P3|STARTED|Overall Study||528
618509|NCT00306384|1517125|P2|STARTED|Overall Study||1399
618510|NCT00306384|1517126|P1|STARTED|Overall Study||1396
618511|NCT00306293|1517158|P2|NOT COMPLETED|Period 2 (Day 67 to Day 126 )||1
618512|NCT00306293|1517159|P1|NOT COMPLETED|Period 2 (Day 67 to Day 126 )||3
618513|NCT00306293|1517158|P2|COMPLETED|Period 2 (Day 67 to Day 126 )||26
618514|NCT00306293|1517159|P1|COMPLETED|Period 2 (Day 67 to Day 126 )||24
618515|NCT00306293|1517158|P2|STARTED|Period 2 (Day 67 to Day 126 )||27
618516|NCT00306293|1517159|P1|STARTED|Period 2 (Day 67 to Day 126 )||27
618517|NCT00306293|1517158|P2|NOT COMPLETED|Washout (Day 61 to Day 66)||0
618518|NCT00306293|1517159|P1|NOT COMPLETED|Washout (Day 61 to Day 66)||0
618519|NCT00306293|1517158|P2|COMPLETED|Washout (Day 61 to Day 66)||27
618520|NCT00306293|1517159|P1|COMPLETED|Washout (Day 61 to Day 66)||27
618521|NCT00306293|1517158|P2|STARTED|Washout (Day 61 to Day 66)||27
618522|NCT00306293|1517159|P1|STARTED|Washout (Day 61 to Day 66)||27
618523|NCT00306293|1517158|P2|NOT COMPLETED|Period 1 (Day 1 to Day 60)||8
618524|NCT00306293|1517159|P1|NOT COMPLETED|Period 1 (Day 1 to Day 60)||8
618525|NCT00306293|1517158|P2|COMPLETED|Period 1 (Day 1 to Day 60)||27
618526|NCT00306293|1517159|P1|COMPLETED|Period 1 (Day 1 to Day 60)||27
618527|NCT00306293|1517158|P2|STARTED|Period 1 (Day 1 to Day 60)||35
618528|NCT00306293|1517159|P1|STARTED|Period 1 (Day 1 to Day 60)||35
618529|NCT00306202|1517180|P3|NOT COMPLETED|Overall Study||0
618530|NCT00306202|1517181|P2|NOT COMPLETED|Overall Study||1
618531|NCT00306202|1517182|P1|NOT COMPLETED|Overall Study||6
618532|NCT00306202|1517180|P3|COMPLETED|Overall Study|Completed = Off-treatment|24
618533|NCT00306202|1517181|P2|COMPLETED|Overall Study|Completed = Off-treatment|16
618534|NCT00306202|1517182|P1|COMPLETED|Overall Study|Completed = Off-treatment|11
618535|NCT00306202|1517180|P3|STARTED|Overall Study|Started = Treated. 24 were enrolled; 1 no longer met study criteria and was never treated|24
618536|NCT00306202|1517181|P2|STARTED|Overall Study|Started=Treated. 20 were enrolled;3 never treated(2 no longer met study criteria;1 withdrew consent)|17
618537|NCT00306202|1517182|P1|STARTED|Overall Study|Started = Treated. 18 were enrolled; 1 no longer met study criteria and was never treated|17
618538|NCT00306189|1517342|P4|NOT COMPLETED|Overall Study||5
618539|NCT00306189|1517343|P3|NOT COMPLETED|Overall Study||11
618540|NCT00306189|1517344|P2|NOT COMPLETED|Overall Study||6
618541|NCT00306189|1517345|P1|NOT COMPLETED|Overall Study||9
618542|NCT00306189|1517342|P4|COMPLETED|Overall Study||52
618543|NCT00306189|1517343|P3|COMPLETED|Overall Study||45
618544|NCT00306189|1517344|P2|COMPLETED|Overall Study||50
618545|NCT00306189|1517345|P1|COMPLETED|Overall Study||48
618546|NCT00306189|1517342|P4|STARTED|Overall Study||57
618547|NCT00306189|1517343|P3|STARTED|Overall Study||56
618548|NCT00306189|1517344|P2|STARTED|Overall Study||56
618549|NCT00306189|1517345|P1|STARTED|Overall Study||57
618550|NCT00306163|1517357|P2|NOT COMPLETED|Overall Study||0
618551|NCT00306163|1517358|P1|NOT COMPLETED|Overall Study||0
618552|NCT00306163|1517357|P2|COMPLETED|Overall Study||18
618553|NCT00306163|1517358|P1|COMPLETED|Overall Study||19
618554|NCT00306163|1517357|P2|STARTED|Overall Study||18
618555|NCT00306163|1517358|P1|STARTED|Overall Study||19
618556|NCT00305942|1517364|P1|NOT COMPLETED|Overall Study||38
618557|NCT00305942|1517364|P1|COMPLETED|Overall Study||23
618558|NCT00305942|1517364|P1|STARTED|Overall Study||61
618559|NCT00305877|1517372|P2|NOT COMPLETED|Overall Study||34
618560|NCT00305877|1517373|P1|NOT COMPLETED|Overall Study||24
618561|NCT00305877|1517372|P2|COMPLETED|Overall Study||34
618562|NCT00305877|1517373|P1|COMPLETED|Overall Study||45
618563|NCT00305877|1517372|P2|Included in Efficacy Analysis|Overall Study||62
618564|NCT00305877|1517373|P1|Included in Efficacy Analysis|Overall Study||65
618565|NCT00305877|1517372|P2|Eligible|Overall Study||66
618566|NCT00305877|1517373|P1|Eligible|Overall Study||66
618567|NCT00305877|1517372|P2|Treated|Overall Study||63
618568|NCT00305877|1517373|P1|Treated|Overall Study||67
618569|NCT00305877|1517372|P2|STARTED|Overall Study||68
618570|NCT00305877|1517373|P1|STARTED|Overall Study||69
618571|NCT00305864|1517387|P4|NOT COMPLETED|Overall Study||13
618572|NCT00305864|1517388|P3|NOT COMPLETED|Overall Study||1
618573|NCT00305864|1517389|P2|NOT COMPLETED|Overall Study||1
618574|NCT00305864|1517390|P1|NOT COMPLETED|Overall Study||0
618575|NCT00305864|1517387|P4|COMPLETED|Overall Study||81
618576|NCT00305864|1517388|P3|COMPLETED|Overall Study||6
618577|NCT00305864|1517389|P2|COMPLETED|Overall Study||9
618578|NCT00305864|1517390|P1|COMPLETED|Overall Study||7
618579|NCT00305864|1517387|P4|STARTED|Overall Study||94
618580|NCT00305864|1517388|P3|STARTED|Overall Study||7
618581|NCT00305864|1517389|P2|STARTED|Overall Study||10
618582|NCT00305864|1517390|P1|STARTED|Overall Study||7
618583|NCT00305773|1517403|P2|NOT COMPLETED|Overall Study||18
618584|NCT00305773|1517404|P1|NOT COMPLETED|Overall Study||14
618585|NCT00305773|1517403|P2|COMPLETED|Overall Study||4
618586|NCT00305773|1517404|P1|COMPLETED|Overall Study||1
618587|NCT00305773|1517403|P2|STARTED|Overall Study||22
618588|NCT00305773|1517404|P1|STARTED|Overall Study||15
618589|NCT00305760|1517418|P1|NOT COMPLETED|Overall Study||47
618590|NCT00305760|1517418|P1|COMPLETED|Overall Study||13
618591|NCT00305760|1517418|P1|STARTED|Overall Study||60
618592|NCT00305643|1517424|P2|NOT COMPLETED|Overall Study||0
618593|NCT00305643|1517425|P1|NOT COMPLETED|Overall Study||0
618594|NCT00305643|1517424|P2|COMPLETED|Overall Study||5
618595|NCT00305643|1517425|P1|COMPLETED|Overall Study||6
618596|NCT00305643|1517424|P2|STARTED|Overall Study||5
618597|NCT00305643|1517425|P1|STARTED|Overall Study||6
618598|NCT00305604|1517435|P2|NOT COMPLETED|Overall Study||47
618599|NCT00305604|1517436|P1|NOT COMPLETED|Overall Study||32
618600|NCT00305604|1517435|P2|COMPLETED|Overall Study||57
618601|NCT00305604|1517436|P1|COMPLETED|Overall Study||70
618602|NCT00305604|1517435|P2|STARTED|Overall Study||104
618603|NCT00305604|1517436|P1|STARTED|Overall Study||102
618604|NCT00305578|1517450|P2|NOT COMPLETED|Overall Study||2
618605|NCT00305578|1517451|P1|NOT COMPLETED|Overall Study||3
618606|NCT00305578|1517450|P2|COMPLETED|Overall Study||12
618607|NCT00305578|1517451|P1|COMPLETED|Overall Study||12
618608|NCT00305578|1517450|P2|STARTED|Overall Study||14
618609|NCT00305578|1517451|P1|STARTED|Overall Study||15
618610|NCT00305565|1517460|P3|NOT COMPLETED|Overall Study (ITT Population)||5
618611|NCT00305565|1517461|P2|NOT COMPLETED|Overall Study (ITT Population)||11
618612|NCT00305565|1517462|P1|NOT COMPLETED|Overall Study (ITT Population)||13
618613|NCT00305565|1517460|P3|COMPLETED|Overall Study (ITT Population)||102
618614|NCT00305565|1517461|P2|COMPLETED|Overall Study (ITT Population)||90
618615|NCT00305565|1517462|P1|COMPLETED|Overall Study (ITT Population)||89
618616|NCT00305565|1517460|P3|STARTED|Overall Study (ITT Population)||107
618617|NCT00305565|1517461|P2|STARTED|Overall Study (ITT Population)||101
618618|NCT00305565|1517462|P1|STARTED|Overall Study (ITT Population)||102
618619|NCT00305565|1517460|P3|NOT COMPLETED|Overall Study (Safety Population)||7
618620|NCT00305565|1517461|P2|NOT COMPLETED|Overall Study (Safety Population)||12
618621|NCT00305565|1517462|P1|NOT COMPLETED|Overall Study (Safety Population)||14
618622|NCT00305565|1517460|P3|COMPLETED|Overall Study (Safety Population)||106
618623|NCT00305565|1517461|P2|COMPLETED|Overall Study (Safety Population)||95
618624|NCT00305565|1517462|P1|COMPLETED|Overall Study (Safety Population)||97
618625|NCT00305565|1517460|P3|STARTED|Overall Study (Safety Population)||113
618626|NCT00305565|1517461|P2|STARTED|Overall Study (Safety Population)||107
618627|NCT00305565|1517462|P1|STARTED|Overall Study (Safety Population)||111
618628|NCT00305448|1517580|P3|NOT COMPLETED|Overall Study||33
618629|NCT00305448|1517581|P2|NOT COMPLETED|Overall Study||34
618630|NCT00305448|1517582|P1|NOT COMPLETED|Overall Study||31
618631|NCT00305448|1517580|P3|COMPLETED|Overall Study||14
618632|NCT00305448|1517581|P2|COMPLETED|Overall Study||17
618633|NCT00305448|1517582|P1|COMPLETED|Overall Study||14
618634|NCT00305448|1517580|P3|STARTED|Overall Study||47
618635|NCT00305448|1517581|P2|STARTED|Overall Study||51
618636|NCT00305448|1517582|P1|STARTED|Overall Study||45
618637|NCT00305344|1517598|P1|NOT COMPLETED|Overall Study||0
618638|NCT00305344|1517598|P1|COMPLETED|Overall Study||23
618639|NCT00305344|1517598|P1|STARTED|Overall Study||23
618640|NCT00305253|1517604|P2|NOT COMPLETED|Overall Study||1
618641|NCT00305253|1517605|P1|NOT COMPLETED|Overall Study||0
618642|NCT00305253|1517604|P2|COMPLETED|Overall Study||558
618643|NCT00305253|1517605|P1|COMPLETED|Overall Study||432
618644|NCT00305253|1517604|P2|STARTED|Overall Study||559
618645|NCT00305253|1517605|P1|STARTED|Overall Study||432
618646|NCT00305227|1517617|P2|NOT COMPLETED|Overall Study||6
618647|NCT00305227|1517618|P1|NOT COMPLETED|Overall Study||7
618648|NCT00305227|1517617|P2|COMPLETED|Overall Study|with at least 8 weeks of observation|44
618649|NCT00305227|1517618|P1|COMPLETED|Overall Study|with at least 8 weeks of observation|43
618650|NCT00305227|1517617|P2|STARTED|Overall Study||50
618651|NCT00305227|1517618|P1|STARTED|Overall Study||50
618652|NCT00305162|1517626|P2|NOT COMPLETED|1 Year Follow-up Period||65
618653|NCT00305162|1517627|P1|NOT COMPLETED|1 Year Follow-up Period||55
618654|NCT00305162|1517626|P2|COMPLETED|1 Year Follow-up Period|intent-to-treat (ITT) completers at 1-year follow-up|4382
618655|NCT00305162|1517627|P1|COMPLETED|1 Year Follow-up Period|intent-to-treat (ITT) completers at 1-year follow-up|4380
618656|NCT00305162|1517626|P2|Modified ITT (mITT): STEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|444
618657|NCT00305162|1517627|P1|Modified ITT (mITT): STEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|446
618658|NCT00305162|1517626|P2|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|3818
618659|NCT00305162|1517627|P1|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|3851
618660|NCT00305162|1517626|P2|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period|Completed through 1 year|504
618661|NCT00305162|1517627|P1|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period|Completed through 1 year|480
618662|NCT00305162|1517626|P2|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year|3878
618663|NCT00305162|1517627|P1|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year|3900
618664|NCT00305162|1517626|P2|STARTED|1 Year Follow-up Period||4447
618665|NCT00305162|1517627|P1|STARTED|1 Year Follow-up Period||4435
618666|NCT00305162|1517626|P2|NOT COMPLETED|30-day Follow-up Period||63
618667|NCT00305162|1517627|P1|NOT COMPLETED|30-day Follow-up Period||62
618668|NCT00305162|1517626|P2|COMPLETED|30-day Follow-up Period|intent-to-treat (ITT) completers at 30-day follow-up|4384
618669|NCT00305162|1517627|P1|COMPLETED|30-day Follow-up Period|intent-to-treat (ITT) completers at 30-day follow-up|4373
618670|NCT00305162|1517626|P2|Modified ITT (mITT): STEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|444
618671|NCT00305162|1517627|P1|Modified ITT (mITT): STEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|438
618672|NCT00305162|1517626|P2|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|3827
618673|NCT00305162|1517627|P1|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|3860
618674|NCT00305162|1517626|P2|Intent-to-treat (ITT): STEMI|30-day Follow-up Period|Completed through 30-days|501
618675|NCT00305162|1517627|P1|Intent-to-treat (ITT): STEMI|30-day Follow-up Period|Completed through 30-days|471
618676|NCT00305162|1517626|P2|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days|3883
618677|NCT00305162|1517627|P1|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days|3902
618678|NCT00305162|1517626|P2|STARTED|30-day Follow-up Period||4447
618679|NCT00305162|1517627|P1|STARTED|30-day Follow-up Period||4435
618680|NCT00305162|1517626|P2|NOT COMPLETED|48 Hour Follow-up Period||16
618681|NCT00305162|1517627|P1|NOT COMPLETED|48 Hour Follow-up Period||20
618682|NCT00305162|1517626|P2|COMPLETED|48 Hour Follow-up Period|intent-to-treat (ITT) completers at 48 hour follow-up|4431
618683|NCT00305162|1517627|P1|COMPLETED|48 Hour Follow-up Period|intent-to-treat (ITT) completers at 48 hour follow-up|4415
618684|NCT00305162|1517626|P2|Safety Population|48 Hour Follow-up Period|Patients who received at least 1 dose of study drug, according to the actual treatment received.|4365
618685|NCT00305162|1517627|P1|Safety Population|48 Hour Follow-up Period|Patients who received at least 1 dose of study drug, according to the actual treatment received.|4374
618686|NCT00305162|1517626|P2|Modified ITT (mITT): STEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|447
618687|NCT00305162|1517627|P1|Modified ITT (mITT): STEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|446
618688|NCT00305162|1517626|P2|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|3865
618689|NCT00305162|1517627|P1|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|3889
618690|NCT00305162|1517626|P2|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|507
618691|NCT00305162|1517627|P1|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|482
618692|NCT00305162|1517626|P2|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|3924
618693|NCT00305162|1517627|P1|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|3933
618694|NCT00305162|1517626|P2|STARTED|48 Hour Follow-up Period||4447
618695|NCT00305162|1517627|P1|STARTED|48 Hour Follow-up Period||4435
618696|NCT00304954|1517669|P4|NOT COMPLETED|Overall Study||0
618697|NCT00304954|1517670|P3|NOT COMPLETED|Overall Study||1
618698|NCT00304954|1517671|P2|NOT COMPLETED|Overall Study||0
618699|NCT00304954|1517672|P1|NOT COMPLETED|Overall Study||1
618700|NCT00304954|1517669|P4|COMPLETED|Overall Study||3
618701|NCT00304954|1517670|P3|COMPLETED|Overall Study||2
618702|NCT00304954|1517671|P2|COMPLETED|Overall Study||3
618703|NCT00304954|1517672|P1|COMPLETED|Overall Study||3
618704|NCT00304954|1517669|P4|STARTED|Overall Study||3
618705|NCT00304954|1517670|P3|STARTED|Overall Study||3
618706|NCT00304954|1517671|P2|STARTED|Overall Study||3
618707|NCT00304954|1517672|P1|STARTED|Overall Study||4
618708|NCT00304915|1517692|P2|NOT COMPLETED|Overall Study||16
618709|NCT00304915|1517693|P1|NOT COMPLETED|Overall Study||18
618710|NCT00304915|1517692|P2|COMPLETED|Overall Study||110
618711|NCT00304915|1517693|P1|COMPLETED|Overall Study||105
618712|NCT00304915|1517692|P2|STARTED|Overall Study||126
618713|NCT00304915|1517693|P1|STARTED|Overall Study||123
618714|NCT00304746|1517701|P2|NOT COMPLETED|Overall Study||0
618715|NCT00304746|1517702|P1|NOT COMPLETED|Overall Study||0
618716|NCT00304746|1517701|P2|COMPLETED|Overall Study||50
618717|NCT00304746|1517702|P1|COMPLETED|Overall Study||50
618718|NCT00304746|1517701|P2|STARTED|Overall Study||50
618719|NCT00304746|1517702|P1|STARTED|Overall Study||50
618720|NCT00304707|1517712|P2|NOT COMPLETED|Overall Study||6
618721|NCT00304707|1517713|P1|NOT COMPLETED|Overall Study||7
618722|NCT00304707|1517712|P2|COMPLETED|Overall Study||64
618723|NCT00304707|1517713|P1|COMPLETED|Overall Study||66
618724|NCT00304707|1517712|P2|STARTED|Overall Study||70
618725|NCT00304707|1517713|P1|STARTED|Overall Study||73
618726|NCT00304356|1517719|P1|NOT COMPLETED|Nitazoxanide||5
618727|NCT00304356|1517719|P1|COMPLETED|Nitazoxanide||22
618728|NCT00304356|1517719|P1|STARTED|Nitazoxanide||27
618729|NCT00304356|1517719|P1|NOT COMPLETED|Nitazoxanide||5
618730|NCT00304356|1517719|P1|COMPLETED|Nitazoxanide||22
618731|NCT00304356|1517719|P1|STARTED|Nitazoxanide||27
618732|NCT00304278|1517723|P1|NOT COMPLETED|Overall Study||2
618733|NCT00304278|1517723|P1|COMPLETED|Overall Study||19
618734|NCT00304278|1517723|P1|STARTED|Overall Study||21
618735|NCT00304265|1517730|P2|NOT COMPLETED|Overall Study||0
618736|NCT00304265|1517731|P1|NOT COMPLETED|Overall Study||0
618737|NCT00304265|1517730|P2|COMPLETED|Overall Study||98
618738|NCT00304265|1517731|P1|COMPLETED|Overall Study||117
618739|NCT00304265|1517730|P2|STARTED|Overall Study||98
618740|NCT00304265|1517731|P1|STARTED|Overall Study||117
618741|NCT00304187|1517739|P2|NOT COMPLETED|Overall Study||1
618742|NCT00304187|1517740|P1|NOT COMPLETED|Overall Study||2
618743|NCT00304187|1517739|P2|COMPLETED|Overall Study||13
618744|NCT00304187|1517740|P1|COMPLETED|Overall Study||13
618745|NCT00304187|1517739|P2|STARTED|Overall Study||14
618746|NCT00304187|1517740|P1|STARTED|Overall Study||15
618747|NCT00304161|1517748|P2|NOT COMPLETED|Overall Study||6
618748|NCT00304161|1517749|P1|NOT COMPLETED|Overall Study||6
618749|NCT00304161|1517748|P2|COMPLETED|Overall Study||21
618750|NCT00304161|1517749|P1|COMPLETED|Overall Study||22
618751|NCT00304161|1517748|P2|STARTED|Overall Study||27
618752|NCT00304161|1517749|P1|STARTED|Overall Study||28
618753|NCT00304096|1517759|P2|NOT COMPLETED|Overall Study||0
618754|NCT00304096|1517760|P1|NOT COMPLETED|Overall Study||0
618755|NCT00304096|1517759|P2|COMPLETED|Overall Study|6 patients enrolled, 1 not treated|5
618756|NCT00304096|1517760|P1|COMPLETED|Overall Study||6
618757|NCT00304096|1517759|P2|STARTED|Overall Study||5
618758|NCT00304096|1517760|P1|STARTED|Overall Study||6
618759|NCT00304083|1517770|P2|NOT COMPLETED|Overall Study||8
618760|NCT00304083|1517771|P1|NOT COMPLETED|Overall Study||22
618761|NCT00304083|1517770|P2|COMPLETED|Overall Study||6
618762|NCT00304083|1517771|P1|COMPLETED|Overall Study||12
618763|NCT00304083|1517770|P2|Completed 4 Cycles|Overall Study||7
618764|NCT00304083|1517771|P1|Completed 4 Cycles|Overall Study||22
618765|NCT00304083|1517770|P2|STARTED|Overall Study||14
618766|NCT00304083|1517771|P1|STARTED|Overall Study||34
618767|NCT00304070|1517779|P3|NOT COMPLETED|Overall Study||12
618768|NCT00304070|1517780|P2|NOT COMPLETED|Overall Study||7
618769|NCT00304070|1517781|P1|NOT COMPLETED|Overall Study||3
618770|NCT00304070|1517779|P3|COMPLETED|Overall Study||27
618771|NCT00304070|1517780|P2|COMPLETED|Overall Study||8
618772|NCT00304070|1517781|P1|COMPLETED|Overall Study||21
618773|NCT00304070|1517779|P3|STARTED|Overall Study||39
618774|NCT00304070|1517780|P2|STARTED|Overall Study||15
618775|NCT00304070|1517781|P1|STARTED|Overall Study||24
618776|NCT00304031|1517796|P3|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||2
618777|NCT00304031|1517797|P2|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0
618778|NCT00304031|1517798|P1|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0
618779|NCT00304031|1517796|P3|COMPLETED|Randomization to Adjuvant TMZ Arm|Subjects contributing data to the primary analysis are considered to have completed the study|420
618780|NCT00304031|1517797|P2|COMPLETED|Randomization to Adjuvant TMZ Arm|Subjects contributing data to the primary analysis are considered to have completed the study.|411
618781|NCT00304031|1517798|P1|COMPLETED|Randomization to Adjuvant TMZ Arm||0
618782|NCT00304031|1517796|P3|STARTED|Randomization to Adjuvant TMZ Arm|Patients who met requirements were randomized to an adjuvant TMZ arm after concomitant treatment.|422
618783|NCT00304031|1517797|P2|STARTED|Randomization to Adjuvant TMZ Arm|Patients who met requirements were randomized to an adjuvant TMZ arm after concomitant treatment.|411
618784|NCT00304031|1517798|P1|STARTED|Randomization to Adjuvant TMZ Arm|Patients who met requirements were randomized to an adjuvant TMZ arm after concomitant treatment.|0
618785|NCT00304031|1517796|P3|NOT COMPLETED|Concomitant Radiation Therapy and TMZ||0
618786|NCT00304031|1517797|P2|NOT COMPLETED|Concomitant Radiation Therapy and TMZ||0
618787|NCT00304031|1517798|P1|NOT COMPLETED|Concomitant Radiation Therapy and TMZ||292
618788|NCT00304031|1517796|P3|COMPLETED|Concomitant Radiation Therapy and TMZ||0
618789|NCT00304031|1517797|P2|COMPLETED|Concomitant Radiation Therapy and TMZ||0
618790|NCT00304031|1517798|P1|COMPLETED|Concomitant Radiation Therapy and TMZ|These patients successfully completed concomitant treatment and met requirements for randomization.|833
618791|NCT00304031|1517796|P3|STARTED|Concomitant Radiation Therapy and TMZ|Patients were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
618792|NCT00304031|1517797|P2|STARTED|Concomitant Radiation Therapy and TMZ|Patients were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
618793|NCT00304031|1517798|P1|STARTED|Concomitant Radiation Therapy and TMZ|All patients were registered to concomitant treatment; randomized after completing this treatment.|1125
618794|NCT00304031|1517796|P3|NOT COMPLETED|Registration||0
618795|NCT00304031|1517797|P2|NOT COMPLETED|Registration||0
618796|NCT00304031|1517798|P1|NOT COMPLETED|Registration||48
618797|NCT00304031|1517796|P3|COMPLETED|Registration||0
618798|NCT00304031|1517797|P2|COMPLETED|Registration||0
618799|NCT00304031|1517798|P1|COMPLETED|Registration|Patients determined to be ineligible after registration were excluded.|1125
618800|NCT00304031|1517796|P3|STARTED|Registration|Patients were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
618801|NCT00304031|1517797|P2|STARTED|Registration|Patients were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
618802|NCT00304031|1517798|P1|STARTED|Registration|All patients were registered to concomitant treatment; randomized after completing this treatment.|1173
618803|NCT00303979|1517808|P3|NOT COMPLETED|Single Time Point (18 Month)||0
618804|NCT00303979|1517809|P2|NOT COMPLETED|Single Time Point (18 Month)||0
618805|NCT00303979|1517810|P1|NOT COMPLETED|Single Time Point (18 Month)||0
618806|NCT00303979|1517808|P3|COMPLETED|Single Time Point (18 Month)||9641
618807|NCT00303979|1517809|P2|COMPLETED|Single Time Point (18 Month)||0
618808|NCT00303979|1517810|P1|COMPLETED|Single Time Point (18 Month)||0
618809|NCT00303979|1517808|P3|STARTED|Single Time Point (18 Month)||9641
618810|NCT00303979|1517809|P2|STARTED|Single Time Point (18 Month)||0
618811|NCT00303979|1517810|P1|STARTED|Single Time Point (18 Month)||0
618812|NCT00303979|1517808|P3|NOT COMPLETED|Single Time Point (6 Month)||0
618813|NCT00303979|1517809|P2|NOT COMPLETED|Single Time Point (6 Month)||0
618814|NCT00303979|1517810|P1|NOT COMPLETED|Single Time Point (6 Month)||0
618815|NCT00303979|1517808|P3|COMPLETED|Single Time Point (6 Month)||0
618816|NCT00303979|1517809|P2|COMPLETED|Single Time Point (6 Month)||9992
618817|NCT00303979|1517810|P1|COMPLETED|Single Time Point (6 Month)||0
618818|NCT00303979|1517808|P3|STARTED|Single Time Point (6 Month)||0
618819|NCT00303979|1517809|P2|STARTED|Single Time Point (6 Month)||9992
618820|NCT00303979|1517810|P1|STARTED|Single Time Point (6 Month)||0
618821|NCT00303979|1517808|P3|NOT COMPLETED|Longitudinal (Baseline, 12 and 24 Month)||0
618822|NCT00303979|1517809|P2|NOT COMPLETED|Longitudinal (Baseline, 12 and 24 Month)||0
618823|NCT00303979|1517810|P1|NOT COMPLETED|Longitudinal (Baseline, 12 and 24 Month)||7572
618824|NCT00303979|1517808|P3|COMPLETED|Longitudinal (Baseline, 12 and 24 Month)||0
618825|NCT00303979|1517809|P2|COMPLETED|Longitudinal (Baseline, 12 and 24 Month)||0
618826|NCT00303979|1517810|P1|COMPLETED|Longitudinal (Baseline, 12 and 24 Month)|at 24 Month|7605
618827|NCT00303979|1517808|P3|STARTED|Longitudinal (Baseline, 12 and 24 Month)||0
618828|NCT00303979|1517809|P2|STARTED|Longitudinal (Baseline, 12 and 24 Month)||0
618829|NCT00303979|1517810|P1|STARTED|Longitudinal (Baseline, 12 and 24 Month)|at Baseline|15177
618830|NCT00303966|1517820|P1|NOT COMPLETED|Overall Study||0
618831|NCT00303966|1517820|P1|COMPLETED|Overall Study||5
618832|NCT00303966|1517820|P1|STARTED|Overall Study||5
618833|NCT00303953|1517829|P1|NOT COMPLETED|Overall Study||19
618834|NCT00303953|1517829|P1|COMPLETED|Overall Study||3
618835|NCT00303953|1517829|P1|Eligible and Treated|Overall Study||20
618836|NCT00303953|1517829|P1|Eligible|Overall Study||21
618837|NCT00303953|1517829|P1|STARTED|Overall Study||22
618838|NCT00303901|1517835|P1|NOT COMPLETED|Overall Study||0
618839|NCT00303901|1517835|P1|COMPLETED|Overall Study||40
618840|NCT00303901|1517835|P1|STARTED|Overall Study||40
618841|NCT00303862|1517840|P1|NOT COMPLETED|Overall Study||0
618842|NCT00303862|1517840|P1|COMPLETED|Overall Study||10
618843|NCT00303862|1517840|P1|STARTED|Overall Study||10
618844|NCT00303823|1517849|P2|NOT COMPLETED|Overall Study||10
618845|NCT00303823|1517850|P1|NOT COMPLETED|Overall Study||15
618846|NCT00303823|1517849|P2|COMPLETED|Overall Study||38
618847|NCT00303823|1517850|P1|COMPLETED|Overall Study||35
618848|NCT00303823|1517849|P2|STARTED|Overall Study||48
618849|NCT00303823|1517850|P1|STARTED|Overall Study||50
618850|NCT00303667|1517864|P2|NOT COMPLETED|Overall Study||4
618851|NCT00303667|1517865|P1|NOT COMPLETED|Overall Study||0
618852|NCT00303667|1517864|P2|COMPLETED|Overall Study|Completed = remained alive and on study through Day 0 (day of transplant)|35
618853|NCT00303667|1517865|P1|COMPLETED|Overall Study||8
618854|NCT00303667|1517864|P2|STARTED|Overall Study||39
618855|NCT00303667|1517865|P1|STARTED|Overall Study||8
618856|NCT00303628|1517889|P2|NOT COMPLETED|Overall Study||73
618857|NCT00303628|1517890|P1|NOT COMPLETED|Overall Study||50
618858|NCT00303628|1517889|P2|COMPLETED|Overall Study||106
618859|NCT00303628|1517890|P1|COMPLETED|Overall Study||126
618860|NCT00303628|1517889|P2|Treated|Overall Study||174
618861|NCT00303628|1517890|P1|Treated|Overall Study||173
618862|NCT00303628|1517889|P2|Eligible|Overall Study||177
618863|NCT00303628|1517890|P1|Eligible|Overall Study||171
618864|NCT00303628|1517889|P2|STARTED|Overall Study||179
618865|NCT00303628|1517890|P1|STARTED|Overall Study||176
618866|NCT00303602|1517908|P2|NOT COMPLETED|Overall Study||15
618867|NCT00303602|1517909|P1|NOT COMPLETED|Overall Study||19
618868|NCT00303602|1517908|P2|COMPLETED|Overall Study||50
618869|NCT00303602|1517909|P1|COMPLETED|Overall Study||65
618870|NCT00303602|1517908|P2|STARTED|Overall Study||65
618871|NCT00303602|1517909|P1|STARTED|Overall Study||84
618872|NCT00303511|1517949|P1|NOT COMPLETED|Overall Study||0
618873|NCT00303511|1517949|P1|COMPLETED|Overall Study||10
618874|NCT00303511|1517949|P1|STARTED|Overall Study||10
618875|NCT00303485|1517955|P2|NOT COMPLETED|Overall Study||2
618876|NCT00303485|1517956|P1|NOT COMPLETED|Overall Study||1
618877|NCT00303485|1517955|P2|COMPLETED|Overall Study||15
618878|NCT00303485|1517956|P1|COMPLETED|Overall Study||48
618879|NCT00303485|1517955|P2|STARTED|Overall Study||17
618880|NCT00303485|1517956|P1|STARTED|Overall Study||49
618881|NCT00303472|1517987|P7|NOT COMPLETED|Treatment Extension (Optional)||0
618882|NCT00303472|1517988|P6|NOT COMPLETED|Treatment Extension (Optional)||1
618883|NCT00303472|1517989|P5|NOT COMPLETED|Treatment Extension (Optional)||4
618884|NCT00303472|1517990|P4|NOT COMPLETED|Treatment Extension (Optional)||8
618885|NCT00303472|1517991|P3|NOT COMPLETED|Treatment Extension (Optional)||9
618886|NCT00303472|1517992|P2|NOT COMPLETED|Treatment Extension (Optional)||6
618887|NCT00303472|1517993|P1|NOT COMPLETED|Treatment Extension (Optional)||5
618888|NCT00303472|1517987|P7|COMPLETED|Treatment Extension (Optional)||1
618889|NCT00303472|1517988|P6|COMPLETED|Treatment Extension (Optional)||4
618890|NCT00303472|1517989|P5|COMPLETED|Treatment Extension (Optional)||1
618891|NCT00303472|1517990|P4|COMPLETED|Treatment Extension (Optional)||5
618892|NCT00303472|1517991|P3|COMPLETED|Treatment Extension (Optional)||2
618893|NCT00303472|1517992|P2|COMPLETED|Treatment Extension (Optional)||5
618894|NCT00303472|1517993|P1|COMPLETED|Treatment Extension (Optional)||1
618895|NCT00303472|1517987|P7|STARTED|Treatment Extension (Optional)||1
618896|NCT00303472|1517988|P6|STARTED|Treatment Extension (Optional)||5
618897|NCT00303472|1517989|P5|STARTED|Treatment Extension (Optional)||5
618898|NCT00303472|1517990|P4|STARTED|Treatment Extension (Optional)||13
618899|NCT00303472|1517991|P3|STARTED|Treatment Extension (Optional)||11
618900|NCT00303472|1517992|P2|STARTED|Treatment Extension (Optional)||11
618901|NCT00303472|1517993|P1|STARTED|Treatment Extension (Optional)||6
618902|NCT00303472|1517987|P7|NOT COMPLETED|Treatment Period||2
618903|NCT00303472|1517988|P6|NOT COMPLETED|Treatment Period||1
618904|NCT00303472|1517989|P5|NOT COMPLETED|Treatment Period||3
618905|NCT00303472|1517990|P4|NOT COMPLETED|Treatment Period||2
618906|NCT00303472|1517991|P3|NOT COMPLETED|Treatment Period||0
618907|NCT00303472|1517992|P2|NOT COMPLETED|Treatment Period||0
618908|NCT00303472|1517993|P1|NOT COMPLETED|Treatment Period||0
618909|NCT00303472|1517987|P7|COMPLETED|Treatment Period||3
618910|NCT00303472|1517988|P6|COMPLETED|Treatment Period||11
618911|NCT00303472|1517989|P5|COMPLETED|Treatment Period||8
618912|NCT00303472|1517990|P4|COMPLETED|Treatment Period||14
618913|NCT00303472|1517991|P3|COMPLETED|Treatment Period||11
618914|NCT00303472|1517992|P2|COMPLETED|Treatment Period||11
618915|NCT00303472|1517993|P1|COMPLETED|Treatment Period||6
618916|NCT00303472|1517987|P7|STARTED|Treatment Period||5
618917|NCT00303472|1517988|P6|STARTED|Treatment Period||12
618918|NCT00303472|1517989|P5|STARTED|Treatment Period||11
618919|NCT00303472|1517990|P4|STARTED|Treatment Period||16
618920|NCT00303472|1517991|P3|STARTED|Treatment Period||11
618921|NCT00303472|1517992|P2|STARTED|Treatment Period||11
618922|NCT00303472|1517993|P1|STARTED|Treatment Period||6
618923|NCT00303459|1518053|P2|NOT COMPLETED|Overall Study||89
618924|NCT00303459|1518054|P1|NOT COMPLETED|Overall Study||83
618925|NCT00303459|1518053|P2|COMPLETED|Overall Study||86
618926|NCT00303459|1518054|P1|COMPLETED|Overall Study||76
618927|NCT00303459|1518053|P2|STARTED|Overall Study|One subject randomized to placebo did not receive study treatment|175
618928|NCT00303459|1518054|P1|STARTED|Overall Study||159
618929|NCT00303446|1518080|P2|NOT COMPLETED|Overall Study||4
618930|NCT00303446|1518081|P1|NOT COMPLETED|Overall Study||2
618931|NCT00303446|1518080|P2|COMPLETED|Overall Study||21
618932|NCT00303446|1518081|P1|COMPLETED|Overall Study||23
618933|NCT00303446|1518080|P2|STARTED|Overall Study||25
618934|NCT00303446|1518081|P1|STARTED|Overall Study||25
618935|NCT00303329|1518117|P2|NOT COMPLETED|Overall Study||62
618936|NCT00303329|1518118|P1|NOT COMPLETED|Overall Study||35
618937|NCT00303329|1518117|P2|COMPLETED|Overall Study||37
618938|NCT00303329|1518118|P1|COMPLETED|Overall Study||50
618939|NCT00303329|1518117|P2|STARTED|Overall Study||99
618940|NCT00303329|1518118|P1|STARTED|Overall Study||85
618941|NCT00303316|1518132|P2|NOT COMPLETED|Overall Study||3
618942|NCT00303316|1518133|P1|NOT COMPLETED|Overall Study||2
618943|NCT00303316|1518132|P2|COMPLETED|Overall Study||223
618944|NCT00303316|1518133|P1|COMPLETED|Overall Study||230
618945|NCT00303316|1518132|P2|STARTED|Overall Study||226
618946|NCT00303316|1518133|P1|STARTED|Overall Study||232
618947|NCT00303186|1518145|P1|NOT COMPLETED|Overall Study||52
618948|NCT00303186|1518145|P1|COMPLETED|Overall Study||55
618949|NCT00303186|1518145|P1|STARTED|Overall Study||107
618950|NCT00303108|1518179|P3|NOT COMPLETED|Overall Study||16
618951|NCT00303108|1518180|P2|NOT COMPLETED|Overall Study||9
618952|NCT00303108|1518181|P1|NOT COMPLETED|Overall Study||12
618953|NCT00303108|1518179|P3|COMPLETED|Overall Study||31
618954|NCT00303108|1518180|P2|COMPLETED|Overall Study||37
618955|NCT00303108|1518181|P1|COMPLETED|Overall Study||31
618956|NCT00303108|1518179|P3|STARTED|Overall Study||47
618957|NCT00303108|1518180|P2|STARTED|Overall Study||46
618958|NCT00303108|1518181|P1|STARTED|Overall Study||43
618959|NCT00303069|1518201|P4|NOT COMPLETED|Overall Study||2
618960|NCT00303069|1518202|P3|NOT COMPLETED|Overall Study||1
618961|NCT00303069|1518203|P2|NOT COMPLETED|Overall Study||0
618962|NCT00303069|1518204|P1|NOT COMPLETED|Overall Study||2
618963|NCT00303069|1518201|P4|COMPLETED|Overall Study||29
618964|NCT00303069|1518202|P3|COMPLETED|Overall Study||33
618965|NCT00303069|1518203|P2|COMPLETED|Overall Study||28
618966|NCT00303069|1518204|P1|COMPLETED|Overall Study||29
618967|NCT00303069|1518201|P4|STARTED|Overall Study||31
618968|NCT00303069|1518202|P3|STARTED|Overall Study||34
618969|NCT00303069|1518203|P2|STARTED|Overall Study||28
618970|NCT00303069|1518204|P1|STARTED|Overall Study||31
618971|NCT00302952|1518224|P2|NOT COMPLETED|Overall Study||5
618972|NCT00302952|1518225|P1|NOT COMPLETED|Overall Study||3
618973|NCT00302952|1518224|P2|COMPLETED|Overall Study||25
618974|NCT00302952|1518225|P1|COMPLETED|Overall Study||31
618975|NCT00302952|1518224|P2|Completed Intent-to-Treat (ITT)|Overall Study|One participant did not have a baseline C-reactive Protein and was excluded from the ITT population.|29
618976|NCT00302952|1518225|P1|Completed Intent-to-Treat (ITT)|Overall Study||34
618977|NCT00302952|1518224|P2|Started Intent-to-Treat (ITT)|Overall Study||30
618978|NCT00302952|1518225|P1|Started Intent-to-Treat (ITT)|Overall Study||34
618979|NCT00302952|1518224|P2|STARTED|Overall Study||30
618980|NCT00302952|1518225|P1|STARTED|Overall Study||34
618981|NCT00302848|1518262|P3|NOT COMPLETED|Overall Study||579
618982|NCT00302848|1518263|P2|NOT COMPLETED|Overall Study||419
618983|NCT00302848|1518264|P1|NOT COMPLETED|Overall Study||401
618984|NCT00302848|1518262|P3|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|25762
618985|NCT00302848|1518263|P2|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|15009
618986|NCT00302848|1518264|P1|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|16133
618987|NCT00302848|1518262|P3|STARTED|Overall Study||26341
618988|NCT00302848|1518263|P2|STARTED|Overall Study||15428
618989|NCT00302848|1518264|P1|STARTED|Overall Study||16534
618990|NCT00302731|1518275|P4|NOT COMPLETED|Overall Study||0
618991|NCT00302731|1518276|P3|NOT COMPLETED|Overall Study||3
618992|NCT00302731|1518277|P2|NOT COMPLETED|Overall Study||5
618993|NCT00302731|1518278|P1|NOT COMPLETED|Overall Study||4
618994|NCT00302731|1518275|P4|COMPLETED|Overall Study||4
618995|NCT00302731|1518276|P3|COMPLETED|Overall Study||2
618996|NCT00302731|1518277|P2|COMPLETED|Overall Study||1
618997|NCT00302731|1518278|P1|COMPLETED|Overall Study||2
618998|NCT00302731|1518275|P4|STARTED|Overall Study||4
618999|NCT00302731|1518276|P3|STARTED|Overall Study||5
619000|NCT00302731|1518277|P2|STARTED|Overall Study||6
619001|NCT00302731|1518278|P1|STARTED|Overall Study||6
619002|NCT00302718|1518304|P4|NOT COMPLETED|Overall Study||2
619003|NCT00302718|1518305|P3|NOT COMPLETED|Overall Study||2
619004|NCT00302718|1518306|P2|NOT COMPLETED|Overall Study||1
619005|NCT00302718|1518307|P1|NOT COMPLETED|Overall Study||1
619006|NCT00302718|1518304|P4|COMPLETED|Overall Study||19
619007|NCT00302718|1518305|P3|COMPLETED|Overall Study||19
619008|NCT00302718|1518306|P2|COMPLETED|Overall Study||20
619009|NCT00302718|1518307|P1|COMPLETED|Overall Study||19
619010|NCT00302718|1518304|P4|STARTED|Overall Study||21
619011|NCT00302718|1518305|P3|STARTED|Overall Study||21
619012|NCT00302718|1518306|P2|STARTED|Overall Study||21
619013|NCT00302718|1518307|P1|STARTED|Overall Study||20
619014|NCT00302458|1518339|P1|NOT COMPLETED|Overall Study||3
619015|NCT00302458|1518339|P1|COMPLETED|Overall Study||26
619016|NCT00302458|1518339|P1|STARTED|Overall Study||29
619017|NCT00302328|1518350|P3|NOT COMPLETED|Overall Study||0
619018|NCT00302328|1518351|P2|NOT COMPLETED|Overall Study||1
619019|NCT00302328|1518352|P1|NOT COMPLETED|Overall Study||0
619020|NCT00302328|1518350|P3|COMPLETED|Overall Study||18
619021|NCT00302328|1518351|P2|COMPLETED|Overall Study|developed cancer during the study|34
619022|NCT00302328|1518352|P1|COMPLETED|Overall Study||25
619023|NCT00302328|1518350|P3|STARTED|Overall Study||18
619024|NCT00302328|1518351|P2|STARTED|Overall Study||35
619025|NCT00302328|1518352|P1|STARTED|Overall Study||25
619026|NCT00302211|1518369|P5|NOT COMPLETED|Open Label-Patients From Double-Blind||8
619027|NCT00302211|1518370|P4|NOT COMPLETED|Open Label-Patients From Double-Blind||8
619028|NCT00302211|1518371|P3|NOT COMPLETED|Open Label-Patients From Double-Blind||0
619029|NCT00302211|1518372|P2|NOT COMPLETED|Open Label-Patients From Double-Blind||0
619030|NCT00302211|1518373|P1|NOT COMPLETED|Open Label-Patients From Double-Blind||0
619031|NCT00302211|1518369|P5|COMPLETED|Open Label-Patients From Double-Blind||24
619032|NCT00302211|1518370|P4|COMPLETED|Open Label-Patients From Double-Blind||18
619033|NCT00302211|1518371|P3|COMPLETED|Open Label-Patients From Double-Blind||0
619034|NCT00302211|1518372|P2|COMPLETED|Open Label-Patients From Double-Blind||0
619035|NCT00302211|1518373|P1|COMPLETED|Open Label-Patients From Double-Blind||0
619036|NCT00302211|1518369|P5|STARTED|Open Label-Patients From Double-Blind|26 pts in 4x/day + placebo 2x/day DB phase & 6 pts in placebo 6x/day DB phase enrolled in OL 4x/day|32
619037|NCT00302211|1518370|P4|STARTED|Open Label-Patients From Double-Blind|21 patients (pts) in 6x/day DB phase & 5 patients in placebo 6x/day DB phase enrolled in OL 6x/day|26
619038|NCT00302211|1518371|P3|STARTED|Open Label-Patients From Double-Blind||0
619039|NCT00302211|1518372|P2|STARTED|Open Label-Patients From Double-Blind||0
619040|NCT00302211|1518373|P1|STARTED|Open Label-Patients From Double-Blind||0
619041|NCT00302211|1518369|P5|NOT COMPLETED|Double Blind Period (New Patients)||0
619042|NCT00302211|1518370|P4|NOT COMPLETED|Double Blind Period (New Patients)||0
619043|NCT00302211|1518371|P3|NOT COMPLETED|Double Blind Period (New Patients)||4
619044|NCT00302211|1518372|P2|NOT COMPLETED|Double Blind Period (New Patients)||2
619045|NCT00302211|1518373|P1|NOT COMPLETED|Double Blind Period (New Patients)||3
619046|NCT00302211|1518369|P5|COMPLETED|Double Blind Period (New Patients)||0
619047|NCT00302211|1518370|P4|COMPLETED|Double Blind Period (New Patients)||0
619048|NCT00302211|1518371|P3|COMPLETED|Double Blind Period (New Patients)||10
619049|NCT00302211|1518372|P2|COMPLETED|Double Blind Period (New Patients)||25
619050|NCT00302211|1518373|P1|COMPLETED|Double Blind Period (New Patients)||23
619051|NCT00302211|1518369|P5|STARTED|Double Blind Period (New Patients)||0
619052|NCT00302211|1518370|P4|STARTED|Double Blind Period (New Patients)||0
619053|NCT00302211|1518371|P3|STARTED|Double Blind Period (New Patients)|placebo plus sildenafil with or without bosentan|14
619054|NCT00302211|1518372|P2|STARTED|Double Blind Period (New Patients)|iloprost 4x/day plus sildenafil with or without bosentan|27
619055|NCT00302211|1518373|P1|STARTED|Double Blind Period (New Patients)|iloprost 6x/day plus sildenafil with or without bosentan|26
619056|NCT00302159|1518385|P1|NOT COMPLETED|Overall Study||2
619057|NCT00302159|1518385|P1|COMPLETED|Overall Study||41
619058|NCT00302159|1518385|P1|STARTED|Overall Study||43
619059|NCT00302133|1518396|P2|NOT COMPLETED|Overall Study||4
619060|NCT00302133|1518397|P1|NOT COMPLETED|Overall Study||4
619061|NCT00302133|1518396|P2|COMPLETED|Overall Study||5
619062|NCT00302133|1518397|P1|COMPLETED|Overall Study||5
619063|NCT00302133|1518396|P2|STARTED|Overall Study||9
619064|NCT00302133|1518397|P1|STARTED|Overall Study||9
619065|NCT00302107|1518407|P2|NOT COMPLETED|Overall Study||9
619066|NCT00302107|1518408|P1|NOT COMPLETED|Overall Study||8
619067|NCT00302107|1518407|P2|COMPLETED|Overall Study||30
619068|NCT00302107|1518408|P1|COMPLETED|Overall Study||31
619069|NCT00302107|1518407|P2|STARTED|Overall Study||39
619070|NCT00302107|1518408|P1|STARTED|Overall Study||39
619071|NCT00302081|1518417|P3|NOT COMPLETED|Overall Study||52
619072|NCT00302081|1518418|P2|NOT COMPLETED|Overall Study||43
619073|NCT00302081|1518419|P1|NOT COMPLETED|Overall Study||56
619074|NCT00302081|1518417|P3|COMPLETED|Overall Study||178
619075|NCT00302081|1518418|P2|COMPLETED|Overall Study||186
619076|NCT00302081|1518419|P1|COMPLETED|Overall Study||181
619077|NCT00302081|1518417|P3|STARTED|Overall Study||230
619078|NCT00302081|1518418|P2|STARTED|Overall Study||229
619079|NCT00302081|1518419|P1|STARTED|Overall Study||237
619080|NCT00302068|1518430|P3|NOT COMPLETED|Overall Study||1
619081|NCT00302068|1518431|P2|NOT COMPLETED|Overall Study||4
619082|NCT00302068|1518432|P1|NOT COMPLETED|Overall Study||1
619083|NCT00302068|1518430|P3|COMPLETED|Overall Study||23
619084|NCT00302068|1518431|P2|COMPLETED|Overall Study||36
619085|NCT00302068|1518432|P1|COMPLETED|Overall Study||36
619086|NCT00302068|1518430|P3|STARTED|Overall Study||24
619087|NCT00302068|1518431|P2|STARTED|Overall Study||40
619088|NCT00302068|1518432|P1|STARTED|Overall Study||37
619089|NCT00302055|1518460|P2|NOT COMPLETED|Overall Study||13
619090|NCT00302055|1518461|P1|NOT COMPLETED|Overall Study||9
619091|NCT00302055|1518460|P2|COMPLETED|Overall Study||36
619092|NCT00302055|1518461|P1|COMPLETED|Overall Study||14
619093|NCT00302055|1518460|P2|STARTED|Overall Study||49
619094|NCT00302055|1518461|P1|STARTED|Overall Study||23
619095|NCT00302042|1518469|P2|NOT COMPLETED|Overall Study||8
619096|NCT00302042|1518470|P1|NOT COMPLETED|Overall Study||7
619097|NCT00302042|1518469|P2|COMPLETED|Overall Study||38
619098|NCT00302042|1518470|P1|COMPLETED|Overall Study||39
619099|NCT00302042|1518469|P2|STARTED|Overall Study||46
619100|NCT00302042|1518470|P1|STARTED|Overall Study||46
619101|NCT00302003|1518476|P1|NOT COMPLETED|Overall Study||80
619102|NCT00302003|1518476|P1|COMPLETED|Overall Study||207
619103|NCT00302003|1518476|P1|STARTED|Overall Study||287
619104|NCT00301964|1518483|P1|NOT COMPLETED|Overall Study||4
619105|NCT00301964|1518483|P1|COMPLETED|Overall Study|Total number of eligible and evaluable participants|52
619106|NCT00301964|1518483|P1|STARTED|Overall Study||56
619107|NCT00301873|1518498|P1|NOT COMPLETED|Overall Study||0
619108|NCT00301873|1518498|P1|COMPLETED|Overall Study||59
619109|NCT00301873|1518498|P1|STARTED|Overall Study||59
619110|NCT00301834|1518504|P1|NOT COMPLETED|Overall Study||1
619111|NCT00301834|1518504|P1|COMPLETED|Overall Study||34
619112|NCT00301834|1518504|P1|STARTED|Overall Study||35
619113|NCT00301821|1518513|P1|NOT COMPLETED|Overall Study||26
619114|NCT00301821|1518513|P1|COMPLETED|Overall Study||81
619115|NCT00301821|1518513|P1|STARTED|Overall Study||107
619116|NCT00301808|1518520|P1|NOT COMPLETED|Overall Study||12
619117|NCT00301808|1518520|P1|COMPLETED|Overall Study||17
619118|NCT00301808|1518520|P1|STARTED|Overall Study||29
619119|NCT00301756|1518527|P1|NOT COMPLETED|Overall Study||0
619120|NCT00301756|1518527|P1|COMPLETED|Overall Study||32
619121|NCT00301756|1518527|P1|STARTED|Overall Study||32
619122|NCT00301418|1518536|P1|NOT COMPLETED|Overall Study||0
619123|NCT00301418|1518536|P1|COMPLETED|Overall Study||11
619124|NCT00301418|1518536|P1|STARTED|Overall Study||11
619125|NCT00301366|1518542|P1|NOT COMPLETED|Overall Study||1
619126|NCT00301366|1518542|P1|COMPLETED|Overall Study||37
619127|NCT00301366|1518542|P1|STARTED|Overall Study||38
619128|NCT00301262|1518548|P2|NOT COMPLETED|Open Label Phase (OL)||2
619129|NCT00301262|1518549|P1|NOT COMPLETED|Open Label Phase (OL)||4
619130|NCT00301262|1518548|P2|COMPLETED|Open Label Phase (OL)||67
619131|NCT00301262|1518549|P1|COMPLETED|Open Label Phase (OL)||79
619132|NCT00301262|1518548|P2|STARTED|Open Label Phase (OL)||69
619133|NCT00301262|1518549|P1|STARTED|Open Label Phase (OL)||83
619134|NCT00301262|1518548|P2|NOT COMPLETED|Double Blind Phase (DB)||13
619135|NCT00301262|1518549|P1|NOT COMPLETED|Double Blind Phase (DB)||10
619136|NCT00301262|1518548|P2|COMPLETED|Double Blind Phase (DB)||69
619137|NCT00301262|1518549|P1|COMPLETED|Double Blind Phase (DB)||84
619138|NCT00301262|1518548|P2|STARTED|Double Blind Phase (DB)||82
619139|NCT00301262|1518549|P1|STARTED|Double Blind Phase (DB)||94
619140|NCT00301080|1518707|P5|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
619141|NCT00301080|1518708|P4|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
619142|NCT00301080|1518709|P3|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
619143|NCT00301080|1518710|P2|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
619144|NCT00301080|1518711|P1|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
619145|NCT00301080|1518707|P5|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
619146|NCT00301080|1518708|P4|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
619147|NCT00301080|1518709|P3|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
619148|NCT00301080|1518710|P2|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
619149|NCT00301080|1518711|P1|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
619150|NCT00301080|1518707|P5|STARTED|Revised Version (3 Arms & 12 Weeks)||0
619151|NCT00301080|1518708|P4|STARTED|Revised Version (3 Arms & 12 Weeks)||0
619152|NCT00301080|1518709|P3|STARTED|Revised Version (3 Arms & 12 Weeks)||0
619153|NCT00301080|1518710|P2|STARTED|Revised Version (3 Arms & 12 Weeks)|This arm was not a part of the revised study design.|0
619154|NCT00301080|1518711|P1|STARTED|Revised Version (3 Arms & 12 Weeks)|This arm was not a part of the revised study design.|0
619155|NCT00301080|1518707|P5|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
619156|NCT00301080|1518708|P4|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
619157|NCT00301080|1518709|P3|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
619158|NCT00301080|1518710|P2|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
619159|NCT00301080|1518711|P1|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||1
619160|NCT00301080|1518707|P5|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
619161|NCT00301080|1518708|P4|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
619162|NCT00301080|1518709|P3|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
619163|NCT00301080|1518710|P2|COMPLETED|Original Version (2 Arms & 4 Weeks)||3
619164|NCT00301080|1518711|P1|COMPLETED|Original Version (2 Arms & 4 Weeks)||3
619165|NCT00301080|1518707|P5|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
619166|NCT00301080|1518708|P4|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
619167|NCT00301080|1518709|P3|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
619168|NCT00301080|1518710|P2|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3
619169|NCT00301080|1518711|P1|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3
619170|NCT00301080|1518707|P5|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
619171|NCT00301080|1518708|P4|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
619172|NCT00301080|1518709|P3|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
619173|NCT00301080|1518710|P2|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3
619174|NCT00301080|1518711|P1|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3
619175|NCT00301080|1518707|P5|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
619176|NCT00301080|1518708|P4|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
619177|NCT00301080|1518709|P3|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
619178|NCT00301080|1518710|P2|STARTED|Original Version (2 Arms & 4 Weeks)||3
619179|NCT00301080|1518711|P1|STARTED|Original Version (2 Arms & 4 Weeks)||4
619180|NCT00301028|1518740|P1|NOT COMPLETED|Overall Study||0
619181|NCT00301028|1518740|P1|COMPLETED|Overall Study||47
619182|NCT00301028|1518740|P1|STARTED|Overall Study||47
619183|NCT00300885|1518746|P2|NOT COMPLETED|Follow-up||195
619184|NCT00300885|1518747|P1|NOT COMPLETED|Follow-up||178
619185|NCT00300885|1518746|P2|COMPLETED|Follow-up|Subjects still in Follow up period at data cut-off date.|174
619186|NCT00300885|1518747|P1|COMPLETED|Follow-up|Subjects still in Follow up period at data cut-off date.|176
619187|NCT00300885|1518746|P2|STARTED|Follow-up|Subjects entered Follow-up period after termination of Treatment period due to any reason.|369
619188|NCT00300885|1518747|P1|STARTED|Follow-up|Subjects entered Follow-up period after termination of Treatment period due to any reason.|354
619189|NCT00300885|1518746|P2|NOT COMPLETED|Treatment||374
619190|NCT00300885|1518747|P1|NOT COMPLETED|Treatment||373
619191|NCT00300885|1518746|P2|COMPLETED|Treatment||88
619192|NCT00300885|1518747|P1|COMPLETED|Treatment||91
619193|NCT00300885|1518746|P2|Received Treatment|Treatment||459
619194|NCT00300885|1518747|P1|Received Treatment|Treatment||463
619195|NCT00300885|1518746|P2|STARTED|Treatment|ongoing in double -blind treatment at data cut-off|462
619196|NCT00300885|1518747|P1|STARTED|Treatment||464
619197|NCT00300781|1518765|P2|NOT COMPLETED|Overall Study||62
619198|NCT00300781|1518766|P1|NOT COMPLETED|Overall Study||63
619199|NCT00300781|1518765|P2|COMPLETED|Overall Study||8
619200|NCT00300781|1518766|P1|COMPLETED|Overall Study||3
619201|NCT00300781|1518765|P2|STARTED|Overall Study||70
619202|NCT00300781|1518766|P1|STARTED|Overall Study||66
619203|NCT00300755|1518781|P3|NOT COMPLETED|Overall Study||2
619204|NCT00300755|1518782|P2|NOT COMPLETED|Overall Study||4
619205|NCT00300755|1518783|P1|NOT COMPLETED|Overall Study||1
619206|NCT00300755|1518781|P3|COMPLETED|Overall Study||19
619207|NCT00300755|1518782|P2|COMPLETED|Overall Study||17
619208|NCT00300755|1518783|P1|COMPLETED|Overall Study||17
619209|NCT00300755|1518781|P3|STARTED|Overall Study||21
619210|NCT00300755|1518782|P2|STARTED|Overall Study||21
619211|NCT00300755|1518783|P1|STARTED|Overall Study||18
619212|NCT00300742|1518800|P1|NOT COMPLETED|Overall Study||2
619213|NCT00300742|1518800|P1|COMPLETED|Overall Study||3
619214|NCT00300742|1518800|P1|STARTED|Overall Study||5
619215|NCT00300677|1518808|P1|NOT COMPLETED|Overall Study||0
619216|NCT00300677|1518808|P1|COMPLETED|Overall Study||12
619217|NCT00300677|1518808|P1|STARTED|Overall Study||12
619218|NCT00300495|1518817|P2|NOT COMPLETED|Overall Study||1
619219|NCT00300495|1518818|P1|NOT COMPLETED|Overall Study||4
619220|NCT00300495|1518817|P2|COMPLETED|Overall Study||8
619221|NCT00300495|1518818|P1|COMPLETED|Overall Study||6
619222|NCT00300495|1518817|P2|STARTED|Overall Study||9
619223|NCT00300495|1518818|P1|STARTED|Overall Study||10
619224|NCT00300482|1518832|P6|NOT COMPLETED|Overall Study||16
619225|NCT00300482|1518833|P5|NOT COMPLETED|Overall Study||23
619226|NCT00300482|1518834|P4|NOT COMPLETED|Overall Study||24
619227|NCT00300482|1518835|P3|NOT COMPLETED|Overall Study||51
619228|NCT00300482|1518836|P2|NOT COMPLETED|Overall Study||41
619229|NCT00300482|1518837|P1|NOT COMPLETED|Overall Study||41
619230|NCT00300482|1518832|P6|COMPLETED|Overall Study||115
619231|NCT00300482|1518833|P5|COMPLETED|Overall Study||243
619232|NCT00300482|1518834|P4|COMPLETED|Overall Study||237
619233|NCT00300482|1518835|P3|COMPLETED|Overall Study||208
619234|NCT00300482|1518836|P2|COMPLETED|Overall Study||220
619235|NCT00300482|1518837|P1|COMPLETED|Overall Study||220
619236|NCT00300482|1518832|P6|STARTED|Overall Study||131
619237|NCT00300482|1518833|P5|STARTED|Overall Study||266
619238|NCT00300482|1518834|P4|STARTED|Overall Study||261
619239|NCT00300482|1518835|P3|STARTED|Overall Study||259
619240|NCT00300482|1518836|P2|STARTED|Overall Study||261
619241|NCT00300482|1518837|P1|STARTED|Overall Study|"For all arms, started means treated."|261
619242|NCT00300469|1518899|P6|NOT COMPLETED|Overall Study||9
619243|NCT00300469|1518900|P5|NOT COMPLETED|Overall Study||14
619244|NCT00300469|1518901|P4|NOT COMPLETED|Overall Study||9
619245|NCT00300469|1518902|P3|NOT COMPLETED|Overall Study||17
619246|NCT00300469|1518903|P2|NOT COMPLETED|Overall Study||21
619247|NCT00300469|1518904|P1|NOT COMPLETED|Overall Study||21
619248|NCT00300469|1518899|P6|COMPLETED|Overall Study||46
619249|NCT00300469|1518900|P5|COMPLETED|Overall Study||95
619250|NCT00300469|1518901|P4|COMPLETED|Overall Study||104
619251|NCT00300469|1518902|P3|COMPLETED|Overall Study||95
619252|NCT00300469|1518903|P2|COMPLETED|Overall Study||89
619253|NCT00300469|1518904|P1|COMPLETED|Overall Study||89
619254|NCT00300469|1518899|P6|STARTED|Overall Study||55
619255|NCT00300469|1518900|P5|STARTED|Overall Study||109
619256|NCT00300469|1518901|P4|STARTED|Overall Study||113
619257|NCT00300469|1518902|P3|STARTED|Overall Study||112
619258|NCT00300469|1518903|P2|STARTED|Overall Study||110
619259|NCT00300469|1518904|P1|STARTED|Overall Study|"For all arms, started means treated."|110
619260|NCT00300456|1518966|P6|NOT COMPLETED|Overall Study||11
619261|NCT00300456|1518967|P5|NOT COMPLETED|Overall Study||17
619262|NCT00300456|1518968|P4|NOT COMPLETED|Overall Study||14
619263|NCT00300456|1518969|P3|NOT COMPLETED|Overall Study||21
619264|NCT00300456|1518970|P2|NOT COMPLETED|Overall Study||16
619265|NCT00300456|1518971|P1|NOT COMPLETED|Overall Study||16
619266|NCT00300456|1518966|P6|COMPLETED|Overall Study||48
619267|NCT00300456|1518967|P5|COMPLETED|Overall Study||99
619268|NCT00300456|1518968|P4|COMPLETED|Overall Study||105
619269|NCT00300456|1518969|P3|COMPLETED|Overall Study||98
619270|NCT00300456|1518970|P2|COMPLETED|Overall Study||102
619271|NCT00300456|1518971|P1|COMPLETED|Overall Study||103
619272|NCT00300456|1518966|P6|STARTED|Overall Study||59
619273|NCT00300456|1518967|P5|STARTED|Overall Study||116
619274|NCT00300456|1518968|P4|STARTED|Overall Study||119
619275|NCT00300456|1518969|P3|STARTED|Overall Study||119
619276|NCT00300456|1518970|P2|STARTED|Overall Study||118
619277|NCT00300456|1518971|P1|STARTED|Overall Study|"For all arms, started means treated."|119
619278|NCT00300430|1519030|P3|NOT COMPLETED|Overall Study||151
619279|NCT00300430|1519031|P2|NOT COMPLETED|Overall Study||169
619280|NCT00300430|1519032|P1|NOT COMPLETED|Overall Study||367
619281|NCT00300430|1519030|P3|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|350
619282|NCT00300430|1519031|P2|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|345
619283|NCT00300430|1519032|P1|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|819
619284|NCT00300430|1519030|P3|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|501
619285|NCT00300430|1519031|P2|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|514
619286|NCT00300430|1519032|P1|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|1186
619287|NCT00300391|1519066|P2|NOT COMPLETED|Overall Study||0
619288|NCT00300391|1519067|P1|NOT COMPLETED|Overall Study||0
619289|NCT00300391|1519066|P2|COMPLETED|Overall Study||14
619290|NCT00300391|1519067|P1|COMPLETED|Overall Study||16
619291|NCT00300391|1519066|P2|STARTED|Overall Study||14
619292|NCT00300391|1519067|P1|STARTED|Overall Study||16
619293|NCT00300365|1519085|P2|NOT COMPLETED|Overall Study||2
619294|NCT00300365|1519086|P1|NOT COMPLETED|Overall Study||4
619295|NCT00300365|1519085|P2|COMPLETED|Overall Study||38
619296|NCT00300365|1519086|P1|COMPLETED|Overall Study||34
619297|NCT00300365|1519085|P2|STARTED|Overall Study||40
619298|NCT00300365|1519086|P1|STARTED|Overall Study||38
619299|NCT00300274|1519095|P3|NOT COMPLETED|Overall Study||45
619300|NCT00300274|1519096|P2|NOT COMPLETED|Overall Study||27
619301|NCT00300274|1519097|P1|NOT COMPLETED|Overall Study||46
619302|NCT00300274|1519095|P3|COMPLETED|Overall Study||226
619303|NCT00300274|1519096|P2|COMPLETED|Overall Study||141
619304|NCT00300274|1519097|P1|COMPLETED|Overall Study||236
619305|NCT00300274|1519095|P3|Completed 12 Month|Overall Study||248
619306|NCT00300274|1519096|P2|Completed 12 Month|Overall Study||149
619307|NCT00300274|1519097|P1|Completed 12 Month|Overall Study||250
619308|NCT00300274|1519095|P3|STARTED|Overall Study||271
619309|NCT00300274|1519096|P2|STARTED|Overall Study||168
619310|NCT00300274|1519097|P1|STARTED|Overall Study||282
619311|NCT00300235|1519137|P5|NOT COMPLETED|Overall Study||0
619312|NCT00300235|1519138|P4|NOT COMPLETED|Overall Study||0
619313|NCT00300235|1519139|P3|NOT COMPLETED|Overall Study||0
619314|NCT00300235|1519140|P2|NOT COMPLETED|Overall Study||0
619315|NCT00300235|1519141|P1|NOT COMPLETED|Overall Study||0
619316|NCT00300235|1519137|P5|COMPLETED|Overall Study||251
619317|NCT00300235|1519138|P4|COMPLETED|Overall Study||362
619318|NCT00300235|1519139|P3|COMPLETED|Overall Study||398
619319|NCT00300235|1519140|P2|COMPLETED|Overall Study||240
619320|NCT00300235|1519141|P1|COMPLETED|Overall Study||208
619321|NCT00300235|1519137|P5|STARTED|Overall Study||251
619322|NCT00300235|1519138|P4|STARTED|Overall Study||362
619323|NCT00300235|1519139|P3|STARTED|Overall Study||398
619324|NCT00300235|1519140|P2|STARTED|Overall Study||240
619325|NCT00300235|1519141|P1|STARTED|Overall Study||208
619326|NCT00299975|1519156|P3|NOT COMPLETED|Overall Study||8
619327|NCT00299975|1519157|P2|NOT COMPLETED|Overall Study||1
619328|NCT00299975|1519158|P1|NOT COMPLETED|Overall Study||3
619329|NCT00299975|1519156|P3|COMPLETED|Overall Study||25
619330|NCT00299975|1519157|P2|COMPLETED|Overall Study||31
619331|NCT00299975|1519158|P1|COMPLETED|Overall Study||29
619332|NCT00299975|1519156|P3|Received Allocated Intervention|Overall Study||32
619333|NCT00299975|1519157|P2|Received Allocated Intervention|Overall Study||32
619334|NCT00299975|1519158|P1|Received Allocated Intervention|Overall Study||32
619335|NCT00299975|1519156|P3|STARTED|Overall Study||33
619336|NCT00299975|1519157|P2|STARTED|Overall Study||32
619337|NCT00299975|1519158|P1|STARTED|Overall Study||32
619338|NCT00299741|1519208|P1|NOT COMPLETED|Overall Study||0
619339|NCT00299741|1519208|P1|COMPLETED|Overall Study||36
619340|NCT00299741|1519208|P1|STARTED|Overall Study||36
619341|NCT00299702|1519215|P2|NOT COMPLETED|Overall Study||50
619342|NCT00299702|1519216|P1|NOT COMPLETED|Overall Study||53
619343|NCT00299702|1519215|P2|COMPLETED|Overall Study||126
619344|NCT00299702|1519216|P1|COMPLETED|Overall Study||126
619345|NCT00299702|1519215|P2|STARTED|Overall Study||176
619346|NCT00299702|1519216|P1|STARTED|Overall Study||179
619347|NCT00299689|1519224|P1|NOT COMPLETED|Overall Study||0
619348|NCT00299689|1519224|P1|COMPLETED|Overall Study||69
619349|NCT00299689|1519224|P1|STARTED|Overall Study||69
619350|NCT00299546|1519231|P3|NOT COMPLETED|Overall Study||86
619351|NCT00299546|1519232|P2|NOT COMPLETED|Overall Study||92
619352|NCT00299546|1519233|P1|NOT COMPLETED|Overall Study||100
619353|NCT00299546|1519231|P3|COMPLETED|Overall Study||67
619354|NCT00299546|1519232|P2|COMPLETED|Overall Study||61
619355|NCT00299546|1519233|P1|COMPLETED|Overall Study||55
619356|NCT00299546|1519231|P3|STARTED|Overall Study||153
619357|NCT00299546|1519232|P2|STARTED|Overall Study||153
619358|NCT00299546|1519233|P1|STARTED|Overall Study||155
619359|NCT00299494|1519264|P6|NOT COMPLETED|Overall Study||26
619360|NCT00299494|1519265|P5|NOT COMPLETED|Overall Study||27
619361|NCT00299494|1519266|P4|NOT COMPLETED|Overall Study||10
619362|NCT00299494|1519267|P3|NOT COMPLETED|Overall Study||4
619363|NCT00299494|1519268|P2|NOT COMPLETED|Overall Study||1
619364|NCT00299494|1519269|P1|NOT COMPLETED|Overall Study||3
619365|NCT00299494|1519264|P6|COMPLETED|Overall Study||4
619366|NCT00299494|1519265|P5|COMPLETED|Overall Study||13
619367|NCT00299494|1519266|P4|COMPLETED|Overall Study||24
619368|NCT00299494|1519267|P3|COMPLETED|Overall Study||3
619369|NCT00299494|1519268|P2|COMPLETED|Overall Study||2
619370|NCT00299494|1519269|P1|COMPLETED|Overall Study||2
619371|NCT00299494|1519264|P6|STARTED|Overall Study||30
619372|NCT00299494|1519265|P5|STARTED|Overall Study|1 participant received rituximab only, and did not receive inotuzumab ozogamicin|40
619373|NCT00299494|1519266|P4|STARTED|Overall Study||34
619374|NCT00299494|1519267|P3|STARTED|Overall Study||7
619375|NCT00299494|1519268|P2|STARTED|Overall Study||3
619376|NCT00299494|1519269|P1|STARTED|Overall Study||5
619377|NCT00299416|1519372|P1|NOT COMPLETED|Overall Study||0
619378|NCT00299416|1519372|P1|COMPLETED|Overall Study||30
619379|NCT00299416|1519372|P1|STARTED|Overall Study||30
619380|NCT00299221|1519380|P2|NOT COMPLETED|Overall Study||0
619381|NCT00299221|1519381|P1|NOT COMPLETED|Overall Study||0
619382|NCT00299221|1519380|P2|COMPLETED|Overall Study||71
619383|NCT00299221|1519381|P1|COMPLETED|Overall Study||79
619384|NCT00299221|1519380|P2|STARTED|Overall Study||71
619385|NCT00299221|1519381|P1|STARTED|Overall Study||79
619386|NCT00299156|1519398|P3|NOT COMPLETED|Period 2 (Randomized)||0
619387|NCT00299156|1519399|P2|NOT COMPLETED|Period 2 (Randomized)||1
619388|NCT00299156|1519400|P1|NOT COMPLETED|Period 2 (Randomized)||0
619389|NCT00299156|1519398|P3|COMPLETED|Period 2 (Randomized)||16
619390|NCT00299156|1519399|P2|COMPLETED|Period 2 (Randomized)||16
619391|NCT00299156|1519400|P1|COMPLETED|Period 2 (Randomized)||0
619392|NCT00299156|1519398|P3|STARTED|Period 2 (Randomized)||16
619393|NCT00299156|1519399|P2|STARTED|Period 2 (Randomized)||17
619394|NCT00299156|1519400|P1|STARTED|Period 2 (Randomized)||0
619395|NCT00299156|1519398|P3|NOT COMPLETED|Period 1 (Non-Randomized)||0
619396|NCT00299156|1519399|P2|NOT COMPLETED|Period 1 (Non-Randomized)||0
619397|NCT00299156|1519400|P1|NOT COMPLETED|Period 1 (Non-Randomized)||0
619398|NCT00299156|1519398|P3|COMPLETED|Period 1 (Non-Randomized)||0
619399|NCT00299156|1519399|P2|COMPLETED|Period 1 (Non-Randomized)||0
619400|NCT00299156|1519400|P1|COMPLETED|Period 1 (Non-Randomized)||32
619401|NCT00299156|1519398|P3|STARTED|Period 1 (Non-Randomized)||0
619402|NCT00299156|1519399|P2|STARTED|Period 1 (Non-Randomized)||0
619403|NCT00299156|1519400|P1|STARTED|Period 1 (Non-Randomized)||32
619404|NCT00299130|1519411|P3|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||6
619405|NCT00299130|1519412|P2|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||8
619406|NCT00299130|1519413|P1|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0
619407|NCT00299130|1519411|P3|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||38
619408|NCT00299130|1519412|P2|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||74
619409|NCT00299130|1519413|P1|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0
619410|NCT00299130|1519411|P3|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||44
619411|NCT00299130|1519412|P2|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||82
619412|NCT00299130|1519413|P1|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||0
619413|NCT00299130|1519411|P3|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
619414|NCT00299130|1519412|P2|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
619415|NCT00299130|1519413|P1|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
619416|NCT00299130|1519411|P3|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||123
619417|NCT00299130|1519412|P2|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||120
619418|NCT00299130|1519413|P1|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||122
619419|NCT00299130|1519411|P3|STARTED|Safety Follow-up (SFU) (48 Weeks)||168
619420|NCT00299130|1519412|P2|STARTED|Safety Follow-up (SFU) (48 Weeks)||165
619421|NCT00299130|1519413|P1|STARTED|Safety Follow-up (SFU) (48 Weeks)||167
619422|NCT00299130|1519411|P3|NOT COMPLETED|Treatment Period (up to 5 Years)||50
619423|NCT00299130|1519412|P2|NOT COMPLETED|Treatment Period (up to 5 Years)||43
619424|NCT00299130|1519413|P1|NOT COMPLETED|Treatment Period (up to 5 Years)||53
619425|NCT00299130|1519411|P3|COMPLETED|Treatment Period (up to 5 Years)||121
619426|NCT00299130|1519412|P2|COMPLETED|Treatment Period (up to 5 Years)||125
619427|NCT00299130|1519413|P1|COMPLETED|Treatment Period (up to 5 Years)||119
619428|NCT00299130|1519411|P3|Completed 144 Weeks|Treatment Period (up to 5 Years)||132
619429|NCT00299130|1519412|P2|Completed 144 Weeks|Treatment Period (up to 5 Years)||138
619430|NCT00299130|1519413|P1|Completed 144 Weeks|Treatment Period (up to 5 Years)||133
619431|NCT00299130|1519411|P3|Completed 48 Weeks|Treatment Period (up to 5 Years)||158
619432|NCT00299130|1519412|P2|Completed 48 Weeks|Treatment Period (up to 5 Years)||157
619433|NCT00299130|1519413|P1|Completed 48 Weeks|Treatment Period (up to 5 Years)||155
619434|NCT00299130|1519411|P3|Completed 24 Weeks|Treatment Period (up to 5 Years)||166
619435|NCT00299130|1519412|P2|Completed 24 Weeks|Treatment Period (up to 5 Years)||162
619436|NCT00299130|1519413|P1|Completed 24 Weeks|Treatment Period (up to 5 Years)||159
619437|NCT00299130|1519411|P3|Treated|Treatment Period (up to 5 Years)||170
619438|NCT00299130|1519412|P2|Treated|Treatment Period (up to 5 Years)||167
619439|NCT00299130|1519413|P1|Treated|Treatment Period (up to 5 Years)|155 participants in placebo arm switched to active therapy (rituximab 2 x 0.5g) between Weeks 16-48.|172
619440|NCT00299130|1519411|P3|STARTED|Treatment Period (up to 5 Years)||171
619441|NCT00299130|1519412|P2|STARTED|Treatment Period (up to 5 Years)||168
619442|NCT00299130|1519413|P1|STARTED|Treatment Period (up to 5 Years)||172
619443|NCT00299104|1519518|P3|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||12
619444|NCT00299104|1519519|P2|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||9
619445|NCT00299104|1519520|P1|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||5
619446|NCT00299104|1519518|P3|COMPLETED|Extended Safety Follow-Up (ESFU) Period||39
619447|NCT00299104|1519519|P2|COMPLETED|Extended Safety Follow-Up (ESFU) Period||31
619448|NCT00299104|1519520|P1|COMPLETED|Extended Safety Follow-Up (ESFU) Period||29
619449|NCT00299104|1519518|P3|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|51
619450|NCT00299104|1519519|P2|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|40
619451|NCT00299104|1519520|P1|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|34
619452|NCT00299104|1519518|P3|NOT COMPLETED|Safety Follow-Up (SFU) Period||37
619453|NCT00299104|1519519|P2|NOT COMPLETED|Safety Follow-Up (SFU) Period||41
619454|NCT00299104|1519520|P1|NOT COMPLETED|Safety Follow-Up (SFU) Period||55
619455|NCT00299104|1519518|P3|COMPLETED|Safety Follow-Up (SFU) Period||176
619456|NCT00299104|1519519|P2|COMPLETED|Safety Follow-Up (SFU) Period||171
619457|NCT00299104|1519520|P1|COMPLETED|Safety Follow-Up (SFU) Period||129
619458|NCT00299104|1519518|P3|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|213
619459|NCT00299104|1519519|P2|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|212
619460|NCT00299104|1519520|P1|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|184
619461|NCT00299104|1519518|P3|NOT COMPLETED|Treatment Period||172
619462|NCT00299104|1519519|P2|NOT COMPLETED|Treatment Period||175
619463|NCT00299104|1519520|P1|NOT COMPLETED|Treatment Period||189
619464|NCT00299104|1519518|P3|COMPLETED|Treatment Period||80
619465|NCT00299104|1519519|P2|COMPLETED|Treatment Period||77
619466|NCT00299104|1519520|P1|COMPLETED|Treatment Period|Completed Week 152|62
619467|NCT00299104|1519518|P3|Completed Week 104|Treatment Period||216
619468|NCT00299104|1519519|P2|Completed Week 104|Treatment Period||213
619469|NCT00299104|1519520|P1|Completed Week 104|Treatment Period||178
619470|NCT00299104|1519518|P3|Completed Week 52|Treatment Period||232
619471|NCT00299104|1519519|P2|Completed Week 52|Treatment Period||227
619472|NCT00299104|1519520|P1|Completed Week 52|Treatment Period||213
619473|NCT00299104|1519518|P3|Completed Week 24|Treatment Period||241
619474|NCT00299104|1519519|P2|Completed Week 24|Treatment Period||240
619475|NCT00299104|1519520|P1|Completed Week 24|Treatment Period||227
619476|NCT00299104|1519518|P3|Safety/ITT: Received Study Drug|Treatment Period||250
619477|NCT00299104|1519519|P2|Safety/ITT: Received Study Drug|Treatment Period||249
619478|NCT00299104|1519520|P1|Safety/ITT: Received Study Drug|Treatment Period||249
619479|NCT00299104|1519518|P3|STARTED|Treatment Period||252
619480|NCT00299104|1519519|P2|STARTED|Treatment Period||252
619481|NCT00299104|1519520|P1|STARTED|Treatment Period||251
619482|NCT00299000|1519617|P2|NOT COMPLETED|Overall Study||0
619483|NCT00299000|1519618|P1|NOT COMPLETED|Overall Study||0
619484|NCT00299000|1519617|P2|COMPLETED|Overall Study||2
619485|NCT00299000|1519618|P1|COMPLETED|Overall Study||2
619486|NCT00299000|1519617|P2|STARTED|Overall Study||2
619487|NCT00299000|1519618|P1|STARTED|Overall Study||2
619488|NCT00298766|1519630|P1|NOT COMPLETED|Overall Study||46
619489|NCT00298766|1519630|P1|COMPLETED|Overall Study||24
619490|NCT00298766|1519630|P1|STARTED|Overall Study||70
619491|NCT00298740|1519639|P1|NOT COMPLETED|Overall Study||9
619492|NCT00298740|1519639|P1|COMPLETED|Overall Study||3
619493|NCT00298740|1519639|P1|STARTED|Overall Study||12
619494|NCT00298610|1519643|P1|NOT COMPLETED|Overall Study||0
619495|NCT00298610|1519643|P1|COMPLETED|Overall Study||30
619496|NCT00298610|1519643|P1|STARTED|Overall Study||30
619497|NCT00298558|1519657|P4|NOT COMPLETED|10th Annual (A10)||163
619498|NCT00298558|1519658|P3|NOT COMPLETED|10th Annual (A10)||171
619499|NCT00298558|1519659|P2|NOT COMPLETED|10th Annual (A10)||153
619500|NCT00298558|1519660|P1|NOT COMPLETED|10th Annual (A10)||172
619501|NCT00298558|1519657|P4|COMPLETED|10th Annual (A10)||285
619502|NCT00298558|1519658|P3|COMPLETED|10th Annual (A10)||319
619503|NCT00298558|1519659|P2|COMPLETED|10th Annual (A10)||316
619504|NCT00298558|1519660|P1|COMPLETED|10th Annual (A10)||300
619505|NCT00298558|1519657|P4|STARTED|10th Annual (A10)||448
619506|NCT00298558|1519658|P3|STARTED|10th Annual (A10)||490
619507|NCT00298558|1519659|P2|STARTED|10th Annual (A10)||469
619508|NCT00298558|1519660|P1|STARTED|10th Annual (A10)||472
619509|NCT00298558|1519657|P4|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||104
619510|NCT00298558|1519658|P3|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||84
619511|NCT00298558|1519659|P2|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||86
619512|NCT00298558|1519660|P1|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||91
619513|NCT00298558|1519657|P4|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||448
619514|NCT00298558|1519658|P3|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||490
619515|NCT00298558|1519659|P2|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||469
619516|NCT00298558|1519660|P1|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||472
619517|NCT00298558|1519657|P4|STARTED|3rd Annual (A3) and 5th Annual (A5)||552
619518|NCT00298558|1519658|P3|STARTED|3rd Annual (A3) and 5th Annual (A5)||574
619519|NCT00298558|1519659|P2|STARTED|3rd Annual (A3) and 5th Annual (A5)||555
619520|NCT00298558|1519660|P1|STARTED|3rd Annual (A3) and 5th Annual (A5)||563
619521|NCT00298558|1519657|P4|NOT COMPLETED|3rd Annual Booster||0
619522|NCT00298558|1519658|P3|NOT COMPLETED|3rd Annual Booster||140
619523|NCT00298558|1519659|P2|NOT COMPLETED|3rd Annual Booster||128
619524|NCT00298558|1519660|P1|NOT COMPLETED|3rd Annual Booster||122
619525|NCT00298558|1519657|P4|COMPLETED|3rd Annual Booster||0
619526|NCT00298558|1519658|P3|COMPLETED|3rd Annual Booster||230
619527|NCT00298558|1519659|P2|COMPLETED|3rd Annual Booster||243
619528|NCT00298558|1519660|P1|COMPLETED|3rd Annual Booster||250
619529|NCT00298558|1519657|P4|STARTED|3rd Annual Booster||0
619530|NCT00298558|1519658|P3|STARTED|3rd Annual Booster||370
619531|NCT00298558|1519659|P2|STARTED|3rd Annual Booster||371
619532|NCT00298558|1519660|P1|STARTED|3rd Annual Booster||372
619533|NCT00298558|1519657|P4|NOT COMPLETED|2nd Annual (A2)||32
619534|NCT00298558|1519658|P3|NOT COMPLETED|2nd Annual (A2)||27
619535|NCT00298558|1519659|P2|NOT COMPLETED|2nd Annual (A2)||11
619536|NCT00298558|1519660|P1|NOT COMPLETED|2nd Annual (A2)||22
619537|NCT00298558|1519657|P4|COMPLETED|2nd Annual (A2)||552
619538|NCT00298558|1519658|P3|COMPLETED|2nd Annual (A2)||574
619539|NCT00298558|1519659|P2|COMPLETED|2nd Annual (A2)||555
619540|NCT00298558|1519660|P1|COMPLETED|2nd Annual (A2)||563
619541|NCT00298558|1519657|P4|STARTED|2nd Annual (A2)||584
619542|NCT00298558|1519658|P3|STARTED|2nd Annual (A2)||601
619543|NCT00298558|1519659|P2|STARTED|2nd Annual (A2)||566
619544|NCT00298558|1519660|P1|STARTED|2nd Annual (A2)||585
619545|NCT00298558|1519657|P4|NOT COMPLETED|1st Annual (A1)||55
619546|NCT00298558|1519658|P3|NOT COMPLETED|1st Annual (A1)||52
619547|NCT00298558|1519659|P2|NOT COMPLETED|1st Annual (A1)||63
619548|NCT00298558|1519660|P1|NOT COMPLETED|1st Annual (A1)||55
619549|NCT00298558|1519657|P4|COMPLETED|1st Annual (A1)||584
619550|NCT00298558|1519658|P3|COMPLETED|1st Annual (A1)||601
619551|NCT00298558|1519659|P2|COMPLETED|1st Annual (A1)||566
619552|NCT00298558|1519660|P1|COMPLETED|1st Annual (A1)||585
619553|NCT00298558|1519657|P4|STARTED|1st Annual (A1)||639
619554|NCT00298558|1519658|P3|STARTED|1st Annual (A1)||653
619555|NCT00298558|1519659|P2|STARTED|1st Annual (A1)||629
619556|NCT00298558|1519660|P1|STARTED|1st Annual (A1)||640
619557|NCT00298558|1519657|P4|NOT COMPLETED|Booster||0
619558|NCT00298558|1519658|P3|NOT COMPLETED|Booster||75
619559|NCT00298558|1519659|P2|NOT COMPLETED|Booster||70
619560|NCT00298558|1519660|P1|NOT COMPLETED|Booster||89
619561|NCT00298558|1519657|P4|COMPLETED|Booster||0
619562|NCT00298558|1519658|P3|COMPLETED|Booster||295
619563|NCT00298558|1519659|P2|COMPLETED|Booster||301
619564|NCT00298558|1519660|P1|COMPLETED|Booster||283
619565|NCT00298558|1519657|P4|STARTED|Booster||0
619566|NCT00298558|1519658|P3|STARTED|Booster||370
619567|NCT00298558|1519659|P2|STARTED|Booster||371
619568|NCT00298558|1519660|P1|STARTED|Booster||372
619569|NCT00298558|1519657|P4|NOT COMPLETED|Immediate Post Test||65
619570|NCT00298558|1519658|P3|NOT COMPLETED|Immediate Post Test||59
619571|NCT00298558|1519659|P2|NOT COMPLETED|Immediate Post Test||76
619572|NCT00298558|1519660|P1|NOT COMPLETED|Immediate Post Test||71
619573|NCT00298558|1519657|P4|COMPLETED|Immediate Post Test||639
619574|NCT00298558|1519658|P3|COMPLETED|Immediate Post Test||653
619575|NCT00298558|1519659|P2|COMPLETED|Immediate Post Test||629
619576|NCT00298558|1519660|P1|COMPLETED|Immediate Post Test||640
619577|NCT00298558|1519657|P4|STARTED|Immediate Post Test||704
619578|NCT00298558|1519658|P3|STARTED|Immediate Post Test||712
619579|NCT00298558|1519659|P2|STARTED|Immediate Post Test||705
619580|NCT00298558|1519660|P1|STARTED|Immediate Post Test||711
619581|NCT00298558|1519657|P4|NOT COMPLETED|Intervention||419
619582|NCT00298558|1519658|P3|NOT COMPLETED|Intervention||75
619583|NCT00298558|1519659|P2|NOT COMPLETED|Intervention||78
619584|NCT00298558|1519660|P1|NOT COMPLETED|Intervention||91
619585|NCT00298558|1519657|P4|COMPLETED|Intervention||285
619586|NCT00298558|1519658|P3|COMPLETED|Intervention||637
619587|NCT00298558|1519659|P2|COMPLETED|Intervention||627
619588|NCT00298558|1519660|P1|COMPLETED|Intervention||620
619589|NCT00298558|1519657|P4|STARTED|Intervention||704
619590|NCT00298558|1519658|P3|STARTED|Intervention||712
619591|NCT00298558|1519659|P2|STARTED|Intervention||705
619592|NCT00298558|1519660|P1|STARTED|Intervention||711
619593|NCT00298558|1519657|P4|NOT COMPLETED|Baseline||0
619594|NCT00298558|1519658|P3|NOT COMPLETED|Baseline||0
619595|NCT00298558|1519659|P2|NOT COMPLETED|Baseline||0
619596|NCT00298558|1519660|P1|NOT COMPLETED|Baseline||0
619597|NCT00298558|1519657|P4|COMPLETED|Baseline||704
619598|NCT00298558|1519658|P3|COMPLETED|Baseline||712
619599|NCT00298558|1519659|P2|COMPLETED|Baseline||705
619600|NCT00298558|1519660|P1|COMPLETED|Baseline||711
619601|NCT00298558|1519657|P4|STARTED|Baseline||704
619602|NCT00298558|1519658|P3|STARTED|Baseline||712
619603|NCT00298558|1519659|P2|STARTED|Baseline||705
619604|NCT00298558|1519660|P1|STARTED|Baseline||711
619605|NCT00298363|1519693|P3|NOT COMPLETED|Overall Study||6
619606|NCT00298363|1519694|P2|NOT COMPLETED|Overall Study||8
619607|NCT00298363|1519695|P1|NOT COMPLETED|Overall Study||17
619608|NCT00298363|1519693|P3|COMPLETED|Overall Study|13 completed while taking DB ETV; 3 completed following switch from DB ETV to OL FTC/TDF.|16
619609|NCT00298363|1519694|P2|COMPLETED|Overall Study|34 completed while taking DB FTC/TDF; 3 completed following switch from DB TDF to OL FTC/TDF.|37
619610|NCT00298363|1519695|P1|COMPLETED|Overall Study|22 completed while taking DB TDF; 6 completed following switch from DB TDF to OL FTC/TDF.|28
619611|NCT00298363|1519693|P3|STARTED|Overall Study||22
619612|NCT00298363|1519694|P2|STARTED|Overall Study||45
619613|NCT00298363|1519695|P1|STARTED|Overall Study||45
619614|NCT00298272|1519853|P2|NOT COMPLETED|Safety Follow-up Phase||4
619615|NCT00298272|1519854|P1|NOT COMPLETED|Safety Follow-up Phase||4
619616|NCT00298272|1519853|P2|COMPLETED|Safety Follow-up Phase||13
619617|NCT00298272|1519854|P1|COMPLETED|Safety Follow-up Phase||18
619618|NCT00298272|1519853|P2|STARTED|Safety Follow-up Phase||17
619619|NCT00298272|1519854|P1|STARTED|Safety Follow-up Phase||22
619620|NCT00298272|1519853|P2|NOT COMPLETED|Open Label Retreatment Phase||4
619621|NCT00298272|1519854|P1|NOT COMPLETED|Open Label Retreatment Phase||9
619622|NCT00298272|1519853|P2|COMPLETED|Open Label Retreatment Phase||12
619623|NCT00298272|1519854|P1|COMPLETED|Open Label Retreatment Phase||13
619624|NCT00298272|1519853|P2|Completed to Week 56|Open Label Retreatment Phase||12
619625|NCT00298272|1519854|P1|Completed to Week 56|Open Label Retreatment Phase||13
619626|NCT00298272|1519853|P2|Completed to Week 24|Open Label Retreatment Phase|received full course of open-label rituximab therapy|15
619627|NCT00298272|1519854|P1|Completed to Week 24|Open Label Retreatment Phase|received full course of open-label rituximab therapy|22
619628|NCT00298272|1519853|P2|STARTED|Open Label Retreatment Phase||16
619629|NCT00298272|1519854|P1|STARTED|Open Label Retreatment Phase||22
619630|NCT00298272|1519853|P2|NOT COMPLETED|Double-blind Phase||0
619631|NCT00298272|1519854|P1|NOT COMPLETED|Double-blind Phase||8
619632|NCT00298272|1519853|P2|COMPLETED|Double-blind Phase||18
619633|NCT00298272|1519854|P1|COMPLETED|Double-blind Phase||28
619634|NCT00298272|1519853|P2|Completed to Week 56|Double-blind Phase||3
619635|NCT00298272|1519854|P1|Completed to Week 56|Double-blind Phase||8
619636|NCT00298272|1519853|P2|Completed to Week 24|Double-blind Phase|received full course of placebo therapy|18
619637|NCT00298272|1519854|P1|Completed to Week 24|Double-blind Phase|received full course of rituximab therapy|31
619638|NCT00298272|1519853|P2|Safety Population|Double-blind Phase||18
619639|NCT00298272|1519854|P1|Safety Population|Double-blind Phase|received treatment|33
619640|NCT00298272|1519853|P2|STARTED|Double-blind Phase||18
619641|NCT00298272|1519854|P1|STARTED|Double-blind Phase|enrolled and randomized (2:1 scheme)|36
619642|NCT00298233|1519877|P4|NOT COMPLETED|Overall Study||0
619643|NCT00298233|1519878|P3|NOT COMPLETED|Overall Study||0
619644|NCT00298233|1519879|P2|NOT COMPLETED|Overall Study||0
619645|NCT00298233|1519880|P1|NOT COMPLETED|Overall Study||0
619646|NCT00298233|1519877|P4|COMPLETED|Overall Study||124
619647|NCT00298233|1519878|P3|COMPLETED|Overall Study||122
619648|NCT00298233|1519879|P2|COMPLETED|Overall Study||41
619649|NCT00298233|1519880|P1|COMPLETED|Overall Study||39
619650|NCT00298233|1519877|P4|STARTED|Overall Study||124
619651|NCT00298233|1519878|P3|STARTED|Overall Study||122
619652|NCT00298233|1519879|P2|STARTED|Overall Study||41
619653|NCT00298233|1519880|P1|STARTED|Overall Study||39
619654|NCT00298155|1519899|P3|NOT COMPLETED|Overall Study||0
619655|NCT00298155|1519900|P2|NOT COMPLETED|Overall Study||0
619656|NCT00298155|1519901|P1|NOT COMPLETED|Overall Study||0
619657|NCT00298155|1519899|P3|COMPLETED|Overall Study||13
619658|NCT00298155|1519900|P2|COMPLETED|Overall Study||10
619659|NCT00298155|1519901|P1|COMPLETED|Overall Study||12
619660|NCT00298155|1519899|P3|STARTED|Overall Study||13
619661|NCT00298155|1519900|P2|STARTED|Overall Study||10
619662|NCT00298155|1519901|P1|STARTED|Overall Study||12
619663|NCT00298090|1519912|P1|NOT COMPLETED|Overall Study||18
619664|NCT00298090|1519912|P1|COMPLETED|Overall Study|Eighteen subjects were not included in final analysis due to incomplete data sets|29
619665|NCT00298090|1519912|P1|STARTED|Overall Study||47
619666|NCT00297830|1519919|P3|NOT COMPLETED|12 Month Visit||0
619667|NCT00297830|1519920|P2|NOT COMPLETED|12 Month Visit||6
619668|NCT00297830|1519921|P1|NOT COMPLETED|12 Month Visit||1
619669|NCT00297830|1519919|P3|COMPLETED|12 Month Visit||24
619670|NCT00297830|1519920|P2|COMPLETED|12 Month Visit||35
619671|NCT00297830|1519921|P1|COMPLETED|12 Month Visit||37
619672|NCT00297830|1519919|P3|STARTED|12 Month Visit||24
619673|NCT00297830|1519920|P2|STARTED|12 Month Visit||41
619674|NCT00297830|1519921|P1|STARTED|12 Month Visit||38
619675|NCT00297830|1519919|P3|NOT COMPLETED|6 Month Visit||3
619676|NCT00297830|1519920|P2|NOT COMPLETED|6 Month Visit||2
619677|NCT00297830|1519921|P1|NOT COMPLETED|6 Month Visit||3
619678|NCT00297830|1519919|P3|COMPLETED|6 Month Visit||24
619679|NCT00297830|1519920|P2|COMPLETED|6 Month Visit||41
619680|NCT00297830|1519921|P1|COMPLETED|6 Month Visit||38
619681|NCT00297830|1519919|P3|STARTED|6 Month Visit||27
619682|NCT00297830|1519920|P2|STARTED|6 Month Visit||43
619683|NCT00297830|1519921|P1|STARTED|6 Month Visit||41
619684|NCT00297830|1519919|P3|NOT COMPLETED|Baseline||0
619685|NCT00297830|1519920|P2|NOT COMPLETED|Baseline||0
619686|NCT00297830|1519921|P1|NOT COMPLETED|Baseline||0
619687|NCT00297830|1519919|P3|COMPLETED|Baseline||27
619688|NCT00297830|1519920|P2|COMPLETED|Baseline||43
619689|NCT00297830|1519921|P1|COMPLETED|Baseline||41
619690|NCT00297830|1519919|P3|STARTED|Baseline||27
619691|NCT00297830|1519920|P2|STARTED|Baseline||43
619692|NCT00297830|1519921|P1|STARTED|Baseline||41
619693|NCT00297778|1519940|P2|NOT COMPLETED|Overall Study||20
619694|NCT00297778|1519941|P1|NOT COMPLETED|Overall Study||19
619695|NCT00297778|1519940|P2|COMPLETED|Overall Study||124
619696|NCT00297778|1519941|P1|COMPLETED|Overall Study||133
619697|NCT00297778|1519940|P2|STARTED|Overall Study||144
619698|NCT00297778|1519941|P1|STARTED|Overall Study||152
619699|NCT00297648|1519975|P1|NOT COMPLETED|Overall Study||36
619700|NCT00297648|1519975|P1|COMPLETED|Overall Study||53
619701|NCT00297648|1519975|P1|STARTED|Overall Study||89
619702|NCT00297596|1520014|P1|NOT COMPLETED|Overall Study||0
619703|NCT00297596|1520014|P1|COMPLETED|Overall Study||25
619704|NCT00297596|1520014|P1|STARTED|Overall Study||25
619705|NCT00297492|1520021|P3|NOT COMPLETED|6 Month Follow-up||27
619706|NCT00297492|1520022|P2|NOT COMPLETED|6 Month Follow-up||49
619707|NCT00297492|1520023|P1|NOT COMPLETED|6 Month Follow-up||63
619708|NCT00297492|1520021|P3|COMPLETED|6 Month Follow-up||118
619709|NCT00297492|1520022|P2|COMPLETED|6 Month Follow-up||237
619710|NCT00297492|1520023|P1|COMPLETED|6 Month Follow-up||227
619711|NCT00297492|1520021|P3|STARTED|6 Month Follow-up||145
619712|NCT00297492|1520022|P2|STARTED|6 Month Follow-up||286
619713|NCT00297492|1520023|P1|STARTED|6 Month Follow-up||290
619714|NCT00297492|1520021|P3|NOT COMPLETED|Set Quit Date||5
619715|NCT00297492|1520022|P2|NOT COMPLETED|Set Quit Date||13
619716|NCT00297492|1520023|P1|NOT COMPLETED|Set Quit Date||7
619717|NCT00297492|1520021|P3|COMPLETED|Set Quit Date||145
619718|NCT00297492|1520022|P2|COMPLETED|Set Quit Date||286
619719|NCT00297492|1520023|P1|COMPLETED|Set Quit Date||290
619720|NCT00297492|1520021|P3|STARTED|Set Quit Date||150
619721|NCT00297492|1520022|P2|STARTED|Set Quit Date||299
619722|NCT00297492|1520023|P1|STARTED|Set Quit Date||297
619723|NCT00297427|1520033|P2|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||0
619724|NCT00297427|1520034|P1|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||34
619725|NCT00297427|1520033|P2|COMPLETED|Phase 3: Follow-up Post-True Acupuncture|Only subjects who received true acupuncture initially or after cross-over entered follow-up|0
619726|NCT00297427|1520034|P1|COMPLETED|Phase 3: Follow-up Post-True Acupuncture|Subjects who completed=/>1 follow-up visits and were evaluated for booster acupuncture|60
619727|NCT00297427|1520033|P2|STARTED|Phase 3: Follow-up Post-True Acupuncture|Only subjects who received true acupuncture initially or after cross-over entered follow-up|0
619728|NCT00297427|1520034|P1|STARTED|Phase 3: Follow-up Post-True Acupuncture||94
619729|NCT00297427|1520033|P2|NOT COMPLETED|Phase 2: Optional Crossover for Sham||0
619730|NCT00297427|1520034|P1|NOT COMPLETED|Phase 2: Optional Crossover for Sham||16
619731|NCT00297427|1520033|P2|COMPLETED|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
619732|NCT00297427|1520034|P1|COMPLETED|Phase 2: Optional Crossover for Sham||38
619733|NCT00297427|1520033|P2|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
619734|NCT00297427|1520034|P1|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham|54 subjects completed the sham acupuncture & were offered the opportunity to cross-over; 12 declined|42
619735|NCT00297427|1520033|P2|STARTED|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
619736|NCT00297427|1520034|P1|STARTED|Phase 2: Optional Crossover for Sham||54
619737|NCT00297427|1520033|P2|NOT COMPLETED|Phase 1: Initial Intervention||9
619738|NCT00297427|1520034|P1|NOT COMPLETED|Phase 1: Initial Intervention||8
619739|NCT00297427|1520033|P2|COMPLETED|Phase 1: Initial Intervention||54
619740|NCT00297427|1520034|P1|COMPLETED|Phase 1: Initial Intervention||56
619741|NCT00297427|1520033|P2|STARTED|Phase 1: Initial Intervention|Intention-to-treat analysis; all randomized subjects were included in analysis|63
619742|NCT00297427|1520034|P1|STARTED|Phase 1: Initial Intervention|Intention-to-treat analysis; all randomized subjects were included in analysis|64
619743|NCT00297258|1520075|P1|NOT COMPLETED|Overall Study||142
619744|NCT00297258|1520075|P1|COMPLETED|Overall Study||0
619745|NCT00297258|1520075|P1|STARTED|Overall Study||142
619746|NCT00297232|1520094|P1|NOT COMPLETED|Overall Study||605
619747|NCT00297232|1520094|P1|COMPLETED|Overall Study||489
619748|NCT00297232|1520094|P1|STARTED|Overall Study||1094
619749|NCT00297167|1520100|P3|NOT COMPLETED|Open-label Dose Normalization Period 2||0
619750|NCT00297167|1520101|P2|NOT COMPLETED|Open-label Dose Normalization Period 2||0
619751|NCT00297167|1520102|P1|NOT COMPLETED|Open-label Dose Normalization Period 2||0
619752|NCT00297167|1520100|P3|COMPLETED|Open-label Dose Normalization Period 2||31
619753|NCT00297167|1520101|P2|COMPLETED|Open-label Dose Normalization Period 2||0
619754|NCT00297167|1520102|P1|COMPLETED|Open-label Dose Normalization Period 2||0
619755|NCT00297167|1520100|P3|STARTED|Open-label Dose Normalization Period 2||31
619756|NCT00297167|1520101|P2|STARTED|Open-label Dose Normalization Period 2||0
619757|NCT00297167|1520102|P1|STARTED|Open-label Dose Normalization Period 2||0
619758|NCT00297167|1520100|P3|NOT COMPLETED|Second Double-blind Intervention Period||0
619759|NCT00297167|1520101|P2|NOT COMPLETED|Second Double-blind Intervention Period||0
619760|NCT00297167|1520102|P1|NOT COMPLETED|Second Double-blind Intervention Period||1
619761|NCT00297167|1520100|P3|COMPLETED|Second Double-blind Intervention Period||0
619762|NCT00297167|1520101|P2|COMPLETED|Second Double-blind Intervention Period||15
619763|NCT00297167|1520102|P1|COMPLETED|Second Double-blind Intervention Period||16
619764|NCT00297167|1520100|P3|STARTED|Second Double-blind Intervention Period||0
619765|NCT00297167|1520101|P2|STARTED|Second Double-blind Intervention Period||15
619766|NCT00297167|1520102|P1|STARTED|Second Double-blind Intervention Period||17
619767|NCT00297167|1520100|P3|NOT COMPLETED|Open-label Dose Normalization Period 1||1
619768|NCT00297167|1520101|P2|NOT COMPLETED|Open-label Dose Normalization Period 1||0
619769|NCT00297167|1520102|P1|NOT COMPLETED|Open-label Dose Normalization Period 1||0
619770|NCT00297167|1520100|P3|COMPLETED|Open-label Dose Normalization Period 1||32
619771|NCT00297167|1520101|P2|COMPLETED|Open-label Dose Normalization Period 1||0
619772|NCT00297167|1520102|P1|COMPLETED|Open-label Dose Normalization Period 1||0
619773|NCT00297167|1520100|P3|STARTED|Open-label Dose Normalization Period 1||33
619774|NCT00297167|1520101|P2|STARTED|Open-label Dose Normalization Period 1||0
619775|NCT00297167|1520102|P1|STARTED|Open-label Dose Normalization Period 1||0
619776|NCT00297167|1520100|P3|NOT COMPLETED|First Double-blind Intervention Period||0
619777|NCT00297167|1520101|P2|NOT COMPLETED|First Double-blind Intervention Period||0
619778|NCT00297167|1520102|P1|NOT COMPLETED|First Double-blind Intervention Period||0
619779|NCT00297167|1520100|P3|COMPLETED|First Double-blind Intervention Period||0
619780|NCT00297167|1520101|P2|COMPLETED|First Double-blind Intervention Period||16
619781|NCT00297167|1520102|P1|COMPLETED|First Double-blind Intervention Period||17
619782|NCT00297167|1520100|P3|STARTED|First Double-blind Intervention Period||0
619783|NCT00297167|1520101|P2|STARTED|First Double-blind Intervention Period||16
619784|NCT00297167|1520102|P1|STARTED|First Double-blind Intervention Period||17
619785|NCT00297115|1520128|P2|NOT COMPLETED|Overall Study||246
619786|NCT00297115|1520129|P1|NOT COMPLETED|Overall Study||245
619787|NCT00297115|1520128|P2|COMPLETED|Overall Study||550
619788|NCT00297115|1520129|P1|COMPLETED|Overall Study||527
619789|NCT00297115|1520128|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|796
619790|NCT00297115|1520129|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|772
619791|NCT00297102|1520147|P2|NOT COMPLETED|Overall Study||233
619792|NCT00297102|1520148|P1|NOT COMPLETED|Overall Study||263
619793|NCT00297102|1520147|P2|COMPLETED|Overall Study||525
619794|NCT00297102|1520148|P1|COMPLETED|Overall Study||502
619795|NCT00297102|1520147|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|758
619796|NCT00297102|1520148|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|765
619797|NCT00297037|1520166|P2|NOT COMPLETED|Overall Study||0
619798|NCT00297037|1520167|P1|NOT COMPLETED|Overall Study||2
619799|NCT00297037|1520166|P2|COMPLETED|Overall Study||11
619800|NCT00297037|1520167|P1|COMPLETED|Overall Study||8
619801|NCT00297037|1520166|P2|STARTED|Overall Study||11
619802|NCT00297037|1520167|P1|STARTED|Overall Study||10
619803|NCT00296816|1520179|P1|NOT COMPLETED|Overall Study||74
619804|NCT00296816|1520179|P1|COMPLETED|Overall Study|Completed study treatment for a minimum of three years|58
619805|NCT00296816|1520179|P1|STARTED|Overall Study||132
619806|NCT00296647|1520196|P5|NOT COMPLETED|Overall Study||20
619807|NCT00296647|1520197|P4|NOT COMPLETED|Overall Study||17
619808|NCT00296647|1520198|P3|NOT COMPLETED|Overall Study||34
619809|NCT00296647|1520199|P2|NOT COMPLETED|Overall Study||28
619810|NCT00296647|1520200|P1|NOT COMPLETED|Overall Study||32
619811|NCT00296647|1520196|P5|COMPLETED|Overall Study||248
619812|NCT00296647|1520197|P4|COMPLETED|Overall Study||262
619813|NCT00296647|1520198|P3|COMPLETED|Overall Study||222
619814|NCT00296647|1520199|P2|COMPLETED|Overall Study||233
619815|NCT00296647|1520200|P1|COMPLETED|Overall Study||250
619816|NCT00296647|1520196|P5|STARTED|Overall Study||268
619817|NCT00296647|1520197|P4|STARTED|Overall Study||279
619818|NCT00296647|1520198|P3|STARTED|Overall Study||256
619819|NCT00296647|1520199|P2|STARTED|Overall Study||261
619820|NCT00296647|1520200|P1|STARTED|Overall Study||282
619821|NCT00296517|1520214|P2|NOT COMPLETED|Dose Level 3 - Weeks 3-12||62
619822|NCT00296517|1520215|P1|NOT COMPLETED|Dose Level 3 - Weeks 3-12||45
619823|NCT00296517|1520214|P2|COMPLETED|Dose Level 3 - Weeks 3-12||99
619824|NCT00296517|1520215|P1|COMPLETED|Dose Level 3 - Weeks 3-12||112
619825|NCT00296517|1520214|P2|STARTED|Dose Level 3 - Weeks 3-12||161
619826|NCT00296517|1520215|P1|STARTED|Dose Level 3 - Weeks 3-12||157
619827|NCT00296517|1520214|P2|NOT COMPLETED|Dose Level 2 - Week 2||5
619828|NCT00296517|1520215|P1|NOT COMPLETED|Dose Level 2 - Week 2||2
619829|NCT00296517|1520214|P2|COMPLETED|Dose Level 2 - Week 2||161
619830|NCT00296517|1520215|P1|COMPLETED|Dose Level 2 - Week 2||157
619831|NCT00296517|1520214|P2|STARTED|Dose Level 2 - Week 2||166
619832|NCT00296517|1520215|P1|STARTED|Dose Level 2 - Week 2||159
619833|NCT00296517|1520214|P2|NOT COMPLETED|Dose Level 1 - Week 1||0
619834|NCT00296517|1520215|P1|NOT COMPLETED|Dose Level 1 - Week 1||0
619835|NCT00296517|1520214|P2|COMPLETED|Dose Level 1 - Week 1||166
619836|NCT00296517|1520215|P1|COMPLETED|Dose Level 1 - Week 1||159
619837|NCT00296517|1520214|P2|STARTED|Dose Level 1 - Week 1||166
619838|NCT00296517|1520215|P1|STARTED|Dose Level 1 - Week 1||159
619839|NCT00296504|1520251|P9|NOT COMPLETED|Final Analysis||21
619840|NCT00296504|1520252|P8|NOT COMPLETED|Final Analysis||0
619841|NCT00296504|1520253|P7|NOT COMPLETED|Final Analysis||0
619842|NCT00296504|1520254|P6|NOT COMPLETED|Final Analysis||0
619843|NCT00296504|1520255|P5|NOT COMPLETED|Final Analysis||0
619844|NCT00296504|1520256|P4|NOT COMPLETED|Final Analysis||0
619845|NCT00296504|1520257|P3|NOT COMPLETED|Final Analysis||0
619846|NCT00296504|1520258|P2|NOT COMPLETED|Final Analysis||0
619847|NCT00296504|1520259|P1|NOT COMPLETED|Final Analysis||0
619848|NCT00296504|1520251|P9|COMPLETED|Final Analysis||90
619849|NCT00296504|1520252|P8|COMPLETED|Final Analysis||0
619850|NCT00296504|1520253|P7|COMPLETED|Final Analysis||0
619851|NCT00296504|1520254|P6|COMPLETED|Final Analysis||0
619852|NCT00296504|1520255|P5|COMPLETED|Final Analysis||0
619853|NCT00296504|1520256|P4|COMPLETED|Final Analysis||0
619854|NCT00296504|1520257|P3|COMPLETED|Final Analysis||0
619855|NCT00296504|1520258|P2|COMPLETED|Final Analysis||0
619856|NCT00296504|1520259|P1|COMPLETED|Final Analysis||0
619857|NCT00296504|1520251|P9|STARTED|Final Analysis|Continued in study; commercial supplies of FPV were unavailable locally at end of Interim Analysis.|111
619858|NCT00296504|1520252|P8|STARTED|Final Analysis||0
619859|NCT00296504|1520253|P7|STARTED|Final Analysis||0
619860|NCT00296504|1520254|P6|STARTED|Final Analysis||0
619861|NCT00296504|1520255|P5|STARTED|Final Analysis||0
619862|NCT00296504|1520256|P4|STARTED|Final Analysis||0
619863|NCT00296504|1520257|P3|STARTED|Final Analysis||0
619864|NCT00296504|1520258|P2|STARTED|Final Analysis||0
619865|NCT00296504|1520259|P1|STARTED|Final Analysis||0
619866|NCT00296504|1520251|P9|NOT COMPLETED|Interim Analysis||0
619867|NCT00296504|1520252|P8|NOT COMPLETED|Interim Analysis||49
619868|NCT00296504|1520253|P7|NOT COMPLETED|Interim Analysis||74
619869|NCT00296504|1520254|P6|NOT COMPLETED|Interim Analysis||37
619870|NCT00296504|1520255|P5|NOT COMPLETED|Interim Analysis||37
619871|NCT00296504|1520256|P4|NOT COMPLETED|Interim Analysis||43
619872|NCT00296504|1520257|P3|NOT COMPLETED|Interim Analysis||105
619873|NCT00296504|1520258|P2|NOT COMPLETED|Interim Analysis||18
619874|NCT00296504|1520259|P1|NOT COMPLETED|Interim Analysis||76
619875|NCT00296504|1520251|P9|COMPLETED|Interim Analysis||0
619876|NCT00296504|1520252|P8|COMPLETED|Interim Analysis||37
619877|NCT00296504|1520253|P7|COMPLETED|Interim Analysis||30
619878|NCT00296504|1520254|P6|COMPLETED|Interim Analysis||41
619879|NCT00296504|1520255|P5|COMPLETED|Interim Analysis||36
619880|NCT00296504|1520256|P4|COMPLETED|Interim Analysis||11
619881|NCT00296504|1520257|P3|COMPLETED|Interim Analysis||116
619882|NCT00296504|1520258|P2|COMPLETED|Interim Analysis||0
619883|NCT00296504|1520259|P1|COMPLETED|Interim Analysis||43
619884|NCT00296504|1520251|P9|Ongoing|Interim Analysis||0
619885|NCT00296504|1520252|P8|Ongoing|Interim Analysis||1
619886|NCT00296504|1520253|P7|Ongoing|Interim Analysis||30
619887|NCT00296504|1520254|P6|Ongoing|Interim Analysis||0
619888|NCT00296504|1520255|P5|Ongoing|Interim Analysis||0
619889|NCT00296504|1520256|P4|Ongoing|Interim Analysis||22
619890|NCT00296504|1520257|P3|Ongoing|Interim Analysis||16
619891|NCT00296504|1520258|P2|Ongoing|Interim Analysis||12
619892|NCT00296504|1520259|P1|Ongoing|Interim Analysis||32
619893|NCT00296504|1520251|P9|STARTED|Interim Analysis||0
619894|NCT00296504|1520252|P8|STARTED|Interim Analysis||86
619895|NCT00296504|1520253|P7|STARTED|Interim Analysis||104
619896|NCT00296504|1520254|P6|STARTED|Interim Analysis||78
619897|NCT00296504|1520255|P5|STARTED|Interim Analysis||73
619898|NCT00296504|1520256|P4|STARTED|Interim Analysis||54
619899|NCT00296504|1520257|P3|STARTED|Interim Analysis||221
619900|NCT00296504|1520258|P2|STARTED|Interim Analysis||18
619901|NCT00296504|1520259|P1|STARTED|Interim Analysis||119
619902|NCT00296491|1520352|P4|NOT COMPLETED|Overall Study||43
619903|NCT00296491|1520353|P3|NOT COMPLETED|Overall Study||43
619904|NCT00296491|1520354|P2|NOT COMPLETED|Overall Study||53
619905|NCT00296491|1520355|P1|NOT COMPLETED|Overall Study||42
619906|NCT00296491|1520352|P4|COMPLETED|Overall Study||138
619907|NCT00296491|1520353|P3|COMPLETED|Overall Study||137
619908|NCT00296491|1520354|P2|COMPLETED|Overall Study||129
619909|NCT00296491|1520355|P1|COMPLETED|Overall Study||140
619910|NCT00296491|1520352|P4|STARTED|Overall Study||181
619911|NCT00296491|1520353|P3|STARTED|Overall Study||180
619912|NCT00296491|1520354|P2|STARTED|Overall Study||182
619913|NCT00296491|1520355|P1|STARTED|Overall Study|Please note: Outcome Measures generally conducts analysis of 2 of the 4 Arms at a time.|182
619914|NCT00296400|1520384|P3|NOT COMPLETED|Overall Study||13
619915|NCT00296400|1520385|P2|NOT COMPLETED|Overall Study||18
619916|NCT00296400|1520386|P1|NOT COMPLETED|Overall Study||17
619917|NCT00296400|1520384|P3|COMPLETED|Overall Study||67
619918|NCT00296400|1520385|P2|COMPLETED|Overall Study||69
619919|NCT00296400|1520386|P1|COMPLETED|Overall Study||53
619920|NCT00296400|1520384|P3|STARTED|Overall Study||80
619921|NCT00296400|1520385|P2|STARTED|Overall Study||87
619922|NCT00296400|1520386|P1|STARTED|Overall Study||70
619923|NCT00296374|1520610|P3|NOT COMPLETED|Overall Study||29
619924|NCT00296374|1520611|P2|NOT COMPLETED|Overall Study||23
619925|NCT00296374|1520612|P1|NOT COMPLETED|Overall Study||25
619926|NCT00296374|1520610|P3|COMPLETED|Overall Study||82
619927|NCT00296374|1520611|P2|COMPLETED|Overall Study||101
619928|NCT00296374|1520612|P1|COMPLETED|Overall Study||93
619929|NCT00296374|1520610|P3|STARTED|Overall Study||111
619930|NCT00296374|1520611|P2|STARTED|Overall Study||124
619931|NCT00296374|1520612|P1|STARTED|Overall Study||118
619932|NCT00296335|1520835|P2|NOT COMPLETED|Overall Study||122
619933|NCT00296335|1520836|P1|NOT COMPLETED|Overall Study||30
619934|NCT00296335|1520835|P2|COMPLETED|Overall Study||309
619935|NCT00296335|1520836|P1|COMPLETED|Overall Study||394
619936|NCT00296335|1520835|P2|STARTED|Overall Study||431
619937|NCT00296335|1520836|P1|STARTED|Overall Study||424
619938|NCT00296322|1520848|P2|NOT COMPLETED|Overall Study||79
619939|NCT00296322|1520849|P1|NOT COMPLETED|Overall Study||21
619940|NCT00296322|1520848|P2|COMPLETED|Overall Study||184
619941|NCT00296322|1520849|P1|COMPLETED|Overall Study||237
619942|NCT00296322|1520848|P2|STARTED|Overall Study||263
619943|NCT00296322|1520849|P1|STARTED|Overall Study||258
619944|NCT00296296|1520861|P2|NOT COMPLETED|Overall Study||13
619945|NCT00296296|1520862|P1|NOT COMPLETED|Overall Study||2
619946|NCT00296296|1520861|P2|COMPLETED|Overall Study||5
619947|NCT00296296|1520862|P1|COMPLETED|Overall Study||9
619948|NCT00296296|1520861|P2|STARTED|Overall Study||18
619949|NCT00296296|1520862|P1|STARTED|Overall Study||11
619950|NCT00296244|1520876|P2|NOT COMPLETED|Overall Study||1
619951|NCT00296244|1520877|P1|NOT COMPLETED|Overall Study||0
619952|NCT00296244|1520876|P2|COMPLETED|Overall Study||19
619953|NCT00296244|1520877|P1|COMPLETED|Overall Study||20
619954|NCT00296244|1520876|P2|STARTED|Overall Study||20
619955|NCT00296244|1520877|P1|STARTED|Overall Study||20
619956|NCT00296231|1520893|P1|NOT COMPLETED|Overall Study||0
619957|NCT00296231|1520893|P1|COMPLETED|Overall Study||14
619958|NCT00296231|1520893|P1|STARTED|Overall Study||14
619959|NCT00296192|1520903|P5|NOT COMPLETED|Overall Study||0
619960|NCT00296192|1520904|P4|NOT COMPLETED|Overall Study||0
619961|NCT00296192|1520905|P3|NOT COMPLETED|Overall Study||0
619962|NCT00296192|1520906|P2|NOT COMPLETED|Overall Study||0
619963|NCT00296192|1520907|P1|NOT COMPLETED|Overall Study||0
619964|NCT00296192|1520903|P5|COMPLETED|Overall Study||16
619965|NCT00296192|1520904|P4|COMPLETED|Overall Study||17
619966|NCT00296192|1520905|P3|COMPLETED|Overall Study||16
619967|NCT00296192|1520906|P2|COMPLETED|Overall Study||16
619968|NCT00296192|1520907|P1|COMPLETED|Overall Study||17
619969|NCT00296192|1520903|P5|STARTED|Overall Study||16
619970|NCT00296192|1520904|P4|STARTED|Overall Study||17
619971|NCT00296192|1520905|P3|STARTED|Overall Study||16
619972|NCT00296192|1520906|P2|STARTED|Overall Study||16
619973|NCT00296192|1520907|P1|STARTED|Overall Study||17
619974|NCT00296036|1520941|P6|NOT COMPLETED|Overall Study||4
619975|NCT00296036|1520942|P5|NOT COMPLETED|Overall Study||2
619976|NCT00296036|1520943|P4|NOT COMPLETED|Overall Study||1
619977|NCT00296036|1520944|P3|NOT COMPLETED|Overall Study||2
619978|NCT00296036|1520945|P2|NOT COMPLETED|Overall Study||0
619979|NCT00296036|1520946|P1|NOT COMPLETED|Overall Study||1
619980|NCT00296036|1520941|P6|COMPLETED|Overall Study||28
619981|NCT00296036|1520942|P5|COMPLETED|Overall Study||31
619982|NCT00296036|1520943|P4|COMPLETED|Overall Study||16
619983|NCT00296036|1520944|P3|COMPLETED|Overall Study||16
619984|NCT00296036|1520945|P2|COMPLETED|Overall Study||18
619985|NCT00296036|1520946|P1|COMPLETED|Overall Study||18
619986|NCT00296036|1520941|P6|STARTED|Overall Study||32
619987|NCT00296036|1520942|P5|STARTED|Overall Study||33
619988|NCT00296036|1520943|P4|STARTED|Overall Study||17
619989|NCT00296036|1520944|P3|STARTED|Overall Study||18
619990|NCT00296036|1520945|P2|STARTED|Overall Study||18
619991|NCT00296036|1520946|P1|STARTED|Overall Study||19
619992|NCT00295880|1520972|P1|NOT COMPLETED|Overall Study||2
619993|NCT00295880|1520972|P1|COMPLETED|Overall Study||10
619994|NCT00295880|1520972|P1|STARTED|Overall Study||12
619995|NCT00295854|1520986|P3|NOT COMPLETED|Overall Study||15
619996|NCT00295854|1520987|P2|NOT COMPLETED|Overall Study||21
619997|NCT00295854|1520988|P1|NOT COMPLETED|Overall Study||18
619998|NCT00295854|1520986|P3|COMPLETED|Overall Study||87
619999|NCT00295854|1520987|P2|COMPLETED|Overall Study||87
620000|NCT00295854|1520988|P1|COMPLETED|Overall Study||77
620001|NCT00295854|1520986|P3|ITT Population (N=296)|Overall Study||99
620002|NCT00295854|1520987|P2|ITT Population (N=296)|Overall Study||105
620003|NCT00295854|1520988|P1|ITT Population (N=296)|Overall Study||92
620004|NCT00295854|1520986|P3|Safety Population (N=304)|Overall Study||101
620005|NCT00295854|1520987|P2|Safety Population (N=304)|Overall Study||108
620006|NCT00295854|1520988|P1|Safety Population (N=304)|Overall Study||95
620007|NCT00295854|1520986|P3|STARTED|Overall Study||102
620008|NCT00295854|1520987|P2|STARTED|Overall Study||108
620009|NCT00295854|1520988|P1|STARTED|Overall Study||95
620010|NCT00295750|1521002|P3|NOT COMPLETED|Overall Study||32
620011|NCT00295750|1521003|P2|NOT COMPLETED|Overall Study||41
620012|NCT00295750|1521004|P1|NOT COMPLETED|Overall Study||43
620013|NCT00295750|1521002|P3|COMPLETED|Overall Study||172
620014|NCT00295750|1521003|P2|COMPLETED|Overall Study||169
620015|NCT00295750|1521004|P1|COMPLETED|Overall Study||163
620016|NCT00295750|1521002|P3|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|201
620017|NCT00295750|1521003|P2|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|207
620018|NCT00295750|1521004|P1|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|202
620019|NCT00295750|1521002|P3|STARTED|Overall Study|randomized|204
620020|NCT00295750|1521003|P2|STARTED|Overall Study|randomized|210
620021|NCT00295750|1521004|P1|STARTED|Overall Study|randomized|206
620022|NCT00295633|1521039|P3|NOT COMPLETED|Overall Study||76
620023|NCT00295633|1521040|P2|NOT COMPLETED|Overall Study||67
620024|NCT00295633|1521041|P1|NOT COMPLETED|Overall Study||62
620025|NCT00295633|1521039|P3|COMPLETED|Overall Study||108
620026|NCT00295633|1521040|P2|COMPLETED|Overall Study||119
620027|NCT00295633|1521041|P1|COMPLETED|Overall Study||133
620028|NCT00295633|1521039|P3|Completed Study Without Being Rescued|Overall Study||51
620029|NCT00295633|1521040|P2|Completed Study Without Being Rescued|Overall Study||82
620030|NCT00295633|1521041|P1|Completed Study Without Being Rescued|Overall Study||88
620031|NCT00295633|1521039|P3|STARTED|Overall Study||184
620032|NCT00295633|1521040|P2|STARTED|Overall Study||186
620033|NCT00295633|1521041|P1|STARTED|Overall Study||195
620034|NCT00295503|1521058|P1|NOT COMPLETED|Overall Study||0
620035|NCT00295503|1521058|P1|COMPLETED|Overall Study||53
620036|NCT00295503|1521058|P1|STARTED|Overall Study||53
620037|NCT00295490|1521068|P4|NOT COMPLETED|Overall Study||5
620038|NCT00295490|1521069|P3|NOT COMPLETED|Overall Study||4
620039|NCT00295490|1521070|P2|NOT COMPLETED|Overall Study||4
620040|NCT00295490|1521071|P1|NOT COMPLETED|Overall Study||1
620041|NCT00295490|1521068|P4|COMPLETED|Overall Study||12
620042|NCT00295490|1521069|P3|COMPLETED|Overall Study||12
620043|NCT00295490|1521070|P2|COMPLETED|Overall Study||15
620044|NCT00295490|1521071|P1|COMPLETED|Overall Study||14
620045|NCT00295490|1521068|P4|STARTED|Overall Study||17
620046|NCT00295490|1521069|P3|STARTED|Overall Study||16
620047|NCT00295490|1521070|P2|STARTED|Overall Study||19
620048|NCT00295490|1521071|P1|STARTED|Overall Study||15
620049|NCT00295061|1521111|P2|NOT COMPLETED|Overall Study||0
620050|NCT00295061|1521112|P1|NOT COMPLETED|Overall Study||0
620051|NCT00295061|1521111|P2|COMPLETED|Overall Study||12
620052|NCT00295061|1521112|P1|COMPLETED|Overall Study||12
620053|NCT00295061|1521111|P2|STARTED|Overall Study||12
620054|NCT00295061|1521112|P1|STARTED|Overall Study||12
620055|NCT00295009|1521124|P6|NOT COMPLETED|Overall Study||269
620056|NCT00295009|1521125|P5|NOT COMPLETED|Overall Study||58
620057|NCT00295009|1521126|P4|NOT COMPLETED|Overall Study||25
620058|NCT00295009|1521127|P3|NOT COMPLETED|Overall Study||12
620059|NCT00295009|1521128|P2|NOT COMPLETED|Overall Study||49
620060|NCT00295009|1521129|P1|NOT COMPLETED|Overall Study||41
620061|NCT00295009|1521124|P6|COMPLETED|Overall Study|Continued Access patients were only followed out to 24 months|0
620062|NCT00295009|1521125|P5|COMPLETED|Overall Study|Completed 60 month visit|116
620063|NCT00295009|1521126|P4|COMPLETED|Overall Study|Completed 60 month visit|57
620064|NCT00295009|1521127|P3|COMPLETED|Overall Study|Completed 60 month visit|39
620065|NCT00295009|1521128|P2|COMPLETED|Overall Study|Completed 60 month visit|134
620066|NCT00295009|1521129|P1|COMPLETED|Overall Study|Completed 60 month visit|52
620067|NCT00295009|1521124|P6|Completed 24 Month Analysis|Overall Study||198
620068|NCT00295009|1521125|P5|Completed 24 Month Analysis|Overall Study||133
620069|NCT00295009|1521126|P4|Completed 24 Month Analysis|Overall Study||60
620070|NCT00295009|1521127|P3|Completed 24 Month Analysis|Overall Study||45
620071|NCT00295009|1521128|P2|Completed 24 Month Analysis|Overall Study||148
620072|NCT00295009|1521129|P1|Completed 24 Month Analysis|Overall Study||71
620073|NCT00295009|1521124|P6|Treated|Overall Study||259
620074|NCT00295009|1521125|P5|Treated|Overall Study||165
620075|NCT00295009|1521126|P4|Treated|Overall Study||72
620076|NCT00295009|1521127|P3|Treated|Overall Study||50
620077|NCT00295009|1521128|P2|Treated|Overall Study||162
620078|NCT00295009|1521129|P1|Treated|Overall Study||80
620079|NCT00295009|1521124|P6|STARTED|Overall Study||269
620080|NCT00295009|1521125|P5|STARTED|Overall Study||174
620081|NCT00295009|1521126|P4|STARTED|Overall Study||82
620082|NCT00295009|1521127|P3|STARTED|Overall Study||51
620083|NCT00295009|1521128|P2|STARTED|Overall Study||183
620084|NCT00295009|1521129|P1|STARTED|Overall Study||93
620085|NCT00294762|1521151|P2|NOT COMPLETED|Overall Study||3
620086|NCT00294762|1521152|P1|NOT COMPLETED|Overall Study||3
620087|NCT00294762|1521151|P2|COMPLETED|Overall Study||68
620088|NCT00294762|1521152|P1|COMPLETED|Overall Study||69
620089|NCT00294762|1521151|P2|STARTED|Overall Study||71
620090|NCT00294762|1521152|P1|STARTED|Overall Study||72
620091|NCT00294723|1521171|P3|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||20
620092|NCT00294723|1521172|P2|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||21
620093|NCT00294723|1521173|P1|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||28
620094|NCT00294723|1521171|P3|COMPLETED|Additional Open-Label Extension 91 Weeks||8
620095|NCT00294723|1521172|P2|COMPLETED|Additional Open-Label Extension 91 Weeks||32
620096|NCT00294723|1521173|P1|COMPLETED|Additional Open-Label Extension 91 Weeks||34
620097|NCT00294723|1521171|P3|STARTED|Additional Open-Label Extension 91 Weeks|69 subjects did not continue into the extension period|28
620098|NCT00294723|1521172|P2|STARTED|Additional Open-Label Extension 91 Weeks|57 subjects did not continue into the extension period|53
620099|NCT00294723|1521173|P1|STARTED|Additional Open-Label Extension 91 Weeks|52 subjects did not continue into the extension period|62
620100|NCT00294723|1521171|P3|NOT COMPLETED|Open-Label Extension 52 Weeks||40
620101|NCT00294723|1521172|P2|NOT COMPLETED|Open-Label Extension 52 Weeks||39
620102|NCT00294723|1521173|P1|NOT COMPLETED|Open-Label Extension 52 Weeks||40
620103|NCT00294723|1521171|P3|COMPLETED|Open-Label Extension 52 Weeks||97
620104|NCT00294723|1521172|P2|COMPLETED|Open-Label Extension 52 Weeks||110
620105|NCT00294723|1521173|P1|COMPLETED|Open-Label Extension 52 Weeks||114
620106|NCT00294723|1521171|P3|STARTED|Open-Label Extension 52 Weeks|15 subjects did not continue into the extension period|137
620107|NCT00294723|1521172|P2|STARTED|Open-Label Extension 52 Weeks|13 subjects did not continue into the extension period|149
620108|NCT00294723|1521173|P1|STARTED|Open-Label Extension 52 Weeks|19 subjects did not continue into the extension period|154
620109|NCT00294723|1521171|P3|NOT COMPLETED|Double-Blind Period 52 Weeks||96
620110|NCT00294723|1521172|P2|NOT COMPLETED|Double-Blind Period 52 Weeks||89
620111|NCT00294723|1521173|P1|NOT COMPLETED|Double-Blind Period 52 Weeks||74
620112|NCT00294723|1521171|P3|COMPLETED|Double-Blind Period 52 Weeks||152
620113|NCT00294723|1521172|P2|COMPLETED|Double-Blind Period 52 Weeks||162
620114|NCT00294723|1521173|P1|COMPLETED|Double-Blind Period 52 Weeks||173
620115|NCT00294723|1521171|P3|Exposed to Study Drug|Double-Blind Period 52 Weeks||248
620116|NCT00294723|1521172|P2|Exposed to Study Drug|Double-Blind Period 52 Weeks||251
620117|NCT00294723|1521173|P1|Exposed to Study Drug|Double-Blind Period 52 Weeks|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|246
620118|NCT00294723|1521171|P3|STARTED|Double-Blind Period 52 Weeks|Randomised|248
620119|NCT00294723|1521172|P2|STARTED|Double-Blind Period 52 Weeks|Randomised|251
620120|NCT00294723|1521173|P1|STARTED|Double-Blind Period 52 Weeks|Randomised|247
620121|NCT00294684|1521234|P2|NOT COMPLETED|Overall Study||8
620122|NCT00294684|1521235|P1|NOT COMPLETED|Overall Study||5
620123|NCT00294684|1521234|P2|COMPLETED|Overall Study||62
620124|NCT00294684|1521235|P1|COMPLETED|Overall Study||65
620125|NCT00294684|1521234|P2|STARTED|Overall Study||70
620126|NCT00294684|1521235|P1|STARTED|Overall Study||70
620127|NCT00294671|1521275|P2|NOT COMPLETED|Overall Study||40
620128|NCT00294671|1521276|P1|NOT COMPLETED|Overall Study||27
620129|NCT00294671|1521275|P2|COMPLETED|Overall Study||26
620130|NCT00294671|1521276|P1|COMPLETED|Overall Study||37
620131|NCT00294671|1521275|P2|STARTED|Overall Study||66
620132|NCT00294671|1521276|P1|STARTED|Overall Study||64
620133|NCT00294658|1521292|P2|NOT COMPLETED|Overall Study||9
620134|NCT00294658|1521293|P1|NOT COMPLETED|Overall Study||6
620135|NCT00294658|1521292|P2|COMPLETED|Overall Study||51
620136|NCT00294658|1521293|P1|COMPLETED|Overall Study||60
620137|NCT00294658|1521292|P2|STARTED|Overall Study||60
620138|NCT00294658|1521293|P1|STARTED|Overall Study||66
620139|NCT00294645|1521357|P2|NOT COMPLETED|Overall Study||92
620140|NCT00294645|1521358|P1|NOT COMPLETED|Overall Study||48
620141|NCT00294645|1521357|P2|COMPLETED|Overall Study||510
620142|NCT00294645|1521358|P1|COMPLETED|Overall Study||247
620143|NCT00294645|1521357|P2|STARTED|Overall Study||602
620144|NCT00294645|1521358|P1|STARTED|Overall Study||295
620145|NCT00294554|1521392|P2|NOT COMPLETED|Overall Study||2
620146|NCT00294554|1521393|P1|NOT COMPLETED|Overall Study||0
620147|NCT00294554|1521392|P2|COMPLETED|Overall Study|"1 S withdrew @ 20 wks for lack perceived benefit~1 S withdrawn @ 13 wks b/o extreme agitation"|8
620148|NCT00294554|1521393|P1|COMPLETED|Overall Study||10
620149|NCT00294554|1521392|P2|STARTED|Overall Study||10
620150|NCT00294554|1521393|P1|STARTED|Overall Study||10
620151|NCT00294515|1521403|P2|NOT COMPLETED|Overall Study||28
620152|NCT00294515|1521404|P1|NOT COMPLETED|Overall Study||34
620153|NCT00294515|1521403|P2|COMPLETED|Overall Study||132
620154|NCT00294515|1521404|P1|COMPLETED|Overall Study||132
620155|NCT00294515|1521403|P2|STARTED|Overall Study|Randomized|160
620156|NCT00294515|1521404|P1|STARTED|Overall Study|Randomized|166
620157|NCT00294398|1521420|P2|NOT COMPLETED|Overall Study||26
620158|NCT00294398|1521421|P1|NOT COMPLETED|Overall Study||21
620159|NCT00294398|1521420|P2|COMPLETED|Overall Study||48
620160|NCT00294398|1521421|P1|COMPLETED|Overall Study||57
620161|NCT00294398|1521420|P2|STARTED|Overall Study||74
620162|NCT00294398|1521421|P1|STARTED|Overall Study||78
620163|NCT00294060|1521429|P1|NOT COMPLETED|Overall Study||1173
620164|NCT00294060|1521429|P1|COMPLETED|Overall Study||840
620165|NCT00294060|1521429|P1|STARTED|Overall Study||2013
620166|NCT00294047|1521437|P2|NOT COMPLETED|Month 84||989
620167|NCT00294047|1521438|P1|NOT COMPLETED|Month 84||973
620168|NCT00294047|1521437|P2|COMPLETED|Month 84|The number of subjects who remained up to Month 48 in the Aluminium Hydroxide Group = 2116|1881
620169|NCT00294047|1521438|P1|COMPLETED|Month 84|The number of subjects who remained up to Month 48 in the Cervarix Group = 2146|1904
620170|NCT00294047|1521437|P2|STARTED|Month 84||2870
620171|NCT00294047|1521438|P1|STARTED|Month 84||2877
620172|NCT00294047|1521437|P2|NOT COMPLETED|Month 48||433
620173|NCT00294047|1521438|P1|NOT COMPLETED|Month 48||425
620174|NCT00294047|1521437|P2|COMPLETED|Month 48||2438
620175|NCT00294047|1521438|P1|COMPLETED|Month 48||2456
620176|NCT00294047|1521437|P2|Participated up to Month 48|Month 48||2281
620177|NCT00294047|1521438|P1|Participated up to Month 48|Month 48||2305
620178|NCT00294047|1521437|P2|STARTED|Month 48||2871
620179|NCT00294047|1521438|P1|STARTED|Month 48||2881
620180|NCT00293813|1521543|P3|NOT COMPLETED|Overall Study||8
620181|NCT00293813|1521544|P2|NOT COMPLETED|Overall Study||9
620182|NCT00293813|1521545|P1|NOT COMPLETED|Overall Study||13
620183|NCT00293813|1521543|P3|COMPLETED|Overall Study||74
620184|NCT00293813|1521544|P2|COMPLETED|Overall Study||74
620185|NCT00293813|1521545|P1|COMPLETED|Overall Study||69
620186|NCT00293813|1521543|P3|STARTED|Overall Study||82
620187|NCT00293813|1521544|P2|STARTED|Overall Study||83
620188|NCT00293813|1521545|P1|STARTED|Overall Study||82
620189|NCT00293722|1521556|P1|NOT COMPLETED|Overall Study||427
620190|NCT00293722|1521556|P1|COMPLETED|Overall Study||864
620191|NCT00293722|1521556|P1|STARTED|Overall Study||1291
620192|NCT00293709|1521570|P1|NOT COMPLETED|Overall Study||47
620193|NCT00293709|1521570|P1|COMPLETED|Overall Study||102
620194|NCT00293709|1521570|P1|STARTED|Overall Study||149
620195|NCT00293579|1521584|P1|NOT COMPLETED|Overall Study||1
620196|NCT00293579|1521584|P1|COMPLETED|Overall Study||4
620197|NCT00293579|1521584|P1|STARTED|Overall Study||5
620198|NCT00293540|1521593|P2|NOT COMPLETED|Overall Study||8
620199|NCT00293540|1521594|P1|NOT COMPLETED|Overall Study||7
620200|NCT00293540|1521593|P2|COMPLETED|Overall Study||119
620201|NCT00293540|1521594|P1|COMPLETED|Overall Study||115
620202|NCT00293540|1521593|P2|STARTED|Overall Study||127
620203|NCT00293540|1521594|P1|STARTED|Overall Study||122
620204|NCT00293462|1521603|P3|NOT COMPLETED|Overall Study||10
620205|NCT00293462|1521604|P2|NOT COMPLETED|Overall Study||8
620206|NCT00293462|1521605|P1|NOT COMPLETED|Overall Study||7
620207|NCT00293462|1521603|P3|COMPLETED|Overall Study||21
620208|NCT00293462|1521604|P2|COMPLETED|Overall Study||21
620209|NCT00293462|1521605|P1|COMPLETED|Overall Study||24
620210|NCT00293462|1521603|P3|STARTED|Overall Study||31
620211|NCT00293462|1521604|P2|STARTED|Overall Study||29
620212|NCT00293462|1521605|P1|STARTED|Overall Study||31
620213|NCT00293384|1521624|P1|NOT COMPLETED|Overall Study||5
620214|NCT00293384|1521624|P1|COMPLETED|Overall Study||35
620215|NCT00293384|1521624|P1|STARTED|Overall Study||40
620216|NCT00293293|1521633|P2|NOT COMPLETED|Overall Study||2
620217|NCT00293293|1521634|P1|NOT COMPLETED|Overall Study||2
620218|NCT00293293|1521633|P2|COMPLETED|Overall Study||21
620219|NCT00293293|1521634|P1|COMPLETED|Overall Study||18
620220|NCT00293293|1521633|P2|STARTED|Overall Study||23
620221|NCT00293293|1521634|P1|STARTED|Overall Study||20
620222|NCT00293267|1521662|P2|NOT COMPLETED|Open-Label Post Virologic Failure Phase||37
620223|NCT00293267|1521663|P1|NOT COMPLETED|Open-Label Post Virologic Failure Phase||33
620224|NCT00293267|1521662|P2|COMPLETED|Open-Label Post Virologic Failure Phase||29
620225|NCT00293267|1521663|P1|COMPLETED|Open-Label Post Virologic Failure Phase||15
620226|NCT00293267|1521662|P2|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|66
620227|NCT00293267|1521663|P1|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|48
620228|NCT00293267|1521662|P2|NOT COMPLETED|Extension - Open-Label Week 157-240||2
620229|NCT00293267|1521663|P1|NOT COMPLETED|Extension - Open-Label Week 157-240||20
620230|NCT00293267|1521662|P2|COMPLETED|Extension - Open-Label Week 157-240||26
620231|NCT00293267|1521663|P1|COMPLETED|Extension - Open-Label Week 157-240||111
620232|NCT00293267|1521662|P2|STARTED|Extension - Open-Label Week 157-240|7 of 35 participants who completed the double-blind phase did not enter this open-label phase|28
620233|NCT00293267|1521663|P1|STARTED|Extension - Open-Label Week 157-240|8 of 139 participants who completed the double-blind phase did not enter this open-label phase|131
620234|NCT00293267|1521662|P2|NOT COMPLETED|Extension - Double-Blind Week 49-156||15
620235|NCT00293267|1521663|P1|NOT COMPLETED|Extension - Double-Blind Week 49-156||52
620236|NCT00293267|1521662|P2|COMPLETED|Extension - Double-Blind Week 49-156||35
620237|NCT00293267|1521663|P1|COMPLETED|Extension - Double-Blind Week 49-156||139
620238|NCT00293267|1521662|P2|STARTED|Extension - Double-Blind Week 49-156||50
620239|NCT00293267|1521663|P1|STARTED|Extension - Double-Blind Week 49-156|2 participants who completed Week 48 did not enter the extension study|191
620240|NCT00293267|1521662|P2|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||68
620241|NCT00293267|1521663|P1|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||41
620242|NCT00293267|1521662|P2|COMPLETED|Primary Study - Double-Blind Week 0-48||50
620243|NCT00293267|1521663|P1|COMPLETED|Primary Study - Double-Blind Week 0-48||193
620244|NCT00293267|1521662|P2|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48||50
620245|NCT00293267|1521663|P1|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the open-label post virological failure (OLPVF) phase|193
620246|NCT00293267|1521662|P2|Treated|Primary Study - Double-Blind Week 0-48||118
620247|NCT00293267|1521663|P1|Treated|Primary Study - Double-Blind Week 0-48||232
620248|NCT00293267|1521662|P2|STARTED|Primary Study - Double-Blind Week 0-48||118
620249|NCT00293267|1521663|P1|STARTED|Primary Study - Double-Blind Week 0-48||234
620250|NCT00293254|1521703|P2|NOT COMPLETED|Open-Label Post Virologic Failure Phase||27
620251|NCT00293254|1521704|P1|NOT COMPLETED|Open-Label Post Virologic Failure Phase||31
620252|NCT00293254|1521703|P2|COMPLETED|Open-Label Post Virologic Failure Phase||37
620253|NCT00293254|1521704|P1|COMPLETED|Open-Label Post Virologic Failure Phase||19
620254|NCT00293254|1521703|P2|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|64
620255|NCT00293254|1521704|P1|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|50
620256|NCT00293254|1521703|P2|NOT COMPLETED|Extension - Open-Label Week 157-240||1
620257|NCT00293254|1521704|P1|NOT COMPLETED|Extension - Open-Label Week 157-240||10
620258|NCT00293254|1521703|P2|COMPLETED|Extension - Open-Label Week 157-240||18
620259|NCT00293254|1521704|P1|COMPLETED|Extension - Open-Label Week 157-240||110
620260|NCT00293254|1521703|P2|STARTED|Extension - Open-Label Week 157-240|6 of 25 participants who completed the double-blind phase did not enter this open-label phase.|19
620261|NCT00293254|1521704|P1|STARTED|Extension - Open-Label Week 157-240||120
620262|NCT00293254|1521703|P2|NOT COMPLETED|Extension - Double-Blind Week 49-156||29
620263|NCT00293254|1521704|P1|NOT COMPLETED|Extension - Double-Blind Week 49-156||57
620264|NCT00293254|1521703|P2|COMPLETED|Extension - Double-Blind Week 49-156||25
620265|NCT00293254|1521704|P1|COMPLETED|Extension - Double-Blind Week 49-156||120
620266|NCT00293254|1521703|P2|STARTED|Extension - Double-Blind Week 49-156|1 of 55 participants who completed Week 48 did not enter the extension study.|54
620267|NCT00293254|1521704|P1|STARTED|Extension - Double-Blind Week 49-156||177
620268|NCT00293254|1521703|P2|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||64
620269|NCT00293254|1521704|P1|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||55
620270|NCT00293254|1521703|P2|COMPLETED|Primary Study - Double-Blind Week 0-48||55
620271|NCT00293254|1521704|P1|COMPLETED|Primary Study - Double-Blind Week 0-48||177
620272|NCT00293254|1521703|P2|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the OLPVF phase|55
620273|NCT00293254|1521704|P1|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the Open-Label Post-Virologic Failure (OLPVF) Phase|177
620274|NCT00293254|1521703|P2|Treated|Primary Study - Double-Blind Week 0-48||119
620275|NCT00293254|1521704|P1|Treated|Primary Study - Double-Blind Week 0-48||230
620276|NCT00293254|1521703|P2|STARTED|Primary Study - Double-Blind Week 0-48||119
620277|NCT00293254|1521704|P1|STARTED|Primary Study - Double-Blind Week 0-48||232
620278|NCT00293241|1521744|P2|NOT COMPLETED|Overall Study||41
620279|NCT00293241|1521745|P1|NOT COMPLETED|Overall Study||36
620280|NCT00293241|1521744|P2|COMPLETED|Overall Study||265
620281|NCT00293241|1521745|P1|COMPLETED|Overall Study||263
620282|NCT00293241|1521744|P2|STARTED|Overall Study||306
620283|NCT00293241|1521745|P1|STARTED|Overall Study||299
620284|NCT00293059|1521789|P2|NOT COMPLETED|Overall Study||19
620285|NCT00293059|1521790|P1|NOT COMPLETED|Overall Study||35
620286|NCT00293059|1521789|P2|COMPLETED|Overall Study||51
620287|NCT00293059|1521790|P1|COMPLETED|Overall Study||85
620288|NCT00293059|1521789|P2|Cycle 7/Treatment Day 196|Overall Study|Includes participants that prematurely discontinued and may not be counted in earlier visits.|62
620289|NCT00293059|1521790|P1|Cycle 7/Treatment Day 196|Overall Study|Includes participants that prematurely discontinued and may not be counted in earlier visits.|113
620290|NCT00293059|1521789|P2|Cycle 3/Treatment Day 84|Overall Study||55
620291|NCT00293059|1521790|P1|Cycle 3/Treatment Day 84|Overall Study||100
620292|NCT00293059|1521789|P2|Cycle 1/Treatment Day 28|Overall Study||64
620293|NCT00293059|1521790|P1|Cycle 1/Treatment Day 28|Overall Study||115
620294|NCT00293059|1521789|P2|Subjects Received Treatment|Overall Study||66
620295|NCT00293059|1521790|P1|Subjects Received Treatment|Overall Study||119
620296|NCT00293059|1521789|P2|STARTED|Overall Study||70
620297|NCT00293059|1521790|P1|STARTED|Overall Study||120
620298|NCT00293020|1521902|P1|NOT COMPLETED|Overall Study||162
620299|NCT00293020|1521902|P1|COMPLETED|Overall Study||82
620300|NCT00293020|1521902|P1|STARTED|Overall Study||244
620301|NCT00292981|1521906|P1|NOT COMPLETED|Overall Study||39
620302|NCT00292981|1521906|P1|COMPLETED|Overall Study||18
620303|NCT00292981|1521906|P1|STARTED|Overall Study||57
620304|NCT00292591|1521916|P3|NOT COMPLETED|Overall Study||58
620305|NCT00292591|1521917|P2|NOT COMPLETED|Overall Study||56
620306|NCT00292591|1521918|P1|NOT COMPLETED|Overall Study||64
620307|NCT00292591|1521916|P3|COMPLETED|Overall Study||110
620308|NCT00292591|1521917|P2|COMPLETED|Overall Study||111
620309|NCT00292591|1521918|P1|COMPLETED|Overall Study||102
620310|NCT00292591|1521916|P3|STARTED|Overall Study||168
620311|NCT00292591|1521917|P2|STARTED|Overall Study||167
620312|NCT00292591|1521918|P1|STARTED|Overall Study||166
620313|NCT00292461|1521928|P2|NOT COMPLETED|Overall Study||6
620314|NCT00292461|1521929|P1|NOT COMPLETED|Overall Study||10
620315|NCT00292461|1521928|P2|COMPLETED|Overall Study||24
620316|NCT00292461|1521929|P1|COMPLETED|Overall Study||24
620317|NCT00292461|1521928|P2|STARTED|Overall Study||30
620318|NCT00292461|1521929|P1|STARTED|Overall Study||34
620319|NCT00292370|1521944|P3|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||7
620320|NCT00292370|1521945|P2|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||4
620321|NCT00292370|1521946|P1|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0
620322|NCT00292370|1521944|P3|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||18
620323|NCT00292370|1521945|P2|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||21
620324|NCT00292370|1521946|P1|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0
620325|NCT00292370|1521944|P3|STARTED|Phase II: OLP + DB Quetiapine or Placebo|25 out of 50 in Arm I PhI, eligible for Ph II|25
620326|NCT00292370|1521945|P2|STARTED|Phase II: OLP + DB Quetiapine or Placebo|25 out of 50 in Arm I PhI, eligible for Ph II|25
620327|NCT00292370|1521946|P1|STARTED|Phase II: OLP + DB Quetiapine or Placebo|"78 Completed Ph I~28 Excluded Ph II:~20 responded~7 declined~1 medical~50 to Arm 2 & 3"|0
620328|NCT00292370|1521944|P3|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
620329|NCT00292370|1521945|P2|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
620330|NCT00292370|1521946|P1|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||46
620331|NCT00292370|1521944|P3|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
620332|NCT00292370|1521945|P2|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
620333|NCT00292370|1521946|P1|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||78
620334|NCT00292370|1521944|P3|STARTED|Phase I - Open-Label Paroxetine (OLP)||0
620335|NCT00292370|1521945|P2|STARTED|Phase I - Open-Label Paroxetine (OLP)||0
620336|NCT00292370|1521946|P1|STARTED|Phase I - Open-Label Paroxetine (OLP)||124
620337|NCT00292318|1521955|P2|NOT COMPLETED|Overall Study||1
620338|NCT00292318|1521956|P1|NOT COMPLETED|Overall Study||2
620339|NCT00292318|1521955|P2|COMPLETED|Overall Study||2
620340|NCT00292318|1521956|P1|COMPLETED|Overall Study||2
620341|NCT00292318|1521955|P2|STARTED|Overall Study||3
620342|NCT00292318|1521956|P1|STARTED|Overall Study||4
620343|NCT00292227|1521966|P3|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
620344|NCT00292227|1521967|P2|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
620345|NCT00292227|1521968|P1|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
620346|NCT00292227|1521966|P3|COMPLETED|Cross-over Period 2 (Day 39)||30
620347|NCT00292227|1521967|P2|COMPLETED|Cross-over Period 2 (Day 39)||31
620348|NCT00292227|1521968|P1|COMPLETED|Cross-over Period 2 (Day 39)||65
620349|NCT00292227|1521966|P3|STARTED|Cross-over Period 2 (Day 39)||30
620350|NCT00292227|1521967|P2|STARTED|Cross-over Period 2 (Day 39)||31
620351|NCT00292227|1521968|P1|STARTED|Cross-over Period 2 (Day 39)||65
620352|NCT00292227|1521966|P3|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
620353|NCT00292227|1521967|P2|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
620354|NCT00292227|1521968|P1|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
620355|NCT00292227|1521966|P3|COMPLETED|Cross-over Period 1 (Day 32)||30
620356|NCT00292227|1521967|P2|COMPLETED|Cross-over Period 1 (Day 32)||31
620357|NCT00292227|1521968|P1|COMPLETED|Cross-over Period 1 (Day 32)||65
620358|NCT00292227|1521966|P3|STARTED|Cross-over Period 1 (Day 32)||30
620359|NCT00292227|1521967|P2|STARTED|Cross-over Period 1 (Day 32)||31
620360|NCT00292227|1521968|P1|STARTED|Cross-over Period 1 (Day 32)||65
620361|NCT00292227|1521966|P3|NOT COMPLETED|Patch Period||3
620362|NCT00292227|1521967|P2|NOT COMPLETED|Patch Period||0
620363|NCT00292227|1521968|P1|NOT COMPLETED|Patch Period||1
620364|NCT00292227|1521966|P3|COMPLETED|Patch Period||30
620365|NCT00292227|1521967|P2|COMPLETED|Patch Period||31
620366|NCT00292227|1521968|P1|COMPLETED|Patch Period||65
620367|NCT00292227|1521966|P3|STARTED|Patch Period||33
620368|NCT00292227|1521967|P2|STARTED|Patch Period||31
620369|NCT00292227|1521968|P1|STARTED|Patch Period||66
620370|NCT00292188|1522050|P3|NOT COMPLETED|Double-Blind||29
620371|NCT00292188|1522051|P2|NOT COMPLETED|Double-Blind||31
620372|NCT00292188|1522052|P1|NOT COMPLETED|Double-Blind||0
620373|NCT00292188|1522050|P3|COMPLETED|Double-Blind||98
620374|NCT00292188|1522051|P2|COMPLETED|Double-Blind||96
620375|NCT00292188|1522052|P1|COMPLETED|Double-Blind||0
620376|NCT00292188|1522050|P3|STARTED|Double-Blind||127
620377|NCT00292188|1522051|P2|STARTED|Double-Blind||127
620378|NCT00292188|1522052|P1|STARTED|Double-Blind||0
620379|NCT00292188|1522050|P3|NOT COMPLETED|Single-Blind||0
620380|NCT00292188|1522051|P2|NOT COMPLETED|Single-Blind||0
620381|NCT00292188|1522052|P1|NOT COMPLETED|Single-Blind||114
620382|NCT00292188|1522050|P3|COMPLETED|Single-Blind||0
620383|NCT00292188|1522051|P2|COMPLETED|Single-Blind||0
620384|NCT00292188|1522052|P1|COMPLETED|Single-Blind||254
620385|NCT00292188|1522050|P3|Received Treatment|Single-Blind||0
620386|NCT00292188|1522051|P2|Received Treatment|Single-Blind||0
620387|NCT00292188|1522052|P1|Received Treatment|Single-Blind||367
620388|NCT00292188|1522050|P3|STARTED|Single-Blind||0
620389|NCT00292188|1522051|P2|STARTED|Single-Blind||0
620390|NCT00292188|1522052|P1|STARTED|Single-Blind||368
620391|NCT00292162|1522113|P2|NOT COMPLETED|Overall Study||2
620392|NCT00292162|1522114|P1|NOT COMPLETED|Overall Study||1
620393|NCT00292162|1522113|P2|COMPLETED|Overall Study||20
620394|NCT00292162|1522114|P1|COMPLETED|Overall Study||18
620395|NCT00292162|1522113|P2|STARTED|Overall Study||22
620396|NCT00292162|1522114|P1|STARTED|Overall Study||19
620397|NCT00291876|1522130|P1|NOT COMPLETED|Month 246||0
620398|NCT00291876|1522130|P1|COMPLETED|Month 246||116
620399|NCT00291876|1522130|P1|STARTED|Month 246||116
620400|NCT00291876|1522130|P1|NOT COMPLETED|Month 234||0
620401|NCT00291876|1522130|P1|COMPLETED|Month 234||110
620402|NCT00291876|1522130|P1|STARTED|Month 234||110
620403|NCT00291876|1522130|P1|NOT COMPLETED|Month 222||0
620404|NCT00291876|1522130|P1|COMPLETED|Month 222||114
620405|NCT00291876|1522130|P1|STARTED|Month 222||114
620406|NCT00291876|1522130|P1|NOT COMPLETED|Month 210||0
620407|NCT00291876|1522130|P1|COMPLETED|Month 210||124
620408|NCT00291876|1522130|P1|STARTED|Month 210||124
620409|NCT00291876|1522130|P1|NOT COMPLETED|Month 198||0
620410|NCT00291876|1522130|P1|COMPLETED|Month 198||135
620411|NCT00291876|1522130|P1|STARTED|Month 198||135
620412|NCT00291876|1522130|P1|NOT COMPLETED|Month 186||0
620413|NCT00291876|1522130|P1|COMPLETED|Month 186||129
620414|NCT00291876|1522130|P1|STARTED|Month 186||129
620415|NCT00291876|1522130|P1|NOT COMPLETED|Month 174||0
620416|NCT00291876|1522130|P1|COMPLETED|Month 174||127
620417|NCT00291876|1522130|P1|STARTED|Month 174||127
620418|NCT00291876|1522130|P1|NOT COMPLETED|Month 162||0
620419|NCT00291876|1522130|P1|COMPLETED|Month 162||127
620420|NCT00291876|1522130|P1|STARTED|Month 162||127
620421|NCT00291876|1522130|P1|NOT COMPLETED|Month 150||0
620422|NCT00291876|1522130|P1|COMPLETED|Month 150||117
620423|NCT00291876|1522130|P1|STARTED|Month 150||117
620424|NCT00291876|1522130|P1|NOT COMPLETED|Month 138||0
620425|NCT00291876|1522130|P1|COMPLETED|Month 138||107
620426|NCT00291876|1522130|P1|STARTED|Month 138||107
620427|NCT00291694|1522144|P2|NOT COMPLETED|Overall Study||5
620428|NCT00291694|1522145|P1|NOT COMPLETED|Overall Study||3
620429|NCT00291694|1522144|P2|COMPLETED|Overall Study||43
620430|NCT00291694|1522145|P1|COMPLETED|Overall Study||21
620431|NCT00291694|1522144|P2|STARTED|Overall Study||48
620432|NCT00291694|1522145|P1|STARTED|Overall Study||24
620433|NCT00291655|1522159|P1|NOT COMPLETED|Overall Study||15
620434|NCT00291655|1522159|P1|COMPLETED|Overall Study||115
620435|NCT00291655|1522159|P1|STARTED|Overall Study||130
620436|NCT00291577|1522164|P1|NOT COMPLETED|Overall Study||21
620437|NCT00291577|1522164|P1|COMPLETED|Overall Study|Subject End of Study=Completed; not per protocol reason. PI reason=withdrawn during active treatment|1
620438|NCT00291577|1522164|P1|STARTED|Overall Study||22
620439|NCT00291551|1522183|P1|NOT COMPLETED|Overall Study||13
620440|NCT00291551|1522183|P1|COMPLETED|Overall Study||26
620441|NCT00291551|1522183|P1|STARTED|Overall Study||39
620442|NCT00291343|1522200|P2|NOT COMPLETED|Overall Study||0
620443|NCT00291343|1522201|P1|NOT COMPLETED|Overall Study||0
620444|NCT00291343|1522200|P2|COMPLETED|Overall Study||93
620445|NCT00291343|1522201|P1|COMPLETED|Overall Study||203
620446|NCT00291343|1522200|P2|STARTED|Overall Study||93
620447|NCT00291343|1522201|P1|STARTED|Overall Study||203
620448|NCT00291330|1522231|P2|NOT COMPLETED|Overall Study||97
620449|NCT00291330|1522232|P1|NOT COMPLETED|Overall Study||101
620450|NCT00291330|1522231|P2|COMPLETED|Overall Study|Completed planned observation time|1169
620451|NCT00291330|1522232|P1|COMPLETED|Overall Study|Completed planned observation time|1172
620452|NCT00291330|1522231|P2|STARTED|Overall Study|Started Treatment|1266
620453|NCT00291330|1522232|P1|STARTED|Overall Study|Started Treatment|1273
620454|NCT00291317|1522254|P1|NOT COMPLETED|Overall Study||0
620455|NCT00291317|1522254|P1|COMPLETED|Overall Study||6
620456|NCT00291317|1522254|P1|STARTED|Overall Study||6
620457|NCT00291226|1522261|P2|NOT COMPLETED|Overall Study||1
620458|NCT00291226|1522262|P1|NOT COMPLETED|Overall Study||1
620459|NCT00291226|1522261|P2|COMPLETED|Overall Study||3
620460|NCT00291226|1522262|P1|COMPLETED|Overall Study||3
620461|NCT00291226|1522261|P2|STARTED|Overall Study||4
620462|NCT00291226|1522262|P1|STARTED|Overall Study||4
620463|NCT00291187|1522274|P4|NOT COMPLETED|Overall Study||0
620464|NCT00291187|1522275|P3|NOT COMPLETED|Overall Study||1
620465|NCT00291187|1522276|P2|NOT COMPLETED|Overall Study||0
620466|NCT00291187|1522277|P1|NOT COMPLETED|Overall Study||0
620467|NCT00291187|1522274|P4|COMPLETED|Overall Study||106
620468|NCT00291187|1522275|P3|COMPLETED|Overall Study||102
620469|NCT00291187|1522276|P2|COMPLETED|Overall Study||100
620470|NCT00291187|1522277|P1|COMPLETED|Overall Study||103
620471|NCT00291187|1522274|P4|STARTED|Overall Study||106
620472|NCT00291187|1522275|P3|STARTED|Overall Study||103
620473|NCT00291187|1522276|P2|STARTED|Overall Study||100
620474|NCT00291187|1522277|P1|STARTED|Overall Study||103
620475|NCT00291161|1522303|P4|NOT COMPLETED|Overall Study||65
620476|NCT00291161|1522304|P3|NOT COMPLETED|Overall Study||93
620477|NCT00291161|1522305|P2|NOT COMPLETED|Overall Study||58
620478|NCT00291161|1522306|P1|NOT COMPLETED|Overall Study||81
620479|NCT00291161|1522303|P4|COMPLETED|Overall Study||122
620480|NCT00291161|1522304|P3|COMPLETED|Overall Study||206
620481|NCT00291161|1522305|P2|COMPLETED|Overall Study||134
620482|NCT00291161|1522306|P1|COMPLETED|Overall Study||235
620483|NCT00291161|1522303|P4|STARTED|Overall Study||187
620484|NCT00291161|1522304|P3|STARTED|Overall Study||299
620485|NCT00291161|1522305|P2|STARTED|Overall Study||192
620486|NCT00291161|1522306|P1|STARTED|Overall Study||316
620487|NCT00291135|1522314|P1|NOT COMPLETED|Overall Study||0
620488|NCT00291135|1522314|P1|COMPLETED|Overall Study||42
620489|NCT00291135|1522314|P1|STARTED|Overall Study||42
620490|NCT00291018|1522321|P3|NOT COMPLETED|Overall Study||43
620491|NCT00291018|1522322|P2|NOT COMPLETED|Overall Study||42
620492|NCT00291018|1522323|P1|NOT COMPLETED|Overall Study||25
620493|NCT00291018|1522321|P3|COMPLETED|Overall Study|Evaluated at 84 Months|93
620494|NCT00291018|1522322|P2|COMPLETED|Overall Study|Evaluated at 84 Months|64
620495|NCT00291018|1522323|P1|COMPLETED|Overall Study|Evaluated at 84 Months|78
620496|NCT00291018|1522321|P3|Evaluated at 24 Months|Overall Study||105
620497|NCT00291018|1522322|P2|Evaluated at 24 Months|Overall Study||92
620498|NCT00291018|1522323|P1|Evaluated at 24 Months|Overall Study||99
620499|NCT00291018|1522321|P3|STARTED|Overall Study|Enrolled and Treated. 140 PDC-CA subjects were Enrolled but only 136 were Treated.|136
620500|NCT00291018|1522322|P2|STARTED|Overall Study|Enrolled and Treated. 117 ACDF subjects were Enrolled but only 106 were Treated.|106
620501|NCT00291018|1522323|P1|STARTED|Overall Study|Enrolled and Treated. 111 PDC subjects were Enrolled but only 103 were Treated.|103
620502|NCT00290888|1522363|P2|NOT COMPLETED|Overall Study||1
620503|NCT00290888|1522364|P1|NOT COMPLETED|Overall Study||3
620504|NCT00290888|1522363|P2|COMPLETED|Overall Study||44
620505|NCT00290888|1522364|P1|COMPLETED|Overall Study||38
620506|NCT00290888|1522363|P2|STARTED|Overall Study||45
620507|NCT00290888|1522364|P1|STARTED|Overall Study||41
620508|NCT00290810|1522372|P1|NOT COMPLETED|Overall Study||0
620509|NCT00290810|1522372|P1|COMPLETED|Overall Study||12
620510|NCT00290810|1522372|P1|STARTED|Overall Study||12
620511|NCT00290771|1522381|P2|NOT COMPLETED|Overall Study||97
620512|NCT00290771|1522382|P1|NOT COMPLETED|Overall Study||127
620513|NCT00290771|1522381|P2|COMPLETED|Overall Study||3
620514|NCT00290771|1522382|P1|COMPLETED|Overall Study||4
620515|NCT00290771|1522381|P2|STARTED|Overall Study||100
620516|NCT00290771|1522382|P1|STARTED|Overall Study||131
620517|NCT00290758|1522406|P2|NOT COMPLETED|Post Intervention rFNA||5
620518|NCT00290758|1522407|P1|NOT COMPLETED|Post Intervention rFNA||6
620519|NCT00290758|1522406|P2|COMPLETED|Post Intervention rFNA||49
620520|NCT00290758|1522407|P1|COMPLETED|Post Intervention rFNA||49
620521|NCT00290758|1522406|P2|STARTED|Post Intervention rFNA||54
620522|NCT00290758|1522407|P1|STARTED|Post Intervention rFNA||55
620523|NCT00290758|1522406|P2|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||10
620524|NCT00290758|1522407|P1|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||7
620525|NCT00290758|1522406|P2|COMPLETED|Pre-Intervention rFNA Through Follow-Up||54
620526|NCT00290758|1522407|P1|COMPLETED|Pre-Intervention rFNA Through Follow-Up||55
620527|NCT00290758|1522406|P2|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||54
620528|NCT00290758|1522407|P1|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||55
620529|NCT00290758|1522406|P2|Treatment|Pre-Intervention rFNA Through Follow-Up||64
620530|NCT00290758|1522407|P1|Treatment|Pre-Intervention rFNA Through Follow-Up||61
620531|NCT00290758|1522406|P2|Randomization|Pre-Intervention rFNA Through Follow-Up||62
620532|NCT00290758|1522407|P1|Randomization|Pre-Intervention rFNA Through Follow-Up||62
620533|NCT00290758|1522406|P2|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||64
620534|NCT00290758|1522407|P1|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||62
620535|NCT00290758|1522406|P2|STARTED|Pre-Intervention rFNA Through Follow-Up||64
620536|NCT00290758|1522407|P1|STARTED|Pre-Intervention rFNA Through Follow-Up||62
620537|NCT00290732|1522429|P5|NOT COMPLETED|Overall Study||0
620538|NCT00290732|1522430|P4|NOT COMPLETED|Overall Study||0
620539|NCT00290732|1522431|P3|NOT COMPLETED|Overall Study||1
620540|NCT00290732|1522432|P2|NOT COMPLETED|Overall Study||1
620541|NCT00290732|1522433|P1|NOT COMPLETED|Overall Study||0
620542|NCT00290732|1522429|P5|COMPLETED|Overall Study||3
620543|NCT00290732|1522430|P4|COMPLETED|Overall Study||6
620544|NCT00290732|1522431|P3|COMPLETED|Overall Study||3
620545|NCT00290732|1522432|P2|COMPLETED|Overall Study||3
620546|NCT00290732|1522433|P1|COMPLETED|Overall Study||3
620547|NCT00290732|1522429|P5|STARTED|Overall Study||3
620548|NCT00290732|1522430|P4|STARTED|Overall Study||6
620549|NCT00290732|1522431|P3|STARTED|Overall Study||4
620550|NCT00290732|1522432|P2|STARTED|Overall Study||4
620551|NCT00290732|1522433|P1|STARTED|Overall Study||3
620552|NCT00290693|1522451|P1|NOT COMPLETED|Overall Study||2
620553|NCT00290693|1522451|P1|COMPLETED|Overall Study||43
620554|NCT00290693|1522451|P1|STARTED|Overall Study||45
620555|NCT00290654|1522459|P1|NOT COMPLETED|Overall Study||0
620556|NCT00290654|1522459|P1|COMPLETED|Overall Study||41
620557|NCT00290654|1522459|P1|STARTED|Overall Study||41
620558|NCT00290615|1522470|P1|NOT COMPLETED|Overall Study||0
620559|NCT00290615|1522470|P1|COMPLETED|Overall Study||30
620560|NCT00290615|1522470|P1|STARTED|Overall Study||30
620561|NCT00290537|1522477|P2|NOT COMPLETED|Overall Study||0
620562|NCT00290537|1522478|P1|NOT COMPLETED|Overall Study||0
620563|NCT00290537|1522477|P2|COMPLETED|Overall Study||0
620564|NCT00290537|1522478|P1|COMPLETED|Overall Study||4
620565|NCT00290537|1522477|P2|STARTED|Overall Study||0
620566|NCT00290537|1522478|P1|STARTED|Overall Study||4
620567|NCT00290472|1522486|P3|NOT COMPLETED|Overall Study||0
620568|NCT00290472|1522487|P2|NOT COMPLETED|Overall Study||0
620569|NCT00290472|1522488|P1|NOT COMPLETED|Overall Study||0
620570|NCT00290472|1522486|P3|COMPLETED|Overall Study||18
620571|NCT00290472|1522487|P2|COMPLETED|Overall Study||39
620572|NCT00290472|1522488|P1|COMPLETED|Overall Study||32
620573|NCT00290472|1522486|P3|STARTED|Overall Study||18
620574|NCT00290472|1522487|P2|STARTED|Overall Study||39
620575|NCT00290472|1522488|P1|STARTED|Overall Study||32
620576|NCT00290407|1522500|P1|NOT COMPLETED|Overall Study||2
620577|NCT00290407|1522500|P1|COMPLETED|Overall Study||0
620578|NCT00290407|1522500|P1|STARTED|Overall Study||2
620579|NCT00290329|1522508|P3|NOT COMPLETED|Overall Study||0
620580|NCT00290329|1522509|P2|NOT COMPLETED|Overall Study||0
620581|NCT00290329|1522510|P1|NOT COMPLETED|Overall Study||0
620582|NCT00290329|1522508|P3|COMPLETED|Overall Study||61
620583|NCT00290329|1522509|P2|COMPLETED|Overall Study||86
620584|NCT00290329|1522510|P1|COMPLETED|Overall Study||102
620585|NCT00290329|1522508|P3|STARTED|Overall Study||61
620586|NCT00290329|1522509|P2|STARTED|Overall Study||86
620587|NCT00290329|1522510|P1|STARTED|Overall Study||102
620588|NCT00290290|1522532|P2|NOT COMPLETED|Overall Study||18
620589|NCT00290290|1522533|P1|NOT COMPLETED|Overall Study||18
620590|NCT00290290|1522532|P2|COMPLETED|Overall Study||391
620591|NCT00290290|1522533|P1|COMPLETED|Overall Study||422
620592|NCT00290290|1522532|P2|STARTED|Overall Study||409
620593|NCT00290290|1522533|P1|STARTED|Overall Study||440
620594|NCT00290251|1522539|P3|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
620595|NCT00290251|1522540|P2|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
620596|NCT00290251|1522541|P1|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
620597|NCT00290251|1522539|P3|COMPLETED|Elective Extension (to 12 Months no Rx)||5
620598|NCT00290251|1522540|P2|COMPLETED|Elective Extension (to 12 Months no Rx)||3
620599|NCT00290251|1522541|P1|COMPLETED|Elective Extension (to 12 Months no Rx)||5
620600|NCT00290251|1522539|P3|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|5
620601|NCT00290251|1522540|P2|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|3
620602|NCT00290251|1522541|P1|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|5
620603|NCT00290251|1522539|P3|NOT COMPLETED|Treatment 2 (Months 4 - 6)||0
620604|NCT00290251|1522540|P2|NOT COMPLETED|Treatment 2 (Months 4 - 6)||0
620605|NCT00290251|1522541|P1|NOT COMPLETED|Treatment 2 (Months 4 - 6)||2
620606|NCT00290251|1522539|P3|COMPLETED|Treatment 2 (Months 4 - 6)||0
620607|NCT00290251|1522540|P2|COMPLETED|Treatment 2 (Months 4 - 6)||5
620608|NCT00290251|1522541|P1|COMPLETED|Treatment 2 (Months 4 - 6)||6
620609|NCT00290251|1522539|P3|STARTED|Treatment 2 (Months 4 - 6)|Women were randomized from PLC to ulipristal acetate or continued same dose ulipristal acetate|0
620610|NCT00290251|1522540|P2|STARTED|Treatment 2 (Months 4 - 6)|2 crossed over from placebo; others in treatment 1 PLC or ulipristal acetate 10 grp did not continue|5
620611|NCT00290251|1522541|P1|STARTED|Treatment 2 (Months 4 - 6)|2 crossed over from placebo; others in treatment 1 PLC or ulipristal acetate 20 did not continue|8
620612|NCT00290251|1522539|P3|NOT COMPLETED|Treatment 1 (Months 1 - 3)||2
620613|NCT00290251|1522540|P2|NOT COMPLETED|Treatment 1 (Months 1 - 3)||1
620614|NCT00290251|1522541|P1|NOT COMPLETED|Treatment 1 (Months 1 - 3)||1
620615|NCT00290251|1522539|P3|COMPLETED|Treatment 1 (Months 1 - 3)||12
620616|NCT00290251|1522540|P2|COMPLETED|Treatment 1 (Months 1 - 3)||13
620617|NCT00290251|1522541|P1|COMPLETED|Treatment 1 (Months 1 - 3)||13
620618|NCT00290251|1522539|P3|STARTED|Treatment 1 (Months 1 - 3)||14
620619|NCT00290251|1522540|P2|STARTED|Treatment 1 (Months 1 - 3)||14
620620|NCT00290251|1522541|P1|STARTED|Treatment 1 (Months 1 - 3)||14
620621|NCT00290238|1522553|P2|NOT COMPLETED|Overall Study||41
620622|NCT00290238|1522554|P1|NOT COMPLETED|Overall Study||42
620623|NCT00290238|1522553|P2|COMPLETED|Overall Study||24
620624|NCT00290238|1522554|P1|COMPLETED|Overall Study||15
620625|NCT00290238|1522553|P2|STARTED|Overall Study|One subject had an invalid birth date and was excluded from the Age Categorical counts.|65
620626|NCT00290238|1522554|P1|STARTED|Overall Study||57
620627|NCT00290199|1522564|P2|NOT COMPLETED|Overall Study||0
620628|NCT00290199|1522565|P1|NOT COMPLETED|Overall Study||0
620629|NCT00290199|1522564|P2|COMPLETED|Overall Study||82
620630|NCT00290199|1522565|P1|COMPLETED|Overall Study||87
620631|NCT00290199|1522564|P2|STARTED|Overall Study||82
620632|NCT00290199|1522565|P1|STARTED|Overall Study||87
620633|NCT00290186|1522579|P2|NOT COMPLETED|Overall Study||5
620634|NCT00290186|1522580|P1|NOT COMPLETED|Overall Study||5
620635|NCT00290186|1522579|P2|COMPLETED|Overall Study||19
620636|NCT00290186|1522580|P1|COMPLETED|Overall Study||20
620637|NCT00290186|1522579|P2|Completed 6-month Followup Assessments|Overall Study||19
620638|NCT00290186|1522580|P1|Completed 6-month Followup Assessments|Overall Study||20
620639|NCT00290186|1522579|P2|Completed 3-month Followup Assessments|Overall Study||21
620640|NCT00290186|1522580|P1|Completed 3-month Followup Assessments|Overall Study||20
620641|NCT00290186|1522579|P2|Completed Post-treatment Assessments|Overall Study||22
620642|NCT00290186|1522580|P1|Completed Post-treatment Assessments|Overall Study||24
620643|NCT00290186|1522579|P2|Completed 8 Weeks of Treatment|Overall Study||22
620644|NCT00290186|1522580|P1|Completed 8 Weeks of Treatment|Overall Study||24
620645|NCT00290186|1522579|P2|Completed Baseline Assessments|Overall Study||24
620646|NCT00290186|1522580|P1|Completed Baseline Assessments|Overall Study||25
620647|NCT00290186|1522579|P2|STARTED|Overall Study||24
620648|NCT00290186|1522580|P1|STARTED|Overall Study||25
620649|NCT00290147|1522620|P2|NOT COMPLETED|Overall Study||0
620650|NCT00290147|1522621|P1|NOT COMPLETED|Overall Study||0
620651|NCT00290147|1522620|P2|COMPLETED|Overall Study||12
620652|NCT00290147|1522621|P1|COMPLETED|Overall Study||10
620653|NCT00290147|1522620|P2|STARTED|Overall Study||12
620654|NCT00290147|1522621|P1|STARTED|Overall Study||10
620655|NCT00289991|1522631|P2|NOT COMPLETED|Overall Study||80
620656|NCT00289991|1522632|P1|NOT COMPLETED|Overall Study||58
620657|NCT00289991|1522631|P2|COMPLETED|Overall Study||175
620658|NCT00289991|1522632|P1|COMPLETED|Overall Study||176
620659|NCT00289991|1522631|P2|STARTED|Overall Study||255
620660|NCT00289991|1522632|P1|STARTED|Overall Study||234
620661|NCT00289978|1522657|P3|NOT COMPLETED|Overall Study||86
620662|NCT00289978|1522658|P2|NOT COMPLETED|Overall Study||56
620663|NCT00289978|1522659|P1|NOT COMPLETED|Overall Study||97
620664|NCT00289978|1522657|P3|COMPLETED|Overall Study|303 completed on study drug, 29 completed off study drug.|332
620665|NCT00289978|1522658|P2|COMPLETED|Overall Study|345 completed on study drug, 24 completed off study drug.|369
620666|NCT00289978|1522659|P1|COMPLETED|Overall Study|296 completed on study drug, 35 completed off study drug.|332
620667|NCT00289978|1522657|P3|STARTED|Overall Study||418
620668|NCT00289978|1522658|P2|STARTED|Overall Study||425
620669|NCT00289978|1522659|P1|STARTED|Overall Study||429
620670|NCT00289913|1522678|P5|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
620671|NCT00289913|1522679|P4|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
620672|NCT00289913|1522680|P3|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
620673|NCT00289913|1522681|P2|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
620674|NCT00289913|1522682|P1|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
620675|NCT00289913|1522678|P5|COMPLETED|Visit 4 (Stage I and Stage II)||597
620676|NCT00289913|1522679|P4|COMPLETED|Visit 4 (Stage I and Stage II)||131
620677|NCT00289913|1522680|P3|COMPLETED|Visit 4 (Stage I and Stage II)||138
620678|NCT00289913|1522681|P2|COMPLETED|Visit 4 (Stage I and Stage II)||106
620679|NCT00289913|1522682|P1|COMPLETED|Visit 4 (Stage I and Stage II)||122
620680|NCT00289913|1522678|P5|STARTED|Visit 4 (Stage I and Stage II)||597
620681|NCT00289913|1522679|P4|STARTED|Visit 4 (Stage I and Stage II)||131
620682|NCT00289913|1522680|P3|STARTED|Visit 4 (Stage I and Stage II)||138
620683|NCT00289913|1522681|P2|STARTED|Visit 4 (Stage I and Stage II)||106
620684|NCT00289913|1522682|P1|STARTED|Visit 4 (Stage I and Stage II)||122
620685|NCT00289913|1522678|P5|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8
620686|NCT00289913|1522679|P4|NOT COMPLETED|Visit 3 (Stage I and Stage II)||4
620687|NCT00289913|1522680|P3|NOT COMPLETED|Visit 3 (Stage I and Stage II)||2
620688|NCT00289913|1522681|P2|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8
620689|NCT00289913|1522682|P1|NOT COMPLETED|Visit 3 (Stage I and Stage II)||9
620690|NCT00289913|1522678|P5|COMPLETED|Visit 3 (Stage I and Stage II)||597
620691|NCT00289913|1522679|P4|COMPLETED|Visit 3 (Stage I and Stage II)||131
620692|NCT00289913|1522680|P3|COMPLETED|Visit 3 (Stage I and Stage II)||138
620693|NCT00289913|1522681|P2|COMPLETED|Visit 3 (Stage I and Stage II)||106
620694|NCT00289913|1522682|P1|COMPLETED|Visit 3 (Stage I and Stage II)||122
620695|NCT00289913|1522678|P5|STARTED|Visit 3 (Stage I and Stage II)||605
620696|NCT00289913|1522679|P4|STARTED|Visit 3 (Stage I and Stage II)||135
620697|NCT00289913|1522680|P3|STARTED|Visit 3 (Stage I and Stage II)||140
620698|NCT00289913|1522681|P2|STARTED|Visit 3 (Stage I and Stage II)||114
620699|NCT00289913|1522682|P1|STARTED|Visit 3 (Stage I and Stage II)||131
620700|NCT00289913|1522678|P5|NOT COMPLETED|Visit 2 (Stage I and Stage II)||40
620701|NCT00289913|1522679|P4|NOT COMPLETED|Visit 2 (Stage I and Stage II)||6
620702|NCT00289913|1522680|P3|NOT COMPLETED|Visit 2 (Stage I and Stage II)||10
620703|NCT00289913|1522681|P2|NOT COMPLETED|Visit 2 (Stage I and Stage II)||21
620704|NCT00289913|1522682|P1|NOT COMPLETED|Visit 2 (Stage I and Stage II)||15
620705|NCT00289913|1522678|P5|COMPLETED|Visit 2 (Stage I and Stage II)||605
620706|NCT00289913|1522679|P4|COMPLETED|Visit 2 (Stage I and Stage II)||135
620707|NCT00289913|1522680|P3|COMPLETED|Visit 2 (Stage I and Stage II)||140
620708|NCT00289913|1522681|P2|COMPLETED|Visit 2 (Stage I and Stage II)||114
620709|NCT00289913|1522682|P1|COMPLETED|Visit 2 (Stage I and Stage II)||131
620710|NCT00289913|1522678|P5|STARTED|Visit 2 (Stage I and Stage II)|No vaccine administered at Visit 2 (Stage II), therefore there was no safety F/U period.|645
620711|NCT00289913|1522679|P4|STARTED|Visit 2 (Stage I and Stage II)||141
620712|NCT00289913|1522680|P3|STARTED|Visit 2 (Stage I and Stage II)||150
620713|NCT00289913|1522681|P2|STARTED|Visit 2 (Stage I and Stage II)||135
620714|NCT00289913|1522682|P1|STARTED|Visit 2 (Stage I and Stage II)||146
620715|NCT00289913|1522678|P5|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
620716|NCT00289913|1522679|P4|NOT COMPLETED|Visit 1 (Stage I and Stage II)||11
620717|NCT00289913|1522680|P3|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
620718|NCT00289913|1522681|P2|NOT COMPLETED|Visit 1 (Stage I and Stage II)||16
620719|NCT00289913|1522682|P1|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
620720|NCT00289913|1522678|P5|COMPLETED|Visit 1 (Stage I and Stage II)||645
620721|NCT00289913|1522679|P4|COMPLETED|Visit 1 (Stage I and Stage II)||141
620722|NCT00289913|1522680|P3|COMPLETED|Visit 1 (Stage I and Stage II)||150
620723|NCT00289913|1522681|P2|COMPLETED|Visit 1 (Stage I and Stage II)||135
620724|NCT00289913|1522682|P1|COMPLETED|Visit 1 (Stage I and Stage II)||146
620725|NCT00289913|1522678|P5|STARTED|Visit 1 (Stage I and Stage II)|Participants were enrolled during Stage II.|654
620726|NCT00289913|1522679|P4|STARTED|Visit 1 (Stage I and Stage II)||152
620727|NCT00289913|1522680|P3|STARTED|Visit 1 (Stage I and Stage II)||159
620728|NCT00289913|1522681|P2|STARTED|Visit 1 (Stage I and Stage II)||151
620729|NCT00289913|1522682|P1|STARTED|Visit 1 (Stage I and Stage II)||155
620730|NCT00289900|1522713|P6|NOT COMPLETED|Overall Study||61
620731|NCT00289900|1522714|P5|NOT COMPLETED|Overall Study||45
620732|NCT00289900|1522715|P4|NOT COMPLETED|Overall Study||59
620733|NCT00289900|1522716|P3|NOT COMPLETED|Overall Study||33
620734|NCT00289900|1522717|P2|NOT COMPLETED|Overall Study||120
620735|NCT00289900|1522718|P1|NOT COMPLETED|Overall Study||68
620736|NCT00289900|1522713|P6|COMPLETED|Overall Study||372
620737|NCT00289900|1522714|P5|COMPLETED|Overall Study||392
620738|NCT00289900|1522715|P4|COMPLETED|Overall Study||380
620739|NCT00289900|1522716|P3|COMPLETED|Overall Study||265
620740|NCT00289900|1522717|P2|COMPLETED|Overall Study||316
620741|NCT00289900|1522718|P1|COMPLETED|Overall Study||229
620742|NCT00289900|1522713|P6|Treated|Overall Study||433
620743|NCT00289900|1522714|P5|Treated|Overall Study||437
620744|NCT00289900|1522715|P4|Treated|Overall Study||439
620745|NCT00289900|1522716|P3|Treated|Overall Study||298
620746|NCT00289900|1522717|P2|Treated|Overall Study||435
620747|NCT00289900|1522718|P1|Treated|Overall Study||297
620748|NCT00289900|1522713|P6|STARTED|Overall Study||433
620749|NCT00289900|1522714|P5|STARTED|Overall Study||437
620750|NCT00289900|1522715|P4|STARTED|Overall Study||439
620751|NCT00289900|1522716|P3|STARTED|Overall Study||298
620752|NCT00289900|1522717|P2|STARTED|Overall Study||436
620753|NCT00289900|1522718|P1|STARTED|Overall Study||297
620754|NCT00289887|1522822|P2|NOT COMPLETED|Overall Study||29
620755|NCT00289887|1522823|P1|NOT COMPLETED|Overall Study||22
620756|NCT00289887|1522822|P2|COMPLETED|Overall Study||105
620757|NCT00289887|1522823|P1|COMPLETED|Overall Study||105
620758|NCT00289887|1522822|P2|STARTED|Overall Study||134
620759|NCT00289887|1522823|P1|STARTED|Overall Study||127
620760|NCT00289874|1522841|P2|NOT COMPLETED|Overall Study||8
620761|NCT00289874|1522842|P1|NOT COMPLETED|Overall Study||6
620762|NCT00289874|1522841|P2|COMPLETED|Overall Study||210
620763|NCT00289874|1522842|P1|COMPLETED|Overall Study||197
620764|NCT00289874|1522841|P2|STARTED|Overall Study||218
620765|NCT00289874|1522842|P1|STARTED|Overall Study||203
620766|NCT00289848|1522852|P2|NOT COMPLETED|Overall Study||45
620767|NCT00289848|1522853|P1|NOT COMPLETED|Overall Study||46
620768|NCT00289848|1522852|P2|COMPLETED|Overall Study||133
620769|NCT00289848|1522853|P1|COMPLETED|Overall Study||306
620770|NCT00289848|1522852|P2|STARTED|Overall Study||178
620771|NCT00289848|1522853|P1|STARTED|Overall Study||352
620772|NCT00289783|1522865|P2|NOT COMPLETED|Fourth Dose Phase||24
620773|NCT00289783|1522866|P1|NOT COMPLETED|Fourth Dose Phase||87
620774|NCT00289783|1522865|P2|COMPLETED|Fourth Dose Phase||899
620775|NCT00289783|1522866|P1|COMPLETED|Fourth Dose Phase||2682
620776|NCT00289783|1522865|P2|STARTED|Fourth Dose Phase||923
620777|NCT00289783|1522866|P1|STARTED|Fourth Dose Phase||2769
620778|NCT00289783|1522865|P2|NOT COMPLETED|Primary Phase||83
620779|NCT00289783|1522866|P1|NOT COMPLETED|Primary Phase||248
620780|NCT00289783|1522865|P2|COMPLETED|Primary Phase||961
620781|NCT00289783|1522866|P1|COMPLETED|Primary Phase||2888
620782|NCT00289783|1522865|P2|STARTED|Primary Phase||1044
620783|NCT00289783|1522866|P1|STARTED|Primary Phase||3136
620784|NCT00289770|1523044|P1|NOT COMPLETED|Year 15||1
620785|NCT00289770|1523044|P1|COMPLETED|Year 15||49
620786|NCT00289770|1523044|P1|STARTED|Year 15||50
620787|NCT00289770|1523044|P1|NOT COMPLETED|Year 14||0
620788|NCT00289770|1523044|P1|COMPLETED|Year 14||43
620789|NCT00289770|1523044|P1|STARTED|Year 14||43
620790|NCT00289770|1523044|P1|NOT COMPLETED|Year 13||0
620791|NCT00289770|1523044|P1|COMPLETED|Year 13||37
620792|NCT00289770|1523044|P1|STARTED|Year 13||37
620793|NCT00289770|1523044|P1|NOT COMPLETED|Year 12||0
620794|NCT00289770|1523044|P1|COMPLETED|Year 12||40
620795|NCT00289770|1523044|P1|STARTED|Year 12||40
620796|NCT00289770|1523044|P1|NOT COMPLETED|Year 11||0
620797|NCT00289770|1523044|P1|COMPLETED|Year 11||37
620798|NCT00289770|1523044|P1|STARTED|Year 11||37
620799|NCT00289757|1523056|P1|NOT COMPLETED|Overall Study||0
620800|NCT00289757|1523056|P1|COMPLETED|Overall Study||78
620801|NCT00289757|1523056|P1|STARTED|Overall Study||78
620802|NCT00289744|1523067|P3|NOT COMPLETED|Additional Dose Phase||0
620803|NCT00289744|1523068|P2|NOT COMPLETED|Additional Dose Phase||0
620804|NCT00289744|1523069|P1|NOT COMPLETED|Additional Dose Phase||0
620805|NCT00289744|1523067|P3|COMPLETED|Additional Dose Phase||6
620806|NCT00289744|1523068|P2|COMPLETED|Additional Dose Phase||19
620807|NCT00289744|1523069|P1|COMPLETED|Additional Dose Phase||0
620808|NCT00289744|1523067|P3|STARTED|Additional Dose Phase||6
620809|NCT00289744|1523068|P2|STARTED|Additional Dose Phase||19
620810|NCT00289744|1523069|P1|STARTED|Additional Dose Phase||0
620811|NCT00289744|1523067|P3|NOT COMPLETED|Year 10 Long-term Follow-up||0
620812|NCT00289744|1523068|P2|NOT COMPLETED|Year 10 Long-term Follow-up||0
620813|NCT00289744|1523069|P1|NOT COMPLETED|Year 10 Long-term Follow-up||0
620814|NCT00289744|1523067|P3|COMPLETED|Year 10 Long-term Follow-up||0
620815|NCT00289744|1523068|P2|COMPLETED|Year 10 Long-term Follow-up||0
620816|NCT00289744|1523069|P1|COMPLETED|Year 10 Long-term Follow-up||171
620817|NCT00289744|1523067|P3|STARTED|Year 10 Long-term Follow-up||0
620818|NCT00289744|1523068|P2|STARTED|Year 10 Long-term Follow-up||0
620819|NCT00289744|1523069|P1|STARTED|Year 10 Long-term Follow-up|Subjects who came back at Year 10 blood sampling time-point|171
620820|NCT00289744|1523067|P3|NOT COMPLETED|Year 9 Long-term Follow-up||0
620821|NCT00289744|1523068|P2|NOT COMPLETED|Year 9 Long-term Follow-up||0
620822|NCT00289744|1523069|P1|NOT COMPLETED|Year 9 Long-term Follow-up||0
620823|NCT00289744|1523067|P3|COMPLETED|Year 9 Long-term Follow-up||0
620824|NCT00289744|1523068|P2|COMPLETED|Year 9 Long-term Follow-up||0
620825|NCT00289744|1523069|P1|COMPLETED|Year 9 Long-term Follow-up||173
620826|NCT00289744|1523067|P3|STARTED|Year 9 Long-term Follow-up||0
620827|NCT00289744|1523068|P2|STARTED|Year 9 Long-term Follow-up||0
620828|NCT00289744|1523069|P1|STARTED|Year 9 Long-term Follow-up|Subjects who came back at Year 9 blood sampling time-point|173
620829|NCT00289744|1523067|P3|NOT COMPLETED|Year 8 Long-term Follow-up||0
620830|NCT00289744|1523068|P2|NOT COMPLETED|Year 8 Long-term Follow-up||0
620831|NCT00289744|1523069|P1|NOT COMPLETED|Year 8 Long-term Follow-up||0
620832|NCT00289744|1523067|P3|COMPLETED|Year 8 Long-term Follow-up||0
620833|NCT00289744|1523068|P2|COMPLETED|Year 8 Long-term Follow-up||0
620834|NCT00289744|1523069|P1|COMPLETED|Year 8 Long-term Follow-up||174
620835|NCT00289744|1523067|P3|STARTED|Year 8 Long-term Follow-up||0
620836|NCT00289744|1523068|P2|STARTED|Year 8 Long-term Follow-up||0
620837|NCT00289744|1523069|P1|STARTED|Year 8 Long-term Follow-up|Subjects who came back at Year 8 blood sampling time-point|174
620838|NCT00289744|1523067|P3|NOT COMPLETED|Year 7 Long-term Follow-up||0
620839|NCT00289744|1523068|P2|NOT COMPLETED|Year 7 Long-term Follow-up||0
620840|NCT00289744|1523069|P1|NOT COMPLETED|Year 7 Long-term Follow-up||0
620841|NCT00289744|1523067|P3|COMPLETED|Year 7 Long-term Follow-up||0
620842|NCT00289744|1523068|P2|COMPLETED|Year 7 Long-term Follow-up||0
620843|NCT00289744|1523069|P1|COMPLETED|Year 7 Long-term Follow-up||175
620844|NCT00289744|1523067|P3|STARTED|Year 7 Long-term Follow-up||0
620845|NCT00289744|1523068|P2|STARTED|Year 7 Long-term Follow-up||0
620846|NCT00289744|1523069|P1|STARTED|Year 7 Long-term Follow-up|Subjects who came back at Year 7 blood sampling time-point|175
620847|NCT00289744|1523067|P3|NOT COMPLETED|Year 6 Long-term Follow-up||0
620848|NCT00289744|1523068|P2|NOT COMPLETED|Year 6 Long-term Follow-up||0
620849|NCT00289744|1523069|P1|NOT COMPLETED|Year 6 Long-term Follow-up||0
620850|NCT00289744|1523067|P3|COMPLETED|Year 6 Long-term Follow-up||0
620851|NCT00289744|1523068|P2|COMPLETED|Year 6 Long-term Follow-up||0
620852|NCT00289744|1523069|P1|COMPLETED|Year 6 Long-term Follow-up||178
620853|NCT00289744|1523067|P3|STARTED|Year 6 Long-term Follow-up||0
620854|NCT00289744|1523068|P2|STARTED|Year 6 Long-term Follow-up||0
620855|NCT00289744|1523069|P1|STARTED|Year 6 Long-term Follow-up|Number of subjects who come back at Year 6 blood sampling time-point|178
620856|NCT00289718|1523087|P1|NOT COMPLETED|Overall Study||0
620857|NCT00289718|1523087|P1|COMPLETED|Overall Study||51
620858|NCT00289718|1523087|P1|STARTED|Overall Study||51
620859|NCT00289536|1523102|P3|NOT COMPLETED|Period 3||1
620860|NCT00289536|1523103|P2|NOT COMPLETED|Period 3||0
620861|NCT00289536|1523104|P1|NOT COMPLETED|Period 3||0
620862|NCT00289536|1523102|P3|COMPLETED|Period 3||9
620863|NCT00289536|1523103|P2|COMPLETED|Period 3||9
620864|NCT00289536|1523104|P1|COMPLETED|Period 3||7
620865|NCT00289536|1523102|P3|STARTED|Period 3|5 participants received Low Dose and 5 participants received Medium Dose in Period 2|10
620866|NCT00289536|1523103|P2|STARTED|Period 3|5 participants received Low Dose and 4 participants received High Dose in Period 2|9
620867|NCT00289536|1523104|P1|STARTED|Period 3|3 participants received Medium Dose and 4 participants received High Dose in Period 2|7
620868|NCT00289536|1523102|P3|NOT COMPLETED|Period 2||0
620869|NCT00289536|1523103|P2|NOT COMPLETED|Period 2||0
620870|NCT00289536|1523104|P1|NOT COMPLETED|Period 2||0
620871|NCT00289536|1523102|P3|COMPLETED|Period 2||7
620872|NCT00289536|1523103|P2|COMPLETED|Period 2||9
620873|NCT00289536|1523104|P1|COMPLETED|Period 2||10
620874|NCT00289536|1523102|P3|STARTED|Period 2|4 participants received Low Dose and 3 participants received Medium Dose in Period 1|7
620875|NCT00289536|1523103|P2|STARTED|Period 2|5 participants received Low Dose and 4 participants received High Dose in Period 1|9
620876|NCT00289536|1523104|P1|STARTED|Period 2|5 participants received Medium Dose and 5 participants received High Dose in Period 1|10
620877|NCT00289536|1523102|P3|NOT COMPLETED|Period 1||0
620878|NCT00289536|1523103|P2|NOT COMPLETED|Period 1||0
620879|NCT00289536|1523104|P1|NOT COMPLETED|Period 1||0
620880|NCT00289536|1523102|P3|COMPLETED|Period 1||9
620881|NCT00289536|1523103|P2|COMPLETED|Period 1||8
620882|NCT00289536|1523104|P1|COMPLETED|Period 1||9
620883|NCT00289536|1523102|P3|STARTED|Period 1||9
620884|NCT00289536|1523103|P2|STARTED|Period 1||8
620885|NCT00289536|1523104|P1|STARTED|Period 1||9
620886|NCT00289471|1523143|P1|NOT COMPLETED|Overall Study||0
620887|NCT00289471|1523143|P1|COMPLETED|Overall Study||630
620888|NCT00289471|1523143|P1|STARTED|Overall Study||630
620889|NCT00289458|1523150|P3|NOT COMPLETED|Overall Study||6
620890|NCT00289458|1523151|P2|NOT COMPLETED|Overall Study||6
620891|NCT00289458|1523152|P1|NOT COMPLETED|Overall Study||6
620892|NCT00289458|1523150|P3|COMPLETED|Overall Study||22
620893|NCT00289458|1523151|P2|COMPLETED|Overall Study||20
620894|NCT00289458|1523152|P1|COMPLETED|Overall Study||19
620895|NCT00289458|1523150|P3|STARTED|Overall Study||28
620896|NCT00289458|1523151|P2|STARTED|Overall Study||26
620897|NCT00289458|1523152|P1|STARTED|Overall Study||25
620898|NCT00289341|1523177|P2|NOT COMPLETED|Overall Study||0
620899|NCT00289341|1523178|P1|NOT COMPLETED|Overall Study||0
620900|NCT00289341|1523177|P2|COMPLETED|Overall Study||12
620901|NCT00289341|1523178|P1|COMPLETED|Overall Study||12
620902|NCT00289341|1523177|P2|STARTED|Overall Study||12
620903|NCT00289341|1523178|P1|STARTED|Overall Study||12
620904|NCT00289315|1523191|P3|NOT COMPLETED|Overall Study||140
620905|NCT00289315|1523192|P2|NOT COMPLETED|Overall Study||122
620906|NCT00289315|1523193|P1|NOT COMPLETED|Overall Study||101
620907|NCT00289315|1523191|P3|COMPLETED|Overall Study||447
620908|NCT00289315|1523192|P2|COMPLETED|Overall Study||638
620909|NCT00289315|1523193|P1|COMPLETED|Overall Study||612
620910|NCT00289315|1523191|P3|STARTED|Overall Study||587
620911|NCT00289315|1523192|P2|STARTED|Overall Study||760
620912|NCT00289315|1523193|P1|STARTED|Overall Study||713
620913|NCT00289289|1523213|P3|NOT COMPLETED|Overall Study||49
620914|NCT00289289|1523214|P2|NOT COMPLETED|Overall Study||10
620915|NCT00289289|1523215|P1|NOT COMPLETED|Overall Study||19
620916|NCT00289289|1523213|P3|COMPLETED|Overall Study||95
620917|NCT00289289|1523214|P2|COMPLETED|Overall Study||114
620918|NCT00289289|1523215|P1|COMPLETED|Overall Study||113
620919|NCT00289289|1523213|P3|STARTED|Overall Study||144
620920|NCT00289289|1523214|P2|STARTED|Overall Study||124
620921|NCT00289289|1523215|P1|STARTED|Overall Study||132
620922|NCT00289276|1523230|P2|NOT COMPLETED|Second Part of FAST Study (Expansion)||3
620923|NCT00289276|1523231|P1|NOT COMPLETED|Second Part of FAST Study (Expansion)||0
620924|NCT00289276|1523230|P2|COMPLETED|Second Part of FAST Study (Expansion)||106
620925|NCT00289276|1523231|P1|COMPLETED|Second Part of FAST Study (Expansion)||0
620926|NCT00289276|1523230|P2|STARTED|Second Part of FAST Study (Expansion)||109
620927|NCT00289276|1523231|P1|STARTED|Second Part of FAST Study (Expansion)||0
620928|NCT00289276|1523230|P2|NOT COMPLETED|First Part of FAST Study (Pivotal)||0
620929|NCT00289276|1523231|P1|NOT COMPLETED|First Part of FAST Study (Pivotal)||0
620930|NCT00289276|1523230|P2|COMPLETED|First Part of FAST Study (Pivotal)||0
620931|NCT00289276|1523231|P1|COMPLETED|First Part of FAST Study (Pivotal)||47
620932|NCT00289276|1523230|P2|STARTED|First Part of FAST Study (Pivotal)||0
620933|NCT00289276|1523231|P1|STARTED|First Part of FAST Study (Pivotal)|11 patients were re-consented under version 7 of the CIP, but are included in Pivotal results only|47
620934|NCT00289211|1523246|P3|NOT COMPLETED|Overall Study||10
620935|NCT00289211|1523247|P2|NOT COMPLETED|Overall Study||1
620936|NCT00289211|1523248|P1|NOT COMPLETED|Overall Study||0
620937|NCT00289211|1523246|P3|COMPLETED|Overall Study||2
620938|NCT00289211|1523247|P2|COMPLETED|Overall Study||34
620939|NCT00289211|1523248|P1|COMPLETED|Overall Study||36
620940|NCT00289211|1523246|P3|STARTED|Overall Study||12
620941|NCT00289211|1523247|P2|STARTED|Overall Study||35
620942|NCT00289211|1523248|P1|STARTED|Overall Study||36
620943|NCT00289198|1523266|P2|NOT COMPLETED|Overall Study||30
620944|NCT00289198|1523267|P1|NOT COMPLETED|Overall Study||31
620945|NCT00289198|1523266|P2|COMPLETED|Overall Study||121
620946|NCT00289198|1523267|P1|COMPLETED|Overall Study||120
620947|NCT00289198|1523266|P2|STARTED|Overall Study||151
620948|NCT00289198|1523267|P1|STARTED|Overall Study||151
620949|NCT00289185|1523317|P2|NOT COMPLETED|Overall Study||26
620950|NCT00289185|1523318|P1|NOT COMPLETED|Overall Study||28
620951|NCT00289185|1523317|P2|COMPLETED|Overall Study||144
620952|NCT00289185|1523318|P1|COMPLETED|Overall Study||142
620953|NCT00289185|1523317|P2|STARTED|Overall Study||170
620954|NCT00289185|1523318|P1|STARTED|Overall Study||170
620955|NCT00289133|1523365|P2|NOT COMPLETED|Overall Study||298
620956|NCT00289133|1523366|P1|NOT COMPLETED|Overall Study||272
620957|NCT00289133|1523365|P2|COMPLETED|Overall Study||179
620958|NCT00289133|1523366|P1|COMPLETED|Overall Study||189
620959|NCT00289133|1523365|P2|STARTED|Overall Study||477
620960|NCT00289133|1523366|P1|STARTED|Overall Study||461
620961|NCT00289120|1523388|P1|NOT COMPLETED|Overall Study||0
620962|NCT00289120|1523388|P1|COMPLETED|Overall Study||13
620963|NCT00289120|1523388|P1|STARTED|Overall Study||13
620964|NCT00289107|1523406|P2|NOT COMPLETED|Overall Study||44
620965|NCT00289107|1523407|P1|NOT COMPLETED|Overall Study||53
620966|NCT00289107|1523406|P2|COMPLETED|Overall Study||28
620967|NCT00289107|1523407|P1|COMPLETED|Overall Study||24
620968|NCT00289107|1523406|P2|STARTED|Overall Study||72
620969|NCT00289107|1523407|P1|STARTED|Overall Study||77
620970|NCT00289094|1523415|P2|NOT COMPLETED|Overall Study||47
620971|NCT00289094|1523416|P1|NOT COMPLETED|Overall Study||47
620972|NCT00289094|1523415|P2|COMPLETED|Overall Study||2
620973|NCT00289094|1523416|P1|COMPLETED|Overall Study||3
620974|NCT00289094|1523415|P2|STARTED|Overall Study||49
620975|NCT00289094|1523416|P1|STARTED|Overall Study||50
620976|NCT00289016|1523422|P1|NOT COMPLETED|Overall Study||37
620977|NCT00289016|1523422|P1|COMPLETED|Overall Study||13
620978|NCT00289016|1523422|P1|STARTED|Overall Study||50
620979|NCT00288912|1523434|P3|NOT COMPLETED|Overall Study||28
620980|NCT00288912|1523435|P2|NOT COMPLETED|Overall Study||17
620981|NCT00288912|1523436|P1|NOT COMPLETED|Overall Study||17
620982|NCT00288912|1523434|P3|COMPLETED|Overall Study||146
620983|NCT00288912|1523435|P2|COMPLETED|Overall Study||157
620984|NCT00288912|1523436|P1|COMPLETED|Overall Study||158
620985|NCT00288912|1523434|P3|STARTED|Overall Study||174
620986|NCT00288912|1523435|P2|STARTED|Overall Study||174
620987|NCT00288912|1523436|P1|STARTED|Overall Study||175
620988|NCT00288886|1523455|P2|NOT COMPLETED|Overall Study||11
620989|NCT00288886|1523456|P1|NOT COMPLETED|Overall Study||11
620990|NCT00288886|1523455|P2|COMPLETED|Overall Study||81
620991|NCT00288886|1523456|P1|COMPLETED|Overall Study||80
620992|NCT00288886|1523455|P2|12-month Follow Up|Overall Study||81
620993|NCT00288886|1523456|P1|12-month Follow Up|Overall Study||80
620994|NCT00288886|1523455|P2|6-month Follow Up|Overall Study||84
620995|NCT00288886|1523456|P1|6-month Follow Up|Overall Study||85
620996|NCT00288886|1523455|P2|3-month Follow Up|Overall Study||85
620997|NCT00288886|1523456|P1|3-month Follow Up|Overall Study||82
620998|NCT00288886|1523455|P2|STARTED|Overall Study||92
620999|NCT00288886|1523456|P1|STARTED|Overall Study||91
621000|NCT00288860|1523476|P2|NOT COMPLETED|Overall Study||97
621001|NCT00288860|1523477|P1|NOT COMPLETED|Overall Study||102
621002|NCT00288860|1523476|P2|COMPLETED|Overall Study|328 completed 4 or 12 month survey. Used all with intake (n=417) in intent to treat.|328
621003|NCT00288860|1523477|P1|COMPLETED|Overall Study|310 completed either 4 or 12 month survey. Used all with intake (n = 408) in intent-to-treat.|310
621004|NCT00288860|1523476|P2|Completed 12 Month fu Survey|Overall Study||281
621005|NCT00288860|1523477|P1|Completed 12 Month fu Survey|Overall Study||257
621006|NCT00288860|1523476|P2|Completed 4 Month fu Survey|Overall Study||299
621007|NCT00288860|1523477|P1|Completed 4 Month fu Survey|Overall Study||275
621008|NCT00288860|1523476|P2|Completed Intake Survey|Overall Study||417
621009|NCT00288860|1523477|P1|Completed Intake Survey|Overall Study||408
621010|NCT00288860|1523476|P2|STARTED|Overall Study||425
621011|NCT00288860|1523477|P1|STARTED|Overall Study||412
621012|NCT00288704|1523490|P3|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||20
621013|NCT00288704|1523491|P2|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
621014|NCT00288704|1523492|P1|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
621015|NCT00288704|1523490|P3|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||81
621016|NCT00288704|1523491|P2|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
621017|NCT00288704|1523492|P1|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
621018|NCT00288704|1523490|P3|STARTED|Open-Label Extension (OLE) Weeks 24-117||101
621019|NCT00288704|1523491|P2|STARTED|Open-Label Extension (OLE) Weeks 24-117||0
621020|NCT00288704|1523492|P1|STARTED|Open-Label Extension (OLE) Weeks 24-117|After week 24, all subjects are treated with Open label rilonacept.|0
621021|NCT00288704|1523490|P3|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
621022|NCT00288704|1523491|P2|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||1
621023|NCT00288704|1523492|P1|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
621024|NCT00288704|1523490|P3|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
621025|NCT00288704|1523491|P2|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||21
621026|NCT00288704|1523492|P1|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||23
621027|NCT00288704|1523490|P3|STARTED|Part B, Randomized Withdrawal, Wks 15-24||0
621028|NCT00288704|1523491|P2|STARTED|Part B, Randomized Withdrawal, Wks 15-24||22
621113|NCT00287716|1523699|P1|NOT COMPLETED|Overall Study||38
621114|NCT00287716|1523697|P3|COMPLETED|Overall Study||143
621029|NCT00288704|1523492|P1|STARTED|Part B, Randomized Withdrawal, Wks 15-24|1 subject discontinued during weeks 6-14 due to non-compliance with study drug dosing procedures.|23
621030|NCT00288704|1523490|P3|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0
621031|NCT00288704|1523491|P2|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||1
621032|NCT00288704|1523492|P1|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0
621033|NCT00288704|1523490|P3|COMPLETED|Part A, Double Blind, Weeks 1-6||0
621034|NCT00288704|1523491|P2|COMPLETED|Part A, Double Blind, Weeks 1-6||22
621035|NCT00288704|1523492|P1|COMPLETED|Part A, Double Blind, Weeks 1-6||24
621036|NCT00288704|1523490|P3|STARTED|Part A, Double Blind, Weeks 1-6|Subjects enrolled into the open-label phase do not complete this part of the study.|0
621037|NCT00288704|1523491|P2|STARTED|Part A, Double Blind, Weeks 1-6||23
621038|NCT00288704|1523492|P1|STARTED|Part A, Double Blind, Weeks 1-6||24
621039|NCT00288639|1523519|P1|NOT COMPLETED|Overall Study||12
621040|NCT00288639|1523519|P1|COMPLETED|Overall Study||86
621041|NCT00288639|1523519|P1|STARTED|Overall Study||98
621042|NCT00288626|1523536|P1|NOT COMPLETED|Overall Study||7
621043|NCT00288626|1523536|P1|COMPLETED|Overall Study||17
621044|NCT00288626|1523536|P1|STARTED|Overall Study||24
621045|NCT00288600|1523561|P2|NOT COMPLETED|Overall Study||0
621046|NCT00288600|1523562|P1|NOT COMPLETED|Overall Study||0
621047|NCT00288600|1523561|P2|COMPLETED|Overall Study||46
621048|NCT00288600|1523562|P1|COMPLETED|Overall Study||46
621049|NCT00288600|1523561|P2|STARTED|Overall Study||46
621050|NCT00288600|1523562|P1|STARTED|Overall Study||46
621051|NCT00288587|1523570|P2|NOT COMPLETED|Overall Study||10
621052|NCT00288587|1523571|P1|NOT COMPLETED|Overall Study||5
621053|NCT00288587|1523570|P2|COMPLETED|Overall Study||7
621054|NCT00288587|1523571|P1|COMPLETED|Overall Study||14
621055|NCT00288587|1523570|P2|STARTED|Overall Study||17
621056|NCT00288587|1523571|P1|STARTED|Overall Study||19
621057|NCT00288574|1523587|P2|NOT COMPLETED|Overall Study||0
621058|NCT00288574|1523588|P1|NOT COMPLETED|Overall Study||0
621059|NCT00288574|1523587|P2|COMPLETED|Overall Study||44
621060|NCT00288574|1523588|P1|COMPLETED|Overall Study||49
621061|NCT00288574|1523587|P2|STARTED|Overall Study||44
621062|NCT00288574|1523588|P1|STARTED|Overall Study||49
621063|NCT00288509|1523614|P1|NOT COMPLETED|Treatment Cycle 4||8
621064|NCT00288509|1523614|P1|COMPLETED|Treatment Cycle 4||80
621065|NCT00288509|1523614|P1|STARTED|Treatment Cycle 4|3 subjects completed Cycle 3 but withdrew before Cycle 4, treatment stopped according to protocol|88
621066|NCT00288509|1523614|P1|NOT COMPLETED|Treatment Cycle 3||5
621067|NCT00288509|1523614|P1|COMPLETED|Treatment Cycle 3||91
621068|NCT00288509|1523614|P1|STARTED|Treatment Cycle 3|One subject completed Cycle 2 but withdrew before Cycle 3 due to insufficient clinical response|96
621069|NCT00288509|1523614|P1|NOT COMPLETED|Treatment Cycle 2||3
621070|NCT00288509|1523614|P1|COMPLETED|Treatment Cycle 2||97
621071|NCT00288509|1523614|P1|STARTED|Treatment Cycle 2|2 subjects completed Cycle 1 but withdrew before Cycle 2 due to insufficient clinical response|100
621072|NCT00288509|1523614|P1|NOT COMPLETED|Treatment Cycle 1||6
621073|NCT00288509|1523614|P1|COMPLETED|Treatment Cycle 1||102
621074|NCT00288509|1523614|P1|STARTED|Treatment Cycle 1||108
621075|NCT00288080|1523623|P2|NOT COMPLETED|Overall Study||23
621076|NCT00288080|1523624|P1|NOT COMPLETED|Overall Study||26
621077|NCT00288080|1523623|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|282
621078|NCT00288080|1523624|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|281
621079|NCT00288080|1523623|P2|STARTED|Overall Study||305
621080|NCT00288080|1523624|P1|STARTED|Overall Study||307
621081|NCT00288067|1523640|P1|NOT COMPLETED|Overall Study||0
621082|NCT00288067|1523640|P1|COMPLETED|Overall Study||32
621083|NCT00288067|1523640|P1|STARTED|Overall Study||32
621084|NCT00288054|1523646|P1|NOT COMPLETED|Overall Study||24
621085|NCT00288054|1523646|P1|COMPLETED|Overall Study||0
621086|NCT00288054|1523646|P1|STARTED|Overall Study||24
621087|NCT00288015|1523654|P1|NOT COMPLETED|Follow up for Survival x 2 Years||26
621088|NCT00288015|1523654|P1|COMPLETED|Follow up for Survival x 2 Years||3
621089|NCT00288015|1523654|P1|STARTED|Follow up for Survival x 2 Years||29
621090|NCT00288015|1523654|P1|NOT COMPLETED|Continued Bevacizumab Cycle 3+||7
621091|NCT00288015|1523654|P1|COMPLETED|Continued Bevacizumab Cycle 3+||19
621092|NCT00288015|1523654|P1|STARTED|Continued Bevacizumab Cycle 3+||26
621093|NCT00288015|1523654|P1|NOT COMPLETED|First Response Assessment||4
621094|NCT00288015|1523654|P1|COMPLETED|First Response Assessment||26
621095|NCT00288015|1523654|P1|STARTED|First Response Assessment||30
621096|NCT00288015|1523654|P1|NOT COMPLETED|Bevacizumab Treatment Cycles 1-2||2
621097|NCT00288015|1523654|P1|COMPLETED|Bevacizumab Treatment Cycles 1-2||30
621098|NCT00288015|1523654|P1|STARTED|Bevacizumab Treatment Cycles 1-2||32
621099|NCT00288015|1523654|P1|NOT COMPLETED|Registered to Study||0
621100|NCT00288015|1523654|P1|COMPLETED|Registered to Study||32
621101|NCT00288015|1523654|P1|STARTED|Registered to Study||32
621102|NCT00287872|1523663|P1|NOT COMPLETED|Overall Study||0
621103|NCT00287872|1523663|P1|COMPLETED|Overall Study||30
621104|NCT00287872|1523663|P1|STARTED|Overall Study||30
621105|NCT00287729|1523673|P2|NOT COMPLETED|Overall Study||31
621106|NCT00287729|1523674|P1|NOT COMPLETED|Overall Study||34
621107|NCT00287729|1523673|P2|COMPLETED|Overall Study||142
621108|NCT00287729|1523674|P1|COMPLETED|Overall Study||137
621109|NCT00287729|1523673|P2|STARTED|Overall Study||173
621110|NCT00287729|1523674|P1|STARTED|Overall Study||171
621111|NCT00287716|1523697|P3|NOT COMPLETED|Overall Study||31
621112|NCT00287716|1523698|P2|NOT COMPLETED|Overall Study||17
621115|NCT00287716|1523698|P2|COMPLETED|Overall Study||70
621116|NCT00287716|1523699|P1|COMPLETED|Overall Study||136
621117|NCT00287716|1523697|P3|STARTED|Overall Study||174
621118|NCT00287716|1523698|P2|STARTED|Overall Study||87
621119|NCT00287716|1523699|P1|STARTED|Overall Study||174
621120|NCT00287586|1523730|P2|NOT COMPLETED|Overall Study||52
621121|NCT00287586|1523731|P1|NOT COMPLETED|Overall Study||45
621122|NCT00287586|1523730|P2|COMPLETED|Overall Study||100
621123|NCT00287586|1523731|P1|COMPLETED|Overall Study||111
621124|NCT00287586|1523730|P2|Intent-to-treat: Received Study Drug|Overall Study||151
621125|NCT00287586|1523731|P1|Intent-to-treat: Received Study Drug|Overall Study||155
621126|NCT00287586|1523730|P2|STARTED|Overall Study||152
621127|NCT00287586|1523731|P1|STARTED|Overall Study||156
621128|NCT00287365|1523767|P1|NOT COMPLETED|Overall Study||13
621129|NCT00287365|1523767|P1|COMPLETED|Overall Study||12
621130|NCT00287365|1523767|P1|STARTED|Overall Study||25
621131|NCT00287339|1523778|P2|NOT COMPLETED|Overall Study||0
621132|NCT00287339|1523779|P1|NOT COMPLETED|Overall Study||0
621133|NCT00287339|1523778|P2|COMPLETED|Overall Study||18
621134|NCT00287339|1523779|P1|COMPLETED|Overall Study||22
621135|NCT00287339|1523778|P2|STARTED|Overall Study||18
621136|NCT00287339|1523779|P1|STARTED|Overall Study||22
621137|NCT00287222|1523785|P1|NOT COMPLETED|Overall Study||0
621138|NCT00287222|1523785|P1|COMPLETED|Overall Study||21
621139|NCT00287222|1523785|P1|STARTED|Overall Study||21
621140|NCT00287118|1523789|P1|NOT COMPLETED|Overall Study||52
621141|NCT00287118|1523789|P1|COMPLETED|Overall Study||137
621142|NCT00287118|1523789|P1|STARTED|Overall Study||189
621143|NCT00287079|1523795|P2|NOT COMPLETED|Overall Study||1
621144|NCT00287079|1523796|P1|NOT COMPLETED|Overall Study||22
621145|NCT00287079|1523795|P2|COMPLETED|Overall Study||2
621146|NCT00287079|1523796|P1|COMPLETED|Overall Study||10
621147|NCT00287079|1523795|P2|STARTED|Overall Study||3
621148|NCT00287079|1523796|P1|STARTED|Overall Study||32
621149|NCT00287053|1523808|P2|NOT COMPLETED|Overall Study||1
621150|NCT00287053|1523809|P1|NOT COMPLETED|Overall Study||4
621151|NCT00287053|1523808|P2|COMPLETED|Overall Study||26
621152|NCT00287053|1523809|P1|COMPLETED|Overall Study||26
621153|NCT00287053|1523808|P2|STARTED|Overall Study||27
621154|NCT00287053|1523809|P1|STARTED|Overall Study||30
621155|NCT00286949|1523815|P1|NOT COMPLETED|Overall Study||0
621156|NCT00286949|1523815|P1|COMPLETED|Overall Study||12
621157|NCT00286949|1523815|P1|STARTED|Overall Study||12
621158|NCT00286754|1523824|P3|NOT COMPLETED|Overall Study||10
621159|NCT00286754|1523825|P2|NOT COMPLETED|Overall Study||18
621160|NCT00286754|1523826|P1|NOT COMPLETED|Overall Study||20
621161|NCT00286754|1523824|P3|COMPLETED|Overall Study||170
621162|NCT00286754|1523825|P2|COMPLETED|Overall Study||159
621163|NCT00286754|1523826|P1|COMPLETED|Overall Study||156
621164|NCT00286754|1523824|P3|STARTED|Overall Study||180
621165|NCT00286754|1523825|P2|STARTED|Overall Study||177
621166|NCT00286754|1523826|P1|STARTED|Overall Study||176
621167|NCT00286741|1523860|P2|NOT COMPLETED|Overall Study||17
621168|NCT00286741|1523861|P1|NOT COMPLETED|Overall Study||11
621169|NCT00286741|1523860|P2|COMPLETED|Overall Study||89
621170|NCT00286741|1523861|P1|COMPLETED|Overall Study||122
621171|NCT00286741|1523860|P2|STARTED|Overall Study||106
621172|NCT00286741|1523861|P1|STARTED|Overall Study||133
621173|NCT00286728|1523871|P2|NOT COMPLETED|Overall Study||29
621174|NCT00286728|1523872|P1|NOT COMPLETED|Overall Study||36
621175|NCT00286728|1523871|P2|COMPLETED|Overall Study||116
621176|NCT00286728|1523872|P1|COMPLETED|Overall Study||106
621177|NCT00286728|1523871|P2|STARTED|Overall Study||145
621178|NCT00286728|1523872|P1|STARTED|Overall Study||142
621179|NCT00286494|1523881|P3|NOT COMPLETED|Overall Study||39
621180|NCT00286494|1523882|P2|NOT COMPLETED|Overall Study||44
621181|NCT00286494|1523883|P1|NOT COMPLETED|Overall Study||26
621182|NCT00286494|1523881|P3|COMPLETED|Overall Study||160
621183|NCT00286494|1523882|P2|COMPLETED|Overall Study||153
621184|NCT00286494|1523883|P1|COMPLETED|Overall Study||71
621185|NCT00286494|1523881|P3|STARTED|Overall Study||199
621186|NCT00286494|1523882|P2|STARTED|Overall Study||197
621187|NCT00286494|1523883|P1|STARTED|Overall Study||97
621188|NCT00286468|1524044|P3|NOT COMPLETED|Overall Study||50
621189|NCT00286468|1524045|P2|NOT COMPLETED|Overall Study||50
621190|NCT00286468|1524046|P1|NOT COMPLETED|Overall Study||37
621191|NCT00286468|1524044|P3|COMPLETED|Overall Study||148
621192|NCT00286468|1524045|P2|COMPLETED|Overall Study||153
621193|NCT00286468|1524046|P1|COMPLETED|Overall Study||62
621194|NCT00286468|1524044|P3|STARTED|Overall Study||198
621195|NCT00286468|1524045|P2|STARTED|Overall Study||203
621196|NCT00286468|1524046|P1|STARTED|Overall Study||99
621197|NCT00286455|1524207|P3|NOT COMPLETED|Overall Study||24
621198|NCT00286455|1524208|P2|NOT COMPLETED|Overall Study||28
621199|NCT00286455|1524209|P1|NOT COMPLETED|Overall Study||25
621200|NCT00286455|1524207|P3|COMPLETED|Overall Study||107
621201|NCT00286455|1524208|P2|COMPLETED|Overall Study||105
621202|NCT00286455|1524209|P1|COMPLETED|Overall Study||40
621203|NCT00286455|1524207|P3|STARTED|Overall Study||131
621204|NCT00286455|1524208|P2|STARTED|Overall Study||133
621205|NCT00286455|1524209|P1|STARTED|Overall Study||65
621206|NCT00286442|1524388|P3|NOT COMPLETED|Overall Study||32
621207|NCT00286442|1524389|P2|NOT COMPLETED|Overall Study||45
621208|NCT00286442|1524390|P1|NOT COMPLETED|Overall Study||37
621209|NCT00286442|1524388|P3|COMPLETED|Overall Study||72
621210|NCT00286442|1524389|P2|COMPLETED|Overall Study||165
621211|NCT00286442|1524390|P1|COMPLETED|Overall Study||176
621212|NCT00286442|1524388|P3|STARTED|Overall Study||104
621213|NCT00286442|1524389|P2|STARTED|Overall Study||210
621214|NCT00286442|1524390|P1|STARTED|Overall Study||213
621215|NCT00286429|1524551|P3|NOT COMPLETED|Overall Study||52
621216|NCT00286429|1524552|P2|NOT COMPLETED|Overall Study||48
621217|NCT00286429|1524553|P1|NOT COMPLETED|Overall Study||75
621218|NCT00286429|1524551|P3|COMPLETED|Overall Study||77
621219|NCT00286429|1524552|P2|COMPLETED|Overall Study||83
621220|NCT00286429|1524553|P1|COMPLETED|Overall Study||55
621221|NCT00286429|1524551|P3|STARTED|Overall Study||129
621222|NCT00286429|1524552|P2|STARTED|Overall Study||131
621223|NCT00286429|1524553|P1|STARTED|Overall Study||130
621224|NCT00286325|1524657|P1|NOT COMPLETED|Overall Study||0
621225|NCT00286325|1524657|P1|COMPLETED|Overall Study||8
621226|NCT00286325|1524657|P1|STARTED|Overall Study||8
621227|NCT00286221|1524669|P4|NOT COMPLETED|Overall Study||6
621228|NCT00286221|1524670|P3|NOT COMPLETED|Overall Study||9
621229|NCT00286221|1524671|P2|NOT COMPLETED|Overall Study||5
621230|NCT00286221|1524672|P1|NOT COMPLETED|Overall Study||10
621231|NCT00286221|1524669|P4|COMPLETED|Overall Study||34
621232|NCT00286221|1524670|P3|COMPLETED|Overall Study||31
621233|NCT00286221|1524671|P2|COMPLETED|Overall Study||35
621234|NCT00286221|1524672|P1|COMPLETED|Overall Study||29
621235|NCT00286221|1524669|P4|STARTED|Overall Study||40
621236|NCT00286221|1524670|P3|STARTED|Overall Study||40
621237|NCT00286221|1524671|P2|STARTED|Overall Study||40
621238|NCT00286221|1524672|P1|STARTED|Overall Study||39
621239|NCT00286182|1524688|P2|NOT COMPLETED|Overall Study||3
621240|NCT00286182|1524689|P1|NOT COMPLETED|Overall Study||5
621241|NCT00286182|1524688|P2|COMPLETED|Overall Study||25
621242|NCT00286182|1524689|P1|COMPLETED|Overall Study||23
621243|NCT00286182|1524688|P2|STARTED|Overall Study||28
621244|NCT00286182|1524689|P1|STARTED|Overall Study||28
621245|NCT00286156|1524698|P3|NOT COMPLETED|Overall Study||1
621246|NCT00286156|1524699|P2|NOT COMPLETED|Overall Study||1
621247|NCT00286156|1524700|P1|NOT COMPLETED|Overall Study||2
621248|NCT00286156|1524698|P3|COMPLETED|Overall Study||9
621249|NCT00286156|1524699|P2|COMPLETED|Overall Study||9
621250|NCT00286156|1524700|P1|COMPLETED|Overall Study||8
621251|NCT00286156|1524698|P3|STARTED|Overall Study||10
621252|NCT00286156|1524699|P2|STARTED|Overall Study||10
621253|NCT00286156|1524700|P1|STARTED|Overall Study||10
621254|NCT00286091|1524713|P2|NOT COMPLETED|Open-label Treatment Phase||71
621255|NCT00286091|1524714|P1|NOT COMPLETED|Open-label Treatment Phase||77
621256|NCT00286091|1524713|P2|COMPLETED|Open-label Treatment Phase|Completed 3 years of open-label treatment|33
621257|NCT00286091|1524714|P1|COMPLETED|Open-label Treatment Phase|Completed 3 years of open-label treatment|33
621258|NCT00286091|1524713|P2|Received Treatment|Open-label Treatment Phase||101
621259|NCT00286091|1524714|P1|Received Treatment|Open-label Treatment Phase||109
621260|NCT00286091|1524713|P2|STARTED|Open-label Treatment Phase|Participants in the Czech Republic and UK are reported separately (Study 20080585; NCT01824342)|104
621261|NCT00286091|1524714|P1|STARTED|Open-label Treatment Phase|Participants in the Czech Republic and UK are reported separately (Study 20080585; NCT01824342)|110
621262|NCT00286091|1524713|P2|NOT COMPLETED|Double-blind Treatment Phase||593
621263|NCT00286091|1524714|P1|NOT COMPLETED|Double-blind Treatment Phase||584
621264|NCT00286091|1524713|P2|COMPLETED|Double-blind Treatment Phase|On study through blinded treatment cutoff date of 09 January 2011|123
621265|NCT00286091|1524714|P1|COMPLETED|Double-blind Treatment Phase|On study through blinded treatment cutoff date of 09 January 2011|132
621266|NCT00286091|1524713|P2|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase|Primary analysis cut-off date was 30 July 2010|174
621267|NCT00286091|1524714|P1|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase|Primary analysis cut-off date was 30 July 2010|164
621268|NCT00286091|1524713|P2|Received Treatment|Double-blind Treatment Phase||716
621269|NCT00286091|1524714|P1|Received Treatment|Double-blind Treatment Phase|4 participants received ≥ 1 dose of denosumab in error|709
621270|NCT00286091|1524713|P2|STARTED|Double-blind Treatment Phase||716
621271|NCT00286091|1524714|P1|STARTED|Double-blind Treatment Phase||716
621272|NCT00286078|1524728|P2|NOT COMPLETED|Overall Study||34
621273|NCT00286078|1524729|P1|NOT COMPLETED|Overall Study||32
621274|NCT00286078|1524728|P2|COMPLETED|Overall Study||34
621275|NCT00286078|1524729|P1|COMPLETED|Overall Study||40
621276|NCT00286078|1524728|P2|12 Weeks|Overall Study||62
621277|NCT00286078|1524729|P1|12 Weeks|Overall Study||63
621278|NCT00286078|1524728|P2|STARTED|Overall Study||68
621279|NCT00286078|1524729|P1|STARTED|Overall Study||72
621280|NCT00285857|1524737|P1|NOT COMPLETED|Overall Study||4
621281|NCT00285857|1524737|P1|COMPLETED|Overall Study||26
621282|NCT00285857|1524737|P1|STARTED|Overall Study||30
621283|NCT00285818|1524750|P2|NOT COMPLETED|Overall Study||2
621284|NCT00285818|1524751|P1|NOT COMPLETED|Overall Study||4
621285|NCT00285818|1524750|P2|COMPLETED|Overall Study||3
621286|NCT00285818|1524751|P1|COMPLETED|Overall Study||2
621287|NCT00285818|1524750|P2|STARTED|Overall Study||5
621288|NCT00285818|1524751|P1|STARTED|Overall Study||6
621289|NCT00285779|1524759|P2|NOT COMPLETED|Follow-up Period (wk 24-32)||0
621290|NCT00285779|1524760|P1|NOT COMPLETED|Follow-up Period (wk 24-32)||1
621291|NCT00285779|1524759|P2|COMPLETED|Follow-up Period (wk 24-32)||10
621292|NCT00285779|1524760|P1|COMPLETED|Follow-up Period (wk 24-32)||8
621293|NCT00285779|1524759|P2|STARTED|Follow-up Period (wk 24-32)||10
621294|NCT00285779|1524760|P1|STARTED|Follow-up Period (wk 24-32)||9
621295|NCT00285779|1524759|P2|NOT COMPLETED|Open Label Period (wk 12-24)||2
621296|NCT00285779|1524760|P1|NOT COMPLETED|Open Label Period (wk 12-24)||2
621297|NCT00285779|1524759|P2|COMPLETED|Open Label Period (wk 12-24)||10
621298|NCT00285779|1524760|P1|COMPLETED|Open Label Period (wk 12-24)||9
621299|NCT00285779|1524759|P2|STARTED|Open Label Period (wk 12-24)||12
621300|NCT00285779|1524760|P1|STARTED|Open Label Period (wk 12-24)||11
621301|NCT00285779|1524759|P2|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||1
621302|NCT00285779|1524760|P1|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||3
621303|NCT00285779|1524759|P2|COMPLETED|Placebo-controlled Period (wk 1-12)||12
621304|NCT00285779|1524760|P1|COMPLETED|Placebo-controlled Period (wk 1-12)||11
621305|NCT00285779|1524759|P2|STARTED|Placebo-controlled Period (wk 1-12)||13
621306|NCT00285779|1524760|P1|STARTED|Placebo-controlled Period (wk 1-12)||14
621307|NCT00285649|1524796|P3|NOT COMPLETED|Overall Study||6
621308|NCT00285649|1524797|P2|NOT COMPLETED|Overall Study||6
621309|NCT00285649|1524798|P1|NOT COMPLETED|Overall Study||9
621310|NCT00285649|1524796|P3|COMPLETED|Overall Study||42
621311|NCT00285649|1524797|P2|COMPLETED|Overall Study||66
621312|NCT00285649|1524798|P1|COMPLETED|Overall Study||63
621313|NCT00285649|1524796|P3|STARTED|Overall Study||48
621314|NCT00285649|1524797|P2|STARTED|Overall Study||72
621315|NCT00285649|1524798|P1|STARTED|Overall Study||72
621316|NCT00285584|1524808|P2|NOT COMPLETED|Month 9||3
621317|NCT00285584|1524809|P1|NOT COMPLETED|Month 9||1
621318|NCT00285584|1524808|P2|COMPLETED|Month 9||14
621319|NCT00285584|1524809|P1|COMPLETED|Month 9||15
621320|NCT00285584|1524808|P2|STARTED|Month 9||17
621321|NCT00285584|1524809|P1|STARTED|Month 9||16
621322|NCT00285584|1524808|P2|NOT COMPLETED|Month 6||1
621323|NCT00285584|1524809|P1|NOT COMPLETED|Month 6||0
621324|NCT00285584|1524808|P2|COMPLETED|Month 6||17
621325|NCT00285584|1524809|P1|COMPLETED|Month 6||16
621326|NCT00285584|1524808|P2|STARTED|Month 6||18
621327|NCT00285584|1524809|P1|STARTED|Month 6||16
621328|NCT00285584|1524808|P2|NOT COMPLETED|Month 3||3
621329|NCT00285584|1524809|P1|NOT COMPLETED|Month 3||4
621330|NCT00285584|1524808|P2|COMPLETED|Month 3||18
621331|NCT00285584|1524809|P1|COMPLETED|Month 3||16
621332|NCT00285584|1524808|P2|STARTED|Month 3||21
621333|NCT00285584|1524809|P1|STARTED|Month 3||20
621334|NCT00285584|1524808|P2|NOT COMPLETED|Enrollment (Month 0)||0
621335|NCT00285584|1524809|P1|NOT COMPLETED|Enrollment (Month 0)||0
621336|NCT00285584|1524808|P2|COMPLETED|Enrollment (Month 0)||21
621337|NCT00285584|1524809|P1|COMPLETED|Enrollment (Month 0)||20
621338|NCT00285584|1524808|P2|STARTED|Enrollment (Month 0)||21
621339|NCT00285584|1524809|P1|STARTED|Enrollment (Month 0)||20
621340|NCT00285467|1524823|P2|NOT COMPLETED|Overall Study||0
621341|NCT00285467|1524824|P1|NOT COMPLETED|Overall Study||0
621342|NCT00285467|1524823|P2|COMPLETED|Overall Study||22
621343|NCT00285467|1524824|P1|COMPLETED|Overall Study||25
621344|NCT00285467|1524823|P2|STARTED|Overall Study||22
621345|NCT00285467|1524824|P1|STARTED|Overall Study||25
621346|NCT00285246|1524832|P1|NOT COMPLETED|Overall Study||48
621347|NCT00285246|1524832|P1|COMPLETED|Overall Study|Number of participants who were eligible and completed at least one phase of data collection|790
621348|NCT00285246|1524832|P1|STARTED|Overall Study||838
621349|NCT00285207|1524841|P2|NOT COMPLETED|Overall Study||6
621350|NCT00285207|1524842|P1|NOT COMPLETED|Overall Study||9
621351|NCT00285207|1524841|P2|COMPLETED|Overall Study||71
621352|NCT00285207|1524842|P1|COMPLETED|Overall Study||61
621353|NCT00285207|1524841|P2|Treated|Overall Study||75
621354|NCT00285207|1524842|P1|Treated|Overall Study||63
621355|NCT00285207|1524841|P2|STARTED|Overall Study||77
621356|NCT00285207|1524842|P1|STARTED|Overall Study||70
621357|NCT00285012|1524850|P2|NOT COMPLETED|Received Study Tx||94
621358|NCT00285012|1524851|P1|NOT COMPLETED|Received Study Tx||72
621359|NCT00285012|1524850|P2|COMPLETED|Received Study Tx|Completed study through nontreatment follow-up phase Week 13 to Week 52|157
621360|NCT00285012|1524851|P1|COMPLETED|Received Study Tx|Completed study through nontreatment follow-up phase Week 13 to Week 52|176
621361|NCT00285012|1524850|P2|Discontinued Tx (May Continue in Study)|Received Study Tx|Discontinued Tx=14 AE;3 Lack of efficacy;10 Lost to follow up;25 subject withdrawal;6 other, unknown|58
621362|NCT00285012|1524851|P1|Discontinued Tx (May Continue in Study)|Received Study Tx|Discontinued Tx=12 Adverse Event (AE); 10 Lost to follow up; 13 subject withdrawal; 6 other, unknown|41
621363|NCT00285012|1524850|P2|Completed Tx (May Continue in Study)|Received Study Tx|After treatment completion at Wk 12, subjects may continue in nontreatment follow-up phase|193
621364|NCT00285012|1524851|P1|Completed Tx (May Continue in Study)|Received Study Tx|After treatment completion at Wk 12, subjects may continue in nontreatment follow-up phase|207
621365|NCT00285012|1524850|P2|STARTED|Received Study Tx||251
621366|NCT00285012|1524851|P1|STARTED|Received Study Tx||248
621367|NCT00285012|1524850|P2|NOT COMPLETED|Assigned to Study Treatment (Tx)||3
621368|NCT00285012|1524851|P1|NOT COMPLETED|Assigned to Study Treatment (Tx)||2
621369|NCT00285012|1524850|P2|COMPLETED|Assigned to Study Treatment (Tx)||251
621370|NCT00285012|1524851|P1|COMPLETED|Assigned to Study Treatment (Tx)||248
621371|NCT00285012|1524850|P2|STARTED|Assigned to Study Treatment (Tx)||254
621372|NCT00285012|1524851|P1|STARTED|Assigned to Study Treatment (Tx)||250
621373|NCT00284934|1524877|P2|NOT COMPLETED|Overall Study||3
621374|NCT00284934|1524878|P1|NOT COMPLETED|Overall Study||4
621375|NCT00284934|1524877|P2|COMPLETED|Overall Study||43
621376|NCT00284934|1524878|P1|COMPLETED|Overall Study||44
621377|NCT00284934|1524877|P2|Intent-to-treat Population (ITT)|Overall Study||45
621378|NCT00284934|1524878|P1|Intent-to-treat Population (ITT)|Overall Study||47
621379|NCT00284934|1524877|P2|STARTED|Overall Study||46
621380|NCT00284934|1524878|P1|STARTED|Overall Study||48
621381|NCT00284856|1524893|P3|NOT COMPLETED|Overall Study||60
621382|NCT00284856|1524894|P2|NOT COMPLETED|Overall Study||50
621383|NCT00284856|1524895|P1|NOT COMPLETED|Overall Study||51
621384|NCT00284856|1524893|P3|COMPLETED|Overall Study||276
621385|NCT00284856|1524894|P2|COMPLETED|Overall Study||286
621386|NCT00284856|1524895|P1|COMPLETED|Overall Study||296
621387|NCT00284856|1524893|P3|STARTED|Overall Study||336
621388|NCT00284856|1524894|P2|STARTED|Overall Study||336
621389|NCT00284856|1524895|P1|STARTED|Overall Study||347
621390|NCT00284739|1524911|P2|NOT COMPLETED|Overall Study||0
621391|NCT00284739|1524912|P1|NOT COMPLETED|Overall Study||0
621392|NCT00284739|1524911|P2|COMPLETED|Overall Study||9
621393|NCT00284739|1524912|P1|COMPLETED|Overall Study||11
621394|NCT00284739|1524911|P2|STARTED|Overall Study||9
621395|NCT00284739|1524912|P1|STARTED|Overall Study||11
621396|NCT00284557|1524924|P2|NOT COMPLETED|Overall Study||13
621397|NCT00284557|1524925|P1|NOT COMPLETED|Overall Study||9
621398|NCT00284557|1524924|P2|COMPLETED|Overall Study||50
621399|NCT00284557|1524925|P1|COMPLETED|Overall Study||58
621400|NCT00284557|1524924|P2|STARTED|Overall Study||63
621401|NCT00284557|1524925|P1|STARTED|Overall Study||67
621402|NCT00284518|1524937|P4|NOT COMPLETED|Overall Study||33
621403|NCT00284518|1524938|P3|NOT COMPLETED|Overall Study||28
621404|NCT00284518|1524939|P2|NOT COMPLETED|Overall Study||28
621405|NCT00284518|1524940|P1|NOT COMPLETED|Overall Study||26
621406|NCT00284518|1524937|P4|COMPLETED|Overall Study||61
621407|NCT00284518|1524938|P3|COMPLETED|Overall Study||67
621408|NCT00284518|1524939|P2|COMPLETED|Overall Study||66
621409|NCT00284518|1524940|P1|COMPLETED|Overall Study||71
621410|NCT00284518|1524937|P4|STARTED|Overall Study||94
621411|NCT00284518|1524938|P3|STARTED|Overall Study||95
621412|NCT00284518|1524939|P2|STARTED|Overall Study||94
621413|NCT00284518|1524940|P1|STARTED|Overall Study||97
621414|NCT00284180|1524980|P2|NOT COMPLETED|Overall Study||4
621415|NCT00284180|1524981|P1|NOT COMPLETED|Overall Study||0
621416|NCT00284180|1524980|P2|COMPLETED|Overall Study||17
621417|NCT00284180|1524981|P1|COMPLETED|Overall Study||11
621418|NCT00284180|1524980|P2|STARTED|Overall Study||21
621419|NCT00284180|1524981|P1|STARTED|Overall Study||11
621420|NCT00284154|1524987|P1|NOT COMPLETED|Overall Study||42
621421|NCT00284154|1524987|P1|COMPLETED|Overall Study||9
621422|NCT00284154|1524987|P1|STARTED|Overall Study||51
621423|NCT00284141|1524994|P1|NOT COMPLETED|Overall Study||98
621424|NCT00284141|1524994|P1|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were still ongoing treatment.|0
621425|NCT00284141|1524994|P1|ONGOING TREATMENT|Overall Study|Participants were still on study treatment at the clinical database cut-off date.|2
621426|NCT00284141|1524994|P1|TREATED|Overall Study|Participants received at least part of one dose of Aflibercept.|96
621427|NCT00284141|1524994|P1|STARTED|Overall Study||98
621428|NCT00284089|1525017|P4|NOT COMPLETED|Extension Phase||12
621429|NCT00284089|1525018|P3|NOT COMPLETED|Extension Phase||6
621430|NCT00284089|1525019|P2|NOT COMPLETED|Extension Phase||0
621431|NCT00284089|1525020|P1|NOT COMPLETED|Extension Phase||2
621432|NCT00284089|1525017|P4|COMPLETED|Extension Phase||21
621433|NCT00284089|1525018|P3|COMPLETED|Extension Phase||22
621434|NCT00284089|1525019|P2|COMPLETED|Extension Phase||6
621435|NCT00284089|1525020|P1|COMPLETED|Extension Phase||1
621436|NCT00284089|1525017|P4|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|33
621437|NCT00284089|1525018|P3|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|28
621438|NCT00284089|1525019|P2|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|6
621439|NCT00284089|1525020|P1|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|3
621440|NCT00284089|1525017|P4|NOT COMPLETED|Multiple Dose Phase||4
621441|NCT00284089|1525018|P3|NOT COMPLETED|Multiple Dose Phase||4
621442|NCT00284089|1525019|P2|NOT COMPLETED|Multiple Dose Phase||0
621443|NCT00284089|1525020|P1|NOT COMPLETED|Multiple Dose Phase||1
621444|NCT00284089|1525017|P4|COMPLETED|Multiple Dose Phase||37
621445|NCT00284089|1525018|P3|COMPLETED|Multiple Dose Phase||31
621446|NCT00284089|1525019|P2|COMPLETED|Multiple Dose Phase||6
621447|NCT00284089|1525020|P1|COMPLETED|Multiple Dose Phase||4
621448|NCT00284089|1525017|P4|STARTED|Multiple Dose Phase||41
621449|NCT00284089|1525018|P3|STARTED|Multiple Dose Phase||35
621450|NCT00284089|1525019|P2|STARTED|Multiple Dose Phase||6
621451|NCT00284089|1525020|P1|STARTED|Multiple Dose Phase|1 subject chose to receive other treatment & discontinued before starting the multiple dose phase.|5
621452|NCT00284089|1525017|P4|NOT COMPLETED|Single Dose Phase||0
621453|NCT00284089|1525018|P3|NOT COMPLETED|Single Dose Phase||0
621454|NCT00284089|1525019|P2|NOT COMPLETED|Single Dose Phase||0
621455|NCT00284089|1525020|P1|NOT COMPLETED|Single Dose Phase||0
621456|NCT00284089|1525017|P4|COMPLETED|Single Dose Phase||0
621457|NCT00284089|1525018|P3|COMPLETED|Single Dose Phase||0
621458|NCT00284089|1525019|P2|COMPLETED|Single Dose Phase||6
621459|NCT00284089|1525020|P1|COMPLETED|Single Dose Phase||6
621460|NCT00284089|1525017|P4|STARTED|Single Dose Phase|Group B patients did not participate in the Single Dose Phase of the study.|0
621461|NCT00284089|1525018|P3|STARTED|Single Dose Phase|Group B patients did not participate in the Single Dose Phase of the study.|0
621462|NCT00284089|1525019|P2|STARTED|Single Dose Phase||6
621463|NCT00284089|1525020|P1|STARTED|Single Dose Phase||6
621464|NCT00284050|1525049|P3|NOT COMPLETED|Overall Study||9
621465|NCT00284050|1525050|P2|NOT COMPLETED|Overall Study||5
621466|NCT00284050|1525051|P1|NOT COMPLETED|Overall Study||5
621467|NCT00284050|1525049|P3|COMPLETED|Overall Study||40
621468|NCT00284050|1525050|P2|COMPLETED|Overall Study||46
621469|NCT00284050|1525051|P1|COMPLETED|Overall Study||46
621470|NCT00284050|1525049|P3|STARTED|Overall Study||49
621471|NCT00284050|1525050|P2|STARTED|Overall Study||51
621472|NCT00284050|1525051|P1|STARTED|Overall Study||51
621473|NCT00283868|1525067|P2|NOT COMPLETED|Overall Study||8
621474|NCT00283868|1525068|P1|NOT COMPLETED|Overall Study||7
621475|NCT00283868|1525067|P2|COMPLETED|Overall Study||103
621476|NCT00283868|1525068|P1|COMPLETED|Overall Study||104
621477|NCT00283868|1525067|P2|STARTED|Overall Study||111
621478|NCT00283868|1525068|P1|STARTED|Overall Study||111
621479|NCT00283842|1525085|P5|NOT COMPLETED|Overall Study||15
621480|NCT00283842|1525086|P4|NOT COMPLETED|Overall Study||27
621481|NCT00283842|1525087|P3|NOT COMPLETED|Overall Study||31
621482|NCT00283842|1525088|P2|NOT COMPLETED|Overall Study||18
621483|NCT00283842|1525089|P1|NOT COMPLETED|Overall Study||12
621484|NCT00283842|1525085|P5|COMPLETED|Overall Study||75
621485|NCT00283842|1525086|P4|COMPLETED|Overall Study||42
621486|NCT00283842|1525087|P3|COMPLETED|Overall Study||68
621487|NCT00283842|1525088|P2|COMPLETED|Overall Study||69
621488|NCT00283842|1525089|P1|COMPLETED|Overall Study||51
621489|NCT00283842|1525085|P5|STARTED|Overall Study||90
621490|NCT00283842|1525086|P4|STARTED|Overall Study||69
621491|NCT00283842|1525087|P3|STARTED|Overall Study||99
621492|NCT00283842|1525088|P2|STARTED|Overall Study||87
621493|NCT00283842|1525089|P1|STARTED|Overall Study||63
621494|NCT00283816|1525108|P2|NOT COMPLETED|Overall Study||2
621495|NCT00283816|1525109|P1|NOT COMPLETED|Overall Study||2
621496|NCT00283816|1525108|P2|COMPLETED|Overall Study||16
621497|NCT00283816|1525109|P1|COMPLETED|Overall Study||16
621498|NCT00283816|1525108|P2|STARTED|Overall Study||18
621499|NCT00283816|1525109|P1|STARTED|Overall Study||18
621500|NCT00283803|1525121|P1|NOT COMPLETED|Overall Study||13
621501|NCT00283803|1525121|P1|COMPLETED|Overall Study||19
621502|NCT00283803|1525121|P1|STARTED|Overall Study||32
621503|NCT00283712|1525129|P2|NOT COMPLETED|Overall Study||1
621504|NCT00283712|1525130|P1|NOT COMPLETED|Overall Study||0
621505|NCT00283712|1525129|P2|COMPLETED|Overall Study|One subject in placebo arm died prior to study completion.|9
621506|NCT00283712|1525130|P1|COMPLETED|Overall Study||10
621507|NCT00283712|1525129|P2|Per-Protocol Sample|Overall Study||7
621508|NCT00283712|1525130|P1|Per-Protocol Sample|Overall Study||6
621509|NCT00283712|1525129|P2|Safety Sample|Overall Study||10
621510|NCT00283712|1525130|P1|Safety Sample|Overall Study||10
621511|NCT00283712|1525129|P2|Intent-to-treat Sample|Overall Study||10
621512|NCT00283712|1525130|P1|Intent-to-treat Sample|Overall Study||10
621513|NCT00283712|1525129|P2|STARTED|Overall Study||10
621514|NCT00283712|1525130|P1|STARTED|Overall Study||10
621515|NCT00283686|1525168|P4|NOT COMPLETED|Overall Study||32
621516|NCT00283686|1525169|P3|NOT COMPLETED|Overall Study||33
621517|NCT00283686|1525170|P2|NOT COMPLETED|Overall Study||41
621518|NCT00283686|1525171|P1|NOT COMPLETED|Overall Study||29
621519|NCT00283686|1525168|P4|COMPLETED|Overall Study||109
621520|NCT00283686|1525169|P3|COMPLETED|Overall Study||111
621521|NCT00283686|1525170|P2|COMPLETED|Overall Study||92
621522|NCT00283686|1525171|P1|COMPLETED|Overall Study||111
621523|NCT00283686|1525168|P4|STARTED|Overall Study||141
621524|NCT00283686|1525169|P3|STARTED|Overall Study||144
621525|NCT00283686|1525170|P2|STARTED|Overall Study||133
621526|NCT00283686|1525171|P1|STARTED|Overall Study||140
621527|NCT00283595|1525215|P2|NOT COMPLETED|Overall Study||2
621528|NCT00283595|1525216|P1|NOT COMPLETED|Overall Study||1
621529|NCT00283595|1525215|P2|COMPLETED|Overall Study||9
621530|NCT00283595|1525216|P1|COMPLETED|Overall Study||9
621531|NCT00283595|1525215|P2|STARTED|Overall Study||11
621532|NCT00283595|1525216|P1|STARTED|Overall Study||10
621533|NCT00283504|1525226|P2|NOT COMPLETED|Overall Study||0
621534|NCT00283504|1525227|P1|NOT COMPLETED|Overall Study||0
621535|NCT00283504|1525226|P2|COMPLETED|Overall Study||6
621536|NCT00283504|1525227|P1|COMPLETED|Overall Study||7
621537|NCT00283504|1525226|P2|STARTED|Overall Study||6
621538|NCT00283504|1525227|P1|STARTED|Overall Study||7
621539|NCT00283439|1525241|P4|NOT COMPLETED|Overall Study||9
621540|NCT00283439|1525242|P3|NOT COMPLETED|Overall Study||11
621541|NCT00283439|1525243|P2|NOT COMPLETED|Overall Study||11
621542|NCT00283439|1525244|P1|NOT COMPLETED|Overall Study||8
621543|NCT00283439|1525241|P4|COMPLETED|Overall Study||0
621544|NCT00283439|1525242|P3|COMPLETED|Overall Study||0
621545|NCT00283439|1525243|P2|COMPLETED|Overall Study||0
621546|NCT00283439|1525244|P1|COMPLETED|Overall Study||0
621547|NCT00283439|1525241|P4|STARTED|Overall Study||9
621548|NCT00283439|1525242|P3|STARTED|Overall Study||11
621549|NCT00283439|1525243|P2|STARTED|Overall Study||11
621550|NCT00283439|1525244|P1|STARTED|Overall Study||8
621551|NCT00283400|1525270|P4|NOT COMPLETED|Overall Study||0
621552|NCT00283400|1525271|P3|NOT COMPLETED|Overall Study||1
621553|NCT00283400|1525272|P2|NOT COMPLETED|Overall Study||1
621554|NCT00283400|1525273|P1|NOT COMPLETED|Overall Study||2
621555|NCT00283400|1525270|P4|COMPLETED|Overall Study||0
621556|NCT00283400|1525271|P3|COMPLETED|Overall Study||6
621557|NCT00283400|1525272|P2|COMPLETED|Overall Study||19
621558|NCT00283400|1525273|P1|COMPLETED|Overall Study||18
621559|NCT00283400|1525270|P4|STARTED|Overall Study||0
621560|NCT00283400|1525271|P3|STARTED|Overall Study||7
621561|NCT00283400|1525272|P2|STARTED|Overall Study||20
621562|NCT00283400|1525273|P1|STARTED|Overall Study||20
621563|NCT00283387|1525291|P2|NOT COMPLETED|Second Intervention||0
621564|NCT00283387|1525292|P1|NOT COMPLETED|Second Intervention||0
621565|NCT00283387|1525291|P2|COMPLETED|Second Intervention||5
621566|NCT00283387|1525292|P1|COMPLETED|Second Intervention||5
621567|NCT00283387|1525291|P2|STARTED|Second Intervention||5
621568|NCT00283387|1525292|P1|STARTED|Second Intervention||5
621569|NCT00283387|1525291|P2|NOT COMPLETED|Washout Period of 2 Months||0
621570|NCT00283387|1525292|P1|NOT COMPLETED|Washout Period of 2 Months||0
621571|NCT00283387|1525291|P2|COMPLETED|Washout Period of 2 Months||5
621572|NCT00283387|1525292|P1|COMPLETED|Washout Period of 2 Months||5
621573|NCT00283387|1525291|P2|STARTED|Washout Period of 2 Months||5
621574|NCT00283387|1525292|P1|STARTED|Washout Period of 2 Months||5
621575|NCT00283387|1525291|P2|NOT COMPLETED|First Intervention||2
621576|NCT00283387|1525292|P1|NOT COMPLETED|First Intervention||1
621577|NCT00283387|1525291|P2|COMPLETED|First Intervention||5
621578|NCT00283387|1525292|P1|COMPLETED|First Intervention||5
621579|NCT00283387|1525291|P2|STARTED|First Intervention||7
621580|NCT00283387|1525292|P1|STARTED|First Intervention||6
621581|NCT00283296|1525298|P1|NOT COMPLETED|Overall Study||5
621582|NCT00283296|1525298|P1|COMPLETED|Overall Study|Completed in-lab and in-home trial.|9
621583|NCT00283296|1525298|P1|STARTED|Overall Study||14
621584|NCT00283244|1525307|P3|NOT COMPLETED|Overall Study||51
621585|NCT00283244|1525308|P2|NOT COMPLETED|Overall Study||51
621586|NCT00283244|1525309|P1|NOT COMPLETED|Overall Study||18
621587|NCT00283244|1525307|P3|COMPLETED|Overall Study|Patients treated until progression or unacceptable toxicity; 9 patients received 2nd line therapy|0
621588|NCT00283244|1525308|P2|COMPLETED|Overall Study|Patients treated until progression or unacceptable toxicity; 12 patients received 2nd line therapy|0
621589|NCT00283244|1525309|P1|COMPLETED|Overall Study|19 patients went on to receive second line Erlotinib|26
621590|NCT00283244|1525307|P3|STARTED|Overall Study||51
621591|NCT00283244|1525308|P2|STARTED|Overall Study||51
621592|NCT00283244|1525309|P1|STARTED|Overall Study||44
621593|NCT00283075|1525329|P2|NOT COMPLETED|Overall Study||0
621594|NCT00283075|1525330|P1|NOT COMPLETED|Overall Study||0
621595|NCT00283075|1525329|P2|COMPLETED|Overall Study||6
621596|NCT00283075|1525330|P1|COMPLETED|Overall Study||25
621597|NCT00283075|1525329|P2|STARTED|Overall Study||6
621598|NCT00283075|1525330|P1|STARTED|Overall Study||25
621599|NCT00283062|1525345|P4|NOT COMPLETED|Overall Study||49
621600|NCT00283062|1525346|P3|NOT COMPLETED|Overall Study||41
621601|NCT00283062|1525347|P2|NOT COMPLETED|Overall Study||7
621602|NCT00283062|1525348|P1|NOT COMPLETED|Overall Study||12
621603|NCT00283062|1525345|P4|COMPLETED|Overall Study||13
621604|NCT00283062|1525346|P3|COMPLETED|Overall Study||15
621605|NCT00283062|1525347|P2|COMPLETED|Overall Study||48
621606|NCT00283062|1525348|P1|COMPLETED|Overall Study||43
621607|NCT00283062|1525345|P4|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study|Not applicable, since participants in this arm did not receive chemotherapy.|0
621608|NCT00283062|1525346|P3|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||15
621609|NCT00283062|1525347|P2|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study|Not applicable, since participants in this arm did not receive chemotherapy.|0
621610|NCT00283062|1525348|P1|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||43
621611|NCT00283062|1525345|P4|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||13
621612|NCT00283062|1525346|P3|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||15
621613|NCT00283062|1525347|P2|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||48
621614|NCT00283062|1525348|P1|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||44
621615|NCT00283062|1525345|P4|ADMINISTERED STUDY TREATMENT|Overall Study||17
621616|NCT00283062|1525346|P3|ADMINISTERED STUDY TREATMENT|Overall Study||20
621617|NCT00283062|1525347|P2|ADMINISTERED STUDY TREATMENT|Overall Study||51
621618|NCT00283062|1525348|P1|ADMINISTERED STUDY TREATMENT|Overall Study||50
621619|NCT00283062|1525345|P4|STARTED|Overall Study||62
621620|NCT00283062|1525346|P3|STARTED|Overall Study||56
621621|NCT00283062|1525347|P2|STARTED|Overall Study||55
621622|NCT00283062|1525348|P1|STARTED|Overall Study||55
621623|NCT00283049|1525381|P3|NOT COMPLETED|Overall Study||54
621624|NCT00283049|1525382|P2|NOT COMPLETED|Overall Study||45
621625|NCT00283049|1525383|P1|NOT COMPLETED|Overall Study||58
621626|NCT00283049|1525381|P3|COMPLETED|Overall Study||76
621627|NCT00283049|1525382|P2|COMPLETED|Overall Study||83
621628|NCT00283049|1525383|P1|COMPLETED|Overall Study||70
621629|NCT00283049|1525381|P3|STARTED|Overall Study|1 randomized patient did not receive study drug and was not included in the safety population|130
621630|NCT00283049|1525382|P2|STARTED|Overall Study|1 randomized patient did not receive study drug and was not included in the safety population|128
621631|NCT00283049|1525383|P1|STARTED|Overall Study|2 randomized patients did not receive study drug and were not included in the safety population|128
621632|NCT00282984|1525411|P2|NOT COMPLETED|Overall Study||61
621633|NCT00282984|1525412|P1|NOT COMPLETED|Overall Study||51
621634|NCT00282984|1525411|P2|COMPLETED|Overall Study||289
621635|NCT00282984|1525412|P1|COMPLETED|Overall Study||302
621636|NCT00282984|1525411|P2|STARTED|Overall Study||350
621637|NCT00282984|1525412|P1|STARTED|Overall Study||353
621638|NCT00282971|1525438|P2|NOT COMPLETED|Overall Study||22
621639|NCT00282971|1525439|P1|NOT COMPLETED|Overall Study||34
621640|NCT00282971|1525438|P2|COMPLETED|Overall Study||149
621641|NCT00282971|1525439|P1|COMPLETED|Overall Study||146
621642|NCT00282971|1525438|P2|STARTED|Overall Study||171
621643|NCT00282971|1525439|P1|STARTED|Overall Study||180
621644|NCT00282919|1525449|P1|NOT COMPLETED|Overall Study||7
621645|NCT00282919|1525449|P1|COMPLETED|Overall Study||103
621646|NCT00282919|1525449|P1|STARTED|Overall Study||110
621647|NCT00282867|1525464|P3|NOT COMPLETED|Overall Study||0
621648|NCT00282867|1525465|P2|NOT COMPLETED|Overall Study||1
621649|NCT00282867|1525466|P1|NOT COMPLETED|Overall Study||1
621650|NCT00282867|1525464|P3|COMPLETED|Overall Study||25
621651|NCT00282867|1525465|P2|COMPLETED|Overall Study||24
621652|NCT00282867|1525466|P1|COMPLETED|Overall Study||23
621653|NCT00282867|1525464|P3|STARTED|Overall Study||25
621654|NCT00282867|1525465|P2|STARTED|Overall Study||25
621655|NCT00282867|1525466|P1|STARTED|Overall Study||24
621656|NCT00282828|1525483|P3|NOT COMPLETED|Overall Study||9
621657|NCT00282828|1525484|P2|NOT COMPLETED|Overall Study||12
621658|NCT00282828|1525485|P1|NOT COMPLETED|Overall Study||6
621659|NCT00282828|1525483|P3|COMPLETED|Overall Study||50
621660|NCT00282828|1525484|P2|COMPLETED|Overall Study||47
621661|NCT00282828|1525485|P1|COMPLETED|Overall Study||57
621662|NCT00282828|1525483|P3|STARTED|Overall Study||59
621663|NCT00282828|1525484|P2|STARTED|Overall Study||59
621664|NCT00282828|1525485|P1|STARTED|Overall Study||63
621665|NCT00282815|1525498|P2|NOT COMPLETED|Overall Study||6
621666|NCT00282815|1525499|P1|NOT COMPLETED|Overall Study||7
621667|NCT00282815|1525498|P2|COMPLETED|Overall Study||11
621668|NCT00282815|1525499|P1|COMPLETED|Overall Study||8
621669|NCT00282815|1525498|P2|STARTED|Overall Study||17
621670|NCT00282815|1525499|P1|STARTED|Overall Study||15
621671|NCT00282672|1525512|P4|NOT COMPLETED|5 Year: Follow up||5
621672|NCT00282672|1525513|P3|NOT COMPLETED|5 Year: Follow up||0
621673|NCT00282672|1525514|P2|NOT COMPLETED|5 Year: Follow up||5
621674|NCT00282672|1525515|P1|NOT COMPLETED|5 Year: Follow up||1
621675|NCT00282672|1525512|P4|COMPLETED|5 Year: Follow up||20
621676|NCT00282672|1525513|P3|COMPLETED|5 Year: Follow up||12
621677|NCT00282672|1525514|P2|COMPLETED|5 Year: Follow up||27
621678|NCT00282672|1525515|P1|COMPLETED|5 Year: Follow up||14
621679|NCT00282672|1525512|P4|STARTED|5 Year: Follow up|11 withdrew|25
621680|NCT00282672|1525513|P3|STARTED|5 Year: Follow up|3 withdrew|12
621681|NCT00282672|1525514|P2|STARTED|5 Year: Follow up|7 withdrew|32
621682|NCT00282672|1525515|P1|STARTED|5 Year: Follow up|1 withdrew|15
621683|NCT00282672|1525512|P4|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||2
621684|NCT00282672|1525513|P3|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1
621685|NCT00282672|1525514|P2|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1
621686|NCT00282672|1525515|P1|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||3
621687|NCT00282672|1525512|P4|COMPLETED|2 Year: Sham Crossed Over to RFA||36
621688|NCT00282672|1525513|P3|COMPLETED|2 Year: Sham Crossed Over to RFA||15
621689|NCT00282672|1525514|P2|COMPLETED|2 Year: Sham Crossed Over to RFA||39
621690|NCT00282672|1525515|P1|COMPLETED|2 Year: Sham Crossed Over to RFA||16
621691|NCT00282672|1525512|P4|STARTED|2 Year: Sham Crossed Over to RFA||38
621692|NCT00282672|1525513|P3|STARTED|2 Year: Sham Crossed Over to RFA|16 Crossed over to RFA treatment|16
621693|NCT00282672|1525514|P2|STARTED|2 Year: Sham Crossed Over to RFA||40
621694|NCT00282672|1525515|P1|STARTED|2 Year: Sham Crossed Over to RFA|19 crossed over to RFA treatment|19
621695|NCT00282672|1525512|P4|NOT COMPLETED|1 Year||4
621696|NCT00282672|1525513|P3|NOT COMPLETED|1 Year||1
621697|NCT00282672|1525514|P2|NOT COMPLETED|1 Year||2
621698|NCT00282672|1525515|P1|NOT COMPLETED|1 Year||3
621699|NCT00282672|1525512|P4|COMPLETED|1 Year||38
621700|NCT00282672|1525513|P3|COMPLETED|1 Year||20
621701|NCT00282672|1525514|P2|COMPLETED|1 Year||40
621702|NCT00282672|1525515|P1|COMPLETED|1 Year||19
621703|NCT00282672|1525512|P4|STARTED|1 Year||42
621704|NCT00282672|1525513|P3|STARTED|1 Year||21
621705|NCT00282672|1525514|P2|STARTED|1 Year||42
621706|NCT00282672|1525515|P1|STARTED|1 Year||22
621707|NCT00282568|1525563|P1|NOT COMPLETED|Extended Treatment Period||24
621708|NCT00282568|1525563|P1|COMPLETED|Extended Treatment Period||42
621709|NCT00282568|1525563|P1|STARTED|Extended Treatment Period|One patient who completed the PK period did not enter the extended treatment period.|66
621710|NCT00282568|1525563|P1|NOT COMPLETED|Pharmacokinetic Treatment Period||3
621711|NCT00282568|1525563|P1|COMPLETED|Pharmacokinetic Treatment Period||67
621712|NCT00282568|1525563|P1|Received Tacrolimus MR|Pharmacokinetic Treatment Period||67
621713|NCT00282568|1525563|P1|Received Tacrolimus|Pharmacokinetic Treatment Period||68
621714|NCT00282568|1525563|P1|STARTED|Pharmacokinetic Treatment Period||70
621715|NCT00282464|1525589|P2|NOT COMPLETED|Overall Study||62
621716|NCT00282464|1525590|P1|NOT COMPLETED|Overall Study||73
621717|NCT00282464|1525589|P2|COMPLETED|Overall Study||134
621718|NCT00282464|1525590|P1|COMPLETED|Overall Study||112
621719|NCT00282464|1525589|P2|STARTED|Overall Study||196
621720|NCT00282464|1525590|P1|STARTED|Overall Study||185
621721|NCT00282438|1525640|P2|NOT COMPLETED|Overall Study||1
621722|NCT00282438|1525641|P1|NOT COMPLETED|Overall Study||1
621723|NCT00282438|1525640|P2|COMPLETED|Overall Study||0
621724|NCT00282438|1525641|P1|COMPLETED|Overall Study||0
621725|NCT00282438|1525640|P2|STARTED|Overall Study||1
621726|NCT00282438|1525641|P1|STARTED|Overall Study||1
621727|NCT00282347|1525649|P2|NOT COMPLETED|B Cell Follow-up Period||0
621728|NCT00282347|1525650|P1|NOT COMPLETED|B Cell Follow-up Period||5
621729|NCT00282347|1525649|P2|COMPLETED|B Cell Follow-up Period||4
621730|NCT00282347|1525650|P1|COMPLETED|B Cell Follow-up Period||15
621731|NCT00282347|1525649|P2|STARTED|B Cell Follow-up Period||4
621732|NCT00282347|1525650|P1|STARTED|B Cell Follow-up Period||20
621733|NCT00282347|1525649|P2|NOT COMPLETED|Safety Follow-up Period||6
621734|NCT00282347|1525650|P1|NOT COMPLETED|Safety Follow-up Period||3
621735|NCT00282347|1525649|P2|COMPLETED|Safety Follow-up Period||57
621736|NCT00282347|1525650|P1|COMPLETED|Safety Follow-up Period||64
621737|NCT00282347|1525649|P2|STARTED|Safety Follow-up Period||63
621738|NCT00282347|1525650|P1|STARTED|Safety Follow-up Period||67
621739|NCT00282347|1525649|P2|NOT COMPLETED|Treatment Period||9
621740|NCT00282347|1525650|P1|NOT COMPLETED|Treatment Period||5
621741|NCT00282347|1525649|P2|COMPLETED|Treatment Period||63
621742|NCT00282347|1525650|P1|COMPLETED|Treatment Period||67
621743|NCT00282347|1525649|P2|STARTED|Treatment Period||72
621744|NCT00282347|1525650|P1|STARTED|Treatment Period||72
621745|NCT00282334|1525676|P2|NOT COMPLETED|Overall Study||5
621746|NCT00282334|1525677|P1|NOT COMPLETED|Overall Study||8
621747|NCT00282334|1525676|P2|COMPLETED|Overall Study||118
621748|NCT00282334|1525677|P1|COMPLETED|Overall Study||105
621749|NCT00282334|1525676|P2|STARTED|Overall Study||123
621750|NCT00282334|1525677|P1|STARTED|Overall Study||113
621751|NCT00282308|1525685|P3|NOT COMPLETED|Safety Follow-up Period||19
621752|NCT00282308|1525686|P2|NOT COMPLETED|Safety Follow-up Period||0
621753|NCT00282308|1525687|P1|NOT COMPLETED|Safety Follow-up Period||0
621754|NCT00282308|1525685|P3|COMPLETED|Safety Follow-up Period||81
621755|NCT00282308|1525686|P2|COMPLETED|Safety Follow-up Period||0
621756|NCT00282308|1525687|P1|COMPLETED|Safety Follow-up Period||0
621757|NCT00282308|1525685|P3|STARTED|Safety Follow-up Period|Some patients entered this Safety Follow-up Period directly from the Treatment Period.|100
621758|NCT00282308|1525686|P2|STARTED|Safety Follow-up Period|Participant Flow is reported for the combined treatment groups for this Period.|0
621759|NCT00282308|1525687|P1|STARTED|Safety Follow-up Period|Participant Flow is reported for the combined treatment groups for this Period.|0
621760|NCT00282308|1525685|P3|NOT COMPLETED|Optional Extension Re-treatment Period||6
621761|NCT00282308|1525686|P2|NOT COMPLETED|Optional Extension Re-treatment Period||0
621762|NCT00282308|1525687|P1|NOT COMPLETED|Optional Extension Re-treatment Period||0
621763|NCT00282308|1525685|P3|COMPLETED|Optional Extension Re-treatment Period||72
621764|NCT00282308|1525686|P2|COMPLETED|Optional Extension Re-treatment Period||0
621765|NCT00282308|1525687|P1|COMPLETED|Optional Extension Re-treatment Period||0
621766|NCT00282308|1525685|P3|STARTED|Optional Extension Re-treatment Period|Not all patients who completed the Treatment Period entered this Optional Re-treatment Period.|78
621767|NCT00282308|1525686|P2|STARTED|Optional Extension Re-treatment Period|Participant Flow is reported for the combined treatment groups for this Period.|0
621768|NCT00282308|1525687|P1|STARTED|Optional Extension Re-treatment Period|Participant Flow is reported for the combined treatment groups for this Period.|0
621769|NCT00282308|1525685|P3|NOT COMPLETED|Treatment Period||0
621770|NCT00282308|1525686|P2|NOT COMPLETED|Treatment Period||6
621771|NCT00282308|1525687|P1|NOT COMPLETED|Treatment Period||4
621772|NCT00282308|1525685|P3|COMPLETED|Treatment Period||0
621773|NCT00282308|1525686|P2|COMPLETED|Treatment Period||28
621774|NCT00282308|1525687|P1|COMPLETED|Treatment Period||65
621775|NCT00282308|1525685|P3|STARTED|Treatment Period|Participant Flow is reported separately for the treatment groups for this Period.|0
621776|NCT00282308|1525686|P2|STARTED|Treatment Period||34
621777|NCT00282308|1525687|P1|STARTED|Treatment Period||69
621778|NCT00282295|1525717|P3|NOT COMPLETED|Overall Study||8
621779|NCT00282295|1525718|P2|NOT COMPLETED|Overall Study||17
621780|NCT00282295|1525719|P1|NOT COMPLETED|Overall Study||3
621781|NCT00282295|1525717|P3|COMPLETED|Overall Study||441
621782|NCT00282295|1525718|P2|COMPLETED|Overall Study||429
621783|NCT00282295|1525719|P1|COMPLETED|Overall Study||443
621784|NCT00282295|1525717|P3|STARTED|Overall Study||449
621785|NCT00282295|1525718|P2|STARTED|Overall Study||446
621786|NCT00282295|1525719|P1|STARTED|Overall Study||446
621787|NCT00282282|1525768|P1|NOT COMPLETED|Overall Study||0
621788|NCT00282282|1525768|P1|COMPLETED|Overall Study||29
621789|NCT00282282|1525768|P1|STARTED|Overall Study|31 patients enrolled but 2 patients did not go through with transplant|29
621790|NCT00282256|1525774|P1|NOT COMPLETED|Extension Treatment Period||2
621791|NCT00282256|1525774|P1|COMPLETED|Extension Treatment Period||16
621792|NCT00282256|1525774|P1|STARTED|Extension Treatment Period||18
621793|NCT00282256|1525774|P1|NOT COMPLETED|Pharmacokinetic Treatment Period||1
621794|NCT00282256|1525774|P1|COMPLETED|Pharmacokinetic Treatment Period||18
621795|NCT00282256|1525774|P1|Received Tacrolimus MR|Pharmacokinetic Treatment Period||18
621796|NCT00282256|1525774|P1|Received Tacrolimus|Pharmacokinetic Treatment Period||19
621797|NCT00282256|1525774|P1|STARTED|Pharmacokinetic Treatment Period||19
621798|NCT00282243|1525795|P1|NOT COMPLETED|Extension Treatment Period||22
621799|NCT00282243|1525795|P1|COMPLETED|Extension Treatment Period||43
621800|NCT00282243|1525795|P1|STARTED|Extension Treatment Period||65
621801|NCT00282243|1525795|P1|NOT COMPLETED|Pharmacokinetic Treatment Period||5
621802|NCT00282243|1525795|P1|COMPLETED|Pharmacokinetic Treatment Period||65
621803|NCT00282243|1525795|P1|Received Tacrolimus MR|Pharmacokinetic Treatment Period||69
621804|NCT00282243|1525795|P1|Received Tacrolimus|Pharmacokinetic Treatment Period||70
621805|NCT00282243|1525795|P1|STARTED|Pharmacokinetic Treatment Period||70
621806|NCT00282152|1525821|P2|NOT COMPLETED|Overall Study||0
621807|NCT00282152|1525822|P1|NOT COMPLETED|Overall Study||1
621808|NCT00282152|1525821|P2|COMPLETED|Overall Study||15
621809|NCT00282152|1525822|P1|COMPLETED|Overall Study||14
621810|NCT00282152|1525821|P2|STARTED|Overall Study||15
621811|NCT00282152|1525822|P1|STARTED|Overall Study||15
621812|NCT00282113|1525843|P3|NOT COMPLETED|Overall Study||0
621813|NCT00282113|1525844|P2|NOT COMPLETED|Overall Study||0
621814|NCT00282113|1525845|P1|NOT COMPLETED|Overall Study||1
621815|NCT00282113|1525843|P3|COMPLETED|Overall Study||29
621816|NCT00282113|1525844|P2|COMPLETED|Overall Study||30
621817|NCT00282113|1525845|P1|COMPLETED|Overall Study||30
621818|NCT00282113|1525843|P3|STARTED|Overall Study||29
621819|NCT00282113|1525844|P2|STARTED|Overall Study||30
621820|NCT00282113|1525845|P1|STARTED|Overall Study||31
621821|NCT00282087|1525859|P1|NOT COMPLETED|Overall Study||1
621822|NCT00282087|1525859|P1|COMPLETED|Overall Study|One patient died during cycle 1 of treatment because of infectious complications of AIDS.|46
621823|NCT00282087|1525859|P1|STARTED|Overall Study||47
621824|NCT00282048|1525872|P1|NOT COMPLETED|Overall Study||62
621825|NCT00282048|1525872|P1|COMPLETED|Overall Study||0
621826|NCT00282048|1525872|P1|STARTED|Overall Study||62
621827|NCT00281957|1525886|P2|NOT COMPLETED|Overall Study||42
621828|NCT00281957|1525887|P1|NOT COMPLETED|Overall Study||67
621829|NCT00281957|1525886|P2|COMPLETED|Overall Study||0
621830|NCT00281957|1525887|P1|COMPLETED|Overall Study||0
621831|NCT00281957|1525886|P2|Eligible and Received Treatment|Overall Study||39
621832|NCT00281957|1525887|P1|Eligible and Received Treatment|Overall Study||63
621833|NCT00281957|1525886|P2|Eligible|Overall Study||40
621834|NCT00281957|1525887|P1|Eligible|Overall Study||66
621835|NCT00281957|1525886|P2|STARTED|Overall Study||42
621836|NCT00281957|1525887|P1|STARTED|Overall Study||67
621837|NCT00281918|1525901|P2|NOT COMPLETED|Overall Study||108
621838|NCT00281918|1525902|P1|NOT COMPLETED|Overall Study||142
621839|NCT00281918|1525901|P2|COMPLETED|Overall Study|Completed all 6 cycles of study medication.|300
621840|NCT00281918|1525902|P1|COMPLETED|Overall Study|Completed all 6 cycles of study medication.|267
621841|NCT00281918|1525901|P2|Safety Population; Received Study Drug|Overall Study||402
621842|NCT00281918|1525902|P1|Safety Population; Received Study Drug|Overall Study||398
621843|NCT00281918|1525901|P2|STARTED|Overall Study|Informed consent unavailable for 5 patients at time of analysis; intent-to-treat population was 403.|408
621844|NCT00281918|1525902|P1|STARTED|Overall Study|Informed consent unavailable for 2 patients at time of analysis; intent-to-treat population was 407.|409
621845|NCT00281879|1525936|P8|NOT COMPLETED|Overall Study||1
621846|NCT00281879|1525937|P7|NOT COMPLETED|Overall Study||0
621847|NCT00281879|1525938|P6|NOT COMPLETED|Overall Study||9
621848|NCT00281879|1525939|P5|NOT COMPLETED|Overall Study||6
621849|NCT00281879|1525940|P4|NOT COMPLETED|Overall Study||0
621850|NCT00281879|1525941|P3|NOT COMPLETED|Overall Study||20
621851|NCT00281879|1525942|P2|NOT COMPLETED|Overall Study||36
621852|NCT00281879|1525943|P1|NOT COMPLETED|Overall Study||128
621853|NCT00281879|1525936|P8|COMPLETED|Overall Study||0
621854|NCT00281879|1525937|P7|COMPLETED|Overall Study||0
621855|NCT00281879|1525938|P6|COMPLETED|Overall Study||0
621856|NCT00281879|1525939|P5|COMPLETED|Overall Study||0
621857|NCT00281879|1525940|P4|COMPLETED|Overall Study||0
621858|NCT00281879|1525941|P3|COMPLETED|Overall Study||0
621859|NCT00281879|1525942|P2|COMPLETED|Overall Study||0
621860|NCT00281879|1525943|P1|COMPLETED|Overall Study||0
621861|NCT00281879|1525936|P8|STARTED|Overall Study||1
621862|NCT00281879|1525937|P7|STARTED|Overall Study||0
621863|NCT00281879|1525938|P6|STARTED|Overall Study||9
621864|NCT00281879|1525939|P5|STARTED|Overall Study||6
621865|NCT00281879|1525940|P4|STARTED|Overall Study||0
621866|NCT00281879|1525941|P3|STARTED|Overall Study||20
621867|NCT00281879|1525942|P2|STARTED|Overall Study||36
621868|NCT00281879|1525943|P1|STARTED|Overall Study||128
621869|NCT00281840|1525961|P1|NOT COMPLETED|Overall Study||25
621870|NCT00281840|1525961|P1|COMPLETED|Overall Study||5
621871|NCT00281840|1525961|P1|STARTED|Overall Study||30
621872|NCT00281827|1525966|P1|NOT COMPLETED|Overall Study||0
621873|NCT00281827|1525966|P1|COMPLETED|Overall Study|All patients received 3 cycles of therapy; 2 did not receive all 3 thalidomide cycles|22
621874|NCT00281827|1525966|P1|STARTED|Overall Study||22
621875|NCT00281697|1525977|P2|NOT COMPLETED|Overall Study||197
621876|NCT00281697|1525978|P1|NOT COMPLETED|Overall Study||401
621877|NCT00281697|1525977|P2|COMPLETED|Overall Study||28
621878|NCT00281697|1525978|P1|COMPLETED|Overall Study||58
621879|NCT00281697|1525977|P2|STARTED|Overall Study||225
621880|NCT00281697|1525978|P1|STARTED|Overall Study||459
621881|NCT00281658|1525996|P3|NOT COMPLETED|Open-label Monotherapy Extension Phase||101
621882|NCT00281658|1525997|P2|NOT COMPLETED|Open-label Monotherapy Extension Phase||0
621883|NCT00281658|1525998|P1|NOT COMPLETED|Open-label Monotherapy Extension Phase||0
621884|NCT00281658|1525996|P3|COMPLETED|Open-label Monotherapy Extension Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|48
621885|NCT00281658|1525997|P2|COMPLETED|Open-label Monotherapy Extension Phase||0
621886|NCT00281658|1525998|P1|COMPLETED|Open-label Monotherapy Extension Phase||0
621887|NCT00281658|1525996|P3|STARTED|Open-label Monotherapy Extension Phase||149
621888|NCT00281658|1525997|P2|STARTED|Open-label Monotherapy Extension Phase||0
621889|NCT00281658|1525998|P1|STARTED|Open-label Monotherapy Extension Phase||0
621890|NCT00281658|1525996|P3|NOT COMPLETED|Double-blind, Randomized Phase||0
621891|NCT00281658|1525997|P2|NOT COMPLETED|Double-blind, Randomized Phase||54
621892|NCT00281658|1525998|P1|NOT COMPLETED|Double-blind, Randomized Phase||137
621893|NCT00281658|1525996|P3|COMPLETED|Double-blind, Randomized Phase||0
621894|NCT00281658|1525997|P2|COMPLETED|Double-blind, Randomized Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|168
621895|NCT00281658|1525998|P1|COMPLETED|Double-blind, Randomized Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|85
621896|NCT00281658|1525996|P3|STARTED|Double-blind, Randomized Phase||0
621897|NCT00281658|1525997|P2|STARTED|Double-blind, Randomized Phase|Of these participants, 149 entered the open-label extension phase.|222
621898|NCT00281658|1525998|P1|STARTED|Double-blind, Randomized Phase||222
621899|NCT00281632|1526015|P1|NOT COMPLETED|Overall Study||36
621900|NCT00281632|1526015|P1|COMPLETED|Overall Study|Three participants were ongoing in the study at the time of the data cut-off (30 Apr 2008).|0
621901|NCT00281632|1526015|P1|STARTED|Overall Study||36
621902|NCT00281580|1526057|P16|NOT COMPLETED|Overall Study||13
621903|NCT00281580|1526058|P15|NOT COMPLETED|Overall Study||7
621904|NCT00281580|1526059|P14|NOT COMPLETED|Overall Study||7
621905|NCT00281580|1526060|P13|NOT COMPLETED|Overall Study||13
621906|NCT00281580|1526061|P12|NOT COMPLETED|Overall Study||10
621907|NCT00281580|1526062|P11|NOT COMPLETED|Overall Study||4
621908|NCT00281580|1526063|P10|NOT COMPLETED|Overall Study||12
621909|NCT00281580|1526064|P9|NOT COMPLETED|Overall Study||8
621910|NCT00281580|1526065|P8|NOT COMPLETED|Overall Study||1
621911|NCT00281580|1526066|P7|NOT COMPLETED|Overall Study||5
621912|NCT00281580|1526067|P6|NOT COMPLETED|Overall Study||3
621913|NCT00281580|1526068|P5|NOT COMPLETED|Overall Study||4
621914|NCT00281580|1526069|P4|NOT COMPLETED|Overall Study||17
621915|NCT00281580|1526070|P3|NOT COMPLETED|Overall Study||5
621916|NCT00281580|1526071|P2|NOT COMPLETED|Overall Study||1
621917|NCT00281580|1526072|P1|NOT COMPLETED|Overall Study||7
621918|NCT00281580|1526057|P16|COMPLETED|Overall Study||116
621919|NCT00281580|1526058|P15|COMPLETED|Overall Study||133
621920|NCT00281580|1526059|P14|COMPLETED|Overall Study||43
621921|NCT00281580|1526060|P13|COMPLETED|Overall Study||129
621922|NCT00281580|1526061|P12|COMPLETED|Overall Study||136
621923|NCT00281580|1526062|P11|COMPLETED|Overall Study||44
621924|NCT00281580|1526063|P10|COMPLETED|Overall Study||117
621925|NCT00281580|1526064|P9|COMPLETED|Overall Study||135
621926|NCT00281580|1526065|P8|COMPLETED|Overall Study||46
621927|NCT00281580|1526066|P7|COMPLETED|Overall Study||39
621928|NCT00281580|1526067|P6|COMPLETED|Overall Study||43
621929|NCT00281580|1526068|P5|COMPLETED|Overall Study||40
621930|NCT00281580|1526069|P4|COMPLETED|Overall Study||118
621931|NCT00281580|1526070|P3|COMPLETED|Overall Study||125
621932|NCT00281580|1526071|P2|COMPLETED|Overall Study||41
621933|NCT00281580|1526072|P1|COMPLETED|Overall Study||39
621934|NCT00281580|1526057|P16|STARTED|Overall Study||129
621935|NCT00281580|1526058|P15|STARTED|Overall Study||140
621936|NCT00281580|1526059|P14|STARTED|Overall Study||50
621937|NCT00281580|1526060|P13|STARTED|Overall Study||142
621938|NCT00281580|1526061|P12|STARTED|Overall Study||146
621939|NCT00281580|1526062|P11|STARTED|Overall Study||48
621940|NCT00281580|1526063|P10|STARTED|Overall Study||129
621941|NCT00281580|1526064|P9|STARTED|Overall Study||143
621942|NCT00281580|1526065|P8|STARTED|Overall Study||47
621943|NCT00281580|1526066|P7|STARTED|Overall Study||44
621944|NCT00281580|1526067|P6|STARTED|Overall Study||46
621945|NCT00281580|1526068|P5|STARTED|Overall Study||44
621946|NCT00281580|1526069|P4|STARTED|Overall Study||135
621947|NCT00281580|1526070|P3|STARTED|Overall Study||130
621948|NCT00281580|1526071|P2|STARTED|Overall Study||42
621949|NCT00281580|1526072|P1|STARTED|Overall Study||46
621950|NCT00281528|1526419|P3|NOT COMPLETED|Overall Study||79
621951|NCT00281528|1526420|P2|NOT COMPLETED|Overall Study||54
621952|NCT00281528|1526421|P1|NOT COMPLETED|Overall Study||75
621953|NCT00281528|1526419|P3|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
621954|NCT00281528|1526420|P2|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
621955|NCT00281528|1526421|P1|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
621956|NCT00281528|1526419|P3|STARTED|Overall Study||79
621957|NCT00281528|1526420|P2|STARTED|Overall Study||54
621958|NCT00281528|1526421|P1|STARTED|Overall Study||75
621959|NCT00281463|1526465|P1|NOT COMPLETED|Overall Study||0
621960|NCT00281463|1526465|P1|COMPLETED|Overall Study||45
621961|NCT00281463|1526465|P1|STARTED|Overall Study||45
621962|NCT00281320|1526472|P2|NOT COMPLETED|Overall Study||21
621963|NCT00281320|1526473|P1|NOT COMPLETED|Overall Study||25
621964|NCT00281320|1526472|P2|COMPLETED|Overall Study||40
621965|NCT00281320|1526473|P1|COMPLETED|Overall Study||36
621966|NCT00281320|1526472|P2|STARTED|Overall Study||61
621967|NCT00281320|1526473|P1|STARTED|Overall Study||61
621968|NCT00281099|1526495|P2|NOT COMPLETED|Overall Study||222
621969|NCT00281099|1526496|P1|NOT COMPLETED|Overall Study||205
621970|NCT00281099|1526495|P2|COMPLETED|Overall Study||296
621971|NCT00281099|1526496|P1|COMPLETED|Overall Study||308
621972|NCT00281099|1526495|P2|STARTED|Overall Study||518
621973|NCT00281099|1526496|P1|STARTED|Overall Study||513
621974|NCT00281021|1526537|P1|NOT COMPLETED|Overall Study||2
621975|NCT00281021|1526537|P1|COMPLETED|Overall Study||24
621976|NCT00281021|1526537|P1|STARTED|Overall Study||26
621977|NCT00280917|1526545|P4|NOT COMPLETED|Overall Study||2
621978|NCT00280917|1526546|P3|NOT COMPLETED|Overall Study||6
621979|NCT00280917|1526547|P2|NOT COMPLETED|Overall Study||6
621980|NCT00280917|1526548|P1|NOT COMPLETED|Overall Study||2
621981|NCT00280917|1526545|P4|COMPLETED|Overall Study||61
621982|NCT00280917|1526546|P3|COMPLETED|Overall Study||57
621983|NCT00280917|1526547|P2|COMPLETED|Overall Study||57
621984|NCT00280917|1526548|P1|COMPLETED|Overall Study||63
621985|NCT00280917|1526545|P4|STARTED|Overall Study||63
621986|NCT00280917|1526546|P3|STARTED|Overall Study||63
621987|NCT00280917|1526547|P2|STARTED|Overall Study||63
621988|NCT00280917|1526548|P1|STARTED|Overall Study||65
621989|NCT00280904|1526558|P1|NOT COMPLETED|Overall Study||0
621990|NCT00280904|1526558|P1|COMPLETED|Overall Study||433
621991|NCT00280904|1526558|P1|STARTED|Overall Study||433
621992|NCT00280826|1526563|P1|NOT COMPLETED|Overall Study||0
621993|NCT00280826|1526563|P1|COMPLETED|Overall Study||6
621994|NCT00280826|1526563|P1|STARTED|Overall Study||6
621995|NCT00280748|1526571|P1|NOT COMPLETED|Overall Study||4
621996|NCT00280748|1526571|P1|COMPLETED|Overall Study||6
621997|NCT00280748|1526571|P1|STARTED|Overall Study||10
621998|NCT00280735|1526581|P1|NOT COMPLETED|Overall Study||18
621999|NCT00280735|1526581|P1|COMPLETED|Overall Study||57
622000|NCT00280735|1526581|P1|Received Adequate Exposure|Overall Study||57
622001|NCT00280735|1526581|P1|Received Treatment|Overall Study||72
622002|NCT00280735|1526581|P1|STARTED|Overall Study||75
622003|NCT00280683|1526593|P2|NOT COMPLETED|Overall Study||3
622004|NCT00280683|1526594|P1|NOT COMPLETED|Overall Study||2
622005|NCT00280683|1526593|P2|COMPLETED|Overall Study||7
622006|NCT00280683|1526594|P1|COMPLETED|Overall Study|Reasons for subjects discontinuing included inability to adhere to the schedule or adverse event.|8
622007|NCT00280683|1526593|P2|STARTED|Overall Study||10
622008|NCT00280683|1526594|P1|STARTED|Overall Study||10
622009|NCT00280566|1526604|P3|NOT COMPLETED|Period 2 Double Blind||57
622010|NCT00280566|1526605|P2|NOT COMPLETED|Period 2 Double Blind||43
622011|NCT00280566|1526606|P1|NOT COMPLETED|Period 2 Double Blind||0
622012|NCT00280566|1526604|P3|COMPLETED|Period 2 Double Blind||54
622013|NCT00280566|1526605|P2|COMPLETED|Period 2 Double Blind||84
622014|NCT00280566|1526606|P1|COMPLETED|Period 2 Double Blind||0
622015|NCT00280566|1526604|P3|STARTED|Period 2 Double Blind||111
622016|NCT00280566|1526605|P2|STARTED|Period 2 Double Blind||127
622017|NCT00280566|1526606|P1|STARTED|Period 2 Double Blind|1 subject in Period 1 did not want to be randomized into Period 2|0
622018|NCT00280566|1526604|P3|NOT COMPLETED|Period 1 Open Label Ziprasidone||0
622019|NCT00280566|1526605|P2|NOT COMPLETED|Period 1 Open Label Ziprasidone||0
622020|NCT00280566|1526606|P1|NOT COMPLETED|Period 1 Open Label Ziprasidone||343
622021|NCT00280566|1526604|P3|COMPLETED|Period 1 Open Label Ziprasidone||0
622022|NCT00280566|1526605|P2|COMPLETED|Period 1 Open Label Ziprasidone||0
622023|NCT00280566|1526606|P1|COMPLETED|Period 1 Open Label Ziprasidone|Subject excluded as described above is counted as 2; enrolled in 2 sites (2 identification numbers)|241
622024|NCT00280566|1526604|P3|STARTED|Period 1 Open Label Ziprasidone||0
622025|NCT00280566|1526605|P2|STARTED|Period 1 Open Label Ziprasidone||0
622026|NCT00280566|1526606|P1|STARTED|Period 1 Open Label Ziprasidone|1 subject inappropriately randomized into 2 different sites. Data from this subject was excluded.|584
622027|NCT00280397|1526631|P1|NOT COMPLETED|Overall Study||1
622028|NCT00280397|1526631|P1|COMPLETED|Overall Study||26
622029|NCT00280397|1526631|P1|STARTED|Overall Study||27
622030|NCT00280384|1526646|P8|NOT COMPLETED|Overall Study||0
622031|NCT00280384|1526647|P7|NOT COMPLETED|Overall Study||0
622032|NCT00280384|1526648|P6|NOT COMPLETED|Overall Study||0
622033|NCT00280384|1526649|P5|NOT COMPLETED|Overall Study||0
622034|NCT00280384|1526650|P4|NOT COMPLETED|Overall Study||0
622035|NCT00280384|1526651|P3|NOT COMPLETED|Overall Study||0
622036|NCT00280384|1526652|P2|NOT COMPLETED|Overall Study||0
622037|NCT00280384|1526653|P1|NOT COMPLETED|Overall Study||0
622038|NCT00280384|1526646|P8|COMPLETED|Overall Study||6
622039|NCT00280384|1526647|P7|COMPLETED|Overall Study||6
622040|NCT00280384|1526648|P6|COMPLETED|Overall Study||6
622041|NCT00280384|1526649|P5|COMPLETED|Overall Study||6
622042|NCT00280384|1526650|P4|COMPLETED|Overall Study||6
622043|NCT00280384|1526651|P3|COMPLETED|Overall Study||6
622044|NCT00280384|1526652|P2|COMPLETED|Overall Study||6
622045|NCT00280384|1526653|P1|COMPLETED|Overall Study||6
622046|NCT00280384|1526646|P8|STARTED|Overall Study||6
622047|NCT00280384|1526647|P7|STARTED|Overall Study||6
622048|NCT00280384|1526648|P6|STARTED|Overall Study||6
622049|NCT00280384|1526649|P5|STARTED|Overall Study||6
622050|NCT00280384|1526650|P4|STARTED|Overall Study||6
622051|NCT00280384|1526651|P3|STARTED|Overall Study||6
622052|NCT00280384|1526652|P2|STARTED|Overall Study||6
622053|NCT00280384|1526653|P1|STARTED|Overall Study||6
622054|NCT00280293|1526697|P2|NOT COMPLETED|Overall Study||23
622055|NCT00280293|1526698|P1|NOT COMPLETED|Overall Study||26
622056|NCT00280293|1526697|P2|COMPLETED|Overall Study||34
622057|NCT00280293|1526698|P1|COMPLETED|Overall Study||29
622058|NCT00280293|1526697|P2|STARTED|Overall Study||57
622059|NCT00280293|1526698|P1|STARTED|Overall Study||55
622060|NCT00280241|1526710|P1|NOT COMPLETED|Overall Study||10
622061|NCT00280241|1526710|P1|COMPLETED|Overall Study||55
622062|NCT00280241|1526710|P1|STARTED|Overall Study||65
622063|NCT00280150|1526721|P4|NOT COMPLETED|Overall Study||10
622064|NCT00280150|1526722|P3|NOT COMPLETED|Overall Study||5
622065|NCT00280150|1526723|P2|NOT COMPLETED|Overall Study||1
622066|NCT00280150|1526724|P1|NOT COMPLETED|Overall Study||3
622067|NCT00280150|1526721|P4|COMPLETED|Overall Study||20
622068|NCT00280150|1526722|P3|COMPLETED|Overall Study||1
622069|NCT00280150|1526723|P2|COMPLETED|Overall Study||4
622070|NCT00280150|1526724|P1|COMPLETED|Overall Study||2
622071|NCT00280150|1526721|P4|Consolidation Therapy|Overall Study|Phase II participants did not receive consolidation therapy.|0
622072|NCT00280150|1526722|P3|Consolidation Therapy|Overall Study||3
622073|NCT00280150|1526723|P2|Consolidation Therapy|Overall Study||5
622074|NCT00280150|1526724|P1|Consolidation Therapy|Overall Study||2
622075|NCT00280150|1526721|P4|Cohort Induction|Overall Study||30
622076|NCT00280150|1526722|P3|Cohort Induction|Overall Study||6
622077|NCT00280150|1526723|P2|Cohort Induction|Overall Study||5
622078|NCT00280150|1526724|P1|Cohort Induction|Overall Study||5
622079|NCT00280150|1526721|P4|STARTED|Overall Study||30
622080|NCT00280150|1526722|P3|STARTED|Overall Study||6
622081|NCT00280150|1526723|P2|STARTED|Overall Study||5
622082|NCT00280150|1526724|P1|STARTED|Overall Study||5
622083|NCT00280059|1526739|P2|NOT COMPLETED|Extension Phase||38
622084|NCT00280059|1526740|P1|NOT COMPLETED|Extension Phase||49
622085|NCT00280059|1526739|P2|COMPLETED|Extension Phase||177
622086|NCT00280059|1526740|P1|COMPLETED|Extension Phase||145
622087|NCT00280059|1526739|P2|STARTED|Extension Phase|Optional phase; number entered was less than the number who completed the efficacy assessment phase.|215
622088|NCT00280059|1526740|P1|STARTED|Extension Phase|Optional phase; number entered was less than the number who completed the efficacy assessment phase.|194
622089|NCT00280059|1526739|P2|NOT COMPLETED|Efficacy Assessment Phase||80
622090|NCT00280059|1526740|P1|NOT COMPLETED|Efficacy Assessment Phase||94
622091|NCT00280059|1526739|P2|COMPLETED|Efficacy Assessment Phase|Week 56: up to end of efficacy assessment phase (excluding extension phase).|250
622092|NCT00280059|1526740|P1|COMPLETED|Efficacy Assessment Phase|Week 56: up to end of efficacy assessment phase (excluding extension phase).|236
622093|NCT00280059|1526739|P2|STARTED|Efficacy Assessment Phase||330
622094|NCT00280059|1526740|P1|STARTED|Efficacy Assessment Phase||330
622095|NCT00279955|1526789|P3|NOT COMPLETED|Overall Study||0
622096|NCT00279955|1526790|P2|NOT COMPLETED|Overall Study||0
622097|NCT00279955|1526791|P1|NOT COMPLETED|Overall Study||0
622098|NCT00279955|1526789|P3|COMPLETED|Overall Study|They are still counted as completes, though they are never used for the analyses of objectives.|358
622099|NCT00279955|1526790|P2|COMPLETED|Overall Study||486
622100|NCT00279955|1526791|P1|COMPLETED|Overall Study||157
622101|NCT00279955|1526789|P3|STARTED|Overall Study||358
622102|NCT00279955|1526790|P2|STARTED|Overall Study||486
622103|NCT00279955|1526791|P1|STARTED|Overall Study||157
622104|NCT00279916|1526804|P2|NOT COMPLETED|Overall Study||5
622105|NCT00279916|1526805|P1|NOT COMPLETED|Overall Study||7
622106|NCT00279916|1526804|P2|COMPLETED|Overall Study||41
622107|NCT00279916|1526805|P1|COMPLETED|Overall Study||38
622108|NCT00279916|1526804|P2|STARTED|Overall Study||46
622109|NCT00279916|1526805|P1|STARTED|Overall Study||45
622110|NCT00279708|1526827|P2|NOT COMPLETED|Overall Study||4
622111|NCT00279708|1526828|P1|NOT COMPLETED|Overall Study||3
622112|NCT00279708|1526827|P2|COMPLETED|Overall Study||24
622113|NCT00279708|1526828|P1|COMPLETED|Overall Study||24
622114|NCT00279708|1526827|P2|STARTED|Overall Study||28
622115|NCT00279708|1526828|P1|STARTED|Overall Study|"Started meaning randomized"|27
622116|NCT00279591|1526836|P2|NOT COMPLETED|Overall Study||0
622117|NCT00279591|1526837|P1|NOT COMPLETED|Overall Study||0
622118|NCT00279591|1526836|P2|COMPLETED|Overall Study||46
622119|NCT00279591|1526837|P1|COMPLETED|Overall Study||48
622120|NCT00279591|1526836|P2|STARTED|Overall Study||46
622121|NCT00279591|1526837|P1|STARTED|Overall Study||48
622122|NCT00279500|1526851|P1|NOT COMPLETED|Overall Study||0
622123|NCT00279500|1526851|P1|COMPLETED|Overall Study|6 patients treated|6
622124|NCT00279500|1526851|P1|STARTED|Overall Study|6 patients treated|6
622125|NCT00279305|1526857|P2|NOT COMPLETED|Overall Study||1
622126|NCT00279305|1526858|P1|NOT COMPLETED|Overall Study||8
622127|NCT00279305|1526857|P2|COMPLETED|Overall Study||29
622128|NCT00279305|1526858|P1|COMPLETED|Overall Study||49
622129|NCT00279305|1526857|P2|STARTED|Overall Study||30
622130|NCT00279305|1526858|P1|STARTED|Overall Study||57
622131|NCT00279214|1526866|P2|NOT COMPLETED|Overall Study||2
622132|NCT00279214|1526867|P1|NOT COMPLETED|Overall Study||3
622133|NCT00279214|1526866|P2|COMPLETED|Overall Study|Completed means the number of per-protocol patients in the study|19
622134|NCT00279214|1526867|P1|COMPLETED|Overall Study|Completed means the number of per-protocol patients in the study|19
622135|NCT00279214|1526866|P2|STARTED|Overall Study||21
622136|NCT00279214|1526867|P1|STARTED|Overall Study||22
622137|NCT00279201|1526897|P6|NOT COMPLETED|Intensification Addendum||37
622138|NCT00279201|1526898|P5|NOT COMPLETED|Intensification Addendum||29
622139|NCT00279201|1526899|P4|NOT COMPLETED|Intensification Addendum||28
622140|NCT00279201|1526900|P3|NOT COMPLETED|Intensification Addendum||23
622141|NCT00279201|1526901|P2|NOT COMPLETED|Intensification Addendum||0
622142|NCT00279201|1526902|P1|NOT COMPLETED|Intensification Addendum||0
622143|NCT00279201|1526897|P6|COMPLETED|Intensification Addendum||162
622144|NCT00279201|1526898|P5|COMPLETED|Intensification Addendum||142
622145|NCT00279201|1526899|P4|COMPLETED|Intensification Addendum||172
622146|NCT00279201|1526900|P3|COMPLETED|Intensification Addendum||151
622147|NCT00279201|1526901|P2|COMPLETED|Intensification Addendum||0
622148|NCT00279201|1526902|P1|COMPLETED|Intensification Addendum||0
622149|NCT00279201|1526897|P6|STARTED|Intensification Addendum||199
622150|NCT00279201|1526898|P5|STARTED|Intensification Addendum||171
622151|NCT00279201|1526899|P4|STARTED|Intensification Addendum||200
622152|NCT00279201|1526900|P3|STARTED|Intensification Addendum||174
622153|NCT00279201|1526901|P2|STARTED|Intensification Addendum||0
622154|NCT00279201|1526902|P1|STARTED|Intensification Addendum||0
622155|NCT00279201|1526897|P6|NOT COMPLETED|Maintenance||0
622156|NCT00279201|1526898|P5|NOT COMPLETED|Maintenance||0
622157|NCT00279201|1526899|P4|NOT COMPLETED|Maintenance||0
622158|NCT00279201|1526900|P3|NOT COMPLETED|Maintenance||0
622159|NCT00279201|1526901|P2|NOT COMPLETED|Maintenance||234
622160|NCT00279201|1526902|P1|NOT COMPLETED|Maintenance||231
622161|NCT00279201|1526897|P6|COMPLETED|Maintenance||0
622162|NCT00279201|1526898|P5|COMPLETED|Maintenance||0
622163|NCT00279201|1526899|P4|COMPLETED|Maintenance||0
622164|NCT00279201|1526900|P3|COMPLETED|Maintenance||0
622165|NCT00279201|1526901|P2|COMPLETED|Maintenance||239
622166|NCT00279201|1526902|P1|COMPLETED|Maintenance||188
622167|NCT00279201|1526897|P6|STARTED|Maintenance||0
622168|NCT00279201|1526898|P5|STARTED|Maintenance||0
622169|NCT00279201|1526899|P4|STARTED|Maintenance||0
622170|NCT00279201|1526900|P3|STARTED|Maintenance||0
622171|NCT00279201|1526901|P2|STARTED|Maintenance|82 left the study after initiation. 345 had HbA1c>7% and enrolled in intensification addendum.|473
622172|NCT00279201|1526902|P1|STARTED|Maintenance|100 left the study after initiation. 399 had HbA1c>7% and enrolled in intensification addendum.|419
622173|NCT00279201|1526897|P6|NOT COMPLETED|Initiation||0
622174|NCT00279201|1526898|P5|NOT COMPLETED|Initiation||0
622175|NCT00279201|1526899|P4|NOT COMPLETED|Initiation||0
622176|NCT00279201|1526900|P3|NOT COMPLETED|Initiation||0
622177|NCT00279201|1526901|P2|NOT COMPLETED|Initiation||145
622178|NCT00279201|1526902|P1|NOT COMPLETED|Initiation||128
622179|NCT00279201|1526897|P6|COMPLETED|Initiation||0
622180|NCT00279201|1526898|P5|COMPLETED|Initiation||0
622181|NCT00279201|1526899|P4|COMPLETED|Initiation||0
622182|NCT00279201|1526900|P3|COMPLETED|Initiation||0
622183|NCT00279201|1526901|P2|COMPLETED|Initiation||900
622184|NCT00279201|1526902|P1|COMPLETED|Initiation||918
622185|NCT00279201|1526897|P6|STARTED|Initiation||0
622186|NCT00279201|1526898|P5|STARTED|Initiation||0
622187|NCT00279201|1526899|P4|STARTED|Initiation||0
622188|NCT00279201|1526900|P3|STARTED|Initiation||0
622189|NCT00279201|1526901|P2|STARTED|Initiation||1045
622190|NCT00279201|1526902|P1|STARTED|Initiation||1046
622191|NCT00278993|1527046|P1|NOT COMPLETED|Overall Study||107
622192|NCT00278993|1527046|P1|COMPLETED|Overall Study||1
622193|NCT00278993|1527046|P1|STARTED|Overall Study||108
622194|NCT00278954|1527054|P1|NOT COMPLETED|Overall Study||5
622195|NCT00278954|1527054|P1|COMPLETED|Overall Study||45
622196|NCT00278954|1527054|P1|STARTED|Overall Study||50
622197|NCT00278915|1527062|P1|NOT COMPLETED|Overall Study||1
622198|NCT00278915|1527062|P1|COMPLETED|Overall Study||29
622199|NCT00278915|1527062|P1|STARTED|Overall Study|First 6 patients were dosed at 2mg/kg then increased to 4 mg/kg. Remaining 24 were dosed at 4mg/kg.|30
622200|NCT00278889|1527098|P3|NOT COMPLETED|Overall Study||20
622201|NCT00278889|1527099|P2|NOT COMPLETED|Overall Study||27
622202|NCT00278889|1527100|P1|NOT COMPLETED|Overall Study||25
622203|NCT00278889|1527098|P3|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|48
622204|NCT00278889|1527099|P2|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|47
622205|NCT00278889|1527100|P1|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|48
622206|NCT00278889|1527098|P3|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|19
622207|NCT00278889|1527099|P2|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|20
622208|NCT00278889|1527100|P1|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|16
622209|NCT00278889|1527098|P3|STARTED|Overall Study|Randomised|68
622210|NCT00278889|1527099|P2|STARTED|Overall Study|Randomised|74
622211|NCT00278889|1527100|P1|STARTED|Overall Study|Randomised|73
622212|NCT00278876|1527126|P1|NOT COMPLETED|Overall Study||9
622213|NCT00278876|1527126|P1|COMPLETED|Overall Study||38
622214|NCT00278876|1527126|P1|STARTED|Overall Study||47
622215|NCT00278863|1527134|P2|NOT COMPLETED|Overall Study||2
622216|NCT00278863|1527135|P1|NOT COMPLETED|Overall Study||5
622217|NCT00278863|1527134|P2|COMPLETED|Overall Study||45
622218|NCT00278863|1527135|P1|COMPLETED|Overall Study||44
622219|NCT00278863|1527134|P2|STARTED|Overall Study||47
622220|NCT00278863|1527135|P1|STARTED|Overall Study||49
622221|NCT00278655|1527143|P1|NOT COMPLETED|Overall Study||0
622222|NCT00278655|1527143|P1|COMPLETED|Overall Study||21
622223|NCT00278655|1527143|P1|STARTED|Overall Study||21
622224|NCT00278525|1527150|P2|NOT COMPLETED|Overall Study||0
622225|NCT00278525|1527151|P1|NOT COMPLETED|Overall Study||0
622226|NCT00278525|1527150|P2|COMPLETED|Overall Study|7 participant crossed over to the HSCT arm and underwent HSCT, in accordance with the protocol.|10
622227|NCT00278525|1527151|P1|COMPLETED|Overall Study|7 participants crossed to HSCT arm in accordance with the protocol|9
622228|NCT00278525|1527150|P2|STARTED|Overall Study||10
622229|NCT00278525|1527151|P1|STARTED|Overall Study||9
622230|NCT00278473|1527161|P2|NOT COMPLETED|Overall Study||3
622231|NCT00278473|1527162|P1|NOT COMPLETED|Overall Study||4
622232|NCT00278473|1527161|P2|COMPLETED|Overall Study||40
622233|NCT00278473|1527162|P1|COMPLETED|Overall Study||41
622234|NCT00278473|1527161|P2|STARTED|Overall Study||43
622235|NCT00278473|1527162|P1|STARTED|Overall Study||45
622236|NCT00278395|1527178|P1|NOT COMPLETED|Overall Study||3
622237|NCT00278395|1527178|P1|COMPLETED|Overall Study||11
622238|NCT00278395|1527178|P1|STARTED|Overall Study||14
622239|NCT00278343|1527185|P1|NOT COMPLETED|Overall Study||0
622240|NCT00278343|1527185|P1|COMPLETED|Overall Study||74
622241|NCT00278343|1527185|P1|STARTED|Overall Study||74
622242|NCT00277524|1527192|P4|NOT COMPLETED|Overall Study||0
622243|NCT00277524|1527193|P3|NOT COMPLETED|Overall Study||0
622244|NCT00277524|1527194|P2|NOT COMPLETED|Overall Study||0
622245|NCT00277524|1527195|P1|NOT COMPLETED|Overall Study||0
622246|NCT00277524|1527192|P4|COMPLETED|Overall Study||850
622247|NCT00277524|1527193|P3|COMPLETED|Overall Study||1088
622248|NCT00277524|1527194|P2|COMPLETED|Overall Study||324
622249|NCT00277524|1527195|P1|COMPLETED|Overall Study||621
622250|NCT00277524|1527192|P4|STARTED|Overall Study||850
622251|NCT00277524|1527193|P3|STARTED|Overall Study||1088
622252|NCT00277524|1527194|P2|STARTED|Overall Study||324
622253|NCT00277524|1527195|P1|STARTED|Overall Study||621
622254|NCT00277446|1527213|P1|NOT COMPLETED|Overall Study||0
622255|NCT00277446|1527213|P1|COMPLETED|Overall Study||13
622256|NCT00277446|1527213|P1|STARTED|Overall Study||13
622257|NCT00277394|1527221|P2|NOT COMPLETED|Overall Study||24
622258|NCT00277394|1527222|P1|NOT COMPLETED|Overall Study||37
622259|NCT00277394|1527221|P2|COMPLETED|Overall Study||246
622260|NCT00277394|1527222|P1|COMPLETED|Overall Study||232
622261|NCT00277394|1527221|P2|STARTED|Overall Study||270
622262|NCT00277394|1527222|P1|STARTED|Overall Study||269
622263|NCT00277355|1527234|P2|NOT COMPLETED|Overall Study||5
622264|NCT00277355|1527235|P1|NOT COMPLETED|Overall Study||14
622265|NCT00277355|1527234|P2|COMPLETED|Overall Study||22
622266|NCT00277355|1527235|P1|COMPLETED|Overall Study||73
622267|NCT00277355|1527234|P2|STARTED|Overall Study||27
622268|NCT00277355|1527235|P1|STARTED|Overall Study||87
622269|NCT00277212|1527243|P3|NOT COMPLETED|Phase 2 - Double-Blind Treatment||113
622270|NCT00277212|1527244|P2|NOT COMPLETED|Phase 2 - Double-Blind Treatment||120
622271|NCT00277212|1527245|P1|NOT COMPLETED|Phase 2 - Double-Blind Treatment||0
622272|NCT00277212|1527243|P3|COMPLETED|Phase 2 - Double-Blind Treatment||65
622273|NCT00277212|1527244|P2|COMPLETED|Phase 2 - Double-Blind Treatment||53
622274|NCT00277212|1527245|P1|COMPLETED|Phase 2 - Double-Blind Treatment||0
622275|NCT00277212|1527243|P3|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||174
622276|NCT00277212|1527244|P2|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||164
622277|NCT00277212|1527245|P1|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||0
622278|NCT00277212|1527243|P3|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||176
622279|NCT00277212|1527244|P2|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||165
622280|NCT00277212|1527245|P1|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||0
622281|NCT00277212|1527243|P3|STARTED|Phase 2 - Double-Blind Treatment|1 participant did not want to continue in the study for personal reasons, and did not enter Phase 2.|178
622282|NCT00277212|1527244|P2|STARTED|Phase 2 - Double-Blind Treatment||173
622283|NCT00277212|1527245|P1|STARTED|Phase 2 - Double-Blind Treatment||0
622284|NCT00277212|1527243|P3|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0
622285|NCT00277212|1527244|P2|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0
622286|NCT00277212|1527245|P1|NOT COMPLETED|Phase 1 - Single-Blind Treatment||435
622287|NCT00277212|1527243|P3|COMPLETED|Phase 1 - Single-Blind Treatment||0
622288|NCT00277212|1527244|P2|COMPLETED|Phase 1 - Single-Blind Treatment||0
622289|NCT00277212|1527245|P1|COMPLETED|Phase 1 - Single-Blind Treatment||352
622290|NCT00277212|1527243|P3|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0
622291|NCT00277212|1527244|P2|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0
622292|NCT00277212|1527245|P1|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||756
622293|NCT00277212|1527243|P3|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0
622294|NCT00277212|1527244|P2|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0
622295|NCT00277212|1527245|P1|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||787
622296|NCT00277212|1527243|P3|STARTED|Phase 1 - Single-Blind Treatment||0
622297|NCT00277212|1527244|P2|STARTED|Phase 1 - Single-Blind Treatment||0
622298|NCT00277212|1527245|P1|STARTED|Phase 1 - Single-Blind Treatment||787
622299|NCT00277095|1527283|P1|NOT COMPLETED|Overall Study||21
622300|NCT00277095|1527283|P1|COMPLETED|Overall Study|Details of patients who did not complete study are given below.|103
622301|NCT00277095|1527283|P1|STARTED|Overall Study|Anatomy of 1 patient did not allow ProACT to be implanted, hence only 123 patients were implanted.|124
622302|NCT00276861|1527287|P1|NOT COMPLETED|Overall Study||0
622303|NCT00276861|1527287|P1|COMPLETED|Overall Study||10
622304|NCT00276861|1527287|P1|STARTED|Overall Study||10
622305|NCT00276614|1527292|P1|NOT COMPLETED|Overall Study||3
622306|NCT00276614|1527292|P1|COMPLETED|Overall Study||1
622307|NCT00276614|1527292|P1|STARTED|Overall Study||4
622308|NCT00276549|1527296|P1|NOT COMPLETED|Overall Study||0
622309|NCT00276549|1527296|P1|COMPLETED|Overall Study||35
622310|NCT00276549|1527296|P1|STARTED|Overall Study||35
622311|NCT00276484|1527303|P2|NOT COMPLETED|Overall Study||13
622312|NCT00276484|1527304|P1|NOT COMPLETED|Overall Study||9
622313|NCT00276484|1527303|P2|COMPLETED|Overall Study||278
622314|NCT00276484|1527304|P1|COMPLETED|Overall Study||279
622315|NCT00276484|1527303|P2|STARTED|Overall Study||291
622316|NCT00276484|1527304|P1|STARTED|Overall Study||288
622317|NCT00276458|1527336|P2|NOT COMPLETED|Overall Study||7
622318|NCT00276458|1527337|P1|NOT COMPLETED|Overall Study||6
622319|NCT00276458|1527336|P2|COMPLETED|Overall Study||91
622320|NCT00276458|1527337|P1|COMPLETED|Overall Study||92
622321|NCT00276458|1527336|P2|STARTED|Overall Study||98
622322|NCT00276458|1527337|P1|STARTED|Overall Study||98
622323|NCT00276419|1527371|P2|NOT COMPLETED|Second Intervention||0
622324|NCT00276419|1527372|P1|NOT COMPLETED|Second Intervention||0
622325|NCT00276419|1527371|P2|COMPLETED|Second Intervention||8
622326|NCT00276419|1527372|P1|COMPLETED|Second Intervention||7
622327|NCT00276419|1527371|P2|STARTED|Second Intervention||8
622328|NCT00276419|1527372|P1|STARTED|Second Intervention||7
622329|NCT00276419|1527371|P2|NOT COMPLETED|Wash-out Phase||0
622330|NCT00276419|1527372|P1|NOT COMPLETED|Wash-out Phase||0
622331|NCT00276419|1527371|P2|COMPLETED|Wash-out Phase||8
622332|NCT00276419|1527372|P1|COMPLETED|Wash-out Phase||7
622333|NCT00276419|1527371|P2|STARTED|Wash-out Phase||8
622334|NCT00276419|1527372|P1|STARTED|Wash-out Phase||7
622335|NCT00276419|1527371|P2|NOT COMPLETED|First Intervention||2
622336|NCT00276419|1527372|P1|NOT COMPLETED|First Intervention||1
622337|NCT00276419|1527371|P2|COMPLETED|First Intervention||8
622338|NCT00276419|1527372|P1|COMPLETED|First Intervention||7
622339|NCT00276419|1527371|P2|STARTED|First Intervention||10
622340|NCT00276419|1527372|P1|STARTED|First Intervention||8
622341|NCT00276406|1527384|P2|NOT COMPLETED|Overall Study||0
622342|NCT00276406|1527385|P1|NOT COMPLETED|Overall Study||0
622343|NCT00276406|1527384|P2|COMPLETED|Overall Study||14
622344|NCT00276406|1527385|P1|COMPLETED|Overall Study|14 of 16 subjects tolerated 360mg daily, while 2 of 16 tolerated 180mg daily.|16
622345|NCT00276406|1527384|P2|STARTED|Overall Study||14
622346|NCT00276406|1527385|P1|STARTED|Overall Study||16
622347|NCT00276380|1527415|P2|NOT COMPLETED|Overall Study||14
622348|NCT00276380|1527416|P1|NOT COMPLETED|Overall Study||14
622349|NCT00276380|1527415|P2|COMPLETED|Overall Study||88
622350|NCT00276380|1527416|P1|COMPLETED|Overall Study||88
622351|NCT00276380|1527415|P2|STARTED|Overall Study||102
622352|NCT00276380|1527416|P1|STARTED|Overall Study||102
622353|NCT00276250|1527437|P3|NOT COMPLETED|Overall Study||0
622354|NCT00276250|1527438|P2|NOT COMPLETED|Overall Study||0
622355|NCT00276250|1527439|P1|NOT COMPLETED|Overall Study||0
622356|NCT00276250|1527437|P3|COMPLETED|Overall Study||0
622357|NCT00276250|1527438|P2|COMPLETED|Overall Study||1
622358|NCT00276250|1527439|P1|COMPLETED|Overall Study||4
622359|NCT00276250|1527437|P3|STARTED|Overall Study||0
622360|NCT00276250|1527438|P2|STARTED|Overall Study||1
622361|NCT00276250|1527439|P1|STARTED|Overall Study||4
622362|NCT00276159|1527471|P1|NOT COMPLETED|Overall Study||6
622363|NCT00276159|1527471|P1|COMPLETED|Overall Study||0
622364|NCT00276159|1527471|P1|STARTED|Overall Study||6
622365|NCT00276094|1527481|P3|NOT COMPLETED|Overall Study||38
622366|NCT00276094|1527482|P2|NOT COMPLETED|Overall Study||42
622367|NCT00276094|1527483|P1|NOT COMPLETED|Overall Study||57
622368|NCT00276094|1527481|P3|COMPLETED|Overall Study||230
622369|NCT00276094|1527482|P2|COMPLETED|Overall Study||234
622370|NCT00276094|1527483|P1|COMPLETED|Overall Study||225
622371|NCT00276094|1527481|P3|STARTED|Overall Study||268
622372|NCT00276094|1527482|P2|STARTED|Overall Study||276
622373|NCT00276094|1527483|P1|STARTED|Overall Study||282
622374|NCT00276016|1527536|P6|NOT COMPLETED|Intervention 3||0
622375|NCT00276016|1527537|P5|NOT COMPLETED|Intervention 3||0
622376|NCT00276016|1527538|P4|NOT COMPLETED|Intervention 3||0
622377|NCT00276016|1527539|P3|NOT COMPLETED|Intervention 3||0
622378|NCT00276016|1527540|P2|NOT COMPLETED|Intervention 3||0
622379|NCT00276016|1527541|P1|NOT COMPLETED|Intervention 3||0
622380|NCT00276016|1527536|P6|COMPLETED|Intervention 3||6
622381|NCT00276016|1527537|P5|COMPLETED|Intervention 3||6
622382|NCT00276016|1527538|P4|COMPLETED|Intervention 3||6
622383|NCT00276016|1527539|P3|COMPLETED|Intervention 3||7
622384|NCT00276016|1527540|P2|COMPLETED|Intervention 3||6
622385|NCT00276016|1527541|P1|COMPLETED|Intervention 3||7
622386|NCT00276016|1527536|P6|STARTED|Intervention 3||6
622387|NCT00276016|1527537|P5|STARTED|Intervention 3||6
622388|NCT00276016|1527538|P4|STARTED|Intervention 3||6
622389|NCT00276016|1527539|P3|STARTED|Intervention 3||7
622390|NCT00276016|1527540|P2|STARTED|Intervention 3||6
622391|NCT00276016|1527541|P1|STARTED|Intervention 3||7
622392|NCT00276016|1527536|P6|NOT COMPLETED|Wash Out 2||0
622393|NCT00276016|1527537|P5|NOT COMPLETED|Wash Out 2||0
622394|NCT00276016|1527538|P4|NOT COMPLETED|Wash Out 2||0
622395|NCT00276016|1527539|P3|NOT COMPLETED|Wash Out 2||0
622396|NCT00276016|1527540|P2|NOT COMPLETED|Wash Out 2||0
622397|NCT00276016|1527541|P1|NOT COMPLETED|Wash Out 2||0
622398|NCT00276016|1527536|P6|COMPLETED|Wash Out 2||6
622399|NCT00276016|1527537|P5|COMPLETED|Wash Out 2||6
622400|NCT00276016|1527538|P4|COMPLETED|Wash Out 2||6
622401|NCT00276016|1527539|P3|COMPLETED|Wash Out 2||7
622402|NCT00276016|1527540|P2|COMPLETED|Wash Out 2||6
622403|NCT00276016|1527541|P1|COMPLETED|Wash Out 2||7
622404|NCT00276016|1527536|P6|STARTED|Wash Out 2||6
622405|NCT00276016|1527537|P5|STARTED|Wash Out 2||6
622406|NCT00276016|1527538|P4|STARTED|Wash Out 2||6
622407|NCT00276016|1527539|P3|STARTED|Wash Out 2||7
622408|NCT00276016|1527540|P2|STARTED|Wash Out 2||6
622409|NCT00276016|1527541|P1|STARTED|Wash Out 2||7
622410|NCT00276016|1527536|P6|NOT COMPLETED|Intervention 2||0
622411|NCT00276016|1527537|P5|NOT COMPLETED|Intervention 2||0
622412|NCT00276016|1527538|P4|NOT COMPLETED|Intervention 2||0
622413|NCT00276016|1527539|P3|NOT COMPLETED|Intervention 2||0
622414|NCT00276016|1527540|P2|NOT COMPLETED|Intervention 2||0
622415|NCT00276016|1527541|P1|NOT COMPLETED|Intervention 2||0
622416|NCT00276016|1527536|P6|COMPLETED|Intervention 2||6
622417|NCT00276016|1527537|P5|COMPLETED|Intervention 2||6
622418|NCT00276016|1527538|P4|COMPLETED|Intervention 2||6
622419|NCT00276016|1527539|P3|COMPLETED|Intervention 2||7
622420|NCT00276016|1527540|P2|COMPLETED|Intervention 2||6
622421|NCT00276016|1527541|P1|COMPLETED|Intervention 2||7
622422|NCT00276016|1527536|P6|STARTED|Intervention 2||6
622423|NCT00276016|1527537|P5|STARTED|Intervention 2||6
622424|NCT00276016|1527538|P4|STARTED|Intervention 2||6
622425|NCT00276016|1527539|P3|STARTED|Intervention 2||7
622426|NCT00276016|1527540|P2|STARTED|Intervention 2||6
622427|NCT00276016|1527541|P1|STARTED|Intervention 2||7
622428|NCT00276016|1527536|P6|NOT COMPLETED|Wash Out 1||0
622429|NCT00276016|1527537|P5|NOT COMPLETED|Wash Out 1||0
622430|NCT00276016|1527538|P4|NOT COMPLETED|Wash Out 1||0
622431|NCT00276016|1527539|P3|NOT COMPLETED|Wash Out 1||0
622432|NCT00276016|1527540|P2|NOT COMPLETED|Wash Out 1||0
622433|NCT00276016|1527541|P1|NOT COMPLETED|Wash Out 1||0
622434|NCT00276016|1527536|P6|COMPLETED|Wash Out 1||6
622435|NCT00276016|1527537|P5|COMPLETED|Wash Out 1||6
622436|NCT00276016|1527538|P4|COMPLETED|Wash Out 1||6
622437|NCT00276016|1527539|P3|COMPLETED|Wash Out 1||7
622438|NCT00276016|1527540|P2|COMPLETED|Wash Out 1||6
622439|NCT00276016|1527541|P1|COMPLETED|Wash Out 1||7
622440|NCT00276016|1527536|P6|STARTED|Wash Out 1||6
622441|NCT00276016|1527537|P5|STARTED|Wash Out 1||6
622442|NCT00276016|1527538|P4|STARTED|Wash Out 1||6
622443|NCT00276016|1527539|P3|STARTED|Wash Out 1||7
622444|NCT00276016|1527540|P2|STARTED|Wash Out 1||6
622445|NCT00276016|1527541|P1|STARTED|Wash Out 1||7
622446|NCT00276016|1527536|P6|NOT COMPLETED|Intervention 1||0
622447|NCT00276016|1527537|P5|NOT COMPLETED|Intervention 1||0
622448|NCT00276016|1527538|P4|NOT COMPLETED|Intervention 1||0
622449|NCT00276016|1527539|P3|NOT COMPLETED|Intervention 1||0
622450|NCT00276016|1527540|P2|NOT COMPLETED|Intervention 1||1
622451|NCT00276016|1527541|P1|NOT COMPLETED|Intervention 1||0
622452|NCT00276016|1527536|P6|COMPLETED|Intervention 1||6
622453|NCT00276016|1527537|P5|COMPLETED|Intervention 1||6
622454|NCT00276016|1527538|P4|COMPLETED|Intervention 1||6
622455|NCT00276016|1527539|P3|COMPLETED|Intervention 1||7
622456|NCT00276016|1527540|P2|COMPLETED|Intervention 1||6
622457|NCT00276016|1527541|P1|COMPLETED|Intervention 1||7
622458|NCT00276016|1527536|P6|STARTED|Intervention 1||6
622459|NCT00276016|1527537|P5|STARTED|Intervention 1||6
622460|NCT00276016|1527538|P4|STARTED|Intervention 1||6
622461|NCT00276016|1527539|P3|STARTED|Intervention 1||7
622462|NCT00276016|1527540|P2|STARTED|Intervention 1||7
622463|NCT00276016|1527541|P1|STARTED|Intervention 1||7
622464|NCT00275834|1527553|P3|NOT COMPLETED|Overall Study||1
622465|NCT00275834|1527554|P2|NOT COMPLETED|Overall Study||3
622466|NCT00275834|1527555|P1|NOT COMPLETED|Overall Study||3
622467|NCT00275834|1527553|P3|COMPLETED|Overall Study||74
622468|NCT00275834|1527554|P2|COMPLETED|Overall Study||73
622469|NCT00275834|1527555|P1|COMPLETED|Overall Study||71
622470|NCT00275834|1527553|P3|Completed Study While on Study Drug|Overall Study||62
622471|NCT00275834|1527554|P2|Completed Study While on Study Drug|Overall Study||51
622472|NCT00275834|1527555|P1|Completed Study While on Study Drug|Overall Study||54
622473|NCT00275834|1527553|P3|STARTED|Overall Study||75
622474|NCT00275834|1527554|P2|STARTED|Overall Study||76
622475|NCT00275834|1527555|P1|STARTED|Overall Study||74
622476|NCT00275821|1527587|P3|NOT COMPLETED|Overall Study||12
622477|NCT00275821|1527588|P2|NOT COMPLETED|Overall Study||23
622478|NCT00275821|1527589|P1|NOT COMPLETED|Overall Study||14
622479|NCT00275821|1527587|P3|COMPLETED|Overall Study||103
622480|NCT00275821|1527588|P2|COMPLETED|Overall Study||95
622481|NCT00275821|1527589|P1|COMPLETED|Overall Study||106
622482|NCT00275821|1527587|P3|STARTED|Overall Study||115
622483|NCT00275821|1527588|P2|STARTED|Overall Study||118
622484|NCT00275821|1527589|P1|STARTED|Overall Study||120
622485|NCT00275561|1527608|P2|NOT COMPLETED|Overall Study||6
622486|NCT00275561|1527609|P1|NOT COMPLETED|Overall Study||2
622487|NCT00275561|1527608|P2|COMPLETED|Overall Study||15
622488|NCT00275561|1527609|P1|COMPLETED|Overall Study||19
622489|NCT00275561|1527608|P2|STARTED|Overall Study||21
622490|NCT00275561|1527609|P1|STARTED|Overall Study||21
622491|NCT00275509|1527621|P2|NOT COMPLETED|Overall Study||1
622492|NCT00275509|1527622|P1|NOT COMPLETED|Overall Study||0
622493|NCT00275509|1527621|P2|COMPLETED|Overall Study||25
622494|NCT00275509|1527622|P1|COMPLETED|Overall Study||30
622495|NCT00275509|1527621|P2|STARTED|Overall Study||26
622496|NCT00275509|1527622|P1|STARTED|Overall Study||30
622497|NCT00275392|1527634|P2|NOT COMPLETED|Overall Study||2
622498|NCT00275392|1527635|P1|NOT COMPLETED|Overall Study||0
622499|NCT00275392|1527634|P2|COMPLETED|Overall Study||17
622500|NCT00275392|1527635|P1|COMPLETED|Overall Study||20
622501|NCT00275392|1527634|P2|STARTED|Overall Study||19
622502|NCT00275392|1527635|P1|STARTED|Overall Study||20
622503|NCT00275340|1527645|P2|NOT COMPLETED|Overall Study||4
622504|NCT00275340|1527646|P1|NOT COMPLETED|Overall Study||2
622505|NCT00275340|1527645|P2|COMPLETED|Overall Study||45
622506|NCT00275340|1527646|P1|COMPLETED|Overall Study||50
622507|NCT00275340|1527645|P2|STARTED|Overall Study||49
622508|NCT00275340|1527646|P1|STARTED|Overall Study||52
622509|NCT00275301|1527650|P1|NOT COMPLETED|Overall Study||5
622510|NCT00275301|1527650|P1|COMPLETED|Overall Study||14
622511|NCT00275301|1527650|P1|STARTED|Overall Study||19
622512|NCT00275275|1527657|P3|NOT COMPLETED|Overall Study||6
622513|NCT00275275|1527658|P2|NOT COMPLETED|Overall Study||2
622514|NCT00275275|1527659|P1|NOT COMPLETED|Overall Study||6
622515|NCT00275275|1527657|P3|COMPLETED|Overall Study||15
622516|NCT00275275|1527658|P2|COMPLETED|Overall Study||18
622517|NCT00275275|1527659|P1|COMPLETED|Overall Study||14
622518|NCT00275275|1527657|P3|STARTED|Overall Study|One participant was removed after enrollment and before any data was collected for him.|21
622519|NCT00275275|1527658|P2|STARTED|Overall Study||20
622520|NCT00275275|1527659|P1|STARTED|Overall Study||20
622521|NCT00275262|1527669|P2|NOT COMPLETED|Overall Study||9
622522|NCT00275262|1527670|P1|NOT COMPLETED|Overall Study||6
622523|NCT00275262|1527669|P2|COMPLETED|Overall Study|Patients who completed the entire 12 month study period|4
622524|NCT00275262|1527670|P1|COMPLETED|Overall Study|Patients who completed the entire 12 month study period|6
622525|NCT00275262|1527669|P2|STARTED|Overall Study||13
622526|NCT00275262|1527670|P1|STARTED|Overall Study||12
622527|NCT00275028|1527684|P1|NOT COMPLETED|Overall Study||47
622528|NCT00275028|1527684|P1|COMPLETED|Overall Study|Participants are treated until one of the below milestones is reached. Completion is N/A.|0
622529|NCT00275028|1527684|P1|STARTED|Overall Study||47
622530|NCT00275002|1527691|P2|NOT COMPLETED|Overall Study||16
622531|NCT00275002|1527692|P1|NOT COMPLETED|Overall Study||22
622532|NCT00275002|1527691|P2|COMPLETED|Overall Study||0
622533|NCT00275002|1527692|P1|COMPLETED|Overall Study||3
622534|NCT00275002|1527691|P2|STARTED|Overall Study||16
622535|NCT00275002|1527692|P1|STARTED|Overall Study||25
622536|NCT00274937|1527700|P1|NOT COMPLETED|Overall Study||20
622537|NCT00274937|1527700|P1|COMPLETED|Overall Study||91
622538|NCT00274937|1527700|P1|STARTED|Overall Study||111
622539|NCT00274924|1527710|P3|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0
622540|NCT00274924|1527711|P2|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||18
622541|NCT00274924|1527712|P1|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||7
622542|NCT00274924|1527710|P3|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0
622543|NCT00274924|1527711|P2|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||58
622544|NCT00274924|1527712|P1|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||10
622545|NCT00274924|1527710|P3|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||0
622546|NCT00274924|1527711|P2|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||61
622547|NCT00274924|1527712|P1|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||13
622548|NCT00274924|1527710|P3|STARTED|Step 2 (Tx Based on Mid-treatment PET)||0
622549|NCT00274924|1527711|P2|STARTED|Step 2 (Tx Based on Mid-treatment PET)|One patient withdrew from the study after step 1 treatment.|76
622550|NCT00274924|1527712|P1|STARTED|Step 2 (Tx Based on Mid-treatment PET)|All patients who started step 2 therapy were included regardless of eligibility.|17
622551|NCT00274924|1527710|P3|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||6
622552|NCT00274924|1527711|P2|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||14
622553|NCT00274924|1527712|P1|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||4
622554|NCT00274924|1527710|P3|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||0
622555|NCT00274924|1527711|P2|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||63
622556|NCT00274924|1527712|P1|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||13
622557|NCT00274924|1527710|P3|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||4
622558|NCT00274924|1527711|P2|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||63
622559|NCT00274924|1527712|P1|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||13
622560|NCT00274924|1527710|P3|Treated|Step 1 (R-CHOP X 3 Cycles)||5
622561|NCT00274924|1527711|P2|Treated|Step 1 (R-CHOP X 3 Cycles)||77
622562|NCT00274924|1527712|P1|Treated|Step 1 (R-CHOP X 3 Cycles)||17
622563|NCT00274924|1527710|P3|STARTED|Step 1 (R-CHOP X 3 Cycles)||6
622564|NCT00274924|1527711|P2|STARTED|Step 1 (R-CHOP X 3 Cycles)||77
622565|NCT00274924|1527712|P1|STARTED|Step 1 (R-CHOP X 3 Cycles)||17
622566|NCT00274846|1527721|P1|NOT COMPLETED|Overall Study||1
622567|NCT00274846|1527721|P1|COMPLETED|Overall Study|Evaluable patients - received adequate natural killer (NK) cells|20
622568|NCT00274846|1527721|P1|STARTED|Overall Study||21
622569|NCT00274781|1527729|P1|NOT COMPLETED|Overall Study||0
622570|NCT00274781|1527729|P1|COMPLETED|Overall Study||30
622571|NCT00274781|1527729|P1|STARTED|Overall Study||30
622572|NCT00274768|1527735|P1|NOT COMPLETED|Overall Study||0
622573|NCT00274768|1527735|P1|COMPLETED|Overall Study||26
622574|NCT00274768|1527735|P1|STARTED|Overall Study||26
622575|NCT00274742|1527745|P6|NOT COMPLETED|Overall Study||3
622576|NCT00274742|1527746|P5|NOT COMPLETED|Overall Study||16
622577|NCT00274742|1527747|P4|NOT COMPLETED|Overall Study||5
622578|NCT00274742|1527748|P3|NOT COMPLETED|Overall Study||2
622579|NCT00274742|1527749|P2|NOT COMPLETED|Overall Study||8
622580|NCT00274742|1527750|P1|NOT COMPLETED|Overall Study||0
622581|NCT00274742|1527745|P6|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|1
622582|NCT00274742|1527746|P5|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|16
622583|NCT00274742|1527747|P4|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|4
622584|NCT00274742|1527748|P3|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|4
622585|NCT00274742|1527749|P2|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|5
622586|NCT00274742|1527750|P1|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|12
622587|NCT00274742|1527745|P6|STARTED|Overall Study||4
622588|NCT00274742|1527746|P5|STARTED|Overall Study||32
622589|NCT00274742|1527747|P4|STARTED|Overall Study||9
622590|NCT00274742|1527748|P3|STARTED|Overall Study||6
622591|NCT00274742|1527749|P2|STARTED|Overall Study||13
622592|NCT00274742|1527750|P1|STARTED|Overall Study||12
622593|NCT00274716|1527788|P6|NOT COMPLETED|Phase B||1
622594|NCT00274716|1527789|P5|NOT COMPLETED|Phase B||0
622595|NCT00274716|1527790|P4|NOT COMPLETED|Phase B||1
622596|NCT00274716|1527791|P3|NOT COMPLETED|Phase B||3
622597|NCT00274716|1527792|P2|NOT COMPLETED|Phase B||4
622598|NCT00274716|1527793|P1|NOT COMPLETED|Phase B||1
622599|NCT00274716|1527788|P6|COMPLETED|Phase B||14
622600|NCT00274716|1527789|P5|COMPLETED|Phase B||16
622601|NCT00274716|1527790|P4|COMPLETED|Phase B||41
622602|NCT00274716|1527791|P3|COMPLETED|Phase B||41
622603|NCT00274716|1527792|P2|COMPLETED|Phase B||40
622604|NCT00274716|1527793|P1|COMPLETED|Phase B||42
622605|NCT00274716|1527788|P6|STARTED|Phase B||15
622606|NCT00274716|1527789|P5|STARTED|Phase B||16
622607|NCT00274716|1527790|P4|STARTED|Phase B||42
622608|NCT00274716|1527791|P3|STARTED|Phase B||44
622609|NCT00274716|1527792|P2|STARTED|Phase B||44
622610|NCT00274716|1527793|P1|STARTED|Phase B||43
622611|NCT00274716|1527788|P6|NOT COMPLETED|Phase A||4
622612|NCT00274716|1527789|P5|NOT COMPLETED|Phase A||3
622613|NCT00274716|1527790|P4|NOT COMPLETED|Phase A||9
622614|NCT00274716|1527791|P3|NOT COMPLETED|Phase A||8
622615|NCT00274716|1527792|P2|NOT COMPLETED|Phase A||10
622616|NCT00274716|1527793|P1|NOT COMPLETED|Phase A||11
622617|NCT00274716|1527788|P6|COMPLETED|Phase A||15
622618|NCT00274716|1527789|P5|COMPLETED|Phase A||16
622619|NCT00274716|1527790|P4|COMPLETED|Phase A||42
622620|NCT00274716|1527791|P3|COMPLETED|Phase A||44
622621|NCT00274716|1527792|P2|COMPLETED|Phase A||44
622622|NCT00274716|1527793|P1|COMPLETED|Phase A||43
622623|NCT00274716|1527788|P6|STARTED|Phase A||19
622624|NCT00274716|1527789|P5|STARTED|Phase A||19
622625|NCT00274716|1527790|P4|STARTED|Phase A||51
622626|NCT00274716|1527791|P3|STARTED|Phase A||52
622627|NCT00274716|1527792|P2|STARTED|Phase A||54
622628|NCT00274716|1527793|P1|STARTED|Phase A||54
622629|NCT00274651|1527855|P2|NOT COMPLETED|Overall Study||20
622630|NCT00274651|1527856|P1|NOT COMPLETED|Overall Study||28
622631|NCT00274651|1527855|P2|COMPLETED|Overall Study||4
622632|NCT00274651|1527856|P1|COMPLETED|Overall Study||1
622633|NCT00274651|1527855|P2|STARTED|Overall Study||24
622634|NCT00274651|1527856|P1|STARTED|Overall Study||29
622635|NCT00274625|1527871|P2|NOT COMPLETED|Overall Study||62
622636|NCT00274625|1527872|P1|NOT COMPLETED|Overall Study||60
622637|NCT00274625|1527871|P2|COMPLETED|Overall Study||141
622638|NCT00274625|1527872|P1|COMPLETED|Overall Study||139
622639|NCT00274625|1527871|P2|STARTED|Overall Study||203
622640|NCT00274625|1527872|P1|STARTED|Overall Study||199
622641|NCT00274469|1527880|P2|NOT COMPLETED|Overall Study||50
622642|NCT00274469|1527881|P1|NOT COMPLETED|Overall Study||38
622643|NCT00274469|1527880|P2|COMPLETED|Overall Study|Number of patients ongoing study treatment at data cut-off|53
622644|NCT00274469|1527881|P1|COMPLETED|Overall Study|Number of patients ongoing study treatment at data cut-off|64
622645|NCT00274469|1527880|P2|STARTED|Overall Study|Number of patients randomized|103
622646|NCT00274469|1527881|P1|STARTED|Overall Study|Number of patients randomized|102
622647|NCT00274456|1527899|P4|NOT COMPLETED|Overall Study||45
622648|NCT00274456|1527900|P3|NOT COMPLETED|Overall Study||35
622649|NCT00274456|1527901|P2|NOT COMPLETED|Overall Study||27
622650|NCT00274456|1527902|P1|NOT COMPLETED|Overall Study||37
622651|NCT00274456|1527899|P4|COMPLETED|Overall Study|Treatment completed upon progressive disease|29
622652|NCT00274456|1527900|P3|COMPLETED|Overall Study|Treatment completed upon progressive disease|39
622653|NCT00274456|1527901|P2|COMPLETED|Overall Study|Treatment completed upon progressive disease|49
622654|NCT00274456|1527902|P1|COMPLETED|Overall Study|Treatment completed upon progressive disease|39
622655|NCT00274456|1527899|P4|At Least One Response Assessment|Overall Study||70
622656|NCT00274456|1527900|P3|At Least One Response Assessment|Overall Study||73
622657|NCT00274456|1527901|P2|At Least One Response Assessment|Overall Study||76
622658|NCT00274456|1527902|P1|At Least One Response Assessment|Overall Study||73
622659|NCT00274456|1527899|P4|STARTED|Overall Study||74
622660|NCT00274456|1527900|P3|STARTED|Overall Study||74
622661|NCT00274456|1527901|P2|STARTED|Overall Study||76
622662|NCT00274456|1527902|P1|STARTED|Overall Study||76
622663|NCT00274287|1527944|P1|NOT COMPLETED|Overall Study||2
622664|NCT00274287|1527944|P1|COMPLETED|Overall Study||13
622665|NCT00274287|1527944|P1|STARTED|Overall Study||15
622666|NCT00274261|1527950|P2|NOT COMPLETED|Overall Study||337
622667|NCT00274261|1527951|P1|NOT COMPLETED|Overall Study||489
622668|NCT00274261|1527950|P2|COMPLETED|Overall Study||296
622669|NCT00274261|1527951|P1|COMPLETED|Overall Study||443
622670|NCT00274261|1527950|P2|STARTED|Overall Study||633
622671|NCT00274261|1527951|P1|STARTED|Overall Study||932
622672|NCT00273910|1527965|P6|NOT COMPLETED|Overall Study||0
622673|NCT00273910|1527966|P5|NOT COMPLETED|Overall Study||0
622674|NCT00273910|1527967|P4|NOT COMPLETED|Overall Study||0
622675|NCT00273910|1527968|P3|NOT COMPLETED|Overall Study||0
622676|NCT00273910|1527969|P2|NOT COMPLETED|Overall Study||0
622677|NCT00273910|1527970|P1|NOT COMPLETED|Overall Study||0
622678|NCT00273910|1527965|P6|COMPLETED|Overall Study||14
622679|NCT00273910|1527966|P5|COMPLETED|Overall Study||15
622680|NCT00273910|1527967|P4|COMPLETED|Overall Study||19
622681|NCT00273910|1527968|P3|COMPLETED|Overall Study||18
622682|NCT00273910|1527969|P2|COMPLETED|Overall Study||19
622683|NCT00273910|1527970|P1|COMPLETED|Overall Study||19
622684|NCT00273910|1527965|P6|STARTED|Overall Study||14
622685|NCT00273910|1527966|P5|STARTED|Overall Study||15
622686|NCT00273910|1527967|P4|STARTED|Overall Study||19
622687|NCT00273910|1527968|P3|STARTED|Overall Study||18
622688|NCT00273910|1527969|P2|STARTED|Overall Study||19
622689|NCT00273910|1527970|P1|STARTED|Overall Study||19
622690|NCT00273858|1527990|P1|NOT COMPLETED|Overall Study||537
622691|NCT00273858|1527990|P1|COMPLETED|Overall Study||343
622692|NCT00273858|1527990|P1|STARTED|Overall Study||880
622693|NCT00273793|1528005|P6|NOT COMPLETED|Overall Study||0
622694|NCT00273793|1528006|P5|NOT COMPLETED|Overall Study||0
622695|NCT00273793|1528007|P4|NOT COMPLETED|Overall Study||0
622696|NCT00273793|1528008|P3|NOT COMPLETED|Overall Study||0
622697|NCT00273793|1528009|P2|NOT COMPLETED|Overall Study||0
622698|NCT00273793|1528010|P1|NOT COMPLETED|Overall Study||0
622699|NCT00273793|1528005|P6|COMPLETED|Overall Study||29
622700|NCT00273793|1528006|P5|COMPLETED|Overall Study||58
622701|NCT00273793|1528007|P4|COMPLETED|Overall Study||60
622702|NCT00273793|1528008|P3|COMPLETED|Overall Study||18
622703|NCT00273793|1528009|P2|COMPLETED|Overall Study||38
622704|NCT00273793|1528010|P1|COMPLETED|Overall Study||36
622705|NCT00273793|1528005|P6|STARTED|Overall Study||29
622706|NCT00273793|1528006|P5|STARTED|Overall Study||58
622707|NCT00273793|1528007|P4|STARTED|Overall Study||60
622708|NCT00273793|1528008|P3|STARTED|Overall Study||18
622709|NCT00273793|1528009|P2|STARTED|Overall Study||38
622710|NCT00273793|1528010|P1|STARTED|Overall Study||36
622711|NCT00273754|1528032|P2|NOT COMPLETED|Overall Study||0
622712|NCT00273754|1528033|P1|NOT COMPLETED|Overall Study||0
622713|NCT00273754|1528032|P2|COMPLETED|Overall Study||36
622714|NCT00273754|1528033|P1|COMPLETED|Overall Study||36
622715|NCT00273754|1528032|P2|STARTED|Overall Study||36
622716|NCT00273754|1528033|P1|STARTED|Overall Study||36
622717|NCT00273182|1528049|P1|NOT COMPLETED|Overall Study||985
622718|NCT00273182|1528049|P1|COMPLETED|Overall Study||1014
622719|NCT00273182|1528049|P1|STARTED|Overall Study||1999
622720|NCT00273052|1528059|P2|NOT COMPLETED|Overall Study||88
622721|NCT00273052|1528060|P1|NOT COMPLETED|Overall Study||69
622722|NCT00273052|1528059|P2|COMPLETED|Overall Study||190
622723|NCT00273052|1528060|P1|COMPLETED|Overall Study||221
622724|NCT00273052|1528059|P2|STARTED|Overall Study||278
622725|NCT00273052|1528060|P1|STARTED|Overall Study||290
622726|NCT00272987|1528095|P3|NOT COMPLETED|Overall Study||19
622727|NCT00272987|1528096|P2|NOT COMPLETED|Overall Study||14
622728|NCT00272987|1528097|P1|NOT COMPLETED|Overall Study||21
622729|NCT00272987|1528095|P3|COMPLETED|Overall Study||1
622730|NCT00272987|1528096|P2|COMPLETED|Overall Study||0
622731|NCT00272987|1528097|P1|COMPLETED|Overall Study||8
622732|NCT00272987|1528095|P3|Ongoing|Overall Study||15
622733|NCT00272987|1528096|P2|Ongoing|Overall Study||14
622734|NCT00272987|1528097|P1|Ongoing|Overall Study||20
622735|NCT00272987|1528095|P3|STARTED|Overall Study||20
622736|NCT00272987|1528096|P2|STARTED|Overall Study||14
622737|NCT00272987|1528097|P1|STARTED|Overall Study||29
622738|NCT00272961|1528161|P5|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
622739|NCT00272961|1528162|P4|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||3
622740|NCT00272961|1528163|P3|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
622741|NCT00272961|1528164|P2|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
622742|NCT00272961|1528165|P1|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||2
622743|NCT00272961|1528161|P5|COMPLETED|Treatment Phase: Week 3 Up to Week 12||6
622744|NCT00272961|1528162|P4|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7
622745|NCT00272961|1528163|P3|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7
622746|NCT00272961|1528164|P2|COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
622747|NCT00272961|1528165|P1|COMPLETED|Treatment Phase: Week 3 Up to Week 12||8
622748|NCT00272961|1528161|P5|STARTED|Treatment Phase: Week 3 Up to Week 12||10
622749|NCT00272961|1528162|P4|STARTED|Treatment Phase: Week 3 Up to Week 12||10
622750|NCT00272961|1528163|P3|STARTED|Treatment Phase: Week 3 Up to Week 12||11
622751|NCT00272961|1528164|P2|STARTED|Treatment Phase: Week 3 Up to Week 12||8
622752|NCT00272961|1528165|P1|STARTED|Treatment Phase: Week 3 Up to Week 12||10
622753|NCT00272961|1528161|P5|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
622754|NCT00272961|1528162|P4|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
622755|NCT00272961|1528163|P3|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
622756|NCT00272961|1528164|P2|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
622757|NCT00272961|1528165|P1|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||11
622758|NCT00272961|1528161|P5|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
622759|NCT00272961|1528162|P4|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
622760|NCT00272961|1528163|P3|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
622761|NCT00272961|1528164|P2|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
622762|NCT00272961|1528165|P1|COMPLETED|Placebo Run-in Phase: Up to Week 2||49
622763|NCT00272961|1528161|P5|STARTED|Placebo Run-in Phase: Up to Week 2||0
622764|NCT00272961|1528162|P4|STARTED|Placebo Run-in Phase: Up to Week 2||0
622765|NCT00272961|1528163|P3|STARTED|Placebo Run-in Phase: Up to Week 2||0
622766|NCT00272961|1528164|P2|STARTED|Placebo Run-in Phase: Up to Week 2||0
622767|NCT00272961|1528165|P1|STARTED|Placebo Run-in Phase: Up to Week 2||60
622768|NCT00272844|1528222|P1|NOT COMPLETED|Overall Study||5
622769|NCT00272844|1528222|P1|COMPLETED|Overall Study||18
622770|NCT00272844|1528222|P1|STARTED|Overall Study||23
622771|NCT00272792|1528230|P2|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||3
622772|NCT00272792|1528231|P1|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||1
622773|NCT00272792|1528230|P2|COMPLETED|Part 2: Blinded, Placebo Control Period||9
622774|NCT00272792|1528231|P1|COMPLETED|Part 2: Blinded, Placebo Control Period||32
622775|NCT00272792|1528230|P2|STARTED|Part 2: Blinded, Placebo Control Period||12
622776|NCT00272792|1528231|P1|STARTED|Part 2: Blinded, Placebo Control Period||33
622777|NCT00272792|1528230|P2|NOT COMPLETED|Part 1: Responsiveness||0
622778|NCT00272792|1528231|P1|NOT COMPLETED|Part 1: Responsiveness||1
622779|NCT00272792|1528230|P2|COMPLETED|Part 1: Responsiveness||0
622780|NCT00272792|1528231|P1|COMPLETED|Part 1: Responsiveness||89
622781|NCT00272792|1528230|P2|STARTED|Part 1: Responsiveness||0
622782|NCT00272792|1528231|P1|STARTED|Part 1: Responsiveness||90
622783|NCT00272779|1528241|P2|NOT COMPLETED|Baseline Through Week 96||136
622784|NCT00272779|1528242|P1|NOT COMPLETED|Baseline Through Week 96||139
622785|NCT00272779|1528241|P2|COMPLETED|Baseline Through Week 96||307
622786|NCT00272779|1528242|P1|COMPLETED|Baseline Through Week 96||301
622787|NCT00272779|1528241|P2|RECEIVED ANY TREATMENT|Baseline Through Week 96|3 participants received ATV instead of LPV (treatment error) and 3 participants never treated|437
622788|NCT00272779|1528242|P1|RECEIVED ANY TREATMENT|Baseline Through Week 96|1 participant randomized to LPV received ATV instead (treatment error)|441
622789|NCT00272779|1528241|P2|STARTED|Baseline Through Week 96|Number randomized to LPV|443
622790|NCT00272779|1528242|P1|STARTED|Baseline Through Week 96|Number randomized to ATV|440
622791|NCT00272779|1528241|P2|NOT COMPLETED|Baseline Through Week 48||443
622792|NCT00272779|1528242|P1|NOT COMPLETED|Baseline Through Week 48||440
622793|NCT00272779|1528241|P2|COMPLETED|Baseline Through Week 48||0
622794|NCT00272779|1528242|P1|COMPLETED|Baseline Through Week 48||0
622795|NCT00272779|1528241|P2|STILL ON TREATMENT|Baseline Through Week 48||368
622796|NCT00272779|1528242|P1|STILL ON TREATMENT|Baseline Through Week 48||385
622797|NCT00272779|1528241|P2|Discontinued on or After Week 48|Baseline Through Week 48||14
622798|NCT00272779|1528242|P1|Discontinued on or After Week 48|Baseline Through Week 48||14
622799|NCT00272779|1528241|P2|Discontinued Before Week 48|Baseline Through Week 48||58
622800|NCT00272779|1528242|P1|Discontinued Before Week 48|Baseline Through Week 48||39
622801|NCT00272779|1528241|P2|TREATED AS RANDOMIZED|Baseline Through Week 48||440
622802|NCT00272779|1528242|P1|TREATED AS RANDOMIZED|Baseline Through Week 48||438
622803|NCT00272779|1528241|P2|RECEIVED ANY TREATMENT|Baseline Through Week 48|3 participants received ATV instead of LPV (treatment error), 3 participants never treated with LPV|437
622804|NCT00272779|1528242|P1|RECEIVED ANY TREATMENT|Baseline Through Week 48|1 participant randomized to LPV received ATV instead (treatment error)|441
622805|NCT00272779|1528241|P2|STARTED|Baseline Through Week 48|Number of participants randomized to LPV|443
622806|NCT00272779|1528242|P1|STARTED|Baseline Through Week 48|Number of participants randomized to ATV|440
622807|NCT00272337|1528426|P5|NOT COMPLETED|Overall Study||0
622808|NCT00272337|1528427|P4|NOT COMPLETED|Overall Study||0
622809|NCT00272337|1528428|P3|NOT COMPLETED|Overall Study||0
622810|NCT00272337|1528429|P2|NOT COMPLETED|Overall Study||0
622811|NCT00272337|1528430|P1|NOT COMPLETED|Overall Study||0
622812|NCT00272337|1528426|P5|COMPLETED|Overall Study||8
622813|NCT00272337|1528427|P4|COMPLETED|Overall Study||7
622814|NCT00272337|1528428|P3|COMPLETED|Overall Study||7
622815|NCT00272337|1528429|P2|COMPLETED|Overall Study||7
622816|NCT00272337|1528430|P1|COMPLETED|Overall Study||8
622817|NCT00272337|1528426|P5|STARTED|Overall Study||8
622818|NCT00272337|1528427|P4|STARTED|Overall Study||7
622819|NCT00272337|1528428|P3|STARTED|Overall Study||7
622820|NCT00272337|1528429|P2|STARTED|Overall Study||7
622821|NCT00272337|1528430|P1|STARTED|Overall Study||8
622822|NCT00272311|1528447|P5|NOT COMPLETED|Overall Study||0
622823|NCT00272311|1528448|P4|NOT COMPLETED|Overall Study||0
622824|NCT00272311|1528449|P3|NOT COMPLETED|Overall Study||0
622825|NCT00272311|1528450|P2|NOT COMPLETED|Overall Study||0
622826|NCT00272311|1528451|P1|NOT COMPLETED|Overall Study||0
622827|NCT00272311|1528447|P5|COMPLETED|Overall Study||14
622828|NCT00272311|1528448|P4|COMPLETED|Overall Study||14
622829|NCT00272311|1528449|P3|COMPLETED|Overall Study||14
622830|NCT00272311|1528450|P2|COMPLETED|Overall Study||14
622831|NCT00272311|1528451|P1|COMPLETED|Overall Study||14
622832|NCT00272311|1528447|P5|STARTED|Overall Study||14
622833|NCT00272311|1528448|P4|STARTED|Overall Study||14
622834|NCT00272311|1528449|P3|STARTED|Overall Study||14
622835|NCT00272311|1528450|P2|STARTED|Overall Study||14
622836|NCT00272311|1528451|P1|STARTED|Overall Study||14
622837|NCT00272168|1528465|P2|NOT COMPLETED|Overall Study||10
622838|NCT00272168|1528466|P1|NOT COMPLETED|Overall Study||10
622839|NCT00272168|1528465|P2|COMPLETED|Overall Study||31
622840|NCT00272168|1528466|P1|COMPLETED|Overall Study||37
622841|NCT00272168|1528465|P2|STARTED|Overall Study||41
622842|NCT00272168|1528466|P1|STARTED|Overall Study||47
622843|NCT00272038|1528482|P1|NOT COMPLETED|Overall Study||7
622844|NCT00272038|1528482|P1|COMPLETED|Overall Study||22
622845|NCT00272038|1528482|P1|STARTED|Overall Study||29
622846|NCT00271947|1528488|P1|NOT COMPLETED|Overall Study||1
622847|NCT00271947|1528488|P1|COMPLETED|Overall Study||0
622848|NCT00271947|1528488|P1|STARTED|Overall Study||1
622849|NCT00271856|1528494|P2|NOT COMPLETED|Overall Study||18
622850|NCT00271856|1528495|P1|NOT COMPLETED|Overall Study||11
622851|NCT00271856|1528494|P2|COMPLETED|Overall Study||70
622852|NCT00271856|1528495|P1|COMPLETED|Overall Study||78
622853|NCT00271856|1528494|P2|STARTED|Overall Study||88
622854|NCT00271856|1528495|P1|STARTED|Overall Study||89
622855|NCT00271817|1528514|P3|NOT COMPLETED|Part 2||84
622856|NCT00271817|1528515|P2|NOT COMPLETED|Part 2||32
622857|NCT00271817|1528516|P1|NOT COMPLETED|Part 2||0
622858|NCT00271817|1528514|P3|COMPLETED|Part 2||401
622859|NCT00271817|1528515|P2|COMPLETED|Part 2||234
622860|NCT00271817|1528516|P1|COMPLETED|Part 2||0
622861|NCT00271817|1528514|P3|STARTED|Part 2|Includes 105 patients re-allocated from the niacin group in Part 1|485
622862|NCT00271817|1528515|P2|STARTED|Part 2|Includes 54 patients re-allocated from the niacin group in Part 1|266
622863|NCT00271817|1528516|P1|STARTED|Part 2|Patients completing the niacin group in Part 1, were re-allocated to one of the two arms in Part 2|0
622864|NCT00271817|1528514|P3|NOT COMPLETED|Part 1||285
622865|NCT00271817|1528515|P2|NOT COMPLETED|Part 1||59
622866|NCT00271817|1528516|P1|NOT COMPLETED|Part 1||106
622867|NCT00271817|1528514|P3|COMPLETED|Part 1|11 patients who completed Part 1 did not continue to Part 2|391
622868|NCT00271817|1528515|P2|COMPLETED|Part 1|1 patient who completed Part 1 did not continue to Part 2|213
622869|NCT00271817|1528516|P1|COMPLETED|Part 1|6 patients who completed Part 1 did not continue to Part 2; 1 patient never received drug in Part 2|166
622870|NCT00271817|1528514|P3|STARTED|Part 1||676
622871|NCT00271817|1528515|P2|STARTED|Part 1||272
622872|NCT00271817|1528516|P1|STARTED|Part 1||272
622873|NCT00271739|1528545|P2|NOT COMPLETED|Overall Study||105
622874|NCT00271739|1528546|P1|NOT COMPLETED|Overall Study||115
622875|NCT00271739|1528545|P2|COMPLETED|Overall Study||716
622876|NCT00271739|1528546|P1|COMPLETED|Overall Study||729
622877|NCT00271739|1528545|P2|STARTED|Overall Study||821
622878|NCT00271739|1528546|P1|STARTED|Overall Study||844
622879|NCT00271609|1528558|P2|NOT COMPLETED|Overall Study||3
622880|NCT00271609|1528559|P1|NOT COMPLETED|Overall Study||13
622881|NCT00271609|1528558|P2|COMPLETED|Overall Study||29
622882|NCT00271609|1528559|P1|COMPLETED|Overall Study||43
622883|NCT00271609|1528558|P2|STARTED|Overall Study||32
622884|NCT00271609|1528559|P1|STARTED|Overall Study||56
622885|NCT00271596|1528569|P2|NOT COMPLETED|Overall Study||1
622886|NCT00271596|1528570|P1|NOT COMPLETED|Overall Study||1
622887|NCT00271596|1528569|P2|COMPLETED|Overall Study||15
622888|NCT00271596|1528570|P1|COMPLETED|Overall Study||16
622889|NCT00271596|1528569|P2|STARTED|Overall Study||16
622890|NCT00271596|1528570|P1|STARTED|Overall Study||17
622891|NCT00271570|1528596|P2|NOT COMPLETED|Overall Study||0
622892|NCT00271570|1528597|P1|NOT COMPLETED|Overall Study||0
622893|NCT00271570|1528596|P2|COMPLETED|Overall Study||12
622894|NCT00271570|1528597|P1|COMPLETED|Overall Study||12
622895|NCT00271570|1528596|P2|STARTED|Overall Study||12
622896|NCT00271570|1528597|P1|STARTED|Overall Study||12
622897|NCT00271544|1528605|P1|NOT COMPLETED|Overall Study||20
622898|NCT00271544|1528605|P1|COMPLETED|Overall Study|Total number subjects successfully implanted 4196 lead.|170
622899|NCT00271544|1528605|P1|Model 4196 Lead Attempted|Overall Study|Total number of subjects attempted Model 4196 lead.|177
622900|NCT00271544|1528605|P1|Implant Attempted|Overall Study|Total number of subjects completed baseline and underwent system implant attempt.|186
622901|NCT00271544|1528605|P1|STARTED|Overall Study|Total number of subjects enrolled.|190
622902|NCT00271375|1528629|P3|NOT COMPLETED|Overall Study||0
622903|NCT00271375|1528630|P2|NOT COMPLETED|Overall Study||0
622904|NCT00271375|1528631|P1|NOT COMPLETED|Overall Study||0
622905|NCT00271375|1528629|P3|COMPLETED|Overall Study||57
622906|NCT00271375|1528630|P2|COMPLETED|Overall Study||83
622907|NCT00271375|1528631|P1|COMPLETED|Overall Study||114
622908|NCT00271375|1528629|P3|STARTED|Overall Study||57
622909|NCT00271375|1528630|P2|STARTED|Overall Study||83
622910|NCT00271375|1528631|P1|STARTED|Overall Study||114
622911|NCT00271219|1528669|P2|NOT COMPLETED|Overall Study||28
622912|NCT00271219|1528670|P1|NOT COMPLETED|Overall Study||16
622913|NCT00271219|1528669|P2|COMPLETED|Overall Study||58
622914|NCT00271219|1528670|P1|COMPLETED|Overall Study||73
622915|NCT00271219|1528669|P2|STARTED|Overall Study||86
622916|NCT00271219|1528670|P1|STARTED|Overall Study||89
622917|NCT00271154|1528696|P2|NOT COMPLETED|Overall Study||0
622918|NCT00271154|1528697|P1|NOT COMPLETED|Overall Study||0
622919|NCT00271154|1528696|P2|COMPLETED|Overall Study||419
622920|NCT00271154|1528697|P1|COMPLETED|Overall Study||191
622921|NCT00271154|1528696|P2|STARTED|Overall Study||419
622922|NCT00271154|1528697|P1|STARTED|Overall Study||191
622923|NCT00271024|1528710|P4|NOT COMPLETED|Overall Study||24
622924|NCT00271024|1528711|P3|NOT COMPLETED|Overall Study||23
622925|NCT00271024|1528712|P2|NOT COMPLETED|Overall Study||26
622926|NCT00271024|1528713|P1|NOT COMPLETED|Overall Study||22
622927|NCT00271024|1528710|P4|COMPLETED|Overall Study|Discontinued: 9 smoking related, 2 reaction to tablet, 4 time commitment, 1 other, 3 unspecified|64
622928|NCT00271024|1528711|P3|COMPLETED|Overall Study|Discontinued: 5 smoking related, 4 reaction to tablet, 4 time commitment, 3 other, 4 unspecified|65
622929|NCT00271024|1528712|P2|COMPLETED|Overall Study|Discontinued: 5 smoking related, 3 reaction to tablet, 2 time commitment, 1 other, 9 unspecified|51
622930|NCT00271024|1528713|P1|COMPLETED|Overall Study|Discontinued: 1 smoking related, 1 reaction to tablet, 6 time commitment, 2 other, 8 unspecified|58
622931|NCT00271024|1528710|P4|Received Study Treatment|Overall Study|n=5 did not start treatment (2 health problems, 1 wanted diff. treatment method, 2 lost interest)|83
622932|NCT00271024|1528711|P3|Received Study Treatment|Overall Study|n=3 did not start treatment (2 lost interest, 1 unknown)|85
622933|NCT00271024|1528712|P2|Received Study Treatment|Overall Study|n=6 did not start treatment (1 diff treat. desired, 3 lost interest, 1 began psych meds, 1 unknown)|71
622934|NCT00271024|1528713|P1|Received Study Treatment|Overall Study|n=4 did not start treatment (3 lost interest, 1 unknown)|76
622935|NCT00271024|1528710|P4|STARTED|Overall Study||88
622936|NCT00271024|1528711|P3|STARTED|Overall Study||88
622937|NCT00271024|1528712|P2|STARTED|Overall Study||77
622938|NCT00271024|1528713|P1|STARTED|Overall Study||80
622939|NCT00271011|1528755|P1|NOT COMPLETED|Overall Study||0
622940|NCT00271011|1528755|P1|COMPLETED|Overall Study||13
622941|NCT00271011|1528755|P1|STARTED|Overall Study||13
622942|NCT00270998|1528763|P3|NOT COMPLETED|12 Month Follow-up||21
622943|NCT00270998|1528764|P2|NOT COMPLETED|12 Month Follow-up||25
622944|NCT00270998|1528765|P1|NOT COMPLETED|12 Month Follow-up||14
622945|NCT00270998|1528763|P3|COMPLETED|12 Month Follow-up||111
622946|NCT00270998|1528764|P2|COMPLETED|12 Month Follow-up||99
622947|NCT00270998|1528765|P1|COMPLETED|12 Month Follow-up||96
622948|NCT00270998|1528763|P3|STARTED|12 Month Follow-up||132
622949|NCT00270998|1528764|P2|STARTED|12 Month Follow-up||124
622950|NCT00270998|1528765|P1|STARTED|12 Month Follow-up||110
622951|NCT00270998|1528763|P3|NOT COMPLETED|3 Month Follow-up||18
622952|NCT00270998|1528764|P2|NOT COMPLETED|3 Month Follow-up||22
622953|NCT00270998|1528765|P1|NOT COMPLETED|3 Month Follow-up||39
622954|NCT00270998|1528763|P3|COMPLETED|3 Month Follow-up||132
622955|NCT00270998|1528764|P2|COMPLETED|3 Month Follow-up||124
622956|NCT00270998|1528765|P1|COMPLETED|3 Month Follow-up||110
622957|NCT00270998|1528763|P3|STARTED|3 Month Follow-up|1 participant randomized to combined found ineligible at first treatment visit, removed from study.|150
622958|NCT00270998|1528764|P2|STARTED|3 Month Follow-up||146
622959|NCT00270998|1528765|P1|STARTED|3 Month Follow-up||149
622960|NCT00270894|1528794|P1|NOT COMPLETED|Overall Study||2
622961|NCT00270894|1528794|P1|COMPLETED|Overall Study||28
622962|NCT00270894|1528794|P1|STARTED|Overall Study||30
622963|NCT00270855|1528806|P2|NOT COMPLETED|Overall Study||8
622964|NCT00270855|1528807|P1|NOT COMPLETED|Overall Study||8
622965|NCT00270855|1528806|P2|COMPLETED|Overall Study||6
622966|NCT00270855|1528807|P1|COMPLETED|Overall Study||7
622967|NCT00270855|1528806|P2|STARTED|Overall Study||14
622968|NCT00270855|1528807|P1|STARTED|Overall Study||15
622969|NCT00270842|1528866|P3|NOT COMPLETED|Overall Study||16
622970|NCT00270842|1528867|P2|NOT COMPLETED|Overall Study||16
622971|NCT00270842|1528868|P1|NOT COMPLETED|Overall Study||15
622972|NCT00270842|1528866|P3|COMPLETED|Overall Study||18
622973|NCT00270842|1528867|P2|COMPLETED|Overall Study||18
622974|NCT00270842|1528868|P1|COMPLETED|Overall Study||18
622975|NCT00270842|1528866|P3|STARTED|Overall Study||34
622976|NCT00270842|1528867|P2|STARTED|Overall Study||34
622977|NCT00270842|1528868|P1|STARTED|Overall Study||33
622978|NCT00270790|1528879|P1|NOT COMPLETED|Overall Study||5
622979|NCT00270790|1528879|P1|COMPLETED|Overall Study||16
622980|NCT00270790|1528879|P1|STARTED|Overall Study||21
622981|NCT00270634|1528888|P4|NOT COMPLETED|Overall Study||5
622982|NCT00270634|1528889|P3|NOT COMPLETED|Overall Study||22
622983|NCT00270634|1528890|P2|NOT COMPLETED|Overall Study||13
622984|NCT00270634|1528891|P1|NOT COMPLETED|Overall Study||17
622985|NCT00270634|1528888|P4|COMPLETED|Overall Study||81
622986|NCT00270634|1528889|P3|COMPLETED|Overall Study||62
622987|NCT00270634|1528890|P2|COMPLETED|Overall Study||64
622988|NCT00270634|1528891|P1|COMPLETED|Overall Study||70
622989|NCT00270634|1528888|P4|STARTED|Overall Study||86
622990|NCT00270634|1528889|P3|STARTED|Overall Study||84
622991|NCT00270634|1528890|P2|STARTED|Overall Study||77
622992|NCT00270634|1528891|P1|STARTED|Overall Study||87
622993|NCT00270296|1528928|P3|NOT COMPLETED|Overall Study||61
622994|NCT00270296|1528929|P2|NOT COMPLETED|Overall Study||90
622995|NCT00270296|1528930|P1|NOT COMPLETED|Overall Study||99
622996|NCT00270296|1528928|P3|COMPLETED|Overall Study||109
622997|NCT00270296|1528929|P2|COMPLETED|Overall Study||185
622998|NCT00270296|1528930|P1|COMPLETED|Overall Study||186
622999|NCT00270296|1528928|P3|STARTED|Overall Study||170
623000|NCT00270296|1528929|P2|STARTED|Overall Study||275
623001|NCT00270296|1528930|P1|STARTED|Overall Study||285
623002|NCT00270257|1528943|P2|NOT COMPLETED|Overall Study||424
623003|NCT00270257|1528944|P1|NOT COMPLETED|Overall Study||412
623004|NCT00270257|1528943|P2|COMPLETED|Overall Study||204
623005|NCT00270257|1528944|P1|COMPLETED|Overall Study||211
623006|NCT00270257|1528943|P2|Visit 104|Overall Study||204
623007|NCT00270257|1528944|P1|Visit 104|Overall Study||211
623008|NCT00270257|1528943|P2|Week 78|Overall Study||285
623009|NCT00270257|1528944|P1|Week 78|Overall Study||283
623010|NCT00270257|1528943|P2|Week 52|Overall Study||340
623011|NCT00270257|1528944|P1|Week 52|Overall Study||362
623012|NCT00270257|1528943|P2|Week 26|Overall Study||440
623013|NCT00270257|1528944|P1|Week 26|Overall Study||460
623014|NCT00270257|1528943|P2|Week 8|Overall Study||443
623015|NCT00270257|1528944|P1|Week 8|Overall Study||510
623016|NCT00270257|1528943|P2|STARTED|Overall Study|1 excluded from analysis (enrollment date exceeded eligibility window by 13 days)|628
623017|NCT00270257|1528944|P1|STARTED|Overall Study||623
623018|NCT00270231|1528962|P2|NOT COMPLETED|Second Intervention||1
623019|NCT00270231|1528963|P1|NOT COMPLETED|Second Intervention||0
623020|NCT00270231|1528962|P2|COMPLETED|Second Intervention||30
623021|NCT00270231|1528963|P1|COMPLETED|Second Intervention||30
623022|NCT00270231|1528962|P2|STARTED|Second Intervention||31
623023|NCT00270231|1528963|P1|STARTED|Second Intervention||30
623024|NCT00270231|1528962|P2|NOT COMPLETED|Washout Period||0
623025|NCT00270231|1528963|P1|NOT COMPLETED|Washout Period||1
623026|NCT00270231|1528962|P2|COMPLETED|Washout Period||31
623027|NCT00270231|1528963|P1|COMPLETED|Washout Period||30
623028|NCT00270231|1528962|P2|STARTED|Washout Period||31
623029|NCT00270231|1528963|P1|STARTED|Washout Period||31
623030|NCT00270231|1528962|P2|NOT COMPLETED|First Intervention||1
623031|NCT00270231|1528963|P1|NOT COMPLETED|First Intervention||1
623032|NCT00270231|1528962|P2|COMPLETED|First Intervention||31
623033|NCT00270231|1528963|P1|COMPLETED|First Intervention||31
623034|NCT00270231|1528962|P2|STARTED|First Intervention||32
623035|NCT00270231|1528963|P1|STARTED|First Intervention||32
623036|NCT00270205|1528973|P4|NOT COMPLETED|Overall Study||1
623037|NCT00270205|1528974|P3|NOT COMPLETED|Overall Study||0
623038|NCT00270205|1528975|P2|NOT COMPLETED|Overall Study||0
623039|NCT00270205|1528976|P1|NOT COMPLETED|Overall Study||1
623040|NCT00270205|1528973|P4|COMPLETED|Overall Study||6
623041|NCT00270205|1528974|P3|COMPLETED|Overall Study||6
623042|NCT00270205|1528975|P2|COMPLETED|Overall Study||6
623043|NCT00270205|1528976|P1|COMPLETED|Overall Study||5
623044|NCT00270205|1528973|P4|STARTED|Overall Study||7
623045|NCT00270205|1528974|P3|STARTED|Overall Study||6
623046|NCT00270205|1528975|P2|STARTED|Overall Study|7 participants enrolled. One never started study vaccination and was excluded from all analyses.|6
623047|NCT00270205|1528976|P1|STARTED|Overall Study||6
623048|NCT00269919|1529094|P1|NOT COMPLETED|Overall Study||27
623049|NCT00269919|1529094|P1|COMPLETED|Overall Study||13
623050|NCT00269919|1529094|P1|Treated|Overall Study||39
623051|NCT00269919|1529094|P1|STARTED|Overall Study||40
623052|NCT00269633|1529113|P2|NOT COMPLETED|Overall Study||0
623053|NCT00269633|1529114|P1|NOT COMPLETED|Overall Study||1
623054|NCT00269633|1529113|P2|COMPLETED|Overall Study||5
623055|NCT00269633|1529114|P1|COMPLETED|Overall Study||3
623056|NCT00269633|1529113|P2|STARTED|Overall Study||5
623057|NCT00269633|1529114|P1|STARTED|Overall Study||4
623058|NCT00269477|1529124|P4|NOT COMPLETED|Overall Study||0
623059|NCT00269477|1529125|P3|NOT COMPLETED|Overall Study||1
623060|NCT00269477|1529126|P2|NOT COMPLETED|Overall Study||6
623061|NCT00269477|1529127|P1|NOT COMPLETED|Overall Study||5
623062|NCT00269477|1529124|P4|COMPLETED|Overall Study||60
623063|NCT00269477|1529125|P3|COMPLETED|Overall Study||57
623064|NCT00269477|1529126|P2|COMPLETED|Overall Study||12
623065|NCT00269477|1529127|P1|COMPLETED|Overall Study||4
623066|NCT00269477|1529124|P4|STARTED|Overall Study||60
623067|NCT00269477|1529125|P3|STARTED|Overall Study||58
623068|NCT00269477|1529126|P2|STARTED|Overall Study||18
623069|NCT00269477|1529127|P1|STARTED|Overall Study||9
623070|NCT00269152|1529143|P2|NOT COMPLETED|Overall Study||10
623071|NCT00269152|1529144|P1|NOT COMPLETED|Overall Study||18
623072|NCT00269152|1529143|P2|COMPLETED|Overall Study||49
623073|NCT00269152|1529144|P1|COMPLETED|Overall Study||45
623074|NCT00269152|1529143|P2|STARTED|Overall Study|4 were randomized without receiving any study drug.|59
623075|NCT00269152|1529144|P1|STARTED|Overall Study|One participant in Pemetrexed+Carboplatin actually received Pemetrexed+Cisplatin|63
623076|NCT00269113|1529160|P2|NOT COMPLETED|Overall Study||37
623077|NCT00269113|1529161|P1|NOT COMPLETED|Overall Study||74
623078|NCT00269113|1529160|P2|COMPLETED|Overall Study||146
623079|NCT00269113|1529161|P1|COMPLETED|Overall Study||103
623080|NCT00269113|1529160|P2|STARTED|Overall Study||183
623081|NCT00269113|1529161|P1|STARTED|Overall Study||177
623082|NCT00268996|1529181|P2|NOT COMPLETED|Overall Study||20
623083|NCT00268996|1529182|P1|NOT COMPLETED|Overall Study||21
623084|NCT00268996|1529181|P2|COMPLETED|Overall Study||152
623085|NCT00268996|1529182|P1|COMPLETED|Overall Study||130
623086|NCT00268996|1529181|P2|STARTED|Overall Study||172
623087|NCT00268996|1529182|P1|STARTED|Overall Study||151
623088|NCT00268983|1529226|P2|NOT COMPLETED|Overall Study||0
623089|NCT00268983|1529227|P1|NOT COMPLETED|Overall Study||3
623090|NCT00268983|1529226|P2|COMPLETED|Overall Study||8
623091|NCT00268983|1529227|P1|COMPLETED|Overall Study||3
623092|NCT00268983|1529226|P2|STARTED|Overall Study||8
623093|NCT00268983|1529227|P1|STARTED|Overall Study||6
623094|NCT00268905|1529270|P3|NOT COMPLETED|Overall Study||12
623095|NCT00268905|1529271|P2|NOT COMPLETED|Overall Study||9
623096|NCT00268905|1529272|P1|NOT COMPLETED|Overall Study||43
623097|NCT00268905|1529270|P3|COMPLETED|Overall Study||0
623098|NCT00268905|1529271|P2|COMPLETED|Overall Study||0
623099|NCT00268905|1529272|P1|COMPLETED|Overall Study||0
623100|NCT00268905|1529270|P3|STARTED|Overall Study||12
623101|NCT00268905|1529271|P2|STARTED|Overall Study||9
623102|NCT00268905|1529272|P1|STARTED|Overall Study||43
623103|NCT00268892|1529289|P3|NOT COMPLETED|Overall Study||39
623104|NCT00268892|1529290|P2|NOT COMPLETED|Overall Study||42
623105|NCT00268892|1529291|P1|NOT COMPLETED|Overall Study||39
623106|NCT00268892|1529289|P3|COMPLETED|Overall Study||54
623107|NCT00268892|1529290|P2|COMPLETED|Overall Study||53
623108|NCT00268892|1529291|P1|COMPLETED|Overall Study||51
623109|NCT00268892|1529289|P3|Switched to Higher Dose|Overall Study||76
623110|NCT00268892|1529290|P2|Switched to Higher Dose|Overall Study||68
623111|NCT00268892|1529291|P1|Switched to Higher Dose|Overall Study||59
623112|NCT00268892|1529289|P3|STARTED|Overall Study||93
623113|NCT00268892|1529290|P2|STARTED|Overall Study||95
623114|NCT00268892|1529291|P1|STARTED|Overall Study||90
623115|NCT00268762|1529302|P1|NOT COMPLETED|Overall Study||0
623116|NCT00268762|1529302|P1|COMPLETED|Overall Study||65
623117|NCT00268762|1529302|P1|STARTED|Overall Study||65
623118|NCT00268463|1529310|P2|NOT COMPLETED|Overall Study||12
623119|NCT00268463|1529311|P1|NOT COMPLETED|Overall Study||10
623120|NCT00268463|1529310|P2|COMPLETED|Overall Study||0
623121|NCT00268463|1529311|P1|COMPLETED|Overall Study||0
623122|NCT00268463|1529310|P2|STARTED|Overall Study||12
623123|NCT00268463|1529311|P1|STARTED|Overall Study||10
623124|NCT00268437|1529317|P1|NOT COMPLETED|Overall Study||1
623125|NCT00268437|1529317|P1|COMPLETED|Overall Study||26
623126|NCT00268437|1529317|P1|STARTED|Overall Study||27
623127|NCT00268346|1529324|P2|NOT COMPLETED|Overall Study||3
623128|NCT00268346|1529325|P1|NOT COMPLETED|Overall Study||0
623129|NCT00268346|1529324|P2|COMPLETED|Overall Study||37
623130|NCT00268346|1529325|P1|COMPLETED|Overall Study||18
623131|NCT00268346|1529324|P2|Started Treatment|Overall Study||40
623132|NCT00268346|1529325|P1|Started Treatment|Overall Study||18
623133|NCT00268346|1529324|P2|STARTED|Overall Study||40
623134|NCT00268346|1529325|P1|STARTED|Overall Study||18
623135|NCT00268242|1529331|P1|NOT COMPLETED|Overall Study||1
623136|NCT00268242|1529331|P1|COMPLETED|Overall Study||23
623137|NCT00268242|1529331|P1|STARTED|Overall Study||24
623138|NCT00268203|1529340|P1|NOT COMPLETED|Overall Study||647
623139|NCT00268203|1529340|P1|COMPLETED|Overall Study|These participants completed 10 years of follow-up.|118
623140|NCT00268203|1529340|P1|Completed 2 Years of Follow-up|Overall Study||62
623141|NCT00268203|1529340|P1|STARTED|Overall Study||765
623142|NCT00267969|1529354|P7|NOT COMPLETED|After Controlled Period||72
623143|NCT00267969|1529355|P6|NOT COMPLETED|After Controlled Period||82
623144|NCT00267969|1529356|P5|NOT COMPLETED|After Controlled Period||35
623145|NCT00267969|1529357|P4|NOT COMPLETED|After Controlled Period||36
623146|NCT00267969|1529358|P3|NOT COMPLETED|After Controlled Period||0
623147|NCT00267969|1529359|P2|NOT COMPLETED|After Controlled Period||0
623148|NCT00267969|1529360|P1|NOT COMPLETED|After Controlled Period||0
623149|NCT00267969|1529354|P7|COMPLETED|After Controlled Period||173
623150|NCT00267969|1529355|P6|COMPLETED|After Controlled Period||172
623151|NCT00267969|1529356|P5|COMPLETED|After Controlled Period||85
623152|NCT00267969|1529357|P4|COMPLETED|After Controlled Period||87
623153|NCT00267969|1529358|P3|COMPLETED|After Controlled Period||0
623154|NCT00267969|1529359|P2|COMPLETED|After Controlled Period||0
623155|NCT00267969|1529360|P1|COMPLETED|After Controlled Period||0
623156|NCT00267969|1529354|P7|STARTED|After Controlled Period||245
623157|NCT00267969|1529355|P6|STARTED|After Controlled Period||254
623158|NCT00267969|1529356|P5|STARTED|After Controlled Period||120
623159|NCT00267969|1529357|P4|STARTED|After Controlled Period||123
623160|NCT00267969|1529358|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
623161|NCT00267969|1529359|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
623162|NCT00267969|1529360|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
623163|NCT00267969|1529354|P7|NOT COMPLETED|Controlled Period||0
623164|NCT00267969|1529355|P6|NOT COMPLETED|Controlled Period||0
623165|NCT00267969|1529356|P5|NOT COMPLETED|Controlled Period||0
623166|NCT00267969|1529357|P4|NOT COMPLETED|Controlled Period||0
623167|NCT00267969|1529358|P3|NOT COMPLETED|Controlled Period||11
623168|NCT00267969|1529359|P2|NOT COMPLETED|Controlled Period||1
623169|NCT00267969|1529360|P1|NOT COMPLETED|Controlled Period||12
623170|NCT00267969|1529354|P7|COMPLETED|Controlled Period||0
623171|NCT00267969|1529355|P6|COMPLETED|Controlled Period||0
623172|NCT00267969|1529356|P5|COMPLETED|Controlled Period||0
623173|NCT00267969|1529357|P4|COMPLETED|Controlled Period||0
623174|NCT00267969|1529358|P3|COMPLETED|Controlled Period||245
623175|NCT00267969|1529359|P2|COMPLETED|Controlled Period||254
623176|NCT00267969|1529360|P1|COMPLETED|Controlled Period||243
623177|NCT00267969|1529354|P7|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
623178|NCT00267969|1529355|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
623179|NCT00267969|1529356|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
623180|NCT00267969|1529357|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
623181|NCT00267969|1529358|P3|STARTED|Controlled Period|Number of patients randomized|256
623182|NCT00267969|1529359|P2|STARTED|Controlled Period|Number of patients randomized|255
623183|NCT00267969|1529360|P1|STARTED|Controlled Period|Number of patients randomized|255
623184|NCT00267956|1529386|P4|NOT COMPLETED|After Controlled Period||2
623185|NCT00267956|1529387|P3|NOT COMPLETED|After Controlled Period||5
623186|NCT00267956|1529388|P2|NOT COMPLETED|After Controlled Period||0
623187|NCT00267956|1529389|P1|NOT COMPLETED|After Controlled Period||0
623188|NCT00267956|1529386|P4|COMPLETED|After Controlled Period||70
623189|NCT00267956|1529387|P3|COMPLETED|After Controlled Period||52
623190|NCT00267956|1529388|P2|COMPLETED|After Controlled Period||0
623191|NCT00267956|1529389|P1|COMPLETED|After Controlled Period||0
623192|NCT00267956|1529386|P4|STARTED|After Controlled Period||72
623193|NCT00267956|1529387|P3|STARTED|After Controlled Period||57
623194|NCT00267956|1529388|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
623195|NCT00267956|1529389|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
623196|NCT00267956|1529386|P4|NOT COMPLETED|Controlled Period||0
623197|NCT00267956|1529387|P3|NOT COMPLETED|Controlled Period||0
623198|NCT00267956|1529388|P2|NOT COMPLETED|Controlled Period||4
623199|NCT00267956|1529389|P1|NOT COMPLETED|Controlled Period||13
623200|NCT00267956|1529386|P4|COMPLETED|Controlled Period||0
623201|NCT00267956|1529387|P3|COMPLETED|Controlled Period||0
623202|NCT00267956|1529388|P2|COMPLETED|Controlled Period||72
623203|NCT00267956|1529389|P1|COMPLETED|Controlled Period||57
623204|NCT00267956|1529386|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
623205|NCT00267956|1529387|P3|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
623206|NCT00267956|1529388|P2|STARTED|Controlled Period||76
623207|NCT00267956|1529389|P1|STARTED|Controlled Period||70
623208|NCT00267774|1529409|P2|NOT COMPLETED|Overall Study||0
623209|NCT00267774|1529410|P1|NOT COMPLETED|Overall Study||0
623210|NCT00267774|1529409|P2|COMPLETED|Overall Study||496
623211|NCT00267774|1529410|P1|COMPLETED|Overall Study||509
623212|NCT00267774|1529409|P2|STARTED|Overall Study||496
623213|NCT00267774|1529410|P1|STARTED|Overall Study||509
623214|NCT00267748|1529421|P3|NOT COMPLETED|Randomized Period||132
623215|NCT00267748|1529422|P2|NOT COMPLETED|Randomized Period||127
623216|NCT00267748|1529423|P1|NOT COMPLETED|Randomized Period||0
623217|NCT00267748|1529421|P3|COMPLETED|Randomized Period||14
623218|NCT00267748|1529422|P2|COMPLETED|Randomized Period||19
623219|NCT00267748|1529423|P1|COMPLETED|Randomized Period||0
623220|NCT00267748|1529421|P3|Treated|Randomized Period||143
623221|NCT00267748|1529422|P2|Treated|Randomized Period||146
623222|NCT00267748|1529423|P1|Treated|Randomized Period||0
623223|NCT00267748|1529421|P3|STARTED|Randomized Period||146
623224|NCT00267748|1529422|P2|STARTED|Randomized Period||146
623225|NCT00267748|1529423|P1|STARTED|Randomized Period||0
623226|NCT00267748|1529421|P3|NOT COMPLETED|Non-randomized Period||0
623227|NCT00267748|1529422|P2|NOT COMPLETED|Non-randomized Period||0
623228|NCT00267748|1529423|P1|NOT COMPLETED|Non-randomized Period||23
623229|NCT00267748|1529421|P3|COMPLETED|Non-randomized Period||0
623230|NCT00267748|1529422|P2|COMPLETED|Non-randomized Period||0
623231|NCT00267748|1529423|P1|COMPLETED|Non-randomized Period||2
623232|NCT00267748|1529421|P3|STARTED|Non-randomized Period||0
623233|NCT00267748|1529422|P2|STARTED|Non-randomized Period||0
623234|NCT00267748|1529423|P1|STARTED|Non-randomized Period||25
623235|NCT00267696|1529440|P1|NOT COMPLETED|Overall Study||0
623236|NCT00267696|1529440|P1|COMPLETED|Overall Study||45
623237|NCT00267696|1529440|P1|STARTED|Overall Study||45
623238|NCT00267670|1529447|P2|NOT COMPLETED|Overall Study||0
623239|NCT00267670|1529448|P1|NOT COMPLETED|Overall Study||4
623240|NCT00267670|1529447|P2|COMPLETED|Overall Study||7
623241|NCT00267670|1529448|P1|COMPLETED|Overall Study||15
623242|NCT00267670|1529447|P2|STARTED|Overall Study||7
623243|NCT00267670|1529448|P1|STARTED|Overall Study||19
623244|NCT00267644|1529462|P2|NOT COMPLETED|Overall Study||0
623245|NCT00267644|1529463|P1|NOT COMPLETED|Overall Study||0
623246|NCT00267644|1529462|P2|COMPLETED|Overall Study||63
623247|NCT00267644|1529463|P1|COMPLETED|Overall Study||13
623248|NCT00267644|1529462|P2|STARTED|Overall Study||63
623249|NCT00267644|1529463|P1|STARTED|Overall Study||13
623250|NCT00267631|1529473|P2|NOT COMPLETED|Overall Study||0
623251|NCT00267631|1529474|P1|NOT COMPLETED|Overall Study||0
623252|NCT00267631|1529473|P2|COMPLETED|Overall Study||3031
623253|NCT00267631|1529474|P1|COMPLETED|Overall Study||2361
623254|NCT00267631|1529473|P2|STARTED|Overall Study||3031
623255|NCT00267631|1529474|P1|STARTED|Overall Study||2361
623256|NCT00267488|1529480|P1|NOT COMPLETED|Overall Study||11
623257|NCT00267488|1529480|P1|COMPLETED|Overall Study||26
623258|NCT00267488|1529480|P1|STARTED|Overall Study||37
623259|NCT00267293|1529492|P3|NOT COMPLETED|Overall Study||0
623260|NCT00267293|1529493|P2|NOT COMPLETED|Overall Study||0
623261|NCT00267293|1529494|P1|NOT COMPLETED|Overall Study||0
623262|NCT00267293|1529492|P3|COMPLETED|Overall Study||20
623263|NCT00267293|1529493|P2|COMPLETED|Overall Study||20
623264|NCT00267293|1529494|P1|COMPLETED|Overall Study||20
623265|NCT00267293|1529492|P3|STARTED|Overall Study||20
623266|NCT00267293|1529493|P2|STARTED|Overall Study||20
623267|NCT00267293|1529494|P1|STARTED|Overall Study||20
623268|NCT00267202|1529504|P2|NOT COMPLETED|Overall Study||34
623269|NCT00267202|1529505|P1|NOT COMPLETED|Overall Study||53
623270|NCT00267202|1529504|P2|COMPLETED|Overall Study||105
623271|NCT00267202|1529505|P1|COMPLETED|Overall Study||83
623272|NCT00267202|1529504|P2|STARTED|Overall Study||139
623273|NCT00267202|1529505|P1|STARTED|Overall Study||136
623274|NCT00267189|1529526|P2|NOT COMPLETED|Overall Study||1
623275|NCT00267189|1529527|P1|NOT COMPLETED|Overall Study||5
623276|NCT00267189|1529526|P2|COMPLETED|Overall Study||72
623277|NCT00267189|1529527|P1|COMPLETED|Overall Study|"Completed indicates completed study."|67
623278|NCT00267189|1529526|P2|Completed Study Medication|Overall Study||72
623279|NCT00267189|1529527|P1|Completed Study Medication|Overall Study||54
623280|NCT00267189|1529526|P2|STARTED|Overall Study||73
623281|NCT00267189|1529527|P1|STARTED|Overall Study|Intention to treat (ITT) population.|72
623282|NCT00267150|1529537|P1|NOT COMPLETED|Overall Study||1
623283|NCT00267150|1529537|P1|COMPLETED|Overall Study||30
623284|NCT00267150|1529537|P1|STARTED|Overall Study||31
623285|NCT00267111|1529544|P2|NOT COMPLETED|Overall Study||0
623286|NCT00267111|1529545|P1|NOT COMPLETED|Overall Study||0
623287|NCT00267111|1529544|P2|COMPLETED|Overall Study||55
623288|NCT00267111|1529545|P1|COMPLETED|Overall Study||55
623289|NCT00267111|1529544|P2|STARTED|Overall Study||55
623290|NCT00267111|1529545|P1|STARTED|Overall Study||55
623291|NCT00267098|1529561|P8|NOT COMPLETED|Overall Study||15
623292|NCT00267098|1529562|P7|NOT COMPLETED|Overall Study||46
623293|NCT00267098|1529563|P6|NOT COMPLETED|Overall Study||40
623294|NCT00267098|1529564|P5|NOT COMPLETED|Overall Study||37
623295|NCT00267098|1529565|P4|NOT COMPLETED|Overall Study||106
623296|NCT00267098|1529566|P3|NOT COMPLETED|Overall Study||94
623297|NCT00267098|1529567|P2|NOT COMPLETED|Overall Study||51
623298|NCT00267098|1529568|P1|NOT COMPLETED|Overall Study||109
623299|NCT00267098|1529561|P8|COMPLETED|Overall Study||5
623300|NCT00267098|1529562|P7|COMPLETED|Overall Study||55
623301|NCT00267098|1529563|P6|COMPLETED|Overall Study||66
623302|NCT00267098|1529564|P5|COMPLETED|Overall Study||10
623303|NCT00267098|1529565|P4|COMPLETED|Overall Study||135
623304|NCT00267098|1529566|P3|COMPLETED|Overall Study||149
623305|NCT00267098|1529567|P2|COMPLETED|Overall Study||0
623306|NCT00267098|1529568|P1|COMPLETED|Overall Study||0
623307|NCT00267098|1529561|P8|STARTED|Overall Study||20
623308|NCT00267098|1529562|P7|STARTED|Overall Study||101
623309|NCT00267098|1529563|P6|STARTED|Overall Study||106
623310|NCT00267098|1529564|P5|STARTED|Overall Study||47
623311|NCT00267098|1529565|P4|STARTED|Overall Study||241
623312|NCT00267098|1529566|P3|STARTED|Overall Study||243
623313|NCT00267098|1529567|P2|STARTED|Overall Study||51
623314|NCT00267098|1529568|P1|STARTED|Overall Study||109
623315|NCT00267085|1529701|P1|NOT COMPLETED|Overall Study||0
623316|NCT00267085|1529701|P1|COMPLETED|Overall Study||10
623317|NCT00267085|1529701|P1|STARTED|Overall Study||10
623318|NCT00267059|1529705|P1|NOT COMPLETED|Overall Study||0
623319|NCT00267059|1529705|P1|COMPLETED|Overall Study||44
623320|NCT00267059|1529705|P1|STARTED|Overall Study||44
623321|NCT00267046|1529711|P2|NOT COMPLETED|Overall Study||11
623322|NCT00267046|1529712|P1|NOT COMPLETED|Overall Study||12
623323|NCT00267046|1529711|P2|COMPLETED|Overall Study||5
623324|NCT00267046|1529712|P1|COMPLETED|Overall Study||20
623325|NCT00267046|1529711|P2|STARTED|Overall Study||16
623326|NCT00267046|1529712|P1|STARTED|Overall Study||32
623327|NCT00267007|1529722|P2|NOT COMPLETED|Overall Study||1
623328|NCT00267007|1529723|P1|NOT COMPLETED|Overall Study||8
623329|NCT00267007|1529722|P2|COMPLETED|Overall Study||10
623330|NCT00267007|1529723|P1|COMPLETED|Overall Study||11
623331|NCT00267007|1529722|P2|STARTED|Overall Study||11
623332|NCT00267007|1529723|P1|STARTED|Overall Study|2 additional patients were randomized but never received study medication and no data were collected|19
623333|NCT00266877|1529734|P3|NOT COMPLETED|Overall Study||28
623334|NCT00266877|1529735|P2|NOT COMPLETED|Overall Study||48
623335|NCT00266877|1529736|P1|NOT COMPLETED|Overall Study||91
623336|NCT00266877|1529734|P3|COMPLETED|Overall Study||0
623337|NCT00266877|1529735|P2|COMPLETED|Overall Study||0
623338|NCT00266877|1529736|P1|COMPLETED|Overall Study||0
623339|NCT00266877|1529734|P3|STARTED|Overall Study||28
623340|NCT00266877|1529735|P2|STARTED|Overall Study||48
623341|NCT00266877|1529736|P1|STARTED|Overall Study||91
623342|NCT00266864|1529755|P2|NOT COMPLETED|Overall Study||2
623343|NCT00266864|1529756|P1|NOT COMPLETED|Overall Study||5
623344|NCT00266864|1529755|P2|COMPLETED|Overall Study||11
623345|NCT00266864|1529756|P1|COMPLETED|Overall Study||13
623346|NCT00266864|1529755|P2|STARTED|Overall Study||13
623347|NCT00266864|1529756|P1|STARTED|Overall Study||18
623348|NCT00266825|1529765|P2|NOT COMPLETED|Completed Follow-Up||24
623349|NCT00266825|1529766|P1|NOT COMPLETED|Completed Follow-Up||25
623350|NCT00266825|1529765|P2|COMPLETED|Completed Follow-Up||154
623351|NCT00266825|1529766|P1|COMPLETED|Completed Follow-Up||147
623352|NCT00266825|1529765|P2|STARTED|Completed Follow-Up||178
623353|NCT00266825|1529766|P1|STARTED|Completed Follow-Up||172
623354|NCT00266825|1529765|P2|NOT COMPLETED|Enrolled and Allocated Intervention||0
623355|NCT00266825|1529766|P1|NOT COMPLETED|Enrolled and Allocated Intervention||0
623356|NCT00266825|1529765|P2|COMPLETED|Enrolled and Allocated Intervention||178
623357|NCT00266825|1529766|P1|COMPLETED|Enrolled and Allocated Intervention||172
623358|NCT00266825|1529765|P2|STARTED|Enrolled and Allocated Intervention||178
623359|NCT00266825|1529766|P1|STARTED|Enrolled and Allocated Intervention||172
623360|NCT00266812|1529792|P2|NOT COMPLETED|Overall Study||11
623361|NCT00266812|1529793|P1|NOT COMPLETED|Overall Study||21
623362|NCT00266812|1529792|P2|COMPLETED|Overall Study||2
623363|NCT00266812|1529793|P1|COMPLETED|Overall Study||1
623364|NCT00266812|1529792|P2|STARTED|Overall Study||13
623365|NCT00266812|1529793|P1|STARTED|Overall Study||22
623366|NCT00266799|1529801|P2|NOT COMPLETED|Overall Study||34
623367|NCT00266799|1529802|P1|NOT COMPLETED|Overall Study||36
623368|NCT00266799|1529801|P2|COMPLETED|Overall Study||68
623369|NCT00266799|1529802|P1|COMPLETED|Overall Study||62
623370|NCT00266799|1529801|P2|STARTED|Overall Study||102
623371|NCT00266799|1529802|P1|STARTED|Overall Study||98
623372|NCT00266695|1529816|P1|NOT COMPLETED|Overall Study||29
623373|NCT00266695|1529816|P1|COMPLETED|Overall Study||174
623374|NCT00266695|1529816|P1|STARTED|Overall Study||203
623375|NCT00266656|1529828|P2|NOT COMPLETED|Overall Study||13
623376|NCT00266656|1529829|P1|NOT COMPLETED|Overall Study||14
623377|NCT00266656|1529828|P2|COMPLETED|Overall Study||20
623378|NCT00266656|1529829|P1|COMPLETED|Overall Study||22
623379|NCT00266656|1529828|P2|STARTED|Overall Study||33
623380|NCT00266656|1529829|P1|STARTED|Overall Study||36
623381|NCT00266630|1529853|P2|NOT COMPLETED|Overall Study||28
623382|NCT00266630|1529854|P1|NOT COMPLETED|Overall Study||42
623383|NCT00266630|1529853|P2|COMPLETED|Overall Study||11
623384|NCT00266630|1529854|P1|COMPLETED|Overall Study||58
623385|NCT00266630|1529853|P2|STARTED|Overall Study||39
623386|NCT00266630|1529854|P1|STARTED|Overall Study||100
623387|NCT00266409|1529896|P4|NOT COMPLETED|Overall Study||22
623388|NCT00266409|1529897|P3|NOT COMPLETED|Overall Study||17
623389|NCT00266409|1529898|P2|NOT COMPLETED|Overall Study||46
623390|NCT00266409|1529899|P1|NOT COMPLETED|Overall Study||45
623391|NCT00266409|1529896|P4|COMPLETED|Overall Study||49
623392|NCT00266409|1529897|P3|COMPLETED|Overall Study||55
623393|NCT00266409|1529898|P2|COMPLETED|Overall Study||92
623394|NCT00266409|1529899|P1|COMPLETED|Overall Study||92
623395|NCT00266409|1529896|P4|STARTED|Overall Study||71
623396|NCT00266409|1529897|P3|STARTED|Overall Study||72
623397|NCT00266409|1529898|P2|STARTED|Overall Study||138
623398|NCT00266409|1529899|P1|STARTED|Overall Study||137
623399|NCT00266279|1530181|P1|NOT COMPLETED|Overall Study||2
623400|NCT00266279|1530181|P1|COMPLETED|Overall Study||15
623401|NCT00266279|1530181|P1|STARTED|Overall Study||17
623483|NCT00265785|1530333|P1|STARTED|Overall Study||27
623402|NCT00266227|1530187|P3|NOT COMPLETED|Retreatment: Week 48 to Week 72||0
623403|NCT00266227|1530188|P2|NOT COMPLETED|Retreatment: Week 48 to Week 72||42
623404|NCT00266227|1530189|P1|NOT COMPLETED|Retreatment: Week 48 to Week 72||64
623405|NCT00266227|1530187|P3|COMPLETED|Retreatment: Week 48 to Week 72||0
623406|NCT00266227|1530188|P2|COMPLETED|Retreatment: Week 48 to Week 72||92
623407|NCT00266227|1530189|P1|COMPLETED|Retreatment: Week 48 to Week 72||227
623408|NCT00266227|1530187|P3|STARTED|Retreatment: Week 48 to Week 72||0
623409|NCT00266227|1530188|P2|STARTED|Retreatment: Week 48 to Week 72||134
623410|NCT00266227|1530189|P1|STARTED|Retreatment: Week 48 to Week 72||291
623411|NCT00266227|1530187|P3|NOT COMPLETED|Retreatment: Up to Week 48||0
623412|NCT00266227|1530188|P2|NOT COMPLETED|Retreatment: Up to Week 48||23
623413|NCT00266227|1530189|P1|NOT COMPLETED|Retreatment: Up to Week 48||27
623414|NCT00266227|1530187|P3|COMPLETED|Retreatment: Up to Week 48||0
623415|NCT00266227|1530188|P2|COMPLETED|Retreatment: Up to Week 48||134
623416|NCT00266227|1530189|P1|COMPLETED|Retreatment: Up to Week 48||291
623417|NCT00266227|1530187|P3|STARTED|Retreatment: Up to Week 48||0
623418|NCT00266227|1530188|P2|STARTED|Retreatment: Up to Week 48||157
623419|NCT00266227|1530189|P1|STARTED|Retreatment: Up to Week 48||318
623420|NCT00266227|1530187|P3|NOT COMPLETED|Initial Treatment||77
623421|NCT00266227|1530188|P2|NOT COMPLETED|Initial Treatment||0
623422|NCT00266227|1530189|P1|NOT COMPLETED|Initial Treatment||0
623423|NCT00266227|1530187|P3|COMPLETED|Initial Treatment||482
623424|NCT00266227|1530188|P2|COMPLETED|Initial Treatment||0
623425|NCT00266227|1530189|P1|COMPLETED|Initial Treatment||0
623426|NCT00266227|1530187|P3|STARTED|Initial Treatment||559
623427|NCT00266227|1530188|P2|STARTED|Initial Treatment||0
623428|NCT00266227|1530189|P1|STARTED|Initial Treatment||0
623432|NCT00266032|1530241|P3|NOT COMPLETED|Open-label Safety Extension||25
623433|NCT00266032|1530242|P2|NOT COMPLETED|Open-label Safety Extension||14
623434|NCT00266032|1530243|P1|NOT COMPLETED|Open-label Safety Extension||41
623435|NCT00266032|1530241|P3|COMPLETED|Open-label Safety Extension||140
623436|NCT00266032|1530242|P2|COMPLETED|Open-label Safety Extension||115
623437|NCT00266032|1530243|P1|COMPLETED|Open-label Safety Extension||448
623438|NCT00266032|1530241|P3|STARTED|Open-label Safety Extension|21 subjects continued their treatment in second period (safety extension)|165
623439|NCT00266032|1530242|P2|STARTED|Open-label Safety Extension|7 subjects continued their treatment in second period (safety extension)|129
623440|NCT00266032|1530243|P1|STARTED|Open-label Safety Extension|treatment for subjects of all 3 treatment groups in 2nd period, except for 28 in subgroups|489
623441|NCT00266032|1530241|P3|NOT COMPLETED|Treatment||47
623442|NCT00266032|1530242|P2|NOT COMPLETED|Treatment||64
623443|NCT00266032|1530243|P1|NOT COMPLETED|Treatment||111
623444|NCT00266032|1530241|P3|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|192
623445|NCT00266032|1530242|P2|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|172
623446|NCT00266032|1530243|P1|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|580
623447|NCT00266032|1530241|P3|Patients Treated and in FAS|Treatment|FAS|216
623448|NCT00266032|1530242|P2|Patients Treated and in FAS|Treatment|FAS|209
623449|NCT00266032|1530243|P1|Patients Treated and in FAS|Treatment|FAS|642
623450|NCT00266032|1530241|P3|Patients Treated|Treatment||229
623451|NCT00266032|1530242|P2|Patients Treated|Treatment||221
623452|NCT00266032|1530243|P1|Patients Treated|Treatment||684
623453|NCT00266032|1530241|P3|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|239
623454|NCT00266032|1530242|P2|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|236
623455|NCT00266032|1530243|P1|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|691
623456|NCT00265941|1530273|P2|NOT COMPLETED|Overall Study||26
623457|NCT00265941|1530274|P1|NOT COMPLETED|Overall Study||23
623458|NCT00265941|1530273|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|444
623459|NCT00265941|1530274|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|447
623460|NCT00265941|1530273|P2|STARTED|Overall Study||470
623461|NCT00265941|1530274|P1|STARTED|Overall Study||470
623462|NCT00265889|1530306|P1|NOT COMPLETED|Overall Study||5
623463|NCT00265889|1530306|P1|COMPLETED|Overall Study||37
623464|NCT00265889|1530306|P1|Cycle 2: 2nd Regimen/Transplant|Overall Study||37
623465|NCT00265889|1530306|P1|Cycle 1: 1st Regimen/Transplant|Overall Study||37
623466|NCT00265889|1530306|P1|STARTED|Overall Study||42
623467|NCT00265850|1530315|P3|NOT COMPLETED|Overall Study||0
623468|NCT00265850|1530316|P2|NOT COMPLETED|Overall Study||0
623469|NCT00265850|1530317|P1|NOT COMPLETED|Overall Study||0
623470|NCT00265850|1530315|P3|COMPLETED|Overall Study||533
623471|NCT00265850|1530316|P2|COMPLETED|Overall Study||902
623472|NCT00265850|1530317|P1|COMPLETED|Overall Study||899
623473|NCT00265850|1530315|P3|STARTED|Overall Study||533
623474|NCT00265850|1530316|P2|STARTED|Overall Study||902
623475|NCT00265850|1530317|P1|STARTED|Overall Study||899
623476|NCT00265798|1530327|P1|NOT COMPLETED|Overall Study||0
623477|NCT00265798|1530327|P1|COMPLETED|Overall Study||38
623478|NCT00265798|1530327|P1|STARTED|Overall Study||38
623479|NCT00265785|1530333|P1|NOT COMPLETED|Overall Study||27
623480|NCT00265785|1530333|P1|COMPLETED|Overall Study||0
623481|NCT00265785|1530333|P1|Eligible and Began Protocol Treatment|Overall Study||24
623482|NCT00265785|1530333|P1|Eligible|Overall Study||26
623484|NCT00265759|1530346|P4|NOT COMPLETED|Overall Study||9
623485|NCT00265759|1530347|P3|NOT COMPLETED|Overall Study||2
623486|NCT00265759|1530348|P2|NOT COMPLETED|Overall Study||1
623487|NCT00265759|1530349|P1|NOT COMPLETED|Overall Study||0
623488|NCT00265759|1530346|P4|COMPLETED|Overall Study||236
623489|NCT00265759|1530347|P3|COMPLETED|Overall Study||123
623490|NCT00265759|1530348|P2|COMPLETED|Overall Study||127
623491|NCT00265759|1530349|P1|COMPLETED|Overall Study||124
623492|NCT00265759|1530346|P4|STARTED|Overall Study||245
623493|NCT00265759|1530347|P3|STARTED|Overall Study||125
623494|NCT00265759|1530348|P2|STARTED|Overall Study||128
623495|NCT00265759|1530349|P1|STARTED|Overall Study||124
623496|NCT00265616|1530380|P2|NOT COMPLETED|Overall Study||0
623497|NCT00265616|1530381|P1|NOT COMPLETED|Overall Study||0
623498|NCT00265616|1530380|P2|COMPLETED|Overall Study||9
623499|NCT00265616|1530381|P1|COMPLETED|Overall Study||14
623500|NCT00265616|1530380|P2|STARTED|Overall Study||9
623501|NCT00265616|1530381|P1|STARTED|Overall Study||14
623502|NCT00265512|1530399|P2|NOT COMPLETED|Overall Study||95
623503|NCT00265512|1530400|P1|NOT COMPLETED|Overall Study||45
623504|NCT00265512|1530399|P2|COMPLETED|Overall Study||359
623505|NCT00265512|1530400|P1|COMPLETED|Overall Study||168
623506|NCT00265512|1530399|P2|STARTED|Overall Study||454
623507|NCT00265512|1530400|P1|STARTED|Overall Study||213
623508|NCT00265473|1530406|P1|NOT COMPLETED|Overall Study||0
623509|NCT00265473|1530406|P1|COMPLETED|Overall Study||5
623510|NCT00265473|1530406|P1|STARTED|Overall Study||5
623511|NCT00265395|1530416|P2|NOT COMPLETED|Overall Study||17
623512|NCT00265395|1530417|P1|NOT COMPLETED|Overall Study||8
623513|NCT00265395|1530416|P2|COMPLETED|Overall Study||56
623514|NCT00265395|1530417|P1|COMPLETED|Overall Study||78
623515|NCT00265395|1530416|P2|STARTED|Overall Study||73
623516|NCT00265395|1530417|P1|STARTED|Overall Study||86
623517|NCT00265382|1530422|P1|NOT COMPLETED|Overall Study||145
623518|NCT00265382|1530422|P1|COMPLETED|Overall Study||76
623519|NCT00265382|1530422|P1|STARTED|Overall Study||221
623520|NCT00265343|1530442|P2|NOT COMPLETED|Overall Study||19
623521|NCT00265343|1530443|P1|NOT COMPLETED|Overall Study||21
623522|NCT00265343|1530442|P2|COMPLETED|Overall Study||153
623523|NCT00265343|1530443|P1|COMPLETED|Overall Study||113
623524|NCT00265343|1530442|P2|STARTED|Overall Study||172
623525|NCT00265343|1530443|P1|STARTED|Overall Study||134
623526|NCT00265330|1530451|P1|NOT COMPLETED|Overall Study||95
623527|NCT00265330|1530451|P1|COMPLETED|Overall Study||67
623528|NCT00265330|1530451|P1|STARTED|Overall Study||162
623529|NCT00265317|1530477|P4|NOT COMPLETED|Phase 2||65
623530|NCT00265317|1530478|P3|NOT COMPLETED|Phase 2||64
623531|NCT00265317|1530479|P2|NOT COMPLETED|Phase 2||0
623532|NCT00265317|1530480|P1|NOT COMPLETED|Phase 2||0
623533|NCT00265317|1530477|P4|COMPLETED|Phase 2||2
623534|NCT00265317|1530478|P3|COMPLETED|Phase 2||1
623535|NCT00265317|1530479|P2|COMPLETED|Phase 2||0
623536|NCT00265317|1530480|P1|COMPLETED|Phase 2||0
623537|NCT00265317|1530477|P4|STARTED|Phase 2||67
623538|NCT00265317|1530478|P3|STARTED|Phase 2||65
623539|NCT00265317|1530479|P2|STARTED|Phase 2||0
623540|NCT00265317|1530480|P1|STARTED|Phase 2||0
623541|NCT00265317|1530477|P4|NOT COMPLETED|Lead-In||0
623542|NCT00265317|1530478|P3|NOT COMPLETED|Lead-In||0
623543|NCT00265317|1530479|P2|NOT COMPLETED|Lead-In||17
623544|NCT00265317|1530480|P1|NOT COMPLETED|Lead-In||12
623545|NCT00265317|1530477|P4|COMPLETED|Lead-In||0
623546|NCT00265317|1530478|P3|COMPLETED|Lead-In||0
623547|NCT00265317|1530479|P2|COMPLETED|Lead-In||0
623548|NCT00265317|1530480|P1|COMPLETED|Lead-In||1
623549|NCT00265317|1530477|P4|STARTED|Lead-In||0
623550|NCT00265317|1530478|P3|STARTED|Lead-In||0
623551|NCT00265317|1530479|P2|STARTED|Lead-In||17
623552|NCT00265317|1530480|P1|STARTED|Lead-In||13
623553|NCT00265239|1530595|P2|NOT COMPLETED|Overall Study||1
623554|NCT00265239|1530596|P1|NOT COMPLETED|Overall Study||2
623555|NCT00265239|1530595|P2|COMPLETED|Overall Study||51
623556|NCT00265239|1530596|P1|COMPLETED|Overall Study||50
623557|NCT00265239|1530595|P2|STARTED|Overall Study||52
623558|NCT00265239|1530596|P1|STARTED|Overall Study||52
623559|NCT00265200|1530608|P1|NOT COMPLETED|Overall Study||4
623560|NCT00265200|1530608|P1|COMPLETED|Overall Study||24
623561|NCT00265200|1530608|P1|STARTED|Overall Study||28
623562|NCT00265122|1530618|P6|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1
623563|NCT00265122|1530619|P5|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||5
623564|NCT00265122|1530620|P4|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4
623565|NCT00265122|1530621|P3|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4
623566|NCT00265122|1530622|P2|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1
623567|NCT00265122|1530623|P1|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||7
623568|NCT00265122|1530618|P6|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||12
623569|NCT00265122|1530619|P5|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||8
623570|NCT00265122|1530620|P4|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||20
623571|NCT00265122|1530621|P3|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||18
623572|NCT00265122|1530622|P2|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||22
623573|NCT00265122|1530623|P1|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||17
623574|NCT00265122|1530618|P6|STARTED|Intervention Period 2 (Weeks 8 to 28):||13
623575|NCT00265122|1530619|P5|STARTED|Intervention Period 2 (Weeks 8 to 28):||13
623576|NCT00265122|1530620|P4|STARTED|Intervention Period 2 (Weeks 8 to 28):||24
623577|NCT00265122|1530621|P3|STARTED|Intervention Period 2 (Weeks 8 to 28):||22
623578|NCT00265122|1530622|P2|STARTED|Intervention Period 2 (Weeks 8 to 28):||23
623579|NCT00265122|1530623|P1|STARTED|Intervention Period 2 (Weeks 8 to 28):||24
623580|NCT00265122|1530618|P6|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||0
623581|NCT00265122|1530619|P5|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||1
623582|NCT00265122|1530620|P4|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
623583|NCT00265122|1530621|P3|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||5
623584|NCT00265122|1530622|P2|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
623585|NCT00265122|1530623|P1|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
623586|NCT00265122|1530618|P6|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13
623587|NCT00265122|1530619|P5|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13
623588|NCT00265122|1530620|P4|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24
623589|NCT00265122|1530621|P3|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||22
623590|NCT00265122|1530622|P2|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||23
623591|NCT00265122|1530623|P1|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24
623592|NCT00265122|1530618|P6|STARTED|Intervention Period 1 (Weeks 0 to 8):||13
623593|NCT00265122|1530619|P5|STARTED|Intervention Period 1 (Weeks 0 to 8):||14
623594|NCT00265122|1530620|P4|STARTED|Intervention Period 1 (Weeks 0 to 8):||26
623595|NCT00265122|1530621|P3|STARTED|Intervention Period 1 (Weeks 0 to 8):||27
623596|NCT00265122|1530622|P2|STARTED|Intervention Period 1 (Weeks 0 to 8):||25
623597|NCT00265122|1530623|P1|STARTED|Intervention Period 1 (Weeks 0 to 8):||26
623598|NCT00265109|1530645|P1|NOT COMPLETED|Overall Study||6
623599|NCT00265109|1530645|P1|COMPLETED|Overall Study||11
623600|NCT00265109|1530645|P1|STARTED|Overall Study||17
623601|NCT00265096|1530652|P3|NOT COMPLETED|Overall Study||39
623602|NCT00265096|1530653|P2|NOT COMPLETED|Overall Study||51
623603|NCT00265096|1530654|P1|NOT COMPLETED|Overall Study||36
623604|NCT00265096|1530652|P3|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|107
623605|NCT00265096|1530653|P2|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|95
623606|NCT00265096|1530654|P1|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|77
623607|NCT00265096|1530652|P3|STARTED|Overall Study||146
623608|NCT00265096|1530653|P2|STARTED|Overall Study||146
623609|NCT00265096|1530654|P1|STARTED|Overall Study||113
623610|NCT00265083|1530686|P3|NOT COMPLETED|Overall Study||42
623611|NCT00265083|1530687|P2|NOT COMPLETED|Overall Study||42
623612|NCT00265083|1530688|P1|NOT COMPLETED|Overall Study||17
623613|NCT00265083|1530686|P3|COMPLETED|Overall Study||98
623614|NCT00265083|1530687|P2|COMPLETED|Overall Study|One patient did not receive study agent.|96
623615|NCT00265083|1530688|P1|COMPLETED|Overall Study||61
623616|NCT00265083|1530686|P3|STARTED|Overall Study||140
623617|NCT00265083|1530687|P2|STARTED|Overall Study|One patient did not receive study agent.|138
623618|NCT00265083|1530688|P1|STARTED|Overall Study||78
623619|NCT00264875|1530709|P1|NOT COMPLETED|Overall Study||30
623620|NCT00264875|1530709|P1|COMPLETED|Overall Study||190
623621|NCT00264875|1530709|P1|STARTED|Overall Study||220
623628|NCT00264810|1530750|P2|NOT COMPLETED|Open Label Evaluation Period||6
623629|NCT00264810|1530751|P1|NOT COMPLETED|Open Label Evaluation Period||6
623630|NCT00264810|1530750|P2|COMPLETED|Open Label Evaluation Period||86
623631|NCT00264810|1530751|P1|COMPLETED|Open Label Evaluation Period||89
623632|NCT00264810|1530750|P2|1-year Post-implant|Open Label Evaluation Period||90
623633|NCT00264810|1530751|P1|1-year Post-implant|Open Label Evaluation Period||92
623634|NCT00264810|1530750|P2|STARTED|Open Label Evaluation Period||92
623635|NCT00264810|1530751|P1|STARTED|Open Label Evaluation Period||95
623636|NCT00264810|1530750|P2|NOT COMPLETED|Blinded Evaluation Period||1
623637|NCT00264810|1530751|P1|NOT COMPLETED|Blinded Evaluation Period||1
623638|NCT00264810|1530750|P2|COMPLETED|Blinded Evaluation Period||92
623639|NCT00264810|1530751|P1|COMPLETED|Blinded Evaluation Period||95
623640|NCT00264810|1530750|P2|STARTED|Blinded Evaluation Period||93
623641|NCT00264810|1530751|P1|STARTED|Blinded Evaluation Period||96
623642|NCT00264810|1530750|P2|NOT COMPLETED|Stimulation Optimization Period||1
623643|NCT00264810|1530751|P1|NOT COMPLETED|Stimulation Optimization Period||1
623644|NCT00264810|1530750|P2|COMPLETED|Stimulation Optimization Period||93
623645|NCT00264810|1530751|P1|COMPLETED|Stimulation Optimization Period||96
623646|NCT00264810|1530750|P2|STARTED|Stimulation Optimization Period||94
623647|NCT00264810|1530751|P1|STARTED|Stimulation Optimization Period||97
623648|NCT00264810|1530750|P2|NOT COMPLETED|Post-Operative Stabilization Period||0
623649|NCT00264810|1530751|P1|NOT COMPLETED|Post-Operative Stabilization Period||0
623650|NCT00264810|1530750|P2|COMPLETED|Post-Operative Stabilization Period||94
623651|NCT00264810|1530751|P1|COMPLETED|Post-Operative Stabilization Period||97
623652|NCT00264810|1530750|P2|STARTED|Post-Operative Stabilization Period|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|94
623653|NCT00264810|1530751|P1|STARTED|Post-Operative Stabilization Period|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|97
623654|NCT00264810|1530750|P2|NOT COMPLETED|Baseline||26
623655|NCT00264810|1530751|P1|NOT COMPLETED|Baseline||23
623656|NCT00264810|1530750|P2|COMPLETED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|94
623657|NCT00264810|1530751|P1|COMPLETED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|97
623658|NCT00264810|1530750|P2|STARTED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|120
623659|NCT00264810|1530751|P1|STARTED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|120
623660|NCT00264797|1530761|P2|NOT COMPLETED|Overall Study||43
623661|NCT00264797|1530762|P1|NOT COMPLETED|Overall Study||33
623662|NCT00264797|1530761|P2|COMPLETED|Overall Study||109
623663|NCT00264797|1530762|P1|COMPLETED|Overall Study||118
623664|NCT00264797|1530761|P2|STARTED|Overall Study||152
623665|NCT00264797|1530762|P1|STARTED|Overall Study||151
623666|NCT00264641|1530776|P2|NOT COMPLETED|Overall Study||0
623667|NCT00264641|1530777|P1|NOT COMPLETED|Overall Study||0
623668|NCT00264641|1530776|P2|COMPLETED|Overall Study||10
623669|NCT00264641|1530777|P1|COMPLETED|Overall Study||10
623670|NCT00264641|1530776|P2|Initiation of the Study|Overall Study||10
623671|NCT00264641|1530777|P1|Initiation of the Study|Overall Study||10
623672|NCT00264641|1530776|P2|STARTED|Overall Study||10
623673|NCT00264641|1530777|P1|STARTED|Overall Study||10
623674|NCT00264576|1530784|P2|NOT COMPLETED|Overall Study||1
623675|NCT00264576|1530785|P1|NOT COMPLETED|Overall Study||1
623676|NCT00264576|1530784|P2|COMPLETED|Overall Study||304
623677|NCT00264576|1530785|P1|COMPLETED|Overall Study||307
623678|NCT00264576|1530784|P2|STARTED|Overall Study||305
623679|NCT00264576|1530785|P1|STARTED|Overall Study||308
623680|NCT00264550|1530809|P4|NOT COMPLETED|Overall Study||30
623681|NCT00264550|1530810|P3|NOT COMPLETED|Overall Study||17
623682|NCT00264550|1530811|P2|NOT COMPLETED|Overall Study||41
623683|NCT00264550|1530812|P1|NOT COMPLETED|Overall Study||43
623684|NCT00264550|1530809|P4|COMPLETED|Overall Study||59
623685|NCT00264550|1530810|P3|COMPLETED|Overall Study||72
623686|NCT00264550|1530811|P2|COMPLETED|Overall Study||92
623687|NCT00264550|1530812|P1|COMPLETED|Overall Study||90
623688|NCT00264550|1530809|P4|STARTED|Overall Study||89
623689|NCT00264550|1530810|P3|STARTED|Overall Study||89
623690|NCT00264550|1530811|P2|STARTED|Overall Study||133
623691|NCT00264550|1530812|P1|STARTED|Overall Study||133
623692|NCT00264537|1530851|P4|NOT COMPLETED|Overall Study||60
623693|NCT00264537|1530852|P3|NOT COMPLETED|Overall Study||50
623694|NCT00264537|1530853|P2|NOT COMPLETED|Overall Study||58
623695|NCT00264537|1530854|P1|NOT COMPLETED|Overall Study||50
623696|NCT00264537|1530851|P4|COMPLETED|Overall Study||99
623697|NCT00264537|1530852|P3|COMPLETED|Overall Study||109
623698|NCT00264537|1530853|P2|COMPLETED|Overall Study||101
623699|NCT00264537|1530854|P1|COMPLETED|Overall Study||110
623700|NCT00264537|1530851|P4|STARTED|Overall Study||159
623701|NCT00264537|1530852|P3|STARTED|Overall Study||159
623702|NCT00264537|1530853|P2|STARTED|Overall Study||159
623703|NCT00264537|1530854|P1|STARTED|Overall Study||160
623704|NCT00264498|1530886|P2|NOT COMPLETED|Crossover Treatment||9
623705|NCT00264498|1530887|P1|NOT COMPLETED|Crossover Treatment||6
623706|NCT00264498|1530886|P2|COMPLETED|Crossover Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
623707|NCT00264498|1530887|P1|COMPLETED|Crossover Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
623708|NCT00264498|1530886|P2|STARTED|Crossover Treatment||9
623709|NCT00264498|1530887|P1|STARTED|Crossover Treatment||6
623710|NCT00264498|1530886|P2|NOT COMPLETED|Randomized Treatment||18
623711|NCT00264498|1530887|P1|NOT COMPLETED|Randomized Treatment||17
623712|NCT00264498|1530886|P2|COMPLETED|Randomized Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
623713|NCT00264498|1530887|P1|COMPLETED|Randomized Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
623714|NCT00264498|1530886|P2|STARTED|Randomized Treatment||18
623715|NCT00264498|1530887|P1|STARTED|Randomized Treatment||17
623716|NCT00264381|1530895|P2|NOT COMPLETED|Overall Study||0
623717|NCT00264381|1530896|P1|NOT COMPLETED|Overall Study||0
623718|NCT00264381|1530895|P2|COMPLETED|Overall Study||37
623719|NCT00264381|1530896|P1|COMPLETED|Overall Study||35
623720|NCT00264381|1530895|P2|STARTED|Overall Study||37
623721|NCT00264381|1530896|P1|STARTED|Overall Study||35
623722|NCT00264303|1530910|P2|NOT COMPLETED|Overall Study||29
623723|NCT00264303|1530911|P1|NOT COMPLETED|Overall Study||25
623724|NCT00264303|1530910|P2|COMPLETED|Overall Study||419
623725|NCT00264303|1530911|P1|COMPLETED|Overall Study||413
623726|NCT00264303|1530910|P2|STARTED|Overall Study||448
623727|NCT00264303|1530911|P1|STARTED|Overall Study||438
623728|NCT00264290|1530929|P2|NOT COMPLETED|Observation (4 Weeks)||0
623729|NCT00264290|1530930|P1|NOT COMPLETED|Observation (4 Weeks)||0
623730|NCT00264290|1530929|P2|COMPLETED|Observation (4 Weeks)||14
623731|NCT00264290|1530930|P1|COMPLETED|Observation (4 Weeks)||15
623732|NCT00264290|1530929|P2|STARTED|Observation (4 Weeks)||14
623733|NCT00264290|1530930|P1|STARTED|Observation (4 Weeks)||15
623734|NCT00264290|1530929|P2|NOT COMPLETED|Intervention (8 Weeks)||0
623735|NCT00264290|1530930|P1|NOT COMPLETED|Intervention (8 Weeks)||1
623736|NCT00264290|1530929|P2|COMPLETED|Intervention (8 Weeks)||14
623737|NCT00264290|1530930|P1|COMPLETED|Intervention (8 Weeks)||15
623738|NCT00264290|1530929|P2|STARTED|Intervention (8 Weeks)||14
623739|NCT00264290|1530930|P1|STARTED|Intervention (8 Weeks)||16
623740|NCT00264238|1530936|P1|NOT COMPLETED|Overall Study||1
623741|NCT00264238|1530936|P1|COMPLETED|Overall Study||14
623742|NCT00264238|1530936|P1|STARTED|Overall Study||15
623743|NCT00264147|1530948|P6|NOT COMPLETED|Treatment II Period||33
623744|NCT00264147|1530949|P5|NOT COMPLETED|Treatment II Period||33
623745|NCT00264147|1530950|P4|NOT COMPLETED|Treatment II Period||0
623746|NCT00264147|1530951|P3|NOT COMPLETED|Treatment II Period||0
623747|NCT00264147|1530952|P2|NOT COMPLETED|Treatment II Period||0
623748|NCT00264147|1530953|P1|NOT COMPLETED|Treatment II Period||0
623749|NCT00264147|1530948|P6|COMPLETED|Treatment II Period||116
623750|NCT00264147|1530949|P5|COMPLETED|Treatment II Period||147
623751|NCT00264147|1530950|P4|COMPLETED|Treatment II Period||0
623752|NCT00264147|1530951|P3|COMPLETED|Treatment II Period||0
623753|NCT00264147|1530952|P2|COMPLETED|Treatment II Period||0
623754|NCT00264147|1530953|P1|COMPLETED|Treatment II Period||0
623755|NCT00264147|1530948|P6|STARTED|Treatment II Period|Etoricoxib 10 mg (34), 30 mg (37), 60 mg (29), and placebo (49) reassigned to diclofenac (149)|149
623756|NCT00264147|1530949|P5|STARTED|Treatment II Period|Etoricoxib 10 mg (38), 30 mg (28), 60 mg (33), 90 mg (45) and placebo (36) reassigned to 90 mg (180)|180
623757|NCT00264147|1530950|P4|STARTED|Treatment II Period||0
623758|NCT00264147|1530951|P3|STARTED|Treatment II Period||0
623759|NCT00264147|1530952|P2|STARTED|Treatment II Period||0
623760|NCT00264147|1530953|P1|STARTED|Treatment II Period||0
623761|NCT00264147|1530948|P6|NOT COMPLETED|Treatment I Period||0
623762|NCT00264147|1530949|P5|NOT COMPLETED|Treatment I Period||56
623763|NCT00264147|1530950|P4|NOT COMPLETED|Treatment I Period||72
623764|NCT00264147|1530951|P3|NOT COMPLETED|Treatment I Period||77
623765|NCT00264147|1530952|P2|NOT COMPLETED|Treatment I Period||83
623766|NCT00264147|1530953|P1|NOT COMPLETED|Treatment I Period||98
623767|NCT00264147|1530948|P6|COMPLETED|Treatment I Period||0
623768|NCT00264147|1530949|P5|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|99
623769|NCT00264147|1530950|P4|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|68
623770|NCT00264147|1530951|P3|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|74
623771|NCT00264147|1530952|P2|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|71
623772|NCT00264147|1530953|P1|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|63
623773|NCT00264147|1530948|P6|STARTED|Treatment I Period||0
623774|NCT00264147|1530949|P5|STARTED|Treatment I Period||155
623775|NCT00264147|1530950|P4|STARTED|Treatment I Period||140
623776|NCT00264147|1530951|P3|STARTED|Treatment I Period||151
623777|NCT00264147|1530952|P2|STARTED|Treatment I Period||154
623778|NCT00264147|1530953|P1|STARTED|Treatment I Period||161
623779|NCT00264004|1530996|P4|NOT COMPLETED|Overall Study||15
623780|NCT00264004|1530997|P3|NOT COMPLETED|Overall Study||14
623781|NCT00264004|1530998|P2|NOT COMPLETED|Overall Study||11
623782|NCT00264004|1530999|P1|NOT COMPLETED|Overall Study||17
623783|NCT00264004|1530996|P4|COMPLETED|Overall Study|Completed 12 weeks treatment|19
623784|NCT00264004|1530997|P3|COMPLETED|Overall Study|Completed 12 weeks treatment|16
623785|NCT00264004|1530998|P2|COMPLETED|Overall Study|Completed 12 weeks treatment|21
623786|NCT00264004|1530999|P1|COMPLETED|Overall Study|Completed 12 weeks treatment|13
623787|NCT00264004|1530996|P4|STARTED|Overall Study|Randomised|34
623788|NCT00264004|1530997|P3|STARTED|Overall Study|Randomised|30
623789|NCT00264004|1530998|P2|STARTED|Overall Study|Randomised|32
623790|NCT00264004|1530999|P1|STARTED|Overall Study|Randomised|30
623791|NCT00263887|1531027|P2|NOT COMPLETED|Overall Study||7
623792|NCT00263887|1531028|P1|NOT COMPLETED|Overall Study||3
623793|NCT00263887|1531027|P2|COMPLETED|Overall Study||32
623794|NCT00263887|1531028|P1|COMPLETED|Overall Study||35
623795|NCT00263887|1531027|P2|STARTED|Overall Study||39
623796|NCT00263887|1531028|P1|STARTED|Overall Study||38
623797|NCT00263757|1531036|P2|NOT COMPLETED|Overall Study||8
623798|NCT00263757|1531037|P1|NOT COMPLETED|Overall Study||8
623799|NCT00263757|1531036|P2|COMPLETED|Overall Study||5
623800|NCT00263757|1531037|P1|COMPLETED|Overall Study||4
623801|NCT00263757|1531036|P2|STARTED|Overall Study||13
623802|NCT00263757|1531037|P1|STARTED|Overall Study||12
623803|NCT00263666|1531049|P2|NOT COMPLETED|Overall Study||11
623804|NCT00263666|1531050|P1|NOT COMPLETED|Overall Study||7
623805|NCT00263666|1531049|P2|COMPLETED|Overall Study||39
623806|NCT00263666|1531050|P1|COMPLETED|Overall Study||43
623807|NCT00263666|1531049|P2|STARTED|Overall Study||50
623808|NCT00263666|1531050|P1|STARTED|Overall Study||50
623809|NCT00263328|1531104|P3|NOT COMPLETED|Overall Study||7
623810|NCT00263328|1531105|P2|NOT COMPLETED|Overall Study||2
623811|NCT00263328|1531106|P1|NOT COMPLETED|Overall Study||8
623812|NCT00263328|1531104|P3|COMPLETED|Overall Study||6
623813|NCT00263328|1531105|P2|COMPLETED|Overall Study||12
623814|NCT00263328|1531106|P1|COMPLETED|Overall Study||10
623815|NCT00263328|1531104|P3|STARTED|Overall Study||13
623816|NCT00263328|1531105|P2|STARTED|Overall Study||14
623817|NCT00263328|1531106|P1|STARTED|Overall Study||18
623818|NCT00263211|1531264|P2|NOT COMPLETED|Overall Study||1
623819|NCT00263211|1531265|P1|NOT COMPLETED|Overall Study||5
623820|NCT00263211|1531264|P2|COMPLETED|Overall Study||23
623821|NCT00263211|1531265|P1|COMPLETED|Overall Study||19
623822|NCT00263211|1531264|P2|STARTED|Overall Study||24
623823|NCT00263211|1531265|P1|STARTED|Overall Study||24
623824|NCT00262964|1531283|P4|NOT COMPLETED|Overall Study||0
623825|NCT00262964|1531284|P3|NOT COMPLETED|Overall Study||0
623826|NCT00262964|1531285|P2|NOT COMPLETED|Overall Study||0
623827|NCT00262964|1531286|P1|NOT COMPLETED|Overall Study||0
623828|NCT00262964|1531283|P4|COMPLETED|Overall Study||12
623829|NCT00262964|1531284|P3|COMPLETED|Overall Study||17
623830|NCT00262964|1531285|P2|COMPLETED|Overall Study||11
623831|NCT00262964|1531286|P1|COMPLETED|Overall Study||11
623832|NCT00262964|1531283|P4|STARTED|Overall Study||12
623833|NCT00262964|1531284|P3|STARTED|Overall Study||17
623834|NCT00262964|1531285|P2|STARTED|Overall Study||11
623835|NCT00262964|1531286|P1|STARTED|Overall Study||11
623836|NCT00262951|1531316|P1|NOT COMPLETED|Overall Study||16
623837|NCT00262951|1531316|P1|COMPLETED|Overall Study||7
623838|NCT00262951|1531316|P1|STARTED|Overall Study||23
623839|NCT00262925|1531321|P1|NOT COMPLETED|Overall Study||11
623840|NCT00262925|1531321|P1|COMPLETED|Overall Study||1
623841|NCT00262925|1531321|P1|STARTED|Overall Study|7 patients were enrolled to step 1, and 5 patients were enrolled to step 2|12
623842|NCT00262873|1531327|P1|NOT COMPLETED|Overall Study||8
623843|NCT00262873|1531327|P1|COMPLETED|Overall Study||0
623844|NCT00262873|1531327|P1|STARTED|Overall Study||8
623845|NCT00262860|1531338|P1|NOT COMPLETED|Overall Study||2
623846|NCT00262860|1531338|P1|COMPLETED|Overall Study||16
623847|NCT00262860|1531338|P1|STARTED|Overall Study||18
623848|NCT00262847|1531347|P3|NOT COMPLETED|Overall Study||396
623849|NCT00262847|1531348|P2|NOT COMPLETED|Overall Study||513
623850|NCT00262847|1531349|P1|NOT COMPLETED|Overall Study||518
623851|NCT00262847|1531347|P3|COMPLETED|Overall Study||227
623852|NCT00262847|1531348|P2|COMPLETED|Overall Study||112
623853|NCT00262847|1531349|P1|COMPLETED|Overall Study||107
623854|NCT00262847|1531347|P3|STARTED|Overall Study|Total enrolled and included in efficacy analysis|623
623855|NCT00262847|1531348|P2|STARTED|Overall Study|Total enrolled and included in efficacy analysis|625
623856|NCT00262847|1531349|P1|STARTED|Overall Study|Total enrolled and included in efficacy analysis|625
623857|NCT00262834|1531368|P2|NOT COMPLETED|Overall Study||4
623858|NCT00262834|1531369|P1|NOT COMPLETED|Overall Study||1
623859|NCT00262834|1531368|P2|COMPLETED|Overall Study||25
623860|NCT00262834|1531369|P1|COMPLETED|Overall Study||24
623861|NCT00262834|1531368|P2|STARTED|Overall Study||29
623862|NCT00262834|1531369|P1|STARTED|Overall Study||25
623863|NCT00262821|1531382|P2|NOT COMPLETED|Overall Study||19
623864|NCT00262821|1531383|P1|NOT COMPLETED|Overall Study||4
623865|NCT00262821|1531382|P2|COMPLETED|Overall Study||185
623866|NCT00262821|1531383|P1|COMPLETED|Overall Study||194
623867|NCT00262821|1531382|P2|STARTED|Overall Study||204
623868|NCT00262821|1531383|P1|STARTED|Overall Study||198
623869|NCT00262743|1531395|P2|NOT COMPLETED|Overall Study||12
623870|NCT00262743|1531396|P1|NOT COMPLETED|Overall Study||0
623871|NCT00262743|1531395|P2|COMPLETED|Overall Study||30
623872|NCT00262743|1531396|P1|COMPLETED|Overall Study||27
623873|NCT00262743|1531395|P2|STARTED|Overall Study||42
623874|NCT00262743|1531396|P1|STARTED|Overall Study||27
623875|NCT00262730|1531403|P1|NOT COMPLETED|Overall Study||0
623876|NCT00262730|1531403|P1|COMPLETED|Overall Study||97
623877|NCT00262730|1531403|P1|STARTED|Overall Study||97
623878|NCT00262639|1531411|P4|NOT COMPLETED|Overall Study||0
623879|NCT00262639|1531412|P3|NOT COMPLETED|Overall Study||0
623880|NCT00262639|1531413|P2|NOT COMPLETED|Overall Study||0
623881|NCT00262639|1531414|P1|NOT COMPLETED|Overall Study||0
623882|NCT00262639|1531411|P4|COMPLETED|Overall Study||7
623883|NCT00262639|1531412|P3|COMPLETED|Overall Study||9
623884|NCT00262639|1531413|P2|COMPLETED|Overall Study||26
623885|NCT00262639|1531414|P1|COMPLETED|Overall Study||18
623886|NCT00262639|1531411|P4|STARTED|Overall Study||7
623887|NCT00262639|1531412|P3|STARTED|Overall Study||9
623888|NCT00262639|1531413|P2|STARTED|Overall Study||26
623889|NCT00262639|1531414|P1|STARTED|Overall Study||18
623890|NCT00262600|1531431|P3|NOT COMPLETED|Overall Study||266
623891|NCT00262600|1531432|P2|NOT COMPLETED|Overall Study||252
623892|NCT00262600|1531433|P1|NOT COMPLETED|Overall Study||235
623893|NCT00262600|1531431|P3|COMPLETED|Overall Study||5756
623894|NCT00262600|1531432|P2|COMPLETED|Overall Study||5824
623895|NCT00262600|1531433|P1|COMPLETED|Overall Study||5780
623896|NCT00262600|1531431|P3|STARTED|Overall Study||6022
623897|NCT00262600|1531432|P2|STARTED|Overall Study||6076
623898|NCT00262600|1531433|P1|STARTED|Overall Study||6015
623899|NCT00262522|1531460|P4|NOT COMPLETED|Study Start Through 96 Weeks||0
623900|NCT00262522|1531461|P3|NOT COMPLETED|Study Start Through 96 Weeks||77
623901|NCT00262522|1531462|P2|NOT COMPLETED|Study Start Through 96 Weeks||0
623902|NCT00262522|1531463|P1|NOT COMPLETED|Study Start Through 96 Weeks||77
623903|NCT00262522|1531460|P4|COMPLETED|Study Start Through 96 Weeks||0
623904|NCT00262522|1531461|P3|COMPLETED|Study Start Through 96 Weeks||254
623905|NCT00262522|1531462|P2|COMPLETED|Study Start Through 96 Weeks||0
623906|NCT00262522|1531463|P1|COMPLETED|Study Start Through 96 Weeks||256
623907|NCT00262522|1531460|P4|STARTED|Study Start Through 96 Weeks|After Week 8, these subjects received the tablet formulation twice daily through the end of study.|0
623908|NCT00262522|1531461|P3|STARTED|Study Start Through 96 Weeks|Number of subjects who started the study, not the number who completed the first 48 weeks.|331
623909|NCT00262522|1531462|P2|STARTED|Study Start Through 96 Weeks|After Week 8, these subjects received the tablet formulation once daily through the end of study.|0
623910|NCT00262522|1531463|P1|STARTED|Study Start Through 96 Weeks|Number of subjects who started the study, not the number who completed the first 48 weeks.|333
623911|NCT00262522|1531460|P4|NOT COMPLETED|Study Start Through 48 Weeks||0
623912|NCT00262522|1531461|P3|NOT COMPLETED|Study Start Through 48 Weeks||55
623913|NCT00262522|1531462|P2|NOT COMPLETED|Study Start Through 48 Weeks||0
623914|NCT00262522|1531463|P1|NOT COMPLETED|Study Start Through 48 Weeks||49
623915|NCT00262522|1531460|P4|COMPLETED|Study Start Through 48 Weeks||0
623916|NCT00262522|1531461|P3|COMPLETED|Study Start Through 48 Weeks||276
623917|NCT00262522|1531462|P2|COMPLETED|Study Start Through 48 Weeks||0
623918|NCT00262522|1531463|P1|COMPLETED|Study Start Through 48 Weeks||284
623919|NCT00262522|1531460|P4|STARTED|Study Start Through 48 Weeks|After Week 8, these subjects received the tablet formulation twice daily through the end of study.|0
623920|NCT00262522|1531461|P3|STARTED|Study Start Through 48 Weeks|Number of subjects who started the study, not the number who completed the first 8 weeks.|331
623921|NCT00262522|1531462|P2|STARTED|Study Start Through 48 Weeks|After Week 8, these subjects received the tablet formulation once daily through the end of study.|0
623922|NCT00262522|1531463|P1|STARTED|Study Start Through 48 Weeks|Number of subjects who started the study, not the number who completed the first 8 weeks.|333
623923|NCT00262522|1531460|P4|NOT COMPLETED|Study Start Through 8 Weeks||5
623924|NCT00262522|1531461|P3|NOT COMPLETED|Study Start Through 8 Weeks||11
623925|NCT00262522|1531462|P2|NOT COMPLETED|Study Start Through 8 Weeks||5
623926|NCT00262522|1531463|P1|NOT COMPLETED|Study Start Through 8 Weeks||4
623927|NCT00262522|1531460|P4|COMPLETED|Study Start Through 8 Weeks||160
623928|NCT00262522|1531461|P3|COMPLETED|Study Start Through 8 Weeks||155
623929|NCT00262522|1531462|P2|COMPLETED|Study Start Through 8 Weeks||161
623930|NCT00262522|1531463|P1|COMPLETED|Study Start Through 8 Weeks||163
623931|NCT00262522|1531460|P4|STARTED|Study Start Through 8 Weeks||165
623932|NCT00262522|1531461|P3|STARTED|Study Start Through 8 Weeks||166
623933|NCT00262522|1531462|P2|STARTED|Study Start Through 8 Weeks||166
623934|NCT00262522|1531463|P1|STARTED|Study Start Through 8 Weeks||167
623935|NCT00262509|1531485|P2|NOT COMPLETED|Overall Study||0
623936|NCT00262509|1531486|P1|NOT COMPLETED|Overall Study||0
623937|NCT00262509|1531485|P2|COMPLETED|Overall Study||9
623938|NCT00262509|1531486|P1|COMPLETED|Overall Study||8
623939|NCT00262509|1531485|P2|STARTED|Overall Study||9
623940|NCT00262509|1531486|P1|STARTED|Overall Study||8
623941|NCT00262314|1531492|P1|NOT COMPLETED|Overall Study||337
623942|NCT00262314|1531492|P1|COMPLETED|Overall Study|Patients in the study for 5 years +/-3 months are considered to have completed the 5-year study|172
623943|NCT00262314|1531492|P1|STARTED|Overall Study|Patients with validated data who received at least 1 dose of Novantrone®|509
623944|NCT00262301|1531510|P3|NOT COMPLETED|Open-label Phase||0
623945|NCT00262301|1531511|P2|NOT COMPLETED|Open-label Phase||0
623946|NCT00262301|1531512|P1|NOT COMPLETED|Open-label Phase||0
623947|NCT00262301|1531510|P3|COMPLETED|Open-label Phase||57
623948|NCT00262301|1531511|P2|COMPLETED|Open-label Phase||0
623949|NCT00262301|1531512|P1|COMPLETED|Open-label Phase||0
623950|NCT00262301|1531510|P3|STARTED|Open-label Phase|"14/57 patients crossed over from the double-blind phase (7/14 were treated with 100 U/kg rhC1INH)"|57
623951|NCT00262301|1531511|P2|STARTED|Open-label Phase||0
623952|NCT00262301|1531512|P1|STARTED|Open-label Phase||0
623953|NCT00262301|1531510|P3|NOT COMPLETED|Double-blind Phase||0
623954|NCT00262301|1531511|P2|NOT COMPLETED|Double-blind Phase||1
623955|NCT00262301|1531512|P1|NOT COMPLETED|Double-blind Phase||1
623956|NCT00262301|1531510|P3|COMPLETED|Double-blind Phase||0
623957|NCT00262301|1531511|P2|COMPLETED|Double-blind Phase||15
623958|NCT00262301|1531512|P1|COMPLETED|Double-blind Phase||15
623959|NCT00262301|1531510|P3|STARTED|Double-blind Phase||0
623960|NCT00262301|1531511|P2|STARTED|Double-blind Phase||16
623961|NCT00262301|1531512|P1|STARTED|Double-blind Phase||16
623962|NCT00262223|1531525|P2|NOT COMPLETED|12-month Post-treatment Follow-up||7
623963|NCT00262223|1531526|P1|NOT COMPLETED|12-month Post-treatment Follow-up||7
623964|NCT00262223|1531525|P2|COMPLETED|12-month Post-treatment Follow-up||22
623965|NCT00262223|1531526|P1|COMPLETED|12-month Post-treatment Follow-up||21
623966|NCT00262223|1531525|P2|STARTED|12-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|29
623967|NCT00262223|1531526|P1|STARTED|12-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|28
623968|NCT00262223|1531525|P2|NOT COMPLETED|6-month Post-treatment Follow-up||1
623969|NCT00262223|1531526|P1|NOT COMPLETED|6-month Post-treatment Follow-up||6
623970|NCT00262223|1531525|P2|COMPLETED|6-month Post-treatment Follow-up||28
623971|NCT00262223|1531526|P1|COMPLETED|6-month Post-treatment Follow-up||22
623972|NCT00262223|1531525|P2|STARTED|6-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|29
623973|NCT00262223|1531526|P1|STARTED|6-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|28
623974|NCT00262223|1531525|P2|NOT COMPLETED|1-week Post-treatment Follow-up||4
623975|NCT00262223|1531526|P1|NOT COMPLETED|1-week Post-treatment Follow-up||4
623976|NCT00262223|1531525|P2|COMPLETED|1-week Post-treatment Follow-up||25
623977|NCT00262223|1531526|P1|COMPLETED|1-week Post-treatment Follow-up||24
623978|NCT00262223|1531525|P2|STARTED|1-week Post-treatment Follow-up||29
623979|NCT00262223|1531526|P1|STARTED|1-week Post-treatment Follow-up||28
623980|NCT00262223|1531525|P2|NOT COMPLETED|Treatment Phase||8
623981|NCT00262223|1531526|P1|NOT COMPLETED|Treatment Phase||4
623982|NCT00262223|1531525|P2|COMPLETED|Treatment Phase||29
623983|NCT00262223|1531526|P1|COMPLETED|Treatment Phase||28
623984|NCT00262223|1531525|P2|STARTED|Treatment Phase||37
623985|NCT00262223|1531526|P1|STARTED|Treatment Phase||32
623986|NCT00262119|1531537|P3|NOT COMPLETED|Overall Study||58
623987|NCT00262119|1531538|P2|NOT COMPLETED|Overall Study||70
623988|NCT00262119|1531539|P1|NOT COMPLETED|Overall Study||58
623989|NCT00262119|1531537|P3|COMPLETED|Overall Study||325
623990|NCT00262119|1531538|P2|COMPLETED|Overall Study||328
623991|NCT00262119|1531539|P1|COMPLETED|Overall Study||327
623992|NCT00262119|1531537|P3|STARTED|Overall Study||383
623993|NCT00262119|1531538|P2|STARTED|Overall Study||398
623994|NCT00262119|1531539|P1|STARTED|Overall Study||385
623995|NCT00262080|1531559|P3|NOT COMPLETED|Repeat Dose Treatment Period||5
623996|NCT00262080|1531560|P2|NOT COMPLETED|Repeat Dose Treatment Period||1
623997|NCT00262080|1531561|P1|NOT COMPLETED|Repeat Dose Treatment Period||4
623998|NCT00262080|1531559|P3|COMPLETED|Repeat Dose Treatment Period||14
623999|NCT00262080|1531560|P2|COMPLETED|Repeat Dose Treatment Period||25
624000|NCT00262080|1531561|P1|COMPLETED|Repeat Dose Treatment Period|Some patients participated in only the double-blind or the open label phase.|18
624001|NCT00262080|1531559|P3|STARTED|Repeat Dose Treatment Period|This arm represents new patients, not treated in the double-blind part of the study.|19
624002|NCT00262080|1531560|P2|STARTED|Repeat Dose Treatment Period|Not all patients treated in the double-blind part came for treatment in the repeat-dose part.|26
624003|NCT00262080|1531561|P1|STARTED|Repeat Dose Treatment Period|Not all patients treated in the double-blind part came for treatment in the repeat-dose part.|22
624004|NCT00262080|1531559|P3|NOT COMPLETED|Double Blind Treatment Period||0
624005|NCT00262080|1531560|P2|NOT COMPLETED|Double Blind Treatment Period||0
624006|NCT00262080|1531561|P1|NOT COMPLETED|Double Blind Treatment Period||1
624007|NCT00262080|1531559|P3|COMPLETED|Double Blind Treatment Period||0
624008|NCT00262080|1531560|P2|COMPLETED|Double Blind Treatment Period||36
624009|NCT00262080|1531561|P1|COMPLETED|Double Blind Treatment Period||35
624010|NCT00262080|1531559|P3|STARTED|Double Blind Treatment Period||0
624011|NCT00262080|1531560|P2|STARTED|Double Blind Treatment Period|One patient was randomized to receive placebo but was treated with ecallantide.|36
624012|NCT00262080|1531561|P1|STARTED|Double Blind Treatment Period|One patient was randomized to receive ecallantide but was treated with placebo.|36
624013|NCT00262067|1531581|P4|NOT COMPLETED|Overall Study||113
624014|NCT00262067|1531582|P3|NOT COMPLETED|Overall Study||216
624015|NCT00262067|1531583|P2|NOT COMPLETED|Overall Study||100
624016|NCT00262067|1531584|P1|NOT COMPLETED|Overall Study||219
624017|NCT00262067|1531581|P4|COMPLETED|Overall Study||93
624018|NCT00262067|1531582|P3|COMPLETED|Overall Study||193
624019|NCT00262067|1531583|P2|COMPLETED|Overall Study||107
624020|NCT00262067|1531584|P1|COMPLETED|Overall Study||196
624021|NCT00262067|1531581|P4|STARTED|Overall Study||206
624022|NCT00262067|1531582|P3|STARTED|Overall Study||409
624023|NCT00262067|1531583|P2|STARTED|Overall Study||207
624024|NCT00262067|1531584|P1|STARTED|Overall Study||415
624025|NCT00262041|1531618|P3|NOT COMPLETED|Overall Study||6
624026|NCT00262041|1531619|P2|NOT COMPLETED|Overall Study||4
624027|NCT00262041|1531620|P1|NOT COMPLETED|Overall Study||2
624028|NCT00262041|1531618|P3|COMPLETED|Overall Study||203
624029|NCT00262041|1531619|P2|COMPLETED|Overall Study||147
624030|NCT00262041|1531620|P1|COMPLETED|Overall Study||162
624031|NCT00262041|1531618|P3|STARTED|Overall Study||209
624032|NCT00262041|1531619|P2|STARTED|Overall Study||151
624033|NCT00262041|1531620|P1|STARTED|Overall Study||164
624034|NCT00262028|1531649|P9|NOT COMPLETED|Overall Study||19
624035|NCT00262028|1531650|P8|NOT COMPLETED|Overall Study||18
624036|NCT00262028|1531651|P7|NOT COMPLETED|Overall Study||12
624037|NCT00262028|1531652|P6|NOT COMPLETED|Overall Study||13
624038|NCT00262028|1531653|P5|NOT COMPLETED|Overall Study||12
624039|NCT00262028|1531654|P4|NOT COMPLETED|Overall Study||23
624040|NCT00262028|1531655|P3|NOT COMPLETED|Overall Study||20
624041|NCT00262028|1531656|P2|NOT COMPLETED|Overall Study||27
624042|NCT00262028|1531657|P1|NOT COMPLETED|Overall Study||24
624043|NCT00262028|1531649|P9|COMPLETED|Overall Study||81
624044|NCT00262028|1531650|P8|COMPLETED|Overall Study||55
624045|NCT00262028|1531651|P7|COMPLETED|Overall Study||59
624046|NCT00262028|1531652|P6|COMPLETED|Overall Study||60
624047|NCT00262028|1531653|P5|COMPLETED|Overall Study||62
624048|NCT00262028|1531654|P4|COMPLETED|Overall Study||134
624049|NCT00262028|1531655|P3|COMPLETED|Overall Study||137
624050|NCT00262028|1531656|P2|COMPLETED|Overall Study||126
624051|NCT00262028|1531657|P1|COMPLETED|Overall Study||128
624052|NCT00262028|1531649|P9|STARTED|Overall Study||100
624053|NCT00262028|1531650|P8|STARTED|Overall Study||73
624054|NCT00262028|1531651|P7|STARTED|Overall Study||71
624055|NCT00262028|1531652|P6|STARTED|Overall Study||73
624056|NCT00262028|1531653|P5|STARTED|Overall Study||74
624057|NCT00262028|1531654|P4|STARTED|Overall Study||157
624058|NCT00262028|1531655|P3|STARTED|Overall Study||157
624059|NCT00262028|1531656|P2|STARTED|Overall Study||153
624060|NCT00262028|1531657|P1|STARTED|Overall Study||152
624061|NCT00262002|1531719|P7|NOT COMPLETED|Overall Study||6
624062|NCT00262002|1531720|P6|NOT COMPLETED|Overall Study||7
624063|NCT00262002|1531721|P5|NOT COMPLETED|Overall Study||7
624064|NCT00262002|1531722|P4|NOT COMPLETED|Overall Study||5
624065|NCT00262002|1531723|P3|NOT COMPLETED|Overall Study||0
624066|NCT00262002|1531724|P2|NOT COMPLETED|Overall Study||6
624067|NCT00262002|1531725|P1|NOT COMPLETED|Overall Study||11
624068|NCT00262002|1531719|P7|COMPLETED|Overall Study||84
624069|NCT00262002|1531720|P6|COMPLETED|Overall Study||83
624070|NCT00262002|1531721|P5|COMPLETED|Overall Study||91
624071|NCT00262002|1531722|P4|COMPLETED|Overall Study||93
624072|NCT00262002|1531723|P3|COMPLETED|Overall Study||45
624073|NCT00262002|1531724|P2|COMPLETED|Overall Study||84
624074|NCT00262002|1531725|P1|COMPLETED|Overall Study||79
624075|NCT00262002|1531719|P7|STARTED|Overall Study||90
624076|NCT00262002|1531720|P6|STARTED|Overall Study||90
624077|NCT00262002|1531721|P5|STARTED|Overall Study||98
624078|NCT00262002|1531722|P4|STARTED|Overall Study||98
624079|NCT00262002|1531723|P3|STARTED|Overall Study||45
624080|NCT00262002|1531724|P2|STARTED|Overall Study||90
624081|NCT00262002|1531725|P1|STARTED|Overall Study||90
624082|NCT00261950|1531818|P1|NOT COMPLETED|Overall Study||26
624083|NCT00261950|1531818|P1|COMPLETED|Overall Study||84
624084|NCT00261950|1531818|P1|STARTED|Overall Study||110
624085|NCT00261846|1531843|P12|NOT COMPLETED|Period 2: Part 2 (Efficacy)||23
624086|NCT00261846|1531844|P11|NOT COMPLETED|Period 2: Part 2 (Efficacy)||49
624087|NCT00261846|1531845|P10|NOT COMPLETED|Period 2: Part 2 (Efficacy)||49
624088|NCT00261846|1531846|P9|NOT COMPLETED|Period 2: Part 2 (Efficacy)||14
624089|NCT00261846|1531847|P8|NOT COMPLETED|Period 2: Part 2 (Efficacy)||29
624090|NCT00261846|1531848|P7|NOT COMPLETED|Period 2: Part 2 (Efficacy)||22
624091|NCT00261846|1531849|P6|NOT COMPLETED|Period 2: Part 2 (Efficacy)||2
624092|NCT00261846|1531850|P5|NOT COMPLETED|Period 2: Part 2 (Efficacy)||50
624093|NCT00261846|1531851|P4|NOT COMPLETED|Period 2: Part 2 (Efficacy)||135
624094|NCT00261846|1531852|P3|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
624095|NCT00261846|1531853|P2|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
624096|NCT00261846|1531854|P1|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
624097|NCT00261846|1531843|P12|COMPLETED|Period 2: Part 2 (Efficacy)||1
624098|NCT00261846|1531844|P11|COMPLETED|Period 2: Part 2 (Efficacy)||15
624099|NCT00261846|1531845|P10|COMPLETED|Period 2: Part 2 (Efficacy)||30
624100|NCT00261846|1531846|P9|COMPLETED|Period 2: Part 2 (Efficacy)||12
624101|NCT00261846|1531847|P8|COMPLETED|Period 2: Part 2 (Efficacy)||21
624102|NCT00261846|1531848|P7|COMPLETED|Period 2: Part 2 (Efficacy)||16
624103|NCT00261846|1531849|P6|COMPLETED|Period 2: Part 2 (Efficacy)||3
624104|NCT00261846|1531850|P5|COMPLETED|Period 2: Part 2 (Efficacy)||39
624105|NCT00261846|1531851|P4|COMPLETED|Period 2: Part 2 (Efficacy)||60
624106|NCT00261846|1531852|P3|COMPLETED|Period 2: Part 2 (Efficacy)||0
624107|NCT00261846|1531853|P2|COMPLETED|Period 2: Part 2 (Efficacy)||0
624108|NCT00261846|1531854|P1|COMPLETED|Period 2: Part 2 (Efficacy)||0
624109|NCT00261846|1531843|P12|STARTED|Period 2: Part 2 (Efficacy)||24
624110|NCT00261846|1531844|P11|STARTED|Period 2: Part 2 (Efficacy)||64
624111|NCT00261846|1531845|P10|STARTED|Period 2: Part 2 (Efficacy)|1 participant from Part 1 (Bosutinib 600mg cohort) continued in Part 2 of the study.|79
624112|NCT00261846|1531846|P9|STARTED|Period 2: Part 2 (Efficacy)||26
624113|NCT00261846|1531847|P8|STARTED|Period 2: Part 2 (Efficacy)||50
624114|NCT00261846|1531848|P7|STARTED|Period 2: Part 2 (Efficacy)||38
624115|NCT00261846|1531849|P6|STARTED|Period 2: Part 2 (Efficacy)||5
624116|NCT00261846|1531850|P5|STARTED|Period 2: Part 2 (Efficacy)||89
624117|NCT00261846|1531851|P4|STARTED|Period 2: Part 2 (Efficacy)|17 participants from Part 1 (Bosutinib 400mg, 500mg, 600mg cohort) continued in Part 2 of the study.|195
624118|NCT00261846|1531852|P3|STARTED|Period 2: Part 2 (Efficacy)||0
624119|NCT00261846|1531853|P2|STARTED|Period 2: Part 2 (Efficacy)||0
624120|NCT00261846|1531854|P1|STARTED|Period 2: Part 2 (Efficacy)||0
624121|NCT00261846|1531843|P12|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
624122|NCT00261846|1531844|P11|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
624123|NCT00261846|1531845|P10|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
624124|NCT00261846|1531846|P9|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
624125|NCT00261846|1531847|P8|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
624126|NCT00261846|1531848|P7|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
624127|NCT00261846|1531849|P6|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
624128|NCT00261846|1531850|P5|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
624129|NCT00261846|1531851|P4|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
624130|NCT00261846|1531852|P3|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||12
624131|NCT00261846|1531853|P2|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||3
624132|NCT00261846|1531854|P1|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||3
624133|NCT00261846|1531843|P12|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
624134|NCT00261846|1531844|P11|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
624135|NCT00261846|1531845|P10|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
624136|NCT00261846|1531846|P9|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
624137|NCT00261846|1531847|P8|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
624138|NCT00261846|1531848|P7|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
624139|NCT00261846|1531849|P6|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
624140|NCT00261846|1531850|P5|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
624141|NCT00261846|1531851|P4|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
624142|NCT00261846|1531852|P3|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
624143|NCT00261846|1531853|P2|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
624144|NCT00261846|1531854|P1|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
624145|NCT00261846|1531843|P12|STARTED|Period 1: Part 1 (Dose Escalation)||0
624146|NCT00261846|1531844|P11|STARTED|Period 1: Part 1 (Dose Escalation)||0
624147|NCT00261846|1531845|P10|STARTED|Period 1: Part 1 (Dose Escalation)||0
624148|NCT00261846|1531846|P9|STARTED|Period 1: Part 1 (Dose Escalation)||0
624149|NCT00261846|1531847|P8|STARTED|Period 1: Part 1 (Dose Escalation)||0
624150|NCT00261846|1531848|P7|STARTED|Period 1: Part 1 (Dose Escalation)||0
624151|NCT00261846|1531849|P6|STARTED|Period 1: Part 1 (Dose Escalation)||0
624152|NCT00261846|1531850|P5|STARTED|Period 1: Part 1 (Dose Escalation)||0
624153|NCT00261846|1531851|P4|STARTED|Period 1: Part 1 (Dose Escalation)||0
624154|NCT00261846|1531852|P3|STARTED|Period 1: Part 1 (Dose Escalation)||12
624155|NCT00261846|1531853|P2|STARTED|Period 1: Part 1 (Dose Escalation)||3
624156|NCT00261846|1531854|P1|STARTED|Period 1: Part 1 (Dose Escalation)||3
624157|NCT00261833|1532113|P2|NOT COMPLETED|Overall Study||18
624158|NCT00261833|1532114|P1|NOT COMPLETED|Overall Study||9
624159|NCT00261833|1532113|P2|COMPLETED|Overall Study||69
624160|NCT00261833|1532114|P1|COMPLETED|Overall Study||84
624161|NCT00261833|1532113|P2|STARTED|Overall Study||87
624162|NCT00261833|1532114|P1|STARTED|Overall Study||93
624163|NCT00261716|1532148|P2|NOT COMPLETED|Overall Study||10
624164|NCT00261716|1532149|P1|NOT COMPLETED|Overall Study||6
624165|NCT00261716|1532148|P2|COMPLETED|Overall Study||11
624166|NCT00261716|1532149|P1|COMPLETED|Overall Study||11
624167|NCT00261716|1532148|P2|STARTED|Overall Study||21
624168|NCT00261716|1532149|P1|STARTED|Overall Study||17
624169|NCT00261495|1532169|P2|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
624170|NCT00261495|1532170|P1|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||10
624171|NCT00261495|1532169|P2|COMPLETED|Extension Phase (Weeks 24 to 52)||47
624172|NCT00261495|1532170|P1|COMPLETED|Extension Phase (Weeks 24 to 52)||50
624173|NCT00261495|1532169|P2|STARTED|Extension Phase (Weeks 24 to 52)|Number started is different to number completed maintenance phase owing to drop outs (85 subjects).|52
624174|NCT00261495|1532170|P1|STARTED|Extension Phase (Weeks 24 to 52)|Number started is different to number completed maintenance phase owing to drop outs (80 subjects).|60
624175|NCT00261495|1532169|P2|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||48
624176|NCT00261495|1532170|P1|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||66
624177|NCT00261495|1532169|P2|COMPLETED|Maintenance Phase (Weeks 4 to 24)||137
624178|NCT00261495|1532170|P1|COMPLETED|Maintenance Phase (Weeks 4 to 24)||140
624179|NCT00261495|1532169|P2|STARTED|Maintenance Phase (Weeks 4 to 24)||185
624180|NCT00261495|1532170|P1|STARTED|Maintenance Phase (Weeks 4 to 24)||206
624181|NCT00261495|1532169|P2|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||65
624182|NCT00261495|1532170|P1|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||48
624183|NCT00261495|1532169|P2|COMPLETED|Titration Phase (Weeks 0 to 4)||185
624184|NCT00261495|1532170|P1|COMPLETED|Titration Phase (Weeks 0 to 4)||206
624185|NCT00261495|1532169|P2|STARTED|Titration Phase (Weeks 0 to 4)||250
624186|NCT00261495|1532170|P1|STARTED|Titration Phase (Weeks 0 to 4)||254
624187|NCT00261443|1532334|P3|NOT COMPLETED|4: Extension Phase||2
624188|NCT00261443|1532335|P2|NOT COMPLETED|4: Extension Phase||3
624189|NCT00261443|1532336|P1|NOT COMPLETED|4: Extension Phase||0
624190|NCT00261443|1532334|P3|COMPLETED|4: Extension Phase||21
624191|NCT00261443|1532335|P2|COMPLETED|4: Extension Phase||16
624192|NCT00261443|1532336|P1|COMPLETED|4: Extension Phase||0
624193|NCT00261443|1532334|P3|STARTED|4: Extension Phase||23
624194|NCT00261443|1532335|P2|STARTED|4: Extension Phase||19
624195|NCT00261443|1532336|P1|STARTED|4: Extension Phase||0
624196|NCT00261443|1532334|P3|NOT COMPLETED|3: Assessment of Relapse||65
624197|NCT00261443|1532335|P2|NOT COMPLETED|3: Assessment of Relapse||80
624198|NCT00261443|1532336|P1|NOT COMPLETED|3: Assessment of Relapse||0
624199|NCT00261443|1532334|P3|COMPLETED|3: Assessment of Relapse||103
624200|NCT00261443|1532335|P2|COMPLETED|3: Assessment of Relapse||89
624201|NCT00261443|1532336|P1|COMPLETED|3: Assessment of Relapse||0
624202|NCT00261443|1532334|P3|STARTED|3: Assessment of Relapse||168
624203|NCT00261443|1532335|P2|STARTED|3: Assessment of Relapse||169
624204|NCT00261443|1532336|P1|STARTED|3: Assessment of Relapse||0
624205|NCT00261443|1532334|P3|NOT COMPLETED|2: Stability & Maintenance of Stability||0
624206|NCT00261443|1532335|P2|NOT COMPLETED|2: Stability & Maintenance of Stability||0
624207|NCT00261443|1532336|P1|NOT COMPLETED|2: Stability & Maintenance of Stability||340
624208|NCT00261443|1532334|P3|COMPLETED|2: Stability & Maintenance of Stability||0
624209|NCT00261443|1532335|P2|COMPLETED|2: Stability & Maintenance of Stability||0
624210|NCT00261443|1532336|P1|COMPLETED|2: Stability & Maintenance of Stability||346
624211|NCT00261443|1532334|P3|STARTED|2: Stability & Maintenance of Stability||0
624212|NCT00261443|1532335|P2|STARTED|2: Stability & Maintenance of Stability||0
624213|NCT00261443|1532336|P1|STARTED|2: Stability & Maintenance of Stability||686
624214|NCT00261443|1532334|P3|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0
624215|NCT00261443|1532335|P2|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0
624216|NCT00261443|1532336|P1|NOT COMPLETED|1: Confirmation of Partial Nonresponse||584
624217|NCT00261443|1532334|P3|COMPLETED|1: Confirmation of Partial Nonresponse||0
624218|NCT00261443|1532335|P2|COMPLETED|1: Confirmation of Partial Nonresponse||0
624219|NCT00261443|1532336|P1|COMPLETED|1: Confirmation of Partial Nonresponse||686
624220|NCT00261443|1532334|P3|STARTED|1: Confirmation of Partial Nonresponse||0
624221|NCT00261443|1532335|P2|STARTED|1: Confirmation of Partial Nonresponse||0
624222|NCT00261443|1532336|P1|STARTED|1: Confirmation of Partial Nonresponse||1270
624223|NCT00260962|1532593|P2|NOT COMPLETED|Overall Study||2
624224|NCT00260962|1532594|P1|NOT COMPLETED|Overall Study||4
624225|NCT00260962|1532593|P2|COMPLETED|Overall Study||14
624226|NCT00260962|1532594|P1|COMPLETED|Overall Study||14
624227|NCT00260962|1532593|P2|STARTED|Overall Study||16
624228|NCT00260962|1532594|P1|STARTED|Overall Study||18
624229|NCT00260832|1532604|P2|NOT COMPLETED|Overall Study||211
624230|NCT00260832|1532605|P1|NOT COMPLETED|Overall Study||228
624231|NCT00260832|1532604|P2|COMPLETED|Overall Study|At study completion, these subjects chose to remain on treatment|31
624232|NCT00260832|1532605|P1|COMPLETED|Overall Study|At study completion, these subjects chose to remain on treatment|15
624233|NCT00260832|1532604|P2|STARTED|Overall Study||242
624234|NCT00260832|1532605|P1|STARTED|Overall Study||243
624235|NCT00260689|1532614|P3|NOT COMPLETED|Overall Study||15
624236|NCT00260689|1532615|P2|NOT COMPLETED|Overall Study||49
624237|NCT00260689|1532616|P1|NOT COMPLETED|Overall Study||41
624238|NCT00260689|1532614|P3|COMPLETED|Overall Study||1
624239|NCT00260689|1532615|P2|COMPLETED|Overall Study||11
624240|NCT00260689|1532616|P1|COMPLETED|Overall Study||19
624241|NCT00260689|1532614|P3|STARTED|Overall Study||16
624242|NCT00260689|1532615|P2|STARTED|Overall Study||60
624243|NCT00260689|1532616|P1|STARTED|Overall Study||60
624244|NCT00260533|1532632|P2|NOT COMPLETED|Overall Study||3
624245|NCT00260533|1532633|P1|NOT COMPLETED|Overall Study||3
624246|NCT00260533|1532632|P2|COMPLETED|Overall Study||10
624247|NCT00260533|1532633|P1|COMPLETED|Overall Study||11
624248|NCT00260533|1532632|P2|STARTED|Overall Study||13
624249|NCT00260533|1532633|P1|STARTED|Overall Study||14
624250|NCT00260429|1532641|P2|NOT COMPLETED|Overall Study||0
624251|NCT00260429|1532642|P1|NOT COMPLETED|Overall Study||2
624252|NCT00260429|1532641|P2|COMPLETED|Overall Study||12
624253|NCT00260429|1532642|P1|COMPLETED|Overall Study||21
624254|NCT00260429|1532641|P2|STARTED|Overall Study||12
624255|NCT00260429|1532642|P1|STARTED|Overall Study||23
624256|NCT00260208|1532650|P2|NOT COMPLETED|Overall Study||34
624257|NCT00260208|1532651|P1|NOT COMPLETED|Overall Study||47
624258|NCT00260208|1532650|P2|COMPLETED|Overall Study||138
624259|NCT00260208|1532651|P1|COMPLETED|Overall Study||137
624260|NCT00260208|1532650|P2|Modified ITT|Overall Study||96
624261|NCT00260208|1532651|P1|Modified ITT|Overall Study||101
624262|NCT00260208|1532650|P2|Intent to Treat (ITT) Population|Overall Study||169
624263|NCT00260208|1532651|P1|Intent to Treat (ITT) Population|Overall Study||182
624264|NCT00260208|1532650|P2|STARTED|Overall Study||172
624265|NCT00260208|1532651|P1|STARTED|Overall Study|"Started indicates safety population."|184
624266|NCT00260195|1532681|P2|NOT COMPLETED|Overall Study||0
624267|NCT00260195|1532682|P1|NOT COMPLETED|Overall Study||0
624268|NCT00260195|1532681|P2|COMPLETED|Overall Study||37
624269|NCT00260195|1532682|P1|COMPLETED|Overall Study||39
624270|NCT00260195|1532681|P2|STARTED|Overall Study||37
624271|NCT00260195|1532682|P1|STARTED|Overall Study||39
624272|NCT00260065|1532694|P1|NOT COMPLETED|Overall Study||93
624273|NCT00260065|1532694|P1|COMPLETED|Overall Study||6
624274|NCT00260065|1532694|P1|STARTED|Overall Study||99
624275|NCT00259857|1532701|P2|NOT COMPLETED|24 Months Treatment||3
624276|NCT00259857|1532702|P1|NOT COMPLETED|24 Months Treatment||0
624277|NCT00259857|1532701|P2|COMPLETED|24 Months Treatment||6
624278|NCT00259857|1532702|P1|COMPLETED|24 Months Treatment||10
624279|NCT00259857|1532701|P2|STARTED|24 Months Treatment||9
624280|NCT00259857|1532702|P1|STARTED|24 Months Treatment||10
624281|NCT00259857|1532701|P2|NOT COMPLETED|12 Months Treatment||2
624282|NCT00259857|1532702|P1|NOT COMPLETED|12 Months Treatment||1
624283|NCT00259857|1532701|P2|COMPLETED|12 Months Treatment||9
624284|NCT00259857|1532702|P1|COMPLETED|12 Months Treatment||10
624285|NCT00259857|1532701|P2|STARTED|12 Months Treatment||11
624286|NCT00259857|1532702|P1|STARTED|12 Months Treatment||11
624287|NCT00259740|1532720|P2|NOT COMPLETED|Overall Study||53
624288|NCT00259740|1532721|P1|NOT COMPLETED|Overall Study||43
624289|NCT00259740|1532720|P2|COMPLETED|Overall Study||0
624290|NCT00259740|1532721|P1|COMPLETED|Overall Study||0
624291|NCT00259740|1532720|P2|Received Study Medication|Overall Study||53
624292|NCT00259740|1532721|P1|Received Study Medication|Overall Study||42
624293|NCT00259740|1532720|P2|STARTED|Overall Study||53
624294|NCT00259740|1532721|P1|STARTED|Overall Study||43
624295|NCT00259649|1532731|P1|NOT COMPLETED|Overall Study||10
624296|NCT00259649|1532731|P1|COMPLETED|Overall Study||61
624297|NCT00259649|1532731|P1|STARTED|Overall Study||71
624298|NCT00259610|1532739|P4|NOT COMPLETED|Overall Study||43
624299|NCT00259610|1532740|P3|NOT COMPLETED|Overall Study||73
624300|NCT00259610|1532741|P2|NOT COMPLETED|Overall Study||46
624301|NCT00259610|1532742|P1|NOT COMPLETED|Overall Study||76
624302|NCT00259610|1532739|P4|COMPLETED|Overall Study||81
624303|NCT00259610|1532740|P3|COMPLETED|Overall Study||182
624304|NCT00259610|1532741|P2|COMPLETED|Overall Study||86
624305|NCT00259610|1532742|P1|COMPLETED|Overall Study||168
624306|NCT00259610|1532739|P4|STARTED|Overall Study||124
624307|NCT00259610|1532740|P3|STARTED|Overall Study||255
624308|NCT00259610|1532741|P2|STARTED|Overall Study||132
624309|NCT00259610|1532742|P1|STARTED|Overall Study||244
624310|NCT00259298|1532756|P1|NOT COMPLETED|Overall Study||3
624311|NCT00259298|1532756|P1|COMPLETED|Overall Study||9
624312|NCT00259298|1532756|P1|Received at Least 1 Dose of Study Drug|Overall Study||10
624313|NCT00259298|1532756|P1|STARTED|Overall Study||12
624314|NCT00259285|1532764|P1|NOT COMPLETED|Overall Study||0
624315|NCT00259285|1532764|P1|COMPLETED|Overall Study||10
624316|NCT00259285|1532764|P1|STARTED|Overall Study||10
624317|NCT00259272|1532774|P4|NOT COMPLETED|Overall Study||21
624318|NCT00259272|1532775|P3|NOT COMPLETED|Overall Study||5
624319|NCT00259272|1532776|P2|NOT COMPLETED|Overall Study||7
624320|NCT00259272|1532777|P1|NOT COMPLETED|Overall Study||15
624321|NCT00259272|1532774|P4|COMPLETED|Overall Study||27
624322|NCT00259272|1532775|P3|COMPLETED|Overall Study||21
624323|NCT00259272|1532776|P2|COMPLETED|Overall Study||24
624324|NCT00259272|1532777|P1|COMPLETED|Overall Study||21
624325|NCT00259272|1532774|P4|STARTED|Overall Study||48
624326|NCT00259272|1532775|P3|STARTED|Overall Study||26
624327|NCT00259272|1532776|P2|STARTED|Overall Study||31
624328|NCT00259272|1532777|P1|STARTED|Overall Study||36
624329|NCT00259090|1532855|P3|NOT COMPLETED|Overall Study||0
624330|NCT00259090|1532856|P2|NOT COMPLETED|Overall Study||0
624331|NCT00259090|1532857|P1|NOT COMPLETED|Overall Study||0
624332|NCT00259090|1532855|P3|COMPLETED|Overall Study||37
624333|NCT00259090|1532856|P2|COMPLETED|Overall Study||31
624334|NCT00259090|1532857|P1|COMPLETED|Overall Study||35
624335|NCT00259090|1532855|P3|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|37
624336|NCT00259090|1532856|P2|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|31
624337|NCT00259090|1532857|P1|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|35
624338|NCT00259012|1532873|P2|NOT COMPLETED|Overall Study||4
624339|NCT00259012|1532874|P1|NOT COMPLETED|Overall Study||2
624340|NCT00259012|1532873|P2|COMPLETED|Overall Study||30
624341|NCT00259012|1532874|P1|COMPLETED|Overall Study||31
624342|NCT00259012|1532873|P2|STARTED|Overall Study||34
624343|NCT00259012|1532874|P1|STARTED|Overall Study||33
624344|NCT00258908|1532906|P1|NOT COMPLETED|Overall Study||0
624345|NCT00258908|1532906|P1|COMPLETED|Overall Study||112
624346|NCT00258908|1532906|P1|STARTED|Overall Study|3 participants were not vaccinated and were not included in the final analysis and in this report.|112
624347|NCT00258895|1532914|P2|NOT COMPLETED|Overall Study||3
624348|NCT00258895|1532915|P1|NOT COMPLETED|Overall Study||10
624349|NCT00258895|1532914|P2|COMPLETED|Overall Study||159
624350|NCT00258895|1532915|P1|COMPLETED|Overall Study||477
624351|NCT00258895|1532914|P2|STARTED|Overall Study||162
624352|NCT00258895|1532915|P1|STARTED|Overall Study||487
624353|NCT00258882|1532931|P2|NOT COMPLETED|Pregnancy Surveillance||0
624354|NCT00258882|1532932|P1|NOT COMPLETED|Pregnancy Surveillance||0
624355|NCT00258882|1532931|P2|COMPLETED|Pregnancy Surveillance||675
624356|NCT00258882|1532932|P1|COMPLETED|Pregnancy Surveillance||225
624357|NCT00258882|1532931|P2|STARTED|Pregnancy Surveillance|Non-vaccinated age-matched subjects with first positive pregnancy test in the same month (± 1 month)|675
624358|NCT00258882|1532932|P1|STARTED|Pregnancy Surveillance|Adacel recipients who were pregnant at the time of vaccination or within 28 days thereafter.|225
624359|NCT00258882|1532931|P2|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0
624360|NCT00258882|1532932|P1|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0
624361|NCT00258882|1532931|P2|COMPLETED|Adacel Recipients-Risk Interval Method||0
624362|NCT00258882|1532932|P1|COMPLETED|Adacel Recipients-Risk Interval Method||124139
624363|NCT00258882|1532931|P2|STARTED|Adacel Recipients-Risk Interval Method|Study participants served as their own controls for this analysis|0
624364|NCT00258882|1532932|P1|STARTED|Adacel Recipients-Risk Interval Method||124139
624365|NCT00258882|1532931|P2|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0
624366|NCT00258882|1532932|P1|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0
624367|NCT00258882|1532931|P2|COMPLETED|Adacel Recipients Historic Cohort Method||203154
624368|NCT00258882|1532932|P1|COMPLETED|Adacel Recipients Historic Cohort Method||124139
624369|NCT00258882|1532931|P2|STARTED|Adacel Recipients Historic Cohort Method||203154
624370|NCT00258882|1532932|P1|STARTED|Adacel Recipients Historic Cohort Method||124139
624371|NCT00258856|1532951|P4|NOT COMPLETED|Overall Study||1
624372|NCT00258856|1532952|P3|NOT COMPLETED|Overall Study||2
624373|NCT00258856|1532953|P2|NOT COMPLETED|Overall Study||0
624374|NCT00258856|1532954|P1|NOT COMPLETED|Overall Study||3
624375|NCT00258856|1532951|P4|COMPLETED|Overall Study||58
624376|NCT00258856|1532952|P3|COMPLETED|Overall Study||56
624377|NCT00258856|1532953|P2|COMPLETED|Overall Study||58
624378|NCT00258856|1532954|P1|COMPLETED|Overall Study||56
624379|NCT00258856|1532951|P4|STARTED|Overall Study||59
624380|NCT00258856|1532952|P3|STARTED|Overall Study||58
624381|NCT00258856|1532953|P2|STARTED|Overall Study||58
624382|NCT00258856|1532954|P1|STARTED|Overall Study||59
624383|NCT00258830|1532966|P2|NOT COMPLETED|Overall Study||0
624384|NCT00258830|1532967|P1|NOT COMPLETED|Overall Study||0
624385|NCT00258830|1532966|P2|COMPLETED|Overall Study||60
624386|NCT00258830|1532967|P1|COMPLETED|Overall Study||60
624387|NCT00258830|1532966|P2|STARTED|Overall Study||60
624388|NCT00258830|1532967|P1|STARTED|Overall Study||60
624389|NCT00258817|1532981|P2|NOT COMPLETED|Overall Study||0
624390|NCT00258817|1532982|P1|NOT COMPLETED|Overall Study||0
624391|NCT00258817|1532981|P2|COMPLETED|Overall Study||15
624392|NCT00258817|1532982|P1|COMPLETED|Overall Study||15
624393|NCT00258817|1532981|P2|STARTED|Overall Study||15
624394|NCT00258817|1532982|P1|STARTED|Overall Study||15
624395|NCT00258674|1532995|P3|NOT COMPLETED|Overall Study||34
624396|NCT00258674|1532996|P2|NOT COMPLETED|Overall Study||53
624397|NCT00258674|1532997|P1|NOT COMPLETED|Overall Study||32
624398|NCT00258674|1532995|P3|COMPLETED|Overall Study||568
624399|NCT00258674|1532996|P2|COMPLETED|Overall Study||758
624400|NCT00258674|1532997|P1|COMPLETED|Overall Study||565
624401|NCT00258674|1532995|P3|STARTED|Overall Study||602
624402|NCT00258674|1532996|P2|STARTED|Overall Study||811
624403|NCT00258674|1532997|P1|STARTED|Overall Study||597
624404|NCT00258440|1533056|P3|NOT COMPLETED|Overall Study||1
624405|NCT00258440|1533057|P2|NOT COMPLETED|Overall Study||0
624406|NCT00258440|1533058|P1|NOT COMPLETED|Overall Study||0
624407|NCT00258440|1533056|P3|COMPLETED|Overall Study||5
624408|NCT00258440|1533057|P2|COMPLETED|Overall Study||0
624409|NCT00258440|1533058|P1|COMPLETED|Overall Study||1
624410|NCT00258440|1533056|P3|STARTED|Overall Study||6
624411|NCT00258440|1533057|P2|STARTED|Overall Study||0
624412|NCT00258440|1533058|P1|STARTED|Overall Study||1
624413|NCT00258362|1533069|P1|NOT COMPLETED|Overall Study||0
624414|NCT00258362|1533069|P1|COMPLETED|Overall Study||41
624415|NCT00258362|1533069|P1|STARTED|Overall Study||41
624416|NCT00258349|1533074|P1|NOT COMPLETED|Overall Study||0
624417|NCT00258349|1533074|P1|COMPLETED|Overall Study||16
624418|NCT00258349|1533074|P1|HER2-positive by Central Review|Overall Study||10
624419|NCT00258349|1533074|P1|STARTED|Overall Study||16
624420|NCT00258310|1533081|P1|NOT COMPLETED|Overall Study||0
624421|NCT00258310|1533081|P1|COMPLETED|Overall Study||35
624422|NCT00258310|1533081|P1|STARTED|Overall Study||35
624423|NCT00258206|1533085|P1|NOT COMPLETED|Overall Study||0
624424|NCT00258206|1533085|P1|COMPLETED|Overall Study||21
624425|NCT00258206|1533085|P1|STARTED|Overall Study||21
624426|NCT00258154|1533091|P2|NOT COMPLETED|Overall Study||7
624427|NCT00258154|1533092|P1|NOT COMPLETED|Overall Study||9
624428|NCT00258154|1533091|P2|COMPLETED|Overall Study|Subjects who completed the study.|195
624429|NCT00258154|1533092|P1|COMPLETED|Overall Study|Subjects who completed the study.|192
624430|NCT00258154|1533091|P2|Vaccinated at Visit 3|Overall Study||197
624431|NCT00258154|1533092|P1|Vaccinated at Visit 3|Overall Study||195
624432|NCT00258154|1533091|P2|Vaccinated at Visit 2|Overall Study||198
624433|NCT00258154|1533092|P1|Vaccinated at Visit 2|Overall Study||198
624434|NCT00258154|1533091|P2|Vaccinated at Visit 1|Overall Study||202
624435|NCT00258154|1533092|P1|Vaccinated at Visit 1|Overall Study||201
624436|NCT00258154|1533091|P2|STARTED|Overall Study|Healthy infants who started in the Placebo concomitantly with INFANRIX™ hexa group.|202
624437|NCT00258154|1533092|P1|STARTED|Overall Study|Healthy infants who started in the RotaTeq™ concomitantly with INFANRIX™ hexa group.|201
624438|NCT00258011|1533160|P1|NOT COMPLETED|Overall Study||0
624439|NCT00258011|1533160|P1|COMPLETED|Overall Study||3
624440|NCT00258011|1533160|P1|STARTED|Overall Study||3
624441|NCT00257933|1533167|P2|NOT COMPLETED|Overall Study||0
624442|NCT00257933|1533168|P1|NOT COMPLETED|Overall Study||0
624443|NCT00257933|1533167|P2|COMPLETED|Overall Study||78
624444|NCT00257933|1533168|P1|COMPLETED|Overall Study||74
624445|NCT00257933|1533167|P2|STARTED|Overall Study||78
624446|NCT00257933|1533168|P1|STARTED|Overall Study||74
624447|NCT00257920|1533176|P2|NOT COMPLETED|Period: Second Intervention||1
624448|NCT00257920|1533177|P1|NOT COMPLETED|Period: Second Intervention||2
624449|NCT00257920|1533176|P2|COMPLETED|Period: Second Intervention||18
624450|NCT00257920|1533177|P1|COMPLETED|Period: Second Intervention||19
624451|NCT00257920|1533176|P2|STARTED|Period: Second Intervention||19
624452|NCT00257920|1533177|P1|STARTED|Period: Second Intervention||21
624453|NCT00257920|1533176|P2|NOT COMPLETED|Period: Washout Period of Two Weeks||1
624454|NCT00257920|1533177|P1|NOT COMPLETED|Period: Washout Period of Two Weeks||0
624455|NCT00257920|1533176|P2|COMPLETED|Period: Washout Period of Two Weeks||19
624456|NCT00257920|1533177|P1|COMPLETED|Period: Washout Period of Two Weeks||21
624457|NCT00257920|1533176|P2|STARTED|Period: Washout Period of Two Weeks||20
624458|NCT00257920|1533177|P1|STARTED|Period: Washout Period of Two Weeks||21
624459|NCT00257920|1533176|P2|NOT COMPLETED|Period: First Intervention||0
624460|NCT00257920|1533177|P1|NOT COMPLETED|Period: First Intervention||0
624461|NCT00257920|1533176|P2|COMPLETED|Period: First Intervention||20
624462|NCT00257920|1533177|P1|COMPLETED|Period: First Intervention||21
624463|NCT00257920|1533176|P2|STARTED|Period: First Intervention||20
624464|NCT00257920|1533177|P1|STARTED|Period: First Intervention||21
624465|NCT00257894|1533187|P2|NOT COMPLETED|Overall Study||5
624466|NCT00257894|1533188|P1|NOT COMPLETED|Overall Study||4
624467|NCT00257894|1533187|P2|COMPLETED|Overall Study||15
624468|NCT00257894|1533188|P1|COMPLETED|Overall Study||17
624469|NCT00257894|1533187|P2|STARTED|Overall Study||20
624470|NCT00257894|1533188|P1|STARTED|Overall Study||21
624471|NCT00257686|1533206|P6|NOT COMPLETED|Overall Study||9
624472|NCT00257686|1533207|P5|NOT COMPLETED|Overall Study||22
624473|NCT00257686|1533208|P4|NOT COMPLETED|Overall Study||11
624474|NCT00257686|1533209|P3|NOT COMPLETED|Overall Study||18
624475|NCT00257686|1533210|P2|NOT COMPLETED|Overall Study||19
624476|NCT00257686|1533211|P1|NOT COMPLETED|Overall Study||21
624477|NCT00257686|1533206|P6|COMPLETED|Overall Study||95
624478|NCT00257686|1533207|P5|COMPLETED|Overall Study||194
624479|NCT00257686|1533208|P4|COMPLETED|Overall Study||88
624480|NCT00257686|1533209|P3|COMPLETED|Overall Study||208
624481|NCT00257686|1533210|P2|COMPLETED|Overall Study||89
624482|NCT00257686|1533211|P1|COMPLETED|Overall Study||188
624483|NCT00257686|1533206|P6|Safety Population|Overall Study|Subjects who received at least one dose of study medication|102
624484|NCT00257686|1533207|P5|Safety Population|Overall Study|Subjects who received at least one dose of study medication|210
624485|NCT00257686|1533208|P4|Safety Population|Overall Study|Subjects who received at least one dose of study medication|96
624486|NCT00257686|1533209|P3|Safety Population|Overall Study|Subjects who received at least one dose of study medication|224
624487|NCT00257686|1533210|P2|Safety Population|Overall Study|Subjects who received at least one dose of study medication|103
624488|NCT00257686|1533211|P1|Safety Population|Overall Study|Subjects who received at least one dose of study medication|207
624489|NCT00257686|1533206|P6|STARTED|Overall Study||104
624490|NCT00257686|1533207|P5|STARTED|Overall Study||216
624491|NCT00257686|1533208|P4|STARTED|Overall Study||99
624492|NCT00257686|1533209|P3|STARTED|Overall Study||226
624493|NCT00257686|1533210|P2|STARTED|Overall Study||108
624494|NCT00257686|1533211|P1|STARTED|Overall Study||209
624495|NCT00257660|1533233|P2|NOT COMPLETED|Overall Study||23
624496|NCT00257660|1533234|P1|NOT COMPLETED|Overall Study||10
624497|NCT00257660|1533233|P2|COMPLETED|Overall Study||38
624498|NCT00257660|1533234|P1|COMPLETED|Overall Study||45
624499|NCT00257660|1533233|P2|STARTED|Overall Study||61
624500|NCT00257660|1533234|P1|STARTED|Overall Study||55
624501|NCT00257608|1533264|P3|NOT COMPLETED|Post Chemotherapy Phase||244
624502|NCT00257608|1533265|P2|NOT COMPLETED|Post Chemotherapy Phase||264
624503|NCT00257608|1533266|P1|NOT COMPLETED|Post Chemotherapy Phase||0
624504|NCT00257608|1533264|P3|COMPLETED|Post Chemotherapy Phase||126
624505|NCT00257608|1533265|P2|COMPLETED|Post Chemotherapy Phase||109
624506|NCT00257608|1533266|P1|COMPLETED|Post Chemotherapy Phase||0
624507|NCT00257608|1533264|P3|STARTED|Post Chemotherapy Phase||370
624508|NCT00257608|1533265|P2|STARTED|Post Chemotherapy Phase||373
624509|NCT00257608|1533266|P1|STARTED|Post Chemotherapy Phase||0
624510|NCT00257608|1533264|P3|NOT COMPLETED|Chemotherapy Phase||0
624511|NCT00257608|1533265|P2|NOT COMPLETED|Chemotherapy Phase||0
624512|NCT00257608|1533266|P1|NOT COMPLETED|Chemotherapy Phase||376
624513|NCT00257608|1533264|P3|COMPLETED|Chemotherapy Phase||0
624514|NCT00257608|1533265|P2|COMPLETED|Chemotherapy Phase||0
624515|NCT00257608|1533266|P1|COMPLETED|Chemotherapy Phase||769
624516|NCT00257608|1533264|P3|STARTED|Chemotherapy Phase||0
624517|NCT00257608|1533265|P2|STARTED|Chemotherapy Phase||0
624518|NCT00257608|1533266|P1|STARTED|Chemotherapy Phase||1145
624519|NCT00257556|1533292|P2|NOT COMPLETED|Overall Study||10
624520|NCT00257556|1533293|P1|NOT COMPLETED|Overall Study||14
624521|NCT00257556|1533292|P2|COMPLETED|Overall Study||32
624522|NCT00257556|1533293|P1|COMPLETED|Overall Study||24
624523|NCT00257556|1533292|P2|All Patients Treated Population|Overall Study|Also the safety population. Three randomized patients did not receive study medication.|39
624524|NCT00257556|1533293|P1|All Patients Treated Population|Overall Study|Also the safety population. One randomized patient did not receive study medication.|37
624525|NCT00257556|1533292|P2|STARTED|Overall Study||42
624526|NCT00257556|1533293|P1|STARTED|Overall Study||38
624527|NCT00257322|1533319|P1|NOT COMPLETED|Overall Study||4
624528|NCT00257322|1533319|P1|COMPLETED|Overall Study|4 subjects withdrew from this study.|16
624529|NCT00257322|1533319|P1|STARTED|Overall Study|20 subjects accrued.|20
624530|NCT00257309|1533326|P2|NOT COMPLETED|Overall Study||2
624531|NCT00257309|1533327|P1|NOT COMPLETED|Overall Study||2
624532|NCT00257309|1533326|P2|COMPLETED|Overall Study||130
624533|NCT00257309|1533327|P1|COMPLETED|Overall Study||132
624534|NCT00257309|1533326|P2|STARTED|Overall Study||132
624535|NCT00257309|1533327|P1|STARTED|Overall Study||134
624536|NCT00257192|1533337|P2|NOT COMPLETED|Overall Study||39
624537|NCT00257192|1533338|P1|NOT COMPLETED|Overall Study||58
624538|NCT00257192|1533337|P2|COMPLETED|Overall Study||52
624539|NCT00257192|1533338|P1|COMPLETED|Overall Study||135
624540|NCT00257192|1533337|P2|Received Study Treatment|Overall Study||90
624541|NCT00257192|1533338|P1|Received Study Treatment|Overall Study||193
624542|NCT00257192|1533337|P2|STARTED|Overall Study|Includes 1 subject randomized but not treated|91
624543|NCT00257192|1533338|P1|STARTED|Overall Study||193
624544|NCT00257166|1533382|P2|NOT COMPLETED|Overall Study||37
624545|NCT00257166|1533383|P1|NOT COMPLETED|Overall Study||53
624546|NCT00257166|1533382|P2|COMPLETED|Overall Study||51
624547|NCT00257166|1533383|P1|COMPLETED|Overall Study||97
624548|NCT00257166|1533382|P2|Treated|Overall Study||88
624549|NCT00257166|1533383|P1|Treated|Overall Study||149
624550|NCT00257166|1533382|P2|STARTED|Overall Study||88
624551|NCT00257166|1533383|P1|STARTED|Overall Study||150
624552|NCT00257010|1533395|P1|NOT COMPLETED|Overall Study||128
624553|NCT00257010|1533395|P1|COMPLETED|Overall Study||319
624554|NCT00257010|1533395|P1|STARTED|Overall Study||447
624555|NCT00256997|1533406|P2|NOT COMPLETED|Overall Study||55
624556|NCT00256997|1533407|P1|NOT COMPLETED|Overall Study||48
624557|NCT00256997|1533406|P2|COMPLETED|Overall Study||31
624558|NCT00256997|1533407|P1|COMPLETED|Overall Study||33
624559|NCT00256997|1533406|P2|Treated|Overall Study||86
624560|NCT00256997|1533407|P1|Treated|Overall Study||79
624561|NCT00256997|1533406|P2|STARTED|Overall Study||86
624562|NCT00256997|1533407|P1|STARTED|Overall Study||81
624563|NCT00256984|1533431|P1|NOT COMPLETED|Overall Study||16
624564|NCT00256984|1533431|P1|COMPLETED|Overall Study||59
624565|NCT00256984|1533431|P1|STARTED|Overall Study||75
624566|NCT00256867|1533449|P8|NOT COMPLETED|Overall Study||11
624567|NCT00256867|1533450|P7|NOT COMPLETED|Overall Study||5
624568|NCT00256867|1533451|P6|NOT COMPLETED|Overall Study||6
624569|NCT00256867|1533452|P5|NOT COMPLETED|Overall Study||7
624570|NCT00256867|1533453|P4|NOT COMPLETED|Overall Study||6
624571|NCT00256867|1533454|P3|NOT COMPLETED|Overall Study||5
624572|NCT00256867|1533455|P2|NOT COMPLETED|Overall Study||5
624573|NCT00256867|1533456|P1|NOT COMPLETED|Overall Study||2
624574|NCT00256867|1533449|P8|COMPLETED|Overall Study||36
624575|NCT00256867|1533450|P7|COMPLETED|Overall Study||41
624576|NCT00256867|1533451|P6|COMPLETED|Overall Study||40
624577|NCT00256867|1533452|P5|COMPLETED|Overall Study||41
624578|NCT00256867|1533453|P4|COMPLETED|Overall Study||40
624579|NCT00256867|1533454|P3|COMPLETED|Overall Study||40
624580|NCT00256867|1533455|P2|COMPLETED|Overall Study||39
624581|NCT00256867|1533456|P1|COMPLETED|Overall Study||45
624582|NCT00256867|1533449|P8|STARTED|Overall Study||47
624583|NCT00256867|1533450|P7|STARTED|Overall Study||46
624584|NCT00256867|1533451|P6|STARTED|Overall Study||46
624585|NCT00256867|1533452|P5|STARTED|Overall Study||48
624586|NCT00256867|1533453|P4|STARTED|Overall Study||46
624587|NCT00256867|1533454|P3|STARTED|Overall Study||45
624588|NCT00256867|1533455|P2|STARTED|Overall Study||44
624589|NCT00256867|1533456|P1|STARTED|Overall Study||47
624590|NCT00256750|1533543|P3|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||28
624591|NCT00256750|1533544|P2|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||30
624592|NCT00256750|1533545|P1|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||47
624593|NCT00256750|1533543|P3|COMPLETED|Long Term Extension (LTE; 84 Months)||127
624594|NCT00256750|1533544|P2|COMPLETED|Long Term Extension (LTE; 84 Months)||136
624595|NCT00256750|1533545|P1|COMPLETED|Long Term Extension (LTE; 84 Months)||89
624596|NCT00256750|1533543|P3|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 were eligible to enroll in LTE; 3 withdrew or refused.|155
624597|NCT00256750|1533544|P2|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 were eligible to enroll in LTE; 4 withdrew or refused.|166
624598|NCT00256750|1533545|P1|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 eligible to enroll in LTE; 2 ineligible, 5 withdrew or refused|136
624599|NCT00256750|1533543|P3|NOT COMPLETED|Post-Transplant Treated (36 Months)||6
624600|NCT00256750|1533544|P2|NOT COMPLETED|Post-Transplant Treated (36 Months)||6
624601|NCT00256750|1533545|P1|NOT COMPLETED|Post-Transplant Treated (36 Months)||10
624602|NCT00256750|1533543|P3|COMPLETED|Post-Transplant Treated (36 Months)||158
624603|NCT00256750|1533544|P2|COMPLETED|Post-Transplant Treated (36 Months)||170
624604|NCT00256750|1533545|P1|COMPLETED|Post-Transplant Treated (36 Months)||143
624605|NCT00256750|1533543|P3|STARTED|Post-Transplant Treated (36 Months)||164
624606|NCT00256750|1533544|P2|STARTED|Post-Transplant Treated (36 Months)||176
624607|NCT00256750|1533545|P1|STARTED|Post-Transplant Treated (36 Months)||153
624608|NCT00256750|1533543|P3|NOT COMPLETED|Post-Transplant Treated (24 Months)||9
624609|NCT00256750|1533544|P2|NOT COMPLETED|Post-Transplant Treated (24 Months)||7
624610|NCT00256750|1533545|P1|NOT COMPLETED|Post-Transplant Treated (24 Months)||21
624611|NCT00256750|1533543|P3|COMPLETED|Post-Transplant Treated (24 Months)||164
624612|NCT00256750|1533544|P2|COMPLETED|Post-Transplant Treated (24 Months)||176
624613|NCT00256750|1533545|P1|COMPLETED|Post-Transplant Treated (24 Months)||153
624614|NCT00256750|1533543|P3|STARTED|Post-Transplant Treated (24 Months)||173
624615|NCT00256750|1533544|P2|STARTED|Post-Transplant Treated (24 Months)||183
624616|NCT00256750|1533545|P1|STARTED|Post-Transplant Treated (24 Months)||174
624617|NCT00256750|1533543|P3|NOT COMPLETED|Post-Transplant Treated (12 Months)||46
624618|NCT00256750|1533544|P2|NOT COMPLETED|Post-Transplant Treated (12 Months)||43
624619|NCT00256750|1533545|P1|NOT COMPLETED|Post-Transplant Treated (12 Months)||41
624620|NCT00256750|1533543|P3|COMPLETED|Post-Transplant Treated (12 Months)||173
624621|NCT00256750|1533544|P2|COMPLETED|Post-Transplant Treated (12 Months)||183
624622|NCT00256750|1533545|P1|COMPLETED|Post-Transplant Treated (12 Months)||174
624623|NCT00256750|1533543|P3|STARTED|Post-Transplant Treated (12 Months)||219
624624|NCT00256750|1533544|P2|STARTED|Post-Transplant Treated (12 Months)||226
624625|NCT00256750|1533545|P1|STARTED|Post-Transplant Treated (12 Months)||215
624626|NCT00256750|1533543|P3|NOT COMPLETED|Transplanted Pre-Treatment||0
624627|NCT00256750|1533544|P2|NOT COMPLETED|Transplanted Pre-Treatment||0
624628|NCT00256750|1533545|P1|NOT COMPLETED|Transplanted Pre-Treatment||6
624629|NCT00256750|1533543|P3|COMPLETED|Transplanted Pre-Treatment||219
624630|NCT00256750|1533544|P2|COMPLETED|Transplanted Pre-Treatment||226
624631|NCT00256750|1533545|P1|COMPLETED|Transplanted Pre-Treatment||215
624632|NCT00256750|1533543|P3|STARTED|Transplanted Pre-Treatment||219
624633|NCT00256750|1533544|P2|STARTED|Transplanted Pre-Treatment||226
624634|NCT00256750|1533545|P1|STARTED|Transplanted Pre-Treatment||221
624635|NCT00256724|1533681|P2|NOT COMPLETED|Overall Study||8
624636|NCT00256724|1533682|P1|NOT COMPLETED|Overall Study||5
624637|NCT00256724|1533681|P2|COMPLETED|Overall Study||16
624638|NCT00256724|1533682|P1|COMPLETED|Overall Study||18
624639|NCT00256724|1533681|P2|STARTED|Overall Study||24
624640|NCT00256724|1533682|P1|STARTED|Overall Study||23
624641|NCT00256698|1533692|P2|NOT COMPLETED|Overall Study||172
624642|NCT00256698|1533693|P1|NOT COMPLETED|Overall Study||167
624643|NCT00256698|1533692|P2|COMPLETED|Overall Study||84
624644|NCT00256698|1533693|P1|COMPLETED|Overall Study||91
624645|NCT00256698|1533692|P2|STARTED|Overall Study||256
624646|NCT00256698|1533693|P1|STARTED|Overall Study||258
624647|NCT00256308|1533711|P1|NOT COMPLETED|Overall Study||2
624648|NCT00256308|1533711|P1|COMPLETED|Overall Study||4
624649|NCT00256308|1533711|P1|STARTED|Overall Study||6
624650|NCT00256295|1533719|P1|NOT COMPLETED|Overall Study||4
624651|NCT00256295|1533719|P1|COMPLETED|Overall Study||3
624652|NCT00256295|1533719|P1|STARTED|Overall Study|Of the 8 subjects consented, 1 withdrew prior to treatment.|7
624653|NCT00256282|1533725|P1|NOT COMPLETED|Overall Study||16
624654|NCT00256282|1533725|P1|COMPLETED|Overall Study||36
624655|NCT00256282|1533725|P1|STARTED|Overall Study||52
624656|NCT00256243|1533730|P1|NOT COMPLETED|Overall Study||10
624657|NCT00256243|1533730|P1|COMPLETED|Overall Study||38
624658|NCT00256243|1533730|P1|STARTED|Overall Study||48
624659|NCT00256204|1533739|P4|NOT COMPLETED|Overall Study||49
624660|NCT00256204|1533740|P3|NOT COMPLETED|Overall Study||54
624661|NCT00256204|1533741|P2|NOT COMPLETED|Overall Study||50
624662|NCT00256204|1533742|P1|NOT COMPLETED|Overall Study||67
624663|NCT00256204|1533739|P4|COMPLETED|Overall Study||244
624664|NCT00256204|1533740|P3|COMPLETED|Overall Study||241
624665|NCT00256204|1533741|P2|COMPLETED|Overall Study||238
624666|NCT00256204|1533742|P1|COMPLETED|Overall Study||231
624667|NCT00256204|1533739|P4|STARTED|Overall Study||293
624668|NCT00256204|1533740|P3|STARTED|Overall Study||295
624669|NCT00256204|1533741|P2|STARTED|Overall Study||288
624670|NCT00256204|1533742|P1|STARTED|Overall Study||298
624671|NCT00256126|1533757|P2|NOT COMPLETED|Overall Study||2
624672|NCT00256126|1533758|P1|NOT COMPLETED|Overall Study||2
624673|NCT00256126|1533757|P2|COMPLETED|Overall Study||167
624674|NCT00256126|1533758|P1|COMPLETED|Overall Study||147
624675|NCT00256126|1533757|P2|STARTED|Overall Study||169
624676|NCT00256126|1533758|P1|STARTED|Overall Study||149
624677|NCT00255970|1533776|P2|NOT COMPLETED|Overall Study||0
624678|NCT00255970|1533777|P1|NOT COMPLETED|Overall Study||0
624679|NCT00255970|1533776|P2|COMPLETED|Overall Study||19
624680|NCT00255970|1533777|P1|COMPLETED|Overall Study||21
624681|NCT00255970|1533776|P2|Final Visit Week 24|Overall Study||19
624682|NCT00255970|1533777|P1|Final Visit Week 24|Overall Study||21
624683|NCT00255970|1533776|P2|Screening Visit|Overall Study||19
624684|NCT00255970|1533777|P1|Screening Visit|Overall Study||21
624685|NCT00255970|1533776|P2|STARTED|Overall Study||19
624686|NCT00255970|1533777|P1|STARTED|Overall Study||21
624687|NCT00255840|1533797|P2|NOT COMPLETED|Overall Study||70
624688|NCT00255840|1533798|P1|NOT COMPLETED|Overall Study||63
624689|NCT00255840|1533797|P2|COMPLETED|Overall Study||334
624690|NCT00255840|1533798|P1|COMPLETED|Overall Study||345
624691|NCT00255840|1533797|P2|STARTED|Overall Study||404
624692|NCT00255840|1533798|P1|STARTED|Overall Study||408
624693|NCT00255723|1533806|P2|NOT COMPLETED|Overall Study||2
624694|NCT00255723|1533807|P1|NOT COMPLETED|Overall Study||2
624695|NCT00255723|1533806|P2|COMPLETED|Overall Study||39
624696|NCT00255723|1533807|P1|COMPLETED|Overall Study||54
624697|NCT00255723|1533806|P2|STARTED|Overall Study||41
624698|NCT00255723|1533807|P1|STARTED|Overall Study||56
624699|NCT00255684|1533813|P1|NOT COMPLETED|Overall Study||0
624700|NCT00255684|1533813|P1|COMPLETED|Overall Study||16
624701|NCT00255684|1533813|P1|STARTED|Overall Study||16
624702|NCT00255190|1533820|P2|NOT COMPLETED|Overall Study||157
624703|NCT00255190|1533821|P1|NOT COMPLETED|Overall Study||50
624704|NCT00255190|1533820|P2|COMPLETED|Overall Study||281
624705|NCT00255190|1533821|P1|COMPLETED|Overall Study||103
624706|NCT00255190|1533820|P2|STARTED|Overall Study||438
624707|NCT00255190|1533821|P1|STARTED|Overall Study||153
624708|NCT00255177|1533889|P4|NOT COMPLETED|Overall Study||2
624709|NCT00255177|1533890|P3|NOT COMPLETED|Overall Study||1
624710|NCT00255177|1533891|P2|NOT COMPLETED|Overall Study||1
624711|NCT00255177|1533892|P1|NOT COMPLETED|Overall Study||2
624712|NCT00255177|1533889|P4|COMPLETED|Overall Study||4
624713|NCT00255177|1533890|P3|COMPLETED|Overall Study||12
624714|NCT00255177|1533891|P2|COMPLETED|Overall Study||13
624715|NCT00255177|1533892|P1|COMPLETED|Overall Study||9
624716|NCT00255177|1533889|P4|STARTED|Overall Study||6
624717|NCT00255177|1533890|P3|STARTED|Overall Study||13
624718|NCT00255177|1533891|P2|STARTED|Overall Study||14
624719|NCT00255177|1533892|P1|STARTED|Overall Study||11
624720|NCT00255164|1533905|P3|NOT COMPLETED|Overall Study||49
624721|NCT00255164|1533906|P2|NOT COMPLETED|Overall Study||49
624722|NCT00255164|1533907|P1|NOT COMPLETED|Overall Study||123
624723|NCT00255164|1533905|P3|COMPLETED|Overall Study||103
624724|NCT00255164|1533906|P2|COMPLETED|Overall Study||110
624725|NCT00255164|1533907|P1|COMPLETED|Overall Study||17
624726|NCT00255164|1533905|P3|STARTED|Overall Study||152
624727|NCT00255164|1533906|P2|STARTED|Overall Study||159
624728|NCT00255164|1533907|P1|STARTED|Overall Study||140
624729|NCT00255151|1533933|P3|NOT COMPLETED|Overall Study||49
624730|NCT00255151|1533934|P2|NOT COMPLETED|Overall Study||49
624731|NCT00255151|1533935|P1|NOT COMPLETED|Overall Study||123
624732|NCT00255151|1533933|P3|COMPLETED|Overall Study||103
624733|NCT00255151|1533934|P2|COMPLETED|Overall Study||110
624734|NCT00255151|1533935|P1|COMPLETED|Overall Study||17
624735|NCT00255151|1533933|P3|STARTED|Overall Study||152
624736|NCT00255151|1533934|P2|STARTED|Overall Study||159
624737|NCT00255151|1533935|P1|STARTED|Overall Study||140
624738|NCT00255125|1533960|P2|NOT COMPLETED|Overall Study||0
624739|NCT00255125|1533961|P1|NOT COMPLETED|Overall Study||0
624740|NCT00255125|1533960|P2|COMPLETED|Overall Study||42
624741|NCT00255125|1533961|P1|COMPLETED|Overall Study||44
624742|NCT00255125|1533960|P2|STARTED|Overall Study||42
624743|NCT00255125|1533961|P1|STARTED|Overall Study||44
624744|NCT00255086|1533969|P2|NOT COMPLETED|Overall Study||2
624745|NCT00255086|1533970|P1|NOT COMPLETED|Overall Study||2
624746|NCT00255086|1533969|P2|COMPLETED|Overall Study||6
624747|NCT00255086|1533970|P1|COMPLETED|Overall Study||7
624748|NCT00255086|1533969|P2|STARTED|Overall Study||8
624749|NCT00255086|1533970|P1|STARTED|Overall Study||9
624750|NCT00255047|1533982|P4|NOT COMPLETED|Overall Study||46
624751|NCT00255047|1533983|P3|NOT COMPLETED|Overall Study||50
624752|NCT00255047|1533984|P2|NOT COMPLETED|Overall Study||48
624753|NCT00255047|1533985|P1|NOT COMPLETED|Overall Study||48
624754|NCT00255047|1533982|P4|COMPLETED|Overall Study||502
624755|NCT00255047|1533983|P3|COMPLETED|Overall Study||496
624756|NCT00255047|1533984|P2|COMPLETED|Overall Study||487
624757|NCT00255047|1533985|P1|COMPLETED|Overall Study||490
624758|NCT00255047|1533982|P4|STARTED|Overall Study||548
624759|NCT00255047|1533983|P3|STARTED|Overall Study||546
624760|NCT00255047|1533984|P2|STARTED|Overall Study||535
624761|NCT00255047|1533985|P1|STARTED|Overall Study||538
624762|NCT00255034|1534009|P2|NOT COMPLETED|Overall Study||38
624763|NCT00255034|1534010|P1|NOT COMPLETED|Overall Study||15
624764|NCT00255034|1534009|P2|COMPLETED|Overall Study||26
624765|NCT00255034|1534010|P1|COMPLETED|Overall Study||64
624766|NCT00255034|1534009|P2|STARTED|Overall Study||64
624767|NCT00255034|1534010|P1|STARTED|Overall Study||79
624768|NCT00255008|1534020|P4|NOT COMPLETED|Overall Study||22
624769|NCT00255008|1534021|P3|NOT COMPLETED|Overall Study||16
624770|NCT00255008|1534022|P2|NOT COMPLETED|Overall Study||9
624771|NCT00255008|1534023|P1|NOT COMPLETED|Overall Study||32
624772|NCT00255008|1534020|P4|COMPLETED|Overall Study||12
624773|NCT00255008|1534021|P3|COMPLETED|Overall Study||17
624774|NCT00255008|1534022|P2|COMPLETED|Overall Study||0
624775|NCT00255008|1534023|P1|COMPLETED|Overall Study|The study was terminated early and as a result only 42 patients completed the study.|13
624776|NCT00255008|1534020|P4|STARTED|Overall Study||34
624777|NCT00255008|1534021|P3|STARTED|Overall Study||33
624778|NCT00255008|1534022|P2|STARTED|Overall Study||9
624779|NCT00255008|1534023|P1|STARTED|Overall Study||45
624780|NCT00254995|1534035|P2|NOT COMPLETED|Overall Study||0
624781|NCT00254995|1534036|P1|NOT COMPLETED|Overall Study||0
624782|NCT00254995|1534035|P2|COMPLETED|Overall Study||31065
624783|NCT00254995|1534036|P1|COMPLETED|Overall Study||31561
624784|NCT00254995|1534035|P2|STARTED|Overall Study||31065
624785|NCT00254995|1534036|P1|STARTED|Overall Study||31561
624786|NCT00254982|1534059|P2|NOT COMPLETED|Overall Study||31
624787|NCT00254982|1534060|P1|NOT COMPLETED|Overall Study||36
624788|NCT00254982|1534059|P2|COMPLETED|Overall Study||265
624789|NCT00254982|1534060|P1|COMPLETED|Overall Study||261
624790|NCT00254982|1534059|P2|STARTED|Overall Study||296
624791|NCT00254982|1534060|P1|STARTED|Overall Study||297
624792|NCT00254592|1534066|P1|NOT COMPLETED|Overall Study||2
624793|NCT00254592|1534066|P1|COMPLETED|Overall Study||41
624794|NCT00254592|1534066|P1|STARTED|Overall Study||43
624795|NCT00254566|1534072|P2|NOT COMPLETED|Overall Study||26
624796|NCT00254566|1534073|P1|NOT COMPLETED|Overall Study||31
624797|NCT00254566|1534072|P2|COMPLETED|Overall Study||172
624798|NCT00254566|1534073|P1|COMPLETED|Overall Study||167
624799|NCT00254566|1534072|P2|STARTED|Overall Study||198
624800|NCT00254566|1534073|P1|STARTED|Overall Study||198
624801|NCT00254540|1534097|P2|NOT COMPLETED|Overall Study||22
624802|NCT00254540|1534098|P1|NOT COMPLETED|Overall Study||19
624803|NCT00254540|1534097|P2|COMPLETED|Overall Study||4
624804|NCT00254540|1534098|P1|COMPLETED|Overall Study||6
624805|NCT00254540|1534097|P2|STARTED|Overall Study|All 26 subjects enrolled were included in Intent-To Treat population.|26
624806|NCT00254540|1534098|P1|STARTED|Overall Study|All 25 subjects enrolled were included in Intent-To Treat population.|25
624807|NCT00254501|1534127|P2|NOT COMPLETED|Overall Study||1
624808|NCT00254501|1534128|P1|NOT COMPLETED|Overall Study||1
624809|NCT00254501|1534127|P2|COMPLETED|Overall Study||36
624810|NCT00254501|1534128|P1|COMPLETED|Overall Study||31
624811|NCT00254501|1534127|P2|STARTED|Overall Study||37
624812|NCT00254501|1534128|P1|STARTED|Overall Study||32
624813|NCT00254462|1534142|P2|NOT COMPLETED|Overall Study||10
624814|NCT00254462|1534143|P1|NOT COMPLETED|Overall Study||8
624815|NCT00254462|1534142|P2|COMPLETED|Overall Study||39
624816|NCT00254462|1534143|P1|COMPLETED|Overall Study||36
624817|NCT00254462|1534142|P2|STARTED|Overall Study||49
624818|NCT00254462|1534143|P1|STARTED|Overall Study||44
624819|NCT00254293|1534157|P7|NOT COMPLETED|LTE Open Label Fixed Dosing||13
624820|NCT00254293|1534158|P6|NOT COMPLETED|LTE Open Label Fixed Dosing||0
624821|NCT00254293|1534159|P5|NOT COMPLETED|LTE Open Label Fixed Dosing||0
624822|NCT00254293|1534160|P4|NOT COMPLETED|LTE Open Label Fixed Dosing||0
624823|NCT00254293|1534161|P3|NOT COMPLETED|LTE Open Label Fixed Dosing||0
624824|NCT00254293|1534162|P2|NOT COMPLETED|LTE Open Label Fixed Dosing||0
624825|NCT00254293|1534163|P1|NOT COMPLETED|LTE Open Label Fixed Dosing||0
624826|NCT00254293|1534157|P7|COMPLETED|LTE Open Label Fixed Dosing||35
624827|NCT00254293|1534158|P6|COMPLETED|LTE Open Label Fixed Dosing||0
624828|NCT00254293|1534159|P5|COMPLETED|LTE Open Label Fixed Dosing||0
624829|NCT00254293|1534160|P4|COMPLETED|LTE Open Label Fixed Dosing||0
624830|NCT00254293|1534161|P3|COMPLETED|LTE Open Label Fixed Dosing||0
624831|NCT00254293|1534162|P2|COMPLETED|LTE Open Label Fixed Dosing||0
624832|NCT00254293|1534163|P1|COMPLETED|LTE Open Label Fixed Dosing||0
624833|NCT00254293|1534157|P7|STARTED|LTE Open Label Fixed Dosing||48
624834|NCT00254293|1534158|P6|STARTED|LTE Open Label Fixed Dosing||0
624835|NCT00254293|1534159|P5|STARTED|LTE Open Label Fixed Dosing||0
624836|NCT00254293|1534160|P4|STARTED|LTE Open Label Fixed Dosing||0
624837|NCT00254293|1534161|P3|STARTED|LTE Open Label Fixed Dosing||0
624838|NCT00254293|1534162|P2|STARTED|LTE Open Label Fixed Dosing||0
624839|NCT00254293|1534163|P1|STARTED|LTE Open Label Fixed Dosing||0
624840|NCT00254293|1534157|P7|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
624841|NCT00254293|1534158|P6|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
624842|NCT00254293|1534159|P5|NOT COMPLETED|LTE Open Label Variable SC Dosing||2
624843|NCT00254293|1534160|P4|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
624844|NCT00254293|1534161|P3|NOT COMPLETED|LTE Open Label Variable SC Dosing||10
624845|NCT00254293|1534162|P2|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
624846|NCT00254293|1534163|P1|NOT COMPLETED|LTE Open Label Variable SC Dosing||3
624847|NCT00254293|1534157|P7|COMPLETED|LTE Open Label Variable SC Dosing||0
624848|NCT00254293|1534158|P6|COMPLETED|LTE Open Label Variable SC Dosing||0
624849|NCT00254293|1534159|P5|COMPLETED|LTE Open Label Variable SC Dosing||8
624850|NCT00254293|1534160|P4|COMPLETED|LTE Open Label Variable SC Dosing||0
624851|NCT00254293|1534161|P3|COMPLETED|LTE Open Label Variable SC Dosing||32
624852|NCT00254293|1534162|P2|COMPLETED|LTE Open Label Variable SC Dosing||0
624853|NCT00254293|1534163|P1|COMPLETED|LTE Open Label Variable SC Dosing||8
624854|NCT00254293|1534157|P7|STARTED|LTE Open Label Variable SC Dosing|Participant rolled over from LTE (Variable Dose Period) to LTE (Fixed Dose Period).|0
624855|NCT00254293|1534158|P6|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to a variable SC dose group of 75, 125 or 200 mg Weekly by body weight.|0
624938|NCT00253513|1534378|P1|STARTED|Overall Study||60
624856|NCT00254293|1534159|P5|STARTED|LTE Open Label Variable SC Dosing|Participants who received ST placebo rolled over to variable SC dose group (by body weight, >100kg).|10
624857|NCT00254293|1534160|P4|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to 125mg dose group summarized as one group (body weight <60 to >100 kg).|0
624858|NCT00254293|1534161|P3|STARTED|LTE Open Label Variable SC Dosing|Variable SC dose group: 125 mg Weekly, body weight <60 to >100kg (Groups 2, 3, 4 in ST Period).|42
624859|NCT00254293|1534162|P2|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to 125mg dose group summarized as one group (body weight <60 to >100 kg).|0
624860|NCT00254293|1534163|P1|STARTED|LTE Open Label Variable SC Dosing|Participants who received ST placebo rolled over to 75mg SC dose group (by body weight, <60kg).|11
624861|NCT00254293|1534157|P7|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
624862|NCT00254293|1534158|P6|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
624863|NCT00254293|1534159|P5|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
624864|NCT00254293|1534160|P4|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1
624865|NCT00254293|1534161|P3|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||3
624866|NCT00254293|1534162|P2|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1
624867|NCT00254293|1534163|P1|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
624868|NCT00254293|1534157|P7|COMPLETED|Short Term (12 Week) Randomized Dosing||0
624869|NCT00254293|1534158|P6|COMPLETED|Short Term (12 Week) Randomized Dosing||17
624870|NCT00254293|1534159|P5|COMPLETED|Short Term (12 Week) Randomized Dosing||5
624871|NCT00254293|1534160|P4|COMPLETED|Short Term (12 Week) Randomized Dosing||5
624872|NCT00254293|1534161|P3|COMPLETED|Short Term (12 Week) Randomized Dosing||26
624873|NCT00254293|1534162|P2|COMPLETED|Short Term (12 Week) Randomized Dosing||3
624874|NCT00254293|1534163|P1|COMPLETED|Short Term (12 Week) Randomized Dosing||7
624875|NCT00254293|1534157|P7|STARTED|Short Term (12 Week) Randomized Dosing||0
624876|NCT00254293|1534158|P6|STARTED|Short Term (12 Week) Randomized Dosing|2, 2, 9, 2, and 2 were randomized to placebo in body weight Groups 1, 2, 3, 4, 5, respectively.|17
624877|NCT00254293|1534159|P5|STARTED|Short Term (12 Week) Randomized Dosing||5
624878|NCT00254293|1534160|P4|STARTED|Short Term (12 Week) Randomized Dosing||6
624879|NCT00254293|1534161|P3|STARTED|Short Term (12 Week) Randomized Dosing||29
624880|NCT00254293|1534162|P2|STARTED|Short Term (12 Week) Randomized Dosing||4
624881|NCT00254293|1534163|P1|STARTED|Short Term (12 Week) Randomized Dosing||7
624882|NCT00254163|1534246|P2|NOT COMPLETED|Overall Study||46
624883|NCT00254163|1534247|P1|NOT COMPLETED|Overall Study||45
624884|NCT00254163|1534246|P2|COMPLETED|Overall Study||46
624885|NCT00254163|1534247|P1|COMPLETED|Overall Study||47
624886|NCT00254163|1534246|P2|STARTED|Overall Study||92
624887|NCT00254163|1534247|P1|STARTED|Overall Study||92
624888|NCT00254072|1534271|P2|NOT COMPLETED|Overall Study||0
624889|NCT00254072|1534272|P1|NOT COMPLETED|Overall Study||0
624890|NCT00254072|1534271|P2|COMPLETED|Overall Study||175
624891|NCT00254072|1534272|P1|COMPLETED|Overall Study||180
624892|NCT00254072|1534271|P2|STARTED|Overall Study||175
624893|NCT00254072|1534272|P1|STARTED|Overall Study||180
624894|NCT00253981|1534280|P2|NOT COMPLETED|Overall Study||0
624895|NCT00253981|1534281|P1|NOT COMPLETED|Overall Study||0
624896|NCT00253981|1534280|P2|COMPLETED|Overall Study||14
624897|NCT00253981|1534281|P1|COMPLETED|Overall Study||16
624898|NCT00253981|1534280|P2|STARTED|Overall Study||14
624899|NCT00253981|1534281|P1|STARTED|Overall Study||16
624900|NCT00253890|1534289|P2|NOT COMPLETED|Overall Study||7
624901|NCT00253890|1534290|P1|NOT COMPLETED|Overall Study||7
624902|NCT00253890|1534289|P2|COMPLETED|Overall Study||61
624903|NCT00253890|1534290|P1|COMPLETED|Overall Study||62
624904|NCT00253890|1534289|P2|STARTED|Overall Study||68
624905|NCT00253890|1534290|P1|STARTED|Overall Study||69
624906|NCT00253747|1534298|P2|NOT COMPLETED|Overall Study||27
624907|NCT00253747|1534299|P1|NOT COMPLETED|Overall Study||24
624908|NCT00253747|1534298|P2|COMPLETED|Overall Study||101
624909|NCT00253747|1534299|P1|COMPLETED|Overall Study||103
624910|NCT00253747|1534298|P2|STARTED|Overall Study||128
624911|NCT00253747|1534299|P1|STARTED|Overall Study||127
624912|NCT00253708|1534320|P3|NOT COMPLETED|Overall Study||1
624913|NCT00253708|1534321|P2|NOT COMPLETED|Overall Study||0
624914|NCT00253708|1534322|P1|NOT COMPLETED|Overall Study||0
624915|NCT00253708|1534320|P3|COMPLETED|Overall Study||8
624916|NCT00253708|1534321|P2|COMPLETED|Overall Study||10
624917|NCT00253708|1534322|P1|COMPLETED|Overall Study||20
624918|NCT00253708|1534320|P3|STARTED|Overall Study||9
624919|NCT00253708|1534321|P2|STARTED|Overall Study||10
624920|NCT00253708|1534322|P1|STARTED|Overall Study||20
624921|NCT00253643|1534352|P4|NOT COMPLETED|Overall Study||3
624922|NCT00253643|1534353|P3|NOT COMPLETED|Overall Study||1
624923|NCT00253643|1534354|P2|NOT COMPLETED|Overall Study||0
624924|NCT00253643|1534355|P1|NOT COMPLETED|Overall Study||0
624925|NCT00253643|1534352|P4|COMPLETED|Overall Study||28
624926|NCT00253643|1534353|P3|COMPLETED|Overall Study||28
624927|NCT00253643|1534354|P2|COMPLETED|Overall Study||15
624928|NCT00253643|1534355|P1|COMPLETED|Overall Study||14
624929|NCT00253643|1534352|P4|STARTED|Overall Study||31
624930|NCT00253643|1534353|P3|STARTED|Overall Study||29
624931|NCT00253643|1534354|P2|STARTED|Overall Study||15
624932|NCT00253643|1534355|P1|STARTED|Overall Study||14
624933|NCT00253630|1534369|P1|NOT COMPLETED|Overall Study||2
624934|NCT00253630|1534369|P1|COMPLETED|Overall Study||35
624935|NCT00253630|1534369|P1|STARTED|Overall Study||37
624936|NCT00253513|1534378|P1|NOT COMPLETED|Overall Study||0
624937|NCT00253513|1534378|P1|COMPLETED|Overall Study||60
624939|NCT00253448|1534385|P1|NOT COMPLETED|Overall Study||1
624940|NCT00253448|1534385|P1|COMPLETED|Overall Study||34
624941|NCT00253448|1534385|P1|STARTED|Overall Study||35
624942|NCT00253435|1534391|P2|NOT COMPLETED|Overall Study||0
624943|NCT00253435|1534392|P1|NOT COMPLETED|Overall Study||0
624944|NCT00253435|1534391|P2|COMPLETED|Overall Study|Eight evaluable patients enrolled.|8
624945|NCT00253435|1534392|P1|COMPLETED|Overall Study|Forty-two evaluable poor risk patients enrolled.|42
624946|NCT00253435|1534391|P2|3rd Interim Analysis|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|0
624947|NCT00253435|1534392|P1|3rd Interim Analysis|Overall Study|Third interim analysis: need 4+ responses in first 35 patients. Goal met study continued.|10
624948|NCT00253435|1534391|P2|2nd Interim Analysis|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|0
624949|NCT00253435|1534392|P1|2nd Interim Analysis|Overall Study|Second interim analysis: need 3+ responses in first 25 patients. Goal met study continued.|10
624950|NCT00253435|1534391|P2|1st Interim Analysis|Overall Study|Only interim analysis: need 1+ response in first 10 patients.|8
624951|NCT00253435|1534392|P1|1st Interim Analysis|Overall Study|First interim analysis: need 2+ responses in first 15 patients. Goal met study continued.|15
624952|NCT00253435|1534391|P2|STARTED|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|8
624953|NCT00253435|1534392|P1|STARTED|Overall Study|Total number is 42|42
624954|NCT00253370|1534404|P1|NOT COMPLETED|Overall Study||43
624955|NCT00253370|1534404|P1|COMPLETED|Overall Study||1
624956|NCT00253370|1534404|P1|STARTED|Overall Study||44
624957|NCT00253019|1534413|P3|NOT COMPLETED|Overall Study||18
624958|NCT00253019|1534414|P2|NOT COMPLETED|Overall Study||31
624959|NCT00253019|1534415|P1|NOT COMPLETED|Overall Study||29
624960|NCT00253019|1534413|P3|COMPLETED|Overall Study||83
624961|NCT00253019|1534414|P2|COMPLETED|Overall Study||78
624962|NCT00253019|1534415|P1|COMPLETED|Overall Study||82
624963|NCT00253019|1534413|P3|STARTED|Overall Study||101
624964|NCT00253019|1534414|P2|STARTED|Overall Study||109
624965|NCT00253019|1534415|P1|STARTED|Overall Study||111
624966|NCT00252967|1534425|P2|NOT COMPLETED|Overall Study||0
624967|NCT00252967|1534426|P1|NOT COMPLETED|Overall Study||0
624968|NCT00252967|1534425|P2|COMPLETED|Overall Study||33
624969|NCT00252967|1534426|P1|COMPLETED|Overall Study||31
624970|NCT00252967|1534425|P2|STARTED|Overall Study||33
624971|NCT00252967|1534426|P1|STARTED|Overall Study||31
624972|NCT00252733|1534450|P2|NOT COMPLETED|Overall Study||92
624973|NCT00252733|1534451|P1|NOT COMPLETED|Overall Study||106
624974|NCT00252733|1534450|P2|COMPLETED|Overall Study||618
624975|NCT00252733|1534451|P1|COMPLETED|Overall Study||605
624976|NCT00252733|1534450|P2|STARTED|Overall Study||710
624977|NCT00252733|1534451|P1|STARTED|Overall Study||711
624978|NCT00252720|1534461|P2|NOT COMPLETED|Overall Study||165
624979|NCT00252720|1534462|P1|NOT COMPLETED|Overall Study||132
624980|NCT00252720|1534461|P2|COMPLETED|Overall Study||789
624981|NCT00252720|1534462|P1|COMPLETED|Overall Study||819
624982|NCT00252720|1534461|P2|STARTED|Overall Study||954
624983|NCT00252720|1534462|P1|STARTED|Overall Study||951
624984|NCT00252694|1534476|P2|NOT COMPLETED|Overall Study||154
624985|NCT00252694|1534477|P1|NOT COMPLETED|Overall Study||144
624986|NCT00252694|1534476|P2|COMPLETED|Overall Study||800
624987|NCT00252694|1534477|P1|COMPLETED|Overall Study||807
624988|NCT00252694|1534476|P2|STARTED|Overall Study||954
624989|NCT00252694|1534477|P1|STARTED|Overall Study||951
624990|NCT00252629|1534492|P3|NOT COMPLETED|Overall Study||0
624991|NCT00252629|1534493|P2|NOT COMPLETED|Overall Study||0
624992|NCT00252629|1534494|P1|NOT COMPLETED|Overall Study||1
624993|NCT00252629|1534492|P3|COMPLETED|Overall Study|We used data from the 18 veterans with GWS in addition to the 11 control|11
624994|NCT00252629|1534493|P2|COMPLETED|Overall Study||9
624995|NCT00252629|1534494|P1|COMPLETED|Overall Study|One participant assigned to therapeutic CPAP was excluded from the trial before starting treatment.|8
624996|NCT00252629|1534492|P3|STARTED|Overall Study|We used data from the 18 veterans with GWS in addition to the 11 control|11
624997|NCT00252629|1534493|P2|STARTED|Overall Study||9
624998|NCT00252629|1534494|P1|STARTED|Overall Study||9
624999|NCT00252590|1534510|P3|NOT COMPLETED|Overall Study||3
625000|NCT00252590|1534511|P2|NOT COMPLETED|Overall Study||2
625001|NCT00252590|1534512|P1|NOT COMPLETED|Overall Study||2
625002|NCT00252590|1534510|P3|COMPLETED|Overall Study||31
625003|NCT00252590|1534511|P2|COMPLETED|Overall Study||28
625004|NCT00252590|1534512|P1|COMPLETED|Overall Study||33
625005|NCT00252590|1534510|P3|STARTED|Overall Study||34
625006|NCT00252590|1534511|P2|STARTED|Overall Study||30
625007|NCT00252590|1534512|P1|STARTED|Overall Study||35
625008|NCT00252564|1534525|P2|NOT COMPLETED|Overall Study||44
625009|NCT00252564|1534526|P1|NOT COMPLETED|Overall Study||39
625010|NCT00252564|1534525|P2|COMPLETED|Overall Study|Received 6+ cycles OR had response (RECIST criteria, CR or PR)|79
625011|NCT00252564|1534526|P1|COMPLETED|Overall Study|Received 6+ cycles OR had response (RECIST criteria, CR or PR)|85
625012|NCT00252564|1534525|P2|STARTED|Overall Study|From randomization|123
625013|NCT00252564|1534526|P1|STARTED|Overall Study|From randomization|124
625014|NCT00252538|1534538|P2|NOT COMPLETED|Overall Study||0
625015|NCT00252538|1534539|P1|NOT COMPLETED|Overall Study||0
625016|NCT00252538|1534538|P2|COMPLETED|Overall Study||114
625017|NCT00252538|1534539|P1|COMPLETED|Overall Study||19
625018|NCT00252538|1534538|P2|STARTED|Overall Study||114
625019|NCT00252538|1534539|P1|STARTED|Overall Study||19
625020|NCT00252512|1534546|P2|NOT COMPLETED|12 Month Follow up||1
625021|NCT00252512|1534547|P1|NOT COMPLETED|12 Month Follow up||9
625022|NCT00252512|1534546|P2|COMPLETED|12 Month Follow up||121
625023|NCT00252512|1534547|P1|COMPLETED|12 Month Follow up||123
625024|NCT00252512|1534546|P2|STARTED|12 Month Follow up||122
625025|NCT00252512|1534547|P1|STARTED|12 Month Follow up||132
625026|NCT00252512|1534546|P2|NOT COMPLETED|Six Month Follow up||12
625027|NCT00252512|1534547|P1|NOT COMPLETED|Six Month Follow up||4
625028|NCT00252512|1534546|P2|COMPLETED|Six Month Follow up||122
625029|NCT00252512|1534547|P1|COMPLETED|Six Month Follow up||132
625030|NCT00252512|1534546|P2|STARTED|Six Month Follow up||134
625031|NCT00252512|1534547|P1|STARTED|Six Month Follow up||136
625032|NCT00252512|1534546|P2|NOT COMPLETED|Intervention||31
625033|NCT00252512|1534547|P1|NOT COMPLETED|Intervention||29
625034|NCT00252512|1534546|P2|COMPLETED|Intervention||134
625035|NCT00252512|1534547|P1|COMPLETED|Intervention||136
625036|NCT00252512|1534546|P2|STARTED|Intervention||165
625037|NCT00252512|1534547|P1|STARTED|Intervention||165
625038|NCT00252499|1534556|P3|NOT COMPLETED|Overall Study||0
625039|NCT00252499|1534557|P2|NOT COMPLETED|Overall Study||0
625040|NCT00252499|1534558|P1|NOT COMPLETED|Overall Study||1
625041|NCT00252499|1534556|P3|COMPLETED|Overall Study||6
625042|NCT00252499|1534557|P2|COMPLETED|Overall Study||2
625043|NCT00252499|1534558|P1|COMPLETED|Overall Study||4
625044|NCT00252499|1534556|P3|STARTED|Overall Study||6
625045|NCT00252499|1534557|P2|STARTED|Overall Study||2
625046|NCT00252499|1534558|P1|STARTED|Overall Study||5
625047|NCT00252382|1534581|P1|NOT COMPLETED|Overall Study||26
625048|NCT00252382|1534581|P1|COMPLETED|Overall Study||5
625049|NCT00252382|1534581|P1|STARTED|Overall Study||31
625050|NCT00252239|1534590|P4|NOT COMPLETED|Overall Study||1
625051|NCT00252239|1534591|P3|NOT COMPLETED|Overall Study||2
625052|NCT00252239|1534592|P2|NOT COMPLETED|Overall Study||0
625053|NCT00252239|1534593|P1|NOT COMPLETED|Overall Study||1
625054|NCT00252239|1534590|P4|COMPLETED|Overall Study||30
625055|NCT00252239|1534591|P3|COMPLETED|Overall Study||17
625056|NCT00252239|1534592|P2|COMPLETED|Overall Study||31
625057|NCT00252239|1534593|P1|COMPLETED|Overall Study||30
625058|NCT00252239|1534590|P4|STARTED|Overall Study||31
625059|NCT00252239|1534591|P3|STARTED|Overall Study||19
625060|NCT00252239|1534592|P2|STARTED|Overall Study||31
625061|NCT00252239|1534593|P1|STARTED|Overall Study||31
625062|NCT00252187|1534605|P2|NOT COMPLETED|Overall Study||1
625063|NCT00252187|1534606|P1|NOT COMPLETED|Overall Study||4
625064|NCT00252187|1534605|P2|COMPLETED|Overall Study||20
625065|NCT00252187|1534606|P1|COMPLETED|Overall Study||20
625066|NCT00252187|1534605|P2|STARTED|Overall Study||21
625067|NCT00252187|1534606|P1|STARTED|Overall Study||24
625068|NCT00252174|1534629|P3|NOT COMPLETED|Overall Study||0
625069|NCT00252174|1534630|P2|NOT COMPLETED|Overall Study||1
625070|NCT00252174|1534631|P1|NOT COMPLETED|Overall Study||0
625071|NCT00252174|1534629|P3|COMPLETED|Overall Study||0
625072|NCT00252174|1534630|P2|COMPLETED|Overall Study||1
625073|NCT00252174|1534631|P1|COMPLETED|Overall Study||0
625074|NCT00252174|1534629|P3|STARTED|Overall Study|No subjects entered Stage 2|0
625075|NCT00252174|1534630|P2|STARTED|Overall Study|2 subjects entered the control arm in total|2
625076|NCT00252174|1534631|P1|STARTED|Overall Study|No subjects were randomized into Active Arm as only 2 subjects were randomized into the Control Arm.|0
625077|NCT00252057|1534671|P2|NOT COMPLETED|Overall Study||8
625078|NCT00252057|1534672|P1|NOT COMPLETED|Overall Study||3
625079|NCT00252057|1534671|P2|COMPLETED|Overall Study||368
625080|NCT00252057|1534672|P1|COMPLETED|Overall Study||370
625081|NCT00252057|1534671|P2|STARTED|Overall Study||376
625082|NCT00252057|1534672|P1|STARTED|Overall Study||373
625083|NCT00251979|1534680|P2|NOT COMPLETED|Overall Study||40
625084|NCT00251979|1534681|P1|NOT COMPLETED|Overall Study||38
625085|NCT00251979|1534680|P2|COMPLETED|Overall Study||349
625086|NCT00251979|1534681|P1|COMPLETED|Overall Study||337
625087|NCT00251979|1534680|P2|STARTED|Overall Study|ITT population|389
625088|NCT00251979|1534681|P1|STARTED|Overall Study|ITT population|375
625089|NCT00251927|1534713|P2|NOT COMPLETED|Overall Study||74
625090|NCT00251927|1534714|P1|NOT COMPLETED|Overall Study||108
625091|NCT00251927|1534713|P2|COMPLETED|Overall Study|Completed 5 year visit|192
625092|NCT00251927|1534714|P1|COMPLETED|Overall Study|Completed 5 year visit|180
625093|NCT00251927|1534713|P2|STARTED|Overall Study|Randomised|266
625094|NCT00251927|1534714|P1|STARTED|Overall Study|Randomised|288
625095|NCT00251862|1534744|P3|NOT COMPLETED|Overall Study||0
625096|NCT00251862|1534745|P2|NOT COMPLETED|Overall Study||0
625097|NCT00251862|1534746|P1|NOT COMPLETED|Overall Study||0
625098|NCT00251862|1534744|P3|COMPLETED|Overall Study||276
625099|NCT00251862|1534745|P2|COMPLETED|Overall Study||269
625100|NCT00251862|1534746|P1|COMPLETED|Overall Study||280
625101|NCT00251862|1534744|P3|STARTED|Overall Study||276
625102|NCT00251862|1534745|P2|STARTED|Overall Study||269
625103|NCT00251862|1534746|P1|STARTED|Overall Study||280
625104|NCT00251758|1534766|P3|NOT COMPLETED|Overall Study||27
625105|NCT00251758|1534767|P2|NOT COMPLETED|Overall Study||27
625106|NCT00251758|1534768|P1|NOT COMPLETED|Overall Study||28
625107|NCT00251758|1534766|P3|COMPLETED|Overall Study||277
625108|NCT00251758|1534767|P2|COMPLETED|Overall Study||285
625109|NCT00251758|1534768|P1|COMPLETED|Overall Study||264
625110|NCT00251758|1534766|P3|STARTED|Overall Study||304
625111|NCT00251758|1534767|P2|STARTED|Overall Study||312
625112|NCT00251758|1534768|P1|STARTED|Overall Study||292
625113|NCT00251745|1534788|P3|NOT COMPLETED|Overall Study||27
625114|NCT00251745|1534789|P2|NOT COMPLETED|Overall Study||27
625115|NCT00251745|1534790|P1|NOT COMPLETED|Overall Study||28
625116|NCT00251745|1534788|P3|COMPLETED|Overall Study||277
625117|NCT00251745|1534789|P2|COMPLETED|Overall Study||285
625118|NCT00251745|1534790|P1|COMPLETED|Overall Study||264
625119|NCT00251745|1534788|P3|STARTED|Overall Study||304
625120|NCT00251745|1534789|P2|STARTED|Overall Study||312
625121|NCT00251745|1534790|P1|STARTED|Overall Study||292
625122|NCT00251719|1534810|P3|NOT COMPLETED|Overall Study||30
625123|NCT00251719|1534811|P2|NOT COMPLETED|Overall Study||45
625124|NCT00251719|1534812|P1|NOT COMPLETED|Overall Study||53
625125|NCT00251719|1534810|P3|COMPLETED|Overall Study||643
625126|NCT00251719|1534811|P2|COMPLETED|Overall Study||642
625127|NCT00251719|1534812|P1|COMPLETED|Overall Study||641
625128|NCT00251719|1534810|P3|STARTED|Overall Study||673
625129|NCT00251719|1534811|P2|STARTED|Overall Study||687
625130|NCT00251719|1534812|P1|STARTED|Overall Study||694
625131|NCT00251693|1534838|P3|NOT COMPLETED|Overall Study||46
625132|NCT00251693|1534839|P2|NOT COMPLETED|Overall Study||44
625133|NCT00251693|1534840|P1|NOT COMPLETED|Overall Study||51
625134|NCT00251693|1534838|P3|COMPLETED|Overall Study||644
625135|NCT00251693|1534839|P2|COMPLETED|Overall Study||624
625136|NCT00251693|1534840|P1|COMPLETED|Overall Study||629
625137|NCT00251693|1534838|P3|STARTED|Overall Study||690
625138|NCT00251693|1534839|P2|STARTED|Overall Study||668
625139|NCT00251693|1534840|P1|STARTED|Overall Study||680
625140|NCT00251641|1534865|P2|NOT COMPLETED|Overall Study||88
625141|NCT00251641|1534866|P1|NOT COMPLETED|Overall Study||112
625142|NCT00251641|1534865|P2|COMPLETED|Overall Study||127
625143|NCT00251641|1534866|P1|COMPLETED|Overall Study||541
625144|NCT00251641|1534865|P2|STARTED|Overall Study||215
625145|NCT00251641|1534866|P1|STARTED|Overall Study||653
625146|NCT00251589|1534884|P4|NOT COMPLETED|Overall Study||2
625147|NCT00251589|1534885|P3|NOT COMPLETED|Overall Study||2
625148|NCT00251589|1534886|P2|NOT COMPLETED|Overall Study||3
625149|NCT00251589|1534887|P1|NOT COMPLETED|Overall Study||15
625150|NCT00251589|1534884|P4|COMPLETED|Overall Study||0
625151|NCT00251589|1534885|P3|COMPLETED|Overall Study||0
625152|NCT00251589|1534886|P2|COMPLETED|Overall Study||0
625153|NCT00251589|1534887|P1|COMPLETED|Overall Study||1
625154|NCT00251589|1534884|P4|STARTED|Overall Study||2
625155|NCT00251589|1534885|P3|STARTED|Overall Study||2
625156|NCT00251589|1534886|P2|STARTED|Overall Study||3
625157|NCT00251589|1534887|P1|STARTED|Overall Study|4 of the 16 patients participated in Phase I and II portions. 12 participated in Phase II only.|16
625158|NCT00251316|1534924|P2|NOT COMPLETED|Overall Study||3
625159|NCT00251316|1534925|P1|NOT COMPLETED|Overall Study||2
625160|NCT00251316|1534924|P2|COMPLETED|Overall Study||14
625161|NCT00251316|1534925|P1|COMPLETED|Overall Study||15
625162|NCT00251316|1534924|P2|STARTED|Overall Study||17
625163|NCT00251316|1534925|P1|STARTED|Overall Study||17
625164|NCT00251303|1534933|P2|NOT COMPLETED|Overall Study||1
625165|NCT00251303|1534934|P1|NOT COMPLETED|Overall Study||8
625166|NCT00251303|1534933|P2|COMPLETED|Overall Study||29
625167|NCT00251303|1534934|P1|COMPLETED|Overall Study||22
625168|NCT00251303|1534933|P2|STARTED|Overall Study||30
625169|NCT00251303|1534934|P1|STARTED|Overall Study|78 subjects signed any consent. 60 started drug (30 riluzole & 30 placebo).|30
625170|NCT00251238|1534944|P2|NOT COMPLETED|Overall Study||0
625171|NCT00251238|1534945|P1|NOT COMPLETED|Overall Study||0
625172|NCT00251238|1534944|P2|COMPLETED|Overall Study||20
625173|NCT00251238|1534945|P1|COMPLETED|Overall Study||21
625174|NCT00251238|1534944|P2|STARTED|Overall Study||20
625175|NCT00251238|1534945|P1|STARTED|Overall Study||21
625176|NCT00251225|1534955|P1|NOT COMPLETED|Overall Study||0
625177|NCT00251225|1534955|P1|COMPLETED|Overall Study||49
625178|NCT00251225|1534955|P1|STARTED|Overall Study||49
625179|NCT00251004|1534964|P3|NOT COMPLETED|Overall Study||31
625180|NCT00251004|1534965|P2|NOT COMPLETED|Overall Study||41
625181|NCT00251004|1534966|P1|NOT COMPLETED|Overall Study||45
625182|NCT00251004|1534964|P3|COMPLETED|Overall Study||246
625183|NCT00251004|1534965|P2|COMPLETED|Overall Study||238
625184|NCT00251004|1534966|P1|COMPLETED|Overall Study||232
625185|NCT00251004|1534964|P3|24 Month Analysis|Overall Study|Under 24 month analysis under group 3, 185 Completed study medication.|246
625186|NCT00251004|1534965|P2|24 Month Analysis|Overall Study|Under 24 month analysis under group 2, 161 Completed study medication.|238
625187|NCT00251004|1534966|P1|24 Month Analysis|Overall Study|Under 24 month analysis under group 1, 167 Completed study medication.|232
625188|NCT00251004|1534964|P3|12 Month Analysis|Overall Study|Under 12 month analysis under group 3, 200 Completed study medication.|253
625189|NCT00251004|1534965|P2|12 Month Analysis|Overall Study|Under 12 month analysis under group 2, 175 Completed study medication.|249
625190|NCT00251004|1534966|P1|12 Month Analysis|Overall Study|Under 12 month analysis under group 1, 179 Completed study medication.|241
625191|NCT00251004|1534964|P3|STARTED|Overall Study||277
625192|NCT00251004|1534965|P2|STARTED|Overall Study||279
625193|NCT00251004|1534966|P1|STARTED|Overall Study||277
625194|NCT00250926|1534983|P1|NOT COMPLETED|Overall Study||0
625195|NCT00250926|1534983|P1|COMPLETED|Overall Study||23
625196|NCT00250926|1534983|P1|STARTED|Overall Study||23
625197|NCT00250835|1534990|P1|NOT COMPLETED|Overall Study||1
625198|NCT00250835|1534990|P1|COMPLETED|Overall Study||37
625199|NCT00250835|1534990|P1|STARTED|Overall Study||38
625200|NCT00250718|1534999|P1|NOT COMPLETED|Overall Study||3
625201|NCT00250718|1534999|P1|COMPLETED|Overall Study||14
625202|NCT00250718|1534999|P1|Received Treatment|Overall Study||16
625203|NCT00250718|1534999|P1|STARTED|Overall Study||17
625204|NCT00250705|1535004|P1|NOT COMPLETED|Overall Study||2
625205|NCT00250705|1535004|P1|COMPLETED|Overall Study||10
625206|NCT00250705|1535004|P1|STARTED|Overall Study||12
625207|NCT00250679|1535015|P3|NOT COMPLETED|Overall Study||44
625208|NCT00250679|1535016|P2|NOT COMPLETED|Overall Study||49
625209|NCT00250679|1535017|P1|NOT COMPLETED|Overall Study||39
625210|NCT00250679|1535015|P3|COMPLETED|Overall Study||103
625211|NCT00250679|1535016|P2|COMPLETED|Overall Study||100
625212|NCT00250679|1535017|P1|COMPLETED|Overall Study||108
625213|NCT00250679|1535015|P3|STARTED|Overall Study||147
625214|NCT00250679|1535016|P2|STARTED|Overall Study||149
625215|NCT00250679|1535017|P1|STARTED|Overall Study||147
625216|NCT00250588|1535118|P3|NOT COMPLETED|Overall Study||13
625217|NCT00250588|1535119|P2|NOT COMPLETED|Overall Study||19
625218|NCT00250588|1535120|P1|NOT COMPLETED|Overall Study||9
625219|NCT00250588|1535118|P3|COMPLETED|Overall Study||74
625220|NCT00250588|1535119|P2|COMPLETED|Overall Study||65
625221|NCT00250588|1535120|P1|COMPLETED|Overall Study||72
625222|NCT00250588|1535118|P3|STARTED|Overall Study||87
625223|NCT00250588|1535119|P2|STARTED|Overall Study||84
625224|NCT00250588|1535120|P1|STARTED|Overall Study||81
625225|NCT00250497|1535136|P2|NOT COMPLETED|Overall Study||15
625226|NCT00250497|1535137|P1|NOT COMPLETED|Overall Study||5
625227|NCT00250497|1535136|P2|COMPLETED|Overall Study||159
625228|NCT00250497|1535137|P1|COMPLETED|Overall Study||177
625229|NCT00250497|1535136|P2|STARTED|Overall Study||174
625230|NCT00250497|1535137|P1|STARTED|Overall Study||182
625231|NCT00250484|1535155|P2|NOT COMPLETED|Overall Study||0
625232|NCT00250484|1535156|P1|NOT COMPLETED|Overall Study||0
625233|NCT00250484|1535155|P2|COMPLETED|Overall Study||8
625234|NCT00250484|1535156|P1|COMPLETED|Overall Study||9
625235|NCT00250484|1535155|P2|STARTED|Overall Study||8
625236|NCT00250484|1535156|P1|STARTED|Overall Study||9
625237|NCT00250458|1535168|P2|NOT COMPLETED|Overall Study||17
625238|NCT00250458|1535169|P1|NOT COMPLETED|Overall Study||32
625239|NCT00250458|1535168|P2|COMPLETED|Overall Study||97
625240|NCT00250458|1535169|P1|COMPLETED|Overall Study||200
625241|NCT00250458|1535168|P2|STARTED|Overall Study||114
625242|NCT00250458|1535169|P1|STARTED|Overall Study||232
625243|NCT00250432|1535179|P2|NOT COMPLETED|Overall Study||47
625244|NCT00250432|1535180|P1|NOT COMPLETED|Overall Study||45
625245|NCT00250432|1535179|P2|COMPLETED|Overall Study||53
625246|NCT00250432|1535180|P1|COMPLETED|Overall Study||59
625247|NCT00250432|1535179|P2|STARTED|Overall Study||100
625248|NCT00250432|1535180|P1|STARTED|Overall Study||104
625249|NCT00250276|1535192|P4|NOT COMPLETED|Overall Study||19
625250|NCT00250276|1535193|P3|NOT COMPLETED|Overall Study||19
625251|NCT00250276|1535194|P2|NOT COMPLETED|Overall Study||21
625252|NCT00250276|1535195|P1|NOT COMPLETED|Overall Study||17
625253|NCT00250276|1535192|P4|COMPLETED|Overall Study||181
625254|NCT00250276|1535193|P3|COMPLETED|Overall Study||182
625255|NCT00250276|1535194|P2|COMPLETED|Overall Study||177
625256|NCT00250276|1535195|P1|COMPLETED|Overall Study||182
625257|NCT00250276|1535192|P4|STARTED|Overall Study||200
625258|NCT00250276|1535193|P3|STARTED|Overall Study||201
625259|NCT00250276|1535194|P2|STARTED|Overall Study||198
625260|NCT00250276|1535195|P1|STARTED|Overall Study||199
625261|NCT00249873|1535275|P2|NOT COMPLETED|Overall Study||1254
625262|NCT00249873|1535276|P1|NOT COMPLETED|Overall Study||1330
625263|NCT00249873|1535275|P2|COMPLETED|Overall Study|started and completed study drug|2528
625264|NCT00249873|1535276|P1|COMPLETED|Overall Study|started and completed study drug|2442
625265|NCT00249873|1535275|P2|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|3782
625266|NCT00249873|1535276|P1|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|3772
625267|NCT00249834|1535296|P8|NOT COMPLETED|Overall Study||0
625268|NCT00249834|1535297|P7|NOT COMPLETED|Overall Study||1
625269|NCT00249834|1535298|P6|NOT COMPLETED|Overall Study||2
625270|NCT00249834|1535299|P5|NOT COMPLETED|Overall Study||5
625271|NCT00249834|1535300|P4|NOT COMPLETED|Overall Study||8
625272|NCT00249834|1535301|P3|NOT COMPLETED|Overall Study||14
625273|NCT00249834|1535302|P2|NOT COMPLETED|Overall Study||19
625274|NCT00249834|1535303|P1|NOT COMPLETED|Overall Study||1
625275|NCT00249834|1535296|P8|COMPLETED|Overall Study||2
625276|NCT00249834|1535297|P7|COMPLETED|Overall Study||1
625277|NCT00249834|1535298|P6|COMPLETED|Overall Study||8
625278|NCT00249834|1535299|P5|COMPLETED|Overall Study||19
625279|NCT00249834|1535300|P4|COMPLETED|Overall Study||26
625280|NCT00249834|1535301|P3|COMPLETED|Overall Study||31
625281|NCT00249834|1535302|P2|COMPLETED|Overall Study||29
625282|NCT00249834|1535303|P1|COMPLETED|Overall Study||0
625283|NCT00249834|1535296|P8|STARTED|Overall Study||2
625284|NCT00249834|1535297|P7|STARTED|Overall Study||2
625285|NCT00249834|1535298|P6|STARTED|Overall Study||10
625286|NCT00249834|1535299|P5|STARTED|Overall Study||24
625287|NCT00249834|1535300|P4|STARTED|Overall Study||34
625288|NCT00249834|1535301|P3|STARTED|Overall Study||45
625289|NCT00249834|1535302|P2|STARTED|Overall Study||48
625290|NCT00249834|1535303|P1|STARTED|Overall Study||1
625291|NCT00249821|1535352|P2|NOT COMPLETED|Overall Study||1
625292|NCT00249821|1535353|P1|NOT COMPLETED|Overall Study||0
625293|NCT00249821|1535352|P2|COMPLETED|Overall Study||11
625294|NCT00249821|1535353|P1|COMPLETED|Overall Study||10
625295|NCT00249821|1535352|P2|STARTED|Overall Study||12
625296|NCT00249821|1535353|P1|STARTED|Overall Study||10
625297|NCT00249808|1535373|P1|NOT COMPLETED|Overall Study||182
625298|NCT00249808|1535373|P1|COMPLETED|Overall Study||1084
625299|NCT00249808|1535373|P1|STARTED|Overall Study||1266
625300|NCT00249795|1535381|P2|NOT COMPLETED|Overall Study||1390
625301|NCT00249795|1535382|P1|NOT COMPLETED|Overall Study||1394
625302|NCT00249795|1535381|P2|COMPLETED|Overall Study|started and completed study drug|3108
625303|NCT00249795|1535382|P1|COMPLETED|Overall Study|started and completed study drug|3124
625304|NCT00249795|1535381|P2|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|4498
625305|NCT00249795|1535382|P1|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|4518
625306|NCT00249613|1535402|P2|NOT COMPLETED|12 Month Follow-up||15
625307|NCT00249613|1535403|P1|NOT COMPLETED|12 Month Follow-up||17
625308|NCT00249613|1535402|P2|COMPLETED|12 Month Follow-up||124
625309|NCT00249613|1535403|P1|COMPLETED|12 Month Follow-up||135
625310|NCT00249613|1535402|P2|STARTED|12 Month Follow-up||139
625311|NCT00249613|1535403|P1|STARTED|12 Month Follow-up||152
625312|NCT00249613|1535402|P2|NOT COMPLETED|Baseline||0
625313|NCT00249613|1535403|P1|NOT COMPLETED|Baseline||0
625314|NCT00249613|1535402|P2|COMPLETED|Baseline||139
625315|NCT00249613|1535403|P1|COMPLETED|Baseline||152
625316|NCT00249613|1535402|P2|STARTED|Baseline||139
625317|NCT00249613|1535403|P1|STARTED|Baseline||152
625318|NCT00249496|1535414|P2|NOT COMPLETED|Overall Study||1
625319|NCT00249496|1535415|P1|NOT COMPLETED|Overall Study||0
625320|NCT00249496|1535414|P2|COMPLETED|Overall Study||26
625321|NCT00249496|1535415|P1|COMPLETED|Overall Study||24
625322|NCT00249496|1535414|P2|STARTED|Overall Study||27
625323|NCT00249496|1535415|P1|STARTED|Overall Study||24
625324|NCT00249470|1535431|P2|NOT COMPLETED|Overall Study||0
625325|NCT00249470|1535432|P1|NOT COMPLETED|Overall Study||0
625326|NCT00249470|1535431|P2|COMPLETED|Overall Study||28
625327|NCT00249470|1535432|P1|COMPLETED|Overall Study||28
625328|NCT00249470|1535431|P2|STARTED|Overall Study||28
625329|NCT00249470|1535432|P1|STARTED|Overall Study||28
625330|NCT00249444|1535444|P2|NOT COMPLETED|Overall Study||15
625331|NCT00249444|1535445|P1|NOT COMPLETED|Overall Study||12
625332|NCT00249444|1535444|P2|COMPLETED|Overall Study||29
625333|NCT00249444|1535445|P1|COMPLETED|Overall Study||30
625334|NCT00249444|1535444|P2|STARTED|Overall Study||44
625335|NCT00249444|1535445|P1|STARTED|Overall Study||42
625336|NCT00249379|1535455|P2|NOT COMPLETED|Overall Study||8
625337|NCT00249379|1535456|P1|NOT COMPLETED|Overall Study||8
625338|NCT00249379|1535455|P2|COMPLETED|Overall Study||4
625339|NCT00249379|1535456|P1|COMPLETED|Overall Study||6
625340|NCT00249379|1535455|P2|STARTED|Overall Study||12
625341|NCT00249379|1535456|P1|STARTED|Overall Study||14
625342|NCT00249288|1535470|P2|NOT COMPLETED|Overall Study||5
625343|NCT00249288|1535471|P1|NOT COMPLETED|Overall Study||5
625344|NCT00249288|1535470|P2|COMPLETED|Overall Study||14
625345|NCT00249288|1535471|P1|COMPLETED|Overall Study||14
625346|NCT00249288|1535470|P2|Initiated Treatment|Overall Study||15
625347|NCT00249288|1535471|P1|Initiated Treatment|Overall Study||17
625348|NCT00249288|1535470|P2|STARTED|Overall Study||19
625349|NCT00249288|1535471|P1|STARTED|Overall Study||19
625350|NCT00249249|1535506|P4|NOT COMPLETED|Overall Study||3
625351|NCT00249249|1535507|P3|NOT COMPLETED|Overall Study||15
625352|NCT00249249|1535508|P2|NOT COMPLETED|Overall Study||5
625353|NCT00249249|1535509|P1|NOT COMPLETED|Overall Study||20
625354|NCT00249249|1535506|P4|COMPLETED|Overall Study||100
625355|NCT00249249|1535507|P3|COMPLETED|Overall Study||288
625356|NCT00249249|1535508|P2|COMPLETED|Overall Study||98
625357|NCT00249249|1535509|P1|COMPLETED|Overall Study||301
625358|NCT00249249|1535506|P4|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|103
625359|NCT00249249|1535507|P3|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|300
625360|NCT00249249|1535508|P2|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|102
625361|NCT00249249|1535509|P1|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|316
625362|NCT00249249|1535506|P4|STARTED|Overall Study||103
625363|NCT00249249|1535507|P3|STARTED|Overall Study||303
625364|NCT00249249|1535508|P2|STARTED|Overall Study||103
625365|NCT00249249|1535509|P1|STARTED|Overall Study||321
625366|NCT00249002|1535563|P1|NOT COMPLETED|Overall Study||7
625367|NCT00249002|1535563|P1|COMPLETED|Overall Study||2
625368|NCT00249002|1535563|P1|STARTED|Overall Study||9
625369|NCT00248807|1535581|P2|NOT COMPLETED|Overall Study||0
625370|NCT00248807|1535582|P1|NOT COMPLETED|Overall Study||0
625371|NCT00248807|1535581|P2|COMPLETED|Overall Study||11
625372|NCT00248807|1535582|P1|COMPLETED|Overall Study||19
625373|NCT00248807|1535581|P2|STARTED|Overall Study||11
625374|NCT00248807|1535582|P1|STARTED|Overall Study||19
625375|NCT00248794|1535599|P3|NOT COMPLETED|Overall Study||3
625376|NCT00248794|1535600|P2|NOT COMPLETED|Overall Study||8
625377|NCT00248794|1535601|P1|NOT COMPLETED|Overall Study||6
625378|NCT00248794|1535599|P3|COMPLETED|Overall Study||7
625379|NCT00248794|1535600|P2|COMPLETED|Overall Study||16
625380|NCT00248794|1535601|P1|COMPLETED|Overall Study||19
625381|NCT00248794|1535599|P3|STARTED|Overall Study||10
625382|NCT00248794|1535600|P2|STARTED|Overall Study||24
625383|NCT00248794|1535601|P1|STARTED|Overall Study||25
625384|NCT00248781|1535623|P2|NOT COMPLETED|Overall Study||4
625385|NCT00248781|1535624|P1|NOT COMPLETED|Overall Study||10
625386|NCT00248781|1535623|P2|COMPLETED|Overall Study||47
625387|NCT00248781|1535624|P1|COMPLETED|Overall Study||42
625388|NCT00248781|1535623|P2|STARTED|Overall Study||51
625389|NCT00248781|1535624|P1|STARTED|Overall Study||52
625390|NCT00248651|1535651|P3|NOT COMPLETED|Overall Study||32
625391|NCT00248651|1535652|P2|NOT COMPLETED|Overall Study||40
625392|NCT00248651|1535653|P1|NOT COMPLETED|Overall Study||28
625393|NCT00248651|1535651|P3|COMPLETED|Overall Study||65
625394|NCT00248651|1535652|P2|COMPLETED|Overall Study||58
625395|NCT00248651|1535653|P1|COMPLETED|Overall Study||69
625396|NCT00248651|1535651|P3|Completed 12 Weeks of Treatment|Overall Study||75
625397|NCT00248651|1535652|P2|Completed 12 Weeks of Treatment|Overall Study||66
625398|NCT00248651|1535653|P1|Completed 12 Weeks of Treatment|Overall Study||78
625399|NCT00248651|1535651|P3|STARTED|Overall Study||97
625400|NCT00248651|1535652|P2|STARTED|Overall Study||98
625401|NCT00248651|1535653|P1|STARTED|Overall Study||97
625402|NCT00248638|1535672|P2|NOT COMPLETED|Overall Study||0
625403|NCT00248638|1535673|P1|NOT COMPLETED|Overall Study||0
625404|NCT00248638|1535672|P2|COMPLETED|Overall Study||75
625405|NCT00248638|1535673|P1|COMPLETED|Overall Study||75
625406|NCT00248638|1535672|P2|STARTED|Overall Study||75
625407|NCT00248638|1535673|P1|STARTED|Overall Study||75
625408|NCT00248625|1535689|P2|NOT COMPLETED|Overall Study||2
625409|NCT00248625|1535690|P1|NOT COMPLETED|Overall Study||0
625410|NCT00248625|1535689|P2|COMPLETED|Overall Study||90
625411|NCT00248625|1535690|P1|COMPLETED|Overall Study||92
625412|NCT00248625|1535689|P2|STARTED|Overall Study||92
625413|NCT00248625|1535690|P1|STARTED|Overall Study||92
625414|NCT00248612|1535714|P4|NOT COMPLETED|Overall Study||0
625415|NCT00248612|1535715|P3|NOT COMPLETED|Overall Study||0
625416|NCT00248612|1535716|P2|NOT COMPLETED|Overall Study||0
625417|NCT00248612|1535717|P1|NOT COMPLETED|Overall Study||0
625418|NCT00248612|1535714|P4|COMPLETED|Overall Study||22
625419|NCT00248612|1535715|P3|COMPLETED|Overall Study||14
625420|NCT00248612|1535716|P2|COMPLETED|Overall Study||21
625421|NCT00248612|1535717|P1|COMPLETED|Overall Study||24
625422|NCT00248612|1535714|P4|STARTED|Overall Study||22
625423|NCT00248612|1535715|P3|STARTED|Overall Study||14
625424|NCT00248612|1535716|P2|STARTED|Overall Study||21
625425|NCT00248612|1535717|P1|STARTED|Overall Study||24
625426|NCT00248560|1535759|P1|NOT COMPLETED|Overall Study||0
625427|NCT00248560|1535759|P1|COMPLETED|Overall Study||36
625428|NCT00248560|1535759|P1|STARTED|Overall Study||36
625429|NCT00248547|1535765|P2|NOT COMPLETED|Overall Study||0
625430|NCT00248547|1535766|P1|NOT COMPLETED|Overall Study||0
625431|NCT00248547|1535765|P2|COMPLETED|Overall Study||20
625432|NCT00248547|1535766|P1|COMPLETED|Overall Study||20
625433|NCT00248547|1535765|P2|STARTED|Overall Study||20
625434|NCT00248547|1535766|P1|STARTED|Overall Study||20
625435|NCT00248495|1535772|P1|NOT COMPLETED|Overall Study||1
625436|NCT00248495|1535772|P1|COMPLETED|Overall Study||37
625437|NCT00248495|1535772|P1|STARTED|Overall Study||38
625438|NCT00248287|1535783|P2|NOT COMPLETED|Overall Study||19
625439|NCT00248287|1535784|P1|NOT COMPLETED|Overall Study||24
625440|NCT00248287|1535783|P2|COMPLETED|Overall Study||60
625441|NCT00248287|1535784|P1|COMPLETED|Overall Study||51
625442|NCT00248287|1535783|P2|STARTED|Overall Study||79
625443|NCT00248287|1535784|P1|STARTED|Overall Study||75
625444|NCT00248170|1535798|P2|NOT COMPLETED|Overall Study||808
625445|NCT00248170|1535799|P1|NOT COMPLETED|Overall Study||761
625446|NCT00248170|1535798|P2|COMPLETED|Overall Study||1286
625447|NCT00248170|1535799|P1|COMPLETED|Overall Study||1317
625448|NCT00248170|1535798|P2|Safety Set|Overall Study||2062
625449|NCT00248170|1535799|P1|Safety Set|Overall Study||2049
625450|NCT00248170|1535798|P2|Intent-to-treat (ITT)|Overall Study||2075
625451|NCT00248170|1535799|P1|Intent-to-treat (ITT)|Overall Study||2061
625452|NCT00248170|1535798|P2|STARTED|Overall Study||2094
625453|NCT00248170|1535799|P1|STARTED|Overall Study||2078
625454|NCT00247962|1535821|P2|NOT COMPLETED|Overall Study||19
625455|NCT00247962|1535822|P1|NOT COMPLETED|Overall Study||26
625456|NCT00247962|1535821|P2|COMPLETED|Overall Study||168
625457|NCT00247962|1535822|P1|COMPLETED|Overall Study||353
625458|NCT00247962|1535821|P2|STARTED|Overall Study||187
625459|NCT00247962|1535822|P1|STARTED|Overall Study||379
625460|NCT00247676|1535830|P1|NOT COMPLETED|Overall Study||36
625461|NCT00247676|1535830|P1|COMPLETED|Overall Study||1
625462|NCT00247676|1535830|P1|STARTED|Overall Study||37
625463|NCT00247624|1535860|P2|NOT COMPLETED|Overall Study||4
625464|NCT00247624|1535861|P1|NOT COMPLETED|Overall Study||5
625465|NCT00247624|1535860|P2|COMPLETED|Overall Study||26
625466|NCT00247624|1535861|P1|COMPLETED|Overall Study||25
625467|NCT00247624|1535860|P2|STARTED|Overall Study||30
625468|NCT00247624|1535861|P1|STARTED|Overall Study||30
625469|NCT00247611|1535875|P2|NOT COMPLETED|On Protocol Sample||125
625470|NCT00247611|1535876|P1|NOT COMPLETED|On Protocol Sample||111
625471|NCT00247611|1535875|P2|COMPLETED|On Protocol Sample|Participants with no interruptions in ART receipt and completing 6 or more LifeWindows assessments|152
625472|NCT00247611|1535876|P1|COMPLETED|On Protocol Sample|Participants with no interruptions in ART receipt and completing 6 or more LifeWindows assessments|176
625473|NCT00247611|1535875|P2|STARTED|On Protocol Sample|ITT sample participants|277
625474|NCT00247611|1535876|P1|STARTED|On Protocol Sample|ITT sample participants|287
625475|NCT00247611|1535875|P2|NOT COMPLETED|Intention to Treat Sample||13
625476|NCT00247611|1535876|P1|NOT COMPLETED|Intention to Treat Sample||17
625477|NCT00247611|1535875|P2|COMPLETED|Intention to Treat Sample|Randomized participants who completed at least 2 adherence assessments/sessions|277
625478|NCT00247611|1535876|P1|COMPLETED|Intention to Treat Sample|Randomized participants who completed at least 2 adherence assessments/sessions|287
625479|NCT00247611|1535875|P2|STARTED|Intention to Treat Sample|Participants randomized|290
625480|NCT00247611|1535876|P1|STARTED|Intention to Treat Sample|Participants randomized|304
625481|NCT00247611|1535875|P2|NOT COMPLETED|Baselined||13
625482|NCT00247611|1535876|P1|NOT COMPLETED|Baselined||17
625483|NCT00247611|1535875|P2|COMPLETED|Baselined|Randomized participants who completed at least 2 adherence assessments/sessions|277
625484|NCT00247611|1535876|P1|COMPLETED|Baselined|Randomized participants who completed at least 2 adherence assessments/sessions|287
625485|NCT00247611|1535875|P2|STARTED|Baselined|Participants randomized|290
625486|NCT00247611|1535876|P1|STARTED|Baselined|Participants randomized|304
625487|NCT00247416|1535894|P2|NOT COMPLETED|Overall Study||2
625488|NCT00247416|1535895|P1|NOT COMPLETED|Overall Study||1
625489|NCT00247416|1535894|P2|COMPLETED|Overall Study||31
625490|NCT00247416|1535895|P1|COMPLETED|Overall Study||25
625491|NCT00247416|1535894|P2|STARTED|Overall Study||33
625492|NCT00247416|1535895|P1|STARTED|Overall Study||26
625493|NCT00247377|1535909|P2|NOT COMPLETED|Overall Study||0
625494|NCT00247377|1535910|P1|NOT COMPLETED|Overall Study||0
625495|NCT00247377|1535909|P2|COMPLETED|Overall Study||86
625496|NCT00247377|1535910|P1|COMPLETED|Overall Study||111
625497|NCT00247377|1535909|P2|STARTED|Overall Study||86
625498|NCT00247377|1535910|P1|STARTED|Overall Study||111
625499|NCT00247273|1535936|P2|NOT COMPLETED|Overall Study||137
625500|NCT00247273|1535937|P1|NOT COMPLETED|Overall Study||146
625501|NCT00247273|1535936|P2|COMPLETED|Overall Study||513
625502|NCT00247273|1535937|P1|COMPLETED|Overall Study||498
625503|NCT00247273|1535936|P2|Intent to Treat Population|Overall Study||650
625504|NCT00247273|1535937|P1|Intent to Treat Population|Overall Study|Two subjects not included as they did not take any study medication.|642
625505|NCT00247273|1535936|P2|STARTED|Overall Study||650
625506|NCT00247273|1535937|P1|STARTED|Overall Study||644
625507|NCT00246805|1535983|P2|NOT COMPLETED|Phase 2||0
625508|NCT00246805|1535984|P1|NOT COMPLETED|Phase 2||0
625509|NCT00246805|1535983|P2|COMPLETED|Phase 2||33
625510|NCT00246805|1535984|P1|COMPLETED|Phase 2||33
625511|NCT00246805|1535983|P2|STARTED|Phase 2||33
625512|NCT00246805|1535984|P1|STARTED|Phase 2||33
625513|NCT00246805|1535983|P2|NOT COMPLETED|Phase 1||0
625514|NCT00246805|1535984|P1|NOT COMPLETED|Phase 1||1
625515|NCT00246805|1535983|P2|COMPLETED|Phase 1||33
625516|NCT00246805|1535984|P1|COMPLETED|Phase 1||33
625517|NCT00246805|1535983|P2|STARTED|Phase 1||33
625518|NCT00246805|1535984|P1|STARTED|Phase 1||34
625519|NCT00246753|1535990|P1|NOT COMPLETED|Overall Study||8
625520|NCT00246753|1535990|P1|COMPLETED|Overall Study||21
625521|NCT00246753|1535990|P1|STARTED|Overall Study||29
625522|NCT00246740|1535998|P2|NOT COMPLETED|Experimental Phase||0
625523|NCT00246740|1535999|P1|NOT COMPLETED|Experimental Phase||0
625524|NCT00246740|1535998|P2|COMPLETED|Experimental Phase||20
625525|NCT00246740|1535999|P1|COMPLETED|Experimental Phase||22
625526|NCT00246740|1535998|P2|STARTED|Experimental Phase||20
625527|NCT00246740|1535999|P1|STARTED|Experimental Phase||22
625528|NCT00246740|1535998|P2|NOT COMPLETED|Initial Enrollment||8
625529|NCT00246740|1535999|P1|NOT COMPLETED|Initial Enrollment||6
625530|NCT00246740|1535998|P2|COMPLETED|Initial Enrollment||20
625531|NCT00246740|1535999|P1|COMPLETED|Initial Enrollment||22
625532|NCT00246740|1535998|P2|STARTED|Initial Enrollment||28
625533|NCT00246740|1535999|P1|STARTED|Initial Enrollment||28
625534|NCT00246571|1536023|P2|NOT COMPLETED|Overall Study||104
625535|NCT00246571|1536024|P1|NOT COMPLETED|Overall Study||113
625536|NCT00246571|1536023|P2|COMPLETED|Overall Study||0
625537|NCT00246571|1536024|P1|COMPLETED|Overall Study||0
625538|NCT00246571|1536023|P2|Randomized But Not Treated|Overall Study||1
625539|NCT00246571|1536024|P1|Randomized But Not Treated|Overall Study||3
625540|NCT00246571|1536023|P2|STARTED|Overall Study||104
625541|NCT00246571|1536024|P1|STARTED|Overall Study||113
625542|NCT00246519|1536064|P2|NOT COMPLETED|Overall Study||64
625543|NCT00246519|1536065|P1|NOT COMPLETED|Overall Study||56
625544|NCT00246519|1536064|P2|COMPLETED|Overall Study||382
625545|NCT00246519|1536065|P1|COMPLETED|Overall Study||386
625546|NCT00246519|1536064|P2|STARTED|Overall Study||446
625547|NCT00246519|1536065|P1|STARTED|Overall Study||442
625548|NCT00246376|1536076|P5|NOT COMPLETED|Overall Study||17
625549|NCT00246376|1536077|P4|NOT COMPLETED|Overall Study||26
625550|NCT00246376|1536078|P3|NOT COMPLETED|Overall Study||16
625551|NCT00246376|1536079|P2|NOT COMPLETED|Overall Study||19
625552|NCT00246376|1536080|P1|NOT COMPLETED|Overall Study||15
625553|NCT00246376|1536076|P5|COMPLETED|Overall Study||28
625554|NCT00246376|1536077|P4|COMPLETED|Overall Study||21
625555|NCT00246376|1536078|P3|COMPLETED|Overall Study||29
625556|NCT00246376|1536079|P2|COMPLETED|Overall Study||24
625557|NCT00246376|1536080|P1|COMPLETED|Overall Study||26
625558|NCT00246376|1536076|P5|After Dietary run-in at Two Weeks|Overall Study||42
625559|NCT00246376|1536077|P4|After Dietary run-in at Two Weeks|Overall Study||40
625560|NCT00246376|1536078|P3|After Dietary run-in at Two Weeks|Overall Study||41
625561|NCT00246376|1536079|P2|After Dietary run-in at Two Weeks|Overall Study||38
625562|NCT00246376|1536080|P1|After Dietary run-in at Two Weeks|Overall Study||30
625563|NCT00246376|1536076|P5|STARTED|Overall Study||45
625564|NCT00246376|1536077|P4|STARTED|Overall Study||47
625565|NCT00246376|1536078|P3|STARTED|Overall Study||45
625566|NCT00246376|1536079|P2|STARTED|Overall Study||43
625567|NCT00246376|1536080|P1|STARTED|Overall Study||41
625568|NCT00246337|1536131|P9|NOT COMPLETED|Overall Study||11
625569|NCT00246337|1536132|P8|NOT COMPLETED|Overall Study||13
625570|NCT00246337|1536133|P7|NOT COMPLETED|Overall Study||9
625571|NCT00246337|1536134|P6|NOT COMPLETED|Overall Study||15
625572|NCT00246337|1536135|P5|NOT COMPLETED|Overall Study||4
625573|NCT00246337|1536136|P4|NOT COMPLETED|Overall Study||1
625574|NCT00246337|1536137|P3|NOT COMPLETED|Overall Study||3
625575|NCT00246337|1536138|P2|NOT COMPLETED|Overall Study||2
625576|NCT00246337|1536139|P1|NOT COMPLETED|Overall Study||32
625577|NCT00246337|1536131|P9|COMPLETED|Overall Study||34
625578|NCT00246337|1536132|P8|COMPLETED|Overall Study||40
625579|NCT00246337|1536133|P7|COMPLETED|Overall Study||45
625580|NCT00246337|1536134|P6|COMPLETED|Overall Study||39
625581|NCT00246337|1536135|P5|COMPLETED|Overall Study||12
625582|NCT00246337|1536136|P4|COMPLETED|Overall Study||16
625583|NCT00246337|1536137|P3|COMPLETED|Overall Study||15
625584|NCT00246337|1536138|P2|COMPLETED|Overall Study||14
625585|NCT00246337|1536139|P1|COMPLETED|Overall Study||115
625586|NCT00246337|1536131|P9|Completed Period (Both Doses)|Overall Study||15
625587|NCT00246337|1536132|P8|Completed Period (Both Doses)|Overall Study||13
625588|NCT00246337|1536133|P7|Completed Period (Both Doses)|Overall Study||16
625589|NCT00246337|1536134|P6|Completed Period (Both Doses)|Overall Study||10
625590|NCT00246337|1536135|P5|Completed Period (Both Doses)|Overall Study||4
625591|NCT00246337|1536136|P4|Completed Period (Both Doses)|Overall Study||11
625592|NCT00246337|1536137|P3|Completed Period (Both Doses)|Overall Study||6
625593|NCT00246337|1536138|P2|Completed Period (Both Doses)|Overall Study||10
625594|NCT00246337|1536139|P1|Completed Period (Both Doses)|Overall Study||69
625595|NCT00246337|1536131|P9|Completed Period (Initial Dose)|Overall Study||19
625596|NCT00246337|1536132|P8|Completed Period (Initial Dose)|Overall Study||27
625597|NCT00246337|1536133|P7|Completed Period (Initial Dose)|Overall Study||29
625598|NCT00246337|1536134|P6|Completed Period (Initial Dose)|Overall Study||29
625599|NCT00246337|1536135|P5|Completed Period (Initial Dose)|Overall Study||8
625600|NCT00246337|1536136|P4|Completed Period (Initial Dose)|Overall Study||5
625601|NCT00246337|1536137|P3|Completed Period (Initial Dose)|Overall Study||9
625602|NCT00246337|1536138|P2|Completed Period (Initial Dose)|Overall Study||4
625603|NCT00246337|1536139|P1|Completed Period (Initial Dose)|Overall Study||46
625604|NCT00246337|1536131|P9|STARTED|Overall Study||45
625605|NCT00246337|1536132|P8|STARTED|Overall Study||53
625606|NCT00246337|1536133|P7|STARTED|Overall Study||54
625607|NCT00246337|1536134|P6|STARTED|Overall Study||54
625608|NCT00246337|1536135|P5|STARTED|Overall Study||16
625609|NCT00246337|1536136|P4|STARTED|Overall Study||17
625610|NCT00246337|1536137|P3|STARTED|Overall Study||18
625611|NCT00246337|1536138|P2|STARTED|Overall Study||16
625612|NCT00246337|1536139|P1|STARTED|Overall Study||147
625613|NCT00246324|1536186|P1|NOT COMPLETED|Overall Study||1
625614|NCT00246324|1536186|P1|COMPLETED|Overall Study||15
625615|NCT00246324|1536186|P1|STARTED|Overall Study||16
625616|NCT00246259|1536193|P2|NOT COMPLETED|Overall Study||26
625617|NCT00246259|1536194|P1|NOT COMPLETED|Overall Study||28
625618|NCT00246259|1536193|P2|COMPLETED|Overall Study||15
625619|NCT00246259|1536194|P1|COMPLETED|Overall Study||16
625620|NCT00246259|1536193|P2|Eligible for Intent-to-treat (ITT)|Overall Study||35
625621|NCT00246259|1536194|P1|Eligible for Intent-to-treat (ITT)|Overall Study||42
625622|NCT00246259|1536193|P2|STARTED|Overall Study||41
625623|NCT00246259|1536194|P1|STARTED|Overall Study||44
625624|NCT00246090|1536228|P1|NOT COMPLETED|Overall Study||295
625625|NCT00246090|1536228|P1|COMPLETED|Overall Study||3
625626|NCT00246090|1536228|P1|STARTED|Overall Study||298
625627|NCT00246025|1536237|P4|NOT COMPLETED|Overall Study||13
625628|NCT00246025|1536238|P3|NOT COMPLETED|Overall Study||10
625629|NCT00246025|1536239|P2|NOT COMPLETED|Overall Study||9
625630|NCT00246025|1536240|P1|NOT COMPLETED|Overall Study||10
625631|NCT00246025|1536237|P4|COMPLETED|Overall Study||116
625632|NCT00246025|1536238|P3|COMPLETED|Overall Study||116
625633|NCT00246025|1536239|P2|COMPLETED|Overall Study||124
625634|NCT00246025|1536240|P1|COMPLETED|Overall Study||114
625635|NCT00246025|1536237|P4|STARTED|Overall Study||129
625636|NCT00246025|1536238|P3|STARTED|Overall Study||126
625637|NCT00246025|1536239|P2|STARTED|Overall Study||133
625638|NCT00246025|1536240|P1|STARTED|Overall Study||124
625639|NCT00246012|1536299|P9|NOT COMPLETED|Overall Study||28
625640|NCT00246012|1536300|P8|NOT COMPLETED|Overall Study||28
625641|NCT00246012|1536301|P7|NOT COMPLETED|Overall Study||31
625642|NCT00246012|1536302|P6|NOT COMPLETED|Overall Study||28
625643|NCT00246012|1536303|P5|NOT COMPLETED|Overall Study||3
625644|NCT00246012|1536304|P4|NOT COMPLETED|Overall Study||3
625645|NCT00246012|1536305|P3|NOT COMPLETED|Overall Study||2
625646|NCT00246012|1536306|P2|NOT COMPLETED|Overall Study||1
625647|NCT00246012|1536307|P1|NOT COMPLETED|Overall Study||3
625648|NCT00246012|1536299|P9|COMPLETED|Overall Study||4
625649|NCT00246012|1536300|P8|COMPLETED|Overall Study||5
625650|NCT00246012|1536301|P7|COMPLETED|Overall Study||1
625651|NCT00246012|1536302|P6|COMPLETED|Overall Study||4
625652|NCT00246012|1536303|P5|COMPLETED|Overall Study||0
625653|NCT00246012|1536304|P4|COMPLETED|Overall Study||0
625654|NCT00246012|1536305|P3|COMPLETED|Overall Study||1
625655|NCT00246012|1536306|P2|COMPLETED|Overall Study||2
625656|NCT00246012|1536307|P1|COMPLETED|Overall Study||0
625657|NCT00246012|1536299|P9|Treated|Overall Study||32
625658|NCT00246012|1536300|P8|Treated|Overall Study||33
625659|NCT00246012|1536301|P7|Treated|Overall Study||31
625660|NCT00246012|1536302|P6|Treated|Overall Study||31
625661|NCT00246012|1536303|P5|Treated|Overall Study||3
625662|NCT00246012|1536304|P4|Treated|Overall Study||3
625663|NCT00246012|1536305|P3|Treated|Overall Study||3
625664|NCT00246012|1536306|P2|Treated|Overall Study||3
625665|NCT00246012|1536307|P1|Treated|Overall Study||3
625666|NCT00246012|1536299|P9|STARTED|Overall Study||32
625667|NCT00246012|1536300|P8|STARTED|Overall Study||33
625668|NCT00246012|1536301|P7|STARTED|Overall Study||32
625669|NCT00246012|1536302|P6|STARTED|Overall Study||32
625670|NCT00246012|1536303|P5|STARTED|Overall Study||3
625671|NCT00246012|1536304|P4|STARTED|Overall Study||3
625672|NCT00246012|1536305|P3|STARTED|Overall Study||3
625673|NCT00246012|1536306|P2|STARTED|Overall Study||3
625674|NCT00246012|1536307|P1|STARTED|Overall Study||3
625675|NCT00245960|1536402|P2|NOT COMPLETED|Overall Study||28
625676|NCT00245960|1536403|P1|NOT COMPLETED|Overall Study||29
625677|NCT00245960|1536402|P2|COMPLETED|Overall Study||345
625678|NCT00245960|1536403|P1|COMPLETED|Overall Study||350
625679|NCT00245960|1536402|P2|STARTED|Overall Study||373
625680|NCT00245960|1536403|P1|STARTED|Overall Study||379
625681|NCT00245856|1536411|P2|NOT COMPLETED|Period Two||1
625682|NCT00245856|1536412|P1|NOT COMPLETED|Period Two||0
625683|NCT00245856|1536411|P2|COMPLETED|Period Two||38
625684|NCT00245856|1536412|P1|COMPLETED|Period Two||0
625685|NCT00245856|1536411|P2|STARTED|Period Two||39
625686|NCT00245856|1536412|P1|STARTED|Period Two||0
625687|NCT00245856|1536411|P2|NOT COMPLETED|Period One||0
625688|NCT00245856|1536412|P1|NOT COMPLETED|Period One||0
625689|NCT00245856|1536411|P2|COMPLETED|Period One||0
625690|NCT00245856|1536412|P1|COMPLETED|Period One||28
625691|NCT00245856|1536411|P2|STARTED|Period One||0
625692|NCT00245856|1536412|P1|STARTED|Period One||28
625693|NCT00245635|1536421|P2|NOT COMPLETED|Overall Study||0
625694|NCT00245635|1536422|P1|NOT COMPLETED|Overall Study||0
625695|NCT00245635|1536421|P2|COMPLETED|Overall Study||18
625696|NCT00245635|1536422|P1|COMPLETED|Overall Study||25
625697|NCT00245635|1536421|P2|STARTED|Overall Study||18
625698|NCT00245635|1536422|P1|STARTED|Overall Study||25
625699|NCT00245570|1536428|P6|NOT COMPLETED|Treatment Period IV||0
625700|NCT00245570|1536429|P5|NOT COMPLETED|Treatment Period IV||0
625701|NCT00245570|1536430|P4|NOT COMPLETED|Treatment Period IV||0
625702|NCT00245570|1536431|P3|NOT COMPLETED|Treatment Period IV||0
625703|NCT00245570|1536432|P2|NOT COMPLETED|Treatment Period IV||0
625704|NCT00245570|1536433|P1|NOT COMPLETED|Treatment Period IV||0
625705|NCT00245570|1536428|P6|COMPLETED|Treatment Period IV||8
625706|NCT00245570|1536429|P5|COMPLETED|Treatment Period IV||8
625707|NCT00245570|1536430|P4|COMPLETED|Treatment Period IV||8
625708|NCT00245570|1536431|P3|COMPLETED|Treatment Period IV||8
625709|NCT00245570|1536432|P2|COMPLETED|Treatment Period IV||7
625710|NCT00245570|1536433|P1|COMPLETED|Treatment Period IV||7
625711|NCT00245570|1536428|P6|STARTED|Treatment Period IV||8
625712|NCT00245570|1536429|P5|STARTED|Treatment Period IV||8
625713|NCT00245570|1536430|P4|STARTED|Treatment Period IV||8
625714|NCT00245570|1536431|P3|STARTED|Treatment Period IV||8
625715|NCT00245570|1536432|P2|STARTED|Treatment Period IV||7
625716|NCT00245570|1536433|P1|STARTED|Treatment Period IV||7
625717|NCT00245570|1536428|P6|NOT COMPLETED|Washout Between Periods III and IV||0
625718|NCT00245570|1536429|P5|NOT COMPLETED|Washout Between Periods III and IV||0
625719|NCT00245570|1536430|P4|NOT COMPLETED|Washout Between Periods III and IV||0
625720|NCT00245570|1536431|P3|NOT COMPLETED|Washout Between Periods III and IV||0
625721|NCT00245570|1536432|P2|NOT COMPLETED|Washout Between Periods III and IV||1
625722|NCT00245570|1536433|P1|NOT COMPLETED|Washout Between Periods III and IV||0
625723|NCT00245570|1536428|P6|COMPLETED|Washout Between Periods III and IV||8
625724|NCT00245570|1536429|P5|COMPLETED|Washout Between Periods III and IV||8
625725|NCT00245570|1536430|P4|COMPLETED|Washout Between Periods III and IV||8
625726|NCT00245570|1536431|P3|COMPLETED|Washout Between Periods III and IV||8
625727|NCT00245570|1536432|P2|COMPLETED|Washout Between Periods III and IV||7
625728|NCT00245570|1536433|P1|COMPLETED|Washout Between Periods III and IV||7
625729|NCT00245570|1536428|P6|STARTED|Washout Between Periods III and IV||8
625730|NCT00245570|1536429|P5|STARTED|Washout Between Periods III and IV||8
625731|NCT00245570|1536430|P4|STARTED|Washout Between Periods III and IV||8
625732|NCT00245570|1536431|P3|STARTED|Washout Between Periods III and IV||8
625733|NCT00245570|1536432|P2|STARTED|Washout Between Periods III and IV|1 pt in the montelukast/placebo/salmeterol group discontinued during washout period 2 after placebo|8
625734|NCT00245570|1536433|P1|STARTED|Washout Between Periods III and IV||7
625735|NCT00245570|1536428|P6|NOT COMPLETED|Treatment Period III||0
625736|NCT00245570|1536429|P5|NOT COMPLETED|Treatment Period III||0
625737|NCT00245570|1536430|P4|NOT COMPLETED|Treatment Period III||0
625738|NCT00245570|1536431|P3|NOT COMPLETED|Treatment Period III||0
625739|NCT00245570|1536432|P2|NOT COMPLETED|Treatment Period III||0
625740|NCT00245570|1536433|P1|NOT COMPLETED|Treatment Period III||0
625741|NCT00245570|1536428|P6|COMPLETED|Treatment Period III||8
625742|NCT00245570|1536429|P5|COMPLETED|Treatment Period III||8
625743|NCT00245570|1536430|P4|COMPLETED|Treatment Period III||8
625744|NCT00245570|1536431|P3|COMPLETED|Treatment Period III||8
625745|NCT00245570|1536432|P2|COMPLETED|Treatment Period III||8
625746|NCT00245570|1536433|P1|COMPLETED|Treatment Period III||7
625747|NCT00245570|1536428|P6|STARTED|Treatment Period III||8
625748|NCT00245570|1536429|P5|STARTED|Treatment Period III||8
625749|NCT00245570|1536430|P4|STARTED|Treatment Period III||8
625750|NCT00245570|1536431|P3|STARTED|Treatment Period III||8
625751|NCT00245570|1536432|P2|STARTED|Treatment Period III||8
625752|NCT00245570|1536433|P1|STARTED|Treatment Period III||7
625753|NCT00245570|1536428|P6|NOT COMPLETED|Washout Between Periods II and III||0
625754|NCT00245570|1536429|P5|NOT COMPLETED|Washout Between Periods II and III||0
625755|NCT00245570|1536430|P4|NOT COMPLETED|Washout Between Periods II and III||0
625756|NCT00245570|1536431|P3|NOT COMPLETED|Washout Between Periods II and III||0
625757|NCT00245570|1536432|P2|NOT COMPLETED|Washout Between Periods II and III||0
625758|NCT00245570|1536433|P1|NOT COMPLETED|Washout Between Periods II and III||0
625759|NCT00245570|1536428|P6|COMPLETED|Washout Between Periods II and III||8
625760|NCT00245570|1536429|P5|COMPLETED|Washout Between Periods II and III||8
625761|NCT00245570|1536430|P4|COMPLETED|Washout Between Periods II and III||8
625762|NCT00245570|1536431|P3|COMPLETED|Washout Between Periods II and III||8
625763|NCT00245570|1536432|P2|COMPLETED|Washout Between Periods II and III||8
625764|NCT00245570|1536433|P1|COMPLETED|Washout Between Periods II and III||7
625765|NCT00245570|1536428|P6|STARTED|Washout Between Periods II and III||8
625766|NCT00245570|1536429|P5|STARTED|Washout Between Periods II and III||8
625767|NCT00245570|1536430|P4|STARTED|Washout Between Periods II and III||8
625768|NCT00245570|1536431|P3|STARTED|Washout Between Periods II and III||8
625769|NCT00245570|1536432|P2|STARTED|Washout Between Periods II and III||8
625770|NCT00245570|1536433|P1|STARTED|Washout Between Periods II and III||7
625771|NCT00245570|1536428|P6|NOT COMPLETED|Treatment Period II||0
625772|NCT00245570|1536429|P5|NOT COMPLETED|Treatment Period II||0
625773|NCT00245570|1536430|P4|NOT COMPLETED|Treatment Period II||0
625774|NCT00245570|1536431|P3|NOT COMPLETED|Treatment Period II||0
625775|NCT00245570|1536432|P2|NOT COMPLETED|Treatment Period II||0
625776|NCT00245570|1536433|P1|NOT COMPLETED|Treatment Period II||0
625777|NCT00245570|1536428|P6|COMPLETED|Treatment Period II||8
625778|NCT00245570|1536429|P5|COMPLETED|Treatment Period II||8
625779|NCT00245570|1536430|P4|COMPLETED|Treatment Period II||8
625780|NCT00245570|1536431|P3|COMPLETED|Treatment Period II||8
625781|NCT00245570|1536432|P2|COMPLETED|Treatment Period II||8
625782|NCT00245570|1536433|P1|COMPLETED|Treatment Period II||7
625783|NCT00245570|1536428|P6|STARTED|Treatment Period II||8
625784|NCT00245570|1536429|P5|STARTED|Treatment Period II||8
625785|NCT00245570|1536430|P4|STARTED|Treatment Period II||8
625786|NCT00245570|1536431|P3|STARTED|Treatment Period II||8
625787|NCT00245570|1536432|P2|STARTED|Treatment Period II||8
625788|NCT00245570|1536433|P1|STARTED|Treatment Period II||7
625789|NCT00245557|1536479|P2|NOT COMPLETED|Overall Study||16
625790|NCT00245557|1536480|P1|NOT COMPLETED|Overall Study||6
625791|NCT00245557|1536479|P2|COMPLETED|Overall Study||10
625792|NCT00245557|1536480|P1|COMPLETED|Overall Study||11
625793|NCT00245557|1536479|P2|STARTED|Overall Study||26
625794|NCT00245557|1536480|P1|STARTED|Overall Study||17
625795|NCT00245518|1536493|P2|NOT COMPLETED|Overall Study||0
625796|NCT00245518|1536494|P1|NOT COMPLETED|Overall Study||0
625797|NCT00245518|1536493|P2|COMPLETED|Overall Study||16
625798|NCT00245518|1536494|P1|COMPLETED|Overall Study||17
625799|NCT00245518|1536493|P2|STARTED|Overall Study||16
625800|NCT00245518|1536494|P1|STARTED|Overall Study||17
625801|NCT00245466|1536567|P3|NOT COMPLETED|Overall Study||37
625802|NCT00245466|1536568|P2|NOT COMPLETED|Overall Study||44
625803|NCT00245466|1536569|P1|NOT COMPLETED|Overall Study||36
625804|NCT00245466|1536567|P3|COMPLETED|Overall Study||3
625805|NCT00245466|1536568|P2|COMPLETED|Overall Study||2
625806|NCT00245466|1536569|P1|COMPLETED|Overall Study|Defined as those participants ongoing when the extension study was terminated|7
625807|NCT00245466|1536567|P3|Started FE200486 CS02A|Overall Study||26
625808|NCT00245466|1536568|P2|Started FE200486 CS02A|Overall Study||30
625809|NCT00245466|1536569|P1|Started FE200486 CS02A|Overall Study||32
625810|NCT00245466|1536567|P3|STARTED|Overall Study||40
625811|NCT00245466|1536568|P2|STARTED|Overall Study||46
625812|NCT00245466|1536569|P1|STARTED|Overall Study||43
625813|NCT00245219|1536586|P3|NOT COMPLETED|Overall Study||2
625814|NCT00245219|1536587|P2|NOT COMPLETED|Overall Study||6
625815|NCT00245219|1536588|P1|NOT COMPLETED|Overall Study||6
625816|NCT00245219|1536586|P3|COMPLETED|Overall Study||58
625817|NCT00245219|1536587|P2|COMPLETED|Overall Study||88
625818|NCT00245219|1536588|P1|COMPLETED|Overall Study||85
625819|NCT00245219|1536586|P3|STARTED|Overall Study||60
625820|NCT00245219|1536587|P2|STARTED|Overall Study||94
625821|NCT00245219|1536588|P1|STARTED|Overall Study||91
625822|NCT00245128|1536602|P1|NOT COMPLETED|Overall Study||10
625823|NCT00245128|1536602|P1|COMPLETED|Overall Study||0
625824|NCT00245128|1536602|P1|STARTED|Overall Study||10
625825|NCT00245102|1536612|P6|NOT COMPLETED|Overall Study||4
625826|NCT00245102|1536613|P5|NOT COMPLETED|Overall Study||0
625827|NCT00245102|1536614|P4|NOT COMPLETED|Overall Study||3
625828|NCT00245102|1536615|P3|NOT COMPLETED|Overall Study||7
625829|NCT00245102|1536616|P2|NOT COMPLETED|Overall Study||4
625830|NCT00245102|1536617|P1|NOT COMPLETED|Overall Study||7
625831|NCT00245102|1536612|P6|COMPLETED|Overall Study||19
625832|NCT00245102|1536613|P5|COMPLETED|Overall Study||5
625833|NCT00245102|1536614|P4|COMPLETED|Overall Study||10
625834|NCT00245102|1536615|P3|COMPLETED|Overall Study||39
625835|NCT00245102|1536616|P2|COMPLETED|Overall Study||12
625836|NCT00245102|1536617|P1|COMPLETED|Overall Study||37
625837|NCT00245102|1536612|P6|STARTED|Overall Study||23
625838|NCT00245102|1536613|P5|STARTED|Overall Study||5
625839|NCT00245102|1536614|P4|STARTED|Overall Study||13
625840|NCT00245102|1536615|P3|STARTED|Overall Study||46
625841|NCT00245102|1536616|P2|STARTED|Overall Study||16
625842|NCT00245102|1536617|P1|STARTED|Overall Study||44
625843|NCT00245063|1536633|P2|NOT COMPLETED|Overall Study||5
625844|NCT00245063|1536634|P1|NOT COMPLETED|Overall Study||7
625845|NCT00245063|1536633|P2|COMPLETED|Overall Study||8
625846|NCT00245063|1536634|P1|COMPLETED|Overall Study||5
625847|NCT00245063|1536633|P2|STARTED|Overall Study||13
625848|NCT00245063|1536634|P1|STARTED|Overall Study||12
625849|NCT00245050|1536642|P2|NOT COMPLETED|Overall Study||2
625850|NCT00245050|1536643|P1|NOT COMPLETED|Overall Study||3
625851|NCT00245050|1536642|P2|COMPLETED|Overall Study||14
625852|NCT00245050|1536643|P1|COMPLETED|Overall Study||15
625853|NCT00245050|1536642|P2|STARTED|Overall Study||16
625854|NCT00245050|1536643|P1|STARTED|Overall Study||18
625855|NCT00245037|1536651|P1|NOT COMPLETED|Overall Study||17
625856|NCT00245037|1536651|P1|COMPLETED|Overall Study|17 participants died from infectious complications.|130
625857|NCT00245037|1536651|P1|STARTED|Overall Study||147
625858|NCT00245011|1536661|P1|NOT COMPLETED|Overall Study||1
625859|NCT00245011|1536661|P1|COMPLETED|Overall Study|Subject had disease progression prior to completing study.|10
625860|NCT00245011|1536661|P1|STARTED|Overall Study||11
625861|NCT00244985|1536665|P1|NOT COMPLETED|Overall Study||0
625862|NCT00244985|1536665|P1|COMPLETED|Overall Study||42
625863|NCT00244985|1536665|P1|STARTED|Overall Study||42
625864|NCT00244933|1536673|P1|NOT COMPLETED|Overall Study||2
625865|NCT00244933|1536673|P1|COMPLETED|Overall Study||17
625866|NCT00244933|1536673|P1|STARTED|Overall Study||19
625867|NCT00244881|1536677|P1|NOT COMPLETED|Overall Study||3
625868|NCT00244881|1536677|P1|COMPLETED|Overall Study||23
625869|NCT00244881|1536677|P1|STARTED|Overall Study||26
625870|NCT00244855|1536685|P2|NOT COMPLETED|Overall Study||1
625871|NCT00244855|1536686|P1|NOT COMPLETED|Overall Study||0
625872|NCT00244855|1536685|P2|COMPLETED|Overall Study||24
625873|NCT00244855|1536686|P1|COMPLETED|Overall Study||7
625874|NCT00244855|1536685|P2|STARTED|Overall Study||25
625875|NCT00244855|1536686|P1|STARTED|Overall Study||7
625876|NCT00244764|1536694|P1|NOT COMPLETED|Overall Study||96
625877|NCT00244764|1536694|P1|COMPLETED|Overall Study||129
625878|NCT00244764|1536694|P1|STARTED|Overall Study||225
625879|NCT00244751|1536704|P3|NOT COMPLETED|Overall Study||10
625880|NCT00244751|1536705|P2|NOT COMPLETED|Overall Study||15
625881|NCT00244751|1536706|P1|NOT COMPLETED|Overall Study||16
625882|NCT00244751|1536704|P3|COMPLETED|Overall Study||78
625883|NCT00244751|1536705|P2|COMPLETED|Overall Study||74
625884|NCT00244751|1536706|P1|COMPLETED|Overall Study||72
625885|NCT00244751|1536704|P3|STARTED|Overall Study||88
625886|NCT00244751|1536705|P2|STARTED|Overall Study||89
625887|NCT00244751|1536706|P1|STARTED|Overall Study||88
625888|NCT00244725|1536807|P4|NOT COMPLETED|Overall Study||21
625889|NCT00244725|1536808|P3|NOT COMPLETED|Overall Study||24
625890|NCT00244725|1536809|P2|NOT COMPLETED|Overall Study||19
625891|NCT00244725|1536810|P1|NOT COMPLETED|Overall Study||23
625892|NCT00244725|1536807|P4|COMPLETED|Overall Study||216
625893|NCT00244725|1536808|P3|COMPLETED|Overall Study||215
625894|NCT00244725|1536809|P2|COMPLETED|Overall Study||226
625895|NCT00244725|1536810|P1|COMPLETED|Overall Study||214
625896|NCT00244725|1536807|P4|STARTED|Overall Study||237
625897|NCT00244725|1536808|P3|STARTED|Overall Study||239
625898|NCT00244725|1536809|P2|STARTED|Overall Study||245
625899|NCT00244725|1536810|P1|STARTED|Overall Study||237
625900|NCT00244712|1536866|P2|NOT COMPLETED|Overall Study||124
625901|NCT00244712|1536867|P1|NOT COMPLETED|Overall Study||109
625902|NCT00244712|1536866|P2|COMPLETED|Overall Study||221
625903|NCT00244712|1536867|P1|COMPLETED|Overall Study||234
625904|NCT00244712|1536866|P2|STARTED|Overall Study||345
625905|NCT00244712|1536867|P1|STARTED|Overall Study||343
625906|NCT00244621|1536902|P3|NOT COMPLETED|Open-label Treatment Period||2
625907|NCT00244621|1536903|P2|NOT COMPLETED|Open-label Treatment Period||1
625908|NCT00244621|1536904|P1|NOT COMPLETED|Open-label Treatment Period||1
625909|NCT00244621|1536902|P3|COMPLETED|Open-label Treatment Period||28
625910|NCT00244621|1536903|P2|COMPLETED|Open-label Treatment Period||28
625911|NCT00244621|1536904|P1|COMPLETED|Open-label Treatment Period||25
625912|NCT00244621|1536902|P3|STARTED|Open-label Treatment Period||30
625913|NCT00244621|1536903|P2|STARTED|Open-label Treatment Period||29
625914|NCT00244621|1536904|P1|STARTED|Open-label Treatment Period|One participant discontinued study due to Adverse Event after completing the double-blind period.|26
625915|NCT00244621|1536902|P3|NOT COMPLETED|Double-blind Treatment Period||2
625916|NCT00244621|1536903|P2|NOT COMPLETED|Double-blind Treatment Period||3
625917|NCT00244621|1536904|P1|NOT COMPLETED|Double-blind Treatment Period||2
625918|NCT00244621|1536902|P3|COMPLETED|Double-blind Treatment Period||30
625919|NCT00244621|1536903|P2|COMPLETED|Double-blind Treatment Period||29
625920|NCT00244621|1536904|P1|COMPLETED|Double-blind Treatment Period||27
625921|NCT00244621|1536902|P3|STARTED|Double-blind Treatment Period||32
625922|NCT00244621|1536903|P2|STARTED|Double-blind Treatment Period||32
625923|NCT00244621|1536904|P1|STARTED|Double-blind Treatment Period||29
625924|NCT00244374|1536921|P5|NOT COMPLETED|Vaccine Adherence Cohort||0
625925|NCT00244374|1536922|P4|NOT COMPLETED|Vaccine Adherence Cohort||0
625926|NCT00244374|1536923|P3|NOT COMPLETED|Vaccine Adherence Cohort||0
625927|NCT00244374|1536924|P2|NOT COMPLETED|Vaccine Adherence Cohort||0
625928|NCT00244374|1536925|P1|NOT COMPLETED|Vaccine Adherence Cohort||0
625929|NCT00244374|1536921|P5|COMPLETED|Vaccine Adherence Cohort||41
625930|NCT00244374|1536922|P4|COMPLETED|Vaccine Adherence Cohort||36
625931|NCT00244374|1536923|P3|COMPLETED|Vaccine Adherence Cohort||43
625932|NCT00244374|1536924|P2|COMPLETED|Vaccine Adherence Cohort||47
625933|NCT00244374|1536925|P1|COMPLETED|Vaccine Adherence Cohort||0
625934|NCT00244374|1536921|P5|STARTED|Vaccine Adherence Cohort||41
625935|NCT00244374|1536922|P4|STARTED|Vaccine Adherence Cohort||36
625936|NCT00244374|1536923|P3|STARTED|Vaccine Adherence Cohort||43
625937|NCT00244374|1536924|P2|STARTED|Vaccine Adherence Cohort||47
625938|NCT00244374|1536925|P1|STARTED|Vaccine Adherence Cohort|Eligible and willing cross-sectional study participants progressed to adherence cohort randomization|0
625939|NCT00244374|1536921|P5|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
625940|NCT00244374|1536922|P4|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
625941|NCT00244374|1536923|P3|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
625942|NCT00244374|1536924|P2|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
625943|NCT00244374|1536925|P1|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||273
625944|NCT00244374|1536921|P5|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
625945|NCT00244374|1536922|P4|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
625946|NCT00244374|1536923|P3|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
625947|NCT00244374|1536924|P2|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
625948|NCT00244374|1536925|P1|COMPLETED|Evaluation for Vaccine Adherence Cohort||167
625949|NCT00244374|1536921|P5|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
625950|NCT00244374|1536922|P4|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
625951|NCT00244374|1536923|P3|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
625952|NCT00244374|1536924|P2|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
625953|NCT00244374|1536925|P1|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||217
625954|NCT00244374|1536921|P5|STARTED|Evaluation for Vaccine Adherence Cohort||0
625955|NCT00244374|1536922|P4|STARTED|Evaluation for Vaccine Adherence Cohort||0
625956|NCT00244374|1536923|P3|STARTED|Evaluation for Vaccine Adherence Cohort||0
625957|NCT00244374|1536924|P2|STARTED|Evaluation for Vaccine Adherence Cohort||0
625958|NCT00244374|1536925|P1|STARTED|Evaluation for Vaccine Adherence Cohort|440 study participants enrolled prior to 3/31/2007 were evaluated for vaccine adherence cohort|440
625959|NCT00244374|1536921|P5|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
625960|NCT00244374|1536922|P4|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
625961|NCT00244374|1536923|P3|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
625962|NCT00244374|1536924|P2|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
625963|NCT00244374|1536925|P1|NOT COMPLETED|Pre-Randomization Cross-sectional Study||137
625964|NCT00244374|1536921|P5|COMPLETED|Pre-Randomization Cross-sectional Study||0
625965|NCT00244374|1536922|P4|COMPLETED|Pre-Randomization Cross-sectional Study||0
625966|NCT00244374|1536923|P3|COMPLETED|Pre-Randomization Cross-sectional Study||0
625967|NCT00244374|1536924|P2|COMPLETED|Pre-Randomization Cross-sectional Study||0
625968|NCT00244374|1536925|P1|COMPLETED|Pre-Randomization Cross-sectional Study||409
625969|NCT00244374|1536921|P5|STARTED|Pre-Randomization Cross-sectional Study||0
625970|NCT00244374|1536922|P4|STARTED|Pre-Randomization Cross-sectional Study||0
625971|NCT00244374|1536923|P3|STARTED|Pre-Randomization Cross-sectional Study||0
625972|NCT00244374|1536924|P2|STARTED|Pre-Randomization Cross-sectional Study||0
625973|NCT00244374|1536925|P1|STARTED|Pre-Randomization Cross-sectional Study||546
625974|NCT00244140|1536943|P2|NOT COMPLETED|Overall Study||0
625975|NCT00244140|1536944|P1|NOT COMPLETED|Overall Study||0
625976|NCT00244140|1536943|P2|COMPLETED|Overall Study||22
625977|NCT00244140|1536944|P1|COMPLETED|Overall Study||412
625978|NCT00244140|1536943|P2|STARTED|Overall Study||22
625979|NCT00244140|1536944|P1|STARTED|Overall Study||412
625980|NCT00244101|1536959|P3|NOT COMPLETED|Overall Study||0
625981|NCT00244101|1536960|P2|NOT COMPLETED|Overall Study||0
625982|NCT00244101|1536961|P1|NOT COMPLETED|Overall Study||0
625983|NCT00244101|1536959|P3|COMPLETED|Overall Study||216
625984|NCT00244101|1536960|P2|COMPLETED|Overall Study||223
625985|NCT00244101|1536961|P1|COMPLETED|Overall Study||209
625986|NCT00244101|1536959|P3|STARTED|Overall Study||216
625987|NCT00244101|1536960|P2|STARTED|Overall Study||223
625988|NCT00244101|1536961|P1|STARTED|Overall Study||209
625989|NCT00244010|1536971|P2|NOT COMPLETED|Overall Study||0
625990|NCT00244010|1536972|P1|NOT COMPLETED|Overall Study||0
625991|NCT00244010|1536971|P2|COMPLETED|Overall Study||2
625992|NCT00244010|1536972|P1|COMPLETED|Overall Study||2
625993|NCT00244010|1536971|P2|STARTED|Overall Study||2
625994|NCT00244010|1536972|P1|STARTED|Overall Study||2
625995|NCT00243932|1536981|P3|NOT COMPLETED|Stage 2: Efficacy||0
625996|NCT00243932|1536982|P2|NOT COMPLETED|Stage 2: Efficacy||0
625997|NCT00243932|1536983|P1|NOT COMPLETED|Stage 2: Efficacy||0
625998|NCT00243932|1536981|P3|COMPLETED|Stage 2: Efficacy||0
625999|NCT00243932|1536982|P2|COMPLETED|Stage 2: Efficacy||40
626000|NCT00243932|1536983|P1|COMPLETED|Stage 2: Efficacy||40
626001|NCT00243932|1536981|P3|STARTED|Stage 2: Efficacy|No new pts. randomized because selection procedure in Stage 1 selected the 2,700 mg dose.|0
626002|NCT00243932|1536982|P2|STARTED|Stage 2: Efficacy|40 newly randomized pts. Efficacy analysis included Stage 1 + Stage 2 patients|40
626003|NCT00243932|1536983|P1|STARTED|Stage 2: Efficacy|40 newly randomized pts. Efficacy analysis included Stage 1 + Stage 2 patients|40
626004|NCT00243932|1536981|P3|NOT COMPLETED|Stage 1: Dose Selection||0
626005|NCT00243932|1536982|P2|NOT COMPLETED|Stage 1: Dose Selection||0
626006|NCT00243932|1536983|P1|NOT COMPLETED|Stage 1: Dose Selection||2
626007|NCT00243932|1536981|P3|COMPLETED|Stage 1: Dose Selection||35
626008|NCT00243932|1536982|P2|COMPLETED|Stage 1: Dose Selection||35
626009|NCT00243932|1536983|P1|COMPLETED|Stage 1: Dose Selection||33
626010|NCT00243932|1536981|P3|STARTED|Stage 1: Dose Selection||35
626011|NCT00243932|1536982|P2|STARTED|Stage 1: Dose Selection||35
626012|NCT00243932|1536983|P1|STARTED|Stage 1: Dose Selection||35
626013|NCT00243919|1536994|P3|NOT COMPLETED|Overall Study||11
626014|NCT00243919|1536995|P2|NOT COMPLETED|Overall Study||18
626015|NCT00243919|1536996|P1|NOT COMPLETED|Overall Study||17
626016|NCT00243919|1536994|P3|COMPLETED|Overall Study||115
626017|NCT00243919|1536995|P2|COMPLETED|Overall Study||125
626018|NCT00243919|1536996|P1|COMPLETED|Overall Study||122
626019|NCT00243919|1536994|P3|STARTED|Overall Study||126
626020|NCT00243919|1536995|P2|STARTED|Overall Study||143
626021|NCT00243919|1536996|P1|STARTED|Overall Study||139
626022|NCT00243659|1537039|P2|NOT COMPLETED|Overall Study||3
626023|NCT00243659|1537040|P1|NOT COMPLETED|Overall Study||2
626024|NCT00243659|1537039|P2|COMPLETED|Overall Study||5
626025|NCT00243659|1537040|P1|COMPLETED|Overall Study||20
626026|NCT00243659|1537039|P2|STARTED|Overall Study||8
626027|NCT00243659|1537040|P1|STARTED|Overall Study||22
626028|NCT00243503|1537048|P1|NOT COMPLETED|Overall Study||58
626029|NCT00243503|1537048|P1|COMPLETED|Overall Study||2
626030|NCT00243503|1537048|P1|STARTED|Overall Study|3 participants discontinued and only took Trastuzumab.|60
626031|NCT00243412|1537065|P2|NOT COMPLETED|Overall Study||11
626032|NCT00243412|1537066|P1|NOT COMPLETED|Overall Study||10
626033|NCT00243412|1537065|P2|COMPLETED|Overall Study|Completed Week 104|10
626034|NCT00243412|1537066|P1|COMPLETED|Overall Study|Completed Week 104|11
626035|NCT00243412|1537065|P2|Safety Evaluable|Overall Study||20
626036|NCT00243412|1537066|P1|Safety Evaluable|Overall Study||21
626037|NCT00243412|1537065|P2|STARTED|Overall Study|Intent to treat|21
626038|NCT00243412|1537066|P1|STARTED|Overall Study|Intent to treat|21
626039|NCT00243386|1537092|P3|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0
626040|NCT00243386|1537093|P2|NOT COMPLETED|PK-Driven or Standard Prophylaxis||3
626041|NCT00243386|1537094|P1|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0
626042|NCT00243386|1537092|P3|COMPLETED|PK-Driven or Standard Prophylaxis||32
626043|NCT00243386|1537093|P2|COMPLETED|PK-Driven or Standard Prophylaxis||31
626044|NCT00243386|1537094|P1|COMPLETED|PK-Driven or Standard Prophylaxis||0
626045|NCT00243386|1537092|P3|STARTED|PK-Driven or Standard Prophylaxis||32
626046|NCT00243386|1537093|P2|STARTED|PK-Driven or Standard Prophylaxis||34
626047|NCT00243386|1537094|P1|STARTED|PK-Driven or Standard Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
626048|NCT00243386|1537092|P3|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0
626049|NCT00243386|1537093|P2|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0
626050|NCT00243386|1537094|P1|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||3
626051|NCT00243386|1537092|P3|COMPLETED|End of Part 1, But Prior to Prophylaxis||0
626052|NCT00243386|1537093|P2|COMPLETED|End of Part 1, But Prior to Prophylaxis||0
626053|NCT00243386|1537094|P1|COMPLETED|End of Part 1, But Prior to Prophylaxis||66
626054|NCT00243386|1537092|P3|STARTED|End of Part 1, But Prior to Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
626055|NCT00243386|1537093|P2|STARTED|End of Part 1, But Prior to Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
626056|NCT00243386|1537094|P1|STARTED|End of Part 1, But Prior to Prophylaxis||69
626057|NCT00243386|1537092|P3|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0
626058|NCT00243386|1537093|P2|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0
626059|NCT00243386|1537094|P1|NOT COMPLETED|On-Demand Regimen (Study Part 1)||4
626060|NCT00243386|1537092|P3|COMPLETED|On-Demand Regimen (Study Part 1)||0
626061|NCT00243386|1537093|P2|COMPLETED|On-Demand Regimen (Study Part 1)||0
626062|NCT00243386|1537094|P1|COMPLETED|On-Demand Regimen (Study Part 1)||69
626063|NCT00243386|1537092|P3|STARTED|On-Demand Regimen (Study Part 1)|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
626064|NCT00243386|1537093|P2|STARTED|On-Demand Regimen (Study Part 1)|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
626065|NCT00243386|1537094|P1|STARTED|On-Demand Regimen (Study Part 1)||73
626066|NCT00243347|1537159|P1|NOT COMPLETED|Overall Study||19
626067|NCT00243347|1537159|P1|COMPLETED|Overall Study|Completed study|0
626068|NCT00243347|1537159|P1|STARTED|Overall Study|Treated|19
626069|NCT00243269|1537168|P4|NOT COMPLETED|Overall Study||4
626070|NCT00243269|1537169|P3|NOT COMPLETED|Overall Study||1
626071|NCT00243269|1537170|P2|NOT COMPLETED|Overall Study||1
626072|NCT00243269|1537171|P1|NOT COMPLETED|Overall Study||3
626073|NCT00243269|1537168|P4|COMPLETED|Overall Study||25
626074|NCT00243269|1537169|P3|COMPLETED|Overall Study||11
626075|NCT00243269|1537170|P2|COMPLETED|Overall Study||10
626076|NCT00243269|1537171|P1|COMPLETED|Overall Study||28
626077|NCT00243269|1537168|P4|STARTED|Overall Study||29
626078|NCT00243269|1537169|P3|STARTED|Overall Study||12
626079|NCT00243269|1537170|P2|STARTED|Overall Study||11
626080|NCT00243269|1537171|P1|STARTED|Overall Study||31
626081|NCT00243243|1537187|P2|NOT COMPLETED|Overall Study||0
626082|NCT00243243|1537188|P1|NOT COMPLETED|Overall Study||0
626083|NCT00243243|1537187|P2|COMPLETED|Overall Study||10
626084|NCT00243243|1537188|P1|COMPLETED|Overall Study||10
626085|NCT00243243|1537187|P2|STARTED|Overall Study||10
626086|NCT00243243|1537188|P1|STARTED|Overall Study||10
626087|NCT00243191|1537194|P1|NOT COMPLETED|Overall Study||0
626088|NCT00243191|1537194|P1|COMPLETED|Overall Study||18
626089|NCT00243191|1537194|P1|STARTED|Overall Study||18
626090|NCT00243074|1537198|P1|NOT COMPLETED|Overall Study||54
626091|NCT00243074|1537198|P1|COMPLETED|Overall Study||0
626092|NCT00243074|1537198|P1|STARTED|Overall Study||54
626093|NCT00243061|1537208|P1|NOT COMPLETED|Overall Study||0
626094|NCT00243061|1537208|P1|COMPLETED|Overall Study||24
626095|NCT00243061|1537208|P1|STARTED|Overall Study||24
626096|NCT00243022|1537224|P2|NOT COMPLETED|Overall Study||1
626097|NCT00243022|1537225|P1|NOT COMPLETED|Overall Study||2
626098|NCT00243022|1537224|P2|COMPLETED|Overall Study||4
626099|NCT00243022|1537225|P1|COMPLETED|Overall Study||5
626100|NCT00243022|1537224|P2|STARTED|Overall Study||5
626101|NCT00243022|1537225|P1|STARTED|Overall Study||7
626102|NCT00242710|1537247|P4|NOT COMPLETED|Study Extension (up to Year 2)||10
626103|NCT00242710|1537248|P3|NOT COMPLETED|Study Extension (up to Year 2)||15
626104|NCT00242710|1537249|P2|NOT COMPLETED|Study Extension (up to Year 2)||29
626105|NCT00242710|1537250|P1|NOT COMPLETED|Study Extension (up to Year 2)||27
626106|NCT00242710|1537247|P4|COMPLETED|Study Extension (up to Year 2)||84
626107|NCT00242710|1537248|P3|COMPLETED|Study Extension (up to Year 2)||69
626108|NCT00242710|1537249|P2|COMPLETED|Study Extension (up to Year 2)||148
626109|NCT00242710|1537250|P1|COMPLETED|Study Extension (up to Year 2)||141
626110|NCT00242710|1537247|P4|STARTED|Study Extension (up to Year 2)||94
626111|NCT00242710|1537248|P3|STARTED|Study Extension (up to Year 2)||84
626112|NCT00242710|1537249|P2|STARTED|Study Extension (up to Year 2)||177
626113|NCT00242710|1537250|P1|STARTED|Study Extension (up to Year 2)||168
626114|NCT00242710|1537247|P4|NOT COMPLETED|Period Between Core Study and Extension||49
626115|NCT00242710|1537248|P3|NOT COMPLETED|Period Between Core Study and Extension||48
626116|NCT00242710|1537249|P2|NOT COMPLETED|Period Between Core Study and Extension||112
626117|NCT00242710|1537250|P1|NOT COMPLETED|Period Between Core Study and Extension||119
626118|NCT00242710|1537247|P4|COMPLETED|Period Between Core Study and Extension||94
626119|NCT00242710|1537248|P3|COMPLETED|Period Between Core Study and Extension||84
626120|NCT00242710|1537249|P2|COMPLETED|Period Between Core Study and Extension||177
626121|NCT00242710|1537250|P1|COMPLETED|Period Between Core Study and Extension||168
626122|NCT00242710|1537247|P4|STARTED|Period Between Core Study and Extension||143
626123|NCT00242710|1537248|P3|STARTED|Period Between Core Study and Extension||132
626124|NCT00242710|1537249|P2|STARTED|Period Between Core Study and Extension||289
626125|NCT00242710|1537250|P1|STARTED|Period Between Core Study and Extension||287
626126|NCT00242710|1537247|P4|NOT COMPLETED|Core Study (up to Year 1)||31
626127|NCT00242710|1537248|P3|NOT COMPLETED|Core Study (up to Year 1)||51
626128|NCT00242710|1537249|P2|NOT COMPLETED|Core Study (up to Year 1)||64
626129|NCT00242710|1537250|P1|NOT COMPLETED|Core Study (up to Year 1)||86
626130|NCT00242710|1537247|P4|COMPLETED|Core Study (up to Year 1)||143
626131|NCT00242710|1537248|P3|COMPLETED|Core Study (up to Year 1)||132
626132|NCT00242710|1537249|P2|COMPLETED|Core Study (up to Year 1)||289
626133|NCT00242710|1537250|P1|COMPLETED|Core Study (up to Year 1)||287
626134|NCT00242710|1537247|P4|Treated|Core Study (up to Year 1)||172
626135|NCT00242710|1537248|P3|Treated|Core Study (up to Year 1)||179
626136|NCT00242710|1537249|P2|Treated|Core Study (up to Year 1)||349
626137|NCT00242710|1537250|P1|Treated|Core Study (up to Year 1)||361
626138|NCT00242710|1537247|P4|STARTED|Core Study (up to Year 1)||174
626139|NCT00242710|1537248|P3|STARTED|Core Study (up to Year 1)||183
626140|NCT00242710|1537249|P2|STARTED|Core Study (up to Year 1)||353
626141|NCT00242710|1537250|P1|STARTED|Core Study (up to Year 1)||373
626142|NCT00242684|1537300|P1|NOT COMPLETED|Overall Study||0
626143|NCT00242684|1537300|P1|COMPLETED|Overall Study||446
626144|NCT00242684|1537300|P1|STARTED|Overall Study||446
626145|NCT00242658|1537307|P2|NOT COMPLETED|Overall Study||19
626146|NCT00242658|1537308|P1|NOT COMPLETED|Overall Study||22
626147|NCT00242658|1537307|P2|COMPLETED|Overall Study||188
626148|NCT00242658|1537308|P1|COMPLETED|Overall Study||165
626149|NCT00242658|1537307|P2|STARTED|Overall Study||207
626150|NCT00242658|1537308|P1|STARTED|Overall Study||187
626151|NCT00242632|1537318|P2|NOT COMPLETED|Overall Study||0
626152|NCT00242632|1537319|P1|NOT COMPLETED|Overall Study||0
626153|NCT00242632|1537318|P2|COMPLETED|Overall Study||11
626154|NCT00242632|1537319|P1|COMPLETED|Overall Study||11
626155|NCT00242632|1537318|P2|STARTED|Overall Study||11
626156|NCT00242632|1537319|P1|STARTED|Overall Study||11
626157|NCT00242619|1537327|P2|NOT COMPLETED|Overall Study||0
626158|NCT00242619|1537328|P1|NOT COMPLETED|Overall Study||0
626159|NCT00242619|1537327|P2|COMPLETED|Overall Study||4
626160|NCT00242619|1537328|P1|COMPLETED|Overall Study||8
626161|NCT00242619|1537327|P2|STARTED|Overall Study||4
626162|NCT00242619|1537328|P1|STARTED|Overall Study||8
626163|NCT00242580|1537339|P3|NOT COMPLETED|Overall Study||14
626164|NCT00242580|1537340|P2|NOT COMPLETED|Overall Study||12
626165|NCT00242580|1537341|P1|NOT COMPLETED|Overall Study||10
626166|NCT00242580|1537339|P3|COMPLETED|Overall Study||24
626167|NCT00242580|1537340|P2|COMPLETED|Overall Study||29
626168|NCT00242580|1537341|P1|COMPLETED|Overall Study|"Completed indicates 12 month data."|22
626169|NCT00242580|1537339|P3|STARTED|Overall Study||38
626170|NCT00242580|1537340|P2|STARTED|Overall Study||41
626171|NCT00242580|1537341|P1|STARTED|Overall Study||32
626172|NCT00242567|1537366|P2|NOT COMPLETED|Overall Study||140
626173|NCT00242567|1537367|P1|NOT COMPLETED|Overall Study||166
626174|NCT00242567|1537366|P2|COMPLETED|Overall Study||123
626175|NCT00242567|1537367|P1|COMPLETED|Overall Study||93
626176|NCT00242567|1537366|P2|Never Received Study Drug|Overall Study||191
626177|NCT00242567|1537367|P1|Never Received Study Drug|Overall Study||0
626178|NCT00242567|1537366|P2|Received at Least 1 Dose of Study Drug|Overall Study||72
626179|NCT00242567|1537367|P1|Received at Least 1 Dose of Study Drug|Overall Study||259
626180|NCT00242567|1537366|P2|STARTED|Overall Study||263
626181|NCT00242567|1537367|P1|STARTED|Overall Study||259
626182|NCT00242502|1537383|P1|NOT COMPLETED|Overall Study||0
626183|NCT00242502|1537383|P1|COMPLETED|Overall Study||59
626184|NCT00242502|1537383|P1|STARTED|Overall Study||59
626185|NCT00242385|1537387|P2|NOT COMPLETED|Period 2||0
626186|NCT00242385|1537388|P1|NOT COMPLETED|Period 2||0
626187|NCT00242385|1537387|P2|COMPLETED|Period 2||11
626188|NCT00242385|1537388|P1|COMPLETED|Period 2||14
626189|NCT00242385|1537387|P2|STARTED|Period 2||11
626190|NCT00242385|1537388|P1|STARTED|Period 2||14
626191|NCT00242385|1537387|P2|NOT COMPLETED|Period 1||0
626192|NCT00242385|1537388|P1|NOT COMPLETED|Period 1||0
626193|NCT00242385|1537387|P2|COMPLETED|Period 1||11
626194|NCT00242385|1537388|P1|COMPLETED|Period 1||14
626195|NCT00242385|1537387|P2|STARTED|Period 1||11
626196|NCT00242385|1537388|P1|STARTED|Period 1||14
626197|NCT00242216|1537414|P2|NOT COMPLETED|Overall Study||22
626198|NCT00242216|1537415|P1|NOT COMPLETED|Overall Study||18
626199|NCT00242216|1537414|P2|COMPLETED|Overall Study||15
626200|NCT00242216|1537415|P1|COMPLETED|Overall Study||21
626201|NCT00242216|1537414|P2|STARTED|Overall Study||37
626202|NCT00242216|1537415|P1|STARTED|Overall Study||39
626203|NCT00241969|1537425|P2|NOT COMPLETED|Overall Study||0
626204|NCT00241969|1537426|P1|NOT COMPLETED|Overall Study||0
626205|NCT00241969|1537425|P2|COMPLETED|Overall Study||42
626206|NCT00241969|1537426|P1|COMPLETED|Overall Study||36
626207|NCT00241969|1537425|P2|STARTED|Overall Study||42
626208|NCT00241969|1537426|P1|STARTED|Overall Study||36
626209|NCT00241904|1537438|P2|NOT COMPLETED|Overall Study||24
626210|NCT00241904|1537439|P1|NOT COMPLETED|Overall Study||34
626211|NCT00241904|1537438|P2|COMPLETED|Overall Study||240
626212|NCT00241904|1537439|P1|COMPLETED|Overall Study||227
626213|NCT00241904|1537438|P2|STARTED|Overall Study||264
626214|NCT00241904|1537439|P1|STARTED|Overall Study||261
626215|NCT00241839|1537453|P2|NOT COMPLETED|Overall Study||18
626216|NCT00241839|1537454|P1|NOT COMPLETED|Overall Study||19
626217|NCT00241839|1537453|P2|COMPLETED|Overall Study|N=53 represents number with both baseline and 8-10 week data. N<53 implies missing data.|53
626218|NCT00241839|1537454|P1|COMPLETED|Overall Study|N=52 represents number with both baseline and 8-10 week data. N<52 implies missing data.|52
626219|NCT00241839|1537453|P2|STARTED|Overall Study||71
626220|NCT00241839|1537454|P1|STARTED|Overall Study||71
626221|NCT00241644|1537470|P4|NOT COMPLETED|Second Efficacy Period (Year 2)||118
626222|NCT00241644|1537471|P3|NOT COMPLETED|Second Efficacy Period (Year 2)||64
626223|NCT00241644|1537472|P2|NOT COMPLETED|Second Efficacy Period (Year 2)||57
626224|NCT00241644|1537473|P1|NOT COMPLETED|Second Efficacy Period (Year 2)||61
626225|NCT00241644|1537470|P4|COMPLETED|Second Efficacy Period (Year 2)||1407
626226|NCT00241644|1537471|P3|COMPLETED|Second Efficacy Period (Year 2)||682
626227|NCT00241644|1537472|P2|COMPLETED|Second Efficacy Period (Year 2)||697
626228|NCT00241644|1537473|P1|COMPLETED|Second Efficacy Period (Year 2)||710
626229|NCT00241644|1537470|P4|STARTED|Second Efficacy Period (Year 2)||1525
626230|NCT00241644|1537471|P3|STARTED|Second Efficacy Period (Year 2)||746
626231|NCT00241644|1537472|P2|STARTED|Second Efficacy Period (Year 2)||754
626232|NCT00241644|1537473|P1|STARTED|Second Efficacy Period (Year 2)||771
626233|NCT00241644|1537470|P4|NOT COMPLETED|First Efficacy Period (Year 1)||495
626234|NCT00241644|1537471|P3|NOT COMPLETED|First Efficacy Period (Year 1)||249
626235|NCT00241644|1537472|P2|NOT COMPLETED|First Efficacy Period (Year 1)||268
626236|NCT00241644|1537473|P1|NOT COMPLETED|First Efficacy Period (Year 1)||227
626237|NCT00241644|1537470|P4|COMPLETED|First Efficacy Period (Year 1)||2803
626238|NCT00241644|1537471|P3|COMPLETED|First Efficacy Period (Year 1)||1392
626239|NCT00241644|1537472|P2|COMPLETED|First Efficacy Period (Year 1)||1383
626240|NCT00241644|1537473|P1|COMPLETED|First Efficacy Period (Year 1)||1420
626241|NCT00241644|1537470|P4|STARTED|First Efficacy Period (Year 1)||3298
626242|NCT00241644|1537471|P3|STARTED|First Efficacy Period (Year 1)||1641
626243|NCT00241644|1537472|P2|STARTED|First Efficacy Period (Year 1)||1651
626244|NCT00241644|1537473|P1|STARTED|First Efficacy Period (Year 1)||1647
626245|NCT00241358|1537558|P3|NOT COMPLETED|Overall Study||1
626246|NCT00241358|1537559|P2|NOT COMPLETED|Overall Study||1
626247|NCT00241358|1537560|P1|NOT COMPLETED|Overall Study||0
626248|NCT00241358|1537558|P3|COMPLETED|Overall Study||20
626249|NCT00241358|1537559|P2|COMPLETED|Overall Study||45
626250|NCT00241358|1537560|P1|COMPLETED|Overall Study||25
626251|NCT00241358|1537558|P3|STARTED|Overall Study||21
626252|NCT00241358|1537559|P2|STARTED|Overall Study||46
626253|NCT00241358|1537560|P1|STARTED|Overall Study||25
626254|NCT00241280|1537593|P2|NOT COMPLETED|Overall Study||68
626255|NCT00241280|1537594|P1|NOT COMPLETED|Overall Study||48
626256|NCT00241280|1537593|P2|COMPLETED|Overall Study||186
626257|NCT00241280|1537594|P1|COMPLETED|Overall Study||199
626258|NCT00241280|1537593|P2|STARTED|Overall Study||254
626259|NCT00241280|1537594|P1|STARTED|Overall Study||247
626260|NCT00241176|1537602|P1|NOT COMPLETED|Overall Study||0
626261|NCT00241176|1537602|P1|COMPLETED|Overall Study||11
626262|NCT00241176|1537602|P1|STARTED|Overall Study||11
626263|NCT00240994|1537609|P1|NOT COMPLETED|Overall Study||3
626264|NCT00240994|1537609|P1|COMPLETED|Overall Study||32
626265|NCT00240994|1537609|P1|STARTED|Overall Study||35
626266|NCT00240981|1537615|P2|NOT COMPLETED|Overall Study||33
626267|NCT00240981|1537616|P1|NOT COMPLETED|Overall Study||38
626268|NCT00240981|1537615|P2|COMPLETED|Overall Study||70
626269|NCT00240981|1537616|P1|COMPLETED|Overall Study||68
626270|NCT00240981|1537615|P2|Intent to Treat Sample|Overall Study||83
626271|NCT00240981|1537616|P1|Intent to Treat Sample|Overall Study||82
626272|NCT00240981|1537615|P2|STARTED|Overall Study||103
626273|NCT00240981|1537616|P1|STARTED|Overall Study||106
626274|NCT00240539|1537644|P4|NOT COMPLETED|Overall Study||0
626275|NCT00240539|1537645|P3|NOT COMPLETED|Overall Study||0
626276|NCT00240539|1537646|P2|NOT COMPLETED|Overall Study||0
626277|NCT00240539|1537647|P1|NOT COMPLETED|Overall Study||0
626278|NCT00240539|1537644|P4|COMPLETED|Overall Study||1
626279|NCT00240539|1537645|P3|COMPLETED|Overall Study||31
626280|NCT00240539|1537646|P2|COMPLETED|Overall Study||2
626281|NCT00240539|1537647|P1|COMPLETED|Overall Study||2
626282|NCT00240539|1537644|P4|STARTED|Overall Study||1
626283|NCT00240539|1537645|P3|STARTED|Overall Study||31
626284|NCT00240539|1537646|P2|STARTED|Overall Study||2
626285|NCT00240539|1537647|P1|STARTED|Overall Study||2
626286|NCT00240526|1537669|P4|NOT COMPLETED|Year 20||0
626287|NCT00240526|1537670|P3|NOT COMPLETED|Year 20||0
626288|NCT00240526|1537671|P2|NOT COMPLETED|Year 20||0
626289|NCT00240526|1537672|P1|NOT COMPLETED|Year 20||0
626290|NCT00240526|1537669|P4|COMPLETED|Year 20||20
626291|NCT00240526|1537670|P3|COMPLETED|Year 20||13
626292|NCT00240526|1537671|P2|COMPLETED|Year 20||17
626293|NCT00240526|1537672|P1|COMPLETED|Year 20||19
626294|NCT00240526|1537669|P4|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|20
626295|NCT00240526|1537670|P3|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|13
626296|NCT00240526|1537671|P2|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|17
626297|NCT00240526|1537672|P1|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|19
626298|NCT00240526|1537669|P4|NOT COMPLETED|Year 19||0
626299|NCT00240526|1537670|P3|NOT COMPLETED|Year 19||0
626300|NCT00240526|1537671|P2|NOT COMPLETED|Year 19||0
626301|NCT00240526|1537672|P1|NOT COMPLETED|Year 19||0
626302|NCT00240526|1537669|P4|COMPLETED|Year 19||18
626303|NCT00240526|1537670|P3|COMPLETED|Year 19||12
626304|NCT00240526|1537671|P2|COMPLETED|Year 19||16
626305|NCT00240526|1537672|P1|COMPLETED|Year 19||17
626306|NCT00240526|1537669|P4|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|18
626307|NCT00240526|1537670|P3|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|12
626308|NCT00240526|1537671|P2|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|16
626309|NCT00240526|1537672|P1|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|17
626310|NCT00240526|1537669|P4|NOT COMPLETED|Year 18||0
626311|NCT00240526|1537670|P3|NOT COMPLETED|Year 18||0
626312|NCT00240526|1537671|P2|NOT COMPLETED|Year 18||0
626313|NCT00240526|1537672|P1|NOT COMPLETED|Year 18||0
626314|NCT00240526|1537669|P4|COMPLETED|Year 18||20
626315|NCT00240526|1537670|P3|COMPLETED|Year 18||14
626316|NCT00240526|1537671|P2|COMPLETED|Year 18||17
626317|NCT00240526|1537672|P1|COMPLETED|Year 18||16
626318|NCT00240526|1537669|P4|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|20
626319|NCT00240526|1537670|P3|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|14
626320|NCT00240526|1537671|P2|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|17
626321|NCT00240526|1537672|P1|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|16
626322|NCT00240526|1537669|P4|NOT COMPLETED|Year 17||0
626323|NCT00240526|1537670|P3|NOT COMPLETED|Year 17||0
626324|NCT00240526|1537671|P2|NOT COMPLETED|Year 17||0
626325|NCT00240526|1537672|P1|NOT COMPLETED|Year 17||0
626326|NCT00240526|1537669|P4|COMPLETED|Year 17||20
626327|NCT00240526|1537670|P3|COMPLETED|Year 17||13
626328|NCT00240526|1537671|P2|COMPLETED|Year 17||17
626329|NCT00240526|1537672|P1|COMPLETED|Year 17||19
626330|NCT00240526|1537669|P4|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|20
626331|NCT00240526|1537670|P3|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|13
626332|NCT00240526|1537671|P2|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|17
626333|NCT00240526|1537672|P1|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|19
626334|NCT00240526|1537669|P4|NOT COMPLETED|Year 16||0
626335|NCT00240526|1537670|P3|NOT COMPLETED|Year 16||0
626336|NCT00240526|1537671|P2|NOT COMPLETED|Year 16||0
626337|NCT00240526|1537672|P1|NOT COMPLETED|Year 16||0
626338|NCT00240526|1537669|P4|COMPLETED|Year 16||22
626339|NCT00240526|1537670|P3|COMPLETED|Year 16||16
626340|NCT00240526|1537671|P2|COMPLETED|Year 16||19
626341|NCT00240526|1537672|P1|COMPLETED|Year 16||17
626342|NCT00240526|1537669|P4|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|22
626343|NCT00240526|1537670|P3|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|16
626344|NCT00240526|1537671|P2|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|19
626345|NCT00240526|1537672|P1|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|17
626346|NCT00240526|1537669|P4|NOT COMPLETED|Year 15||0
626347|NCT00240526|1537670|P3|NOT COMPLETED|Year 15||0
626348|NCT00240526|1537671|P2|NOT COMPLETED|Year 15||0
626349|NCT00240526|1537672|P1|NOT COMPLETED|Year 15||0
626350|NCT00240526|1537669|P4|COMPLETED|Year 15||21
626351|NCT00240526|1537670|P3|COMPLETED|Year 15||14
626352|NCT00240526|1537671|P2|COMPLETED|Year 15||19
626353|NCT00240526|1537672|P1|COMPLETED|Year 15||19
626354|NCT00240526|1537669|P4|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|21
626355|NCT00240526|1537670|P3|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|14
626356|NCT00240526|1537671|P2|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|19
626357|NCT00240526|1537672|P1|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|19
626358|NCT00240500|1537708|P6|NOT COMPLETED|Overall Study||1
626359|NCT00240500|1537709|P5|NOT COMPLETED|Overall Study||3
626360|NCT00240500|1537710|P4|NOT COMPLETED|Overall Study||4
626361|NCT00240500|1537711|P3|NOT COMPLETED|Overall Study||3
626362|NCT00240500|1537712|P2|NOT COMPLETED|Overall Study||3
626363|NCT00240500|1537713|P1|NOT COMPLETED|Overall Study||1
626364|NCT00240500|1537708|P6|COMPLETED|Overall Study||2
626365|NCT00240500|1537709|P5|COMPLETED|Overall Study||26
626366|NCT00240500|1537710|P4|COMPLETED|Overall Study||19
626367|NCT00240500|1537711|P3|COMPLETED|Overall Study||14
626368|NCT00240500|1537712|P2|COMPLETED|Overall Study||17
626369|NCT00240500|1537713|P1|COMPLETED|Overall Study||16
626370|NCT00240500|1537708|P6|STARTED|Overall Study||3
626371|NCT00240500|1537709|P5|STARTED|Overall Study||29
626372|NCT00240500|1537710|P4|STARTED|Overall Study||23
626373|NCT00240500|1537711|P3|STARTED|Overall Study||17
626374|NCT00240500|1537712|P2|STARTED|Overall Study||20
626375|NCT00240500|1537713|P1|STARTED|Overall Study||17
626376|NCT00240487|1537735|P2|NOT COMPLETED|Overall Study||0
626377|NCT00240487|1537736|P1|NOT COMPLETED|Overall Study||0
626378|NCT00240487|1537735|P2|COMPLETED|Overall Study||28
626379|NCT00240487|1537736|P1|COMPLETED|Overall Study||24
626380|NCT00240487|1537735|P2|STARTED|Overall Study||28
626381|NCT00240487|1537736|P1|STARTED|Overall Study||24
626382|NCT00240331|1537744|P2|NOT COMPLETED|Overall Study||134
626383|NCT00240331|1537745|P1|NOT COMPLETED|Overall Study||126
626384|NCT00240331|1537744|P2|COMPLETED|Overall Study|Vital status was obtained for all randomised patients at the end of the study|1250
626385|NCT00240331|1537745|P1|COMPLETED|Overall Study|Vital status was obtained for all randomised patients at the end of the study|1263
626386|NCT00240331|1537744|P2|STARTED|Overall Study|One patient was incorrectly randomised and not included in the analyses|1384
626387|NCT00240331|1537745|P1|STARTED|Overall Study|Two patients were incorrectly randomised and not included in the analyses.|1389
626388|NCT00240227|1537763|P1|NOT COMPLETED|Overall Study||0
626389|NCT00240227|1537763|P1|COMPLETED|Overall Study||8
626390|NCT00240227|1537763|P1|STARTED|Overall Study||8
626391|NCT00240162|1537769|P1|NOT COMPLETED|Overall Study||0
626392|NCT00240162|1537769|P1|COMPLETED|Overall Study||21
626393|NCT00240162|1537769|P1|STARTED|Overall Study||21
626394|NCT00240110|1537778|P2|NOT COMPLETED|Overall Study||7
626395|NCT00240110|1537779|P1|NOT COMPLETED|Overall Study||6
626396|NCT00240110|1537778|P2|COMPLETED|Overall Study||6
626397|NCT00240110|1537779|P1|COMPLETED|Overall Study||7
626398|NCT00240110|1537778|P2|STARTED|Overall Study||13
626399|NCT00240110|1537779|P1|STARTED|Overall Study||13
626400|NCT00240097|1537787|P1|NOT COMPLETED|Part II||23
626401|NCT00240097|1537787|P1|COMPLETED|Part II||3
626402|NCT00240097|1537787|P1|STARTED|Part II||26
626403|NCT00240097|1537787|P1|NOT COMPLETED|Part I||4
626404|NCT00240097|1537787|P1|COMPLETED|Part I||26
626405|NCT00240097|1537787|P1|STARTED|Part I||30
626406|NCT00240071|1537797|P1|NOT COMPLETED|Overall Study||3
626407|NCT00240071|1537797|P1|COMPLETED|Overall Study|3 patients withdrew consent after 29, 5 and 3 1/2 months on study.|27
626408|NCT00240071|1537797|P1|STARTED|Overall Study||30
626409|NCT00239928|1537802|P1|NOT COMPLETED|Overall Study||10
626410|NCT00239928|1537802|P1|COMPLETED|Overall Study||51
626411|NCT00239928|1537802|P1|STARTED|Overall Study||61
626412|NCT00239837|1537814|P2|NOT COMPLETED|Overall Study||7
626413|NCT00239837|1537815|P1|NOT COMPLETED|Overall Study||3
626414|NCT00239837|1537814|P2|COMPLETED|Overall Study|3-year follow-up|45
626415|NCT00239837|1537815|P1|COMPLETED|Overall Study|3-year follow-up|45
626416|NCT00239837|1537814|P2|6 Months|Overall Study||50
626417|NCT00239837|1537815|P1|6 Months|Overall Study||48
626418|NCT00239837|1537814|P2|STARTED|Overall Study||52
626419|NCT00239837|1537815|P1|STARTED|Overall Study||48
626420|NCT00239733|1537835|P1|NOT COMPLETED|Overall Study||0
626421|NCT00239733|1537835|P1|COMPLETED|Overall Study||6
626422|NCT00239733|1537835|P1|STARTED|Overall Study||6
626423|NCT00239720|1537842|P2|NOT COMPLETED|Overall Study||1
626424|NCT00239720|1537843|P1|NOT COMPLETED|Overall Study||1
626425|NCT00239720|1537842|P2|COMPLETED|Overall Study|One participant lost to follow-up|0
626426|NCT00239720|1537843|P1|COMPLETED|Overall Study|One participant discontinued due to an adverse event|2
626427|NCT00239720|1537842|P2|STARTED|Overall Study||1
626428|NCT00239720|1537843|P1|STARTED|Overall Study||3
626429|NCT00239681|1537851|P2|NOT COMPLETED|Overall Study||715
626430|NCT00239681|1537852|P1|NOT COMPLETED|Overall Study||693
626431|NCT00239681|1537851|P2|COMPLETED|Overall Study||8186
626432|NCT00239681|1537852|P1|COMPLETED|Overall Study||8208
626433|NCT00239681|1537851|P2|Randomized and Treated (Safety Pop)|Overall Study||8864
626434|NCT00239681|1537852|P1|Randomized and Treated (Safety Pop)|Overall Study||8869
626435|NCT00239681|1537851|P2|STARTED|Overall Study||8901
626436|NCT00239681|1537852|P1|STARTED|Overall Study||8901
626437|NCT00239642|1537871|P3|NOT COMPLETED|Overall Study||2
626438|NCT00239642|1537872|P2|NOT COMPLETED|Overall Study||0
626439|NCT00239642|1537873|P1|NOT COMPLETED|Overall Study||2
626440|NCT00239642|1537871|P3|COMPLETED|Overall Study||47
626441|NCT00239642|1537872|P2|COMPLETED|Overall Study||47
626442|NCT00239642|1537873|P1|COMPLETED|Overall Study||47
626443|NCT00239642|1537871|P3|STARTED|Overall Study||49
626444|NCT00239642|1537872|P2|STARTED|Overall Study||47
626445|NCT00239642|1537873|P1|STARTED|Overall Study||49
626446|NCT00239356|1537907|P2|NOT COMPLETED|Overall Study||9
626447|NCT00239356|1537908|P1|NOT COMPLETED|Overall Study||39
626448|NCT00239356|1537907|P2|COMPLETED|Overall Study||11
626449|NCT00239356|1537908|P1|COMPLETED|Overall Study||58
626450|NCT00239356|1537907|P2|STARTED|Overall Study||20
626451|NCT00239356|1537908|P1|STARTED|Overall Study||97
626452|NCT00239226|1537930|P4|NOT COMPLETED|Overall Study||3
626453|NCT00239226|1537931|P3|NOT COMPLETED|Overall Study||1
626454|NCT00239226|1537932|P2|NOT COMPLETED|Overall Study||0
626455|NCT00239226|1537933|P1|NOT COMPLETED|Overall Study||1
626456|NCT00239226|1537930|P4|COMPLETED|Overall Study||14
626457|NCT00239226|1537931|P3|COMPLETED|Overall Study||36
626458|NCT00239226|1537932|P2|COMPLETED|Overall Study||18
626459|NCT00239226|1537933|P1|COMPLETED|Overall Study||29
626460|NCT00239226|1537930|P4|STARTED|Overall Study||17
626461|NCT00239226|1537931|P3|STARTED|Overall Study||37
626462|NCT00239226|1537932|P2|STARTED|Overall Study||18
626463|NCT00239226|1537933|P1|STARTED|Overall Study||30
626464|NCT00239005|1537945|P2|NOT COMPLETED|Overall Study||12
626465|NCT00239005|1537946|P1|NOT COMPLETED|Overall Study||12
626466|NCT00239005|1537945|P2|COMPLETED|Overall Study||53
626467|NCT00239005|1537946|P1|COMPLETED|Overall Study||57
626468|NCT00239005|1537945|P2|Intention-to-treat Population (ITT)|Overall Study||61
626469|NCT00239005|1537946|P1|Intention-to-treat Population (ITT)|Overall Study||68
626470|NCT00239005|1537945|P2|STARTED|Overall Study||65
626471|NCT00239005|1537946|P1|STARTED|Overall Study||69
626472|NCT00238615|1537956|P1|NOT COMPLETED|Overall Study||0
626473|NCT00238615|1537956|P1|COMPLETED|Overall Study||13
626474|NCT00238615|1537956|P1|STARTED|Overall Study||13
626475|NCT00238433|1537962|P1|NOT COMPLETED|Overall Study||3
626476|NCT00238433|1537962|P1|COMPLETED|Overall Study||34
626477|NCT00238433|1537962|P1|STARTED|Overall Study||37
626478|NCT00238420|1537969|P2|NOT COMPLETED|Overall Study||1
626479|NCT00238420|1537970|P1|NOT COMPLETED|Overall Study||1
626480|NCT00238420|1537969|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|47
626481|NCT00238420|1537970|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|21
626482|NCT00238420|1537969|P2|STARTED|Overall Study||48
626483|NCT00238420|1537970|P1|STARTED|Overall Study||22
626484|NCT00238355|1537980|P1|NOT COMPLETED|Overall Study||3
626485|NCT00238355|1537980|P1|COMPLETED|Overall Study||10
626486|NCT00238355|1537980|P1|STARTED|Overall Study||13
626487|NCT00238303|1537987|P3|NOT COMPLETED|Overall Study||9
626488|NCT00238303|1537988|P2|NOT COMPLETED|Overall Study||2
626489|NCT00238303|1537989|P1|NOT COMPLETED|Overall Study||15
626490|NCT00238303|1537987|P3|COMPLETED|Overall Study||11
626491|NCT00238303|1537988|P2|COMPLETED|Overall Study||13
626492|NCT00238303|1537989|P1|COMPLETED|Overall Study||53
626493|NCT00238303|1537987|P3|STARTED|Overall Study||20
626494|NCT00238303|1537988|P2|STARTED|Overall Study||15
626495|NCT00238303|1537989|P1|STARTED|Overall Study||68
626496|NCT00238264|1538006|P1|NOT COMPLETED|Overall Study||36
626497|NCT00238264|1538006|P1|COMPLETED|Overall Study||56
626498|NCT00238264|1538006|P1|STARTED|Overall Study||92
626499|NCT00238238|1538019|P3|NOT COMPLETED|Overall Study||0
626500|NCT00238238|1538020|P2|NOT COMPLETED|Overall Study||3
626501|NCT00238238|1538021|P1|NOT COMPLETED|Overall Study||0
626502|NCT00238238|1538019|P3|COMPLETED|Overall Study||46
626503|NCT00238238|1538020|P2|COMPLETED|Overall Study||45
626504|NCT00238238|1538021|P1|COMPLETED|Overall Study||3
626505|NCT00238238|1538019|P3|STARTED|Overall Study||46
626506|NCT00238238|1538020|P2|STARTED|Overall Study||48
626507|NCT00238238|1538021|P1|STARTED|Overall Study||3
626508|NCT00238121|1538034|P2|NOT COMPLETED|Overall Study||2
626509|NCT00238121|1538035|P1|NOT COMPLETED|Overall Study||3
626510|NCT00238121|1538034|P2|COMPLETED|Overall Study||14
626511|NCT00238121|1538035|P1|COMPLETED|Overall Study||37
626512|NCT00238121|1538034|P2|STARTED|Overall Study||16
626513|NCT00238121|1538035|P1|STARTED|Overall Study||40
626514|NCT00238108|1538048|P2|NOT COMPLETED|Overall Study||0
626515|NCT00238108|1538049|P1|NOT COMPLETED|Overall Study||0
626516|NCT00238108|1538048|P2|COMPLETED|Overall Study||8
626517|NCT00238108|1538049|P1|COMPLETED|Overall Study||8
626518|NCT00238108|1538048|P2|STARTED|Overall Study||8
626519|NCT00238108|1538049|P1|STARTED|Overall Study||8
626520|NCT00237809|1538061|P4|NOT COMPLETED|Overall Study||9
626521|NCT00237809|1538062|P3|NOT COMPLETED|Overall Study||9
626522|NCT00237809|1538063|P2|NOT COMPLETED|Overall Study||10
626523|NCT00237809|1538064|P1|NOT COMPLETED|Overall Study||11
626524|NCT00237809|1538061|P4|COMPLETED|Overall Study||17
626525|NCT00237809|1538062|P3|COMPLETED|Overall Study||15
626526|NCT00237809|1538063|P2|COMPLETED|Overall Study||17
626527|NCT00237809|1538064|P1|COMPLETED|Overall Study||16
626528|NCT00237809|1538061|P4|STARTED|Overall Study||26
626529|NCT00237809|1538062|P3|STARTED|Overall Study||24
626530|NCT00237809|1538063|P2|STARTED|Overall Study||27
626531|NCT00237809|1538064|P1|STARTED|Overall Study||27
626532|NCT00237796|1538100|P2|NOT COMPLETED|Overall Study||5
626533|NCT00237796|1538101|P1|NOT COMPLETED|Overall Study||10
626534|NCT00237796|1538100|P2|COMPLETED|Overall Study||33
626535|NCT00237796|1538101|P1|COMPLETED|Overall Study||31
626536|NCT00237796|1538100|P2|STARTED|Overall Study||38
626537|NCT00237796|1538101|P1|STARTED|Overall Study||41
626538|NCT00237770|1538121|P2|NOT COMPLETED|Overall Study||0
626539|NCT00237770|1538122|P1|NOT COMPLETED|Overall Study||0
626540|NCT00237770|1538121|P2|COMPLETED|Overall Study||7
626541|NCT00237770|1538122|P1|COMPLETED|Overall Study||9
626542|NCT00237770|1538121|P2|STARTED|Overall Study||7
626543|NCT00237770|1538122|P1|STARTED|Overall Study||9
626544|NCT00237744|1538135|P3|NOT COMPLETED|Overall Study||0
626545|NCT00237744|1538136|P2|NOT COMPLETED|Overall Study||1
626546|NCT00237744|1538137|P1|NOT COMPLETED|Overall Study||3
626547|NCT00237744|1538135|P3|COMPLETED|Overall Study||18
626548|NCT00237744|1538136|P2|COMPLETED|Overall Study||10
626549|NCT00237744|1538137|P1|COMPLETED|Overall Study||8
626550|NCT00237744|1538135|P3|STARTED|Overall Study||18
626551|NCT00237744|1538136|P2|STARTED|Overall Study||11
626552|NCT00237744|1538137|P1|STARTED|Overall Study||11
626553|NCT00237718|1538150|P2|NOT COMPLETED|Overall Study||41
626554|NCT00237718|1538151|P1|NOT COMPLETED|Overall Study||46
626555|NCT00237718|1538150|P2|COMPLETED|Overall Study||124
626556|NCT00237718|1538151|P1|COMPLETED|Overall Study||114
626557|NCT00237718|1538150|P2|STARTED|Overall Study||165
626558|NCT00237718|1538151|P1|STARTED|Overall Study||160
626559|NCT00237692|1538163|P4|NOT COMPLETED|Overall Study||19
626560|NCT00237692|1538164|P3|NOT COMPLETED|Overall Study||22
626561|NCT00237692|1538165|P2|NOT COMPLETED|Overall Study||14
626562|NCT00237692|1538166|P1|NOT COMPLETED|Overall Study||18
626563|NCT00237692|1538163|P4|COMPLETED|Overall Study||128
626564|NCT00237692|1538164|P3|COMPLETED|Overall Study||127
626565|NCT00237692|1538165|P2|COMPLETED|Overall Study||134
626566|NCT00237692|1538166|P1|COMPLETED|Overall Study||129
626567|NCT00237692|1538163|P4|18 Month f/u|Overall Study||122
626568|NCT00237692|1538164|P3|18 Month f/u|Overall Study||126
626569|NCT00237692|1538165|P2|18 Month f/u|Overall Study||131
626570|NCT00237692|1538166|P1|18 Month f/u|Overall Study||124
626571|NCT00237692|1538163|P4|12 Month f/u|Overall Study||127
626572|NCT00237692|1538164|P3|12 Month f/u|Overall Study||132
626573|NCT00237692|1538165|P2|12 Month f/u|Overall Study||127
626574|NCT00237692|1538166|P1|12 Month f/u|Overall Study||137
626575|NCT00237692|1538163|P4|6 Month f/u|Overall Study||134
626576|NCT00237692|1538164|P3|6 Month f/u|Overall Study||135
626577|NCT00237692|1538165|P2|6 Month f/u|Overall Study||134
626578|NCT00237692|1538166|P1|6 Month f/u|Overall Study||132
626579|NCT00237692|1538163|P4|STARTED|Overall Study||147
626580|NCT00237692|1538164|P3|STARTED|Overall Study||149
626581|NCT00237692|1538165|P2|STARTED|Overall Study||148
626582|NCT00237692|1538166|P1|STARTED|Overall Study||147
626583|NCT00237666|1538196|P1|NOT COMPLETED|Overall Study||6
626584|NCT00237666|1538196|P1|COMPLETED|Overall Study||24
626585|NCT00237666|1538196|P1|STARTED|Overall Study||30
626586|NCT00237458|1538206|P1|NOT COMPLETED|Overall Study||3
626587|NCT00237458|1538206|P1|COMPLETED|Overall Study||4
626588|NCT00237458|1538206|P1|STARTED|Overall Study||7
626589|NCT00237185|1538224|P2|NOT COMPLETED|Extension||19
626590|NCT00237185|1538225|P1|NOT COMPLETED|Extension||16
626591|NCT00237185|1538224|P2|COMPLETED|Extension||13
626592|NCT00237185|1538225|P1|COMPLETED|Extension||8
626593|NCT00237185|1538224|P2|STARTED|Extension|A portion of the participants, who completed the core, entered the extension.|32
626594|NCT00237185|1538225|P1|STARTED|Extension|A portion of the participants, who completed the core, entered the extension.|24
626595|NCT00237185|1538224|P2|NOT COMPLETED|Core||37
626596|NCT00237185|1538225|P1|NOT COMPLETED|Core||44
626597|NCT00237185|1538224|P2|COMPLETED|Core||37
626598|NCT00237185|1538225|P1|COMPLETED|Core||30
626599|NCT00237185|1538224|P2|Treated Participants|Core||74
626600|NCT00237185|1538225|P1|Treated Participants|Core||73
626601|NCT00237185|1538224|P2|STARTED|Core||74
626602|NCT00237185|1538225|P1|STARTED|Core||74
626603|NCT00237042|1538256|P3|NOT COMPLETED|Long Term (12 Month) Follow up||9
626604|NCT00237042|1538257|P2|NOT COMPLETED|Long Term (12 Month) Follow up||9
626605|NCT00237042|1538258|P1|NOT COMPLETED|Long Term (12 Month) Follow up||11
626606|NCT00237042|1538256|P3|COMPLETED|Long Term (12 Month) Follow up||48
626607|NCT00237042|1538257|P2|COMPLETED|Long Term (12 Month) Follow up||46
626608|NCT00237042|1538258|P1|COMPLETED|Long Term (12 Month) Follow up||48
626609|NCT00237042|1538256|P3|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|57
626610|NCT00237042|1538257|P2|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|55
626611|NCT00237042|1538258|P1|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|59
626612|NCT00237042|1538256|P3|NOT COMPLETED|Short Term (6 Month) Follow up||11
626613|NCT00237042|1538257|P2|NOT COMPLETED|Short Term (6 Month) Follow up||8
626614|NCT00237042|1538258|P1|NOT COMPLETED|Short Term (6 Month) Follow up||9
626615|NCT00237042|1538256|P3|COMPLETED|Short Term (6 Month) Follow up||46
626616|NCT00237042|1538257|P2|COMPLETED|Short Term (6 Month) Follow up||47
626617|NCT00237042|1538258|P1|COMPLETED|Short Term (6 Month) Follow up||50
626618|NCT00237042|1538256|P3|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|57
626619|NCT00237042|1538257|P2|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|55
626712|NCT00235989|1538414|P5|NOT COMPLETED|Core Treatment Period (CT)||0
626620|NCT00237042|1538258|P1|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|59
626621|NCT00237042|1538256|P3|NOT COMPLETED|Treatment||38
626622|NCT00237042|1538257|P2|NOT COMPLETED|Treatment||7
626623|NCT00237042|1538258|P1|NOT COMPLETED|Treatment||6
626624|NCT00237042|1538256|P3|COMPLETED|Treatment||36
626625|NCT00237042|1538257|P2|COMPLETED|Treatment||50
626626|NCT00237042|1538258|P1|COMPLETED|Treatment||54
626627|NCT00237042|1538256|P3|STARTED|Treatment||74
626628|NCT00237042|1538257|P2|STARTED|Treatment||57
626629|NCT00237042|1538258|P1|STARTED|Treatment||60
626630|NCT00236977|1538277|P2|NOT COMPLETED|Overall Study||19
626631|NCT00236977|1538278|P1|NOT COMPLETED|Overall Study||21
626632|NCT00236977|1538277|P2|COMPLETED|Overall Study||72
626633|NCT00236977|1538278|P1|COMPLETED|Overall Study||70
626634|NCT00236977|1538277|P2|STARTED|Overall Study||91
626635|NCT00236977|1538278|P1|STARTED|Overall Study||91
626636|NCT00236951|1538300|P4|NOT COMPLETED|Overall Study||31
626637|NCT00236951|1538301|P3|NOT COMPLETED|Overall Study||19
626638|NCT00236951|1538302|P2|NOT COMPLETED|Overall Study||31
626639|NCT00236951|1538303|P1|NOT COMPLETED|Overall Study||26
626640|NCT00236951|1538300|P4|COMPLETED|Overall Study||17
626641|NCT00236951|1538301|P3|COMPLETED|Overall Study||21
626642|NCT00236951|1538302|P2|COMPLETED|Overall Study||46
626643|NCT00236951|1538303|P1|COMPLETED|Overall Study||33
626644|NCT00236951|1538300|P4|STARTED|Overall Study||48
626645|NCT00236951|1538301|P3|STARTED|Overall Study||40
626646|NCT00236951|1538302|P2|STARTED|Overall Study||77
626647|NCT00236951|1538303|P1|STARTED|Overall Study||59
626648|NCT00236938|1538315|P2|NOT COMPLETED|Overall Study||20
626649|NCT00236938|1538316|P1|NOT COMPLETED|Overall Study||13
626650|NCT00236938|1538315|P2|COMPLETED|Overall Study||26
626651|NCT00236938|1538316|P1|COMPLETED|Overall Study||62
626652|NCT00236938|1538315|P2|STARTED|Overall Study||46
626653|NCT00236938|1538316|P1|STARTED|Overall Study||75
626654|NCT00236899|1538332|P4|NOT COMPLETED|Overall Study||40
626655|NCT00236899|1538333|P3|NOT COMPLETED|Overall Study||44
626656|NCT00236899|1538334|P2|NOT COMPLETED|Overall Study||40
626657|NCT00236899|1538335|P1|NOT COMPLETED|Overall Study||42
626658|NCT00236899|1538332|P4|COMPLETED|Overall Study||19
626659|NCT00236899|1538333|P3|COMPLETED|Overall Study||14
626660|NCT00236899|1538334|P2|COMPLETED|Overall Study||24
626661|NCT00236899|1538335|P1|COMPLETED|Overall Study||18
626662|NCT00236899|1538332|P4|STARTED|Overall Study||59
626663|NCT00236899|1538333|P3|STARTED|Overall Study||58
626664|NCT00236899|1538334|P2|STARTED|Overall Study||64
626665|NCT00236899|1538335|P1|STARTED|Overall Study||60
626666|NCT00236197|1538367|P2|NOT COMPLETED|Overall Study||14
626667|NCT00236197|1538368|P1|NOT COMPLETED|Overall Study||5
626668|NCT00236197|1538367|P2|COMPLETED|Overall Study||293
626669|NCT00236197|1538368|P1|COMPLETED|Overall Study||307
626670|NCT00236197|1538367|P2|STARTED|Overall Study||307
626671|NCT00236197|1538368|P1|STARTED|Overall Study||312
626672|NCT00236184|1538376|P2|NOT COMPLETED|Overall Study||11
626673|NCT00236184|1538377|P1|NOT COMPLETED|Overall Study||18
626674|NCT00236184|1538376|P2|COMPLETED|Overall Study||308
626675|NCT00236184|1538377|P1|COMPLETED|Overall Study||292
626676|NCT00236184|1538376|P2|STARTED|Overall Study||319
626677|NCT00236184|1538377|P1|STARTED|Overall Study||310
626678|NCT00236080|1538388|P5|NOT COMPLETED|Overall Study||1
626679|NCT00236080|1538389|P4|NOT COMPLETED|Overall Study||2
626680|NCT00236080|1538390|P3|NOT COMPLETED|Overall Study||5
626681|NCT00236080|1538391|P2|NOT COMPLETED|Overall Study||1
626682|NCT00236080|1538392|P1|NOT COMPLETED|Overall Study||2
626683|NCT00236080|1538388|P5|COMPLETED|Overall Study||26
626684|NCT00236080|1538389|P4|COMPLETED|Overall Study||23
626685|NCT00236080|1538390|P3|COMPLETED|Overall Study||22
626686|NCT00236080|1538391|P2|COMPLETED|Overall Study||27
626687|NCT00236080|1538392|P1|COMPLETED|Overall Study||27
626688|NCT00236080|1538388|P5|STARTED|Overall Study||27
626689|NCT00236080|1538389|P4|STARTED|Overall Study||25
626690|NCT00236080|1538390|P3|STARTED|Overall Study||27
626691|NCT00236080|1538391|P2|STARTED|Overall Study||28
626692|NCT00236080|1538392|P1|STARTED|Overall Study||29
626693|NCT00235989|1538413|P6|NOT COMPLETED|Extension Treatment Period (ET)||0
626694|NCT00235989|1538414|P5|NOT COMPLETED|Extension Treatment Period (ET)||0
626695|NCT00235989|1538415|P4|NOT COMPLETED|Extension Treatment Period (ET)||6
626696|NCT00235989|1538416|P3|NOT COMPLETED|Extension Treatment Period (ET)||5
626697|NCT00235989|1538417|P2|NOT COMPLETED|Extension Treatment Period (ET)||4
626698|NCT00235989|1538418|P1|NOT COMPLETED|Extension Treatment Period (ET)||8
626699|NCT00235989|1538413|P6|COMPLETED|Extension Treatment Period (ET)||0
626700|NCT00235989|1538414|P5|COMPLETED|Extension Treatment Period (ET)||0
626701|NCT00235989|1538415|P4|COMPLETED|Extension Treatment Period (ET)||14
626702|NCT00235989|1538416|P3|COMPLETED|Extension Treatment Period (ET)||14
626703|NCT00235989|1538417|P2|COMPLETED|Extension Treatment Period (ET)||2
626704|NCT00235989|1538418|P1|COMPLETED|Extension Treatment Period (ET)||8
626705|NCT00235989|1538413|P6|STARTED|Extension Treatment Period (ET)||0
626706|NCT00235989|1538414|P5|STARTED|Extension Treatment Period (ET)||0
626707|NCT00235989|1538415|P4|STARTED|Extension Treatment Period (ET)||20
626708|NCT00235989|1538416|P3|STARTED|Extension Treatment Period (ET)||19
626709|NCT00235989|1538417|P2|STARTED|Extension Treatment Period (ET)||6
626710|NCT00235989|1538418|P1|STARTED|Extension Treatment Period (ET)||16
626711|NCT00235989|1538413|P6|NOT COMPLETED|Core Treatment Period (CT)||2
626713|NCT00235989|1538415|P4|NOT COMPLETED|Core Treatment Period (CT)||0
626714|NCT00235989|1538416|P3|NOT COMPLETED|Core Treatment Period (CT)||0
626715|NCT00235989|1538417|P2|NOT COMPLETED|Core Treatment Period (CT)||0
626716|NCT00235989|1538418|P1|NOT COMPLETED|Core Treatment Period (CT)||0
626717|NCT00235989|1538413|P6|COMPLETED|Core Treatment Period (CT)||25
626718|NCT00235989|1538414|P5|COMPLETED|Core Treatment Period (CT)||36
626719|NCT00235989|1538415|P4|COMPLETED|Core Treatment Period (CT)||0
626720|NCT00235989|1538416|P3|COMPLETED|Core Treatment Period (CT)||0
626721|NCT00235989|1538417|P2|COMPLETED|Core Treatment Period (CT)||0
626722|NCT00235989|1538418|P1|COMPLETED|Core Treatment Period (CT)||0
626723|NCT00235989|1538413|P6|STARTED|Core Treatment Period (CT)||27
626724|NCT00235989|1538414|P5|STARTED|Core Treatment Period (CT)||36
626725|NCT00235989|1538415|P4|STARTED|Core Treatment Period (CT)||0
626726|NCT00235989|1538416|P3|STARTED|Core Treatment Period (CT)||0
626727|NCT00235989|1538417|P2|STARTED|Core Treatment Period (CT)||0
626728|NCT00235989|1538418|P1|STARTED|Core Treatment Period (CT)||0
626729|NCT00235872|1538432|P1|NOT COMPLETED|Overall Study||147
626730|NCT00235872|1538432|P1|COMPLETED|Overall Study||162
626731|NCT00235872|1538432|P1|STARTED|Overall Study||309
626732|NCT00235833|1538447|P1|NOT COMPLETED|Overall Study||16
626733|NCT00235833|1538447|P1|COMPLETED|Overall Study||9
626734|NCT00235833|1538447|P1|STARTED|Overall Study||25
626735|NCT00235755|1538463|P3|NOT COMPLETED|12-Week Maintenance Phase||31
626736|NCT00235755|1538464|P2|NOT COMPLETED|12-Week Maintenance Phase||27
626737|NCT00235755|1538465|P1|NOT COMPLETED|12-Week Maintenance Phase||16
626738|NCT00235755|1538463|P3|COMPLETED|12-Week Maintenance Phase||122
626739|NCT00235755|1538464|P2|COMPLETED|12-Week Maintenance Phase||135
626740|NCT00235755|1538465|P1|COMPLETED|12-Week Maintenance Phase||152
626741|NCT00235755|1538463|P3|STARTED|12-Week Maintenance Phase||153
626742|NCT00235755|1538464|P2|STARTED|12-Week Maintenance Phase||162
626743|NCT00235755|1538465|P1|STARTED|12-Week Maintenance Phase||168
626744|NCT00235755|1538463|P3|NOT COMPLETED|4-Week Titration Phase||26
626745|NCT00235755|1538464|P2|NOT COMPLETED|4-Week Titration Phase||19
626746|NCT00235755|1538465|P1|NOT COMPLETED|4-Week Titration Phase||11
626747|NCT00235755|1538463|P3|COMPLETED|4-Week Titration Phase||153
626748|NCT00235755|1538464|P2|COMPLETED|4-Week Titration Phase||162
626749|NCT00235755|1538465|P1|COMPLETED|4-Week Titration Phase||168
626750|NCT00235755|1538463|P3|STARTED|4-Week Titration Phase||179
626751|NCT00235755|1538464|P2|STARTED|4-Week Titration Phase||181
626752|NCT00235755|1538465|P1|STARTED|4-Week Titration Phase||179
626753|NCT00235716|1538543|P4|NOT COMPLETED|Overall Study||62
626754|NCT00235716|1538544|P3|NOT COMPLETED|Overall Study||65
626755|NCT00235716|1538545|P2|NOT COMPLETED|Overall Study||67
626756|NCT00235716|1538546|P1|NOT COMPLETED|Overall Study||62
626757|NCT00235716|1538543|P4|COMPLETED|Overall Study||90
626758|NCT00235716|1538544|P3|COMPLETED|Overall Study||89
626759|NCT00235716|1538545|P2|COMPLETED|Overall Study||88
626760|NCT00235716|1538546|P1|COMPLETED|Overall Study||90
626761|NCT00235716|1538543|P4|STARTED|Overall Study||152
626762|NCT00235716|1538544|P3|STARTED|Overall Study||154
626763|NCT00235716|1538545|P2|STARTED|Overall Study||155
626764|NCT00235716|1538546|P1|STARTED|Overall Study||152
626765|NCT00235573|1538580|P1|NOT COMPLETED|Overall Study||0
626766|NCT00235573|1538580|P1|COMPLETED|Overall Study||21
626767|NCT00235573|1538580|P1|STARTED|Overall Study|35 subjects screened; 14 not eligible; 21 started and completed study|21
626768|NCT00235456|1538586|P2|NOT COMPLETED|Overall Study||7
626769|NCT00235456|1538587|P1|NOT COMPLETED|Overall Study||2
626770|NCT00235456|1538586|P2|COMPLETED|Overall Study||143
626771|NCT00235456|1538587|P1|COMPLETED|Overall Study||148
626772|NCT00235456|1538586|P2|STARTED|Overall Study||150
626773|NCT00235456|1538587|P1|STARTED|Overall Study||150
626774|NCT00235443|1538609|P6|NOT COMPLETED|Overall Study||45
626775|NCT00235443|1538610|P5|NOT COMPLETED|Overall Study||30
626776|NCT00235443|1538611|P4|NOT COMPLETED|Overall Study||97
626777|NCT00235443|1538612|P3|NOT COMPLETED|Overall Study||62
626778|NCT00235443|1538613|P2|NOT COMPLETED|Overall Study||38
626779|NCT00235443|1538614|P1|NOT COMPLETED|Overall Study||8
626780|NCT00235443|1538609|P6|COMPLETED|Overall Study||9
626781|NCT00235443|1538610|P5|COMPLETED|Overall Study||9
626782|NCT00235443|1538611|P4|COMPLETED|Overall Study||108
626783|NCT00235443|1538612|P3|COMPLETED|Overall Study||23
626784|NCT00235443|1538613|P2|COMPLETED|Overall Study||19
626785|NCT00235443|1538614|P1|COMPLETED|Overall Study||3
626786|NCT00235443|1538609|P6|STARTED|Overall Study||54
626787|NCT00235443|1538610|P5|STARTED|Overall Study||39
626788|NCT00235443|1538611|P4|STARTED|Overall Study||205
626789|NCT00235443|1538612|P3|STARTED|Overall Study||85
626790|NCT00235443|1538613|P2|STARTED|Overall Study||57
626791|NCT00235443|1538614|P1|STARTED|Overall Study||11
626792|NCT00235391|1538755|P6|NOT COMPLETED|Overall Study||4
626793|NCT00235391|1538756|P5|NOT COMPLETED|Overall Study||12
626794|NCT00235391|1538757|P4|NOT COMPLETED|Overall Study||220
626795|NCT00235391|1538758|P3|NOT COMPLETED|Overall Study||24
626796|NCT00235391|1538759|P2|NOT COMPLETED|Overall Study||18
626797|NCT00235391|1538760|P1|NOT COMPLETED|Overall Study||12
626798|NCT00235391|1538755|P6|COMPLETED|Overall Study||3
626799|NCT00235391|1538756|P5|COMPLETED|Overall Study||31
626800|NCT00235391|1538757|P4|COMPLETED|Overall Study||944
626801|NCT00235391|1538758|P3|COMPLETED|Overall Study||148
626802|NCT00235391|1538759|P2|COMPLETED|Overall Study||182
626803|NCT00235391|1538760|P1|COMPLETED|Overall Study||85
626804|NCT00235391|1538755|P6|Deferasirox Treatment|Overall Study||7
626805|NCT00235391|1538756|P5|Deferasirox Treatment|Overall Study||43
626806|NCT00235391|1538757|P4|Deferasirox Treatment|Overall Study||1164
626807|NCT00235391|1538758|P3|Deferasirox Treatment|Overall Study||172
626808|NCT00235391|1538759|P2|Deferasirox Treatment|Overall Study||200
626809|NCT00235391|1538760|P1|Deferasirox Treatment|Overall Study||97
626810|NCT00235391|1538755|P6|STARTED|Overall Study||7
626811|NCT00235391|1538756|P5|STARTED|Overall Study||43
626812|NCT00235391|1538757|P4|STARTED|Overall Study||1164
626813|NCT00235391|1538758|P3|STARTED|Overall Study||172
626814|NCT00235391|1538759|P2|STARTED|Overall Study||200
626815|NCT00235391|1538760|P1|STARTED|Overall Study||97
626816|NCT00235326|1538777|P2|NOT COMPLETED|Overall Study||1400
626817|NCT00235326|1538778|P1|NOT COMPLETED|Overall Study||746
626818|NCT00235326|1538777|P2|COMPLETED|Overall Study||1586
626819|NCT00235326|1538778|P1|COMPLETED|Overall Study||829
626820|NCT00235326|1538777|P2|STARTED|Overall Study||2986
626821|NCT00235326|1538778|P1|STARTED|Overall Study||1575
626822|NCT00234884|1538782|P1|NOT COMPLETED|Overall Study||1630
626823|NCT00234884|1538782|P1|COMPLETED|Overall Study||1805
626824|NCT00234884|1538782|P1|STARTED|Overall Study||3435
626825|NCT00234832|1538792|P2|NOT COMPLETED|Overall Study||996
626826|NCT00234832|1538793|P1|NOT COMPLETED|Overall Study||1016
626827|NCT00234832|1538792|P2|COMPLETED|Overall Study|Subjects completed the Randomization Phase.|3902
626828|NCT00234832|1538793|P1|COMPLETED|Overall Study|Subjects completed the Randomization Phase.|3890
626829|NCT00234832|1538792|P2|STARTED|Overall Study|Subjects completed the 6-week Lead-in Period and were dispensed randomized study drug.|4898
626830|NCT00234832|1538793|P1|STARTED|Overall Study|Subjects completed the 6-week Lead-in Period and were dispensed randomized study drug.|4906
626831|NCT00234494|1538818|P1|NOT COMPLETED|Overall Study||2
626832|NCT00234494|1538818|P1|COMPLETED|Overall Study||43
626833|NCT00234494|1538818|P1|STARTED|Overall Study||45
626834|NCT00234286|1538825|P1|NOT COMPLETED|Overall Study||0
626835|NCT00234286|1538825|P1|COMPLETED|Overall Study|We reviewed eletronic health records for 6066 deceased individuals within 6 VA Hospitals|6066
626836|NCT00234286|1538825|P1|STARTED|Overall Study|We reviewed eletronic health records for 6066 deceased individuals within 6 VA Hospitals|6066
626837|NCT00234104|1538864|P4|NOT COMPLETED|Overall Study||8
626838|NCT00234104|1538865|P3|NOT COMPLETED|Overall Study||5
626839|NCT00234104|1538866|P2|NOT COMPLETED|Overall Study||1
626840|NCT00234104|1538867|P1|NOT COMPLETED|Overall Study||4
626841|NCT00234104|1538864|P4|COMPLETED|Overall Study||21
626842|NCT00234104|1538865|P3|COMPLETED|Overall Study||29
626843|NCT00234104|1538866|P2|COMPLETED|Overall Study||28
626844|NCT00234104|1538867|P1|COMPLETED|Overall Study||26
626845|NCT00234104|1538864|P4|STARTED|Overall Study||29
626846|NCT00234104|1538865|P3|STARTED|Overall Study||34
626847|NCT00234104|1538866|P2|STARTED|Overall Study||29
626848|NCT00234104|1538867|P1|STARTED|Overall Study||30
626849|NCT00234078|1538881|P4|NOT COMPLETED|Overall Study||4
626850|NCT00234078|1538882|P3|NOT COMPLETED|Overall Study||10
626851|NCT00234078|1538883|P2|NOT COMPLETED|Overall Study||9
626852|NCT00234078|1538884|P1|NOT COMPLETED|Overall Study||6
626853|NCT00234078|1538881|P4|COMPLETED|Overall Study||68
626854|NCT00234078|1538882|P3|COMPLETED|Overall Study||64
626855|NCT00234078|1538883|P2|COMPLETED|Overall Study||63
626856|NCT00234078|1538884|P1|COMPLETED|Overall Study||66
626857|NCT00234078|1538881|P4|STARTED|Overall Study||72
626858|NCT00234078|1538882|P3|STARTED|Overall Study||74
626859|NCT00234078|1538883|P2|STARTED|Overall Study||72
626860|NCT00234078|1538884|P1|STARTED|Overall Study||72
626861|NCT00234065|1538908|P2|NOT COMPLETED|Overall Study||356
626862|NCT00234065|1538909|P1|NOT COMPLETED|Overall Study||475
626863|NCT00234065|1538908|P2|COMPLETED|Overall Study||1004
626864|NCT00234065|1538909|P1|COMPLETED|Overall Study||881
626865|NCT00234065|1538908|P2|STARTED|Overall Study||1360
626866|NCT00234065|1538909|P1|STARTED|Overall Study||1356
626867|NCT00234039|1538925|P1|NOT COMPLETED|Overall Study||50
626868|NCT00234039|1538925|P1|COMPLETED|Overall Study||8
626869|NCT00234039|1538925|P1|Eligible and Began Protocol Therapy|Overall Study||47
626870|NCT00234039|1538925|P1|Eligible|Overall Study||49
626871|NCT00234039|1538925|P1|STARTED|Overall Study||58
626872|NCT00233987|1538932|P1|NOT COMPLETED|Overall Study||15
626873|NCT00233987|1538932|P1|COMPLETED|Overall Study||83
626874|NCT00233987|1538932|P1|Eligible and Treated|Overall Study||92
626875|NCT00233987|1538932|P1|Eligible|Overall Study||94
626876|NCT00233987|1538932|P1|STARTED|Overall Study||98
626877|NCT00233948|1538941|P6|NOT COMPLETED|Overall Study||0
626878|NCT00233948|1538942|P5|NOT COMPLETED|Overall Study||0
626879|NCT00233948|1538943|P4|NOT COMPLETED|Overall Study||0
626880|NCT00233948|1538944|P3|NOT COMPLETED|Overall Study||0
626881|NCT00233948|1538945|P2|NOT COMPLETED|Overall Study||0
626882|NCT00233948|1538946|P1|NOT COMPLETED|Overall Study||1
626883|NCT00233948|1538941|P6|COMPLETED|Overall Study||12
626884|NCT00233948|1538942|P5|COMPLETED|Overall Study||4
626885|NCT00233948|1538943|P4|COMPLETED|Overall Study||3
626886|NCT00233948|1538944|P3|COMPLETED|Overall Study||3
626887|NCT00233948|1538945|P2|COMPLETED|Overall Study||3
626888|NCT00233948|1538946|P1|COMPLETED|Overall Study||3
626889|NCT00233948|1538941|P6|STARTED|Overall Study||12
626890|NCT00233948|1538942|P5|STARTED|Overall Study||4
626891|NCT00233948|1538943|P4|STARTED|Overall Study||3
626892|NCT00233948|1538944|P3|STARTED|Overall Study||3
626893|NCT00233948|1538945|P2|STARTED|Overall Study||3
626894|NCT00233948|1538946|P1|STARTED|Overall Study||4
626895|NCT00233519|1538963|P2|NOT COMPLETED|Overall Study||1
626896|NCT00233519|1538964|P1|NOT COMPLETED|Overall Study||1
626897|NCT00233519|1538963|P2|COMPLETED|Overall Study||9
626898|NCT00233519|1538964|P1|COMPLETED|Overall Study||6
626899|NCT00233519|1538963|P2|STARTED|Overall Study||10
626900|NCT00233519|1538964|P1|STARTED|Overall Study||7
626901|NCT00233454|1538970|P1|NOT COMPLETED|Overall Study||6
626902|NCT00233454|1538970|P1|COMPLETED|Overall Study||20
626903|NCT00233454|1538970|P1|2 Months (for Response Rate)|Overall Study||26
626904|NCT00233454|1538970|P1|STARTED|Overall Study||26
626905|NCT00233402|1538977|P2|NOT COMPLETED|Overall Study||124
626906|NCT00233402|1538978|P1|NOT COMPLETED|Overall Study||104
626907|NCT00233402|1538977|P2|COMPLETED|Overall Study||271
626908|NCT00233402|1538978|P1|COMPLETED|Overall Study||280
626909|NCT00233402|1538977|P2|STARTED|Overall Study||395
626910|NCT00233402|1538978|P1|STARTED|Overall Study||384
626911|NCT00233324|1538993|P4|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||11
626912|NCT00233324|1538994|P3|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||18
626913|NCT00233324|1538995|P2|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||14
626914|NCT00233324|1538996|P1|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||13
626915|NCT00233324|1538993|P4|COMPLETED|Follow up at 18-22 Months Corrected Age||269
626916|NCT00233324|1538994|P3|COMPLETED|Follow up at 18-22 Months Corrected Age||256
626917|NCT00233324|1538995|P2|COMPLETED|Follow up at 18-22 Months Corrected Age||261
626918|NCT00233324|1538996|P1|COMPLETED|Follow up at 18-22 Months Corrected Age||237
626919|NCT00233324|1538993|P4|STARTED|Follow up at 18-22 Months Corrected Age||280
626920|NCT00233324|1538994|P3|STARTED|Follow up at 18-22 Months Corrected Age||274
626921|NCT00233324|1538995|P2|STARTED|Follow up at 18-22 Months Corrected Age||275
626922|NCT00233324|1538996|P1|STARTED|Follow up at 18-22 Months Corrected Age||250
626923|NCT00233324|1538993|P4|NOT COMPLETED|Main Study||47
626924|NCT00233324|1538994|P3|NOT COMPLETED|Main Study||62
626925|NCT00233324|1538995|P2|NOT COMPLETED|Main Study||60
626926|NCT00233324|1538996|P1|NOT COMPLETED|Main Study||68
626927|NCT00233324|1538993|P4|COMPLETED|Main Study||280
626928|NCT00233324|1538994|P3|COMPLETED|Main Study||274
626929|NCT00233324|1538995|P2|COMPLETED|Main Study||275
626930|NCT00233324|1538996|P1|COMPLETED|Main Study||250
626931|NCT00233324|1538993|P4|STARTED|Main Study||327
626932|NCT00233324|1538994|P3|STARTED|Main Study||336
626933|NCT00233324|1538995|P2|STARTED|Main Study||335
626934|NCT00233324|1538996|P1|STARTED|Main Study||318
626935|NCT00233103|1539012|P2|NOT COMPLETED|Overall Study||6
626936|NCT00233103|1539013|P1|NOT COMPLETED|Overall Study||5
626937|NCT00233103|1539012|P2|COMPLETED|Overall Study||19
626938|NCT00233103|1539013|P1|COMPLETED|Overall Study||22
626939|NCT00233103|1539012|P2|STARTED|Overall Study||25
626940|NCT00233103|1539013|P1|STARTED|Overall Study||27
626941|NCT00233090|1539027|P2|NOT COMPLETED|Overall Study||0
626942|NCT00233090|1539028|P1|NOT COMPLETED|Overall Study||0
626943|NCT00233090|1539027|P2|COMPLETED|Overall Study||9
626944|NCT00233090|1539028|P1|COMPLETED|Overall Study||12
626945|NCT00233090|1539027|P2|STARTED|Overall Study||9
626946|NCT00233090|1539028|P1|STARTED|Overall Study||12
626947|NCT00233064|1539050|P2|NOT COMPLETED|Overall Study||12
626948|NCT00233064|1539051|P1|NOT COMPLETED|Overall Study||14
626949|NCT00233064|1539050|P2|COMPLETED|Overall Study||190
626950|NCT00233064|1539051|P1|COMPLETED|Overall Study||197
626951|NCT00233064|1539050|P2|STARTED|Overall Study||202
626952|NCT00233064|1539051|P1|STARTED|Overall Study||211
626953|NCT00232739|1539058|P1|NOT COMPLETED|Overall Study||9
626954|NCT00232739|1539058|P1|COMPLETED|Overall Study||91
626955|NCT00232739|1539058|P1|STARTED|Overall Study||100
626956|NCT00232596|1539077|P2|NOT COMPLETED|12-Week Maintenance Phase||28
626957|NCT00232596|1539078|P1|NOT COMPLETED|12-Week Maintenance Phase||12
626958|NCT00232596|1539077|P2|COMPLETED|12-Week Maintenance Phase||97
626959|NCT00232596|1539078|P1|COMPLETED|12-Week Maintenance Phase|One participant withdrew after being considered a “completer” and is listed as an early withdraw.|126
626960|NCT00232596|1539077|P2|STARTED|12-Week Maintenance Phase||125
626961|NCT00232596|1539078|P1|STARTED|12-Week Maintenance Phase||138
626962|NCT00232596|1539077|P2|NOT COMPLETED|6-Week Titration Phase||29
626963|NCT00232596|1539078|P1|NOT COMPLETED|6-Week Titration Phase||14
626964|NCT00232596|1539077|P2|COMPLETED|6-Week Titration Phase||125
626965|NCT00232596|1539078|P1|COMPLETED|6-Week Titration Phase||138
626966|NCT00232596|1539077|P2|STARTED|6-Week Titration Phase||154
626967|NCT00232596|1539078|P1|STARTED|6-Week Titration Phase||152
626968|NCT00232583|1539130|P2|NOT COMPLETED|Overall Study||13
626969|NCT00232583|1539131|P1|NOT COMPLETED|Overall Study||10
626970|NCT00232583|1539130|P2|COMPLETED|Overall Study||16
626971|NCT00232583|1539131|P1|COMPLETED|Overall Study||19
626972|NCT00232583|1539130|P2|STARTED|Overall Study||29
626973|NCT00232583|1539131|P1|STARTED|Overall Study||29
626974|NCT00232557|1539169|P2|NOT COMPLETED|Overall Study||5
626975|NCT00232557|1539170|P1|NOT COMPLETED|Overall Study||3
626976|NCT00232557|1539169|P2|COMPLETED|Overall Study||60
626977|NCT00232557|1539170|P1|COMPLETED|Overall Study||68
626978|NCT00232557|1539169|P2|STARTED|Overall Study||65
626979|NCT00232557|1539170|P1|STARTED|Overall Study||71
626980|NCT00232544|1539180|P2|NOT COMPLETED|Overall Study||15
626981|NCT00232544|1539181|P1|NOT COMPLETED|Overall Study||20
626982|NCT00232544|1539180|P2|COMPLETED|Overall Study||111
626983|NCT00232544|1539181|P1|COMPLETED|Overall Study||104
626984|NCT00232544|1539180|P2|STARTED|Overall Study||126
626985|NCT00232544|1539181|P1|STARTED|Overall Study||124
626986|NCT00232505|1539191|P2|NOT COMPLETED|Overall Study||11
626987|NCT00232505|1539192|P1|NOT COMPLETED|Overall Study||5
626988|NCT00232505|1539191|P2|COMPLETED|Overall Study||60
626989|NCT00232505|1539192|P1|COMPLETED|Overall Study||26
626990|NCT00232505|1539191|P2|Off Protocol|Overall Study||0
626991|NCT00232505|1539192|P1|Off Protocol|Overall Study||5
626992|NCT00232505|1539191|P2|Early Progressors|Overall Study||5
626993|NCT00232505|1539192|P1|Early Progressors|Overall Study||2
626994|NCT00232505|1539191|P2|Not Evaluable|Overall Study||6
626995|NCT00232505|1539192|P1|Not Evaluable|Overall Study||0
626996|NCT00232505|1539191|P2|STARTED|Overall Study||71
626997|NCT00232505|1539192|P1|STARTED|Overall Study||31
626998|NCT00232479|1539205|P1|NOT COMPLETED|Overall Study||0
626999|NCT00232479|1539205|P1|COMPLETED|Overall Study||44
627000|NCT00232479|1539205|P1|STARTED|Overall Study||44
627001|NCT00232180|1539212|P3|NOT COMPLETED|Open Label Phase||148
627002|NCT00232180|1539213|P2|NOT COMPLETED|Open Label Phase||0
627003|NCT00232180|1539214|P1|NOT COMPLETED|Open Label Phase||0
627004|NCT00232180|1539212|P3|COMPLETED|Open Label Phase||1098
627005|NCT00232180|1539213|P2|COMPLETED|Open Label Phase||0
627006|NCT00232180|1539214|P1|COMPLETED|Open Label Phase||0
627007|NCT00232180|1539212|P3|Treated|Open Label Phase||1245
627008|NCT00232180|1539213|P2|Treated|Open Label Phase||0
627009|NCT00232180|1539214|P1|Treated|Open Label Phase||0
627010|NCT00232180|1539212|P3|STARTED|Open Label Phase||1246
627011|NCT00232180|1539213|P2|STARTED|Open Label Phase||0
627012|NCT00232180|1539214|P1|STARTED|Open Label Phase||0
627013|NCT00232180|1539212|P3|NOT COMPLETED|Double-blind (DB) Phase||0
627014|NCT00232180|1539213|P2|NOT COMPLETED|Double-blind (DB) Phase||605
627015|NCT00232180|1539214|P1|NOT COMPLETED|Double-blind (DB) Phase||541
627016|NCT00232180|1539212|P3|COMPLETED|Double-blind (DB) Phase||0
627017|NCT00232180|1539213|P2|COMPLETED|Double-blind (DB) Phase||771
627018|NCT00232180|1539214|P1|COMPLETED|Double-blind (DB) Phase||826
627019|NCT00232180|1539212|P3|Treated|Double-blind (DB) Phase||0
627020|NCT00232180|1539213|P2|Treated|Double-blind (DB) Phase||1372
627021|NCT00232180|1539214|P1|Treated|Double-blind (DB) Phase||1364
627022|NCT00232180|1539212|P3|STARTED|Double-blind (DB) Phase||0
627023|NCT00232180|1539213|P2|STARTED|Double-blind (DB) Phase|Three participants in each arm were enrolled after data cut-off.|1376
627024|NCT00232180|1539214|P1|STARTED|Double-blind (DB) Phase|Three participants in each arm were enrolled after data cut-off.|1367
627025|NCT00232141|1539259|P2|NOT COMPLETED|Overall Study||26
627026|NCT00232141|1539260|P1|NOT COMPLETED|Overall Study||31
627027|NCT00232141|1539259|P2|COMPLETED|Overall Study||125
627028|NCT00232141|1539260|P1|COMPLETED|Overall Study||120
627029|NCT00232141|1539259|P2|STARTED|Overall Study||151
627030|NCT00232141|1539260|P1|STARTED|Overall Study||151
627031|NCT00231894|1539330|P2|NOT COMPLETED|Overall Study||1
627032|NCT00231894|1539331|P1|NOT COMPLETED|Overall Study||1
627033|NCT00231894|1539330|P2|COMPLETED|Overall Study||24
627034|NCT00231894|1539331|P1|COMPLETED|Overall Study||30
627035|NCT00231894|1539330|P2|STARTED|Overall Study||25
627036|NCT00231894|1539331|P1|STARTED|Overall Study||31
627037|NCT00231816|1539355|P2|NOT COMPLETED|Overall Study||12
627038|NCT00231816|1539356|P1|NOT COMPLETED|Overall Study||16
627039|NCT00231816|1539355|P2|COMPLETED|Overall Study|Participant received required vaccines and returned completed vaccination report cards at Visits 2&3|369
627040|NCT00231816|1539356|P1|COMPLETED|Overall Study|Participant received required vaccines and returned completed vaccination report cards at Visits 2&3|366
627041|NCT00231816|1539355|P2|Vaccinated at Visit 2|Overall Study||371
627042|NCT00231816|1539356|P1|Vaccinated at Visit 2|Overall Study||369
627043|NCT00231816|1539355|P2|Vaccinated at Visit 1|Overall Study|One participant was randomized but not vaccinated|380
627044|NCT00231816|1539356|P1|Vaccinated at Visit 1|Overall Study||382
627045|NCT00231816|1539355|P2|STARTED|Overall Study||381
627046|NCT00231816|1539356|P1|STARTED|Overall Study||382
627047|NCT00231777|1539371|P2|NOT COMPLETED|Overall Study||2
627048|NCT00231777|1539372|P1|NOT COMPLETED|Overall Study||6
627049|NCT00231777|1539371|P2|COMPLETED|Overall Study||44
627050|NCT00231777|1539372|P1|COMPLETED|Overall Study||164
627051|NCT00231777|1539371|P2|STARTED|Overall Study||46
627052|NCT00231777|1539372|P1|STARTED|Overall Study||170
627053|NCT00231478|1539386|P2|NOT COMPLETED|Overall Study||6
627054|NCT00231478|1539387|P1|NOT COMPLETED|Overall Study||8
627055|NCT00231478|1539386|P2|COMPLETED|Overall Study||78
627056|NCT00231478|1539387|P1|COMPLETED|Overall Study||79
627057|NCT00231478|1539386|P2|STARTED|Overall Study||84
627058|NCT00231478|1539387|P1|STARTED|Overall Study||87
627059|NCT00231465|1539399|P1|NOT COMPLETED|Overall Study||2
627060|NCT00231465|1539399|P1|COMPLETED|Overall Study||42
627061|NCT00231465|1539399|P1|STARTED|Overall Study||44
627062|NCT00231309|1539405|P1|NOT COMPLETED|Overall Study||0
627063|NCT00231309|1539405|P1|COMPLETED|Overall Study||10
627064|NCT00231309|1539405|P1|STARTED|Overall Study||10
627065|NCT00231283|1539410|P1|NOT COMPLETED|Overall Study||5
627066|NCT00231283|1539410|P1|COMPLETED|Overall Study||95
627067|NCT00231283|1539410|P1|STARTED|Overall Study||100
627068|NCT00231179|1539419|P2|NOT COMPLETED|Overall Study||24
627069|NCT00231179|1539420|P1|NOT COMPLETED|Overall Study||24
627070|NCT00231179|1539419|P2|COMPLETED|Overall Study|126 (93%) in the control group completed the five year follow-up visit.|126
627071|NCT00231179|1539420|P1|COMPLETED|Overall Study|128 (95%) in intervention group completed the five year follow-up visit.|128
627072|NCT00231179|1539419|P2|STARTED|Overall Study||150
627073|NCT00231179|1539420|P1|STARTED|Overall Study||152
627074|NCT00231153|1539436|P2|NOT COMPLETED|Overall Study||188
627075|NCT00231153|1539437|P1|NOT COMPLETED|Overall Study||217
627076|NCT00231153|1539436|P2|COMPLETED|Overall Study||720
627077|NCT00231153|1539437|P1|COMPLETED|Overall Study||690
627078|NCT00231153|1539436|P2|STARTED|Overall Study|Subjects randomized to povidone-iodine who received at least one dose of study treatment.|908
627079|NCT00231153|1539437|P1|STARTED|Overall Study|Subjects randomized to omiganan 1% gel who received at least one dose of study treatment.|907
627080|NCT00231114|1539447|P2|NOT COMPLETED|Post-Treatment Period||1
627081|NCT00231114|1539448|P1|NOT COMPLETED|Post-Treatment Period||8
627082|NCT00231114|1539447|P2|COMPLETED|Post-Treatment Period||97
627083|NCT00231114|1539448|P1|COMPLETED|Post-Treatment Period||181
627084|NCT00231114|1539447|P2|STARTED|Post-Treatment Period||98
627085|NCT00231114|1539448|P1|STARTED|Post-Treatment Period||189
627086|NCT00231114|1539447|P2|NOT COMPLETED|Treatment Period||0
627087|NCT00231114|1539448|P1|NOT COMPLETED|Treatment Period||1
627088|NCT00231114|1539447|P2|COMPLETED|Treatment Period||98
627089|NCT00231114|1539448|P1|COMPLETED|Treatment Period||189
627090|NCT00231114|1539447|P2|STARTED|Treatment Period||98
627091|NCT00231114|1539448|P1|STARTED|Treatment Period||190
627092|NCT00231114|1539447|P2|NOT COMPLETED|Randomized||3
627093|NCT00231114|1539448|P1|NOT COMPLETED|Randomized||6
627094|NCT00231114|1539447|P2|COMPLETED|Randomized||98
627095|NCT00231114|1539448|P1|COMPLETED|Randomized||190
627096|NCT00231114|1539447|P2|STARTED|Randomized||101
627097|NCT00231114|1539448|P1|STARTED|Randomized||196
627098|NCT00231062|1539484|P1|NOT COMPLETED|Overall Study||6
627099|NCT00231062|1539484|P1|COMPLETED|Overall Study||109
627100|NCT00231062|1539484|P1|STARTED|Overall Study||115
627101|NCT00230971|1539492|P2|NOT COMPLETED|Baseline Participants||19
627102|NCT00230971|1539493|P1|NOT COMPLETED|Baseline Participants||22
627103|NCT00230971|1539492|P2|COMPLETED|Baseline Participants||216
627104|NCT00230971|1539493|P1|COMPLETED|Baseline Participants||210
627105|NCT00230971|1539492|P2|STARTED|Baseline Participants||235
627106|NCT00230971|1539493|P1|STARTED|Baseline Participants||232
627107|NCT00230971|1539492|P2|NOT COMPLETED|Randomization||3
627108|NCT00230971|1539493|P1|NOT COMPLETED|Randomization||3
627109|NCT00230971|1539492|P2|COMPLETED|Randomization||235
627110|NCT00230971|1539493|P1|COMPLETED|Randomization||232
627111|NCT00230971|1539492|P2|STARTED|Randomization||238
627112|NCT00230971|1539493|P1|STARTED|Randomization||235
627113|NCT00230802|1539507|P2|NOT COMPLETED|Overall Study||0
627114|NCT00230802|1539508|P1|NOT COMPLETED|Overall Study||0
627115|NCT00230802|1539507|P2|COMPLETED|Overall Study||23
627116|NCT00230802|1539508|P1|COMPLETED|Overall Study||25
627117|NCT00230802|1539507|P2|STARTED|Overall Study||23
627118|NCT00230802|1539508|P1|STARTED|Overall Study||25
627119|NCT00230737|1539521|P3|NOT COMPLETED|Overall Study||0
627120|NCT00230737|1539522|P2|NOT COMPLETED|Overall Study||0
627121|NCT00230737|1539523|P1|NOT COMPLETED|Overall Study||0
627122|NCT00230737|1539521|P3|COMPLETED|Overall Study||8
627123|NCT00230737|1539522|P2|COMPLETED|Overall Study||10
627124|NCT00230737|1539523|P1|COMPLETED|Overall Study||9
627125|NCT00230737|1539521|P3|STARTED|Overall Study||8
627126|NCT00230737|1539522|P2|STARTED|Overall Study||10
627127|NCT00230737|1539523|P1|STARTED|Overall Study||9
627128|NCT00230282|1539531|P1|NOT COMPLETED|Maintanence Therapy With Alemtuzumab||0
627129|NCT00230282|1539531|P1|COMPLETED|Maintanence Therapy With Alemtuzumab||17
627130|NCT00230282|1539531|P1|STARTED|Maintanence Therapy With Alemtuzumab||17
627131|NCT00230282|1539531|P1|NOT COMPLETED|Fludarabine + Cyclophosphamide||8
627132|NCT00230282|1539531|P1|COMPLETED|Fludarabine + Cyclophosphamide||17
627133|NCT00230282|1539531|P1|STARTED|Fludarabine + Cyclophosphamide||25
627134|NCT00230178|1539539|P3|NOT COMPLETED|Overall Study||7
627135|NCT00230178|1539540|P2|NOT COMPLETED|Overall Study||7
627136|NCT00230178|1539541|P1|NOT COMPLETED|Overall Study||4
627137|NCT00230178|1539539|P3|COMPLETED|Overall Study||86
627138|NCT00230178|1539540|P2|COMPLETED|Overall Study||86
627139|NCT00230178|1539541|P1|COMPLETED|Overall Study||90
627140|NCT00230178|1539539|P3|Treated|Overall Study||91
627141|NCT00230178|1539540|P2|Treated|Overall Study||92
627142|NCT00230178|1539541|P1|Treated|Overall Study|Modified ITT population: ITT patients with at least 1 dose of study drug|92
627143|NCT00230178|1539539|P3|STARTED|Overall Study||93
627144|NCT00230178|1539540|P2|STARTED|Overall Study||93
627145|NCT00230178|1539541|P1|STARTED|Overall Study|Intent-to-treat (ITT)population: randomized patients|94
627146|NCT00230126|1539557|P2|NOT COMPLETED|Overall Study||1
627147|NCT00230126|1539558|P1|NOT COMPLETED|Overall Study||2
627148|NCT00230126|1539557|P2|COMPLETED|Overall Study||27
627149|NCT00230126|1539558|P1|COMPLETED|Overall Study||28
627150|NCT00230126|1539557|P2|STARTED|Overall Study||28
627151|NCT00230126|1539558|P1|STARTED|Overall Study||30
627152|NCT00230100|1539570|P2|NOT COMPLETED|Overall Study||0
627153|NCT00230100|1539571|P1|NOT COMPLETED|Overall Study||0
627154|NCT00230100|1539570|P2|COMPLETED|Overall Study||17
627155|NCT00230100|1539571|P1|COMPLETED|Overall Study||29
627156|NCT00230100|1539570|P2|STARTED|Overall Study||17
627157|NCT00230100|1539571|P1|STARTED|Overall Study||29
627158|NCT00230048|1539593|P2|NOT COMPLETED|Overall Study||18
627159|NCT00230048|1539594|P1|NOT COMPLETED|Overall Study||13
627160|NCT00230048|1539593|P2|COMPLETED|Overall Study||37
627161|NCT00230048|1539594|P1|COMPLETED|Overall Study||39
627162|NCT00230048|1539593|P2|Completed Intervention/Control Session|Overall Study||55
627163|NCT00230048|1539594|P1|Completed Intervention/Control Session|Overall Study||52
627164|NCT00230048|1539593|P2|STARTED|Overall Study||55
627165|NCT00230048|1539594|P1|STARTED|Overall Study||52
627166|NCT00230022|1539604|P2|NOT COMPLETED|Overall Study||0
627167|NCT00230022|1539605|P1|NOT COMPLETED|Overall Study||0
627168|NCT00230022|1539604|P2|COMPLETED|Overall Study||15
627169|NCT00230022|1539605|P1|COMPLETED|Overall Study||15
627170|NCT00230022|1539604|P2|STARTED|Overall Study||15
627171|NCT00230022|1539605|P1|STARTED|Overall Study||15
627172|NCT00230009|1539613|P2|NOT COMPLETED|Follow-up||26
627173|NCT00230009|1539614|P1|NOT COMPLETED|Follow-up||31
627174|NCT00230009|1539613|P2|COMPLETED|Follow-up||24
627175|NCT00230009|1539614|P1|COMPLETED|Follow-up||19
627176|NCT00230009|1539613|P2|STARTED|Follow-up||50
627177|NCT00230009|1539614|P1|STARTED|Follow-up||50
627178|NCT00230009|1539613|P2|NOT COMPLETED|Single Session Intervention/Control||0
627179|NCT00230009|1539614|P1|NOT COMPLETED|Single Session Intervention/Control||0
627180|NCT00230009|1539613|P2|COMPLETED|Single Session Intervention/Control||50
627181|NCT00230009|1539614|P1|COMPLETED|Single Session Intervention/Control||50
627182|NCT00230009|1539613|P2|STARTED|Single Session Intervention/Control||50
627183|NCT00230009|1539614|P1|STARTED|Single Session Intervention/Control||50
627184|NCT00229970|1539631|P3|NOT COMPLETED|Overall Study||0
627185|NCT00229970|1539632|P2|NOT COMPLETED|Overall Study||0
627186|NCT00229970|1539633|P1|NOT COMPLETED|Overall Study||0
627187|NCT00229970|1539631|P3|COMPLETED|Overall Study||75
627188|NCT00229970|1539632|P2|COMPLETED|Overall Study||72
627189|NCT00229970|1539633|P1|COMPLETED|Overall Study||78
627190|NCT00229970|1539631|P3|STARTED|Overall Study||75
627191|NCT00229970|1539632|P2|STARTED|Overall Study||72
627192|NCT00229970|1539633|P1|STARTED|Overall Study||78
627193|NCT00229957|1539643|P2|NOT COMPLETED|Overall Study||12
627194|NCT00229957|1539644|P1|NOT COMPLETED|Overall Study||20
627195|NCT00229957|1539643|P2|COMPLETED|Overall Study||139
627196|NCT00229957|1539644|P1|COMPLETED|Overall Study||132
627197|NCT00229957|1539643|P2|STARTED|Overall Study||151
627198|NCT00229957|1539644|P1|STARTED|Overall Study||152
627199|NCT00229931|1539652|P2|NOT COMPLETED|Overall Study||2
627200|NCT00229931|1539653|P1|NOT COMPLETED|Overall Study||4
627201|NCT00229931|1539652|P2|COMPLETED|Overall Study||3
627202|NCT00229931|1539653|P1|COMPLETED|Overall Study||2
627203|NCT00229931|1539652|P2|STARTED|Overall Study||5
627204|NCT00229931|1539653|P1|STARTED|Overall Study||6
627205|NCT00229723|1539668|P7|NOT COMPLETED|Maintenance Phase||10
627206|NCT00229723|1539669|P6|NOT COMPLETED|Maintenance Phase||19
627207|NCT00229723|1539670|P5|NOT COMPLETED|Maintenance Phase||15
627208|NCT00229723|1539671|P4|NOT COMPLETED|Maintenance Phase||17
627209|NCT00229723|1539672|P3|NOT COMPLETED|Maintenance Phase||9
627210|NCT00229723|1539673|P2|NOT COMPLETED|Maintenance Phase||14
627211|NCT00229723|1539674|P1|NOT COMPLETED|Maintenance Phase||25
627212|NCT00229723|1539668|P7|COMPLETED|Maintenance Phase|Completed study on randomized treatment|9
627213|NCT00229723|1539669|P6|COMPLETED|Maintenance Phase|Completed study on randomized treatment|12
627214|NCT00229723|1539670|P5|COMPLETED|Maintenance Phase|Completed study on randomized treatment|7
627215|NCT00229723|1539671|P4|COMPLETED|Maintenance Phase|Completed study on randomized treatment|9
627216|NCT00229723|1539672|P3|COMPLETED|Maintenance Phase|Completed study on randomized treatment|16
627217|NCT00229723|1539673|P2|COMPLETED|Maintenance Phase|Completed study on randomized treatment|5
627218|NCT00229723|1539674|P1|COMPLETED|Maintenance Phase|Completed study on randomized treatment|25
627219|NCT00229723|1539668|P7|STARTED|Maintenance Phase||19
627220|NCT00229723|1539669|P6|STARTED|Maintenance Phase||31
627221|NCT00229723|1539670|P5|STARTED|Maintenance Phase||22
627222|NCT00229723|1539671|P4|STARTED|Maintenance Phase||26
627223|NCT00229723|1539672|P3|STARTED|Maintenance Phase||25
627224|NCT00229723|1539673|P2|STARTED|Maintenance Phase||19
627225|NCT00229723|1539674|P1|STARTED|Maintenance Phase||50
627226|NCT00229723|1539668|P7|NOT COMPLETED|Concomitant Phase||3
627227|NCT00229723|1539669|P6|NOT COMPLETED|Concomitant Phase||3
627228|NCT00229723|1539670|P5|NOT COMPLETED|Concomitant Phase||2
627229|NCT00229723|1539671|P4|NOT COMPLETED|Concomitant Phase||5
627230|NCT00229723|1539672|P3|NOT COMPLETED|Concomitant Phase||6
627231|NCT00229723|1539673|P2|NOT COMPLETED|Concomitant Phase||5
627232|NCT00229723|1539674|P1|NOT COMPLETED|Concomitant Phase||10
627233|NCT00229723|1539668|P7|COMPLETED|Concomitant Phase||19
627234|NCT00229723|1539669|P6|COMPLETED|Concomitant Phase||31
627235|NCT00229723|1539670|P5|COMPLETED|Concomitant Phase||22
627236|NCT00229723|1539671|P4|COMPLETED|Concomitant Phase||26
627237|NCT00229723|1539672|P3|COMPLETED|Concomitant Phase||25
627238|NCT00229723|1539673|P2|COMPLETED|Concomitant Phase||19
627239|NCT00229723|1539674|P1|COMPLETED|Concomitant Phase||50
627240|NCT00229723|1539668|P7|STARTED|Concomitant Phase|Received randomized treatment|22
627241|NCT00229723|1539669|P6|STARTED|Concomitant Phase|Received randomized treatment|34
627242|NCT00229723|1539670|P5|STARTED|Concomitant Phase|Received randomized treatment|24
627243|NCT00229723|1539671|P4|STARTED|Concomitant Phase|Received randomized treatment|31
627244|NCT00229723|1539672|P3|STARTED|Concomitant Phase|Received randomized treatment|31
627245|NCT00229723|1539673|P2|STARTED|Concomitant Phase|Received randomized treatment|24
627246|NCT00229723|1539674|P1|STARTED|Concomitant Phase|Received randomized treatment|60
627247|NCT00229658|1539727|P2|NOT COMPLETED|Overall Study||167
627248|NCT00229658|1539728|P1|NOT COMPLETED|Overall Study||225
627249|NCT00229658|1539727|P2|COMPLETED|Overall Study||364
627250|NCT00229658|1539728|P1|COMPLETED|Overall Study||541
627251|NCT00229658|1539727|P2|STARTED|Overall Study||531
627252|NCT00229658|1539728|P1|STARTED|Overall Study||766
627253|NCT00229619|1539756|P1|NOT COMPLETED|Overall Study||0
627254|NCT00229619|1539756|P1|COMPLETED|Overall Study||11
627255|NCT00229619|1539756|P1|STARTED|Overall Study||11
627256|NCT00229203|1539762|P2|NOT COMPLETED|Overall Study||19
627257|NCT00229203|1539763|P1|NOT COMPLETED|Overall Study||32
627258|NCT00229203|1539762|P2|COMPLETED|Overall Study||0
627259|NCT00229203|1539763|P1|COMPLETED|Overall Study||0
627260|NCT00229203|1539762|P2|STARTED|Overall Study||19
627261|NCT00229203|1539763|P1|STARTED|Overall Study||32
627262|NCT00228943|1539775|P1|NOT COMPLETED|Week 2||1
627263|NCT00228943|1539775|P1|COMPLETED|Week 2||27
627264|NCT00228943|1539775|P1|STARTED|Week 2||28
627265|NCT00228943|1539775|P1|NOT COMPLETED|Week 1||0
627266|NCT00228943|1539775|P1|COMPLETED|Week 1||28
627267|NCT00228943|1539775|P1|STARTED|Week 1||28
627268|NCT00228917|1539787|P4|NOT COMPLETED|Overall Study||0
627269|NCT00228917|1539788|P3|NOT COMPLETED|Overall Study||0
627270|NCT00228917|1539789|P2|NOT COMPLETED|Overall Study||3
627271|NCT00228917|1539790|P1|NOT COMPLETED|Overall Study||1
627272|NCT00228917|1539787|P4|COMPLETED|Overall Study||107
627273|NCT00228917|1539788|P3|COMPLETED|Overall Study||213
627274|NCT00228917|1539789|P2|COMPLETED|Overall Study||320
627275|NCT00228917|1539790|P1|COMPLETED|Overall Study||646
627276|NCT00228917|1539787|P4|STARTED|Overall Study||107
627277|NCT00228917|1539788|P3|STARTED|Overall Study||213
627278|NCT00228917|1539789|P2|STARTED|Overall Study||323
627279|NCT00228917|1539790|P1|STARTED|Overall Study||647
627280|NCT00228813|1539816|P1|NOT COMPLETED|Overall Study||4
627281|NCT00228813|1539816|P1|COMPLETED|Overall Study||4
627282|NCT00228813|1539816|P1|STARTED|Overall Study||8
627283|NCT00228566|1539822|P1|NOT COMPLETED|Overall Study||71
627284|NCT00228566|1539822|P1|COMPLETED|Overall Study||176
627285|NCT00228566|1539822|P1|STARTED|Overall Study||247
627286|NCT00228553|1539826|P1|NOT COMPLETED|Overall Study||430
627287|NCT00228553|1539826|P1|COMPLETED|Overall Study||313
627288|NCT00228553|1539826|P1|STARTED|Overall Study||743
627289|NCT00228384|1539832|P2|NOT COMPLETED|Overall Study||29
627290|NCT00228384|1539833|P1|NOT COMPLETED|Overall Study||29
627291|NCT00228384|1539832|P2|COMPLETED|Overall Study||47
627292|NCT00228384|1539833|P1|COMPLETED|Overall Study||43
627293|NCT00228384|1539832|P2|Three Year Follow-up (Final)|Overall Study||47
627294|NCT00228384|1539833|P1|Three Year Follow-up (Final)|Overall Study||43
627295|NCT00228384|1539832|P2|30-Day Follow-up (Safety Outcome)|Overall Study||72
627296|NCT00228384|1539833|P1|30-Day Follow-up (Safety Outcome)|Overall Study||69
627297|NCT00228384|1539832|P2|Baseline|Overall Study||76
627298|NCT00228384|1539833|P1|Baseline|Overall Study||72
627299|NCT00228384|1539832|P2|STARTED|Overall Study||76
627300|NCT00228384|1539833|P1|STARTED|Overall Study||72
627301|NCT00227994|1539873|P2|NOT COMPLETED|Overall Study||7
627302|NCT00227994|1539874|P1|NOT COMPLETED|Overall Study||7
627303|NCT00227994|1539873|P2|COMPLETED|Overall Study||13
627304|NCT00227994|1539874|P1|COMPLETED|Overall Study||13
627305|NCT00227994|1539873|P2|STARTED|Overall Study||20
627306|NCT00227994|1539874|P1|STARTED|Overall Study||20
627307|NCT00227903|1539884|P2|NOT COMPLETED|Overall Study||10
627308|NCT00227903|1539885|P1|NOT COMPLETED|Overall Study||5
627309|NCT00227903|1539884|P2|COMPLETED|Overall Study|Participants with at least 1 follow-up assessment were analyzed|82
627310|NCT00227903|1539885|P1|COMPLETED|Overall Study|Participants with at least 1 follow-up assessment were analyzed|86
627311|NCT00227903|1539884|P2|Received ≥ 1 Follow-up Assessment|Overall Study|4 participants did not receive any treatment sessions.|82
627312|NCT00227903|1539885|P1|Received ≥ 1 Follow-up Assessment|Overall Study|1 participant did not receive any treatment sessions.|86
627313|NCT00227903|1539884|P2|STARTED|Overall Study||92
627314|NCT00227903|1539885|P1|STARTED|Overall Study||91
627315|NCT00227760|1539945|P1|NOT COMPLETED|Overall Study||0
627316|NCT00227760|1539945|P1|COMPLETED|Overall Study||44
627317|NCT00227760|1539945|P1|STARTED|Overall Study||44
627318|NCT00227721|1539951|P1|NOT COMPLETED|Overall Study||1
627319|NCT00227721|1539951|P1|COMPLETED|Overall Study||29
627320|NCT00227721|1539951|P1|STARTED|Overall Study||30
627321|NCT00227591|1539955|P1|NOT COMPLETED|Overall Study||1
627322|NCT00227591|1539955|P1|COMPLETED|Overall Study||47
627323|NCT00227591|1539955|P1|Began Treatment|Overall Study||47
627324|NCT00227591|1539955|P1|STARTED|Overall Study|48 pts registered to the study|48
627325|NCT00227539|1539959|P1|NOT COMPLETED|Overall Study||1
627326|NCT00227539|1539959|P1|COMPLETED|Overall Study||24
627327|NCT00227539|1539959|P1|STARTED|Overall Study||25
627328|NCT00227370|1539967|P2|NOT COMPLETED|Overall Study||24
627329|NCT00227370|1539968|P1|NOT COMPLETED|Overall Study||21
627330|NCT00227370|1539967|P2|COMPLETED|Overall Study||46
627331|NCT00227370|1539968|P1|COMPLETED|Overall Study||45
627332|NCT00227370|1539967|P2|STARTED|Overall Study|Treatment Group|70
627333|NCT00227370|1539968|P1|STARTED|Overall Study|Placebo Group|66
627334|NCT00227344|1539988|P2|NOT COMPLETED|Overall Study||5
627335|NCT00227344|1539989|P1|NOT COMPLETED|Overall Study||12
627336|NCT00227344|1539988|P2|COMPLETED|Overall Study||37
627337|NCT00227344|1539989|P1|COMPLETED|Overall Study||75
627338|NCT00227344|1539988|P2|STARTED|Overall Study||42
627339|NCT00227344|1539989|P1|STARTED|Overall Study||87
627340|NCT00227305|1540009|P1|NOT COMPLETED|Overall Study||144
627341|NCT00227305|1540009|P1|COMPLETED|Overall Study|Completed 26 weeks|237
627342|NCT00227305|1540009|P1|Drug Received|Overall Study|safety population|380
627343|NCT00227305|1540009|P1|STARTED|Overall Study|enrolled|381
627344|NCT00227266|1540026|P3|NOT COMPLETED|Overall Study||4
627345|NCT00227266|1540027|P2|NOT COMPLETED|Overall Study||0
627346|NCT00227266|1540028|P1|NOT COMPLETED|Overall Study||1
627347|NCT00227266|1540026|P3|COMPLETED|Overall Study||29
627348|NCT00227266|1540027|P2|COMPLETED|Overall Study||30
627349|NCT00227266|1540028|P1|COMPLETED|Overall Study||30
627350|NCT00227266|1540026|P3|STARTED|Overall Study||33
627351|NCT00227266|1540027|P2|STARTED|Overall Study||30
627352|NCT00227266|1540028|P1|STARTED|Overall Study||31
627353|NCT00227019|1540048|P1|NOT COMPLETED|Overall Study||0
627354|NCT00227019|1540048|P1|COMPLETED|Overall Study||16
627355|NCT00227019|1540048|P1|STARTED|Overall Study||16
627356|NCT00226941|1540058|P4|NOT COMPLETED|Overall Study||2
627357|NCT00226941|1540059|P3|NOT COMPLETED|Overall Study||0
627358|NCT00226941|1540060|P2|NOT COMPLETED|Overall Study||0
627359|NCT00226941|1540061|P1|NOT COMPLETED|Overall Study||0
627360|NCT00226941|1540058|P4|COMPLETED|Overall Study||5
627361|NCT00226941|1540059|P3|COMPLETED|Overall Study||4
627362|NCT00226941|1540060|P2|COMPLETED|Overall Study||6
627363|NCT00226941|1540061|P1|COMPLETED|Overall Study||6
627364|NCT00226941|1540058|P4|STARTED|Overall Study||7
627365|NCT00226941|1540059|P3|STARTED|Overall Study||4
627366|NCT00226941|1540060|P2|STARTED|Overall Study||6
627367|NCT00226941|1540061|P1|STARTED|Overall Study||6
627368|NCT00226811|1540095|P1|NOT COMPLETED|Overall Study||76
627369|NCT00226811|1540095|P1|COMPLETED|Overall Study||2
627370|NCT00226811|1540095|P1|STARTED|Overall Study||78
627371|NCT00226655|1540105|P1|NOT COMPLETED|Overall Study||79
627372|NCT00226655|1540105|P1|COMPLETED|Overall Study||33
627373|NCT00226655|1540105|P1|STARTED|Overall Study||112
627374|NCT00226590|1540109|P1|NOT COMPLETED|Overall Study||0
627375|NCT00226590|1540109|P1|COMPLETED|Overall Study||39
627376|NCT00226590|1540109|P1|STARTED|Overall Study||39
627377|NCT00226577|1540116|P1|NOT COMPLETED|Overall Study||0
627378|NCT00226577|1540116|P1|COMPLETED|Overall Study||52
627379|NCT00226577|1540116|P1|STARTED|Overall Study||52
627380|NCT00226239|1540124|P1|NOT COMPLETED|Maintenance Cetuximab||14
627381|NCT00226239|1540124|P1|COMPLETED|Maintenance Cetuximab||17
627382|NCT00226239|1540124|P1|STARTED|Maintenance Cetuximab||31
627383|NCT00226239|1540124|P1|NOT COMPLETED|XPE, Definitive Therapy||4
627384|NCT00226239|1540124|P1|COMPLETED|XPE, Definitive Therapy||33
627385|NCT00226239|1540124|P1|STARTED|XPE, Definitive Therapy||37
627386|NCT00226239|1540124|P1|NOT COMPLETED|TPE, Induction Therapy||2
627387|NCT00226239|1540124|P1|COMPLETED|TPE, Induction Therapy||37
627388|NCT00226239|1540124|P1|STARTED|TPE, Induction Therapy||39
627389|NCT00225784|1540133|P1|NOT COMPLETED|Overall Study||4
627390|NCT00225784|1540133|P1|COMPLETED|Overall Study||33
627391|NCT00225784|1540133|P1|STARTED|Overall Study||37
627392|NCT00225732|1540146|P2|NOT COMPLETED|Overall Study||0
627393|NCT00225732|1540147|P1|NOT COMPLETED|Overall Study||0
627394|NCT00225732|1540146|P2|COMPLETED|Overall Study||166
627395|NCT00225732|1540147|P1|COMPLETED|Overall Study||153
627396|NCT00225732|1540146|P2|STARTED|Overall Study||166
627397|NCT00225732|1540147|P1|STARTED|Overall Study||153
627398|NCT00225498|1540153|P1|NOT COMPLETED|Overall Study||0
627399|NCT00225498|1540153|P1|COMPLETED|Overall Study|The only analyses with adequate statistical power were of the 10 ziprasidone nonresponders.|10
627400|NCT00225498|1540153|P1|STARTED|Overall Study||10
627401|NCT00225420|1540157|P3|NOT COMPLETED|Overall Study||0
627402|NCT00225420|1540158|P2|NOT COMPLETED|Overall Study||0
627403|NCT00225420|1540159|P1|NOT COMPLETED|Overall Study||0
627404|NCT00225420|1540157|P3|COMPLETED|Overall Study||3
627405|NCT00225420|1540158|P2|COMPLETED|Overall Study||6
627406|NCT00225420|1540159|P1|COMPLETED|Overall Study||9
627407|NCT00225420|1540157|P3|STARTED|Overall Study||3
627408|NCT00225420|1540158|P2|STARTED|Overall Study||6
627409|NCT00225420|1540159|P1|STARTED|Overall Study||9
627410|NCT00225277|1540168|P2|NOT COMPLETED|Overall Study||95
627411|NCT00225277|1540169|P1|NOT COMPLETED|Overall Study||97
627412|NCT00225277|1540168|P2|COMPLETED|Overall Study||178
627413|NCT00225277|1540169|P1|COMPLETED|Overall Study||177
627414|NCT00225277|1540168|P2|STARTED|Overall Study|Mean treatment durations were 56.3 weeks (glimepiride) and 56.5 weeks (pioglitazone).|273
627415|NCT00225277|1540169|P1|STARTED|Overall Study|274 subjects randomized, but four subjects did not receive drug.|274
627416|NCT00225251|1540187|P2|NOT COMPLETED|Overall Study||1
627417|NCT00225251|1540188|P1|NOT COMPLETED|Overall Study||1
627418|NCT00225251|1540187|P2|COMPLETED|Overall Study||6
627419|NCT00225251|1540188|P1|COMPLETED|Overall Study||10
627420|NCT00225251|1540187|P2|STARTED|Overall Study||7
627421|NCT00225251|1540188|P1|STARTED|Overall Study||11
627422|NCT00225212|1540202|P1|NOT COMPLETED|Overall Study||6
627423|NCT00225212|1540202|P1|COMPLETED|Overall Study||29
627424|NCT00225212|1540202|P1|STARTED|Overall Study||35
627425|NCT00225147|1540211|P4|NOT COMPLETED|Open-label Phase||10
627426|NCT00225147|1540212|P3|NOT COMPLETED|Open-label Phase||0
627427|NCT00225147|1540213|P2|NOT COMPLETED|Open-label Phase||0
627428|NCT00225147|1540214|P1|NOT COMPLETED|Open-label Phase||0
627429|NCT00225147|1540211|P4|COMPLETED|Open-label Phase||52
627430|NCT00225147|1540212|P3|COMPLETED|Open-label Phase||0
627431|NCT00225147|1540213|P2|COMPLETED|Open-label Phase||0
627432|NCT00225147|1540214|P1|COMPLETED|Open-label Phase||0
627433|NCT00225147|1540211|P4|STARTED|Open-label Phase||62
627434|NCT00225147|1540212|P3|STARTED|Open-label Phase||0
627435|NCT00225147|1540213|P2|STARTED|Open-label Phase||0
627436|NCT00225147|1540214|P1|STARTED|Open-label Phase||0
627437|NCT00225147|1540211|P4|NOT COMPLETED|Double-blind Phase||0
627438|NCT00225147|1540212|P3|NOT COMPLETED|Double-blind Phase||0
627439|NCT00225147|1540213|P2|NOT COMPLETED|Double-blind Phase||0
627440|NCT00225147|1540214|P1|NOT COMPLETED|Double-blind Phase||0
627441|NCT00225147|1540211|P4|COMPLETED|Double-blind Phase||0
627442|NCT00225147|1540212|P3|COMPLETED|Double-blind Phase||13
627443|NCT00225147|1540213|P2|COMPLETED|Double-blind Phase||12
627444|NCT00225147|1540214|P1|COMPLETED|Double-blind Phase||13
627445|NCT00225147|1540211|P4|STARTED|Double-blind Phase||0
627446|NCT00225147|1540212|P3|STARTED|Double-blind Phase||13
627447|NCT00225147|1540213|P2|STARTED|Double-blind Phase||12
627448|NCT00225147|1540214|P1|STARTED|Double-blind Phase||13
627449|NCT00225017|1540230|P2|NOT COMPLETED|Overall Study||1
627450|NCT00225017|1540231|P1|NOT COMPLETED|Overall Study||0
627451|NCT00225017|1540230|P2|COMPLETED|Overall Study|1 subject did not complete week 24 assessments|23
627452|NCT00225017|1540231|P1|COMPLETED|Overall Study||26
627453|NCT00225017|1540230|P2|STARTED|Overall Study||24
627454|NCT00225017|1540231|P1|STARTED|Overall Study||26
627455|NCT00224952|1540244|P3|NOT COMPLETED|Overall Study||0
627456|NCT00224952|1540245|P2|NOT COMPLETED|Overall Study||0
627457|NCT00224952|1540246|P1|NOT COMPLETED|Overall Study||0
627458|NCT00224952|1540244|P3|COMPLETED|Overall Study||134
627459|NCT00224952|1540245|P2|COMPLETED|Overall Study||87
627460|NCT00224952|1540246|P1|COMPLETED|Overall Study||53
627461|NCT00224952|1540244|P3|STARTED|Overall Study||134
627462|NCT00224952|1540245|P2|STARTED|Overall Study||87
627463|NCT00224952|1540246|P1|STARTED|Overall Study||53
627464|NCT00224874|1540261|P4|NOT COMPLETED|Overall Study||0
627465|NCT00224874|1540262|P3|NOT COMPLETED|Overall Study||1
627466|NCT00224874|1540263|P2|NOT COMPLETED|Overall Study||0
627467|NCT00224874|1540264|P1|NOT COMPLETED|Overall Study||0
627468|NCT00224874|1540261|P4|COMPLETED|Overall Study||42
627469|NCT00224874|1540262|P3|COMPLETED|Overall Study||46
627470|NCT00224874|1540263|P2|COMPLETED|Overall Study||45
627471|NCT00224874|1540264|P1|COMPLETED|Overall Study||46
627472|NCT00224874|1540261|P4|STARTED|Overall Study||42
627473|NCT00224874|1540262|P3|STARTED|Overall Study||47
627474|NCT00224874|1540263|P2|STARTED|Overall Study||45
627475|NCT00224874|1540264|P1|STARTED|Overall Study||46
627476|NCT00224770|1540309|P3|NOT COMPLETED|Overall Study||0
627477|NCT00224770|1540310|P2|NOT COMPLETED|Overall Study||2
627478|NCT00224770|1540311|P1|NOT COMPLETED|Overall Study||4
627479|NCT00224770|1540309|P3|COMPLETED|Overall Study||14
627480|NCT00224770|1540310|P2|COMPLETED|Overall Study||52
627481|NCT00224770|1540311|P1|COMPLETED|Overall Study||38
627482|NCT00224770|1540309|P3|STARTED|Overall Study||14
627483|NCT00224770|1540310|P2|STARTED|Overall Study||54
627484|NCT00224770|1540311|P1|STARTED|Overall Study||42
627485|NCT00224484|1540346|P3|NOT COMPLETED|Overall Study||62
627486|NCT00224484|1540347|P2|NOT COMPLETED|Overall Study||65
627487|NCT00224484|1540348|P1|NOT COMPLETED|Overall Study||146
627488|NCT00224484|1540346|P3|COMPLETED|Overall Study||1425
627489|NCT00224484|1540347|P2|COMPLETED|Overall Study||1426
627490|NCT00224484|1540348|P1|COMPLETED|Overall Study||2831
627491|NCT00224484|1540346|P3|STARTED|Overall Study||1487
627492|NCT00224484|1540347|P2|STARTED|Overall Study||1491
627493|NCT00224484|1540348|P1|STARTED|Overall Study||2977
627494|NCT00224289|1540407|P1|NOT COMPLETED|Overall Study||0
627495|NCT00224289|1540407|P1|COMPLETED|Overall Study||17
627496|NCT00224289|1540407|P1|STARTED|Overall Study||17
627497|NCT00224133|1540412|P1|NOT COMPLETED|Overall Study||226
627498|NCT00224133|1540412|P1|COMPLETED|Overall Study||435
627499|NCT00224133|1540412|P1|STARTED|Overall Study||661
627500|NCT00224120|1540418|P2|NOT COMPLETED|Overall Study||24
627501|NCT00224120|1540419|P1|NOT COMPLETED|Overall Study||22
627502|NCT00224120|1540418|P2|COMPLETED|Overall Study||205
627503|NCT00224120|1540419|P1|COMPLETED|Overall Study||211
627504|NCT00224120|1540418|P2|STARTED|Overall Study||229
627505|NCT00224120|1540419|P1|STARTED|Overall Study||233
627506|NCT00224107|1540429|P2|NOT COMPLETED|Overall Study||14
627507|NCT00224107|1540430|P1|NOT COMPLETED|Overall Study||31
627508|NCT00224107|1540429|P2|COMPLETED|Overall Study||214
627509|NCT00224107|1540430|P1|COMPLETED|Overall Study||202
627510|NCT00224107|1540429|P2|STARTED|Overall Study||228
627511|NCT00224107|1540430|P1|STARTED|Overall Study||233
627512|NCT00224055|1540440|P2|NOT COMPLETED|Overall Study||14
627513|NCT00224055|1540441|P1|NOT COMPLETED|Overall Study||15
627514|NCT00224055|1540440|P2|COMPLETED|Overall Study||31
627515|NCT00224055|1540441|P1|COMPLETED|Overall Study||29
627516|NCT00224055|1540440|P2|STARTED|Overall Study||45
627517|NCT00224055|1540441|P1|STARTED|Overall Study||44
627518|NCT00224042|1540451|P2|NOT COMPLETED|Overall Study||6
627519|NCT00224042|1540452|P1|NOT COMPLETED|Overall Study||6
627520|NCT00224042|1540451|P2|COMPLETED|Overall Study||20
627521|NCT00224042|1540452|P1|COMPLETED|Overall Study||20
627522|NCT00224042|1540451|P2|STARTED|Overall Study||26
627523|NCT00224042|1540452|P1|STARTED|Overall Study||26
627524|NCT00224029|1540464|P1|NOT COMPLETED|Overall Study||6
627525|NCT00224029|1540464|P1|COMPLETED|Overall Study||18
627526|NCT00224029|1540464|P1|STARTED|Overall Study||24
627527|NCT00224016|1540470|P2|NOT COMPLETED|Follow-Up Period||0
627528|NCT00224016|1540471|P1|NOT COMPLETED|Follow-Up Period||0
627529|NCT00224016|1540470|P2|COMPLETED|Follow-Up Period||0
627530|NCT00224016|1540471|P1|COMPLETED|Follow-Up Period||35
627531|NCT00224016|1540470|P2|STARTED|Follow-Up Period|This group of subjects did not proceed to follow-up period.|0
627532|NCT00224016|1540471|P1|STARTED|Follow-Up Period||35
627533|NCT00224016|1540470|P2|NOT COMPLETED|Maintenance Period||1
627534|NCT00224016|1540471|P1|NOT COMPLETED|Maintenance Period||2
627535|NCT00224016|1540470|P2|COMPLETED|Maintenance Period||14
627536|NCT00224016|1540471|P1|COMPLETED|Maintenance Period||36
627537|NCT00224016|1540470|P2|STARTED|Maintenance Period||15
627538|NCT00224016|1540471|P1|STARTED|Maintenance Period||38
627539|NCT00224016|1540470|P2|NOT COMPLETED|Titration Period||1
627540|NCT00224016|1540471|P1|NOT COMPLETED|Titration Period||1
627541|NCT00224016|1540470|P2|COMPLETED|Titration Period||15
627542|NCT00224016|1540471|P1|COMPLETED|Titration Period||38
627543|NCT00224016|1540470|P2|STARTED|Titration Period||16
627544|NCT00224016|1540471|P1|STARTED|Titration Period||39
627545|NCT00224003|1540479|P1|NOT COMPLETED|Overall Study||7
627546|NCT00224003|1540479|P1|COMPLETED|Overall Study|Last patient out: March 31, 2004|16
627547|NCT00224003|1540479|P1|STARTED|Overall Study|First patient in: April 2, 2003|23
627548|NCT00223977|1540486|P3|NOT COMPLETED|Overall Study||3
627549|NCT00223977|1540487|P2|NOT COMPLETED|Overall Study||11
627550|NCT00223977|1540488|P1|NOT COMPLETED|Overall Study||9
627551|NCT00223977|1540486|P3|COMPLETED|Overall Study||39
627552|NCT00223977|1540487|P2|COMPLETED|Overall Study||47
627553|NCT00223977|1540488|P1|COMPLETED|Overall Study||37
627554|NCT00223977|1540486|P3|STARTED|Overall Study||42
627555|NCT00223977|1540487|P2|STARTED|Overall Study||58
627556|NCT00223977|1540488|P1|STARTED|Overall Study||46
627557|NCT00223821|1540510|P2|NOT COMPLETED|Overall Study||10
627558|NCT00223821|1540511|P1|NOT COMPLETED|Overall Study||4
627559|NCT00223821|1540510|P2|COMPLETED|Overall Study||22
627560|NCT00223821|1540511|P1|COMPLETED|Overall Study||28
627561|NCT00223821|1540510|P2|Completed 6-month Follow-up|Overall Study||25
627562|NCT00223821|1540511|P1|Completed 6-month Follow-up|Overall Study||28
627563|NCT00223821|1540510|P2|Completed Post-treatment Assessment|Overall Study||27
627564|NCT00223821|1540511|P1|Completed Post-treatment Assessment|Overall Study||31
627565|NCT00223821|1540510|P2|Completed Therapy|Overall Study||28
627566|NCT00223821|1540511|P1|Completed Therapy|Overall Study||31
627567|NCT00223821|1540510|P2|STARTED|Overall Study||32
627568|NCT00223821|1540511|P1|STARTED|Overall Study||32
627569|NCT00223808|1540522|P3|NOT COMPLETED|Overall Study||5
627570|NCT00223808|1540523|P2|NOT COMPLETED|Overall Study||5
627571|NCT00223808|1540524|P1|NOT COMPLETED|Overall Study||3
627572|NCT00223808|1540522|P3|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|18
627573|NCT00223808|1540523|P2|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|17
627574|NCT00223808|1540524|P1|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|19
627575|NCT00223808|1540522|P3|STARTED|Overall Study||23
627576|NCT00223808|1540523|P2|STARTED|Overall Study||22
627577|NCT00223808|1540524|P1|STARTED|Overall Study||22
627578|NCT00223795|1540541|P2|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1
627579|NCT00223795|1540542|P1|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1
627580|NCT00223795|1540541|P2|COMPLETED|Second Intervention - All Use Canes 4 mo||17
627581|NCT00223795|1540542|P1|COMPLETED|Second Intervention - All Use Canes 4 mo||18
627582|NCT00223795|1540541|P2|STARTED|Second Intervention - All Use Canes 4 mo||18
627583|NCT00223795|1540542|P1|STARTED|Second Intervention - All Use Canes 4 mo||19
627584|NCT00223795|1540541|P2|NOT COMPLETED|First Intervention - Eight Weeks||9
627585|NCT00223795|1540542|P1|NOT COMPLETED|First Intervention - Eight Weeks||7
627586|NCT00223795|1540541|P2|COMPLETED|First Intervention - Eight Weeks||18
627587|NCT00223795|1540542|P1|COMPLETED|First Intervention - Eight Weeks||19
627588|NCT00223795|1540541|P2|STARTED|First Intervention - Eight Weeks||27
627589|NCT00223795|1540542|P1|STARTED|First Intervention - Eight Weeks||26
627590|NCT00223704|1540552|P3|NOT COMPLETED|Overall Study||0
627591|NCT00223704|1540553|P2|NOT COMPLETED|Overall Study||0
627592|NCT00223704|1540554|P1|NOT COMPLETED|Overall Study||0
627593|NCT00223704|1540552|P3|COMPLETED|Overall Study||40
627594|NCT00223704|1540553|P2|COMPLETED|Overall Study||37
627595|NCT00223704|1540554|P1|COMPLETED|Overall Study||38
627596|NCT00223704|1540552|P3|STARTED|Overall Study||40
627597|NCT00223704|1540553|P2|STARTED|Overall Study||37
627598|NCT00223704|1540554|P1|STARTED|Overall Study||38
627599|NCT00223678|1540576|P2|NOT COMPLETED|Overall Study||0
627600|NCT00223678|1540577|P1|NOT COMPLETED|Overall Study||0
627601|NCT00223678|1540576|P2|COMPLETED|Overall Study||7
627602|NCT00223678|1540577|P1|COMPLETED|Overall Study||13
627603|NCT00223678|1540576|P2|STARTED|Overall Study||7
627604|NCT00223678|1540577|P1|STARTED|Overall Study||13
627605|NCT00223665|1540583|P1|NOT COMPLETED|Overall Study||0
627606|NCT00223665|1540583|P1|COMPLETED|Overall Study||102
627607|NCT00223665|1540583|P1|STARTED|Overall Study||102
627608|NCT00223652|1540603|P2|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||4
627609|NCT00223652|1540604|P1|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||1
627610|NCT00223652|1540603|P2|COMPLETED|T-CBT and TAU 6 Month Follow-up||37
627611|NCT00223652|1540604|P1|COMPLETED|T-CBT and TAU 6 Month Follow-up||39
627612|NCT00223652|1540603|P2|STARTED|T-CBT and TAU 6 Month Follow-up||41
627613|NCT00223652|1540604|P1|STARTED|T-CBT and TAU 6 Month Follow-up||40
627614|NCT00223652|1540603|P2|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0
627615|NCT00223652|1540604|P1|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0
627616|NCT00223652|1540603|P2|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||41
627617|NCT00223652|1540604|P1|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||40
627618|NCT00223652|1540603|P2|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||41
627619|NCT00223652|1540604|P1|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||40
627620|NCT00223652|1540603|P2|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||3
627621|NCT00223652|1540604|P1|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||1
627622|NCT00223652|1540603|P2|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||41
627623|NCT00223652|1540604|P1|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||40
627624|NCT00223652|1540603|P2|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||44
627625|NCT00223652|1540604|P1|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||41
627626|NCT00223496|1540620|P1|NOT COMPLETED|Overall Study||22
627627|NCT00223496|1540620|P1|COMPLETED|Overall Study||10
627628|NCT00223496|1540620|P1|STARTED|Overall Study|32 people consented, 19 were baselined|32
627629|NCT00223236|1540626|P2|NOT COMPLETED|Overall Study||14
627630|NCT00223236|1540627|P1|NOT COMPLETED|Overall Study||7
627631|NCT00223236|1540626|P2|COMPLETED|Overall Study|4 completed 12 week trial.|4
627632|NCT00223236|1540627|P1|COMPLETED|Overall Study|9 completed 12 week trial.|9
627633|NCT00223236|1540626|P2|STARTED|Overall Study|21 completed baseline assessment but 18 completed at least one treatment visit.|18
627634|NCT00223236|1540627|P1|STARTED|Overall Study|23 completed baseline assessment but 16 completed at least one treatment visit.|16
627635|NCT00222729|1540639|P1|NOT COMPLETED|Overall Study||3
627636|NCT00222729|1540639|P1|COMPLETED|Overall Study||37
627637|NCT00222729|1540639|P1|STARTED|Overall Study||40
627638|NCT00222105|1540646|P1|NOT COMPLETED|Overall Study||14
627639|NCT00222105|1540646|P1|COMPLETED|Overall Study||11
627640|NCT00222105|1540646|P1|STARTED|Overall Study||25
627641|NCT00221299|1540654|P4|NOT COMPLETED|Overall Study||1
627642|NCT00221299|1540655|P3|NOT COMPLETED|Overall Study||0
627643|NCT00221299|1540656|P2|NOT COMPLETED|Overall Study||2
627644|NCT00221299|1540657|P1|NOT COMPLETED|Overall Study||1
627645|NCT00221299|1540654|P4|COMPLETED|Overall Study||10
627646|NCT00221299|1540655|P3|COMPLETED|Overall Study||14
627647|NCT00221299|1540656|P2|COMPLETED|Overall Study||11
627648|NCT00221299|1540657|P1|COMPLETED|Overall Study||10
627649|NCT00221299|1540654|P4|STARTED|Overall Study||11
627650|NCT00221299|1540655|P3|STARTED|Overall Study||14
627651|NCT00221299|1540656|P2|STARTED|Overall Study||13
627652|NCT00221299|1540657|P1|STARTED|Overall Study||11
627653|NCT00221195|1540667|P2|NOT COMPLETED|Overall Study||3
627654|NCT00221195|1540668|P1|NOT COMPLETED|Overall Study||5
627655|NCT00221195|1540667|P2|COMPLETED|Overall Study||14
627656|NCT00221195|1540668|P1|COMPLETED|Overall Study||12
627657|NCT00221195|1540667|P2|STARTED|Overall Study||17
627658|NCT00221195|1540668|P1|STARTED|Overall Study||17
627659|NCT00221117|1540677|P2|NOT COMPLETED|Overall Study||0
627660|NCT00221117|1540678|P1|NOT COMPLETED|Overall Study||0
627661|NCT00221117|1540677|P2|COMPLETED|Overall Study||9
627662|NCT00221117|1540678|P1|COMPLETED|Overall Study||12
627663|NCT00221117|1540677|P2|STARTED|Overall Study|One participant dropped out of the study after signing consent but prior to baseline assessments.|9
627664|NCT00221117|1540678|P1|STARTED|Overall Study||12
627665|NCT00221104|1540688|P2|NOT COMPLETED|Overall Study||76
627666|NCT00221104|1540689|P1|NOT COMPLETED|Overall Study||83
627667|NCT00221104|1540688|P2|COMPLETED|Overall Study||709
627668|NCT00221104|1540689|P1|COMPLETED|Overall Study||710
627669|NCT00221104|1540688|P2|STARTED|Overall Study||785
627670|NCT00221104|1540689|P1|STARTED|Overall Study||793
627671|NCT00220961|1540705|P2|NOT COMPLETED|Overall Study||90
627672|NCT00220961|1540706|P1|NOT COMPLETED|Overall Study||71
627673|NCT00220961|1540705|P2|COMPLETED|Overall Study||213
627674|NCT00220961|1540706|P1|COMPLETED|Overall Study||228
627675|NCT00220961|1540705|P2|STARTED|Overall Study||303
627676|NCT00220961|1540706|P1|STARTED|Overall Study||299
627677|NCT00220805|1540722|P2|NOT COMPLETED|Overall Study||11
627678|NCT00220805|1540723|P1|NOT COMPLETED|Overall Study||8
627679|NCT00220805|1540722|P2|COMPLETED|Overall Study||16
627680|NCT00220805|1540723|P1|COMPLETED|Overall Study||22
627681|NCT00220805|1540722|P2|STARTED|Overall Study||27
627682|NCT00220805|1540723|P1|STARTED|Overall Study||30
627683|NCT00220779|1540744|P3|NOT COMPLETED|Overall Study||4
627684|NCT00220779|1540745|P2|NOT COMPLETED|Overall Study||4
627685|NCT00220779|1540746|P1|NOT COMPLETED|Overall Study||7
627686|NCT00220779|1540744|P3|COMPLETED|Overall Study||37
627687|NCT00220779|1540745|P2|COMPLETED|Overall Study||38
627688|NCT00220779|1540746|P1|COMPLETED|Overall Study||38
627689|NCT00220779|1540744|P3|STARTED|Overall Study||41
627690|NCT00220779|1540745|P2|STARTED|Overall Study||42
627691|NCT00220779|1540746|P1|STARTED|Overall Study||45
627692|NCT00220740|1540756|P2|NOT COMPLETED|Withdrawal Period||15
627693|NCT00220740|1540757|P1|NOT COMPLETED|Withdrawal Period||6
627694|NCT00220740|1540756|P2|COMPLETED|Withdrawal Period||16
627695|NCT00220740|1540757|P1|COMPLETED|Withdrawal Period||37
627696|NCT00220740|1540756|P2|STARTED|Withdrawal Period|The subjects who were success in Efficacy or Rescue Period were re-randomized to Withdrawal period.|31
627697|NCT00220740|1540757|P1|STARTED|Withdrawal Period|The subjects who were success in Efficacy or Rescue Period were re-randomized to Withdrawal period.|43
627698|NCT00220740|1540756|P2|NOT COMPLETED|Rescue Treatment||18
627699|NCT00220740|1540757|P1|NOT COMPLETED|Rescue Treatment||19
627700|NCT00220740|1540756|P2|COMPLETED|Rescue Treatment||5
627701|NCT00220740|1540757|P1|COMPLETED|Rescue Treatment||26
627702|NCT00220740|1540756|P2|STARTED|Rescue Treatment|Only the subjects who failed the treatment in the Efficacy period entered the Rescue period.|23
627703|NCT00220740|1540757|P1|STARTED|Rescue Treatment|Only the subjects who failed the treatment in the Efficacy period entered the Rescue period.|45
627704|NCT00220740|1540756|P2|NOT COMPLETED|Efficacy Period||46
627705|NCT00220740|1540757|P1|NOT COMPLETED|Efficacy Period||26
627706|NCT00220740|1540756|P2|COMPLETED|Efficacy Period||12
627707|NCT00220740|1540757|P1|COMPLETED|Efficacy Period||33
627708|NCT00220740|1540756|P2|STARTED|Efficacy Period||58
627709|NCT00220740|1540757|P1|STARTED|Efficacy Period||59
627710|NCT00220727|1540771|P2|NOT COMPLETED|Second Infusion (Week <6)||0
627711|NCT00220727|1540772|P1|NOT COMPLETED|Second Infusion (Week <6)||1
627712|NCT00220727|1540771|P2|COMPLETED|Second Infusion (Week <6)||4
627713|NCT00220727|1540772|P1|COMPLETED|Second Infusion (Week <6)||3
627714|NCT00220727|1540771|P2|STARTED|Second Infusion (Week <6)||4
627715|NCT00220727|1540772|P1|STARTED|Second Infusion (Week <6)||4
627716|NCT00220727|1540771|P2|NOT COMPLETED|First Infusion (Week 0)||0
627717|NCT00220727|1540772|P1|NOT COMPLETED|First Infusion (Week 0)||0
627718|NCT00220727|1540771|P2|COMPLETED|First Infusion (Week 0)||4
627719|NCT00220727|1540772|P1|COMPLETED|First Infusion (Week 0)||4
627720|NCT00220727|1540771|P2|STARTED|First Infusion (Week 0)||4
627721|NCT00220727|1540772|P1|STARTED|First Infusion (Week 0)||4
627722|NCT00220701|1540788|P2|NOT COMPLETED|Overall Study||4
627723|NCT00220701|1540789|P1|NOT COMPLETED|Overall Study||5
627724|NCT00220701|1540788|P2|COMPLETED|Overall Study||13
627725|NCT00220701|1540789|P1|COMPLETED|Overall Study||12
627726|NCT00220701|1540788|P2|STARTED|Overall Study||17
627727|NCT00220701|1540789|P1|STARTED|Overall Study||17
627728|NCT00220636|1540805|P1|NOT COMPLETED|Overall Study||4
627729|NCT00220636|1540805|P1|COMPLETED|Overall Study||11
627730|NCT00220636|1540805|P1|STARTED|Overall Study||15
627731|NCT00219557|1540815|P3|NOT COMPLETED|Phase 2||33
627732|NCT00219557|1540816|P2|NOT COMPLETED|Phase 2||69
627733|NCT00219557|1540817|P1|NOT COMPLETED|Phase 2||0
627734|NCT00219557|1540815|P3|COMPLETED|Phase 2||1
627735|NCT00219557|1540816|P2|COMPLETED|Phase 2||0
627736|NCT00219557|1540817|P1|COMPLETED|Phase 2||0
627737|NCT00219557|1540815|P3|Treated|Phase 2||31
627738|NCT00219557|1540816|P2|Treated|Phase 2||68
627739|NCT00219557|1540817|P1|Treated|Phase 2||0
627740|NCT00219557|1540815|P3|STARTED|Phase 2||34
627741|NCT00219557|1540816|P2|STARTED|Phase 2||69
627742|NCT00219557|1540817|P1|STARTED|Phase 2||0
627743|NCT00219557|1540815|P3|NOT COMPLETED|Phase 1||0
627744|NCT00219557|1540816|P2|NOT COMPLETED|Phase 1||0
627745|NCT00219557|1540817|P1|NOT COMPLETED|Phase 1||7
627746|NCT00219557|1540815|P3|COMPLETED|Phase 1||0
627747|NCT00219557|1540816|P2|COMPLETED|Phase 1||0
627748|NCT00219557|1540817|P1|COMPLETED|Phase 1||1
627749|NCT00219557|1540815|P3|STARTED|Phase 1||0
627750|NCT00219557|1540816|P2|STARTED|Phase 1||0
627751|NCT00219557|1540817|P1|STARTED|Phase 1||8
627752|NCT00219544|1540845|P2|NOT COMPLETED|Double Blind Treatment Period||0
627753|NCT00219544|1540846|P1|NOT COMPLETED|Double Blind Treatment Period||0
627754|NCT00219544|1540845|P2|COMPLETED|Double Blind Treatment Period||77
627755|NCT00219544|1540846|P1|COMPLETED|Double Blind Treatment Period||80
627756|NCT00219544|1540845|P2|STARTED|Double Blind Treatment Period||77
627757|NCT00219544|1540846|P1|STARTED|Double Blind Treatment Period||80
627758|NCT00219544|1540845|P2|NOT COMPLETED|Single Blind Treatment Period||0
627759|NCT00219544|1540846|P1|NOT COMPLETED|Single Blind Treatment Period||22
627760|NCT00219544|1540845|P2|COMPLETED|Single Blind Treatment Period||0
627761|NCT00219544|1540846|P1|COMPLETED|Single Blind Treatment Period||234
627762|NCT00219544|1540845|P2|STARTED|Single Blind Treatment Period||0
627763|NCT00219544|1540846|P1|STARTED|Single Blind Treatment Period||256
627764|NCT00219349|1540884|P1|NOT COMPLETED|Escitalopram Phase||3
627765|NCT00219349|1540884|P1|COMPLETED|Escitalopram Phase||4
627766|NCT00219349|1540884|P1|STARTED|Escitalopram Phase|7 responders to CBT were ineligible to start and 1 declined, leaving 7 who started escitalopram|7
627767|NCT00219349|1540884|P1|NOT COMPLETED|Cognitive Behavioral Therapy Phase||10
627768|NCT00219349|1540884|P1|COMPLETED|Cognitive Behavioral Therapy Phase||15
627769|NCT00219349|1540884|P1|STARTED|Cognitive Behavioral Therapy Phase||25
627770|NCT00219284|1540897|P2|NOT COMPLETED|Extension Phase - 8 Weeks||7
627771|NCT00219284|1540898|P1|NOT COMPLETED|Extension Phase - 8 Weeks||2
627772|NCT00219284|1540897|P2|COMPLETED|Extension Phase - 8 Weeks||99
627773|NCT00219284|1540898|P1|COMPLETED|Extension Phase - 8 Weeks||112
627774|NCT00219284|1540897|P2|STARTED|Extension Phase - 8 Weeks|Not all subjects who completed the treatment phase chose to enter this optional extension phase.|106
627775|NCT00219284|1540898|P1|STARTED|Extension Phase - 8 Weeks|Not all subjects who completed the treatment phase chose to enter this optional extension phase.|114
627776|NCT00219284|1540897|P2|NOT COMPLETED|Treatment Phase - 16 Weeks||51
627777|NCT00219284|1540898|P1|NOT COMPLETED|Treatment Phase - 16 Weeks||44
627778|NCT00219284|1540897|P2|COMPLETED|Treatment Phase - 16 Weeks||128
627779|NCT00219284|1540898|P1|COMPLETED|Treatment Phase - 16 Weeks||136
627780|NCT00219284|1540897|P2|STARTED|Treatment Phase - 16 Weeks||179
627781|NCT00219284|1540898|P1|STARTED|Treatment Phase - 16 Weeks||180
627782|NCT00219141|1540923|P3|NOT COMPLETED|Overall Study||12
627783|NCT00219141|1540924|P2|NOT COMPLETED|Overall Study||21
627784|NCT00219141|1540925|P1|NOT COMPLETED|Overall Study||14
627785|NCT00219141|1540923|P3|COMPLETED|Overall Study||142
627786|NCT00219141|1540924|P2|COMPLETED|Overall Study||131
627787|NCT00219141|1540925|P1|COMPLETED|Overall Study||140
627788|NCT00219141|1540923|P3|STARTED|Overall Study||154
627789|NCT00219141|1540924|P2|STARTED|Overall Study||152
627790|NCT00219141|1540925|P1|STARTED|Overall Study||154
627791|NCT00218634|1540971|P2|NOT COMPLETED|Overall Study||15
627792|NCT00218634|1540972|P1|NOT COMPLETED|Overall Study||8
627793|NCT00218634|1540971|P2|COMPLETED|Overall Study||30
627794|NCT00218634|1540972|P1|COMPLETED|Overall Study||36
627795|NCT00218634|1540971|P2|STARTED|Overall Study||45
627796|NCT00218634|1540972|P1|STARTED|Overall Study||44
627797|NCT00218543|1540992|P1|NOT COMPLETED|Overall Study||15
627798|NCT00218543|1540992|P1|COMPLETED|Overall Study|13 reached the maintenance dose phase of treatment; 9 completed at least six weeks of treatment.|5
627799|NCT00218543|1540992|P1|STARTED|Overall Study||20
627800|NCT00218465|1540999|P2|NOT COMPLETED|Overall Study||18
627801|NCT00218465|1541000|P1|NOT COMPLETED|Overall Study||17
627802|NCT00218465|1540999|P2|COMPLETED|Overall Study||30
627803|NCT00218465|1541000|P1|COMPLETED|Overall Study||33
627804|NCT00218465|1540999|P2|STARTED|Overall Study||48
627805|NCT00218465|1541000|P1|STARTED|Overall Study||50
627806|NCT00218439|1541012|P2|NOT COMPLETED|Second Intervention (4 Weeks)||5
627807|NCT00218439|1541013|P1|NOT COMPLETED|Second Intervention (4 Weeks)||7
627808|NCT00218439|1541012|P2|COMPLETED|Second Intervention (4 Weeks)||30
627809|NCT00218439|1541013|P1|COMPLETED|Second Intervention (4 Weeks)||33
627810|NCT00218439|1541012|P2|STARTED|Second Intervention (4 Weeks)||35
627811|NCT00218439|1541013|P1|STARTED|Second Intervention (4 Weeks)||40
627812|NCT00218439|1541012|P2|NOT COMPLETED|First Intervention (4 Weeks)||12
627813|NCT00218439|1541013|P1|NOT COMPLETED|First Intervention (4 Weeks)||18
627814|NCT00218439|1541012|P2|COMPLETED|First Intervention (4 Weeks)||35
627815|NCT00218439|1541013|P1|COMPLETED|First Intervention (4 Weeks)||40
627816|NCT00218439|1541012|P2|STARTED|First Intervention (4 Weeks)||47
627817|NCT00218439|1541013|P1|STARTED|First Intervention (4 Weeks)||58
627818|NCT00218335|1541031|P4|NOT COMPLETED|Overall Study||36
627819|NCT00218335|1541032|P3|NOT COMPLETED|Overall Study||54
627820|NCT00218335|1541033|P2|NOT COMPLETED|Overall Study||3
627821|NCT00218335|1541034|P1|NOT COMPLETED|Overall Study||6
627822|NCT00218335|1541031|P4|COMPLETED|Overall Study||388
627823|NCT00218335|1541032|P3|COMPLETED|Overall Study||319
627824|NCT00218335|1541033|P2|COMPLETED|Overall Study||110
627825|NCT00218335|1541034|P1|COMPLETED|Overall Study||108
627826|NCT00218335|1541031|P4|18 Month Follow-up|Overall Study||368
627827|NCT00218335|1541032|P3|18 Month Follow-up|Overall Study||296
627828|NCT00218335|1541033|P2|18 Month Follow-up|Overall Study||108
627829|NCT00218335|1541034|P1|18 Month Follow-up|Overall Study||101
627830|NCT00218335|1541031|P4|12 Month Follow-up|Overall Study||303
627831|NCT00218335|1541032|P3|12 Month Follow-up|Overall Study||244
627832|NCT00218335|1541033|P2|12 Month Follow-up|Overall Study||102
627833|NCT00218335|1541034|P1|12 Month Follow-up|Overall Study||95
627834|NCT00218335|1541031|P4|6 Month Follow-up|Overall Study||301
627835|NCT00218335|1541032|P3|6 Month Follow-up|Overall Study||219
627836|NCT00218335|1541033|P2|6 Month Follow-up|Overall Study||99
627837|NCT00218335|1541034|P1|6 Month Follow-up|Overall Study||103
627838|NCT00218335|1541031|P4|STARTED|Overall Study||424
627839|NCT00218335|1541032|P3|STARTED|Overall Study||373
627840|NCT00218335|1541033|P2|STARTED|Overall Study||113
627841|NCT00218335|1541034|P1|STARTED|Overall Study||114
627842|NCT00218296|1541098|P2|NOT COMPLETED|Overall Study||121
627843|NCT00218296|1541099|P1|NOT COMPLETED|Overall Study||111
627844|NCT00218296|1541098|P2|COMPLETED|Overall Study||48
627845|NCT00218296|1541099|P1|COMPLETED|Overall Study||52
627846|NCT00218296|1541098|P2|Attended Visti|Overall Study||102
627847|NCT00218296|1541099|P1|Attended Visti|Overall Study||97
627848|NCT00218296|1541098|P2|STARTED|Overall Study||169
627849|NCT00218296|1541099|P1|STARTED|Overall Study||163
627850|NCT00218062|1541119|P4|NOT COMPLETED|Overall Study||13
627851|NCT00218062|1541120|P3|NOT COMPLETED|Overall Study||12
627852|NCT00218062|1541121|P2|NOT COMPLETED|Overall Study||16
627853|NCT00218062|1541122|P1|NOT COMPLETED|Overall Study||15
627854|NCT00218062|1541119|P4|COMPLETED|Overall Study||3
627855|NCT00218062|1541120|P3|COMPLETED|Overall Study||3
627856|NCT00218062|1541121|P2|COMPLETED|Overall Study||4
627857|NCT00218062|1541122|P1|COMPLETED|Overall Study||7
627858|NCT00218062|1541119|P4|Received First Dose of Study Medication|Overall Study||12
627859|NCT00218062|1541120|P3|Received First Dose of Study Medication|Overall Study||10
627860|NCT00218062|1541121|P2|Received First Dose of Study Medication|Overall Study||11
627861|NCT00218062|1541122|P1|Received First Dose of Study Medication|Overall Study||16
627862|NCT00218062|1541119|P4|STARTED|Overall Study||16
627863|NCT00218062|1541120|P3|STARTED|Overall Study||15
627864|NCT00218062|1541121|P2|STARTED|Overall Study||20
627865|NCT00218062|1541122|P1|STARTED|Overall Study||22
627866|NCT00218023|1541152|P4|NOT COMPLETED|Overall Study||7
627867|NCT00218023|1541153|P3|NOT COMPLETED|Overall Study||10
627868|NCT00218023|1541154|P2|NOT COMPLETED|Overall Study||15
627869|NCT00218023|1541155|P1|NOT COMPLETED|Overall Study||13
627870|NCT00218023|1541152|P4|COMPLETED|Overall Study||11
627871|NCT00218023|1541153|P3|COMPLETED|Overall Study||6
627872|NCT00218023|1541154|P2|COMPLETED|Overall Study||10
627873|NCT00218023|1541155|P1|COMPLETED|Overall Study||9
627874|NCT00218023|1541152|P4|Received Drug or Placebo in Phase II|Overall Study||18
627875|NCT00218023|1541153|P3|Received Drug or Placebo in Phase II|Overall Study||15
627876|NCT00218023|1541154|P2|Received Drug or Placebo in Phase II|Overall Study||24
627877|NCT00218023|1541155|P1|Received Drug or Placebo in Phase II|Overall Study||18
627878|NCT00218023|1541152|P4|STARTED|Overall Study||18
627879|NCT00218023|1541153|P3|STARTED|Overall Study||16
627880|NCT00218023|1541154|P2|STARTED|Overall Study||25
627881|NCT00218023|1541155|P1|STARTED|Overall Study||22
627882|NCT00217971|1541171|P2|NOT COMPLETED|Overall Study||33
627883|NCT00217971|1541172|P1|NOT COMPLETED|Overall Study||24
627884|NCT00217971|1541171|P2|COMPLETED|Overall Study||44
627885|NCT00217971|1541172|P1|COMPLETED|Overall Study||55
627886|NCT00217971|1541171|P2|STARTED|Overall Study||77
627887|NCT00217971|1541172|P1|STARTED|Overall Study||79
627888|NCT00217724|1541178|P2|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||0
627889|NCT00217724|1541179|P1|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||1
627890|NCT00217724|1541178|P2|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||5
627891|NCT00217724|1541179|P1|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||8
627892|NCT00217724|1541178|P2|STARTED|Course 2, (Glutamine/Placebo Crossover)||5
627893|NCT00217724|1541179|P1|STARTED|Course 2, (Glutamine/Placebo Crossover)||9
627894|NCT00217724|1541178|P2|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||1
627895|NCT00217724|1541179|P1|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||3
627896|NCT00217724|1541178|P2|COMPLETED|Course 1, (Glutamine/Placebo Arms)||9
627897|NCT00217724|1541179|P1|COMPLETED|Course 1, (Glutamine/Placebo Arms)||5
627898|NCT00217724|1541178|P2|STARTED|Course 1, (Glutamine/Placebo Arms)||10
627899|NCT00217724|1541179|P1|STARTED|Course 1, (Glutamine/Placebo Arms)||8
627900|NCT00217672|1541187|P2|NOT COMPLETED|Follow-up||0
627901|NCT00217672|1541188|P1|NOT COMPLETED|Follow-up||5
627902|NCT00217672|1541187|P2|COMPLETED|Follow-up||0
627903|NCT00217672|1541188|P1|COMPLETED|Follow-up||69
627904|NCT00217672|1541187|P2|STARTED|Follow-up||0
627905|NCT00217672|1541188|P1|STARTED|Follow-up|when bevacizumab became available, converted to a 1-arm open-label trial (67+7=74)|74
627906|NCT00217672|1541187|P2|NOT COMPLETED|Treatment||7
627907|NCT00217672|1541188|P1|NOT COMPLETED|Treatment||67
627908|NCT00217672|1541187|P2|COMPLETED|Treatment||0
627909|NCT00217672|1541188|P1|COMPLETED|Treatment||0
627910|NCT00217672|1541187|P2|STARTED|Treatment|When bevacizumab became available, study converted to a 1-arm open-label trial with just bevacizumab|7
627911|NCT00217672|1541188|P1|STARTED|Treatment||67
627912|NCT00217672|1541187|P2|NOT COMPLETED|Allocation||0
627913|NCT00217672|1541188|P1|NOT COMPLETED|Allocation||2
627914|NCT00217672|1541187|P2|COMPLETED|Allocation||7
627915|NCT00217672|1541188|P1|COMPLETED|Allocation||67
627916|NCT00217672|1541187|P2|STARTED|Allocation|When bevacizumab became available, study converted to a 1-arm open-label trial with just bevacizumab|7
627917|NCT00217672|1541188|P1|STARTED|Allocation||69
627918|NCT00217620|1541194|P1|NOT COMPLETED|Overall Study||51
627919|NCT00217620|1541194|P1|COMPLETED|Overall Study||0
627920|NCT00217620|1541194|P1|Eligible and Began Protocol Therapy|Overall Study||37
627921|NCT00217620|1541194|P1|Eligible|Overall Study||38
627922|NCT00217620|1541194|P1|STARTED|Overall Study||51
627923|NCT00217581|1541205|P1|NOT COMPLETED|Overall Study||1
627924|NCT00217581|1541205|P1|COMPLETED|Overall Study||38
627925|NCT00217581|1541205|P1|STARTED|Overall Study||39
627926|NCT00217490|1541217|P4|NOT COMPLETED|Overall Study||23
627927|NCT00217490|1541218|P3|NOT COMPLETED|Overall Study||24
627928|NCT00217490|1541219|P2|NOT COMPLETED|Overall Study||25
627929|NCT00217490|1541220|P1|NOT COMPLETED|Overall Study||17
627930|NCT00217490|1541217|P4|COMPLETED|Overall Study||130
627931|NCT00217490|1541218|P3|COMPLETED|Overall Study||131
627932|NCT00217490|1541219|P2|COMPLETED|Overall Study||128
627933|NCT00217490|1541220|P1|COMPLETED|Overall Study||137
627934|NCT00217490|1541217|P4|STARTED|Overall Study||153
627935|NCT00217490|1541218|P3|STARTED|Overall Study||155
627936|NCT00217490|1541219|P2|STARTED|Overall Study||153
627937|NCT00217490|1541220|P1|STARTED|Overall Study||154
627938|NCT00217464|1541234|P1|NOT COMPLETED|Overall Study||17
627939|NCT00217464|1541234|P1|COMPLETED|Overall Study||0
627940|NCT00217464|1541234|P1|STARTED|Overall Study||17
627941|NCT00217438|1541241|P2|NOT COMPLETED|Overall Study||1
627942|NCT00217438|1541242|P1|NOT COMPLETED|Overall Study||0
627943|NCT00217438|1541241|P2|COMPLETED|Overall Study|One patient did not complete Day 80-120 evaluation tests after returning to referring physician.|63
627944|NCT00217438|1541242|P1|COMPLETED|Overall Study||66
627945|NCT00217438|1541241|P2|STARTED|Overall Study||64
627946|NCT00217438|1541242|P1|STARTED|Overall Study||66
627947|NCT00217425|1541250|P1|NOT COMPLETED|Overall Study||37
627948|NCT00217425|1541250|P1|COMPLETED|Overall Study||9
627949|NCT00217425|1541250|P1|Eligible and Treated|Overall Study||39
627950|NCT00217425|1541250|P1|Treated|Overall Study||44
627951|NCT00217425|1541250|P1|STARTED|Overall Study||46
627952|NCT00217399|1541256|P1|NOT COMPLETED|Overall Study||0
627953|NCT00217399|1541256|P1|COMPLETED|Overall Study||35
627954|NCT00217399|1541256|P1|STARTED|Overall Study||35
627955|NCT00217087|1541264|P2|NOT COMPLETED|Overall Study||20
627956|NCT00217087|1541265|P1|NOT COMPLETED|Overall Study||11
627957|NCT00217087|1541264|P2|COMPLETED|Overall Study||17
627958|NCT00217087|1541265|P1|COMPLETED|Overall Study||25
627959|NCT00217087|1541264|P2|STARTED|Overall Study||37
627960|NCT00217087|1541265|P1|STARTED|Overall Study||36
627961|NCT00217022|1541279|P2|NOT COMPLETED|Overall Study||1
627962|NCT00217022|1541280|P1|NOT COMPLETED|Overall Study||1
627963|NCT00217022|1541279|P2|COMPLETED|Overall Study||3
627964|NCT00217022|1541280|P1|COMPLETED|Overall Study||11
627965|NCT00217022|1541279|P2|STARTED|Overall Study||4
627966|NCT00217022|1541280|P1|STARTED|Overall Study||12
627967|NCT00216736|1541290|P2|NOT COMPLETED|Overall Study||1
627968|NCT00216736|1541291|P1|NOT COMPLETED|Overall Study||1
627969|NCT00216736|1541290|P2|COMPLETED|Overall Study||30
627970|NCT00216736|1541291|P1|COMPLETED|Overall Study||31
627971|NCT00216736|1541290|P2|STARTED|Overall Study||31
627972|NCT00216736|1541291|P1|STARTED|Overall Study||32
627973|NCT00216671|1541305|P2|NOT COMPLETED|Overall Study||50
627974|NCT00216671|1541306|P1|NOT COMPLETED|Overall Study||35
627975|NCT00216671|1541305|P2|COMPLETED|Overall Study||60
627976|NCT00216671|1541306|P1|COMPLETED|Overall Study||75
627977|NCT00216671|1541305|P2|STARTED|Overall Study||110
627978|NCT00216671|1541306|P1|STARTED|Overall Study||110
627979|NCT00216476|1541324|P3|NOT COMPLETED|Overall Study||17
627980|NCT00216476|1541325|P2|NOT COMPLETED|Overall Study||107
627981|NCT00216476|1541326|P1|NOT COMPLETED|Overall Study||105
627982|NCT00216476|1541324|P3|COMPLETED|Overall Study||28
627983|NCT00216476|1541325|P2|COMPLETED|Overall Study||230
627984|NCT00216476|1541326|P1|COMPLETED|Overall Study||224
627985|NCT00216476|1541324|P3|STARTED|Overall Study||45
627986|NCT00216476|1541325|P2|STARTED|Overall Study||337
627987|NCT00216476|1541326|P1|STARTED|Overall Study||329
627988|NCT00216320|1541346|P3|NOT COMPLETED|Phase 2 (Weeks 6 -12)||1
627989|NCT00216320|1541347|P2|NOT COMPLETED|Phase 2 (Weeks 6 -12)||4
627990|NCT00216320|1541348|P1|NOT COMPLETED|Phase 2 (Weeks 6 -12)||5
627991|NCT00216320|1541346|P3|COMPLETED|Phase 2 (Weeks 6 -12)||24
627992|NCT00216320|1541347|P2|COMPLETED|Phase 2 (Weeks 6 -12)||31
627993|NCT00216320|1541348|P1|COMPLETED|Phase 2 (Weeks 6 -12)||38
627994|NCT00216320|1541346|P3|STARTED|Phase 2 (Weeks 6 -12)||25
627995|NCT00216320|1541347|P2|STARTED|Phase 2 (Weeks 6 -12)||35
627996|NCT00216320|1541348|P1|STARTED|Phase 2 (Weeks 6 -12)||43
627997|NCT00216320|1541346|P3|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||5
627998|NCT00216320|1541347|P2|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||4
627999|NCT00216320|1541348|P1|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||0
628000|NCT00216320|1541346|P3|COMPLETED|Phase 1 (Weeks 0 - 6)||25
628001|NCT00216320|1541347|P2|COMPLETED|Phase 1 (Weeks 0 - 6)||35
628002|NCT00216320|1541348|P1|COMPLETED|Phase 1 (Weeks 0 - 6)||43
628003|NCT00216320|1541346|P3|STARTED|Phase 1 (Weeks 0 - 6)||30
628004|NCT00216320|1541347|P2|STARTED|Phase 1 (Weeks 0 - 6)||39
628005|NCT00216320|1541348|P1|STARTED|Phase 1 (Weeks 0 - 6)||43
628006|NCT00216203|1541363|P1|NOT COMPLETED|Overall Study||2
628007|NCT00216203|1541363|P1|COMPLETED|Overall Study||34
628008|NCT00216203|1541363|P1|STARTED|Overall Study||36
628009|NCT00216125|1541371|P3|NOT COMPLETED|Randomization Phase||8
628010|NCT00216125|1541372|P2|NOT COMPLETED|Randomization Phase||11
628011|NCT00216125|1541373|P1|NOT COMPLETED|Randomization Phase||0
628012|NCT00216125|1541371|P3|COMPLETED|Randomization Phase||74
628013|NCT00216125|1541372|P2|COMPLETED|Randomization Phase||73
628014|NCT00216125|1541373|P1|COMPLETED|Randomization Phase||0
628015|NCT00216125|1541371|P3|DSMB Cohort for Futility|Randomization Phase||74
628016|NCT00216125|1541372|P2|DSMB Cohort for Futility|Randomization Phase||73
628017|NCT00216125|1541373|P1|DSMB Cohort for Futility|Randomization Phase||0
628018|NCT00216125|1541371|P3|STARTED|Randomization Phase||82
628019|NCT00216125|1541372|P2|STARTED|Randomization Phase||84
628020|NCT00216125|1541373|P1|STARTED|Randomization Phase||0
628021|NCT00216125|1541371|P3|NOT COMPLETED|Pre-Randomization Phase||0
628022|NCT00216125|1541372|P2|NOT COMPLETED|Pre-Randomization Phase||0
628023|NCT00216125|1541373|P1|NOT COMPLETED|Pre-Randomization Phase||77
628024|NCT00216125|1541371|P3|COMPLETED|Pre-Randomization Phase||0
628025|NCT00216125|1541372|P2|COMPLETED|Pre-Randomization Phase||0
628026|NCT00216125|1541373|P1|COMPLETED|Pre-Randomization Phase||166
628027|NCT00216125|1541371|P3|DSMB Cohort for Futility|Pre-Randomization Phase||0
628028|NCT00216125|1541372|P2|DSMB Cohort for Futility|Pre-Randomization Phase||0
628029|NCT00216125|1541373|P1|DSMB Cohort for Futility|Pre-Randomization Phase||203
628030|NCT00216125|1541371|P3|STARTED|Pre-Randomization Phase||0
628031|NCT00216125|1541372|P2|STARTED|Pre-Randomization Phase||0
628032|NCT00216125|1541373|P1|STARTED|Pre-Randomization Phase||243
628033|NCT00216099|1541382|P1|NOT COMPLETED|Overall Study||1
628034|NCT00216099|1541382|P1|COMPLETED|Overall Study||48
628035|NCT00216099|1541382|P1|Response Analysis|Overall Study||48
628036|NCT00216099|1541382|P1|Toxicity Analysis|Overall Study||49
628037|NCT00216099|1541382|P1|STARTED|Overall Study||49
628038|NCT00216086|1541393|P1|NOT COMPLETED|Overall Study||4
628039|NCT00216086|1541393|P1|COMPLETED|Overall Study||18
628040|NCT00216086|1541393|P1|STARTED|Overall Study||22
628041|NCT00216060|1541402|P2|NOT COMPLETED|Overall Study||0
628042|NCT00216060|1541403|P1|NOT COMPLETED|Overall Study||0
628043|NCT00216060|1541402|P2|COMPLETED|Overall Study||31
628044|NCT00216060|1541403|P1|COMPLETED|Overall Study||32
628045|NCT00216060|1541402|P2|STARTED|Overall Study||31
628046|NCT00216060|1541403|P1|STARTED|Overall Study||32
628047|NCT00215943|1541425|P2|NOT COMPLETED|Overall Study||14
628048|NCT00215943|1541426|P1|NOT COMPLETED|Overall Study||9
628049|NCT00215943|1541425|P2|COMPLETED|Overall Study||23
628050|NCT00215943|1541426|P1|COMPLETED|Overall Study||27
628051|NCT00215943|1541425|P2|STARTED|Overall Study||37
628052|NCT00215943|1541426|P1|STARTED|Overall Study||36
628053|NCT00215930|1541438|P1|NOT COMPLETED|Overall Study||0
628054|NCT00215930|1541438|P1|COMPLETED|Overall Study||53
628055|NCT00215930|1541438|P1|STARTED|Overall Study||53
628056|NCT00215787|1541444|P1|NOT COMPLETED|Overall Study||0
628057|NCT00215787|1541444|P1|COMPLETED|Overall Study||20
628058|NCT00215787|1541444|P1|STARTED|Overall Study||20
628059|NCT00215683|1541451|P3|NOT COMPLETED|Overall Study||32
628060|NCT00215683|1541452|P2|NOT COMPLETED|Overall Study||26
628061|NCT00215683|1541453|P1|NOT COMPLETED|Overall Study||29
628062|NCT00215683|1541451|P3|COMPLETED|Overall Study||12
628063|NCT00215683|1541452|P2|COMPLETED|Overall Study||22
628064|NCT00215683|1541453|P1|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study|16
628065|NCT00215683|1541451|P3|Switched to 160 mg|Overall Study||36
628066|NCT00215683|1541452|P2|Switched to 160 mg|Overall Study||41
628067|NCT00215683|1541453|P1|Switched to 160 mg|Overall Study|A protocol amendment changed the dosage to 160 mg (40 mg/mL) for all participants|32
628068|NCT00215683|1541451|P3|STARTED|Overall Study||44
628069|NCT00215683|1541452|P2|STARTED|Overall Study||48
628070|NCT00215683|1541453|P1|STARTED|Overall Study|Safety analysis set|45
628071|NCT00215657|1541472|P8|NOT COMPLETED|Overall Study||16
628072|NCT00215657|1541473|P7|NOT COMPLETED|Overall Study||23
628073|NCT00215657|1541474|P6|NOT COMPLETED|Overall Study||20
628074|NCT00215657|1541475|P5|NOT COMPLETED|Overall Study||23
628075|NCT00215657|1541476|P4|NOT COMPLETED|Overall Study||18
628076|NCT00215657|1541477|P3|NOT COMPLETED|Overall Study||11
628077|NCT00215657|1541478|P2|NOT COMPLETED|Overall Study||11
628078|NCT00215657|1541479|P1|NOT COMPLETED|Overall Study||22
628079|NCT00215657|1541472|P8|COMPLETED|Overall Study||11
628080|NCT00215657|1541473|P7|COMPLETED|Overall Study||4
628081|NCT00215657|1541474|P6|COMPLETED|Overall Study||4
628082|NCT00215657|1541475|P5|COMPLETED|Overall Study||4
628083|NCT00215657|1541476|P4|COMPLETED|Overall Study||6
628084|NCT00215657|1541477|P3|COMPLETED|Overall Study||2
628085|NCT00215657|1541478|P2|COMPLETED|Overall Study||1
628086|NCT00215657|1541479|P1|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study.|4
628087|NCT00215657|1541472|P8|Started FE200486 CS07A|Overall Study||23
628088|NCT00215657|1541473|P7|Started FE200486 CS07A|Overall Study||14
628089|NCT00215657|1541474|P6|Started FE200486 CS07A|Overall Study||20
628090|NCT00215657|1541475|P5|Started FE200486 CS07A|Overall Study||17
628091|NCT00215657|1541476|P4|Started FE200486 CS07A|Overall Study||24
628092|NCT00215657|1541477|P3|Started FE200486 CS07A|Overall Study||7
628093|NCT00215657|1541478|P2|Started FE200486 CS07A|Overall Study||6
628094|NCT00215657|1541479|P1|Started FE200486 CS07A|Overall Study||20
628095|NCT00215657|1541472|P8|Intention-to-treat Population|Overall Study||27
628096|NCT00215657|1541473|P7|Intention-to-treat Population|Overall Study||24
628097|NCT00215657|1541474|P6|Intention-to-treat Population|Overall Study||24
628098|NCT00215657|1541475|P5|Intention-to-treat Population|Overall Study||24
628099|NCT00215657|1541476|P4|Intention-to-treat Population|Overall Study||24
628100|NCT00215657|1541477|P3|Intention-to-treat Population|Overall Study||12
628101|NCT00215657|1541478|P2|Intention-to-treat Population|Overall Study||12
628102|NCT00215657|1541479|P1|Intention-to-treat Population|Overall Study||25
628103|NCT00215657|1541472|P8|STARTED|Overall Study||27
628104|NCT00215657|1541473|P7|STARTED|Overall Study||27
628105|NCT00215657|1541474|P6|STARTED|Overall Study||24
628106|NCT00215657|1541475|P5|STARTED|Overall Study||27
628107|NCT00215657|1541476|P4|STARTED|Overall Study||24
628108|NCT00215657|1541477|P3|STARTED|Overall Study||13
628109|NCT00215657|1541478|P2|STARTED|Overall Study||12
628110|NCT00215657|1541479|P1|STARTED|Overall Study||26
628111|NCT00215553|1541512|P7|NOT COMPLETED|Overall Study||0
628112|NCT00215553|1541513|P6|NOT COMPLETED|Overall Study||6
628113|NCT00215553|1541514|P5|NOT COMPLETED|Overall Study||2
628114|NCT00215553|1541515|P4|NOT COMPLETED|Overall Study||1
628115|NCT00215553|1541516|P3|NOT COMPLETED|Overall Study||2
628116|NCT00215553|1541517|P2|NOT COMPLETED|Overall Study||1
628117|NCT00215553|1541518|P1|NOT COMPLETED|Overall Study||0
628118|NCT00215553|1541512|P7|COMPLETED|Overall Study||36
628119|NCT00215553|1541513|P6|COMPLETED|Overall Study|6 Subjects discontinued due to AE|32
628120|NCT00215553|1541514|P5|COMPLETED|Overall Study|2 Subjects discontinued due to AE|26
628121|NCT00215553|1541515|P4|COMPLETED|Overall Study|1 Subject discontinued due to AE|4
628122|NCT00215553|1541516|P3|COMPLETED|Overall Study|2 Subjects discontinued due to AE|4
628123|NCT00215553|1541517|P2|COMPLETED|Overall Study|1 Subject discontinued due to AE|5
628124|NCT00215553|1541518|P1|COMPLETED|Overall Study||5
628125|NCT00215553|1541512|P7|STARTED|Overall Study||36
628126|NCT00215553|1541513|P6|STARTED|Overall Study||38
628127|NCT00215553|1541514|P5|STARTED|Overall Study||28
628128|NCT00215553|1541515|P4|STARTED|Overall Study||5
628129|NCT00215553|1541516|P3|STARTED|Overall Study||6
628130|NCT00215553|1541517|P2|STARTED|Overall Study||6
628131|NCT00215553|1541518|P1|STARTED|Overall Study||5
628132|NCT00215540|1541551|P3|NOT COMPLETED|Overall Study||0
628133|NCT00215540|1541552|P2|NOT COMPLETED|Overall Study||0
628134|NCT00215540|1541553|P1|NOT COMPLETED|Overall Study||1
628135|NCT00215540|1541551|P3|COMPLETED|Overall Study||44
628136|NCT00215540|1541552|P2|COMPLETED|Overall Study||47
628137|NCT00215540|1541553|P1|COMPLETED|Overall Study||44
628138|NCT00215540|1541551|P3|STARTED|Overall Study||44
628139|NCT00215540|1541552|P2|STARTED|Overall Study||47
628140|NCT00215540|1541553|P1|STARTED|Overall Study||45
628141|NCT00215150|1541588|P1|NOT COMPLETED|Randomization Phase Placebo||1
628142|NCT00215150|1541588|P1|COMPLETED|Randomization Phase Placebo||10
628143|NCT00215150|1541588|P1|STARTED|Randomization Phase Placebo||11
628144|NCT00215150|1541588|P1|NOT COMPLETED|Randomization Phase Ziprasidone||3
628145|NCT00215150|1541588|P1|COMPLETED|Randomization Phase Ziprasidone||7
628146|NCT00215150|1541588|P1|STARTED|Randomization Phase Ziprasidone||10
628147|NCT00215150|1541588|P1|NOT COMPLETED|Open Label Phase||30
628148|NCT00215150|1541588|P1|COMPLETED|Open Label Phase||21
628149|NCT00215150|1541588|P1|STARTED|Open Label Phase|Number of subjects consented|51
628150|NCT00215137|1541596|P3|NOT COMPLETED|Randomization Period||0
628151|NCT00215137|1541597|P2|NOT COMPLETED|Randomization Period||2
628152|NCT00215137|1541598|P1|NOT COMPLETED|Randomization Period||0
628153|NCT00215137|1541596|P3|COMPLETED|Randomization Period||5
628154|NCT00215137|1541597|P2|COMPLETED|Randomization Period||5
628155|NCT00215137|1541598|P1|COMPLETED|Randomization Period||0
628156|NCT00215137|1541596|P3|STARTED|Randomization Period||5
628157|NCT00215137|1541597|P2|STARTED|Randomization Period||7
628158|NCT00215137|1541598|P1|STARTED|Randomization Period||0
628159|NCT00215137|1541596|P3|NOT COMPLETED|Open Label Escitalopram||0
628160|NCT00215137|1541597|P2|NOT COMPLETED|Open Label Escitalopram||0
628161|NCT00215137|1541598|P1|NOT COMPLETED|Open Label Escitalopram||1
628162|NCT00215137|1541596|P3|COMPLETED|Open Label Escitalopram||0
628163|NCT00215137|1541597|P2|COMPLETED|Open Label Escitalopram||0
628164|NCT00215137|1541598|P1|COMPLETED|Open Label Escitalopram||13
628165|NCT00215137|1541596|P3|STARTED|Open Label Escitalopram||0
628166|NCT00215137|1541597|P2|STARTED|Open Label Escitalopram||0
628167|NCT00215137|1541598|P1|STARTED|Open Label Escitalopram||14
628168|NCT00214903|1541610|P4|NOT COMPLETED|Overall Study||0
628169|NCT00214903|1541611|P3|NOT COMPLETED|Overall Study||0
628170|NCT00214903|1541612|P2|NOT COMPLETED|Overall Study||0
628171|NCT00214903|1541613|P1|NOT COMPLETED|Overall Study||0
628172|NCT00214903|1541610|P4|COMPLETED|Overall Study||3057
628173|NCT00214903|1541611|P3|COMPLETED|Overall Study||4113
628174|NCT00214903|1541612|P2|COMPLETED|Overall Study||13384
628175|NCT00214903|1541613|P1|COMPLETED|Overall Study||10043
628176|NCT00214903|1541610|P4|STARTED|Overall Study||3057
628177|NCT00214903|1541611|P3|STARTED|Overall Study||4113
628178|NCT00214903|1541612|P2|STARTED|Overall Study||13384
628179|NCT00214903|1541613|P1|STARTED|Overall Study||10043
628180|NCT00214786|1541627|P1|NOT COMPLETED|Overall Study||3
628181|NCT00214786|1541627|P1|COMPLETED|Overall Study||1
628182|NCT00214786|1541627|P1|STARTED|Overall Study||4
628183|NCT00214539|1541642|P2|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0
628184|NCT00214539|1541643|P1|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0
628185|NCT00214539|1541642|P2|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||17
628186|NCT00214539|1541643|P1|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||15
628187|NCT00214539|1541642|P2|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||17
628188|NCT00214539|1541643|P1|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||15
628189|NCT00214539|1541642|P2|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0
628190|NCT00214539|1541643|P1|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0
628191|NCT00214539|1541642|P2|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||17
628192|NCT00214539|1541643|P1|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||15
628193|NCT00214539|1541642|P2|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||17
628194|NCT00214539|1541643|P1|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||15
628195|NCT00214539|1541642|P2|NOT COMPLETED|Treatment Period||0
628196|NCT00214539|1541643|P1|NOT COMPLETED|Treatment Period||0
628197|NCT00214539|1541642|P2|COMPLETED|Treatment Period||17
628198|NCT00214539|1541643|P1|COMPLETED|Treatment Period||15
628199|NCT00214539|1541642|P2|STARTED|Treatment Period||17
628200|NCT00214539|1541643|P1|STARTED|Treatment Period||15
628201|NCT00214539|1541642|P2|NOT COMPLETED|Randomized||0
628202|NCT00214539|1541643|P1|NOT COMPLETED|Randomized||2
628203|NCT00214539|1541642|P2|COMPLETED|Randomized||17
628204|NCT00214539|1541643|P1|COMPLETED|Randomized||15
628205|NCT00214539|1541642|P2|STARTED|Randomized||17
628206|NCT00214539|1541643|P1|STARTED|Randomized||17
628207|NCT00214526|1541669|P2|NOT COMPLETED|Post-Treatment Period||0
628208|NCT00214526|1541670|P1|NOT COMPLETED|Post-Treatment Period||1
628209|NCT00214526|1541669|P2|COMPLETED|Post-Treatment Period||49
628210|NCT00214526|1541670|P1|COMPLETED|Post-Treatment Period||52
628211|NCT00214526|1541669|P2|STARTED|Post-Treatment Period||49
628212|NCT00214526|1541670|P1|STARTED|Post-Treatment Period||53
628213|NCT00214526|1541669|P2|NOT COMPLETED|Treatment Period||5
628214|NCT00214526|1541670|P1|NOT COMPLETED|Treatment Period||2
628215|NCT00214526|1541669|P2|COMPLETED|Treatment Period||49
628216|NCT00214526|1541670|P1|COMPLETED|Treatment Period||53
628217|NCT00214526|1541669|P2|STARTED|Treatment Period||54
628218|NCT00214526|1541670|P1|STARTED|Treatment Period||55
628219|NCT00214526|1541669|P2|NOT COMPLETED|Randomized||2
628220|NCT00214526|1541670|P1|NOT COMPLETED|Randomized||1
628221|NCT00214526|1541669|P2|COMPLETED|Randomized||54
628222|NCT00214526|1541670|P1|COMPLETED|Randomized||55
628223|NCT00214526|1541669|P2|STARTED|Randomized||56
628224|NCT00214526|1541670|P1|STARTED|Randomized||56
628225|NCT00214487|1541698|P2|NOT COMPLETED|Overall Study||3
628226|NCT00214487|1541699|P1|NOT COMPLETED|Overall Study||5
628227|NCT00214487|1541698|P2|COMPLETED|Overall Study||40
628228|NCT00214487|1541699|P1|COMPLETED|Overall Study||38
628229|NCT00214487|1541698|P2|STARTED|Overall Study||43
628230|NCT00214487|1541699|P1|STARTED|Overall Study||43
628231|NCT00214461|1541709|P4|NOT COMPLETED|Overall Study||1
628232|NCT00214461|1541710|P3|NOT COMPLETED|Overall Study||2
628233|NCT00214461|1541711|P2|NOT COMPLETED|Overall Study||0
628234|NCT00214461|1541712|P1|NOT COMPLETED|Overall Study||0
628235|NCT00214461|1541709|P4|COMPLETED|Overall Study||11
628236|NCT00214461|1541710|P3|COMPLETED|Overall Study||10
628237|NCT00214461|1541711|P2|COMPLETED|Overall Study||12
628238|NCT00214461|1541712|P1|COMPLETED|Overall Study||12
628239|NCT00214461|1541709|P4|STARTED|Overall Study||12
628240|NCT00214461|1541710|P3|STARTED|Overall Study||12
628241|NCT00214461|1541711|P2|STARTED|Overall Study||12
628242|NCT00214461|1541712|P1|STARTED|Overall Study||12
628243|NCT00214383|1541728|P2|NOT COMPLETED|Overall Study||26
628244|NCT00214383|1541729|P1|NOT COMPLETED|Overall Study||16
628245|NCT00214383|1541728|P2|COMPLETED|Overall Study||127
628246|NCT00214383|1541729|P1|COMPLETED|Overall Study||132
628247|NCT00214383|1541728|P2|STARTED|Overall Study||153
628248|NCT00214383|1541729|P1|STARTED|Overall Study||148
628249|NCT00214201|1541741|P2|NOT COMPLETED|Overall Study||2
628250|NCT00214201|1541742|P1|NOT COMPLETED|Overall Study||2
628251|NCT00214201|1541741|P2|COMPLETED|Overall Study||18
628252|NCT00214201|1541742|P1|COMPLETED|Overall Study||18
628253|NCT00214201|1541741|P2|STARTED|Overall Study||20
628254|NCT00214201|1541742|P1|STARTED|Overall Study||20
628255|NCT00214136|1541752|P1|NOT COMPLETED|Overall Study||5
628256|NCT00214136|1541752|P1|COMPLETED|Overall Study||25
628257|NCT00214136|1541752|P1|STARTED|Overall Study||30
628258|NCT00214019|1541757|P1|NOT COMPLETED|Overall Study||30
628259|NCT00214019|1541757|P1|COMPLETED|Overall Study||6
628260|NCT00214019|1541757|P1|Fluticason/Salmeterol Arm|Overall Study||6
628261|NCT00214019|1541757|P1|Fluticasone/Placebo Arm|Overall Study||6
628262|NCT00214019|1541757|P1|Placebo/Salmeterol Arm|Overall Study||6
628263|NCT00214019|1541757|P1|Placebo/Placebo Arm|Overall Study||6
628264|NCT00214019|1541757|P1|STARTED|Overall Study||36
628265|NCT00213980|1541766|P2|NOT COMPLETED|Overall Study||7
628266|NCT00213980|1541767|P1|NOT COMPLETED|Overall Study||6
628267|NCT00213980|1541766|P2|COMPLETED|Overall Study||29
628268|NCT00213980|1541767|P1|COMPLETED|Overall Study||26
628269|NCT00213980|1541766|P2|STARTED|Overall Study||36
628270|NCT00213980|1541767|P1|STARTED|Overall Study||32
628271|NCT00213135|1541782|P3|NOT COMPLETED|Overall Study||57
628272|NCT00213135|1541783|P2|NOT COMPLETED|Overall Study||35
628273|NCT00213135|1541784|P1|NOT COMPLETED|Overall Study||50
628274|NCT00213135|1541782|P3|COMPLETED|Overall Study||380
628275|NCT00213135|1541783|P2|COMPLETED|Overall Study||398
628276|NCT00213135|1541784|P1|COMPLETED|Overall Study||406
628277|NCT00213135|1541782|P3|STARTED|Overall Study||437
628278|NCT00213135|1541783|P2|STARTED|Overall Study||433
628279|NCT00213135|1541784|P1|STARTED|Overall Study||456
628280|NCT00212758|1541801|P2|NOT COMPLETED|Standard Therapy of GH (12 Months)||1
628281|NCT00212758|1541802|P1|NOT COMPLETED|Standard Therapy of GH (12 Months)||2
628282|NCT00212758|1541801|P2|COMPLETED|Standard Therapy of GH (12 Months)||8
628283|NCT00212758|1541802|P1|COMPLETED|Standard Therapy of GH (12 Months)||6
628284|NCT00212758|1541801|P2|STARTED|Standard Therapy of GH (12 Months)||9
628285|NCT00212758|1541802|P1|STARTED|Standard Therapy of GH (12 Months)||8
628286|NCT00212758|1541801|P2|NOT COMPLETED|Second Intervention (7 Days)||0
628287|NCT00212758|1541802|P1|NOT COMPLETED|Second Intervention (7 Days)||0
628288|NCT00212758|1541801|P2|COMPLETED|Second Intervention (7 Days)||9
628289|NCT00212758|1541802|P1|COMPLETED|Second Intervention (7 Days)||8
628290|NCT00212758|1541801|P2|STARTED|Second Intervention (7 Days)||9
628291|NCT00212758|1541802|P1|STARTED|Second Intervention (7 Days)||8
628292|NCT00212758|1541801|P2|NOT COMPLETED|Wash Out Period (2 Weeks)||0
628293|NCT00212758|1541802|P1|NOT COMPLETED|Wash Out Period (2 Weeks)||0
628294|NCT00212758|1541801|P2|COMPLETED|Wash Out Period (2 Weeks)||9
628295|NCT00212758|1541802|P1|COMPLETED|Wash Out Period (2 Weeks)||8
628296|NCT00212758|1541801|P2|STARTED|Wash Out Period (2 Weeks)||9
628297|NCT00212758|1541802|P1|STARTED|Wash Out Period (2 Weeks)||8
628298|NCT00212758|1541801|P2|NOT COMPLETED|First Intervention (7 Days)||0
628299|NCT00212758|1541802|P1|NOT COMPLETED|First Intervention (7 Days)||0
628300|NCT00212758|1541801|P2|COMPLETED|First Intervention (7 Days)||9
628301|NCT00212758|1541802|P1|COMPLETED|First Intervention (7 Days)||8
628302|NCT00212758|1541801|P2|STARTED|First Intervention (7 Days)||9
628303|NCT00212758|1541802|P1|STARTED|First Intervention (7 Days)||8
628304|NCT00212355|1541808|P1|NOT COMPLETED|Overall Study||3
628305|NCT00212355|1541808|P1|COMPLETED|Overall Study||34
628306|NCT00212355|1541808|P1|STARTED|Overall Study||37
628307|NCT00212264|1541815|P3|NOT COMPLETED|Overall Study||4
628308|NCT00212264|1541816|P2|NOT COMPLETED|Overall Study||16
628309|NCT00212264|1541817|P1|NOT COMPLETED|Overall Study||12
628310|NCT00212264|1541815|P3|COMPLETED|Overall Study||64
628311|NCT00212264|1541816|P2|COMPLETED|Overall Study||54
628312|NCT00212264|1541817|P1|COMPLETED|Overall Study||58
628313|NCT00212264|1541815|P3|STARTED|Overall Study||68
628314|NCT00212264|1541816|P2|STARTED|Overall Study||70
628315|NCT00212264|1541817|P1|STARTED|Overall Study||70
628316|NCT00212134|1541829|P2|NOT COMPLETED|Phase 3 (Age 10 Years)||21
628317|NCT00212134|1541830|P1|NOT COMPLETED|Phase 3 (Age 10 Years)||21
628318|NCT00212134|1541829|P2|COMPLETED|Phase 3 (Age 10 Years)||35
628319|NCT00212134|1541830|P1|COMPLETED|Phase 3 (Age 10 Years)||36
628320|NCT00212134|1541829|P2|STARTED|Phase 3 (Age 10 Years)||56
628321|NCT00212134|1541830|P1|STARTED|Phase 3 (Age 10 Years)||57
628322|NCT00212134|1541829|P2|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||1
628323|NCT00212134|1541830|P1|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||0
628324|NCT00212134|1541829|P2|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)|Patient lost to follow-up.|56
628325|NCT00212134|1541830|P1|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||57
628326|NCT00212134|1541829|P2|STARTED|Phase 2 (Age 1 Year to Age 5 Years)|Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.|57
628327|NCT00212134|1541830|P1|STARTED|Phase 2 (Age 1 Year to Age 5 Years)|Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.|57
628328|NCT00212134|1541829|P2|NOT COMPLETED|Phase 1 (to Age 1 Year)||0
628329|NCT00212134|1541830|P1|NOT COMPLETED|Phase 1 (to Age 1 Year)||0
628330|NCT00212134|1541829|P2|COMPLETED|Phase 1 (to Age 1 Year)|Age 1 data collection visit|57
628331|NCT00212134|1541830|P1|COMPLETED|Phase 1 (to Age 1 Year)|Age 1 data collection visit|57
628332|NCT00212134|1541829|P2|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57
628333|NCT00212134|1541830|P1|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57
628334|NCT00212134|1541829|P2|STARTED|Phase 1 (to Age 1 Year)||57
628335|NCT00212134|1541830|P1|STARTED|Phase 1 (to Age 1 Year)||57
628336|NCT00211887|1541851|P3|NOT COMPLETED|Overall Study||36
628337|NCT00211887|1541852|P2|NOT COMPLETED|Overall Study||56
628338|NCT00211887|1541853|P1|NOT COMPLETED|Overall Study||102
628339|NCT00211887|1541851|P3|COMPLETED|Overall Study||223
628340|NCT00211887|1541852|P2|COMPLETED|Overall Study||194
628341|NCT00211887|1541853|P1|COMPLETED|Overall Study||397
628342|NCT00211887|1541851|P3|STARTED|Overall Study||259
628343|NCT00211887|1541852|P2|STARTED|Overall Study||250
628344|NCT00211887|1541853|P1|STARTED|Overall Study||499
628345|NCT00211809|1541870|P1|NOT COMPLETED|Overall Study||6
628346|NCT00211809|1541870|P1|COMPLETED|Overall Study||11
628347|NCT00211809|1541870|P1|STARTED|Overall Study||17
628348|NCT00211692|1541886|P2|NOT COMPLETED|Overall Study||0
628349|NCT00211692|1541887|P1|NOT COMPLETED|Overall Study||0
628350|NCT00211692|1541886|P2|COMPLETED|Overall Study||31
628351|NCT00211692|1541887|P1|COMPLETED|Overall Study||33
628352|NCT00211692|1541886|P2|STARTED|Overall Study||31
628353|NCT00211692|1541887|P1|STARTED|Overall Study||33
628354|NCT00211536|1541897|P2|NOT COMPLETED|Overall Study||7
628355|NCT00211536|1541898|P1|NOT COMPLETED|Overall Study||4
628356|NCT00211536|1541897|P2|COMPLETED|Overall Study|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|47
628357|NCT00211536|1541898|P1|COMPLETED|Overall Study||49
628358|NCT00211536|1541897|P2|As Treated Data Analysis Set|Overall Study||48
628359|NCT00211536|1541898|P1|As Treated Data Analysis Set|Overall Study|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|52
628360|NCT00211536|1541897|P2|STARTED|Overall Study||54
628361|NCT00211536|1541898|P1|STARTED|Overall Study||53
628362|NCT00211510|1541914|P2|NOT COMPLETED|Overall Study||2
628363|NCT00211510|1541915|P1|NOT COMPLETED|Overall Study||6
628364|NCT00211510|1541914|P2|COMPLETED|Overall Study||72
628365|NCT00211510|1541915|P1|COMPLETED|Overall Study||66
628366|NCT00211510|1541914|P2|STARTED|Overall Study||74
628367|NCT00211510|1541915|P1|STARTED|Overall Study||72
628368|NCT00211237|1541933|P3|NOT COMPLETED|12 Months||6
628369|NCT00211237|1541934|P2|NOT COMPLETED|12 Months||2
628370|NCT00211237|1541935|P1|NOT COMPLETED|12 Months||9
628371|NCT00211237|1541933|P3|COMPLETED|12 Months||28
628372|NCT00211237|1541934|P2|COMPLETED|12 Months||6
628373|NCT00211237|1541935|P1|COMPLETED|12 Months||40
628374|NCT00211237|1541933|P3|STARTED|12 Months||34
628375|NCT00211237|1541934|P2|STARTED|12 Months|1 patient crossed over Balloon Kyphoplasty|8
628376|NCT00211237|1541935|P1|STARTED|12 Months||49
628377|NCT00211237|1541933|P3|NOT COMPLETED|6 Months||3
628378|NCT00211237|1541934|P2|NOT COMPLETED|6 Months||2
628379|NCT00211237|1541935|P1|NOT COMPLETED|6 Months||8
628380|NCT00211237|1541933|P3|COMPLETED|6 Months||33
628381|NCT00211237|1541934|P2|COMPLETED|6 Months||9
628382|NCT00211237|1541935|P1|COMPLETED|6 Months||49
628383|NCT00211237|1541933|P3|STARTED|6 Months||36
628384|NCT00211237|1541934|P2|STARTED|6 Months|3 patients crossed over Balloon Kyphoplasty|11
628385|NCT00211237|1541935|P1|STARTED|6 Months||57
628386|NCT00211237|1541933|P3|NOT COMPLETED|3 Months||1
628387|NCT00211237|1541934|P2|NOT COMPLETED|3 Months||4
628388|NCT00211237|1541935|P1|NOT COMPLETED|3 Months||8
628389|NCT00211237|1541933|P3|COMPLETED|3 Months||33
628390|NCT00211237|1541934|P2|COMPLETED|3 Months||14
628391|NCT00211237|1541935|P1|COMPLETED|3 Months||57
628392|NCT00211237|1541933|P3|STARTED|3 Months||34
628393|NCT00211237|1541934|P2|STARTED|3 Months|34 patients crossed over to Balloon Kyphoplasty.|18
628394|NCT00211237|1541935|P1|STARTED|3 Months||65
628395|NCT00211237|1541933|P3|NOT COMPLETED|1 Month||0
628396|NCT00211237|1541934|P2|NOT COMPLETED|1 Month||9
628397|NCT00211237|1541935|P1|NOT COMPLETED|1 Month||3
628398|NCT00211237|1541933|P3|COMPLETED|1 Month||0
628399|NCT00211237|1541934|P2|COMPLETED|1 Month||52
628400|NCT00211237|1541935|P1|COMPLETED|1 Month||65
628401|NCT00211237|1541933|P3|STARTED|1 Month||0
628402|NCT00211237|1541934|P2|STARTED|1 Month||61
628403|NCT00211237|1541935|P1|STARTED|1 Month||68
628404|NCT00211237|1541933|P3|NOT COMPLETED|Baseline||0
628405|NCT00211237|1541934|P2|NOT COMPLETED|Baseline||3
628406|NCT00211237|1541935|P1|NOT COMPLETED|Baseline||2
628407|NCT00211237|1541933|P3|COMPLETED|Baseline||0
628408|NCT00211237|1541934|P2|COMPLETED|Baseline||61
628409|NCT00211237|1541935|P1|COMPLETED|Baseline||68
628410|NCT00211237|1541933|P3|STARTED|Baseline||0
628411|NCT00211237|1541934|P2|STARTED|Baseline||64
628412|NCT00211237|1541935|P1|STARTED|Baseline||70
628413|NCT00211172|1542027|P2|NOT COMPLETED|Overall Study||32
628414|NCT00211172|1542028|P1|NOT COMPLETED|Overall Study||39
628415|NCT00211172|1542027|P2|COMPLETED|Overall Study|32 patients died or lost health plan eligibility|426
628416|NCT00211172|1542028|P1|COMPLETED|Overall Study|39 patients died or lost health plan eligibility|410
628417|NCT00211172|1542027|P2|STARTED|Overall Study||458
628418|NCT00211172|1542028|P1|STARTED|Overall Study||449
628419|NCT00211081|1542034|P1|NOT COMPLETED|Overall Study||2
628420|NCT00211081|1542034|P1|COMPLETED|Overall Study||10
628421|NCT00211081|1542034|P1|STARTED|Overall Study||12
628422|NCT00210639|1542046|P2|NOT COMPLETED|Overall Study||42
628423|NCT00210639|1542047|P1|NOT COMPLETED|Overall Study||63
628424|NCT00210639|1542046|P2|COMPLETED|Overall Study||41
628425|NCT00210639|1542047|P1|COMPLETED|Overall Study||61
628426|NCT00210639|1542046|P2|STARTED|Overall Study||83
628427|NCT00210639|1542047|P1|STARTED|Overall Study||124
628428|NCT00210626|1542055|P2|NOT COMPLETED|Overall Study||45
628429|NCT00210626|1542056|P1|NOT COMPLETED|Overall Study||48
628430|NCT00210626|1542055|P2|COMPLETED|Overall Study||50
628431|NCT00210626|1542056|P1|COMPLETED|Overall Study||49
628432|NCT00210626|1542055|P2|STARTED|Overall Study||95
628433|NCT00210626|1542056|P1|STARTED|Overall Study||97
628434|NCT00210470|1542064|P1|NOT COMPLETED|Overall Study||1
628435|NCT00210470|1542064|P1|COMPLETED|Overall Study||26
628436|NCT00210470|1542064|P1|STARTED|Overall Study||27
628437|NCT00209560|1542070|P2|NOT COMPLETED|Overall Study||0
628438|NCT00209560|1542071|P1|NOT COMPLETED|Overall Study||1
628439|NCT00209560|1542070|P2|COMPLETED|Overall Study||42
628440|NCT00209560|1542071|P1|COMPLETED|Overall Study||120
628441|NCT00209560|1542070|P2|STARTED|Overall Study||42
628442|NCT00209560|1542071|P1|STARTED|Overall Study||121
628443|NCT00209417|1542081|P2|NOT COMPLETED|Overall Study||0
628444|NCT00209417|1542082|P1|NOT COMPLETED|Overall Study||0
628445|NCT00209417|1542081|P2|COMPLETED|Overall Study||327
628446|NCT00209417|1542082|P1|COMPLETED|Overall Study||321
628447|NCT00209417|1542081|P2|STARTED|Overall Study||327
628448|NCT00209417|1542082|P1|STARTED|Overall Study||321
628449|NCT00209339|1542090|P1|NOT COMPLETED|At 5 Years Follow-up||8
628450|NCT00209339|1542090|P1|COMPLETED|At 5 Years Follow-up||15
628451|NCT00209339|1542090|P1|STARTED|At 5 Years Follow-up||23
628452|NCT00209339|1542090|P1|NOT COMPLETED|At 4 Years Follow-up||5
628453|NCT00209339|1542090|P1|COMPLETED|At 4 Years Follow-up||23
628454|NCT00209339|1542090|P1|STARTED|At 4 Years Follow-up||28
628455|NCT00209339|1542090|P1|NOT COMPLETED|At 3 Years Follow-up||1
628456|NCT00209339|1542090|P1|COMPLETED|At 3 Years Follow-up||28
628457|NCT00209339|1542090|P1|STARTED|At 3 Years Follow-up||29
628458|NCT00209339|1542090|P1|NOT COMPLETED|At 24 Months Follow-up||11
628459|NCT00209339|1542090|P1|COMPLETED|At 24 Months Follow-up||29
628460|NCT00209339|1542090|P1|STARTED|At 24 Months Follow-up||40
628461|NCT00209339|1542090|P1|NOT COMPLETED|At 12 Months Follow-up||15
628462|NCT00209339|1542090|P1|COMPLETED|At 12 Months Follow-up||40
628463|NCT00209339|1542090|P1|STARTED|At 12 Months Follow-up||55
628464|NCT00209274|1542174|P2|NOT COMPLETED|Overall Study||47
628465|NCT00209274|1542175|P1|NOT COMPLETED|Overall Study||71
628466|NCT00209274|1542174|P2|COMPLETED|Overall Study||48
628467|NCT00209274|1542175|P1|COMPLETED|Overall Study||113
628468|NCT00209274|1542174|P2|STARTED|Overall Study||95
628469|NCT00209274|1542175|P1|STARTED|Overall Study||184
628470|NCT00209170|1542495|P2|NOT COMPLETED|Overall Study||3
628471|NCT00209170|1542496|P1|NOT COMPLETED|Overall Study||2
628472|NCT00209170|1542495|P2|COMPLETED|Overall Study||4
628473|NCT00209170|1542496|P1|COMPLETED|Overall Study||5
628474|NCT00209170|1542495|P2|STARTED|Overall Study||7
628475|NCT00209170|1542496|P1|STARTED|Overall Study||7
628476|NCT00209131|1542504|P2|NOT COMPLETED|Overall Study||11
628477|NCT00209131|1542505|P1|NOT COMPLETED|Overall Study||15
628478|NCT00209131|1542504|P2|COMPLETED|Overall Study|Lack of personnel for adequate followup and data collection.|0
628479|NCT00209131|1542505|P1|COMPLETED|Overall Study|Lack of personnel for adequate followup and data collection.|0
628480|NCT00209131|1542504|P2|STARTED|Overall Study|Patients enrolled for participation but did not complete the study.|11
628481|NCT00209131|1542505|P1|STARTED|Overall Study|Patients enrolled for participation but did not complete the study.|15
628482|NCT00209092|1542515|P2|NOT COMPLETED|Overall Study||2
628483|NCT00209092|1542516|P1|NOT COMPLETED|Overall Study||8
628484|NCT00209092|1542515|P2|COMPLETED|Overall Study||24
628485|NCT00209092|1542516|P1|COMPLETED|Overall Study||17
628486|NCT00209092|1542515|P2|STARTED|Overall Study||26
628487|NCT00209092|1542516|P1|STARTED|Overall Study||25
628488|NCT00209027|1542526|P2|NOT COMPLETED|Overall Study||0
628489|NCT00209027|1542527|P1|NOT COMPLETED|Overall Study||10
628490|NCT00209027|1542526|P2|COMPLETED|Overall Study||10
628491|NCT00209027|1542527|P1|COMPLETED|Overall Study||0
628492|NCT00209027|1542526|P2|STARTED|Overall Study||10
628493|NCT00209027|1542527|P1|STARTED|Overall Study||10
628494|NCT00208975|1542533|P1|NOT COMPLETED|Overall Study||0
628495|NCT00208975|1542533|P1|COMPLETED|Overall Study||15
628496|NCT00208975|1542533|P1|STARTED|Overall Study||15
628497|NCT00208949|1542540|P2|NOT COMPLETED|Overall Study||0
628498|NCT00208949|1542541|P1|NOT COMPLETED|Overall Study||0
628499|NCT00208949|1542540|P2|COMPLETED|Overall Study||25
628500|NCT00208949|1542541|P1|COMPLETED|Overall Study||25
628501|NCT00208949|1542540|P2|STARTED|Overall Study||25
628502|NCT00208949|1542541|P1|STARTED|Overall Study||25
628503|NCT00208767|1542551|P2|NOT COMPLETED|Overall Study||7
628504|NCT00208767|1542552|P1|NOT COMPLETED|Overall Study||27
628505|NCT00208767|1542551|P2|COMPLETED|Overall Study||33
628506|NCT00208767|1542552|P1|COMPLETED|Overall Study||53
628507|NCT00208767|1542551|P2|STARTED|Overall Study||40
628508|NCT00208767|1542552|P1|STARTED|Overall Study||80
628509|NCT00208507|1542560|P2|NOT COMPLETED|Overall Study||8
628510|NCT00208507|1542561|P1|NOT COMPLETED|Overall Study||14
628511|NCT00208507|1542560|P2|COMPLETED|Overall Study||79
628512|NCT00208507|1542561|P1|COMPLETED|Overall Study||163
628513|NCT00208507|1542560|P2|STARTED|Overall Study||87
628514|NCT00208507|1542561|P1|STARTED|Overall Study||177
628515|NCT00208494|1542569|P2|NOT COMPLETED|Overall Study||34
628516|NCT00208494|1542570|P1|NOT COMPLETED|Overall Study||30
628517|NCT00208494|1542569|P2|COMPLETED|Overall Study||162
628518|NCT00208494|1542570|P1|COMPLETED|Overall Study||164
628519|NCT00208494|1542569|P2|STARTED|Overall Study||196
628520|NCT00208494|1542570|P1|STARTED|Overall Study||194
628521|NCT00208325|1542580|P4|NOT COMPLETED|Overall Study||14
628522|NCT00208325|1542581|P3|NOT COMPLETED|Overall Study||14
628523|NCT00208325|1542582|P2|NOT COMPLETED|Overall Study||54
628524|NCT00208325|1542583|P1|NOT COMPLETED|Overall Study||51
628525|NCT00208325|1542580|P4|COMPLETED|Overall Study||147
628526|NCT00208325|1542581|P3|COMPLETED|Overall Study||156
628527|NCT00208325|1542582|P2|COMPLETED|Overall Study||142
628528|NCT00208325|1542583|P1|COMPLETED|Overall Study||142
628529|NCT00208325|1542580|P4|STARTED|Overall Study||161
628530|NCT00208325|1542581|P3|STARTED|Overall Study||170
628531|NCT00208325|1542582|P2|STARTED|Overall Study||196
628532|NCT00208325|1542583|P1|STARTED|Overall Study||193
628533|NCT00208091|1542691|P1|NOT COMPLETED|Overall Study||0
628534|NCT00208091|1542691|P1|COMPLETED|Overall Study||16
628535|NCT00208091|1542691|P1|STARTED|Overall Study||16
628536|NCT00208026|1542699|P1|NOT COMPLETED|Overall Study||0
628537|NCT00208026|1542699|P1|COMPLETED|Overall Study||3
628538|NCT00208026|1542699|P1|STARTED|Overall Study||3
628539|NCT00207883|1542705|P2|NOT COMPLETED|Overall Study||0
628540|NCT00207883|1542706|P1|NOT COMPLETED|Overall Study||0
628541|NCT00207883|1542705|P2|COMPLETED|Overall Study||119
628542|NCT00207883|1542706|P1|COMPLETED|Overall Study||93
628543|NCT00207883|1542705|P2|STARTED|Overall Study||119
628544|NCT00207883|1542706|P1|STARTED|Overall Study||93
628545|NCT00207740|1542718|P4|NOT COMPLETED|Overall Study||43
628546|NCT00207740|1542719|P3|NOT COMPLETED|Overall Study||40
628547|NCT00207740|1542720|P2|NOT COMPLETED|Overall Study||41
628548|NCT00207740|1542721|P1|NOT COMPLETED|Overall Study||29
628549|NCT00207740|1542718|P4|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|35
628550|NCT00207740|1542719|P3|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|36
628551|NCT00207740|1542720|P2|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|36
628552|NCT00207740|1542721|P1|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|49
628553|NCT00207740|1542718|P4|STARTED|Overall Study||78
628554|NCT00207740|1542719|P3|STARTED|Overall Study||76
628555|NCT00207740|1542720|P2|STARTED|Overall Study||77
628556|NCT00207740|1542721|P1|STARTED|Overall Study||78
628557|NCT00207727|1542767|P5|NOT COMPLETED|Overall Study||34
628558|NCT00207727|1542768|P4|NOT COMPLETED|Overall Study||37
628559|NCT00207727|1542769|P3|NOT COMPLETED|Overall Study||41
628560|NCT00207727|1542770|P2|NOT COMPLETED|Overall Study||42
628561|NCT00207727|1542771|P1|NOT COMPLETED|Overall Study||38
628562|NCT00207727|1542767|P5|COMPLETED|Overall Study||16
628563|NCT00207727|1542768|P4|COMPLETED|Overall Study||13
628564|NCT00207727|1542769|P3|COMPLETED|Overall Study||9
628565|NCT00207727|1542770|P2|COMPLETED|Overall Study||8
628566|NCT00207727|1542771|P1|COMPLETED|Overall Study||11
628567|NCT00207727|1542767|P5|STARTED|Overall Study||50
628568|NCT00207727|1542768|P4|STARTED|Overall Study||50
628569|NCT00207727|1542769|P3|STARTED|Overall Study||50
628570|NCT00207727|1542770|P2|STARTED|Overall Study||50
628571|NCT00207727|1542771|P1|STARTED|Overall Study||49
628572|NCT00207714|1542798|P5|NOT COMPLETED|Overall Study||5
628573|NCT00207714|1542799|P4|NOT COMPLETED|Overall Study||8
628574|NCT00207714|1542800|P3|NOT COMPLETED|Overall Study||10
628575|NCT00207714|1542801|P2|NOT COMPLETED|Overall Study||7
628576|NCT00207714|1542802|P1|NOT COMPLETED|Overall Study||14
628577|NCT00207714|1542798|P5|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|29
628578|NCT00207714|1542799|P4|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|26
628579|NCT00207714|1542800|P3|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|24
628580|NCT00207714|1542801|P2|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|28
628581|NCT00207714|1542802|P1|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|21
628582|NCT00207714|1542798|P5|STARTED|Overall Study||34
628583|NCT00207714|1542799|P4|STARTED|Overall Study||34
628584|NCT00207714|1542800|P3|STARTED|Overall Study||34
628585|NCT00207714|1542801|P2|STARTED|Overall Study||35
628586|NCT00207714|1542802|P1|STARTED|Overall Study||35
628587|NCT00207142|1542824|P4|NOT COMPLETED|Maintenance Phase/Rescue Phase||9
628588|NCT00207142|1542825|P3|NOT COMPLETED|Maintenance Phase/Rescue Phase||13
628589|NCT00207142|1542826|P2|NOT COMPLETED|Maintenance Phase/Rescue Phase||9
628590|NCT00207142|1542827|P1|NOT COMPLETED|Maintenance Phase/Rescue Phase||0
628591|NCT00207142|1542824|P4|COMPLETED|Maintenance Phase/Rescue Phase||41
628592|NCT00207142|1542825|P3|COMPLETED|Maintenance Phase/Rescue Phase||72
628593|NCT00207142|1542826|P2|COMPLETED|Maintenance Phase/Rescue Phase||78
628594|NCT00207142|1542827|P1|COMPLETED|Maintenance Phase/Rescue Phase||0
628595|NCT00207142|1542824|P4|STARTED|Maintenance Phase/Rescue Phase||50
628596|NCT00207142|1542825|P3|STARTED|Maintenance Phase/Rescue Phase||85
628597|NCT00207142|1542826|P2|STARTED|Maintenance Phase/Rescue Phase||87
628598|NCT00207142|1542827|P1|STARTED|Maintenance Phase/Rescue Phase||0
628599|NCT00207142|1542824|P4|NOT COMPLETED|Induction Phase||0
628600|NCT00207142|1542825|P3|NOT COMPLETED|Induction Phase||0
628601|NCT00207142|1542826|P2|NOT COMPLETED|Induction Phase||0
628602|NCT00207142|1542827|P1|NOT COMPLETED|Induction Phase||30
628603|NCT00207142|1542824|P4|COMPLETED|Induction Phase||0
628604|NCT00207142|1542825|P3|COMPLETED|Induction Phase||0
628605|NCT00207142|1542826|P2|COMPLETED|Induction Phase||0
628606|NCT00207142|1542827|P1|COMPLETED|Induction Phase|Subjects randomized into Maintenance Phase=172 (87 ATV +85 ATV/RTV); Rescue Phase subjects=50|222
628607|NCT00207142|1542824|P4|STARTED|Induction Phase||0
628608|NCT00207142|1542825|P3|STARTED|Induction Phase||0
628609|NCT00207142|1542826|P2|STARTED|Induction Phase||0
628610|NCT00207142|1542827|P1|STARTED|Induction Phase||252
628611|NCT00207090|1542864|P1|NOT COMPLETED|Overall Study||7
628612|NCT00207090|1542864|P1|COMPLETED|Overall Study||8
628613|NCT00207090|1542864|P1|STARTED|Overall Study|Number of participants treated|15
628614|NCT00206726|1542893|P1|NOT COMPLETED|Overall Study||51
628615|NCT00206726|1542893|P1|COMPLETED|Overall Study|4-6 cycles of treatment with assessments at 2, 6, and 9 months post last dose|9
628616|NCT00206726|1542893|P1|4 Cycles Completed|Overall Study|per protocol population|41
628617|NCT00206726|1542893|P1|Treatment Started|Overall Study|Safety population (3 withdrew consent prior to receiving study drug)|57
628618|NCT00206726|1542893|P1|STARTED|Overall Study||60
628619|NCT00206518|1542904|P2|NOT COMPLETED|Overall Study||6
628620|NCT00206518|1542905|P1|NOT COMPLETED|Overall Study||10
628621|NCT00206518|1542904|P2|COMPLETED|Overall Study||78
628622|NCT00206518|1542905|P1|COMPLETED|Overall Study||73
628623|NCT00206518|1542904|P2|STARTED|Overall Study||84
628624|NCT00206518|1542905|P1|STARTED|Overall Study||83
628625|NCT00206440|1542917|P2|NOT COMPLETED|Overall Study||4
628626|NCT00206440|1542918|P1|NOT COMPLETED|Overall Study||5
628627|NCT00206440|1542917|P2|COMPLETED|Overall Study||18
628628|NCT00206440|1542918|P1|COMPLETED|Overall Study||16
628629|NCT00206440|1542917|P2|STARTED|Overall Study||22
628630|NCT00206440|1542918|P1|STARTED|Overall Study||21
628631|NCT00206427|1542924|P1|NOT COMPLETED|Overall Study||2
628632|NCT00206427|1542924|P1|COMPLETED|Overall Study|Complete 6-week therapy|47
628633|NCT00206427|1542924|P1|STARTED|Overall Study|Received First Dose|49
628634|NCT00206336|1542928|P1|NOT COMPLETED|Overall Study||0
628635|NCT00206336|1542928|P1|COMPLETED|Overall Study||20
628636|NCT00206336|1542928|P1|STARTED|Overall Study||20
628637|NCT00206323|1542934|P2|NOT COMPLETED|Overall Study||3
628638|NCT00206323|1542935|P1|NOT COMPLETED|Overall Study||6
628639|NCT00206323|1542934|P2|COMPLETED|Overall Study||12
628640|NCT00206323|1542935|P1|COMPLETED|Overall Study||8
628641|NCT00206323|1542934|P2|STARTED|Overall Study||15
628642|NCT00206323|1542935|P1|STARTED|Overall Study||14
628643|NCT00206102|1542943|P2|NOT COMPLETED|Overall Study||315
628644|NCT00206102|1542944|P1|NOT COMPLETED|Overall Study||408
628645|NCT00206102|1542943|P2|COMPLETED|Overall Study||187
628646|NCT00206102|1542944|P1|COMPLETED|Overall Study||188
628647|NCT00206102|1542943|P2|STARTED|Overall Study||502
628648|NCT00206102|1542944|P1|STARTED|Overall Study||596
628649|NCT00206076|1542980|P2|NOT COMPLETED|Overall Study||1
628650|NCT00206076|1542981|P1|NOT COMPLETED|Overall Study||3
628651|NCT00206076|1542980|P2|COMPLETED|Overall Study||9
628652|NCT00206076|1542981|P1|COMPLETED|Overall Study||6
628653|NCT00206076|1542980|P2|STARTED|Overall Study||10
628654|NCT00206076|1542981|P1|STARTED|Overall Study||9
628655|NCT00205881|1542991|P1|NOT COMPLETED|Overall Study||16
628656|NCT00205881|1542991|P1|COMPLETED|Overall Study|32 enrolled. 1 unilateral. 25 bilateral for data analysis at 8 months. 16 completed study.|16
628657|NCT00205881|1542991|P1|STARTED|Overall Study||32
628658|NCT00205855|1542996|P1|NOT COMPLETED|Overall Study||21
628659|NCT00205855|1542996|P1|COMPLETED|Overall Study||44
628660|NCT00205855|1542996|P1|STARTED|Overall Study||65
628661|NCT00205803|1543002|P2|NOT COMPLETED|Toddler Dose||3
628662|NCT00205803|1543003|P1|NOT COMPLETED|Toddler Dose||2
628663|NCT00205803|1543002|P2|COMPLETED|Toddler Dose||100
628664|NCT00205803|1543003|P1|COMPLETED|Toddler Dose||84
628665|NCT00205803|1543002|P2|STARTED|Toddler Dose||103
628666|NCT00205803|1543003|P1|STARTED|Toddler Dose||86
628667|NCT00205803|1543002|P2|NOT COMPLETED|After Infant Series||13
628668|NCT00205803|1543003|P1|NOT COMPLETED|After Infant Series||18
628669|NCT00205803|1543002|P2|COMPLETED|After Infant Series||103
628670|NCT00205803|1543003|P1|COMPLETED|After Infant Series||86
628671|NCT00205803|1543002|P2|STARTED|After Infant Series||116
628672|NCT00205803|1543003|P1|STARTED|After Infant Series||104
628673|NCT00205803|1543002|P2|NOT COMPLETED|Infant Series||11
628674|NCT00205803|1543003|P1|NOT COMPLETED|Infant Series||18
628675|NCT00205803|1543002|P2|COMPLETED|Infant Series||116
628676|NCT00205803|1543003|P1|COMPLETED|Infant Series||104
628677|NCT00205803|1543002|P2|Vaccinated Dose 3|Infant Series||118
628678|NCT00205803|1543003|P1|Vaccinated Dose 3|Infant Series||110
628679|NCT00205803|1543002|P2|Vaccinated Dose 2|Infant Series||122
628680|NCT00205803|1543003|P1|Vaccinated Dose 2|Infant Series||115
628681|NCT00205803|1543002|P2|Vaccinated Dose 1|Infant Series||126
628682|NCT00205803|1543003|P1|Vaccinated Dose 1|Infant Series||121
628683|NCT00205803|1543002|P2|STARTED|Infant Series||127
628684|NCT00205803|1543003|P1|STARTED|Infant Series||122
628685|NCT00205777|1543059|P6|NOT COMPLETED|Study Extension II||282
628686|NCT00205777|1543060|P5|NOT COMPLETED|Study Extension II||0
628687|NCT00205777|1543061|P4|NOT COMPLETED|Study Extension II||149
628688|NCT00205777|1543062|P3|NOT COMPLETED|Study Extension II||0
628689|NCT00205777|1543063|P2|NOT COMPLETED|Study Extension II||0
628690|NCT00205777|1543064|P1|NOT COMPLETED|Study Extension II||0
628691|NCT00205777|1543059|P6|COMPLETED|Study Extension II||860
628692|NCT00205777|1543060|P5|COMPLETED|Study Extension II||0
628693|NCT00205777|1543061|P4|COMPLETED|Study Extension II||441
628694|NCT00205777|1543062|P3|COMPLETED|Study Extension II||0
628695|NCT00205777|1543063|P2|COMPLETED|Study Extension II||0
628696|NCT00205777|1543064|P1|COMPLETED|Study Extension II||0
628697|NCT00205777|1543059|P6|TREATED|Study Extension II||1011
628698|NCT00205777|1543060|P5|TREATED|Study Extension II||0
628699|NCT00205777|1543061|P4|TREATED|Study Extension II||519
628700|NCT00205777|1543062|P3|TREATED|Study Extension II||0
628701|NCT00205777|1543063|P2|TREATED|Study Extension II||0
628702|NCT00205777|1543064|P1|TREATED|Study Extension II||0
628703|NCT00205777|1543059|P6|STARTED|Study Extension II||1142
628704|NCT00205777|1543060|P5|STARTED|Study Extension II||0
628705|NCT00205777|1543061|P4|STARTED|Study Extension II||590
628706|NCT00205777|1543062|P3|STARTED|Study Extension II||0
628707|NCT00205777|1543063|P2|STARTED|Study Extension II||0
628708|NCT00205777|1543064|P1|STARTED|Study Extension II||0
628709|NCT00205777|1543059|P6|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
628710|NCT00205777|1543060|P5|NOT COMPLETED|Completed SE I, Entered Extension SE II||258
628711|NCT00205777|1543061|P4|NOT COMPLETED|Completed SE I, Entered Extension SE II||240
628712|NCT00205777|1543062|P3|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
628713|NCT00205777|1543063|P2|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
628714|NCT00205777|1543064|P1|NOT COMPLETED|Completed SE I, Entered Extension SE II||273
628715|NCT00205777|1543059|P6|COMPLETED|Completed SE I, Entered Extension SE II||0
628716|NCT00205777|1543060|P5|COMPLETED|Completed SE I, Entered Extension SE II||582
628717|NCT00205777|1543061|P4|COMPLETED|Completed SE I, Entered Extension SE II||590
628718|NCT00205777|1543062|P3|COMPLETED|Completed SE I, Entered Extension SE II||0
628719|NCT00205777|1543063|P2|COMPLETED|Completed SE I, Entered Extension SE II||0
628720|NCT00205777|1543064|P1|COMPLETED|Completed SE I, Entered Extension SE II||560
628721|NCT00205777|1543059|P6|STARTED|Completed SE I, Entered Extension SE II||0
628722|NCT00205777|1543060|P5|STARTED|Completed SE I, Entered Extension SE II||840
628723|NCT00205777|1543061|P4|STARTED|Completed SE I, Entered Extension SE II||830
628724|NCT00205777|1543062|P3|STARTED|Completed SE I, Entered Extension SE II||0
628725|NCT00205777|1543063|P2|STARTED|Completed SE I, Entered Extension SE II||0
628726|NCT00205777|1543064|P1|STARTED|Completed SE I, Entered Extension SE II||833
628727|NCT00205777|1543059|P6|NOT COMPLETED|Study Extension I||0
628728|NCT00205777|1543060|P5|NOT COMPLETED|Study Extension I||201
628729|NCT00205777|1543061|P4|NOT COMPLETED|Study Extension I||228
628730|NCT00205777|1543062|P3|NOT COMPLETED|Study Extension I||1070
628731|NCT00205777|1543063|P2|NOT COMPLETED|Study Extension I||0
628732|NCT00205777|1543064|P1|NOT COMPLETED|Study Extension I||214
628733|NCT00205777|1543059|P6|COMPLETED|Study Extension I||0
628734|NCT00205777|1543060|P5|COMPLETED|Study Extension I||840
628735|NCT00205777|1543061|P4|COMPLETED|Study Extension I||830
628736|NCT00205777|1543062|P3|COMPLETED|Study Extension I||0
628737|NCT00205777|1543063|P2|COMPLETED|Study Extension I||0
628738|NCT00205777|1543064|P1|COMPLETED|Study Extension I||833
628739|NCT00205777|1543059|P6|STARTED|Study Extension I||0
628740|NCT00205777|1543060|P5|STARTED|Study Extension I||1041
628741|NCT00205777|1543061|P4|STARTED|Study Extension I||1058
628742|NCT00205777|1543062|P3|STARTED|Study Extension I||1070
628743|NCT00205777|1543063|P2|STARTED|Study Extension I||0
628744|NCT00205777|1543064|P1|STARTED|Study Extension I||1047
628745|NCT00205777|1543059|P6|NOT COMPLETED|Completed Core Study, Entered SE I||0
628746|NCT00205777|1543060|P5|NOT COMPLETED|Completed Core Study, Entered SE I||0
628747|NCT00205777|1543061|P4|NOT COMPLETED|Completed Core Study, Entered SE I||224
628748|NCT00205777|1543062|P3|NOT COMPLETED|Completed Core Study, Entered SE I||207
628749|NCT00205777|1543063|P2|NOT COMPLETED|Completed Core Study, Entered SE I||204
628750|NCT00205777|1543064|P1|NOT COMPLETED|Completed Core Study, Entered SE I||232
628751|NCT00205777|1543059|P6|COMPLETED|Completed Core Study, Entered SE I||0
628752|NCT00205777|1543060|P5|COMPLETED|Completed Core Study, Entered SE I||0
628753|NCT00205777|1543061|P4|COMPLETED|Completed Core Study, Entered SE I||1058
628754|NCT00205777|1543062|P3|COMPLETED|Completed Core Study, Entered SE I||1070
628755|NCT00205777|1543063|P2|COMPLETED|Completed Core Study, Entered SE I||1041
628756|NCT00205777|1543064|P1|COMPLETED|Completed Core Study, Entered SE I||1047
628757|NCT00205777|1543059|P6|STARTED|Completed Core Study, Entered SE I||0
628758|NCT00205777|1543060|P5|STARTED|Completed Core Study, Entered SE I||0
628759|NCT00205777|1543061|P4|STARTED|Completed Core Study, Entered SE I||1282
628760|NCT00205777|1543062|P3|STARTED|Completed Core Study, Entered SE I||1277
628761|NCT00205777|1543063|P2|STARTED|Completed Core Study, Entered SE I||1245
628762|NCT00205777|1543064|P1|STARTED|Completed Core Study, Entered SE I||1279
628763|NCT00205777|1543059|P6|NOT COMPLETED|Core Study (Up to 3 Years)||0
628764|NCT00205777|1543060|P5|NOT COMPLETED|Core Study (Up to 3 Years)||0
628765|NCT00205777|1543061|P4|NOT COMPLETED|Core Study (Up to 3 Years)||632
628766|NCT00205777|1543062|P3|NOT COMPLETED|Core Study (Up to 3 Years)||607
628767|NCT00205777|1543063|P2|NOT COMPLETED|Core Study (Up to 3 Years)||659
628768|NCT00205777|1543064|P1|NOT COMPLETED|Core Study (Up to 3 Years)||628
628769|NCT00205777|1543059|P6|COMPLETED|Core Study (Up to 3 Years)||0
628770|NCT00205777|1543060|P5|COMPLETED|Core Study (Up to 3 Years)||0
628771|NCT00205777|1543061|P4|COMPLETED|Core Study (Up to 3 Years)||1282
628772|NCT00205777|1543062|P3|COMPLETED|Core Study (Up to 3 Years)||1277
628773|NCT00205777|1543063|P2|COMPLETED|Core Study (Up to 3 Years)||1245
628774|NCT00205777|1543064|P1|COMPLETED|Core Study (Up to 3 Years)||1279
628775|NCT00205777|1543059|P6|TREATED|Core Study (Up to 3 Years)||0
628776|NCT00205777|1543060|P5|TREATED|Core Study (Up to 3 Years)||0
628777|NCT00205777|1543061|P4|TREATED|Core Study (Up to 3 Years)||1885
628778|NCT00205777|1543062|P3|TREATED|Core Study (Up to 3 Years)||1849
628779|NCT00205777|1543063|P2|TREATED|Core Study (Up to 3 Years)||1872
628780|NCT00205777|1543064|P1|TREATED|Core Study (Up to 3 Years)||1886
628781|NCT00205777|1543059|P6|STARTED|Core Study (Up to 3 Years)||0
628782|NCT00205777|1543060|P5|STARTED|Core Study (Up to 3 Years)||0
628783|NCT00205777|1543061|P4|STARTED|Core Study (Up to 3 Years)||1914
628784|NCT00205777|1543062|P3|STARTED|Core Study (Up to 3 Years)||1884
628785|NCT00205777|1543063|P2|STARTED|Core Study (Up to 3 Years)||1904
628786|NCT00205777|1543064|P1|STARTED|Core Study (Up to 3 Years)||1907
628787|NCT00205712|1543273|P2|NOT COMPLETED|Overall Study||1
628788|NCT00205712|1543274|P1|NOT COMPLETED|Overall Study||0
628789|NCT00205712|1543273|P2|COMPLETED|Overall Study||19
628790|NCT00205712|1543274|P1|COMPLETED|Overall Study||20
628791|NCT00205712|1543273|P2|STARTED|Overall Study||20
628792|NCT00205712|1543274|P1|STARTED|Overall Study||20
628793|NCT00205699|1543287|P3|NOT COMPLETED|Overall Study||6
628794|NCT00205699|1543288|P2|NOT COMPLETED|Overall Study||6
628795|NCT00205699|1543289|P1|NOT COMPLETED|Overall Study||3
628796|NCT00205699|1543287|P3|COMPLETED|Overall Study||43
628797|NCT00205699|1543288|P2|COMPLETED|Overall Study||40
628798|NCT00205699|1543289|P1|COMPLETED|Overall Study||46
628799|NCT00205699|1543287|P3|STARTED|Overall Study||49
628800|NCT00205699|1543288|P2|STARTED|Overall Study||46
628801|NCT00205699|1543289|P1|STARTED|Overall Study||49
628802|NCT00205504|1543314|P2|NOT COMPLETED|Overall Study||0
628803|NCT00205504|1543315|P1|NOT COMPLETED|Overall Study||7
628804|NCT00205504|1543314|P2|COMPLETED|Overall Study||15
628805|NCT00205504|1543315|P1|COMPLETED|Overall Study||14
628806|NCT00205504|1543314|P2|STARTED|Overall Study||15
628807|NCT00205504|1543315|P1|STARTED|Overall Study||21
628808|NCT00205374|1543341|P2|NOT COMPLETED|Overall Study||0
628809|NCT00205374|1543342|P1|NOT COMPLETED|Overall Study||0
628810|NCT00205374|1543341|P2|COMPLETED|Overall Study||9
628811|NCT00205374|1543342|P1|COMPLETED|Overall Study||10
628812|NCT00205374|1543341|P2|STARTED|Overall Study||9
628813|NCT00205374|1543342|P1|STARTED|Overall Study||10
628814|NCT00205348|1543350|P1|NOT COMPLETED|Overall Study||30
628815|NCT00205348|1543350|P1|COMPLETED|Overall Study||116
628816|NCT00205348|1543350|P1|STARTED|Overall Study||146
628817|NCT00205049|1543356|P2|NOT COMPLETED|Overall Study||0
628818|NCT00205049|1543357|P1|NOT COMPLETED|Overall Study||0
628819|NCT00205049|1543356|P2|COMPLETED|Overall Study||0
628820|NCT00205049|1543357|P1|COMPLETED|Overall Study||0
628821|NCT00205049|1543356|P2|STARTED|Overall Study||0
628822|NCT00205049|1543357|P1|STARTED|Overall Study||0
628823|NCT00204932|1543365|P2|NOT COMPLETED|Overall Study||6
628824|NCT00204932|1543366|P1|NOT COMPLETED|Overall Study||2
628825|NCT00204932|1543365|P2|COMPLETED|Overall Study||18
628826|NCT00204932|1543366|P1|COMPLETED|Overall Study||22
628827|NCT00204932|1543365|P2|STARTED|Overall Study||24
628828|NCT00204932|1543366|P1|STARTED|Overall Study||24
628829|NCT00204373|1543372|P1|NOT COMPLETED|Overall Study||0
628830|NCT00204373|1543372|P1|COMPLETED|Overall Study||72
628831|NCT00204373|1543372|P1|STARTED|Overall Study||72
628832|NCT00203996|1543383|P10|NOT COMPLETED|Overall Study||1
628833|NCT00203996|1543384|P9|NOT COMPLETED|Overall Study||0
628834|NCT00203996|1543385|P8|NOT COMPLETED|Overall Study||2
628835|NCT00203996|1543386|P7|NOT COMPLETED|Overall Study||0
628836|NCT00203996|1543387|P6|NOT COMPLETED|Overall Study||0
628837|NCT00203996|1543388|P5|NOT COMPLETED|Overall Study||1
628838|NCT00203996|1543389|P4|NOT COMPLETED|Overall Study||10
628839|NCT00203996|1543390|P3|NOT COMPLETED|Overall Study||0
628840|NCT00203996|1543391|P2|NOT COMPLETED|Overall Study||0
628841|NCT00203996|1543392|P1|NOT COMPLETED|Overall Study||0
628842|NCT00203996|1543383|P10|COMPLETED|Overall Study||2
628843|NCT00203996|1543384|P9|COMPLETED|Overall Study||2
628844|NCT00203996|1543385|P8|COMPLETED|Overall Study||2
628845|NCT00203996|1543386|P7|COMPLETED|Overall Study||2
628846|NCT00203996|1543387|P6|COMPLETED|Overall Study||3
628847|NCT00203996|1543388|P5|COMPLETED|Overall Study||3
628848|NCT00203996|1543389|P4|COMPLETED|Overall Study||9
628849|NCT00203996|1543390|P3|COMPLETED|Overall Study||0
628850|NCT00203996|1543391|P2|COMPLETED|Overall Study||0
628851|NCT00203996|1543392|P1|COMPLETED|Overall Study||0
628852|NCT00203996|1543383|P10|Aim 3 Only: Third Intervention|Overall Study||2
628853|NCT00203996|1543384|P9|Aim 3 Only: Third Intervention|Overall Study||2
628854|NCT00203996|1543385|P8|Aim 3 Only: Third Intervention|Overall Study||2
628855|NCT00203996|1543386|P7|Aim 3 Only: Third Intervention|Overall Study||2
628856|NCT00203996|1543387|P6|Aim 3 Only: Third Intervention|Overall Study||3
628857|NCT00203996|1543388|P5|Aim 3 Only: Third Intervention|Overall Study||0
628858|NCT00203996|1543389|P4|Aim 3 Only: Third Intervention|Overall Study||0
628859|NCT00203996|1543390|P3|Aim 3 Only: Third Intervention|Overall Study||0
628860|NCT00203996|1543391|P2|Aim 3 Only: Third Intervention|Overall Study||0
628861|NCT00203996|1543392|P1|Aim 3 Only: Third Intervention|Overall Study||0
628862|NCT00203996|1543383|P10|Aim 3 Only: Second Washout|Overall Study||2
628863|NCT00203996|1543384|P9|Aim 3 Only: Second Washout|Overall Study||2
628864|NCT00203996|1543385|P8|Aim 3 Only: Second Washout|Overall Study||2
628865|NCT00203996|1543386|P7|Aim 3 Only: Second Washout|Overall Study||2
628866|NCT00203996|1543387|P6|Aim 3 Only: Second Washout|Overall Study||3
628867|NCT00203996|1543388|P5|Aim 3 Only: Second Washout|Overall Study||0
628868|NCT00203996|1543389|P4|Aim 3 Only: Second Washout|Overall Study||0
628869|NCT00203996|1543390|P3|Aim 3 Only: Second Washout|Overall Study||0
628870|NCT00203996|1543391|P2|Aim 3 Only: Second Washout|Overall Study||0
628871|NCT00203996|1543392|P1|Aim 3 Only: Second Washout|Overall Study||0
628872|NCT00203996|1543383|P10|Aim 3 Only: Second Intervention|Overall Study||2
628873|NCT00203996|1543384|P9|Aim 3 Only: Second Intervention|Overall Study||2
628874|NCT00203996|1543385|P8|Aim 3 Only: Second Intervention|Overall Study||2
628875|NCT00203996|1543386|P7|Aim 3 Only: Second Intervention|Overall Study||2
628876|NCT00203996|1543387|P6|Aim 3 Only: Second Intervention|Overall Study||3
628877|NCT00203996|1543388|P5|Aim 3 Only: Second Intervention|Overall Study||0
628878|NCT00203996|1543389|P4|Aim 3 Only: Second Intervention|Overall Study||0
628879|NCT00203996|1543390|P3|Aim 3 Only: Second Intervention|Overall Study||0
628880|NCT00203996|1543391|P2|Aim 3 Only: Second Intervention|Overall Study||0
628881|NCT00203996|1543392|P1|Aim 3 Only: Second Intervention|Overall Study||0
628882|NCT00203996|1543383|P10|Aim 3 Only: Washout|Overall Study||2
628883|NCT00203996|1543384|P9|Aim 3 Only: Washout|Overall Study||2
628884|NCT00203996|1543385|P8|Aim 3 Only: Washout|Overall Study||2
628885|NCT00203996|1543386|P7|Aim 3 Only: Washout|Overall Study||2
628886|NCT00203996|1543387|P6|Aim 3 Only: Washout|Overall Study||3
628887|NCT00203996|1543388|P5|Aim 3 Only: Washout|Overall Study||0
628888|NCT00203996|1543389|P4|Aim 3 Only: Washout|Overall Study||0
628889|NCT00203996|1543390|P3|Aim 3 Only: Washout|Overall Study||0
628890|NCT00203996|1543391|P2|Aim 3 Only: Washout|Overall Study||0
628891|NCT00203996|1543392|P1|Aim 3 Only: Washout|Overall Study||0
628892|NCT00203996|1543383|P10|Aim 3 Only: First Intervention|Overall Study||3
628893|NCT00203996|1543384|P9|Aim 3 Only: First Intervention|Overall Study||2
628894|NCT00203996|1543385|P8|Aim 3 Only: First Intervention|Overall Study||4
628895|NCT00203996|1543386|P7|Aim 3 Only: First Intervention|Overall Study||2
628896|NCT00203996|1543387|P6|Aim 3 Only: First Intervention|Overall Study||3
628897|NCT00203996|1543388|P5|Aim 3 Only: First Intervention|Overall Study||0
628898|NCT00203996|1543389|P4|Aim 3 Only: First Intervention|Overall Study||0
628899|NCT00203996|1543390|P3|Aim 3 Only: First Intervention|Overall Study||0
628900|NCT00203996|1543391|P2|Aim 3 Only: First Intervention|Overall Study||0
628901|NCT00203996|1543392|P1|Aim 3 Only: First Intervention|Overall Study||0
628902|NCT00203996|1543383|P10|STARTED|Overall Study||3
628903|NCT00203996|1543384|P9|STARTED|Overall Study||2
628904|NCT00203996|1543385|P8|STARTED|Overall Study||4
628905|NCT00203996|1543386|P7|STARTED|Overall Study||2
628906|NCT00203996|1543387|P6|STARTED|Overall Study||3
628907|NCT00203996|1543388|P5|STARTED|Overall Study||4
628908|NCT00203996|1543389|P4|STARTED|Overall Study||19
628909|NCT00203996|1543390|P3|STARTED|Overall Study||0
628910|NCT00203996|1543391|P2|STARTED|Overall Study||0
628911|NCT00203996|1543392|P1|STARTED|Overall Study||0
628912|NCT00203931|1543441|P2|NOT COMPLETED|Overall Study||5
628913|NCT00203931|1543442|P1|NOT COMPLETED|Overall Study||7
628914|NCT00203931|1543441|P2|COMPLETED|Overall Study|These are the evaluable patients who received at least 3 doses of cetuximab.|23
628915|NCT00203931|1543442|P1|COMPLETED|Overall Study|These are the evaluable patients who received at least 3 doses of cetuximab.|20
628916|NCT00203931|1543441|P2|STARTED|Overall Study||28
628917|NCT00203931|1543442|P1|STARTED|Overall Study||27
628918|NCT00203892|1543459|P3|NOT COMPLETED|Overall Study||0
628919|NCT00203892|1543460|P2|NOT COMPLETED|Overall Study||2
628920|NCT00203892|1543461|P1|NOT COMPLETED|Overall Study||2
628921|NCT00203892|1543459|P3|COMPLETED|Overall Study||6
628922|NCT00203892|1543460|P2|COMPLETED|Overall Study|2 patients not completing study were randomized but never treated|8
628923|NCT00203892|1543461|P1|COMPLETED|Overall Study|2 patients not completing study were randomized but never treated|5
628924|NCT00203892|1543459|P3|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|4
628925|NCT00203892|1543460|P2|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|5
628926|NCT00203892|1543461|P1|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|5
628927|NCT00203892|1543459|P3|STARTED|Overall Study||6
628928|NCT00203892|1543460|P2|STARTED|Overall Study||10
628929|NCT00203892|1543461|P1|STARTED|Overall Study||7
628930|NCT00203502|1543472|P1|NOT COMPLETED|Overall Study||1
628931|NCT00203502|1543472|P1|COMPLETED|Overall Study||39
628932|NCT00203502|1543472|P1|STARTED|Overall Study||40
628933|NCT00203476|1543483|P3|NOT COMPLETED|Overall Study||0
628934|NCT00203476|1543484|P2|NOT COMPLETED|Overall Study||1
628935|NCT00203476|1543485|P1|NOT COMPLETED|Overall Study||1
628936|NCT00203476|1543483|P3|COMPLETED|Overall Study||10
628937|NCT00203476|1543484|P2|COMPLETED|Overall Study||9
628938|NCT00203476|1543485|P1|COMPLETED|Overall Study||9
628939|NCT00203476|1543483|P3|STARTED|Overall Study||10
628940|NCT00203476|1543484|P2|STARTED|Overall Study||10
628941|NCT00203476|1543485|P1|STARTED|Overall Study||10
628942|NCT00203424|1543502|P1|NOT COMPLETED|Follow-up Period||6
628943|NCT00203424|1543502|P1|COMPLETED|Follow-up Period||10
628944|NCT00203424|1543502|P1|STARTED|Follow-up Period|followup includes 11 pts that completed treatment + 5 pts who stopped treatment due to adverse event|16
628945|NCT00203424|1543502|P1|NOT COMPLETED|Treatment Period||11
628946|NCT00203424|1543502|P1|COMPLETED|Treatment Period|Of 11 pts that did not complete treatment,5 stopped due to adverse event and entered followup period|11
628947|NCT00203424|1543502|P1|STARTED|Treatment Period|23 subjects registered for treatment, 1 withdrew consent after registration,22 received treatment.|22
628948|NCT00203411|1543509|P1|NOT COMPLETED|Follow-up||4
628949|NCT00203411|1543509|P1|COMPLETED|Follow-up||41
628950|NCT00203411|1543509|P1|STARTED|Follow-up||45
628951|NCT00203411|1543509|P1|NOT COMPLETED|Treatment Period||0
628952|NCT00203411|1543509|P1|COMPLETED|Treatment Period||45
628953|NCT00203411|1543509|P1|STARTED|Treatment Period||45
628954|NCT00203307|1543518|P2|NOT COMPLETED|Second Intervention||0
628955|NCT00203307|1543519|P1|NOT COMPLETED|Second Intervention||0
628956|NCT00203307|1543518|P2|COMPLETED|Second Intervention||0
628957|NCT00203307|1543519|P1|COMPLETED|Second Intervention||1
628958|NCT00203307|1543518|P2|STARTED|Second Intervention||0
628959|NCT00203307|1543519|P1|STARTED|Second Intervention|2 subjects dropped out of the 1st intervention period, due to fatugue.|1
628960|NCT00203307|1543518|P2|NOT COMPLETED|First Intervention||0
628961|NCT00203307|1543519|P1|NOT COMPLETED|First Intervention||2
628962|NCT00203307|1543518|P2|COMPLETED|First Intervention||0
628963|NCT00203307|1543519|P1|COMPLETED|First Intervention||1
628964|NCT00203307|1543518|P2|STARTED|First Intervention||0
628965|NCT00203307|1543519|P1|STARTED|First Intervention|Double-blind cross-over design. Study terminated early. Results not analyzed.|3
628966|NCT00203294|1543527|P2|NOT COMPLETED|Overall Study||13
628967|NCT00203294|1543528|P1|NOT COMPLETED|Overall Study||8
628968|NCT00203294|1543527|P2|COMPLETED|Overall Study||10
628969|NCT00203294|1543528|P1|COMPLETED|Overall Study||14
628970|NCT00203294|1543527|P2|STARTED|Overall Study||23
628971|NCT00203294|1543528|P1|STARTED|Overall Study||22
628972|NCT00203268|1543534|P1|NOT COMPLETED|Late Treatment||0
628973|NCT00203268|1543534|P1|COMPLETED|Late Treatment||9
628974|NCT00203268|1543534|P1|STARTED|Late Treatment||9
628975|NCT00203268|1543534|P1|NOT COMPLETED|Early Treatment||4
628976|NCT00203268|1543534|P1|COMPLETED|Early Treatment||9
628977|NCT00203268|1543534|P1|STARTED|Early Treatment||13
628978|NCT00203242|1543540|P1|NOT COMPLETED|Overall Study||1
628979|NCT00203242|1543540|P1|COMPLETED|Overall Study||14
628980|NCT00203242|1543540|P1|STARTED|Overall Study||15
628981|NCT00203229|1543546|P2|NOT COMPLETED|Overall Study||3
628982|NCT00203229|1543547|P1|NOT COMPLETED|Overall Study||3
628983|NCT00203229|1543546|P2|COMPLETED|Overall Study||7
628984|NCT00203229|1543547|P1|COMPLETED|Overall Study||7
628985|NCT00203229|1543546|P2|STARTED|Overall Study||10
628986|NCT00203229|1543547|P1|STARTED|Overall Study||10
628987|NCT00203216|1543553|P1|NOT COMPLETED|Overall Study||4
628988|NCT00203216|1543553|P1|COMPLETED|Overall Study||27
628989|NCT00203216|1543553|P1|STARTED|Overall Study||31
628990|NCT00203203|1543559|P2|NOT COMPLETED|Overall Study||0
628991|NCT00203203|1543560|P1|NOT COMPLETED|Overall Study||1
628992|NCT00203203|1543559|P2|COMPLETED|Overall Study||20
628993|NCT00203203|1543560|P1|COMPLETED|Overall Study||9
628994|NCT00203203|1543559|P2|STARTED|Overall Study||20
628995|NCT00203203|1543560|P1|STARTED|Overall Study||10
628996|NCT00203047|1543592|P2|NOT COMPLETED|Overall Study||203
628997|NCT00203047|1543593|P1|NOT COMPLETED|Overall Study||191
628998|NCT00203047|1543592|P2|COMPLETED|Overall Study||7
628999|NCT00203047|1543593|P1|COMPLETED|Overall Study||13
629000|NCT00203047|1543592|P2|In Database as of January 29, 2009|Overall Study||209
629001|NCT00203047|1543593|P1|In Database as of January 29, 2009|Overall Study||199
629002|NCT00203047|1543592|P2|STARTED|Overall Study||210
629003|NCT00203047|1543593|P1|STARTED|Overall Study||204
629004|NCT00202878|1543607|P2|NOT COMPLETED|Overall Study||2217
629005|NCT00202878|1543608|P1|NOT COMPLETED|Overall Study||2199
629006|NCT00202878|1543607|P2|COMPLETED|Overall Study||6860
629007|NCT00202878|1543608|P1|COMPLETED|Overall Study||6868
629008|NCT00202878|1543607|P2|STARTED|Overall Study||9077
629009|NCT00202878|1543608|P1|STARTED|Overall Study||9067
629010|NCT00202839|1543622|P2|NOT COMPLETED|Overall Study||10
629011|NCT00202839|1543623|P1|NOT COMPLETED|Overall Study||24
629012|NCT00202839|1543622|P2|COMPLETED|Overall Study||72
629013|NCT00202839|1543623|P1|COMPLETED|Overall Study||54
629014|NCT00202839|1543622|P2|STARTED|Overall Study||82
629015|NCT00202839|1543623|P1|STARTED|Overall Study||78
629016|NCT00202722|1543631|P1|NOT COMPLETED|Overall Study||0
629017|NCT00202722|1543631|P1|COMPLETED|Overall Study||41
629018|NCT00202722|1543631|P1|STARTED|Overall Study||41
629019|NCT00202644|1543638|P2|NOT COMPLETED|Overall Study||27
629020|NCT00202644|1543639|P1|NOT COMPLETED|Overall Study||35
629021|NCT00202644|1543638|P2|COMPLETED|Overall Study||43
629022|NCT00202644|1543639|P1|COMPLETED|Overall Study||41
629023|NCT00202644|1543638|P2|STARTED|Overall Study||70
629024|NCT00202644|1543639|P1|STARTED|Overall Study|One participant not randomized but treated.|76
629025|NCT00202449|1543666|P3|NOT COMPLETED|Overall Study||12
629026|NCT00202449|1543667|P2|NOT COMPLETED|Overall Study||11
629027|NCT00202449|1543668|P1|NOT COMPLETED|Overall Study||11
629028|NCT00202449|1543666|P3|COMPLETED|Overall Study||9
629029|NCT00202449|1543667|P2|COMPLETED|Overall Study||9
629030|NCT00202449|1543668|P1|COMPLETED|Overall Study||7
629031|NCT00202449|1543666|P3|STARTED|Overall Study||21
629032|NCT00202449|1543667|P2|STARTED|Overall Study||20
629033|NCT00202449|1543668|P1|STARTED|Overall Study||18
629034|NCT00201877|1543682|P1|NOT COMPLETED|Overall Study||0
629035|NCT00201877|1543682|P1|COMPLETED|Overall Study||25
629036|NCT00201877|1543682|P1|STARTED|Overall Study||25
629037|NCT00201864|1543689|P1|NOT COMPLETED|Overall Study||0
629038|NCT00201864|1543689|P1|COMPLETED|Overall Study||40
629039|NCT00201864|1543689|P1|STARTED|Overall Study||40
629040|NCT00201851|1543700|P3|NOT COMPLETED|Overall Study||1
629041|NCT00201851|1543701|P2|NOT COMPLETED|Overall Study||2
629042|NCT00201851|1543702|P1|NOT COMPLETED|Overall Study||8
629043|NCT00201851|1543700|P3|COMPLETED|Overall Study||230
629044|NCT00201851|1543701|P2|COMPLETED|Overall Study||255
629045|NCT00201851|1543702|P1|COMPLETED|Overall Study||244
629046|NCT00201851|1543700|P3|STARTED|Overall Study||231
629047|NCT00201851|1543701|P2|STARTED|Overall Study||257
629048|NCT00201851|1543702|P1|STARTED|Overall Study||252
629049|NCT00201838|1543712|P2|NOT COMPLETED|Overall Study||0
629050|NCT00201838|1543713|P1|NOT COMPLETED|Overall Study||0
629051|NCT00201838|1543712|P2|COMPLETED|Overall Study||8
629052|NCT00201838|1543713|P1|COMPLETED|Overall Study||30
629053|NCT00201838|1543712|P2|Treatment Cohort|Overall Study||8
629054|NCT00201838|1543713|P1|Treatment Cohort|Overall Study||30
629055|NCT00201838|1543712|P2|STARTED|Overall Study||8
629056|NCT00201838|1543713|P1|STARTED|Overall Study||30
629057|NCT00201825|1543727|P1|NOT COMPLETED|Overall Study||0
629058|NCT00201825|1543727|P1|COMPLETED|Overall Study||29
629059|NCT00201825|1543727|P1|STARTED|Overall Study||29
629060|NCT00201773|1543734|P1|NOT COMPLETED|Overall Study||6
629061|NCT00201773|1543734|P1|COMPLETED|Overall Study||16
629062|NCT00201773|1543734|P1|Stopped Exemestane After 4 Weeks|Overall Study||1
629063|NCT00201773|1543734|P1|Received All Exemestane Therapy|Overall Study||5
629064|NCT00201773|1543734|P1|Completed 8 Weeks of Planned Therapy|Overall Study||16
629065|NCT00201773|1543734|P1|STARTED|Overall Study||22
629066|NCT00201760|1543743|P2|NOT COMPLETED|Overall Study||0
629067|NCT00201760|1543744|P1|NOT COMPLETED|Overall Study||0
629068|NCT00201760|1543743|P2|COMPLETED|Overall Study||5
629069|NCT00201760|1543744|P1|COMPLETED|Overall Study||5
629070|NCT00201760|1543743|P2|STARTED|Overall Study||5
629071|NCT00201760|1543744|P1|STARTED|Overall Study||5
629072|NCT00201734|1543756|P2|NOT COMPLETED|Overall Study||0
629073|NCT00201734|1543757|P1|NOT COMPLETED|Overall Study||3
629074|NCT00201734|1543756|P2|COMPLETED|Overall Study||25
629075|NCT00201734|1543757|P1|COMPLETED|Overall Study||29
629076|NCT00201734|1543756|P2|Patients Not Evaluable|Overall Study||0
629077|NCT00201734|1543757|P1|Patients Not Evaluable|Overall Study||3
629078|NCT00201734|1543756|P2|STARTED|Overall Study||25
629079|NCT00201734|1543757|P1|STARTED|Overall Study||32
629080|NCT00201643|1543774|P2|NOT COMPLETED|Overall Study||4
629081|NCT00201643|1543775|P1|NOT COMPLETED|Overall Study||5
629082|NCT00201643|1543774|P2|COMPLETED|Overall Study||210
629083|NCT00201643|1543775|P1|COMPLETED|Overall Study||218
629084|NCT00201643|1543774|P2|STARTED|Overall Study||214
629085|NCT00201643|1543775|P1|STARTED|Overall Study||223
629086|NCT00201448|1543799|P2|NOT COMPLETED|Overall Study||0
629087|NCT00201448|1543800|P1|NOT COMPLETED|Overall Study||0
629088|NCT00201448|1543799|P2|COMPLETED|Overall Study||40
629089|NCT00201448|1543800|P1|COMPLETED|Overall Study||42
629090|NCT00201448|1543799|P2|STARTED|Overall Study||40
629091|NCT00201448|1543800|P1|STARTED|Overall Study||42
629092|NCT00201409|1543810|P2|NOT COMPLETED|Overall Study||1
629093|NCT00201409|1543811|P1|NOT COMPLETED|Overall Study||1
629094|NCT00201409|1543810|P2|COMPLETED|Overall Study||66
629095|NCT00201409|1543811|P1|COMPLETED|Overall Study||64
629096|NCT00201409|1543810|P2|STARTED|Overall Study||67
629097|NCT00201409|1543811|P1|STARTED|Overall Study||65
629098|NCT00201240|1543821|P1|NOT COMPLETED|Overall Study||3
629099|NCT00201240|1543821|P1|COMPLETED|Overall Study||44
629100|NCT00201240|1543821|P1|STARTED|Overall Study||47
629101|NCT00201201|1543839|P2|NOT COMPLETED|Overall Study||7
629102|NCT00201201|1543840|P1|NOT COMPLETED|Overall Study||5
629103|NCT00201201|1543839|P2|COMPLETED|Overall Study||66
629104|NCT00201201|1543840|P1|COMPLETED|Overall Study||82
629105|NCT00201201|1543839|P2|STARTED|Overall Study||73
629106|NCT00201201|1543840|P1|STARTED|Overall Study||87
629107|NCT00201123|1543859|P3|NOT COMPLETED|Overall Study||9
629108|NCT00201123|1543860|P2|NOT COMPLETED|Overall Study||4
629109|NCT00201123|1543861|P1|NOT COMPLETED|Overall Study||6
629110|NCT00201123|1543859|P3|COMPLETED|Overall Study||23
629111|NCT00201123|1543860|P2|COMPLETED|Overall Study||28
629112|NCT00201123|1543861|P1|COMPLETED|Overall Study||26
629113|NCT00201123|1543859|P3|Did Not Meet Continuation Criteria|Overall Study||5
629114|NCT00201123|1543860|P2|Did Not Meet Continuation Criteria|Overall Study||0
629115|NCT00201123|1543861|P1|Did Not Meet Continuation Criteria|Overall Study||2
629116|NCT00201123|1543859|P3|STARTED|Overall Study||32
629117|NCT00201123|1543860|P2|STARTED|Overall Study||32
629118|NCT00201123|1543861|P1|STARTED|Overall Study||32
629119|NCT00201006|1543878|P3|NOT COMPLETED|Overall Study||4
629120|NCT00201006|1543879|P2|NOT COMPLETED|Overall Study||2
629121|NCT00201006|1543880|P1|NOT COMPLETED|Overall Study||8
629122|NCT00201006|1543878|P3|COMPLETED|Overall Study||75
629123|NCT00201006|1543879|P2|COMPLETED|Overall Study||70
629124|NCT00201006|1543880|P1|COMPLETED|Overall Study||75
629125|NCT00201006|1543878|P3|STARTED|Overall Study||79
629126|NCT00201006|1543879|P2|STARTED|Overall Study||72
629127|NCT00201006|1543880|P1|STARTED|Overall Study||83
629128|NCT00200967|1543890|P2|NOT COMPLETED|Run-out Period||0
629129|NCT00200967|1543891|P1|NOT COMPLETED|Run-out Period||1
629130|NCT00200967|1543890|P2|COMPLETED|Run-out Period||41
629131|NCT00200967|1543891|P1|COMPLETED|Run-out Period||34
629132|NCT00200967|1543890|P2|STARTED|Run-out Period||41
629133|NCT00200967|1543891|P1|STARTED|Run-out Period||35
629134|NCT00200967|1543890|P2|NOT COMPLETED|Second Treatment Period||2
629135|NCT00200967|1543891|P1|NOT COMPLETED|Second Treatment Period||1
629136|NCT00200967|1543890|P2|COMPLETED|Second Treatment Period||41
629137|NCT00200967|1543891|P1|COMPLETED|Second Treatment Period||35
629138|NCT00200967|1543890|P2|STARTED|Second Treatment Period||43
629139|NCT00200967|1543891|P1|STARTED|Second Treatment Period||36
629140|NCT00200967|1543890|P2|NOT COMPLETED|Wash-out Period||1
629141|NCT00200967|1543891|P1|NOT COMPLETED|Wash-out Period||0
629142|NCT00200967|1543890|P2|COMPLETED|Wash-out Period||43
629143|NCT00200967|1543891|P1|COMPLETED|Wash-out Period||36
629144|NCT00200967|1543890|P2|STARTED|Wash-out Period||44
629145|NCT00200967|1543891|P1|STARTED|Wash-out Period||36
629146|NCT00200967|1543890|P2|NOT COMPLETED|First Treatment Period||1
629147|NCT00200967|1543891|P1|NOT COMPLETED|First Treatment Period||6
629148|NCT00200967|1543890|P2|COMPLETED|First Treatment Period||44
629149|NCT00200967|1543891|P1|COMPLETED|First Treatment Period||36
629150|NCT00200967|1543890|P2|First Treatment Period|First Treatment Period||45
629151|NCT00200967|1543891|P1|First Treatment Period|First Treatment Period||42
629152|NCT00200967|1543890|P2|STARTED|First Treatment Period||45
629153|NCT00200967|1543891|P1|STARTED|First Treatment Period||42
629154|NCT00200785|1543921|P2|NOT COMPLETED|Second Intervention||0
629155|NCT00200785|1543922|P1|NOT COMPLETED|Second Intervention||0
629156|NCT00200785|1543921|P2|COMPLETED|Second Intervention||6
629157|NCT00200785|1543922|P1|COMPLETED|Second Intervention||9
629158|NCT00200785|1543921|P2|STARTED|Second Intervention||6
629159|NCT00200785|1543922|P1|STARTED|Second Intervention||9
629160|NCT00200785|1543921|P2|NOT COMPLETED|Washout Period of 1 Week||0
629161|NCT00200785|1543922|P1|NOT COMPLETED|Washout Period of 1 Week||0
629162|NCT00200785|1543921|P2|COMPLETED|Washout Period of 1 Week||6
629163|NCT00200785|1543922|P1|COMPLETED|Washout Period of 1 Week||9
629164|NCT00200785|1543921|P2|STARTED|Washout Period of 1 Week||6
629165|NCT00200785|1543922|P1|STARTED|Washout Period of 1 Week||9
629166|NCT00200785|1543921|P2|NOT COMPLETED|First Intervention||0
629167|NCT00200785|1543922|P1|NOT COMPLETED|First Intervention||0
629168|NCT00200785|1543921|P2|COMPLETED|First Intervention||6
629169|NCT00200785|1543922|P1|COMPLETED|First Intervention||9
629170|NCT00200785|1543921|P2|STARTED|First Intervention||6
629171|NCT00200785|1543922|P1|STARTED|First Intervention||9
629172|NCT00200356|1543932|P2|NOT COMPLETED|Overall Study||7
629173|NCT00200356|1543933|P1|NOT COMPLETED|Overall Study||8
629174|NCT00200356|1543932|P2|COMPLETED|Overall Study||195
629175|NCT00200356|1543933|P1|COMPLETED|Overall Study||191
629176|NCT00200356|1543932|P2|Safety Analysis Set|Overall Study||198
629177|NCT00200356|1543933|P1|Safety Analysis Set|Overall Study||194
629178|NCT00200356|1543932|P2|STARTED|Overall Study||202
629179|NCT00200356|1543933|P1|STARTED|Overall Study||199
629180|NCT00200343|1543960|P3|NOT COMPLETED|Overall Study||13
629181|NCT00200343|1543961|P2|NOT COMPLETED|Overall Study||8
629182|NCT00200343|1543962|P1|NOT COMPLETED|Overall Study||16
629183|NCT00200343|1543960|P3|COMPLETED|Overall Study||184
629184|NCT00200343|1543961|P2|COMPLETED|Overall Study||192
629185|NCT00200343|1543962|P1|COMPLETED|Overall Study||183
629186|NCT00200343|1543960|P3|STARTED|Overall Study||197
629187|NCT00200343|1543961|P2|STARTED|Overall Study||200
629188|NCT00200343|1543962|P1|STARTED|Overall Study||199
629189|NCT00200161|1543987|P2|NOT COMPLETED|Overall Study||0
629190|NCT00200161|1543988|P1|NOT COMPLETED|Overall Study||0
629191|NCT00200161|1543987|P2|COMPLETED|Overall Study||42
629192|NCT00200161|1543988|P1|COMPLETED|Overall Study||43
629193|NCT00200161|1543987|P2|STARTED|Overall Study||42
629194|NCT00200161|1543988|P1|STARTED|Overall Study||43
629195|NCT00200057|1544000|P1|NOT COMPLETED|Overall Study||9
629196|NCT00200057|1544000|P1|COMPLETED|Overall Study||111
629197|NCT00200057|1544000|P1|12 Month Follow-up|Overall Study||111
629198|NCT00200057|1544000|P1|6 Month Follow-up|Overall Study||114
629199|NCT00200057|1544000|P1|3 Month Follow-up|Overall Study||116
629200|NCT00200057|1544000|P1|1 Month Follow-up|Overall Study||117
629201|NCT00200057|1544000|P1|STARTED|Overall Study||120
629202|NCT00199914|1544012|P2|NOT COMPLETED|Overall Study||6
629203|NCT00199914|1544013|P1|NOT COMPLETED|Overall Study||3
629204|NCT00199914|1544012|P2|COMPLETED|Overall Study||54
629205|NCT00199914|1544013|P1|COMPLETED|Overall Study||50
629206|NCT00199914|1544012|P2|STARTED|Overall Study||60
629207|NCT00199914|1544013|P1|STARTED|Overall Study||53
629208|NCT00199381|1544019|P1|NOT COMPLETED|Overall Study||504
629209|NCT00199381|1544019|P1|COMPLETED|Overall Study|Premature study termination by the Sponsor.|0
629210|NCT00199381|1544019|P1|STARTED|Overall Study||504
629211|NCT00198822|1544026|P3|NOT COMPLETED|Overall Study||21
629212|NCT00198822|1544027|P2|NOT COMPLETED|Overall Study||20
629213|NCT00198822|1544028|P1|NOT COMPLETED|Overall Study||14
629298|NCT00197119|1544224|P1|NOT COMPLETED|Year 7||0
629214|NCT00198822|1544026|P3|COMPLETED|Overall Study|No. of consented pregnant women in beta-catorene arm with vital status known at 12 weeks postpartum|19998
629215|NCT00198822|1544027|P2|COMPLETED|Overall Study|No. of consented pregnant women in vitamin A arm with vital status known at 12 weeks postpartum|19806
629216|NCT00198822|1544028|P1|COMPLETED|Overall Study|No. of consented pregnant women in placebo arm with vital status known at 12 weeks postpartum|19862
629217|NCT00198822|1544026|P3|STARTED|Overall Study|No. of consenting pregnant women in the beta-catorene arm of trial cohort|20019
629218|NCT00198822|1544027|P2|STARTED|Overall Study|No. of consenting pregnant women in the vitamin A arm of trial cohort|19826
629219|NCT00198822|1544028|P1|STARTED|Overall Study|No. of consenting pregnant women in the placebo arm of trial cohort|19876
629220|NCT00198133|1544047|P2|NOT COMPLETED|Overall Study||8
629221|NCT00198133|1544048|P1|NOT COMPLETED|Overall Study||5
629222|NCT00198133|1544047|P2|COMPLETED|Overall Study||3
629223|NCT00198133|1544048|P1|COMPLETED|Overall Study||11
629224|NCT00198133|1544047|P2|STARTED|Overall Study||11
629225|NCT00198133|1544048|P1|STARTED|Overall Study||16
629226|NCT00198081|1544060|P2|NOT COMPLETED|Overall Study||0
629227|NCT00198081|1544061|P1|NOT COMPLETED|Overall Study||1
629228|NCT00198081|1544060|P2|COMPLETED|Overall Study|No enrollment on this arm.|0
629229|NCT00198081|1544061|P1|COMPLETED|Overall Study||4
629230|NCT00198081|1544060|P2|STARTED|Overall Study|No enrollment on this arm.|0
629231|NCT00198081|1544061|P1|STARTED|Overall Study|Eight (8) persons consented to participate but 3 withdrew prior to beginning protocol treatment.|5
629232|NCT00198042|1544087|P1|NOT COMPLETED|Overall Study||0
629233|NCT00198042|1544087|P1|COMPLETED|Overall Study||18
629234|NCT00198042|1544087|P1|STARTED|Overall Study||18
629235|NCT00198029|1544091|P1|NOT COMPLETED|Overall Study||4
629236|NCT00198029|1544091|P1|COMPLETED|Overall Study||28
629237|NCT00198029|1544091|P1|STARTED|Overall Study||32
629238|NCT00197496|1544098|P2|NOT COMPLETED|Follow-up||1
629239|NCT00197496|1544099|P1|NOT COMPLETED|Follow-up||2
629240|NCT00197496|1544098|P2|COMPLETED|Follow-up||4
629241|NCT00197496|1544099|P1|COMPLETED|Follow-up||10
629242|NCT00197496|1544098|P2|STARTED|Follow-up||5
629243|NCT00197496|1544099|P1|STARTED|Follow-up||12
629244|NCT00197496|1544098|P2|NOT COMPLETED|Baseline to Discharge||2
629245|NCT00197496|1544099|P1|NOT COMPLETED|Baseline to Discharge||2
629246|NCT00197496|1544098|P2|COMPLETED|Baseline to Discharge||5
629247|NCT00197496|1544099|P1|COMPLETED|Baseline to Discharge||12
629248|NCT00197496|1544098|P2|STARTED|Baseline to Discharge||7
629249|NCT00197496|1544099|P1|STARTED|Baseline to Discharge||14
629250|NCT00197392|1544114|P2|NOT COMPLETED|Overall Study||86
629251|NCT00197392|1544115|P1|NOT COMPLETED|Overall Study||88
629252|NCT00197392|1544114|P2|COMPLETED|Overall Study||134
629253|NCT00197392|1544115|P1|COMPLETED|Overall Study||126
629254|NCT00197392|1544114|P2|Per Protocol|Overall Study||134
629255|NCT00197392|1544115|P1|Per Protocol|Overall Study||126
629256|NCT00197392|1544114|P2|Evaluable|Overall Study||181
629257|NCT00197392|1544115|P1|Evaluable|Overall Study||176
629258|NCT00197392|1544114|P2|Modified Intent to Treat|Overall Study||210
629259|NCT00197392|1544115|P1|Modified Intent to Treat|Overall Study||209
629260|NCT00197392|1544114|P2|Safety Population|Overall Study||220
629261|NCT00197392|1544115|P1|Safety Population|Overall Study||214
629262|NCT00197392|1544114|P2|STARTED|Overall Study||220
629263|NCT00197392|1544115|P1|STARTED|Overall Study||214
629264|NCT00197236|1544147|P3|NOT COMPLETED|Overall Study||23
629265|NCT00197236|1544148|P2|NOT COMPLETED|Overall Study||17
629266|NCT00197236|1544149|P1|NOT COMPLETED|Overall Study||14
629267|NCT00197236|1544147|P3|COMPLETED|Overall Study||109
629268|NCT00197236|1544148|P2|COMPLETED|Overall Study||110
629269|NCT00197236|1544149|P1|COMPLETED|Overall Study||121
629270|NCT00197236|1544147|P3|STARTED|Overall Study||132
629271|NCT00197236|1544148|P2|STARTED|Overall Study||127
629272|NCT00197236|1544149|P1|STARTED|Overall Study||135
629273|NCT00197184|1544198|P2|NOT COMPLETED|Overall Study||0
629274|NCT00197184|1544199|P1|NOT COMPLETED|Overall Study||0
629275|NCT00197184|1544198|P2|COMPLETED|Overall Study||137
629276|NCT00197184|1544199|P1|COMPLETED|Overall Study||139
629277|NCT00197184|1544198|P2|STARTED|Overall Study||137
629278|NCT00197184|1544199|P1|STARTED|Overall Study||139
629279|NCT00197119|1544223|P2|NOT COMPLETED|Year 10||0
629280|NCT00197119|1544224|P1|NOT COMPLETED|Year 10||0
629281|NCT00197119|1544223|P2|COMPLETED|Year 10||108
629282|NCT00197119|1544224|P1|COMPLETED|Year 10||120
629283|NCT00197119|1544223|P2|STARTED|Year 10|Six subjects participating in the Year 9 time point did not return for the current time point.|108
629284|NCT00197119|1544224|P1|STARTED|Year 10|One subject participating in the Year 9 time point did not return for the current time point.|120
629285|NCT00197119|1544223|P2|NOT COMPLETED|Year 9||0
629286|NCT00197119|1544224|P1|NOT COMPLETED|Year 9||0
629287|NCT00197119|1544223|P2|COMPLETED|Year 9||114
629288|NCT00197119|1544224|P1|COMPLETED|Year 9||121
629289|NCT00197119|1544223|P2|STARTED|Year 9|One subject participating in the Year 8 time point did not return for the current time point.|114
629290|NCT00197119|1544224|P1|STARTED|Year 9|One subject participating in the Year 8 time point did not return for the current time point.|121
629291|NCT00197119|1544223|P2|NOT COMPLETED|Year 8||0
629292|NCT00197119|1544224|P1|NOT COMPLETED|Year 8||0
629293|NCT00197119|1544223|P2|COMPLETED|Year 8||115
629294|NCT00197119|1544224|P1|COMPLETED|Year 8||122
629295|NCT00197119|1544223|P2|STARTED|Year 8|One additional subject (compared to Year 7) participated in the current follow-up time point.|115
629296|NCT00197119|1544224|P1|STARTED|Year 8||122
629297|NCT00197119|1544223|P2|NOT COMPLETED|Year 7||0
629299|NCT00197119|1544223|P2|COMPLETED|Year 7||114
629300|NCT00197119|1544224|P1|COMPLETED|Year 7||122
629301|NCT00197119|1544223|P2|STARTED|Year 7|4 subjects who participated in the Year 6 follow-up time point did not return for this time point.|114
629302|NCT00197119|1544224|P1|STARTED|Year 7|4 subjects who participated in the Year 6 follow-up time point did not return for this time point.|122
629303|NCT00197119|1544223|P2|NOT COMPLETED|Year 6||0
629304|NCT00197119|1544224|P1|NOT COMPLETED|Year 6||0
629305|NCT00197119|1544223|P2|COMPLETED|Year 6||118
629306|NCT00197119|1544224|P1|COMPLETED|Year 6||126
629307|NCT00197119|1544223|P2|STARTED|Year 6||118
629308|NCT00197119|1544224|P1|STARTED|Year 6||126
629309|NCT00197106|1544236|P3|NOT COMPLETED|Overall Treatment Period||6
629310|NCT00197106|1544237|P2|NOT COMPLETED|Overall Treatment Period||1
629311|NCT00197106|1544238|P1|NOT COMPLETED|Overall Treatment Period||0
629312|NCT00197106|1544236|P3|COMPLETED|Overall Treatment Period||74
629313|NCT00197106|1544237|P2|COMPLETED|Overall Treatment Period||77
629314|NCT00197106|1544238|P1|COMPLETED|Overall Treatment Period||0
629315|NCT00197106|1544236|P3|STARTED|Overall Treatment Period||80
629316|NCT00197106|1544237|P2|STARTED|Overall Treatment Period||78
629317|NCT00197106|1544238|P1|STARTED|Overall Treatment Period||0
629318|NCT00197106|1544236|P3|NOT COMPLETED|4-Week Run-In Period||0
629319|NCT00197106|1544237|P2|NOT COMPLETED|4-Week Run-In Period||0
629320|NCT00197106|1544238|P1|NOT COMPLETED|4-Week Run-In Period||99
629321|NCT00197106|1544236|P3|COMPLETED|4-Week Run-In Period||0
629322|NCT00197106|1544237|P2|COMPLETED|4-Week Run-In Period||0
629323|NCT00197106|1544238|P1|COMPLETED|4-Week Run-In Period||158
629324|NCT00197106|1544236|P3|STARTED|4-Week Run-In Period||0
629325|NCT00197106|1544237|P2|STARTED|4-Week Run-In Period||0
629326|NCT00197106|1544238|P1|STARTED|4-Week Run-In Period||257
629327|NCT00197028|1544274|P2|NOT COMPLETED|Overall Study||21
629328|NCT00197028|1544275|P1|NOT COMPLETED|Overall Study||16
629329|NCT00197028|1544274|P2|COMPLETED|Overall Study||86
629330|NCT00197028|1544275|P1|COMPLETED|Overall Study||91
629331|NCT00197028|1544274|P2|STARTED|Overall Study||107
629332|NCT00197028|1544275|P1|STARTED|Overall Study||107
629333|NCT00197015|1544318|P3|NOT COMPLETED|Overall Study||77
629334|NCT00197015|1544319|P2|NOT COMPLETED|Overall Study||89
629335|NCT00197015|1544320|P1|NOT COMPLETED|Overall Study||50
629336|NCT00197015|1544318|P3|COMPLETED|Overall Study||385
629337|NCT00197015|1544319|P2|COMPLETED|Overall Study||366
629338|NCT00197015|1544320|P1|COMPLETED|Overall Study||274
629339|NCT00197015|1544318|P3|STARTED|Overall Study||462
629340|NCT00197015|1544319|P2|STARTED|Overall Study||455
629341|NCT00197015|1544320|P1|STARTED|Overall Study||324
629342|NCT00197002|1544379|P3|NOT COMPLETED|Overall Study||17
629343|NCT00197002|1544380|P2|NOT COMPLETED|Overall Study||18
629344|NCT00197002|1544381|P1|NOT COMPLETED|Overall Study||22
629345|NCT00197002|1544379|P3|COMPLETED|Overall Study||132
629346|NCT00197002|1544380|P2|COMPLETED|Overall Study||119
629347|NCT00197002|1544381|P1|COMPLETED|Overall Study||125
629348|NCT00197002|1544379|P3|STARTED|Overall Study||149
629349|NCT00197002|1544380|P2|STARTED|Overall Study||137
629350|NCT00197002|1544381|P1|STARTED|Overall Study||147
629351|NCT00196976|1544432|P14|NOT COMPLETED|Booster Study||0
629352|NCT00196976|1544433|P13|NOT COMPLETED|Booster Study||0
629353|NCT00196976|1544434|P12|NOT COMPLETED|Booster Study||2
629354|NCT00196976|1544435|P11|NOT COMPLETED|Booster Study||2
629355|NCT00196976|1544436|P10|NOT COMPLETED|Booster Study||0
629356|NCT00196976|1544437|P9|NOT COMPLETED|Booster Study||0
629357|NCT00196976|1544438|P8|NOT COMPLETED|Booster Study||0
629358|NCT00196976|1544439|P7|NOT COMPLETED|Booster Study||0
629359|NCT00196976|1544440|P6|NOT COMPLETED|Booster Study||0
629360|NCT00196976|1544441|P5|NOT COMPLETED|Booster Study||0
629361|NCT00196976|1544442|P4|NOT COMPLETED|Booster Study||0
629362|NCT00196976|1544443|P3|NOT COMPLETED|Booster Study||0
629363|NCT00196976|1544444|P2|NOT COMPLETED|Booster Study||0
629364|NCT00196976|1544445|P1|NOT COMPLETED|Booster Study||0
629365|NCT00196976|1544432|P14|COMPLETED|Booster Study||43
629366|NCT00196976|1544433|P13|COMPLETED|Booster Study||45
629367|NCT00196976|1544434|P12|COMPLETED|Booster Study||30
629368|NCT00196976|1544435|P11|COMPLETED|Booster Study||31
629369|NCT00196976|1544436|P10|COMPLETED|Booster Study||0
629370|NCT00196976|1544437|P9|COMPLETED|Booster Study||0
629371|NCT00196976|1544438|P8|COMPLETED|Booster Study||0
629372|NCT00196976|1544439|P7|COMPLETED|Booster Study||0
629373|NCT00196976|1544440|P6|COMPLETED|Booster Study||0
629374|NCT00196976|1544441|P5|COMPLETED|Booster Study||0
629375|NCT00196976|1544442|P4|COMPLETED|Booster Study||0
629376|NCT00196976|1544443|P3|COMPLETED|Booster Study||0
629377|NCT00196976|1544444|P2|COMPLETED|Booster Study||0
629378|NCT00196976|1544445|P1|COMPLETED|Booster Study||0
629379|NCT00196976|1544432|P14|STARTED|Booster Study||43
629380|NCT00196976|1544433|P13|STARTED|Booster Study||45
629381|NCT00196976|1544434|P12|STARTED|Booster Study||32
629382|NCT00196976|1544435|P11|STARTED|Booster Study||33
629383|NCT00196976|1544436|P10|STARTED|Booster Study||0
629384|NCT00196976|1544437|P9|STARTED|Booster Study||0
629385|NCT00196976|1544438|P8|STARTED|Booster Study||0
629386|NCT00196976|1544439|P7|STARTED|Booster Study||0
629387|NCT00196976|1544440|P6|STARTED|Booster Study||0
629388|NCT00196976|1544441|P5|STARTED|Booster Study||0
629389|NCT00196976|1544442|P4|STARTED|Booster Study||0
629390|NCT00196976|1544443|P3|STARTED|Booster Study||0
629391|NCT00196976|1544444|P2|STARTED|Booster Study||0
629392|NCT00196976|1544445|P1|STARTED|Booster Study||0
629393|NCT00196976|1544432|P14|NOT COMPLETED|Primary Study||0
629394|NCT00196976|1544433|P13|NOT COMPLETED|Primary Study||0
629395|NCT00196976|1544434|P12|NOT COMPLETED|Primary Study||0
629396|NCT00196976|1544435|P11|NOT COMPLETED|Primary Study||0
629397|NCT00196976|1544436|P10|NOT COMPLETED|Primary Study||1
629398|NCT00196976|1544437|P9|NOT COMPLETED|Primary Study||0
629399|NCT00196976|1544438|P8|NOT COMPLETED|Primary Study||3
629400|NCT00196976|1544439|P7|NOT COMPLETED|Primary Study||0
629401|NCT00196976|1544440|P6|NOT COMPLETED|Primary Study||2
629402|NCT00196976|1544441|P5|NOT COMPLETED|Primary Study||3
629403|NCT00196976|1544442|P4|NOT COMPLETED|Primary Study||1
629404|NCT00196976|1544443|P3|NOT COMPLETED|Primary Study||4
629405|NCT00196976|1544444|P2|NOT COMPLETED|Primary Study||1
629406|NCT00196976|1544445|P1|NOT COMPLETED|Primary Study||1
629407|NCT00196976|1544432|P14|COMPLETED|Primary Study||0
629408|NCT00196976|1544433|P13|COMPLETED|Primary Study||0
629409|NCT00196976|1544434|P12|COMPLETED|Primary Study||0
629410|NCT00196976|1544435|P11|COMPLETED|Primary Study||0
629411|NCT00196976|1544436|P10|COMPLETED|Primary Study||51
629412|NCT00196976|1544437|P9|COMPLETED|Primary Study||52
629413|NCT00196976|1544438|P8|COMPLETED|Primary Study||49
629414|NCT00196976|1544439|P7|COMPLETED|Primary Study||50
629415|NCT00196976|1544440|P6|COMPLETED|Primary Study||52
629416|NCT00196976|1544441|P5|COMPLETED|Primary Study||37
629417|NCT00196976|1544442|P4|COMPLETED|Primary Study||39
629418|NCT00196976|1544443|P3|COMPLETED|Primary Study||37
629419|NCT00196976|1544444|P2|COMPLETED|Primary Study||40
629420|NCT00196976|1544445|P1|COMPLETED|Primary Study||38
629421|NCT00196976|1544432|P14|STARTED|Primary Study||0
629422|NCT00196976|1544433|P13|STARTED|Primary Study||0
629423|NCT00196976|1544434|P12|STARTED|Primary Study||0
629424|NCT00196976|1544435|P11|STARTED|Primary Study||0
629425|NCT00196976|1544436|P10|STARTED|Primary Study||52
629426|NCT00196976|1544437|P9|STARTED|Primary Study||52
629427|NCT00196976|1544438|P8|STARTED|Primary Study||52
629428|NCT00196976|1544439|P7|STARTED|Primary Study||50
629429|NCT00196976|1544440|P6|STARTED|Primary Study||54
629430|NCT00196976|1544441|P5|STARTED|Primary Study||40
629431|NCT00196976|1544442|P4|STARTED|Primary Study||40
629432|NCT00196976|1544443|P3|STARTED|Primary Study||41
629433|NCT00196976|1544444|P2|STARTED|Primary Study||41
629434|NCT00196976|1544445|P1|STARTED|Primary Study||39
629435|NCT00196937|1544641|P3|NOT COMPLETED|Overall Study||7
629436|NCT00196937|1544642|P2|NOT COMPLETED|Overall Study||5
629437|NCT00196937|1544643|P1|NOT COMPLETED|Overall Study||9
629438|NCT00196937|1544641|P3|COMPLETED|Overall Study||204
629439|NCT00196937|1544642|P2|COMPLETED|Overall Study||221
629440|NCT00196937|1544643|P1|COMPLETED|Overall Study||220
629441|NCT00196937|1544641|P3|STARTED|Overall Study||211
629442|NCT00196937|1544642|P2|STARTED|Overall Study||226
629443|NCT00196937|1544643|P1|STARTED|Overall Study||229
629444|NCT00196716|1544681|P1|NOT COMPLETED|0.3 mg/kg Period||0
629445|NCT00196716|1544681|P1|COMPLETED|0.3 mg/kg Period||21
629446|NCT00196716|1544681|P1|STARTED|0.3 mg/kg Period||21
629447|NCT00196716|1544681|P1|NOT COMPLETED|1.0 mg/kg Period||0
629448|NCT00196716|1544681|P1|COMPLETED|1.0 mg/kg Period||21
629449|NCT00196716|1544681|P1|STARTED|1.0 mg/kg Period||21
629450|NCT00196326|1544691|P1|NOT COMPLETED|Overall Study||986
629451|NCT00196326|1544691|P1|COMPLETED|Overall Study||1249
629452|NCT00196326|1544691|P1|Pregnancy Intent-to-treat Cohort (PITT)|Overall Study|Completed one cycle and 18-35 years old|1735
629453|NCT00196326|1544691|P1|Safety Population|Overall Study|Treated participants|2185
629454|NCT00196326|1544691|P1|STARTED|Overall Study|Took at least one dose of study medication|2235
629455|NCT00196313|1544699|P2|NOT COMPLETED|Overall Study||8
629456|NCT00196313|1544700|P1|NOT COMPLETED|Overall Study||11
629457|NCT00196313|1544699|P2|COMPLETED|Overall Study||40
629458|NCT00196313|1544700|P1|COMPLETED|Overall Study||36
629459|NCT00196313|1544699|P2|STARTED|Overall Study||48
629460|NCT00196313|1544700|P1|STARTED|Overall Study||47
629461|NCT00196196|1544714|P1|NOT COMPLETED|Overall Study||7
629462|NCT00196196|1544714|P1|COMPLETED|Overall Study||267
629463|NCT00196196|1544714|P1|STARTED|Overall Study||274
629464|NCT00196105|1544722|P3|NOT COMPLETED|Overall Study||7
629465|NCT00196105|1544723|P2|NOT COMPLETED|Overall Study||5
629466|NCT00196105|1544724|P1|NOT COMPLETED|Overall Study||4
629467|NCT00196105|1544722|P3|COMPLETED|Overall Study||82
629468|NCT00196105|1544723|P2|COMPLETED|Overall Study||83
629469|NCT00196105|1544724|P1|COMPLETED|Overall Study||60
629470|NCT00196105|1544722|P3|STARTED|Overall Study||89
629471|NCT00196105|1544723|P2|STARTED|Overall Study||88
629472|NCT00196105|1544724|P1|STARTED|Overall Study||64
629473|NCT00195819|1544744|P2|NOT COMPLETED|Open-label||20
629474|NCT00195819|1544745|P1|NOT COMPLETED|Open-label||0
629475|NCT00195819|1544744|P2|COMPLETED|Open-label||62
629476|NCT00195819|1544745|P1|COMPLETED|Open-label||0
629477|NCT00195819|1544744|P2|STARTED|Open-label||82
629478|NCT00195819|1544745|P1|STARTED|Open-label||0
629479|NCT00195819|1544744|P2|NOT COMPLETED|Double-Blind||0
629480|NCT00195819|1544745|P1|NOT COMPLETED|Double-Blind||2
629481|NCT00195819|1544744|P2|COMPLETED|Double-Blind||38
629482|NCT00195819|1544745|P1|COMPLETED|Double-Blind||42
629483|NCT00195819|1544744|P2|STARTED|Double-Blind||38
629484|NCT00195819|1544745|P1|STARTED|Double-Blind||44
629485|NCT00195715|1544795|P1|NOT COMPLETED|Overall Study||377
629486|NCT00195715|1544795|P1|COMPLETED|Overall Study||400
629487|NCT00195715|1544795|P1|STARTED|Overall Study||777
629488|NCT00195702|1544826|P6|NOT COMPLETED|Open-label Extension Phase||78
629489|NCT00195702|1544827|P5|NOT COMPLETED|Open-label Extension Phase||78
629490|NCT00195702|1544828|P4|NOT COMPLETED|Open-label Extension Phase||99
629491|NCT00195702|1544829|P3|NOT COMPLETED|Open-label Extension Phase||0
629492|NCT00195702|1544830|P2|NOT COMPLETED|Open-label Extension Phase||0
629493|NCT00195702|1544831|P1|NOT COMPLETED|Open-label Extension Phase||0
629494|NCT00195702|1544826|P6|COMPLETED|Open-label Extension Phase||56
629495|NCT00195702|1544827|P5|COMPLETED|Open-label Extension Phase||80
629496|NCT00195702|1544828|P4|COMPLETED|Open-label Extension Phase||66
629497|NCT00195702|1544829|P3|COMPLETED|Open-label Extension Phase||0
629498|NCT00195702|1544830|P2|COMPLETED|Open-label Extension Phase||0
629499|NCT00195702|1544831|P1|COMPLETED|Open-label Extension Phase||0
629500|NCT00195702|1544826|P6|STARTED|Open-label Extension Phase|6 subjects completed the double-blind phase but did not enter the open-label extension phase.|134
629501|NCT00195702|1544827|P5|STARTED|Open-label Extension Phase|1 subject completed the double-blind phase but did not enter the open-label extension phase.|158
629502|NCT00195702|1544828|P4|STARTED|Open-label Extension Phase|3 subjects completed the double-blind phase but did not enter the open-label extension phase.|165
629503|NCT00195702|1544829|P3|STARTED|Open-label Extension Phase||0
629504|NCT00195702|1544830|P2|STARTED|Open-label Extension Phase||0
629505|NCT00195702|1544831|P1|STARTED|Open-label Extension Phase||0
629506|NCT00195702|1544826|P6|NOT COMPLETED|Double-blind Phase||0
629507|NCT00195702|1544827|P5|NOT COMPLETED|Double-blind Phase||0
629508|NCT00195702|1544828|P4|NOT COMPLETED|Double-blind Phase||0
629509|NCT00195702|1544829|P3|NOT COMPLETED|Double-blind Phase||60
629510|NCT00195702|1544830|P2|NOT COMPLETED|Double-blind Phase||48
629511|NCT00195702|1544831|P1|NOT COMPLETED|Double-blind Phase||44
629512|NCT00195702|1544826|P6|COMPLETED|Double-blind Phase||0
629513|NCT00195702|1544827|P5|COMPLETED|Double-blind Phase||0
629514|NCT00195702|1544828|P4|COMPLETED|Double-blind Phase||0
629515|NCT00195702|1544829|P3|COMPLETED|Double-blind Phase||140
629516|NCT00195702|1544830|P2|COMPLETED|Double-blind Phase||159
629517|NCT00195702|1544831|P1|COMPLETED|Double-blind Phase||168
629518|NCT00195702|1544826|P6|STARTED|Double-blind Phase||0
629519|NCT00195702|1544827|P5|STARTED|Double-blind Phase||0
629520|NCT00195702|1544828|P4|STARTED|Double-blind Phase||0
629521|NCT00195702|1544829|P3|STARTED|Double-blind Phase||200
629522|NCT00195702|1544830|P2|STARTED|Double-blind Phase||207
629523|NCT00195702|1544831|P1|STARTED|Double-blind Phase|For all groups, started indicates when the subjects entered the 52-week double-blind phase.|212
629524|NCT00195676|1544895|P1|NOT COMPLETED|Period R - Retreatment 16 Weeks||35
629525|NCT00195676|1544895|P1|COMPLETED|Period R - Retreatment 16 Weeks||490
629526|NCT00195676|1544895|P1|STARTED|Period R - Retreatment 16 Weeks|Number who entered from Period W, including those who did and did not relapse in that period.|525
629527|NCT00195676|1544895|P1|NOT COMPLETED|Period W (Withdrawal) - No Treatment||608
629528|NCT00195676|1544895|P1|COMPLETED|Period W (Withdrawal) - No Treatment|Non-completers may have entered Period R, whether or not they relapsed (PGA >= 3).|0
629529|NCT00195676|1544895|P1|STARTED|Period W (Withdrawal) - No Treatment|Period O completers with a Physician's Global Assessment =<2 who continued into Periods W and R.|608
629530|NCT00195676|1544895|P1|NOT COMPLETED|Period O - Open-label Treatment||606
629531|NCT00195676|1544895|P1|COMPLETED|Period O - Open-label Treatment|254 Period O completers did not consent or were not eligible to continue into Period W and Period R.|862
629532|NCT00195676|1544895|P1|STARTED|Period O - Open-label Treatment|Number receiving adalimumab in Period O (1 additional participant enrolled but did not receive drug)|1468
629533|NCT00195663|1544909|P3|NOT COMPLETED|Open-Label Extension Period||97
629534|NCT00195663|1544910|P2|NOT COMPLETED|Open-Label Extension Period||74
629535|NCT00195663|1544911|P1|NOT COMPLETED|Open-Label Extension Period||76
629536|NCT00195663|1544909|P3|COMPLETED|Open-Label Extension Period||86
629537|NCT00195663|1544910|P2|COMPLETED|Open-Label Extension Period||85
629538|NCT00195663|1544911|P1|COMPLETED|Open-Label Extension Period||79
629539|NCT00195663|1544909|P3|STARTED|Open-Label Extension Period||183
629540|NCT00195663|1544910|P2|STARTED|Open-Label Extension Period||159
629541|NCT00195663|1544911|P1|STARTED|Open-Label Extension Period||155
629542|NCT00195663|1544909|P3|NOT COMPLETED|2-year Double-blind Treatment Period||72
629543|NCT00195663|1544910|P2|NOT COMPLETED|2-year Double-blind Treatment Period||108
629544|NCT00195663|1544911|P1|NOT COMPLETED|2-year Double-blind Treatment Period||93
629545|NCT00195663|1544909|P3|COMPLETED|2-year Double-blind Treatment Period||196
629546|NCT00195663|1544910|P2|COMPLETED|2-year Double-blind Treatment Period||166
629547|NCT00195663|1544911|P1|COMPLETED|2-year Double-blind Treatment Period||164
629548|NCT00195663|1544909|P3|STARTED|2-year Double-blind Treatment Period||268
629549|NCT00195663|1544910|P2|STARTED|2-year Double-blind Treatment Period||274
629550|NCT00195663|1544911|P1|STARTED|2-year Double-blind Treatment Period||257
629551|NCT00195650|1545005|P1|NOT COMPLETED|Overall Study||525
629552|NCT00195650|1545005|P1|COMPLETED|Overall Study||321
629553|NCT00195650|1545005|P1|STARTED|Overall Study|Participants who received at least 1 adalimumab dose in study;3 enrolled did not receive adalimumab.|846
629554|NCT00195507|1545021|P2|NOT COMPLETED|Overall Study||118
629555|NCT00195507|1545022|P1|NOT COMPLETED|Overall Study||99
629556|NCT00195507|1545021|P2|COMPLETED|Overall Study||245
629557|NCT00195507|1545022|P1|COMPLETED|Overall Study||258
629558|NCT00195507|1545021|P2|STARTED|Overall Study||363
629559|NCT00195507|1545022|P1|STARTED|Overall Study||357
629560|NCT00195494|1545036|P6|NOT COMPLETED|Year 2||0
629561|NCT00195494|1545037|P5|NOT COMPLETED|Year 2||0
629562|NCT00195494|1545038|P4|NOT COMPLETED|Year 2||23
629563|NCT00195494|1545039|P3|NOT COMPLETED|Year 2||18
629564|NCT00195494|1545040|P2|NOT COMPLETED|Year 2||16
629565|NCT00195494|1545041|P1|NOT COMPLETED|Year 2||7
629566|NCT00195494|1545036|P6|COMPLETED|Year 2||0
629567|NCT00195494|1545037|P5|COMPLETED|Year 2||0
629568|NCT00195494|1545038|P4|COMPLETED|Year 2||76
629569|NCT00195494|1545039|P3|COMPLETED|Year 2||93
629570|NCT00195494|1545040|P2|COMPLETED|Year 2||74
629571|NCT00195494|1545041|P1|COMPLETED|Year 2||104
629572|NCT00195494|1545036|P6|STARTED|Year 2||0
629573|NCT00195494|1545037|P5|STARTED|Year 2||0
629574|NCT00195494|1545038|P4|STARTED|Year 2||99
629575|NCT00195494|1545039|P3|STARTED|Year 2|A patient with Year 1 termination had taken drug briefly during Year 2 and thus counted in the data.|111
629576|NCT00195494|1545040|P2|STARTED|Year 2||90
629577|NCT00195494|1545041|P1|STARTED|Year 2|A patient with Year 1 termination had taken drug briefly during Year 2 and thus counted in the data.|111
629578|NCT00195494|1545036|P6|NOT COMPLETED|Year 1||53
629579|NCT00195494|1545037|P5|NOT COMPLETED|Year 1||79
629580|NCT00195494|1545038|P4|NOT COMPLETED|Year 1||0
629581|NCT00195494|1545039|P3|NOT COMPLETED|Year 1||0
629582|NCT00195494|1545040|P2|NOT COMPLETED|Year 1||0
629583|NCT00195494|1545041|P1|NOT COMPLETED|Year 1||0
629584|NCT00195494|1545036|P6|COMPLETED|Year 1||221
629585|NCT00195494|1545037|P5|COMPLETED|Year 1||189
629586|NCT00195494|1545038|P4|COMPLETED|Year 1||0
629587|NCT00195494|1545039|P3|COMPLETED|Year 1||0
629588|NCT00195494|1545040|P2|COMPLETED|Year 1||0
629589|NCT00195494|1545041|P1|COMPLETED|Year 1||0
629590|NCT00195494|1545036|P6|STARTED|Year 1||274
629591|NCT00195494|1545037|P5|STARTED|Year 1||268
629592|NCT00195494|1545038|P4|STARTED|Year 1||0
629593|NCT00195494|1545039|P3|STARTED|Year 1||0
629594|NCT00195494|1545040|P2|STARTED|Year 1||0
629595|NCT00195494|1545041|P1|STARTED|Year 1||0
629596|NCT00195442|1545059|P1|NOT COMPLETED|Overall Study||136
629597|NCT00195442|1545059|P1|COMPLETED|Overall Study||152
629598|NCT00195442|1545059|P1|STARTED|Overall Study||288
629599|NCT00195429|1545078|P2|NOT COMPLETED|Overall Study||5
629600|NCT00195429|1545079|P1|NOT COMPLETED|Overall Study||5
629601|NCT00195429|1545078|P2|COMPLETED|Overall Study||18
629602|NCT00195429|1545079|P1|COMPLETED|Overall Study||19
629603|NCT00195429|1545078|P2|STARTED|Overall Study||23
629604|NCT00195429|1545079|P1|STARTED|Overall Study||24
629605|NCT00195403|1545087|P1|NOT COMPLETED|Overall Study||0
629606|NCT00195403|1545087|P1|COMPLETED|Overall Study||1014
629607|NCT00195403|1545087|P1|STARTED|Overall Study||1014
629608|NCT00195351|1545095|P2|NOT COMPLETED|Overall Study||16
629609|NCT00195351|1545096|P1|NOT COMPLETED|Overall Study||21
629610|NCT00195351|1545095|P2|COMPLETED|Overall Study||215
629611|NCT00195351|1545096|P1|COMPLETED|Overall Study||215
629612|NCT00195351|1545095|P2|STARTED|Overall Study||231
629613|NCT00195351|1545096|P1|STARTED|Overall Study||236
629614|NCT00195338|1545106|P1|NOT COMPLETED|Overall Study||12
629615|NCT00195338|1545106|P1|COMPLETED|Overall Study||13
629616|NCT00195338|1545106|P1|STARTED|Overall Study||25
629617|NCT00195273|1545116|P2|NOT COMPLETED|Overall Study||14
629618|NCT00195273|1545117|P1|NOT COMPLETED|Overall Study||21
629619|NCT00195273|1545116|P2|COMPLETED|Overall Study||16
629620|NCT00195273|1545117|P1|COMPLETED|Overall Study||10
629621|NCT00195273|1545116|P2|STARTED|Overall Study||30
629622|NCT00195273|1545117|P1|STARTED|Overall Study||31
629623|NCT00195260|1545131|P11|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||23
629624|NCT00195260|1545132|P10|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||38
629625|NCT00195260|1545133|P9|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||33
629626|NCT00195260|1545134|P8|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
629627|NCT00195260|1545135|P7|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
629628|NCT00195260|1545136|P6|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
629629|NCT00195260|1545137|P5|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
629630|NCT00195260|1545138|P4|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
629631|NCT00195260|1545139|P3|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
629632|NCT00195260|1545140|P2|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
629633|NCT00195260|1545141|P1|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
629634|NCT00195260|1545131|P11|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||2
629635|NCT00195260|1545132|P10|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
629636|NCT00195260|1545133|P9|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||4
629637|NCT00195260|1545134|P8|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
629638|NCT00195260|1545135|P7|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
629639|NCT00195260|1545136|P6|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
629640|NCT00195260|1545137|P5|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
629641|NCT00195260|1545138|P4|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
629642|NCT00195260|1545139|P3|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
629643|NCT00195260|1545140|P2|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
629644|NCT00195260|1545141|P1|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
629645|NCT00195260|1545131|P11|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||25
629646|NCT00195260|1545132|P10|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||38
629647|NCT00195260|1545133|P9|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||37
629648|NCT00195260|1545134|P8|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
629649|NCT00195260|1545135|P7|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
629650|NCT00195260|1545136|P6|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
629651|NCT00195260|1545137|P5|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
629652|NCT00195260|1545138|P4|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
629653|NCT00195260|1545139|P3|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
629654|NCT00195260|1545140|P2|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
629655|NCT00195260|1545141|P1|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
629656|NCT00195260|1545131|P11|NOT COMPLETED|Part 1: Dose Escalation||0
629657|NCT00195260|1545132|P10|NOT COMPLETED|Part 1: Dose Escalation||0
629658|NCT00195260|1545133|P9|NOT COMPLETED|Part 1: Dose Escalation||0
629659|NCT00195260|1545134|P8|NOT COMPLETED|Part 1: Dose Escalation||6
629660|NCT00195260|1545135|P7|NOT COMPLETED|Part 1: Dose Escalation||10
629661|NCT00195260|1545136|P6|NOT COMPLETED|Part 1: Dose Escalation||7
629662|NCT00195260|1545137|P5|NOT COMPLETED|Part 1: Dose Escalation||7
629663|NCT00195260|1545138|P4|NOT COMPLETED|Part 1: Dose Escalation||7
629664|NCT00195260|1545139|P3|NOT COMPLETED|Part 1: Dose Escalation||6
629665|NCT00195260|1545140|P2|NOT COMPLETED|Part 1: Dose Escalation||4
629666|NCT00195260|1545141|P1|NOT COMPLETED|Part 1: Dose Escalation||4
629667|NCT00195260|1545131|P11|COMPLETED|Part 1: Dose Escalation||0
629668|NCT00195260|1545132|P10|COMPLETED|Part 1: Dose Escalation||0
629669|NCT00195260|1545133|P9|COMPLETED|Part 1: Dose Escalation||0
629670|NCT00195260|1545134|P8|COMPLETED|Part 1: Dose Escalation||0
629671|NCT00195260|1545135|P7|COMPLETED|Part 1: Dose Escalation||0
629672|NCT00195260|1545136|P6|COMPLETED|Part 1: Dose Escalation||0
629673|NCT00195260|1545137|P5|COMPLETED|Part 1: Dose Escalation||0
629674|NCT00195260|1545138|P4|COMPLETED|Part 1: Dose Escalation||0
629675|NCT00195260|1545139|P3|COMPLETED|Part 1: Dose Escalation||0
629676|NCT00195260|1545140|P2|COMPLETED|Part 1: Dose Escalation||0
629677|NCT00195260|1545141|P1|COMPLETED|Part 1: Dose Escalation||0
629678|NCT00195260|1545131|P11|STARTED|Part 1: Dose Escalation||0
629679|NCT00195260|1545132|P10|STARTED|Part 1: Dose Escalation||0
629680|NCT00195260|1545133|P9|STARTED|Part 1: Dose Escalation||0
629681|NCT00195260|1545134|P8|STARTED|Part 1: Dose Escalation||6
629682|NCT00195260|1545135|P7|STARTED|Part 1: Dose Escalation||10
629683|NCT00195260|1545136|P6|STARTED|Part 1: Dose Escalation||7
629684|NCT00195260|1545137|P5|STARTED|Part 1: Dose Escalation||7
629685|NCT00195260|1545138|P4|STARTED|Part 1: Dose Escalation||7
629686|NCT00195260|1545139|P3|STARTED|Part 1: Dose Escalation||6
629687|NCT00195260|1545140|P2|STARTED|Part 1: Dose Escalation||4
629688|NCT00195260|1545141|P1|STARTED|Part 1: Dose Escalation||4
629689|NCT00195039|1545287|P1|NOT COMPLETED|Overall Study||0
629690|NCT00195039|1545287|P1|COMPLETED|Overall Study||47
629691|NCT00195039|1545287|P1|STARTED|Overall Study||47
629692|NCT00195013|1545300|P2|NOT COMPLETED|Overall Study||1
629693|NCT00195013|1545301|P1|NOT COMPLETED|Overall Study||2
629694|NCT00195013|1545300|P2|COMPLETED|Overall Study||15
629695|NCT00195013|1545301|P1|COMPLETED|Overall Study||12
629696|NCT00195013|1545300|P2|STARTED|Overall Study||16
629697|NCT00195013|1545301|P1|STARTED|Overall Study||14
629698|NCT00194896|1545311|P4|NOT COMPLETED|Overall Study||12
629699|NCT00194896|1545312|P3|NOT COMPLETED|Overall Study||6
629700|NCT00194896|1545313|P2|NOT COMPLETED|Overall Study||5
629701|NCT00194896|1545314|P1|NOT COMPLETED|Overall Study||11
629702|NCT00194896|1545311|P4|COMPLETED|Overall Study||9
629703|NCT00194896|1545312|P3|COMPLETED|Overall Study||7
629704|NCT00194896|1545313|P2|COMPLETED|Overall Study||10
629705|NCT00194896|1545314|P1|COMPLETED|Overall Study||4
629706|NCT00194896|1545311|P4|STARTED|Overall Study||21
629707|NCT00194896|1545312|P3|STARTED|Overall Study||13
629708|NCT00194896|1545313|P2|STARTED|Overall Study||15
629709|NCT00194896|1545314|P1|STARTED|Overall Study||15
629710|NCT00194792|1545328|P1|NOT COMPLETED|Overall Study||1
629711|NCT00194792|1545328|P1|COMPLETED|Overall Study||27
629712|NCT00194792|1545328|P1|STARTED|Overall Study||28
629713|NCT00194779|1545338|P1|NOT COMPLETED|Overall Study||0
629714|NCT00194779|1545338|P1|COMPLETED|Overall Study||50
629715|NCT00194779|1545338|P1|STARTED|Overall Study||50
629716|NCT00194675|1545352|P2|NOT COMPLETED|Overall Study||2
629717|NCT00194675|1545353|P1|NOT COMPLETED|Overall Study||5
629718|NCT00194675|1545352|P2|COMPLETED|Overall Study||24
629719|NCT00194675|1545353|P1|COMPLETED|Overall Study||22
629720|NCT00194675|1545352|P2|STARTED|Overall Study||26
629721|NCT00194675|1545353|P1|STARTED|Overall Study||27
629722|NCT00194610|1545371|P2|NOT COMPLETED|Overall Study||0
629723|NCT00194610|1545372|P1|NOT COMPLETED|Overall Study||0
629724|NCT00194610|1545371|P2|COMPLETED|Overall Study||9
629725|NCT00194610|1545372|P1|COMPLETED|Overall Study||11
629726|NCT00194610|1545371|P2|STARTED|Overall Study||9
629727|NCT00194610|1545372|P1|STARTED|Overall Study||11
629728|NCT00194532|1545380|P2|NOT COMPLETED|Overall Study||0
629729|NCT00194532|1545381|P1|NOT COMPLETED|Overall Study||0
629730|NCT00194532|1545380|P2|COMPLETED|Overall Study||150
629731|NCT00194532|1545381|P1|COMPLETED|Overall Study||150
629732|NCT00194532|1545380|P2|STARTED|Overall Study||150
629733|NCT00194532|1545381|P1|STARTED|Overall Study||150
629734|NCT00194129|1545391|P2|NOT COMPLETED|Overall Study||13
629735|NCT00194129|1545392|P1|NOT COMPLETED|Overall Study||10
629736|NCT00194129|1545391|P2|COMPLETED|Overall Study||3
629737|NCT00194129|1545392|P1|COMPLETED|Overall Study||5
629738|NCT00194129|1545391|P2|STARTED|Overall Study||16
629739|NCT00194129|1545392|P1|STARTED|Overall Study||15
629740|NCT00194077|1545407|P2|NOT COMPLETED|Overall Study||30
629741|NCT00194077|1545408|P1|NOT COMPLETED|Overall Study||24
629742|NCT00194077|1545407|P2|COMPLETED|Overall Study|"Lack of efficacy:~hypomania n=17 Cycling n=6 Mania n=5 Mixed state n=1 Concern regarding tx n=1"|0
629743|NCT00194077|1545408|P1|COMPLETED|Overall Study|"Lack of efficacy:~Hypomania n=12 Cycling n=5 Mixed state=4 Mania n=1"|6
629744|NCT00194077|1545407|P2|STARTED|Overall Study||30
629745|NCT00194077|1545408|P1|STARTED|Overall Study||30
629746|NCT00194025|1545414|P1|NOT COMPLETED|Overall Study||5
629747|NCT00194025|1545414|P1|COMPLETED|Overall Study|5 participants withdrew prematurely|15
629748|NCT00194025|1545414|P1|STARTED|Overall Study|The intent-to-treat population received at least one dose of valproate semisodium.|20
629749|NCT00194012|1545429|P2|NOT COMPLETED|Open Label Extension (OLE)||6
629750|NCT00194012|1545430|P1|NOT COMPLETED|Open Label Extension (OLE)||5
629751|NCT00194012|1545429|P2|COMPLETED|Open Label Extension (OLE)||15
629752|NCT00194012|1545430|P1|COMPLETED|Open Label Extension (OLE)||17
629753|NCT00194012|1545429|P2|STARTED|Open Label Extension (OLE)|Participants from placebo group started OLE (eligible even if randomized period not completed).|21
629754|NCT00194012|1545430|P1|STARTED|Open Label Extension (OLE)|Participants from aripiprazole group started OLE (eligible even if randomized period not completed).|22
629755|NCT00194012|1545429|P2|NOT COMPLETED|Randomized Phase||25
629756|NCT00194012|1545430|P1|NOT COMPLETED|Randomized Phase||16
629757|NCT00194012|1545429|P2|COMPLETED|Randomized Phase||6
629758|NCT00194012|1545430|P1|COMPLETED|Randomized Phase||15
629759|NCT00194012|1545429|P2|Received More Than One Dose|Randomized Phase||29
629760|NCT00194012|1545430|P1|Received More Than One Dose|Randomized Phase||30
629761|NCT00194012|1545429|P2|STARTED|Randomized Phase||31
629762|NCT00194012|1545430|P1|STARTED|Randomized Phase||31
629763|NCT00193609|1545466|P1|NOT COMPLETED|Overall Study||4
629764|NCT00193609|1545466|P1|COMPLETED|Overall Study||44
629765|NCT00193609|1545466|P1|STARTED|Overall Study||48
629766|NCT00193596|1545473|P2|NOT COMPLETED|Overall Study||66
629767|NCT00193596|1545474|P1|NOT COMPLETED|Overall Study||56
629768|NCT00193596|1545473|P2|COMPLETED|Overall Study||39
629769|NCT00193596|1545474|P1|COMPLETED|Overall Study||37
629770|NCT00193596|1545473|P2|STARTED|Overall Study||105
629771|NCT00193596|1545474|P1|STARTED|Overall Study||93
629772|NCT00193492|1545484|P2|NOT COMPLETED|Overall Study||15
629773|NCT00193492|1545485|P1|NOT COMPLETED|Overall Study||17
629774|NCT00193492|1545484|P2|COMPLETED|Overall Study||14
629775|NCT00193492|1545485|P1|COMPLETED|Overall Study||14
629776|NCT00193492|1545484|P2|STARTED|Overall Study||29
629777|NCT00193492|1545485|P1|STARTED|Overall Study||31
629778|NCT00193479|1545493|P1|NOT COMPLETED|Maintenance Rituximab||0
629779|NCT00193479|1545493|P1|COMPLETED|Maintenance Rituximab||44
629780|NCT00193479|1545493|P1|STARTED|Maintenance Rituximab||44
629781|NCT00193479|1545493|P1|NOT COMPLETED|Induction Chemotherapy||3
629782|NCT00193479|1545493|P1|COMPLETED|Induction Chemotherapy||48
629783|NCT00193479|1545493|P1|STARTED|Induction Chemotherapy||51
629784|NCT00193453|1545497|P1|NOT COMPLETED|Overall Study||48
629785|NCT00193453|1545497|P1|COMPLETED|Overall Study||21
629786|NCT00193453|1545497|P1|STARTED|Overall Study||69
629787|NCT00193427|1545503|P1|NOT COMPLETED|Overall Study||49
629788|NCT00193427|1545503|P1|COMPLETED|Overall Study||26
629789|NCT00193427|1545503|P1|STARTED|Overall Study||75
629790|NCT00193414|1545510|P1|NOT COMPLETED|Overall Study||58
629791|NCT00193414|1545510|P1|COMPLETED|Overall Study||14
629792|NCT00193414|1545510|P1|STARTED|Overall Study||72
629793|NCT00193375|1545516|P1|NOT COMPLETED|Overall Study||19
629794|NCT00193375|1545516|P1|COMPLETED|Overall Study||41
629795|NCT00193375|1545516|P1|STARTED|Overall Study||60
629796|NCT00193258|1545522|P1|NOT COMPLETED|Overall Study||0
629797|NCT00193258|1545522|P1|COMPLETED|Overall Study||94
629798|NCT00193258|1545522|P1|STARTED|Overall Study||94
629799|NCT00193219|1545528|P1|NOT COMPLETED|Overall Study||30
629800|NCT00193219|1545528|P1|COMPLETED|Overall Study||6
629801|NCT00193219|1545528|P1|STARTED|Overall Study||36
629802|NCT00193206|1545534|P1|NOT COMPLETED|Postoperative Therapy||14
629803|NCT00193206|1545534|P1|COMPLETED|Postoperative Therapy||102
629804|NCT00193206|1545534|P1|STARTED|Postoperative Therapy||116
629805|NCT00193206|1545534|P1|NOT COMPLETED|Surgery||0
629806|NCT00193206|1545534|P1|COMPLETED|Surgery||116
629807|NCT00193206|1545534|P1|STARTED|Surgery||116
629808|NCT00193206|1545534|P1|NOT COMPLETED|Preoperative Therapy||7
629809|NCT00193206|1545534|P1|COMPLETED|Preoperative Therapy||116
629810|NCT00193206|1545534|P1|STARTED|Preoperative Therapy||123
629811|NCT00193180|1545538|P1|NOT COMPLETED|Overall Study||10
629812|NCT00193180|1545538|P1|COMPLETED|Overall Study||27
629813|NCT00193180|1545538|P1|STARTED|Overall Study||37
629814|NCT00193128|1545546|P2|NOT COMPLETED|Overall Study||10
629815|NCT00193128|1545547|P1|NOT COMPLETED|Overall Study||0
629816|NCT00193128|1545546|P2|COMPLETED|Overall Study||39
629817|NCT00193128|1545547|P1|COMPLETED|Overall Study||10
629818|NCT00193128|1545546|P2|STARTED|Overall Study||49
629819|NCT00193128|1545547|P1|STARTED|Overall Study||10
629820|NCT00193063|1545553|P1|NOT COMPLETED|Overall Study||4
629821|NCT00193063|1545553|P1|COMPLETED|Overall Study||37
629822|NCT00193063|1545553|P1|STARTED|Overall Study||41
629823|NCT00193050|1545559|P1|NOT COMPLETED|Adjuvant||10
629824|NCT00193050|1545559|P1|COMPLETED|Adjuvant||77
629825|NCT00193050|1545559|P1|STARTED|Adjuvant|16 patients never initiated postoperative adjuvant therapy|87
629826|NCT00193050|1545559|P1|NOT COMPLETED|Surgery||0
629827|NCT00193050|1545559|P1|COMPLETED|Surgery||103
629912|NCT00191906|1545762|P4|NOT COMPLETED|Study Period II||0
629828|NCT00193050|1545559|P1|STARTED|Surgery|2 patients had surgery after 2 cycles of neoadjuvant treatment|103
629829|NCT00193050|1545559|P1|NOT COMPLETED|Neoadjuvant Treatment||9
629830|NCT00193050|1545559|P1|COMPLETED|Neoadjuvant Treatment||101
629831|NCT00193050|1545559|P1|STARTED|Neoadjuvant Treatment||110
629832|NCT00193037|1545565|P2|NOT COMPLETED|Crossover Treatment||0
629833|NCT00193037|1545566|P1|NOT COMPLETED|Crossover Treatment||0
629834|NCT00193037|1545565|P2|COMPLETED|Crossover Treatment||24
629835|NCT00193037|1545566|P1|COMPLETED|Crossover Treatment||32
629836|NCT00193037|1545565|P2|STARTED|Crossover Treatment||24
629837|NCT00193037|1545566|P1|STARTED|Crossover Treatment||32
629838|NCT00193037|1545565|P2|NOT COMPLETED|Randomized Treatment||28
629839|NCT00193037|1545566|P1|NOT COMPLETED|Randomized Treatment||18
629840|NCT00193037|1545565|P2|COMPLETED|Randomized Treatment||24
629841|NCT00193037|1545566|P1|COMPLETED|Randomized Treatment||32
629842|NCT00193037|1545565|P2|STARTED|Randomized Treatment||52
629843|NCT00193037|1545566|P1|STARTED|Randomized Treatment||50
629844|NCT00192647|1545576|P2|NOT COMPLETED|Overall Study||146
629845|NCT00192647|1545577|P1|NOT COMPLETED|Overall Study||128
629846|NCT00192647|1545576|P2|COMPLETED|Overall Study||302
629847|NCT00192647|1545577|P1|COMPLETED|Overall Study||320
629848|NCT00192647|1545576|P2|Treated|Overall Study||438
629849|NCT00192647|1545577|P1|Treated|Overall Study||433
629850|NCT00192647|1545576|P2|STARTED|Overall Study||448
629851|NCT00192647|1545577|P1|STARTED|Overall Study||448
629852|NCT00192296|1545597|P4|NOT COMPLETED|Overall Study||0
629853|NCT00192296|1545598|P3|NOT COMPLETED|Overall Study||0
629854|NCT00192296|1545599|P2|NOT COMPLETED|Overall Study||1
629855|NCT00192296|1545600|P1|NOT COMPLETED|Overall Study||0
629856|NCT00192296|1545597|P4|COMPLETED|Overall Study||6
629857|NCT00192296|1545598|P3|COMPLETED|Overall Study||6
629858|NCT00192296|1545599|P2|COMPLETED|Overall Study||5
629859|NCT00192296|1545600|P1|COMPLETED|Overall Study||6
629860|NCT00192296|1545597|P4|STARTED|Overall Study||6
629861|NCT00192296|1545598|P3|STARTED|Overall Study||6
629862|NCT00192296|1545599|P2|STARTED|Overall Study||6
629863|NCT00192296|1545600|P1|STARTED|Overall Study||6
629864|NCT00192075|1545656|P2|NOT COMPLETED|Overall Study||19
629865|NCT00192075|1545657|P1|NOT COMPLETED|Overall Study||39
629866|NCT00192075|1545656|P2|COMPLETED|Overall Study||23
629867|NCT00192075|1545657|P1|COMPLETED|Overall Study||3
629868|NCT00192075|1545656|P2|STARTED|Overall Study||42
629869|NCT00192075|1545657|P1|STARTED|Overall Study||42
629870|NCT00192036|1545682|P1|NOT COMPLETED|Overall Study||21
629871|NCT00192036|1545682|P1|COMPLETED|Overall Study||28
629872|NCT00192036|1545682|P1|STARTED|Overall Study||49
629873|NCT00192023|1545692|P2|NOT COMPLETED|Period IV - Optional Open-Label||0
629874|NCT00192023|1545693|P1|NOT COMPLETED|Period IV - Optional Open-Label||75
629875|NCT00192023|1545692|P2|COMPLETED|Period IV - Optional Open-Label||0
629876|NCT00192023|1545693|P1|COMPLETED|Period IV - Optional Open-Label||49
629877|NCT00192023|1545692|P2|STARTED|Period IV - Optional Open-Label|Placebo patients received atomoxetine during the optional open-label period.|0
629878|NCT00192023|1545693|P1|STARTED|Period IV - Optional Open-Label||124
629879|NCT00192023|1545692|P2|NOT COMPLETED|Period III - Double-Blind||0
629880|NCT00192023|1545693|P1|NOT COMPLETED|Period III - Double-Blind||7
629881|NCT00192023|1545692|P2|COMPLETED|Period III - Double-Blind|2 patients who completed the protocol did not enter the optional open-label period.|32
629882|NCT00192023|1545693|P1|COMPLETED|Period III - Double-Blind|6 patients who completed the protocol did not enter optional open-label period.|100
629883|NCT00192023|1545692|P2|STARTED|Period III - Double-Blind||32
629884|NCT00192023|1545693|P1|STARTED|Period III - Double-Blind||107
629885|NCT00191984|1545715|P1|NOT COMPLETED|Overall Study||39
629886|NCT00191984|1545715|P1|COMPLETED|Overall Study||7
629887|NCT00191984|1545715|P1|STARTED|Overall Study||46
629888|NCT00191945|1545725|P2|NOT COMPLETED|Open-Label Treatment Extension||0
629889|NCT00191945|1545726|P1|NOT COMPLETED|Open-Label Treatment Extension||0
629890|NCT00191945|1545725|P2|COMPLETED|Open-Label Treatment Extension||48
629891|NCT00191945|1545726|P1|COMPLETED|Open-Label Treatment Extension||94
629892|NCT00191945|1545725|P2|STARTED|Open-Label Treatment Extension||48
629893|NCT00191945|1545726|P1|STARTED|Open-Label Treatment Extension||94
629894|NCT00191945|1545725|P2|NOT COMPLETED|Double-Blind Acute Treatment||3
629895|NCT00191945|1545726|P1|NOT COMPLETED|Double-Blind Acute Treatment||6
629896|NCT00191945|1545725|P2|COMPLETED|Double-Blind Acute Treatment||48
629897|NCT00191945|1545726|P1|COMPLETED|Double-Blind Acute Treatment||94
629898|NCT00191945|1545725|P2|STARTED|Double-Blind Acute Treatment||51
629899|NCT00191945|1545726|P1|STARTED|Double-Blind Acute Treatment||100
629900|NCT00191906|1545762|P4|NOT COMPLETED|Study Period III||0
629901|NCT00191906|1545763|P3|NOT COMPLETED|Study Period III||0
629902|NCT00191906|1545764|P2|NOT COMPLETED|Study Period III||4
629903|NCT00191906|1545765|P1|NOT COMPLETED|Study Period III||5
629904|NCT00191906|1545762|P4|COMPLETED|Study Period III||0
629905|NCT00191906|1545763|P3|COMPLETED|Study Period III||0
629906|NCT00191906|1545764|P2|COMPLETED|Study Period III||7
629907|NCT00191906|1545765|P1|COMPLETED|Study Period III||9
629908|NCT00191906|1545762|P4|STARTED|Study Period III||0
629909|NCT00191906|1545763|P3|STARTED|Study Period III||0
629910|NCT00191906|1545764|P2|STARTED|Study Period III|These are patients who continued in optional open-label period (1 country). All received atomoxetine|11
629911|NCT00191906|1545765|P1|STARTED|Study Period III|These are patients who continued in optional open-label period (1 country). All received atomoxetine|14
629913|NCT00191906|1545763|P3|NOT COMPLETED|Study Period II||1
629914|NCT00191906|1545764|P2|NOT COMPLETED|Study Period II||5
629915|NCT00191906|1545765|P1|NOT COMPLETED|Study Period II||0
629916|NCT00191906|1545762|P4|COMPLETED|Study Period II||18
629917|NCT00191906|1545763|P3|COMPLETED|Study Period II||26
629918|NCT00191906|1545764|P2|COMPLETED|Study Period II||32
629919|NCT00191906|1545765|P1|COMPLETED|Study Period II||39
629920|NCT00191906|1545762|P4|STARTED|Study Period II||18
629921|NCT00191906|1545763|P3|STARTED|Study Period II||27
629922|NCT00191906|1545764|P2|STARTED|Study Period II||37
629923|NCT00191906|1545765|P1|STARTED|Study Period II||39
629924|NCT00191854|1545808|P3|NOT COMPLETED|Overall Study||39
629925|NCT00191854|1545809|P2|NOT COMPLETED|Overall Study||30
629926|NCT00191854|1545810|P1|NOT COMPLETED|Overall Study||37
629927|NCT00191854|1545808|P3|COMPLETED|Overall Study||12
629928|NCT00191854|1545809|P2|COMPLETED|Overall Study||17
629929|NCT00191854|1545810|P1|COMPLETED|Overall Study||12
629930|NCT00191854|1545808|P3|Received at Least One Dose of Study Drug|Overall Study|Screen failure: discontinued prior to receiving study drug.|50
629931|NCT00191854|1545809|P2|Received at Least One Dose of Study Drug|Overall Study||47
629932|NCT00191854|1545810|P1|Received at Least One Dose of Study Drug|Overall Study||49
629933|NCT00191854|1545808|P3|STARTED|Overall Study||51
629934|NCT00191854|1545809|P2|STARTED|Overall Study||47
629935|NCT00191854|1545810|P1|STARTED|Overall Study||49
629936|NCT00191815|1545830|P1|NOT COMPLETED|Overall Study||40
629937|NCT00191815|1545830|P1|COMPLETED|Overall Study||30
629938|NCT00191815|1545830|P1|Treated|Overall Study||67
629939|NCT00191815|1545830|P1|STARTED|Overall Study||70
629940|NCT00191789|1545842|P1|NOT COMPLETED|Overall Study||25
629941|NCT00191789|1545842|P1|COMPLETED|Overall Study||40
629942|NCT00191789|1545842|P1|STARTED|Overall Study||65
629943|NCT00191724|1545859|P5|NOT COMPLETED|Overall Study||3
629944|NCT00191724|1545860|P4|NOT COMPLETED|Overall Study||3
629945|NCT00191724|1545861|P3|NOT COMPLETED|Overall Study||1
629946|NCT00191724|1545862|P2|NOT COMPLETED|Overall Study||1
629947|NCT00191724|1545863|P1|NOT COMPLETED|Overall Study||1
629948|NCT00191724|1545859|P5|COMPLETED|Overall Study||12
629949|NCT00191724|1545860|P4|COMPLETED|Overall Study||5
629950|NCT00191724|1545861|P3|COMPLETED|Overall Study||8
629951|NCT00191724|1545862|P2|COMPLETED|Overall Study||8
629952|NCT00191724|1545863|P1|COMPLETED|Overall Study||5
629953|NCT00191724|1545859|P5|STARTED|Overall Study||15
629954|NCT00191724|1545860|P4|STARTED|Overall Study||8
629955|NCT00191724|1545861|P3|STARTED|Overall Study||9
629956|NCT00191724|1545862|P2|STARTED|Overall Study||9
629957|NCT00191724|1545863|P1|STARTED|Overall Study||6
629958|NCT00191646|1545892|P2|NOT COMPLETED|Overall Study||153
629959|NCT00191646|1545893|P1|NOT COMPLETED|Overall Study||171
629960|NCT00191646|1545892|P2|COMPLETED|Overall Study|Completed was defined as the patients treated in either consolidation therapy or crossover therapy.|261
629961|NCT00191646|1545893|P1|COMPLETED|Overall Study|Completed was defined as the patients treated in either consolidation therapy or crossover therapy.|246
629962|NCT00191646|1545892|P2|Received Crossover Therapy|Overall Study||78
629963|NCT00191646|1545893|P1|Received Crossover Therapy|Overall Study||77
629964|NCT00191646|1545892|P2|Received Consolidation Therapy|Overall Study||183
629965|NCT00191646|1545893|P1|Received Consolidation Therapy|Overall Study||169
629966|NCT00191646|1545892|P2|Received Induction Therapy|Overall Study||409
629967|NCT00191646|1545893|P1|Received Induction Therapy|Overall Study||411
629968|NCT00191646|1545892|P2|STARTED|Overall Study||414
629969|NCT00191646|1545893|P1|STARTED|Overall Study||417
629970|NCT00191477|1545913|P2|NOT COMPLETED|Overall Study||129
629971|NCT00191477|1545914|P1|NOT COMPLETED|Overall Study||138
629972|NCT00191477|1545913|P2|COMPLETED|Overall Study||47
629973|NCT00191477|1545914|P1|COMPLETED|Overall Study||41
629974|NCT00191477|1545913|P2|Received Study Drug|Overall Study||162
629975|NCT00191477|1545914|P1|Received Study Drug|Overall Study||166
629976|NCT00191477|1545913|P2|STARTED|Overall Study||176
629977|NCT00191477|1545914|P1|STARTED|Overall Study||179
629978|NCT00191451|1545933|P3|NOT COMPLETED|Overall Study||14
629979|NCT00191451|1545934|P2|NOT COMPLETED|Overall Study||14
629980|NCT00191451|1545935|P1|NOT COMPLETED|Overall Study||7
629981|NCT00191451|1545933|P3|COMPLETED|Overall Study||35
629982|NCT00191451|1545934|P2|COMPLETED|Overall Study||37
629983|NCT00191451|1545935|P1|COMPLETED|Overall Study||43
629984|NCT00191451|1545933|P3|Received at Least One Dose of Study Drug|Overall Study||47
629985|NCT00191451|1545934|P2|Received at Least One Dose of Study Drug|Overall Study||48
629986|NCT00191451|1545935|P1|Received at Least One Dose of Study Drug|Overall Study||50
629987|NCT00191451|1545933|P3|STARTED|Overall Study||49
629988|NCT00191451|1545934|P2|STARTED|Overall Study||51
629989|NCT00191451|1545935|P1|STARTED|Overall Study||50
629990|NCT00191386|1545955|P1|NOT COMPLETED|Overall Study||160
629991|NCT00191386|1545955|P1|COMPLETED|Overall Study||68
629992|NCT00191386|1545955|P1|3 Years|Overall Study||65
629993|NCT00191386|1545955|P1|2 Years|Overall Study||105
629994|NCT00191386|1545955|P1|12 Months|Overall Study||149
629995|NCT00191386|1545955|P1|6 Months|Overall Study||183
629996|NCT00191386|1545955|P1|STARTED|Overall Study||228
629997|NCT00191334|1545962|P1|NOT COMPLETED|Overall Study||17
629998|NCT00191334|1545962|P1|COMPLETED|Overall Study||33
629999|NCT00191334|1545962|P1|STARTED|Overall Study||50
630000|NCT00191308|1545970|P1|NOT COMPLETED|Overall Study||1
630001|NCT00191308|1545970|P1|COMPLETED|Overall Study||29
630002|NCT00191308|1545970|P1|STARTED|Overall Study||30
630003|NCT00191282|1545980|P2|NOT COMPLETED|Overall Study||212
630004|NCT00191282|1545981|P1|NOT COMPLETED|Overall Study||220
630005|NCT00191282|1545980|P2|COMPLETED|Overall Study||346
630006|NCT00191282|1545981|P1|COMPLETED|Overall Study||338
630007|NCT00191282|1545980|P2|STARTED|Overall Study||558
630008|NCT00191282|1545981|P1|STARTED|Overall Study||558
630009|NCT00191269|1546041|P2|NOT COMPLETED|Overall Study||58
630010|NCT00191269|1546042|P1|NOT COMPLETED|Overall Study||6
630011|NCT00191269|1546041|P2|COMPLETED|Overall Study||4
630012|NCT00191269|1546042|P1|COMPLETED|Overall Study||0
630013|NCT00191269|1546041|P2|STARTED|Overall Study||62
630014|NCT00191269|1546042|P1|STARTED|Overall Study||6
630015|NCT00191191|1546058|P2|NOT COMPLETED|Overall Study||112
630016|NCT00191191|1546059|P1|NOT COMPLETED|Overall Study||114
630017|NCT00191191|1546058|P2|COMPLETED|Overall Study||0
630018|NCT00191191|1546059|P1|COMPLETED|Overall Study||0
630019|NCT00191191|1546058|P2|Full Analysis Set Population|Overall Study||108
630020|NCT00191191|1546059|P1|Full Analysis Set Population|Overall Study||108
630021|NCT00191191|1546058|P2|Safety Analysis Population|Overall Study||111
630022|NCT00191191|1546059|P1|Safety Analysis Population|Overall Study||114
630023|NCT00191191|1546058|P2|STARTED|Overall Study||112
630024|NCT00191191|1546059|P1|STARTED|Overall Study||114
630025|NCT00191165|1546075|P2|NOT COMPLETED|Overall Study||2
630026|NCT00191165|1546076|P1|NOT COMPLETED|Overall Study||2
630027|NCT00191165|1546075|P2|COMPLETED|Overall Study||11
630028|NCT00191165|1546076|P1|COMPLETED|Overall Study||12
630029|NCT00191165|1546075|P2|STARTED|Overall Study||13
630030|NCT00191165|1546076|P1|STARTED|Overall Study||14
630031|NCT00191152|1546088|P2|NOT COMPLETED|Crossover Treatment||28
630032|NCT00191152|1546089|P1|NOT COMPLETED|Crossover Treatment||27
630033|NCT00191152|1546088|P2|COMPLETED|Crossover Treatment||53
630034|NCT00191152|1546089|P1|COMPLETED|Crossover Treatment||50
630035|NCT00191152|1546088|P2|Received Treatment|Crossover Treatment||80
630036|NCT00191152|1546089|P1|Received Treatment|Crossover Treatment||76
630037|NCT00191152|1546088|P2|STARTED|Crossover Treatment||81
630038|NCT00191152|1546089|P1|STARTED|Crossover Treatment||77
630039|NCT00191152|1546088|P2|NOT COMPLETED|Initial Treatment||153
630040|NCT00191152|1546089|P1|NOT COMPLETED|Initial Treatment||141
630041|NCT00191152|1546088|P2|COMPLETED|Initial Treatment||83
630042|NCT00191152|1546089|P1|COMPLETED|Initial Treatment||98
630043|NCT00191152|1546088|P2|Received Initial Treatment|Initial Treatment||227
630044|NCT00191152|1546089|P1|Received Initial Treatment|Initial Treatment||236
630045|NCT00191152|1546088|P2|STARTED|Initial Treatment||236
630046|NCT00191152|1546089|P1|STARTED|Initial Treatment||239
630047|NCT00191139|1546121|P2|NOT COMPLETED|Overall Study||12
630048|NCT00191139|1546122|P1|NOT COMPLETED|Overall Study||5
630049|NCT00191139|1546121|P2|COMPLETED|Overall Study||20
630050|NCT00191139|1546122|P1|COMPLETED|Overall Study||27
630051|NCT00191139|1546121|P2|STARTED|Overall Study||32
630052|NCT00191139|1546122|P1|STARTED|Overall Study||32
630053|NCT00191113|1546138|P2|NOT COMPLETED|Addendum 3||0
630054|NCT00191113|1546139|P1|NOT COMPLETED|Addendum 3||0
630055|NCT00191113|1546138|P2|COMPLETED|Addendum 3||37
630056|NCT00191113|1546139|P1|COMPLETED|Addendum 3||20
630057|NCT00191113|1546138|P2|STARTED|Addendum 3||37
630058|NCT00191113|1546139|P1|STARTED|Addendum 3||20
630059|NCT00191113|1546138|P2|NOT COMPLETED|Addendum 2||17
630060|NCT00191113|1546139|P1|NOT COMPLETED|Addendum 2||10
630061|NCT00191113|1546138|P2|COMPLETED|Addendum 2||31
630062|NCT00191113|1546139|P1|COMPLETED|Addendum 2||18
630063|NCT00191113|1546138|P2|STARTED|Addendum 2||48
630064|NCT00191113|1546139|P1|STARTED|Addendum 2||28
630065|NCT00191113|1546138|P2|NOT COMPLETED|Addendum 1||0
630066|NCT00191113|1546139|P1|NOT COMPLETED|Addendum 1||0
630067|NCT00191113|1546138|P2|COMPLETED|Addendum 1|Not Applicable -- only Control patients were eligible for Addendum 1|0
630068|NCT00191113|1546139|P1|COMPLETED|Addendum 1||2
630069|NCT00191113|1546138|P2|STARTED|Addendum 1|Not Applicable -- only Control patients were eligible for Addendum 1|0
630070|NCT00191113|1546139|P1|STARTED|Addendum 1||2
630071|NCT00191113|1546138|P2|NOT COMPLETED|Core Study||15
630072|NCT00191113|1546139|P1|NOT COMPLETED|Core Study||35
630073|NCT00191113|1546138|P2|COMPLETED|Core Study||61
630074|NCT00191113|1546139|P1|COMPLETED|Core Study||43
630075|NCT00191113|1546138|P2|STARTED|Core Study||76
630076|NCT00191113|1546139|P1|STARTED|Core Study||78
630077|NCT00191100|1546181|P2|NOT COMPLETED|Overall Study||12
630078|NCT00191100|1546182|P1|NOT COMPLETED|Overall Study||42
630079|NCT00191100|1546181|P2|COMPLETED|Overall Study||244
630080|NCT00191100|1546182|P1|COMPLETED|Overall Study||217
630081|NCT00191100|1546181|P2|STARTED|Overall Study||256
630082|NCT00191100|1546182|P1|STARTED|Overall Study||259
630083|NCT00190983|1546198|P1|NOT COMPLETED|Overall Study||2
630084|NCT00190983|1546198|P1|COMPLETED|Overall Study|Completed means patient received treatment and was evaluable for response.|27
630085|NCT00190983|1546198|P1|STARTED|Overall Study||29
630086|NCT00190775|1546207|P2|NOT COMPLETED|Overall Study||100
630087|NCT00190775|1546208|P1|NOT COMPLETED|Overall Study||149
630088|NCT00190775|1546207|P2|COMPLETED|Overall Study||134
630089|NCT00190775|1546208|P1|COMPLETED|Overall Study||119
630090|NCT00190775|1546207|P2|Received Study Drug|Overall Study||234
630091|NCT00190775|1546208|P1|Received Study Drug|Overall Study||266
630092|NCT00190775|1546207|P2|STARTED|Overall Study||234
630093|NCT00190775|1546208|P1|STARTED|Overall Study||268
630094|NCT00190749|1546279|P2|NOT COMPLETED|Overall Study||31
630095|NCT00190749|1546280|P1|NOT COMPLETED|Overall Study||26
630096|NCT00190749|1546279|P2|COMPLETED|Overall Study||31
630097|NCT00190749|1546280|P1|COMPLETED|Overall Study||42
630098|NCT00190749|1546279|P2|STARTED|Overall Study||62
630099|NCT00190749|1546280|P1|STARTED|Overall Study||68
630100|NCT00190684|1546344|P1|NOT COMPLETED|Overall Study||1489
630101|NCT00190684|1546344|P1|COMPLETED|Overall Study|Number of patients that completed overall study (through Period VI)|64
630102|NCT00190684|1546344|P1|Received at Least 1 Dose of Study Drug|Overall Study|1553 patients entered the study; 1551 were enrolled and received study drug.|1551
630103|NCT00190684|1546344|P1|STARTED|Overall Study||1553
630104|NCT00190671|1546365|P2|NOT COMPLETED|Overall Study||42
630105|NCT00190671|1546366|P1|NOT COMPLETED|Overall Study||27
630106|NCT00190671|1546365|P2|COMPLETED|Overall Study||19
630107|NCT00190671|1546366|P1|COMPLETED|Overall Study||15
630108|NCT00190671|1546365|P2|STARTED|Overall Study||61
630109|NCT00190671|1546366|P1|STARTED|Overall Study||42
630110|NCT00189540|1546386|P2|NOT COMPLETED|Overall Study||1
630111|NCT00189540|1546387|P1|NOT COMPLETED|Overall Study||7
630112|NCT00189540|1546386|P2|COMPLETED|Overall Study||5
630113|NCT00189540|1546387|P1|COMPLETED|Overall Study||14
630114|NCT00189540|1546386|P2|STARTED|Overall Study||6
630115|NCT00189540|1546387|P1|STARTED|Overall Study||21
630116|NCT00189488|1546405|P2|NOT COMPLETED|Overall Study||22
630117|NCT00189488|1546406|P1|NOT COMPLETED|Overall Study||15
630118|NCT00189488|1546405|P2|COMPLETED|Overall Study||55
630119|NCT00189488|1546406|P1|COMPLETED|Overall Study||63
630120|NCT00189488|1546405|P2|Received Palifermin/Placebo|Overall Study||76
630121|NCT00189488|1546406|P1|Received Palifermin/Placebo|Overall Study||75
630122|NCT00189488|1546405|P2|STARTED|Overall Study||77
630123|NCT00189488|1546406|P1|STARTED|Overall Study||78
630124|NCT00189475|1546428|P2|NOT COMPLETED|Overall Study||0
630125|NCT00189475|1546429|P1|NOT COMPLETED|Overall Study||0
630126|NCT00189475|1546428|P2|COMPLETED|Overall Study||42
630127|NCT00189475|1546429|P1|COMPLETED|Overall Study||42
630128|NCT00189475|1546428|P2|STARTED|Overall Study||42
630129|NCT00189475|1546429|P1|STARTED|Overall Study||42
630130|NCT00189462|1546437|P2|NOT COMPLETED|Overall Study||21
630131|NCT00189462|1546438|P1|NOT COMPLETED|Overall Study||23
630132|NCT00189462|1546437|P2|COMPLETED|Overall Study||28
630133|NCT00189462|1546438|P1|COMPLETED|Overall Study||27
630134|NCT00189462|1546437|P2|STARTED|Overall Study||49
630135|NCT00189462|1546438|P1|STARTED|Overall Study||50
630136|NCT00189436|1546446|P2|NOT COMPLETED|Overall Study||5
630137|NCT00189436|1546447|P1|NOT COMPLETED|Overall Study||8
630138|NCT00189436|1546446|P2|COMPLETED|Overall Study||25
630139|NCT00189436|1546447|P1|COMPLETED|Overall Study||23
630140|NCT00189436|1546446|P2|STARTED|Overall Study||30
630141|NCT00189436|1546447|P1|STARTED|Overall Study||31
630142|NCT00189423|1546455|P2|NOT COMPLETED|Overall Study||766
630143|NCT00189423|1546456|P1|NOT COMPLETED|Overall Study||765
630144|NCT00189423|1546455|P2|COMPLETED|Overall Study||74
630145|NCT00189423|1546456|P1|COMPLETED|Overall Study||48
630146|NCT00189423|1546455|P2|STARTED|Overall Study||840
630147|NCT00189423|1546456|P1|STARTED|Overall Study||813
630148|NCT00189306|1546478|P1|NOT COMPLETED|Long-Term Follow-up||38
630149|NCT00189306|1546478|P1|COMPLETED|Long-Term Follow-up||119
630150|NCT00189306|1546478|P1|STARTED|Long-Term Follow-up||157
630151|NCT00189306|1546478|P1|NOT COMPLETED|Posttreatment Period||12
630152|NCT00189306|1546478|P1|COMPLETED|Posttreatment Period|11 subjects discontinued during the 12-week Posttreatment Period|157
630153|NCT00189306|1546478|P1|STARTED|Posttreatment Period|5 of the 169 discontinued, but 4 returned for the Posttreatment Period|169
630154|NCT00189306|1546478|P1|NOT COMPLETED|Treatment Period||5
630155|NCT00189306|1546478|P1|COMPLETED|Treatment Period|5 subjects discontinued during treatment - 4 subjects returned for the Posttreatment Period|164
630156|NCT00189306|1546478|P1|STARTED|Treatment Period||169
630157|NCT00189202|1546483|P1|NOT COMPLETED|Overall Study||5
630158|NCT00189202|1546483|P1|COMPLETED|Overall Study||44
630159|NCT00189202|1546483|P1|STARTED|Overall Study||49
630160|NCT00189137|1546494|P2|NOT COMPLETED|Overall Study||0
630161|NCT00189137|1546495|P1|NOT COMPLETED|Overall Study||0
630162|NCT00189137|1546494|P2|COMPLETED|Overall Study||43
630163|NCT00189137|1546495|P1|COMPLETED|Overall Study||37
630164|NCT00189137|1546494|P2|STARTED|Overall Study||43
630165|NCT00189137|1546495|P1|STARTED|Overall Study||37
630166|NCT00189098|1546505|P2|NOT COMPLETED|Overall Study||6
630167|NCT00189098|1546506|P1|NOT COMPLETED|Overall Study||5
630168|NCT00189098|1546505|P2|COMPLETED|Overall Study||44
630169|NCT00189098|1546506|P1|COMPLETED|Overall Study||46
630170|NCT00189098|1546505|P2|STARTED|Overall Study||50
630171|NCT00189098|1546506|P1|STARTED|Overall Study||51
630172|NCT00187889|1546524|P2|NOT COMPLETED|Overall Study||4
630173|NCT00187889|1546525|P1|NOT COMPLETED|Overall Study||6
630174|NCT00187889|1546524|P2|COMPLETED|Overall Study||22
630175|NCT00187889|1546525|P1|COMPLETED|Overall Study||19
630176|NCT00187889|1546524|P2|STARTED|Overall Study||26
630177|NCT00187889|1546525|P1|STARTED|Overall Study||25
630178|NCT00187876|1546535|P2|NOT COMPLETED|Overall Study||0
630179|NCT00187876|1546536|P1|NOT COMPLETED|Overall Study||0
630180|NCT00187876|1546535|P2|COMPLETED|Overall Study||43
630181|NCT00187876|1546536|P1|COMPLETED|Overall Study||24
630182|NCT00187876|1546535|P2|STARTED|Overall Study||43
630183|NCT00187876|1546536|P1|STARTED|Overall Study||24
630184|NCT00187720|1546544|P2|NOT COMPLETED|Overall Study||0
630185|NCT00187720|1546545|P1|NOT COMPLETED|Overall Study||0
630186|NCT00187720|1546544|P2|COMPLETED|Overall Study||14
630187|NCT00187720|1546545|P1|COMPLETED|Overall Study||9
630188|NCT00187720|1546544|P2|STARTED|Overall Study||14
630189|NCT00187720|1546545|P1|STARTED|Overall Study||9
630190|NCT00187681|1546553|P2|NOT COMPLETED|Overall Study||0
630191|NCT00187681|1546554|P1|NOT COMPLETED|Overall Study||0
630192|NCT00187681|1546553|P2|COMPLETED|Overall Study||8
630193|NCT00187681|1546554|P1|COMPLETED|Overall Study||12
630194|NCT00187681|1546553|P2|STARTED|Overall Study||8
630195|NCT00187681|1546554|P1|STARTED|Overall Study||12
630196|NCT00187655|1546562|P1|NOT COMPLETED|Overall Study||0
630197|NCT00187655|1546562|P1|COMPLETED|Overall Study||24
630198|NCT00187655|1546562|P1|STARTED|Overall Study||24
630199|NCT00187486|1546567|P1|NOT COMPLETED|Overall Study||1
630200|NCT00187486|1546567|P1|COMPLETED|Overall Study||65
630201|NCT00187486|1546567|P1|STARTED|Overall Study||66
630202|NCT00187226|1546578|P6|NOT COMPLETED|Overall Study||0
630203|NCT00187226|1546579|P5|NOT COMPLETED|Overall Study||0
630204|NCT00187226|1546580|P4|NOT COMPLETED|Overall Study||0
630205|NCT00187226|1546581|P3|NOT COMPLETED|Overall Study||0
630206|NCT00187226|1546582|P2|NOT COMPLETED|Overall Study||0
630207|NCT00187226|1546583|P1|NOT COMPLETED|Overall Study||0
630208|NCT00187226|1546578|P6|COMPLETED|Overall Study||1
630209|NCT00187226|1546579|P5|COMPLETED|Overall Study||34
630210|NCT00187226|1546580|P4|COMPLETED|Overall Study||2
630211|NCT00187226|1546581|P3|COMPLETED|Overall Study||28
630212|NCT00187226|1546582|P2|COMPLETED|Overall Study||49
630213|NCT00187226|1546583|P1|COMPLETED|Overall Study||88
630214|NCT00187226|1546578|P6|STARTED|Overall Study||1
630215|NCT00187226|1546579|P5|STARTED|Overall Study||34
630216|NCT00187226|1546580|P4|STARTED|Overall Study||2
630217|NCT00187226|1546581|P3|STARTED|Overall Study||28
630218|NCT00187226|1546582|P2|STARTED|Overall Study||49
630219|NCT00187226|1546583|P1|STARTED|Overall Study||88
630220|NCT00187200|1546599|P2|NOT COMPLETED|Overall Study||18
630221|NCT00187200|1546600|P1|NOT COMPLETED|Overall Study||18
630222|NCT00187200|1546599|P2|COMPLETED|Overall Study||26
630223|NCT00187200|1546600|P1|COMPLETED|Overall Study||31
630224|NCT00187200|1546599|P2|STARTED|Overall Study||44
630225|NCT00187200|1546600|P1|STARTED|Overall Study||49
630226|NCT00187135|1546618|P6|NOT COMPLETED|Visit Three||6
630227|NCT00187135|1546619|P5|NOT COMPLETED|Visit Three||8
630228|NCT00187135|1546620|P4|NOT COMPLETED|Visit Three||9
630229|NCT00187135|1546621|P3|NOT COMPLETED|Visit Three||9
630230|NCT00187135|1546622|P2|NOT COMPLETED|Visit Three||7
630231|NCT00187135|1546623|P1|NOT COMPLETED|Visit Three||7
630232|NCT00187135|1546618|P6|COMPLETED|Visit Three||12
630233|NCT00187135|1546619|P5|COMPLETED|Visit Three||11
630234|NCT00187135|1546620|P4|COMPLETED|Visit Three||9
630235|NCT00187135|1546621|P3|COMPLETED|Visit Three||14
630236|NCT00187135|1546622|P2|COMPLETED|Visit Three||17
630237|NCT00187135|1546623|P1|COMPLETED|Visit Three||14
630238|NCT00187135|1546618|P6|STARTED|Visit Three||18
630239|NCT00187135|1546619|P5|STARTED|Visit Three||19
630240|NCT00187135|1546620|P4|STARTED|Visit Three||18
630241|NCT00187135|1546621|P3|STARTED|Visit Three||23
630242|NCT00187135|1546622|P2|STARTED|Visit Three||24
630243|NCT00187135|1546623|P1|STARTED|Visit Three||21
630244|NCT00187135|1546618|P6|NOT COMPLETED|Visit Two||8
630245|NCT00187135|1546619|P5|NOT COMPLETED|Visit Two||6
630246|NCT00187135|1546620|P4|NOT COMPLETED|Visit Two||8
630247|NCT00187135|1546621|P3|NOT COMPLETED|Visit Two||2
630248|NCT00187135|1546622|P2|NOT COMPLETED|Visit Two||3
630249|NCT00187135|1546623|P1|NOT COMPLETED|Visit Two||5
630250|NCT00187135|1546618|P6|COMPLETED|Visit Two||18
630251|NCT00187135|1546619|P5|COMPLETED|Visit Two||19
630252|NCT00187135|1546620|P4|COMPLETED|Visit Two||18
630253|NCT00187135|1546621|P3|COMPLETED|Visit Two||23
630254|NCT00187135|1546622|P2|COMPLETED|Visit Two||24
630255|NCT00187135|1546623|P1|COMPLETED|Visit Two||21
630256|NCT00187135|1546618|P6|STARTED|Visit Two||26
630257|NCT00187135|1546619|P5|STARTED|Visit Two||25
630258|NCT00187135|1546620|P4|STARTED|Visit Two||26
630259|NCT00187135|1546621|P3|STARTED|Visit Two||25
630260|NCT00187135|1546622|P2|STARTED|Visit Two||27
630261|NCT00187135|1546623|P1|STARTED|Visit Two||26
630262|NCT00187135|1546618|P6|NOT COMPLETED|Visit One||2
630263|NCT00187135|1546619|P5|NOT COMPLETED|Visit One||0
630264|NCT00187135|1546620|P4|NOT COMPLETED|Visit One||0
630265|NCT00187135|1546621|P3|NOT COMPLETED|Visit One||0
630266|NCT00187135|1546622|P2|NOT COMPLETED|Visit One||1
630267|NCT00187135|1546623|P1|NOT COMPLETED|Visit One||4
630268|NCT00187135|1546618|P6|COMPLETED|Visit One||26
630269|NCT00187135|1546619|P5|COMPLETED|Visit One||25
630270|NCT00187135|1546620|P4|COMPLETED|Visit One||26
630271|NCT00187135|1546621|P3|COMPLETED|Visit One||25
630272|NCT00187135|1546622|P2|COMPLETED|Visit One||27
630273|NCT00187135|1546623|P1|COMPLETED|Visit One||26
630274|NCT00187135|1546618|P6|STARTED|Visit One||28
630275|NCT00187135|1546619|P5|STARTED|Visit One||25
630276|NCT00187135|1546620|P4|STARTED|Visit One||26
630277|NCT00187135|1546621|P3|STARTED|Visit One||25
630278|NCT00187135|1546622|P2|STARTED|Visit One||28
630279|NCT00187135|1546623|P1|STARTED|Visit One||30
630280|NCT00187096|1546646|P3|NOT COMPLETED|Overall Study||1
630281|NCT00187096|1546647|P2|NOT COMPLETED|Overall Study||0
630282|NCT00187096|1546648|P1|NOT COMPLETED|Overall Study||0
630283|NCT00187096|1546646|P3|COMPLETED|Overall Study||11
630284|NCT00187096|1546647|P2|COMPLETED|Overall Study||3
630285|NCT00187096|1546648|P1|COMPLETED|Overall Study||10
630286|NCT00187096|1546646|P3|STARTED|Overall Study||12
630287|NCT00187096|1546647|P2|STARTED|Overall Study||3
630288|NCT00187096|1546648|P1|STARTED|Overall Study||10
630289|NCT00186901|1546686|P3|NOT COMPLETED|Overall Study||149
630290|NCT00186901|1546687|P2|NOT COMPLETED|Overall Study||45
630291|NCT00186901|1546688|P1|NOT COMPLETED|Overall Study||49
630292|NCT00186901|1546686|P3|COMPLETED|Overall Study||0
630293|NCT00186901|1546687|P2|COMPLETED|Overall Study||96
630294|NCT00186901|1546688|P1|COMPLETED|Overall Study||85
630295|NCT00186901|1546686|P3|24 Month Follow-up|Overall Study||0
630296|NCT00186901|1546687|P2|24 Month Follow-up|Overall Study||107
630297|NCT00186901|1546688|P1|24 Month Follow-up|Overall Study||106
630298|NCT00186901|1546686|P3|12 Month Follow-up|Overall Study||0
630299|NCT00186901|1546687|P2|12 Month Follow-up|Overall Study||122
630300|NCT00186901|1546688|P1|12 Month Follow-up|Overall Study||117
630301|NCT00186901|1546686|P3|Baseline|Overall Study||0
630302|NCT00186901|1546687|P2|Baseline|Overall Study||141
630303|NCT00186901|1546688|P1|Baseline|Overall Study||134
630304|NCT00186901|1546686|P3|STARTED|Overall Study||149
630305|NCT00186901|1546687|P2|STARTED|Overall Study||141
630306|NCT00186901|1546688|P1|STARTED|Overall Study||134
630307|NCT00186888|1546728|P3|NOT COMPLETED|Overall Study||0
630308|NCT00186888|1546729|P2|NOT COMPLETED|Overall Study||3
630309|NCT00186888|1546730|P1|NOT COMPLETED|Overall Study||4
630310|NCT00186888|1546728|P3|COMPLETED|Overall Study||55
630311|NCT00186888|1546729|P2|COMPLETED|Overall Study||24
630312|NCT00186888|1546730|P1|COMPLETED|Overall Study||19
630313|NCT00186888|1546728|P3|Window Therapy|Overall Study||0
630314|NCT00186888|1546729|P2|Window Therapy|Overall Study||27
630315|NCT00186888|1546730|P1|Window Therapy|Overall Study||0
630316|NCT00186888|1546728|P3|STARTED|Overall Study||55
630317|NCT00186888|1546729|P2|STARTED|Overall Study||27
630318|NCT00186888|1546730|P1|STARTED|Overall Study||23
630319|NCT00186875|1546807|P2|NOT COMPLETED|Overall Study||0
630320|NCT00186875|1546808|P1|NOT COMPLETED|Overall Study||0
630321|NCT00186875|1546807|P2|COMPLETED|Overall Study||14
630322|NCT00186875|1546808|P1|COMPLETED|Overall Study||26
630323|NCT00186875|1546807|P2|STARTED|Overall Study||14
630324|NCT00186875|1546808|P1|STARTED|Overall Study||26
630325|NCT00186628|1546822|P1|NOT COMPLETED|Overall Study||3
630326|NCT00186628|1546822|P1|COMPLETED|Overall Study||33
630327|NCT00186628|1546822|P1|STARTED|Overall Study||36
630328|NCT00186537|1546833|P3|NOT COMPLETED|Overall Study||3
630329|NCT00186537|1546834|P2|NOT COMPLETED|Overall Study||0
630330|NCT00186537|1546835|P1|NOT COMPLETED|Overall Study||7
630331|NCT00186537|1546833|P3|COMPLETED|Overall Study||13
630332|NCT00186537|1546834|P2|COMPLETED|Overall Study||12
630333|NCT00186537|1546835|P1|COMPLETED|Overall Study||12
630334|NCT00186537|1546833|P3|STARTED|Overall Study||16
630335|NCT00186537|1546834|P2|STARTED|Overall Study||12
630336|NCT00186537|1546835|P1|STARTED|Overall Study||19
630337|NCT00186485|1546849|P1|NOT COMPLETED|Overall Study||3
630338|NCT00186485|1546849|P1|COMPLETED|Overall Study||25
630339|NCT00186485|1546849|P1|STARTED|Overall Study||28
630340|NCT00186446|1546855|P1|NOT COMPLETED|Overall Study||9
630341|NCT00186446|1546855|P1|COMPLETED|Overall Study||11
630342|NCT00186446|1546855|P1|STARTED|Overall Study||20
630343|NCT00186186|1546861|P1|NOT COMPLETED|Overall Study||8
630344|NCT00186186|1546861|P1|COMPLETED|Overall Study||20
630345|NCT00186186|1546861|P1|STARTED|Overall Study||28
630346|NCT00186121|1546866|P1|NOT COMPLETED|Overall Study||3
630347|NCT00186121|1546866|P1|COMPLETED|Overall Study||32
630348|NCT00186121|1546866|P1|STARTED|Overall Study||35
630349|NCT00186069|1546878|P2|NOT COMPLETED|Overall Study||0
630350|NCT00186069|1546879|P1|NOT COMPLETED|Overall Study||0
630351|NCT00186069|1546878|P2|COMPLETED|Overall Study||15
630352|NCT00186069|1546879|P1|COMPLETED|Overall Study||15
630353|NCT00186069|1546878|P2|STARTED|Overall Study|Enrollment goal was not reached due to the introduction of magnesium sulfate for neuroprotection|15
630354|NCT00186069|1546879|P1|STARTED|Overall Study|Enrollment goal was not reached due to the introduction of magnesium sulfate for neuroprotection|15
630355|NCT00186056|1546891|P2|NOT COMPLETED|Overall Study||1
630356|NCT00186056|1546892|P1|NOT COMPLETED|Overall Study||2
630357|NCT00186056|1546891|P2|COMPLETED|Overall Study||16
630358|NCT00186056|1546892|P1|COMPLETED|Overall Study||12
630359|NCT00186056|1546891|P2|STARTED|Overall Study||17
630360|NCT00186056|1546892|P1|STARTED|Overall Study||14
630361|NCT00186043|1546900|P2|NOT COMPLETED|Overall Study||13
630362|NCT00186043|1546901|P1|NOT COMPLETED|Overall Study||15
630363|NCT00186043|1546900|P2|COMPLETED|Overall Study||12
630364|NCT00186043|1546901|P1|COMPLETED|Overall Study||15
630365|NCT00186043|1546900|P2|STARTED|Overall Study||25
630366|NCT00186043|1546901|P1|STARTED|Overall Study||30
630367|NCT00186017|1546913|P2|NOT COMPLETED|Overall Study||3
630368|NCT00186017|1546914|P1|NOT COMPLETED|Overall Study||2
630369|NCT00186017|1546913|P2|COMPLETED|Overall Study||22
630370|NCT00186017|1546914|P1|COMPLETED|Overall Study||23
630371|NCT00186017|1546913|P2|STARTED|Overall Study||25
630372|NCT00186017|1546914|P1|STARTED|Overall Study||25
630373|NCT00185965|1546928|P2|NOT COMPLETED|Overall Study||1
630374|NCT00185965|1546929|P1|NOT COMPLETED|Overall Study||0
630375|NCT00185965|1546928|P2|COMPLETED|Overall Study||14
630376|NCT00185965|1546929|P1|COMPLETED|Overall Study||15
630377|NCT00185965|1546928|P2|STARTED|Overall Study||15
630378|NCT00185965|1546929|P1|STARTED|Overall Study||15
630379|NCT00185731|1546935|P1|NOT COMPLETED|Overall Study||2
630380|NCT00185731|1546935|P1|COMPLETED|Overall Study||23
630381|NCT00185731|1546935|P1|STARTED|Overall Study||25
630382|NCT00185692|1546941|P1|NOT COMPLETED|Overall Study||16
630383|NCT00185692|1546941|P1|COMPLETED|Overall Study||0
630384|NCT00185692|1546941|P1|STARTED|Overall Study||16
630385|NCT00185679|1546946|P1|NOT COMPLETED|Overall Study||0
630386|NCT00185679|1546946|P1|COMPLETED|Overall Study||13
630387|NCT00185679|1546946|P1|STARTED|Overall Study||13
630388|NCT00185640|1546952|P1|NOT COMPLETED|Overall Study||145
630389|NCT00185640|1546952|P1|COMPLETED|Overall Study||158
630390|NCT00185640|1546952|P1|90 Days Post-transplant|Overall Study||161
630391|NCT00185640|1546952|P1|Transplanted|Overall Study||296
630392|NCT00185640|1546952|P1|STARTED|Overall Study||303
630393|NCT00185614|1546961|P1|NOT COMPLETED|Allogenic HCT (Allo-HCT)||0
630394|NCT00185614|1546961|P1|COMPLETED|Allogenic HCT (Allo-HCT)||59
630395|NCT00185614|1546961|P1|STARTED|Allogenic HCT (Allo-HCT)||59
630396|NCT00185614|1546961|P1|NOT COMPLETED|Inter-treatment Period||4
630397|NCT00185614|1546961|P1|COMPLETED|Inter-treatment Period||59
630398|NCT00185614|1546961|P1|STARTED|Inter-treatment Period|Not all participants who received autologous transplant continued to receive allogeneic transplant.|63
630399|NCT00185614|1546961|P1|NOT COMPLETED|Autologous HCT (Auto-HCT)||0
630400|NCT00185614|1546961|P1|COMPLETED|Autologous HCT (Auto-HCT)||63
630401|NCT00185614|1546961|P1|STARTED|Autologous HCT (Auto-HCT)||63
630402|NCT00185588|1546973|P4|NOT COMPLETED|Overall Study||4
630403|NCT00185588|1546974|P3|NOT COMPLETED|Overall Study||6
630404|NCT00185588|1546975|P2|NOT COMPLETED|Overall Study||2
630405|NCT00185588|1546976|P1|NOT COMPLETED|Overall Study||3
630406|NCT00185588|1546973|P4|COMPLETED|Overall Study||13
630407|NCT00185588|1546974|P3|COMPLETED|Overall Study||0
630408|NCT00185588|1546975|P2|COMPLETED|Overall Study||2
630409|NCT00185588|1546976|P1|COMPLETED|Overall Study||3
630410|NCT00185588|1546973|P4|STARTED|Overall Study||17
630411|NCT00185588|1546974|P3|STARTED|Overall Study||6
630412|NCT00185588|1546975|P2|STARTED|Overall Study||4
630413|NCT00185588|1546976|P1|STARTED|Overall Study||6
630414|NCT00185458|1546990|P1|NOT COMPLETED|HRT Phase||27
630415|NCT00185458|1546990|P1|COMPLETED|HRT Phase||141
630416|NCT00185458|1546990|P1|STARTED|HRT Phase|168 subjects were eligible for the HRT phase out 336 who completed contraception phase.|168
630417|NCT00185458|1546990|P1|NOT COMPLETED|Contraception Phase||58
630418|NCT00185458|1546990|P1|COMPLETED|Contraception Phase||336
630419|NCT00185458|1546990|P1|STARTED|Contraception Phase||394
630420|NCT00185380|1547053|P3|NOT COMPLETED|Overall Study||74
630421|NCT00185380|1547054|P2|NOT COMPLETED|Overall Study||72
630422|NCT00185380|1547055|P1|NOT COMPLETED|Overall Study||66
630423|NCT00185380|1547053|P3|COMPLETED|Overall Study||182
630424|NCT00185380|1547054|P2|COMPLETED|Overall Study||174
630425|NCT00185380|1547055|P1|COMPLETED|Overall Study||174
630426|NCT00185380|1547053|P3|Subjects Received Treatment|Overall Study||254
630427|NCT00185380|1547054|P2|Subjects Received Treatment|Overall Study||245
630428|NCT00185380|1547055|P1|Subjects Received Treatment|Overall Study||239
630429|NCT00185380|1547053|P3|STARTED|Overall Study||256
630430|NCT00185380|1547054|P2|STARTED|Overall Study||246
630431|NCT00185380|1547055|P1|STARTED|Overall Study||240
630432|NCT00185211|1547083|P2|NOT COMPLETED|Follow-up Study (91031 - This Study)||34
630433|NCT00185211|1547084|P1|NOT COMPLETED|Follow-up Study (91031 - This Study)||26
630434|NCT00185211|1547083|P2|COMPLETED|Follow-up Study (91031 - This Study)||123
630435|NCT00185211|1547084|P1|COMPLETED|Follow-up Study (91031 - This Study)||235
630436|NCT00185211|1547083|P2|STARTED|Follow-up Study (91031 - This Study)|9 of the 166 subjects completing the placebo-controlled study did not consent to the Follow-up.|157
630437|NCT00185211|1547084|P1|STARTED|Follow-up Study (91031 - This Study)|10 of the 271 subjects completing the placebo-controlled study did not consent to the Follow-up.|261
630438|NCT00185211|1547083|P2|NOT COMPLETED|Placebo-controlled Study (92012)||10
630439|NCT00185211|1547084|P1|NOT COMPLETED|Placebo-controlled Study (92012)||21
630440|NCT00185211|1547083|P2|COMPLETED|Placebo-controlled Study (92012)||166
630441|NCT00185211|1547084|P1|COMPLETED|Placebo-controlled Study (92012)||271
630442|NCT00185211|1547083|P2|STARTED|Placebo-controlled Study (92012)||176
630443|NCT00185211|1547084|P1|STARTED|Placebo-controlled Study (92012)||292
630444|NCT00184717|1547112|P5|NOT COMPLETED|Extension Period (GHLIQUID-1517)||5
630445|NCT00184717|1547113|P4|NOT COMPLETED|Extension Period (GHLIQUID-1517)||3
630446|NCT00184717|1547114|P3|NOT COMPLETED|Extension Period (GHLIQUID-1517)||0
630447|NCT00184717|1547115|P2|NOT COMPLETED|Extension Period (GHLIQUID-1517)||6
630448|NCT00184717|1547116|P1|NOT COMPLETED|Extension Period (GHLIQUID-1517)||10
630449|NCT00184717|1547112|P5|COMPLETED|Extension Period (GHLIQUID-1517)||5
630450|NCT00184717|1547113|P4|COMPLETED|Extension Period (GHLIQUID-1517)||7
630451|NCT00184717|1547114|P3|COMPLETED|Extension Period (GHLIQUID-1517)||0
630452|NCT00184717|1547115|P2|COMPLETED|Extension Period (GHLIQUID-1517)||27
630453|NCT00184717|1547116|P1|COMPLETED|Extension Period (GHLIQUID-1517)||23
630454|NCT00184717|1547112|P5|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised from No treatment group|10
630455|NCT00184717|1547113|P4|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised from No treatment group|10
630456|NCT00184717|1547114|P3|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised to receive 0.033 or 0.067 mg|0
630457|NCT00184717|1547115|P2|STARTED|Extension Period (GHLIQUID-1517)|Three subjects did not continue in extension period|33
630458|NCT00184717|1547116|P1|STARTED|Extension Period (GHLIQUID-1517)|Three subjects did not continue in extension period|33
630459|NCT00184717|1547112|P5|NOT COMPLETED|Main Period (GHLIQUID-1516)||0
630460|NCT00184717|1547113|P4|NOT COMPLETED|Main Period (GHLIQUID-1516)||0
630461|NCT00184717|1547114|P3|NOT COMPLETED|Main Period (GHLIQUID-1516)||1
630462|NCT00184717|1547115|P2|NOT COMPLETED|Main Period (GHLIQUID-1516)||2
630463|NCT00184717|1547116|P1|NOT COMPLETED|Main Period (GHLIQUID-1516)||3
630464|NCT00184717|1547112|P5|COMPLETED|Main Period (GHLIQUID-1516)||0
630465|NCT00184717|1547113|P4|COMPLETED|Main Period (GHLIQUID-1516)||0
630466|NCT00184717|1547114|P3|COMPLETED|Main Period (GHLIQUID-1516)||20
630467|NCT00184717|1547115|P2|COMPLETED|Main Period (GHLIQUID-1516)||36
630468|NCT00184717|1547116|P1|COMPLETED|Main Period (GHLIQUID-1516)||36
630469|NCT00184717|1547112|P5|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0
630470|NCT00184717|1547113|P4|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0
630471|NCT00184717|1547114|P3|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||21
630472|NCT00184717|1547115|P2|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38
630473|NCT00184717|1547116|P1|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38
630474|NCT00184717|1547112|P5|STARTED|Main Period (GHLIQUID-1516)||0
630475|NCT00184717|1547113|P4|STARTED|Main Period (GHLIQUID-1516)||0
630476|NCT00184717|1547114|P3|STARTED|Main Period (GHLIQUID-1516)||21
630477|NCT00184717|1547115|P2|STARTED|Main Period (GHLIQUID-1516)||38
630478|NCT00184717|1547116|P1|STARTED|Main Period (GHLIQUID-1516)||39
630479|NCT00184600|1547157|P3|NOT COMPLETED|Overall Study||34
630480|NCT00184600|1547158|P2|NOT COMPLETED|Overall Study||51
630481|NCT00184600|1547159|P1|NOT COMPLETED|Overall Study||45
630482|NCT00184600|1547157|P3|COMPLETED|Overall Study||201
630483|NCT00184600|1547158|P2|COMPLETED|Overall Study||188
630484|NCT00184600|1547159|P1|COMPLETED|Overall Study||189
630485|NCT00184600|1547157|P3|STARTED|Overall Study||235
630486|NCT00184600|1547158|P2|STARTED|Overall Study||239
630487|NCT00184600|1547159|P1|STARTED|Overall Study||234
630488|NCT00184548|1547213|P4|NOT COMPLETED|Overall Study||7
630489|NCT00184548|1547214|P3|NOT COMPLETED|Overall Study||3
630490|NCT00184548|1547215|P2|NOT COMPLETED|Overall Study||13
630491|NCT00184548|1547216|P1|NOT COMPLETED|Overall Study||8
630492|NCT00184548|1547213|P4|COMPLETED|Overall Study||38
630493|NCT00184548|1547214|P3|COMPLETED|Overall Study||44
630494|NCT00184548|1547215|P2|COMPLETED|Overall Study||242
630495|NCT00184548|1547216|P1|COMPLETED|Overall Study||218
630496|NCT00184548|1547213|P4|Exposed|Overall Study|Four subjects withdrew due to ineligibility, one subject died. Excluded from safety analysis set|40
630497|NCT00184548|1547214|P3|Exposed|Overall Study|One subject withdrew due to ineligibility. Excluded from safety analysis set|46
630498|NCT00184548|1547215|P2|Exposed|Overall Study|Three subjects withdrew due to ineligibility, two subjects died. Excluded from safety analysis set|250
630499|NCT00184548|1547216|P1|Exposed|Overall Study|Two subjects withdrew due to ineligibility. Excluded from safety analysis set|224
630500|NCT00184548|1547213|P4|STARTED|Overall Study||45
630501|NCT00184548|1547214|P3|STARTED|Overall Study||47
630502|NCT00184548|1547215|P2|STARTED|Overall Study||255
630503|NCT00184548|1547216|P1|STARTED|Overall Study||226
630504|NCT00184093|1547250|P1|NOT COMPLETED|Overall Study||9
630505|NCT00184093|1547250|P1|COMPLETED|Overall Study||26
630506|NCT00184093|1547250|P1|STARTED|Overall Study|Phase 1 participants = 6 Phase 2 participants = 29|35
630507|NCT00184054|1547255|P1|NOT COMPLETED|Overall Study||1
630508|NCT00184054|1547255|P1|COMPLETED|Overall Study||10
630509|NCT00184054|1547255|P1|STARTED|Overall Study||11
630510|NCT00184028|1547260|P1|NOT COMPLETED|Overall Study||10
630511|NCT00184028|1547260|P1|COMPLETED|Overall Study||2
630512|NCT00184028|1547260|P1|STARTED|Overall Study||12
630513|NCT00184002|1547265|P1|NOT COMPLETED|Overall Study||17
630514|NCT00184002|1547265|P1|COMPLETED|Overall Study||51
630515|NCT00184002|1547265|P1|STARTED|Overall Study||68
630516|NCT00183963|1547274|P4|NOT COMPLETED|Overall Study||1
630517|NCT00183963|1547275|P3|NOT COMPLETED|Overall Study||1
630518|NCT00183963|1547276|P2|NOT COMPLETED|Overall Study||1
630519|NCT00183963|1547277|P1|NOT COMPLETED|Overall Study||1
630520|NCT00183963|1547274|P4|COMPLETED|Overall Study||0
630521|NCT00183963|1547275|P3|COMPLETED|Overall Study||0
630522|NCT00183963|1547276|P2|COMPLETED|Overall Study||0
630523|NCT00183963|1547277|P1|COMPLETED|Overall Study||0
630524|NCT00183963|1547274|P4|STARTED|Overall Study||1
630525|NCT00183963|1547275|P3|STARTED|Overall Study||1
630526|NCT00183963|1547276|P2|STARTED|Overall Study||1
630527|NCT00183963|1547277|P1|STARTED|Overall Study||1
630528|NCT00183872|1547291|P1|NOT COMPLETED|Overall Study||16
630529|NCT00183872|1547291|P1|COMPLETED|Overall Study||24
630530|NCT00183872|1547291|P1|STARTED|Overall Study||40
630531|NCT00183794|1547296|P1|NOT COMPLETED|Overall Study||0
630532|NCT00183794|1547296|P1|COMPLETED|Overall Study||20
630533|NCT00183794|1547296|P1|STARTED|Overall Study||20
630534|NCT00183729|1547303|P2|NOT COMPLETED|Overall Study||5
630535|NCT00183729|1547304|P1|NOT COMPLETED|Overall Study||3
630536|NCT00183729|1547303|P2|COMPLETED|Overall Study||13
630537|NCT00183729|1547304|P1|COMPLETED|Overall Study||14
630538|NCT00183729|1547303|P2|STARTED|Overall Study||18
630539|NCT00183729|1547304|P1|STARTED|Overall Study||17
630540|NCT00183677|1547314|P1|NOT COMPLETED|Overall Study||44
630541|NCT00183677|1547314|P1|COMPLETED|Overall Study||53
630542|NCT00183677|1547314|P1|STARTED|Overall Study||97
630543|NCT00183625|1547320|P4|NOT COMPLETED|Overall Study||14
630544|NCT00183625|1547321|P3|NOT COMPLETED|Overall Study||19
630545|NCT00183625|1547322|P2|NOT COMPLETED|Overall Study||18
630546|NCT00183625|1547323|P1|NOT COMPLETED|Overall Study||18
630547|NCT00183625|1547320|P4|COMPLETED|Overall Study||10
630548|NCT00183625|1547321|P3|COMPLETED|Overall Study||9
630549|NCT00183625|1547322|P2|COMPLETED|Overall Study||10
630550|NCT00183625|1547323|P1|COMPLETED|Overall Study||9
630551|NCT00183625|1547320|P4|Obtained Employment|Overall Study||14
630552|NCT00183625|1547321|P3|Obtained Employment|Overall Study||14
630553|NCT00183625|1547322|P2|Obtained Employment|Overall Study||18
630554|NCT00183625|1547323|P1|Obtained Employment|Overall Study||21
630555|NCT00183625|1547320|P4|STARTED|Overall Study||24
630556|NCT00183625|1547321|P3|STARTED|Overall Study||28
630557|NCT00183625|1547322|P2|STARTED|Overall Study||28
630558|NCT00183625|1547323|P1|STARTED|Overall Study||27
630559|NCT00183469|1547333|P2|NOT COMPLETED|Overall Study||29
630560|NCT00183469|1547334|P1|NOT COMPLETED|Overall Study||28
630561|NCT00183469|1547333|P2|COMPLETED|Overall Study||16
630562|NCT00183469|1547334|P1|COMPLETED|Overall Study||13
630563|NCT00183469|1547333|P2|STARTED|Overall Study||45
630564|NCT00183469|1547334|P1|STARTED|Overall Study||41
630565|NCT00183456|1547344|P4|NOT COMPLETED|Overall Study||28
630566|NCT00183456|1547345|P3|NOT COMPLETED|Overall Study||16
630567|NCT00183456|1547346|P2|NOT COMPLETED|Overall Study||1
630568|NCT00183456|1547347|P1|NOT COMPLETED|Overall Study||3
630569|NCT00183456|1547344|P4|COMPLETED|Overall Study|total # of non-randomized index participants that completed any follow-up|220
630570|NCT00183456|1547345|P3|COMPLETED|Overall Study|total # of network participants that completed any follow-up|313
630571|NCT00183456|1547346|P2|COMPLETED|Overall Study|total # of comparison condition participants that completed any follow-up|83
630572|NCT00183456|1547347|P1|COMPLETED|Overall Study|total # of intervention participants that completed any follow-up (6, 12, or 18 month Follow-up)|82
630573|NCT00183456|1547344|P4|18 Month Follow-up|Overall Study||207
630574|NCT00183456|1547345|P3|18 Month Follow-up|Overall Study||303
630575|NCT00183456|1547346|P2|18 Month Follow-up|Overall Study||81
630576|NCT00183456|1547347|P1|18 Month Follow-up|Overall Study||80
630577|NCT00183456|1547344|P4|12 Month Follow-up|Overall Study||186
630578|NCT00183456|1547345|P3|12 Month Follow-up|Overall Study||267
630579|NCT00183456|1547346|P2|12 Month Follow-up|Overall Study||74
630580|NCT00183456|1547347|P1|12 Month Follow-up|Overall Study||76
630581|NCT00183456|1547344|P4|6 Month Follow-up|Overall Study||175
630582|NCT00183456|1547345|P3|6 Month Follow-up|Overall Study||278
630583|NCT00183456|1547346|P2|6 Month Follow-up|Overall Study||77
630584|NCT00183456|1547347|P1|6 Month Follow-up|Overall Study||74
630585|NCT00183456|1547344|P4|STARTED|Overall Study||248
630586|NCT00183456|1547345|P3|STARTED|Overall Study||329
630587|NCT00183456|1547346|P2|STARTED|Overall Study||84
630588|NCT00183456|1547347|P1|STARTED|Overall Study||85
630589|NCT00183430|1547395|P2|NOT COMPLETED|Overall Study||0
630590|NCT00183430|1547396|P1|NOT COMPLETED|Overall Study||6
630591|NCT00183430|1547395|P2|COMPLETED|Overall Study||11
630592|NCT00183430|1547396|P1|COMPLETED|Overall Study||3
630593|NCT00183430|1547395|P2|STARTED|Overall Study||11
630594|NCT00183430|1547396|P1|STARTED|Overall Study||9
630595|NCT00183391|1547408|P2|NOT COMPLETED|Block 2 - 5 Weeks||2
630596|NCT00183391|1547409|P1|NOT COMPLETED|Block 2 - 5 Weeks||4
630597|NCT00183391|1547408|P2|COMPLETED|Block 2 - 5 Weeks||108
630598|NCT00183391|1547409|P1|COMPLETED|Block 2 - 5 Weeks||91
630599|NCT00183391|1547408|P2|STARTED|Block 2 - 5 Weeks||110
630600|NCT00183391|1547409|P1|STARTED|Block 2 - 5 Weeks||95
630601|NCT00183391|1547408|P2|NOT COMPLETED|Crossover Placebo - 2 Weeks||0
630602|NCT00183391|1547409|P1|NOT COMPLETED|Crossover Placebo - 2 Weeks||0
630603|NCT00183391|1547408|P2|COMPLETED|Crossover Placebo - 2 Weeks||110
630604|NCT00183391|1547409|P1|COMPLETED|Crossover Placebo - 2 Weeks||95
630605|NCT00183391|1547408|P2|STARTED|Crossover Placebo - 2 Weeks||110
630606|NCT00183391|1547409|P1|STARTED|Crossover Placebo - 2 Weeks||95
630607|NCT00183391|1547408|P2|NOT COMPLETED|Block 1 - 5 Weeks||14
630608|NCT00183391|1547409|P1|NOT COMPLETED|Block 1 - 5 Weeks||13
630609|NCT00183391|1547408|P2|COMPLETED|Block 1 - 5 Weeks||110
630610|NCT00183391|1547409|P1|COMPLETED|Block 1 - 5 Weeks||95
630611|NCT00183391|1547408|P2|STARTED|Block 1 - 5 Weeks||124
630612|NCT00183391|1547409|P1|STARTED|Block 1 - 5 Weeks||108
630613|NCT00183339|1547469|P2|NOT COMPLETED|Overall Study||4
630614|NCT00183339|1547470|P1|NOT COMPLETED|Overall Study||6
630615|NCT00183339|1547469|P2|COMPLETED|Overall Study||4
630616|NCT00183339|1547470|P1|COMPLETED|Overall Study||4
630617|NCT00183339|1547469|P2|STARTED|Overall Study||8
630618|NCT00183339|1547470|P1|STARTED|Overall Study||10
630619|NCT00183274|1547482|P6|NOT COMPLETED|Phase 3: Double-Blind||4
630620|NCT00183274|1547483|P5|NOT COMPLETED|Phase 3: Double-Blind||20
630621|NCT00183274|1547484|P4|NOT COMPLETED|Phase 3: Double-Blind||2
630622|NCT00183274|1547485|P3|NOT COMPLETED|Phase 3: Double-Blind||0
630623|NCT00183274|1547486|P2|NOT COMPLETED|Phase 3: Double-Blind||0
630624|NCT00183274|1547487|P1|NOT COMPLETED|Phase 3: Double-Blind||0
630625|NCT00183274|1547482|P6|COMPLETED|Phase 3: Double-Blind|2 lost to relapse and 2 lost to dropout|6
630626|NCT00183274|1547483|P5|COMPLETED|Phase 3: Double-Blind|11 lost to relapse and 9 lost to dropout|14
630627|NCT00183274|1547484|P4|COMPLETED|Phase 3: Double-Blind|1 lost to relapse and 1 lost to dropout|13
630628|NCT00183274|1547485|P3|COMPLETED|Phase 3: Double-Blind||0
630629|NCT00183274|1547486|P2|COMPLETED|Phase 3: Double-Blind||0
630630|NCT00183274|1547487|P1|COMPLETED|Phase 3: Double-Blind||0
630631|NCT00183274|1547482|P6|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|10
630632|NCT00183274|1547483|P5|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|34
630633|NCT00183274|1547484|P4|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|15
630634|NCT00183274|1547485|P3|STARTED|Phase 3: Double-Blind|Phase 2 ended at the end of 12 months of study.|0
630635|NCT00183274|1547486|P2|STARTED|Phase 3: Double-Blind|Phase 2 ended at the end of 12 months of study.|0
630636|NCT00183274|1547487|P1|STARTED|Phase 3: Double-Blind||0
630637|NCT00183274|1547482|P6|NOT COMPLETED|Phase 2: Double-Blind||0
630638|NCT00183274|1547483|P5|NOT COMPLETED|Phase 2: Double-Blind||0
630639|NCT00183274|1547484|P4|NOT COMPLETED|Phase 2: Double-Blind||0
630640|NCT00183274|1547485|P3|NOT COMPLETED|Phase 2: Double-Blind||43
630641|NCT00183274|1547486|P2|NOT COMPLETED|Phase 2: Double-Blind||26
630642|NCT00183274|1547487|P1|NOT COMPLETED|Phase 2: Double-Blind||0
630643|NCT00183274|1547482|P6|COMPLETED|Phase 2: Double-Blind||0
630644|NCT00183274|1547483|P5|COMPLETED|Phase 2: Double-Blind||0
630645|NCT00183274|1547484|P4|COMPLETED|Phase 2: Double-Blind||0
630646|NCT00183274|1547485|P3|COMPLETED|Phase 2: Double-Blind|29 lost to relapse, 14 lost to dropout|11
630647|NCT00183274|1547486|P2|COMPLETED|Phase 2: Double-Blind|8 lost to relapse, 18 lost to dropout|56
630648|NCT00183274|1547487|P1|COMPLETED|Phase 2: Double-Blind||0
630649|NCT00183274|1547482|P6|STARTED|Phase 2: Double-Blind||0
630650|NCT00183274|1547483|P5|STARTED|Phase 2: Double-Blind||0
630651|NCT00183274|1547484|P4|STARTED|Phase 2: Double-Blind||0
630652|NCT00183274|1547485|P3|STARTED|Phase 2: Double-Blind|22 did not enter phase 2 due to lack of efficacy and withdrawal of consent|54
630653|NCT00183274|1547486|P2|STARTED|Phase 2: Double-Blind|22 did not enter phase 2 due to lack of efficacy and withdrawal of consent|82
630654|NCT00183274|1547487|P1|STARTED|Phase 2: Double-Blind|This phase ended after 6 months. There were no longer participants in this phase.|0
630655|NCT00183274|1547482|P6|NOT COMPLETED|Phase 1: Open-Label||0
630656|NCT00183274|1547483|P5|NOT COMPLETED|Phase 1: Open-Label||0
630657|NCT00183274|1547484|P4|NOT COMPLETED|Phase 1: Open-Label||0
630658|NCT00183274|1547485|P3|NOT COMPLETED|Phase 1: Open-Label||0
630659|NCT00183274|1547486|P2|NOT COMPLETED|Phase 1: Open-Label||0
630660|NCT00183274|1547487|P1|NOT COMPLETED|Phase 1: Open-Label||110
630661|NCT00183274|1547482|P6|COMPLETED|Phase 1: Open-Label||0
630662|NCT00183274|1547483|P5|COMPLETED|Phase 1: Open-Label||0
630663|NCT00183274|1547484|P4|COMPLETED|Phase 1: Open-Label||0
630664|NCT00183274|1547485|P3|COMPLETED|Phase 1: Open-Label||0
630665|NCT00183274|1547486|P2|COMPLETED|Phase 1: Open-Label||0
630666|NCT00183274|1547487|P1|COMPLETED|Phase 1: Open-Label|110 dropouts during phase 1|158
630667|NCT00183274|1547482|P6|STARTED|Phase 1: Open-Label||0
630668|NCT00183274|1547483|P5|STARTED|Phase 1: Open-Label||0
630669|NCT00183274|1547484|P4|STARTED|Phase 1: Open-Label||0
630670|NCT00183274|1547485|P3|STARTED|Phase 1: Open-Label||0
630671|NCT00183274|1547486|P2|STARTED|Phase 1: Open-Label||0
630672|NCT00183274|1547487|P1|STARTED|Phase 1: Open-Label||268
630673|NCT00183248|1547504|P2|NOT COMPLETED|Overall Study||1
630674|NCT00183248|1547505|P1|NOT COMPLETED|Overall Study||1
630675|NCT00183248|1547504|P2|COMPLETED|Overall Study||4
630676|NCT00183248|1547505|P1|COMPLETED|Overall Study||3
630677|NCT00183248|1547504|P2|STARTED|Overall Study||5
630678|NCT00183248|1547505|P1|STARTED|Overall Study||4
630679|NCT00183196|1547526|P3|NOT COMPLETED|Overall Study||18
630680|NCT00183196|1547527|P2|NOT COMPLETED|Overall Study||15
630681|NCT00183196|1547528|P1|NOT COMPLETED|Overall Study||20
630682|NCT00183196|1547526|P3|COMPLETED|Overall Study||32
630683|NCT00183196|1547527|P2|COMPLETED|Overall Study||35
630684|NCT00183196|1547528|P1|COMPLETED|Overall Study||30
630685|NCT00183196|1547526|P3|STARTED|Overall Study|1 subject had no post-randomization data|50
630686|NCT00183196|1547527|P2|STARTED|Overall Study|1 subject had no post-randomization data|50
630687|NCT00183196|1547528|P1|STARTED|Overall Study|2 subjects had no post-randomization data|50
630688|NCT00183092|1547538|P4|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1
630689|NCT00183092|1547539|P3|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1
630690|NCT00183092|1547540|P2|NOT COMPLETED|Open-label Period (Month 2 Until Death)||14
630691|NCT00183092|1547541|P1|NOT COMPLETED|Open-label Period (Month 2 Until Death)||10
630692|NCT00183092|1547538|P4|COMPLETED|Open-label Period (Month 2 Until Death)||0
630693|NCT00183092|1547539|P3|COMPLETED|Open-label Period (Month 2 Until Death)||0
630694|NCT00183092|1547540|P2|COMPLETED|Open-label Period (Month 2 Until Death)||0
630695|NCT00183092|1547541|P1|COMPLETED|Open-label Period (Month 2 Until Death)||0
630696|NCT00183092|1547538|P4|STARTED|Open-label Period (Month 2 Until Death)|Participants assigned to Placebo opted to continue assigned drug during open-label period|1
630697|NCT00183092|1547539|P3|STARTED|Open-label Period (Month 2 Until Death)|Participants assigned to Quinacrine opted to continue assigned drug during open-label period|1
630698|NCT00183092|1547540|P2|STARTED|Open-label Period (Month 2 Until Death)|Participants initially assigned to Placebo opted to begin open-label Quinacrine at Month 2|14
630699|NCT00183092|1547541|P1|STARTED|Open-label Period (Month 2 Until Death)|Participants initially assigned to Quinacrine opted to begin open-label Quinacrine at Month 2|10
630700|NCT00183092|1547538|P4|NOT COMPLETED|Double-blind (Baseline - Month 2)||0
630701|NCT00183092|1547539|P3|NOT COMPLETED|Double-blind (Baseline - Month 2)||0
630702|NCT00183092|1547540|P2|NOT COMPLETED|Double-blind (Baseline - Month 2)||12
630703|NCT00183092|1547541|P1|NOT COMPLETED|Double-blind (Baseline - Month 2)||12
630704|NCT00183092|1547538|P4|COMPLETED|Double-blind (Baseline - Month 2)||0
630705|NCT00183092|1547539|P3|COMPLETED|Double-blind (Baseline - Month 2)||0
630706|NCT00183092|1547540|P2|COMPLETED|Double-blind (Baseline - Month 2)||16
630707|NCT00183092|1547541|P1|COMPLETED|Double-blind (Baseline - Month 2)||11
630708|NCT00183092|1547538|P4|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0
630709|NCT00183092|1547539|P3|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0
630710|NCT00183092|1547540|P2|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||16
630711|NCT00183092|1547541|P1|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||10
630712|NCT00183092|1547538|P4|Alive at Month 2|Double-blind (Baseline - Month 2)||0
630713|NCT00183092|1547539|P3|Alive at Month 2|Double-blind (Baseline - Month 2)||0
630714|NCT00183092|1547540|P2|Alive at Month 2|Double-blind (Baseline - Month 2)||19
630715|NCT00183092|1547541|P1|Alive at Month 2|Double-blind (Baseline - Month 2)||13
630716|NCT00183092|1547538|P4|STARTED|Double-blind (Baseline - Month 2)||0
630717|NCT00183092|1547539|P3|STARTED|Double-blind (Baseline - Month 2)||0
630718|NCT00183092|1547540|P2|STARTED|Double-blind (Baseline - Month 2)||28
630719|NCT00183092|1547541|P1|STARTED|Double-blind (Baseline - Month 2)||23
630720|NCT00182793|1547562|P1|NOT COMPLETED|Overall Study||0
630721|NCT00182793|1547562|P1|COMPLETED|Overall Study||32
630722|NCT00182793|1547562|P1|STARTED|Overall Study||32
630723|NCT00182767|1547567|P5|NOT COMPLETED|Overall Study||0
630724|NCT00182767|1547568|P4|NOT COMPLETED|Overall Study||0
630725|NCT00182767|1547569|P3|NOT COMPLETED|Overall Study||0
630726|NCT00182767|1547570|P2|NOT COMPLETED|Overall Study||0
630727|NCT00182767|1547571|P1|NOT COMPLETED|Overall Study||0
630728|NCT00182767|1547567|P5|COMPLETED|Overall Study||24
630729|NCT00182767|1547568|P4|COMPLETED|Overall Study||3
630730|NCT00182767|1547569|P3|COMPLETED|Overall Study||6
630731|NCT00182767|1547570|P2|COMPLETED|Overall Study||6
630732|NCT00182767|1547571|P1|COMPLETED|Overall Study||6
630733|NCT00182767|1547567|P5|STARTED|Overall Study||24
630734|NCT00182767|1547568|P4|STARTED|Overall Study||3
630735|NCT00182767|1547569|P3|STARTED|Overall Study||6
630736|NCT00182767|1547570|P2|STARTED|Overall Study||6
630737|NCT00182767|1547571|P1|STARTED|Overall Study||6
630738|NCT00182754|1547588|P2|NOT COMPLETED|Overall Study||0
630739|NCT00182754|1547589|P1|NOT COMPLETED|Overall Study||0
630740|NCT00182754|1547588|P2|COMPLETED|Overall Study||17
630741|NCT00182754|1547589|P1|COMPLETED|Overall Study||16
630742|NCT00182754|1547588|P2|STARTED|Overall Study||17
630743|NCT00182754|1547589|P1|STARTED|Overall Study||16
630744|NCT00182728|1547599|P1|NOT COMPLETED|Overall Study||0
630745|NCT00182728|1547599|P1|COMPLETED|Overall Study||71
630746|NCT00182728|1547599|P1|STARTED|Overall Study||71
630747|NCT00182689|1547611|P2|NOT COMPLETED|Overall Study||49
630748|NCT00182689|1547612|P1|NOT COMPLETED|Overall Study||40
630749|NCT00182689|1547611|P2|COMPLETED|Overall Study||0
630750|NCT00182689|1547612|P1|COMPLETED|Overall Study||0
630751|NCT00182689|1547611|P2|Eligible and Began Protocol Therapy|Overall Study||45
630752|NCT00182689|1547612|P1|Eligible and Began Protocol Therapy|Overall Study||38
630753|NCT00182689|1547611|P2|Eligible|Overall Study||45
630754|NCT00182689|1547612|P1|Eligible|Overall Study||39
630755|NCT00182689|1547611|P2|STARTED|Overall Study||49
630756|NCT00182689|1547612|P1|STARTED|Overall Study||40
630757|NCT00182637|1547622|P1|NOT COMPLETED|Overall Study||3
630758|NCT00182637|1547622|P1|COMPLETED|Overall Study|off study date|2
630759|NCT00182637|1547622|P1|STARTED|Overall Study|active/on treatment date|5
630760|NCT00182091|1547632|P4|NOT COMPLETED|Overall Study||0
630761|NCT00182091|1547633|P3|NOT COMPLETED|Overall Study||0
630762|NCT00182091|1547634|P2|NOT COMPLETED|Overall Study||0
630763|NCT00182091|1547635|P1|NOT COMPLETED|Overall Study||1
630764|NCT00182091|1547632|P4|COMPLETED|Overall Study||20
630765|NCT00182091|1547633|P3|COMPLETED|Overall Study||25
630766|NCT00182091|1547634|P2|COMPLETED|Overall Study||15
630767|NCT00182091|1547635|P1|COMPLETED|Overall Study||14
630768|NCT00182091|1547632|P4|STARTED|Overall Study||20
630769|NCT00182091|1547633|P3|STARTED|Overall Study||25
630770|NCT00182091|1547634|P2|STARTED|Overall Study||15
630771|NCT00182091|1547635|P1|STARTED|Overall Study||15
630772|NCT00182078|1547651|P2|NOT COMPLETED|Overall Study||0
630773|NCT00182078|1547652|P1|NOT COMPLETED|Overall Study||1
630774|NCT00182078|1547651|P2|COMPLETED|Overall Study||17
630775|NCT00182078|1547652|P1|COMPLETED|Overall Study||8
630776|NCT00182078|1547651|P2|STARTED|Overall Study||17
630777|NCT00182078|1547652|P1|STARTED|Overall Study||9
630778|NCT00182000|1547664|P2|NOT COMPLETED|Overall Study||2
630779|NCT00182000|1547665|P1|NOT COMPLETED|Overall Study||5
630780|NCT00182000|1547664|P2|COMPLETED|Overall Study||13
630781|NCT00182000|1547665|P1|COMPLETED|Overall Study||9
630782|NCT00182000|1547664|P2|STARTED|Overall Study||15
630783|NCT00182000|1547665|P1|STARTED|Overall Study||14
630784|NCT00181883|1547671|P1|NOT COMPLETED|Overall Study||10
630785|NCT00181883|1547671|P1|COMPLETED|Overall Study||20
630786|NCT00181883|1547671|P1|STARTED|Overall Study||30
630787|NCT00181844|1547675|P1|NOT COMPLETED|Exposed to Study Medication||17
630788|NCT00181844|1547675|P1|COMPLETED|Exposed to Study Medication||22
630789|NCT00181844|1547675|P1|STARTED|Exposed to Study Medication||39
630790|NCT00181844|1547675|P1|NOT COMPLETED|Signed Consent||12
630791|NCT00181844|1547675|P1|COMPLETED|Signed Consent||39
630792|NCT00181844|1547675|P1|STARTED|Signed Consent||51
630793|NCT00181766|1547679|P1|NOT COMPLETED|Overall Study||12
630794|NCT00181766|1547679|P1|COMPLETED|Overall Study|Completed the trial.|33
630795|NCT00181766|1547679|P1|STARTED|Overall Study|Number of subjects enrolled and treated with Atomoxetine.|45
630796|NCT00181714|1547684|P1|NOT COMPLETED|Began Treatment With OROS-MPH||124
630797|NCT00181714|1547684|P1|COMPLETED|Began Treatment With OROS-MPH||30
630798|NCT00181714|1547684|P1|STARTED|Began Treatment With OROS-MPH||154
630799|NCT00181714|1547684|P1|NOT COMPLETED|Signed Consent/Enrolled||49
630800|NCT00181714|1547684|P1|COMPLETED|Signed Consent/Enrolled||154
630801|NCT00181714|1547684|P1|STARTED|Signed Consent/Enrolled||203
630802|NCT00181623|1547688|P1|NOT COMPLETED|Overall Study||1
630803|NCT00181623|1547688|P1|COMPLETED|Overall Study||5
630804|NCT00181623|1547688|P1|STARTED|Overall Study||6
630805|NCT00181610|1547696|P3|NOT COMPLETED|Overall Study||0
630806|NCT00181610|1547697|P2|NOT COMPLETED|Overall Study||1
630807|NCT00181610|1547698|P1|NOT COMPLETED|Overall Study||0
630808|NCT00181610|1547696|P3|COMPLETED|Overall Study||3
630809|NCT00181610|1547697|P2|COMPLETED|Overall Study||3
630810|NCT00181610|1547698|P1|COMPLETED|Overall Study||4
630811|NCT00181610|1547696|P3|STARTED|Overall Study||3
630812|NCT00181610|1547697|P2|STARTED|Overall Study||4
630813|NCT00181610|1547698|P1|STARTED|Overall Study||4
630814|NCT00181155|1547709|P2|NOT COMPLETED|Overall Study||0
630815|NCT00181155|1547710|P1|NOT COMPLETED|Overall Study||2
630816|NCT00181155|1547709|P2|COMPLETED|Overall Study||3
630817|NCT00181155|1547710|P1|COMPLETED|Overall Study||13
630818|NCT00181155|1547709|P2|STARTED|Overall Study||3
630819|NCT00181155|1547710|P1|STARTED|Overall Study||15
630820|NCT00180687|1547722|P4|NOT COMPLETED|Overall Study||0
630821|NCT00180687|1547723|P3|NOT COMPLETED|Overall Study||0
630822|NCT00180687|1547724|P2|NOT COMPLETED|Overall Study||0
630823|NCT00180687|1547725|P1|NOT COMPLETED|Overall Study||0
630824|NCT00180687|1547722|P4|COMPLETED|Overall Study||20
630825|NCT00180687|1547723|P3|COMPLETED|Overall Study||20
630826|NCT00180687|1547724|P2|COMPLETED|Overall Study||20
630827|NCT00180687|1547725|P1|COMPLETED|Overall Study||20
630828|NCT00180687|1547722|P4|STARTED|Overall Study||20
630829|NCT00180687|1547723|P3|STARTED|Overall Study||20
630830|NCT00180687|1547724|P2|STARTED|Overall Study||20
630831|NCT00180687|1547725|P1|STARTED|Overall Study||20
630832|NCT00180479|1547749|P2|NOT COMPLETED|Overall Study||13
630833|NCT00180479|1547750|P1|NOT COMPLETED|Overall Study||16
630834|NCT00180479|1547749|P2|COMPLETED|Overall Study||320
630835|NCT00180479|1547750|P1|COMPLETED|Overall Study||653
630836|NCT00180479|1547749|P2|STARTED|Overall Study|1 patient randomized never signed consent, therefore no data collected. Analysis group = 332.|333
630837|NCT00180479|1547750|P1|STARTED|Overall Study||669
630838|NCT00180323|1547842|P1|NOT COMPLETED|Overall Study||0
630839|NCT00180323|1547842|P1|COMPLETED|Overall Study||43
630840|NCT00180323|1547842|P1|STARTED|Overall Study||43
630841|NCT00180271|1547851|P2|NOT COMPLETED|Overall Study||0
630842|NCT00180271|1547852|P1|NOT COMPLETED|Overall Study||0
630843|NCT00180271|1547851|P2|COMPLETED|Overall Study||731
630844|NCT00180271|1547852|P1|COMPLETED|Overall Study||1089
630845|NCT00180271|1547851|P2|STARTED|Overall Study||731
630846|NCT00180271|1547852|P1|STARTED|Overall Study||1089
630847|NCT00179959|1547860|P2|NOT COMPLETED|Overall Study||3
630848|NCT00179959|1547861|P1|NOT COMPLETED|Overall Study||6
630849|NCT00179959|1547860|P2|COMPLETED|Overall Study||13
630850|NCT00179959|1547861|P1|COMPLETED|Overall Study||9
630851|NCT00179959|1547860|P2|STARTED|Overall Study||16
630852|NCT00179959|1547861|P1|STARTED|Overall Study||15
630853|NCT00179673|1547867|P1|NOT COMPLETED|Overall Study||43
630854|NCT00179673|1547867|P1|COMPLETED|Overall Study|Completed refers to participants ongoing in the study at the time of analysis.|0
630855|NCT00179673|1547867|P1|Received Study Drug|Overall Study||43
630856|NCT00179673|1547867|P1|STARTED|Overall Study||43
630857|NCT00179660|1547875|P1|NOT COMPLETED|Overall Study||50
630858|NCT00179660|1547875|P1|COMPLETED|Overall Study|Completed refers to participants ongoing in the study at the time of analysis.|0
630859|NCT00179660|1547875|P1|Completed 12 Cycles of Treatment|Overall Study||12
630860|NCT00179660|1547875|P1|Received Study Drug|Overall Study||49
630861|NCT00179660|1547875|P1|STARTED|Overall Study||50
630862|NCT00179647|1547884|P1|NOT COMPLETED|Overall Study||1913
630863|NCT00179647|1547884|P1|COMPLETED|Overall Study|Subjects participated in study until they presented with reason for discontinuation.|0
630864|NCT00179647|1547884|P1|STARTED|Overall Study||1913
630865|NCT00179621|1547891|P4|NOT COMPLETED|Open-Label Period||43
630866|NCT00179621|1547892|P3|NOT COMPLETED|Open-Label Period||28
630867|NCT00179621|1547893|P2|NOT COMPLETED|Open-Label Period||28
630868|NCT00179621|1547894|P1|NOT COMPLETED|Open-Label Period||0
630869|NCT00179621|1547891|P4|COMPLETED|Open-Label Period||13
630870|NCT00179621|1547892|P3|COMPLETED|Open-Label Period||19
630871|NCT00179621|1547893|P2|COMPLETED|Open-Label Period||14
630872|NCT00179621|1547894|P1|COMPLETED|Open-Label Period||0
630873|NCT00179621|1547891|P4|STARTED|Open-Label Period|'Started' includes 1 participant who completed double-blind and 55 who discontinued double-blind.|56
630874|NCT00179621|1547892|P3|STARTED|Open-Label Period|'Started' includes 39 participants who completed double-blind and 8 who discontinued double-blind.|47
630875|NCT00179621|1547893|P2|STARTED|Open-Label Period|'Started' includes 23 participants who completed double-blind and 19 who discontinued double-blind.|42
630876|NCT00179621|1547894|P1|STARTED|Open-Label Period||0
630877|NCT00179621|1547891|P4|NOT COMPLETED|Double-Blind Period||0
630878|NCT00179621|1547892|P3|NOT COMPLETED|Double-Blind Period||30
630879|NCT00179621|1547893|P2|NOT COMPLETED|Double-Blind Period||46
630880|NCT00179621|1547894|P1|NOT COMPLETED|Double-Blind Period||64
630881|NCT00179621|1547891|P4|COMPLETED|Double-Blind Period||0
630882|NCT00179621|1547892|P3|COMPLETED|Double-Blind Period||39
630883|NCT00179621|1547893|P2|COMPLETED|Double-Blind Period||23
630884|NCT00179621|1547894|P1|COMPLETED|Double-Blind Period||3
630885|NCT00179621|1547891|P4|STARTED|Double-Blind Period||0
630886|NCT00179621|1547892|P3|STARTED|Double-Blind Period||69
630887|NCT00179621|1547893|P2|STARTED|Double-Blind Period||69
630888|NCT00179621|1547894|P1|STARTED|Double-Blind Period||67
630889|NCT00179517|1547947|P2|NOT COMPLETED|Overall Study||1
630890|NCT00179517|1547948|P1|NOT COMPLETED|Overall Study||2
630891|NCT00179517|1547947|P2|COMPLETED|Overall Study||19
630892|NCT00179517|1547948|P1|COMPLETED|Overall Study||18
630893|NCT00179517|1547947|P2|STARTED|Overall Study||20
630894|NCT00179517|1547948|P1|STARTED|Overall Study||20
630895|NCT00179478|1547972|P2|NOT COMPLETED|Overall Study||15
630896|NCT00179478|1547973|P1|NOT COMPLETED|Overall Study||13
630897|NCT00179478|1547972|P2|COMPLETED|Overall Study||59
630898|NCT00179478|1547973|P1|COMPLETED|Overall Study||68
630899|NCT00179478|1547972|P2|STARTED|Overall Study||74
630900|NCT00179478|1547973|P1|STARTED|Overall Study||81
630901|NCT00179413|1547986|P2|NOT COMPLETED|Overall Study||115
630902|NCT00179413|1547987|P1|NOT COMPLETED|Overall Study||125
630903|NCT00179413|1547986|P2|COMPLETED|Overall Study||152
630904|NCT00179413|1547987|P1|COMPLETED|Overall Study||157
630905|NCT00179413|1547986|P2|STARTED|Overall Study||267
630906|NCT00179413|1547987|P1|STARTED|Overall Study||282
630907|NCT00179309|1547999|P2|NOT COMPLETED|Crossover||0
630908|NCT00179309|1548000|P1|NOT COMPLETED|Crossover||0
630909|NCT00179309|1547999|P2|COMPLETED|Crossover||3
630910|NCT00179309|1548000|P1|COMPLETED|Crossover||0
630911|NCT00179309|1547999|P2|STARTED|Crossover|Crossover was allowed so that patients randomized to B could receive the vaccine upon progression.|3
630912|NCT00179309|1548000|P1|STARTED|Crossover||0
630913|NCT00179309|1547999|P2|NOT COMPLETED|Treatment||5
630914|NCT00179309|1548000|P1|NOT COMPLETED|Treatment||4
630915|NCT00179309|1547999|P2|COMPLETED|Treatment||18
630916|NCT00179309|1548000|P1|COMPLETED|Treatment||21
630917|NCT00179309|1547999|P2|STARTED|Treatment||23
630918|NCT00179309|1548000|P1|STARTED|Treatment||25
630919|NCT00178919|1548010|P2|NOT COMPLETED|Overall Study||25
630920|NCT00178919|1548011|P1|NOT COMPLETED|Overall Study||0
630921|NCT00178919|1548010|P2|COMPLETED|Overall Study||68
630922|NCT00178919|1548011|P1|COMPLETED|Overall Study||19
630923|NCT00178919|1548010|P2|STARTED|Overall Study||93
630924|NCT00178919|1548011|P1|STARTED|Overall Study||19
630925|NCT00178841|1548019|P1|NOT COMPLETED|Overall Study||0
630926|NCT00178841|1548019|P1|COMPLETED|Overall Study||4
630927|NCT00178841|1548019|P1|STARTED|Overall Study||4
630928|NCT00178711|1548027|P2|NOT COMPLETED|Overall Study||0
630929|NCT00178711|1548028|P1|NOT COMPLETED|Overall Study||0
630930|NCT00178711|1548027|P2|COMPLETED|Overall Study||45
630931|NCT00178711|1548028|P1|COMPLETED|Overall Study||52
630932|NCT00178711|1548027|P2|STARTED|Overall Study||45
630933|NCT00178711|1548028|P1|STARTED|Overall Study||52
630934|NCT00178685|1548039|P3|NOT COMPLETED|Overall Study||196
630935|NCT00178685|1548040|P2|NOT COMPLETED|Overall Study||204
630936|NCT00178685|1548041|P1|NOT COMPLETED|Overall Study||111
630937|NCT00178685|1548039|P3|COMPLETED|Overall Study||128
630938|NCT00178685|1548040|P2|COMPLETED|Overall Study||120
630939|NCT00178685|1548041|P1|COMPLETED|Overall Study||61
630940|NCT00178685|1548039|P3|STARTED|Overall Study||324
630941|NCT00178685|1548040|P2|STARTED|Overall Study||324
630942|NCT00178685|1548041|P1|STARTED|Overall Study||172
630943|NCT00178633|1548052|P1|NOT COMPLETED|Overall Study||6
630944|NCT00178633|1548052|P1|COMPLETED|Overall Study||37
630945|NCT00178633|1548052|P1|STARTED|Overall Study||43
630946|NCT00178503|1548060|P1|NOT COMPLETED|MPH Trial: High Dose||0
630947|NCT00178503|1548060|P1|COMPLETED|MPH Trial: High Dose||24
630948|NCT00178503|1548060|P1|STARTED|MPH Trial: High Dose||24
630949|NCT00178503|1548060|P1|NOT COMPLETED|MPH Trial: Med Dose||0
630950|NCT00178503|1548060|P1|COMPLETED|MPH Trial: Med Dose||24
630951|NCT00178503|1548060|P1|STARTED|MPH Trial: Med Dose||24
630952|NCT00178503|1548060|P1|NOT COMPLETED|MPH Trial: Low Dose||0
630953|NCT00178503|1548060|P1|COMPLETED|MPH Trial: Low Dose||24
630954|NCT00178503|1548060|P1|STARTED|MPH Trial: Low Dose||24
630955|NCT00178503|1548060|P1|NOT COMPLETED|MPH Trial: Placebo||0
630956|NCT00178503|1548060|P1|COMPLETED|MPH Trial: Placebo||24
630957|NCT00178503|1548060|P1|STARTED|MPH Trial: Placebo||24
630958|NCT00178477|1548078|P1|NOT COMPLETED|Overall Study||5
630959|NCT00178477|1548078|P1|COMPLETED|Overall Study||5
630960|NCT00178477|1548078|P1|STARTED|Overall Study||10
630961|NCT00178464|1548082|P1|NOT COMPLETED|Overall Study||2
630962|NCT00178464|1548082|P1|COMPLETED|Overall Study||9
630963|NCT00178464|1548082|P1|STARTED|Overall Study||11
630964|NCT00178256|1548087|P4|NOT COMPLETED|Overall Study||2
630965|NCT00178256|1548088|P3|NOT COMPLETED|Overall Study||0
630966|NCT00178256|1548089|P2|NOT COMPLETED|Overall Study||1
630967|NCT00178256|1548090|P1|NOT COMPLETED|Overall Study||4
630968|NCT00178256|1548087|P4|COMPLETED|Overall Study||16
630969|NCT00178256|1548088|P3|COMPLETED|Overall Study||6
630970|NCT00178256|1548089|P2|COMPLETED|Overall Study||6
630971|NCT00178256|1548090|P1|COMPLETED|Overall Study||6
630972|NCT00178256|1548087|P4|STARTED|Overall Study||18
630973|NCT00178256|1548088|P3|STARTED|Overall Study||6
630974|NCT00178256|1548089|P2|STARTED|Overall Study||7
630975|NCT00178256|1548090|P1|STARTED|Overall Study||10
630976|NCT00178191|1548100|P3|NOT COMPLETED|Overall Study||0
630977|NCT00178191|1548101|P2|NOT COMPLETED|Overall Study||0
630978|NCT00178191|1548102|P1|NOT COMPLETED|Overall Study||0
630979|NCT00178191|1548100|P3|COMPLETED|Overall Study||7
630980|NCT00178191|1548101|P2|COMPLETED|Overall Study||10
630981|NCT00178191|1548102|P1|COMPLETED|Overall Study||11
630982|NCT00178191|1548100|P3|STARTED|Overall Study||7
630983|NCT00178191|1548101|P2|STARTED|Overall Study||10
630984|NCT00178191|1548102|P1|STARTED|Overall Study||11
630985|NCT00178178|1548114|P4|NOT COMPLETED|Overall Study||0
630986|NCT00178178|1548115|P3|NOT COMPLETED|Overall Study||0
630987|NCT00178178|1548116|P2|NOT COMPLETED|Overall Study||0
630988|NCT00178178|1548117|P1|NOT COMPLETED|Overall Study||0
630989|NCT00178178|1548114|P4|COMPLETED|Overall Study||24
630990|NCT00178178|1548115|P3|COMPLETED|Overall Study||24
630991|NCT00178178|1548116|P2|COMPLETED|Overall Study||24
630992|NCT00178178|1548117|P1|COMPLETED|Overall Study||24
630993|NCT00178178|1548114|P4|STARTED|Overall Study||24
630994|NCT00178178|1548115|P3|STARTED|Overall Study||24
630995|NCT00178178|1548116|P2|STARTED|Overall Study||24
630996|NCT00178178|1548117|P1|STARTED|Overall Study||24
630997|NCT00178126|1548129|P2|NOT COMPLETED|Overall Study||27
630998|NCT00178126|1548130|P1|NOT COMPLETED|Overall Study||25
630999|NCT00178126|1548129|P2|COMPLETED|Overall Study||86
631000|NCT00178126|1548130|P1|COMPLETED|Overall Study||94
631001|NCT00178126|1548129|P2|STARTED|Overall Study||113
631002|NCT00178126|1548130|P1|STARTED|Overall Study||119
631003|NCT00177970|1548138|P2|NOT COMPLETED|Overall Study||0
631004|NCT00177970|1548139|P1|NOT COMPLETED|Overall Study||0
631005|NCT00177970|1548138|P2|COMPLETED|Overall Study|No results available record destroyed due to age of study. no publications|0
631006|NCT00177970|1548139|P1|COMPLETED|Overall Study|No results available record destroyed due to age of study. no publications|0
631007|NCT00177970|1548138|P2|STARTED|Overall Study|No results available record destroyed due to age of study. no publications|0
631008|NCT00177970|1548139|P1|STARTED|Overall Study|No results available record destroyed due to age of study. no publications|0
631009|NCT00177866|1548161|P2|NOT COMPLETED|Overall Study||0
631010|NCT00177866|1548162|P1|NOT COMPLETED|Overall Study||0
631011|NCT00177866|1548161|P2|COMPLETED|Overall Study|No results or publication, data destroyed due to age of study.|0
631012|NCT00177866|1548162|P1|COMPLETED|Overall Study|No results or publication, data destroyed due to age of study.|0
631013|NCT00177866|1548161|P2|STARTED|Overall Study|No results or publication, data destroyed due to age of study.|0
631014|NCT00177866|1548162|P1|STARTED|Overall Study|No results or publication, data destroyed due to age of study.|0
631015|NCT00177671|1548172|P2|NOT COMPLETED|Overall Study||14
631016|NCT00177671|1548173|P1|NOT COMPLETED|Overall Study||25
631017|NCT00177671|1548172|P2|COMPLETED|Overall Study||49
631018|NCT00177671|1548173|P1|COMPLETED|Overall Study||42
631019|NCT00177671|1548172|P2|Month 24|Overall Study||49
631020|NCT00177671|1548173|P1|Month 24|Overall Study||42
631021|NCT00177671|1548172|P2|Month 12|Overall Study||57
631022|NCT00177671|1548173|P1|Month 12|Overall Study||45
631023|NCT00177671|1548172|P2|STARTED|Overall Study||63
631024|NCT00177671|1548173|P1|STARTED|Overall Study||67
631025|NCT00177307|1548185|P1|NOT COMPLETED|Overall Study||1
631026|NCT00177307|1548185|P1|COMPLETED|Overall Study||39
631027|NCT00177307|1548185|P1|STARTED|Overall Study||40
631028|NCT00177294|1548194|P2|NOT COMPLETED|Overall Study||5
631029|NCT00177294|1548195|P1|NOT COMPLETED|Overall Study||7
631030|NCT00177294|1548194|P2|COMPLETED|Overall Study||59
631031|NCT00177294|1548195|P1|COMPLETED|Overall Study||53
631032|NCT00177294|1548194|P2|STARTED|Overall Study||64
631033|NCT00177294|1548195|P1|STARTED|Overall Study||60
631034|NCT00177255|1548201|P1|NOT COMPLETED|Overall Study||0
631035|NCT00177255|1548201|P1|COMPLETED|Overall Study||39
631036|NCT00177255|1548201|P1|STARTED|Overall Study||39
631037|NCT00177216|1548209|P3|NOT COMPLETED|Overall Study||1
631038|NCT00177216|1548210|P2|NOT COMPLETED|Overall Study||3
631039|NCT00177216|1548211|P1|NOT COMPLETED|Overall Study||6
631040|NCT00177216|1548209|P3|COMPLETED|Overall Study||19
631041|NCT00177216|1548210|P2|COMPLETED|Overall Study||20
631042|NCT00177216|1548211|P1|COMPLETED|Overall Study||20
631043|NCT00177216|1548209|P3|STARTED|Overall Study||20
631044|NCT00177216|1548210|P2|STARTED|Overall Study||23
631045|NCT00177216|1548211|P1|STARTED|Overall Study||26
631046|NCT00177164|1548227|P2|NOT COMPLETED|Overall Study||16
631047|NCT00177164|1548228|P1|NOT COMPLETED|Overall Study||9
631048|NCT00177164|1548227|P2|COMPLETED|Overall Study||9
631049|NCT00177164|1548228|P1|COMPLETED|Overall Study||14
631050|NCT00177164|1548227|P2|STARTED|Overall Study||25
631051|NCT00177164|1548228|P1|STARTED|Overall Study||23
631052|NCT00176917|1548240|P1|NOT COMPLETED|Overall Study||0
631053|NCT00176917|1548240|P1|COMPLETED|Overall Study||41
631054|NCT00176917|1548240|P1|STARTED|Overall Study||41
631055|NCT00176904|1548247|P1|NOT COMPLETED|Overall Study||0
631056|NCT00176904|1548247|P1|COMPLETED|Overall Study||135
631057|NCT00176904|1548247|P1|STARTED|Overall Study||135
631058|NCT00176878|1548255|P1|NOT COMPLETED|Overall Study||0
631059|NCT00176878|1548255|P1|COMPLETED|Overall Study||10
631060|NCT00176878|1548255|P1|STARTED|Overall Study||10
631061|NCT00176865|1548267|P3|NOT COMPLETED|Overall Study||0
631062|NCT00176865|1548268|P2|NOT COMPLETED|Overall Study||0
631063|NCT00176865|1548269|P1|NOT COMPLETED|Overall Study||0
631064|NCT00176865|1548267|P3|COMPLETED|Overall Study||6
631065|NCT00176865|1548268|P2|COMPLETED|Overall Study||10
631066|NCT00176865|1548269|P1|COMPLETED|Overall Study||3
631067|NCT00176865|1548267|P3|STARTED|Overall Study||6
631068|NCT00176865|1548268|P2|STARTED|Overall Study||10
631069|NCT00176865|1548269|P1|STARTED|Overall Study||3
631070|NCT00176852|1548307|P3|NOT COMPLETED|Overall Study||0
631071|NCT00176852|1548308|P2|NOT COMPLETED|Overall Study||0
631072|NCT00176852|1548309|P1|NOT COMPLETED|Overall Study||0
631073|NCT00176852|1548307|P3|COMPLETED|Overall Study||14
631074|NCT00176852|1548308|P2|COMPLETED|Overall Study||5
631075|NCT00176852|1548309|P1|COMPLETED|Overall Study||3
631076|NCT00176852|1548307|P3|STARTED|Overall Study||14
631077|NCT00176852|1548308|P2|STARTED|Overall Study||5
631078|NCT00176852|1548309|P1|STARTED|Overall Study||3
631079|NCT00176839|1548368|P1|NOT COMPLETED|Overall Study||0
631080|NCT00176839|1548368|P1|COMPLETED|Overall Study||11
631081|NCT00176839|1548368|P1|STARTED|Overall Study||11
631082|NCT00176826|1548377|P1|NOT COMPLETED|Overall Study||0
631083|NCT00176826|1548377|P1|COMPLETED|Overall Study||22
631084|NCT00176826|1548377|P1|STARTED|Overall Study||22
631085|NCT00176800|1548387|P1|NOT COMPLETED|Overall Study||0
631086|NCT00176800|1548387|P1|COMPLETED|Overall Study||69
631087|NCT00176800|1548387|P1|STARTED|Overall Study||69
631088|NCT00176644|1548393|P1|NOT COMPLETED|Overall Study||1
631089|NCT00176644|1548393|P1|COMPLETED|Overall Study||22
631090|NCT00176644|1548393|P1|STARTED|Overall Study||23
631091|NCT00176631|1548401|P1|NOT COMPLETED|Overall Study||0
631092|NCT00176631|1548401|P1|COMPLETED|Overall Study||10
631093|NCT00176631|1548401|P1|STARTED|Overall Study||10
631094|NCT00176605|1548406|P1|NOT COMPLETED|Overall Study||2
631095|NCT00176605|1548406|P1|COMPLETED|Overall Study||13
631096|NCT00176605|1548406|P1|STARTED|Overall Study||15
631097|NCT00176501|1548411|P1|NOT COMPLETED|Overall Study||0
631098|NCT00176501|1548411|P1|COMPLETED|Overall Study||3
631099|NCT00176501|1548411|P1|STARTED|Overall Study||3
631100|NCT00176488|1548417|P1|NOT COMPLETED|Overall Study||1
631101|NCT00176488|1548417|P1|COMPLETED|Overall Study||30
631102|NCT00176488|1548417|P1|STARTED|Overall Study||31
631103|NCT00176462|1548425|P2|NOT COMPLETED|Continuation -up to 30mos Post Remission||0
631104|NCT00176462|1548426|P1|NOT COMPLETED|Continuation -up to 30mos Post Remission||0
631105|NCT00176462|1548425|P2|COMPLETED|Continuation -up to 30mos Post Remission||26
631106|NCT00176462|1548426|P1|COMPLETED|Continuation -up to 30mos Post Remission||19
631107|NCT00176462|1548425|P2|STARTED|Continuation -up to 30mos Post Remission||26
631108|NCT00176462|1548426|P1|STARTED|Continuation -up to 30mos Post Remission||19
631109|NCT00176462|1548425|P2|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||3
631110|NCT00176462|1548426|P1|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||1
631111|NCT00176462|1548425|P2|COMPLETED|Intensive Continuation (8X8-week Cycles)||26
631112|NCT00176462|1548426|P1|COMPLETED|Intensive Continuation (8X8-week Cycles)||19
631113|NCT00176462|1548425|P2|STARTED|Intensive Continuation (8X8-week Cycles)||29
631114|NCT00176462|1548426|P1|STARTED|Intensive Continuation (8X8-week Cycles)||20
631115|NCT00176462|1548425|P2|NOT COMPLETED|Delayed Intensification (8 Weeks)||0
631116|NCT00176462|1548426|P1|NOT COMPLETED|Delayed Intensification (8 Weeks)||0
631117|NCT00176462|1548425|P2|COMPLETED|Delayed Intensification (8 Weeks)||29
631118|NCT00176462|1548426|P1|COMPLETED|Delayed Intensification (8 Weeks)||20
631119|NCT00176462|1548425|P2|STARTED|Delayed Intensification (8 Weeks)||29
631120|NCT00176462|1548426|P1|STARTED|Delayed Intensification (8 Weeks)||20
631121|NCT00176462|1548425|P2|NOT COMPLETED|Consolidation (12 Weeks)||5
631122|NCT00176462|1548426|P1|NOT COMPLETED|Consolidation (12 Weeks)||0
631123|NCT00176462|1548425|P2|COMPLETED|Consolidation (12 Weeks)||29
631124|NCT00176462|1548426|P1|COMPLETED|Consolidation (12 Weeks)||20
631125|NCT00176462|1548425|P2|STARTED|Consolidation (12 Weeks)||34
631126|NCT00176462|1548426|P1|STARTED|Consolidation (12 Weeks)||20
631127|NCT00176462|1548425|P2|NOT COMPLETED|Induction (4 Weeks)||5
631128|NCT00176462|1548426|P1|NOT COMPLETED|Induction (4 Weeks)||1
631129|NCT00176462|1548425|P2|COMPLETED|Induction (4 Weeks)||34
631130|NCT00176462|1548426|P1|COMPLETED|Induction (4 Weeks)||20
631131|NCT00176462|1548425|P2|STARTED|Induction (4 Weeks)||39
631132|NCT00176462|1548426|P1|STARTED|Induction (4 Weeks)||21
631133|NCT00176436|1548435|P2|NOT COMPLETED|Overall Study||5
631134|NCT00176436|1548436|P1|NOT COMPLETED|Overall Study||6
631135|NCT00176436|1548435|P2|COMPLETED|Overall Study||12
631136|NCT00176436|1548436|P1|COMPLETED|Overall Study||14
631137|NCT00176436|1548435|P2|STARTED|Overall Study||17
631138|NCT00176436|1548436|P1|STARTED|Overall Study||20
631139|NCT00176306|1548442|P1|NOT COMPLETED|Overall Study||0
631140|NCT00176306|1548442|P1|COMPLETED|Overall Study||15
631141|NCT00176306|1548442|P1|STARTED|Overall Study||15
631142|NCT00176254|1548446|P1|NOT COMPLETED|Overall Study||1
631143|NCT00176254|1548446|P1|COMPLETED|Overall Study|1 patient only received 1 cycle and refused further induction, another progressed in neck nodes|39
631144|NCT00176254|1548446|P1|STARTED|Overall Study||40
631145|NCT00176228|1548454|P1|NOT COMPLETED|Overall Study||2
631146|NCT00176228|1548454|P1|COMPLETED|Overall Study|Study ended|46
631147|NCT00176228|1548454|P1|STARTED|Overall Study|When study began|48
631148|NCT00176202|1548461|P2|NOT COMPLETED|Overall Study||16
631149|NCT00176202|1548462|P1|NOT COMPLETED|Overall Study||5
631150|NCT00176202|1548461|P2|COMPLETED|Overall Study||17
631151|NCT00176202|1548462|P1|COMPLETED|Overall Study||27
631152|NCT00176202|1548461|P2|STARTED|Overall Study||33
631153|NCT00176202|1548462|P1|STARTED|Overall Study||32
631154|NCT00175877|1548474|P1|NOT COMPLETED|Overall Study||349
631155|NCT00175877|1548474|P1|COMPLETED|Overall Study||497
631156|NCT00175877|1548474|P1|STARTED|Overall Study||846
631157|NCT00175019|1548508|P3|NOT COMPLETED|Overall Study||57
631158|NCT00175019|1548509|P2|NOT COMPLETED|Overall Study||171
631159|NCT00175019|1548510|P1|NOT COMPLETED|Overall Study||194
631160|NCT00175019|1548508|P3|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|35
631161|NCT00175019|1548509|P2|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|217
631162|NCT00175019|1548510|P1|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|412
631163|NCT00175019|1548508|P3|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|92
631164|NCT00175019|1548509|P2|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|388
631165|NCT00175019|1548510|P1|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|606
631166|NCT00175006|1548554|P1|NOT COMPLETED|Overall Study||0
631167|NCT00175006|1548554|P1|COMPLETED|Overall Study||13
631168|NCT00175006|1548554|P1|STARTED|Overall Study||13
631169|NCT00174967|1548563|P4|NOT COMPLETED|Overall Study||2
631170|NCT00174967|1548564|P3|NOT COMPLETED|Overall Study||2
631171|NCT00174967|1548565|P2|NOT COMPLETED|Overall Study||3
631172|NCT00174967|1548566|P1|NOT COMPLETED|Overall Study||1
631173|NCT00174967|1548563|P4|COMPLETED|Overall Study||36
631174|NCT00174967|1548564|P3|COMPLETED|Overall Study||36
631175|NCT00174967|1548565|P2|COMPLETED|Overall Study||37
631176|NCT00174967|1548566|P1|COMPLETED|Overall Study||36
631177|NCT00174967|1548563|P4|STARTED|Overall Study||38
631178|NCT00174967|1548564|P3|STARTED|Overall Study||38
631179|NCT00174967|1548565|P2|STARTED|Overall Study||40
631180|NCT00174967|1548566|P1|STARTED|Overall Study||37
631181|NCT00174954|1548612|P1|NOT COMPLETED|Overall Study||4
631182|NCT00174954|1548612|P1|COMPLETED|Overall Study||28
631183|NCT00174954|1548612|P1|STARTED|Overall Study||32
631184|NCT00174941|1548620|P4|NOT COMPLETED|Overall Study||58
631185|NCT00174941|1548621|P3|NOT COMPLETED|Overall Study||18
631186|NCT00174941|1548622|P2|NOT COMPLETED|Overall Study||38
631187|NCT00174941|1548623|P1|NOT COMPLETED|Overall Study||2
631188|NCT00174941|1548620|P4|COMPLETED|Overall Study||58
631189|NCT00174941|1548621|P3|COMPLETED|Overall Study||11
631190|NCT00174941|1548622|P2|COMPLETED|Overall Study||41
631191|NCT00174941|1548623|P1|COMPLETED|Overall Study||6
631192|NCT00174941|1548620|P4|STARTED|Overall Study||116
631193|NCT00174941|1548621|P3|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|29
631194|NCT00174941|1548622|P2|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|79
631195|NCT00174941|1548623|P1|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|8
631196|NCT00174915|1548698|P5|NOT COMPLETED|Overall Study||33
631197|NCT00174915|1548699|P4|NOT COMPLETED|Overall Study||57
631198|NCT00174915|1548700|P3|NOT COMPLETED|Overall Study||48
631199|NCT00174915|1548701|P2|NOT COMPLETED|Overall Study||69
631200|NCT00174915|1548702|P1|NOT COMPLETED|Overall Study||93
631201|NCT00174915|1548698|P5|COMPLETED|Overall Study||101
631202|NCT00174915|1548699|P4|COMPLETED|Overall Study||211
631203|NCT00174915|1548700|P3|COMPLETED|Overall Study||86
631204|NCT00174915|1548701|P2|COMPLETED|Overall Study||200
631205|NCT00174915|1548702|P1|COMPLETED|Overall Study||174
631206|NCT00174915|1548698|P5|STARTED|Overall Study||134
631207|NCT00174915|1548699|P4|STARTED|Overall Study||268
631208|NCT00174915|1548700|P3|STARTED|Overall Study||134
631209|NCT00174915|1548701|P2|STARTED|Overall Study||269
631210|NCT00174915|1548702|P1|STARTED|Overall Study||267
631211|NCT00174785|1548761|P2|NOT COMPLETED|Overall Study||716
631212|NCT00174785|1548762|P1|NOT COMPLETED|Overall Study||696
631213|NCT00174785|1548761|P2|COMPLETED|Overall Study|completed study drug|1611
631214|NCT00174785|1548762|P1|COMPLETED|Overall Study|completed study drug|1605
631215|NCT00174785|1548761|P2|STARTED|Overall Study|randomized patients; among them, 14 patients did not receive any study drug in the placebo group|2327
631216|NCT00174785|1548762|P1|STARTED|Overall Study|randomized patients; among them, 10 patients did not receive any study drug in the dronedarone group|2301
631217|NCT00174460|1548778|P2|NOT COMPLETED|Overall Study||1
631218|NCT00174460|1548779|P1|NOT COMPLETED|Overall Study||0
631219|NCT00174460|1548778|P2|COMPLETED|Overall Study||14
631220|NCT00174460|1548779|P1|COMPLETED|Overall Study||18
631221|NCT00174460|1548778|P2|Received Study Treatment|Overall Study||14
631222|NCT00174460|1548779|P1|Received Study Treatment|Overall Study||18
631223|NCT00174460|1548778|P2|STARTED|Overall Study||15
631224|NCT00174460|1548779|P1|STARTED|Overall Study||18
631225|NCT00174447|1548825|P1|NOT COMPLETED|Overall Study||38
631226|NCT00174447|1548825|P1|COMPLETED|Overall Study||5
631227|NCT00174447|1548825|P1|STARTED|Overall Study||43
631228|NCT00174382|1548834|P1|NOT COMPLETED|Overall Study||33
631229|NCT00174382|1548834|P1|COMPLETED|Overall Study||116
631230|NCT00174382|1548834|P1|STARTED|Overall Study|148 are summarized below: 1 subject entered the study but was lost to follow up.|149
631231|NCT00174291|1548853|P2|NOT COMPLETED|Overall Study||6
631232|NCT00174291|1548854|P1|NOT COMPLETED|Overall Study||5
631233|NCT00174291|1548853|P2|COMPLETED|Overall Study||4
631234|NCT00174291|1548854|P1|COMPLETED|Overall Study||6
631235|NCT00174291|1548853|P2|STARTED|Overall Study||10
631236|NCT00174291|1548854|P1|STARTED|Overall Study||11
631237|NCT00174265|1548884|P2|NOT COMPLETED|Overall Study||21
631238|NCT00174265|1548885|P1|NOT COMPLETED|Overall Study||29
631239|NCT00174265|1548884|P2|COMPLETED|Overall Study||89
631240|NCT00174265|1548885|P1|COMPLETED|Overall Study||57
631241|NCT00174265|1548884|P2|STARTED|Overall Study||110
631242|NCT00174265|1548885|P1|STARTED|Overall Study|85 participants received randomized treatment assignment and at least one dose of study medication.|86
631243|NCT00174252|1548893|P1|NOT COMPLETED|Overall Study||2
631244|NCT00174252|1548893|P1|COMPLETED|Overall Study||55
631245|NCT00174252|1548893|P1|STARTED|Overall Study||57
631246|NCT00174187|1548928|P3|NOT COMPLETED|Period 2 (After 3 Years)||8
631247|NCT00174187|1548929|P2|NOT COMPLETED|Period 2 (After 3 Years)||0
631248|NCT00174187|1548930|P1|NOT COMPLETED|Period 2 (After 3 Years)||0
631249|NCT00174187|1548928|P3|COMPLETED|Period 2 (After 3 Years)||13
631250|NCT00174187|1548929|P2|COMPLETED|Period 2 (After 3 Years)||0
631251|NCT00174187|1548930|P1|COMPLETED|Period 2 (After 3 Years)||0
631252|NCT00174187|1548928|P3|STARTED|Period 2 (After 3 Years)||21
631253|NCT00174187|1548929|P2|STARTED|Period 2 (After 3 Years)||0
631254|NCT00174187|1548930|P1|STARTED|Period 2 (After 3 Years)||0
631255|NCT00174187|1548928|P3|NOT COMPLETED|Between Period 1 and Period 2||5
631256|NCT00174187|1548929|P2|NOT COMPLETED|Between Period 1 and Period 2||0
631257|NCT00174187|1548930|P1|NOT COMPLETED|Between Period 1 and Period 2||0
631258|NCT00174187|1548928|P3|COMPLETED|Between Period 1 and Period 2||21
631259|NCT00174187|1548929|P2|COMPLETED|Between Period 1 and Period 2||0
631260|NCT00174187|1548930|P1|COMPLETED|Between Period 1 and Period 2||0
631261|NCT00174187|1548928|P3|Consented|Between Period 1 and Period 2||24
631262|NCT00174187|1548929|P2|Consented|Between Period 1 and Period 2||0
631263|NCT00174187|1548930|P1|Consented|Between Period 1 and Period 2||0
631264|NCT00174187|1548928|P3|STARTED|Between Period 1 and Period 2||26
631265|NCT00174187|1548929|P2|STARTED|Between Period 1 and Period 2||0
631266|NCT00174187|1548930|P1|STARTED|Between Period 1 and Period 2||0
631267|NCT00174187|1548928|P3|NOT COMPLETED|Period 1 (up to 3 Years)||0
631268|NCT00174187|1548929|P2|NOT COMPLETED|Period 1 (up to 3 Years)||4
631269|NCT00174187|1548930|P1|NOT COMPLETED|Period 1 (up to 3 Years)||0
631270|NCT00174187|1548928|P3|COMPLETED|Period 1 (up to 3 Years)||0
631271|NCT00174187|1548929|P2|COMPLETED|Period 1 (up to 3 Years)||11
631272|NCT00174187|1548930|P1|COMPLETED|Period 1 (up to 3 Years)||15
631273|NCT00174187|1548928|P3|STARTED|Period 1 (up to 3 Years)||0
631274|NCT00174187|1548929|P2|STARTED|Period 1 (up to 3 Years)||15
631275|NCT00174187|1548930|P1|STARTED|Period 1 (up to 3 Years)||15
631276|NCT00172185|1548995|P4|NOT COMPLETED|Overall Study||4
631277|NCT00172185|1548996|P3|NOT COMPLETED|Overall Study||5
631278|NCT00172185|1548997|P2|NOT COMPLETED|Overall Study||2
631279|NCT00172185|1548998|P1|NOT COMPLETED|Overall Study||0
631280|NCT00172185|1548995|P4|COMPLETED|Overall Study||23
631281|NCT00172185|1548996|P3|COMPLETED|Overall Study||20
631282|NCT00172185|1548997|P2|COMPLETED|Overall Study||5
631283|NCT00172185|1548998|P1|COMPLETED|Overall Study||6
631284|NCT00172185|1548995|P4|STARTED|Overall Study||27
631285|NCT00172185|1548996|P3|STARTED|Overall Study||25
631286|NCT00172185|1548997|P2|STARTED|Overall Study||7
631287|NCT00172185|1548998|P1|STARTED|Overall Study||6
631288|NCT00172042|1549014|P2|NOT COMPLETED|Overall Study||125
631289|NCT00172042|1549015|P1|NOT COMPLETED|Overall Study||158
631290|NCT00172042|1549014|P2|COMPLETED|Overall Study||86
631291|NCT00172042|1549015|P1|COMPLETED|Overall Study||68
631292|NCT00172042|1549014|P2|STARTED|Overall Study||211
631293|NCT00172042|1549015|P1|STARTED|Overall Study||226
631294|NCT00171925|1549037|P2|NOT COMPLETED|Overall Study||31
631295|NCT00171925|1549038|P1|NOT COMPLETED|Overall Study||30
631296|NCT00171925|1549037|P2|COMPLETED|Overall Study||40
631297|NCT00171925|1549038|P1|COMPLETED|Overall Study||42
631298|NCT00171925|1549037|P2|STARTED|Overall Study||71
631299|NCT00171925|1549038|P1|STARTED|Overall Study||72
631300|NCT00171873|1549050|P2|NOT COMPLETED|Overall Study||3
631301|NCT00171873|1549051|P1|NOT COMPLETED|Overall Study||9
631302|NCT00171873|1549050|P2|COMPLETED|Overall Study||40
631303|NCT00171873|1549051|P1|COMPLETED|Overall Study||33
631304|NCT00171873|1549050|P2|STARTED|Overall Study||43
631305|NCT00171873|1549051|P1|STARTED|Overall Study||42
631306|NCT00171834|1549064|P7|NOT COMPLETED|Overall Study||4
631307|NCT00171834|1549065|P6|NOT COMPLETED|Overall Study||35
631308|NCT00171834|1549066|P5|NOT COMPLETED|Overall Study||8
631309|NCT00171834|1549067|P4|NOT COMPLETED|Overall Study||12
631310|NCT00171834|1549068|P3|NOT COMPLETED|Overall Study||12
631311|NCT00171834|1549069|P2|NOT COMPLETED|Overall Study||12
631312|NCT00171834|1549070|P1|NOT COMPLETED|Overall Study||6
631313|NCT00171834|1549064|P7|COMPLETED|Overall Study||0
631314|NCT00171834|1549065|P6|COMPLETED|Overall Study||0
631315|NCT00171834|1549066|P5|COMPLETED|Overall Study||0
631316|NCT00171834|1549067|P4|COMPLETED|Overall Study||0
631317|NCT00171834|1549068|P3|COMPLETED|Overall Study||0
631318|NCT00171834|1549069|P2|COMPLETED|Overall Study||0
631319|NCT00171834|1549070|P1|COMPLETED|Overall Study||0
631320|NCT00171834|1549064|P7|Completed 6 Cycles of Treatment|Overall Study||0
631321|NCT00171834|1549065|P6|Completed 6 Cycles of Treatment|Overall Study||1
631322|NCT00171834|1549066|P5|Completed 6 Cycles of Treatment|Overall Study||2
631323|NCT00171834|1549067|P4|Completed 6 Cycles of Treatment|Overall Study||0
631324|NCT00171834|1549068|P3|Completed 6 Cycles of Treatment|Overall Study||1
631325|NCT00171834|1549069|P2|Completed 6 Cycles of Treatment|Overall Study||0
631326|NCT00171834|1549070|P1|Completed 6 Cycles of Treatment|Overall Study||0
631327|NCT00171834|1549064|P7|STARTED|Overall Study||4
631328|NCT00171834|1549065|P6|STARTED|Overall Study||35
631329|NCT00171834|1549066|P5|STARTED|Overall Study||8
631330|NCT00171834|1549067|P4|STARTED|Overall Study||12
631331|NCT00171834|1549068|P3|STARTED|Overall Study||12
631332|NCT00171834|1549069|P2|STARTED|Overall Study||12
631333|NCT00171834|1549070|P1|STARTED|Overall Study||6
631334|NCT00171704|1549110|P2|NOT COMPLETED|Overall Study||49
631335|NCT00171704|1549111|P1|NOT COMPLETED|Overall Study||44
631336|NCT00171704|1549110|P2|COMPLETED|Overall Study||81
631337|NCT00171704|1549111|P1|COMPLETED|Overall Study||89
631338|NCT00171704|1549110|P2|STARTED|Overall Study||130
631339|NCT00171704|1549111|P1|STARTED|Overall Study||133
631340|NCT00171340|1549133|P2|NOT COMPLETED|Overall Study||135
631341|NCT00171340|1549134|P1|NOT COMPLETED|Overall Study||124
631342|NCT00171340|1549133|P2|COMPLETED|Overall Study||398
631343|NCT00171340|1549134|P1|COMPLETED|Overall Study||408
631344|NCT00171340|1549133|P2|STARTED|Overall Study||533
631345|NCT00171340|1549134|P1|STARTED|Overall Study||532
631346|NCT00171314|1549150|P2|NOT COMPLETED|Overall Study||78
631347|NCT00171314|1549151|P1|NOT COMPLETED|Overall Study||91
631348|NCT00171314|1549150|P2|COMPLETED|Overall Study||186
631349|NCT00171314|1549151|P1|COMPLETED|Overall Study||172
631350|NCT00171314|1549150|P2|Safety Population|Overall Study|"Treatment Actually Received = 10 from upfront Arm and 259 from delayed Arm"|269
631351|NCT00171314|1549151|P1|Safety Population|Overall Study|"Treatment Actually Received = 251 from upfront Arm and 3 from delayed Arm"|254
631352|NCT00171314|1549150|P2|STARTED|Overall Study||264
631353|NCT00171314|1549151|P1|STARTED|Overall Study|2 patients in each arm were randomized but not treated.|263
631354|NCT00171301|1549167|P2|NOT COMPLETED|Overall Study||9
631355|NCT00171301|1549168|P1|NOT COMPLETED|Overall Study||8
631356|NCT00171301|1549167|P2|COMPLETED|Overall Study||62
631357|NCT00171301|1549168|P1|COMPLETED|Overall Study||154
631358|NCT00171301|1549167|P2|Received Deferasirox|Overall Study||69
631359|NCT00171301|1549168|P1|Received Deferasirox|Overall Study||162
631360|NCT00171301|1549167|P2|STARTED|Overall Study|2 participants in this group never received deferasirox.|71
631361|NCT00171301|1549168|P1|STARTED|Overall Study||162
631362|NCT00171210|1549181|P2|NOT COMPLETED|Overall Study||115
631363|NCT00171210|1549182|P1|NOT COMPLETED|Overall Study||69
631364|NCT00171210|1549181|P2|COMPLETED|Overall Study||181
631365|NCT00171210|1549182|P1|COMPLETED|Overall Study||190
631366|NCT00171210|1549181|P2|STARTED EXTENSION STUDY|Overall Study||247
631367|NCT00171210|1549182|P1|STARTED EXTENSION STUDY|Overall Study||259
631368|NCT00171210|1549181|P2|STARTED|Overall Study||296
631369|NCT00171210|1549182|P1|STARTED|Overall Study||259
631370|NCT00171054|1549212|P2|NOT COMPLETED|Overall Study||12
631371|NCT00171054|1549213|P1|NOT COMPLETED|Overall Study||10
631372|NCT00171054|1549212|P2|COMPLETED|Overall Study||50
631373|NCT00171054|1549213|P1|COMPLETED|Overall Study||53
631374|NCT00171054|1549212|P2|STARTED|Overall Study||62
631375|NCT00171054|1549213|P1|STARTED|Overall Study||63
631376|NCT00170950|1549245|P2|NOT COMPLETED|Overall Study||910
631377|NCT00170950|1549246|P1|NOT COMPLETED|Overall Study||885
631378|NCT00170950|1549245|P2|COMPLETED|Overall Study||4852
631379|NCT00170950|1549246|P1|COMPLETED|Overall Study||4859
631380|NCT00170950|1549245|P2|STARTED|Overall Study||5762
631381|NCT00170950|1549246|P1|STARTED|Overall Study||5744
631382|NCT00170846|1549259|P3|NOT COMPLETED|Overall Study||13
631383|NCT00170846|1549260|P2|NOT COMPLETED|Overall Study||19
631384|NCT00170846|1549261|P1|NOT COMPLETED|Overall Study||11
631385|NCT00170846|1549259|P3|COMPLETED|Overall Study||131
631386|NCT00170846|1549260|P2|COMPLETED|Overall Study||108
631387|NCT00170846|1549261|P1|COMPLETED|Overall Study||112
631388|NCT00170846|1549259|P3|STARTED|Overall Study||144
631389|NCT00170846|1549260|P2|STARTED|Overall Study||127
631390|NCT00170846|1549261|P1|STARTED|Overall Study||123
631391|NCT00170625|1549275|P1|NOT COMPLETED|Overall Study||0
631392|NCT00170625|1549275|P1|COMPLETED|Overall Study||26
631393|NCT00170625|1549275|P1|STARTED|Overall Study||26
631394|NCT00170157|1549280|P2|NOT COMPLETED|Treatment Period 2 Crossover||0
631395|NCT00170157|1549281|P1|NOT COMPLETED|Treatment Period 2 Crossover||0
631396|NCT00170157|1549280|P2|COMPLETED|Treatment Period 2 Crossover||41
631397|NCT00170157|1549281|P1|COMPLETED|Treatment Period 2 Crossover||0
631398|NCT00170157|1549280|P2|STARTED|Treatment Period 2 Crossover||41
631399|NCT00170157|1549281|P1|STARTED|Treatment Period 2 Crossover|Participants initially randomized to this arm were not eligible for crossover.|0
631400|NCT00170157|1549280|P2|NOT COMPLETED|Washout Period of 14 Days||17
631401|NCT00170157|1549281|P1|NOT COMPLETED|Washout Period of 14 Days||0
631402|NCT00170157|1549280|P2|COMPLETED|Washout Period of 14 Days||41
631403|NCT00170157|1549281|P1|COMPLETED|Washout Period of 14 Days||0
631404|NCT00170157|1549280|P2|STARTED|Washout Period of 14 Days||58
631405|NCT00170157|1549281|P1|STARTED|Washout Period of 14 Days|Participants initially randomized to this arm were not eligible for crossover.|0
631406|NCT00170157|1549280|P2|NOT COMPLETED|Treatment Period 1 Initial Randomization||0
631407|NCT00170157|1549281|P1|NOT COMPLETED|Treatment Period 1 Initial Randomization||0
631408|NCT00170157|1549280|P2|COMPLETED|Treatment Period 1 Initial Randomization||58
631409|NCT00170157|1549281|P1|COMPLETED|Treatment Period 1 Initial Randomization||54
631410|NCT00170157|1549280|P2|STARTED|Treatment Period 1 Initial Randomization||58
631411|NCT00170157|1549281|P1|STARTED|Treatment Period 1 Initial Randomization||54
631412|NCT00169442|1549293|P6|NOT COMPLETED|Overall Study||2
631413|NCT00169442|1549294|P5|NOT COMPLETED|Overall Study||1
631414|NCT00169442|1549295|P4|NOT COMPLETED|Overall Study||0
631415|NCT00169442|1549296|P3|NOT COMPLETED|Overall Study||1
631416|NCT00169442|1549297|P2|NOT COMPLETED|Overall Study||1
631417|NCT00169442|1549298|P1|NOT COMPLETED|Overall Study||0
631418|NCT00169442|1549293|P6|COMPLETED|Overall Study||41
631419|NCT00169442|1549294|P5|COMPLETED|Overall Study||41
631420|NCT00169442|1549295|P4|COMPLETED|Overall Study||250
631421|NCT00169442|1549296|P3|COMPLETED|Overall Study||166
631422|NCT00169442|1549297|P2|COMPLETED|Overall Study||123
631423|NCT00169442|1549298|P1|COMPLETED|Overall Study||119
631424|NCT00169442|1549293|P6|STARTED|Overall Study||43
631425|NCT00169442|1549294|P5|STARTED|Overall Study||42
631426|NCT00169442|1549295|P4|STARTED|Overall Study||250
631427|NCT00169442|1549296|P3|STARTED|Overall Study||167
631428|NCT00169442|1549297|P2|STARTED|Overall Study||124
631429|NCT00169442|1549298|P1|STARTED|Overall Study||119
631430|NCT00168844|1549408|P3|NOT COMPLETED|Overall Study||91
631431|NCT00168844|1549409|P2|NOT COMPLETED|Overall Study||55
631432|NCT00168844|1549410|P1|NOT COMPLETED|Overall Study||55
631433|NCT00168844|1549408|P3|COMPLETED|Overall Study||228
631434|NCT00168844|1549409|P2|COMPLETED|Overall Study||277
631435|NCT00168844|1549410|P1|COMPLETED|Overall Study||277
631436|NCT00168844|1549408|P3|STARTED|Overall Study||319
631437|NCT00168844|1549409|P2|STARTED|Overall Study||332
631438|NCT00168844|1549410|P1|STARTED|Overall Study||332
631439|NCT00168831|1549592|P3|NOT COMPLETED|Overall Study||114
631440|NCT00168831|1549593|P2|NOT COMPLETED|Overall Study||81
631441|NCT00168831|1549594|P1|NOT COMPLETED|Overall Study||60
631442|NCT00168831|1549592|P3|COMPLETED|Overall Study||220
631443|NCT00168831|1549593|P2|COMPLETED|Overall Study||254
631444|NCT00168831|1549594|P1|COMPLETED|Overall Study||278
631445|NCT00168831|1549592|P3|STARTED|Overall Study||334
631446|NCT00168831|1549593|P2|STARTED|Overall Study||335
631447|NCT00168831|1549594|P1|STARTED|Overall Study||338
631448|NCT00168818|1549776|P3|NOT COMPLETED|Treatment||133
631449|NCT00168818|1549777|P2|NOT COMPLETED|Treatment||151
631450|NCT00168818|1549778|P1|NOT COMPLETED|Treatment||133
631451|NCT00168818|1549776|P3|COMPLETED|Treatment||1021
631452|NCT00168818|1549777|P2|COMPLETED|Treatment||1012
631453|NCT00168818|1549778|P1|COMPLETED|Treatment||1013
631454|NCT00168818|1549776|P3|STARTED|Treatment||1154
631455|NCT00168818|1549777|P2|STARTED|Treatment||1163
631456|NCT00168818|1549778|P1|STARTED|Treatment||1146
631457|NCT00168818|1549776|P3|NOT COMPLETED|Overall Study||124
631458|NCT00168818|1549777|P2|NOT COMPLETED|Overall Study||109
631459|NCT00168818|1549778|P1|NOT COMPLETED|Overall Study||117
631460|NCT00168818|1549776|P3|COMPLETED|Overall Study||1030
631461|NCT00168818|1549777|P2|COMPLETED|Overall Study||1054
631462|NCT00168818|1549778|P1|COMPLETED|Overall Study||1029
631463|NCT00168818|1549776|P3|STARTED|Overall Study||1154
631464|NCT00168818|1549777|P2|STARTED|Overall Study||1163
631465|NCT00168818|1549778|P1|STARTED|Overall Study||1146
631466|NCT00168805|1549822|P3|NOT COMPLETED|Treatment||62
631467|NCT00168805|1549823|P2|NOT COMPLETED|Treatment||56
631468|NCT00168805|1549824|P1|NOT COMPLETED|Treatment||49
631469|NCT00168805|1549822|P3|COMPLETED|Treatment||632
631470|NCT00168805|1549823|P2|COMPLETED|Treatment||647
631471|NCT00168805|1549824|P1|COMPLETED|Treatment||630
631472|NCT00168805|1549822|P3|STARTED|Treatment||694
631473|NCT00168805|1549823|P2|STARTED|Treatment||703
631474|NCT00168805|1549824|P1|STARTED|Treatment||679
631475|NCT00168805|1549822|P3|NOT COMPLETED|Overall Study||78
631476|NCT00168805|1549823|P2|NOT COMPLETED|Overall Study||78
631477|NCT00168805|1549824|P1|NOT COMPLETED|Overall Study||71
631478|NCT00168805|1549822|P3|COMPLETED|Overall Study||616
631479|NCT00168805|1549823|P2|COMPLETED|Overall Study||625
631480|NCT00168805|1549824|P1|COMPLETED|Overall Study||608
631481|NCT00168805|1549822|P3|STARTED|Overall Study||694
631482|NCT00168805|1549823|P2|STARTED|Overall Study||703
631483|NCT00168805|1549824|P1|STARTED|Overall Study||679
631484|NCT00168454|1549871|P6|NOT COMPLETED|Overall Study||6
631485|NCT00168454|1549872|P5|NOT COMPLETED|Overall Study||6
631486|NCT00168454|1549873|P4|NOT COMPLETED|Overall Study||9
631487|NCT00168454|1549874|P3|NOT COMPLETED|Overall Study||6
631488|NCT00168454|1549875|P2|NOT COMPLETED|Overall Study||7
631489|NCT00168454|1549876|P1|NOT COMPLETED|Overall Study||7
631490|NCT00168454|1549871|P6|COMPLETED|Overall Study||50
631491|NCT00168454|1549872|P5|COMPLETED|Overall Study||47
631492|NCT00168454|1549873|P4|COMPLETED|Overall Study||40
631493|NCT00168454|1549874|P3|COMPLETED|Overall Study||48
631494|NCT00168454|1549875|P2|COMPLETED|Overall Study||50
631495|NCT00168454|1549876|P1|COMPLETED|Overall Study||37
631496|NCT00168454|1549871|P6|STARTED|Overall Study||56
631497|NCT00168454|1549872|P5|STARTED|Overall Study||53
631498|NCT00168454|1549873|P4|STARTED|Overall Study||49
631499|NCT00168454|1549874|P3|STARTED|Overall Study||54
631500|NCT00168454|1549875|P2|STARTED|Overall Study||57
631501|NCT00168454|1549876|P1|STARTED|Overall Study||44
631502|NCT00168428|1549922|P2|NOT COMPLETED|Open-Label Phase (OL)||68
631503|NCT00168428|1549923|P1|NOT COMPLETED|Open-Label Phase (OL)||44
631504|NCT00168428|1549922|P2|COMPLETED|Open-Label Phase (OL)||261
631505|NCT00168428|1549923|P1|COMPLETED|Open-Label Phase (OL)||261
631506|NCT00168428|1549922|P2|STARTED|Open-Label Phase (OL)|Number of DB Placebo patients who rolled into OL phase|329
631507|NCT00168428|1549923|P1|STARTED|Open-Label Phase (OL)|Number of DB Botulinum toxin type A patients who rolled into OL phase|305
631508|NCT00168428|1549922|P2|NOT COMPLETED|Double-Blind Phase (DB)||24
631509|NCT00168428|1549923|P1|NOT COMPLETED|Double-Blind Phase (DB)||36
631510|NCT00168428|1549922|P2|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|334
631511|NCT00168428|1549923|P1|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|311
631512|NCT00168428|1549922|P2|STARTED|Double-Blind Phase (DB)||358
631513|NCT00168428|1549923|P1|STARTED|Double-Blind Phase (DB)||347
631514|NCT00168389|1549942|P3|NOT COMPLETED|Overall Study||95
631515|NCT00168389|1549943|P2|NOT COMPLETED|Overall Study||48
631516|NCT00168389|1549944|P1|NOT COMPLETED|Overall Study||56
631517|NCT00168389|1549942|P3|COMPLETED|Overall Study||70
631518|NCT00168389|1549943|P2|COMPLETED|Overall Study||118
631519|NCT00168389|1549944|P1|COMPLETED|Overall Study||107
631520|NCT00168389|1549942|P3|STARTED|Overall Study||165
631521|NCT00168389|1549943|P2|STARTED|Overall Study||166
631522|NCT00168389|1549944|P1|STARTED|Overall Study||163
631523|NCT00168337|1549973|P3|NOT COMPLETED|Overall Study||103
631524|NCT00168337|1549974|P2|NOT COMPLETED|Overall Study||69
631525|NCT00168337|1549975|P1|NOT COMPLETED|Overall Study||70
631526|NCT00168337|1549973|P3|COMPLETED|Overall Study||82
631527|NCT00168337|1549974|P2|COMPLETED|Overall Study||112
631528|NCT00168337|1549975|P1|COMPLETED|Overall Study||118
631529|NCT00168337|1549973|P3|STARTED|Overall Study||185
631530|NCT00168337|1549974|P2|STARTED|Overall Study||181
631531|NCT00168337|1549975|P1|STARTED|Overall Study||188
631532|NCT00168324|1550004|P3|NOT COMPLETED|Open-Label Period||6
631533|NCT00168324|1550005|P2|NOT COMPLETED|Open-Label Period||8
631534|NCT00168324|1550006|P1|NOT COMPLETED|Open-Label Period||4
631535|NCT00168324|1550004|P3|COMPLETED|Open-Label Period||152
631536|NCT00168324|1550005|P2|COMPLETED|Open-Label Period||147
631537|NCT00168324|1550006|P1|COMPLETED|Open-Label Period||160
631538|NCT00168324|1550004|P3|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|158
631539|NCT00168324|1550005|P2|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|155
631540|NCT00168324|1550006|P1|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|164
631541|NCT00168324|1550004|P3|NOT COMPLETED|Double-Blind Period||13
631542|NCT00168324|1550005|P2|NOT COMPLETED|Double-Blind Period||7
631543|NCT00168324|1550006|P1|NOT COMPLETED|Double-Blind Period||12
631544|NCT00168324|1550004|P3|COMPLETED|Double-Blind Period||189
631545|NCT00168324|1550005|P2|COMPLETED|Double-Blind Period||189
631546|NCT00168324|1550006|P1|COMPLETED|Double-Blind Period||189
631547|NCT00168324|1550004|P3|STARTED|Double-Blind Period||202
631548|NCT00168324|1550005|P2|STARTED|Double-Blind Period||196
631549|NCT00168324|1550006|P1|STARTED|Double-Blind Period||201
631550|NCT00168311|1550028|P2|NOT COMPLETED|Overall Study||2
631551|NCT00168311|1550029|P1|NOT COMPLETED|Overall Study||0
631552|NCT00168311|1550028|P2|COMPLETED|Overall Study||8
631553|NCT00168311|1550029|P1|COMPLETED|Overall Study||12
631554|NCT00168311|1550028|P2|STARTED|Overall Study||10
631555|NCT00168311|1550029|P1|STARTED|Overall Study||12
631556|NCT00168298|1550038|P3|NOT COMPLETED|Open-Label Period||8
631557|NCT00168298|1550039|P2|NOT COMPLETED|Open-Label Period||5
631558|NCT00168298|1550040|P1|NOT COMPLETED|Open-Label Period||7
631559|NCT00168298|1550038|P3|COMPLETED|Open-Label Period||160
631560|NCT00168298|1550039|P2|COMPLETED|Open-Label Period||168
631561|NCT00168298|1550040|P1|COMPLETED|Open-Label Period||172
631562|NCT00168298|1550038|P3|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|168
631563|NCT00168298|1550039|P2|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|173
631564|NCT00168298|1550040|P1|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|179
631565|NCT00168298|1550038|P3|NOT COMPLETED|Double-Blind Period||15
631566|NCT00168298|1550039|P2|NOT COMPLETED|Double-Blind Period||12
631567|NCT00168298|1550040|P1|NOT COMPLETED|Double-Blind Period||12
631568|NCT00168298|1550038|P3|COMPLETED|Double-Blind Period||209
631569|NCT00168298|1550039|P2|COMPLETED|Double-Blind Period||206
631570|NCT00168298|1550040|P1|COMPLETED|Double-Blind Period||214
631571|NCT00168298|1550038|P3|STARTED|Double-Blind Period||224
631572|NCT00168298|1550039|P2|STARTED|Double-Blind Period||218
631573|NCT00168298|1550040|P1|STARTED|Double-Blind Period||226
631574|NCT00168103|1550060|P4|NOT COMPLETED|Overall Study||0
631575|NCT00168103|1550061|P3|NOT COMPLETED|Overall Study||1
631576|NCT00168103|1550062|P2|NOT COMPLETED|Overall Study||5
631577|NCT00168103|1550063|P1|NOT COMPLETED|Overall Study||2
631578|NCT00168103|1550060|P4|COMPLETED|Overall Study||1
631579|NCT00168103|1550061|P3|COMPLETED|Overall Study||41
631580|NCT00168103|1550062|P2|COMPLETED|Overall Study||38
631581|NCT00168103|1550063|P1|COMPLETED|Overall Study|1 randomized subject received open-label rescue medication before receiving randomized treatment.|38
631582|NCT00168103|1550060|P4|STARTED|Overall Study||1
631583|NCT00168103|1550061|P3|STARTED|Overall Study||42
631584|NCT00168103|1550062|P2|STARTED|Overall Study||43
631585|NCT00168103|1550063|P1|STARTED|Overall Study||40
631586|NCT00168064|1550085|P2|NOT COMPLETED|Overall Study||44
631587|NCT00168064|1550086|P1|NOT COMPLETED|Overall Study||49
631588|NCT00168064|1550085|P2|COMPLETED|Overall Study||86
631589|NCT00168064|1550086|P1|COMPLETED|Overall Study||81
631590|NCT00168064|1550085|P2|STARTED|Overall Study|127 participants received AP formulation|130
631591|NCT00168064|1550086|P1|STARTED|Overall Study|128 participants received PG formulation|130
631592|NCT00168038|1550094|P1|NOT COMPLETED|Overall Study||2
631593|NCT00168038|1550094|P1|COMPLETED|Overall Study||55
631594|NCT00168038|1550094|P1|STARTED|Overall Study||57
631595|NCT00167778|1550106|P1|NOT COMPLETED|Overall Study||1
631596|NCT00167778|1550106|P1|COMPLETED|Overall Study||10
631597|NCT00167778|1550106|P1|STARTED|Overall Study||11
631598|NCT00167544|1550157|P2|NOT COMPLETED|Overall Study||0
631599|NCT00167544|1550158|P1|NOT COMPLETED|Overall Study||1
631600|NCT00167544|1550157|P2|COMPLETED|Overall Study||33
631601|NCT00167544|1550158|P1|COMPLETED|Overall Study||30
631602|NCT00167544|1550157|P2|STARTED|Overall Study||33
631603|NCT00167544|1550158|P1|STARTED|Overall Study||31
631604|NCT00167414|1550172|P1|NOT COMPLETED|Overall Study||10
631605|NCT00167414|1550172|P1|COMPLETED|Overall Study||39
631606|NCT00167414|1550172|P1|STARTED|Overall Study||49
631607|NCT00167388|1550184|P4|NOT COMPLETED|Overall Study||0
631608|NCT00167388|1550185|P3|NOT COMPLETED|Overall Study||0
631609|NCT00167388|1550186|P2|NOT COMPLETED|Overall Study||0
631610|NCT00167388|1550187|P1|NOT COMPLETED|Overall Study||0
631611|NCT00167388|1550184|P4|COMPLETED|Overall Study||6
631612|NCT00167388|1550185|P3|COMPLETED|Overall Study||6
631613|NCT00167388|1550186|P2|COMPLETED|Overall Study||5
631614|NCT00167388|1550187|P1|COMPLETED|Overall Study||5
631615|NCT00167388|1550184|P4|Completed Doppler Study|Overall Study||6
631616|NCT00167388|1550185|P3|Completed Doppler Study|Overall Study||6
631617|NCT00167388|1550186|P2|Completed Doppler Study|Overall Study||5
631618|NCT00167388|1550187|P1|Completed Doppler Study|Overall Study||5
631619|NCT00167388|1550184|P4|STARTED|Overall Study||6
631620|NCT00167388|1550185|P3|STARTED|Overall Study||6
631621|NCT00167388|1550186|P2|STARTED|Overall Study||5
631622|NCT00167388|1550187|P1|STARTED|Overall Study||5
631623|NCT00167310|1550197|P2|NOT COMPLETED|Overall Study||10
631624|NCT00167310|1550198|P1|NOT COMPLETED|Overall Study||8
631625|NCT00167310|1550197|P2|COMPLETED|Overall Study||18
631626|NCT00167310|1550198|P1|COMPLETED|Overall Study||21
631627|NCT00167310|1550197|P2|STARTED|Overall Study||28
631628|NCT00167310|1550198|P1|STARTED|Overall Study||29
631629|NCT00167245|1550208|P2|NOT COMPLETED|Overall Study||41
631630|NCT00167245|1550209|P1|NOT COMPLETED|Overall Study||29
631631|NCT00167245|1550208|P2|COMPLETED|Overall Study||46
631632|NCT00167245|1550209|P1|COMPLETED|Overall Study||54
631633|NCT00167245|1550208|P2|STARTED|Overall Study||87
631634|NCT00167245|1550209|P1|STARTED|Overall Study||83
631635|NCT00167206|1550217|P1|NOT COMPLETED|Overall Study||0
631636|NCT00167206|1550217|P1|COMPLETED|Overall Study||16
631637|NCT00167206|1550217|P1|STARTED|Overall Study||16
631638|NCT00167180|1550231|P2|NOT COMPLETED|Overall Study||0
631639|NCT00167180|1550232|P1|NOT COMPLETED|Overall Study||0
631640|NCT00167180|1550231|P2|COMPLETED|Overall Study||57
631641|NCT00167180|1550232|P1|COMPLETED|Overall Study||0
631642|NCT00167180|1550231|P2|STARTED|Overall Study||57
631643|NCT00167180|1550232|P1|STARTED|Overall Study||0
631644|NCT00167102|1550248|P2|NOT COMPLETED|Overall Study||0
631645|NCT00167102|1550249|P1|NOT COMPLETED|Overall Study||0
631646|NCT00167102|1550248|P2|COMPLETED|Overall Study||22
631647|NCT00167102|1550249|P1|COMPLETED|Overall Study||23
631648|NCT00167102|1550248|P2|STARTED|Overall Study||22
631649|NCT00167102|1550249|P1|STARTED|Overall Study||23
631650|NCT00166712|1550259|P2|NOT COMPLETED|Overall Study||5
631651|NCT00166712|1550260|P1|NOT COMPLETED|Overall Study||2
631652|NCT00166712|1550259|P2|COMPLETED|Overall Study|Completed study participation.|11
631653|NCT00166712|1550260|P1|COMPLETED|Overall Study|Completed study participation.|22
631654|NCT00166712|1550259|P2|Phase 3|Overall Study|# weaned off Sirolimus at 12 months post-transplant.|0
631655|NCT00166712|1550260|P1|Phase 3|Overall Study|Subjects from Phase 2b who were weaned off Sirolimus @ 12 months post-transplant.|0
631656|NCT00166712|1550259|P2|Phase 2b|Overall Study|Subjects weaned off Sirolimus|0
631657|NCT00166712|1550260|P1|Phase 2b|Overall Study|Subjects converted to Sirolimus post-transplant.|3
631658|NCT00166712|1550259|P2|Phase 2a|Overall Study|Subject who remained on Sirolimus at 6 months post-transplant.|12
631659|NCT00166712|1550260|P1|Phase 2a|Overall Study|Subjects who remained on Prograf at 6mo post-transplant.|19
631660|NCT00166712|1550259|P2|Phase 1|Overall Study|Evaluated at 6 month post-transplant to potentially be weaned off Sirolimus.|12
631661|NCT00166712|1550260|P1|Phase 1|Overall Study|Evaluated for rejection at 6months post-transplant|22
631662|NCT00166712|1550259|P2|STARTED|Overall Study|Consented: Randomized-Group 2. Given Sirolimus & MMF prior to surgery, Alemtuzumab day of surgery.|16
631663|NCT00166712|1550260|P1|STARTED|Overall Study|Consented:Randomized-Group 1. Given MMF prior to surgery, Alemtuzumab & TAC (Prograf) day of surgery|24
631664|NCT00166517|1550277|P2|NOT COMPLETED|Overall Study||2
631665|NCT00166517|1550278|P1|NOT COMPLETED|Overall Study||5
631666|NCT00166517|1550277|P2|COMPLETED|Overall Study||61
631667|NCT00166517|1550278|P1|COMPLETED|Overall Study||110
631668|NCT00166517|1550277|P2|Vaccinated at Visit 3|Overall Study||61
631669|NCT00166517|1550278|P1|Vaccinated at Visit 3|Overall Study||110
631670|NCT00166517|1550277|P2|Vaccinated at Visit 2|Overall Study||61
631671|NCT00166517|1550278|P1|Vaccinated at Visit 2|Overall Study||112
631672|NCT00166517|1550277|P2|Vaccinated at Visit 1|Overall Study||63
631673|NCT00166517|1550278|P1|Vaccinated at Visit 1|Overall Study||115
631674|NCT00166517|1550277|P2|STARTED|Overall Study||63
631675|NCT00166517|1550278|P1|STARTED|Overall Study||115
631676|NCT00166504|1550288|P2|NOT COMPLETED|Overall Study||4
631677|NCT00166504|1550289|P1|NOT COMPLETED|Overall Study||5
631678|NCT00166504|1550288|P2|COMPLETED|Overall Study||91
631679|NCT00166504|1550289|P1|COMPLETED|Overall Study||103
631680|NCT00166504|1550288|P2|STARTED|Overall Study||95
631681|NCT00166504|1550289|P1|STARTED|Overall Study||108
631682|NCT00166361|1550297|P2|NOT COMPLETED|Overall Study||0
631683|NCT00166361|1550298|P1|NOT COMPLETED|Overall Study||0
631684|NCT00166361|1550297|P2|COMPLETED|Overall Study||10
631685|NCT00166361|1550298|P1|COMPLETED|Overall Study||14
631686|NCT00166361|1550297|P2|STARTED|Overall Study||10
631687|NCT00166361|1550298|P1|STARTED|Overall Study||14
631688|NCT00166296|1550306|P2|NOT COMPLETED|Overall Study||9
631689|NCT00166296|1550307|P1|NOT COMPLETED|Overall Study||7
631690|NCT00166296|1550306|P2|COMPLETED|Overall Study|Patients who completed both trial medication and interferon+ribavirin treatment for 12 weeks|57
631691|NCT00166296|1550307|P1|COMPLETED|Overall Study|Patients who completed both trial medication and interferon+ribavirin treatment for 12 weeks|60
631692|NCT00166296|1550306|P2|ANALYZED|Overall Study|Patients who did receive at least the first dose of study medications, included in the analysis|63
631788|NCT00163657|1550557|P2|STARTED|Overall Study||79
631693|NCT00166296|1550307|P1|ANALYZED|Overall Study|Patients who did receive at least the first dose of study medications, included in the analysis|66
631694|NCT00166296|1550306|P2|STARTED|Overall Study|Randomized patients|66
631695|NCT00166296|1550307|P1|STARTED|Overall Study|Randomized patients|67
631696|NCT00166205|1550319|P1|NOT COMPLETED|Overall Study||48
631697|NCT00166205|1550319|P1|COMPLETED|Overall Study||228
631698|NCT00166205|1550319|P1|Intervention - SAGB Surgery|Overall Study||276
631699|NCT00166205|1550319|P1|STARTED|Overall Study||276
631700|NCT00166166|1550335|P2|NOT COMPLETED|Overall Study||0
631701|NCT00166166|1550336|P1|NOT COMPLETED|Overall Study||0
631702|NCT00166166|1550335|P2|COMPLETED|Overall Study||71
631703|NCT00166166|1550336|P1|COMPLETED|Overall Study||103
631704|NCT00166166|1550335|P2|STARTED|Overall Study||71
631705|NCT00166166|1550336|P1|STARTED|Overall Study||103
631706|NCT00166114|1550359|P2|NOT COMPLETED|Overall Study||6
631707|NCT00166114|1550360|P1|NOT COMPLETED|Overall Study||14
631708|NCT00166114|1550359|P2|COMPLETED|Overall Study||13
631709|NCT00166114|1550360|P1|COMPLETED|Overall Study||7
631710|NCT00166114|1550359|P2|STARTED|Overall Study||19
631711|NCT00166114|1550360|P1|STARTED|Overall Study||21
631712|NCT00166036|1550368|P2|NOT COMPLETED|Overall Study||0
631713|NCT00166036|1550369|P1|NOT COMPLETED|Overall Study||0
631714|NCT00166036|1550368|P2|COMPLETED|Overall Study||19
631715|NCT00166036|1550369|P1|COMPLETED|Overall Study||17
631716|NCT00166036|1550368|P2|STARTED|Overall Study||19
631717|NCT00166036|1550369|P1|STARTED|Overall Study||17
631718|NCT00165984|1550377|P1|NOT COMPLETED|Overall Study||15
631719|NCT00165984|1550377|P1|COMPLETED|Overall Study||150
631720|NCT00165984|1550377|P1|STARTED|Overall Study||165
631721|NCT00165958|1550386|P2|NOT COMPLETED|Overall Study||2
631722|NCT00165958|1550387|P1|NOT COMPLETED|Overall Study||1
631723|NCT00165958|1550386|P2|COMPLETED|Overall Study||19
631724|NCT00165958|1550387|P1|COMPLETED|Overall Study||18
631725|NCT00165958|1550386|P2|STARTED|Overall Study||21
631726|NCT00165958|1550387|P1|STARTED|Overall Study||19
631727|NCT00165841|1550395|P2|NOT COMPLETED|Overall Study||62
631728|NCT00165841|1550396|P1|NOT COMPLETED|Overall Study||30
631729|NCT00165841|1550395|P2|COMPLETED|Overall Study||35
631730|NCT00165841|1550396|P1|COMPLETED|Overall Study||73
631731|NCT00165841|1550395|P2|STARTED|Overall Study||97
631732|NCT00165841|1550396|P1|STARTED|Overall Study||103
631733|NCT00165789|1550406|P4|NOT COMPLETED|Overall Study||14
631734|NCT00165789|1550407|P3|NOT COMPLETED|Overall Study||1
631735|NCT00165789|1550408|P2|NOT COMPLETED|Overall Study||4
631736|NCT00165789|1550409|P1|NOT COMPLETED|Overall Study||0
631737|NCT00165789|1550406|P4|COMPLETED|Overall Study||21
631738|NCT00165789|1550407|P3|COMPLETED|Overall Study||11
631739|NCT00165789|1550408|P2|COMPLETED|Overall Study||16
631740|NCT00165789|1550409|P1|COMPLETED|Overall Study||8
631741|NCT00165789|1550406|P4|STARTED|Overall Study||35
631742|NCT00165789|1550407|P3|STARTED|Overall Study||12
631743|NCT00165789|1550408|P2|STARTED|Overall Study||20
631744|NCT00165789|1550409|P1|STARTED|Overall Study||8
631745|NCT00165776|1550463|P4|NOT COMPLETED|Overall Study||2
631746|NCT00165776|1550464|P3|NOT COMPLETED|Overall Study||2
631747|NCT00165776|1550465|P2|NOT COMPLETED|Overall Study||1
631748|NCT00165776|1550466|P1|NOT COMPLETED|Overall Study||4
631749|NCT00165776|1550463|P4|COMPLETED|Overall Study||29
631750|NCT00165776|1550464|P3|COMPLETED|Overall Study||31
631751|NCT00165776|1550465|P2|COMPLETED|Overall Study||33
631752|NCT00165776|1550466|P1|COMPLETED|Overall Study||31
631753|NCT00165776|1550463|P4|STARTED|Overall Study||31
631754|NCT00165776|1550464|P3|STARTED|Overall Study||33
631755|NCT00165776|1550465|P2|STARTED|Overall Study||34
631756|NCT00165776|1550466|P1|STARTED|Overall Study||35
631757|NCT00165698|1550502|P2|NOT COMPLETED|Overall Study||15
631758|NCT00165698|1550503|P1|NOT COMPLETED|Overall Study||8
631759|NCT00165698|1550502|P2|COMPLETED|Overall Study||105
631760|NCT00165698|1550503|P1|COMPLETED|Overall Study||112
631761|NCT00165698|1550502|P2|STARTED|Overall Study||120
631762|NCT00165698|1550503|P1|STARTED|Overall Study||120
631763|NCT00165672|1550529|P2|NOT COMPLETED|Overall Study||1
631764|NCT00165672|1550530|P1|NOT COMPLETED|Overall Study||0
631765|NCT00165672|1550529|P2|COMPLETED|Overall Study||12
631766|NCT00165672|1550530|P1|COMPLETED|Overall Study||13
631767|NCT00165672|1550529|P2|STARTED|Overall Study||13
631768|NCT00165672|1550530|P1|STARTED|Overall Study||13
631769|NCT00165646|1550539|P3|NOT COMPLETED|Overall Study||4
631770|NCT00165646|1550540|P2|NOT COMPLETED|Overall Study||5
631771|NCT00165646|1550541|P1|NOT COMPLETED|Overall Study||5
631772|NCT00165646|1550539|P3|COMPLETED|Overall Study||98
631773|NCT00165646|1550540|P2|COMPLETED|Overall Study||88
631774|NCT00165646|1550541|P1|COMPLETED|Overall Study||88
631775|NCT00165646|1550539|P3|STARTED|Overall Study||102
631776|NCT00165646|1550540|P2|STARTED|Overall Study||93
631777|NCT00165646|1550541|P1|STARTED|Overall Study||93
631778|NCT00165503|1550549|P1|NOT COMPLETED|Overall Study||16
631779|NCT00165503|1550549|P1|COMPLETED|Overall Study||0
631780|NCT00165503|1550549|P1|STARTED|Overall Study||16
631781|NCT00163657|1550556|P3|NOT COMPLETED|Overall Study||37
631782|NCT00163657|1550557|P2|NOT COMPLETED|Overall Study||23
631783|NCT00163657|1550558|P1|NOT COMPLETED|Overall Study||20
631784|NCT00163657|1550556|P3|COMPLETED|Overall Study||116
631785|NCT00163657|1550557|P2|COMPLETED|Overall Study||56
631786|NCT00163657|1550558|P1|COMPLETED|Overall Study||60
631787|NCT00163657|1550556|P3|STARTED|Overall Study||153
631789|NCT00163657|1550558|P1|STARTED|Overall Study||80
631790|NCT00163293|1550572|P3|NOT COMPLETED|Overall Study||19
631791|NCT00163293|1550573|P2|NOT COMPLETED|Overall Study||7
631792|NCT00163293|1550574|P1|NOT COMPLETED|Overall Study||13
631793|NCT00163293|1550572|P3|COMPLETED|Overall Study||66
631794|NCT00163293|1550573|P2|COMPLETED|Overall Study||69
631795|NCT00163293|1550574|P1|COMPLETED|Overall Study||66
631796|NCT00163293|1550572|P3|STARTED|Overall Study||85
631797|NCT00163293|1550573|P2|STARTED|Overall Study||76
631798|NCT00163293|1550574|P1|STARTED|Overall Study||79
631799|NCT00163215|1550648|P1|NOT COMPLETED|Overall Study||15
631800|NCT00163215|1550648|P1|COMPLETED|Overall Study||31
631801|NCT00163215|1550648|P1|STARTED|Overall Study||46
631802|NCT00163189|1550668|P1|NOT COMPLETED|Overall Study||63
631803|NCT00163189|1550668|P1|COMPLETED|Overall Study||35
631804|NCT00163189|1550668|P1|STARTED|Overall Study||98
631805|NCT00163020|1550692|P2|NOT COMPLETED|Overall Study||2
631806|NCT00163020|1550693|P1|NOT COMPLETED|Overall Study||0
631807|NCT00163020|1550692|P2|COMPLETED|Overall Study|Twins = 78 Triplets = 25|103
631808|NCT00163020|1550693|P1|COMPLETED|Overall Study|Twins = 160 Triplets = 56|216
631809|NCT00163020|1550692|P2|STARTED|Overall Study|Twins = 80 Triplets = 25|105
631810|NCT00163020|1550693|P1|STARTED|Overall Study|Twins = 160 Triplets = 56|216
631811|NCT00162981|1550733|P2|NOT COMPLETED|Overall Study||6
631812|NCT00162981|1550734|P1|NOT COMPLETED|Overall Study||4
631813|NCT00162981|1550733|P2|COMPLETED|Overall Study||30
631814|NCT00162981|1550734|P1|COMPLETED|Overall Study||28
631815|NCT00162981|1550733|P2|STARTED|Overall Study||36
631816|NCT00162981|1550734|P1|STARTED|Overall Study||32
631817|NCT00162942|1550750|P2|NOT COMPLETED|Overall Study||52
631818|NCT00162942|1550751|P1|NOT COMPLETED|Overall Study||106
631819|NCT00162942|1550750|P2|COMPLETED|Overall Study||26
631820|NCT00162942|1550751|P1|COMPLETED|Overall Study||51
631821|NCT00162942|1550750|P2|Week 12|Overall Study||61
631822|NCT00162942|1550751|P1|Week 12|Overall Study||127
631823|NCT00162942|1550750|P2|STARTED|Overall Study||78
631824|NCT00162942|1550751|P1|STARTED|Overall Study||157
631825|NCT00162773|1550799|P1|NOT COMPLETED|Overall Study||22
631826|NCT00162773|1550799|P1|COMPLETED|Overall Study||7
631827|NCT00162773|1550799|P1|STARTED|Overall Study||29
631828|NCT00162370|1550803|P1|NOT COMPLETED|Efficacy Population||51
631829|NCT00162370|1550803|P1|COMPLETED|Efficacy Population|Efficacy population, completed rest/stress echo with Definity & completed 2 and/or 5 year follow up|315
631830|NCT00162370|1550803|P1|STARTED|Efficacy Population||366
631831|NCT00162370|1550803|P1|NOT COMPLETED|Completed Echocardiography Imaging||0
631832|NCT00162370|1550803|P1|COMPLETED|Completed Echocardiography Imaging|number of subjects who under went Definity-enhanced rest and stress echocardiogram|366
631833|NCT00162370|1550803|P1|STARTED|Completed Echocardiography Imaging|Received at least one dose of Definity|366
631834|NCT00162266|1550811|P4|NOT COMPLETED|Open-Label Period||137
631835|NCT00162266|1550812|P3|NOT COMPLETED|Open-Label Period||0
631836|NCT00162266|1550813|P2|NOT COMPLETED|Open-Label Period||0
631837|NCT00162266|1550814|P1|NOT COMPLETED|Open-Label Period||0
631838|NCT00162266|1550811|P4|COMPLETED|Open-Label Period||82
631839|NCT00162266|1550812|P3|COMPLETED|Open-Label Period||0
631840|NCT00162266|1550813|P2|COMPLETED|Open-Label Period||0
631841|NCT00162266|1550814|P1|COMPLETED|Open-Label Period||0
631842|NCT00162266|1550811|P4|STARTED|Open-Label Period||219
631843|NCT00162266|1550812|P3|STARTED|Open-Label Period||0
631844|NCT00162266|1550813|P2|STARTED|Open-Label Period||0
631845|NCT00162266|1550814|P1|STARTED|Open-Label Period||0
631846|NCT00162266|1550811|P4|NOT COMPLETED|Double-Blind Period||0
631847|NCT00162266|1550812|P3|NOT COMPLETED|Double-Blind Period||48
631848|NCT00162266|1550813|P2|NOT COMPLETED|Double-Blind Period||31
631849|NCT00162266|1550814|P1|NOT COMPLETED|Double-Blind Period||25
631850|NCT00162266|1550811|P4|COMPLETED|Double-Blind Period||0
631851|NCT00162266|1550812|P3|COMPLETED|Double-Blind Period||71
631852|NCT00162266|1550813|P2|COMPLETED|Double-Blind Period||74
631853|NCT00162266|1550814|P1|COMPLETED|Double-Blind Period||90
631854|NCT00162266|1550811|P4|Completed Day 1 to Day 181|Double-Blind Period||0
631855|NCT00162266|1550812|P3|Completed Day 1 to Day 181|Double-Blind Period||78
631856|NCT00162266|1550813|P2|Completed Day 1 to Day 181|Double-Blind Period||80
631857|NCT00162266|1550814|P1|Completed Day 1 to Day 181|Double-Blind Period||98
631858|NCT00162266|1550811|P4|STARTED|Double-Blind Period||0
631859|NCT00162266|1550812|P3|STARTED|Double-Blind Period||119
631860|NCT00162266|1550813|P2|STARTED|Double-Blind Period||105
631861|NCT00162266|1550814|P1|STARTED|Double-Blind Period||115
631862|NCT00162136|1551015|P1|NOT COMPLETED|Overall Study||35
631863|NCT00162136|1551015|P1|COMPLETED|Overall Study|Number of Participants still on treatment at study termination|0
631864|NCT00162136|1551015|P1|STARTED|Overall Study||35
631865|NCT00162123|1551047|P8|NOT COMPLETED|Overall Study||58
631866|NCT00162123|1551048|P7|NOT COMPLETED|Overall Study||4
631867|NCT00162123|1551049|P6|NOT COMPLETED|Overall Study||9
631868|NCT00162123|1551050|P5|NOT COMPLETED|Overall Study||31
631869|NCT00162123|1551051|P4|NOT COMPLETED|Overall Study||8
631870|NCT00162123|1551052|P3|NOT COMPLETED|Overall Study||21
631871|NCT00162123|1551053|P2|NOT COMPLETED|Overall Study||29
631872|NCT00162123|1551054|P1|NOT COMPLETED|Overall Study||44
631873|NCT00162123|1551047|P8|COMPLETED|Overall Study|Still on treatment|0
631874|NCT00162123|1551048|P7|COMPLETED|Overall Study|Still on treatment|0
631875|NCT00162123|1551049|P6|COMPLETED|Overall Study|Still on treatment|4
631876|NCT00162123|1551050|P5|COMPLETED|Overall Study|Still on treatment|14
631877|NCT00162123|1551051|P4|COMPLETED|Overall Study|Still on treatment|3
631878|NCT00162123|1551052|P3|COMPLETED|Overall Study|Still on treatment|3
631879|NCT00162123|1551053|P2|COMPLETED|Overall Study|Still on treatment|5
631880|NCT00162123|1551054|P1|COMPLETED|Overall Study|Still on treatment|9
631881|NCT00162123|1551047|P8|Received Treatment|Overall Study||0
631882|NCT00162123|1551048|P7|Received Treatment|Overall Study||4
631883|NCT00162123|1551049|P6|Received Treatment|Overall Study||12
631884|NCT00162123|1551050|P5|Received Treatment|Overall Study||33
631885|NCT00162123|1551051|P4|Received Treatment|Overall Study||11
631886|NCT00162123|1551052|P3|Received Treatment|Overall Study||24
631887|NCT00162123|1551053|P2|Received Treatment|Overall Study||34
631888|NCT00162123|1551054|P1|Received Treatment|Overall Study||53
631889|NCT00162123|1551047|P8|STARTED|Overall Study|Enrolled|58
631890|NCT00162123|1551048|P7|STARTED|Overall Study|Enrolled|4
631891|NCT00162123|1551049|P6|STARTED|Overall Study|Enrolled|13
631892|NCT00162123|1551050|P5|STARTED|Overall Study|Enrolled|45
631893|NCT00162123|1551051|P4|STARTED|Overall Study|Enrolled|11
631894|NCT00162123|1551052|P3|STARTED|Overall Study|Enrolled|24
631895|NCT00162123|1551053|P2|STARTED|Overall Study|Enrolled|34
631896|NCT00162123|1551054|P1|STARTED|Overall Study|Enrolled|53
631897|NCT00162097|1551087|P4|NOT COMPLETED|Overall Study||1
631898|NCT00162097|1551088|P3|NOT COMPLETED|Overall Study||0
631899|NCT00162097|1551089|P2|NOT COMPLETED|Overall Study||0
631900|NCT00162097|1551090|P1|NOT COMPLETED|Overall Study||0
631901|NCT00162097|1551087|P4|COMPLETED|Overall Study||6
631902|NCT00162097|1551088|P3|COMPLETED|Overall Study||1
631903|NCT00162097|1551089|P2|COMPLETED|Overall Study||2
631904|NCT00162097|1551090|P1|COMPLETED|Overall Study||6
631905|NCT00162097|1551087|P4|STARTED|Overall Study|Treated on Day 1. One participant enrolled twice in the study and is hence counted twice|7
631906|NCT00162097|1551088|P3|STARTED|Overall Study|Treated on Day 1|1
631907|NCT00162097|1551089|P2|STARTED|Overall Study|Treated on Day 1|2
631908|NCT00162097|1551090|P1|STARTED|Overall Study|Treated on Day 1|6
631909|NCT00162032|1551152|P2|NOT COMPLETED|Overall Study||2
631910|NCT00162032|1551153|P1|NOT COMPLETED|Overall Study||5
631911|NCT00162032|1551152|P2|COMPLETED|Overall Study|Completed is all subjects who completed 3 yr FU whether or not they were seen in the previous year.|114
631912|NCT00162032|1551153|P1|COMPLETED|Overall Study|Completed is all subjects who completed 3 yr FU whether or not they were seen in the previous year.|324
631913|NCT00162032|1551152|P2|STARTED|Overall Study||116
631914|NCT00162032|1551153|P1|STARTED|Overall Study||329
631915|NCT00161616|1551163|P2|NOT COMPLETED|Overall Study||19
631916|NCT00161616|1551164|P1|NOT COMPLETED|Overall Study||26
631917|NCT00161616|1551163|P2|COMPLETED|Overall Study||119
631918|NCT00161616|1551164|P1|COMPLETED|Overall Study||113
631919|NCT00161616|1551163|P2|STARTED|Overall Study||138
631920|NCT00161616|1551164|P1|STARTED|Overall Study||139
631921|NCT00161473|1551174|P2|NOT COMPLETED|Overall Study||6
631922|NCT00161473|1551175|P1|NOT COMPLETED|Overall Study||5
631923|NCT00161473|1551174|P2|COMPLETED|Overall Study||6
631924|NCT00161473|1551175|P1|COMPLETED|Overall Study||7
631925|NCT00161473|1551174|P2|STARTED|Overall Study||12
631926|NCT00161473|1551175|P1|STARTED|Overall Study||12
631927|NCT00161382|1551189|P2|NOT COMPLETED|Overall Study||289
631928|NCT00161382|1551190|P1|NOT COMPLETED|Overall Study||249
631929|NCT00161382|1551189|P2|COMPLETED|Overall Study|Number of control students included in the analyzed cohort (i.e., completed 9th-grade survey)|558
631930|NCT00161382|1551190|P1|COMPLETED|Overall Study|Number of intervention students included in the analyzed cohort (i.e., completed 9th-grade survey)|349
631931|NCT00161382|1551189|P2|STARTED|Overall Study|Number of students allocated to comparison group|847
631932|NCT00161382|1551190|P1|STARTED|Overall Study|Number of students allocated to intervention group|598
631933|NCT00161213|1551196|P1|NOT COMPLETED|Overall Study||2
631934|NCT00161213|1551196|P1|COMPLETED|Overall Study||42
631935|NCT00161213|1551196|P1|STARTED|Overall Study||44
631936|NCT00160706|1551203|P1|NOT COMPLETED|Overall Study||286
631937|NCT00160706|1551203|P1|COMPLETED|Overall Study||24
631938|NCT00160706|1551203|P1|STARTED|Overall Study||310
631939|NCT00160693|1551215|P1|NOT COMPLETED|Overall Study||235
631940|NCT00160693|1551215|P1|COMPLETED|Overall Study||167
631941|NCT00160693|1551215|P1|STARTED|Overall Study||402
631942|NCT00160641|1551232|P1|NOT COMPLETED|Overall Study||221
631943|NCT00160641|1551232|P1|COMPLETED|Overall Study||346
631944|NCT00160641|1551232|P1|STARTED|Overall Study||567
631945|NCT00160563|1551266|P3|NOT COMPLETED|Overall Study||90
631946|NCT00160563|1551267|P2|NOT COMPLETED|Overall Study||45
631947|NCT00160563|1551268|P1|NOT COMPLETED|Overall Study||51
631948|NCT00160563|1551266|P3|COMPLETED|Overall Study||11
631949|NCT00160563|1551267|P2|COMPLETED|Overall Study||2
631950|NCT00160563|1551268|P1|COMPLETED|Overall Study||8
631951|NCT00160563|1551266|P3|STARTED|Overall Study||101
631952|NCT00160563|1551267|P2|STARTED|Overall Study||47
631953|NCT00160563|1551268|P1|STARTED|Overall Study||59
631954|NCT00160524|1551280|P1|NOT COMPLETED|Overall Study||478
631955|NCT00160524|1551280|P1|COMPLETED|Overall Study||117
631956|NCT00160524|1551280|P1|STARTED|Overall Study|One subject was enrolled erroneously and has no data in the database.|595
631957|NCT00160251|1551297|P8|NOT COMPLETED|Post-amendment 2||55
631958|NCT00160251|1551298|P7|NOT COMPLETED|Post-amendment 2||0
631959|NCT00160251|1551299|P6|NOT COMPLETED|Post-amendment 2||0
631960|NCT00160251|1551300|P5|NOT COMPLETED|Post-amendment 2||0
631961|NCT00160251|1551301|P4|NOT COMPLETED|Post-amendment 2||0
631962|NCT00160251|1551302|P3|NOT COMPLETED|Post-amendment 2||0
631963|NCT00160251|1551303|P2|NOT COMPLETED|Post-amendment 2||0
631964|NCT00160251|1551304|P1|NOT COMPLETED|Post-amendment 2||0
631965|NCT00160251|1551297|P8|COMPLETED|Post-amendment 2||88
631966|NCT00160251|1551298|P7|COMPLETED|Post-amendment 2||0
631967|NCT00160251|1551299|P6|COMPLETED|Post-amendment 2||0
631968|NCT00160251|1551300|P5|COMPLETED|Post-amendment 2||0
631969|NCT00160251|1551301|P4|COMPLETED|Post-amendment 2||0
631970|NCT00160251|1551302|P3|COMPLETED|Post-amendment 2||0
631971|NCT00160251|1551303|P2|COMPLETED|Post-amendment 2||0
631972|NCT00160251|1551304|P1|COMPLETED|Post-amendment 2||0
631973|NCT00160251|1551297|P8|STARTED|Post-amendment 2||143
631974|NCT00160251|1551298|P7|STARTED|Post-amendment 2||0
631975|NCT00160251|1551299|P6|STARTED|Post-amendment 2||0
631976|NCT00160251|1551300|P5|STARTED|Post-amendment 2||0
631977|NCT00160251|1551301|P4|STARTED|Post-amendment 2||0
631978|NCT00160251|1551302|P3|STARTED|Post-amendment 2||0
631979|NCT00160251|1551303|P2|STARTED|Post-amendment 2||0
631980|NCT00160251|1551304|P1|STARTED|Post-amendment 2||0
631981|NCT00160251|1551297|P8|NOT COMPLETED|Prior to Amendment 2||0
631982|NCT00160251|1551298|P7|NOT COMPLETED|Prior to Amendment 2||4
631983|NCT00160251|1551299|P6|NOT COMPLETED|Prior to Amendment 2||83
631984|NCT00160251|1551300|P5|NOT COMPLETED|Prior to Amendment 2||28
631985|NCT00160251|1551301|P4|NOT COMPLETED|Prior to Amendment 2||40
631986|NCT00160251|1551302|P3|NOT COMPLETED|Prior to Amendment 2||44
631987|NCT00160251|1551303|P2|NOT COMPLETED|Prior to Amendment 2||6
631988|NCT00160251|1551304|P1|NOT COMPLETED|Prior to Amendment 2||9
631989|NCT00160251|1551297|P8|COMPLETED|Prior to Amendment 2||0
631990|NCT00160251|1551298|P7|COMPLETED|Prior to Amendment 2||61
631991|NCT00160251|1551299|P6|COMPLETED|Prior to Amendment 2||14
631992|NCT00160251|1551300|P5|COMPLETED|Prior to Amendment 2||21
631993|NCT00160251|1551301|P4|COMPLETED|Prior to Amendment 2||9
631994|NCT00160251|1551302|P3|COMPLETED|Prior to Amendment 2||4
631995|NCT00160251|1551303|P2|COMPLETED|Prior to Amendment 2||28
631996|NCT00160251|1551304|P1|COMPLETED|Prior to Amendment 2||6
631997|NCT00160251|1551297|P8|STARTED|Prior to Amendment 2||0
631998|NCT00160251|1551298|P7|STARTED|Prior to Amendment 2||65
631999|NCT00160251|1551299|P6|STARTED|Prior to Amendment 2||97
632000|NCT00160251|1551300|P5|STARTED|Prior to Amendment 2||49
632001|NCT00160251|1551301|P4|STARTED|Prior to Amendment 2||49
632002|NCT00160251|1551302|P3|STARTED|Prior to Amendment 2||48
632003|NCT00160251|1551303|P2|STARTED|Prior to Amendment 2||34
632004|NCT00160251|1551304|P1|STARTED|Prior to Amendment 2||15
632005|NCT00160199|1551380|P2|NOT COMPLETED|Overall Study||37
632006|NCT00160199|1551381|P1|NOT COMPLETED|Overall Study||24
632007|NCT00160199|1551380|P2|COMPLETED|Overall Study||81
632008|NCT00160199|1551381|P1|COMPLETED|Overall Study||98
632009|NCT00160199|1551380|P2|STARTED|Overall Study||118
632010|NCT00160199|1551381|P1|STARTED|Overall Study||122
632011|NCT00159965|1551401|P2|NOT COMPLETED|Overall Study||5
632012|NCT00159965|1551402|P1|NOT COMPLETED|Overall Study||7
632013|NCT00159965|1551401|P2|COMPLETED|Overall Study||14
632014|NCT00159965|1551402|P1|COMPLETED|Overall Study||12
632015|NCT00159965|1551401|P2|STARTED|Overall Study||19
632016|NCT00159965|1551402|P1|STARTED|Overall Study||19
632017|NCT00159913|1551438|P4|NOT COMPLETED|Overall Study||2
632018|NCT00159913|1551439|P3|NOT COMPLETED|Overall Study||2
632019|NCT00159913|1551440|P2|NOT COMPLETED|Overall Study||0
632020|NCT00159913|1551441|P1|NOT COMPLETED|Overall Study||2
632021|NCT00159913|1551438|P4|COMPLETED|Overall Study||58
632022|NCT00159913|1551439|P3|COMPLETED|Overall Study||75
632023|NCT00159913|1551440|P2|COMPLETED|Overall Study||55
632024|NCT00159913|1551441|P1|COMPLETED|Overall Study||40
632025|NCT00159913|1551438|P4|STARTED|Overall Study||60
632026|NCT00159913|1551439|P3|STARTED|Overall Study||77
632027|NCT00159913|1551440|P2|STARTED|Overall Study||55
632028|NCT00159913|1551441|P1|STARTED|Overall Study||42
632029|NCT00159874|1551515|P7|NOT COMPLETED|Overall Study||5
632030|NCT00159874|1551516|P6|NOT COMPLETED|Overall Study||12
632031|NCT00159874|1551517|P5|NOT COMPLETED|Overall Study||8
632032|NCT00159874|1551518|P4|NOT COMPLETED|Overall Study||6
632033|NCT00159874|1551519|P3|NOT COMPLETED|Overall Study||43
632034|NCT00159874|1551520|P2|NOT COMPLETED|Overall Study||30
632035|NCT00159874|1551521|P1|NOT COMPLETED|Overall Study||20
632036|NCT00159874|1551515|P7|COMPLETED|Overall Study||0
632037|NCT00159874|1551516|P6|COMPLETED|Overall Study||11
632038|NCT00159874|1551517|P5|COMPLETED|Overall Study||11
632039|NCT00159874|1551518|P4|COMPLETED|Overall Study||7
632040|NCT00159874|1551519|P3|COMPLETED|Overall Study||34
632041|NCT00159874|1551520|P2|COMPLETED|Overall Study||25
632042|NCT00159874|1551521|P1|COMPLETED|Overall Study||22
632043|NCT00159874|1551515|P7|Treated|Overall Study||5
632044|NCT00159874|1551516|P6|Treated|Overall Study||23
632045|NCT00159874|1551517|P5|Treated|Overall Study||19
632046|NCT00159874|1551518|P4|Treated|Overall Study||13
632047|NCT00159874|1551519|P3|Treated|Overall Study||77
632048|NCT00159874|1551520|P2|Treated|Overall Study||55
632049|NCT00159874|1551521|P1|Treated|Overall Study||42
632050|NCT00159874|1551515|P7|STARTED|Overall Study||5
632051|NCT00159874|1551516|P6|STARTED|Overall Study||23
632052|NCT00159874|1551517|P5|STARTED|Overall Study||19
632053|NCT00159874|1551518|P4|STARTED|Overall Study||13
632054|NCT00159874|1551519|P3|STARTED|Overall Study||77
632055|NCT00159874|1551520|P2|STARTED|Overall Study||55
632056|NCT00159874|1551521|P1|STARTED|Overall Study||42
632057|NCT00159861|1551691|P2|NOT COMPLETED|Extension Study - up to 3 Years||71
632058|NCT00159861|1551692|P1|NOT COMPLETED|Extension Study - up to 3 Years||62
632059|NCT00159861|1551691|P2|COMPLETED|Extension Study - up to 3 Years||56
632060|NCT00159861|1551692|P1|COMPLETED|Extension Study - up to 3 Years||53
632061|NCT00159861|1551691|P2|Treated|Extension Study - up to 3 Years||127
632062|NCT00159861|1551692|P1|Treated|Extension Study - up to 3 Years||115
632063|NCT00159861|1551691|P2|STARTED|Extension Study - up to 3 Years|Subjects may have entered extension study after 4 weeks in core study (prior to completion).|127
632064|NCT00159861|1551692|P1|STARTED|Extension Study - up to 3 Years|Subjects may have entered extension study after 4 weeks in core study (prior to completion).|115
632065|NCT00159861|1551691|P2|NOT COMPLETED|Core Study - 16 Weeks||12
632066|NCT00159861|1551692|P1|NOT COMPLETED|Core Study - 16 Weeks||25
632067|NCT00159861|1551691|P2|COMPLETED|Core Study - 16 Weeks|Entered A1481153: 127; Did not enter A1481153: 7|122
632068|NCT00159861|1551692|P1|COMPLETED|Core Study - 16 Weeks|Entered A1481153: 115; Did not enter A1481153: 16|108
632069|NCT00159861|1551691|P2|Treated|Core Study - 16 Weeks||134
632070|NCT00159861|1551692|P1|Treated|Core Study - 16 Weeks||131
632071|NCT00159861|1551691|P2|STARTED|Core Study - 16 Weeks||134
632072|NCT00159861|1551692|P1|STARTED|Core Study - 16 Weeks||133
632073|NCT00159822|1551713|P1|NOT COMPLETED|Post-treatment Follow-up Period||3
632074|NCT00159822|1551713|P1|COMPLETED|Post-treatment Follow-up Period||23
632075|NCT00159822|1551713|P1|STARTED|Post-treatment Follow-up Period||26
632076|NCT00159822|1551713|P1|NOT COMPLETED|Voriconazole Treatment Period||22
632077|NCT00159822|1551713|P1|COMPLETED|Voriconazole Treatment Period|Number of subjects completed treatment: 36 up to month 6 (M6); 26 after M6.|26
632078|NCT00159822|1551713|P1|STARTED|Voriconazole Treatment Period||48
632079|NCT00159783|1551731|P3|NOT COMPLETED|Overall Study||39
632080|NCT00159783|1551732|P2|NOT COMPLETED|Overall Study||27
632081|NCT00159783|1551733|P1|NOT COMPLETED|Overall Study||19
632082|NCT00159783|1551731|P3|COMPLETED|Overall Study||68
632083|NCT00159783|1551732|P2|COMPLETED|Overall Study||52
632084|NCT00159783|1551733|P1|COMPLETED|Overall Study||13
632085|NCT00159783|1551731|P3|STARTED|Overall Study||107
632086|NCT00159783|1551732|P2|STARTED|Overall Study||79
632087|NCT00159783|1551733|P1|STARTED|Overall Study||32
632088|NCT00159432|1551763|P1|NOT COMPLETED|Overall Study||10
632089|NCT00159432|1551763|P1|COMPLETED|Overall Study||53
632090|NCT00159432|1551763|P1|STARTED|Overall Study||63
632091|NCT00159419|1551770|P2|NOT COMPLETED|Overall Study||0
632092|NCT00159419|1551771|P1|NOT COMPLETED|Overall Study||0
632093|NCT00159419|1551770|P2|COMPLETED|Overall Study||9
632094|NCT00159419|1551771|P1|COMPLETED|Overall Study||9
632095|NCT00159419|1551770|P2|STARTED|Overall Study||9
632096|NCT00159419|1551771|P1|STARTED|Overall Study||9
632097|NCT00158925|1551777|P1|NOT COMPLETED|Overall Study||12
632098|NCT00158925|1551777|P1|COMPLETED|Overall Study||84
632099|NCT00158925|1551777|P1|STARTED|Overall Study|96 subjects were implanted or attempted with the study lead|96
632100|NCT00158756|1551790|P5|NOT COMPLETED|Overall Study||3
632101|NCT00158756|1551791|P4|NOT COMPLETED|Overall Study||1
632102|NCT00158756|1551792|P3|NOT COMPLETED|Overall Study||8
632103|NCT00158756|1551793|P2|NOT COMPLETED|Overall Study||0
632104|NCT00158756|1551794|P1|NOT COMPLETED|Overall Study||5
632105|NCT00158756|1551790|P5|COMPLETED|Overall Study||96
632106|NCT00158756|1551791|P4|COMPLETED|Overall Study||22
632107|NCT00158756|1551792|P3|COMPLETED|Overall Study||73
632108|NCT00158756|1551793|P2|COMPLETED|Overall Study||25
632109|NCT00158756|1551794|P1|COMPLETED|Overall Study||75
632110|NCT00158756|1551790|P5|STARTED|Overall Study||99
632111|NCT00158756|1551791|P4|STARTED|Overall Study||23
632112|NCT00158756|1551792|P3|STARTED|Overall Study||81
632113|NCT00158756|1551793|P2|STARTED|Overall Study||25
632114|NCT00158756|1551794|P1|STARTED|Overall Study||80
632115|NCT00158743|1551891|P2|NOT COMPLETED|Overall Study||7
632116|NCT00158743|1551892|P1|NOT COMPLETED|Overall Study||9
632117|NCT00158743|1551891|P2|COMPLETED|Overall Study||20
632118|NCT00158743|1551892|P1|COMPLETED|Overall Study||15
632119|NCT00158743|1551891|P2|STARTED|Overall Study||27
632120|NCT00158743|1551892|P1|STARTED|Overall Study||24
632121|NCT00158600|1551900|P2|NOT COMPLETED|Overall Study||4
632122|NCT00158600|1551901|P1|NOT COMPLETED|Overall Study||5
632123|NCT00158600|1551900|P2|COMPLETED|Overall Study||26
632124|NCT00158600|1551901|P1|COMPLETED|Overall Study||55
632125|NCT00158600|1551900|P2|STARTED|Overall Study||30
632126|NCT00158600|1551901|P1|STARTED|Overall Study||60
632127|NCT00158379|1551919|P1|NOT COMPLETED|Overall Study||0
632128|NCT00158379|1551919|P1|COMPLETED|Overall Study||105
632129|NCT00158379|1551919|P1|STARTED|Overall Study||105
632130|NCT00158262|1551926|P2|NOT COMPLETED|Overall Study||1
632131|NCT00158262|1551927|P1|NOT COMPLETED|Overall Study||1
632132|NCT00158262|1551926|P2|COMPLETED|Overall Study||21
632133|NCT00158262|1551927|P1|COMPLETED|Overall Study||20
632134|NCT00158262|1551926|P2|STARTED|Overall Study||22
632135|NCT00158262|1551927|P1|STARTED|Overall Study||21
632136|NCT00158249|1551939|P2|NOT COMPLETED|Overall Study||0
632137|NCT00158249|1551940|P1|NOT COMPLETED|Overall Study||2
632138|NCT00158249|1551939|P2|COMPLETED|Overall Study||10
632139|NCT00158249|1551940|P1|COMPLETED|Overall Study||9
632140|NCT00158249|1551939|P2|STARTED|Overall Study||10
632141|NCT00158249|1551940|P1|STARTED|Overall Study||11
632142|NCT00158223|1551950|P2|NOT COMPLETED|Overall Study||3
632143|NCT00158223|1551951|P1|NOT COMPLETED|Overall Study||5
632144|NCT00158223|1551950|P2|COMPLETED|Overall Study||22
632145|NCT00158223|1551951|P1|COMPLETED|Overall Study||23
632146|NCT00158223|1551950|P2|STARTED|Overall Study||25
632147|NCT00158223|1551951|P1|STARTED|Overall Study||28
632148|NCT00158197|1551965|P4|NOT COMPLETED|Overall Study||0
632149|NCT00158197|1551966|P3|NOT COMPLETED|Overall Study||0
632150|NCT00158197|1551967|P2|NOT COMPLETED|Overall Study||0
632151|NCT00158197|1551968|P1|NOT COMPLETED|Overall Study||0
632152|NCT00158197|1551965|P4|COMPLETED|Overall Study||29
632153|NCT00158197|1551966|P3|COMPLETED|Overall Study||28
632154|NCT00158197|1551967|P2|COMPLETED|Overall Study||30
632155|NCT00158197|1551968|P1|COMPLETED|Overall Study||32
632156|NCT00158197|1551965|P4|STARTED|Overall Study||29
632157|NCT00158197|1551966|P3|STARTED|Overall Study||28
632158|NCT00158197|1551967|P2|STARTED|Overall Study||30
632159|NCT00158197|1551968|P1|STARTED|Overall Study||32
632160|NCT00158184|1551988|P2|NOT COMPLETED|Overall Study||2
632161|NCT00158184|1551989|P1|NOT COMPLETED|Overall Study||6
632162|NCT00158184|1551988|P2|COMPLETED|Overall Study||9
632163|NCT00158184|1551989|P1|COMPLETED|Overall Study||10
632164|NCT00158184|1551988|P2|STARTED|Overall Study||11
632165|NCT00158184|1551989|P1|STARTED|Overall Study||16
632166|NCT00158054|1551999|P2|NOT COMPLETED|Overall Study||3
632167|NCT00158054|1552000|P1|NOT COMPLETED|Overall Study||10
632168|NCT00158054|1551999|P2|COMPLETED|Overall Study||74
632169|NCT00158054|1552000|P1|COMPLETED|Overall Study||70
632170|NCT00158054|1551999|P2|STARTED|Overall Study||77
632171|NCT00158054|1552000|P1|STARTED|Overall Study||80
632172|NCT00157950|1552014|P2|NOT COMPLETED|Overall Study||0
632173|NCT00157950|1552015|P1|NOT COMPLETED|Overall Study||1
632174|NCT00157950|1552014|P2|COMPLETED|Overall Study||59
632175|NCT00157950|1552015|P1|COMPLETED|Overall Study||116
632176|NCT00157950|1552014|P2|Vaccinated at Dose 3|Overall Study||59
632177|NCT00157950|1552015|P1|Vaccinated at Dose 3|Overall Study||116
632178|NCT00157950|1552014|P2|Vaccinated at Dose 2|Overall Study||59
632179|NCT00157950|1552015|P1|Vaccinated at Dose 2|Overall Study||117
632180|NCT00157950|1552014|P2|Vaccinated at Dose 1|Overall Study||59
632181|NCT00157950|1552015|P1|Vaccinated at Dose 1|Overall Study||117
632182|NCT00157950|1552014|P2|STARTED|Overall Study||59
632183|NCT00157950|1552015|P1|STARTED|Overall Study||117
632184|NCT00157820|1552032|P3|NOT COMPLETED|2nd 8 Months||14
632185|NCT00157820|1552033|P2|NOT COMPLETED|2nd 8 Months||13
632186|NCT00157820|1552034|P1|NOT COMPLETED|2nd 8 Months||5
632187|NCT00157820|1552032|P3|COMPLETED|2nd 8 Months||94
632188|NCT00157820|1552033|P2|COMPLETED|2nd 8 Months||88
632189|NCT00157820|1552034|P1|COMPLETED|2nd 8 Months||98
632190|NCT00157820|1552032|P3|STARTED|2nd 8 Months||108
632191|NCT00157820|1552033|P2|STARTED|2nd 8 Months||101
632192|NCT00157820|1552034|P1|STARTED|2nd 8 Months||103
632193|NCT00157820|1552032|P3|NOT COMPLETED|1 Month Wash Out Period||0
632194|NCT00157820|1552033|P2|NOT COMPLETED|1 Month Wash Out Period||0
632195|NCT00157820|1552034|P1|NOT COMPLETED|1 Month Wash Out Period||0
632196|NCT00157820|1552032|P3|COMPLETED|1 Month Wash Out Period||108
632197|NCT00157820|1552033|P2|COMPLETED|1 Month Wash Out Period||101
632198|NCT00157820|1552034|P1|COMPLETED|1 Month Wash Out Period||103
632199|NCT00157820|1552032|P3|STARTED|1 Month Wash Out Period|2 patients had crossed over prematurely in DC true period, that are now carried to SC sim period|108
632200|NCT00157820|1552033|P2|STARTED|1 Month Wash Out Period|2 patients had crossed over prematurely in SC sim period, that are now carried to DC true period|101
632201|NCT00157820|1552034|P1|STARTED|1 Month Wash Out Period||103
632202|NCT00157820|1552032|P3|NOT COMPLETED|1st 8 Month||6
632203|NCT00157820|1552033|P2|NOT COMPLETED|1st 8 Month||12
632204|NCT00157820|1552034|P1|NOT COMPLETED|1st 8 Month||8
632205|NCT00157820|1552032|P3|COMPLETED|1st 8 Month||106
632206|NCT00157820|1552033|P2|COMPLETED|1st 8 Month||99
632207|NCT00157820|1552034|P1|COMPLETED|1st 8 Month||103
632208|NCT00157820|1552032|P3|STARTED|1st 8 Month||112
632209|NCT00157820|1552033|P2|STARTED|1st 8 Month||111
632210|NCT00157820|1552034|P1|STARTED|1st 8 Month||111
632211|NCT00157820|1552032|P3|NOT COMPLETED|Randomized||8
632212|NCT00157820|1552033|P2|NOT COMPLETED|Randomized||5
632213|NCT00157820|1552034|P1|NOT COMPLETED|Randomized||7
632214|NCT00157820|1552032|P3|COMPLETED|Randomized||112
632215|NCT00157820|1552033|P2|COMPLETED|Randomized||111
632216|NCT00157820|1552034|P1|COMPLETED|Randomized||111
632217|NCT00157820|1552032|P3|STARTED|Randomized||120
632218|NCT00157820|1552033|P2|STARTED|Randomized||116
632219|NCT00157820|1552034|P1|STARTED|Randomized||118
632220|NCT00157755|1552047|P6|NOT COMPLETED|Overall Study||5
632221|NCT00157755|1552048|P5|NOT COMPLETED|Overall Study||2
632222|NCT00157755|1552049|P4|NOT COMPLETED|Overall Study||4
632223|NCT00157755|1552050|P3|NOT COMPLETED|Overall Study||7
632224|NCT00157755|1552051|P2|NOT COMPLETED|Overall Study||4
632225|NCT00157755|1552052|P1|NOT COMPLETED|Overall Study||2
632226|NCT00157755|1552047|P6|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|0
632227|NCT00157755|1552048|P5|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|10
632228|NCT00157755|1552049|P4|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|11
632229|NCT00157755|1552050|P3|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|3
632230|NCT00157755|1552051|P2|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|15
632231|NCT00157755|1552052|P1|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|24
632232|NCT00157755|1552047|P6|STARTED|Overall Study||5
632233|NCT00157755|1552048|P5|STARTED|Overall Study||12
632234|NCT00157755|1552049|P4|STARTED|Overall Study||15
632235|NCT00157755|1552050|P3|STARTED|Overall Study||10
632236|NCT00157755|1552051|P2|STARTED|Overall Study||19
632237|NCT00157755|1552052|P1|STARTED|Overall Study||26
632238|NCT00157573|1552074|P2|NOT COMPLETED|Overall Study||0
632239|NCT00157573|1552075|P1|NOT COMPLETED|Overall Study||0
632240|NCT00157573|1552074|P2|COMPLETED|Overall Study||37
632241|NCT00157573|1552075|P1|COMPLETED|Overall Study||35
632242|NCT00157573|1552074|P2|STARTED|Overall Study||37
632243|NCT00157573|1552075|P1|STARTED|Overall Study||35
632244|NCT00157248|1552088|P4|NOT COMPLETED|Overall Study||47
632245|NCT00157248|1552089|P3|NOT COMPLETED|Overall Study||21
632246|NCT00157248|1552090|P2|NOT COMPLETED|Overall Study||37
632247|NCT00157248|1552091|P1|NOT COMPLETED|Overall Study||48
632248|NCT00157248|1552088|P4|COMPLETED|Overall Study||77
632249|NCT00157248|1552089|P3|COMPLETED|Overall Study||29
632250|NCT00157248|1552090|P2|COMPLETED|Overall Study||52
632251|NCT00157248|1552091|P1|COMPLETED|Overall Study|Completed: Participant without premature discontinuation of study medication.|50
632252|NCT00157248|1552088|P4|STARTED|Overall Study||124
632253|NCT00157248|1552089|P3|STARTED|Overall Study||50
632254|NCT00157248|1552090|P2|STARTED|Overall Study||89
632255|NCT00157248|1552091|P1|STARTED|Overall Study|Started: Participant completed previous trial on Dabigatran and took study drug of present trial.|98
632256|NCT00157209|1552197|P2|NOT COMPLETED|Overall Study||0
632257|NCT00157209|1552198|P1|NOT COMPLETED|Overall Study||10
632258|NCT00157209|1552197|P2|COMPLETED|Overall Study||83
632259|NCT00157209|1552198|P1|COMPLETED|Overall Study||78
632260|NCT00157209|1552197|P2|STARTED|Overall Study||83
632261|NCT00157209|1552198|P1|STARTED|Overall Study||88
632262|NCT00157196|1552212|P1|NOT COMPLETED|Overall Study||9
632263|NCT00157196|1552212|P1|COMPLETED|Overall Study||13
632264|NCT00157196|1552212|P1|STARTED|Overall Study||22
632265|NCT00157157|1552218|P1|NOT COMPLETED|Overall Study||11
632266|NCT00157157|1552218|P1|COMPLETED|Overall Study||44
632267|NCT00157157|1552218|P1|STARTED|Overall Study||55
632268|NCT00157014|1552245|P4|NOT COMPLETED|Overall Study||1
632269|NCT00157014|1552246|P3|NOT COMPLETED|Overall Study||1
632270|NCT00157014|1552247|P2|NOT COMPLETED|Overall Study||5
632271|NCT00157014|1552248|P1|NOT COMPLETED|Overall Study||7
632272|NCT00157014|1552245|P4|COMPLETED|Overall Study||5
632273|NCT00157014|1552246|P3|COMPLETED|Overall Study||4
632274|NCT00157014|1552247|P2|COMPLETED|Overall Study||41
632275|NCT00157014|1552248|P1|COMPLETED|Overall Study||45
632276|NCT00157014|1552245|P4|STARTED|Overall Study||6
632277|NCT00157014|1552246|P3|STARTED|Overall Study||5
632278|NCT00157014|1552247|P2|STARTED|Overall Study||46
632279|NCT00157014|1552248|P1|STARTED|Overall Study||52
632280|NCT00156936|1552328|P2|NOT COMPLETED|Overall Study||11
632281|NCT00156936|1552329|P1|NOT COMPLETED|Overall Study||72
632282|NCT00156936|1552328|P2|COMPLETED|Overall Study||5
632283|NCT00156936|1552329|P1|COMPLETED|Overall Study||20
632284|NCT00156936|1552328|P2|STARTED|Overall Study||16
632285|NCT00156936|1552329|P1|STARTED|Overall Study||92
632286|NCT00156923|1552337|P2|NOT COMPLETED|Overall Study||32
632287|NCT00156923|1552338|P1|NOT COMPLETED|Overall Study||34
632288|NCT00156923|1552337|P2|COMPLETED|Overall Study||20
632289|NCT00156923|1552338|P1|COMPLETED|Overall Study||22
632290|NCT00156923|1552337|P2|STARTED|Overall Study||52
632291|NCT00156923|1552338|P1|STARTED|Overall Study||56
632292|NCT00156910|1552346|P2|NOT COMPLETED|Open-Label Phase (OL)||55
632293|NCT00156910|1552347|P1|NOT COMPLETED|Open-Label Phase (OL)||33
632294|NCT00156910|1552346|P2|COMPLETED|Open-Label Phase (OL)||231
632295|NCT00156910|1552347|P1|COMPLETED|Open-Label Phase (OL)||252
632296|NCT00156910|1552346|P2|STARTED|Open-Label Phase (OL)|Number of DB Placebo patients who rolled into OL Phase|286
632297|NCT00156910|1552347|P1|STARTED|Open-Label Phase (OL)|Number of DB Botulinum toxin type A patients who rolled into OL phase|285
632298|NCT00156910|1552346|P2|NOT COMPLETED|Double-Blind Phase (DB)||43
632299|NCT00156910|1552347|P1|NOT COMPLETED|Double-Blind Phase (DB)||45
632300|NCT00156910|1552346|P2|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|295
632301|NCT00156910|1552347|P1|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|296
632302|NCT00156910|1552346|P2|STARTED|Double-Blind Phase (DB)||338
632303|NCT00156910|1552347|P1|STARTED|Double-Blind Phase (DB)||341
632304|NCT00156819|1552364|P3|NOT COMPLETED|Overall Study||3
632305|NCT00156819|1552365|P2|NOT COMPLETED|Overall Study||1
632306|NCT00156819|1552366|P1|NOT COMPLETED|Overall Study||1
632307|NCT00156819|1552364|P3|COMPLETED|Overall Study||162
632308|NCT00156819|1552365|P2|COMPLETED|Overall Study||165
632309|NCT00156819|1552366|P1|COMPLETED|Overall Study||168
632310|NCT00156819|1552364|P3|STARTED|Overall Study||165
632311|NCT00156819|1552365|P2|STARTED|Overall Study||166
632312|NCT00156819|1552366|P1|STARTED|Overall Study||169
632313|NCT00156715|1552374|P1|NOT COMPLETED|Overall Study||7
632314|NCT00156715|1552374|P1|COMPLETED|Overall Study||16
632315|NCT00156715|1552374|P1|STARTED|Overall Study||23
632316|NCT00156533|1552383|P4|NOT COMPLETED|Overall Study||2
632317|NCT00156533|1552384|P3|NOT COMPLETED|Overall Study||2
632318|NCT00156533|1552385|P2|NOT COMPLETED|Overall Study||2
632319|NCT00156533|1552386|P1|NOT COMPLETED|Overall Study||2
632320|NCT00156533|1552383|P4|COMPLETED|Overall Study||3
632321|NCT00156533|1552384|P3|COMPLETED|Overall Study||3
632322|NCT00156533|1552385|P2|COMPLETED|Overall Study||3
632323|NCT00156533|1552386|P1|COMPLETED|Overall Study||3
632324|NCT00156533|1552383|P4|STARTED|Overall Study||5
632325|NCT00156533|1552384|P3|STARTED|Overall Study||5
632326|NCT00156533|1552385|P2|STARTED|Overall Study||5
632327|NCT00156533|1552386|P1|STARTED|Overall Study||5
632328|NCT00156390|1552402|P2|NOT COMPLETED|Overall Study||8
632329|NCT00156390|1552403|P1|NOT COMPLETED|Overall Study||14
632330|NCT00156390|1552402|P2|COMPLETED|Overall Study||69
632331|NCT00156390|1552403|P1|COMPLETED|Overall Study||96
632332|NCT00156390|1552402|P2|STARTED|Overall Study||77
632333|NCT00156390|1552403|P1|STARTED|Overall Study||110
632334|NCT00156247|1552411|P1|NOT COMPLETED|Overall Study||4
632335|NCT00156247|1552411|P1|COMPLETED|Overall Study||5
632336|NCT00156247|1552411|P1|STARTED|Overall Study||9
632337|NCT00156065|1552420|P3|NOT COMPLETED|Overall Study||27
632338|NCT00156065|1552421|P2|NOT COMPLETED|Overall Study||63
632339|NCT00156065|1552422|P1|NOT COMPLETED|Overall Study||31
632340|NCT00156065|1552420|P3|COMPLETED|Overall Study||16
632341|NCT00156065|1552421|P2|COMPLETED|Overall Study||30
632342|NCT00156065|1552422|P1|COMPLETED|Overall Study||20
632343|NCT00156065|1552420|P3|STARTED|Overall Study||43
632344|NCT00156065|1552421|P2|STARTED|Overall Study||93
632345|NCT00156065|1552422|P1|STARTED|Overall Study||51
632346|NCT00156013|1552433|P1|NOT COMPLETED|Overall Study||2
632347|NCT00156013|1552433|P1|COMPLETED|Overall Study||31
632348|NCT00156013|1552433|P1|STARTED|Overall Study||33
632349|NCT00154466|1552442|P3|NOT COMPLETED|Overall Study||0
632350|NCT00154466|1552443|P2|NOT COMPLETED|Overall Study||0
632351|NCT00154466|1552444|P1|NOT COMPLETED|Overall Study||0
632352|NCT00154466|1552442|P3|COMPLETED|Overall Study||19
632353|NCT00154466|1552443|P2|COMPLETED|Overall Study||19
632354|NCT00154466|1552444|P1|COMPLETED|Overall Study||20
632355|NCT00154466|1552442|P3|STARTED|Overall Study|Healthy controls underwent the test of myocardial perfusion only at baseline.|19
632356|NCT00154466|1552443|P2|STARTED|Overall Study||19
632357|NCT00154466|1552444|P1|STARTED|Overall Study||20
632358|NCT00154375|1552456|P2|NOT COMPLETED|Overall Study||106
632359|NCT00154375|1552457|P1|NOT COMPLETED|Overall Study||113
632360|NCT00154375|1552456|P2|COMPLETED|Overall Study||14
632361|NCT00154375|1552457|P1|COMPLETED|Overall Study||7
632362|NCT00154375|1552456|P2|Not Exposed to Study Treatment|Overall Study||2
632363|NCT00154375|1552457|P1|Not Exposed to Study Treatment|Overall Study|4 randomized patients didn't receive study treatment were excluded from the safety analyses.|2
632364|NCT00154375|1552456|P2|Discontinued Study Treatment|Overall Study||104
632365|NCT00154375|1552457|P1|Discontinued Study Treatment|Overall Study||111
632366|NCT00154375|1552456|P2|STARTED|Overall Study||120
632367|NCT00154375|1552457|P1|STARTED|Overall Study||120
632368|NCT00154310|1552468|P2|NOT COMPLETED|Overall Study||28
632369|NCT00154310|1552469|P1|NOT COMPLETED|Overall Study||37
632370|NCT00154310|1552468|P2|COMPLETED|Overall Study||117
632371|NCT00154310|1552469|P1|COMPLETED|Overall Study||118
632372|NCT00154310|1552468|P2|STARTED|Overall Study||145
632373|NCT00154310|1552469|P1|STARTED|Overall Study|"Started indicates enrolled participants. Randomized participants for two arms are 154 and 146."|155
632374|NCT00154297|1552485|P2|NOT COMPLETED|Overall Study||7
632375|NCT00154297|1552486|P1|NOT COMPLETED|Overall Study||8
632376|NCT00154297|1552485|P2|COMPLETED|Overall Study|Completed study by 12 month.|67
632377|NCT00154297|1552486|P1|COMPLETED|Overall Study|Completed study by 12 month.|57
632378|NCT00154297|1552485|P2|STARTED|Overall Study|Randomized population.|74
632379|NCT00154297|1552486|P1|STARTED|Overall Study|Randomized population.|65
632380|NCT00154284|1552504|P2|NOT COMPLETED|Overall Study||13
632381|NCT00154284|1552505|P1|NOT COMPLETED|Overall Study||7
632382|NCT00154284|1552504|P2|COMPLETED|Overall Study||42
632383|NCT00154284|1552505|P1|COMPLETED|Overall Study|"Completed means patients completed on study medication.All patients of both arms completed study."|52
632384|NCT00154284|1552504|P2|Intent to Treat (ITT) Population|Overall Study||53
632385|NCT00154284|1552505|P1|Intent to Treat (ITT) Population|Overall Study||57
632386|NCT00154284|1552504|P2|STARTED|Overall Study||55
632387|NCT00154284|1552505|P1|STARTED|Overall Study|"Started indicates Safety Population (randomized patients and treated after randomization.)"|59
632388|NCT00154102|1552519|P2|NOT COMPLETED|Overall Study||2
632389|NCT00154102|1552520|P1|NOT COMPLETED|Overall Study||7
632390|NCT00154102|1552519|P2|COMPLETED|Overall Study||597
632391|NCT00154102|1552520|P1|COMPLETED|Overall Study||592
632392|NCT00154102|1552519|P2|STARTED|Overall Study|Randomized and treated subjects; 3 additional subjects were treated but not randomised|599
632393|NCT00154102|1552520|P1|STARTED|Overall Study|Randomized and treated subjects; 1 additional subject was treated but not randomised|599
632394|NCT00154063|1552556|P2|NOT COMPLETED|Overall Study||22
632395|NCT00154063|1552557|P1|NOT COMPLETED|Overall Study||12
632396|NCT00154063|1552556|P2|COMPLETED|Overall Study||80
632397|NCT00154063|1552557|P1|COMPLETED|Overall Study||92
632398|NCT00154063|1552556|P2|STARTED|Overall Study||102
632399|NCT00154063|1552557|P1|STARTED|Overall Study||104
632400|NCT00153985|1552613|P1|NOT COMPLETED|Overall Study||0
632401|NCT00153985|1552613|P1|COMPLETED|Overall Study||2
632402|NCT00153985|1552613|P1|STARTED|Overall Study||2
632403|NCT00153920|1552619|P1|NOT COMPLETED|Overall Study||30
632404|NCT00153920|1552619|P1|COMPLETED|Overall Study||36
632405|NCT00153920|1552619|P1|Eligible and Treated|Overall Study||64
632406|NCT00153920|1552619|P1|STARTED|Overall Study||66
632407|NCT00153816|1552634|P6|NOT COMPLETED|Overall Study||27
632408|NCT00153816|1552635|P5|NOT COMPLETED|Overall Study||17
632409|NCT00153816|1552636|P4|NOT COMPLETED|Overall Study||31
632410|NCT00153816|1552637|P3|NOT COMPLETED|Overall Study||32
632411|NCT00153816|1552638|P2|NOT COMPLETED|Overall Study||32
632412|NCT00153816|1552639|P1|NOT COMPLETED|Overall Study||32
632413|NCT00153816|1552634|P6|COMPLETED|Overall Study||262
632414|NCT00153816|1552635|P5|COMPLETED|Overall Study||278
632415|NCT00153816|1552636|P4|COMPLETED|Overall Study||390
632416|NCT00153816|1552637|P3|COMPLETED|Overall Study||388
632417|NCT00153816|1552638|P2|COMPLETED|Overall Study||387
632418|NCT00153816|1552639|P1|COMPLETED|Overall Study||383
632419|NCT00153816|1552634|P6|STARTED|Overall Study||289
632420|NCT00153816|1552635|P5|STARTED|Overall Study||295
632421|NCT00153816|1552636|P4|STARTED|Overall Study||421
632422|NCT00153816|1552637|P3|STARTED|Overall Study||420
632423|NCT00153816|1552638|P2|STARTED|Overall Study||419
632424|NCT00153816|1552639|P1|STARTED|Overall Study||415
632425|NCT00153179|1552661|P4|NOT COMPLETED|Study Visit Day 2||0
632426|NCT00153179|1552662|P3|NOT COMPLETED|Study Visit Day 2||0
632427|NCT00153179|1552663|P2|NOT COMPLETED|Study Visit Day 2||0
632428|NCT00153179|1552664|P1|NOT COMPLETED|Study Visit Day 2||0
632429|NCT00153179|1552661|P4|COMPLETED|Study Visit Day 2||7
632430|NCT00153179|1552662|P3|COMPLETED|Study Visit Day 2||11
632431|NCT00153179|1552663|P2|COMPLETED|Study Visit Day 2||8
632432|NCT00153179|1552664|P1|COMPLETED|Study Visit Day 2||9
632433|NCT00153179|1552661|P4|STARTED|Study Visit Day 2||7
632434|NCT00153179|1552662|P3|STARTED|Study Visit Day 2||11
632435|NCT00153179|1552663|P2|STARTED|Study Visit Day 2||8
632436|NCT00153179|1552664|P1|STARTED|Study Visit Day 2||9
632437|NCT00153179|1552661|P4|NOT COMPLETED|Study Visit Day 1||0
632438|NCT00153179|1552662|P3|NOT COMPLETED|Study Visit Day 1||0
632439|NCT00153179|1552663|P2|NOT COMPLETED|Study Visit Day 1||0
632440|NCT00153179|1552664|P1|NOT COMPLETED|Study Visit Day 1||0
632441|NCT00153179|1552661|P4|COMPLETED|Study Visit Day 1||9
632442|NCT00153179|1552662|P3|COMPLETED|Study Visit Day 1||13
632443|NCT00153179|1552663|P2|COMPLETED|Study Visit Day 1||8
632444|NCT00153179|1552664|P1|COMPLETED|Study Visit Day 1||10
632445|NCT00153179|1552661|P4|STARTED|Study Visit Day 1||9
632446|NCT00153179|1552662|P3|STARTED|Study Visit Day 1||13
632447|NCT00153179|1552663|P2|STARTED|Study Visit Day 1||8
632448|NCT00153179|1552664|P1|STARTED|Study Visit Day 1||10
632449|NCT00153166|1552675|P3|NOT COMPLETED|Overall Study||0
632450|NCT00153166|1552676|P2|NOT COMPLETED|Overall Study||0
632451|NCT00153166|1552677|P1|NOT COMPLETED|Overall Study||0
632452|NCT00153166|1552675|P3|COMPLETED|Overall Study||28
632453|NCT00153166|1552676|P2|COMPLETED|Overall Study||37
632454|NCT00153166|1552677|P1|COMPLETED|Overall Study||11
632455|NCT00153166|1552675|P3|Received Placebo and Placebo|Overall Study||7
632456|NCT00153166|1552676|P2|Received Placebo and Placebo|Overall Study||9
632457|NCT00153166|1552677|P1|Received Placebo and Placebo|Overall Study||3
632458|NCT00153166|1552675|P3|Received Placebo and Pioglitazone|Overall Study||7
632459|NCT00153166|1552676|P2|Received Placebo and Pioglitazone|Overall Study||10
632460|NCT00153166|1552677|P1|Received Placebo and Pioglitazone|Overall Study||3
632461|NCT00153166|1552675|P3|Received Atorvastatin and Placebo|Overall Study||7
632462|NCT00153166|1552676|P2|Received Atorvastatin and Placebo|Overall Study||9
632463|NCT00153166|1552677|P1|Received Atorvastatin and Placebo|Overall Study||2
632464|NCT00153166|1552675|P3|Received Atorvastatin and Pioglitazone|Overall Study||7
632465|NCT00153166|1552676|P2|Received Atorvastatin and Pioglitazone|Overall Study||9
632466|NCT00153166|1552677|P1|Received Atorvastatin and Pioglitazone|Overall Study||3
632467|NCT00153166|1552675|P3|STARTED|Overall Study||28
632468|NCT00153166|1552676|P2|STARTED|Overall Study||37
632469|NCT00153166|1552677|P1|STARTED|Overall Study||11
632470|NCT00153101|1552694|P5|NOT COMPLETED|Overall Study||10
632471|NCT00153101|1552695|P4|NOT COMPLETED|Overall Study||8
632472|NCT00153101|1552696|P3|NOT COMPLETED|Overall Study||15
632473|NCT00153101|1552697|P2|NOT COMPLETED|Overall Study||18
632474|NCT00153101|1552698|P1|NOT COMPLETED|Overall Study||17
632475|NCT00153101|1552694|P5|COMPLETED|Overall Study||2962
632476|NCT00153101|1552695|P4|COMPLETED|Overall Study||2946
632477|NCT00153101|1552696|P3|COMPLETED|Overall Study||8561
632478|NCT00153101|1552697|P2|COMPLETED|Overall Study||8524
632479|NCT00153101|1552698|P1|COMPLETED|Overall Study||8485
632480|NCT00153101|1552694|P5|STARTED|Overall Study||2972
632481|NCT00153101|1552695|P4|STARTED|Overall Study||2954
632482|NCT00153101|1552696|P3|STARTED|Overall Study||8576
632483|NCT00153101|1552697|P2|STARTED|Overall Study||8542
632484|NCT00153101|1552698|P1|STARTED|Overall Study||8502
632485|NCT00153062|1552806|P4|NOT COMPLETED|Overall Study||411
632486|NCT00153062|1552807|P3|NOT COMPLETED|Overall Study||415
632487|NCT00153062|1552808|P2|NOT COMPLETED|Overall Study||406
632488|NCT00153062|1552809|P1|NOT COMPLETED|Overall Study||387
632489|NCT00153062|1552806|P4|COMPLETED|Overall Study||4680
632490|NCT00153062|1552807|P3|COMPLETED|Overall Study||4645
632491|NCT00153062|1552808|P2|COMPLETED|Overall Study||4689
632492|NCT00153062|1552809|P1|COMPLETED|Overall Study||4699
632493|NCT00153062|1552806|P4|STARTED|Overall Study||5091
632494|NCT00153062|1552807|P3|STARTED|Overall Study||5060
632495|NCT00153062|1552808|P2|STARTED|Overall Study||5095
632496|NCT00153062|1552809|P1|STARTED|Overall Study||5086
632497|NCT00152971|1552828|P3|NOT COMPLETED|Treatment||80
632498|NCT00152971|1552829|P2|NOT COMPLETED|Treatment||63
632499|NCT00152971|1552830|P1|NOT COMPLETED|Treatment||71
632500|NCT00152971|1552828|P3|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|788
632501|NCT00152971|1552829|P2|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|808
632502|NCT00152971|1552830|P1|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|786
632503|NCT00152971|1552828|P3|STARTED|Treatment||868
632504|NCT00152971|1552829|P2|STARTED|Treatment||871
632505|NCT00152971|1552830|P1|STARTED|Treatment||857
632506|NCT00152971|1552828|P3|NOT COMPLETED|Overall Study||49
632507|NCT00152971|1552829|P2|NOT COMPLETED|Overall Study||48
632508|NCT00152971|1552830|P1|NOT COMPLETED|Overall Study||51
632509|NCT00152971|1552828|P3|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|819
632510|NCT00152971|1552829|P2|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|823
632511|NCT00152971|1552830|P1|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|806
632512|NCT00152971|1552828|P3|STARTED|Overall Study||868
632513|NCT00152971|1552829|P2|STARTED|Overall Study||871
632514|NCT00152971|1552830|P1|STARTED|Overall Study||857
632515|NCT00152763|1552866|P4|NOT COMPLETED|Overall Study||14
632516|NCT00152763|1552867|P3|NOT COMPLETED|Overall Study||4
632517|NCT00152763|1552868|P2|NOT COMPLETED|Overall Study||5
632518|NCT00152763|1552869|P1|NOT COMPLETED|Overall Study||10
632519|NCT00152763|1552866|P4|COMPLETED|Overall Study||63
632520|NCT00152763|1552867|P3|COMPLETED|Overall Study||16
632521|NCT00152763|1552868|P2|COMPLETED|Overall Study||14
632522|NCT00152763|1552869|P1|COMPLETED|Overall Study||67
632523|NCT00152763|1552866|P4|STARTED|Overall Study||77
632524|NCT00152763|1552867|P3|STARTED|Overall Study||20
632525|NCT00152763|1552868|P2|STARTED|Overall Study||19
632526|NCT00152763|1552869|P1|STARTED|Overall Study||77
632527|NCT00152516|1552985|P1|NOT COMPLETED|Overall Study||75
632528|NCT00152516|1552985|P1|COMPLETED|Overall Study|Subjects ongoing until study close-out|180
632529|NCT00152516|1552985|P1|STARTED|Overall Study|Subjects that were dispensed at least 1 dose of study medication|255
632530|NCT00152009|1553013|P4|NOT COMPLETED|Overall Study||33
632531|NCT00152009|1553014|P3|NOT COMPLETED|Overall Study||37
632532|NCT00152009|1553015|P2|NOT COMPLETED|Overall Study||31
632533|NCT00152009|1553016|P1|NOT COMPLETED|Overall Study||29
632534|NCT00152009|1553013|P4|COMPLETED|Overall Study||53
632535|NCT00152009|1553014|P3|COMPLETED|Overall Study||49
632536|NCT00152009|1553015|P2|COMPLETED|Overall Study||55
632537|NCT00152009|1553016|P1|COMPLETED|Overall Study||58
632538|NCT00152009|1553013|P4|STARTED|Overall Study||86
632539|NCT00152009|1553014|P3|STARTED|Overall Study||86
632540|NCT00152009|1553015|P2|STARTED|Overall Study||86
632541|NCT00152009|1553016|P1|STARTED|Overall Study||87
632542|NCT00151996|1553048|P2|NOT COMPLETED|Overall Study||7
632543|NCT00151996|1553049|P1|NOT COMPLETED|Overall Study||5
632544|NCT00151996|1553048|P2|COMPLETED|Overall Study||26
632545|NCT00151996|1553049|P1|COMPLETED|Overall Study||37
632546|NCT00151996|1553048|P2|STARTED|Overall Study||33
632547|NCT00151996|1553049|P1|STARTED|Overall Study||42
632548|NCT00151892|1553065|P2|NOT COMPLETED|Overall Study||83
632549|NCT00151892|1553066|P1|NOT COMPLETED|Overall Study||76
632550|NCT00151892|1553065|P2|COMPLETED|Overall Study||330
632551|NCT00151892|1553066|P1|COMPLETED|Overall Study||340
632552|NCT00151892|1553065|P2|STARTED|Overall Study||413
632553|NCT00151892|1553066|P1|STARTED|Overall Study||416
632554|NCT00151814|1553083|P3|NOT COMPLETED|Overall Study||0
632555|NCT00151814|1553084|P2|NOT COMPLETED|Overall Study||0
632556|NCT00151814|1553085|P1|NOT COMPLETED|Overall Study||0
632557|NCT00151814|1553083|P3|COMPLETED|Overall Study||10
632558|NCT00151814|1553084|P2|COMPLETED|Overall Study||10
632559|NCT00151814|1553085|P1|COMPLETED|Overall Study||4
632560|NCT00151814|1553083|P3|STARTED|Overall Study||10
632561|NCT00151814|1553084|P2|STARTED|Overall Study||10
632562|NCT00151814|1553085|P1|STARTED|Overall Study||4
632563|NCT00151775|1553111|P12|NOT COMPLETED|Period 4: Open Label||0
632564|NCT00151775|1553112|P11|NOT COMPLETED|Period 4: Open Label||0
632565|NCT00151775|1553113|P10|NOT COMPLETED|Period 4: Open Label||21
632566|NCT00151775|1553114|P9|NOT COMPLETED|Period 4: Open Label||0
632567|NCT00151775|1553115|P8|NOT COMPLETED|Period 4: Open Label||0
632568|NCT00151775|1553116|P7|NOT COMPLETED|Period 4: Open Label||0
632569|NCT00151775|1553117|P6|NOT COMPLETED|Period 4: Open Label||0
632570|NCT00151775|1553118|P5|NOT COMPLETED|Period 4: Open Label||30
632571|NCT00151775|1553119|P4|NOT COMPLETED|Period 4: Open Label||0
632572|NCT00151775|1553120|P3|NOT COMPLETED|Period 4: Open Label||0
632573|NCT00151775|1553121|P2|NOT COMPLETED|Period 4: Open Label||0
632574|NCT00151775|1553122|P1|NOT COMPLETED|Period 4: Open Label||0
632575|NCT00151775|1553111|P12|COMPLETED|Period 4: Open Label||0
632576|NCT00151775|1553112|P11|COMPLETED|Period 4: Open Label||57
632577|NCT00151775|1553113|P10|COMPLETED|Period 4: Open Label||83
632578|NCT00151775|1553114|P9|COMPLETED|Period 4: Open Label||0
632579|NCT00151775|1553115|P8|COMPLETED|Period 4: Open Label||0
632580|NCT00151775|1553116|P7|COMPLETED|Period 4: Open Label||0
632581|NCT00151775|1553117|P6|COMPLETED|Period 4: Open Label||0
632582|NCT00151775|1553118|P5|COMPLETED|Period 4: Open Label||149
632583|NCT00151775|1553119|P4|COMPLETED|Period 4: Open Label||0
632584|NCT00151775|1553120|P3|COMPLETED|Period 4: Open Label||0
632585|NCT00151775|1553121|P2|COMPLETED|Period 4: Open Label||0
632586|NCT00151775|1553122|P1|COMPLETED|Period 4: Open Label||0
632587|NCT00151775|1553111|P12|STARTED|Period 4: Open Label||0
632588|NCT00151775|1553112|P11|STARTED|Period 4: Open Label||57
632589|NCT00151775|1553113|P10|STARTED|Period 4: Open Label||104
632590|NCT00151775|1553114|P9|STARTED|Period 4: Open Label||0
632591|NCT00151775|1553115|P8|STARTED|Period 4: Open Label||0
632592|NCT00151775|1553116|P7|STARTED|Period 4: Open Label||0
632593|NCT00151775|1553117|P6|STARTED|Period 4: Open Label||0
632594|NCT00151775|1553118|P5|STARTED|Period 4: Open Label||179
632595|NCT00151775|1553119|P4|STARTED|Period 4: Open Label||0
632596|NCT00151775|1553120|P3|STARTED|Period 4: Open Label||0
632597|NCT00151775|1553121|P2|STARTED|Period 4: Open Label||0
632598|NCT00151775|1553122|P1|STARTED|Period 4: Open Label||0
632599|NCT00151775|1553111|P12|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
632600|NCT00151775|1553112|P11|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
632601|NCT00151775|1553113|P10|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
632602|NCT00151775|1553114|P9|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
632603|NCT00151775|1553115|P8|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
632604|NCT00151775|1553116|P7|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
632605|NCT00151775|1553117|P6|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
632606|NCT00151775|1553118|P5|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
632607|NCT00151775|1553119|P4|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
632608|NCT00151775|1553120|P3|NOT COMPLETED|Period 3: Double-blind, Withdrawal||3
632609|NCT00151775|1553121|P2|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
632610|NCT00151775|1553122|P1|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
632611|NCT00151775|1553111|P12|COMPLETED|Period 3: Double-blind, Withdrawal||28
632612|NCT00151775|1553112|P11|COMPLETED|Period 3: Double-blind, Withdrawal||29
632613|NCT00151775|1553113|P10|COMPLETED|Period 3: Double-blind, Withdrawal||0
632614|NCT00151775|1553114|P9|COMPLETED|Period 3: Double-blind, Withdrawal||26
632615|NCT00151775|1553115|P8|COMPLETED|Period 3: Double-blind, Withdrawal||27
632616|NCT00151775|1553116|P7|COMPLETED|Period 3: Double-blind, Withdrawal||26
632617|NCT00151775|1553117|P6|COMPLETED|Period 3: Double-blind, Withdrawal||25
632618|NCT00151775|1553118|P5|COMPLETED|Period 3: Double-blind, Withdrawal||0
632619|NCT00151775|1553119|P4|COMPLETED|Period 3: Double-blind, Withdrawal||44
632620|NCT00151775|1553120|P3|COMPLETED|Period 3: Double-blind, Withdrawal||42
632621|NCT00151775|1553121|P2|COMPLETED|Period 3: Double-blind, Withdrawal||45
632622|NCT00151775|1553122|P1|COMPLETED|Period 3: Double-blind, Withdrawal||48
632623|NCT00151775|1553111|P12|STARTED|Period 3: Double-blind, Withdrawal||29
632624|NCT00151775|1553112|P11|STARTED|Period 3: Double-blind, Withdrawal||29
632625|NCT00151775|1553113|P10|STARTED|Period 3: Double-blind, Withdrawal||0
632626|NCT00151775|1553114|P9|STARTED|Period 3: Double-blind, Withdrawal||26
632627|NCT00151775|1553115|P8|STARTED|Period 3: Double-blind, Withdrawal||28
632628|NCT00151775|1553116|P7|STARTED|Period 3: Double-blind, Withdrawal||27
632629|NCT00151775|1553117|P6|STARTED|Period 3: Double-blind, Withdrawal||26
632630|NCT00151775|1553118|P5|STARTED|Period 3: Double-blind, Withdrawal||0
632631|NCT00151775|1553119|P4|STARTED|Period 3: Double-blind, Withdrawal||44
632632|NCT00151775|1553120|P3|STARTED|Period 3: Double-blind, Withdrawal||45
632633|NCT00151775|1553121|P2|STARTED|Period 3: Double-blind, Withdrawal||45
632634|NCT00151775|1553122|P1|STARTED|Period 3: Double-blind, Withdrawal||48
632635|NCT00151775|1553111|P12|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
632636|NCT00151775|1553112|P11|NOT COMPLETED|Period 2 - Double-Blind Dose Response||1
632637|NCT00151775|1553113|P10|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
632638|NCT00151775|1553114|P9|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
632639|NCT00151775|1553115|P8|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
632640|NCT00151775|1553116|P7|NOT COMPLETED|Period 2 - Double-Blind Dose Response||3
632641|NCT00151775|1553117|P6|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2
632642|NCT00151775|1553118|P5|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
632643|NCT00151775|1553119|P4|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
632644|NCT00151775|1553120|P3|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
632645|NCT00151775|1553121|P2|NOT COMPLETED|Period 2 - Double-Blind Dose Response||6
632646|NCT00151775|1553122|P1|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2
632647|NCT00151775|1553111|P12|COMPLETED|Period 2 - Double-Blind Dose Response||0
632648|NCT00151775|1553112|P11|COMPLETED|Period 2 - Double-Blind Dose Response||59
632649|NCT00151775|1553113|P10|COMPLETED|Period 2 - Double-Blind Dose Response||0
632650|NCT00151775|1553114|P9|COMPLETED|Period 2 - Double-Blind Dose Response||0
632651|NCT00151775|1553115|P8|COMPLETED|Period 2 - Double-Blind Dose Response||0
632652|NCT00151775|1553116|P7|COMPLETED|Period 2 - Double-Blind Dose Response||53
632653|NCT00151775|1553117|P6|COMPLETED|Period 2 - Double-Blind Dose Response||54
632654|NCT00151775|1553118|P5|COMPLETED|Period 2 - Double-Blind Dose Response||0
632655|NCT00151775|1553119|P4|COMPLETED|Period 2 - Double-Blind Dose Response||0
632656|NCT00151775|1553120|P3|COMPLETED|Period 2 - Double-Blind Dose Response||0
632657|NCT00151775|1553121|P2|COMPLETED|Period 2 - Double-Blind Dose Response||89
632658|NCT00151775|1553122|P1|COMPLETED|Period 2 - Double-Blind Dose Response||93
632659|NCT00151775|1553111|P12|STARTED|Period 2 - Double-Blind Dose Response||0
632660|NCT00151775|1553112|P11|STARTED|Period 2 - Double-Blind Dose Response||60
632661|NCT00151775|1553113|P10|STARTED|Period 2 - Double-Blind Dose Response||0
632662|NCT00151775|1553114|P9|STARTED|Period 2 - Double-Blind Dose Response||0
632663|NCT00151775|1553115|P8|STARTED|Period 2 - Double-Blind Dose Response||0
632664|NCT00151775|1553116|P7|STARTED|Period 2 - Double-Blind Dose Response||56
632665|NCT00151775|1553117|P6|STARTED|Period 2 - Double-Blind Dose Response||56
632666|NCT00151775|1553118|P5|STARTED|Period 2 - Double-Blind Dose Response||0
632667|NCT00151775|1553119|P4|STARTED|Period 2 - Double-Blind Dose Response||0
632668|NCT00151775|1553120|P3|STARTED|Period 2 - Double-Blind Dose Response||0
632669|NCT00151775|1553121|P2|STARTED|Period 2 - Double-Blind Dose Response||95
632670|NCT00151775|1553122|P1|STARTED|Period 2 - Double-Blind Dose Response||95
632671|NCT00151476|1553166|P2|NOT COMPLETED|FAP Analyzed Subjects||3
632672|NCT00151476|1553167|P1|NOT COMPLETED|FAP Analyzed Subjects||0
632673|NCT00151476|1553166|P2|COMPLETED|FAP Analyzed Subjects||51
632674|NCT00151476|1553167|P1|COMPLETED|FAP Analyzed Subjects||13
632675|NCT00151476|1553166|P2|STARTED|FAP Analyzed Subjects||54
632676|NCT00151476|1553167|P1|STARTED|FAP Analyzed Subjects||13
632677|NCT00151476|1553166|P2|NOT COMPLETED|FAP Identified Subjects||1
632678|NCT00151476|1553167|P1|NOT COMPLETED|FAP Identified Subjects||0
632679|NCT00151476|1553166|P2|COMPLETED|FAP Identified Subjects||54
632680|NCT00151476|1553167|P1|COMPLETED|FAP Identified Subjects||13
632681|NCT00151476|1553166|P2|STARTED|FAP Identified Subjects||55
632682|NCT00151476|1553167|P1|STARTED|FAP Identified Subjects||13
632683|NCT00151411|1553224|P2|NOT COMPLETED|Overall Study||43
632684|NCT00151411|1553225|P1|NOT COMPLETED|Overall Study||33
632685|NCT00151411|1553224|P2|COMPLETED|Overall Study||16
632686|NCT00151411|1553225|P1|COMPLETED|Overall Study||22
632687|NCT00151411|1553224|P2|STARTED|Overall Study||59
632688|NCT00151411|1553225|P1|STARTED|Overall Study||55
632689|NCT00151372|1553237|P2|NOT COMPLETED|Overall Study||29
632690|NCT00151372|1553238|P1|NOT COMPLETED|Overall Study||29
632691|NCT00151372|1553237|P2|COMPLETED|Overall Study||45
632692|NCT00151372|1553238|P1|COMPLETED|Overall Study||38
632693|NCT00151372|1553237|P2|STARTED|Overall Study||74
632694|NCT00151372|1553238|P1|STARTED|Overall Study||67
632695|NCT00151320|1553248|P1|NOT COMPLETED|Overall Study||0
632696|NCT00151320|1553248|P1|COMPLETED|Overall Study||76
632697|NCT00151320|1553248|P1|STARTED|Overall Study||76
632698|NCT00151281|1553253|P1|NOT COMPLETED|Overall Study||3
632699|NCT00151281|1553253|P1|COMPLETED|Overall Study||22
632700|NCT00151281|1553253|P1|STARTED|Overall Study||25
632701|NCT00150969|1553262|P2|NOT COMPLETED|24-48 Month Extension||100
632702|NCT00150969|1553263|P1|NOT COMPLETED|24-48 Month Extension||88
632703|NCT00150969|1553262|P2|COMPLETED|24-48 Month Extension||40
632704|NCT00150969|1553263|P1|COMPLETED|24-48 Month Extension||33
632705|NCT00150969|1553262|P2|STARTED|24-48 Month Extension||140
632706|NCT00150969|1553263|P1|STARTED|24-48 Month Extension||121
632707|NCT00150969|1553262|P2|NOT COMPLETED|24 Month Main Study||21
632708|NCT00150969|1553263|P1|NOT COMPLETED|24 Month Main Study||19
632709|NCT00150969|1553262|P2|COMPLETED|24 Month Main Study||202
632710|NCT00150969|1553263|P1|COMPLETED|24 Month Main Study||198
632711|NCT00150969|1553262|P2|STARTED|24 Month Main Study||223
632712|NCT00150969|1553263|P1|STARTED|24 Month Main Study||217
632713|NCT00150618|1553300|P5|NOT COMPLETED|Overall Study||25
632714|NCT00150618|1553301|P4|NOT COMPLETED|Overall Study||26
632715|NCT00150618|1553302|P3|NOT COMPLETED|Overall Study||27
632716|NCT00150618|1553303|P2|NOT COMPLETED|Overall Study||18
632717|NCT00150618|1553304|P1|NOT COMPLETED|Overall Study||17
632718|NCT00150618|1553300|P5|COMPLETED|Overall Study||41
632719|NCT00150618|1553301|P4|COMPLETED|Overall Study||40
632720|NCT00150618|1553302|P3|COMPLETED|Overall Study||38
632721|NCT00150618|1553303|P2|COMPLETED|Overall Study||47
632722|NCT00150618|1553304|P1|COMPLETED|Overall Study||45
632723|NCT00150618|1553300|P5|STARTED|Overall Study||66
632724|NCT00150618|1553301|P4|STARTED|Overall Study||66
632725|NCT00150618|1553302|P3|STARTED|Overall Study||65
632726|NCT00150618|1553303|P2|STARTED|Overall Study||65
632727|NCT00150618|1553304|P1|STARTED|Overall Study||62
632728|NCT00150592|1553338|P2|NOT COMPLETED|Overall Study||3
632729|NCT00150592|1553339|P1|NOT COMPLETED|Overall Study||7
632730|NCT00150592|1553338|P2|COMPLETED|Overall Study||54
632731|NCT00150592|1553339|P1|COMPLETED|Overall Study||114
632732|NCT00150592|1553338|P2|STARTED|Overall Study||57
632733|NCT00150592|1553339|P1|STARTED|Overall Study||121
632734|NCT00150462|1553370|P11|NOT COMPLETED|Overall Study||3
632735|NCT00150462|1553371|P10|NOT COMPLETED|Overall Study||6
632736|NCT00150462|1553372|P9|NOT COMPLETED|Overall Study||6
632737|NCT00150462|1553373|P8|NOT COMPLETED|Overall Study||8
632738|NCT00150462|1553374|P7|NOT COMPLETED|Overall Study||3
632739|NCT00150462|1553375|P6|NOT COMPLETED|Overall Study||4
632740|NCT00150462|1553376|P5|NOT COMPLETED|Overall Study||3
632741|NCT00150462|1553377|P4|NOT COMPLETED|Overall Study||3
632742|NCT00150462|1553378|P3|NOT COMPLETED|Overall Study||4
632743|NCT00150462|1553379|P2|NOT COMPLETED|Overall Study||3
632744|NCT00150462|1553380|P1|NOT COMPLETED|Overall Study||3
632745|NCT00150462|1553370|P11|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of treatment.|1
632746|NCT00150462|1553371|P10|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of treatment.|1
632747|NCT00150462|1553372|P9|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
632748|NCT00150462|1553373|P8|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
632749|NCT00150462|1553374|P7|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
632750|NCT00150462|1553375|P6|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
632751|NCT00150462|1553376|P5|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
632752|NCT00150462|1553377|P4|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
632753|NCT00150462|1553378|P3|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
632754|NCT00150462|1553379|P2|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
632755|NCT00150462|1553380|P1|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
632756|NCT00150462|1553370|P11|STARTED|Overall Study||4
632757|NCT00150462|1553371|P10|STARTED|Overall Study||7
632758|NCT00150462|1553372|P9|STARTED|Overall Study||6
632759|NCT00150462|1553373|P8|STARTED|Overall Study||8
632760|NCT00150462|1553374|P7|STARTED|Overall Study||3
632761|NCT00150462|1553375|P6|STARTED|Overall Study||4
632762|NCT00150462|1553376|P5|STARTED|Overall Study||3
632763|NCT00150462|1553377|P4|STARTED|Overall Study||3
632764|NCT00150462|1553378|P3|STARTED|Overall Study||4
632765|NCT00150462|1553379|P2|STARTED|Overall Study||3
632766|NCT00150462|1553380|P1|STARTED|Overall Study||3
632767|NCT00150345|1553490|P2|NOT COMPLETED|Overall Study||32
632768|NCT00150345|1553491|P1|NOT COMPLETED|Overall Study||34
632769|NCT00150345|1553490|P2|COMPLETED|Overall Study||34
632770|NCT00150345|1553491|P1|COMPLETED|Overall Study||47
632771|NCT00150345|1553490|P2|STARTED|Overall Study||66
632772|NCT00150345|1553491|P1|STARTED|Overall Study||81
632773|NCT00150176|1553555|P2|NOT COMPLETED|Overall Study||120
632774|NCT00150176|1553556|P1|NOT COMPLETED|Overall Study||59
632775|NCT00150176|1553555|P2|COMPLETED|Overall Study||72
632776|NCT00150176|1553556|P1|COMPLETED|Overall Study||135
632777|NCT00150176|1553555|P2|STARTED|Overall Study|subjects who were screened and received at least one dose of double-blind trial medication|192
632778|NCT00150176|1553556|P1|STARTED|Overall Study|subjects who were screened and received at least one dose of double-blind trial medication|194
632779|NCT00149994|1553567|P2|NOT COMPLETED|Overall Study||1
632780|NCT00149994|1553568|P1|NOT COMPLETED|Overall Study||1
632781|NCT00149994|1553567|P2|COMPLETED|Overall Study||85
632782|NCT00149994|1553568|P1|COMPLETED|Overall Study|"Completed indicates intention to treat (ITT) population."|84
632783|NCT00149994|1553567|P2|STARTED|Overall Study||86
632784|NCT00149994|1553568|P1|STARTED|Overall Study|"Started indicates Safety population."|85
632785|NCT00149890|1553576|P2|NOT COMPLETED|Overall Study||18
632786|NCT00149890|1553577|P1|NOT COMPLETED|Overall Study||13
632787|NCT00149890|1553576|P2|COMPLETED|Overall Study||20
632788|NCT00149890|1553577|P1|COMPLETED|Overall Study||26
632789|NCT00149890|1553576|P2|STARTED|Overall Study||38
632790|NCT00149890|1553577|P1|STARTED|Overall Study|"Started indicates all screened and treated participants."|39
632791|NCT00149825|1553597|P2|NOT COMPLETED|Overall Study||3
632792|NCT00149825|1553598|P1|NOT COMPLETED|Overall Study||5
632793|NCT00149825|1553597|P2|COMPLETED|Overall Study||12
632794|NCT00149825|1553598|P1|COMPLETED|Overall Study||10
632795|NCT00149825|1553597|P2|STARTED|Overall Study||15
632796|NCT00149825|1553598|P1|STARTED|Overall Study||15
632797|NCT00149799|1553608|P3|NOT COMPLETED|Discontinuation (Phase II)||9
632798|NCT00149799|1553609|P2|NOT COMPLETED|Discontinuation (Phase II)||3
632799|NCT00149799|1553610|P1|NOT COMPLETED|Discontinuation (Phase II)||0
632800|NCT00149799|1553608|P3|COMPLETED|Discontinuation (Phase II)||21
632801|NCT00149799|1553609|P2|COMPLETED|Discontinuation (Phase II)||25
632802|NCT00149799|1553610|P1|COMPLETED|Discontinuation (Phase II)||0
632803|NCT00149799|1553608|P3|STARTED|Discontinuation (Phase II)|Only responders who completed Phase I and were willing to continue were randomized in Phase II|30
632804|NCT00149799|1553609|P2|STARTED|Discontinuation (Phase II)|Only responders who completed Phase I and were willing to continue were randomized in Phase II|28
632805|NCT00149799|1553610|P1|STARTED|Discontinuation (Phase II)||0
632806|NCT00149799|1553608|P3|NOT COMPLETED|Open Label Escitalopram (Phase I)||0
632807|NCT00149799|1553609|P2|NOT COMPLETED|Open Label Escitalopram (Phase I)||0
632808|NCT00149799|1553610|P1|NOT COMPLETED|Open Label Escitalopram (Phase I)||26
632809|NCT00149799|1553608|P3|COMPLETED|Open Label Escitalopram (Phase I)||0
632810|NCT00149799|1553609|P2|COMPLETED|Open Label Escitalopram (Phase I)||0
632811|NCT00149799|1553610|P1|COMPLETED|Open Label Escitalopram (Phase I)|14 completers were non-responders and 2 responders terminated the study after completing Phase I|74
632812|NCT00149799|1553608|P3|STARTED|Open Label Escitalopram (Phase I)||0
632813|NCT00149799|1553609|P2|STARTED|Open Label Escitalopram (Phase I)||0
632814|NCT00149799|1553610|P1|STARTED|Open Label Escitalopram (Phase I)||100
632815|NCT00149747|1553626|P2|NOT COMPLETED|Overall Study||3
632816|NCT00149747|1553627|P1|NOT COMPLETED|Overall Study||4
632817|NCT00149747|1553626|P2|COMPLETED|Overall Study||27
632818|NCT00149747|1553627|P1|COMPLETED|Overall Study||32
632819|NCT00149747|1553626|P2|STARTED|Overall Study||30
632820|NCT00149747|1553627|P1|STARTED|Overall Study||36
632821|NCT00149669|1553639|P2|NOT COMPLETED|Overall Study||5
632822|NCT00149669|1553640|P1|NOT COMPLETED|Overall Study||3
632823|NCT00149669|1553639|P2|COMPLETED|Overall Study||30
632824|NCT00149669|1553640|P1|COMPLETED|Overall Study||29
632825|NCT00149669|1553639|P2|STARTED|Overall Study||35
632826|NCT00149669|1553640|P1|STARTED|Overall Study||32
632827|NCT00149643|1553660|P2|NOT COMPLETED|Overall Study||36
632828|NCT00149643|1553661|P1|NOT COMPLETED|Overall Study||34
632829|NCT00149643|1553660|P2|COMPLETED|Overall Study||0
632830|NCT00149643|1553661|P1|COMPLETED|Overall Study||0
632831|NCT00149643|1553660|P2|STARTED|Overall Study||36
632832|NCT00149643|1553661|P1|STARTED|Overall Study||34
632833|NCT00149630|1553673|P2|NOT COMPLETED|Overall Study||5
632834|NCT00149630|1553674|P1|NOT COMPLETED|Overall Study||8
632835|NCT00149630|1553673|P2|COMPLETED|Overall Study||35
632836|NCT00149630|1553674|P1|COMPLETED|Overall Study||26
632837|NCT00149630|1553673|P2|STARTED|Overall Study||40
632838|NCT00149630|1553674|P1|STARTED|Overall Study||34
632839|NCT00149396|1553684|P1|NOT COMPLETED|Overall Study||23
632840|NCT00149396|1553684|P1|COMPLETED|Overall Study||9
632841|NCT00149396|1553684|P1|Completed NV1020 and Chemotherapy|Overall Study||9
632842|NCT00149396|1553684|P1|Completed NV1020 Therapy|Overall Study||29
632843|NCT00149396|1553684|P1|STARTED|Overall Study||32
632844|NCT00149227|1553727|P2|NOT COMPLETED|Overall Study||0
632845|NCT00149227|1553728|P1|NOT COMPLETED|Overall Study||0
632846|NCT00149227|1553727|P2|COMPLETED|Overall Study||1514
632847|NCT00149227|1553728|P1|COMPLETED|Overall Study||1517
632848|NCT00149227|1553727|P2|STARTED|Overall Study||1514
632849|NCT00149227|1553728|P1|STARTED|Overall Study||1517
632850|NCT00149214|1553754|P2|NOT COMPLETED|Overall Study||17
632851|NCT00149214|1553755|P1|NOT COMPLETED|Overall Study||26
632852|NCT00149214|1553754|P2|COMPLETED|Overall Study||105
632853|NCT00149214|1553755|P1|COMPLETED|Overall Study|The patient treated with Cyclophosphamide (C) was included in that arm (C) for safety analysis.|109
632854|NCT00149214|1553754|P2|STARTED|Overall Study||122
632855|NCT00149214|1553755|P1|STARTED|Overall Study|One patient randomized to Pemetrexed (P) was treated with Cyclophosphamide (C).|135
632856|NCT00148954|1553771|P2|NOT COMPLETED|Overall Study||300
632857|NCT00148954|1553772|P1|NOT COMPLETED|Overall Study||307
632858|NCT00148954|1553771|P2|COMPLETED|Overall Study||677
632859|NCT00148954|1553772|P1|COMPLETED|Overall Study||678
632860|NCT00148954|1553771|P2|STARTED|Overall Study||977
632861|NCT00148954|1553772|P1|STARTED|Overall Study||985
632862|NCT00148798|1553780|P2|NOT COMPLETED|Overall Study||0
632863|NCT00148798|1553781|P1|NOT COMPLETED|Overall Study||0
632864|NCT00148798|1553780|P2|COMPLETED|Overall Study||568
632865|NCT00148798|1553781|P1|COMPLETED|Overall Study||557
632866|NCT00148798|1553780|P2|STARTED|Overall Study|ITT Population|568
632867|NCT00148798|1553781|P1|STARTED|Overall Study|Intent To Treat (ITT) Population|557
632868|NCT00148759|1553803|P2|NOT COMPLETED|Overall Study||1
632869|NCT00148759|1553804|P1|NOT COMPLETED|Overall Study||2
632870|NCT00148759|1553803|P2|COMPLETED|Overall Study||11
632871|NCT00148759|1553804|P1|COMPLETED|Overall Study||9
632872|NCT00148759|1553803|P2|24-hr PK Sampling|Overall Study||11
632873|NCT00148759|1553804|P1|24-hr PK Sampling|Overall Study||9
632874|NCT00148759|1553803|P2|STARTED|Overall Study||12
632875|NCT00148759|1553804|P1|STARTED|Overall Study||11
632876|NCT00148733|1553814|P2|NOT COMPLETED|Overall Study||15
632877|NCT00148733|1553815|P1|NOT COMPLETED|Overall Study||14
632878|NCT00148733|1553814|P2|COMPLETED|Overall Study||1299
632879|NCT00148733|1553815|P1|COMPLETED|Overall Study||1300
632880|NCT00148733|1553814|P2|STARTED|Overall Study||1314
632881|NCT00148733|1553815|P1|STARTED|Overall Study||1314
632882|NCT00148668|1553823|P2|NOT COMPLETED|Overall Study||0
632883|NCT00148668|1553824|P1|NOT COMPLETED|Overall Study||0
632884|NCT00148668|1553823|P2|COMPLETED|Overall Study||40
632885|NCT00148668|1553824|P1|COMPLETED|Overall Study||41
632886|NCT00148668|1553823|P2|STARTED|Overall Study||40
632887|NCT00148668|1553824|P1|STARTED|Overall Study||41
632888|NCT00148343|1553832|P2|NOT COMPLETED|Overall Study||11
632889|NCT00148343|1553833|P1|NOT COMPLETED|Overall Study||15
632890|NCT00148343|1553832|P2|COMPLETED|Overall Study||45
632891|NCT00148343|1553833|P1|COMPLETED|Overall Study||39
632892|NCT00148343|1553832|P2|STARTED|Overall Study||56
632893|NCT00148343|1553833|P1|STARTED|Overall Study||54
632894|NCT00148317|1553847|P1|NOT COMPLETED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||11
632895|NCT00148317|1553847|P1|COMPLETED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||27
632896|NCT00148317|1553847|P1|STARTED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||38
632897|NCT00148317|1553847|P1|NOT COMPLETED|Consolidation (VEL + DEX)||0
632898|NCT00148317|1553847|P1|COMPLETED|Consolidation (VEL + DEX)||38
632899|NCT00148317|1553847|P1|no DOXIL Added|Consolidation (VEL + DEX)||10
632900|NCT00148317|1553847|P1|DOXIL Added at Cycle 5|Consolidation (VEL + DEX)||12
632901|NCT00148317|1553847|P1|DOXIL Added at Cycle 3|Consolidation (VEL + DEX)||16
632902|NCT00148317|1553847|P1|STARTED|Consolidation (VEL + DEX)||38
632903|NCT00148122|1553854|P1|NOT COMPLETED|Overall Study||2
632904|NCT00148122|1553854|P1|COMPLETED|Overall Study||38
632905|NCT00148122|1553854|P1|STARTED|Overall Study||40
632906|NCT00148109|1553862|P2|NOT COMPLETED|Overall Study||20
632907|NCT00148109|1553863|P1|NOT COMPLETED|Overall Study||12
632908|NCT00148109|1553862|P2|COMPLETED|Overall Study||1
632909|NCT00148109|1553863|P1|COMPLETED|Overall Study||3
632910|NCT00148109|1553862|P2|STARTED|Overall Study||21
632911|NCT00148109|1553863|P1|STARTED|Overall Study||15
632912|NCT00147966|1553873|P1|NOT COMPLETED|Overall Study||0
632913|NCT00147966|1553873|P1|COMPLETED|Overall Study||24
632914|NCT00147966|1553873|P1|STARTED|Overall Study||24
632915|NCT00147823|1553879|P2|NOT COMPLETED|Overall Study||15
632916|NCT00147823|1553880|P1|NOT COMPLETED|Overall Study||13
632917|NCT00147823|1553879|P2|COMPLETED|Overall Study||16
632918|NCT00147823|1553880|P1|COMPLETED|Overall Study||19
632919|NCT00147823|1553879|P2|Month 24 Visit|Overall Study||18
632920|NCT00147823|1553880|P1|Month 24 Visit|Overall Study||21
632921|NCT00147823|1553879|P2|Month 18 Visit|Overall Study||20
632922|NCT00147823|1553880|P1|Month 18 Visit|Overall Study|As stated previously ea. subject is counted at each milestone, as data is collected at ea. timepoint|21
632923|NCT00147823|1553879|P2|Month 12 CT Scan|Overall Study||25
632924|NCT00147823|1553880|P1|Month 12 CT Scan|Overall Study||20
632925|NCT00147823|1553879|P2|Month 12 Visit|Overall Study|Subjects are counted at each milestone as that is when data is collectec|25
632926|NCT00147823|1553880|P1|Month 12 Visit|Overall Study||21
632927|NCT00147823|1553879|P2|Month 6 Visit|Overall Study||21
632928|NCT00147823|1553880|P1|Month 6 Visit|Overall Study||25
632929|NCT00147823|1553879|P2|Month 3 Visit|Overall Study||24
632930|NCT00147823|1553880|P1|Month 3 Visit|Overall Study||25
632931|NCT00147823|1553879|P2|Week 6 Visit|Overall Study||28
632932|NCT00147823|1553880|P1|Week 6 Visit|Overall Study||26
632933|NCT00147823|1553879|P2|STARTED|Overall Study||31
632934|NCT00147823|1553880|P1|STARTED|Overall Study||32
632935|NCT00147745|1553911|P3|NOT COMPLETED|Overall Study||0
632936|NCT00147745|1553912|P2|NOT COMPLETED|Overall Study||0
632937|NCT00147745|1553913|P1|NOT COMPLETED|Overall Study||1
632938|NCT00147745|1553911|P3|COMPLETED|Overall Study||6
632939|NCT00147745|1553912|P2|COMPLETED|Overall Study||14
632940|NCT00147745|1553913|P1|COMPLETED|Overall Study||15
632941|NCT00147745|1553911|P3|STARTED|Overall Study||6
632942|NCT00147745|1553912|P2|STARTED|Overall Study||14
632943|NCT00147745|1553913|P1|STARTED|Overall Study||16
632944|NCT00147537|1553935|P11|NOT COMPLETED|Phase 2||52
632945|NCT00147537|1553936|P10|NOT COMPLETED|Phase 2||161
632946|NCT00147537|1553937|P9|NOT COMPLETED|Phase 2||0
632947|NCT00147537|1553938|P8|NOT COMPLETED|Phase 2||0
632948|NCT00147537|1553939|P7|NOT COMPLETED|Phase 2||0
632949|NCT00147537|1553940|P6|NOT COMPLETED|Phase 2||0
632950|NCT00147537|1553941|P5|NOT COMPLETED|Phase 2||0
632951|NCT00147537|1553942|P4|NOT COMPLETED|Phase 2||0
632952|NCT00147537|1553943|P3|NOT COMPLETED|Phase 2||0
632953|NCT00147537|1553944|P2|NOT COMPLETED|Phase 2||0
632954|NCT00147537|1553945|P1|NOT COMPLETED|Phase 2||0
632955|NCT00147537|1553935|P11|COMPLETED|Phase 2||3
632956|NCT00147537|1553936|P10|COMPLETED|Phase 2||5
632957|NCT00147537|1553937|P9|COMPLETED|Phase 2||0
632958|NCT00147537|1553938|P8|COMPLETED|Phase 2||0
632959|NCT00147537|1553939|P7|COMPLETED|Phase 2||0
632960|NCT00147537|1553940|P6|COMPLETED|Phase 2||0
632961|NCT00147537|1553941|P5|COMPLETED|Phase 2||0
632962|NCT00147537|1553942|P4|COMPLETED|Phase 2||0
632963|NCT00147537|1553943|P3|COMPLETED|Phase 2||0
632964|NCT00147537|1553944|P2|COMPLETED|Phase 2||0
632965|NCT00147537|1553945|P1|COMPLETED|Phase 2||0
632966|NCT00147537|1553935|P11|STARTED|Phase 2|55 randomized; 56 treated-1 randomized but not treated, 2 randomized to F+P+C rec'd P+C|55
632967|NCT00147537|1553936|P10|STARTED|Phase 2|166 particpants randomized; 163 participants treated|166
632968|NCT00147537|1553937|P9|STARTED|Phase 2||0
632969|NCT00147537|1553938|P8|STARTED|Phase 2||0
632970|NCT00147537|1553939|P7|STARTED|Phase 2||0
632971|NCT00147537|1553940|P6|STARTED|Phase 2||0
632972|NCT00147537|1553941|P5|STARTED|Phase 2||0
632973|NCT00147537|1553942|P4|STARTED|Phase 2||0
632974|NCT00147537|1553943|P3|STARTED|Phase 2||0
632975|NCT00147537|1553944|P2|STARTED|Phase 2||0
632976|NCT00147537|1553945|P1|STARTED|Phase 2||0
632977|NCT00147537|1553935|P11|NOT COMPLETED|Phase 1b||0
632978|NCT00147537|1553936|P10|NOT COMPLETED|Phase 1b||0
632979|NCT00147537|1553937|P9|NOT COMPLETED|Phase 1b||17
632980|NCT00147537|1553938|P8|NOT COMPLETED|Phase 1b||7
632981|NCT00147537|1553939|P7|NOT COMPLETED|Phase 1b||18
632982|NCT00147537|1553940|P6|NOT COMPLETED|Phase 1b||3
632983|NCT00147537|1553941|P5|NOT COMPLETED|Phase 1b||3
632984|NCT00147537|1553942|P4|NOT COMPLETED|Phase 1b||2
632985|NCT00147537|1553943|P3|NOT COMPLETED|Phase 1b||4
632986|NCT00147537|1553944|P2|NOT COMPLETED|Phase 1b||2
632987|NCT00147537|1553945|P1|NOT COMPLETED|Phase 1b||2
632988|NCT00147537|1553935|P11|COMPLETED|Phase 1b||0
632989|NCT00147537|1553936|P10|COMPLETED|Phase 1b||0
632990|NCT00147537|1553937|P9|COMPLETED|Phase 1b||1
632991|NCT00147537|1553938|P8|COMPLETED|Phase 1b||0
632992|NCT00147537|1553939|P7|COMPLETED|Phase 1b||0
632993|NCT00147537|1553940|P6|COMPLETED|Phase 1b||0
632994|NCT00147537|1553941|P5|COMPLETED|Phase 1b||0
632995|NCT00147537|1553942|P4|COMPLETED|Phase 1b||1
632996|NCT00147537|1553943|P3|COMPLETED|Phase 1b||0
632997|NCT00147537|1553944|P2|COMPLETED|Phase 1b||0
632998|NCT00147537|1553945|P1|COMPLETED|Phase 1b||1
632999|NCT00147537|1553935|P11|STARTED|Phase 1b||0
633000|NCT00147537|1553936|P10|STARTED|Phase 1b||0
633001|NCT00147537|1553937|P9|STARTED|Phase 1b|18 participants randomized; 17 participants treated|18
633002|NCT00147537|1553938|P8|STARTED|Phase 1b||7
633003|NCT00147537|1553939|P7|STARTED|Phase 1b|18 participants randomized; 17 participants treated|18
633004|NCT00147537|1553940|P6|STARTED|Phase 1b||3
633005|NCT00147537|1553941|P5|STARTED|Phase 1b||3
633006|NCT00147537|1553942|P4|STARTED|Phase 1b||3
633007|NCT00147537|1553943|P3|STARTED|Phase 1b||4
633008|NCT00147537|1553944|P2|STARTED|Phase 1b||2
633009|NCT00147537|1553945|P1|STARTED|Phase 1b||3
633010|NCT00147498|1554128|P4|NOT COMPLETED|Overall Study||17
633011|NCT00147498|1554129|P3|NOT COMPLETED|Overall Study||17
633012|NCT00147498|1554130|P2|NOT COMPLETED|Overall Study||9
633013|NCT00147498|1554131|P1|NOT COMPLETED|Overall Study||3
633014|NCT00147498|1554128|P4|COMPLETED|Overall Study||48
633015|NCT00147498|1554129|P3|COMPLETED|Overall Study||52
633016|NCT00147498|1554130|P2|COMPLETED|Overall Study||60
633017|NCT00147498|1554131|P1|COMPLETED|Overall Study||58
633018|NCT00147498|1554128|P4|STARTED|Overall Study||65
633019|NCT00147498|1554129|P3|STARTED|Overall Study||69
633020|NCT00147498|1554130|P2|STARTED|Overall Study||69
633021|NCT00147498|1554131|P1|STARTED|Overall Study||61
633022|NCT00147446|1554227|P2|NOT COMPLETED|Overall Study||0
633023|NCT00147446|1554228|P1|NOT COMPLETED|Overall Study||0
633024|NCT00147446|1554227|P2|COMPLETED|Overall Study||61
633025|NCT00147446|1554228|P1|COMPLETED|Overall Study||60
633026|NCT00147446|1554227|P2|STARTED|Overall Study||61
633027|NCT00147446|1554228|P1|STARTED|Overall Study||60
633028|NCT00147316|1554236|P1|NOT COMPLETED|Overall Study||0
633029|NCT00147316|1554236|P1|COMPLETED|Overall Study||103
633030|NCT00147316|1554236|P1|STARTED|Overall Study||103
633031|NCT00147290|1554243|P2|NOT COMPLETED|Overall Study||0
633032|NCT00147290|1554244|P1|NOT COMPLETED|Overall Study||0
633033|NCT00147290|1554243|P2|COMPLETED|Overall Study||260
633034|NCT00147290|1554244|P1|COMPLETED|Overall Study||266
633035|NCT00147290|1554243|P2|STARTED|Overall Study||260
633036|NCT00147290|1554244|P1|STARTED|Overall Study||266
633037|NCT00147277|1554250|P2|NOT COMPLETED|Overall Study||0
633038|NCT00147277|1554251|P1|NOT COMPLETED|Overall Study||0
633039|NCT00147277|1554250|P2|COMPLETED|Overall Study||450
633040|NCT00147277|1554251|P1|COMPLETED|Overall Study||475
633041|NCT00147277|1554250|P2|STARTED|Overall Study||450
633042|NCT00147277|1554251|P1|STARTED|Overall Study||475
633043|NCT00147238|1554255|P1|NOT COMPLETED|Overall Study||8
633044|NCT00147238|1554255|P1|COMPLETED|Overall Study||2
633045|NCT00147238|1554255|P1|STARTED|Overall Study||10
633046|NCT00147225|1554265|P6|NOT COMPLETED|Overall Study||2
633047|NCT00147225|1554266|P5|NOT COMPLETED|Overall Study||1
633048|NCT00147225|1554267|P4|NOT COMPLETED|Overall Study||1
633049|NCT00147225|1554268|P3|NOT COMPLETED|Overall Study||2
633050|NCT00147225|1554269|P2|NOT COMPLETED|Overall Study||0
633051|NCT00147225|1554270|P1|NOT COMPLETED|Overall Study||1
633052|NCT00147225|1554265|P6|COMPLETED|Overall Study||10
633053|NCT00147225|1554266|P5|COMPLETED|Overall Study||10
633054|NCT00147225|1554267|P4|COMPLETED|Overall Study||10
633055|NCT00147225|1554268|P3|COMPLETED|Overall Study||6
633056|NCT00147225|1554269|P2|COMPLETED|Overall Study||6
633057|NCT00147225|1554270|P1|COMPLETED|Overall Study||6
633058|NCT00147225|1554265|P6|STARTED|Overall Study||12
633059|NCT00147225|1554266|P5|STARTED|Overall Study||11
633060|NCT00147225|1554267|P4|STARTED|Overall Study||11
633061|NCT00147225|1554268|P3|STARTED|Overall Study||8
633062|NCT00147225|1554269|P2|STARTED|Overall Study||6
633063|NCT00147225|1554270|P1|STARTED|Overall Study||7
633064|NCT00147212|1554290|P1|NOT COMPLETED|Overall Study||0
633065|NCT00147212|1554290|P1|COMPLETED|Overall Study||50
633066|NCT00147212|1554290|P1|STARTED|Overall Study||50
633067|NCT00147199|1554296|P2|NOT COMPLETED|Overall Study||10
633068|NCT00147199|1554297|P1|NOT COMPLETED|Overall Study||13
633069|NCT00147199|1554296|P2|COMPLETED|Overall Study||110
633070|NCT00147199|1554297|P1|COMPLETED|Overall Study||102
633071|NCT00147199|1554296|P2|STARTED|Overall Study||120
633072|NCT00147199|1554297|P1|STARTED|Overall Study||115
633073|NCT00147030|1554321|P2|NOT COMPLETED|Overall Study||0
633074|NCT00147030|1554322|P1|NOT COMPLETED|Overall Study||0
633075|NCT00147030|1554321|P2|COMPLETED|Overall Study||162
633076|NCT00147030|1554322|P1|COMPLETED|Overall Study||163
633077|NCT00147030|1554321|P2|STARTED|Overall Study||162
633078|NCT00147030|1554322|P1|STARTED|Overall Study||163
633079|NCT00146848|1554373|P3|NOT COMPLETED|Post-randomization||39
633080|NCT00146848|1554374|P2|NOT COMPLETED|Post-randomization||47
633081|NCT00146848|1554375|P1|NOT COMPLETED|Post-randomization||38
633082|NCT00146848|1554373|P3|COMPLETED|Post-randomization||431
633083|NCT00146848|1554374|P2|COMPLETED|Post-randomization||441
633084|NCT00146848|1554375|P1|COMPLETED|Post-randomization||437
633085|NCT00146848|1554373|P3|STARTED|Post-randomization||470
633086|NCT00146848|1554374|P2|STARTED|Post-randomization||488
633087|NCT00146848|1554375|P1|STARTED|Post-randomization||475
633088|NCT00146848|1554373|P3|NOT COMPLETED|Pre-randomization||0
633089|NCT00146848|1554374|P2|NOT COMPLETED|Pre-randomization||0
633090|NCT00146848|1554375|P1|NOT COMPLETED|Pre-randomization||309
633091|NCT00146848|1554373|P3|COMPLETED|Pre-randomization||0
633092|NCT00146848|1554374|P2|COMPLETED|Pre-randomization||0
633093|NCT00146848|1554375|P1|COMPLETED|Pre-randomization|Reached 6-week visit and were randomized|1433
633094|NCT00146848|1554373|P3|STARTED|Pre-randomization||0
633095|NCT00146848|1554374|P2|STARTED|Pre-randomization||0
633096|NCT00146848|1554375|P1|STARTED|Pre-randomization|Registered|1742
633097|NCT00146770|1554391|P2|NOT COMPLETED|Overall Study||0
633098|NCT00146770|1554392|P1|NOT COMPLETED|Overall Study||5
633099|NCT00146770|1554391|P2|COMPLETED|Overall Study||22
633100|NCT00146770|1554392|P1|COMPLETED|Overall Study||18
633101|NCT00146770|1554391|P2|STARTED|Overall Study||22
633102|NCT00146770|1554392|P1|STARTED|Overall Study||23
633103|NCT00146757|1554410|P2|NOT COMPLETED|Overall Study||0
633104|NCT00146757|1554411|P1|NOT COMPLETED|Overall Study||2
633105|NCT00146757|1554410|P2|COMPLETED|Overall Study||4
633106|NCT00146757|1554411|P1|COMPLETED|Overall Study||14
633107|NCT00146757|1554410|P2|STARTED|Overall Study||4
633108|NCT00146757|1554411|P1|STARTED|Overall Study||16
633109|NCT00146640|1554430|P2|NOT COMPLETED|Overall Study||14
633110|NCT00146640|1554431|P1|NOT COMPLETED|Overall Study||23
633111|NCT00146640|1554430|P2|COMPLETED|Overall Study||130
633112|NCT00146640|1554431|P1|COMPLETED|Overall Study||121
633113|NCT00146640|1554430|P2|STARTED|Overall Study||144
633114|NCT00146640|1554431|P1|STARTED|Overall Study||144
633115|NCT00146328|1554454|P3|NOT COMPLETED|Overall Study||291
633116|NCT00146328|1554455|P2|NOT COMPLETED|Overall Study||154
633117|NCT00146328|1554456|P1|NOT COMPLETED|Overall Study||141
633118|NCT00146328|1554454|P3|COMPLETED|Overall Study||158
633119|NCT00146328|1554455|P2|COMPLETED|Overall Study||101
633120|NCT00146328|1554456|P1|COMPLETED|Overall Study||150
633121|NCT00146328|1554454|P3|STARTED|Overall Study||449
633122|NCT00146328|1554455|P2|STARTED|Overall Study||255
633123|NCT00146328|1554456|P1|STARTED|Overall Study||291
633124|NCT00146172|1554547|P8|NOT COMPLETED|Overall Study||40
633125|NCT00146172|1554548|P7|NOT COMPLETED|Overall Study||6
633126|NCT00146172|1554549|P6|NOT COMPLETED|Overall Study||7
633127|NCT00146172|1554550|P5|NOT COMPLETED|Overall Study||3
633128|NCT00146172|1554551|P4|NOT COMPLETED|Overall Study||6
633129|NCT00146172|1554552|P3|NOT COMPLETED|Overall Study||4
633130|NCT00146172|1554553|P2|NOT COMPLETED|Overall Study||4
633131|NCT00146172|1554554|P1|NOT COMPLETED|Overall Study||3
633132|NCT00146172|1554547|P8|COMPLETED|Overall Study||0
633133|NCT00146172|1554548|P7|COMPLETED|Overall Study||0
633134|NCT00146172|1554549|P6|COMPLETED|Overall Study||0
633135|NCT00146172|1554550|P5|COMPLETED|Overall Study||0
633136|NCT00146172|1554551|P4|COMPLETED|Overall Study||0
633137|NCT00146172|1554552|P3|COMPLETED|Overall Study||0
633138|NCT00146172|1554553|P2|COMPLETED|Overall Study||0
633139|NCT00146172|1554554|P1|COMPLETED|Overall Study||0
633140|NCT00146172|1554547|P8|Received Drug|Overall Study||39
633141|NCT00146172|1554548|P7|Received Drug|Overall Study||6
633142|NCT00146172|1554549|P6|Received Drug|Overall Study||7
633143|NCT00146172|1554550|P5|Received Drug|Overall Study||3
633144|NCT00146172|1554551|P4|Received Drug|Overall Study||6
633145|NCT00146172|1554552|P3|Received Drug|Overall Study||4
633146|NCT00146172|1554553|P2|Received Drug|Overall Study||4
633147|NCT00146172|1554554|P1|Received Drug|Overall Study||3
633148|NCT00146172|1554547|P8|STARTED|Overall Study||40
633149|NCT00146172|1554548|P7|STARTED|Overall Study||6
633150|NCT00146172|1554549|P6|STARTED|Overall Study||7
633151|NCT00146172|1554550|P5|STARTED|Overall Study||3
633152|NCT00146172|1554551|P4|STARTED|Overall Study||6
633153|NCT00146172|1554552|P3|STARTED|Overall Study||4
633154|NCT00146172|1554553|P2|STARTED|Overall Study||4
633155|NCT00146172|1554554|P1|STARTED|Overall Study||3
633156|NCT00145795|1554588|P2|NOT COMPLETED|Overall Study||0
633157|NCT00145795|1554589|P1|NOT COMPLETED|Overall Study||1
633158|NCT00145795|1554588|P2|COMPLETED|Overall Study||10
633159|NCT00145795|1554589|P1|COMPLETED|Overall Study|1 patient discontinued early due to grade II gastrointestinal symptoms.|9
633160|NCT00145795|1554588|P2|STARTED|Overall Study||10
633161|NCT00145795|1554589|P1|STARTED|Overall Study||10
633162|NCT00145704|1554615|P2|NOT COMPLETED|Overall Study||3
633163|NCT00145704|1554616|P1|NOT COMPLETED|Overall Study||3
633164|NCT00145704|1554615|P2|COMPLETED|Overall Study||0
633165|NCT00145704|1554616|P1|COMPLETED|Overall Study||0
633166|NCT00145704|1554615|P2|STARTED|Overall Study||3
633167|NCT00145704|1554616|P1|STARTED|Overall Study||3
633168|NCT00145626|1554624|P1|NOT COMPLETED|Overall Study||5
633169|NCT00145626|1554624|P1|COMPLETED|Overall Study||14
633170|NCT00145626|1554624|P1|STARTED|Overall Study||19
633171|NCT00145600|1554670|P4|NOT COMPLETED|Overall Study||16
633172|NCT00145600|1554671|P3|NOT COMPLETED|Overall Study||5
633173|NCT00145600|1554672|P2|NOT COMPLETED|Overall Study||10
633174|NCT00145600|1554673|P1|NOT COMPLETED|Overall Study||8
633175|NCT00145600|1554670|P4|COMPLETED|Overall Study||130
633176|NCT00145600|1554671|P3|COMPLETED|Overall Study||8
633177|NCT00145600|1554672|P2|COMPLETED|Overall Study||36
633178|NCT00145600|1554673|P1|COMPLETED|Overall Study||83
633179|NCT00145600|1554670|P4|STARTED|Overall Study||146
633180|NCT00145600|1554671|P3|STARTED|Overall Study||13
633181|NCT00145600|1554672|P2|STARTED|Overall Study||46
633182|NCT00145600|1554673|P1|STARTED|Overall Study||91
633183|NCT00145587|1554787|P2|NOT COMPLETED|Overall Study||0
633184|NCT00145587|1554788|P1|NOT COMPLETED|Overall Study||0
633185|NCT00145587|1554787|P2|COMPLETED|Overall Study||1
633186|NCT00145587|1554788|P1|COMPLETED|Overall Study||5
633187|NCT00145587|1554787|P2|STARTED|Overall Study||1
633188|NCT00145587|1554788|P1|STARTED|Overall Study||5
633189|NCT00145574|1554797|P3|NOT COMPLETED|Open Label Long-term Extension||11
633190|NCT00145574|1554798|P2|NOT COMPLETED|Open Label Long-term Extension||0
633191|NCT00145574|1554799|P1|NOT COMPLETED|Open Label Long-term Extension||0
633192|NCT00145574|1554797|P3|COMPLETED|Open Label Long-term Extension||173
633193|NCT00145574|1554798|P2|COMPLETED|Open Label Long-term Extension||0
633194|NCT00145574|1554799|P1|COMPLETED|Open Label Long-term Extension||0
633195|NCT00145574|1554797|P3|STARTED|Open Label Long-term Extension|2 participants discontinued after completing double-blind but before starting open label.|184
633196|NCT00145574|1554798|P2|STARTED|Open Label Long-term Extension||0
633197|NCT00145574|1554799|P1|STARTED|Open Label Long-term Extension||0
633198|NCT00145574|1554797|P3|NOT COMPLETED|Double Blind||2
633199|NCT00145574|1554798|P2|NOT COMPLETED|Double Blind||5
633200|NCT00145574|1554799|P1|NOT COMPLETED|Double Blind||1
633201|NCT00145574|1554797|P3|COMPLETED|Double Blind||62
633202|NCT00145574|1554798|P2|COMPLETED|Double Blind||60
633203|NCT00145574|1554799|P1|COMPLETED|Double Blind||64
633204|NCT00145574|1554797|P3|STARTED|Double Blind||64
633205|NCT00145574|1554798|P2|STARTED|Double Blind||65
633206|NCT00145574|1554799|P1|STARTED|Double Blind||65
633207|NCT00145509|1554856|P2|NOT COMPLETED|Overall Study||21
633208|NCT00145509|1554857|P1|NOT COMPLETED|Overall Study||22
633209|NCT00145509|1554856|P2|COMPLETED|Overall Study||15
633210|NCT00145509|1554857|P1|COMPLETED|Overall Study||19
633211|NCT00145509|1554856|P2|STARTED|Overall Study||36
633212|NCT00145509|1554857|P1|STARTED|Overall Study||41
633213|NCT00145496|1554871|P2|NOT COMPLETED|Overall Study||81
633214|NCT00145496|1554872|P1|NOT COMPLETED|Overall Study||123
633215|NCT00145496|1554871|P2|COMPLETED|Overall Study||143
633216|NCT00145496|1554872|P1|COMPLETED|Overall Study||121
633305|NCT00143598|1555524|P1|NOT COMPLETED|Overall Study||92
633217|NCT00145496|1554871|P2|STARTED|Overall Study|Subjects who received randomized treatment assignment and at least one dose of study medication.|224
633218|NCT00145496|1554872|P1|STARTED|Overall Study|Subjects who received randomized treatment assignment and at least one dose of study medication.|244
633219|NCT00145418|1554882|P1|NOT COMPLETED|Overall Study||0
633220|NCT00145418|1554882|P1|COMPLETED|Overall Study||15
633221|NCT00145418|1554882|P1|STARTED|Overall Study||15
633222|NCT00145327|1554892|P3|NOT COMPLETED|Overall Study||248
633223|NCT00145327|1554893|P2|NOT COMPLETED|Overall Study||124
633224|NCT00145327|1554894|P1|NOT COMPLETED|Overall Study||142
633225|NCT00145327|1554892|P3|COMPLETED|Overall Study||975
633226|NCT00145327|1554893|P2|COMPLETED|Overall Study||493
633227|NCT00145327|1554894|P1|COMPLETED|Overall Study||474
633228|NCT00145327|1554892|P3|STARTED|Overall Study|Group P3Z3 have non-randomized participants|1223
633229|NCT00145327|1554893|P2|STARTED|Overall Study||617
633230|NCT00145327|1554894|P1|STARTED|Overall Study|Group Z6 and Group Z3P3 have randomized participants.|616
633231|NCT00145249|1554950|P3|NOT COMPLETED|Overall Study||17
633232|NCT00145249|1554951|P2|NOT COMPLETED|Overall Study||15
633233|NCT00145249|1554952|P1|NOT COMPLETED|Overall Study||11
633234|NCT00145249|1554950|P3|COMPLETED|Overall Study||31
633235|NCT00145249|1554951|P2|COMPLETED|Overall Study||33
633236|NCT00145249|1554952|P1|COMPLETED|Overall Study||36
633237|NCT00145249|1554950|P3|STARTED|Overall Study|48 subjects randomized; 49 treated-3 subjects randomized to AmphoB+Fluc400 rec'd AmphoB+Fluc800|48
633238|NCT00145249|1554951|P2|STARTED|Overall Study|48 subjects randomized; 47 subjects treated-2 subjects randomized to AmphoB rec'd AmphoB+Fluc400|48
633239|NCT00145249|1554952|P1|STARTED|Overall Study|47 subjects randomized; 45 subjects treated|47
633240|NCT00145119|1554993|P1|NOT COMPLETED|Overall Study||45
633241|NCT00145119|1554993|P1|COMPLETED|Overall Study||267
633242|NCT00145119|1554993|P1|STARTED|Overall Study||312
633243|NCT00145041|1554997|P1|NOT COMPLETED|Overall Study||0
633244|NCT00145041|1554997|P1|COMPLETED|Overall Study||7
633245|NCT00145041|1554997|P1|STARTED|Overall Study||7
633246|NCT00144963|1555003|P1|NOT COMPLETED|Overall Study||0
633247|NCT00144963|1555003|P1|COMPLETED|Overall Study||36
633248|NCT00144963|1555003|P1|STARTED|Overall Study||36
633249|NCT00144781|1555011|P4|NOT COMPLETED|Overall Study||0
633250|NCT00144781|1555012|P3|NOT COMPLETED|Overall Study||0
633251|NCT00144781|1555013|P2|NOT COMPLETED|Overall Study||2
633252|NCT00144781|1555014|P1|NOT COMPLETED|Overall Study||0
633253|NCT00144781|1555011|P4|COMPLETED|Overall Study||9
633254|NCT00144781|1555012|P3|COMPLETED|Overall Study||8
633255|NCT00144781|1555013|P2|COMPLETED|Overall Study||7
633256|NCT00144781|1555014|P1|COMPLETED|Overall Study||8
633257|NCT00144781|1555011|P4|STARTED|Overall Study||9
633258|NCT00144781|1555012|P3|STARTED|Overall Study||8
633259|NCT00144781|1555013|P2|STARTED|Overall Study||9
633260|NCT00144781|1555014|P1|STARTED|Overall Study||8
633261|NCT00144391|1555034|P2|NOT COMPLETED|Overall Study||0
633262|NCT00144391|1555035|P1|NOT COMPLETED|Overall Study||0
633263|NCT00144391|1555034|P2|COMPLETED|Overall Study||9
633264|NCT00144391|1555035|P1|COMPLETED|Overall Study||11
633265|NCT00144391|1555034|P2|STARTED|Overall Study||9
633266|NCT00144391|1555035|P1|STARTED|Overall Study||11
633267|NCT00144339|1555043|P2|NOT COMPLETED|Overall Study||1099
633268|NCT00144339|1555044|P1|NOT COMPLETED|Overall Study||1358
633269|NCT00144339|1555043|P2|COMPLETED|Overall Study||1887
633270|NCT00144339|1555044|P1|COMPLETED|Overall Study||1648
633271|NCT00144339|1555043|P2|STARTED|Overall Study||2986
633272|NCT00144339|1555044|P1|STARTED|Overall Study||3006
633273|NCT00144300|1555252|P2|NOT COMPLETED|Overall Study||28
633274|NCT00144300|1555253|P1|NOT COMPLETED|Overall Study||29
633275|NCT00144300|1555252|P2|COMPLETED|Overall Study||97
633276|NCT00144300|1555253|P1|COMPLETED|Overall Study||92
633277|NCT00144300|1555252|P2|STARTED|Overall Study||125
633278|NCT00144300|1555253|P1|STARTED|Overall Study||121
633279|NCT00144170|1555301|P2|NOT COMPLETED|Overall Study||396
633280|NCT00144170|1555302|P1|NOT COMPLETED|Overall Study||352
633281|NCT00144170|1555301|P2|COMPLETED|Overall Study||32
633282|NCT00144170|1555302|P1|COMPLETED|Overall Study||86
633283|NCT00144170|1555301|P2|STARTED|Overall Study||428
633284|NCT00144170|1555302|P1|STARTED|Overall Study||438
633285|NCT00144027|1555492|P2|NOT COMPLETED|Overall Study||11
633286|NCT00144027|1555493|P1|NOT COMPLETED|Overall Study||3
633287|NCT00144027|1555492|P2|COMPLETED|Overall Study|participants who completed 12-month follow-up|25
633288|NCT00144027|1555493|P1|COMPLETED|Overall Study|participants who completed 12-month follow-up|36
633289|NCT00144027|1555492|P2|Completed 6 Month Assessment|Overall Study||24
633290|NCT00144027|1555493|P1|Completed 6 Month Assessment|Overall Study||37
633291|NCT00144027|1555492|P2|Completed Baseline Assessment|Overall Study||29
633292|NCT00144027|1555493|P1|Completed Baseline Assessment|Overall Study||39
633293|NCT00144027|1555492|P2|STARTED|Overall Study|participants who consented|36
633294|NCT00144027|1555493|P1|STARTED|Overall Study|participants who consented|39
633295|NCT00143845|1555499|P1|NOT COMPLETED|Overall Study||0
633296|NCT00143845|1555499|P1|COMPLETED|Overall Study||54
633297|NCT00143845|1555499|P1|STARTED|Overall Study||54
633298|NCT00143819|1555507|P2|NOT COMPLETED|Overall Study||3
633299|NCT00143819|1555508|P1|NOT COMPLETED|Overall Study||2
633300|NCT00143819|1555507|P2|COMPLETED|Overall Study||5
633301|NCT00143819|1555508|P1|COMPLETED|Overall Study||3
633302|NCT00143819|1555507|P2|STARTED|Overall Study||8
633303|NCT00143819|1555508|P1|STARTED|Overall Study||5
633304|NCT00143598|1555523|P2|NOT COMPLETED|Overall Study||94
633306|NCT00143598|1555523|P2|COMPLETED|Overall Study||302
633307|NCT00143598|1555524|P1|COMPLETED|Overall Study||318
633308|NCT00143598|1555523|P2|STARTED|Overall Study||396
633309|NCT00143598|1555524|P1|STARTED|Overall Study||410
633310|NCT00143507|1555538|P2|NOT COMPLETED|Overall Study||652
633311|NCT00143507|1555539|P1|NOT COMPLETED|Overall Study||687
633312|NCT00143507|1555538|P2|COMPLETED|Overall Study||4786
633313|NCT00143507|1555539|P1|COMPLETED|Overall Study||4792
633314|NCT00143507|1555538|P2|STARTED|Overall Study||5438
633315|NCT00143507|1555539|P1|STARTED|Overall Study||5479
633316|NCT00143455|1555573|P4|NOT COMPLETED|Cohort 2||93
633317|NCT00143455|1555574|P3|NOT COMPLETED|Cohort 2||106
633318|NCT00143455|1555575|P2|NOT COMPLETED|Cohort 2||0
633319|NCT00143455|1555576|P1|NOT COMPLETED|Cohort 2||0
633320|NCT00143455|1555573|P4|COMPLETED|Cohort 2||111
633321|NCT00143455|1555574|P3|COMPLETED|Cohort 2||97
633322|NCT00143455|1555575|P2|COMPLETED|Cohort 2||0
633323|NCT00143455|1555576|P1|COMPLETED|Cohort 2||0
633324|NCT00143455|1555573|P4|Received Treatment|Cohort 2||203
633325|NCT00143455|1555574|P3|Received Treatment|Cohort 2||202
633326|NCT00143455|1555575|P2|Received Treatment|Cohort 2||0
633327|NCT00143455|1555576|P1|Received Treatment|Cohort 2||0
633328|NCT00143455|1555573|P4|STARTED|Cohort 2||204
633329|NCT00143455|1555574|P3|STARTED|Cohort 2||203
633330|NCT00143455|1555575|P2|STARTED|Cohort 2||0
633331|NCT00143455|1555576|P1|STARTED|Cohort 2||0
633332|NCT00143455|1555573|P4|NOT COMPLETED|Cohort 1||0
633333|NCT00143455|1555574|P3|NOT COMPLETED|Cohort 1||0
633334|NCT00143455|1555575|P2|NOT COMPLETED|Cohort 1||17
633335|NCT00143455|1555576|P1|NOT COMPLETED|Cohort 1||14
633336|NCT00143455|1555573|P4|COMPLETED|Cohort 1||0
633337|NCT00143455|1555574|P3|COMPLETED|Cohort 1||0
633338|NCT00143455|1555575|P2|COMPLETED|Cohort 1||22
633339|NCT00143455|1555576|P1|COMPLETED|Cohort 1||25
633340|NCT00143455|1555573|P4|Received Treatment|Cohort 1||0
633341|NCT00143455|1555574|P3|Received Treatment|Cohort 1||0
633342|NCT00143455|1555575|P2|Received Treatment|Cohort 1||38
633343|NCT00143455|1555576|P1|Received Treatment|Cohort 1||39
633344|NCT00143455|1555573|P4|STARTED|Cohort 1||0
633345|NCT00143455|1555574|P3|STARTED|Cohort 1||0
633346|NCT00143455|1555575|P2|STARTED|Cohort 1||39
633347|NCT00143455|1555576|P1|STARTED|Cohort 1||39
633348|NCT00143403|1555610|P2|NOT COMPLETED|Overall Study||46
633349|NCT00143403|1555611|P1|NOT COMPLETED|Overall Study||35
633350|NCT00143403|1555610|P2|COMPLETED|Overall Study|Received maximum number of cycles.|115
633351|NCT00143403|1555611|P1|COMPLETED|Overall Study|Received maximum number of cycles.|125
633352|NCT00143403|1555610|P2|Treated|Overall Study||153
633353|NCT00143403|1555611|P1|Treated|Overall Study||153
633354|NCT00143403|1555610|P2|STARTED|Overall Study||161
633355|NCT00143403|1555611|P1|STARTED|Overall Study||160
633356|NCT00143390|1555621|P2|NOT COMPLETED|Overall Study||149
633357|NCT00143390|1555622|P1|NOT COMPLETED|Overall Study||149
633358|NCT00143390|1555621|P2|COMPLETED|Overall Study||0
633359|NCT00143390|1555622|P1|COMPLETED|Overall Study||0
633360|NCT00143390|1555621|P2|STARTED|Overall Study||149
633361|NCT00143390|1555622|P1|STARTED|Overall Study||149
633362|NCT00143312|1555638|P1|NOT COMPLETED|Overall Study||16
633363|NCT00143312|1555638|P1|COMPLETED|Overall Study||29
633364|NCT00143312|1555638|P1|STARTED|Overall Study||45
633365|NCT00143247|1555648|P1|NOT COMPLETED|Overall Study||156
633366|NCT00143247|1555648|P1|COMPLETED|Overall Study||17
633367|NCT00143247|1555648|P1|STARTED|Overall Study|173=total subjects of current + 3 previous protocols|173
633368|NCT00142935|1555665|P3|NOT COMPLETED|Overall Study||7
633369|NCT00142935|1555666|P2|NOT COMPLETED|Overall Study||8
633370|NCT00142935|1555667|P1|NOT COMPLETED|Overall Study||3
633371|NCT00142935|1555665|P3|COMPLETED|Overall Study||23
633372|NCT00142935|1555666|P2|COMPLETED|Overall Study||20
633373|NCT00142935|1555667|P1|COMPLETED|Overall Study||26
633374|NCT00142935|1555665|P3|STARTED|Overall Study||30
633375|NCT00142935|1555666|P2|STARTED|Overall Study||28
633376|NCT00142935|1555667|P1|STARTED|Overall Study||29
633377|NCT00142909|1555692|P2|NOT COMPLETED|Medications Begin||3
633378|NCT00142909|1555693|P1|NOT COMPLETED|Medications Begin||9
633379|NCT00142909|1555692|P2|COMPLETED|Medications Begin||31
633380|NCT00142909|1555693|P1|COMPLETED|Medications Begin||26
633381|NCT00142909|1555692|P2|STARTED|Medications Begin||34
633382|NCT00142909|1555693|P1|STARTED|Medications Begin||35
633383|NCT00142909|1555692|P2|NOT COMPLETED|Randomization||10
633384|NCT00142909|1555693|P1|NOT COMPLETED|Randomization||7
633385|NCT00142909|1555692|P2|COMPLETED|Randomization||34
633386|NCT00142909|1555693|P1|COMPLETED|Randomization||35
633387|NCT00142909|1555692|P2|STARTED|Randomization||44
633388|NCT00142909|1555693|P1|STARTED|Randomization||42
633389|NCT00142818|1555713|P4|NOT COMPLETED|Overall Study||22
633390|NCT00142818|1555714|P3|NOT COMPLETED|Overall Study||13
633391|NCT00142818|1555715|P2|NOT COMPLETED|Overall Study||21
633392|NCT00142818|1555716|P1|NOT COMPLETED|Overall Study||17
633393|NCT00142818|1555713|P4|COMPLETED|Overall Study||20
633394|NCT00142818|1555714|P3|COMPLETED|Overall Study||24
633395|NCT00142818|1555715|P2|COMPLETED|Overall Study||19
633396|NCT00142818|1555716|P1|COMPLETED|Overall Study||28
633397|NCT00142818|1555713|P4|STARTED|Overall Study||42
633398|NCT00142818|1555714|P3|STARTED|Overall Study||37
633399|NCT00142818|1555715|P2|STARTED|Overall Study||40
633400|NCT00142818|1555716|P1|STARTED|Overall Study||45
633401|NCT00142792|1555729|P3|NOT COMPLETED|Overall Study||12
633402|NCT00142792|1555730|P2|NOT COMPLETED|Overall Study||15
633403|NCT00142792|1555731|P1|NOT COMPLETED|Overall Study||12
633404|NCT00142792|1555729|P3|COMPLETED|Overall Study||30
633405|NCT00142792|1555730|P2|COMPLETED|Overall Study||26
633406|NCT00142792|1555731|P1|COMPLETED|Overall Study||27
633407|NCT00142792|1555729|P3|Completed Intervention|Overall Study||37
633408|NCT00142792|1555730|P2|Completed Intervention|Overall Study||37
633409|NCT00142792|1555731|P1|Completed Intervention|Overall Study||35
633410|NCT00142792|1555729|P3|STARTED|Overall Study||42
633411|NCT00142792|1555730|P2|STARTED|Overall Study||41
633412|NCT00142792|1555731|P1|STARTED|Overall Study||39
633413|NCT00142597|1555744|P2|NOT COMPLETED|Overall Study||1
633414|NCT00142597|1555745|P1|NOT COMPLETED|Overall Study||3
633415|NCT00142597|1555744|P2|COMPLETED|Overall Study|N=10 completed PET imaging|22
633416|NCT00142597|1555745|P1|COMPLETED|Overall Study|N=10 completed PET imaging|20
633417|NCT00142597|1555744|P2|STARTED|Overall Study|N=10 underwent PET imaging|23
633418|NCT00142597|1555745|P1|STARTED|Overall Study|N=10 underwent PET imaging|23
633419|NCT00142506|1555753|P2|NOT COMPLETED|Overall Study||29
633420|NCT00142506|1555754|P1|NOT COMPLETED|Overall Study||72
633421|NCT00142506|1555753|P2|COMPLETED|Overall Study||77
633422|NCT00142506|1555754|P1|COMPLETED|Overall Study||112
633423|NCT00142506|1555753|P2|STARTED|Overall Study||106
633424|NCT00142506|1555754|P1|STARTED|Overall Study||184
633425|NCT00142415|1555766|P6|NOT COMPLETED|Overall Study||2
633426|NCT00142415|1555767|P5|NOT COMPLETED|Overall Study||1
633427|NCT00142415|1555768|P4|NOT COMPLETED|Overall Study||0
633428|NCT00142415|1555769|P3|NOT COMPLETED|Overall Study||0
633429|NCT00142415|1555770|P2|NOT COMPLETED|Overall Study||0
633430|NCT00142415|1555771|P1|NOT COMPLETED|Overall Study||0
633431|NCT00142415|1555766|P6|COMPLETED|Overall Study||6
633432|NCT00142415|1555767|P5|COMPLETED|Overall Study||2
633433|NCT00142415|1555768|P4|COMPLETED|Overall Study||3
633434|NCT00142415|1555769|P3|COMPLETED|Overall Study||6
633435|NCT00142415|1555770|P2|COMPLETED|Overall Study||3
633436|NCT00142415|1555771|P1|COMPLETED|Overall Study||3
633437|NCT00142415|1555766|P6|STARTED|Overall Study||8
633438|NCT00142415|1555767|P5|STARTED|Overall Study||3
633439|NCT00142415|1555768|P4|STARTED|Overall Study||3
633440|NCT00142415|1555769|P3|STARTED|Overall Study||6
633441|NCT00142415|1555770|P2|STARTED|Overall Study||3
633442|NCT00142415|1555771|P1|STARTED|Overall Study||3
633443|NCT00142298|1555809|P10|NOT COMPLETED|Overall Study||0
633444|NCT00142298|1555810|P9|NOT COMPLETED|Overall Study||5
633445|NCT00142298|1555811|P8|NOT COMPLETED|Overall Study||8
633446|NCT00142298|1555812|P7|NOT COMPLETED|Overall Study||8
633447|NCT00142298|1555813|P6|NOT COMPLETED|Overall Study||16
633448|NCT00142298|1555814|P5|NOT COMPLETED|Overall Study||10
633449|NCT00142298|1555815|P4|NOT COMPLETED|Overall Study||85
633450|NCT00142298|1555816|P3|NOT COMPLETED|Overall Study||33
633451|NCT00142298|1555817|P2|NOT COMPLETED|Overall Study||176
633452|NCT00142298|1555818|P1|NOT COMPLETED|Overall Study||160
633453|NCT00142298|1555809|P10|COMPLETED|Overall Study||13
633454|NCT00142298|1555810|P9|COMPLETED|Overall Study||52
633455|NCT00142298|1555811|P8|COMPLETED|Overall Study||58
633456|NCT00142298|1555812|P7|COMPLETED|Overall Study||15
633457|NCT00142298|1555813|P6|COMPLETED|Overall Study||10
633458|NCT00142298|1555814|P5|COMPLETED|Overall Study||46
633459|NCT00142298|1555815|P4|COMPLETED|Overall Study||121
633460|NCT00142298|1555816|P3|COMPLETED|Overall Study||90
633461|NCT00142298|1555817|P2|COMPLETED|Overall Study||456
633462|NCT00142298|1555818|P1|COMPLETED|Overall Study|Completed week 104/week 208.|507
633463|NCT00142298|1555809|P10|Per Protocol Population|Overall Study||13
633464|NCT00142298|1555810|P9|Per Protocol Population|Overall Study||56
633465|NCT00142298|1555811|P8|Per Protocol Population|Overall Study||64
633466|NCT00142298|1555812|P7|Per Protocol Population|Overall Study||19
633467|NCT00142298|1555813|P6|Per Protocol Population|Overall Study||25
633468|NCT00142298|1555814|P5|Per Protocol Population|Overall Study||50
633469|NCT00142298|1555815|P4|Per Protocol Population|Overall Study||202
633470|NCT00142298|1555816|P3|Per Protocol Population|Overall Study||120
633471|NCT00142298|1555817|P2|Per Protocol Population|Overall Study||606
633472|NCT00142298|1555818|P1|Per Protocol Population|Overall Study||635
633473|NCT00142298|1555809|P10|Safety Population|Overall Study||13
633474|NCT00142298|1555810|P9|Safety Population|Overall Study||57
633475|NCT00142298|1555811|P8|Safety Population|Overall Study||66
633476|NCT00142298|1555812|P7|Safety Population|Overall Study||23
633477|NCT00142298|1555813|P6|Safety Population|Overall Study||26
633478|NCT00142298|1555814|P5|Safety Population|Overall Study||50
633479|NCT00142298|1555815|P4|Safety Population|Overall Study||206
633480|NCT00142298|1555816|P3|Safety Population|Overall Study||122
633481|NCT00142298|1555817|P2|Safety Population|Overall Study||626
633482|NCT00142298|1555818|P1|Safety Population|Overall Study||655
633483|NCT00142298|1555809|P10|STARTED|Overall Study||13
633484|NCT00142298|1555810|P9|STARTED|Overall Study||57
633485|NCT00142298|1555811|P8|STARTED|Overall Study||66
633486|NCT00142298|1555812|P7|STARTED|Overall Study||23
633487|NCT00142298|1555813|P6|STARTED|Overall Study||26
633488|NCT00142298|1555814|P5|STARTED|Overall Study||56
633489|NCT00142298|1555815|P4|STARTED|Overall Study||206
633490|NCT00142298|1555816|P3|STARTED|Overall Study||123
633491|NCT00142298|1555817|P2|STARTED|Overall Study||632
633492|NCT00142298|1555818|P1|STARTED|Overall Study||667
633493|NCT00142168|1555840|P1|NOT COMPLETED|Overall Study||0
633494|NCT00142168|1555840|P1|COMPLETED|Overall Study||16
633495|NCT00142168|1555840|P1|STARTED|Overall Study||16
633496|NCT00142116|1555847|P1|NOT COMPLETED|Overall Study||0
633497|NCT00142116|1555847|P1|COMPLETED|Overall Study||25
633498|NCT00142116|1555847|P1|STARTED|Overall Study||25
633499|NCT00141921|1555852|P1|NOT COMPLETED|Overall Study||141
633500|NCT00141921|1555852|P1|COMPLETED|Overall Study||41
633501|NCT00141921|1555852|P1|Received Treatment|Overall Study||181
633502|NCT00141921|1555852|P1|STARTED|Overall Study||182
633503|NCT00141817|1555878|P4|NOT COMPLETED|Overall Study||0
633504|NCT00141817|1555879|P3|NOT COMPLETED|Overall Study||1
633505|NCT00141817|1555880|P2|NOT COMPLETED|Overall Study||0
633506|NCT00141817|1555881|P1|NOT COMPLETED|Overall Study||1
633507|NCT00141817|1555878|P4|COMPLETED|Overall Study||13
633508|NCT00141817|1555879|P3|COMPLETED|Overall Study||10
633509|NCT00141817|1555880|P2|COMPLETED|Overall Study||10
633510|NCT00141817|1555881|P1|COMPLETED|Overall Study||6
633511|NCT00141817|1555878|P4|STARTED|Overall Study||13
633512|NCT00141817|1555879|P3|STARTED|Overall Study||11
633513|NCT00141817|1555880|P2|STARTED|Overall Study||10
633514|NCT00141817|1555881|P1|STARTED|Overall Study||7
633515|NCT00141778|1555922|P3|NOT COMPLETED|Started Study Medication||4
633516|NCT00141778|1555923|P2|NOT COMPLETED|Started Study Medication||7
633517|NCT00141778|1555924|P1|NOT COMPLETED|Started Study Medication||2
633518|NCT00141778|1555922|P3|COMPLETED|Started Study Medication||143
633519|NCT00141778|1555923|P2|COMPLETED|Started Study Medication||144
633520|NCT00141778|1555924|P1|COMPLETED|Started Study Medication||145
633521|NCT00141778|1555922|P3|STARTED|Started Study Medication||147
633522|NCT00141778|1555923|P2|STARTED|Started Study Medication||151
633523|NCT00141778|1555924|P1|STARTED|Started Study Medication||147
633524|NCT00141778|1555922|P3|NOT COMPLETED|Randomization Prior to Study Med||6
633525|NCT00141778|1555923|P2|NOT COMPLETED|Randomization Prior to Study Med||2
633526|NCT00141778|1555924|P1|NOT COMPLETED|Randomization Prior to Study Med||5
633527|NCT00141778|1555922|P3|COMPLETED|Randomization Prior to Study Med||147
633528|NCT00141778|1555923|P2|COMPLETED|Randomization Prior to Study Med||151
633529|NCT00141778|1555924|P1|COMPLETED|Randomization Prior to Study Med||147
633530|NCT00141778|1555922|P3|STARTED|Randomization Prior to Study Med||153
633531|NCT00141778|1555923|P2|STARTED|Randomization Prior to Study Med||153
633532|NCT00141778|1555924|P1|STARTED|Randomization Prior to Study Med||152
633533|NCT00141765|1555962|P1|NOT COMPLETED|Overall Study||0
633534|NCT00141765|1555962|P1|COMPLETED|Overall Study||25
633535|NCT00141765|1555962|P1|STARTED|Overall Study||25
633536|NCT00141739|1555966|P1|NOT COMPLETED|Overall Study||0
633537|NCT00141739|1555966|P1|COMPLETED|Overall Study||100
633538|NCT00141739|1555966|P1|STARTED|Overall Study|Number of evaluable patients|100
633539|NCT00141726|1555977|P1|NOT COMPLETED|Overall Study||3
633540|NCT00141726|1555977|P1|COMPLETED|Overall Study||31
633541|NCT00141726|1555977|P1|STARTED|Overall Study||34
633542|NCT00141518|1555985|P3|NOT COMPLETED|Overall Study||6
633543|NCT00141518|1555986|P2|NOT COMPLETED|Overall Study||6
633544|NCT00141518|1555987|P1|NOT COMPLETED|Overall Study||16
633545|NCT00141518|1555985|P3|COMPLETED|Overall Study||12
633546|NCT00141518|1555986|P2|COMPLETED|Overall Study||16
633547|NCT00141518|1555987|P1|COMPLETED|Overall Study||21
633548|NCT00141518|1555985|P3|Full Analysis Sample|Overall Study||18
633549|NCT00141518|1555986|P2|Full Analysis Sample|Overall Study||22
633550|NCT00141518|1555987|P1|Full Analysis Sample|Overall Study||27
633551|NCT00141518|1555985|P3|Safety Sample|Overall Study||18
633552|NCT00141518|1555986|P2|Safety Sample|Overall Study||22
633553|NCT00141518|1555987|P1|Safety Sample|Overall Study||36
633554|NCT00141518|1555985|P3|STARTED|Overall Study||18
633555|NCT00141518|1555986|P2|STARTED|Overall Study||22
633556|NCT00141518|1555987|P1|STARTED|Overall Study||37
633557|NCT00141453|1556176|P2|NOT COMPLETED|Overall Study||5
633558|NCT00141453|1556177|P1|NOT COMPLETED|Overall Study||6
633559|NCT00141453|1556176|P2|COMPLETED|Overall Study||284
633560|NCT00141453|1556177|P1|COMPLETED|Overall Study||282
633561|NCT00141453|1556176|P2|STARTED|Overall Study||289
633562|NCT00141453|1556177|P1|STARTED|Overall Study||288
633563|NCT00141297|1556191|P10|NOT COMPLETED|Overall Study||6
633564|NCT00141297|1556192|P9|NOT COMPLETED|Overall Study||20
633565|NCT00141297|1556193|P8|NOT COMPLETED|Overall Study||4
633566|NCT00141297|1556194|P7|NOT COMPLETED|Overall Study||3
633567|NCT00141297|1556195|P6|NOT COMPLETED|Overall Study||3
633568|NCT00141297|1556196|P5|NOT COMPLETED|Overall Study||22
633569|NCT00141297|1556197|P4|NOT COMPLETED|Overall Study||3
633570|NCT00141297|1556198|P3|NOT COMPLETED|Overall Study||7
633571|NCT00141297|1556199|P2|NOT COMPLETED|Overall Study||3
633572|NCT00141297|1556200|P1|NOT COMPLETED|Overall Study||3
633573|NCT00141297|1556191|P10|COMPLETED|Overall Study||0
633574|NCT00141297|1556192|P9|COMPLETED|Overall Study||0
633575|NCT00141297|1556193|P8|COMPLETED|Overall Study||0
633576|NCT00141297|1556194|P7|COMPLETED|Overall Study||0
633577|NCT00141297|1556195|P6|COMPLETED|Overall Study||0
633578|NCT00141297|1556196|P5|COMPLETED|Overall Study||0
633579|NCT00141297|1556197|P4|COMPLETED|Overall Study||0
633580|NCT00141297|1556198|P3|COMPLETED|Overall Study||0
633581|NCT00141297|1556199|P2|COMPLETED|Overall Study||0
633582|NCT00141297|1556200|P1|COMPLETED|Overall Study||0
633583|NCT00141297|1556191|P10|STARTED|Overall Study||6
633584|NCT00141297|1556192|P9|STARTED|Overall Study||20
633585|NCT00141297|1556193|P8|STARTED|Overall Study||4
633586|NCT00141297|1556194|P7|STARTED|Overall Study||3
633587|NCT00141297|1556195|P6|STARTED|Overall Study||3
633588|NCT00141297|1556196|P5|STARTED|Overall Study||22
633589|NCT00141297|1556197|P4|STARTED|Overall Study||3
633590|NCT00141297|1556198|P3|STARTED|Overall Study||7
633591|NCT00141297|1556199|P2|STARTED|Overall Study||3
633592|NCT00141297|1556200|P1|STARTED|Overall Study||3
633593|NCT00141271|1556478|P3|NOT COMPLETED|Overall Study||57
633594|NCT00141271|1556479|P2|NOT COMPLETED|Overall Study||63
633595|NCT00141271|1556480|P1|NOT COMPLETED|Overall Study||80
633596|NCT00141271|1556478|P3|COMPLETED|Overall Study||111
633597|NCT00141271|1556479|P2|COMPLETED|Overall Study||102
633598|NCT00141271|1556480|P1|COMPLETED|Overall Study||91
633599|NCT00141271|1556478|P3|STARTED|Overall Study||168
633600|NCT00141271|1556479|P2|STARTED|Overall Study||165
633601|NCT00141271|1556480|P1|STARTED|Overall Study||171
633602|NCT00141219|1556601|P2|NOT COMPLETED|Overall Study||16
633603|NCT00141219|1556602|P1|NOT COMPLETED|Overall Study||24
633604|NCT00141219|1556601|P2|COMPLETED|Overall Study||62
633605|NCT00141219|1556602|P1|COMPLETED|Overall Study||138
633606|NCT00141219|1556601|P2|STARTED|Overall Study||78
633607|NCT00141219|1556602|P1|STARTED|Overall Study||162
633608|NCT00141115|1556652|P1|NOT COMPLETED|Overall Study||1
633609|NCT00141115|1556652|P1|COMPLETED|Overall Study||2
633610|NCT00141115|1556652|P1|STARTED|Overall Study||3
633611|NCT00141102|1556659|P2|NOT COMPLETED|Overall Study||625
633612|NCT00141102|1556660|P1|NOT COMPLETED|Overall Study||508
633613|NCT00141102|1556659|P2|COMPLETED|Overall Study||1621
633614|NCT00141102|1556660|P1|COMPLETED|Overall Study||1730
633615|NCT00141102|1556659|P2|Received Treatment|Overall Study||2237
633616|NCT00141102|1556660|P1|Received Treatment|Overall Study||2223
633617|NCT00141102|1556659|P2|STARTED|Overall Study||2246
633618|NCT00141102|1556660|P1|STARTED|Overall Study||2238
633619|NCT00141037|1556700|P2|NOT COMPLETED|Overall Study||18
633620|NCT00141037|1556701|P1|NOT COMPLETED|Overall Study||10
633621|NCT00141037|1556700|P2|COMPLETED|Overall Study|8 subjects had reduced follow-up|52
633622|NCT00141037|1556701|P1|COMPLETED|Overall Study|16 subjects had reduced follow-up|50
633623|NCT00141037|1556700|P2|STARTED|Overall Study||70
633624|NCT00141037|1556701|P1|STARTED|Overall Study||60
633625|NCT00140842|1556711|P2|NOT COMPLETED|Overall Study||0
633626|NCT00140842|1556712|P1|NOT COMPLETED|Overall Study||0
633627|NCT00140842|1556711|P2|COMPLETED|Overall Study||15
633628|NCT00140842|1556712|P1|COMPLETED|Overall Study||15
633629|NCT00140842|1556711|P2|STARTED|Overall Study||15
633630|NCT00140842|1556712|P1|STARTED|Overall Study||15
633631|NCT00140621|1556720|P1|NOT COMPLETED|Overall Study||0
633632|NCT00140621|1556720|P1|COMPLETED|Overall Study||6
633633|NCT00140621|1556720|P1|STARTED|Overall Study||6
633634|NCT00140556|1556730|P1|NOT COMPLETED|Chemoradiotherapy Period||0
633635|NCT00140556|1556730|P1|COMPLETED|Chemoradiotherapy Period||28
633636|NCT00140556|1556730|P1|STARTED|Chemoradiotherapy Period||28
633637|NCT00140556|1556730|P1|NOT COMPLETED|Pre Radiation Period: Avastin / Tarceva||0
633638|NCT00140556|1556730|P1|COMPLETED|Pre Radiation Period: Avastin / Tarceva||28
633639|NCT00140556|1556730|P1|STARTED|Pre Radiation Period: Avastin / Tarceva||28
633640|NCT00140426|1556736|P2|NOT COMPLETED|Overall Study||3
633641|NCT00140426|1556737|P1|NOT COMPLETED|Overall Study||0
633642|NCT00140426|1556736|P2|COMPLETED|Overall Study||16
633643|NCT00140426|1556737|P1|COMPLETED|Overall Study||22
633644|NCT00140426|1556736|P2|STARTED|Overall Study||19
633645|NCT00140426|1556737|P1|STARTED|Overall Study||22
633646|NCT00140413|1556770|P2|NOT COMPLETED|Overall Study||0
633647|NCT00140413|1556771|P1|NOT COMPLETED|Overall Study||3
633648|NCT00140413|1556770|P2|COMPLETED|Overall Study|Crossed over subjects were treated as controls for purpose of intent to treat analysis.|7
633649|NCT00140413|1556771|P1|COMPLETED|Overall Study||10
633650|NCT00140413|1556770|P2|Received at Least One Dose of GH|Overall Study|Controls were crossed over to GH if they met criteria for growth deceleration during the study.|3
633651|NCT00140413|1556771|P1|Received at Least One Dose of GH|Overall Study||13
633652|NCT00140413|1556770|P2|STARTED|Overall Study||7
633653|NCT00140413|1556771|P1|STARTED|Overall Study||13
633654|NCT00140244|1556778|P2|NOT COMPLETED|Intervention 2||2
633655|NCT00140244|1556779|P1|NOT COMPLETED|Intervention 2||0
633656|NCT00140244|1556778|P2|COMPLETED|Intervention 2||2
633657|NCT00140244|1556779|P1|COMPLETED|Intervention 2||3
633658|NCT00140244|1556778|P2|STARTED|Intervention 2||4
633659|NCT00140244|1556779|P1|STARTED|Intervention 2||3
633660|NCT00140244|1556778|P2|NOT COMPLETED|Washout||0
633661|NCT00140244|1556779|P1|NOT COMPLETED|Washout||0
633662|NCT00140244|1556778|P2|COMPLETED|Washout||4
633663|NCT00140244|1556779|P1|COMPLETED|Washout||3
633664|NCT00140244|1556778|P2|STARTED|Washout||4
633665|NCT00140244|1556779|P1|STARTED|Washout||3
633666|NCT00140244|1556778|P2|NOT COMPLETED|Intervention 1||0
633667|NCT00140244|1556779|P1|NOT COMPLETED|Intervention 1||0
633668|NCT00140244|1556778|P2|COMPLETED|Intervention 1||4
633669|NCT00140244|1556779|P1|COMPLETED|Intervention 1||3
633670|NCT00140244|1556778|P2|STARTED|Intervention 1||4
633671|NCT00140244|1556779|P1|STARTED|Intervention 1||3
633672|NCT00140231|1556811|P2|NOT COMPLETED|Fasting State With Leptin and Crossover||0
633673|NCT00140231|1556812|P1|NOT COMPLETED|Fasting State With Leptin and Crossover||0
633674|NCT00140231|1556811|P2|COMPLETED|Fasting State With Leptin and Crossover||6
633675|NCT00140231|1556812|P1|COMPLETED|Fasting State With Leptin and Crossover||7
633676|NCT00140231|1556811|P2|STARTED|Fasting State With Leptin and Crossover||6
633677|NCT00140231|1556812|P1|STARTED|Fasting State With Leptin and Crossover||7
633678|NCT00140231|1556811|P2|NOT COMPLETED|Washout 8 Weeks||0
633679|NCT00140231|1556812|P1|NOT COMPLETED|Washout 8 Weeks||0
633680|NCT00140231|1556811|P2|COMPLETED|Washout 8 Weeks||6
633681|NCT00140231|1556812|P1|COMPLETED|Washout 8 Weeks||7
633682|NCT00140231|1556811|P2|STARTED|Washout 8 Weeks||6
633683|NCT00140231|1556812|P1|STARTED|Washout 8 Weeks||7
633684|NCT00140231|1556811|P2|NOT COMPLETED|First Fasting State 3 Days With Placebo||0
633685|NCT00140231|1556812|P1|NOT COMPLETED|First Fasting State 3 Days With Placebo||0
633686|NCT00140231|1556811|P2|COMPLETED|First Fasting State 3 Days With Placebo||6
633687|NCT00140231|1556812|P1|COMPLETED|First Fasting State 3 Days With Placebo||7
633688|NCT00140231|1556811|P2|STARTED|First Fasting State 3 Days With Placebo||6
633689|NCT00140231|1556812|P1|STARTED|First Fasting State 3 Days With Placebo||7
633690|NCT00140231|1556811|P2|NOT COMPLETED|Washout 8weeks||0
633691|NCT00140231|1556812|P1|NOT COMPLETED|Washout 8weeks||0
633692|NCT00140231|1556811|P2|COMPLETED|Washout 8weeks||6
633693|NCT00140231|1556812|P1|COMPLETED|Washout 8weeks||7
633694|NCT00140231|1556811|P2|STARTED|Washout 8weeks||6
633695|NCT00140231|1556812|P1|STARTED|Washout 8weeks||7
633696|NCT00140231|1556811|P2|NOT COMPLETED|Fed State 1 Day- day5||0
633697|NCT00140231|1556812|P1|NOT COMPLETED|Fed State 1 Day- day5||0
633698|NCT00140231|1556811|P2|COMPLETED|Fed State 1 Day- day5||6
633699|NCT00140231|1556812|P1|COMPLETED|Fed State 1 Day- day5||7
633700|NCT00140231|1556811|P2|STARTED|Fed State 1 Day- day5||6
633701|NCT00140231|1556812|P1|STARTED|Fed State 1 Day- day5||7
633702|NCT00140140|1556831|P3|NOT COMPLETED|Overall Study||2
633703|NCT00140140|1556832|P2|NOT COMPLETED|Overall Study||2
633704|NCT00140140|1556833|P1|NOT COMPLETED|Overall Study||2
633705|NCT00140140|1556831|P3|COMPLETED|Overall Study|Progressive disease|4
633706|NCT00140140|1556832|P2|COMPLETED|Overall Study|Progressive disease|4
633707|NCT00140140|1556833|P1|COMPLETED|Overall Study|Progressive disease|2
633708|NCT00140140|1556831|P3|STARTED|Overall Study||6
633709|NCT00140140|1556832|P2|STARTED|Overall Study||6
633710|NCT00140140|1556833|P1|STARTED|Overall Study||4
633711|NCT00139997|1556872|P2|NOT COMPLETED|Overall Study||2
633712|NCT00139997|1556873|P1|NOT COMPLETED|Overall Study||1
633713|NCT00139997|1556872|P2|COMPLETED|Overall Study||9
633714|NCT00139997|1556873|P1|COMPLETED|Overall Study||14
633715|NCT00139997|1556872|P2|STARTED|Overall Study||11
633716|NCT00139997|1556873|P1|STARTED|Overall Study||15
633717|NCT00139776|1556883|P4|NOT COMPLETED|Period III||106
633718|NCT00139776|1556884|P3|NOT COMPLETED|Period III||76
633719|NCT00139776|1556885|P2|NOT COMPLETED|Period III||0
633720|NCT00139776|1556886|P1|NOT COMPLETED|Period III||0
633721|NCT00139776|1556883|P4|COMPLETED|Period III||321
633722|NCT00139776|1556884|P3|COMPLETED|Period III||355
633723|NCT00139776|1556885|P2|COMPLETED|Period III||0
633724|NCT00139776|1556886|P1|COMPLETED|Period III||0
633725|NCT00139776|1556883|P4|STARTED|Period III|Randomized 435: 8 participants not treated|427
633726|NCT00139776|1556884|P3|STARTED|Period III|Randomized 440: 9 participants not treated|431
633727|NCT00139776|1556885|P2|STARTED|Period III||0
633728|NCT00139776|1556886|P1|STARTED|Period III||0
633729|NCT00139776|1556883|P4|NOT COMPLETED|Period II||0
633730|NCT00139776|1556884|P3|NOT COMPLETED|Period II||0
633731|NCT00139776|1556885|P2|NOT COMPLETED|Period II||322
633732|NCT00139776|1556886|P1|NOT COMPLETED|Period II||0
633733|NCT00139776|1556883|P4|COMPLETED|Period II||0
633734|NCT00139776|1556884|P3|COMPLETED|Period II||0
633735|NCT00139776|1556885|P2|COMPLETED|Period II||875
633736|NCT00139776|1556886|P1|COMPLETED|Period II||0
633737|NCT00139776|1556883|P4|STARTED|Period II||0
633738|NCT00139776|1556884|P3|STARTED|Period II||0
633739|NCT00139776|1556885|P2|STARTED|Period II||1197
633740|NCT00139776|1556886|P1|STARTED|Period II||0
633741|NCT00139776|1556883|P4|NOT COMPLETED|Period I||0
633742|NCT00139776|1556884|P3|NOT COMPLETED|Period I||0
633743|NCT00139776|1556885|P2|NOT COMPLETED|Period I||0
633744|NCT00139776|1556886|P1|NOT COMPLETED|Period I||575
633745|NCT00139776|1556883|P4|COMPLETED|Period I||0
633746|NCT00139776|1556884|P3|COMPLETED|Period I||0
633747|NCT00139776|1556885|P2|COMPLETED|Period I||0
633748|NCT00139776|1556886|P1|COMPLETED|Period I||1197
633749|NCT00139776|1556883|P4|STARTED|Period I||0
633750|NCT00139776|1556884|P3|STARTED|Period I||0
633751|NCT00139776|1556885|P2|STARTED|Period I||0
633752|NCT00139776|1556886|P1|STARTED|Period I||1772
633753|NCT00139737|1556921|P1|NOT COMPLETED|Overall Study||341
633754|NCT00139737|1556921|P1|COMPLETED|Overall Study||3
633755|NCT00139737|1556921|P1|Received Treatment|Overall Study||331
633756|NCT00139737|1556921|P1|STARTED|Overall Study||344
633757|NCT00139659|1556927|P2|NOT COMPLETED|Overall Study||18
633758|NCT00139659|1556928|P1|NOT COMPLETED|Overall Study||40
633759|NCT00139659|1556927|P2|COMPLETED|Overall Study||123
633760|NCT00139659|1556928|P1|COMPLETED|Overall Study||106
633761|NCT00139659|1556927|P2|STARTED|Overall Study|1 subject randomized DC'd before receiving subcutaneous insulin and is not included in # of subjects|141
633762|NCT00139659|1556928|P1|STARTED|Overall Study|1 subject randomized was DC'd prior to receiving inhaled insulin but received subcutaneous insulin|146
633763|NCT00139477|1557006|P2|NOT COMPLETED|Second Intervention -6Months to 12Months||5
633764|NCT00139477|1557007|P1|NOT COMPLETED|Second Intervention -6Months to 12Months||5
633765|NCT00139477|1557006|P2|COMPLETED|Second Intervention -6Months to 12Months||18
633766|NCT00139477|1557007|P1|COMPLETED|Second Intervention -6Months to 12Months||14
633767|NCT00139477|1557006|P2|STARTED|Second Intervention -6Months to 12Months||23
633768|NCT00139477|1557007|P1|STARTED|Second Intervention -6Months to 12Months||19
633769|NCT00139477|1557006|P2|NOT COMPLETED|First Intervention -Baseline to 6Months||12
633770|NCT00139477|1557007|P1|NOT COMPLETED|First Intervention -Baseline to 6Months||12
633771|NCT00139477|1557006|P2|COMPLETED|First Intervention -Baseline to 6Months||23
633772|NCT00139477|1557007|P1|COMPLETED|First Intervention -Baseline to 6Months||19
633773|NCT00139477|1557006|P2|STARTED|First Intervention -Baseline to 6Months||35
633774|NCT00139477|1557007|P1|STARTED|First Intervention -Baseline to 6Months||31
633775|NCT00138671|1557029|P2|NOT COMPLETED|Overall Study||16
633776|NCT00138671|1557030|P1|NOT COMPLETED|Overall Study||13
633777|NCT00138671|1557029|P2|COMPLETED|Overall Study||30
633778|NCT00138671|1557030|P1|COMPLETED|Overall Study||46
633779|NCT00138671|1557029|P2|STARTED|Overall Study||46
633780|NCT00138671|1557030|P1|STARTED|Overall Study||59
633781|NCT00138658|1557080|P1|NOT COMPLETED|Overall Study||61
633782|NCT00138658|1557080|P1|COMPLETED|Overall Study||20
633783|NCT00138658|1557080|P1|STARTED|Overall Study||81
633784|NCT00138645|1557092|P2|NOT COMPLETED|Overall Study||7
633785|NCT00138645|1557093|P1|NOT COMPLETED|Overall Study||6
633786|NCT00138645|1557092|P2|COMPLETED|Overall Study||23
633787|NCT00138645|1557093|P1|COMPLETED|Overall Study||24
633788|NCT00138645|1557092|P2|STARTED|Overall Study||30
633789|NCT00138645|1557093|P1|STARTED|Overall Study||30
633790|NCT00138424|1557103|P4|NOT COMPLETED|Overall Study||0
633791|NCT00138424|1557104|P3|NOT COMPLETED|Overall Study||0
633792|NCT00138424|1557105|P2|NOT COMPLETED|Overall Study||1
633793|NCT00138424|1557106|P1|NOT COMPLETED|Overall Study||0
633794|NCT00138424|1557103|P4|COMPLETED|Overall Study||3
633795|NCT00138424|1557104|P3|COMPLETED|Overall Study||5
633796|NCT00138424|1557105|P2|COMPLETED|Overall Study||4
633797|NCT00138424|1557106|P1|COMPLETED|Overall Study||9
633798|NCT00138424|1557103|P4|STARTED|Overall Study||3
633799|NCT00138424|1557104|P3|STARTED|Overall Study||5
633800|NCT00138424|1557105|P2|STARTED|Overall Study||5
633801|NCT00138424|1557106|P1|STARTED|Overall Study||9
633802|NCT00138294|1557172|P1|NOT COMPLETED|Overall Study||0
633803|NCT00138294|1557172|P1|COMPLETED|Overall Study||29255
633804|NCT00138294|1557172|P1|STARTED|Overall Study||29255
633805|NCT00138203|1557182|P1|NOT COMPLETED|Overall Study||0
633806|NCT00138203|1557182|P1|COMPLETED|Overall Study||16
633807|NCT00138203|1557182|P1|STARTED|Overall Study||16
633808|NCT00138151|1557189|P1|NOT COMPLETED|Overall Study||4
633809|NCT00138151|1557189|P1|COMPLETED|Overall Study||29
633810|NCT00138151|1557189|P1|STARTED|Overall Study||33
633811|NCT00138125|1557195|P1|NOT COMPLETED|Overall Study||0
633812|NCT00138125|1557195|P1|COMPLETED|Overall Study||2
633813|NCT00138125|1557195|P1|STARTED|Overall Study||2
633814|NCT00138073|1557199|P1|NOT COMPLETED|Overall Study||55
633815|NCT00138073|1557199|P1|COMPLETED|Overall Study||0
633816|NCT00138073|1557199|P1|Pre-intervention Testing|Overall Study||55
633817|NCT00138073|1557199|P1|STARTED|Overall Study||55
633818|NCT00138034|1557206|P2|NOT COMPLETED|Overall Study||3
633819|NCT00138034|1557207|P1|NOT COMPLETED|Overall Study||3
633820|NCT00138034|1557206|P2|COMPLETED|Overall Study||20
633821|NCT00138034|1557207|P1|COMPLETED|Overall Study||23
633822|NCT00138034|1557206|P2|STARTED|Overall Study||23
633823|NCT00138034|1557207|P1|STARTED|Overall Study||26
633824|NCT00137969|1557217|P2|NOT COMPLETED|Overall Study||21
633825|NCT00137969|1557218|P1|NOT COMPLETED|Overall Study||67
633826|NCT00137969|1557217|P2|COMPLETED|Overall Study||67
633827|NCT00137969|1557218|P1|COMPLETED|Overall Study||107
633828|NCT00137969|1557217|P2|Received Study Drug|Overall Study||88
633829|NCT00137969|1557218|P1|Received Study Drug|Overall Study||169
633830|NCT00137969|1557217|P2|STARTED|Overall Study||88
633831|NCT00137969|1557218|P1|STARTED|Overall Study||174
633832|NCT00137631|1557240|P2|NOT COMPLETED|Overall Study||41
633833|NCT00137631|1557241|P1|NOT COMPLETED|Overall Study||37
633834|NCT00137631|1557240|P2|COMPLETED|Overall Study||133
633835|NCT00137631|1557241|P1|COMPLETED|Overall Study||127
633836|NCT00137631|1557240|P2|Completed 6-month Follow-up|Overall Study|8 participants who were lost to follow-up at 3-months were retained at 6-months|133
633837|NCT00137631|1557241|P1|Completed 6-month Follow-up|Overall Study|7 participants who were lost to follow-up at 3-months were retained at 6-months|127
633838|NCT00137631|1557240|P2|Complete 3-month Follow-up|Overall Study||125
633839|NCT00137631|1557241|P1|Complete 3-month Follow-up|Overall Study||120
633840|NCT00137631|1557240|P2|STARTED|Overall Study||174
633841|NCT00137631|1557241|P1|STARTED|Overall Study||164
633842|NCT00137449|1557257|P2|NOT COMPLETED|Overall Study||18
633843|NCT00137449|1557258|P1|NOT COMPLETED|Overall Study||16
633844|NCT00137449|1557257|P2|COMPLETED|Overall Study||12
633845|NCT00137449|1557258|P1|COMPLETED|Overall Study||14
633846|NCT00137449|1557257|P2|STARTED|Overall Study||30
633847|NCT00137449|1557258|P1|STARTED|Overall Study||30
633848|NCT00137436|1557295|P1|NOT COMPLETED|Overall Study||43
633849|NCT00137436|1557295|P1|COMPLETED|Overall Study||12
633850|NCT00137436|1557295|P1|STARTED|Overall Study|Phase 2 did not include 38 participants from Phase 1.|55
633851|NCT00137423|1557314|P2|NOT COMPLETED|Overall Study||44
633852|NCT00137423|1557315|P1|NOT COMPLETED|Overall Study||39
633853|NCT00137423|1557314|P2|COMPLETED|Overall Study||9
633854|NCT00137423|1557315|P1|COMPLETED|Overall Study||15
633855|NCT00137423|1557314|P2|STARTED|Overall Study||53
633856|NCT00137423|1557315|P1|STARTED|Overall Study||54
633857|NCT00137280|1557337|P2|NOT COMPLETED|Overall Study||55
633858|NCT00137280|1557338|P1|NOT COMPLETED|Overall Study||84
633859|NCT00137280|1557337|P2|COMPLETED|Overall Study||357
633860|NCT00137280|1557338|P1|COMPLETED|Overall Study||305
633861|NCT00137280|1557337|P2|STARTED|Overall Study||412
633862|NCT00137280|1557338|P1|STARTED|Overall Study||389
633863|NCT00137267|1557352|P2|NOT COMPLETED|Overall Study||21
633864|NCT00137267|1557353|P1|NOT COMPLETED|Overall Study||15
633865|NCT00137267|1557352|P2|COMPLETED|Overall Study||26
633866|NCT00137267|1557353|P1|COMPLETED|Overall Study||40
633867|NCT00137267|1557352|P2|STARTED|Overall Study||47
633868|NCT00137267|1557353|P1|STARTED|Overall Study||55
633869|NCT00137111|1557365|P4|NOT COMPLETED|Total Therapy||0
633870|NCT00137111|1557366|P3|NOT COMPLETED|Total Therapy||0
633871|NCT00137111|1557367|P2|NOT COMPLETED|Total Therapy||0
633872|NCT00137111|1557368|P1|NOT COMPLETED|Total Therapy||40
633873|NCT00137111|1557365|P4|COMPLETED|Total Therapy||0
633874|NCT00137111|1557366|P3|COMPLETED|Total Therapy||0
633875|NCT00137111|1557367|P2|COMPLETED|Total Therapy||0
633876|NCT00137111|1557368|P1|COMPLETED|Total Therapy||458
633877|NCT00137111|1557365|P4|STARTED|Total Therapy||0
633878|NCT00137111|1557366|P3|STARTED|Total Therapy||0
633879|NCT00137111|1557367|P2|STARTED|Total Therapy||0
633880|NCT00137111|1557368|P1|STARTED|Total Therapy||498
633881|NCT00137111|1557365|P4|NOT COMPLETED|Window Therapy||0
633882|NCT00137111|1557366|P3|NOT COMPLETED|Window Therapy||0
633883|NCT00137111|1557367|P2|NOT COMPLETED|Window Therapy||0
633884|NCT00137111|1557368|P1|NOT COMPLETED|Window Therapy||0
633885|NCT00137111|1557365|P4|COMPLETED|Window Therapy||142
633886|NCT00137111|1557366|P3|COMPLETED|Window Therapy||180
633887|NCT00137111|1557367|P2|COMPLETED|Window Therapy||176
633888|NCT00137111|1557368|P1|COMPLETED|Window Therapy||0
633889|NCT00137111|1557365|P4|STARTED|Window Therapy||142
633890|NCT00137111|1557366|P3|STARTED|Window Therapy||180
633891|NCT00137111|1557367|P2|STARTED|Window Therapy||176
633892|NCT00137111|1557368|P1|STARTED|Window Therapy||0
633893|NCT00137046|1557382|P2|NOT COMPLETED|Overall Study||93
633894|NCT00137046|1557383|P1|NOT COMPLETED|Overall Study||99
633895|NCT00137046|1557382|P2|COMPLETED|Overall Study||198
633896|NCT00137046|1557383|P1|COMPLETED|Overall Study|Completed subjects were those subjects who did not discontinue while on active drug.|192
633897|NCT00137046|1557382|P2|Received Study Treatment|Overall Study||290
633898|NCT00137046|1557383|P1|Received Study Treatment|Overall Study||290
633899|NCT00137046|1557382|P2|STARTED|Overall Study|One subject was randomized to subcutaneous insulin but never received treatment.|291
633900|NCT00137046|1557383|P1|STARTED|Overall Study|One subject was randomized to inhaled insulin but never received treatment.|291
633901|NCT00136955|1557431|P1|NOT COMPLETED|Overall Study||23
633902|NCT00136955|1557431|P1|COMPLETED|Overall Study||18
633903|NCT00136955|1557431|P1|STARTED|Overall Study||41
633904|NCT00136916|1557440|P2|NOT COMPLETED|Overall Study||104
633905|NCT00136916|1557441|P1|NOT COMPLETED|Overall Study||125
633906|NCT00136916|1557440|P2|COMPLETED|Overall Study|At study termination, active subjects completed end-of-study assessment and 3-month follow-up visit|212
633907|NCT00136916|1557441|P1|COMPLETED|Overall Study|At study termination, active subjects completed end-of-study assessment and 3-month follow-up visit|194
633908|NCT00136916|1557440|P2|Received Treatment|Overall Study||311
633909|NCT00136916|1557441|P1|Received Treatment|Overall Study||316
633910|NCT00136916|1557440|P2|STARTED|Overall Study||316
633911|NCT00136916|1557441|P1|STARTED|Overall Study||319
633912|NCT00136838|1557495|P2|NOT COMPLETED|Second Intervention ( 5 Days)||0
633913|NCT00136838|1557496|P1|NOT COMPLETED|Second Intervention ( 5 Days)||0
633914|NCT00136838|1557495|P2|COMPLETED|Second Intervention ( 5 Days)||6
633915|NCT00136838|1557496|P1|COMPLETED|Second Intervention ( 5 Days)||6
633916|NCT00136838|1557495|P2|STARTED|Second Intervention ( 5 Days)||6
633917|NCT00136838|1557496|P1|STARTED|Second Intervention ( 5 Days)||6
633918|NCT00136838|1557495|P2|NOT COMPLETED|First Intervention ( 5 Days)||0
633919|NCT00136838|1557496|P1|NOT COMPLETED|First Intervention ( 5 Days)||0
633920|NCT00136838|1557495|P2|COMPLETED|First Intervention ( 5 Days)||6
633921|NCT00136838|1557496|P1|COMPLETED|First Intervention ( 5 Days)||6
633922|NCT00136838|1557495|P2|STARTED|First Intervention ( 5 Days)||6
633923|NCT00136838|1557496|P1|STARTED|First Intervention ( 5 Days)||6
633924|NCT00136812|1557506|P2|NOT COMPLETED|Overall Study||0
633925|NCT00136812|1557507|P1|NOT COMPLETED|Overall Study||0
633926|NCT00136812|1557506|P2|COMPLETED|Overall Study||113
633927|NCT00136812|1557507|P1|COMPLETED|Overall Study||111
633928|NCT00136812|1557506|P2|STARTED|Overall Study||113
633929|NCT00136812|1557507|P1|STARTED|Overall Study||111
633930|NCT00136760|1557517|P4|NOT COMPLETED|Overall Study||0
633931|NCT00136760|1557518|P3|NOT COMPLETED|Overall Study||0
633932|NCT00136760|1557519|P2|NOT COMPLETED|Overall Study||0
633933|NCT00136760|1557520|P1|NOT COMPLETED|Overall Study||0
633934|NCT00136760|1557517|P4|COMPLETED|Overall Study||13
633935|NCT00136760|1557518|P3|COMPLETED|Overall Study||11
633936|NCT00136760|1557519|P2|COMPLETED|Overall Study||16
633937|NCT00136760|1557520|P1|COMPLETED|Overall Study||12
633938|NCT00136760|1557517|P4|STARTED|Overall Study||13
633939|NCT00136760|1557518|P3|STARTED|Overall Study||11
633940|NCT00136760|1557519|P2|STARTED|Overall Study||16
633941|NCT00136760|1557520|P1|STARTED|Overall Study||12
633942|NCT00136695|1557536|P2|NOT COMPLETED|Overall Study||8
633943|NCT00136695|1557537|P1|NOT COMPLETED|Overall Study||11
633944|NCT00136695|1557536|P2|COMPLETED|Overall Study||35
633945|NCT00136695|1557537|P1|COMPLETED|Overall Study||34
633946|NCT00136695|1557536|P2|STARTED|Overall Study||43
633947|NCT00136695|1557537|P1|STARTED|Overall Study||45
633948|NCT00136357|1557545|P2|NOT COMPLETED|Overall Study||2
633949|NCT00136357|1557546|P1|NOT COMPLETED|Overall Study||3
633950|NCT00136357|1557545|P2|COMPLETED|Overall Study||39
633951|NCT00136357|1557546|P1|COMPLETED|Overall Study||38
633952|NCT00136357|1557545|P2|STARTED|Overall Study||41
633953|NCT00136357|1557546|P1|STARTED|Overall Study||41
633954|NCT00136318|1557554|P2|NOT COMPLETED|Overall Study||7
633955|NCT00136318|1557555|P1|NOT COMPLETED|Overall Study||7
633956|NCT00136318|1557554|P2|COMPLETED|Overall Study||84
633957|NCT00136318|1557555|P1|COMPLETED|Overall Study|reached end-point of antiviral treatment|83
633958|NCT00136318|1557554|P2|STARTED|Overall Study|Took first dose of study medication|91
633959|NCT00136318|1557555|P1|STARTED|Overall Study|Took first dose of study medication|90
633960|NCT00136084|1557571|P2|NOT COMPLETED|Overall Study||42
633961|NCT00136084|1557572|P1|NOT COMPLETED|Overall Study||48
633962|NCT00136084|1557571|P2|COMPLETED|Overall Study||72
633963|NCT00136084|1557572|P1|COMPLETED|Overall Study||61
633964|NCT00136084|1557571|P2|STARTED|Overall Study||114
633965|NCT00136084|1557572|P1|STARTED|Overall Study||109
633966|NCT00135798|1557588|P3|NOT COMPLETED|Overall Study||0
633967|NCT00135798|1557589|P2|NOT COMPLETED|Overall Study||0
633968|NCT00135798|1557590|P1|NOT COMPLETED|Overall Study||0
633969|NCT00135798|1557588|P3|COMPLETED|Overall Study||32
633970|NCT00135798|1557589|P2|COMPLETED|Overall Study||31
633971|NCT00135798|1557590|P1|COMPLETED|Overall Study||16
633972|NCT00135798|1557588|P3|STARTED|Overall Study||32
633973|NCT00135798|1557589|P2|STARTED|Overall Study||31
633974|NCT00135798|1557590|P1|STARTED|Overall Study||16
633975|NCT00135694|1557609|P3|NOT COMPLETED|Overall Study||7
633976|NCT00135694|1557610|P2|NOT COMPLETED|Overall Study||21
633977|NCT00135694|1557611|P1|NOT COMPLETED|Overall Study||180
633978|NCT00135694|1557609|P3|COMPLETED|Overall Study||11
633979|NCT00135694|1557610|P2|COMPLETED|Overall Study||56
633980|NCT00135694|1557611|P1|COMPLETED|Overall Study|Subjects were assessed as ineligible for random assignment and subsequently terminated per protocol.|0
633981|NCT00135694|1557609|P3|STARTED|Overall Study||18
633982|NCT00135694|1557610|P2|STARTED|Overall Study||77
633983|NCT00135694|1557611|P1|STARTED|Overall Study||180
633984|NCT00135356|1557631|P2|NOT COMPLETED|Overall Study||9
633985|NCT00135356|1557632|P1|NOT COMPLETED|Overall Study||17
633986|NCT00135356|1557631|P2|COMPLETED|Overall Study||60
633987|NCT00135356|1557632|P1|COMPLETED|Overall Study||114
633988|NCT00135356|1557631|P2|Discontinued on or After Week 96 Visit|Overall Study||0
633989|NCT00135356|1557632|P1|Discontinued on or After Week 96 Visit|Overall Study||1
633990|NCT00135356|1557631|P2|Discontinued Prior to Week 96 Visit|Overall Study||9
633991|NCT00135356|1557632|P1|Discontinued Prior to Week 96 Visit|Overall Study||16
633992|NCT00135356|1557631|P2|STARTED|Overall Study|Number randomized and treated(1 randomized and never treated subject not included in this number.)|69
633993|NCT00135356|1557632|P1|STARTED|Overall Study|Number randomized and treated|131
633994|NCT00135330|1557675|P3|NOT COMPLETED|Overall Study||11
633995|NCT00135330|1557676|P2|NOT COMPLETED|Overall Study||13
633996|NCT00135330|1557677|P1|NOT COMPLETED|Overall Study||12
633997|NCT00135330|1557675|P3|COMPLETED|Overall Study||34
633998|NCT00135330|1557676|P2|COMPLETED|Overall Study||34
633999|NCT00135330|1557677|P1|COMPLETED|Overall Study||33
634000|NCT00135330|1557675|P3|STARTED|Overall Study||45
634001|NCT00135330|1557676|P2|STARTED|Overall Study||47
634002|NCT00135330|1557677|P1|STARTED|Overall Study||45
634003|NCT00135200|1557769|P1|NOT COMPLETED|Overall Study||0
634004|NCT00135200|1557769|P1|COMPLETED|Overall Study||16
634005|NCT00135200|1557769|P1|STARTED|Overall Study||16
634006|NCT00134901|1557776|P2|NOT COMPLETED|Overall Study||15
634007|NCT00134901|1557777|P1|NOT COMPLETED|Overall Study||17
634008|NCT00134901|1557776|P2|COMPLETED|Overall Study||27
634009|NCT00134901|1557777|P1|COMPLETED|Overall Study||22
634010|NCT00134901|1557776|P2|STARTED|Overall Study||42
634011|NCT00134901|1557777|P1|STARTED|Overall Study||39
634012|NCT00134784|1557789|P4|NOT COMPLETED|Overall Study||1
634013|NCT00134784|1557790|P3|NOT COMPLETED|Overall Study||2
634014|NCT00134784|1557791|P2|NOT COMPLETED|Overall Study||2
634015|NCT00134784|1557792|P1|NOT COMPLETED|Overall Study||2
634016|NCT00134784|1557789|P4|COMPLETED|Overall Study||37
634017|NCT00134784|1557790|P3|COMPLETED|Overall Study||35
634018|NCT00134784|1557791|P2|COMPLETED|Overall Study||36
634019|NCT00134784|1557792|P1|COMPLETED|Overall Study||27
634020|NCT00134784|1557789|P4|STARTED|Overall Study||38
634021|NCT00134784|1557790|P3|STARTED|Overall Study||37
634022|NCT00134784|1557791|P2|STARTED|Overall Study||38
634023|NCT00134784|1557792|P1|STARTED|Overall Study||29
634024|NCT00134719|1557802|P3|NOT COMPLETED|Fourth Dose Vaccination Phase||1
634025|NCT00134719|1557803|P2|NOT COMPLETED|Fourth Dose Vaccination Phase||3
634026|NCT00134719|1557804|P1|NOT COMPLETED|Fourth Dose Vaccination Phase||2
634027|NCT00134719|1557802|P3|COMPLETED|Fourth Dose Vaccination Phase||203
634028|NCT00134719|1557803|P2|COMPLETED|Fourth Dose Vaccination Phase||203
634029|NCT00134719|1557804|P1|COMPLETED|Fourth Dose Vaccination Phase||623
634030|NCT00134719|1557802|P3|STARTED|Fourth Dose Vaccination Phase||204
634031|NCT00134719|1557803|P2|STARTED|Fourth Dose Vaccination Phase||206
634032|NCT00134719|1557804|P1|STARTED|Fourth Dose Vaccination Phase||625
634033|NCT00134719|1557802|P3|NOT COMPLETED|Primary Vaccination Phase||5
634034|NCT00134719|1557803|P2|NOT COMPLETED|Primary Vaccination Phase||6
634035|NCT00134719|1557804|P1|NOT COMPLETED|Primary Vaccination Phase||14
634036|NCT00134719|1557802|P3|COMPLETED|Primary Vaccination Phase||216
634037|NCT00134719|1557803|P2|COMPLETED|Primary Vaccination Phase||215
634038|NCT00134719|1557804|P1|COMPLETED|Primary Vaccination Phase||647
634039|NCT00134719|1557802|P3|STARTED|Primary Vaccination Phase||221
634040|NCT00134719|1557803|P2|STARTED|Primary Vaccination Phase||221
634041|NCT00134719|1557804|P1|STARTED|Primary Vaccination Phase||661
634042|NCT00134563|1557935|P3|NOT COMPLETED|Overall Study||96
634043|NCT00134563|1557936|P2|NOT COMPLETED|Overall Study||92
634044|NCT00134563|1557937|P1|NOT COMPLETED|Overall Study||104
634045|NCT00134563|1557935|P3|COMPLETED|Overall Study|completed treatment period|263
634046|NCT00134563|1557936|P2|COMPLETED|Overall Study|completed treatment period|274
634047|NCT00134563|1557937|P1|COMPLETED|Overall Study|completed treatment period|259
634048|NCT00134563|1557935|P3|Treated|Overall Study|one participant received doses of Teriflunomide 7 mg|358
634049|NCT00134563|1557936|P2|Treated|Overall Study||365
634050|NCT00134563|1557937|P1|Treated|Overall Study|Two participants received doses of Teriflunomide 7 mg, one participant doses of Teriflunomide 14 mg|363
634051|NCT00134563|1557935|P3|STARTED|Overall Study|Randomized|359
634052|NCT00134563|1557936|P2|STARTED|Overall Study|Randomized|366
634053|NCT00134563|1557937|P1|STARTED|Overall Study|Randomized|363
634054|NCT00134381|1557960|P6|NOT COMPLETED|Overall Study||2
634055|NCT00134381|1557961|P5|NOT COMPLETED|Overall Study||0
634056|NCT00134381|1557962|P4|NOT COMPLETED|Overall Study||0
634057|NCT00134381|1557963|P3|NOT COMPLETED|Overall Study||0
634058|NCT00134381|1557964|P2|NOT COMPLETED|Overall Study||0
634059|NCT00134381|1557965|P1|NOT COMPLETED|Overall Study||0
634060|NCT00134381|1557960|P6|COMPLETED|Overall Study||29
634061|NCT00134381|1557961|P5|COMPLETED|Overall Study||31
634062|NCT00134381|1557962|P4|COMPLETED|Overall Study||2
634063|NCT00134381|1557963|P3|COMPLETED|Overall Study||1
634064|NCT00134381|1557964|P2|COMPLETED|Overall Study||2
634065|NCT00134381|1557965|P1|COMPLETED|Overall Study||1
634066|NCT00134381|1557960|P6|STARTED|Overall Study||31
634067|NCT00134381|1557961|P5|STARTED|Overall Study||31
634068|NCT00134381|1557962|P4|STARTED|Overall Study||2
634069|NCT00134381|1557963|P3|STARTED|Overall Study||1
634070|NCT00134381|1557964|P2|STARTED|Overall Study||2
634071|NCT00134381|1557965|P1|STARTED|Overall Study||1
634072|NCT00134056|1558000|P2|NOT COMPLETED|Eligible for Protocol Assigned Treatment||315
634073|NCT00134056|1558001|P1|NOT COMPLETED|Eligible for Protocol Assigned Treatment||327
634074|NCT00134056|1558000|P2|COMPLETED|Eligible for Protocol Assigned Treatment||185
634075|NCT00134056|1558001|P1|COMPLETED|Eligible for Protocol Assigned Treatment||169
634076|NCT00134056|1558000|P2|STARTED|Eligible for Protocol Assigned Treatment||500
634077|NCT00134056|1558001|P1|STARTED|Eligible for Protocol Assigned Treatment||496
634078|NCT00134056|1558000|P2|NOT COMPLETED|Randomization||20
634079|NCT00134056|1558001|P1|NOT COMPLETED|Randomization||22
634080|NCT00134056|1558000|P2|COMPLETED|Randomization||500
634081|NCT00134056|1558001|P1|COMPLETED|Randomization||496
634082|NCT00134056|1558000|P2|STARTED|Randomization||520
634083|NCT00134056|1558001|P1|STARTED|Randomization||518
634084|NCT00134043|1558023|P2|NOT COMPLETED|Overall Study||0
634085|NCT00134043|1558024|P1|NOT COMPLETED|Overall Study||0
634086|NCT00134043|1558023|P2|COMPLETED|Overall Study||3
634087|NCT00134043|1558024|P1|COMPLETED|Overall Study||16
634088|NCT00134043|1558023|P2|STARTED|Overall Study||3
634089|NCT00134043|1558024|P1|STARTED|Overall Study||16
634090|NCT00134004|1558029|P1|NOT COMPLETED|Overall Study||0
634091|NCT00134004|1558029|P1|COMPLETED|Overall Study||210
634092|NCT00134004|1558029|P1|STARTED|Overall Study||210
634093|NCT00133978|1558041|P4|NOT COMPLETED|Overall Study||2
634094|NCT00133978|1558042|P3|NOT COMPLETED|Overall Study||0
634095|NCT00133978|1558043|P2|NOT COMPLETED|Overall Study||1
634096|NCT00133978|1558044|P1|NOT COMPLETED|Overall Study||2
634097|NCT00133978|1558041|P4|COMPLETED|Overall Study||300
634098|NCT00133978|1558042|P3|COMPLETED|Overall Study||310
634099|NCT00133978|1558043|P2|COMPLETED|Overall Study||307
634100|NCT00133978|1558044|P1|COMPLETED|Overall Study||301
634101|NCT00133978|1558041|P4|STARTED|Overall Study||302
634102|NCT00133978|1558042|P3|STARTED|Overall Study||310
634103|NCT00133978|1558043|P2|STARTED|Overall Study||308
634104|NCT00133978|1558044|P1|STARTED|Overall Study||303
634105|NCT00133952|1558068|P2|NOT COMPLETED|Overall Study||28
634106|NCT00133952|1558069|P1|NOT COMPLETED|Overall Study||42
634107|NCT00133952|1558068|P2|COMPLETED|Overall Study||124
634108|NCT00133952|1558069|P1|COMPLETED|Overall Study||115
634109|NCT00133952|1558068|P2|Received at Least One Dose of Study Drug|Overall Study||149
634110|NCT00133952|1558069|P1|Received at Least One Dose of Study Drug|Overall Study||153
634111|NCT00133952|1558068|P2|STARTED|Overall Study||152
634112|NCT00133952|1558069|P1|STARTED|Overall Study||157
634113|NCT00133809|1558091|P1|NOT COMPLETED|Overall Study||0
634114|NCT00133809|1558091|P1|COMPLETED|Overall Study||8
634115|NCT00133809|1558091|P1|STARTED|Overall Study||8
634116|NCT00133705|1558100|P2|NOT COMPLETED|Overall Study||3
634117|NCT00133705|1558101|P1|NOT COMPLETED|Overall Study||2
634118|NCT00133705|1558100|P2|COMPLETED|Overall Study||17
634119|NCT00133705|1558101|P1|COMPLETED|Overall Study||20
634120|NCT00133705|1558100|P2|STARTED|Overall Study||20
634121|NCT00133705|1558101|P1|STARTED|Overall Study||22
634122|NCT00133575|1558114|P7|NOT COMPLETED|Overall Study||3
634123|NCT00133575|1558115|P6|NOT COMPLETED|Overall Study||1
634124|NCT00133575|1558116|P5|NOT COMPLETED|Overall Study||4
634125|NCT00133575|1558117|P4|NOT COMPLETED|Overall Study||1
634126|NCT00133575|1558118|P3|NOT COMPLETED|Overall Study||2
634127|NCT00133575|1558119|P2|NOT COMPLETED|Overall Study||0
634128|NCT00133575|1558120|P1|NOT COMPLETED|Overall Study||0
634129|NCT00133575|1558114|P7|COMPLETED|Overall Study||9
634130|NCT00133575|1558115|P6|COMPLETED|Overall Study||9
634131|NCT00133575|1558116|P5|COMPLETED|Overall Study||6
634132|NCT00133575|1558117|P4|COMPLETED|Overall Study||9
634133|NCT00133575|1558118|P3|COMPLETED|Overall Study||8
634134|NCT00133575|1558119|P2|COMPLETED|Overall Study||10
634135|NCT00133575|1558120|P1|COMPLETED|Overall Study||10
634136|NCT00133575|1558114|P7|STARTED|Overall Study||12
634137|NCT00133575|1558115|P6|STARTED|Overall Study||10
634138|NCT00133575|1558116|P5|STARTED|Overall Study||10
634139|NCT00133575|1558117|P4|STARTED|Overall Study||10
634140|NCT00133575|1558118|P3|STARTED|Overall Study||10
634141|NCT00133575|1558119|P2|STARTED|Overall Study||10
634142|NCT00133575|1558120|P1|STARTED|Overall Study||10
634143|NCT00132873|1558227|P1|NOT COMPLETED|Overall Study||9
634144|NCT00132873|1558227|P1|COMPLETED|Overall Study||50
634145|NCT00132873|1558227|P1|STARTED|Overall Study||59
634146|NCT00132808|1558235|P3|NOT COMPLETED|Stratum II||9
634147|NCT00132808|1558236|P2|NOT COMPLETED|Stratum II||15
634148|NCT00132808|1558237|P1|NOT COMPLETED|Stratum II||8
634149|NCT00132808|1558235|P3|COMPLETED|Stratum II||116
634150|NCT00132808|1558236|P2|COMPLETED|Stratum II||96
634151|NCT00132808|1558237|P1|COMPLETED|Stratum II||113
634152|NCT00132808|1558235|P3|STARTED|Stratum II||125
634153|NCT00132808|1558236|P2|STARTED|Stratum II||111
634154|NCT00132808|1558237|P1|STARTED|Stratum II||121
634155|NCT00132808|1558235|P3|NOT COMPLETED|Stratum I||5
634156|NCT00132808|1558236|P2|NOT COMPLETED|Stratum I||12
634157|NCT00132808|1558237|P1|NOT COMPLETED|Stratum I||9
634158|NCT00132808|1558235|P3|COMPLETED|Stratum I||72
634159|NCT00132808|1558236|P2|COMPLETED|Stratum I||58
634160|NCT00132808|1558237|P1|COMPLETED|Stratum I||68
634161|NCT00132808|1558235|P3|STARTED|Stratum I||77
634162|NCT00132808|1558236|P2|STARTED|Stratum I||70
634163|NCT00132808|1558237|P1|STARTED|Stratum I||77
634164|NCT00132769|1558262|P2|NOT COMPLETED|Overall Study||11
634165|NCT00132769|1558263|P1|NOT COMPLETED|Overall Study||11
634166|NCT00132769|1558262|P2|COMPLETED|Overall Study||42
634167|NCT00132769|1558263|P1|COMPLETED|Overall Study||42
634168|NCT00132769|1558262|P2|STARTED|Overall Study||53
634169|NCT00132769|1558263|P1|STARTED|Overall Study||53
634170|NCT00132730|1558289|P6|NOT COMPLETED|Period V - Open-label Extension (EXT2)||2
634171|NCT00132730|1558290|P5|NOT COMPLETED|Period V - Open-label Extension (EXT2)||7
634172|NCT00132730|1558291|P4|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
634173|NCT00132730|1558292|P3|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
634174|NCT00132730|1558293|P2|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
634175|NCT00132730|1558294|P1|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
634176|NCT00132730|1558289|P6|COMPLETED|Period V - Open-label Extension (EXT2)||0
634177|NCT00132730|1558290|P5|COMPLETED|Period V - Open-label Extension (EXT2)||0
634178|NCT00132730|1558291|P4|COMPLETED|Period V - Open-label Extension (EXT2)||0
634179|NCT00132730|1558292|P3|COMPLETED|Period V - Open-label Extension (EXT2)||0
634180|NCT00132730|1558293|P2|COMPLETED|Period V - Open-label Extension (EXT2)||0
634181|NCT00132730|1558294|P1|COMPLETED|Period V - Open-label Extension (EXT2)||0
634182|NCT00132730|1558289|P6|STARTED|Period V - Open-label Extension (EXT2)|Not all participants who completed Period IV entered Period V|2
634183|NCT00132730|1558290|P5|STARTED|Period V - Open-label Extension (EXT2)|Not all participants who completed Period IV entered Period V|7
634184|NCT00132730|1558291|P4|STARTED|Period V - Open-label Extension (EXT2)||0
634185|NCT00132730|1558292|P3|STARTED|Period V - Open-label Extension (EXT2)||0
634186|NCT00132730|1558293|P2|STARTED|Period V - Open-label Extension (EXT2)||0
634187|NCT00132730|1558294|P1|STARTED|Period V - Open-label Extension (EXT2)||0
634188|NCT00132730|1558289|P6|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||68
634189|NCT00132730|1558290|P5|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||179
634190|NCT00132730|1558291|P4|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
634191|NCT00132730|1558292|P3|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
634192|NCT00132730|1558293|P2|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
634193|NCT00132730|1558294|P1|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
634194|NCT00132730|1558289|P6|COMPLETED|Period IV - Open-label Extension (EXT2)||3
634195|NCT00132730|1558290|P5|COMPLETED|Period IV - Open-label Extension (EXT2)||8
634196|NCT00132730|1558291|P4|COMPLETED|Period IV - Open-label Extension (EXT2)||0
634197|NCT00132730|1558292|P3|COMPLETED|Period IV - Open-label Extension (EXT2)||0
634198|NCT00132730|1558293|P2|COMPLETED|Period IV - Open-label Extension (EXT2)||0
634199|NCT00132730|1558294|P1|COMPLETED|Period IV - Open-label Extension (EXT2)||0
634200|NCT00132730|1558289|P6|STARTED|Period IV - Open-label Extension (EXT2)|Includes paricipants from Period III. Not all eligible participants entered EXT2|71
634201|NCT00132730|1558290|P5|STARTED|Period IV - Open-label Extension (EXT2)|Includes participants from Period III. Not all eligible participants entered EXT2|187
634202|NCT00132730|1558291|P4|STARTED|Period IV - Open-label Extension (EXT2)||0
634203|NCT00132730|1558292|P3|STARTED|Period IV - Open-label Extension (EXT2)||0
634204|NCT00132730|1558293|P2|STARTED|Period IV - Open-label Extension (EXT2)||0
634205|NCT00132730|1558294|P1|STARTED|Period IV - Open-label Extension (EXT2)||0
634206|NCT00132730|1558289|P6|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
634207|NCT00132730|1558290|P5|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
634208|NCT00132730|1558291|P4|NOT COMPLETED|Period III - Blinded Extension (EXT1)||25
634209|NCT00132730|1558292|P3|NOT COMPLETED|Period III - Blinded Extension (EXT1)||82
634210|NCT00132730|1558293|P2|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
634211|NCT00132730|1558294|P1|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
634212|NCT00132730|1558289|P6|COMPLETED|Period III - Blinded Extension (EXT1)||0
634213|NCT00132730|1558290|P5|COMPLETED|Period III - Blinded Extension (EXT1)||0
634214|NCT00132730|1558291|P4|COMPLETED|Period III - Blinded Extension (EXT1)||82
634215|NCT00132730|1558292|P3|COMPLETED|Period III - Blinded Extension (EXT1)||235
634216|NCT00132730|1558293|P2|COMPLETED|Period III - Blinded Extension (EXT1)||0
634217|NCT00132730|1558294|P1|COMPLETED|Period III - Blinded Extension (EXT1)||0
634218|NCT00132730|1558289|P6|STARTED|Period III - Blinded Extension (EXT1)||0
634219|NCT00132730|1558290|P5|STARTED|Period III - Blinded Extension (EXT1)||0
634220|NCT00132730|1558291|P4|STARTED|Period III - Blinded Extension (EXT1)|Not all eligible participants entered EXT1|107
634221|NCT00132730|1558292|P3|STARTED|Period III - Blinded Extension (EXT1)|Includes all MK-0873 participants from Period II. Not all eligible participants entered EXT1|317
634222|NCT00132730|1558293|P2|STARTED|Period III - Blinded Extension (EXT1)||0
634223|NCT00132730|1558294|P1|STARTED|Period III - Blinded Extension (EXT1)||0
634224|NCT00132730|1558289|P6|NOT COMPLETED|Period II - 12-week Treatment (Base)||0
634225|NCT00132730|1558290|P5|NOT COMPLETED|Period II - 12-week Treatment (Base)||0
634226|NCT00132730|1558291|P4|NOT COMPLETED|Period II - 12-week Treatment (Base)||22
634227|NCT00132730|1558292|P3|NOT COMPLETED|Period II - 12-week Treatment (Base)||18
634228|NCT00132730|1558293|P2|NOT COMPLETED|Period II - 12-week Treatment (Base)||15
634229|NCT00132730|1558294|P1|NOT COMPLETED|Period II - 12-week Treatment (Base)||23
634230|NCT00132730|1558289|P6|COMPLETED|Period II - 12-week Treatment (Base)||0
634231|NCT00132730|1558290|P5|COMPLETED|Period II - 12-week Treatment (Base)||0
634232|NCT00132730|1558291|P4|COMPLETED|Period II - 12-week Treatment (Base)||131
634233|NCT00132730|1558292|P3|COMPLETED|Period II - 12-week Treatment (Base)||135
634234|NCT00132730|1558293|P2|COMPLETED|Period II - 12-week Treatment (Base)||133
634235|NCT00132730|1558294|P1|COMPLETED|Period II - 12-week Treatment (Base)||127
634236|NCT00132730|1558289|P6|STARTED|Period II - 12-week Treatment (Base)||0
634237|NCT00132730|1558290|P5|STARTED|Period II - 12-week Treatment (Base)||0
634238|NCT00132730|1558291|P4|STARTED|Period II - 12-week Treatment (Base)||153
634239|NCT00132730|1558292|P3|STARTED|Period II - 12-week Treatment (Base)||153
634240|NCT00132730|1558293|P2|STARTED|Period II - 12-week Treatment (Base)||148
634241|NCT00132730|1558294|P1|STARTED|Period II - 12-week Treatment (Base)||150
634242|NCT00132730|1558289|P6|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
634243|NCT00132730|1558290|P5|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
634244|NCT00132730|1558291|P4|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
634245|NCT00132730|1558292|P3|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
634246|NCT00132730|1558293|P2|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
634247|NCT00132730|1558294|P1|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
634248|NCT00132730|1558289|P6|COMPLETED|Period I - Placebo Run-in (Base)||0
634249|NCT00132730|1558290|P5|COMPLETED|Period I - Placebo Run-in (Base)||0
634250|NCT00132730|1558291|P4|COMPLETED|Period I - Placebo Run-in (Base)||153
634251|NCT00132730|1558292|P3|COMPLETED|Period I - Placebo Run-in (Base)||153
634252|NCT00132730|1558293|P2|COMPLETED|Period I - Placebo Run-in (Base)||148
634253|NCT00132730|1558294|P1|COMPLETED|Period I - Placebo Run-in (Base)||150
634254|NCT00132730|1558289|P6|STARTED|Period I - Placebo Run-in (Base)||0
634255|NCT00132730|1558290|P5|STARTED|Period I - Placebo Run-in (Base)||0
634256|NCT00132730|1558291|P4|STARTED|Period I - Placebo Run-in (Base)||153
634257|NCT00132730|1558292|P3|STARTED|Period I - Placebo Run-in (Base)||153
634258|NCT00132730|1558293|P2|STARTED|Period I - Placebo Run-in (Base)||148
634259|NCT00132730|1558294|P1|STARTED|Period I - Placebo Run-in (Base)||150
634260|NCT00132691|1558338|P2|NOT COMPLETED|Overall Study||12
634261|NCT00132691|1558339|P1|NOT COMPLETED|Overall Study||11
634262|NCT00132691|1558338|P2|COMPLETED|Overall Study|114 participants completed the 2-year anniversary visit|114
634263|NCT00132691|1558339|P1|COMPLETED|Overall Study|118 participants completed the 2-year anniversary visit|118
634264|NCT00132691|1558338|P2|STARTED|Overall Study|126 participants were assigned to systemic treatment; 121 received systemic therapy|126
634265|NCT00132691|1558339|P1|STARTED|Overall Study|129 participants were assigned to implant; 122 received implant|129
634266|NCT00132678|1558379|P3|NOT COMPLETED|Period IV (Double-Blind Treatment)||0
634267|NCT00132678|1558380|P2|NOT COMPLETED|Period IV (Double-Blind Treatment)||40
634268|NCT00132678|1558381|P1|NOT COMPLETED|Period IV (Double-Blind Treatment)||37
634269|NCT00132678|1558379|P3|COMPLETED|Period IV (Double-Blind Treatment)||0
634270|NCT00132678|1558380|P2|COMPLETED|Period IV (Double-Blind Treatment)||109
634271|NCT00132678|1558381|P1|COMPLETED|Period IV (Double-Blind Treatment)||117
634272|NCT00132678|1558379|P3|STARTED|Period IV (Double-Blind Treatment)||0
634273|NCT00132678|1558380|P2|STARTED|Period IV (Double-Blind Treatment)||149
634274|NCT00132678|1558381|P1|STARTED|Period IV (Double-Blind Treatment)||154
634275|NCT00132678|1558379|P3|NOT COMPLETED|Period III (Open-Label Stabilization)||0
634276|NCT00132678|1558380|P2|NOT COMPLETED|Period III (Open-Label Stabilization)||0
634277|NCT00132678|1558381|P1|NOT COMPLETED|Period III (Open-Label Stabilization)||198
634278|NCT00132678|1558379|P3|COMPLETED|Period III (Open-Label Stabilization)||0
634279|NCT00132678|1558380|P2|COMPLETED|Period III (Open-Label Stabilization)||0
634280|NCT00132678|1558381|P1|COMPLETED|Period III (Open-Label Stabilization)||303
634281|NCT00132678|1558379|P3|STARTED|Period III (Open-Label Stabilization)||0
634282|NCT00132678|1558380|P2|STARTED|Period III (Open-Label Stabilization)||0
634283|NCT00132678|1558381|P1|STARTED|Period III (Open-Label Stabilization)||501
634284|NCT00132678|1558379|P3|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||58
634285|NCT00132678|1558380|P2|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0
634286|NCT00132678|1558381|P1|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0
634287|NCT00132678|1558379|P3|COMPLETED|Period II (Open-Label Oral Risperidone)||382
634288|NCT00132678|1558380|P2|COMPLETED|Period II (Open-Label Oral Risperidone)||0
634289|NCT00132678|1558381|P1|COMPLETED|Period II (Open-Label Oral Risperidone)||0
634290|NCT00132678|1558379|P3|STARTED|Period II (Open-Label Oral Risperidone)||440
634291|NCT00132678|1558380|P2|STARTED|Period II (Open-Label Oral Risperidone)||0
634292|NCT00132678|1558381|P1|STARTED|Period II (Open-Label Oral Risperidone)||0
634293|NCT00132496|1558395|P2|NOT COMPLETED|Overall Study||2
634294|NCT00132496|1558396|P1|NOT COMPLETED|Overall Study||2
634295|NCT00132496|1558395|P2|COMPLETED|Overall Study||55
634296|NCT00132496|1558396|P1|COMPLETED|Overall Study||52
634297|NCT00132496|1558395|P2|STARTED|Overall Study||57
634298|NCT00132496|1558396|P1|STARTED|Overall Study||54
634299|NCT00132314|1558404|P2|NOT COMPLETED|Overall Study||72
634300|NCT00132314|1558405|P1|NOT COMPLETED|Overall Study||73
634301|NCT00132314|1558404|P2|COMPLETED|Overall Study||120
634302|NCT00132314|1558405|P1|COMPLETED|Overall Study||117
634303|NCT00132314|1558404|P2|Completed Baseline Visit, Provided SSN|Overall Study|This is the ITT cohort.|182
634304|NCT00132314|1558405|P1|Completed Baseline Visit, Provided SSN|Overall Study|This is the ITT cohort|187
634305|NCT00132314|1558404|P2|Received Treatment|Overall Study||185
634306|NCT00132314|1558405|P1|Received Treatment|Overall Study||188
634307|NCT00132314|1558404|P2|STARTED|Overall Study||192
634308|NCT00132314|1558405|P1|STARTED|Overall Study||190
634309|NCT00132301|1558415|P2|NOT COMPLETED|Overall Study||13
634310|NCT00132301|1558416|P1|NOT COMPLETED|Overall Study||20
634311|NCT00132301|1558415|P2|COMPLETED|Overall Study||144
634312|NCT00132301|1558416|P1|COMPLETED|Overall Study||121
634313|NCT00132301|1558415|P2|STARTED|Overall Study||157
634314|NCT00132301|1558416|P1|STARTED|Overall Study||141
634315|NCT00132132|1558424|P2|NOT COMPLETED|Overall Study||2
634316|NCT00132132|1558425|P1|NOT COMPLETED|Overall Study||7
634317|NCT00132132|1558424|P2|COMPLETED|Overall Study||13
634318|NCT00132132|1558425|P1|COMPLETED|Overall Study||8
634319|NCT00132132|1558424|P2|STARTED|Overall Study||15
634320|NCT00132132|1558425|P1|STARTED|Overall Study||15
634321|NCT00132028|1558433|P1|NOT COMPLETED|Overall Study||27
634322|NCT00132028|1558433|P1|COMPLETED|Overall Study|"Since there was no maximum number of cycles, patients could not complete treatment."|0
634323|NCT00132028|1558433|P1|Eligible and Began Protocol Therapy|Overall Study||25
634324|NCT00132028|1558433|P1|Eligible|Overall Study||25
634325|NCT00132028|1558433|P1|STARTED|Overall Study||27
634326|NCT00132002|1558439|P1|NOT COMPLETED|Overall Study||0
634327|NCT00132002|1558439|P1|COMPLETED|Overall Study||14
634328|NCT00132002|1558439|P1|STARTED|Overall Study||14
634329|NCT00131937|1558445|P1|NOT COMPLETED|Overall Study||14
634330|NCT00131937|1558445|P1|COMPLETED|Overall Study||0
634331|NCT00131937|1558445|P1|STARTED|Overall Study||14
634332|NCT00131911|1558453|P2|NOT COMPLETED|Overall Study||0
634333|NCT00131911|1558454|P1|NOT COMPLETED|Overall Study||1
634334|NCT00131911|1558453|P2|COMPLETED|Overall Study||42
634335|NCT00131911|1558454|P1|COMPLETED|Overall Study||50
634336|NCT00131911|1558453|P2|STARTED|Overall Study||42
634337|NCT00131911|1558454|P1|STARTED|Overall Study||51
634338|NCT00131885|1558471|P4|NOT COMPLETED|Time 2: Second Intervention||0
634339|NCT00131885|1558472|P3|NOT COMPLETED|Time 2: Second Intervention||0
634340|NCT00131885|1558473|P2|NOT COMPLETED|Time 2: Second Intervention||0
634341|NCT00131885|1558474|P1|NOT COMPLETED|Time 2: Second Intervention||0
634342|NCT00131885|1558471|P4|COMPLETED|Time 2: Second Intervention||9
634343|NCT00131885|1558472|P3|COMPLETED|Time 2: Second Intervention||9
634344|NCT00131885|1558473|P2|COMPLETED|Time 2: Second Intervention||9
634345|NCT00131885|1558474|P1|COMPLETED|Time 2: Second Intervention||9
634346|NCT00131885|1558471|P4|STARTED|Time 2: Second Intervention||9
634347|NCT00131885|1558472|P3|STARTED|Time 2: Second Intervention||9
634348|NCT00131885|1558473|P2|STARTED|Time 2: Second Intervention||9
634349|NCT00131885|1558474|P1|STARTED|Time 2: Second Intervention||9
634350|NCT00131885|1558471|P4|NOT COMPLETED|Time 1: First Intervention||0
634351|NCT00131885|1558472|P3|NOT COMPLETED|Time 1: First Intervention||0
634352|NCT00131885|1558473|P2|NOT COMPLETED|Time 1: First Intervention||0
634353|NCT00131885|1558474|P1|NOT COMPLETED|Time 1: First Intervention||0
634354|NCT00131885|1558471|P4|COMPLETED|Time 1: First Intervention||9
634355|NCT00131885|1558472|P3|COMPLETED|Time 1: First Intervention||9
634356|NCT00131885|1558473|P2|COMPLETED|Time 1: First Intervention||9
634357|NCT00131885|1558474|P1|COMPLETED|Time 1: First Intervention||9
634358|NCT00131885|1558471|P4|STARTED|Time 1: First Intervention||9
634359|NCT00131885|1558472|P3|STARTED|Time 1: First Intervention||9
634360|NCT00131885|1558473|P2|STARTED|Time 1: First Intervention||9
634361|NCT00131885|1558474|P1|STARTED|Time 1: First Intervention||9
634362|NCT00131677|1558506|P2|NOT COMPLETED|Overall Study||39
634363|NCT00131677|1558507|P1|NOT COMPLETED|Overall Study||30
634364|NCT00131677|1558506|P2|COMPLETED|Overall Study||160
634365|NCT00131677|1558507|P1|COMPLETED|Overall Study||171
634366|NCT00131677|1558506|P2|STARTED|Overall Study|199 randomized to placebo; 99 to start immediately and 100 after a 9 month delay.|199
634367|NCT00131677|1558507|P1|STARTED|Overall Study|201 randomized to active drug; 101 to start immediately and 100 after a 9 month delay.|201
634368|NCT00131664|1558524|P6|NOT COMPLETED|Second Period (Additional Drug Added)||3
634369|NCT00131664|1558525|P5|NOT COMPLETED|Second Period (Additional Drug Added)||1
634370|NCT00131664|1558526|P4|NOT COMPLETED|Second Period (Additional Drug Added)||2
634371|NCT00131664|1558527|P3|NOT COMPLETED|Second Period (Additional Drug Added)||3
634372|NCT00131664|1558528|P2|NOT COMPLETED|Second Period (Additional Drug Added)||4
634373|NCT00131664|1558529|P1|NOT COMPLETED|Second Period (Additional Drug Added)||9
634374|NCT00131664|1558524|P6|COMPLETED|Second Period (Additional Drug Added)||22
634375|NCT00131664|1558525|P5|COMPLETED|Second Period (Additional Drug Added)||15
634376|NCT00131664|1558526|P4|COMPLETED|Second Period (Additional Drug Added)||19
634377|NCT00131664|1558527|P3|COMPLETED|Second Period (Additional Drug Added)||76
634378|NCT00131664|1558528|P2|COMPLETED|Second Period (Additional Drug Added)||97
634379|NCT00131664|1558529|P1|COMPLETED|Second Period (Additional Drug Added)||81
634380|NCT00131664|1558524|P6|STARTED|Second Period (Additional Drug Added)||25
634381|NCT00131664|1558525|P5|STARTED|Second Period (Additional Drug Added)||16
634382|NCT00131664|1558526|P4|STARTED|Second Period (Additional Drug Added)||21
634383|NCT00131664|1558527|P3|STARTED|Second Period (Additional Drug Added)|25 had added Amaryl at Month 6|79
634384|NCT00131664|1558528|P2|STARTED|Second Period (Additional Drug Added)|16 had added Amaryl at Month 6|101
634385|NCT00131664|1558529|P1|STARTED|Second Period (Additional Drug Added)|21 had added Metformin at Month 6|90
634386|NCT00131664|1558524|P6|NOT COMPLETED|First Period (First 6 Months)||0
634387|NCT00131664|1558525|P5|NOT COMPLETED|First Period (First 6 Months)||0
634388|NCT00131664|1558526|P4|NOT COMPLETED|First Period (First 6 Months)||0
634389|NCT00131664|1558527|P3|NOT COMPLETED|First Period (First 6 Months)||16
634390|NCT00131664|1558528|P2|NOT COMPLETED|First Period (First 6 Months)||18
634391|NCT00131664|1558529|P1|NOT COMPLETED|First Period (First 6 Months)||25
634392|NCT00131664|1558524|P6|COMPLETED|First Period (First 6 Months)||0
634393|NCT00131664|1558525|P5|COMPLETED|First Period (First 6 Months)||0
634394|NCT00131664|1558526|P4|COMPLETED|First Period (First 6 Months)||0
634395|NCT00131664|1558527|P3|COMPLETED|First Period (First 6 Months)||104
634396|NCT00131664|1558528|P2|COMPLETED|First Period (First 6 Months)||117
634397|NCT00131664|1558529|P1|COMPLETED|First Period (First 6 Months)||111
634398|NCT00131664|1558524|P6|STARTED|First Period (First 6 Months)||0
634399|NCT00131664|1558525|P5|STARTED|First Period (First 6 Months)||0
634400|NCT00131664|1558526|P4|STARTED|First Period (First 6 Months)||0
634401|NCT00131664|1558527|P3|STARTED|First Period (First 6 Months)||120
634402|NCT00131664|1558528|P2|STARTED|First Period (First 6 Months)||135
634403|NCT00131664|1558529|P1|STARTED|First Period (First 6 Months)||136
634404|NCT00131573|1558590|P2|NOT COMPLETED|Overall Study||26
634405|NCT00131573|1558591|P1|NOT COMPLETED|Overall Study||33
634406|NCT00131573|1558590|P2|COMPLETED|Overall Study||13
634407|NCT00131573|1558591|P1|COMPLETED|Overall Study||13
634408|NCT00131573|1558590|P2|STARTED|Overall Study||39
634409|NCT00131573|1558591|P1|STARTED|Overall Study||46
634410|NCT00131508|1558601|P2|NOT COMPLETED|Overall Study||8
634411|NCT00131508|1558602|P1|NOT COMPLETED|Overall Study||3
634412|NCT00131508|1558601|P2|COMPLETED|Overall Study||5
634413|NCT00131508|1558602|P1|COMPLETED|Overall Study||9
634414|NCT00131508|1558601|P2|STARTED|Overall Study||13
634415|NCT00131508|1558602|P1|STARTED|Overall Study||12
634416|NCT00131456|1558626|P2|NOT COMPLETED|Overall Study||20
634417|NCT00131456|1558627|P1|NOT COMPLETED|Overall Study||19
634418|NCT00131456|1558626|P2|COMPLETED|Overall Study||31
634419|NCT00131456|1558627|P1|COMPLETED|Overall Study||33
634420|NCT00131456|1558626|P2|STARTED|Overall Study||51
634421|NCT00131456|1558627|P1|STARTED|Overall Study||52
634422|NCT00131378|1558637|P4|NOT COMPLETED|Overall Study||9
634423|NCT00131378|1558638|P3|NOT COMPLETED|Overall Study||10
634424|NCT00131378|1558639|P2|NOT COMPLETED|Overall Study||18
634425|NCT00131378|1558640|P1|NOT COMPLETED|Overall Study||11
634426|NCT00131378|1558637|P4|COMPLETED|Overall Study||21
634427|NCT00131378|1558638|P3|COMPLETED|Overall Study||22
634428|NCT00131378|1558639|P2|COMPLETED|Overall Study||22
634429|NCT00131378|1558640|P1|COMPLETED|Overall Study||29
634430|NCT00131378|1558637|P4|STARTED|Overall Study||30
634431|NCT00131378|1558638|P3|STARTED|Overall Study||32
634432|NCT00131378|1558639|P2|STARTED|Overall Study||40
634433|NCT00131378|1558640|P1|STARTED|Overall Study||40
634434|NCT00131352|1558664|P2|NOT COMPLETED|Repeat Treatment Period||0
634435|NCT00131352|1558665|P1|NOT COMPLETED|Repeat Treatment Period||2
634436|NCT00131352|1558664|P2|COMPLETED|Repeat Treatment Period||0
634437|NCT00131352|1558665|P1|COMPLETED|Repeat Treatment Period||158
634438|NCT00131352|1558664|P2|STARTED|Repeat Treatment Period||0
634439|NCT00131352|1558665|P1|STARTED|Repeat Treatment Period|Safety population: 77 Synvisc + 83 Saline Control participants from the Initial Treatment period.|160
634440|NCT00131352|1558664|P2|NOT COMPLETED|Initial Treatment Period||12
634441|NCT00131352|1558665|P1|NOT COMPLETED|Initial Treatment Period||9
634442|NCT00131352|1558664|P2|COMPLETED|Initial Treatment Period||118
634443|NCT00131352|1558665|P1|COMPLETED|Initial Treatment Period||114
634444|NCT00131352|1558664|P2|Intent to Treat Population|Initial Treatment Period||129
634445|NCT00131352|1558665|P1|Intent to Treat Population|Initial Treatment Period||124
634446|NCT00131352|1558664|P2|STARTED|Initial Treatment Period|Safety population|130
634447|NCT00131352|1558665|P1|STARTED|Initial Treatment Period|Safety population|123
634448|NCT00131248|1558687|P2|NOT COMPLETED|Intervention 3 (4-day Course)||0
634449|NCT00131248|1558688|P1|NOT COMPLETED|Intervention 3 (4-day Course)||0
634450|NCT00131248|1558687|P2|COMPLETED|Intervention 3 (4-day Course)||9
634451|NCT00131248|1558688|P1|COMPLETED|Intervention 3 (4-day Course)||8
634452|NCT00131248|1558687|P2|STARTED|Intervention 3 (4-day Course)||9
634453|NCT00131248|1558688|P1|STARTED|Intervention 3 (4-day Course)||8
634454|NCT00131248|1558687|P2|NOT COMPLETED|Washout 2 (24 Hours)||0
634455|NCT00131248|1558688|P1|NOT COMPLETED|Washout 2 (24 Hours)||0
634456|NCT00131248|1558687|P2|COMPLETED|Washout 2 (24 Hours)||9
634457|NCT00131248|1558688|P1|COMPLETED|Washout 2 (24 Hours)||8
634458|NCT00131248|1558687|P2|STARTED|Washout 2 (24 Hours)||9
634459|NCT00131248|1558688|P1|STARTED|Washout 2 (24 Hours)||8
634460|NCT00131248|1558687|P2|NOT COMPLETED|Intervention 2 (7-day Course)||0
634461|NCT00131248|1558688|P1|NOT COMPLETED|Intervention 2 (7-day Course)||0
634462|NCT00131248|1558687|P2|COMPLETED|Intervention 2 (7-day Course)||9
634463|NCT00131248|1558688|P1|COMPLETED|Intervention 2 (7-day Course)||8
634464|NCT00131248|1558687|P2|STARTED|Intervention 2 (7-day Course)||9
634465|NCT00131248|1558688|P1|STARTED|Intervention 2 (7-day Course)||8
634466|NCT00131248|1558687|P2|NOT COMPLETED|Washout (24 Hour)||0
634467|NCT00131248|1558688|P1|NOT COMPLETED|Washout (24 Hour)||0
634468|NCT00131248|1558687|P2|COMPLETED|Washout (24 Hour)||9
634469|NCT00131248|1558688|P1|COMPLETED|Washout (24 Hour)||8
634470|NCT00131248|1558687|P2|STARTED|Washout (24 Hour)||9
634471|NCT00131248|1558688|P1|STARTED|Washout (24 Hour)||8
634472|NCT00131248|1558687|P2|NOT COMPLETED|Intervention 1 (3-day Course)||0
634473|NCT00131248|1558688|P1|NOT COMPLETED|Intervention 1 (3-day Course)||1
634474|NCT00131248|1558687|P2|COMPLETED|Intervention 1 (3-day Course)||9
634475|NCT00131248|1558688|P1|COMPLETED|Intervention 1 (3-day Course)||8
634476|NCT00131248|1558687|P2|STARTED|Intervention 1 (3-day Course)||9
634477|NCT00131248|1558688|P1|STARTED|Intervention 1 (3-day Course)||9
634478|NCT00130923|1558696|P2|NOT COMPLETED|Overall Study||14
634479|NCT00130923|1558697|P1|NOT COMPLETED|Overall Study||13
634480|NCT00130923|1558696|P2|COMPLETED|Overall Study||32
634481|NCT00130923|1558697|P1|COMPLETED|Overall Study||36
634482|NCT00130923|1558696|P2|STARTED|Overall Study||46
634483|NCT00130923|1558697|P1|STARTED|Overall Study||49
634484|NCT00130832|1558705|P2|NOT COMPLETED|Overall Study||17
634485|NCT00130832|1558706|P1|NOT COMPLETED|Overall Study||16
634486|NCT00130832|1558705|P2|COMPLETED|Overall Study|Those who received all 3 doses; last 2 blood draws ~42 days postdose 3 of RotaTeq™ and postdose OPV|346
634487|NCT00130832|1558706|P1|COMPLETED|Overall Study|Those who received all 3 doses of concomitant RotaTeq™/ OPV with blood draw ~42 days postdose 3|356
634488|NCT00130832|1558705|P2|STARTED|Overall Study||363
634489|NCT00130832|1558706|P1|STARTED|Overall Study||372
634490|NCT00130793|1558718|P2|NOT COMPLETED|Overall Study||4
634491|NCT00130793|1558719|P1|NOT COMPLETED|Overall Study||3
634492|NCT00130793|1558718|P2|COMPLETED|Overall Study|Subject received vaccine, completed blood draws, returned VRC at Week 4|181
634493|NCT00130793|1558719|P1|COMPLETED|Overall Study|Subject received vaccine, completed blood draws, returned vaccination report card (VRC) at Week 4|180
634494|NCT00130793|1558718|P2|Vaccinated|Overall Study||185
634495|NCT00130793|1558719|P1|Vaccinated|Overall Study|One subject was allocated but not vaccinated.|182
634496|NCT00130793|1558718|P2|STARTED|Overall Study||185
634497|NCT00130793|1558719|P1|STARTED|Overall Study||183
634498|NCT00130780|1558731|P2|NOT COMPLETED|Overall Study||0
634499|NCT00130780|1558732|P1|NOT COMPLETED|Overall Study||0
634500|NCT00130780|1558731|P2|COMPLETED|Overall Study||20
634501|NCT00130780|1558732|P1|COMPLETED|Overall Study||51
634502|NCT00130780|1558731|P2|STARTED|Overall Study||20
634503|NCT00130780|1558732|P1|STARTED|Overall Study||51
634504|NCT00130728|1558740|P2|NOT COMPLETED|Overall Study||213
634505|NCT00130728|1558741|P1|NOT COMPLETED|Overall Study||211
634506|NCT00130728|1558740|P2|COMPLETED|Overall Study||104
634507|NCT00130728|1558741|P1|COMPLETED|Overall Study||108
634508|NCT00130728|1558740|P2|Received Study Drug (Safety Population)|Overall Study||313
634509|NCT00130728|1558741|P1|Received Study Drug (Safety Population)|Overall Study||313
634510|NCT00130728|1558740|P2|STARTED|Overall Study||317
634511|NCT00130728|1558741|P1|STARTED|Overall Study||319
634512|NCT00130689|1558753|P1|NOT COMPLETED|Overall Study||43
634513|NCT00130689|1558753|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
634514|NCT00130689|1558753|P1|Treated|Overall Study||35
634515|NCT00130689|1558753|P1|Eligible|Overall Study||37
634516|NCT00130689|1558753|P1|STARTED|Overall Study||43
634517|NCT00130637|1558757|P1|NOT COMPLETED|Overall Study||3
634518|NCT00130637|1558757|P1|COMPLETED|Overall Study||3
634519|NCT00130637|1558757|P1|STARTED|Overall Study||6
634520|NCT00130520|1558762|P1|NOT COMPLETED|Overall Study||39
634521|NCT00130520|1558762|P1|COMPLETED|Overall Study||1
634522|NCT00130520|1558762|P1|Completion of at Least One Cycle|Overall Study||39
634523|NCT00130520|1558762|P1|STARTED|Overall Study|85 women were screened for eligibility, 56 consented, 40 treated.|40
634524|NCT00130286|1558772|P4|NOT COMPLETED|Overall Study||2
634525|NCT00130286|1558773|P3|NOT COMPLETED|Overall Study||4
634526|NCT00130286|1558774|P2|NOT COMPLETED|Overall Study||3
634527|NCT00130286|1558775|P1|NOT COMPLETED|Overall Study||0
634528|NCT00130286|1558772|P4|COMPLETED|Overall Study||17
634529|NCT00130286|1558773|P3|COMPLETED|Overall Study||13
634530|NCT00130286|1558774|P2|COMPLETED|Overall Study||16
634531|NCT00130286|1558775|P1|COMPLETED|Overall Study||22
634532|NCT00130286|1558772|P4|STARTED|Overall Study||19
634533|NCT00130286|1558773|P3|STARTED|Overall Study||17
634534|NCT00130286|1558774|P2|STARTED|Overall Study||19
634535|NCT00130286|1558775|P1|STARTED|Overall Study||22
634536|NCT00130247|1558795|P2|NOT COMPLETED|Overall Study||4
634537|NCT00130247|1558796|P1|NOT COMPLETED|Overall Study||2
634538|NCT00130247|1558795|P2|COMPLETED|Overall Study||194
634539|NCT00130247|1558796|P1|COMPLETED|Overall Study||194
634540|NCT00130247|1558795|P2|STARTED|Overall Study||198
634541|NCT00130247|1558796|P1|STARTED|Overall Study||196
634542|NCT00130208|1558814|P2|NOT COMPLETED|Washout Period (8 Weeks)||12
634543|NCT00130208|1558815|P1|NOT COMPLETED|Washout Period (8 Weeks)||6
634544|NCT00130208|1558814|P2|COMPLETED|Washout Period (8 Weeks)||490
634545|NCT00130208|1558815|P1|COMPLETED|Washout Period (8 Weeks)||494
634546|NCT00130208|1558814|P2|STARTED|Washout Period (8 Weeks)||502
634547|NCT00130208|1558815|P1|STARTED|Washout Period (8 Weeks)||500
634548|NCT00130208|1558814|P2|NOT COMPLETED|Maintenance Period (26 Weeks)||30
634549|NCT00130208|1558815|P1|NOT COMPLETED|Maintenance Period (26 Weeks)||24
634550|NCT00130208|1558814|P2|COMPLETED|Maintenance Period (26 Weeks)||502
634551|NCT00130208|1558815|P1|COMPLETED|Maintenance Period (26 Weeks)||500
634552|NCT00130208|1558814|P2|Valid Albumin Creatinine Ratio|Maintenance Period (26 Weeks)||494
634553|NCT00130208|1558815|P1|Valid Albumin Creatinine Ratio|Maintenance Period (26 Weeks)||492
634554|NCT00130208|1558814|P2|STARTED|Maintenance Period (26 Weeks)||532
634555|NCT00130208|1558815|P1|STARTED|Maintenance Period (26 Weeks)||524
634556|NCT00130117|1558827|P2|NOT COMPLETED|Overall Study||3
634557|NCT00130117|1558828|P1|NOT COMPLETED|Overall Study||4
634558|NCT00130117|1558827|P2|COMPLETED|Overall Study||6
634559|NCT00130117|1558828|P1|COMPLETED|Overall Study||7
634560|NCT00130117|1558827|P2|STARTED|Overall Study||9
634561|NCT00130117|1558828|P1|STARTED|Overall Study||11
634562|NCT00130039|1558851|P2|NOT COMPLETED|Overall Study||18
634563|NCT00130039|1558852|P1|NOT COMPLETED|Overall Study||30
634564|NCT00130039|1558851|P2|COMPLETED|Overall Study|full analysis set|207
634565|NCT00130039|1558852|P1|COMPLETED|Overall Study|full analysis set|202
634566|NCT00130039|1558851|P2|STARTED|Overall Study||225
634567|NCT00130039|1558852|P1|STARTED|Overall Study||232
634568|NCT00129974|1558868|P1|NOT COMPLETED|Overall Study||1
634569|NCT00129974|1558868|P1|COMPLETED|Overall Study||0
634570|NCT00129974|1558868|P1|STARTED|Overall Study||1
634571|NCT00129961|1558875|P2|NOT COMPLETED|Overall Study||23
634572|NCT00129961|1558876|P1|NOT COMPLETED|Overall Study||19
634573|NCT00129961|1558875|P2|COMPLETED|Overall Study||24
634574|NCT00129961|1558876|P1|COMPLETED|Overall Study||20
634575|NCT00129961|1558875|P2|STARTED|Overall Study||47
634576|NCT00129961|1558876|P1|STARTED|Overall Study||39
634577|NCT00129766|1558912|P2|NOT COMPLETED|Overall Study||59
634578|NCT00129766|1558913|P1|NOT COMPLETED|Overall Study||60
634579|NCT00129766|1558912|P2|COMPLETED|Overall Study||3270
634580|NCT00129766|1558913|P1|COMPLETED|Overall Study||3246
634581|NCT00129766|1558912|P2|STARTED|Overall Study||3329
634582|NCT00129766|1558913|P1|STARTED|Overall Study||3306
634583|NCT00129727|1558951|P1|NOT COMPLETED|Overall Study||5
634584|NCT00129727|1558951|P1|COMPLETED|Overall Study||57
634585|NCT00129727|1558951|P1|STARTED|Overall Study||62
634586|NCT00129623|1558959|P2|NOT COMPLETED|Overall Study||12
634587|NCT00129623|1558960|P1|NOT COMPLETED|Overall Study||10
634588|NCT00129623|1558959|P2|COMPLETED|Overall Study||65
634589|NCT00129623|1558960|P1|COMPLETED|Overall Study||73
634590|NCT00129623|1558959|P2|Intent-to-treat (ITT)/ Safety Population|Overall Study||77
634591|NCT00129623|1558960|P1|Intent-to-treat (ITT)/ Safety Population|Overall Study||83
634592|NCT00129623|1558959|P2|STARTED|Overall Study||77
634593|NCT00129623|1558960|P1|STARTED|Overall Study||83
634594|NCT00129545|1558985|P3|NOT COMPLETED|Overall Study||111
634595|NCT00129545|1558986|P2|NOT COMPLETED|Overall Study||164
634596|NCT00129545|1558987|P1|NOT COMPLETED|Overall Study||26
634597|NCT00129545|1558985|P3|COMPLETED|Overall Study||133
634598|NCT00129545|1558986|P2|COMPLETED|Overall Study||299
634599|NCT00129545|1558987|P1|COMPLETED|Overall Study||67
634600|NCT00129545|1558985|P3|STARTED|Overall Study||244
634601|NCT00129545|1558986|P2|STARTED|Overall Study|2:1 randomization WATCHMAN to warfarin|463
634602|NCT00129545|1558987|P1|STARTED|Overall Study||93
634603|NCT00129480|1558999|P2|NOT COMPLETED|Overall Study||0
634604|NCT00129480|1559000|P1|NOT COMPLETED|Overall Study||0
634605|NCT00129480|1558999|P2|COMPLETED|Overall Study||214
634606|NCT00129480|1559000|P1|COMPLETED|Overall Study||187
634607|NCT00129480|1558999|P2|STARTED|Overall Study||214
634608|NCT00129480|1559000|P1|STARTED|Overall Study||187
634609|NCT00129467|1559008|P2|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||0
634610|NCT00129467|1559009|P1|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||2
634611|NCT00129467|1559008|P2|COMPLETED|Open Label for SSRI+Methylphenidate Arm||0
634612|NCT00129467|1559009|P1|COMPLETED|Open Label for SSRI+Methylphenidate Arm||2
634613|NCT00129467|1559008|P2|STARTED|Open Label for SSRI+Methylphenidate Arm||0
634614|NCT00129467|1559009|P1|STARTED|Open Label for SSRI+Methylphenidate Arm|Eligible if in methylphenidate arm & had 50% reduction in Montgomery-Asberg Depression Rating score|4
634615|NCT00129467|1559008|P2|NOT COMPLETED|Received Intervention||4
634616|NCT00129467|1559009|P1|NOT COMPLETED|Received Intervention||6
634617|NCT00129467|1559008|P2|COMPLETED|Received Intervention||13
634618|NCT00129467|1559009|P1|COMPLETED|Received Intervention||9
634619|NCT00129467|1559008|P2|STARTED|Received Intervention||17
634620|NCT00129467|1559009|P1|STARTED|Received Intervention||15
634621|NCT00129441|1559017|P2|NOT COMPLETED|Overall Study||0
634622|NCT00129441|1559018|P1|NOT COMPLETED|Overall Study||0
634623|NCT00129441|1559017|P2|COMPLETED|Overall Study||6
634624|NCT00129441|1559018|P1|COMPLETED|Overall Study||9
634625|NCT00129441|1559017|P2|Year 1, Visit 8|Overall Study||6
634626|NCT00129441|1559018|P1|Year 1, Visit 8|Overall Study||9
634627|NCT00129441|1559017|P2|Week 26, Visit 7|Overall Study||6
634628|NCT00129441|1559018|P1|Week 26, Visit 7|Overall Study||9
634629|NCT00129441|1559017|P2|Week 5, Visit 6|Overall Study||6
634630|NCT00129441|1559018|P1|Week 5, Visit 6|Overall Study||9
634631|NCT00129441|1559017|P2|Week 4, Visit 5|Overall Study||6
634632|NCT00129441|1559018|P1|Week 4, Visit 5|Overall Study||9
634633|NCT00129441|1559017|P2|Week 3, Visit 4|Overall Study||6
634634|NCT00129441|1559018|P1|Week 3, Visit 4|Overall Study||9
634635|NCT00129441|1559017|P2|Week 2, Visit 3|Overall Study||6
634636|NCT00129441|1559018|P1|Week 2, Visit 3|Overall Study||9
634637|NCT00129441|1559017|P2|Week 1, Visit 2|Overall Study||6
634638|NCT00129441|1559018|P1|Week 1, Visit 2|Overall Study||9
634639|NCT00129441|1559017|P2|Baseline, Visit 1|Overall Study||6
634640|NCT00129441|1559018|P1|Baseline, Visit 1|Overall Study|Baseline # only includes those who completed 4-week trial (one L-830982 subject did not complete).|9
634641|NCT00129441|1559017|P2|STARTED|Overall Study||6
634642|NCT00129441|1559018|P1|STARTED|Overall Study||9
634643|NCT00129402|1559040|P7|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||6
634644|NCT00129402|1559041|P6|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
634645|NCT00129402|1559042|P5|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
634646|NCT00129402|1559043|P4|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
634647|NCT00129402|1559044|P3|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
634648|NCT00129402|1559045|P2|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
634649|NCT00129402|1559046|P1|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
634650|NCT00129402|1559040|P7|COMPLETED|Start Period3 to End Period3(Week 34-53)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|222
634651|NCT00129402|1559041|P6|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
634652|NCT00129402|1559042|P5|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
634653|NCT00129402|1559043|P4|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
634654|NCT00129402|1559044|P3|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
634655|NCT00129402|1559045|P2|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
634656|NCT00129402|1559046|P1|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
634657|NCT00129402|1559040|P7|STARTED|Start Period3 to End Period3(Week 34-53)|In Period 3, all subjects from Period 1 and Period 2 were combined into one treatment group.|228
634658|NCT00129402|1559041|P6|STARTED|Start Period3 to End Period3(Week 34-53)||0
634659|NCT00129402|1559042|P5|STARTED|Start Period3 to End Period3(Week 34-53)||0
634660|NCT00129402|1559043|P4|STARTED|Start Period3 to End Period3(Week 34-53)||0
634661|NCT00129402|1559044|P3|STARTED|Start Period3 to End Period3(Week 34-53)||0
634662|NCT00129402|1559045|P2|STARTED|Start Period3 to End Period3(Week 34-53)||0
634663|NCT00129402|1559046|P1|STARTED|Start Period3 to End Period3(Week 34-53)||0
634664|NCT00129402|1559040|P7|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
634665|NCT00129402|1559041|P6|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||5
634666|NCT00129402|1559042|P5|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
634667|NCT00129402|1559043|P4|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
634668|NCT00129402|1559044|P3|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||8
634669|NCT00129402|1559045|P2|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
634670|NCT00129402|1559046|P1|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
634671|NCT00129402|1559040|P7|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
634672|NCT00129402|1559041|P6|COMPLETED|Start Period2 to End Period2 (Week 7-33)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|113
634673|NCT00129402|1559042|P5|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
634674|NCT00129402|1559043|P4|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
634675|NCT00129402|1559044|P3|COMPLETED|Start Period2 to End Period2 (Week 7-33)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|114
634676|NCT00129402|1559045|P2|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
634677|NCT00129402|1559046|P1|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
634678|NCT00129402|1559040|P7|STARTED|Start Period2 to End Period2 (Week 7-33)||0
634679|NCT00129402|1559041|P6|STARTED|Start Period2 to End Period2 (Week 7-33)|# of subjects were combined from the 3 arms in Period 1 who received simvastatin monotherapy|118
634680|NCT00129402|1559042|P5|STARTED|Start Period2 to End Period2 (Week 7-33)||0
634681|NCT00129402|1559043|P4|STARTED|Start Period2 to End Period2 (Week 7-33)||0
634682|NCT00129402|1559044|P3|STARTED|Start Period2 to End Period2 (Week 7-33)|# of subjects were combined from the 3 arms in Period 1 who received ezetimibe with simvastatin|122
634683|NCT00129402|1559045|P2|STARTED|Start Period2 to End Period2 (Week 7-33)||0
634684|NCT00129402|1559046|P1|STARTED|Start Period2 to End Period2 (Week 7-33)||0
634685|NCT00129402|1559040|P7|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
634686|NCT00129402|1559041|P6|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2
634687|NCT00129402|1559042|P5|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
634688|NCT00129402|1559043|P4|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
634689|NCT00129402|1559044|P3|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2
634690|NCT00129402|1559045|P2|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
634691|NCT00129402|1559046|P1|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
634692|NCT00129402|1559040|P7|COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
634693|NCT00129402|1559041|P6|COMPLETED|Start Period1 to End Period1 (Week 1-6)||40
634694|NCT00129402|1559042|P5|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
634695|NCT00129402|1559043|P4|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
634696|NCT00129402|1559044|P3|COMPLETED|Start Period1 to End Period1 (Week 1-6)||41
634697|NCT00129402|1559045|P2|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
634698|NCT00129402|1559046|P1|COMPLETED|Start Period1 to End Period1 (Week 1-6)||43
634699|NCT00129402|1559040|P7|STARTED|Start Period1 to End Period1 (Week 1-6)||0
634700|NCT00129402|1559041|P6|STARTED|Start Period1 to End Period1 (Week 1-6)||42
634701|NCT00129402|1559042|P5|STARTED|Start Period1 to End Period1 (Week 1-6)||40
634702|NCT00129402|1559043|P4|STARTED|Start Period1 to End Period1 (Week 1-6)||40
634703|NCT00129402|1559044|P3|STARTED|Start Period1 to End Period1 (Week 1-6)||43
634704|NCT00129402|1559045|P2|STARTED|Start Period1 to End Period1 (Week 1-6)||40
634705|NCT00129402|1559046|P1|STARTED|Start Period1 to End Period1 (Week 1-6)||43
634706|NCT00129311|1559065|P2|NOT COMPLETED|Overall Study||19
634707|NCT00129311|1559066|P1|NOT COMPLETED|Overall Study||12
634708|NCT00129311|1559065|P2|COMPLETED|Overall Study||31
634709|NCT00129311|1559066|P1|COMPLETED|Overall Study||39
634710|NCT00129311|1559065|P2|STARTED|Overall Study||50
634711|NCT00129311|1559066|P1|STARTED|Overall Study||51
634712|NCT00129285|1559077|P3|NOT COMPLETED|Overall Study||38
634713|NCT00129285|1559078|P2|NOT COMPLETED|Overall Study||27
634714|NCT00129285|1559079|P1|NOT COMPLETED|Overall Study||25
634715|NCT00129285|1559077|P3|COMPLETED|Overall Study||37
634716|NCT00129285|1559078|P2|COMPLETED|Overall Study||43
634717|NCT00129285|1559079|P1|COMPLETED|Overall Study||40
634718|NCT00129285|1559077|P3|STARTED|Overall Study||75
634719|NCT00129285|1559078|P2|STARTED|Overall Study||70
634720|NCT00129285|1559079|P1|STARTED|Overall Study||65
634721|NCT00129272|1559095|P2|NOT COMPLETED|Overall Study||22
634722|NCT00129272|1559096|P1|NOT COMPLETED|Overall Study||17
634723|NCT00129272|1559095|P2|COMPLETED|Overall Study||51
634724|NCT00129272|1559096|P1|COMPLETED|Overall Study||54
634725|NCT00129272|1559095|P2|STARTED|Overall Study||73
634726|NCT00129272|1559096|P1|STARTED|Overall Study||71
634727|NCT00129259|1559106|P2|NOT COMPLETED|Overall Study||3
634728|NCT00129259|1559107|P1|NOT COMPLETED|Overall Study||3
634729|NCT00129259|1559106|P2|COMPLETED|Overall Study||22
634730|NCT00129259|1559107|P1|COMPLETED|Overall Study||49
634731|NCT00129259|1559106|P2|Received All or Part of Cycle 2|Overall Study||0
634732|NCT00129259|1559107|P1|Received All or Part of Cycle 2|Overall Study||40
634733|NCT00129259|1559106|P2|Received All or Part of Cycle 1|Overall Study||0
634734|NCT00129259|1559107|P1|Received All or Part of Cycle 1|Overall Study||52
634735|NCT00129259|1559106|P2|STARTED|Overall Study|Subjects not in the Intent-to-treat group did not have a baseline visit and are not included here|25
634736|NCT00129259|1559107|P1|STARTED|Overall Study|Subjects not in the Intent-to-treat group did not have a baseline visit and are not included here|52
634737|NCT00129246|1559119|P2|NOT COMPLETED|Overall Study||0
634738|NCT00129246|1559120|P1|NOT COMPLETED|Overall Study||0
634739|NCT00129246|1559119|P2|COMPLETED|Overall Study||20
634740|NCT00129246|1559120|P1|COMPLETED|Overall Study||20
634741|NCT00129246|1559119|P2|STARTED|Overall Study||20
634742|NCT00129246|1559120|P1|STARTED|Overall Study||20
634743|NCT00129220|1559135|P3|NOT COMPLETED|Study Period III||10
634744|NCT00129220|1559136|P2|NOT COMPLETED|Study Period III||1
634745|NCT00129220|1559137|P1|NOT COMPLETED|Study Period III||13
634746|NCT00129220|1559135|P3|COMPLETED|Study Period III||42
634747|NCT00129220|1559136|P2|COMPLETED|Study Period III||7
634748|NCT00129220|1559137|P1|COMPLETED|Study Period III||59
634749|NCT00129220|1559135|P3|STARTED|Study Period III||52
634750|NCT00129220|1559136|P2|STARTED|Study Period III||8
634751|NCT00129220|1559137|P1|STARTED|Study Period III||72
634752|NCT00129220|1559135|P3|NOT COMPLETED|Study Period II||47
634753|NCT00129220|1559136|P2|NOT COMPLETED|Study Period II||12
634754|NCT00129220|1559137|P1|NOT COMPLETED|Study Period II||33
634755|NCT00129220|1559135|P3|COMPLETED|Study Period II||52
634756|NCT00129220|1559136|P2|COMPLETED|Study Period II||8
634757|NCT00129220|1559137|P1|COMPLETED|Study Period II||72
634758|NCT00129220|1559135|P3|Received at Least One Dose of Study Drug|Study Period II||97
634759|NCT00129220|1559136|P2|Received at Least One Dose of Study Drug|Study Period II||20
634760|NCT00129220|1559137|P1|Received at Least One Dose of Study Drug|Study Period II||104
634761|NCT00129220|1559135|P3|STARTED|Study Period II||99
634762|NCT00129220|1559136|P2|STARTED|Study Period II||20
634763|NCT00129220|1559137|P1|STARTED|Study Period II||105
634764|NCT00129129|1559177|P5|NOT COMPLETED|Fourth Dose Phase||6
634765|NCT00129129|1559178|P4|NOT COMPLETED|Fourth Dose Phase||4
634766|NCT00129129|1559179|P3|NOT COMPLETED|Fourth Dose Phase||0
634767|NCT00129129|1559180|P2|NOT COMPLETED|Fourth Dose Phase||0
634768|NCT00129129|1559181|P1|NOT COMPLETED|Fourth Dose Phase||4
634769|NCT00129129|1559177|P5|COMPLETED|Fourth Dose Phase||124
634770|NCT00129129|1559178|P4|COMPLETED|Fourth Dose Phase||128
634771|NCT00129129|1559179|P3|COMPLETED|Fourth Dose Phase||0
634772|NCT00129129|1559180|P2|COMPLETED|Fourth Dose Phase||0
634773|NCT00129129|1559181|P1|COMPLETED|Fourth Dose Phase||232
634774|NCT00129129|1559177|P5|STARTED|Fourth Dose Phase||130
634775|NCT00129129|1559178|P4|STARTED|Fourth Dose Phase||132
634776|NCT00129129|1559179|P3|STARTED|Fourth Dose Phase||0
634777|NCT00129129|1559180|P2|STARTED|Fourth Dose Phase||0
634778|NCT00129129|1559181|P1|STARTED|Fourth Dose Phase||236
634779|NCT00129129|1559177|P5|NOT COMPLETED|Primary Phase||0
634780|NCT00129129|1559178|P4|NOT COMPLETED|Primary Phase||0
634781|NCT00129129|1559179|P3|NOT COMPLETED|Primary Phase||0
634782|NCT00129129|1559180|P2|NOT COMPLETED|Primary Phase||25
634783|NCT00129129|1559181|P1|NOT COMPLETED|Primary Phase||25
634784|NCT00129129|1559177|P5|COMPLETED|Primary Phase||0
634785|NCT00129129|1559178|P4|COMPLETED|Primary Phase||0
634786|NCT00129129|1559179|P3|COMPLETED|Primary Phase||150
634787|NCT00129129|1559180|P2|COMPLETED|Primary Phase||294
634788|NCT00129129|1559181|P1|COMPLETED|Primary Phase||262
634789|NCT00129129|1559177|P5|STARTED|Primary Phase||0
634790|NCT00129129|1559178|P4|STARTED|Primary Phase||0
634791|NCT00129129|1559179|P3|STARTED|Primary Phase||150
634792|NCT00129129|1559180|P2|STARTED|Primary Phase||319
634793|NCT00129129|1559181|P1|STARTED|Primary Phase||287
634794|NCT00129116|1559388|P5|NOT COMPLETED|Booster Phase||1
634795|NCT00129116|1559389|P4|NOT COMPLETED|Booster Phase||0
634796|NCT00129116|1559390|P3|NOT COMPLETED|Booster Phase||0
634797|NCT00129116|1559391|P2|NOT COMPLETED|Booster Phase||0
634798|NCT00129116|1559392|P1|NOT COMPLETED|Booster Phase||2
634799|NCT00129116|1559388|P5|COMPLETED|Booster Phase||43
634800|NCT00129116|1559389|P4|COMPLETED|Booster Phase||44
634801|NCT00129116|1559390|P3|COMPLETED|Booster Phase||44
634802|NCT00129116|1559391|P2|COMPLETED|Booster Phase||42
634803|NCT00129116|1559392|P1|COMPLETED|Booster Phase||45
634804|NCT00129116|1559388|P5|STARTED|Booster Phase||44
634805|NCT00129116|1559389|P4|STARTED|Booster Phase||44
634806|NCT00129116|1559390|P3|STARTED|Booster Phase||44
634807|NCT00129116|1559391|P2|STARTED|Booster Phase||42
634808|NCT00129116|1559392|P1|STARTED|Booster Phase||47
634809|NCT00129116|1559388|P5|NOT COMPLETED|Primary Phase||1
634810|NCT00129116|1559389|P4|NOT COMPLETED|Primary Phase||1
634811|NCT00129116|1559390|P3|NOT COMPLETED|Primary Phase||1
634812|NCT00129116|1559391|P2|NOT COMPLETED|Primary Phase||4
634813|NCT00129116|1559392|P1|NOT COMPLETED|Primary Phase||2
634814|NCT00129116|1559388|P5|COMPLETED|Primary Phase||76
634815|NCT00129116|1559389|P4|COMPLETED|Primary Phase||77
634816|NCT00129116|1559390|P3|COMPLETED|Primary Phase||77
634817|NCT00129116|1559391|P2|COMPLETED|Primary Phase||73
634818|NCT00129116|1559392|P1|COMPLETED|Primary Phase||76
634819|NCT00129116|1559388|P5|STARTED|Primary Phase||77
634820|NCT00129116|1559389|P4|STARTED|Primary Phase||78
634821|NCT00129116|1559390|P3|STARTED|Primary Phase||78
634822|NCT00129116|1559391|P2|STARTED|Primary Phase||77
634823|NCT00129116|1559392|P1|STARTED|Primary Phase||78
634824|NCT00128921|1559657|P3|NOT COMPLETED|Overall Study||0
634825|NCT00128921|1559658|P2|NOT COMPLETED|Overall Study||5
634826|NCT00128921|1559659|P1|NOT COMPLETED|Overall Study||5
634827|NCT00128921|1559657|P3|COMPLETED|Overall Study||0
634828|NCT00128921|1559658|P2|COMPLETED|Overall Study||3
634829|NCT00128921|1559659|P1|COMPLETED|Overall Study||5
634830|NCT00128921|1559657|P3|Received Bortezomib|Overall Study||0
634831|NCT00128921|1559658|P2|Received Bortezomib|Overall Study||6
634832|NCT00128921|1559659|P1|Received Bortezomib|Overall Study||10
634833|NCT00128921|1559657|P3|STARTED|Overall Study||0
634834|NCT00128921|1559658|P2|STARTED|Overall Study||8
634835|NCT00128921|1559659|P1|STARTED|Overall Study||10
634836|NCT00128830|1559676|P1|NOT COMPLETED|Overall Study||72
634837|NCT00128830|1559676|P1|COMPLETED|Overall Study||139
634838|NCT00128830|1559676|P1|STARTED|Overall Study||211
634839|NCT00128713|1559694|P3|NOT COMPLETED|Overall Study||0
634840|NCT00128713|1559695|P2|NOT COMPLETED|Overall Study||0
634841|NCT00128713|1559696|P1|NOT COMPLETED|Overall Study||0
634842|NCT00128713|1559694|P3|COMPLETED|Overall Study||449
634843|NCT00128713|1559695|P2|COMPLETED|Overall Study||449
634844|NCT00128713|1559696|P1|COMPLETED|Overall Study||453
634845|NCT00128713|1559694|P3|STARTED|Overall Study||449
634846|NCT00128713|1559695|P2|STARTED|Overall Study||449
634847|NCT00128713|1559696|P1|STARTED|Overall Study||453
634848|NCT00128661|1559718|P2|NOT COMPLETED|Overall Study||258
634849|NCT00128661|1559719|P1|NOT COMPLETED|Overall Study||274
634850|NCT00128661|1559718|P2|COMPLETED|Overall Study||3481
634851|NCT00128661|1559719|P1|COMPLETED|Overall Study||3453
634852|NCT00128661|1559718|P2|STARTED|Overall Study||3739
634853|NCT00128661|1559719|P1|STARTED|Overall Study||3727
634854|NCT00128492|1559765|P2|NOT COMPLETED|Overall Study||59
634855|NCT00128492|1559766|P1|NOT COMPLETED|Overall Study||20
634856|NCT00128492|1559765|P2|COMPLETED|Overall Study||130
634857|NCT00128492|1559766|P1|COMPLETED|Overall Study||65
634858|NCT00128492|1559765|P2|STARTED|Overall Study||189
634859|NCT00128492|1559766|P1|STARTED|Overall Study||85
634860|NCT00128401|1559826|P2|NOT COMPLETED|Overall Study||4
634861|NCT00128401|1559827|P1|NOT COMPLETED|Overall Study||6
634862|NCT00128401|1559826|P2|COMPLETED|Overall Study||15
634863|NCT00128401|1559827|P1|COMPLETED|Overall Study||14
634864|NCT00128401|1559826|P2|STARTED|Overall Study||19
634865|NCT00128401|1559827|P1|STARTED|Overall Study||20
634866|NCT00128219|1559838|P2|NOT COMPLETED|Overall Study||71
634867|NCT00128219|1559839|P1|NOT COMPLETED|Overall Study||69
634868|NCT00128219|1559838|P2|COMPLETED|Overall Study||263
634869|NCT00128219|1559839|P1|COMPLETED|Overall Study||264
634870|NCT00128219|1559838|P2|STARTED|Overall Study||334
634871|NCT00128219|1559839|P1|STARTED|Overall Study||333
634872|NCT00128206|1559923|P2|NOT COMPLETED|Overall Study||120
634873|NCT00128206|1559924|P1|NOT COMPLETED|Overall Study||137
634874|NCT00128206|1559923|P2|COMPLETED|Overall Study||60
634875|NCT00128206|1559924|P1|COMPLETED|Overall Study||47
634876|NCT00128206|1559923|P2|STARTED|Overall Study||180
634877|NCT00128206|1559924|P1|STARTED|Overall Study||184
634878|NCT00128193|1559942|P12|NOT COMPLETED|Overall Study||2
634879|NCT00128193|1559943|P11|NOT COMPLETED|Overall Study||3
634880|NCT00128193|1559944|P10|NOT COMPLETED|Overall Study||2
634881|NCT00128193|1559945|P9|NOT COMPLETED|Overall Study||2
634882|NCT00128193|1559946|P8|NOT COMPLETED|Overall Study||0
634883|NCT00128193|1559947|P7|NOT COMPLETED|Overall Study||4
634884|NCT00128193|1559948|P6|NOT COMPLETED|Overall Study||3
634885|NCT00128193|1559949|P5|NOT COMPLETED|Overall Study||2
634886|NCT00128193|1559950|P4|NOT COMPLETED|Overall Study||1
634887|NCT00128193|1559951|P3|NOT COMPLETED|Overall Study||3
634888|NCT00128193|1559952|P2|NOT COMPLETED|Overall Study||0
634889|NCT00128193|1559953|P1|NOT COMPLETED|Overall Study||0
634890|NCT00128193|1559942|P12|COMPLETED|Overall Study||18
634891|NCT00128193|1559943|P11|COMPLETED|Overall Study||17
634892|NCT00128193|1559944|P10|COMPLETED|Overall Study||18
634893|NCT00128193|1559945|P9|COMPLETED|Overall Study||18
634894|NCT00128193|1559946|P8|COMPLETED|Overall Study||20
634895|NCT00128193|1559947|P7|COMPLETED|Overall Study||16
634896|NCT00128193|1559948|P6|COMPLETED|Overall Study||17
634897|NCT00128193|1559949|P5|COMPLETED|Overall Study||18
634898|NCT00128193|1559950|P4|COMPLETED|Overall Study||44
634899|NCT00128193|1559951|P3|COMPLETED|Overall Study||42
634900|NCT00128193|1559952|P2|COMPLETED|Overall Study||5
634901|NCT00128193|1559953|P1|COMPLETED|Overall Study||5
634902|NCT00128193|1559942|P12|STARTED|Overall Study||20
634903|NCT00128193|1559943|P11|STARTED|Overall Study||20
634904|NCT00128193|1559944|P10|STARTED|Overall Study||20
634905|NCT00128193|1559945|P9|STARTED|Overall Study||20
634906|NCT00128193|1559946|P8|STARTED|Overall Study||20
634907|NCT00128193|1559947|P7|STARTED|Overall Study||20
634908|NCT00128193|1559948|P6|STARTED|Overall Study||20
634909|NCT00128193|1559949|P5|STARTED|Overall Study||20
634910|NCT00128193|1559950|P4|STARTED|Overall Study||45
634911|NCT00128193|1559951|P3|STARTED|Overall Study||45
634912|NCT00128193|1559952|P2|STARTED|Overall Study||5
634913|NCT00128193|1559953|P1|STARTED|Overall Study||5
634914|NCT00128180|1560189|P2|NOT COMPLETED|Overall Study||0
634915|NCT00128180|1560190|P1|NOT COMPLETED|Overall Study||0
634916|NCT00128180|1560189|P2|COMPLETED|Overall Study||34
634917|NCT00128180|1560190|P1|COMPLETED|Overall Study||32
634918|NCT00128180|1560189|P2|STARTED|Overall Study||34
634919|NCT00128180|1560190|P1|STARTED|Overall Study||32
634920|NCT00127933|1560216|P2|NOT COMPLETED|Overall Study||0
634921|NCT00127933|1560217|P1|NOT COMPLETED|Overall Study||1
634922|NCT00127933|1560216|P2|COMPLETED|Overall Study||34
634923|NCT00127933|1560217|P1|COMPLETED|Overall Study||122
634924|NCT00127933|1560216|P2|Postoperative|Overall Study||27
634925|NCT00127933|1560217|P1|Postoperative|Overall Study||98
634926|NCT00127933|1560216|P2|Quality of Life Population|Overall Study||33
634927|NCT00127933|1560217|P1|Quality of Life Population|Overall Study||118
634928|NCT00127933|1560216|P2|Safety Population|Overall Study||34
634929|NCT00127933|1560217|P1|Safety Population|Overall Study||122
634930|NCT00127933|1560216|P2|Clinical Response|Overall Study||34
634931|NCT00127933|1560217|P1|Clinical Response|Overall Study||122
634932|NCT00127933|1560216|P2|Pathological Response|Overall Study||28
634933|NCT00127933|1560217|P1|Pathological Response|Overall Study||101
634934|NCT00127933|1560216|P2|STARTED|Overall Study||34
634935|NCT00127933|1560217|P1|STARTED|Overall Study||123
634936|NCT00127855|1560238|P5|NOT COMPLETED|Polysaccharide Challenge Dose||0
634937|NCT00127855|1560239|P4|NOT COMPLETED|Polysaccharide Challenge Dose||0
634938|NCT00127855|1560240|P3|NOT COMPLETED|Polysaccharide Challenge Dose||0
634939|NCT00127855|1560241|P2|NOT COMPLETED|Polysaccharide Challenge Dose||0
634940|NCT00127855|1560242|P1|NOT COMPLETED|Polysaccharide Challenge Dose||0
634941|NCT00127855|1560238|P5|COMPLETED|Polysaccharide Challenge Dose||77
634942|NCT00127855|1560239|P4|COMPLETED|Polysaccharide Challenge Dose||81
634943|NCT00127855|1560240|P3|COMPLETED|Polysaccharide Challenge Dose||77
634944|NCT00127855|1560241|P2|COMPLETED|Polysaccharide Challenge Dose||79
634945|NCT00127855|1560242|P1|COMPLETED|Polysaccharide Challenge Dose||80
634946|NCT00127855|1560238|P5|STARTED|Polysaccharide Challenge Dose||77
634947|NCT00127855|1560239|P4|STARTED|Polysaccharide Challenge Dose||81
634948|NCT00127855|1560240|P3|STARTED|Polysaccharide Challenge Dose||77
634949|NCT00127855|1560241|P2|STARTED|Polysaccharide Challenge Dose||79
634950|NCT00127855|1560242|P1|STARTED|Polysaccharide Challenge Dose||80
634951|NCT00127855|1560238|P5|NOT COMPLETED|Primary Vaccination Course||4
634952|NCT00127855|1560239|P4|NOT COMPLETED|Primary Vaccination Course||0
634953|NCT00127855|1560240|P3|NOT COMPLETED|Primary Vaccination Course||2
634954|NCT00127855|1560241|P2|NOT COMPLETED|Primary Vaccination Course||1
634955|NCT00127855|1560242|P1|NOT COMPLETED|Primary Vaccination Course||2
634956|NCT00127855|1560238|P5|COMPLETED|Primary Vaccination Course||78
634957|NCT00127855|1560239|P4|COMPLETED|Primary Vaccination Course||81
634958|NCT00127855|1560240|P3|COMPLETED|Primary Vaccination Course||78
634959|NCT00127855|1560241|P2|COMPLETED|Primary Vaccination Course||81
634960|NCT00127855|1560242|P1|COMPLETED|Primary Vaccination Course||80
634961|NCT00127855|1560238|P5|STARTED|Primary Vaccination Course||82
634962|NCT00127855|1560239|P4|STARTED|Primary Vaccination Course||81
634963|NCT00127855|1560240|P3|STARTED|Primary Vaccination Course||80
634964|NCT00127855|1560241|P2|STARTED|Primary Vaccination Course||82
634965|NCT00127855|1560242|P1|STARTED|Primary Vaccination Course||82
634966|NCT00127842|1560424|P1|NOT COMPLETED|Overall Study||39
634967|NCT00127842|1560424|P1|COMPLETED|Overall Study||71
634968|NCT00127842|1560424|P1|STARTED|Overall Study||110
634969|NCT00127803|1560442|P4|NOT COMPLETED|Overall Study||1
634970|NCT00127803|1560443|P3|NOT COMPLETED|Overall Study||0
634971|NCT00127803|1560444|P2|NOT COMPLETED|Overall Study||0
634972|NCT00127803|1560445|P1|NOT COMPLETED|Overall Study||3
634973|NCT00127803|1560442|P4|COMPLETED|Overall Study||11
634974|NCT00127803|1560443|P3|COMPLETED|Overall Study||12
634975|NCT00127803|1560444|P2|COMPLETED|Overall Study||13
634976|NCT00127803|1560445|P1|COMPLETED|Overall Study||10
634977|NCT00127803|1560442|P4|STARTED|Overall Study||12
634978|NCT00127803|1560443|P3|STARTED|Overall Study||12
634979|NCT00127803|1560444|P2|STARTED|Overall Study||13
634980|NCT00127803|1560445|P1|STARTED|Overall Study||13
634981|NCT00127790|1560467|P4|NOT COMPLETED|Post-Treatment||0
634982|NCT00127790|1560468|P3|NOT COMPLETED|Post-Treatment||0
634983|NCT00127790|1560469|P2|NOT COMPLETED|Post-Treatment||0
634984|NCT00127790|1560470|P1|NOT COMPLETED|Post-Treatment||0
634985|NCT00127790|1560467|P4|COMPLETED|Post-Treatment||4
634986|NCT00127790|1560468|P3|COMPLETED|Post-Treatment||6
634987|NCT00127790|1560469|P2|COMPLETED|Post-Treatment||5
634988|NCT00127790|1560470|P1|COMPLETED|Post-Treatment||6
634989|NCT00127790|1560467|P4|STARTED|Post-Treatment||4
634990|NCT00127790|1560468|P3|STARTED|Post-Treatment||6
634991|NCT00127790|1560469|P2|STARTED|Post-Treatment||5
634992|NCT00127790|1560470|P1|STARTED|Post-Treatment||6
634993|NCT00127790|1560467|P4|NOT COMPLETED|Pre-Treatment||0
634994|NCT00127790|1560468|P3|NOT COMPLETED|Pre-Treatment||0
634995|NCT00127790|1560469|P2|NOT COMPLETED|Pre-Treatment||0
634996|NCT00127790|1560470|P1|NOT COMPLETED|Pre-Treatment||0
634997|NCT00127790|1560467|P4|COMPLETED|Pre-Treatment||4
634998|NCT00127790|1560468|P3|COMPLETED|Pre-Treatment||6
634999|NCT00127790|1560469|P2|COMPLETED|Pre-Treatment||5
635000|NCT00127790|1560470|P1|COMPLETED|Pre-Treatment||6
635001|NCT00127790|1560467|P4|STARTED|Pre-Treatment||4
635002|NCT00127790|1560468|P3|STARTED|Pre-Treatment||6
635003|NCT00127790|1560469|P2|STARTED|Pre-Treatment||5
635004|NCT00127790|1560470|P1|STARTED|Pre-Treatment|7 enrolled subjects were withdrawn prior to randomization; 21 of 28 enrolled were randomized.|6
635005|NCT00127712|1560494|P2|NOT COMPLETED|Overall Study||0
635006|NCT00127712|1560495|P1|NOT COMPLETED|Overall Study||5
635007|NCT00127712|1560494|P2|COMPLETED|Overall Study||65
635008|NCT00127712|1560495|P1|COMPLETED|Overall Study||60
635009|NCT00127712|1560494|P2|STARTED|Overall Study||65
635010|NCT00127712|1560495|P1|STARTED|Overall Study||65
635011|NCT00127660|1560511|P4|NOT COMPLETED|Overall Study||0
635012|NCT00127660|1560512|P3|NOT COMPLETED|Overall Study||5
635013|NCT00127660|1560513|P2|NOT COMPLETED|Overall Study||3
635014|NCT00127660|1560514|P1|NOT COMPLETED|Overall Study||3
635015|NCT00127660|1560511|P4|COMPLETED|Overall Study||150
635016|NCT00127660|1560512|P3|COMPLETED|Overall Study||143
635017|NCT00127660|1560513|P2|COMPLETED|Overall Study||151
635018|NCT00127660|1560514|P1|COMPLETED|Overall Study||150
635019|NCT00127660|1560511|P4|STARTED|Overall Study||150
635020|NCT00127660|1560512|P3|STARTED|Overall Study||148
635021|NCT00127660|1560513|P2|STARTED|Overall Study||154
635022|NCT00127660|1560514|P1|STARTED|Overall Study||153
635023|NCT00127530|1560526|P2|NOT COMPLETED|Overall Study||21
635024|NCT00127530|1560527|P1|NOT COMPLETED|Overall Study||1
635025|NCT00127530|1560526|P2|COMPLETED|Overall Study||207
635026|NCT00127530|1560527|P1|COMPLETED|Overall Study||71
635027|NCT00127530|1560526|P2|STARTED|Overall Study||228
635028|NCT00127530|1560527|P1|STARTED|Overall Study||72
635029|NCT00127439|1560535|P2|NOT COMPLETED|Overall Study||0
635030|NCT00127439|1560536|P1|NOT COMPLETED|Overall Study||0
635031|NCT00127439|1560535|P2|COMPLETED|Overall Study||10
635032|NCT00127439|1560536|P1|COMPLETED|Overall Study||9
635033|NCT00127439|1560535|P2|STARTED|Overall Study||10
635034|NCT00127439|1560536|P1|STARTED|Overall Study||9
635035|NCT00127413|1560562|P4|NOT COMPLETED|Overall Study||2
635036|NCT00127413|1560563|P3|NOT COMPLETED|Overall Study||8
635037|NCT00127413|1560564|P2|NOT COMPLETED|Overall Study||4
635038|NCT00127413|1560565|P1|NOT COMPLETED|Overall Study||6
635039|NCT00127413|1560562|P4|COMPLETED|Overall Study||5
635040|NCT00127413|1560563|P3|COMPLETED|Overall Study||5
635041|NCT00127413|1560564|P2|COMPLETED|Overall Study||6
635042|NCT00127413|1560565|P1|COMPLETED|Overall Study||6
635043|NCT00127413|1560562|P4|STARTED|Overall Study||7
635044|NCT00127413|1560563|P3|STARTED|Overall Study||13
635045|NCT00127413|1560564|P2|STARTED|Overall Study||10
635046|NCT00127413|1560565|P1|STARTED|Overall Study||12
635047|NCT00127231|1560577|P2|NOT COMPLETED|Overall Study||6
635048|NCT00127231|1560578|P1|NOT COMPLETED|Overall Study||6
635049|NCT00127231|1560577|P2|COMPLETED|Overall Study||68
635050|NCT00127231|1560578|P1|COMPLETED|Overall Study||68
635051|NCT00127231|1560577|P2|STARTED|Overall Study||74
635052|NCT00127231|1560578|P1|STARTED|Overall Study||74
635053|NCT00127218|1560594|P2|NOT COMPLETED|Overall Study||15
635054|NCT00127218|1560595|P1|NOT COMPLETED|Overall Study||13
635055|NCT00127218|1560594|P2|COMPLETED|Overall Study||58
635056|NCT00127218|1560595|P1|COMPLETED|Overall Study||59
635057|NCT00127218|1560594|P2|STARTED|Overall Study||73
635058|NCT00127218|1560595|P1|STARTED|Overall Study||72
635059|NCT00127192|1560608|P5|NOT COMPLETED|Overall Study||5
635060|NCT00127192|1560609|P4|NOT COMPLETED|Overall Study||1
635061|NCT00127192|1560610|P3|NOT COMPLETED|Overall Study||2
635062|NCT00127192|1560611|P2|NOT COMPLETED|Overall Study||1
635063|NCT00127192|1560612|P1|NOT COMPLETED|Overall Study||3
635064|NCT00127192|1560608|P5|COMPLETED|Overall Study||68
635065|NCT00127192|1560609|P4|COMPLETED|Overall Study||67
635066|NCT00127192|1560610|P3|COMPLETED|Overall Study||68
635067|NCT00127192|1560611|P2|COMPLETED|Overall Study||71
635068|NCT00127192|1560612|P1|COMPLETED|Overall Study||77
635069|NCT00127192|1560608|P5|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|73
635070|NCT00127192|1560609|P4|STARTED|Overall Study|Study enrolled slightly less than the target of N=70|68
635071|NCT00127192|1560610|P3|STARTED|Overall Study|Study enrolled as per the target of N=70|70
635072|NCT00127192|1560611|P2|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|72
635073|NCT00127192|1560612|P1|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|80
635074|NCT00127166|1560636|P2|NOT COMPLETED|Period II||0
635075|NCT00127166|1560637|P1|NOT COMPLETED|Period II||3
635076|NCT00127166|1560636|P2|COMPLETED|Period II||73
635077|NCT00127166|1560637|P1|COMPLETED|Period II||72
635078|NCT00127166|1560636|P2|STARTED|Period II||73
635079|NCT00127166|1560637|P1|STARTED|Period II||75
635080|NCT00127166|1560636|P2|NOT COMPLETED|Washout Period||1
635081|NCT00127166|1560637|P1|NOT COMPLETED|Washout Period||0
635082|NCT00127166|1560636|P2|COMPLETED|Washout Period||73
635083|NCT00127166|1560637|P1|COMPLETED|Washout Period||75
635084|NCT00127166|1560636|P2|STARTED|Washout Period||74
635085|NCT00127166|1560637|P1|STARTED|Washout Period||75
635086|NCT00127166|1560636|P2|NOT COMPLETED|Period I||2
635087|NCT00127166|1560637|P1|NOT COMPLETED|Period I||3
635088|NCT00127166|1560636|P2|COMPLETED|Period I||74
635089|NCT00127166|1560637|P1|COMPLETED|Period I||75
635090|NCT00127166|1560636|P2|STARTED|Period I||76
635091|NCT00127166|1560637|P1|STARTED|Period I||78
635092|NCT00127101|1560657|P6|NOT COMPLETED|Continuation Phase||3
635093|NCT00127101|1560658|P5|NOT COMPLETED|Continuation Phase||3
635094|NCT00127101|1560659|P4|NOT COMPLETED|Continuation Phase||0
635095|NCT00127101|1560660|P3|NOT COMPLETED|Continuation Phase||1
635096|NCT00127101|1560661|P2|NOT COMPLETED|Continuation Phase||0
635097|NCT00127101|1560662|P1|NOT COMPLETED|Continuation Phase||0
635098|NCT00127101|1560657|P6|COMPLETED|Continuation Phase||0
635099|NCT00127101|1560658|P5|COMPLETED|Continuation Phase||0
635100|NCT00127101|1560659|P4|COMPLETED|Continuation Phase||0
635101|NCT00127101|1560660|P3|COMPLETED|Continuation Phase||0
635102|NCT00127101|1560661|P2|COMPLETED|Continuation Phase||0
635103|NCT00127101|1560662|P1|COMPLETED|Continuation Phase||0
635104|NCT00127101|1560657|P6|STARTED|Continuation Phase||3
635105|NCT00127101|1560658|P5|STARTED|Continuation Phase||3
635106|NCT00127101|1560659|P4|STARTED|Continuation Phase|No patients from the 2b Cohort entered into the extension phase|0
635107|NCT00127101|1560660|P3|STARTED|Continuation Phase||1
635108|NCT00127101|1560661|P2|STARTED|Continuation Phase||0
635109|NCT00127101|1560662|P1|STARTED|Continuation Phase||0
635110|NCT00127101|1560657|P6|NOT COMPLETED|Base Protocol||1
635111|NCT00127101|1560658|P5|NOT COMPLETED|Base Protocol||2
635112|NCT00127101|1560659|P4|NOT COMPLETED|Base Protocol||0
635113|NCT00127101|1560660|P3|NOT COMPLETED|Base Protocol||2
635114|NCT00127101|1560661|P2|NOT COMPLETED|Base Protocol||4
635115|NCT00127101|1560662|P1|NOT COMPLETED|Base Protocol||2
635116|NCT00127101|1560657|P6|COMPLETED|Base Protocol||3
635117|NCT00127101|1560658|P5|COMPLETED|Base Protocol||3
635118|NCT00127101|1560659|P4|COMPLETED|Base Protocol||3
635119|NCT00127101|1560660|P3|COMPLETED|Base Protocol||1
635120|NCT00127101|1560661|P2|COMPLETED|Base Protocol||1
635121|NCT00127101|1560662|P1|COMPLETED|Base Protocol||1
635122|NCT00127101|1560657|P6|STARTED|Base Protocol||4
635123|NCT00127101|1560658|P5|STARTED|Base Protocol||5
635124|NCT00127101|1560659|P4|STARTED|Base Protocol||3
635125|NCT00127101|1560660|P3|STARTED|Base Protocol||3
635126|NCT00127101|1560661|P2|STARTED|Base Protocol||5
635127|NCT00127101|1560662|P1|STARTED|Base Protocol||3
635128|NCT00127036|1560684|P2|NOT COMPLETED|Overall Study||11
635129|NCT00127036|1560685|P1|NOT COMPLETED|Overall Study||8
635130|NCT00127036|1560684|P2|COMPLETED|Overall Study|20 Participants were evaluable.|20
635131|NCT00127036|1560685|P1|COMPLETED|Overall Study|26 Participants were evaluable.|26
635132|NCT00127036|1560684|P2|STARTED|Overall Study||31
635133|NCT00127036|1560685|P1|STARTED|Overall Study||34
635134|NCT00126776|1560697|P2|NOT COMPLETED|Overall Study||0
635135|NCT00126776|1560698|P1|NOT COMPLETED|Overall Study||0
635136|NCT00126776|1560697|P2|COMPLETED|Overall Study||371
635137|NCT00126776|1560698|P1|COMPLETED|Overall Study||372
635138|NCT00126776|1560697|P2|STARTED|Overall Study||371
635139|NCT00126776|1560698|P1|STARTED|Overall Study||372
635140|NCT00126750|1560704|P2|NOT COMPLETED|Overall Study||266
635141|NCT00126750|1560705|P1|NOT COMPLETED|Overall Study||180
635142|NCT00126750|1560704|P2|COMPLETED|Overall Study|Total providers at clinic locations were given the option to 'enroll'.|196
635143|NCT00126750|1560705|P1|COMPLETED|Overall Study|Total providers at participating clinic locations were given the option to 'enroll'.|205
635144|NCT00126750|1560704|P2|STARTED|Overall Study|Number of providers from 84 clinics|462
635145|NCT00126750|1560705|P1|STARTED|Overall Study|Number of providers from 84 clinics|385
635146|NCT00126737|1560715|P4|NOT COMPLETED|Overall Study||7
635147|NCT00126737|1560716|P3|NOT COMPLETED|Overall Study||6
635148|NCT00126737|1560717|P2|NOT COMPLETED|Overall Study||3
635149|NCT00126737|1560718|P1|NOT COMPLETED|Overall Study||6
635150|NCT00126737|1560715|P4|COMPLETED|Overall Study||18
635151|NCT00126737|1560716|P3|COMPLETED|Overall Study||24
635152|NCT00126737|1560717|P2|COMPLETED|Overall Study||24
635153|NCT00126737|1560718|P1|COMPLETED|Overall Study||22
635154|NCT00126737|1560715|P4|STARTED|Overall Study||25
635155|NCT00126737|1560716|P3|STARTED|Overall Study||30
635156|NCT00126737|1560717|P2|STARTED|Overall Study||27
635157|NCT00126737|1560718|P1|STARTED|Overall Study||28
635158|NCT00126659|1560747|P3|NOT COMPLETED|Overall Study||2
635159|NCT00126659|1560748|P2|NOT COMPLETED|Overall Study||0
635160|NCT00126659|1560749|P1|NOT COMPLETED|Overall Study||0
635161|NCT00126659|1560747|P3|COMPLETED|Overall Study||2
635162|NCT00126659|1560748|P2|COMPLETED|Overall Study||3
635163|NCT00126659|1560749|P1|COMPLETED|Overall Study||3
635164|NCT00126659|1560747|P3|STARTED|Overall Study||4
635165|NCT00126659|1560748|P2|STARTED|Overall Study||3
635166|NCT00126659|1560749|P1|STARTED|Overall Study||3
635167|NCT00126594|1560757|P2|NOT COMPLETED|Overall Study||37
635168|NCT00126594|1560758|P1|NOT COMPLETED|Overall Study||39
635169|NCT00126594|1560757|P2|COMPLETED|Overall Study||3
635170|NCT00126594|1560758|P1|COMPLETED|Overall Study||1
635171|NCT00126594|1560757|P2|STARTED|Overall Study||40
635172|NCT00126594|1560758|P1|STARTED|Overall Study||40
635173|NCT00126581|1560775|P2|NOT COMPLETED|Overall Study||20
635174|NCT00126581|1560776|P1|NOT COMPLETED|Overall Study||13
635175|NCT00126581|1560775|P2|COMPLETED|Overall Study||80
635176|NCT00126581|1560776|P1|COMPLETED|Overall Study||68
635177|NCT00126581|1560775|P2|STARTED|Overall Study||100
635178|NCT00126581|1560776|P1|STARTED|Overall Study||81
635179|NCT00126568|1560796|P1|NOT COMPLETED|Overall Study||2
635180|NCT00126568|1560796|P1|COMPLETED|Overall Study|Disease progression at beginning of study, not evaluable|18
635181|NCT00126568|1560796|P1|STARTED|Overall Study||20
635182|NCT00126555|1560803|P1|NOT COMPLETED|Overall Study||6
635183|NCT00126555|1560803|P1|COMPLETED|Overall Study||17
635184|NCT00126555|1560803|P1|STARTED|Overall Study||23
635185|NCT00126503|1560819|P2|NOT COMPLETED|Overall Study||21
635186|NCT00126503|1560820|P1|NOT COMPLETED|Overall Study||47
635187|NCT00126503|1560819|P2|COMPLETED|Overall Study||0
635188|NCT00126503|1560820|P1|COMPLETED|Overall Study||1
635189|NCT00126503|1560819|P2|STARTED|Overall Study||21
635190|NCT00126503|1560820|P1|STARTED|Overall Study||48
635191|NCT00126490|1560832|P1|NOT COMPLETED|Overall Study||1
635192|NCT00126490|1560832|P1|COMPLETED|Overall Study||18
635193|NCT00126490|1560832|P1|STARTED|Overall Study||19
635194|NCT00126438|1560842|P2|NOT COMPLETED|Overall Study||10
635195|NCT00126438|1560843|P1|NOT COMPLETED|Overall Study||34
635196|NCT00126438|1560842|P2|COMPLETED|Overall Study||52
635197|NCT00126438|1560843|P1|COMPLETED|Overall Study||419
635198|NCT00126438|1560842|P2|STARTED|Overall Study||62
635199|NCT00126438|1560843|P1|STARTED|Overall Study||453
635200|NCT00126425|1560851|P2|NOT COMPLETED|Overall Study||11
635201|NCT00126425|1560852|P1|NOT COMPLETED|Overall Study||41
635202|NCT00126425|1560851|P2|COMPLETED|Overall Study||37
635203|NCT00126425|1560852|P1|COMPLETED|Overall Study||498
635204|NCT00126425|1560851|P2|STARTED|Overall Study||48
635205|NCT00126425|1560852|P1|STARTED|Overall Study||539
635206|NCT00126191|1560860|P2|NOT COMPLETED|Overall Study||2
635207|NCT00126191|1560861|P1|NOT COMPLETED|Overall Study||0
635208|NCT00126191|1560860|P2|COMPLETED|Overall Study|1 pt off study during cycle 1 due to toxicity|6
635209|NCT00126191|1560861|P1|COMPLETED|Overall Study||2
635210|NCT00126191|1560860|P2|STARTED|Overall Study||8
635211|NCT00126191|1560861|P1|STARTED|Overall Study||2
635212|NCT00126126|1560871|P2|NOT COMPLETED|Overall Study||2
635213|NCT00126126|1560872|P1|NOT COMPLETED|Overall Study||0
635214|NCT00126126|1560871|P2|COMPLETED|Overall Study||7
635215|NCT00126126|1560872|P1|COMPLETED|Overall Study||9
635216|NCT00126126|1560871|P2|STARTED|Overall Study||9
635217|NCT00126126|1560872|P1|STARTED|Overall Study||9
635218|NCT00126113|1560882|P2|NOT COMPLETED|Overall Study||2
635219|NCT00126113|1560883|P1|NOT COMPLETED|Overall Study||3
635220|NCT00126113|1560882|P2|COMPLETED|Overall Study||35
635221|NCT00126113|1560883|P1|COMPLETED|Overall Study||34
635222|NCT00126113|1560882|P2|STARTED|Overall Study||37
635223|NCT00126113|1560883|P1|STARTED|Overall Study||37
635224|NCT00125957|1560897|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
635225|NCT00125957|1560898|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
635226|NCT00125957|1560897|P2|COMPLETED|Second Intervention (3 Weeks)||17
635227|NCT00125957|1560898|P1|COMPLETED|Second Intervention (3 Weeks)||15
635228|NCT00125957|1560897|P2|STARTED|Second Intervention (3 Weeks)||17
635229|NCT00125957|1560898|P1|STARTED|Second Intervention (3 Weeks)||15
635230|NCT00125957|1560897|P2|NOT COMPLETED|First Intervention (3 Weeks)||0
635231|NCT00125957|1560898|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
635232|NCT00125957|1560897|P2|COMPLETED|First Intervention (3 Weeks)||17
635233|NCT00125957|1560898|P1|COMPLETED|First Intervention (3 Weeks)||15
635234|NCT00125957|1560897|P2|STARTED|First Intervention (3 Weeks)||17
635235|NCT00125957|1560898|P1|STARTED|First Intervention (3 Weeks)||15
635236|NCT00125931|1560906|P1|NOT COMPLETED|Overall Study||0
635237|NCT00125931|1560906|P1|COMPLETED|Overall Study||10
635238|NCT00125931|1560906|P1|STARTED|Overall Study||10
635239|NCT00125762|1560911|P1|NOT COMPLETED|Overall Study||159
635240|NCT00125762|1560911|P1|COMPLETED|Overall Study||748
635241|NCT00125762|1560911|P1|STARTED|Overall Study||907
635242|NCT00125658|1560918|P2|NOT COMPLETED|Overall Study||0
635243|NCT00125658|1560919|P1|NOT COMPLETED|Overall Study||0
635244|NCT00125658|1560918|P2|COMPLETED|Overall Study||6
635245|NCT00125658|1560919|P1|COMPLETED|Overall Study||8
635246|NCT00125658|1560918|P2|STARTED|Overall Study||6
635247|NCT00125658|1560919|P1|STARTED|Overall Study||8
635248|NCT00125619|1560939|P2|NOT COMPLETED|Overall Study||0
635249|NCT00125619|1560940|P1|NOT COMPLETED|Overall Study||0
635250|NCT00125619|1560939|P2|COMPLETED|Overall Study||8
635251|NCT00125619|1560940|P1|COMPLETED|Overall Study||8
635252|NCT00125619|1560939|P2|STARTED|Overall Study||8
635253|NCT00125619|1560940|P1|STARTED|Overall Study||8
635254|NCT00125593|1560960|P2|NOT COMPLETED|Overall Study||103
635255|NCT00125593|1560961|P1|NOT COMPLETED|Overall Study||101
635256|NCT00125593|1560960|P2|COMPLETED|Overall Study||4517
635257|NCT00125593|1560961|P1|COMPLETED|Overall Study||4549
635258|NCT00125593|1560960|P2|STARTED|Overall Study||4620
635259|NCT00125593|1560961|P1|STARTED|Overall Study||4650
635260|NCT00125528|1560981|P2|NOT COMPLETED|Overall Study||1
635261|NCT00125528|1560982|P1|NOT COMPLETED|Overall Study||2
635262|NCT00125528|1560981|P2|COMPLETED|Overall Study||20
635263|NCT00125528|1560982|P1|COMPLETED|Overall Study||18
635264|NCT00125528|1560981|P2|STARTED|Overall Study||21
635265|NCT00125528|1560982|P1|STARTED|Overall Study||20
635266|NCT00125515|1560993|P3|NOT COMPLETED|Overall Study||21
635267|NCT00125515|1560994|P2|NOT COMPLETED|Overall Study||20
635268|NCT00125515|1560995|P1|NOT COMPLETED|Overall Study||20
635269|NCT00125515|1560993|P3|COMPLETED|Overall Study||6
635270|NCT00125515|1560994|P2|COMPLETED|Overall Study||7
635271|NCT00125515|1560995|P1|COMPLETED|Overall Study||7
635272|NCT00125515|1560993|P3|STARTED|Overall Study||27
635273|NCT00125515|1560994|P2|STARTED|Overall Study||27
635274|NCT00125515|1560995|P1|STARTED|Overall Study||27
635275|NCT00125268|1561005|P2|NOT COMPLETED|Overall Study||1
635276|NCT00125268|1561006|P1|NOT COMPLETED|Overall Study||1
635277|NCT00125268|1561005|P2|COMPLETED|Overall Study||13
635278|NCT00125268|1561006|P1|COMPLETED|Overall Study||15
635279|NCT00125268|1561005|P2|STARTED|Overall Study||14
635280|NCT00125268|1561006|P1|STARTED|Overall Study||16
635281|NCT00125242|1561018|P2|NOT COMPLETED|Overall Study||2
635282|NCT00125242|1561019|P1|NOT COMPLETED|Overall Study||7
635283|NCT00125242|1561018|P2|COMPLETED|Overall Study||14
635284|NCT00125242|1561019|P1|COMPLETED|Overall Study||87
635285|NCT00125242|1561018|P2|STARTED|Overall Study||16
635286|NCT00125242|1561019|P1|STARTED|Overall Study||94
635287|NCT00125190|1561024|P1|NOT COMPLETED|Overall Study||15
635288|NCT00125190|1561024|P1|COMPLETED|Overall Study||30
635289|NCT00125190|1561024|P1|STARTED|Overall Study||45
635290|NCT00125164|1561042|P4|NOT COMPLETED|Overall Study||6
635291|NCT00125164|1561043|P3|NOT COMPLETED|Overall Study||4
635292|NCT00125164|1561044|P2|NOT COMPLETED|Overall Study||0
635293|NCT00125164|1561045|P1|NOT COMPLETED|Overall Study||2
635294|NCT00125164|1561042|P4|COMPLETED|Overall Study||45
635295|NCT00125164|1561043|P3|COMPLETED|Overall Study||40
635296|NCT00125164|1561044|P2|COMPLETED|Overall Study||16
635297|NCT00125164|1561045|P1|COMPLETED|Overall Study||23
635298|NCT00125164|1561042|P4|STARTED|Overall Study||51
635299|NCT00125164|1561043|P3|STARTED|Overall Study||44
635300|NCT00125164|1561044|P2|STARTED|Overall Study||16
635301|NCT00125164|1561045|P1|STARTED|Overall Study||25
635302|NCT00125138|1561099|P4|NOT COMPLETED|Overall Study||5
635303|NCT00125138|1561100|P3|NOT COMPLETED|Overall Study||4
635304|NCT00125138|1561101|P2|NOT COMPLETED|Overall Study||3
635305|NCT00125138|1561102|P1|NOT COMPLETED|Overall Study||3
635306|NCT00125138|1561099|P4|COMPLETED|Overall Study||25
635307|NCT00125138|1561100|P3|COMPLETED|Overall Study||21
635308|NCT00125138|1561101|P2|COMPLETED|Overall Study||17
635309|NCT00125138|1561102|P1|COMPLETED|Overall Study||12
635310|NCT00125138|1561099|P4|STARTED|Overall Study||30
635311|NCT00125138|1561100|P3|STARTED|Overall Study||25
635312|NCT00125138|1561101|P2|STARTED|Overall Study|One subject requested withdrawal prior to treatment; data for the subject are excluded from results.|20
635313|NCT00125138|1561102|P1|STARTED|Overall Study||15
635314|NCT00125034|1561118|P2|NOT COMPLETED|Overall Study||0
635315|NCT00125034|1561119|P1|NOT COMPLETED|Overall Study||0
635316|NCT00125034|1561118|P2|COMPLETED|Overall Study||168
635317|NCT00125034|1561119|P1|COMPLETED|Overall Study||170
635318|NCT00125034|1561118|P2|STARTED|Overall Study|Randomized & treated|168
635319|NCT00125034|1561119|P1|STARTED|Overall Study|Randomized & treated. 1 subject was not randomized correctly and was excluded in the ITT population.|170
635320|NCT00124982|1561151|P3|NOT COMPLETED|Long-term Period||89
635321|NCT00124982|1561152|P2|NOT COMPLETED|Long-term Period||0
635322|NCT00124982|1561153|P1|NOT COMPLETED|Long-term Period||0
635323|NCT00124982|1561151|P3|COMPLETED|Long-term Period||441
635324|NCT00124982|1561152|P2|COMPLETED|Long-term Period||0
635325|NCT00124982|1561153|P1|COMPLETED|Long-term Period||0
635326|NCT00124982|1561151|P3|STARTED|Long-term Period|A large number did not continue due to a rollover from study drug to commercially available drug.|530
635327|NCT00124982|1561152|P2|STARTED|Long-term Period||0
635328|NCT00124982|1561153|P1|STARTED|Long-term Period||0
635329|NCT00124982|1561151|P3|NOT COMPLETED|Short-term Period||0
635330|NCT00124982|1561152|P2|NOT COMPLETED|Short-term Period||114
635331|NCT00124982|1561153|P1|NOT COMPLETED|Short-term Period||72
635332|NCT00124982|1561151|P3|COMPLETED|Short-term Period||0
635333|NCT00124982|1561152|P2|COMPLETED|Short-term Period||483
635334|NCT00124982|1561153|P1|COMPLETED|Short-term Period||377
635335|NCT00124982|1561151|P3|STARTED|Short-term Period||0
635336|NCT00124982|1561152|P2|STARTED|Short-term Period||597
635337|NCT00124982|1561153|P1|STARTED|Short-term Period||449
635338|NCT00124943|1561235|P4|NOT COMPLETED|Phase II||5
635339|NCT00124943|1561236|P3|NOT COMPLETED|Phase II||0
635340|NCT00124943|1561237|P2|NOT COMPLETED|Phase II||2
635341|NCT00124943|1561238|P1|NOT COMPLETED|Phase II||0
635342|NCT00124943|1561235|P4|COMPLETED|Phase II||50
635343|NCT00124943|1561236|P3|COMPLETED|Phase II||3
635344|NCT00124943|1561237|P2|COMPLETED|Phase II||49
635345|NCT00124943|1561238|P1|COMPLETED|Phase II||3
635346|NCT00124943|1561235|P4|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|55
635347|NCT00124943|1561236|P3|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|3
635348|NCT00124943|1561237|P2|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|51
635349|NCT00124943|1561238|P1|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|3
635350|NCT00124943|1561235|P4|NOT COMPLETED|Phase I||0
635351|NCT00124943|1561236|P3|NOT COMPLETED|Phase I||0
635352|NCT00124943|1561237|P2|NOT COMPLETED|Phase I||0
635353|NCT00124943|1561238|P1|NOT COMPLETED|Phase I||0
635354|NCT00124943|1561235|P4|COMPLETED|Phase I||3
635355|NCT00124943|1561236|P3|COMPLETED|Phase I||3
635356|NCT00124943|1561237|P2|COMPLETED|Phase I||3
635357|NCT00124943|1561238|P1|COMPLETED|Phase I||3
635358|NCT00124943|1561235|P4|STARTED|Phase I||3
635359|NCT00124943|1561236|P3|STARTED|Phase I||3
635360|NCT00124943|1561237|P2|STARTED|Phase I||3
635361|NCT00124943|1561238|P1|STARTED|Phase I||3
635362|NCT00124748|1561278|P2|NOT COMPLETED|Overall Study||284
635363|NCT00124748|1561279|P1|NOT COMPLETED|Overall Study||143
635364|NCT00124748|1561278|P2|COMPLETED|Overall Study||35
635365|NCT00124748|1561279|P1|COMPLETED|Overall Study||14
635366|NCT00124748|1561278|P2|Safety Population|Overall Study||316
635367|NCT00124748|1561279|P1|Safety Population|Overall Study||157
635368|NCT00124748|1561278|P2|STARTED|Overall Study||319
635369|NCT00124748|1561279|P1|STARTED|Overall Study||157
635370|NCT00124735|1561331|P10|NOT COMPLETED|Overall Study||2
635371|NCT00124735|1561332|P9|NOT COMPLETED|Overall Study||3
635372|NCT00124735|1561333|P8|NOT COMPLETED|Overall Study||1
635373|NCT00124735|1561334|P7|NOT COMPLETED|Overall Study||0
635374|NCT00124735|1561335|P6|NOT COMPLETED|Overall Study||2
635375|NCT00124735|1561336|P5|NOT COMPLETED|Overall Study||2
635376|NCT00124735|1561337|P4|NOT COMPLETED|Overall Study||3
635377|NCT00124735|1561338|P3|NOT COMPLETED|Overall Study||0
635378|NCT00124735|1561339|P2|NOT COMPLETED|Overall Study||2
635379|NCT00124735|1561340|P1|NOT COMPLETED|Overall Study||1
635380|NCT00124735|1561331|P10|COMPLETED|Overall Study||18
635381|NCT00124735|1561332|P9|COMPLETED|Overall Study||22
635382|NCT00124735|1561333|P8|COMPLETED|Overall Study||19
635383|NCT00124735|1561334|P7|COMPLETED|Overall Study||6
635384|NCT00124735|1561335|P6|COMPLETED|Overall Study||5
635385|NCT00124735|1561336|P5|COMPLETED|Overall Study||17
635386|NCT00124735|1561337|P4|COMPLETED|Overall Study||18
635387|NCT00124735|1561338|P3|COMPLETED|Overall Study||18
635388|NCT00124735|1561339|P2|COMPLETED|Overall Study||6
635389|NCT00124735|1561340|P1|COMPLETED|Overall Study||4
635390|NCT00124735|1561331|P10|STARTED|Overall Study||20
635391|NCT00124735|1561332|P9|STARTED|Overall Study||25
635392|NCT00124735|1561333|P8|STARTED|Overall Study||20
635393|NCT00124735|1561334|P7|STARTED|Overall Study||6
635394|NCT00124735|1561335|P6|STARTED|Overall Study||7
635395|NCT00124735|1561336|P5|STARTED|Overall Study||19
635396|NCT00124735|1561337|P4|STARTED|Overall Study||21
635397|NCT00124735|1561338|P3|STARTED|Overall Study||18
635398|NCT00124735|1561339|P2|STARTED|Overall Study||8
635399|NCT00124735|1561340|P1|STARTED|Overall Study||5
635400|NCT00124709|1561386|P2|NOT COMPLETED|Overall Study||272
635401|NCT00124709|1561387|P1|NOT COMPLETED|Overall Study||255
635402|NCT00124709|1561386|P2|COMPLETED|Overall Study|232 Participants entered the OL phase of the study.|273
635403|NCT00124709|1561387|P1|COMPLETED|Overall Study|232 Participants entered the OL phase of the study.|291
635404|NCT00124709|1561386|P2|Patients Who Received Study Medication|Overall Study||544
635405|NCT00124709|1561387|P1|Patients Who Received Study Medication|Overall Study||543
635406|NCT00124709|1561386|P2|STARTED|Overall Study||545
635407|NCT00124709|1561387|P1|STARTED|Overall Study||546
635408|NCT00124657|1561404|P3|NOT COMPLETED|Overall Study||32
635409|NCT00124657|1561405|P2|NOT COMPLETED|Overall Study||5
635410|NCT00124657|1561406|P1|NOT COMPLETED|Overall Study||16
635411|NCT00124657|1561404|P3|COMPLETED|Overall Study||7
635412|NCT00124657|1561405|P2|COMPLETED|Overall Study||0
635413|NCT00124657|1561406|P1|COMPLETED|Overall Study||2
635414|NCT00124657|1561404|P3|STARTED|Overall Study||39
635415|NCT00124657|1561405|P2|STARTED|Overall Study||5
635416|NCT00124657|1561406|P1|STARTED|Overall Study||18
635417|NCT00124618|1561441|P1|NOT COMPLETED|Overall Study||1
635418|NCT00124618|1561441|P1|COMPLETED|Overall Study||57
635419|NCT00124618|1561441|P1|STARTED|Overall Study||58
635420|NCT00124579|1561448|P1|NOT COMPLETED|Maintenance||2
635421|NCT00124579|1561448|P1|COMPLETED|Maintenance||0
635422|NCT00124579|1561448|P1|STARTED|Maintenance||2
635423|NCT00124579|1561448|P1|NOT COMPLETED|Induction||5
635424|NCT00124579|1561448|P1|COMPLETED|Induction||2
635425|NCT00124579|1561448|P1|STARTED|Induction||7
635426|NCT00124462|1561456|P2|NOT COMPLETED|Overall Study||13
635427|NCT00124462|1561457|P1|NOT COMPLETED|Overall Study||11
635428|NCT00124462|1561456|P2|COMPLETED|Overall Study||27
635429|NCT00124462|1561457|P1|COMPLETED|Overall Study||29
635430|NCT00124462|1561456|P2|STARTED|Overall Study||40
635431|NCT00124462|1561457|P1|STARTED|Overall Study||40
635432|NCT00124449|1561467|P2|NOT COMPLETED|18-Month Untreated Observation Period||13
635433|NCT00124449|1561468|P1|NOT COMPLETED|18-Month Untreated Observation Period||15
635434|NCT00124449|1561467|P2|COMPLETED|18-Month Untreated Observation Period||4
635435|NCT00124449|1561468|P1|COMPLETED|18-Month Untreated Observation Period||7
635436|NCT00124449|1561467|P2|Completed Year 1 of Study|18-Month Untreated Observation Period||9
635437|NCT00124449|1561468|P1|Completed Year 1 of Study|18-Month Untreated Observation Period||14
635438|NCT00124449|1561467|P2|STARTED|18-Month Untreated Observation Period||17
635439|NCT00124449|1561468|P1|STARTED|18-Month Untreated Observation Period||22
635440|NCT00124449|1561467|P2|NOT COMPLETED|6-month Double-Blind Treatment Period||11
635441|NCT00124449|1561468|P1|NOT COMPLETED|6-month Double-Blind Treatment Period||6
635442|NCT00124449|1561467|P2|COMPLETED|6-month Double-Blind Treatment Period||17
635443|NCT00124449|1561468|P1|COMPLETED|6-month Double-Blind Treatment Period||22
635444|NCT00124449|1561467|P2|STARTED|6-month Double-Blind Treatment Period||28
635445|NCT00124449|1561468|P1|STARTED|6-month Double-Blind Treatment Period||28
635446|NCT00124176|1561503|P2|NOT COMPLETED|Overall Study||0
635447|NCT00124176|1561504|P1|NOT COMPLETED|Overall Study||0
635448|NCT00124176|1561503|P2|COMPLETED|Overall Study||41
635449|NCT00124176|1561504|P1|COMPLETED|Overall Study||40
635450|NCT00124176|1561503|P2|Received Study Drug|Overall Study||41
635451|NCT00124176|1561504|P1|Received Study Drug|Overall Study|3 never started on drug due to improvement but were kept in the study by intention to treat.|37
635452|NCT00124176|1561503|P2|STARTED|Overall Study||41
635453|NCT00124176|1561504|P1|STARTED|Overall Study||40
635454|NCT00124072|1561522|P4|NOT COMPLETED|Overall Study||500
635455|NCT00124072|1561523|P3|NOT COMPLETED|Overall Study||492
635456|NCT00124072|1561524|P2|NOT COMPLETED|Overall Study||512
635457|NCT00124072|1561525|P1|NOT COMPLETED|Overall Study||514
635458|NCT00124072|1561522|P4|COMPLETED|Overall Study||2515
635459|NCT00124072|1561523|P3|COMPLETED|Overall Study||2524
635460|NCT00124072|1561524|P2|COMPLETED|Overall Study||2504
635461|NCT00124072|1561525|P1|COMPLETED|Overall Study||2503
635462|NCT00124072|1561522|P4|STARTED|Overall Study||3015
635463|NCT00124072|1561523|P3|STARTED|Overall Study||3016
635464|NCT00124072|1561524|P2|STARTED|Overall Study||3016
635465|NCT00124072|1561525|P1|STARTED|Overall Study||3017
635466|NCT00124020|1561537|P2|NOT COMPLETED|Overall Study||91
635467|NCT00124020|1561538|P1|NOT COMPLETED|Overall Study||88
635468|NCT00124020|1561537|P2|COMPLETED|Overall Study||289
635469|NCT00124020|1561538|P1|COMPLETED|Overall Study||289
635470|NCT00124020|1561537|P2|STARTED|Overall Study||380
635471|NCT00124020|1561538|P1|STARTED|Overall Study||377
635472|NCT00123955|1561546|P2|NOT COMPLETED|Overall Study||4
635473|NCT00123955|1561547|P1|NOT COMPLETED|Overall Study||5
635474|NCT00123955|1561546|P2|COMPLETED|Overall Study||34
635475|NCT00123955|1561547|P1|COMPLETED|Overall Study||37
635476|NCT00123955|1561546|P2|STARTED|Overall Study||38
635477|NCT00123955|1561547|P1|STARTED|Overall Study||42
635478|NCT00123734|1561559|P1|NOT COMPLETED|Overall Study||8
635479|NCT00123734|1561559|P1|COMPLETED|Overall Study||74
635480|NCT00123734|1561559|P1|STARTED|Overall Study||82
635481|NCT00123682|1561594|P4|NOT COMPLETED|Overall Study||95
635482|NCT00123682|1561595|P3|NOT COMPLETED|Overall Study||154
635483|NCT00123682|1561596|P2|NOT COMPLETED|Overall Study||203
635484|NCT00123682|1561597|P1|NOT COMPLETED|Overall Study||320
635485|NCT00123682|1561594|P4|COMPLETED|Overall Study||430
635486|NCT00123682|1561595|P3|COMPLETED|Overall Study||438
635487|NCT00123682|1561596|P2|COMPLETED|Overall Study||731
635488|NCT00123682|1561597|P1|COMPLETED|Overall Study||749
635489|NCT00123682|1561594|P4|STARTED|Overall Study||525
635490|NCT00123682|1561595|P3|STARTED|Overall Study||592
635491|NCT00123682|1561596|P2|STARTED|Overall Study||934
635492|NCT00123682|1561597|P1|STARTED|Overall Study||1069
635493|NCT00123643|1561617|P2|NOT COMPLETED|Overall Study||0
635494|NCT00123643|1561618|P1|NOT COMPLETED|Overall Study||0
635495|NCT00123643|1561617|P2|COMPLETED|Overall Study||16
635496|NCT00123643|1561618|P1|COMPLETED|Overall Study||20
635497|NCT00123643|1561617|P2|STARTED|Overall Study||16
635498|NCT00123643|1561618|P1|STARTED|Overall Study||20
635499|NCT00123630|1561626|P2|NOT COMPLETED|Overall Study||0
635500|NCT00123630|1561627|P1|NOT COMPLETED|Overall Study||0
635501|NCT00123630|1561626|P2|COMPLETED|Overall Study||15
635502|NCT00123630|1561627|P1|COMPLETED|Overall Study||15
635503|NCT00123630|1561626|P2|STARTED|Overall Study||15
635504|NCT00123630|1561627|P1|STARTED|Overall Study||15
635505|NCT00123604|1561635|P2|NOT COMPLETED|Overall Study||1
635506|NCT00123604|1561636|P1|NOT COMPLETED|Overall Study||1
635507|NCT00123604|1561635|P2|COMPLETED|Overall Study||16
635508|NCT00123604|1561636|P1|COMPLETED|Overall Study||18
635509|NCT00123604|1561635|P2|STARTED|Overall Study||17
635510|NCT00123604|1561636|P1|STARTED|Overall Study||19
635511|NCT00123487|1561644|P2|NOT COMPLETED|Treated With Study Drug||305
635512|NCT00123487|1561645|P1|NOT COMPLETED|Treated With Study Drug||304
635513|NCT00123487|1561644|P2|COMPLETED|Treated With Study Drug||0
635514|NCT00123487|1561645|P1|COMPLETED|Treated With Study Drug||0
635515|NCT00123487|1561644|P2|STARTED|Treated With Study Drug|1 participant randomized to QD but received BID in error. 305 represents actual BID treatment.|305
635516|NCT00123487|1561645|P1|STARTED|Treated With Study Drug|1 participant randomized to QD but received BID in error. 304 represents actual QD treatment.|304
635517|NCT00123487|1561644|P2|NOT COMPLETED|Randomized||1
635518|NCT00123487|1561645|P1|NOT COMPLETED|Randomized||1
635519|NCT00123487|1561644|P2|COMPLETED|Randomized||304
635520|NCT00123487|1561645|P1|COMPLETED|Randomized||305
635521|NCT00123487|1561644|P2|STARTED|Randomized||305
635522|NCT00123487|1561645|P1|STARTED|Randomized||306
635523|NCT00123474|1561689|P4|NOT COMPLETED|As Treated at Study Closure||167
635524|NCT00123474|1561690|P3|NOT COMPLETED|As Treated at Study Closure||167
635525|NCT00123474|1561691|P2|NOT COMPLETED|As Treated at Study Closure||163
635526|NCT00123474|1561692|P1|NOT COMPLETED|As Treated at Study Closure||165
635527|NCT00123474|1561689|P4|COMPLETED|As Treated at Study Closure||0
635528|NCT00123474|1561690|P3|COMPLETED|As Treated at Study Closure|Randomized to 100 mg QD but received 50 mg BID.|0
635529|NCT00123474|1561691|P2|COMPLETED|As Treated at Study Closure||0
635530|NCT00123474|1561692|P1|COMPLETED|As Treated at Study Closure||0
635531|NCT00123474|1561689|P4|STARTED|As Treated at Study Closure||167
635532|NCT00123474|1561690|P3|STARTED|As Treated at Study Closure||167
635533|NCT00123474|1561691|P2|STARTED|As Treated at Study Closure||163
635534|NCT00123474|1561692|P1|STARTED|As Treated at Study Closure|Randomized to 50 mg BID but received 100 mg QD.|165
635535|NCT00123474|1561689|P4|NOT COMPLETED|Randomized to Treatment||1
635536|NCT00123474|1561690|P3|NOT COMPLETED|Randomized to Treatment||2
635537|NCT00123474|1561691|P2|NOT COMPLETED|Randomized to Treatment||4
635538|NCT00123474|1561692|P1|NOT COMPLETED|Randomized to Treatment||1
635539|NCT00123474|1561689|P4|COMPLETED|Randomized to Treatment||167
635540|NCT00123474|1561690|P3|COMPLETED|Randomized to Treatment||166
635541|NCT00123474|1561691|P2|COMPLETED|Randomized to Treatment||163
635542|NCT00123474|1561692|P1|COMPLETED|Randomized to Treatment||166
635543|NCT00123474|1561689|P4|STARTED|Randomized to Treatment||168
635544|NCT00123474|1561690|P3|STARTED|Randomized to Treatment||168
635545|NCT00123474|1561691|P2|STARTED|Randomized to Treatment||167
635546|NCT00123474|1561692|P1|STARTED|Randomized to Treatment||167
635547|NCT00123422|1561786|P3|NOT COMPLETED|Overall Study||10
635548|NCT00123422|1561787|P2|NOT COMPLETED|Overall Study||6
635549|NCT00123422|1561788|P1|NOT COMPLETED|Overall Study||4
635550|NCT00123422|1561786|P3|COMPLETED|Overall Study||25
635551|NCT00123422|1561787|P2|COMPLETED|Overall Study||27
635552|NCT00123422|1561788|P1|COMPLETED|Overall Study||31
635553|NCT00123422|1561786|P3|8-week Testing|Overall Study||27
635554|NCT00123422|1561787|P2|8-week Testing|Overall Study||30
635555|NCT00123422|1561788|P1|8-week Testing|Overall Study||32
635556|NCT00123422|1561786|P3|STARTED|Overall Study||35
635557|NCT00123422|1561787|P2|STARTED|Overall Study||33
635558|NCT00123422|1561788|P1|STARTED|Overall Study||35
635559|NCT00123409|1561801|P2|NOT COMPLETED|Overall Study||3
635560|NCT00123409|1561802|P1|NOT COMPLETED|Overall Study||4
635561|NCT00123409|1561801|P2|COMPLETED|Overall Study||71
635562|NCT00123409|1561802|P1|COMPLETED|Overall Study||68
635563|NCT00123409|1561801|P2|STARTED|Overall Study||74
635564|NCT00123409|1561802|P1|STARTED|Overall Study||72
635565|NCT00123162|1561812|P2|NOT COMPLETED|Overall Study||0
635566|NCT00123162|1561813|P1|NOT COMPLETED|Overall Study||0
635567|NCT00123162|1561812|P2|COMPLETED|Overall Study||12
635568|NCT00123162|1561813|P1|COMPLETED|Overall Study||13
635569|NCT00123162|1561812|P2|STARTED|Overall Study||12
635570|NCT00123162|1561813|P1|STARTED|Overall Study||13
635571|NCT00123123|1561824|P3|NOT COMPLETED|Overall Study||0
635572|NCT00123123|1561825|P2|NOT COMPLETED|Overall Study||0
635573|NCT00123123|1561826|P1|NOT COMPLETED|Overall Study||0
635574|NCT00123123|1561824|P3|COMPLETED|Overall Study||58
635575|NCT00123123|1561825|P2|COMPLETED|Overall Study||58
635576|NCT00123123|1561826|P1|COMPLETED|Overall Study||59
635577|NCT00123123|1561824|P3|STARTED|Overall Study||58
635578|NCT00123123|1561825|P2|STARTED|Overall Study||58
635579|NCT00123123|1561826|P1|STARTED|Overall Study||59
635580|NCT00122980|1561839|P2|NOT COMPLETED|Overall Study||40
635581|NCT00122980|1561840|P1|NOT COMPLETED|Overall Study||43
635582|NCT00122980|1561839|P2|COMPLETED|Overall Study|Study terminated early|26
635583|NCT00122980|1561840|P1|COMPLETED|Overall Study|Study terminated early|24
635584|NCT00122980|1561839|P2|STARTED|Overall Study|Randomized sample: 67; Intent-to-treat sample: 66|66
635585|NCT00122980|1561840|P1|STARTED|Overall Study|Randomized sample: 67; Intent-to-treat sample: 67|67
635586|NCT00122954|1561864|P2|NOT COMPLETED|Overall Study||3
635587|NCT00122954|1561865|P1|NOT COMPLETED|Overall Study||2
635588|NCT00122954|1561864|P2|COMPLETED|Overall Study||18
635589|NCT00122954|1561865|P1|COMPLETED|Overall Study||16
635590|NCT00122954|1561864|P2|STARTED|Overall Study||21
635591|NCT00122954|1561865|P1|STARTED|Overall Study||18
635592|NCT00122681|1561875|P2|NOT COMPLETED|Overall Study||1521
635593|NCT00122681|1561876|P1|NOT COMPLETED|Overall Study||1514
635594|NCT00122681|1561875|P2|COMPLETED|Overall Study||7798
635595|NCT00122681|1561876|P1|COMPLETED|Overall Study||7811
635596|NCT00122681|1561875|P2|STARTED|Overall Study||9319
635597|NCT00122681|1561876|P1|STARTED|Overall Study||9325
635598|NCT00122460|1561950|P2|NOT COMPLETED|Overall Study||1
635599|NCT00122460|1561951|P1|NOT COMPLETED|Overall Study||7
635600|NCT00122460|1561950|P2|COMPLETED|Overall Study||219
635601|NCT00122460|1561951|P1|COMPLETED|Overall Study||215
635602|NCT00122460|1561950|P2|STARTED|Overall Study|Intention To Treat population, treatment group as randomized|220
635603|NCT00122460|1561951|P1|STARTED|Overall Study|Intention To Treat population, treatment group as randomized|222
635604|NCT00122447|1561977|P4|NOT COMPLETED|Overall Study||3
635605|NCT00122447|1561978|P3|NOT COMPLETED|Overall Study||1
635606|NCT00122447|1561979|P2|NOT COMPLETED|Overall Study||5
635607|NCT00122447|1561980|P1|NOT COMPLETED|Overall Study||1
635608|NCT00122447|1561977|P4|COMPLETED|Overall Study||14
635609|NCT00122447|1561978|P3|COMPLETED|Overall Study||16
635610|NCT00122447|1561979|P2|COMPLETED|Overall Study||13
635611|NCT00122447|1561980|P1|COMPLETED|Overall Study||17
635612|NCT00122447|1561977|P4|STARTED|Overall Study||17
635613|NCT00122447|1561978|P3|STARTED|Overall Study||17
635614|NCT00122447|1561979|P2|STARTED|Overall Study||18
635615|NCT00122447|1561980|P1|STARTED|Overall Study||18
635616|NCT00122382|1562000|P3|NOT COMPLETED|Open-Label Study||26
635617|NCT00122382|1562001|P2|NOT COMPLETED|Open-Label Study||0
635618|NCT00122382|1562002|P1|NOT COMPLETED|Open-Label Study||0
635619|NCT00122382|1562000|P3|COMPLETED|Open-Label Study||433
635620|NCT00122382|1562001|P2|COMPLETED|Open-Label Study||0
635621|NCT00122382|1562002|P1|COMPLETED|Open-Label Study||0
635622|NCT00122382|1562000|P3|STARTED|Open-Label Study||459
635623|NCT00122382|1562001|P2|STARTED|Open-Label Study||0
635624|NCT00122382|1562002|P1|STARTED|Open-Label Study||0
635625|NCT00122382|1562000|P3|NOT COMPLETED|Double-Blind Study||0
635626|NCT00122382|1562001|P2|NOT COMPLETED|Double-Blind Study||28
635627|NCT00122382|1562002|P1|NOT COMPLETED|Double-Blind Study||24
635628|NCT00122382|1562000|P3|COMPLETED|Double-Blind Study||0
635629|NCT00122382|1562001|P2|COMPLETED|Double-Blind Study||227
635630|NCT00122382|1562002|P1|COMPLETED|Double-Blind Study||232
635631|NCT00122382|1562000|P3|Treated|Double-Blind Study||0
635632|NCT00122382|1562001|P2|Treated|Double-Blind Study||253
635633|NCT00122382|1562002|P1|Treated|Double-Blind Study||256
635634|NCT00122382|1562000|P3|STARTED|Double-Blind Study||0
635635|NCT00122382|1562001|P2|STARTED|Double-Blind Study|participants randomized|255
635636|NCT00122382|1562002|P1|STARTED|Double-Blind Study|participants randomized|256
635637|NCT00122369|1562055|P3|NOT COMPLETED|Overall Study||0
635638|NCT00122369|1562056|P2|NOT COMPLETED|Overall Study||0
635639|NCT00122369|1562057|P1|NOT COMPLETED|Overall Study||0
635640|NCT00122369|1562055|P3|COMPLETED|Overall Study||78
635641|NCT00122369|1562056|P2|COMPLETED|Overall Study||82
635642|NCT00122369|1562057|P1|COMPLETED|Overall Study||76
635643|NCT00122369|1562055|P3|STARTED|Overall Study||78
635644|NCT00122369|1562056|P2|STARTED|Overall Study||82
635645|NCT00122369|1562057|P1|STARTED|Overall Study||76
635646|NCT00122317|1562146|P1|NOT COMPLETED|Overall Study||11
635647|NCT00122317|1562146|P1|COMPLETED|Overall Study||176
635648|NCT00122317|1562146|P1|STARTED|Overall Study||187
635649|NCT00122187|1562155|P2|NOT COMPLETED|Overall Study||2
635650|NCT00122187|1562156|P1|NOT COMPLETED|Overall Study||2
635651|NCT00122187|1562155|P2|COMPLETED|Overall Study||2
635652|NCT00122187|1562156|P1|COMPLETED|Overall Study||2
635653|NCT00122187|1562155|P2|Post-intervention Data Collection|Overall Study||2
635654|NCT00122187|1562156|P1|Post-intervention Data Collection|Overall Study||2
635655|NCT00122187|1562155|P2|Intervention Implemented|Overall Study||4
635656|NCT00122187|1562156|P1|Intervention Implemented|Overall Study||3
635657|NCT00122187|1562155|P2|Randomized to Intervention or Usual Care|Overall Study||4
635658|NCT00122187|1562156|P1|Randomized to Intervention or Usual Care|Overall Study||4
635659|NCT00122187|1562155|P2|Matched by Colonoscopy Volume|Overall Study||4
635660|NCT00122187|1562156|P1|Matched by Colonoscopy Volume|Overall Study||4
635661|NCT00122187|1562155|P2|STARTED|Overall Study||4
635662|NCT00122187|1562156|P1|STARTED|Overall Study||4
635663|NCT00122135|1562170|P2|NOT COMPLETED|Overall Study||0
635664|NCT00122135|1562171|P1|NOT COMPLETED|Overall Study||3
635665|NCT00122135|1562170|P2|COMPLETED|Overall Study||60
635666|NCT00122135|1562171|P1|COMPLETED|Overall Study||57
635667|NCT00122135|1562170|P2|STARTED|Overall Study||60
635668|NCT00122135|1562171|P1|STARTED|Overall Study||60
635669|NCT00122109|1562179|P2|NOT COMPLETED|Overall Study||7
635670|NCT00122109|1562180|P1|NOT COMPLETED|Overall Study||6
635671|NCT00122109|1562179|P2|COMPLETED|Overall Study||57
635672|NCT00122109|1562180|P1|COMPLETED|Overall Study||55
635673|NCT00122109|1562179|P2|STARTED|Overall Study|ITT|64
635674|NCT00122109|1562180|P1|STARTED|Overall Study|ITT|61
635675|NCT00121836|1562204|P1|NOT COMPLETED|Overall Study||55
635676|NCT00121836|1562204|P1|COMPLETED|Overall Study||54
635677|NCT00121836|1562204|P1|STARTED|Overall Study||109
635678|NCT00121810|1562215|P2|NOT COMPLETED|Overall Study||39
635679|NCT00121810|1562216|P1|NOT COMPLETED|Overall Study||30
635680|NCT00121810|1562215|P2|COMPLETED|Overall Study||115
635681|NCT00121810|1562216|P1|COMPLETED|Overall Study||121
635682|NCT00121810|1562215|P2|Intent-to-Treat (ITT) Population|Overall Study||151
635683|NCT00121810|1562216|P1|Intent-to-Treat (ITT) Population|Overall Study||148
635684|NCT00121810|1562215|P2|Safety Population|Overall Study||153
635685|NCT00121810|1562216|P1|Safety Population|Overall Study||148
635686|NCT00121810|1562215|P2|STARTED|Overall Study||154
635687|NCT00121810|1562216|P1|STARTED|Overall Study||151
635688|NCT00121719|1562244|P14|NOT COMPLETED|Overall Study||7
635689|NCT00121719|1562245|P13|NOT COMPLETED|Overall Study||24
635690|NCT00121719|1562246|P12|NOT COMPLETED|Overall Study||5
635691|NCT00121719|1562247|P11|NOT COMPLETED|Overall Study||6
635692|NCT00121719|1562248|P10|NOT COMPLETED|Overall Study||3
635693|NCT00121719|1562249|P9|NOT COMPLETED|Overall Study||6
635694|NCT00121719|1562250|P8|NOT COMPLETED|Overall Study||9
635695|NCT00121719|1562251|P7|NOT COMPLETED|Overall Study||12
635696|NCT00121719|1562252|P6|NOT COMPLETED|Overall Study||3
635697|NCT00121719|1562253|P5|NOT COMPLETED|Overall Study||3
635698|NCT00121719|1562254|P4|NOT COMPLETED|Overall Study||3
635699|NCT00121719|1562255|P3|NOT COMPLETED|Overall Study||4
635700|NCT00121719|1562256|P2|NOT COMPLETED|Overall Study||4
635701|NCT00121719|1562257|P1|NOT COMPLETED|Overall Study||4
635702|NCT00121719|1562244|P14|COMPLETED|Overall Study||0
635703|NCT00121719|1562245|P13|COMPLETED|Overall Study||0
635704|NCT00121719|1562246|P12|COMPLETED|Overall Study||0
635705|NCT00121719|1562247|P11|COMPLETED|Overall Study||0
635706|NCT00121719|1562248|P10|COMPLETED|Overall Study||0
635707|NCT00121719|1562249|P9|COMPLETED|Overall Study||0
635708|NCT00121719|1562250|P8|COMPLETED|Overall Study||0
635709|NCT00121719|1562251|P7|COMPLETED|Overall Study||0
635710|NCT00121719|1562252|P6|COMPLETED|Overall Study||0
635711|NCT00121719|1562253|P5|COMPLETED|Overall Study||0
635712|NCT00121719|1562254|P4|COMPLETED|Overall Study||0
635713|NCT00121719|1562255|P3|COMPLETED|Overall Study||0
635714|NCT00121719|1562256|P2|COMPLETED|Overall Study||0
635715|NCT00121719|1562257|P1|COMPLETED|Overall Study||0
635716|NCT00121719|1562244|P14|STARTED|Overall Study||7
635717|NCT00121719|1562245|P13|STARTED|Overall Study||24
635718|NCT00121719|1562246|P12|STARTED|Overall Study||5
635719|NCT00121719|1562247|P11|STARTED|Overall Study||6
635720|NCT00121719|1562248|P10|STARTED|Overall Study||3
635721|NCT00121719|1562249|P9|STARTED|Overall Study||6
635722|NCT00121719|1562250|P8|STARTED|Overall Study||9
635723|NCT00121719|1562251|P7|STARTED|Overall Study||12
635724|NCT00121719|1562252|P6|STARTED|Overall Study||3
635725|NCT00121719|1562253|P5|STARTED|Overall Study||3
635726|NCT00121719|1562254|P4|STARTED|Overall Study||3
635727|NCT00121719|1562255|P3|STARTED|Overall Study||4
635728|NCT00121719|1562256|P2|STARTED|Overall Study||4
635729|NCT00121719|1562257|P1|STARTED|Overall Study||4
635730|NCT00121667|1562434|P4|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||140
635731|NCT00121667|1562435|P3|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||113
635732|NCT00121667|1562436|P2|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||133
635733|NCT00121667|1562437|P1|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||128
635734|NCT00121667|1562434|P4|COMPLETED|Short Term (ST) + Long Term (LT) Period||39
635735|NCT00121667|1562435|P3|COMPLETED|Short Term (ST) + Long Term (LT) Period||68
635736|NCT00121667|1562436|P2|COMPLETED|Short Term (ST) + Long Term (LT) Period||58
635737|NCT00121667|1562437|P1|COMPLETED|Short Term (ST) + Long Term (LT) Period||64
635738|NCT00121667|1562434|P4|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||7
635739|NCT00121667|1562435|P3|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||23
635740|NCT00121667|1562436|P2|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||18
635741|NCT00121667|1562437|P1|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||14
635742|NCT00121667|1562434|P4|STARTED|Short Term (ST) + Long Term (LT) Period||179
635743|NCT00121667|1562435|P3|STARTED|Short Term (ST) + Long Term (LT) Period||181
635744|NCT00121667|1562436|P2|STARTED|Short Term (ST) + Long Term (LT) Period||191
635745|NCT00121667|1562437|P1|STARTED|Short Term (ST) + Long Term (LT) Period||192
635746|NCT00121667|1562434|P4|NOT COMPLETED|Short Term (ST) Period||67
635747|NCT00121667|1562435|P3|NOT COMPLETED|Short Term (ST) Period||41
635748|NCT00121667|1562436|P2|NOT COMPLETED|Short Term (ST) Period||48
635749|NCT00121667|1562437|P1|NOT COMPLETED|Short Term (ST) Period||44
635750|NCT00121667|1562434|P4|COMPLETED|Short Term (ST) Period||112
635751|NCT00121667|1562435|P3|COMPLETED|Short Term (ST) Period||140
635752|NCT00121667|1562436|P2|COMPLETED|Short Term (ST) Period||143
635753|NCT00121667|1562437|P1|COMPLETED|Short Term (ST) Period||148
635754|NCT00121667|1562434|P4|STARTED|Short Term (ST) Period||179
635755|NCT00121667|1562435|P3|STARTED|Short Term (ST) Period||181
635756|NCT00121667|1562436|P2|STARTED|Short Term (ST) Period||191
635757|NCT00121667|1562437|P1|STARTED|Short Term (ST) Period||192
635758|NCT00121641|1562535|P5|NOT COMPLETED|48-month Short Term + Long Term Period||58
635759|NCT00121641|1562536|P4|NOT COMPLETED|48-month Short Term + Long Term Period||71
635760|NCT00121641|1562537|P3|NOT COMPLETED|48-month Short Term + Long Term Period||70
635761|NCT00121641|1562538|P2|NOT COMPLETED|48-month Short Term + Long Term Period||82
635762|NCT00121641|1562539|P1|NOT COMPLETED|48-month Short Term + Long Term Period||79
635763|NCT00121641|1562535|P5|COMPLETED|48-month Short Term + Long Term Period||8
635764|NCT00121641|1562536|P4|COMPLETED|48-month Short Term + Long Term Period||24
635765|NCT00121641|1562537|P3|COMPLETED|48-month Short Term + Long Term Period||28
635766|NCT00121641|1562538|P2|COMPLETED|48-month Short Term + Long Term Period||24
635767|NCT00121641|1562539|P1|COMPLETED|48-month Short Term + Long Term Period||23
635768|NCT00121641|1562535|P5|STARTED|48-month Short Term + Long Term Period||66
635769|NCT00121641|1562536|P4|STARTED|48-month Short Term + Long Term Period||95
635770|NCT00121641|1562537|P3|STARTED|48-month Short Term + Long Term Period||98
635771|NCT00121641|1562538|P2|STARTED|48-month Short Term + Long Term Period||106
635772|NCT00121641|1562539|P1|STARTED|48-month Short Term + Long Term Period||102
635773|NCT00121641|1562535|P5|NOT COMPLETED|24-week Short-term Treatment Period||41
635774|NCT00121641|1562536|P4|NOT COMPLETED|24-week Short-term Treatment Period||40
635775|NCT00121641|1562537|P3|NOT COMPLETED|24-week Short-term Treatment Period||29
635776|NCT00121641|1562538|P2|NOT COMPLETED|24-week Short-term Treatment Period||38
635777|NCT00121641|1562539|P1|NOT COMPLETED|24-week Short-term Treatment Period||29
635778|NCT00121641|1562535|P5|COMPLETED|24-week Short-term Treatment Period||25
635779|NCT00121641|1562536|P4|COMPLETED|24-week Short-term Treatment Period||55
635780|NCT00121641|1562537|P3|COMPLETED|24-week Short-term Treatment Period||69
635864|NCT00120289|1562844|P1|STARTED|Overall Study||1718
635781|NCT00121641|1562538|P2|COMPLETED|24-week Short-term Treatment Period||68
635782|NCT00121641|1562539|P1|COMPLETED|24-week Short-term Treatment Period||73
635783|NCT00121641|1562535|P5|STARTED|24-week Short-term Treatment Period||66
635784|NCT00121641|1562536|P4|STARTED|24-week Short-term Treatment Period||95
635785|NCT00121641|1562537|P3|STARTED|24-week Short-term Treatment Period||98
635786|NCT00121641|1562538|P2|STARTED|24-week Short-term Treatment Period||106
635787|NCT00121641|1562539|P1|STARTED|24-week Short-term Treatment Period||102
635788|NCT00121485|1562652|P2|NOT COMPLETED|Overall Study||7
635789|NCT00121485|1562653|P1|NOT COMPLETED|Overall Study||1
635790|NCT00121485|1562652|P2|COMPLETED|Overall Study||59
635791|NCT00121485|1562653|P1|COMPLETED|Overall Study||133
635792|NCT00121485|1562652|P2|STARTED|Overall Study||66
635793|NCT00121485|1562653|P1|STARTED|Overall Study||134
635794|NCT00121472|1562687|P1|NOT COMPLETED|Overall Study||0
635795|NCT00121472|1562687|P1|COMPLETED|Overall Study|Followed for at least 1 year after implantation of HM II LVAS.|194
635796|NCT00121472|1562687|P1|STARTED|Overall Study||194
635797|NCT00121238|1562698|P1|NOT COMPLETED|Overall Study||3
635798|NCT00121238|1562698|P1|COMPLETED|Overall Study|2 were later deemed ineligible (PSA rise), censored from efficacy but included for toxicity analysis|13
635799|NCT00121238|1562698|P1|STARTED|Overall Study||16
635800|NCT00121225|1562706|P1|NOT COMPLETED|Overall Study||0
635801|NCT00121225|1562706|P1|COMPLETED|Overall Study||32
635802|NCT00121225|1562706|P1|STARTED|Overall Study||32
635803|NCT00121199|1562710|P1|NOT COMPLETED|Overall Study||28
635804|NCT00121199|1562710|P1|COMPLETED|Overall Study||45
635805|NCT00121199|1562710|P1|Eligible and Began Protocol Therapy|Overall Study||64
635806|NCT00121199|1562710|P1|Eligible|Overall Study||64
635807|NCT00121199|1562710|P1|STARTED|Overall Study||73
635808|NCT00121186|1562717|P1|NOT COMPLETED|Overall Study||0
635809|NCT00121186|1562717|P1|COMPLETED|Overall Study||1
635810|NCT00121186|1562717|P1|STARTED|Overall Study||1
635811|NCT00121134|1562726|P4|NOT COMPLETED|Overall Study||9
635812|NCT00121134|1562727|P3|NOT COMPLETED|Overall Study||21
635813|NCT00121134|1562728|P2|NOT COMPLETED|Overall Study||15
635814|NCT00121134|1562729|P1|NOT COMPLETED|Overall Study||16
635815|NCT00121134|1562726|P4|COMPLETED|Overall Study||31
635816|NCT00121134|1562727|P3|COMPLETED|Overall Study||20
635817|NCT00121134|1562728|P2|COMPLETED|Overall Study||26
635818|NCT00121134|1562729|P1|COMPLETED|Overall Study||24
635819|NCT00121134|1562726|P4|STARTED|Overall Study||40
635820|NCT00121134|1562727|P3|STARTED|Overall Study||41
635821|NCT00121134|1562728|P2|STARTED|Overall Study||41
635822|NCT00121134|1562729|P1|STARTED|Overall Study||40
635823|NCT00120874|1562741|P2|NOT COMPLETED|Overall Study||1
635824|NCT00120874|1562742|P1|NOT COMPLETED|Overall Study||0
635825|NCT00120874|1562741|P2|COMPLETED|Overall Study||9
635826|NCT00120874|1562742|P1|COMPLETED|Overall Study||10
635827|NCT00120874|1562741|P2|Completed Study; Started Extension Study|Overall Study||10
635828|NCT00120874|1562742|P1|Completed Study; Started Extension Study|Overall Study||10
635829|NCT00120874|1562741|P2|STARTED|Overall Study||10
635830|NCT00120874|1562742|P1|STARTED|Overall Study||10
635831|NCT00120627|1562780|P2|NOT COMPLETED|Overall Study||5
635832|NCT00120627|1562781|P1|NOT COMPLETED|Overall Study||5
635833|NCT00120627|1562780|P2|COMPLETED|Overall Study|Three people refused the post-assessments CAPS interview only.|70
635834|NCT00120627|1562781|P1|COMPLETED|Overall Study||66
635835|NCT00120627|1562780|P2|Did Not Complete Post-tx Assessments|Overall Study|Three people dropped out but no reason given.|3
635836|NCT00120627|1562781|P1|Did Not Complete Post-tx Assessments|Overall Study|One person had a scheduling conflict and two people were incarcerated.|3
635837|NCT00120627|1562780|P2|Began Interventions|Overall Study|Two people dropped due to scheduling conflict and an unknown reason.|73
635838|NCT00120627|1562781|P1|Began Interventions|Overall Study|Two people dropped due to scheduling conflict and illness.|69
635839|NCT00120627|1562780|P2|STARTED|Overall Study|This was the number that enrolled and was randomly assigned to receive the control condition.|75
635840|NCT00120627|1562781|P1|STARTED|Overall Study|This is the number who enrolled and was randomly assigned to receive the Mantram Repetition Program.|71
635841|NCT00120523|1562807|P2|NOT COMPLETED|Follow-Up Period||24
635842|NCT00120523|1562808|P1|NOT COMPLETED|Follow-Up Period||30
635843|NCT00120523|1562807|P2|COMPLETED|Follow-Up Period||46
635844|NCT00120523|1562808|P1|COMPLETED|Follow-Up Period||90
635845|NCT00120523|1562807|P2|STARTED|Follow-Up Period|Patients discontinued due to lost to follow-up or who withdrew consent were not part of this period.|70
635846|NCT00120523|1562808|P1|STARTED|Follow-Up Period|Patients discontinued due to lost to follow-up or who withdrew consent were not part of this period.|120
635847|NCT00120523|1562807|P2|NOT COMPLETED|Treatment Period||339
635848|NCT00120523|1562808|P1|NOT COMPLETED|Treatment Period||369
635849|NCT00120523|1562807|P2|COMPLETED|Treatment Period||874
635850|NCT00120523|1562808|P1|COMPLETED|Treatment Period||836
635851|NCT00120523|1562807|P2|STARTED|Treatment Period||1213
635852|NCT00120523|1562808|P1|STARTED|Treatment Period||1205
635853|NCT00120406|1562832|P2|NOT COMPLETED|Overall Study||16
635854|NCT00120406|1562833|P1|NOT COMPLETED|Overall Study||19
635855|NCT00120406|1562832|P2|COMPLETED|Overall Study||222
635856|NCT00120406|1562833|P1|COMPLETED|Overall Study||217
635857|NCT00120406|1562832|P2|STARTED|Overall Study||238
635858|NCT00120406|1562833|P1|STARTED|Overall Study||236
635859|NCT00120289|1562843|P2|NOT COMPLETED|Overall Study||109
635860|NCT00120289|1562844|P1|NOT COMPLETED|Overall Study||121
635861|NCT00120289|1562843|P2|COMPLETED|Overall Study||1587
635862|NCT00120289|1562844|P1|COMPLETED|Overall Study||1597
635863|NCT00120289|1562843|P2|STARTED|Overall Study||1696
635865|NCT00120250|1562856|P2|NOT COMPLETED|Overall Study||2
635866|NCT00120250|1562857|P1|NOT COMPLETED|Overall Study||1
635867|NCT00120250|1562856|P2|COMPLETED|Overall Study||12
635868|NCT00120250|1562857|P1|COMPLETED|Overall Study||12
635869|NCT00120250|1562856|P2|STARTED|Overall Study||14
635870|NCT00120250|1562857|P1|STARTED|Overall Study||13
635871|NCT00120042|1562873|P3|NOT COMPLETED|Overall Study||0
635872|NCT00120042|1562874|P2|NOT COMPLETED|Overall Study||0
635873|NCT00120042|1562875|P1|NOT COMPLETED|Overall Study||0
635874|NCT00120042|1562873|P3|COMPLETED|Overall Study||83
635875|NCT00120042|1562874|P2|COMPLETED|Overall Study||83
635876|NCT00120042|1562875|P1|COMPLETED|Overall Study||85
635877|NCT00120042|1562873|P3|STARTED|Overall Study||83
635878|NCT00120042|1562874|P2|STARTED|Overall Study||83
635879|NCT00120042|1562875|P1|STARTED|Overall Study||85
635880|NCT00119678|1562885|P2|NOT COMPLETED|Open-label Treatment Period||0
635881|NCT00119678|1562886|P1|NOT COMPLETED|Open-label Treatment Period||110
635882|NCT00119678|1562885|P2|COMPLETED|Open-label Treatment Period||0
635883|NCT00119678|1562886|P1|COMPLETED|Open-label Treatment Period||0
635884|NCT00119678|1562885|P2|STARTED|Open-label Treatment Period||0
635885|NCT00119678|1562886|P1|STARTED|Open-label Treatment Period|Number of participants treated|110
635886|NCT00119678|1562885|P2|NOT COMPLETED|Double-blind Treatment Period||26
635887|NCT00119678|1562886|P1|NOT COMPLETED|Double-blind Treatment Period||41
635888|NCT00119678|1562885|P2|COMPLETED|Double-blind Treatment Period||35
635889|NCT00119678|1562886|P1|COMPLETED|Double-blind Treatment Period||81
635890|NCT00119678|1562885|P2|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||57
635891|NCT00119678|1562886|P1|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||118
635892|NCT00119678|1562885|P2|RANDOMIZED AND TREATED|Double-blind Treatment Period||59
635893|NCT00119678|1562886|P1|RANDOMIZED AND TREATED|Double-blind Treatment Period||121
635894|NCT00119678|1562885|P2|STARTED|Double-blind Treatment Period||61
635895|NCT00119678|1562886|P1|STARTED|Double-blind Treatment Period||122
635896|NCT00119405|1562932|P1|NOT COMPLETED|Overall Study||1
635897|NCT00119405|1562932|P1|COMPLETED|Overall Study||17
635898|NCT00119405|1562932|P1|STARTED|Overall Study||18
635902|NCT00119379|1562946|P2|NOT COMPLETED|Overall Study||1
635903|NCT00119379|1562947|P1|NOT COMPLETED|Overall Study||4
635904|NCT00119379|1562946|P2|COMPLETED|Overall Study||23
635905|NCT00119379|1562947|P1|COMPLETED|Overall Study||22
635906|NCT00119379|1562946|P2|STARTED|Overall Study||24
635907|NCT00119379|1562947|P1|STARTED|Overall Study||26
635908|NCT00119262|1562965|P2|NOT COMPLETED|Overall Study||58
635909|NCT00119262|1562966|P1|NOT COMPLETED|Overall Study||46
635910|NCT00119262|1562965|P2|COMPLETED|Overall Study||64
635911|NCT00119262|1562966|P1|COMPLETED|Overall Study||58
635912|NCT00119262|1562965|P2|Eligible and Treated|Overall Study||119
635913|NCT00119262|1562966|P1|Eligible and Treated|Overall Study||102
635914|NCT00119262|1562965|P2|Treated|Overall Study||120
635915|NCT00119262|1562966|P1|Treated|Overall Study||103
635916|NCT00119262|1562965|P2|Eligible|Overall Study||120
635917|NCT00119262|1562966|P1|Eligible|Overall Study||103
635918|NCT00119262|1562965|P2|STARTED|Overall Study||122
635919|NCT00119262|1562966|P1|STARTED|Overall Study||104
635920|NCT00119158|1562978|P2|NOT COMPLETED|Placebo Treatment||0
635921|NCT00119158|1562979|P1|NOT COMPLETED|Placebo Treatment||0
635922|NCT00119158|1562978|P2|COMPLETED|Placebo Treatment||45
635923|NCT00119158|1562979|P1|COMPLETED|Placebo Treatment||45
635924|NCT00119158|1562978|P2|STARTED|Placebo Treatment||45
635925|NCT00119158|1562979|P1|STARTED|Placebo Treatment||45
635926|NCT00119158|1562978|P2|NOT COMPLETED|Active Treatment||0
635927|NCT00119158|1562979|P1|NOT COMPLETED|Active Treatment||0
635928|NCT00119158|1562978|P2|COMPLETED|Active Treatment||45
635929|NCT00119158|1562979|P1|COMPLETED|Active Treatment||45
635930|NCT00119158|1562978|P2|STARTED|Active Treatment||45
635931|NCT00119158|1562979|P1|STARTED|Active Treatment|patients are self controls|45
635932|NCT00119041|1562990|P3|NOT COMPLETED|Overall Study||0
635933|NCT00119041|1562991|P2|NOT COMPLETED|Overall Study||0
635934|NCT00119041|1562992|P1|NOT COMPLETED|Overall Study||0
635935|NCT00119041|1562990|P3|COMPLETED|Overall Study||22
635936|NCT00119041|1562991|P2|COMPLETED|Overall Study||83
635937|NCT00119041|1562992|P1|COMPLETED|Overall Study||199
635938|NCT00119041|1562990|P3|STARTED|Overall Study||22
635939|NCT00119041|1562991|P2|STARTED|Overall Study||83
635940|NCT00119041|1562992|P1|STARTED|Overall Study||199
635941|NCT00119015|1563003|P3|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
635942|NCT00119015|1563004|P2|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
635943|NCT00119015|1563005|P1|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
635944|NCT00119015|1563003|P3|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||26
635945|NCT00119015|1563004|P2|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||28
635946|NCT00119015|1563005|P1|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
635947|NCT00119015|1563003|P3|STARTED|Double-Blind, Randomized Phase (2 Weeks)|Baseline Analysis Population|26
635948|NCT00119015|1563004|P2|STARTED|Double-Blind, Randomized Phase (2 Weeks)|Baseline Analysis Population|28
635949|NCT00119015|1563005|P1|STARTED|Double-Blind, Randomized Phase (2 Weeks)||0
635950|NCT00119015|1563003|P3|NOT COMPLETED|Open-Label Phase (2 Weeks)||0
635951|NCT00119015|1563004|P2|NOT COMPLETED|Open-Label Phase (2 Weeks)||0
635952|NCT00119015|1563005|P1|NOT COMPLETED|Open-Label Phase (2 Weeks)||48
635953|NCT00119015|1563003|P3|COMPLETED|Open-Label Phase (2 Weeks)||0
635954|NCT00119015|1563004|P2|COMPLETED|Open-Label Phase (2 Weeks)||0
635955|NCT00119015|1563005|P1|COMPLETED|Open-Label Phase (2 Weeks)||54
635956|NCT00119015|1563003|P3|STARTED|Open-Label Phase (2 Weeks)||0
635957|NCT00119015|1563004|P2|STARTED|Open-Label Phase (2 Weeks)||0
635958|NCT00119015|1563005|P1|STARTED|Open-Label Phase (2 Weeks)||102
635959|NCT00118911|1563021|P2|NOT COMPLETED|Overall Study||5
635960|NCT00118911|1563022|P1|NOT COMPLETED|Overall Study||2
635961|NCT00118911|1563021|P2|COMPLETED|Overall Study||38
635962|NCT00118911|1563022|P1|COMPLETED|Overall Study||41
635963|NCT00118911|1563021|P2|12 Month Follow-up|Overall Study|2 participants did not complete the 6 month follow-up but did complete the 12 month follow-up|32
635964|NCT00118911|1563022|P1|12 Month Follow-up|Overall Study|1 participant did not complete the 6 month follow-up but did complete the 12 month follow-up|38
635965|NCT00118911|1563021|P2|6 Month Follow-up|Overall Study||30
635966|NCT00118911|1563022|P1|6 Month Follow-up|Overall Study||37
635967|NCT00118911|1563021|P2|Completed Post-Treatment Assessment|Overall Study||37
635968|NCT00118911|1563022|P1|Completed Post-Treatment Assessment|Overall Study||41
635969|NCT00118911|1563021|P2|Received Intervention as Assigned|Overall Study||38
635970|NCT00118911|1563022|P1|Received Intervention as Assigned|Overall Study||41
635971|NCT00118911|1563021|P2|STARTED|Overall Study||43
635972|NCT00118911|1563022|P1|STARTED|Overall Study||43
635973|NCT00118898|1563034|P4|NOT COMPLETED|Overall Study||141
635974|NCT00118898|1563035|P3|NOT COMPLETED|Overall Study||123
635975|NCT00118898|1563036|P2|NOT COMPLETED|Overall Study||141
635976|NCT00118898|1563037|P1|NOT COMPLETED|Overall Study||121
635977|NCT00118898|1563034|P4|COMPLETED|Overall Study||322
635978|NCT00118898|1563035|P3|COMPLETED|Overall Study||342
635979|NCT00118898|1563036|P2|COMPLETED|Overall Study||324
635980|NCT00118898|1563037|P1|COMPLETED|Overall Study||343
635981|NCT00118898|1563034|P4|Initiated Treatment|Overall Study||462
635982|NCT00118898|1563035|P3|Initiated Treatment|Overall Study||464
635983|NCT00118898|1563036|P2|Initiated Treatment|Overall Study||461
635984|NCT00118898|1563037|P1|Initiated Treatment|Overall Study||461
635985|NCT00118898|1563034|P4|STARTED|Overall Study||463
635986|NCT00118898|1563035|P3|STARTED|Overall Study||465
635987|NCT00118898|1563036|P2|STARTED|Overall Study||465
635988|NCT00118898|1563037|P1|STARTED|Overall Study||464
635989|NCT00118755|1563133|P2|NOT COMPLETED|Overall Study||215
635990|NCT00118755|1563134|P1|NOT COMPLETED|Overall Study||210
635991|NCT00118755|1563133|P2|COMPLETED|Overall Study||3
635992|NCT00118755|1563134|P1|COMPLETED|Overall Study||7
635993|NCT00118755|1563133|P2|Safety Population|Overall Study||211
635994|NCT00118755|1563134|P1|Safety Population|Overall Study||208
635995|NCT00118755|1563133|P2|STARTED|Overall Study||218
635996|NCT00118755|1563134|P1|STARTED|Overall Study||217
635997|NCT00118742|1563148|P2|NOT COMPLETED|Overall Study||66
635998|NCT00118742|1563149|P1|NOT COMPLETED|Overall Study||49
635999|NCT00118742|1563148|P2|COMPLETED|Overall Study||82
636000|NCT00118742|1563149|P1|COMPLETED|Overall Study||96
636001|NCT00118742|1563148|P2|STARTED|Overall Study||148
636002|NCT00118742|1563149|P1|STARTED|Overall Study||145
636003|NCT00118703|1563163|P2|NOT COMPLETED|Overall Study||9
636004|NCT00118703|1563164|P1|NOT COMPLETED|Overall Study||5
636005|NCT00118703|1563163|P2|COMPLETED|Overall Study||165
636006|NCT00118703|1563164|P1|COMPLETED|Overall Study||168
636007|NCT00118703|1563163|P2|STARTED|Overall Study||174
636008|NCT00118703|1563164|P1|STARTED|Overall Study||173
636009|NCT00118534|1563176|P2|NOT COMPLETED|Overall Study||0
636010|NCT00118534|1563177|P1|NOT COMPLETED|Overall Study||0
636011|NCT00118534|1563176|P2|COMPLETED|Overall Study||471
636012|NCT00118534|1563177|P1|COMPLETED|Overall Study||472
636013|NCT00118534|1563176|P2|STARTED|Overall Study||471
636014|NCT00118534|1563177|P1|STARTED|Overall Study||472
636015|NCT00118482|1563261|P2|NOT COMPLETED|Overall Study||29
636016|NCT00118482|1563262|P1|NOT COMPLETED|Overall Study||30
636017|NCT00118482|1563261|P2|COMPLETED|Overall Study||76
636018|NCT00118482|1563262|P1|COMPLETED|Overall Study|210 in the Intention To Treat analysis|75
636019|NCT00118482|1563261|P2|STARTED|Overall Study||105
636020|NCT00118482|1563262|P1|STARTED|Overall Study|3 patients signed the consent but did not take the study medication.|105
636021|NCT00118430|1563273|P3|NOT COMPLETED|Overall Study||28
636022|NCT00118430|1563274|P2|NOT COMPLETED|Overall Study||24
636023|NCT00118430|1563275|P1|NOT COMPLETED|Overall Study||21
636024|NCT00118430|1563273|P3|COMPLETED|Overall Study||222
636025|NCT00118430|1563274|P2|COMPLETED|Overall Study|127 included in primary analysis due to repeated measures and interim 1,3 and 6 month assessments|103
636026|NCT00118430|1563275|P1|COMPLETED|Overall Study|123 included in primary analysis due to repeated measures and interim 1,3 and 6 month assessments|102
636027|NCT00118430|1563273|P3|STARTED|Overall Study||250
636028|NCT00118430|1563274|P2|STARTED|Overall Study||127
636029|NCT00118430|1563275|P1|STARTED|Overall Study||123
636030|NCT00118417|1563290|P2|NOT COMPLETED|Phase III (Weeks 12 to 24)||1
636031|NCT00118417|1563291|P1|NOT COMPLETED|Phase III (Weeks 12 to 24)||1
636032|NCT00118417|1563290|P2|COMPLETED|Phase III (Weeks 12 to 24)||9
636033|NCT00118417|1563291|P1|COMPLETED|Phase III (Weeks 12 to 24)||8
636034|NCT00118417|1563290|P2|STARTED|Phase III (Weeks 12 to 24)||10
636035|NCT00118417|1563291|P1|STARTED|Phase III (Weeks 12 to 24)||9
636036|NCT00118417|1563290|P2|NOT COMPLETED|Phase II (Weeks 6 to 12)||3
636037|NCT00118417|1563291|P1|NOT COMPLETED|Phase II (Weeks 6 to 12)||2
636038|NCT00118417|1563290|P2|COMPLETED|Phase II (Weeks 6 to 12)||10
636039|NCT00118417|1563291|P1|COMPLETED|Phase II (Weeks 6 to 12)||9
636040|NCT00118417|1563290|P2|STARTED|Phase II (Weeks 6 to 12)||13
636041|NCT00118417|1563291|P1|STARTED|Phase II (Weeks 6 to 12)|Three new participants on Phase 1 endpoint doses of SSRIs entered at Phase 2.|11
636042|NCT00118417|1563290|P2|NOT COMPLETED|Phase I (Weeks 0 to 6)||0
636043|NCT00118417|1563291|P1|NOT COMPLETED|Phase I (Weeks 0 to 6)||18
636044|NCT00118417|1563290|P2|COMPLETED|Phase I (Weeks 0 to 6)||0
636045|NCT00118417|1563291|P1|COMPLETED|Phase I (Weeks 0 to 6)||21
636046|NCT00118417|1563290|P2|STARTED|Phase I (Weeks 0 to 6)|In Phase 1, all participants received open label SSRI - no second treatment arm.|0
636047|NCT00118417|1563291|P1|STARTED|Phase I (Weeks 0 to 6)||39
636048|NCT00118404|1563304|P3|NOT COMPLETED|Overall Study||20
636049|NCT00118404|1563305|P2|NOT COMPLETED|Overall Study||16
636050|NCT00118404|1563306|P1|NOT COMPLETED|Overall Study||24
636051|NCT00118404|1563304|P3|COMPLETED|Overall Study||49
636052|NCT00118404|1563305|P2|COMPLETED|Overall Study||70
636053|NCT00118404|1563306|P1|COMPLETED|Overall Study||62
636054|NCT00118404|1563304|P3|STARTED|Overall Study||69
636055|NCT00118404|1563305|P2|STARTED|Overall Study||86
636056|NCT00118404|1563306|P1|STARTED|Overall Study||86
636057|NCT00118378|1563322|P2|NOT COMPLETED|Overall Study||8
636058|NCT00118378|1563323|P1|NOT COMPLETED|Overall Study||2
636059|NCT00118378|1563322|P2|COMPLETED|Overall Study||45
636060|NCT00118378|1563323|P1|COMPLETED|Overall Study||60
636061|NCT00118378|1563322|P2|STARTED|Overall Study||53
636062|NCT00118378|1563323|P1|STARTED|Overall Study||62
636063|NCT00118365|1563337|P2|NOT COMPLETED|Overall Study||60
636064|NCT00118365|1563338|P1|NOT COMPLETED|Overall Study||59
636065|NCT00118365|1563337|P2|COMPLETED|Overall Study||124
636066|NCT00118365|1563338|P1|COMPLETED|Overall Study||132
636067|NCT00118365|1563337|P2|STARTED|Overall Study||184
636068|NCT00118365|1563338|P1|STARTED|Overall Study||191
636069|NCT00118352|1563407|P3|NOT COMPLETED|Overall Study||0
636070|NCT00118352|1563408|P2|NOT COMPLETED|Overall Study||0
636071|NCT00118352|1563409|P1|NOT COMPLETED|Overall Study||0
636072|NCT00118352|1563407|P3|COMPLETED|Overall Study||0
636073|NCT00118352|1563408|P2|COMPLETED|Overall Study||0
636074|NCT00118352|1563409|P1|COMPLETED|Overall Study||12
636075|NCT00118352|1563407|P3|STARTED|Overall Study||0
636076|NCT00118352|1563408|P2|STARTED|Overall Study||0
636077|NCT00118352|1563409|P1|STARTED|Overall Study||12
636078|NCT00118287|1563435|P1|NOT COMPLETED|Overall Study||2
636079|NCT00118287|1563435|P1|COMPLETED|Overall Study||30
636080|NCT00118287|1563435|P1|STARTED|Overall Study||32
636081|NCT00118248|1563441|P2|NOT COMPLETED|Overall Study||0
636082|NCT00118248|1563442|P1|NOT COMPLETED|Overall Study||0
636083|NCT00118248|1563441|P2|COMPLETED|Overall Study||24
636084|NCT00118248|1563442|P1|COMPLETED|Overall Study||17
636085|NCT00118248|1563441|P2|STARTED|Overall Study||24
636086|NCT00118248|1563442|P1|STARTED|Overall Study||17
636087|NCT00118157|1563455|P1|NOT COMPLETED|Overall Study||12
636088|NCT00118157|1563455|P1|COMPLETED|Overall Study||7
636089|NCT00118157|1563455|P1|STARTED|Overall Study||19
636090|NCT00118144|1563460|P1|NOT COMPLETED|Overall Study||1
636091|NCT00118144|1563460|P1|COMPLETED|Overall Study||41
636092|NCT00118144|1563460|P1|STARTED|Overall Study||42
636093|NCT00118131|1563466|P1|NOT COMPLETED|Overall Study||0
636094|NCT00118131|1563466|P1|COMPLETED|Overall Study||49
636095|NCT00118131|1563466|P1|STARTED|Overall Study||49
636096|NCT00118092|1563473|P1|NOT COMPLETED|Overall Study||2
636097|NCT00118092|1563473|P1|COMPLETED|Overall Study||15
636098|NCT00118092|1563473|P1|STARTED|Overall Study||17
636099|NCT00118053|1563481|P1|NOT COMPLETED|Overall Study||0
636100|NCT00118053|1563481|P1|COMPLETED|Overall Study||5
636101|NCT00118053|1563481|P1|STARTED|Overall Study||5
636102|NCT00118040|1563491|P3|NOT COMPLETED|Overall Study||6
636103|NCT00118040|1563492|P2|NOT COMPLETED|Overall Study||2
636104|NCT00118040|1563493|P1|NOT COMPLETED|Overall Study||1
636105|NCT00118040|1563491|P3|COMPLETED|Overall Study||14
636106|NCT00118040|1563492|P2|COMPLETED|Overall Study||18
636107|NCT00118040|1563493|P1|COMPLETED|Overall Study||19
636108|NCT00118040|1563491|P3|STARTED|Overall Study||20
636109|NCT00118040|1563492|P2|STARTED|Overall Study||20
636110|NCT00118040|1563493|P1|STARTED|Overall Study||20
636111|NCT00117988|1563554|P1|NOT COMPLETED|Overall Study||4
636112|NCT00117988|1563554|P1|COMPLETED|Overall Study||18
636113|NCT00117988|1563554|P1|STARTED|Overall Study||22
636114|NCT00117962|1563560|P2|NOT COMPLETED|Overall Study||25
636115|NCT00117962|1563561|P1|NOT COMPLETED|Overall Study||22
636116|NCT00117962|1563560|P2|COMPLETED|Overall Study||28
636117|NCT00117962|1563561|P1|COMPLETED|Overall Study||26
636118|NCT00117962|1563560|P2|STARTED|Overall Study||53
636119|NCT00117962|1563561|P1|STARTED|Overall Study||48
636120|NCT00117949|1563577|P4|NOT COMPLETED|Overall Study||24
636121|NCT00117949|1563578|P3|NOT COMPLETED|Overall Study||24
636122|NCT00117949|1563579|P2|NOT COMPLETED|Overall Study||24
636123|NCT00117949|1563580|P1|NOT COMPLETED|Overall Study||10
636124|NCT00117949|1563577|P4|COMPLETED|Overall Study||0
636125|NCT00117949|1563578|P3|COMPLETED|Overall Study||0
636126|NCT00117949|1563579|P2|COMPLETED|Overall Study||0
636127|NCT00117949|1563580|P1|COMPLETED|Overall Study||0
636128|NCT00117949|1563577|P4|STARTED|Overall Study||24
636129|NCT00117949|1563578|P3|STARTED|Overall Study||24
636130|NCT00117949|1563579|P2|STARTED|Overall Study||24
636131|NCT00117949|1563580|P1|STARTED|Overall Study|Dose level terminated prematurely due to inadequate testosterone response|10
636132|NCT00117845|1563614|P1|NOT COMPLETED|Overall Study||1
636133|NCT00117845|1563614|P1|COMPLETED|Overall Study||16
636134|NCT00117845|1563614|P1|STARTED|Overall Study||17
636135|NCT00117806|1563621|P2|NOT COMPLETED|Overall Study||16
636136|NCT00117806|1563622|P1|NOT COMPLETED|Overall Study||38
636137|NCT00117806|1563621|P2|COMPLETED|Overall Study||60
636138|NCT00117806|1563622|P1|COMPLETED|Overall Study||43
636139|NCT00117806|1563621|P2|STARTED|Overall Study||76
636140|NCT00117806|1563622|P1|STARTED|Overall Study||81
636141|NCT00117793|1563632|P1|NOT COMPLETED|Overall Study||12
636142|NCT00117793|1563632|P1|COMPLETED|Overall Study||5
636143|NCT00117793|1563632|P1|STARTED|Overall Study||17
636144|NCT00117715|1563647|P1|NOT COMPLETED|Overall Study||72
636145|NCT00117715|1563647|P1|COMPLETED|Overall Study||49
636146|NCT00117715|1563647|P1|5 Year|Overall Study||49
636147|NCT00117715|1563647|P1|4.5 Year|Overall Study||55
636148|NCT00117715|1563647|P1|4 Year|Overall Study||58
636149|NCT00117715|1563647|P1|3.5 Year|Overall Study||60
636150|NCT00117715|1563647|P1|3 Year|Overall Study||61
636151|NCT00117715|1563647|P1|2.5 Year|Overall Study||70
636152|NCT00117715|1563647|P1|2 Year|Overall Study||76
636153|NCT00117715|1563647|P1|1.5 Year|Overall Study||85
636154|NCT00117715|1563647|P1|1 Year|Overall Study||88
636155|NCT00117715|1563647|P1|STARTED|Overall Study||121
636156|NCT00117676|1563655|P2|NOT COMPLETED|Open-label Period: Weeks 433 - 480||2
636157|NCT00117676|1563656|P1|NOT COMPLETED|Open-label Period: Weeks 433 - 480||2
636158|NCT00117676|1563655|P2|COMPLETED|Open-label Period: Weeks 433 - 480||41
636159|NCT00117676|1563656|P1|COMPLETED|Open-label Period: Weeks 433 - 480||80
636160|NCT00117676|1563655|P2|STARTED|Open-label Period: Weeks 433 - 480|1 participant completed 432 weeks but did not continue on study.|43
636161|NCT00117676|1563656|P1|STARTED|Open-label Period: Weeks 433 - 480||82
636162|NCT00117676|1563655|P2|NOT COMPLETED|Open-label Period: Weeks 385 - 432||2
636163|NCT00117676|1563656|P1|NOT COMPLETED|Open-label Period: Weeks 385 - 432||0
636164|NCT00117676|1563655|P2|COMPLETED|Open-label Period: Weeks 385 - 432||44
636165|NCT00117676|1563656|P1|COMPLETED|Open-label Period: Weeks 385 - 432||82
636166|NCT00117676|1563655|P2|STARTED|Open-label Period: Weeks 385 - 432|44 participants completed 384 weeks but did not continue on study.|46
636167|NCT00117676|1563656|P1|STARTED|Open-label Period: Weeks 385 - 432|94 participants completed 384 weeks but did not continue on study.|82
636168|NCT00117676|1563655|P2|NOT COMPLETED|Open-label Period: Weeks 337 - 384||3
636169|NCT00117676|1563656|P1|NOT COMPLETED|Open-label Period: Weeks 337 - 384||7
636170|NCT00117676|1563655|P2|COMPLETED|Open-label Period: Weeks 337 - 384||90
636171|NCT00117676|1563656|P1|COMPLETED|Open-label Period: Weeks 337 - 384||176
636172|NCT00117676|1563655|P2|STARTED|Open-label Period: Weeks 337 - 384||93
636173|NCT00117676|1563656|P1|STARTED|Open-label Period: Weeks 337 - 384||183
636174|NCT00117676|1563655|P2|NOT COMPLETED|Open-label Period: Weeks 289 - 336||7
636175|NCT00117676|1563656|P1|NOT COMPLETED|Open-label Period: Weeks 289 - 336||9
636176|NCT00117676|1563655|P2|COMPLETED|Open-label Period: Weeks 289 - 336||93
636177|NCT00117676|1563656|P1|COMPLETED|Open-label Period: Weeks 289 - 336||183
636178|NCT00117676|1563655|P2|STARTED|Open-label Period: Weeks 289 - 336||100
636179|NCT00117676|1563656|P1|STARTED|Open-label Period: Weeks 289 - 336||192
636180|NCT00117676|1563655|P2|NOT COMPLETED|Open-label Period: Weeks 241 - 288||3
636181|NCT00117676|1563656|P1|NOT COMPLETED|Open-label Period: Weeks 241 - 288||10
636182|NCT00117676|1563655|P2|COMPLETED|Open-label Period: Weeks 241 - 288||100
636183|NCT00117676|1563656|P1|COMPLETED|Open-label Period: Weeks 241 - 288||192
636184|NCT00117676|1563655|P2|STARTED|Open-label Period: Weeks 241 - 288||103
636185|NCT00117676|1563656|P1|STARTED|Open-label Period: Weeks 241 - 288||202
636186|NCT00117676|1563655|P2|NOT COMPLETED|Open-label Period: Weeks 193 - 240||3
636187|NCT00117676|1563656|P1|NOT COMPLETED|Open-label Period: Weeks 193 - 240||7
636188|NCT00117676|1563655|P2|COMPLETED|Open-label Period: Weeks 193 - 240||103
636189|NCT00117676|1563656|P1|COMPLETED|Open-label Period: Weeks 193 - 240||202
636190|NCT00117676|1563655|P2|STARTED|Open-label Period: Weeks 193 - 240||106
636191|NCT00117676|1563656|P1|STARTED|Open-label Period: Weeks 193 - 240||209
636192|NCT00117676|1563655|P2|NOT COMPLETED|Open-label Period: Weeks 145 - 192||3
636193|NCT00117676|1563656|P1|NOT COMPLETED|Open-label Period: Weeks 145 - 192||10
636194|NCT00117676|1563655|P2|COMPLETED|Open-label Period: Weeks 145 - 192||106
636195|NCT00117676|1563656|P1|COMPLETED|Open-label Period: Weeks 145 - 192||209
636196|NCT00117676|1563655|P2|STARTED|Open-label Period: Weeks 145 - 192||109
636197|NCT00117676|1563656|P1|STARTED|Open-label Period: Weeks 145 - 192||219
636198|NCT00117676|1563655|P2|NOT COMPLETED|Open-label Period: Weeks 97 - 144||1
636199|NCT00117676|1563656|P1|NOT COMPLETED|Open-label Period: Weeks 97 - 144||6
636200|NCT00117676|1563655|P2|COMPLETED|Open-label Period: Weeks 97 - 144||109
636201|NCT00117676|1563656|P1|COMPLETED|Open-label Period: Weeks 97 - 144||219
636202|NCT00117676|1563655|P2|STARTED|Open-label Period: Weeks 97 - 144||110
636203|NCT00117676|1563656|P1|STARTED|Open-label Period: Weeks 97 - 144||225
636204|NCT00117676|1563655|P2|NOT COMPLETED|Open-label Period: Weeks 49 - 96||2
636205|NCT00117676|1563656|P1|NOT COMPLETED|Open-label Period: Weeks 49 - 96||10
636206|NCT00117676|1563655|P2|COMPLETED|Open-label Period: Weeks 49 - 96||110
636207|NCT00117676|1563656|P1|COMPLETED|Open-label Period: Weeks 49 - 96||225
636208|NCT00117676|1563655|P2|STARTED|Open-label Period: Weeks 49 - 96|9 participants completed 48 weeks but did not continue on study.|112
636209|NCT00117676|1563656|P1|STARTED|Open-label Period: Weeks 49 - 96|9 participants completed 48 weeks but did not continue on study.|235
636210|NCT00117676|1563655|P2|NOT COMPLETED|Double-blind Period Through Week 48||7
636211|NCT00117676|1563656|P1|NOT COMPLETED|Double-blind Period Through Week 48||10
636212|NCT00117676|1563655|P2|COMPLETED|Double-blind Period Through Week 48||121
636213|NCT00117676|1563656|P1|COMPLETED|Double-blind Period Through Week 48||244
636214|NCT00117676|1563655|P2|STARTED|Double-blind Period Through Week 48||128
636215|NCT00117676|1563656|P1|STARTED|Double-blind Period Through Week 48||254
636216|NCT00117637|1563745|P2|NOT COMPLETED|Second Intervention (Period 2)||22
636217|NCT00117637|1563746|P1|NOT COMPLETED|Second Intervention (Period 2)||10
636218|NCT00117637|1563745|P2|COMPLETED|Second Intervention (Period 2)||39
636219|NCT00117637|1563746|P1|COMPLETED|Second Intervention (Period 2)||39
636220|NCT00117637|1563745|P2|Subjects Received Treatment|Second Intervention (Period 2)||61
636221|NCT00117637|1563746|P1|Subjects Received Treatment|Second Intervention (Period 2)||49
636222|NCT00117637|1563745|P2|STARTED|Second Intervention (Period 2)|Not all patients who completed Period 1 (first progression) enter into Period 2|61
636223|NCT00117637|1563746|P1|STARTED|Second Intervention (Period 2)|Not all patients who completed Period 1 (first progression) enter into Period 2|49
636224|NCT00117637|1563745|P2|NOT COMPLETED|First Intervention (Period 1)||25
636225|NCT00117637|1563746|P1|NOT COMPLETED|First Intervention (Period 1)||18
636226|NCT00117637|1563745|P2|COMPLETED|First Intervention (Period 1)||67
636227|NCT00117637|1563746|P1|COMPLETED|First Intervention (Period 1)||79
636228|NCT00117637|1563745|P2|Subjects Received Treatment|First Intervention (Period 1)||90
636229|NCT00117637|1563746|P1|Subjects Received Treatment|First Intervention (Period 1)||97
636230|NCT00117637|1563745|P2|STARTED|First Intervention (Period 1)||92
636231|NCT00117637|1563746|P1|STARTED|First Intervention (Period 1)||97
636232|NCT00117598|1563821|P5|NOT COMPLETED|After Treament Cross Over||4
636233|NCT00117598|1563822|P4|NOT COMPLETED|After Treament Cross Over||3
636234|NCT00117598|1563823|P3|NOT COMPLETED|After Treament Cross Over||0
636235|NCT00117598|1563824|P2|NOT COMPLETED|After Treament Cross Over||0
636236|NCT00117598|1563825|P1|NOT COMPLETED|After Treament Cross Over||0
636237|NCT00117598|1563821|P5|COMPLETED|After Treament Cross Over||0
636238|NCT00117598|1563822|P4|COMPLETED|After Treament Cross Over||0
636239|NCT00117598|1563823|P3|COMPLETED|After Treament Cross Over||0
636240|NCT00117598|1563824|P2|COMPLETED|After Treament Cross Over||0
636241|NCT00117598|1563825|P1|COMPLETED|After Treament Cross Over||0
636242|NCT00117598|1563821|P5|STARTED|After Treament Cross Over||4
636243|NCT00117598|1563822|P4|STARTED|After Treament Cross Over||3
636244|NCT00117598|1563823|P3|STARTED|After Treament Cross Over||0
636245|NCT00117598|1563824|P2|STARTED|After Treament Cross Over||0
636246|NCT00117598|1563825|P1|STARTED|After Treament Cross Over||0
636247|NCT00117598|1563821|P5|NOT COMPLETED|Prior to Treatment Cross Over||0
636248|NCT00117598|1563822|P4|NOT COMPLETED|Prior to Treatment Cross Over||0
636249|NCT00117598|1563823|P3|NOT COMPLETED|Prior to Treatment Cross Over||52
636250|NCT00117598|1563824|P2|NOT COMPLETED|Prior to Treatment Cross Over||53
636251|NCT00117598|1563825|P1|NOT COMPLETED|Prior to Treatment Cross Over||57
636252|NCT00117598|1563821|P5|COMPLETED|Prior to Treatment Cross Over||0
636253|NCT00117598|1563822|P4|COMPLETED|Prior to Treatment Cross Over||0
636254|NCT00117598|1563823|P3|COMPLETED|Prior to Treatment Cross Over||4
636255|NCT00117598|1563824|P2|COMPLETED|Prior to Treatment Cross Over||3
636256|NCT00117598|1563825|P1|COMPLETED|Prior to Treatment Cross Over||0
636257|NCT00117598|1563821|P5|STARTED|Prior to Treatment Cross Over||0
636258|NCT00117598|1563822|P4|STARTED|Prior to Treatment Cross Over||0
636259|NCT00117598|1563823|P3|STARTED|Prior to Treatment Cross Over||56
636260|NCT00117598|1563824|P2|STARTED|Prior to Treatment Cross Over||56
636261|NCT00117598|1563825|P1|STARTED|Prior to Treatment Cross Over||57
636262|NCT00117585|1563853|P1|NOT COMPLETED|Overall Study||0
636263|NCT00117585|1563853|P1|COMPLETED|Overall Study||341
636264|NCT00117585|1563853|P1|STARTED|Overall Study||341
636265|NCT00117572|1563859|P2|NOT COMPLETED|Overall Study||6
636266|NCT00117572|1563860|P1|NOT COMPLETED|Overall Study||6
636267|NCT00117572|1563859|P2|COMPLETED|Overall Study||135
636268|NCT00117572|1563860|P1|COMPLETED|Overall Study||138
636269|NCT00117572|1563859|P2|STARTED|Overall Study||141
636270|NCT00117572|1563860|P1|STARTED|Overall Study||144
636271|NCT00117559|1563892|P2|NOT COMPLETED|Overall Study||1
636272|NCT00117559|1563893|P1|NOT COMPLETED|Overall Study||1
636273|NCT00117559|1563892|P2|COMPLETED|Overall Study||9
636274|NCT00117559|1563893|P1|COMPLETED|Overall Study||8
636275|NCT00117559|1563892|P2|STARTED|Overall Study||10
636276|NCT00117559|1563893|P1|STARTED|Overall Study||9
636277|NCT00117338|1563901|P2|NOT COMPLETED|Overall Study||4
636278|NCT00117338|1563902|P1|NOT COMPLETED|Overall Study||5
636279|NCT00117338|1563901|P2|COMPLETED|Overall Study||127
636280|NCT00117338|1563902|P1|COMPLETED|Overall Study||140
636281|NCT00117338|1563901|P2|STARTED|Overall Study||131
636282|NCT00117338|1563902|P1|STARTED|Overall Study||145
636283|NCT00117325|1563922|P2|NOT COMPLETED|Overall Study||12
636284|NCT00117325|1563923|P1|NOT COMPLETED|Overall Study||13
636285|NCT00117325|1563922|P2|COMPLETED|Overall Study||167
636286|NCT00117325|1563923|P1|COMPLETED|Overall Study||160
636287|NCT00117325|1563922|P2|STARTED|Overall Study||179
636288|NCT00117325|1563923|P1|STARTED|Overall Study||173
636289|NCT00117312|1563955|P4|NOT COMPLETED|Overall Study||21
636290|NCT00117312|1563956|P3|NOT COMPLETED|Overall Study||24
636291|NCT00117312|1563957|P2|NOT COMPLETED|Overall Study||20
636292|NCT00117312|1563958|P1|NOT COMPLETED|Overall Study||10
636293|NCT00117312|1563955|P4|COMPLETED|Overall Study||3
636294|NCT00117312|1563956|P3|COMPLETED|Overall Study||0
636374|NCT00116805|1564100|P2|STARTED|Open-label Period Weeks 241 - 288||64
636295|NCT00117312|1563957|P2|COMPLETED|Overall Study|Defined as those patients ongoing when the extension study was terminated|4
636296|NCT00117312|1563958|P1|COMPLETED|Overall Study||0
636297|NCT00117312|1563955|P4|Started FE200486 CS06A|Overall Study||9
636298|NCT00117312|1563956|P3|Started FE200486 CS06A|Overall Study||16
636299|NCT00117312|1563957|P2|Started FE200486 CS06A|Overall Study||11
636300|NCT00117312|1563958|P1|Started FE200486 CS06A|Overall Study||1
636301|NCT00117312|1563955|P4|STARTED|Overall Study||24
636302|NCT00117312|1563956|P3|STARTED|Overall Study||24
636303|NCT00117312|1563957|P2|STARTED|Overall Study||24
636304|NCT00117312|1563958|P1|STARTED|Overall Study||10
636305|NCT00117286|1563974|P2|NOT COMPLETED|Overall Study||21
636306|NCT00117286|1563975|P1|NOT COMPLETED|Overall Study||28
636307|NCT00117286|1563974|P2|COMPLETED|Overall Study||6
636308|NCT00117286|1563975|P1|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study|2
636309|NCT00117286|1563974|P2|Switched to Higher Dose|Overall Study||17
636310|NCT00117286|1563975|P1|Switched to Higher Dose|Overall Study|A protocol amendment changed the dosage to 160 mg (40 mg/mL)|17
636311|NCT00117286|1563974|P2|STARTED|Overall Study||27
636312|NCT00117286|1563975|P1|STARTED|Overall Study|Safety analysis set|30
636313|NCT00117156|1563983|P1|NOT COMPLETED|Overall Study||11
636314|NCT00117156|1563983|P1|COMPLETED|Overall Study||15
636315|NCT00117156|1563983|P1|STARTED|Overall Study||26
636316|NCT00116857|1563993|P2|NOT COMPLETED|Overall Study||4
636317|NCT00116857|1563994|P1|NOT COMPLETED|Overall Study||3
636318|NCT00116857|1563993|P2|COMPLETED|Overall Study||56
636319|NCT00116857|1563994|P1|COMPLETED|Overall Study||59
636320|NCT00116857|1563993|P2|STARTED|Overall Study||60
636321|NCT00116857|1563994|P1|STARTED|Overall Study||62
636322|NCT00116844|1564002|P2|NOT COMPLETED|Period 1: Treatment Period 2 (60 Days)||5
636323|NCT00116844|1564003|P1|NOT COMPLETED|Period 1: Treatment Period 2 (60 Days)||4
636324|NCT00116844|1564002|P2|COMPLETED|Period 1: Treatment Period 2 (60 Days)||28
636325|NCT00116844|1564003|P1|COMPLETED|Period 1: Treatment Period 2 (60 Days)||24
636326|NCT00116844|1564002|P2|STARTED|Period 1: Treatment Period 2 (60 Days)||33
636327|NCT00116844|1564003|P1|STARTED|Period 1: Treatment Period 2 (60 Days)||28
636328|NCT00116844|1564002|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
636329|NCT00116844|1564003|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
636330|NCT00116844|1564002|P2|COMPLETED|Period 2: Washout Period (7 Days)||33
636331|NCT00116844|1564003|P1|COMPLETED|Period 2: Washout Period (7 Days)||28
636332|NCT00116844|1564002|P2|STARTED|Period 2: Washout Period (7 Days)||33
636333|NCT00116844|1564003|P1|STARTED|Period 2: Washout Period (7 Days)||28
636334|NCT00116844|1564002|P2|NOT COMPLETED|Period 1: Treatment Period 1 (60 Days)||3
636335|NCT00116844|1564003|P1|NOT COMPLETED|Period 1: Treatment Period 1 (60 Days)||7
636336|NCT00116844|1564002|P2|COMPLETED|Period 1: Treatment Period 1 (60 Days)||33
636337|NCT00116844|1564003|P1|COMPLETED|Period 1: Treatment Period 1 (60 Days)||28
636338|NCT00116844|1564002|P2|STARTED|Period 1: Treatment Period 1 (60 Days)||36
636339|NCT00116844|1564003|P1|STARTED|Period 1: Treatment Period 1 (60 Days)||35
636340|NCT00116831|1564021|P2|NOT COMPLETED|Overall Study||72
636341|NCT00116831|1564022|P1|NOT COMPLETED|Overall Study||73
636342|NCT00116831|1564021|P2|COMPLETED|Overall Study||259
636343|NCT00116831|1564022|P1|COMPLETED|Overall Study||264
636344|NCT00116831|1564021|P2|STARTED|Overall Study||331
636345|NCT00116831|1564022|P1|STARTED|Overall Study||337
636346|NCT00116805|1564100|P2|NOT COMPLETED|Open-label Period Weeks 433 - 480||0
636347|NCT00116805|1564101|P1|NOT COMPLETED|Open-label Period Weeks 433 - 480||4
636348|NCT00116805|1564100|P2|COMPLETED|Open-label Period Weeks 433 - 480||29
636349|NCT00116805|1564101|P1|COMPLETED|Open-label Period Weeks 433 - 480||53
636350|NCT00116805|1564100|P2|STARTED|Open-label Period Weeks 433 - 480|1 participant completed 432 weeks but did not continue on study.|29
636351|NCT00116805|1564101|P1|STARTED|Open-label Period Weeks 433 - 480||57
636352|NCT00116805|1564100|P2|NOT COMPLETED|Open-label Period Weeks 385 - 432||0
636353|NCT00116805|1564101|P1|NOT COMPLETED|Open-label Period Weeks 385 - 432||2
636354|NCT00116805|1564100|P2|COMPLETED|Open-label Period Weeks 385 - 432||30
636355|NCT00116805|1564101|P1|COMPLETED|Open-label Period Weeks 385 - 432||57
636356|NCT00116805|1564100|P2|STARTED|Open-label Period Weeks 385 - 432|26 participants completed 384 weeks but did not continue on study.|30
636357|NCT00116805|1564101|P1|STARTED|Open-label Period Weeks 385 - 432|31 participants completed 384 weeks but did not continue on study.|59
636358|NCT00116805|1564100|P2|NOT COMPLETED|Open-label Period Weeks 337 - 384||1
636359|NCT00116805|1564101|P1|NOT COMPLETED|Open-label Period Weeks 337 - 384||8
636360|NCT00116805|1564100|P2|COMPLETED|Open-label Period Weeks 337 - 384||56
636361|NCT00116805|1564101|P1|COMPLETED|Open-label Period Weeks 337 - 384||90
636362|NCT00116805|1564100|P2|STARTED|Open-label Period Weeks 337 - 384||57
636363|NCT00116805|1564101|P1|STARTED|Open-label Period Weeks 337 - 384||98
636364|NCT00116805|1564100|P2|NOT COMPLETED|Open-label Period Weeks 289 - 336||7
636365|NCT00116805|1564101|P1|NOT COMPLETED|Open-label Period Weeks 289 - 336||6
636366|NCT00116805|1564100|P2|COMPLETED|Open-label Period Weeks 289 - 336||57
636367|NCT00116805|1564101|P1|COMPLETED|Open-label Period Weeks 289 - 336||98
636368|NCT00116805|1564100|P2|STARTED|Open-label Period Weeks 289 - 336||64
636369|NCT00116805|1564101|P1|STARTED|Open-label Period Weeks 289 - 336||104
636370|NCT00116805|1564100|P2|NOT COMPLETED|Open-label Period Weeks 241 - 288||0
636371|NCT00116805|1564101|P1|NOT COMPLETED|Open-label Period Weeks 241 - 288||6
636372|NCT00116805|1564100|P2|COMPLETED|Open-label Period Weeks 241 - 288||64
636373|NCT00116805|1564101|P1|COMPLETED|Open-label Period Weeks 241 - 288||104
636375|NCT00116805|1564101|P1|STARTED|Open-label Period Weeks 241 - 288||110
636376|NCT00116805|1564100|P2|NOT COMPLETED|Open-label Period Weeks 193 - 240||4
636377|NCT00116805|1564101|P1|NOT COMPLETED|Open-label Period Weeks 193 - 240||13
636378|NCT00116805|1564100|P2|COMPLETED|Open-label Period Weeks 193 - 240||64
636379|NCT00116805|1564101|P1|COMPLETED|Open-label Period Weeks 193 - 240||110
636380|NCT00116805|1564100|P2|STARTED|Open-label Period Weeks 193 - 240||68
636381|NCT00116805|1564101|P1|STARTED|Open-label Period Weeks 193 - 240||123
636382|NCT00116805|1564100|P2|NOT COMPLETED|Open-label Period Weeks 145 - 192||6
636383|NCT00116805|1564101|P1|NOT COMPLETED|Open-label Period Weeks 145 - 192||10
636384|NCT00116805|1564100|P2|COMPLETED|Open-label Period Weeks 145 - 192||68
636385|NCT00116805|1564101|P1|COMPLETED|Open-label Period Weeks 145 - 192||123
636386|NCT00116805|1564100|P2|STARTED|Open-label Period Weeks 145 - 192||74
636387|NCT00116805|1564101|P1|STARTED|Open-label Period Weeks 145 - 192||133
636388|NCT00116805|1564100|P2|NOT COMPLETED|Open-label Period Weeks 97 - 144||9
636389|NCT00116805|1564101|P1|NOT COMPLETED|Open-label Period Weeks 97 - 144||11
636390|NCT00116805|1564100|P2|COMPLETED|Open-label Period Weeks 97 - 144||74
636391|NCT00116805|1564101|P1|COMPLETED|Open-label Period Weeks 97 - 144||133
636392|NCT00116805|1564100|P2|STARTED|Open-label Period Weeks 97 - 144||83
636393|NCT00116805|1564101|P1|STARTED|Open-label Period Weeks 97 - 144||144
636394|NCT00116805|1564100|P2|NOT COMPLETED|Open-label Period Weeks 49 - 96||1
636395|NCT00116805|1564101|P1|NOT COMPLETED|Open-label Period Weeks 49 - 96||10
636396|NCT00116805|1564100|P2|COMPLETED|Open-label Period Weeks 49 - 96||83
636397|NCT00116805|1564101|P1|COMPLETED|Open-label Period Weeks 49 - 96||144
636398|NCT00116805|1564100|P2|STARTED|Open-label Period Weeks 49 - 96|1 participant completed 48 weeks but did not continue on study.|84
636399|NCT00116805|1564101|P1|STARTED|Open-label Period Weeks 49 - 96|11 participants completed 48 weeks but did not continue on study.|154
636400|NCT00116805|1564100|P2|NOT COMPLETED|Double-blind Period Through Week 48||5
636401|NCT00116805|1564101|P1|NOT COMPLETED|Double-blind Period Through Week 48||11
636402|NCT00116805|1564100|P2|COMPLETED|Double-blind Period Through Week 48||85
636403|NCT00116805|1564101|P1|COMPLETED|Double-blind Period Through Week 48||165
636404|NCT00116805|1564100|P2|STARTED|Double-blind Period Through Week 48||90
636405|NCT00116805|1564101|P1|STARTED|Double-blind Period Through Week 48||176
636406|NCT00116779|1564194|P2|NOT COMPLETED|Overall Study||19
636407|NCT00116779|1564195|P1|NOT COMPLETED|Overall Study||21
636408|NCT00116779|1564194|P2|COMPLETED|Overall Study||45
636409|NCT00116779|1564195|P1|COMPLETED|Overall Study||42
636410|NCT00116779|1564194|P2|STARTED|Overall Study|Randomized and treated; intent-to-treat population|64
636411|NCT00116779|1564195|P1|STARTED|Overall Study|Randomized and treated; Intent-to-treat population|63
636412|NCT00116753|1564228|P3|NOT COMPLETED|Overall Study||24
636413|NCT00116753|1564229|P2|NOT COMPLETED|Overall Study||30
636414|NCT00116753|1564230|P1|NOT COMPLETED|Overall Study||32
636415|NCT00116753|1564228|P3|COMPLETED|Overall Study||128
636416|NCT00116753|1564229|P2|COMPLETED|Overall Study||125
636417|NCT00116753|1564230|P1|COMPLETED|Overall Study||121
636418|NCT00116753|1564228|P3|ITT Population|Overall Study||147
636419|NCT00116753|1564229|P2|ITT Population|Overall Study||150
636420|NCT00116753|1564230|P1|ITT Population|Overall Study||150
636421|NCT00116753|1564228|P3|STARTED|Overall Study||152
636422|NCT00116753|1564229|P2|STARTED|Overall Study||155
636423|NCT00116753|1564230|P1|STARTED|Overall Study|Randomised.|153
636424|NCT00116688|1564252|P2|NOT COMPLETED|Overall Study||4
636425|NCT00116688|1564253|P1|NOT COMPLETED|Overall Study||92
636426|NCT00116688|1564252|P2|COMPLETED|Overall Study||17
636427|NCT00116688|1564253|P1|COMPLETED|Overall Study||200
636428|NCT00116688|1564252|P2|Received Study Medication|Overall Study||20
636429|NCT00116688|1564253|P1|Received Study Medication|Overall Study||291
636430|NCT00116688|1564252|P2|STARTED|Overall Study||21
636431|NCT00116688|1564253|P1|STARTED|Overall Study||292
636432|NCT00116649|1564268|P1|NOT COMPLETED|Overall Study||155
636433|NCT00116649|1564268|P1|COMPLETED|Overall Study||396
636434|NCT00116649|1564268|P1|STARTED|Overall Study|586 screened (34 not eligible) 552 enrolled 551 study population (1 subject not treated)|551
636435|NCT00116428|1564275|P2|NOT COMPLETED|Overall Study||5
636436|NCT00116428|1564276|P1|NOT COMPLETED|Overall Study||3
636437|NCT00116428|1564275|P2|COMPLETED|Overall Study||56
636438|NCT00116428|1564276|P1|COMPLETED|Overall Study||103
636439|NCT00116428|1564275|P2|Underwent Study Ablation Procedure|Overall Study||36
636440|NCT00116428|1564276|P1|Underwent Study Ablation Procedure|Overall Study||103
636441|NCT00116428|1564275|P2|STARTED|Overall Study||61
636442|NCT00116428|1564276|P1|STARTED|Overall Study||106
636443|NCT00116272|1564294|P2|NOT COMPLETED|Overall Study||6
636444|NCT00116272|1564295|P1|NOT COMPLETED|Overall Study||11
636445|NCT00116272|1564294|P2|COMPLETED|Overall Study|Indicates participants with a known outcome of pregnancy|158
636446|NCT00116272|1564295|P1|COMPLETED|Overall Study|Indicates participants with a known outcome of pregnancy|359
636447|NCT00116272|1564294|P2|STARTED|Overall Study||164
636448|NCT00116272|1564295|P1|STARTED|Overall Study||370
636449|NCT00116207|1564347|P2|NOT COMPLETED|Overall Study||4
636450|NCT00116207|1564348|P1|NOT COMPLETED|Overall Study||9
636451|NCT00116207|1564347|P2|COMPLETED|Overall Study||18
636452|NCT00116207|1564348|P1|COMPLETED|Overall Study||13
636453|NCT00116207|1564347|P2|STARTED|Overall Study||22
636454|NCT00116207|1564348|P1|STARTED|Overall Study||22
636455|NCT00116168|1564364|P4|NOT COMPLETED|Overall Study||0
636456|NCT00116168|1564365|P3|NOT COMPLETED|Overall Study||0
636457|NCT00116168|1564366|P2|NOT COMPLETED|Overall Study||5
636458|NCT00116168|1564367|P1|NOT COMPLETED|Overall Study||6
636459|NCT00116168|1564364|P4|COMPLETED|Overall Study||6
636460|NCT00116168|1564365|P3|COMPLETED|Overall Study||6
636461|NCT00116168|1564366|P2|COMPLETED|Overall Study||6
636462|NCT00116168|1564367|P1|COMPLETED|Overall Study||0
636463|NCT00116168|1564364|P4|STARTED|Overall Study||6
636464|NCT00116168|1564365|P3|STARTED|Overall Study||6
636465|NCT00116168|1564366|P2|STARTED|Overall Study||11
636466|NCT00116168|1564367|P1|STARTED|Overall Study||6
636467|NCT00115934|1564431|P2|NOT COMPLETED|Overall Study||2
636468|NCT00115934|1564432|P1|NOT COMPLETED|Overall Study||4
636469|NCT00115934|1564431|P2|COMPLETED|Overall Study||274
636470|NCT00115934|1564432|P1|COMPLETED|Overall Study||275
636471|NCT00115934|1564431|P2|STARTED|Overall Study|276 randomized to RVPAS, but 2 did not have a Norwood surgery and were excluded from analyses.|276
636472|NCT00115934|1564432|P1|STARTED|Overall Study|279 randomized to MBTS, but 3 did not have a Norwood surgery; one was withdrawn-with limited data.|279
636473|NCT00115869|1564472|P2|NOT COMPLETED|Overall Study||296
636474|NCT00115869|1564473|P1|NOT COMPLETED|Overall Study||317
636475|NCT00115869|1564472|P2|COMPLETED|Overall Study|Follow-up at two years post high school.|3881
636476|NCT00115869|1564473|P1|COMPLETED|Overall Study||3894
636477|NCT00115869|1564472|P2|Completed Data Collection at 12th Grade|Overall Study||3847
636478|NCT00115869|1564473|P1|Completed Data Collection at 12th Grade|Overall Study||3876
636479|NCT00115869|1564472|P2|STARTED|Overall Study||4177
636480|NCT00115869|1564473|P1|STARTED|Overall Study||4211
636481|NCT00115804|1564481|P1|NOT COMPLETED|Overall Study||2
636482|NCT00115804|1564481|P1|COMPLETED|Overall Study||4
636483|NCT00115804|1564481|P1|STARTED|Overall Study||6
636484|NCT00115765|1564496|P4|NOT COMPLETED|Overall Study||31
636485|NCT00115765|1564497|P3|NOT COMPLETED|Overall Study||121
636486|NCT00115765|1564498|P2|NOT COMPLETED|Overall Study||100
636487|NCT00115765|1564499|P1|NOT COMPLETED|Overall Study||35
636488|NCT00115765|1564496|P4|COMPLETED|Overall Study|Participants who were on study at closure or died|84
636489|NCT00115765|1564497|P3|COMPLETED|Overall Study|Participants who were on study at closure or died|289
636490|NCT00115765|1564498|P2|COMPLETED|Overall Study|Participants who were on study at closure or died|313
636491|NCT00115765|1564499|P1|COMPLETED|Overall Study|Participants who were on study at closure or died|80
636492|NCT00115765|1564496|P4|STARTED|Overall Study||115
636493|NCT00115765|1564497|P3|STARTED|Overall Study||410
636494|NCT00115765|1564498|P2|STARTED|Overall Study||413
636495|NCT00115765|1564499|P1|STARTED|Overall Study||115
636496|NCT00115739|1564537|P1|NOT COMPLETED|Overall Study||3
636497|NCT00115739|1564537|P1|COMPLETED|Overall Study||8
636498|NCT00115739|1564537|P1|STARTED|Overall Study||11
636499|NCT00115349|1564546|P2|NOT COMPLETED|Overall Study||9
636500|NCT00115349|1564547|P1|NOT COMPLETED|Overall Study||11
636501|NCT00115349|1564546|P2|COMPLETED|Overall Study|study closed due to low enrollment.|0
636502|NCT00115349|1564547|P1|COMPLETED|Overall Study|Study closed due to low enrollment.|0
636503|NCT00115349|1564546|P2|STARTED|Overall Study|Target was 43 subjects in this arm.|9
636504|NCT00115349|1564547|P1|STARTED|Overall Study|Target was 43 subjects in this arm.|11
636505|NCT00115297|1564555|P2|NOT COMPLETED|Overall Study||0
636506|NCT00115297|1564556|P1|NOT COMPLETED|Overall Study||0
636507|NCT00115297|1564555|P2|COMPLETED|Overall Study||32
636508|NCT00115297|1564556|P1|COMPLETED|Overall Study||30
636509|NCT00115297|1564555|P2|STARTED|Overall Study||32
636510|NCT00115297|1564556|P1|STARTED|Overall Study||30
636511|NCT00115063|1564568|P2|NOT COMPLETED|Overall Study||104
636512|NCT00115063|1564569|P1|NOT COMPLETED|Overall Study||99
636513|NCT00115063|1564568|P2|COMPLETED|Overall Study||86
636514|NCT00115063|1564569|P1|COMPLETED|Overall Study||101
636515|NCT00115063|1564568|P2|STARTED|Overall Study||190
636516|NCT00115063|1564569|P1|STARTED|Overall Study||200
636517|NCT00114972|1564587|P2|NOT COMPLETED|Overall Study||12
636518|NCT00114972|1564588|P1|NOT COMPLETED|Overall Study||48
636519|NCT00114972|1564587|P2|COMPLETED|Overall Study||891
636520|NCT00114972|1564588|P1|COMPLETED|Overall Study||849
636521|NCT00114972|1564587|P2|STARTED|Overall Study||903
636522|NCT00114972|1564588|P1|STARTED|Overall Study||897
636523|NCT00114959|1564608|P1|NOT COMPLETED|Overall Study||8
636524|NCT00114959|1564608|P1|COMPLETED|Overall Study|protocol definition of completed study is having received >= 4 cycles of treatment|7
636525|NCT00114959|1564608|P1|STARTED|Overall Study||15
636526|NCT00114777|1564618|P3|NOT COMPLETED|Long-Term Extension to Month 84||30
636527|NCT00114777|1564619|P2|NOT COMPLETED|Long-Term Extension to Month 84||29
636528|NCT00114777|1564620|P1|NOT COMPLETED|Long-Term Extension to Month 84||30
636529|NCT00114777|1564618|P3|COMPLETED|Long-Term Extension to Month 84||57
636530|NCT00114777|1564619|P2|COMPLETED|Long-Term Extension to Month 84||84
636531|NCT00114777|1564620|P1|COMPLETED|Long-Term Extension to Month 84||74
636532|NCT00114777|1564618|P3|STARTED|Long-Term Extension to Month 84||87
636533|NCT00114777|1564619|P2|STARTED|Long-Term Extension to Month 84||113
636534|NCT00114777|1564620|P1|STARTED|Long-Term Extension to Month 84||104
636535|NCT00114777|1564618|P3|NOT COMPLETED|Randomization to Month 36||84
636536|NCT00114777|1564619|P2|NOT COMPLETED|Randomization to Month 36||61
636537|NCT00114777|1564620|P1|NOT COMPLETED|Randomization to Month 36||75
636538|NCT00114777|1564618|P3|COMPLETED|Randomization to Month 36||100
636539|NCT00114777|1564619|P2|COMPLETED|Randomization to Month 36||114
636540|NCT00114777|1564620|P1|COMPLETED|Randomization to Month 36||109
636541|NCT00114777|1564618|P3|STARTED|Randomization to Month 36||184
636542|NCT00114777|1564619|P2|STARTED|Randomization to Month 36||175
636543|NCT00114777|1564620|P1|STARTED|Randomization to Month 36||184
636544|NCT00114634|1564694|P1|NOT COMPLETED|Overall Study||3
636545|NCT00114634|1564694|P1|COMPLETED|Overall Study|Assessment forms lost by one failure to complete and return forms by two|10
636546|NCT00114634|1564694|P1|STARTED|Overall Study||13
636547|NCT00114530|1564710|P2|NOT COMPLETED|Overall Study||20
636548|NCT00114530|1564711|P1|NOT COMPLETED|Overall Study||9
636549|NCT00114530|1564710|P2|COMPLETED|Overall Study|Completed 72 mo, 54 mo after failure, or at least 54 mo at study end (last patient’s 54 mo visit)|19
636550|NCT00114530|1564711|P1|COMPLETED|Overall Study|Completed 72 mo, 54 mo after failure, or at least 54 mo at study end (last patient’s 54 mo visit)|27
636551|NCT00114530|1564710|P2|STARTED|Overall Study||39
636552|NCT00114530|1564711|P1|STARTED|Overall Study||36
636553|NCT00114517|1564820|P4|NOT COMPLETED|Overall Study||10
636554|NCT00114517|1564821|P3|NOT COMPLETED|Overall Study||14
636555|NCT00114517|1564822|P2|NOT COMPLETED|Overall Study||11
636556|NCT00114517|1564823|P1|NOT COMPLETED|Overall Study||12
636557|NCT00114517|1564820|P4|COMPLETED|Overall Study||176
636558|NCT00114517|1564821|P3|COMPLETED|Overall Study||172
636559|NCT00114517|1564822|P2|COMPLETED|Overall Study||123
636560|NCT00114517|1564823|P1|COMPLETED|Overall Study||125
636561|NCT00114517|1564820|P4|STARTED|Overall Study||186
636562|NCT00114517|1564821|P3|STARTED|Overall Study||186
636563|NCT00114517|1564822|P2|STARTED|Overall Study||134
636564|NCT00114517|1564823|P1|STARTED|Overall Study||137
636565|NCT00114504|1564835|P2|NOT COMPLETED|Overall Study||0
636566|NCT00114504|1564836|P1|NOT COMPLETED|Overall Study||0
636567|NCT00114504|1564835|P2|COMPLETED|Overall Study||22
636568|NCT00114504|1564836|P1|COMPLETED|Overall Study||21
636569|NCT00114504|1564835|P2|STARTED|Overall Study||22
636570|NCT00114504|1564836|P1|STARTED|Overall Study||21
636571|NCT00114244|1564848|P2|NOT COMPLETED|Overall Study||7
636572|NCT00114244|1564849|P1|NOT COMPLETED|Overall Study||2
636573|NCT00114244|1564848|P2|COMPLETED|Overall Study||30
636574|NCT00114244|1564849|P1|COMPLETED|Overall Study||13
636575|NCT00114244|1564848|P2|STARTED|Overall Study||37
636576|NCT00114244|1564849|P1|STARTED|Overall Study||15
636577|NCT00114231|1564861|P2|NOT COMPLETED|Overall Study||2
636578|NCT00114231|1564862|P1|NOT COMPLETED|Overall Study||9
636579|NCT00114231|1564861|P2|COMPLETED|Overall Study||26
636580|NCT00114231|1564862|P1|COMPLETED|Overall Study||53
636581|NCT00114231|1564861|P2|STARTED|Overall Study||28
636582|NCT00114231|1564862|P1|STARTED|Overall Study||62
636583|NCT00114166|1564871|P1|NOT COMPLETED|Overall Study||1
636584|NCT00114166|1564871|P1|COMPLETED|Overall Study|total numbers of eligible and evaluable participants|80
636585|NCT00114166|1564871|P1|Registered to Regimen II|Overall Study||65
636586|NCT00114166|1564871|P1|Registered to Regimen I|Overall Study||15
636587|NCT00114166|1564871|P1|STARTED|Overall Study|total number of participants enrolled|81
636588|NCT00114140|1564877|P1|NOT COMPLETED|Overall Study||7
636589|NCT00114140|1564877|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|129
636590|NCT00114140|1564877|P1|STARTED|Overall Study||136
636591|NCT00114127|1564891|P2|NOT COMPLETED|Overall Study||4
636592|NCT00114127|1564892|P1|NOT COMPLETED|Overall Study||4
636593|NCT00114127|1564891|P2|COMPLETED|Overall Study||11
636594|NCT00114127|1564892|P1|COMPLETED|Overall Study||9
636595|NCT00114127|1564891|P2|STARTED|Overall Study||15
636596|NCT00114127|1564892|P1|STARTED|Overall Study||13
636597|NCT00114101|1564902|P2|NOT COMPLETED|Overall Study||0
636598|NCT00114101|1564903|P1|NOT COMPLETED|Overall Study||0
636599|NCT00114101|1564902|P2|COMPLETED|Overall Study||229
636600|NCT00114101|1564903|P1|COMPLETED|Overall Study||231
636601|NCT00114101|1564902|P2|STARTED|Overall Study||229
636602|NCT00114101|1564903|P1|STARTED|Overall Study||231
636603|NCT00113919|1564915|P1|NOT COMPLETED|Overall Study||14
636604|NCT00113919|1564915|P1|COMPLETED|Overall Study||0
636605|NCT00113919|1564915|P1|STARTED|Overall Study||14
636606|NCT00113880|1564922|P3|NOT COMPLETED|Overall Study||0
636607|NCT00113880|1564923|P2|NOT COMPLETED|Overall Study||0
636608|NCT00113880|1564924|P1|NOT COMPLETED|Overall Study||0
636609|NCT00113880|1564922|P3|COMPLETED|Overall Study||62492
636610|NCT00113880|1564923|P2|COMPLETED|Overall Study||71949
636611|NCT00113880|1564924|P1|COMPLETED|Overall Study||63061
636612|NCT00113880|1564922|P3|STARTED|Overall Study||62492
636613|NCT00113880|1564923|P2|STARTED|Overall Study||71949
636614|NCT00113880|1564924|P1|STARTED|Overall Study||63061
636615|NCT00113841|1564983|P2|NOT COMPLETED|Overall Study||2
636616|NCT00113841|1564984|P1|NOT COMPLETED|Overall Study||1
636617|NCT00113841|1564983|P2|COMPLETED|Overall Study||15
636618|NCT00113841|1564984|P1|COMPLETED|Overall Study||15
636619|NCT00113841|1564983|P2|STARTED|Overall Study||17
636620|NCT00113841|1564984|P1|STARTED|Overall Study||16
636621|NCT00113763|1564992|P2|NOT COMPLETED|Overall Study||26
636622|NCT00113763|1564993|P1|NOT COMPLETED|Overall Study||73
636623|NCT00113763|1564992|P2|COMPLETED|Overall Study|Defined as participants who completed safety follow-up visit or who died.|206
636624|NCT00113763|1564993|P1|COMPLETED|Overall Study|Defined as participants who completed safety follow-up visit or who died.|158
636625|NCT00113763|1564992|P2|Received Study Drug|Overall Study||0
636626|NCT00113763|1564993|P1|Received Study Drug|Overall Study||229
636627|NCT00113763|1564992|P2|STARTED|Overall Study||232
636628|NCT00113763|1564993|P1|STARTED|Overall Study||231
636629|NCT00113607|1565019|P2|NOT COMPLETED|Overall Study||337
636630|NCT00113607|1565020|P1|NOT COMPLETED|Overall Study||335
636631|NCT00113607|1565019|P2|COMPLETED|Overall Study||0
636632|NCT00113607|1565020|P1|COMPLETED|Overall Study||0
636633|NCT00113607|1565019|P2|STARTED|Overall Study|Number of randomized participants|337
636634|NCT00113607|1565020|P1|STARTED|Overall Study|Number of randomized participants|335
636635|NCT00113568|1565034|P1|NOT COMPLETED|Overall Study||545
636636|NCT00113568|1565034|P1|COMPLETED|Overall Study||239
636637|NCT00113568|1565034|P1|Intent to Treat Population|Overall Study||723
636638|NCT00113568|1565034|P1|STARTED|Overall Study||784
636639|NCT00113555|1565046|P1|NOT COMPLETED|Overall Study||79
636640|NCT00113555|1565046|P1|COMPLETED|Overall Study|All treated patients were considered in the Intent to Treat analysis.|142
636641|NCT00113555|1565046|P1|TREATED|Overall Study|1 Additional Patient was treated on a compassionate use basis.|162
636642|NCT00113555|1565046|P1|STARTED|Overall Study||221
636643|NCT00113529|1565056|P1|NOT COMPLETED|Overall Study||34
636644|NCT00113529|1565056|P1|COMPLETED|Overall Study|Subject discontinued from the study and continued treatment on commercially available sunitinib.|1
636645|NCT00113529|1565056|P1|STARTED|Overall Study|Phase 2 included 4 subjects from Phase 1 and 31 from Phase 2, for a total of 35 subjects.|35
636646|NCT00113516|1565089|P2|NOT COMPLETED|Part 2||66
636647|NCT00113516|1565090|P1|NOT COMPLETED|Part 2||0
636648|NCT00113516|1565089|P2|COMPLETED|Part 2||0
636649|NCT00113516|1565090|P1|COMPLETED|Part 2||0
636650|NCT00113516|1565089|P2|STARTED|Part 2||66
636651|NCT00113516|1565090|P1|STARTED|Part 2||0
636652|NCT00113516|1565089|P2|NOT COMPLETED|Part 1||0
636653|NCT00113516|1565090|P1|NOT COMPLETED|Part 1||84
636654|NCT00113516|1565089|P2|COMPLETED|Part 1||0
636655|NCT00113516|1565090|P1|COMPLETED|Part 1|66 subjects continued into Part 2 of the study.|0
636656|NCT00113516|1565089|P2|STARTED|Part 1||0
636657|NCT00113516|1565090|P1|STARTED|Part 1||84
636658|NCT00113490|1565133|P2|NOT COMPLETED|Overall Study||3
636659|NCT00113490|1565134|P1|NOT COMPLETED|Overall Study||2
636660|NCT00113490|1565133|P2|COMPLETED|Overall Study||67
636661|NCT00113490|1565134|P1|COMPLETED|Overall Study||64
636662|NCT00113490|1565133|P2|STARTED|Overall Study||70
636663|NCT00113490|1565134|P1|STARTED|Overall Study||66
636664|NCT00113425|1565147|P1|NOT COMPLETED|Overall Study||15
636665|NCT00113425|1565147|P1|COMPLETED|Overall Study||29
636666|NCT00113425|1565147|P1|STARTED|Overall Study||44
636667|NCT00113399|1565167|P2|NOT COMPLETED|Overall Study||5
636668|NCT00113399|1565168|P1|NOT COMPLETED|Overall Study||2
636669|NCT00113399|1565167|P2|COMPLETED|Overall Study||3
636670|NCT00113399|1565168|P1|COMPLETED|Overall Study||5
636671|NCT00113399|1565167|P2|STARTED|Overall Study||8
636672|NCT00113399|1565168|P1|STARTED|Overall Study||7
636673|NCT00113386|1565176|P2|NOT COMPLETED|Overall Study||4
636674|NCT00113386|1565177|P1|NOT COMPLETED|Overall Study||7
636675|NCT00113386|1565176|P2|COMPLETED|Overall Study||5
636676|NCT00113386|1565177|P1|COMPLETED|Overall Study||3
636677|NCT00113386|1565176|P2|STARTED|Overall Study||9
636678|NCT00113386|1565177|P1|STARTED|Overall Study||10
636679|NCT00113373|1565183|P1|NOT COMPLETED|Overall Study||3
636680|NCT00113373|1565183|P1|COMPLETED|Overall Study|Eligible and treated patients.|25
636681|NCT00113373|1565183|P1|STARTED|Overall Study||28
636682|NCT00113360|1565198|P1|NOT COMPLETED|Overall Study||7
636683|NCT00113360|1565198|P1|COMPLETED|Overall Study||60
636684|NCT00113360|1565198|P1|STARTED|Overall Study|67 participants were enrolled for screening.|67
636685|NCT00113334|1565202|P1|NOT COMPLETED|Overall Study||0
636686|NCT00113334|1565202|P1|COMPLETED|Overall Study||6
636687|NCT00113334|1565202|P1|STARTED|Overall Study||6
636688|NCT00113321|1565206|P1|NOT COMPLETED|Overall Study||0
636689|NCT00113321|1565206|P1|COMPLETED|Overall Study||16
636690|NCT00113321|1565206|P1|STARTED|Overall Study||16
636691|NCT00113295|1565212|P2|NOT COMPLETED|Overall Study||1
636692|NCT00113295|1565213|P1|NOT COMPLETED|Overall Study||5
636693|NCT00113295|1565212|P2|COMPLETED|Overall Study||10
636694|NCT00113295|1565213|P1|COMPLETED|Overall Study||6
636695|NCT00113295|1565212|P2|STARTED|Overall Study||11
636696|NCT00113295|1565213|P1|STARTED|Overall Study||11
636697|NCT00113269|1565232|P4|NOT COMPLETED|Overall Study||40
636698|NCT00113269|1565233|P3|NOT COMPLETED|Overall Study||41
636699|NCT00113269|1565234|P2|NOT COMPLETED|Overall Study||22
636700|NCT00113269|1565235|P1|NOT COMPLETED|Overall Study||25
636701|NCT00113269|1565232|P4|COMPLETED|Overall Study||140
636702|NCT00113269|1565233|P3|COMPLETED|Overall Study||134
636703|NCT00113269|1565234|P2|COMPLETED|Overall Study||48
636704|NCT00113269|1565235|P1|COMPLETED|Overall Study||51
636705|NCT00113269|1565232|P4|Received Treatment|Overall Study||171
636706|NCT00113269|1565233|P3|Received Treatment|Overall Study||164
636707|NCT00113269|1565234|P2|Received Treatment|Overall Study||69
636708|NCT00113269|1565235|P1|Received Treatment|Overall Study||70
636709|NCT00113269|1565232|P4|STARTED|Overall Study||180
636710|NCT00113269|1565233|P3|STARTED|Overall Study||175
636711|NCT00113269|1565234|P2|STARTED|Overall Study||70
636712|NCT00113269|1565235|P1|STARTED|Overall Study||76
636713|NCT00113230|1565285|P1|NOT COMPLETED|Overall Study||0
636714|NCT00113230|1565285|P1|COMPLETED|Overall Study||25
636715|NCT00113230|1565285|P1|STARTED|Overall Study||25
636716|NCT00113217|1565289|P1|NOT COMPLETED|Overall Study||0
636717|NCT00113217|1565289|P1|COMPLETED|Overall Study||50
636718|NCT00113217|1565289|P1|STARTED|Overall Study||50
636719|NCT00113087|1565295|P2|NOT COMPLETED|Overall Study||21
636720|NCT00113087|1565296|P1|NOT COMPLETED|Overall Study||24
636721|NCT00113087|1565295|P2|COMPLETED|Overall Study||94
636722|NCT00113087|1565296|P1|COMPLETED|Overall Study||91
636723|NCT00113087|1565295|P2|STARTED|Overall Study||115
636724|NCT00113087|1565296|P1|STARTED|Overall Study||115
636725|NCT00113022|1565360|P2|NOT COMPLETED|Overall Study||2
636726|NCT00113022|1565361|P1|NOT COMPLETED|Overall Study||3
636727|NCT00113022|1565360|P2|COMPLETED|Overall Study||2
636728|NCT00113022|1565361|P1|COMPLETED|Overall Study||2
636729|NCT00113022|1565360|P2|STARTED|Overall Study||4
636730|NCT00113022|1565361|P1|STARTED|Overall Study||5
636731|NCT00112957|1565367|P1|NOT COMPLETED|Overall Study||19
636732|NCT00112957|1565367|P1|COMPLETED|Overall Study||4
636733|NCT00112957|1565367|P1|STARTED|Overall Study||23
636734|NCT00112918|1565382|P3|NOT COMPLETED|Overall Study||299
636735|NCT00112918|1565383|P2|NOT COMPLETED|Overall Study||345
636736|NCT00112918|1565384|P1|NOT COMPLETED|Overall Study||297
636737|NCT00112918|1565382|P3|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|846
636738|NCT00112918|1565383|P2|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|810
636739|NCT00112918|1565384|P1|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|854
636740|NCT00112918|1565382|P3|Stage III Disease Population|Overall Study||952
636741|NCT00112918|1565383|P2|Stage III Disease Population|Overall Study||960
636742|NCT00112918|1565384|P1|Stage III Disease Population|Overall Study||955
636743|NCT00112918|1565382|P3|Received Treatment|Overall Study||1135
636744|NCT00112918|1565383|P2|Received Treatment|Overall Study|Includes two patients from FOLFOX4 who received Bv and were assigned to FOLFOX4+Bv safety analysis|1145
636745|NCT00112918|1565384|P1|Received Treatment|Overall Study||1126
636746|NCT00112918|1565382|P3|STARTED|Overall Study||1145
636747|NCT00112918|1565383|P2|STARTED|Overall Study||1155
636748|NCT00112918|1565384|P1|STARTED|Overall Study||1151
636749|NCT00112905|1565407|P1|NOT COMPLETED|Overall Study||12
636750|NCT00112905|1565407|P1|COMPLETED|Overall Study||15
636751|NCT00112905|1565407|P1|Eligible and Treated|Overall Study||22
636752|NCT00112905|1565407|P1|STARTED|Overall Study||27
636753|NCT00112866|1565416|P2|NOT COMPLETED|Overall Study||2
636754|NCT00112866|1565417|P1|NOT COMPLETED|Overall Study||2
636755|NCT00112866|1565416|P2|COMPLETED|Overall Study||13
636756|NCT00112866|1565417|P1|COMPLETED|Overall Study||13
636757|NCT00112866|1565416|P2|STARTED|Overall Study||15
636758|NCT00112866|1565417|P1|STARTED|Overall Study||15
636759|NCT00112840|1565439|P3|NOT COMPLETED|Overall Study||6
636760|NCT00112840|1565440|P2|NOT COMPLETED|Overall Study||0
636761|NCT00112840|1565441|P1|NOT COMPLETED|Overall Study||2
636762|NCT00112840|1565439|P3|COMPLETED|Overall Study||40
636763|NCT00112840|1565440|P2|COMPLETED|Overall Study||6
636764|NCT00112840|1565441|P1|COMPLETED|Overall Study||6
636765|NCT00112840|1565439|P3|STARTED|Overall Study||46
636766|NCT00112840|1565440|P2|STARTED|Overall Study||6
636767|NCT00112840|1565441|P1|STARTED|Overall Study||8
636768|NCT00112736|1565460|P2|NOT COMPLETED|Overall Study||0
636769|NCT00112736|1565461|P1|NOT COMPLETED|Overall Study||1
636770|NCT00112736|1565460|P2|COMPLETED|Overall Study|12 additional pts from phase 1 study were used in analysis for Phase 2 as they were treated at MTD|47
636771|NCT00112736|1565461|P1|COMPLETED|Overall Study|12 of Phase I pts treated at MTD and hence considered part of the Phase II analysis|21
636772|NCT00112736|1565460|P2|STARTED|Overall Study||47
636773|NCT00112736|1565461|P1|STARTED|Overall Study||22
636774|NCT00112723|1565474|P3|NOT COMPLETED|Overall Study||2
636775|NCT00112723|1565475|P2|NOT COMPLETED|Overall Study||7
636776|NCT00112723|1565476|P1|NOT COMPLETED|Overall Study||2
636777|NCT00112723|1565474|P3|COMPLETED|Overall Study||12
636778|NCT00112723|1565475|P2|COMPLETED|Overall Study||12
636779|NCT00112723|1565476|P1|COMPLETED|Overall Study||11
636780|NCT00112723|1565474|P3|Patients Evaluable for Toxicity|Overall Study||12
636781|NCT00112723|1565475|P2|Patients Evaluable for Toxicity|Overall Study||12
636782|NCT00112723|1565476|P1|Patients Evaluable for Toxicity|Overall Study||11
636783|NCT00112723|1565474|P3|STARTED|Overall Study||14
636784|NCT00112723|1565475|P2|STARTED|Overall Study||19
636785|NCT00112723|1565476|P1|STARTED|Overall Study||13
636786|NCT00112671|1565501|P1|NOT COMPLETED|Overall Study||0
636787|NCT00112671|1565501|P1|COMPLETED|Overall Study||17
636788|NCT00112671|1565501|P1|STARTED|Overall Study||17
636789|NCT00112593|1565507|P1|NOT COMPLETED|Overall Study||0
636790|NCT00112593|1565507|P1|COMPLETED|Overall Study||5
636791|NCT00112593|1565507|P1|STARTED|Overall Study||5
636792|NCT00112489|1565516|P1|NOT COMPLETED|Overall Study||40
636793|NCT00112489|1565516|P1|COMPLETED|Overall Study|Completed regimen due to progression|15
636794|NCT00112489|1565516|P1|STARTED|Overall Study|All patients enrolled on study|55
636795|NCT00112463|1565520|P1|NOT COMPLETED|Overall Study||39
636796|NCT00112463|1565520|P1|COMPLETED|Overall Study||1
636797|NCT00112463|1565520|P1|STARTED|Overall Study||40
636798|NCT00112437|1565532|P26|NOT COMPLETED|Years 6-10 (60-Month Extension)||5
636799|NCT00112437|1565533|P25|NOT COMPLETED|Years 6-10 (60-Month Extension)||1
636800|NCT00112437|1565534|P24|NOT COMPLETED|Years 6-10 (60-Month Extension)||12
636801|NCT00112437|1565535|P23|NOT COMPLETED|Years 6-10 (60-Month Extension)||5
636802|NCT00112437|1565536|P22|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
636803|NCT00112437|1565537|P21|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
636804|NCT00112437|1565538|P20|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
636805|NCT00112437|1565539|P19|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
636806|NCT00112437|1565540|P18|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
636807|NCT00112437|1565541|P17|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
636808|NCT00112437|1565542|P16|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
636809|NCT00112437|1565543|P15|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
636810|NCT00112437|1565544|P14|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
636811|NCT00112437|1565545|P13|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
636812|NCT00112437|1565546|P12|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
636813|NCT00112437|1565547|P11|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
636814|NCT00112437|1565548|P10|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
636815|NCT00112437|1565549|P9|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
636816|NCT00112437|1565550|P8|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
636817|NCT00112437|1565551|P7|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
636818|NCT00112437|1565552|P6|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
636819|NCT00112437|1565553|P5|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
636820|NCT00112437|1565554|P4|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
636821|NCT00112437|1565555|P3|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
636822|NCT00112437|1565556|P2|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
636823|NCT00112437|1565557|P1|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
636824|NCT00112437|1565532|P26|COMPLETED|Years 6-10 (60-Month Extension)||27
636825|NCT00112437|1565533|P25|COMPLETED|Years 6-10 (60-Month Extension)||22
636826|NCT00112437|1565534|P24|COMPLETED|Years 6-10 (60-Month Extension)||22
636827|NCT00112437|1565535|P23|COMPLETED|Years 6-10 (60-Month Extension)||23
636828|NCT00112437|1565536|P22|COMPLETED|Years 6-10 (60-Month Extension)||0
636829|NCT00112437|1565537|P21|COMPLETED|Years 6-10 (60-Month Extension)||0
636830|NCT00112437|1565538|P20|COMPLETED|Years 6-10 (60-Month Extension)||0
636831|NCT00112437|1565539|P19|COMPLETED|Years 6-10 (60-Month Extension)||0
636832|NCT00112437|1565540|P18|COMPLETED|Years 6-10 (60-Month Extension)||0
636833|NCT00112437|1565541|P17|COMPLETED|Years 6-10 (60-Month Extension)||0
636834|NCT00112437|1565542|P16|COMPLETED|Years 6-10 (60-Month Extension)||0
636835|NCT00112437|1565543|P15|COMPLETED|Years 6-10 (60-Month Extension)||0
636836|NCT00112437|1565544|P14|COMPLETED|Years 6-10 (60-Month Extension)||0
636837|NCT00112437|1565545|P13|COMPLETED|Years 6-10 (60-Month Extension)||0
636838|NCT00112437|1565546|P12|COMPLETED|Years 6-10 (60-Month Extension)||0
636839|NCT00112437|1565547|P11|COMPLETED|Years 6-10 (60-Month Extension)||0
636840|NCT00112437|1565548|P10|COMPLETED|Years 6-10 (60-Month Extension)||0
636841|NCT00112437|1565549|P9|COMPLETED|Years 6-10 (60-Month Extension)||0
636842|NCT00112437|1565550|P8|COMPLETED|Years 6-10 (60-Month Extension)||0
636843|NCT00112437|1565551|P7|COMPLETED|Years 6-10 (60-Month Extension)||0
636844|NCT00112437|1565552|P6|COMPLETED|Years 6-10 (60-Month Extension)||0
636845|NCT00112437|1565553|P5|COMPLETED|Years 6-10 (60-Month Extension)||0
636846|NCT00112437|1565554|P4|COMPLETED|Years 6-10 (60-Month Extension)||0
636847|NCT00112437|1565555|P3|COMPLETED|Years 6-10 (60-Month Extension)||0
636848|NCT00112437|1565556|P2|COMPLETED|Years 6-10 (60-Month Extension)||0
636849|NCT00112437|1565557|P1|COMPLETED|Years 6-10 (60-Month Extension)||0
636850|NCT00112437|1565532|P26|STARTED|Years 6-10 (60-Month Extension)||32
636851|NCT00112437|1565533|P25|STARTED|Years 6-10 (60-Month Extension)||23
636852|NCT00112437|1565534|P24|STARTED|Years 6-10 (60-Month Extension)||34
636853|NCT00112437|1565535|P23|STARTED|Years 6-10 (60-Month Extension)||28
636854|NCT00112437|1565536|P22|STARTED|Years 6-10 (60-Month Extension)||0
636855|NCT00112437|1565537|P21|STARTED|Years 6-10 (60-Month Extension)||0
636856|NCT00112437|1565538|P20|STARTED|Years 6-10 (60-Month Extension)||0
636857|NCT00112437|1565539|P19|STARTED|Years 6-10 (60-Month Extension)||0
636858|NCT00112437|1565540|P18|STARTED|Years 6-10 (60-Month Extension)||0
636859|NCT00112437|1565541|P17|STARTED|Years 6-10 (60-Month Extension)||0
636860|NCT00112437|1565542|P16|STARTED|Years 6-10 (60-Month Extension)||0
636861|NCT00112437|1565543|P15|STARTED|Years 6-10 (60-Month Extension)||0
636862|NCT00112437|1565544|P14|STARTED|Years 6-10 (60-Month Extension)||0
636863|NCT00112437|1565545|P13|STARTED|Years 6-10 (60-Month Extension)||0
636864|NCT00112437|1565546|P12|STARTED|Years 6-10 (60-Month Extension)||0
636865|NCT00112437|1565547|P11|STARTED|Years 6-10 (60-Month Extension)||0
636866|NCT00112437|1565548|P10|STARTED|Years 6-10 (60-Month Extension)||0
636867|NCT00112437|1565549|P9|STARTED|Years 6-10 (60-Month Extension)||0
636868|NCT00112437|1565550|P8|STARTED|Years 6-10 (60-Month Extension)||0
636869|NCT00112437|1565551|P7|STARTED|Years 6-10 (60-Month Extension)||0
636870|NCT00112437|1565552|P6|STARTED|Years 6-10 (60-Month Extension)||0
636871|NCT00112437|1565553|P5|STARTED|Years 6-10 (60-Month Extension)||0
636872|NCT00112437|1565554|P4|STARTED|Years 6-10 (60-Month Extension)||0
636873|NCT00112437|1565555|P3|STARTED|Years 6-10 (60-Month Extension)||0
636874|NCT00112437|1565556|P2|STARTED|Years 6-10 (60-Month Extension)||0
636875|NCT00112437|1565557|P1|STARTED|Years 6-10 (60-Month Extension)||0
636876|NCT00112437|1565532|P26|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
636877|NCT00112437|1565533|P25|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
636878|NCT00112437|1565534|P24|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
636879|NCT00112437|1565535|P23|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
636880|NCT00112437|1565536|P22|NOT COMPLETED|Years 4-5 (24-Month Extension)||8
636881|NCT00112437|1565537|P21|NOT COMPLETED|Years 4-5 (24-Month Extension)||4
636882|NCT00112437|1565538|P20|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
636883|NCT00112437|1565539|P19|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
636884|NCT00112437|1565540|P18|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
636885|NCT00112437|1565541|P17|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
636886|NCT00112437|1565542|P16|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
636887|NCT00112437|1565543|P15|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
636888|NCT00112437|1565544|P14|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
636889|NCT00112437|1565545|P13|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
636890|NCT00112437|1565546|P12|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
636891|NCT00112437|1565547|P11|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
636892|NCT00112437|1565548|P10|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
636893|NCT00112437|1565549|P9|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
636894|NCT00112437|1565550|P8|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
636895|NCT00112437|1565551|P7|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
636896|NCT00112437|1565552|P6|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
636897|NCT00112437|1565553|P5|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
636898|NCT00112437|1565554|P4|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
636899|NCT00112437|1565555|P3|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
636900|NCT00112437|1565556|P2|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
636901|NCT00112437|1565557|P1|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
636902|NCT00112437|1565532|P26|COMPLETED|Years 4-5 (24-Month Extension)||0
636903|NCT00112437|1565533|P25|COMPLETED|Years 4-5 (24-Month Extension)||0
636904|NCT00112437|1565534|P24|COMPLETED|Years 4-5 (24-Month Extension)||0
636905|NCT00112437|1565535|P23|COMPLETED|Years 4-5 (24-Month Extension)||0
636906|NCT00112437|1565536|P22|COMPLETED|Years 4-5 (24-Month Extension)||92
636907|NCT00112437|1565537|P21|COMPLETED|Years 4-5 (24-Month Extension)||37
636908|NCT00112437|1565538|P20|COMPLETED|Years 4-5 (24-Month Extension)||0
636909|NCT00112437|1565539|P19|COMPLETED|Years 4-5 (24-Month Extension)||0
636910|NCT00112437|1565540|P18|COMPLETED|Years 4-5 (24-Month Extension)||0
636911|NCT00112437|1565541|P17|COMPLETED|Years 4-5 (24-Month Extension)||0
636912|NCT00112437|1565542|P16|COMPLETED|Years 4-5 (24-Month Extension)||0
636913|NCT00112437|1565543|P15|COMPLETED|Years 4-5 (24-Month Extension)||0
636914|NCT00112437|1565544|P14|COMPLETED|Years 4-5 (24-Month Extension)||0
636915|NCT00112437|1565545|P13|COMPLETED|Years 4-5 (24-Month Extension)||0
636916|NCT00112437|1565546|P12|COMPLETED|Years 4-5 (24-Month Extension)||0
636917|NCT00112437|1565547|P11|COMPLETED|Years 4-5 (24-Month Extension)||0
636918|NCT00112437|1565548|P10|COMPLETED|Years 4-5 (24-Month Extension)||0
636919|NCT00112437|1565549|P9|COMPLETED|Years 4-5 (24-Month Extension)||0
636920|NCT00112437|1565550|P8|COMPLETED|Years 4-5 (24-Month Extension)||0
636921|NCT00112437|1565551|P7|COMPLETED|Years 4-5 (24-Month Extension)||0
636922|NCT00112437|1565552|P6|COMPLETED|Years 4-5 (24-Month Extension)||0
636923|NCT00112437|1565553|P5|COMPLETED|Years 4-5 (24-Month Extension)||0
636924|NCT00112437|1565554|P4|COMPLETED|Years 4-5 (24-Month Extension)||0
636925|NCT00112437|1565555|P3|COMPLETED|Years 4-5 (24-Month Extension)||0
636926|NCT00112437|1565556|P2|COMPLETED|Years 4-5 (24-Month Extension)||0
636927|NCT00112437|1565557|P1|COMPLETED|Years 4-5 (24-Month Extension)||0
636928|NCT00112437|1565532|P26|STARTED|Years 4-5 (24-Month Extension)||0
636929|NCT00112437|1565533|P25|STARTED|Years 4-5 (24-Month Extension)||0
636930|NCT00112437|1565534|P24|STARTED|Years 4-5 (24-Month Extension)||0
636931|NCT00112437|1565535|P23|STARTED|Years 4-5 (24-Month Extension)||0
636932|NCT00112437|1565536|P22|STARTED|Years 4-5 (24-Month Extension)||100
636933|NCT00112437|1565537|P21|STARTED|Years 4-5 (24-Month Extension)||41
636934|NCT00112437|1565538|P20|STARTED|Years 4-5 (24-Month Extension)||0
636935|NCT00112437|1565539|P19|STARTED|Years 4-5 (24-Month Extension)||0
636936|NCT00112437|1565540|P18|STARTED|Years 4-5 (24-Month Extension)||0
636937|NCT00112437|1565541|P17|STARTED|Years 4-5 (24-Month Extension)||0
636938|NCT00112437|1565542|P16|STARTED|Years 4-5 (24-Month Extension)||0
636939|NCT00112437|1565543|P15|STARTED|Years 4-5 (24-Month Extension)||0
636940|NCT00112437|1565544|P14|STARTED|Years 4-5 (24-Month Extension)||0
636941|NCT00112437|1565545|P13|STARTED|Years 4-5 (24-Month Extension)||0
636942|NCT00112437|1565546|P12|STARTED|Years 4-5 (24-Month Extension)||0
636943|NCT00112437|1565547|P11|STARTED|Years 4-5 (24-Month Extension)||0
636944|NCT00112437|1565548|P10|STARTED|Years 4-5 (24-Month Extension)||0
636945|NCT00112437|1565549|P9|STARTED|Years 4-5 (24-Month Extension)||0
636946|NCT00112437|1565550|P8|STARTED|Years 4-5 (24-Month Extension)||0
636947|NCT00112437|1565551|P7|STARTED|Years 4-5 (24-Month Extension)||0
636948|NCT00112437|1565552|P6|STARTED|Years 4-5 (24-Month Extension)||0
636949|NCT00112437|1565553|P5|STARTED|Years 4-5 (24-Month Extension)||0
636950|NCT00112437|1565554|P4|STARTED|Years 4-5 (24-Month Extension)||0
636951|NCT00112437|1565555|P3|STARTED|Years 4-5 (24-Month Extension)||0
636952|NCT00112437|1565556|P2|STARTED|Years 4-5 (24-Month Extension)||0
636953|NCT00112437|1565557|P1|STARTED|Years 4-5 (24-Month Extension)||0
636954|NCT00112437|1565532|P26|NOT COMPLETED|Year 3 (12-Month Extension)||0
636955|NCT00112437|1565533|P25|NOT COMPLETED|Year 3 (12-Month Extension)||0
636956|NCT00112437|1565534|P24|NOT COMPLETED|Year 3 (12-Month Extension)||0
636957|NCT00112437|1565535|P23|NOT COMPLETED|Year 3 (12-Month Extension)||0
636958|NCT00112437|1565536|P22|NOT COMPLETED|Year 3 (12-Month Extension)||0
636959|NCT00112437|1565537|P21|NOT COMPLETED|Year 3 (12-Month Extension)||0
636960|NCT00112437|1565538|P20|NOT COMPLETED|Year 3 (12-Month Extension)||1
636961|NCT00112437|1565539|P19|NOT COMPLETED|Year 3 (12-Month Extension)||2
636962|NCT00112437|1565540|P18|NOT COMPLETED|Year 3 (12-Month Extension)||1
636963|NCT00112437|1565541|P17|NOT COMPLETED|Year 3 (12-Month Extension)||3
636964|NCT00112437|1565542|P16|NOT COMPLETED|Year 3 (12-Month Extension)||4
636965|NCT00112437|1565543|P15|NOT COMPLETED|Year 3 (12-Month Extension)||1
636966|NCT00112437|1565544|P14|NOT COMPLETED|Year 3 (12-Month Extension)||1
636967|NCT00112437|1565545|P13|NOT COMPLETED|Year 3 (12-Month Extension)||0
636968|NCT00112437|1565546|P12|NOT COMPLETED|Year 3 (12-Month Extension)||5
636969|NCT00112437|1565547|P11|NOT COMPLETED|Year 3 (12-Month Extension)||2
636970|NCT00112437|1565548|P10|NOT COMPLETED|Year 3 (12-Month Extension)||0
636971|NCT00112437|1565549|P9|NOT COMPLETED|Year 3 (12-Month Extension)||0
636972|NCT00112437|1565550|P8|NOT COMPLETED|Year 3 (12-Month Extension)||0
636973|NCT00112437|1565551|P7|NOT COMPLETED|Year 3 (12-Month Extension)||0
636974|NCT00112437|1565552|P6|NOT COMPLETED|Year 3 (12-Month Extension)||0
636975|NCT00112437|1565553|P5|NOT COMPLETED|Year 3 (12-Month Extension)||0
636976|NCT00112437|1565554|P4|NOT COMPLETED|Year 3 (12-Month Extension)||0
636977|NCT00112437|1565555|P3|NOT COMPLETED|Year 3 (12-Month Extension)||0
636978|NCT00112437|1565556|P2|NOT COMPLETED|Year 3 (12-Month Extension)||0
636979|NCT00112437|1565557|P1|NOT COMPLETED|Year 3 (12-Month Extension)||0
636980|NCT00112437|1565532|P26|COMPLETED|Year 3 (12-Month Extension)||0
636981|NCT00112437|1565533|P25|COMPLETED|Year 3 (12-Month Extension)||0
636982|NCT00112437|1565534|P24|COMPLETED|Year 3 (12-Month Extension)||0
636983|NCT00112437|1565535|P23|COMPLETED|Year 3 (12-Month Extension)||0
636984|NCT00112437|1565536|P22|COMPLETED|Year 3 (12-Month Extension)||0
636985|NCT00112437|1565537|P21|COMPLETED|Year 3 (12-Month Extension)||0
636986|NCT00112437|1565538|P20|COMPLETED|Year 3 (12-Month Extension)||19
636987|NCT00112437|1565539|P19|COMPLETED|Year 3 (12-Month Extension)||16
636988|NCT00112437|1565540|P18|COMPLETED|Year 3 (12-Month Extension)||20
636989|NCT00112437|1565541|P17|COMPLETED|Year 3 (12-Month Extension)||16
636990|NCT00112437|1565542|P16|COMPLETED|Year 3 (12-Month Extension)||13
636991|NCT00112437|1565543|P15|COMPLETED|Year 3 (12-Month Extension)||17
636992|NCT00112437|1565544|P14|COMPLETED|Year 3 (12-Month Extension)||16
636993|NCT00112437|1565545|P13|COMPLETED|Year 3 (12-Month Extension)||18
636994|NCT00112437|1565546|P12|COMPLETED|Year 3 (12-Month Extension)||17
636995|NCT00112437|1565547|P11|COMPLETED|Year 3 (12-Month Extension)||17
636996|NCT00112437|1565548|P10|COMPLETED|Year 3 (12-Month Extension)||0
636997|NCT00112437|1565549|P9|COMPLETED|Year 3 (12-Month Extension)||0
636998|NCT00112437|1565550|P8|COMPLETED|Year 3 (12-Month Extension)||0
636999|NCT00112437|1565551|P7|COMPLETED|Year 3 (12-Month Extension)||0
637000|NCT00112437|1565552|P6|COMPLETED|Year 3 (12-Month Extension)||0
637001|NCT00112437|1565553|P5|COMPLETED|Year 3 (12-Month Extension)||0
637002|NCT00112437|1565554|P4|COMPLETED|Year 3 (12-Month Extension)||0
637003|NCT00112437|1565555|P3|COMPLETED|Year 3 (12-Month Extension)||0
637004|NCT00112437|1565556|P2|COMPLETED|Year 3 (12-Month Extension)||0
637005|NCT00112437|1565557|P1|COMPLETED|Year 3 (12-Month Extension)||0
637006|NCT00112437|1565532|P26|STARTED|Year 3 (12-Month Extension)||0
637007|NCT00112437|1565533|P25|STARTED|Year 3 (12-Month Extension)||0
637008|NCT00112437|1565534|P24|STARTED|Year 3 (12-Month Extension)||0
637009|NCT00112437|1565535|P23|STARTED|Year 3 (12-Month Extension)||0
637010|NCT00112437|1565536|P22|STARTED|Year 3 (12-Month Extension)||0
637011|NCT00112437|1565537|P21|STARTED|Year 3 (12-Month Extension)||0
637012|NCT00112437|1565538|P20|STARTED|Year 3 (12-Month Extension)||20
637013|NCT00112437|1565539|P19|STARTED|Year 3 (12-Month Extension)||18
637014|NCT00112437|1565540|P18|STARTED|Year 3 (12-Month Extension)||21
637015|NCT00112437|1565541|P17|STARTED|Year 3 (12-Month Extension)||19
637016|NCT00112437|1565542|P16|STARTED|Year 3 (12-Month Extension)||17
637017|NCT00112437|1565543|P15|STARTED|Year 3 (12-Month Extension)||18
637018|NCT00112437|1565544|P14|STARTED|Year 3 (12-Month Extension)||17
637019|NCT00112437|1565545|P13|STARTED|Year 3 (12-Month Extension)||18
637020|NCT00112437|1565546|P12|STARTED|Year 3 (12-Month Extension)||22
637021|NCT00112437|1565547|P11|STARTED|Year 3 (12-Month Extension)||19
637022|NCT00112437|1565548|P10|STARTED|Year 3 (12-Month Extension)||0
637023|NCT00112437|1565549|P9|STARTED|Year 3 (12-Month Extension)||0
637024|NCT00112437|1565550|P8|STARTED|Year 3 (12-Month Extension)||0
637025|NCT00112437|1565551|P7|STARTED|Year 3 (12-Month Extension)||0
637026|NCT00112437|1565552|P6|STARTED|Year 3 (12-Month Extension)||0
637027|NCT00112437|1565553|P5|STARTED|Year 3 (12-Month Extension)||0
637028|NCT00112437|1565554|P4|STARTED|Year 3 (12-Month Extension)||0
637029|NCT00112437|1565555|P3|STARTED|Year 3 (12-Month Extension)||0
637030|NCT00112437|1565556|P2|STARTED|Year 3 (12-Month Extension)||0
637031|NCT00112437|1565557|P1|STARTED|Year 3 (12-Month Extension)||0
637032|NCT00112437|1565532|P26|NOT COMPLETED|Year 2 (12-Month Extension)||0
637033|NCT00112437|1565533|P25|NOT COMPLETED|Year 2 (12-Month Extension)||0
637034|NCT00112437|1565534|P24|NOT COMPLETED|Year 2 (12-Month Extension)||0
637035|NCT00112437|1565535|P23|NOT COMPLETED|Year 2 (12-Month Extension)||0
637036|NCT00112437|1565536|P22|NOT COMPLETED|Year 2 (12-Month Extension)||0
637037|NCT00112437|1565537|P21|NOT COMPLETED|Year 2 (12-Month Extension)||0
637038|NCT00112437|1565538|P20|NOT COMPLETED|Year 2 (12-Month Extension)||0
637039|NCT00112437|1565539|P19|NOT COMPLETED|Year 2 (12-Month Extension)||0
637040|NCT00112437|1565540|P18|NOT COMPLETED|Year 2 (12-Month Extension)||0
637041|NCT00112437|1565541|P17|NOT COMPLETED|Year 2 (12-Month Extension)||0
637042|NCT00112437|1565542|P16|NOT COMPLETED|Year 2 (12-Month Extension)||0
637043|NCT00112437|1565543|P15|NOT COMPLETED|Year 2 (12-Month Extension)||0
637044|NCT00112437|1565544|P14|NOT COMPLETED|Year 2 (12-Month Extension)||0
637045|NCT00112437|1565545|P13|NOT COMPLETED|Year 2 (12-Month Extension)||0
637046|NCT00112437|1565546|P12|NOT COMPLETED|Year 2 (12-Month Extension)||0
637047|NCT00112437|1565547|P11|NOT COMPLETED|Year 2 (12-Month Extension)||0
637048|NCT00112437|1565548|P10|NOT COMPLETED|Year 2 (12-Month Extension)||13
637049|NCT00112437|1565549|P9|NOT COMPLETED|Year 2 (12-Month Extension)||7
637050|NCT00112437|1565550|P8|NOT COMPLETED|Year 2 (12-Month Extension)||8
637051|NCT00112437|1565551|P7|NOT COMPLETED|Year 2 (12-Month Extension)||9
637052|NCT00112437|1565552|P6|NOT COMPLETED|Year 2 (12-Month Extension)||3
637053|NCT00112437|1565553|P5|NOT COMPLETED|Year 2 (12-Month Extension)||0
637054|NCT00112437|1565554|P4|NOT COMPLETED|Year 2 (12-Month Extension)||0
637055|NCT00112437|1565555|P3|NOT COMPLETED|Year 2 (12-Month Extension)||0
637056|NCT00112437|1565556|P2|NOT COMPLETED|Year 2 (12-Month Extension)||0
637057|NCT00112437|1565557|P1|NOT COMPLETED|Year 2 (12-Month Extension)||0
637058|NCT00112437|1565532|P26|COMPLETED|Year 2 (12-Month Extension)||0
637059|NCT00112437|1565533|P25|COMPLETED|Year 2 (12-Month Extension)||0
637060|NCT00112437|1565534|P24|COMPLETED|Year 2 (12-Month Extension)||0
637061|NCT00112437|1565535|P23|COMPLETED|Year 2 (12-Month Extension)||0
637062|NCT00112437|1565536|P22|COMPLETED|Year 2 (12-Month Extension)||0
637063|NCT00112437|1565537|P21|COMPLETED|Year 2 (12-Month Extension)||0
637064|NCT00112437|1565538|P20|COMPLETED|Year 2 (12-Month Extension)||0
637065|NCT00112437|1565539|P19|COMPLETED|Year 2 (12-Month Extension)||0
637066|NCT00112437|1565540|P18|COMPLETED|Year 2 (12-Month Extension)||0
637067|NCT00112437|1565541|P17|COMPLETED|Year 2 (12-Month Extension)||0
637068|NCT00112437|1565542|P16|COMPLETED|Year 2 (12-Month Extension)||0
637069|NCT00112437|1565543|P15|COMPLETED|Year 2 (12-Month Extension)||0
637070|NCT00112437|1565544|P14|COMPLETED|Year 2 (12-Month Extension)||0
637071|NCT00112437|1565545|P13|COMPLETED|Year 2 (12-Month Extension)||0
637072|NCT00112437|1565546|P12|COMPLETED|Year 2 (12-Month Extension)||0
637073|NCT00112437|1565547|P11|COMPLETED|Year 2 (12-Month Extension)||0
637074|NCT00112437|1565548|P10|COMPLETED|Year 2 (12-Month Extension)||50
637075|NCT00112437|1565549|P9|COMPLETED|Year 2 (12-Month Extension)||62
637076|NCT00112437|1565550|P8|COMPLETED|Year 2 (12-Month Extension)||55
637077|NCT00112437|1565551|P7|COMPLETED|Year 2 (12-Month Extension)||53
637078|NCT00112437|1565552|P6|COMPLETED|Year 2 (12-Month Extension)||60
637079|NCT00112437|1565553|P5|COMPLETED|Year 2 (12-Month Extension)||0
637080|NCT00112437|1565554|P4|COMPLETED|Year 2 (12-Month Extension)||0
637081|NCT00112437|1565555|P3|COMPLETED|Year 2 (12-Month Extension)||0
637082|NCT00112437|1565556|P2|COMPLETED|Year 2 (12-Month Extension)||0
637083|NCT00112437|1565557|P1|COMPLETED|Year 2 (12-Month Extension)||0
637084|NCT00112437|1565532|P26|STARTED|Year 2 (12-Month Extension)||0
637085|NCT00112437|1565533|P25|STARTED|Year 2 (12-Month Extension)||0
637086|NCT00112437|1565534|P24|STARTED|Year 2 (12-Month Extension)||0
637087|NCT00112437|1565535|P23|STARTED|Year 2 (12-Month Extension)||0
637088|NCT00112437|1565536|P22|STARTED|Year 2 (12-Month Extension)||0
637089|NCT00112437|1565537|P21|STARTED|Year 2 (12-Month Extension)||0
637090|NCT00112437|1565538|P20|STARTED|Year 2 (12-Month Extension)||0
637091|NCT00112437|1565539|P19|STARTED|Year 2 (12-Month Extension)||0
637092|NCT00112437|1565540|P18|STARTED|Year 2 (12-Month Extension)||0
637093|NCT00112437|1565541|P17|STARTED|Year 2 (12-Month Extension)||0
637094|NCT00112437|1565542|P16|STARTED|Year 2 (12-Month Extension)||0
637095|NCT00112437|1565543|P15|STARTED|Year 2 (12-Month Extension)||0
637096|NCT00112437|1565544|P14|STARTED|Year 2 (12-Month Extension)||0
637097|NCT00112437|1565545|P13|STARTED|Year 2 (12-Month Extension)||0
637098|NCT00112437|1565546|P12|STARTED|Year 2 (12-Month Extension)||0
637099|NCT00112437|1565547|P11|STARTED|Year 2 (12-Month Extension)||0
637100|NCT00112437|1565548|P10|STARTED|Year 2 (12-Month Extension)||63
637101|NCT00112437|1565549|P9|STARTED|Year 2 (12-Month Extension)||69
637102|NCT00112437|1565550|P8|STARTED|Year 2 (12-Month Extension)||63
637103|NCT00112437|1565551|P7|STARTED|Year 2 (12-Month Extension)||62
637104|NCT00112437|1565552|P6|STARTED|Year 2 (12-Month Extension)||63
637105|NCT00112437|1565553|P5|STARTED|Year 2 (12-Month Extension)||0
637106|NCT00112437|1565554|P4|STARTED|Year 2 (12-Month Extension)||0
637107|NCT00112437|1565555|P3|STARTED|Year 2 (12-Month Extension)||0
637108|NCT00112437|1565556|P2|STARTED|Year 2 (12-Month Extension)||0
637109|NCT00112437|1565557|P1|STARTED|Year 2 (12-Month Extension)||0
637110|NCT00112437|1565532|P26|NOT COMPLETED|Year 1 (12-Month Base Study)||0
637111|NCT00112437|1565533|P25|NOT COMPLETED|Year 1 (12-Month Base Study)||0
637112|NCT00112437|1565534|P24|NOT COMPLETED|Year 1 (12-Month Base Study)||0
637113|NCT00112437|1565535|P23|NOT COMPLETED|Year 1 (12-Month Base Study)||0
637114|NCT00112437|1565536|P22|NOT COMPLETED|Year 1 (12-Month Base Study)||0
637115|NCT00112437|1565537|P21|NOT COMPLETED|Year 1 (12-Month Base Study)||0
637116|NCT00112437|1565538|P20|NOT COMPLETED|Year 1 (12-Month Base Study)||0
637117|NCT00112437|1565539|P19|NOT COMPLETED|Year 1 (12-Month Base Study)||0
637118|NCT00112437|1565540|P18|NOT COMPLETED|Year 1 (12-Month Base Study)||0
637119|NCT00112437|1565541|P17|NOT COMPLETED|Year 1 (12-Month Base Study)||0
637120|NCT00112437|1565542|P16|NOT COMPLETED|Year 1 (12-Month Base Study)||0
637121|NCT00112437|1565543|P15|NOT COMPLETED|Year 1 (12-Month Base Study)||0
637122|NCT00112437|1565544|P14|NOT COMPLETED|Year 1 (12-Month Base Study)||0
637123|NCT00112437|1565545|P13|NOT COMPLETED|Year 1 (12-Month Base Study)||0
637124|NCT00112437|1565546|P12|NOT COMPLETED|Year 1 (12-Month Base Study)||0
637125|NCT00112437|1565547|P11|NOT COMPLETED|Year 1 (12-Month Base Study)||0
637126|NCT00112437|1565548|P10|NOT COMPLETED|Year 1 (12-Month Base Study)||0
637127|NCT00112437|1565549|P9|NOT COMPLETED|Year 1 (12-Month Base Study)||0
637128|NCT00112437|1565550|P8|NOT COMPLETED|Year 1 (12-Month Base Study)||0
637129|NCT00112437|1565551|P7|NOT COMPLETED|Year 1 (12-Month Base Study)||0
637130|NCT00112437|1565552|P6|NOT COMPLETED|Year 1 (12-Month Base Study)||0
637131|NCT00112437|1565553|P5|NOT COMPLETED|Year 1 (12-Month Base Study)||12
637132|NCT00112437|1565554|P4|NOT COMPLETED|Year 1 (12-Month Base Study)||8
637133|NCT00112437|1565555|P3|NOT COMPLETED|Year 1 (12-Month Base Study)||12
637134|NCT00112437|1565556|P2|NOT COMPLETED|Year 1 (12-Month Base Study)||18
637135|NCT00112437|1565557|P1|NOT COMPLETED|Year 1 (12-Month Base Study)||15
637136|NCT00112437|1565532|P26|COMPLETED|Year 1 (12-Month Base Study)||0
637137|NCT00112437|1565533|P25|COMPLETED|Year 1 (12-Month Base Study)||0
637138|NCT00112437|1565534|P24|COMPLETED|Year 1 (12-Month Base Study)||0
637139|NCT00112437|1565535|P23|COMPLETED|Year 1 (12-Month Base Study)||0
637140|NCT00112437|1565536|P22|COMPLETED|Year 1 (12-Month Base Study)||0
637141|NCT00112437|1565537|P21|COMPLETED|Year 1 (12-Month Base Study)||0
637142|NCT00112437|1565538|P20|COMPLETED|Year 1 (12-Month Base Study)||0
637143|NCT00112437|1565539|P19|COMPLETED|Year 1 (12-Month Base Study)||0
637144|NCT00112437|1565540|P18|COMPLETED|Year 1 (12-Month Base Study)||0
637145|NCT00112437|1565541|P17|COMPLETED|Year 1 (12-Month Base Study)||0
637146|NCT00112437|1565542|P16|COMPLETED|Year 1 (12-Month Base Study)||0
637147|NCT00112437|1565543|P15|COMPLETED|Year 1 (12-Month Base Study)||0
637148|NCT00112437|1565544|P14|COMPLETED|Year 1 (12-Month Base Study)||0
637149|NCT00112437|1565545|P13|COMPLETED|Year 1 (12-Month Base Study)||0
637150|NCT00112437|1565546|P12|COMPLETED|Year 1 (12-Month Base Study)||0
637151|NCT00112437|1565547|P11|COMPLETED|Year 1 (12-Month Base Study)||0
637152|NCT00112437|1565548|P10|COMPLETED|Year 1 (12-Month Base Study)||0
637153|NCT00112437|1565549|P9|COMPLETED|Year 1 (12-Month Base Study)||0
637154|NCT00112437|1565550|P8|COMPLETED|Year 1 (12-Month Base Study)||0
637155|NCT00112437|1565551|P7|COMPLETED|Year 1 (12-Month Base Study)||0
637156|NCT00112437|1565552|P6|COMPLETED|Year 1 (12-Month Base Study)||0
637157|NCT00112437|1565553|P5|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in the completed total.|66
637158|NCT00112437|1565554|P4|COMPLETED|Year 1 (12-Month Base Study)||71
637159|NCT00112437|1565555|P3|COMPLETED|Year 1 (12-Month Base Study)||65
637160|NCT00112437|1565556|P2|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in completed total.|64
637161|NCT00112437|1565557|P1|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in completed total.|68
637162|NCT00112437|1565532|P26|STARTED|Year 1 (12-Month Base Study)||0
637163|NCT00112437|1565533|P25|STARTED|Year 1 (12-Month Base Study)||0
637164|NCT00112437|1565534|P24|STARTED|Year 1 (12-Month Base Study)||0
637165|NCT00112437|1565535|P23|STARTED|Year 1 (12-Month Base Study)||0
637166|NCT00112437|1565536|P22|STARTED|Year 1 (12-Month Base Study)||0
637167|NCT00112437|1565537|P21|STARTED|Year 1 (12-Month Base Study)||0
637168|NCT00112437|1565538|P20|STARTED|Year 1 (12-Month Base Study)||0
637169|NCT00112437|1565539|P19|STARTED|Year 1 (12-Month Base Study)||0
637170|NCT00112437|1565540|P18|STARTED|Year 1 (12-Month Base Study)||0
637171|NCT00112437|1565541|P17|STARTED|Year 1 (12-Month Base Study)||0
637172|NCT00112437|1565542|P16|STARTED|Year 1 (12-Month Base Study)||0
637173|NCT00112437|1565543|P15|STARTED|Year 1 (12-Month Base Study)||0
637174|NCT00112437|1565544|P14|STARTED|Year 1 (12-Month Base Study)||0
637175|NCT00112437|1565545|P13|STARTED|Year 1 (12-Month Base Study)||0
637176|NCT00112437|1565546|P12|STARTED|Year 1 (12-Month Base Study)||0
637177|NCT00112437|1565547|P11|STARTED|Year 1 (12-Month Base Study)||0
637178|NCT00112437|1565548|P10|STARTED|Year 1 (12-Month Base Study)||0
637179|NCT00112437|1565549|P9|STARTED|Year 1 (12-Month Base Study)||0
637180|NCT00112437|1565550|P8|STARTED|Year 1 (12-Month Base Study)||0
637181|NCT00112437|1565551|P7|STARTED|Year 1 (12-Month Base Study)||0
637182|NCT00112437|1565552|P6|STARTED|Year 1 (12-Month Base Study)||0
637183|NCT00112437|1565553|P5|STARTED|Year 1 (12-Month Base Study)||78
637184|NCT00112437|1565554|P4|STARTED|Year 1 (12-Month Base Study)||79
637185|NCT00112437|1565555|P3|STARTED|Year 1 (12-Month Base Study)||77
637186|NCT00112437|1565556|P2|STARTED|Year 1 (12-Month Base Study)||82
637187|NCT00112437|1565557|P1|STARTED|Year 1 (12-Month Base Study)||83
637188|NCT00112385|1565837|P2|NOT COMPLETED|Overall Study||1
637189|NCT00112385|1565838|P1|NOT COMPLETED|Overall Study||1
637190|NCT00112385|1565837|P2|COMPLETED|Overall Study||4
637191|NCT00112385|1565838|P1|COMPLETED|Overall Study||10
637192|NCT00112385|1565837|P2|STARTED|Overall Study||5
637193|NCT00112385|1565838|P1|STARTED|Overall Study||11
637194|NCT00112359|1565928|P2|NOT COMPLETED|Overall Study||13
637195|NCT00112359|1565929|P1|NOT COMPLETED|Overall Study||27
637196|NCT00112359|1565928|P2|COMPLETED|Overall Study||67
637197|NCT00112359|1565929|P1|COMPLETED|Overall Study||57
637198|NCT00112359|1565928|P2|STARTED|Overall Study||80
637199|NCT00112359|1565929|P1|STARTED|Overall Study||84
637200|NCT00112294|1565955|P2|NOT COMPLETED|Overall Study||0
637201|NCT00112294|1565956|P1|NOT COMPLETED|Overall Study||5
637202|NCT00112294|1565955|P2|COMPLETED|Overall Study|Off all study therapies.|320
637203|NCT00112294|1565956|P1|COMPLETED|Overall Study|Off all study therapies.|320
637204|NCT00112294|1565955|P2|Never Treated|Overall Study|Number by randomized group = 20, but 2 participants received C/T/C instead of T/C.|18
637205|NCT00112294|1565956|P1|Never Treated|Overall Study|Number by randomized group = 11, but 2 participants received C/T/C instead of T/C.|13
637206|NCT00112294|1565955|P2|STARTED|Overall Study|338 randomized and 320 treated.|320
637207|NCT00112294|1565956|P1|STARTED|Overall Study|338 randomized and 325 treated.|325
637208|NCT00112151|1566000|P6|NOT COMPLETED|Overall Study||3
637209|NCT00112151|1566001|P5|NOT COMPLETED|Overall Study||6
637210|NCT00112151|1566002|P4|NOT COMPLETED|Overall Study||3
637211|NCT00112151|1566003|P3|NOT COMPLETED|Overall Study||3
637212|NCT00112151|1566004|P2|NOT COMPLETED|Overall Study||5
637213|NCT00112151|1566005|P1|NOT COMPLETED|Overall Study||4
637214|NCT00112151|1566000|P6|COMPLETED|Overall Study||25
637215|NCT00112151|1566001|P5|COMPLETED|Overall Study||22
637216|NCT00112151|1566002|P4|COMPLETED|Overall Study||24
637217|NCT00112151|1566003|P3|COMPLETED|Overall Study||25
637218|NCT00112151|1566004|P2|COMPLETED|Overall Study||23
637219|NCT00112151|1566005|P1|COMPLETED|Overall Study||24
637220|NCT00112151|1566000|P6|STARTED|Overall Study||28
637221|NCT00112151|1566001|P5|STARTED|Overall Study||28
637222|NCT00112151|1566002|P4|STARTED|Overall Study||27
637223|NCT00112151|1566003|P3|STARTED|Overall Study||28
637224|NCT00112151|1566004|P2|STARTED|Overall Study||28
637225|NCT00112151|1566005|P1|STARTED|Overall Study||28
637226|NCT00112112|1566036|P2|NOT COMPLETED|Overall Study||0
637227|NCT00112112|1566037|P1|NOT COMPLETED|Overall Study||0
637228|NCT00112112|1566036|P2|COMPLETED|Overall Study||10
637229|NCT00112112|1566037|P1|COMPLETED|Overall Study||10
637230|NCT00112112|1566036|P2|STARTED|Overall Study||10
637231|NCT00112112|1566037|P1|STARTED|Overall Study||10
637232|NCT00112047|1566179|P2|NOT COMPLETED|Atripla Phase||20
637233|NCT00112047|1566180|P1|NOT COMPLETED|Atripla Phase||18
637234|NCT00112047|1566179|P2|COMPLETED|Atripla Phase||106
637235|NCT00112047|1566180|P1|COMPLETED|Atripla Phase||142
637236|NCT00112047|1566179|P2|STARTED|Atripla Phase|Number of participants who completed randomized phase and opted to roll over to Atripla at Week 144|126
637237|NCT00112047|1566180|P1|STARTED|Atripla Phase|Number of participants who completed randomized phase and opted to roll over to Atripla at Week 144|160
637238|NCT00112047|1566179|P2|NOT COMPLETED|Randomized Phase||88
637239|NCT00112047|1566180|P1|NOT COMPLETED|Randomized Phase||70
637240|NCT00112047|1566179|P2|COMPLETED|Randomized Phase||166
637241|NCT00112047|1566180|P1|COMPLETED|Randomized Phase||187
637242|NCT00112047|1566179|P2|STARTED|Randomized Phase|ITT analysis population|254
637243|NCT00112047|1566180|P1|STARTED|Randomized Phase|Intention to treat (ITT) population N=255 (2 participants had received prior antiretroviral therapy)|257
637244|NCT00111917|1566280|P2|NOT COMPLETED|Overall Study||1
637245|NCT00111917|1566281|P1|NOT COMPLETED|Overall Study||1
637246|NCT00111917|1566280|P2|COMPLETED|Overall Study||3
637247|NCT00111917|1566281|P1|COMPLETED|Overall Study||8
637248|NCT00111917|1566280|P2|STARTED|Overall Study||4
637249|NCT00111917|1566281|P1|STARTED|Overall Study||9
637250|NCT00111839|1566296|P3|NOT COMPLETED|Overall Study||49
637251|NCT00111839|1566297|P2|NOT COMPLETED|Overall Study||46
637252|NCT00111839|1566298|P1|NOT COMPLETED|Overall Study||48
637253|NCT00111839|1566296|P3|COMPLETED|Overall Study||0
637254|NCT00111839|1566297|P2|COMPLETED|Overall Study||5
637255|NCT00111839|1566298|P1|COMPLETED|Overall Study||2
637256|NCT00111839|1566296|P3|Treated|Overall Study||47
637257|NCT00111839|1566297|P2|Treated|Overall Study||51
637258|NCT00111839|1566298|P1|Treated|Overall Study||50
637259|NCT00111839|1566296|P3|STARTED|Overall Study||49
637260|NCT00111839|1566297|P2|STARTED|Overall Study||51
637261|NCT00111839|1566298|P1|STARTED|Overall Study||50
637262|NCT00111813|1566318|P6|NOT COMPLETED|Overall Study||6
637263|NCT00111813|1566319|P5|NOT COMPLETED|Overall Study||6
637264|NCT00111813|1566320|P4|NOT COMPLETED|Overall Study||5
637265|NCT00111813|1566321|P3|NOT COMPLETED|Overall Study||10
637266|NCT00111813|1566322|P2|NOT COMPLETED|Overall Study||3
637267|NCT00111813|1566323|P1|NOT COMPLETED|Overall Study||3
637268|NCT00111813|1566318|P6|COMPLETED|Overall Study||0
637269|NCT00111813|1566319|P5|COMPLETED|Overall Study||0
637270|NCT00111813|1566320|P4|COMPLETED|Overall Study||1
637271|NCT00111813|1566321|P3|COMPLETED|Overall Study||0
637272|NCT00111813|1566322|P2|COMPLETED|Overall Study||0
637273|NCT00111813|1566323|P1|COMPLETED|Overall Study||0
637274|NCT00111813|1566318|P6|STARTED|Overall Study||6
637275|NCT00111813|1566319|P5|STARTED|Overall Study||6
637276|NCT00111813|1566320|P4|STARTED|Overall Study||6
637277|NCT00111813|1566321|P3|STARTED|Overall Study||10
637278|NCT00111813|1566322|P2|STARTED|Overall Study||3
637279|NCT00111813|1566323|P1|STARTED|Overall Study||3
637280|NCT00111800|1566362|P6|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||2
637281|NCT00111800|1566363|P5|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||4
637282|NCT00111800|1566364|P4|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||5
637283|NCT00111800|1566365|P3|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||7
637284|NCT00111800|1566366|P2|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||7
637285|NCT00111800|1566367|P1|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||2
637286|NCT00111800|1566362|P6|COMPLETED|Period 2: Extension Phase (12 Weeks)||53
637287|NCT00111800|1566363|P5|COMPLETED|Period 2: Extension Phase (12 Weeks)||51
637288|NCT00111800|1566364|P4|COMPLETED|Period 2: Extension Phase (12 Weeks)||54
637289|NCT00111800|1566365|P3|COMPLETED|Period 2: Extension Phase (12 Weeks)||47
637290|NCT00111800|1566366|P2|COMPLETED|Period 2: Extension Phase (12 Weeks)||40
637291|NCT00111800|1566367|P1|COMPLETED|Period 2: Extension Phase (12 Weeks)||46
637292|NCT00111800|1566362|P6|STARTED|Period 2: Extension Phase (12 Weeks)||55
637293|NCT00111800|1566363|P5|STARTED|Period 2: Extension Phase (12 Weeks)||55
637294|NCT00111800|1566364|P4|STARTED|Period 2: Extension Phase (12 Weeks)||59
637295|NCT00111800|1566365|P3|STARTED|Period 2: Extension Phase (12 Weeks)||54
637296|NCT00111800|1566366|P2|STARTED|Period 2: Extension Phase (12 Weeks)||47
637297|NCT00111800|1566367|P1|STARTED|Period 2: Extension Phase (12 Weeks)||48
637298|NCT00111800|1566362|P6|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||5
637299|NCT00111800|1566363|P5|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||5
637300|NCT00111800|1566364|P4|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||6
637301|NCT00111800|1566365|P3|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||9
637302|NCT00111800|1566366|P2|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||14
637303|NCT00111800|1566367|P1|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||15
637304|NCT00111800|1566362|P6|COMPLETED|Period 1: Main Phase (12 Weeks)||56
637305|NCT00111800|1566363|P5|COMPLETED|Period 1: Main Phase (12 Weeks)||55
637306|NCT00111800|1566364|P4|COMPLETED|Period 1: Main Phase (12 Weeks)||60
637307|NCT00111800|1566365|P3|COMPLETED|Period 1: Main Phase (12 Weeks)||54
637308|NCT00111800|1566366|P2|COMPLETED|Period 1: Main Phase (12 Weeks)||47
637309|NCT00111800|1566367|P1|COMPLETED|Period 1: Main Phase (12 Weeks)||49
637310|NCT00111800|1566362|P6|STARTED|Period 1: Main Phase (12 Weeks)||61
637311|NCT00111800|1566363|P5|STARTED|Period 1: Main Phase (12 Weeks)||60
637312|NCT00111800|1566364|P4|STARTED|Period 1: Main Phase (12 Weeks)||66
637313|NCT00111800|1566365|P3|STARTED|Period 1: Main Phase (12 Weeks)||63
637314|NCT00111800|1566366|P2|STARTED|Period 1: Main Phase (12 Weeks)||61
637315|NCT00111800|1566367|P1|STARTED|Period 1: Main Phase (12 Weeks)||64
637316|NCT00111761|1566537|P2|NOT COMPLETED|Part 2||0
637317|NCT00111761|1566538|P1|NOT COMPLETED|Part 2||8
637318|NCT00111761|1566537|P2|COMPLETED|Part 2||0
637319|NCT00111761|1566538|P1|COMPLETED|Part 2||16
637320|NCT00111761|1566537|P2|STARTED|Part 2|This treatment group was used in Part 1 only|0
637321|NCT00111761|1566538|P1|STARTED|Part 2||24
637322|NCT00111761|1566537|P2|NOT COMPLETED|Part 1||5
637323|NCT00111761|1566538|P1|NOT COMPLETED|Part 1||0
637324|NCT00111761|1566537|P2|COMPLETED|Part 1|Completed through safety followup|14
637325|NCT00111761|1566538|P1|COMPLETED|Part 1||0
637326|NCT00111761|1566537|P2|STARTED|Part 1||19
637327|NCT00111761|1566538|P1|STARTED|Part 1|This treatment group was not initiated until Part 2|0
637328|NCT00111657|1566555|P1|NOT COMPLETED|Overall Study||16
637329|NCT00111657|1566555|P1|COMPLETED|Overall Study|Completed all intended doses.|21
637330|NCT00111657|1566555|P1|STARTED|Overall Study|37 consented. 30 initiated treatment. 29 completed at least 1 dose.|37
637331|NCT00111007|1566567|P2|NOT COMPLETED|Long Term Follow-up||45
637332|NCT00111007|1566568|P1|NOT COMPLETED|Long Term Follow-up||47
637333|NCT00111007|1566567|P2|COMPLETED|Long Term Follow-up||62
637334|NCT00111007|1566568|P1|COMPLETED|Long Term Follow-up||54
637335|NCT00111007|1566567|P2|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|107
637336|NCT00111007|1566568|P1|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|101
637337|NCT00111007|1566567|P2|NOT COMPLETED|Active Follow-up||2
637338|NCT00111007|1566568|P1|NOT COMPLETED|Active Follow-up||6
637339|NCT00111007|1566567|P2|COMPLETED|Active Follow-up||2
637340|NCT00111007|1566568|P1|COMPLETED|Active Follow-up||0
637341|NCT00111007|1566567|P2|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|4
637342|NCT00111007|1566568|P1|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|6
637343|NCT00111007|1566567|P2|NOT COMPLETED|Double-blind (DB) Treatment||111
637344|NCT00111007|1566568|P1|NOT COMPLETED|Double-blind (DB) Treatment||108
637345|NCT00111007|1566567|P2|COMPLETED|Double-blind (DB) Treatment||24
637346|NCT00111007|1566568|P1|COMPLETED|Double-blind (DB) Treatment||27
637347|NCT00111007|1566567|P2|Received Treatment|Double-blind (DB) Treatment|Safety population|134
637348|NCT00111007|1566568|P1|Received Treatment|Double-blind (DB) Treatment|Safety population|134
637349|NCT00111007|1566567|P2|STARTED|Double-blind (DB) Treatment|ITT population|135
637350|NCT00111007|1566568|P1|STARTED|Double-blind (DB) Treatment|ITT population|135
637351|NCT00110994|1566584|P2|NOT COMPLETED|Long Term Follow-up||17
637352|NCT00110994|1566585|P1|NOT COMPLETED|Long Term Follow-up||19
637353|NCT00110994|1566584|P2|COMPLETED|Long Term Follow-up||30
637354|NCT00110994|1566585|P1|COMPLETED|Long Term Follow-up||22
637355|NCT00110994|1566584|P2|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|47
637356|NCT00110994|1566585|P1|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|41
637357|NCT00110994|1566584|P2|NOT COMPLETED|Active Follow-up||2
637358|NCT00110994|1566585|P1|NOT COMPLETED|Active Follow-up||1
637359|NCT00110994|1566584|P2|COMPLETED|Active Follow-up||0
637360|NCT00110994|1566585|P1|COMPLETED|Active Follow-up||0
637361|NCT00110994|1566584|P2|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|2
637362|NCT00110994|1566585|P1|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|1
637363|NCT00110994|1566584|P2|NOT COMPLETED|Double-blind (DB) Treatment||47
637364|NCT00110994|1566585|P1|NOT COMPLETED|Double-blind (DB) Treatment||42
637365|NCT00110994|1566584|P2|COMPLETED|Double-blind (DB) Treatment||3
637366|NCT00110994|1566585|P1|COMPLETED|Double-blind (DB) Treatment||9
637367|NCT00110994|1566584|P2|Received Treatment|Double-blind (DB) Treatment|Safety population|50
637368|NCT00110994|1566585|P1|Received Treatment|Double-blind (DB) Treatment|Safety population|51
637369|NCT00110994|1566584|P2|STARTED|Double-blind (DB) Treatment|ITT population|50
637370|NCT00110994|1566585|P1|STARTED|Double-blind (DB) Treatment|ITT population|51
637371|NCT00110890|1566611|P2|NOT COMPLETED|Overall Study||179
637372|NCT00110890|1566612|P1|NOT COMPLETED|Overall Study||361
637373|NCT00110890|1566611|P2|COMPLETED|Overall Study|Follow-up Phase|5
637374|NCT00110890|1566612|P1|COMPLETED|Overall Study|Follow-up Phase|7
637375|NCT00110890|1566611|P2|End of Efficacy Assessment Phase|Overall Study|Weeks 17 to 23|150
637376|NCT00110890|1566612|P1|End of Efficacy Assessment Phase|Overall Study|Weeks 17 to 23|280
637377|NCT00110890|1566611|P2|End of Dose Optimization Phase|Overall Study|Weeks 1 to 16|170
637378|NCT00110890|1566612|P1|End of Dose Optimization Phase|Overall Study|Weeks 1 to 16|316
637379|NCT00110890|1566611|P2|STARTED|Overall Study||184
637380|NCT00110890|1566612|P1|STARTED|Overall Study||368
637381|NCT00110812|1566629|P3|NOT COMPLETED|Extended Follow-up||4
637382|NCT00110812|1566630|P2|NOT COMPLETED|Extended Follow-up||4
637383|NCT00110812|1566631|P1|NOT COMPLETED|Extended Follow-up||2
637384|NCT00110812|1566629|P3|COMPLETED|Extended Follow-up||69
637385|NCT00110812|1566630|P2|COMPLETED|Extended Follow-up||65
637386|NCT00110812|1566631|P1|COMPLETED|Extended Follow-up||78
637387|NCT00110812|1566629|P3|STARTED|Extended Follow-up||73
637388|NCT00110812|1566630|P2|STARTED|Extended Follow-up||69
637389|NCT00110812|1566631|P1|STARTED|Extended Follow-up||80
637390|NCT00110812|1566629|P3|NOT COMPLETED|Main Study||13
637391|NCT00110812|1566630|P2|NOT COMPLETED|Main Study||11
637392|NCT00110812|1566631|P1|NOT COMPLETED|Main Study||8
637393|NCT00110812|1566629|P3|COMPLETED|Main Study||74
637394|NCT00110812|1566630|P2|COMPLETED|Main Study||78
637395|NCT00110812|1566631|P1|COMPLETED|Main Study||83
637396|NCT00110812|1566629|P3|STARTED|Main Study||87
637397|NCT00110812|1566630|P2|STARTED|Main Study||89
637398|NCT00110812|1566631|P1|STARTED|Main Study||91
637399|NCT00110617|1566676|P2|NOT COMPLETED|Overall Study||29
637400|NCT00110617|1566677|P1|NOT COMPLETED|Overall Study||39
637401|NCT00110617|1566676|P2|COMPLETED|Overall Study||39
637402|NCT00110617|1566677|P1|COMPLETED|Overall Study||96
637403|NCT00110617|1566676|P2|On Going at Week 24|Overall Study||53
637404|NCT00110617|1566677|P1|On Going at Week 24|Overall Study||126
637405|NCT00110617|1566676|P2|Full Analysis 2; Received ICL670|Overall Study||53
637406|NCT00110617|1566677|P1|Full Analysis 2; Received ICL670|Overall Study||135
637407|NCT00110617|1566676|P2|Safety Set 1; Received Study Drug|Overall Study||56
637408|NCT00110617|1566677|P1|Safety Set 1; Received Study Drug|Overall Study||135
637409|NCT00110617|1566676|P2|STARTED|Overall Study|Full Analysis Set 1 does not include 9 participants who were excluded due to GCP violations.|68
637410|NCT00110617|1566677|P1|STARTED|Overall Study||135
637411|NCT00110513|1566690|P1|NOT COMPLETED|Overall Study||0
637412|NCT00110513|1566690|P1|COMPLETED|Overall Study||18
637413|NCT00110513|1566690|P1|STARTED|Overall Study||18
637414|NCT00110461|1566697|P3|NOT COMPLETED|Acute Phase||23
637415|NCT00110461|1566698|P2|NOT COMPLETED|Acute Phase||22
637416|NCT00110461|1566699|P1|NOT COMPLETED|Acute Phase||14
637417|NCT00110461|1566697|P3|COMPLETED|Acute Phase||76
637418|NCT00110461|1566698|P2|COMPLETED|Acute Phase||77
637419|NCT00110461|1566699|P1|COMPLETED|Acute Phase||84
637420|NCT00110461|1566697|P3|STARTED|Acute Phase||99
637421|NCT00110461|1566698|P2|STARTED|Acute Phase||99
637422|NCT00110461|1566699|P1|STARTED|Acute Phase||98
637423|NCT00110461|1566697|P3|NOT COMPLETED|30-Week, Double-blind Treatment Phase||87
637424|NCT00110461|1566698|P2|NOT COMPLETED|30-Week, Double-blind Treatment Phase||77
637425|NCT00110461|1566699|P1|NOT COMPLETED|30-Week, Double-blind Treatment Phase||64
637426|NCT00110461|1566697|P3|COMPLETED|30-Week, Double-blind Treatment Phase||12
637427|NCT00110461|1566698|P2|COMPLETED|30-Week, Double-blind Treatment Phase||22
637428|NCT00110461|1566699|P1|COMPLETED|30-Week, Double-blind Treatment Phase||34
637429|NCT00110461|1566697|P3|STARTED|30-Week, Double-blind Treatment Phase||99
637430|NCT00110461|1566698|P2|STARTED|30-Week, Double-blind Treatment Phase||99
637431|NCT00110461|1566699|P1|STARTED|30-Week, Double-blind Treatment Phase||98
637432|NCT00110396|1566794|P1|NOT COMPLETED|Overall Study||36
637433|NCT00110396|1566794|P1|COMPLETED|Overall Study|260 participants included in the Safety Population.207 completed treatment. 224 completed the trial|224
637434|NCT00110396|1566794|P1|STARTED|Overall Study||260
637435|NCT00110357|1566802|P2|NOT COMPLETED|Overall Study||19
637436|NCT00110357|1566803|P1|NOT COMPLETED|Overall Study||27
637437|NCT00110357|1566802|P2|COMPLETED|Overall Study|Number Still on Study|0
637438|NCT00110357|1566803|P1|COMPLETED|Overall Study|Number Still on Study|0
637439|NCT00110357|1566802|P2|STARTED|Overall Study||19
637440|NCT00110357|1566803|P1|STARTED|Overall Study||27
637441|NCT00110305|1566891|P2|NOT COMPLETED|Overall Study||32
637442|NCT00110305|1566892|P1|NOT COMPLETED|Overall Study||114
637443|NCT00110305|1566891|P2|COMPLETED|Overall Study||57
637444|NCT00110305|1566892|P1|COMPLETED|Overall Study||165
637445|NCT00110305|1566891|P2|STARTED|Overall Study||89
637446|NCT00110305|1566892|P1|STARTED|Overall Study||279
637447|NCT00110214|1566945|P2|NOT COMPLETED|Overall Study||503
637448|NCT00110214|1566946|P1|NOT COMPLETED|Overall Study||509
637449|NCT00110214|1566945|P2|COMPLETED|Overall Study||21
637450|NCT00110214|1566946|P1|COMPLETED|Overall Study||17
637451|NCT00110214|1566945|P2|STARTED|Overall Study||524
637452|NCT00110214|1566946|P1|STARTED|Overall Study||526
637453|NCT00110149|1566958|P1|NOT COMPLETED|Overall Study||3
637454|NCT00110149|1566958|P1|COMPLETED|Overall Study||9
637455|NCT00110149|1566958|P1|Received Treatment|Overall Study|total number of patient that passed screening and received treatment.|9
637456|NCT00110149|1566958|P1|STARTED|Overall Study|total number that signed consent to be screened.|12
637457|NCT00110136|1566963|P1|NOT COMPLETED|Overall Study||0
637458|NCT00110136|1566963|P1|COMPLETED|Overall Study||9
637459|NCT00110136|1566963|P1|STARTED|Overall Study||9
637460|NCT00110084|1566972|P1|NOT COMPLETED|Overall Study||28
637461|NCT00110084|1566972|P1|COMPLETED|Overall Study||22
637462|NCT00110084|1566972|P1|STARTED|Overall Study||50
637463|NCT00110019|1566981|P2|NOT COMPLETED|Overall Study||413
637464|NCT00110019|1566982|P1|NOT COMPLETED|Overall Study||406
637465|NCT00110019|1566981|P2|COMPLETED|Overall Study||0
637466|NCT00110019|1566982|P1|COMPLETED|Overall Study||4
637467|NCT00110019|1566981|P2|Treated|Overall Study||397
637468|NCT00110019|1566982|P1|Treated|Overall Study||393
637469|NCT00110019|1566981|P2|Eligible|Overall Study||398
637470|NCT00110019|1566982|P1|Eligible|Overall Study||395
637471|NCT00110019|1566981|P2|STARTED|Overall Study||413
637472|NCT00110019|1566982|P1|STARTED|Overall Study||410
637473|NCT00109967|1566994|P2|NOT COMPLETED|Overall Study||6
637474|NCT00109967|1566995|P1|NOT COMPLETED|Overall Study||20
637475|NCT00109967|1566994|P2|COMPLETED|Overall Study||15
637476|NCT00109967|1566995|P1|COMPLETED|Overall Study||30
637477|NCT00109967|1566994|P2|STARTED|Overall Study||21
637478|NCT00109967|1566995|P1|STARTED|Overall Study||50
637479|NCT00109928|1567009|P1|NOT COMPLETED|Overall Study||13
637480|NCT00109928|1567009|P1|COMPLETED|Overall Study||21
637481|NCT00109928|1567009|P1|Eligible and Began Protocol Therapy|Overall Study||33
637482|NCT00109928|1567009|P1|Eligible|Overall Study||33
637483|NCT00109928|1567009|P1|STARTED|Overall Study||34
637484|NCT00109876|1567016|P1|NOT COMPLETED|Overall Study||0
637485|NCT00109876|1567016|P1|COMPLETED|Overall Study||51
637486|NCT00109876|1567016|P1|STARTED|Overall Study||51
637487|NCT00109850|1567026|P1|NOT COMPLETED|Overall Study||4
637488|NCT00109850|1567026|P1|COMPLETED|Overall Study||18
637489|NCT00109850|1567026|P1|Eligible and Began Protocol Therapy|Overall Study||21
637490|NCT00109850|1567026|P1|Eligible|Overall Study||21
637491|NCT00109850|1567026|P1|STARTED|Overall Study||22
637492|NCT00109837|1567033|P1|NOT COMPLETED|Overall Study||23
637493|NCT00109837|1567033|P1|COMPLETED|Overall Study||56
637494|NCT00109837|1567033|P1|Eligible and Ph- and Treated|Overall Study||60
637495|NCT00109837|1567033|P1|Eligible and Ph-|Overall Study||61
637496|NCT00109837|1567033|P1|Eligible|Overall Study||78
637497|NCT00109837|1567033|P1|STARTED|Overall Study||79
637498|NCT00109772|1567043|P2|NOT COMPLETED|Open-label Extension||49
637499|NCT00109772|1567044|P1|NOT COMPLETED|Open-label Extension||45
637500|NCT00109772|1567043|P2|COMPLETED|Open-label Extension|Participants who were active in extension period when the sponsor terminated the study.|29
637501|NCT00109772|1567044|P1|COMPLETED|Open-label Extension|Participants who were active in extension period when the sponsor terminated the study.|19
637502|NCT00109772|1567043|P2|STARTED|Open-label Extension|One double-blind participant did not continue into the open-label extension|78
637503|NCT00109772|1567044|P1|STARTED|Open-label Extension|Four double-blind participants did not continue into the open-label extension|64
637504|NCT00109772|1567043|P2|NOT COMPLETED|Double-blind Treatment||15
637505|NCT00109772|1567044|P1|NOT COMPLETED|Double-blind Treatment||22
637506|NCT00109772|1567043|P2|COMPLETED|Double-blind Treatment||79
637507|NCT00109772|1567044|P1|COMPLETED|Double-blind Treatment||68
637508|NCT00109772|1567043|P2|Safety and ITT Population|Double-blind Treatment|Safety: at least one dose of study drug ITT: treated and at least one post dose diary measurement|93
637509|NCT00109772|1567044|P1|Safety and ITT Population|Double-blind Treatment|Safety: at least one dose of study drug ITT: treated and at least one post dose diary measurement|87
637510|NCT00109772|1567043|P2|STARTED|Double-blind Treatment||94
637511|NCT00109772|1567044|P1|STARTED|Double-blind Treatment||90
637512|NCT00109733|1567084|P2|NOT COMPLETED|Overall Study||4
637513|NCT00109733|1567085|P1|NOT COMPLETED|Overall Study||2
637514|NCT00109733|1567084|P2|COMPLETED|Overall Study||12
637515|NCT00109733|1567085|P1|COMPLETED|Overall Study||13
637516|NCT00109733|1567084|P2|STARTED|Overall Study||16
637517|NCT00109733|1567085|P1|STARTED|Overall Study||15
637518|NCT00109590|1567102|P3|NOT COMPLETED|Overall Study||4
637519|NCT00109590|1567103|P2|NOT COMPLETED|Overall Study||2
637520|NCT00109590|1567104|P1|NOT COMPLETED|Overall Study||2
637521|NCT00109590|1567102|P3|COMPLETED|Overall Study||56
637522|NCT00109590|1567103|P2|COMPLETED|Overall Study||56
637523|NCT00109590|1567104|P1|COMPLETED|Overall Study||55
637524|NCT00109590|1567102|P3|RECEIVED TREATMENT|Overall Study||57
637525|NCT00109590|1567103|P2|RECEIVED TREATMENT|Overall Study||56
637526|NCT00109590|1567104|P1|RECEIVED TREATMENT|Overall Study||56
637527|NCT00109590|1567102|P3|STARTED|Overall Study||60
637528|NCT00109590|1567103|P2|STARTED|Overall Study||58
637529|NCT00109590|1567104|P1|STARTED|Overall Study||57
637530|NCT00109577|1567146|P2|NOT COMPLETED|Overall Study||3
637531|NCT00109577|1567147|P1|NOT COMPLETED|Overall Study||3
637532|NCT00109577|1567146|P2|COMPLETED|Overall Study||17
637533|NCT00109577|1567147|P1|COMPLETED|Overall Study||17
637534|NCT00109577|1567146|P2|STARTED|Overall Study||20
637535|NCT00109577|1567147|P1|STARTED|Overall Study||20
637536|NCT00109473|1567155|P2|NOT COMPLETED|52 Week Extension Phase||5
637537|NCT00109473|1567156|P1|NOT COMPLETED|52 Week Extension Phase||4
637538|NCT00109473|1567155|P2|COMPLETED|52 Week Extension Phase|Extension phase ends when subjects discontinue intervention due to active disease or reaches week 64|3
637539|NCT00109473|1567156|P1|COMPLETED|52 Week Extension Phase|Extension phase ends when subjects discontinue intervention due to active disease or reaches week 64|5
637540|NCT00109473|1567155|P2|Analyzed|52 Week Extension Phase||8
637541|NCT00109473|1567156|P1|Analyzed|52 Week Extension Phase||9
637542|NCT00109473|1567155|P2|STARTED|52 Week Extension Phase||8
637543|NCT00109473|1567156|P1|STARTED|52 Week Extension Phase||9
637544|NCT00109473|1567155|P2|NOT COMPLETED|Week 12 to Week 24||0
637545|NCT00109473|1567156|P1|NOT COMPLETED|Week 12 to Week 24||1
637630|NCT00108628|1567341|P1|STARTED|Overall Study||61
637546|NCT00109473|1567155|P2|COMPLETED|Week 12 to Week 24|one subject discontinued intervention due to active disease requiring surgery|9
637547|NCT00109473|1567156|P1|COMPLETED|Week 12 to Week 24|One subject withdrew consent|9
637548|NCT00109473|1567155|P2|Analyzed|Week 12 to Week 24||9
637549|NCT00109473|1567156|P1|Analyzed|Week 12 to Week 24||9
637550|NCT00109473|1567155|P2|STARTED|Week 12 to Week 24||9
637551|NCT00109473|1567156|P1|STARTED|Week 12 to Week 24||10
637552|NCT00109473|1567155|P2|NOT COMPLETED|Baseline (0 Through 12 Weeks)||1
637553|NCT00109473|1567156|P1|NOT COMPLETED|Baseline (0 Through 12 Weeks)||0
637554|NCT00109473|1567155|P2|COMPLETED|Baseline (0 Through 12 Weeks)|One subject discontinued intervention because of active disease requiring imfliximab|9
637555|NCT00109473|1567156|P1|COMPLETED|Baseline (0 Through 12 Weeks)||10
637556|NCT00109473|1567155|P2|Analyzed|Baseline (0 Through 12 Weeks)||10
637557|NCT00109473|1567156|P1|Analyzed|Baseline (0 Through 12 Weeks)||10
637558|NCT00109473|1567155|P2|STARTED|Baseline (0 Through 12 Weeks)||10
637559|NCT00109473|1567156|P1|STARTED|Baseline (0 Through 12 Weeks)|11 subjects allocated to Group A; one withdrew consent, only 10 receieved intervention.|10
637560|NCT00109343|1567178|P3|NOT COMPLETED|Overall Study||30
637561|NCT00109343|1567179|P2|NOT COMPLETED|Overall Study||37
637562|NCT00109343|1567180|P1|NOT COMPLETED|Overall Study||64
637563|NCT00109343|1567178|P3|COMPLETED|Overall Study||229
637564|NCT00109343|1567179|P2|COMPLETED|Overall Study||221
637565|NCT00109343|1567180|P1|COMPLETED|Overall Study||446
637566|NCT00109343|1567178|P3|Vaccinated at Visit 4|Overall Study||240
637567|NCT00109343|1567179|P2|Vaccinated at Visit 4|Overall Study||235
637568|NCT00109343|1567180|P1|Vaccinated at Visit 4|Overall Study||466
637569|NCT00109343|1567178|P3|Vaccinated at Visit 2|Overall Study||246
637570|NCT00109343|1567179|P2|Vaccinated at Visit 2|Overall Study||246
637571|NCT00109343|1567180|P1|Vaccinated at Visit 2|Overall Study|Per-protocol, subjects in Group 1 were not vaccinated at Visit 2|0
637572|NCT00109343|1567178|P3|Vaccinated at Visit 1|Overall Study||259
637573|NCT00109343|1567179|P2|Vaccinated at Visit 1|Overall Study||258
637574|NCT00109343|1567180|P1|Vaccinated at Visit 1|Overall Study||510
637575|NCT00109343|1567178|P3|STARTED|Overall Study||259
637576|NCT00109343|1567179|P2|STARTED|Overall Study||258
637577|NCT00109343|1567180|P1|STARTED|Overall Study||510
637578|NCT00109031|1567225|P4|NOT COMPLETED|Overall Study||0
637579|NCT00109031|1567226|P3|NOT COMPLETED|Overall Study||2
637580|NCT00109031|1567227|P2|NOT COMPLETED|Overall Study||2
637581|NCT00109031|1567228|P1|NOT COMPLETED|Overall Study||0
637582|NCT00109031|1567225|P4|COMPLETED|Overall Study||12
637583|NCT00109031|1567226|P3|COMPLETED|Overall Study||12
637584|NCT00109031|1567227|P2|COMPLETED|Overall Study||8
637585|NCT00109031|1567228|P1|COMPLETED|Overall Study||11
637586|NCT00109031|1567225|P4|STARTED|Overall Study||12
637587|NCT00109031|1567226|P3|STARTED|Overall Study||14
637588|NCT00109031|1567227|P2|STARTED|Overall Study||10
637589|NCT00109031|1567228|P1|STARTED|Overall Study||11
637590|NCT00109005|1567264|P2|NOT COMPLETED|Overall Study||0
637591|NCT00109005|1567265|P1|NOT COMPLETED|Overall Study||0
637592|NCT00109005|1567264|P2|COMPLETED|Overall Study||9
637593|NCT00109005|1567265|P1|COMPLETED|Overall Study||8
637594|NCT00109005|1567264|P2|STARTED|Overall Study||9
637595|NCT00109005|1567265|P1|STARTED|Overall Study||8
637596|NCT00108953|1567279|P2|NOT COMPLETED|Follow-up||33
637597|NCT00108953|1567280|P1|NOT COMPLETED|Follow-up||29
637598|NCT00108953|1567279|P2|COMPLETED|Follow-up||12
637599|NCT00108953|1567280|P1|COMPLETED|Follow-up||11
637600|NCT00108953|1567279|P2|STARTED|Follow-up|45 out of 49 patients were followed after end of double blind treatment|45
637601|NCT00108953|1567280|P1|STARTED|Follow-up|40 out of 47 patients were followed after end of double blind treatment|40
637602|NCT00108953|1567279|P2|NOT COMPLETED|Treatment Period||0
637603|NCT00108953|1567280|P1|NOT COMPLETED|Treatment Period||0
637604|NCT00108953|1567279|P2|COMPLETED|Treatment Period|No patient under study medication anymore|49
637605|NCT00108953|1567280|P1|COMPLETED|Treatment Period|No patient under study medication anymore|47
637606|NCT00108953|1567279|P2|STARTED|Treatment Period|ITT population|49
637607|NCT00108953|1567280|P1|STARTED|Treatment Period|ITT population|47
637608|NCT00108862|1567302|P2|NOT COMPLETED|Overall Study||62
637609|NCT00108862|1567303|P1|NOT COMPLETED|Overall Study||68
637610|NCT00108862|1567302|P2|COMPLETED|Overall Study||339
637611|NCT00108862|1567303|P1|COMPLETED|Overall Study||337
637612|NCT00108862|1567302|P2|STARTED|Overall Study|Three participants who were deemed clinically ineligible and taken off study were omitted.|401
637613|NCT00108862|1567303|P1|STARTED|Overall Study||405
637614|NCT00108732|1567331|P1|NOT COMPLETED|Step 2 (Androgen Ablation and Vaccine)||5
637615|NCT00108732|1567331|P1|COMPLETED|Step 2 (Androgen Ablation and Vaccine)||26
637616|NCT00108732|1567331|P1|STARTED|Step 2 (Androgen Ablation and Vaccine)||31
637617|NCT00108732|1567331|P1|NOT COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||14
637618|NCT00108732|1567331|P1|COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||36
637619|NCT00108732|1567331|P1|Eligible and Treated|Step 1 (Vaccinia/Fowlpox/GM-CSF)||40
637620|NCT00108732|1567331|P1|STARTED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||50
637621|NCT00108628|1567340|P2|NOT COMPLETED|Overall Study||10
637622|NCT00108628|1567341|P1|NOT COMPLETED|Overall Study||20
637623|NCT00108628|1567340|P2|COMPLETED|Overall Study||53
637624|NCT00108628|1567341|P1|COMPLETED|Overall Study||41
637625|NCT00108628|1567340|P2|Completed Treatment|Overall Study||57
637626|NCT00108628|1567341|P1|Completed Treatment|Overall Study||42
637627|NCT00108628|1567340|P2|Received One or More Sessions|Overall Study||58
637628|NCT00108628|1567341|P1|Received One or More Sessions|Overall Study||53
637629|NCT00108628|1567340|P2|STARTED|Overall Study||63
637631|NCT00108550|1567367|P2|NOT COMPLETED|Overall Study||16
637632|NCT00108550|1567368|P1|NOT COMPLETED|Overall Study||16
637633|NCT00108550|1567367|P2|COMPLETED|Overall Study||37
637634|NCT00108550|1567368|P1|COMPLETED|Overall Study||39
637635|NCT00108550|1567367|P2|STARTED|Overall Study||53
637636|NCT00108550|1567368|P1|STARTED|Overall Study||55
637637|NCT00108524|1567378|P2|NOT COMPLETED|Overall Study||18
637638|NCT00108524|1567379|P1|NOT COMPLETED|Overall Study||29
637639|NCT00108524|1567378|P2|COMPLETED|Overall Study||61
637640|NCT00108524|1567379|P1|COMPLETED|Overall Study||52
637641|NCT00108524|1567378|P2|STARTED|Overall Study||79
637642|NCT00108524|1567379|P1|STARTED|Overall Study||81
637643|NCT00108485|1567391|P2|NOT COMPLETED|Overall Study||2
637644|NCT00108485|1567392|P1|NOT COMPLETED|Overall Study||3
637645|NCT00108485|1567391|P2|COMPLETED|Overall Study||2
637646|NCT00108485|1567392|P1|COMPLETED|Overall Study||2
637647|NCT00108485|1567391|P2|STARTED|Overall Study||4
637648|NCT00108485|1567392|P1|STARTED|Overall Study||5
637649|NCT00108433|1567400|P2|NOT COMPLETED|Overall Study||17
637650|NCT00108433|1567401|P1|NOT COMPLETED|Overall Study||21
637651|NCT00108433|1567400|P2|COMPLETED|Overall Study||14
637652|NCT00108433|1567401|P1|COMPLETED|Overall Study||9
637653|NCT00108433|1567400|P2|STARTED|Overall Study||31
637654|NCT00108433|1567401|P1|STARTED|Overall Study||30
637655|NCT00108355|1567417|P2|NOT COMPLETED|Overall Study||2
637656|NCT00108355|1567418|P1|NOT COMPLETED|Overall Study||2
637657|NCT00108355|1567417|P2|COMPLETED|Overall Study||12
637658|NCT00108355|1567418|P1|COMPLETED|Overall Study||13
637659|NCT00108355|1567417|P2|STARTED|Overall Study|Two patients met inclusion criteria not randomized, one had peritonitis, other loculated ascites.|14
637660|NCT00108355|1567418|P1|STARTED|Overall Study|Two patients met inclusion criteria not randomized, one had peritonitis , other loculated ascites.|15
637661|NCT00108342|1567428|P2|NOT COMPLETED|Overall Study||0
637662|NCT00108342|1567429|P1|NOT COMPLETED|Overall Study||1
637663|NCT00108342|1567428|P2|COMPLETED|Overall Study||9
637664|NCT00108342|1567429|P1|COMPLETED|Overall Study||7
637665|NCT00108342|1567428|P2|STARTED|Overall Study||9
637666|NCT00108342|1567429|P1|STARTED|Overall Study||8
637667|NCT00108303|1567438|P3|NOT COMPLETED|Overall Study||0
637668|NCT00108303|1567439|P2|NOT COMPLETED|Overall Study||0
637669|NCT00108303|1567440|P1|NOT COMPLETED|Overall Study||0
637670|NCT00108303|1567438|P3|COMPLETED|Overall Study||180
637671|NCT00108303|1567439|P2|COMPLETED|Overall Study||179
637672|NCT00108303|1567440|P1|COMPLETED|Overall Study||179
637673|NCT00108303|1567438|P3|STARTED|Overall Study||180
637674|NCT00108303|1567439|P2|STARTED|Overall Study||179
637675|NCT00108303|1567440|P1|STARTED|Overall Study||179
637676|NCT00108277|1567455|P3|NOT COMPLETED|Overall Study||16
637677|NCT00108277|1567456|P2|NOT COMPLETED|Overall Study||12
637678|NCT00108277|1567457|P1|NOT COMPLETED|Overall Study||10
637679|NCT00108277|1567455|P3|COMPLETED|Overall Study||19
637680|NCT00108277|1567456|P2|COMPLETED|Overall Study||16
637681|NCT00108277|1567457|P1|COMPLETED|Overall Study||19
637682|NCT00108277|1567455|P3|STARTED|Overall Study||35
637683|NCT00108277|1567456|P2|STARTED|Overall Study||28
637684|NCT00108277|1567457|P1|STARTED|Overall Study||29
637685|NCT00108160|1567467|P2|NOT COMPLETED|Overall Study||21
637686|NCT00108160|1567468|P1|NOT COMPLETED|Overall Study||39
637687|NCT00108160|1567467|P2|COMPLETED|Overall Study|Participants who completed 18 months of placebo or developed new (recurrent) S. aureus infection.|42
637688|NCT00108160|1567468|P1|COMPLETED|Overall Study|Patients who completed 18 months of mupirocin or developed new (recurrent) S. aureus infection.|44
637689|NCT00108160|1567467|P2|Completed Visit 7 (18 mo)|Overall Study||31
637690|NCT00108160|1567468|P1|Completed Visit 7 (18 mo)|Overall Study||34
637691|NCT00108160|1567467|P2|Completed Visit 6 (15 mo)|Overall Study||33
637692|NCT00108160|1567468|P1|Completed Visit 6 (15 mo)|Overall Study||36
637693|NCT00108160|1567467|P2|Completed Visit 5 (12 mo)|Overall Study||37
637694|NCT00108160|1567468|P1|Completed Visit 5 (12 mo)|Overall Study||37
637695|NCT00108160|1567467|P2|Completed Visit 4 (9 mo)|Overall Study||37
637696|NCT00108160|1567468|P1|Completed Visit 4 (9 mo)|Overall Study||38
637697|NCT00108160|1567467|P2|Completed Visit 3 (6 mo)|Overall Study||38
637698|NCT00108160|1567468|P1|Completed Visit 3 (6 mo)|Overall Study||44
637699|NCT00108160|1567467|P2|Completed Visit 2 (3 mo)|Overall Study||46
637700|NCT00108160|1567468|P1|Completed Visit 2 (3 mo)|Overall Study||54
637701|NCT00108160|1567467|P2|Completed Visit 1 (2 Wks)|Overall Study||54
637702|NCT00108160|1567468|P1|Completed Visit 1 (2 Wks)|Overall Study||72
637703|NCT00108160|1567467|P2|Completed Visit 0 (Baseline)|Overall Study|3 patients who signed a consent and were randomized did not complete the initial visit to start drug|60
637704|NCT00108160|1567468|P1|Completed Visit 0 (Baseline)|Overall Study|4 patients who signed consent and were randomized did not complete the initial visit to start drug|79
637705|NCT00108160|1567467|P2|STARTED|Overall Study||63
637706|NCT00108160|1567468|P1|STARTED|Overall Study||83
637707|NCT00108082|1567481|P3|NOT COMPLETED|Overall Study||43
637708|NCT00108082|1567482|P2|NOT COMPLETED|Overall Study||32
637709|NCT00108082|1567483|P1|NOT COMPLETED|Overall Study||38
637710|NCT00108082|1567481|P3|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|53
637711|NCT00108082|1567482|P2|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|68
637712|NCT00108082|1567483|P1|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|53
637713|NCT00108082|1567481|P3|STARTED|Overall Study||96
637714|NCT00108082|1567482|P2|STARTED|Overall Study||100
637715|NCT00108082|1567483|P1|STARTED|Overall Study||91
637716|NCT00108069|1567532|P2|NOT COMPLETED|Overall Study||13
637717|NCT00108069|1567533|P1|NOT COMPLETED|Overall Study||30
637718|NCT00108069|1567532|P2|COMPLETED|Overall Study||0
637719|NCT00108069|1567533|P1|COMPLETED|Overall Study||0
637720|NCT00108069|1567532|P2|STARTED|Overall Study||13
637721|NCT00108069|1567533|P1|STARTED|Overall Study||30
637722|NCT00107991|1567547|P1|NOT COMPLETED|18-Week Post Treatment Assessment||2
637723|NCT00107991|1567547|P1|COMPLETED|18-Week Post Treatment Assessment||8
637724|NCT00107991|1567547|P1|STARTED|18-Week Post Treatment Assessment||10
637725|NCT00107991|1567547|P1|NOT COMPLETED|12 Week Treatment Period||5
637726|NCT00107991|1567547|P1|COMPLETED|12 Week Treatment Period||10
637727|NCT00107991|1567547|P1|STARTED|12 Week Treatment Period||15
637728|NCT00107991|1567547|P1|NOT COMPLETED|Eligibility Assessment||23
637729|NCT00107991|1567547|P1|COMPLETED|Eligibility Assessment||15
637730|NCT00107991|1567547|P1|STARTED|Eligibility Assessment||38
637731|NCT00107978|1567557|P2|NOT COMPLETED|Overall Study||50
637732|NCT00107978|1567558|P1|NOT COMPLETED|Overall Study||33
637733|NCT00107978|1567557|P2|COMPLETED|Overall Study||431
637734|NCT00107978|1567558|P1|COMPLETED|Overall Study||425
637735|NCT00107978|1567557|P2|STARTED|Overall Study||481
637736|NCT00107978|1567558|P1|STARTED|Overall Study||458
637737|NCT00107952|1567566|P2|NOT COMPLETED|Overall Study||81
637738|NCT00107952|1567567|P1|NOT COMPLETED|Overall Study||95
637739|NCT00107952|1567566|P2|COMPLETED|Overall Study||299
637740|NCT00107952|1567567|P1|COMPLETED|Overall Study||286
637741|NCT00107952|1567566|P2|STARTED|Overall Study||380
637742|NCT00107952|1567567|P1|STARTED|Overall Study||381
637743|NCT00107900|1567579|P6|NOT COMPLETED|Overall Study||9
637744|NCT00107900|1567580|P5|NOT COMPLETED|Overall Study||21
637745|NCT00107900|1567581|P4|NOT COMPLETED|Overall Study||12
637746|NCT00107900|1567582|P3|NOT COMPLETED|Overall Study||25
637747|NCT00107900|1567583|P2|NOT COMPLETED|Overall Study||3
637748|NCT00107900|1567584|P1|NOT COMPLETED|Overall Study||10
637749|NCT00107900|1567579|P6|COMPLETED|Overall Study||94
637750|NCT00107900|1567580|P5|COMPLETED|Overall Study||94
637751|NCT00107900|1567581|P4|COMPLETED|Overall Study||87
637752|NCT00107900|1567582|P3|COMPLETED|Overall Study||104
637753|NCT00107900|1567583|P2|COMPLETED|Overall Study||72
637754|NCT00107900|1567584|P1|COMPLETED|Overall Study||75
637755|NCT00107900|1567579|P6|STARTED|Overall Study||103
637756|NCT00107900|1567580|P5|STARTED|Overall Study||115
637757|NCT00107900|1567581|P4|STARTED|Overall Study||99
637758|NCT00107900|1567582|P3|STARTED|Overall Study||129
637759|NCT00107900|1567583|P2|STARTED|Overall Study||75
637760|NCT00107900|1567584|P1|STARTED|Overall Study||85
637761|NCT00107783|1567618|P2|NOT COMPLETED|Overall Study||4
637762|NCT00107783|1567619|P1|NOT COMPLETED|Overall Study||3
637763|NCT00107783|1567618|P2|COMPLETED|Overall Study||16
637764|NCT00107783|1567619|P1|COMPLETED|Overall Study||17
637765|NCT00107783|1567618|P2|STARTED|Overall Study||20
637766|NCT00107783|1567619|P1|STARTED|Overall Study||20
637767|NCT00107653|1567635|P2|NOT COMPLETED|Overall Study||76
637768|NCT00107653|1567636|P1|NOT COMPLETED|Overall Study||79
637769|NCT00107653|1567635|P2|COMPLETED|Overall Study||224
637770|NCT00107653|1567636|P1|COMPLETED|Overall Study||190
637771|NCT00107653|1567635|P2|STARTED|Overall Study||300
637772|NCT00107653|1567636|P1|STARTED|Overall Study||269
637773|NCT00107614|1567682|P1|NOT COMPLETED|Overall Study||12
637774|NCT00107614|1567682|P1|COMPLETED|Overall Study||0
637775|NCT00107614|1567682|P1|STARTED|Overall Study||12
637776|NCT00107575|1567688|P2|NOT COMPLETED|Overall Study||10
637777|NCT00107575|1567689|P1|NOT COMPLETED|Overall Study||11
637778|NCT00107575|1567688|P2|COMPLETED|Overall Study||107
637779|NCT00107575|1567689|P1|COMPLETED|Overall Study||108
637780|NCT00107575|1567688|P2|STARTED|Overall Study||117
637781|NCT00107575|1567689|P1|STARTED|Overall Study||119
637782|NCT00107536|1567703|P1|NOT COMPLETED|Overall Study||0
637783|NCT00107536|1567703|P1|COMPLETED|Overall Study||26
637784|NCT00107536|1567703|P1|STARTED|Overall Study||26
637785|NCT00107380|1567713|P1|NOT COMPLETED|Overall Study||30
637786|NCT00107380|1567713|P1|COMPLETED|Overall Study||56
637787|NCT00107380|1567713|P1|Eligible|Overall Study||84
637788|NCT00107380|1567713|P1|STARTED|Overall Study||86
637789|NCT00107315|1567719|P1|NOT COMPLETED|Overall Study||15
637790|NCT00107315|1567719|P1|COMPLETED|Overall Study||1
637791|NCT00107315|1567719|P1|STARTED|Overall Study||16
637792|NCT00107276|1567726|P1|NOT COMPLETED|Overall Study||72
637793|NCT00107276|1567726|P1|COMPLETED|Overall Study||40
637794|NCT00107276|1567726|P1|Eligible|Overall Study||96
637795|NCT00107276|1567726|P1|STARTED|Overall Study||112
637796|NCT00107198|1567732|P1|NOT COMPLETED|Overall Study||52
637797|NCT00107198|1567732|P1|COMPLETED|Overall Study||136
637798|NCT00107198|1567732|P1|STARTED|Overall Study||188
637799|NCT00107172|1567742|P2|NOT COMPLETED|Overall Study||5
637800|NCT00107172|1567743|P1|NOT COMPLETED|Overall Study||5
637801|NCT00107172|1567742|P2|COMPLETED|Overall Study||103
637802|NCT00107172|1567743|P1|COMPLETED|Overall Study||109
637803|NCT00107172|1567742|P2|STARTED|Overall Study||108
637804|NCT00107172|1567743|P1|STARTED|Overall Study||114
637805|NCT00107120|1567773|P2|NOT COMPLETED|Overall Study||24
637806|NCT00107120|1567774|P1|NOT COMPLETED|Overall Study||29
637807|NCT00107120|1567773|P2|COMPLETED|Overall Study||133
637808|NCT00107120|1567774|P1|COMPLETED|Overall Study||126
637809|NCT00107120|1567773|P2|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|157
637810|NCT00107120|1567774|P1|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|155
637811|NCT00107042|1567786|P2|NOT COMPLETED|Overall Study||16
637812|NCT00107042|1567787|P1|NOT COMPLETED|Overall Study||22
637813|NCT00107042|1567786|P2|COMPLETED|Overall Study||47
637814|NCT00107042|1567787|P1|COMPLETED|Overall Study||38
637815|NCT00107042|1567786|P2|STARTED|Overall Study||63
637816|NCT00107042|1567787|P1|STARTED|Overall Study||60
637817|NCT00106964|1567853|P3|NOT COMPLETED|Overall Study||7
637818|NCT00106964|1567854|P2|NOT COMPLETED|Overall Study||15
637819|NCT00106964|1567855|P1|NOT COMPLETED|Overall Study||13
637820|NCT00106964|1567853|P3|COMPLETED|Overall Study|The number of those who completed the vaccine series was 120.|120
637821|NCT00106964|1567854|P2|COMPLETED|Overall Study|The number of those who completed the vaccine series was 111.|111
637822|NCT00106964|1567855|P1|COMPLETED|Overall Study|The number of those those who completed the vaccine series was 105.|105
637823|NCT00106964|1567853|P3|STARTED|Overall Study||127
637824|NCT00106964|1567854|P2|STARTED|Overall Study||126
637825|NCT00106964|1567855|P1|STARTED|Overall Study||118
637826|NCT00106938|1567880|P2|NOT COMPLETED|Overall Study||71
637827|NCT00106938|1567881|P1|NOT COMPLETED|Overall Study||176
637828|NCT00106938|1567880|P2|COMPLETED|Overall Study||293
637829|NCT00106938|1567881|P1|COMPLETED|Overall Study||913
637830|NCT00106938|1567880|P2|STARTED|Overall Study||364
637831|NCT00106938|1567881|P1|STARTED|Overall Study||1089
637832|NCT00106704|1567950|P2|NOT COMPLETED|Overall Study||151
637833|NCT00106704|1567951|P1|NOT COMPLETED|Overall Study||131
637834|NCT00106704|1567950|P2|COMPLETED|Overall Study||68
637835|NCT00106704|1567951|P1|COMPLETED|Overall Study||91
637836|NCT00106704|1567950|P2|STARTED|Overall Study||219
637837|NCT00106704|1567951|P1|STARTED|Overall Study||222
637838|NCT00106639|1567962|P3|NOT COMPLETED|Overall Study||2
637839|NCT00106639|1567963|P2|NOT COMPLETED|Overall Study||7
637840|NCT00106639|1567964|P1|NOT COMPLETED|Overall Study||3
637841|NCT00106639|1567962|P3|COMPLETED|Overall Study||19
637842|NCT00106639|1567963|P2|COMPLETED|Overall Study||13
637843|NCT00106639|1567964|P1|COMPLETED|Overall Study||17
637844|NCT00106639|1567962|P3|STARTED|Overall Study||21
637845|NCT00106639|1567963|P2|STARTED|Overall Study||20
637846|NCT00106639|1567964|P1|STARTED|Overall Study||20
637847|NCT00106626|1568091|P4|NOT COMPLETED|Overall Study||13
637848|NCT00106626|1568092|P3|NOT COMPLETED|Overall Study||12
637849|NCT00106626|1568093|P2|NOT COMPLETED|Overall Study||6
637850|NCT00106626|1568094|P1|NOT COMPLETED|Overall Study||10
637851|NCT00106626|1568091|P4|COMPLETED|Overall Study||3
637852|NCT00106626|1568092|P3|COMPLETED|Overall Study||2
637853|NCT00106626|1568093|P2|COMPLETED|Overall Study||3
637854|NCT00106626|1568094|P1|COMPLETED|Overall Study||3
637855|NCT00106626|1568091|P4|STARTED|Overall Study||16
637856|NCT00106626|1568092|P3|STARTED|Overall Study||14
637857|NCT00106626|1568093|P2|STARTED|Overall Study||9
637858|NCT00106626|1568094|P1|STARTED|Overall Study||13
637859|NCT00106535|1568112|P4|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||190
637860|NCT00106535|1568113|P3|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
637861|NCT00106535|1568114|P2|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
637862|NCT00106535|1568115|P1|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
637863|NCT00106535|1568112|P4|COMPLETED|Long-term Extension Period (Year 3 to 5)|Completed the study.|704
637864|NCT00106535|1568113|P3|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
637865|NCT00106535|1568114|P2|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
637866|NCT00106535|1568115|P1|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
637867|NCT00106535|1568112|P4|STARTED|Long-term Extension Period (Year 3 to 5)|Entered the Long-term Extension.|894
637868|NCT00106535|1568113|P3|STARTED|Long-term Extension Period (Year 3 to 5)||0
637869|NCT00106535|1568114|P2|STARTED|Long-term Extension Period (Year 3 to 5)||0
637870|NCT00106535|1568115|P1|STARTED|Long-term Extension Period (Year 3 to 5)||0
637871|NCT00106535|1568112|P4|NOT COMPLETED|2-year Placebo Controlled Period||0
637872|NCT00106535|1568113|P3|NOT COMPLETED|2-year Placebo Controlled Period||91
637873|NCT00106535|1568114|P2|NOT COMPLETED|2-year Placebo Controlled Period||92
637874|NCT00106535|1568115|P1|NOT COMPLETED|2-year Placebo Controlled Period||107
637875|NCT00106535|1568112|P4|COMPLETED|2-year Placebo Controlled Period||0
637876|NCT00106535|1568113|P3|COMPLETED|2-year Placebo Controlled Period|Completed Week 104. 306 participants randomized to the TCZ 8 mg/kg arm entered the LTE period.|310
637877|NCT00106535|1568114|P2|COMPLETED|2-year Placebo Controlled Period|Completed Week 104. 304 participants randomized to the TCZ 4 mg/kg arm entered the LTE period.|309
637878|NCT00106535|1568115|P1|COMPLETED|2-year Placebo Controlled Period|Completed Week 104 (Year 2). 284 participants randomized to the Placebo arm entered the LTE period.|287
637879|NCT00106535|1568112|P4|Completed Week 52|2-year Placebo Controlled Period||0
637880|NCT00106535|1568113|P3|Completed Week 52|2-year Placebo Controlled Period||338
637881|NCT00106535|1568114|P2|Completed Week 52|2-year Placebo Controlled Period||342
637882|NCT00106535|1568115|P1|Completed Week 52|2-year Placebo Controlled Period||326
637883|NCT00106535|1568112|P4|Completed Week 24|2-year Placebo Controlled Period||0
637884|NCT00106535|1568113|P3|Completed Week 24|2-year Placebo Controlled Period||366
637885|NCT00106535|1568114|P2|Completed Week 24|2-year Placebo Controlled Period||373
637886|NCT00106535|1568115|P1|Completed Week 24|2-year Placebo Controlled Period||356
637887|NCT00106535|1568112|P4|Safety: Actual Treatment Received|2-year Placebo Controlled Period||0
637888|NCT00106535|1568113|P3|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399
637889|NCT00106535|1568114|P2|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399
637890|NCT00106535|1568115|P1|Safety: Actual Treatment Received|2-year Placebo Controlled Period||392
637891|NCT00106535|1568112|P4|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||0
637892|NCT00106535|1568113|P3|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||398
637893|NCT00106535|1568114|P2|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||399
637894|NCT00106535|1568115|P1|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||393
637895|NCT00106535|1568112|P4|STARTED|2-year Placebo Controlled Period||0
637896|NCT00106535|1568113|P3|STARTED|2-year Placebo Controlled Period||401
637897|NCT00106535|1568114|P2|STARTED|2-year Placebo Controlled Period||401
637898|NCT00106535|1568115|P1|STARTED|2-year Placebo Controlled Period||394
637899|NCT00106431|1568408|P1|NOT COMPLETED|Overall Study||65
637900|NCT00106431|1568408|P1|COMPLETED|Overall Study|37 represents the number of patients who reached at least 6 months treatment|37
637901|NCT00106431|1568408|P1|STARTED|Overall Study||102
637902|NCT00106392|1568420|P2|NOT COMPLETED|Overall Study||27
637903|NCT00106392|1568421|P1|NOT COMPLETED|Overall Study||26
637904|NCT00106392|1568420|P2|COMPLETED|Overall Study||42
637905|NCT00106392|1568421|P1|COMPLETED|Overall Study||36
637906|NCT00106392|1568420|P2|Full Analysis Set (FAS)|Overall Study||61
637907|NCT00106392|1568421|P1|Full Analysis Set (FAS)|Overall Study||53
637908|NCT00106392|1568420|P2|Baseline Participants|Overall Study|4 patients withdrew: all prior to surgery and study drug|65
637909|NCT00106392|1568421|P1|Baseline Participants|Overall Study|3 patients withdrew: 2 prior to surgery and study drug; 1 took study drug but did not have surgery|59
637910|NCT00106392|1568420|P2|STARTED|Overall Study||69
637911|NCT00106392|1568421|P1|STARTED|Overall Study||62
637912|NCT00106353|1568439|P7|NOT COMPLETED|Part 2||16
637913|NCT00106353|1568440|P6|NOT COMPLETED|Part 2||18
637914|NCT00106353|1568441|P5|NOT COMPLETED|Part 2||16
637915|NCT00106353|1568442|P4|NOT COMPLETED|Part 2||0
637916|NCT00106353|1568443|P3|NOT COMPLETED|Part 2||0
637917|NCT00106353|1568444|P2|NOT COMPLETED|Part 2||0
637918|NCT00106353|1568445|P1|NOT COMPLETED|Part 2||0
637919|NCT00106353|1568439|P7|COMPLETED|Part 2||0
637920|NCT00106353|1568440|P6|COMPLETED|Part 2||1
637921|NCT00106353|1568441|P5|COMPLETED|Part 2||1
637922|NCT00106353|1568442|P4|COMPLETED|Part 2||0
637923|NCT00106353|1568443|P3|COMPLETED|Part 2||0
637924|NCT00106353|1568444|P2|COMPLETED|Part 2||0
637925|NCT00106353|1568445|P1|COMPLETED|Part 2||0
637926|NCT00106353|1568439|P7|STARTED|Part 2||16
637927|NCT00106353|1568440|P6|STARTED|Part 2||19
637928|NCT00106353|1568441|P5|STARTED|Part 2||17
637929|NCT00106353|1568442|P4|STARTED|Part 2||0
637930|NCT00106353|1568443|P3|STARTED|Part 2||0
637931|NCT00106353|1568444|P2|STARTED|Part 2||0
637932|NCT00106353|1568445|P1|STARTED|Part 2||0
637933|NCT00106353|1568439|P7|NOT COMPLETED|Part 1||0
637934|NCT00106353|1568440|P6|NOT COMPLETED|Part 1||0
637935|NCT00106353|1568441|P5|NOT COMPLETED|Part 1||0
637936|NCT00106353|1568442|P4|NOT COMPLETED|Part 1||7
637937|NCT00106353|1568443|P3|NOT COMPLETED|Part 1||3
637938|NCT00106353|1568444|P2|NOT COMPLETED|Part 1||5
637939|NCT00106353|1568445|P1|NOT COMPLETED|Part 1||4
637940|NCT00106353|1568439|P7|COMPLETED|Part 1||0
637941|NCT00106353|1568440|P6|COMPLETED|Part 1||0
637942|NCT00106353|1568441|P5|COMPLETED|Part 1||0
637943|NCT00106353|1568442|P4|COMPLETED|Part 1||0
637944|NCT00106353|1568443|P3|COMPLETED|Part 1||0
637945|NCT00106353|1568444|P2|COMPLETED|Part 1||0
637946|NCT00106353|1568445|P1|COMPLETED|Part 1||0
637947|NCT00106353|1568439|P7|STARTED|Part 1||0
637948|NCT00106353|1568440|P6|STARTED|Part 1||0
637949|NCT00106353|1568441|P5|STARTED|Part 1||0
637950|NCT00106353|1568442|P4|STARTED|Part 1||7
637951|NCT00106353|1568443|P3|STARTED|Part 1||3
637952|NCT00106353|1568444|P2|STARTED|Part 1||5
637953|NCT00106353|1568445|P1|STARTED|Part 1||4
637954|NCT00106249|1568572|P2|NOT COMPLETED|Overall Study||2
637955|NCT00106249|1568573|P1|NOT COMPLETED|Overall Study||3
637956|NCT00106249|1568572|P2|COMPLETED|Overall Study||11
637957|NCT00106249|1568573|P1|COMPLETED|Overall Study||11
637958|NCT00106249|1568572|P2|STARTED|Overall Study||13
637959|NCT00106249|1568573|P1|STARTED|Overall Study||14
637960|NCT00106184|1568585|P2|NOT COMPLETED|Overall Study||2
637961|NCT00106184|1568586|P1|NOT COMPLETED|Overall Study||3
637962|NCT00106184|1568585|P2|COMPLETED|Overall Study||102
637963|NCT00106184|1568586|P1|COMPLETED|Overall Study||93
637964|NCT00106184|1568585|P2|Treated|Overall Study|104 subjects were randomized.|102
637965|NCT00106184|1568586|P1|Treated|Overall Study|96 subjects were randomized.|93
637966|NCT00106184|1568585|P2|STARTED|Overall Study||104
637967|NCT00106184|1568586|P1|STARTED|Overall Study||96
637968|NCT00106119|1568596|P2|NOT COMPLETED|Second Intervention||0
637969|NCT00106119|1568597|P1|NOT COMPLETED|Second Intervention||0
637970|NCT00106119|1568596|P2|COMPLETED|Second Intervention||7
637971|NCT00106119|1568597|P1|COMPLETED|Second Intervention||7
637972|NCT00106119|1568596|P2|STARTED|Second Intervention||7
637973|NCT00106119|1568597|P1|STARTED|Second Intervention||7
637974|NCT00106119|1568596|P2|NOT COMPLETED|Washout Period of 30 Days||0
637975|NCT00106119|1568597|P1|NOT COMPLETED|Washout Period of 30 Days||0
637976|NCT00106119|1568596|P2|COMPLETED|Washout Period of 30 Days||7
637977|NCT00106119|1568597|P1|COMPLETED|Washout Period of 30 Days||7
637978|NCT00106119|1568596|P2|STARTED|Washout Period of 30 Days||7
637979|NCT00106119|1568597|P1|STARTED|Washout Period of 30 Days||7
637980|NCT00106119|1568596|P2|NOT COMPLETED|First Intervention||0
637981|NCT00106119|1568597|P1|NOT COMPLETED|First Intervention||0
637982|NCT00106119|1568596|P2|COMPLETED|First Intervention||7
637983|NCT00106119|1568597|P1|COMPLETED|First Intervention||7
637984|NCT00106119|1568596|P2|STARTED|First Intervention||7
637985|NCT00106119|1568597|P1|STARTED|First Intervention||7
637986|NCT00106106|1568617|P2|NOT COMPLETED|Overall Study||4
637987|NCT00106106|1568618|P1|NOT COMPLETED|Overall Study||4
637988|NCT00106106|1568617|P2|COMPLETED|Overall Study|Although 19 subjects completed all other assessments for the study, only 15 completed both MRS scans|19
637989|NCT00106106|1568618|P1|COMPLETED|Overall Study|Although 22 subjects completed all other assessments for the study, only 18 completed both MRS scans|22
637990|NCT00106106|1568617|P2|Completed Both MRS Scans|Overall Study||15
637991|NCT00106106|1568618|P1|Completed Both MRS Scans|Overall Study||18
637992|NCT00106106|1568617|P2|STARTED|Overall Study||23
637993|NCT00106106|1568618|P1|STARTED|Overall Study||26
637994|NCT00106080|1568628|P2|NOT COMPLETED|Overall Study||27
637995|NCT00106080|1568629|P1|NOT COMPLETED|Overall Study||43
637996|NCT00106080|1568628|P2|COMPLETED|Overall Study||155
637997|NCT00106080|1568629|P1|COMPLETED|Overall Study||151
637998|NCT00106080|1568628|P2|STARTED|Overall Study||182
637999|NCT00106080|1568629|P1|STARTED|Overall Study||194
638000|NCT00106028|1568639|P2|NOT COMPLETED|Overall Study||12
638001|NCT00106028|1568640|P1|NOT COMPLETED|Overall Study||6
638002|NCT00106028|1568639|P2|COMPLETED|Overall Study|Completed Month 36|82
638003|NCT00106028|1568640|P1|COMPLETED|Overall Study|Completed Month 36|43
638004|NCT00106028|1568639|P2|Month 12 Completed/Started Open Label|Overall Study||87
638005|NCT00106028|1568640|P1|Month 12 Completed/Started Open Label|Overall Study||49
638006|NCT00106028|1568639|P2|STARTED|Overall Study|ITT Population: Patients Randomized and Received at least 1 Dose of Study Drug|94
638007|NCT00106028|1568640|P1|STARTED|Overall Study|ITT Population: Patients Randomized and Received at least 1 Dose of Study Drug|49
638008|NCT00106002|1568734|P1|NOT COMPLETED|Overall Study||2
638009|NCT00106002|1568734|P1|COMPLETED|Overall Study|Completed means that the patient was evaluable for response.|35
638010|NCT00106002|1568734|P1|STARTED|Overall Study||37
638011|NCT00105989|1568742|P2|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||69
638012|NCT00105989|1568743|P1|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||50
638013|NCT00105989|1568742|P2|COMPLETED|Maintenance - Double-Blind:Week 34-86||73
638014|NCT00105989|1568743|P1|COMPLETED|Maintenance - Double-Blind:Week 34-86||96
638015|NCT00105989|1568742|P2|STARTED|Maintenance - Double-Blind:Week 34-86||142
638016|NCT00105989|1568743|P1|STARTED|Maintenance - Double-Blind:Week 34-86||146
638017|NCT00105989|1568742|P2|NOT COMPLETED|Continuation - Open Label:Week 10-34||0
638018|NCT00105989|1568743|P1|NOT COMPLETED|Continuation - Open Label:Week 10-34||125
638019|NCT00105989|1568742|P2|COMPLETED|Continuation - Open Label:Week 10-34||0
638020|NCT00105989|1568743|P1|COMPLETED|Continuation - Open Label:Week 10-34||288
638021|NCT00105989|1568742|P2|STARTED|Continuation - Open Label:Week 10-34||0
638022|NCT00105989|1568743|P1|STARTED|Continuation - Open Label:Week 10-34||413
638023|NCT00105989|1568742|P2|NOT COMPLETED|Acute - Open Label: Week 0-10||0
638024|NCT00105989|1568743|P1|NOT COMPLETED|Acute - Open Label: Week 0-10||101
638025|NCT00105989|1568742|P2|COMPLETED|Acute - Open Label: Week 0-10||0
638026|NCT00105989|1568743|P1|COMPLETED|Acute - Open Label: Week 0-10||413
638027|NCT00105989|1568742|P2|STARTED|Acute - Open Label: Week 0-10||0
638028|NCT00105989|1568743|P1|STARTED|Acute - Open Label: Week 0-10||514
638029|NCT00105586|1568859|P2|NOT COMPLETED|Overall Study||16
638030|NCT00105586|1568860|P1|NOT COMPLETED|Overall Study||17
638031|NCT00105586|1568859|P2|COMPLETED|Overall Study||69
638032|NCT00105586|1568860|P1|COMPLETED|Overall Study||75
638033|NCT00105586|1568859|P2|STARTED|Overall Study||85
638034|NCT00105586|1568860|P1|STARTED|Overall Study||92
638035|NCT00105560|1568868|P1|NOT COMPLETED|Overall Study||1
638036|NCT00105560|1568868|P1|COMPLETED|Overall Study||58
638037|NCT00105560|1568868|P1|STARTED|Overall Study||59
638038|NCT00105534|1568890|P2|NOT COMPLETED|Overall Study||33
638039|NCT00105534|1568891|P1|NOT COMPLETED|Overall Study||22
638040|NCT00105534|1568890|P2|COMPLETED|Overall Study||317
638041|NCT00105534|1568891|P1|COMPLETED|Overall Study||313
638042|NCT00105534|1568890|P2|STARTED|Overall Study||350
638043|NCT00105534|1568891|P1|STARTED|Overall Study||335
638044|NCT00105521|1568903|P4|NOT COMPLETED|Overall Study||17
638045|NCT00105521|1568904|P3|NOT COMPLETED|Overall Study||17
638046|NCT00105521|1568905|P2|NOT COMPLETED|Overall Study||11
638047|NCT00105521|1568906|P1|NOT COMPLETED|Overall Study||15
638048|NCT00105521|1568903|P4|COMPLETED|Overall Study||85
638049|NCT00105521|1568904|P3|COMPLETED|Overall Study||80
638050|NCT00105521|1568905|P2|COMPLETED|Overall Study||90
638051|NCT00105521|1568906|P1|COMPLETED|Overall Study||83
638052|NCT00105521|1568903|P4|STARTED|Overall Study||102
638053|NCT00105521|1568904|P3|STARTED|Overall Study||97
638054|NCT00105521|1568905|P2|STARTED|Overall Study||101
638055|NCT00105521|1568906|P1|STARTED|Overall Study||98
638056|NCT00105482|1568930|P2|NOT COMPLETED|Overall Study||55
638057|NCT00105482|1568931|P1|NOT COMPLETED|Overall Study||59
638058|NCT00105482|1568930|P2|COMPLETED|Overall Study||30
638059|NCT00105482|1568931|P1|COMPLETED|Overall Study||28
638060|NCT00105482|1568930|P2|STARTED|Overall Study||85
638061|NCT00105482|1568931|P1|STARTED|Overall Study||87
638062|NCT00105469|1568947|P2|NOT COMPLETED|Overall Study||11
638063|NCT00105469|1568948|P1|NOT COMPLETED|Overall Study||22
638064|NCT00105469|1568947|P2|COMPLETED|Overall Study||367
638065|NCT00105469|1568948|P1|COMPLETED|Overall Study||343
638066|NCT00105469|1568947|P2|STARTED|Overall Study||378
638067|NCT00105469|1568948|P1|STARTED|Overall Study||365
638068|NCT00105443|1568958|P4|NOT COMPLETED|Follow-up and/or Open Label Nexavar||47
638069|NCT00105443|1568959|P3|NOT COMPLETED|Follow-up and/or Open Label Nexavar||245
638070|NCT00105443|1568960|P2|NOT COMPLETED|Follow-up and/or Open Label Nexavar||57
638071|NCT00105443|1568961|P1|NOT COMPLETED|Follow-up and/or Open Label Nexavar||228
638072|NCT00105443|1568958|P4|COMPLETED|Follow-up and/or Open Label Nexavar|47 participants in total (36 + 11) received Open Label Sorafenib treatment (Subjects at Risk)|0
638073|NCT00105443|1568959|P3|COMPLETED|Follow-up and/or Open Label Nexavar||0
638074|NCT00105443|1568960|P2|COMPLETED|Follow-up and/or Open Label Nexavar|57 participants in total (47 + 10) received Open Label Sorafenib treatment (Subjects at Risk)|0
638075|NCT00105443|1568961|P1|COMPLETED|Follow-up and/or Open Label Nexavar||0
638076|NCT00105443|1568958|P4|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||11
638077|NCT00105443|1568959|P3|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0
638078|NCT00105443|1568960|P2|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||10
638079|NCT00105443|1568961|P1|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0
638080|NCT00105443|1568958|P4|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar|"In parallel to Follow-up only phase; participants received Sorafenib 400 mg bid"|36
638081|NCT00105443|1568959|P3|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0
638082|NCT00105443|1568960|P2|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar|"In parallel to Follow-up only phase; participants received Sorafenib 400 mg bid"|47
638083|NCT00105443|1568961|P1|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0
638084|NCT00105443|1568958|P4|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0
638085|NCT00105443|1568959|P3|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar|"In parallel to Open Label treatment only phase"|245
638086|NCT00105443|1568960|P2|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0
638087|NCT00105443|1568961|P1|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar|"In parallel to Open Label treatment only phase"|228
638088|NCT00105443|1568958|P4|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 36 participants directly switched to Open Label (OL) Sorafenib treatment|47
638089|NCT00105443|1568959|P3|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 245 participants directly switched to Follow-up (FU)|245
638090|NCT00105443|1568960|P2|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 47 participants directly switched to Open Label (OL) Sorafenib treatment|57
638091|NCT00105443|1568961|P1|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 228 participants directly switched to Follow-up (FU)|228
638092|NCT00105443|1568958|P4|NOT COMPLETED|Double-Blind Treatment||0
638093|NCT00105443|1568959|P3|NOT COMPLETED|Double-Blind Treatment||11
638094|NCT00105443|1568960|P2|NOT COMPLETED|Double-Blind Treatment||0
638095|NCT00105443|1568961|P1|NOT COMPLETED|Double-Blind Treatment||14
638096|NCT00105443|1568958|P4|COMPLETED|Double-Blind Treatment|36 participants switched to Sorafenib Open Label (OL); 11 first to FU prior to also switch to OL|47
638097|NCT00105443|1568959|P3|COMPLETED|Double-Blind Treatment|245 participants directly switched to the Follow-up (FU) phase|245
638098|NCT00105443|1568960|P2|COMPLETED|Double-Blind Treatment|47 participants continued with Sorafenib Open Label (OL); 10 first to FU prior to also switch to OL|57
638099|NCT00105443|1568961|P1|COMPLETED|Double-Blind Treatment|228 participants directly switched to the Follow-up (FU) phase only|228
638100|NCT00105443|1568958|P4|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG2 and RG4 as well as RG5|47
638101|NCT00105443|1568959|P3|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG2 and RG4|255
638102|NCT00105443|1568960|P2|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG1 and RG3|57
638103|NCT00105443|1568961|P1|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG1 and RG3 (RG = Reporting Group for Safety Data)|240
638104|NCT00105443|1568958|P4|STARTED|Double-Blind Treatment||47
638105|NCT00105443|1568959|P3|STARTED|Double-Blind Treatment||256
638106|NCT00105443|1568960|P2|STARTED|Double-Blind Treatment||57
638107|NCT00105443|1568961|P1|STARTED|Double-Blind Treatment||242
638108|NCT00105235|1568988|P1|NOT COMPLETED|Overall Study||7
638109|NCT00105235|1568988|P1|COMPLETED|Overall Study||20
638110|NCT00105235|1568988|P1|STARTED|Overall Study||27
638111|NCT00105196|1569001|P2|NOT COMPLETED|Overall Study||23
638112|NCT00105196|1569002|P1|NOT COMPLETED|Overall Study||30
638113|NCT00105196|1569001|P2|COMPLETED|Overall Study||149
638114|NCT00105196|1569002|P1|COMPLETED|Overall Study||147
638115|NCT00105196|1569001|P2|STARTED|Overall Study||172
638116|NCT00105196|1569002|P1|STARTED|Overall Study||177
638117|NCT00105183|1569025|P3|NOT COMPLETED|Overall Study||23
638118|NCT00105183|1569026|P2|NOT COMPLETED|Overall Study||19
638119|NCT00105183|1569027|P1|NOT COMPLETED|Overall Study||22
638120|NCT00105183|1569025|P3|COMPLETED|Overall Study|Completed at least 12 months follow up|39
638121|NCT00105183|1569026|P2|COMPLETED|Overall Study|Completed at least 12 months follow up|60
638122|NCT00105183|1569027|P1|COMPLETED|Overall Study|Completed at least 12 months follow up|60
638123|NCT00105183|1569025|P3|STARTED|Overall Study|Randomized|62
638124|NCT00105183|1569026|P2|STARTED|Overall Study|Randomized|79
638125|NCT00105183|1569027|P1|STARTED|Overall Study|Randomized|82
638126|NCT00105157|1569063|P4|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||18
638127|NCT00105157|1569064|P3|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6
638128|NCT00105157|1569065|P2|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6
638129|NCT00105157|1569066|P1|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||9
638130|NCT00105157|1569063|P4|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||19
638131|NCT00105157|1569064|P3|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||5
638132|NCT00105157|1569065|P2|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||7
638133|NCT00105157|1569066|P1|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||2
638134|NCT00105157|1569063|P4|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|37
638135|NCT00105157|1569064|P3|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|11
638136|NCT00105157|1569065|P2|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|13
638137|NCT00105157|1569066|P1|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|11
638138|NCT00105157|1569063|P4|NOT COMPLETED|Open-Label Continuation of DB||1
638139|NCT00105157|1569064|P3|NOT COMPLETED|Open-Label Continuation of DB||9
638140|NCT00105157|1569065|P2|NOT COMPLETED|Open-Label Continuation of DB||10
638141|NCT00105157|1569066|P1|NOT COMPLETED|Open-Label Continuation of DB||7
638142|NCT00105157|1569063|P4|COMPLETED|Open-Label Continuation of DB||5
638143|NCT00105157|1569064|P3|COMPLETED|Open-Label Continuation of DB||24
638144|NCT00105157|1569065|P2|COMPLETED|Open-Label Continuation of DB||21
638145|NCT00105157|1569066|P1|COMPLETED|Open-Label Continuation of DB||23
638146|NCT00105157|1569063|P4|STARTED|Open-Label Continuation of DB||6
638147|NCT00105157|1569064|P3|STARTED|Open-Label Continuation of DB||33
638148|NCT00105157|1569065|P2|STARTED|Open-Label Continuation of DB||31
638149|NCT00105157|1569066|P1|STARTED|Open-Label Continuation of DB||30
638150|NCT00105157|1569063|P4|NOT COMPLETED|Double-Blind (DB)||39
638151|NCT00105157|1569064|P3|NOT COMPLETED|Double-Blind (DB)||12
638152|NCT00105157|1569065|P2|NOT COMPLETED|Double-Blind (DB)||14
638153|NCT00105157|1569066|P1|NOT COMPLETED|Double-Blind (DB)||14
638154|NCT00105157|1569063|P4|COMPLETED|Double-Blind (DB)||6
638155|NCT00105157|1569064|P3|COMPLETED|Double-Blind (DB)||33
638156|NCT00105157|1569065|P2|COMPLETED|Double-Blind (DB)||31
638157|NCT00105157|1569066|P1|COMPLETED|Double-Blind (DB)||30
638158|NCT00105157|1569063|P4|Treated|Double-Blind (DB)||45
638159|NCT00105157|1569064|P3|Treated|Double-Blind (DB)||45
638160|NCT00105157|1569065|P2|Treated|Double-Blind (DB)||45
638161|NCT00105157|1569066|P1|Treated|Double-Blind (DB)||43
638162|NCT00105157|1569063|P4|STARTED|Double-Blind (DB)||45
638163|NCT00105157|1569064|P3|STARTED|Double-Blind (DB)||45
638164|NCT00105157|1569065|P2|STARTED|Double-Blind (DB)||45
638165|NCT00105157|1569066|P1|STARTED|Double-Blind (DB)||44
638166|NCT00105079|1569260|P2|NOT COMPLETED|Overall Study||35
638167|NCT00105079|1569261|P1|NOT COMPLETED|Overall Study||39
638168|NCT00105079|1569260|P2|COMPLETED|Overall Study||135
638169|NCT00105079|1569261|P1|COMPLETED|Overall Study||128
638170|NCT00105079|1569260|P2|Safety Population|Overall Study||168
638171|NCT00105079|1569261|P1|Safety Population|Overall Study||163
638172|NCT00105079|1569260|P2|STARTED|Overall Study||170
638173|NCT00105079|1569261|P1|STARTED|Overall Study||167
638174|NCT00105066|1569279|P2|NOT COMPLETED|Overall Study||5
638175|NCT00105066|1569280|P1|NOT COMPLETED|Overall Study||2
638176|NCT00105066|1569279|P2|COMPLETED|Overall Study||45
638177|NCT00105066|1569280|P1|COMPLETED|Overall Study||25
638178|NCT00105066|1569279|P2|STARTED|Overall Study||50
638179|NCT00105066|1569280|P1|STARTED|Overall Study||27
638180|NCT00105027|1569296|P6|NOT COMPLETED|Overall Study||13
638181|NCT00105027|1569297|P5|NOT COMPLETED|Overall Study||15
638182|NCT00105027|1569298|P4|NOT COMPLETED|Overall Study||16
638183|NCT00105027|1569299|P3|NOT COMPLETED|Overall Study||9
638184|NCT00105027|1569300|P2|NOT COMPLETED|Overall Study||9
638185|NCT00105027|1569301|P1|NOT COMPLETED|Overall Study||15
638186|NCT00105027|1569296|P6|COMPLETED|Overall Study||125
638187|NCT00105027|1569297|P5|COMPLETED|Overall Study||121
638188|NCT00105027|1569298|P4|COMPLETED|Overall Study||121
638189|NCT00105027|1569299|P3|COMPLETED|Overall Study||82
638190|NCT00105027|1569300|P2|COMPLETED|Overall Study||83
638191|NCT00105027|1569301|P1|COMPLETED|Overall Study||73
638192|NCT00105027|1569296|P6|STARTED|Overall Study||138
638193|NCT00105027|1569297|P5|STARTED|Overall Study||136
638194|NCT00105027|1569298|P4|STARTED|Overall Study||137
638195|NCT00105027|1569299|P3|STARTED|Overall Study||91
638196|NCT00105027|1569300|P2|STARTED|Overall Study||92
638197|NCT00105027|1569301|P1|STARTED|Overall Study||88
638198|NCT00105001|1569318|P3|NOT COMPLETED|Overall Study||0
638199|NCT00105001|1569319|P2|NOT COMPLETED|Overall Study||0
638200|NCT00105001|1569320|P1|NOT COMPLETED|Overall Study||0
638201|NCT00105001|1569318|P3|COMPLETED|Overall Study||69
638202|NCT00105001|1569319|P2|COMPLETED|Overall Study||71
638203|NCT00105001|1569320|P1|COMPLETED|Overall Study||70
638204|NCT00105001|1569318|P3|STARTED|Overall Study||69
638205|NCT00105001|1569319|P2|STARTED|Overall Study||71
638206|NCT00105001|1569320|P1|STARTED|Overall Study||70
638207|NCT00104884|1569340|P1|NOT COMPLETED|Overall Study||4
638208|NCT00104884|1569340|P1|COMPLETED|Overall Study||0
638209|NCT00104884|1569340|P1|STARTED|Overall Study||4
638210|NCT00104871|1569344|P1|NOT COMPLETED|Overall Study||1
638211|NCT00104871|1569344|P1|COMPLETED|Overall Study||21
638212|NCT00104871|1569344|P1|STARTED|Overall Study||22
638213|NCT00104728|1569349|P1|NOT COMPLETED|Overall Study||19
638214|NCT00104728|1569349|P1|COMPLETED|Overall Study||23
638215|NCT00104728|1569349|P1|STARTED|Overall Study|42 consented on study|42
638216|NCT00104650|1569357|P3|NOT COMPLETED|Follow-up Period||10
638217|NCT00104650|1569358|P2|NOT COMPLETED|Follow-up Period||13
638218|NCT00104650|1569359|P1|NOT COMPLETED|Follow-up Period||11
638219|NCT00104650|1569357|P3|COMPLETED|Follow-up Period||18
638220|NCT00104650|1569358|P2|COMPLETED|Follow-up Period||12
638221|NCT00104650|1569359|P1|COMPLETED|Follow-up Period||14
638222|NCT00104650|1569357|P3|STARTED|Follow-up Period||28
638223|NCT00104650|1569358|P2|STARTED|Follow-up Period||25
638224|NCT00104650|1569359|P1|STARTED|Follow-up Period||25
638225|NCT00104650|1569357|P3|NOT COMPLETED|Treatment Period (25 Weeks)||10
638226|NCT00104650|1569358|P2|NOT COMPLETED|Treatment Period (25 Weeks)||11
638227|NCT00104650|1569359|P1|NOT COMPLETED|Treatment Period (25 Weeks)||12
638228|NCT00104650|1569357|P3|COMPLETED|Treatment Period (25 Weeks)||28
638229|NCT00104650|1569358|P2|COMPLETED|Treatment Period (25 Weeks)||25
638230|NCT00104650|1569359|P1|COMPLETED|Treatment Period (25 Weeks)||25
638231|NCT00104650|1569357|P3|Received Investigational Product|Treatment Period (25 Weeks)||38
638232|NCT00104650|1569358|P2|Received Investigational Product|Treatment Period (25 Weeks)||35
638233|NCT00104650|1569359|P1|Received Investigational Product|Treatment Period (25 Weeks)||35
638234|NCT00104650|1569357|P3|STARTED|Treatment Period (25 Weeks)||38
638235|NCT00104650|1569358|P2|STARTED|Treatment Period (25 Weeks)||36
638236|NCT00104650|1569359|P1|STARTED|Treatment Period (25 Weeks)||37
638237|NCT00104637|1569391|P2|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0
638238|NCT00104637|1569392|P1|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0
638239|NCT00104637|1569391|P2|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||4
638240|NCT00104637|1569392|P1|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||5
638241|NCT00104637|1569391|P2|STARTED|Period 3 ( TREATMENT: 4 Weeks)||4
638242|NCT00104637|1569392|P1|STARTED|Period 3 ( TREATMENT: 4 Weeks)||5
638243|NCT00104637|1569391|P2|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0
638244|NCT00104637|1569392|P1|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0
638245|NCT00104637|1569391|P2|COMPLETED|Period 2 (WASHOUT: 1 Week)||4
638246|NCT00104637|1569392|P1|COMPLETED|Period 2 (WASHOUT: 1 Week)||5
638247|NCT00104637|1569391|P2|STARTED|Period 2 (WASHOUT: 1 Week)||4
638248|NCT00104637|1569392|P1|STARTED|Period 2 (WASHOUT: 1 Week)||5
638249|NCT00104637|1569391|P2|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||0
638250|NCT00104637|1569392|P1|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||1
638251|NCT00104637|1569391|P2|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||4
638252|NCT00104637|1569392|P1|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||5
638253|NCT00104637|1569391|P2|STARTED|Period 1: ( TREATMENT: 4 Weeks)||4
638254|NCT00104637|1569392|P1|STARTED|Period 1: ( TREATMENT: 4 Weeks)||6
638255|NCT00104572|1569421|P3|NOT COMPLETED|Overall Study||0
638256|NCT00104572|1569422|P2|NOT COMPLETED|Overall Study||3
638257|NCT00104572|1569423|P1|NOT COMPLETED|Overall Study||3
638258|NCT00104572|1569421|P3|COMPLETED|Overall Study||9
638259|NCT00104572|1569422|P2|COMPLETED|Overall Study||10
638260|NCT00104572|1569423|P1|COMPLETED|Overall Study||10
638261|NCT00104572|1569421|P3|STARTED|Overall Study|(N=11) in placebo, physician removed 2 men due to total testosterone>450 ng/DL, N=9 analysed.|9
638262|NCT00104572|1569422|P2|STARTED|Overall Study|These are the analysed subjects|13
638263|NCT00104572|1569423|P1|STARTED|Overall Study|These are the analysed subjects|13
638264|NCT00104520|1569433|P2|NOT COMPLETED|Overall Study||71
638265|NCT00104520|1569434|P1|NOT COMPLETED|Overall Study||50
638266|NCT00104520|1569433|P2|COMPLETED|Overall Study||64
638267|NCT00104520|1569434|P1|COMPLETED|Overall Study||26
638268|NCT00104520|1569433|P2|STARTED|Overall Study||135
638269|NCT00104520|1569434|P1|STARTED|Overall Study||76
638270|NCT00104416|1569454|P5|NOT COMPLETED|Continuation Phase||5
638271|NCT00104416|1569455|P4|NOT COMPLETED|Continuation Phase||2
638272|NCT00104416|1569456|P3|NOT COMPLETED|Continuation Phase||6
638273|NCT00104416|1569457|P2|NOT COMPLETED|Continuation Phase||0
638274|NCT00104416|1569458|P1|NOT COMPLETED|Continuation Phase||0
638275|NCT00104416|1569454|P5|COMPLETED|Continuation Phase||27
638276|NCT00104416|1569455|P4|COMPLETED|Continuation Phase||65
638277|NCT00104416|1569456|P3|COMPLETED|Continuation Phase||63
638278|NCT00104416|1569457|P2|COMPLETED|Continuation Phase||0
638279|NCT00104416|1569458|P1|COMPLETED|Continuation Phase||0
638280|NCT00104416|1569454|P5|STARTED|Continuation Phase||32
638281|NCT00104416|1569455|P4|STARTED|Continuation Phase|One participant did not complete the Double-Blind Phase but was enrolled in the Continuation Phase.|67
638282|NCT00104416|1569456|P3|STARTED|Continuation Phase||69
638283|NCT00104416|1569457|P2|STARTED|Continuation Phase||0
638284|NCT00104416|1569458|P1|STARTED|Continuation Phase||0
638285|NCT00104416|1569454|P5|NOT COMPLETED|Double-Blind Phase||0
638286|NCT00104416|1569455|P4|NOT COMPLETED|Double-Blind Phase||0
638287|NCT00104416|1569456|P3|NOT COMPLETED|Double-Blind Phase||0
638288|NCT00104416|1569457|P2|NOT COMPLETED|Double-Blind Phase||10
638289|NCT00104416|1569458|P1|NOT COMPLETED|Double-Blind Phase||8
638290|NCT00104416|1569454|P5|COMPLETED|Double-Blind Phase||0
638291|NCT00104416|1569455|P4|COMPLETED|Double-Blind Phase||0
638292|NCT00104416|1569456|P3|COMPLETED|Double-Blind Phase||0
638293|NCT00104416|1569457|P2|COMPLETED|Double-Blind Phase||66
638294|NCT00104416|1569458|P1|COMPLETED|Double-Blind Phase||69
638295|NCT00104416|1569454|P5|STARTED|Double-Blind Phase||0
638296|NCT00104416|1569455|P4|STARTED|Double-Blind Phase||0
638297|NCT00104416|1569456|P3|STARTED|Double-Blind Phase||0
638298|NCT00104416|1569457|P2|STARTED|Double-Blind Phase||76
638299|NCT00104416|1569458|P1|STARTED|Double-Blind Phase||77
638300|NCT00104299|1569503|P2|NOT COMPLETED|Overall Study||10
638301|NCT00104299|1569504|P1|NOT COMPLETED|Overall Study||9
638302|NCT00104299|1569503|P2|COMPLETED|Overall Study|Number of participants who completed 18 months post-randomization|88
638303|NCT00104299|1569504|P1|COMPLETED|Overall Study|Number of participants who completed 18 months post-randomization|90
638304|NCT00104299|1569503|P2|STARTED|Overall Study||98
638305|NCT00104299|1569504|P1|STARTED|Overall Study||99
638306|NCT00104247|1569526|P2|NOT COMPLETED|Overall Study||1
638307|NCT00104247|1569527|P1|NOT COMPLETED|Overall Study||1
638308|NCT00104247|1569526|P2|COMPLETED|Overall Study|One subject withdrew at Week 4, but is included in the data analysis|46
638309|NCT00104247|1569527|P1|COMPLETED|Overall Study|Subject withdrew prior to dosing|41
638310|NCT00104247|1569526|P2|STARTED|Overall Study||47
638311|NCT00104247|1569527|P1|STARTED|Overall Study||42
638312|NCT00104234|1569535|P2|NOT COMPLETED|Overall Study||1
638313|NCT00104234|1569536|P1|NOT COMPLETED|Overall Study||0
638314|NCT00104234|1569535|P2|COMPLETED|Overall Study||19
638315|NCT00104234|1569536|P1|COMPLETED|Overall Study||19
638316|NCT00104234|1569535|P2|STARTED|Overall Study||20
638317|NCT00104234|1569536|P1|STARTED|Overall Study||19
638318|NCT00104104|1569546|P2|NOT COMPLETED|Overall Study||72
638319|NCT00104104|1569547|P1|NOT COMPLETED|Overall Study||75
638320|NCT00104104|1569546|P2|COMPLETED|Overall Study||17
638321|NCT00104104|1569547|P1|COMPLETED|Overall Study||15
638322|NCT00104104|1569546|P2|Safety Population (Excluding Site 74)|Overall Study|Because of GCP violations at Site 74, post-baseline data for 4 patients in this arm were excluded.|84
638323|NCT00104104|1569547|P1|Safety Population (Excluding Site 74)|Overall Study|Because of GCP violations at Site 74, post-baseline data for 3 patients in this arm were excluded.|85
638324|NCT00104104|1569546|P2|Safety Population (Including Site 74)|Overall Study||88
638325|NCT00104104|1569547|P1|Safety Population (Including Site 74)|Overall Study||88
638326|NCT00104104|1569546|P2|STARTED|Overall Study|1 Participants in the 30-minute infusion group did not receive study drug.|89
638327|NCT00104104|1569547|P1|STARTED|Overall Study|2 Participants in the 15-minute infusion group did not receive study drug.|90
638328|NCT00104052|1569561|P1|NOT COMPLETED|Overall Study||29
638329|NCT00104052|1569561|P1|COMPLETED|Overall Study||78
638330|NCT00104052|1569561|P1|STARTED|Overall Study||107
638331|NCT00103857|1569572|P7|NOT COMPLETED|50-Week Extension Study||0
638332|NCT00103857|1569573|P6|NOT COMPLETED|50-Week Extension Study||20
638333|NCT00103857|1569574|P5|NOT COMPLETED|50-Week Extension Study||21
638334|NCT00103857|1569575|P4|NOT COMPLETED|50-Week Extension Study||36
638335|NCT00103857|1569576|P3|NOT COMPLETED|50-Week Extension Study||26
638336|NCT00103857|1569577|P2|NOT COMPLETED|50-Week Extension Study||27
638337|NCT00103857|1569578|P1|NOT COMPLETED|50-Week Extension Study||38
638338|NCT00103857|1569572|P7|COMPLETED|50-Week Extension Study||0
638339|NCT00103857|1569573|P6|COMPLETED|50-Week Extension Study||78
638340|NCT00103857|1569574|P5|COMPLETED|50-Week Extension Study||101
638341|NCT00103857|1569575|P4|COMPLETED|50-Week Extension Study||98
638342|NCT00103857|1569576|P3|COMPLETED|50-Week Extension Study||95
638343|NCT00103857|1569577|P2|COMPLETED|50-Week Extension Study||80
638344|NCT00103857|1569578|P1|COMPLETED|50-Week Extension Study||65
638345|NCT00103857|1569572|P7|STARTED|50-Week Extension Study||0
638346|NCT00103857|1569573|P6|STARTED|50-Week Extension Study|17 randomized patients completed Period 1 but did not enter Period 2.|98
638347|NCT00103857|1569574|P5|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|122
638348|NCT00103857|1569575|P4|STARTED|50-Week Extension Study|14 randomized patients completed Period 1 but did not enter Period 2.|134
638349|NCT00103857|1569576|P3|STARTED|50-Week Extension Study|14 randomized patients completed Period 1 but did not enter Period 2.|121
638350|NCT00103857|1569577|P2|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|107
638351|NCT00103857|1569578|P1|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|103
638352|NCT00103857|1569572|P7|NOT COMPLETED|54-Week Base Study||38
638353|NCT00103857|1569573|P6|NOT COMPLETED|54-Week Base Study||61
638354|NCT00103857|1569574|P5|NOT COMPLETED|54-Week Base Study||41
638355|NCT00103857|1569575|P4|NOT COMPLETED|54-Week Base Study||42
638356|NCT00103857|1569576|P3|NOT COMPLETED|54-Week Base Study||47
638357|NCT00103857|1569577|P2|NOT COMPLETED|54-Week Base Study||56
638358|NCT00103857|1569578|P1|NOT COMPLETED|54-Week Base Study||57
638359|NCT00103857|1569572|P7|COMPLETED|54-Week Base Study||79
638360|NCT00103857|1569573|P6|COMPLETED|54-Week Base Study||115
638361|NCT00103857|1569574|P5|COMPLETED|54-Week Base Study||141
638362|NCT00103857|1569575|P4|COMPLETED|54-Week Base Study||148
638363|NCT00103857|1569576|P3|COMPLETED|54-Week Base Study||135
638364|NCT00103857|1569577|P2|COMPLETED|54-Week Base Study||126
638365|NCT00103857|1569578|P1|COMPLETED|54-Week Base Study||122
638366|NCT00103857|1569572|P7|STARTED|54-Week Base Study|Results for the OLC are through Week 24. Results for the 6 randomized groups are through Week 54.|117
638367|NCT00103857|1569573|P6|STARTED|54-Week Base Study||176
638368|NCT00103857|1569574|P5|STARTED|54-Week Base Study||182
638369|NCT00103857|1569575|P4|STARTED|54-Week Base Study||190
638370|NCT00103857|1569576|P3|STARTED|54-Week Base Study||182
638371|NCT00103857|1569577|P2|STARTED|54-Week Base Study||182
638372|NCT00103857|1569578|P1|STARTED|54-Week Base Study||179
638373|NCT00103844|1569643|P2|NOT COMPLETED|Overall Study||0
638374|NCT00103844|1569644|P1|NOT COMPLETED|Overall Study||0
638375|NCT00103844|1569643|P2|COMPLETED|Overall Study|Completed=no longer on treatment.Treatment continued until disease progression/intolerable toxicity.|49
638376|NCT00103844|1569644|P1|COMPLETED|Overall Study|Completed=no longer on treatment.Treatment continued until disease progression/intolerable toxicity.|101
638461|NCT00103012|1569835|P1|STARTED|Overall Study||17
638377|NCT00103844|1569643|P2|Crossed Over|Overall Study|40 participants from the imatinib arm crossed over the dasatinib|40
638378|NCT00103844|1569644|P1|Crossed Over|Overall Study|22 participants from the dasatinib arm crossed over to imatinib|22
638379|NCT00103844|1569643|P2|STARTED|Overall Study||49
638380|NCT00103844|1569644|P1|STARTED|Overall Study||101
638381|NCT00103740|1569677|P2|NOT COMPLETED|Period 2 - Extended Observation Period||36
638382|NCT00103740|1569678|P1|NOT COMPLETED|Period 2 - Extended Observation Period||69
638383|NCT00103740|1569677|P2|COMPLETED|Period 2 - Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|27
638384|NCT00103740|1569678|P1|COMPLETED|Period 2 - Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|9
638385|NCT00103740|1569677|P2|STARTED|Period 2 - Extended Observation Period||63
638386|NCT00103740|1569678|P1|STARTED|Period 2 - Extended Observation Period||78
638387|NCT00103740|1569677|P2|NOT COMPLETED|Period 1 - Core||4
638388|NCT00103740|1569678|P1|NOT COMPLETED|Period 1 - Core||7
638389|NCT00103740|1569677|P2|COMPLETED|Period 1 - Core||89
638390|NCT00103740|1569678|P1|COMPLETED|Period 1 - Core||85
638391|NCT00103740|1569677|P2|STARTED|Period 1 - Core||93
638392|NCT00103740|1569678|P1|STARTED|Period 1 - Core||92
638393|NCT00103662|1569706|P2|NOT COMPLETED|Overall Study||33
638394|NCT00103662|1569707|P1|NOT COMPLETED|Overall Study||19
638395|NCT00103662|1569706|P2|COMPLETED|Overall Study|1 participant was wrongly terminated due to 'other'; the participant stayed on study until death.|121
638396|NCT00103662|1569707|P1|COMPLETED|Overall Study|1 participant was wrongly terminated due to 'other'; the participant stayed on study until death.|129
638397|NCT00103662|1569706|P2|STARTED|Overall Study||154
638398|NCT00103662|1569707|P1|STARTED|Overall Study||148
638399|NCT00103610|1569733|P2|NOT COMPLETED|Overall Study||80
638400|NCT00103610|1569734|P1|NOT COMPLETED|Overall Study||38
638401|NCT00103610|1569733|P2|COMPLETED|Overall Study||68
638402|NCT00103610|1569734|P1|COMPLETED|Overall Study||112
638403|NCT00103610|1569733|P2|STARTED|Overall Study||148
638404|NCT00103610|1569734|P1|STARTED|Overall Study||150
638405|NCT00103506|1569758|P2|NOT COMPLETED|Overall Study||324
638406|NCT00103506|1569759|P1|NOT COMPLETED|Overall Study||322
638407|NCT00103506|1569758|P2|COMPLETED|Overall Study||0
638408|NCT00103506|1569759|P1|COMPLETED|Overall Study||0
638409|NCT00103506|1569758|P2|STARTED|Overall Study||324
638410|NCT00103506|1569759|P1|STARTED|Overall Study||322
638411|NCT00103311|1569771|P2|NOT COMPLETED|Overall Study||1
638412|NCT00103311|1569772|P1|NOT COMPLETED|Overall Study||4
638413|NCT00103311|1569771|P2|COMPLETED|Overall Study||30
638414|NCT00103311|1569772|P1|COMPLETED|Overall Study||29
638415|NCT00103311|1569771|P2|STARTED|Overall Study||31
638416|NCT00103311|1569772|P1|STARTED|Overall Study||33
638417|NCT00103259|1569784|P2|NOT COMPLETED|Overall Study||12
638418|NCT00103259|1569785|P1|NOT COMPLETED|Overall Study||12
638419|NCT00103259|1569784|P2|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.This number is for stage I.|32
638420|NCT00103259|1569785|P1|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.|15
638421|NCT00103259|1569784|P2|Eligible Patients Who Cross Over|Overall Study||10
638422|NCT00103259|1569785|P1|Eligible Patients Who Cross Over|Overall Study||0
638423|NCT00103259|1569784|P2|Cross Over to the Other Arm|Overall Study|11 patients who progressed on bortezomib crossed over to Arm I. 10 of them were eligible|11
638424|NCT00103259|1569785|P1|Cross Over to the Other Arm|Overall Study||0
638425|NCT00103259|1569784|P2|Eligible and Treated|Overall Study||38
638426|NCT00103259|1569785|P1|Eligible and Treated|Overall Study||23
638427|NCT00103259|1569784|P2|Treated|Overall Study||41
638428|NCT00103259|1569785|P1|Treated|Overall Study||23
638429|NCT00103259|1569784|P2|Eligible|Overall Study||41
638430|NCT00103259|1569785|P1|Eligible|Overall Study||27
638431|NCT00103259|1569784|P2|STARTED|Overall Study||44
638432|NCT00103259|1569785|P1|STARTED|Overall Study||27
638433|NCT00103207|1569797|P1|NOT COMPLETED|Overall Study||38
638434|NCT00103207|1569797|P1|COMPLETED|Overall Study||34
638435|NCT00103207|1569797|P1|Eligible Patients w/ Smoking Status Data|Overall Study||37
638436|NCT00103207|1569797|P1|Eligible Patients w/ Confirmed Diagnosis|Overall Study||41
638437|NCT00103207|1569797|P1|STARTED|Overall Study||72
638438|NCT00103194|1569807|P1|NOT COMPLETED|Overall Study||31
638439|NCT00103194|1569807|P1|COMPLETED|Overall Study||18
638440|NCT00103194|1569807|P1|Eligible and Treated|Overall Study||35
638441|NCT00103194|1569807|P1|Eligible|Overall Study||35
638442|NCT00103194|1569807|P1|Treated|Overall Study||49
638443|NCT00103194|1569807|P1|STARTED|Overall Study||49
638444|NCT00103142|1569816|P2|NOT COMPLETED|Overall Study||1
638445|NCT00103142|1569817|P1|NOT COMPLETED|Overall Study||3
638446|NCT00103142|1569816|P2|COMPLETED|Overall Study||36
638447|NCT00103142|1569817|P1|COMPLETED|Overall Study||33
638448|NCT00103142|1569816|P2|STARTED|Overall Study||37
638449|NCT00103142|1569817|P1|STARTED|Overall Study||36
638450|NCT00103116|1569825|P1|NOT COMPLETED|Overall Study||0
638451|NCT00103116|1569825|P1|COMPLETED|Overall Study||32
638452|NCT00103116|1569825|P1|STARTED|Overall Study||32
638453|NCT00103012|1569833|P3|NOT COMPLETED|Overall Study||4
638454|NCT00103012|1569834|P2|NOT COMPLETED|Overall Study||1
638455|NCT00103012|1569835|P1|NOT COMPLETED|Overall Study||3
638456|NCT00103012|1569833|P3|COMPLETED|Overall Study||12
638457|NCT00103012|1569834|P2|COMPLETED|Overall Study||13
638458|NCT00103012|1569835|P1|COMPLETED|Overall Study||14
638459|NCT00103012|1569833|P3|STARTED|Overall Study||16
638460|NCT00103012|1569834|P2|STARTED|Overall Study||14
638462|NCT00102804|1569845|P2|NOT COMPLETED|Overall Study||222
638463|NCT00102804|1569846|P1|NOT COMPLETED|Overall Study||441
638464|NCT00102804|1569845|P2|COMPLETED|Overall Study||0
638465|NCT00102804|1569846|P1|COMPLETED|Overall Study||0
638466|NCT00102804|1569845|P2|Received at Least 1 Dose of Study Drug|Overall Study|Four participants randomized to placebo received pemetrexed.|222
638467|NCT00102804|1569846|P1|Received at Least 1 Dose of Study Drug|Overall Study||434
638468|NCT00102804|1569845|P2|STARTED|Overall Study||222
638469|NCT00102804|1569846|P1|STARTED|Overall Study||441
638470|NCT00102687|1569867|P5|NOT COMPLETED|Maintenance Period||13
638471|NCT00102687|1569868|P4|NOT COMPLETED|Maintenance Period||10
638472|NCT00102687|1569869|P3|NOT COMPLETED|Maintenance Period||6
638473|NCT00102687|1569870|P2|NOT COMPLETED|Maintenance Period||4
638474|NCT00102687|1569871|P1|NOT COMPLETED|Maintenance Period||7
638475|NCT00102687|1569867|P5|COMPLETED|Maintenance Period||8
638476|NCT00102687|1569868|P4|COMPLETED|Maintenance Period||12
638477|NCT00102687|1569869|P3|COMPLETED|Maintenance Period||2
638478|NCT00102687|1569870|P2|COMPLETED|Maintenance Period||2
638479|NCT00102687|1569871|P1|COMPLETED|Maintenance Period||6
638480|NCT00102687|1569867|P5|STARTED|Maintenance Period|Second randomization to one of two maintenance regimens|21
638481|NCT00102687|1569868|P4|STARTED|Maintenance Period|Second randomization to one of two maintenance regimens|22
638482|NCT00102687|1569869|P3|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|8
638483|NCT00102687|1569870|P2|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|6
638484|NCT00102687|1569871|P1|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|13
638485|NCT00102687|1569867|P5|NOT COMPLETED|Initial Period||0
638486|NCT00102687|1569868|P4|NOT COMPLETED|Initial Period||0
638487|NCT00102687|1569869|P3|NOT COMPLETED|Initial Period||26
638488|NCT00102687|1569870|P2|NOT COMPLETED|Initial Period||28
638489|NCT00102687|1569871|P1|NOT COMPLETED|Initial Period||18
638490|NCT00102687|1569867|P5|COMPLETED|Initial Period||0
638491|NCT00102687|1569868|P4|COMPLETED|Initial Period||0
638492|NCT00102687|1569869|P3|COMPLETED|Initial Period||25
638493|NCT00102687|1569870|P2|COMPLETED|Initial Period||22
638494|NCT00102687|1569871|P1|COMPLETED|Initial Period||32
638495|NCT00102687|1569867|P5|STARTED|Initial Period||0
638496|NCT00102687|1569868|P4|STARTED|Initial Period||0
638497|NCT00102687|1569869|P3|STARTED|Initial Period|3 randomized participants did not receive treatment.|51
638498|NCT00102687|1569870|P2|STARTED|Initial Period||50
638499|NCT00102687|1569871|P1|STARTED|Initial Period||50
638500|NCT00102596|1569935|P2|NOT COMPLETED|Part C||0
638501|NCT00102596|1569936|P1|NOT COMPLETED|Part C||0
638502|NCT00102596|1569935|P2|COMPLETED|Part C||2
638503|NCT00102596|1569936|P1|COMPLETED|Part C||0
638504|NCT00102596|1569935|P2|STARTED|Part C|Only 2 patients participated in Part C|2
638505|NCT00102596|1569936|P1|STARTED|Part C||0
638506|NCT00102596|1569935|P2|NOT COMPLETED|Part B||0
638507|NCT00102596|1569936|P1|NOT COMPLETED|Part B||0
638508|NCT00102596|1569935|P2|COMPLETED|Part B||10
638509|NCT00102596|1569936|P1|COMPLETED|Part B||0
638510|NCT00102596|1569935|P2|STARTED|Part B||10
638511|NCT00102596|1569936|P1|STARTED|Part B|Participants from Part A did not continue to Part B|0
638512|NCT00102596|1569935|P2|NOT COMPLETED|Part A||0
638513|NCT00102596|1569936|P1|NOT COMPLETED|Part A||7
638514|NCT00102596|1569935|P2|COMPLETED|Part A||0
638515|NCT00102596|1569936|P1|COMPLETED|Part A||4
638516|NCT00102596|1569935|P2|Participants Assigned Treatment|Part A||0
638517|NCT00102596|1569936|P1|Participants Assigned Treatment|Part A||5
638518|NCT00102596|1569935|P2|STARTED|Part A||0
638519|NCT00102596|1569936|P1|STARTED|Part A||11
638520|NCT00102531|1569947|P2|NOT COMPLETED|Overall Study||11
638521|NCT00102531|1569948|P1|NOT COMPLETED|Overall Study||5
638522|NCT00102531|1569947|P2|COMPLETED|Overall Study||1
638523|NCT00102531|1569948|P1|COMPLETED|Overall Study||2
638524|NCT00102531|1569947|P2|STARTED|Overall Study||12
638525|NCT00102531|1569948|P1|STARTED|Overall Study||7
638526|NCT00102518|1569954|P1|NOT COMPLETED|Overall Study||87
638527|NCT00102518|1569954|P1|COMPLETED|Overall Study||238
638528|NCT00102518|1569954|P1|STARTED|Overall Study||325
638529|NCT00102440|1569963|P3|NOT COMPLETED|Overall Study||66
638530|NCT00102440|1569964|P2|NOT COMPLETED|Overall Study||98
638531|NCT00102440|1569965|P1|NOT COMPLETED|Overall Study||88
638532|NCT00102440|1569963|P3|COMPLETED|Overall Study||187
638533|NCT00102440|1569964|P2|COMPLETED|Overall Study||153
638534|NCT00102440|1569965|P1|COMPLETED|Overall Study||168
638535|NCT00102440|1569963|P3|STARTED|Overall Study||253
638536|NCT00102440|1569964|P2|STARTED|Overall Study||251
638537|NCT00102440|1569965|P1|STARTED|Overall Study||256
638538|NCT00102063|1570015|P3|NOT COMPLETED|Overall Study||10
638539|NCT00102063|1570016|P2|NOT COMPLETED|Overall Study||18
638540|NCT00102063|1570017|P1|NOT COMPLETED|Overall Study||16
638541|NCT00102063|1570015|P3|COMPLETED|Overall Study||90
638542|NCT00102063|1570016|P2|COMPLETED|Overall Study||84
638543|NCT00102063|1570017|P1|COMPLETED|Overall Study||84
638544|NCT00102063|1570015|P3|STARTED|Overall Study||100
638545|NCT00102063|1570016|P2|STARTED|Overall Study||102
638546|NCT00102063|1570017|P1|STARTED|Overall Study||100
638547|NCT00101933|1570048|P2|NOT COMPLETED|Overall Study||0
638548|NCT00101933|1570049|P1|NOT COMPLETED|Overall Study||0
638549|NCT00101933|1570048|P2|COMPLETED|Overall Study||55
638550|NCT00101933|1570049|P1|COMPLETED|Overall Study||54
638551|NCT00101933|1570048|P2|STARTED|Overall Study||55
638552|NCT00101933|1570049|P1|STARTED|Overall Study||54
638553|NCT00101907|1570075|P6|NOT COMPLETED|Overall Study||0
638554|NCT00101907|1570076|P5|NOT COMPLETED|Overall Study||5
638555|NCT00101907|1570077|P4|NOT COMPLETED|Overall Study||1
638556|NCT00101907|1570078|P3|NOT COMPLETED|Overall Study||1
638557|NCT00101907|1570079|P2|NOT COMPLETED|Overall Study||1
638558|NCT00101907|1570080|P1|NOT COMPLETED|Overall Study||2
638559|NCT00101907|1570075|P6|COMPLETED|Overall Study||2
638560|NCT00101907|1570076|P5|COMPLETED|Overall Study||6
638561|NCT00101907|1570077|P4|COMPLETED|Overall Study||5
638562|NCT00101907|1570078|P3|COMPLETED|Overall Study||5
638563|NCT00101907|1570079|P2|COMPLETED|Overall Study||7
638564|NCT00101907|1570080|P1|COMPLETED|Overall Study||6
638565|NCT00101907|1570075|P6|STARTED|Overall Study||2
638566|NCT00101907|1570076|P5|STARTED|Overall Study||11
638567|NCT00101907|1570077|P4|STARTED|Overall Study||6
638568|NCT00101907|1570078|P3|STARTED|Overall Study||6
638569|NCT00101907|1570079|P2|STARTED|Overall Study||8
638570|NCT00101907|1570080|P1|STARTED|Overall Study||8
638571|NCT00101868|1570122|P2|NOT COMPLETED|Overall Study||32
638572|NCT00101868|1570123|P1|NOT COMPLETED|Overall Study||29
638573|NCT00101868|1570122|P2|COMPLETED|Overall Study|zero hospital physician with zero patients lost to follow up|283
638574|NCT00101868|1570123|P1|COMPLETED|Overall Study|1 hospital physician with zero patients lost to follow up|287
638575|NCT00101868|1570122|P2|STARTED|Overall Study|35 hospital physicians allocated to usual care discharge|315
638576|NCT00101868|1570123|P1|STARTED|Overall Study|35 hospital physicians allocated to discharge software|316
638577|NCT00101816|1570135|P2|NOT COMPLETED|Overall Study||0
638578|NCT00101816|1570136|P1|NOT COMPLETED|Overall Study||0
638579|NCT00101816|1570135|P2|COMPLETED|Overall Study||99
638580|NCT00101816|1570136|P1|COMPLETED|Overall Study||10
638581|NCT00101816|1570135|P2|STARTED|Overall Study||99
638582|NCT00101816|1570136|P1|STARTED|Overall Study||10
638583|NCT00101686|1570193|P10|NOT COMPLETED|Overall Study||30
638584|NCT00101686|1570194|P9|NOT COMPLETED|Overall Study||30
638585|NCT00101686|1570195|P8|NOT COMPLETED|Overall Study||30
638586|NCT00101686|1570196|P7|NOT COMPLETED|Overall Study||27
638587|NCT00101686|1570197|P6|NOT COMPLETED|Overall Study||72
638588|NCT00101686|1570198|P5|NOT COMPLETED|Overall Study||73
638589|NCT00101686|1570199|P4|NOT COMPLETED|Overall Study||72
638590|NCT00101686|1570200|P3|NOT COMPLETED|Overall Study||69
638591|NCT00101686|1570201|P2|NOT COMPLETED|Overall Study||73
638592|NCT00101686|1570202|P1|NOT COMPLETED|Overall Study||71
638593|NCT00101686|1570193|P10|COMPLETED|Overall Study|Patients treated until disease progression.|0
638594|NCT00101686|1570194|P9|COMPLETED|Overall Study|Patients treated until disease progression.|0
638595|NCT00101686|1570195|P8|COMPLETED|Overall Study|Patients treated until disease progression.|0
638596|NCT00101686|1570196|P7|COMPLETED|Overall Study|Patients treated until disease progression.|0
638597|NCT00101686|1570197|P6|COMPLETED|Overall Study|Patients treated until disease progression.|0
638598|NCT00101686|1570198|P5|COMPLETED|Overall Study|Patients treated until disease progression.|0
638599|NCT00101686|1570199|P4|COMPLETED|Overall Study|Patients treated until disease progression.|0
638600|NCT00101686|1570200|P3|COMPLETED|Overall Study|Patients treated until disease progression.|0
638601|NCT00101686|1570201|P2|COMPLETED|Overall Study|Patients treated until disease progression.|0
638602|NCT00101686|1570202|P1|COMPLETED|Overall Study|Patients treated until disease progression.|0
638603|NCT00101686|1570193|P10|Received Treatment|Overall Study||29
638604|NCT00101686|1570194|P9|Received Treatment|Overall Study||30
638605|NCT00101686|1570195|P8|Received Treatment|Overall Study||29
638606|NCT00101686|1570196|P7|Received Treatment|Overall Study||27
638607|NCT00101686|1570197|P6|Received Treatment|Overall Study||70
638608|NCT00101686|1570198|P5|Received Treatment|Overall Study||71
638609|NCT00101686|1570199|P4|Received Treatment|Overall Study||70
638610|NCT00101686|1570200|P3|Received Treatment|Overall Study||67
638611|NCT00101686|1570201|P2|Received Treatment|Overall Study||67
638612|NCT00101686|1570202|P1|Received Treatment|Overall Study||70
638613|NCT00101686|1570193|P10|STARTED|Overall Study||30
638614|NCT00101686|1570194|P9|STARTED|Overall Study||30
638615|NCT00101686|1570195|P8|STARTED|Overall Study||30
638616|NCT00101686|1570196|P7|STARTED|Overall Study||27
638617|NCT00101686|1570197|P6|STARTED|Overall Study||72
638618|NCT00101686|1570198|P5|STARTED|Overall Study||73
638619|NCT00101686|1570199|P4|STARTED|Overall Study||72
638620|NCT00101686|1570200|P3|STARTED|Overall Study||69
638621|NCT00101686|1570201|P2|STARTED|Overall Study||73
638622|NCT00101686|1570202|P1|STARTED|Overall Study||71
638623|NCT00101660|1570249|P2|NOT COMPLETED|Overall Study||0
638624|NCT00101660|1570250|P1|NOT COMPLETED|Overall Study||0
638625|NCT00101660|1570249|P2|COMPLETED|Overall Study||288
638626|NCT00101660|1570250|P1|COMPLETED|Overall Study||99
638627|NCT00101660|1570249|P2|STARTED|Overall Study||288
638628|NCT00101660|1570250|P1|STARTED|Overall Study||99
638629|NCT00101647|1570268|P2|NOT COMPLETED|Overall Study||0
638630|NCT00101647|1570269|P1|NOT COMPLETED|Overall Study||0
638631|NCT00101647|1570268|P2|COMPLETED|Overall Study||161
638632|NCT00101647|1570269|P1|COMPLETED|Overall Study||13
638633|NCT00101647|1570268|P2|STARTED|Overall Study|Randomized|161
638634|NCT00101647|1570269|P1|STARTED|Overall Study|Randomized|13
638635|NCT00101582|1570319|P2|NOT COMPLETED|Overall Study||15
638636|NCT00101582|1570320|P1|NOT COMPLETED|Overall Study||11
638637|NCT00101582|1570319|P2|COMPLETED|Overall Study|Participants who completed the acute oral mucositis evaluation phase|79
638638|NCT00101582|1570320|P1|COMPLETED|Overall Study|Participants who completed the acute oral mucositis evaluation phase|83
638639|NCT00101582|1570319|P2|Received Study Drug|Overall Study||94
638640|NCT00101582|1570320|P1|Received Study Drug|Overall Study||91
638641|NCT00101582|1570319|P2|STARTED|Overall Study||94
638642|NCT00101582|1570320|P1|STARTED|Overall Study||94
638643|NCT00101452|1570343|P3|NOT COMPLETED|Overall Study||43
638644|NCT00101452|1570344|P2|NOT COMPLETED|Overall Study||43
638645|NCT00101452|1570345|P1|NOT COMPLETED|Overall Study||44
638646|NCT00101452|1570343|P3|COMPLETED|Overall Study||22
638647|NCT00101452|1570344|P2|COMPLETED|Overall Study||26
638648|NCT00101452|1570345|P1|COMPLETED|Overall Study||21
638649|NCT00101452|1570343|P3|STARTED|Overall Study||65
638650|NCT00101452|1570344|P2|STARTED|Overall Study||69
638651|NCT00101452|1570345|P1|STARTED|Overall Study||65
638652|NCT00101439|1570359|P2|NOT COMPLETED|Period 2||2
638653|NCT00101439|1570360|P1|NOT COMPLETED|Period 2||0
638654|NCT00101439|1570359|P2|COMPLETED|Period 2||28
638655|NCT00101439|1570360|P1|COMPLETED|Period 2||28
638656|NCT00101439|1570359|P2|STARTED|Period 2||30
638657|NCT00101439|1570360|P1|STARTED|Period 2||28
638658|NCT00101439|1570359|P2|NOT COMPLETED|Period 1||0
638659|NCT00101439|1570360|P1|NOT COMPLETED|Period 1||0
638660|NCT00101439|1570359|P2|COMPLETED|Period 1||30
638661|NCT00101439|1570360|P1|COMPLETED|Period 1||28
638662|NCT00101439|1570359|P2|STARTED|Period 1||30
638663|NCT00101439|1570360|P1|STARTED|Period 1||28
638664|NCT00101413|1570368|P1|NOT COMPLETED|Overall Study||0
638665|NCT00101413|1570368|P1|COMPLETED|Overall Study|Safety data collected for 4 subjects after 30 Jun 2005 until 11 Apr 2008.|52
638666|NCT00101413|1570368|P1|STARTED|Overall Study||52
638667|NCT00101400|1570376|P1|NOT COMPLETED|Survival Follow-Up||7
638668|NCT00101400|1570376|P1|COMPLETED|Survival Follow-Up|44 subjects reached endpoint (death); 7 subjects were still alive|44
638669|NCT00101400|1570376|P1|STARTED|Survival Follow-Up|3 subjects died during previous period (completion as defined in protocol)|51
638670|NCT00101400|1570376|P1|NOT COMPLETED|Treatment||0
638671|NCT00101400|1570376|P1|COMPLETED|Treatment|Reasons for treatment termination: 4 Adverse Events, 3 Deaths, 46 Progression, 1 Withdrawal.|54
638672|NCT00101400|1570376|P1|STARTED|Treatment|Treated until disease progression, unacceptable sorafenib-related toxicity or withdrawal of consent.|54
638673|NCT00101361|1570387|P2|NOT COMPLETED|Overall Study||0
638674|NCT00101361|1570388|P1|NOT COMPLETED|Overall Study||0
638675|NCT00101361|1570387|P2|COMPLETED|Overall Study||104
638676|NCT00101361|1570388|P1|COMPLETED|Overall Study||108
638677|NCT00101361|1570387|P2|STARTED|Overall Study||104
638678|NCT00101361|1570388|P1|STARTED|Overall Study||108
638679|NCT00101283|1570396|P2|NOT COMPLETED|Overall Study||3
638680|NCT00101283|1570397|P1|NOT COMPLETED|Overall Study||0
638681|NCT00101283|1570396|P2|COMPLETED|Overall Study||13
638682|NCT00101283|1570397|P1|COMPLETED|Overall Study||16
638683|NCT00101283|1570396|P2|Began Treatment|Overall Study||13
638684|NCT00101283|1570397|P1|Began Treatment|Overall Study||16
638685|NCT00101283|1570396|P2|STARTED|Overall Study||16
638686|NCT00101283|1570397|P1|STARTED|Overall Study||16
638687|NCT00101192|1570407|P1|NOT COMPLETED|Overall Study||7
638688|NCT00101192|1570407|P1|COMPLETED|Overall Study||69
638689|NCT00101192|1570407|P1|STARTED|Overall Study||76
638690|NCT00101166|1570411|P1|NOT COMPLETED|Overall Study||10
638691|NCT00101166|1570411|P1|COMPLETED|Overall Study||18
638692|NCT00101166|1570411|P1|STARTED|Overall Study||28
638693|NCT00101101|1570419|P1|NOT COMPLETED|Overall Study||20
638694|NCT00101101|1570419|P1|COMPLETED|Overall Study|Participants who received at least one vaccine injection.|23
638695|NCT00101101|1570419|P1|STARTED|Overall Study||43
638696|NCT00101036|1570427|P2|NOT COMPLETED|Overall Study||0
638697|NCT00101036|1570428|P1|NOT COMPLETED|Overall Study||0
638698|NCT00101036|1570427|P2|COMPLETED|Overall Study||40
638699|NCT00101036|1570428|P1|COMPLETED|Overall Study||17
638700|NCT00101036|1570427|P2|STARTED|Overall Study||40
638701|NCT00101036|1570428|P1|STARTED|Overall Study||17
638702|NCT00100932|1570442|P2|NOT COMPLETED|Overall Study||27
638703|NCT00100932|1570443|P1|NOT COMPLETED|Overall Study||73
638704|NCT00100932|1570442|P2|COMPLETED|Overall Study||1
638705|NCT00100932|1570443|P1|COMPLETED|Overall Study||5
638706|NCT00100932|1570442|P2|STARTED|Overall Study|Represents all enrolled pts; counts in demographic section represents ITT/Safety Population.|28
638707|NCT00100932|1570443|P1|STARTED|Overall Study|Represents all enrolled pts; counts in demographic section represents ITT/Safety Population.|78
638708|NCT00100841|1570453|P1|NOT COMPLETED|Overall Study||0
638709|NCT00100841|1570453|P1|COMPLETED|Overall Study||66
638710|NCT00100841|1570453|P1|STARTED|Overall Study||66
638711|NCT00100815|1570458|P1|NOT COMPLETED|Overall Study||49
638712|NCT00100815|1570458|P1|COMPLETED|Overall Study||1
638713|NCT00100815|1570458|P1|STARTED|Overall Study||50
638714|NCT00100802|1570466|P1|NOT COMPLETED|Overall Study||80
638715|NCT00100802|1570466|P1|COMPLETED|Overall Study||38
638716|NCT00100802|1570466|P1|STARTED|Overall Study||118
638717|NCT00100789|1570471|P1|NOT COMPLETED|Overall Study||64
638718|NCT00100789|1570471|P1|COMPLETED|Overall Study||3
638719|NCT00100789|1570471|P1|Eligible and Began Protocol Therapy|Overall Study||63
638720|NCT00100789|1570471|P1|Eligible|Overall Study||64
638721|NCT00100789|1570471|P1|STARTED|Overall Study||67
638722|NCT00100698|1570480|P2|NOT COMPLETED|Overall Study||2
638723|NCT00100698|1570481|P1|NOT COMPLETED|Overall Study||6
638724|NCT00100698|1570480|P2|COMPLETED|Overall Study||27
638725|NCT00100698|1570481|P1|COMPLETED|Overall Study||21
638726|NCT00100698|1570480|P2|STARTED|Overall Study||29
638727|NCT00100698|1570481|P1|STARTED|Overall Study||27
638728|NCT00100659|1570523|P2|NOT COMPLETED|Overall Study||2
638729|NCT00100659|1570524|P1|NOT COMPLETED|Overall Study||3
638730|NCT00100659|1570523|P2|COMPLETED|Overall Study||57
638731|NCT00100659|1570524|P1|COMPLETED|Overall Study||52
638732|NCT00100659|1570523|P2|STARTED|Overall Study||59
638733|NCT00100659|1570524|P1|STARTED|Overall Study||55
638734|NCT00100230|1570532|P2|NOT COMPLETED|Overall Study||15
638735|NCT00100230|1570533|P1|NOT COMPLETED|Overall Study||12
638736|NCT00100230|1570532|P2|COMPLETED|Overall Study||22
638737|NCT00100230|1570533|P1|COMPLETED|Overall Study||29
638738|NCT00100230|1570532|P2|STARTED|Overall Study||37
638739|NCT00100230|1570533|P1|STARTED|Overall Study||41
638740|NCT00100178|1570546|P3|NOT COMPLETED|Overall Study||10
638741|NCT00100178|1570547|P2|NOT COMPLETED|Overall Study||10
638742|NCT00100178|1570548|P1|NOT COMPLETED|Overall Study||9
638743|NCT00100178|1570546|P3|COMPLETED|Overall Study||32
638744|NCT00100178|1570547|P2|COMPLETED|Overall Study||21
638745|NCT00100178|1570548|P1|COMPLETED|Overall Study||32
638746|NCT00100178|1570546|P3|STARTED|Overall Study||42
638747|NCT00100178|1570547|P2|STARTED|Overall Study|12 subjects randomized to the MMF alone group were excluded from analysis due to randomization error|31
638748|NCT00100178|1570548|P1|STARTED|Overall Study||41
638749|NCT00100048|1570561|P6|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13
638750|NCT00100048|1570562|P5|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||0
638751|NCT00100048|1570563|P4|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||10
638752|NCT00100048|1570564|P3|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13
638753|NCT00100048|1570565|P2|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||9
638754|NCT00100048|1570566|P1|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||14
638755|NCT00100048|1570561|P6|COMPLETED|Cohort I & II-Combination Therapy Phase||26
638756|NCT00100048|1570562|P5|COMPLETED|Cohort I & II-Combination Therapy Phase||0
638757|NCT00100048|1570563|P4|COMPLETED|Cohort I & II-Combination Therapy Phase||30
638758|NCT00100048|1570564|P3|COMPLETED|Cohort I & II-Combination Therapy Phase||28
638759|NCT00100048|1570565|P2|COMPLETED|Cohort I & II-Combination Therapy Phase||31
638760|NCT00100048|1570566|P1|COMPLETED|Cohort I & II-Combination Therapy Phase||27
638761|NCT00100048|1570561|P6|Never Treated|Cohort I & II-Combination Therapy Phase|Randomised in Cohort II did not start Period|1
638762|NCT00100048|1570562|P5|Never Treated|Cohort I & II-Combination Therapy Phase||0
638763|NCT00100048|1570563|P4|Never Treated|Cohort I & II-Combination Therapy Phase||0
638764|NCT00100048|1570564|P3|Never Treated|Cohort I & II-Combination Therapy Phase||0
638765|NCT00100048|1570565|P2|Never Treated|Cohort I & II-Combination Therapy Phase||0
638766|NCT00100048|1570566|P1|Never Treated|Cohort I & II-Combination Therapy Phase|Randomised in Cohort II did not start Period|2
638767|NCT00100048|1570561|P6|Treated|Cohort I & II-Combination Therapy Phase||38
638768|NCT00100048|1570562|P5|Treated|Cohort I & II-Combination Therapy Phase||0
638769|NCT00100048|1570563|P4|Treated|Cohort I & II-Combination Therapy Phase||40
638770|NCT00100048|1570564|P3|Treated|Cohort I & II-Combination Therapy Phase||41
638771|NCT00100048|1570565|P2|Treated|Cohort I & II-Combination Therapy Phase||40
638772|NCT00100048|1570566|P1|Treated|Cohort I & II-Combination Therapy Phase||39
638773|NCT00100048|1570561|P6|STARTED|Cohort I & II-Combination Therapy Phase|4 subjects from the Monotherapy Phase (Placebo)and 35 new subjects|39
638774|NCT00100048|1570562|P5|STARTED|Cohort I & II-Combination Therapy Phase|participants only assigned Placebo in Cohort I-Monotherapy Phase.|0
638775|NCT00100048|1570563|P4|STARTED|Cohort I & II-Combination Therapy Phase|8 subjects from the Monotherapy Phase and 32 new subjects|40
638776|NCT00100048|1570564|P3|STARTED|Cohort I & II-Combination Therapy Phase|6 subjects from the Monotherapy Phase and 35 new subjects|41
638777|NCT00100048|1570565|P2|STARTED|Cohort I & II-Combination Therapy Phase|7 subjects from the Monotherapy Phase and 33 new subjects|40
638778|NCT00100048|1570566|P1|STARTED|Cohort I & II-Combination Therapy Phase|7 subjects from the Monotherapy Phase and 34 new subjects|41
638779|NCT00100048|1570561|P6|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
638780|NCT00100048|1570562|P5|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
638781|NCT00100048|1570563|P4|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
638782|NCT00100048|1570564|P3|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
638783|NCT00100048|1570565|P2|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
638784|NCT00100048|1570566|P1|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
638785|NCT00100048|1570561|P6|COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
638786|NCT00100048|1570562|P5|COMPLETED|Cohort I-Monotherapy Phase 10 Days|4 Subjects Continued to Cohort II, as part of the Efavirenz 600 mg q.d. arm|7
638787|NCT00100048|1570563|P4|COMPLETED|Cohort I-Monotherapy Phase 10 Days|6 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|8
638788|NCT00100048|1570564|P3|COMPLETED|Cohort I-Monotherapy Phase 10 Days|6 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|6
638789|NCT00100048|1570565|P2|COMPLETED|Cohort I-Monotherapy Phase 10 Days|7 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|7
638790|NCT00100048|1570566|P1|COMPLETED|Cohort I-Monotherapy Phase 10 Days|7 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|7
638791|NCT00100048|1570561|P6|Treated|Cohort I-Monotherapy Phase 10 Days||0
638792|NCT00100048|1570562|P5|Treated|Cohort I-Monotherapy Phase 10 Days||7
638793|NCT00100048|1570563|P4|Treated|Cohort I-Monotherapy Phase 10 Days||8
638794|NCT00100048|1570564|P3|Treated|Cohort I-Monotherapy Phase 10 Days||6
638795|NCT00100048|1570565|P2|Treated|Cohort I-Monotherapy Phase 10 Days||7
638796|NCT00100048|1570566|P1|Treated|Cohort I-Monotherapy Phase 10 Days||7
638797|NCT00100048|1570561|P6|STARTED|Cohort I-Monotherapy Phase 10 Days|participants only assigned Efavirenz 600 mg q.h.s in Cohort II Combined-Combination Therapy Phase|0
638798|NCT00100048|1570562|P5|STARTED|Cohort I-Monotherapy Phase 10 Days||7
638799|NCT00100048|1570563|P4|STARTED|Cohort I-Monotherapy Phase 10 Days||8
638800|NCT00100048|1570564|P3|STARTED|Cohort I-Monotherapy Phase 10 Days||6
638801|NCT00100048|1570565|P2|STARTED|Cohort I-Monotherapy Phase 10 Days||7
638802|NCT00100048|1570566|P1|STARTED|Cohort I-Monotherapy Phase 10 Days||7
638803|NCT00099983|1570675|P2|NOT COMPLETED|Overall Study||25
638804|NCT00099983|1570676|P1|NOT COMPLETED|Overall Study||24
638805|NCT00099983|1570675|P2|COMPLETED|Overall Study||124
638806|NCT00099983|1570676|P1|COMPLETED|Overall Study||123
638807|NCT00099983|1570675|P2|STARTED|Overall Study||149
638808|NCT00099983|1570676|P1|STARTED|Overall Study||147
638809|NCT00099632|1570688|P6|NOT COMPLETED|Overall Study||2
638810|NCT00099632|1570689|P5|NOT COMPLETED|Overall Study||1
638811|NCT00099632|1570690|P4|NOT COMPLETED|Overall Study||1
638812|NCT00099632|1570691|P3|NOT COMPLETED|Overall Study||3
638813|NCT00099632|1570692|P2|NOT COMPLETED|Overall Study||1
638814|NCT00099632|1570693|P1|NOT COMPLETED|Overall Study||1
638815|NCT00099632|1570688|P6|COMPLETED|Overall Study||66
638816|NCT00099632|1570689|P5|COMPLETED|Overall Study||70
638817|NCT00099632|1570690|P4|COMPLETED|Overall Study||66
638818|NCT00099632|1570691|P3|COMPLETED|Overall Study||72
638819|NCT00099632|1570692|P2|COMPLETED|Overall Study||67
638820|NCT00099632|1570693|P1|COMPLETED|Overall Study||72
638821|NCT00099632|1570688|P6|STARTED|Overall Study||68
638822|NCT00099632|1570689|P5|STARTED|Overall Study||71
638823|NCT00099632|1570690|P4|STARTED|Overall Study||67
638824|NCT00099632|1570691|P3|STARTED|Overall Study||75
638825|NCT00099632|1570692|P2|STARTED|Overall Study||68
638826|NCT00099632|1570693|P1|STARTED|Overall Study||73
638827|NCT00099437|1570733|P2|NOT COMPLETED|Overall Study||349
638828|NCT00099437|1570734|P1|NOT COMPLETED|Overall Study||366
638829|NCT00099437|1570733|P2|COMPLETED|Overall Study|ongoing study treatment at survival follow-up data cut-off|13
638830|NCT00099437|1570734|P1|COMPLETED|Overall Study|ongoing study treatment at survival follow-up data cut-off|8
638831|NCT00099437|1570733|P2|STARTED|Overall Study|randomised patients|362
638832|NCT00099437|1570734|P1|STARTED|Overall Study|randomised patients|374
638833|NCT00099359|1570757|P3|NOT COMPLETED|Overall Study||68
638834|NCT00099359|1570758|P2|NOT COMPLETED|Overall Study||65
638835|NCT00099359|1570759|P1|NOT COMPLETED|Overall Study||54
638836|NCT00099359|1570757|P3|COMPLETED|Overall Study||506
638837|NCT00099359|1570758|P2|COMPLETED|Overall Study||515
638838|NCT00099359|1570759|P1|COMPLETED|Overall Study||527
638839|NCT00099359|1570757|P3|STARTED|Overall Study||574
638840|NCT00099359|1570758|P2|STARTED|Overall Study||580
638841|NCT00099359|1570759|P1|STARTED|Overall Study||581
638842|NCT00099268|1570782|P2|NOT COMPLETED|Overall Study||82
638843|NCT00099268|1570783|P1|NOT COMPLETED|Overall Study||92
638844|NCT00099268|1570782|P2|COMPLETED|Overall Study|Plus 1 death in the carbidopa/levodopa group within 30 days of treatment discontinuation|291
638845|NCT00099268|1570783|P1|COMPLETED|Overall Study|Plus 1 death in the carbidopa/levodopa/entacapone group within 30 days of treatment discontinuation|282
638846|NCT00099268|1570782|P2|Intent-to-Treat|Overall Study||372
638847|NCT00099268|1570783|P1|Intent-to-Treat|Overall Study|One patient from each group discontinued without receiving a single dose of study drug.|373
638848|NCT00099268|1570782|P2|STARTED|Overall Study||373
638849|NCT00099268|1570783|P1|STARTED|Overall Study||374
638850|NCT00099047|1570801|P2|NOT COMPLETED|Overall Study||0
638851|NCT00099047|1570802|P1|NOT COMPLETED|Overall Study||0
638852|NCT00099047|1570801|P2|COMPLETED|Overall Study||12
638853|NCT00099047|1570802|P1|COMPLETED|Overall Study||11
638854|NCT00099047|1570801|P2|STARTED|Overall Study||12
638855|NCT00099047|1570802|P1|STARTED|Overall Study||11
638856|NCT00099021|1570808|P1|NOT COMPLETED|Overall Study||0
638857|NCT00099021|1570808|P1|COMPLETED|Overall Study||21
638858|NCT00099021|1570808|P1|STARTED|Overall Study||21
638859|NCT00098956|1570814|P1|NOT COMPLETED|Overall Study||0
638860|NCT00098956|1570814|P1|COMPLETED|Overall Study||19
638861|NCT00098956|1570814|P1|STARTED|Overall Study||19
638862|NCT00098865|1570819|P1|NOT COMPLETED|Overall Study||9
638863|NCT00098865|1570819|P1|COMPLETED|Overall Study||6
638864|NCT00098865|1570819|P1|STARTED|Overall Study||15
638865|NCT00098839|1570827|P2|NOT COMPLETED|Overall Study||33
638866|NCT00098839|1570828|P1|NOT COMPLETED|Overall Study||32
638867|NCT00098839|1570827|P2|COMPLETED|Overall Study||27
638868|NCT00098839|1570828|P1|COMPLETED|Overall Study||24
638869|NCT00098839|1570827|P2|STARTED|Overall Study||60
638870|NCT00098839|1570828|P1|STARTED|Overall Study||56
638871|NCT00098813|1570839|P1|NOT COMPLETED|Overall Study||19
638872|NCT00098813|1570839|P1|COMPLETED|Overall Study||1
638873|NCT00098813|1570839|P1|STARTED|Overall Study||20
638874|NCT00098787|1570846|P3|NOT COMPLETED|Overall Study||63
638875|NCT00098787|1570847|P2|NOT COMPLETED|Overall Study||75
638876|NCT00098787|1570848|P1|NOT COMPLETED|Overall Study||73
638877|NCT00098787|1570846|P3|COMPLETED|Overall Study||0
638878|NCT00098787|1570847|P2|COMPLETED|Overall Study||0
638879|NCT00098787|1570848|P1|COMPLETED|Overall Study||0
638880|NCT00098787|1570846|P3|Eligible and Treated|Overall Study||59
638881|NCT00098787|1570847|P2|Eligible and Treated|Overall Study||66
638882|NCT00098787|1570848|P1|Eligible and Treated|Overall Study||61
638883|NCT00098787|1570846|P3|Treated|Overall Study||62
638884|NCT00098787|1570847|P2|Treated|Overall Study||73
638885|NCT00098787|1570848|P1|Treated|Overall Study||70
638886|NCT00098787|1570846|P3|STARTED|Overall Study||63
638887|NCT00098787|1570847|P2|STARTED|Overall Study||75
638888|NCT00098787|1570848|P1|STARTED|Overall Study||73
638889|NCT00098774|1570862|P1|NOT COMPLETED|Overall Study||18
638890|NCT00098774|1570862|P1|COMPLETED|Overall Study||26
638891|NCT00098774|1570862|P1|STARTED|Overall Study||44
638892|NCT00098748|1570872|P3|NOT COMPLETED|Continued on Open-Label Treatment||0
638893|NCT00098748|1570873|P2|NOT COMPLETED|Continued on Open-Label Treatment||15
638894|NCT00098748|1570874|P1|NOT COMPLETED|Continued on Open-Label Treatment||8
638895|NCT00098748|1570872|P3|COMPLETED|Continued on Open-Label Treatment||0
638896|NCT00098748|1570873|P2|COMPLETED|Continued on Open-Label Treatment||10
638897|NCT00098748|1570874|P1|COMPLETED|Continued on Open-Label Treatment||7
638898|NCT00098748|1570872|P3|STARTED|Continued on Open-Label Treatment|Placebo group not offered open-label maraviroc due to study not reaching primary endpoint at Week 24|0
638899|NCT00098748|1570873|P2|STARTED|Continued on Open-Label Treatment||25
638900|NCT00098748|1570874|P1|STARTED|Continued on Open-Label Treatment||15
638901|NCT00098748|1570872|P3|NOT COMPLETED|Received Study Treatment||44
638902|NCT00098748|1570873|P2|NOT COMPLETED|Received Study Treatment||36
638903|NCT00098748|1570874|P1|NOT COMPLETED|Received Study Treatment||48
638904|NCT00098748|1570872|P3|COMPLETED|Received Study Treatment||18
638905|NCT00098748|1570873|P2|COMPLETED|Received Study Treatment||25
638906|NCT00098748|1570874|P1|COMPLETED|Received Study Treatment||15
638907|NCT00098748|1570872|P3|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||58
638908|NCT00098748|1570873|P2|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||52
638909|NCT00098748|1570874|P1|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment|Dual-tropic: Virus capable of using both CCR5 and CXCR4 coreceptors for cell entry.|57
638910|NCT00098748|1570872|P3|STARTED|Received Study Treatment|Due to 1 placebo subject switched to maraviroc BID, Placebo = 61 subjects in Adverse event tables.|62
638911|NCT00098748|1570873|P2|STARTED|Received Study Treatment|Due to 1 placebo subject switched to maraviroc BID, BID = 62 subjects in Adverse event tables.|61
638912|NCT00098748|1570874|P1|STARTED|Received Study Treatment||63
638913|NCT00098748|1570872|P3|NOT COMPLETED|Assigned to Study Treatment||2
638914|NCT00098748|1570873|P2|NOT COMPLETED|Assigned to Study Treatment||2
638915|NCT00098748|1570874|P1|NOT COMPLETED|Assigned to Study Treatment||0
638916|NCT00098748|1570872|P3|COMPLETED|Assigned to Study Treatment||62
638917|NCT00098748|1570873|P2|COMPLETED|Assigned to Study Treatment||61
638918|NCT00098748|1570874|P1|COMPLETED|Assigned to Study Treatment||63
638919|NCT00098748|1570872|P3|STARTED|Assigned to Study Treatment||64
638920|NCT00098748|1570873|P2|STARTED|Assigned to Study Treatment||63
638921|NCT00098748|1570874|P1|STARTED|Assigned to Study Treatment||63
638922|NCT00098722|1570930|P7|NOT COMPLETED|Observation Phase||17
638923|NCT00098722|1570931|P6|NOT COMPLETED|Observation Phase||45
638924|NCT00098722|1570932|P5|NOT COMPLETED|Observation Phase||0
638925|NCT00098722|1570933|P4|NOT COMPLETED|Observation Phase||0
638926|NCT00098722|1570934|P3|NOT COMPLETED|Observation Phase||0
638927|NCT00098722|1570935|P2|NOT COMPLETED|Observation Phase||0
638928|NCT00098722|1570936|P1|NOT COMPLETED|Observation Phase||0
638929|NCT00098722|1570930|P7|COMPLETED|Observation Phase||48
638930|NCT00098722|1570931|P6|COMPLETED|Observation Phase||160
638931|NCT00098722|1570932|P5|COMPLETED|Observation Phase||0
638932|NCT00098722|1570933|P4|COMPLETED|Observation Phase||0
638933|NCT00098722|1570934|P3|COMPLETED|Observation Phase||0
638934|NCT00098722|1570935|P2|COMPLETED|Observation Phase||0
638935|NCT00098722|1570936|P1|COMPLETED|Observation Phase||0
638936|NCT00098722|1570930|P7|STARTED|Observation Phase||65
638937|NCT00098722|1570931|P6|STARTED|Observation Phase||205
638938|NCT00098722|1570932|P5|STARTED|Observation Phase||0
638939|NCT00098722|1570933|P4|STARTED|Observation Phase||0
638940|NCT00098722|1570934|P3|STARTED|Observation Phase||0
638941|NCT00098722|1570935|P2|STARTED|Observation Phase||0
638942|NCT00098722|1570936|P1|STARTED|Observation Phase||0
638943|NCT00098722|1570930|P7|NOT COMPLETED|Open Label Phase||0
638944|NCT00098722|1570931|P6|NOT COMPLETED|Open Label Phase||0
638945|NCT00098722|1570932|P5|NOT COMPLETED|Open Label Phase||50
638946|NCT00098722|1570933|P4|NOT COMPLETED|Open Label Phase||272
638947|NCT00098722|1570934|P3|NOT COMPLETED|Open Label Phase||0
638948|NCT00098722|1570935|P2|NOT COMPLETED|Open Label Phase||0
638949|NCT00098722|1570936|P1|NOT COMPLETED|Open Label Phase||0
638950|NCT00098722|1570930|P7|COMPLETED|Open Label Phase||0
638951|NCT00098722|1570931|P6|COMPLETED|Open Label Phase||0
638952|NCT00098722|1570932|P5|COMPLETED|Open Label Phase||0
638953|NCT00098722|1570933|P4|COMPLETED|Open Label Phase||0
638954|NCT00098722|1570934|P3|COMPLETED|Open Label Phase||0
638955|NCT00098722|1570935|P2|COMPLETED|Open Label Phase||0
638956|NCT00098722|1570936|P1|COMPLETED|Open Label Phase||0
638957|NCT00098722|1570930|P7|STARTED|Open Label Phase||0
638958|NCT00098722|1570931|P6|STARTED|Open Label Phase||0
638959|NCT00098722|1570932|P5|STARTED|Open Label Phase||50
638960|NCT00098722|1570933|P4|STARTED|Open Label Phase||272
638961|NCT00098722|1570934|P3|STARTED|Open Label Phase||0
638962|NCT00098722|1570935|P2|STARTED|Open Label Phase||0
638963|NCT00098722|1570936|P1|STARTED|Open Label Phase||0
638964|NCT00098722|1570930|P7|NOT COMPLETED|Double Blind Phase||0
638965|NCT00098722|1570931|P6|NOT COMPLETED|Double Blind Phase||0
638966|NCT00098722|1570932|P5|NOT COMPLETED|Double Blind Phase||0
638967|NCT00098722|1570933|P4|NOT COMPLETED|Double Blind Phase||0
638968|NCT00098722|1570934|P3|NOT COMPLETED|Double Blind Phase||94
638969|NCT00098722|1570935|P2|NOT COMPLETED|Double Blind Phase||194
638970|NCT00098722|1570936|P1|NOT COMPLETED|Double Blind Phase||186
638971|NCT00098722|1570930|P7|COMPLETED|Double Blind Phase||0
638972|NCT00098722|1570931|P6|COMPLETED|Double Blind Phase||0
638973|NCT00098722|1570932|P5|COMPLETED|Double Blind Phase||0
638974|NCT00098722|1570933|P4|COMPLETED|Double Blind Phase||0
638975|NCT00098722|1570934|P3|COMPLETED|Double Blind Phase||0
638976|NCT00098722|1570935|P2|COMPLETED|Double Blind Phase||0
638977|NCT00098722|1570936|P1|COMPLETED|Double Blind Phase||0
638978|NCT00098722|1570930|P7|Treated|Double Blind Phase||0
638979|NCT00098722|1570931|P6|Treated|Double Blind Phase||0
638980|NCT00098722|1570932|P5|Treated|Double Blind Phase||0
638981|NCT00098722|1570933|P4|Treated|Double Blind Phase||0
638982|NCT00098722|1570934|P3|Treated|Double Blind Phase||91
638983|NCT00098722|1570935|P2|Treated|Double Blind Phase||191
638984|NCT00098722|1570936|P1|Treated|Double Blind Phase||182
638985|NCT00098722|1570930|P7|STARTED|Double Blind Phase||0
638986|NCT00098722|1570931|P6|STARTED|Double Blind Phase||0
638987|NCT00098722|1570932|P5|STARTED|Double Blind Phase||0
638988|NCT00098722|1570933|P4|STARTED|Double Blind Phase||0
638989|NCT00098722|1570934|P3|STARTED|Double Blind Phase||94
638990|NCT00098722|1570935|P2|STARTED|Double Blind Phase||194
638991|NCT00098722|1570936|P1|STARTED|Double Blind Phase||186
638992|NCT00098670|1570999|P1|NOT COMPLETED|Overall Study||0
638993|NCT00098670|1570999|P1|COMPLETED|Overall Study||102
638994|NCT00098670|1570999|P1|STARTED|Overall Study||102
638995|NCT00098475|1571010|P4|NOT COMPLETED|Step 2||0
638996|NCT00098475|1571011|P3|NOT COMPLETED|Step 2||0
638997|NCT00098475|1571012|P2|NOT COMPLETED|Step 2||10
638998|NCT00098475|1571013|P1|NOT COMPLETED|Step 2||5
638999|NCT00098475|1571010|P4|COMPLETED|Step 2||0
639000|NCT00098475|1571011|P3|COMPLETED|Step 2||0
639001|NCT00098475|1571012|P2|COMPLETED|Step 2||5
639002|NCT00098475|1571013|P1|COMPLETED|Step 2||0
639003|NCT00098475|1571010|P4|Eligible|Step 2||0
639004|NCT00098475|1571011|P3|Eligible|Step 2||0
639005|NCT00098475|1571012|P2|Eligible|Step 2|Some patients were considered eligible at registration but found ineligible in the analysis.|9
639006|NCT00098475|1571013|P1|Eligible|Step 2|Some patients were considered eligible at registration but found ineligible in the analysis.|2
639007|NCT00098475|1571010|P4|Treated|Step 2||0
639008|NCT00098475|1571011|P3|Treated|Step 2||0
639009|NCT00098475|1571012|P2|Treated|Step 2||14
639010|NCT00098475|1571013|P1|Treated|Step 2||4
639011|NCT00098475|1571010|P4|STARTED|Step 2||0
639012|NCT00098475|1571011|P3|STARTED|Step 2||0
639013|NCT00098475|1571012|P2|STARTED|Step 2|Step 2 treatment was an option but not required for patients who ended step 1 treatment.|15
639014|NCT00098475|1571013|P1|STARTED|Step 2|Step 2 treatment was an option but not required for patients who ended step 1 treatment.|5
639015|NCT00098475|1571010|P4|NOT COMPLETED|Step 1||3
639016|NCT00098475|1571011|P3|NOT COMPLETED|Step 1||4
639017|NCT00098475|1571012|P2|NOT COMPLETED|Step 1||173
639018|NCT00098475|1571013|P1|NOT COMPLETED|Step 1||171
639019|NCT00098475|1571010|P4|COMPLETED|Step 1||0
639020|NCT00098475|1571011|P3|COMPLETED|Step 1||0
639021|NCT00098475|1571012|P2|COMPLETED|Step 1||49
639022|NCT00098475|1571013|P1|COMPLETED|Step 1||52
639023|NCT00098475|1571010|P4|Eligible|Step 1||3
639024|NCT00098475|1571011|P3|Eligible|Step 1||4
639025|NCT00098475|1571012|P2|Eligible|Step 1|Some patients were considered eligible at registration but found ineligible in the analysis.|208
639026|NCT00098475|1571013|P1|Eligible|Step 1|Some patients were considered eligible at registration but found ineligible in the analysis.|214
639027|NCT00098475|1571010|P4|Treated|Step 1||3
639028|NCT00098475|1571011|P3|Treated|Step 1||4
639029|NCT00098475|1571012|P2|Treated|Step 1||220
639030|NCT00098475|1571013|P1|Treated|Step 1||223
639031|NCT00098475|1571010|P4|STARTED|Step 1||3
639032|NCT00098475|1571011|P3|STARTED|Step 1||4
639033|NCT00098475|1571012|P2|STARTED|Step 1||222
639034|NCT00098475|1571013|P1|STARTED|Step 1||223
639035|NCT00098371|1571025|P1|NOT COMPLETED|Overall Study||0
639036|NCT00098371|1571025|P1|COMPLETED|Overall Study||64
639037|NCT00098371|1571025|P1|STARTED|Overall Study||64
639038|NCT00098345|1571050|P1|NOT COMPLETED|Overall Study||13
639039|NCT00098345|1571050|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|17
639040|NCT00098345|1571050|P1|STARTED|Overall Study||30
639041|NCT00098306|1571063|P7|NOT COMPLETED|Observational Phase||26
639042|NCT00098306|1571064|P6|NOT COMPLETED|Observational Phase||46
639043|NCT00098306|1571065|P5|NOT COMPLETED|Observational Phase||0
639044|NCT00098306|1571066|P4|NOT COMPLETED|Observational Phase||0
639045|NCT00098306|1571067|P3|NOT COMPLETED|Observational Phase||0
639046|NCT00098306|1571068|P2|NOT COMPLETED|Observational Phase||0
639047|NCT00098306|1571069|P1|NOT COMPLETED|Observational Phase||0
639048|NCT00098306|1571063|P7|COMPLETED|Observational Phase||55
639049|NCT00098306|1571064|P6|COMPLETED|Observational Phase||204
639050|NCT00098306|1571065|P5|COMPLETED|Observational Phase||0
639051|NCT00098306|1571066|P4|COMPLETED|Observational Phase||0
639052|NCT00098306|1571067|P3|COMPLETED|Observational Phase||0
639053|NCT00098306|1571068|P2|COMPLETED|Observational Phase||0
639054|NCT00098306|1571069|P1|COMPLETED|Observational Phase||0
639055|NCT00098306|1571063|P7|STARTED|Observational Phase||81
639056|NCT00098306|1571064|P6|STARTED|Observational Phase||250
639057|NCT00098306|1571065|P5|STARTED|Observational Phase||0
639058|NCT00098306|1571066|P4|STARTED|Observational Phase||0
639059|NCT00098306|1571067|P3|STARTED|Observational Phase||0
639060|NCT00098306|1571068|P2|STARTED|Observational Phase||0
639061|NCT00098306|1571069|P1|STARTED|Observational Phase||0
639062|NCT00098306|1571063|P7|NOT COMPLETED|Open Label||0
639063|NCT00098306|1571064|P6|NOT COMPLETED|Open Label||0
639064|NCT00098306|1571065|P5|NOT COMPLETED|Open Label||62
639065|NCT00098306|1571066|P4|NOT COMPLETED|Open Label||327
639066|NCT00098306|1571067|P3|NOT COMPLETED|Open Label||0
639067|NCT00098306|1571068|P2|NOT COMPLETED|Open Label||0
639068|NCT00098306|1571069|P1|NOT COMPLETED|Open Label||0
639069|NCT00098306|1571063|P7|COMPLETED|Open Label||0
639070|NCT00098306|1571064|P6|COMPLETED|Open Label||0
639071|NCT00098306|1571065|P5|COMPLETED|Open Label||0
639072|NCT00098306|1571066|P4|COMPLETED|Open Label||0
639073|NCT00098306|1571067|P3|COMPLETED|Open Label||0
639074|NCT00098306|1571068|P2|COMPLETED|Open Label||0
639075|NCT00098306|1571069|P1|COMPLETED|Open Label||0
639076|NCT00098306|1571063|P7|STARTED|Open Label||0
639077|NCT00098306|1571064|P6|STARTED|Open Label||0
639078|NCT00098306|1571065|P5|STARTED|Open Label||62
639079|NCT00098306|1571066|P4|STARTED|Open Label||327
639080|NCT00098306|1571067|P3|STARTED|Open Label||0
639081|NCT00098306|1571068|P2|STARTED|Open Label||0
639082|NCT00098306|1571069|P1|STARTED|Open Label||0
639083|NCT00098306|1571063|P7|NOT COMPLETED|Double Blind||0
639084|NCT00098306|1571064|P6|NOT COMPLETED|Double Blind||0
639085|NCT00098306|1571065|P5|NOT COMPLETED|Double Blind||0
639086|NCT00098306|1571066|P4|NOT COMPLETED|Double Blind||0
639087|NCT00098306|1571067|P3|NOT COMPLETED|Double Blind||120
639088|NCT00098306|1571068|P2|NOT COMPLETED|Double Blind||240
639089|NCT00098306|1571069|P1|NOT COMPLETED|Double Blind||241
639090|NCT00098306|1571063|P7|COMPLETED|Double Blind||0
639091|NCT00098306|1571064|P6|COMPLETED|Double Blind||0
639092|NCT00098306|1571065|P5|COMPLETED|Double Blind||0
639093|NCT00098306|1571066|P4|COMPLETED|Double Blind||0
639094|NCT00098306|1571067|P3|COMPLETED|Double Blind||0
639095|NCT00098306|1571068|P2|COMPLETED|Double Blind||0
639096|NCT00098306|1571069|P1|COMPLETED|Double Blind||0
639097|NCT00098306|1571063|P7|Treated|Double Blind||0
639098|NCT00098306|1571064|P6|Treated|Double Blind||0
639099|NCT00098306|1571065|P5|Treated|Double Blind||0
639100|NCT00098306|1571066|P4|Treated|Double Blind||0
639101|NCT00098306|1571067|P3|Treated|Double Blind||118
639102|NCT00098306|1571068|P2|Treated|Double Blind||235
639103|NCT00098306|1571069|P1|Treated|Double Blind||232
639104|NCT00098306|1571063|P7|STARTED|Double Blind||0
639105|NCT00098306|1571064|P6|STARTED|Double Blind||0
639106|NCT00098306|1571065|P5|STARTED|Double Blind||0
639107|NCT00098306|1571066|P4|STARTED|Double Blind||0
639108|NCT00098306|1571067|P3|STARTED|Double Blind||120
639109|NCT00098306|1571068|P2|STARTED|Double Blind||240
639110|NCT00098306|1571069|P1|STARTED|Double Blind||241
639111|NCT00098293|1571135|P5|NOT COMPLETED|Supplemental Phase (SP)||33
639112|NCT00098293|1571136|P4|NOT COMPLETED|Supplemental Phase (SP)||0
639113|NCT00098293|1571137|P3|NOT COMPLETED|Supplemental Phase (SP)||0
639114|NCT00098293|1571138|P2|NOT COMPLETED|Supplemental Phase (SP)||0
639115|NCT00098293|1571139|P1|NOT COMPLETED|Supplemental Phase (SP)||0
639116|NCT00098293|1571135|P5|COMPLETED|Supplemental Phase (SP)||94
639117|NCT00098293|1571136|P4|COMPLETED|Supplemental Phase (SP)||0
639118|NCT00098293|1571137|P3|COMPLETED|Supplemental Phase (SP)||0
639119|NCT00098293|1571138|P2|COMPLETED|Supplemental Phase (SP)||0
639120|NCT00098293|1571139|P1|COMPLETED|Supplemental Phase (SP)||0
639121|NCT00098293|1571135|P5|STARTED|Supplemental Phase (SP)||127
639122|NCT00098293|1571136|P4|STARTED|Supplemental Phase (SP)||0
639123|NCT00098293|1571137|P3|STARTED|Supplemental Phase (SP)||0
639124|NCT00098293|1571138|P2|STARTED|Supplemental Phase (SP)||0
639125|NCT00098293|1571139|P1|STARTED|Supplemental Phase (SP)||0
639126|NCT00098293|1571135|P5|NOT COMPLETED|Open-label (OL) Phase||0
639127|NCT00098293|1571136|P4|NOT COMPLETED|Open-label (OL) Phase||65
639128|NCT00098293|1571137|P3|NOT COMPLETED|Open-label (OL) Phase||41
639129|NCT00098293|1571138|P2|NOT COMPLETED|Open-label (OL) Phase||25
639130|NCT00098293|1571139|P1|NOT COMPLETED|Open-label (OL) Phase||0
639131|NCT00098293|1571135|P5|COMPLETED|Open-label (OL) Phase||0
639132|NCT00098293|1571136|P4|COMPLETED|Open-label (OL) Phase||65
639133|NCT00098293|1571137|P3|COMPLETED|Open-label (OL) Phase||158
639134|NCT00098293|1571138|P2|COMPLETED|Open-label (OL) Phase||177
639135|NCT00098293|1571139|P1|COMPLETED|Open-label (OL) Phase||0
639136|NCT00098293|1571135|P5|STARTED|Open-label (OL) Phase||0
639137|NCT00098293|1571136|P4|STARTED|Open-label (OL) Phase||130
639138|NCT00098293|1571137|P3|STARTED|Open-label (OL) Phase||199
639139|NCT00098293|1571138|P2|STARTED|Open-label (OL) Phase||202
639140|NCT00098293|1571139|P1|STARTED|Open-label (OL) Phase||0
639141|NCT00098293|1571135|P5|NOT COMPLETED|Between DB and OL Phase||0
639142|NCT00098293|1571136|P4|NOT COMPLETED|Between DB and OL Phase||0
639143|NCT00098293|1571137|P3|NOT COMPLETED|Between DB and OL Phase||3
639144|NCT00098293|1571138|P2|NOT COMPLETED|Between DB and OL Phase||0
639145|NCT00098293|1571139|P1|NOT COMPLETED|Between DB and OL Phase||0
639146|NCT00098293|1571135|P5|COMPLETED|Between DB and OL Phase||0
639147|NCT00098293|1571136|P4|COMPLETED|Between DB and OL Phase||0
639148|NCT00098293|1571137|P3|COMPLETED|Between DB and OL Phase||199
639149|NCT00098293|1571138|P2|COMPLETED|Between DB and OL Phase||202
639150|NCT00098293|1571139|P1|COMPLETED|Between DB and OL Phase||0
639151|NCT00098293|1571135|P5|STARTED|Between DB and OL Phase||0
639152|NCT00098293|1571136|P4|STARTED|Between DB and OL Phase||0
639153|NCT00098293|1571137|P3|STARTED|Between DB and OL Phase||202
639154|NCT00098293|1571138|P2|STARTED|Between DB and OL Phase||202
639155|NCT00098293|1571139|P1|STARTED|Between DB and OL Phase||0
639156|NCT00098293|1571135|P5|NOT COMPLETED|Double-blind (DB) Phase||0
639157|NCT00098293|1571136|P4|NOT COMPLETED|Double-blind (DB) Phase||0
639158|NCT00098293|1571137|P3|NOT COMPLETED|Double-blind (DB) Phase||170
639159|NCT00098293|1571138|P2|NOT COMPLETED|Double-blind (DB) Phase||166
639160|NCT00098293|1571139|P1|NOT COMPLETED|Double-blind (DB) Phase||177
639161|NCT00098293|1571135|P5|COMPLETED|Double-blind (DB) Phase||0
639162|NCT00098293|1571136|P4|COMPLETED|Double-blind (DB) Phase||0
639163|NCT00098293|1571137|P3|COMPLETED|Double-blind (DB) Phase||202
639164|NCT00098293|1571138|P2|COMPLETED|Double-blind (DB) Phase||202
639165|NCT00098293|1571139|P1|COMPLETED|Double-blind (DB) Phase||0
639166|NCT00098293|1571135|P5|Treated|Double-blind (DB) Phase||0
639167|NCT00098293|1571136|P4|Treated|Double-blind (DB) Phase||0
639168|NCT00098293|1571137|P3|Treated|Double-blind (DB) Phase||361
639169|NCT00098293|1571138|P2|Treated|Double-blind (DB) Phase||360
639170|NCT00098293|1571139|P1|Treated|Double-blind (DB) Phase||174
639171|NCT00098293|1571135|P5|STARTED|Double-blind (DB) Phase||0
639172|NCT00098293|1571136|P4|STARTED|Double-blind (DB) Phase||0
639173|NCT00098293|1571137|P3|STARTED|Double-blind (DB) Phase||372
639174|NCT00098293|1571138|P2|STARTED|Double-blind (DB) Phase||368
639175|NCT00098293|1571139|P1|STARTED|Double-blind (DB) Phase||177
639176|NCT00098254|1571192|P1|NOT COMPLETED|Overall Study||3
639177|NCT00098254|1571192|P1|COMPLETED|Overall Study||34
639178|NCT00098254|1571192|P1|STARTED|Overall Study||37
639179|NCT00098059|1571213|P2|NOT COMPLETED|Overall Study||1
639180|NCT00098059|1571214|P1|NOT COMPLETED|Overall Study||0
639181|NCT00098059|1571213|P2|COMPLETED|Overall Study||46
639182|NCT00098059|1571214|P1|COMPLETED|Overall Study||27
639183|NCT00098059|1571213|P2|STARTED|Overall Study||47
639184|NCT00098059|1571214|P1|STARTED|Overall Study||27
639185|NCT00098020|1571258|P1|NOT COMPLETED|Overall Study||6
639186|NCT00098020|1571258|P1|COMPLETED|Overall Study||6
639187|NCT00098020|1571258|P1|Started Isotretinoin|Overall Study||8
639188|NCT00098020|1571258|P1|STARTED|Overall Study||12
639189|NCT00097981|1571265|P2|NOT COMPLETED|Overall Study||100
639190|NCT00097981|1571266|P1|NOT COMPLETED|Overall Study||106
639191|NCT00097981|1571265|P2|COMPLETED|Overall Study|Completion of 2 or more cycles after CR or nCR, or completion of 12 cycles.|12
639192|NCT00097981|1571266|P1|COMPLETED|Overall Study|Completion of 2 or more cycles after CR or nCR, or completion of 12 cycles.|7
639193|NCT00097981|1571265|P2|Received Study Medication|Overall Study||106
639194|NCT00097981|1571266|P1|Received Study Medication|Overall Study||110
639195|NCT00097981|1571265|P2|STARTED|Overall Study|Enrollment at randomization|112
639196|NCT00097981|1571266|P1|STARTED|Overall Study|Enrollment at randomization|113
639197|NCT00097786|1571288|P4|NOT COMPLETED|Overall Study||310
639198|NCT00097786|1571289|P3|NOT COMPLETED|Overall Study||313
639199|NCT00097786|1571290|P2|NOT COMPLETED|Overall Study||292
639200|NCT00097786|1571291|P1|NOT COMPLETED|Overall Study||296
639201|NCT00097786|1571288|P4|COMPLETED|Overall Study||2036
639202|NCT00097786|1571289|P3|COMPLETED|Overall Study||2016
639203|NCT00097786|1571290|P2|COMPLETED|Overall Study||2023
639204|NCT00097786|1571291|P1|COMPLETED|Overall Study|"Completed means completed follow up for all cause death."|2020
639205|NCT00097786|1571288|P4|Complete Follow-up for Core CV EPs|Overall Study||1988
639206|NCT00097786|1571289|P3|Complete Follow-up for Core CV EPs|Overall Study||1966
639207|NCT00097786|1571290|P2|Complete Follow-up for Core CV EPs|Overall Study||1963
639208|NCT00097786|1571291|P1|Complete Follow-up for Core CV EPs|Overall Study||1948
639209|NCT00097786|1571288|P4|Complete Follow-up for Extended CV EPs|Overall Study||2015
639210|NCT00097786|1571289|P3|Complete Follow-up for Extended CV EPs|Overall Study||1987
639211|NCT00097786|1571290|P2|Complete Follow-up for Extended CV EPs|Overall Study||1985
639212|NCT00097786|1571291|P1|Complete Follow-up for Extended CV EPs|Overall Study||1969
639213|NCT00097786|1571288|P4|Complete FU for Progression to Diabetes|Overall Study||1762
639214|NCT00097786|1571289|P3|Complete FU for Progression to Diabetes|Overall Study||1734
639215|NCT00097786|1571290|P2|Complete FU for Progression to Diabetes|Overall Study||1712
639216|NCT00097786|1571291|P1|Complete FU for Progression to Diabetes|Overall Study||1709
639217|NCT00097786|1571288|P4|STARTED|Overall Study||2346
639218|NCT00097786|1571289|P3|STARTED|Overall Study||2329
639219|NCT00097786|1571290|P2|STARTED|Overall Study||2315
639220|NCT00097786|1571291|P1|STARTED|Overall Study|"Started indicates Full Analysis Set (FAS) population. Initially enrolled 9518, 212 excluded."|2316
639221|NCT00097773|1571313|P4|NOT COMPLETED|Overall Study||3
639222|NCT00097773|1571314|P3|NOT COMPLETED|Overall Study||8
639223|NCT00097773|1571315|P2|NOT COMPLETED|Overall Study||8
639224|NCT00097773|1571316|P1|NOT COMPLETED|Overall Study||8
639225|NCT00097773|1571313|P4|COMPLETED|Overall Study||73
639226|NCT00097773|1571314|P3|COMPLETED|Overall Study||68
639227|NCT00097773|1571315|P2|COMPLETED|Overall Study||68
639228|NCT00097773|1571316|P1|COMPLETED|Overall Study||68
639229|NCT00097773|1571313|P4|STARTED|Overall Study||76
639230|NCT00097773|1571314|P3|STARTED|Overall Study||76
639231|NCT00097773|1571315|P2|STARTED|Overall Study||76
639232|NCT00097773|1571316|P1|STARTED|Overall Study||76
639233|NCT00097721|1571336|P2|NOT COMPLETED|Overall Study||33
639234|NCT00097721|1571337|P1|NOT COMPLETED|Overall Study||71
639235|NCT00097721|1571336|P2|COMPLETED|Overall Study||0
639236|NCT00097721|1571337|P1|COMPLETED|Overall Study||0
639237|NCT00097721|1571336|P2|STARTED|Overall Study||33
639238|NCT00097721|1571337|P1|STARTED|Overall Study|The number started is all enrolled subjects.BL Characteristics consists of Safety Population.|71
639239|NCT00097708|1571354|P3|NOT COMPLETED|Overall Study||65
639240|NCT00097708|1571355|P2|NOT COMPLETED|Overall Study||56
639241|NCT00097708|1571356|P1|NOT COMPLETED|Overall Study||64
639242|NCT00097708|1571354|P3|COMPLETED|Overall Study||97
639243|NCT00097708|1571355|P2|COMPLETED|Overall Study||120
639244|NCT00097708|1571356|P1|COMPLETED|Overall Study||109
639245|NCT00097708|1571354|P3|Treated|Overall Study||160
639246|NCT00097708|1571355|P2|Treated|Overall Study||176
639247|NCT00097708|1571356|P1|Treated|Overall Study||171
639248|NCT00097708|1571354|P3|Intent-to-Treat (ITT)|Overall Study||149
639249|NCT00097708|1571355|P2|Intent-to-Treat (ITT)|Overall Study||169
639250|NCT00097708|1571356|P1|Intent-to-Treat (ITT)|Overall Study||165
639251|NCT00097708|1571354|P3|STARTED|Overall Study||162
639252|NCT00097708|1571355|P2|STARTED|Overall Study||176
639253|NCT00097708|1571356|P1|STARTED|Overall Study||173
639254|NCT00097695|1571368|P4|NOT COMPLETED|The Open Label Extension (OLE) Phase||5
639255|NCT00097695|1571369|P3|NOT COMPLETED|The Open Label Extension (OLE) Phase||2
639256|NCT00097695|1571370|P2|NOT COMPLETED|The Open Label Extension (OLE) Phase||15
639257|NCT00097695|1571371|P1|NOT COMPLETED|The Open Label Extension (OLE) Phase||13
639258|NCT00097695|1571368|P4|COMPLETED|The Open Label Extension (OLE) Phase||15
639259|NCT00097695|1571369|P3|COMPLETED|The Open Label Extension (OLE) Phase||1
639260|NCT00097695|1571370|P2|COMPLETED|The Open Label Extension (OLE) Phase||11
639261|NCT00097695|1571371|P1|COMPLETED|The Open Label Extension (OLE) Phase||10
639262|NCT00097695|1571368|P4|STARTED|The Open Label Extension (OLE) Phase||20
639263|NCT00097695|1571369|P3|STARTED|The Open Label Extension (OLE) Phase||3
639264|NCT00097695|1571370|P2|STARTED|The Open Label Extension (OLE) Phase||26
639265|NCT00097695|1571371|P1|STARTED|The Open Label Extension (OLE) Phase||23
639266|NCT00097695|1571368|P4|NOT COMPLETED|The Controlled Phase||20
639267|NCT00097695|1571369|P3|NOT COMPLETED|The Controlled Phase||5
639268|NCT00097695|1571370|P2|NOT COMPLETED|The Controlled Phase||3
639269|NCT00097695|1571371|P1|NOT COMPLETED|The Controlled Phase||4
639270|NCT00097695|1571368|P4|COMPLETED|The Controlled Phase|Patients screened and found eligible but did not have HAE attack or attack was not severe enough|0
639271|NCT00097695|1571369|P3|COMPLETED|The Controlled Phase||3
639272|NCT00097695|1571370|P2|COMPLETED|The Controlled Phase||26
639273|NCT00097695|1571371|P1|COMPLETED|The Controlled Phase||23
639274|NCT00097695|1571368|P4|STARTED|The Controlled Phase||20
639275|NCT00097695|1571369|P3|STARTED|The Controlled Phase||8
639276|NCT00097695|1571370|P2|STARTED|The Controlled Phase||29
639277|NCT00097695|1571371|P1|STARTED|The Controlled Phase||27
639278|NCT00097591|1571387|P2|NOT COMPLETED|Overall Study||394
639279|NCT00097591|1571388|P1|NOT COMPLETED|Overall Study||410
639280|NCT00097591|1571387|P2|COMPLETED|Overall Study||6401
639281|NCT00097591|1571388|P1|COMPLETED|Overall Study||6403
639282|NCT00097591|1571387|P2|STARTED|Overall Study|4 subjects randomized but not analyzed due to an incomplete informed consent document|6795
639283|NCT00097591|1571388|P1|STARTED|Overall Study|7 subjects randomized but not analyzed due to an incomplete informed consent document|6813
639284|NCT00097539|1571411|P7|NOT COMPLETED|Overall Study||171
639285|NCT00097539|1571412|P6|NOT COMPLETED|Overall Study||5892
639286|NCT00097539|1571413|P5|NOT COMPLETED|Overall Study||1758
639287|NCT00097539|1571414|P4|NOT COMPLETED|Overall Study||3585
639288|NCT00097539|1571415|P3|NOT COMPLETED|Overall Study||9108
639289|NCT00097539|1571416|P2|NOT COMPLETED|Overall Study||6531
639290|NCT00097539|1571417|P1|NOT COMPLETED|Overall Study||19066
639291|NCT00097539|1571411|P7|COMPLETED|Overall Study||68
639292|NCT00097539|1571412|P6|COMPLETED|Overall Study||2118
639293|NCT00097539|1571413|P5|COMPLETED|Overall Study||386
639294|NCT00097539|1571414|P4|COMPLETED|Overall Study||2066
639295|NCT00097539|1571415|P3|COMPLETED|Overall Study||3411
639296|NCT00097539|1571416|P2|COMPLETED|Overall Study||2825
639297|NCT00097539|1571417|P1|COMPLETED|Overall Study||8220
639298|NCT00097539|1571411|P7|STARTED|Overall Study||239
639299|NCT00097539|1571412|P6|STARTED|Overall Study||8010
639300|NCT00097539|1571413|P5|STARTED|Overall Study||2144
639301|NCT00097539|1571414|P4|STARTED|Overall Study||5651
639302|NCT00097539|1571415|P3|STARTED|Overall Study||12519
639303|NCT00097539|1571416|P2|STARTED|Overall Study||9356
639304|NCT00097539|1571417|P1|STARTED|Overall Study||27286
639305|NCT00097500|1571463|P2|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||4
639306|NCT00097500|1571464|P1|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||5
639307|NCT00097500|1571463|P2|COMPLETED|Off-drug Period (Week 52 to Week 64)||26
639308|NCT00097500|1571464|P1|COMPLETED|Off-drug Period (Week 52 to Week 64)||25
639309|NCT00097500|1571463|P2|STARTED|Off-drug Period (Week 52 to Week 64)|Insulin Glargine is discontinued, metformin is continued|30
639310|NCT00097500|1571464|P1|STARTED|Off-drug Period (Week 52 to Week 64)|Exenatide is discontinued, metformin is continued|30
639311|NCT00097500|1571463|P2|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||3
639312|NCT00097500|1571464|P1|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||6
639313|NCT00097500|1571463|P2|COMPLETED|On-drug Period (Week 0 to Week 52)|Subjects experiencing loss of glucose control after Week 52 are considered to have completed study.|30
639314|NCT00097500|1571464|P1|COMPLETED|On-drug Period (Week 0 to Week 52)|Subjects experiencing loss of glucose control after Week 52 are considered to have completed study.|30
639315|NCT00097500|1571463|P2|STARTED|On-drug Period (Week 0 to Week 52)||33
639316|NCT00097500|1571464|P1|STARTED|On-drug Period (Week 0 to Week 52)||36
639317|NCT00097448|1571488|P2|NOT COMPLETED|Overall Study||1
639318|NCT00097448|1571489|P1|NOT COMPLETED|Overall Study||4
639319|NCT00097448|1571488|P2|COMPLETED|Overall Study||129
639320|NCT00097448|1571489|P1|COMPLETED|Overall Study||121
639321|NCT00097448|1571488|P2|STARTED|Overall Study||130
639322|NCT00097448|1571489|P1|STARTED|Overall Study||125
639323|NCT00097370|1571495|P1|NOT COMPLETED|Stage 3||59
639324|NCT00097370|1571495|P1|COMPLETED|Stage 3||0
639325|NCT00097370|1571495|P1|STARTED|Stage 3|Participants continued from Stage 2.|59
639326|NCT00097370|1571495|P1|NOT COMPLETED|Stage 2||13
639327|NCT00097370|1571495|P1|COMPLETED|Stage 2||59
639328|NCT00097370|1571495|P1|STARTED|Stage 2|41 participants entered from study MHE100185 and 31 participants continued from Stage 1.|72
639329|NCT00097370|1571495|P1|NOT COMPLETED|Stage 1||6
639330|NCT00097370|1571495|P1|COMPLETED|Stage 1||31
639331|NCT00097370|1571495|P1|STARTED|Stage 1|Participants entered from study MHE100185.|37
639332|NCT00097253|1571512|P1|NOT COMPLETED|Water (Control)||0
639333|NCT00097253|1571512|P1|COMPLETED|Water (Control)||56
639334|NCT00097253|1571512|P1|STARTED|Water (Control)||56
639335|NCT00097253|1571512|P1|NOT COMPLETED|Lemon||0
639336|NCT00097253|1571512|P1|COMPLETED|Lemon||56
639337|NCT00097253|1571512|P1|STARTED|Lemon||56
639338|NCT00097253|1571512|P1|NOT COMPLETED|Lavender||0
639339|NCT00097253|1571512|P1|COMPLETED|Lavender||56
639340|NCT00097253|1571512|P1|STARTED|Lavender||56
639341|NCT00096993|1571529|P2|NOT COMPLETED|Overall Study||65
639342|NCT00096993|1571530|P1|NOT COMPLETED|Overall Study||65
639343|NCT00096993|1571529|P2|COMPLETED|Overall Study||0
639344|NCT00096993|1571530|P1|COMPLETED|Overall Study||1
639345|NCT00096993|1571529|P2|STARTED|Overall Study||65
639346|NCT00096993|1571530|P1|STARTED|Overall Study||66
639347|NCT00096954|1571546|P2|NOT COMPLETED|Overall Study||20
639348|NCT00096954|1571547|P1|NOT COMPLETED|Overall Study||24
639349|NCT00096954|1571546|P2|COMPLETED|Overall Study||154
639350|NCT00096954|1571547|P1|COMPLETED|Overall Study||135
639351|NCT00096954|1571546|P2|Received Study Drug|Overall Study||171
639352|NCT00096954|1571547|P1|Received Study Drug|Overall Study||157
639353|NCT00096954|1571546|P2|STARTED|Overall Study||174
639354|NCT00096954|1571547|P1|STARTED|Overall Study||159
639355|NCT00096941|1571559|P1|NOT COMPLETED|Overall Study||3
639356|NCT00096941|1571559|P1|COMPLETED|Overall Study||0
639357|NCT00096941|1571559|P1|STARTED|Overall Study||3
639358|NCT00096785|1571566|P2|NOT COMPLETED|Overall Study||1
639359|NCT00096785|1571567|P1|NOT COMPLETED|Overall Study||2
639360|NCT00096785|1571566|P2|COMPLETED|Overall Study|As randomized cohort|33
639361|NCT00096785|1571567|P1|COMPLETED|Overall Study|As randomized cohort|33
639362|NCT00096785|1571566|P2|As-Treated Population|Overall Study||33
639363|NCT00096785|1571567|P1|As-Treated Population|Overall Study||36
639364|NCT00096785|1571566|P2|As-Randomized Population|Overall Study||34
639365|NCT00096785|1571567|P1|As-Randomized Population|Overall Study||35
639366|NCT00096785|1571566|P2|STARTED|Overall Study|1 participant randomized to ADV, treated with ETV. (As randomized= 34; as treated=33)|34
639367|NCT00096785|1571567|P1|STARTED|Overall Study|1 participant randomized to ADV, treated with ETV. (As randomized= 35; as treated=36)|35
639368|NCT00096681|1571591|P1|NOT COMPLETED|Overall Study||0
639369|NCT00096681|1571591|P1|COMPLETED|Overall Study||762
639370|NCT00096681|1571591|P1|STARTED|Overall Study||762
639371|NCT00096538|1571596|P1|NOT COMPLETED|Overall Study||1
639372|NCT00096538|1571596|P1|COMPLETED|Overall Study||5
639373|NCT00096538|1571596|P1|STARTED|Overall Study||6
639374|NCT00096486|1571604|P4|NOT COMPLETED|Overall Study||2
639375|NCT00096486|1571605|P3|NOT COMPLETED|Overall Study||2
639376|NCT00096486|1571606|P2|NOT COMPLETED|Overall Study||0
639377|NCT00096486|1571607|P1|NOT COMPLETED|Overall Study||0
639378|NCT00096486|1571604|P4|COMPLETED|Overall Study||36
639379|NCT00096486|1571605|P3|COMPLETED|Overall Study||24
639380|NCT00096486|1571606|P2|COMPLETED|Overall Study||6
639381|NCT00096486|1571607|P1|COMPLETED|Overall Study||4
639382|NCT00096486|1571604|P4|STARTED|Overall Study||38
639383|NCT00096486|1571605|P3|STARTED|Overall Study||26
639384|NCT00096486|1571606|P2|STARTED|Overall Study||6
639385|NCT00096486|1571607|P1|STARTED|Overall Study||4
639386|NCT00096460|1571619|P2|NOT COMPLETED|Overall Study||1
639387|NCT00096460|1571620|P1|NOT COMPLETED|Overall Study||7
639388|NCT00096460|1571619|P2|COMPLETED|Overall Study||7
639389|NCT00096460|1571620|P1|COMPLETED|Overall Study||15
639390|NCT00096460|1571619|P2|STARTED|Overall Study||8
639391|NCT00096460|1571620|P1|STARTED|Overall Study||22
639392|NCT00096447|1571626|P1|NOT COMPLETED|Overall Study||1
639393|NCT00096447|1571626|P1|COMPLETED|Overall Study|Eligible and treated patients.|30
639394|NCT00096447|1571626|P1|STARTED|Overall Study||31
639395|NCT00096382|1571642|P2|NOT COMPLETED|Overall Study||0
639396|NCT00096382|1571643|P1|NOT COMPLETED|Overall Study||2
639397|NCT00096382|1571642|P2|COMPLETED|Overall Study||3
639398|NCT00096382|1571643|P1|COMPLETED|Overall Study||21
639399|NCT00096382|1571642|P2|STARTED|Overall Study||3
639400|NCT00096382|1571643|P1|STARTED|Overall Study||23
639401|NCT00096356|1571653|P2|NOT COMPLETED|Overall Study||53
639402|NCT00096356|1571654|P1|NOT COMPLETED|Overall Study||44
639403|NCT00096356|1571653|P2|COMPLETED|Overall Study||61
639404|NCT00096356|1571654|P1|COMPLETED|Overall Study||78
639405|NCT00096356|1571653|P2|STARTED|Overall Study||114
639406|NCT00096356|1571654|P1|STARTED|Overall Study||122
639407|NCT00096278|1571666|P2|NOT COMPLETED|Overall Study||20
639408|NCT00096278|1571667|P1|NOT COMPLETED|Overall Study||18
639409|NCT00096278|1571666|P2|COMPLETED|Overall Study||1334
639410|NCT00096278|1571667|P1|COMPLETED|Overall Study||1338
639411|NCT00096278|1571666|P2|STARTED|Overall Study||1354
639412|NCT00096278|1571667|P1|STARTED|Overall Study||1356
639413|NCT00096265|1571676|P3|NOT COMPLETED|Overall Study||0
639414|NCT00096265|1571677|P2|NOT COMPLETED|Overall Study||0
639415|NCT00096265|1571678|P1|NOT COMPLETED|Overall Study||1
639416|NCT00096265|1571676|P3|COMPLETED|Overall Study||41
639417|NCT00096265|1571677|P2|COMPLETED|Overall Study||40
639418|NCT00096265|1571678|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
639419|NCT00096265|1571676|P3|STARTED|Overall Study||41
639420|NCT00096265|1571677|P2|STARTED|Overall Study||40
639421|NCT00096265|1571678|P1|STARTED|Overall Study||45
639422|NCT00096226|1571704|P1|NOT COMPLETED|Overall Study||17
639423|NCT00096226|1571704|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|43
639424|NCT00096226|1571704|P1|STARTED|Overall Study||60
639425|NCT00096200|1571711|P3|NOT COMPLETED|Overall Study||0
639426|NCT00096200|1571712|P2|NOT COMPLETED|Overall Study||7
639427|NCT00096200|1571713|P1|NOT COMPLETED|Overall Study||1
639428|NCT00096200|1571711|P3|COMPLETED|Overall Study||5
639429|NCT00096200|1571712|P2|COMPLETED|Overall Study||23
639430|NCT00096200|1571713|P1|COMPLETED|Overall Study||8
639431|NCT00096200|1571711|P3|STARTED|Overall Study||5
639432|NCT00096200|1571712|P2|STARTED|Overall Study||30
639433|NCT00096200|1571713|P1|STARTED|Overall Study||9
639434|NCT00096174|1571721|P1|NOT COMPLETED|Overall Study||62
639435|NCT00096174|1571721|P1|COMPLETED|Overall Study||7
639436|NCT00096174|1571721|P1|Eligible and Treated|Overall Study|6 treated patients were ineligible|60
639437|NCT00096174|1571721|P1|Began Protocol Therapy|Overall Study|3 patients never started treatment|66
639438|NCT00096174|1571721|P1|STARTED|Overall Study||69
639439|NCT00096161|1571731|P4|NOT COMPLETED|Overall Study||0
639440|NCT00096161|1571732|P3|NOT COMPLETED|Overall Study||0
639441|NCT00096161|1571733|P2|NOT COMPLETED|Overall Study||0
639442|NCT00096161|1571734|P1|NOT COMPLETED|Overall Study||0
639443|NCT00096161|1571731|P4|COMPLETED|Overall Study||0
639444|NCT00096161|1571732|P3|COMPLETED|Overall Study||6
639445|NCT00096161|1571733|P2|COMPLETED|Overall Study||10
639446|NCT00096161|1571734|P1|COMPLETED|Overall Study||20
639447|NCT00096161|1571731|P4|STARTED|Overall Study||0
639448|NCT00096161|1571732|P3|STARTED|Overall Study||6
639449|NCT00096161|1571733|P2|STARTED|Overall Study||10
639450|NCT00096161|1571734|P1|STARTED|Overall Study||20
639451|NCT00096135|1571766|P2|NOT COMPLETED|Overall Study||15
639452|NCT00096135|1571767|P1|NOT COMPLETED|Overall Study||63
639453|NCT00096135|1571766|P2|COMPLETED|Overall Study||27
639454|NCT00096135|1571767|P1|COMPLETED|Overall Study||63
639455|NCT00096135|1571766|P2|STARTED|Overall Study||42
639456|NCT00096135|1571767|P1|STARTED|Overall Study||126
639457|NCT00096122|1571773|P1|NOT COMPLETED|Overall Study||0
639458|NCT00096122|1571773|P1|COMPLETED|Overall Study||95
639459|NCT00096122|1571773|P1|STARTED|Overall Study||95
639460|NCT00096109|1571777|P1|NOT COMPLETED|Overall Study||0
639461|NCT00096109|1571777|P1|COMPLETED|Overall Study||11
639462|NCT00096109|1571777|P1|STARTED|Overall Study||11
639463|NCT00096044|1571783|P1|NOT COMPLETED|Overall Study||34
639464|NCT00096044|1571783|P1|COMPLETED|Overall Study||11
639465|NCT00096044|1571783|P1|STARTED|Overall Study||45
639466|NCT00096031|1571792|P1|NOT COMPLETED|Overall Study||63
639467|NCT00096031|1571792|P1|COMPLETED|Overall Study||0
639468|NCT00096031|1571792|P1|Eligible and Began Protocol Therapy|Overall Study||55
639469|NCT00096031|1571792|P1|Eligible|Overall Study||57
639470|NCT00096031|1571792|P1|STARTED|Overall Study||63
639471|NCT00096018|1571800|P2|NOT COMPLETED|Overall Study||14
639472|NCT00096018|1571801|P1|NOT COMPLETED|Overall Study||2
639473|NCT00096018|1571800|P2|COMPLETED|Overall Study||16
639474|NCT00096018|1571801|P1|COMPLETED|Overall Study||11
639475|NCT00096018|1571800|P2|Treated With Study Therapy|Overall Study||25
639476|NCT00096018|1571801|P1|Treated With Study Therapy|Overall Study||13
639477|NCT00096018|1571800|P2|STARTED|Overall Study||30
639478|NCT00096018|1571801|P1|STARTED|Overall Study||13
639479|NCT00095979|1571809|P1|NOT COMPLETED|Overall Study||2
639480|NCT00095979|1571809|P1|COMPLETED|Overall Study||50
639481|NCT00095979|1571809|P1|STARTED|Overall Study||52
639482|NCT00095940|1571827|P9|NOT COMPLETED|Lapatinib Continuation/Phase II||13
639483|NCT00095940|1571828|P8|NOT COMPLETED|Lapatinib Continuation/Phase II||2
639484|NCT00095940|1571829|P7|NOT COMPLETED|Lapatinib Continuation/Phase II||2
639485|NCT00095940|1571830|P6|NOT COMPLETED|Lapatinib Continuation/Phase II||13
639486|NCT00095940|1571831|P5|NOT COMPLETED|Lapatinib Continuation/Phase II||0
639487|NCT00095940|1571832|P4|NOT COMPLETED|Lapatinib Continuation/Phase II||0
639488|NCT00095940|1571833|P3|NOT COMPLETED|Lapatinib Continuation/Phase II||16
639489|NCT00095940|1571834|P2|NOT COMPLETED|Lapatinib Continuation/Phase II||2
639490|NCT00095940|1571835|P1|NOT COMPLETED|Lapatinib Continuation/Phase II||2
639491|NCT00095940|1571827|P9|COMPLETED|Lapatinib Continuation/Phase II||1
639492|NCT00095940|1571828|P8|COMPLETED|Lapatinib Continuation/Phase II||0
639493|NCT00095940|1571829|P7|COMPLETED|Lapatinib Continuation/Phase II||0
639494|NCT00095940|1571830|P6|COMPLETED|Lapatinib Continuation/Phase II||0
639495|NCT00095940|1571831|P5|COMPLETED|Lapatinib Continuation/Phase II||0
639496|NCT00095940|1571832|P4|COMPLETED|Lapatinib Continuation/Phase II||0
639497|NCT00095940|1571833|P3|COMPLETED|Lapatinib Continuation/Phase II||1
639498|NCT00095940|1571834|P2|COMPLETED|Lapatinib Continuation/Phase II||0
639499|NCT00095940|1571835|P1|COMPLETED|Lapatinib Continuation/Phase II||0
639500|NCT00095940|1571827|P9|STARTED|Lapatinib Continuation/Phase II||14
639581|NCT00095303|1572364|P1|COMPLETED|Follow Up Study||140
639501|NCT00095940|1571828|P8|STARTED|Lapatinib Continuation/Phase II|No measurable disease post surgery - ineligible for the phase II. Continued to receive lapatinib.|2
639502|NCT00095940|1571829|P7|STARTED|Lapatinib Continuation/Phase II|Continued to receive lapatinib but were ineligible for the phase II.|2
639503|NCT00095940|1571830|P6|STARTED|Lapatinib Continuation/Phase II||13
639504|NCT00095940|1571831|P5|STARTED|Lapatinib Continuation/Phase II||0
639505|NCT00095940|1571832|P4|STARTED|Lapatinib Continuation/Phase II||0
639506|NCT00095940|1571833|P3|STARTED|Lapatinib Continuation/Phase II||17
639507|NCT00095940|1571834|P2|STARTED|Lapatinib Continuation/Phase II|No measurable disease post surgery - ineligible for the phase II. Continued to receive lapatinib.|2
639508|NCT00095940|1571835|P1|STARTED|Lapatinib Continuation/Phase II|Continued to receive lapatinib but were ineligible for the phase II.|2
639509|NCT00095940|1571827|P9|NOT COMPLETED|Molecular Biology Phase||0
639510|NCT00095940|1571828|P8|NOT COMPLETED|Molecular Biology Phase||0
639511|NCT00095940|1571829|P7|NOT COMPLETED|Molecular Biology Phase||0
639512|NCT00095940|1571830|P6|NOT COMPLETED|Molecular Biology Phase||0
639513|NCT00095940|1571831|P5|NOT COMPLETED|Molecular Biology Phase||0
639514|NCT00095940|1571832|P4|NOT COMPLETED|Molecular Biology Phase||0
639515|NCT00095940|1571833|P3|NOT COMPLETED|Molecular Biology Phase||0
639516|NCT00095940|1571834|P2|NOT COMPLETED|Molecular Biology Phase||0
639517|NCT00095940|1571835|P1|NOT COMPLETED|Molecular Biology Phase||0
639518|NCT00095940|1571827|P9|COMPLETED|Molecular Biology Phase||0
639519|NCT00095940|1571828|P8|COMPLETED|Molecular Biology Phase||2
639520|NCT00095940|1571829|P7|COMPLETED|Molecular Biology Phase||2
639521|NCT00095940|1571830|P6|COMPLETED|Molecular Biology Phase||0
639522|NCT00095940|1571831|P5|COMPLETED|Molecular Biology Phase||0
639523|NCT00095940|1571832|P4|COMPLETED|Molecular Biology Phase||0
639524|NCT00095940|1571833|P3|COMPLETED|Molecular Biology Phase||0
639525|NCT00095940|1571834|P2|COMPLETED|Molecular Biology Phase||2
639526|NCT00095940|1571835|P1|COMPLETED|Molecular Biology Phase||2
639527|NCT00095940|1571827|P9|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
639528|NCT00095940|1571828|P8|STARTED|Molecular Biology Phase||2
639529|NCT00095940|1571829|P7|STARTED|Molecular Biology Phase||2
639530|NCT00095940|1571830|P6|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
639531|NCT00095940|1571831|P5|STARTED|Molecular Biology Phase||0
639532|NCT00095940|1571832|P4|STARTED|Molecular Biology Phase||0
639533|NCT00095940|1571833|P3|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
639534|NCT00095940|1571834|P2|STARTED|Molecular Biology Phase||2
639535|NCT00095940|1571835|P1|STARTED|Molecular Biology Phase||2
639536|NCT00095875|1571859|P2|NOT COMPLETED|Overall Study||9
639537|NCT00095875|1571860|P1|NOT COMPLETED|Overall Study||14
639538|NCT00095875|1571859|P2|COMPLETED|Overall Study||66
639539|NCT00095875|1571860|P1|COMPLETED|Overall Study||56
639540|NCT00095875|1571859|P2|STARTED|Overall Study||75
639541|NCT00095875|1571860|P1|STARTED|Overall Study||70
639542|NCT00095836|1571868|P1|NOT COMPLETED|Overall Study||4
639543|NCT00095836|1571868|P1|COMPLETED|Overall Study||23
639544|NCT00095836|1571868|P1|STARTED|Overall Study||27
639545|NCT00095784|1571875|P1|NOT COMPLETED|Overall Study||0
639546|NCT00095784|1571875|P1|COMPLETED|Overall Study||21
639547|NCT00095784|1571875|P1|STARTED|Overall Study||21
639548|NCT00095628|1571898|P1|NOT COMPLETED|Overall Study||1
639549|NCT00095628|1571898|P1|COMPLETED|Overall Study||20
639550|NCT00095628|1571898|P1|STARTED|Overall Study||21
639551|NCT00095576|1571909|P2|NOT COMPLETED|Overall Study||1481
639552|NCT00095576|1571910|P1|NOT COMPLETED|Overall Study||1475
639553|NCT00095576|1571909|P2|COMPLETED|Overall Study|Subjects not completing entire study were eligible for observational long term follow up in V520-030|14
639554|NCT00095576|1571910|P1|COMPLETED|Overall Study|Subjects not completing entire study were eligible for observational long term follow up in V520-030|9
639555|NCT00095576|1571909|P2|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1361
639556|NCT00095576|1571910|P1|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1328
639557|NCT00095576|1571909|P2|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1443
639558|NCT00095576|1571910|P1|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1426
639559|NCT00095576|1571909|P2|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1495
639560|NCT00095576|1571910|P1|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1484
639561|NCT00095576|1571909|P2|STARTED|Overall Study||1495
639562|NCT00095576|1571910|P1|STARTED|Overall Study||1484
639563|NCT00095563|1571922|P1|NOT COMPLETED|Overall Study||0
639564|NCT00095563|1571922|P1|COMPLETED|Overall Study||39
639565|NCT00095563|1571922|P1|STARTED|Overall Study||39
639566|NCT00095498|1571934|P3|NOT COMPLETED|Overall Study||39
639567|NCT00095498|1571935|P2|NOT COMPLETED|Overall Study||35
639568|NCT00095498|1571936|P1|NOT COMPLETED|Overall Study||37
639569|NCT00095498|1571934|P3|COMPLETED|Overall Study||39
639570|NCT00095498|1571935|P2|COMPLETED|Overall Study||38
639571|NCT00095498|1571936|P1|COMPLETED|Overall Study||39
639572|NCT00095498|1571934|P3|Received Investigational Product|Overall Study||75
639573|NCT00095498|1571935|P2|Received Investigational Product|Overall Study||71
639574|NCT00095498|1571936|P1|Received Investigational Product|Overall Study||72
639575|NCT00095498|1571934|P3|STARTED|Overall Study||78
639576|NCT00095498|1571935|P2|STARTED|Overall Study||73
639577|NCT00095498|1571936|P1|STARTED|Overall Study||76
639578|NCT00095303|1572363|P2|NOT COMPLETED|Follow Up Study||58
639579|NCT00095303|1572364|P1|NOT COMPLETED|Follow Up Study||59
639580|NCT00095303|1572363|P2|COMPLETED|Follow Up Study||121
639582|NCT00095303|1572363|P2|STARTED|Follow Up Study|179 (TAU) gave permission for future contact; not a requirement to finish Main to start Follow up|179
639583|NCT00095303|1572364|P1|STARTED|Follow Up Study|199 (BSFT) gave permission for future contact; not a requirement to finish Main to start Follow up|199
639584|NCT00095303|1572363|P2|NOT COMPLETED|Main Study||87
639585|NCT00095303|1572364|P1|NOT COMPLETED|Main Study||91
639586|NCT00095303|1572363|P2|COMPLETED|Main Study||148
639587|NCT00095303|1572364|P1|COMPLETED|Main Study||154
639588|NCT00095303|1572363|P2|STARTED|Main Study||235
639589|NCT00095303|1572364|P1|STARTED|Main Study||245
639590|NCT00095238|1572432|P2|NOT COMPLETED|Overall Study||852
639591|NCT00095238|1572433|P1|NOT COMPLETED|Overall Study||857
639592|NCT00095238|1572432|P2|COMPLETED|Overall Study|completed double-blind therapy|1209
639593|NCT00095238|1572433|P1|COMPLETED|Overall Study|completed double-blind therapy|1210
639594|NCT00095238|1572432|P2|Safety (Treated) Population|Overall Study|One participant randomized to irbesartan received placebo.|2062
639595|NCT00095238|1572433|P1|Safety (Treated) Population|Overall Study|Two participants were randomized but not treated; 1 randomized to irbesartan received placebo|2064
639596|NCT00095238|1572432|P2|STARTED|Overall Study|number randomized|2061
639597|NCT00095238|1572433|P1|STARTED|Overall Study|number randomized|2067
639598|NCT00095212|1572495|P2|NOT COMPLETED|Overall Study||3
639599|NCT00095212|1572496|P1|NOT COMPLETED|Overall Study||1
639600|NCT00095212|1572495|P2|COMPLETED|Overall Study||9
639601|NCT00095212|1572496|P1|COMPLETED|Overall Study||12
639602|NCT00095212|1572495|P2|STARTED|Overall Study||12
639603|NCT00095212|1572496|P1|STARTED|Overall Study||13
639604|NCT00095199|1572526|P4|NOT COMPLETED|Overall Study||143
639605|NCT00095199|1572527|P3|NOT COMPLETED|Overall Study||160
639606|NCT00095199|1572528|P2|NOT COMPLETED|Overall Study||242
639607|NCT00095199|1572529|P1|NOT COMPLETED|Overall Study||296
639608|NCT00095199|1572526|P4|COMPLETED|Overall Study||23
639609|NCT00095199|1572527|P3|COMPLETED|Overall Study||7
639610|NCT00095199|1572528|P2|COMPLETED|Overall Study||62
639611|NCT00095199|1572529|P1|COMPLETED|Overall Study||6
639612|NCT00095199|1572526|P4|STARTED|Overall Study||166
639613|NCT00095199|1572527|P3|STARTED|Overall Study||167
639614|NCT00095199|1572528|P2|STARTED|Overall Study||304
639615|NCT00095199|1572529|P1|STARTED|Overall Study|1 participant has no data in database; not included in analyses. Data was lost/destroyed at site.|302
639616|NCT00095173|1572567|P6|NOT COMPLETED|Open-Label Extension Phase (Period C)||32
639617|NCT00095173|1572568|P5|NOT COMPLETED|Open-Label Extension Phase (Period C)||29
639618|NCT00095173|1572569|P4|NOT COMPLETED|Open-Label Extension Phase (Period C)||23
639619|NCT00095173|1572570|P3|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
639620|NCT00095173|1572571|P2|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
639621|NCT00095173|1572572|P1|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
639622|NCT00095173|1572567|P6|COMPLETED|Open-Label Extension Phase (Period C)||27
639623|NCT00095173|1572568|P5|COMPLETED|Open-Label Extension Phase (Period C)||29
639624|NCT00095173|1572569|P4|COMPLETED|Open-Label Extension Phase (Period C)||13
639625|NCT00095173|1572570|P3|COMPLETED|Open-Label Extension Phase (Period C)||0
639626|NCT00095173|1572571|P2|COMPLETED|Open-Label Extension Phase (Period C)||0
639627|NCT00095173|1572572|P1|COMPLETED|Open-Label Extension Phase (Period C)||0
639628|NCT00095173|1572567|P6|STARTED|Open-Label Extension Phase (Period C)|Includes 33 who discontinued Period B due to a flare and 26 who completed Period B with no flare|59
639629|NCT00095173|1572568|P5|STARTED|Open-Label Extension Phase (Period C)|Includes 47 who completed Period B with no flare and 11 who discontinued Period B due to a flare|58
639630|NCT00095173|1572569|P4|STARTED|Open-Label Extension Phase (Period C)|Participants were non-responders from Period A who re-entered in Period C.|36
639631|NCT00095173|1572570|P3|STARTED|Open-Label Extension Phase (Period C)||0
639632|NCT00095173|1572571|P2|STARTED|Open-Label Extension Phase (Period C)||0
639633|NCT00095173|1572572|P1|STARTED|Open-Label Extension Phase (Period C)||0
639634|NCT00095173|1572567|P6|NOT COMPLETED|Double-Blind Phase (Period B)||0
639635|NCT00095173|1572568|P5|NOT COMPLETED|Double-Blind Phase (Period B)||0
639636|NCT00095173|1572569|P4|NOT COMPLETED|Double-Blind Phase (Period B)||0
639637|NCT00095173|1572570|P3|NOT COMPLETED|Double-Blind Phase (Period B)||31
639638|NCT00095173|1572571|P2|NOT COMPLETED|Double-Blind Phase (Period B)||11
639639|NCT00095173|1572572|P1|NOT COMPLETED|Double-Blind Phase (Period B)||0
639640|NCT00095173|1572567|P6|COMPLETED|Double-Blind Phase (Period B)||0
639641|NCT00095173|1572568|P5|COMPLETED|Double-Blind Phase (Period B)||0
639642|NCT00095173|1572569|P4|COMPLETED|Double-Blind Phase (Period B)||0
639643|NCT00095173|1572570|P3|COMPLETED|Double-Blind Phase (Period B)||31
639644|NCT00095173|1572571|P2|COMPLETED|Double-Blind Phase (Period B)||49
639645|NCT00095173|1572572|P1|COMPLETED|Double-Blind Phase (Period B)||0
639646|NCT00095173|1572567|P6|STARTED|Double-Blind Phase (Period B)||0
639647|NCT00095173|1572568|P5|STARTED|Double-Blind Phase (Period B)||0
639648|NCT00095173|1572569|P4|STARTED|Double-Blind Phase (Period B)||0
639649|NCT00095173|1572570|P3|STARTED|Double-Blind Phase (Period B)|123 responders from Period A qualified;122 entered and were randomized to abatacept and placebo.|62
639650|NCT00095173|1572571|P2|STARTED|Double-Blind Phase (Period B)|123 responders from Period A qualified;122 entered and were randomized to abatacept and placebo.|60
639651|NCT00095173|1572572|P1|STARTED|Double-Blind Phase (Period B)|All participants did not continue; responders entered Period B; non-responders re-entered Period C.|0
639652|NCT00095173|1572567|P6|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
639653|NCT00095173|1572568|P5|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
639654|NCT00095173|1572569|P4|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
639655|NCT00095173|1572570|P3|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
639656|NCT00095173|1572571|P2|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
639657|NCT00095173|1572572|P1|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||20
639658|NCT00095173|1572567|P6|COMPLETED|Open-Label Lead-In Phase (Period A)||0
639659|NCT00095173|1572568|P5|COMPLETED|Open-Label Lead-In Phase (Period A)||0
639660|NCT00095173|1572569|P4|COMPLETED|Open-Label Lead-In Phase (Period A)||0
639661|NCT00095173|1572570|P3|COMPLETED|Open-Label Lead-In Phase (Period A)||0
639662|NCT00095173|1572571|P2|COMPLETED|Open-Label Lead-In Phase (Period A)||0
639663|NCT00095173|1572572|P1|COMPLETED|Open-Label Lead-In Phase (Period A)||170
639664|NCT00095173|1572567|P6|STARTED|Open-Label Lead-In Phase (Period A)||0
639665|NCT00095173|1572568|P5|STARTED|Open-Label Lead-In Phase (Period A)||0
639666|NCT00095173|1572569|P4|STARTED|Open-Label Lead-In Phase (Period A)||0
639667|NCT00095173|1572570|P3|STARTED|Open-Label Lead-In Phase (Period A)||0
639668|NCT00095173|1572571|P2|STARTED|Open-Label Lead-In Phase (Period A)||0
639669|NCT00095173|1572572|P1|STARTED|Open-Label Lead-In Phase (Period A)||190
639670|NCT00095147|1572610|P5|NOT COMPLETED|Long-term Extension Period||45
639671|NCT00095147|1572611|P4|NOT COMPLETED|Long-term Extension Period||0
639672|NCT00095147|1572612|P3|NOT COMPLETED|Long-term Extension Period||0
639673|NCT00095147|1572613|P2|NOT COMPLETED|Long-term Extension Period||0
639674|NCT00095147|1572614|P1|NOT COMPLETED|Long-term Extension Period||0
639675|NCT00095147|1572610|P5|COMPLETED|Long-term Extension Period||327
639676|NCT00095147|1572611|P4|COMPLETED|Long-term Extension Period||0
639677|NCT00095147|1572612|P3|COMPLETED|Long-term Extension Period||0
639678|NCT00095147|1572613|P2|COMPLETED|Long-term Extension Period||0
639679|NCT00095147|1572614|P1|COMPLETED|Long-term Extension Period||0
639680|NCT00095147|1572610|P5|STARTED|Long-term Extension Period||372
639681|NCT00095147|1572611|P4|STARTED|Long-term Extension Period||0
639682|NCT00095147|1572612|P3|STARTED|Long-term Extension Period||0
639683|NCT00095147|1572613|P2|STARTED|Long-term Extension Period||0
639684|NCT00095147|1572614|P1|STARTED|Long-term Extension Period||0
639685|NCT00095147|1572610|P5|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0
639686|NCT00095147|1572611|P4|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||3
639687|NCT00095147|1572612|P3|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0
639688|NCT00095147|1572613|P2|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||11
639689|NCT00095147|1572614|P1|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||8
639690|NCT00095147|1572610|P5|COMPLETED|Double-blind Period 2 (Days 198-365)||0
639691|NCT00095147|1572611|P4|COMPLETED|Double-blind Period 2 (Days 198-365)||104
639692|NCT00095147|1572612|P3|COMPLETED|Double-blind Period 2 (Days 198-365)||0
639693|NCT00095147|1572613|P2|COMPLETED|Double-blind Period 2 (Days 198-365)||141
639694|NCT00095147|1572614|P1|COMPLETED|Double-blind Period 2 (Days 198-365)||139
639695|NCT00095147|1572610|P5|STARTED|Double-blind Period 2 (Days 198-365)||0
639696|NCT00095147|1572611|P4|STARTED|Double-blind Period 2 (Days 198-365)||107
639697|NCT00095147|1572612|P3|STARTED|Double-blind Period 2 (Days 198-365)||0
639698|NCT00095147|1572613|P2|STARTED|Double-blind Period 2 (Days 198-365)||152
639699|NCT00095147|1572614|P1|STARTED|Double-blind Period 2 (Days 198-365)||147
639700|NCT00095147|1572610|P5|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0
639701|NCT00095147|1572611|P4|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0
639702|NCT00095147|1572612|P3|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||3
639703|NCT00095147|1572613|P2|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||13
639704|NCT00095147|1572614|P1|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||9
639705|NCT00095147|1572610|P5|COMPLETED|Double-blind Period 1 (Days 1-197)||0
639706|NCT00095147|1572611|P4|COMPLETED|Double-blind Period 1 (Days 1-197)||0
639707|NCT00095147|1572612|P3|COMPLETED|Double-blind Period 1 (Days 1-197)||107
639708|NCT00095147|1572613|P2|COMPLETED|Double-blind Period 1 (Days 1-197)||152
639709|NCT00095147|1572614|P1|COMPLETED|Double-blind Period 1 (Days 1-197)||147
639710|NCT00095147|1572610|P5|STARTED|Double-blind Period 1 (Days 1-197)||0
639711|NCT00095147|1572611|P4|STARTED|Double-blind Period 1 (Days 1-197)||0
639712|NCT00095147|1572612|P3|STARTED|Double-blind Period 1 (Days 1-197)||110
639713|NCT00095147|1572613|P2|STARTED|Double-blind Period 1 (Days 1-197)||165
639714|NCT00095147|1572614|P1|STARTED|Double-blind Period 1 (Days 1-197)||156
639715|NCT00095121|1572809|P2|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||19
639716|NCT00095121|1572810|P1|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||62
639717|NCT00095121|1572809|P2|COMPLETED|Open-Label (Study Weeks 49 Through 240)|Completed the 240-week study period either on or off treatment at Week 240.|35
639718|NCT00095121|1572810|P1|COMPLETED|Open-Label (Study Weeks 49 Through 240)|Completed the 240-week study period either on or off treatment at Week 240.|46
639719|NCT00095121|1572809|P2|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||11
639720|NCT00095121|1572810|P1|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||21
639721|NCT00095121|1572809|P2|STARTED|Open-Label (Study Weeks 49 Through 240)||54
639722|NCT00095121|1572810|P1|STARTED|Open-Label (Study Weeks 49 Through 240)||108
639723|NCT00095121|1572809|P2|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||0
639724|NCT00095121|1572810|P1|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||3
639725|NCT00095121|1572809|P2|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||58
639726|NCT00095121|1572810|P1|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||112
639727|NCT00095121|1572809|P2|STARTED|Double-Blind (Study Weeks 0 Through 48)||58
639728|NCT00095121|1572810|P1|STARTED|Double-Blind (Study Weeks 0 Through 48)||115
639729|NCT00095056|1572856|P2|NOT COMPLETED|Phase B (Weeks 12-54)||5
639730|NCT00095056|1572857|P1|NOT COMPLETED|Phase B (Weeks 12-54)||10
639731|NCT00095056|1572856|P2|COMPLETED|Phase B (Weeks 12-54)||20
639732|NCT00095056|1572857|P1|COMPLETED|Phase B (Weeks 12-54)||46
639733|NCT00095056|1572856|P2|STARTED|Phase B (Weeks 12-54)||25
639734|NCT00095056|1572857|P1|STARTED|Phase B (Weeks 12-54)|2 randomized patients completed Period 1 but did not enter Period 2.|56
639735|NCT00095056|1572856|P2|NOT COMPLETED|Phase A (Weeks 0-12)||1
639736|NCT00095056|1572857|P1|NOT COMPLETED|Phase A (Weeks 0-12)||7
639737|NCT00095056|1572856|P2|COMPLETED|Phase A (Weeks 0-12)||25
639738|NCT00095056|1572857|P1|COMPLETED|Phase A (Weeks 0-12)||58
639739|NCT00095056|1572856|P2|STARTED|Phase A (Weeks 0-12)||26
639740|NCT00095056|1572857|P1|STARTED|Phase A (Weeks 0-12)||65
639741|NCT00094900|1572865|P1|NOT COMPLETED|Overall Study||1
639742|NCT00094900|1572865|P1|COMPLETED|Overall Study||10
639743|NCT00094900|1572865|P1|STARTED|Overall Study||11
639744|NCT00094887|1572967|P2|NOT COMPLETED|Overall Study||6
639745|NCT00094887|1572968|P1|NOT COMPLETED|Overall Study||5
639746|NCT00094887|1572967|P2|COMPLETED|Overall Study||69
639747|NCT00094887|1572968|P1|COMPLETED|Overall Study||70
639748|NCT00094887|1572967|P2|STARTED|Overall Study|75|75
639749|NCT00094887|1572968|P1|STARTED|Overall Study|75|75
639750|NCT00094861|1572976|P2|NOT COMPLETED|Overall Study||9
639751|NCT00094861|1572977|P1|NOT COMPLETED|Overall Study||18
639752|NCT00094861|1572976|P2|COMPLETED|Overall Study|Participants who completed the acute dysphagia evaluation phase|40
639753|NCT00094861|1572977|P1|COMPLETED|Overall Study|Participants who completed the acute dysphagia evaluation phase|28
639754|NCT00094861|1572976|P2|Participants Treated|Overall Study||48
639755|NCT00094861|1572977|P1|Participants Treated|Overall Study||46
639756|NCT00094861|1572976|P2|STARTED|Overall Study||49
639757|NCT00094861|1572977|P1|STARTED|Overall Study||46
639758|NCT00094835|1573004|P7|NOT COMPLETED|Overall Study||2
639759|NCT00094835|1573005|P6|NOT COMPLETED|Overall Study||3
639760|NCT00094835|1573006|P5|NOT COMPLETED|Overall Study||4
639761|NCT00094835|1573007|P4|NOT COMPLETED|Overall Study||1
639762|NCT00094835|1573008|P3|NOT COMPLETED|Overall Study||3
639763|NCT00094835|1573009|P2|NOT COMPLETED|Overall Study||3
639764|NCT00094835|1573010|P1|NOT COMPLETED|Overall Study||4
639765|NCT00094835|1573004|P7|COMPLETED|Overall Study||4
639766|NCT00094835|1573005|P6|COMPLETED|Overall Study||3
639767|NCT00094835|1573006|P5|COMPLETED|Overall Study||3
639768|NCT00094835|1573007|P4|COMPLETED|Overall Study||4
639769|NCT00094835|1573008|P3|COMPLETED|Overall Study||4
639770|NCT00094835|1573009|P2|COMPLETED|Overall Study||8
639771|NCT00094835|1573010|P1|COMPLETED|Overall Study||5
639772|NCT00094835|1573004|P7|Treated With Motesanib|Overall Study||6
639773|NCT00094835|1573005|P6|Treated With Motesanib|Overall Study||5
639774|NCT00094835|1573006|P5|Treated With Motesanib|Overall Study||7
639775|NCT00094835|1573007|P4|Treated With Motesanib|Overall Study||4
639776|NCT00094835|1573008|P3|Treated With Motesanib|Overall Study||6
639777|NCT00094835|1573009|P2|Treated With Motesanib|Overall Study||11
639778|NCT00094835|1573010|P1|Treated With Motesanib|Overall Study||6
639779|NCT00094835|1573004|P7|STARTED|Overall Study||6
639780|NCT00094835|1573005|P6|STARTED|Overall Study||6
639781|NCT00094835|1573006|P5|STARTED|Overall Study||7
639782|NCT00094835|1573007|P4|STARTED|Overall Study||5
639783|NCT00094835|1573008|P3|STARTED|Overall Study||7
639784|NCT00094835|1573009|P2|STARTED|Overall Study||11
639785|NCT00094835|1573010|P1|STARTED|Overall Study||9
639786|NCT00094809|1573088|P2|NOT COMPLETED|Overall Study||65
639787|NCT00094809|1573089|P1|NOT COMPLETED|Overall Study||52
639788|NCT00094809|1573088|P2|COMPLETED|Overall Study|Subjects who completed treatment and LTFU|61
639789|NCT00094809|1573089|P1|COMPLETED|Overall Study|Subjects who completed treatment and Long term follow up (LTFU)|74
639790|NCT00094809|1573088|P2|Completed All 4 Cycles of Treatment|Overall Study||90
639791|NCT00094809|1573089|P1|Completed All 4 Cycles of Treatment|Overall Study||98
639792|NCT00094809|1573088|P2|Properly Consented; Received Study Drug|Overall Study||118
639793|NCT00094809|1573089|P1|Properly Consented; Received Study Drug|Overall Study||123
639794|NCT00094809|1573088|P2|Received Study Drug|Overall Study||118
639795|NCT00094809|1573089|P1|Received Study Drug|Overall Study||124
639796|NCT00094809|1573088|P2|STARTED|Overall Study||126
639797|NCT00094809|1573089|P1|STARTED|Overall Study||126
639798|NCT00094770|1573115|P2|NOT COMPLETED|Year 2 (Week 0 to Week 104)||320
639799|NCT00094770|1573116|P1|NOT COMPLETED|Year 2 (Week 0 to Week 104)||333
639800|NCT00094770|1573115|P2|COMPLETED|Year 2 (Week 0 to Week 104)||264
639801|NCT00094770|1573116|P1|COMPLETED|Year 2 (Week 0 to Week 104)||255
639802|NCT00094770|1573115|P2|STARTED|Year 2 (Week 0 to Week 104)||584
639803|NCT00094770|1573116|P1|STARTED|Year 2 (Week 0 to Week 104)||588
639804|NCT00094770|1573115|P2|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||172
639805|NCT00094770|1573116|P1|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||202
639806|NCT00094770|1573115|P2|COMPLETED|Year 1 ( Week 0 to Week 52)|11 Participants who Completed Week 52, Did NOT Enter second year|412
639807|NCT00094770|1573116|P1|COMPLETED|Year 1 ( Week 0 to Week 52)|4 Participants who Completed Week 52, Did NOT Enter second year|386
639808|NCT00094770|1573115|P2|STARTED|Year 1 ( Week 0 to Week 52)||584
639809|NCT00094770|1573116|P1|STARTED|Year 1 ( Week 0 to Week 52)||588
639810|NCT00094757|1573147|P3|NOT COMPLETED|Overall Study||30
639811|NCT00094757|1573148|P2|NOT COMPLETED|Overall Study||62
639812|NCT00094757|1573149|P1|NOT COMPLETED|Overall Study||53
639813|NCT00094757|1573147|P3|COMPLETED|Overall Study||80
639814|NCT00094757|1573148|P2|COMPLETED|Overall Study||144
639815|NCT00094757|1573149|P1|COMPLETED|Overall Study||152
639816|NCT00094757|1573147|P3|STARTED|Overall Study||110
639817|NCT00094757|1573148|P2|STARTED|Overall Study||206
639818|NCT00094757|1573149|P1|STARTED|Overall Study||205
639819|NCT00094653|1573169|P3|NOT COMPLETED|Overall Study||126
639820|NCT00094653|1573170|P2|NOT COMPLETED|Overall Study||106
639821|NCT00094653|1573171|P1|NOT COMPLETED|Overall Study||321
639822|NCT00094653|1573169|P3|COMPLETED|Overall Study||10
639823|NCT00094653|1573170|P2|COMPLETED|Overall Study||31
639824|NCT00094653|1573171|P1|COMPLETED|Overall Study||82
639825|NCT00094653|1573169|P3|Treated|Overall Study||131
639826|NCT00094653|1573170|P2|Treated|Overall Study||131
639827|NCT00094653|1573171|P1|Treated|Overall Study||381
639828|NCT00094653|1573169|P3|STARTED|Overall Study||136
639829|NCT00094653|1573170|P2|STARTED|Overall Study||137
639830|NCT00094653|1573171|P1|STARTED|Overall Study||403
639831|NCT00094575|1573234|P2|NOT COMPLETED|Overall Study||146
639832|NCT00094575|1573235|P1|NOT COMPLETED|Overall Study||146
639833|NCT00094575|1573234|P2|COMPLETED|Overall Study||291
639834|NCT00094575|1573235|P1|COMPLETED|Overall Study||298
639835|NCT00094575|1573234|P2|STARTED|Overall Study||437
639836|NCT00094575|1573235|P1|STARTED|Overall Study||444
639837|NCT00094536|1573255|P1|NOT COMPLETED|Treatment and Follow-up||31
639838|NCT00094536|1573255|P1|COMPLETED|Treatment and Follow-up|51 subjects successfully completed the study.|51
639839|NCT00094536|1573255|P1|36 Month Follow-up|Treatment and Follow-up||51
639840|NCT00094536|1573255|P1|24 Month Follow-up|Treatment and Follow-up||53
639841|NCT00094536|1573255|P1|12 Month Follow-up|Treatment and Follow-up|69 subjects were evaluated at 1-year post-treatment for the primary endpoint of success.|69
639842|NCT00094536|1573255|P1|STARTED|Treatment and Follow-up|82 subjects qualified for and underwent the study treatment.|82
639843|NCT00094536|1573255|P1|NOT COMPLETED|Inclusion Exclusion Evaluation||24
639844|NCT00094536|1573255|P1|COMPLETED|Inclusion Exclusion Evaluation||82
639845|NCT00094536|1573255|P1|STARTED|Inclusion Exclusion Evaluation||106
639846|NCT00094497|1573261|P2|NOT COMPLETED|Overall Study||0
639847|NCT00094497|1573262|P1|NOT COMPLETED|Overall Study||0
639848|NCT00094497|1573261|P2|COMPLETED|Overall Study||153
639849|NCT00094497|1573262|P1|COMPLETED|Overall Study||151
639850|NCT00094497|1573261|P2|Received Second Line Therapy|Overall Study||101
639851|NCT00094497|1573262|P1|Received Second Line Therapy|Overall Study||84
639852|NCT00094497|1573261|P2|Treated|Overall Study||149
639853|NCT00094497|1573262|P1|Treated|Overall Study||148
639854|NCT00094497|1573261|P2|STARTED|Overall Study||153
639855|NCT00094497|1573262|P1|STARTED|Overall Study||151
639856|NCT00094458|1573279|P6|NOT COMPLETED|OLE: Open-Label Extension||4
639857|NCT00094458|1573280|P5|NOT COMPLETED|OLE: Open-Label Extension||5
639858|NCT00094458|1573281|P4|NOT COMPLETED|OLE: Open-Label Extension||1
639859|NCT00094458|1573282|P3|NOT COMPLETED|OLE: Open-Label Extension||0
639860|NCT00094458|1573283|P2|NOT COMPLETED|OLE: Open-Label Extension||0
639861|NCT00094458|1573284|P1|NOT COMPLETED|OLE: Open-Label Extension||0
639862|NCT00094458|1573279|P6|COMPLETED|OLE: Open-Label Extension||13
639863|NCT00094458|1573280|P5|COMPLETED|OLE: Open-Label Extension||13
639864|NCT00094458|1573281|P4|COMPLETED|OLE: Open-Label Extension||7
639865|NCT00094458|1573282|P3|COMPLETED|OLE: Open-Label Extension||0
639866|NCT00094458|1573283|P2|COMPLETED|OLE: Open-Label Extension||0
639867|NCT00094458|1573284|P1|COMPLETED|OLE: Open-Label Extension||0
639868|NCT00094458|1573279|P6|STARTED|OLE: Open-Label Extension||17
639869|NCT00094458|1573280|P5|STARTED|OLE: Open-Label Extension||18
639870|NCT00094458|1573281|P4|STARTED|OLE: Open-Label Extension||8
639871|NCT00094458|1573282|P3|STARTED|OLE: Open-Label Extension||0
639872|NCT00094458|1573283|P2|STARTED|OLE: Open-Label Extension||0
639873|NCT00094458|1573284|P1|STARTED|OLE: Open-Label Extension||0
639874|NCT00094458|1573279|P6|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
639875|NCT00094458|1573280|P5|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
639876|NCT00094458|1573281|P4|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
639877|NCT00094458|1573282|P3|NOT COMPLETED|Study Extension: Week 30 Through Week 50||18
639878|NCT00094458|1573283|P2|NOT COMPLETED|Study Extension: Week 30 Through Week 50||12
639879|NCT00094458|1573284|P1|NOT COMPLETED|Study Extension: Week 30 Through Week 50||8
639880|NCT00094458|1573279|P6|COMPLETED|Study Extension: Week 30 Through Week 50||0
639881|NCT00094458|1573280|P5|COMPLETED|Study Extension: Week 30 Through Week 50||0
639882|NCT00094458|1573281|P4|COMPLETED|Study Extension: Week 30 Through Week 50||0
639883|NCT00094458|1573282|P3|COMPLETED|Study Extension: Week 30 Through Week 50||90
639884|NCT00094458|1573283|P2|COMPLETED|Study Extension: Week 30 Through Week 50||85
639885|NCT00094458|1573284|P1|COMPLETED|Study Extension: Week 30 Through Week 50||67
639886|NCT00094458|1573279|P6|STARTED|Study Extension: Week 30 Through Week 50||0
639887|NCT00094458|1573280|P5|STARTED|Study Extension: Week 30 Through Week 50||0
639888|NCT00094458|1573281|P4|STARTED|Study Extension: Week 30 Through Week 50||0
639889|NCT00094458|1573282|P3|STARTED|Study Extension: Week 30 Through Week 50||108
639890|NCT00094458|1573283|P2|STARTED|Study Extension: Week 30 Through Week 50||97
639891|NCT00094458|1573284|P1|STARTED|Study Extension: Week 30 Through Week 50||75
639892|NCT00094458|1573279|P6|NOT COMPLETED|Main Study: Through Week 30||0
639893|NCT00094458|1573280|P5|NOT COMPLETED|Main Study: Through Week 30||0
639894|NCT00094458|1573281|P4|NOT COMPLETED|Main Study: Through Week 30||0
639895|NCT00094458|1573282|P3|NOT COMPLETED|Main Study: Through Week 30||48
639896|NCT00094458|1573283|P2|NOT COMPLETED|Main Study: Through Week 30||58
639897|NCT00094458|1573284|P1|NOT COMPLETED|Main Study: Through Week 30||84
639898|NCT00094458|1573279|P6|COMPLETED|Main Study: Through Week 30||0
639899|NCT00094458|1573280|P5|COMPLETED|Main Study: Through Week 30||0
639900|NCT00094458|1573281|P4|COMPLETED|Main Study: Through Week 30||0
639901|NCT00094458|1573282|P3|COMPLETED|Main Study: Through Week 30||121
639902|NCT00094458|1573283|P2|COMPLETED|Main Study: Through Week 30||111
639903|NCT00094458|1573284|P1|COMPLETED|Main Study: Through Week 30||86
639904|NCT00094458|1573279|P6|STARTED|Main Study: Through Week 30||0
639905|NCT00094458|1573280|P5|STARTED|Main Study: Through Week 30||0
639906|NCT00094458|1573281|P4|STARTED|Main Study: Through Week 30||0
639907|NCT00094458|1573282|P3|STARTED|Main Study: Through Week 30||169
639908|NCT00094458|1573283|P2|STARTED|Main Study: Through Week 30||169
639909|NCT00094458|1573284|P1|STARTED|Main Study: Through Week 30||170
639910|NCT00094328|1573322|P1|NOT COMPLETED|Overall Study||1
639911|NCT00094328|1573322|P1|COMPLETED|Overall Study|Completed 12 months on treatment|13
639912|NCT00094328|1573322|P1|STARTED|Overall Study|Received treatment|14
639913|NCT00094302|1573336|P2|NOT COMPLETED|Overall Study||406
639914|NCT00094302|1573337|P1|NOT COMPLETED|Overall Study||417
639915|NCT00094302|1573336|P2|COMPLETED|Overall Study||1316
639916|NCT00094302|1573337|P1|COMPLETED|Overall Study||1306
639917|NCT00094302|1573336|P2|STARTED|Overall Study||1722
639918|NCT00094302|1573337|P1|STARTED|Overall Study||1723
639919|NCT00094172|1573393|P2|NOT COMPLETED|Overall Study||7
639920|NCT00094172|1573394|P1|NOT COMPLETED|Overall Study||14
639921|NCT00094172|1573393|P2|COMPLETED|Overall Study||25
639922|NCT00094172|1573394|P1|COMPLETED|Overall Study||36
639923|NCT00094172|1573393|P2|STARTED|Overall Study|Safety Sample: 32; Intent-to-Treat Sample: 32; Per Protocol Sample: 28|32
639924|NCT00094172|1573394|P1|STARTED|Overall Study|Safety Sample: 49; Intent-to-Treat Sample: 49; Per Protocol Sample: 39|50
639925|NCT00094107|1573404|P1|NOT COMPLETED|Overall Study||32
639926|NCT00094107|1573404|P1|COMPLETED|Overall Study||0
639927|NCT00094107|1573404|P1|STARTED|Overall Study||32
639928|NCT00094094|1573413|P1|NOT COMPLETED|Overall Study||32
639929|NCT00094094|1573413|P1|COMPLETED|Overall Study||0
639930|NCT00094094|1573413|P1|STARTED|Overall Study||32
639931|NCT00094055|1573422|P1|NOT COMPLETED|Overall Study||60
639932|NCT00094055|1573422|P1|COMPLETED|Overall Study||0
639933|NCT00094055|1573422|P1|STARTED|Overall Study||60
639934|NCT00093847|1573433|P2|NOT COMPLETED|Overall Study||10
639935|NCT00093847|1573434|P1|NOT COMPLETED|Overall Study||8
639936|NCT00093847|1573433|P2|COMPLETED|Overall Study||24
639937|NCT00093847|1573434|P1|COMPLETED|Overall Study||31
639938|NCT00093847|1573433|P2|STARTED|Overall Study||34
639939|NCT00093847|1573434|P1|STARTED|Overall Study||39
639940|NCT00093808|1573442|P1|NOT COMPLETED|Overall Study||2
639941|NCT00093808|1573442|P1|COMPLETED|Overall Study||45
639942|NCT00093808|1573442|P1|STARTED|Overall Study||47
639943|NCT00093795|1573452|P3|NOT COMPLETED|Overall Study||17
639944|NCT00093795|1573453|P2|NOT COMPLETED|Overall Study||16
639945|NCT00093795|1573454|P1|NOT COMPLETED|Overall Study||20
639946|NCT00093795|1573452|P3|COMPLETED|Overall Study||1613
639947|NCT00093795|1573453|P2|COMPLETED|Overall Study||1618
639948|NCT00093795|1573454|P1|COMPLETED|Overall Study||1610
639949|NCT00093795|1573452|P3|STARTED|Overall Study||1630
639950|NCT00093795|1573453|P2|STARTED|Overall Study||1634
639951|NCT00093795|1573454|P1|STARTED|Overall Study||1630
639952|NCT00093782|1573474|P1|NOT COMPLETED|Overall Study||0
639953|NCT00093782|1573474|P1|COMPLETED|Overall Study||36
639954|NCT00093782|1573474|P1|STARTED|Overall Study||36
639955|NCT00093756|1573486|P2|NOT COMPLETED|Overall Study||0
639956|NCT00093756|1573487|P1|NOT COMPLETED|Overall Study||0
639957|NCT00093756|1573486|P2|COMPLETED|Overall Study||21
639958|NCT00093756|1573487|P1|COMPLETED|Overall Study||27
639959|NCT00093756|1573486|P2|STARTED|Overall Study||21
639960|NCT00093756|1573487|P1|STARTED|Overall Study||27
639961|NCT00093496|1573499|P2|NOT COMPLETED|Overall Study||3
639962|NCT00093496|1573500|P1|NOT COMPLETED|Overall Study||1
639963|NCT00093496|1573499|P2|COMPLETED|Overall Study||11
639964|NCT00093496|1573500|P1|COMPLETED|Overall Study||14
639965|NCT00093496|1573499|P2|STARTED|Overall Study||14
639966|NCT00093496|1573500|P1|STARTED|Overall Study||15
639967|NCT00093470|1573513|P2|NOT COMPLETED|Overall Study||0
639968|NCT00093470|1573514|P1|NOT COMPLETED|Overall Study||73
639969|NCT00093470|1573513|P2|COMPLETED|Overall Study|Patients underwent observation only.|71
639970|NCT00093470|1573514|P1|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
639971|NCT00093470|1573513|P2|Patients With Toxicity Assessment|Overall Study||69
639972|NCT00093470|1573514|P1|Patients With Toxicity Assessment|Overall Study||72
639973|NCT00093470|1573513|P2|Treated|Overall Study||71
639974|NCT00093470|1573514|P1|Treated|Overall Study||72
639975|NCT00093470|1573513|P2|STARTED|Overall Study||71
639976|NCT00093470|1573514|P1|STARTED|Overall Study||73
639977|NCT00093379|1573522|P1|NOT COMPLETED|Overall Study||0
639978|NCT00093379|1573522|P1|COMPLETED|Overall Study||20
639979|NCT00093379|1573522|P1|STARTED|Overall Study||20
639980|NCT00093145|1573528|P1|NOT COMPLETED|Overall Study||17
639981|NCT00093145|1573528|P1|COMPLETED|Overall Study|Treatment completed upon progressive disease|15
639982|NCT00093145|1573528|P1|At Least One Response Assessment|Overall Study||31
639983|NCT00093145|1573528|P1|STARTED|Overall Study||32
639984|NCT00093041|1573543|P6|NOT COMPLETED|Overall Study||3
639985|NCT00093041|1573544|P5|NOT COMPLETED|Overall Study||1
639986|NCT00093041|1573545|P4|NOT COMPLETED|Overall Study||1
639987|NCT00093041|1573546|P3|NOT COMPLETED|Overall Study||2
639988|NCT00093041|1573547|P2|NOT COMPLETED|Overall Study||3
639989|NCT00093041|1573548|P1|NOT COMPLETED|Overall Study||2
639990|NCT00093041|1573543|P6|COMPLETED|Overall Study|Three discontinued during multiple dose period|4
639991|NCT00093041|1573544|P5|COMPLETED|Overall Study|One discontinued during multiple dose period|3
639992|NCT00093041|1573545|P4|COMPLETED|Overall Study|One discontinued during single dose period|3
639993|NCT00093041|1573546|P3|COMPLETED|Overall Study|Two discontinued during single dose period|3
639994|NCT00093041|1573547|P2|COMPLETED|Overall Study|Three discontinued during single dose period|1
639995|NCT00093041|1573548|P1|COMPLETED|Overall Study|One discontinued during single dose period and one during multiple dose period|2
639996|NCT00093041|1573543|P6|STARTED|Overall Study||7
639997|NCT00093041|1573544|P5|STARTED|Overall Study||4
639998|NCT00093041|1573545|P4|STARTED|Overall Study||4
639999|NCT00093041|1573546|P3|STARTED|Overall Study||5
640000|NCT00093041|1573547|P2|STARTED|Overall Study||4
640001|NCT00093041|1573548|P1|STARTED|Overall Study||4
640002|NCT00093015|1573570|P2|NOT COMPLETED|Overall Study||664
640003|NCT00093015|1573571|P1|NOT COMPLETED|Overall Study||665
640004|NCT00093015|1573570|P2|COMPLETED|Overall Study||1348
640005|NCT00093015|1573571|P1|COMPLETED|Overall Study||1361
640006|NCT00093015|1573570|P2|Received Study Medication|Overall Study||2004
640007|NCT00093015|1573571|P1|Received Study Medication|Overall Study||2019
640008|NCT00093015|1573570|P2|STARTED|Overall Study||2012
640009|NCT00093015|1573571|P1|STARTED|Overall Study||2026
640010|NCT00092677|1573599|P2|NOT COMPLETED|Overall Study||11
640011|NCT00092677|1573600|P1|NOT COMPLETED|Overall Study||5
640012|NCT00092677|1573599|P2|COMPLETED|Overall Study|Placebo: 698 (on drug), 120 (after drug discon), 100 (at death)|918
640013|NCT00092677|1573600|P1|COMPLETED|Overall Study|EZ/Simva: 694 (on drug), 140 (after drug discon), 105 (at death)|939
640014|NCT00092677|1573599|P2|STARTED|Overall Study||929
640015|NCT00092677|1573600|P1|STARTED|Overall Study||944
640016|NCT00092547|1573644|P3|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
640017|NCT00092547|1573645|P2|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
640018|NCT00092547|1573646|P1|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
640019|NCT00092547|1573644|P3|COMPLETED|Long-term Follow-up (Month 126 Visit)||211
640020|NCT00092547|1573645|P2|COMPLETED|Long-term Follow-up (Month 126 Visit)||0
640021|NCT00092547|1573646|P1|COMPLETED|Long-term Follow-up (Month 126 Visit)||454
640022|NCT00092547|1573644|P3|STARTED|Long-term Follow-up (Month 126 Visit)||211
640023|NCT00092547|1573645|P2|STARTED|Long-term Follow-up (Month 126 Visit)||0
640024|NCT00092547|1573646|P1|STARTED|Long-term Follow-up (Month 126 Visit)||454
640025|NCT00092547|1573644|P3|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
640026|NCT00092547|1573645|P2|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
640027|NCT00092547|1573646|P1|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
640028|NCT00092547|1573644|P3|COMPLETED|Long-term Follow-up (Month 96 Visit)||267
640029|NCT00092547|1573645|P2|COMPLETED|Long-term Follow-up (Month 96 Visit)||0
640030|NCT00092547|1573646|P1|COMPLETED|Long-term Follow-up (Month 96 Visit)||508
640031|NCT00092547|1573644|P3|STARTED|Long-term Follow-up (Month 96 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|267
640032|NCT00092547|1573645|P2|STARTED|Long-term Follow-up (Month 96 Visit)||0
640033|NCT00092547|1573646|P1|STARTED|Long-term Follow-up (Month 96 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|508
640034|NCT00092547|1573644|P3|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
640035|NCT00092547|1573645|P2|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
640036|NCT00092547|1573646|P1|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
640037|NCT00092547|1573644|P3|COMPLETED|Long-term Follow-up (Month 72 Visit)||276
640038|NCT00092547|1573645|P2|COMPLETED|Long-term Follow-up (Month 72 Visit)||0
640039|NCT00092547|1573646|P1|COMPLETED|Long-term Follow-up (Month 72 Visit)||550
640040|NCT00092547|1573644|P3|STARTED|Long-term Follow-up (Month 72 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|276
640041|NCT00092547|1573645|P2|STARTED|Long-term Follow-up (Month 72 Visit)||0
640042|NCT00092547|1573646|P1|STARTED|Long-term Follow-up (Month 72 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|550
640043|NCT00092547|1573644|P3|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0
640044|NCT00092547|1573645|P2|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0
640045|NCT00092547|1573646|P1|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||1
640046|NCT00092547|1573644|P3|COMPLETED|Long-term Follow-up (Month 42 Visit)||308
640047|NCT00092547|1573645|P2|COMPLETED|Long-term Follow-up (Month 42 Visit)||0
640048|NCT00092547|1573646|P1|COMPLETED|Long-term Follow-up (Month 42 Visit)||611
640049|NCT00092547|1573644|P3|STARTED|Long-term Follow-up (Month 42 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|308
640050|NCT00092547|1573645|P2|STARTED|Long-term Follow-up (Month 42 Visit)||0
640051|NCT00092547|1573646|P1|STARTED|Long-term Follow-up (Month 42 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|612
640052|NCT00092547|1573644|P3|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||16
640053|NCT00092547|1573645|P2|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0
640054|NCT00092547|1573646|P1|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||23
640055|NCT00092547|1573644|P3|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||469
640056|NCT00092547|1573645|P2|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0
640057|NCT00092547|1573646|P1|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||933
640058|NCT00092547|1573644|P3|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||482
640059|NCT00092547|1573645|P2|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0
640060|NCT00092547|1573646|P1|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0
640133|NCT00092521|1573710|P4|Initiated Extension Study|Extension Study (Group 4)||829
640061|NCT00092547|1573644|P3|STARTED|Extension Vaccine Phase (Month 30 to 37)|Includes participants continuing and who previously discontinued who re-entered the study|485
640062|NCT00092547|1573645|P2|STARTED|Extension Vaccine Phase (Month 30 to 37)||0
640063|NCT00092547|1573646|P1|STARTED|Extension Vaccine Phase (Month 30 to 37)|Includes participants continuing and who previously discontinued who re-entered the study|956
640064|NCT00092547|1573644|P3|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||0
640065|NCT00092547|1573645|P2|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||5
640066|NCT00092547|1573646|P1|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||8
640067|NCT00092547|1573644|P3|COMPLETED|Base Follow-up Phase (Month 18 to 30)||0
640068|NCT00092547|1573645|P2|COMPLETED|Base Follow-up Phase (Month 18 to 30)||485
640069|NCT00092547|1573646|P1|COMPLETED|Base Follow-up Phase (Month 18 to 30)||956
640070|NCT00092547|1573644|P3|STARTED|Base Follow-up Phase (Month 18 to 30)||0
640071|NCT00092547|1573645|P2|STARTED|Base Follow-up Phase (Month 18 to 30)|Includes participants continuing and who previously discontinued who re-entered the study|490
640072|NCT00092547|1573646|P1|STARTED|Base Follow-up Phase (Month 18 to 30)|Includes participants continuing and who previously discontinued who re-entered the study|964
640073|NCT00092547|1573644|P3|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||0
640074|NCT00092547|1573645|P2|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||14
640075|NCT00092547|1573646|P1|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||20
640076|NCT00092547|1573644|P3|COMPLETED|Base Follow-up Phase (Month 7 to 18)||0
640077|NCT00092547|1573645|P2|COMPLETED|Base Follow-up Phase (Month 7 to 18)||551
640078|NCT00092547|1573646|P1|COMPLETED|Base Follow-up Phase (Month 7 to 18)||1108
640079|NCT00092547|1573644|P3|STARTED|Base Follow-up Phase (Month 7 to 18)||0
640080|NCT00092547|1573645|P2|STARTED|Base Follow-up Phase (Month 7 to 18)|Includes participants continuing and who previously discontinued who re-entered the study|565
640081|NCT00092547|1573646|P1|STARTED|Base Follow-up Phase (Month 7 to 18)|Includes participants continuing and who previously discontinued who re-entered the study|1128
640082|NCT00092547|1573644|P3|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0
640083|NCT00092547|1573645|P2|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||36
640084|NCT00092547|1573646|P1|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||63
640085|NCT00092547|1573644|P3|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0
640086|NCT00092547|1573645|P2|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||561
640087|NCT00092547|1573646|P1|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||1121
640088|NCT00092547|1573644|P3|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||0
640089|NCT00092547|1573645|P2|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||596
640090|NCT00092547|1573646|P1|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||1179
640091|NCT00092547|1573644|P3|STARTED|Base Vaccine Phase (Day 1 to Month 7)||0
640092|NCT00092547|1573645|P2|STARTED|Base Vaccine Phase (Day 1 to Month 7)||597
640093|NCT00092547|1573646|P1|STARTED|Base Vaccine Phase (Day 1 to Month 7)||1184
640094|NCT00092534|1573690|P3|NOT COMPLETED|Extension Study||145
640095|NCT00092534|1573691|P2|NOT COMPLETED|Extension Study||0
640096|NCT00092534|1573692|P1|NOT COMPLETED|Extension Study||0
640097|NCT00092534|1573690|P3|COMPLETED|Extension Study||449
640098|NCT00092534|1573691|P2|COMPLETED|Extension Study||0
640099|NCT00092534|1573692|P1|COMPLETED|Extension Study||0
640100|NCT00092534|1573690|P3|STARTED|Extension Study||594
640101|NCT00092534|1573691|P2|STARTED|Extension Study||0
640102|NCT00092534|1573692|P1|STARTED|Extension Study||0
640103|NCT00092534|1573690|P3|NOT COMPLETED|Base Study Follow Up Period||0
640104|NCT00092534|1573691|P2|NOT COMPLETED|Base Study Follow Up Period||694
640105|NCT00092534|1573692|P1|NOT COMPLETED|Base Study Follow Up Period||316
640106|NCT00092534|1573690|P3|COMPLETED|Base Study Follow Up Period||0
640107|NCT00092534|1573691|P2|COMPLETED|Base Study Follow Up Period||5277
640108|NCT00092534|1573692|P1|COMPLETED|Base Study Follow Up Period||5626
640109|NCT00092534|1573690|P3|STARTED|Base Study Follow Up Period||0
640110|NCT00092534|1573691|P2|STARTED|Base Study Follow Up Period|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up.|5971
640111|NCT00092534|1573692|P1|STARTED|Base Study Follow Up Period|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up.|5942
640112|NCT00092534|1573690|P3|NOT COMPLETED|Base Study Vaccination Period||0
640113|NCT00092534|1573691|P2|NOT COMPLETED|Base Study Vaccination Period||126
640114|NCT00092534|1573692|P1|NOT COMPLETED|Base Study Vaccination Period||171
640115|NCT00092534|1573690|P3|COMPLETED|Base Study Vaccination Period||0
640116|NCT00092534|1573691|P2|COMPLETED|Base Study Vaccination Period||5954
640117|NCT00092534|1573692|P1|COMPLETED|Base Study Vaccination Period||5916
640118|NCT00092534|1573690|P3|STARTED|Base Study Vaccination Period||0
640119|NCT00092534|1573691|P2|STARTED|Base Study Vaccination Period||6080
640120|NCT00092534|1573692|P1|STARTED|Base Study Vaccination Period||6087
640121|NCT00092521|1573710|P4|NOT COMPLETED|Extension Study (Group 4)||209
640122|NCT00092521|1573711|P3|NOT COMPLETED|Extension Study (Group 4)||0
640123|NCT00092521|1573712|P2|NOT COMPLETED|Extension Study (Group 4)||0
640124|NCT00092521|1573713|P1|NOT COMPLETED|Extension Study (Group 4)||0
640125|NCT00092521|1573710|P4|COMPLETED|Extension Study (Group 4)||635
640126|NCT00092521|1573711|P3|COMPLETED|Extension Study (Group 4)||0
640127|NCT00092521|1573712|P2|COMPLETED|Extension Study (Group 4)||0
640128|NCT00092521|1573713|P1|COMPLETED|Extension Study (Group 4)||0
640129|NCT00092521|1573710|P4|Received >=1 Dose in Extension Study|Extension Study (Group 4)||801
640130|NCT00092521|1573711|P3|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
640131|NCT00092521|1573712|P2|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
640132|NCT00092521|1573713|P1|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
640134|NCT00092521|1573711|P3|Initiated Extension Study|Extension Study (Group 4)||0
640135|NCT00092521|1573712|P2|Initiated Extension Study|Extension Study (Group 4)||0
640136|NCT00092521|1573713|P1|Initiated Extension Study|Extension Study (Group 4)||0
640137|NCT00092521|1573710|P4|STARTED|Extension Study (Group 4)||844
640138|NCT00092521|1573711|P3|STARTED|Extension Study (Group 4)||0
640139|NCT00092521|1573712|P2|STARTED|Extension Study (Group 4)||0
640140|NCT00092521|1573713|P1|STARTED|Extension Study (Group 4)||0
640141|NCT00092521|1573710|P4|NOT COMPLETED|Follow-Up (After Month 7)||0
640142|NCT00092521|1573711|P3|NOT COMPLETED|Follow-Up (After Month 7)||648
640143|NCT00092521|1573712|P2|NOT COMPLETED|Follow-Up (After Month 7)||136
640144|NCT00092521|1573713|P1|NOT COMPLETED|Follow-Up (After Month 7)||246
640145|NCT00092521|1573710|P4|COMPLETED|Follow-Up (After Month 7)||0
640146|NCT00092521|1573711|P3|COMPLETED|Follow-Up (After Month 7)||1959
640147|NCT00092521|1573712|P2|COMPLETED|Follow-Up (After Month 7)||155
640148|NCT00092521|1573713|P1|COMPLETED|Follow-Up (After Month 7)||2353
640149|NCT00092521|1573710|P4|STARTED|Follow-Up (After Month 7)||0
640150|NCT00092521|1573711|P3|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|2607
640151|NCT00092521|1573712|P2|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|291
640152|NCT00092521|1573713|P1|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|2599
640153|NCT00092521|1573710|P4|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||0
640154|NCT00092521|1573711|P3|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||146
640155|NCT00092521|1573712|P2|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||14
640156|NCT00092521|1573713|P1|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||140
640157|NCT00092521|1573710|P4|COMPLETED|Vaccination (Day 1 Through Month 7)||0
640158|NCT00092521|1573711|P3|COMPLETED|Vaccination (Day 1 Through Month 7)||2586
640159|NCT00092521|1573712|P2|COMPLETED|Vaccination (Day 1 Through Month 7)||290
640160|NCT00092521|1573713|P1|COMPLETED|Vaccination (Day 1 Through Month 7)||2583
640161|NCT00092521|1573710|P4|STARTED|Vaccination (Day 1 Through Month 7)||0
640162|NCT00092521|1573711|P3|STARTED|Vaccination (Day 1 Through Month 7)||2732
640163|NCT00092521|1573712|P2|STARTED|Vaccination (Day 1 Through Month 7)||304
640164|NCT00092521|1573713|P1|STARTED|Vaccination (Day 1 Through Month 7)||2723
640165|NCT00092495|1573727|P5|NOT COMPLETED|Extension Study||0
640166|NCT00092495|1573728|P4|NOT COMPLETED|Extension Study||0
640167|NCT00092495|1573729|P3|NOT COMPLETED|Extension Study||0
640168|NCT00092495|1573730|P2|NOT COMPLETED|Extension Study||0
640169|NCT00092495|1573731|P1|NOT COMPLETED|Extension Study||0
640170|NCT00092495|1573727|P5|COMPLETED|Extension Study||12
640171|NCT00092495|1573728|P4|COMPLETED|Extension Study||0
640172|NCT00092495|1573729|P3|COMPLETED|Extension Study||0
640173|NCT00092495|1573730|P2|COMPLETED|Extension Study||0
640174|NCT00092495|1573731|P1|COMPLETED|Extension Study||0
640175|NCT00092495|1573727|P5|STARTED|Extension Study||12
640176|NCT00092495|1573728|P4|STARTED|Extension Study||0
640177|NCT00092495|1573729|P3|STARTED|Extension Study||0
640178|NCT00092495|1573730|P2|STARTED|Extension Study||0
640179|NCT00092495|1573731|P1|STARTED|Extension Study||0
640180|NCT00092495|1573727|P5|NOT COMPLETED|Base Study Follow-up Period||0
640181|NCT00092495|1573728|P4|NOT COMPLETED|Base Study Follow-up Period||14
640182|NCT00092495|1573729|P3|NOT COMPLETED|Base Study Follow-up Period||4
640183|NCT00092495|1573730|P2|NOT COMPLETED|Base Study Follow-up Period||3
640184|NCT00092495|1573731|P1|NOT COMPLETED|Base Study Follow-up Period||3
640185|NCT00092495|1573727|P5|COMPLETED|Base Study Follow-up Period||0
640186|NCT00092495|1573728|P4|COMPLETED|Base Study Follow-up Period||446
640187|NCT00092495|1573729|P3|COMPLETED|Base Study Follow-up Period||126
640188|NCT00092495|1573730|P2|COMPLETED|Base Study Follow-up Period||122
640189|NCT00092495|1573731|P1|COMPLETED|Base Study Follow-up Period||112
640190|NCT00092495|1573727|P5|STARTED|Base Study Follow-up Period||0
640191|NCT00092495|1573728|P4|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|460
640192|NCT00092495|1573729|P3|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|130
640193|NCT00092495|1573730|P2|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|125
640194|NCT00092495|1573731|P1|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|115
640195|NCT00092495|1573727|P5|NOT COMPLETED|Base Study Vaccination Period||0
640196|NCT00092495|1573728|P4|NOT COMPLETED|Base Study Vaccination Period||88
640197|NCT00092495|1573729|P3|NOT COMPLETED|Base Study Vaccination Period||34
640198|NCT00092495|1573730|P2|NOT COMPLETED|Base Study Vaccination Period||22
640199|NCT00092495|1573731|P1|NOT COMPLETED|Base Study Vaccination Period||37
640200|NCT00092495|1573727|P5|COMPLETED|Base Study Vaccination Period||0
640201|NCT00092495|1573728|P4|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|1441
640202|NCT00092495|1573729|P3|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|474
640203|NCT00092495|1573730|P2|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|492
640204|NCT00092495|1573731|P1|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|467
640205|NCT00092495|1573727|P5|Without Long-term Follow-up|Base Study Vaccination Period||0
640271|NCT00092131|1573883|P1|NOT COMPLETED|Treatment Period I||1
640206|NCT00092495|1573728|P4|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|73
640207|NCT00092495|1573729|P3|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|28
640208|NCT00092495|1573730|P2|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|20
640209|NCT00092495|1573731|P1|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|34
640210|NCT00092495|1573727|P5|With Long-term Follow-up *|Base Study Vaccination Period||0
640211|NCT00092495|1573728|P4|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|10
640212|NCT00092495|1573729|P3|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|6
640213|NCT00092495|1573730|P2|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|2
640214|NCT00092495|1573731|P1|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|2
640215|NCT00092495|1573727|P5|STARTED|Base Study Vaccination Period||0
640216|NCT00092495|1573728|P4|STARTED|Base Study Vaccination Period||1529
640217|NCT00092495|1573729|P3|STARTED|Base Study Vaccination Period||508
640218|NCT00092495|1573730|P2|STARTED|Base Study Vaccination Period||514
640219|NCT00092495|1573731|P1|STARTED|Base Study Vaccination Period||504
640220|NCT00092456|1573797|P4|NOT COMPLETED|Overall Study||16
640221|NCT00092456|1573798|P3|NOT COMPLETED|Overall Study||29
640222|NCT00092456|1573799|P2|NOT COMPLETED|Overall Study||17
640223|NCT00092456|1573800|P1|NOT COMPLETED|Overall Study||25
640224|NCT00092456|1573797|P4|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|97
640225|NCT00092456|1573798|P3|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|200
640226|NCT00092456|1573799|P2|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|208
640227|NCT00092456|1573800|P1|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|201
640228|NCT00092456|1573797|P4|Vaccinated at Visit 3|Overall Study||98
640229|NCT00092456|1573798|P3|Vaccinated at Visit 3|Overall Study||200
640230|NCT00092456|1573799|P2|Vaccinated at Visit 3|Overall Study||210
640231|NCT00092456|1573800|P1|Vaccinated at Visit 3|Overall Study||202
640232|NCT00092456|1573797|P4|Vaccinated at Visit 2|Overall Study||104
640233|NCT00092456|1573798|P3|Vaccinated at Visit 2|Overall Study||210
640234|NCT00092456|1573799|P2|Vaccinated at Visit 2|Overall Study||217
640235|NCT00092456|1573800|P1|Vaccinated at Visit 2|Overall Study||208
640236|NCT00092456|1573797|P4|Vaccinated at Visit 1|Overall Study||113
640237|NCT00092456|1573798|P3|Vaccinated at Visit 1|Overall Study||229
640238|NCT00092456|1573799|P2|Vaccinated at Visit 1|Overall Study||225
640239|NCT00092456|1573800|P1|Vaccinated at Visit 1|Overall Study||226
640240|NCT00092456|1573797|P4|STARTED|Overall Study|Subjects assigned to Placebo-matching RotaTeq™|113
640241|NCT00092456|1573798|P3|STARTED|Overall Study|Subject assigned to ~6.91 X 10^7 IU/Dose of RotaTeq™ - Lot 3|229
640242|NCT00092456|1573799|P2|STARTED|Overall Study|Subject assigned to ~8.01 X 10^7 IU/Dose of RotaTeq™ - Lot 2|225
640243|NCT00092456|1573800|P1|STARTED|Overall Study|Subject assigned to ~8.81 X 10^7 IU/Dose of RotaTeq™ - Lot 1|226
640244|NCT00092443|1573848|P2|NOT COMPLETED|Overall Study||54
640245|NCT00092443|1573849|P1|NOT COMPLETED|Overall Study||58
640246|NCT00092443|1573848|P2|COMPLETED|Overall Study|Subjects vaccinated and followed up 42 days after each dose, thru 1st rotavirus season post study|607
640247|NCT00092443|1573849|P1|COMPLETED|Overall Study|Subjects vaccinated and followed up 42 days after each dose, thru 1st rotavirus season post study|593
640248|NCT00092443|1573848|P2|Vaccinated at Visit 3|Overall Study||608
640249|NCT00092443|1573849|P1|Vaccinated at Visit 3|Overall Study||593
640250|NCT00092443|1573848|P2|Vaccinated at Visit 2|Overall Study||627
640251|NCT00092443|1573849|P1|Vaccinated at Visit 2|Overall Study||618
640252|NCT00092443|1573848|P2|Vaccinated at Visit 1|Overall Study||660
640253|NCT00092443|1573849|P1|Vaccinated at Visit 1|Overall Study||650
640254|NCT00092443|1573848|P2|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|661
640255|NCT00092443|1573849|P1|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|651
640256|NCT00092417|1573867|P2|NOT COMPLETED|Overall Study||1
640257|NCT00092417|1573868|P1|NOT COMPLETED|Overall Study||5
640258|NCT00092417|1573867|P2|COMPLETED|Overall Study|Received the lower potency zoster vaccine & completed 42 days of safety follow-up post vaccination|233
640259|NCT00092417|1573868|P1|COMPLETED|Overall Study|Received the higher potency zoster vaccine & completed 42 days of safety follow-up post vaccination|459
640260|NCT00092417|1573867|P2|Vaccinated|Overall Study||234
640261|NCT00092417|1573868|P1|Vaccinated|Overall Study|3 participants were allocated,not vaccinated; they are not reported in the Baseline Characteristics|461
640262|NCT00092417|1573867|P2|STARTED|Overall Study|Started Period Group 2|234
640263|NCT00092417|1573868|P1|STARTED|Overall Study|Started Period Group 1|464
640264|NCT00092131|1573882|P2|NOT COMPLETED|Treatment Period II||1
640265|NCT00092131|1573883|P1|NOT COMPLETED|Treatment Period II||0
640266|NCT00092131|1573882|P2|COMPLETED|Treatment Period II||25
640267|NCT00092131|1573883|P1|COMPLETED|Treatment Period II||24
640268|NCT00092131|1573882|P2|STARTED|Treatment Period II|1 patient discontinued after taking Period II study medication, due to asthma exacerbation|26
640269|NCT00092131|1573883|P1|STARTED|Treatment Period II||24
640270|NCT00092131|1573882|P2|NOT COMPLETED|Treatment Period I||0
640272|NCT00092131|1573882|P2|COMPLETED|Treatment Period I||26
640273|NCT00092131|1573883|P1|COMPLETED|Treatment Period I||24
640274|NCT00092131|1573882|P2|STARTED|Treatment Period I||26
640275|NCT00092131|1573883|P1|STARTED|Treatment Period I|1 patient discontinued due to influenza which started in washout (11 days after Period I medication)|25
640276|NCT00092118|1573913|P2|NOT COMPLETED|Overall Study||89
640277|NCT00092118|1573914|P1|NOT COMPLETED|Overall Study||84
640278|NCT00092118|1573913|P2|COMPLETED|Overall Study||913
640279|NCT00092118|1573914|P1|COMPLETED|Overall Study||906
640280|NCT00092118|1573913|P2|STARTED|Overall Study|2 patients discontinued after randomization due to adverse experience that began pre-randomization.|1002
640281|NCT00092118|1573914|P1|STARTED|Overall Study|1 patient discontinued after randomization due to a adverse experience that began pre-randomization.|990
640282|NCT00091962|1573927|P3|NOT COMPLETED|Overall Study||0
640283|NCT00091962|1573928|P2|NOT COMPLETED|Overall Study||0
640284|NCT00091962|1573929|P1|NOT COMPLETED|Overall Study||0
640285|NCT00091962|1573927|P3|COMPLETED|Overall Study||151
640286|NCT00091962|1573928|P2|COMPLETED|Overall Study||152
640287|NCT00091962|1573929|P1|COMPLETED|Overall Study||150
640288|NCT00091962|1573927|P3|STARTED|Overall Study||151
640289|NCT00091962|1573928|P2|STARTED|Overall Study||152
640290|NCT00091962|1573929|P1|STARTED|Overall Study||150
640291|NCT00091949|1573948|P2|NOT COMPLETED|Overall Study||151
640292|NCT00091949|1573949|P1|NOT COMPLETED|Overall Study||175
640293|NCT00091949|1573948|P2|COMPLETED|Overall Study||1786
640294|NCT00091949|1573949|P1|COMPLETED|Overall Study||1764
640295|NCT00091949|1573948|P2|STARTED|Overall Study||1937
640296|NCT00091949|1573949|P1|STARTED|Overall Study||1939
640297|NCT00091832|1573973|P6|NOT COMPLETED|Overall Study||11
640298|NCT00091832|1573974|P5|NOT COMPLETED|Overall Study||15
640299|NCT00091832|1573975|P4|NOT COMPLETED|Overall Study||14
640300|NCT00091832|1573976|P3|NOT COMPLETED|Overall Study||12
640301|NCT00091832|1573977|P2|NOT COMPLETED|Overall Study||11
640302|NCT00091832|1573978|P1|NOT COMPLETED|Overall Study||14
640303|NCT00091832|1573973|P6|COMPLETED|Overall Study||32
640304|NCT00091832|1573974|P5|COMPLETED|Overall Study||27
640305|NCT00091832|1573975|P4|COMPLETED|Overall Study||29
640306|NCT00091832|1573976|P3|COMPLETED|Overall Study||30
640307|NCT00091832|1573977|P2|COMPLETED|Overall Study||31
640308|NCT00091832|1573978|P1|COMPLETED|Overall Study||29
640309|NCT00091832|1573973|P6|Received Study Medication|Overall Study||43
640310|NCT00091832|1573974|P5|Received Study Medication|Overall Study||42
640311|NCT00091832|1573975|P4|Received Study Medication|Overall Study||43
640312|NCT00091832|1573976|P3|Received Study Medication|Overall Study||41
640313|NCT00091832|1573977|P2|Received Study Medication|Overall Study||42
640314|NCT00091832|1573978|P1|Received Study Medication|Overall Study||43
640315|NCT00091832|1573973|P6|STARTED|Overall Study||43
640316|NCT00091832|1573974|P5|STARTED|Overall Study||42
640317|NCT00091832|1573975|P4|STARTED|Overall Study||43
640318|NCT00091832|1573976|P3|STARTED|Overall Study||42
640319|NCT00091832|1573977|P2|STARTED|Overall Study||42
640320|NCT00091832|1573978|P1|STARTED|Overall Study||43
640321|NCT00091819|1574096|P2|NOT COMPLETED|Overall Study||46
640322|NCT00091819|1574097|P1|NOT COMPLETED|Overall Study||42
640323|NCT00091819|1574096|P2|COMPLETED|Overall Study||387
640324|NCT00091819|1574097|P1|COMPLETED|Overall Study||387
640325|NCT00091819|1574096|P2|STARTED|Overall Study||433
640326|NCT00091819|1574097|P1|STARTED|Overall Study||429
640327|NCT00091793|1574105|P2|NOT COMPLETED|Overall Study||22
640328|NCT00091793|1574106|P1|NOT COMPLETED|Overall Study||24
640329|NCT00091793|1574105|P2|COMPLETED|Overall Study||144
640330|NCT00091793|1574106|P1|COMPLETED|Overall Study||142
640331|NCT00091793|1574105|P2|STARTED|Overall Study||166
640332|NCT00091793|1574106|P1|STARTED|Overall Study||166
640333|NCT00091572|1574130|P2|NOT COMPLETED|Overall Study||82
640334|NCT00091572|1574131|P1|NOT COMPLETED|Overall Study||95
640335|NCT00091572|1574130|P2|COMPLETED|Overall Study|Progressive disease/relapse/death due to progressive disease|348
640336|NCT00091572|1574131|P1|COMPLETED|Overall Study|Progressive disease/relapse/death due to progressive disease|334
640337|NCT00091572|1574130|P2|STARTED|Overall Study|9 subjects in dacarbazine group not treated.|430
640338|NCT00091572|1574131|P1|STARTED|Overall Study|10 subjects in temozolomide group not treated.|429
640339|NCT00091507|1574145|P2|NOT COMPLETED|Overall Study||19
640340|NCT00091507|1574146|P1|NOT COMPLETED|Overall Study||21
640341|NCT00091507|1574145|P2|COMPLETED|Overall Study||460
640342|NCT00091507|1574146|P1|COMPLETED|Overall Study||411
640343|NCT00091507|1574145|P2|STARTED|Overall Study||479
640344|NCT00091507|1574146|P1|STARTED|Overall Study||432
640345|NCT00091442|1574162|P2|NOT COMPLETED|Overall Study||373
640346|NCT00091442|1574163|P1|NOT COMPLETED|Overall Study||369
640347|NCT00091442|1574162|P2|COMPLETED|Overall Study|Indicates number of participants on study treatment at time of the primary objective|5
640348|NCT00091442|1574163|P1|COMPLETED|Overall Study|Indicates number of participants on study treatment at time of the primary objective|4
640349|NCT00091442|1574162|P2|STARTED|Overall Study||378
640350|NCT00091442|1574163|P1|STARTED|Overall Study||373
640351|NCT00091390|1574173|P1|NOT COMPLETED|Overall Study||4
640352|NCT00091390|1574173|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|125
640353|NCT00091390|1574173|P1|STARTED|Overall Study||129
640354|NCT00091273|1574177|P1|NOT COMPLETED|Overall Study||0
640355|NCT00091273|1574177|P1|COMPLETED|Overall Study||9
640356|NCT00091273|1574177|P1|STARTED|Overall Study||9
640357|NCT00091260|1574183|P1|NOT COMPLETED|Overall Study||0
640358|NCT00091260|1574183|P1|COMPLETED|Overall Study||82
640359|NCT00091260|1574183|P1|STARTED|Overall Study||82
640360|NCT00091169|1574191|P2|NOT COMPLETED|Overall Study||53
640361|NCT00091169|1574192|P1|NOT COMPLETED|Overall Study||57
640362|NCT00091169|1574191|P2|COMPLETED|Overall Study||134
640363|NCT00091169|1574192|P1|COMPLETED|Overall Study||132
640364|NCT00091169|1574191|P2|Treated|Overall Study||170
640365|NCT00091169|1574192|P1|Treated|Overall Study||163
640366|NCT00091169|1574191|P2|STARTED|Overall Study||187
640367|NCT00091169|1574192|P1|STARTED|Overall Study||189
640368|NCT00091026|1574210|P2|NOT COMPLETED|Overall Study||3
640369|NCT00091026|1574211|P1|NOT COMPLETED|Overall Study||1
640370|NCT00091026|1574210|P2|COMPLETED|Overall Study||68
640371|NCT00091026|1574211|P1|COMPLETED|Overall Study||71
640372|NCT00091026|1574210|P2|STARTED|Overall Study||71
640373|NCT00091026|1574211|P1|STARTED|Overall Study||72
640374|NCT00090987|1574221|P1|NOT COMPLETED|Overall Study||21
640375|NCT00090987|1574221|P1|COMPLETED|Overall Study||9
640376|NCT00090987|1574221|P1|STARTED|Overall Study||30
640377|NCT00090857|1574227|P2|NOT COMPLETED|Overall Study||3
640378|NCT00090857|1574228|P1|NOT COMPLETED|Overall Study||4
640379|NCT00090857|1574227|P2|COMPLETED|Overall Study||13
640380|NCT00090857|1574228|P1|COMPLETED|Overall Study||29
640381|NCT00090857|1574227|P2|STARTED|Overall Study||16
640382|NCT00090857|1574228|P1|STARTED|Overall Study||33
640383|NCT00090844|1574258|P2|NOT COMPLETED|Overall Study||1
640384|NCT00090844|1574259|P1|NOT COMPLETED|Overall Study||1
640385|NCT00090844|1574258|P2|COMPLETED|Overall Study||21
640386|NCT00090844|1574259|P1|COMPLETED|Overall Study||26
640387|NCT00090844|1574258|P2|STARTED|Overall Study||22
640388|NCT00090844|1574259|P1|STARTED|Overall Study||27
640389|NCT00090779|1574267|P2|NOT COMPLETED|Step 3||5
640390|NCT00090779|1574268|P1|NOT COMPLETED|Step 3||7
640391|NCT00090779|1574267|P2|COMPLETED|Step 3||0
640392|NCT00090779|1574268|P1|COMPLETED|Step 3||0
640393|NCT00090779|1574267|P2|STARTED|Step 3||5
640394|NCT00090779|1574268|P1|STARTED|Step 3||7
640395|NCT00090779|1574267|P2|NOT COMPLETED|Step 2||18
640396|NCT00090779|1574268|P1|NOT COMPLETED|Step 2||6
640397|NCT00090779|1574267|P2|COMPLETED|Step 2||1
640398|NCT00090779|1574268|P1|COMPLETED|Step 2||0
640399|NCT00090779|1574267|P2|STARTED|Step 2|Three with two consecutive CD4<350cells/mm^3 and one with CDC category B event didn't enter step 2.|19
640400|NCT00090779|1574268|P1|STARTED|Step 2|One subject who had two consecutive CD4<350cells/mm^3 did not enter step 2.|6
640401|NCT00090779|1574267|P2|NOT COMPLETED|Step 1||15
640402|NCT00090779|1574268|P1|NOT COMPLETED|Step 1||11
640403|NCT00090779|1574267|P2|COMPLETED|Step 1|Results are based on the database frozen on July 2, 2009 per DSMB recommendation of study closure.|49
640404|NCT00090779|1574268|P1|COMPLETED|Step 1|Results are based on the database frozen on July 2, 2009 per DSMB recommendation of study closure.|55
640405|NCT00090779|1574267|P2|STARTED|Step 1||64
640406|NCT00090779|1574268|P1|STARTED|Step 1||66
640407|NCT00090766|1574292|P3|NOT COMPLETED|Overall Study||3
640408|NCT00090766|1574293|P2|NOT COMPLETED|Overall Study||2
640409|NCT00090766|1574294|P1|NOT COMPLETED|Overall Study||3
640410|NCT00090766|1574292|P3|COMPLETED|Overall Study||22
640411|NCT00090766|1574293|P2|COMPLETED|Overall Study||19
640412|NCT00090766|1574294|P1|COMPLETED|Overall Study||14
640413|NCT00090766|1574292|P3|STARTED|Overall Study||25
640414|NCT00090766|1574293|P2|STARTED|Overall Study||21
640415|NCT00090766|1574294|P1|STARTED|Overall Study||17
640416|NCT00090753|1574336|P2|NOT COMPLETED|Extended Treatment Period||191
640417|NCT00090753|1574337|P1|NOT COMPLETED|Extended Treatment Period||359
640418|NCT00090753|1574336|P2|COMPLETED|Extended Treatment Period||59
640419|NCT00090753|1574337|P1|COMPLETED|Extended Treatment Period||94
640420|NCT00090753|1574336|P2|STARTED|Extended Treatment Period|52 patients who completed the first treatment period refused to enter the extended treatment period.|250
640421|NCT00090753|1574337|P1|STARTED|Extended Treatment Period|39 patients who completed the first treatment period refused to enter the extended treatment period.|453
640422|NCT00090753|1574336|P2|NOT COMPLETED|First Treatment Period||178
640423|NCT00090753|1574337|P1|NOT COMPLETED|First Treatment Period||256
640424|NCT00090753|1574336|P2|COMPLETED|First Treatment Period||302
640425|NCT00090753|1574337|P1|COMPLETED|First Treatment Period||492
640426|NCT00090753|1574336|P2|STARTED|First Treatment Period||480
640427|NCT00090753|1574337|P1|STARTED|First Treatment Period||748
640428|NCT00090610|1574347|P2|NOT COMPLETED|Overall Study||1
640429|NCT00090610|1574348|P1|NOT COMPLETED|Overall Study||1
640430|NCT00090610|1574347|P2|COMPLETED|Overall Study||74
640431|NCT00090610|1574348|P1|COMPLETED|Overall Study||74
640432|NCT00090610|1574347|P2|STARTED|Overall Study||75
640433|NCT00090610|1574348|P1|STARTED|Overall Study||75
640434|NCT00090584|1574364|P2|NOT COMPLETED|Baseline to 8 Months||41
640435|NCT00090584|1574365|P1|NOT COMPLETED|Baseline to 8 Months||44
640436|NCT00090584|1574364|P2|COMPLETED|Baseline to 8 Months||112
640437|NCT00090584|1574365|P1|COMPLETED|Baseline to 8 Months||110
640438|NCT00090584|1574364|P2|STARTED|Baseline to 8 Months||153
640439|NCT00090584|1574365|P1|STARTED|Baseline to 8 Months||154
640440|NCT00090584|1574364|P2|NOT COMPLETED|Baseline to 10 Weeks||12
640441|NCT00090584|1574365|P1|NOT COMPLETED|Baseline to 10 Weeks||15
640442|NCT00090584|1574364|P2|COMPLETED|Baseline to 10 Weeks||141
640443|NCT00090584|1574365|P1|COMPLETED|Baseline to 10 Weeks||139
640444|NCT00090584|1574364|P2|STARTED|Baseline to 10 Weeks||153
640445|NCT00090584|1574365|P1|STARTED|Baseline to 10 Weeks||154
640446|NCT00090519|1574397|P2|NOT COMPLETED|Overall Study||75
640447|NCT00090519|1574398|P1|NOT COMPLETED|Overall Study||73
640448|NCT00090519|1574397|P2|COMPLETED|Overall Study||285
640449|NCT00090519|1574398|P1|COMPLETED|Overall Study||298
640450|NCT00090519|1574397|P2|STARTED|Overall Study||360
640451|NCT00090519|1574398|P1|STARTED|Overall Study||371
640452|NCT00090493|1574422|P1|NOT COMPLETED|Overall Study||2
640453|NCT00090493|1574422|P1|COMPLETED|Overall Study||2
640454|NCT00090493|1574422|P1|STARTED|Overall Study||4
640455|NCT00090363|1574429|P3|NOT COMPLETED|Overall Study||96
640456|NCT00090363|1574430|P2|NOT COMPLETED|Overall Study||107
640457|NCT00090363|1574431|P1|NOT COMPLETED|Overall Study||106
640458|NCT00090363|1574429|P3|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|2
640459|NCT00090363|1574430|P2|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|0
640460|NCT00090363|1574431|P1|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|1
640461|NCT00090363|1574429|P3|Received Study Treatment.|Overall Study||98
640462|NCT00090363|1574430|P2|Received Study Treatment.|Overall Study||107
640463|NCT00090363|1574431|P1|Received Study Treatment.|Overall Study||107
640464|NCT00090363|1574429|P3|STARTED|Overall Study||98
640465|NCT00090363|1574430|P2|STARTED|Overall Study||107
640466|NCT00090363|1574431|P1|STARTED|Overall Study||107
640467|NCT00090545|1574453|P2|NOT COMPLETED|Overall Study||24
640468|NCT00090545|1574454|P1|NOT COMPLETED|Overall Study||22
640469|NCT00090545|1574453|P2|COMPLETED|Overall Study||0
640470|NCT00090545|1574454|P1|COMPLETED|Overall Study||0
640471|NCT00090545|1574453|P2|STARTED|Overall Study||24
640472|NCT00090545|1574454|P1|STARTED|Overall Study||22
640551|NCT00090259|1574516|P2|NOT COMPLETED|Overall Study||48
640552|NCT00090259|1574517|P1|NOT COMPLETED|Overall Study||62
640553|NCT00090259|1574516|P2|COMPLETED|Overall Study|Completed follow-up: 1005 on drug, 233 off drug,& 635 at death (death was considered an endpoint)|1873
640554|NCT00090259|1574517|P1|COMPLETED|Overall Study|Completed follow-up: 963 on drug, 223 off drug, & 665 at death (death was considered an endpoint)|1851
640555|NCT00090259|1574516|P2|STARTED|Overall Study||1921
640556|NCT00090259|1574517|P1|STARTED|Overall Study||1913
640557|NCT00090233|1574533|P2|NOT COMPLETED|Overall Study||5065
640558|NCT00090233|1574534|P1|NOT COMPLETED|Overall Study||4999
640559|NCT00090233|1574533|P2|COMPLETED|Overall Study|Does not include participants who discontinued prior to the 42 day safety follow-up|29565
640560|NCT00090233|1574534|P1|COMPLETED|Overall Study|Does not include participants who discontinued prior to the 42 day safety follow-up|29645
640561|NCT00090233|1574533|P2|Vaccinated at Visit 3|Overall Study||29598
640562|NCT00090233|1574534|P1|Vaccinated at Visit 3|Overall Study||29667
640563|NCT00090233|1574533|P2|Vaccinated at Visit 2|Overall Study||31066
640564|NCT00090233|1574534|P1|Vaccinated at Visit 2|Overall Study||31052
640565|NCT00090233|1574533|P2|Vaccinated at Visit 1|Overall Study|Randomized Not vaccinated 627|34003
640566|NCT00090233|1574534|P1|Vaccinated at Visit 1|Overall Study|Randomized Not vaccinated 609|34035
640567|NCT00090233|1574533|P2|STARTED|Overall Study|Evaluated by data safety monitoring board when they recommended stopping enrollment|34630
640568|NCT00090233|1574534|P1|STARTED|Overall Study|Evaluated by data safety monitoring board (DSMB) when they recommended stopping enrollment|34644
640569|NCT00090220|1574558|P6|NOT COMPLETED|Long-term Follow-up (EXT2)||28
640570|NCT00090220|1574559|P5|NOT COMPLETED|Long-term Follow-up (EXT2)||44
640571|NCT00090220|1574560|P4|NOT COMPLETED|Long-term Follow-up (EXT2)||0
640572|NCT00090220|1574561|P3|NOT COMPLETED|Long-term Follow-up (EXT2)||0
640573|NCT00090220|1574562|P2|NOT COMPLETED|Long-term Follow-up (EXT2)||0
640574|NCT00090220|1574563|P1|NOT COMPLETED|Long-term Follow-up (EXT2)||0
640575|NCT00090220|1574558|P6|COMPLETED|Long-term Follow-up (EXT2)||623
640576|NCT00090220|1574559|P5|COMPLETED|Long-term Follow-up (EXT2)||641
640577|NCT00090220|1574560|P4|COMPLETED|Long-term Follow-up (EXT2)||0
640578|NCT00090220|1574561|P3|COMPLETED|Long-term Follow-up (EXT2)||0
640579|NCT00090220|1574562|P2|COMPLETED|Long-term Follow-up (EXT2)||0
640580|NCT00090220|1574563|P1|COMPLETED|Long-term Follow-up (EXT2)||0
640581|NCT00090220|1574558|P6|STARTED|Long-term Follow-up (EXT2)|Participation in LTFU was voluntary; not all participants eligible for LTFU enrolled.|651
640582|NCT00090220|1574559|P5|STARTED|Long-term Follow-up (EXT2)|Participation in LTFU was voluntary; not all participants eligible for LTFU enrolled.|685
640583|NCT00090220|1574560|P4|STARTED|Long-term Follow-up (EXT2)||0
640584|NCT00090220|1574561|P3|STARTED|Long-term Follow-up (EXT2)||0
640585|NCT00090220|1574562|P2|STARTED|Long-term Follow-up (EXT2)||0
640586|NCT00090220|1574563|P1|STARTED|Long-term Follow-up (EXT2)||0
640587|NCT00090220|1574558|P6|NOT COMPLETED|Extension 1 (EXT1)||0
640588|NCT00090220|1574559|P5|NOT COMPLETED|Extension 1 (EXT1)||0
640589|NCT00090220|1574560|P4|NOT COMPLETED|Extension 1 (EXT1)||2
640590|NCT00090220|1574561|P3|NOT COMPLETED|Extension 1 (EXT1)||55
640591|NCT00090220|1574562|P2|NOT COMPLETED|Extension 1 (EXT1)||0
640592|NCT00090220|1574563|P1|NOT COMPLETED|Extension 1 (EXT1)||0
640593|NCT00090220|1574558|P6|COMPLETED|Extension 1 (EXT1)||0
640594|NCT00090220|1574559|P5|COMPLETED|Extension 1 (EXT1)||0
640595|NCT00090220|1574560|P4|COMPLETED|Extension 1 (EXT1)||5
640596|NCT00090220|1574561|P3|COMPLETED|Extension 1 (EXT1)||1267
640597|NCT00090220|1574562|P2|COMPLETED|Extension 1 (EXT1)||0
640598|NCT00090220|1574563|P1|COMPLETED|Extension 1 (EXT1)||0
640599|NCT00090220|1574558|P6|Vaccinated|Extension 1 (EXT1)||0
640600|NCT00090220|1574559|P5|Vaccinated|Extension 1 (EXT1)||0
640601|NCT00090220|1574560|P4|Vaccinated|Extension 1 (EXT1)||7
640602|NCT00090220|1574561|P3|Vaccinated|Extension 1 (EXT1)||1321
640603|NCT00090220|1574562|P2|Vaccinated|Extension 1 (EXT1)||0
640604|NCT00090220|1574563|P1|Vaccinated|Extension 1 (EXT1)||0
640605|NCT00090220|1574558|P6|STARTED|Extension 1 (EXT1)||0
640606|NCT00090220|1574559|P5|STARTED|Extension 1 (EXT1)||0
640607|NCT00090220|1574560|P4|STARTED|Extension 1 (EXT1)|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|7
640608|NCT00090220|1574561|P3|STARTED|Extension 1 (EXT1)|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|1322
640609|NCT00090220|1574562|P2|STARTED|Extension 1 (EXT1)||0
640610|NCT00090220|1574563|P1|STARTED|Extension 1 (EXT1)||0
640611|NCT00090220|1574558|P6|NOT COMPLETED|Base Study Follow-up Period||0
640612|NCT00090220|1574559|P5|NOT COMPLETED|Base Study Follow-up Period||0
640613|NCT00090220|1574560|P4|NOT COMPLETED|Base Study Follow-up Period||0
640614|NCT00090220|1574561|P3|NOT COMPLETED|Base Study Follow-up Period||0
640615|NCT00090220|1574562|P2|NOT COMPLETED|Base Study Follow-up Period||164
640616|NCT00090220|1574563|P1|NOT COMPLETED|Base Study Follow-up Period||160
640617|NCT00090220|1574558|P6|COMPLETED|Base Study Follow-up Period||0
640618|NCT00090220|1574559|P5|COMPLETED|Base Study Follow-up Period||0
640619|NCT00090220|1574560|P4|COMPLETED|Base Study Follow-up Period||0
640620|NCT00090220|1574561|P3|COMPLETED|Base Study Follow-up Period||0
640621|NCT00090220|1574562|P2|COMPLETED|Base Study Follow-up Period||1687
640622|NCT00090220|1574563|P1|COMPLETED|Base Study Follow-up Period||1695
640623|NCT00090220|1574558|P6|STARTED|Base Study Follow-up Period||0
640624|NCT00090220|1574559|P5|STARTED|Base Study Follow-up Period||0
640625|NCT00090220|1574560|P4|STARTED|Base Study Follow-up Period||0
640626|NCT00090220|1574561|P3|STARTED|Base Study Follow-up Period||0
640627|NCT00090220|1574562|P2|STARTED|Base Study Follow-up Period|5 participants did not complete the Vaccination Period but entered the Follow-up Period.|1851
640628|NCT00090220|1574563|P1|STARTED|Base Study Follow-up Period|8 participants did not complete the Vaccination Period but entered the Follow-up Period.|1855
640629|NCT00090220|1574558|P6|NOT COMPLETED|Base Study Vaccination Period||0
640630|NCT00090220|1574559|P5|NOT COMPLETED|Base Study Vaccination Period||0
640631|NCT00090220|1574560|P4|NOT COMPLETED|Base Study Vaccination Period||0
640632|NCT00090220|1574561|P3|NOT COMPLETED|Base Study Vaccination Period||0
640633|NCT00090220|1574562|P2|NOT COMPLETED|Base Study Vaccination Period||63
640634|NCT00090220|1574563|P1|NOT COMPLETED|Base Study Vaccination Period||64
640635|NCT00090220|1574558|P6|COMPLETED|Base Study Vaccination Period||0
640636|NCT00090220|1574559|P5|COMPLETED|Base Study Vaccination Period||0
640637|NCT00090220|1574560|P4|COMPLETED|Base Study Vaccination Period||0
640638|NCT00090220|1574561|P3|COMPLETED|Base Study Vaccination Period||0
640639|NCT00090220|1574562|P2|COMPLETED|Base Study Vaccination Period||1845
640640|NCT00090220|1574563|P1|COMPLETED|Base Study Vaccination Period||1847
640641|NCT00090220|1574558|P6|Vaccinated|Base Study Vaccination Period||0
640642|NCT00090220|1574559|P5|Vaccinated|Base Study Vaccination Period||0
640643|NCT00090220|1574560|P4|Vaccinated|Base Study Vaccination Period||0
640644|NCT00090220|1574561|P3|Vaccinated|Base Study Vaccination Period||0
640645|NCT00090220|1574562|P2|Vaccinated|Base Study Vaccination Period||1907
640646|NCT00090220|1574563|P1|Vaccinated|Base Study Vaccination Period||1910
640647|NCT00090220|1574558|P6|STARTED|Base Study Vaccination Period||0
640648|NCT00090220|1574559|P5|STARTED|Base Study Vaccination Period||0
640649|NCT00090220|1574560|P4|STARTED|Base Study Vaccination Period||0
640650|NCT00090220|1574561|P3|STARTED|Base Study Vaccination Period||0
640651|NCT00090220|1574562|P2|STARTED|Base Study Vaccination Period||1908
640652|NCT00090220|1574563|P1|STARTED|Base Study Vaccination Period||1911
640653|NCT00090402|1574658|P3|NOT COMPLETED|Overall Study||1
640654|NCT00090402|1574659|P2|NOT COMPLETED|Overall Study||2
640655|NCT00090402|1574660|P1|NOT COMPLETED|Overall Study||2
640656|NCT00090402|1574658|P3|COMPLETED|Overall Study||12
640657|NCT00090402|1574659|P2|COMPLETED|Overall Study||11
640658|NCT00090402|1574660|P1|COMPLETED|Overall Study||11
640659|NCT00090402|1574658|P3|STARTED|Overall Study||13
640660|NCT00090402|1574659|P2|STARTED|Overall Study||13
640661|NCT00090402|1574660|P1|STARTED|Overall Study||13
640662|NCT00090142|1574674|P2|NOT COMPLETED|Treatment Period II||0
640663|NCT00090142|1574675|P1|NOT COMPLETED|Treatment Period II||1
640664|NCT00090142|1574674|P2|COMPLETED|Treatment Period II||28
640665|NCT00090142|1574675|P1|COMPLETED|Treatment Period II||25
640666|NCT00090142|1574674|P2|STARTED|Treatment Period II||28
640667|NCT00090142|1574675|P1|STARTED|Treatment Period II||26
640668|NCT00090142|1574674|P2|NOT COMPLETED|Treatment Period I||3
640669|NCT00090142|1574675|P1|NOT COMPLETED|Treatment Period I||5
640670|NCT00090142|1574674|P2|COMPLETED|Treatment Period I||28
640671|NCT00090142|1574675|P1|COMPLETED|Treatment Period I||26
640672|NCT00090142|1574674|P2|STARTED|Treatment Period I||31
640673|NCT00090142|1574675|P1|STARTED|Treatment Period I|1 patient was lost to follow-up after randomization and did not receive any study drug.|31
640674|NCT00090103|1574706|P3|NOT COMPLETED|16-Week Safety Follow-up Period||457
640675|NCT00090103|1574707|P2|NOT COMPLETED|16-Week Safety Follow-up Period||410
640676|NCT00090103|1574708|P1|NOT COMPLETED|16-Week Safety Follow-up Period||374
640677|NCT00090103|1574706|P3|COMPLETED|16-Week Safety Follow-up Period||1143
640678|NCT00090103|1574707|P2|COMPLETED|16-Week Safety Follow-up Period||1205
640679|NCT00090103|1574708|P1|COMPLETED|16-Week Safety Follow-up Period||1224
640680|NCT00090103|1574706|P3|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1600
640681|NCT00090103|1574707|P2|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1615
640682|NCT00090103|1574708|P1|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1598
640683|NCT00090103|1574706|P3|NOT COMPLETED|Four-Year Double-Blind Treatment Period||622
640684|NCT00090103|1574707|P2|NOT COMPLETED|Four-Year Double-Blind Treatment Period||530
640685|NCT00090103|1574708|P1|NOT COMPLETED|Four-Year Double-Blind Treatment Period||497
640686|NCT00090103|1574706|P3|COMPLETED|Four-Year Double-Blind Treatment Period||989
640687|NCT00090103|1574707|P2|COMPLETED|Four-Year Double-Blind Treatment Period||1093
640688|NCT00090103|1574708|P1|COMPLETED|Four-Year Double-Blind Treatment Period||1113
640689|NCT00090103|1574706|P3|STARTED|Four-Year Double-Blind Treatment Period||1611
640690|NCT00090103|1574707|P2|STARTED|Four-Year Double-Blind Treatment Period||1623
640691|NCT00090103|1574708|P1|STARTED|Four-Year Double-Blind Treatment Period||1610
640692|NCT00090051|1574808|P2|NOT COMPLETED|Overall Study||95
640693|NCT00090051|1574809|P1|NOT COMPLETED|Overall Study||109
640694|NCT00090051|1574808|P2|COMPLETED|Overall Study|Completed 6 Cycles of Treatment|181
640695|NCT00090051|1574809|P1|COMPLETED|Overall Study|Completed 6 Cycles of Treatment|167
640696|NCT00090051|1574808|P2|Safety Population; Received Study Drug|Overall Study||274
640697|NCT00090051|1574809|P1|Safety Population; Received Study Drug|Overall Study||272
640698|NCT00090051|1574808|P2|STARTED|Overall Study||276
640699|NCT00090051|1574809|P1|STARTED|Overall Study||276
640700|NCT00003224|1574849|P6|NOT COMPLETED|Overall Study||0
640701|NCT00003224|1574850|P5|NOT COMPLETED|Overall Study||0
640702|NCT00003224|1574851|P4|NOT COMPLETED|Overall Study||0
640703|NCT00003224|1574852|P3|NOT COMPLETED|Overall Study||0
640704|NCT00003224|1574853|P2|NOT COMPLETED|Overall Study||0
640705|NCT00003224|1574854|P1|NOT COMPLETED|Overall Study||0
640706|NCT00003224|1574849|P6|COMPLETED|Overall Study||3
640707|NCT00003224|1574850|P5|COMPLETED|Overall Study||4
640708|NCT00003224|1574851|P4|COMPLETED|Overall Study||2
640709|NCT00003224|1574852|P3|COMPLETED|Overall Study||4
640710|NCT00003224|1574853|P2|COMPLETED|Overall Study||5
640711|NCT00003224|1574854|P1|COMPLETED|Overall Study||4
640712|NCT00003224|1574849|P6|STARTED|Overall Study||3
640713|NCT00003224|1574850|P5|STARTED|Overall Study||4
640714|NCT00003224|1574851|P4|STARTED|Overall Study||2
640715|NCT00003224|1574852|P3|STARTED|Overall Study||4
640716|NCT00003224|1574853|P2|STARTED|Overall Study||5
640717|NCT00003224|1574854|P1|STARTED|Overall Study||4
640718|NCT00089999|1574874|P2|NOT COMPLETED|Overall Study||69
640719|NCT00089999|1574875|P1|NOT COMPLETED|Overall Study||69
640720|NCT00089999|1574874|P2|COMPLETED|Overall Study||0
640721|NCT00089999|1574875|P1|COMPLETED|Overall Study||0
640722|NCT00089999|1574874|P2|STARTED|Overall Study||69
640723|NCT00089999|1574875|P1|STARTED|Overall Study||69
640724|NCT00089986|1574898|P3|NOT COMPLETED|Overall Study||10
640725|NCT00089986|1574899|P2|NOT COMPLETED|Overall Study||24
640726|NCT00089986|1574900|P1|NOT COMPLETED|Overall Study||15
640727|NCT00089986|1574898|P3|COMPLETED|Overall Study||172
640728|NCT00089986|1574899|P2|COMPLETED|Overall Study||574
640729|NCT00089986|1574900|P1|COMPLETED|Overall Study||584
640730|NCT00089986|1574898|P3|STARTED|Overall Study||182
640731|NCT00089986|1574899|P2|STARTED|Overall Study||598
640732|NCT00089986|1574900|P1|STARTED|Overall Study||599
640733|NCT00089973|1574917|P1|NOT COMPLETED|Overall Study||50
640734|NCT00089973|1574917|P1|COMPLETED|Overall Study||0
640735|NCT00089973|1574917|P1|STARTED|Overall Study||50
640736|NCT00089895|1574932|P2|NOT COMPLETED|Overall Study||42
640737|NCT00089895|1574933|P1|NOT COMPLETED|Overall Study||35
640738|NCT00089895|1574932|P2|COMPLETED|Overall Study|Number of Subjects treated|4642
640739|NCT00089895|1574933|P1|COMPLETED|Overall Study|Number of Subjects treated|4687
640740|NCT00089895|1574932|P2|STARTED|Overall Study|Number of Subjects Randomized with Intent to Treat|4684
640741|NCT00089895|1574933|P1|STARTED|Overall Study|Number of Subjects Randomized with Intent to Treat|4722
640742|NCT00089843|1574945|P4|NOT COMPLETED|Overall Study||7
640743|NCT00089843|1574946|P3|NOT COMPLETED|Overall Study||5
640744|NCT00089843|1574947|P2|NOT COMPLETED|Overall Study||4
640745|NCT00089843|1574948|P1|NOT COMPLETED|Overall Study||2
640746|NCT00089843|1574945|P4|COMPLETED|Overall Study||11
640747|NCT00089843|1574946|P3|COMPLETED|Overall Study||15
640748|NCT00089843|1574947|P2|COMPLETED|Overall Study||16
640749|NCT00089843|1574948|P1|COMPLETED|Overall Study||17
640750|NCT00089843|1574945|P4|STARTED|Overall Study||18
640751|NCT00089843|1574946|P3|STARTED|Overall Study||20
640752|NCT00089843|1574947|P2|STARTED|Overall Study||20
640753|NCT00089843|1574948|P1|STARTED|Overall Study||19
640754|NCT00089791|1574960|P2|NOT COMPLETED|Overall Study||630
640755|NCT00089791|1574961|P1|NOT COMPLETED|Overall Study||700
640756|NCT00089791|1574960|P2|COMPLETED|Overall Study||3272
640757|NCT00089791|1574961|P1|COMPLETED|Overall Study||3206
640758|NCT00089791|1574960|P2|Safety Analysis Set|Overall Study||3886
640759|NCT00089791|1574961|P1|Safety Analysis Set|Overall Study|7 participants in the placebo arm received ≥1 dose of denosumab & were analyzed in the denosumab arm|3876
640760|NCT00089791|1574960|P2|Received Study Medication|Overall Study||3879
640761|NCT00089791|1574961|P1|Received Study Medication|Overall Study||3883
640762|NCT00089791|1574960|P2|STARTED|Overall Study||3902
640763|NCT00089791|1574961|P1|STARTED|Overall Study||3906
640764|NCT00089752|1574973|P2|NOT COMPLETED|Overall Study||22
640765|NCT00089752|1574974|P1|NOT COMPLETED|Overall Study||20
640766|NCT00089752|1574973|P2|COMPLETED|Overall Study||118
640767|NCT00089752|1574974|P1|COMPLETED|Overall Study||121
640768|NCT00089752|1574973|P2|STARTED|Overall Study||140
640769|NCT00089752|1574974|P1|STARTED|Overall Study||141
640770|NCT00089778|1574995|P3|NOT COMPLETED|Overall Study||1
640771|NCT00089778|1574996|P2|NOT COMPLETED|Overall Study||0
640772|NCT00089778|1574997|P1|NOT COMPLETED|Overall Study||0
640773|NCT00089778|1574995|P3|COMPLETED|Overall Study||7
640774|NCT00089778|1574996|P2|COMPLETED|Overall Study||1
640775|NCT00089778|1574997|P1|COMPLETED|Overall Study||2
640776|NCT00089778|1574995|P3|STARTED|Overall Study||8
640777|NCT00089778|1574996|P2|STARTED|Overall Study||1
640778|NCT00089778|1574997|P1|STARTED|Overall Study||2
640779|NCT00089674|1575010|P2|NOT COMPLETED|Overall Study||267
640780|NCT00089674|1575011|P1|NOT COMPLETED|Overall Study||289
640781|NCT00089674|1575010|P2|COMPLETED|Overall Study||467
640782|NCT00089674|1575011|P1|COMPLETED|Overall Study||445
640783|NCT00089674|1575010|P2|Received Study Drug|Overall Study||726
640784|NCT00089674|1575011|P1|Received Study Drug|Overall Study||730
640785|NCT00089674|1575010|P2|STARTED|Overall Study||734
640786|NCT00089674|1575011|P1|STARTED|Overall Study||734
640787|NCT00089661|1575037|P2|NOT COMPLETED|Overall Study||26
640788|NCT00089661|1575038|P1|NOT COMPLETED|Overall Study||21
640789|NCT00089661|1575037|P2|COMPLETED|Overall Study||99
640790|NCT00089661|1575038|P1|COMPLETED|Overall Study||106
640791|NCT00089661|1575037|P2|STARTED|Overall Study||125
640792|NCT00089661|1575038|P1|STARTED|Overall Study||127
640793|NCT00089648|1575054|P1|NOT COMPLETED|Overall Study||41
640794|NCT00089648|1575054|P1|COMPLETED|Overall Study||20
640795|NCT00089648|1575054|P1|STARTED|Overall Study||61
640796|NCT00089635|1575070|P1|NOT COMPLETED|Overall Study||43
640797|NCT00089635|1575070|P1|COMPLETED|Overall Study||160
640798|NCT00089635|1575070|P1|STARTED|Overall Study||203
640799|NCT00089583|1575084|P2|NOT COMPLETED|Overall Study||38
640800|NCT00089583|1575085|P1|NOT COMPLETED|Overall Study||7
640801|NCT00089583|1575084|P2|COMPLETED|Overall Study||51
640802|NCT00089583|1575085|P1|COMPLETED|Overall Study||13
640803|NCT00089583|1575084|P2|STARTED|Overall Study||89
640804|NCT00089583|1575085|P1|STARTED|Overall Study||20
640805|NCT00089609|1575179|P2|NOT COMPLETED|Overall Study||1
640806|NCT00089609|1575180|P1|NOT COMPLETED|Overall Study||3
640807|NCT00089609|1575179|P2|COMPLETED|Overall Study||12
640808|NCT00089609|1575180|P1|COMPLETED|Overall Study||57
640809|NCT00089609|1575179|P2|STARTED|Overall Study||13
640810|NCT00089609|1575180|P1|STARTED|Overall Study||60
640811|NCT00089544|1575199|P2|NOT COMPLETED|Overall Study||0
640812|NCT00089544|1575200|P1|NOT COMPLETED|Overall Study||1
640813|NCT00089544|1575199|P2|COMPLETED|Overall Study||7
640814|NCT00089544|1575200|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|15
640815|NCT00089544|1575199|P2|STARTED|Overall Study||7
640816|NCT00089544|1575200|P1|STARTED|Overall Study||16
640817|NCT00089505|1575214|P4|NOT COMPLETED|Overall Study||21
640818|NCT00089505|1575215|P3|NOT COMPLETED|Overall Study||21
640819|NCT00089505|1575216|P2|NOT COMPLETED|Overall Study||2
640820|NCT00089505|1575217|P1|NOT COMPLETED|Overall Study||9
640821|NCT00089505|1575214|P4|COMPLETED|Overall Study||230
640822|NCT00089505|1575215|P3|COMPLETED|Overall Study||228
640823|NCT00089505|1575216|P2|COMPLETED|Overall Study|The results for NVP/LPV_r were through database cutoff for DSMB review (by 6 October 2008).|118
640824|NCT00089505|1575217|P1|COMPLETED|Overall Study|The results for NVP/NVP were through database cutoff for DSMB review (by 6 October 2008).|112
640825|NCT00089505|1575214|P4|STARTED|Overall Study||251
640826|NCT00089505|1575215|P3|STARTED|Overall Study|2 women never started treatment and per protocol, were not followed and not included in analysis.|249
640827|NCT00089505|1575216|P2|STARTED|Overall Study||120
640828|NCT00089505|1575217|P1|STARTED|Overall Study|2 women never started treatment and per protocol, were not followed and not included in analysis.|121
640829|NCT00089479|1575261|P2|NOT COMPLETED|Overall Study||289
640830|NCT00089479|1575262|P1|NOT COMPLETED|Overall Study||331
640831|NCT00089479|1575261|P2|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|1018
640832|NCT00089479|1575262|P1|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|973
640833|NCT00089479|1575261|P2|Received Treatment|Overall Study|Safety Population (includes 5 patients randomized to ACT, who received ACXT)|1283
640834|NCT00089479|1575262|P1|Received Treatment|Overall Study|Safety Population (includes 19 patients randomized to ACXT, who received ACT)|1305
640835|NCT00089479|1575261|P2|STARTED|Overall Study||1307
640836|NCT00089479|1575262|P1|STARTED|Overall Study||1304
640837|NCT00089414|1575289|P3|NOT COMPLETED|Overall Study||0
640838|NCT00089414|1575290|P2|NOT COMPLETED|Overall Study||0
640839|NCT00089414|1575291|P1|NOT COMPLETED|Overall Study||0
640840|NCT00089414|1575289|P3|COMPLETED|Overall Study||2
640841|NCT00089414|1575290|P2|COMPLETED|Overall Study||1
640842|NCT00089414|1575291|P1|COMPLETED|Overall Study||2
640843|NCT00089414|1575289|P3|STARTED|Overall Study||2
640844|NCT00089414|1575290|P2|STARTED|Overall Study||1
640845|NCT00089414|1575291|P1|STARTED|Overall Study||2
640846|NCT00089297|1575305|P1|NOT COMPLETED|Overall Study||38
640847|NCT00089297|1575305|P1|COMPLETED|Overall Study||36
640848|NCT00089297|1575305|P1|Eligible|Overall Study||63
640849|NCT00089297|1575305|P1|Treated|Overall Study||70
640850|NCT00089297|1575305|P1|STARTED|Overall Study||74
640851|NCT00089141|1575314|P2|NOT COMPLETED|Overall Study||24
640852|NCT00089141|1575315|P1|NOT COMPLETED|Overall Study||18
640853|NCT00089141|1575314|P2|COMPLETED|Overall Study||53
640854|NCT00089141|1575315|P1|COMPLETED|Overall Study||56
640855|NCT00089141|1575314|P2|STARTED|Overall Study||77
640856|NCT00089141|1575315|P1|STARTED|Overall Study||74
640857|NCT00089076|1575337|P1|NOT COMPLETED|Overall Study||10
640858|NCT00089076|1575337|P1|COMPLETED|Overall Study||8
640859|NCT00089076|1575337|P1|STARTED|Overall Study||18
640860|NCT00089011|1575350|P2|NOT COMPLETED|Overall Study||0
640861|NCT00089011|1575351|P1|NOT COMPLETED|Overall Study||0
640862|NCT00089011|1575350|P2|COMPLETED|Overall Study||50
640863|NCT00089011|1575351|P1|COMPLETED|Overall Study||100
640864|NCT00089011|1575350|P2|STARTED|Overall Study||50
640865|NCT00089011|1575351|P1|STARTED|Overall Study||100
640866|NCT00088985|1575371|P1|NOT COMPLETED|Overall Study||3
640867|NCT00088985|1575371|P1|COMPLETED|Overall Study||4
640868|NCT00088985|1575371|P1|STARTED|Overall Study||7
640869|NCT00088972|1575378|P2|NOT COMPLETED|Overall Study||4
640870|NCT00088972|1575379|P1|NOT COMPLETED|Overall Study||2
640871|NCT00088972|1575378|P2|COMPLETED|Overall Study||1
640872|NCT00088972|1575379|P1|COMPLETED|Overall Study||1
640873|NCT00088972|1575378|P2|STARTED|Overall Study||5
640874|NCT00088972|1575379|P1|STARTED|Overall Study||3
640875|NCT00088907|1575389|P2|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||0
640876|NCT00088907|1575390|P1|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||24
640877|NCT00088907|1575389|P2|COMPLETED|Single Gefitinib Treatment (Step 2)||0
640878|NCT00088907|1575390|P1|COMPLETED|Single Gefitinib Treatment (Step 2)||0
640879|NCT00088907|1575389|P2|Treated|Single Gefitinib Treatment (Step 2)||0
640880|NCT00088907|1575390|P1|Treated|Single Gefitinib Treatment (Step 2)||19
640881|NCT00088907|1575389|P2|STARTED|Single Gefitinib Treatment (Step 2)|Cross over to single gefitinib therapy at progression was allowed for patients on Arm I only.|0
640882|NCT00088907|1575390|P1|STARTED|Single Gefitinib Treatment (Step 2)|Patients on Arm I could cross over to gefitinib after disease progression on step 1.|24
640883|NCT00088907|1575389|P2|NOT COMPLETED|Randomized Study (Step 1)||134
640884|NCT00088907|1575390|P1|NOT COMPLETED|Randomized Study (Step 1)||136
640885|NCT00088907|1575389|P2|COMPLETED|Randomized Study (Step 1)|Treatment would continue until disease progression, no certain fixed number of cycles|0
640886|NCT00088907|1575390|P1|COMPLETED|Randomized Study (Step 1)|Treatment would continue until disease progression, no certain fixed number of cycles.|0
640887|NCT00088907|1575389|P2|Eligible and Treated|Randomized Study (Step 1)||122
640888|NCT00088907|1575390|P1|Eligible and Treated|Randomized Study (Step 1)||117
640889|NCT00088907|1575389|P2|Eligible|Randomized Study (Step 1)||122
640890|NCT00088907|1575390|P1|Eligible|Randomized Study (Step 1)||117
640891|NCT00088907|1575389|P2|Treated|Randomized Study (Step 1)||124
640892|NCT00088907|1575390|P1|Treated|Randomized Study (Step 1)||129
640893|NCT00088907|1575389|P2|STARTED|Randomized Study (Step 1)||134
640894|NCT00088907|1575390|P1|STARTED|Randomized Study (Step 1)||136
640895|NCT00088881|1575401|P1|NOT COMPLETED|Step 3 - Radiation Therapy||0
640896|NCT00088881|1575401|P1|COMPLETED|Step 3 - Radiation Therapy||1
640897|NCT00088881|1575401|P1|STARTED|Step 3 - Radiation Therapy||1
640898|NCT00088881|1575401|P1|NOT COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||11
640899|NCT00088881|1575401|P1|COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||45
640900|NCT00088881|1575401|P1|Eligible and Treated|Step 2 - Zevalin™ Radioimmunotherapy||48
640901|NCT00088881|1575401|P1|STARTED|Step 2 - Zevalin™ Radioimmunotherapy|This includes all patients who received step 2 treatment regardless of eligibility.|56
640902|NCT00088881|1575401|P1|NOT COMPLETED|Step 1 - R-CHOP||14
640903|NCT00088881|1575401|P1|COMPLETED|Step 1 - R-CHOP||48
640904|NCT00088881|1575401|P1|Eligible and Treated|Step 1 - R-CHOP||53
640905|NCT00088881|1575401|P1|STARTED|Step 1 - R-CHOP||62
640906|NCT00088634|1575412|P2|NOT COMPLETED|Overall Study||43
640907|NCT00088634|1575413|P1|NOT COMPLETED|Overall Study||38
640908|NCT00088634|1575412|P2|COMPLETED|Overall Study||47
640909|NCT00088634|1575413|P1|COMPLETED|Overall Study||52
640910|NCT00088634|1575412|P2|STARTED|Overall Study||90
640911|NCT00088634|1575413|P1|STARTED|Overall Study||90
640912|NCT00088621|1575425|P1|NOT COMPLETED|Overall Study||54
640913|NCT00088621|1575425|P1|COMPLETED|Overall Study||7
640914|NCT00088621|1575425|P1|STARTED|Overall Study||61
640915|NCT00088595|1575429|P1|NOT COMPLETED|Overall Study||28
640916|NCT00088595|1575429|P1|COMPLETED|Overall Study||17
640917|NCT00088595|1575429|P1|STARTED|Overall Study||45
640918|NCT00088530|1575447|P2|NOT COMPLETED|Overall Study||54
640919|NCT00088530|1575448|P1|NOT COMPLETED|Overall Study||50
640920|NCT00088530|1575447|P2|COMPLETED|Overall Study||16
640921|NCT00088530|1575448|P1|COMPLETED|Overall Study||20
640922|NCT00088530|1575447|P2|STARTED|Overall Study||70
640923|NCT00088530|1575448|P1|STARTED|Overall Study||70
640924|NCT00088465|1575460|P1|NOT COMPLETED|Overall Study||561
640925|NCT00088465|1575460|P1|COMPLETED|Overall Study||370
640926|NCT00088465|1575460|P1|STARTED|Overall Study||931
640927|NCT00088374|1575483|P1|NOT COMPLETED|Overall Study||2
640928|NCT00088374|1575483|P1|COMPLETED|Overall Study||7
640929|NCT00088374|1575483|P1|STARTED|Overall Study||9
640930|NCT00088218|1575494|P2|NOT COMPLETED|Overall Study||0
640931|NCT00088218|1575495|P1|NOT COMPLETED|Overall Study||0
640932|NCT00088218|1575494|P2|COMPLETED|Overall Study||79
640933|NCT00088218|1575495|P1|COMPLETED|Overall Study||16
640934|NCT00088218|1575494|P2|STARTED|Overall Study||79
640935|NCT00088218|1575495|P1|STARTED|Overall Study||16
640936|NCT00088166|1575503|P2|NOT COMPLETED|Overall Study||61
640937|NCT00088166|1575504|P1|NOT COMPLETED|Overall Study||53
640938|NCT00088166|1575503|P2|COMPLETED|Overall Study||39
640939|NCT00088166|1575504|P1|COMPLETED|Overall Study||47
640940|NCT00088166|1575503|P2|STARTED|Overall Study||100
640941|NCT00088166|1575504|P1|STARTED|Overall Study||100
640942|NCT00088153|1575528|P2|NOT COMPLETED|Overall Study||25
640943|NCT00088153|1575529|P1|NOT COMPLETED|Overall Study||24
640944|NCT00088153|1575528|P2|COMPLETED|Overall Study||30
640945|NCT00088153|1575529|P1|COMPLETED|Overall Study||31
640946|NCT00088153|1575528|P2|STARTED|Overall Study||55
640947|NCT00088153|1575529|P1|STARTED|Overall Study||55
640948|NCT00087698|1575539|P1|NOT COMPLETED|Overall Study||36
640949|NCT00087698|1575539|P1|COMPLETED|Overall Study||41
640950|NCT00087698|1575539|P1|STARTED|Overall Study||77
640951|NCT00087685|1575548|P1|NOT COMPLETED|Overall Study||14
640952|NCT00087685|1575548|P1|COMPLETED|Overall Study||21
640953|NCT00087685|1575548|P1|STARTED|Overall Study||35
640954|NCT00087672|1575553|P1|NOT COMPLETED|Overall Study||0
640955|NCT00087672|1575553|P1|COMPLETED|Overall Study||41
640956|NCT00087672|1575553|P1|STARTED|Overall Study||41
640957|NCT00087646|1575561|P4|NOT COMPLETED|Overall Study||84
640958|NCT00087646|1575562|P3|NOT COMPLETED|Overall Study||65
640959|NCT00087646|1575563|P2|NOT COMPLETED|Overall Study||42
640960|NCT00087646|1575564|P1|NOT COMPLETED|Overall Study||135
640961|NCT00087646|1575561|P4|COMPLETED|Overall Study||229
640962|NCT00087646|1575562|P3|COMPLETED|Overall Study||91
640963|NCT00087646|1575563|P2|COMPLETED|Overall Study||114
640964|NCT00087646|1575564|P1|COMPLETED|Overall Study||182
640965|NCT00087646|1575561|P4|STARTED|Overall Study||313
640966|NCT00087646|1575562|P3|STARTED|Overall Study||156
640967|NCT00087646|1575563|P2|STARTED|Overall Study||156
640968|NCT00087646|1575564|P1|STARTED|Overall Study||317
640969|NCT00087633|1575592|P2|NOT COMPLETED|Overall Study||17
640970|NCT00087633|1575593|P1|NOT COMPLETED|Overall Study||24
640971|NCT00087633|1575592|P2|COMPLETED|Overall Study|Completed 48 weeks of treatment/observation|43
640972|NCT00087633|1575593|P1|COMPLETED|Overall Study|Completed 48 weeks of treatment/observation|31
640973|NCT00087633|1575592|P2|STARTED|Overall Study|Randomized|60
640974|NCT00087633|1575593|P1|STARTED|Overall Study|Randomized|55
640975|NCT00087607|1575603|P2|NOT COMPLETED|Overall Study||122
640976|NCT00087607|1575604|P1|NOT COMPLETED|Overall Study||122
640977|NCT00087607|1575603|P2|COMPLETED|Overall Study||71
640978|NCT00087607|1575604|P1|COMPLETED|Overall Study||70
640979|NCT00087607|1575603|P2|STARTED|Overall Study||193
640980|NCT00087607|1575604|P1|STARTED|Overall Study||192
640981|NCT00087594|1575644|P2|NOT COMPLETED|Overall Study||12
640982|NCT00087594|1575645|P1|NOT COMPLETED|Overall Study||8
640983|NCT00087594|1575644|P2|COMPLETED|Overall Study||12
640984|NCT00087594|1575645|P1|COMPLETED|Overall Study||16
640985|NCT00087594|1575644|P2|STARTED|Overall Study||24
640986|NCT00087594|1575645|P1|STARTED|Overall Study||24
640987|NCT00087568|1575679|P2|NOT COMPLETED|Overall Study||2
640988|NCT00087568|1575680|P1|NOT COMPLETED|Overall Study||30
640989|NCT00087568|1575679|P2|COMPLETED|Overall Study||23
640990|NCT00087568|1575680|P1|COMPLETED|Overall Study||2
640991|NCT00087568|1575679|P2|STARTED|Overall Study||25
640992|NCT00087568|1575680|P1|STARTED|Overall Study||32
640993|NCT00087555|1575707|P3|NOT COMPLETED|Overall Study||21
640994|NCT00087555|1575708|P2|NOT COMPLETED|Overall Study||11
640995|NCT00087555|1575709|P1|NOT COMPLETED|Overall Study||12
640996|NCT00087555|1575707|P3|COMPLETED|Overall Study||46
640997|NCT00087555|1575708|P2|COMPLETED|Overall Study||51
640998|NCT00087555|1575709|P1|COMPLETED|Overall Study||54
640999|NCT00087555|1575707|P3|Treated|Overall Study||67
641000|NCT00087555|1575708|P2|Treated|Overall Study||60
641001|NCT00087555|1575709|P1|Treated|Overall Study||65
641002|NCT00087555|1575707|P3|STARTED|Overall Study||67
641003|NCT00087555|1575708|P2|STARTED|Overall Study||62
641004|NCT00087555|1575709|P1|STARTED|Overall Study||66
641005|NCT00087529|1575719|P2|NOT COMPLETED|Overall Study||68
641006|NCT00087529|1575720|P1|NOT COMPLETED|Overall Study||31
641007|NCT00087529|1575719|P2|COMPLETED|Overall Study||224
641008|NCT00087529|1575720|P1|COMPLETED|Overall Study||116
641009|NCT00087529|1575719|P2|STARTED|Overall Study||292
641010|NCT00087529|1575720|P1|STARTED|Overall Study||147
641011|NCT00087516|1575735|P4|NOT COMPLETED|Overall Study||85
641012|NCT00087516|1575736|P3|NOT COMPLETED|Overall Study||97
641013|NCT00087516|1575737|P2|NOT COMPLETED|Overall Study||169
641014|NCT00087516|1575738|P1|NOT COMPLETED|Overall Study||161
641015|NCT00087516|1575735|P4|COMPLETED|Overall Study||38
641016|NCT00087516|1575736|P3|COMPLETED|Overall Study||33
641017|NCT00087516|1575737|P2|COMPLETED|Overall Study||81
641018|NCT00087516|1575738|P1|COMPLETED|Overall Study||77
641019|NCT00087516|1575735|P4|STARTED|Overall Study||123
641020|NCT00087516|1575736|P3|STARTED|Overall Study||130
641021|NCT00087516|1575737|P2|STARTED|Overall Study||250
641022|NCT00087516|1575738|P1|STARTED|Overall Study||238
641023|NCT00087490|1575767|P2|NOT COMPLETED|Overall Study||269
641024|NCT00087490|1575768|P1|NOT COMPLETED|Overall Study||258
641025|NCT00087490|1575767|P2|COMPLETED|Overall Study||264
641026|NCT00087490|1575768|P1|COMPLETED|Overall Study||286
641027|NCT00087490|1575767|P2|Treated|Overall Study||515
641028|NCT00087490|1575768|P1|Treated|Overall Study||537
641029|NCT00087490|1575767|P2|STARTED|Overall Study||533
641030|NCT00087490|1575768|P1|STARTED|Overall Study||544
641031|NCT00087438|1575802|P1|NOT COMPLETED|Overall Study||4
641032|NCT00087438|1575802|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|55
641033|NCT00087438|1575802|P1|STARTED|Overall Study||59
641034|NCT00087152|1575806|P1|NOT COMPLETED|Overall Study||6
641035|NCT00087152|1575806|P1|COMPLETED|Overall Study||21
641036|NCT00087152|1575806|P1|STARTED|Overall Study||27
641037|NCT00087139|1575815|P3|NOT COMPLETED|Overall Study||36
641038|NCT00087139|1575816|P2|NOT COMPLETED|Overall Study||49
641039|NCT00087139|1575817|P1|NOT COMPLETED|Overall Study||39
641040|NCT00087139|1575815|P3|COMPLETED|Overall Study||0
641041|NCT00087139|1575816|P2|COMPLETED|Overall Study||0
641042|NCT00087139|1575817|P1|COMPLETED|Overall Study||0
641043|NCT00087139|1575815|P3|Patients w/ Measurable Disease Response|Overall Study||0
641044|NCT00087139|1575816|P2|Patients w/ Measurable Disease Response|Overall Study||2
641045|NCT00087139|1575817|P1|Patients w/ Measurable Disease Response|Overall Study||5
641046|NCT00087139|1575815|P3|Patients With PSA Response|Overall Study||4
641047|NCT00087139|1575816|P2|Patients With PSA Response|Overall Study||8
641048|NCT00087139|1575817|P1|Patients With PSA Response|Overall Study||10
641049|NCT00087139|1575815|P3|Patients With Measurable Disease|Overall Study||24
641050|NCT00087139|1575816|P2|Patients With Measurable Disease|Overall Study||25
641051|NCT00087139|1575817|P1|Patients With Measurable Disease|Overall Study||22
641052|NCT00087139|1575815|P3|Patients for the Analysis of PSA Respons|Overall Study||22
641053|NCT00087139|1575816|P2|Patients for the Analysis of PSA Respons|Overall Study||34
641054|NCT00087139|1575817|P1|Patients for the Analysis of PSA Respons|Overall Study||30
641055|NCT00087139|1575815|P3|Eligible and Treated|Overall Study||32
641056|NCT00087139|1575816|P2|Eligible and Treated|Overall Study||42
641057|NCT00087139|1575817|P1|Eligible and Treated|Overall Study||35
641058|NCT00087139|1575815|P3|Treated|Overall Study||36
641059|NCT00087139|1575816|P2|Treated|Overall Study||48
641060|NCT00087139|1575817|P1|Treated|Overall Study||39
641061|NCT00087139|1575815|P3|STARTED|Overall Study||36
641062|NCT00087139|1575816|P2|STARTED|Overall Study||49
641063|NCT00087139|1575817|P1|STARTED|Overall Study||39
641064|NCT00086996|1575832|P1|NOT COMPLETED|Overall Study||64
641065|NCT00086996|1575832|P1|COMPLETED|Overall Study||34
641066|NCT00086996|1575832|P1|Eligible and Began Protocol Therapy|Overall Study||93
641067|NCT00086996|1575832|P1|Eligible|Overall Study||93
641068|NCT00086996|1575832|P1|STARTED|Overall Study||98
641069|NCT00086957|1575839|P3|NOT COMPLETED|Overall Study||0
641070|NCT00086957|1575840|P2|NOT COMPLETED|Overall Study||0
641071|NCT00086957|1575841|P1|NOT COMPLETED|Overall Study||0
641072|NCT00086957|1575839|P3|COMPLETED|Overall Study||22
641073|NCT00086957|1575840|P2|COMPLETED|Overall Study||7
641074|NCT00086957|1575841|P1|COMPLETED|Overall Study||2
641075|NCT00086957|1575839|P3|STARTED|Overall Study||22
641076|NCT00086957|1575840|P2|STARTED|Overall Study||7
641077|NCT00086957|1575841|P1|STARTED|Overall Study||2
641078|NCT00086684|1575854|P3|NOT COMPLETED|Overall Study||53
641079|NCT00086684|1575855|P2|NOT COMPLETED|Overall Study||55
641080|NCT00086684|1575856|P1|NOT COMPLETED|Overall Study||55
641081|NCT00086684|1575854|P3|COMPLETED|Overall Study||69
641082|NCT00086684|1575855|P2|COMPLETED|Overall Study||74
641083|NCT00086684|1575856|P1|COMPLETED|Overall Study||63
641084|NCT00086684|1575854|P3|STARTED|Overall Study||122
641085|NCT00086684|1575855|P2|STARTED|Overall Study||129
641086|NCT00086684|1575856|P1|STARTED|Overall Study||118
641087|NCT00086619|1575869|P2|NOT COMPLETED|Overall Study||17
641088|NCT00086619|1575870|P1|NOT COMPLETED|Overall Study||15
641089|NCT00086619|1575869|P2|COMPLETED|Overall Study||23
641090|NCT00086619|1575870|P1|COMPLETED|Overall Study||25
641091|NCT00086619|1575869|P2|Completed 12 Month Visit|Overall Study||26
641092|NCT00086619|1575870|P1|Completed 12 Month Visit|Overall Study||26
641093|NCT00086619|1575869|P2|Completed Baseline Visit|Overall Study||36
641094|NCT00086619|1575870|P1|Completed Baseline Visit|Overall Study||34
641095|NCT00086619|1575869|P2|STARTED|Overall Study||40
641096|NCT00086619|1575870|P1|STARTED|Overall Study||40
641097|NCT00086580|1575880|P2|NOT COMPLETED|Observation Period||65
641098|NCT00086580|1575881|P1|NOT COMPLETED|Observation Period||46
641099|NCT00086580|1575880|P2|COMPLETED|Observation Period||56
641100|NCT00086580|1575881|P1|COMPLETED|Observation Period||49
641101|NCT00086580|1575880|P2|STARTED|Observation Period||121
641102|NCT00086580|1575881|P1|STARTED|Observation Period||95
641103|NCT00086580|1575880|P2|NOT COMPLETED|Follow-up Period||119
641104|NCT00086580|1575881|P1|NOT COMPLETED|Follow-up Period||104
641105|NCT00086580|1575880|P2|COMPLETED|Follow-up Period||18
641106|NCT00086580|1575881|P1|COMPLETED|Follow-up Period||37
641107|NCT00086580|1575880|P2|STARTED|Follow-up Period||137
641108|NCT00086580|1575881|P1|STARTED|Follow-up Period||141
641109|NCT00086580|1575880|P2|NOT COMPLETED|Treatment Period||60
641110|NCT00086580|1575881|P1|NOT COMPLETED|Treatment Period||65
641111|NCT00086580|1575880|P2|COMPLETED|Treatment Period|Finished 6 cycles of study drug|107
641112|NCT00086580|1575881|P1|COMPLETED|Treatment Period|Finished 6 cycles of study drugs|103
641113|NCT00086580|1575880|P2|Safety Population|Treatment Period|Two participants did not receive treatment|165
641114|NCT00086580|1575881|P1|Safety Population|Treatment Period|Four participants did not receive treatment|164
641115|NCT00086580|1575880|P2|STARTED|Treatment Period||167
641116|NCT00086580|1575881|P1|STARTED|Treatment Period||168
641117|NCT00086411|1575929|P4|NOT COMPLETED|Overall Study||12
641118|NCT00086411|1575930|P3|NOT COMPLETED|Overall Study||13
641119|NCT00086411|1575931|P2|NOT COMPLETED|Overall Study||11
641120|NCT00086411|1575932|P1|NOT COMPLETED|Overall Study||11
641121|NCT00086411|1575929|P4|COMPLETED|Overall Study||53
641122|NCT00086411|1575930|P3|COMPLETED|Overall Study||49
641123|NCT00086411|1575931|P2|COMPLETED|Overall Study||52
641124|NCT00086411|1575932|P1|COMPLETED|Overall Study||59
641125|NCT00086411|1575929|P4|STARTED|Overall Study||65
641126|NCT00086411|1575930|P3|STARTED|Overall Study||62
641127|NCT00086411|1575931|P2|STARTED|Overall Study||63
641128|NCT00086411|1575932|P1|STARTED|Overall Study||70
641129|NCT00086385|1575946|P4|NOT COMPLETED|Overall Study||1
641130|NCT00086385|1575947|P3|NOT COMPLETED|Overall Study||1
641131|NCT00086385|1575948|P2|NOT COMPLETED|Overall Study||2
641132|NCT00086385|1575949|P1|NOT COMPLETED|Overall Study||2
641133|NCT00086385|1575946|P4|COMPLETED|Overall Study||98
641134|NCT00086385|1575947|P3|COMPLETED|Overall Study||103
641135|NCT00086385|1575948|P2|COMPLETED|Overall Study||97
641136|NCT00086385|1575949|P1|COMPLETED|Overall Study||98
641137|NCT00086385|1575946|P4|STARTED|Overall Study||99
641138|NCT00086385|1575947|P3|STARTED|Overall Study||104
641139|NCT00086385|1575948|P2|STARTED|Overall Study||99
641140|NCT00086385|1575949|P1|STARTED|Overall Study||100
641141|NCT00086515|1575961|P2|NOT COMPLETED|Phase B (Weeks 24-104)||55
641142|NCT00086515|1575962|P1|NOT COMPLETED|Phase B (Weeks 24-104)||190
641143|NCT00086515|1575961|P2|COMPLETED|Phase B (Weeks 24-104)||109
641144|NCT00086515|1575962|P1|COMPLETED|Phase B (Weeks 24-104)||201
641145|NCT00086515|1575961|P2|STARTED|Phase B (Weeks 24-104)||164
641146|NCT00086515|1575962|P1|STARTED|Phase B (Weeks 24-104)||391
641147|NCT00086515|1575961|P2|NOT COMPLETED|Phase A to Phase B Transition Period||28
641148|NCT00086515|1575962|P1|NOT COMPLETED|Phase A to Phase B Transition Period||24
641149|NCT00086515|1575961|P2|COMPLETED|Phase A to Phase B Transition Period||164
641150|NCT00086515|1575962|P1|COMPLETED|Phase A to Phase B Transition Period||391
641151|NCT00086515|1575961|P2|STARTED|Phase A to Phase B Transition Period||192
641152|NCT00086515|1575962|P1|STARTED|Phase A to Phase B Transition Period||415
641153|NCT00086515|1575961|P2|NOT COMPLETED|Phase A (Weeks 0-24)||45
641154|NCT00086515|1575962|P1|NOT COMPLETED|Phase A (Weeks 0-24)||49
641155|NCT00086515|1575961|P2|COMPLETED|Phase A (Weeks 0-24)||192
641156|NCT00086515|1575962|P1|COMPLETED|Phase A (Weeks 0-24)||415
641157|NCT00086515|1575961|P2|STARTED|Phase A (Weeks 0-24)||237
641158|NCT00086515|1575962|P1|STARTED|Phase A (Weeks 0-24)||464
641159|NCT00086502|1575974|P2|NOT COMPLETED|Overall Study||20
641160|NCT00086502|1575975|P1|NOT COMPLETED|Overall Study||26
641161|NCT00086502|1575974|P2|COMPLETED|Overall Study||158
641162|NCT00086502|1575975|P1|COMPLETED|Overall Study||149
641163|NCT00086502|1575974|P2|STARTED|Overall Study||178
641164|NCT00086502|1575975|P1|STARTED|Overall Study||175
641165|NCT00086450|1575985|P2|NOT COMPLETED|Overall Study||0
641166|NCT00086450|1575986|P1|NOT COMPLETED|Overall Study||0
641167|NCT00086450|1575985|P2|COMPLETED|Overall Study||947
641168|NCT00086450|1575986|P1|COMPLETED|Overall Study||953
641169|NCT00086450|1575985|P2|STARTED|Overall Study||947
641170|NCT00086450|1575986|P1|STARTED|Overall Study||953
641171|NCT00086346|1576000|P2|NOT COMPLETED|Patients Dosed With Test Article||23
641172|NCT00086346|1576001|P1|NOT COMPLETED|Patients Dosed With Test Article||140
641173|NCT00086346|1576000|P2|COMPLETED|Patients Dosed With Test Article||187
641174|NCT00086346|1576001|P1|COMPLETED|Patients Dosed With Test Article||249
641175|NCT00086346|1576000|P2|STARTED|Patients Dosed With Test Article||210
641176|NCT00086346|1576001|P1|STARTED|Patients Dosed With Test Article||389
641177|NCT00086346|1576000|P2|NOT COMPLETED|Randomization||4
641178|NCT00086346|1576001|P1|NOT COMPLETED|Randomization||4
641179|NCT00086346|1576000|P2|COMPLETED|Randomization||210
641180|NCT00086346|1576001|P1|COMPLETED|Randomization||389
641181|NCT00086346|1576000|P2|STARTED|Randomization||214
641182|NCT00086346|1576001|P1|STARTED|Randomization||393
641183|NCT00086281|1576028|P15|NOT COMPLETED|Phase 2||0
641184|NCT00086281|1576029|P14|NOT COMPLETED|Phase 2||1
641185|NCT00086281|1576030|P13|NOT COMPLETED|Phase 2||1
641186|NCT00086281|1576031|P12|NOT COMPLETED|Phase 2||0
641187|NCT00086281|1576032|P11|NOT COMPLETED|Phase 2||0
641188|NCT00086281|1576033|P10|NOT COMPLETED|Phase 2||0
641189|NCT00086281|1576034|P9|NOT COMPLETED|Phase 2||0
641190|NCT00086281|1576035|P8|NOT COMPLETED|Phase 2||0
641191|NCT00086281|1576036|P7|NOT COMPLETED|Phase 2||0
641192|NCT00086281|1576037|P6|NOT COMPLETED|Phase 2||0
641193|NCT00086281|1576038|P5|NOT COMPLETED|Phase 2||0
641194|NCT00086281|1576039|P4|NOT COMPLETED|Phase 2||0
641195|NCT00086281|1576040|P3|NOT COMPLETED|Phase 2||0
641196|NCT00086281|1576041|P2|NOT COMPLETED|Phase 2||0
641197|NCT00086281|1576042|P1|NOT COMPLETED|Phase 2||0
641198|NCT00086281|1576028|P15|COMPLETED|Phase 2||0
641199|NCT00086281|1576029|P14|COMPLETED|Phase 2||26
641200|NCT00086281|1576030|P13|COMPLETED|Phase 2||22
641201|NCT00086281|1576031|P12|COMPLETED|Phase 2||0
641202|NCT00086281|1576032|P11|COMPLETED|Phase 2||0
641203|NCT00086281|1576033|P10|COMPLETED|Phase 2||0
641204|NCT00086281|1576034|P9|COMPLETED|Phase 2||0
641205|NCT00086281|1576035|P8|COMPLETED|Phase 2||0
641206|NCT00086281|1576036|P7|COMPLETED|Phase 2||0
641207|NCT00086281|1576037|P6|COMPLETED|Phase 2||0
641208|NCT00086281|1576038|P5|COMPLETED|Phase 2||0
641209|NCT00086281|1576039|P4|COMPLETED|Phase 2||0
641210|NCT00086281|1576040|P3|COMPLETED|Phase 2||0
641211|NCT00086281|1576041|P2|COMPLETED|Phase 2||0
641212|NCT00086281|1576042|P1|COMPLETED|Phase 2||0
641213|NCT00086281|1576028|P15|STARTED|Phase 2||0
641214|NCT00086281|1576029|P14|STARTED|Phase 2||27
641215|NCT00086281|1576030|P13|STARTED|Phase 2||23
641216|NCT00086281|1576031|P12|STARTED|Phase 2||0
641217|NCT00086281|1576032|P11|STARTED|Phase 2||0
641218|NCT00086281|1576033|P10|STARTED|Phase 2||0
641219|NCT00086281|1576034|P9|STARTED|Phase 2||0
641220|NCT00086281|1576035|P8|STARTED|Phase 2||0
641221|NCT00086281|1576036|P7|STARTED|Phase 2||0
641222|NCT00086281|1576037|P6|STARTED|Phase 2||0
641223|NCT00086281|1576038|P5|STARTED|Phase 2||0
641224|NCT00086281|1576039|P4|STARTED|Phase 2||0
641225|NCT00086281|1576040|P3|STARTED|Phase 2||0
641226|NCT00086281|1576041|P2|STARTED|Phase 2||0
641227|NCT00086281|1576042|P1|STARTED|Phase 2||0
641228|NCT00086281|1576028|P15|NOT COMPLETED|Phase 1||3
641229|NCT00086281|1576029|P14|NOT COMPLETED|Phase 1||1
641230|NCT00086281|1576030|P13|NOT COMPLETED|Phase 1||1
641231|NCT00086281|1576031|P12|NOT COMPLETED|Phase 1||1
641232|NCT00086281|1576032|P11|NOT COMPLETED|Phase 1||3
641233|NCT00086281|1576033|P10|NOT COMPLETED|Phase 1||1
641234|NCT00086281|1576034|P9|NOT COMPLETED|Phase 1||0
641235|NCT00086281|1576035|P8|NOT COMPLETED|Phase 1||0
641236|NCT00086281|1576036|P7|NOT COMPLETED|Phase 1||0
641237|NCT00086281|1576037|P6|NOT COMPLETED|Phase 1||0
641238|NCT00086281|1576038|P5|NOT COMPLETED|Phase 1||0
641239|NCT00086281|1576039|P4|NOT COMPLETED|Phase 1||0
641240|NCT00086281|1576040|P3|NOT COMPLETED|Phase 1||0
641241|NCT00086281|1576041|P2|NOT COMPLETED|Phase 1||0
641242|NCT00086281|1576042|P1|NOT COMPLETED|Phase 1||0
641243|NCT00086281|1576028|P15|COMPLETED|Phase 1||0
641244|NCT00086281|1576029|P14|COMPLETED|Phase 1||0
641245|NCT00086281|1576030|P13|COMPLETED|Phase 1||0
641246|NCT00086281|1576031|P12|COMPLETED|Phase 1||0
641247|NCT00086281|1576032|P11|COMPLETED|Phase 1||0
641248|NCT00086281|1576033|P10|COMPLETED|Phase 1||0
641249|NCT00086281|1576034|P9|COMPLETED|Phase 1||2
641250|NCT00086281|1576035|P8|COMPLETED|Phase 1||1
641251|NCT00086281|1576036|P7|COMPLETED|Phase 1||1
641252|NCT00086281|1576037|P6|COMPLETED|Phase 1||3
641253|NCT00086281|1576038|P5|COMPLETED|Phase 1||1
641254|NCT00086281|1576039|P4|COMPLETED|Phase 1||11
641255|NCT00086281|1576040|P3|COMPLETED|Phase 1||8
641256|NCT00086281|1576041|P2|COMPLETED|Phase 1||12
641257|NCT00086281|1576042|P1|COMPLETED|Phase 1||11
641258|NCT00086281|1576028|P15|STARTED|Phase 1||3
641259|NCT00086281|1576029|P14|STARTED|Phase 1||1
641260|NCT00086281|1576030|P13|STARTED|Phase 1||1
641261|NCT00086281|1576031|P12|STARTED|Phase 1||1
641262|NCT00086281|1576032|P11|STARTED|Phase 1||3
641263|NCT00086281|1576033|P10|STARTED|Phase 1||1
641264|NCT00086281|1576034|P9|STARTED|Phase 1||2
641265|NCT00086281|1576035|P8|STARTED|Phase 1||1
641266|NCT00086281|1576036|P7|STARTED|Phase 1||1
641267|NCT00086281|1576037|P6|STARTED|Phase 1||3
641268|NCT00086281|1576038|P5|STARTED|Phase 1||1
641269|NCT00086281|1576039|P4|STARTED|Phase 1||11
641270|NCT00086281|1576040|P3|STARTED|Phase 1||8
641271|NCT00086281|1576041|P2|STARTED|Phase 1||12
641272|NCT00086281|1576042|P1|STARTED|Phase 1||11
641273|NCT00086307|1576055|P3|NOT COMPLETED|Overall Study||8
641274|NCT00086307|1576056|P2|NOT COMPLETED|Overall Study||1
641275|NCT00086307|1576057|P1|NOT COMPLETED|Overall Study||2
641276|NCT00086307|1576055|P3|COMPLETED|Overall Study||5
641277|NCT00086307|1576056|P2|COMPLETED|Overall Study||12
641278|NCT00086307|1576057|P1|COMPLETED|Overall Study||11
641279|NCT00086307|1576055|P3|STARTED|Overall Study||13
641280|NCT00086307|1576056|P2|STARTED|Overall Study||13
641281|NCT00086307|1576057|P1|STARTED|Overall Study||13
641282|NCT00086190|1576068|P3|NOT COMPLETED|Overall Study||6
641283|NCT00086190|1576069|P2|NOT COMPLETED|Overall Study||4
641284|NCT00086190|1576070|P1|NOT COMPLETED|Overall Study||8
641285|NCT00086190|1576068|P3|COMPLETED|Overall Study||33
641286|NCT00086190|1576069|P2|COMPLETED|Overall Study||30
641287|NCT00086190|1576070|P1|COMPLETED|Overall Study||34
641288|NCT00086190|1576068|P3|STARTED|Overall Study||39
641289|NCT00086190|1576069|P2|STARTED|Overall Study||34
641290|NCT00086190|1576070|P1|STARTED|Overall Study||42
641291|NCT00086138|1576128|P2|NOT COMPLETED|Overall Study||3
641292|NCT00086138|1576129|P1|NOT COMPLETED|Overall Study||4
641293|NCT00086138|1576128|P2|COMPLETED|Overall Study||64
641294|NCT00086138|1576129|P1|COMPLETED|Overall Study||60
641295|NCT00086138|1576128|P2|STARTED|Overall Study||67
641296|NCT00086138|1576129|P1|STARTED|Overall Study||64
641297|NCT00086047|1576139|P2|NOT COMPLETED|Overall Study||7
641298|NCT00086047|1576140|P1|NOT COMPLETED|Overall Study||7
641299|NCT00086047|1576139|P2|COMPLETED|Overall Study||50
641300|NCT00086047|1576140|P1|COMPLETED|Overall Study||50
641301|NCT00086047|1576139|P2|STARTED|Overall Study||57
641302|NCT00086047|1576140|P1|STARTED|Overall Study||57
641303|NCT00085917|1576148|P2|NOT COMPLETED|Overall Study||3
641304|NCT00085917|1576149|P1|NOT COMPLETED|Overall Study||4
641305|NCT00085917|1576148|P2|COMPLETED|Overall Study||11
641306|NCT00085917|1576149|P1|COMPLETED|Overall Study||11
641307|NCT00085917|1576148|P2|STARTED|Overall Study||14
641308|NCT00085917|1576149|P1|STARTED|Overall Study||15
641309|NCT00085839|1576161|P2|NOT COMPLETED|Overall Study||0
641310|NCT00085839|1576162|P1|NOT COMPLETED|Overall Study||0
641311|NCT00085839|1576161|P2|COMPLETED|Overall Study||51
641312|NCT00085839|1576162|P1|COMPLETED|Overall Study||52
641313|NCT00085839|1576161|P2|STARTED|Overall Study||51
641314|NCT00085839|1576162|P1|STARTED|Overall Study||52
641315|NCT00085735|1576178|P6|NOT COMPLETED|Overall Study||31
641316|NCT00085735|1576179|P5|NOT COMPLETED|Overall Study||42
641317|NCT00085735|1576180|P4|NOT COMPLETED|Overall Study||19
641318|NCT00085735|1576181|P3|NOT COMPLETED|Overall Study||17
641319|NCT00085735|1576182|P2|NOT COMPLETED|Overall Study||10
641320|NCT00085735|1576183|P1|NOT COMPLETED|Overall Study||12
641321|NCT00085735|1576178|P6|COMPLETED|Overall Study||115
641322|NCT00085735|1576179|P5|COMPLETED|Overall Study||105
641323|NCT00085735|1576180|P4|COMPLETED|Overall Study||46
641324|NCT00085735|1576181|P3|COMPLETED|Overall Study||46
641325|NCT00085735|1576182|P2|COMPLETED|Overall Study||54
641326|NCT00085735|1576183|P1|COMPLETED|Overall Study||52
641327|NCT00085735|1576178|P6|STARTED|Overall Study||146
641328|NCT00085735|1576179|P5|STARTED|Overall Study||147
641329|NCT00085735|1576180|P4|STARTED|Overall Study||65
641330|NCT00085735|1576181|P3|STARTED|Overall Study||63
641331|NCT00085735|1576182|P2|STARTED|Overall Study||64
641332|NCT00085735|1576183|P1|STARTED|Overall Study||64
641333|NCT00085709|1576211|P2|NOT COMPLETED|Overall Study||50
641334|NCT00085709|1576212|P1|NOT COMPLETED|Overall Study||53
641335|NCT00085709|1576211|P2|COMPLETED|Overall Study||270
641336|NCT00085709|1576212|P1|COMPLETED|Overall Study||264
641337|NCT00085709|1576211|P2|Eligible and Did Not Withdraw Consent|Overall Study||300
641338|NCT00085709|1576212|P1|Eligible and Did Not Withdraw Consent|Overall Study||296
641339|NCT00085709|1576211|P2|Eligible|Overall Study||301
641340|NCT00085709|1576212|P1|Eligible|Overall Study||298
641341|NCT00085709|1576211|P2|STARTED|Overall Study||320
641342|NCT00085709|1576212|P1|STARTED|Overall Study||317
641343|NCT00085644|1576228|P3|NOT COMPLETED|Open-Label Period||109
641344|NCT00085644|1576229|P2|NOT COMPLETED|Open-Label Period||0
641345|NCT00085644|1576230|P1|NOT COMPLETED|Open-Label Period||0
641346|NCT00085644|1576228|P3|COMPLETED|Open-Label Period||202
641347|NCT00085644|1576229|P2|COMPLETED|Open-Label Period||0
641348|NCT00085644|1576230|P1|COMPLETED|Open-Label Period||0
641349|NCT00085644|1576228|P3|STARTED|Open-Label Period|1 subject who discontinued for personal reasons subsequently died 450 days after last dose.|311
641350|NCT00085644|1576229|P2|STARTED|Open-Label Period|This treatment group is not applicable to the Open-Label Period.|0
641351|NCT00085644|1576230|P1|STARTED|Open-Label Period|This treatment group is not applicable to the Open-Label Period.|0
641352|NCT00085644|1576228|P3|NOT COMPLETED|Double-Blind Period||0
641353|NCT00085644|1576229|P2|NOT COMPLETED|Double-Blind Period||6
641354|NCT00085644|1576230|P1|NOT COMPLETED|Double-Blind Period||13
641355|NCT00085644|1576228|P3|COMPLETED|Double-Blind Period||0
641356|NCT00085644|1576229|P2|COMPLETED|Double-Blind Period||101
641357|NCT00085644|1576230|P1|COMPLETED|Double-Blind Period||195
641358|NCT00085644|1576228|P3|STARTED|Double-Blind Period|This treatment group is not applicable to the Double-Blind Period.|0
641359|NCT00085644|1576229|P2|STARTED|Double-Blind Period||107
641360|NCT00085644|1576230|P1|STARTED|Double-Blind Period||208
641361|NCT00085631|1576271|P3|NOT COMPLETED|Overall Study||7
641362|NCT00085631|1576272|P2|NOT COMPLETED|Overall Study||11
641363|NCT00085631|1576273|P1|NOT COMPLETED|Overall Study||4
641364|NCT00085631|1576271|P3|COMPLETED|Overall Study||32
641365|NCT00085631|1576272|P2|COMPLETED|Overall Study||38
641366|NCT00085631|1576273|P1|COMPLETED|Overall Study||9
641367|NCT00085631|1576271|P3|STARTED|Overall Study||39
641368|NCT00085631|1576272|P2|STARTED|Overall Study||49
641369|NCT00085631|1576273|P1|STARTED|Overall Study||13
641370|NCT00085566|1576283|P3|NOT COMPLETED|Overall Study||14
641371|NCT00085566|1576284|P2|NOT COMPLETED|Overall Study||0
641372|NCT00085566|1576285|P1|NOT COMPLETED|Overall Study||0
641373|NCT00085566|1576283|P3|COMPLETED|Overall Study||43
641374|NCT00085566|1576284|P2|COMPLETED|Overall Study||3
641375|NCT00085566|1576285|P1|COMPLETED|Overall Study||3
641376|NCT00085566|1576283|P3|STARTED|Overall Study||57
641377|NCT00085566|1576284|P2|STARTED|Overall Study||3
641378|NCT00085566|1576285|P1|STARTED|Overall Study||3
641379|NCT00085540|1576295|P2|NOT COMPLETED|Overall Study||2
641380|NCT00085540|1576296|P1|NOT COMPLETED|Overall Study||0
641381|NCT00085540|1576295|P2|COMPLETED|Overall Study||40
641382|NCT00085540|1576296|P1|COMPLETED|Overall Study||8
641383|NCT00085540|1576295|P2|STARTED|Overall Study||42
641384|NCT00085540|1576296|P1|STARTED|Overall Study||8
641385|NCT00085436|1576303|P1|NOT COMPLETED|Overall Study||0
641386|NCT00085436|1576303|P1|COMPLETED|Overall Study||18
641387|NCT00085436|1576303|P1|STARTED|Overall Study||18
641388|NCT00085423|1576308|P1|NOT COMPLETED|Overall Study||2
641389|NCT00085423|1576308|P1|COMPLETED|Overall Study||18
641390|NCT00085423|1576308|P1|STARTED|Overall Study||20
641391|NCT00085410|1576314|P1|NOT COMPLETED|Overall Study||0
641392|NCT00085410|1576314|P1|COMPLETED|Overall Study||20
641393|NCT00085410|1576314|P1|STARTED|Overall Study||20
641394|NCT00085293|1576328|P1|NOT COMPLETED|Overall Study||0
641395|NCT00085293|1576328|P1|COMPLETED|Overall Study||12
641396|NCT00085293|1576328|P1|STARTED|Overall Study||12
641397|NCT00085254|1576336|P3|NOT COMPLETED|Overall Study||0
641398|NCT00085254|1576337|P2|NOT COMPLETED|Overall Study||0
641399|NCT00085254|1576338|P1|NOT COMPLETED|Overall Study||0
641400|NCT00085254|1576336|P3|COMPLETED|Overall Study||48
641401|NCT00085254|1576337|P2|COMPLETED|Overall Study||46
641402|NCT00085254|1576338|P1|COMPLETED|Overall Study||18
641403|NCT00085254|1576336|P3|STARTED|Overall Study||48
641404|NCT00085254|1576337|P2|STARTED|Overall Study||46
641405|NCT00085254|1576338|P1|STARTED|Overall Study||18
641406|NCT00085202|1576354|P2|NOT COMPLETED|Overall Study||24
641407|NCT00085202|1576355|P1|NOT COMPLETED|Overall Study||18
641408|NCT00085202|1576354|P2|COMPLETED|Overall Study||120
641409|NCT00085202|1576355|P1|COMPLETED|Overall Study||251
641410|NCT00085202|1576354|P2|STARTED|Overall Study||144
641411|NCT00085202|1576355|P1|STARTED|Overall Study||269
641412|NCT00085098|1576376|P2|NOT COMPLETED|Overall Study||2
641413|NCT00085098|1576377|P1|NOT COMPLETED|Overall Study||1
641414|NCT00085098|1576376|P2|COMPLETED|Overall Study||11
641415|NCT00085098|1576377|P1|COMPLETED|Overall Study||10
641416|NCT00085098|1576376|P2|STARTED|Overall Study||13
641417|NCT00085098|1576377|P1|STARTED|Overall Study||11
641418|NCT00084864|1576387|P4|NOT COMPLETED|Overall Study||0
641419|NCT00084864|1576388|P3|NOT COMPLETED|Overall Study||0
641420|NCT00084864|1576389|P2|NOT COMPLETED|Overall Study||0
641421|NCT00084864|1576390|P1|NOT COMPLETED|Overall Study||1
641422|NCT00084864|1576387|P4|COMPLETED|Overall Study||4
641423|NCT00084864|1576388|P3|COMPLETED|Overall Study||4
641424|NCT00084864|1576389|P2|COMPLETED|Overall Study||7
641425|NCT00084864|1576390|P1|COMPLETED|Overall Study||9
641426|NCT00084864|1576387|P4|STARTED|Overall Study||4
641427|NCT00084864|1576388|P3|STARTED|Overall Study||4
641428|NCT00084864|1576389|P2|STARTED|Overall Study||7
641429|NCT00084864|1576390|P1|STARTED|Overall Study||10
641430|NCT00084838|1576416|P1|NOT COMPLETED|Overall Study||13
641431|NCT00084838|1576416|P1|COMPLETED|Overall Study||12
641432|NCT00084838|1576416|P1|Eligible and Treated|Overall Study|4 ineligible pts upon central path review (n=3) and per DFCI IRB (n=1); 1 pt withdrew before rcv trt|20
641433|NCT00084838|1576416|P1|STARTED|Overall Study||25
641434|NCT00084747|1576438|P1|NOT COMPLETED|Overall Study||13
641435|NCT00084747|1576438|P1|COMPLETED|Overall Study||17
641436|NCT00084747|1576438|P1|STARTED|Overall Study||30
641437|NCT00084682|1576443|P1|NOT COMPLETED|Overall Study||1
641438|NCT00084682|1576443|P1|COMPLETED|Overall Study||13
641439|NCT00084682|1576443|P1|STARTED|Overall Study||14
641440|NCT00084617|1576447|P1|NOT COMPLETED|Overall Study||9
641441|NCT00084617|1576447|P1|COMPLETED|Overall Study||30
641442|NCT00084617|1576447|P1|STARTED|Overall Study||39
641443|NCT00084487|1576453|P1|NOT COMPLETED|Overall Study||1
641444|NCT00084487|1576453|P1|COMPLETED|Overall Study||20
641445|NCT00084487|1576453|P1|STARTED|Overall Study||21
641446|NCT00084409|1576463|P2|NOT COMPLETED|Overall Study||12
641447|NCT00084409|1576464|P1|NOT COMPLETED|Overall Study||15
641448|NCT00084409|1576463|P2|COMPLETED|Overall Study|4 Current, 8 former|65
641449|NCT00084409|1576464|P1|COMPLETED|Overall Study|9 current, 6 former|60
641450|NCT00084409|1576463|P2|STARTED|Overall Study|41 current, 36 former|77
641451|NCT00084409|1576464|P1|STARTED|Overall Study|40 Current, 35 former|75
641452|NCT00084383|1576492|P1|NOT COMPLETED|Overall Study||47
641453|NCT00084383|1576492|P1|COMPLETED|Overall Study||13
641454|NCT00084383|1576492|P1|STARTED|Overall Study||60
641455|NCT00084318|1576499|P2|NOT COMPLETED|Overall Study||13
641456|NCT00084318|1576500|P1|NOT COMPLETED|Overall Study||22
641457|NCT00084318|1576499|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|106
641458|NCT00084318|1576500|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|97
641459|NCT00084318|1576499|P2|STARTED|Overall Study||119
641460|NCT00084318|1576500|P1|STARTED|Overall Study||119
641461|NCT00084266|1576518|P2|NOT COMPLETED|Overall Study||423
641462|NCT00084266|1576519|P1|NOT COMPLETED|Overall Study||441
641463|NCT00084266|1576518|P2|COMPLETED|Overall Study||184
641464|NCT00084266|1576519|P1|COMPLETED|Overall Study||177
641465|NCT00084266|1576518|P2|Treated|Overall Study||587
641466|NCT00084266|1576519|P1|Treated|Overall Study||597
641467|NCT00084266|1576518|P2|STARTED|Overall Study||607
641468|NCT00084266|1576519|P1|STARTED|Overall Study||618
641469|NCT00084136|1576556|P3|NOT COMPLETED|NRTI Comparison||82
641470|NCT00084136|1576557|P2|NOT COMPLETED|NRTI Comparison||0
641471|NCT00084136|1576558|P1|NOT COMPLETED|NRTI Comparison||101
641472|NCT00084136|1576556|P3|COMPLETED|NRTI Comparison|Follow-up though study closeout period (final visit between April 1 and May 31, 2010).|444
641473|NCT00084136|1576557|P2|COMPLETED|NRTI Comparison||0
641474|NCT00084136|1576558|P1|COMPLETED|NRTI Comparison|Follow-up though study closeout period (final visit between April 1 and May 31, 2010).|418
641475|NCT00084136|1576556|P3|STARTED|NRTI Comparison||526
641476|NCT00084136|1576557|P2|STARTED|NRTI Comparison||0
641477|NCT00084136|1576558|P1|STARTED|NRTI Comparison||519
641478|NCT00084136|1576556|P3|NOT COMPLETED|PI Comparison||0
641479|NCT00084136|1576557|P2|NOT COMPLETED|PI Comparison||47
641480|NCT00084136|1576558|P1|NOT COMPLETED|PI Comparison||55
641481|NCT00084136|1576556|P3|COMPLETED|PI Comparison||0
641482|NCT00084136|1576557|P2|COMPLETED|PI Comparison|Follow-up was until ddI+FTC+ATV arm was closed per DSMB recommendation on May 23, 2008.|479
641483|NCT00084136|1576558|P1|COMPLETED|PI Comparison|Follow-up was until ddI+FTC+ATV arm was closed per DSMB recommendation on May 23, 2008.|464
641484|NCT00084136|1576556|P3|STARTED|PI Comparison||0
641485|NCT00084136|1576557|P2|STARTED|PI Comparison||526
641486|NCT00084136|1576558|P1|STARTED|PI Comparison||519
641487|NCT00084084|1576617|P1|NOT COMPLETED|Phase 2 (Transition to Replagal AF)||1
641488|NCT00084084|1576617|P1|COMPLETED|Phase 2 (Transition to Replagal AF)||10
641489|NCT00084084|1576617|P1|STARTED|Phase 2 (Transition to Replagal AF)|The 11 patients remaining in TKT029 at the time Replagal AF was made available continued to Phase 2.|11
641490|NCT00084084|1576617|P1|NOT COMPLETED|Phase 1 (Treatment With Replagal RB)||1
641491|NCT00084084|1576617|P1|COMPLETED|Phase 1 (Treatment With Replagal RB)||16
641492|NCT00084084|1576617|P1|STARTED|Phase 1 (Treatment With Replagal RB)||17
641493|NCT00083915|1576627|P2|NOT COMPLETED|Overall Study||37
641494|NCT00083915|1576628|P1|NOT COMPLETED|Overall Study||50
641495|NCT00083915|1576627|P2|COMPLETED|Overall Study||8
641496|NCT00083915|1576628|P1|COMPLETED|Overall Study||2
641497|NCT00083915|1576627|P2|STARTED|Overall Study||45
641498|NCT00083915|1576628|P1|STARTED|Overall Study||52
641499|NCT00083889|1576636|P2|NOT COMPLETED|Overall Study||375
641500|NCT00083889|1576637|P1|NOT COMPLETED|Overall Study||375
641670|NCT00081458|1577030|P1|Received Treatment|Overall Study||16
641501|NCT00083889|1576636|P2|COMPLETED|Overall Study|Discontinuation crossover subjects: AEs 5,consent withdrawn 2, lack efficacy 13, sponsor decision 5.|0
641502|NCT00083889|1576637|P1|COMPLETED|Overall Study||0
641503|NCT00083889|1576636|P2|Received Treatment|Overall Study|15 subjects randomized to IFN-α discontinued before receiving their first dose of study medication.|360
641504|NCT00083889|1576637|P1|Received Treatment|Overall Study||375
641505|NCT00083889|1576636|P2|STARTED|Overall Study||375
641506|NCT00083889|1576637|P1|STARTED|Overall Study||375
641507|NCT00004146|1576686|P1|NOT COMPLETED|Overall Study||0
641508|NCT00004146|1576686|P1|COMPLETED|Overall Study||55
641509|NCT00004146|1576686|P1|STARTED|Overall Study||55
641510|NCT00083759|1576695|P2|NOT COMPLETED|Overall Study||83
641511|NCT00083759|1576696|P1|NOT COMPLETED|Overall Study||84
641512|NCT00083759|1576695|P2|COMPLETED|Overall Study||66
641513|NCT00083759|1576696|P1|COMPLETED|Overall Study||66
641514|NCT00083759|1576695|P2|STARTED|Overall Study|149 subjects enrolled, 136 (Modified Intention-to-Treat [MITT] Population) for efficacy analyses|149
641515|NCT00083759|1576696|P1|STARTED|Overall Study|150 subjects enrolled, 137 (Modified Intention-to-Treat [MITT] Population) for efficacy analyses|150
641516|NCT00083720|1576704|P1|NOT COMPLETED|Overall Study||0
641517|NCT00083720|1576704|P1|COMPLETED|Overall Study|Two patients died prior to receiving cetuximab.|85
641518|NCT00083720|1576704|P1|STARTED|Overall Study|Patients analyzed for efficacy who met the epidermal growth factor receptor (EGFR) negative criteria|85
641519|NCT00083616|1576714|P1|NOT COMPLETED|Overall Study||31
641520|NCT00083616|1576714|P1|COMPLETED|Overall Study|Completed safety followup or died on study as of the data cut-off date of 22 December 2006|154
641521|NCT00083616|1576714|P1|Received Study Medication|Overall Study||182
641522|NCT00083616|1576714|P1|STARTED|Overall Study||185
641523|NCT00083551|1576728|P2|NOT COMPLETED|Overall Study||0
641524|NCT00083551|1576729|P1|NOT COMPLETED|Overall Study||0
641525|NCT00083551|1576728|P2|COMPLETED|Overall Study||345
641526|NCT00083551|1576729|P1|COMPLETED|Overall Study||323
641527|NCT00083551|1576728|P2|STARTED|Overall Study||345
641528|NCT00083551|1576729|P1|STARTED|Overall Study||323
641529|NCT00083382|1576735|P1|NOT COMPLETED|Overall Study||0
641530|NCT00083382|1576735|P1|COMPLETED|Overall Study||83
641531|NCT00083382|1576735|P1|STARTED|Overall Study||83
641532|NCT00082888|1576739|P1|NOT COMPLETED|Overall Study||22
641533|NCT00082888|1576739|P1|COMPLETED|Overall Study||71
641534|NCT00082888|1576739|P1|STARTED|Overall Study||93
641535|NCT00082810|1576743|P1|NOT COMPLETED|Overall Study||31
641536|NCT00082810|1576743|P1|COMPLETED|Overall Study||2
641537|NCT00082810|1576743|P1|STARTED|Overall Study||33
641538|NCT00082758|1576753|P3|NOT COMPLETED|Overall Study||0
641539|NCT00082758|1576754|P2|NOT COMPLETED|Overall Study||17
641540|NCT00082758|1576755|P1|NOT COMPLETED|Overall Study||15
641541|NCT00082758|1576753|P3|COMPLETED|Overall Study||0
641542|NCT00082758|1576754|P2|COMPLETED|Overall Study||7
641543|NCT00082758|1576755|P1|COMPLETED|Overall Study||0
641544|NCT00082758|1576753|P3|STARTED|Overall Study||0
641545|NCT00082758|1576754|P2|STARTED|Overall Study||24
641546|NCT00082758|1576755|P1|STARTED|Overall Study||15
641547|NCT00083226|1576763|P1|NOT COMPLETED|Overall Study||42
641548|NCT00083226|1576763|P1|COMPLETED|Overall Study||0
641549|NCT00083226|1576763|P1|STARTED|Overall Study||42
641550|NCT00083174|1576771|P3|NOT COMPLETED|Open-label Extension||0
641551|NCT00083174|1576772|P2|NOT COMPLETED|Open-label Extension||0
641552|NCT00083174|1576773|P1|NOT COMPLETED|Open-label Extension||0
641553|NCT00083174|1576771|P3|COMPLETED|Open-label Extension||2831
641554|NCT00083174|1576772|P2|COMPLETED|Open-label Extension||0
641555|NCT00083174|1576773|P1|COMPLETED|Open-label Extension||0
641556|NCT00083174|1576771|P3|STARTED|Open-label Extension||2831
641557|NCT00083174|1576772|P2|STARTED|Open-label Extension||0
641558|NCT00083174|1576773|P1|STARTED|Open-label Extension||0
641559|NCT00083174|1576771|P3|NOT COMPLETED|Randomization Period||0
641560|NCT00083174|1576772|P2|NOT COMPLETED|Randomization Period||0
641561|NCT00083174|1576773|P1|NOT COMPLETED|Randomization Period||0
641562|NCT00083174|1576771|P3|COMPLETED|Randomization Period||0
641563|NCT00083174|1576772|P2|COMPLETED|Randomization Period|All women randomized were included in the analysis based on intent-to-treat principle.|2275
641564|NCT00083174|1576773|P1|COMPLETED|Randomization Period|All women randomized were included in the analysis based on intent-to-treat principle.|2285
641565|NCT00083174|1576771|P3|STARTED|Randomization Period||0
641566|NCT00083174|1576772|P2|STARTED|Randomization Period||2275
641567|NCT00083174|1576773|P1|STARTED|Randomization Period||2285
641568|NCT00083122|1576795|P2|NOT COMPLETED|Overall Study||0
641569|NCT00083122|1576796|P1|NOT COMPLETED|Overall Study||0
641570|NCT00083122|1576795|P2|COMPLETED|Overall Study||5
641571|NCT00083122|1576796|P1|COMPLETED|Overall Study||40
641572|NCT00083122|1576795|P2|STARTED|Overall Study||5
641573|NCT00083122|1576796|P1|STARTED|Overall Study||40
641574|NCT00082433|1576807|P2|NOT COMPLETED|Overall Study||597
641575|NCT00082433|1576808|P1|NOT COMPLETED|Overall Study||594
641576|NCT00082433|1576807|P2|COMPLETED|Overall Study|Participants who received 18 or more cycles of treatment.|15
641577|NCT00082433|1576808|P1|COMPLETED|Overall Study|Participants who received 18 or more cycles of treatment.|15
641578|NCT00082433|1576807|P2|STARTED|Overall Study||612
641579|NCT00082433|1576808|P1|STARTED|Overall Study||609
641580|NCT00082381|1576828|P2|NOT COMPLETED|Overall Study||26
641581|NCT00082381|1576829|P1|NOT COMPLETED|Overall Study||55
641582|NCT00082381|1576828|P2|COMPLETED|Overall Study||242
641583|NCT00082381|1576829|P1|COMPLETED|Overall Study||228
641584|NCT00082381|1576828|P2|Received Treatment (Intent to Treat)|Overall Study||267
641585|NCT00082381|1576829|P1|Received Treatment (Intent to Treat)|Overall Study||282
641586|NCT00082381|1576828|P2|STARTED|Overall Study||268
641587|NCT00082381|1576829|P1|STARTED|Overall Study||283
641588|NCT00082407|1576849|P2|NOT COMPLETED|Overall Study||27
641589|NCT00082407|1576850|P1|NOT COMPLETED|Overall Study||56
641590|NCT00082407|1576849|P2|COMPLETED|Overall Study||223
641591|NCT00082407|1576850|P1|COMPLETED|Overall Study||199
641592|NCT00082407|1576849|P2|Received Treatment (Intent to Treat)|Overall Study||248
641593|NCT00082407|1576850|P1|Received Treatment (Intent to Treat)|Overall Study||253
641594|NCT00082407|1576849|P2|STARTED|Overall Study||250
641595|NCT00082407|1576850|P1|STARTED|Overall Study||255
641596|NCT00082368|1576868|P1|NOT COMPLETED|Overall Study||1
641597|NCT00082368|1576868|P1|COMPLETED|Overall Study||11
641598|NCT00082368|1576868|P1|STARTED|Overall Study||12
641599|NCT00082355|1576873|P1|NOT COMPLETED|5 Year Recurrent Thromboembolism Rate||28
641600|NCT00082355|1576873|P1|COMPLETED|5 Year Recurrent Thromboembolism Rate|data will not be complied until 2014|0
641601|NCT00082355|1576873|P1|STARTED|5 Year Recurrent Thromboembolism Rate||28
641602|NCT00082355|1576873|P1|NOT COMPLETED|Initial Results of Thrombolytic Therapy||2
641603|NCT00082355|1576873|P1|COMPLETED|Initial Results of Thrombolytic Therapy||28
641604|NCT00082355|1576873|P1|STARTED|Initial Results of Thrombolytic Therapy||30
641605|NCT00082342|1576880|P2|NOT COMPLETED|Overall Study||0
641606|NCT00082342|1576881|P1|NOT COMPLETED|Overall Study||0
641607|NCT00082342|1576880|P2|COMPLETED|Overall Study||12
641608|NCT00082342|1576881|P1|COMPLETED|Overall Study||13
641609|NCT00082342|1576880|P2|STARTED|Overall Study||12
641610|NCT00082342|1576881|P1|STARTED|Overall Study||13
641611|NCT00082329|1576901|P1|NOT COMPLETED|Overall Study||0
641612|NCT00082329|1576901|P1|COMPLETED|Overall Study||9
641613|NCT00082329|1576901|P1|STARTED|Overall Study||9
641614|NCT00082173|1576907|P2|NOT COMPLETED|Overall Study||11
641615|NCT00082173|1576908|P1|NOT COMPLETED|Overall Study||10
641616|NCT00082173|1576907|P2|COMPLETED|Overall Study||61
641617|NCT00082173|1576908|P1|COMPLETED|Overall Study||64
641618|NCT00082173|1576907|P2|STARTED|Overall Study||72
641619|NCT00082173|1576908|P1|STARTED|Overall Study||74
641620|NCT00003726|1576916|P1|NOT COMPLETED|Overall Study||1
641621|NCT00003726|1576916|P1|COMPLETED|Overall Study|Funding was pulled on the trial and therefore no other participants were enrolled|0
641622|NCT00003726|1576916|P1|STARTED|Overall Study||1
641623|NCT00081939|1576920|P1|NOT COMPLETED|Overall Study||0
641624|NCT00081939|1576920|P1|COMPLETED|Overall Study||303
641625|NCT00081939|1576920|P1|STARTED|Overall Study||303
641626|NCT00082017|1576924|P2|NOT COMPLETED|Overall Study||0
641627|NCT00082017|1576925|P1|NOT COMPLETED|Overall Study||0
641628|NCT00082017|1576924|P2|COMPLETED|Overall Study||9
641629|NCT00082017|1576925|P1|COMPLETED|Overall Study||11
641630|NCT00082017|1576924|P2|STARTED|Overall Study||9
641631|NCT00082017|1576925|P1|STARTED|Overall Study||11
641632|NCT00081861|1576941|P1|NOT COMPLETED|Overall Study||0
641633|NCT00081861|1576941|P1|COMPLETED|Overall Study||13
641634|NCT00081861|1576941|P1|STARTED|Overall Study||13
641635|NCT00081770|1576948|P3|NOT COMPLETED|Overall Study||456
641636|NCT00081770|1576949|P2|NOT COMPLETED|Overall Study||546
641637|NCT00081770|1576950|P1|NOT COMPLETED|Overall Study||502
641638|NCT00081770|1576948|P3|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|579
641639|NCT00081770|1576949|P2|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|470
641640|NCT00081770|1576950|P1|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|517
641641|NCT00081770|1576948|P3|STARTED|Overall Study||1035
641642|NCT00081770|1576949|P2|STARTED|Overall Study||1016
641643|NCT00081770|1576950|P1|STARTED|Overall Study||1019
641644|NCT00081731|1576969|P2|NOT COMPLETED|Overall Study||8
641645|NCT00081731|1576970|P1|NOT COMPLETED|Overall Study||8
641646|NCT00081731|1576969|P2|COMPLETED|Overall Study||459
641647|NCT00081731|1576970|P1|COMPLETED|Overall Study||472
641648|NCT00081731|1576969|P2|STARTED|Overall Study||467
641649|NCT00081731|1576970|P1|STARTED|Overall Study||480
641650|NCT00081653|1576990|P2|NOT COMPLETED|Overall Study||37
641651|NCT00081653|1576991|P1|NOT COMPLETED|Overall Study||47
641652|NCT00081653|1576990|P2|COMPLETED|Overall Study|Completed 3 years of treatment|324
641653|NCT00081653|1576991|P1|COMPLETED|Overall Study|Completed 3 years of treatment|311
641654|NCT00081653|1576990|P2|STARTED|Overall Study|Patients entering Study MA17903 from Study BM16549|361
641655|NCT00081653|1576991|P1|STARTED|Overall Study|Patients entering Study MA17903 from Study BM16549|358
641656|NCT00081497|1577009|P2|NOT COMPLETED|Overall Study||2
641657|NCT00081497|1577010|P1|NOT COMPLETED|Overall Study||3
641658|NCT00081497|1577009|P2|COMPLETED|Overall Study||37
641659|NCT00081497|1577010|P1|COMPLETED|Overall Study||25
641660|NCT00081497|1577009|P2|STARTED|Overall Study|Patients who were randomized to Fabrazyme in AGAL-008-00 (NCT00074984).|39
641661|NCT00081497|1577010|P1|STARTED|Overall Study|Patients who were randomized to placebo in AGAL-008-00 (NCT00074984).|28
641662|NCT00081458|1577028|P3|NOT COMPLETED|Overall Study||4
641663|NCT00081458|1577029|P2|NOT COMPLETED|Overall Study||8
641664|NCT00081458|1577030|P1|NOT COMPLETED|Overall Study||1
641665|NCT00081458|1577028|P3|COMPLETED|Overall Study||29
641666|NCT00081458|1577029|P2|COMPLETED|Overall Study||27
641667|NCT00081458|1577030|P1|COMPLETED|Overall Study||15
641668|NCT00081458|1577028|P3|Received Treatment|Overall Study|1 subject was randomized but did not receive the study drug|32
641669|NCT00081458|1577029|P2|Received Treatment|Overall Study||35
641671|NCT00081458|1577028|P3|STARTED|Overall Study||33
641672|NCT00081458|1577029|P2|STARTED|Overall Study||35
641673|NCT00081458|1577030|P1|STARTED|Overall Study||16
641674|NCT00081328|1577044|P3|NOT COMPLETED|Overall Study||0
641675|NCT00081328|1577045|P2|NOT COMPLETED|Overall Study||0
641676|NCT00081328|1577046|P1|NOT COMPLETED|Overall Study||0
641677|NCT00081328|1577044|P3|COMPLETED|Overall Study||234
641678|NCT00081328|1577045|P2|COMPLETED|Overall Study||233
641679|NCT00081328|1577046|P1|COMPLETED|Overall Study||232
641680|NCT00081328|1577044|P3|STARTED|Overall Study||234
641681|NCT00081328|1577045|P2|STARTED|Overall Study||233
641682|NCT00081328|1577046|P1|STARTED|Overall Study||232
641683|NCT00081289|1577086|P2|NOT COMPLETED|Overall Study||21
641684|NCT00081289|1577087|P1|NOT COMPLETED|Overall Study||21
641685|NCT00081289|1577086|P2|COMPLETED|Overall Study||52
641686|NCT00081289|1577087|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52
641687|NCT00081289|1577086|P2|STARTED|Overall Study||73
641688|NCT00081289|1577087|P1|STARTED|Overall Study||73
641689|NCT00081263|1577095|P2|NOT COMPLETED|Overall Study||22
641690|NCT00081263|1577096|P1|NOT COMPLETED|Overall Study||17
641691|NCT00081263|1577095|P2|COMPLETED|Overall Study||41
641692|NCT00081263|1577096|P1|COMPLETED|Overall Study||50
641693|NCT00081263|1577095|P2|STARTED|Overall Study||63
641694|NCT00081263|1577096|P1|STARTED|Overall Study||67
641695|NCT00081159|1577106|P2|NOT COMPLETED|Overall Study||5
641696|NCT00081159|1577107|P1|NOT COMPLETED|Overall Study||2
641697|NCT00081159|1577106|P2|COMPLETED|Overall Study||35
641698|NCT00081159|1577107|P1|COMPLETED|Overall Study||37
641699|NCT00081159|1577106|P2|STARTED|Overall Study||40
641700|NCT00081159|1577107|P1|STARTED|Overall Study||39
641701|NCT00080938|1577117|P1|NOT COMPLETED|Overall Study||24
641702|NCT00080938|1577117|P1|COMPLETED|Overall Study||2
641703|NCT00080938|1577117|P1|Eligible and Treated|Overall Study||21
641704|NCT00080938|1577117|P1|Began Protocol Therapy|Overall Study||25
641705|NCT00080938|1577117|P1|STARTED|Overall Study||26
641706|NCT00080912|1577126|P2|NOT COMPLETED|Overall Study||0
641707|NCT00080912|1577127|P1|NOT COMPLETED|Overall Study||0
641708|NCT00080912|1577126|P2|COMPLETED|Overall Study||425
641709|NCT00080912|1577127|P1|COMPLETED|Overall Study||425
641710|NCT00080912|1577126|P2|STARTED|Overall Study||425
641711|NCT00080912|1577127|P1|STARTED|Overall Study||425
641712|NCT00080899|1577133|P1|NOT COMPLETED|Overall Study||1
641713|NCT00080899|1577133|P1|COMPLETED|Overall Study||22
641714|NCT00080899|1577133|P1|STARTED|Overall Study||23
641715|NCT00080535|1577138|P1|NOT COMPLETED|Overall Study||0
641716|NCT00080535|1577138|P1|COMPLETED|Overall Study||10
641717|NCT00080535|1577138|P1|STARTED|Overall Study||10
641718|NCT00080483|1577145|P2|NOT COMPLETED|Overall Study||2
641719|NCT00080483|1577146|P1|NOT COMPLETED|Overall Study||2
641720|NCT00080483|1577145|P2|COMPLETED|Overall Study||16
641721|NCT00080483|1577146|P1|COMPLETED|Overall Study||15
641722|NCT00080483|1577145|P2|STARTED|Overall Study||18
641723|NCT00080483|1577146|P1|STARTED|Overall Study||17
641724|NCT00002525|1577154|P2|NOT COMPLETED|Overall Study||0
641725|NCT00002525|1577155|P1|NOT COMPLETED|Overall Study||186
641726|NCT00002525|1577154|P2|COMPLETED|Overall Study|"Patients on No perioperative 5-FU arm received no perioperative chemotherapy"|428
641727|NCT00002525|1577155|P1|COMPLETED|Overall Study||241
641728|NCT00002525|1577154|P2|Dukes' B2 Stage|Overall Study||139
641729|NCT00002525|1577155|P1|Dukes' B2 Stage|Overall Study||150
641730|NCT00002525|1577154|P2|Dukes' B3 or C Stage|Overall Study||158
641731|NCT00002525|1577155|P1|Dukes' B3 or C Stage|Overall Study|"Primary population: pts with Duke's B3, C disease. 158 such pts on No perioperative 5-FU arm"|156
641732|NCT00002525|1577154|P2|Treated|Overall Study|"Patients on No perioperative 5-FU arm received no perioperative chemotherapy"|0
641733|NCT00002525|1577155|P1|Treated|Overall Study||419
641734|NCT00002525|1577154|P2|STARTED|Overall Study||428
641735|NCT00002525|1577155|P1|STARTED|Overall Study|859 patients were enrolled to the study, but 4 patients were not randomized to any treatment arm|427
641736|NCT00080470|1577171|P2|NOT COMPLETED|Overall Study||28
641737|NCT00080470|1577172|P1|NOT COMPLETED|Overall Study||34
641738|NCT00080470|1577171|P2|COMPLETED|Overall Study||14
641739|NCT00080470|1577172|P1|COMPLETED|Overall Study||11
641740|NCT00080470|1577171|P2|STARTED|Overall Study||42
641741|NCT00080470|1577172|P1|STARTED|Overall Study||45
641742|NCT00080301|1577182|P2|NOT COMPLETED|Overall Study||11
641743|NCT00080301|1577183|P1|NOT COMPLETED|Overall Study||5
641744|NCT00080301|1577182|P2|COMPLETED|Overall Study|Participants who are off treatment|366
641745|NCT00080301|1577183|P1|COMPLETED|Overall Study|Participants who are off treatment|370
641746|NCT00080301|1577182|P2|Still on Treatment|Overall Study||1
641747|NCT00080301|1577183|P1|Still on Treatment|Overall Study||0
641748|NCT00080301|1577182|P2|Never Treated|Overall Study||10
641749|NCT00080301|1577183|P1|Never Treated|Overall Study||5
641750|NCT00080301|1577182|P2|STARTED|Overall Study||377
641751|NCT00080301|1577183|P1|STARTED|Overall Study||375
641752|NCT00080288|1577203|P2|NOT COMPLETED|Overall Study||38
641753|NCT00080288|1577204|P1|NOT COMPLETED|Overall Study||30
641754|NCT00080288|1577203|P2|COMPLETED|Overall Study||89
641755|NCT00080288|1577204|P1|COMPLETED|Overall Study||97
641756|NCT00080288|1577203|P2|STARTED|Overall Study||127
641757|NCT00080288|1577204|P1|STARTED|Overall Study||127
641758|NCT00080223|1577212|P1|NOT COMPLETED|Overall Study||76
641759|NCT00080223|1577212|P1|COMPLETED|Overall Study||7
641760|NCT00080223|1577212|P1|STARTED|Overall Study||83
641761|NCT00002540|1577222|P2|NOT COMPLETED|Overall Study||2464
641762|NCT00002540|1577223|P1|NOT COMPLETED|Overall Study||801
641763|NCT00002540|1577222|P2|COMPLETED|Overall Study||35876
641764|NCT00002540|1577223|P1|COMPLETED|Overall Study||37544
641765|NCT00002540|1577222|P2|STARTED|Overall Study||38340
641766|NCT00002540|1577223|P1|STARTED|Overall Study||38345
641767|NCT00080119|1577253|P4|NOT COMPLETED|Overall Study||163
641768|NCT00080119|1577254|P3|NOT COMPLETED|Overall Study||165
641769|NCT00080119|1577255|P2|NOT COMPLETED|Overall Study||62
641770|NCT00080119|1577256|P1|NOT COMPLETED|Overall Study||56
641771|NCT00080119|1577253|P4|COMPLETED|Overall Study||111
641772|NCT00080119|1577254|P3|COMPLETED|Overall Study||108
641773|NCT00080119|1577255|P2|COMPLETED|Overall Study||339
641774|NCT00080119|1577256|P1|COMPLETED|Overall Study||347
641775|NCT00080119|1577253|P4|STARTED|Overall Study||274
641776|NCT00080119|1577254|P3|STARTED|Overall Study||273
641777|NCT00080119|1577255|P2|STARTED|Overall Study||401
641778|NCT00080119|1577256|P1|STARTED|Overall Study||403
641779|NCT00079937|1577290|P2|NOT COMPLETED|Overall Study||32
641780|NCT00079937|1577291|P1|NOT COMPLETED|Overall Study||69
641781|NCT00079937|1577290|P2|COMPLETED|Overall Study||175
641782|NCT00079937|1577291|P1|COMPLETED|Overall Study||352
641783|NCT00079937|1577290|P2|STARTED|Overall Study||207
641784|NCT00079937|1577291|P1|STARTED|Overall Study||421
641785|NCT00009737|1577309|P2|NOT COMPLETED|Overall Study||123
641786|NCT00009737|1577310|P1|NOT COMPLETED|Overall Study||170
641787|NCT00009737|1577309|P2|COMPLETED|Overall Study||860
641788|NCT00009737|1577310|P1|COMPLETED|Overall Study||834
641789|NCT00009737|1577309|P2|STARTED|Overall Study||983
641790|NCT00009737|1577310|P1|STARTED|Overall Study||1004
641791|NCT00079781|1577329|P3|NOT COMPLETED|Follow-up Period||2
641792|NCT00079781|1577330|P2|NOT COMPLETED|Follow-up Period||0
641793|NCT00079781|1577331|P1|NOT COMPLETED|Follow-up Period||4
641794|NCT00079781|1577329|P3|COMPLETED|Follow-up Period||12
641795|NCT00079781|1577330|P2|COMPLETED|Follow-up Period||9
641796|NCT00079781|1577331|P1|COMPLETED|Follow-up Period||38
641797|NCT00079781|1577329|P3|STARTED|Follow-up Period||14
641798|NCT00079781|1577330|P2|STARTED|Follow-up Period||9
641799|NCT00079781|1577331|P1|STARTED|Follow-up Period||42
641800|NCT00079781|1577329|P3|NOT COMPLETED|Evaluation Period||0
641801|NCT00079781|1577330|P2|NOT COMPLETED|Evaluation Period||0
641802|NCT00079781|1577331|P1|NOT COMPLETED|Evaluation Period||0
641803|NCT00079781|1577329|P3|COMPLETED|Evaluation Period||14
641804|NCT00079781|1577330|P2|COMPLETED|Evaluation Period||9
641805|NCT00079781|1577331|P1|COMPLETED|Evaluation Period||42
641806|NCT00079781|1577329|P3|STARTED|Evaluation Period||14
641807|NCT00079781|1577330|P2|STARTED|Evaluation Period||9
641808|NCT00079781|1577331|P1|STARTED|Evaluation Period||42
641809|NCT00079781|1577329|P3|NOT COMPLETED|Pre-implant Period||1
641810|NCT00079781|1577330|P2|NOT COMPLETED|Pre-implant Period||1
641811|NCT00079781|1577331|P1|NOT COMPLETED|Pre-implant Period||3
641812|NCT00079781|1577329|P3|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|14
641813|NCT00079781|1577330|P2|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|9
641814|NCT00079781|1577331|P1|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|42
641815|NCT00079781|1577329|P3|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|15
641816|NCT00079781|1577330|P2|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|10
641817|NCT00079781|1577331|P1|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|45
641818|NCT00079677|1577340|P2|NOT COMPLETED|Overall Study||14
641819|NCT00079677|1577341|P1|NOT COMPLETED|Overall Study||20
641820|NCT00079677|1577340|P2|COMPLETED|Overall Study||118
641821|NCT00079677|1577341|P1|COMPLETED|Overall Study||111
641822|NCT00079677|1577340|P2|STARTED|Overall Study||132
641823|NCT00079677|1577341|P1|STARTED|Overall Study||131
641824|NCT00002601|1577349|P1|NOT COMPLETED|Overall Study||0
641825|NCT00002601|1577349|P1|COMPLETED|Overall Study||13
641826|NCT00002601|1577349|P1|STARTED|Overall Study||13
641827|NCT00079417|1577357|P1|NOT COMPLETED|Overall Study||9
641828|NCT00079417|1577357|P1|COMPLETED|Overall Study||19
641829|NCT00079417|1577357|P1|STARTED|Overall Study||28
641830|NCT00079391|1577361|P1|NOT COMPLETED|Overall Study||1
641831|NCT00079391|1577361|P1|COMPLETED|Overall Study||49
641832|NCT00079391|1577361|P1|STARTED|Overall Study|1 of these withdrew after consent.|50
641833|NCT00079339|1577373|P3|NOT COMPLETED|Overall Study||6
641834|NCT00079339|1577374|P2|NOT COMPLETED|Overall Study||39
641835|NCT00079339|1577375|P1|NOT COMPLETED|Overall Study||5
641836|NCT00079339|1577373|P3|COMPLETED|Overall Study||0
641837|NCT00079339|1577374|P2|COMPLETED|Overall Study||1
641838|NCT00079339|1577375|P1|COMPLETED|Overall Study||0
641839|NCT00079339|1577373|P3|Enrolled in Phase II|Overall Study|Participants treated at the 150 mg/m2 dose level did not participate in the phase II part.|0
641840|NCT00079339|1577374|P2|Enrolled in Phase II|Overall Study|This number includes the 6 patients enrolled on the phase I part.|40
641841|NCT00079339|1577375|P1|Enrolled in Phase II|Overall Study|Participants treated at the 100 mg/m2 dose level did not participate in the phase II part.|0
641842|NCT00079339|1577373|P3|Maximum Tolerated Dose (MTD) Estimation|Overall Study|One participant enrolled in the phase I part did not complete the 8 week MTD estimation period.|5
641843|NCT00079339|1577374|P2|Maximum Tolerated Dose (MTD) Estimation|Overall Study||6
641844|NCT00079339|1577375|P1|Maximum Tolerated Dose (MTD) Estimation|Overall Study|2 participants enrolled in the phase I part did not complete the 8 week MTD estimation period.|3
641845|NCT00079339|1577373|P3|Enrolled in Phase I|Overall Study||6
641846|NCT00079339|1577374|P2|Enrolled in Phase I|Overall Study||6
641847|NCT00079339|1577375|P1|Enrolled in Phase I|Overall Study||5
641848|NCT00079339|1577373|P3|STARTED|Overall Study||6
641849|NCT00079339|1577374|P2|STARTED|Overall Study||40
641850|NCT00079339|1577375|P1|STARTED|Overall Study||5
641851|NCT00079326|1577391|P2|NOT COMPLETED|Overall Study||0
641852|NCT00079326|1577392|P1|NOT COMPLETED|Overall Study||0
641853|NCT00079326|1577391|P2|COMPLETED|Overall Study||24
641854|NCT00079326|1577392|P1|COMPLETED|Overall Study||15
641855|NCT00079326|1577391|P2|STARTED|Overall Study||24
641856|NCT00079326|1577392|P1|STARTED|Overall Study||15
641857|NCT00079274|1577406|P7|NOT COMPLETED|Overall Study||0
641858|NCT00079274|1577407|P6|NOT COMPLETED|Overall Study||20
641859|NCT00079274|1577408|P5|NOT COMPLETED|Overall Study||15
641860|NCT00079274|1577409|P4|NOT COMPLETED|Overall Study||444
641861|NCT00079274|1577410|P3|NOT COMPLETED|Overall Study||27
641862|NCT00079274|1577411|P2|NOT COMPLETED|Overall Study||27
641863|NCT00079274|1577412|P1|NOT COMPLETED|Overall Study||321
641864|NCT00079274|1577406|P7|COMPLETED|Overall Study||332
641865|NCT00079274|1577407|P6|COMPLETED|Overall Study||26
641866|NCT00079274|1577408|P5|COMPLETED|Overall Study||30
641867|NCT00079274|1577409|P4|COMPLETED|Overall Study||906
641868|NCT00079274|1577410|P3|COMPLETED|Overall Study||84
641869|NCT00079274|1577411|P2|COMPLETED|Overall Study||84
641870|NCT00079274|1577412|P1|COMPLETED|Overall Study||1081
641871|NCT00079274|1577406|P7|STARTED|Overall Study||332
641872|NCT00079274|1577407|P6|STARTED|Overall Study||46
641873|NCT00079274|1577408|P5|STARTED|Overall Study||45
641874|NCT00079274|1577409|P4|STARTED|Overall Study||1350
641875|NCT00079274|1577410|P3|STARTED|Overall Study||111
641876|NCT00079274|1577411|P2|STARTED|Overall Study||111
641877|NCT00079274|1577412|P1|STARTED|Overall Study||1402
641878|NCT00079183|1577425|P1|NOT COMPLETED|Overall Study||7
641879|NCT00079183|1577425|P1|COMPLETED|Overall Study||37
641880|NCT00079183|1577425|P1|Drop Outs|Overall Study||7
641881|NCT00079183|1577425|P1|STARTED|Overall Study||44
641882|NCT00079040|1577440|P1|NOT COMPLETED|Overall Study||2
641883|NCT00079040|1577440|P1|COMPLETED|Overall Study||63
641884|NCT00079040|1577440|P1|STARTED|Overall Study||65
641885|NCT00079001|1577448|P2|NOT COMPLETED|Overall Study||0
641886|NCT00079001|1577449|P1|NOT COMPLETED|Overall Study||0
641887|NCT00079001|1577448|P2|COMPLETED|Overall Study||322
641888|NCT00079001|1577449|P1|COMPLETED|Overall Study||323
641889|NCT00079001|1577448|P2|STARTED|Overall Study||322
641890|NCT00079001|1577449|P1|STARTED|Overall Study||323
641891|NCT00078949|1577463|P4|NOT COMPLETED|Maintenance||3
641892|NCT00078949|1577464|P3|NOT COMPLETED|Maintenance||3
641893|NCT00078949|1577465|P2|NOT COMPLETED|Maintenance||0
641894|NCT00078949|1577466|P1|NOT COMPLETED|Maintenance||0
641895|NCT00078949|1577463|P4|COMPLETED|Maintenance||112
641896|NCT00078949|1577464|P3|COMPLETED|Maintenance||112
641897|NCT00078949|1577465|P2|COMPLETED|Maintenance||0
641898|NCT00078949|1577466|P1|COMPLETED|Maintenance||0
641899|NCT00078949|1577463|P4|STARTED|Maintenance||115
641900|NCT00078949|1577464|P3|STARTED|Maintenance||115
641901|NCT00078949|1577465|P2|STARTED|Maintenance||0
641902|NCT00078949|1577466|P1|STARTED|Maintenance||0
641903|NCT00078949|1577463|P4|NOT COMPLETED|Salvage||0
641904|NCT00078949|1577464|P3|NOT COMPLETED|Salvage||0
641905|NCT00078949|1577465|P2|NOT COMPLETED|Salvage||5
641906|NCT00078949|1577466|P1|NOT COMPLETED|Salvage||4
641907|NCT00078949|1577463|P4|COMPLETED|Salvage||0
641908|NCT00078949|1577464|P3|COMPLETED|Salvage||0
641909|NCT00078949|1577465|P2|COMPLETED|Salvage||304
641910|NCT00078949|1577466|P1|COMPLETED|Salvage||306
641911|NCT00078949|1577463|P4|STARTED|Salvage||0
641912|NCT00078949|1577464|P3|STARTED|Salvage||0
641913|NCT00078949|1577465|P2|STARTED|Salvage||309
641914|NCT00078949|1577466|P1|STARTED|Salvage||310
641915|NCT00078767|1577480|P2|NOT COMPLETED|Overall Study||1
641916|NCT00078767|1577481|P1|NOT COMPLETED|Overall Study||1
641917|NCT00078767|1577480|P2|COMPLETED|Overall Study||11
641918|NCT00078767|1577481|P1|COMPLETED|Overall Study||11
641919|NCT00078767|1577480|P2|STARTED|Overall Study||12
641920|NCT00078767|1577481|P1|STARTED|Overall Study||12
641921|NCT00078754|1577498|P3|NOT COMPLETED|Overall Study||15
641922|NCT00078754|1577499|P2|NOT COMPLETED|Overall Study||19
641923|NCT00078754|1577500|P1|NOT COMPLETED|Overall Study||15
641924|NCT00078754|1577498|P3|COMPLETED|Overall Study||16
641925|NCT00078754|1577499|P2|COMPLETED|Overall Study||11
641926|NCT00078754|1577500|P1|COMPLETED|Overall Study||14
641927|NCT00078754|1577498|P3|STARTED|Overall Study||31
641928|NCT00078754|1577499|P2|STARTED|Overall Study||30
641929|NCT00078754|1577500|P1|STARTED|Overall Study||29
641930|NCT00078728|1577510|P2|NOT COMPLETED|Overall Study||3
641931|NCT00078728|1577511|P1|NOT COMPLETED|Overall Study||4
641932|NCT00078728|1577510|P2|COMPLETED|Overall Study||17
641933|NCT00078728|1577511|P1|COMPLETED|Overall Study||16
641934|NCT00078728|1577510|P2|STARTED|Overall Study||20
641935|NCT00078728|1577511|P1|STARTED|Overall Study||20
641936|NCT00078715|1577519|P2|NOT COMPLETED|Second Intervention||0
641937|NCT00078715|1577520|P1|NOT COMPLETED|Second Intervention||0
641938|NCT00078715|1577519|P2|COMPLETED|Second Intervention||4
641939|NCT00078715|1577520|P1|COMPLETED|Second Intervention||2
641940|NCT00078715|1577519|P2|STARTED|Second Intervention||4
641941|NCT00078715|1577520|P1|STARTED|Second Intervention||2
641942|NCT00078715|1577519|P2|NOT COMPLETED|First Intervention||0
641943|NCT00078715|1577520|P1|NOT COMPLETED|First Intervention||0
641944|NCT00078715|1577519|P2|COMPLETED|First Intervention||4
641945|NCT00078715|1577520|P1|COMPLETED|First Intervention||2
641946|NCT00078715|1577519|P2|STARTED|First Intervention||4
641947|NCT00078715|1577520|P1|STARTED|First Intervention||2
641948|NCT00005947|1577528|P2|NOT COMPLETED|Overall Study||41
641949|NCT00005947|1577529|P1|NOT COMPLETED|Overall Study||57
641950|NCT00005947|1577528|P2|COMPLETED|Overall Study||4
641951|NCT00005947|1577529|P1|COMPLETED|Overall Study||25
641952|NCT00005947|1577528|P2|STARTED|Overall Study||45
641953|NCT00005947|1577529|P1|STARTED|Overall Study||82
641957|NCT00002597|1577565|P2|NOT COMPLETED|Overall Study||23
641958|NCT00002597|1577566|P1|NOT COMPLETED|Overall Study||26
641959|NCT00002597|1577565|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|992
641960|NCT00002597|1577566|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|987
641961|NCT00002597|1577565|P2|STARTED|Overall Study||1015
641962|NCT00002597|1577566|P1|STARTED|Overall Study||1013
641963|NCT00078377|1577591|P3|NOT COMPLETED|Overall Study||9
641964|NCT00078377|1577592|P2|NOT COMPLETED|Overall Study||16
641965|NCT00078377|1577593|P1|NOT COMPLETED|Overall Study||11
641966|NCT00078377|1577591|P3|COMPLETED|Overall Study||55
641967|NCT00078377|1577592|P2|COMPLETED|Overall Study||49
641968|NCT00078377|1577593|P1|COMPLETED|Overall Study||56
641969|NCT00078377|1577591|P3|STARTED|Overall Study||64
641970|NCT00078377|1577592|P2|STARTED|Overall Study||65
641971|NCT00078377|1577593|P1|STARTED|Overall Study||67
641972|NCT00078338|1577608|P2|NOT COMPLETED|Overall Study||54
641973|NCT00078338|1577609|P1|NOT COMPLETED|Overall Study||85
641974|NCT00078338|1577608|P2|COMPLETED|Overall Study||324
641975|NCT00078338|1577609|P1|COMPLETED|Overall Study||301
641976|NCT00078338|1577608|P2|Safety Population|Overall Study|Safety population=subjects who received at least 1 dose of treatment and had followup safety data.|375
641977|NCT00078338|1577609|P1|Safety Population|Overall Study|Safety population=subjects who received at least 1 dose of treatment and had followup safety data.|381
641978|NCT00078338|1577608|P2|STARTED|Overall Study||378
641979|NCT00078338|1577609|P1|STARTED|Overall Study||386
641980|NCT00076687|1577618|P3|NOT COMPLETED|Overall Study||4
641981|NCT00076687|1577619|P2|NOT COMPLETED|Overall Study||5
641982|NCT00076687|1577620|P1|NOT COMPLETED|Overall Study||6
641983|NCT00076687|1577618|P3|COMPLETED|Overall Study||51
641984|NCT00076687|1577619|P2|COMPLETED|Overall Study||47
641985|NCT00076687|1577620|P1|COMPLETED|Overall Study||42
641986|NCT00076687|1577618|P3|STARTED|Overall Study||55
641987|NCT00076687|1577619|P2|STARTED|Overall Study||52
641988|NCT00076687|1577620|P1|STARTED|Overall Study||48
641989|NCT00078403|1577640|P3|NOT COMPLETED|Overall Study||28
641990|NCT00078403|1577641|P2|NOT COMPLETED|Overall Study||16
641991|NCT00078403|1577642|P1|NOT COMPLETED|Overall Study||18
641992|NCT00078403|1577640|P3|COMPLETED|Overall Study||141
641993|NCT00078403|1577641|P2|COMPLETED|Overall Study||26
641994|NCT00078403|1577642|P1|COMPLETED|Overall Study||26
641995|NCT00078403|1577640|P3|STARTED|Overall Study||169
641996|NCT00078403|1577641|P2|STARTED|Overall Study|Eligible at pre-assignment (40), direct (1), Arm C week 36 non-response (1).|42
641997|NCT00078403|1577642|P1|STARTED|Overall Study|Eligible at pre-assignment (40), direct (2), Arm C week 36 non-response (1), EVR inadvertently (1).|44
641998|NCT00078325|1577702|P3|NOT COMPLETED|Overall Study||11
641999|NCT00078325|1577703|P2|NOT COMPLETED|Overall Study||19
642000|NCT00078325|1577704|P1|NOT COMPLETED|Overall Study||21
642001|NCT00078325|1577702|P3|COMPLETED|Overall Study||120
642002|NCT00078325|1577703|P2|COMPLETED|Overall Study||114
642003|NCT00078325|1577704|P1|COMPLETED|Overall Study||110
642004|NCT00078325|1577702|P3|STARTED|Overall Study||131
642005|NCT00078325|1577703|P2|STARTED|Overall Study||133
642006|NCT00078325|1577704|P1|STARTED|Overall Study||131
642007|NCT00078312|1577715|P1|NOT COMPLETED|Overall Study||177
642008|NCT00078312|1577715|P1|COMPLETED|Overall Study||151
642009|NCT00078312|1577715|P1|STARTED|Overall Study||328
642010|NCT00078286|1577721|P2|NOT COMPLETED|Overall Study||83
642011|NCT00078286|1577722|P1|NOT COMPLETED|Overall Study||96
642012|NCT00078286|1577721|P2|COMPLETED|Overall Study||152
642013|NCT00078286|1577722|P1|COMPLETED|Overall Study||138
642014|NCT00078286|1577721|P2|STARTED|Overall Study||235
642015|NCT00078286|1577722|P1|STARTED|Overall Study||234
642016|NCT00077974|1577730|P1|NOT COMPLETED|Overall Study||104
642017|NCT00077974|1577730|P1|COMPLETED|Overall Study||2
642018|NCT00077974|1577730|P1|STARTED|Overall Study||106
642019|NCT00077857|1577747|P2|NOT COMPLETED|Overall Study||204
642020|NCT00077857|1577748|P1|NOT COMPLETED|Overall Study||201
642021|NCT00077857|1577747|P2|COMPLETED|Overall Study||31
642022|NCT00077857|1577748|P1|COMPLETED|Overall Study||34
642023|NCT00077857|1577747|P2|Safety Population: Actual Dose Received|Overall Study||248
642024|NCT00077857|1577748|P1|Safety Population: Actual Dose Received|Overall Study|14 patients in the 1250 dose arm received a lower dose and were included in the 825 arm for Safety.|217
642025|NCT00077857|1577747|P2|Received Study Drug|Overall Study||234
642026|NCT00077857|1577748|P1|Received Study Drug|Overall Study||231
642027|NCT00077857|1577747|P2|STARTED|Overall Study||235
642028|NCT00077857|1577748|P1|STARTED|Overall Study||235
642029|NCT00077766|1577768|P2|NOT COMPLETED|Overall Study||25
642030|NCT00077766|1577769|P1|NOT COMPLETED|Overall Study||39
642031|NCT00077766|1577768|P2|COMPLETED|Overall Study||131
642032|NCT00077766|1577769|P1|COMPLETED|Overall Study||118
642033|NCT00077766|1577768|P2|STARTED|Overall Study||156
642034|NCT00077766|1577769|P1|STARTED|Overall Study||157
642035|NCT00077922|1577787|P1|NOT COMPLETED|Overall Study||0
642036|NCT00077922|1577787|P1|COMPLETED|Overall Study||15
642037|NCT00077922|1577787|P1|STARTED|Overall Study||15
642038|NCT00077675|1577794|P2|NOT COMPLETED|Overall Study||9
642039|NCT00077675|1577795|P1|NOT COMPLETED|Overall Study||11
642040|NCT00077675|1577794|P2|COMPLETED|Overall Study||89
642041|NCT00077675|1577795|P1|COMPLETED|Overall Study||92
642042|NCT00077675|1577794|P2|STARTED|Overall Study||98
642043|NCT00077675|1577795|P1|STARTED|Overall Study||103
642044|NCT00077649|1577805|P4|NOT COMPLETED|Overall Study||17
642045|NCT00077649|1577806|P3|NOT COMPLETED|Overall Study||15
642046|NCT00077649|1577807|P2|NOT COMPLETED|Overall Study||9
642047|NCT00077649|1577808|P1|NOT COMPLETED|Overall Study||14
642048|NCT00077649|1577805|P4|COMPLETED|Overall Study||30
642049|NCT00077649|1577806|P3|COMPLETED|Overall Study||32
642050|NCT00077649|1577807|P2|COMPLETED|Overall Study||38
642051|NCT00077649|1577808|P1|COMPLETED|Overall Study||33
642052|NCT00077649|1577805|P4|Completed 24 Weeks of Follow-up|Overall Study||31
642053|NCT00077649|1577806|P3|Completed 24 Weeks of Follow-up|Overall Study||36
642054|NCT00077649|1577807|P2|Completed 24 Weeks of Follow-up|Overall Study||40
642055|NCT00077649|1577808|P1|Completed 24 Weeks of Follow-up|Overall Study||36
642056|NCT00077649|1577805|P4|STARTED|Overall Study||47
642057|NCT00077649|1577806|P3|STARTED|Overall Study||47
642058|NCT00077649|1577807|P2|STARTED|Overall Study||47
642059|NCT00077649|1577808|P1|STARTED|Overall Study||47
642060|NCT00077636|1577856|P2|NOT COMPLETED|Overall Study||92
642061|NCT00077636|1577857|P1|NOT COMPLETED|Overall Study||44
642062|NCT00077636|1577856|P2|COMPLETED|Overall Study||641
642063|NCT00077636|1577857|P1|COMPLETED|Overall Study||692
642064|NCT00077636|1577856|P2|STARTED|Overall Study||733
642065|NCT00077636|1577857|P1|STARTED|Overall Study||736
642066|NCT00077623|1577878|P3|NOT COMPLETED|Overall Study||32
642067|NCT00077623|1577879|P2|NOT COMPLETED|Overall Study||43
642068|NCT00077623|1577880|P1|NOT COMPLETED|Overall Study||36
642069|NCT00077623|1577878|P3|COMPLETED|Overall Study||159
642070|NCT00077623|1577879|P2|COMPLETED|Overall Study||148
642071|NCT00077623|1577880|P1|COMPLETED|Overall Study||154
642072|NCT00077623|1577878|P3|STARTED|Overall Study||191
642073|NCT00077623|1577879|P2|STARTED|Overall Study||191
642074|NCT00077623|1577880|P1|STARTED|Overall Study||190
642075|NCT00077610|1577915|P3|NOT COMPLETED|Overall Study||46
642076|NCT00077610|1577916|P2|NOT COMPLETED|Overall Study||56
642077|NCT00077610|1577917|P1|NOT COMPLETED|Overall Study||54
642078|NCT00077610|1577915|P3|COMPLETED|Overall Study||180
642079|NCT00077610|1577916|P2|COMPLETED|Overall Study||168
642080|NCT00077610|1577917|P1|COMPLETED|Overall Study||169
642081|NCT00077610|1577915|P3|Started Treatment|Overall Study||225
642082|NCT00077610|1577916|P2|Started Treatment|Overall Study||220
642083|NCT00077610|1577917|P1|Started Treatment|Overall Study||221
642084|NCT00077610|1577915|P3|STARTED|Overall Study||226
642085|NCT00077610|1577916|P2|STARTED|Overall Study||224
642086|NCT00077610|1577917|P1|STARTED|Overall Study||223
642087|NCT00077376|1577946|P1|NOT COMPLETED|Overall Study||22
642088|NCT00077376|1577946|P1|COMPLETED|Overall Study||39
642089|NCT00077376|1577946|P1|HER2+ in Central Testing|Overall Study||39
642090|NCT00077376|1577946|P1|Treated|Overall Study||59
642091|NCT00077376|1577946|P1|STARTED|Overall Study||61
642092|NCT00077207|1577957|P1|NOT COMPLETED|Overall Study||30
642093|NCT00077207|1577957|P1|COMPLETED|Overall Study||36
642094|NCT00077207|1577957|P1|STARTED|Overall Study||66
642095|NCT00077064|1577969|P2|NOT COMPLETED|Overall Study||6
642096|NCT00077064|1577970|P1|NOT COMPLETED|Overall Study||0
642097|NCT00077064|1577969|P2|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|10
642098|NCT00077064|1577970|P1|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|17
642099|NCT00077064|1577969|P2|STARTED|Overall Study||16
642100|NCT00077064|1577970|P1|STARTED|Overall Study||17
642101|NCT00076999|1577986|P5|NOT COMPLETED|Overall Study||25
642102|NCT00076999|1577987|P4|NOT COMPLETED|Overall Study||1
642103|NCT00076999|1577988|P3|NOT COMPLETED|Overall Study||17
642104|NCT00076999|1577989|P2|NOT COMPLETED|Overall Study||24
642105|NCT00076999|1577990|P1|NOT COMPLETED|Overall Study||12
642106|NCT00076999|1577986|P5|COMPLETED|Overall Study||9
642107|NCT00076999|1577987|P4|COMPLETED|Overall Study||5
642108|NCT00076999|1577988|P3|COMPLETED|Overall Study||2
642109|NCT00076999|1577989|P2|COMPLETED|Overall Study||7
642110|NCT00076999|1577990|P1|COMPLETED|Overall Study||13
642111|NCT00076999|1577986|P5|STARTED|Overall Study||34
642112|NCT00076999|1577987|P4|STARTED|Overall Study||6
642113|NCT00076999|1577988|P3|STARTED|Overall Study||19
642114|NCT00076999|1577989|P2|STARTED|Overall Study||31
642115|NCT00076999|1577990|P1|STARTED|Overall Study||25
642116|NCT00003222|1578109|P2|NOT COMPLETED|Overall Study||1
642117|NCT00003222|1578110|P1|NOT COMPLETED|Overall Study||0
642118|NCT00003222|1578109|P2|COMPLETED|Overall Study|Decline in performance status between enrollment and initiation of therapy.|27
642119|NCT00003222|1578110|P1|COMPLETED|Overall Study||13
642120|NCT00003222|1578109|P2|STARTED|Overall Study||28
642121|NCT00003222|1578110|P1|STARTED|Overall Study||13
642122|NCT00076804|1578122|P2|NOT COMPLETED|Overall Study||69
642123|NCT00076804|1578123|P1|NOT COMPLETED|Overall Study||60
642124|NCT00076804|1578122|P2|COMPLETED|Overall Study|102 completed week 48, 68 completed week 96|68
642125|NCT00076804|1578123|P1|COMPLETED|Overall Study|111 completed week 48, 77 completed week 96.|77
642126|NCT00076804|1578122|P2|STARTED|Overall Study||137
642127|NCT00076804|1578123|P1|STARTED|Overall Study||137
642128|NCT00076752|1578135|P1|NOT COMPLETED|Overall Study||3
642129|NCT00076752|1578135|P1|COMPLETED|Overall Study||6
642130|NCT00076752|1578135|P1|STARTED|Overall Study||9
642131|NCT00076622|1578158|P4|NOT COMPLETED|Overall Study||0
642132|NCT00076622|1578159|P3|NOT COMPLETED|Overall Study||0
642133|NCT00076622|1578160|P2|NOT COMPLETED|Overall Study||0
642134|NCT00076622|1578161|P1|NOT COMPLETED|Overall Study||0
642135|NCT00076622|1578158|P4|COMPLETED|Overall Study||18
642136|NCT00076622|1578159|P3|COMPLETED|Overall Study||40
642137|NCT00076622|1578160|P2|COMPLETED|Overall Study||13
642138|NCT00076622|1578161|P1|COMPLETED|Overall Study||23
642139|NCT00076622|1578158|P4|STARTED|Overall Study||18
642140|NCT00076622|1578159|P3|STARTED|Overall Study||40
642141|NCT00076622|1578160|P2|STARTED|Overall Study||13
642142|NCT00076622|1578161|P1|STARTED|Overall Study||23
642143|NCT00076570|1578181|P2|NOT COMPLETED|Overall Study||8
642144|NCT00076570|1578182|P1|NOT COMPLETED|Overall Study||8
642145|NCT00076570|1578181|P2|COMPLETED|Overall Study||8
642146|NCT00076570|1578182|P1|COMPLETED|Overall Study||7
642147|NCT00076570|1578181|P2|STARTED|Overall Study||16
642148|NCT00076570|1578182|P1|STARTED|Overall Study||15
642149|NCT00003298|1578190|P1|NOT COMPLETED|Step 2 (Adjuvant Therapy)||6
642150|NCT00003298|1578190|P1|COMPLETED|Step 2 (Adjuvant Therapy)||4
642151|NCT00003298|1578190|P1|Eligible and Treated on Step 2|Step 2 (Adjuvant Therapy)||7
642152|NCT00003298|1578190|P1|STARTED|Step 2 (Adjuvant Therapy)||10
642153|NCT00003298|1578190|P1|NOT COMPLETED|Re-register to Step 2 After Surgery||18
642154|NCT00003298|1578190|P1|COMPLETED|Re-register to Step 2 After Surgery||10
642155|NCT00003298|1578190|P1|STARTED|Re-register to Step 2 After Surgery||28
642156|NCT00003298|1578190|P1|NOT COMPLETED|Surgery||7
642157|NCT00003298|1578190|P1|COMPLETED|Surgery|1 patient did not complete neoadjuvant therapy but went to surgery anyway, not included here.|28
642158|NCT00003298|1578190|P1|STARTED|Surgery||35
642159|NCT00003298|1578190|P1|NOT COMPLETED|Step 1 (Neoadjuvant Therapy)||4
642160|NCT00003298|1578190|P1|COMPLETED|Step 1 (Neoadjuvant Therapy)||35
642161|NCT00003298|1578190|P1|Complete 3 Cycles of Neoadjuvant Therapy|Step 1 (Neoadjuvant Therapy)||35
642162|NCT00003298|1578190|P1|Eligible and Treated|Step 1 (Neoadjuvant Therapy)||38
642163|NCT00003298|1578190|P1|STARTED|Step 1 (Neoadjuvant Therapy)||39
642164|NCT00076336|1578200|P2|NOT COMPLETED|Overall Study||56
642165|NCT00076336|1578201|P1|NOT COMPLETED|Overall Study||52
642166|NCT00076336|1578200|P2|COMPLETED|Overall Study||60
642167|NCT00076336|1578201|P1|COMPLETED|Overall Study||64
642168|NCT00076336|1578200|P2|Completed Week 104|Overall Study||62
642169|NCT00076336|1578201|P1|Completed Week 104|Overall Study||70
642170|NCT00076336|1578200|P2|Completed Week 52|Overall Study||94
642171|NCT00076336|1578201|P1|Completed Week 52|Overall Study||97
642172|NCT00076336|1578200|P2|Intent to Treat (ITT) Population|Overall Study|2 patients had no HBV DNA assessments after baseline and were excluded from ITT population.|114
642173|NCT00076336|1578201|P1|Intent to Treat (ITT) Population|Overall Study|1 patient had no HBV DNA assessments after baseline and was excluded from ITT population.|114
642174|NCT00076336|1578200|P2|Safety Population|Overall Study||116
642175|NCT00076336|1578201|P1|Safety Population|Overall Study|1 patient was randomized but never received study drug and not included in safety population.|115
642176|NCT00076336|1578200|P2|STARTED|Overall Study||116
642177|NCT00076336|1578201|P1|STARTED|Overall Study||116
642178|NCT00076258|1578217|P2|NOT COMPLETED|Overall Study||3
642179|NCT00076258|1578218|P1|NOT COMPLETED|Overall Study||1
642180|NCT00076258|1578217|P2|COMPLETED|Overall Study||61
642181|NCT00076258|1578218|P1|COMPLETED|Overall Study||61
642182|NCT00076258|1578217|P2|STARTED|Overall Study||64
642183|NCT00076258|1578218|P1|STARTED|Overall Study||62
642184|NCT00076245|1578228|P4|NOT COMPLETED|Overall Study||1
642185|NCT00076245|1578229|P3|NOT COMPLETED|Overall Study||0
642186|NCT00076245|1578230|P2|NOT COMPLETED|Overall Study||0
642187|NCT00076245|1578231|P1|NOT COMPLETED|Overall Study||0
642188|NCT00076245|1578228|P4|COMPLETED|Overall Study||14
642189|NCT00076245|1578229|P3|COMPLETED|Overall Study||15
642190|NCT00076245|1578230|P2|COMPLETED|Overall Study||15
642191|NCT00076245|1578231|P1|COMPLETED|Overall Study||16
642192|NCT00076245|1578228|P4|STARTED|Overall Study||15
642193|NCT00076245|1578229|P3|STARTED|Overall Study||15
642194|NCT00076245|1578230|P2|STARTED|Overall Study||15
642195|NCT00076245|1578231|P1|STARTED|Overall Study||16
642196|NCT00076219|1578247|P2|NOT COMPLETED|Overall Study||11
642197|NCT00076219|1578248|P1|NOT COMPLETED|Overall Study||18
642198|NCT00076219|1578247|P2|COMPLETED|Overall Study||550
642199|NCT00076219|1578248|P1|COMPLETED|Overall Study||545
642200|NCT00076219|1578247|P2|STARTED|Overall Study||561
642201|NCT00076219|1578248|P1|STARTED|Overall Study||563
642202|NCT00076102|1578254|P1|NOT COMPLETED|Overall Study||5
642203|NCT00076102|1578254|P1|COMPLETED|Overall Study||31
642204|NCT00076102|1578254|P1|STARTED|Overall Study||36
642205|NCT00076050|1578268|P2|NOT COMPLETED|Overall Study||43
642206|NCT00076050|1578269|P1|NOT COMPLETED|Overall Study||23
642207|NCT00076050|1578268|P2|COMPLETED|Overall Study||83
642208|NCT00076050|1578269|P1|COMPLETED|Overall Study||99
642209|NCT00076050|1578268|P2|STARTED|Overall Study||126
642210|NCT00076050|1578269|P1|STARTED|Overall Study||122
642211|NCT00076024|1578282|P4|NOT COMPLETED|Phase 2, Open-label||16
642212|NCT00076024|1578283|P3|NOT COMPLETED|Phase 2, Open-label||0
642213|NCT00076024|1578284|P2|NOT COMPLETED|Phase 2, Open-label||0
642214|NCT00076024|1578285|P1|NOT COMPLETED|Phase 2, Open-label||0
642215|NCT00076024|1578282|P4|COMPLETED|Phase 2, Open-label||0
642216|NCT00076024|1578283|P3|COMPLETED|Phase 2, Open-label||0
642217|NCT00076024|1578284|P2|COMPLETED|Phase 2, Open-label||0
642218|NCT00076024|1578285|P1|COMPLETED|Phase 2, Open-label||0
642219|NCT00076024|1578282|P4|STARTED|Phase 2, Open-label||16
642220|NCT00076024|1578283|P3|STARTED|Phase 2, Open-label||0
642221|NCT00076024|1578284|P2|STARTED|Phase 2, Open-label||0
642222|NCT00076024|1578285|P1|STARTED|Phase 2, Open-label||0
642223|NCT00076024|1578282|P4|NOT COMPLETED|Phase 2, Double-blind||0
642224|NCT00076024|1578283|P3|NOT COMPLETED|Phase 2, Double-blind||56
642225|NCT00076024|1578284|P2|NOT COMPLETED|Phase 2, Double-blind||112
642226|NCT00076024|1578285|P1|NOT COMPLETED|Phase 2, Double-blind||0
642227|NCT00076024|1578282|P4|COMPLETED|Phase 2, Double-blind||0
642228|NCT00076024|1578283|P3|COMPLETED|Phase 2, Double-blind||0
642229|NCT00076024|1578284|P2|COMPLETED|Phase 2, Double-blind||0
642230|NCT00076024|1578285|P1|COMPLETED|Phase 2, Double-blind||0
642231|NCT00076024|1578282|P4|Treated|Phase 2, Double-blind||0
642232|NCT00076024|1578283|P3|Treated|Phase 2, Double-blind||56
642233|NCT00076024|1578284|P2|Treated|Phase 2, Double-blind||111
642234|NCT00076024|1578285|P1|Treated|Phase 2, Double-blind||0
642235|NCT00076024|1578282|P4|STARTED|Phase 2, Double-blind||0
642236|NCT00076024|1578283|P3|STARTED|Phase 2, Double-blind||56
642237|NCT00076024|1578284|P2|STARTED|Phase 2, Double-blind||112
642238|NCT00076024|1578285|P1|STARTED|Phase 2, Double-blind||0
642239|NCT00076024|1578282|P4|NOT COMPLETED|Phase 1, Lead-in||0
642240|NCT00076024|1578283|P3|NOT COMPLETED|Phase 1, Lead-in||0
642241|NCT00076024|1578284|P2|NOT COMPLETED|Phase 1, Lead-in||0
642242|NCT00076024|1578285|P1|NOT COMPLETED|Phase 1, Lead-in||6
642243|NCT00076024|1578282|P4|COMPLETED|Phase 1, Lead-in||0
642244|NCT00076024|1578283|P3|COMPLETED|Phase 1, Lead-in||0
642245|NCT00076024|1578284|P2|COMPLETED|Phase 1, Lead-in||0
642246|NCT00076024|1578285|P1|COMPLETED|Phase 1, Lead-in||0
642247|NCT00076024|1578282|P4|STARTED|Phase 1, Lead-in||0
642248|NCT00076024|1578283|P3|STARTED|Phase 1, Lead-in||0
642249|NCT00076024|1578284|P2|STARTED|Phase 1, Lead-in||0
642250|NCT00076024|1578285|P1|STARTED|Phase 1, Lead-in||6
642251|NCT00076011|1578299|P1|NOT COMPLETED|Overall Study||52
642252|NCT00076011|1578299|P1|COMPLETED|Overall Study||0
642253|NCT00076011|1578299|P1|STARTED|Overall Study||52
642254|NCT00075946|1578311|P5|NOT COMPLETED|Overall Study||188
642255|NCT00075946|1578312|P4|NOT COMPLETED|Overall Study||30
642256|NCT00075946|1578313|P3|NOT COMPLETED|Overall Study||28
642257|NCT00075946|1578314|P2|NOT COMPLETED|Overall Study||151
642258|NCT00075946|1578315|P1|NOT COMPLETED|Overall Study||148
642259|NCT00075946|1578311|P5|COMPLETED|Overall Study||0
642260|NCT00075946|1578312|P4|COMPLETED|Overall Study||0
642261|NCT00075946|1578313|P3|COMPLETED|Overall Study||0
642262|NCT00075946|1578314|P2|COMPLETED|Overall Study||0
642263|NCT00075946|1578315|P1|COMPLETED|Overall Study||0
642264|NCT00075946|1578311|P5|Included in Primary Analysis|Overall Study||0
642265|NCT00075946|1578312|P4|Included in Primary Analysis|Overall Study||29
642266|NCT00075946|1578313|P3|Included in Primary Analysis|Overall Study||23
642267|NCT00075946|1578314|P2|Included in Primary Analysis|Overall Study||146
642268|NCT00075946|1578315|P1|Included in Primary Analysis|Overall Study||143
642269|NCT00075946|1578311|P5|Treated and With Toxicity Data Available|Overall Study||154
642270|NCT00075946|1578312|P4|Treated and With Toxicity Data Available|Overall Study||29
642271|NCT00075946|1578313|P3|Treated and With Toxicity Data Available|Overall Study||27
642272|NCT00075946|1578314|P2|Treated and With Toxicity Data Available|Overall Study||148
642273|NCT00075946|1578315|P1|Treated and With Toxicity Data Available|Overall Study||142
642274|NCT00075946|1578311|P5|STARTED|Overall Study||188
642275|NCT00075946|1578312|P4|STARTED|Overall Study||30
642276|NCT00075946|1578313|P3|STARTED|Overall Study||28
642277|NCT00075946|1578314|P2|STARTED|Overall Study||151
642278|NCT00075946|1578315|P1|STARTED|Overall Study||148
642279|NCT00075881|1578330|P1|NOT COMPLETED|Overall Study||43
642280|NCT00075881|1578330|P1|COMPLETED|Overall Study||1
642281|NCT00075881|1578330|P1|Reinduction Treatment|Overall Study||7
642282|NCT00075881|1578330|P1|Maintenance Treatment|Overall Study||15
642283|NCT00075881|1578330|P1|Induction Treatment|Overall Study||42
642284|NCT00075881|1578330|P1|Treated|Overall Study||42
642285|NCT00075881|1578330|P1|Eligible|Overall Study||43
642286|NCT00075881|1578330|P1|STARTED|Overall Study||44
642287|NCT00075829|1578341|P4|NOT COMPLETED|Overall Study||24
642288|NCT00075829|1578342|P3|NOT COMPLETED|Overall Study||34
642289|NCT00075829|1578343|P2|NOT COMPLETED|Overall Study||118
642290|NCT00075829|1578344|P1|NOT COMPLETED|Overall Study||258
642291|NCT00075829|1578341|P4|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|13
642292|NCT00075829|1578342|P3|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|14
642293|NCT00075829|1578343|P2|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|71
642294|NCT00075829|1578344|P1|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|178
642295|NCT00075829|1578341|P4|STARTED|Overall Study||37
642296|NCT00075829|1578342|P3|STARTED|Overall Study||48
642297|NCT00075829|1578343|P2|STARTED|Overall Study||189
642298|NCT00075829|1578344|P1|STARTED|Overall Study||436
642299|NCT00075816|1578374|P2|NOT COMPLETED|Overall Study||11
642300|NCT00075816|1578375|P1|NOT COMPLETED|Overall Study||14
642301|NCT00075816|1578374|P2|COMPLETED|Overall Study||262
642302|NCT00075816|1578375|P1|COMPLETED|Overall Study||264
642303|NCT00075816|1578374|P2|STARTED|Overall Study||273
642304|NCT00075816|1578375|P1|STARTED|Overall Study||278
642305|NCT00075803|1578415|P2|NOT COMPLETED|Overall Study||0
642306|NCT00075803|1578416|P1|NOT COMPLETED|Overall Study||0
642307|NCT00075803|1578415|P2|COMPLETED|Overall Study||305
642308|NCT00075803|1578416|P1|COMPLETED|Overall Study||295
642309|NCT00075803|1578415|P2|STARTED|Overall Study||305
642310|NCT00075803|1578416|P1|STARTED|Overall Study||295
642311|NCT00075764|1578444|P2|NOT COMPLETED|Overall Study||349
642312|NCT00075764|1578445|P1|NOT COMPLETED|Overall Study||345
642313|NCT00075764|1578444|P2|COMPLETED|Overall Study||0
642314|NCT00075764|1578445|P1|COMPLETED|Overall Study||0
642315|NCT00075764|1578444|P2|STARTED|Overall Study||349
642316|NCT00075764|1578445|P1|STARTED|Overall Study||345
642317|NCT00075725|1578469|P12|NOT COMPLETED|Overall Study||18
642318|NCT00075725|1578470|P11|NOT COMPLETED|Overall Study||9
642319|NCT00075725|1578471|P10|NOT COMPLETED|Overall Study||18
642320|NCT00075725|1578472|P9|NOT COMPLETED|Overall Study||117
642321|NCT00075725|1578473|P8|NOT COMPLETED|Overall Study||295
642322|NCT00075725|1578474|P7|NOT COMPLETED|Overall Study||75
642323|NCT00075725|1578475|P6|NOT COMPLETED|Overall Study||313
642324|NCT00075725|1578476|P5|NOT COMPLETED|Overall Study||66
642325|NCT00075725|1578477|P4|NOT COMPLETED|Overall Study||78
642326|NCT00075725|1578478|P3|NOT COMPLETED|Overall Study||121
642327|NCT00075725|1578479|P2|NOT COMPLETED|Overall Study||49
642328|NCT00075725|1578480|P1|NOT COMPLETED|Overall Study||74
642329|NCT00075725|1578469|P12|COMPLETED|Overall Study||10
642330|NCT00075725|1578470|P11|COMPLETED|Overall Study||3
642331|NCT00075725|1578471|P10|COMPLETED|Overall Study||16
642332|NCT00075725|1578472|P9|COMPLETED|Overall Study||185
642333|NCT00075725|1578473|P8|COMPLETED|Overall Study||401
642334|NCT00075725|1578474|P7|COMPLETED|Overall Study||171
642335|NCT00075725|1578475|P6|COMPLETED|Overall Study||397
642336|NCT00075725|1578476|P5|COMPLETED|Overall Study||166
642337|NCT00075725|1578477|P4|COMPLETED|Overall Study||168
642338|NCT00075725|1578478|P3|COMPLETED|Overall Study||175
642339|NCT00075725|1578479|P2|COMPLETED|Overall Study||57
642340|NCT00075725|1578480|P1|COMPLETED|Overall Study||172
642341|NCT00075725|1578469|P12|STARTED|Overall Study||28
642342|NCT00075725|1578470|P11|STARTED|Overall Study||12
642343|NCT00075725|1578471|P10|STARTED|Overall Study||34
642344|NCT00075725|1578472|P9|STARTED|Overall Study||302
642345|NCT00075725|1578473|P8|STARTED|Overall Study||696
642346|NCT00075725|1578474|P7|STARTED|Overall Study||246
642347|NCT00075725|1578475|P6|STARTED|Overall Study||710
642348|NCT00075725|1578476|P5|STARTED|Overall Study||232
642349|NCT00075725|1578477|P4|STARTED|Overall Study||246
642350|NCT00075725|1578478|P3|STARTED|Overall Study||296
642351|NCT00075725|1578479|P2|STARTED|Overall Study||106
642352|NCT00075725|1578480|P1|STARTED|Overall Study||246
642353|NCT00075608|1578569|P1|NOT COMPLETED|Overall Study||0
642354|NCT00075608|1578569|P1|COMPLETED|Overall Study||12
642355|NCT00075608|1578569|P1|STARTED|Overall Study||12
642356|NCT00075582|1578577|P2|NOT COMPLETED|Overall Study||35
642357|NCT00075582|1578578|P1|NOT COMPLETED|Overall Study||50
642358|NCT00075582|1578577|P2|COMPLETED|Overall Study||50
642359|NCT00075582|1578578|P1|COMPLETED|Overall Study||255
642360|NCT00075582|1578577|P2|STARTED|Overall Study||85
642361|NCT00075582|1578578|P1|STARTED|Overall Study||305
642362|NCT00075504|1578588|P2|NOT COMPLETED|Overall Study||7
642363|NCT00075504|1578589|P1|NOT COMPLETED|Overall Study||9
642364|NCT00075504|1578588|P2|COMPLETED|Overall Study||3
642365|NCT00075504|1578589|P1|COMPLETED|Overall Study||14
642366|NCT00075504|1578588|P2|STARTED|Overall Study||10
642367|NCT00075504|1578589|P1|STARTED|Overall Study||23
642368|NCT00075478|1578601|P2|NOT COMPLETED|Overall Study||1
642369|NCT00075478|1578602|P1|NOT COMPLETED|Overall Study||1
642370|NCT00075478|1578601|P2|COMPLETED|Overall Study||44
642371|NCT00075478|1578602|P1|COMPLETED|Overall Study||41
642372|NCT00075478|1578601|P2|STARTED|Overall Study||45
642373|NCT00075478|1578602|P1|STARTED|Overall Study||42
642374|NCT00075400|1578622|P1|NOT COMPLETED|Overall Study||3
642375|NCT00075400|1578622|P1|COMPLETED|Overall Study|Eligible and treated patients.|23
642376|NCT00075400|1578622|P1|STARTED|Overall Study||26
642377|NCT00075335|1578636|P1|NOT COMPLETED|Overall Study||0
642378|NCT00075335|1578636|P1|COMPLETED|Overall Study||8
642379|NCT00075335|1578636|P1|STARTED|Overall Study||8
642380|NCT00075270|1578643|P2|NOT COMPLETED|Overall Study||284
642381|NCT00075270|1578644|P1|NOT COMPLETED|Overall Study||286
642382|NCT00075270|1578643|P2|COMPLETED|Overall Study||4
642383|NCT00075270|1578644|P1|COMPLETED|Overall Study||5
642384|NCT00075270|1578643|P2|Missing|Overall Study|These participants have no completion status information recorded on the case report forms.|13
642385|NCT00075270|1578644|P1|Missing|Overall Study|These participants have no completion status information recorded on the case report forms.|26
642386|NCT00075270|1578643|P2|STARTED|Overall Study||288
642387|NCT00075270|1578644|P1|STARTED|Overall Study||291
642388|NCT00075218|1578690|P3|NOT COMPLETED|Open-Label Treatment||255
642389|NCT00075218|1578691|P2|NOT COMPLETED|Open-Label Treatment||0
642390|NCT00075218|1578692|P1|NOT COMPLETED|Open-Label Treatment||0
642391|NCT00075218|1578690|P3|COMPLETED|Open-Label Treatment||0
642392|NCT00075218|1578691|P2|COMPLETED|Open-Label Treatment||0
642393|NCT00075218|1578692|P1|COMPLETED|Open-Label Treatment||0
642394|NCT00075218|1578690|P3|STARTED|Open-Label Treatment||255
642395|NCT00075218|1578691|P2|STARTED|Open-Label Treatment||0
642396|NCT00075218|1578692|P1|STARTED|Open-Label Treatment||0
642397|NCT00075218|1578690|P3|NOT COMPLETED|Double-Blind Treatment||0
642398|NCT00075218|1578691|P2|NOT COMPLETED|Double-Blind Treatment||15
642399|NCT00075218|1578692|P1|NOT COMPLETED|Double-Blind Treatment||91
642400|NCT00075218|1578690|P3|COMPLETED|Double-Blind Treatment||0
642401|NCT00075218|1578691|P2|COMPLETED|Double-Blind Treatment|Defined:subjects completed double-blind treatment phase and/or entered open-label treatment phase.|103
642402|NCT00075218|1578692|P1|COMPLETED|Double-Blind Treatment|Defined:subjects completed double-blind treatment phase and/or entered open-label treatment phase.|152
642403|NCT00075218|1578690|P3|Crossed Over to Open-Label Treatment|Double-Blind Treatment||0
642404|NCT00075218|1578691|P2|Crossed Over to Open-Label Treatment|Double-Blind Treatment||103
642405|NCT00075218|1578692|P1|Crossed Over to Open-Label Treatment|Double-Blind Treatment||152
642406|NCT00075218|1578690|P3|Received Double-Blind Treatment|Double-Blind Treatment||0
642407|NCT00075218|1578691|P2|Received Double-Blind Treatment|Double-Blind Treatment|As Treated Population (AT)|114
642408|NCT00075218|1578692|P1|Received Double-Blind Treatment|Double-Blind Treatment|As Treated Population (AT)|228
642409|NCT00075218|1578690|P3|STARTED|Double-Blind Treatment||0
642410|NCT00075218|1578691|P2|STARTED|Double-Blind Treatment|Intent To Treat Population (ITT)|118
642411|NCT00075218|1578692|P1|STARTED|Double-Blind Treatment|Intent To Treat Population (ITT)|243
642412|NCT00075088|1578727|P2|NOT COMPLETED|Overall Study||0
642413|NCT00075088|1578728|P1|NOT COMPLETED|Overall Study||0
642414|NCT00075088|1578727|P2|COMPLETED|Overall Study||391
642415|NCT00075088|1578728|P1|COMPLETED|Overall Study||403
642416|NCT00075088|1578727|P2|STARTED|Overall Study||391
642417|NCT00075088|1578728|P1|STARTED|Overall Study||403
642418|NCT00075023|1578741|P2|NOT COMPLETED|Part Two||0
642419|NCT00075023|1578742|P1|NOT COMPLETED|Part Two||0
642420|NCT00075023|1578741|P2|COMPLETED|Part Two||0
642421|NCT00075023|1578742|P1|COMPLETED|Part Two||0
642422|NCT00075023|1578741|P2|STARTED|Part Two|Study was terminated after the pilot study. No participants entered Part Two.|0
642423|NCT00075023|1578742|P1|STARTED|Part Two|Study was terminated after the pilot study. No participants entered Part Two.|0
642424|NCT00075023|1578741|P2|NOT COMPLETED|Pilot Study||2
642425|NCT00075023|1578742|P1|NOT COMPLETED|Pilot Study||2
642426|NCT00075023|1578741|P2|COMPLETED|Pilot Study||3
642427|NCT00075023|1578742|P1|COMPLETED|Pilot Study||3
642428|NCT00075023|1578741|P2|STARTED|Pilot Study||5
642429|NCT00075023|1578742|P1|STARTED|Pilot Study||5
642430|NCT00074984|1578751|P2|NOT COMPLETED|Overall Study||8
642431|NCT00074984|1578752|P1|NOT COMPLETED|Overall Study||3
642432|NCT00074984|1578751|P2|COMPLETED|Overall Study||43
642433|NCT00074984|1578752|P1|COMPLETED|Overall Study||28
642434|NCT00074984|1578751|P2|STARTED|Overall Study||51
642435|NCT00074984|1578752|P1|STARTED|Overall Study||31
642436|NCT00074958|1578767|P1|NOT COMPLETED|Overall Study||1
642437|NCT00074958|1578767|P1|COMPLETED|Overall Study||15
642438|NCT00074958|1578767|P1|STARTED|Overall Study||16
642439|NCT00074815|1578775|P3|NOT COMPLETED|Overall Study||12
642440|NCT00074815|1578776|P2|NOT COMPLETED|Overall Study||6
642441|NCT00074815|1578777|P1|NOT COMPLETED|Overall Study||5
642442|NCT00074815|1578775|P3|COMPLETED|Overall Study||30
642443|NCT00074815|1578776|P2|COMPLETED|Overall Study||34
642444|NCT00074815|1578777|P1|COMPLETED|Overall Study||37
642445|NCT00074815|1578775|P3|STARTED|Overall Study||42
642446|NCT00074815|1578776|P2|STARTED|Overall Study||40
642447|NCT00074815|1578777|P1|STARTED|Overall Study||42
642448|NCT00074802|1578787|P2|NOT COMPLETED|Overall Study||7
642449|NCT00074802|1578788|P1|NOT COMPLETED|Overall Study||9
642450|NCT00074802|1578787|P2|COMPLETED|Overall Study||25
642451|NCT00074802|1578788|P1|COMPLETED|Overall Study||20
642452|NCT00074802|1578787|P2|STARTED|Overall Study||32
642453|NCT00074802|1578788|P1|STARTED|Overall Study||29
642454|NCT00074711|1578808|P2|NOT COMPLETED|Overall Study||15
642455|NCT00074711|1578809|P1|NOT COMPLETED|Overall Study||15
642456|NCT00074711|1578808|P2|COMPLETED|Overall Study||106
642457|NCT00074711|1578809|P1|COMPLETED|Overall Study||105
642458|NCT00074711|1578808|P2|STARTED|Overall Study||121
642459|NCT00074711|1578809|P1|STARTED|Overall Study||120
642460|NCT00074581|1578827|P2|NOT COMPLETED|Overall Study||226
642461|NCT00074581|1578828|P1|NOT COMPLETED|Overall Study||244
642462|NCT00074581|1578827|P2|COMPLETED|Overall Study||1541
642463|NCT00074581|1578828|P1|COMPLETED|Overall Study||1545
642464|NCT00074581|1578827|P2|STARTED|Overall Study|877 HIV-infected index cases and 890 HIV-uninfected partners|1767
642465|NCT00074581|1578828|P1|STARTED|Overall Study|886 HIV-infected index cases and 903 HIV-uninfected partners|1789
642466|NCT00074412|1578838|P2|NOT COMPLETED|Overall Study||84
642467|NCT00074412|1578839|P1|NOT COMPLETED|Overall Study||82
642468|NCT00074412|1578838|P2|COMPLETED|Overall Study|Number of infants who completed final 18 month visit: out of 733 infants who were expected.|675
642469|NCT00074412|1578839|P1|COMPLETED|Overall Study|Number of infants who completed final 18 month visit: out of 733 infants who were expected.|681
642470|NCT00074412|1578838|P2|Month 12 Visit|Overall Study||735
642471|NCT00074412|1578839|P1|Month 12 Visit|Overall Study||733
642472|NCT00074412|1578838|P2|Month 9 Visit|Overall Study||741
642473|NCT00074412|1578839|P1|Month 9 Visit|Overall Study||741
642474|NCT00074412|1578838|P2|Month 6 Visit|Overall Study||748
642475|NCT00074412|1578839|P1|Month 6 Visit|Overall Study||748
642476|NCT00074412|1578838|P2|Month 5 Visit|Overall Study||750
642477|NCT00074412|1578839|P1|Month 5 Visit|Overall Study||756
642478|NCT00074412|1578838|P2|Month 4 Visit|Overall Study||752
642479|NCT00074412|1578839|P1|Month 4 Visit|Overall Study||758
642480|NCT00074412|1578838|P2|Month 3 Visit|Overall Study||755
642481|NCT00074412|1578839|P1|Month 3 Visit|Overall Study||759
642482|NCT00074412|1578838|P2|Week 8 Visit|Overall Study||759
642483|NCT00074412|1578839|P1|Week 8 Visit|Overall Study||759
642484|NCT00074412|1578838|P2|STARTED|Overall Study|Number of infants randomized at 6 weeks.|759
642485|NCT00074412|1578839|P1|STARTED|Overall Study|Number of infants randomized at 6 weeks.|763
642486|NCT00074308|1578855|P5|NOT COMPLETED|Overall Study||0
642487|NCT00074308|1578856|P4|NOT COMPLETED|Overall Study||0
642488|NCT00074308|1578857|P3|NOT COMPLETED|Overall Study||0
642489|NCT00074308|1578858|P2|NOT COMPLETED|Overall Study||0
642490|NCT00074308|1578859|P1|NOT COMPLETED|Overall Study||0
642491|NCT00074308|1578855|P5|COMPLETED|Overall Study||23
642492|NCT00074308|1578856|P4|COMPLETED|Overall Study||8
642493|NCT00074308|1578857|P3|COMPLETED|Overall Study||3
642494|NCT00074308|1578858|P2|COMPLETED|Overall Study||3
642495|NCT00074308|1578859|P1|COMPLETED|Overall Study||3
642496|NCT00074308|1578855|P5|STARTED|Overall Study||23
642497|NCT00074308|1578856|P4|STARTED|Overall Study||8
642498|NCT00074308|1578857|P3|STARTED|Overall Study||3
642499|NCT00074308|1578858|P2|STARTED|Overall Study||3
642500|NCT00074308|1578859|P1|STARTED|Overall Study||3
642501|NCT00074269|1578870|P1|NOT COMPLETED|Overall Study||0
642502|NCT00074269|1578870|P1|COMPLETED|Overall Study||5
642503|NCT00074269|1578870|P1|STARTED|Overall Study||5
642504|NCT00074165|1578880|P1|NOT COMPLETED|Overall Study||0
642505|NCT00074165|1578880|P1|COMPLETED|Overall Study||17
642506|NCT00074165|1578880|P1|STARTED|Overall Study||17
642507|NCT00074152|1578887|P2|NOT COMPLETED|Overall Study||33
642508|NCT00074152|1578888|P1|NOT COMPLETED|Overall Study||55
642509|NCT00074152|1578887|P2|COMPLETED|Overall Study||52
642510|NCT00074152|1578888|P1|COMPLETED|Overall Study||22
642511|NCT00074152|1578887|P2|STARTED|Overall Study||85
642512|NCT00074152|1578888|P1|STARTED|Overall Study||77
642513|NCT00074035|1578898|P1|NOT COMPLETED|Overall Study||0
642514|NCT00074035|1578898|P1|COMPLETED|Overall Study||38
642515|NCT00074035|1578898|P1|STARTED|Overall Study||38
642516|NCT00073983|1578905|P1|NOT COMPLETED|Overall Study||1
642517|NCT00073983|1578905|P1|COMPLETED|Overall Study|One patient in the chondrosarcoma subtype was not evaluable.|53
642518|NCT00073983|1578905|P1|STARTED|Overall Study||54
642519|NCT00073957|1578920|P1|NOT COMPLETED|Overall Study||0
642520|NCT00073957|1578920|P1|COMPLETED|Overall Study||25
642521|NCT00073957|1578920|P1|STARTED|Overall Study||25
642522|NCT00073918|1578926|P1|NOT COMPLETED|Overall Study||4
642523|NCT00073918|1578926|P1|COMPLETED|Overall Study||107
642524|NCT00073918|1578926|P1|STARTED|Overall Study||111
642525|NCT00073528|1578935|P2|NOT COMPLETED|Overall Study||642
642526|NCT00073528|1578936|P1|NOT COMPLETED|Overall Study||644
642527|NCT00073528|1578935|P2|COMPLETED|Overall Study||0
642528|NCT00073528|1578936|P1|COMPLETED|Overall Study||0
642529|NCT00073528|1578935|P2|Ongoing|Overall Study|These participants are still on study and do not yet have end of study data available.|344
642530|NCT00073528|1578936|P1|Ongoing|Overall Study|These participants are still on study and do not yet have end of study data available.|349
642531|NCT00073528|1578935|P2|STARTED|Overall Study||642
642532|NCT00073528|1578936|P1|STARTED|Overall Study||644
642533|NCT00073333|1579013|P3|NOT COMPLETED|Overall Study||0
642534|NCT00073333|1579014|P2|NOT COMPLETED|Overall Study||14
642535|NCT00073333|1579015|P1|NOT COMPLETED|Overall Study||14
642536|NCT00073333|1579013|P3|COMPLETED|Overall Study||19
642537|NCT00073333|1579014|P2|COMPLETED|Overall Study||27
642538|NCT00073333|1579015|P1|COMPLETED|Overall Study||32
642539|NCT00073333|1579013|P3|STARTED|Overall Study||19
642540|NCT00073333|1579014|P2|STARTED|Overall Study||41
642541|NCT00073333|1579015|P1|STARTED|Overall Study||46
642542|NCT00073307|1579025|P3|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||156
642543|NCT00073307|1579026|P2|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0
642544|NCT00073307|1579027|P1|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||134
642545|NCT00073307|1579025|P3|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||143
642546|NCT00073307|1579026|P2|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0
642547|NCT00073307|1579027|P1|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||120
642548|NCT00073307|1579025|P3|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||216
642549|NCT00073307|1579026|P2|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||0
642550|NCT00073307|1579027|P1|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||219
642551|NCT00073307|1579025|P3|STARTED|Open Label-Sorafenib Only [30Jun2008]||299
642552|NCT00073307|1579026|P2|STARTED|Open Label-Sorafenib Only [30Jun2008]|Placebo treatment ended ~ 31May2005. Those who continued, switched to receive Sorafenib.|0
642553|NCT00073307|1579027|P1|STARTED|Open Label-Sorafenib Only [30Jun2008]||254
642554|NCT00073307|1579025|P3|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||0
642555|NCT00073307|1579026|P2|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||153
642556|NCT00073307|1579027|P1|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||197
642557|NCT00073307|1579025|P3|COMPLETED|Double-Blind (DB, as of ~31May2005)||0
642558|NCT00073307|1579026|P2|COMPLETED|Double-Blind (DB, as of ~31May2005)||299
642559|NCT00073307|1579027|P1|COMPLETED|Double-Blind (DB, as of ~31May2005)||254
642560|NCT00073307|1579025|P3|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||0
642561|NCT00073307|1579026|P2|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451
642562|NCT00073307|1579027|P1|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451
642563|NCT00073307|1579025|P3|STARTED|Double-Blind (DB, as of ~31May2005)||0
642564|NCT00073307|1579026|P2|STARTED|Double-Blind (DB, as of ~31May2005)||452
642565|NCT00073307|1579027|P1|STARTED|Double-Blind (DB, as of ~31May2005)||451
642566|NCT00073073|1579045|P1|NOT COMPLETED|Overall Study||4
642567|NCT00073073|1579045|P1|COMPLETED|Overall Study||42
642568|NCT00073073|1579045|P1|STARTED|Overall Study||46
642569|NCT00073021|1579058|P2|NOT COMPLETED|Overall Study||16
642570|NCT00073021|1579059|P1|NOT COMPLETED|Overall Study||26
642571|NCT00073021|1579058|P2|COMPLETED|Overall Study||113
642572|NCT00073021|1579059|P1|COMPLETED|Overall Study||113
642573|NCT00073021|1579058|P2|STARTED|Overall Study|Subjects with Moderate Disease [PGA = 2] at Baseline|129
642574|NCT00073021|1579059|P1|STARTED|Overall Study|Subjects with Moderate Disease [PGA = 2] at Baseline|139
642575|NCT00073008|1579089|P2|NOT COMPLETED|Overall Study||63
642576|NCT00073008|1579090|P1|NOT COMPLETED|Overall Study||62
642577|NCT00073008|1579089|P2|COMPLETED|Overall Study||3
642578|NCT00073008|1579090|P1|COMPLETED|Overall Study||3
642579|NCT00073008|1579089|P2|STARTED|Overall Study||66
642580|NCT00073008|1579090|P1|STARTED|Overall Study||65
642581|NCT00072761|1579122|P2|NOT COMPLETED|Overall Study||2
642582|NCT00072761|1579123|P1|NOT COMPLETED|Overall Study||9
642583|NCT00072761|1579122|P2|COMPLETED|Overall Study||95
642584|NCT00072761|1579123|P1|COMPLETED|Overall Study||90
642585|NCT00072761|1579122|P2|STARTED|Overall Study||97
642586|NCT00072761|1579123|P1|STARTED|Overall Study||99
642587|NCT00072475|1579129|P1|NOT COMPLETED|Overall Study||97
642588|NCT00072475|1579129|P1|COMPLETED|Overall Study||45
642589|NCT00072475|1579129|P1|STARTED|Overall Study||142
642590|NCT00072449|1579137|P1|NOT COMPLETED|Overall Study||0
642591|NCT00072449|1579137|P1|COMPLETED|Overall Study||12
642592|NCT00072449|1579137|P1|STARTED|Overall Study||12
642593|NCT00072293|1579146|P2|NOT COMPLETED|Overall Study||2
642594|NCT00072293|1579147|P1|NOT COMPLETED|Overall Study||1
642595|NCT00072293|1579146|P2|COMPLETED|Overall Study||467
642596|NCT00072293|1579147|P1|COMPLETED|Overall Study||464
642597|NCT00072293|1579146|P2|STARTED|Overall Study||469
642598|NCT00072293|1579147|P1|STARTED|Overall Study||465
642599|NCT00072280|1579159|P2|NOT COMPLETED|Follow-up||2
642600|NCT00072280|1579160|P1|NOT COMPLETED|Follow-up||2
642601|NCT00072280|1579159|P2|COMPLETED|Follow-up||0
642602|NCT00072280|1579160|P1|COMPLETED|Follow-up||0
642603|NCT00072280|1579159|P2|STARTED|Follow-up||2
642604|NCT00072280|1579160|P1|STARTED|Follow-up||2
642605|NCT00072280|1579159|P2|NOT COMPLETED|Treatment||2
642606|NCT00072280|1579160|P1|NOT COMPLETED|Treatment||1
642607|NCT00072280|1579159|P2|COMPLETED|Treatment||2
642608|NCT00072280|1579160|P1|COMPLETED|Treatment||2
642609|NCT00072280|1579159|P2|STARTED|Treatment||4
642610|NCT00072280|1579160|P1|STARTED|Treatment||3
642611|NCT00072189|1579165|P1|NOT COMPLETED|Overall Study||1
642612|NCT00072189|1579165|P1|COMPLETED|Overall Study||16
642613|NCT00072189|1579165|P1|STARTED|Overall Study||17
642614|NCT00072176|1579173|P2|NOT COMPLETED|Overall Study||1
642615|NCT00072176|1579174|P1|NOT COMPLETED|Overall Study||1
642616|NCT00072176|1579173|P2|COMPLETED|Overall Study||27
642617|NCT00072176|1579174|P1|COMPLETED|Overall Study||33
642618|NCT00072176|1579173|P2|STARTED|Overall Study||28
642619|NCT00072176|1579174|P1|STARTED|Overall Study||34
642620|NCT00071981|1579186|P4|NOT COMPLETED|Overall Study||45
642621|NCT00071981|1579187|P3|NOT COMPLETED|Overall Study||37
642622|NCT00071981|1579188|P2|NOT COMPLETED|Overall Study||41
642623|NCT00071981|1579189|P1|NOT COMPLETED|Overall Study||46
642624|NCT00071981|1579186|P4|COMPLETED|Overall Study||3
642625|NCT00071981|1579187|P3|COMPLETED|Overall Study||0
642626|NCT00071981|1579188|P2|COMPLETED|Overall Study||2
642627|NCT00071981|1579189|P1|COMPLETED|Overall Study||1
642628|NCT00071981|1579186|P4|Have Helper T Cell Response Data|Overall Study||39
642629|NCT00071981|1579187|P3|Have Helper T Cell Response Data|Overall Study||25
642630|NCT00071981|1579188|P2|Have Helper T Cell Response Data|Overall Study||27
642631|NCT00071981|1579189|P1|Have Helper T Cell Response Data|Overall Study||37
642632|NCT00071981|1579186|P4|Have CTL Response Data|Overall Study||41
642633|NCT00071981|1579187|P3|Have CTL Response Data|Overall Study||29
642634|NCT00071981|1579188|P2|Have CTL Response Data|Overall Study||30
642635|NCT00071981|1579189|P1|Have CTL Response Data|Overall Study||40
642636|NCT00071981|1579186|P4|Eligible and Treated|Overall Study||42
642637|NCT00071981|1579187|P3|Eligible and Treated|Overall Study||32
642638|NCT00071981|1579188|P2|Eligible and Treated|Overall Study||33
642639|NCT00071981|1579189|P1|Eligible and Treated|Overall Study||41
642640|NCT00071981|1579186|P4|Treated|Overall Study||48
642641|NCT00071981|1579187|P3|Treated|Overall Study||36
642642|NCT00071981|1579188|P2|Treated|Overall Study||38
642643|NCT00071981|1579189|P1|Treated|Overall Study||45
642644|NCT00071981|1579186|P4|Eligible|Overall Study||42
642645|NCT00071981|1579187|P3|Eligible|Overall Study||33
642646|NCT00071981|1579188|P2|Eligible|Overall Study||36
642647|NCT00071981|1579189|P1|Eligible|Overall Study||43
642648|NCT00071981|1579186|P4|STARTED|Overall Study||48
642649|NCT00071981|1579187|P3|STARTED|Overall Study||37
642650|NCT00071981|1579188|P2|STARTED|Overall Study||43
642651|NCT00071981|1579189|P1|STARTED|Overall Study||47
642652|NCT00072566|1579215|P1|NOT COMPLETED|Overall Study||0
642653|NCT00072566|1579215|P1|COMPLETED|Overall Study||70
642654|NCT00072566|1579215|P1|STARTED|Overall Study||70
642655|NCT00072514|1579221|P1|NOT COMPLETED|Overall Study||4
642656|NCT00072514|1579221|P1|COMPLETED|Overall Study||51
642657|NCT00072514|1579221|P1|STARTED|Overall Study||55
642658|NCT00071812|1579232|P4|NOT COMPLETED|24-Week Open-Label Extension Period||40
642659|NCT00071812|1579233|P3|NOT COMPLETED|24-Week Open-Label Extension Period||1
642660|NCT00071812|1579234|P2|NOT COMPLETED|24-Week Open-Label Extension Period||0
642661|NCT00071812|1579235|P1|NOT COMPLETED|24-Week Open-Label Extension Period||0
642662|NCT00071812|1579232|P4|COMPLETED|24-Week Open-Label Extension Period||178
642663|NCT00071812|1579233|P3|COMPLETED|24-Week Open-Label Extension Period||7
642664|NCT00071812|1579234|P2|COMPLETED|24-Week Open-Label Extension Period||11
642665|NCT00071812|1579235|P1|COMPLETED|24-Week Open-Label Extension Period||0
642666|NCT00071812|1579232|P4|STARTED|24-Week Open-Label Extension Period|Of 60: 56 continued with 10 mg/kg; 4 elected not to continue in the open-label extension.|218
642667|NCT00071812|1579233|P3|STARTED|24-Week Open-Label Extension Period|Of 63: 53 switched to 10 mg/kg; 2 elected not continue in the open-label extension.|8
642668|NCT00071812|1579234|P2|STARTED|24-Week Open-Label Extension Period|Of 66: 53 switched to 10 mg/kg; 2 elected not continue in the open-label extension.|11
642669|NCT00071812|1579235|P1|STARTED|24-Week Open-Label Extension Period|Of 59: 56 switched to 10 mg/kg; 3 elected not to continue in the open-label extension.|0
642670|NCT00071812|1579232|P4|NOT COMPLETED|24-Week Double-Blind Period||11
642671|NCT00071812|1579233|P3|NOT COMPLETED|24-Week Double-Blind Period||8
642672|NCT00071812|1579234|P2|NOT COMPLETED|24-Week Double-Blind Period||6
642673|NCT00071812|1579235|P1|NOT COMPLETED|24-Week Double-Blind Period||10
642674|NCT00071812|1579232|P4|COMPLETED|24-Week Double-Blind Period||60
642675|NCT00071812|1579233|P3|COMPLETED|24-Week Double-Blind Period||63
642676|NCT00071812|1579234|P2|COMPLETED|24-Week Double-Blind Period||66
642677|NCT00071812|1579235|P1|COMPLETED|24-Week Double-Blind Period||59
642678|NCT00071812|1579232|P4|STARTED|24-Week Double-Blind Period||71
642679|NCT00071812|1579233|P3|STARTED|24-Week Double-Blind Period||71
642680|NCT00071812|1579234|P2|STARTED|24-Week Double-Blind Period||72
642681|NCT00071812|1579235|P1|STARTED|24-Week Double-Blind Period||69
642682|NCT00071799|1579277|P2|NOT COMPLETED|Overall Study||98
642683|NCT00071799|1579278|P1|NOT COMPLETED|Overall Study||70
642684|NCT00071799|1579277|P2|COMPLETED|Overall Study|Includes patients who died or transformed to AML during treatment, or were still receiving drug.|81
642685|NCT00071799|1579278|P1|COMPLETED|Overall Study|Includes those who died or transformed to AML, or receiving drug + eligible for extension period.|109
642686|NCT00071799|1579277|P2|STARTED|Overall Study|Best supportive care: 105, Low-dose cytarabine: 49, Standard chemotherapy: 25 patients|179
642687|NCT00071799|1579278|P1|STARTED|Overall Study||179
642688|NCT00071890|1579320|P2|NOT COMPLETED|Overall Study||0
642689|NCT00071890|1579321|P1|NOT COMPLETED|Overall Study||0
642690|NCT00071890|1579320|P2|COMPLETED|Overall Study|"1 withdrawal~1 lost of follow-up~1 death 67 patients analysed"|67
642691|NCT00071890|1579321|P1|COMPLETED|Overall Study|"1 withdrawal~1 death 81 patients analysed"|81
642692|NCT00071890|1579320|P2|STARTED|Overall Study|1 patients stopped HAART at week 0|67
642693|NCT00071890|1579321|P1|STARTED|Overall Study|3 patients did not received Interleukin-2|81
642694|NCT00071760|1579331|P1|NOT COMPLETED|Overall Study||54
642695|NCT00071760|1579331|P1|COMPLETED|Overall Study||0
642696|NCT00071760|1579331|P1|Ongoing|Overall Study||25
642697|NCT00071760|1579331|P1|STARTED|Overall Study||54
642698|NCT00071721|1579392|P2|NOT COMPLETED|Overall Study||91
642699|NCT00071721|1579393|P1|NOT COMPLETED|Overall Study||72
642700|NCT00071721|1579392|P2|COMPLETED|Overall Study||69
642701|NCT00071721|1579393|P1|COMPLETED|Overall Study||81
642702|NCT00071721|1579392|P2|STARTED|Overall Study||160
642703|NCT00071721|1579393|P1|STARTED|Overall Study||153
642704|NCT00071513|1579411|P2|NOT COMPLETED|Follow-up Assessment||6
642705|NCT00071513|1579412|P1|NOT COMPLETED|Follow-up Assessment||6
642706|NCT00071513|1579411|P2|COMPLETED|Follow-up Assessment||247
642707|NCT00071513|1579412|P1|COMPLETED|Follow-up Assessment||233
642708|NCT00071513|1579411|P2|STARTED|Follow-up Assessment||253
642709|NCT00071513|1579412|P1|STARTED|Follow-up Assessment||239
642710|NCT00071513|1579411|P2|NOT COMPLETED|Intervention Component||3
642711|NCT00071513|1579412|P1|NOT COMPLETED|Intervention Component||2
642712|NCT00071513|1579411|P2|COMPLETED|Intervention Component||253
642713|NCT00071513|1579412|P1|COMPLETED|Intervention Component||239
642714|NCT00071513|1579411|P2|STARTED|Intervention Component||256
642715|NCT00071513|1579412|P1|STARTED|Intervention Component||241
642716|NCT00071487|1579424|P4|NOT COMPLETED|24-Week Open-Label Extension Period||23
642717|NCT00071487|1579425|P3|NOT COMPLETED|24-Week Open-Label Extension Period||1
642718|NCT00071487|1579426|P2|NOT COMPLETED|24-Week Open-Label Extension Period||0
642719|NCT00071487|1579427|P1|NOT COMPLETED|24-Week Open-Label Extension Period||0
642720|NCT00071487|1579424|P4|COMPLETED|24-Week Open-Label Extension Period||279
642721|NCT00071487|1579425|P3|COMPLETED|24-Week Open-Label Extension Period||23
642722|NCT00071487|1579426|P2|COMPLETED|24-Week Open-Label Extension Period||19
642723|NCT00071487|1579427|P1|COMPLETED|24-Week Open-Label Extension Period||0
642724|NCT00071487|1579424|P4|STARTED|24-Week Open-Label Extension Period|Of 90: 85 continued with 10 mg/kg; 5 elected not to continue in the open-label extension period.|302
642725|NCT00071487|1579425|P3|STARTED|24-Week Open-Label Extension Period|Of 94: 64 switched to 10 mg/kg; 6 elected not to continue in the open-label extension period.|24
642817|NCT00070499|1579608|P3|STARTED|Overall Study||126
642726|NCT00071487|1579426|P2|STARTED|24-Week Open-Label Extension Period|Of 87: 65 switched to 10 mg/kg; 3 elected not to continue in the open-label extension period.|19
642727|NCT00071487|1579427|P1|STARTED|24-Week Open-Label Extension Period|Of 93: 88 switched to 10 mg/kg; 5 elected not to continue in the open-label extension period.|0
642728|NCT00071487|1579424|P4|NOT COMPLETED|52-Week Double-Blind Period||21
642729|NCT00071487|1579425|P3|NOT COMPLETED|52-Week Double-Blind Period||17
642730|NCT00071487|1579426|P2|NOT COMPLETED|52-Week Double-Blind Period||27
642731|NCT00071487|1579427|P1|NOT COMPLETED|52-Week Double-Blind Period||20
642732|NCT00071487|1579424|P4|COMPLETED|52-Week Double-Blind Period||90
642733|NCT00071487|1579425|P3|COMPLETED|52-Week Double-Blind Period||94
642734|NCT00071487|1579426|P2|COMPLETED|52-Week Double-Blind Period||87
642735|NCT00071487|1579427|P1|COMPLETED|52-Week Double-Blind Period||93
642736|NCT00071487|1579424|P4|STARTED|52-Week Double-Blind Period||111
642737|NCT00071487|1579425|P3|STARTED|52-Week Double-Blind Period||111
642738|NCT00071487|1579426|P2|STARTED|52-Week Double-Blind Period||114
642739|NCT00071487|1579427|P1|STARTED|52-Week Double-Blind Period||113
642740|NCT00071396|1579471|P1|NOT COMPLETED|Overall Study||3
642741|NCT00071396|1579471|P1|COMPLETED|Overall Study|Evaluable for response.|41
642742|NCT00071396|1579471|P1|STARTED|Overall Study||44
642743|NCT00071110|1579477|P2|NOT COMPLETED|Overall Study||4
642744|NCT00071110|1579478|P1|NOT COMPLETED|Overall Study||0
642745|NCT00071110|1579477|P2|COMPLETED|Overall Study||25
642746|NCT00071110|1579478|P1|COMPLETED|Overall Study||28
642747|NCT00071110|1579477|P2|STARTED|Overall Study||29
642748|NCT00071110|1579478|P1|STARTED|Overall Study||28
642749|NCT00071032|1579492|P2|NOT COMPLETED|Overall Study||8
642750|NCT00071032|1579493|P1|NOT COMPLETED|Overall Study||9
642751|NCT00071032|1579492|P2|COMPLETED|Overall Study||1001
642752|NCT00071032|1579493|P1|COMPLETED|Overall Study||998
642753|NCT00071032|1579492|P2|STARTED|Overall Study||1009
642754|NCT00071032|1579493|P1|STARTED|Overall Study||1007
642755|NCT00071006|1579501|P1|NOT COMPLETED|Overall Study||12
642756|NCT00071006|1579501|P1|COMPLETED|Overall Study||0
642757|NCT00071006|1579501|P1|STARTED|Overall Study||12
642758|NCT00070941|1579514|P3|NOT COMPLETED|Overall Study||4
642759|NCT00070941|1579515|P2|NOT COMPLETED|Overall Study||8
642760|NCT00070941|1579516|P1|NOT COMPLETED|Overall Study||10
642761|NCT00070941|1579514|P3|COMPLETED|Overall Study||2
642762|NCT00070941|1579515|P2|COMPLETED|Overall Study||3
642763|NCT00070941|1579516|P1|COMPLETED|Overall Study||2
642764|NCT00070941|1579514|P3|STARTED|Overall Study||6
642765|NCT00070941|1579515|P2|STARTED|Overall Study||11
642766|NCT00070941|1579516|P1|STARTED|Overall Study||12
642767|NCT00071058|1579524|P1|NOT COMPLETED|Overall Study||1
642768|NCT00071058|1579524|P1|COMPLETED|Overall Study||49
642769|NCT00071058|1579524|P1|STARTED|Overall Study||50
642770|NCT00003907|1579531|P2|NOT COMPLETED|Overall Study||23
642771|NCT00003907|1579532|P1|NOT COMPLETED|Overall Study||13
642772|NCT00003907|1579531|P2|COMPLETED|Overall Study||8
642773|NCT00003907|1579532|P1|COMPLETED|Overall Study||6
642774|NCT00003907|1579531|P2|Eligible and Treated|Overall Study||29
642775|NCT00003907|1579532|P1|Eligible and Treated|Overall Study||17
642776|NCT00003907|1579531|P2|Received Protocol Therapy (Treated)|Overall Study||31
642777|NCT00003907|1579532|P1|Received Protocol Therapy (Treated)|Overall Study||18
642778|NCT00003907|1579531|P2|Eligible|Overall Study||29
642779|NCT00003907|1579532|P1|Eligible|Overall Study||18
642780|NCT00003907|1579531|P2|STARTED|Overall Study||31
642781|NCT00003907|1579532|P1|STARTED|Overall Study||19
642782|NCT00070564|1579548|P6|NOT COMPLETED|Overall Study||52
642783|NCT00070564|1579549|P5|NOT COMPLETED|Overall Study||79
642784|NCT00070564|1579550|P4|NOT COMPLETED|Overall Study||167
642785|NCT00070564|1579551|P3|NOT COMPLETED|Overall Study||171
642786|NCT00070564|1579552|P2|NOT COMPLETED|Overall Study||203
642787|NCT00070564|1579553|P1|NOT COMPLETED|Overall Study||200
642788|NCT00070564|1579548|P6|COMPLETED|Overall Study||244
642789|NCT00070564|1579549|P5|COMPLETED|Overall Study||203
642790|NCT00070564|1579550|P4|COMPLETED|Overall Study||481
642791|NCT00070564|1579551|P3|COMPLETED|Overall Study||526
642792|NCT00070564|1579552|P2|COMPLETED|Overall Study||490
642793|NCT00070564|1579553|P1|COMPLETED|Overall Study||478
642794|NCT00070564|1579548|P6|STARTED|Overall Study||296
642795|NCT00070564|1579549|P5|STARTED|Overall Study||282
642796|NCT00070564|1579550|P4|STARTED|Overall Study||648
642797|NCT00070564|1579551|P3|STARTED|Overall Study||697
642798|NCT00070564|1579552|P2|STARTED|Overall Study||693
642799|NCT00070564|1579553|P1|STARTED|Overall Study||678
642800|NCT00070499|1579607|P4|NOT COMPLETED|Overall Study||110
642801|NCT00070499|1579608|P3|NOT COMPLETED|Overall Study||120
642802|NCT00070499|1579609|P2|NOT COMPLETED|Overall Study||26
642803|NCT00070499|1579610|P1|NOT COMPLETED|Overall Study||38
642804|NCT00070499|1579607|P4|COMPLETED|Overall Study||17
642805|NCT00070499|1579608|P3|COMPLETED|Overall Study||6
642806|NCT00070499|1579609|P2|COMPLETED|Overall Study||52
642807|NCT00070499|1579610|P1|COMPLETED|Overall Study||37
642808|NCT00070499|1579607|P4|Eligible and Treated|Overall Study||123
642809|NCT00070499|1579608|P3|Eligible and Treated|Overall Study||123
642810|NCT00070499|1579609|P2|Eligible and Treated|Overall Study||73
642811|NCT00070499|1579610|P1|Eligible and Treated|Overall Study||72
642812|NCT00070499|1579607|P4|Eligible|Overall Study||125
642813|NCT00070499|1579608|P3|Eligible|Overall Study||123
642814|NCT00070499|1579609|P2|Eligible|Overall Study||73
642815|NCT00070499|1579610|P1|Eligible|Overall Study||73
642816|NCT00070499|1579607|P4|STARTED|Overall Study||127
642818|NCT00070499|1579609|P2|STARTED|Overall Study||78
642819|NCT00070499|1579610|P1|STARTED|Overall Study||75
642820|NCT00070317|1579636|P1|NOT COMPLETED|Overall Study||13
642821|NCT00070317|1579636|P1|COMPLETED|Overall Study||89
642822|NCT00070317|1579636|P1|STARTED|Overall Study||102
642823|NCT00070291|1579641|P1|NOT COMPLETED|Step 2||1
642824|NCT00070291|1579641|P1|COMPLETED|Step 2||0
642825|NCT00070291|1579641|P1|STARTED|Step 2|One patient completed step 1, but opted to get alternative therapy. One patient entered step 2.|1
642826|NCT00070291|1579641|P1|NOT COMPLETED|Step 1||2
642827|NCT00070291|1579641|P1|COMPLETED|Step 1||2
642828|NCT00070291|1579641|P1|Treated|Step 1||3
642829|NCT00070291|1579641|P1|STARTED|Step 1||4
642830|NCT00070135|1579646|P1|NOT COMPLETED|Overall Study||0
642831|NCT00070135|1579646|P1|COMPLETED|Overall Study||114
642832|NCT00070135|1579646|P1|STARTED|Overall Study||114
642833|NCT00070109|1579657|P5|NOT COMPLETED|Overall Study||8
642834|NCT00070109|1579658|P4|NOT COMPLETED|Overall Study||20
642835|NCT00070109|1579659|P3|NOT COMPLETED|Overall Study||8
642836|NCT00070109|1579660|P2|NOT COMPLETED|Overall Study||6
642837|NCT00070109|1579661|P1|NOT COMPLETED|Overall Study||8
642838|NCT00070109|1579657|P5|COMPLETED|Overall Study||0
642839|NCT00070109|1579658|P4|COMPLETED|Overall Study||0
642840|NCT00070109|1579659|P3|COMPLETED|Overall Study||0
642841|NCT00070109|1579660|P2|COMPLETED|Overall Study||0
642842|NCT00070109|1579661|P1|COMPLETED|Overall Study||0
642843|NCT00070109|1579657|P5|STARTED|Overall Study||8
642844|NCT00070109|1579658|P4|STARTED|Overall Study||20
642845|NCT00070109|1579659|P3|STARTED|Overall Study||8
642846|NCT00070109|1579660|P2|STARTED|Overall Study||6
642847|NCT00070109|1579661|P1|STARTED|Overall Study||8
642848|NCT00070018|1579674|P1|NOT COMPLETED|Overall Study||4
642849|NCT00070018|1579674|P1|COMPLETED|Overall Study||42
642850|NCT00070018|1579674|P1|Eligible and Began Protocol Therapy|Overall Study||46
642851|NCT00070018|1579674|P1|Eligible|Overall Study||46
642852|NCT00070018|1579674|P1|STARTED|Overall Study||46
642853|NCT00069953|1579678|P1|NOT COMPLETED|Overall Study||2
642854|NCT00069953|1579678|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study|41
642855|NCT00069953|1579678|P1|STARTED|Overall Study||43
642856|NCT00069784|1579684|P2|NOT COMPLETED|Overall Study||0
642857|NCT00069784|1579685|P1|NOT COMPLETED|Overall Study||1212
642858|NCT00069784|1579684|P2|COMPLETED|Overall Study|not applicable (no treatment)|6273
642859|NCT00069784|1579685|P1|COMPLETED|Overall Study|completed study treatment|5052
642860|NCT00069784|1579684|P2|Safety Population (Treated)|Overall Study|patients randomized to standard care arm|6273
642861|NCT00069784|1579685|P1|Safety Population (Treated)|Overall Study|randomized patients who received at least one dose of insulin glargine|6231
642862|NCT00069784|1579684|P2|STARTED|Overall Study|randomized participants = intent-to-treat (ITT) population|6273
642863|NCT00069784|1579685|P1|STARTED|Overall Study|randomized participants = intent-to-treat (ITT) population|6264
642864|NCT00069823|1579705|P2|NOT COMPLETED|Overall Study||3
642865|NCT00069823|1579706|P1|NOT COMPLETED|Overall Study||6
642866|NCT00069823|1579705|P2|COMPLETED|Overall Study||200
642867|NCT00069823|1579706|P1|COMPLETED|Overall Study||193
642868|NCT00069823|1579705|P2|STARTED|Overall Study|The design was for 200 participants per group, the study did not exactly meet the design.|203
642869|NCT00069823|1579706|P1|STARTED|Overall Study|The design was for 200 participants per group, the study did not exactly meet the design.|199
642870|NCT00069641|1579749|P3|NOT COMPLETED|Overall Study||1
642871|NCT00069641|1579750|P2|NOT COMPLETED|Overall Study||0
642872|NCT00069641|1579751|P1|NOT COMPLETED|Overall Study||1
642873|NCT00069641|1579749|P3|COMPLETED|Overall Study||31
642874|NCT00069641|1579750|P2|COMPLETED|Overall Study||32
642875|NCT00069641|1579751|P1|COMPLETED|Overall Study||31
642876|NCT00069641|1579749|P3|STARTED|Overall Study||32
642877|NCT00069641|1579750|P2|STARTED|Overall Study||32
642878|NCT00069641|1579751|P1|STARTED|Overall Study||32
642879|NCT00069277|1579776|P1|NOT COMPLETED|Overall Study||21
642880|NCT00069277|1579776|P1|COMPLETED|Overall Study||0
642881|NCT00069277|1579776|P1|STARTED|Overall Study||21
642882|NCT00069264|1579780|P1|NOT COMPLETED|Overall Study||32
642883|NCT00069264|1579780|P1|COMPLETED|Overall Study||0
642884|NCT00069264|1579780|P1|STARTED|Overall Study||32
642885|NCT00069329|1579784|P1|NOT COMPLETED|Overall Study||2
642886|NCT00069329|1579784|P1|COMPLETED|Overall Study||41
642887|NCT00069329|1579784|P1|STARTED|Overall Study||43
642888|NCT00069238|1579808|P3|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||2
642889|NCT00069238|1579809|P2|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
642890|NCT00069238|1579810|P1|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
642891|NCT00069238|1579808|P3|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||1
642892|NCT00069238|1579809|P2|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
642893|NCT00069238|1579810|P1|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
642894|NCT00069238|1579808|P3|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||3
642895|NCT00069238|1579809|P2|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
642896|NCT00069238|1579810|P1|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
642897|NCT00069238|1579808|P3|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
642898|NCT00069238|1579809|P2|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||2
642899|NCT00069238|1579810|P1|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
642900|NCT00069238|1579808|P3|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
642901|NCT00069238|1579809|P2|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||1
642902|NCT00069238|1579810|P1|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
642903|NCT00069238|1579808|P3|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
642904|NCT00069238|1579809|P2|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||3
642905|NCT00069238|1579810|P1|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
642906|NCT00069238|1579808|P3|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
642907|NCT00069238|1579809|P2|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
642908|NCT00069238|1579810|P1|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||9
642909|NCT00069238|1579808|P3|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
642910|NCT00069238|1579809|P2|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
642911|NCT00069238|1579810|P1|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||16
642912|NCT00069238|1579808|P3|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
642913|NCT00069238|1579809|P2|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
642914|NCT00069238|1579810|P1|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||25
642915|NCT00069121|1579818|P2|NOT COMPLETED|Overall Study||276
642916|NCT00069121|1579819|P1|NOT COMPLETED|Overall Study||302
642917|NCT00069121|1579818|P2|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|668
642918|NCT00069121|1579819|P1|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|640
642919|NCT00069121|1579818|P2|Received Treatment|Overall Study|Safety Population|938
642920|NCT00069121|1579819|P1|Received Treatment|Overall Study|Safety Population|926
642921|NCT00069121|1579818|P2|STARTED|Overall Study||944
642922|NCT00069121|1579819|P1|STARTED|Overall Study||942
642923|NCT00069108|1579841|P2|NOT COMPLETED|Overall Study||219
642924|NCT00069108|1579842|P1|NOT COMPLETED|Overall Study||213
642925|NCT00069108|1579841|P2|COMPLETED|Overall Study||95
642926|NCT00069108|1579842|P1|COMPLETED|Overall Study||100
642927|NCT00069108|1579841|P2|STARTED|Overall Study||314
642928|NCT00069108|1579842|P1|STARTED|Overall Study||313
642929|NCT00069095|1579874|P6|NOT COMPLETED|Follow-up Phase||101
642930|NCT00069095|1579875|P5|NOT COMPLETED|Follow-up Phase||92
642931|NCT00069095|1579876|P4|NOT COMPLETED|Follow-up Phase||112
642932|NCT00069095|1579877|P3|NOT COMPLETED|Follow-up Phase||120
642933|NCT00069095|1579878|P2|NOT COMPLETED|Follow-up Phase||206
642934|NCT00069095|1579879|P1|NOT COMPLETED|Follow-up Phase||174
642935|NCT00069095|1579874|P6|COMPLETED|Follow-up Phase||171
642936|NCT00069095|1579875|P5|COMPLETED|Follow-up Phase||186
642937|NCT00069095|1579876|P4|COMPLETED|Follow-up Phase||187
642938|NCT00069095|1579877|P3|COMPLETED|Follow-up Phase||178
642939|NCT00069095|1579878|P2|COMPLETED|Follow-up Phase||93
642940|NCT00069095|1579879|P1|COMPLETED|Follow-up Phase||110
642941|NCT00069095|1579874|P6|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|272
642942|NCT00069095|1579875|P5|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|278
642943|NCT00069095|1579876|P4|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|299
642944|NCT00069095|1579877|P3|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|298
642945|NCT00069095|1579878|P2|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|299
642946|NCT00069095|1579879|P1|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|284
642947|NCT00069095|1579874|P6|NOT COMPLETED|Post-study Treatment Phase||29
642948|NCT00069095|1579875|P5|NOT COMPLETED|Post-study Treatment Phase||36
642949|NCT00069095|1579876|P4|NOT COMPLETED|Post-study Treatment Phase||17
642950|NCT00069095|1579877|P3|NOT COMPLETED|Post-study Treatment Phase||21
642951|NCT00069095|1579878|P2|NOT COMPLETED|Post-study Treatment Phase||13
642952|NCT00069095|1579879|P1|NOT COMPLETED|Post-study Treatment Phase||8
642953|NCT00069095|1579874|P6|COMPLETED|Post-study Treatment Phase||0
642954|NCT00069095|1579875|P5|COMPLETED|Post-study Treatment Phase||0
642955|NCT00069095|1579876|P4|COMPLETED|Post-study Treatment Phase||0
642956|NCT00069095|1579877|P3|COMPLETED|Post-study Treatment Phase||0
642957|NCT00069095|1579878|P2|COMPLETED|Post-study Treatment Phase||0
642958|NCT00069095|1579879|P1|COMPLETED|Post-study Treatment Phase||0
642959|NCT00069095|1579874|P6|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|29
642960|NCT00069095|1579875|P5|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|36
642961|NCT00069095|1579876|P4|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|17
642962|NCT00069095|1579877|P3|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|21
642963|NCT00069095|1579878|P2|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|13
642964|NCT00069095|1579879|P1|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|8
642965|NCT00069095|1579874|P6|NOT COMPLETED|Primary Treatment Phase||301
642966|NCT00069095|1579875|P5|NOT COMPLETED|Primary Treatment Phase||302
642967|NCT00069095|1579876|P4|NOT COMPLETED|Primary Treatment Phase||320
642968|NCT00069095|1579877|P3|NOT COMPLETED|Primary Treatment Phase||314
642969|NCT00069095|1579878|P2|NOT COMPLETED|Primary Treatment Phase||302
642970|NCT00069095|1579879|P1|NOT COMPLETED|Primary Treatment Phase||295
642971|NCT00069095|1579874|P6|COMPLETED|Primary Treatment Phase||48
642972|NCT00069095|1579875|P5|COMPLETED|Primary Treatment Phase||48
642973|NCT00069095|1579876|P4|COMPLETED|Primary Treatment Phase||31
642974|NCT00069095|1579877|P3|COMPLETED|Primary Treatment Phase||36
642975|NCT00069095|1579878|P2|COMPLETED|Primary Treatment Phase||15
642976|NCT00069095|1579879|P1|COMPLETED|Primary Treatment Phase||22
642977|NCT00069095|1579874|P6|STARTED|Primary Treatment Phase||349
642978|NCT00069095|1579875|P5|STARTED|Primary Treatment Phase||350
642979|NCT00069095|1579876|P4|STARTED|Primary Treatment Phase||351
642980|NCT00069095|1579877|P3|STARTED|Primary Treatment Phase||350
642981|NCT00069095|1579878|P2|STARTED|Primary Treatment Phase||317
642982|NCT00069095|1579879|P1|STARTED|Primary Treatment Phase||317
642983|NCT00069160|1579933|P2|NOT COMPLETED|Overall Study||0
642984|NCT00069160|1579934|P1|NOT COMPLETED|Overall Study||0
642985|NCT00069160|1579933|P2|COMPLETED|Overall Study||25
642986|NCT00069160|1579934|P1|COMPLETED|Overall Study||23
642987|NCT00069160|1579933|P2|STARTED|Overall Study||25
642988|NCT00069160|1579934|P1|STARTED|Overall Study||23
642989|NCT00068822|1579949|P2|NOT COMPLETED|Optional Crossover Intervention||0
642990|NCT00068822|1579950|P1|NOT COMPLETED|Optional Crossover Intervention||0
642991|NCT00068822|1579949|P2|COMPLETED|Optional Crossover Intervention||29
642992|NCT00068822|1579950|P1|COMPLETED|Optional Crossover Intervention||9
642993|NCT00068822|1579949|P2|Crossover at Month 3|Optional Crossover Intervention||27
642994|NCT00068822|1579950|P1|Crossover at Month 3|Optional Crossover Intervention||8
642995|NCT00068822|1579949|P2|Crossover at Month 1|Optional Crossover Intervention||2
642996|NCT00068822|1579950|P1|Crossover at Month 1|Optional Crossover Intervention||1
642997|NCT00068822|1579949|P2|STARTED|Optional Crossover Intervention||29
642998|NCT00068822|1579950|P1|STARTED|Optional Crossover Intervention||9
642999|NCT00068822|1579949|P2|NOT COMPLETED|First Randomized Intervention||2
643000|NCT00068822|1579950|P1|NOT COMPLETED|First Randomized Intervention||1
643001|NCT00068822|1579949|P2|COMPLETED|First Randomized Intervention||61
643002|NCT00068822|1579950|P1|COMPLETED|First Randomized Intervention||67
643003|NCT00068822|1579949|P2|STARTED|First Randomized Intervention||63
643004|NCT00068822|1579950|P1|STARTED|First Randomized Intervention||68
643005|NCT00068770|1579962|P2|NOT COMPLETED|Overall Study||0
643006|NCT00068770|1579963|P1|NOT COMPLETED|Overall Study||0
643007|NCT00068770|1579962|P2|COMPLETED|Overall Study||22
643008|NCT00068770|1579963|P1|COMPLETED|Overall Study||13
643009|NCT00068770|1579962|P2|STARTED|Overall Study||22
643010|NCT00068770|1579963|P1|STARTED|Overall Study||13
643011|NCT00068718|1579971|P1|NOT COMPLETED|Overall Study||0
643012|NCT00068718|1579971|P1|COMPLETED|Overall Study||35
643013|NCT00068718|1579971|P1|STARTED|Overall Study||35
643014|NCT00068601|1579983|P2|NOT COMPLETED|Overall Study||60
643015|NCT00068601|1579984|P1|NOT COMPLETED|Overall Study||62
643016|NCT00068601|1579983|P2|COMPLETED|Overall Study||66
643017|NCT00068601|1579984|P1|COMPLETED|Overall Study||69
643018|NCT00068601|1579983|P2|STARTED|Overall Study||126
643019|NCT00068601|1579984|P1|STARTED|Overall Study||131
643020|NCT00068588|1579997|P3|NOT COMPLETED|Overall Study||4
643021|NCT00068588|1579998|P2|NOT COMPLETED|Overall Study||0
643022|NCT00068588|1579999|P1|NOT COMPLETED|Overall Study||0
643023|NCT00068588|1579997|P3|COMPLETED|Overall Study||17
643024|NCT00068588|1579998|P2|COMPLETED|Overall Study||3
643025|NCT00068588|1579999|P1|COMPLETED|Overall Study||0
643026|NCT00068588|1579997|P3|STARTED|Overall Study||21
643027|NCT00068588|1579998|P2|STARTED|Overall Study||3
643028|NCT00068588|1579999|P1|STARTED|Overall Study||0
643029|NCT00068575|1580009|P1|NOT COMPLETED|Overall Study||0
643030|NCT00068575|1580009|P1|COMPLETED|Overall Study||28
643031|NCT00068575|1580009|P1|STARTED|Overall Study||28
643032|NCT00068445|1580015|P2|NOT COMPLETED|Treatment||16
643033|NCT00068445|1580016|P1|NOT COMPLETED|Treatment||29
643034|NCT00068445|1580015|P2|COMPLETED|Treatment||46
643035|NCT00068445|1580016|P1|COMPLETED|Treatment||34
643036|NCT00068445|1580015|P2|STARTED|Treatment||62
643037|NCT00068445|1580016|P1|STARTED|Treatment||63
643038|NCT00068445|1580015|P2|NOT COMPLETED|Randomization||4
643039|NCT00068445|1580016|P1|NOT COMPLETED|Randomization||2
643040|NCT00068445|1580015|P2|COMPLETED|Randomization||62
643041|NCT00068445|1580016|P1|COMPLETED|Randomization||63
643042|NCT00068445|1580015|P2|STARTED|Randomization||66
643043|NCT00068445|1580016|P1|STARTED|Randomization||65
643044|NCT00068419|1580040|P1|NOT COMPLETED|Overall Study||60
643045|NCT00068419|1580040|P1|COMPLETED|Overall Study|Participant flow data reported here are for the period of protocol therapy.|10
643046|NCT00068419|1580040|P1|STARTED|Overall Study||70
643047|NCT00068406|1580044|P1|NOT COMPLETED|Overall Study||3
643048|NCT00068406|1580044|P1|COMPLETED|Overall Study||58
643049|NCT00068406|1580044|P1|STARTED|Overall Study||61
643050|NCT00068393|1580049|P1|NOT COMPLETED|Overall Study||10
643051|NCT00068393|1580049|P1|COMPLETED|Overall Study||29
643052|NCT00068393|1580049|P1|Eligible and Treated|Overall Study||38
643053|NCT00068393|1580049|P1|STARTED|Overall Study||39
643054|NCT00068380|1580055|P1|NOT COMPLETED|Overall Study||5
643055|NCT00068380|1580055|P1|COMPLETED|Overall Study||12
643056|NCT00068380|1580055|P1|STARTED|Overall Study||17
643057|NCT00068367|1580064|P1|NOT COMPLETED|Overall Study||0
643058|NCT00068367|1580064|P1|COMPLETED|Overall Study||20
643059|NCT00068367|1580064|P1|STARTED|Overall Study||20
643060|NCT00068341|1580073|P3|NOT COMPLETED|Overall Study||0
643061|NCT00068341|1580074|P2|NOT COMPLETED|Overall Study||0
643062|NCT00068341|1580075|P1|NOT COMPLETED|Overall Study||0
643063|NCT00068341|1580073|P3|COMPLETED|Overall Study||44
643064|NCT00068341|1580074|P2|COMPLETED|Overall Study||15
643065|NCT00068341|1580075|P1|COMPLETED|Overall Study||15
643066|NCT00068341|1580073|P3|STARTED|Overall Study||44
643067|NCT00068341|1580074|P2|STARTED|Overall Study||15
643068|NCT00068341|1580075|P1|STARTED|Overall Study||15
643069|NCT00068250|1580099|P4|NOT COMPLETED|Phase II: Dose Level 2||0
643070|NCT00068250|1580100|P3|NOT COMPLETED|Phase II: Dose Level 2||0
643071|NCT00068250|1580101|P2|NOT COMPLETED|Phase II: Dose Level 2||0
643072|NCT00068250|1580102|P1|NOT COMPLETED|Phase II: Dose Level 2||0
643073|NCT00068250|1580099|P4|COMPLETED|Phase II: Dose Level 2|Subjects with data available for the primary analysis are considered to have completed the study.|47
643074|NCT00068250|1580100|P3|COMPLETED|Phase II: Dose Level 2||0
643075|NCT00068250|1580101|P2|COMPLETED|Phase II: Dose Level 2||0
643076|NCT00068250|1580102|P1|COMPLETED|Phase II: Dose Level 2||0
643077|NCT00068250|1580099|P4|STARTED|Phase II: Dose Level 2||47
643078|NCT00068250|1580100|P3|STARTED|Phase II: Dose Level 2||0
643079|NCT00068250|1580101|P2|STARTED|Phase II: Dose Level 2||0
643080|NCT00068250|1580102|P1|STARTED|Phase II: Dose Level 2||0
643081|NCT00068250|1580099|P4|NOT COMPLETED|Phase I: Dose Level 2||0
643082|NCT00068250|1580100|P3|NOT COMPLETED|Phase I: Dose Level 2||0
643083|NCT00068250|1580101|P2|NOT COMPLETED|Phase I: Dose Level 2||1
643084|NCT00068250|1580102|P1|NOT COMPLETED|Phase I: Dose Level 2||0
643085|NCT00068250|1580099|P4|COMPLETED|Phase I: Dose Level 2||0
643086|NCT00068250|1580100|P3|COMPLETED|Phase I: Dose Level 2||0
643087|NCT00068250|1580101|P2|COMPLETED|Phase I: Dose Level 2|Subjects with data available for the primary analysis are considered to have completed the study.|6
643088|NCT00068250|1580102|P1|COMPLETED|Phase I: Dose Level 2||0
643089|NCT00068250|1580099|P4|STARTED|Phase I: Dose Level 2||0
643090|NCT00068250|1580100|P3|STARTED|Phase I: Dose Level 2||0
643091|NCT00068250|1580101|P2|STARTED|Phase I: Dose Level 2||7
643092|NCT00068250|1580102|P1|STARTED|Phase I: Dose Level 2||0
643093|NCT00068250|1580099|P4|NOT COMPLETED|Phase I: Dose Level 1||0
643094|NCT00068250|1580100|P3|NOT COMPLETED|Phase I: Dose Level 1||0
643095|NCT00068250|1580101|P2|NOT COMPLETED|Phase I: Dose Level 1||0
643096|NCT00068250|1580102|P1|NOT COMPLETED|Phase I: Dose Level 1||0
643097|NCT00068250|1580099|P4|COMPLETED|Phase I: Dose Level 1||0
643098|NCT00068250|1580100|P3|COMPLETED|Phase I: Dose Level 1||0
643099|NCT00068250|1580101|P2|COMPLETED|Phase I: Dose Level 1||0
643100|NCT00068250|1580102|P1|COMPLETED|Phase I: Dose Level 1|Subjects with data available for the primary analysis are considered to have completed the study.|6
643101|NCT00068250|1580099|P4|STARTED|Phase I: Dose Level 1||0
643102|NCT00068250|1580100|P3|STARTED|Phase I: Dose Level 1||0
643103|NCT00068250|1580101|P2|STARTED|Phase I: Dose Level 1||0
643104|NCT00068250|1580102|P1|STARTED|Phase I: Dose Level 1||6
643105|NCT00068237|1580112|P1|NOT COMPLETED|Overall Study||5
643106|NCT00068237|1580112|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
643107|NCT00068237|1580112|P1|STARTED|Overall Study||49
643108|NCT00068107|1580116|P1|NOT COMPLETED|Overall Study||9
643109|NCT00068107|1580116|P1|COMPLETED|Overall Study||3
643110|NCT00068107|1580116|P1|STARTED|Overall Study||12
643111|NCT00067990|1580129|P2|NOT COMPLETED|Overall Study||22
643112|NCT00067990|1580130|P1|NOT COMPLETED|Overall Study||10
643113|NCT00067990|1580129|P2|COMPLETED|Overall Study||54
643114|NCT00067990|1580130|P1|COMPLETED|Overall Study||67
643115|NCT00067990|1580129|P2|STARTED|Overall Study||76
643116|NCT00067990|1580130|P1|STARTED|Overall Study||77
643117|NCT00067808|1580141|P3|NOT COMPLETED|Overall Study||0
643118|NCT00067808|1580142|P2|NOT COMPLETED|Overall Study||0
643119|NCT00067808|1580143|P1|NOT COMPLETED|Overall Study||0
643120|NCT00067808|1580141|P3|COMPLETED|Overall Study||14
643121|NCT00067808|1580142|P2|COMPLETED|Overall Study||93
643122|NCT00067808|1580143|P1|COMPLETED|Overall Study||17
643123|NCT00067808|1580141|P3|STARTED|Overall Study||14
643124|NCT00067808|1580142|P2|STARTED|Overall Study||93
643125|NCT00067808|1580143|P1|STARTED|Overall Study||17
643126|NCT00067470|1580153|P2|NOT COMPLETED|Overall Study||1
643127|NCT00067470|1580154|P1|NOT COMPLETED|Overall Study||0
643128|NCT00067470|1580153|P2|COMPLETED|Overall Study||19
643129|NCT00067470|1580154|P1|COMPLETED|Overall Study||19
643130|NCT00067470|1580153|P2|STARTED|Overall Study||20
643131|NCT00067470|1580154|P1|STARTED|Overall Study||19
643132|NCT00067236|1580166|P2|NOT COMPLETED|Overall Study||26
643133|NCT00067236|1580167|P1|NOT COMPLETED|Overall Study||20
643134|NCT00067236|1580166|P2|COMPLETED|Overall Study||99
643135|NCT00067236|1580167|P1|COMPLETED|Overall Study||108
643136|NCT00067236|1580166|P2|STARTED|Overall Study||125
643137|NCT00067236|1580167|P1|STARTED|Overall Study||128
643138|NCT00066963|1580176|P3|NOT COMPLETED|Overall Study||39
643139|NCT00066963|1580177|P2|NOT COMPLETED|Overall Study||31
643140|NCT00066963|1580178|P1|NOT COMPLETED|Overall Study||26
643141|NCT00066963|1580176|P3|COMPLETED|Overall Study||87
643142|NCT00066963|1580177|P2|COMPLETED|Overall Study||93
643143|NCT00066963|1580178|P1|COMPLETED|Overall Study|any follow-up|100
643144|NCT00066963|1580176|P3|STARTED|Overall Study||126
643145|NCT00066963|1580177|P2|STARTED|Overall Study||124
643146|NCT00066963|1580178|P1|STARTED|Overall Study||126
643147|NCT00066937|1580190|P4|NOT COMPLETED|6 Month Follow-up||1
643148|NCT00066937|1580191|P3|NOT COMPLETED|6 Month Follow-up||3
643149|NCT00066937|1580192|P2|NOT COMPLETED|6 Month Follow-up||3
643150|NCT00066937|1580193|P1|NOT COMPLETED|6 Month Follow-up||7
643151|NCT00066937|1580190|P4|COMPLETED|6 Month Follow-up||14
643152|NCT00066937|1580191|P3|COMPLETED|6 Month Follow-up||22
643153|NCT00066937|1580192|P2|COMPLETED|6 Month Follow-up||29
643154|NCT00066937|1580193|P1|COMPLETED|6 Month Follow-up||26
643155|NCT00066937|1580190|P4|STARTED|6 Month Follow-up||15
643156|NCT00066937|1580191|P3|STARTED|6 Month Follow-up||25
643157|NCT00066937|1580192|P2|STARTED|6 Month Follow-up||32
643158|NCT00066937|1580193|P1|STARTED|6 Month Follow-up||33
643159|NCT00066937|1580190|P4|NOT COMPLETED|3 Month Follow-up||4
643160|NCT00066937|1580191|P3|NOT COMPLETED|3 Month Follow-up||1
643161|NCT00066937|1580192|P2|NOT COMPLETED|3 Month Follow-up||1
643162|NCT00066937|1580193|P1|NOT COMPLETED|3 Month Follow-up||5
643163|NCT00066937|1580190|P4|COMPLETED|3 Month Follow-up||15
643164|NCT00066937|1580191|P3|COMPLETED|3 Month Follow-up||25
643165|NCT00066937|1580192|P2|COMPLETED|3 Month Follow-up||32
643166|NCT00066937|1580193|P1|COMPLETED|3 Month Follow-up||33
643167|NCT00066937|1580190|P4|STARTED|3 Month Follow-up||19
643168|NCT00066937|1580191|P3|STARTED|3 Month Follow-up||26
643169|NCT00066937|1580192|P2|STARTED|3 Month Follow-up||33
643170|NCT00066937|1580193|P1|STARTED|3 Month Follow-up||38
643171|NCT00066937|1580190|P4|NOT COMPLETED|Treatment Phase||5
643172|NCT00066937|1580191|P3|NOT COMPLETED|Treatment Phase||11
643173|NCT00066937|1580192|P2|NOT COMPLETED|Treatment Phase||5
643174|NCT00066937|1580193|P1|NOT COMPLETED|Treatment Phase||3
643175|NCT00066937|1580190|P4|COMPLETED|Treatment Phase||19
643176|NCT00066937|1580191|P3|COMPLETED|Treatment Phase||26
643177|NCT00066937|1580192|P2|COMPLETED|Treatment Phase||33
643178|NCT00066937|1580193|P1|COMPLETED|Treatment Phase||38
643179|NCT00066937|1580190|P4|STARTED|Treatment Phase||24
643180|NCT00066937|1580191|P3|STARTED|Treatment Phase||37
643181|NCT00066937|1580192|P2|STARTED|Treatment Phase||38
643182|NCT00066937|1580193|P1|STARTED|Treatment Phase||41
643183|NCT00066807|1580217|P2|NOT COMPLETED|Overall Study||15
643184|NCT00066807|1580218|P1|NOT COMPLETED|Overall Study||14
643185|NCT00066807|1580217|P2|COMPLETED|Overall Study||0
643186|NCT00066807|1580218|P1|COMPLETED|Overall Study||0
643187|NCT00066807|1580217|P2|STARTED|Overall Study||15
643188|NCT00066807|1580218|P1|STARTED|Overall Study||14
643189|NCT00066781|1580232|P2|NOT COMPLETED|Overall Study||0
643190|NCT00066781|1580233|P1|NOT COMPLETED|Overall Study||0
643191|NCT00066781|1580232|P2|COMPLETED|Overall Study||17
643192|NCT00066781|1580233|P1|COMPLETED|Overall Study||14
643193|NCT00066781|1580232|P2|STARTED|Overall Study||17
643194|NCT00066781|1580233|P1|STARTED|Overall Study||14
643195|NCT00066742|1580243|P1|NOT COMPLETED|Consolidation Chemotherapy||3
643196|NCT00066742|1580243|P1|COMPLETED|Consolidation Chemotherapy||39
643197|NCT00066742|1580243|P1|Eligible|Consolidation Chemotherapy||40
643198|NCT00066742|1580243|P1|STARTED|Consolidation Chemotherapy||42
643199|NCT00066742|1580243|P1|NOT COMPLETED|Induction Chemoradiotherapy||29
643200|NCT00066742|1580243|P1|COMPLETED|Induction Chemoradiotherapy||43
643201|NCT00066742|1580243|P1|Began Protocol Treatment|Induction Chemoradiotherapy||68
643202|NCT00066742|1580243|P1|Eligible|Induction Chemoradiotherapy||69
643203|NCT00066742|1580243|P1|STARTED|Induction Chemoradiotherapy||72
643204|NCT00066703|1580252|P2|NOT COMPLETED|Overall Study||582
643205|NCT00066703|1580253|P1|NOT COMPLETED|Overall Study||612
643206|NCT00066703|1580252|P2|COMPLETED|Overall Study||756
643207|NCT00066703|1580253|P1|COMPLETED|Overall Study||722
643208|NCT00066703|1580252|P2|STARTED|Overall Study||1338
643209|NCT00066703|1580253|P1|STARTED|Overall Study||1334
643210|NCT00066690|1580266|P3|NOT COMPLETED|Overall Study||564
643211|NCT00066690|1580267|P2|NOT COMPLETED|Overall Study||522
643212|NCT00066690|1580268|P1|NOT COMPLETED|Overall Study||598
643213|NCT00066690|1580266|P3|COMPLETED|Overall Study||457
643214|NCT00066690|1580267|P2|COMPLETED|Overall Study||502
643215|NCT00066690|1580268|P1|COMPLETED|Overall Study||423
643216|NCT00066690|1580266|P3|STARTED|Overall Study||1021
643217|NCT00066690|1580267|P2|STARTED|Overall Study||1024
643218|NCT00066690|1580268|P1|STARTED|Overall Study||1021
643219|NCT00066573|1580284|P2|NOT COMPLETED|Overall Study||28
643220|NCT00066573|1580285|P1|NOT COMPLETED|Overall Study||28
643221|NCT00066573|1580284|P2|COMPLETED|Overall Study||3759
643222|NCT00066573|1580285|P1|COMPLETED|Overall Study||3761
643223|NCT00066573|1580284|P2|STARTED|Overall Study||3787
643224|NCT00066573|1580285|P1|STARTED|Overall Study||3789
643225|NCT00066469|1580297|P1|NOT COMPLETED|Overall Study||16
643226|NCT00066469|1580297|P1|COMPLETED|Overall Study||39
643227|NCT00066469|1580297|P1|STARTED|Overall Study||55
643228|NCT00066365|1580303|P2|NOT COMPLETED|Overall Study||14
643229|NCT00066365|1580304|P1|NOT COMPLETED|Overall Study||23
643230|NCT00066365|1580303|P2|COMPLETED|Overall Study||4
643231|NCT00066365|1580304|P1|COMPLETED|Overall Study||8
643232|NCT00066365|1580303|P2|STARTED|Overall Study||18
643233|NCT00066365|1580304|P1|STARTED|Overall Study||31
643234|NCT00066222|1580332|P1|NOT COMPLETED|Overall Study||1
643235|NCT00066222|1580332|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|71
643236|NCT00066222|1580332|P1|STARTED|Overall Study||72
643237|NCT00066170|1580345|P4|NOT COMPLETED|Overall Study||9
643238|NCT00066170|1580346|P3|NOT COMPLETED|Overall Study||4
643239|NCT00066170|1580347|P2|NOT COMPLETED|Overall Study||10
643240|NCT00066170|1580348|P1|NOT COMPLETED|Overall Study||7
643241|NCT00066170|1580345|P4|COMPLETED|Overall Study||48
643242|NCT00066170|1580346|P3|COMPLETED|Overall Study||59
643243|NCT00066170|1580347|P2|COMPLETED|Overall Study||45
643244|NCT00066170|1580348|P1|COMPLETED|Overall Study||49
643245|NCT00066170|1580345|P4|Intent to Treat|Overall Study||54
643246|NCT00066170|1580346|P3|Intent to Treat|Overall Study||63
643247|NCT00066170|1580347|P2|Intent to Treat|Overall Study||50
643248|NCT00066170|1580348|P1|Intent to Treat|Overall Study||55
643249|NCT00066170|1580345|P4|STARTED|Overall Study||57
643250|NCT00066170|1580346|P3|STARTED|Overall Study||63
643251|NCT00066170|1580347|P2|STARTED|Overall Study||55
643252|NCT00066170|1580348|P1|STARTED|Overall Study||56
643253|NCT00066066|1580361|P6|NOT COMPLETED|Overall Study||5
643254|NCT00066066|1580362|P5|NOT COMPLETED|Overall Study||3
643255|NCT00066066|1580363|P4|NOT COMPLETED|Overall Study||4
643256|NCT00066066|1580364|P3|NOT COMPLETED|Overall Study||7
643257|NCT00066066|1580365|P2|NOT COMPLETED|Overall Study||4
643258|NCT00066066|1580366|P1|NOT COMPLETED|Overall Study||6
643259|NCT00066066|1580361|P6|COMPLETED|Overall Study|20 enrolled, 15 analyzed,9 subjects had complete data,6 subjects had data carried forward.|15
643260|NCT00066066|1580362|P5|COMPLETED|Overall Study|27 enrolled, 24 analyzed,19 subjects had complete data,5 subjects had data carried forward.|24
643261|NCT00066066|1580363|P4|COMPLETED|Overall Study|20 enrolled, 16 analyzed,11 subjects had complete data,5 subjects had data carried forward.|16
643262|NCT00066066|1580364|P3|COMPLETED|Overall Study|30 enrolled, 23 analyzed,21 subjects had complete data,2 subjects had data carried forward.|23
643263|NCT00066066|1580365|P2|COMPLETED|Overall Study|22 enrolled, 18 analyzed,11 subjects had complete data,7 subjects had data carried forward.|18
643264|NCT00066066|1580366|P1|COMPLETED|Overall Study|27 enrolled, 21 analyzed,18 subjects had complete data,3 subjects had data carried forward.|21
643265|NCT00066066|1580361|P6|12 Month|Overall Study||9
643266|NCT00066066|1580362|P5|12 Month|Overall Study||19
643267|NCT00066066|1580363|P4|12 Month|Overall Study||11
643268|NCT00066066|1580364|P3|12 Month|Overall Study||21
643269|NCT00066066|1580365|P2|12 Month|Overall Study||11
643270|NCT00066066|1580366|P1|12 Month|Overall Study||18
643271|NCT00066066|1580361|P6|6 Month|Overall Study||14
643272|NCT00066066|1580362|P5|6 Month|Overall Study||21
643273|NCT00066066|1580363|P4|6 Month|Overall Study||13
643274|NCT00066066|1580364|P3|6 Month|Overall Study||23
643275|NCT00066066|1580365|P2|6 Month|Overall Study||13
643276|NCT00066066|1580366|P1|6 Month|Overall Study||19
643277|NCT00066066|1580361|P6|3 Month|Overall Study||15
643278|NCT00066066|1580362|P5|3 Month|Overall Study||22
643279|NCT00066066|1580363|P4|3 Month|Overall Study||16
643280|NCT00066066|1580364|P3|3 Month|Overall Study||23
643281|NCT00066066|1580365|P2|3 Month|Overall Study||17
643282|NCT00066066|1580366|P1|3 Month|Overall Study||21
643283|NCT00066066|1580361|P6|Baseline|Overall Study||20
643284|NCT00066066|1580362|P5|Baseline|Overall Study||27
643285|NCT00066066|1580363|P4|Baseline|Overall Study||20
643286|NCT00066066|1580364|P3|Baseline|Overall Study||30
643287|NCT00066066|1580365|P2|Baseline|Overall Study||22
643288|NCT00066066|1580366|P1|Baseline|Overall Study||27
643289|NCT00066066|1580361|P6|STARTED|Overall Study||20
643290|NCT00066066|1580362|P5|STARTED|Overall Study||27
643291|NCT00066066|1580363|P4|STARTED|Overall Study||20
643292|NCT00066066|1580364|P3|STARTED|Overall Study||30
643293|NCT00066066|1580365|P2|STARTED|Overall Study||22
643294|NCT00066066|1580366|P1|STARTED|Overall Study||27
643295|NCT00065806|1580382|P2|NOT COMPLETED|Overall Study||19
643296|NCT00065806|1580383|P1|NOT COMPLETED|Overall Study||20
643297|NCT00065806|1580382|P2|COMPLETED|Overall Study||89
643298|NCT00065806|1580383|P1|COMPLETED|Overall Study||93
643299|NCT00065806|1580382|P2|STARTED|Overall Study||108
643300|NCT00065806|1580383|P1|STARTED|Overall Study||113
643301|NCT00014560|1580425|P1|NOT COMPLETED|Overall Study||3
643302|NCT00014560|1580425|P1|COMPLETED|Overall Study||0
643303|NCT00014560|1580425|P1|STARTED|Overall Study||3
643304|NCT00065611|1580431|P2|NOT COMPLETED|Overall Study||1
643305|NCT00065611|1580432|P1|NOT COMPLETED|Overall Study||0
643306|NCT00065611|1580431|P2|COMPLETED|Overall Study||3
643307|NCT00065611|1580432|P1|COMPLETED|Overall Study||4
643308|NCT00065611|1580431|P2|STARTED|Overall Study||4
643309|NCT00065611|1580432|P1|STARTED|Overall Study||4
643310|NCT00065507|1580444|P2|NOT COMPLETED|Overall Study||29
643311|NCT00065507|1580445|P1|NOT COMPLETED|Overall Study||29
643312|NCT00065507|1580444|P2|COMPLETED|Overall Study|Completed first 48 weeks of treatment|62
643313|NCT00065507|1580445|P1|COMPLETED|Overall Study|Completed first 48 weeks of treatment|71
643314|NCT00065507|1580444|P2|Treated, 24-Week Follow-Up Population|Overall Study||28
643315|NCT00065507|1580445|P1|Treated, 24-Week Follow-Up Population|Overall Study||25
643316|NCT00065507|1580444|P2|Treated, Wk 48 (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|89
643317|NCT00065507|1580445|P1|Treated, Wk 48 (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|102
643318|NCT00065507|1580444|P2|Treated (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|89
643319|NCT00065507|1580445|P1|Treated (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|102
643320|NCT00065507|1580444|P2|Treated (As-Randomized Population)|Overall Study|As-randomized population was used in efficacy analyses, unless otherwise noted.|91
643321|NCT00065507|1580445|P1|Treated (As-Randomized Population)|Overall Study|As-randomized population was used in efficacy analyses, unless otherwise noted.|100
643322|NCT00065507|1580444|P2|STARTED|Overall Study|94 participants were randomized; 3 never treated.|91
643323|NCT00065507|1580445|P1|STARTED|Overall Study|101 participants were randomized; 1 never treated.|100
643324|NCT00065468|1580510|P3|NOT COMPLETED|Overall Study||210
643325|NCT00065468|1580511|P2|NOT COMPLETED|Overall Study||209
643326|NCT00065468|1580512|P1|NOT COMPLETED|Overall Study||207
643327|NCT00065468|1580510|P3|COMPLETED|Overall Study||0
643328|NCT00065468|1580511|P2|COMPLETED|Overall Study||0
643329|NCT00065468|1580512|P1|COMPLETED|Overall Study||0
643330|NCT00065468|1580510|P3|Received Treatment|Overall Study||208
643331|NCT00065468|1580511|P2|Received Treatment|Overall Study||208
643332|NCT00065468|1580512|P1|Received Treatment|Overall Study||200
643333|NCT00065468|1580510|P3|STARTED|Overall Study||210
643334|NCT00065468|1580511|P2|STARTED|Overall Study||209
643335|NCT00065468|1580512|P1|STARTED|Overall Study||207
643336|NCT00065442|1580543|P2|NOT COMPLETED|Overall Study||220
643337|NCT00065442|1580544|P1|NOT COMPLETED|Overall Study||125
643338|NCT00065442|1580543|P2|COMPLETED|Overall Study||121
643339|NCT00065442|1580544|P1|COMPLETED|Overall Study||46
643340|NCT00065442|1580543|P2|STARTED|Overall Study||341
643341|NCT00065442|1580544|P1|STARTED|Overall Study||171
643342|NCT00065429|1580559|P7|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
643343|NCT00065429|1580560|P6|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
643344|NCT00065429|1580561|P5|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||6
643345|NCT00065429|1580562|P4|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
643346|NCT00065429|1580563|P3|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
643347|NCT00065429|1580564|P2|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
643348|NCT00065429|1580565|P1|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
643349|NCT00065429|1580559|P7|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
643350|NCT00065429|1580560|P6|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
643351|NCT00065429|1580561|P5|COMPLETED|Phase II - Apr 2003 - Aug 2008||26
643352|NCT00065429|1580562|P4|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
643353|NCT00065429|1580563|P3|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
643354|NCT00065429|1580564|P2|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
643355|NCT00065429|1580565|P1|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
643356|NCT00065429|1580559|P7|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
643357|NCT00065429|1580560|P6|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
643358|NCT00065429|1580561|P5|STARTED|Phase II - Apr 2003 - Aug 2008|All 32 patients enrolled in Phase 2 were at 60 mg/m2.|32
643359|NCT00065429|1580562|P4|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
643360|NCT00065429|1580563|P3|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
643361|NCT00065429|1580564|P2|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
643362|NCT00065429|1580565|P1|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
643363|NCT00065429|1580559|P7|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2
643364|NCT00065429|1580560|P6|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2
643365|NCT00065429|1580561|P5|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
643366|NCT00065429|1580562|P4|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
643367|NCT00065429|1580563|P3|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
643368|NCT00065429|1580564|P2|NOT COMPLETED|Phase I - May 2001 - Oct 2002||0
643369|NCT00065429|1580565|P1|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
643370|NCT00065429|1580559|P7|COMPLETED|Phase I - May 2001 - Oct 2002||2
643371|NCT00065429|1580560|P6|COMPLETED|Phase I - May 2001 - Oct 2002||2
643372|NCT00065429|1580561|P5|COMPLETED|Phase I - May 2001 - Oct 2002||8
643373|NCT00065429|1580562|P4|COMPLETED|Phase I - May 2001 - Oct 2002||3
643374|NCT00065429|1580563|P3|COMPLETED|Phase I - May 2001 - Oct 2002||3
643375|NCT00065429|1580564|P2|COMPLETED|Phase I - May 2001 - Oct 2002||3
643376|NCT00065429|1580565|P1|COMPLETED|Phase I - May 2001 - Oct 2002||3
643377|NCT00065429|1580559|P7|STARTED|Phase I - May 2001 - Oct 2002||4
643378|NCT00065429|1580560|P6|STARTED|Phase I - May 2001 - Oct 2002||4
643379|NCT00065429|1580561|P5|STARTED|Phase I - May 2001 - Oct 2002||9
643380|NCT00065429|1580562|P4|STARTED|Phase I - May 2001 - Oct 2002||4
643381|NCT00065429|1580563|P3|STARTED|Phase I - May 2001 - Oct 2002||4
643382|NCT00065429|1580564|P2|STARTED|Phase I - May 2001 - Oct 2002||3
643383|NCT00065429|1580565|P1|STARTED|Phase I - May 2001 - Oct 2002||4
643384|NCT00065260|1580579|P2|NOT COMPLETED|Overall Study||1
643385|NCT00065260|1580580|P1|NOT COMPLETED|Overall Study||0
643386|NCT00065260|1580579|P2|COMPLETED|Overall Study||26
643387|NCT00065260|1580580|P1|COMPLETED|Overall Study||27
643388|NCT00065260|1580579|P2|STARTED|Overall Study||27
643389|NCT00065260|1580580|P1|STARTED|Overall Study||27
643390|NCT00065156|1580586|P1|NOT COMPLETED|Overall Study||124
643391|NCT00065156|1580586|P1|COMPLETED|Overall Study|24 patients rolled over to free drug due to sponsor closure of study.|24
643392|NCT00065156|1580586|P1|Modified Intent to Treat Population|Overall Study||94
643393|NCT00065156|1580586|P1|STARTED|Overall Study||148
643394|NCT00065065|1580603|P2|NOT COMPLETED|Overall Study||20
643395|NCT00065065|1580604|P1|NOT COMPLETED|Overall Study||10
643396|NCT00065065|1580603|P2|COMPLETED|Overall Study||33
643397|NCT00065065|1580604|P1|COMPLETED|Overall Study||42
643398|NCT00065065|1580603|P2|STARTED|Overall Study||53
643399|NCT00065065|1580604|P1|STARTED|Overall Study||52
643400|NCT00003895|1580616|P2|NOT COMPLETED|Overall Study||4
643401|NCT00003895|1580617|P1|NOT COMPLETED|Overall Study||7
643402|NCT00003895|1580616|P2|COMPLETED|Overall Study||14
643403|NCT00003895|1580617|P1|COMPLETED|Overall Study||11
643404|NCT00003895|1580616|P2|STARTED|Overall Study||18
643405|NCT00003895|1580617|P1|STARTED|Overall Study||18
643406|NCT00064987|1580625|P2|NOT COMPLETED|Overall Study||0
643407|NCT00064987|1580626|P1|NOT COMPLETED|Overall Study||3
643408|NCT00064987|1580625|P2|COMPLETED|Overall Study||6
643409|NCT00064987|1580626|P1|COMPLETED|Overall Study||7
643410|NCT00064987|1580625|P2|STARTED|Overall Study||6
643411|NCT00064987|1580626|P1|STARTED|Overall Study||10
643412|NCT00064844|1580646|P2|NOT COMPLETED|Overall Study||19
643413|NCT00064844|1580647|P1|NOT COMPLETED|Overall Study||8
643414|NCT00064844|1580646|P2|COMPLETED|Overall Study||32
643415|NCT00064844|1580647|P1|COMPLETED|Overall Study||37
643416|NCT00064844|1580646|P2|12 Month Follow-up|Overall Study||32
643417|NCT00064844|1580647|P1|12 Month Follow-up|Overall Study||37
643418|NCT00064844|1580646|P2|6 Month Follow-up|Overall Study||40
643419|NCT00064844|1580647|P1|6 Month Follow-up|Overall Study||39
643420|NCT00064844|1580646|P2|3 Month Follow-up|Overall Study||47
643421|NCT00064844|1580647|P1|3 Month Follow-up|Overall Study||40
643422|NCT00064844|1580646|P2|2 Week Follow-up|Overall Study||51
643423|NCT00064844|1580647|P1|2 Week Follow-up|Overall Study||45
643424|NCT00064844|1580646|P2|STARTED|Overall Study||51
643425|NCT00064844|1580647|P1|STARTED|Overall Study||45
643426|NCT00064753|1580657|P2|NOT COMPLETED|Overall Study||648
643427|NCT00064753|1580658|P1|NOT COMPLETED|Overall Study||674
643428|NCT00064753|1580657|P2|COMPLETED|Overall Study||1406
643429|NCT00064753|1580658|P1|COMPLETED|Overall Study||1382
643430|NCT00064753|1580657|P2|STARTED|Overall Study||2054
643431|NCT00064753|1580658|P1|STARTED|Overall Study||2056
643432|NCT00064792|1580688|P2|NOT COMPLETED|Overall Study||0
643433|NCT00064792|1580689|P1|NOT COMPLETED|Overall Study||5
643434|NCT00064792|1580688|P2|COMPLETED|Overall Study||10
643435|NCT00064792|1580689|P1|COMPLETED|Overall Study||8
643436|NCT00064792|1580688|P2|STARTED|Overall Study||10
643437|NCT00064792|1580689|P1|STARTED|Overall Study||13
643438|NCT00064701|1580700|P3|NOT COMPLETED|Clinical Continuation Phase||140
643439|NCT00064701|1580701|P2|NOT COMPLETED|Clinical Continuation Phase||178
643440|NCT00064701|1580702|P1|NOT COMPLETED|Clinical Continuation Phase||170
643441|NCT00064701|1580700|P3|COMPLETED|Clinical Continuation Phase||11
643442|NCT00064701|1580701|P2|COMPLETED|Clinical Continuation Phase||4
643443|NCT00064701|1580702|P1|COMPLETED|Clinical Continuation Phase||9
643444|NCT00064701|1580700|P3|STARTED|Clinical Continuation Phase||151
643445|NCT00064701|1580701|P2|STARTED|Clinical Continuation Phase|One participant did not enter the Clinical Continuation phase|182
643446|NCT00064701|1580702|P1|STARTED|Clinical Continuation Phase||179
643447|NCT00064701|1580700|P3|NOT COMPLETED|One Year Post-transplant||72
643448|NCT00064701|1580701|P2|NOT COMPLETED|One Year Post-transplant||43
643449|NCT00064701|1580702|P1|NOT COMPLETED|One Year Post-transplant||40
643450|NCT00064701|1580700|P3|COMPLETED|One Year Post-transplant||151
643451|NCT00064701|1580701|P2|COMPLETED|One Year Post-transplant||183
643452|NCT00064701|1580702|P1|COMPLETED|One Year Post-transplant||179
643453|NCT00064701|1580700|P3|Received Study Drug|One Year Post-transplant||212
643454|NCT00064701|1580701|P2|Received Study Drug|One Year Post-transplant||214
643455|NCT00064701|1580702|P1|Received Study Drug|One Year Post-transplant||212
643456|NCT00064701|1580700|P3|STARTED|One Year Post-transplant||223
643457|NCT00064701|1580701|P2|STARTED|One Year Post-transplant||226
643458|NCT00064701|1580702|P1|STARTED|One Year Post-transplant||219
643459|NCT00064662|1580754|P2|NOT COMPLETED|Overall Study||61
643460|NCT00064662|1580755|P1|NOT COMPLETED|Overall Study||74
643461|NCT00064662|1580754|P2|COMPLETED|Overall Study||265
643462|NCT00064662|1580755|P1|COMPLETED|Overall Study||255
643463|NCT00064662|1580754|P2|STARTED|Overall Study||326
643464|NCT00064662|1580755|P1|STARTED|Overall Study||329
643465|NCT00064350|1580766|P3|NOT COMPLETED|Cross-Over||0
643466|NCT00064350|1580767|P2|NOT COMPLETED|Cross-Over||14
643467|NCT00064350|1580768|P1|NOT COMPLETED|Cross-Over||6
643468|NCT00064350|1580766|P3|COMPLETED|Cross-Over||0
643469|NCT00064350|1580767|P2|COMPLETED|Cross-Over||13
643470|NCT00064350|1580768|P1|COMPLETED|Cross-Over||4
643471|NCT00064350|1580766|P3|Eligible and Treated|Cross-Over||0
643472|NCT00064350|1580767|P2|Eligible and Treated|Cross-Over||21
643473|NCT00064350|1580768|P1|Eligible and Treated|Cross-Over||7
643474|NCT00064350|1580766|P3|Treated|Cross-Over||0
643475|NCT00064350|1580767|P2|Treated|Cross-Over||26
643476|NCT00064350|1580768|P1|Treated|Cross-Over||9
643477|NCT00064350|1580766|P3|STARTED|Cross-Over||0
643478|NCT00064350|1580767|P2|STARTED|Cross-Over||27
643479|NCT00064350|1580768|P1|STARTED|Cross-Over||10
643480|NCT00064350|1580766|P3|NOT COMPLETED|Randomization||0
643481|NCT00064350|1580767|P2|NOT COMPLETED|Randomization||18
643482|NCT00064350|1580768|P1|NOT COMPLETED|Randomization||26
643483|NCT00064350|1580766|P3|COMPLETED|Randomization||0
643484|NCT00064350|1580767|P2|COMPLETED|Randomization||28
643485|NCT00064350|1580768|P1|COMPLETED|Randomization||33
643486|NCT00064350|1580766|P3|Eligible and Treated|Randomization||0
643487|NCT00064350|1580767|P2|Eligible and Treated|Randomization||31
643488|NCT00064350|1580768|P1|Eligible and Treated|Randomization||50
643489|NCT00064350|1580766|P3|Treated|Randomization||0
643490|NCT00064350|1580767|P2|Treated|Randomization||40
643491|NCT00064350|1580768|P1|Treated|Randomization||55
643492|NCT00064350|1580766|P3|STARTED|Randomization||0
643493|NCT00064350|1580767|P2|STARTED|Randomization||46
643494|NCT00064350|1580768|P1|STARTED|Randomization||59
643495|NCT00064350|1580766|P3|NOT COMPLETED|Induction Treatment||236
643496|NCT00064350|1580767|P2|NOT COMPLETED|Induction Treatment||9
643497|NCT00064350|1580768|P1|NOT COMPLETED|Induction Treatment||8
643498|NCT00064350|1580766|P3|COMPLETED|Induction Treatment||1
643499|NCT00064350|1580767|P2|COMPLETED|Induction Treatment||37
643500|NCT00064350|1580768|P1|COMPLETED|Induction Treatment||51
643501|NCT00064350|1580766|P3|Eligible and Treated|Induction Treatment||194
643502|NCT00064350|1580767|P2|Eligible and Treated|Induction Treatment||46
643503|NCT00064350|1580768|P1|Eligible and Treated|Induction Treatment||59
643504|NCT00064350|1580766|P3|Treated|Induction Treatment||228
643505|NCT00064350|1580767|P2|Treated|Induction Treatment||46
643506|NCT00064350|1580768|P1|Treated|Induction Treatment||59
643507|NCT00064350|1580766|P3|STARTED|Induction Treatment||237
643508|NCT00064350|1580767|P2|STARTED|Induction Treatment||46
643509|NCT00064350|1580768|P1|STARTED|Induction Treatment||59
643510|NCT00064337|1580783|P1|NOT COMPLETED|Maintenance||10
643511|NCT00064337|1580783|P1|COMPLETED|Maintenance||3
643512|NCT00064337|1580783|P1|STARTED|Maintenance|Only patients with High Risk MM or AL + MM were allowed to enroll to Maintenance treatment.|13
643513|NCT00064337|1580783|P1|NOT COMPLETED|Transplant||21
643514|NCT00064337|1580783|P1|COMPLETED|Transplant||46
643515|NCT00064337|1580783|P1|STARTED|Transplant|6 patients who completed PBSCC or Induction/PBSCC did not begin Transplant|67
643516|NCT00064337|1580783|P1|NOT COMPLETED|PBSCC or Induction/PBSCC||20
643517|NCT00064337|1580783|P1|COMPLETED|PBSCC or Induction/PBSCC||73
643518|NCT00064337|1580783|P1|STARTED|PBSCC or Induction/PBSCC|104 patients were registered, 93 of whom were eligible and analyzable.|93
643519|NCT00064298|1580792|P2|NOT COMPLETED|Overall Study||5
643520|NCT00064298|1580793|P1|NOT COMPLETED|Overall Study||6
643521|NCT00064298|1580792|P2|COMPLETED|Overall Study||57
643522|NCT00064298|1580793|P1|COMPLETED|Overall Study||66
643523|NCT00064298|1580792|P2|STARTED|Overall Study||62
643524|NCT00064298|1580793|P1|STARTED|Overall Study||72
643525|NCT00064259|1580801|P4|NOT COMPLETED|Overall Study||1
643526|NCT00064259|1580802|P3|NOT COMPLETED|Overall Study||0
643527|NCT00064259|1580803|P2|NOT COMPLETED|Overall Study||0
643528|NCT00064259|1580804|P1|NOT COMPLETED|Overall Study||1
643529|NCT00064259|1580801|P4|COMPLETED|Overall Study||0
643530|NCT00064259|1580802|P3|COMPLETED|Overall Study||6
643531|NCT00064259|1580803|P2|COMPLETED|Overall Study||4
643532|NCT00064259|1580804|P1|COMPLETED|Overall Study||3
643533|NCT00064259|1580801|P4|STARTED|Overall Study||1
643534|NCT00064259|1580802|P3|STARTED|Overall Study||6
643535|NCT00064259|1580803|P2|STARTED|Overall Study||4
643536|NCT00064259|1580804|P1|STARTED|Overall Study||4
643537|NCT00064038|1580810|P3|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||2
643538|NCT00064038|1580811|P2|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
643539|NCT00064038|1580812|P1|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
643540|NCT00064038|1580810|P3|COMPLETED|Crossover to Lenalidomide+Dexamethasone||40
643541|NCT00064038|1580811|P2|COMPLETED|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
643542|NCT00064038|1580812|P1|COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
643543|NCT00064038|1580810|P3|Safety Population|Crossover to Lenalidomide+Dexamethasone||40
643544|NCT00064038|1580811|P2|Safety Population|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
643545|NCT00064038|1580812|P1|Safety Population|Crossover to Lenalidomide+Dexamethasone||0
643546|NCT00064038|1580810|P3|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||40
643547|NCT00064038|1580811|P2|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
643548|NCT00064038|1580812|P1|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||0
643549|NCT00064038|1580810|P3|STARTED|Crossover to Lenalidomide+Dexamethasone||42
643550|NCT00064038|1580811|P2|STARTED|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
643551|NCT00064038|1580812|P1|STARTED|Crossover to Lenalidomide+Dexamethasone||0
643552|NCT00064038|1580810|P3|NOT COMPLETED|Initial Randomization||0
643553|NCT00064038|1580811|P2|NOT COMPLETED|Initial Randomization||98
643554|NCT00064038|1580812|P1|NOT COMPLETED|Initial Randomization||100
643555|NCT00064038|1580810|P3|COMPLETED|Initial Randomization||0
643556|NCT00064038|1580811|P2|COMPLETED|Initial Randomization|The study was closed early per recommedation of the Data Safety Monitoring Committee.|0
643557|NCT00064038|1580812|P1|COMPLETED|Initial Randomization|The study was closed early per recommedation of the Data Safety Monitoring Committee.|0
643558|NCT00064038|1580810|P3|Safety Population|Initial Randomization||0
643559|NCT00064038|1580811|P2|Safety Population|Initial Randomization||94
643560|NCT00064038|1580812|P1|Safety Population|Initial Randomization||96
643561|NCT00064038|1580810|P3|Eligible and Analyzable|Initial Randomization||0
643562|NCT00064038|1580811|P2|Eligible and Analyzable|Initial Randomization||95
643563|NCT00064038|1580812|P1|Eligible and Analyzable|Initial Randomization||97
643564|NCT00064038|1580810|P3|STARTED|Initial Randomization||0
643565|NCT00064038|1580811|P2|STARTED|Initial Randomization||98
643566|NCT00064038|1580812|P1|STARTED|Initial Randomization||100
643567|NCT00064025|1580822|P1|NOT COMPLETED|Overall Study||7
643568|NCT00064025|1580822|P1|COMPLETED|Overall Study||68
643569|NCT00064025|1580822|P1|STARTED|Overall Study||75
643570|NCT00063999|1580831|P2|NOT COMPLETED|Overall Study||24
643571|NCT00063999|1580832|P1|NOT COMPLETED|Overall Study||45
643572|NCT00063999|1580831|P2|COMPLETED|Overall Study||665
643573|NCT00063999|1580832|P1|COMPLETED|Overall Study||647
643574|NCT00063999|1580831|P2|STARTED|Overall Study||689
643575|NCT00063999|1580832|P1|STARTED|Overall Study||692
643576|NCT00063986|1580848|P1|NOT COMPLETED|Overall Study||6
643577|NCT00063986|1580848|P1|COMPLETED|Overall Study||104
643578|NCT00063986|1580848|P1|Eligible and Treated|Overall Study||104
643579|NCT00063986|1580848|P1|Treated|Overall Study||105
643580|NCT00063986|1580848|P1|STARTED|Overall Study||110
643581|NCT00063934|1580860|P1|NOT COMPLETED|Overall Study||1
643582|NCT00063934|1580860|P1|COMPLETED|Overall Study||30
643583|NCT00063934|1580860|P1|STARTED|Overall Study||31
643584|NCT00063635|1580869|P3|NOT COMPLETED|Overall Study||9
643585|NCT00063635|1580870|P2|NOT COMPLETED|Overall Study||8
643586|NCT00063635|1580871|P1|NOT COMPLETED|Overall Study||6
643587|NCT00063635|1580869|P3|COMPLETED|Overall Study||49
643588|NCT00063635|1580870|P2|COMPLETED|Overall Study||50
643589|NCT00063635|1580871|P1|COMPLETED|Overall Study||51
643590|NCT00063635|1580869|P3|STARTED|Overall Study||58
643591|NCT00063635|1580870|P2|STARTED|Overall Study||58
643592|NCT00063635|1580871|P1|STARTED|Overall Study||57
643593|NCT00063622|1580912|P3|NOT COMPLETED|Overall Study||11
643594|NCT00063622|1580913|P2|NOT COMPLETED|Overall Study||4
643595|NCT00063622|1580914|P1|NOT COMPLETED|Overall Study||10
643596|NCT00063622|1580912|P3|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|72
643597|NCT00063622|1580913|P2|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|80
643598|NCT00063622|1580914|P1|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|70
643599|NCT00063622|1580912|P3|STARTED|Overall Study||83
643600|NCT00063622|1580913|P2|STARTED|Overall Study||84
643601|NCT00063622|1580914|P1|STARTED|Overall Study||80
643602|NCT00063570|1580939|P2|NOT COMPLETED|Overall Study||0
643603|NCT00063570|1580940|P1|NOT COMPLETED|Overall Study||0
643604|NCT00063570|1580939|P2|COMPLETED|Overall Study|Completed for this study means patient received study drug and was eligible for efficacy analysis.|21
643605|NCT00063570|1580940|P1|COMPLETED|Overall Study|Completed for this study means patient received study drug and was eligible for efficacy analysis.|52
643606|NCT00063570|1580939|P2|STARTED|Overall Study||21
643607|NCT00063570|1580940|P1|STARTED|Overall Study||52
643608|NCT00063362|1580956|P2|NOT COMPLETED|Overall Study||4
643609|NCT00063362|1580957|P1|NOT COMPLETED|Overall Study||4
643610|NCT00063362|1580956|P2|COMPLETED|Overall Study||22
643611|NCT00063362|1580957|P1|COMPLETED|Overall Study||19
643612|NCT00063362|1580956|P2|STARTED|Overall Study||26
643613|NCT00063362|1580957|P1|STARTED|Overall Study||23
643614|NCT00063258|1580965|P2|NOT COMPLETED|Overall Study||0
643615|NCT00063258|1580966|P1|NOT COMPLETED|Overall Study||4
643616|NCT00063258|1580965|P2|COMPLETED|Overall Study||0
643617|NCT00063258|1580966|P1|COMPLETED|Overall Study||1
643618|NCT00063258|1580965|P2|STARTED|Overall Study||0
643619|NCT00063258|1580966|P1|STARTED|Overall Study||5
643620|NCT00063154|1580972|P1|NOT COMPLETED|Overall Study||51
643621|NCT00063154|1580972|P1|COMPLETED|Overall Study||0
643622|NCT00063154|1580972|P1|STARTED|Overall Study||51
643623|NCT00063232|1580979|P1|NOT COMPLETED|Overall Study||0
643624|NCT00063232|1580979|P1|COMPLETED|Overall Study||26
643625|NCT00063232|1580979|P1|STARTED|Overall Study||26
643626|NCT00062764|1580985|P1|NOT COMPLETED|Overall Study||0
643627|NCT00062764|1580985|P1|COMPLETED|Overall Study||18
643628|NCT00062764|1580985|P1|STARTED|Overall Study||18
643629|NCT00062751|1580998|P5|NOT COMPLETED|Overall Study||6
643630|NCT00062751|1580999|P4|NOT COMPLETED|Overall Study||5
643631|NCT00062751|1581000|P3|NOT COMPLETED|Overall Study||30
643632|NCT00062751|1581001|P2|NOT COMPLETED|Overall Study||30
643633|NCT00062751|1581002|P1|NOT COMPLETED|Overall Study||33
643634|NCT00062751|1580998|P5|COMPLETED|Overall Study||0
643635|NCT00062751|1580999|P4|COMPLETED|Overall Study||1
643636|NCT00062751|1581000|P3|COMPLETED|Overall Study||3
643637|NCT00062751|1581001|P2|COMPLETED|Overall Study||0
643638|NCT00062751|1581002|P1|COMPLETED|Overall Study||0
643639|NCT00062751|1580998|P5|STARTED|Overall Study||6
643640|NCT00062751|1580999|P4|STARTED|Overall Study||6
643641|NCT00062751|1581000|P3|STARTED|Overall Study||33
643642|NCT00062751|1581001|P2|STARTED|Overall Study||30
643643|NCT00062751|1581002|P1|STARTED|Overall Study||33
643644|NCT00062738|1581073|P3|NOT COMPLETED|Overall Study||0
643645|NCT00062738|1581074|P2|NOT COMPLETED|Overall Study||0
643646|NCT00062738|1581075|P1|NOT COMPLETED|Overall Study||0
643647|NCT00062738|1581073|P3|COMPLETED|Overall Study||17
643648|NCT00062738|1581074|P2|COMPLETED|Overall Study||18
643649|NCT00062738|1581075|P1|COMPLETED|Overall Study||17
643650|NCT00062738|1581073|P3|STARTED|Overall Study||17
643651|NCT00062738|1581074|P2|STARTED|Overall Study||18
643652|NCT00062738|1581075|P1|STARTED|Overall Study||17
643653|NCT00062647|1581088|P2|NOT COMPLETED|Overall Study||13
643654|NCT00062647|1581089|P1|NOT COMPLETED|Overall Study||16
643655|NCT00062647|1581088|P2|COMPLETED|Overall Study||17
643656|NCT00062647|1581089|P1|COMPLETED|Overall Study||14
643657|NCT00062647|1581088|P2|STARTED|Overall Study||30
643658|NCT00062647|1581089|P1|STARTED|Overall Study||30
643659|NCT00062439|1581095|P1|NOT COMPLETED|Consolidation Chemotherapy||2
643660|NCT00062439|1581095|P1|COMPLETED|Consolidation Chemotherapy||20
643661|NCT00062439|1581095|P1|STARTED|Consolidation Chemotherapy||22
643662|NCT00062439|1581095|P1|NOT COMPLETED|Surgery||7
643663|NCT00062439|1581095|P1|COMPLETED|Surgery||22
643664|NCT00062439|1581095|P1|STARTED|Surgery||29
643665|NCT00062439|1581095|P1|NOT COMPLETED|Post Chemoradiation Assessment||9
643666|NCT00062439|1581095|P1|COMPLETED|Post Chemoradiation Assessment||29
643667|NCT00062439|1581095|P1|STARTED|Post Chemoradiation Assessment||38
643668|NCT00062439|1581095|P1|NOT COMPLETED|Induction Chemotherapy + Radiotherapy||8
643669|NCT00062439|1581095|P1|COMPLETED|Induction Chemotherapy + Radiotherapy||38
643670|NCT00062439|1581095|P1|STARTED|Induction Chemotherapy + Radiotherapy||46
643671|NCT00062374|1581107|P1|NOT COMPLETED|Overall Study||12
643672|NCT00062374|1581107|P1|COMPLETED|Overall Study||43
643673|NCT00062374|1581107|P1|STARTED|Overall Study||55
643674|NCT00062010|1581112|P1|NOT COMPLETED|Overall Study||3
643675|NCT00062010|1581112|P1|COMPLETED|Overall Study||34
643676|NCT00062010|1581112|P1|Eligible and Treated|Overall Study||34
643677|NCT00062010|1581112|P1|STARTED|Overall Study||37
643678|NCT00061945|1581120|P2|NOT COMPLETED|Course IV: Alemtuzumab||16
643679|NCT00061945|1581121|P1|NOT COMPLETED|Course IV: Alemtuzumab||7
643680|NCT00061945|1581120|P2|COMPLETED|Course IV: Alemtuzumab||50
643681|NCT00061945|1581121|P1|COMPLETED|Course IV: Alemtuzumab||18
643682|NCT00061945|1581120|P2|STARTED|Course IV: Alemtuzumab||66
643683|NCT00061945|1581121|P1|STARTED|Course IV: Alemtuzumab||25
643684|NCT00061945|1581120|P2|NOT COMPLETED|Registration Through Course 3||115
643685|NCT00061945|1581121|P1|NOT COMPLETED|Registration Through Course 3||94
643686|NCT00061945|1581120|P2|COMPLETED|Registration Through Course 3||66
643687|NCT00061945|1581121|P1|COMPLETED|Registration Through Course 3||25
643688|NCT00061945|1581120|P2|STARTED|Registration Through Course 3||181
643689|NCT00061945|1581121|P1|STARTED|Registration Through Course 3||119
643690|NCT00061932|1581131|P2|NOT COMPLETED|Overall Study||4
643691|NCT00061932|1581132|P1|NOT COMPLETED|Overall Study||13
643692|NCT00061932|1581131|P2|COMPLETED|Overall Study||8
643693|NCT00061932|1581132|P1|COMPLETED|Overall Study||16
643694|NCT00061932|1581131|P2|STARTED|Overall Study||12
643695|NCT00061932|1581132|P1|STARTED|Overall Study||29
643696|NCT00061893|1581138|P1|NOT COMPLETED|Overall Study||18
643697|NCT00061893|1581138|P1|COMPLETED|Overall Study||20
643698|NCT00061893|1581138|P1|STARTED|Overall Study||38
643699|NCT00061633|1581145|P2|NOT COMPLETED|Overall Study||11
643700|NCT00061633|1581146|P1|NOT COMPLETED|Overall Study||5
643701|NCT00061633|1581145|P2|COMPLETED|Overall Study||74
643702|NCT00061633|1581146|P1|COMPLETED|Overall Study||79
643703|NCT00061633|1581145|P2|STARTED|Overall Study||85
643704|NCT00061633|1581146|P1|STARTED|Overall Study||84
643705|NCT00061373|1581154|P2|NOT COMPLETED|Overall Study||0
643706|NCT00061373|1581155|P1|NOT COMPLETED|Overall Study||0
643707|NCT00061373|1581154|P2|COMPLETED|Overall Study||3
643708|NCT00061373|1581155|P1|COMPLETED|Overall Study||15
643709|NCT00061373|1581154|P2|Aspirin and Tinzaparin|Overall Study||3
643710|NCT00061373|1581155|P1|Aspirin and Tinzaparin|Overall Study||15
643711|NCT00061373|1581154|P2|STARTED|Overall Study||3
643712|NCT00061373|1581155|P1|STARTED|Overall Study||15
643713|NCT00061048|1581171|P1|NOT COMPLETED|Overall Study||22
643714|NCT00061048|1581171|P1|COMPLETED|Overall Study|Began protocol specified follow-up period.|7
643715|NCT00061048|1581171|P1|STARTED|Overall Study||29
643716|NCT00060944|1581181|P2|NOT COMPLETED|Overall Study||134
643717|NCT00060944|1581182|P1|NOT COMPLETED|Overall Study||136
643718|NCT00060944|1581181|P2|COMPLETED|Overall Study||0
643719|NCT00060944|1581182|P1|COMPLETED|Overall Study||0
643720|NCT00060944|1581181|P2|Treated|Overall Study||130
643721|NCT00060944|1581182|P1|Treated|Overall Study||130
643722|NCT00060944|1581181|P2|STARTED|Overall Study||134
643723|NCT00060944|1581182|P1|STARTED|Overall Study||136
643724|NCT00060840|1581198|P2|NOT COMPLETED|Overall Study||9
643725|NCT00060840|1581199|P1|NOT COMPLETED|Overall Study||4
643726|NCT00060840|1581198|P2|COMPLETED|Overall Study||68
643727|NCT00060840|1581199|P1|COMPLETED|Overall Study||69
643728|NCT00060840|1581198|P2|STARTED|Overall Study||77
643729|NCT00060840|1581199|P1|STARTED|Overall Study||73
643730|NCT00060528|1581205|P4|NOT COMPLETED|Overall Study||0
643731|NCT00060528|1581206|P3|NOT COMPLETED|Overall Study||0
643732|NCT00060528|1581207|P2|NOT COMPLETED|Overall Study||0
643733|NCT00060528|1581208|P1|NOT COMPLETED|Overall Study||0
643734|NCT00060528|1581205|P4|COMPLETED|Overall Study||8
643735|NCT00060528|1581206|P3|COMPLETED|Overall Study||7
643736|NCT00060528|1581207|P2|COMPLETED|Overall Study||9
643737|NCT00060528|1581208|P1|COMPLETED|Overall Study||8
643738|NCT00060528|1581205|P4|STARTED|Overall Study||8
643739|NCT00060528|1581206|P3|STARTED|Overall Study||7
643740|NCT00060528|1581207|P2|STARTED|Overall Study||9
643741|NCT00060528|1581208|P1|STARTED|Overall Study|32 participants are reported for the phase II portion.|8
643742|NCT00060424|1581222|P1|NOT COMPLETED|Overall Study||0
643743|NCT00060424|1581222|P1|COMPLETED|Overall Study||21
643744|NCT00060424|1581222|P1|STARTED|Overall Study||21
643745|NCT00060346|1581230|P1|NOT COMPLETED|Overall Study||0
643746|NCT00060346|1581230|P1|COMPLETED|Overall Study||16
643747|NCT00060346|1581230|P1|Eligible and Treated|Overall Study||16
643748|NCT00060346|1581230|P1|STARTED|Overall Study||16
643749|NCT00060333|1581234|P1|NOT COMPLETED|Overall Study||0
643750|NCT00060333|1581234|P1|COMPLETED|Overall Study||20
643751|NCT00060333|1581234|P1|STARTED|Overall Study||20
643752|NCT00060008|1581245|P1|NOT COMPLETED|Overall Study||0
643753|NCT00060008|1581245|P1|COMPLETED|Overall Study||18
643754|NCT00060008|1581245|P1|STARTED|Overall Study||18
643755|NCT00059839|1581252|P2|NOT COMPLETED|Overall Study||17
643756|NCT00059839|1581253|P1|NOT COMPLETED|Overall Study||12
643757|NCT00059839|1581252|P2|COMPLETED|Overall Study||47
643758|NCT00059839|1581253|P1|COMPLETED|Overall Study||53
643759|NCT00059839|1581252|P2|STARTED|Overall Study||64
643760|NCT00059839|1581253|P1|STARTED|Overall Study||65
643761|NCT00059787|1581259|P1|NOT COMPLETED|Overall Study||20
643762|NCT00059787|1581259|P1|COMPLETED|Overall Study||36
643763|NCT00059787|1581259|P1|STARTED|Overall Study||56
643764|NCT00059475|1581275|P8|NOT COMPLETED|Overall Study||0
643765|NCT00059475|1581276|P7|NOT COMPLETED|Overall Study||0
643766|NCT00059475|1581277|P6|NOT COMPLETED|Overall Study||0
643767|NCT00059475|1581278|P5|NOT COMPLETED|Overall Study||0
643768|NCT00059475|1581279|P4|NOT COMPLETED|Overall Study||0
643769|NCT00059475|1581280|P3|NOT COMPLETED|Overall Study||0
643770|NCT00059475|1581281|P2|NOT COMPLETED|Overall Study||0
643771|NCT00059475|1581282|P1|NOT COMPLETED|Overall Study||0
643772|NCT00059475|1581275|P8|COMPLETED|Overall Study||7
643773|NCT00059475|1581276|P7|COMPLETED|Overall Study||34
643774|NCT00059475|1581277|P6|COMPLETED|Overall Study||2
643775|NCT00059475|1581278|P5|COMPLETED|Overall Study||33
643776|NCT00059475|1581279|P4|COMPLETED|Overall Study||3
643777|NCT00059475|1581280|P3|COMPLETED|Overall Study||24
643778|NCT00059475|1581281|P2|COMPLETED|Overall Study||2
643779|NCT00059475|1581282|P1|COMPLETED|Overall Study||33
643780|NCT00059475|1581275|P8|STARTED|Overall Study||7
643781|NCT00059475|1581276|P7|STARTED|Overall Study||34
643782|NCT00059475|1581277|P6|STARTED|Overall Study||2
643783|NCT00059475|1581278|P5|STARTED|Overall Study||33
643784|NCT00059475|1581279|P4|STARTED|Overall Study||3
643785|NCT00059475|1581280|P3|STARTED|Overall Study||24
643786|NCT00059475|1581281|P2|STARTED|Overall Study||2
643787|NCT00059475|1581282|P1|STARTED|Overall Study||33
643788|NCT00059332|1581310|P2|NOT COMPLETED|Overall Study||2
643789|NCT00059332|1581311|P1|NOT COMPLETED|Overall Study||3
643790|NCT00059332|1581310|P2|COMPLETED|Overall Study||855
643791|NCT00059332|1581311|P1|COMPLETED|Overall Study||840
643792|NCT00059332|1581310|P2|STARTED|Overall Study||857
643793|NCT00059332|1581311|P1|STARTED|Overall Study||843
643794|NCT00059215|1581337|P4|NOT COMPLETED|Overall Study||15
643795|NCT00059215|1581338|P3|NOT COMPLETED|Overall Study||15
643796|NCT00059215|1581339|P2|NOT COMPLETED|Overall Study||14
643797|NCT00059215|1581340|P1|NOT COMPLETED|Overall Study||13
643798|NCT00059215|1581337|P4|COMPLETED|Overall Study||239
643799|NCT00059215|1581338|P3|COMPLETED|Overall Study||236
643800|NCT00059215|1581339|P2|COMPLETED|Overall Study||186
643801|NCT00059215|1581340|P1|COMPLETED|Overall Study|One subject discontinued before receiving treatment and is not included in the evaluable set.|187
643802|NCT00059215|1581337|P4|STARTED|Overall Study||254
643803|NCT00059215|1581338|P3|STARTED|Overall Study||251
643804|NCT00059215|1581339|P2|STARTED|Overall Study||200
643805|NCT00059215|1581340|P1|STARTED|Overall Study||200
643806|NCT00059228|1581368|P2|NOT COMPLETED|Overall Study||1
643807|NCT00059228|1581369|P1|NOT COMPLETED|Overall Study||0
643808|NCT00059228|1581368|P2|COMPLETED|Overall Study||5
643809|NCT00059228|1581369|P1|COMPLETED|Overall Study||6
643810|NCT00059228|1581368|P2|STARTED|Overall Study||6
643811|NCT00059228|1581369|P1|STARTED|Overall Study||6
643812|NCT00058825|1581377|P1|NOT COMPLETED|Overall Study||22
643813|NCT00058825|1581377|P1|COMPLETED|Overall Study||5
643814|NCT00058825|1581377|P1|STARTED|Overall Study||27
643815|NCT00058552|1581393|P2|NOT COMPLETED|Overall Study||62
643816|NCT00058552|1581394|P1|NOT COMPLETED|Overall Study||65
643817|NCT00058552|1581393|P2|COMPLETED|Overall Study||2
643818|NCT00058552|1581394|P1|COMPLETED|Overall Study||0
643819|NCT00058552|1581393|P2|STARTED|Overall Study||64
643820|NCT00058552|1581394|P1|STARTED|Overall Study||65
643821|NCT00058539|1581412|P1|NOT COMPLETED|Overall Study||42
643822|NCT00058539|1581412|P1|COMPLETED|Overall Study||0
643823|NCT00058539|1581412|P1|STARTED|Overall Study||42
643824|NCT00058240|1581426|P4|NOT COMPLETED|Second Dose Level||0
643825|NCT00058240|1581427|P3|NOT COMPLETED|Second Dose Level||0
643826|NCT00058240|1581428|P2|NOT COMPLETED|Second Dose Level||0
643827|NCT00058240|1581429|P1|NOT COMPLETED|Second Dose Level||0
643828|NCT00058240|1581426|P4|COMPLETED|Second Dose Level||4
643829|NCT00058240|1581427|P3|COMPLETED|Second Dose Level||2
643830|NCT00058240|1581428|P2|COMPLETED|Second Dose Level||0
643831|NCT00058240|1581429|P1|COMPLETED|Second Dose Level||0
643832|NCT00058240|1581426|P4|STARTED|Second Dose Level|4 patients previously relapsed on a different Dose level and were retreated at Dose level 4.|4
643833|NCT00058240|1581427|P3|STARTED|Second Dose Level|2 patients were previously treated at Dose level 1, relapsed, and retreated at Dose level 3.|2
643834|NCT00058240|1581428|P2|STARTED|Second Dose Level||0
643835|NCT00058240|1581429|P1|STARTED|Second Dose Level||0
643836|NCT00058240|1581426|P4|NOT COMPLETED|First Dose Level||0
643837|NCT00058240|1581427|P3|NOT COMPLETED|First Dose Level||0
643838|NCT00058240|1581428|P2|NOT COMPLETED|First Dose Level||0
643839|NCT00058240|1581429|P1|NOT COMPLETED|First Dose Level||0
643840|NCT00058240|1581426|P4|COMPLETED|First Dose Level||12
643841|NCT00058240|1581427|P3|COMPLETED|First Dose Level||17
643842|NCT00058240|1581428|P2|COMPLETED|First Dose Level||3
643843|NCT00058240|1581429|P1|COMPLETED|First Dose Level||20
643844|NCT00058240|1581426|P4|Treated|First Dose Level||12
643845|NCT00058240|1581427|P3|Treated|First Dose Level||17
643846|NCT00058240|1581428|P2|Treated|First Dose Level||3
643847|NCT00058240|1581429|P1|Treated|First Dose Level||20
643848|NCT00058240|1581426|P4|STARTED|First Dose Level||12
643849|NCT00058240|1581427|P3|STARTED|First Dose Level||17
643850|NCT00058240|1581428|P2|STARTED|First Dose Level||3
643851|NCT00058240|1581429|P1|STARTED|First Dose Level||20
643852|NCT00058214|1581439|P1|NOT COMPLETED|Overall Study||1
643853|NCT00058214|1581439|P1|COMPLETED|Overall Study||24
643854|NCT00058214|1581439|P1|STARTED|Overall Study||25
643855|NCT00058019|1581446|P2|NOT COMPLETED|Overall Study||0
643856|NCT00058019|1581447|P1|NOT COMPLETED|Overall Study||0
643857|NCT00058019|1581446|P2|COMPLETED|Overall Study||12
643858|NCT00058019|1581447|P1|COMPLETED|Overall Study||39
643859|NCT00058019|1581446|P2|STARTED|Overall Study||12
643860|NCT00058019|1581447|P1|STARTED|Overall Study||39
643861|NCT00057954|1581460|P1|NOT COMPLETED|Overall Study||2
643862|NCT00057954|1581460|P1|COMPLETED|Overall Study||4
643863|NCT00057954|1581460|P1|STARTED|Overall Study||6
643864|NCT00057941|1581468|P2|NOT COMPLETED|Overall Study||74
643865|NCT00057941|1581469|P1|NOT COMPLETED|Overall Study||74
643866|NCT00057941|1581468|P2|COMPLETED|Overall Study||0
643867|NCT00057941|1581469|P1|COMPLETED|Overall Study||0
643868|NCT00057941|1581468|P2|Eligible|Overall Study||69
643869|NCT00057941|1581469|P1|Eligible|Overall Study||72
643870|NCT00057941|1581468|P2|Treated|Overall Study||74
643871|NCT00057941|1581469|P1|Treated|Overall Study||74
643872|NCT00057941|1581468|P2|STARTED|Overall Study||74
643873|NCT00057941|1581469|P1|STARTED|Overall Study||74
643874|NCT00057876|1581477|P2|NOT COMPLETED|Overall Study||27
643875|NCT00057876|1581478|P1|NOT COMPLETED|Overall Study||29
643876|NCT00057876|1581477|P2|COMPLETED|Overall Study||9
643877|NCT00057876|1581478|P1|COMPLETED|Overall Study||9
643878|NCT00057876|1581477|P2|Eligible and Treated|Overall Study||34
643879|NCT00057876|1581478|P1|Eligible and Treated|Overall Study||34
643880|NCT00057876|1581477|P2|Began Protocol Therapy|Overall Study||34
643881|NCT00057876|1581478|P1|Began Protocol Therapy|Overall Study||35
643882|NCT00057876|1581477|P2|Eligible|Overall Study||34
643883|NCT00057876|1581478|P1|Eligible|Overall Study||37
643884|NCT00057876|1581477|P2|STARTED|Overall Study||36
643885|NCT00057876|1581478|P1|STARTED|Overall Study||38
643886|NCT00057863|1581488|P1|NOT COMPLETED|Overall Study||3
643887|NCT00057863|1581488|P1|COMPLETED|Overall Study||32
643888|NCT00057863|1581488|P1|STARTED|Overall Study||35
643889|NCT00057837|1581497|P2|NOT COMPLETED|Overall Study||39
643890|NCT00057837|1581498|P1|NOT COMPLETED|Overall Study||31
643891|NCT00057837|1581497|P2|COMPLETED|Overall Study||31
643892|NCT00057837|1581498|P1|COMPLETED|Overall Study||39
643893|NCT00057837|1581497|P2|Patients With Response|Overall Study||38
643894|NCT00057837|1581498|P1|Patients With Response|Overall Study||46
643895|NCT00057837|1581497|P2|Eligible and Treated|Overall Study||66
643896|NCT00057837|1581498|P1|Eligible and Treated|Overall Study||66
643897|NCT00057837|1581497|P2|Treated|Overall Study||68
643898|NCT00057837|1581498|P1|Treated|Overall Study||69
643899|NCT00057837|1581497|P2|STARTED|Overall Study||70
643900|NCT00057837|1581498|P1|STARTED|Overall Study||70
643901|NCT00057811|1581510|P2|NOT COMPLETED|Overall Study||12
643902|NCT00057811|1581511|P1|NOT COMPLETED|Overall Study||10
643903|NCT00057811|1581510|P2|COMPLETED|Overall Study||34
643904|NCT00057811|1581511|P1|COMPLETED|Overall Study||41
643905|NCT00057811|1581510|P2|STARTED|Overall Study||46
643906|NCT00057811|1581511|P1|STARTED|Overall Study||51
643907|NCT00057785|1581523|P1|NOT COMPLETED|Overall Study||0
643908|NCT00057785|1581523|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|68
643909|NCT00057785|1581523|P1|STARTED|Overall Study||68
643910|NCT00057746|1581530|P3|NOT COMPLETED|Overall Study||1
643911|NCT00057746|1581531|P2|NOT COMPLETED|Overall Study||0
643912|NCT00057746|1581532|P1|NOT COMPLETED|Overall Study||0
643913|NCT00057746|1581530|P3|COMPLETED|Overall Study||66
643914|NCT00057746|1581531|P2|COMPLETED|Overall Study||67
643915|NCT00057746|1581532|P1|COMPLETED|Overall Study||131
643916|NCT00057746|1581530|P3|STARTED|Overall Study||67
643917|NCT00057746|1581531|P2|STARTED|Overall Study||67
643918|NCT00057746|1581532|P1|STARTED|Overall Study||131
643919|NCT00023673|1581543|P4|NOT COMPLETED|Overall Study||2
643920|NCT00023673|1581544|P3|NOT COMPLETED|Overall Study||0
643921|NCT00023673|1581545|P2|NOT COMPLETED|Overall Study||0
643922|NCT00023673|1581546|P1|NOT COMPLETED|Overall Study||0
643923|NCT00023673|1581543|P4|COMPLETED|Overall Study|Phase II subjects contributing data to primary analysis are considered to have completed the study.|44
643924|NCT00023673|1581544|P3|COMPLETED|Overall Study|This arm was not used since further de-escalation was not required.|0
643925|NCT00023673|1581545|P2|COMPLETED|Overall Study|Phase I eligible patients starting protocol treatment are considered to have completed the study.|9
643926|NCT00023673|1581546|P1|COMPLETED|Overall Study|Phase I eligible patients starting protocol treatment are considered to have completed the study.|8
643927|NCT00023673|1581543|P4|STARTED|Overall Study||46
643928|NCT00023673|1581544|P3|STARTED|Overall Study||0
643929|NCT00023673|1581545|P2|STARTED|Overall Study||9
643930|NCT00023673|1581546|P1|STARTED|Overall Study||8
643931|NCT00057681|1581562|P3|NOT COMPLETED|Overall Study||34
643932|NCT00057681|1581563|P2|NOT COMPLETED|Overall Study||72
643933|NCT00057681|1581564|P1|NOT COMPLETED|Overall Study||65
643934|NCT00057681|1581562|P3|COMPLETED|Overall Study||69
643935|NCT00057681|1581563|P2|COMPLETED|Overall Study||67
643936|NCT00057681|1581564|P1|COMPLETED|Overall Study||72
643937|NCT00057681|1581562|P3|STARTED|Overall Study||103
643938|NCT00057681|1581563|P2|STARTED|Overall Study||139
643939|NCT00057681|1581564|P1|STARTED|Overall Study||137
643940|NCT00057577|1581580|P2|NOT COMPLETED|Overall Study||0
643941|NCT00057577|1581581|P1|NOT COMPLETED|Overall Study||0
643942|NCT00057577|1581580|P2|COMPLETED|Overall Study||225
643943|NCT00057577|1581581|P1|COMPLETED|Overall Study||227
643944|NCT00057577|1581580|P2|STARTED|Overall Study||225
643945|NCT00057577|1581581|P1|STARTED|Overall Study||227
643946|NCT00057551|1581598|P3|NOT COMPLETED|Overall Study||16
643947|NCT00057551|1581599|P2|NOT COMPLETED|Overall Study||27
643948|NCT00057551|1581600|P1|NOT COMPLETED|Overall Study||25
643949|NCT00057551|1581598|P3|COMPLETED|Overall Study||80
643950|NCT00057551|1581599|P2|COMPLETED|Overall Study||168
643951|NCT00057551|1581600|P1|COMPLETED|Overall Study||175
643952|NCT00057551|1581598|P3|STARTED|Overall Study||96
643953|NCT00057551|1581599|P2|STARTED|Overall Study||195
643954|NCT00057551|1581600|P1|STARTED|Overall Study||200
643955|NCT00057330|1581610|P2|NOT COMPLETED|Overall Study||920
643956|NCT00057330|1581611|P1|NOT COMPLETED|Overall Study||1132
643957|NCT00057330|1581610|P2|COMPLETED|Overall Study||2826
643958|NCT00057330|1581611|P1|COMPLETED|Overall Study||3445
643959|NCT00057330|1581610|P2|STARTED|Overall Study||3746
643960|NCT00057330|1581611|P1|STARTED|Overall Study||4577
643961|NCT00056862|1581641|P2|NOT COMPLETED|Overall Study||0
643962|NCT00056862|1581642|P1|NOT COMPLETED|Overall Study||1
643963|NCT00056862|1581641|P2|COMPLETED|Overall Study||27
643964|NCT00056862|1581642|P1|COMPLETED|Overall Study||30
643965|NCT00056862|1581641|P2|STARTED|Overall Study||27
643966|NCT00056862|1581642|P1|STARTED|Overall Study||31
643967|NCT00056563|1581658|P2|NOT COMPLETED|Overall Study||0
643968|NCT00056563|1581659|P1|NOT COMPLETED|Overall Study||0
643969|NCT00056563|1581658|P2|COMPLETED|Overall Study||134
643970|NCT00056563|1581659|P1|COMPLETED|Overall Study||121
643971|NCT00056563|1581658|P2|STARTED|Overall Study||134
643972|NCT00056563|1581659|P1|STARTED|Overall Study||121
643973|NCT00056550|1581667|P1|NOT COMPLETED|Overall Study||0
643974|NCT00056550|1581667|P1|COMPLETED|Overall Study||14
643975|NCT00056550|1581667|P1|STARTED|Overall Study||14
643976|NCT00056498|1581674|P2|NOT COMPLETED|Overall Study||7
643977|NCT00056498|1581675|P1|NOT COMPLETED|Overall Study||5
643978|NCT00056498|1581674|P2|COMPLETED|Overall Study||28
643979|NCT00056498|1581675|P1|COMPLETED|Overall Study||25
643980|NCT00056498|1581674|P2|STARTED|Overall Study||35
643981|NCT00056498|1581675|P1|STARTED|Overall Study||30
643982|NCT00056472|1581687|P2|NOT COMPLETED|Overall Study||69
643983|NCT00056472|1581688|P1|NOT COMPLETED|Overall Study||48
643984|NCT00056472|1581687|P2|COMPLETED|Overall Study||61
643985|NCT00056472|1581688|P1|COMPLETED|Overall Study||81
643986|NCT00056472|1581687|P2|STARTED|Overall Study||130
643987|NCT00056472|1581688|P1|STARTED|Overall Study||129
643988|NCT00056407|1581700|P2|NOT COMPLETED|Overall Study||1193
643989|NCT00056407|1581701|P1|NOT COMPLETED|Overall Study||1211
643990|NCT00056407|1581700|P2|COMPLETED|Overall Study||2912
643991|NCT00056407|1581701|P1|COMPLETED|Overall Study||2915
643992|NCT00056407|1581700|P2|STARTED|Overall Study||4105
643993|NCT00056407|1581701|P1|STARTED|Overall Study||4126
643994|NCT00056316|1581759|P2|NOT COMPLETED|Overall Study||3
643995|NCT00056316|1581760|P1|NOT COMPLETED|Overall Study||3
643996|NCT00056316|1581759|P2|COMPLETED|Overall Study||38
643997|NCT00056316|1581760|P1|COMPLETED|Overall Study||30
643998|NCT00056316|1581759|P2|STARTED|Overall Study|over-enrolled due to potential higher rates of drop-out.|41
643999|NCT00056316|1581760|P1|STARTED|Overall Study||33
644000|NCT00056160|1581774|P2|NOT COMPLETED|Final Follow-up||0
644001|NCT00056160|1581775|P1|NOT COMPLETED|Final Follow-up||6
644002|NCT00056160|1581774|P2|COMPLETED|Final Follow-up||0
644003|NCT00056160|1581775|P1|COMPLETED|Final Follow-up||0
644004|NCT00056160|1581774|P2|STARTED|Final Follow-up||0
644005|NCT00056160|1581775|P1|STARTED|Final Follow-up||6
644006|NCT00056160|1581774|P2|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0
644007|NCT00056160|1581775|P1|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||171
644008|NCT00056160|1581774|P2|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0
644009|NCT00056160|1581775|P1|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||6
644010|NCT00056160|1581774|P2|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||0
644011|NCT00056160|1581775|P1|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||177
644012|NCT00056160|1581774|P2|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||163
644013|NCT00056160|1581775|P1|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||113
644014|NCT00056160|1581774|P2|COMPLETED|Up to Unblinding (07 Jun 2005)||13
644015|NCT00056160|1581775|P1|COMPLETED|Up to Unblinding (07 Jun 2005)||64
644016|NCT00056160|1581774|P2|STARTED|Up to Unblinding (07 Jun 2005)||176
644017|NCT00056160|1581775|P1|STARTED|Up to Unblinding (07 Jun 2005)||177
644018|NCT00055692|1581787|P1|NOT COMPLETED|Overall Study||0
644019|NCT00055692|1581787|P1|COMPLETED|Overall Study||46
644020|NCT00055692|1581787|P1|STARTED|Overall Study||46
644021|NCT00055601|1581798|P2|NOT COMPLETED|Overall Study||2
644022|NCT00055601|1581799|P1|NOT COMPLETED|Overall Study||2
644023|NCT00055601|1581798|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|47
644024|NCT00055601|1581799|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|46
644025|NCT00055601|1581798|P2|STARTED|Overall Study||49
644026|NCT00055601|1581799|P1|STARTED|Overall Study||48
644027|NCT00055497|1581813|P4|NOT COMPLETED|Overall Study||90
644028|NCT00055497|1581814|P3|NOT COMPLETED|Overall Study||2
644029|NCT00055497|1581815|P2|NOT COMPLETED|Overall Study||3
644030|NCT00055497|1581816|P1|NOT COMPLETED|Overall Study||5
644031|NCT00055497|1581813|P4|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|131
644032|NCT00055497|1581814|P3|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|16
644033|NCT00055497|1581815|P2|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|16
644034|NCT00055497|1581816|P1|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|13
644035|NCT00055497|1581813|P4|STARTED|Overall Study|17 participants who discontinued at/before Week 4 are counted here because they were not randomized.|221
644036|NCT00055497|1581814|P3|STARTED|Overall Study||18
644037|NCT00055497|1581815|P2|STARTED|Overall Study||19
644038|NCT00055497|1581816|P1|STARTED|Overall Study||18
644039|NCT00055471|1581861|P3|NOT COMPLETED|Period 2: Extension Period||0
644040|NCT00055471|1581862|P2|NOT COMPLETED|Period 2: Extension Period||0
644041|NCT00055471|1581863|P1|NOT COMPLETED|Period 2: Extension Period||0
644042|NCT00055471|1581861|P3|COMPLETED|Period 2: Extension Period||0
644043|NCT00055471|1581862|P2|COMPLETED|Period 2: Extension Period||6
644044|NCT00055471|1581863|P1|COMPLETED|Period 2: Extension Period||3
644045|NCT00055471|1581861|P3|STARTED|Period 2: Extension Period||0
644046|NCT00055471|1581862|P2|STARTED|Period 2: Extension Period|2 pts discontinued after completion of Period1,therefore 9 pts proceeded to participate in Period2|6
644047|NCT00055471|1581863|P1|STARTED|Period 2: Extension Period|Period 2 - attend Pts who,in the opinion of the Investigator,show benefit from treatment with ZD4054|3
644048|NCT00055471|1581861|P3|NOT COMPLETED|Period 1: Dose Escalation Period||3
644049|NCT00055471|1581862|P2|NOT COMPLETED|Period 1: Dose Escalation Period||2
644050|NCT00055471|1581863|P1|NOT COMPLETED|Period 1: Dose Escalation Period||0
644051|NCT00055471|1581861|P3|COMPLETED|Period 1: Dose Escalation Period||0
644052|NCT00055471|1581862|P2|COMPLETED|Period 1: Dose Escalation Period||8
644053|NCT00055471|1581863|P1|COMPLETED|Period 1: Dose Escalation Period||3
644054|NCT00055471|1581861|P3|STARTED|Period 1: Dose Escalation Period|Dose level given only after lower dose was successfully administered.|3
644055|NCT00055471|1581862|P2|STARTED|Period 1: Dose Escalation Period|Dose level given only after lower dose was successfully administered.|10
644056|NCT00055471|1581863|P1|STARTED|Period 1: Dose Escalation Period||3
644057|NCT00055237|1581891|P2|NOT COMPLETED|Overall Study||0
644058|NCT00055237|1581892|P1|NOT COMPLETED|Overall Study||0
644059|NCT00055237|1581891|P2|COMPLETED|Overall Study||2
644060|NCT00055237|1581892|P1|COMPLETED|Overall Study||17
644061|NCT00055237|1581891|P2|STARTED|Overall Study||2
644062|NCT00055237|1581892|P1|STARTED|Overall Study||17
644063|NCT00054847|1581899|P2|NOT COMPLETED|Overall Study||100
644064|NCT00054847|1581900|P1|NOT COMPLETED|Overall Study||98
644065|NCT00054847|1581899|P2|COMPLETED|Overall Study||266
644066|NCT00054847|1581900|P1|COMPLETED|Overall Study||269
644067|NCT00054847|1581899|P2|STARTED|Overall Study||366
644068|NCT00054847|1581900|P1|STARTED|Overall Study||367
644069|NCT00054717|1581914|P2|NOT COMPLETED|Overall Study||299
644070|NCT00054717|1581915|P1|NOT COMPLETED|Overall Study||262
644071|NCT00054717|1581914|P2|COMPLETED|Overall Study||18
644072|NCT00054717|1581915|P1|COMPLETED|Overall Study||51
644073|NCT00054717|1581914|P2|STARTED|Overall Study||317
644074|NCT00054717|1581915|P1|STARTED|Overall Study||313
644075|NCT00054704|1582103|P2|NOT COMPLETED|Overall Study||5
644076|NCT00054704|1582104|P1|NOT COMPLETED|Overall Study||5
644077|NCT00054704|1582103|P2|COMPLETED|Overall Study||6
644078|NCT00054704|1582104|P1|COMPLETED|Overall Study||4
644079|NCT00054704|1582103|P2|STARTED|Overall Study||11
644080|NCT00054704|1582104|P1|STARTED|Overall Study||9
644081|NCT00054691|1582110|P1|NOT COMPLETED|Overall Study||3
644082|NCT00054691|1582110|P1|COMPLETED|Overall Study||37
644083|NCT00054691|1582110|P1|STARTED|Overall Study||40
644084|NCT00054665|1582115|P2|NOT COMPLETED|Part B||0
644085|NCT00054665|1582116|P1|NOT COMPLETED|Part B||0
644086|NCT00054665|1582115|P2|COMPLETED|Part B||44
644087|NCT00054665|1582116|P1|COMPLETED|Part B||0
644088|NCT00054665|1582115|P2|STARTED|Part B|26 participants received only Part B|44
644089|NCT00054665|1582116|P1|STARTED|Part B||0
644090|NCT00054665|1582115|P2|NOT COMPLETED|Part A||0
644091|NCT00054665|1582116|P1|NOT COMPLETED|Part A||0
644092|NCT00054665|1582115|P2|COMPLETED|Part A||0
644093|NCT00054665|1582116|P1|COMPLETED|Part A||23
644094|NCT00054665|1582115|P2|STARTED|Part A||0
644095|NCT00054665|1582116|P1|STARTED|Part A|5 participants only received Part A and 18 participants received Part B after Part A.|23
644096|NCT00054639|1582124|P1|NOT COMPLETED|Overall Study||2
644097|NCT00054639|1582124|P1|COMPLETED|Overall Study||46
644098|NCT00054639|1582124|P1|STARTED|Overall Study||48
644099|NCT00054353|1582130|P2|NOT COMPLETED|Overall Study||0
644100|NCT00054353|1582131|P1|NOT COMPLETED|Overall Study||0
644101|NCT00054353|1582130|P2|COMPLETED|Overall Study||4
644102|NCT00054353|1582131|P1|COMPLETED|Overall Study||12
644103|NCT00054353|1582130|P2|STARTED|Overall Study||4
644104|NCT00054353|1582131|P1|STARTED|Overall Study||12
644105|NCT00054327|1582157|P6|NOT COMPLETED|Overall Study||0
644106|NCT00054327|1582158|P5|NOT COMPLETED|Overall Study||0
644107|NCT00054327|1582159|P4|NOT COMPLETED|Overall Study||0
644108|NCT00054327|1582160|P3|NOT COMPLETED|Overall Study||0
644109|NCT00054327|1582161|P2|NOT COMPLETED|Overall Study||0
644110|NCT00054327|1582162|P1|NOT COMPLETED|Overall Study||1
644111|NCT00054327|1582157|P6|COMPLETED|Overall Study||2
644112|NCT00054327|1582158|P5|COMPLETED|Overall Study||10
644113|NCT00054327|1582159|P4|COMPLETED|Overall Study||4
644114|NCT00054327|1582160|P3|COMPLETED|Overall Study||3
644115|NCT00054327|1582161|P2|COMPLETED|Overall Study||4
644116|NCT00054327|1582162|P1|COMPLETED|Overall Study||10
644117|NCT00054327|1582157|P6|STARTED|Overall Study||2
644118|NCT00054327|1582158|P5|STARTED|Overall Study||10
644119|NCT00054327|1582159|P4|STARTED|Overall Study||4
644120|NCT00054327|1582160|P3|STARTED|Overall Study||3
644121|NCT00054327|1582161|P2|STARTED|Overall Study||4
644122|NCT00054327|1582162|P1|STARTED|Overall Study||11
644123|NCT00054275|1582200|P1|NOT COMPLETED|Overall Study||11
644124|NCT00054275|1582200|P1|COMPLETED|Overall Study||28
644125|NCT00054275|1582200|P1|STARTED|Overall Study||39
644126|NCT00054132|1582206|P1|NOT COMPLETED|Overall Study||1
644127|NCT00054132|1582206|P1|COMPLETED|Overall Study||37
644128|NCT00054132|1582206|P1|STARTED|Overall Study||38
644129|NCT00054028|1582217|P1|NOT COMPLETED|Overall Study||0
644130|NCT00054028|1582217|P1|COMPLETED|Overall Study||31
644131|NCT00054028|1582217|P1|Phase II|Overall Study||22
644132|NCT00054028|1582217|P1|Phase I|Overall Study||9
644133|NCT00054028|1582217|P1|STARTED|Overall Study||31
644134|NCT00053898|1582225|P2|NOT COMPLETED|Overall Study||13
644135|NCT00053898|1582226|P1|NOT COMPLETED|Overall Study||14
644136|NCT00053898|1582225|P2|COMPLETED|Overall Study||1539
644137|NCT00053898|1582226|P1|COMPLETED|Overall Study||1538
644138|NCT00053898|1582225|P2|STARTED|Overall Study||1552
644139|NCT00053898|1582226|P1|STARTED|Overall Study||1552
644140|NCT00053846|1582250|P2|NOT COMPLETED|Overall Study||27
644141|NCT00053846|1582251|P1|NOT COMPLETED|Overall Study||26
644142|NCT00053846|1582250|P2|COMPLETED|Overall Study||192
644143|NCT00053846|1582251|P1|COMPLETED|Overall Study||187
644144|NCT00053846|1582250|P2|STARTED|Overall Study||219
644145|NCT00053846|1582251|P1|STARTED|Overall Study||213
644146|NCT00053703|1582260|P3|NOT COMPLETED|Overall Study||15
644147|NCT00053703|1582261|P2|NOT COMPLETED|Overall Study||13
644148|NCT00053703|1582262|P1|NOT COMPLETED|Overall Study||18
644149|NCT00053703|1582260|P3|COMPLETED|Overall Study||25
644150|NCT00053703|1582261|P2|COMPLETED|Overall Study||28
644151|NCT00053703|1582262|P1|COMPLETED|Overall Study||17
644152|NCT00053703|1582260|P3|STARTED|Overall Study||40
644153|NCT00053703|1582261|P2|STARTED|Overall Study||41
644154|NCT00053703|1582262|P1|STARTED|Overall Study||35
644155|NCT00053677|1582287|P2|NOT COMPLETED|Overall Study||6
644156|NCT00053677|1582288|P1|NOT COMPLETED|Overall Study||22
644157|NCT00053677|1582287|P2|COMPLETED|Overall Study||13
644158|NCT00053677|1582288|P1|COMPLETED|Overall Study||36
644159|NCT00053677|1582287|P2|STARTED|Overall Study||19
644160|NCT00053677|1582288|P1|STARTED|Overall Study||58
644161|NCT00053495|1582299|P5|NOT COMPLETED|Overall Study||0
644162|NCT00053495|1582300|P4|NOT COMPLETED|Overall Study||0
644163|NCT00053495|1582301|P3|NOT COMPLETED|Overall Study||0
644164|NCT00053495|1582302|P2|NOT COMPLETED|Overall Study||0
644165|NCT00053495|1582303|P1|NOT COMPLETED|Overall Study||0
644166|NCT00053495|1582299|P5|COMPLETED|Overall Study||49
644167|NCT00053495|1582300|P4|COMPLETED|Overall Study||51
644168|NCT00053495|1582301|P3|COMPLETED|Overall Study||101
644169|NCT00053495|1582302|P2|COMPLETED|Overall Study||101
644170|NCT00053495|1582303|P1|COMPLETED|Overall Study||51
644171|NCT00053495|1582299|P5|STARTED|Overall Study||49
644172|NCT00053495|1582300|P4|STARTED|Overall Study||51
644173|NCT00053495|1582301|P3|STARTED|Overall Study||101
644174|NCT00053495|1582302|P2|STARTED|Overall Study||101
644175|NCT00053495|1582303|P1|STARTED|Overall Study||51
644176|NCT00053482|1582355|P5|NOT COMPLETED|Overall Study||0
644177|NCT00053482|1582356|P4|NOT COMPLETED|Overall Study||0
644178|NCT00053482|1582357|P3|NOT COMPLETED|Overall Study||0
644179|NCT00053482|1582358|P2|NOT COMPLETED|Overall Study||0
644180|NCT00053482|1582359|P1|NOT COMPLETED|Overall Study||0
644181|NCT00053482|1582355|P5|COMPLETED|Overall Study||52
644182|NCT00053482|1582356|P4|COMPLETED|Overall Study||50
644183|NCT00053482|1582357|P3|COMPLETED|Overall Study||102
644184|NCT00053482|1582358|P2|COMPLETED|Overall Study||102
644185|NCT00053482|1582359|P1|COMPLETED|Overall Study||51
644186|NCT00053482|1582355|P5|STARTED|Overall Study||52
644187|NCT00053482|1582356|P4|STARTED|Overall Study||50
644188|NCT00053482|1582357|P3|STARTED|Overall Study||102
644189|NCT00053482|1582358|P2|STARTED|Overall Study||102
644190|NCT00053482|1582359|P1|STARTED|Overall Study||51
644191|NCT00053417|1582410|P4|NOT COMPLETED|Overall Study||6
644192|NCT00053417|1582411|P3|NOT COMPLETED|Overall Study||1
644193|NCT00053417|1582412|P2|NOT COMPLETED|Overall Study||2
644194|NCT00053417|1582413|P1|NOT COMPLETED|Overall Study||2
644195|NCT00053417|1582410|P4|COMPLETED|Overall Study||51
644196|NCT00053417|1582411|P3|COMPLETED|Overall Study||49
644197|NCT00053417|1582412|P2|COMPLETED|Overall Study||50
644198|NCT00053417|1582413|P1|COMPLETED|Overall Study||45
644199|NCT00053417|1582410|P4|STARTED|Overall Study||57
644200|NCT00053417|1582411|P3|STARTED|Overall Study||50
644201|NCT00053417|1582412|P2|STARTED|Overall Study||52
644202|NCT00053417|1582413|P1|STARTED|Overall Study||47
644203|NCT00053365|1582423|P1|NOT COMPLETED|Overall Study||6
644204|NCT00053365|1582423|P1|COMPLETED|Overall Study||55
644205|NCT00053365|1582423|P1|STARTED|Overall Study||61
644206|NCT00053352|1582433|P2|NOT COMPLETED|Overall Study||10
644207|NCT00053352|1582434|P1|NOT COMPLETED|Overall Study||21
644208|NCT00053352|1582433|P2|COMPLETED|Overall Study||102
644209|NCT00053352|1582434|P1|COMPLETED|Overall Study||169
644210|NCT00053352|1582433|P2|STARTED|Overall Study||112
644211|NCT00053352|1582434|P1|STARTED|Overall Study||190
644212|NCT00053014|1582443|P1|NOT COMPLETED|Overall Study||0
644213|NCT00053014|1582443|P1|COMPLETED|Overall Study||5
644214|NCT00053014|1582443|P1|STARTED|Overall Study||5
644215|NCT00003830|1582450|P2|NOT COMPLETED|Overall Study||793
644216|NCT00003830|1582451|P1|NOT COMPLETED|Overall Study||832
644217|NCT00003830|1582450|P2|COMPLETED|Overall Study||2011
644218|NCT00003830|1582451|P1|COMPLETED|Overall Study||1975
644219|NCT00003830|1582450|P2|STARTED|Overall Study||2804
644220|NCT00003830|1582451|P1|STARTED|Overall Study||2807
644221|NCT00052962|1582477|P2|NOT COMPLETED|Overall Study||2
644222|NCT00052962|1582478|P1|NOT COMPLETED|Overall Study||1
644223|NCT00052962|1582477|P2|COMPLETED|Overall Study||15
644224|NCT00052962|1582478|P1|COMPLETED|Overall Study||12
644225|NCT00052962|1582477|P2|STARTED|Overall Study||17
644226|NCT00052962|1582478|P1|STARTED|Overall Study||13
644227|NCT00052715|1582486|P1|NOT COMPLETED|Overall Study||1
644228|NCT00052715|1582486|P1|COMPLETED|Overall Study||30
644229|NCT00052715|1582486|P1|STARTED|Overall Study||31
644230|NCT00052429|1582493|P1|NOT COMPLETED|Overall Study||0
644231|NCT00052429|1582493|P1|COMPLETED|Overall Study||25
644232|NCT00052429|1582493|P1|STARTED|Overall Study||25
644233|NCT00049543|1582500|P2|NOT COMPLETED|Overall Study||9
644234|NCT00049543|1582501|P1|NOT COMPLETED|Overall Study||2
644235|NCT00049543|1582500|P2|COMPLETED|Overall Study||243
644236|NCT00049543|1582501|P1|COMPLETED|Overall Study||249
644237|NCT00049543|1582500|P2|STARTED|Overall Study||252
644238|NCT00049543|1582501|P1|STARTED|Overall Study||251
644239|NCT00049530|1582511|P1|NOT COMPLETED|Overall Study||32
644240|NCT00049530|1582511|P1|COMPLETED|Overall Study||0
644241|NCT00049530|1582511|P1|Eligible and Treated|Overall Study||29
644242|NCT00049530|1582511|P1|STARTED|Overall Study||32
644243|NCT00049517|1582520|P6|NOT COMPLETED|Conditioning/Transplant||6
644244|NCT00049517|1582521|P5|NOT COMPLETED|Conditioning/Transplant||6
644245|NCT00049517|1582522|P4|NOT COMPLETED|Conditioning/Transplant||43
644246|NCT00049517|1582523|P3|NOT COMPLETED|Conditioning/Transplant||38
644247|NCT00049517|1582524|P2|NOT COMPLETED|Conditioning/Transplant||50
644248|NCT00049517|1582525|P1|NOT COMPLETED|Conditioning/Transplant||52
644249|NCT00049517|1582520|P6|COMPLETED|Conditioning/Transplant||18
644250|NCT00049517|1582521|P5|COMPLETED|Conditioning/Transplant||15
644251|NCT00049517|1582522|P4|COMPLETED|Conditioning/Transplant||32
644252|NCT00049517|1582523|P3|COMPLETED|Conditioning/Transplant||25
644253|NCT00049517|1582524|P2|COMPLETED|Conditioning/Transplant||40
644254|NCT00049517|1582525|P1|COMPLETED|Conditioning/Transplant||27
644255|NCT00049517|1582520|P6|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|These 24 patients received Allogeneic HCT without randomization.|0
644256|NCT00049517|1582521|P5|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|These 21 patients received Allogeneic HCT without randomization.|0
644257|NCT00049517|1582522|P4|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||75
644258|NCT00049517|1582523|P3|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||63
644259|NCT00049517|1582524|P2|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|Additional 17 patients received Autologous HCT without randomization.|73
644260|NCT00049517|1582525|P1|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|Additional 20 patients received Autologous HCT without randomization.|59
644261|NCT00049517|1582520|P6|STARTED|Conditioning/Transplant||24
644262|NCT00049517|1582521|P5|STARTED|Conditioning/Transplant||21
644263|NCT00049517|1582522|P4|STARTED|Conditioning/Transplant||75
644264|NCT00049517|1582523|P3|STARTED|Conditioning/Transplant||63
644265|NCT00049517|1582524|P2|STARTED|Conditioning/Transplant||90
644266|NCT00049517|1582525|P1|STARTED|Conditioning/Transplant||79
644267|NCT00049517|1582520|P6|NOT COMPLETED|Induction||54
644268|NCT00049517|1582521|P5|NOT COMPLETED|Induction||60
644269|NCT00049517|1582522|P4|NOT COMPLETED|Induction||0
644270|NCT00049517|1582523|P3|NOT COMPLETED|Induction||0
644271|NCT00049517|1582524|P2|NOT COMPLETED|Induction||0
644272|NCT00049517|1582525|P1|NOT COMPLETED|Induction||0
644273|NCT00049517|1582520|P6|COMPLETED|Induction||108
644274|NCT00049517|1582521|P5|COMPLETED|Induction||128
644275|NCT00049517|1582522|P4|COMPLETED|Induction||75
644276|NCT00049517|1582523|P3|COMPLETED|Induction||63
644277|NCT00049517|1582524|P2|COMPLETED|Induction||90
644278|NCT00049517|1582525|P1|COMPLETED|Induction||79
644279|NCT00049517|1582520|P6|Treated|Induction||160
644280|NCT00049517|1582521|P5|Treated|Induction||186
644281|NCT00049517|1582522|P4|Treated|Induction||75
644282|NCT00049517|1582523|P3|Treated|Induction||63
644283|NCT00049517|1582524|P2|Treated|Induction||90
644284|NCT00049517|1582525|P1|Treated|Induction||79
644285|NCT00049517|1582520|P6|STARTED|Induction||162
644286|NCT00049517|1582521|P5|STARTED|Induction||188
644287|NCT00049517|1582522|P4|STARTED|Induction||75
644288|NCT00049517|1582523|P3|STARTED|Induction||63
644289|NCT00049517|1582524|P2|STARTED|Induction||90
644290|NCT00049517|1582525|P1|STARTED|Induction||79
644291|NCT00049504|1582535|P1|NOT COMPLETED|Overall Study||0
644292|NCT00049504|1582535|P1|COMPLETED|Overall Study||55
644293|NCT00049504|1582535|P1|STARTED|Overall Study||55
644294|NCT00049322|1582543|P2|NOT COMPLETED|Overall Study||6
644295|NCT00049322|1582544|P1|NOT COMPLETED|Overall Study||1
644296|NCT00049322|1582543|P2|COMPLETED|Overall Study||9
644297|NCT00049322|1582544|P1|COMPLETED|Overall Study||14
644298|NCT00049322|1582543|P2|STARTED|Overall Study||15
644299|NCT00049322|1582544|P1|STARTED|Overall Study||15
644300|NCT00049257|1582556|P1|NOT COMPLETED|Follow-up Period for Survival Status||4
644301|NCT00049257|1582556|P1|COMPLETED|Follow-up Period for Survival Status||41
644302|NCT00049257|1582556|P1|STARTED|Follow-up Period for Survival Status||45
644303|NCT00049257|1582556|P1|NOT COMPLETED|Carboplatin, Paclitaxel||13
644304|NCT00049257|1582556|P1|COMPLETED|Carboplatin, Paclitaxel|13 participants did not complete treatment|45
644305|NCT00049257|1582556|P1|STARTED|Carboplatin, Paclitaxel||58
644306|NCT00049127|1582568|P5|NOT COMPLETED|Overall Study||0
644307|NCT00049127|1582569|P4|NOT COMPLETED|Overall Study||0
644308|NCT00049127|1582570|P3|NOT COMPLETED|Overall Study||1
644309|NCT00049127|1582571|P2|NOT COMPLETED|Overall Study||0
644310|NCT00049127|1582572|P1|NOT COMPLETED|Overall Study||0
644311|NCT00049127|1582568|P5|COMPLETED|Overall Study||12
644312|NCT00049127|1582569|P4|COMPLETED|Overall Study||0
644313|NCT00049127|1582570|P3|COMPLETED|Overall Study||39
644314|NCT00049127|1582571|P2|COMPLETED|Overall Study||0
644315|NCT00049127|1582572|P1|COMPLETED|Overall Study||12
644316|NCT00049127|1582568|P5|STARTED|Overall Study||12
644317|NCT00049127|1582569|P4|STARTED|Overall Study||0
644318|NCT00049127|1582570|P3|STARTED|Overall Study||40
644319|NCT00049127|1582571|P2|STARTED|Overall Study||0
644320|NCT00049127|1582572|P1|STARTED|Overall Study||12
644321|NCT00049036|1582601|P2|NOT COMPLETED|Overall Study||0
644322|NCT00049036|1582602|P1|NOT COMPLETED|Overall Study||0
644323|NCT00049036|1582601|P2|COMPLETED|Overall Study||55
644324|NCT00049036|1582602|P1|COMPLETED|Overall Study||51
644325|NCT00049036|1582601|P2|STARTED|Overall Study||55
644326|NCT00049036|1582602|P1|STARTED|Overall Study||51
644327|NCT00048997|1582610|P2|NOT COMPLETED|Overall Study||3
644328|NCT00048997|1582611|P1|NOT COMPLETED|Overall Study||13
644329|NCT00048997|1582610|P2|COMPLETED|Overall Study||177
644330|NCT00048997|1582611|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|163
644331|NCT00048997|1582610|P2|STARTED|Overall Study||180
644332|NCT00048997|1582611|P1|STARTED|Overall Study||176
644333|NCT00047385|1582634|P2|NOT COMPLETED|Overall Study||500
644334|NCT00047385|1582635|P1|NOT COMPLETED|Overall Study||267
644335|NCT00047385|1582634|P2|COMPLETED|Overall Study||26232
644336|NCT00047385|1582635|P1|COMPLETED|Overall Study|Had at least one screening exam.|26455
644337|NCT00047385|1582634|P2|STARTED|Overall Study||26732
644338|NCT00047385|1582635|P1|STARTED|Overall Study||26722
644339|NCT00047320|1582653|P1|NOT COMPLETED|Overall Study||28
644340|NCT00047320|1582653|P1|COMPLETED|Overall Study||76
644341|NCT00047320|1582653|P1|STARTED|Overall Study||104
644342|NCT00047008|1582664|P2|NOT COMPLETED|Overall Study||11
644343|NCT00047008|1582665|P1|NOT COMPLETED|Overall Study||11
644344|NCT00047008|1582664|P2|COMPLETED|Overall Study||360
644345|NCT00047008|1582665|P1|COMPLETED|Overall Study||361
644346|NCT00047008|1582664|P2|STARTED|Overall Study||371
644347|NCT00047008|1582665|P1|STARTED|Overall Study||372
644348|NCT00046930|1582673|P2|NOT COMPLETED|Overall Study||4
644349|NCT00046930|1582674|P1|NOT COMPLETED|Overall Study||12
644350|NCT00046930|1582673|P2|COMPLETED|Overall Study||221
644351|NCT00046930|1582674|P1|COMPLETED|Overall Study||212
644352|NCT00046930|1582673|P2|STARTED|Overall Study||225
644353|NCT00046930|1582674|P1|STARTED|Overall Study||224
644354|NCT00046891|1582689|P2|NOT COMPLETED|Overall Study||30
644355|NCT00046891|1582690|P1|NOT COMPLETED|Overall Study||29
644356|NCT00046891|1582689|P2|COMPLETED|Overall Study||83
644357|NCT00046891|1582690|P1|COMPLETED|Overall Study||84
644358|NCT00046891|1582689|P2|STARTED|Overall Study||113
644359|NCT00046891|1582690|P1|STARTED|Overall Study||113
644360|NCT00046839|1582710|P2|NOT COMPLETED|Overall Study||2
644361|NCT00046839|1582711|P1|NOT COMPLETED|Overall Study||1
644362|NCT00046839|1582710|P2|COMPLETED|Overall Study|Subjects contributing data to either primary analysis are considered to have completed the study.|11
644363|NCT00046839|1582711|P1|COMPLETED|Overall Study|Subjects contributing data to either primary analysis are considered to have completed the study.|7
644364|NCT00046839|1582710|P2|STARTED|Overall Study||13
644365|NCT00046839|1582711|P1|STARTED|Overall Study||8
644366|NCT00045734|1582718|P1|NOT COMPLETED|Overall Study||1
644367|NCT00045734|1582718|P1|COMPLETED|Overall Study||22
644368|NCT00045734|1582718|P1|STARTED|Overall Study||23
644369|NCT00045708|1582733|P3|NOT COMPLETED|Phase 2||0
644370|NCT00045708|1582734|P2|NOT COMPLETED|Phase 2||0
644371|NCT00045708|1582735|P1|NOT COMPLETED|Phase 2||0
644372|NCT00045708|1582733|P3|COMPLETED|Phase 2||19
644373|NCT00045708|1582734|P2|COMPLETED|Phase 2||0
644374|NCT00045708|1582735|P1|COMPLETED|Phase 2||0
644375|NCT00045708|1582733|P3|STARTED|Phase 2||19
644376|NCT00045708|1582734|P2|STARTED|Phase 2||0
644377|NCT00045708|1582735|P1|STARTED|Phase 2||0
644378|NCT00045708|1582733|P3|NOT COMPLETED|Phase 1||0
644379|NCT00045708|1582734|P2|NOT COMPLETED|Phase 1||1
644380|NCT00045708|1582735|P1|NOT COMPLETED|Phase 1||0
644381|NCT00045708|1582733|P3|COMPLETED|Phase 1||0
644382|NCT00045708|1582734|P2|COMPLETED|Phase 1||16
644383|NCT00045708|1582735|P1|COMPLETED|Phase 1||21
644384|NCT00045708|1582733|P3|STARTED|Phase 1||0
644385|NCT00045708|1582734|P2|STARTED|Phase 1||17
644386|NCT00045708|1582735|P1|STARTED|Phase 1||21
644387|NCT00045630|1582760|P1|NOT COMPLETED|Overall Study||6
644388|NCT00045630|1582760|P1|COMPLETED|Overall Study||71
644389|NCT00045630|1582760|P1|Eligible and Began Protocol Therapy|Overall Study||74
644390|NCT00045630|1582760|P1|Eligible|Overall Study||75
644391|NCT00045630|1582760|P1|STARTED|Overall Study||77
644392|NCT00045487|1582766|P1|NOT COMPLETED|Overall Study||11
644393|NCT00045487|1582766|P1|COMPLETED|Overall Study||30
644394|NCT00045487|1582766|P1|STARTED|Overall Study||41
644395|NCT00045435|1582770|P1|NOT COMPLETED|Overall Study||0
644396|NCT00045435|1582770|P1|COMPLETED|Overall Study||17
644397|NCT00045435|1582770|P1|STARTED|Overall Study||17
644398|NCT00045305|1582779|P1|NOT COMPLETED|Overall Study||14
644399|NCT00045305|1582779|P1|COMPLETED|Overall Study||3
644400|NCT00045305|1582779|P1|Eligible and Treated|Overall Study||17
644401|NCT00045305|1582779|P1|STARTED|Overall Study||17
644402|NCT00045162|1582790|P2|NOT COMPLETED|Overall Study||118
644403|NCT00045162|1582791|P1|NOT COMPLETED|Overall Study||142
644404|NCT00045162|1582790|P2|COMPLETED|Overall Study||217
644405|NCT00045162|1582791|P1|COMPLETED|Overall Study||194
644406|NCT00045162|1582790|P2|STARTED|Overall Study||335
644407|NCT00045162|1582791|P1|STARTED|Overall Study||336
644408|NCT00045110|1582806|P3|NOT COMPLETED|775mg Dose Escalation||0
644409|NCT00045110|1582807|P2|NOT COMPLETED|775mg Dose Escalation||0
644410|NCT00045110|1582808|P1|NOT COMPLETED|775mg Dose Escalation||0
644411|NCT00045110|1582806|P3|COMPLETED|775mg Dose Escalation||0
644412|NCT00045110|1582807|P2|COMPLETED|775mg Dose Escalation||0
644413|NCT00045110|1582808|P1|COMPLETED|775mg Dose Escalation||7
644414|NCT00045110|1582806|P3|STARTED|775mg Dose Escalation||0
644415|NCT00045110|1582807|P2|STARTED|775mg Dose Escalation||0
644416|NCT00045110|1582808|P1|STARTED|775mg Dose Escalation||7
644417|NCT00045110|1582806|P3|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
644418|NCT00045110|1582807|P2|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
644419|NCT00045110|1582808|P1|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
644420|NCT00045110|1582806|P3|COMPLETED|650mg Phase 1 Dose Escalation||0
644421|NCT00045110|1582807|P2|COMPLETED|650mg Phase 1 Dose Escalation||0
644422|NCT00045110|1582808|P1|COMPLETED|650mg Phase 1 Dose Escalation||6
644423|NCT00045110|1582806|P3|STARTED|650mg Phase 1 Dose Escalation||0
644424|NCT00045110|1582807|P2|STARTED|650mg Phase 1 Dose Escalation||0
644425|NCT00045110|1582808|P1|STARTED|650mg Phase 1 Dose Escalation||6
644426|NCT00045110|1582806|P3|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
644427|NCT00045110|1582807|P2|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
644428|NCT00045110|1582808|P1|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
644429|NCT00045110|1582806|P3|COMPLETED|525mg Phase 1 Dose Escalation||0
644430|NCT00045110|1582807|P2|COMPLETED|525mg Phase 1 Dose Escalation||0
644431|NCT00045110|1582808|P1|COMPLETED|525mg Phase 1 Dose Escalation||3
644432|NCT00045110|1582806|P3|STARTED|525mg Phase 1 Dose Escalation||0
644433|NCT00045110|1582807|P2|STARTED|525mg Phase 1 Dose Escalation||0
644434|NCT00045110|1582808|P1|STARTED|525mg Phase 1 Dose Escalation||3
644435|NCT00045110|1582806|P3|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
644436|NCT00045110|1582807|P2|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
644437|NCT00045110|1582808|P1|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
644438|NCT00045110|1582806|P3|COMPLETED|400mg Phase 1 Dose Escalation||0
644439|NCT00045110|1582807|P2|COMPLETED|400mg Phase 1 Dose Escalation||0
644440|NCT00045110|1582808|P1|COMPLETED|400mg Phase 1 Dose Escalation||3
644441|NCT00045110|1582806|P3|STARTED|400mg Phase 1 Dose Escalation||0
644442|NCT00045110|1582807|P2|STARTED|400mg Phase 1 Dose Escalation||0
644443|NCT00045110|1582808|P1|STARTED|400mg Phase 1 Dose Escalation||3
644444|NCT00045110|1582806|P3|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
644445|NCT00045110|1582807|P2|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
644446|NCT00045110|1582808|P1|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
644447|NCT00045110|1582806|P3|COMPLETED|275mg Phase 1 Dose Escalation||0
644448|NCT00045110|1582807|P2|COMPLETED|275mg Phase 1 Dose Escalation||0
644449|NCT00045110|1582808|P1|COMPLETED|275mg Phase 1 Dose Escalation||3
644450|NCT00045110|1582806|P3|STARTED|275mg Phase 1 Dose Escalation||0
644451|NCT00045110|1582807|P2|STARTED|275mg Phase 1 Dose Escalation||0
644452|NCT00045110|1582808|P1|STARTED|275mg Phase 1 Dose Escalation||3
644453|NCT00045110|1582806|P3|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
644454|NCT00045110|1582807|P2|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
644455|NCT00045110|1582808|P1|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
644456|NCT00045110|1582806|P3|COMPLETED|200mg Phase 1 Dose Escalation||0
644457|NCT00045110|1582807|P2|COMPLETED|200mg Phase 1 Dose Escalation||0
644458|NCT00045110|1582808|P1|COMPLETED|200mg Phase 1 Dose Escalation||4
644459|NCT00045110|1582806|P3|STARTED|200mg Phase 1 Dose Escalation||0
644460|NCT00045110|1582807|P2|STARTED|200mg Phase 1 Dose Escalation||0
644461|NCT00045110|1582808|P1|STARTED|200mg Phase 1 Dose Escalation||4
644462|NCT00045110|1582806|P3|NOT COMPLETED|100mg Phase 1 Dose Escalalation||2
644463|NCT00045110|1582807|P2|NOT COMPLETED|100mg Phase 1 Dose Escalalation||6
644464|NCT00045110|1582808|P1|NOT COMPLETED|100mg Phase 1 Dose Escalalation||0
644465|NCT00045110|1582806|P3|COMPLETED|100mg Phase 1 Dose Escalalation||43
644466|NCT00045110|1582807|P2|COMPLETED|100mg Phase 1 Dose Escalalation||53
644467|NCT00045110|1582808|P1|COMPLETED|100mg Phase 1 Dose Escalalation||6
644468|NCT00045110|1582806|P3|STARTED|100mg Phase 1 Dose Escalalation||45
644469|NCT00045110|1582807|P2|STARTED|100mg Phase 1 Dose Escalalation||59
644470|NCT00045110|1582808|P1|STARTED|100mg Phase 1 Dose Escalalation||6
644471|NCT00045032|1582857|P3|NOT COMPLETED|Overall Study||726
644472|NCT00045032|1582858|P2|NOT COMPLETED|Overall Study||708
644473|NCT00045032|1582859|P1|NOT COMPLETED|Overall Study||863
644474|NCT00045032|1582857|P3|COMPLETED|Overall Study||974
644475|NCT00045032|1582858|P2|COMPLETED|Overall Study||994
644476|NCT00045032|1582859|P1|COMPLETED|Overall Study||834
644477|NCT00045032|1582857|P3|Crossover to Adjuvant Herceptin|Overall Study|This milestone is not applicable to participants who were already randomized to Herceptin.|0
644478|NCT00045032|1582858|P2|Crossover to Adjuvant Herceptin|Overall Study|This milestone is not applicable to participants who were already randomized to Herceptin.|0
644479|NCT00045032|1582859|P1|Crossover to Adjuvant Herceptin|Overall Study||888
644480|NCT00045032|1582857|P3|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1700
644481|NCT00045032|1582858|P2|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1702
644482|NCT00045032|1582859|P1|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1697
644483|NCT00042991|1582993|P7|NOT COMPLETED|Overall Study||2
644484|NCT00042991|1582994|P6|NOT COMPLETED|Overall Study||5
644485|NCT00042991|1582995|P5|NOT COMPLETED|Overall Study||3
644486|NCT00042991|1582996|P4|NOT COMPLETED|Overall Study||2
644487|NCT00042991|1582997|P3|NOT COMPLETED|Overall Study||6
644488|NCT00042991|1582998|P2|NOT COMPLETED|Overall Study||40
644489|NCT00042991|1582999|P1|NOT COMPLETED|Overall Study||6
644490|NCT00042991|1582993|P7|COMPLETED|Overall Study||1
644491|NCT00042991|1582994|P6|COMPLETED|Overall Study||0
644492|NCT00042991|1582995|P5|COMPLETED|Overall Study||0
644493|NCT00042991|1582996|P4|COMPLETED|Overall Study||0
644494|NCT00042991|1582997|P3|COMPLETED|Overall Study||1
644495|NCT00042991|1582998|P2|COMPLETED|Overall Study||3
644496|NCT00042991|1582999|P1|COMPLETED|Overall Study||0
644497|NCT00042991|1582993|P7|Phase-II Trial|Overall Study||0
644498|NCT00042991|1582994|P6|Phase-II Trial|Overall Study||0
644499|NCT00042991|1582995|P5|Phase-II Trial|Overall Study||0
644500|NCT00042991|1582996|P4|Phase-II Trial|Overall Study||0
644501|NCT00042991|1582997|P3|Phase-II Trial|Overall Study||0
644502|NCT00042991|1582998|P2|Phase-II Trial|Overall Study||36
644503|NCT00042991|1582999|P1|Phase-II Trial|Overall Study||0
644504|NCT00042991|1582993|P7|Phase-I Trial|Overall Study||3
644505|NCT00042991|1582994|P6|Phase-I Trial|Overall Study||5
644506|NCT00042991|1582995|P5|Phase-I Trial|Overall Study||3
644507|NCT00042991|1582996|P4|Phase-I Trial|Overall Study||2
644508|NCT00042991|1582997|P3|Phase-I Trial|Overall Study||7
644509|NCT00042991|1582998|P2|Phase-I Trial|Overall Study|These seven patients contributed to both Phase-I and Phase-II objectives.|7
644510|NCT00042991|1582999|P1|Phase-I Trial|Overall Study||6
644511|NCT00042991|1582993|P7|STARTED|Overall Study||3
644512|NCT00042991|1582994|P6|STARTED|Overall Study||5
644513|NCT00042991|1582995|P5|STARTED|Overall Study||3
644514|NCT00042991|1582996|P4|STARTED|Overall Study||2
644515|NCT00042991|1582997|P3|STARTED|Overall Study||7
644516|NCT00042991|1582998|P2|STARTED|Overall Study|These 43 patients form the Phase-II cohort, seven contributing from the Phase-I trial.|43
644517|NCT00042991|1582999|P1|STARTED|Overall Study||6
644518|NCT00042939|1583042|P2|NOT COMPLETED|Overall Study||21
644519|NCT00042939|1583043|P1|NOT COMPLETED|Overall Study||24
644520|NCT00042939|1583042|P2|COMPLETED|Overall Study||25
644521|NCT00042939|1583043|P1|COMPLETED|Overall Study||24
644522|NCT00042939|1583042|P2|Patients With EGFR Results Available|Overall Study||31
644523|NCT00042939|1583043|P1|Patients With EGFR Results Available|Overall Study||30
644524|NCT00042939|1583042|P2|Eligible and Began Protocol Therapy|Overall Study||43
644525|NCT00042939|1583043|P1|Eligible and Began Protocol Therapy|Overall Study||44
644526|NCT00042939|1583042|P2|Treated|Overall Study||45
644527|NCT00042939|1583043|P1|Treated|Overall Study||46
644528|NCT00042939|1583042|P2|STARTED|Overall Study||46
644529|NCT00042939|1583043|P1|STARTED|Overall Study||48
644530|NCT00041132|1583057|P1|NOT COMPLETED|Overall Study||30
644531|NCT00041132|1583057|P1|COMPLETED|Overall Study||26
644532|NCT00041132|1583057|P1|Eligible and Began Protocol Therapy|Overall Study||49
644533|NCT00041132|1583057|P1|Eligible|Overall Study||49
644534|NCT00041132|1583057|P1|STARTED|Overall Study||56
644535|NCT00041119|1583067|P4|NOT COMPLETED|Overall Study||0
644536|NCT00041119|1583068|P3|NOT COMPLETED|Overall Study||0
644537|NCT00041119|1583069|P2|NOT COMPLETED|Overall Study||0
644538|NCT00041119|1583070|P1|NOT COMPLETED|Overall Study||0
644539|NCT00041119|1583067|P4|COMPLETED|Overall Study||789
644540|NCT00041119|1583068|P3|COMPLETED|Overall Study||1151
644541|NCT00041119|1583069|P2|COMPLETED|Overall Study||789
644542|NCT00041119|1583070|P1|COMPLETED|Overall Study||1142
644543|NCT00041119|1583067|P4|STARTED|Overall Study||789
644544|NCT00041119|1583068|P3|STARTED|Overall Study||1151
644545|NCT00041119|1583069|P2|STARTED|Overall Study||789
644546|NCT00041119|1583070|P1|STARTED|Overall Study||1142
644547|NCT00041080|1583092|P2|NOT COMPLETED|Overall Study||10
644548|NCT00041080|1583093|P1|NOT COMPLETED|Overall Study||30
644549|NCT00041080|1583092|P2|COMPLETED|Overall Study||60
644550|NCT00041080|1583093|P1|COMPLETED|Overall Study||39
644551|NCT00041080|1583092|P2|STARTED|Overall Study|number patients enrolled on study|70
644552|NCT00041080|1583093|P1|STARTED|Overall Study|number patients enrolled on study|69
644553|NCT00041067|1583099|P1|NOT COMPLETED|Overall Study||76
644554|NCT00041067|1583099|P1|COMPLETED|Overall Study||0
644555|NCT00041067|1583099|P1|Eligible|Overall Study||74
644556|NCT00041067|1583099|P1|STARTED|Overall Study||76
644557|NCT00040937|1583106|P1|NOT COMPLETED|Maintenance||0
644558|NCT00040937|1583106|P1|COMPLETED|Maintenance|Patients remained on protocol therapy until progression.|76
644559|NCT00040937|1583106|P1|STARTED|Maintenance||76
644560|NCT00040937|1583106|P1|NOT COMPLETED|Autologous PBSCT||31
644561|NCT00040937|1583106|P1|COMPLETED|Autologous PBSCT||77
644562|NCT00040937|1583106|P1|STARTED|Autologous PBSCT|108 registered to this period; 105 were eligible and analyzable; 105 were assessable for toxicity.|108
644563|NCT00040937|1583106|P1|NOT COMPLETED|Induction/PBSC Mobilization||37
644564|NCT00040937|1583106|P1|COMPLETED|Induction/PBSC Mobilization||110
644565|NCT00040937|1583106|P1|STARTED|Induction/PBSC Mobilization|147 registered to this period; 142 were eligible and analyzable; 140 were assessable for toxicity.|147
644566|NCT00040846|1583119|P6|NOT COMPLETED|Overall Study||0
644567|NCT00040846|1583120|P5|NOT COMPLETED|Overall Study||0
644568|NCT00040846|1583121|P4|NOT COMPLETED|Overall Study||0
644569|NCT00040846|1583122|P3|NOT COMPLETED|Overall Study||0
644570|NCT00040846|1583123|P2|NOT COMPLETED|Overall Study||0
644571|NCT00040846|1583124|P1|NOT COMPLETED|Overall Study||0
644572|NCT00040846|1583119|P6|COMPLETED|Overall Study||0
644573|NCT00040846|1583120|P5|COMPLETED|Overall Study||0
644574|NCT00040846|1583121|P4|COMPLETED|Overall Study||0
644575|NCT00040846|1583122|P3|COMPLETED|Overall Study||0
644576|NCT00040846|1583123|P2|COMPLETED|Overall Study||0
644577|NCT00040846|1583124|P1|COMPLETED|Overall Study||60
644578|NCT00040846|1583119|P6|STARTED|Overall Study||0
644579|NCT00040846|1583120|P5|STARTED|Overall Study||0
644580|NCT00040846|1583121|P4|STARTED|Overall Study||0
644581|NCT00040846|1583122|P3|STARTED|Overall Study||0
644582|NCT00040846|1583123|P2|STARTED|Overall Study||0
644583|NCT00040846|1583124|P1|STARTED|Overall Study||60
644584|NCT00040742|1583166|P4|NOT COMPLETED|Overall Study||34
644585|NCT00040742|1583167|P3|NOT COMPLETED|Overall Study||46
644586|NCT00040742|1583168|P2|NOT COMPLETED|Overall Study||49
644587|NCT00040742|1583169|P1|NOT COMPLETED|Overall Study||39
644588|NCT00040742|1583166|P4|COMPLETED|Overall Study||152
644589|NCT00040742|1583167|P3|COMPLETED|Overall Study||141
644590|NCT00040742|1583168|P2|COMPLETED|Overall Study||134
644591|NCT00040742|1583169|P1|COMPLETED|Overall Study||149
644592|NCT00040742|1583166|P4|STARTED|Overall Study|One subject found to be ineligible after randomization. No baseline data collected.|186
644593|NCT00040742|1583167|P3|STARTED|Overall Study||187
644594|NCT00040742|1583168|P2|STARTED|Overall Study||183
644595|NCT00040742|1583169|P1|STARTED|Overall Study||188
644596|NCT00039377|1583183|P4|NOT COMPLETED|Course 5 (Transplant Assignments)||0
644597|NCT00039377|1583184|P3|NOT COMPLETED|Course 5 (Transplant Assignments)||0
644598|NCT00039377|1583185|P2|NOT COMPLETED|Course 5 (Transplant Assignments)||0
644599|NCT00039377|1583186|P1|NOT COMPLETED|Course 5 (Transplant Assignments)||0
644600|NCT00039377|1583183|P4|COMPLETED|Course 5 (Transplant Assignments)||1
644601|NCT00039377|1583184|P3|COMPLETED|Course 5 (Transplant Assignments)||19
644602|NCT00039377|1583185|P2|COMPLETED|Course 5 (Transplant Assignments)||15
644603|NCT00039377|1583186|P1|COMPLETED|Course 5 (Transplant Assignments)||0
644604|NCT00039377|1583183|P4|STARTED|Course 5 (Transplant Assignments)||1
644605|NCT00039377|1583184|P3|STARTED|Course 5 (Transplant Assignments)||19
644606|NCT00039377|1583185|P2|STARTED|Course 5 (Transplant Assignments)||15
644607|NCT00039377|1583186|P1|STARTED|Course 5 (Transplant Assignments)|After Course I-IV, participants were grouped into autologous, allogeneic or no transplant arms.|0
644608|NCT00039377|1583183|P4|NOT COMPLETED|Initial Registration||0
644609|NCT00039377|1583184|P3|NOT COMPLETED|Initial Registration||0
644610|NCT00039377|1583185|P2|NOT COMPLETED|Initial Registration||0
644611|NCT00039377|1583186|P1|NOT COMPLETED|Initial Registration||22
644612|NCT00039377|1583183|P4|COMPLETED|Initial Registration||0
644613|NCT00039377|1583184|P3|COMPLETED|Initial Registration||0
644614|NCT00039377|1583185|P2|COMPLETED|Initial Registration||0
644615|NCT00039377|1583186|P1|COMPLETED|Initial Registration||35
644616|NCT00039377|1583183|P4|STARTED|Initial Registration||0
644617|NCT00039377|1583184|P3|STARTED|Initial Registration||0
644618|NCT00039377|1583185|P2|STARTED|Initial Registration||0
644619|NCT00039377|1583186|P1|STARTED|Initial Registration||57
644620|NCT00039195|1583198|P1|NOT COMPLETED|Overall Study||0
644621|NCT00039195|1583198|P1|COMPLETED|Overall Study||98
644622|NCT00039195|1583198|P1|STARTED|Overall Study||98
644623|NCT00039130|1583202|P1|NOT COMPLETED|Overall Study||30
644624|NCT00039130|1583202|P1|COMPLETED|Overall Study||75
644625|NCT00039130|1583202|P1|STARTED|Overall Study||105
644626|NCT00036738|1583208|P1|NOT COMPLETED|Overall Study||0
644627|NCT00036738|1583208|P1|COMPLETED|Overall Study||28
644628|NCT00036738|1583208|P1|STARTED|Overall Study||28
644629|NCT00033657|1583216|P2|NOT COMPLETED|Adjuvant Chemotherapy||17
644630|NCT00033657|1583217|P1|NOT COMPLETED|Adjuvant Chemotherapy||18
644631|NCT00033657|1583216|P2|COMPLETED|Adjuvant Chemotherapy||16
644632|NCT00033657|1583217|P1|COMPLETED|Adjuvant Chemotherapy||18
644633|NCT00033657|1583216|P2|STARTED|Adjuvant Chemotherapy||33
644634|NCT00033657|1583217|P1|STARTED|Adjuvant Chemotherapy||36
644635|NCT00033657|1583216|P2|NOT COMPLETED|Surgical Resection||3
644636|NCT00033657|1583217|P1|NOT COMPLETED|Surgical Resection||0
644637|NCT00033657|1583216|P2|COMPLETED|Surgical Resection||33
644638|NCT00033657|1583217|P1|COMPLETED|Surgical Resection||36
644639|NCT00033657|1583216|P2|STARTED|Surgical Resection||36
644640|NCT00033657|1583217|P1|STARTED|Surgical Resection||36
644641|NCT00033657|1583216|P2|NOT COMPLETED|Neoadjuvant Chemotherapy||11
644642|NCT00033657|1583217|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||14
644643|NCT00033657|1583216|P2|COMPLETED|Neoadjuvant Chemotherapy||36
644644|NCT00033657|1583217|P1|COMPLETED|Neoadjuvant Chemotherapy||36
644645|NCT00033657|1583216|P2|Eligible and Treated|Neoadjuvant Chemotherapy||42
644646|NCT00033657|1583217|P1|Eligible and Treated|Neoadjuvant Chemotherapy||39
644647|NCT00033657|1583216|P2|Eligible|Neoadjuvant Chemotherapy||43
644648|NCT00033657|1583217|P1|Eligible|Neoadjuvant Chemotherapy||42
644649|NCT00033657|1583216|P2|STARTED|Neoadjuvant Chemotherapy||47
644650|NCT00033657|1583217|P1|STARTED|Neoadjuvant Chemotherapy||50
644651|NCT00033631|1583231|P2|NOT COMPLETED|Overall Study||15
644652|NCT00033631|1583232|P1|NOT COMPLETED|Overall Study||18
644653|NCT00033631|1583231|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|748
644744|NCT00026312|1583381|P1|STARTED|Overall Study||116
644654|NCT00033631|1583232|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|751
644655|NCT00033631|1583231|P2|STARTED|Overall Study||763
644656|NCT00033631|1583232|P1|STARTED|Overall Study||769
644657|NCT00033540|1583250|P1|NOT COMPLETED|Overall Study||57
644658|NCT00033540|1583250|P1|COMPLETED|Overall Study||0
644659|NCT00033540|1583250|P1|Eligible and Began Protocol Therapy|Overall Study|One patient went off study prior to any toxicity assessments and is not evaluable for toxicities.|52
644660|NCT00033540|1583250|P1|Eligible|Overall Study||54
644661|NCT00033540|1583250|P1|STARTED|Overall Study||57
644662|NCT00033514|1583260|P2|NOT COMPLETED|Overall Study||4
644663|NCT00033514|1583261|P1|NOT COMPLETED|Overall Study||1
644664|NCT00033514|1583260|P2|COMPLETED|Overall Study||7
644665|NCT00033514|1583261|P1|COMPLETED|Overall Study||15
644666|NCT00033514|1583260|P2|STARTED|Overall Study||11
644667|NCT00033514|1583261|P1|STARTED|Overall Study||16
644668|NCT00033371|1583271|P2|NOT COMPLETED|Overall Study||10
644669|NCT00033371|1583272|P1|NOT COMPLETED|Overall Study||6
644670|NCT00033371|1583271|P2|COMPLETED|Overall Study||47
644671|NCT00033371|1583272|P1|COMPLETED|Overall Study||49
644672|NCT00033371|1583271|P2|STARTED|Overall Study||57
644673|NCT00033371|1583272|P1|STARTED|Overall Study||55
644674|NCT00033293|1583280|P2|NOT COMPLETED|Overall Study||18
644675|NCT00033293|1583281|P1|NOT COMPLETED|Overall Study||10
644676|NCT00033293|1583280|P2|COMPLETED|Overall Study||9
644677|NCT00033293|1583281|P1|COMPLETED|Overall Study||16
644678|NCT00033293|1583280|P2|STARTED|Overall Study||27
644679|NCT00033293|1583281|P1|STARTED|Overall Study||26
644680|NCT00031694|1583299|P1|NOT COMPLETED|Overall Study||19
644681|NCT00031694|1583299|P1|COMPLETED|Overall Study||0
644682|NCT00031694|1583299|P1|STARTED|Overall Study||19
644683|NCT00030901|1583305|P3|NOT COMPLETED|Randomization||88
644684|NCT00030901|1583306|P2|NOT COMPLETED|Randomization||101
644685|NCT00030901|1583307|P1|NOT COMPLETED|Randomization||0
644686|NCT00030901|1583305|P3|COMPLETED|Randomization||137
644687|NCT00030901|1583306|P2|COMPLETED|Randomization||126
644688|NCT00030901|1583307|P1|COMPLETED|Randomization||0
644689|NCT00030901|1583305|P3|Eligible|Randomization||211
644690|NCT00030901|1583306|P2|Eligible|Randomization||212
644691|NCT00030901|1583307|P1|Eligible|Randomization||0
644692|NCT00030901|1583305|P3|STARTED|Randomization||225
644693|NCT00030901|1583306|P2|STARTED|Randomization||227
644694|NCT00030901|1583307|P1|STARTED|Randomization||0
644695|NCT00030901|1583305|P3|NOT COMPLETED|Initial Registration||0
644696|NCT00030901|1583306|P2|NOT COMPLETED|Initial Registration||0
644697|NCT00030901|1583307|P1|NOT COMPLETED|Initial Registration||167
644698|NCT00030901|1583305|P3|COMPLETED|Initial Registration||0
644699|NCT00030901|1583306|P2|COMPLETED|Initial Registration||0
644700|NCT00030901|1583307|P1|COMPLETED|Initial Registration||452
644701|NCT00030901|1583305|P3|STARTED|Initial Registration||0
644702|NCT00030901|1583306|P2|STARTED|Initial Registration||0
644703|NCT00030901|1583307|P1|STARTED|Initial Registration||619
644704|NCT00030823|1583315|P1|NOT COMPLETED|Overall Study||1
644705|NCT00030823|1583315|P1|COMPLETED|Overall Study||13
644706|NCT00030823|1583315|P1|STARTED|Overall Study||14
644707|NCT00028769|1583319|P1|NOT COMPLETED|Overall Study||41
644708|NCT00028769|1583319|P1|COMPLETED|Overall Study|Patients receive protocol treatments until evidence of disease progression|0
644709|NCT00028769|1583319|P1|Eligible and Began Protocol Therapy|Overall Study|One patient refused all protocol treatment and was not evaluable for the present analysis|35
644710|NCT00028769|1583319|P1|Eligible|Overall Study||36
644711|NCT00028769|1583319|P1|STARTED|Overall Study||41
644712|NCT00028002|1583325|P1|NOT COMPLETED|Overall Study||11
644713|NCT00028002|1583325|P1|COMPLETED|Overall Study|Subjects comtributing data to the primary analysis are considered to have completed the study.|52
644714|NCT00028002|1583325|P1|STARTED|Overall Study||63
644715|NCT00027846|1583332|P3|NOT COMPLETED|Overall Study||37
644716|NCT00027846|1583333|P2|NOT COMPLETED|Overall Study||68
644717|NCT00027846|1583334|P1|NOT COMPLETED|Overall Study||2
644718|NCT00027846|1583332|P3|COMPLETED|Overall Study||41
644719|NCT00027846|1583333|P2|COMPLETED|Overall Study||219
644720|NCT00027846|1583334|P1|COMPLETED|Overall Study||11
644721|NCT00027846|1583332|P3|STARTED|Overall Study||78
644722|NCT00027846|1583333|P2|STARTED|Overall Study||287
644723|NCT00027846|1583334|P1|STARTED|Overall Study||13
644724|NCT00027560|1583352|P1|NOT COMPLETED|Overall Study||1
644725|NCT00027560|1583352|P1|COMPLETED|Overall Study||50
644726|NCT00027560|1583352|P1|STARTED|Overall Study||51
644727|NCT00026494|1583365|P4|NOT COMPLETED|Overall Study||0
644728|NCT00026494|1583366|P3|NOT COMPLETED|Overall Study||6
644729|NCT00026494|1583367|P2|NOT COMPLETED|Overall Study||0
644730|NCT00026494|1583368|P1|NOT COMPLETED|Overall Study||2
644731|NCT00026494|1583365|P4|COMPLETED|Overall Study||16
644732|NCT00026494|1583366|P3|COMPLETED|Overall Study||16
644733|NCT00026494|1583367|P2|COMPLETED|Overall Study||4
644734|NCT00026494|1583368|P1|COMPLETED|Overall Study||5
644735|NCT00026494|1583365|P4|STARTED|Overall Study||16
644736|NCT00026494|1583366|P3|STARTED|Overall Study||22
644737|NCT00026494|1583367|P2|STARTED|Overall Study||4
644738|NCT00026494|1583368|P1|STARTED|Overall Study||7
644739|NCT00026312|1583380|P2|NOT COMPLETED|Overall Study||269
644740|NCT00026312|1583381|P1|NOT COMPLETED|Overall Study||34
644741|NCT00026312|1583380|P2|COMPLETED|Overall Study||1064
644742|NCT00026312|1583381|P1|COMPLETED|Overall Study||82
644743|NCT00026312|1583380|P2|STARTED|Overall Study||1333
644745|NCT00026221|1583399|P3|NOT COMPLETED|Overall Study||0
644746|NCT00026221|1583400|P2|NOT COMPLETED|Overall Study||0
644747|NCT00026221|1583401|P1|NOT COMPLETED|Overall Study||0
644748|NCT00026221|1583399|P3|COMPLETED|Overall Study||25
644749|NCT00026221|1583400|P2|COMPLETED|Overall Study||16
644750|NCT00026221|1583401|P1|COMPLETED|Overall Study||16
644751|NCT00026221|1583399|P3|STARTED|Overall Study||25
644752|NCT00026221|1583400|P2|STARTED|Overall Study||16
644753|NCT00026221|1583401|P1|STARTED|Overall Study||16
644754|NCT00026208|1583420|P2|NOT COMPLETED|Overall Study||0
644755|NCT00026208|1583421|P1|NOT COMPLETED|Overall Study||1
644756|NCT00026208|1583420|P2|COMPLETED|Overall Study||4
644757|NCT00026208|1583421|P1|COMPLETED|Overall Study||71
644758|NCT00026208|1583420|P2|STARTED|Overall Study||4
644759|NCT00026208|1583421|P1|STARTED|Overall Study||72
644760|NCT00025662|1583439|P1|NOT COMPLETED|Overall Study||3
644761|NCT00025662|1583439|P1|COMPLETED|Overall Study|One patient who received a transplant did not meet eligibility and was a special exemption.|22
644762|NCT00025662|1583439|P1|STARTED|Overall Study||25
644763|NCT00025506|1583447|P1|NOT COMPLETED|Overall Study||10
644764|NCT00025506|1583447|P1|COMPLETED|Overall Study|Eligible and treated patients.|45
644765|NCT00025506|1583447|P1|STARTED|Overall Study||55
644766|NCT00025259|1583468|P7|NOT COMPLETED|Overall Study||51
644767|NCT00025259|1583469|P6|NOT COMPLETED|Overall Study||52
644768|NCT00025259|1583470|P5|NOT COMPLETED|Overall Study||36
644769|NCT00025259|1583471|P4|NOT COMPLETED|Overall Study||114
644770|NCT00025259|1583472|P3|NOT COMPLETED|Overall Study||81
644771|NCT00025259|1583473|P2|NOT COMPLETED|Overall Study||89
644772|NCT00025259|1583474|P1|NOT COMPLETED|Overall Study||45
644773|NCT00025259|1583468|P7|COMPLETED|Overall Study||102
644774|NCT00025259|1583469|P6|COMPLETED|Overall Study||101
644775|NCT00025259|1583470|P5|COMPLETED|Overall Study||6
644776|NCT00025259|1583471|P4|COMPLETED|Overall Study||457
644777|NCT00025259|1583472|P3|COMPLETED|Overall Study||301
644778|NCT00025259|1583473|P2|COMPLETED|Overall Study||292
644779|NCT00025259|1583474|P1|COMPLETED|Overall Study||7
644780|NCT00025259|1583468|P7|STARTED|Overall Study||153
644781|NCT00025259|1583469|P6|STARTED|Overall Study||153
644782|NCT00025259|1583470|P5|STARTED|Overall Study||42
644783|NCT00025259|1583471|P4|STARTED|Overall Study||571
644784|NCT00025259|1583472|P3|STARTED|Overall Study||382
644785|NCT00025259|1583473|P2|STARTED|Overall Study||381
644786|NCT00025259|1583474|P1|STARTED|Overall Study||52
644787|NCT00025233|1583510|P1|NOT COMPLETED|Overall Study||4
644788|NCT00025233|1583510|P1|COMPLETED|Overall Study||46
644789|NCT00025233|1583510|P1|STARTED|Overall Study||50
644790|NCT00025155|1583525|P1|NOT COMPLETED|Overall Study||2
644791|NCT00025155|1583525|P1|COMPLETED|Overall Study|Patients who were eligible and received any study treatment.|49
644792|NCT00025155|1583525|P1|STARTED|Overall Study||51
644793|NCT00024258|1583536|P1|NOT COMPLETED|Overall Study||9
644794|NCT00024258|1583536|P1|COMPLETED|Overall Study||13
644795|NCT00024258|1583536|P1|STARTED|Overall Study||22
644796|NCT00024167|1583543|P2|NOT COMPLETED|Overall Study||47
644797|NCT00024167|1583544|P1|NOT COMPLETED|Overall Study||53
644798|NCT00024167|1583543|P2|COMPLETED|Overall Study||15
644799|NCT00024167|1583544|P1|COMPLETED|Overall Study||12
644800|NCT00024167|1583543|P2|Induction Treatment Option 2 Completed|Overall Study||41
644801|NCT00024167|1583544|P1|Induction Treatment Option 2 Completed|Overall Study||43
644802|NCT00024167|1583543|P2|Induction Treatment Option 1 Completed|Overall Study||21
644803|NCT00024167|1583544|P1|Induction Treatment Option 1 Completed|Overall Study||22
644804|NCT00024167|1583543|P2|STARTED|Overall Study||62
644805|NCT00024167|1583544|P1|STARTED|Overall Study||65
644806|NCT00024102|1583555|P2|NOT COMPLETED|Overall Study||0
644807|NCT00024102|1583556|P1|NOT COMPLETED|Overall Study||0
644808|NCT00024102|1583555|P2|COMPLETED|Overall Study||307
644809|NCT00024102|1583556|P1|COMPLETED|Overall Study||326
644810|NCT00024102|1583555|P2|STARTED|Overall Study||307
644811|NCT00024102|1583556|P1|STARTED|Overall Study||326
644812|NCT00023764|1583568|P1|NOT COMPLETED|Overall Study||14
644813|NCT00023764|1583568|P1|COMPLETED|Overall Study||89
644814|NCT00023764|1583568|P1|STARTED|Overall Study||103
644815|NCT00023712|1583575|P2|NOT COMPLETED|Overall Study||1
644816|NCT00023712|1583576|P1|NOT COMPLETED|Overall Study||2
644817|NCT00023712|1583575|P2|COMPLETED|Overall Study|total number of participants eligible and evaluable|29
644818|NCT00023712|1583576|P1|COMPLETED|Overall Study|total number of participants eligible and evaluable|26
644819|NCT00023712|1583575|P2|STARTED|Overall Study|total number of participants enrolled on study|30
644820|NCT00023712|1583576|P1|STARTED|Overall Study|total number of participants enrolled on study|28
644821|NCT00022698|1583600|P2|NOT COMPLETED|Overall Study||35
644822|NCT00022698|1583601|P1|NOT COMPLETED|Overall Study||8
644823|NCT00022698|1583600|P2|COMPLETED|Overall Study||17
644824|NCT00022698|1583601|P1|COMPLETED|Overall Study||7
644825|NCT00022698|1583600|P2|STARTED|Overall Study||52
644826|NCT00022698|1583601|P1|STARTED|Overall Study||15
644827|NCT00022672|1583626|P2|NOT COMPLETED|Extension Phase||51
644828|NCT00022672|1583627|P1|NOT COMPLETED|Extension Phase||3
644829|NCT00022672|1583626|P2|COMPLETED|Extension Phase||7
644830|NCT00022672|1583627|P1|COMPLETED|Extension Phase||11
644831|NCT00022672|1583626|P2|Safety Set: Received Study Drug|Extension Phase||58
644832|NCT00022672|1583627|P1|Safety Set: Received Study Drug|Extension Phase||14
644833|NCT00022672|1583626|P2|STARTED|Extension Phase||58
644916|NCT00017563|1583796|P1|STARTED|Overall Study||57
644834|NCT00022672|1583627|P1|STARTED|Extension Phase|2 patients completed Main Phase; but did not enter Extension (1-did not cooperate and 1-withdrew).|14
644835|NCT00022672|1583626|P2|NOT COMPLETED|Main Phase: 24 Months||100
644836|NCT00022672|1583627|P1|NOT COMPLETED|Main Phase: 24 Months||87
644837|NCT00022672|1583626|P2|COMPLETED|Main Phase: 24 Months||4
644838|NCT00022672|1583627|P1|COMPLETED|Main Phase: 24 Months||16
644839|NCT00022672|1583626|P2|Safety Set: Received Study Drug|Main Phase: 24 Months||104
644840|NCT00022672|1583627|P1|Safety Set: Received Study Drug|Main Phase: 24 Months||103
644841|NCT00022672|1583626|P2|STARTED|Main Phase: 24 Months||104
644842|NCT00022672|1583627|P1|STARTED|Main Phase: 24 Months||103
644843|NCT00022659|1583660|P1|NOT COMPLETED|Overall Study||2
644844|NCT00022659|1583660|P1|COMPLETED|Overall Study|Eligible and treated patients.|62
644845|NCT00022659|1583660|P1|STARTED|Overall Study||64
644846|NCT00022633|1583673|P2|NOT COMPLETED|Overall Study||5
644847|NCT00022633|1583674|P1|NOT COMPLETED|Overall Study||32
644848|NCT00022633|1583673|P2|COMPLETED|Overall Study||5
644849|NCT00022633|1583674|P1|COMPLETED|Overall Study||23
644850|NCT00022633|1583673|P2|Eligible|Overall Study||10
644851|NCT00022633|1583674|P1|Eligible|Overall Study||51
644852|NCT00022633|1583673|P2|STARTED|Overall Study||10
644853|NCT00022633|1583674|P1|STARTED|Overall Study||55
644854|NCT00022516|1583687|P2|NOT COMPLETED|Overall Study||230
644855|NCT00022516|1583688|P1|NOT COMPLETED|Overall Study||3
644856|NCT00022516|1583687|P2|COMPLETED|Overall Study||314
644857|NCT00022516|1583688|P1|COMPLETED|Overall Study||539
644858|NCT00022516|1583687|P2|STARTED|Overall Study||544
644859|NCT00022516|1583688|P1|STARTED|Overall Study||542
644860|NCT00022490|1583700|P1|NOT COMPLETED|Overall Study||0
644861|NCT00022490|1583700|P1|COMPLETED|Overall Study||24
644862|NCT00022490|1583700|P1|STARTED|Overall Study||24
644863|NCT00021255|1583707|P3|NOT COMPLETED|Overall Study||149
644864|NCT00021255|1583708|P2|NOT COMPLETED|Overall Study||270
644865|NCT00021255|1583709|P1|NOT COMPLETED|Overall Study||121
644866|NCT00021255|1583707|P3|COMPLETED|Overall Study||926
644867|NCT00021255|1583708|P2|COMPLETED|Overall Study||804
644868|NCT00021255|1583709|P1|COMPLETED|Overall Study||952
644869|NCT00021255|1583707|P3|Safety Population|Overall Study|1056 participants received TCH.|1056
644870|NCT00021255|1583708|P2|Safety Population|Overall Study|1100 participants received AC-TH (1066 from AC-TH arm, 33 from AC-T arm and 1 from TCH arm).|1100
644871|NCT00021255|1583709|P1|Safety Population|Overall Study|1018 participants received AC-T (1012 from AC-T arm, 6 from AC-TH arm).|1018
644872|NCT00021255|1583707|P3|Treated|Overall Study||1057
644873|NCT00021255|1583708|P2|Treated|Overall Study||1072
644874|NCT00021255|1583709|P1|Treated|Overall Study||1045
644875|NCT00021255|1583707|P3|STARTED|Overall Study|Randomized|1075
644876|NCT00021255|1583708|P2|STARTED|Overall Study|Randomized|1074
644877|NCT00021255|1583709|P1|STARTED|Overall Study|Randomized|1073
644878|NCT00021229|1583726|P3|NOT COMPLETED|Overall Study||16
644879|NCT00021229|1583727|P2|NOT COMPLETED|Overall Study||33
644880|NCT00021229|1583728|P1|NOT COMPLETED|Overall Study||35
644881|NCT00021229|1583726|P3|COMPLETED|Overall Study||0
644882|NCT00021229|1583727|P2|COMPLETED|Overall Study||0
644883|NCT00021229|1583728|P1|COMPLETED|Overall Study|1 participant completed 13 courses of therapy|1
644884|NCT00021229|1583726|P3|Enrolled in Phase II|Overall Study|Participants from stratum IIB did not participate in the phase II part of the study.|0
644885|NCT00021229|1583727|P2|Enrolled in Phase II|Overall Study|Participants from stratum IIA did not participate in the phase II part of the study.|0
644886|NCT00021229|1583728|P1|Enrolled in Phase II|Overall Study|Thirteen participants treated at the MTD in the phase I were also part of the phase II.|14
644887|NCT00021229|1583726|P3|Maximum Tolerated Dose (MTD) Estimation|Overall Study|4 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|12
644888|NCT00021229|1583727|P2|Maximum Tolerated Dose (MTD) Estimation|Overall Study|13 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|20
644889|NCT00021229|1583728|P1|Maximum Tolerated Dose (MTD) Estimation|Overall Study|12 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|23
644890|NCT00021229|1583726|P3|Enrolled in Phase I|Overall Study||16
644891|NCT00021229|1583727|P2|Enrolled in Phase I|Overall Study||33
644892|NCT00021229|1583728|P1|Enrolled in Phase I|Overall Study||35
644893|NCT00021229|1583726|P3|STARTED|Overall Study||16
644894|NCT00021229|1583727|P2|STARTED|Overall Study||33
644895|NCT00021229|1583728|P1|STARTED|Overall Study||36
644896|NCT00020722|1583754|P1|NOT COMPLETED|Overall Study||0
644897|NCT00020722|1583754|P1|COMPLETED|Overall Study||7
644898|NCT00020722|1583754|P1|STARTED|Overall Study||7
644899|NCT00019747|1583761|P2|NOT COMPLETED|Overall Study||0
644900|NCT00019747|1583762|P1|NOT COMPLETED|Overall Study||0
644901|NCT00019747|1583761|P2|COMPLETED|Overall Study||16
644902|NCT00019747|1583762|P1|COMPLETED|Overall Study||23
644903|NCT00019747|1583761|P2|STARTED|Overall Study||16
644904|NCT00019747|1583762|P1|STARTED|Overall Study||23
644905|NCT00019682|1583770|P2|NOT COMPLETED|Overall Study||6
644906|NCT00019682|1583771|P1|NOT COMPLETED|Overall Study||1
644907|NCT00019682|1583770|P2|COMPLETED|Overall Study||85
644908|NCT00019682|1583771|P1|COMPLETED|Overall Study||93
644909|NCT00019682|1583770|P2|STARTED|Overall Study||91
644910|NCT00019682|1583771|P1|STARTED|Overall Study||94
644911|NCT00019604|1583783|P1|NOT COMPLETED|Overall Study||39
644912|NCT00019604|1583783|P1|COMPLETED|Overall Study||5
644913|NCT00019604|1583783|P1|STARTED|Overall Study||44
644914|NCT00017563|1583796|P1|NOT COMPLETED|Overall Study||1
644915|NCT00017563|1583796|P1|COMPLETED|Overall Study||56
644917|NCT00016913|1583800|P1|NOT COMPLETED|Overall Study||0
644918|NCT00016913|1583800|P1|COMPLETED|Overall Study||27
644919|NCT00016913|1583800|P1|STARTED|Overall Study||27
644920|NCT00016354|1583806|P8|NOT COMPLETED|Overall Study||1
644921|NCT00016354|1583807|P7|NOT COMPLETED|Overall Study||0
644922|NCT00016354|1583808|P6|NOT COMPLETED|Overall Study||0
644923|NCT00016354|1583809|P5|NOT COMPLETED|Overall Study||0
644924|NCT00016354|1583810|P4|NOT COMPLETED|Overall Study||0
644925|NCT00016354|1583811|P3|NOT COMPLETED|Overall Study||0
644926|NCT00016354|1583812|P2|NOT COMPLETED|Overall Study||0
644927|NCT00016354|1583813|P1|NOT COMPLETED|Overall Study||0
644928|NCT00016354|1583806|P8|COMPLETED|Overall Study||6
644929|NCT00016354|1583807|P7|COMPLETED|Overall Study||6
644930|NCT00016354|1583808|P6|COMPLETED|Overall Study||1
644931|NCT00016354|1583809|P5|COMPLETED|Overall Study||1
644932|NCT00016354|1583810|P4|COMPLETED|Overall Study||1
644933|NCT00016354|1583811|P3|COMPLETED|Overall Study||1
644934|NCT00016354|1583812|P2|COMPLETED|Overall Study||1
644935|NCT00016354|1583813|P1|COMPLETED|Overall Study||1
644936|NCT00016354|1583806|P8|STARTED|Overall Study||7
644937|NCT00016354|1583807|P7|STARTED|Overall Study||6
644938|NCT00016354|1583808|P6|STARTED|Overall Study||1
644939|NCT00016354|1583809|P5|STARTED|Overall Study||1
644940|NCT00016354|1583810|P4|STARTED|Overall Study||1
644941|NCT00016354|1583811|P3|STARTED|Overall Study||1
644942|NCT00016354|1583812|P2|STARTED|Overall Study||1
644943|NCT00016354|1583813|P1|STARTED|Overall Study||1
644944|NCT00015847|1583817|P1|NOT COMPLETED|Overall Study||0
644945|NCT00015847|1583817|P1|COMPLETED|Overall Study||25
644946|NCT00015847|1583817|P1|STARTED|Overall Study||25
644947|NCT00014495|1583827|P4|NOT COMPLETED|Overall Study||1
644948|NCT00014495|1583828|P3|NOT COMPLETED|Overall Study||1
644949|NCT00014495|1583829|P2|NOT COMPLETED|Overall Study||0
644950|NCT00014495|1583830|P1|NOT COMPLETED|Overall Study||0
644951|NCT00014495|1583827|P4|COMPLETED|Overall Study||5
644952|NCT00014495|1583828|P3|COMPLETED|Overall Study||19
644953|NCT00014495|1583829|P2|COMPLETED|Overall Study||3
644954|NCT00014495|1583830|P1|COMPLETED|Overall Study||3
644955|NCT00014495|1583827|P4|STARTED|Overall Study||6
644956|NCT00014495|1583828|P3|STARTED|Overall Study||20
644957|NCT00014495|1583829|P2|STARTED|Overall Study||3
644958|NCT00014495|1583830|P1|STARTED|Overall Study||3
644959|NCT00012298|1583844|P7|NOT COMPLETED|Overall Study||0
644960|NCT00012298|1583845|P6|NOT COMPLETED|Overall Study||0
644961|NCT00012298|1583846|P5|NOT COMPLETED|Overall Study||0
644962|NCT00012298|1583847|P4|NOT COMPLETED|Overall Study||0
644963|NCT00012298|1583848|P3|NOT COMPLETED|Overall Study||0
644964|NCT00012298|1583849|P2|NOT COMPLETED|Overall Study||0
644965|NCT00012298|1583850|P1|NOT COMPLETED|Overall Study||0
644966|NCT00012298|1583844|P7|COMPLETED|Overall Study||39
644967|NCT00012298|1583845|P6|COMPLETED|Overall Study||6
644968|NCT00012298|1583846|P5|COMPLETED|Overall Study||5
644969|NCT00012298|1583847|P4|COMPLETED|Overall Study||4
644970|NCT00012298|1583848|P3|COMPLETED|Overall Study||9
644971|NCT00012298|1583849|P2|COMPLETED|Overall Study||7
644972|NCT00012298|1583850|P1|COMPLETED|Overall Study||11
644973|NCT00012298|1583844|P7|STARTED|Overall Study||39
644974|NCT00012298|1583845|P6|STARTED|Overall Study||6
644975|NCT00012298|1583846|P5|STARTED|Overall Study||5
644976|NCT00012298|1583847|P4|STARTED|Overall Study||4
644977|NCT00012298|1583848|P3|STARTED|Overall Study||9
644978|NCT00012298|1583849|P2|STARTED|Overall Study||7
644979|NCT00012298|1583850|P1|STARTED|Overall Study||11
644980|NCT00012012|1583874|P2|NOT COMPLETED|Overall Study||3
644981|NCT00012012|1583875|P1|NOT COMPLETED|Overall Study||1
644982|NCT00012012|1583874|P2|COMPLETED|Overall Study||15
644983|NCT00012012|1583875|P1|COMPLETED|Overall Study||26
644984|NCT00012012|1583874|P2|STARTED|Overall Study||18
644985|NCT00012012|1583875|P1|STARTED|Overall Study||27
644986|NCT00011986|1583886|P5|NOT COMPLETED|Overall Study||0
644987|NCT00011986|1583887|P4|NOT COMPLETED|Overall Study||0
644988|NCT00011986|1583888|P3|NOT COMPLETED|Overall Study||0
644989|NCT00011986|1583889|P2|NOT COMPLETED|Overall Study||0
644990|NCT00011986|1583890|P1|NOT COMPLETED|Overall Study||0
644991|NCT00011986|1583886|P5|COMPLETED|Overall Study||861
644992|NCT00011986|1583887|P4|COMPLETED|Overall Study||861
644993|NCT00011986|1583888|P3|COMPLETED|Overall Study||862
644994|NCT00011986|1583889|P2|COMPLETED|Overall Study||864
644995|NCT00011986|1583890|P1|COMPLETED|Overall Study||864
644996|NCT00011986|1583886|P5|Initiated Treatment|Overall Study||851
644997|NCT00011986|1583887|P4|Initiated Treatment|Overall Study||846
644998|NCT00011986|1583888|P3|Initiated Treatment|Overall Study||854
644999|NCT00011986|1583889|P2|Initiated Treatment|Overall Study||860
645000|NCT00011986|1583890|P1|Initiated Treatment|Overall Study||862
645001|NCT00011986|1583886|P5|STARTED|Overall Study||861
645002|NCT00011986|1583887|P4|STARTED|Overall Study||861
645003|NCT00011986|1583888|P3|STARTED|Overall Study||862
645004|NCT00011986|1583889|P2|STARTED|Overall Study||864
645005|NCT00011986|1583890|P1|STARTED|Overall Study||864
645006|NCT00010257|1583904|P2|NOT COMPLETED|Overall Study||0
645007|NCT00010257|1583905|P1|NOT COMPLETED|Overall Study||1
645008|NCT00010257|1583904|P2|COMPLETED|Overall Study||21
645009|NCT00010257|1583905|P1|COMPLETED|Overall Study||24
645010|NCT00010257|1583904|P2|STARTED|Overall Study||21
645011|NCT00010257|1583905|P1|STARTED|Overall Study||25
645012|NCT00009945|1583915|P2|NOT COMPLETED|Overall Study||5
645013|NCT00009945|1583916|P1|NOT COMPLETED|Overall Study||7
645014|NCT00009945|1583915|P2|COMPLETED|Overall Study||1656
645015|NCT00009945|1583916|P1|COMPLETED|Overall Study||1655
645016|NCT00009945|1583915|P2|STARTED|Overall Study||1661
645017|NCT00009945|1583916|P1|STARTED|Overall Study||1662
645018|NCT00008385|1583932|P2|NOT COMPLETED|Overall Study||802
645019|NCT00008385|1583933|P1|NOT COMPLETED|Overall Study||387
645020|NCT00008385|1583932|P2|COMPLETED|Overall Study||238
645021|NCT00008385|1583933|P1|COMPLETED|Overall Study||134
645022|NCT00008385|1583932|P2|Off Treatment Reasons Reported|Overall Study||795
645023|NCT00008385|1583933|P1|Off Treatment Reasons Reported|Overall Study||398
645024|NCT00008385|1583932|P2|Treated|Overall Study||865
645025|NCT00008385|1583933|P1|Treated|Overall Study||477
645026|NCT00008385|1583932|P2|STARTED|Overall Study||1040
645027|NCT00008385|1583933|P1|STARTED|Overall Study||521
645028|NCT00008138|1583943|P1|NOT COMPLETED|Post-Cytoreduction Chemotherapy||8
645029|NCT00008138|1583943|P1|COMPLETED|Post-Cytoreduction Chemotherapy||18
645030|NCT00008138|1583943|P1|STARTED|Post-Cytoreduction Chemotherapy|Among 36 patients from previous period, 5 patients rejected and 5 patients are ineligible.|26
645031|NCT00008138|1583943|P1|NOT COMPLETED|Interval Debulking||2
645032|NCT00008138|1583943|P1|COMPLETED|Interval Debulking||36
645033|NCT00008138|1583943|P1|Received Protocol Surgery|Interval Debulking||36
645034|NCT00008138|1583943|P1|STARTED|Interval Debulking||38
645035|NCT00008138|1583943|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||20
645036|NCT00008138|1583943|P1|COMPLETED|Neoadjuvant Chemotherapy||38
645037|NCT00008138|1583943|P1|Eligible|Neoadjuvant Chemotherapy||58
645038|NCT00008138|1583943|P1|STARTED|Neoadjuvant Chemotherapy||58
645039|NCT00006916|1583949|P1|NOT COMPLETED|Overall Study||5
645040|NCT00006916|1583949|P1|COMPLETED|Overall Study|Subjects with survival data for the primary analysis are considered to have completed the study.|14
645041|NCT00006916|1583949|P1|STARTED|Overall Study||19
645042|NCT00006903|1583955|P3|NOT COMPLETED|Overall Study||6
645043|NCT00006903|1583956|P2|NOT COMPLETED|Overall Study||4
645044|NCT00006903|1583957|P1|NOT COMPLETED|Overall Study||10
645045|NCT00006903|1583955|P3|COMPLETED|Overall Study||27
645046|NCT00006903|1583956|P2|COMPLETED|Overall Study||20
645047|NCT00006903|1583957|P1|COMPLETED|Overall Study||0
645048|NCT00006903|1583955|P3|STARTED|Overall Study||33
645049|NCT00006903|1583956|P2|STARTED|Overall Study||24
645050|NCT00006903|1583957|P1|STARTED|Overall Study||10
645051|NCT00006721|1583970|P3|NOT COMPLETED|Overall Study||33
645052|NCT00006721|1583971|P2|NOT COMPLETED|Overall Study||25
645053|NCT00006721|1583972|P1|NOT COMPLETED|Overall Study||4
645054|NCT00006721|1583970|P3|COMPLETED|Overall Study||242
645055|NCT00006721|1583971|P2|COMPLETED|Overall Study||254
645056|NCT00006721|1583972|P1|COMPLETED|Overall Study||13
645057|NCT00006721|1583970|P3|Eligible and Began Protocol Therapy|Overall Study||265
645058|NCT00006721|1583971|P2|Eligible and Began Protocol Therapy|Overall Study||267
645059|NCT00006721|1583972|P1|Eligible and Began Protocol Therapy|Overall Study||14
645060|NCT00006721|1583970|P3|Eligible|Overall Study||265
645061|NCT00006721|1583971|P2|Eligible|Overall Study||267
645062|NCT00006721|1583972|P1|Eligible|Overall Study||15
645063|NCT00006721|1583970|P3|STARTED|Overall Study||275
645064|NCT00006721|1583971|P2|STARTED|Overall Study||279
645065|NCT00006721|1583972|P1|STARTED|Overall Study||17
645066|NCT00006478|1583990|P1|NOT COMPLETED|Overall Study||7
645067|NCT00006478|1583990|P1|COMPLETED|Overall Study||12
645068|NCT00006478|1583990|P1|STARTED|Overall Study||19
645069|NCT00006392|1583998|P4|NOT COMPLETED|Overall Study||160
645070|NCT00006392|1583999|P3|NOT COMPLETED|Overall Study||160
645071|NCT00006392|1584000|P2|NOT COMPLETED|Overall Study||158
645072|NCT00006392|1584001|P1|NOT COMPLETED|Overall Study||167
645073|NCT00006392|1583998|P4|COMPLETED|Overall Study||8696
645074|NCT00006392|1583999|P3|COMPLETED|Overall Study||8703
645075|NCT00006392|1584000|P2|COMPLETED|Overall Study||8752
645076|NCT00006392|1584001|P1|COMPLETED|Overall Study||8737
645077|NCT00006392|1583998|P4|STARTED|Overall Study||8856
645078|NCT00006392|1583999|P3|STARTED|Overall Study||8863
645079|NCT00006392|1584000|P2|STARTED|Overall Study||8910
645080|NCT00006392|1584001|P1|STARTED|Overall Study||8904
645081|NCT00006389|1584031|P1|NOT COMPLETED|Overall Study||1
645082|NCT00006389|1584031|P1|COMPLETED|Overall Study||11
645083|NCT00006389|1584031|P1|STARTED|Overall Study||12
645084|NCT00006244|1584037|P1|NOT COMPLETED|Overall Study||0
645085|NCT00006244|1584037|P1|COMPLETED|Overall Study||36
645086|NCT00006244|1584037|P1|STARTED|Overall Study||36
645087|NCT00006237|1584048|P2|NOT COMPLETED|Overall Study||61
645088|NCT00006237|1584049|P1|NOT COMPLETED|Overall Study||125
645089|NCT00006237|1584048|P2|COMPLETED|Overall Study||159
645090|NCT00006237|1584049|P1|COMPLETED|Overall Study||87
645091|NCT00006237|1584048|P2|Eligible and Treated|Overall Study||199
645092|NCT00006237|1584049|P1|Eligible and Treated|Overall Study||203
645093|NCT00006237|1584048|P2|Eligible|Overall Study||200
645094|NCT00006237|1584049|P1|Eligible|Overall Study||203
645095|NCT00006237|1584048|P2|STARTED|Overall Study||220
645096|NCT00006237|1584049|P1|STARTED|Overall Study||212
645097|NCT00006110|1584061|P2|NOT COMPLETED|Overall Study||0
645098|NCT00006110|1584062|P1|NOT COMPLETED|Overall Study||0
645099|NCT00006110|1584061|P2|COMPLETED|Overall Study||30
645100|NCT00006110|1584062|P1|COMPLETED|Overall Study||52
645101|NCT00006110|1584061|P2|STARTED|Overall Study||30
645102|NCT00006110|1584062|P1|STARTED|Overall Study||52
645103|NCT00006101|1584076|P2|NOT COMPLETED|Overall Study||5
645104|NCT00006101|1584077|P1|NOT COMPLETED|Overall Study||5
645105|NCT00006101|1584076|P2|COMPLETED|Overall Study||33
645106|NCT00006101|1584077|P1|COMPLETED|Overall Study||33
645107|NCT00006101|1584076|P2|STARTED|Overall Study||38
645108|NCT00006101|1584077|P1|STARTED|Overall Study||38
645109|NCT00006011|1584086|P3|NOT COMPLETED|Overall Study||73
645110|NCT00006011|1584087|P2|NOT COMPLETED|Overall Study||77
645111|NCT00006011|1584088|P1|NOT COMPLETED|Overall Study||65
645112|NCT00006011|1584086|P3|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|0
645113|NCT00006011|1584087|P2|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|221
645114|NCT00006011|1584088|P1|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|223
645115|NCT00006011|1584086|P3|STARTED|Overall Study|total number of participants enrolled, that only received radiation treatment.|73
645116|NCT00006011|1584087|P2|STARTED|Overall Study|total number of participants enrolled, that received random treatment assignment to Arm 2 of study.|298
645117|NCT00006011|1584088|P1|STARTED|Overall Study|total number of participants enrolled, that received random treatment assignment to Arm 1 of study.|288
645118|NCT00005957|1584096|P2|NOT COMPLETED|Overall Study||28
645119|NCT00005957|1584097|P1|NOT COMPLETED|Overall Study||8
645120|NCT00005957|1584096|P2|COMPLETED|Overall Study||888
645121|NCT00005957|1584097|P1|COMPLETED|Overall Study||908
645122|NCT00005957|1584096|P2|STARTED|Overall Study||916
645123|NCT00005957|1584097|P1|STARTED|Overall Study||916
645124|NCT00005879|1584107|P2|NOT COMPLETED|Overall Study||10
645125|NCT00005879|1584108|P1|NOT COMPLETED|Overall Study||8
645126|NCT00005879|1584107|P2|COMPLETED|Overall Study||88
645127|NCT00005879|1584108|P1|COMPLETED|Overall Study||93
645128|NCT00005879|1584107|P2|STARTED|Overall Study||98
645129|NCT00005879|1584108|P1|STARTED|Overall Study||101
645130|NCT00005803|1584116|P1|NOT COMPLETED|Overall Study||22
645131|NCT00005803|1584116|P1|COMPLETED|Overall Study||54
645132|NCT00005803|1584116|P1|STARTED|Overall Study||76
645133|NCT00005047|1584131|P4|NOT COMPLETED|Overall Study||0
645134|NCT00005047|1584132|P3|NOT COMPLETED|Overall Study||0
645135|NCT00005047|1584133|P2|NOT COMPLETED|Overall Study||0
645136|NCT00005047|1584134|P1|NOT COMPLETED|Overall Study||19
645137|NCT00005047|1584131|P4|COMPLETED|Overall Study||158
645138|NCT00005047|1584132|P3|COMPLETED|Overall Study||227
645139|NCT00005047|1584133|P2|COMPLETED|Overall Study||56
645140|NCT00005047|1584134|P1|COMPLETED|Overall Study||39
645141|NCT00005047|1584131|P4|STARTED|Overall Study||158
645142|NCT00005047|1584132|P3|STARTED|Overall Study||227
645143|NCT00005047|1584133|P2|STARTED|Overall Study||56
645144|NCT00005047|1584134|P1|STARTED|Overall Study||58
645145|NCT00005044|1584150|P2|NOT COMPLETED|Overall Study||52
645146|NCT00005044|1584151|P1|NOT COMPLETED|Overall Study||38
645147|NCT00005044|1584150|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|737
645148|NCT00005044|1584151|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|752
645149|NCT00005044|1584150|P2|STARTED|Overall Study||789
645150|NCT00005044|1584151|P1|STARTED|Overall Study||790
645151|NCT00004888|1584171|P2|NOT COMPLETED|Overall Study||24
645152|NCT00004888|1584172|P1|NOT COMPLETED|Overall Study||11
645153|NCT00004888|1584171|P2|COMPLETED|Overall Study||22
645154|NCT00004888|1584172|P1|COMPLETED|Overall Study||27
645155|NCT00004888|1584171|P2|STARTED|Overall Study|Of the 48 pts, 2 were ineligible.|46
645156|NCT00004888|1584172|P1|STARTED|Overall Study|Of the 41 pts, 3 were ineligible.|38
645157|NCT00004859|1584190|P2|NOT COMPLETED|Overall Study||282
645158|NCT00004859|1584191|P1|NOT COMPLETED|Overall Study||118
645159|NCT00004859|1584190|P2|COMPLETED|Overall Study||12
645160|NCT00004859|1584191|P1|COMPLETED|Overall Study||177
645161|NCT00004859|1584190|P2|Treated and Having Toxicity Data|Overall Study|1 patient had missing record for toxicity|288
645162|NCT00004859|1584191|P1|Treated and Having Toxicity Data|Overall Study||289
645163|NCT00004859|1584190|P2|Treated|Overall Study||289
645164|NCT00004859|1584191|P1|Treated|Overall Study||289
645165|NCT00004859|1584190|P2|Eligible|Overall Study||271
645166|NCT00004859|1584191|P1|Eligible|Overall Study||275
645167|NCT00004859|1584190|P2|STARTED|Overall Study||294
645168|NCT00004859|1584191|P1|STARTED|Overall Study||295
645169|NCT00004259|1584205|P4|NOT COMPLETED|Overall Study||0
645170|NCT00004259|1584206|P3|NOT COMPLETED|Overall Study||0
645171|NCT00004259|1584207|P2|NOT COMPLETED|Overall Study||4
645172|NCT00004259|1584208|P1|NOT COMPLETED|Overall Study||1
645173|NCT00004259|1584205|P4|COMPLETED|Overall Study||14
645174|NCT00004259|1584206|P3|COMPLETED|Overall Study||15
645175|NCT00004259|1584207|P2|COMPLETED|Overall Study||99
645176|NCT00004259|1584208|P1|COMPLETED|Overall Study||97
645177|NCT00004259|1584205|P4|STARTED|Overall Study||14
645178|NCT00004259|1584206|P3|STARTED|Overall Study||15
645179|NCT00004259|1584207|P2|STARTED|Overall Study||103
645180|NCT00004259|1584208|P1|STARTED|Overall Study||98
645181|NCT00004228|1584229|P7|NOT COMPLETED|Overall Study||12
645182|NCT00004228|1584230|P6|NOT COMPLETED|Overall Study||14
645183|NCT00004228|1584231|P5|NOT COMPLETED|Overall Study||16
645184|NCT00004228|1584232|P4|NOT COMPLETED|Overall Study||7
645185|NCT00004228|1584233|P3|NOT COMPLETED|Overall Study||19
645186|NCT00004228|1584234|P2|NOT COMPLETED|Overall Study||15
645187|NCT00004228|1584235|P1|NOT COMPLETED|Overall Study||9
645188|NCT00004228|1584229|P7|COMPLETED|Overall Study||45
645189|NCT00004228|1584230|P6|COMPLETED|Overall Study||51
645190|NCT00004228|1584231|P5|COMPLETED|Overall Study||51
645191|NCT00004228|1584232|P4|COMPLETED|Overall Study||6
645192|NCT00004228|1584233|P3|COMPLETED|Overall Study||46
645193|NCT00004228|1584234|P2|COMPLETED|Overall Study||51
645194|NCT00004228|1584235|P1|COMPLETED|Overall Study||51
645195|NCT00004228|1584229|P7|STARTED|Overall Study||57
645196|NCT00004228|1584230|P6|STARTED|Overall Study||65
645197|NCT00004228|1584231|P5|STARTED|Overall Study||67
645198|NCT00004228|1584232|P4|STARTED|Overall Study||13
645199|NCT00004228|1584233|P3|STARTED|Overall Study||65
645200|NCT00004228|1584234|P2|STARTED|Overall Study||66
645201|NCT00004228|1584235|P1|STARTED|Overall Study||60
645202|NCT00004143|1584258|P1|NOT COMPLETED|Overall Study||0
645203|NCT00004143|1584258|P1|COMPLETED|Overall Study||2
645204|NCT00004143|1584258|P1|STARTED|Overall Study||2
645205|NCT00004092|1584269|P2|NOT COMPLETED|Overall Study||0
645206|NCT00004092|1584270|P1|NOT COMPLETED|Overall Study||0
645207|NCT00004092|1584269|P2|COMPLETED|Overall Study||51
645208|NCT00004092|1584270|P1|COMPLETED|Overall Study||21
645209|NCT00004092|1584269|P2|STARTED|Overall Study||51
645210|NCT00004092|1584270|P1|STARTED|Overall Study||21
645211|NCT00004054|1584280|P2|NOT COMPLETED|Overall Study||0
645212|NCT00004054|1584281|P1|NOT COMPLETED|Overall Study||0
645213|NCT00004054|1584280|P2|COMPLETED|Overall Study||200
645214|NCT00004054|1584281|P1|COMPLETED|Overall Study||197
645215|NCT00004054|1584280|P2|STARTED|Overall Study||200
645216|NCT00004054|1584281|P1|STARTED|Overall Study||197
645217|NCT00003910|1584295|P2|NOT COMPLETED|Step 2||0
645218|NCT00003910|1584296|P1|NOT COMPLETED|Step 2||0
645219|NCT00003910|1584295|P2|COMPLETED|Step 2||16
645220|NCT00003910|1584296|P1|COMPLETED|Step 2||0
645221|NCT00003910|1584295|P2|STARTED|Step 2|The 16 includes 2 ineligible pts.|16
645222|NCT00003910|1584296|P1|STARTED|Step 2||0
645223|NCT00003910|1584295|P2|NOT COMPLETED|Step 1||0
645224|NCT00003910|1584296|P1|NOT COMPLETED|Step 1||0
645225|NCT00003910|1584295|P2|COMPLETED|Step 1||0
645226|NCT00003910|1584296|P1|COMPLETED|Step 1||55
645227|NCT00003910|1584295|P2|STARTED|Step 1||0
645228|NCT00003910|1584296|P1|STARTED|Step 1|Of 59 (step 1), 4 pts were ineligible.|55
645229|NCT00003901|1584301|P1|NOT COMPLETED|Overall Study||17
645230|NCT00003901|1584301|P1|COMPLETED|Overall Study||1030
645231|NCT00003901|1584301|P1|STARTED|Overall Study||1047
645232|NCT00003896|1584312|P1|NOT COMPLETED|Overall Study||29
645233|NCT00003896|1584312|P1|COMPLETED|Overall Study||39
645234|NCT00003896|1584312|P1|Eligible|Overall Study|2 eligible patients did not have any toxicity assessments reported.|63
645235|NCT00003896|1584312|P1|STARTED|Overall Study||68
645236|NCT00003875|1584318|P1|NOT COMPLETED|Overall Study||1
645237|NCT00003875|1584318|P1|COMPLETED|Overall Study||29
645238|NCT00003875|1584318|P1|STARTED|Overall Study||30
645239|NCT00003869|1584327|P2|NOT COMPLETED|Overall Study||12
645240|NCT00003869|1584328|P1|NOT COMPLETED|Overall Study||41
645241|NCT00003869|1584327|P2|COMPLETED|Overall Study||80
645242|NCT00003869|1584328|P1|COMPLETED|Overall Study||53
645243|NCT00003869|1584327|P2|STARTED|Overall Study||92
645244|NCT00003869|1584328|P1|STARTED|Overall Study||94
645245|NCT00003820|1584344|P2|NOT COMPLETED|Cycle 4 (Maintenance Treatment)||0
645246|NCT00003820|1584345|P1|NOT COMPLETED|Cycle 4 (Maintenance Treatment)||0
645247|NCT00003820|1584344|P2|COMPLETED|Cycle 4 (Maintenance Treatment)|Patients with treatment assessment at 24 months|16
645248|NCT00003820|1584345|P1|COMPLETED|Cycle 4 (Maintenance Treatment)||0
645249|NCT00003820|1584344|P2|STARTED|Cycle 4 (Maintenance Treatment)|Patients with treatment response/stable disease at 18 months|16
645250|NCT00003820|1584345|P1|STARTED|Cycle 4 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
645251|NCT00003820|1584344|P2|NOT COMPLETED|Cycle 3 (Maintenance Treatment)||0
645252|NCT00003820|1584345|P1|NOT COMPLETED|Cycle 3 (Maintenance Treatment)||0
645253|NCT00003820|1584344|P2|COMPLETED|Cycle 3 (Maintenance Treatment)|Patients with treatment assessment at 18 months|16
645254|NCT00003820|1584345|P1|COMPLETED|Cycle 3 (Maintenance Treatment)||0
645255|NCT00003820|1584344|P2|STARTED|Cycle 3 (Maintenance Treatment)|Patients with treatment response/stable disease at 12 months|16
645256|NCT00003820|1584345|P1|STARTED|Cycle 3 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
645257|NCT00003820|1584344|P2|NOT COMPLETED|Cycle 2 (Maintenance Treatment)||0
645258|NCT00003820|1584345|P1|NOT COMPLETED|Cycle 2 (Maintenance Treatment)||0
645259|NCT00003820|1584344|P2|COMPLETED|Cycle 2 (Maintenance Treatment)|Patients with treatment assessment at 12 months|16
645260|NCT00003820|1584345|P1|COMPLETED|Cycle 2 (Maintenance Treatment)||0
645261|NCT00003820|1584344|P2|STARTED|Cycle 2 (Maintenance Treatment)|Pts with treatment response/stable disease at 6 mos, & eligible to continue.|16
645262|NCT00003820|1584345|P1|STARTED|Cycle 2 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
645263|NCT00003820|1584344|P2|NOT COMPLETED|Cycle 1 (Initial Treatment)||0
645264|NCT00003820|1584345|P1|NOT COMPLETED|Cycle 1 (Initial Treatment)||0
645265|NCT00003820|1584344|P2|COMPLETED|Cycle 1 (Initial Treatment)||16
645266|NCT00003820|1584345|P1|COMPLETED|Cycle 1 (Initial Treatment)||23
645267|NCT00003820|1584344|P2|STARTED|Cycle 1 (Initial Treatment)||16
645268|NCT00003820|1584345|P1|STARTED|Cycle 1 (Initial Treatment)||23
645269|NCT00003782|1584354|P3|NOT COMPLETED|Overall Study||26
645270|NCT00003782|1584355|P2|NOT COMPLETED|Overall Study||31
645271|NCT00003782|1584356|P1|NOT COMPLETED|Overall Study||30
645272|NCT00003782|1584354|P3|COMPLETED|Overall Study||1758
645273|NCT00003782|1584355|P2|COMPLETED|Overall Study||1753
645274|NCT00003782|1584356|P1|COMPLETED|Overall Study||1753
645275|NCT00003782|1584354|P3|STARTED|Overall Study||1784
645276|NCT00003782|1584355|P2|STARTED|Overall Study||1784
645277|NCT00003782|1584356|P1|STARTED|Overall Study||1783
645278|NCT00003702|1584366|P2|NOT COMPLETED|Overall Study||11
645279|NCT00003702|1584367|P1|NOT COMPLETED|Overall Study||13
645280|NCT00003702|1584366|P2|COMPLETED|Overall Study||109
645281|NCT00003702|1584367|P1|COMPLETED|Overall Study||107
645282|NCT00003702|1584366|P2|STARTED|Overall Study||120
645283|NCT00003702|1584367|P1|STARTED|Overall Study||120
645284|NCT00003659|1584376|P1|NOT COMPLETED|Overall Study||3
645285|NCT00003659|1584376|P1|COMPLETED|Overall Study||36
645286|NCT00003659|1584376|P1|STARTED|Overall Study||39
645287|NCT00003641|1584384|P2|NOT COMPLETED|Overall Study||174
645288|NCT00003641|1584385|P1|NOT COMPLETED|Overall Study||569
645289|NCT00003641|1584384|P2|COMPLETED|Overall Study||407
645290|NCT00003641|1584385|P1|COMPLETED|Overall Study||0
645291|NCT00003641|1584384|P2|Toxicity Assessed|Overall Study||568
645292|NCT00003641|1584385|P1|Toxicity Assessed|Overall Study|439 patients on arm I had their toxicity assessed even though they did not receive any treatment|439
645293|NCT00003641|1584384|P2|Treated|Overall Study||569
645294|NCT00003641|1584385|P1|Treated|Overall Study|Patients on arm I should undergo observation, but 2 patients received interferon therapy|2
645295|NCT00003641|1584384|P2|STARTED|Overall Study||581
645296|NCT00003641|1584385|P1|STARTED|Overall Study||569
645297|NCT00003631|1584396|P3|NOT COMPLETED|Overall Study||9
645298|NCT00003631|1584397|P2|NOT COMPLETED|Overall Study||1
645299|NCT00003631|1584398|P1|NOT COMPLETED|Overall Study||3
645300|NCT00003631|1584396|P3|COMPLETED|Overall Study||15
645301|NCT00003631|1584397|P2|COMPLETED|Overall Study||43
645302|NCT00003631|1584398|P1|COMPLETED|Overall Study||47
645303|NCT00003631|1584396|P3|STARTED|Overall Study||24
645304|NCT00003631|1584397|P2|STARTED|Overall Study||44
645305|NCT00003631|1584398|P1|STARTED|Overall Study||50
645306|NCT00003590|1584406|P1|NOT COMPLETED|Overall Study||22
645307|NCT00003590|1584406|P1|COMPLETED|Overall Study|Patients were to receive Hydroxyurea up to 2 years in absence of progressive disease.|7
645308|NCT00003590|1584406|P1|Eligible and Began Protocol Therapy|Overall Study||28
645309|NCT00003590|1584406|P1|Eligible|Overall Study||28
645310|NCT00003590|1584406|P1|STARTED|Overall Study||29
645311|NCT00003537|1584411|P1|NOT COMPLETED|Overall Study||1
645312|NCT00003537|1584411|P1|COMPLETED|Overall Study||18
645313|NCT00003537|1584411|P1|STARTED|Overall Study||19
645314|NCT00003535|1584416|P1|NOT COMPLETED|Overall Study||5
645315|NCT00003535|1584416|P1|COMPLETED|Overall Study||4
645316|NCT00003535|1584416|P1|STARTED|Overall Study||9
645317|NCT00003483|1584421|P1|NOT COMPLETED|Overall Study||1
645318|NCT00003483|1584421|P1|COMPLETED|Overall Study||2
645319|NCT00003483|1584421|P1|STARTED|Overall Study||3
645320|NCT00003479|1584426|P1|NOT COMPLETED|Overall Study||3
645321|NCT00003479|1584426|P1|COMPLETED|Overall Study||6
645322|NCT00003479|1584426|P1|STARTED|Overall Study||9
645323|NCT00003477|1584431|P1|NOT COMPLETED|Overall Study||4
645324|NCT00003477|1584431|P1|COMPLETED|Overall Study||8
645325|NCT00003477|1584431|P1|STARTED|Overall Study||12
645326|NCT00003476|1584436|P1|NOT COMPLETED|Overall Study||1
645327|NCT00003476|1584436|P1|COMPLETED|Overall Study||7
645328|NCT00003476|1584436|P1|STARTED|Overall Study||8
645329|NCT00003475|1584441|P1|NOT COMPLETED|Overall Study||13
645330|NCT00003475|1584441|P1|COMPLETED|Overall Study||27
645331|NCT00003475|1584441|P1|STARTED|Overall Study||40
645332|NCT00003474|1584446|P1|NOT COMPLETED|Overall Study||14
645333|NCT00003474|1584446|P1|COMPLETED|Overall Study||26
645334|NCT00003474|1584446|P1|STARTED|Overall Study||40
645335|NCT00003473|1584451|P1|NOT COMPLETED|Overall Study||3
645336|NCT00003473|1584451|P1|COMPLETED|Overall Study||17
645337|NCT00003473|1584451|P1|STARTED|Overall Study||20
645338|NCT00003472|1584456|P1|NOT COMPLETED|Overall Study||3
645339|NCT00003472|1584456|P1|COMPLETED|Overall Study||10
645340|NCT00003472|1584456|P1|STARTED|Overall Study||13
645341|NCT00003471|1584461|P1|NOT COMPLETED|Overall Study||4
645342|NCT00003471|1584461|P1|COMPLETED|Overall Study||3
645343|NCT00003471|1584461|P1|STARTED|Overall Study||7
645344|NCT00003470|1584466|P1|NOT COMPLETED|Overall Study||6
645345|NCT00003470|1584466|P1|COMPLETED|Overall Study||21
645346|NCT00003470|1584466|P1|STARTED|Overall Study||27
645347|NCT00003469|1584471|P1|NOT COMPLETED|Overall Study||0
645348|NCT00003469|1584471|P1|COMPLETED|Overall Study||4
645349|NCT00003469|1584471|P1|STARTED|Overall Study||4
645350|NCT00003468|1584476|P1|NOT COMPLETED|Overall Study||2
645351|NCT00003468|1584476|P1|COMPLETED|Overall Study|Two patients were not evaluable.|9
645352|NCT00003468|1584476|P1|STARTED|Overall Study||11
645353|NCT00003460|1584481|P1|NOT COMPLETED|Overall Study||1
645354|NCT00003460|1584481|P1|COMPLETED|Overall Study|One patient was not evaluable.|12
645355|NCT00003460|1584481|P1|STARTED|Overall Study||13
645356|NCT00003459|1584486|P1|NOT COMPLETED|Overall Study||9
645357|NCT00003459|1584486|P1|COMPLETED|Overall Study|Nine patients were not evaluable.|31
645358|NCT00003459|1584486|P1|STARTED|Overall Study||40
645359|NCT00003458|1584491|P1|NOT COMPLETED|Overall Study||4
645360|NCT00003458|1584491|P1|COMPLETED|Overall Study||30
645361|NCT00003458|1584491|P1|STARTED|Overall Study||34
645362|NCT00003457|1584496|P1|NOT COMPLETED|Overall Study||9
645363|NCT00003457|1584496|P1|COMPLETED|Overall Study||31
645364|NCT00003457|1584496|P1|STARTED|Overall Study||40
645365|NCT00003456|1584501|P1|NOT COMPLETED|Overall Study||8
645366|NCT00003456|1584501|P1|COMPLETED|Overall Study||32
645367|NCT00003456|1584501|P1|STARTED|Overall Study||40
645368|NCT00003453|1584506|P1|NOT COMPLETED|Overall Study||1
645369|NCT00003453|1584506|P1|COMPLETED|Overall Study|One patient was not evaluable|5
645370|NCT00003453|1584506|P1|STARTED|Overall Study||6
645371|NCT00003389|1584513|P2|NOT COMPLETED|Overall Study||60
645372|NCT00003389|1584514|P1|NOT COMPLETED|Overall Study||98
645373|NCT00003389|1584513|P2|COMPLETED|Overall Study||366
645374|NCT00003389|1584514|P1|COMPLETED|Overall Study||330
645375|NCT00003389|1584513|P2|Eligible Patients|Overall Study||399
645376|NCT00003389|1584514|P1|Eligible Patients|Overall Study||395
645377|NCT00003389|1584513|P2|Treated Pts w/ Toxicity Data Available|Overall Study||422
645378|NCT00003389|1584514|P1|Treated Pts w/ Toxicity Data Available|Overall Study||414
645379|NCT00003389|1584513|P2|STARTED|Overall Study||426
645380|NCT00003389|1584514|P1|STARTED|Overall Study||428
645381|NCT00003377|1584529|P5|NOT COMPLETED|Period II||1
645382|NCT00003377|1584530|P4|NOT COMPLETED|Period II||0
645383|NCT00003377|1584531|P3|NOT COMPLETED|Period II||0
645384|NCT00003377|1584532|P2|NOT COMPLETED|Period II||0
645385|NCT00003377|1584533|P1|NOT COMPLETED|Period II||0
645386|NCT00003377|1584529|P5|COMPLETED|Period II||16
645387|NCT00003377|1584530|P4|COMPLETED|Period II||0
645388|NCT00003377|1584531|P3|COMPLETED|Period II||0
645389|NCT00003377|1584532|P2|COMPLETED|Period II||0
645390|NCT00003377|1584533|P1|COMPLETED|Period II||0
645391|NCT00003377|1584529|P5|STARTED|Period II|All pts enrolled on Per II received cisplatin 40 mg/m2 & paclitaxel 40 mg/m2 concurrent w/ radiation|17
645392|NCT00003377|1584530|P4|STARTED|Period II|Patients participated at this dose level only in Period I.|0
645393|NCT00003377|1584531|P3|STARTED|Period II|Patients participated at this dose level only in Period I.|0
645394|NCT00003377|1584532|P2|STARTED|Period II|Patients participated at this dose level only in Period I.|0
645395|NCT00003377|1584533|P1|STARTED|Period II|Patients participated at this dose level only in Period I.|0
645396|NCT00003377|1584529|P5|NOT COMPLETED|Period I||0
645397|NCT00003377|1584530|P4|NOT COMPLETED|Period I||1
645398|NCT00003377|1584531|P3|NOT COMPLETED|Period I||1
645399|NCT00003377|1584532|P2|NOT COMPLETED|Period I||0
645400|NCT00003377|1584533|P1|NOT COMPLETED|Period I||0
645401|NCT00003377|1584529|P5|COMPLETED|Period I||0
645402|NCT00003377|1584530|P4|COMPLETED|Period I||2
645403|NCT00003377|1584531|P3|COMPLETED|Period I||2
645404|NCT00003377|1584532|P2|COMPLETED|Period I||3
645405|NCT00003377|1584533|P1|COMPLETED|Period I||3
645406|NCT00003377|1584529|P5|STARTED|Period I||0
645407|NCT00003377|1584530|P4|STARTED|Period I||3
645408|NCT00003377|1584531|P3|STARTED|Period I||3
645409|NCT00003377|1584532|P2|STARTED|Period I||3
645410|NCT00003377|1584533|P1|STARTED|Period I||3
645411|NCT00003199|1584547|P1|NOT COMPLETED|Overall Study||22
645412|NCT00003199|1584547|P1|COMPLETED|Overall Study||28
645413|NCT00003199|1584547|P1|STARTED|Overall Study||50
645414|NCT00003138|1584555|P2|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||7
645415|NCT00003138|1584556|P1|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||6
645416|NCT00003138|1584555|P2|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0
645417|NCT00003138|1584556|P1|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0
645418|NCT00003138|1584555|P2|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||7
645419|NCT00003138|1584556|P1|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||6
645420|NCT00003138|1584555|P2|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||20
645421|NCT00003138|1584556|P1|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||12
645422|NCT00003138|1584555|P2|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0
645423|NCT00003138|1584556|P1|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0
645424|NCT00003138|1584555|P2|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||19
645425|NCT00003138|1584556|P1|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||12
645426|NCT00003138|1584555|P2|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||20
645427|NCT00003138|1584556|P1|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||12
645428|NCT00003138|1584555|P2|NOT COMPLETED|Step 2 (Cross Over)||0
645429|NCT00003138|1584556|P1|NOT COMPLETED|Step 2 (Cross Over)||26
645430|NCT00003138|1584555|P2|COMPLETED|Step 2 (Cross Over)||0
645431|NCT00003138|1584556|P1|COMPLETED|Step 2 (Cross Over)||0
645432|NCT00003138|1584555|P2|STARTED|Step 2 (Cross Over)|Only patients in the supportive care arm are eligible to cross over to the Erythropoietin arm.|0
645433|NCT00003138|1584556|P1|STARTED|Step 2 (Cross Over)||26
645434|NCT00003138|1584555|P2|NOT COMPLETED|Step 1||57
645435|NCT00003138|1584556|P1|NOT COMPLETED|Step 1||61
645436|NCT00003138|1584555|P2|COMPLETED|Step 1||0
645437|NCT00003138|1584556|P1|COMPLETED|Step 1||0
645438|NCT00003138|1584555|P2|Patients With Transfusion Data|Step 1||42
645439|NCT00003138|1584556|P1|Patients With Transfusion Data|Step 1||37
645440|NCT00003138|1584555|P2|Patients With QOL Data at 4 Months|Step 1||42
645441|NCT00003138|1584556|P1|Patients With QOL Data at 4 Months|Step 1||42
645442|NCT00003138|1584555|P2|Eligible and Treated|Step 1||50
645443|NCT00003138|1584556|P1|Eligible and Treated|Step 1||52
645444|NCT00003138|1584555|P2|Treated|Step 1||53
645445|NCT00003138|1584556|P1|Treated|Step 1||56
645446|NCT00003138|1584555|P2|Patients With Complete Data|Step 1||53
645447|NCT00003138|1584556|P1|Patients With Complete Data|Step 1||57
645448|NCT00003138|1584555|P2|STARTED|Step 1||57
645449|NCT00003138|1584556|P1|STARTED|Step 1||61
645450|NCT00002975|1584569|P1|NOT COMPLETED|Overall Study||5
645451|NCT00002975|1584569|P1|COMPLETED|Overall Study||175
645452|NCT00002975|1584569|P1|Treated With Study Therapy|Overall Study||175
645453|NCT00002975|1584569|P1|STARTED|Overall Study||180
645454|NCT00002931|1584573|P1|NOT COMPLETED|Overall Study||2
645455|NCT00002931|1584573|P1|COMPLETED|Overall Study||46
645456|NCT00002931|1584573|P1|STARTED|Overall Study||48
645457|NCT00002874|1584581|P2|NOT COMPLETED|Overall Study||35
645458|NCT00002874|1584582|P1|NOT COMPLETED|Overall Study||45
645459|NCT00002874|1584581|P2|COMPLETED|Overall Study||384
645460|NCT00002874|1584582|P1|COMPLETED|Overall Study||376
645461|NCT00002874|1584581|P2|STARTED|Overall Study||419
645462|NCT00002874|1584582|P1|STARTED|Overall Study||421
645463|NCT00002850|1584607|P3|NOT COMPLETED|Overall Study||4
645464|NCT00002850|1584608|P2|NOT COMPLETED|Overall Study||2
645465|NCT00002850|1584609|P1|NOT COMPLETED|Overall Study||5
645466|NCT00002850|1584607|P3|COMPLETED|Overall Study||63
645467|NCT00002850|1584608|P2|COMPLETED|Overall Study||74
645468|NCT00002850|1584609|P1|COMPLETED|Overall Study||64
645469|NCT00002850|1584607|P3|STARTED|Overall Study||67
645470|NCT00002850|1584608|P2|STARTED|Overall Study||76
645471|NCT00002850|1584609|P1|STARTED|Overall Study||69
645472|NCT00002842|1584617|P1|NOT COMPLETED|Overall Study||27
645473|NCT00002842|1584617|P1|COMPLETED|Overall Study||22
645474|NCT00002842|1584617|P1|STARTED|Overall Study||49
645475|NCT00002766|1584623|P2|NOT COMPLETED|Overall Study||4
645476|NCT00002766|1584624|P1|NOT COMPLETED|Overall Study||3
645477|NCT00002766|1584623|P2|COMPLETED|Overall Study||85
645478|NCT00002766|1584624|P1|COMPLETED|Overall Study||78
645479|NCT00002766|1584623|P2|STARTED|Overall Study||89
645480|NCT00002766|1584624|P1|STARTED|Overall Study||81
645481|NCT00002651|1584632|P3|NOT COMPLETED|Consolidation and Randomization||860
645482|NCT00002651|1584633|P2|NOT COMPLETED|Consolidation and Randomization||838
645483|NCT00002651|1584634|P1|NOT COMPLETED|Consolidation and Randomization||0
645484|NCT00002651|1584632|P3|COMPLETED|Consolidation and Randomization||22
645485|NCT00002651|1584633|P2|COMPLETED|Consolidation and Randomization||29
645486|NCT00002651|1584634|P1|COMPLETED|Consolidation and Randomization||0
645487|NCT00002651|1584632|P3|Assessable for Toxicity|Consolidation and Randomization||702
645488|NCT00002651|1584633|P2|Assessable for Toxicity|Consolidation and Randomization||732
645489|NCT00002651|1584634|P1|Assessable for Toxicity|Consolidation and Randomization||0
645490|NCT00002651|1584632|P3|Eligible|Consolidation and Randomization||770
645491|NCT00002651|1584633|P2|Eligible|Consolidation and Randomization||765
645492|NCT00002651|1584634|P1|Eligible|Consolidation and Randomization||0
645493|NCT00002651|1584632|P3|STARTED|Consolidation and Randomization|After induction,patients with stable or declining PSA (≤ 4.0 ng/mL) were eligible for randomization|882
645494|NCT00002651|1584633|P2|STARTED|Consolidation and Randomization|After induction,patients with stable or declining PSA (≤ 4.0 ng/mL) were eligible for randomization|867
645495|NCT00002651|1584634|P1|STARTED|Consolidation and Randomization||0
645496|NCT00002651|1584632|P3|NOT COMPLETED|Induction||0
645497|NCT00002651|1584633|P2|NOT COMPLETED|Induction||0
645498|NCT00002651|1584634|P1|NOT COMPLETED|Induction||1343
645499|NCT00002651|1584632|P3|COMPLETED|Induction||0
645500|NCT00002651|1584633|P2|COMPLETED|Induction||0
645501|NCT00002651|1584634|P1|COMPLETED|Induction||1697
645502|NCT00002651|1584632|P3|Eligible and Began Protocol Therapy|Induction||0
645503|NCT00002651|1584633|P2|Eligible and Began Protocol Therapy|Induction||0
645504|NCT00002651|1584634|P1|Eligible and Began Protocol Therapy|Induction||2950
645505|NCT00002651|1584632|P3|Eligible|Induction||0
645506|NCT00002651|1584633|P2|Eligible|Induction||0
645507|NCT00002651|1584634|P1|Eligible|Induction||2950
645508|NCT00002651|1584632|P3|STARTED|Induction||0
645509|NCT00002651|1584633|P2|STARTED|Induction||0
645510|NCT00002651|1584634|P1|STARTED|Induction||3040
645511|NCT00002558|1584652|P2|NOT COMPLETED|Overall Study||1
645512|NCT00002558|1584653|P1|NOT COMPLETED|Overall Study||0
645513|NCT00002558|1584652|P2|COMPLETED|Overall Study||15
645514|NCT00002558|1584653|P1|COMPLETED|Overall Study||92
645515|NCT00002558|1584652|P2|STARTED|Overall Study||16
645516|NCT00002558|1584653|P1|STARTED|Overall Study||92
645517|NCT00052078|1584663|P4|NOT COMPLETED|Overall Study||15
645518|NCT00052078|1584664|P3|NOT COMPLETED|Overall Study||13
645519|NCT00052078|1584665|P2|NOT COMPLETED|Overall Study||6
645520|NCT00052078|1584666|P1|NOT COMPLETED|Overall Study||23
645521|NCT00052078|1584663|P4|COMPLETED|Overall Study||61
645522|NCT00052078|1584664|P3|COMPLETED|Overall Study||127
645523|NCT00052078|1584665|P2|COMPLETED|Overall Study||133
645524|NCT00052078|1584666|P1|COMPLETED|Overall Study||110
645525|NCT00052078|1584663|P4|STARTED|Overall Study||76
645526|NCT00052078|1584664|P3|STARTED|Overall Study||140
645527|NCT00052078|1584665|P2|STARTED|Overall Study||139
645528|NCT00052078|1584666|P1|STARTED|Overall Study||133
645529|NCT00051636|1584678|P2|NOT COMPLETED|Period 2- Extended Observation Period||30
645530|NCT00051636|1584679|P1|NOT COMPLETED|Period 2- Extended Observation Period||70
645531|NCT00051636|1584678|P2|COMPLETED|Period 2- Extended Observation Period|Includes patients retreated for Paget's disease|22
645532|NCT00051636|1584679|P1|COMPLETED|Period 2- Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|5
645533|NCT00051636|1584678|P2|STARTED|Period 2- Extended Observation Period||52
645534|NCT00051636|1584679|P1|STARTED|Period 2- Extended Observation Period||75
645535|NCT00051636|1584678|P2|NOT COMPLETED|Period 1 - Core||6
645536|NCT00051636|1584679|P1|NOT COMPLETED|Period 1 - Core||4
645537|NCT00051636|1584678|P2|COMPLETED|Period 1 - Core||76
645538|NCT00051636|1584679|P1|COMPLETED|Period 1 - Core||86
645539|NCT00051636|1584678|P2|STARTED|Period 1 - Core||82
645540|NCT00051636|1584679|P1|STARTED|Period 1 - Core||90
645541|NCT00051558|1584707|P2|NOT COMPLETED|Overall Study||96
645542|NCT00051558|1584708|P1|NOT COMPLETED|Overall Study||91
645543|NCT00051558|1584707|P2|COMPLETED|Overall Study||118
645544|NCT00051558|1584708|P1|COMPLETED|Overall Study||123
645545|NCT00051558|1584707|P2|STARTED|Overall Study||214
645546|NCT00051558|1584708|P1|STARTED|Overall Study||214
645547|NCT00051363|1584744|P2|NOT COMPLETED|Overall Study||144
645548|NCT00051363|1584745|P1|NOT COMPLETED|Overall Study||115
645549|NCT00051363|1584744|P2|COMPLETED|Overall Study||403
645550|NCT00051363|1584745|P1|COMPLETED|Overall Study||443
645551|NCT00051363|1584744|P2|Completed 6M Vist On-Study|Overall Study||403
645552|NCT00051363|1584745|P1|Completed 6M Vist On-Study|Overall Study||443
645553|NCT00051363|1584744|P2|Completed 6M Visit On-Treatment|Overall Study||372
645554|NCT00051363|1584745|P1|Completed 6M Visit On-Treatment|Overall Study||427
645555|NCT00051363|1584744|P2|Completed 2M Visit On-Study|Overall Study||432
645556|NCT00051363|1584745|P1|Completed 2M Visit On-Study|Overall Study||468
645557|NCT00051363|1584744|P2|Completed 2M Visit On-Treatment|Overall Study||417
645558|NCT00051363|1584745|P1|Completed 2M Visit On-Treatment|Overall Study||456
645559|NCT00051363|1584744|P2|Randomized & Analyzed|Overall Study||542
645560|NCT00051363|1584745|P1|Randomized & Analyzed|Overall Study||556
645561|NCT00051363|1584744|P2|STARTED|Overall Study||547
645562|NCT00051363|1584745|P1|STARTED|Overall Study||558
645563|NCT00051168|1584779|P1|NOT COMPLETED|Overall Study||135
645564|NCT00051168|1584779|P1|COMPLETED|Overall Study||367
645565|NCT00051168|1584779|P1|STARTED|Overall Study||502
645566|NCT00051025|1584785|P2|NOT COMPLETED|Overall Study||4
645567|NCT00051025|1584786|P1|NOT COMPLETED|Overall Study||2
645568|NCT00051025|1584785|P2|COMPLETED|Overall Study||0
645569|NCT00051025|1584786|P1|COMPLETED|Overall Study||3
645570|NCT00051025|1584785|P2|STARTED|Overall Study||4
645571|NCT00051025|1584786|P1|STARTED|Overall Study||5
645572|NCT00050986|1584794|P1|NOT COMPLETED|Overall Study||2
645573|NCT00050986|1584794|P1|COMPLETED|Overall Study|Two participants had withdrawn consents before the study treatment was initiated.|53
645574|NCT00050986|1584794|P1|STARTED|Overall Study||55
645575|NCT00050960|1584800|P2|NOT COMPLETED|Overall Study||304
645576|NCT00050960|1584801|P1|NOT COMPLETED|Overall Study||302
645577|NCT00050960|1584800|P2|COMPLETED|Overall Study|Represents number of patients with no primary reason for termination|2
645578|NCT00050960|1584801|P1|COMPLETED|Overall Study|Represents number of patients with no primary reason for termination|4
645579|NCT00050960|1584800|P2|STARTED|Overall Study||306
645580|NCT00050960|1584801|P1|STARTED|Overall Study||306
645581|NCT00050778|1584810|P3|NOT COMPLETED|Overall Study||18
645582|NCT00050778|1584811|P2|NOT COMPLETED|Overall Study||21
645583|NCT00050778|1584812|P1|NOT COMPLETED|Overall Study||45
645584|NCT00050778|1584810|P3|COMPLETED|Overall Study||92
645585|NCT00050778|1584811|P2|COMPLETED|Overall Study||92
645586|NCT00050778|1584812|P1|COMPLETED|Overall Study||66
645587|NCT00050778|1584810|P3|Treated|Overall Study||108
645588|NCT00050778|1584811|P2|Treated|Overall Study||108
645589|NCT00050778|1584812|P1|Treated|Overall Study||107
645590|NCT00050778|1584810|P3|STARTED|Overall Study||110
645591|NCT00050778|1584811|P2|STARTED|Overall Study||113
645592|NCT00050778|1584812|P1|STARTED|Overall Study|Randomized.|111
645593|NCT00050622|1584838|P1|NOT COMPLETED|Overall Study||1
645594|NCT00050622|1584838|P1|COMPLETED|Overall Study||153
645595|NCT00050622|1584838|P1|STARTED|Overall Study||154
645596|NCT00050167|1584876|P2|NOT COMPLETED|Overall Study||1
645597|NCT00050167|1584877|P1|NOT COMPLETED|Overall Study||1
645598|NCT00050167|1584876|P2|COMPLETED|Overall Study||300
645599|NCT00050167|1584877|P1|COMPLETED|Overall Study||301
645600|NCT00050167|1584876|P2|STARTED|Overall Study||301
645601|NCT00050167|1584877|P1|STARTED|Overall Study||302
645602|NCT00050089|1584887|P4|NOT COMPLETED|Overall Study||0
645603|NCT00050089|1584888|P3|NOT COMPLETED|Overall Study||0
645604|NCT00050089|1584889|P2|NOT COMPLETED|Overall Study||0
645605|NCT00050089|1584890|P1|NOT COMPLETED|Overall Study||0
645606|NCT00050089|1584887|P4|COMPLETED|Overall Study|For primary outcome assessment|78
645607|NCT00050089|1584888|P3|COMPLETED|Overall Study|For primary outcome assessment|86
645608|NCT00050089|1584889|P2|COMPLETED|Overall Study|For primary outcome assessment|98
645609|NCT00050089|1584890|P1|COMPLETED|Overall Study|For primary outcome assessment|106
645610|NCT00050089|1584887|P4|Baseline|Overall Study||78
645611|NCT00050089|1584888|P3|Baseline|Overall Study||86
645612|NCT00050089|1584889|P2|Baseline|Overall Study|14 participants randomized in the UK Option scheme (not shown in 2X2 baseline data)|84
645613|NCT00050089|1584890|P1|Baseline|Overall Study|15 participants randomized in the UK Option scheme (not displayed in the 2X2 baseline data)|91
645614|NCT00050089|1584887|P4|STARTED|Overall Study||78
645615|NCT00050089|1584888|P3|STARTED|Overall Study||86
645616|NCT00050089|1584889|P2|STARTED|Overall Study||98
645617|NCT00050089|1584890|P1|STARTED|Overall Study||106
645618|NCT00050011|1584910|P2|NOT COMPLETED|Overall Study||126
645619|NCT00050011|1584911|P1|NOT COMPLETED|Overall Study||121
645620|NCT00050011|1584910|P2|COMPLETED|Overall Study||175
645621|NCT00050011|1584911|P1|COMPLETED|Overall Study||180
645622|NCT00050011|1584910|P2|Intent-to-treat Population|Overall Study||300
645623|NCT00050011|1584911|P1|Intent-to-treat Population|Overall Study||300
645624|NCT00050011|1584910|P2|STARTED|Overall Study||301
645625|NCT00050011|1584911|P1|STARTED|Overall Study||301
645626|NCT00049842|1584933|P2|NOT COMPLETED|Follow-up Phase||5
645627|NCT00049842|1584934|P1|NOT COMPLETED|Follow-up Phase||7
645628|NCT00049842|1584933|P2|COMPLETED|Follow-up Phase||189
645629|NCT00049842|1584934|P1|COMPLETED|Follow-up Phase||211
645716|NCT00048724|1585472|P2|NOT COMPLETED|Overall Study||118
645630|NCT00049842|1584933|P2|STARTED|Follow-up Phase|Population is all treatment phase completers plus some who discontinued the treatment phase.|194
645631|NCT00049842|1584934|P1|STARTED|Follow-up Phase|Population is all treatment phase completers plus some who discontinued the treatment phase.|218
645632|NCT00049842|1584933|P2|NOT COMPLETED|Treatment Phase||78
645633|NCT00049842|1584934|P1|NOT COMPLETED|Treatment Phase||93
645634|NCT00049842|1584933|P2|COMPLETED|Treatment Phase||192
645635|NCT00049842|1584934|P1|COMPLETED|Treatment Phase||177
645636|NCT00049842|1584933|P2|STARTED|Treatment Phase||270
645637|NCT00049842|1584934|P1|STARTED|Treatment Phase||270
645638|NCT00048932|1584952|P3|NOT COMPLETED|Open Label Period (OL)||441
645639|NCT00048932|1584953|P2|NOT COMPLETED|Open Label Period (OL)||0
645640|NCT00048932|1584954|P1|NOT COMPLETED|Open Label Period (OL)||0
645641|NCT00048932|1584952|P3|COMPLETED|Open Label Period (OL)||743
645642|NCT00048932|1584953|P2|COMPLETED|Open Label Period (OL)||0
645643|NCT00048932|1584954|P1|COMPLETED|Open Label Period (OL)||0
645644|NCT00048932|1584952|P3|STARTED|Open Label Period (OL)|47 participants who completed the double-blind did not enter the open-label|1184
645645|NCT00048932|1584953|P2|STARTED|Open Label Period (OL)||0
645646|NCT00048932|1584954|P1|STARTED|Open Label Period (OL)||0
645647|NCT00048932|1584952|P3|NOT COMPLETED|Double Blind Period (DB)||0
645648|NCT00048932|1584953|P2|NOT COMPLETED|Double Blind Period (DB)||87
645649|NCT00048932|1584954|P1|NOT COMPLETED|Double Blind Period (DB)||123
645650|NCT00048932|1584952|P3|COMPLETED|Double Blind Period (DB)||0
645651|NCT00048932|1584953|P2|COMPLETED|Double Blind Period (DB)||395
645652|NCT00048932|1584954|P1|COMPLETED|Double Blind Period (DB)||836
645653|NCT00048932|1584952|P3|STARTED|Double Blind Period (DB)||0
645654|NCT00048932|1584953|P2|STARTED|Double Blind Period (DB)|Number Treated|482
645655|NCT00048932|1584954|P1|STARTED|Double Blind Period (DB)|Number Treated|959
645656|NCT00048815|1584981|P3|NOT COMPLETED|Overall Study||4
645657|NCT00048815|1584982|P2|NOT COMPLETED|Overall Study||4
645658|NCT00048815|1584983|P1|NOT COMPLETED|Overall Study||6
645659|NCT00048815|1584981|P3|COMPLETED|Overall Study||19
645660|NCT00048815|1584982|P2|COMPLETED|Overall Study||22
645661|NCT00048815|1584983|P1|COMPLETED|Overall Study||18
645662|NCT00048815|1584981|P3|STARTED|Overall Study||23
645663|NCT00048815|1584982|P2|STARTED|Overall Study||26
645664|NCT00048815|1584983|P1|STARTED|Overall Study||24
645665|NCT00048581|1584996|P3|NOT COMPLETED|Open-Label Period||167
645666|NCT00048581|1584997|P2|NOT COMPLETED|Open-Label Period||0
645667|NCT00048581|1584998|P1|NOT COMPLETED|Open-Label Period||0
645668|NCT00048581|1584996|P3|COMPLETED|Open-Label Period||150
645669|NCT00048581|1584997|P2|COMPLETED|Open-Label Period||0
645670|NCT00048581|1584998|P1|COMPLETED|Open-Label Period||0
645671|NCT00048581|1584996|P3|STARTED|Open-Label Period||317
645672|NCT00048581|1584997|P2|STARTED|Open-Label Period||0
645673|NCT00048581|1584998|P1|STARTED|Open-Label Period||0
645674|NCT00048581|1584996|P3|NOT COMPLETED|Double-Blind Period||0
645675|NCT00048581|1584997|P2|NOT COMPLETED|Double-Blind Period||34
645676|NCT00048581|1584998|P1|NOT COMPLETED|Double-Blind Period||35
645677|NCT00048581|1584996|P3|COMPLETED|Double-Blind Period||0
645678|NCT00048581|1584997|P2|COMPLETED|Double-Blind Period||99
645679|NCT00048581|1584998|P1|COMPLETED|Double-Blind Period||223
645680|NCT00048581|1584996|P3|STARTED|Double-Blind Period||0
645681|NCT00048581|1584997|P2|STARTED|Double-Blind Period||133
645682|NCT00048581|1584998|P1|STARTED|Double-Blind Period||258
645683|NCT00048568|1585165|P3|NOT COMPLETED|Open-Label Period||160
645684|NCT00048568|1585166|P2|NOT COMPLETED|Open-Label Period||0
645685|NCT00048568|1585167|P1|NOT COMPLETED|Open-Label Period||0
645686|NCT00048568|1585165|P3|COMPLETED|Open-Label Period||379
645687|NCT00048568|1585166|P2|COMPLETED|Open-Label Period||0
645688|NCT00048568|1585167|P1|COMPLETED|Open-Label Period||0
645689|NCT00048568|1585165|P3|STARTED|Open-Label Period||539
645690|NCT00048568|1585166|P2|STARTED|Open-Label Period||0
645691|NCT00048568|1585167|P1|STARTED|Open-Label Period||0
645692|NCT00048568|1585165|P3|NOT COMPLETED|Double-Blind Period Days 170 to 365||0
645693|NCT00048568|1585166|P2|NOT COMPLETED|Double-Blind Period Days 170 to 365||12
645694|NCT00048568|1585167|P1|NOT COMPLETED|Double-Blind Period Days 170 to 365||16
645695|NCT00048568|1585165|P3|COMPLETED|Double-Blind Period Days 170 to 365||0
645696|NCT00048568|1585166|P2|COMPLETED|Double-Blind Period Days 170 to 365||162
645697|NCT00048568|1585167|P1|COMPLETED|Double-Blind Period Days 170 to 365||385
645698|NCT00048568|1585165|P3|STARTED|Double-Blind Period Days 170 to 365||0
645699|NCT00048568|1585166|P2|STARTED|Double-Blind Period Days 170 to 365||174
645700|NCT00048568|1585167|P1|STARTED|Double-Blind Period Days 170 to 365||401
645701|NCT00048568|1585165|P3|NOT COMPLETED|Double-Blind Period Days 1 to 169||0
645702|NCT00048568|1585166|P2|NOT COMPLETED|Double-Blind Period Days 1 to 169||45
645703|NCT00048568|1585167|P1|NOT COMPLETED|Double-Blind Period Days 1 to 169||32
645704|NCT00048568|1585165|P3|COMPLETED|Double-Blind Period Days 1 to 169||0
645705|NCT00048568|1585166|P2|COMPLETED|Double-Blind Period Days 1 to 169||174
645706|NCT00048568|1585167|P1|COMPLETED|Double-Blind Period Days 1 to 169||401
645707|NCT00048568|1585165|P3|STARTED|Double-Blind Period Days 1 to 169||0
645708|NCT00048568|1585166|P2|STARTED|Double-Blind Period Days 1 to 169||219
645709|NCT00048568|1585167|P1|STARTED|Double-Blind Period Days 1 to 169||433
645710|NCT00048893|1585455|P1|NOT COMPLETED|Overall Study||0
645711|NCT00048893|1585455|P1|COMPLETED|Overall Study||37
645712|NCT00048893|1585455|P1|STARTED|Overall Study||37
645713|NCT00048737|1585466|P1|NOT COMPLETED|Overall Study||0
645714|NCT00048737|1585466|P1|COMPLETED|Overall Study||70
645715|NCT00048737|1585466|P1|STARTED|Overall Study||70
645717|NCT00048724|1585473|P1|NOT COMPLETED|Overall Study||116
645718|NCT00048724|1585472|P2|COMPLETED|Overall Study||197
645719|NCT00048724|1585473|P1|COMPLETED|Overall Study||195
645720|NCT00048724|1585472|P2|STARTED|Overall Study||315
645721|NCT00048724|1585473|P1|STARTED|Overall Study||311
645722|NCT00048542|1585485|P8|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22
645723|NCT00048542|1585486|P7|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22
645724|NCT00048542|1585487|P6|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
645725|NCT00048542|1585488|P5|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
645726|NCT00048542|1585489|P4|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
645727|NCT00048542|1585490|P3|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
645728|NCT00048542|1585491|P2|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
645729|NCT00048542|1585492|P1|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
645730|NCT00048542|1585485|P8|COMPLETED|Open-Label Extension Fixed Dose Phase||25
645731|NCT00048542|1585486|P7|COMPLETED|Open-Label Extension Fixed Dose Phase||37
645732|NCT00048542|1585487|P6|COMPLETED|Open-Label Extension Fixed Dose Phase||0
645733|NCT00048542|1585488|P5|COMPLETED|Open-Label Extension Fixed Dose Phase||0
645734|NCT00048542|1585489|P4|COMPLETED|Open-Label Extension Fixed Dose Phase||0
645735|NCT00048542|1585490|P3|COMPLETED|Open-Label Extension Fixed Dose Phase||0
645736|NCT00048542|1585491|P2|COMPLETED|Open-Label Extension Fixed Dose Phase||0
645737|NCT00048542|1585492|P1|COMPLETED|Open-Label Extension Fixed Dose Phase||0
645738|NCT00048542|1585485|P8|STARTED|Open-Label Extension Fixed Dose Phase||47
645739|NCT00048542|1585486|P7|STARTED|Open-Label Extension Fixed Dose Phase||59
645740|NCT00048542|1585487|P6|STARTED|Open-Label Extension Fixed Dose Phase||0
645741|NCT00048542|1585488|P5|STARTED|Open-Label Extension Fixed Dose Phase||0
645742|NCT00048542|1585489|P4|STARTED|Open-Label Extension Fixed Dose Phase||0
645743|NCT00048542|1585490|P3|STARTED|Open-Label Extension Fixed Dose Phase||0
645744|NCT00048542|1585491|P2|STARTED|Open-Label Extension Fixed Dose Phase||0
645745|NCT00048542|1585492|P1|STARTED|Open-Label Extension Fixed Dose Phase||0
645746|NCT00048542|1585485|P8|NOT COMPLETED|Open-Label Extension BSA Phase||0
645747|NCT00048542|1585486|P7|NOT COMPLETED|Open-Label Extension BSA Phase||0
645748|NCT00048542|1585487|P6|NOT COMPLETED|Open-Label Extension BSA Phase||10
645749|NCT00048542|1585488|P5|NOT COMPLETED|Open-Label Extension BSA Phase||12
645750|NCT00048542|1585489|P4|NOT COMPLETED|Open-Label Extension BSA Phase||0
645751|NCT00048542|1585490|P3|NOT COMPLETED|Open-Label Extension BSA Phase||0
645752|NCT00048542|1585491|P2|NOT COMPLETED|Open-Label Extension BSA Phase||0
645753|NCT00048542|1585492|P1|NOT COMPLETED|Open-Label Extension BSA Phase||0
645754|NCT00048542|1585485|P8|COMPLETED|Open-Label Extension BSA Phase||0
645755|NCT00048542|1585486|P7|COMPLETED|Open-Label Extension BSA Phase||0
645756|NCT00048542|1585487|P6|COMPLETED|Open-Label Extension BSA Phase||47
645757|NCT00048542|1585488|P5|COMPLETED|Open-Label Extension BSA Phase||59
645758|NCT00048542|1585489|P4|COMPLETED|Open-Label Extension BSA Phase||0
645759|NCT00048542|1585490|P3|COMPLETED|Open-Label Extension BSA Phase||0
645760|NCT00048542|1585491|P2|COMPLETED|Open-Label Extension BSA Phase||0
645761|NCT00048542|1585492|P1|COMPLETED|Open-Label Extension BSA Phase||0
645762|NCT00048542|1585485|P8|STARTED|Open-Label Extension BSA Phase||0
645763|NCT00048542|1585486|P7|STARTED|Open-Label Extension BSA Phase||0
645764|NCT00048542|1585487|P6|STARTED|Open-Label Extension BSA Phase||57
645765|NCT00048542|1585488|P5|STARTED|Open-Label Extension BSA Phase||71
645766|NCT00048542|1585489|P4|STARTED|Open-Label Extension BSA Phase||0
645767|NCT00048542|1585490|P3|STARTED|Open-Label Extension BSA Phase||0
645768|NCT00048542|1585491|P2|STARTED|Open-Label Extension BSA Phase||0
645769|NCT00048542|1585492|P1|STARTED|Open-Label Extension BSA Phase||0
645770|NCT00048542|1585485|P8|NOT COMPLETED|Double-Blind Phase||0
645771|NCT00048542|1585486|P7|NOT COMPLETED|Double-Blind Phase||0
645772|NCT00048542|1585487|P6|NOT COMPLETED|Double-Blind Phase||0
645773|NCT00048542|1585488|P5|NOT COMPLETED|Double-Blind Phase||0
645774|NCT00048542|1585489|P4|NOT COMPLETED|Double-Blind Phase||0
645775|NCT00048542|1585490|P3|NOT COMPLETED|Double-Blind Phase||1
645776|NCT00048542|1585491|P2|NOT COMPLETED|Double-Blind Phase||1
645777|NCT00048542|1585492|P1|NOT COMPLETED|Double-Blind Phase||3
645778|NCT00048542|1585485|P8|COMPLETED|Double-Blind Phase||0
645779|NCT00048542|1585486|P7|COMPLETED|Double-Blind Phase||0
645780|NCT00048542|1585487|P6|COMPLETED|Double-Blind Phase||0
645781|NCT00048542|1585488|P5|COMPLETED|Double-Blind Phase||0
645782|NCT00048542|1585489|P4|COMPLETED|Double-Blind Phase||28
645783|NCT00048542|1585490|P3|COMPLETED|Double-Blind Phase||29
645784|NCT00048542|1585491|P2|COMPLETED|Double-Blind Phase||36
645785|NCT00048542|1585492|P1|COMPLETED|Double-Blind Phase||35
645786|NCT00048542|1585485|P8|STARTED|Double-Blind Phase||0
645787|NCT00048542|1585486|P7|STARTED|Double-Blind Phase||0
645788|NCT00048542|1585487|P6|STARTED|Double-Blind Phase||0
645789|NCT00048542|1585488|P5|STARTED|Double-Blind Phase||0
645790|NCT00048542|1585489|P4|STARTED|Double-Blind Phase||28
645791|NCT00048542|1585490|P3|STARTED|Double-Blind Phase||30
645792|NCT00048542|1585491|P2|STARTED|Double-Blind Phase||37
645793|NCT00048542|1585492|P1|STARTED|Double-Blind Phase|For all groups, started indicates when the subjects entered the double-blind treatment phase.|38
645794|NCT00048347|1585558|P1|NOT COMPLETED|Overall Study||2
645795|NCT00048347|1585558|P1|COMPLETED|Overall Study||16
645796|NCT00048347|1585558|P1|STARTED|Overall Study||18
645797|NCT00048165|1585564|P2|NOT COMPLETED|Completed 12 Months Study||3
645798|NCT00048165|1585565|P1|NOT COMPLETED|Completed 12 Months Study||3
645799|NCT00048165|1585564|P2|COMPLETED|Completed 12 Months Study||167
645800|NCT00048165|1585565|P1|COMPLETED|Completed 12 Months Study||162
645801|NCT00048165|1585564|P2|STARTED|Completed 12 Months Study||170
645802|NCT00048165|1585565|P1|STARTED|Completed 12 Months Study||165
645803|NCT00048165|1585564|P2|NOT COMPLETED|Completed 6 Months Study||48
645804|NCT00048165|1585565|P1|NOT COMPLETED|Completed 6 Months Study||51
645805|NCT00048165|1585564|P2|COMPLETED|Completed 6 Months Study||170
645806|NCT00048165|1585565|P1|COMPLETED|Completed 6 Months Study||165
645807|NCT00048165|1585564|P2|STARTED|Completed 6 Months Study||218
645808|NCT00048165|1585565|P1|STARTED|Completed 6 Months Study||216
645809|NCT00048074|1585600|P3|NOT COMPLETED|Overall Study||97
645810|NCT00048074|1585601|P2|NOT COMPLETED|Overall Study||87
645811|NCT00048074|1585602|P1|NOT COMPLETED|Overall Study||81
645812|NCT00048074|1585600|P3|COMPLETED|Overall Study||372
645813|NCT00048074|1585601|P2|COMPLETED|Overall Study||361
645814|NCT00048074|1585602|P1|COMPLETED|Overall Study||384
645815|NCT00048074|1585600|P3|STARTED|Overall Study||469
645816|NCT00048074|1585601|P2|STARTED|Overall Study||448
645817|NCT00048074|1585602|P1|STARTED|Overall Study||465
645818|NCT00048061|1585659|P4|NOT COMPLETED|Overall Study||79
645819|NCT00048061|1585660|P3|NOT COMPLETED|Overall Study||84
645820|NCT00048061|1585661|P2|NOT COMPLETED|Overall Study||73
645821|NCT00048061|1585662|P1|NOT COMPLETED|Overall Study||75
645822|NCT00048061|1585659|P4|COMPLETED|Overall Study||322
645823|NCT00048061|1585660|P3|COMPLETED|Overall Study||316
645824|NCT00048061|1585661|P2|COMPLETED|Overall Study||328
645825|NCT00048061|1585662|P1|COMPLETED|Overall Study||325
645826|NCT00048061|1585659|P4|STARTED|Overall Study||401
645827|NCT00048061|1585660|P3|STARTED|Overall Study||400
645828|NCT00048061|1585661|P2|STARTED|Overall Study||401
645829|NCT00048061|1585662|P1|STARTED|Overall Study||400
645830|NCT00048048|1585741|P12|NOT COMPLETED|Extension Year 2||2
645831|NCT00048048|1585742|P11|NOT COMPLETED|Extension Year 2||4
645832|NCT00048048|1585743|P10|NOT COMPLETED|Extension Year 2||0
645833|NCT00048048|1585744|P9|NOT COMPLETED|Extension Year 2||0
645834|NCT00048048|1585745|P8|NOT COMPLETED|Extension Year 2||0
645835|NCT00048048|1585746|P7|NOT COMPLETED|Extension Year 2||0
645836|NCT00048048|1585747|P6|NOT COMPLETED|Extension Year 2||0
645837|NCT00048048|1585748|P5|NOT COMPLETED|Extension Year 2||0
645838|NCT00048048|1585749|P4|NOT COMPLETED|Extension Year 2||0
645839|NCT00048048|1585750|P3|NOT COMPLETED|Extension Year 2||0
645840|NCT00048048|1585751|P2|NOT COMPLETED|Extension Year 2||0
645841|NCT00048048|1585752|P1|NOT COMPLETED|Extension Year 2||0
645842|NCT00048048|1585741|P12|COMPLETED|Extension Year 2||13
645843|NCT00048048|1585742|P11|COMPLETED|Extension Year 2||19
645844|NCT00048048|1585743|P10|COMPLETED|Extension Year 2||2
645845|NCT00048048|1585744|P9|COMPLETED|Extension Year 2||0
645846|NCT00048048|1585745|P8|COMPLETED|Extension Year 2||0
645847|NCT00048048|1585746|P7|COMPLETED|Extension Year 2||0
645848|NCT00048048|1585747|P6|COMPLETED|Extension Year 2||0
645849|NCT00048048|1585748|P5|COMPLETED|Extension Year 2||0
645850|NCT00048048|1585749|P4|COMPLETED|Extension Year 2||0
645851|NCT00048048|1585750|P3|COMPLETED|Extension Year 2||0
645852|NCT00048048|1585751|P2|COMPLETED|Extension Year 2||0
645853|NCT00048048|1585752|P1|COMPLETED|Extension Year 2||0
645854|NCT00048048|1585741|P12|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|15
645855|NCT00048048|1585742|P11|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1 + 12 participants from RO0503821 (1X/Week).|23
645856|NCT00048048|1585743|P10|STARTED|Extension Year 2|Twelve participants who completed Extension Year 1 were switched to RO0503821 (1x/2Week).|2
645857|NCT00048048|1585744|P9|STARTED|Extension Year 2||0
645858|NCT00048048|1585745|P8|STARTED|Extension Year 2||0
645859|NCT00048048|1585746|P7|STARTED|Extension Year 2||0
645860|NCT00048048|1585747|P6|STARTED|Extension Year 2||0
645861|NCT00048048|1585748|P5|STARTED|Extension Year 2||0
645862|NCT00048048|1585749|P4|STARTED|Extension Year 2||0
645863|NCT00048048|1585750|P3|STARTED|Extension Year 2||0
645864|NCT00048048|1585751|P2|STARTED|Extension Year 2||0
645865|NCT00048048|1585752|P1|STARTED|Extension Year 2||0
645866|NCT00048048|1585741|P12|NOT COMPLETED|Extension Year 1||4
645867|NCT00048048|1585742|P11|NOT COMPLETED|Extension Year 1||2
645868|NCT00048048|1585743|P10|NOT COMPLETED|Extension Year 1||2
645869|NCT00048048|1585744|P9|NOT COMPLETED|Extension Year 1||0
645870|NCT00048048|1585745|P8|NOT COMPLETED|Extension Year 1||0
645871|NCT00048048|1585746|P7|NOT COMPLETED|Extension Year 1||0
645872|NCT00048048|1585747|P6|NOT COMPLETED|Extension Year 1||0
645873|NCT00048048|1585748|P5|NOT COMPLETED|Extension Year 1||0
645874|NCT00048048|1585749|P4|NOT COMPLETED|Extension Year 1||0
645875|NCT00048048|1585750|P3|NOT COMPLETED|Extension Year 1||0
645876|NCT00048048|1585751|P2|NOT COMPLETED|Extension Year 1||0
645877|NCT00048048|1585752|P1|NOT COMPLETED|Extension Year 1||0
645878|NCT00048048|1585741|P12|COMPLETED|Extension Year 1||15
645879|NCT00048048|1585742|P11|COMPLETED|Extension Year 1||14
645880|NCT00048048|1585743|P10|COMPLETED|Extension Year 1||14
645881|NCT00048048|1585744|P9|COMPLETED|Extension Year 1||0
645882|NCT00048048|1585745|P8|COMPLETED|Extension Year 1||0
645883|NCT00048048|1585746|P7|COMPLETED|Extension Year 1||0
645884|NCT00048048|1585747|P6|COMPLETED|Extension Year 1||0
645885|NCT00048048|1585748|P5|COMPLETED|Extension Year 1||0
645886|NCT00048048|1585749|P4|COMPLETED|Extension Year 1||0
645887|NCT00048048|1585750|P3|COMPLETED|Extension Year 1||0
645888|NCT00048048|1585751|P2|COMPLETED|Extension Year 1||0
645889|NCT00048048|1585752|P1|COMPLETED|Extension Year 1||0
645890|NCT00048048|1585741|P12|STARTED|Extension Year 1|Participants (Cohorts 7, 8, and 9) who completed core, entered extension period (entry optional).|19
645891|NCT00048048|1585742|P11|STARTED|Extension Year 1|Participants (Cohorts 4, 5, and 6) who completed core, entered extension period (entry optional).|16
645892|NCT00048048|1585743|P10|STARTED|Extension Year 1|Participants (Cohorts 1, 2, and 3) who completed core, entered extension period (entry optional).|16
645893|NCT00048048|1585744|P9|STARTED|Extension Year 1||0
645894|NCT00048048|1585745|P8|STARTED|Extension Year 1||0
645895|NCT00048048|1585746|P7|STARTED|Extension Year 1||0
645896|NCT00048048|1585747|P6|STARTED|Extension Year 1||0
645897|NCT00048048|1585748|P5|STARTED|Extension Year 1||0
645898|NCT00048048|1585749|P4|STARTED|Extension Year 1||0
645899|NCT00048048|1585750|P3|STARTED|Extension Year 1||0
645900|NCT00048048|1585751|P2|STARTED|Extension Year 1||0
645901|NCT00048048|1585752|P1|STARTED|Extension Year 1||0
645902|NCT00048048|1585741|P12|NOT COMPLETED|Core Treatment||0
645903|NCT00048048|1585742|P11|NOT COMPLETED|Core Treatment||0
645904|NCT00048048|1585743|P10|NOT COMPLETED|Core Treatment||0
645905|NCT00048048|1585744|P9|NOT COMPLETED|Core Treatment||0
645906|NCT00048048|1585745|P8|NOT COMPLETED|Core Treatment||1
645907|NCT00048048|1585746|P7|NOT COMPLETED|Core Treatment||0
645908|NCT00048048|1585747|P6|NOT COMPLETED|Core Treatment||0
645909|NCT00048048|1585748|P5|NOT COMPLETED|Core Treatment||0
645910|NCT00048048|1585749|P4|NOT COMPLETED|Core Treatment||0
645911|NCT00048048|1585750|P3|NOT COMPLETED|Core Treatment||1
645912|NCT00048048|1585751|P2|NOT COMPLETED|Core Treatment||0
645913|NCT00048048|1585752|P1|NOT COMPLETED|Core Treatment||0
645914|NCT00048048|1585741|P12|COMPLETED|Core Treatment||0
645915|NCT00048048|1585742|P11|COMPLETED|Core Treatment||0
645916|NCT00048048|1585743|P10|COMPLETED|Core Treatment||0
645917|NCT00048048|1585744|P9|COMPLETED|Core Treatment||10
645918|NCT00048048|1585745|P8|COMPLETED|Core Treatment||5
645919|NCT00048048|1585746|P7|COMPLETED|Core Treatment||6
645920|NCT00048048|1585747|P6|COMPLETED|Core Treatment||9
645921|NCT00048048|1585748|P5|COMPLETED|Core Treatment||6
645922|NCT00048048|1585749|P4|COMPLETED|Core Treatment||6
645923|NCT00048048|1585750|P3|COMPLETED|Core Treatment||9
645924|NCT00048048|1585751|P2|COMPLETED|Core Treatment||6
645925|NCT00048048|1585752|P1|COMPLETED|Core Treatment||6
645926|NCT00048048|1585741|P12|STARTED|Core Treatment||0
645927|NCT00048048|1585742|P11|STARTED|Core Treatment||0
645928|NCT00048048|1585743|P10|STARTED|Core Treatment||0
645929|NCT00048048|1585744|P9|STARTED|Core Treatment||10
645930|NCT00048048|1585745|P8|STARTED|Core Treatment||6
645931|NCT00048048|1585746|P7|STARTED|Core Treatment||6
645932|NCT00048048|1585747|P6|STARTED|Core Treatment||9
645933|NCT00048048|1585748|P5|STARTED|Core Treatment||6
645934|NCT00048048|1585749|P4|STARTED|Core Treatment||6
645935|NCT00048048|1585750|P3|STARTED|Core Treatment||10
645936|NCT00048048|1585751|P2|STARTED|Core Treatment||6
645937|NCT00048048|1585752|P1|STARTED|Core Treatment||6
645938|NCT00048035|1585808|P8|NOT COMPLETED|Extension Year 2||3
645939|NCT00048035|1585809|P7|NOT COMPLETED|Extension Year 2||3
645940|NCT00048035|1585810|P6|NOT COMPLETED|Extension Year 2||0
645941|NCT00048035|1585811|P5|NOT COMPLETED|Extension Year 2||0
645942|NCT00048035|1585812|P4|NOT COMPLETED|Extension Year 2||0
645943|NCT00048035|1585813|P3|NOT COMPLETED|Extension Year 2||0
645944|NCT00048035|1585814|P2|NOT COMPLETED|Extension Year 2||0
645945|NCT00048035|1585815|P1|NOT COMPLETED|Extension Year 2||0
645946|NCT00048035|1585808|P8|COMPLETED|Extension Year 2||10
645947|NCT00048035|1585809|P7|COMPLETED|Extension Year 2||11
645948|NCT00048035|1585810|P6|COMPLETED|Extension Year 2||0
645949|NCT00048035|1585811|P5|COMPLETED|Extension Year 2||0
645950|NCT00048035|1585812|P4|COMPLETED|Extension Year 2||0
645951|NCT00048035|1585813|P3|COMPLETED|Extension Year 2||0
645952|NCT00048035|1585814|P2|COMPLETED|Extension Year 2||0
645953|NCT00048035|1585815|P1|COMPLETED|Extension Year 2||0
645954|NCT00048035|1585808|P8|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|13
645955|NCT00048035|1585809|P7|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
645956|NCT00048035|1585810|P6|STARTED|Extension Year 2||0
645957|NCT00048035|1585811|P5|STARTED|Extension Year 2||0
645958|NCT00048035|1585812|P4|STARTED|Extension Year 2||0
645959|NCT00048035|1585813|P3|STARTED|Extension Year 2||0
645960|NCT00048035|1585814|P2|STARTED|Extension Year 2||0
645961|NCT00048035|1585815|P1|STARTED|Extension Year 2||0
645962|NCT00048035|1585808|P8|NOT COMPLETED|Extension Year 1||11
645963|NCT00048035|1585809|P7|NOT COMPLETED|Extension Year 1||11
645964|NCT00048035|1585810|P6|NOT COMPLETED|Extension Year 1||0
645965|NCT00048035|1585811|P5|NOT COMPLETED|Extension Year 1||0
645966|NCT00048035|1585812|P4|NOT COMPLETED|Extension Year 1||0
645967|NCT00048035|1585813|P3|NOT COMPLETED|Extension Year 1||0
645968|NCT00048035|1585814|P2|NOT COMPLETED|Extension Year 1||0
645969|NCT00048035|1585815|P1|NOT COMPLETED|Extension Year 1||0
645970|NCT00048035|1585808|P8|COMPLETED|Extension Year 1||15
645971|NCT00048035|1585809|P7|COMPLETED|Extension Year 1||16
645972|NCT00048035|1585810|P6|COMPLETED|Extension Year 1||0
645973|NCT00048035|1585811|P5|COMPLETED|Extension Year 1||0
645974|NCT00048035|1585812|P4|COMPLETED|Extension Year 1||0
645975|NCT00048035|1585813|P3|COMPLETED|Extension Year 1||0
645976|NCT00048035|1585814|P2|COMPLETED|Extension Year 1||0
645977|NCT00048035|1585815|P1|COMPLETED|Extension Year 1||0
645978|NCT00048035|1585808|P8|STARTED|Extension Year 1|Participants (Cohorts 2, 4 and 6) who completed core, entered extension period (entry optional).|26
645979|NCT00048035|1585809|P7|STARTED|Extension Year 1|Participants (Cohorts 1, 3, and 5) who completed core, entered extension period (entry optional).|27
645980|NCT00048035|1585810|P6|STARTED|Extension Year 1||0
645981|NCT00048035|1585811|P5|STARTED|Extension Year 1||0
645982|NCT00048035|1585812|P4|STARTED|Extension Year 1||0
645983|NCT00048035|1585813|P3|STARTED|Extension Year 1||0
645984|NCT00048035|1585814|P2|STARTED|Extension Year 1||0
645985|NCT00048035|1585815|P1|STARTED|Extension Year 1||0
645986|NCT00048035|1585808|P8|NOT COMPLETED|Core Period||0
645987|NCT00048035|1585809|P7|NOT COMPLETED|Core Period||0
645988|NCT00048035|1585810|P6|NOT COMPLETED|Core Period||1
645989|NCT00048035|1585811|P5|NOT COMPLETED|Core Period||1
645990|NCT00048035|1585812|P4|NOT COMPLETED|Core Period||1
645991|NCT00048035|1585813|P3|NOT COMPLETED|Core Period||1
645992|NCT00048035|1585814|P2|NOT COMPLETED|Core Period||2
645993|NCT00048035|1585815|P1|NOT COMPLETED|Core Period||4
645994|NCT00048035|1585808|P8|COMPLETED|Core Period||0
645995|NCT00048035|1585809|P7|COMPLETED|Core Period||0
645996|NCT00048035|1585810|P6|COMPLETED|Core Period||14
645997|NCT00048035|1585811|P5|COMPLETED|Core Period||15
645998|NCT00048035|1585812|P4|COMPLETED|Core Period||14
645999|NCT00048035|1585813|P3|COMPLETED|Core Period||14
646000|NCT00048035|1585814|P2|COMPLETED|Core Period||13
646001|NCT00048035|1585815|P1|COMPLETED|Core Period||11
646002|NCT00048035|1585808|P8|STARTED|Core Period||0
646003|NCT00048035|1585809|P7|STARTED|Core Period||0
646004|NCT00048035|1585810|P6|STARTED|Core Period||15
646005|NCT00048035|1585811|P5|STARTED|Core Period||16
646006|NCT00048035|1585812|P4|STARTED|Core Period||15
646007|NCT00048035|1585813|P3|STARTED|Core Period||15
646008|NCT00048035|1585814|P2|STARTED|Core Period||15
646009|NCT00048035|1585815|P1|STARTED|Core Period||15
646010|NCT00047879|1585853|P2|NOT COMPLETED|Overall Study||3
646011|NCT00047879|1585854|P1|NOT COMPLETED|Overall Study||4
646012|NCT00047879|1585853|P2|COMPLETED|Overall Study||0
646013|NCT00047879|1585854|P1|COMPLETED|Overall Study||0
646014|NCT00047879|1585853|P2|STARTED|Overall Study||3
646015|NCT00047879|1585854|P1|STARTED|Overall Study||4
646016|NCT00047697|1585866|P2|NOT COMPLETED|Overall Study||2
646017|NCT00047697|1585867|P1|NOT COMPLETED|Overall Study||0
646018|NCT00047697|1585866|P2|COMPLETED|Overall Study||14
646019|NCT00047697|1585867|P1|COMPLETED|Overall Study||18
646020|NCT00047697|1585866|P2|STARTED|Overall Study||16
646021|NCT00047697|1585867|P1|STARTED|Overall Study||18
646022|NCT00047619|1585879|P2|NOT COMPLETED|Overall Study||0
646023|NCT00047619|1585880|P1|NOT COMPLETED|Overall Study||0
646024|NCT00047619|1585879|P2|COMPLETED|Overall Study||14
646025|NCT00047619|1585880|P1|COMPLETED|Overall Study||14
646026|NCT00047619|1585879|P2|STARTED|Overall Study||14
646027|NCT00047619|1585880|P1|STARTED|Overall Study||14
646028|NCT00047463|1585890|P2|NOT COMPLETED|Overall Study||3
646029|NCT00047463|1585891|P1|NOT COMPLETED|Overall Study||0
646030|NCT00047463|1585890|P2|COMPLETED|Overall Study||19
646031|NCT00047463|1585891|P1|COMPLETED|Overall Study||13
646032|NCT00047463|1585890|P2|STARTED|Overall Study||22
646033|NCT00047463|1585891|P1|STARTED|Overall Study||13
646034|NCT00046475|1585902|P3|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
646035|NCT00046475|1585903|P2|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||1
646036|NCT00046475|1585904|P1|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
646037|NCT00046475|1585902|P3|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||59
646038|NCT00046475|1585903|P2|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||44
646039|NCT00046475|1585904|P1|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
646040|NCT00046475|1585902|P3|STARTED|Treatment Period 2 (Up to 2 Weeks)||59
646041|NCT00046475|1585903|P2|STARTED|Treatment Period 2 (Up to 2 Weeks)||45
646042|NCT00046475|1585904|P1|STARTED|Treatment Period 2 (Up to 2 Weeks)||0
646043|NCT00046475|1585902|P3|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||1
646044|NCT00046475|1585903|P2|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
646045|NCT00046475|1585904|P1|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
646046|NCT00046475|1585902|P3|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||59
646047|NCT00046475|1585903|P2|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||45
646048|NCT00046475|1585904|P1|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
646049|NCT00046475|1585902|P3|STARTED|Treatment Period 1 (Up to 2 Weeks)|Patients did not meet the criteria for randomization, had an AE, or withdrew from the study.|60
646050|NCT00046475|1585903|P2|STARTED|Treatment Period 1 (Up to 2 Weeks)|Patients did not meet the criteria for randomization, had an AE, or withdrew from the study.|45
646051|NCT00046475|1585904|P1|STARTED|Treatment Period 1 (Up to 2 Weeks)||0
646052|NCT00046475|1585902|P3|NOT COMPLETED|Titration (1 Week)||0
646053|NCT00046475|1585903|P2|NOT COMPLETED|Titration (1 Week)||0
646054|NCT00046475|1585904|P1|NOT COMPLETED|Titration (1 Week)||0
646055|NCT00046475|1585902|P3|COMPLETED|Titration (1 Week)||0
646056|NCT00046475|1585903|P2|COMPLETED|Titration (1 Week)||0
646057|NCT00046475|1585904|P1|COMPLETED|Titration (1 Week)||136
646058|NCT00046475|1585902|P3|STARTED|Titration (1 Week)||0
646059|NCT00046475|1585903|P2|STARTED|Titration (1 Week)||0
646060|NCT00046475|1585904|P1|STARTED|Titration (1 Week)||136
646061|NCT00046475|1585902|P3|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
646062|NCT00046475|1585903|P2|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
646063|NCT00046475|1585904|P1|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||4
646064|NCT00046475|1585902|P3|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
646065|NCT00046475|1585903|P2|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
646066|NCT00046475|1585904|P1|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||136
646067|NCT00046475|1585902|P3|STARTED|Screening/Washout Period (Up to 2 Weeks)||0
646068|NCT00046475|1585903|P2|STARTED|Screening/Washout Period (Up to 2 Weeks)||0
646069|NCT00046475|1585904|P1|STARTED|Screening/Washout Period (Up to 2 Weeks)||140
646070|NCT00046566|1585943|P3|NOT COMPLETED|Intervention 3 (8 Weeks)||0
646071|NCT00046566|1585944|P2|NOT COMPLETED|Intervention 3 (8 Weeks)||0
646072|NCT00046566|1585945|P1|NOT COMPLETED|Intervention 3 (8 Weeks)||0
646073|NCT00046566|1585943|P3|COMPLETED|Intervention 3 (8 Weeks)||88
646074|NCT00046566|1585944|P2|COMPLETED|Intervention 3 (8 Weeks)||92
646075|NCT00046566|1585945|P1|COMPLETED|Intervention 3 (8 Weeks)||93
646076|NCT00046566|1585943|P3|STARTED|Intervention 3 (8 Weeks)||88
646077|NCT00046566|1585944|P2|STARTED|Intervention 3 (8 Weeks)||92
646078|NCT00046566|1585945|P1|STARTED|Intervention 3 (8 Weeks)||93
646079|NCT00046566|1585943|P3|NOT COMPLETED|Intervention 2 (8 Weeks)||13
646080|NCT00046566|1585944|P2|NOT COMPLETED|Intervention 2 (8 Weeks)||12
646081|NCT00046566|1585945|P1|NOT COMPLETED|Intervention 2 (8 Weeks)||8
646082|NCT00046566|1585943|P3|COMPLETED|Intervention 2 (8 Weeks)||88
646083|NCT00046566|1585944|P2|COMPLETED|Intervention 2 (8 Weeks)||92
646084|NCT00046566|1585945|P1|COMPLETED|Intervention 2 (8 Weeks)||93
646085|NCT00046566|1585943|P3|STARTED|Intervention 2 (8 Weeks)|Soy protein 8 weeks|101
646086|NCT00046566|1585944|P2|STARTED|Intervention 2 (8 Weeks)|Carbohydrate 8 weeks|104
646087|NCT00046566|1585945|P1|STARTED|Intervention 2 (8 Weeks)|Milk protein 8 weeks|101
646088|NCT00046566|1585943|P3|NOT COMPLETED|Intervention 1 (8 Weeks)||17
646089|NCT00046566|1585944|P2|NOT COMPLETED|Intervention 1 (8 Weeks)||13
646090|NCT00046566|1585945|P1|NOT COMPLETED|Intervention 1 (8 Weeks)||16
646091|NCT00046566|1585943|P3|COMPLETED|Intervention 1 (8 Weeks)||101
646092|NCT00046566|1585944|P2|COMPLETED|Intervention 1 (8 Weeks)||104
646093|NCT00046566|1585945|P1|COMPLETED|Intervention 1 (8 Weeks)||101
646094|NCT00046566|1585943|P3|STARTED|Intervention 1 (8 Weeks)|Carbohydrate 8 weeks|118
646095|NCT00046566|1585944|P2|STARTED|Intervention 1 (8 Weeks)|Milk protein 8 weeks|117
646096|NCT00046566|1585945|P1|STARTED|Intervention 1 (8 Weeks)|Soy protein 8 weeks|117
646097|NCT00046228|1585962|P3|NOT COMPLETED|1 Year||12
646098|NCT00046228|1585963|P2|NOT COMPLETED|1 Year||14
646099|NCT00046228|1585964|P1|NOT COMPLETED|1 Year||19
646100|NCT00046228|1585962|P3|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window|816
646101|NCT00046228|1585963|P2|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window.|804
646102|NCT00046228|1585964|P1|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window.|787
646103|NCT00046228|1585962|P3|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|828
646104|NCT00046228|1585963|P2|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|818
646105|NCT00046228|1585964|P1|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|806
646106|NCT00046228|1585962|P3|NOT COMPLETED|90 Days||15
646107|NCT00046228|1585963|P2|NOT COMPLETED|90 Days||8
646108|NCT00046228|1585964|P1|NOT COMPLETED|90 Days||13
646109|NCT00046228|1585962|P3|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|813
646110|NCT00046228|1585963|P2|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|810
646111|NCT00046228|1585964|P1|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|793
646112|NCT00046228|1585962|P3|STARTED|90 Days||828
646113|NCT00046228|1585963|P2|STARTED|90 Days||818
646114|NCT00046228|1585964|P1|STARTED|90 Days||806
646115|NCT00045942|1586008|P9|NOT COMPLETED|PKC412A2104E2||6
646116|NCT00045942|1586009|P8|NOT COMPLETED|PKC412A2104E2||7
646117|NCT00045942|1586010|P7|NOT COMPLETED|PKC412A2104E2||7
646118|NCT00045942|1586011|P6|NOT COMPLETED|PKC412A2104E2||9
646119|NCT00045942|1586012|P5|NOT COMPLETED|PKC412A2104E2||0
646120|NCT00045942|1586013|P4|NOT COMPLETED|PKC412A2104E2||0
646121|NCT00045942|1586014|P3|NOT COMPLETED|PKC412A2104E2||0
646122|NCT00045942|1586015|P2|NOT COMPLETED|PKC412A2104E2||0
646123|NCT00045942|1586016|P1|NOT COMPLETED|PKC412A2104E2||0
646124|NCT00045942|1586008|P9|COMPLETED|PKC412A2104E2||0
646125|NCT00045942|1586009|P8|COMPLETED|PKC412A2104E2||0
646126|NCT00045942|1586010|P7|COMPLETED|PKC412A2104E2||0
646127|NCT00045942|1586011|P6|COMPLETED|PKC412A2104E2||0
646128|NCT00045942|1586012|P5|COMPLETED|PKC412A2104E2||0
646129|NCT00045942|1586013|P4|COMPLETED|PKC412A2104E2||0
646130|NCT00045942|1586014|P3|COMPLETED|PKC412A2104E2||0
646131|NCT00045942|1586015|P2|COMPLETED|PKC412A2104E2||0
646132|NCT00045942|1586016|P1|COMPLETED|PKC412A2104E2||0
646133|NCT00045942|1586008|P9|Primary Efficacy|PKC412A2104E2||6
646134|NCT00045942|1586009|P8|Primary Efficacy|PKC412A2104E2||7
646135|NCT00045942|1586010|P7|Primary Efficacy|PKC412A2104E2||7
646136|NCT00045942|1586011|P6|Primary Efficacy|PKC412A2104E2||9
646137|NCT00045942|1586012|P5|Primary Efficacy|PKC412A2104E2||0
646138|NCT00045942|1586013|P4|Primary Efficacy|PKC412A2104E2||0
646139|NCT00045942|1586014|P3|Primary Efficacy|PKC412A2104E2||0
646140|NCT00045942|1586015|P2|Primary Efficacy|PKC412A2104E2||0
646141|NCT00045942|1586016|P1|Primary Efficacy|PKC412A2104E2||0
646142|NCT00045942|1586008|P9|STARTED|PKC412A2104E2||6
646143|NCT00045942|1586009|P8|STARTED|PKC412A2104E2||7
646144|NCT00045942|1586010|P7|STARTED|PKC412A2104E2||7
646145|NCT00045942|1586011|P6|STARTED|PKC412A2104E2||9
646146|NCT00045942|1586012|P5|STARTED|PKC412A2104E2||0
646147|NCT00045942|1586013|P4|STARTED|PKC412A2104E2||0
646148|NCT00045942|1586014|P3|STARTED|PKC412A2104E2||0
646149|NCT00045942|1586015|P2|STARTED|PKC412A2104E2||0
646150|NCT00045942|1586016|P1|STARTED|PKC412A2104E2||0
646151|NCT00045942|1586008|P9|NOT COMPLETED|PKC412A2104E1||0
646152|NCT00045942|1586009|P8|NOT COMPLETED|PKC412A2104E1||0
646153|NCT00045942|1586010|P7|NOT COMPLETED|PKC412A2104E1||0
646154|NCT00045942|1586011|P6|NOT COMPLETED|PKC412A2104E1||0
646155|NCT00045942|1586012|P5|NOT COMPLETED|PKC412A2104E1||27
646156|NCT00045942|1586013|P4|NOT COMPLETED|PKC412A2104E1||33
646157|NCT00045942|1586014|P3|NOT COMPLETED|PKC412A2104E1||17
646158|NCT00045942|1586015|P2|NOT COMPLETED|PKC412A2104E1||18
646159|NCT00045942|1586016|P1|NOT COMPLETED|PKC412A2104E1||0
646160|NCT00045942|1586008|P9|COMPLETED|PKC412A2104E1||0
646161|NCT00045942|1586009|P8|COMPLETED|PKC412A2104E1||0
646162|NCT00045942|1586010|P7|COMPLETED|PKC412A2104E1||0
646163|NCT00045942|1586011|P6|COMPLETED|PKC412A2104E1||0
646164|NCT00045942|1586012|P5|COMPLETED|PKC412A2104E1||0
646165|NCT00045942|1586013|P4|COMPLETED|PKC412A2104E1||0
646166|NCT00045942|1586014|P3|COMPLETED|PKC412A2104E1||0
646167|NCT00045942|1586015|P2|COMPLETED|PKC412A2104E1||0
646168|NCT00045942|1586016|P1|COMPLETED|PKC412A2104E1||0
646169|NCT00045942|1586008|P9|Primary Efficacy|PKC412A2104E1||0
646170|NCT00045942|1586009|P8|Primary Efficacy|PKC412A2104E1||0
646171|NCT00045942|1586010|P7|Primary Efficacy|PKC412A2104E1||0
646172|NCT00045942|1586011|P6|Primary Efficacy|PKC412A2104E1||0
646173|NCT00045942|1586012|P5|Primary Efficacy|PKC412A2104E1||25
646174|NCT00045942|1586013|P4|Primary Efficacy|PKC412A2104E1||32
646175|NCT00045942|1586014|P3|Primary Efficacy|PKC412A2104E1||17
646176|NCT00045942|1586015|P2|Primary Efficacy|PKC412A2104E1||18
646177|NCT00045942|1586016|P1|Primary Efficacy|PKC412A2104E1||0
646178|NCT00045942|1586008|P9|STARTED|PKC412A2104E1||0
646179|NCT00045942|1586009|P8|STARTED|PKC412A2104E1||0
646180|NCT00045942|1586010|P7|STARTED|PKC412A2104E1||0
646181|NCT00045942|1586011|P6|STARTED|PKC412A2104E1||0
646182|NCT00045942|1586012|P5|STARTED|PKC412A2104E1||27
646183|NCT00045942|1586013|P4|STARTED|PKC412A2104E1||33
646184|NCT00045942|1586014|P3|STARTED|PKC412A2104E1||17
646185|NCT00045942|1586015|P2|STARTED|PKC412A2104E1||18
646186|NCT00045942|1586016|P1|STARTED|PKC412A2104E1||0
646187|NCT00045942|1586008|P9|NOT COMPLETED|PKC412A2104 (Core)||0
646188|NCT00045942|1586009|P8|NOT COMPLETED|PKC412A2104 (Core)||0
646189|NCT00045942|1586010|P7|NOT COMPLETED|PKC412A2104 (Core)||0
646190|NCT00045942|1586011|P6|NOT COMPLETED|PKC412A2104 (Core)||0
646191|NCT00045942|1586012|P5|NOT COMPLETED|PKC412A2104 (Core)||0
646192|NCT00045942|1586013|P4|NOT COMPLETED|PKC412A2104 (Core)||0
646193|NCT00045942|1586014|P3|NOT COMPLETED|PKC412A2104 (Core)||0
646194|NCT00045942|1586015|P2|NOT COMPLETED|PKC412A2104 (Core)||0
646195|NCT00045942|1586016|P1|NOT COMPLETED|PKC412A2104 (Core)||20
646196|NCT00045942|1586008|P9|COMPLETED|PKC412A2104 (Core)||0
646197|NCT00045942|1586009|P8|COMPLETED|PKC412A2104 (Core)||0
646198|NCT00045942|1586010|P7|COMPLETED|PKC412A2104 (Core)||0
646199|NCT00045942|1586011|P6|COMPLETED|PKC412A2104 (Core)||0
646200|NCT00045942|1586012|P5|COMPLETED|PKC412A2104 (Core)||0
646201|NCT00045942|1586013|P4|COMPLETED|PKC412A2104 (Core)||0
646202|NCT00045942|1586014|P3|COMPLETED|PKC412A2104 (Core)||0
646203|NCT00045942|1586015|P2|COMPLETED|PKC412A2104 (Core)||0
646204|NCT00045942|1586016|P1|COMPLETED|PKC412A2104 (Core)||0
646205|NCT00045942|1586008|P9|Core Primary Efficacy|PKC412A2104 (Core)||0
646206|NCT00045942|1586009|P8|Core Primary Efficacy|PKC412A2104 (Core)||0
646207|NCT00045942|1586010|P7|Core Primary Efficacy|PKC412A2104 (Core)||0
646208|NCT00045942|1586011|P6|Core Primary Efficacy|PKC412A2104 (Core)||0
646209|NCT00045942|1586012|P5|Core Primary Efficacy|PKC412A2104 (Core)||0
646210|NCT00045942|1586013|P4|Core Primary Efficacy|PKC412A2104 (Core)||0
646211|NCT00045942|1586014|P3|Core Primary Efficacy|PKC412A2104 (Core)||0
646212|NCT00045942|1586015|P2|Core Primary Efficacy|PKC412A2104 (Core)||0
646213|NCT00045942|1586016|P1|Core Primary Efficacy|PKC412A2104 (Core)||20
646214|NCT00045942|1586008|P9|STARTED|PKC412A2104 (Core)||0
646215|NCT00045942|1586009|P8|STARTED|PKC412A2104 (Core)||0
646216|NCT00045942|1586010|P7|STARTED|PKC412A2104 (Core)||0
646217|NCT00045942|1586011|P6|STARTED|PKC412A2104 (Core)||0
646218|NCT00045942|1586012|P5|STARTED|PKC412A2104 (Core)||0
646219|NCT00045942|1586013|P4|STARTED|PKC412A2104 (Core)||0
646220|NCT00045942|1586014|P3|STARTED|PKC412A2104 (Core)||0
646221|NCT00045942|1586015|P2|STARTED|PKC412A2104 (Core)||0
646222|NCT00045942|1586016|P1|STARTED|PKC412A2104 (Core)||20
646223|NCT00044655|1586098|P2|NOT COMPLETED|Overall Study||38
646224|NCT00044655|1586099|P1|NOT COMPLETED|Overall Study||20
646225|NCT00044655|1586098|P2|COMPLETED|Overall Study||79
646226|NCT00044655|1586099|P1|COMPLETED|Overall Study||82
646227|NCT00044655|1586098|P2|STARTED|Overall Study||117
646228|NCT00044655|1586099|P1|STARTED|Overall Study||102
646229|NCT00044512|1586105|P1|NOT COMPLETED|Follow Up||2
646230|NCT00044512|1586105|P1|COMPLETED|Follow Up||135
646231|NCT00044512|1586105|P1|STARTED|Follow Up||137
646232|NCT00044512|1586105|P1|NOT COMPLETED|Treatment||0
646233|NCT00044512|1586105|P1|COMPLETED|Treatment||137
646234|NCT00044512|1586105|P1|STARTED|Treatment||137
646235|NCT00044213|1586120|P4|NOT COMPLETED|Overall Study||136
646236|NCT00044213|1586121|P3|NOT COMPLETED|Overall Study||138
646237|NCT00044213|1586122|P2|NOT COMPLETED|Overall Study||112
646238|NCT00044213|1586123|P1|NOT COMPLETED|Overall Study||100
646239|NCT00044213|1586120|P4|COMPLETED|Overall Study||301
646240|NCT00044213|1586121|P3|COMPLETED|Overall Study||294
646241|NCT00044213|1586122|P2|COMPLETED|Overall Study||306
646242|NCT00044213|1586123|P1|COMPLETED|Overall Study||321
646243|NCT00044213|1586120|P4|STARTED|Overall Study||437
646244|NCT00044213|1586121|P3|STARTED|Overall Study||432
646245|NCT00044213|1586122|P2|STARTED|Overall Study||418
646246|NCT00044213|1586123|P1|STARTED|Overall Study||421
646247|NCT00044044|1586142|P5|NOT COMPLETED|Overall Study||36
646248|NCT00044044|1586143|P4|NOT COMPLETED|Overall Study||44
646249|NCT00044044|1586144|P3|NOT COMPLETED|Overall Study||40
646250|NCT00044044|1586145|P2|NOT COMPLETED|Overall Study||41
646251|NCT00044044|1586146|P1|NOT COMPLETED|Overall Study||44
646252|NCT00044044|1586142|P5|COMPLETED|Overall Study||36
646253|NCT00044044|1586143|P4|COMPLETED|Overall Study||29
646254|NCT00044044|1586144|P3|COMPLETED|Overall Study||31
646255|NCT00044044|1586145|P2|COMPLETED|Overall Study||28
646256|NCT00044044|1586146|P1|COMPLETED|Overall Study||27
646257|NCT00044044|1586142|P5|STARTED|Overall Study||72
646258|NCT00044044|1586143|P4|STARTED|Overall Study||73
646259|NCT00044044|1586144|P3|STARTED|Overall Study||71
646260|NCT00044044|1586145|P2|STARTED|Overall Study||69
646261|NCT00044044|1586146|P1|STARTED|Overall Study||71
646262|NCT00044005|1586176|P3|NOT COMPLETED|Overall Study||22
646263|NCT00044005|1586177|P2|NOT COMPLETED|Overall Study||14
646264|NCT00044005|1586178|P1|NOT COMPLETED|Overall Study||19
646265|NCT00044005|1586176|P3|COMPLETED|Overall Study||11
646266|NCT00044005|1586177|P2|COMPLETED|Overall Study||19
646267|NCT00044005|1586178|P1|COMPLETED|Overall Study||13
646268|NCT00044005|1586176|P3|STARTED|Overall Study||33
646269|NCT00044005|1586177|P2|STARTED|Overall Study||33
646270|NCT00044005|1586178|P1|STARTED|Overall Study||32
646271|NCT00043979|1586188|P3|NOT COMPLETED|Period 2||0
646272|NCT00043979|1586189|P2|NOT COMPLETED|Period 2||0
646273|NCT00043979|1586190|P1|NOT COMPLETED|Period 2||0
646274|NCT00043979|1586188|P3|COMPLETED|Period 2||10
646275|NCT00043979|1586189|P2|COMPLETED|Period 2||13
646276|NCT00043979|1586190|P1|COMPLETED|Period 2||0
646277|NCT00043979|1586188|P3|STARTED|Period 2||10
646278|NCT00043979|1586189|P2|STARTED|Period 2||13
646279|NCT00043979|1586190|P1|STARTED|Period 2||0
646280|NCT00043979|1586188|P3|NOT COMPLETED|Period 1||3
646281|NCT00043979|1586189|P2|NOT COMPLETED|Period 1||4
646282|NCT00043979|1586190|P1|NOT COMPLETED|Period 1||7
646283|NCT00043979|1586188|P3|COMPLETED|Period 1||10
646284|NCT00043979|1586189|P2|COMPLETED|Period 1||13
646285|NCT00043979|1586190|P1|COMPLETED|Period 1||23
646286|NCT00043979|1586188|P3|STARTED|Period 1||13
646287|NCT00043979|1586189|P2|STARTED|Period 1||17
646288|NCT00043979|1586190|P1|STARTED|Period 1||30
646289|NCT00043550|1586211|P3|NOT COMPLETED|Overall Study||20
646290|NCT00043550|1586212|P2|NOT COMPLETED|Overall Study||12
646291|NCT00043550|1586213|P1|NOT COMPLETED|Overall Study||22
646292|NCT00043550|1586211|P3|COMPLETED|Overall Study||30
646293|NCT00043550|1586212|P2|COMPLETED|Overall Study||39
646294|NCT00043550|1586213|P1|COMPLETED|Overall Study||33
646295|NCT00043550|1586211|P3|Week 8 Completed|Overall Study||35
646296|NCT00043550|1586212|P2|Week 8 Completed|Overall Study||40
646297|NCT00043550|1586213|P1|Week 8 Completed|Overall Study||35
646298|NCT00043550|1586211|P3|STARTED|Overall Study||50
646299|NCT00043550|1586212|P2|STARTED|Overall Study||51
646300|NCT00043550|1586213|P1|STARTED|Overall Study||55
646301|NCT00043186|1586230|P9|NOT COMPLETED|Overall Study||17
646302|NCT00043186|1586231|P8|NOT COMPLETED|Overall Study||16
646303|NCT00043186|1586232|P7|NOT COMPLETED|Overall Study||17
646304|NCT00043186|1586233|P6|NOT COMPLETED|Overall Study||8
646305|NCT00043186|1586234|P5|NOT COMPLETED|Overall Study||18
646306|NCT00043186|1586235|P4|NOT COMPLETED|Overall Study||22
646307|NCT00043186|1586236|P3|NOT COMPLETED|Overall Study||20
646308|NCT00043186|1586237|P2|NOT COMPLETED|Overall Study||15
646309|NCT00043186|1586238|P1|NOT COMPLETED|Overall Study||17
646310|NCT00043186|1586230|P9|COMPLETED|Overall Study||30
646311|NCT00043186|1586231|P8|COMPLETED|Overall Study||31
646312|NCT00043186|1586232|P7|COMPLETED|Overall Study||25
646313|NCT00043186|1586233|P6|COMPLETED|Overall Study||39
646314|NCT00043186|1586234|P5|COMPLETED|Overall Study||36
646315|NCT00043186|1586235|P4|COMPLETED|Overall Study||19
646316|NCT00043186|1586236|P3|COMPLETED|Overall Study||24
646317|NCT00043186|1586237|P2|COMPLETED|Overall Study||29
646318|NCT00043186|1586238|P1|COMPLETED|Overall Study||29
646319|NCT00043186|1586230|P9|STARTED|Overall Study||47
646320|NCT00043186|1586231|P8|STARTED|Overall Study||47
646321|NCT00043186|1586232|P7|STARTED|Overall Study||42
646322|NCT00043186|1586233|P6|STARTED|Overall Study||47
646323|NCT00043186|1586234|P5|STARTED|Overall Study||54
646324|NCT00043186|1586235|P4|STARTED|Overall Study||41
646325|NCT00043186|1586236|P3|STARTED|Overall Study||44
646326|NCT00043186|1586237|P2|STARTED|Overall Study||44
646327|NCT00043186|1586238|P1|STARTED|Overall Study||46
646328|NCT00042432|1586566|P2|NOT COMPLETED|Overall Study||7
646329|NCT00042432|1586567|P1|NOT COMPLETED|Overall Study||9
646330|NCT00042432|1586566|P2|COMPLETED|Overall Study||20
646331|NCT00042432|1586567|P1|COMPLETED|Overall Study||18
646332|NCT00042432|1586566|P2|STARTED|Overall Study||27
646333|NCT00042432|1586567|P1|STARTED|Overall Study||27
646334|NCT00042224|1586577|P2|NOT COMPLETED|Overall Study||3
646335|NCT00042224|1586578|P1|NOT COMPLETED|Overall Study||3
646336|NCT00042224|1586577|P2|COMPLETED|Overall Study||16
646337|NCT00042224|1586578|P1|COMPLETED|Overall Study||17
646338|NCT00042224|1586577|P2|STARTED|Overall Study||19
646339|NCT00042224|1586578|P1|STARTED|Overall Study||20
646340|NCT00041938|1586586|P2|NOT COMPLETED|Overall Study||31
646341|NCT00041938|1586587|P1|NOT COMPLETED|Overall Study||38
646342|NCT00041938|1586586|P2|COMPLETED|Overall Study||1111
646343|NCT00041938|1586587|P1|COMPLETED|Overall Study||1125
646344|NCT00041938|1586586|P2|Withdrew Consent|Overall Study||14
646345|NCT00041938|1586587|P1|Withdrew Consent|Overall Study||20
646346|NCT00041938|1586586|P2|Lost to Follow-up|Overall Study||17
646347|NCT00041938|1586587|P1|Lost to Follow-up|Overall Study||18
646348|NCT00041938|1586586|P2|Only Vital Status Known|Overall Study||46
646349|NCT00041938|1586587|P1|Only Vital Status Known|Overall Study||44
646350|NCT00041938|1586586|P2|Primary Endpoint|Overall Study||302
646351|NCT00041938|1586587|P1|Primary Endpoint|Overall Study||320
646352|NCT00041938|1586586|P2|Completed Follow-up|Overall Study||745
646353|NCT00041938|1586587|P1|Completed Follow-up|Overall Study||761
646354|NCT00041938|1586586|P2|STARTED|Overall Study||1142
646355|NCT00041938|1586587|P1|STARTED|Overall Study||1163
646356|NCT00041756|1586620|P5|NOT COMPLETED|Overall Study||60
646357|NCT00041756|1586621|P4|NOT COMPLETED|Overall Study||16
646358|NCT00041756|1586622|P3|NOT COMPLETED|Overall Study||13
646359|NCT00041756|1586623|P2|NOT COMPLETED|Overall Study||15
646360|NCT00041756|1586624|P1|NOT COMPLETED|Overall Study||8
646361|NCT00041756|1586620|P5|COMPLETED|Overall Study||19
646362|NCT00041756|1586621|P4|COMPLETED|Overall Study||64
646363|NCT00041756|1586622|P3|COMPLETED|Overall Study||66
646364|NCT00041756|1586623|P2|COMPLETED|Overall Study||65
646365|NCT00041756|1586624|P1|COMPLETED|Overall Study||69
646366|NCT00041756|1586620|P5|STARTED|Overall Study||79
646367|NCT00041756|1586621|P4|STARTED|Overall Study||80
646368|NCT00041756|1586622|P3|STARTED|Overall Study||79
646369|NCT00041756|1586623|P2|STARTED|Overall Study||80
646370|NCT00041756|1586624|P1|STARTED|Overall Study||77
646371|NCT00041717|1586643|P2|NOT COMPLETED|Overall Study||12
646372|NCT00041717|1586644|P1|NOT COMPLETED|Overall Study||33
646373|NCT00041717|1586643|P2|COMPLETED|Overall Study||86
646374|NCT00041717|1586644|P1|COMPLETED|Overall Study||81
646375|NCT00041717|1586643|P2|STARTED|Overall Study||98
646376|NCT00041717|1586644|P1|STARTED|Overall Study||114
646377|NCT00041470|1586652|P1|NOT COMPLETED|Overall Study||38
646378|NCT00041470|1586652|P1|COMPLETED|Overall Study||0
646379|NCT00041470|1586652|P1|STARTED|Overall Study||38
646380|NCT00040664|1586657|P4|NOT COMPLETED|Overall Study||27
646381|NCT00040664|1586658|P3|NOT COMPLETED|Overall Study||13
646382|NCT00040664|1586659|P2|NOT COMPLETED|Overall Study||13
646383|NCT00040664|1586660|P1|NOT COMPLETED|Overall Study||53
646384|NCT00040664|1586657|P4|COMPLETED|Overall Study||8
646385|NCT00040664|1586658|P3|COMPLETED|Overall Study||4
646386|NCT00040664|1586659|P2|COMPLETED|Overall Study||4
646387|NCT00040664|1586660|P1|COMPLETED|Overall Study||16
646388|NCT00040664|1586657|P4|STARTED|Overall Study||35
646389|NCT00040664|1586658|P3|STARTED|Overall Study||17
646390|NCT00040664|1586659|P2|STARTED|Overall Study||17
646391|NCT00040664|1586660|P1|STARTED|Overall Study|All (69) enrolled on QD; 10 switched to twice daily. Participant flow not collected for this group.|69
646392|NCT00041392|1586710|P2|NOT COMPLETED|Overall Study||0
646393|NCT00041392|1586711|P1|NOT COMPLETED|Overall Study||0
646394|NCT00041392|1586710|P2|COMPLETED|Overall Study||191
646395|NCT00041392|1586711|P1|COMPLETED|Overall Study||198
646396|NCT00041392|1586710|P2|STARTED|Overall Study||191
646397|NCT00041392|1586711|P1|STARTED|Overall Study||198
646398|NCT00040365|1586717|P1|NOT COMPLETED|Overall Study||11
646399|NCT00040365|1586717|P1|COMPLETED|Overall Study||19
646400|NCT00040365|1586717|P1|Completed Follow Up Phase|Overall Study||19
646401|NCT00040365|1586717|P1|STARTED|Overall Study||30
646402|NCT00039871|1586726|P1|NOT COMPLETED|Overall Study||1384
646403|NCT00039871|1586726|P1|COMPLETED|Overall Study||928
646404|NCT00039871|1586726|P1|STARTED|Overall Study|Enrolled 2333; 21 subjects excluded due to GCP non-compliance|2312
646405|NCT00039741|1586736|P4|NOT COMPLETED|Overall Study||14
646406|NCT00039741|1586737|P3|NOT COMPLETED|Overall Study||11
646407|NCT00039741|1586738|P2|NOT COMPLETED|Overall Study||12
646408|NCT00039741|1586739|P1|NOT COMPLETED|Overall Study||15
646409|NCT00039741|1586736|P4|COMPLETED|Overall Study||50
646410|NCT00039741|1586737|P3|COMPLETED|Overall Study||54
646411|NCT00039741|1586738|P2|COMPLETED|Overall Study||56
646412|NCT00039741|1586739|P1|COMPLETED|Overall Study||51
646413|NCT00039741|1586736|P4|Death|Overall Study||0
646414|NCT00039741|1586737|P3|Death|Overall Study||0
646415|NCT00039741|1586738|P2|Death|Overall Study||1
646416|NCT00039741|1586739|P1|Death|Overall Study||0
646417|NCT00039741|1586736|P4|STARTED|Overall Study||64
646418|NCT00039741|1586737|P3|STARTED|Overall Study||65
646419|NCT00039741|1586738|P2|STARTED|Overall Study||68
646420|NCT00039741|1586739|P1|STARTED|Overall Study||66
646421|NCT00038948|1586783|P2|NOT COMPLETED|Overall Study||77
646422|NCT00038948|1586784|P1|NOT COMPLETED|Overall Study||169
646423|NCT00038948|1586783|P2|COMPLETED|Overall Study||198
646424|NCT00038948|1586784|P1|COMPLETED|Overall Study||386
646425|NCT00038948|1586783|P2|STARTED|Overall Study||275
646426|NCT00038948|1586784|P1|STARTED|Overall Study||555
646427|NCT00038857|1586796|P1|NOT COMPLETED|Overall Study||1
646428|NCT00038857|1586796|P1|COMPLETED|Overall Study||28
646429|NCT00038857|1586796|P1|STARTED|Overall Study||29
646430|NCT00038727|1586803|P3|NOT COMPLETED|Overall Study||0
646431|NCT00038727|1586804|P2|NOT COMPLETED|Overall Study||0
646432|NCT00038727|1586805|P1|NOT COMPLETED|Overall Study||0
646433|NCT00038727|1586803|P3|COMPLETED|Overall Study||936
646434|NCT00038727|1586804|P2|COMPLETED|Overall Study||927
646435|NCT00038727|1586805|P1|COMPLETED|Overall Study||916
646436|NCT00038727|1586803|P3|DPPOS Phase 3 Enrolled|Overall Study||936
646437|NCT00038727|1586804|P2|DPPOS Phase 3 Enrolled|Overall Study||927
646438|NCT00038727|1586805|P1|DPPOS Phase 3 Enrolled|Overall Study||916
646439|NCT00038727|1586803|P3|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|780
646440|NCT00038727|1586804|P2|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|772
646441|NCT00038727|1586805|P1|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|751
646442|NCT00038727|1586803|P3|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|935
646443|NCT00038727|1586804|P2|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|926
646444|NCT00038727|1586805|P1|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|915
646445|NCT00038727|1586803|P3|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|932
646446|NCT00038727|1586804|P2|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|924
646447|NCT00038727|1586805|P1|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|910
646448|NCT00038727|1586803|P3|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|936
646449|NCT00038727|1586804|P2|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|927
646450|NCT00038727|1586805|P1|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|916
646451|NCT00038610|1586816|P1|NOT COMPLETED|Overall Study||0
646452|NCT00038610|1586816|P1|COMPLETED|Overall Study||54
646453|NCT00038610|1586816|P1|STARTED|Overall Study||54
646454|NCT00038467|1586824|P2|NOT COMPLETED|Overall Study||542
646455|NCT00038467|1586825|P1|NOT COMPLETED|Overall Study||542
646456|NCT00038467|1586824|P2|COMPLETED|Overall Study||1830
646457|NCT00038467|1586825|P1|COMPLETED|Overall Study||1810
646458|NCT00038467|1586824|P2|Treated|Overall Study|7 participants randomized to receive tamoxifen, received exemestane. Reported as per randomization.|2337
646459|NCT00038467|1586825|P1|Treated|Overall Study|8 participants randomized to receive exemestane, received tamoxifen. Reported as per randomization.|2321
646460|NCT00038467|1586824|P2|STARTED|Overall Study||2372
646461|NCT00038467|1586825|P1|STARTED|Overall Study||2352
646462|NCT00038103|1586887|P2|NOT COMPLETED|Overall Study||56
646463|NCT00038103|1586888|P1|NOT COMPLETED|Overall Study||55
646464|NCT00038103|1586887|P2|COMPLETED|Overall Study||0
646465|NCT00038103|1586888|P1|COMPLETED|Overall Study||0
646466|NCT00038103|1586887|P2|End of Treatment|Overall Study|patients remained on treatment until discontinued|56
646467|NCT00038103|1586888|P1|End of Treatment|Overall Study|patients remained on treatment until discontinued|53
646468|NCT00038103|1586887|P2|STARTED|Overall Study||56
646469|NCT00038103|1586888|P1|STARTED|Overall Study||55
646470|NCT00037830|1586911|P3|NOT COMPLETED|Overall Study||1
646471|NCT00037830|1586912|P2|NOT COMPLETED|Overall Study||7
646472|NCT00037830|1586913|P1|NOT COMPLETED|Overall Study||10
646473|NCT00037830|1586911|P3|COMPLETED|Overall Study||16
646474|NCT00037830|1586912|P2|COMPLETED|Overall Study||31
646475|NCT00037830|1586913|P1|COMPLETED|Overall Study||29
646476|NCT00037830|1586911|P3|STARTED|Overall Study||17
646477|NCT00037830|1586912|P2|STARTED|Overall Study||38
646478|NCT00037830|1586913|P1|STARTED|Overall Study||39
646479|NCT00036569|1586934|P1|NOT COMPLETED|Overall Study||0
646480|NCT00036569|1586934|P1|COMPLETED|Overall Study||32
646481|NCT00036569|1586934|P1|STARTED|Overall Study||32
646482|NCT00036270|1586945|P2|NOT COMPLETED|Study Treatment to 5 Year Report||3488
646483|NCT00036270|1586946|P1|NOT COMPLETED|Study Treatment to 5 Year Report||2565
646484|NCT00036270|1586945|P2|COMPLETED|Study Treatment to 5 Year Report||1380
646485|NCT00036270|1586946|P1|COMPLETED|Study Treatment to 5 Year Report||2333
646486|NCT00036270|1586945|P2|Treated|Study Treatment to 5 Year Report||4814
646487|NCT00036270|1586946|P1|Treated|Study Treatment to 5 Year Report||4852
646488|NCT00036270|1586945|P2|STARTED|Study Treatment to 5 Year Report||4868
646489|NCT00036270|1586946|P1|STARTED|Study Treatment to 5 Year Report||4898
646490|NCT00036270|1586945|P2|NOT COMPLETED|Randomized to Study Treatment||7
646491|NCT00036270|1586946|P1|NOT COMPLETED|Randomized to Study Treatment||6
646492|NCT00036270|1586945|P2|COMPLETED|Randomized to Study Treatment||4868
646493|NCT00036270|1586946|P1|COMPLETED|Randomized to Study Treatment||4898
646494|NCT00036270|1586945|P2|STARTED|Randomized to Study Treatment||4875
646495|NCT00036270|1586946|P1|STARTED|Randomized to Study Treatment||4904
646496|NCT00035932|1586965|P3|NOT COMPLETED|Overall Study||49
646497|NCT00035932|1586966|P2|NOT COMPLETED|Overall Study||60
646498|NCT00035932|1586967|P1|NOT COMPLETED|Overall Study||56
646499|NCT00035932|1586965|P3|COMPLETED|Overall Study|59 remained on treatment, 10 completed at Week 96|69
646500|NCT00035932|1586966|P2|COMPLETED|Overall Study|50 remained on treatment, 0 completed at Week 96|50
646501|NCT00035932|1586967|P1|COMPLETED|Overall Study|63 remained on treatment, 0 completed at Week 96|63
646502|NCT00035932|1586965|P3|Discontinued on or After Week 96|Overall Study||6
646503|NCT00035932|1586966|P2|Discontinued on or After Week 96|Overall Study||4
646504|NCT00035932|1586967|P1|Discontinued on or After Week 96|Overall Study||4
646505|NCT00035932|1586965|P3|Discontinued Between Weeks 48 and 96|Overall Study||30
646506|NCT00035932|1586966|P2|Discontinued Between Weeks 48 and 96|Overall Study||27
646507|NCT00035932|1586967|P1|Discontinued Between Weeks 48 and 96|Overall Study||26
646508|NCT00035932|1586965|P3|Discontinued Prior to Week 48 Visit|Overall Study||13
646509|NCT00035932|1586966|P2|Discontinued Prior to Week 48 Visit|Overall Study||29
646510|NCT00035932|1586967|P1|Discontinued Prior to Week 48 Visit|Overall Study||26
646511|NCT00035932|1586965|P3|STARTED|Overall Study|123 randomized, 118 treated|118
646512|NCT00035932|1586966|P2|STARTED|Overall Study|115 randomized, 110 treated|110
646513|NCT00035932|1586967|P1|STARTED|Overall Study|120 randomized, 119 treated|119
646514|NCT00035815|1587093|P2|NOT COMPLETED|Overall Study||11
646515|NCT00035815|1587094|P1|NOT COMPLETED|Overall Study||17
646516|NCT00035815|1587093|P2|COMPLETED|Overall Study||152
646517|NCT00035815|1587094|P1|COMPLETED|Overall Study||150
646518|NCT00035815|1587093|P2|STARTED|Overall Study|Enrollment began June 2003, accrual was for 2 years, follow-up period was 2 years.|163
646519|NCT00035815|1587094|P1|STARTED|Overall Study|Enrollment began June 2003, accrual was for 2 years, follow-up period was 2 years.|167
646520|NCT00035555|1587107|P3|NOT COMPLETED|Overall Study||22
646521|NCT00035555|1587108|P2|NOT COMPLETED|Overall Study||16
646522|NCT00035555|1587109|P1|NOT COMPLETED|Overall Study||16
646523|NCT00035555|1587107|P3|COMPLETED|Overall Study||51
646524|NCT00035555|1587108|P2|COMPLETED|Overall Study||55
646525|NCT00035555|1587109|P1|COMPLETED|Overall Study||58
646526|NCT00035555|1587107|P3|Number Who Received Study Drug|Overall Study||71
646527|NCT00035555|1587108|P2|Number Who Received Study Drug|Overall Study||71
646528|NCT00035555|1587109|P1|Number Who Received Study Drug|Overall Study||74
646529|NCT00035555|1587107|P3|Number Who Had Undergone Transplantation|Overall Study||73
646530|NCT00035555|1587108|P2|Number Who Had Undergone Transplantation|Overall Study||71
646531|NCT00035555|1587109|P1|Number Who Had Undergone Transplantation|Overall Study||74
646532|NCT00035555|1587107|P3|STARTED|Overall Study|Randomized patients|73
646533|NCT00035555|1587108|P2|STARTED|Overall Study|Randomized patients|71
646534|NCT00035555|1587109|P1|STARTED|Overall Study|Randomized patients|74
646535|NCT00033917|1587152|P2|NOT COMPLETED|Overall Study||0
646536|NCT00033917|1587153|P1|NOT COMPLETED|Overall Study||0
646537|NCT00033917|1587152|P2|COMPLETED|Overall Study||222
646538|NCT00033917|1587153|P1|COMPLETED|Overall Study||209
646539|NCT00033917|1587152|P2|STARTED|Overall Study||222
646540|NCT00033917|1587153|P1|STARTED|Overall Study||209
646541|NCT00032630|1587165|P2|NOT COMPLETED|Overall Study||43
646542|NCT00032630|1587166|P1|NOT COMPLETED|Overall Study||49
646543|NCT00032630|1587165|P2|COMPLETED|Overall Study||1061
646544|NCT00032630|1587166|P1|COMPLETED|Overall Study||1050
646545|NCT00032630|1587165|P2|STARTED|Overall Study||1104
646546|NCT00032630|1587166|P1|STARTED|Overall Study||1099
646547|NCT00032591|1587176|P2|NOT COMPLETED|Follow-up||5
646548|NCT00032591|1587177|P1|NOT COMPLETED|Follow-up||2
646549|NCT00032591|1587176|P2|COMPLETED|Follow-up|1452 were included in analysis with greater than 1 day of follow-up|1452
646550|NCT00032591|1587177|P1|COMPLETED|Follow-up|1463 were included in analysis with greater than 1 day of follow-up|1463
646551|NCT00032591|1587176|P2|STARTED|Follow-up|5 were lost to follow-up, all with Atrial Fibrillation, no Mechanical Heart Valves|1457
646552|NCT00032591|1587177|P1|STARTED|Follow-up|2 were lost to follow-up, both with Atrial Fibrillation, no Mechanical Heart Valves|1465
646553|NCT00032591|1587176|P2|NOT COMPLETED|Randomization||0
646554|NCT00032591|1587177|P1|NOT COMPLETED|Randomization||0
646555|NCT00032591|1587176|P2|COMPLETED|Randomization|1457 were assigned to clinic testing|1457
646556|NCT00032591|1587177|P1|COMPLETED|Randomization|1465 were assigned to self-testing|1465
646557|NCT00032591|1587176|P2|STARTED|Randomization||1457
646558|NCT00032591|1587177|P1|STARTED|Randomization|2922 underwent randomization|1465
646559|NCT00032591|1587176|P2|NOT COMPLETED|Screening||415
646560|NCT00032591|1587177|P1|NOT COMPLETED|Screening||408
646561|NCT00032591|1587176|P2|COMPLETED|Screening||1457
646562|NCT00032591|1587177|P1|COMPLETED|Screening|823 were excluded from the study|1465
646563|NCT00032591|1587176|P2|STARTED|Screening|Treatment assigned at randomization; screening counts by arm represent half of the total screened.|1872
646564|NCT00032591|1587177|P1|STARTED|Screening|3745 patients provided informed consent and were screened for participation.|1873
646565|NCT00032487|1587193|P2|NOT COMPLETED|Overall Study||120
646566|NCT00032487|1587194|P1|NOT COMPLETED|Overall Study||139
646567|NCT00032487|1587193|P2|COMPLETED|Overall Study||772
646568|NCT00032487|1587194|P1|COMPLETED|Overall Study||760
646569|NCT00032487|1587193|P2|STARTED|Overall Study||892
646570|NCT00032487|1587194|P1|STARTED|Overall Study||899
646571|NCT00031551|1587204|P2|NOT COMPLETED|Overall Study||0
646572|NCT00031551|1587205|P1|NOT COMPLETED|Overall Study||2
646573|NCT00031551|1587204|P2|COMPLETED|Overall Study||25
646574|NCT00031551|1587205|P1|COMPLETED|Overall Study||0
646575|NCT00031551|1587204|P2|STARTED|Overall Study||25
646576|NCT00031551|1587205|P1|STARTED|Overall Study||2
646577|NCT00031486|1587217|P2|NOT COMPLETED|Overall Study||12
646578|NCT00031486|1587218|P1|NOT COMPLETED|Overall Study||7
646579|NCT00031486|1587217|P2|COMPLETED|Overall Study||35
646580|NCT00031486|1587218|P1|COMPLETED|Overall Study||33
646581|NCT00031486|1587217|P2|STARTED|Overall Study||47
646582|NCT00031486|1587218|P1|STARTED|Overall Study||40
646583|NCT00031460|1587244|P2|NOT COMPLETED|Overall Study||14
646584|NCT00031460|1587245|P1|NOT COMPLETED|Overall Study||9
646585|NCT00031460|1587244|P2|COMPLETED|Overall Study||8
646586|NCT00031460|1587245|P1|COMPLETED|Overall Study||15
646587|NCT00031460|1587244|P2|STARTED|Overall Study||22
646588|NCT00031460|1587245|P1|STARTED|Overall Study||24
646589|NCT00031447|1587259|P2|NOT COMPLETED|Overall Study||7
646590|NCT00031447|1587260|P1|NOT COMPLETED|Overall Study||10
646591|NCT00031447|1587259|P2|COMPLETED|Overall Study||8
646592|NCT00031447|1587260|P1|COMPLETED|Overall Study||4
646593|NCT00031447|1587259|P2|STARTED|Overall Study||15
646594|NCT00031447|1587260|P1|STARTED|Overall Study||14
646595|NCT00030992|1587272|P1|NOT COMPLETED|Overall Study||0
646596|NCT00030992|1587272|P1|COMPLETED|Overall Study||102
646597|NCT00030992|1587272|P1|STARTED|Overall Study||102
646598|NCT00030147|1587281|P4|NOT COMPLETED|Overall Study||0
646599|NCT00030147|1587282|P3|NOT COMPLETED|Overall Study||0
646600|NCT00030147|1587283|P2|NOT COMPLETED|Overall Study||1
646601|NCT00030147|1587284|P1|NOT COMPLETED|Overall Study||0
646602|NCT00030147|1587281|P4|COMPLETED|Overall Study||11
646603|NCT00030147|1587282|P3|COMPLETED|Overall Study||16
646604|NCT00030147|1587283|P2|COMPLETED|Overall Study||18
646605|NCT00030147|1587284|P1|COMPLETED|Overall Study||17
646606|NCT00030147|1587281|P4|STARTED|Overall Study||11
646607|NCT00030147|1587282|P3|STARTED|Overall Study||16
646608|NCT00030147|1587283|P2|STARTED|Overall Study||19
646609|NCT00030147|1587284|P1|STARTED|Overall Study||17
646610|NCT00029536|1587302|P4|NOT COMPLETED|Overall Study||0
646611|NCT00029536|1587303|P3|NOT COMPLETED|Overall Study||0
646612|NCT00029536|1587304|P2|NOT COMPLETED|Overall Study||0
646613|NCT00029536|1587305|P1|NOT COMPLETED|Overall Study||0
646614|NCT00029536|1587302|P4|COMPLETED|Overall Study||59
646615|NCT00029536|1587303|P3|COMPLETED|Overall Study||105
646616|NCT00029536|1587304|P2|COMPLETED|Overall Study||45
646617|NCT00029536|1587305|P1|COMPLETED|Overall Study||85
646618|NCT00029536|1587302|P4|STARTED|Overall Study||59
646619|NCT00029536|1587303|P3|STARTED|Overall Study||105
646620|NCT00029536|1587304|P2|STARTED|Overall Study||45
646621|NCT00029536|1587305|P1|STARTED|Overall Study||85
646622|NCT00029172|1587329|P1|NOT COMPLETED|Overall Study||6
646623|NCT00029172|1587329|P1|COMPLETED|Overall Study||182
646624|NCT00029172|1587329|P1|STARTED|Overall Study||188
646625|NCT00029146|1587335|P2|NOT COMPLETED|Overall Study||1
646626|NCT00029146|1587336|P1|NOT COMPLETED|Overall Study||2
646627|NCT00029146|1587335|P2|COMPLETED|Overall Study||97
646628|NCT00029146|1587336|P1|COMPLETED|Overall Study||95
646629|NCT00029146|1587335|P2|STARTED|Overall Study||98
646630|NCT00029146|1587336|P1|STARTED|Overall Study||97
646631|NCT00029107|1587365|P2|NOT COMPLETED|Overall Study||0
646632|NCT00029107|1587366|P1|NOT COMPLETED|Overall Study||0
646633|NCT00029107|1587365|P2|COMPLETED|Overall Study||12
646634|NCT00029107|1587366|P1|COMPLETED|Overall Study||12
646635|NCT00029107|1587365|P2|STARTED|Overall Study||12
646636|NCT00029107|1587366|P1|STARTED|Overall Study||12
646637|NCT00028262|1587372|P1|NOT COMPLETED|Overall Study||1
646638|NCT00028262|1587372|P1|COMPLETED|Overall Study||9
646639|NCT00028262|1587372|P1|STARTED|Overall Study||10
646640|NCT00028093|1587378|P2|NOT COMPLETED|Overall Study||0
646641|NCT00028093|1587379|P1|NOT COMPLETED|Overall Study||0
646642|NCT00028093|1587378|P2|COMPLETED|Overall Study||25
646643|NCT00028093|1587379|P1|COMPLETED|Overall Study||25
646644|NCT00028093|1587378|P2|STARTED|Overall Study||25
646645|NCT00028093|1587379|P1|STARTED|Overall Study||25
646646|NCT00027378|1587387|P2|NOT COMPLETED|Overall Study||3
646647|NCT00027378|1587388|P1|NOT COMPLETED|Overall Study||0
646648|NCT00027378|1587387|P2|COMPLETED|Overall Study||23
646649|NCT00027378|1587388|P1|COMPLETED|Overall Study||24
646650|NCT00027378|1587387|P2|STARTED|Overall Study||26
646651|NCT00027378|1587388|P1|STARTED|Overall Study||24
646652|NCT00027027|1587401|P5|NOT COMPLETED|Overall Study||8
646653|NCT00027027|1587402|P4|NOT COMPLETED|Overall Study||3
646654|NCT00027027|1587403|P3|NOT COMPLETED|Overall Study||4
646655|NCT00027027|1587404|P2|NOT COMPLETED|Overall Study||3
646656|NCT00027027|1587405|P1|NOT COMPLETED|Overall Study||3
646657|NCT00027027|1587401|P5|COMPLETED|Overall Study||0
646658|NCT00027027|1587402|P4|COMPLETED|Overall Study||0
646659|NCT00027027|1587403|P3|COMPLETED|Overall Study||0
646660|NCT00027027|1587404|P2|COMPLETED|Overall Study||0
646661|NCT00027027|1587405|P1|COMPLETED|Overall Study||0
646662|NCT00027027|1587401|P5|Treated Beyond Cycle 2|Overall Study||4
646663|NCT00027027|1587402|P4|Treated Beyond Cycle 2|Overall Study||2
646664|NCT00027027|1587403|P3|Treated Beyond Cycle 2|Overall Study||2
646665|NCT00027027|1587404|P2|Treated Beyond Cycle 2|Overall Study||1
646666|NCT00027027|1587405|P1|Treated Beyond Cycle 2|Overall Study||1
646667|NCT00027027|1587401|P5|Discontinued at Cycle 2|Overall Study||3
646668|NCT00027027|1587402|P4|Discontinued at Cycle 2|Overall Study||1
646669|NCT00027027|1587403|P3|Discontinued at Cycle 2|Overall Study||1
646670|NCT00027027|1587404|P2|Discontinued at Cycle 2|Overall Study||2
646671|NCT00027027|1587405|P1|Discontinued at Cycle 2|Overall Study||2
646672|NCT00027027|1587401|P5|Completed 2 Cycles of Treatment|Overall Study||7
646673|NCT00027027|1587402|P4|Completed 2 Cycles of Treatment|Overall Study||3
646674|NCT00027027|1587403|P3|Completed 2 Cycles of Treatment|Overall Study||3
646675|NCT00027027|1587404|P2|Completed 2 Cycles of Treatment|Overall Study||3
646676|NCT00027027|1587405|P1|Completed 2 Cycles of Treatment|Overall Study||3
646677|NCT00027027|1587401|P5|Discontinued Before 2 Treatment Cycles|Overall Study||1
646678|NCT00027027|1587402|P4|Discontinued Before 2 Treatment Cycles|Overall Study||0
646679|NCT00027027|1587403|P3|Discontinued Before 2 Treatment Cycles|Overall Study||1
646680|NCT00027027|1587404|P2|Discontinued Before 2 Treatment Cycles|Overall Study||0
646681|NCT00027027|1587405|P1|Discontinued Before 2 Treatment Cycles|Overall Study||0
646682|NCT00027027|1587401|P5|STARTED|Overall Study||8
646683|NCT00027027|1587402|P4|STARTED|Overall Study||3
646684|NCT00027027|1587403|P3|STARTED|Overall Study||4
646685|NCT00027027|1587404|P2|STARTED|Overall Study||3
646686|NCT00027027|1587405|P1|STARTED|Overall Study||3
646687|NCT00025883|1587452|P1|NOT COMPLETED|Overall Study||17
646688|NCT00025883|1587452|P1|COMPLETED|Overall Study||86
646689|NCT00025883|1587452|P1|Partial Lipodystrophy|Overall Study||40
646690|NCT00025883|1587452|P1|Generalized Lipodystrophy|Overall Study||63
646691|NCT00025883|1587452|P1|STARTED|Overall Study||103
646692|NCT00023595|1587464|P5|NOT COMPLETED|10 Year Follow up||0
646693|NCT00023595|1587465|P4|NOT COMPLETED|10 Year Follow up||0
646694|NCT00023595|1587466|P3|NOT COMPLETED|10 Year Follow up||3
646695|NCT00023595|1587467|P2|NOT COMPLETED|10 Year Follow up||10
646696|NCT00023595|1587468|P1|NOT COMPLETED|10 Year Follow up||12
646697|NCT00023595|1587464|P5|COMPLETED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
646698|NCT00023595|1587465|P4|COMPLETED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
646699|NCT00023595|1587466|P3|COMPLETED|10 Year Follow up||73
646700|NCT00023595|1587467|P2|COMPLETED|10 Year Follow up||524
646701|NCT00023595|1587468|P1|COMPLETED|10 Year Follow up||590
646702|NCT00023595|1587464|P5|STARTED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
646703|NCT00023595|1587465|P4|STARTED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
646704|NCT00023595|1587466|P3|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|76
646705|NCT00023595|1587467|P2|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|534
646706|NCT00023595|1587468|P1|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|602
646707|NCT00023595|1587464|P5|NOT COMPLETED|5 Year Follow up||3
646708|NCT00023595|1587465|P4|NOT COMPLETED|5 Year Follow up||7
646709|NCT00023595|1587466|P3|NOT COMPLETED|5 Year Follow up||1
646710|NCT00023595|1587467|P2|NOT COMPLETED|5 Year Follow up||2
646711|NCT00023595|1587468|P1|NOT COMPLETED|5 Year Follow up||2
646712|NCT00023595|1587464|P5|COMPLETED|5 Year Follow up||498
646713|NCT00023595|1587465|P4|COMPLETED|5 Year Follow up||416
646714|NCT00023595|1587466|P3|COMPLETED|5 Year Follow up||75
646715|NCT00023595|1587467|P2|COMPLETED|5 Year Follow up||532
646716|NCT00023595|1587468|P1|COMPLETED|5 Year Follow up||600
646717|NCT00023595|1587464|P5|STARTED|5 Year Follow up||501
646718|NCT00023595|1587465|P4|STARTED|5 Year Follow up|76 of stratum B pts who were randomized to med therapy + CABG group belong to both H01 and H02.|423
646719|NCT00023595|1587466|P3|STARTED|5 Year Follow up||76
646720|NCT00023595|1587467|P2|STARTED|5 Year Follow up||534
646721|NCT00023595|1587468|P1|STARTED|5 Year Follow up||602
646722|NCT00023452|1587679|P2|NOT COMPLETED|Overall Study||872
646723|NCT00023452|1587680|P1|NOT COMPLETED|Overall Study||1323
646724|NCT00023452|1587679|P2|COMPLETED|Overall Study||3273
646725|NCT00023452|1587680|P1|COMPLETED|Overall Study||2585
646726|NCT00023452|1587679|P2|Completed Study|Overall Study||3475
646727|NCT00023452|1587680|P1|Completed Study|Overall Study||3174
646728|NCT00023452|1587679|P2|Not Treated|Overall Study||105
646729|NCT00023452|1587680|P1|Not Treated|Overall Study||149
646730|NCT00023452|1587679|P2|Completed Treatment|Overall Study||3273
646731|NCT00023452|1587680|P1|Completed Treatment|Overall Study||2585
646732|NCT00023452|1587679|P2|Enrolled as Part of a Cluster|Overall Study||971
646733|NCT00023452|1587680|P1|Enrolled as Part of a Cluster|Overall Study||718
646734|NCT00023452|1587679|P2|Randomized|Overall Study||3174
646735|NCT00023452|1587680|P1|Randomized|Overall Study||3190
646736|NCT00023452|1587679|P2|STARTED|Overall Study||4145
646737|NCT00023452|1587680|P1|STARTED|Overall Study||3908
646738|NCT00023322|1587704|P1|NOT COMPLETED|Overall Study||1
646739|NCT00023322|1587704|P1|COMPLETED|Overall Study||12
646740|NCT00023322|1587704|P1|STARTED|Overall Study||13
646741|NCT00023309|1587711|P2|NOT COMPLETED|Overall Study||0
646742|NCT00023309|1587712|P1|NOT COMPLETED|Overall Study||0
646743|NCT00023309|1587711|P2|COMPLETED|Overall Study||19
646744|NCT00023309|1587712|P1|COMPLETED|Overall Study||22
646745|NCT00023309|1587711|P2|STARTED|Overall Study||19
646746|NCT00023309|1587712|P1|STARTED|Overall Study||22
646747|NCT00022763|1587728|P2|NOT COMPLETED|Overall Study||17
646748|NCT00022763|1587729|P1|NOT COMPLETED|Overall Study||9
646749|NCT00022763|1587728|P2|COMPLETED|Overall Study||11
646750|NCT00022763|1587729|P1|COMPLETED|Overall Study||15
646751|NCT00022763|1587728|P2|STARTED|Overall Study||28
646752|NCT00022763|1587729|P1|STARTED|Overall Study||24
646753|NCT00016718|1587755|P3|NOT COMPLETED|Overall Study||0
646754|NCT00016718|1587756|P2|NOT COMPLETED|Overall Study||0
646755|NCT00016718|1587757|P1|NOT COMPLETED|Overall Study||0
646756|NCT00016718|1587755|P3|COMPLETED|Overall Study||16
646757|NCT00016718|1587756|P2|COMPLETED|Overall Study||21
646758|NCT00016718|1587757|P1|COMPLETED|Overall Study||6
646759|NCT00016718|1587755|P3|STARTED|Overall Study||16
646760|NCT00016718|1587756|P2|STARTED|Overall Study||21
646761|NCT00016718|1587757|P1|STARTED|Overall Study||6
646762|NCT00014911|1587771|P1|NOT COMPLETED|Overall Study||11
646763|NCT00014911|1587771|P1|COMPLETED|Overall Study|One subject experienced pneumonia, myocardial infarction, and acute renal failure|25
646764|NCT00014911|1587771|P1|STARTED|Overall Study||36
646765|NCT00006604|1587787|P17|NOT COMPLETED|Overall Study||9
646766|NCT00006604|1587788|P16|NOT COMPLETED|Overall Study||5
646767|NCT00006604|1587789|P15|NOT COMPLETED|Overall Study||10
646768|NCT00006604|1587790|P14|NOT COMPLETED|Overall Study||6
646769|NCT00006604|1587791|P13|NOT COMPLETED|Overall Study||4
646770|NCT00006604|1587792|P12|NOT COMPLETED|Overall Study||6
646771|NCT00006604|1587793|P11|NOT COMPLETED|Overall Study||8
646772|NCT00006604|1587794|P10|NOT COMPLETED|Overall Study||19
646773|NCT00006604|1587795|P9|NOT COMPLETED|Overall Study||1
646774|NCT00006604|1587796|P8|NOT COMPLETED|Overall Study||3
646775|NCT00006604|1587797|P7|NOT COMPLETED|Overall Study||9
646776|NCT00006604|1587798|P6|NOT COMPLETED|Overall Study||3
646777|NCT00006604|1587799|P5|NOT COMPLETED|Overall Study||2
646778|NCT00006604|1587800|P4|NOT COMPLETED|Overall Study||5
646779|NCT00006604|1587801|P3|NOT COMPLETED|Overall Study||4
646780|NCT00006604|1587802|P2|NOT COMPLETED|Overall Study||0
646781|NCT00006604|1587803|P1|NOT COMPLETED|Overall Study||2
646782|NCT00006604|1587787|P17|COMPLETED|Overall Study||6
646783|NCT00006604|1587788|P16|COMPLETED|Overall Study||1
646784|NCT00006604|1587789|P15|COMPLETED|Overall Study||14
646785|NCT00006604|1587790|P14|COMPLETED|Overall Study||0
646786|NCT00006604|1587791|P13|COMPLETED|Overall Study||22
646787|NCT00006604|1587792|P12|COMPLETED|Overall Study||6
646788|NCT00006604|1587793|P11|COMPLETED|Overall Study||13
646789|NCT00006604|1587794|P10|COMPLETED|Overall Study||6
646790|NCT00006604|1587795|P9|COMPLETED|Overall Study||4
646791|NCT00006604|1587796|P8|COMPLETED|Overall Study||2
646792|NCT00006604|1587797|P7|COMPLETED|Overall Study||12
646793|NCT00006604|1587798|P6|COMPLETED|Overall Study||2
646794|NCT00006604|1587799|P5|COMPLETED|Overall Study||3
646795|NCT00006604|1587800|P4|COMPLETED|Overall Study||1
646796|NCT00006604|1587801|P3|COMPLETED|Overall Study||1
646797|NCT00006604|1587802|P2|COMPLETED|Overall Study||2
646798|NCT00006604|1587803|P1|COMPLETED|Overall Study||4
646799|NCT00006604|1587787|P17|STARTED|Overall Study||15
646800|NCT00006604|1587788|P16|STARTED|Overall Study||6
646801|NCT00006604|1587789|P15|STARTED|Overall Study||24
646802|NCT00006604|1587790|P14|STARTED|Overall Study||6
646803|NCT00006604|1587791|P13|STARTED|Overall Study||26
646804|NCT00006604|1587792|P12|STARTED|Overall Study||12
646805|NCT00006604|1587793|P11|STARTED|Overall Study||21
646806|NCT00006604|1587794|P10|STARTED|Overall Study||25
646807|NCT00006604|1587795|P9|STARTED|Overall Study||5
646808|NCT00006604|1587796|P8|STARTED|Overall Study||5
646809|NCT00006604|1587797|P7|STARTED|Overall Study||21
646810|NCT00006604|1587798|P6|STARTED|Overall Study||5
646811|NCT00006604|1587799|P5|STARTED|Overall Study||5
646812|NCT00006604|1587800|P4|STARTED|Overall Study||6
646813|NCT00006604|1587801|P3|STARTED|Overall Study||5
646814|NCT00006604|1587802|P2|STARTED|Overall Study||2
646815|NCT00006604|1587803|P1|STARTED|Overall Study||6
646816|NCT00004978|1587919|P2|NOT COMPLETED|Overall Study||270
646817|NCT00004978|1587920|P1|NOT COMPLETED|Overall Study||244
646818|NCT00004978|1587919|P2|COMPLETED|Overall Study||1790
646819|NCT00004978|1587920|P1|COMPLETED|Overall Study||1846
646820|NCT00004978|1587919|P2|STARTED|Overall Study|includes patients participating in Vanguard studies from the sites which participated in ESPRIT|2060
646821|NCT00004978|1587920|P1|STARTED|Overall Study|includes patients participating in Vanguard studies from the sites which participated in ESPRIT|2090
646822|NCT00021541|1587946|P2|NOT COMPLETED|Period 2-crossover||11
646823|NCT00021541|1587947|P1|NOT COMPLETED|Period 2-crossover||10
646824|NCT00021541|1587946|P2|COMPLETED|Period 2-crossover||12
646825|NCT00021541|1587947|P1|COMPLETED|Period 2-crossover||10
646826|NCT00021541|1587946|P2|STARTED|Period 2-crossover||23
646827|NCT00021541|1587947|P1|STARTED|Period 2-crossover||20
646828|NCT00021541|1587946|P2|NOT COMPLETED|Period 1-First Treatment||8
646829|NCT00021541|1587947|P1|NOT COMPLETED|Period 1-First Treatment||11
646830|NCT00021541|1587946|P2|COMPLETED|Period 1-First Treatment||23
646831|NCT00021541|1587947|P1|COMPLETED|Period 1-First Treatment||20
646832|NCT00021541|1587946|P2|Ineligible Patients|Period 1-First Treatment||2
646833|NCT00021541|1587947|P1|Ineligible Patients|Period 1-First Treatment||0
646834|NCT00021541|1587946|P2|Pts Who Progressed to Second Treatment|Period 1-First Treatment||23
646835|NCT00021541|1587947|P1|Pts Who Progressed to Second Treatment|Period 1-First Treatment||20
646836|NCT00021541|1587946|P2|STARTED|Period 1-First Treatment|These are the patients randomized to receive placebo. Two of these patients were deemed ineligible.|31
646837|NCT00021541|1587947|P1|STARTED|Period 1-First Treatment||31
646838|NCT00018031|1587957|P1|NOT COMPLETED|Overall Study||0
646839|NCT00018031|1587957|P1|COMPLETED|Overall Study||36
646840|NCT00018031|1587957|P1|STARTED|Overall Study||36
646841|NCT00015457|1587961|P2|NOT COMPLETED|Second Intervention||0
646842|NCT00015457|1587962|P1|NOT COMPLETED|Second Intervention||1
646843|NCT00015457|1587961|P2|COMPLETED|Second Intervention||5
646844|NCT00015457|1587962|P1|COMPLETED|Second Intervention||7
646845|NCT00015457|1587961|P2|STARTED|Second Intervention||5
646846|NCT00015457|1587962|P1|STARTED|Second Intervention||8
646847|NCT00015457|1587961|P2|NOT COMPLETED|First Intervention||3
646848|NCT00015457|1587962|P1|NOT COMPLETED|First Intervention||0
646849|NCT00015457|1587961|P2|COMPLETED|First Intervention||5
646850|NCT00015457|1587962|P1|COMPLETED|First Intervention||8
646851|NCT00015457|1587961|P2|STARTED|First Intervention||8
646852|NCT00015457|1587962|P1|STARTED|First Intervention||8
646853|NCT00013611|1587972|P2|NOT COMPLETED|Overall Study||100
646854|NCT00013611|1587973|P1|NOT COMPLETED|Overall Study||91
646855|NCT00013611|1587972|P2|COMPLETED|Overall Study||746
646856|NCT00013611|1587973|P1|COMPLETED|Overall Study||758
646857|NCT00013611|1587972|P2|STARTED|Overall Study|138 were excluded from sites that did not re-consent 2/3 of patients to the amended protocol in 2003|846
646858|NCT00013611|1587973|P1|STARTED|Overall Study|138 were excluded from sites that did not re-consent 2/3 of patients to the amended protocol in 2003|849
646859|NCT00010803|1587991|P2|NOT COMPLETED|Overall Study||98
646860|NCT00010803|1587992|P1|NOT COMPLETED|Overall Study||97
646861|NCT00010803|1587991|P2|COMPLETED|Overall Study|Reached endpoint of dementia, death or completion|1426
646862|NCT00010803|1587992|P1|COMPLETED|Overall Study|Reached endpoint of dementia, death or completion|1448
646863|NCT00010803|1587991|P2|STARTED|Overall Study|Randomized|1524
646864|NCT00010803|1587992|P1|STARTED|Overall Study|Randomized|1545
646865|NCT00010439|1588002|P1|NOT COMPLETED|Overall Study||0
646866|NCT00010439|1588002|P1|COMPLETED|Overall Study||10
646867|NCT00010439|1588002|P1|6 Months|Overall Study||10
646868|NCT00010439|1588002|P1|STARTED|Overall Study||10
646869|NCT00007644|1588009|P2|NOT COMPLETED|Overall Study||0
646870|NCT00007644|1588010|P1|NOT COMPLETED|Overall Study||0
646871|NCT00007644|1588009|P2|COMPLETED|Overall Study||367
646872|NCT00007644|1588010|P1|COMPLETED|Overall Study||364
646873|NCT00007644|1588009|P2|STARTED|Overall Study||367
646874|NCT00007644|1588010|P1|STARTED|Overall Study||364
646875|NCT00007475|1588019|P4|NOT COMPLETED|Overall Study||0
646876|NCT00007475|1588020|P3|NOT COMPLETED|Overall Study||0
646877|NCT00007475|1588021|P2|NOT COMPLETED|Overall Study||0
646878|NCT00007475|1588022|P1|NOT COMPLETED|Overall Study||4
646879|NCT00007475|1588019|P4|COMPLETED|Overall Study||0
646880|NCT00007475|1588020|P3|COMPLETED|Overall Study||2
646881|NCT00007475|1588021|P2|COMPLETED|Overall Study||1
646882|NCT00007475|1588022|P1|COMPLETED|Overall Study||8
646883|NCT00007475|1588019|P4|Initiate Cyclophosphamide|Overall Study||0
646884|NCT00007475|1588020|P3|Initiate Cyclophosphamide|Overall Study||2
646885|NCT00007475|1588021|P2|Initiate Cyclophosphamide|Overall Study||1
646886|NCT00007475|1588022|P1|Initiate Cyclophosphamide|Overall Study||12
646887|NCT00007475|1588019|P4|Initial Plasma Exchange|Overall Study||0
646888|NCT00007475|1588020|P3|Initial Plasma Exchange|Overall Study||2
646889|NCT00007475|1588021|P2|Initial Plasma Exchange|Overall Study||1
646890|NCT00007475|1588022|P1|Initial Plasma Exchange|Overall Study||12
646891|NCT00007475|1588019|P4|Post-initial Transplant Proteinuria|Overall Study||0
646892|NCT00007475|1588020|P3|Post-initial Transplant Proteinuria|Overall Study||2
646893|NCT00007475|1588021|P2|Post-initial Transplant Proteinuria|Overall Study||1
646894|NCT00007475|1588022|P1|Post-initial Transplant Proteinuria|Overall Study||12
646895|NCT00007475|1588019|P4|Initial Transplant|Overall Study||0
646896|NCT00007475|1588020|P3|Initial Transplant|Overall Study||2
646897|NCT00007475|1588021|P2|Initial Transplant|Overall Study||1
646898|NCT00007475|1588022|P1|Initial Transplant|Overall Study||12
646899|NCT00007475|1588019|P4|FSGS Permeability Factor (FPF) Assayed|Overall Study||0
646900|NCT00007475|1588020|P3|FSGS Permeability Factor (FPF) Assayed|Overall Study||2
646901|NCT00007475|1588021|P2|FSGS Permeability Factor (FPF) Assayed|Overall Study||1
646902|NCT00007475|1588022|P1|FSGS Permeability Factor (FPF) Assayed|Overall Study|FSGS Permeability Factor's provisional assay only applied to minority of early enrollees, by design.|0
646903|NCT00007475|1588019|P4|STARTED|Overall Study||0
646904|NCT00007475|1588020|P3|STARTED|Overall Study|[ arm reflects eventual participant disposition ]|2
646905|NCT00007475|1588021|P2|STARTED|Overall Study|[ arm reflects eventual participant disposition ]|1
646906|NCT00007475|1588022|P1|STARTED|Overall Study|[ arm reflects un-assayed participants' disposition ]|12
646907|NCT00007345|1588044|P2|NOT COMPLETED|Overall Study||11
646908|NCT00007345|1588045|P1|NOT COMPLETED|Overall Study||2
646909|NCT00007345|1588044|P2|COMPLETED|Overall Study||73
646910|NCT00007345|1588045|P1|COMPLETED|Overall Study||45
646911|NCT00007345|1588044|P2|STARTED|Overall Study||84
646912|NCT00007345|1588045|P1|STARTED|Overall Study||47
646913|NCT00006489|1588067|P4|NOT COMPLETED|Overall Study||11
646914|NCT00006489|1588068|P3|NOT COMPLETED|Overall Study||15
646915|NCT00006489|1588069|P2|NOT COMPLETED|Overall Study||14
646916|NCT00006489|1588070|P1|NOT COMPLETED|Overall Study||13
646917|NCT00006489|1588067|P4|COMPLETED|Overall Study||32
646918|NCT00006489|1588068|P3|COMPLETED|Overall Study||25
646919|NCT00006489|1588069|P2|COMPLETED|Overall Study||26
646920|NCT00006489|1588070|P1|COMPLETED|Overall Study||29
646921|NCT00006489|1588067|P4|STARTED|Overall Study||43
646922|NCT00006489|1588068|P3|STARTED|Overall Study||40
646923|NCT00006489|1588069|P2|STARTED|Overall Study||40
646924|NCT00006489|1588070|P1|STARTED|Overall Study||42
646925|NCT00006409|1588094|P6|NOT COMPLETED|Post-3 Year Intervention||62
646926|NCT00006409|1588095|P5|NOT COMPLETED|Post-3 Year Intervention||62
646927|NCT00006409|1588096|P4|NOT COMPLETED|Post-3 Year Intervention||0
646928|NCT00006409|1588097|P3|NOT COMPLETED|Post-3 Year Intervention||0
646929|NCT00006409|1588098|P2|NOT COMPLETED|Post-3 Year Intervention||0
646930|NCT00006409|1588099|P1|NOT COMPLETED|Post-3 Year Intervention||0
646931|NCT00006409|1588094|P6|COMPLETED|Post-3 Year Intervention||1714
646932|NCT00006409|1588095|P5|COMPLETED|Post-3 Year Intervention||1664
646933|NCT00006409|1588096|P4|COMPLETED|Post-3 Year Intervention||0
646934|NCT00006409|1588097|P3|COMPLETED|Post-3 Year Intervention||0
646935|NCT00006409|1588098|P2|COMPLETED|Post-3 Year Intervention||0
646936|NCT00006409|1588099|P1|COMPLETED|Post-3 Year Intervention||0
646937|NCT00006409|1588094|P6|STARTED|Post-3 Year Intervention|Sample is independent of 8th-grade/2005 sample that was measured post-2 year intervention|1776
646938|NCT00006409|1588095|P5|STARTED|Post-3 Year Intervention|Sample is independent of 8th-grade/2005 sample that was measured post-2 year intervention|1726
646939|NCT00006409|1588096|P4|STARTED|Post-3 Year Intervention|8th-grade/2005 sample was not followed over time|0
646940|NCT00006409|1588097|P3|STARTED|Post-3 Year Intervention|8th-grade/2005 sample was not followed over time|0
646941|NCT00006409|1588098|P2|STARTED|Post-3 Year Intervention||0
646942|NCT00006409|1588099|P1|STARTED|Post-3 Year Intervention||0
646943|NCT00006409|1588094|P6|NOT COMPLETED|Post-2 Year Intervention||0
646944|NCT00006409|1588095|P5|NOT COMPLETED|Post-2 Year Intervention||0
646945|NCT00006409|1588096|P4|NOT COMPLETED|Post-2 Year Intervention||168
646946|NCT00006409|1588097|P3|NOT COMPLETED|Post-2 Year Intervention||251
646947|NCT00006409|1588098|P2|NOT COMPLETED|Post-2 Year Intervention||0
646948|NCT00006409|1588099|P1|NOT COMPLETED|Post-2 Year Intervention||0
646949|NCT00006409|1588094|P6|COMPLETED|Post-2 Year Intervention||0
646950|NCT00006409|1588095|P5|COMPLETED|Post-2 Year Intervention||0
646951|NCT00006409|1588096|P4|COMPLETED|Post-2 Year Intervention||1545
646952|NCT00006409|1588097|P3|COMPLETED|Post-2 Year Intervention||1540
646953|NCT00006409|1588098|P2|COMPLETED|Post-2 Year Intervention||0
646954|NCT00006409|1588099|P1|COMPLETED|Post-2 Year Intervention||0
646955|NCT00006409|1588094|P6|STARTED|Post-2 Year Intervention||0
646956|NCT00006409|1588095|P5|STARTED|Post-2 Year Intervention||0
646957|NCT00006409|1588096|P4|STARTED|Post-2 Year Intervention|Sample is independent of 6th-grade/2003 sample that was measured at baseline|1713
646958|NCT00006409|1588097|P3|STARTED|Post-2 Year Intervention|Sample is independent of 6th-grade/2003 sample that was measured at baseline|1791
646959|NCT00006409|1588098|P2|STARTED|Post-2 Year Intervention|6th grade/2003 sample was not followed over time|0
646960|NCT00006409|1588099|P1|STARTED|Post-2 Year Intervention|6th grade/2003 sample was not followed over time|0
646961|NCT00006409|1588094|P6|NOT COMPLETED|Baseline||0
646962|NCT00006409|1588095|P5|NOT COMPLETED|Baseline||0
646963|NCT00006409|1588096|P4|NOT COMPLETED|Baseline||0
646964|NCT00006409|1588097|P3|NOT COMPLETED|Baseline||0
646965|NCT00006409|1588098|P2|NOT COMPLETED|Baseline||70
646966|NCT00006409|1588099|P1|NOT COMPLETED|Baseline||48
646967|NCT00006409|1588094|P6|COMPLETED|Baseline||0
646968|NCT00006409|1588095|P5|COMPLETED|Baseline||0
646969|NCT00006409|1588096|P4|COMPLETED|Baseline||0
646970|NCT00006409|1588097|P3|COMPLETED|Baseline||0
646971|NCT00006409|1588098|P2|COMPLETED|Baseline||786
646972|NCT00006409|1588099|P1|COMPLETED|Baseline||817
646973|NCT00006409|1588094|P6|STARTED|Baseline||0
646974|NCT00006409|1588095|P5|STARTED|Baseline||0
646975|NCT00006409|1588096|P4|STARTED|Baseline||0
646976|NCT00006409|1588097|P3|STARTED|Baseline||0
646977|NCT00006409|1588098|P2|STARTED|Baseline||856
646978|NCT00006409|1588099|P1|STARTED|Baseline||865
646979|NCT00006305|1588123|P4|NOT COMPLETED|Overall Study||14
646980|NCT00006305|1588124|P3|NOT COMPLETED|Overall Study||15
646981|NCT00006305|1588125|P2|NOT COMPLETED|Overall Study||10
646982|NCT00006305|1588126|P1|NOT COMPLETED|Overall Study||17
646983|NCT00006305|1588123|P4|COMPLETED|Overall Study||585
646984|NCT00006305|1588124|P3|COMPLETED|Overall Study||578
646985|NCT00006305|1588125|P2|COMPLETED|Overall Study||574
646986|NCT00006305|1588126|P1|COMPLETED|Overall Study||575
646987|NCT00006305|1588123|P4|STARTED|Overall Study||599
646988|NCT00006305|1588124|P3|STARTED|Overall Study||593
646989|NCT00006305|1588125|P2|STARTED|Overall Study||584
646990|NCT00006305|1588126|P1|STARTED|Overall Study||592
646991|NCT00006289|1588142|P2|NOT COMPLETED|Second Intervention (5 Weeks)||1
646992|NCT00006289|1588143|P1|NOT COMPLETED|Second Intervention (5 Weeks)||1
646993|NCT00006289|1588142|P2|COMPLETED|Second Intervention (5 Weeks)||9
646994|NCT00006289|1588143|P1|COMPLETED|Second Intervention (5 Weeks)||9
646995|NCT00006289|1588142|P2|STARTED|Second Intervention (5 Weeks)||10
646996|NCT00006289|1588143|P1|STARTED|Second Intervention (5 Weeks)||10
646997|NCT00006289|1588142|P2|NOT COMPLETED|Washout (>= 1 Week)||0
646998|NCT00006289|1588143|P1|NOT COMPLETED|Washout (>= 1 Week)||0
646999|NCT00006289|1588142|P2|COMPLETED|Washout (>= 1 Week)||10
647000|NCT00006289|1588143|P1|COMPLETED|Washout (>= 1 Week)||10
647001|NCT00006289|1588142|P2|STARTED|Washout (>= 1 Week)||10
647002|NCT00006289|1588143|P1|STARTED|Washout (>= 1 Week)||10
647003|NCT00006289|1588142|P2|NOT COMPLETED|First Intervention (5 Weeks)||0
647004|NCT00006289|1588143|P1|NOT COMPLETED|First Intervention (5 Weeks)||1
647005|NCT00006289|1588142|P2|COMPLETED|First Intervention (5 Weeks)||10
647006|NCT00006289|1588143|P1|COMPLETED|First Intervention (5 Weeks)||10
647007|NCT00006289|1588142|P2|STARTED|First Intervention (5 Weeks)||10
647008|NCT00006289|1588143|P1|STARTED|First Intervention (5 Weeks)||11
647009|NCT00006184|1588161|P2|NOT COMPLETED|Overall Study||0
647010|NCT00006184|1588162|P1|NOT COMPLETED|Overall Study||1
647011|NCT00006184|1588161|P2|COMPLETED|Overall Study||10
647012|NCT00006184|1588162|P1|COMPLETED|Overall Study||9
647013|NCT00006184|1588161|P2|STARTED|Overall Study||10
647014|NCT00006184|1588162|P1|STARTED|Overall Study||10
647015|NCT00006178|1588169|P1|NOT COMPLETED|Overall Study||0
647016|NCT00006178|1588169|P1|COMPLETED|Overall Study||12
647017|NCT00006178|1588169|P1|STARTED|Overall Study||12
647018|NCT00006170|1588180|P4|NOT COMPLETED|Overall Study||39
647019|NCT00006170|1588181|P3|NOT COMPLETED|Overall Study||43
647020|NCT00006170|1588182|P2|NOT COMPLETED|Overall Study||50
647021|NCT00006170|1588183|P1|NOT COMPLETED|Overall Study||49
647022|NCT00006170|1588180|P4|COMPLETED|Overall Study||28
647023|NCT00006170|1588181|P3|COMPLETED|Overall Study||46
647024|NCT00006170|1588182|P2|COMPLETED|Overall Study||37
647025|NCT00006170|1588183|P1|COMPLETED|Overall Study||57
647026|NCT00006170|1588180|P4|STARTED|Overall Study||67
647027|NCT00006170|1588181|P3|STARTED|Overall Study||89
647028|NCT00006170|1588182|P2|STARTED|Overall Study||87
647029|NCT00006170|1588183|P1|STARTED|Overall Study||106
647030|NCT00006156|1588203|P2|NOT COMPLETED|Overall Study||0
647031|NCT00006156|1588204|P1|NOT COMPLETED|Overall Study||0
647032|NCT00006156|1588203|P2|COMPLETED|Overall Study||7
647033|NCT00006156|1588204|P1|COMPLETED|Overall Study||42
647034|NCT00006156|1588203|P2|STARTED|Overall Study||7
647035|NCT00006156|1588204|P1|STARTED|Overall Study||42
647036|NCT00006164|1588213|P2|NOT COMPLETED|Overall Study||81
647037|NCT00006164|1588214|P1|NOT COMPLETED|Overall Study||70
647038|NCT00006164|1588213|P2|COMPLETED|Overall Study|81 Withdrew or were lost to followup; 9 took peginterferon outside of protocol|452
647039|NCT00006164|1588214|P1|COMPLETED|Overall Study|70 Withdrew or were lost to followup; 158 Discontinued peginterferon but were followed|447
647040|NCT00006164|1588213|P2|STARTED|Overall Study||533
647041|NCT00006164|1588214|P1|STARTED|Overall Study||517
647042|NCT00006151|1588250|P2|NOT COMPLETED|Overall Study||14
647043|NCT00006151|1588251|P1|NOT COMPLETED|Overall Study||13
647044|NCT00006151|1588250|P2|COMPLETED|Overall Study||16
647045|NCT00006151|1588251|P1|COMPLETED|Overall Study||17
647046|NCT00006151|1588250|P2|STARTED|Overall Study||30
647047|NCT00006151|1588251|P1|STARTED|Overall Study||30
647048|NCT00005937|1588257|P1|NOT COMPLETED|Overall Study||5
647049|NCT00005937|1588257|P1|COMPLETED|Overall Study||37
647050|NCT00005937|1588257|P1|STARTED|Overall Study||42
647051|NCT00005908|1588261|P2|NOT COMPLETED|Overall Study||0
647052|NCT00005908|1588262|P1|NOT COMPLETED|Overall Study||1
647053|NCT00005908|1588261|P2|COMPLETED|Overall Study||20
647054|NCT00005908|1588262|P1|COMPLETED|Overall Study||9
647055|NCT00005908|1588261|P2|STARTED|Overall Study||20
647056|NCT00005908|1588262|P1|STARTED|Overall Study||10
647057|NCT00005906|1588271|P1|NOT COMPLETED|Overall Study||3
647058|NCT00005906|1588271|P1|COMPLETED|Overall Study||1
647059|NCT00005906|1588271|P1|STARTED|Overall Study||4
647060|NCT00005901|1588279|P2|NOT COMPLETED|Overall Study||0
647061|NCT00005901|1588280|P1|NOT COMPLETED|Overall Study||0
647062|NCT00005901|1588279|P2|COMPLETED|Overall Study||15
647063|NCT00005901|1588280|P1|COMPLETED|Overall Study||19
647064|NCT00005901|1588279|P2|STARTED|Overall Study||15
647065|NCT00005901|1588280|P1|STARTED|Overall Study||19
647066|NCT00005669|1588298|P2|NOT COMPLETED|Overall Study||7
647067|NCT00005669|1588299|P1|NOT COMPLETED|Overall Study||8
647068|NCT00005669|1588298|P2|COMPLETED|Overall Study||40
647069|NCT00005669|1588299|P1|COMPLETED|Overall Study||45
647070|NCT00005669|1588298|P2|STARTED|Overall Study||47
647071|NCT00005669|1588299|P1|STARTED|Overall Study||53
647072|NCT00004980|1588315|P2|NOT COMPLETED|Overall Study||2
647073|NCT00004980|1588316|P1|NOT COMPLETED|Overall Study||2
647074|NCT00004980|1588315|P2|COMPLETED|Overall Study||21
647075|NCT00004980|1588316|P1|COMPLETED|Overall Study||25
647076|NCT00004980|1588315|P2|STARTED|Overall Study||23
647077|NCT00004980|1588316|P1|STARTED|Overall Study||27
647078|NCT00004732|1588330|P2|NOT COMPLETED|Overall Study||111
647079|NCT00004732|1588331|P1|NOT COMPLETED|Overall Study||69
647080|NCT00004732|1588330|P2|COMPLETED|Overall Study||1129
647081|NCT00004732|1588331|P1|COMPLETED|Overall Study||1193
647082|NCT00004732|1588330|P2|STARTED|Overall Study||1240
647083|NCT00004732|1588331|P1|STARTED|Overall Study||1262
647084|NCT00004635|1588341|P2|NOT COMPLETED|Period Two||9
647085|NCT00004635|1588342|P1|NOT COMPLETED|Period Two||6
647086|NCT00004635|1588341|P2|COMPLETED|Period Two||50
647087|NCT00004635|1588342|P1|COMPLETED|Period Two||38
647088|NCT00004635|1588341|P2|STARTED|Period Two||59
647089|NCT00004635|1588342|P1|STARTED|Period Two||44
647090|NCT00004635|1588341|P2|NOT COMPLETED|Period One||6
647091|NCT00004635|1588342|P1|NOT COMPLETED|Period One||6
647092|NCT00004635|1588341|P2|COMPLETED|Period One||74
647093|NCT00004635|1588342|P1|COMPLETED|Period One||73
647094|NCT00004635|1588341|P2|Received Treatment|Period One||75
647095|NCT00004635|1588342|P1|Received Treatment|Period One||73
647096|NCT00004635|1588341|P2|STARTED|Period One||80
647097|NCT00004635|1588342|P1|STARTED|Period One||79
647098|NCT00004563|1588354|P2|NOT COMPLETED|Overall Study||24
647099|NCT00004563|1588355|P1|NOT COMPLETED|Overall Study||25
647100|NCT00004563|1588354|P2|COMPLETED|Overall Study||55
647101|NCT00004563|1588355|P1|COMPLETED|Overall Study||54
647102|NCT00004563|1588354|P2|STARTED|Overall Study||79
647103|NCT00004563|1588355|P1|STARTED|Overall Study||79
647104|NCT00004562|1588367|P2|NOT COMPLETED|Overall Study||91
647105|NCT00004562|1588368|P1|NOT COMPLETED|Overall Study||102
647106|NCT00004562|1588367|P2|COMPLETED|Overall Study||1009
647107|NCT00004562|1588368|P1|COMPLETED|Overall Study||999
647108|NCT00004562|1588367|P2|STARTED|Overall Study||1100
647109|NCT00004562|1588368|P1|STARTED|Overall Study||1101
647110|NCT00004547|1588379|P3|NOT COMPLETED|Overall Study||22
647111|NCT00004547|1588380|P2|NOT COMPLETED|Overall Study||9
647112|NCT00004547|1588381|P1|NOT COMPLETED|Overall Study||22
647113|NCT00004547|1588379|P3|COMPLETED|Overall Study||35
647114|NCT00004547|1588380|P2|COMPLETED|Overall Study||39
647115|NCT00004547|1588381|P1|COMPLETED|Overall Study||61
647116|NCT00004547|1588379|P3|Not Evaluable|Overall Study||23
647117|NCT00004547|1588380|P2|Not Evaluable|Overall Study||9
647118|NCT00004547|1588381|P1|Not Evaluable|Overall Study||21
647119|NCT00004547|1588379|P3|STARTED|Overall Study||57
647120|NCT00004547|1588380|P2|STARTED|Overall Study||48
647121|NCT00004547|1588381|P1|STARTED|Overall Study||83
647122|NCT00001984|1588399|P1|NOT COMPLETED|Overall Study||0
647123|NCT00001984|1588399|P1|COMPLETED|Overall Study||5
647124|NCT00001984|1588399|P1|STARTED|Overall Study||5
647125|NCT00001962|1588409|P1|NOT COMPLETED|Overall Study||28
647126|NCT00001962|1588409|P1|COMPLETED|Overall Study||72
647127|NCT00001962|1588409|P1|STARTED|Overall Study||100
647128|NCT00001959|1588413|P1|NOT COMPLETED|Overall Study||3
647129|NCT00001959|1588413|P1|COMPLETED|Overall Study||18
647130|NCT00001959|1588413|P1|STARTED|Overall Study||21
647131|NCT00001941|1588419|P5|NOT COMPLETED|Overall Study||1
647132|NCT00001941|1588420|P4|NOT COMPLETED|Overall Study||0
647133|NCT00001941|1588421|P3|NOT COMPLETED|Overall Study||0
647134|NCT00001941|1588422|P2|NOT COMPLETED|Overall Study||0
647135|NCT00001941|1588423|P1|NOT COMPLETED|Overall Study||0
647136|NCT00001941|1588419|P5|COMPLETED|Overall Study||19
647137|NCT00001941|1588420|P4|COMPLETED|Overall Study||3
647138|NCT00001941|1588421|P3|COMPLETED|Overall Study||3
647139|NCT00001941|1588422|P2|COMPLETED|Overall Study||5
647140|NCT00001941|1588423|P1|COMPLETED|Overall Study||3
647141|NCT00001941|1588419|P5|STARTED|Overall Study||20
647142|NCT00001941|1588420|P4|STARTED|Overall Study||3
647143|NCT00001941|1588421|P3|STARTED|Overall Study||3
647144|NCT00001941|1588422|P2|STARTED|Overall Study||5
647145|NCT00001941|1588423|P1|STARTED|Overall Study||3
647146|NCT00000392|1588432|P2|NOT COMPLETED|Overall Study||32
647147|NCT00000392|1588433|P1|NOT COMPLETED|Overall Study||40
647148|NCT00000392|1588432|P2|COMPLETED|Overall Study|provided complete NP outcome data constituted the sample for the primary efficacy analyses|77
647149|NCT00000392|1588433|P1|COMPLETED|Overall Study|provided complete NP outcome data constituted the sample for the primary efficacy analyses|66
647150|NCT00000392|1588432|P2|STARTED|Overall Study||109
647151|NCT00000392|1588433|P1|STARTED|Overall Study||106
647152|NCT00001832|1588455|P15|NOT COMPLETED|Treatment Period||0
647153|NCT00001832|1588456|P14|NOT COMPLETED|Treatment Period||0
647154|NCT00001832|1588457|P13|NOT COMPLETED|Treatment Period||0
647155|NCT00001832|1588458|P12|NOT COMPLETED|Treatment Period||0
647156|NCT00001832|1588459|P11|NOT COMPLETED|Treatment Period||0
647157|NCT00001832|1588460|P10|NOT COMPLETED|Treatment Period||0
647158|NCT00001832|1588461|P9|NOT COMPLETED|Treatment Period||0
647159|NCT00001832|1588462|P8|NOT COMPLETED|Treatment Period||1
647160|NCT00001832|1588463|P7|NOT COMPLETED|Treatment Period||0
647161|NCT00001832|1588464|P6|NOT COMPLETED|Treatment Period||1
647162|NCT00001832|1588465|P5|NOT COMPLETED|Treatment Period||0
647163|NCT00001832|1588466|P4|NOT COMPLETED|Treatment Period||0
647164|NCT00001832|1588467|P3|NOT COMPLETED|Treatment Period||0
647165|NCT00001832|1588468|P2|NOT COMPLETED|Treatment Period||0
647166|NCT00001832|1588469|P1|NOT COMPLETED|Treatment Period||0
647167|NCT00001832|1588455|P15|COMPLETED|Treatment Period||2
647168|NCT00001832|1588456|P14|COMPLETED|Treatment Period||3
647169|NCT00001832|1588457|P13|COMPLETED|Treatment Period||6
647170|NCT00001832|1588458|P12|COMPLETED|Treatment Period||7
647171|NCT00001832|1588459|P11|COMPLETED|Treatment Period||1
647172|NCT00001832|1588460|P10|COMPLETED|Treatment Period||6
647173|NCT00001832|1588461|P9|COMPLETED|Treatment Period||8
647174|NCT00001832|1588462|P8|COMPLETED|Treatment Period||6
647175|NCT00001832|1588463|P7|COMPLETED|Treatment Period||4
647176|NCT00001832|1588464|P6|COMPLETED|Treatment Period||50
647177|NCT00001832|1588465|P5|COMPLETED|Treatment Period||6
647178|NCT00001832|1588466|P4|COMPLETED|Treatment Period||3
647179|NCT00001832|1588467|P3|COMPLETED|Treatment Period||3
647180|NCT00001832|1588468|P2|COMPLETED|Treatment Period||3
647181|NCT00001832|1588469|P1|COMPLETED|Treatment Period||0
647182|NCT00001832|1588455|P15|STARTED|Treatment Period||2
647183|NCT00001832|1588456|P14|STARTED|Treatment Period||3
647184|NCT00001832|1588457|P13|STARTED|Treatment Period||6
647185|NCT00001832|1588458|P12|STARTED|Treatment Period||7
647186|NCT00001832|1588459|P11|STARTED|Treatment Period||1
647187|NCT00001832|1588460|P10|STARTED|Treatment Period||6
647188|NCT00001832|1588461|P9|STARTED|Treatment Period||8
647189|NCT00001832|1588462|P8|STARTED|Treatment Period||7
647190|NCT00001832|1588463|P7|STARTED|Treatment Period||4
647191|NCT00001832|1588464|P6|STARTED|Treatment Period||51
647192|NCT00001832|1588465|P5|STARTED|Treatment Period||6
647193|NCT00001832|1588466|P4|STARTED|Treatment Period||3
647194|NCT00001832|1588467|P3|STARTED|Treatment Period||3
647195|NCT00001832|1588468|P2|STARTED|Treatment Period||3
647196|NCT00001832|1588469|P1|STARTED|Treatment Period||0
647197|NCT00001832|1588455|P15|NOT COMPLETED|Apheresis Period||0
647198|NCT00001832|1588456|P14|NOT COMPLETED|Apheresis Period||0
647199|NCT00001832|1588457|P13|NOT COMPLETED|Apheresis Period||0
647200|NCT00001832|1588458|P12|NOT COMPLETED|Apheresis Period||0
647201|NCT00001832|1588459|P11|NOT COMPLETED|Apheresis Period||0
647202|NCT00001832|1588460|P10|NOT COMPLETED|Apheresis Period||0
647203|NCT00001832|1588461|P9|NOT COMPLETED|Apheresis Period||0
647204|NCT00001832|1588462|P8|NOT COMPLETED|Apheresis Period||0
647205|NCT00001832|1588463|P7|NOT COMPLETED|Apheresis Period||0
647206|NCT00001832|1588464|P6|NOT COMPLETED|Apheresis Period||0
647207|NCT00001832|1588465|P5|NOT COMPLETED|Apheresis Period||0
647208|NCT00001832|1588466|P4|NOT COMPLETED|Apheresis Period||0
647209|NCT00001832|1588467|P3|NOT COMPLETED|Apheresis Period||0
647210|NCT00001832|1588468|P2|NOT COMPLETED|Apheresis Period||0
647211|NCT00001832|1588469|P1|NOT COMPLETED|Apheresis Period||60
647212|NCT00001832|1588455|P15|COMPLETED|Apheresis Period||0
647213|NCT00001832|1588456|P14|COMPLETED|Apheresis Period||0
647214|NCT00001832|1588457|P13|COMPLETED|Apheresis Period||0
647215|NCT00001832|1588458|P12|COMPLETED|Apheresis Period||0
647216|NCT00001832|1588459|P11|COMPLETED|Apheresis Period||0
647217|NCT00001832|1588460|P10|COMPLETED|Apheresis Period||0
647218|NCT00001832|1588461|P9|COMPLETED|Apheresis Period||0
647219|NCT00001832|1588462|P8|COMPLETED|Apheresis Period||0
647220|NCT00001832|1588463|P7|COMPLETED|Apheresis Period||0
647221|NCT00001832|1588464|P6|COMPLETED|Apheresis Period||0
647222|NCT00001832|1588465|P5|COMPLETED|Apheresis Period||0
647223|NCT00001832|1588466|P4|COMPLETED|Apheresis Period||0
647224|NCT00001832|1588467|P3|COMPLETED|Apheresis Period||0
647225|NCT00001832|1588468|P2|COMPLETED|Apheresis Period||0
647226|NCT00001832|1588469|P1|COMPLETED|Apheresis Period||110
647227|NCT00001832|1588455|P15|STARTED|Apheresis Period||0
647228|NCT00001832|1588456|P14|STARTED|Apheresis Period||0
647229|NCT00001832|1588457|P13|STARTED|Apheresis Period||0
647230|NCT00001832|1588458|P12|STARTED|Apheresis Period||0
647231|NCT00001832|1588459|P11|STARTED|Apheresis Period||0
647232|NCT00001832|1588460|P10|STARTED|Apheresis Period||0
647233|NCT00001832|1588461|P9|STARTED|Apheresis Period||0
647234|NCT00001832|1588462|P8|STARTED|Apheresis Period||0
647235|NCT00001832|1588463|P7|STARTED|Apheresis Period||0
647236|NCT00001832|1588464|P6|STARTED|Apheresis Period||0
647237|NCT00001832|1588465|P5|STARTED|Apheresis Period||0
647238|NCT00001832|1588466|P4|STARTED|Apheresis Period||0
647239|NCT00001832|1588467|P3|STARTED|Apheresis Period||0
647240|NCT00001832|1588468|P2|STARTED|Apheresis Period||0
647241|NCT00001832|1588469|P1|STARTED|Apheresis Period||170
647242|NCT00001723|1588515|P2|NOT COMPLETED|Overall Study||16
647243|NCT00001723|1588516|P1|NOT COMPLETED|Overall Study||13
647244|NCT00001723|1588515|P2|COMPLETED|Overall Study||84
647245|NCT00001723|1588516|P1|COMPLETED|Overall Study||87
647246|NCT00001723|1588515|P2|STARTED|Overall Study||100
647247|NCT00001723|1588516|P1|STARTED|Overall Study||100
647248|NCT00001703|1588532|P1|NOT COMPLETED|Overall Study||5
647249|NCT00001703|1588532|P1|COMPLETED|Overall Study||1
647250|NCT00001703|1588532|P1|Peptide Stock Completed|Overall Study|off therapy reason for 3 patients|3
647251|NCT00001703|1588532|P1|STARTED|Overall Study||6
647252|NCT00001656|1588539|P2|NOT COMPLETED|Overall Study||0
647253|NCT00001656|1588540|P1|NOT COMPLETED|Overall Study||1
647254|NCT00001656|1588539|P2|COMPLETED|Overall Study||12
647255|NCT00001656|1588540|P1|COMPLETED|Overall Study||12
647256|NCT00001656|1588539|P2|STARTED|Overall Study||12
647257|NCT00001656|1588540|P1|STARTED|Overall Study||13
647258|NCT00001596|1588570|P2|NOT COMPLETED|Overall Study||10
647259|NCT00001596|1588571|P1|NOT COMPLETED|Overall Study||17
647260|NCT00001596|1588570|P2|COMPLETED|Overall Study||2
647261|NCT00001596|1588571|P1|COMPLETED|Overall Study||6
647262|NCT00001596|1588570|P2|STARTED|Overall Study||12
647263|NCT00001596|1588571|P1|STARTED|Overall Study||23
647264|NCT00001586|1588593|P2|NOT COMPLETED|Overall Study||0
647265|NCT00001586|1588594|P1|NOT COMPLETED|Overall Study||0
647266|NCT00001586|1588593|P2|COMPLETED|Overall Study||56
647267|NCT00001586|1588594|P1|COMPLETED|Overall Study||49
647268|NCT00001586|1588593|P2|STARTED|Overall Study||56
647269|NCT00001586|1588594|P1|STARTED|Overall Study||49
647270|NCT00001575|1588602|P1|NOT COMPLETED|Overall Study||45
647271|NCT00001575|1588602|P1|COMPLETED|Overall Study||42
647272|NCT00001575|1588602|P1|Treated|Overall Study||65
647273|NCT00001575|1588602|P1|STARTED|Overall Study||87
647274|NCT00001566|1588608|P1|NOT COMPLETED|Overall Study||19
647275|NCT00001566|1588608|P1|COMPLETED|Overall Study||23
647276|NCT00001566|1588608|P1|Completed Immunotherapy|Overall Study||23
647277|NCT00001566|1588608|P1|STARTED|Overall Study||42
647278|NCT00001304|1588622|P2|NOT COMPLETED|Overall Study||0
647279|NCT00001304|1588623|P1|NOT COMPLETED|Overall Study||0
647280|NCT00001304|1588622|P2|COMPLETED|Overall Study||14
647281|NCT00001304|1588623|P1|COMPLETED|Overall Study||13
647282|NCT00001304|1588622|P2|STARTED|Overall Study||14
647283|NCT00001304|1588623|P1|STARTED|Overall Study||13
647284|NCT00001262|1588644|P3|NOT COMPLETED|Overall Study||0
647285|NCT00001262|1588645|P2|NOT COMPLETED|Overall Study||14
647286|NCT00001262|1588646|P1|NOT COMPLETED|Overall Study||10
647287|NCT00001262|1588644|P3|COMPLETED|Overall Study||3
647288|NCT00001262|1588645|P2|COMPLETED|Overall Study||8
647289|NCT00001262|1588646|P1|COMPLETED|Overall Study||25
647290|NCT00001262|1588644|P3|STARTED|Overall Study||3
647291|NCT00001262|1588645|P2|STARTED|Overall Study||22
647292|NCT00001262|1588646|P1|STARTED|Overall Study||35
647293|NCT00001213|1588672|P1|NOT COMPLETED|Overall Study||18
647294|NCT00001213|1588672|P1|COMPLETED|Overall Study||310
647295|NCT00001213|1588672|P1|STARTED|Overall Study||328
647296|NCT00001151|1588677|P1|NOT COMPLETED|Overall Study||5
647297|NCT00001151|1588677|P1|COMPLETED|Overall Study||1
647298|NCT00001151|1588677|P1|STARTED|Overall Study||6
647299|NCT00000378|1588683|P2|NOT COMPLETED|Overall Study||14
647300|NCT00000378|1588684|P1|NOT COMPLETED|Overall Study||16
647301|NCT00000378|1588683|P2|COMPLETED|Overall Study||38
647302|NCT00000378|1588684|P1|COMPLETED|Overall Study||42
647303|NCT00000378|1588683|P2|STARTED|Overall Study||52
647304|NCT00000378|1588684|P1|STARTED|Overall Study||58
647305|NCT00000371|1588692|P2|NOT COMPLETED|Overall Study||16
647306|NCT00000371|1588693|P1|NOT COMPLETED|Overall Study||13
647307|NCT00000371|1588692|P2|COMPLETED|Overall Study||12
647308|NCT00000371|1588693|P1|COMPLETED|Overall Study||14
647309|NCT00000371|1588692|P2|STARTED|Overall Study||28
647310|NCT00000371|1588693|P1|STARTED|Overall Study||27
647311|NCT00000620|1588701|P8|NOT COMPLETED|Overall Study||146
647312|NCT00000620|1588702|P7|NOT COMPLETED|Overall Study||149
647313|NCT00000620|1588703|P6|NOT COMPLETED|Overall Study||152
647314|NCT00000620|1588704|P5|NOT COMPLETED|Overall Study||135
647315|NCT00000620|1588705|P4|NOT COMPLETED|Overall Study||178
647316|NCT00000620|1588706|P3|NOT COMPLETED|Overall Study||170
647317|NCT00000620|1588707|P2|NOT COMPLETED|Overall Study||136
647318|NCT00000620|1588708|P1|NOT COMPLETED|Overall Study||162
647319|NCT00000620|1588701|P8|COMPLETED|Overall Study||1224
647320|NCT00000620|1588702|P7|COMPLETED|Overall Study||1242
647321|NCT00000620|1588703|P6|COMPLETED|Overall Study||1026
647322|NCT00000620|1588704|P5|COMPLETED|Overall Study||1049
647323|NCT00000620|1588705|P4|COMPLETED|Overall Study||1205
647324|NCT00000620|1588706|P3|COMPLETED|Overall Study||1204
647325|NCT00000620|1588707|P2|COMPLETED|Overall Study||1057
647326|NCT00000620|1588708|P1|COMPLETED|Overall Study||1016
647327|NCT00000620|1588701|P8|STARTED|Overall Study||1370
647328|NCT00000620|1588702|P7|STARTED|Overall Study||1391
647329|NCT00000620|1588703|P6|STARTED|Overall Study||1178
647330|NCT00000620|1588704|P5|STARTED|Overall Study||1184
647331|NCT00000620|1588705|P4|STARTED|Overall Study||1383
647332|NCT00000620|1588706|P3|STARTED|Overall Study||1374
647333|NCT00000620|1588707|P2|STARTED|Overall Study||1193
647334|NCT00000620|1588708|P1|STARTED|Overall Study||1178
647335|NCT00000575|1588727|P3|NOT COMPLETED|Overall Study||0
647336|NCT00000575|1588728|P2|NOT COMPLETED|Overall Study||0
647337|NCT00000575|1588729|P1|NOT COMPLETED|Overall Study||0
647338|NCT00000575|1588727|P3|COMPLETED|Overall Study||418
647339|NCT00000575|1588728|P2|COMPLETED|Overall Study||312
647340|NCT00000575|1588729|P1|COMPLETED|Overall Study||311
647341|NCT00000575|1588727|P3|STARTED|Overall Study||418
647342|NCT00000575|1588728|P2|STARTED|Overall Study||312
647343|NCT00000575|1588729|P1|STARTED|Overall Study||311
647344|NCT00000479|1588759|P4|NOT COMPLETED|Overall Study||0
647345|NCT00000479|1588760|P3|NOT COMPLETED|Overall Study||0
647346|NCT00000479|1588761|P2|NOT COMPLETED|Overall Study||0
647347|NCT00000479|1588762|P1|NOT COMPLETED|Overall Study||0
647348|NCT00000479|1588759|P4|COMPLETED|Overall Study||9971
647349|NCT00000479|1588760|P3|COMPLETED|Overall Study||9966
647350|NCT00000479|1588761|P2|COMPLETED|Overall Study||9971
647351|NCT00000479|1588762|P1|COMPLETED|Overall Study||9968
647352|NCT00000479|1588759|P4|STARTED|Overall Study||9971
647353|NCT00000479|1588760|P3|STARTED|Overall Study||9966
647354|NCT00000479|1588761|P2|STARTED|Overall Study||9971
647355|NCT00000479|1588762|P1|STARTED|Overall Study||9968
647356|NCT00004500|1588778|P2|NOT COMPLETED|Overall Study||0
647357|NCT00004500|1588779|P1|NOT COMPLETED|Overall Study||0
647358|NCT00004500|1588778|P2|COMPLETED|Overall Study||31
647359|NCT00004500|1588779|P1|COMPLETED|Overall Study||38
647360|NCT00004500|1588778|P2|1 Year Follow-Up|Overall Study||24
647361|NCT00004500|1588779|P1|1 Year Follow-Up|Overall Study||24
647362|NCT00004500|1588778|P2|STARTED|Overall Study||31
647363|NCT00004500|1588779|P1|STARTED|Overall Study||38
647364|NCT00004412|1588792|P3|NOT COMPLETED|Crossover Period||0
647365|NCT00004412|1588793|P2|NOT COMPLETED|Crossover Period||0
647366|NCT00004412|1588794|P1|NOT COMPLETED|Crossover Period||0
647367|NCT00004412|1588792|P3|COMPLETED|Crossover Period|Three subjects, from Arm I, who crossed- over to Arm II completed the study.|3
647368|NCT00004412|1588793|P2|COMPLETED|Crossover Period|Twelve subjects in this arm completed the study.|12
647369|NCT00004412|1588794|P1|COMPLETED|Crossover Period|Eight subjects in this arm completed study without crossing over.|8
647370|NCT00004412|1588792|P3|STARTED|Crossover Period|Three of Randomized Period's Arm I elected to move to Crossover Period's Crossover Arm.|3
647371|NCT00004412|1588793|P2|STARTED|Crossover Period|Twelve patients were randomized to the Arginine Butyrate plus Standard local care dressing Arm|12
647372|NCT00004412|1588794|P1|STARTED|Crossover Period|Eight subjects were randomized to Standard of Care dressing Arm|8
647373|NCT00004412|1588792|P3|NOT COMPLETED|Randomized Period||0
647374|NCT00004412|1588793|P2|NOT COMPLETED|Randomized Period||0
647375|NCT00004412|1588794|P1|NOT COMPLETED|Randomized Period||3
647376|NCT00004412|1588792|P3|COMPLETED|Randomized Period||0
647377|NCT00004412|1588793|P2|COMPLETED|Randomized Period||12
647378|NCT00004412|1588794|P1|COMPLETED|Randomized Period||8
647379|NCT00004412|1588792|P3|STARTED|Randomized Period||0
647380|NCT00004412|1588793|P2|STARTED|Randomized Period||12
647381|NCT00004412|1588794|P1|STARTED|Randomized Period||11
647382|NCT00000143|1588804|P2|NOT COMPLETED|Overall Study||0
647383|NCT00000143|1588805|P1|NOT COMPLETED|Overall Study||0
647384|NCT00000143|1588804|P2|COMPLETED|Overall Study||30
647385|NCT00000143|1588805|P1|COMPLETED|Overall Study||31
647386|NCT00000143|1588804|P2|STARTED|Overall Study||30
647387|NCT00000143|1588805|P1|STARTED|Overall Study||31
647388|NCT00000142|1588814|P3|NOT COMPLETED|Overall Study||0
647389|NCT00000142|1588815|P2|NOT COMPLETED|Overall Study||0
647390|NCT00000142|1588816|P1|NOT COMPLETED|Overall Study||0
647391|NCT00000142|1588814|P3|COMPLETED|Overall Study||12
647392|NCT00000142|1588815|P2|COMPLETED|Overall Study||26
647393|NCT00000142|1588816|P1|COMPLETED|Overall Study||26
647394|NCT00000142|1588814|P3|STARTED|Overall Study||12
647395|NCT00000142|1588815|P2|STARTED|Overall Study||26
647396|NCT00000142|1588816|P1|STARTED|Overall Study||26
647397|NCT00000136|1588826|P2|NOT COMPLETED|Overall Study||0
647398|NCT00000136|1588827|P1|NOT COMPLETED|Overall Study||0
647399|NCT00000136|1588826|P2|COMPLETED|Overall Study||127
647400|NCT00000136|1588827|P1|COMPLETED|Overall Study||107
647401|NCT00000136|1588826|P2|STARTED|Overall Study||127
647402|NCT00000136|1588827|P1|STARTED|Overall Study||107
647403|NCT00000135|1588835|P2|NOT COMPLETED|Overall Study||14
647404|NCT00000135|1588836|P1|NOT COMPLETED|Overall Study||27
647405|NCT00000135|1588835|P2|COMPLETED|Overall Study||91
647406|NCT00000135|1588836|P1|COMPLETED|Overall Study||77
647407|NCT00000135|1588835|P2|STARTED|Overall Study||105
647408|NCT00000135|1588836|P1|STARTED|Overall Study||104
647409|NCT00000134|1588845|P3|NOT COMPLETED|Overall Study||0
647410|NCT00000134|1588846|P2|NOT COMPLETED|Overall Study||0
647411|NCT00000134|1588847|P1|NOT COMPLETED|Overall Study||0
647412|NCT00000134|1588845|P3|COMPLETED|Overall Study||96
647413|NCT00000134|1588846|P2|COMPLETED|Overall Study||94
647414|NCT00000134|1588847|P1|COMPLETED|Overall Study||89
647415|NCT00000134|1588845|P3|STARTED|Overall Study||96
647416|NCT00000134|1588846|P2|STARTED|Overall Study||94
647417|NCT00000134|1588847|P1|STARTED|Overall Study||89
647418|NCT00000125|1588857|P2|NOT COMPLETED|Overall Study||238
647419|NCT00000125|1588858|P1|NOT COMPLETED|Overall Study||239
647420|NCT00000125|1588857|P2|COMPLETED|Overall Study|Completed OHTS Phase 2, through March 2009|579
647421|NCT00000125|1588858|P1|COMPLETED|Overall Study|Completed OHTS Phase 2, through March 2009|580
647422|NCT00000125|1588857|P2|Completed OHTS Phase I, June 2002|Overall Study||702
647423|NCT00000125|1588858|P1|Completed OHTS Phase I, June 2002|Overall Study||706
647424|NCT00000125|1588857|P2|STARTED|Overall Study||817
647425|NCT00000125|1588858|P1|STARTED|Overall Study||819
647426|NCT03331315|1588866|P2|NOT COMPLETED|Overall Study||14
647427|NCT03331315|1588867|P1|NOT COMPLETED|Overall Study||18
647428|NCT03331315|1588866|P2|COMPLETED|Overall Study||68
647429|NCT03331315|1588867|P1|COMPLETED|Overall Study||70
647430|NCT03331315|1588866|P2|STARTED|Overall Study||82
647431|NCT03331315|1588867|P1|STARTED|Overall Study||88
647432|NCT03150485|1588887|P6|NOT COMPLETED|Overall Study||0
647433|NCT03150485|1588888|P5|NOT COMPLETED|Overall Study||0
647434|NCT03150485|1588889|P4|NOT COMPLETED|Overall Study||0
647435|NCT03150485|1588890|P3|NOT COMPLETED|Overall Study||0
647436|NCT03150485|1588891|P2|NOT COMPLETED|Overall Study||1
647437|NCT03150485|1588892|P1|NOT COMPLETED|Overall Study||0
647438|NCT03150485|1588887|P6|COMPLETED|Overall Study||1
647439|NCT03150485|1588888|P5|COMPLETED|Overall Study||2
647440|NCT03150485|1588889|P4|COMPLETED|Overall Study||5
647441|NCT03150485|1588890|P3|COMPLETED|Overall Study||4
647442|NCT03150485|1588891|P2|COMPLETED|Overall Study||8
647443|NCT03150485|1588892|P1|COMPLETED|Overall Study||2
647444|NCT03150485|1588887|P6|STARTED|Overall Study||1
647445|NCT03150485|1588888|P5|STARTED|Overall Study||2
647446|NCT03150485|1588889|P4|STARTED|Overall Study||5
647447|NCT03150485|1588890|P3|STARTED|Overall Study||4
647448|NCT03150485|1588891|P2|STARTED|Overall Study||9
647449|NCT03150485|1588892|P1|STARTED|Overall Study||2
647450|NCT03099096|1588907|P1|NOT COMPLETED|Overall Study||2
647451|NCT03099096|1588907|P1|COMPLETED|Overall Study||157
647452|NCT03099096|1588907|P1|STARTED|Overall Study||159
647453|NCT03050541|1588917|P3|NOT COMPLETED|Overall Study||8
647454|NCT03050541|1588918|P2|NOT COMPLETED|Overall Study||8
647455|NCT03050541|1588919|P1|NOT COMPLETED|Overall Study||8
647456|NCT03050541|1588917|P3|COMPLETED|Overall Study||20
647457|NCT03050541|1588918|P2|COMPLETED|Overall Study||20
647458|NCT03050541|1588919|P1|COMPLETED|Overall Study||20
647459|NCT03050541|1588917|P3|STARTED|Overall Study||28
647460|NCT03050541|1588918|P2|STARTED|Overall Study||28
647461|NCT03050541|1588919|P1|STARTED|Overall Study||28
647462|NCT02702921|1588932|P2|NOT COMPLETED|Overall Study||8
647463|NCT02702921|1588933|P1|NOT COMPLETED|Overall Study||14
647464|NCT02702921|1588932|P2|COMPLETED|Overall Study||95
647465|NCT02702921|1588933|P1|COMPLETED|Overall Study||84
647466|NCT02702921|1588932|P2|STARTED|Overall Study||103
647467|NCT02702921|1588933|P1|STARTED|Overall Study||98
647468|NCT02692560|1588943|P2|NOT COMPLETED|Overall Study||6
647469|NCT02692560|1588944|P1|NOT COMPLETED|Overall Study||0
647470|NCT02692560|1588943|P2|COMPLETED|Overall Study||25
647471|NCT02692560|1588944|P1|COMPLETED|Overall Study||29
647472|NCT02692560|1588943|P2|STARTED|Overall Study||31
647473|NCT02692560|1588944|P1|STARTED|Overall Study||29
647474|NCT02459418|1588966|P2|NOT COMPLETED|Overall Study||6
647475|NCT02459418|1588967|P1|NOT COMPLETED|Overall Study||8
647476|NCT02459418|1588966|P2|COMPLETED|Overall Study||15
647477|NCT02459418|1588967|P1|COMPLETED|Overall Study||13
647478|NCT02459418|1588966|P2|Received Second Treatment|Overall Study||15
647479|NCT02459418|1588967|P1|Received Second Treatment|Overall Study||13
647480|NCT02459418|1588966|P2|Received First Treatment|Overall Study||21
647481|NCT02459418|1588967|P1|Received First Treatment|Overall Study||21
647482|NCT02459418|1588966|P2|STARTED|Overall Study||21
647483|NCT02459418|1588967|P1|STARTED|Overall Study||21
647484|NCT02383472|1588989|P2|NOT COMPLETED|Overall Study||1
647485|NCT02383472|1588990|P1|NOT COMPLETED|Overall Study||1
647486|NCT02383472|1588989|P2|COMPLETED|Overall Study||29
647487|NCT02383472|1588990|P1|COMPLETED|Overall Study||22
647488|NCT02383472|1588989|P2|STARTED|Overall Study||30
647489|NCT02383472|1588990|P1|STARTED|Overall Study||23
647490|NCT02229227|1589006|P2|NOT COMPLETED|Overall Study||62
647491|NCT02229227|1589007|P1|NOT COMPLETED|Overall Study||51
647492|NCT02229227|1589006|P2|COMPLETED|Overall Study||350
647493|NCT02229227|1589007|P1|COMPLETED|Overall Study||351
647494|NCT02229227|1589006|P2|STARTED|Overall Study||412
647495|NCT02229227|1589007|P1|STARTED|Overall Study||402
647496|NCT02091869|1589092|P2|NOT COMPLETED|Overall Study||3
647497|NCT02091869|1589093|P1|NOT COMPLETED|Overall Study||0
647498|NCT02091869|1589092|P2|COMPLETED|Overall Study||14
647499|NCT02091869|1589093|P1|COMPLETED|Overall Study||17
647500|NCT02091869|1589092|P2|STARTED|Overall Study||17
647501|NCT02091869|1589093|P1|STARTED|Overall Study||17
647502|NCT02085785|1589107|P2|NOT COMPLETED|Overall Study||2
647503|NCT02085785|1589108|P1|NOT COMPLETED|Overall Study||2
647504|NCT02085785|1589107|P2|COMPLETED|Overall Study||6
647505|NCT02085785|1589108|P1|COMPLETED|Overall Study||5
647506|NCT02085785|1589107|P2|STARTED|Overall Study||8
647507|NCT02085785|1589108|P1|STARTED|Overall Study||7
647508|NCT01910181|1589120|P1|NOT COMPLETED|Overall Study||46
647509|NCT01910181|1589120|P1|COMPLETED|Overall Study||0
647510|NCT01910181|1589120|P1|Expansion Cohort|Overall Study||26
647511|NCT01910181|1589120|P1|PK Cohort|Overall Study||20
647512|NCT01910181|1589120|P1|STARTED|Overall Study||46
647513|NCT01833117|1589147|P2|NOT COMPLETED|Overall Study||0
647514|NCT01833117|1589148|P1|NOT COMPLETED|Overall Study||0
647515|NCT01833117|1589147|P2|COMPLETED|Overall Study||19
647516|NCT01833117|1589148|P1|COMPLETED|Overall Study||43
647517|NCT01833117|1589147|P2|STARTED|Overall Study||19
647518|NCT01833117|1589148|P1|STARTED|Overall Study||43
647519|NCT01816776|1589158|P2|NOT COMPLETED|Overall Study||8
647520|NCT01816776|1589159|P1|NOT COMPLETED|Overall Study||13
647521|NCT01816776|1589158|P2|COMPLETED|Overall Study||70
647522|NCT01816776|1589159|P1|COMPLETED|Overall Study||60
647523|NCT01816776|1589158|P2|6 Month Primary Effectiveness Assessed|Overall Study||73
647524|NCT01816776|1589159|P1|6 Month Primary Effectiveness Assessed|Overall Study||68
647525|NCT01816776|1589158|P2|STARTED|Overall Study||78
647526|NCT01816776|1589159|P1|STARTED|Overall Study||73
647527|NCT01733732|1589181|P2|NOT COMPLETED|Overall Study||0
647528|NCT01733732|1589182|P1|NOT COMPLETED|Overall Study||2
647529|NCT01733732|1589181|P2|COMPLETED|Overall Study||27
647530|NCT01733732|1589182|P1|COMPLETED|Overall Study||25
647531|NCT01733732|1589181|P2|STARTED|Overall Study||27
647532|NCT01733732|1589182|P1|STARTED|Overall Study||27
647533|NCT01733745|1589218|P2|NOT COMPLETED|Overall Study||0
647534|NCT01733745|1589219|P1|NOT COMPLETED|Overall Study||0
647535|NCT01733745|1589218|P2|COMPLETED|Overall Study||13
647536|NCT01733745|1589219|P1|COMPLETED|Overall Study||13
647537|NCT01733745|1589218|P2|STARTED|Overall Study||13
647538|NCT01733745|1589219|P1|STARTED|Overall Study||13
647539|NCT01702961|1589229|P1|NOT COMPLETED|Overall Study||47
647540|NCT01702961|1589229|P1|COMPLETED|Overall Study||28
647541|NCT01702961|1589229|P1|STARTED|Overall Study||75
647542|NCT01699087|1589235|P1|NOT COMPLETED|Overall Study||24
647543|NCT01699087|1589235|P1|COMPLETED|Overall Study||152
647544|NCT01699087|1589235|P1|Treated|Overall Study||161
647545|NCT01699087|1589235|P1|STARTED|Overall Study||176
647546|NCT01688726|1589251|P2|NOT COMPLETED|Overall Study||1
647547|NCT01688726|1589252|P1|NOT COMPLETED|Overall Study||1
647548|NCT01688726|1589251|P2|COMPLETED|Overall Study||44
647549|NCT01688726|1589252|P1|COMPLETED|Overall Study||45
647550|NCT01688726|1589251|P2|STARTED|Overall Study||45
647551|NCT01688726|1589252|P1|STARTED|Overall Study||46
647552|NCT01680783|1589266|P2|NOT COMPLETED|Overall Study||0
647553|NCT01680783|1589267|P1|NOT COMPLETED|Overall Study||0
647554|NCT01680783|1589266|P2|COMPLETED|Overall Study||44
647555|NCT01680783|1589267|P1|COMPLETED|Overall Study||39
647556|NCT01680783|1589266|P2|STARTED|Overall Study||44
647557|NCT01680783|1589267|P1|STARTED|Overall Study||39
647558|NCT01664923|1589275|P2|NOT COMPLETED|Overall Study||158
647559|NCT01664923|1589276|P1|NOT COMPLETED|Overall Study||93
647560|NCT01664923|1589275|P2|COMPLETED|Overall Study|Indicates participants continuing to receive treatment as of 09 February 2015.|40
647561|NCT01664923|1589276|P1|COMPLETED|Overall Study|Indicates participants continuing to receive treatment as of 09 February 2015.|105
647562|NCT01664923|1589275|P2|Received Study Treatment|Overall Study||198
647563|NCT01664923|1589276|P1|Received Study Treatment|Overall Study||197
647564|NCT01664923|1589275|P2|STARTED|Overall Study||198
647565|NCT01664923|1589276|P1|STARTED|Overall Study||198
647566|NCT01642407|1589294|P1|NOT COMPLETED|Overall Study||2
647567|NCT01642407|1589294|P1|COMPLETED|Overall Study||4
647568|NCT01642407|1589294|P1|STARTED|Overall Study||6
647569|NCT01638559|1589336|P1|NOT COMPLETED|Overall Study||0
647570|NCT01638559|1589336|P1|COMPLETED|Overall Study|Completion through the time of the primary endpoint.|88
647571|NCT01638559|1589336|P1|STARTED|Overall Study||88
647572|NCT01580410|1589342|P2|NOT COMPLETED|Overall Study||8
647573|NCT01580410|1589343|P1|NOT COMPLETED|Overall Study||11
647574|NCT01580410|1589342|P2|COMPLETED|Overall Study||60
647575|NCT01580410|1589343|P1|COMPLETED|Overall Study||57
647576|NCT01580410|1589342|P2|STARTED|Overall Study||68
647577|NCT01580410|1589343|P1|STARTED|Overall Study||68
647578|NCT01576276|1589357|P2|NOT COMPLETED|Overall Study||11
647579|NCT01576276|1589358|P1|NOT COMPLETED|Overall Study||8
647580|NCT01576276|1589357|P2|COMPLETED|Overall Study||18
647581|NCT01576276|1589358|P1|COMPLETED|Overall Study||14
647582|NCT01576276|1589357|P2|STARTED|Overall Study||29
647583|NCT01576276|1589358|P1|STARTED|Overall Study||22
647584|NCT01563913|1589367|P2|NOT COMPLETED|Overall Study||0
647585|NCT01563913|1589368|P1|NOT COMPLETED|Overall Study||2
647586|NCT01563913|1589367|P2|COMPLETED|Overall Study||15
647587|NCT01563913|1589368|P1|COMPLETED|Overall Study||13
647588|NCT01563913|1589367|P2|STARTED|Overall Study||15
647589|NCT01563913|1589368|P1|STARTED|Overall Study||15
647590|NCT01557959|1589378|P1|NOT COMPLETED|Overall Study||0
647591|NCT01557959|1589378|P1|COMPLETED|Overall Study||45
647592|NCT01557959|1589378|P1|STARTED|Overall Study||45
647593|NCT01547390|1589388|P2|NOT COMPLETED|Overall Study||10
647594|NCT01547390|1589389|P1|NOT COMPLETED|Overall Study||13
647595|NCT01547390|1589388|P2|COMPLETED|Overall Study||16
647596|NCT01547390|1589389|P1|COMPLETED|Overall Study||14
647597|NCT01547390|1589388|P2|STARTED|Overall Study||26
647598|NCT01547390|1589389|P1|STARTED|Overall Study||27
647599|NCT01529827|1589397|P1|NOT COMPLETED|Overall Study||0
647600|NCT01529827|1589397|P1|COMPLETED|Overall Study||94
647601|NCT01529827|1589397|P1|STARTED|Overall Study||94
647602|NCT01507662|1589406|P2|NOT COMPLETED|Overall Study||831
647603|NCT01507662|1589407|P1|NOT COMPLETED|Overall Study||816
647604|NCT01507662|1589406|P2|COMPLETED|Overall Study||3020
647605|NCT01507662|1589407|P1|COMPLETED|Overall Study||3082
647606|NCT01507662|1589406|P2|STARTED|Overall Study||3851
647607|NCT01507662|1589407|P1|STARTED|Overall Study||3898
647608|NCT01496066|1589415|P2|NOT COMPLETED|Overall Study||9
647609|NCT01496066|1589416|P1|NOT COMPLETED|Overall Study||12
647610|NCT01496066|1589415|P2|COMPLETED|Overall Study||188
647611|NCT01496066|1589416|P1|COMPLETED|Overall Study||391
647612|NCT01496066|1589415|P2|STARTED|Overall Study||197
647613|NCT01496066|1589416|P1|STARTED|Overall Study||403
647614|NCT01493024|1589439|P4|NOT COMPLETED|Overall Study||0
647615|NCT01493024|1589440|P3|NOT COMPLETED|Overall Study||0
647616|NCT01493024|1589441|P2|NOT COMPLETED|Overall Study||0
647617|NCT01493024|1589442|P1|NOT COMPLETED|Overall Study||0
647618|NCT01493024|1589439|P4|COMPLETED|Overall Study||24
647619|NCT01493024|1589440|P3|COMPLETED|Overall Study||24
647620|NCT01493024|1589441|P2|COMPLETED|Overall Study||12
647621|NCT01493024|1589442|P1|COMPLETED|Overall Study||30
647622|NCT01493024|1589439|P4|STARTED|Overall Study||24
647623|NCT01493024|1589440|P3|STARTED|Overall Study||24
647624|NCT01493024|1589441|P2|STARTED|Overall Study||12
647625|NCT01493024|1589442|P1|STARTED|Overall Study||30
647626|NCT01430741|1589520|P4|NOT COMPLETED|Overall Study||0
647627|NCT01430741|1589521|P3|NOT COMPLETED|Overall Study||10
647628|NCT01430741|1589522|P2|NOT COMPLETED|Overall Study||0
647629|NCT01430741|1589523|P1|NOT COMPLETED|Overall Study||0
647630|NCT01430741|1589520|P4|COMPLETED|Overall Study||81
647631|NCT01430741|1589521|P3|COMPLETED|Overall Study||37
647632|NCT01430741|1589522|P2|COMPLETED|Overall Study||87
647633|NCT01430741|1589523|P1|COMPLETED|Overall Study||22
647634|NCT01430741|1589520|P4|STARTED|Overall Study||81
647635|NCT01430741|1589521|P3|STARTED|Overall Study||47
647636|NCT01430741|1589522|P2|STARTED|Overall Study||87
647637|NCT01430741|1589523|P1|STARTED|Overall Study||22
647638|NCT01424189|1589555|P2|NOT COMPLETED|Overall Study||6
647639|NCT01424189|1589556|P1|NOT COMPLETED|Overall Study||13
647640|NCT01424189|1589555|P2|COMPLETED|Overall Study||182
647641|NCT01424189|1589556|P1|COMPLETED|Overall Study||373
647642|NCT01424189|1589555|P2|STARTED|Overall Study||188
647643|NCT01424189|1589556|P1|STARTED|Overall Study||386
647644|NCT01401907|1589570|P2|NOT COMPLETED|Overall Study||51
647645|NCT01401907|1589571|P1|NOT COMPLETED|Overall Study||57
647646|NCT01401907|1589570|P2|COMPLETED|Overall Study||124
647647|NCT01401907|1589571|P1|COMPLETED|Overall Study||118
647648|NCT01401907|1589570|P2|12 Week Outcomes|Overall Study||153
647649|NCT01401907|1589571|P1|12 Week Outcomes|Overall Study||148
647650|NCT01401907|1589570|P2|STARTED|Overall Study||175
647651|NCT01401907|1589571|P1|STARTED|Overall Study||175
647652|NCT01365845|1589589|P3|NOT COMPLETED|Treatment Phase||0
647653|NCT01365845|1589590|P2|NOT COMPLETED|Treatment Phase||0
647654|NCT01365845|1589591|P1|NOT COMPLETED|Treatment Phase||0
647655|NCT01365845|1589589|P3|COMPLETED|Treatment Phase||18
647656|NCT01365845|1589590|P2|COMPLETED|Treatment Phase||0
647657|NCT01365845|1589591|P1|COMPLETED|Treatment Phase||0
647658|NCT01365845|1589589|P3|STARTED|Treatment Phase||18
647659|NCT01365845|1589590|P2|STARTED|Treatment Phase||0
647660|NCT01365845|1589591|P1|STARTED|Treatment Phase||0
647661|NCT01365845|1589589|P3|NOT COMPLETED|Induction Phase||0
647662|NCT01365845|1589590|P2|NOT COMPLETED|Induction Phase||0
647663|NCT01365845|1589591|P1|NOT COMPLETED|Induction Phase||0
647664|NCT01365845|1589589|P3|COMPLETED|Induction Phase||0
647665|NCT01365845|1589590|P2|COMPLETED|Induction Phase||0
647666|NCT01365845|1589591|P1|COMPLETED|Induction Phase||18
647667|NCT01365845|1589589|P3|STARTED|Induction Phase||0
647668|NCT01365845|1589590|P2|STARTED|Induction Phase||0
647669|NCT01365845|1589591|P1|STARTED|Induction Phase||18
647670|NCT01361217|1589596|P1|NOT COMPLETED|Overall Study||0
647671|NCT01361217|1589596|P1|COMPLETED|Overall Study||10
647672|NCT01361217|1589596|P1|STARTED|Overall Study||10
647673|NCT01271803|1589614|P12|NOT COMPLETED|Stage 2||39
647674|NCT01271803|1589615|P11|NOT COMPLETED|Stage 2||27
647675|NCT01271803|1589616|P10|NOT COMPLETED|Stage 2||0
647676|NCT01271803|1589617|P9|NOT COMPLETED|Stage 2||0
647677|NCT01271803|1589618|P8|NOT COMPLETED|Stage 2||0
647678|NCT01271803|1589619|P7|NOT COMPLETED|Stage 2||0
647679|NCT01271803|1589620|P6|NOT COMPLETED|Stage 2||0
647680|NCT01271803|1589621|P5|NOT COMPLETED|Stage 2||0
647681|NCT01271803|1589622|P4|NOT COMPLETED|Stage 2||0
647682|NCT01271803|1589623|P3|NOT COMPLETED|Stage 2||0
647683|NCT01271803|1589624|P2|NOT COMPLETED|Stage 2||0
647684|NCT01271803|1589625|P1|NOT COMPLETED|Stage 2||0
647685|NCT01271803|1589614|P12|COMPLETED|Stage 2||0
647686|NCT01271803|1589615|P11|COMPLETED|Stage 2||0
647687|NCT01271803|1589616|P10|COMPLETED|Stage 2||0
647688|NCT01271803|1589617|P9|COMPLETED|Stage 2||0
647689|NCT01271803|1589618|P8|COMPLETED|Stage 2||0
647690|NCT01271803|1589619|P7|COMPLETED|Stage 2||0
647691|NCT01271803|1589620|P6|COMPLETED|Stage 2||0
647692|NCT01271803|1589621|P5|COMPLETED|Stage 2||0
647693|NCT01271803|1589622|P4|COMPLETED|Stage 2||0
647694|NCT01271803|1589623|P3|COMPLETED|Stage 2||0
647695|NCT01271803|1589624|P2|COMPLETED|Stage 2||0
647696|NCT01271803|1589625|P1|COMPLETED|Stage 2||0
647697|NCT01271803|1589614|P12|STARTED|Stage 2||39
647698|NCT01271803|1589615|P11|STARTED|Stage 2||27
647699|NCT01271803|1589616|P10|STARTED|Stage 2||0
647700|NCT01271803|1589617|P9|STARTED|Stage 2||0
647701|NCT01271803|1589618|P8|STARTED|Stage 2||0
647702|NCT01271803|1589619|P7|STARTED|Stage 2||0
647703|NCT01271803|1589620|P6|STARTED|Stage 2||0
647704|NCT01271803|1589621|P5|STARTED|Stage 2||0
647705|NCT01271803|1589622|P4|STARTED|Stage 2||0
647706|NCT01271803|1589623|P3|STARTED|Stage 2||0
647707|NCT01271803|1589624|P2|STARTED|Stage 2||0
647708|NCT01271803|1589625|P1|STARTED|Stage 2||0
647709|NCT01271803|1589614|P12|NOT COMPLETED|Stage 1||0
647710|NCT01271803|1589615|P11|NOT COMPLETED|Stage 1||0
647711|NCT01271803|1589616|P10|NOT COMPLETED|Stage 1||2
647712|NCT01271803|1589617|P9|NOT COMPLETED|Stage 1||5
647713|NCT01271803|1589618|P8|NOT COMPLETED|Stage 1||3
647714|NCT01271803|1589619|P7|NOT COMPLETED|Stage 1||4
647715|NCT01271803|1589620|P6|NOT COMPLETED|Stage 1||4
647716|NCT01271803|1589621|P5|NOT COMPLETED|Stage 1||4
647717|NCT01271803|1589622|P4|NOT COMPLETED|Stage 1||3
647718|NCT01271803|1589623|P3|NOT COMPLETED|Stage 1||27
647719|NCT01271803|1589624|P2|NOT COMPLETED|Stage 1||8
647720|NCT01271803|1589625|P1|NOT COMPLETED|Stage 1||5
647721|NCT01271803|1589614|P12|COMPLETED|Stage 1||0
647722|NCT01271803|1589615|P11|COMPLETED|Stage 1||0
647723|NCT01271803|1589616|P10|COMPLETED|Stage 1||0
647724|NCT01271803|1589617|P9|COMPLETED|Stage 1||0
647725|NCT01271803|1589618|P8|COMPLETED|Stage 1||0
647726|NCT01271803|1589619|P7|COMPLETED|Stage 1||0
647727|NCT01271803|1589620|P6|COMPLETED|Stage 1||0
647728|NCT01271803|1589621|P5|COMPLETED|Stage 1||0
647729|NCT01271803|1589622|P4|COMPLETED|Stage 1||0
647730|NCT01271803|1589623|P3|COMPLETED|Stage 1||0
647731|NCT01271803|1589624|P2|COMPLETED|Stage 1||0
647732|NCT01271803|1589625|P1|COMPLETED|Stage 1||0
647733|NCT01271803|1589614|P12|STARTED|Stage 1||0
647734|NCT01271803|1589615|P11|STARTED|Stage 1||0
647735|NCT01271803|1589616|P10|STARTED|Stage 1||2
647736|NCT01271803|1589617|P9|STARTED|Stage 1||5
647737|NCT01271803|1589618|P8|STARTED|Stage 1||3
647738|NCT01271803|1589619|P7|STARTED|Stage 1||4
647739|NCT01271803|1589620|P6|STARTED|Stage 1||4
647740|NCT01271803|1589621|P5|STARTED|Stage 1||4
647741|NCT01271803|1589622|P4|STARTED|Stage 1||3
647742|NCT01271803|1589623|P3|STARTED|Stage 1||27
647743|NCT01271803|1589624|P2|STARTED|Stage 1||8
647744|NCT01271803|1589625|P1|STARTED|Stage 1||5
647745|NCT01262365|1589799|P3|NOT COMPLETED|Overall Study||94
647746|NCT01262365|1589800|P2|NOT COMPLETED|Overall Study||81
647747|NCT01262365|1589801|P1|NOT COMPLETED|Overall Study||90
647748|NCT01262365|1589799|P3|COMPLETED|Overall Study||171
647749|NCT01262365|1589800|P2|COMPLETED|Overall Study||181
647750|NCT01262365|1589801|P1|COMPLETED|Overall Study||176
647751|NCT01262365|1589799|P3|STARTED|Overall Study||265
647752|NCT01262365|1589800|P2|STARTED|Overall Study||262
647753|NCT01262365|1589801|P1|STARTED|Overall Study||266
647754|NCT01261793|1589827|P3|NOT COMPLETED|Overall Study||82
647755|NCT01261793|1589828|P2|NOT COMPLETED|Overall Study||91
647756|NCT01261793|1589829|P1|NOT COMPLETED|Overall Study||85
647757|NCT01261793|1589827|P3|COMPLETED|Overall Study||184
647758|NCT01261793|1589828|P2|COMPLETED|Overall Study||171
647759|NCT01261793|1589829|P1|COMPLETED|Overall Study||178
647760|NCT01261793|1589827|P3|STARTED|Overall Study||266
647761|NCT01261793|1589828|P2|STARTED|Overall Study||262
647762|NCT01261793|1589829|P1|STARTED|Overall Study||263
647763|NCT01235910|1589852|P1|NOT COMPLETED|Overall Study||0
647764|NCT01235910|1589852|P1|COMPLETED|Overall Study||1
647765|NCT01235910|1589852|P1|STARTED|Overall Study||1
647766|NCT01228734|1589860|P2|NOT COMPLETED|Overall Study||8
647767|NCT01228734|1589861|P1|NOT COMPLETED|Overall Study||16
647768|NCT01228734|1589860|P2|COMPLETED|Overall Study||196
647769|NCT01228734|1589861|P1|COMPLETED|Overall Study||177
647770|NCT01228734|1589860|P2|Modified Safety Population|Overall Study||199
647771|NCT01228734|1589861|P1|Modified Safety Population|Overall Study|One subject was randomized to FOLFOX-4 group but received cetuximab + FOLFOX-4 treatment instead|194
647772|NCT01228734|1589860|P2|Modified Intent-to-treat (MITT) Populati|Overall Study||200
647773|NCT01228734|1589861|P1|Modified Intent-to-treat (MITT) Populati|Overall Study||193
647774|NCT01228734|1589860|P2|STARTED|Overall Study||204
647775|NCT01228734|1589861|P1|STARTED|Overall Study||193
647776|NCT01225055|1589878|P3|NOT COMPLETED|Overall Study||3
647777|NCT01225055|1589879|P2|NOT COMPLETED|Overall Study||2
647778|NCT01225055|1589880|P1|NOT COMPLETED|Overall Study||0
647779|NCT01225055|1589878|P3|COMPLETED|Overall Study||18
647780|NCT01225055|1589879|P2|COMPLETED|Overall Study||18
647781|NCT01225055|1589880|P1|COMPLETED|Overall Study||20
647782|NCT01225055|1589878|P3|STARTED|Overall Study||21
647783|NCT01225055|1589879|P2|STARTED|Overall Study||20
647784|NCT01225055|1589880|P1|STARTED|Overall Study||20
647785|NCT01170117|1589905|P2|NOT COMPLETED|Overall Study||20
647786|NCT01170117|1589906|P1|NOT COMPLETED|Overall Study||30
647787|NCT01170117|1589905|P2|COMPLETED|Overall Study||55
647788|NCT01170117|1589906|P1|COMPLETED|Overall Study||47
647789|NCT01170117|1589905|P2|STARTED|Overall Study||75
647790|NCT01170117|1589906|P1|STARTED|Overall Study||77
647791|NCT01040624|1589916|P2|NOT COMPLETED|Overall Study||0
647792|NCT01040624|1589917|P1|NOT COMPLETED|Overall Study||0
647793|NCT01040624|1589916|P2|COMPLETED|Overall Study||19
647794|NCT01040624|1589917|P1|COMPLETED|Overall Study||58
647795|NCT01040624|1589916|P2|STARTED|Overall Study||19
647796|NCT01040624|1589917|P1|STARTED|Overall Study||58
647797|NCT00957671|1589923|P1|NOT COMPLETED|Overall Study||0
647798|NCT00957671|1589923|P1|COMPLETED|Overall Study|15 subjects completed the treatment phase of the study.|15
647799|NCT00957671|1589923|P1|STARTED|Overall Study|15 subjects began the treatment phase.|15
647800|NCT00948675|1589982|P2|NOT COMPLETED|Overall Study||4
647801|NCT00948675|1589983|P1|NOT COMPLETED|Overall Study||7
647802|NCT00948675|1589982|P2|COMPLETED|Overall Study||175
647803|NCT00948675|1589983|P1|COMPLETED|Overall Study||175
647804|NCT00948675|1589982|P2|STARTED|Overall Study||179
647805|NCT00948675|1589983|P1|STARTED|Overall Study||182
647806|NCT00943436|1589999|P2|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0
647807|NCT00943436|1590000|P1|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0
647808|NCT00943436|1589999|P2|COMPLETED|Rest Session: 45 Minutes of Reading||10
647809|NCT00943436|1590000|P1|COMPLETED|Rest Session: 45 Minutes of Reading||10
647810|NCT00943436|1589999|P2|STARTED|Rest Session: 45 Minutes of Reading||10
647811|NCT00943436|1590000|P1|STARTED|Rest Session: 45 Minutes of Reading||10
647812|NCT00943436|1589999|P2|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0
647813|NCT00943436|1590000|P1|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0
647814|NCT00943436|1589999|P2|COMPLETED|Exercise Session: 45 Minutes of Activity||10
647815|NCT00943436|1590000|P1|COMPLETED|Exercise Session: 45 Minutes of Activity||10
647816|NCT00943436|1589999|P2|STARTED|Exercise Session: 45 Minutes of Activity||10
647817|NCT00943436|1590000|P1|STARTED|Exercise Session: 45 Minutes of Activity||10
647818|NCT00926380|1590023|P3|NOT COMPLETED|Year 2||5
647819|NCT00926380|1590024|P2|NOT COMPLETED|Year 2||2
647820|NCT00926380|1590025|P1|NOT COMPLETED|Year 2||2
647821|NCT00926380|1590023|P3|COMPLETED|Year 2||24
647822|NCT00926380|1590024|P2|COMPLETED|Year 2||28
647823|NCT00926380|1590025|P1|COMPLETED|Year 2||31
647824|NCT00926380|1590023|P3|STARTED|Year 2||29
647825|NCT00926380|1590024|P2|STARTED|Year 2||30
647826|NCT00926380|1590025|P1|STARTED|Year 2||33
647827|NCT00926380|1590023|P3|NOT COMPLETED|Year 1||1
647828|NCT00926380|1590024|P2|NOT COMPLETED|Year 1||1
647829|NCT00926380|1590025|P1|NOT COMPLETED|Year 1||0
647830|NCT00926380|1590023|P3|COMPLETED|Year 1||29
647831|NCT00926380|1590024|P2|COMPLETED|Year 1||30
647832|NCT00926380|1590025|P1|COMPLETED|Year 1||33
647833|NCT00926380|1590023|P3|STARTED|Year 1||30
647834|NCT00926380|1590024|P2|STARTED|Year 1||31
647835|NCT00926380|1590025|P1|STARTED|Year 1||33
647836|NCT00832637|1590033|P1|NOT COMPLETED|Overall Study||0
647837|NCT00832637|1590033|P1|COMPLETED|Overall Study||33
647838|NCT00832637|1590033|P1|STARTED|Overall Study||33
647839|NCT00832871|1590041|P1|NOT COMPLETED|Overall Study||0
647840|NCT00832871|1590041|P1|COMPLETED|Overall Study||4
647841|NCT00832871|1590041|P1|STARTED|Overall Study||4
647842|NCT00765375|1590047|P1|NOT COMPLETED|Overall Study||0
647843|NCT00765375|1590047|P1|COMPLETED|Overall Study||5
647844|NCT00765375|1590047|P1|STARTED|Overall Study||5
647845|NCT00743730|1590056|P3|NOT COMPLETED|Overall Study||5
647846|NCT00743730|1590057|P2|NOT COMPLETED|Overall Study||4
647847|NCT00743730|1590058|P1|NOT COMPLETED|Overall Study||5
647848|NCT00743730|1590056|P3|COMPLETED|Overall Study||28
647849|NCT00743730|1590057|P2|COMPLETED|Overall Study||30
647850|NCT00743730|1590058|P1|COMPLETED|Overall Study||22
647851|NCT00743730|1590056|P3|STARTED|Overall Study||33
647852|NCT00743730|1590057|P2|STARTED|Overall Study||34
647853|NCT00743730|1590058|P1|STARTED|Overall Study||27
647854|NCT00659360|1590069|P1|NOT COMPLETED|Overall Study||0
647855|NCT00659360|1590069|P1|COMPLETED|Overall Study||17
647856|NCT00659360|1590069|P1|STARTED|Overall Study||17
647857|NCT00596011|1590080|P2|NOT COMPLETED|Overall Study||10
647858|NCT00596011|1590081|P1|NOT COMPLETED|Overall Study||13
647859|NCT00596011|1590080|P2|COMPLETED|Overall Study||38
647860|NCT00596011|1590081|P1|COMPLETED|Overall Study||36
647861|NCT00596011|1590080|P2|STARTED|Overall Study||48
647862|NCT00596011|1590081|P1|STARTED|Overall Study||49
647863|NCT00549172|1590099|P2|NOT COMPLETED|Overall Study||0
647864|NCT00549172|1590100|P1|NOT COMPLETED|Overall Study||0
647865|NCT00549172|1590099|P2|COMPLETED|Overall Study||76
647866|NCT00549172|1590100|P1|COMPLETED|Overall Study||70
647867|NCT00549172|1590099|P2|STARTED|Overall Study||76
647868|NCT00549172|1590100|P1|STARTED|Overall Study||70
647869|NCT00484679|1590114|P1|NOT COMPLETED|Overall Study||3
647870|NCT00484679|1590114|P1|COMPLETED|Overall Study||15
647871|NCT00484679|1590114|P1|STARTED|Overall Study||18
647872|NCT00453388|1590122|P4|NOT COMPLETED|Overall Study||0
647873|NCT00453388|1590123|P3|NOT COMPLETED|Overall Study||0
647874|NCT00453388|1590124|P2|NOT COMPLETED|Overall Study||0
647875|NCT00453388|1590125|P1|NOT COMPLETED|Overall Study||0
647876|NCT00453388|1590122|P4|COMPLETED|Overall Study||0
647877|NCT00453388|1590123|P3|COMPLETED|Overall Study||1
647878|NCT00453388|1590124|P2|COMPLETED|Overall Study||5
647879|NCT00453388|1590125|P1|COMPLETED|Overall Study||0
647880|NCT00453388|1590122|P4|STARTED|Overall Study||0
647881|NCT00453388|1590123|P3|STARTED|Overall Study||1
647882|NCT00453388|1590124|P2|STARTED|Overall Study||5
647883|NCT00453388|1590125|P1|STARTED|Overall Study||0
647884|NCT00423488|1590149|P2|NOT COMPLETED|Overall Study||1
647885|NCT00423488|1590150|P1|NOT COMPLETED|Overall Study||5
647886|NCT00423488|1590149|P2|COMPLETED|Overall Study||50
647887|NCT00423488|1590150|P1|COMPLETED|Overall Study||37
647888|NCT00423488|1590149|P2|STARTED|Overall Study||51
647889|NCT00423488|1590150|P1|STARTED|Overall Study||42
647890|NCT00381966|1590156|P1|NOT COMPLETED|Overall Study||0
647891|NCT00381966|1590156|P1|COMPLETED|Overall Study||5
647892|NCT00381966|1590156|P1|STARTED|Overall Study||5
647893|NCT00266110|1590161|P1|NOT COMPLETED|Overall Study||7
647894|NCT00266110|1590161|P1|COMPLETED|Overall Study||10
647895|NCT00266110|1590161|P1|STARTED|Overall Study||17
647896|NCT00264849|1590167|P2|NOT COMPLETED|Overall Study||25
647897|NCT00264849|1590168|P1|NOT COMPLETED|Overall Study||22
647898|NCT00264849|1590167|P2|COMPLETED|Overall Study||106
647899|NCT00264849|1590168|P1|COMPLETED|Overall Study||253
647900|NCT00264849|1590167|P2|STARTED|Overall Study||131
647901|NCT00264849|1590168|P1|STARTED|Overall Study||275
647902|NCT00119392|1590200|P1|NOT COMPLETED|Overall Study||5
647903|NCT00119392|1590200|P1|COMPLETED|Overall Study||40
647904|NCT00119392|1590200|P1|STARTED|Overall Study||45
647905|NCT00090285|1590210|P6|NOT COMPLETED|Long-term Follow-up (EXT2)||203
647906|NCT00090285|1590211|P5|NOT COMPLETED|Long-term Follow-up (EXT2)||227
647907|NCT00090285|1590212|P4|NOT COMPLETED|Long-term Follow-up (EXT2)||0
647908|NCT00090285|1590213|P3|NOT COMPLETED|Long-term Follow-up (EXT2)||0
647909|NCT00090285|1590214|P2|NOT COMPLETED|Long-term Follow-up (EXT2)||0
647910|NCT00090285|1590215|P1|NOT COMPLETED|Long-term Follow-up (EXT2)||0
647911|NCT00090285|1590210|P6|COMPLETED|Long-term Follow-up (EXT2)||664
647912|NCT00090285|1590211|P5|COMPLETED|Long-term Follow-up (EXT2)||709
647913|NCT00090285|1590212|P4|COMPLETED|Long-term Follow-up (EXT2)||0
647914|NCT00090285|1590213|P3|COMPLETED|Long-term Follow-up (EXT2)||0
647915|NCT00090285|1590214|P2|COMPLETED|Long-term Follow-up (EXT2)||0
647916|NCT00090285|1590215|P1|COMPLETED|Long-term Follow-up (EXT2)||0
647917|NCT00090285|1590210|P6|STARTED|Long-term Follow-up (EXT2)|Not all eligible participants enrolled in LTFU (EXT2)|867
647918|NCT00090285|1590211|P5|STARTED|Long-term Follow-up (EXT2)|Not all eligible participants enrolled in LTFU (EXT2)|936
647919|NCT00090285|1590212|P4|STARTED|Long-term Follow-up (EXT2)||0
647920|NCT00090285|1590213|P3|STARTED|Long-term Follow-up (EXT2)||0
647921|NCT00090285|1590214|P2|STARTED|Long-term Follow-up (EXT2)||0
647922|NCT00090285|1590215|P1|STARTED|Long-term Follow-up (EXT2)||0
647923|NCT00090285|1590210|P6|NOT COMPLETED|Extension 1||0
647924|NCT00090285|1590211|P5|NOT COMPLETED|Extension 1||0
647925|NCT00090285|1590212|P4|NOT COMPLETED|Extension 1||1
647926|NCT00090285|1590213|P3|NOT COMPLETED|Extension 1||57
647927|NCT00090285|1590214|P2|NOT COMPLETED|Extension 1||0
647928|NCT00090285|1590215|P1|NOT COMPLETED|Extension 1||0
647929|NCT00090285|1590210|P6|COMPLETED|Extension 1||0
647930|NCT00090285|1590211|P5|COMPLETED|Extension 1||0
647931|NCT00090285|1590212|P4|COMPLETED|Extension 1||15
647932|NCT00090285|1590213|P3|COMPLETED|Extension 1||1041
647933|NCT00090285|1590214|P2|COMPLETED|Extension 1||0
647934|NCT00090285|1590215|P1|COMPLETED|Extension 1||0
647935|NCT00090285|1590210|P6|STARTED|Extension 1||0
647936|NCT00090285|1590211|P5|STARTED|Extension 1||0
647937|NCT00090285|1590212|P4|STARTED|Extension 1|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|16
647938|NCT00090285|1590213|P3|STARTED|Extension 1|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|1098
647939|NCT00090285|1590214|P2|STARTED|Extension 1||0
647940|NCT00090285|1590215|P1|STARTED|Extension 1||0
647941|NCT00090285|1590210|P6|NOT COMPLETED|Base Study Follow-up Period||0
647942|NCT00090285|1590211|P5|NOT COMPLETED|Base Study Follow-up Period||0
647943|NCT00090285|1590212|P4|NOT COMPLETED|Base Study Follow-up Period||0
647944|NCT00090285|1590213|P3|NOT COMPLETED|Base Study Follow-up Period||0
647945|NCT00090285|1590214|P2|NOT COMPLETED|Base Study Follow-up Period||342
647946|NCT00090285|1590215|P1|NOT COMPLETED|Base Study Follow-up Period||335
647947|NCT00090285|1590210|P6|COMPLETED|Base Study Follow-up Period||0
647948|NCT00090285|1590211|P5|COMPLETED|Base Study Follow-up Period||0
647949|NCT00090285|1590212|P4|COMPLETED|Base Study Follow-up Period||0
647950|NCT00090285|1590213|P3|COMPLETED|Base Study Follow-up Period||0
647951|NCT00090285|1590214|P2|COMPLETED|Base Study Follow-up Period||1479
647952|NCT00090285|1590215|P1|COMPLETED|Base Study Follow-up Period||1487
647953|NCT00090285|1590210|P6|STARTED|Base Study Follow-up Period||0
647954|NCT00090285|1590211|P5|STARTED|Base Study Follow-up Period||0
647955|NCT00090285|1590212|P4|STARTED|Base Study Follow-up Period||0
647956|NCT00090285|1590213|P3|STARTED|Base Study Follow-up Period||0
647957|NCT00090285|1590214|P2|STARTED|Base Study Follow-up Period|7 subjects who did not receive 3 doses of placebo in base study continued into the Follow-up Period|1821
647958|NCT00090285|1590215|P1|STARTED|Base Study Follow-up Period|4 subjects who did not receive 3 doses of vaccine in base study continued into the Follow-up Period|1822
647959|NCT00090285|1590210|P6|NOT COMPLETED|Base Study Vaccination Period||0
647960|NCT00090285|1590211|P5|NOT COMPLETED|Base Study Vaccination Period||0
647961|NCT00090285|1590212|P4|NOT COMPLETED|Base Study Vaccination Period||0
647962|NCT00090285|1590213|P3|NOT COMPLETED|Base Study Vaccination Period||0
647963|NCT00090285|1590214|P2|NOT COMPLETED|Base Study Vaccination Period||219
647964|NCT00090285|1590215|P1|NOT COMPLETED|Base Study Vaccination Period||214
647965|NCT00090285|1590210|P6|COMPLETED|Base Study Vaccination Period||0
647966|NCT00090285|1590211|P5|COMPLETED|Base Study Vaccination Period||0
647967|NCT00090285|1590212|P4|COMPLETED|Base Study Vaccination Period||0
647968|NCT00090285|1590213|P3|COMPLETED|Base Study Vaccination Period||0
647969|NCT00090285|1590214|P2|COMPLETED|Base Study Vaccination Period||1814
647970|NCT00090285|1590215|P1|COMPLETED|Base Study Vaccination Period||1818
647971|NCT00090285|1590210|P6|Vaccinated|Base Study Vaccination Period||0
647972|NCT00090285|1590211|P5|Vaccinated|Base Study Vaccination Period||0
647973|NCT00090285|1590212|P4|Vaccinated|Base Study Vaccination Period||0
647974|NCT00090285|1590213|P3|Vaccinated|Base Study Vaccination Period||0
647975|NCT00090285|1590214|P2|Vaccinated|Base Study Vaccination Period||2030
647976|NCT00090285|1590215|P1|Vaccinated|Base Study Vaccination Period||2025
647977|NCT00090285|1590210|P6|STARTED|Base Study Vaccination Period||0
647978|NCT00090285|1590211|P5|STARTED|Base Study Vaccination Period||0
647979|NCT00090285|1590212|P4|STARTED|Base Study Vaccination Period||0
647980|NCT00090285|1590213|P3|STARTED|Base Study Vaccination Period||0
647981|NCT00090285|1590214|P2|STARTED|Base Study Vaccination Period||2033
647982|NCT00090285|1590215|P1|STARTED|Base Study Vaccination Period||2032
647983|NCT00078559|1590250|P1|NOT COMPLETED|Overall Study||0
647984|NCT00078559|1590250|P1|COMPLETED|Overall Study|1 subject stopped study drug due to a severe but non-serious AE, and completed the trial|10
647985|NCT00078559|1590250|P1|STARTED|Overall Study||10
